<SEC-DOCUMENT>0001656472-21-000009.txt : 20210226
<SEC-HEADER>0001656472-21-000009.hdr.sgml : 20210226
<ACCEPTANCE-DATETIME>20210226073427
ACCESSION NUMBER:		0001656472-21-000009
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		160
CONFORMED PERIOD OF REPORT:	20201231
FILED AS OF DATE:		20210226
DATE AS OF CHANGE:		20210226

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cronos Group Inc.
		CENTRAL INDEX KEY:			0001656472
		STANDARD INDUSTRIAL CLASSIFICATION:	MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			A6
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38403
		FILM NUMBER:		21683795

	BUSINESS ADDRESS:	
		STREET 1:		111 PETER STREET
		STREET 2:		SUITE 300
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M5V 2H1
		BUSINESS PHONE:		(416) 504-0004

	MAIL ADDRESS:	
		STREET 1:		111 PETER STREET
		STREET 2:		SUITE 300
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M5V 2H1

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PharmaCan Capital Corp.
		DATE OF NAME CHANGE:	20151021
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>cron-20201231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:7f6b4332-a8eb-41ec-8082-7450606ea80c,g:9b8782dc-b83f-424a-b83c-bbf680d16be6,d:1ae9134e40e74e0aac958218112e53d4--><html xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml" xmlns:cron="http://thecronosgroup.com/20201231" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>cron-20201231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF80L2ZyYWc6ZGRlNDQ1ZWQxMzExNDBmOGJiZmYwMWVlYmM5OTgxY2EvdGFibGU6NmJiZWM2M2JjNjc5NDczZmJkNDk0ZjhmNjBkZmE4ZTYvdGFibGVyYW5nZTo2YmJlYzYzYmM2Nzk0NzNmYmQ0OTRmOGY2MGRmYThlNl8xLTEtMS0xLTA_20497f22-0134-42d3-b411-5ef8e671317c">false</ix:nonNumeric><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF80L2ZyYWc6ZGRlNDQ1ZWQxMzExNDBmOGJiZmYwMWVlYmM5OTgxY2EvdGFibGU6NmJiZWM2M2JjNjc5NDczZmJkNDk0ZjhmNjBkZmE4ZTYvdGFibGVyYW5nZTo2YmJlYzYzYmM2Nzk0NzNmYmQ0OTRmOGY2MGRmYThlNl80LTEtMS0xLTA_2ac61f07-d94f-45a1-81f1-de2346777622">2020</ix:nonNumeric><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF80L2ZyYWc6ZGRlNDQ1ZWQxMzExNDBmOGJiZmYwMWVlYmM5OTgxY2EvdGFibGU6NmJiZWM2M2JjNjc5NDczZmJkNDk0ZjhmNjBkZmE4ZTYvdGFibGVyYW5nZTo2YmJlYzYzYmM2Nzk0NzNmYmQ0OTRmOGY2MGRmYThlNl81LTEtMS0xLTA_436bc080-423a-4cf8-9b24-eb855df6e6b5">FY</ix:nonNumeric><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF80L2ZyYWc6ZGRlNDQ1ZWQxMzExNDBmOGJiZmYwMWVlYmM5OTgxY2EvdGFibGU6NmJiZWM2M2JjNjc5NDczZmJkNDk0ZjhmNjBkZmE4ZTYvdGFibGVyYW5nZTo2YmJlYzYzYmM2Nzk0NzNmYmQ0OTRmOGY2MGRmYThlNl80LTEtMS0xLTM4NzY0_5bb0af61-a0c4-4db4-b7e5-6b730cc757ff">0001656472</ix:nonNumeric><ix:nonNumeric contextRef="i1cc8285673b64efc88c9004fdefdd8ad_D20200329-20200329" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90ZXh0cmVnaW9uOmU2MTQ3ODYxMTRhYTRjMmZiZWJkNjc4NjJjOWJjZDRhXzEyNjQ0MzgzODQxMzQy_918fcba7-c0e8-4f1e-a169-2b708f363c2a">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="i49297061d43f400ab77a586292c85f22_D20170101-20171231" name="us-gaap:AccountingStandardsUpdateExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDkvZnJhZzpiYmUxMjVjMjMzNWM0NTEzYjlmZGRjMGY4Y2MyNGIzMi90YWJsZTpjODNhYjhiMmI3MTA0YzA1OTBmMzdlMWEwY2RiNWU5Zi90YWJsZXJhbmdlOmM4M2FiOGIyYjcxMDRjMDU5MGYzN2UxYTBjZGI1ZTlmXzMtMC0xLTEtMA_f0ab88a4-f8e8-45c9-b06f-6577993eb9f0">us-gaap:AccountingStandardsUpdate201601Member</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="ib73cebd3d2c240138864cc3020dbb490_D20200131-20200131" decimals="4" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNzA0L2ZyYWc6NjhmMWY0NTIyZTA1NGIyMzhkMzY3OWRiMmY1MTM5ZTEvdGV4dHJlZ2lvbjo2OGYxZjQ1MjJlMDU0YjIzOGQzNjc5ZGIyZjUxMzllMV84MjQ2MzM3MjA4NTk2_dae13543-228b-4498-b030-244272ff3603">.3333</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i8e07a9cae5c34baeaf7df90ffc19aec5_D20210623-20210623" decimals="4" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNzA0L2ZyYWc6NjhmMWY0NTIyZTA1NGIyMzhkMzY3OWRiMmY1MTM5ZTEvdGV4dHJlZ2lvbjo2OGYxZjQ1MjJlMDU0YjIzOGQzNjc5ZGIyZjUxMzllMV84MjQ2MzM3MjA4NjA5_edb87455-e805-4e59-923c-cf5f165e974f">.3333</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i1d5044d0f0bb4edf9f8a4a948776591c_D20221223-20221223" decimals="4" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNzA0L2ZyYWc6NjhmMWY0NTIyZTA1NGIyMzhkMzY3OWRiMmY1MTM5ZTEvdGV4dHJlZ2lvbjo2OGYxZjQ1MjJlMDU0YjIzOGQzNjc5ZGIyZjUxMzllMV84MjQ2MzM3MjA4NjIy_ae9b14b1-d844-46f1-8f4a-2a21df7bcce8">.3333</ix:nonFraction></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="cron-20201231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i3f1a6d5f4cc14d9da49468102df7fa77_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i05bcebde49834f16a2e8b37499a65600_I20210225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-02-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79fc16ab48f54844a8d5db79a213fc23_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i0451ae32e2d74c6a81c9a1a7d77aea12_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ea5ff615f724f79bc76ea60e882c0d6_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b21d84a8da64ac182924657011dc8f4_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i603e76f89c54407a82af75f4644d6617_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia83e6fe889b142c1b548d3c600ce2460_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb4bf06122354c15966cf5343aa018a5_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85e3d76bfda8415b975e00befcd9609f_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie73bc389412d48679e51974a3e1e0968_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0a8816e9f004feb8e54373b3e932949_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i005d23eef9f84c3993929eefb19a4d19_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96223c9bb10341f4b0f7ca7353171f06_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98a40ef3bd8f4cb7b68cb5bc1907a1e9_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92c8255933de4ada9ebce878a6a77405_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7206d1e564f417f9935a0aca534849a_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f1cb8c6e56c4c8cb1070c81364c66b2_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6bfe263ed9524742b183ccc53bcccba1_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9717dc3b24b24c93ab09a6bfa9b52c89_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6aa79556c9a24064ab5ea55845f31f79_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic77af0ad2ca04f71b6c632243f35b62b_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c3d39b0ddc3421a9ef11be927b7c69c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1710fca0e7c4f9e87a86725cf4c48ff_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6981b713441d4cea8f87dda3a39ac2be_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46c33a2743a34787aa9be59e8b743b3c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8918c1f902e543639e6e68f052bbd4cf_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic63015dad62149c8b50e40927b2c91c6_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6461d38acec49bd9d6a716a38310029_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i713e37bc833e40c3bea5015df9213308_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3783dc27237d46f6944e1a9a6f65eee6_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63eed3a7d9e2479d9b72e7dbc2a9f719_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15d5bb5d21934b388dac2f68df18d863_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3a267e3ba2b422fb71cbfeef4f71c1d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9981ea6f70b413c8a8fed8d7848ea09_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie01b46877add4dd9bb362674520540d1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb8296c494cb4a6a89b362beeaebb94d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f46a47fa0d44ffa9cc475bb9cb26b30_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief7afcb557114192867857af1fa9165f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05ebae3e5a2040bca90eca82e1a3f75f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e0536e1b0794acda99e2177b6ebf26b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cron:AltriaInvestmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7926d13ed9d346928f338c20da686971_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cron:AltriaInvestmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia490cd7402e84baa81df3299a30e84ee_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cron:AltriaInvestmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb90674122f048f78e4d13f37583db9f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cron:BoughtDealOfferingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id725b798c0734bb0a1f1ef33fa132b50_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cron:BoughtDealOfferingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d7cc358c6d64ac19ef8563642446a56_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cron:BoughtDealOfferingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="continent"><xbrli:measure>cron:continent</xbrli:measure></xbrli:unit><xbrli:unit id="brand"><xbrli:measure>cron:brand</xbrli:measure></xbrli:unit><xbrli:unit id="venture"><xbrli:measure>cron:venture</xbrli:measure></xbrli:unit><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i4a854431fb9b495d990aeb067616e389_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosAustraliaLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaedfffab0889492f9c3a60cc78052b32_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cron:CronosIsraelG.S.CultivationsLtd.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i842d385ef42842f5ab91f806ff707433_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cron:CronosIsraelG.S.ManufacturingLtd.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d2b8fcd2f794ec98a558ecf3b27cad4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cron:CronosIsraelG.S.StoreLtd.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1088995f87474d32a8345b0ab39da192_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cron:CronosIsraelG.S.PharmaciesLtd.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2c359ba7b8e4d8cbaea40e6357f543e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i375653de490b4cb88d420b09780d16c9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cron:EnterpriseResourcePlanningSystemMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia97ce75b78b64b17b8c28f247df84a87_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b7cbfec44e1446b940a0588b9f08928_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia73a44b4f86a4aca8cc66989d375acd5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i318609520df948a58aa2a7750e70dc8f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2fa479bb16aa46068e50c07bb76855c0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="reportingunit"><xbrli:measure>cron:reportingUnit</xbrli:measure></xbrli:unit><xbrli:context id="i10a83eea249e41e6b2c310a65280d58b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">cron:InventoryDryCannabisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i96b88f05fde54eb48391a625a3fd6392_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">cron:InventoryDryCannabisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i233dc0b62902408388edf4319b001461_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">cron:InventoryCannabisExtractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25af40180a094722bba3ac7b711fb022_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">cron:InventoryCannabisExtractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d186ec4178c4ab29fa3a2fa261a681f_D20180614-20180614"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-06-14</xbrli:startDate><xbrli:endDate>2018-06-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01dfe784ae954e5eabcb9849e4771b50_D20180313-20180313"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:MedMenCanadaInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-03-13</xbrli:startDate><xbrli:endDate>2018-03-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff55fd87547140e8bb2f3c7af7f88e71_D20180313-20180313"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:MedMenCanadaInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-03-13</xbrli:startDate><xbrli:endDate>2018-03-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08aaf1da351148dabbc15473a8372493_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:NatuEraMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="ils"><xbrli:measure>iso4217:ILS</xbrli:measure></xbrli:unit><xbrli:context id="if0ba41d1bbbd4426a1cae1e0e667c052_I20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CannasoulCollaborationLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CannasoulAnalyticsLtdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06abbbd3d08f420c89556e2d722f7d0a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CannasoulCollaborationLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CannasoulAnalyticsLtdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia530bf80f98848218e4aca2d29c92f27_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CannasoulCollaborationLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CannasoulAnalyticsLtdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i520015d24dc64ccb873f3a7698adf8e8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CannasoulAnalyticsLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1992c389e83f4ed89ee4289b28705c96_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosAustraliaLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i613b07197744400cbbef2fbf605f0d54_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosAustraliaLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i291f9ace020d4518924413d4644527d9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb8971bbe440425c985b311295f2cec9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief35f4e5e0e14975afdc16c2f8b07671_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i578db4ab78c04e03aee4c102f9d17cfe_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:NatuEraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe5479ec3fef4f42a9772f4fad66332d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:NatuEraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i943c6ce876d74af98e5d66bae1d75dd5_D20191025-20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">cron:CronosAustraliaLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-25</xbrli:startDate><xbrli:endDate>2019-10-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="audPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:AUD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="iaa56b775900347199fb903e36ef60844_I20191025"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">cron:CronosAustraliaLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-10-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a335245090a41f88ff82b8dceb50377_D20191106-20191106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosAustraliaLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-06</xbrli:startDate><xbrli:endDate>2019-11-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i958145f694ac404a80377bba4d961f2a_D20191107-20191107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosAustraliaLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-07</xbrli:startDate><xbrli:endDate>2019-11-07</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="cad"><xbrli:measure>iso4217:CAD</xbrli:measure></xbrli:unit><xbrli:context id="ia7faa2556fad44d4a177d4471c6fe14f_D20200925-20200925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-25</xbrli:startDate><xbrli:endDate>2020-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac8ed3a0468448b59a2da8d6539912f4_I20200925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">cron:CronosGroupInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6006e9a66ec247e5977546ab36704286_I20200925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">cron:MucciMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3c92d00b15c48db9d6e48e737227b0a_D20200925-20200925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">cron:MucciMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-25</xbrli:startDate><xbrli:endDate>2020-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9154570513a2434988aa789c0e451da8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:WhistlerMedicalMarijuanaCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i311f8f928bf84db9989bd0476ea75d2c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:WhistlerMedicalMarijuanaCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4403f97e12eb42dd960878337546ae3b_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:WhistlerMedicalMarijuanaCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i295d7b236249421daadace6736fa6dc7_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosAustraliaLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f0e3243c9c049d9bd4653b87b8b4c8a_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosAustraliaLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4252dcfecff4dad93552572230a33b7_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosAustraliaLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06e71f94f83b4681be053f1be423964a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib057cdc4d573476488dcb0661bea31b4_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idfa1e87dd5eb46d78d7da772e2d321bf_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i439b30240d69471792a73a83983aafc9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:MedMenCanadaInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25b4f750539544e98240240c6d96fdc8_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:MedMenCanadaInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9757b53f9bf46aeb73a8053c24786e3_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:MedMenCanadaInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie83a15c30f9b4a8288e090fa665f59d3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:NatuEraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15402ae419444f8291523f27c01226c3_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:NatuEraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieac8a1e4f6ea44899784210564e39358_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:NatuEraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd770601469e44b7b5851f0d7ecea847_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic97e88f092994ad5852be234c493283e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c04b01268f0440ca315cf7bd0d79262_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i62efa1de276f4f6f96606236e0b99714_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb34982583f74b8dac9d2bae655597ac_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic600db9d0b4e488aa9a037277f7ff27f_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6f2e75489a8480f95612249b17b7e5d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:MedMenCanadaInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i056cd5603b3a4298a98af34735228c93_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:MedMenCanadaInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec6bf60d93124adcb6973cf1ba60f17f_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:MedMenCanadaInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07f4be74463d40aebfc7310e82d1c3a4_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc08a58aedc6433cab75cda9cb8d60e1_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosAustraliaLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iefbc11d906474a07a4a0e90e2eb80824_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:NatuEraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="aud"><xbrli:measure>iso4217:AUD</xbrli:measure></xbrli:unit><xbrli:context id="i7de2974205334c71b88361a4a5309899_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosAustraliaLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i742245ee0f214dceb6821001350fd31d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76e00c36f9dd4ecfbf011fe23eac8c61_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:MedMenCanadaInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic86c74eeef9d4c4f9ebc178e09fd7f92_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:MedMenCanadaInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ac21cf5e6b74695a68d659200d9510c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:NatuEraMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8507622f9454b6d8fc0ba0f6058f27c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosAustraliaLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica49af07e43e4dacb2f47f79e38bcf20_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosAustraliaLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2888e238471544cfb7ff8479ad7e82f6_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51188c76d4fe446caa292dafb0517e9f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d96cfff4a7d4ff6a748326af07ca595_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:MedMenCanadaInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d40be89af3b4e0497c3ad54f82f4d44_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:MedMenCanadaInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2575ae85f47848a3b4e481731644b697_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:NatuEraMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5676c3dd147d44a9a8304b45e044a905_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:NatuEraMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc5472b8d3034929a878ea801fa0b849_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CanopyGrowthCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d744562089b40b9827f8e55fbe1e1a6_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CanopyGrowthCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7452ef8eb84342d198c51755bf9c43a4_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CanopyGrowthCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28dbe3b3d492406b844fa6b2d587faa3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:VivoCannabisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1f2f8d063e648d79b58979418dad94b_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:VivoCannabisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifecc77aba9d94529a80a42fc9ce8c7af_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:VivoCannabisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7d82a0c5320482da6d4bbdd7fd59a72_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:VivoCannabisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb82fe39a45a48b684579d0e259b1be9_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:VivoCannabisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i410fb06923684e30987bfd057a982f23_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:VivoCannabisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if177335bf723452a9e53b5cbb69619d9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:WhistlerMedicalMarijuanaCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iafde73babf68415aa902c6377f960aed_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:WhistlerMedicalMarijuanaCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94d61440c397433cae44d842da3ca067_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:WhistlerMedicalMarijuanaCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3633b0f773a4aaea9ea7b4dab12ca13_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:AuroraCannabisInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i253fd691295241ea93a2245f1f94a988_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:AuroraCannabisInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3cddb3f9929c453995ab712b0ead8198_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:AuroraCannabisInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibae6d945308c4710b0b167839c583e5e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i146b3a1d69a94438a07f9724ab5410a5_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2c79796c87c4829ad1e5b4215e49867_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i02c8c20a53a14d20b68fae9142fac983_D20190304-20190304"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:WhistlerMedicalMarijuanaCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-04</xbrli:startDate><xbrli:endDate>2019-03-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i545d2eedc49b488a858211c0dfae5d9e_D20190304-20190304"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:AuroraCannabisInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-04</xbrli:startDate><xbrli:endDate>2019-03-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b816c5b52b043c8a33c4048ab073bc3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:NatuEraSeriesALoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic325dca9bc664509ab8e9daef0295626_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:NatuEraSeriesALoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5835cd4e2e1344e38bcc3bdeeb97d893_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CronosGrowCoCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d58e7e380fd4928a5a4aaf66fb7fa7d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CronosGrowCoCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia3dd9320d6fb49b8af36a67921315f6a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i08888a921a2b4c88b691257e4ea48e15_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6cf7bda411034052a94e3326aff296d1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:A2645485OntarioInc.MucciPromissoryNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b017704f622466f9bd013c4ae05afcc_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:A2645485OntarioInc.MucciPromissoryNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idedac3c668174711a1ce0d5786afbad3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CannasoulCollaborationLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i039760a0355f48f39de64bb56dd8ac81_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CannasoulCollaborationLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7999a4c04ba7440fac47582ee604719d_I20200724"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:NatuEraSeriesALoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41bfa3763a044d118326791c2cd608f4_I20200724"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:NatuEraSeriesALoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">cron:NatuEraMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb88f981f5fb4f0f99e4f3ce4df9e544_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:NatuEraSeriesALoanShareOfNetLossInExcessOfCarryingValueOfEquityInvestmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0cb79bd1f7294820b3cd4e80384aad34_I20190823"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CronosGrowCoCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i499c1e4218d94789b4afa9918d59c37c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">cron:MucciMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:OwnershipAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6677966de35472db8717afeb11c793f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CronosGrowCoCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4799e1f980174942a3388f2d435ce38c_I20190628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:A2645485OntarioInc.MucciPromissoryNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14e23009552044f48cea9a365ae91305_D20190628-20190628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:A2645485OntarioInc.MucciPromissoryNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-06-28</xbrli:startDate><xbrli:endDate>2019-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice5cd225a5a048c281f6386df823c5e3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CannasoulCollaborationLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CannasoulAnalyticsLtdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b043767918a43bfb738d4382571bc3f_D20200401-20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CannasoulCollaborationLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CannasoulAnalyticsLtdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if184b5d95d6e4a88b9063285a8977d46_I20190123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">cron:NonrevolvingTermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cron:CreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-01-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if5da93e8c4dd43b293a795770578b760_D20190123-20190123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cron:ConstructionLoanAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-23</xbrli:startDate><xbrli:endDate>2019-01-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5866afdb41147fba8fa4b3c1ae2fe9d_I20190308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">cron:NonrevolvingTermLoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cron:CreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6db5a3fb2eca4f54b3f90ed1c036dd12_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77c5346ffc2148c0ac4a76f63497a058_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4bd7ce9c19347cdabdc7ac598cb48de_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b7a48365daf408b8997db5c9fdc8a02_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43d67eea34364b749f11c14c15ff8a38_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d514a8da3584157b13f718b5294267b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03c20e15ec0844f8b17b6c80bb9144ce_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d68a5e2b3a0451ab19ab24066e538cd_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i78a071bcbe99463dbb1b5de598353925_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4486ec909cf8480e89364e36b9c8e464_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7d7511be19f4566915140061bc540f6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31a70e4a512044509cf0a927b6ac5a19_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d156ad77f3343718374ed5a6b20465b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib956a338fe1b4ef1a233bc83863cd2d7_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98f184049ae04decbb7e65d448f5eb64_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i08692c3f18fd499fb735fa6f9fa77a18_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cron:EnterpriseResourcePlanningSystemMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id267d45c88934cce96716b0f18048fbe_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cron:HealthCanadaLicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9aeeb3005af2414fbdd7f3f51ba719bb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cron:HealthCanadaLicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibad4f60fad3c4471be8a1d5e1b4b06a2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibae3047412c74ad68bb7c95a00bd81b4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib297b22398ba4d26b972d07a65be9bdc_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cron:IsraeliCodesLicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5d86bf348094cd8bbbbd47d7e3b937d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cron:IsraeliCodesLicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44555a708248410d80d185e52bcf7004_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i279d9d5ab1e349069775769d0b1a44cd_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82c727c670f445f4ab85163fb46012f1_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cron:HealthCanadaLicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i921bbe51679241a68d142cd32305f8a5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cron:HealthCanadaLicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i708ebd12fa8d48aeaf171672ac0bad61_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77ad87a86ffb4a1c94f873eac114b479_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d88b9a8d8e34abdb2c9b7c1bade37bb_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cron:IsraeliCodesLicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e89cc544d3a428ab893432457341368_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cron:IsraeliCodesLicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i857a1897462542f5aca388daf1e74bbf_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2206069e8cc487aab61dab193148424_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cron:PeaceNaturalsReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d3d1ba25f2b4f858447fd45bdf8fbad_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cron:PeaceNaturalsReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8633af9ced72481c8087e79d244f37b7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cron:PeaceNaturalsReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d4ddac5384e48eabee1565aa6cc8a56_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cron:RedwoodReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b13dbcbacfa4879b6f7704dc73f8b29_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cron:RedwoodReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97b06a548fbf4c0cb61a9ab4fcb38d94_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cron:RedwoodReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i62037cbff1aa4252b5cdebcd407fdc1b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cron:BuildingAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7021697d1b94f34b3b9af2716c9a683_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cron:BuildingAndEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa29b1acea664089973579f536d4f49c_D20190308-20190308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cron:AltriaInvestmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-08</xbrli:startDate><xbrli:endDate>2019-03-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="warrant"><xbrli:measure>cron:warrant</xbrli:measure></xbrli:unit><xbrli:context id="i0da6f2ce11e0487499370eb2e182ebf5_D20190308-20190308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-08</xbrli:startDate><xbrli:endDate>2019-03-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib551b9ef8b1d44bcb1db52c16b0f3d77_I20190308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">cron:AltriaGroupInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGroupInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i082bd82cec0746e98c728d8765ac235d_I20190308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">cron:AltriaGroupInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i300b4ad7da784a87a26c8cffe4e5d5c3_I20190308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaInvestmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c2ebabdbc694319b460f7822a98d7ec_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaInvestmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="cadPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:CAD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="if23fc6b156434a4ea635f81fa026311f_I20190308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4aa0595f97de4e99a81b71038dd7e232_I20190308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8b72a5bd98248bea7f4df55a0f96261_D20190308-20190308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-08</xbrli:startDate><xbrli:endDate>2019-03-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b2888ee861546ac8f47f813f636ea76_I20190308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b76c45a8a2b4fbaacb62e55f214d2cf_D20190309-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-09</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i463b1771900c4b5f931730e913e28045_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia99e808e67ba45ec9755b053b88b09fe_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i160db6daa81f47e891c5d92e0c029c65_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27204cc81d264a0baff5a5819c885fff_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i865f9c6470f14034b9c3aa9527060924_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i23e679f22ae84a519b217df003c4e0ca_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9865e6634a1947ae934e34aee71371ad_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic39856d934ae48b2a455091b04383ffc_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie513d3f3a44c445b883b46a6064152ff_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb22be955a4449a9a766febb73b0f3a4_D20190309-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-09</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ea1386c2a494e8fb6de3793f9261b99_D20190309-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-09</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i813499ada2bf48288695564490d30842_I20190308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-03-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i760c8d6a27604682ac45b413f79812b7_D20190309-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-09</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife69a303a50649b0b6f092658ca1d499_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1002f68219ae43b4be932a6273264a7c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ffe884f9b2344429d5d6c7f367928f0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c71bcd46a354ef48c615d33719c2f24_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">cron:MeasurementInputSubscriptionPriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c0529bb277d40f3b988874534a3c039_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">cron:MeasurementInputSubscriptionPriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic392ce3b66a344a49d1bf576e9ecd60b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">cron:MeasurementInputSubscriptionPriceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i62783d3a67304a879fa26fcc257f00d9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1a12f35121a4490a0b734503d514f44_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53eb710ebdeb422f9560e5ed4459a65e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e8fcd467ee0424da748f3c4e639ee5e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03121ba616544c3e9f4c72c77224e550_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if4a40de9976a4a6ea2c284a6a976c110_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1d01fc2d35c4475a2aba575ab42c8f4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b526944dcae4dbfaef739d5f4926f50_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id20cab244ae5423b89f1fbb3f050e58c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibaa2909c766b4db18adc05215c8e5054_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e6e6f6026a74efc8e2d8819d52b47dd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib82c5acab2a34945829d6e887a154631_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i532650c252fe40e8944dc186a1e32d95_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e7fd630e9344584911653a57e1cade2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib31c0e699cee4523929ffe9f0cb71ec3_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8dad115f7a854f8f8535c69c691a66bd_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">cron:MeasurementInputSubscriptionPriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ac25230d48a4dd3b8c55100b4962584_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">cron:MeasurementInputSubscriptionPriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i090d89e22cd84b90b9d10cc6c3747232_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">cron:MeasurementInputSubscriptionPriceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2f5b74993ca4afe861ba1252b560ab3_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc02dbc8bf0d4565843b395d0dac82d6_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67d90ff5508a41d4a7e560c59d4cd97f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i511f22de5c4141928962bdab9879ecea_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0dce3d6d45ea4267a21a2a0361da3f85_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51f073ba36984f5c87fd937fb7d24eff_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ee40ca46ccd4085930f0437fb342632_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1911ee2c91ef4dd592addb1a63a0fc20_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i49e6ac7b6f4a43adb3596a15ec175f15_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84cef257e8654992885dbc495e97fa6a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i375b8aad8904491db84b8c4c1e23cc5d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idcfe25f7b5d4403ea6a60531b21489be_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9ab5c8a35da422c8b07919b72494b75_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreEmptiveRightsAndTopUpRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i449c71c0a6bc41a7843b95924704320f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreEmptiveRightsAndTopUpRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8c37aaed6534f7495f7b25106f852b4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreEmptiveRightsAndTopUpRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3afed61a87ba4d3e991bdb186e51a8eb_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreEmptiveRightsAndTopUpRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8eb7b029c40f44a1a5f9d5ceb456ed65_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreEmptiveRightsAndTopUpRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ee5cf3f81f746e9a91d18e6efa4e418_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreEmptiveRightsAndTopUpRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60f16583657641d1bc65b04b7fcc0429_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreEmptiveRightsAndTopUpRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i301270b5b8644233a9dc1ae42d07c539_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreEmptiveRightsAndTopUpRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="vote"><xbrli:measure>cron:vote</xbrli:measure></xbrli:unit><xbrli:context id="ica622cb684474ab3a25d8fbc0860181c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cron:AltriaInvestmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1db6dad47a0c48f9ba16df4ee15bdba5_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cron:AltriaInvestmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d7e063426374ebba0b27e029f93204e_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cron:AltriaInvestmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d8d3d9a698948f2a7e5b7ede9faa261_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cron:RedwoodAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i399c1d0125d94144839ad09cbfcd4e79_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cron:RedwoodAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63b115fac3df4d088ed98d2fe12e8da5_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cron:RedwoodAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a93d4ff964040f3961be26878cf2aa6_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6385655ed7694227b1ba4c2470a26f37_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i548a898f85674e398f117c44d298a956_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id6e6569c5b684d46b2b88bc879497620_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cron:BoughtDealOfferingsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib38f7a8880414aad875a0b362cbe2fb4_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cron:BoughtDealOfferingsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7104c544b41946c8a7fe225376901625_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cron:BoughtDealOfferingsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id02c7b0ce1ec47f5935d8d2f571108bb_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cron:AdditionalPaidinCapitalAttributableToConvertibleOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cron:AltriaInvestmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6846a599dce44a4fb34169f67a53da26_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cron:RedwoodAcquisitionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7c7fb20be7a4bf1a45f16645365481c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="installment"><xbrli:measure>cron:installment</xbrli:measure></xbrli:unit><xbrli:context id="i5a6b2b55f141445980be073e905ff0d2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1572dfef042a4da7bc0274d5c4a15278_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5372334bf7d347cba8a470a7ae7e08dd_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ce6c21c99f24cd2ae50be03fc1ea89d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7d681ac03c543518d1de73a1d3b5d6d_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec84f453bb6e43d7a3cafa4dad5299d9_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7708af5c622544439ec18767fd24a5c0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">cron:GrantedMay132016ThroughMay272016Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i759cd2f5c6b540b9be3e774364a54f77_I20180628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:A2015StockOptionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i129cd564c18f4becbcf3f71a97fb8da3_I20200625"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:A2018StockOptionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1cc8285673b64efc88c9004fdefdd8ad_D20200329-20200329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-03-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i586e0fbc30bd421ea74d516bbb9228a9_D20200329-20200329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-03-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie390f249c16849189272940f0a025a2b_D20200329-20200329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:A2020OmnibusPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-03-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i264457fca61240599e96951139517526_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:A2020OmnibusPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85edbfd435fc4bd88b7c46410c6c001c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:A2020OmnibusPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27704c0ccaf54adaa2ecfcbaad36eab2_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:A2020OmnibusPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd88a7bbfa5b4fe68c3c0a9725094951_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:A2018StockOptionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6fe8366c01de496cbedaa12a2a996bbd_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:A2018StockOptionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e81bf474eba4613a2f7dd5d05f70c4a_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:A2018StockOptionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i441fae4c3ad14b21962491e07d5bb03d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:A2015StockOptionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifeb79189ae0e437a9c0cf2c3b1563883_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:A2015StockOptionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1906d8b8221f4c0692fad5ac1bce6483_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:A2015StockOptionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bc534f0f44f4850a59aff8f75b91db8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b7f36b7882142ceb233b456769d9d37_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id2927e2128a7487ba8176ee60d748c59_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0adf66dfd8f246e784087297c1693bb8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f915fc11f2b4dae9120fe65ba8822be_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icccaf7b279474dd2a6cc84bf9c862814_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icac62509ad0d4163941ab71cd6a759f4_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9958a0912be6465189458f744de7bd5e_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ab60c8d610648fbbd63e32c23006ba2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ccba8359c8b4e65b7817c72779f76c1_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ea19e5d9ee04882823da13b5fd955dc_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica018a4c7d9446198ea249f354589bec_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40e8761a0c0246969b0c0e0b6a135205_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b7d911f78814b9bab3743f845ab435a_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48cd489dc3e441deb5021b45f107480e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e9d2966a37a4b5092639437289a13e7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a702c872ac7413cadbdd209e21825ba_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7aedae1809744d5bae3e685f27c56a9b_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cron:DeferredShareUnitsDSUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7131d8a1bc5413bafda345c71101f28_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cron:DeferredShareUnitsDSUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06da2ae72791461581a87fa5b29a9243_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cron:DeferredShareUnitsDSUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c3498dbe45c4b4283bce64a55185b1f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cron:DeferredShareUnitsDSUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie21e1229f5684c4f8d8a3917015fd153_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cron:DeferredShareUnitsDSUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18703331ae024841932a2cfa20e595cd_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cron:DeferredShareUnitsDSUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2cbf1f3457444a8a066a4b33bcc0f8d_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7504a998053c4a47a4b5953d769d1663_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c037c87e1ba48679175b63b96788f53_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d1da0bebea24f23b27907644c0febb9_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f6976781f6547bb84cd70d81d6d70c4_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iabcd6f2591c44b2ca171a367b14b3c94_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:GinkgoEquityMilestonesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia13ef8116a4544ff98e7741be32a6862_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:GinkgoEquityMilestonesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id8fe397a667c46d5a2f89689b2a80c59_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:GinkgoEquityMilestonesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia107f20927684430b7ec8a2ee550479f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if4600e9c488a42d59e3c24335cbf41e9_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b57674317f444c9babd29a3fc8677bb_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibbe78d1c31b04bcca9543cdd1b92d857_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:TopUpRightsFixedPriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18896e52388e4a1da87bb89497c230c1_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:TopUpRightsFixedPriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4dbef9b15d143eba0d9488a6bd1b6de_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:TopUpRightsFixedPriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia16bd82ebd994d52bbf2a05aea172f78_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:TopUpRightsMarketPriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i31e5c55249cf4472837632d6378bb9fa_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:TopUpRightsMarketPriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b93f227eda545ceb826b2485055ecd7_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:TopUpRightsMarketPriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i513a3a500da74d7f8646190b65ddac07_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:AltriaWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5d2efd05e19469484982928396a62c5_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:AltriaWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19d2882beeff45f18c65e01d481175ba_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:AltriaWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc0a4d389472474080abbcd7fc478343_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff46fcf5fdd440e98e0b8f5a4f556a79_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9eaef38c64244f4aaea506efaee150a7_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie606d97d090a47379c20114ccad4b834_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8982714a235343b797d9648803250239_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86551ed52b054f04aea18834481b512c_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7086ea760db54de69350dc668c77abf2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib75ab85d304848018363ecdc58cac865_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5e9647b572044ccb1b1d35cba81bf49_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5185ab0b8710451b8f3f523f58af8d12_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cron:AOCIAccumulatedGainLossRevaluationAndDisposalOfOtherInvestmentsParentMemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee60a63d4a4f449784f69d72f30688ce_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cron:AOCIAccumulatedGainLossRevaluationAndDisposalOfOtherInvestmentsParentMemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i732c27b4af274e05b82f35736f73db58_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cron:AOCIAccumulatedGainLossRevaluationAndDisposalOfOtherInvestmentsParentMemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i49297061d43f400ab77a586292c85f22_D20170101-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2017-01-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd18b2c5a9374aadb38dfb21c7374eef_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cron:AOCIAccumulatedGainLossRevaluationAndDisposalOfOtherInvestmentsParentMemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib87fb7dbb00e4f129dce34dfe404bb23_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cron:AOCIAccumulatedGainLossRevaluationAndDisposalOfOtherInvestmentsParentMemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia78503404d8e4407b9a07f1fcae6747d_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cron:AOCIAccumulatedGainLossRevaluationAndDisposalOfOtherInvestmentsParentMemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia325d120afc54411a40573cb6f7e7e7c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cron:AOCIAccumulatedGainLossRevaluationAndDisposalOfOtherInvestmentsParentMemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8386bc114f5f4f5fa2a6bad8bc56e82f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cron:AOCIAccumulatedGainLossRevaluationAndDisposalOfOtherInvestmentsParentMemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i991881dba0a3487e84f8602ec54ef20c_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cron:AOCIAccumulatedGainLossRevaluationAndDisposalOfOtherInvestmentsParentMemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72e668280445401eb2261966b757145c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cron:AOCIAccumulatedGainLossRevaluationAndDisposalOfOtherInvestmentsParentMemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice26ccbdf6064090b029f6a08543b040_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c9d0bafd5cc496fbef4654eb04f5f74_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibfa3a59fdaac409b8d09b830494b7637_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe4e4305d17f496991f192791dce1e14_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6a29a184e724948a6d9fe82803de2b1_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8e3143ddfa141b9ae6ff212b5b3329b_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib808f60258354f1e96cf215dea381edf_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51c8c173d2a64e9a89da94b382ba8309_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33a15aa601734e76889c79308df5f39a_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2810c3b010d94bdeb71d396714ecf592_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5ae31aceb854001ad8f87c6ab2e2250_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i547cfac932ed40edb1c94ffbbad4dcc1_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i344b2df31b18418f873d918c4651229d_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d7bbfdd8ccc40ebaad61885c216b6a2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:CanadaRevenueAgencyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i105f31994b814455b1dd25adfc5232aa_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i78c60b99d62646d091fd871d5b174040_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:IsraelTaxAuthorityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib74df11c3c8e445ea96958153ef913d4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:CanadaRevenueAgencyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2d8a62a5a5c45949a4da4ef35ba51ac_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie931956074a74c9db1111bc5c10fe12e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:IsraelTaxAuthorityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17a122330b5144cf96235a840b3602c1_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie0b8cf648fb646f3aa94a5539664bc50_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d3fb6c71a584d88aa595b49e45b8837_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i172fd75fe227409f982d139db1b09efd_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5ef930d66f146f6b1ee58c6e0b38dbe_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="cannabinoid"><xbrli:measure>cron:cannabinoid</xbrli:measure></xbrli:unit><xbrli:context id="i5a2c9058e29b437fa7075ccaeaad824a_I20180904"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">us-gaap:ResearchAndDevelopmentArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cron:GinkgoBioworksInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28a266ca99354d2f9478d733e4baca53_D20180904-20180904"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">us-gaap:ResearchAndDevelopmentArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cron:GinkgoBioworksInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-04</xbrli:startDate><xbrli:endDate>2018-09-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53d9abb5a7964f51a7a58f6c6614d10b_I20180717"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">us-gaap:ResearchAndDevelopmentArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cron:GinkgoBioworksInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-07-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i102273991043430aac514ac6305e4708_D20181015-20181015"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">us-gaap:ResearchAndDevelopmentArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cron:TechnionResearchAndDevelopmentFoundationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-10-15</xbrli:startDate><xbrli:endDate>2018-10-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2db9aaa38acc4fbfb93e36f09f0da429_D20190218-20190218"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cron:AltriaVenturesInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">cron:ConsultingServicesArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-02-18</xbrli:startDate><xbrli:endDate>2019-02-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2415de0a4c0c4ecf9ed6ea9afe096828_D20191223-20191223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-23</xbrli:startDate><xbrli:endDate>2019-12-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14db1abc7cd640c1ad2cba6b108454c3_I20191223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26f35784de464b1abb30c3a7a284c303_I20191223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cron:SaleOfStockPerformanceMilestoneAxis">cron:SaleOfStockPerformanceMilestoneOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i835de760acba433eab0f8e5932ed1a6f_I20191223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cron:SaleOfStockPerformanceMilestoneAxis">cron:SaleOfStockPerformanceMilestoneTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib73cebd3d2c240138864cc3020dbb490_D20200131-20200131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-31</xbrli:startDate><xbrli:endDate>2020-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e07a9cae5c34baeaf7df90ffc19aec5_D20210623-20210623"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-23</xbrli:startDate><xbrli:endDate>2021-06-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d5044d0f0bb4edf9f8a4a948776591c_D20221223-20221223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-23</xbrli:startDate><xbrli:endDate>2022-12-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="shareholder"><xbrli:measure>cron:shareholder</xbrli:measure></xbrli:unit><xbrli:context id="i68ef62796fa04d8f960de4f0be2cd9a0_D20200311-20200312"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cron:U.S.DistrictCourtofEasternDistrictofNewYorkVs.CronosMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-11</xbrli:startDate><xbrli:endDate>2020-03-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="complaint"><xbrli:measure>cron:complaint</xbrli:measure></xbrli:unit><xbrli:context id="i06603bc91b504293b7f98adf78675927_D20200616-20200616"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:UnfavorableRegulatoryActionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-16</xbrli:startDate><xbrli:endDate>2020-06-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d2f72aaaaf343468a4dc9aae56df2af_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cron:FourCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3ab5c08b2f448ec82c845f60eca7697_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cron:TwoMajorCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95dee7cb129845bf8d27987a1caa0bb3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis">cron:FourVendorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79cb5a37ccf24867aa069dc4b34e18f3_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis">cron:ThreeVendorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84abf62189854b468a350b1f65034a6b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie67dbd083d6c4c81b9b3a7623bbc8983_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia65c0721a7bc4c228d88b512209d7211_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea50dbe7c8794cc8aa0b34bfe4bb4eba_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i744acfb901a1441fb9ff99ac787b5b60_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if66e6d2d74bd44d69e598ab739cad251_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9cf5ee47f74c4feeb97ec1fa3dcfc557_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic809b1e3fd7243ac9c58c7a16950ffcd_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if695526c3a384f66bf0952f4b3b10c1f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cron:AltriaPinnacleLLC.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cron:ConsultingServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82c99c7bc6cf41bbaf798753e7523968_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cron:AltriaPinnacleLLC.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cron:ConsultingServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56950461ca0641258302cc12456209fb_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cron:ConsultingServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id13d81de4dfa4a43aa8e25121fddb996_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cron:ConsultingServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0183de7cbf5a41d98122476254d88bc7_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cron:AltriaPinnacleLLC.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cron:ConsultingServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9fc6d347c95c4553908e2aad286d0722_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cron:AltriaPinnacleLLC.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cron:ConsultingServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc5cfb363b314f4d89d1c4f2a887ca7a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cron:AltriaPinnacleLLC.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cron:ConsultingServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if753a5d3b4dc49c6b14066a7f6662688_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cron:ConsultingServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19b510e302f04461a1edc4df93c4ac57_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cron:ConsultingServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1f93f14e6044577ba1a7b6463b04532_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cron:PurchaseOfMachineryAndEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cron:AltriaGroupInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="transaction"><xbrli:measure>cron:transaction</xbrli:measure></xbrli:unit><xbrli:context id="i91a71d7c7ae04725bf836bbfa7b9724b_D20190328-20190328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:NonmonetaryTransactionTypeAxis">us-gaap:ExchangeOfProductHeldForSaleForSimilarProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-28</xbrli:startDate><xbrli:endDate>2019-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b5d6b4753dd4b52ac5dc0f7319ab8cd_D20190901-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:NonmonetaryTransactionTypeAxis">us-gaap:ExchangeOfProductHeldForSaleForSimilarProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="subsidiary"><xbrli:measure>cron:subsidiary</xbrli:measure></xbrli:unit><xbrli:context id="i09f6b65a08b548dea26ecf66cee73299_D20190905-20190905"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cron:RedwoodHoldingGroupLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-05</xbrli:startDate><xbrli:endDate>2019-09-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide715df8e0104988800b3158e6323d0b_I20190905"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cron:RedwoodHoldingGroupLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1f38277cbb04c8aa6676044144d8fa7_D20190905-20190905"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cron:RedwoodHoldingGroupLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-05</xbrli:startDate><xbrli:endDate>2019-09-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b55b8b5cf3546f08aaece9738addf85_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cron:RedwoodHoldingGroupLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c36b1e540204e59a5d80864743da551_D20190905-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cron:RedwoodHoldingGroupLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-05</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8399af2583a41c49612e5d2b0241e7e_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cron:RedwoodHoldingGroupLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="business"><xbrli:measure>cron:business</xbrli:measure></xbrli:unit><xbrli:context id="i82d2a5bf06814c99a17bdeb480f3837f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">cron:RepurposingPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>cron:segment</xbrli:measure></xbrli:unit><xbrli:context id="ic5679f6a0de14f3187b78de4a56cf6f2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb3e170b4cfb469091d30d5359ec73e7_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic74b0207681843f4ae87a38e8e52aa6c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb7e744f257046829976b63a309059b9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73f1c6d398cd46d4acef80d0079dbfb5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86784f31af7f422abd4f659805b08838_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b0b9f9e9cf7455390995395ccc1002a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i158da074fdac41459e9ec56ee32c9222_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45f14c47e08249fa81b790dc77e17686_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9065255599649529185c91762527139_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5db08a8f1b08405081996c824923fc8d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63f66899247a46fa95fe02f9bd08dfaa_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d31023501b14c078a65f246b312debe_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5954e81faf64c3ba7298da392a8d7ee_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3097ac22f054b5ebd188c0484e23f18_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49db693fb9be41b0a5889e6879f777d0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b096543d02048f3936893861bbb9c57_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibbf8d53ce8964a6cb53e6e367fb6b9a5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87e3d771deca41988f620fd82eacf084_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28e5d16c824541219fc781472e67c692_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic24540413fdd498693ce6bf7a6976a31_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icacdfb65bc3149b38b733a4732feeebb_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i59f625a78ed547beb8ff59308e54c2e5_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c61172a844842b28da319f1cee9e445_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i800f69cd597e4aeca9c474e6c7edd75b_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib13faff76de54e4d94e71c14d2ef55b9_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb03c1afaee344b99a3f11897f6b00a4_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e57dab2b0d04fc68e252c1b8917c76a_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd1d6f418f5d4c8e9280169b3a3fb722_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68edd065b3774520abe09eb1c8de7c1f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26a43a36f7b84e17a5c4a3f441a8d61b_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc0349f558524b69a56d1b79ef3651be_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee19945c297442c99fabe50468a25677_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b5ddf61e50c4278b9972461d7753caf_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a85a077911e4fc5bdd4f6817869ec0e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idcea1837f8ed4b229e10b2a1aa122696_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice17379b564a4ac8b872312066dc43c9_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic30fa899f34b4e0785f35d709b796c68_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iacacb166b362411ab04c61d50004c298_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10910e1c9ff24da3a8beeb51e8fc6acf_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80f7ba51cebb4bd485ecda47d16121b2_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35a6164687bf4736be585df4b9716950_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7744b3aecb5149939539b0f65c16f9e8_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idca36084581840b492066eea650a5de4_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0086f87b13ed455fad8a005cb0c06132_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5bec23ced2546878d05f11ba1514eb0_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f04fed468264acaba7cd3b71598765d_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45ffa1a1923c4ad9a143f62075390ee2_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa76c191d29f4ff1b49de04caf646517_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifdd45fb7a8f94242bcc47ddfad9317d5_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie88f3bf44b8f4d0398751e5198d4d80b_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb62e4fdf37447a3b94f42364a71921e_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifee12228e043414085a5b8c975e48649_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ffe119a68b34b9abbb2f8b5078b5b89_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib40ea4716ab44dde9b0cc0ccf563964b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4158b30eaf8f4fb4928372059c234242_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ce234a38db449af89d262f77eca0633_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cron:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3eb48e3b8cdf43109bd6c4aec124b38c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cron:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2a8cc1e89df42f890fd0544f7d58036_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibacf20036dff4b1cafe624b96ee80e2b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i49c555e7906f4ba3bd9c50b3f3e63909_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i147481f9ccf54c42aab89c6b4142bc85_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff5acdedd7bc45eda6a7ff33e8f0c2ff_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cron:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6216f2542b024e11b06a97e92eb7a918_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cron:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf0cace378954c33a3cfab1cad1ec952_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a1719ab03cd42e2b05239b317a45891_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id96e82b9cf384477a9af4880138f28ff_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cron:FourMajorCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica7d2c4edb04482398d2b6d385a68007_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cron:TwoMajorCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5a5a7b93a18452991b71bf6eb470705_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cron:OneMajorCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc2b8542eb104b93bf4d861b434940bb_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cron:FourMajorCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iade5a2ef289d4446ada902ad69bd2ed7_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cron:TwoMajorCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc2bd3e2f45e4164b7257955608b6e46_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cron:OneMajorCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if3eb5650187c4de5bbc98d6b7274d811_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b7d1cb41ba640babfa7a78721a319f5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5058324201ad4dc6b28728f9d5d3d612_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i056a3d33bb7244a2b1da220202bcbb81_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cron:OGBCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf1081084a8046e199cfa22c963ee2b1_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0190bb591a841c1a6f34ddeea55db58_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48cd8878f431419a9261e7d977504c74_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i483325ccf32a4f0b99f1a6f997a0eb31_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb6f16121fdc4f85b37accd34c0b8570_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5ba3e945f134460b59d45bf05722a40_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMzMtMy0xLTEtMA_b0d849f2-438c-4c4f-902f-c1fb37890e80" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RleHRyZWdpb246NTRhZWU1ZTdjODkwNGYwODlhMzUxMWY2YzczNmE0ZTRfODI0NjMzNzIxMzA3NA_23299789-732b-44be-a54a-9d83261ac818" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMzMtMy0xLTEtMA_b0d849f2-438c-4c4f-902f-c1fb37890e80" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RleHRyZWdpb246NTRhZWU1ZTdjODkwNGYwODlhMzUxMWY2YzczNmE0ZTRfODI0NjMzNzIxMzA3NQ_3fb97ef3-2b33-4a99-a400-62c4df723ca9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMzMtMS0xLTEtMA_030d6cf8-63aa-4cc4-b65e-77df43789c76" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RleHRyZWdpb246NTRhZWU1ZTdjODkwNGYwODlhMzUxMWY2YzczNmE0ZTRfODI0NjMzNzIxMzA3NQ_3fb97ef3-2b33-4a99-a400-62c4df723ca9" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMzMtMS0xLTEtMA_030d6cf8-63aa-4cc4-b65e-77df43789c76" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RleHRyZWdpb246NTRhZWU1ZTdjODkwNGYwODlhMzUxMWY2YzczNmE0ZTRfODI0NjMzNzIxMzA3NA_23299789-732b-44be-a54a-9d83261ac818" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMjYtMS0xLTEtMA_d2c2035b-409d-4d96-80ce-8ff8af18284d id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMjYtMy0xLTEtMA_d5dcbf49-cd7f-40c1-9318-f3853ed34620" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RleHRyZWdpb246NTRhZWU1ZTdjODkwNGYwODlhMzUxMWY2YzczNmE0ZTRfODI0NjMzNzIxMzA3Mg_aa4b8439-f84a-478a-8fb1-f835ca03fa1b" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfNi0zLTEtMS0w_a2311b2b-e900-4984-bdec-0a7931e7bae4 id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfNi0xLTEtMS0w_a0756496-0a08-44aa-a1f2-05e806899e3f" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RleHRyZWdpb246NTRhZWU1ZTdjODkwNGYwODlhMzUxMWY2YzczNmE0ZTRfODI0NjMzNzIxMzA3MQ_c8d7bf53-21c3-41a0-9531-0c2936a525bb" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMTktNy0xLTEtMA_934b407f-5480-4ec9-a08c-c47fa8742b49 id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMTktMy0xLTEtMA_f3e00e2d-0bc3-4c5c-b051-37c080d8a31c id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMTktNS0xLTEtMA_5aa26780-78bf-4c99-8b99-a530f71591bb" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RleHRyZWdpb246OWJlMGFjZTUyNjA2NDczYTkzNTU1YTA2NGVmOTYzYjFfMjMwODk3NDQxODQyNjQ_1f52087e-41b2-45cb-9593-dba04a2a8a65" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY181LTYtMS0xLTE5ODY4_e7daf893-d717-4958-98f7-edf136d089fb id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY181LTQtMS0xLTE5ODY4_a610d7fc-f428-449c-9059-7adfe180fa46 id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY181LTItMS0xLTE5ODY4_d008eb2d-02f4-41de-a9e9-29d7c125013f" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGV4dHJlZ2lvbjpiMjczMTZmYzE3ZGU0Zjc0Yjg2OTI3ZDY0NTdiMzM2Nl8yMzYzOTQ5OTk5NzQzMA_8ef018ed-3e46-49d1-8159-8b1ea3a11d48" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNDgtNS0xLTEtMA_43a535c7-a9f7-4574-8755-ea4af2d6fcf0 id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNDUtMy0xLTEtMA_c9deec0e-b435-414e-9862-97b176eb4753 id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNDgtNy0xLTEtMA_00e023ad-c0ff-44e6-b2d6-18456a9f0e47 id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNDUtNy0xLTEtMA_076615ad-4cea-4475-a55b-1ad3b75ff74f id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNDUtNS0xLTEtMA_493d04be-bc47-414c-9326-3ef9bf61406b id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNDgtMy0xLTEtMA_5d41c6cb-4657-4d84-9d61-e7b6edbd8ed4" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RleHRyZWdpb246OWJlMGFjZTUyNjA2NDczYTkzNTU1YTA2NGVmOTYzYjFfMjMwODk3NDQxODQyNjU_8a1ed1c3-4e3c-44aa-80c9-fe2c7bedff36" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMzEtMy0xLTEtMA_57a937e6-17cd-4abe-ae75-7bda62d7cf42 id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMzEtMS0xLTEtMA_bf994125-524b-467f-a561-898bad11e880" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RleHRyZWdpb246NTRhZWU1ZTdjODkwNGYwODlhMzUxMWY2YzczNmE0ZTRfODI0NjMzNzIxMzA3Mw_eea41acf-1b2e-4562-9b1e-115e0363241f" order="1"></ix:relationship></ix:resources></ix:header></div><div id="i1ae9134e40e74e0aac958218112e53d4_1"></div><div style="min-height:36pt;width:100%"><div style="margin-top:0.55pt"><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="padding-left:391.5pt;text-align:justify"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C.  20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">Form <ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xL2ZyYWc6OTE4MGRjOWM3MjdiNGQ1M2IyYzIxNDI4NzIyZTk2ODkvdGV4dHJlZ2lvbjo5MTgwZGM5YzcyN2I0ZDUzYjJjMjE0Mjg3MjJlOTY4OV84MjQ2MzM3MjEzMjE1_57f6a2cf-d73a-47e1-946a-c09335cf1996">10-K</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:13pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:DocumentAnnualReport" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xL2ZyYWc6OTE4MGRjOWM3MjdiNGQ1M2IyYzIxNDI4NzIyZTk2ODkvdGV4dHJlZ2lvbjo5MTgwZGM5YzcyN2I0ZDUzYjJjMjE0Mjg3MjJlOTY4OV84MjQ2MzM3MjE4NDgx_78ca6ceb-5bff-4471-b45d-1a99a5f1f676">&#9746;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES  </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">            EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the fiscal year ended <ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xL2ZyYWc6OTE4MGRjOWM3MjdiNGQ1M2IyYzIxNDI4NzIyZTk2ODkvdGV4dHJlZ2lvbjo5MTgwZGM5YzcyN2I0ZDUzYjJjMjE0Mjg3MjJlOTY4OV82MDQ3MzEzOTYwMzc0_83e7667e-7667-4acb-998b-83f10a4d7005"><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" format="ixt:datemonthdayen" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xL2ZyYWc6OTE4MGRjOWM3MjdiNGQ1M2IyYzIxNDI4NzIyZTk2ODkvdGV4dHJlZ2lvbjo5MTgwZGM5YzcyN2I0ZDUzYjJjMjE0Mjg3MjJlOTY4OV82MDQ3MzEzOTYwMzc0_b13aa88c-fbae-4e0c-a48d-6c805b178149">December&#160;31</ix:nonNumeric>, 2020</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">or</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xL2ZyYWc6OTE4MGRjOWM3MjdiNGQ1M2IyYzIxNDI4NzIyZTk2ODkvdGV4dHJlZ2lvbjo5MTgwZGM5YzcyN2I0ZDUzYjJjMjE0Mjg3MjJlOTY4OV84MjQ2MzM3MjE4NDU0_6e8f51d3-db47-4708-ac02-b99d27a8edcb">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from  to .</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File No.  <ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xL2ZyYWc6OTE4MGRjOWM3MjdiNGQ1M2IyYzIxNDI4NzIyZTk2ODkvdGV4dHJlZ2lvbjo5MTgwZGM5YzcyN2I0ZDUzYjJjMjE0Mjg3MjJlOTY4OV84MjQ2MzM3MjEzMjE5_aff03124-af84-4a4b-9d68-22b4ff5aacb8">001-38403</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xL2ZyYWc6OTE4MGRjOWM3MjdiNGQ1M2IyYzIxNDI4NzIyZTk2ODkvdGV4dHJlZ2lvbjo5MTgwZGM5YzcyN2I0ZDUzYjJjMjE0Mjg3MjJlOTY4OV84MjQ2MzM3MjEzMjIw_db84713d-c729-4f28-9cf6-dc3e282830e9">CRONOS GROUP INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Exact name of Registrant as specified in its Charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________________</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:93.194%"><tr><td style="width:1.0%"></td><td style="width:48.378%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.230%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">British Columbia, <ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" format="ixt-sec:edgarprovcountryen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xL2ZyYWc6OTE4MGRjOWM3MjdiNGQ1M2IyYzIxNDI4NzIyZTk2ODkvdGFibGU6NDA2NDFhN2M2N2YzNGY5NjlkZjhjNmUzZTJhMmYyOWEvdGFibGVyYW5nZTo0MDY0MWE3YzY3ZjM0Zjk2OWRmOGM2ZTNlMmEyZjI5YV8wLTAtMS0xLTE5NzY5L3RleHRyZWdpb246YThjNGFlNWEzODFiNDVlM2FlNWQ3OGRjNzJhOGRhZTBfNzE0NjgyNTU4MDU5Nw_2159972c-29e6-4381-8245-e8d05cd36aab">Canada</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(State or other jurisdiction of</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(I.R.S.  Employer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Identification No.)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xL2ZyYWc6OTE4MGRjOWM3MjdiNGQ1M2IyYzIxNDI4NzIyZTk2ODkvdGFibGU6NDA2NDFhN2M2N2YzNGY5NjlkZjhjNmUzZTJhMmYyOWEvdGFibGVyYW5nZTo0MDY0MWE3YzY3ZjM0Zjk2OWRmOGM2ZTNlMmEyZjI5YV80LTAtMS0xLTE5NzY0_0bd2e97c-c3cf-4396-b196-cca6bdc0a1b7">111 Peter St., Suite 300</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xL2ZyYWc6OTE4MGRjOWM3MjdiNGQ1M2IyYzIxNDI4NzIyZTk2ODkvdGFibGU6NDA2NDFhN2M2N2YzNGY5NjlkZjhjNmUzZTJhMmYyOWEvdGFibGVyYW5nZTo0MDY0MWE3YzY3ZjM0Zjk2OWRmOGM2ZTNlMmEyZjI5YV81LTAtMS0xLTIyMTM2L3RleHRyZWdpb246MDQ0NWRlOTU3NjYxNDc5ZGIzNTFmMDA0MzY3MjllNmNfNzE0NjgyNTU4MDU3MQ_6ae3e673-5d83-468c-bc16-edef0646d717">Toronto</ix:nonNumeric>, <ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xL2ZyYWc6OTE4MGRjOWM3MjdiNGQ1M2IyYzIxNDI4NzIyZTk2ODkvdGFibGU6NDA2NDFhN2M2N2YzNGY5NjlkZjhjNmUzZTJhMmYyOWEvdGFibGVyYW5nZTo0MDY0MWE3YzY3ZjM0Zjk2OWRmOGM2ZTNlMmEyZjI5YV81LTAtMS0xLTIyMTM2L3RleHRyZWdpb246MDQ0NWRlOTU3NjYxNDc5ZGIzNTFmMDA0MzY3MjllNmNfNzE0NjgyNTU4MDU4MQ_8c5468c6-43d8-4eee-a6f1-7c894a79d16d">Ontario</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xL2ZyYWc6OTE4MGRjOWM3MjdiNGQ1M2IyYzIxNDI4NzIyZTk2ODkvdGFibGU6NDA2NDFhN2M2N2YzNGY5NjlkZjhjNmUzZTJhMmYyOWEvdGFibGVyYW5nZTo0MDY0MWE3YzY3ZjM0Zjk2OWRmOGM2ZTNlMmEyZjI5YV81LTItMS0xLTE5NzY3_60801c1b-52b6-402d-88e4-8a4b5d6d3586">M5V 2H1</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Registrant&#8217;s telephone number, including area code: <ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xL2ZyYWc6OTE4MGRjOWM3MjdiNGQ1M2IyYzIxNDI4NzIyZTk2ODkvdGV4dHJlZ2lvbjo5MTgwZGM5YzcyN2I0ZDUzYjJjMjE0Mjg3MjJlOTY4OV84MjQ2MzM3MjEzMjIy_c3dc9547-4add-4eda-9061-89ea321efef9">416</ix:nonNumeric>-<ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xL2ZyYWc6OTE4MGRjOWM3MjdiNGQ1M2IyYzIxNDI4NzIyZTk2ODkvdGV4dHJlZ2lvbjo5MTgwZGM5YzcyN2I0ZDUzYjJjMjE0Mjg3MjJlOTY4OV84MjQ2MzM3MjEzMjI2_89aac688-ec7e-4ce4-851e-e1cda9b301e9">504-0004</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities registered pursuant to Section&#160;12(b) of the Act:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:87.500%"><tr><td style="width:1.0%"></td><td style="width:31.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.228%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.228%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.284%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Title of Each Class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Trading Symbol</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Name of Each Exchange on Which Registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xL2ZyYWc6OTE4MGRjOWM3MjdiNGQ1M2IyYzIxNDI4NzIyZTk2ODkvdGFibGU6MDEwZTc5NGYwYzc0NGM4Njg2M2ZmYjZlNjZlODA1ZjAvdGFibGVyYW5nZTowMTBlNzk0ZjBjNzQ0Yzg2ODYzZmZiNmU2NmU4MDVmMF8xLTAtMS0xLTE5Nzgx_115fb417-48cf-4e62-9bee-a6117def0544">Common Shares, no par value</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xL2ZyYWc6OTE4MGRjOWM3MjdiNGQ1M2IyYzIxNDI4NzIyZTk2ODkvdGFibGU6MDEwZTc5NGYwYzc0NGM4Njg2M2ZmYjZlNjZlODA1ZjAvdGFibGVyYW5nZTowMTBlNzk0ZjBjNzQ0Yzg2ODYzZmZiNmU2NmU4MDVmMF8xLTItMS0xLTE5Nzg0_ef357467-3d4c-4e4b-a825-04edf1757014">CRON</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xL2ZyYWc6OTE4MGRjOWM3MjdiNGQ1M2IyYzIxNDI4NzIyZTk2ODkvdGFibGU6MDEwZTc5NGYwYzc0NGM4Njg2M2ZmYjZlNjZlODA1ZjAvdGFibGVyYW5nZTowMTBlNzk0ZjBjNzQ0Yzg2ODYzZmZiNmU2NmU4MDVmMF8xLTQtMS0xLTE5Nzg2_7ae071f4-549c-4f09-868d-5ebe95f4d485">The Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Securities registered pursuant to Section&#160;12(g) of the Act: None</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Indicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Yes </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">  </span><span style="background-color:#dbdbdb;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="dei:EntityWellKnownSeasonedIssuer" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xL2ZyYWc6OTE4MGRjOWM3MjdiNGQ1M2IyYzIxNDI4NzIyZTk2ODkvdGV4dHJlZ2lvbjo5MTgwZGM5YzcyN2I0ZDUzYjJjMjE0Mjg3MjJlOTY4OV8xMjY0NDM4MzcyNzM4Mg_52fc3fbf-3421-45ee-a280-79dbc5398a11">No</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">x</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Indicate by check mark if the Registrant is not required to file reports pursuant to Section&#160;13 or 15(d) of the Act.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Yes </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">  <ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="dei:EntityVoluntaryFilers" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xL2ZyYWc6OTE4MGRjOWM3MjdiNGQ1M2IyYzIxNDI4NzIyZTk2ODkvdGV4dHJlZ2lvbjo5MTgwZGM5YzcyN2I0ZDUzYjJjMjE0Mjg3MjJlOTY4OV84MjQ2MzM3MjEzMjI4_878ebe3e-815e-4c91-ab7b-aca03a05d798">No</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">x</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Indicate by check mark whether the Registrant: (1)&#160;has filed all reports required to be filed by Section&#160;13 or Section&#160;15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xL2ZyYWc6OTE4MGRjOWM3MjdiNGQ1M2IyYzIxNDI4NzIyZTk2ODkvdGV4dHJlZ2lvbjo5MTgwZGM5YzcyN2I0ZDUzYjJjMjE0Mjg3MjJlOTY4OV84MjQ2MzM3MjEzMjI5_4ae83eb0-3c21-423c-9e97-185f7b1c256b">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">  No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xL2ZyYWc6OTE4MGRjOWM3MjdiNGQ1M2IyYzIxNDI4NzIyZTk2ODkvdGV4dHJlZ2lvbjo5MTgwZGM5YzcyN2I0ZDUzYjJjMjE0Mjg3MjJlOTY4OV84MjQ2MzM3MjEzMjMw_c0bf7936-177a-4a60-8bd1-5a1113ecb1f5">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">  No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company.  See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:20.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.162%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xL2ZyYWc6OTE4MGRjOWM3MjdiNGQ1M2IyYzIxNDI4NzIyZTk2ODkvdGFibGU6MTdkMzk2M2NhNTQ2NGVlZWFlNjE2MzRlMjEzODY1ZDcvdGFibGVyYW5nZToxN2QzOTYzY2E1NDY0ZWVlYWU2MTYzNGUyMTM4NjVkN18wLTAtMS0xLTE5ODA4_e666f8f5-0a07-4242-a66a-61c3c38b287c">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%">o</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%">o</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xL2ZyYWc6OTE4MGRjOWM3MjdiNGQ1M2IyYzIxNDI4NzIyZTk2ODkvdGFibGU6MTdkMzk2M2NhNTQ2NGVlZWFlNjE2MzRlMjEzODY1ZDcvdGFibGVyYW5nZToxN2QzOTYzY2E1NDY0ZWVlYWU2MTYzNGUyMTM4NjVkN18xLTQtMS0xLTE5ODEx_df960d9c-2f5e-451d-bc97-df656acf7393">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xL2ZyYWc6OTE4MGRjOWM3MjdiNGQ1M2IyYzIxNDI4NzIyZTk2ODkvdGFibGU6MTdkMzk2M2NhNTQ2NGVlZWFlNjE2MzRlMjEzODY1ZDcvdGFibGVyYW5nZToxN2QzOTYzY2E1NDY0ZWVlYWU2MTYzNGUyMTM4NjVkN18yLTEtMS0xLTE5ODEz_67619078-6540-4949-8c44-0b64a4e4de14">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.  <ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xL2ZyYWc6OTE4MGRjOWM3MjdiNGQ1M2IyYzIxNDI4NzIyZTk2ODkvdGV4dHJlZ2lvbjo5MTgwZGM5YzcyN2I0ZDUzYjJjMjE0Mjg3MjJlOTY4OV84MjQ2MzM3MjE4NDU3_e5f188c2-1be9-4afa-b0e0-601b5a5cde2a">&#9744;</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:115%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. Yes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:IcfrAuditorAttestationFlag" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xL2ZyYWc6OTE4MGRjOWM3MjdiNGQ1M2IyYzIxNDI4NzIyZTk2ODkvdGV4dHJlZ2lvbjo5MTgwZGM5YzcyN2I0ZDUzYjJjMjE0Mjg3MjJlOTY4OV84MjQ2MzM3MjE4NDg2_2fe677cb-4967-4eb8-af3e-98dcf446fb56">&#9746;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:115%">  No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:115%">o</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Yes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xL2ZyYWc6OTE4MGRjOWM3MjdiNGQ1M2IyYzIxNDI4NzIyZTk2ODkvdGV4dHJlZ2lvbjo5MTgwZGM5YzcyN2I0ZDUzYjJjMjE0Mjg3MjJlOTY4OV84MjQ2MzM3MjE4NDc0_d59569d1-061c-426c-96b7-5e4469a63f13">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">  No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">x</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">As of June&#160;30, 2020, the last business day of the Registrant&#8217;s most recently completed second fiscal quarter, the aggregate market value of common shares held by non-affiliates of the Registrant computed by reference to the closing price of $6.01 per common share on June 30, 2020 was approximately $<ix:nonFraction unitRef="usd" contextRef="i3f1a6d5f4cc14d9da49468102df7fa77_I20200630" decimals="0" format="ixt:numdotdecimal" name="dei:EntityPublicFloat" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xL2ZyYWc6OTE4MGRjOWM3MjdiNGQ1M2IyYzIxNDI4NzIyZTk2ODkvdGV4dHJlZ2lvbjo5MTgwZGM5YzcyN2I0ZDUzYjJjMjE0Mjg3MjJlOTY4OV84MjQ2MzM3MjEzMjMy_541fecf2-6197-499b-a5f7-30cce4460403">1,099,685,039</ix:nonFraction>.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">As of February&#160;25, 2021, there were <ix:nonFraction unitRef="shares" contextRef="i05bcebde49834f16a2e8b37499a65600_I20210225" decimals="INF" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xL2ZyYWc6OTE4MGRjOWM3MjdiNGQ1M2IyYzIxNDI4NzIyZTk2ODkvdGV4dHJlZ2lvbjo5MTgwZGM5YzcyN2I0ZDUzYjJjMjE0Mjg3MjJlOTY4OV84MjQ2MzM3MjEzMjQ4_21c91b11-5f3e-47e3-bd8d-fd9c6a134f6c">360,258,680</ix:nonFraction> common shares of the Registrant issued and outstanding. </span></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:0.55pt"><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">DOCUMENTS INCORPORATED BY REFERENCE</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xL2ZyYWc6OTE4MGRjOWM3MjdiNGQ1M2IyYzIxNDI4NzIyZTk2ODkvdGV4dHJlZ2lvbjo5MTgwZGM5YzcyN2I0ZDUzYjJjMjE0Mjg3MjJlOTY4OV8yMzA4OTc0NDE5MDkwNw_f23b902d-ef00-42a4-8b97-82430825cbf1" escape="true">Certain information required by Part III of this Annual Report on Form 10-K will either be incorporated into this Annual Report on Form 10-K by reference to the registrant&#8217;s definitive proxy statement for its 2021 Annual Meeting of Shareholders, or will be included in an amendment to this Annual Report on Form 10-K to be filed no later than 120 days after the registrant's fiscal year ended December&#160;31, 2020.</ix:nonNumeric></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i1ae9134e40e74e0aac958218112e53d4_10"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.750%"><tr><td style="width:1.0%"></td><td style="width:9.448%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.029%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.029%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.763%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.231%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Table of Contents</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1.</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_16">Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i1ae9134e40e74e0aac958218112e53d4_16">4</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1A.</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_19">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i1ae9134e40e74e0aac958218112e53d4_19">18</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item&#160;1B.</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_22">Unresolved Staff Comments</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i1ae9134e40e74e0aac958218112e53d4_22">46</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item&#160;2.</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_25">Properties</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i1ae9134e40e74e0aac958218112e53d4_25">46</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item&#160;3.</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_28">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i1ae9134e40e74e0aac958218112e53d4_28">46</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item&#160;4.</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_31">Mine Safety Disclosure</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i1ae9134e40e74e0aac958218112e53d4_31">47</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item&#160;5.</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_34">Market for Registrant&#8217;s Common Equity, Related Shareholder Matters and Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i1ae9134e40e74e0aac958218112e53d4_34">48</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item&#160;6.</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Selected Financial Data</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i1ae9134e40e74e0aac958218112e53d4_2429">51</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item&#160;7.</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_40">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i1ae9134e40e74e0aac958218112e53d4_40">51</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item&#160;7A.</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_43">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i1ae9134e40e74e0aac958218112e53d4_43">65</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item&#160;8.</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_55">Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i1ae9134e40e74e0aac958218112e53d4_46">66</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item&#160;9.</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_196">Changes in and Disagreements With Accountants on Accounting and Financial Disclosure</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i1ae9134e40e74e0aac958218112e53d4_196">118</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item&#160;9A.</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_199">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i1ae9134e40e74e0aac958218112e53d4_199">118</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item&#160;9B.</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_202">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i1ae9134e40e74e0aac958218112e53d4_202">119</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART III</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item&#160;10.</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_208">Directors, Executive Officers and Corporate Governance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i1ae9134e40e74e0aac958218112e53d4_208">120</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item&#160;11.</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_211">Executive Compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i1ae9134e40e74e0aac958218112e53d4_211">120</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item&#160;12.</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_214">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i1ae9134e40e74e0aac958218112e53d4_214">120</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item&#160;13.</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_217">Certain Relationships and Related Transactions, and Director Independence</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i1ae9134e40e74e0aac958218112e53d4_217">120</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item&#160;14.</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_220">Principal Accounting Fees and Services</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i1ae9134e40e74e0aac958218112e53d4_220">120</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART IV</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item 15.</span></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_223">Exhibits, Financial Statement Schedules</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i1ae9134e40e74e0aac958218112e53d4_223">121</a></span></div></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise noted or the context indicates otherwise, references in this Annual Report on Form 10-K (this &#8220;Annual Report&#8221;) to the &#8220;Company&#8221;, &#8220;Cronos Group&#8221;, &#8220;we&#8221;, &#8220;us&#8221; and &#8220;our&#8221; refer to Cronos Group Inc., its direct and indirect wholly owned subsidiaries and, if applicable, its joint ventures and investments accounted for by the equity method; the term &#8220;cannabis&#8221; means the plant of any species or subspecies of genus </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cannabis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and any part of that plant, including all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers; the term &#8220;U.S. hemp&#8221; has the meaning given to term &#8220;hemp&#8221; in the U.S. Agricultural Improvement Act of 2018 (the &#8220;2018 Farm Bill&#8221;), including hemp-derived cannabidiol (&#8220;CBD&#8221;); and the term &#8220;U.S. Schedule I cannabis&#8221; means cannabis excluding U.S. hemp.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">This report contains references to our trademarks and trade names and to trademarks and trade names belonging to other entities. Solely for convenience, trademarks and trade names referred to in this report may appear without the &#174; or &#8482; symbols, but such references are not intended to indicate, in any way, that their respective owners will not assert, to the fullest extent under applicable law, their rights thereto. We do not intend our use or display of other companies&#8217; trademarks or trade names to imply a relationship with, or endorsement or sponsorship of us or our business by, any other companies.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All currency amounts in this Annual Report are stated in U.S. dollars, which is our reporting currency, unless otherwise noted. All references to &#8220;dollars&#8221; or &#8220;$&#8221; are to U.S. dollars; all references to &#8220;C$&#8221; are to Canadian dollars; all references to &#8220;A$&#8221; are to Australian dollars; and all references to &#8220;ILS&#8221; are to New Israeli Shekels. </span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.347%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(Exchange rates are shown as C$ per $)</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3411</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3268</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2955</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spot rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2751</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2990</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3639</span></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All summaries of agreements described herein are qualified by the full text of such agreements (certain of which are filed as exhibits hereto). </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i1ae9134e40e74e0aac958218112e53d4_13"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Special Note Regarding Forward-Looking Statements</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Annual Report, the documents incorporated into this Annual Report by reference, other reports we file with, or furnish to, the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) and other regulatory agencies, and statements by our directors, officers, other employees and other persons authorized to speak on our behalf contain information that may constitute forward-looking information and forward-looking statements within the meaning of applicable securities laws (collectively, &#8220;Forward-Looking Statements&#8221;), which are based upon our current internal expectations, estimates, projections, assumptions and beliefs. All information that is not clearly historical in nature may constitute Forward-Looking Statements. In some cases, Forward-Looking Statements can be identified by the use of forward-looking terminology, such as &#8220;expect&#8221;, &#8220;likely&#8221;, &#8220;may&#8221;, &#8220;will&#8221;, &#8220;should&#8221;, &#8220;intend&#8221;, &#8220;anticipate&#8221;, &#8220;potential&#8221;, &#8220;proposed&#8221;, &#8220;estimate&#8221; and other similar words, expressions and phrases, including negative and grammatical variations thereof, or statements that certain events or conditions &#8220;may&#8221; or &#8220;will&#8221; happen, or by discussion of strategy. Forward-Looking Statements include estimates, plans, expectations, opinions, forecasts, projections, targets, guidance or other statements that are not statements of historical fact.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward-Looking Statements include, but are not limited to, statements with respect to: </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the uncertainties associated with the COVID-19 pandemic, including our ability, and the abilities of our joint ventures and our suppliers and distributors, to effectively deal with the restrictions, limitations and health issues presented by the COVID-19 pandemic, the ability to continue our production, distribution and sale of our products, and demand for and the use of our products by consumers;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">laws and regulations and any amendments thereto applicable to our business and the impact thereof, including uncertainty regarding the application of United States (&#8220;U.S.&#8221;) state and federal law to U.S. hemp (including CBD) products and the scope of any regulations by the U.S. Food and Drug Administration (the &#8220;FDA&#8221;), the U.S. Drug Enforcement Administration (the &#8220;DEA&#8221;), the U.S. Federal Trade Commission (the &#8220;FTC&#8221;), the U.S. Patent and Trademark Office (the &#8220;PTO&#8221;) and any state equivalent regulatory agencies over U.S. hemp (including CBD) products;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the laws and regulations and any amendments thereto relating to the U.S. hemp industry in the U.S., including the promulgation of regulations for the U.S. hemp industry by the U.S. Department of Agriculture (the &#8220;USDA&#8221;) and relevant state regulatory authorities;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the grant, renewal and impact of any license or supplemental license to conduct activities with cannabis or any amendments thereof;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our international activities and joint venture interests, including required regulatory approvals and licensing, anticipated costs and timing, and expected impact;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to successfully create and launch brands and further create, launch and scale U.S. hemp-derived consumer products and cannabis products;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the benefits, viability, safety, efficacy, dosing and social acceptance of cannabis, including CBD and other cannabinoids;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expectations regarding the implementation and effectiveness of key personnel changes;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the anticipated benefits and impact of the Altria Investment (as defined herein);</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the potential exercise of the Altria Warrant (as defined herein), pre-emptive rights and/or top-up rights in connection with the Altria Investment, including proceeds to us that may result therefrom;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expectations regarding the use of proceeds of equity financings, including the proceeds from the Altria Investment;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the legalization of the use of cannabis for medical or adult-use in jurisdictions outside of Canada, the related timing and impact thereof and our intentions to participate in such markets, if and when such use is legalized;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expectations regarding the potential success of, and the costs and benefits associated with, our joint ventures, strategic alliances and equity investments, including the strategic partnership (the &#8220;Ginkgo Strategic Partnership&#8221;) with Ginkgo Bioworks, Inc. (&#8220;Ginkgo&#8221;);</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to execute on our strategy and the anticipated benefits of such strategy;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expectations of the amount or frequency of impairment losses, including as a result of the write-down of intangible assets, including goodwill;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ongoing impact of the legalization of additional cannabis product types and forms for adult-use in Canada, including federal, provincial, territorial and municipal regulations pertaining thereto, the related timing and impact thereof and our intentions to participate in such markets;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the future performance of our business and operations;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our competitive advantages and business strategies;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the competitive conditions of the industry;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the expected growth in the number of customers using our products;</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability or plans to identify, develop, commercialize or expand our technology and R&amp;D initiatives in cannabinoids, or the success thereof;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expectations regarding acquisitions and dispositions and the anticipated benefits therefrom, including the proposed sale of our Original B.C. Ltd. (&#8220;OGBC&#8221;) production facility;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expectations regarding revenues, expenses and anticipated cash needs;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expectations regarding cash flow, liquidity and sources of funding;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expectations regarding capital expenditures;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the expansion of our production and manufacturing, the costs and timing associated therewith and the receipt of applicable production and sale licenses;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the expected growth in our growing, production and supply chain capacities;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expectations regarding the resolution of litigation and other legal and regulatory proceedings, reviews and investigations;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expectations with respect to future production costs;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expectations with respect to future sales and distribution channels and networks;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the expected methods to be used to distribute and sell our products; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the anticipated future gross margins of our operations;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">accounting standards and estimates;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to timely and effectively remediate any material weaknesses in our internal control over financial reporting; and </span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expectations regarding the costs and benefits associated with our contracts and agreements with third parties, including under our third-party supply and manufacturing agreements. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Forward-Looking Statements contained herein concerning the industries in which we conduct our business are based on estimates prepared by us using data from publicly available governmental sources, market research, industry analysis and on assumptions based on data and knowledge of these industries, which we believe to be reasonable. However, although generally indicative of relative market positions, market shares and performance characteristics, such data is inherently imprecise. The industries in which we conduct our business involve risks and uncertainties that are subject to change based on various factors, which are described further below.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Forward-Looking Statements contained herein are based upon certain material assumptions that were applied in drawing a conclusion or making a forecast or projection, including: (i) our ability, and the abilities of our joint ventures and our suppliers and distributors, to effectively deal with the restrictions, limitations and health issues presented by the COVID-19 pandemic and the ability to continue our production, distribution and sale of our products and customer demand for and use of our products; (ii) management&#8217;s perceptions of historical trends, current conditions and expected future developments; (iii) our ability to generate cash flow from operations; (iv) general economic, financial market, regulatory and political conditions in which we operate; (v) the production and manufacturing capabilities and output from our facilities and our joint ventures, strategic alliances and equity investments; (vi) consumer interest in our products; (vii) competition; (viii) anticipated and unanticipated costs; (ix) government regulation of our activities and products including, but not limited to, the areas of taxation and environmental protection; (x) the timely receipt of any required regulatory authorizations, approvals, consents, permits and/or licenses; (xi) our ability to obtain qualified staff, equipment and services in a timely and cost-efficient manner; (xii) our ability to conduct operations in a safe, efficient and effective manner; (xiii) our ability to realize anticipated benefits, synergies or generate revenue, profits or value from our recent acquisitions into our existing operations; (xiv) our ability to complete planned dispositions, including the sale of OGBC, and, if completed, obtain our anticipated sales price; and (xv) other considerations that management believes to be appropriate in the circumstances. While our management considers these assumptions to be reasonable based on information currently available to management, there is no assurance that such expectations will prove to be correct.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By their nature, Forward-Looking Statements are subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. A variety of factors, including known and unknown risks, many of which are beyond our control, could cause actual results to differ materially from the Forward-Looking Statements in this Annual Report and other reports we file with, or furnish to, the SEC and other regulatory agencies and made by our directors, officers, other employees and other persons authorized to speak on our behalf. Such factors include, without limitation, the risk that the COVID-19 pandemic may disrupt our operations and those of our suppliers and distribution channels and negatively impact the demand for and use of our products; the risk that cost savings and any other synergies from the Altria Investment may not be fully realized or may take longer to realize than expected; the risk that we will not complete planned dispositions, including the sale of OGBC, or, if completed, obtain our anticipated sales price; the implementation and effectiveness of key personnel changes; future levels of revenues; consumer demand for cannabis and U.S. hemp products; our ability to manage disruptions in credit markets or changes to our credit ratings; future levels of capital, environmental or maintenance expenditures, general and administrative and other expenses; the success or timing of completion of ongoing or anticipated capital or maintenance projects; business strategies, growth opportunities and expected investment; the adequacy of our capital resources and liquidity, including but not limited to, availability of sufficient cash flow to execute our business plan (either within the expected timeframe or at all); the potential effects of judicial, regulatory or other proceedings, or threatened litigation or proceedings, on our business, financial condition, results of operations and cash flows; volatility in and/or degradation of general economic, market, industry or business conditions; compliance with applicable environmental, economic, health and safety, energy and other policies and regulations and in particular health concerns with respect to vaping and the use of cannabis and U.S. hemp products in vaping devices; the anticipated effects of actions of third parties such as competitors, activist investors or federal (including U.S. federal), state, provincial, territorial or local regulatory authorities or self-regulatory organizations; changes in regulatory requirements in relation to our business and products; and the factors discussed under the heading &#8220;Risk Factors&#8221; in this Annual Report. Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on Forward-Looking Statements.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward-Looking Statements are provided for the purposes of assisting the reader in understanding our financial performance, financial position and cash flows as of and for periods ended on certain dates and to present information about management&#8217;s current expectations and plans relating to the future, and the reader is cautioned that the Forward-Looking Statements may not be appropriate for any other purpose. While we believe that the assumptions and expectations reflected in the Forward-Looking Statements are reasonable based on information currently available to management, there is no assurance that such assumptions and expectations will prove to have been correct. Forward-Looking Statements are made as of the date they are made and are based on the beliefs, estimates, expectations and opinions of management on that date. We undertake no obligation to update or revise any Forward-Looking Statements, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such Forward-Looking Statements. The Forward-Looking Statements contained in this Annual Report and other reports we file with, or furnish to, the SEC and other regulatory agencies and made by our directors, officers, other employees and other persons authorized to speak on our behalf are expressly qualified in their entirety by these cautionary statements.</span></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i1ae9134e40e74e0aac958218112e53d4_16"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="-sec-extract:summary;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="-sec-extract:summary;margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1. BUSINESS</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Group is incorporated under the laws of the Province of British Columbia with principal executive offices located at 111 Peter Street, Suite 300, Toronto, Ontario M5V 2H1. Our telephone number is +1-416-504-0004, our website is https://thecronosgroup.com/ and the investor relations section of our website is https://ir.thecronosgroup.com/. All references to our website are inactive references, are for informational purposes only and are not intended to incorporate any information from or referenced on our website into this Annual Report.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common shares are currently listed on the Toronto Stock Exchange (&#8220;TSX&#8221;) and on the NASDAQ Global Market (&#8220;Nasdaq&#8221;) under the trading symbol &#8220;CRON.&#8221;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Description of the Business</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Group is an innovative global cannabinoid company with international production and distribution across five continents. Cronos Group is committed to building disruptive intellectual property by advancing cannabis research, technology and product development and are building an iconic brand portfolio. Cronos Group&#8217;s brand portfolio includes PEACE NATURALS&#8482;, a global wellness platform; two adult-use brands, COVE&#8482; and Spinach&#8482;; and three U.S. hemp-derived consumer products brands, Lord Jones&#8482;, Happy Dance&#8482; and PEACE+&#8482;.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Strategy</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Group seeks to create value for shareholders by focusing on four core strategic priorities:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">growing a portfolio of iconic brands that responsibly elevate the consumer experience;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">developing a diversified global sales and distribution network;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">establishing an efficient global supply chain; and</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">creating and monetizing disruptive intellectual property.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business Segments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Group reports through two segments: &#8220;United States&#8221; and &#8220;Rest of World.&#8221; These two segments represent the geographic regions in which the Company operates and the different product offerings within each geographic region. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">United States</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 5, 2019, as a result of the acquisition (the &#8220;Redwood Acquisition&#8221;) of four Redwood Holding Group, LLC subsidiaries (collectively, &#8220;Redwood&#8221;), the Company established the United States segment. Redwood manufactures, markets and distributes U.S. hemp-derived supplements and cosmetic products through e-commerce, retail and hospitality partner channels in the United States under the brands Lord Jones&#8482; and Happy Dance&#8482;. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">No U.S. Schedule I Cannabis-Related Activities </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 20, 2018, the 2018 Farm Bill was enacted in the U.S., removing U.S. hemp from the list of Schedule I controlled substances under the U.S. Controlled Substances Act (the &#8220;CSA&#8221;), and on January 19, 2021, the USDA issued a final rule establishing a domestic U.S. hemp production regulatory program, effective March 2021. Though a number of states in the U.S. have authorized the cultivation, distribution or possession of U.S. Schedule I cannabis and U.S. Schedule I cannabis containing products to various degrees and subject to various requirements or conditions, U.S. Schedule I cannabis continues to be a Schedule I controlled substance under the CSA. Therefore, the cultivation, manufacture, distribution and possession of U.S. Schedule I cannabis violates federal law in the U.S. unless a U.S. federal agency, such as the DEA, grants a registration for a specific activity, such as research, with U.S. Schedule I cannabis.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not engage in any activities related to U.S. Schedule I cannabis in the U.S. The Ginkgo Strategic Partnership contemplates the performance of licensed R&amp;D activities in the U.S. in order to produce cultured cannabinoids, but such activities are conducted in compliance with all applicable laws regarding controlled substances. </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="-sec-extract:summary;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Rest of World</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Rest of World operating segment is involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In Canada, Cronos Group operates through a wholly owned license holder under the Cannabis Act (Canada) (the &#8220;Cannabis Act&#8221;), Peace Naturals Project Inc. (&#8220;Peace Naturals&#8221;), which has production facilities near Stayner, Ontario (the &#8220;Peace Naturals Campus&#8221;). Cronos Group has established four strategic joint ventures in Canada, Israel and Colombia and holds approximately 31% of the issued capital of Cronos Australia Limited (&#8220;Cronos Australia&#8221;), which is listed on the Australian Securities Exchange under the trading symbol &#8220;CAU.&#8221; Cronos Group currently exports cannabis products to countries that permit the import of such products, such as Germany, Israel and Australia. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Peace Naturals</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The production facilities at the Peace Naturals Campus are licensed by Health Canada under the Cannabis Act to engage in, among other things, the cultivation, processing, distribution and sale of dried cannabis flower, cannabis resin, cannabis seeds, cannabis plants, cannabis extracts, cannabis topicals and cannabis edibles, among other prescribed activities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Joint Ventures/Strategic Investment</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have established four strategic joint ventures in Canada, Israel and Colombia and also hold approximately 31% of the issued capital of Cronos Australia, which we account for under the equity method of accounting.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ownership interest in each of our joint ventures is summarized in the table below. </span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:46.048%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.608%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.517%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.608%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.519%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Joint Venture</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Jurisdiction</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ownership Interest</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos Israel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70%/90%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos Growing Company Inc. (&#8220;Cronos GrowCo&#8221;)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iii)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NatuEra S.&#224;.r.l. (&#8220;Natuera&#8221;) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iv)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colombia</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedMen Canada Inc. (&#8220;MedMen Canada&#8221;)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(v)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td></tr></table></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">We define ownership interest as the proportionate share of net income to which we are entitled; equity interest may differ from ownership interest shown above. We consolidate the financial results of Cronos Israel and account for our other joint ventures under the equity method of accounting. See Note 2 and Note 6 of our audited consolidated financial statements included in Item 8 of this Annual Report.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">A strategic joint venture with Kibbutz Gan Shmuel (&#8220;Gan Shmuel&#8221;), an Israeli agricultural collective settlement, for the production, manufacture and global distribution of medical cannabis, consisting of a cultivation company (Cronos Israel G.S. Cultivation Ltd.), a manufacturing company (Cronos Israel G.S. Manufacturing Ltd.), a distribution company (Cronos Israel G.S. Store Ltd.) and a pharmacy company (Cronos Israel G.S. Pharmacy Ltd., collectively, &#8220;Cronos Israel&#8221;). We hold a 70% equity interest in the cultivation company and a 90% equity interest in each of the manufacturing, distribution and pharmacy companies.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">A strategic joint venture with a group of investors led by Bert Mucci (the &#8220;Greenhouse Partners&#8221;), a Canadian large-scale greenhouse operator. Each of Cronos Group and the Greenhouse Partners owns a 50% equity interest in Cronos GrowCo and has equal representation on its board of directors.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(iv)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">A strategic joint venture with an affiliate of Agroidea SAS (&#8220;AGI&#8221;), a Colombian agricultural services provider. Each of the Company and AGI owns a 50% equity interest in Natuera. Cronos Group has three manager nominees on the board of managers of Natuera, while AGI has four manager nominees on the board of managers. Natuera intends to develop, cultivate, manufacture, and export cannabis-based medical and consumer products for the Latin American and global markets.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(v)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">A strategic joint venture with MedMen Enterprises USA, LLC (&#8220;MedMen&#8221;) for retail in provinces in Canada that permit private retail. Each of the Company and MedMen owns a 50% equity interest in MedMen Canada, and has equal representation on the board of directors of MedMen Canada.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operations Outside of Canada and the U.S.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Group anticipates expanding in the geographic markets outside of Canada and the U.S. in which we currently participate and entering new geographic markets. By leveraging operational, manufacturing and regulatory expertise, quality standards and procedures and intellectual property, we believe that we are well-positioned to effectively access these markets. Subject to applicable regulatory approvals, strategic international business opportunities pursued by us could include:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">production, distribution, sales and marketing in jurisdictions which have passed legislation to legalize the production, distribution and possession of cannabis and cannabis products at all relevant levels of government; and</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the export of cannabis and cannabis products to markets that permit the import of such products.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We seek to conduct business only in jurisdictions where we believe it is legal to do so and where such operations remain compliant with our listing obligations with the TSX and Nasdaq. Determining whether a business activity is legal in a jurisdiction may require judgment since laws, rules, regulations and licenses may not be clear and legal interpretation and advice of counsel may vary. If a business activity in which we engage in any jurisdiction is determined to be illegal, we could be subject to fines, penalties, reputational harm, delisting from securities exchanges and material civil, criminal and regulatory litigation and proceedings or be enjoined from doing business in the applicable jurisdiction. See &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risks Relating to Regulation and Compliance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We operate in highly regulated sectors where the regulatory environment is rapidly developing, and we may not always succeed in complying fully with applicable regulatory requirements in all jurisdictions where we carry on business.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="-sec-extract:summary;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Brand Portfolio</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are committed to building a portfolio of iconic brands that responsibly elevate the consumer experience. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the U.S., we market and distribute solely U.S. hemp-derived supplements and cosmetic products through e-commerce, retail and hospitality channels under the brands Lord Jones&#8482; and Happy Dance&#8482;. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In Canada, we sell a variety of cannabis and cannabis products, including dried cannabis, pre-rolls and cannabis extracts (in the form of tinctures and vaporizers) through wholesale and direct-to-client channels under our wellness platform, PEACE NATURALS&#8482;, and under our two adult-use brands, COVE&#8482; and Spinach&#8482;. In addition, PEACE NATURALS&#8482; dried cannabis and cannabis oils are currently exported for sale to Australia, Germany and Israel. </span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.722%"><tr><td style="width:1.0%"></td><td style="width:14.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.966%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.966%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.966%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.966%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.966%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.972%"></td><td style="width:0.1%"></td></tr><tr style="height:75pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div style="text-align:center"><img src="cron-20201231_g1.jpg" alt="cron-20201231_g1.jpg" style="height:37px;margin-bottom:5pt;vertical-align:text-bottom;width:82px"/></div></td><td colspan="3" style="padding:0 1pt"><div style="text-align:center"><img src="cron-20201231_g2.jpg" alt="cron-20201231_g2.jpg" style="height:86px;margin-bottom:5pt;vertical-align:text-bottom;width:86px"/></div></td><td colspan="3" style="padding:0 1pt"><div style="text-align:center"><img src="cron-20201231_g3.jpg" alt="cron-20201231_g3.jpg" style="height:55px;margin-bottom:5pt;vertical-align:text-bottom;width:95px"/></div></td><td colspan="3" style="padding:0 1pt"><div style="text-align:center"><img src="cron-20201231_g4.jpg" alt="cron-20201231_g4.jpg" style="height:82px;margin-bottom:5pt;vertical-align:text-bottom;width:82px"/></div></td><td colspan="3" style="padding:0 1pt"><div style="text-align:center"><img src="cron-20201231_g5.jpg" alt="cron-20201231_g5.jpg" style="height:50px;margin-bottom:5pt;vertical-align:text-bottom;width:95px"/></div></td><td colspan="3" style="padding:0 1pt"><div style="text-align:center"><img src="cron-20201231_g6.jpg" alt="cron-20201231_g6.jpg" style="height:74px;margin-bottom:5pt;vertical-align:text-bottom;width:95px"/></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Brand Positioning</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wellness</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium adult-use</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mainstream adult-use</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prestige adult consumer goods</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Masstige adult consumer goods</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mass market </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Product Offering</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dried cannabis, cannabis tinctures, vaporizers</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dried cannabis, cannabis tinctures, </span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">pre-rolls, vaporizers</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dried cannabis, pre-rolls, vaporizers</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. hemp-derived supplements, cosmetics</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S hemp-derived cosmetics</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In development (not yet offered for sale) </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Geographic Availability</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Australia, Canada, Germany and Israel</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anticipated U.S.</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Wellness Brands</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently distribute products under PEACE NATURALS&#8482; for the Canadian and non-U.S. international medical cannabis markets. PEACE NATURALS&#8482; is a global wellness platform committed to producing high-quality cannabis and cannabis products. PEACE NATURALS&#8482; is focused on building and shaping the global cannabis wellness market and promoting a holistic approach to wellness. The brand&#8217;s goal is to improve the lives of others, one client at a time. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adult-Use</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Brands</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COVE&#8482; is a premium positioned brand focused on creating crafted experiences. COVE&#8482;&#8217;s indoor, strain-specific grow rooms seek to maintain the highest quality standards throughout the entire process. The goal of this premium brand is to Make Each Experience a Discovery&#8482;.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Spinach</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is positioned as a mainstream adult-use brand with High Expectations&#8482;, which is geared towards a wide range of consumers who are looking for entertaining and fun ways to enhance activities. A lighthearted and playful brand, Spinach&#8482; is focused on offering Farm-To-Bowl&#8482; products that bring friends together and make experiences more enjoyable. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adult Consumer Product Brands</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates Lord Jones&#8482;, a preeminent U.S. hemp-derived CBD brand in the U.S., for the adult consumer goods market. Lord Jones&#8482; is a prestige beauty and lifestyle brand focusing on high-quality U.S. hemp-derived personal care products. Lord Jones&#8482; U.S. hemp-derived supplements and cosmetics products are distributed online and to approximately 900 premium stores and retail channels, including Sephora, Neiman Marcus and SoulCycle.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2020, the Company launched Happy Dance&#8482;, a U.S. hemp-derived CBD skincare and personal care brand, in partnership with Kristen Bell. Happy Dance&#8482; products are made with CBD from premium full-spectrum hemp extract and provide consumers with high quality skincare at an accessible price point. Happy Dance&#8482; launched with three product offerings: All-Over Whipped Body Butter +CBD, Head-To-Toe Coconut Melt +CBD and Stress Away Bath Bomb +CBD, all of which are currently available online. Happy Dance&#8482; continues its expansion by securing its first major U.S. retailer, ULTA Beauty&#8482;. The full collection of Happy Dance&#8482; products is expected to launch online at ULTA.com and in-store at over 550 ULTA Beauty&#8482; locations across the U.S. in the coming weeks. Through the partnership with Ms. Bell, Cronos Group looks forward to future introductions of innovative products to the hemp-derived CBD market.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="-sec-extract:summary;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company launched PEACE+&#8482;, a U.S. hemp-derived CBD brand in the U.S. PEACE+&#8482; U.S. hemp-derived CBD products are currently under development and are not yet offered for sale. PEACE+&#8482; is about more than making a better, high-quality U.S. hemp-derived CBD product; it stems from the belief that well-being can lead to a better world, full of positivity and possibility. It is a belief that extends beyond the products and into everything the brand seeks to do and stand for. The brand intends to distribute its products through the mass market focused retail channel in the U.S. in the future.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Global Sales and Distribution - Principal Markets </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Group has developed a diversified global sales and distribution network by leveraging established partners for their scale, sales force and market expertise. We have also built a distribution footprint in Canada through the direct-to-client medical market and the adult-use market, as well as a distribution footprint for U.S. hemp-derived consumer products in the U.S. through e-commerce, retail and hospitality channels.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">United States Market and Distribution</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through Redwood, the Company manufactures, markets and distributes U.S. hemp-derived supplements and cosmetic products through e-commerce, retail and hospitality partner channels in the U.S. under the Lord Jones&#8482; and Happy Dance&#8482; brands. Redwood&#8217;s products use high-quality U.S. hemp extract that retains naturally occurring phytocannabinoids and terpenes found in the plant. We plan to use our resources to capitalize on market demand and to further create and scale U.S. hemp-derived consumer products and brands. We do not engage in any commercial activities related to the cultivation, distribution or possession of U.S. Schedule I cannabis in the U.S.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has also launched its PEACE+&#8482; brand for U.S. hemp-derived CBD products in the U.S. PEACE+&#8482; U.S. hemp-derived CBD products are currently under development and are not yet offered for sale. The Company intends to access the U.S. mass market focused retail channel in the future.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Rest of World</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Canadian Market and Distribution</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Direct-to-Client</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently sell dried cannabis and cannabis extracts directly to clients through our wellness platform, PEACE NATURALS&#8482;. These clients are typically sourced through physician and clinic referrals or word-of-mouth recommendations from existing clients. </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Adult-Use</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We currently sell dried flower, pre-rolls and cannabis extracts through our adult-use brands, COVE&#8482; and Spinach&#8482;, to cannabis control authorities in various provinces, including Ontario, Qu&#233;bec, British Columbia, Alberta, Manitoba, Nova Scotia, New Brunswick, and Prince Edward Island, as well as to private-sector retailers in Saskatchewan, subject to the relevant province&#8217;s product or other restrictions and requirements. As the Company&#8217;s supply chain grows, the Company continues to expand its portfolio of cannabis products for the existing markets in Canada. The rate of the Company&#8217;s expansion of distribution remains subject to factors that are beyond the Company&#8217;s control, including evolving regulations, the development of sufficient supply chain and manufacturing infrastructure and development of distribution and retail channels across Canada. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Markets and Distribution Outside of Canada </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Israel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Cronos Israel has received the IMC-GAP, IMC-GMP and IMC-GDP certifications required for the cultivation, production and marketing of dried flower, pre-rolls and oils in Israel. In the second quarter of 2020, Cronos Israel began distributing PEACE NATURALS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> branded cannabis products to the Israeli medical cannabis market. See &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">- Licenses and Regulatory Framework in Israel.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Europe</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We have distributed and anticipate continuing to distribute PEACE NATURALS&#8482; branded cannabis products in Germany through an exclusive distribution relationship with G. Pohl-Boskamp GmbH &amp; Co. KG (&#8220;Pohl-Boskamp&#8221;), an international pharmaceutical manufacturer and distributor with a distribution network of pharmacies. We have also entered into a strategic distribution partnership with Delfarma Sp. Zo.o (&#8220;Delfarma&#8221;), a pharmaceutical wholesaler in Poland. We and Delfarma are currently in the process of obtaining the necessary regulatory approvals to sell cannabis products in Poland.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt;text-decoration:underline">Latin America</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. We intend to distribute cannabis and cannabis products to the Latin American and other cannabis markets through the operations of Natuera. In 2020, Natuera began commercial cultivation of non-psychoactive (hemp) cultivars registered with the Colombian Agricultural Institute. Also in 2020, Natuera completed a number of test exports of hemp-derived CBD extract to the U.S. and United Kingdom for business development and R&amp;D purposes, as well as its first export of hemp-derived CBD extract to the U.S. for commercial purposes.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Australia and Asia-Pacific</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Cronos Australia has received an import license from the Australian Office of Drug Control (the &#8220;ODC&#8221;), together with all necessary permits, to import PEACE NATURALS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> branded cannabis products for sale in the Australian medical market under the terms of the relevant permits. Cronos Australia facilitates distribution of the Company&#8217;s products in Australia, New Zealand and South East Asia, bolstering the Company&#8217;s distribution network in the Australia and Asia-Pacific region.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="-sec-extract:summary;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to seek new international distribution channels in jurisdictions that have legalized the production, distribution and possession of cannabis and cannabis products at all relevant levels of government.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Global Supply Chain</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Group is focused on establishing an efficient global supply chain by seeking to develop industry-leading methodologies and best practices at the Peace Naturals Campus and leveraging this expertise to create beneficial production partnerships. We plan to continue to develop a global supply chain, which will employ a combination of wholly owned production facilities, third-party suppliers and global production partnerships, all of which will support the manufacturing of cannabinoid-based consumer goods. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">United States</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of our business, we</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">enter into contract manufacturing agreements with suppliers of our cosmetic products. We supply these third-party manufacturers with U.S. hemp extract or infused bulk product, fragrances and/or packaging that we source from other third-party suppliers. The contract manufacturers supply any other necessary ingredients to manufacture products using our formulas and fill and package our finished products. Our contract manufacturing and supply agreements generally do not require us to purchase minimum quantities of materials or products.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In producing our supplement products, we source our ingredients from our suppliers on an ongoing as-needed basis. We have not entered into any contracts that obligate us to purchase a minimum quantity or exclusively from any supplier. Our supplements are manufactured at our facilities in Los Angeles, California according to Good Manufacturing Practices (&#8220;GMP&#8221;). </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are obligated to purchase our supply of certain U.S. hemp extract from one supplier unless that supplier cannot provide the agreed-upon quantities in relation to certain brands in the U.S.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Rest of World </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Canadian Supply Chain</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Production Facilities at Peace Naturals</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Peace Naturals Campus is licensed for cannabis production and the manufacturing of certain cannabis products. The production processes at the Peace Naturals Campus are GMP-certified under relevant European Economic Area GMP directives by the national competent authority of Germany. The Peace Naturals Campus is engaged in cultivation, processing, finishing, packaging and shipping activities, as well as tissue culture and micro propagation, providing a year-round supply of cannabis. The Peace Naturals Campus also engages in R&amp;D to pilot various production technologies, with any tests yielding favorable operational improvements evaluated for dissemination to the Company&#8217;s other partnership facilities. In addition, the Peace Naturals Campus engages in R&amp;D on cannabinoid formulations, delivery systems and product development.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Cronos GrowCo.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Cronos GrowCo completed construction of the structure of its greenhouse in Kingsville, Ontario in 2019. Full completion of construction of the facility, including all fixtures within the greenhouse and all post-harvest activity areas was completed in 2020. In November 2020, Cronos GrowCo obtained a cultivation license for the operations contemplated by the first phase of the project. The Company expects the facility to become operational in phases beginning in the first half of 2021. Full commencement of operations at Cronos GrowCo will be subject to obtaining the appropriate licenses and other customary approvals under applicable law.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Third-Party Supply and Manufacturing Agreements.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In the ordinary course of our business, we enter into spot market purchase agreements and supply agreements with suppliers of dried cannabis and other cannabis products. Our supply agreements, for the most part, do not obligate us to purchase minimum quantities of products and generally contain provisions permitting cancellation of orders or termination on notice. We also enter into contract manufacturing agreements with other license holders, pursuant to which such license holders provide cannabis extract and services related to the filling and packaging of vaporizer devices for the Canadian cannabis adult-use and wellness markets.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Supply Chain Outside of Canada </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Cronos Israel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Cronos Israel has received the IMC-GAP, IMC-GMP and IMC-GDP certifications required for the cultivation, production and marketing of dried flower, pre-rolls and oils in Israel. In the second quarter of 2020, Cronos Israel began distributing PEACE NATURALS&#8482; branded cannabis products to the Israeli medical cannabis market. See &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">- Licenses and Regulatory Framework in Israel.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.15pt;text-decoration:underline">Natuera.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Natuera is currently focused on accessing new markets and product development, including developing additional bulk offerings of hemp-derived CBD distillate and water-soluble hemp-derived CBD solutions. In 2020, Natuera began commercial cultivation of non-psychoactive (hemp) cultivars registered with the Colombian Agricultural Institute. Also in 2020, Natuera completed a number of test exports of hemp-derived CBD extract to the U.S. and United Kingdom for business development and R&amp;D purposes, as well as its first export of hemp-derived CBD extract to the U.S. for commercial purposes.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="-sec-extract:summary;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Major Customers</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Four major customers (sales to each of which equaled or exceeded 10% of the Company&#8217;s consolidated net revenues for the year ended December 31, 2020), Alberta Gambling and Liquor Commission, B.C. Liquor Distribution Branch, Ontario Cannabis Retail Corporation, and Soci&#233;t&#233; Qu&#233;b&#233;coise du Cannabis (the &#8220;SQDC&#8221;) (the cannabis control authorities in Alberta, British Columbia, Ontario and Qu&#233;bec, respectively), accounted for approximately 19%, 13%, 16% and 15%, respectively, of our consolidated net revenues for the year ended December 31, 2020. We mitigate credit risk through verification of the customers&#8217; liquidity prior to the authorization of material transactions.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Government Contracts</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In Canada, we sell cannabis and cannabis products to cannabis control authorities in various provinces, including, Ontario, Qu&#233;bec, British Columbia, Alberta, Manitoba, Nova Scotia, New Brunswick and Prince Edward Island, where each such cannabis control authority is the sole wholesale distributor and in certain provinces, the sole retailer, of cannabis and cannabis products. We sell these products to the various cannabis control authorities under supply agreements that are subject to terms that allow for renegotiation of sale prices and termination at the election of the applicable cannabis control authority. In particular, the cannabis control authorities have in the past and may in the future choose to stop purchasing our products, may change the prices at which they purchase our products, may return our products to us and, in certain circumstances, may cancel purchase orders at any time including after products have been shipped. For the year ended December 31, 2020 we had approximately $36.4&#160;million in sales to cannabis control authorities.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development Activities and Intellectual Property</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Cronos Research Labs </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Research Labs Ltd. (&#8220;Cronos Research Labs&#8221;) is our Israel-based global research and development center for innovation. The state-of-the-art facility is equipped with advanced technology and analytical testing infrastructure and is home to an experienced team of scientific talent. The Cronos Research Labs team is comprised of scientific researchers, mechanical, electrical and software engineers, and analytical and formulation scientists. Cronos Group engages in both understanding the fundamental science behind the interactions of cannabinoids with each other and how those interactions can be leveraged to best deliver on the consumer&#8217;s needs. Cronos Group&#8217;s work spans many aspects of cannabis research from strain development, to growing conditions to extraction technology to biosynthesis to product development, all supported by advances in analytical sciences. This global R&amp;D center is expected to significantly enhance Cronos Group&#8217;s innovation capabilities and accelerate development of the next-generation of cannabinoid products. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Ginkgo </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The collaboration and license agreement between Ginkgo and the Company (the &#8220;Ginkgo Collaboration Agreement&#8221;) could enable us to produce certain cultured cannabinoids at commercial scale at a fraction of the cost compared to traditional cultivation practices. These cultured cannabinoid molecules are identical to those produced by plants grown using traditional cultivation but are created by leveraging the power of biological manufacturing via fermentation. In addition to tetrahydrocannabinol (&#8220;THC&#8221;) and CBD, these cultured cannabinoids include rare cannabinoids that are economically impractical or nearly impossible to produce at high purity and scale through traditional cultivation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Ginkgo Strategic Partnership is ultimately successful, Cronos Group expects to be able to produce large volumes of these cultured cannabinoids from custom yeast strains by leveraging existing fermentation infrastructure at Cronos Fermentation in Winnipeg, Manitoba without incurring significant capital expenditures to build new cultivation and extraction facilities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Ginkgo Strategic Partnership contemplates the performance of licensed R&amp;D activities in the U.S. in order to produce cultured cannabinoids and such activities are to be conducted in compliance with all applicable laws regarding controlled substances. We intend to produce and distribute the target cannabinoids globally, where permitted by applicable law, and have received confirmation from Health Canada that this method of production is permitted under the Cannabis Act. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ginkgo has filed certain patent applications pertaining to biosynthesis of cannabinoids to protect the intellectual property developed as part of the research progressing under the Ginkgo Strategic Partnership. Under the partnership, Cronos Group is the exclusive licensee of the intellectual property covered by the patent applications for the target cannabinoids. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cronos Fermentation </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Fermentation is a GMP-standard fermentation and manufacturing facility in Winnipeg, Manitoba. The state-of-the-art facility includes fully equipped laboratories covering microbiology, organic and analytical chemistry, quality control and method development as well as two large-scale microbial fermentation production areas, three downstream processing plants, and bulk product and packaging capabilities. The facility is expected to provide the fermentation and manufacturing capabilities we need in order to capitalize on the progress underway with Ginkgo, by enabling us to produce the target cannabinoids contemplated under the Ginkgo Collaboration Agreement at commercial scale with high quality and high purity.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="-sec-extract:summary;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have begun to work on developing scale-up and downstream processes at Cronos Fermentation, while in parallel Ginkgo develops microorganisms for producing cultured compounds. As we develop the processes and parameters, these learnings will be used for the strains that will be used for commercial production of cultured cannabinoids. Commercial production at the facility is subject to completion of the equipment alignment for cannabinoid-based production, the receipt of the appropriate licenses from Health Canada for the production of cultured cannabinoids under the Cannabis Act and the achievement of the relevant milestones under the Ginkgo Strategic Partnership.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company is prioritizing rare cannabinoids, such as CBG, over common cannabinoids, such as THC and CBD, and will be sequencing commercial production and subsequent product launches based upon this approach. The Company currently expects to achieve its first equity milestone by the third quarter of 2021. The achievement of equity milestones for the remaining seven target cannabinoids will occur sequentially based on the Company&#8217;s future commercialization plans, which will depend on consumer insights, customer preferences and competitive opportunities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Technion Skin Health Research Partnership</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a sponsored research agreement (the &#8220;Technion Research Agreement&#8221;) with the Technion Research and Development Foundation of the Technion - Israel Institute of Technology (&#8220;Technion&#8221;) to explore the use of cannabinoids and their role in regulating skin health and skin disorders. Preclinical studies are being conducted by Technion over a three-year period and will focus on three skin conditions: acne, psoriasis and skin repair.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research is led by Technion faculty members Dr. David &#8220;Dedi&#8221; Meiri and Dr. Yaron Fuchs, two of the world&#8217;s leading researchers in cannabis and skin stem cell research, respectively. Dr. Meiri heads the Laboratory of Cannabis and Cancer Research with vast experience in cannabis and endocannabinoid research. Dr. Fuchs heads the Laboratory of Stem Cell Biology and Regenerative Medicine with years of experience in the biology of the skin and its pathologies. Development and implementation of the research is being conducted at Technion&#8217;s Laboratory of Cancer Biology and Cannabis Research and the Lorry I. Lokey Interdisciplinary Center of Life Sciences and Engineering in Haifa, Israel.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Enterprise Initiatives</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the third quarter of 2020, the Company implemented a new enterprise resource planning (&#8220;ERP&#8221;) system across the Canadian business. Cronos Group has also commenced work to broaden the scope of our ERP system to the U.S. business, which is currently expected to be launched in the first half of 2021. The new ERP system will be a meaningful component of the Company&#8217;s internal control over financial reporting and is expected to enable us to realize efficiencies throughout our supply chain and operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Competitive Conditions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Competitive Conditions in the United States</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We face competition in all aspects of our business in the U.S. hemp market. In addition to numerous small companies and brands, we compete with larger, national companies that may have larger distribution capabilities with more developed and efficient supply chain operations. The principal factors on which we compete with other U.S. hemp brands are product quality, innovation, intellectual property, brand recognition and price. We believe the Company&#8217;s strong capitalization resulting from the Altria Investment, along with the Lord Jones&#8482;, Happy Dance&#8482; and PEACE+&#8482; brand equity, recognition and differentiation in the U.S. hemp retail channel, will enable us to provide better quality consumer products, grow our U.S. hemp business and strengthen our market position in the U.S. However, rapidly evolving and developing federal and state regulatory frameworks affect all areas of our business and could result in our inability to compete successfully against our current and future competitors. See &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> -U.S. Hemp Regulatory Framework</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; for further information on regulatory framework on U.S. hemp.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Rest of World</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Competitive Conditions in Canada</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We face competition in all aspects of our business in the Canadian medical and adult-use markets. As the demand for cannabis increases as a result of the legalization of adult-use cannabis in Canada under the Cannabis Act, we believe that new competitors will continue to enter the market. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal factors on which we compete with other Canadian license holders are product quality, innovation, intellectual property, brand recognition and price. We believe the Company&#8217;s strong capitalization resulting from the Altria Investment will enable us to provide better quality consumer products, grow our Canadian business and strengthen our market position in Canada. However, a rapidly evolving and stringent federal regulatory framework affects all areas of our business. See &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;Regulatory Framework in Canada</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; for further information on the regulatory framework applicable to our Canadian business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also face competition from illegal market participants that are unlicensed and unregulated. As these illegal market participants do not comply with the regulations governing the cannabis industry, their operations may also have significantly lower costs. Any inability of the Canadian federal or provincial law enforcement authorities to enforce existing laws prohibiting the unlicensed cultivation and sale of cannabis and cannabis-based products could result in the perpetuation of the illegal market for cannabis.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="-sec-extract:summary;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Competitive Conditions in Europe and Israel </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We face competition when entering new markets in Europe and in Israel. The principal factors on which we compete are product quality, innovation, intellectual property, brand recognition, price and physician familiarity. We believe we are positioned to enter certain markets in Europe and Israel in a meaningful way while continuing to operate and penetrate the markets we currently serve, such as in Israel and Germany, due to our strong capitalization resulting from the Altria Investment, extensive experience and expertise in the highly regulated cannabis industry in Canada, which can be leveraged when entering new markets or growing existing operations, and strong partnerships with local pharmaceutical distributors. We believe these factors will enable us to develop greater market penetration, provide a greater variety of quality consumer products and enter into new markets and strengthen our existing market position in Europe and Israel. However, a patchwork of regulatory frameworks and federal regulations in these various regions also affect our ability to compete in emerging markets as evolving regulations and federal frameworks have the potential to affect all areas of our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Altria Strategic Investment</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Altria Investment and Investor Rights Agreement</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of December 31, 2020, Altria beneficially owned 156,573,537 of our common shares, had the right to acquire up to an additional 80,056,296 common shares on or prior to March 8, 2023 under the Altria Warrant, which has not been exercised, and the right to acquire additional common shares under its pre-emptive and top-up rights as discussed under</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Pre-Emptive Rights and Top-Up Rights</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">below.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investor Rights Agreement</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Altria Investment, we entered into the investor rights agreement (the &#8220;Investor Rights Agreement&#8221;) with Altria pursuant to which Altria received certain governance rights which are summarized below.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Board Representation</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Investor Rights Agreement provides that, for so long as Altria and certain of its affiliates (the &#8220;Altria Group&#8221;) continue to beneficially own at least 40% of our issued and outstanding common shares and the size of our board of directors (the &#8220;Board&#8221;) is seven directors, we agree to nominate for election as directors to the Board four individuals designated by Altria (the &#8220;Altria Nominees&#8221;). In addition, for so long as the Altria Group continues to beneficially own greater than 10% but less than 40% of our issued and outstanding common shares, Altria shall be entitled to nominate a number of Altria Nominees that represents its proportionate share of the number of directors comprising the Board (rounded up to the next whole number) based on the percentage of our issued and outstanding common shares beneficially owned by the Altria Group at the relevant time. At least one Altria Nominee must be independent as long as Atria has the right to designate at least three Altria Nominees and the Altria Group&#8217;s beneficial ownership of our issued and outstanding common shares does not exceed 50%.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Investor Rights Agreement also provides that, subject to certain exceptions, for so long as Altria is entitled to designate one or more Altria Nominees, we agree to appoint to each committee established by the Board such number of Altria Nominees that represents Altria&#8217;s proportionate share of the number of directors comprising the applicable Board committee (rounded up to the next whole number) based on the percentage of our issued and outstanding common shares beneficially owned by the Altria Group at the relevant time. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Approval Rights</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Investor Rights Agreement also grants Altria, until the Altria Group beneficially owns less than 10% of our issued and outstanding common shares, approval rights over certain transactions that may be undertaken by us. We have agreed that, among other things, we will not (and will use our commercially reasonable efforts to cause our affiliates not to), without the prior written consent of Altria:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">consolidate or merge into or with another person or enter into any similar business combination;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">acquire any shares or similar equity interests, instruments convertible into or exchangeable for shares or similar equity interests, assets, business or operations with an aggregate value of more than C$100,000,000, in a single transaction or a series of related transactions;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">sell, transfer, cause to be transferred, exclusively license, lease, pledge or otherwise dispose of any of our or any of our significant subsidiaries&#8217; assets, business or operations in the aggregate with a value of more than C$60,000,000;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">except as required by applicable law, make any changes to our policy with respect to the declaration and payment of any dividends on our common shares;</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="-sec-extract:summary;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">subject to certain exceptions, enter into any contract or other agreement, arrangement, or understanding with respect to, or consummate, any transaction or series of related transactions between us or any of our subsidiaries, on the one hand, and any related parties, on the other hand, involving consideration or any other transfer of value required to be disclosed pursuant to Item 404 of Regulation S-K promulgated pursuant to the United States Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;); or</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">engage in the production, cultivation, advertisement, marketing, promotion, sale or distribution of cannabis or any Related Products and Services (as defined herein) in any jurisdiction, including the U.S., where such activity is prohibited by applicable law as of the date of the Investor Rights Agreement (subject to certain limitations).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Exclusivity Covenant</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the terms of the Investor Rights Agreement, until the earlier of:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;the six-month anniversary of the date on which the Altria Group beneficially owns less than 10% of our issued and outstanding common shares; and</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;the six-month anniversary of the termination of the Investor Rights Agreement,</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria has agreed to make us its exclusive partner for pursuing cannabis opportunities throughout the world (subject to certain limited exceptions).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pre-Emptive Rights and Top-Up Rights</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the terms of the Investor Rights Agreement and provided the Altria Group continues to beneficially own at least 20% of our issued and outstanding common shares, Altria has a right to purchase, directly or indirectly by another member of the Altria Group, upon the occurrence of certain issuances of common shares by us (including issuances of common shares to Ginkgo under the Ginkgo Collaboration Agreement (each, a &#8220;Ginkgo Issuance&#8221;)) (each, a &#8220;Triggering Event&#8221;) and subject to obtaining the necessary approvals, up to such number of our common shares issuable in connection with the Triggering Event which will, when added to our common shares beneficially owned by the Altria Group immediately prior to the Triggering Event, result in the Altria Group beneficially owning the same percentage of our issued and outstanding common shares that the Altria Group beneficially owned immediately prior to the Triggering Event (in each case, calculated on a non-diluted basis). The price per common share to be paid by Altria pursuant to the exercise of these pre-emptive rights will be, subject to certain limited exceptions, the same price per common share at which the common shares are sold in the relevant Triggering Event; provided that if the consideration paid in connection with any such issuance is non-cash, the price per common share that would have been received had such common shares been issued for cash consideration will be determined by an independent committee (acting reasonably and in good faith); provided further that the price per common share to be paid by Altria pursuant to the exercise of its pre-emptive rights in connection with a Ginkgo Issuance will be C$16.25 per common share.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to (and without duplication of) the aforementioned pre-emptive rights, the Investor Rights Agreement provides Altria with top-up rights, exercisable on a quarterly basis, whereby, subject to obtaining the necessary approvals and for so long as the Altria Group beneficially owns at least 20% of our issued and outstanding common shares, Altria has the right to subscribe for such number of common shares in connection with any Top-Up Securities (as defined below) that we may, from time to time, issue after the date of the Investor Rights Agreement, as will, when added to the common shares beneficially owned by the Altria Group prior to such issuance, result in the Altria Group beneficially owning the same percentage of our issued and outstanding common shares that the Altria Group beneficially owned immediately prior to such issuance. &#8220;Top-Up Securities&#8221; means any of our common shares issued:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">on the exercise, conversion or exchange of our convertible securities issued prior to the date of the Investor Rights Agreement or on the exercise, conversion or exchange of our convertible securities issued after the date of the Investor Rights Agreement in compliance with the terms of the Investor Rights Agreement, in each case, excluding any of our convertible securities owned by any member of the Altria Group;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pursuant to any share incentive plan of the Company;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">on the exercise of any right granted by us pro rata to all shareholders to purchase additional common shares and/or other securities of the Company (other than a right issued in a rights offering in which Altria had the right to participate);</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">in connection with bona fide bank debt, equipment financing or non-equity interim financing transactions with our lenders, in each case, with an equity component; or</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">in connection with bona fide acquisitions (including acquisitions of assets or rights under a license or otherwise), mergers or similar business combination transactions or joint ventures undertaken and completed by us, </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in each case, other than (A) common shares issued pursuant to Altria&#8217;s pre-emptive right and (B) common shares issued pursuant to the Ginkgo Collaboration Agreement.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="-sec-extract:summary;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The price per common share to be paid by Altria pursuant to the exercise of its top-up rights will be, subject to certain limited exceptions, the volume-weighted average price of our common shares on the TSX for the 10 full days preceding such exercise by Altria; provided that the price per common share to be paid by Altria pursuant to the exercise of its top-up rights in connection with the issuance of common shares pursuant to the exercise of options or warrants that were outstanding on the date of closing of the Altria Investment will be C$16.25 per common share without any set off, counterclaim, deduction or withholding.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Standstill Covenant</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a period commencing on the date of the Investor Rights Agreement and ending on the earlier of (i) the date on which the Altria Warrant has been exercised in full by Altria, and (ii) the expiry or termination of the Altria Warrant, the Investor Rights Agreement provides that, without the prior approval of an independent committee of the Board, no member of the Altria Group shall, directly or indirectly, acquire our common shares (other than upon settlement of any of our common shares issued, sold and delivered pursuant to the proper exercise of rights contemplated by the Altria Warrant Certificate or the exercise of pre-emptive rights or top-up rights). The Altria Group, however, may make a take-over bid or commence a tender offer, in each case, to acquire not less than all of our issued and outstanding common shares (other than any such common shares beneficially owned by any member of the Altria Group and its affiliates) in accordance with applicable law.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Registration Rights</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Investor Rights Agreement provides Altria with the right, subject to certain limitations and to the extent permitted by applicable law, to require us to use reasonable commercial efforts to file a prospectus under applicable securities laws and/or a registration statement, qualifying our common shares held by Altria for distribution in Canada and/or the U.S. In addition, the Investor Rights Agreement provides Altria with the right to require us to include our common shares held by Altria in any proposed distribution of common shares in Canada and/or the U.S. by us for our own account.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commercial Arrangements</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Altria Investment, we and Altria have entered into certain commercial arrangements (the &#8220;Commercial Arrangements&#8221;), pursuant to which Altria provides us with consulting services on matters which may include R&amp;D, marketing, advertising and brand management, government relations and regulatory affairs, finance, tax planning, logistics and other corporate administrative matters. The services under the Commercial Arrangements are provided on customary terms and for a services fee payable by us that is equal to Altria&#8217;s reasonably allocated costs plus 5%.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Protection of Intangible Assets </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ownership and protection of our intellectual property rights is a significant aspect of our future success. Currently, we rely on trademarks, patents, copyrights, trade secrets, technical know-how and proprietary information. We protect our intellectual property by strategically seeking and obtaining registered protection where possible, developing and implementing standard operating procedures to protect inventions, germplasm, trade secrets, technical know-how and proprietary information and entering into agreements with parties that have access to our inventions, germplasm, trade secrets, technical know-how and proprietary information, such as our partners, collaborators, employees and consultants, to protect confidentiality and ownership. We also seek to preserve the integrity and confidentiality of our inventions, germplasm, trade secrets, trademarks, technical know-how and proprietary information by maintaining physical security of our premises and physical and electronic security of our information technology systems.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we have sought trademark protection in many jurisdictions, including Canada, Australia, the U.S., China, Israel and Europe. Our ability to obtain registered trademark protection for cannabis-related goods and services, in particular for cannabis itself, may be limited in certain countries outside of Canada. For example, in the U.S., registered federal trademark protection is only available for goods and services that can be lawfully used in interstate commerce; the PTO is not currently approving any trademark applications for U.S. Schedule I cannabis, or certain goods containing U.S. hemp-derived CBD (such as dietary supplements and food) until the FDA provides clearer guidance on the regulation of such products. In Europe, trademarks cannot be obtained for products that are &#8220;contrary to public policy or accepted principles of morality.&#8221; Accordingly, our ability to obtain intellectual property rights and enforce intellectual property rights against third-party uses of similar trademarks may be limited in certain jurisdictions. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Human Capital Resources </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Group is committed to building disruptive intellectual property by advancing cannabis research, technology and product development and is seeking to build an iconic brand portfolio. Our employees are critical to achieving this mission. In order to compete and succeed in our highly competitive and rapidly evolving industry, it is crucial that we continue to attract, develop, motivate and retain skilled, talented and passionate employees. The Company&#8217;s people strategy seeks to build a winning team and to foster a community where everyone feels included and empowered to do to their best work.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, we had 665 full-time employees and 2 full-time contractors. Of our full-time employees, 472 were in Canada, 86 were in the U.S., and 107 were in Israel. None of our employees are represented by a labor union or covered by a collective bargaining agreement.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="-sec-extract:summary;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compensation and Benefits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our compensation program is designed to attract, motivate and reward talented individuals who possess the skills necessary to support our business objectives, assist in the achievement of our strategic goals and create long-term value for our shareholders. We believe we offer competitive compensation and benefits in each of our locations, including long-term equity awards to eligible employees under our 2020 Omnibus Equity Incentive Plan to reward and retain talented individuals and align employee and shareholder interests. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Safety, Health and Well-being</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The safety, health and well-being of our employees are paramount to the Company. We provide our employees and their families with access to a variety of health and welfare programs, including benefits that support their physical and mental health by providing tools and resources to help them improve or maintain their health status. In response to COVID-19, we implemented extensive safety measures throughout the Company to protect our employees from COVID-19, including complying with social distancing and other health and safety standards as required by federal, provincial, state, local and municipal government agencies, taking into consideration guidelines of applicable public health authorities. These measures include reducing the number of employees working on-site at our production facilities to only the roles that are necessary to be performed on-site, implementing work-from-home policies for employees whose work can be performed off-site, and implementing other additional health and safety measures such as enhanced hygiene and sanitation procedures, modified work schedules, social distancing protocols at our production facilities and travel restrictions. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Engagement, Development and Training</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We are committed to developing our talent and building an agile and resilient organization with a workforce with the skillset to effectively adapt to changing business needs in order to best position the Company for success. We seek to foster a culture of employee learning and resiliency through a talent development strategy that adapts to changing business needs. Management is an active enabler of our people strategy as we seek to recruit, retain and engage top talent that will maximize our business performance. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Diversity, Equity and Inclusion and Ethical Business Practices</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We believe that a diverse and inclusive work environment mitigates the risk of group-think, ensures that the Company has the opportunity to benefit from all available talent and enhances, among other things, our organizational strength, problem-solving ability and opportunity for innovation. We continue to focus on understanding our diversity and inclusion strengths and opportunities and executing on a strategy to support further progress. We maintain a whistleblower policy and anonymous hotline for the confidential reporting of any suspected policy violations, and provide training and education to our global workforce with respect to our Code of Business Conduct and Ethics and related policies.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Regulatory Framework in the U.S.</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.S. Hemp Regulatory Framework </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We derive a portion of our revenues from the manufacture, marketing and distribution of U.S. hemp-derived supplement and cosmetic consumer products through e-commerce, retail and hospitality channels in certain states in the U.S. All U.S. hemp-derived products produced and sold by us constitute &#8220;hemp&#8221; (i) under the 2018 Farm Bill and (ii) the applicable state-law equivalent in all states in which we produce and sell such U.S. hemp-derived products. The 2018 Farm Bill was enacted in the U.S. on December 20, 2018. Prior to this enactment, cannabis was scheduled as a controlled substance (marijuana) under the CSA with limited exemptions based on the portion of the cannabis plant. The 2018 Farm Bill, among other things, removed U.S. hemp (which is defined in the 2018 Farm Bill as &#8220;the plant Cannabis sativa L. and any part of that plant, including the seeds thereof and all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers, whether growing or not, with a delta-9 tetrahydrocannabinol concentration of not more than 0.3 percent on a dry weight basis&#8221;) and its derivatives, extracts and cannabinoids, including CBD, derived from hemp, from the definition of &#8220;marijuana&#8221; in the CSA, thereby removing U.S. hemp and its derivatives as controlled substances. The 2018 Farm Bill also amended the Agricultural Marketing Act of 1946 to allow for production and sale of U.S. hemp and its derivatives in the U.S.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2018 Farm Bill tasks the USDA with promulgating regulations in relation to the cultivation and production of U.S. hemp. The 2018 Farm Bill also directs the USDA to promulgate federal regulations that would apply to the production of U.S. hemp in every state that does not put forth a state U.S. hemp plan for approval by the USDA. In January 2021, the USDA issued a final rule governing U.S. hemp production in the U.S. with an effective date of March 22, 2021. There remains some possibility that the effective date of the final rule could be extended, but the USDA has not so indicated that it intends to extend the effective date of the final rule.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The USDA&#8217;s final rule establishes a federal licensing plan for regulating U.S. hemp producers in states that do not have their own USDA-approved plans. In the absence of a state plan, U.S. hemp producers will be subject to regulation directly by the USDA unless the state prohibits U.S. hemp production. Additionally, the final rule includes requirements for maintaining information on the land where U.S. hemp is produced, testing U.S. hemp for THC levels, disposing of plants with more than 0.3 percent THC on a dry-weight basis and licensing for U.S. hemp producers. The USDA&#8217;s final rule requires hemp producers to use a laboratory that is registered with the DEA, although the USDA is delaying enforcement of this requirement until December 31, 2022. The final rule also includes provisions for producers to dispose or remediate violative hemp plants without the use of a DEA-registered reverse distributor or law enforcement.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="-sec-extract:summary;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">States may adopt regulatory schemes that impose different levels of regulation and costs on the production of U.S. hemp. Moreover, the 2018 Farm Bill provides that its provisions do not pre-empt or limit state laws that regulate the production of U.S. hemp. Accordingly, some states may choose to restrict or prohibit some or all U.S. hemp production or sales within the state and variances in states&#8217; laws and regulations on U.S. hemp are likely to persist.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, each state has discretion to develop and implement its own laws and regulations governing the manufacturing, marketing, labeling and sale of U.S. hemp products, which has created a patchwork of different regulatory schemes applicable to such products.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the 2018 Farm Bill, the FDA has retained authority over the Federal Food, Drug, and Cosmetic Act-regulated products (e.g., drugs, food, dietary supplements and cosmetics) containing U.S. hemp and U.S. hemp-derived ingredients, including CBD. Moreover, states have retained regulatory authority through their own analogues to the Federal Food, Drug, and Cosmetic Act, and the states may diverge from the federal treatment of the use of U.S. hemp as, or in, food, dietary supplements or cosmetic products.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA has consistently taken the position that CBD, whether derived from U.S. hemp or U.S. Schedule I cannabis, is prohibited from use as an ingredient in food and dietary supplements. This stems from its interpretation of the exclusionary clauses in the Federal Food, Drug, and Cosmetic Act because CBD has been approved as a prescription drug and is the subject of substantial clinical investigations as a drug, which have been made public. The exclusionary clauses under the Federal Food, Drug, and Cosmetic Act provide that a substance that has been approved or has been subject to substantial clinical investigations as a drug may not be used in a food or dietary supplement, unless the substance was first marketed in a food or dietary supplement prior to the initiation of substantial clinical investigations of the substance as a drug. The exclusionary clause does not apply to cosmetics. Cosmetics containing CBD could be viewed as drug products by the FDA if disease claims are made, or if the FDA determines the use of CBD in the product has a structure or function effect on the body (i.e., a drug effect).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA has not issued regulations that elaborate on the exclusionary clauses and the FDA has not taken any enforcement action in the courts asserting a violation of the exclusionary clauses. To date, the FDA has issued a number of warning letters to companies unlawfully marketing CBD products. In many of these cases, the manufacturers made unsubstantiated claims about the product being able to treat medical conditions (e.g., cancer, Alzheimer&#8217;s disease, opioid withdrawal, anxiety and COVID-19) and had not obtained drug approvals. Others were issued to companies marketing CBD products as dietary supplements despite those products which contain CBD not meeting the definition of a dietary supplement, adding CBD to human and animal foods and marketing CBD products for infants and children and other vulnerable populations. Some of these letters were co-signed with the FTC and cited the companies for making claims about the efficacy of CBD and other ingredients which were not substantiated by competent and reliable scientific evidence. In December 2020, the FTC announced it had entered into settlement agreements with six companies marketing CBD products including oils, gummies, creams, and others with deceptive health claims about serious health conditions. The settlements included monetary penalties ranging from $20,000 to $85,000. The FDA has also issued one warning letter to a dietary supplement manufacturer objecting to a CBD supplement on the basis that CBD was not a permissible dietary supplement ingredient.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2019, the FDA published a revised &#8220;Consumer Update&#8221; on CBD. The update noted that, as at the time of the Consumer Update, the FDA has approved only one CBD product, a prescription drug product to treat two rare, severe forms of epilepsy. The update also stated that it is illegal to market CBD by adding it to a food or labeling it as a dietary supplement, that the FDA has seen only limited data about CBD safety and these data point to real risks that need to be considered before taking CBD for any reason and that some CBD products are being marketed with unproven medical claims and are of unknown quality. Lastly, the FDA stated that it continues to evaluate the regulatory frameworks that apply to certain cannabis-derived products that are intended for non-drug uses, including whether and/or how they might consider updating their regulations, as well as whether potential legislation might be appropriate.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA has stated that it recognizes the potential opportunities and significant interest in drug and other consumer products containing CBD, is committed to evaluating the agency&#8217;s regulatory policies related to CBD and has established a dedicated internal working group to explore potential pathways for various types of CBD products to be lawfully marketed. The FDA held a public hearing in May 2019 to obtain scientific data and information about the safety, manufacturing, product quality, marketing, labeling and sale of products containing cannabis or cannabis-derived compounds. The rules and regulations and enforcement in this area continue to evolve and develop. In July 2020, the FDA sent to the White House Office of Management and Budget (the &#8220;OMB&#8221;) for review a draft guidance, &#8220;Cannabidiol Enforcement Policy,&#8221; the details of which were not made public. This guidance remained under review at the OMB until January 2021, when it was withdrawn by the FDA as a part of the regulatory moratorium Executive Order issued by President Biden. The timeline for further CBD policy development remains uncertain while the new administration is put into place and as the FDA faces competing regulatory priorities. In December 2020, the FDA announced a framework for leveraging real world evidence to better understand CBD safety and a number of research projects the agency plans to develop to address gaps in current CBD research. At the same time, the FDA reiterated that CBD remains subject to the same safety standard as any other ingredient based on its intended use, and that there remain a number of safety issues that need to be addressed in order to support the safety of CBD as a food or dietary supplement ingredient. The FDA also announced an expansion of its market sampling and analytical testing of CBD products, as well as issued a new series of Warning Letters against companies marketing CBD products with serious disease claims, including products that the agency viewed as posing serious health risks based on their route of administration, including nasal, ophthalmic and inhalable products.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="-sec-extract:summary;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For more information regarding certain risks facing our business in connection with the U.S. hemp regulatory framework in the U.S., see the section below entitled &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors - Risks Relating to Regulation and Compliance - Risks Related to U.S. Regulations and Compliance.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Regulatory Framework in Canada</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Licenses and Regulatory Framework</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 17, 2018, the Cannabis Act and the Cannabis Regulations (the &#8220;Cannabis Regulations&#8221;) came into force. The Cannabis Regulations establish six classes of licenses: </span></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">cultivation;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">processing;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">sale for medical purposes;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">analytical testing;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">research; and</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">cannabis drug. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Cannabis Regulations also create subclasses for cultivation licenses (standard cultivation, micro-cultivation and nursery) and processing licenses (standard processing and micro-processing). Different licenses and each sub-class therein carry differing rules and requirements that are intended to be proportional to the public health and safety risks posed by each category and sub-class.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Federal Regime</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Cannabis Act provides a licensing and permitting scheme for, among other things, the cultivation, processing, testing, packaging, labeling, distribution, sale, possession and disposal of adult-use cannabis, implemented by regulations promulgated under the Cannabis Act. The Cannabis Act and Cannabis Regulations include, among other things, strict specifications for the plain packaging and labeling and analytical testing of all cannabis products as well as stringent physical and personnel security requirements for all federally licensed cultivation, processing and sales sites.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 17, 2019, the Regulations Amending the Cannabis Regulations (the &#8220;Further Regulations&#8221;) came into effect. The Further Regulations amend the Cannabis Act and Cannabis Regulations to, among other things, permit the production and sale of cannabis extracts (including concentrates), cannabis topicals and cannabis edibles, in addition to dried cannabis, cannabis oil, fresh cannabis, cannabis plants and cannabis seeds for parties holding the appropriate licenses. The Cannabis Regulations set out certain requirements for the sale of cannabis products, including limiting the THC content and serving size of certain product forms.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Health Canada allows license holders to export cannabis and cannabis products with appropriate export permits. Export permits issued by Health Canada are specific to each shipment and may only be obtained for medical or scientific purposes. To apply for a permit to export cannabis, a license holder must submit significant information to the minister including information about the substance to be exported (including description, intended use, quantity) and the importer. As part of the application, applicants are also required to provide a copy of the import permit issued by a competent authority in the jurisdiction of final destination and to make a declaration to the minister that the shipment does not contravene the laws of the jurisdiction of the final destination or any country of transit or transshipment. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Cannabis Act requires the federal government to conduct a review of the Cannabis Act beginning in October 2021</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This statutory review is required to include, among other things, consideration of (i) the administration and operation of the Cannabis Act, (ii) the impact of the Cannabis Act on public health, (iii) the health and consumption habits of young persons, (iv) the impact of cannabis on indigenous persons and communities and (v) the impact of the cultivation of cannabis plants in a dwelling-house. This statutory review may lead to the amendment, removal or addition of provisions in or to the Cannabis Act which could </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">adversely affect our business</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the current medical and adult-use regimes under the Cannabis Act, Health Canada has also been considering the implementation of a cannabis health product regime for products with potential therapeutic uses that would not require practitioner oversight. Between June and September 2019, Health Canada held a public consultation titled &#8220;Potential Market for Cannabis Health Products (CHPs) that would not Require Practitioner Oversight&#8221;. The consultation sought feedback from Canadians on the kinds of cannabis health products they would be interested in if such products were made available in Canada. A summary report of the consultation results was published by Health Canada in September 2020. Given the results of the consultation, Health Canada has indicated that it intends to obtain external scientific advice on the appropriate evidence standards required to demonstrate safety, efficacy and quality in cannabis health products, with the information it gathers informing the next steps on a potential implementation of a cannabis health product regime.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="-sec-extract:summary;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Provincial and Territorial Developments </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the Cannabis Act provides for the regulation by the Canadian federal government of, among other things, the commercial cultivation and processing of cannabis and the sale of medical cannabis, the various provinces and territories of Canada regulate certain aspects of adult-use cannabis, such as distribution, sale, minimum age requirements, places where cannabis can be consumed, and a range of other matters.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The governments of each Canadian province and territory have implemented their regulatory regimes for the distribution and sale of cannabis for adult-use purposes which continue to evolve over time. Most provinces and territories have announced a minimum age for possession and consumption of 19 years old, except for Qu&#233;bec and Alberta, where the minimum age is 21 and 18, respectively. In addition, provinces and territories may impose restrictions on sales, distribution and promotion which are more stringent than those at the federal level. For example, the SQDC, the exclusive distributor of cannabis in the province and the sole retail and online vendor in Qu&#233;bec, does not permit cannabis vaporizers or other high THC non-edible cannabis products to be sold through its channels. The SQDC has also placed significant restrictions on the types of edibles that may be sold through its channels, prohibiting edibles that are sweet, confectionary, dessert, chocolate or any other product attractive to persons under 21 years of age. Similarly, the Prince Edward Island Cannabis Management Corporation and the province of Newfoundland and Labrador also do not allow cannabis vaporizers to be sold through their channels.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Licenses and Regulatory Framework in Israel</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In Israel, cannabis is subject to the Israeli Dangerous Drugs Ordinance [New Version], 5733 - 1973, and its sale and use are prohibited unless applicable licenses have been obtained. Licenses to cultivate, possess and use cannabis for medical or research purposes in Israel are granted by the Israel Medical Cannabis Agency within the Israeli Ministry of Health (the &#8220;Yakar&#8221; and the &#8220;Israeli MOH&#8221;, respectively). Patients also must obtain licenses either directly from physicians who have been authorized to grant patient licenses or from the Yakar following a request from the patient&#8217;s physician in order to purchase and consume medical cannabis. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2019, the Israeli government approved, in principle, the export from Israel of medical cannabis products that meet applicable quality standards under the strict supervision of the Israeli authorities. Only products that can be directly marketed to patients (including smoking products, oils, and vaporizer products) may be exported, and only to those countries that have signed the United Nations Single Convention on Narcotic Drugs and that have explicitly approved the import of cannabis. The export of plant substances, including seeds and tissue cultures, is not permitted. In October 2020, the Israeli MOH initiated a pilot program in which certain medical cannabis companies were permitted to export their products, and the Yakar issued guidelines relating to the export of medical cannabis products. These guidelines set forth the process and conditions for obtaining an export license, which can only be issued to an applicant already holding a valid Yakar license.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cronos Israel Licenses </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2020, the Yakar granted Cronos Israel: (1) full Good Agricultural Practices (&#8220;GAP&#8221;) certification, including a permit to cultivate at the full capacity of the greenhouse; and (2) GMP and Good Distribution Practices (&#8220;GDP&#8221;) certificates and permits to produce and distribute dried flower. During the third quarter of 2020, Cronos Israel also received GMP and GDP certificates and permits to produce and distribute cannabis oils and pre-rolls.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Licenses and Regulatory Framework in Other Jurisdictions</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and our joint venture partners and strategic investments are subject to comprehensive and evolving regulations in each jurisdiction we and they operate. All aspects of the production, manufacture and distribution of cannabis products are regulated and subject to licensing regimes. These regulations and licensing regimes vary by jurisdiction and we, our joint venture partners and strategic investments spend significant time, effort and money to comply with the applicable requirements. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Available Information</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to the informational requirements of the United States Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), and, in accordance with the Exchange Act, we also file reports with and furnish other information to the SEC. The public may obtain any document that we file with or furnish to the SEC from the SEC&#8217;s Electronic Document Gathering, Analysis, and Retrieval system, which can be accessed at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.sec.gov</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, or via the System for Electronic Document Analysis and Retrieval, which can be accessed at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.sedar.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as well as from commercial document retrieval services. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Copies of this Annual Report may be obtained on request without charge from our Corporate Secretary, corporate.secretary@thecronosgroup.com, telephone: +1-416-504-0004. We also provide access without charge to all of our SEC filings, including copies of this Annual Report, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act, as soon as reasonably practicable after filing or furnishing, on our website located at&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">https://thecronosgroup.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="-sec-extract:summary;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we use our website, as well as the following social media sites, as an additional means of disclosing public information to investors, the media and others interested in the Company.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Facebook (https://www.facebook.com/The-Cronos-Group-419168411987225);</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Twitter (https://twitter.com/cronosgroup); and</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">LinkedIn (https://www.linkedin.com/company/cronosgroupcron/?viewAsMember=true).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is possible that certain information we post on our website or these social media sites could be deemed to be material information, and we encourage investors, the media and others interested in the Company to review the business and financial information we or our officers post on our website or these social media sites. None of the information on our website or disclosed through these social media sites is incorporated by reference into this&#160;Annual Report.&#160;</span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div id="i1ae9134e40e74e0aac958218112e53d4_19"></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1A. RISK FACTORS</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">An investment in us involves a number of risks. In addition to the other information contained in this Annual Report and in other filings we make, investors should give careful consideration to the following risk factors. Any of the matters highlighted in these risk factors could adversely affect our business, results of operations and financial condition, causing an investor to lose all, or part of, its, his or her investment. The risks and uncertainties described below are those we currently believe to be material, but they are not the only ones we face. If any of the following risks, or any other risks and uncertainties that we have not yet identified or that we currently consider not to be material, actually occur or become material risks, our business, prospects, financial condition, results of operations and cash flows and consequently the price of our securities could be materially and adversely affected.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risk Factor Summary</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We have a limited operating history and our growth strategy may not be successful.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our products are new; the safety of our products is subject to conflicting medical data; and our products have been and may be in the future subject to recalls.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The production and distribution of our products is subject to disruption, the risks of an agricultural business and the risk third party suppliers and distributors may not perform their obligations to us. </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Intellectual property is key to our growth strategy and we may be unable to obtain or enforce our intellectual property rights.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our entry into new markets is subject to risks normally associated with the conduct of business in foreign countries.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are subject to extensive regulation and licensing and may not successfully comply with all applicable laws and regulations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our business has been and may be adversely affected by the COVID-19 pandemic.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our businesses face highly competitive conditions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Altria has significant influence over us and may acquire over 50% of our common shares.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The price of our common shares has been and may continue to be highly volatile. </span></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are subject to other risks generally applicable to our industry and the conduct of our businesses.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Relating to Our Growth Strategy.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We and certain of our subsidiaries have limited operating history and therefore we are subject to many of the risks common to early-stage enterprises.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We began carrying on business in 2013; Peace Naturals began operations in 2012 and generated its first revenues in 2013; OGBC began operations in 2014 and generated revenue in 2017 (inter-company bulk transfer); Redwood began operations in 2017. In addition, many of our joint ventures are not yet operational and may not become operational for some time, if at all.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are therefore subject to many of the risks common to early-stage enterprises, including limitations with respect to personnel, financial, and other resources and lack of revenues. </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be able to achieve or maintain profitability and may continue to incur losses in the future.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have incurred significant losses in recent periods. We had negative operating cash flow for the fiscal years ending December 31, 2020, December 31, 2019, December 31, 2018, December 31, 2017, December 31, 2016, December 31, 2015 and December 31, 2014. We may not be able to achieve or maintain profitability and may continue to incur significant losses in the future. In addition, we expect to continue to increase operating expenses as we implement initiatives to continue to grow our business. If our revenues do not increase to offset these expected increases in costs and operating expenses, we will not be profitable. If our revenue declines or fails to grow at a rate faster than our operating expenses, and we are unable to secure funding under terms that are favorable or acceptable to us, or at all, we will not be able to achieve and maintain profitability in future periods. As a result, we may continue to generate losses. We may not achieve profitability in the future and, even if we do become profitable, we might not be able to sustain that profitability.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be able to successfully manage our growth.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are currently in an early development stage and may be subject to growth-related risks, including capacity constraints and pressure on our internal systems and controls, which may place significant strain on our operational and managerial resources. While our revenue has grown in recent years, our ability to manage and sustain revenue growth will depend on a number of factors, many of which are beyond our control, including, but not limited to, changes in laws and regulations respecting the production of U.S. hemp and cannabis products, competition from other license holders, the size of the illegal market and the adult-use market in Canada, and our ability to produce sufficient volumes of our products to meet client demand. In addition, we are subject to a variety of business risks generally associated with developing companies. Our ability to manage growth effectively will require us to continue to implement and improve our operational and financial systems and to expand, train and manage our employee base. There can be no assurances that we will be able to manage growth successfully. Any inability to manage growth successfully could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have identified at year-end 2020 a material weakness in our internal control over financial reporting. If we are unable to remediate this material weakness, or if we experience additional material weaknesses in the future, our business may be harmed.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) and for evaluating and reporting on the effectiveness of our system of internal control. Effective internal controls are necessary for us to provide timely, reliable and accurate financial reports, identify and proactively correct any deficiencies, material weaknesses or fraud and meet our reporting obligations. As disclosed in Part II, Item 9A, we identified a material weakness in the fourth quarter of 2020. Remediation efforts place a significant burden on management and add increased pressure on our financial reporting resources and processes. If we are unable to successfully remediate this material weakness in a timely manner, or if any additional material weaknesses in our internal control over financial reporting are identified, the accuracy of our financial reporting and our ability to timely file with the SEC may be adversely impacted. In addition, if our remedial efforts are insufficient, or if additional material weaknesses or significant deficiencies in our internal controls occur in the future, we could be required to restate our financial statements, which could materially and adversely affect our business, results of operations and financial condition, restrict our ability to access the capital markets, require us to expend significant resources to correct the material weaknesses or deficiencies, subject us to regulatory investigations and penalties, harm our reputation, cause a decline in investor confidence or otherwise cause a decline in our stock price.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not successfully execute our production capacity expansion strategy.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may not be successful in executing our strategy to expand production capacity at our facilities and joint ventures. Continuing and expanding operations at the production facilities of Cronos Israel and Natuera will be subject to obtaining and maintaining the appropriate licenses from the relevant regulatory agencies in those jurisdictions. In addition, continuing and expanding operations at Cronos GrowCo&#8217;s production facilities will be subject to obtaining and maintaining the appropriate licenses from Health Canada. Construction delays or cost over-runs in respect of such operations, howsoever caused, could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we may not be successful in obtaining the necessary approvals required to export or import our products to or from the jurisdictions in which we operate. If we are unable to secure necessary production licenses in respect of our facilities and those of our joint ventures, the expectations of management with respect to the increased future cultivation and growing capacity may not be borne out, which could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The industries and markets in which we operate are relatively new, and these industries and markets may not continue to exist or grow as anticipated or we may ultimately be unable to succeed in these industries and markets.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cannabis and U.S. hemp industries and markets in which we operate are relatively new, can be highly speculative, are rapidly expanding and may ultimately not be successful. In addition to being subject to general business risks, we need to continue to build brand awareness in these industries and markets through significant investments in our strategy, our production capacity, quality assurance and compliance with regulations. These activities may not promote our brand and products as effectively as intended, or at all. Competitive conditions, consumer tastes or client requirements, as applicable, and spending patterns in these new industries and markets are relatively unknown and may have unique circumstances that differ from existing industries and markets. We are subject to all of the business risks associated with a new business in a niche market, including risks of unforeseen capital requirements, failure of widespread market acceptance of our products, failure to establish business relationships and competitive disadvantages against larger and more established competitors. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accordingly, there are no assurances that these industries and markets will continue to exist or grow as currently estimated or anticipated, or function and evolve in a manner consistent with management&#8217;s expectations and assumptions, and a failure to do so could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be able to supply the provincial purchasers in various provinces and territories of Canada with our products in the quantities or prices anticipated, or at all.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into various supply arrangements for cannabis products with various provincial purchasers and have secured listings with various private retailers in those provinces. We have entered into such supply arrangements with eight provinces in Canada (where the relevant provincial body is the sole wholesale distributor and retailer of cannabis and cannabis products in the province) and with private retailers in Saskatchewan. Our supply arrangements with provincial purchasers, each of which we understand to be substantially similar in all material respects with the supply arrangements entered into with the other license holders in the Canadian cannabis industry, do not contain any binding minimum purchase obligations on the part of the relevant provincial purchaser. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect purchase orders to be primarily driven by end-consumer demand for our products and the relevant provincial purchaser supply at the relevant time. Accordingly, we cannot predict the quantities of our products that will be purchased by the provincial purchasers, or if our products will be purchased at all. Provincial purchasers may change the terms of the supply agreements at any time during the supply relationship including pricing, have broad rights of return of products and are under no obligation to purchase our products or maintain any listings of our products for sale. As a result, provincial purchasers have a significant amount of control over the terms of the supply arrangements.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The effect of the legalization of adult-use cannabis in Canada on the medical cannabis market in Canada is still uncertain, and it may have a significant negative effect upon our medical cannabis business if our existing or future medical-use clients decide to purchase products available in the adult-use market instead of purchasing medical-use products from us.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Cannabis Act allows individuals over the age of 18 to legally purchase, process and cultivate limited amounts of cannabis for adult-use in Canada, subject to provincial and territorial age restrictions which may increase the age of purchase in the province or territory. As a result, individuals who rely upon the medical cannabis market to supply their medical cannabis and cannabis-based products may cease this reliance, and instead turn to the adult-use cannabis market to supply their cannabis and cannabis-based products. Factors that will influence this decision include the price of medical cannabis products in relation to similar adult-use cannabis products, the amount of active ingredients in medical cannabis products in relation to similar adult-use cannabis products, the types of cannabis products available to adult users and limitations on access to adult-use cannabis products imposed by the regulations under the Cannabis Act and the legislation governing the distribution and sale of cannabis that has been enacted by the individual provinces and territories of Canada.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impact of the legalization of adult-use cannabis in Canada on the medical cannabis market is uncertain, and while we cannot predict its impact on our sales and revenue prospects, it may be adverse. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The adult-use cannabis market in Canada has in the past been and may in the future become oversupplied following the recent implementation of the Cannabis Act and the related legalization of cannabis for adult-use.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the recent implementation of the Cannabis Act and the legalization of adult cannabis use, numerous additional cannabis producers have and may continue to enter the Canadian adult-use market. We and such other cannabis producers have in the past produced and may in the future produce more cannabis than is needed to satisfy the collective demand of the Canadian medical and adult-use markets, and we may be unable to export that over-supply into other markets. As a result, the available supply of cannabis could exceed demand, which could result in a significant decline in the market price for cannabis, which could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be unsuccessful in competing in the legal adult-use cannabis market in Canada.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We face competition from existing license holders licensed under the Cannabis Act. Certain of these competitors may have significantly greater financial, production, marketing, R&amp;D and technical and human resources than we do. As a result, our competitors may be more successful than us in gaining market penetration and market share in the adult-use cannabis industry in Canada. Our commercial opportunity in the adult-use market could be reduced or eliminated if our competitors produce and commercialize products for the adult-use market that, among other things, are safer, more effective, more convenient or less expensive than the products that we may produce, have greater sales, marketing and distribution support than our products, enjoy enhanced timing of market introduction and perceived effectiveness advantages over our products and receive more favorable publicity than our products. If our adult-use products do not achieve an adequate level of acceptance by the adult-use market, we may not generate sufficient revenue from these products, and our adult-use business may not become profitable.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Cannabis Act allows individuals over the age of 18 to cultivate, propagate, harvest and distribute up to four cannabis plants per household provided that each plant meets certain requirements, although various restrictions on these activities exist in certain provinces and territories. If we are unable to effectively compete with other license holders in the adult-use cannabis market, or a significant number of individuals take advantage of the ability to cultivate and use their own cannabis, our adult-use business may be negatively impacted.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to liability arising from any fraudulent or illegal activity by our employees, contractors and consultants. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to the risk that our employees, independent contractors and consultants may engage in fraudulent or other illegal activity. Misconduct by these parties could include intentional, reckless and/or negligent conduct or disclosure of unauthorized activities to us that violates: (i) applicable laws and regulations; (ii) manufacturing standards; (iii) federal and provincial healthcare fraud and abuse of federal, state and provincial laws and regulations; or (iv) laws that require the true, complete and accurate reporting of financial information or data. It is not always possible for us to identify and deter misconduct by our employees and other third parties, and the precautions taken by us to detect and prevent this activity may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure to be in compliance with such laws or regulations. If any such actions are brought against us, and we are not successful in defending the Company or asserting our rights, those actions could have a significant impact on our business, including the imposition of civil, criminal and administrative penalties, damages, monetary fines, contractual damages, reputational harm, diminished profits and future earnings, and the curtailment of our operations, any of which could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Some jurisdictions may never develop markets for cannabis and U.S. hemp.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many jurisdictions place restrictions on or prohibit commercial activities involving cannabis and U.S. hemp. Such restrictions or prohibitions may make it impossible or impractical for us to enter or expand our operations in such jurisdictions unless there is a change in law or regulation. For example, U.S. Schedule I cannabis remains illegal under U.S. federal law and may never become legal under U.S. federal law. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We must rely largely on our own market research to forecast sales and market demand and market prices which may differ from our forecasts. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We must rely largely on our own market research and internal data to forecast sales as detailed market research is not generally obtainable from other sources at this early stage of the cannabis or U.S. hemp industries. Our market research and sales forecasts, together with factors such as our expectations regarding market conditions, including prices, influence capital expenditure levels, inventory levels, production and supply chain capacity and operating expenses and if such forecasts and expectations prove to be inaccurate, this could have a material adverse effect on our business, financial condition and results of operations. For example, our forecast for product demand and market conditions was impacted by a decline in market prices for cannabis products in the Canadian market, which contributed to our inventory write-down in the second and fourth quarters of 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We could have difficulty transitioning the operations of businesses that we have acquired and will acquire. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The success of our acquisitions, including the Redwood Acquisition and the acquisition of Cronos Fermentation, depends upon our ability to transition any businesses that we acquire. The transitioning of acquired business operations could disrupt our business by causing unforeseen operating difficulties, diverting management&#8217;s attention from day-to-day operations and requiring significant financial resources that would otherwise be used for the ongoing development of our business. The difficulties of transitions could be increased by the necessity of coordinating geographically dispersed organizations, coordinating personnel with disparate business backgrounds and managing different corporate cultures, or discovering previously unknown liabilities. In addition, we could be unable to retain key employees or customers of the acquired businesses. We could face transition issues including those related to operations, internal controls, information systems and operational functions of the acquired companies and we also could fail to realize cost efficiencies or synergies that we anticipated when selecting our acquisition candidates or these acquisitions could fail to complete successfully. Any of these items could adversely affect our results of operations.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Relating to Our Products</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">There is limited long-term data with respect to the efficacy and side effects of our products and future clinical research studies on the effects of cannabis, hemp and cannabinoids may lead to conclusions that dispute or conflict with our understanding and belief regarding their benefits, viability, safety, efficacy, dosing and social acceptance.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research in Canada, the U.S. and internationally regarding the benefits, viability, safety, efficacy, dosing and social acceptance of cannabis, U.S. hemp or isolated cannabinoids (such as CBD and THC) in dietary supplements, food, or cosmetic products remains in early stages. There have been relatively few clinical trials on the benefits of cannabis, U.S. hemp or isolated cannabinoids and there is limited long-term data with respect to efficacy, side effects and/or interaction of these substances with human or animal biochemistry. As a result, our products could have unexpected side effects or safety concerns, the discovery of which could lead to civil litigation, regulatory actions and even possibly criminal enforcement actions. In addition, if the products we sell do not or are not perceived to have the effects intended by the end user, this could have a material adverse effect on our business, financial condition and results of operations. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The statements made by the Company, including in this Annual Report, concerning the potential benefits of cannabis, U.S. hemp and isolated cannabinoids are based on published articles and reports and therefore are subject to the experimental parameters, qualifications and limitations in such studies that have been completed. Although we believe that the existing public scientific literature generally supports our beliefs regarding the benefits, viability, safety, efficacy, dosing and social acceptance of cannabis, U.S. hemp and cannabinoids, future research and clinical trials may cast doubt or disprove such beliefs, or could raise or heighten concerns regarding, and perceptions relating to, cannabis, U.S. hemp and cannabinoids, which could have a material adverse effect on the demand for our products with the potential to lead to a material adverse effect on our business, financial condition and results of operations. Given these risks, uncertainties and assumptions, undue reliance should not be placed on such literature. In particular, the FDA has raised several questions regarding the safety of CBD and gaps in the public scientific literature supporting the use of CBD by the general population.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Clinical trials of cannabis-based medical products and treatments are novel terrain with very limited or non-existent history, and any trials may not result in commercially viable products and treatments.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clinical trials are expensive, time consuming and difficult to design and implement. Regulatory authorities may suspend, delay or terminate any clinical trials we commence at any time, may require us, for various reasons, to conduct additional clinical trials, or may require a particular clinical trial to continue for a longer duration than originally planned. Clinical trials face many risks, including, among others:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">lack of effectiveness of any formulation or delivery system during clinical trials;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">discovery of serious or unexpected toxicities or side effects experienced by trial participants or other safety issues&#894;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">slower than expected subject recruitment and enrollment rates in clinical trials&#894;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">delays or inability in manufacturing or in obtaining sufficient quantities of materials for use in clinical trials due to regulatory and manufacturing constraints&#894;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">delays in obtaining regulatory authorization to commence a trial, including licenses required for obtaining and using cannabis for research, either before or after a trial is commenced&#894;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">unfavorable results from ongoing pre-clinical studies and clinical trials;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">trial participants or investigators failing to comply with study protocols&#894;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">trial participants failing to return for post-treatment follow-up at the expected rate&#894;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">sites participating in an ongoing clinical study withdraw, requiring us to engage new sites&#894; and</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">third-party clinical investigators declining to participate in our clinical studies, not performing the clinical studies on the anticipated schedule, or acting in ways inconsistent with the established investigator agreement, clinical study protocol or good clinical practices.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any of the foregoing could cause our products or treatments not to be commercially viable.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The controversy surrounding vaporizers and vaporizer products may materially and adversely affect the market for vaporizer products and expose us to litigation and additional regulation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been a number of highly publicized cases involving lung and other illnesses and deaths that appear to be related to vaporizer devices and/or products used in such devices (such as vaporizer liquids). The focus is currently on the vaporizer devices, the manner in which the devices were used and the related vaporizer device products &#8211;THC, nicotine, other substances in vaporizer liquids, possibly adulterated products and other illegal unlicensed cannabis vaporizer products. Some states, provinces, territories and cities in the U.S. and Canada have already taken steps to prohibit the sale or distribution of vaporizers, restrict the sale and distribution of such products or impose restrictions on flavors or use of such vaporizers. This trend may continue, accelerate and expand.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cannabis vaporizers in Canada are regulated under the Cannabis Act and Cannabis Regulations. Although this legislation sets rules and standards for the manufacture, composition, packaging, and marketing of cannabis vaporizer products, these rules and standards predate the spate of vaporizer-related health issues that have recently arisen in the U.S. These issues and accompanying negative public sentiment may prompt Health Canada or individual provinces/territories to decide to further limit or defer the industry&#8217;s ability to sell cannabis vaporizer products, and may also diminish consumer demand for such products. Currently, Qu&#233;bec, Newfoundland and Labrador and Prince Edward Island do not allow the sale of cannabis vaporizers in their respective jurisdictions. There can be no assurance that these jurisdictions will allow the sale of cannabis vaporizers in the future, that other jurisdictions will not prohibit the sale of cannabis vaporizers, that we will be able to meet any additional compliance requirements or regulatory restrictions, or that we will remain competitive in face of unexpected changes in market conditions</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An extension of this controversy to non-nicotine vaporizer devices and other product formats could materially and adversely affect our business, financial condition, operating results, liquidity, cash flow and operational performance. In February 2020, the U.S. Centers for Disease Control reported that federal and state agencies were investigating an outbreak of over 2,807 lung injury cases associated with the use of vaporizer products, including non-nicotine containing products. Litigation pertaining to vaporizer products is accelerating and that litigation could potentially expand to include our products, which would materially and adversely affect our business, financial condition, operating results, liquidity, cash flow and operational performance.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Future research may lead to findings that vaporizers, electronic cigarettes and related products are not safe for their intended use.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vaporizers, electronic cigarettes and related products were recently developed and therefore the scientific or medical communities have had a limited period of time to study the long-term health effects of their use. Currently, there is limited scientific or medical data on the safety of such products for their intended use and the medical community is still studying the health effects of the use of such products, including the long-term health effects. If the scientific or medical community were to determine conclusively that use of any or all of these products pose long-term health risks, market demand for these products and their use could materially decline. Such a determination could also lead to litigation, reputational harm and significant regulation. Loss of demand for our product, product liability claims and increased regulation stemming from unfavorable scientific studies on cannabis vaporizer products could have a material adverse effect on our business, financial condition, operating results, liquidity, cash flow and operational performance.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We, or the cannabis and U.S. hemp industries more generally, may receive unfavorable publicity or become subject to negative consumer perception.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe the cannabis and U.S. hemp industries are highly dependent upon broad social acceptance and consumer perception regarding the safety, efficacy and quality of the cannabis and U.S. hemp products, as well as consumer views concerning regulatory compliance. Consumer perception of our products can be significantly influenced by scientific research or findings, regulatory investigations, litigation, media attention, market rumors or speculation and other publicity regarding the consumption of cannabis and U.S. hemp products. There can be no assurance that future scientific research, findings, regulatory proceedings, litigation, media attention or other research findings or publicity will be favorable to the cannabis or U.S. hemp markets or any particular product, or consistent with earlier publicity. Future research reports, findings, regulatory proceedings, litigation, media attention or other publicity that are perceived as less favorable than, or that question, earlier research reports, findings or publicity could have a material adverse effect on the demand for our products and our business, financial condition and results of operations. Our dependence upon consumer perceptions means that adverse scientific research reports, findings, regulatory proceedings, litigation, media attention or other publicity, whether or not accurate or with merit, could have a material adverse effect on the demand for products, and our business, results of operations, financial condition and cash flows. Further, adverse publicity reports or other media attention regarding the safety, efficacy and quality of U.S. hemp or cannabis in general, or our products specifically, or associating the consumption or use of U.S. hemp or cannabis with illness or other negative effects or events, could have such a material adverse effect. Such adverse publicity reports or other media attention could arise even if the adverse effects associated with such products resulted from consumers&#8217; failure to consume such products legally, appropriately or as directed.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increased usage of social media and other web-based tools used to generate, publish and discuss user-generated content and to connect with other users has made it increasingly easier for individuals and groups to communicate and share opinions and views on our operations and activities, whether true or not, and the U.S. hemp and cannabis industries in general, whether true or not. Social media permits user-generated content to be distributed to a broad audience which can respond or react, in near real time, with comments that are often not filtered or checked for accuracy. Accordingly, the speed with which negative publicity (whether true or not) can be disseminated has increased dramatically with the expansion of social media. The dissemination of negative or inaccurate posts, comments or other user-generated content about us on social media (including those published by third-parties) could damage our brand, image and reputation or how the U.S. hemp or cannabis industries are perceived generally, which could have a detrimental impact on the market for our products and thus on our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain well-funded and significant businesses may have strong economic opposition to the U.S. hemp or cannabis industries. Lobbying by such groups, and any resulting inroads they might make in halting or rolling back the U.S. hemp and cannabis movements, could affect how the U.S. hemp or cannabis industries are perceived by others and could have a detrimental impact on the market for our products and thus on our business, financial condition and results of operations.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The parties with which we do business, may perceive that they are exposed to reputational risk as a result of our cannabis or U.S. hemp business activities. Failure to establish or maintain business relationships could have a material adverse effect on our business, financial condition and results of operations. Any third-party service provider or supplier could suspend or withdraw its services to us if it perceives that the potential risks exceed the potential benefits to such services. For example, we face challenges making U.S. dollar wire transfers or engaging any third-party service provider or supplier with a substantial presence where cannabis is not federally legal (including the U.S.). While we have other banking relationships and believe that the services can be procured from other institutions, we may in the future have difficulty maintaining existing, or securing new, bank accounts or clearing services, service providers or other vendors.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we take care in protecting our image and reputation, we do not ultimately have control over how we or the U.S. hemp or cannabis industries are perceived by others. Reputation loss may result in decreased investor confidence, increased challenges in developing and maintaining community relations and an impediment to our overall ability to advance our business strategy and realize on our growth prospects, thereby having a material adverse impact on our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be subject to litigation in the ordinary course of our marketing, distribution and sale of our products. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to litigation, claims and other legal and regulatory proceedings from time to time in the ordinary course of our marketing, distribution and sale of our products, some of which may adversely affect our business, financial condition and results of operations. Several companies in the U.S. hemp-derived CBD industry, including the Company, have recently become party to an increasing number of purported class actions lawsuits relating to their food and dietary supplement products containing U.S. hemp-derived CBD. While the case against the Company was dismissed, similar class actions may be filed against us again, and the plaintiffs in such class action lawsuits, as well as in other lawsuits against us, may seek very large or indeterminate amounts, including punitive damages, which may remain unknown for substantial periods of time. Should any litigation in which we become involved be determined against us, such a decision could adversely affect our ability to continue operating, adversely affect the market price for the common shares and require the use of significant resources. Even if we are involved in litigation and win, litigation can redirect significant resources. Litigation may also create a negative perception of our brands, which could have an adverse effect on our business, financial condition and results of operations. See Item 3 in Part I of this Annual Report for more details on our legal proceedings.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be subject to product liability claims.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a manufacturer and distributor of products designed to be ingested by humans, we face an inherent risk of exposure to product liability claims, regulatory action and litigation if our products are alleged to have caused significant loss or injury. In addition, the manufacture and sale of cannabis and U.S. hemp products involve the risk of injury to consumers due to tampering by unauthorized third parties or product contamination. Previously unknown adverse reactions resulting from human consumption of cannabis or U.S. hemp products alone or in combination with other medications or substances could occur as described under &#8220;&#8212; There is limited long-term data with respect to the efficacy and side effects of our products and future clinical research studies on the effects of cannabis, U.S. hemp and cannabinoids may lead to conclusions that dispute or conflict with our understanding and belief regarding their benefits, viability, safety, efficacy, dosing and social acceptance.&#8221; We may be subject to various product liability claims that include, among others, our products caused injury or illness, incorrect labeling, inadequate instructions for use or inadequate warnings concerning possible side effects or interactions with other substances. A product liability claim or regulatory action against us could result in increased costs, could adversely affect our reputation with our clients and consumers generally, and could have a material adverse effect on our business, financial condition and results of operations. See Part I, Item 3, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Legal Proceedings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, of this Annual Report for a discussion on our legal proceedings.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There can be no assurances that we will be able to obtain or maintain product liability insurance on acceptable terms or with adequate coverage against potential liabilities. Such insurance is expensive and may not be available in the future on acceptable terms, or at all. The inability to obtain sufficient insurance coverage on reasonable terms or to otherwise protect against potential product liability claims could prevent or inhibit the commercialization of products. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our products have in the past and may in the future be subject to recalls.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Manufacturers and distributors of products are sometimes subject to the recall or return of their products for a variety of reasons, including product defects, such as contamination, unintended harmful side effects or interactions with other substances, packaging safety and inadequate or inaccurate labelling disclosure. For example, on May 5, 2017, Peace Naturals announced a voluntary recall with the support of Health Canada for products sold between November 26, 2015 and March 13, 2017. Peace Naturals was notified by Health Canada that upon testing a random cannabis leaf sample, trace levels of Piperonyl Butoxide (&#8220;PBO&#8221;) were discovered at 0.78 parts per million (ppm). PBO is an organic compound known as a synergist. Root cause analysis conducted by Peace Naturals concluded that this was the result of cross-contamination. The source of the PBO was a Pest Management Regulatory Agency approved product that was used to sanitize empty rooms between harvests and which is no longer used. </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If one or more of our products are recalled due to an alleged product defect or for any other reason, we could be required to incur the unexpected expense of the recall and any legal proceedings that might arise in connection with the recall. We may lose a significant amount of sales and may not be able to replace those sales at an acceptable margin, or at all. In addition, a product recall may require significant management attention. Although we have detailed procedures in place for testing finished products, there can be no assurance that any quality, potency or contamination problems will be detected in time to avoid unforeseen product recalls, regulatory action or lawsuits. If one or more of our products were subject to recall, the public perception of that product and us could be harmed. A recall for any of the foregoing reasons could lead to decreased demand for products produced by us and could have a material adverse effect on our business, financial condition and results of operations. Additionally, product recalls may lead to increased scrutiny of our operations by Health Canada, the FDA, the DEA or other regulatory agencies, requiring further management attention and potential legal fees and other expenses. Furthermore, any product recall affecting the cannabis or U.S. hemp industries more broadly could lead consumers to lose confidence in the safety and security of the products sold by participants in these industries generally, which could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We rely on third-party testing and analytical methods which are validated but still being standardized.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For certain of our cannabis and U.S. hemp products, testing for cannabinoid levels, heavy metals and pesticides (among other things) is performed by independent third-party testing laboratories. Testing methods and analytical assays for cannabinoids and levels of detection vary among different testing laboratories in different jurisdictions. There is currently no industry consensus on standards for testing methods or an industry accepted compendium of analytical assays or standard levels of detection. The detected and reported cannabinoid content in our cannabis and U.S. hemp products therefore can differ depending on the laboratory and testing methods (analytical assays) used. Variations in reported cannabinoid content will likely continue until the relevant regulatory agencies and independent certification bodies (e.g., ISO, USP) collaborate to develop, publish and implement standardized analytical assays and levels of detection for cannabis (including U.S. hemp), cannabinoids and their derivative products. Such differences could cause confusion with our consumers which could lead to a negative perception of us and our products, increase the risk of litigation regarding cannabinoid content and regulatory enforcement action and could make it more difficult for us to comply with regulatory requirements regarding contents of ingredients and packaging and labeling. For example, on June 16, 2020, an alleged consumer filed a Statement of Claim on behalf of a class in the Court of Queen&#8217;s Bench of Alberta in Alberta, Canada, against the Company and other Canadian cannabis manufacturers and/or distributors alleging claims related to the defendants&#8217; advertised content of cannabinoids in cannabis products for medicinal use on or after June 16, 2010 and cannabis products for adult use on or after October 17, 2018. See Part I, Item 3,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Legal Proceedings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, of this Annual Report. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The presence of trace amounts of THC in our U.S. hemp products may cause adverse consequences to users of such products that will expose us to the risk of litigation, liability and other consequences.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of our products that are intended to primarily contain U.S. hemp-derived CBD, or other products, may contain trace amounts of THC. THC is a controlled substance in many jurisdictions, including under the federal laws of the U.S. Whether or not ingestion of THC (at low levels or otherwise) is permitted in a particular jurisdiction, there may be adverse consequences to consumers of our U.S. hemp products who test positive for any amounts of THC because of the presence of trace amounts of THC in our U.S. hemp products. In addition, certain metabolic processes in the body may negatively affect the results of drug tests. Positive tests for THC may expose us to litigation from our consumers, adversely affect our reputation, our ability to obtain or retain customers and individuals&#8217; participation in certain athletic or other activities. A claim or regulatory action against us based on such positive test results could materially and adversely affect our business, financial condition, operating results, liquidity, cash flow and operational performance.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be able to successfully develop new products or find a market for their sale.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The legal cannabis and U.S. hemp industries are in their early stages of development and it is likely that we, and our competitors, will seek to introduce new products in the future. In attempting to keep pace with any new market developments, we may need to spend significant amounts of capital in order to successfully develop and generate revenues from new products we introduce. In addition, we may be required to obtain additional regulatory approvals from Health Canada, the FDA and any other applicable regulatory authority, which may take significant amounts of time. We may not be successful in developing effective and safe new products, bringing such products to market in time to be effectively commercialized, or obtaining any required regulatory approvals, and, in the event we are successful, it is possible that there may be little or no demand for the products we develop, which, together with any capital expenditures made in the course of such product development and regulatory approval processes, may have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Canadian excise duty framework may affect profitability.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Canada&#8217;s excise duty framework imposes an excise duty and various regulatory-like restrictions on certain cannabis products sold in Canada. We currently hold licenses issued by the Canada Revenue Agency (&#8220;CRA&#8221;) required to comply with this excise framework. Any change in the rates or application of excise duty to cannabis products sold by us, and any restrictive interpretations by the CRA or the courts of the regulatory-like restrictions contained in the Excise Act, 2001 (which may be different than those contained in the Cannabis Act) may affect our profitability and ability to compete in the market.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Relating to Production and Distribution of Products</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our production facilities are integral to our operations and any adverse changes or developments affecting our facilities may impact our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our activities and resources are focused on various production and manufacturing facilities including in the U.S. (for U.S. hemp products), Canada and Israel. Some licenses are specific to those facilities. Adverse changes or developments affecting our facilities, including but not limited to a breach of security, an outbreak of a communicable illness (such as COVID-19) or a force majeure event, could have a material and adverse effect on our business, financial condition and results of operations. Any breach of the security measures and other facility requirements, including any failure to comply with recommendations or requirements arising from inspections by regulatory agencies, could also have an impact on our ability to continue operating under our licenses or the prospect of renewing our licenses or could result in a revocation of our licenses.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We bear the responsibility for all of the costs of maintenance and upkeep at our facilities and our operations and financial performance may be adversely affected if our facilities are unable to keep up with maintenance requirements.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may experience breaches of security at our facilities or fraudulent or unpermitted data access or other cyber-security breaches, which may cause our customers to lose confidence in our security and data protection measures and may expose us to risks related to breaches of applicable privacy laws.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Given the nature of our products and our lack of legal availability outside of certain legalized or regulated retail or distribution channels, as well as the concentration of inventory in our facilities, despite meeting the applicable security requirements under applicable law, there remains a risk of theft. A security breach at one of our facilities could expose us to additional liability and to potentially costly litigation, increase expenses relating to the resolution and future prevention of these breaches and may deter potential customers from choosing our products.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we collect and store personal information about our customers and are responsible for protecting that information from privacy breaches. A privacy breach may occur through a variety of sources, including, without limitation, procedural or process failure, information technology malfunction, deliberate unauthorized intrusions, computer viruses, cyber-attacks and other electronic security breaches. Theft of data for competitive purposes, such as customer lists and preferences, is an ongoing risk whether perpetrated via employee collusion or negligence or through deliberate cyber-attack. Any such theft or privacy breach would have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are dependent upon information technology systems in the conduct of our operations and we collect, store and use certain sensitive data, intellectual property, our proprietary business information and certain personally identifiable information of our employees and customers on our networks. Any fraudulent, malicious or accidental breach of our data security could result in unintentional disclosure of, or unauthorized access to, third-party, customer, vendor, employee or other confidential or sensitive data or information, which could potentially result in additional costs to us to enhance security or to respond to occurrences, lost sales, violations of privacy or other laws, penalties, fines, regulatory action or litigation. We also rely on third-party service providers for certain information technology systems, such as payment processing, and any data security breach at a third-party service provider could have similar effects. In addition, media or other reports of perceived security vulnerabilities to our systems or those of our third-party suppliers, even if no breach has been attempted or occurred, could adversely impact our brand and reputation and customers could lose confidence in our security measures and reliability, which would harm our ability to retain customers and gain new ones. If any of these were to occur, it could have a material adverse effect on our business, financial position and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, there are a number of federal, state and provincial laws protecting the confidentiality of certain client health information, including client records, and restricting the use and disclosure of that protected information. The privacy rules under the Personal Information Protection and Electronics Documents Act (Canada) (&#8220;PIPEDA&#8221;) protect medical records and other personal health information by limiting their use and disclosure of health information to the minimum level reasonably necessary to accomplish the intended purpose and apply to our operations globally. If we were to be found to be in violation of the privacy or security rules under PIPEDA or other applicable laws protecting the confidentiality of client health information in jurisdictions we operate in, we could be subject to sanctions and civil or criminal penalties, which could increase our liabilities, harm our reputation and have a material adverse effect on our business, results of operations and financial condition. Additional jurisdictions in which we operate or which we may enter also have data privacy and security laws and regulations that govern the collection, use, disclosure, transfer, storage, disposal, and protection of sensitive personal information (such as the California Consumer Privacy Act in California). The interpretation and enforcement of such laws and regulations are uncertain and subject to change and may require substantial costs to monitor and implement compliance with any additional requirements. Failure to comply with data protection laws and regulations could result in government enforcement actions (which could include substantial civil and/or criminal penalties), private litigation and/or adverse publicity and could negatively affect our operating results and business.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our cannabis cultivation and U.S. hemp operations are subject to risks inherent in an agricultural business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business involves the growing of cannabis, an agricultural product, in certain jurisdictions where that activity is permitted. As such, the business is subject to the risks inherent in the agricultural business, such as insects, plant diseases and similar agricultural risks that may create crop failures and supply interruptions for our customers. Although our current operational production facilities grow products indoors under climate-controlled conditions and we carefully monitor the growing conditions with trained personnel, there can be no assurance that natural elements will not have a material adverse effect on the production of our products.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business also involves products containing U.S. hemp. U.S. hemp is typically harvested in or around the month of October. U.S. hemp plants can be vulnerable to various pathogens including bacteria, fungi, viruses and other miscellaneous pathogens. Such instances often lead to reduced crop quality, stunted growth and/or death of the plant. Moreover, U.S. hemp is &#8220;phytoremediative&#8221; (meaning that it may extract toxins or other undesirable chemicals or compounds from the ground in which it is planted). Various regulatory agencies have established maximum limits for pathogens, toxins, chemicals and other compounds that may be present in agricultural materials. If U.S. hemp used in our products is found to have levels of pathogens, toxins, chemicals or other undesirable compounds that exceed permitted limits, it may have to be destroyed. Should the U.S. hemp used in our products be lost due to pathogens, toxins, chemicals or other undesirable compounds, or if we or our suppliers are otherwise unable to obtain U.S. hemp for use in our products on an ongoing basis, it may have a material and adverse effect on our business, financial condition, operating results, liquidity, cash flow and operational performance.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The inability of our customers to meet their financial or contractual obligations to us may result in disruption to our results of operations and could result in financial losses.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have significant exposure to several customers and at least some of these customers are experiencing financial difficulties. We have in the past, and may in the future, need to take allowances against and need to write off receivables due to the creditworthiness of these customers. Further, the inability of these customers to purchase our products could materially adversely affect our results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The inability of our suppliers to meet their financial or contractual obligations to us may result in disruption to our supply chain and could result in financial losses.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We face exposure to our third-party cannabis suppliers that may face financial difficulties which would impact our supply of cannabis material. We have in the past, and may in the future, have disruptions in our supply chain.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We rely on third-party distributors to distribute our products, and those distributors may not perform their obligations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on third-party distributors, including pharmaceutical distributors and other courier services, and may in the future rely on other third parties, to distribute our products. If these distributors do not successfully carry out their contractual obligations or terminate or suspend their contractual arrangements with us, if there is a delay or interruption in the distribution of our products or if these third parties damage our products, it could negatively impact our revenue. In addition, any damage to our products, such as product spoilage, could expose us to potential product liability, damage our reputation and the reputation of our brands or otherwise harm our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Relating to Intellectual Property</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to risks related to the protection and enforcement of our intellectual property rights, and we may be unable to protect or enforce our intellectual property rights.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ownership and protection of our intellectual property rights is a significant aspect of our future success. Currently we rely on trade secrets, technical know-how, proprietary information and certain patent filings to maintain our competitive position. We try to protect our intellectual property by strategically seeking and obtaining registered protection where possible, developing and implementing standard operating procedures to protect trade secrets, technical know-how and proprietary information, and entering into agreements with parties that have access to our inventions, trade secrets, technical know-how and proprietary information, such as our partners, collaborators, employees and consultants, to protect confidentiality and ownership. We also seek to preserve the integrity and confidentiality of our inventions, trade secrets, technical know-how and proprietary information by maintaining physical security of our premises and physical and electronic security of our information technology systems, and we seek to protect our trademarks and the goodwill associated therewith by monitoring and enforcing against unauthorized use of our trademarks.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is possible that we will inadvertently disclose or otherwise fail or be unable to protect our inventions, trade secrets, technical know-how or proprietary information, or will fail to identify our inventions or trademarks as patentable or registrable intellectual property, or fail to obtain patent or registered trademark protection therefor. Any such disclosure or failure could have a material adverse effect on our business.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be unable to protect our inventions, trade secrets, and other intellectual property from discovery or unauthorized use.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In relation to our agreements with parties that have access to our intellectual property, any of these parties may breach their obligations to us, and we may not have adequate remedies for such breach. In relation to our security measures, such security measures may be breached and we may not have adequate remedies for such breach. In addition, our intellectual property that has not yet been applied for or registered may otherwise become known to, or be independently developed by, competitors, or may already be the subject of applications for intellectual property registrations filed by our competitors, which may have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot provide any assurances that our inventions, trade secrets, technical know-how and other proprietary information will not be disclosed in violation of agreements, or that competitors will not otherwise gain access to our intellectual property or independently develop and file applications for intellectual property rights in a manner that adversely impacts our intellectual property rights. Unauthorized parties may attempt to replicate or otherwise obtain and use our inventions, trade secrets, technical know-how and proprietary information. Policing the unauthorized use of our current or future intellectual property rights could be difficult, expensive, time-consuming and unpredictable, as may be enforcing these rights against unauthorized use by others. Identifying unauthorized use of intellectual property rights is difficult as we may be unable to effectively monitor and evaluate the products being distributed by our competitors, including parties such as unlicensed dispensaries, and the processes used to produce such products. If the steps taken to identify and protect our trade secrets are inadequate, we may be unable to enforce our rights in them against third parties.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our intellectual property rights may be invalid or unenforceable under applicable laws, and we may be unable to have issued or registered, and unable to enforce, our intellectual property rights.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The laws and positions of intellectual property offices administering such laws regarding intellectual property rights relating to cannabis and cannabis-related products are constantly evolving, and there is uncertainty regarding which countries will permit the filing, prosecution, issuance, registration and enforcement of intellectual property rights relating to cannabis and cannabis-related products.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Specifically, we have sought trademark protection in many countries, including Canada, the U.S. and others. Our ability to obtain registered trademark protection for cannabis and cannabis-related goods and services (including U.S. hemp and U.S. hemp-related goods and services) may be limited in certain countries outside of Canada, including the U.S., where registered federal trademark protection is currently unavailable for trademarks covering the sale of U.S. Schedule I cannabis products or certain goods containing U.S. hemp-derived CBD (such as dietary supplements and foods) until the FDA provides clearer guidance on the regulation of such products; and including Europe, where laws on the legality of cannabis use are not uniform, and trademarks cannot be obtained for products that are &#8220;contrary to public policy or accepted principles of morality.&#8221; Accordingly, our ability to obtain intellectual property rights or enforce intellectual property rights against third-party uses of similar trademarks may be limited in certain countries.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, in any infringement proceeding, some or all of our current or future trademarks, patents or other intellectual property rights or other proprietary know-how, or arrangements or agreements seeking to protect the same for our benefit, may be found invalid, unenforceable, anti-competitive or not infringed. An adverse result in any litigation or defense proceedings could put one or more of our current or future trademarks, patents or other intellectual property rights at risk of being invalidated or interpreted narrowly and could put existing intellectual property applications at risk of not being issued. Any or all of these events could materially and adversely affect our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is no guarantee that any patent or other intellectual property applications that we file will result in registration or any enforceable intellectual property rights or the breadth of any such protection. Further, there is no assurance that we will find all potentially relevant prior art relating to any patent applications that we file, which may prevent a patent from issuing from a patent application or invalidate any patent that issues from such application. Even if patents do successfully issue, and cover our products and processes, third parties may challenge their validity, enforceability or scope, which may result in such patents being narrowed, found unenforceable or invalidated. Even if they are unchallenged, any patent applications and future patents may not adequately protect our intellectual property rights, provide exclusivity for our products or processes or prevent others from designing around any issued patent claims. Any of these outcomes could impair our ability to prevent competition from third parties, which could materially and adversely affect our business, financial condition and results of operations.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be subject to allegations that we are in violation of third-party intellectual property rights, and we may be found to infringe third-party intellectual property rights, possibly without the ability to obtain licenses necessary to use such third-party intellectual property rights.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other parties may claim that our products infringe on their intellectual property rights, including with respect to patents, and our operation of our business, including our development, manufacture and sale of our goods and services, may be found to infringe third-party intellectual property rights. There may be third-party patents or patent applications with claims to products or processes related to the manufacture, use or sale of our products and processes. There may be currently pending patent applications, some of which may still be confidential, that may later result in issued patents that our products or processes may infringe. In addition, third parties may obtain patents in the future and claim that use of our inventions, trade secrets, technical know-how and proprietary information, or the manufacture, use or sale of our products, infringes upon those patents. Third parties may also claim that our use of our trademarks infringes upon their trademark rights. Such claims, whether or not meritorious, may result in the expenditure of significant financial and managerial resources, legal fees, injunctions, temporary restraining orders, other equitable relief, and/or require the payment of damages, any or all of which may have an adverse impact on our business. In addition, we may need to obtain licenses from third parties who allege that we have infringed on their lawful rights. Such licenses may not be available on terms acceptable to us, and we may be unable to obtain any licenses or other necessary or useful rights under third-party intellectual property.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our germplasm relies heavily on intellectual property, and we may be unable to protect, register or enforce our intellectual property rights in germplasm, and may infringe third-party intellectual property rights with respect to germplasm, possibly without the ability to obtain licenses necessary to use such third-party intellectual property rights. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Germplasm, including seeds, clones and cuttings, is the genetic material used in new cannabis varieties and hybrids. We use advanced breeding technologies to produce cannabis germplasm (hybrids and varieties) with superior performance. We rely on parental varieties for the success of our breeding program. Although we believe that the parental germplasm is proprietary to us, we may need to obtain licenses from third parties who may allege that we have appropriated their germplasm or their rights to such germplasm. Such licenses may not be available on terms acceptable to us, and we may be unable to obtain any licenses or other necessary or useful rights under third-party intellectual property. We seek to protect our parental germplasm, as appropriate, relying on intellectual property rights, including rights related to inventions (patents and plant breeders&#8217; rights), trade secrets, technical know-how, and proprietary information. There is a risk that we will fail to protect such germplasm or that we will fail to register rights in relation to such germplasm.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also seek to protect our parental germplasm, hybrids and varieties from pests and diseases and enhance plant productivity and fertility, and we research products to protect against crop pests and fungus. There are several reasons why new product concepts in these areas may be abandoned, including greater than anticipated development costs, technical difficulties, regulatory obstacles, competition, inability to prove the original concept, lack of demand and the need to divert focus, from time to time, to other initiatives with perceived opportunities for better returns. The processes of breeding, development and trait integration are lengthy, and the germplasm we test may not be selected for commercialization. The length of time and the risk associated with breeding may affect our business. Our sales depend on our germplasm. Commercial success frequently depends on being the first company to the market, and many of our competitors are also making considerable investments in similar new and improved cannabis germplasm products. Consequently, there is no assurance that we will develop and deliver new cannabis germplasm products to the markets we serve on a timely basis.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finally, we seek to protect our germplasm, hybrids and varieties from accidental release, theft, misappropriation and sabotage by maintaining physical security of our premises and through contractual rights with our employees and certain of our independent contractors, consultants and licensees. However, such security measures may be insufficient or breached, and our employees, independent contractors, consultants and licensees may engage in the inadvertent disclosure, theft, misappropriation or sabotage. We may not have adequate remedies in the case of any such security breach, inadvertent disclosure, theft, misappropriation or sabotage.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We receive licenses to use some third-party intellectual property rights; the failure of the owner of such intellectual property to properly maintain or enforce the intellectual property underlying such licenses, or our inability to maintain such licenses, could have a material adverse effect on our business, financial condition and performance.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are party to licenses granted by third parties, including with actress Kristen Bell and through the Ginkgo Strategic Partnership, that give us rights to use third-party intellectual property that is necessary or useful to our business. Our success will depend, in part, on the ability of the applicable licensor to maintain and enforce its licensed intellectual property against other third parties, particularly intellectual property rights to which we have secured exclusive rights. Without protection for the intellectual property we have licensed, other companies might be able to offer substantially similar products for sale, or utilize substantially similar processes or publicity and marketing rights, any of which could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any of our licensors may allege that we have breached our license agreements with those licensors, whether with or without merit, and accordingly seek to terminate our applicable licenses. If successful, this could result in our loss of the right to use applicable licensed intellectual property, which could adversely affect our ability to commercialize our products or services, as well as have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The technologies, process and formulations we use may face competition or become obsolete.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rapidly changing markets, technology, emerging industry standards and frequent introduction of new products characterize our business. The introduction of new products embodying new technologies, including new manufacturing processes or formulations, and the emergence of new industry standards may render our products obsolete, less competitive or less marketable. The process of developing our products is complex and requires significant continuing costs, development efforts and third-party commitments, including licensees, researchers, collaborators and lenders. Our failure to develop new technologies and products and the obsolescence of existing technologies or processes could adversely affect our business, financial condition and results of operations. We may be unable to anticipate changes in our potential customer requirements that could make our existing technology, processes or formulations obsolete. Our success will depend, in part, on our ability to continue to enhance our existing technologies, develop new technology that addresses the increasing sophistication and varied news of the market, and respond to technological advances and emerging industry standards and practices on a timely and cost-effective basis. The development of our proprietary technology, processes and formulations entails significant technical and business risks. We may not be successful in using our new technologies or exploiting our niche markets effectively or adapting our business to evolving customer or medical requirements or preference or emerging industry standards.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Relating to Entry into New Markets</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Controlled substance and other legislation and treaties may restrict or limit our ability to research, manufacture and develop a commercial market for our products outside of the jurisdictions in which we currently operate and our expansion into such jurisdictions is subject to risks.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approximately 250 substances, including cannabis, are listed in the Schedules annexed to the UN Single Convention, the Convention on Psychotropic Substances (Vienna, 1971) and the Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances (introducing control on precursors) (Vienna, 1988). The purpose of these listings is to control and limit the use of these drugs according to a classification of their therapeutic value, risk of abuse and health dangers, and to minimize the diversion of precursor chemicals to illegal drug manufacturers. The 1961 UN Single Convention on Narcotic Drugs, as amended in 1972 classifies cannabis as a Schedule I (&#8220;substances with addictive properties, presenting a serious risk of abuse&#8221;) narcotic drug. In December 2020, the Commission on Narcotic Drugs voted to remove cannabis from Schedule IV (&#8220;the most dangerous substances, already listed in Schedule I, which are particularly harmful and of extremely limited medical or therapeutic value&#8221;). The 1971 UN Convention on Psychotropic Substances classifies THC as a Schedule I psychotropic substance (substances presenting a high risk of abuse, posing a particularly serious threat to public health which are of very little or no therapeutic value). Many countries are parties to these conventions, which govern international trade and domestic control of these substances, including cannabis. They may interpret and implement their obligations in a way that creates legal obstacles to our obtaining manufacturing and/or marketing approval for our products in those countries. These countries may not be willing or able to amend or otherwise modify their laws and regulations to permit our products to be manufactured and/or marketed and achieving such amendments to the laws and regulations may take a prolonged period of time. There can be no assurance that any market for our products will develop in any jurisdiction in which we do not currently have operations. We may face new or unexpected risks or significantly increase our exposure to one or more existing risk factors, including economic instability, political instability, changes in laws and regulations and the effects of competition. These factors may limit our capability to successfully expand our operations into such jurisdictions and may have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments and joint ventures outside of Canada and the U.S. are subject to the risks normally associated with any conduct of business in foreign countries, including varying degrees of political, legal and economic risk.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Much of our exposure to markets in jurisdictions outside of Canada and the U.S. is through investments and joint ventures. These investments and joint ventures are subject to the risks normally associated with any conduct of business in foreign and/or emerging countries including political risks; civil disturbance risks; changes in laws or policies of particular countries, including those relating to royalties, duties, imports, exports and currency; the cancellation or renegotiation of contracts; the imposition of royalties, net profits payments, tax increases or other claims by government entities, including retroactive claims; a disregard for due process and the rule of law by local courts; the risk of expropriation and nationalization; delays in obtaining or the inability to obtain necessary governmental permits or the reimbursement of refundable tax from fiscal authorities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Threats or instability in a country caused by political events including elections, change in government, changes in personnel or legislative bodies, foreign relations or military control present serious political and social risk and instability causing interruptions to the flow of business negotiations and influencing relationships with government officials. Changes in policy or law may have a material adverse effect on our business, financial condition and results of operations. The risks include increased &#8220;unpaid&#8221; state participation, higher energy costs, higher taxation levels and potential expropriation.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other risks include the potential for fraud and corruption by suppliers or personnel or government officials which may implicate us, compliance with applicable anti-corruption laws, including the U.S. Foreign Corrupt Practices Act and the Corruption of Foreign Public Officials Act (Canada), by virtue of our operating in jurisdictions that may be vulnerable to the possibility of bribery, collusion, kickbacks, theft, improper commissions, facilitation payments, conflicts of interest and related party transactions and our possible failure to identify, manage and mitigate instances of fraud, corruption or violations of our code of conduct and applicable regulatory requirements.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is also the risk of increased disclosure requirements; currency fluctuations; restrictions on the ability of local operating companies to hold Canadian dollars, U.S. dollars or other foreign currencies in offshore bank accounts; import and export regulations; increased regulatory requirements and restrictions; increased health-related regulations; limitations on the repatriation of earnings or on our ability to assist in minimizing our expatriate workforce&#8217;s exposure to double taxation in both the home and host jurisdictions; and increased financing costs.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These risks may limit or disrupt our joint ventures, strategic alliances or investments, restrict the movement of funds, cause us to have to expend more funds than previously expected or required or result in the deprivation of contract rights or the taking of property by nationalization or expropriation without fair compensation, and may materially adversely affect our businesses, financial position and/or results of operations. In addition, the enforcement by us of our legal rights in foreign countries, including rights to exploit our properties or utilize our permits and licenses and contractual rights may not be recognized by the court systems in such foreign countries or enforced in accordance with the rule of law.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may invest in companies, or engage in joint ventures, in countries with developing economies. It is difficult to predict the future political, social and economic direction of the countries in which we operate, and the impact government decisions may have on our business. Any political or economic instability in the countries in which we operate could have a material and adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our use of joint ventures may expose us to risks associated with jointly owned investments.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently operate parts of our business through joint ventures with other companies, and we may enter into additional joint ventures and strategic alliances in the future. Joint venture investments may involve risks not otherwise present for investments made solely by us, including: (i) we may not control the joint ventures; (ii) our joint venture partners may not agree to distributions that we believe are appropriate; (iii) where we do not have substantial decision-making authority, we may experience impasses or disputes with our joint venture partners on certain decisions, which could require us to expend additional resources to resolve such impasses or disputes, including litigation or arbitration; (iv) our joint venture partners may become insolvent or bankrupt, fail to fund their share of required capital contributions or fail to fulfil their obligations as a joint venture partner; (v) the arrangements governing our joint ventures may contain certain conditions or milestone events that may never be satisfied or achieved; (vi) our joint venture partners may have business or economic interests that are inconsistent with ours and may take actions contrary to our interests; (vii) we may suffer losses as a result of actions taken by our joint venture partners with respect to our joint venture investments; (viii) it may be difficult for us to exit a joint venture if an impasse arises or if we desire to sell our interest for any reason; and (ix) our joint venture partners may exercise termination rights under the relevant agreements. In addition, we may, in certain circumstances, be liable for the actions of our joint ventures or joint venture partners. Any of the foregoing risks could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">There can be no assurance that our current and future strategic alliances or expansions of scope of existing relationships will have a beneficial impact on our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently have, and may in the future enter into additional, strategic alliances with third parties that we believe will complement or augment our existing business. Our ability to complete strategic alliances is dependent upon, and may be limited by, the availability of suitable candidates and capital. In addition, strategic alliances could present unforeseen integration obstacles or costs, may not enhance our business and may involve risks that could adversely affect us, including significant amounts of management time that may be diverted from operations in order to pursue and complete such transactions or maintain such strategic alliances. Future strategic alliances could result in the incurrence of debt, costs and contingent liabilities, and there can be no assurance that future strategic alliances will achieve, or that our existing strategic alliances will continue to achieve, the expected benefits to our business or that we will be able to consummate future strategic alliances on satisfactory terms, or at all. Any of the foregoing could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the case of the Ginkgo Strategic Partnership, we will have, pursuant to the Ginkgo Collaboration Agreement, the exclusive right to use and commercialize the key patented intellectual property related to the production of the target cannabinoids globally. There can be no assurance that Ginkgo will be able to develop microorganisms that we will be able to commercialize or to obtain patents relating to production of the target cannabinoids, or that third parties will not develop similar microorganisms or obtain patents that may restrict our ability to commercialize the microorganisms developed by Ginkgo, and, as a result, there can be no assurance that we will be able to realize the expected benefits of the Ginkgo Strategic Partnership. Even if we are able to commercialize, there may not be demand for such products or the cultured cannabinoids developed therefrom.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, pursuant to the Ginkgo Collaboration Agreement, if we undergo a change of control that is approved by the Board, including a change of control resulting from the exercise of the Altria Warrant, Ginkgo may elect to receive cash payments, totaling up to $100 million, in lieu of the common shares that would otherwise become issuable in connection with any Equity Milestone Events (as defined in the Ginkgo Collaboration Agreement) achieved following such election (the &#8220;Milestone Cash Election&#8221;). If we undergo a change in control that has not been approved by the Board, then Ginkgo will have the ability to terminate the Ginkgo Collaboration Agreement immediately, in which case, among other things: (i) all rights or licenses granted to us by Ginkgo under the Ginkgo Collaboration Agreement will terminate; (ii) certain expenses and costs incurred by Ginkgo will be accelerated and become due and payable by us; (iii) the then-outstanding and unpaid portion of all cash payments from us to Ginkgo for the achievement of R&amp;D milestones by Ginkgo shall be due immediately as if all R&amp;D milestones had been achieved; and (iv) a lump sum cash payment equal to the aggregate of all Milestone Cash Election amounts in respect of which the relevant Equity Milestone Events have not yet been achieved will be immediately due and payable by us. In addition, should Ginkgo terminate the Ginkgo Collaboration Agreement upon a change of control, we will no longer be able to use or commercialize the key patented intellectual property related to the production of the target cannabinoids, which could have a material adverse effect on our business, financial condition and results of operations. See</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Description of Business - Research and Development Activities and Intellectual Property.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to the Technion Research Agreement, we will have access to the results of preclinical studies conducted by Technion over a three-year period, focusing on acne, psoriasis and skin repair. However, there can be no assurance that the preclinical studies will provide any actionable findings. As a result, there can be no assurance that we will be able to realize the expected benefits of the Technion Research Agreement. Even if the results are actionable, and we are able to develop commercial products based on such research, there may not be demand for such products. See &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Description of Business - Research and Development Activities and Intellectual Property - Technion Skin Health and Research Partnership.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Relating to Regulation and Compliance</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We operate in highly regulated sectors where the regulatory environment is rapidly developing and we may not always succeed in complying fully with applicable regulatory requirements in all jurisdictions where we carry on business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business and activities are heavily regulated in all jurisdictions where we carry on business. Our operations are subject to various laws, regulations and guidelines by governmental authorities (including, in Canada, Health Canada and analogous provincial and local regulatory agencies and, in the U.S., the FDA, DEA and FTC and analogous state agencies) relating to the manufacture, marketing, management, transportation, storage, sale, pricing and disposal of cannabis and U.S. hemp, and also including laws, regulations and guidelines relating to health and safety, insurance coverage, the conduct of operations and the protection of the environment (including relating to emissions and discharges to water, air and land, and the handling and disposal of hazardous and non-hazardous materials and wastes). Our operations may also be affected in varying degrees by government regulations with respect to, but not limited to, price controls, export controls, controls on currency remittance, increased income taxes, restrictions on foreign investment and government policies rewarding contracts to local competitors or requiring domestic producers or vendors to purchase supplies from a particular jurisdiction. Laws, regulations and guidelines, applied generally, grant government agencies and self-regulatory bodies broad administrative discretion over our activities, including the power to limit or restrict business activities as well as impose additional disclosure requirements on our products and services. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Achievement of our business objectives is contingent, in part, upon compliance with regulatory requirements enacted by these governmental authorities and obtaining all necessary regulatory approvals for the production, storage, transportation, sale, import and export, as applicable, of our products. The cannabis and U.S. hemp industries are still new industries and, in Canada, in particular the Cannabis Act, is a new regime that has no close precedent in Canadian law. Similarly, outside of the U.S. and Canada, the regulatory environments in jurisdictions legalizing the import, cultivation, production and sale of cannabis and cannabis products are new and are still being developed without close precedent in such jurisdictions. The effect of relevant governmental authorities&#8217; administration, application and enforcement of their respective regulatory regimes and delays in obtaining, or failure to obtain, applicable regulatory approvals which may be required may significantly delay or impact the development of markets, products and sales initiatives and could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The regulatory environment for our products is rapidly developing, and the need to build and maintain robust systems to comply with different and changing regulations in multiple jurisdictions increases the possibility that we may violate one or more applicable requirements. While we endeavor to comply with all relevant laws, regulations and guidelines, any failure to comply with the regulatory requirements applicable to our operations could subject us to negative consequences, including, civil and criminal penalties, damages, fines, the curtailment or restructuring of our operations, asset seizures, revocation or imposition of additional conditions on licenses to operate our business, the denial of regulatory applications (including, in the U.S., by other regulatory regimes that rely on the positions of the DEA and FDA in the application of their respective regimes), the suspension or expulsion from a particular market or jurisdiction of our key personnel, or the imposition of additional or more stringent inspection, testing and reporting requirements, any of which could materially adversely affect our business and financial results. In the U.S., failure to comply with FDA requirements (and analogous state agencies) may result in, among other things, injunctions, product withdrawals, recalls, product seizures, fines and criminal prosecutions. The outcome of any regulatory or agency proceedings, investigations, audits, and other contingencies could harm our reputation, require us to take, or refrain from taking, actions that could harm our operations or require us to pay substantial amounts of money, harming our results of operations, financial condition and cash flows. There can be no assurance that any pending or future regulatory or agency proceedings, investigations and audits will not result in substantial costs or a diversion of management&#8217;s attention and resources, negatively impact our future growth plans and opportunities or have a material adverse impact on our business, financial condition and results of operations. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Company&#8217;s U.S. hemp business activities are found to be in violation of any of U.S. federal, state or local laws or any other governmental regulations, in addition to the items described above: </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the Company may be subject to &#8220;Warning Letters,&#8221; fines, penalties, administrative sanctions, settlements, injunctions, product recalls and/or other enforcement actions arising from civil, administrative or other proceedings initiated that could adversely affect the Company&#8217;s business, financial condition, operating results, liquidity, cash flow and operational performance; </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the profits or revenues derived therefrom could be subject to money laundering statutes, including the Money Laundering Control Act, which could result in significant disruption to our U.S. hemp business operations and involve significant costs, expenses or other penalties; and </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the Company&#8217;s suppliers, service providers and distributors may elect, at any time, to breach or otherwise cease to participate in supply, service or distribution agreements, or other relationships, on which the Company&#8217;s operations rely.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As it relates to U.S. Schedule I cannabis, in the U.S., despite cannabis possession and use having been legalized at the state level for medical use in many states and for adult-use in a number of states, marijuana as defined by the CSA continues to be categorized as a Schedule I controlled substance under the CSA and subject to the Controlled Substances Import and Export Act (&#8220;CSIEA&#8221;). Although we do not engage in any activities related to marijuana as defined by the CSA in the U.S., violations of any U.S. federal laws and regulations, including the CSA and the CSIEA, whether intentional or inadvertent, could result in civil, criminal and/or administrative enforcement actions, which could result in fines, penalties, and other sanctions, including but not limited to, cessation of business activities. Additionally, U.S. border officials could deny entry into the U.S. to those employed at or investing in legal and licensed non-U.S. cannabis companies and such persons could face detention, denial of entry or lifetime bans from the U.S. for their business associations with cannabis businesses.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We and our joint ventures and strategic investments are reliant on required licenses, authorizations, approvals and permits for our ability to grow, process, store and sell cannabis which are subject to ongoing compliance, reporting and renewal requirements and we may also be required to obtain additional licenses, authorizations, approvals and permits in connection with our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to grow, process, store and sell cannabis in Canada is dependent on our licenses from Health Canada, and in particular the licenses currently held by Peace Naturals. Failure to comply with the requirements of the licenses or failure to maintain the licenses would have a material adverse impact on our business, financial condition and results of operations. Although we believe Peace Naturals will meet the requirements of the Cannabis Act for extension of its license, there can be no guarantee that Health Canada will extend or renew the licenses or, if they are extended or renewed, that they will be extended or renewed on the same or similar terms or that Health Canada will not revoke the licenses. Should we fail to comply with requirements of the licenses, should Health Canada not extend or renew the licenses, should we renew the licenses on different terms (including not allowing for anticipated capacity increases) or should the licenses be revoked, our business, financial condition and results of the operations will be materially adversely affected.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to grow, process, store and sell cannabis in Israel is dependent on maintaining our cannabis cultivation and production licenses and our ability to export products from Cronos Israel is also dependent on obtaining the relevant export permits. Cronos GrowCo&#8217;s ability to grow, process, store and sell cannabis at its cannabis facility in Kingsville, Ontario depends on obtaining and maintaining the appropriate licenses from Health Canada. Natuera&#8217;s ability to grow, process, store and sell cannabis in Colombia is dependent on obtaining and maintaining and being granted the appropriate licenses from the Ministry of Health and Social Security and Natuera&#8217;s ability to export products from Colombia is dependent on its ability to obtain the relevant export permits. Should we or our joint ventures fail to comply with the requirements of the licenses, or should they not be extended or renewed by the applicable regulatory authorities, or should they be renewed on different terms (including not allowing for anticipated capacity increases) or should the licenses be revoked, the business, financial condition and results of our and our joint ventures&#8217; operations will be materially adversely affected. There is no assurance that we or our joint ventures will be able to obtain additional permits or licenses on commercially reasonable terms, if at all. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, Ginkgo&#8217;s ability to conduct certain R&amp;D activities in the U.S. under the Ginkgo Collaboration Agreement is conditional on Ginkgo continuing to maintain all necessary licenses, permits and approvals required for Ginkgo to perform such R&amp;D activities. There are no assurances that Ginkgo will be able to maintain required licenses, permits and approvals and, to the extent such licenses, permits and approvals are not maintained, we may not realize the expected benefits of the Ginkgo Strategic Partnership. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may also be required to obtain and maintain certain permits, licenses and approvals in the jurisdictions where we source, process, or sell products derived from U.S. hemp. We may be unable to obtain or maintain any necessary licenses, permits or approvals. Additional government licenses are currently, and in the future, may be, required in connection with our operations, in addition to other unknown permits and approvals which may be required, including with respect to our other Rest of World operations. To the extent such permits, and approvals are required and not obtained, we may be prevented from operating and/or expanding our business, which could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in the laws, regulations and guidelines governing cannabis and U.S. hemp may adversely impact our business. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our current operations are subject to various laws, regulations and guidelines promulgated by governmental authorities (including, in Canada, Health Canada and, in the U.S., the FDA, DEA, FTC and PTO) relating to the marketing, acquisition, manufacture, packaging/labeling, management, transportation, storage, sale and disposal of cannabis or U.S. hemp but also including laws and regulations relating to health and safety, the conduct of operations and the protection of the environment. Additionally, our growth strategy continues to evolve as regulations governing the cannabis industry in the jurisdictions other than Canada and the U.S. in which we operate become more fully developed. Interpretation of these laws, rules and regulations and their application to our operations is ongoing. No assurance can be given that new laws, regulations and guidelines will not be enacted or that existing laws, regulations and guidelines will not be amended, repealed or interpreted or applied in a manner which could require extensive changes to our operations, increase compliance costs, give rise to material liabilities or a revocation of our licenses and other permits, restrict the growth opportunities that we currently anticipate or otherwise limit or curtail our operations. For example, the Cannabis Act requires the federal government to conduct a review of the Cannabis Act beginning in October 2021. This statutory review is required to include, among other things, consideration of (i) the administration and operation of the Cannabis Act, (ii) the impact of the Cannabis Act on public health, (iii) the health and consumption habits of young persons, (iv) the impact of cannabis on Indigenous persons and communities and (v) the impact of cultivation of cannabis plants in a dwelling-house. This statutory review may lead to the amendment, removal or addition of provisions in or to the Cannabis Act which could adversely affect our business. Amendments to current laws, regulations and guidelines governing the production, sale and use of cannabis and cannabis-based products, more stringent implementation or enforcement thereof or other unanticipated events, including changes in political regimes or political instability, currency controls, fluctuations in currency exchange rates and rates of inflation, labor unrest, changes in taxation laws, regulations and policies, restrictions on foreign exchange and repatriation, governmental regulations relating to foreign investment and the cannabis business more generally, and changes in attitudes toward cannabis, are beyond our control and could require extensive changes to our operations, which in turn may result in a material adverse effect on our business, financial condition and results of operations. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the production of cannabis in Canada is under the regulatory oversight of the federal government, the distribution of adult-use cannabis in Canada falls within the jurisdiction of the provincial and territorial governments. The impact of the legislation regulating adult-use cannabis passed in the provinces and territories on the cannabis industry and our business plans and operations is uncertain. Provinces and territories have announced certain restrictions that are more stringent than the federal rules or regulations such as bans on cannabis edibles, raising minimum age of purchase and flavor restrictions. For example, Qu&#233;bec, Newfoundland and Labrador and Prince Edward Island do not currently permit sales of cannabis vaporizers, and Qu&#233;bec limits the sale of other high THC non-edible cannabis products. In addition, the distribution and retail channels and applicable rules and regulations in the provinces continue to evolve and our ability to distribute and retail cannabis and cannabis products in Canada is dependent on the ability of the provinces and territories of Canada to establish licensed retail networks and outlets. In response to the COVID-19 pandemic, various provinces and territories have introduced a variety of regulatory changes to their respective cannabis regimes, which include in certain jurisdictions, forced store closures, restrictions or bans on in-store shopping experiences, and the authorization of private delivery services. There is no guarantee that the applicable legislation regulating the distribution and sale of cannabis for adult-use purposes, including as amended to respond to the COVID-19 pandemic, will allow for the growth opportunities we currently anticipate.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, additional countries continue to pass laws that allow for the production and distribution of cannabis in some form or another. We have subsidiaries, investments, joint ventures and strategic alliances in place outside of the U.S. and Canada, which may be affected if more countries legalize cannabis. Increased international competition and limitations placed on us by Canadian regulations might lower the demand for our products on a global scale. We also face competition in each jurisdiction outside of the U.S. and Canada where we have subsidiaries, investments, joint ventures and strategic alliances with local companies that have more experience, more in-depth knowledge of local markets or applicable laws, regulations and guidelines or longer operating histories in such jurisdictions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to certain restrictions of the TSX and Nasdaq which may constrain our ability to expand our business internationally.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common shares are listed on the TSX and Nasdaq. We must comply with the TSX and Nasdaq requirements or guidelines when conducting business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 16, 2017, the TSX provided clarity regarding the application of Section 306 (Minimum Listing Requirements), Section 325 (Management) and Part VII (Halting of Trading, Suspension and Delisting of Securities) of the TSX Company Manual (collectively, the &#8220;Requirements&#8221;) to TSX-listed issuers with business activities in the cannabis sector. In TSX Staff Notice 2017- 0009, the TSX notes that issuers with ongoing business activities that violate U.S. federal law regarding U.S. Schedule I cannabis are not in compliance with the Requirements. The TSX reminded issuers that, among other things, should the TSX find that a listed issuer is engaging in activities contrary to the Requirements, the TSX has the discretion to initiate a delisting review. Although we do not conduct any operations in the U.S. with respect to U.S. Schedule I cannabis, failure to comply with the Requirements could result in a delisting of our common shares from the TSX or the denial of an application for certain approvals, such as to have additional securities listed on the TSX, which could have a material adverse effect on the trading price of our common shares and have a material adverse effect on our business, financial condition and results of operations. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While Nasdaq has not issued official rules specific to the cannabis or U.S. hemp industry, stock exchanges in the U.S., including Nasdaq, have historically refused to list certain U.S. Schedule I cannabis related businesses, including U.S. Schedule I cannabis retailers, that operate primarily in the U.S. Failure to comply with any requirements imposed by Nasdaq could result in the delisting of our common shares from Nasdaq or denial of any application to have additional securities listed on Nasdaq which could have a material adverse effect on the trading price of our common shares.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are constrained by law in our ability to market and advertise our products.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our marketing and advertising are subject to regulation by various regulatory bodies in the jurisdictions we operate. In Canada, the development of our business and related results of operations may be hindered by applicable regulatory restrictions on sales and marketing activities. For example, the regulatory environment in Canada limits our ability to compete for market share in a manner similar to other industries. If we are unable to effectively market our products and compete for market share in Canada, or if the costs of compliance with government legislation and regulation cannot be absorbed through increased selling prices for our products, our sales and results of operations could be adversely affected. See &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business &#8211;Regulatory Framework in Canada.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the U.S., our advertising is subject to regulation by the FTC under the Federal Trade Commission Act</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as well as the FDA under the Federal Food, Drug, and Cosmetic Act, including as amended by the Dietary Supplement Health and Education Act of 1994, and by state agencies under analogous and similar state and local laws. In recent years, the FTC, the FDA and state agencies have initiated numerous investigations of food and dietary supplement products both because of their CBD content and based on allegedly deceptive or misleading marketing claims and have, on occasion, issued &#8220;Warning Letters&#8221; or instituted enforcement actions due to such claims. Some U.S. states also permit content, advertising and labeling laws to be enforced by state attorneys general, who may seek civil and criminal penalties, relief for consumers, class action certifications, class wide damages and recalls of products sold by us. There has also been a recent increase in private litigation that seeks, among other things, relief for consumers, class action certifications, class wide damages and recalls of products. We have been subject to such litigation and may be subject to additional private class action litigation. Any actions against us by governmental authorities or private litigants could have a material and adverse effect on our business, financial condition, operating results, liquidity, cash flow and operational performance.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to U.S. Regulation and Compliance </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to uncertainty regarding the legal and regulatory status of U.S. hemp, including with respect to U.S. federal and state implementation of the 2018 Farm Bill and related laws, including the Federal Food, Drug, and Cosmetic Act, and the interpretation or application of, or changes to, such laws and regulations may have material and adverse effects on our business, financial condition, operating results, liquidity, cash flow and operational performance.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2014, U.S. Congress passed the 2014 Farm Bill, which permitted the domestic cultivation of &#8220;industrial hemp&#8221; (defined as the plant Cannabis sativa L. and any part of such plant, whether growing or not, with no more than 0.3% THC on a dry weight basis) as part of agricultural pilot programs adopted by individual states for the purposes of research by state departments of agriculture and institutions of higher education. There is significant uncertainty concerning the permissible scope of commercial activity under the 2014 Farm Bill. The 2014 Farm Bill only authorized institutions of higher education and state agricultural departments to cultivate industrial hemp, and only to do so for research purposes. However, it also gave significant discretion to states to regulate industrial hemp pilot programs. Many states that have adopted pilot programs have licensed private companies to cultivate and process industrial hemp. Additionally, many states have interpreted the 2014 Farm Bill to permit research concerning industrial hemp through, among other things, commercial marketing and sale of industrial hemp and industrial hemp products. In contrast, the DEA, FDA and the USDA have taken the position that, under the 2014 Farm Bill, industrial hemp products may not be sold for the purpose of general commercial activity or in states without agricultural pilot programs that permit their sale for research marketing purposes; these agencies have also taken the position that, under the 2014 Farm Bill, industrial hemp plants and seeds may not be transported across state lines.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 20, 2018, the 2018 Farm Bill was signed into law. The 2018 Farm Bill, among other things, removes &#8220;hemp&#8221; (which we refer to as &#8220;U.S. hemp&#8221; in this Annual Report, defined as the plant Cannabis sativa L. and any part of that plant, including the seeds thereof and all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers, whether growing or not, with a THC concentration of not more than 0.3% on a dry weight basis and its derivatives) from the Controlled Substances Act and amends the Agricultural Marketing Act of 1946 to permit the production and sale of U.S. hemp in the U.S. The 2018 Farm Bill tasks the USDA with promulgating regulations in relation to the cultivation and production of U.S. hemp. The 2018 Farm Bill also directs the USDA to promulgate federal regulations that would apply to the production of U.S. hemp in every state which does not put forth a state U.S. hemp plan for approval by the USDA. The USDA issued a final rule in January 2021 that becomes effective March 2021. Various states are in the process of applying to the USDA for approval of their U.S. hemp production regulations which impose different levels of regulation and costs on the production of U.S. hemp, and certain state plans have been approved by the USDA. The USDA&#8217;s recently issued final rule, requires hemp producers to use a laboratory that is registered with the DEA for analytical testing of hemp plants; however, the USDA is delaying enforcement of this requirement until December 31, 2022. The final rule does provide some flexibility for producers to dispose or remediate non-compliant plants, subject to additional documentation requirements, without requiring the use of a DEA-registered reverse distributor or law enforcement to dispose of non-compliant plants. Moreover, the 2018 Farm Bill provides that its provisions do not preempt or limit state laws that regulate the production of U.S. hemp. Accordingly, some states may choose to restrict or prohibit some or all U.S. hemp production or sales within the state and variances in states&#8217; laws and regulations on U.S. hemp are likely to persist. Further, each state has discretion to develop and implement its own laws and regulations governing the manufacturing, marketing, labeling, and sale of U.S. hemp products, which has created a patchwork of different regulatory schemes applicable to such products.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The FDA or particular states may ultimately prohibit the sale of some or all dietary supplements or conventional foods containing U.S. hemp and U.S. hemp-derived ingredients, including CBD and we may be required to submit a New Dietary Ingredient notification to the FDA, which may not be accepted without objection.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the 2018 Farm Bill, the FDA has retained authority over the Federal Food, Drug, and Cosmetic Act-regulated products (e.g., drugs (human and animal), food (human and animal), dietary supplements and cosmetics) containing U.S. hemp and U.S. hemp-derived ingredients, including CBD. The FDA has consistently taken the position that CBD, whether derived from U.S. hemp or U.S. Schedule I cannabis, is prohibited from use as an ingredient in food and dietary supplements. This stems from its interpretation of the exclusionary clauses in the Federal Food, Drug, and Cosmetic Act because CBD is the active ingredient in a drug that has been approved as a prescription drug and is the subject of substantial clinical investigations as a drug, which have been made public. The exclusionary clauses under the Federal Food, Drug, and Cosmetic Act provide that a substance that has been approved or has been subject to substantial clinical investigations as a drug may not be used in a food or dietary supplement, unless the substance was first marketed in a food or dietary supplement prior to the initiation of substantial clinical investigations of the substance as a drug.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA has not issued regulations that elaborate on the exclusionary clauses, and the FDA has not taken any enforcement action in the courts asserting a violation of the exclusionary clauses due to the marketing of U.S. hemp, U.S. hemp extracts, or CBD. To date, the FDA has issued several &#8220;Warning Letters&#8221; to companies unlawfully marketing CBD products. In many of these cases, the manufacturer made unsubstantiated claims about the product being able to treat medical conditions (e.g., cancer, Alzheimer&#8217;s disease, opioid withdrawal, anxiety and COVID-19) and had not obtained drug approvals. Some of these letters were co-signed with the FTC and cited the companies for making claims about the efficacy of CBD or other ingredients which were not substantiated by competent and reliable scientific evidence. In December 2020, the FTC announced it had entered into settlement agreements with six companies marketing CBD products including oils, gummies, creams, and others with deceptive health claims about serious health conditions. The settlements included monetary penalties ranging from $20,000 to $85,000. The FDA has also issued a &#8220;Warning Letter&#8221; to at least one dietary supplement manufacturer for a number of violations observed during an inspection, including manufacturing CBD supplements in a licensed facility.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Until the FDA formally adopts regulations with respect to CBD products or announces an official position with respect to CBD products, there is a risk that the FDA could take enforcement action (e.g., &#8220;Warning Letter,&#8221; seizure, injunction) against the Company&#8217;s U.S. hemp-derived CBD products sold in the U.S.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, states have retained regulatory authority through their own analogues to the Federal Food, Drug, and Cosmetic Act, and the states may diverge from the federal treatment of the use of U.S. hemp as, or in, food, dietary supplements or cosmetic products. The FDA or applicable states (under their CSA or Federal Food, Drug, and Cosmetic Act analogues) may ultimately not permit the sale of non-pharmaceutical products containing U.S. hemp-derived ingredients, including CBD, which would have a material adverse impact on our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if the exclusionary clause issue discussed above is resolved in a manner favorable to us, we could be required to submit a New Dietary Ingredient Notification (&#8220;NDIN&#8221;) to the FDA with respect to U.S. hemp-derived ingredients, including CBD, used in dietary supplement products. This could depend on whether we can establish that a particular ingredient was marketed as a dietary ingredient in a dietary supplement prior to October 15, 1994 or is otherwise currently in the food supply in the same chemical form as used in our dietary supplement products. If the FDA objects to our NDIN notification, this could prevent us from producing, marketing and selling ingestible U.S. hemp products which would have a material adverse impact on our business, financial condition and results of operations. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The FDA or particular U.S. states may seek to regulate our cosmetic products containing U.S. hemp-derived ingredients, including CBD, as drugs, medical devices, or drug-device combination products.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA may seek to regulate our cosmetic products containing U.S. hemp-derived ingredients, including CBD, under its authorities for medical products (i.e., drugs, medical devices, or drug-device combination products). Specifically, the agency could assert that our lotions, oils, balms and creams are intended for use in diagnosing, treating, mitigating or preventing disease or for use in affecting the structure or any function of the body. In making classification decisions, the agency considers a wide variety of factors to determine a product&#8217;s intended use; indeed, the FDA has sometimes asserted that a product qualifies as a drug based solely on the presence of an ingredient widely understood to have drug effects, even in the absence of express claims about them. Though we do not market our lotions, oils, balms and creams as drugs for use in the treatment of diseases or their symptoms, the FDA could still assert that the products are intended for use as drugs, including based on the understood or presumed physical effects of topically administered cannabinoids. Thus, we may not have the ability to successfully respond to such allegations simply by modifying labeling or advertising claims. Ultimately, if the FDA asserts one of its medical product authorities over our lotion, oil, balm and cream products, and we cannot or elect not to comply with the onerous regulatory requirements applicable to the asserted medical product category (e.g., drug), we could be prevented from producing, marketing and selling cosmetic products containing U.S. hemp-derived ingredients, including CBD. In addition, states may similarly seek to regulate our cosmetic products containing U.S. hemp-derived ingredients, including CBD, as medical products (i.e., drugs, medical devices, or drug-device combination products) under state analogues to the Federal Food, Drug, and Cosmetic Act or otherwise. States have also considered and established additional restrictions on, or requirements for, the marketing of cosmetic products containing U.S. hemp-derived ingredients. If states assert their medical product authorities over our cosmetic products containing U.S. hemp-derived ingredients, including CBD, in a manner that we cannot address simply by modifying labeling or advertising claims, and we cannot or elect not to comply with the onerous regulatory requirements applicable to the asserted medical product category (e.g., drug), we could be prevented from producing, marketing and selling cosmetic products containing U.S. hemp-derived ingredients, including CBD. Likewise, if states enforce or adopt regulatory interpretations or restrictions that limit our ability to market our cosmetic products containing U.S. hemp-derived ingredients, including CBD, in such states, it could materially and adversely affect our business, financial condition, operating results, liquidity, cash flow and operational performance.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The DEA could take enforcement action against us or other participants in the U.S. hemp industry.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is substantial uncertainty concerning the legal status of U.S. hemp and U.S. hemp products containing U.S. hemp-derived ingredients, including CBD. The status of products derived from the cannabis or hemp plant, under both federal and state law can depend on the THC content of the plant or derivative (including whether the plant meets the statutory definition of &#8220;industrial hemp&#8221; or &#8220;hemp&#8221;), the part of the plant from which an individual or entity produces the derivative (including whether the plant meets the statutory definition of &#8220;marihuana&#8221; under the CSA), whether the cultivator, processor, manufacturer or product marketer engages in cannabis-related activities for research versus purely commercial purposes, as well as the form and intended use of the product. The mere presence of a cannabinoid (such as CBD) is not dispositive as to whether the product is legal or illegal. Under U.S. federal law, products containing CBD may be unlawful if derived from U.S. Schedule I cannabis (including hemp with a concentration greater than 0.3% THC on a dry weight basis), or if derived from U.S. hemp grown outside the parameters of an approved U.S. hemp pilot program or U.S. hemp cultivated in violation of the 2018 Farm Bill. Even after enactment of the 2018 Farm Bill, the DEA may not treat all products containing U.S. hemp-derived ingredients, including CBD, as exempt from the CSA. In September 2020, the DEA issued an interim final rule that purported to align the DEA&#8217;s regulations with the statutory changes to the CSA made effective by the 2018 Farm Bill. The DEA received a number of comments objecting to the interim final rule, and the interim final rule is the subject of ongoing litigation. If the DEA takes action against us or other participants in the U.S. hemp industry, this could have a material and adverse effect on our business, financial condition, operating results, liquidity, cash flow and operational performance.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Relating to COVID-19 </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business and results of operations have been adversely affected and will likely continue to be materially adversely impacted by the coronavirus pandemic (COVID-19).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic has severely restricted the level of economic activity around the world and in all countries in which we or our affiliates, investments and joint ventures operate (including the U.S., Canada, Australia, Colombia, and Israel). In response to the COVID-19 pandemic the governments of many countries, states, cities and other geographic regions have taken preventative or protective actions, such as imposing restrictions on travel and business operations, ordering temporary closures of businesses and advising or requiring individuals to limit or forego their time outside of their homes. Numerous businesses have temporarily closed voluntarily or closed permanently. Although some preventative or protective actions have been eased or lifted in varying degrees by different governments of various countries, states and cities, the continued spread of COVID-19 and increase in infection rates have caused, and may continue to cause, some jurisdictions to reinstitute such actions, including rolling back reopening plans. The duration and ultimate impact of the COVID-19 pandemic, including the extent to which the virus may re-emerge following the current outbreak, are highly uncertain.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effects of the COVID-19 pandemic had a material impact on the growth of revenues and sales during the fiscal year ended December 31, 2020 related to the Company&#8217;s U.S. segment. With segments of the U.S. economy currently in an economic contraction, and a significant number of the Company&#8217;s customers&#8217; stores continuing to be challenged by remaining temporarily closed or closing permanently, the U.S. segment is experiencing slower than expected revenue growth. The prolonged closures of retail stores as well as the changes in consumer purchasing during the COVID-19 pandemic have adversely affected our financial results. We anticipate further adverse effects on our financial results so long as the measures implemented to combat the COVID-19 pandemic stay in effect.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effect of the COVID-19 pandemic could include closures of our facilities or the facilities of our suppliers and other vendors in our supply chain and other preventive and protective measures in our supply chain. For example, as a result of the COVID-19 pandemic, closures of manufacturers in China in early 2020 resulted in delays of deliveries of batteries and cartridges for our cannabis vaporizers and personal protective equipment, such as masks and gowns used in our GMP manufacturing processes, from such manufacturers in China. In addition, as a result of a rise in infection rates late in the fourth quarter of 2020 and in the first quarter of 2021 in the U.S., certain contract manufacturers that manufacture U.S. hemp finished products for our U.S. business have experienced temporary closures or reductions in their operations leading to shortages of finished product available via the e-commerce channel. We expect these closures or reductions to ease and product shortages to be ameliorated as the spread of COVID-19 and infection rates decline. If the pandemic persists, closures or other restrictions on the conduct of business operations of our third-party manufacturers, suppliers or vendors could disrupt our supply chain. We have experienced minor delays in shipping and the increased global demand on shipping and transport services, in addition to customs and border control policies put in place in response to COVID-19 that require shipments to undergo quarantine periods, may cause us to experience delays or increased costs in the future which could impact our ability to obtain materials or deliver our products in a timely manner, could otherwise disrupt our operations and could have an adverse effect on our business, financial condition and results of operations. In various provinces in Canada, cannabis retailers have been reducing opening hours, staff onsite and the number of customers allowed in-store for cannabis retailers that continue to be open. Further, retailers of our products in the U.S. and Canada have in some cases determined to, and may in other cases be required to close or choose to suspend or significantly curtail their operations due to health and safety concerns for their employees. Even if our production facilities remain open, mandatory or voluntary self-quarantines and travel restrictions may limit our employees&#8217; ability to get to our facilities, and this, together with impacts on our supply chain and the uncertainty produced by the rapidly evolving nature of the COVID-19 pandemic, may result in reduced or suspended production. Those type of restrictions could also impact the abilities of customers in the U.S. or certain Canadian provinces to continue to have access to our products. Quarantines, shelter-in-place and similar government orders, or the perception that such orders, shutdowns or other restrictions on the conduct of business operations could occur, could impact personnel at third-party manufacturing facilities in the U.S. and Canada and other countries, or the availability or cost of materials, which would disrupt our supply chain, in particular in relation to our supply of masks, gowns and other protective equipment used at our GMP facilities due to the global shortage of such protective equipment and materials. As a result of COVID-19, we have implemented work-from-home policies for certain employees and the effects of our work-from-home policies may negatively impact productivity, disrupt access to books and records, increase cybersecurity risks and the risk of inadvertent disclosure of confidential information and disrupt our business. In addition, the effects of the COVID-19 pandemic may delay our R&amp;D programs and our ability to execute on certain of our new product launches, line extensions and strategic plans involving construction or the receipt and installation of new equipment. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The global impact of the COVID-19 pandemic continues to evolve rapidly, and the extent of its effect on our operational and financial performance will depend on future developments, which are highly uncertain, including the duration, scope and severity of the pandemic, the actions taken to contain or mitigate its impact, and the direct and indirect economic effects of the pandemic and related containment measures, among others. Even after the COVID-19 pandemic subsides, our businesses could also be negatively impacted should the effects of the COVID-19 pandemic lead to changes in consumer behavior, including as a result of a decline in the level of vaping or demand for inhalable products in light of certain recent published articles and studies on the potential increased susceptibility of individuals who smoke or vaporize nicotine or cannabis to COVID-19, in light of changes in consumer behavior such as reduced spending on certain product formats historically used in shared experiences such as pre-rolls or in reductions in discretionary spending. In addition, a severe or prolonged recession resulting from the COVID-19 pandemic would likely materially affect our business and the value of our common shares. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have been and may in the future be required to write down intangible assets, including goodwill, due to impairment, which could have a material adverse effect on our results of operations or financial position.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has been and may in the future be required to write down intangible assets, including goodwill, due to impairment, which would reduce earnings. We periodically calculate the fair value of our reporting units and intangible assets to test for impairment. This calculation may be affected by several factors, including general economic conditions, regulatory developments, changes in category growth rates as a result of changing adult consumer preferences, success of planned new product introductions, and competitive activity. Certain events can also trigger an immediate review of goodwill and intangible assets. If the carrying value of our reporting unit and other intangible assets exceed their fair value, the goodwill and other intangible assets are considered impaired, which would result in impairment losses and could have a material adverse effect on our consolidated financial position or results of operations. We cannot provide any assurance that the U.S. segment will successfully execute its business plans and strategies.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ongoing impact of the COVID-19 pandemic on the Company&#8217;s operating results for the U.S. segment has been difficult, if not impossible to predict. The longer than anticipated closures of retail stores have resulted in slower than anticipated revenue growth. In the second quarter of 2020, we performed an interim impairment test and the Company incurred $35 million of impairment charges on the U.S. reporting unit and $5 million on the Lord Jones&#8482; brand. </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is possible that estimates in the Company&#8217;s financial statements will continue to change in the near-term as a result of the COVID-19 pandemic and the effect of any such changes could be material, which could result in, among other things, further impairment of goodwill and intangible assets.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Relating to Competition</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The markets in which we operate are increasingly competitive and we may compete for market share with other companies, both domestically and internationally, that may have longer operating histories and more financial resources, manufacturing and marketing experience than us.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The markets for cannabis and U.S. hemp are competitive and evolving and we face strong competition from both existing and emerging companies that offer similar products. Some of our current and potential competitors may have longer operating histories, greater financial, marketing and other resources and larger customer bases than us. In addition, there is potential that the cannabis and U.S. hemp industries will undergo consolidation, creating larger companies with financial resources, manufacturing and marketing capabilities and product offerings that are greater than ours. As a result of this competition, we may be unable to maintain our operations or develop them as currently proposed on terms we consider acceptable, or at all. Increased competition by larger, better-financed competitors with geographic advantages could materially and adversely affect our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Given the rapid changes affecting global, national and regional economies generally, and the U.S. hemp industry in particular, we may not be able to create and maintain a competitive advantage in the marketplace. Our success will depend on our ability to respond to, among other things, changes in the economy, regulatory conditions, market conditions and competitive pressures. Any failure by us to anticipate or respond adequately to such changes could have a material and adverse effect on our business, financial condition, operating results, liquidity, cash flow and operational performance.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In Canada, the number of licenses granted by Health Canada could also have an impact on our operations. We expect to face additional competition from new market entrants that are granted licenses under the Cannabis Act or existing license holders which are not yet active in the industry. If a significant number of new licenses are granted by Health Canada in the near term, we may experience increased competition for market share and may experience downward price pressure on our products as new entrants increase production. If the number of users of cannabis in Canada increases, the demand for products will increase and we expect that competition will become more intense, as current and future competitors begin to offer an increasing number of diversified products. To remain competitive, we will require a continued high level of investment in R&amp;D, sales and customer support. We may not have sufficient resources to maintain R&amp;D, sales and customer support efforts on a competitive basis which could have a material adverse effect on our business, financial condition and results of operations. Furthermore, the Canadian federal authorization of home cultivation, outdoor grow, and the easing of other barriers to entry to the Canadian adult-use cannabis market, could materially and adversely affect our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the U.S., the number of competitors in the U.S. hemp industry has increased significantly in recent years and is expected to continue to increase, which could negatively impact our market share and demand for our products. Additionally, if the U.S. takes steps to legalize U.S. Schedule I cannabis, the impact of such a development could result in new entrants into the market and increased levels of competition.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We face competition from the illegal cannabis market.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We face competition from illegal market operators that are unlicensed and unregulated. As these illegal market participants do not comply with the regulations governing the cannabis industry, their operations may also have significantly lower costs. The perpetuation of the illegal market for cannabis may have a material adverse effect on our business, results of operations, as well as the perception of cannabis use. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have been and may in the future be required to write down inventory due to downward pressure on market prices, which could have a material adverse effect on our results of operations or financial position. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the end of each reporting period, management performs an assessment of inventory obsolescence, prices and demand to measure inventory at the lower of cost and net realizable value. Net realizable value is defined as the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. We also consider factors such as slow-moving or non-marketable products in our determination of obsolescence. As a result of this assessment, inventory write-downs may occur from period to period. Due to continued pricing pressures in the Canadian marketplace, we may incur further inventory write-downs in the future.</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have had a series of inventory write-downs due to price compression in the cannabis market. We expect these write-downs to continue as pricing pressures remain elevated. These inventory write-downs have in the past and may in the future materially adversely affect our results of operations and financial position. </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be unable to attract or retain skilled labor and personnel with experience in the cannabis sector, and may be unable to attract, develop and retain additional employees required for our operations and future developments.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may be unable to attract or retain employees with sufficient experience in the cannabis industry, and may prove unable to attract, develop and retain additional employees required for our development and future success.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success is currently largely dependent on the performance of our skilled employees. Our future success depends on our continuing ability to attract, develop, motivate and retain highly qualified and skilled employees. Qualified individuals are in high demand, and we may incur significant costs to attract and retain them.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, certain shareholders, directors, officers and employees in our Canadian operations may require security clearance from Health Canada. Under the Cannabis Act, a security clearance cannot be valid for more than five years and must be renewed before the expiry of a current security clearance. There is no assurance that any of our existing personnel who presently or may in the future require a security clearance will be able to obtain or renew such clearances or that new personnel who require a security clearance will be able to obtain one. A failure by an employee to maintain or renew his or her security clearance may impair our business operations. In addition, if an employee with security clearance leaves and we are unable to find a suitable replacement who has a security clearance required by the Cannabis Act in a timely manner, or at all, there could occur a material adverse effect on our business operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Relating to the Altria Investment</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Altria has significant influence over us following closing of the Altria Investment.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria is our single largest shareholder. As of December 31, 2020, Altria beneficially owned approximately 43.5% of our issued and outstanding common shares (calculated on a non-diluted basis). In light of such ownership, Altria is in a position to exercise significant influence over matters affecting shareholders or requiring shareholder approval, including the election of the Board, amendments to our articles and the determination of significant corporate actions. In addition, pursuant to the Investor Rights Agreement, Altria has certain rights, including the right to nominate a specified number of directors to the Board, approval rights over certain Company actions and pre-emptive and top-up rights entitling Altria to maintain its pro rata beneficial ownership in us. Further, as of the date hereof, four of the seven directors on the Board are Altria Nominees. For more information, see &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business -Altria Strategic Investment - Investor Rights Agreement.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon exercise of the Altria Warrant in full, assuming no other securities of ours are issued, Altria will beneficially hold in excess of a majority of the voting rights of the issued and outstanding common shares and would have the right to elect the entire Board and be able to exercise a controlling influence over our business and affairs, including the selection of our senior management, the acquisition or disposition of our assets, the payment of dividends and any change of control of us, such as a merger or take-over.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accordingly, Altria currently has significant influence over us and has the ability to increase this influence at any time upon the exercise of the Altria Warrant. There can be no assurance that Altria&#8217;s interests will align with our interests or the interests of other shareholders. In addition, such influence could limit the price that an acquirer might be willing to pay in the future for common shares and it may have the effect of delaying or preventing a change of control of us, such as a merger or take-over.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have discretion in the use of net proceeds from the Altria Investment and may not use them effectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Subscription Agreement, we have discretion in the use of net proceeds from the Altria Investment, subject to our obligation to consult with Altria, in certain circumstances, seek the approval of Altria (such approval not to be unreasonably conditioned, withheld or delayed) and certain other limitations regarding the use of net proceeds set forth in the Subscription Agreement. Accordingly, shareholders may not agree with the manner in which management chooses to allocate and spend the net proceeds. Our failure to apply the funds effectively could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have cash on hand, including short-term investments, of approximately $1.3&#160;billion as of December 31, 2020. There can be no assurance that we will be able to deploy the available cash in an effective manner that is accretive to us, or at all. Until such time as we are able to deploy the cash available to us, we anticipate holding the net proceeds as cash balances in our bank account or investing in certificates of deposit and other instruments issued by banks or obligations of or guaranteed by the Government of Canada or any province thereof or in U.S. Treasury securities or other obligations issued or guaranteed by the U.S. Government, its agencies or instrumentalities. Based on the level of current interest rates, we will not earn any material revenue from such invested cash.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not realize the benefits of our strategic partnership with Altria, which could have an adverse effect on our business and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the strategic partnership between us and Altria provides us with additional financial resources, product development and commercialization capabilities, and deep regulatory expertise to better position us to compete, scale and lead the rapidly growing global cannabis industry. We believe that the growth opportunities for us are significant and could extend across the globe as new markets open. With Altria&#8217;s resources, we expect to be even better positioned to support cannabinoid innovation, create differentiated products and brands across medical and adult-use categories and expand our global footprint and growing production capacity. Nevertheless, a number of risks and uncertainties are associated with the expansion into such markets and the pursuit of these other growth opportunities. The successful implementation of the Altria Investment is critical to our growth and capital position. The failure to successfully implement or reap the anticipated benefits of Altria&#8217;s resources and expertise to realize growth and expansion opportunities could have a material adverse effect on our business and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Any common shares issued pursuant to the exercise of the Altria Warrant will dilute shareholders.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Altria Warrant may be exercised in full or in part at any time on or prior to March 8, 2023, from time to time, and entitles the holder thereof, upon valid exercise in full thereof, to acquire, accept and receive from us an aggregate of 80,056,296 of our common shares (subject to adjustment in accordance with the terms of the Altria Warrant Certificate), which represents 10% of the issued and outstanding common shares as of December 31, 2020 (on a non-diluted basis). Any issuance of common shares pursuant to the exercise of the Altria Warrant would dilute all of our other shareholders and give Altria control of us.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Altria&#8217;s significant interest in us may impact the liquidity of the common shares.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common shares may be less liquid and trade at a discount relative to the trading that could occur in circumstances where Altria did not have the ability to significantly influence or determine matters affecting us. Additionally, Altria&#8217;s significant voting interest in us may discourage transactions involving a change of control of us, including transactions in which an investor, as a shareholder, might otherwise receive a premium for its common shares over the then-current market price.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The change of control provisions in certain of our existing or future contractual arrangements may be triggered upon the exercise of the Altria Warrant in part or in full.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our existing or future contractual arrangements may include change of control provisions requiring us to make certain payments or triggering certain termination rights for our counterparties if the change of control trigger is fulfilled. The change of control provisions in certain of our existing arrangements, including, but not limited to, compensatory arrangements, or agreements we may enter into in the future, may be triggered upon the exercise of the Altria Warrant in part or in full.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Future sales of our common shares by Altria could cause the market price for our common shares to fall.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales of a substantial number of our common shares by Altria could occur at any time. Such sales, or the market perception of such sales, could significantly reduce the market price of our common shares. We cannot predict the effect, if any, that future public sales of our common shares beneficially owned by Altria or the availability of these common shares for sale will have on the market price of our common shares. If the market price of our common shares were to drop as a result, this might impede our ability to raise additional capital and might cause a significant decline in the value of the investments of our other shareholders.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The intentions of Altria regarding its long-term economic ownership of our common shares are subject to change as a result of changes in the circumstances of Altria or its affiliates, changes in our management and operation and changes in laws, market conditions and our financial performance.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Conflicts of interest may arise between us and our directors and officers, including as a result of the continuing involvement of certain of our directors with Altria and its affiliates.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may be subject to various potential conflicts of interest because of the fact that some of our directors and officers may be engaged in a range of business activities, or have relationships with or are employed by Altria. One of our directors, Jason Adler, is the co-founder and Managing Member of Gotham Green Partners, a private equity firm focused primarily on early-stage investing in companies in the cannabis industry, and Michael Gorenstein, our Executive Chairman is a co-founder and non-managing Member of Gotham Green Partners. Three of our directors, Jody Begley, Murray Garnick and Heather Newman, are employed by Altria as Executive Vice President and Chief Operating Officer, Executive Vice President and General Counsel, and Senior Vice President, Corporate Strategy, respectively. As a result of these relationships, conflicts of interests may arise between us and them, as described below.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may also become involved in other transactions which are inconsistent or conflict with the interests of our directors and officers, and/or our directors and officers may have interests in persons, firms, institutions, corporations or transactions that are inconsistent or in conflict with our interests and those of our shareholders. In addition, from time to time, Gotham Green Partners or Altria may be competing with us for available investment opportunities. Conflicts of interest, if any, will be subject to the procedures and remedies provided under applicable laws. In particular, in the event that such a conflict of interest arises at a meeting of our directors, a director who has such a conflict will abstain from voting for or against the approval of the transaction and may recuse himself or herself from any related discussion or deliberation. In accordance with applicable laws, our directors are required to act honestly, in good faith and in our best interests.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Relating to Our Common Shares</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">It is not anticipated that any dividend will be paid to holders of common shares for the foreseeable future.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No dividends on the common shares have been paid to date. We currently intend to retain future earnings, if any, for future operation and expansion. Any decision to declare and pay dividends in the future will be made at the discretion of the Board and will depend on, among other things, financial results, cash requirements, contractual restrictions and other factors that the Board may deem relevant. Any changes to our policy with respect to the declaration and payment of any dividends requires Altria&#8217;s approval. As a result, investors may not receive any return on an investment in our common shares unless they sell their shares for a price greater than that which such investors paid for them.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The market price for the common shares may be volatile and subject to fluctuation in response to numerous factors, many of which are beyond our control.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The market price for the common shares may be volatile and subject to wide fluctuations in response to many factors, including:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">actual or anticipated fluctuations in our results of operations;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in estimates of our future results of operations by us or securities research analysts;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in the economic performance or market valuations of other companies that investors deem comparable to us;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">additions or departures of our executive officers and other key personnel;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">transfer restrictions on outstanding common shares;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">sales of additional common shares or the perception in the market that such sales might occur;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">significant acquisitions or business combinations, strategic partnerships, investments, joint ventures or capital commitments by or involving us or our competitors;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increases in speculative trading activity by investors targeting publicly traded cannabis companies, which can further contribute to the volatility of the market price for our common shares if aggregate short exposure exceeds the number of our common shares available for purchase;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">news reports relating to trends, concerns or competitive developments, regulatory changes or enforcement actions and other related issues in our industry or target markets;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the prospect of actual or perceived future changes to the legal and regulatory regimes that govern our products and our industries;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">investors&#8217; general perception of us and the public&#8217;s reaction to our press releases, our other public announcements and our filings with the SEC and Canadian securities regulators;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reports by industry analysts, investor perceptions, and market rumors or speculation; and</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">negative announcements by our customers, competitors or suppliers regarding their own performance.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For example, reports by industry analysts, investor perceptions, market rumors or speculation could trigger a sell-off in our common shares. Any sales of substantial numbers of the common shares in the public market or the perception that such sales might occur may cause the market price of the common shares to decline. In addition, to the extent that other large companies within our industries experience declines in their stock price, the share price of our common shares may decline as well. Moreover, if the market price of our common shares drops significantly, shareholders may institute securities class action lawsuits against us. Lawsuits against us could cause us to incur substantial costs and could divert the time and attention of our management and other resources.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities markets continue to experience significant price and volume fluctuations that have, in some cases, been unrelated to the operating performance, underlying asset values or prospects of public companies. Accordingly, the market price of our common shares may decline even if our results of operations, underlying asset values or prospects have not changed. In addition, certain institutional investors may base their investment decisions on consideration of our environmental, governance, diversity and social practices and performance against such institutions&#8217; respective investment guidelines and criteria, and failure to meet such criteria may result in limited or no investment in our common shares by those institutions, which could adversely affect the trading price of our common shares. There can be no assurance that continuing fluctuations in price and volume will not occur. If such increased levels of volatility and market turmoil continue, the trading price of the common shares may be adversely affected.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities class action litigation often has been brought against companies following periods of volatility in the market price of their securities. We have been the target of such litigation and may in the future be the target of similar litigation. Regardless of merit, such litigation could result in substantial costs and damages and divert management&#8217;s attention and resources, which could adversely affect our business. Any adverse determination in litigation against us could also subject us to significant liabilities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may require additional capital in the future or be required to issue common shares pursuant to certain of our agreements which may dilute holders of our securities. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may be required to issue additional common shares pursuant to the Ginkgo Collaboration Agreement or to Kristen Bell pursuant to a publicity rights agreement entered into with the Company (the &#8220;Publicity Rights Agreement&#8221;). Pursuant to the Ginkgo Collaboration Agreement, upon Ginkgo&#8217;s demonstration that the microorganisms are capable of producing the target cannabinoids above a minimum productivity level, we will issue to Ginkgo up to approximately 14.7 million common shares in the aggregate. Tranches of these common shares will be issued as each of the Equity Milestone Events is reached. The issuance of such common shares, if any, would dilute holders of common shares. Pursuant to the Publicity Rights Agreement, if certain performance milestones are achieved, up to an additional $2 million common shares in the aggregate may be issued. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of common shares will have no pre-emptive rights in connection with such further issuances. Our Board has the discretion to determine if an issuance of common shares is warranted, the price at which such issuance is effected and the other terms of issue of common shares. Any additional capital raised through the sale of equity will dilute the percentage of ownership of holders of our common shares. Capital raised through debt financing would require us to make periodic interest payments and may impose restrictive covenants on the conduct of our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">A substantial number of our securities are owned by a limited number of existing shareholders.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, directors and employees own a substantial number of our outstanding common shares (on a fully diluted basis). In addition, as of December 31, 2020, Altria beneficially owned approximately 43.5% of our outstanding common shares (calculated on a non-diluted basis). As such, our management, directors and employees, as a group, and Altria each are in a position to exercise significant influence over matters requiring shareholder approval, including the election of directors and the determination of significant corporate actions. In addition, these shareholders could delay or prevent a change in control that could otherwise be beneficial to holders of common shares.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investors in the U.S. may have difficulty bringing actions and enforcing judgments against us and others based on securities law civil liability provisions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are incorporated under the laws of the Province of British Columbia and our head office is located in the Province of Ontario. Some of our directors and officers and some of the experts named in this Annual Report are residents of Canada or otherwise reside outside of the U.S., and a substantial portion of their assets and our assets are located outside the U.S. Consequently, it may be difficult for investors in the U.S. to bring an action against such directors, officers or experts or to enforce against those persons or us a judgment obtained in a U.S. court predicated upon the civil liability provisions of U.S. federal securities laws or other laws of the U.S. In addition, while statutory provisions exist in British Columbia for derivative actions to be brought in certain circumstances, the circumstances in which a derivative action may be brought, and the procedures and defenses that may be available in respect of any such action, may be different than those of shareholders of a company incorporated in the U.S.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are a passive foreign investment company for U.S. federal income tax purposes in any year, certain adverse tax rules could apply to U.S. holders of our common shares. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will be classified as a passive foreign investment company (&#8220;PFIC&#8221;) for any taxable year for U.S. federal income tax purposes if for a taxable year, (i) 75% or more of our gross income is passive income, or (ii) 50% or more of the value of our assets either produce passive income or are held for the production of passive income, based on the quarterly average of the fair market value of such assets. The determination of PFIC status depends on interpretive rules and computational conventions that are often unclear. In particular, in making our determination, we are relying on the application of certain &#8220;look-through&#8221; rules, taking into account certain intercompany items. There is, however, no direct legal authority applying these look-through rules to our particular situation (including to what extent, they apply to intercompany items). Likewise, in light of the volatility of our common share price, we intend to take the position that the spot trading price of our stock at each quarter end, as adjusted by liabilities, does not dictate the determination of the fair market value of our assets. Based on current business plans and financial expectations, an independent valuation report in respect of our assets, and the application of certain look-through rules (including the taking into account of certain intercompany items), we do not expect to be a PFIC for the taxable year ending December 31, 2020 and do not expect to become a PFIC in the foreseeable future. However, PFIC status is determined annually and depends upon the composition of our gross income and assets, both of which are subject to change. Moreover, there can be no assurance that the IRS or a court will agree with our interpretation of fair market value or its computation, or with our interpretation of the PFIC rules (including the &#8220;look-through&#8221; rules and the scope of their application, including in respect of intercompany items). Therefore, there can be no assurance as to our PFIC status for the current taxable year or for future taxable years, nor any assurance that the IRS or a court will agree with our determination of our PFIC status.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If securities or industry analysts do not publish research, or publish inaccurate or unfavorable research about our business, our share price and trading volume could decline.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The trading market for our common shares depends, in part, on the research and reports that securities or industry analysts publish about us or our business. If one or more of the analysts who cover us downgrade our common shares or publish inaccurate or unfavorable research about our business, the trading price of our common shares would likely decline. In addition, if our results of operations fail to meet the forecast of analysts, the trading price of our common shares would likely decline. If one or more of these analysts cease coverage of us or fail to publish reports on us regularly, demand for our common shares could decrease, which might cause our trading price and trading volume to decline.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General Risks</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are dependent on our senior management.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success is dependent upon the ability, expertise, judgment, discretion and good faith of our senior management. While employment agreements are customarily used as a primary method of retaining the services of key employees, these agreements cannot assure the continued services of our senior management team. Qualified individuals are in high demand, and we may incur significant costs to attract and retain them. The loss of the services of a member of senior management, or an inability to attract other suitably qualified persons when needed, could have a material adverse effect on our ability to execute on our business plan and strategy, and we may be unable to find adequate replacements on a timely basis, or at all. We do not maintain key-person insurance on the lives of any of our officers or employees.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We will seek to maintain adequate insurance coverage in respect of the risks we face; however, insurance premiums for such insurance may not continue to be commercially justifiable and there may be coverage limitations and other exclusions which may not be sufficient to cover our potential liabilities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have insurance to protect our assets, operations and employees. While we believe our insurance coverage addresses all material risks to which we are exposed in our current state of operations, such insurance is subject to coverage limits and exclusions and may not be available for the risks and hazards to which we are exposed. For example, certain wholesalers, distributors, retailers and other service providers may require suppliers of U.S. hemp products to provide an indemnification from liability in connection with such products, which may not be covered by insurance. In addition, no assurance can be given that such insurance will be adequate to cover our liabilities or will be generally available in the future or, if available, that premiums and deductibles will be commercially justifiable. If we were to incur substantial liability claims and such damages were not covered by insurance or were in excess of policy limits, or if we were to incur such liability at a time when we are not able to obtain liability insurance, there could be a material adverse effect on our business, financial condition and results of operations.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Tax and accounting requirements may change or be interpreted in ways that are unforeseen to us and we may face difficulty or be unable to implement and/or comply with any such changes.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to numerous tax and accounting requirements, and changes in existing accounting or taxation rules or practices, or varying interpretations of current rules or practices, could have a significant adverse effect on our financial results, the manner in which we conduct our business or the marketability of any of our products. In many countries, including the U.S., we are subject to transfer pricing and other tax regulations designed to ensure that appropriate levels of income are reported as earned and are taxed accordingly. Although we believe that we are in substantial compliance with all applicable regulations and restrictions, we are subject to the risk that governmental authorities could audit our transfer pricing and related practices and assert that additional taxes are owed. In the future, the geographic scope of our business may expand, and such expansion will require us to comply with the tax laws and regulations of additional jurisdictions. Requirements as to taxation vary substantially among jurisdictions. Complying with the tax laws of these jurisdictions can be time consuming and expensive and could potentially subject us to penalties and fees in the future if we failed to comply. In the event that we failed to comply with applicable tax laws, this could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Natural disasters, unusual weather, pandemic outbreaks, boycotts and geo-political events or acts of terrorism could adversely affect our operations and financial results.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The occurrence of one or more natural disasters, such as hurricanes, floods and earthquakes, unusually adverse weather, pandemic outbreaks, such as the COVID-19 virus, influenza and other highly communicable diseases or viruses, boycotts and geo-political events, such as civil unrest in countries in which our operations are located and acts of terrorism, or similar disruptions could adversely affect our business, financial condition and results of operations. These events could result in physical damage to one or more of our properties, increases in fuel or other energy prices, the temporary or permanent closure of one or more of our facilities, the temporary lack of an adequate workforce in a market, the temporary or long-term disruption in the supply of products from suppliers, the temporary disruption in the transport of goods, delay in the delivery of goods to our facilities, and disruption to our information systems. Such events could also negatively impact consumer sentiment, reduce demand for consumer products like ours and cause general economic slowdown. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our financial performance is subject to risks of foreign exchange rate fluctuation which could result in foreign exchange losses.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may be exposed to fluctuations of the U.S. dollar against certain other currencies, particularly the Canadian dollar, because we publish our financial statements in U.S. dollars, while a significant portion of our assets, liabilities, revenues and costs are or will be denominated in other currencies. Exchange rates for currencies of the countries in which we operate may fluctuate in relation to the U.S. dollar, and such fluctuations may have a material adverse effect on our earnings or assets when translating foreign currency into U.S. dollars.</span></div><div><span><br/></span></div><div id="i1ae9134e40e74e0aac958218112e53d4_22"></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1B. UNRESOLVED STAFF COMMENTS.</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div id="i1ae9134e40e74e0aac958218112e53d4_25"></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2. PROPERTIES. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our executive offices are located in Toronto, Ontario in Canada, where we lease office space. As of December 31, 2020, our Rest of World segment owned various manufacturing facilities in the Canadian provinces of Manitoba, Ontario and British Columbia and in Hadera, Israel, as well as a research and development facility in Beit Shemesh, Israel. As of December 31, 2020, our United States segment leased office space and a manufacturing facility in Los Angeles, California. Management believes that our existing facilities are adequate to meet our current requirements and, to the extent that our facilities are leased, comparable space is readily available. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div id="i1ae9134e40e74e0aac958218112e53d4_28"></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3. LEGAL PROCEEDINGS.</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to various legal proceedings in the ordinary course of its business and in connection with its marketing, distribution and sale of its products. Many of these legal proceedings are in the early stages of litigation and seek damages that are unspecified or not quantified. Although the outcome of these matters cannot be predicted with certainty, the Company does not believe these legal proceedings, individually or in the aggregate, will have a material adverse effect on its consolidated financial condition but could be material to its results of operations for any particular reporting period depending, in part, on its results for that period. </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Class action complaints relating to restatement</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 11 and 12, 2020, two alleged shareholders of the Company separately filed two putative class action complaints in the U.S. District Court for the Eastern District of New York against the Company and its former Chief Executive Officer (now Executive Chairman) and Chief Financial Officer. The court has consolidated the cases, and the consolidated amended complaint alleges violations of Section 10(b) of the Exchange Act and Rule 10b-5 promulgated thereunder against all defendants, and Section 20(a) of the Exchange Act against the individual defendants. The consolidated amended complaint generally alleges that certain of the Company&#8217;s prior public statements about revenues and internal controls were incorrect based on the Company&#8217;s March 2, 2020 disclosure that the Audit Committee of the Board was conducting a review of the appropriateness of revenue recognized in connection with certain bulk resin purchases and sales of products through the wholesale channel. The consolidated amended complaint does not quantify a damage request. Defendants moved to dismiss on February 8, 2021.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 3, 2020, an alleged shareholder filed a Statement of Claim, as amended on August 12, 2020, in the Ontario Superior Court of Justice in Toronto, Ontario, Canada, seeking, among other things, an order certifying the action as a class action on behalf of a putative class of shareholders and damages of an unspecified amount. The Amended Statement of Claim names the Company, its former Chief Executive Officer (now Executive Chairman), Chief Financial Officer, former Chief Financial Officer and Chief Commercial Officer, and current and former members of the Board as defendants and alleges breaches of the Ontario Securities Act, oppression under the Ontario Business Corporations Act and common law misrepresentation. The Amended Statement of Claim generally alleges that certain of the Company&#8217;s prior public statements about revenues and internal controls were misrepresentations based on the Company&#8217;s March 2, 2020 disclosure that the Audit Committee of the Board was conducting a review of the appropriateness of revenue recognized in connection with certain bulk resin purchases and sales of products through the wholesale channel, and the Company&#8217;s subsequent restatement. The Amended Statement of Claim does not quantify a damage request.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Regulatory reviews relating to restatement</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has been responding to requests for information from various regulatory authorities relating to its previously disclosed restatement of its financial statements for the first three quarters of 2019. The Company is responding to all such requests for information and cooperating with all regulatory authorities. The Company cannot predict the outcome of any such regulatory review or investigation and it is possible that additional investigations or one or more formal proceedings may be commenced against the Company and its current and former officers and directors in connection with these regulatory reviews and investigations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Litigation relating to marketing, distribution and sale of products</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 16, 2020, an alleged consumer filed a Statement of Claim on behalf of a class in the Court of Queen&#8217;s Bench of Alberta in Alberta, Canada, against the Company and other Canadian cannabis manufacturers and/or distributors. On December 4, 2020, a Third Amended Statement of Claim was filed, which added a second alleged consumer. The Third Amended Statement of Claim alleges claims related to the defendants&#8217; advertised content of cannabinoids in cannabis products for medicinal use on or after June 16, 2010 and cannabis products for adult use on or after October 17, 2018. The Third Amended Statement of Claim seeks a total of C$500 million for breach of contract, compensatory damages, and unjust enrichment or such other amount as may be proven in trial and C$5 million in punitive damages against each defendant, including the Company. The Third Amended Statement of Claim also seeks interest and costs associated with the action. The Company has not responded to the Third Amended Statement of the Claim.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A number of claims, including purported class actions, have been brought in the U.S. against companies engaged in the U.S. hemp business alleging, among other things, violations of state consumer protection, health and advertising laws. On April 8, 2020, a putative class action complaint was filed in the U.S. District Court for the Central District of California against Redwood, alleging violations of California&#8217;s Unfair Competition Law, False Advertising Law, Consumers Legal Remedies Act, and breaches of the California Commercial Code for breach of express warranties and implied warranty of merchantability with respect to Redwood&#8217;s marketing and sale of U.S. hemp products. The complaint did not quantify a damage request. On April 10, 2020, the class action complaint was dismissed for certain pleading deficiencies and the plaintiff was granted leave until April 24, 2020 to amend the complaint to establish federal subject matter jurisdiction. On April 28, 2020, the action was dismissed without prejudice for failure to prosecute and for failure to comply with a court order. As of the date of this Annual Report, the plaintiff has not refiled the complaint.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect litigation and regulatory proceedings relating to the marketing, distribution and sale of our products to increase.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div id="i1ae9134e40e74e0aac958218112e53d4_31"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4. MINE SAFETY DISCLOSURE. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><div id="i1ae9134e40e74e0aac958218112e53d4_34"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 5. MARKET FOR REGISTRANT&#8217;S COMMON EQUITY, RELATED SHAREHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common shares are traded on Nasdaq and the TSX under the symbol &#8220;CRON.&#8221;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Holders</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of February&#160;25, 2021, there were approximately 71 holders of record of our common shares. This number of holders of record does not represent the actual number of beneficial owners of our common shares because shares are frequently held in &#8220;street name&#8221; by securities dealers and others for the benefit of individual owners who have the right to vote their shares. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the date of this Annual Report, we have not declared any dividends or made any distributions on our common shares. Furthermore, we have no current intention to declare dividends on our common shares in the foreseeable future. Any decision to pay dividends on our common shares in the future will be at the discretion of the Board and will depend on, among other things, our results of operations, current and anticipated cash requirements and surplus, financial condition, any future contractual restrictions and financing agreement covenants, our ability to meet solvency tests imposed by corporate law and other factors that the Board may deem relevant.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities Authorized for Issuance under Equity Compensation Plans</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information concerning securities authorized for issuance under equity compensation plans will be set forth in the Company&#8217;s definitive proxy statement for its 2021 Annual Meeting of Shareholders or an amendment to this Annual Report to be filed within 120 days of our fiscal year end.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Purchases of Equity Securities by the Issuer and Affiliated Persons</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Sales of Unregistered Securities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Performance Graph</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following performance graph compares the cumulative total shareholder return of our common shares as listed on Nasdaq with the cumulative total return of the S&amp;P 500 Index and two market-weighted indices of publicly traded peers over the 34-month period beginning on February 27, 2018 and ending on December 31, 2020. Because the Company changed the composition of the peer group for 2020 as described below, the peer group used for the corresponding disclosures in 2019 is shown for comparison. The graph assumes that $100 is invested in each of our common shares, the S&amp;P 500 Index, and the indices of publicly traded peers on February 27, 2018 and that all dividends, if applicable, were reinvested. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The publicly traded companies in the new peer group are Aphria Inc., Aurora Cannabis Inc., Canopy Growth Corporation, Green Thumb Industries Inc., GW Pharmaceuticals plc, HEXO Corporation, iAnthus Capital Holdings Inc., Organigram Holdings Inc. and Tilray Inc. (the &#8220;New Peer Group&#8221;). The old peer group also included CannTrust Holdings (the &#8220;Old Peer Group&#8221;) Inc., which has been excluded from the New Peer Group for the year ended December 31, 2020 because we no longer believe that its business model makes it comparable. Past performance may not be indicative of future performance. </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="text-align:justify"><img src="cron-20201231_g7.jpg" alt="cron-20201231_g7.jpg" style="height:350px;margin-bottom:5pt;vertical-align:text-bottom;width:550px"/></div><div style="margin-bottom:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.372%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.372%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.372%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.373%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Date</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cronos Group Inc.</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">S&amp;P 500</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019 Peer Group</span></td><td colspan="3" style="border-right:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020 Peer Group</span></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 27, 2018</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100.00</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.00&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.00&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.00&#160;</span></td><td style="border-right:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2018</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">88.32</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.46&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.89&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105.16&#160;</span></td><td style="border-right:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2018</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">85.56</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.81&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115.49&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116.33&#160;</span></td><td style="border-right:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2018</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">145.93</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108.58&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170.60&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171.08&#160;</span></td><td style="border-right:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2018</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">136.35</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.90&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.54&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.91&#160;</span></td><td style="border-right:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2019</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">241.86</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.71&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135.59&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136.03&#160;</span></td><td style="border-right:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2019</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">209.71</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.31&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.11&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.12&#160;</span></td><td style="border-right:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2019</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">118.77</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113.20&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.69&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.14&#160;</span></td><td style="border-right:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100.66</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123.46&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.31&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.49&#160;</span></td><td style="border-right:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2020</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">74.41</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.27&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.98&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.71&#160;</span></td><td style="border-right:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 30, 2020</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">78.87</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.66&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.09&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.19&#160;</span></td><td style="border-right:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 30, 2020</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">65.75</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130.35&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.58&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.52&#160;</span></td><td style="border-right:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:1.5pt solid #000;border-left:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">91.08</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146.18&#160;</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.28&#160;</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.88&#160;</span></td><td style="border-bottom:1.5pt solid #000;border-right:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">*$100 invested on 2/27/18 in stock or 2/28/18 in index, including reinvestment of dividends. Fiscal year ending December 31.<br/>Copyright&#169; 2021 Standard &amp; Poor&#8217;s, a division of S&amp;P Global. All rights reserved.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because Cronos Group&#8217;s common shares are also traded on the TSX, we are providing additional information in order to enhance the reader&#8217;s understanding of our trading history. The following performance graph compares the cumulative total shareholder return of our common shares as listed on the TSX with the cumulative total return of the S&amp;P 500 Index, the New Peer Group and the Old Peer Group over the five-year period beginning on December 31, 2015 and ending on December 31, 2020. The graph assumes that $100 is invested in each of our common shares, the S&amp;P 500 Index, and the indices of the New Peer Group and Old Peer Group and that all dividends, if applicable, were reinvested. Past performance may not be indicative of future performance.</span></div><div style="text-align:justify"><img src="cron-20201231_g8.jpg" alt="cron-20201231_g8.jpg" style="height:370px;margin-bottom:5pt;vertical-align:text-bottom;width:550px"/></div><div style="margin-bottom:8pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.372%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.372%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.372%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.373%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Date</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cronos Group Inc.</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">S&amp;P 500</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019 Peer Group</span></td><td colspan="3" style="border-right:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020 Peer Group</span></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2015</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100.00</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.00&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.00&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.00&#160;</span></td><td style="border-right:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2016</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">469.84</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.96&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189.24&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189.24&#160;</span></td><td style="border-right:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2017</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,092.06</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136.40&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410.21&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410.21&#160;</span></td><td style="border-right:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2018</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,565.08</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130.42&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328.76&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331.43&#160;</span></td><td style="border-right:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,165.08</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171.49&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207.65&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212.29&#160;</span></td><td style="border-right:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:1.5pt solid #000;border-left:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,806.35</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203.04&#160;</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220.55&#160;</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226.81&#160;</span></td><td style="border-bottom:1.5pt solid #000;border-right:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">*$100 invested on 12/31/15 in stock or index, including reinvestment of dividends. Fiscal year ending December 31.<br/><br/>Copyright&#169; 2021 Standard &amp; Poor&#8217;s, a division of S&amp;P Global. All rights reserved. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share Information</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:78.037%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.608%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.955%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of February 25, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issued and outstanding shares </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common shares </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">360,258,680&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Potentially issuable shares </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock options </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,749,800&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,987,354&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted stock units </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">948,357&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Altria Warrant </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80,056,296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercisable Top-up Rights </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,557,226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total potentially issuable shares </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106,299,033&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total outstanding and potentially issuable shares </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">466,557,713&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt"><span><br/></span></div><div style="margin-bottom:8pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><div id="i1ae9134e40e74e0aac958218112e53d4_2429"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 6. Selected Financial Data</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Omitted.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div id="i1ae9134e40e74e0aac958218112e53d4_40"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You should read the following discussion and analysis together with our consolidated financial statements and the related notes to those statements, which are included in Item 8 of this Annual Report. This discussion contains Forward-Looking Statements that involve risks and uncertainties. As a result of many factors, such as those set forth in Item 1A &#8220;Risk Factors,&#8221; of this Annual Report and elsewhere in this Annual Report, our actual results may differ materially from those anticipated in these Forward-Looking Statements.</span></div><div id="i1ae9134e40e74e0aac958218112e53d4_2246"></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Overview</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Group is an innovative global cannabinoid company with international production and distribution across five continents. We are committed to building disruptive intellectual property by advancing cannabis research, technology and product development and are seeking to build an iconic brand portfolio. Cronos Group&#8217;s brand portfolio includes PEACE NATURALS&#8482;, a global wellness platform; two adult-use brands, COVE&#8482; and Spinach&#8482;; and three U.S. hemp-derived consumer products brands, Lord Jones&#8482;, Happy Dance&#8482; and PEACE+&#8482;. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Strategy</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Group seeks to create value for shareholders by focusing on four core strategic priorities:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">growing a portfolio of iconic brands that responsibly elevate the consumer experience;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">developing a diversified global sales and distribution network;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">establishing an efficient global supply chain; and</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">creating and monetizing disruptive intellectual property.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business Segments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Group reports through two segments: &#8220;United States&#8221; and &#8220;Rest of World.&#8221; These two segments represent the geographic regions in which the Company operates and the different product offerings within each geographic region. On September 5, 2019, as a result of the Redwood Acquisition, the Company established the&#160;United States&#160;segment, which includes only the results of Redwood since the date of acquisition.&#160;Redwood manufactures, markets and distributes U.S. hemp-derived supplements and cosmetic products through e-commerce, retail and hospitality partner channels in the United States (&#8220;U.S.&#8221;) under the brands Lord Jones&#8482; and Happy Dance&#8482;.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Developments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, an outbreak of a novel strain of coronavirus, COVID-19, was identified in Wuhan, China. Since then, COVID-19 has spread across the globe, including the U.S., Canada and Israel, and other countries in which the Company or its affiliates operate (including Australia and Colombia) and was recognized as a pandemic by the World Health Organization. The COVID-19 pandemic has resulted in a sharp contraction in many areas of the global economy and increased volatility and uncertainty in the capital markets. In response to the pandemic, the governments of many countries, provinces, states, cities, and other geographic regions took preventative or protective actions, including closures of certain businesses, mandatory quarantines, limits on individuals&#8217; time outside of their homes, travel restrictions and social distancing or other preventative measures. Such measures were eased or lifted in varying degrees by different governments of various countries, states and cities throughout 2020, but the continued spread of COVID-19 and increased infection rates has caused, and may continue to cause, some jurisdictions to roll back reopening plans that had been underway and re-impose quarantines, border closures, closure of certain businesses and stay-at-home orders. It is possible that jurisdictions in which the Company or its affiliates operate may reintroduce more stringent preventative or protective actions which could result in further closures of businesses. Governments in certain countries such as the U.S., Canada, and those in Europe have responded to the acute economic and market consequences with certain monetary and fiscal policy actions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impact on operating results </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2020, the effects of the COVID-19 pandemic on retail stores and the increase of costs in production and sales in the U.S. had a material impact on the rate of growth of revenue in the U.S. segment, with revenue for the segment remaining flat from the first quarter of 2020. As a result of these impacts and the expectation of future impacts, for the three months ended June 30, 2020, the Company recorded $35 million of impairment charges on its U.S. reporting unit and $5 million on the Lord Jones&#8482; brand (refer to Note 11 of the Company&#8217;s consolidated financial statements for more information regarding intangibles assets and goodwill). </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The continued negative impact on the Company&#8217;s results has been as expected during the three months ended December 31, 2020 and no further impairment charges were recorded to the U.S. reporting unit or brands as a result. The Company expects revenue growth and operating results in the U.S. segment to continue to be negatively impacted as retail closures are expected to continue as a result of the pandemic.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue and the growth in revenue in the Rest of World segment was not materially impacted by the effects of COVID-19 during the year ended December 31, 2020. However, prolonged closures of retail stores due to government mandated lockdowns as well as the changes in consumer purchasing behavior in Canada during the COVID-19 pandemic are expected to have a negative impact on the Company&#8217;s short-term revenue growth in Can</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ada. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In both segments, there were no material increases in the current expected credit loss in connection with COVID-19. The Company continues to closely monitor the effects of COVID-19 on its operating results.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Production and supply chain</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s global production facilities currently remain operational. To comply with governmental orders or other health and safety requirements, the Company has: (i) reduced the number of personnel working on-site at its production facilities to only the roles that are necessary to be performed on-site, (ii) implemented work-from-home policies for other employees whose work can be performed off-site, and (iii) implemented other additional health and safety measures such as, among other things, enhanced hygiene and sanitation procedures, modified work schedules and social distancing protocols at its production facilities. Further, as recommended by certain jurisdictions in which it operates, the Company has implemented a documented COVID-19 prevention plan in these locations. The Company has and will continue to act in accordance with guidance from local, federal, and international health and governmental authorities, such as any government-mandated requirements for people to wear facemasks in all indoor communal spaces or at businesses, and is prepared to make additional operational adjustments, as necessary. Although the Company&#8217;s production facilities currently remain operational, governmental requirements, guidance and health and safety requirements continue to evolve as governmental and health authorities respond to the spread of the virus. Reopening plans in certain jurisdictions have been and may be further reversed, suspended or delayed and quarantines may be re-imposed. The Company&#8217;s production facilities may experience further temporary closures or quarantines if governmental or health authorities make changes to the businesses and workforces allowed to remain operational, which would result in reduced production or suspension of production if such closures or quarantines are mandated. In addition, to the extent the Company&#8217;s employees contract the virus, depending on the employee&#8217;s job duties and access to facilities, the Company&#8217;s ability to keep production and manufacturing facilities open may be impacted for health and safety reasons. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impacts of certain closures or other restrictions on the conduct of business operations at the facilities of third-party manufacturers, suppliers and other vendors in the Company&#8217;s supply chain have not been significant to date but remain uncertain. Earlier closures at manufacturers in China in 2020 had resulted in delays of deliveries of batteries and cartridges for cannabis vaporizers and personal protective equipment, such as masks and gowns used in Cronos Group&#8217;s manufacturing facilities certified in accordance with Good Manufacturing Practices (&#8220;GMP&#8221;), from such manufacturers in China. Most delays have been ameliorated as manufacturers are now operational in China but other vendors or suppliers in the Company&#8217;s supply chain have been, and in the future could potentially be, impacted. Closures or other restrictions on the conduct of business operations on third-party manufacturers, suppliers or vendors may cause disruption in Cronos Group&#8217;s supply chain. As a result of a rise in infection rates late in the fourth quarter of 2020 and in the first quarter of 2021 in the U.S., certain contract manufacturers that manufacture U.S. hemp finished products for our U.S. business have experienced temporary closures or reductions in their operations leading to shortages of finished product available via the e-commerce channel. We expect these closures or reductions to ease and product shortages to be ameliorated as the spread of COVID-19 and infection rates decline. The Company has experienced delays in shipping and expects that the increased global demand on shipping and transport services, which has created challenges to container availability and port capacities, in addition to customs and border control policies put in place in response to the COVID-19 pandemic that require shipments to undergo a quarantine period, may cause the Company to experience further delays in the future which could impact the Company&#8217;s ability to obtain materials or deliver products in a timely and cost efficient manner. In addition, work-from-home policies for certain employees and the effects of the Company&#8217;s work-from-home policies may negatively impact productivity, disrupt access to books and records and disrupt the Company&#8217;s business. Even if the Company&#8217;s production facilities continue to remain open, mandatory or voluntary self-quarantines and travel restrictions may limit the Company&#8217;s employees&#8217; ability to access facilities, and this, together with impacts on the Company&#8217;s supply chain and the uncertainty produced by the rapidly evolving nature of the COVID-19 pandemic, may result in reduced or suspended production.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Customers </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Retailers in the U.S. and Canada have been required to close at times or have curtailed their operations (such as reduced opening hours, reduced staff, limiting brand partner visits, and reduced traffic in stores) due to the implementation of health and safety measures. The slowdown or disruption faced by retailers, in addition to quarantine measures and travel restrictions, impacts the ability of customers to be able to access the Company&#8217;s products. These restrictions on retail stores are mandated by, and differ across, each state, province or territory and continue to change and evolve, which creates uncertainty in forecasting customer demand and sales velocity. In the U.S., while online sales have continued despite facing pressure, certain beauty and other retailers have temporarily closed physical boutiques. State specific limitations on retail capacity has also reduced the ability of larger retailers to offer in-store brand education for the Company&#8217;s products. In Canada, retailers have implemented a combination of measures from closing stores, offering curbside delivery (to the extent permitted by a province) and online sales only, reduced store opening hours and a reduction in the number of customers permitted in stores in light of social distancing measures. Suspensions of the ability of private retailers to offer click-and-collect or curbside delivery in certain provinces in Canada may further impact customer demand for products. Provincial purchasers have also similarly, among other things, reduced staff on-site leading to a decrease in delivery time slots for producers to deliver products or reduced frequency or size of their purchase orders. While various provinces in Canada have continued to increase the number of retail stores during the COVID-19 pandemic, we expect that the expansion of retail stores in various provinces in Canada will be delayed or slowed down in light of continued increases in COVID-19 cases. We anticipate that uncertainty created by these measures on forecasting customer demand and sales will continue as long as such measures are in place. Demand for the Company&#8217;s products could also be negatively impacted should the effects of COVID-19 lead to changes in consumer behavior, including as a result of a potential decline in the level of demand for vaporizer products or in discretionary spending as result of a general economic slowdown. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Macroeconomic impacts</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impacts of these current restrictions and measures on certain strategic projects continue to be uncertain. While facility design and expansion projects and product development initiatives are currently expected to proceed as planned, requirements and restrictions on the operation of businesses and workforces continue to evolve as governmental and health authorities respond to the spread of the virus and changes may result in delays or suspensions if authorities require such activities to be suspended. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, a recession or market correction resulting from the spread of COVID-19 would likely materially affect the Company&#8217;s business and the value of its common shares. Collectively, the effects of the COVID-19 pandemic have adversely affected the Company&#8217;s results of operations and, if the effects continue unabated, could continue to do so as long as measures to combat the COVID-19 pandemic remain in effect. At this time, neither the duration nor scope of the disruption can be predicted; therefore, the ultimate impact to the Company&#8217;s business cannot be reasonably estimated but such impact could materially adversely affect the Company&#8217;s business and financial results. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Liquidity and capital resource impact</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Despite the impacts of the COVID-19 pandemic, the Company believes that its significant cash on hand and short-term investments will be adequate to meet liquidity and capital requirements for at least the next twelve months. The impact of reduced interest rates has inhibited the Company&#8217;s ability to generate interest income in the short-term, but this has not, and is not expected to have, a material impact on the liquidity or capital resources of the Company.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2020 Business Highlights </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cronos Fermentation</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2020, Cronos Fermentation successfully fermented CBGA, one of the Company&#8217;s target cannabinoids under the Ginkgo Strategic Partnership, at research scale. Cronos Fermentation has and will continue to optimize downstream processing and scale up procedures in advance of receiving the final strains and commercial processing license, both of which are required for commercialization.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management Appointments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 9, 2020, Cronos Group expanded its leadership structure to drive its next phase of growth by appointing Kurt Schmidt as President and Chief Executive Officer. This move coincided with Mike Gorenstein&#8217;s appointment to Executive Chairman. Mr. Schmidt brings deep experience in consumer products with decades of leadership experience in the U.S. and overseas. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 31, 2020, the Company added Shannon Buggy as Senior Vice President, Global Head of People. With over 25 years of experience, Ms. Buggy has a proven track record of leading and managing global human resources teams and driving excellence in talent acquisition, development, retention, employee relations, compensation, benefits, talent management and labor relations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> July 20, 2020, Summer Frein was named General Manager USA. Ms. Frein joined Cronos Group in January of 2020; however, she has worked with Cronos Group in various capacities since 2018. Under Ms. Frein&#8217;s leadership, the Company plans to further expand </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">its U.S. hemp-derived business, including introducing new product formats under both Lord Jones&#8482; and Happy Dance&#8482;, that will target different retail channels and consumers.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cronos Research Labs</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the third quarter of 2020, Cronos Device Labs expanded its scope for cannabinoid research and the R&amp;D center was renamed to Cronos Research Labs. Cronos Group engages in both understanding the fundamental science behind the interactions of cannabinoids with each other and how those interactions can be leveraged to best deliver on the consumer&#8217;s needs. Additionally, the Company partners with leading scientific institutions engaged in fundamental cannabis science to augment and accelerate its internal efforts. Cronos Group&#8217;s work spans many aspects of cannabis research from strain development to growing conditions to extraction technology to biosynthesis to product development, all supported by advances in analytical sciences.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Developments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Happy Dance&#8482;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Happy Dance&#8482; continues its expansion by securing its first major U.S. retailer, ULTA Beauty&#8482;. The full collection of Happy Dance&#8482; products is expected to launch online at ULTA.com and in-store at over 550 ULTA Beauty&#8482; locations across the U.S. in the coming weeks. Happy Dance&#8482; was co-founded by actress and New York Times best-selling author Kristen Bell and features an easy-to-use line of clean, vegan and cruelty-free U.S. hemp-derived CBD bath and body products including an All-Over Whipped Body Butter + CBD, Head-to-Toe Coconut Melt + CBD and Stress Away Bath Bomb + CBD.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cronos Israel</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">During 2020, Cronos Israel received all certifications and licenses required for the cultivation, production and marketing of dried flower, pre-rolls and oils in Israel and currently has </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">PEACE NATURALS&#8482; dried flower and oils in market. On January 11, 2021,&#8239;the PEACE NATURALS&#8482; brand was recognized by the Israeli Marketing Association and was given the 2020 Innovation Award for its successful marketing strategy&#8239;in 2020, which led to increased brand exposure. The marketing campaign gained this accolade for standing out amongst its peers by focusing on the high-quality nature of PEACE NATURALS&#8482; products. In February 2021, Cronos Israel signed a distribution agreement with the largest pharmacy chain in Israel, Super-Pharm, which has over 250 branches in Israel. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Cronos Israel continues to build distribution and brand awareness through a growing network of pharmacies.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Natuera</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Throughout 2020, Natuera, the Company&#8217;s joint venture in Latin America, a fully licensed operation in Colombia for hemp and cannabis derived bulk, consumer, and medicinal cannabinoid products, continued to achieve significant operational milestones. In addition to completing a number of test exports of hemp-derived CBD extract to both the U.S. and the United Kingdom for business development and R&amp;D purposes over the course of 2020, during the fourth quarter of 2020, Natuera completed its first export of hemp-derived CBD extract to the U.S. for commercial purposes.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cronos GrowCo</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, Cronos GrowCo, the Company&#8217;s joint venture in Canada, fully completed construction of its production facility, including all fixtures within the greenhouse and all post-harvest activity areas. In November 2020, Cronos GrowCo obtained a cultivation license for the operations contemplated by the first phase of the project. The Company expects the facility to become operational in phases beginning in the first half of 2021.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2019 Financial Results Compared to 2018</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of our 2019 financial results compared to 2018, see Part II, Item 7 &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221;, in our Annual Report on Form 10K/A for the year ended December 31, 2019.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><div id="i1ae9134e40e74e0aac958218112e53d4_2353"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign currency exchange rates</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All currency amounts in this Annual Report are stated in U.S. dollars, which is our reporting currency, unless otherwise noted. All references to &#8220;dollars&#8221; or &#8220;$&#8221; are to U.S. dollars. The assets and liabilities of the Company&#8217;s foreign operations are translated into dollars at the exchange rate in effect as of December&#160;31, 2020, December&#160;31, 2019 and December&#160;31, 2018, as reported on Bloomberg. Transactions affecting the shareholders&#8217; equity (deficit) are translated at historical foreign exchange rates. The consolidated statements of net income (loss) and comprehensive income (loss) and consolidated statements of cash flows of the Company&#8217;s foreign operations are translated into dollars by applying the average foreign exchange rate in effect for the reporting period, as reported on Bloomberg. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The exchange rates used to translate from Canadian dollars (&#8220;C$&#8221;) to dollars is shown below:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.575%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.327%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(Exchange rates are shown as C$ per $)</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3411&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3268</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2955</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spot rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2751&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2990</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3639</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div id="i1ae9134e40e74e0aac958218112e53d4_2239"></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Results of Operations: FY 2020 compared with FY 2019</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Summary of financial results - consolidated</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.538%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.538%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.538%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.544%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands of U.S. dollars)</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,719&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,750&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,969&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25,833)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,597)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,236)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">pp</span></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (i)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(147,253)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98,308)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48,945)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Non-GAAP Measures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"> for information related to Non-GAAP measure.</span></div><div style="margin-bottom:3pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net revenue - consolidated</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.538%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.538%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.538%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.544%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands of U.S. dollars)</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue, before excise taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (i)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,353&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,639&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,714&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excise taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,634)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,889)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,745)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">304&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,719&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,750&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,969&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Net revenue, before excise taxes, is calculated net of sales returns and discounts as described under Note 4 to the consolidated financial statements.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the fiscal year 2020 (&#8220;FY 2020&#8221;), we reported net revenue of $46.7 million, representing an increase of $23.0 million from the fiscal year 2019 (&#8220;FY 2019&#8221;). This change was primarily due to:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">An increase in sales in the Rest of World (&#8220;ROW&#8221;) segment in FY 2020 compared to FY 2019, due to the continued growth of the adult-use market in Canada and sales in the Israeli medical market, partially offset by non-recurring wholesale revenue in the Canadian market in FY 2019 and strategic price reductions on various adult-use cannabis products in Canada in FY 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">An increase in net revenue in the U.S. segment of $6.1 million in FY 2020 compared to FY 2019 due to FY 2020 results including a full year of the Redwood business as opposed to 117 days in FY 2019.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-bottom:3pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of sales and gross profit (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> consolidated</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.444%"><tr><td style="width:1.0%"></td><td style="width:43.173%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.609%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.615%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.609%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.336%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.609%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.336%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.613%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands of U.S. dollars)</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,497&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,174&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,323&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory write-down</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,055&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,118)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25,833)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,597)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,236)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">pp</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For FY 2020, we reported gross loss of $25.8 million, representing an increase in losses of $8.2 million from FY 2019. This change was primarily due to:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">An increase in ROW cost of sales primarily driven by third party purchased flower associated with adult-use products in Canada and a decline in wholesale sales in FY 2020 versus FY 2019.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Partially offset by increased gross profit in the U.S. segment in FY 2020 compared to FY 2019, primarily due to a full year of gross profit in FY 2020 versus 117 days in FY 2019 and a decrease in inventory write-downs in the ROW segment. We may incur further inventory write-downs due to pricing pressures in the marketplace.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adjusted EBITDA </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> consolidated</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.166%"><tr><td style="width:1.0%"></td><td style="width:43.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.645%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.340%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.645%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.340%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.645%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.340%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.648%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands of U.S. dollars)</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(147,253)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98,308)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48,945)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Non-GAAP Measures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"> for information related to non-GAAP measures.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For FY 2020, we reported an adjusted earnings (loss) before interest, taxes, depreciation and amortization (&#8220;Adjusted EBITDA&#8221;) of $(147.3) million, representing a decrease in Adjusted EBITDA of $48.9 million from FY 2019. This change was primarily due to:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">An increase in gross loss as described above.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">An increase in general and administrative costs driven primarily by an increase in salaries and wages as a result of increased headcount in order to support the Company&#8217;s growth strategy, increased office and general expenses and increased costs due to a full year of U.S. segment results versus 117 days in 2019.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">An increase in sales and marketing costs, primarily related to brand development as well as increased costs due to a full year of U.S. segment results versus 117 days in the same period in 2019.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">An increase in R&amp;D costs primarily related to the Ginkgo Strategic Partnership and increased spending on product development and developing cannabinoid intellectual property.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other items affecting the comparability of net income (loss) during FY 2020 and FY 2019 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> consolidated</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Review costs related to restatement of 2019 interim financial statements</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For FY 2020, we reported review costs related to the restatement of 2019 interim financial statements of $9.7 million within the general and administrative line in the consolidated statements of net income (loss). These financial statement review costs include costs related to the restatement of the Company&#8217;s 2019 interim financial statements, costs related to the Company&#8217;s responses to requests for information from various regulatory authorities relating to such restatement and legal costs defending shareholder class action complaints brought against the Company as a result of the restatement. There were no costs related to the restatement of the Company&#8217;s 2019 interim financial statements incurred during FY 2019. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Repurposing charges</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For FY 2019, we reported pre-tax charges of $7.3 million related to the Company&#8217;s decision to redesign its efforts at the Peace Naturals Campus, which includes impairment costs, inventory write-down, and employee termination benefits. There were no repurposing costs incurred during FY 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest income, net</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For FY 2020, we reported interest income, net of $18.4 million representing a decrease of $9.6 million from FY 2019 primarily due to the impact of a decrease in interest rates on cash and cash equivalents and short-term investments during FY 2020 compared to FY 2019.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gain on revaluation of derivative liabilities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For FY 2020, we reported a gain on revaluation of derivative liabilities of $129.3 million representing a decrease of $1,147.6 million from FY 2019 primarily driven by a decrease in our share price since December 31, 2019. The Company expects continued changes in derivative valuations as the Company&#8217;s share price fluctuates period-to-period. For further information, see Note 14 to the consolidated financial statements in Item 8 of this Annual Report.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impairment loss on goodwill and intangible assets</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For FY 2020, we reported an impairment loss on goodwill and intangible assets of $40.0 million representing an increase of $40.0 million from FY 2019 primarily driven by a $35.0 million impairment charge on the U.S. reporting unit and a $5.0 million impairment charge on the Lord Jones&#8482; brand during the year ended December 31, 2020. For further information, see Note 11 to the consolidated financial statements in Item 8 of this Annual Report.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gain on disposal of other investments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For FY 2020, we reported a gain on disposal of other investments of $4.8 million representing a decrease of $11.5 million from FY 2019 primarily driven by a decrease in the sale of shares associated with the Whistler Transaction (as defined below) during FY 2020 compared to FY 2019. For further information, see Note 7 to the consolidated financial statements in Item 8 of this Annual Report.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financing and transaction costs</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For FY 2020, we reported financing and transaction costs of $0.04 million representing a decrease of $32.2 million from FY 2019 primarily driven by the increased financing and transaction costs incurred in FY 2019 compared to FY 2020 as a result of the Altria Investment and the Redwood Acquisition. For further information see Note 27 and Note 14 to the consolidated financial statements in Item 8 of this Annual Report.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income tax expense</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For FY 2020, we reported an income tax expense of $1.3 million representing an increase of $1.3 million from FY 2019 primarily driven by changes in valuation allowance, partially offset by a decrease in the fair value gain on financial liabilities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div id="i1ae9134e40e74e0aac958218112e53d4_2262"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations by Business Segment: FY 2020 compared with FY 2019</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Summary of financial results </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> ROW</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.538%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.538%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.538%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.544%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands of U.S. dollars)</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,224&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,386&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,838&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,993)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,470)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,523)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">pp</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (i)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98,349)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(84,826)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,523)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Non-GAAP Measures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"> for information related to non-GAAP measures.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net revenue </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> ROW </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.205%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.677%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.677%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.677%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.683%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands of U.S. dollars)</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannabis flower</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,932&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,020&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,912&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannabis extracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,759&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,338&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,421&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,804&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,224&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,386&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,838&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For FY 2020, we reported net revenue of $37.2 million, representing an increase of $16.8 million from FY 2019. This change was primarily due to:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">An increase in sales due to the continued growth of the adult-use market in Canada and sales in the Israeli medical market, partially offset by non-recurring wholesale revenue in the Canadian market in FY 2019 and strategic price reductions on various adult-use cannabis products in Canada in FY 2020.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of sales and gross profit (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> ROW</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.395%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.323%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.395%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.323%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.395%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.323%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands of U.S. dollars)</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,162&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,683&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,479&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory write-down</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,055&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,118)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,993)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,470)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,523)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">pp</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For FY 2020, we reported gross loss of $30.0 million, representing an increase in losses of $10.5 million from FY 2019. This change was primarily due to:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">An increase in cost of sales primarily driven by third-party purchased flower associated with adult-use products in Canada and a decline in wholesale sales in FY 2020. The Company anticipates that gross margin will continue to fluctuate as price and mix change from quarter-to-quarter.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Partially offset by an increase in net revenue from FY 2019, as described above and a decrease in inventory write-downs. We may incur further inventory write-downs due to pricing pressures in the marketplace.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adjusted EBITDA </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> ROW</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.166%"><tr><td style="width:1.0%"></td><td style="width:43.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.645%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.340%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.645%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.340%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.645%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.340%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.648%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands of U.S. dollars)</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98,349)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(84,826)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,523)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Non-GAAP Measures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"> for information related to non-GAAP measures.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For FY 2020, we reported Adjusted EBITDA of $(98.3) million, representing a decrease in Adjusted EBITDA of $13.5 million from FY 2019. This change was primarily due to:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">An increase in ROW gross loss from FY 2019, as described above.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">An increase in R&amp;D costs primarily related to the Ginkgo Strategic Partnership and costs related to increased spending on product development and cannabinoid intellectual property.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">An increase in general and administrative costs from FY 2019 driven by an increase in salaries and wages as a result of increased headcount to support the Company&#8217;s growth strategy and increased office and general expenses.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">An increase in sales and marketing costs primarily related to building and developing our brands and products in the Canadian adult-use market.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div id="i1ae9134e40e74e0aac958218112e53d4_2257"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Summary of financial results </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> U.S.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.528%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.503%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.877%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.503%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.877%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.503%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.600%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.509%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands of U.S. dollars)</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,495&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,364&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,131&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,873&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,287&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">pp</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,019)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,703)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26,316)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,545&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Non-GAAP Measures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"> for information related to non-GAAP measures.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net revenue </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> U.S.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.866%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.521%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.880%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.521%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.521%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.464%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.524%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands of U.S. dollars)</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,495&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,364&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,131&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For FY 2020, the U.S. segment reported net revenue of $9.5 million, representing an increase of $6.1 million from FY 2019. The increase was primarily due to:</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">An increase in sales due to a full year of U.S. segment results in FY 2020 as opposed to 117 days in FY 2019.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The growth in existing product lines and introductions of new U.S. hemp-derived CBD products during FY 2020. A significant amount of the U.S. segment&#8217;s FY 2020 revenue was earned during the fourth quarter as a result of increased sales in the direct-to-consumer channel driven by holiday sales.</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of sales and gross profit </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> U.S.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.166%"><tr><td style="width:1.0%"></td><td style="width:43.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.645%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.340%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.645%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.340%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.645%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.340%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.648%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands of U.S. dollars)</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,335&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,491&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,844&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,873&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,287&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit margin</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">pp</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For FY 2020, the U.S. segment reported gross profit of $4.2 million representing an increase in gross profit of $2.3 million from FY 2019. This was primarily due to:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The increase in net revenue, as described above.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Partially offset by an increase in cost of sales primarily driven by a full year of U.S. segment results in FY 2020 as opposed to 117 days in the same period in 2019.</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adjusted EBITDA </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> U.S.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.166%"><tr><td style="width:1.0%"></td><td style="width:43.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.645%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.340%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.645%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.340%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.645%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.340%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.648%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands of U.S. dollars)</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,019)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,703)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26,316)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,545&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Non-GAAP Measures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"> for information related to non-GAAP measures.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For FY 2020, we reported an Adjusted EBITDA of $(28.0) million, representing a decrease in Adjusted EBITDA of $26.3 million from FY 2019. This change was primarily due to:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Sales and marketing costs incurred in relation to the introduction of new U.S. hemp-derived CBD products.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Increased general and administrative costs driven by increased headcount to support the Company&#8217;s growth strategy across a variety of functions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Partially offset by an increase in gross profit from FY 2019, as described above.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div id="i1ae9134e40e74e0aac958218112e53d4_2467"></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Liquidity and Capital Resources</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our existing cash and cash equivalents and short-term investments will be sufficient to fund our business operations and capital expenditures over the next twelve months.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our primary need for liquidity is to fund operations and capital expenditures. Our ability to fund operations and capital expenditures depends on, among other things, future operating performance and cash flows that are subject to general economic conditions and financial and other factors, including factors beyond our control.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, we have primarily funded our operations through equity financing. In March 2019, Altria closed a C$2.4 billion (approximately $1.8 billion) investment in us, pursuant to which we issued to certain wholly owned subsidiaries of Altria 149,831,154 of our common shares and one warrant, as further discussed under &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Altria Strategic Investment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; herein. As of February 23, 2021, we had a cash and cash equivalents balance of $1.1&#160;billion and $0.2&#160;billion in short term investments to fund operations and capital expenditures.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Capital resources</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, we had $1.1 billion in cash and cash equivalents and $0.2 billion in short term investments.&#160;As of December 31, 2020, the Company had no external financing.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contractual obligations</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, the Company had the following contractual obligations:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.444%"><tr><td style="width:1.0%"></td><td style="width:26.693%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.447%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.917%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.447%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.917%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.447%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.917%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.447%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.917%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.451%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands of U.S. dollars)</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Payments Due by Period </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less Than 1 Year</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1-3 Years</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4-5 Years</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">After 5 Years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Capital (finance) lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,017&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,381&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,214&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,261&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,161&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,942&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,489&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,341&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,962&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,962&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total contractual obligations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,980&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,871&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,575&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,373&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,161&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease obligations relate to equipment leases maturing in June 2022. Operating lease obligations relate to land, buildings, vehicles, and office space in Canada, the U.S. and Israel. Purchase obligations include commitments for capital expenditure, information technology services, and other professional services. Other long-term liabilities relate to commitments for research and development such as Ginkgo foundry access fees, as well as undrawn but committed loans to our joint ventures. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Summary of cash flows</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.947%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.165%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.877%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.165%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.877%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.169%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands of U.S. dollars)</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) operating activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142,457)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(130,274)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,517)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(603,272)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93,908)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,465)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,856,941&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,112&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of foreign currency translation on cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,102&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,085)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(121,670)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,175,766&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,602&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">FY 2020 cash flows vs FY 2019 cash flows</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating&#160;activities.&#160;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During FY 2020,&#160;we&#160;used $142.5 million of cash in operating activities as compared to $130.3 million in FY 2019, representing an increase of $12.2 million in cash used. This change is primarily driven by an increase in operating expenses in FY 2020 partially offset by increased revenues in FY 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investing&#160;activities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During FY 2020,&#160;we received $20.2 million of cash in investing activities, as compared to $603.3 million of cash used during FY 2019, representing an increase of $623.5 million in net cash provided.&#160;This change is primarily driven by the Redwood&#160;Acquisition&#160;in FY 2019 for cash consideration of&#160;$224.3 million, as well as a $395.3 million increase from FY 2019 from the net effect of the purchase of and proceeds from maturity short-term investments.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financing&#160;activities.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During FY 2020,&#160;cash used in financing activities was $5.5 million, as compared to $1,856.9 million of cash provided by financing activities in FY&#160;2019, representing a net increase of $1,862.4 million.&#160;This change is primarily driven by proceeds from the strategic investment from Altria of $1,809.6 million as well as the proceeds from exercises Top-up Rights of $67.1 million by Altria partially offset by&#160;the $16.0 million repayment of the&#160;construction loan&#160;payable.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><div id="i1ae9134e40e74e0aac958218112e53d4_2301"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Non-GAAP Measures </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Group reports its financial results in accordance with Generally Accepted Accounting Principles in the United States (&#8220;US GAAP&#8221;). This Annual Report refers to measures not recognized under US GAAP (&#8220;non-GAAP measures&#8221;). These non-GAAP measures do not have a standardized meaning prescribed by US GAAP and are therefore unlikely to be comparable to similar measures presented by other companies. Rather, these non-GAAP measures are provided as a supplement to corresponding US GAAP measures to provide additional information regarding our results of operations from management&#8217;s perspective. Accordingly, non- GAAP measures should not be considered a substitute for, or superior to, the financial information prepared and presented in accordance with US GAAP. All non-GAAP measures presented in this Annual Report are reconciled to their closest reported GAAP measure. Reconciliations of historical adjusted financial measures to corresponding US GAAP measures are provided below.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adjusted EBITDA</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Management reviews Adjusted EBITDA, a non-GAAP measure which excludes non-cash items or items that do not reflect management&#8217;s assessment of on-going business performance. Management defines Adjusted EBITDA as net income (loss) before interest, tax expense, depreciation and amortization adjusted for: impairment loss on goodwill and intangible assets, repurposing charges, financing and transaction costs, loss (gain) on revaluation of derivative liabilities, loss (gain) on disposal of investments, share of loss (income) from equity accounted investees, loss from discontinued operations, other loss (income), review costs related to the restatement of the Company&#8217;s 2019 interim financial statements, the Company&#8217;s responses to the reviews of such interim financial statements by various regulatory authorities and legal costs defending shareholder class action complaints brought against the Company as a result of the restatement (see Part I, Item 3, Legal Proceedings, of this Annual Report for a discussion of the regulatory reviews and shareholder class action complaints relating to the restatement of the 2019 interim financial statements), and share-based payments.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management believes that Adjusted EBITDA provides the most useful insight into underlying business trends and results and provides a more meaningful comparison of year-over-year results. Management uses Adjusted EBITDA for planning, forecasting and evaluating business and financial performance, including allocating resources and evaluating results relative to employee compensation targets. As a result of the appointment of Mr. Schmidt as President and Chief Executive Officer in September 2020 and a review of how management looks at the business, Adjusted EBITDA is now the primary metric upon which management views the consolidated business performance and results year-over-year. </span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adjusted EBITDA by segment</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management also reviews adjusted earnings (loss) before interest, tax, depreciation and amortization by segment (&#8220;Adjusted EBITDA by segment&#8221;), a non-GAAP measure which excludes non-cash items or items that do not reflect management&#8217;s assessment of on-going business performance. Corporate expenses are removed from Adjusted EBITDA by segment. Corporate expenses are expenses that relate to the consolidated business. The Company&#8217;s method of allocating corporate expenses is refined periodically. Management defines Adjusted EBITDA by segment as net income (loss) by segment before interest, tax expense, depreciation and amortization adjusted for the same items that are adjusted in consolidated Adjusted EBITDA.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management believes that Adjusted EBITDA by segment provides useful insight into underlying segment trends and results and provides a more meaningful comparison of year-over-year segment results. Management uses Adjusted EBITDA by segment for planning, forecasting and evaluating business and financial performance, including allocating resources and evaluating results relative to employee compensation targets. As a result of the appointment of Mr. Schmidt as President and Chief Executive Officer in September 2020 and a review of how management looks at the business by segment, Adjusted EBITDA by segment is now the primary metric upon which management views the segment performance and results year-over-year. </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted EBITDA and Adjusted EBITDA by segment is reconciled to net income (loss) as follows for the years ended December&#160;31, 2020 and 2019: </span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.205%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.205%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.205%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.209%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands of U.S. dollars)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December&#160;31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ROW</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate<br/>Expenses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(77,368)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,671&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30,573)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(75,270)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense (income), net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,433)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,415)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,024&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,347&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairment loss on goodwill and intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financing and transaction costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain on revaluation of derivative liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(129,254)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(129,254)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain on disposal of other investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,789)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,789)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share of loss from equity accounted investees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,510&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,510&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss from discontinued operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other loss (income)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,814&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,834&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Review costs related to restatement of 2019 interim financial statements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,688&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,688&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,714&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,647&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,361&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBIT</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(28,253)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(105,160)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20,885)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(154,298)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,811&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,045&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(28,019)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(98,349)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20,885)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(147,253)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.205%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.205%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.205%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.209%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands of U.S. dollars)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December&#160;31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ROW</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate<br/>Expenses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,070)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,180,241&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,597)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,165,574&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27,963)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27,969)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurposing charges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,268&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,268&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financing and transaction costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,091&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,208&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain on revaluation of derivative liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,276,819)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,276,819)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain on disposal of other investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16,277)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16,277)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share of loss from equity accounted investees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,009&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,009&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss from discontinued operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">363&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">363&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other loss (income)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(197)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(182)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(197)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">900&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,719&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,619&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBIT</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,877)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(88,565)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,779)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(102,221)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,739&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,913&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,703)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(84,826)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,779)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(98,308)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adjusted operating loss</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management previously reviewed operating loss on an adjusted basis, which excluded certain income and expense items that management believed were not part of underlying operations. These items typically included repurposing charges and non-recurring charges such as the review costs related to the restatement of the Company&#8217;s 2019 interim financial statements, the Company&#8217;s responses to the reviews of such interim financial statements by various regulatory authorities and legal costs defending shareholder class action complaints brought against the Company as a result of the restatement (see Part I, Item 3, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Legal Proceedings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, of this Annual Report for a discussion of the regulatory reviews and shareholder class action complaints relating to the restatement of the 2019 interim financial statements).</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management did not view these items to be part of underlying results as they may have been highly variable, unusual or infrequent, were difficult to predict or could distort underlying business trends and results. Management believed that adjusted operating loss provided useful insight into underlying business trends and results and provided a more meaningful comparison of year-over-year results. Management used to use adjusted operating loss for planning, forecasting and evaluating business and financial performance, including allocating resources and evaluating results relative to employee compensation targets. As a result of the appointment of Mr. Schmidt as President and Chief Executive Officer in September 2020 and a review of how management looks at the business, adjusted operating loss is no longer a primary metric upon which management views the consolidated business performance and results year-over-year. </span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.316%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.705%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.707%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands of U.S. dollars)</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reported operating loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(179,347)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(121,108)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Review costs related to restatement of 2019 interim financial statements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,688&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurposing charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,268&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted operating loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(169,659)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(113,840)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adjusted operating loss by segment</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management previously reviewed operating loss by segment, which excluded corporate expenses, and adjusted operating loss by segment, which further excluded certain income and expense items that management believed were not part of the underlying segment&#8217;s operations. Corporate expenses were expenses that relate to the consolidated business and not to an individual operating segment while the income and expense items typically included non-recurring charges such as repurposing charges and review costs related to the restatement of the Company&#8217;s 2019 interim financial statements, the Company&#8217;s responses to the reviews of such interim financial statements by various regulatory authorities and legal costs defending shareholder class action complaints brought against the Company as a result of the restatement (see Part I, Item 3, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Legal Proceedings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, of this Annual Report for a discussion of the regulatory reviews and shareholder class action complaints relating to the restatement of the 2019 interim financial statements). Management did not view the income and expense items above to be part of underlying results of the segment as they may have been highly variable, unusual or infrequent, were difficult to predict and could distort underlying business trends and results. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the appointment of Mr. Schmidt as President and Chief Executive Officer in September 2020 and a review of how management looks at the business, adjusted operating loss by segment is no longer the primary metric upon which management views the segment performance and results year-over-year. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.705%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.316%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.316%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.316%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.316%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.323%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands of U.S. dollars)</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December&#160;31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ROW</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Segments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate Expenses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reported operating loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36,967)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(111,807)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(148,774)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30,573)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(179,347)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Review costs related to restatement of 2019 interim financial statements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,688&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,688&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted operating loss</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36,967)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(111,807)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(148,774)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20,885)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(169,659)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.947%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.273%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.321%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.273%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.321%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.273%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.321%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.273%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.321%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.277%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands of U.S. dollars)</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December&#160;31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ROW</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Segments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate Expenses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reported operating loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,777)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(106,552)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(109,329)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,779)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(121,108)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurposing charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,268&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,268&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,268&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted operating loss</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,777)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(99,284)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(102,061)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,779)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(113,840)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:12pt;text-align:justify"><span><br/></span></div><div id="i1ae9134e40e74e0aac958218112e53d4_2291"></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Off-Balance Sheet Arrangements</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not have any material off-balance sheet arrangements.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Estimates</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Estimates and critical judgments by management </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. These estimates are reviewed periodically and adjustments are made as appropriate in the year they become known. Items for which actual results may differ materially from these estimates are described in the following section.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 2 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; within the Consolidated Financial Statements for further information on our critical accounting estimates and policies, which are as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill and indefinite-lived intangible assets</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and indefinite-lived intangible assets are not subject to amortization. We test goodwill and indefinite-lived intangible assets for impairment annually, or more frequently if an event occurs or circumstances change that could indicate a potential impairment. We compare the fair value of our reporting units with their carrying amount and recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit&#8217;s fair value. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the accounting estimate for goodwill and indefinite-lived intangible assets is a critical accounting estimate because of the judgment required in assessing the fair value of each of our reporting units. We estimate fair value through various valuation methods, including the use of discounted expected future cash flows of each reporting unit as well as the use of the relief-from-royalty method on the Lord Jones&#8482; brand. The expected future cash flows for each reporting unit are significantly impacted by current market conditions. If these market conditions and resulting expected future cash flows for each reporting unit decline significantly, the actual results for each segment could differ from our estimate, which would cause goodwill to be impaired. Our accounting for goodwill and indefinite-lived intangible assets represents our best estimate of future events.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on our assessments and after considering potential triggering events, including COVID-19, we recognized an impairment loss related to goodwill and indefinite life intangible assets of $35 million and $5 million in the U.S. reporting unit, respectively, in FY 2020. During our annual quantitative impairment test in the fourth quarter of 2020, no further impairment was recorded. Both fair values of the goodwill as well as the Lord Jones&#8482; brand exceeded carrying value by more than 10%. No impairment was recorded in FY 2019 or FY 2018.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inventory valuation</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We value our inventory at lower of cost or net realizable value determined using weighted average cost. Inventory is reflected at the lower of cost or net realizable value considering future demand, market conditions and market prices. Our estimates are based upon assumptions believed to be reasonable, but which are inherently uncertain and unpredictable. These valuations require the use of management's assumptions which do not reflect unanticipated events and circumstances that may occur. We record an inventory valuation adjustment for excess, slow moving, and obsolete inventory that is equal to the excess of the cost of the inventory over the estimated net realizable value. We also experience inventory write-downs due to reduced market prices. The inventory valuation adjustment to net realizable value establishes a new cost basis of the inventory that cannot be subsequently reversed. Inventory valuation adjustments are based on inventory levels, expected product life, and estimated product demand. In assessing the ultimate realization of inventories, we are required to make judgments as to future demand requirements compared with inventory levels.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share-based compensation</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We measure the fair value of services received in exchange for all stock options granted based on the fair market value of the award as of the grant date. We compute the fair value of stock options with time-based vesting using the Black-Scholes option-pricing model and recognize the cost of the equity awards over the period that services are provided to earn the award. The Black-Scholes option-pricing model includes assumptions regarding dividend yields, expected volatility, expected option term and risk-free interest rates. The assumptions used in computing the fair value of share-based compensation expense reflect our best estimates, but involve uncertainties relating to market and other conditions, many of which are outside of our control. We estimate expected volatility based primarily on historical daily price changes of our stock and peers. The expected option term is the number of years that we estimate that the stock options will be outstanding prior to exercise.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Valuation of derivative liabilities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivative liabilities consist of the Altria Warrant, Pre-emptive Rights, and certain Top-up Rights. We measure derivative liabilities at fair value at each reporting date until settlement with the re-measurement gain or loss being recognized immediately in net income (loss) and comprehensive income (loss). We calculate fair value of the derivative liability using the Black-Scholes model. Significant assumptions are used in the valuation of derivative liabilities, including the volatility of the share price of our Company and our peers, expected dividend yield, expected term and expected risk-free interest rate. The assumptions used in computing the fair value of derivative liabilities reflect our best estimates, but involve uncertainties relating to market and other conditions, many of which are outside of our control. Sensitivity is performed on various inputs, refer to Note 14 &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivative Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; in Item 8 of this Annual Report.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div id="i1ae9134e40e74e0aac958218112e53d4_43"></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest rate risk</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest rate risk is the risk that the value or yield of fixed-income investments may decline if interest rates change. Fluctuations in interest rates may impact the level of income and expense recorded on the cash equivalents and short-term investments, and the market value of all interest-earning assets, other than those which possess a short-term to maturity. During the year ended December&#160;31, 2020, the Company had net interest income of $18.4 million (December&#160;31, 2019 &#8211; $28.0 million). A 10% change in the interest rate in effect on December&#160;31, 2020 and December&#160;31, 2019, would not have a material effect on (i) fair value of the cash equivalents and short-term investments as the majority of the portfolio has a maturity date of three months or less, or (ii) net interest income. Management continues to monitor external interest rates and revise the Company&#8217;s investment strategy as a result.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2020, the Company&#8217;s average variable interest rate fell 1.49%, which resulted in a decrease of net interest income, of $15.7 million in the period. During the year ended December&#160;31, 2019, the Company&#8217;s average variable interest rate did not materially change.</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Currency rate risk</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Currency rate risk is the risk that the fair value of, or future cash flows from, the Company&#8217;s financial instruments will significantly fluctuate due to changes in foreign exchange rates. The Company is exposed to this risk on advances to joint ventures denominated in A$. The Company is further exposed to this risk through subsidiaries operating in Israel and the U.S. as the Company&#8217;s functional currency is in Canadian dollars. The Company does not currently use foreign exchange contracts to hedge its exposure to currency rate risk. As such, the Company&#8217;s financial position and financial results may be adversely affected by the unfavorable fluctuations in currency exchange rates. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the Company had foreign currency gain on translation of $15.0 million (December&#160;31, 2019 &#8211; $37.7 million). A 10% change in the exchange rates for the foreign currencies would affect the carrying value of net assets by approximately $170.8 million as of December&#160;31, 2020 (December&#160;31, 2019 &#8211; $174.9 million).</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><div id="i1ae9134e40e74e0aac958218112e53d4_46"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:92.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.150%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Table of Contents</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reports of KPMG LLP, Independent Registered Public Accounting Firm</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i1ae9134e40e74e0aac958218112e53d4_49">67</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Balance Sheets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i1ae9134e40e74e0aac958218112e53d4_55">71</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Statements of Net Income (Loss) and Comprehensive Income (Loss)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i1ae9134e40e74e0aac958218112e53d4_61">72</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Statements of Changes in Shareholders&#8217; Equity (Deficit)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i1ae9134e40e74e0aac958218112e53d4_64">74</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Statements of Cash Flows</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i1ae9134e40e74e0aac958218112e53d4_2511">76</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes to Consolidated Financial Statements</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i1ae9134e40e74e0aac958218112e53d4_70">77</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><div id="i1ae9134e40e74e0aac958218112e53d4_49"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-bottom:12pt;margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Shareholders and Board of Directors Cronos Group Inc.:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opinion on the Consolidated Financial Statements</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the accompanying consolidated balance sheets of Cronos Group Inc. (the Company) as of December 31, 2020 and December 31, 2019, the related consolidated statements of net income (loss) and comprehensive income (loss), changes in shareholders&#8217; equity (deficit), and cash flows for each of the years in the three&#8209;year period ended December 31, 2020, and the related notes (collectively, the consolidated</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2020 and December 31, 2019, and the results of its operations and its cash flows for each of the years in the three&#8209;year period ended December 31, 2020, in conformity with U.S. generally accepted accounting principles.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company&#8217;s internal control over financial reporting as of December 31, 2020, based on criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control &#8211; Integrated Framework (2013)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> issued by the Committee of Sponsoring Organizations of the Treadway Commission, and our report dated February 26, 2021, expressed an adverse opinion on the effectiveness of the Company&#8217;s internal control over financial reporting.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis for Opinion</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These consolidated financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Critical Audit Matters</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical audit matters communicated below are matters arising from the current period audit of the consolidated financial statements that were communicated or required to be communicated to the Audit Committee and that: (1) relate to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Evaluation of sufficiency of audit evidence over inventory </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note 5 to the consolidated financial statements, inventory consists of raw materials; dry cannabis and cannabis extracts work-in-progress; dry cannabis and cannabis extract finished goods; and supplies and consumables. The Company&#8217;s total inventory as of December 31, 2020 was $44,002 thousand. The accuracy of inventory quantities is dependent upon the performance of an annual physical count and appropriately recording adjustments to inventory quantities in the Company&#8217;s inventory process. The Company has also identified a material weakness related to inventory as of December 31, 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We identified the evaluation of the sufficiency of audit evidence over the accuracy of inventory quantities as a critical audit matter. Evaluating the sufficiency of the audit evidence obtained required especially subjective auditor judgment because of the material weakness described above. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are the primary procedures we performed to address this critical audit matter. We applied auditor judgment to determine the nature and extent of procedures to be performed over inventory. We increased the number of inventory samples selected to perform certain procedures compared to those we would have selected if the Company&#8217;s internal controls were operating effectively at year end. We performed independent test counts of inventory quantities. We compared the results of our independent test counts to the Company&#8217;s inventory records. We confirmed with third parties a selection of inventory quantities held by them. We evaluated the overall sufficiency of audit evidence obtained by assessing the results of procedures performed.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Evaluation of the impairment analysis for goodwill in the U.S. reporting unit and the Lord Jones</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> brand indefinite life intangible asset</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note 2(k) to the consolidated financial statements, goodwill and indefinite life intangible assets are not amortized but are reviewed for impairment annually or more frequently when events or changes in circumstances indicate that fair value of the reporting unit has been reduced to less than its carrying value. As discussed in Note 11 to the consolidated financial statements, the Company had $178,414 thousand of goodwill in the U.S. reporting unit and an indefinite life intangible asset of $59,000 thousand from the Lord JonesTM brand. The Company recorded $35,000 thousand of impairment charges on the goodwill recorded in the U.S. reporting unit and $5,000 thousand of impairment charges on the Lord JonesTM brand indefinite life intangible asset in the year ended December 31, 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We identified the evaluation of the impairment analysis for goodwill in the U.S. reporting unit and the Lord JonesTM brand indefinite life intangible asset as a critical audit matter. The evaluation of the Company&#8217;s key assumptions used in the discounted cash flow valuation model, including the growth rates, the discount rates, and forecasted royalty income from the Lord JonesTM brand indefinite life intangible asset, required a high degree of auditor judgment.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are the primary procedures we performed to address this critical audit matter. We evaluated the design and tested the operating effectiveness of certain internal controls over the Company&#8217;s impairment process, including a control related to the determination and assessment of the reasonableness of key assumptions used in the discounted cash flow valuation model. We evaluated the key assumptions used in the discounted cash flow valuation model, including comparing forecasted growth rates against external analyst expectations for the industry in the United States. We also performed sensitivity analysis on the forecasted growth rates and forecasted royalty income to assess the impact on the Company&#8217;s fair value estimate. We compared a selection of royalty rates of comparable entities used by the Company to determine the royalty rate used in the discounted cash flow valuation model to publicly available information. We involved valuation professionals with specialized skills and knowledge who assisted in:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">evaluating the discount rate, by comparing it against the internal rate of return and comparing the weighted average cost of capital to a range that was independently developed using publicly available market data for comparable entities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">evaluating the royalty rate, which was applied to estimate forecasted revenues, to calculate forecasted royalty income, using industry knowledge and consideration of comparable brand royalty rates and qualitative factors specific to the brand.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">/s/ KPMG LLP</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Chartered Professional Accountants, Licensed Public Accountants</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have served as the Company&#8217;s auditor since 2018.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vaughan, Canada </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February 26, 2021</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><div id="i1ae9134e40e74e0aac958218112e53d4_52"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-bottom:12pt;margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Shareholders and Board of Directors Cronos Group Inc.:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opinion on Internal Control Over Financial Reporting </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited Cronos Group Inc.&#8217;s (the Company) internal control over financial reporting as of December 31, 2020, based on criteria established in Internal Control &#8211; Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. In our opinion, because of the effect of the material weakness, described below, on the achievement of the objectives of the control criteria, the Company has not maintained effective internal control over financial reporting as of December 31, 2020, based on criteria established in Internal Control &#8211; Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of the Company as of December 31, 2020 and December 31, 2019, the related consolidated statements of net income (loss) and comprehensive income (loss), changes in shareholders&#8217; equity (deficit), and cash flows for each of the years in the three-year period ended December 31, 2020, and the related notes (collectively, the consolidated financial statements), and our report dated February 26, 2021 expressed an unqualified opinion on those consolidated financial statements. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company&#8217;s annual or interim financial statements will not be prevented or detected on a timely basis. A material weakness related to the following has been identified and included in management&#8217;s assessment:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory verification: Management failed to properly design and execute sufficient procedures to verify inventory quantities. Specifically, while inventory counts were performed in the fourth quarter, (i) the aggregate value of items excluded from the count exceeded the Company&#8217;s materiality threshold, and (ii) human error in count execution, data transposition and reconciliation analysis resulted in inaccurate adjustments. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The material weakness was considered in determining the nature, timing, and extent of audit tests applied in our audit of the 2020 consolidated financial statements, and this report does not affect our report on those consolidated financial statements.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis for Opinion </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management&#8217;s Report on Internal Control Over Financial Reporting (Item 9A(b)(i) of the Form 10-K). Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit also included performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Definition and Limitations of Internal Control Over Financial Reporting </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">/s/ KPMG LLP</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Chartered Professional Accountants, Licensed Public Accountants</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">February 26, 2021</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Vaughan, Canada</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><div id="i1ae9134e40e74e0aac958218112e53d4_55"></div><hr style="page-break-after:always"/><div style="min-height:108pt;width:100%"><div style="margin-top:0.55pt"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CRONOS GROUP INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED FINANCIAL STATEMENTS </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE YEARS ENDED DECEMBER 31, 2020 AND 2019</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Balance Sheets</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">As of December 31, 2020 and 2019</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars)</span></div></div><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:71.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.834%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.608%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.836%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfNC0xLTEtMS0w_0a340667-7951-40da-ba35-66a9083ffd26">1,078,023</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfNC0zLTEtMS0w_0c33ab2d-63f1-4ef5-9a3c-810ea0eca0a5">1,199,693</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfNS0xLTEtMS0w_8277cb6c-8884-4958-9cb2-7a8660cee687">211,766</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfNS0zLTEtMS0w_81d2faa6-71ec-4652-9633-23a2eb992159">306,347</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfNi0xLTEtMS0w_a0756496-0a08-44aa-a1f2-05e806899e3f">8,928</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfNi0zLTEtMS0w_a2311b2b-e900-4984-bdec-0a7931e7bae4">4,638</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherReceivablesNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfNy0xLTEtMS0w_e68c0831-a24b-470d-be4f-75d2aa0b2805">10,033</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherReceivablesNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfNy0zLTEtMS0w_0a609705-a790-456c-9771-07d2f2b0e2f1">7,232</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of loans receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NotesAndLoansReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfOC0xLTEtMS0w_de00f061-273f-4b07-a2d6-553769b4efcd">7,083</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NotesAndLoansReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfOC0zLTEtMS0w_65bd8f13-8bc0-4e93-89b1-9f5dc39f0d86">4,664</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaids and other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfOS0xLTEtMS0w_ac6207f4-b03e-4bc0-81a3-4bbab5b2e311">11,161</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfOS0zLTEtMS0w_cd0181c0-45c2-4a05-82d2-5c14a36c9f06">9,395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMTAtMS0xLTEtMA_415c89e2-6855-4dee-a8cb-55d9f4c32729">44,002</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMTAtMy0xLTEtMA_82019157-4bfc-4447-ac48-b9713db62884">38,043</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Held-for-sale assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsHeldForSaleNotPartOfDisposalGroupCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMTEtMS0xLTEtMTA3OTg_957b8ca2-c90d-4a40-bb3c-5cef5fbca86b">1,176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsHeldForSaleNotPartOfDisposalGroupCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMTEtMy0xLTEtMTA3OTg_85aafe41-bf15-43f1-98c2-8e9530727db8">3,248</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMTEtMS0xLTEtMA_f16662bb-3eac-43b7-8d8b-6b468a6f1084">1,372,172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMTEtMy0xLTEtMA_07741b26-3faf-44f9-9009-24db206d7601">1,573,260</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in equity accounted investees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMTItMS0xLTEtMA_3a9fa729-e642-46fc-9217-80e5d15f382f">19,235</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" name="us-gaap:EquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMTItMy0xLTEtMA_176a82db-6dc9-470b-9236-d7d3ea2bc992">557</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advances to joint ventures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" name="us-gaap:AdvancesToAffiliate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMTMtMS0xLTEtMA_7a489e72-44da-4f4a-a697-3270ad783bce">467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdvancesToAffiliate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMTMtMy0xLTEtMA_f426fc19-fcb1-4c8e-b2e3-70759fe6e54c">19,437</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loans receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NotesAndLoansReceivableNetNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMTUtMS0xLTEtMA_a47f8e0a-f538-4431-83d0-b985f9524137">87,191</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NotesAndLoansReceivableNetNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMTUtMy0xLTEtMA_79143bb8-7169-4621-9b50-6dacf402dc64">44,967</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMTYtMS0xLTEtMA_7f1d057d-5f99-4ebd-8bc1-bcc15017e291">187,599</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMTYtMy0xLTEtMA_5221ff38-506e-4889-a361-b644216e8064">159,948</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMTctMS0xLTEtMA_652051a1-1ee3-462a-afe6-fab5842b8c44">9,776</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMTctMy0xLTEtMA_dbc9dabb-c261-4d4d-be4b-a535a0318b7b">6,546</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMTgtMS0xLTEtMA_f584e616-a6f4-4a5d-b553-bcc3dcee9794">69,720</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMTgtMy0xLTEtMA_94d43ecd-b48c-47b5-84af-8098bd1c7a99">71,235</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMTktMS0xLTEtMA_fc49fe16-df08-4404-9cbe-3e0a182003ed">179,522</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMTktMy0xLTEtMA_608b6460-3ddc-42b3-89b9-064220cc2618">214,492</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMjAtMS0xLTEtMA_ae87ec60-f198-4cd0-b5dd-693347d9e52f">1,925,682</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMjAtMy0xLTEtMA_e2a46784-45bf-49a5-9241-c6a9ad4c1a95">2,090,442</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and other liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMjQtMS0xLTEtMA_8e0c8937-c001-4ac4-97ed-17535fec90c2">42,102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMjQtMy0xLTEtMA_ae2d8e0a-701f-48de-a2ad-808503fd5643">35,301</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of lease obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMjUtMS0xLTEtMA_e01b7b9b-e419-4955-aa72-3e851e84fc57">1,322</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMjUtMy0xLTEtMA_04c2caa5-8a3c-4146-8577-ddd9ae88671a">427</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMjYtMS0xLTEtMA_d2c2035b-409d-4d96-80ce-8ff8af18284d">163,410</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMjYtMy0xLTEtMA_d5dcbf49-cd7f-40c1-9318-f3853ed34620">297,160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMjctMS0xLTEtMA_72baf3f7-f5cf-4b6d-b234-0cc5747e1b88">206,834</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMjctMy0xLTEtMA_5bedf806-8677-4660-b677-c9ad2af9261c">332,888</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to non-controlling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DueToRelatedPartiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMjgtMS0xLTEtMA_4e9629f1-d1ae-4596-9140-ceb01a40f0bc">2,188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DueToRelatedPartiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMjgtMy0xLTEtMA_a13e10c8-79a8-4ded-90bd-4072e49ab4cc">1,844</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMjktMS0xLTEtMA_963b54b6-7dd8-4610-8e1c-daaa33744753">8,492</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMjktMy0xLTEtMA_a8584bd2-352a-41e7-a5da-283e418255d0">6,680</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMzAtMS0xLTEtMA_02284fd7-6ffb-4363-98ee-fed2ca590dd1">217,514</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMzAtMy0xLTEtMA_4a8d0964-7f83-484b-b141-f43df4a4a101">341,412</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iii)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMzEtMS0xLTEtMA_bf994125-524b-467f-a561-898bad11e880"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMzEtMy0xLTEtMA_57a937e6-17cd-4abe-ae75-7bda62d7cf42"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share capital</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iv, v)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMzMtMS0xLTEtMA_030d6cf8-63aa-4cc4-b65e-77df43789c76">569,260</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMzMtMy0xLTEtMA_b0d849f2-438c-4c4f-902f-c1fb37890e80">561,165</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMzQtMS0xLTEtMA_334a38a1-ea56-4ec6-a7cc-f75c0d7868d6">34,596</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMzQtMy0xLTEtMA_c6985967-0ab8-4af8-b7cd-a69341f7e608">23,234</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMzUtMS0xLTEtMA_57c92702-c955-4681-8ccb-57a5619fbcbc">1,064,509</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMzUtMy0xLTEtMA_b07a1411-bcb1-41bb-aa1e-b82417cb580a">1,137,646</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMzYtMS0xLTEtMA_42e22547-f369-466e-bd1f-176b6c4242ed">42,999</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMzYtMy0xLTEtMA_ee468376-8315-4d34-9ffa-351ec470b067">27,838</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity attributable to shareholders of Cronos Group</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMzctMS0xLTEtMA_7118efc8-955a-4a1b-812a-40d0736f79ed">1,711,364</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMzctMy0xLTEtMA_e2007de6-8e39-4be7-a7b7-b3edecd4466b">1,749,883</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-controlling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:MinorityInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMzgtMS0xLTEtMA_b0c8decd-53f7-415a-aa88-780fe7bb48e2">3,196</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" sign="-" name="us-gaap:MinorityInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMzgtMy0xLTEtMA_4a65b791-b2fa-4959-9f17-779dbed556f8">853</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total shareholders' equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMzktMS0xLTEtMA_ed89c6e5-db51-4820-923f-c2bd78095aad">1,708,168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMzktMy0xLTEtMA_4ef7da0f-365c-4015-839e-0f246d547e08">1,749,030</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities and shareholders&#8217; equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfNDAtMS0xLTEtMA_3f9e68df-12dc-4df3-a967-35d3d90b6e36">1,925,682</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfNDAtMy0xLTEtMA_a7c42ea5-e639-4a2a-91cd-dd10e6e24084">2,090,442</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="margin-top:12pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt"><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RleHRyZWdpb246NTRhZWU1ZTdjODkwNGYwODlhMzUxMWY2YzczNmE0ZTRfODI0NjMzNzIxMzA3MQ_c8d7bf53-21c3-41a0-9531-0c2936a525bb" footnoteRole="http://www.xbrl.org/2003/role/footnote">Net of current expected credit loss allowance of $<ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RleHRyZWdpb246NTRhZWU1ZTdjODkwNGYwODlhMzUxMWY2YzczNmE0ZTRfMTMxOTQxMzk1MzcxODA_a4507069-02ab-457d-b655-27abf8dbbd61">74</ix:nonFraction> as of December&#160;31, 2020 (December 31, 2019 &#8211; $<ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RleHRyZWdpb246NTRhZWU1ZTdjODkwNGYwODlhMzUxMWY2YzczNmE0ZTRfMTMxOTQxMzk1MzY0MTE_4f0e82f8-b967-47e9-842f-cc363312d2d0">136</ix:nonFraction>) </ix:footnote></span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt"><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RleHRyZWdpb246NTRhZWU1ZTdjODkwNGYwODlhMzUxMWY2YzczNmE0ZTRfODI0NjMzNzIxMzA3Mg_aa4b8439-f84a-478a-8fb1-f835ca03fa1b" footnoteRole="http://www.xbrl.org/2003/role/footnote">Refer to Note 14 in the notes to the consolidated financial statements.</ix:footnote></span></div><div style="padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.22pt"><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RleHRyZWdpb246NTRhZWU1ZTdjODkwNGYwODlhMzUxMWY2YzczNmE0ZTRfODI0NjMzNzIxMzA3Mw_eea41acf-1b2e-4562-9b1e-115e0363241f" footnoteRole="http://www.xbrl.org/2003/role/footnote">Refer to Note 20 and Note 21 in the notes to the consolidated financial statements.</ix:footnote></span></div><div style="padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(iv)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.5pt"><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RleHRyZWdpb246NTRhZWU1ZTdjODkwNGYwODlhMzUxMWY2YzczNmE0ZTRfODI0NjMzNzIxMzA3NA_23299789-732b-44be-a54a-9d83261ac818" footnoteRole="http://www.xbrl.org/2003/role/footnote">Authorized for issuance as of December&#160;31, 2020: unlimited (December 31, 2019 &#8211; unlimited).</ix:footnote> </span></div><div style="padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(v)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;padding-left:20.94pt;position:relative;top:-2.8pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RleHRyZWdpb246NTRhZWU1ZTdjODkwNGYwODlhMzUxMWY2YzczNmE0ZTRfODI0NjMzNzIxMzA3NQ_3fb97ef3-2b33-4a99-a400-62c4df723ca9" footnoteRole="http://www.xbrl.org/2003/role/footnote">Shares issued as of December&#160;31, 2020: <ix:nonFraction unitRef="shares" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RleHRyZWdpb246NTRhZWU1ZTdjODkwNGYwODlhMzUxMWY2YzczNmE0ZTRfMTMxOTQxMzk1MzcxODk_bb0f586c-0540-4c15-87e1-83c80bc569d8">360,253,332</ix:nonFraction> (as of December 31, 2019: <ix:nonFraction unitRef="shares" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RleHRyZWdpb246NTRhZWU1ZTdjODkwNGYwODlhMzUxMWY2YzczNmE0ZTRfMTMxOTQxMzk1MzY2MjA_2cb14c3f-cc95-4c57-a8ee-4134d0b3735d">348,817,472</ix:nonFraction>)</ix:footnote></span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">See notes to consolidated financial statements.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><div id="i1ae9134e40e74e0aac958218112e53d4_61"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Net Income (Loss) and Comprehensive Income (Loss)</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December 31, 2020, 2019, and 2018</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S dollars, except share and per share amounts)</span></div><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.900%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.122%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.122%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.124%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenue, before excise taxes</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMi0zLTEtMS0w_6e504903-dc01-4897-ade5-8b8679f9e1ea">54,353</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMi01LTEtMS0w_a094bcaa-4801-4db5-9e6d-7036142fd4f8">25,639</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMi03LTEtMS0w_411837db-8c08-4eb8-ab54-a4c67b25a416">13,234</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excise taxes</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ExciseAndSalesTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMy0zLTEtMS0w_e470f00f-26f5-4397-9d62-945ed7b05dbc">7,634</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ExciseAndSalesTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMy01LTEtMS0w_e37b3b37-87e3-4b2e-81a9-a8a0e9452b16">1,889</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ExciseAndSalesTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMy03LTEtMS0w_dff8d81d-c929-4eff-8a62-debb6f1dfcaa">1,113</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNC0zLTEtMS0w_7bbdae3e-637d-47c4-b02b-8c5912d0f9cf">46,719</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNC01LTEtMS0w_278e8696-09b9-4058-819c-fe4683d0147c">23,750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNC03LTEtMS0w_9c332ecd-c723-4319-acbb-1fbf91307918">12,121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="cron:OtherCostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNS0zLTEtMS0w_7e99575c-05eb-42b9-a42b-72400cd6759f">46,497</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="cron:OtherCostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNS01LTEtMS0w_79fa947b-35ff-44c5-9e79-3000d5a5a543">12,174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="cron:OtherCostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNS03LTEtMS0w_4516ddbe-c161-4ce9-b149-0cb873180b1f">5,908</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory write-down</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryWriteDown" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNi0zLTEtMS0w_08a851f2-544a-431d-823d-1dd1cafe0912">26,055</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryWriteDown" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNi01LTEtMS0w_7a927438-eec1-4fdc-8d1e-a54286777091">29,173</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:InventoryWriteDown" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNi03LTEtMS0w_070d1291-c5a3-406e-9e4f-de605ce6f1c9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross profit (loss)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNy0zLTEtMS0w_2d13d70a-4704-416b-ba7f-87c790b5adc3">25,833</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNy01LTEtMS0w_b9b93a19-0ec8-4735-a39b-9504ed6fd724">17,597</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNy03LTEtMS0w_2a1c8463-190d-49b5-b89c-0c20e1e27cc5">6,213</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingAndMarketingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfOS0zLTEtMS0w_cb693bb1-7ea1-43cc-9b23-d32d8cfb7ed7">34,386</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingAndMarketingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfOS01LTEtMS0w_c8248225-75af-4b8a-9b2d-cfc9f881e33e">23,048</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingAndMarketingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfOS03LTEtMS0w_d17ef977-48e3-4135-90a4-8719a89a959b">2,537</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMTAtMy0xLTEtMA_fa05b824-2f63-4d26-be60-ae0f9214c01c">20,366</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMTAtNS0xLTEtMA_5d935539-7d1a-4cf4-bb8a-d44bc37a4c8f">12,155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMTAtNy0xLTEtMA_c4afbfbc-aa0a-4910-a02f-931816306866">1,814</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMTEtMy0xLTEtMA_1447e5f9-d001-433a-820c-b7e6ba7c6174">80,529</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMTEtNS0xLTEtMA_80fe2c5a-111e-43b3-9d15-ca7079a86bd7">49,271</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMTEtNy0xLTEtMA_0b0d248b-2e5b-4364-8e5d-c256395ba75b">13,349</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based payments</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMTItMy0xLTEtMA_6bcbfeb8-4cdd-481d-88b9-c44d2bb562d8">15,361</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMTItNS0xLTEtMA_e2316509-2e6f-4fbf-89d4-4dd674d3b723">11,619</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMTItNy0xLTEtMA_ce04f65d-fa02-4596-81e8-09cd0d8acb97">8,151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMTMtMy0xLTEtMA_78591308-1d4b-40d3-9085-3b8c7f1da71e">2,872</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMTMtNS0xLTEtMA_fff50e95-c17a-469e-8adf-4c04982b13c4">2,090</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMTMtNy0xLTEtMA_d5e0db30-afcb-4a87-91cc-688fced36cf0">807</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurposing charges</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:RestructuringSettlementAndImpairmentProvisions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMTQtMy0xLTEtMA_247137d6-3aba-4d85-84df-d1047bd687c5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestructuringSettlementAndImpairmentProvisions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMTQtNS0xLTEtMA_859669d0-4da8-4149-90a2-c9d5b3179e98">5,328</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:RestructuringSettlementAndImpairmentProvisions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMTQtNy0xLTEtMA_d7e26c06-f1d5-4183-b2c0-97654491c829">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMTUtMy0xLTEtMA_f6c4b7b8-6b84-4a2d-b9c2-ed92274d4aac">153,514</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMTUtNS0xLTEtMA_bd010ae2-15ae-4e3a-918e-bd91abda1311">103,511</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMTUtNy0xLTEtMA_219053bf-1bfb-4b35-a439-244a7597955d">26,658</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating loss</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMTYtMy0xLTEtMA_dfadae5b-4d0c-4833-a850-e9ce6c1ac492">179,347</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMTYtNS0xLTEtMA_5e2a753a-cb2c-4b22-a86c-47ad862732e6">121,108</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMTYtNy0xLTEtMA_f2ea3104-3675-41af-b12d-d1e1076fa8c1">20,445</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income (expense)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMTgtMy0xLTEtMA_31a5bd44-bbd2-47ea-8d97-74c34a07f0eb">18,415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMTgtNS0xLTEtMA_e3ccd18f-e7ac-49a3-99d6-49f1e6c0328a">27,969</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMTgtNy0xLTEtMA_e1ac8d2a-36dd-46cf-99cc-414226d14247">81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on revaluation of derivative liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMTktMy0xLTEtMA_f3e00e2d-0bc3-4c5c-b051-37c080d8a31c">129,254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMTktNS0xLTEtMA_5aa26780-78bf-4c99-8b99-a530f71591bb">1,276,819</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMTktNy0xLTEtMA_934b407f-5480-4ec9-a08c-c47fa8742b49">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss on goodwill and intangible assets</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMjAtMy0xLTEtMA_87ae8b41-3f96-417c-b6ee-ed7490101169">40,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMjAtNS0xLTEtMA_3f00be6f-ef2e-4624-95ff-5ccb2f294011">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMjAtNy0xLTEtMA_690fbd9c-babc-40f2-b05f-4db59ac5722c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on disposal of other investments</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMjEtMy0xLTEtMA_3a126480-ece1-4f0c-8d6a-3f633eaefd5f">4,789</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMjEtNS0xLTEtMA_e87c96cd-6491-494a-9f03-25885e9c3d7a">16,277</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMjEtNy0xLTEtMA_5726c3f6-ef57-4a1c-8f3c-f5d5db5d8a93">164</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share of loss from investments in equity accounted investees</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMjMtMy0xLTEtMA_655e145b-9014-430a-bfbf-ab26144235ce">4,510</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMjMtNS0xLTEtMA_e5468ec7-4c2e-4dbf-be92-526f23d0eb0e">2,009</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMjMtNy0xLTEtMA_13179e56-bbfb-4f0b-b605-abeaaa5bdd3b">723</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing and transaction costs</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" name="us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMjQtMy0xLTEtMA_5b60be16-b103-4d3e-8622-41df466f2ce4">40</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMjQtNS0xLTEtMA_7fa857d1-e3b0-4872-9576-6809c455b123">32,208</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMjQtNy0xLTEtMA_96af92f8-2f22-40cc-9090-afacd29463f8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (loss)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMjUtMy0xLTEtMTIzNjA_df5f2977-5d30-4c68-b62a-3c4933211f12">1,834</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMjUtNS0xLTEtMTIzNjA_75bc5afe-23fd-47e5-b9a3-0c69ce3b56c6">197</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMjUtNy0xLTEtMTIzNjA_9b266a9a-2b13-4e3d-a6c0-e22de3c90fc0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other income (expense)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMjUtMy0xLTEtMA_6d6c2346-9607-4db2-8fb2-0b57dbc180fb">106,074</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMjUtNS0xLTEtMA_bed2f4a8-bce9-4bf8-ad0d-c17a2c4897a6">1,287,045</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMjUtNy0xLTEtMA_3c81797f-fa66-4f31-a303-19527eb6780c">478</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income taxes</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMjYtMy0xLTEtMA_35a18c2f-6458-4b09-8832-edd2c820a5d9">73,273</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMjYtNS0xLTEtMA_8d0ee71c-911d-4dd7-9ea4-2a746b88f269">1,165,937</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMjYtNy0xLTEtMA_f924f0a2-c05d-48bf-a97b-af01eed2a72c">20,923</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMjctMy0xLTEtMA_c0938543-c07e-42fb-92b8-0de60cb2e47f">1,347</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMjctNS0xLTEtMA_e68aa0b4-7310-416f-9cb8-bc85b2a1f1da">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMjctNy0xLTEtMA_3a4d03a7-b43f-4415-b1f7-786f6d8a374a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income (loss) from continuing operations</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMjgtMy0xLTEtMTA3NzY_8f7e4a45-d51b-457f-93a0-4f22be304802">74,620</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMjgtNS0xLTEtMTA3NzY_dd443046-d7db-439e-b646-b5f6b2901a9c">1,165,937</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMjgtNy0xLTEtMTA3NzY_d4ceef76-ab7f-4b0c-b587-b21f32a3c48b">20,923</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMzAtMy0xLTEtMjMzNjc_c0001be3-6625-4ae8-aafa-d62b6961deed">650</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMjktNS0xLTEtMTA3NzY_f8c1a4f3-ada3-4c08-990f-44d436224766">363</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMjktNy0xLTEtMTA3NzY_8d551f93-fc15-40b1-82a4-4e4b0b35cb4c">894</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income (loss)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMjgtMy0xLTEtMA_338d3114-3acb-4df6-8211-c9ff1f98f15e">75,270</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMjgtNS0xLTEtMA_88744763-16f9-44f4-a644-889328638db9">1,165,574</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMjgtNy0xLTEtMA_6e3259ce-3a6d-4db1-ac09-c4f0d5e2844c">21,817</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income (loss) attributable to:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos Group</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMzAtMy0xLTEtMA_0819561b-ebfb-4767-97ff-452150012136">73,137</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMzAtNS0xLTEtMA_18acf260-f51e-4357-8005-9088e2871f17">1,166,506</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMzAtNy0xLTEtMA_e03a8bfd-2d55-4c25-a885-c007579388a0">21,636</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-controlling interests</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMzEtMy0xLTEtMA_e2502775-6b16-419a-8f6e-cc46f9e9957b">2,133</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMzEtNS0xLTEtMA_4161d923-8933-4630-bf5e-ba0e5eb90d70">932</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMzEtNy0xLTEtMA_02ef7282-9f87-47f1-b3c6-5e3089a44e65">181</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMzItMy0xLTEtMA_5ccefe91-6ce4-40fb-9ff7-99e584108e5d">75,270</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMzItNS0xLTEtMA_dc81a03d-031c-4518-b906-13379c5f0913">1,165,574</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMzItNy0xLTEtMA_0fe1d26d-f684-4a91-ba03-2dfbe88d2a75"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMzItNy0xLTEtMA_aaa120fb-1be9-4e9c-8e53-cbfa570ae078">21,817</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #2c5234;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income (loss) per share</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNDQtMy0xLTEtMA_1dc8f519-1613-4b72-bcb7-69f57812a56e">0.21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNDQtNS0xLTEtMA_b7ecd45d-69a9-4730-91cd-4ee830e5c2f6">3.76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNDQtNy0xLTEtMA_4ffa783c-7bcc-4659-b12b-9ccee24d62bc">0.12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (ii)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNDUtMy0xLTEtMA_c9deec0e-b435-414e-9862-97b176eb4753">0.21</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNDUtNS0xLTEtMA_493d04be-bc47-414c-9326-3ef9bf61406b">3.33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNDUtNy0xLTEtMA_076615ad-4cea-4475-a55b-1ad3b75ff74f">0.12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average number of outstanding shares</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNDctMy0xLTEtMA_c39cca44-6f42-4938-8962-1f058b1aadb2">351,576,848</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNDctNS0xLTEtMA_e221c2d7-3232-4a13-9403-ef2b15b677fb">310,067,179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNDctNy0xLTEtMA_a047dd76-a5f1-4941-b25d-9d5910e70e1e">172,269,170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (ii)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNDgtMy0xLTEtMA_5d41c6cb-4657-4d84-9d61-e7b6edbd8ed4">351,576,848</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNDgtNS0xLTEtMA_43a535c7-a9f7-4574-8755-ea4af2d6fcf0">342,811,992</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNDgtNy0xLTEtMA_00e023ad-c0ff-44e6-b2d6-18456a9f0e47">172,269,170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.1pt"><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RleHRyZWdpb246OWJlMGFjZTUyNjA2NDczYTkzNTU1YTA2NGVmOTYzYjFfMjMwODk3NDQxODQyNjQ_1f52087e-41b2-45cb-9593-dba04a2a8a65" footnoteRole="http://www.xbrl.org/2003/role/footnote">Refer to Note 14 in the notes to the consolidated financial statements</ix:footnote></span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.66pt"><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RleHRyZWdpb246OWJlMGFjZTUyNjA2NDczYTkzNTU1YTA2NGVmOTYzYjFfMjMwODk3NDQxODQyNjU_8a1ed1c3-4e3c-44aa-80c9-fe2c7bedff36" footnoteRole="http://www.xbrl.org/2003/role/footnote">In computing diluted earnings per share, incremental common shares are not considered in periods in which a net loss is reported, as the inclusion of the common share equivalents would be anti-dilutive.</ix:footnote></span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to consolidated financial statements.</span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><div id="i1ae9134e40e74e0aac958218112e53d4_2604"></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Net Income (Loss) and Comprehensive Income (Loss)</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December 31, 2020, 2019, and 2018</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S dollars, except share and per share amounts)</span></div><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div style="margin-top:6pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.900%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.122%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.122%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.124%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNjA0L2ZyYWc6NTA5YmYyOTZkMDFlNDY0YThiNjdlN2EwZWY0MjNkMWMvdGFibGU6MzkwZTUxM2ZjYzk1NDlkZjllZGRiZjc1Y2VjNzFjYzUvdGFibGVyYW5nZTozOTBlNTEzZmNjOTU0OWRmOWVkZGJmNzVjZWM3MWNjNV8zMi0zLTEtMS0zMTE0Mg_338d3114-3acb-4df6-8211-c9ff1f98f15e">75,270</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNjA0L2ZyYWc6NTA5YmYyOTZkMDFlNDY0YThiNjdlN2EwZWY0MjNkMWMvdGFibGU6MzkwZTUxM2ZjYzk1NDlkZjllZGRiZjc1Y2VjNzFjYzUvdGFibGVyYW5nZTozOTBlNTEzZmNjOTU0OWRmOWVkZGJmNzVjZWM3MWNjNV8zLTUtMS0xLTM2Mjg4_1cf83e56-12bb-424a-8fc4-81f2b89de629">1,165,574</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNjA0L2ZyYWc6NTA5YmYyOTZkMDFlNDY0YThiNjdlN2EwZWY0MjNkMWMvdGFibGU6MzkwZTUxM2ZjYzk1NDlkZjllZGRiZjc1Y2VjNzFjYzUvdGFibGVyYW5nZTozOTBlNTEzZmNjOTU0OWRmOWVkZGJmNzVjZWM3MWNjNV8zMi03LTEtMS0zMTE0Mg_6e3259ce-3a6d-4db1-ac09-c4f0d5e2844c">21,817</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange gain (loss) on translation</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNjA0L2ZyYWc6NTA5YmYyOTZkMDFlNDY0YThiNjdlN2EwZWY0MjNkMWMvdGFibGU6MzkwZTUxM2ZjYzk1NDlkZjllZGRiZjc1Y2VjNzFjYzUvdGFibGVyYW5nZTozOTBlNTEzZmNjOTU0OWRmOWVkZGJmNzVjZWM3MWNjNV8zOC0zLTEtMS0zMTE0Mg_4d59590b-f03c-4d58-b88e-5287ea33ddf7">14,951</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNjA0L2ZyYWc6NTA5YmYyOTZkMDFlNDY0YThiNjdlN2EwZWY0MjNkMWMvdGFibGU6MzkwZTUxM2ZjYzk1NDlkZjllZGRiZjc1Y2VjNzFjYzUvdGFibGVyYW5nZTozOTBlNTEzZmNjOTU0OWRmOWVkZGJmNzVjZWM3MWNjNV8zOC01LTEtMS0zMTE0Mg_4d4782a2-fe17-4367-97f1-cde520e4c620">37,687</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNjA0L2ZyYWc6NTA5YmYyOTZkMDFlNDY0YThiNjdlN2EwZWY0MjNkMWMvdGFibGU6MzkwZTUxM2ZjYzk1NDlkZjllZGRiZjc1Y2VjNzFjYzUvdGFibGVyYW5nZTozOTBlNTEzZmNjOTU0OWRmOWVkZGJmNzVjZWM3MWNjNV8zOC03LTEtMS0zMTE0Mg_a0bc4133-bdf1-4188-a9da-b82a0a16929f">12,337</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on revaluation and disposal of other investments, net of tax</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="cron:OtherComprehensiveIncomeLossAccumulatedGainLossDebtSecuritiesRevaluationAndDisposalOfOtherInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNjA0L2ZyYWc6NTA5YmYyOTZkMDFlNDY0YThiNjdlN2EwZWY0MjNkMWMvdGFibGU6MzkwZTUxM2ZjYzk1NDlkZjllZGRiZjc1Y2VjNzFjYzUvdGFibGVyYW5nZTozOTBlNTEzZmNjOTU0OWRmOWVkZGJmNzVjZWM3MWNjNV8zOS0zLTEtMS0zMTE0Mg_cb52045d-3696-4166-ac62-5236911e3bd2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="cron:OtherComprehensiveIncomeLossAccumulatedGainLossDebtSecuritiesRevaluationAndDisposalOfOtherInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNjA0L2ZyYWc6NTA5YmYyOTZkMDFlNDY0YThiNjdlN2EwZWY0MjNkMWMvdGFibGU6MzkwZTUxM2ZjYzk1NDlkZjllZGRiZjc1Y2VjNzFjYzUvdGFibGVyYW5nZTozOTBlNTEzZmNjOTU0OWRmOWVkZGJmNzVjZWM3MWNjNV8zOS01LTEtMS0zMTE0Mg_e72383b8-94f7-40a7-b717-588f18f02fda">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" name="cron:OtherComprehensiveIncomeLossAccumulatedGainLossDebtSecuritiesRevaluationAndDisposalOfOtherInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNjA0L2ZyYWc6NTA5YmYyOTZkMDFlNDY0YThiNjdlN2EwZWY0MjNkMWMvdGFibGU6MzkwZTUxM2ZjYzk1NDlkZjllZGRiZjc1Y2VjNzFjYzUvdGFibGVyYW5nZTozOTBlNTEzZmNjOTU0OWRmOWVkZGJmNzVjZWM3MWNjNV8zOS03LTEtMS0zMTE0Mg_a5309d38-0622-4e8d-b934-db1a91986ba6">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNjA0L2ZyYWc6NTA5YmYyOTZkMDFlNDY0YThiNjdlN2EwZWY0MjNkMWMvdGFibGU6MzkwZTUxM2ZjYzk1NDlkZjllZGRiZjc1Y2VjNzFjYzUvdGFibGVyYW5nZTozOTBlNTEzZmNjOTU0OWRmOWVkZGJmNzVjZWM3MWNjNV80MS0zLTEtMS0zMTE0Mg_2c41a1c4-1619-4ebf-a69a-596077d06584">14,951</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNjA0L2ZyYWc6NTA5YmYyOTZkMDFlNDY0YThiNjdlN2EwZWY0MjNkMWMvdGFibGU6MzkwZTUxM2ZjYzk1NDlkZjllZGRiZjc1Y2VjNzFjYzUvdGFibGVyYW5nZTozOTBlNTEzZmNjOTU0OWRmOWVkZGJmNzVjZWM3MWNjNV80MS01LTEtMS0zMTE0Mg_7e0a49e9-ca28-458f-8ecc-6f6cee2817f5">37,687</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNjA0L2ZyYWc6NTA5YmYyOTZkMDFlNDY0YThiNjdlN2EwZWY0MjNkMWMvdGFibGU6MzkwZTUxM2ZjYzk1NDlkZjllZGRiZjc1Y2VjNzFjYzUvdGFibGVyYW5nZTozOTBlNTEzZmNjOTU0OWRmOWVkZGJmNzVjZWM3MWNjNV80MS03LTEtMS0zMTE0Mg_4f4a3e9a-94f7-4cc4-a560-105871328b71">12,334</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Comprehensive income (loss)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNjA0L2ZyYWc6NTA5YmYyOTZkMDFlNDY0YThiNjdlN2EwZWY0MjNkMWMvdGFibGU6MzkwZTUxM2ZjYzk1NDlkZjllZGRiZjc1Y2VjNzFjYzUvdGFibGVyYW5nZTozOTBlNTEzZmNjOTU0OWRmOWVkZGJmNzVjZWM3MWNjNV80Mi0zLTEtMS0zMTE0Mg_9f1232ed-b35a-412b-a4e4-c0e8342a0dda">60,319</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNjA0L2ZyYWc6NTA5YmYyOTZkMDFlNDY0YThiNjdlN2EwZWY0MjNkMWMvdGFibGU6MzkwZTUxM2ZjYzk1NDlkZjllZGRiZjc1Y2VjNzFjYzUvdGFibGVyYW5nZTozOTBlNTEzZmNjOTU0OWRmOWVkZGJmNzVjZWM3MWNjNV80Mi01LTEtMS0zMTE0Mg_9a69b472-9c20-4444-bdbd-37d2a3b9289b">1,203,261</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNjA0L2ZyYWc6NTA5YmYyOTZkMDFlNDY0YThiNjdlN2EwZWY0MjNkMWMvdGFibGU6MzkwZTUxM2ZjYzk1NDlkZjllZGRiZjc1Y2VjNzFjYzUvdGFibGVyYW5nZTozOTBlNTEzZmNjOTU0OWRmOWVkZGJmNzVjZWM3MWNjNV80Mi03LTEtMS0zMTE0Mg_d2069816-de51-4dea-893e-3798840f2918">34,151</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Comprehensive income (loss) attributable to:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos Group</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNjA0L2ZyYWc6NTA5YmYyOTZkMDFlNDY0YThiNjdlN2EwZWY0MjNkMWMvdGFibGU6MzkwZTUxM2ZjYzk1NDlkZjllZGRiZjc1Y2VjNzFjYzUvdGFibGVyYW5nZTozOTBlNTEzZmNjOTU0OWRmOWVkZGJmNzVjZWM3MWNjNV80NC0zLTEtMS0zMTE0Mg_0a311a83-11b3-4500-a7a2-48ed615ddada">57,976</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNjA0L2ZyYWc6NTA5YmYyOTZkMDFlNDY0YThiNjdlN2EwZWY0MjNkMWMvdGFibGU6MzkwZTUxM2ZjYzk1NDlkZjllZGRiZjc1Y2VjNzFjYzUvdGFibGVyYW5nZTozOTBlNTEzZmNjOTU0OWRmOWVkZGJmNzVjZWM3MWNjNV80NC01LTEtMS0zMTE0Mg_ed26fa61-1504-447f-869b-063a5bb71644">1,204,214</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNjA0L2ZyYWc6NTA5YmYyOTZkMDFlNDY0YThiNjdlN2EwZWY0MjNkMWMvdGFibGU6MzkwZTUxM2ZjYzk1NDlkZjllZGRiZjc1Y2VjNzFjYzUvdGFibGVyYW5nZTozOTBlNTEzZmNjOTU0OWRmOWVkZGJmNzVjZWM3MWNjNV80NC03LTEtMS0zMTE0Mg_e58a9698-bf3f-4378-a1e6-5951bd392fba">33,964</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-controlling interests</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNjA0L2ZyYWc6NTA5YmYyOTZkMDFlNDY0YThiNjdlN2EwZWY0MjNkMWMvdGFibGU6MzkwZTUxM2ZjYzk1NDlkZjllZGRiZjc1Y2VjNzFjYzUvdGFibGVyYW5nZTozOTBlNTEzZmNjOTU0OWRmOWVkZGJmNzVjZWM3MWNjNV80NS0zLTEtMS0zMTE0Mg_2031e58e-9f9a-4351-ab8b-61762bea559b">2,343</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNjA0L2ZyYWc6NTA5YmYyOTZkMDFlNDY0YThiNjdlN2EwZWY0MjNkMWMvdGFibGU6MzkwZTUxM2ZjYzk1NDlkZjllZGRiZjc1Y2VjNzFjYzUvdGFibGVyYW5nZTozOTBlNTEzZmNjOTU0OWRmOWVkZGJmNzVjZWM3MWNjNV80NS01LTEtMS0zMTE0Mg_5508492e-990a-4fb3-ad0b-f7de34145db6">953</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNjA0L2ZyYWc6NTA5YmYyOTZkMDFlNDY0YThiNjdlN2EwZWY0MjNkMWMvdGFibGU6MzkwZTUxM2ZjYzk1NDlkZjllZGRiZjc1Y2VjNzFjYzUvdGFibGVyYW5nZTozOTBlNTEzZmNjOTU0OWRmOWVkZGJmNzVjZWM3MWNjNV80NS03LTEtMS0zMTE0Mg_aa08139e-4751-44d5-92b7-2f31b48109db">187</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNjA0L2ZyYWc6NTA5YmYyOTZkMDFlNDY0YThiNjdlN2EwZWY0MjNkMWMvdGFibGU6MzkwZTUxM2ZjYzk1NDlkZjllZGRiZjc1Y2VjNzFjYzUvdGFibGVyYW5nZTozOTBlNTEzZmNjOTU0OWRmOWVkZGJmNzVjZWM3MWNjNV80Ni0zLTEtMS0zMTE0Mg_56a5d58b-590b-4e55-959f-7c07ca4f939d">60,319</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNjA0L2ZyYWc6NTA5YmYyOTZkMDFlNDY0YThiNjdlN2EwZWY0MjNkMWMvdGFibGU6MzkwZTUxM2ZjYzk1NDlkZjllZGRiZjc1Y2VjNzFjYzUvdGFibGVyYW5nZTozOTBlNTEzZmNjOTU0OWRmOWVkZGJmNzVjZWM3MWNjNV80Ni01LTEtMS0zMTE0Mg_60fbf885-33d3-4c08-9144-1eace1976d24">1,203,261</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNjA0L2ZyYWc6NTA5YmYyOTZkMDFlNDY0YThiNjdlN2EwZWY0MjNkMWMvdGFibGU6MzkwZTUxM2ZjYzk1NDlkZjllZGRiZjc1Y2VjNzFjYzUvdGFibGVyYW5nZTozOTBlNTEzZmNjOTU0OWRmOWVkZGJmNzVjZWM3MWNjNV80Ni03LTEtMS0zMTE0Mg_843a437b-c6ed-46b9-8cbc-ee54ce872f3f">34,151</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to consolidated financial statements.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><div id="i1ae9134e40e74e0aac958218112e53d4_64"></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Changes in Shareholders&#8217; Equity (Deficit)</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December 31, 2020, 2019, and 2018</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S dollars, except number of share amounts)</span></div><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.004%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.587%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.945%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.587%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.945%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.587%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.945%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.587%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.945%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.795%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.945%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.587%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.945%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.596%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Share capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional paid-in capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained earnings (accumulated deficit)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated other comprehensive income (loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-controlling interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total shareholders&#8217; equity</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of January 1, 2018</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0451ae32e2d74c6a81c9a1a7d77aea12_I20171231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfMS03LTEtMS0w_f8850cc2-3f06-452b-83c5-818db2d94223">149,360,603</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0451ae32e2d74c6a81c9a1a7d77aea12_I20171231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfMS05LTEtMS0w_a5ce38a5-de25-4c96-b632-d34644c2d366">62,834</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ea5ff615f724f79bc76ea60e882c0d6_I20171231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfMS0xMS0xLTEtMA_1b94fbee-0285-41ae-a936-cb1bc43037bd">4,734</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b21d84a8da64ac182924657011dc8f4_I20171231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfMS0xMy0xLTEtMA_0568b22d-8152-45df-a618-a77a7ad6bb13">6,293</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i603e76f89c54407a82af75f4644d6617_I20171231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfMS0xNS0xLTEtMA_12363a9a-2066-437e-a03e-5a62e5675405">2,458</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia83e6fe889b142c1b548d3c600ce2460_I20171231" decimals="-3" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfMS0xOS0xLTEtMA_c79b0327-372f-44bf-9c95-9ed9a7d03419">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb4bf06122354c15966cf5343aa018a5_I20171231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfMS0yMS0xLTEtMA_bea550df-4793-4263-997c-febb577dfee5">63,733</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares issued</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i85e3d76bfda8415b975e00befcd9609f_D20180101-20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfMi03LTEtMS0w_5deb7c72-17d3-4ae1-b5a5-a86cc94e5dd2">15,677,143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85e3d76bfda8415b975e00befcd9609f_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfMi05LTEtMS0w_63ba5965-41be-4d5c-baff-ee1976d81c9e">115,510</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfMi0yMS0xLTEtMA_8cd7de5e-e614-416e-abed-9448404e25da">115,510</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i85e3d76bfda8415b975e00befcd9609f_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="cron:StockIssuedDuringPeriodValueNewIssuesIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfMy05LTEtMS0w_4b7b56be-b219-4c5b-ba1e-2dbcebea8c29">7,577</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="cron:StockIssuedDuringPeriodValueNewIssuesIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfMy0yMS0xLTEtMA_88bab2b8-c63e-4093-975f-ecca8f4abcc0">7,577</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vesting of options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73bc389412d48679e51974a3e1e0968_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfNC0xMS0xLTEtMA_7e4c719a-b25c-43ad-a7ef-a09f6cfb2af5">8,151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfNC0yMS0xLTEtMA_a9cfb4aa-adac-4e4a-8895-bee70c10bf6d">8,151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i85e3d76bfda8415b975e00befcd9609f_D20180101-20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfNS03LTEtMS0w_927acb6c-9d83-42b4-b302-bd9ff1abf640">567,940</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85e3d76bfda8415b975e00befcd9609f_D20180101-20181231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfNS05LTEtMS0w_e640f48a-a183-449c-baf0-ff1f28c574ed">671</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie73bc389412d48679e51974a3e1e0968_D20180101-20181231" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfNS0xMS0xLTEtMA_82b220fc-7c34-4447-96f1-90b6056dfd29">220</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0a8816e9f004feb8e54373b3e932949_D20180101-20181231" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfNS0xMy0xLTEtMA_eb5c83df-6f25-449d-978d-c6d6075fa5fb">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfNS0yMS0xLTEtMA_57cfa0e2-62b6-4d3a-a2f0-f456db5e3443">435</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Warrants exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i85e3d76bfda8415b975e00befcd9609f_D20180101-20181231" decimals="INF" format="ixt:numdotdecimal" name="cron:SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisesInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfNi03LTEtMS0w_4f385c9c-bf49-4561-a627-f9b06f89b5fc">13,114,336</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85e3d76bfda8415b975e00befcd9609f_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="cron:StockIssuedDuringPeriodValueWarrantsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfNi05LTEtMS0w_410f4709-64eb-4ba4-a6cd-5e99d1051222">3,563</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie73bc389412d48679e51974a3e1e0968_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:StockIssuedDuringPeriodValueWarrantsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfNi0xMS0xLTEtMA_e1d28c27-5dea-450f-8de8-5b505d83337d">1,402</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="cron:StockIssuedDuringPeriodValueWarrantsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfNi0yMS0xLTEtMA_0f148d5c-7377-47e8-b52e-f78459721fad">2,161</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contribution by non-controlling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i005d23eef9f84c3993929eefb19a4d19_D20180101-20181231" decimals="-3" name="us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfOC0xOS0xLTEtODM1_ae324cf8-7fa7-4239-b5fd-609349a6a960">287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" name="us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfOC0yMS0xLTEtODM1_cea63972-16e8-4ced-9a8c-ea83ede5e864">287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0a8816e9f004feb8e54373b3e932949_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfNy0xMy0xLTEtMA_134c8844-1698-4207-887c-b890f6f8a7e8">21,636</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i005d23eef9f84c3993929eefb19a4d19_D20180101-20181231" decimals="-3" sign="-" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfNy0xOS0xLTEtMA_0cf2891c-fee0-4b4e-a9ac-3113c84b1107">181</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfNy0yMS0xLTEtMA_d8f0a946-1e7a-4de0-9474-007f7f376b12">21,817</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i96223c9bb10341f4b0f7ca7353171f06_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfOC0xNS0xLTEtMA_e67e1366-dec0-4f7f-957a-87642614a524">12,328</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i005d23eef9f84c3993929eefb19a4d19_D20180101-20181231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfOC0xOS0xLTEtMA_ce639f13-5dba-4170-97f4-cbc8df48aca1">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfOC0yMS0xLTEtMA_5ef029ad-a51d-4bf8-a67f-1087cc9ce1e4">12,334</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2018</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i98a40ef3bd8f4cb7b68cb5bc1907a1e9_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfOS03LTEtMS0w_8bbae070-08ba-4ea3-9760-5b2c77da3acc">178,720,022</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a40ef3bd8f4cb7b68cb5bc1907a1e9_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfOS05LTEtMS0w_abe15bee-ac74-4877-8b40-7a6e0443117c">175,001</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92c8255933de4ada9ebce878a6a77405_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfOS0xMS0xLTEtMA_af957da6-d40f-49cb-99bc-7201cfaf2853">11,263</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia7206d1e564f417f9935a0aca534849a_I20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfOS0xMy0xLTEtMA_86ad190d-0ade-4479-9794-9eed551f94f1">27,945</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f1cb8c6e56c4c8cb1070c81364c66b2_I20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfOS0xNS0xLTEtMA_9414897a-2544-4aec-8207-d74d476b51b3">9,870</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bfe263ed9524742b183ccc53bcccba1_I20181231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfOS0xOS0xLTEtMA_5f8d7e13-95e7-4c0d-a7ca-49dee1ceffea">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9717dc3b24b24c93ab09a6bfa9b52c89_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfOS0yMS0xLTEtMA_96ebe7f4-c546-4a9e-ae5f-1815306488b0">148,549</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.212%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.587%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.945%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.587%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.945%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.587%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.945%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.587%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.945%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.587%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.945%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.587%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.945%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.596%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Share capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional paid-in capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained earnings (accumulated deficit)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated other comprehensive income (loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-controlling interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total shareholders&#8217; equity</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of January 1, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i98a40ef3bd8f4cb7b68cb5bc1907a1e9_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMTMtNy0xLTEtNDMwMw_3e0199ef-8783-47c0-a137-f06c56590e53">178,720,022</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98a40ef3bd8f4cb7b68cb5bc1907a1e9_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMTMtOS0xLTEtNDMwMw_2a1b4e85-2d85-4ff4-a952-d6cbf9554f65">175,001</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92c8255933de4ada9ebce878a6a77405_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMTMtMTEtMS0xLTQzMDM_a04c3373-9713-4baa-b886-e71893448b89">11,263</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia7206d1e564f417f9935a0aca534849a_I20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMTMtMTMtMS0xLTQzMDM_03172591-d2ba-4a8f-b1ac-88ceeb8bf025">27,945</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f1cb8c6e56c4c8cb1070c81364c66b2_I20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMTMtMTUtMS0xLTQzMDM_0e607d0f-6e22-43c9-83bd-2d53deaf4bd3">9,870</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bfe263ed9524742b183ccc53bcccba1_I20181231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMTMtMTktMS0xLTQzMDM_47bc91f8-ea3f-44e4-aa36-a38f861c5ee9">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9717dc3b24b24c93ab09a6bfa9b52c89_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMTMtMjEtMS0xLTQzMDM_f47f445b-7456-40b5-8834-f0e7392dbff4">148,549</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares issued</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6aa79556c9a24064ab5ea55845f31f79_D20190101-20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMTQtNy0xLTEtNDMwMw_d1f07695-d15b-4477-810a-b670243d5e1a">155,773,757</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa79556c9a24064ab5ea55845f31f79_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMTQtOS0xLTEtNDMwMw_8c7ac2a1-2a30-411e-873c-54774f7f4007">304,411</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic77af0ad2ca04f71b6c632243f35b62b_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMTQtMTEtMS0xLTQzMDM_2951c220-20a5-4dc7-9105-a5a7f0b69d6d">410</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMTQtMjEtMS0xLTQzMDM_283da201-514e-473f-9e99-5a120562629e">304,821</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6aa79556c9a24064ab5ea55845f31f79_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="cron:StockIssuedDuringPeriodValueNewIssuesIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMTUtOS0xLTEtNDMwMw_0f7e04f6-bd1c-4890-907f-f3dc7875251e">3,722</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="cron:StockIssuedDuringPeriodValueNewIssuesIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMTUtMjEtMS0xLTQzMDM_36d26524-d0ce-44b2-82fb-40d3dda0489a">3,722</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Warrants exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6aa79556c9a24064ab5ea55845f31f79_D20190101-20191231" decimals="INF" format="ixt:numdotdecimal" name="cron:SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisesInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMTYtNy0xLTEtNDMwMw_e3090c7c-cd49-4033-856b-10b31f774393">7,390,961</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa79556c9a24064ab5ea55845f31f79_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="cron:StockIssuedDuringPeriodValueWarrantsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMTYtOS0xLTEtNDMwMw_c8db0e8a-afb2-4457-b8d5-40b6f2650b33">2,034</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic77af0ad2ca04f71b6c632243f35b62b_D20190101-20191231" decimals="-3" sign="-" name="cron:StockIssuedDuringPeriodValueWarrantsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMTYtMTEtMS0xLTQzMDM_60db782f-a355-4dcb-9bc7-0872ce6e81e9">596</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="cron:StockIssuedDuringPeriodValueWarrantsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMTYtMjEtMS0xLTQzMDM_bb141bba-70dd-4467-88f6-919aabca40b4">1,438</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vesting of options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic77af0ad2ca04f71b6c632243f35b62b_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMTctMTEtMS0xLTQzMDM_028bba16-3b98-477d-b561-ee7331273ce3">11,619</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMTctMjEtMS0xLTQzMDM_4053f11a-179f-4260-852d-bb8b14d2d2ea">11,619</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6aa79556c9a24064ab5ea55845f31f79_D20190101-20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMTgtNy0xLTEtNDMwMw_4a97f271-b135-46bb-9238-1fbdc0927566">190,349</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa79556c9a24064ab5ea55845f31f79_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMTgtOS0xLTEtNDMwMw_e0160697-1785-487c-bd46-e48916049bdd">368</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic77af0ad2ca04f71b6c632243f35b62b_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMTgtMTEtMS0xLTQzMDM_3187ac28-2253-4c1f-859f-aeee3f3037f7">351</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c3d39b0ddc3421a9ef11be927b7c69c_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMTgtMTMtMS0xLTQzMDM_a1e77d34-4cf6-4e27-b7e5-333ca9885072">915</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMTgtMjEtMS0xLTQzMDM_8cf2d71c-7584-426e-986b-3f3dacacf689">898</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vesting of restricted share units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic77af0ad2ca04f71b6c632243f35b62b_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMTktMTEtMS0xLTQzMDM_3a2de3f9-879b-4342-b7a1-b34e80991009">889</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMTktMjEtMS0xLTQzMDM_2b1c5c6b-21ef-4e4b-a313-6f5d8caa143c">889</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Top-up Rights exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6aa79556c9a24064ab5ea55845f31f79_D20190101-20191231" decimals="INF" format="ixt:numdotdecimal" name="cron:StockIssuedDuringPeriodSharesTopupRightsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMjEtNy0xLTEtNDMwMw_4e740bf9-cc5c-4d14-a359-0081e3f1ab2f">6,742,383</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aa79556c9a24064ab5ea55845f31f79_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="cron:StockIssuedDuringPeriodValueTopupRightsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMjEtOS0xLTEtNDMwMw_ba72092e-121f-4c37-93d8-1bd65734dadd">83,073</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="cron:StockIssuedDuringPeriodValueTopupRightsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMjEtMjEtMS0xLTQzMDM_fded2f80-e395-4117-9ffa-2e8840669088">83,073</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c3d39b0ddc3421a9ef11be927b7c69c_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMjItMTMtMS0xLTQzMDM_b032baad-3296-4083-9bce-55854b21e910">1,166,506</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic1710fca0e7c4f9e87a86725cf4c48ff_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMjItMTktMS0xLTQzMDM_75779e6d-1a48-4177-886c-6a7afdae793c">932</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMjItMjEtMS0xLTQzMDM_21932298-268b-4cef-bcc5-6eb73224bfd2">1,165,574</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6981b713441d4cea8f87dda3a39ac2be_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMjMtMTUtMS0xLTQzMDM_bd538588-a1c8-4449-af8d-45c8628222cc">37,708</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic1710fca0e7c4f9e87a86725cf4c48ff_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMjMtMTktMS0xLTQzMDM_675381cf-9dff-4a47-ad06-6e7b525397cf">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMjMtMjEtMS0xLTQzMDM_76aa613d-730b-4b9a-8a2c-74710325a0dd">37,687</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i46c33a2743a34787aa9be59e8b743b3c_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMjQtNy0xLTEtNDMwMw_dcc954b8-72aa-4032-a219-89fd479f6b81">348,817,472</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46c33a2743a34787aa9be59e8b743b3c_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMjQtOS0xLTEtNDMwMw_669b91f8-10d0-45fa-85cd-0c71b7e5c325">561,165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8918c1f902e543639e6e68f052bbd4cf_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMjQtMTEtMS0xLTQzMDM_5e253558-21de-4deb-8b5b-ad0ae2a55a54">23,234</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic63015dad62149c8b50e40927b2c91c6_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMjQtMTMtMS0xLTQzMDM_f5e77d31-c550-4d9d-ba27-3a815a1560fe">1,137,646</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6461d38acec49bd9d6a716a38310029_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMjQtMTUtMS0xLTQzMDM_a565eb72-a50e-44eb-a680-04c68cce7497">27,838</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i713e37bc833e40c3bea5015df9213308_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMjQtMTktMS0xLTQzMDM_0a402e0e-d502-4545-b6ad-e21f055ca0fb">853</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMjQtMjEtMS0xLTQzMDM_c58e985f-bdd5-401b-aba8-1aa3d7a14e45">1,749,030</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="height:31.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:67.5pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Changes in Shareholders&#8217; Equity (Deficit)</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December 31, 2020, 2019, and 2018</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S dollars, except number of share amounts)</span></div><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.212%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.587%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.945%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.587%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.945%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.587%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.945%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.587%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.945%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.587%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.945%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.587%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.945%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.596%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Share capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional paid-in capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained earnings (accumulated deficit)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated other comprehensive income (loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-controlling interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total shareholders&#8217; equity</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of January 1, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i46c33a2743a34787aa9be59e8b743b3c_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfMjYtNy0xLTEtNDMwNg_dcc954b8-72aa-4032-a219-89fd479f6b81">348,817,472</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46c33a2743a34787aa9be59e8b743b3c_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfMjYtOS0xLTEtNDMwNg_669b91f8-10d0-45fa-85cd-0c71b7e5c325">561,165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8918c1f902e543639e6e68f052bbd4cf_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfMjYtMTEtMS0xLTQzMDY_5e253558-21de-4deb-8b5b-ad0ae2a55a54">23,234</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic63015dad62149c8b50e40927b2c91c6_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfMjYtMTMtMS0xLTQzMDY_f5e77d31-c550-4d9d-ba27-3a815a1560fe">1,137,646</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6461d38acec49bd9d6a716a38310029_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfMjYtMTUtMS0xLTQzMDY_a565eb72-a50e-44eb-a680-04c68cce7497">27,838</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i713e37bc833e40c3bea5015df9213308_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfMjYtMTktMS0xLTQzMDY_0a402e0e-d502-4545-b6ad-e21f055ca0fb">853</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfMjYtMjEtMS0xLTQzMDY_c58e985f-bdd5-401b-aba8-1aa3d7a14e45">1,749,030</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Warrants exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3783dc27237d46f6944e1a9a6f65eee6_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="cron:SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisesInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfMjktNy0xLTEtNDMwNg_0ab3dff0-07b5-42d1-934d-8e521c3174bd">9,755,642</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3783dc27237d46f6944e1a9a6f65eee6_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="cron:StockIssuedDuringPeriodValueWarrantsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfMjktOS0xLTEtNDMwNg_fa575326-621f-417c-b770-3655609e32d9">1,244</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i63eed3a7d9e2479d9b72e7dbc2a9f719_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:StockIssuedDuringPeriodValueWarrantsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfMjktMTEtMS0xLTQzMDY_327b12cd-248a-45c0-8565-4e199f979dda">1,137</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" name="cron:StockIssuedDuringPeriodValueWarrantsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfNC0xMy0xLTEtMTE5MDk_fcb1e538-cb96-4a69-9f5b-231a696c5e9e">107</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vesting of options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63eed3a7d9e2479d9b72e7dbc2a9f719_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfMzAtMTEtMS0xLTQzMDY_5196f039-24a3-41f6-ad92-38f70b48e742">7,185</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfNS0xMy0xLTEtMTE5MDk_09354b28-25c7-489f-bef1-de3a2f5bb94d">7,185</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3783dc27237d46f6944e1a9a6f65eee6_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfMzEtNy0xLTEtNDMwNg_ec8be51b-d31e-4d78-8222-6d5c234c60d2">1,266,130</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3783dc27237d46f6944e1a9a6f65eee6_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfMzEtOS0xLTEtNDMwNg_a63a67c2-9ad6-434b-b066-6847bd704997">1,586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i63eed3a7d9e2479d9b72e7dbc2a9f719_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfMzEtMTEtMS0xLTQzMDY_267690e1-86e8-4a9f-8edd-50743eda86a3">1,577</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfNi0xMy0xLTEtMTE5MDk_3889804d-fbd8-497a-a02c-f442d38c015b">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted share units settled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3783dc27237d46f6944e1a9a6f65eee6_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfNy0xLTEtMS0yODE3OA_bcb53f91-3961-42a4-a6af-7af3091f32ee">414,088</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vesting of restricted share units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63eed3a7d9e2479d9b72e7dbc2a9f719_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfMzMtMTEtMS0xLTQzMDY_5ce456ba-8f6c-4bac-9404-aa4d0c40cdae">8,176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfOC0xNS0xLTEtNDM1Ng_18ac1b9b-d62b-499b-b817-9d74deada9bd">8,176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Taxes withheld on vesting of restricted share units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i63eed3a7d9e2479d9b72e7dbc2a9f719_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfOS01LTEtMS0zOTEwNw_ceccb0bd-32e5-4c1e-8abb-33d6b9024cf3">2,148</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfOS0xMy0xLTEtMzkxMTE_ba6b341f-3cc6-4e99-96b7-d90ff136c302">2,148</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vesting of common shares issued in connection with the use of certain publicity rights in brand development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3783dc27237d46f6944e1a9a6f65eee6_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfMzQtOS0xLTEtNDMwNg_d975b123-764c-4d72-a52b-b84a60ab12ba">2,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63eed3a7d9e2479d9b72e7dbc2a9f719_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfMzQtMTEtMS0xLTQzMDY_20ef770d-d4ce-4d14-9c5b-30a035d6c056">863</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfOS0xMy0xLTEtMTE5MDk_e414b761-d076-466f-8081-f2754082c45f">2,863</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Top-up Rights exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3783dc27237d46f6944e1a9a6f65eee6_D20200101-20201231" decimals="INF" format="ixt:zerodash" name="cron:StockIssuedDuringPeriodSharesTopupRightsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfMzUtNy0xLTEtNDMwNg_cb767981-b949-405b-94cd-ab6a79f73853">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3783dc27237d46f6944e1a9a6f65eee6_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="cron:StockIssuedDuringPeriodValueTopupRightsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfMzUtOS0xLTEtNDMwNg_3afce97b-9ecc-4e03-a04c-79d01586f876">3,265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="cron:StockIssuedDuringPeriodValueTopupRightsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfMTAtMTMtMS0xLTExOTA5_60201ddf-158a-44fd-86d9-9f8cc4e6bca7">3,265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i15d5bb5d21934b388dac2f68df18d863_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfMzYtMTMtMS0xLTQzMDY_88fe0543-dd5e-49da-828e-320c7c29271c">73,137</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic3a267e3ba2b422fb71cbfeef4f71c1d_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfMzYtMTktMS0xLTQzMDY_da9ec304-ccdb-4699-a63e-1ed29f36fb0d">2,133</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfMTEtMTMtMS0xLTExOTA5_74de67d7-3627-4f57-aeb9-be1d6feb560c">75,270</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9981ea6f70b413c8a8fed8d7848ea09_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfMzctMTUtMS0xLTQzMDY_7b1e4bcf-5db3-4fc1-a22e-1e17b7a3e3f2">15,161</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic3a267e3ba2b422fb71cbfeef4f71c1d_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfMzctMTktMS0xLTQzMDY_43f8e12b-ec8e-4b33-b701-35f2650f75e4">210</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfMzctMjEtMS0xLTQzMDY_49dfea8e-5067-467b-8dc8-7752a9a8f7b1">14,951</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie01b46877add4dd9bb362674520540d1_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfMTMtMS0xLTEtMjM0OTI_11457be1-acfa-4adf-9940-b7e1be264a02">360,253,332</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie01b46877add4dd9bb362674520540d1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfMTMtMy0xLTEtMjM0OTQ_9e56d819-9a4d-48f2-957c-c302c0802bcf">569,260</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb8296c494cb4a6a89b362beeaebb94d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfMTMtNS0xLTEtMjM0OTY_4452574e-a5b8-4925-854d-1e55232c6bfb">34,596</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f46a47fa0d44ffa9cc475bb9cb26b30_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfMTMtNy0xLTEtMjM0OTg_a833badc-5fd3-4c43-9f4f-a13b239b386b">1,064,509</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief7afcb557114192867857af1fa9165f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfMTMtOS0xLTEtMjM1MDA_a4f80f3b-bee2-4dda-bece-c99857e659d6">42,999</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i05ebae3e5a2040bca90eca82e1a3f75f_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfMTMtMTEtMS0xLTIzNTAy_bdf3e259-4284-4bdd-b712-3f6821c44195">3,196</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfMTMtMTMtMS0xLTIzNTA0_86933615-75e6-4854-83d7-c6f66ca804fa">1,708,168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">See notes to consolidated financial statements.</span></div><div style="height:31.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><div id="i1ae9134e40e74e0aac958218112e53d4_2511"></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Cash Flows</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December 31, 2020, 2019, and 2018</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S dollars)</span></div><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.705%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.705%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.708%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18zLTItMS0xLTE5ODY4_8dac2b2e-4613-4b13-85fe-55137b126bbf">75,270</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18zLTQtMS0xLTE5ODY4_5d7a3cfe-cf3d-46eb-a841-6f7baf7b41e0">1,165,574</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18zLTYtMS0xLTE5ODY4_d41ffc2e-4a3f-4491-9307-fbd3288940b7">21,817</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Items not affecting cash:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain on revaluation of derivative liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY181LTItMS0xLTE5ODY4_d008eb2d-02f4-41de-a9e9-29d7c125013f">129,254</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY181LTQtMS0xLTE5ODY4_a610d7fc-f428-449c-9059-7adfe180fa46">1,276,819</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY181LTYtMS0xLTE5ODY4_e7daf893-d717-4958-98f7-edf136d089fb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairment on goodwill and intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY182LTItMS0xLTE5ODY4_ea377b7f-6af1-4a84-b37b-66ac9ab8eada">40,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY182LTQtMS0xLTE5ODY4_e8765533-6c56-4e58-8f11-e84c462b783c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY182LTYtMS0xLTE5ODY4_7beadedc-f144-4bc4-8756-4069a55cddd2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventory write-down</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryWriteDown" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY183LTItMS0xLTE5ODY4_7cb80009-92ac-4f6c-9f56-e723de52a3b6">26,055</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryWriteDown" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY183LTQtMS0xLTE5ODY4_407f5958-0ac9-4e40-8619-e3cf1a754be3">29,173</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:InventoryWriteDown" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY183LTYtMS0xLTE5ODY4_1c2127bc-5cbb-4537-986e-cf460b0d593f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provisions for inventory and doubtful accounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY184LTItMS0xLTE5ODY4_e201bd0b-5fce-46b3-890c-c1b41694d081">3,741</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY184LTQtMS0xLTE5ODY4_fa964f1e-8b86-4740-bb8d-7fc83c41155d">136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY184LTYtMS0xLTE5ODY4_306f1c39-824d-4261-bd45-0073e4f160f5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY185LTItMS0xLTE5ODY4_52c324c6-c850-412b-b286-4b4a99de44e8">15,361</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY185LTQtMS0xLTE5ODY4_adf29a0f-f6f1-4139-aa4a-344c1e8dd1e7">11,619</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY185LTYtMS0xLTE5ODY4_b20956a0-bf0f-4fcb-8e99-8f9273565cea">8,151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18xMS0yLTEtMS0xOTg2OA_1c1b290a-6d17-4f67-b251-deaa82905efe">7,045</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18xMS00LTEtMS0xOTg2OA_f548f478-e97c-455f-8bdd-fe1a1522b881">3,913</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18xMS02LTEtMS0xOTg2OA_cf21c7f1-f9fc-4c0a-a651-83578d35d6a6">1,937</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share of loss from investments in equity accounted investees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18xMi0yLTEtMS0xOTg2OA_69607017-ce53-4938-967b-c6688d9cba41">4,510</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18xMi00LTEtMS0xOTg2OA_5b37cf32-1223-4f80-9b63-4ae86eca7db7">2,009</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18xMi02LTEtMS0xOTg2OA_9debd7ed-f48e-4a24-81c0-d2770615fb49">723</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain on disposal of other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18xNS0xLTEtMS0xOTg5Nw_2c2a8d45-0223-4ab1-a0b4-ff05c86b00d4">4,789</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18xNS0zLTEtMS0xOTg5Nw_06ccc102-8511-42d5-9ecc-c4a252b7179c">16,277</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18xNS01LTEtMS0xOTg5Nw_56b144c1-2e5e-4b2c-90f2-0d1832cfed39">164</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash sales and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="cron:NoncashSellingAndMarketingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18xNC0xLTEtMS0yNjQ0Ng_c445d97e-a38c-467c-885f-018070afe01b">2,863</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" name="cron:NoncashSellingAndMarketingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18xNC0zLTEtMS0yNjQ0Ng_7308e898-96d7-4b50-8ae5-372141e2d77a">410</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="cron:NoncashSellingAndMarketingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18xNC01LTEtMS0yNjQ0Ng_fbb7be93-219f-408d-a839-9b224ed2a079">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18xNi0xLTEtMS0yNjQ0Ng_b719dcea-cae1-4e24-80aa-2f5b2a212940">1,347</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18xNi0zLTEtMS0yNjQ0Ng_ddd62565-f2a3-4be2-bc6f-65ddb9d8080f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18xNi01LTEtMS0yNjQ0Ng_a97437ec-1b15-422c-9a5d-1844bf038c16">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash repurposing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:RestructuringCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18xNy0xLTEtMS0yNjQ0Ng_cedf198a-7e09-4ca4-af52-0892d68b8cd1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestructuringCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18xNy0zLTEtMS0yNjQ0Ng_1e0664bd-b68a-4c24-8280-446cc023b459">4,439</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:RestructuringCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18xNy01LTEtMS0yNjQ0Ng_6ac585f2-0c28-46c2-8be6-95f15d93d880">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-cash operating activity expense (income)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" name="us-gaap:OtherNoncashIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18xOC0xLTEtMS0yNjQ1MA_1bc4e43a-f57f-4f3f-bf83-73541b85d174">123</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" name="us-gaap:OtherNoncashIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18xOC0zLTEtMS0yNjQ1MA_0bac8268-6018-4223-9975-a01eaa2fa110">243</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" name="us-gaap:OtherNoncashIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18xOC01LTEtMS0yNjQ1MA_70afb9d6-6cd3-4c07-b0b2-574698b5a894">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net changes in non-cash working capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOperatingCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18xOS0yLTEtMS0xOTg2OA_a01f998c-c201-49d5-b845-92e30e310f85">33,943</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOperatingCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18xOS00LTEtMS0xOTg2OA_bd26ad3f-56a2-4856-aa4f-2c793cdd7cf9">54,208</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOperatingCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18xOS02LTEtMS0xOTg2OA_c14b8251-5066-4e06-9159-faea425c8d20">3,662</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by (used in) operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18yMC0yLTEtMS0xOTg2OA_c3cea6ac-a870-4a85-8af2-b43b9ced28b2">142,457</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18yMC00LTEtMS0xOTg2OA_9575c75d-57f0-4c00-ad36-348d291c9047">130,274</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18yMC02LTEtMS0xOTg2OA_f782b2cf-9e62-42e7-b419-7f28e2cdc800">7,517</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from (purchase of) short-term investments, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18yMi0yLTEtMS0xOTg2OA_6955a041-fc7f-40c0-b74d-4c766dfc8c70">95,404</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireMarketableSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18yMi00LTEtMS0xOTg2OA_81f20b4d-c3cb-46e0-b799-e1239f38e617">299,923</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireMarketableSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18yMi02LTEtMS0xOTg2OA_38b04a66-60d7-4cc1-8711-0b91e626c463">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments in equity accounted investees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18yNC0yLTEtMS0xOTg2OA_553184d6-02e6-4886-9e2e-4d15d8d6ab0c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18yNC00LTEtMS0xOTg2OA_48b383da-d189-4315-a8b8-42dfc2ac1ac2">1,658</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18yNC02LTEtMS0xOTg2OA_d37e41c7-b1a0-4539-ade8-870e4df8b5e8">480</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from sale of other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="cron:ProceedsFromEquitySecuritiesFVNIAndEquitySecuritiesWithoutDeterminableFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18yNS0yLTEtMS0xOTg2OA_e1e4f467-fab1-4675-818e-4ba2d012d0f8">4,789</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="cron:ProceedsFromEquitySecuritiesFVNIAndEquitySecuritiesWithoutDeterminableFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18yNS00LTEtMS0xOTg2OA_357240a9-7d85-403c-8f92-2025c43d22fb">19,614</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" name="cron:ProceedsFromEquitySecuritiesFVNIAndEquitySecuritiesWithoutDeterminableFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18yNS02LTEtMS0xOTg2OA_004c2134-6e36-4aa0-8185-04347d3fea27">747</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Advances to joint ventures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireInterestInJointVenture" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18yNi0yLTEtMS0xOTg2OA_7cca458b-8ee1-42fa-b64f-0f9c61cb7ef3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireInterestInJointVenture" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18yNi00LTEtMS0xOTg2OA_59a1fa5c-bd05-4922-bb6c-80a9698f8fad">15,135</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireInterestInJointVenture" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18yNi02LTEtMS0xOTg2OA_277587e5-b598-4bf5-aaff-810d8f6ac1d6">5,358</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of property, plant and equipment, net of disposals</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18yNy0yLTEtMS0xOTg2OA_8c383f45-5463-43ca-b921-bcf2e4017b2b">31,412</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18yNy00LTEtMS0xOTg2OA_af9cf4a3-850b-4212-b7fb-58b81c9fc7e3">38,664</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18yNy02LTEtMS0xOTg2OA_6f55dedf-8cbc-4c6b-9320-dbf32132fac5">88,308</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18yOC0yLTEtMS0xOTg2OA_26517278-3999-4f8d-8770-ed9680a43d8c">3,979</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsToAcquireIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18yOC00LTEtMS0xOTg2OA_513968f1-33c8-45e3-80bd-643c3a6e17e7">289</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" name="us-gaap:PaymentsToAcquireIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18yOC02LTEtMS0xOTg2OA_5a1e21f0-7799-470f-8a1e-d7fb080b4b17">278</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition of Redwood</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18yOS0yLTEtMS0xOTg2OA_a6e84014-e580-4d0b-858b-c244129e798d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18yOS00LTEtMS0xOTg2OA_71f31643-44ed-4cff-a9bc-10976d9be568">224,295</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18yOS02LTEtMS0xOTg2OA_0f6ae20c-fb64-4e2d-aa99-270e63e8c4a0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Advances on loans receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireLoansReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18zMC0yLTEtMS0xOTg2OA_cdc46be5-3cfe-4a66-bc78-2fcd5e841a94">44,652</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireLoansReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18zMC00LTEtMS0xOTg2OA_4ed85ddc-6f61-4cfa-8148-930e56ebd854">43,337</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireLoansReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18zMC02LTEtMS0xOTg2OA_50014830-c5a7-4cc2-9e74-c2e232c5cb49">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-cash investing activity expense (income)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18zMS0yLTEtMS0xOTg2OA_44e52087-afae-4f4d-813f-b56753b5639e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18zMS00LTEtMS0xOTg2OA_a0471e11-5597-4d45-9b6c-07a0335a55f6">415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18zMS02LTEtMS0xOTg2OA_9b964c4a-34cc-49d4-897f-a0afdc6a9aa5">231</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by (used in) investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18zNS0yLTEtMS0xOTg2OA_3ca39580-9fa0-4a79-8120-cf7296b900f4">20,150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18zNS00LTEtMS0xOTg2OA_38c5c6e1-64f8-4e3e-b807-637b2991ba26">603,272</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18zNS02LTEtMS0xOTg2OA_b35e2a8d-cfc9-4657-88ad-ed7521e16669">93,908</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Financing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Advance to non-controlling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToMinorityShareholders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18zMy0xLTEtMS0yNjQ5NQ_21d22220-7f45-4eec-a5a7-1ea968da3d62">1,019</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsToMinorityShareholders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18zMy0zLTEtMS0yNjQ5NQ_3504c22b-f9ca-4578-a902-8d6337c292f0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsToMinorityShareholders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18zMy01LTEtMS0yNjQ5NQ_2e5548bd-7488-4106-b77c-8f4eba83a832">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayment of lease obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="cron:PaymentsForLeaseObligationsFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18zNC0xLTEtMS0yNjQ5NQ_881b41fe-2302-467d-aa3a-e3a05ce65d83">2,414</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" name="cron:PaymentsForLeaseObligationsFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18zNC0zLTEtMS0yNjQ5NQ_dc63a46a-64b0-4f25-ae03-219b27eb7724">919</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="cron:PaymentsForLeaseObligationsFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18zNC01LTEtMS0yNjQ5NQ_c487536b-d809-406b-8f44-b38dec4a66c6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Withholding taxes paid on equity awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18zNS0xLTEtMS0yNjQ5NQ_597186a6-fdb5-4cac-80ff-1b1b632fbbb4">2,148</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18zNS0zLTEtMS0yNjQ5NQ_8c05bdaa-2446-4f14-8d2a-64add38b1dcd">915</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18zNS01LTEtMS0yNjQ5NQ_3207ea2c-dc4f-4503-a6db-31852a395b6f">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from Altria Investment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e0536e1b0794acda99e2177b6ebf26b_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18zNy0yLTEtMS0xOTg2OA_6c9ff1bd-5454-4467-a61b-d88516acbbef">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7926d13ed9d346928f338c20da686971_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18zNy00LTEtMS0xOTg2OA_4c8836d5-6d92-4c24-9472-663b0c0f4e50">1,809,556</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia490cd7402e84baa81df3299a30e84ee_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18zNy02LTEtMS0xOTg2OA_15dc6f55-3e65-46c6-b416-b45953e10ed0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from exercise of Top-up Rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="cron:ProceedsFromRightExercises" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18zOC0yLTEtMS0xOTg2OA_7681a905-eb4f-43f3-9320-d38a28b2fce5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="cron:ProceedsFromRightExercises" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18zOC00LTEtMS0xOTg2OA_7220621a-44f7-4d09-ac9a-7d2a89346dd9">67,051</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="cron:ProceedsFromRightExercises" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18zOC02LTEtMS0xOTg2OA_c6620594-914a-4109-93d7-6383a7c8e05f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from exercise of warrants and options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" name="cron:ProceedsFromWarrantExercisedAndStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18zOS0yLTEtMS0xOTg2OA_7c8aea06-d350-489b-a254-2f0d0cc5d7e2">116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="cron:ProceedsFromWarrantExercisedAndStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18zOS00LTEtMS0xOTg2OA_a3ee4f70-b67f-4f7d-abe3-cff12dc5ec94">1,455</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="cron:ProceedsFromWarrantExercisedAndStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18zOS02LTEtMS0xOTg2OA_8a058ccc-9121-4dc5-808a-d4b8133dfd85">2,612</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from share issuance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb90674122f048f78e4d13f37583db9f_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY180MC0yLTEtMS0xOTg2OA_6e874e36-cd9f-43ec-bc00-ea263daade33">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id725b798c0734bb0a1f1ef33fa132b50_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY180MC00LTEtMS0xOTg2OA_9ffa5f10-7376-4c12-8332-65981cc565f5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d7cc358c6d64ac19ef8563642446a56_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY180MC02LTEtMS0xOTg2OA_70b07465-a2bd-43d0-b6b5-005af9f1cbc3">115,510</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY180MS0yLTEtMS0xOTg2OA_fea3f57e-5ede-4155-a926-dad3a0f84460">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY180MS00LTEtMS0xOTg2OA_bfdbb2a5-282c-4936-ba38-2883673e7319">3,722</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY180MS02LTEtMS0xOTg2OA_4f56738d-defc-42d5-8db7-a74aae33d7c7">7,577</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from construction loan payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromIssuanceOfSecuredDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY180Mi0yLTEtMS0xOTg2OA_e1b8f0c5-42da-477f-900e-4beafff4e57f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromIssuanceOfSecuredDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY180Mi00LTEtMS0xOTg2OA_0043ace9-2525-4423-bac0-e0d300744232">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfSecuredDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY180Mi02LTEtMS0xOTg2OA_7c5b1290-9696-42d6-a941-6b6bed45c34f">11,583</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayment of construction loan payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:RepaymentsOfSecuredDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY180My0yLTEtMS0xOTg2OA_c3437dab-fb10-4990-9b75-3a6c5afb6ed2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfSecuredDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY180My00LTEtMS0xOTg2OA_a851ef3c-6b72-4cb4-9384-5f79580ee557">15,971</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:RepaymentsOfSecuredDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY180My02LTEtMS0xOTg2OA_f32ddce7-e96d-4f3d-bfbc-359e75bc50a3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Advance under Credit Facility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromLongTermLinesOfCredit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY180NC0yLTEtMS0xOTg2OA_4e0255e1-4e2b-4a80-b478-f3a1f13b299e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromLongTermLinesOfCredit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY180NC00LTEtMS0xOTg2OA_1db93f80-da53-4317-bae3-bdd930ff8a58">48,715</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromLongTermLinesOfCredit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY180NC02LTEtMS0xOTg2OA_b21cc1ff-d939-4ceb-994a-5fc23feab307">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayment of Credit Facility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:RepaymentsOfLongTermLinesOfCredit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY180NS0yLTEtMS0xOTg2OA_831726e9-9eef-4c14-9261-69b23909b186">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLongTermLinesOfCredit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY180NS00LTEtMS0xOTg2OA_8b2eb6b7-7780-46e0-9739-489a5d77bd74">48,309</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:RepaymentsOfLongTermLinesOfCredit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY180NS02LTEtMS0xOTg2OA_9fd57494-9eec-4b85-b35c-b0c244123a35">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by (used in) financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY181MS0yLTEtMS0xOTg2OA_74a08c96-d583-4d24-8c9a-f6e2e06a2c5f">5,465</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY181MS00LTEtMS0xOTg2OA_635e22e3-9730-46bf-885f-864e8e5fd968">1,856,941</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY181MS02LTEtMS0xOTg2OA_965958bb-d2df-4d9c-b9f0-aebac75956bb">122,112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of foreign currency translation on cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY181Mi0yLTEtMS0xOTg2OA_3f4cdb2d-7add-4bae-b765-f018475fd6e8">6,102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY181Mi00LTEtMS0xOTg2OA_d1a0f27e-42c4-4a43-a915-ab0b1988db2a">52,371</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY181Mi02LTEtMS0xOTg2OA_f098a1bb-df2e-4972-b85b-e443fe491c63">4,085</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Increase in cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY181My0yLTEtMS0xOTg2OA_04dfed5e-5220-46c6-b05c-7fd03a5fa34b">121,670</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY181My00LTEtMS0xOTg2OA_8c40ae3c-8a83-4af5-9e24-84d94599faab">1,175,766</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY181My02LTEtMS0xOTg2OA_ce2fd1ce-405b-4d8b-881f-ebb703435f93">16,602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents, beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY181NC0yLTEtMS0xOTg2OA_7e32501b-a925-4a8b-8604-932df0c858b6">1,199,693</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9717dc3b24b24c93ab09a6bfa9b52c89_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY181NC00LTEtMS0xOTg2OA_9f711bc0-7c28-415d-85ab-d2ded0cb0ba6">23,927</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb4bf06122354c15966cf5343aa018a5_I20171231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY181NC02LTEtMS0xOTg2OA_0078b7dd-38d1-4e53-80f5-19f7e486162b">7,325</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents, end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY181NS0yLTEtMS0xOTg2OA_3cbddb51-2860-41ce-bd7e-cab6b414db16">1,078,023</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY181NS00LTEtMS0xOTg2OA_db85c9b7-65f1-4c68-8e58-5269c9359f24">1,199,693</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9717dc3b24b24c93ab09a6bfa9b52c89_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY181NS02LTEtMS0xOTg2OA_680b0b6f-7824-42b7-9d37-0d5d9aa440f3">23,927</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.1pt"><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGV4dHJlZ2lvbjpiMjczMTZmYzE3ZGU0Zjc0Yjg2OTI3ZDY0NTdiMzM2Nl8yMzYzOTQ5OTk5NzQzMA_8ef018ed-3e46-49d1-8159-8b1ea3a11d48" footnoteRole="http://www.xbrl.org/2003/role/footnote">Refer to Note 14 in the notes to the consolidated financial statements</ix:footnote></span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">See notes to consolidated financial statements.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><div id="i1ae9134e40e74e0aac958218112e53d4_70"></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December 31, 2020, 2019, and 2018</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for gram and share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1. <ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:NatureOfOperations" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83MC9mcmFnOjM4ZTViOTdkM2UzNzQyNmRhZjVhOGY1YmYzOGNjZWRjL3RleHRyZWdpb246MzhlNWI5N2QzZTM3NDI2ZGFmNWE4ZjViZjM4Y2NlZGNfMTY1Ng_69b0c094-4c37-4038-be6e-758520e8debe" continuedAt="i30af9964d3114b388b414041c66efee7" escape="true">Background</ix:nonNumeric></span></div><ix:continuation id="i30af9964d3114b388b414041c66efee7"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Group Inc. (&#8220;Cronos Group&#8221; or the &#8220;Company&#8221;) is incorporated in the Province of British Columbia and under the British Columbia Business Corporations Act with principal executive offices at 111 Peter St. Street, Suite 300, Toronto, Ontario, M5V 2H1. The Company&#8217;s common shares are currently listed on the Toronto Stock Exchange (&#8220;TSX&#8221;) and Nasdaq Global Market (&#8220;Nasdaq&#8221;) under the ticker symbol &#8220;CRON.&#8221;</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Group is an innovative global cannabinoid company, with international production and distribution across <ix:nonFraction unitRef="continent" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="cron:NumberOfContinentsWithInternationalProductionAndDistribution" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83MC9mcmFnOjM4ZTViOTdkM2UzNzQyNmRhZjVhOGY1YmYzOGNjZWRjL3RleHRyZWdpb246MzhlNWI5N2QzZTM3NDI2ZGFmNWE4ZjViZjM4Y2NlZGNfNjA0NzMxMzk1NTI3Mg_9156dfc0-bd1c-449b-bf96-25ce8c64105e">five</ix:nonFraction> continents. The Company is committed to building disruptive intellectual property by advancing cannabis research, technology and product development and is seeking to build an iconic brand portfolio. Cronos Group&#8217;s brand portfolio includes PEACE NATURALS&#8482;, a global wellness platform; <ix:nonFraction unitRef="brand" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="cron:NumberOfAdultuseBrands" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83MC9mcmFnOjM4ZTViOTdkM2UzNzQyNmRhZjVhOGY1YmYzOGNjZWRjL3RleHRyZWdpb246MzhlNWI5N2QzZTM3NDI2ZGFmNWE4ZjViZjM4Y2NlZGNfNjA0NzMxMzk1NTI4NQ_6a35ba44-8afe-4de3-9706-72d03884c563">two</ix:nonFraction> adult-use brands, COVE&#8482; and Spinach&#8482;; and <ix:nonFraction unitRef="brand" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="cron:NumberOfHempderivedCannabidiolPersonalCareBrands" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83MC9mcmFnOjM4ZTViOTdkM2UzNzQyNmRhZjVhOGY1YmYzOGNjZWRjL3RleHRyZWdpb246MzhlNWI5N2QzZTM3NDI2ZGFmNWE4ZjViZjM4Y2NlZGNfMjMwODk3NDQxODkzNDI_94273b9f-4d9e-422c-92b8-5cf5f8f9ce35">three</ix:nonFraction> U.S hemp-derived consumer products brands, Lord Jones&#8482;, Happy Dance&#8482; and PEACE+&#8482;.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Group has established <ix:nonFraction unitRef="venture" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="cron:NumberOfStrategicJointVentures" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83MC9mcmFnOjM4ZTViOTdkM2UzNzQyNmRhZjVhOGY1YmYzOGNjZWRjL3RleHRyZWdpb246MzhlNWI5N2QzZTM3NDI2ZGFmNWE4ZjViZjM4Y2NlZGNfNjA0NzMxMzk1NTI5OA_88966557-b3d2-4b96-8b68-6ff5e27d2b62">four</ix:nonFraction> strategic joint ventures in Canada, Israel, and Colombia. Cronos Israel (as defined herein) is consolidated for financial reporting purposes. The Company also holds approximately <ix:nonFraction unitRef="number" contextRef="i4a854431fb9b495d990aeb067616e389_I20201231" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83MC9mcmFnOjM4ZTViOTdkM2UzNzQyNmRhZjVhOGY1YmYzOGNjZWRjL3RleHRyZWdpb246MzhlNWI5N2QzZTM3NDI2ZGFmNWE4ZjViZjM4Y2NlZGNfMTE5OQ_3db40da1-a27d-400d-a774-cf8238d9853d">31</ix:nonFraction>% of the issued capital of Cronos Australia Limited (&#8220;Cronos Australia&#8221;) and accounts for its investment in Cronos Australia under the equity method of accounting. For additional discussion regarding the joint ventures and strategic investment, see Note 6.</span></div></ix:continuation><div id="i1ae9134e40e74e0aac958218112e53d4_73"></div><div style="margin-bottom:12pt;margin-top:16pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2. <ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RleHRyZWdpb246ZjIyNzhkY2ZkYzhhNDMwMmJiMzM1YWU4Mjc1OTU2NTBfMjMwODk3NDQyMjgzOTk_a40995e0-4e9e-4aaa-a5bc-58755cd277fe" continuedAt="i7c01d9988a5e4bb691dfd4cfb59ff4b5" escape="true">Summary of Significant Accounting Policies </ix:nonNumeric></span></div><ix:continuation id="i7c01d9988a5e4bb691dfd4cfb59ff4b5" continuedAt="i5dd841721999475aa580a04316d937e0"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt"><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RleHRyZWdpb246ZjIyNzhkY2ZkYzhhNDMwMmJiMzM1YWU4Mjc1OTU2NTBfMjg4MDU_3ef0284f-c561-4565-9348-275650ef7f84" continuedAt="if8adb26d7ac7421096bbde29c6d0d443" escape="true">Basis of presentation</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="if8adb26d7ac7421096bbde29c6d0d443">The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;). U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities at the dates of the consolidated financial statements and the reported amounts of net revenues and expenses during the reporting periods. The accounting policies adopted in the preparation of the consolidated financial statements were effective as of January 1, 2020.</ix:continuation> </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt"><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RleHRyZWdpb246ZjIyNzhkY2ZkYzhhNDMwMmJiMzM1YWU4Mjc1OTU2NTBfMjMwODk3NDQyMjg0MDA_9efb66ba-be80-446f-99af-7e40c2a888ca" continuedAt="i816cf1c4a8f348079b1720a6546ec96d" escape="true">Segment structure</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i816cf1c4a8f348079b1720a6546ec96d">The Company undertook a realignment of its management structure along geographic regions in September 2019. As a result, effective September 2019, the Company&#8217;s results are reported through the following operating segments: United States and Rest of World. Prior period amounts contained in these consolidated financial statements have been adjusted to conform to the new segment presentation. Refer to Note 29 for additional information.</ix:continuation> </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.91pt"><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RleHRyZWdpb246ZjIyNzhkY2ZkYzhhNDMwMmJiMzM1YWU4Mjc1OTU2NTBfMjg3ODA_cff5b2eb-97ca-41f9-9f20-27eccea0f50d" continuedAt="i42327e893a0f4d269396e80f21a1dbfd" escape="true">Basis of consolidation</ix:nonNumeric></span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i42327e893a0f4d269396e80f21a1dbfd" continuedAt="ib0023e5a965a4c12ad08c7e8be893725">The accompanying consolidated financial statements include the accounts of the Company, and all entities in which the Company has a controlling voting interest or is the primary beneficiary of a variable interest as of and for the fiscal years ended December&#160;31, 2020, December&#160;31, 2019 and December&#160;31, 2018. The Company assesses control under the variable interest entity (&#8220;VIE&#8221;) model to determine whether the Company is the primary beneficiary of that entity&#8217;s operations.&#160;If an entity is not deemed to be a VIE, the Company consolidates the entity if the Company has a controlling&#160;voting interest. Subsidiaries are fully consolidated from the date on which control is transferred to the Company. They are deconsolidated from the date that control ceases. Investments in which the Company has the ability to exercise significant influence over the operating and financial policies of the investee, but does not have control, are accounted for under the equity method of accounting.</ix:continuation> <ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RleHRyZWdpb246ZjIyNzhkY2ZkYzhhNDMwMmJiMzM1YWU4Mjc1OTU2NTBfMjg3ODU_c50b4d54-0176-4523-98ec-a41a38b0b166" continuedAt="i1dd57967ee9141278f3b91dc839a4eb9" escape="true">The Company consolidates the financial results of the following entities, which the Company controls:</ix:nonNumeric></span></div><ix:continuation id="i1dd57967ee9141278f3b91dc839a4eb9" continuedAt="i8ba30bacc4704c0b9f2107ed5a1f29a3"><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.902%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Subsidiaries </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Jurisdiction of incorporation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incorporation date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ownership interest </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Israel G.S. Cultivation Ltd.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 4, 2018</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iaedfffab0889492f9c3a60cc78052b32_D20200101-20201231" decimals="2" name="us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RhYmxlOjM4YmNjZjViZjlmYTRmYmViY2MzNDJhZjI5NzQ1N2M5L3RhYmxlcmFuZ2U6MzhiY2NmNWJmOWZhNGZiZWJjYzM0MmFmMjk3NDU3YzlfMS02LTEtMS0w_da0737b6-025f-42b4-8ea1-82a709b4ffe0">70</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Israel G.S. Manufacturing Ltd.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 4, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i842d385ef42842f5ab91f806ff707433_D20200101-20201231" decimals="2" name="us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RhYmxlOjM4YmNjZjViZjlmYTRmYmViY2MzNDJhZjI5NzQ1N2M5L3RhYmxlcmFuZ2U6MzhiY2NmNWJmOWZhNGZiZWJjYzM0MmFmMjk3NDU3YzlfMi02LTEtMS0w_0a135b97-45ba-4870-862f-fbc413862e58">90</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Israel G.S. Store Ltd.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 28, 2018</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2d2b8fcd2f794ec98a558ecf3b27cad4_D20200101-20201231" decimals="2" name="us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RhYmxlOjM4YmNjZjViZjlmYTRmYmViY2MzNDJhZjI5NzQ1N2M5L3RhYmxlcmFuZ2U6MzhiY2NmNWJmOWZhNGZiZWJjYzM0MmFmMjk3NDU3YzlfMy02LTEtMS0w_4df4cbfa-af96-465e-aaee-6b7b1f36fb5e">90</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Israel G.S. Pharmacy Ltd.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 15, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1088995f87474d32a8345b0ab39da192_D20200101-20201231" decimals="2" name="us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RhYmxlOjM4YmNjZjViZjlmYTRmYmViY2MzNDJhZjI5NzQ1N2M5L3RhYmxlcmFuZ2U6MzhiY2NmNWJmOWZhNGZiZWJjYzM0MmFmMjk3NDU3YzlfNC02LTEtMS0w_5699944c-4f85-440e-ab5f-7fe1ef485d88">90</ix:nonFraction>%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt">These Israeli entities are collectively referred to as &#8220;Cronos Israel.&#8221;</span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"><ix:continuation id="i8ba30bacc4704c0b9f2107ed5a1f29a3" continuedAt="ia9377275829f449292460c5cc42fe595">(ii)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt"><ix:continuation id="ia9377275829f449292460c5cc42fe595">&#8220;Ownership interest&#8221; is defined as the proportionate share of net income to which the Company is entitled; equity interest may differ from ownership interest as described herein.</ix:continuation> </span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December 31, 2020, 2019, and 2018</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for gram and share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div></div><ix:continuation id="i5dd841721999475aa580a04316d937e0" continuedAt="i8dd28347907d43bd96f0c3c8d276f2cf"><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib0023e5a965a4c12ad08c7e8be893725">In the consolidated statements of net income (loss) and comprehensive income (loss), the net income (loss) and comprehensive income (loss) are attributed to the equity holders of the Company and to the non-controlling interests. Non-controlling interests in the equity of Cronos Israel are presented separately in the shareholders&#8217; equity (deficit) section of the consolidated balance sheets and consolidated statements of shareholders&#8217; equity (deficit). All intercompany transactions and balances are eliminated upon consolidation.</ix:continuation></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt"><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RleHRyZWdpb246ZjIyNzhkY2ZkYzhhNDMwMmJiMzM1YWU4Mjc1OTU2NTBfMjMwODk3NDQyMjg0MDE_7e0ab65c-3498-4082-97d8-ea2c6da195ed" continuedAt="i0774118145fe4378b5c673fb7a7c156b" escape="true">Use of estimates</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i0774118145fe4378b5c673fb7a7c156b">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Significant estimates and assumptions include, among other things, valuation of derivative liabilities, fair value of assets and liabilities assumed in business combinations, impairment of goodwill, inventory write-downs, valuation allowance on deferred income tax assets and uncertain tax liabilities. Actual results could differ from those estimates.</ix:continuation> </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(e)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.91pt"><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RleHRyZWdpb246ZjIyNzhkY2ZkYzhhNDMwMmJiMzM1YWU4Mjc1OTU2NTBfMjg4MDA_cf4a76a0-f71e-4c97-b4fb-e8d9be52e3da" continuedAt="iad689f003bac4be1ab5a34a2b3339944" escape="true">Revenue recognition</ix:nonNumeric></span></div><ix:continuation id="iad689f003bac4be1ab5a34a2b3339944"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s contracts with customers for the sale of dried cannabis, cannabis oil, cannabinoid-derived products and U.S. hemp-derived personal care products consist of one performance obligation. The Company has concluded that revenue from the sale of these products should be recognized at the point in time when control is transferred to the customer, which is on shipment or delivery, depending on the contract. Revenue is recognized at the transaction price, which is the amount of consideration to which the Company expects to be entitled in exchange for transferring promised goods to a customer. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenue before excise taxes from sale of goods, as presented in the consolidated statements of net income (loss) and comprehensive income (loss), represents revenue from the sale of goods less expected price discounts, and allowances for customer returns. Net revenue before excise taxes excludes excise taxes, which the Company pays as principal and excludes duties and taxes collected on behalf of third parties. Excise taxes are a production tax classified as government remittances payable, which when applicable, become payable when a product is delivered to the customer and are not directly related to the value of revenue.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company treats shipping and handling activities as a fulfillment cost, classified as cost of sales. Accordingly, the Company accrues all fulfillment costs related to the shipping and handling of consumer goods at the time of shipment. Within the Company's Rest of World segment, dried cannabis sales outside of Canada may include profit sharing arrangements with distributors which give rise to variable consideration. If the consideration in a contract includes a variable amount, the Company estimates the amount of consideration to which it will be entitled in exchange for transferring the goods to the customer. The variable consideration is estimated as the most likely amount, based on the Company&#8217;s historical information, at contract inception.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s payment terms vary by customer and product type. For individual consumer sales, payment is due prior to the transfer of control. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company elected to treat the costs incurred to obtain a contract, primarily related to sales commissions, as an expense in the period incurred and not an asset to be capitalized, as the amortization period of the related asset would be less than one year. Accordingly, the Company will expense the costs to obtain a contract in the period incurred.</span></div></ix:continuation><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(f)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.01pt">Investments </span></div><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:ConsolidationVariableInterestEntityPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RleHRyZWdpb246ZjIyNzhkY2ZkYzhhNDMwMmJiMzM1YWU4Mjc1OTU2NTBfMjg3OTE_5a3cac76-aeb2-4667-baf8-1b62130eff97" escape="true"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Variable interest entities (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">VIE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">)</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A VIE is an entity having either a total equity investment that is insufficient to finance its activities without additional subordinated financial support or equity investors at risk that lack the ability to control the entity&#8217;s activities. Variable interests are investments or other interests that will absorb portions of a VIE&#8217;s expected losses or receive portions of the VIE&#8217;s expected residual returns. The Company evaluates whether it is the primary beneficiary of each VIE it identifies on an ongoing basis and considers the impact of any reconsideration events. The primary beneficiary is the party that has both the power to direct the activities that most significantly impact the VIE and holds a variable interest that could potentially be significant to the VIE. To make this determination the Company considers both quantitative and qualitative factors regarding the nature, size and form of its involvement with the VIE. The Company consolidates the VIE when it is determined that it is the primary beneficiary of the VIE.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:EquityMethodInvestmentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RleHRyZWdpb246ZjIyNzhkY2ZkYzhhNDMwMmJiMzM1YWU4Mjc1OTU2NTBfMjg3ODM_34005ab9-dc4a-4ec0-a1ac-8093c66a1842" escape="true"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity method investments</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for investments in companies over which it has the ability to exercise significant influence but does not hold a controlling financial interest, using the equity method. Under the equity method, the Company records its proportionate share of income or losses in the consolidated statements of net income (loss) and comprehensive income (loss). If the current fair value of an investment falls below its carrying amount, this may indicate that an impairment loss should be recorded. Any impairment losses recognized cannot be reversed in subsequent periods.</span></div></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December 31, 2020, 2019, and 2018</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for gram and share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div></div><ix:continuation id="i8dd28347907d43bd96f0c3c8d276f2cf" continuedAt="i58a782e579df4c5b8c6c7394b6eeb29f"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(g)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt"><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:InventoryPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RleHRyZWdpb246ZjIyNzhkY2ZkYzhhNDMwMmJiMzM1YWU4Mjc1OTU2NTBfMjg3OTI_bae4057e-ee39-408e-933a-95e1ed5929ec" continuedAt="if0e80dd8b4ea41f5926038f672c549b7" escape="true">Inventory</ix:nonNumeric></span></div><ix:continuation id="if0e80dd8b4ea41f5926038f672c549b7"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory is comprised of raw materials, finished goods and work-in-progress such as pre-harvested cannabis plants, by-products to be extracted, oils, gel caps, tinctures, and boxes. The costs of growing cannabis, including but not limited to labor, utilities, nutrition and irrigation, are capitalized into inventory until the time of harvest.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory is stated at the lower of cost and net realizable value, determined using weighted average cost. Cost includes expenditures directly related to manufacturing and distribution of the products. Primary costs include consumables (insect control, fertilizers, soil), packaging, shipping, direct labor, overhead, supplies and small tools, and the depreciation of manufacturing equipment and production facilities determined at normal capacity. Manufacturing overhead and related expenses include salaries, wages, employee benefits, rent, utilities, security, and property taxes.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net realizable value is defined as the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. At the end of each reporting period, the Company performs an assessment of inventory obsolescence to measure inventory at the lower of cost and net realizable value. Factors considered in the determination of obsolescence include slow-moving or non-marketable products. During the year ended December 31, 2020, we incurred significant inventory write-downs driven by pricing pressures in the marketplace and will continue assessing pricing pressures on the value of inventory at the end of each reporting period. See Note 5.</span></div></ix:continuation><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(h)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt"><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:IntangibleAssetsFiniteLivedPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RleHRyZWdpb246ZjIyNzhkY2ZkYzhhNDMwMmJiMzM1YWU4Mjc1OTU2NTBfMjMwODk3NDQyMjg0MDg_c968b03f-bb7e-4c58-ba19-23864cefd3ac" continuedAt="i48c4ee5c2d7b41958ac7adea6ef0a0c1" escape="true">Definite life intangible assets</ix:nonNumeric></span></div><ix:continuation id="i48c4ee5c2d7b41958ac7adea6ef0a0c1"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets are recorded at cost less any accumulated amortization and accumulated impairment losses. Intangible assets acquired through a business combination are measured at fair value at the acquisition date.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes certain costs incurred in connection with its enterprise software, which include external direct costs of materials and services consumed in developing or obtaining internal-use software, payroll and payroll-related costs for employees who are directly associated with and who devote time to the development of the software for the function intended. All other costs are expensed as incurred.</span></div><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RleHRyZWdpb246ZjIyNzhkY2ZkYzhhNDMwMmJiMzM1YWU4Mjc1OTU2NTBfMjg4MDI_4ecef2bf-7bc0-4cae-835a-fa3b006356c7" continuedAt="i6a7721a9845d4e4bb404cd5ae2137ef7" escape="true"><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets with finite useful lives are amortized over their estimated useful lives using the following methods and rates:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:35.617%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.608%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.638%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Method</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Straight-line</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie2c359ba7b8e4d8cbaea40e6357f543e_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RhYmxlOmYzOTZjNmQ3MzM1OTQyOWE5MDI1ZGVlMTAwNGE1NzViL3RhYmxlcmFuZ2U6ZjM5NmM2ZDczMzU5NDI5YTkwMjVkZWUxMDA0YTU3NWJfMS0zLTEtMS01OTI5_73f987dd-7d75-4432-960d-9f833dd12d0e">5</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Enterprise resource planning (&#8220;ERP&#8221;) software</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Straight-line</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i375653de490b4cb88d420b09780d16c9_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RhYmxlOmYzOTZjNmQ3MzM1OTQyOWE5MDI1ZGVlMTAwNGE1NzViL3RhYmxlcmFuZ2U6ZjM5NmM2ZDczMzU5NDI5YTkwMjVkZWUxMDA0YTU3NWJfMS0zLTEtMS0w_251fc7f7-9b4b-4f47-a94a-75ccbed82cb6">5</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Canada licenses</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Straight-line</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Useful life of corresponding facilities</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israeli codes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Straight-line</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Useful life of corresponding facilities</span></td></tr></table></div><div style="margin-bottom:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(i)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The preliminary licenses granted to Kibbutz Gan Shmuel (the Cronos Israel joint venture partner) by the Medical Cannabis&#160;Unit of the Israeli Ministry of Health in early 2017 (the &#8220;Israeli codes&#8221;) were transferred by non-controlling interests to Cronos Israel in exchange for equity interests in the Cronos Israel entities specified above.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization begins when assets become available for use. The estimated useful life, amortization method, and rate are reviewed at the end of each reporting period, with the effect of any changes in estimate being accounted for on a prospective basis.</span></div></ix:continuation><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.57pt"><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RleHRyZWdpb246ZjIyNzhkY2ZkYzhhNDMwMmJiMzM1YWU4Mjc1OTU2NTBfMjMwODk3NDQyMjg0MDc_62bab99c-bb8d-4726-96fa-98171f9bafd8" continuedAt="idd72d6ccf3ce41389db558b3d4aaa5f5" escape="true">Property, plant &amp; equipment</ix:nonNumeric></span></div><ix:continuation id="idd72d6ccf3ce41389db558b3d4aaa5f5" continuedAt="ic2a9ba9014bd4fef9283cf3ea95f3ed9"><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment are stated at cost less accumulated depreciation and accumulated impairment losses. <ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RleHRyZWdpb246ZjIyNzhkY2ZkYzhhNDMwMmJiMzM1YWU4Mjc1OTU2NTBfMjg3ODY_42099490-3b9b-4c16-b415-13c4d423fca7" continuedAt="i24c928dbb98840cbb53cdfb208529455" escape="true">Depreciation is computed using the straight-line method over the estimated useful lives of the assets as follows:</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:justify"><ix:continuation id="i24c928dbb98840cbb53cdfb208529455" continuedAt="i36eb35fa429945ed88f4bf658e4e2bea"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.927%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:54.873%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia97ce75b78b64b17b8c28f247df84a87_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RhYmxlOjY5NjExMThhNmMzOTQ2MDE5NDUzMWI0MWVmMjQyZDA4L3RhYmxlcmFuZ2U6Njk2MTExOGE2YzM5NDYwMTk0NTMxYjQxZWYyNDJkMDhfMS00LTEtMS0wL3RleHRyZWdpb246ODU4ODM2YTRmNjgxNDk1YWJlMGU3YjQwZTMzMWQ2YTJfMTIwOTQ2Mjc5MDU1NTY_2071bee5-7467-445a-bd43-5ced06460083">15</ix:nonNumeric> to <ix:nonNumeric contextRef="i2b7cbfec44e1446b940a0588b9f08928_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RhYmxlOjY5NjExMThhNmMzOTQ2MDE5NDUzMWI0MWVmMjQyZDA4L3RhYmxlcmFuZ2U6Njk2MTExOGE2YzM5NDYwMTk0NTMxYjQxZWYyNDJkMDhfMS00LTEtMS0wL3RleHRyZWdpb246ODU4ODM2YTRmNjgxNDk1YWJlMGU3YjQwZTMzMWQ2YTJfMTIwOTQ2Mjc5MDU1NjE_2787e526-ec9b-4960-99c0-11f504c7a35f">25</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and equipment</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia73a44b4f86a4aca8cc66989d375acd5_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RhYmxlOjY5NjExMThhNmMzOTQ2MDE5NDUzMWI0MWVmMjQyZDA4L3RhYmxlcmFuZ2U6Njk2MTExOGE2YzM5NDYwMTk0NTMxYjQxZWYyNDJkMDhfMi00LTEtMS0wL3RleHRyZWdpb246YTMyNTQyMDgwZjg3NDM0NGE1MmY1NDQ0ZDMwMzAxODVfMTIwOTQ2Mjc5MDU1NTM_01874a39-ad14-4819-888e-33de0b80ca95">5</ix:nonNumeric> to <ix:nonNumeric contextRef="i318609520df948a58aa2a7750e70dc8f_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RhYmxlOjY5NjExMThhNmMzOTQ2MDE5NDUzMWI0MWVmMjQyZDA4L3RhYmxlcmFuZ2U6Njk2MTExOGE2YzM5NDYwMTk0NTMxYjQxZWYyNDJkMDhfMi00LTEtMS0wL3RleHRyZWdpb246YTMyNTQyMDgwZjg3NDM0NGE1MmY1NDQ0ZDMwMzAxODVfMTIwOTQ2Mjc5MDU1NTc_19c12a16-9eae-42e5-9d93-15a8c4c69d38">7</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2fa479bb16aa46068e50c07bb76855c0_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RhYmxlOjY5NjExMThhNmMzOTQ2MDE5NDUzMWI0MWVmMjQyZDA4L3RhYmxlcmFuZ2U6Njk2MTExOGE2YzM5NDYwMTk0NTMxYjQxZWYyNDJkMDhfMy00LTEtMS0w_f750e2ae-894f-4773-8c38-da1a2e0bafb5">5</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lesser of term of lease and useful life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment under finance lease</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lesser of term of lease and useful life</span></td></tr></table></ix:continuation></div></ix:continuation></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December 31, 2020, 2019, and 2018</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for gram and share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div></div><ix:continuation id="i58a782e579df4c5b8c6c7394b6eeb29f" continuedAt="i14bf77a91c8e465a98bf7151cfa7de88"><ix:continuation id="ic2a9ba9014bd4fef9283cf3ea95f3ed9"><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When assets are disposed of, the cost and accumulated depreciation are removed from the respective accounts and any related gain or loss is recognized. Maintenance and repairs are charged to expense as incurred. Significant expenditures, which increase productivity or extend the useful life of the asset, are capitalized. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest incurred relating to construction or expansion of buildings is capitalized to construction in progress. The Company ceases the capitalization of interest when construction activities are substantially completed and the facility is available for use. At this point, construction in progress is transferred to the appropriate asset class. Available for use is defined as the point at which the related building receives the requisite regulatory licenses to (i) possess cannabis, (ii) obtain dried cannabis, fresh cannabis, cannabis plants or cannabis plant seeds by cultivating, propagating and harvesting cannabis, and (iii) produce cannabis, other than obtaining it by cultivating, propagating, or harvesting. Depreciation commences at the point the assets are available for use.</span></div></ix:continuation><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(j)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.01pt"><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:LesseeLeasesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RleHRyZWdpb246ZjIyNzhkY2ZkYzhhNDMwMmJiMzM1YWU4Mjc1OTU2NTBfMjg3OTc_3dbae194-5cc8-41ba-add7-10e988713d6c" continuedAt="icbfd7521c22143daa7bcdc62471d9185" escape="true">Leases</ix:nonNumeric></span></div><ix:continuation id="icbfd7521c22143daa7bcdc62471d9185"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company enters into leases in the normal course of business, primarily for the land-use rights, office premises, and equipment used in the production of its products. At the inception of a contract, the Company assesses whether a contract is, or contains, a lease. A contract is, or contains, a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. The Company performs an analysis over the classification of the lease agreement as either an operating lease or finance lease. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A right-of-use asset and the related lease obligation associated with the lease are recorded at the inception of the lease. The right-of-use asset&#8217;s recorded amount is based on the present value of future lease payments over the lease term at the commencement date plus any initial direct costs incurred. If the rate implicit in the lease is not readily determinable for the Company&#8217;s operating leases, an incremental borrowing rate is generally used based on information available at the lease commencement date to determine the present value of future lease payments. Subsequent changes to these lease payments due to rate updates are recorded as lease expense in the period incurred. Leases with a term of 12 months or less are not recorded on the balance sheet as a lease. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The right-of-use asset is subject to impairment testing whenever events or changes in circumstances indicate the carrying value of the asset may not be recoverable. The leased asset is amortized over the shorter of the lease term or its estimated useful life if title does not transfer to the Company, while the leased asset is depreciated in accordance with the Company&#8217;s depreciation policy if the title is to eventually transfer to the Company.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s lease agreements generally exclude non-lease components. As a result, non-lease components are accounted for separately for all classes of assets and expensed as incurred. In addition, the Company&#8217;s lease agreements do not contain any material residual value guarantees or material restrictive covenants. For finance leases, from the commencement date to the earlier of the end of the useful life of the right-of-use asset or the end of the lease term, the right-of-use asset is amortized on a straight-line basis and the interest expense is recognized on the lease liability using the effective interest method. For operating leases, lease expense is recognized on a straight-line basis over the term of the lease and presented as a single charge in the consolidated statements of net income (loss) and comprehensive income (loss).</span></div></ix:continuation><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(k)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt"><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RleHRyZWdpb246ZjIyNzhkY2ZkYzhhNDMwMmJiMzM1YWU4Mjc1OTU2NTBfMjg3ODQ_0783b822-aa28-4e33-a99a-ae3fa3e4bab1" continuedAt="id57935d2a4204a7e9d1d736104e5edf9" escape="true">Impairment of long-lived assets</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="id57935d2a4204a7e9d1d736104e5edf9" continuedAt="i471ad5fc16fd4704b3d7c9feef6dc724">The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. The Company groups assets at the lowest level for which cash flows are separately identifiable, referred to as an asset group. The Company prepares projected undiscounted cash flow analyses for each asset or asset group. If the sum of the undiscounted cash flow is less than the carrying value of the asset or asset group, an impairment loss is recognized equal to the excess of the carrying value over the fair value, if any. Impairment losses on assets held for sale are based on the fair value, less costs to sell.</ix:continuation></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i471ad5fc16fd4704b3d7c9feef6dc724">Goodwill and indefinite life intangible assets are not amortized. Goodwill and indefinite life intangible assets are reviewed for impairment annually or more frequently when events or changes in circumstances indicate that fair value of the reporting unit has been reduced to less than its carrying value. The Company performs an impairment test annually in the fourth quarter by comparing the fair value of the reporting unit with its carrying amount, including goodwill. If the fair value of the reporting unit exceeds its carrying amount, goodwill is not considered to be impaired. An impairment charge would be recognized for the amount by which the carrying amount exceeds the reporting unit&#8217;s fair value. The Company determined that it has <ix:nonFraction unitRef="reportingunit" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportingUnits" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RleHRyZWdpb246ZjIyNzhkY2ZkYzhhNDMwMmJiMzM1YWU4Mjc1OTU2NTBfNjA0NzMxMzk5MTYzMA_4b3a0281-28cc-4f45-ae23-30115329f460">two</ix:nonFraction> reporting units: the U.S. reporting unit and the Rest of World reporting unit.</ix:continuation> </span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December 31, 2020, 2019, and 2018</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for gram and share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div></div><ix:continuation id="i14bf77a91c8e465a98bf7151cfa7de88" continuedAt="i1e333479cf3f434eb322e14592996a21"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(l)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.57pt"><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RleHRyZWdpb246ZjIyNzhkY2ZkYzhhNDMwMmJiMzM1YWU4Mjc1OTU2NTBfMjg4MDM_162fd2e7-97e3-4049-9cb9-0584e6b24566" continuedAt="ie9c5ec3f55554c9ab3c89547e6bb5bd4" escape="true">Repurposing charges</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie9c5ec3f55554c9ab3c89547e6bb5bd4">The Company&#8217;s repurposing charges primarily include employee termination benefits and refurbishment costs. The recognition of repurposing charges requires the Company make certain judgments and estimates regarding the nature, timing, and amount of costs associated with the planned activity. To the extent actual results differ from estimates and assumptions, a revision to the estimated liabilities, requiring the recognition of additional repurposing charges or the reduction of liabilities already recognized may be required. At the end of each reporting period, the Company evaluates the remaining accrued balances to ensure these balances are properly stated and the utilization of the reserves are for their intended purpose in accordance with planned activity.</ix:continuation></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(m)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:21.01pt"><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:StockholdersEquityPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RleHRyZWdpb246ZjIyNzhkY2ZkYzhhNDMwMmJiMzM1YWU4Mjc1OTU2NTBfMjg3ODg_1ad41b1c-4099-4d04-84da-f8e8aca7f0ca" continuedAt="i1ab323ca1a974479aedd6f5d67c17211" escape="true">Capital stock</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i1ab323ca1a974479aedd6f5d67c17211">Capital stock is presented at the fair value at the time of issuance of the shares issued. Costs related to the issuance of shares are reported in equity, net of tax, as a deduction from the issuance proceeds.</ix:continuation></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(n)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt"><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RleHRyZWdpb246ZjIyNzhkY2ZkYzhhNDMwMmJiMzM1YWU4Mjc1OTU2NTBfMjg3ODE_5ac5e0f0-877e-4f1d-a1bd-08208dee232a" continuedAt="ia2e6bfee6d244f3c9eb58213968a3329" escape="true">Foreign currency</ix:nonNumeric></span></div><ix:continuation id="ia2e6bfee6d244f3c9eb58213968a3329"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s functional currency is the Canadian dollar (&#8220;C$&#8221;). Prior to the year ended December 31, 2019, the Company reported its financial results in C$, however following the change in the Company&#8217;s status from foreign private issuer to a United States (&#8220;U.S.&#8221;) domestic issuer, the financial results are now reported in U.S dollars (&#8220;dollars&#8221; or &#8220;$&#8221;). Functional currencies for the entities in these consolidated financial statements are their respective local currencies, including C$, Australian dollars (&#8220;A$&#8221;) and Israeli New Shekel (&#8220;ILS&#8221;). The assets and liabilities of the Company&#8217;s foreign operations are translated into dollars at the exchange rate in effect as of December&#160;31, 2020 and 2019. Transactions affecting the shareholders&#8217; equity (deficit) are translated at historical foreign exchange rates. The consolidated statements of net income (loss) and comprehensive income (loss) and the consolidated statements of cash flows of the Company&#8217;s foreign operations are translated into dollars by applying the average foreign exchange rate in effect for the reporting period. The cumulative translation adjustments (&#8220;CTA&#8221;) resulting from translating the consolidated financial statements into their dollar reporting currency are recorded in other comprehensive income (loss). </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Monetary assets and liabilities denominated in foreign currencies are translated to the functional currency by applying the foreign exchange rate in effect at the balance sheet date. Revenues and expenses are translated using the average foreign exchange rate for the reporting period. Realized and unrealized foreign currency differences are recognized in the consolidated statements of net income (loss) and comprehensive income (loss).</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transactions in foreign currencies are translated into the functional currency using the exchange rate prevailing at the date of the transaction and are recorded in other comprehensive income. Exchange differences arising from operating transactions are recorded in net income for the period.</span></div></ix:continuation><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(o)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt"><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RleHRyZWdpb246ZjIyNzhkY2ZkYzhhNDMwMmJiMzM1YWU4Mjc1OTU2NTBfMjg3OTM_6c8d0f88-1960-4533-bc35-538b0f7af52c" continuedAt="i946286f2d3ca418dadfdc81a318810d8" escape="true">Income taxes</ix:nonNumeric></span></div><ix:continuation id="i946286f2d3ca418dadfdc81a318810d8" continuedAt="i716603e006f343578ee0ab1c2830b3d8"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the liability method of accounting for income taxes, under which deferred tax assets and liabilities are recognized for the future tax consequences attributable to the differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted tax rates expected to be in effect when such assets and liabilities are recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the year that includes the enactment date. The Company determines deferred tax assets including net operating losses and liabilities, based on temporary differences between the book and tax bases of assets and liabilities. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A valuation allowance is established to reduce some or all net deferred tax assets to amounts that are more likely than not to be realized. The Company considers all available evidence, both positive and negative including past operating results, estimates of future taxable income, and the feasibility of tax planning strategies, in assessing the need for a valuation allowance. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a full valuation allowance against its net deferred tax assets, and has concluded, based on the weight of all available evidence, that it is more likely than not that the net deferred tax assets will not be realized, primarily due to the historical net operating losses. The valuation allowance against the net deferred tax assets does not in any way impact the Company&#8217;s ability to use future tax deductions such as the Company&#8217;s net operating loss carryforwards; rather, the valuation allowance indicates, according to the provisions of Accounting Standards Codification 740, Income Taxes, it is more likely than not that the deferred tax assets will not be realized. The valuation allowance that was established will be maintained until there is sufficient positive evidence to conclude that it is more likely than not that the net deferred tax assets will be realized. The Company&#8217;s income tax expense for future periods will be reduced to the extent of corresponding decreases in our valuation allowance. There is uncertainty regarding any future realization of the benefit by the Company of all or part of our net deferred tax assets.</span></div></ix:continuation></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December 31, 2020, 2019, and 2018</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for gram and share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div></div><ix:continuation id="i1e333479cf3f434eb322e14592996a21" continuedAt="if5e44ef4eca3438d911021cc76129fcf"><ix:continuation id="i716603e006f343578ee0ab1c2830b3d8"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Judgment is required to determine the recognition and measurement attributes prescribed in the accounting guidance for uncertainty in income taxes. The Company uses a two-step approach for evaluating uncertain tax positions. Step one, recognition, requires us to determine if the weight of available evidence indicates that a tax position is more likely than not to be sustained upon audit, including resolution of related appeals or litigation processes, if any. If a tax position is not considered &#8220;more likely than not&#8221; to be sustained, no benefits of the position are recognized. If we determine that a position is &#8220;more likely than not&#8221; to be sustained, then we proceed to step two, measurement, which is based on the largest amount of benefit which is more likely than not to be realized on effective settlement. This process involves estimating our actual current tax exposure, including assessing the risks associated with income tax audits, together with assessing temporary differences resulting from the different treatment of items for tax and financial reporting purposes. If actual results differ from our estimates, our net operating loss and credit carryforwards could be materially impacted in the period which such determination is made.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes uncertain income tax positions at the largest amount that is more-likely-than-not to be sustained upon examination by the relevant taxing authority. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained. Recognition or measurement is reflected in the period in which the likelihood changes. Any interest and penalties related to unrecognized tax liabilities are presented within income tax expense in the consolidated statements of net income (loss) and comprehensive income (loss). Accrued interest and penalties are included in accounts payable and other liabilities in the consolidated balance sheets.</span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(p)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt"><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RleHRyZWdpb246ZjIyNzhkY2ZkYzhhNDMwMmJiMzM1YWU4Mjc1OTU2NTBfMjg3ODk_66a550b3-ecf4-4165-9186-70a1c2291b41" continuedAt="i9006842ebc774efb987cafb04c7ed79b" escape="true">Share-based compensation</ix:nonNumeric></span></div><ix:continuation id="i9006842ebc774efb987cafb04c7ed79b"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described in more detail below, the Company has five share-based compensation plans under which awards have been made: the 2020 Omnibus Plan (as defined below), the 2018 Stock Option Plan (as defined below), the 2015 Stock Option Plan (as defined below), the Employment Inducement Award Plan #1 (the &#8220;Employment Inducement Award Plan&#8221;) and a cash-settled deferred share unit (&#8220;DSU&#8221;) plan for non-executive directors.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation consists of equity-settled share-based awards such as stock options and restricted share units (&#8220;RSUs&#8221;) that are issued to eligible employees, non-executive directors, and non-employees.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash-settled deferred share units (&#8220;DSUs&#8221;) that are issued to non-executive directors are recorded in accounts payable and other liabilities with the fair value adjustment recorded in other income (loss).</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity instruments granted are initially measured at fair value on the grant date. The fair value of the stock options are determined using the Black-Scholes option pricing model. The fair value of RSUs and DSUs are determined using the market price. This is recognized on a straight-line basis in the consolidated statements of net income (loss) and comprehensive income (loss) over the vesting period for employees, and over the contractual term for non-employees. The fair value of the payout of cash-settled DSUs is determined at each reporting date based on the fair value of the Company&#8217;s common shares at the reporting date and is recorded within other liabilities.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The related costs for all equity-settled share-based awards are reflected in additional paid-in capital until the awards are exercised. Upon exercise, shares are issued and the amount previously reflected in the additional paid-in capital is, along with any proceeds paid upon exercise, credited to share capital. Forfeitures are estimated at the time of grant, and the Company revises these estimates in subsequent periods if there is a difference in actual forfeitures and the estimates.</span></div></ix:continuation><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(q)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt"><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RleHRyZWdpb246ZjIyNzhkY2ZkYzhhNDMwMmJiMzM1YWU4Mjc1OTU2NTBfMjg3OTg_9921c5b2-3c6b-4d78-9f17-128087b45af4" continuedAt="i35fe45be59f248cf80f568fb0c8f004e" escape="true">Net earnings (loss) per share</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i35fe45be59f248cf80f568fb0c8f004e">The Company presents basic and diluted net earnings (loss) per share data for its common shares. Basic net earnings (loss) per share is calculated by dividing the profit or loss attributable to common shareholders of the Company by the weighted average number of common shares outstanding during the period. Diluted net earnings (loss) per share is determined by adjusting the profit or loss attributable to common shareholders and the weighted average number of common shares outstanding for the effects of all potentially dilutive common shares that are issuable upon exercise of warrants, stock options and the Altria Warrant (as defined below) as well as the vesting of RSUs outstanding.</ix:continuation> </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(r)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.91pt"><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RleHRyZWdpb246ZjIyNzhkY2ZkYzhhNDMwMmJiMzM1YWU4Mjc1OTU2NTBfMjg4MDQ_579eeda8-2d0c-4083-b169-9bc0a1300d5a" continuedAt="ib8873f70aceb44038aedd859b8b82252" escape="true">Cash and cash equivalents and short-term investments</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib8873f70aceb44038aedd859b8b82252" continuedAt="i40dc2e22be15493fb80cc61ee1ea824f">Cash and cash equivalents are comprised of cash and highly liquid investments that are readily convertible into known amounts of cash with original maturities of three months or less. Cash and cash equivalents include amounts held in dollars, C$ and ILS and security deposits. </ix:continuation></span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December 31, 2020, 2019, and 2018</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for gram and share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div></div><ix:continuation id="if5e44ef4eca3438d911021cc76129fcf" continuedAt="id3ead90eaa5849e290c7cd457fb6db79"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i40dc2e22be15493fb80cc61ee1ea824f">Short-term investments consist of debt securities that (i) have original maturities of greater than three months and (ii) the Company has the ability to convert into cash within one year. Short-term investments are classified as held-to-maturity.&#160;Our investments classified as held-to-maturity are recorded at cost. Interest earned on short-term investments is recorded in other receivables on the consolidated balance sheet and interest income on the consolidated statement of comprehensive income (loss). Cash inflows and outflows related to the purchase and maturity of short-term investments are classified as investing activities in the Company&#8217;s consolidated statements of cash flows.</ix:continuation></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(s)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:25.45pt"><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:DerivativesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RleHRyZWdpb246ZjIyNzhkY2ZkYzhhNDMwMmJiMzM1YWU4Mjc1OTU2NTBfMjg3Nzg_89d76e41-7e4e-4aab-bbaf-783126188ac1" continuedAt="i6b36e9305d1b463cb023a9d10f9321f4" escape="true">Derivative liabilities</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i6b36e9305d1b463cb023a9d10f9321f4" continuedAt="i3f1106023c9e4c60b532302da81d507e">For financial instruments that are not designated as hedging instruments or do not qualify for hedge accounting, changes in fair value are recorded in the consolidated statements of net income (loss) and comprehensive income (loss) each period. The Company does not enter into or hold derivative financial instruments for trading or speculative purposes. Derivative liabilities are initially recognized at fair value at the date on which the derivative contract was entered into. Any attributable transaction costs are recognized in net income (loss) as incurred. Subsequent to initial recognition, derivative liabilities are measured at fair value at each reporting date until settlement with the re-measurement gain or loss being recognized immediately in comprehensive income. </ix:continuation></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i3f1106023c9e4c60b532302da81d507e">For more details on derivative liabilities consisting of the Altria Warrant, Pre-emptive Rights, and certain Top-up Rights, see Note 14.</ix:continuation> </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(t)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.01pt"><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RleHRyZWdpb246ZjIyNzhkY2ZkYzhhNDMwMmJiMzM1YWU4Mjc1OTU2NTBfMjg3OTU_4717f049-2899-43e1-b2ce-ed91799b2e0b" continuedAt="i4b3695f0430744a09526911fd304479b" escape="true">Fair value measurements</ix:nonNumeric></span></div><ix:continuation id="i4b3695f0430744a09526911fd304479b"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value of the Company&#8217;s cash and cash equivalents, accounts receivable, other receivables, loan receivable, account payables and other liabilities and holdbacks payable approximate fair value, given their short-term nature. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Group uses a fair value hierarchy, which gives the highest priority to unadjusted quoted prices in active markets for identical assets and liabilities, noted as Level 1 measurements, and the lowest priority to unobservable inputs, noted as Level 3 measurements. The following are the three levels of inputs used to measure fair value: </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 &#8211; valuation based on quoted prices (unadjusted) in active markets for identical assets and liabilities. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 &#8211; valuation techniques based on inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 &#8211; valuation techniques using the inputs for the asset or liability that are not based on observable market data.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s policy for determining when transfers between levels of the fair value hierarchy occur is based on the date of the event or changes in circumstances that caused the transfer.</span></div></ix:continuation><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(u)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt"><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:BusinessCombinationsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RleHRyZWdpb246ZjIyNzhkY2ZkYzhhNDMwMmJiMzM1YWU4Mjc1OTU2NTBfMjg3Nzk_68246328-ec75-4c20-8bb1-d46c75ff10b6" continuedAt="i93fde341adbf4c5f8ff4f64d013224d6" escape="true">Acquisitions </ix:nonNumeric></span></div><ix:continuation id="i93fde341adbf4c5f8ff4f64d013224d6" continuedAt="i3eba9c91236546b2b931f81b2e225c1b"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accounting basis for each acquisition is dependent on whether the integrated set of assets and activities acquired constitutes a business. A business consists of inputs and processes applied to those inputs that have the ability to contribute to the creation of outputs. The cost of acquisition is allocated to the assets acquired on a relative fair value basis. No goodwill is recognized in an asset acquisition. If it is determined that a business is not acquired, the transaction is accounted for as an asset acquisition and the relevant values are finalized prior to the next reporting period. On the other hand, when a business is acquired, the acquisition method of accounting in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 805 is applied, which requires that once control of the business is obtained, the assets and liabilities of the acquired business, including amounts attributable to non-controlling interests, be recorded at their respective fair values as of the date of acquisition. Any excess of purchase consideration over the net fair value of tangible and identified intangible assets acquired less liabilities assumed is recorded as goodwill. The costs of business acquisitions, including fees for accounting, legal, professional consulting and valuation specialists, are expensed as incurred. Purchase price allocations may be preliminary and, during the measurement period not to exceed one year from the date of acquisition, changes in assumptions and estimates that result in adjustments to the fair value of assets acquired and liabilities assumed are recorded in the period the adjustments are determined.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For business combinations achieved in stages, the Company&#8217;s previously held interest in the acquiree is remeasured at its subsequent acquisition date fair value, with the resulting gain or loss recorded in the consolidated statements of net income (loss) and comprehensive income (loss). For a pre-existing relationship between the Company and acquiree that is not extinguished on the business combination, such a relationship is considered effectively settled as part of the business combination even if it is not legally cancelled. At the acquisition date, it becomes an intercompany relationship and is eliminated upon consolidation. </span></div></ix:continuation></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December 31, 2020, 2019, and 2018</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for gram and share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div></div><ix:continuation id="id3ead90eaa5849e290c7cd457fb6db79"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i3eba9c91236546b2b931f81b2e225c1b">Contingent consideration in a business combination is initially measured at fair value. Subsequently all liability classified as contingent consideration is remeasured at fair value at each reporting period until the contingency is resolved and any change in the fair value following the date of acquisition is recorded in the consolidated statements of net income (loss) and comprehensive income (loss). All equity classified as contingent consideration is not remeasured and its subsequent settlement is accounted for within equity.</ix:continuation></span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(v)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt"><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:DiscontinuedOperationsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RleHRyZWdpb246ZjIyNzhkY2ZkYzhhNDMwMmJiMzM1YWU4Mjc1OTU2NTBfMjMwODk3NDQyMjg0MDY_ada94cab-2b41-496a-8151-3fbb182c7e0f" continuedAt="i23610194d3054b328aa0fd2476f516d4" escape="true">Assets held for sale and discontinued operations</ix:nonNumeric></span></div><ix:continuation id="i23610194d3054b328aa0fd2476f516d4"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with ASC 205-20 Presentation of Financial Statements: Discontinued Operations, a disposal of a component of an entity or a group of components of an entity is required to be reported as discontinued operations if the disposal represents a strategic shift that has (or will have) a major effect on an entity&#8217;s operations and financial results when the components of an entity meet the criteria in paragraph 205-20-45-10. In the period in which the component meets held-for-sale or discontinued operations criteria the major current assets, other assets, current liabilities, and noncurrent liabilities shall be reported as components of total assets and liabilities separate from those balances of the continuing operations. At the same time, the results of all discontinued operations, less applicable income taxes (benefit), shall be reported as components of net income (loss) separate from the net income (loss) of continuing operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2020, OGBC, formerly included within the Rest of World segment, met the criteria for &#8220;held-for-sale&#8221;. As a result, the Company has reflected amounts relating to OGBC as a disposal group classified as held-for-sale on the consolidated balance sheet and included as part of discontinued operations on the consolidated statement of net income (loss) and comprehensive income (loss) for all periods presented in this Annual Report. OGBC is no longer included in the segment reporting following the reclassification to discontinued operations. The discontinued operations of OGBC are described further in Note 30.</span></div></ix:continuation></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div id="i1ae9134e40e74e0aac958218112e53d4_79"></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">3. <ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83OS9mcmFnOjBmMDBhOWRiMWRjMTQ0ZGI4Y2YxZjgzM2Q5ZmMyZmU3L3RleHRyZWdpb246MGYwMGE5ZGIxZGMxNDRkYjhjZjFmODMzZDlmYzJmZTdfNzA1MQ_0bec261c-81b1-4662-bf92-a4e609a5f0e6" continuedAt="i9c2ffa019bd74e4ca56c0df951782c84" escape="true">New Accounting Pronouncements</ix:nonNumeric></span></div><ix:continuation id="i9c2ffa019bd74e4ca56c0df951782c84" continuedAt="ic423d328755d4c4b8f73fa0f7516504e"><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83OS9mcmFnOjBmMDBhOWRiMWRjMTQ0ZGI4Y2YxZjgzM2Q5ZmMyZmU3L3RleHRyZWdpb246MGYwMGE5ZGIxZGMxNDRkYjhjZjFmODMzZDlmYzJmZTdfNzA1MA_990f48db-9ae3-4c3f-a710-78972819aa30" continuedAt="i9d64f91202924547bcbe07f8c95b0404" escape="true"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt">Adoption of new accounting pronouncements</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2020, the Company adopted ASU No. 2018-13, Disclosure Framework &#8211; Changes to the Disclosure Requirements for Fair Value Measurement (Topic 820) (&#8220;ASU No. 2018-13&#8221;). ASU No. 2018-13 adds, modifies, and removes certain fair value measurement disclosure requirements. The adoption of ASU No. 2018-13 did not have a material impact on the Company&#8217;s consolidated financial statements.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2020, the Company adopted ASU No. 2018-15, Intangibles &#8211; Goodwill and Other Internal-use-software (Subtopic 350-40): Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract (&#8220;ASU No. 2018-15&#8221;). ASU No. 2018-15 amends current guidance to align the accounting for costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing costs associated with developing or obtaining internal-use software. The guidance in ASU No. 2018-15 is effective for annual and interim periods beginning after December 15, 2019, with early adoption permitted. The adoption of ASU No. 2018-15 did not have a material impact on the Company&#8217;s consolidated financial statements.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2020, the Company adopted ASU No. 2017-04, Intangibles &#8211; Goodwill and Other (Topic 350) &#8211; Simplifying the Test for Goodwill Impairment (&#8220;ASU No. 2017-04&#8221;). ASU No. 2017-04 eliminates step 2 from the goodwill impairment test and instead requires an entity to measure the impairment of goodwill assigned to a reporting unit if the carrying value of assets and liabilities assigned to the reporting unit, including goodwill, exceeds the reporting unit&#8217;s fair value. The guidance in ASU No. 2017-04 is effective for annual and interim goodwill tests completed by the Company beginning on January 1, 2020. The adoption of ASU No. 2017-04 was applied prospectively and the Company follows a one-step model for goodwill impairment. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt">New accounting pronouncements not yet adopted</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (&#8220;ASU No. 2019-12&#8221;). ASU No. 2019-12 eliminates certain exceptions and simplifies the application of U.S. GAAP-related changes in enacted tax laws or rates and employee stock option plans. ASU No. 2019-12 is effective for annual and interim periods beginning after December 15, 2020. Early adoption is permitted. The Company has evaluated the impact of ASU No. 2019-12 and the adoption will not have a material impact on the Company&#8217;s consolidated financial statements.</span></div></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December 31, 2020, 2019, and 2018</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for gram and share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div></div><ix:continuation id="ic423d328755d4c4b8f73fa0f7516504e"><ix:continuation id="i9d64f91202924547bcbe07f8c95b0404"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the Financial Accounting Standards Board</span><span style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">issued ASU No. 2020-01, Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) (&#8220;ASU No. 2020-01&#8221;). ASU No. 2020-01 clarifies the interaction of accounting for the transition into and out of the equity method. The new standard also clarifies the accounting for measuring certain purchased options and forward contracts to acquire investments. The guidance in ASU No. 2020-01 is effective for annual and interim periods beginning after December 15, 2020. The Company has evaluated the impact of ASU No. 2020-01 and does not expect the adoption to have a material impact to the Company&#8217;s consolidated financial statements.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06, Debt &#8211;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging &#8211;Contracts in Entity&#8217;s Own Equity (Subtopic 815&#8211;40) (&#8220;ASU No. 2020-06&#8221;). ASU No. 2020-06 simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity&#8217;s own equity. ASU No 2020-06 is part of the FASB&#8217;s simplification initiative, which aims to reduce unnecessary complexity in U.S. GAAP. ASU No 2020-06 is effective for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years. The Company is currently evaluating the impact of ASU No. 2020-06 on its consolidated financial statements and related disclosures.</span></div></ix:continuation></ix:continuation><div style="margin-bottom:6pt;text-align:justify"><span><br/></span></div><div id="i1ae9134e40e74e0aac958218112e53d4_82"></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">4. <ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF84Mi9mcmFnOjVkMDliOTI5NmJhMTQ5ZGFhMjFiMDExZGFkMWJiOTQxL3RleHRyZWdpb246NWQwOWI5Mjk2YmExNDlkYWEyMWIwMTFkYWQxYmI5NDFfMTgxNw_793015d7-656a-4a7b-8862-07eb5e286de4" continuedAt="i515626a24d9b408b94a15abe2a9e5a34" escape="true">Revenues from Contracts with Customers</ix:nonNumeric></span></div><ix:continuation id="i515626a24d9b408b94a15abe2a9e5a34" continuedAt="id87be29e0dd4401f88cb01057e312309"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Group disaggregates net revenues based on product type. For further discussion, see Note 29. Receivables were $<ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF84Mi9mcmFnOjVkMDliOTI5NmJhMTQ5ZGFhMjFiMDExZGFkMWJiOTQxL3RleHRyZWdpb246NWQwOWI5Mjk2YmExNDlkYWEyMWIwMTFkYWQxYmI5NDFfNTQ2_6acc01e1-bf62-4db1-8c04-91e8e4eaa4db">8,928</ix:nonFraction> at December&#160;31, 2020 (December&#160;31, 2019 &#8211; $<ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF84Mi9mcmFnOjVkMDliOTI5NmJhMTQ5ZGFhMjFiMDExZGFkMWJiOTQxL3RleHRyZWdpb246NWQwOWI5Mjk2YmExNDlkYWEyMWIwMTFkYWQxYmI5NDFfNTY0_16b23a01-7ea1-43c3-9c04-ab0c232107a2">4,638</ix:nonFraction>). The Company recorded a current expected credit loss allowance of $<ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF84Mi9mcmFnOjVkMDliOTI5NmJhMTQ5ZGFhMjFiMDExZGFkMWJiOTQxL3RleHRyZWdpb246NWQwOWI5Mjk2YmExNDlkYWEyMWIwMTFkYWQxYmI5NDFfNjAw_a4507069-02ab-457d-b655-27abf8dbbd61">74</ix:nonFraction> as of December&#160;31, 2020 (December&#160;31, 2019 &#8211; $<ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF84Mi9mcmFnOjVkMDliOTI5NmJhMTQ5ZGFhMjFiMDExZGFkMWJiOTQxL3RleHRyZWdpb246NWQwOWI5Mjk2YmExNDlkYWEyMWIwMTFkYWQxYmI5NDFfNjIy_56892b36-c29d-4c8a-b883-256b61076a0e">136</ix:nonFraction>). </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Group offers discounts to customers for prompt payment and calculates cash discounts as a percentage of the list price based on historical experience and agreed-upon payment terms. Cronos Group records an allowance for cash discounts, which is included as a contra-asset against receivables on the Company&#8217;s consolidated balance sheets.</span></div></ix:continuation><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="id87be29e0dd4401f88cb01057e312309">Revenue is measured net of returns. As a result, the Company is required to estimate the amount of returns based on the historical data by customer and product type, adjusted for forward-looking information. This is included as a provision against accounts receivable on the Company&#8217;s consolidated balance sheets. The Company estimates sales returns based principally on historical volume and return rates, as a reduction to revenues. The difference between actual sales and estimated sales returns is recorded in the period in which the actual amounts become known. These differences, if any, have not had a material impact on the Company&#8217;s consolidated financial statements. Upon return, products can be extracted from dried cannabis, resold, or destroyed depending on the nature of the product. The Company has assessed that the amount recoverable is immaterial.</ix:continuation> </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div id="i1ae9134e40e74e0aac958218112e53d4_85"></div><div style="margin-bottom:12pt;margin-top:16pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">5. <ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:InventoryDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF84NS9mcmFnOmJjODJkMDI0NTEyMDRlZDA4ODFjMzEzODVhOWJkMDk4L3RleHRyZWdpb246YmM4MmQwMjQ1MTIwNGVkMDg4MWMzMTM4NWE5YmQwOThfNDQz_2c3aa465-7435-41f7-a111-8a24b8fa9a2a" continuedAt="ie4369b640fd0416494906804492d28c6" escape="true">Inventory</ix:nonNumeric></span></div><ix:continuation id="ie4369b640fd0416494906804492d28c6"><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF84NS9mcmFnOmJjODJkMDI0NTEyMDRlZDA4ODFjMzEzODVhOWJkMDk4L3RleHRyZWdpb246YmM4MmQwMjQ1MTIwNGVkMDg4MWMzMTM4NWE5YmQwOThfNDQ0_56397b55-e6c1-4c8e-b2d6-c885fb6e7847" escape="true"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory is comprised of the following items:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.538%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.541%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF84NS9mcmFnOmJjODJkMDI0NTEyMDRlZDA4ODFjMzEzODVhOWJkMDk4L3RhYmxlOmUxZmI2MDNmYTJmNjRjY2Q5NmM2NGFkNTlhNTY2YTIxL3RhYmxlcmFuZ2U6ZTFmYjYwM2ZhMmY2NGNjZDk2YzY0YWQ1OWE1NjZhMjFfMi0zLTEtMS0w_6616b4cc-e3e2-4b54-abf3-5412456ea0e8">11,489</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF84NS9mcmFnOmJjODJkMDI0NTEyMDRlZDA4ODFjMzEzODVhOWJkMDk4L3RhYmxlOmUxZmI2MDNmYTJmNjRjY2Q5NmM2NGFkNTlhNTY2YTIxL3RhYmxlcmFuZ2U6ZTFmYjYwM2ZhMmY2NGNjZDk2YzY0YWQ1OWE1NjZhMjFfMi02LTEtMS0w_93091995-6d7e-471f-8700-4ee34ce4e7a3">2,469</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-progress &#8211; dry cannabis</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10a83eea249e41e6b2c310a65280d58b_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF84NS9mcmFnOmJjODJkMDI0NTEyMDRlZDA4ODFjMzEzODVhOWJkMDk4L3RhYmxlOmUxZmI2MDNmYTJmNjRjY2Q5NmM2NGFkNTlhNTY2YTIxL3RhYmxlcmFuZ2U6ZTFmYjYwM2ZhMmY2NGNjZDk2YzY0YWQ1OWE1NjZhMjFfMy0zLTEtMS0w_ceb93e78-78a2-4bd1-bb6e-dc59fc45235b">20,520</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96b88f05fde54eb48391a625a3fd6392_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF84NS9mcmFnOmJjODJkMDI0NTEyMDRlZDA4ODFjMzEzODVhOWJkMDk4L3RhYmxlOmUxZmI2MDNmYTJmNjRjY2Q5NmM2NGFkNTlhNTY2YTIxL3RhYmxlcmFuZ2U6ZTFmYjYwM2ZhMmY2NGNjZDk2YzY0YWQ1OWE1NjZhMjFfMy02LTEtMS0w_e0ba3923-59da-4fc3-9bf9-b3c379c137f7">11,538</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-progress &#8211; cannabis extracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i233dc0b62902408388edf4319b001461_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF84NS9mcmFnOmJjODJkMDI0NTEyMDRlZDA4ODFjMzEzODVhOWJkMDk4L3RhYmxlOmUxZmI2MDNmYTJmNjRjY2Q5NmM2NGFkNTlhNTY2YTIxL3RhYmxlcmFuZ2U6ZTFmYjYwM2ZhMmY2NGNjZDk2YzY0YWQ1OWE1NjZhMjFfNC0zLTEtMS0w_c1f84f72-56cf-4733-af82-d3a733493903">5,758</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25af40180a094722bba3ac7b711fb022_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF84NS9mcmFnOmJjODJkMDI0NTEyMDRlZDA4ODFjMzEzODVhOWJkMDk4L3RhYmxlOmUxZmI2MDNmYTJmNjRjY2Q5NmM2NGFkNTlhNTY2YTIxL3RhYmxlcmFuZ2U6ZTFmYjYwM2ZhMmY2NGNjZDk2YzY0YWQ1OWE1NjZhMjFfNC02LTEtMS0w_a086ddb9-7655-466a-b9b7-d4e5b0adcdfa">17,975</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods &#8211; dry cannabis</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10a83eea249e41e6b2c310a65280d58b_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF84NS9mcmFnOmJjODJkMDI0NTEyMDRlZDA4ODFjMzEzODVhOWJkMDk4L3RhYmxlOmUxZmI2MDNmYTJmNjRjY2Q5NmM2NGFkNTlhNTY2YTIxL3RhYmxlcmFuZ2U6ZTFmYjYwM2ZhMmY2NGNjZDk2YzY0YWQ1OWE1NjZhMjFfNS0zLTEtMS0w_85fc566d-dbdf-41cc-8655-30d3ea34ed22">4,894</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96b88f05fde54eb48391a625a3fd6392_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF84NS9mcmFnOmJjODJkMDI0NTEyMDRlZDA4ODFjMzEzODVhOWJkMDk4L3RhYmxlOmUxZmI2MDNmYTJmNjRjY2Q5NmM2NGFkNTlhNTY2YTIxL3RhYmxlcmFuZ2U6ZTFmYjYwM2ZhMmY2NGNjZDk2YzY0YWQ1OWE1NjZhMjFfNS02LTEtMS0w_eb1278e6-865f-4262-b4e6-dd9a168d119d">1,798</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods &#8211; cannabis extracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i233dc0b62902408388edf4319b001461_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF84NS9mcmFnOmJjODJkMDI0NTEyMDRlZDA4ODFjMzEzODVhOWJkMDk4L3RhYmxlOmUxZmI2MDNmYTJmNjRjY2Q5NmM2NGFkNTlhNTY2YTIxL3RhYmxlcmFuZ2U6ZTFmYjYwM2ZhMmY2NGNjZDk2YzY0YWQ1OWE1NjZhMjFfNi0zLTEtMS0w_d26326e7-f89e-40e6-a3f2-256f2365e046">1,011</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25af40180a094722bba3ac7b711fb022_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF84NS9mcmFnOmJjODJkMDI0NTEyMDRlZDA4ODFjMzEzODVhOWJkMDk4L3RhYmxlOmUxZmI2MDNmYTJmNjRjY2Q5NmM2NGFkNTlhNTY2YTIxL3RhYmxlcmFuZ2U6ZTFmYjYwM2ZhMmY2NGNjZDk2YzY0YWQ1OWE1NjZhMjFfNi02LTEtMS0w_a4e5128a-af59-4c4d-ad04-5487a5ee8dd3">2,624</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplies and consumables</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" name="us-gaap:InventorySuppliesNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF84NS9mcmFnOmJjODJkMDI0NTEyMDRlZDA4ODFjMzEzODVhOWJkMDk4L3RhYmxlOmUxZmI2MDNmYTJmNjRjY2Q5NmM2NGFkNTlhNTY2YTIxL3RhYmxlcmFuZ2U6ZTFmYjYwM2ZhMmY2NGNjZDk2YzY0YWQ1OWE1NjZhMjFfNy0zLTEtMS0w_4d6961e6-baa0-4a25-bc9a-6ea17cdaaf11">330</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventorySuppliesNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF84NS9mcmFnOmJjODJkMDI0NTEyMDRlZDA4ODFjMzEzODVhOWJkMDk4L3RhYmxlOmUxZmI2MDNmYTJmNjRjY2Q5NmM2NGFkNTlhNTY2YTIxL3RhYmxlcmFuZ2U6ZTFmYjYwM2ZhMmY2NGNjZDk2YzY0YWQ1OWE1NjZhMjFfNy02LTEtMS0w_16e5dba7-31ca-4972-9dc1-39fc18691d23">1,639</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF84NS9mcmFnOmJjODJkMDI0NTEyMDRlZDA4ODFjMzEzODVhOWJkMDk4L3RhYmxlOmUxZmI2MDNmYTJmNjRjY2Q5NmM2NGFkNTlhNTY2YTIxL3RhYmxlcmFuZ2U6ZTFmYjYwM2ZhMmY2NGNjZDk2YzY0YWQ1OWE1NjZhMjFfOC0zLTEtMS0w_4f2c1fc6-6bcd-4183-bcd3-078fccb4a632">44,002</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF84NS9mcmFnOmJjODJkMDI0NTEyMDRlZDA4ODFjMzEzODVhOWJkMDk4L3RhYmxlOmUxZmI2MDNmYTJmNjRjY2Q5NmM2NGFkNTlhNTY2YTIxL3RhYmxlcmFuZ2U6ZTFmYjYwM2ZhMmY2NGNjZDk2YzY0YWQ1OWE1NjZhMjFfOC02LTEtMS0w_6d9e7d39-4ef7-4d72-a69c-0f144989b46d">38,043</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory is written down for any obsolescence such as slow-moving or non-marketable products, or when the net realizable value of inventory is less than the carrying value. For the year ended December&#160;31, 2020, the Company recorded write-downs related to inventory of $<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryWriteDown" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF84NS9mcmFnOmJjODJkMDI0NTEyMDRlZDA4ODFjMzEzODVhOWJkMDk4L3RleHRyZWdpb246YmM4MmQwMjQ1MTIwNGVkMDg4MWMzMTM4NWE5YmQwOThfMjcw_85e3be2c-6d76-4587-9b1b-3d0ce1b17676">26,055</ix:nonFraction> (December&#160;31, 2019 &#8211; $<ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryWriteDown" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF84NS9mcmFnOmJjODJkMDI0NTEyMDRlZDA4ODFjMzEzODVhOWJkMDk4L3RleHRyZWdpb246YmM4MmQwMjQ1MTIwNGVkMDg4MWMzMTM4NWE5YmQwOThfMTI2NDQzODM3MjAwNzI_76fbdb5f-dfb4-4405-8ba4-724f2d88ce9a">29,173</ix:nonFraction>, December&#160;31, 2018 - $<ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:InventoryWriteDown" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF84NS9mcmFnOmJjODJkMDI0NTEyMDRlZDA4ODFjMzEzODVhOWJkMDk4L3RleHRyZWdpb246YmM4MmQwMjQ1MTIwNGVkMDg4MWMzMTM4NWE5YmQwOThfMTA5OTUxMTYyNzg4NzE_d4ed9ab5-efea-43c1-9542-61ea03c1e46a">nil</ix:nonFraction>) driven by pricing pressures in the Canadian marketplace. As of December&#160;31, 2020, an inventory reserve of $<ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryValuationReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF84NS9mcmFnOmJjODJkMDI0NTEyMDRlZDA4ODFjMzEzODVhOWJkMDk4L3RleHRyZWdpb246YmM4MmQwMjQ1MTIwNGVkMDg4MWMzMTM4NWE5YmQwOThfMTMxOTQxMzk1MzQxNTg_522baaac-244d-4c53-8bf2-4736773a1827">1,229</ix:nonFraction> was recorded (December&#160;31, 2019 &#8211; $<ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt-sec:numwordsen" name="us-gaap:InventoryValuationReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF84NS9mcmFnOmJjODJkMDI0NTEyMDRlZDA4ODFjMzEzODVhOWJkMDk4L3RleHRyZWdpb246YmM4MmQwMjQ1MTIwNGVkMDg4MWMzMTM4NWE5YmQwOThfMTMxOTQxMzk1MzQxODg_aa51ced2-b34d-49c3-ada5-83798a3f8a10">nil</ix:nonFraction>) in cost of sales.</span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85</span></div></div></div><div id="i1ae9134e40e74e0aac958218112e53d4_91"></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December 31, 2020, 2019, and 2018</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for gram and share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:16pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6. <ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:EquityMethodInvestmentsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RleHRyZWdpb246MjQ0MTA2MTgwYTE5NGM2YjkyYjM5ZTUwY2E2ZTMwM2ZfMjMwODk3NDQyNTgzMjg_0548d8dd-aedc-4ed9-9d99-d8b3ee01fe01" continuedAt="ia926ed9915e64f89aa632fc9c0292b74" escape="true">Investments</ix:nonNumeric></span></div><ix:continuation id="ia926ed9915e64f89aa632fc9c0292b74" continuedAt="i5eebf3debd0a4d4e812b72fcbcfb144c"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Variable Interest Entities</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds variable interests in Cronos Growing Company Inc. (&#8220;Cronos GrowCo&#8221;), Natuera S.&#224;.r.l (&#8220;Natuera&#8221;), MedMen Canada Inc. (&#8220;MedMen Canada&#8221;) and Cannasoul Lab Services Ltd. (&#8220;CLS&#8221;).</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos GrowCo is a joint venture incorporated under the Canada Business Corporations Act (&#8220;CBCA&#8221;) on June 14, 2018 with the objective of building a cannabis production greenhouse, applying for cannabis licenses under the Cannabis Act (Canada), and growing, cultivating, extracting, producing and selling cannabis in accordance with such licenses. Cronos Group holds variable interests in Cronos GrowCo through its ownership of <ix:nonFraction unitRef="number" contextRef="i9d186ec4178c4ab29fa3a2fa261a681f_D20180614-20180614" decimals="INF" name="us-gaap:VariableInterestEntityOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RleHRyZWdpb246MjQ0MTA2MTgwYTE5NGM2YjkyYjM5ZTUwY2E2ZTMwM2ZfMTI2NDQzODM3NTM0NDc_c15e6e2b-0248-4303-8024-f8fb8f086759">50</ix:nonFraction>% of Cronos GrowCo&#8217;s common shares and senior secured debt in Cronos GrowCo. Cronos GrowCo&#8217;s economic performance is driven by the quantity and strains of cannabis grown. The joint venture partners mutually determine the quantity and strains of cannabis grown.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MedMen Canada is a joint venture incorporated under the CBCA on March 13, 2018, with the objective of the retail sale and marketing of cannabis products in Canada. MedMen Canada holds the exclusive license to the MedMen brand in Canada for a minimum term of <ix:nonNumeric contextRef="i01dfe784ae954e5eabcb9849e4771b50_D20180313-20180313" format="ixt-sec:duryear" name="cron:VariableInterestEntityQualitativeOrQuantitativeInformationLicenseTerm" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RleHRyZWdpb246MjQ0MTA2MTgwYTE5NGM2YjkyYjM5ZTUwY2E2ZTMwM2ZfODI0NjMzNzI4NzE2Mg_4b7c2a4c-e940-4385-a499-e36d83d59a0e">20</ix:nonNumeric> years. Cronos holds variable interests in MedMen Canada through its ownership of <ix:nonFraction unitRef="number" contextRef="iff55fd87547140e8bb2f3c7af7f88e71_D20180313-20180313" decimals="INF" name="us-gaap:VariableInterestEntityOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RleHRyZWdpb246MjQ0MTA2MTgwYTE5NGM2YjkyYjM5ZTUwY2E2ZTMwM2ZfMTI2NDQzODM3NTM0NTY_23dc1b95-c96b-4ab5-bd2f-154fdb92e139">50</ix:nonFraction>% of MedMen Canada&#8217;s common shares and other subordinated debt in the entity. MedMen Canada&#8217;s economic performance is driven by the quantity and strains of cannabis sold. Subject to applicable law, the joint venture partners mutually determine the quantity and strains of cannabis to be sold in MedMen Canada&#8217;s retail stores, if and when stores are opened. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Natuera is a joint venture registered in Luxembourg with the objective of cultivating and commercializing medical cannabis to serve the export market. Cronos holds variable interests in Natuera through its ownership of <ix:nonFraction unitRef="number" contextRef="i08aaf1da351148dabbc15473a8372493_D20200101-20201231" decimals="INF" name="us-gaap:VariableInterestEntityOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RleHRyZWdpb246MjQ0MTA2MTgwYTE5NGM2YjkyYjM5ZTUwY2E2ZTMwM2ZfMTI2NDQzODM3NTM0NjQ_04418bbc-58ef-435c-b2d5-8176bd08b680">50</ix:nonFraction>% of Natuera&#8217;s common shares and other debt in the entity. Natuera&#8217;s economic performance is driven by the quantity and strains of cannabis to be grown. The joint venture partners mutually determine the quantity and strains of cannabis grown.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s investments in Cronos GrowCo, Natuera and MedMen Canada are exposed to economic variability from each entity&#8217;s performance; however, the Company does not consolidate the entities as it does not have the power to direct the activities that most significantly impact each entities&#8217; economic performance. Thus, Cronos Group is not considered the primary beneficiary of each entity. These investments are accounted for as equity method investments classified as &#8220;Investments in equity accounted investees&#8221; in the consolidated balance sheets.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CLS is a wholly owned subsidiary of Cannasoul Analytics Ltd., incorporated with the purpose of establishing a commercial cannabis analytical testing laboratory located on the premises of Cronos Israel (the &#8220;Cannasoul Collaboration&#8221;). Cronos Israel will advance ILS <ix:nonFraction unitRef="ils" contextRef="if0ba41d1bbbd4426a1cae1e0e667c052_I20200401" decimals="-3" format="ixt:numdotdecimal" name="cron:CollaborativeArrangementAmountOfAdvances" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RleHRyZWdpb246MjQ0MTA2MTgwYTE5NGM2YjkyYjM5ZTUwY2E2ZTMwM2ZfMTI2NDQzODM3NTM2Mjc_f14fe8dc-32f2-494c-bcb3-dfbcece41a36">8,297</ix:nonFraction> (approximately $<ix:nonFraction unitRef="usd" contextRef="if0ba41d1bbbd4426a1cae1e0e667c052_I20200401" decimals="-3" format="ixt:numdotdecimal" name="cron:CollaborativeArrangementAmountOfAdvances" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RleHRyZWdpb246MjQ0MTA2MTgwYTE5NGM2YjkyYjM5ZTUwY2E2ZTMwM2ZfMTI2NDQzODM3NTM2MzU_9e13633c-d9e6-4233-852f-a1d158770210">2,574</ix:nonFraction>) by a non-recourse loan to CLS over a period of <ix:nonNumeric contextRef="i06abbbd3d08f420c89556e2d722f7d0a_D20200101-20201231" format="ixt-sec:durwordsen" name="cron:CollaborativeArrangementTermOfAgreement" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RleHRyZWdpb246MjQ0MTA2MTgwYTE5NGM2YjkyYjM5ZTUwY2E2ZTMwM2ZfODI0NjMzNzI4NzE4MA_1705d5ce-dbb6-4538-a923-8f70a985be0f">two years</ix:nonNumeric> from April 1, 2020 for the capital and operating expenditures of the laboratory. The loan will bear interest at <ix:nonFraction unitRef="number" contextRef="ia530bf80f98848218e4aca2d29c92f27_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RleHRyZWdpb246MjQ0MTA2MTgwYTE5NGM2YjkyYjM5ZTUwY2E2ZTMwM2ZfMTI2NDQzODM3NTM0ODM_2267127f-1be6-4e55-869e-391e591b3b24">3.5</ix:nonFraction>% annually. Cronos Israel will receive <ix:nonFraction unitRef="number" contextRef="i520015d24dc64ccb873f3a7698adf8e8_I20201231" decimals="INF" name="cron:CollaborativeArrangementPercentageOfProfitsToBeReceived" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RleHRyZWdpb246MjQ0MTA2MTgwYTE5NGM2YjkyYjM5ZTUwY2E2ZTMwM2ZfMTI2NDQzODM3NTM0OTQ_142ff41d-c152-4f7e-81d5-877d039d5ca9">70</ix:nonFraction>% of the profits of the laboratory until such time as it has recovered <ix:nonFraction unitRef="number" contextRef="i520015d24dc64ccb873f3a7698adf8e8_I20201231" decimals="INF" name="cron:CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RleHRyZWdpb246MjQ0MTA2MTgwYTE5NGM2YjkyYjM5ZTUwY2E2ZTMwM2ZfODI0NjMzNzI4NzE1Ng_65632bc9-b399-4c12-b900-203e6d7cbca2">150</ix:nonFraction>% of the amounts advanced to CLS, after which time it will receive <ix:nonFraction unitRef="number" contextRef="i520015d24dc64ccb873f3a7698adf8e8_I20201231" decimals="INF" name="cron:CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RleHRyZWdpb246MjQ0MTA2MTgwYTE5NGM2YjkyYjM5ZTUwY2E2ZTMwM2ZfMTI2NDQzODM3NTM1MTk_0891c36f-b577-4ac5-8a67-9912d197945b">50</ix:nonFraction>% of the laboratory profits. As a result, the Company is exposed to economic variability from CLS&#8217;s performance. The Company does not consolidate CLS as it does not have the power to direct the activities that most significantly impact the entity&#8217;s economic performance; thus, the Company is not considered the primary beneficiary of the entity. The carrying amount of the non-recourse loan is recorded under loans receivable and the full loan amount, ILS <ix:nonFraction unitRef="ils" contextRef="if0ba41d1bbbd4426a1cae1e0e667c052_I20200401" decimals="-3" format="ixt:numdotdecimal" name="cron:CollaborativeArrangementAmountOfAdvances" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RleHRyZWdpb246MjQ0MTA2MTgwYTE5NGM2YjkyYjM5ZTUwY2E2ZTMwM2ZfMTI2NDQzODM3NTM1NDk_f14fe8dc-32f2-494c-bcb3-dfbcece41a36">8,297</ix:nonFraction>, represents the Company&#8217;s maximum potential exposure to losses through the Cannasoul Collaboration. See Note 8 for further information regarding loans receivable</span><span style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December 31, 2020, 2019, and 2018</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for gram and share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div></div><ix:continuation id="i5eebf3debd0a4d4e812b72fcbcfb144c" continuedAt="i8cd59785e1db4f31a1d3bdb4541c0b4f"><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt"><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:EquityMethodInvestmentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RleHRyZWdpb246MjQ0MTA2MTgwYTE5NGM2YjkyYjM5ZTUwY2E2ZTMwM2ZfMjMwODk3NDQyNTgzMjk_8d3d7f94-08e7-4583-becd-a70ea096f458" continuedAt="ib1fbe8398c3d4e7e9e53ab57580b4776" escape="true">Equity Method Investments</ix:nonNumeric></span></div><ix:continuation id="ib1fbe8398c3d4e7e9e53ab57580b4776"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the carrying amount of the investments in associates and joint ventures is as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.288%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.150%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.153%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ownership interest</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Amount</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos Australia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4a854431fb9b495d990aeb067616e389_I20201231" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjNhZDBkMzNmYjk0NTQ1OTI5NWJmZTc3Zjk3ODAxY2IyL3RhYmxlcmFuZ2U6M2FkMGQzM2ZiOTQ1NDU5Mjk1YmZlNzdmOTc4MDFjYjJfMi0xLTEtMS0zNjcxMw_50c14e5d-0e48-471f-b991-ec55d40644ba"><ix:nonFraction unitRef="number" contextRef="i1992c389e83f4ed89ee4289b28705c96_D20200101-20201231" decimals="2" name="us-gaap:VariableInterestEntityOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjNhZDBkMzNmYjk0NTQ1OTI5NWJmZTc3Zjk3ODAxY2IyL3RhYmxlcmFuZ2U6M2FkMGQzM2ZiOTQ1NDU5Mjk1YmZlNzdmOTc4MDFjYjJfMi0xLTEtMS0zNjcxMw_9a563966-5cc4-4086-ba1f-14a73f94058c">31</ix:nonFraction></ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a854431fb9b495d990aeb067616e389_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:EquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjNhZDBkMzNmYjk0NTQ1OTI5NWJmZTc3Zjk3ODAxY2IyL3RhYmxlcmFuZ2U6M2FkMGQzM2ZiOTQ1NDU5Mjk1YmZlNzdmOTc4MDFjYjJfMi0zLTEtMS0xNjQxMQ_6e1299cd-2bf8-4be3-b76b-4cd349ba45d0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i613b07197744400cbbef2fbf605f0d54_I20191231" decimals="-3" sign="-" name="us-gaap:EquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjNhZDBkMzNmYjk0NTQ1OTI5NWJmZTc3Zjk3ODAxY2IyL3RhYmxlcmFuZ2U6M2FkMGQzM2ZiOTQ1NDU5Mjk1YmZlNzdmOTc4MDFjYjJfMi01LTEtMS0xNjU2NA_c06a35b4-36f8-4c0b-800c-952356c2773d">346</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos GrowCo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i291f9ace020d4518924413d4644527d9_D20200101-20201231" decimals="2" name="us-gaap:VariableInterestEntityOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjNhZDBkMzNmYjk0NTQ1OTI5NWJmZTc3Zjk3ODAxY2IyL3RhYmxlcmFuZ2U6M2FkMGQzM2ZiOTQ1NDU5Mjk1YmZlNzdmOTc4MDFjYjJfMy0xLTEtMS0zNjcxMw_131ade4a-305f-4216-868e-ca581f5252a6"><ix:nonFraction unitRef="number" contextRef="ieb8971bbe440425c985b311295f2cec9_I20201231" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjNhZDBkMzNmYjk0NTQ1OTI5NWJmZTc3Zjk3ODAxY2IyL3RhYmxlcmFuZ2U6M2FkMGQzM2ZiOTQ1NDU5Mjk1YmZlNzdmOTc4MDFjYjJfMy0xLTEtMS0zNjcxMw_5a7591f4-8e6a-4273-a6b3-637caaa6f476">50</ix:nonFraction></ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb8971bbe440425c985b311295f2cec9_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjNhZDBkMzNmYjk0NTQ1OTI5NWJmZTc3Zjk3ODAxY2IyL3RhYmxlcmFuZ2U6M2FkMGQzM2ZiOTQ1NDU5Mjk1YmZlNzdmOTc4MDFjYjJfMy0zLTEtMS0xNjQxMQ_3b40ac73-f4e4-4e08-9519-f9c9e510fc73">19,235</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief35f4e5e0e14975afdc16c2f8b07671_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjNhZDBkMzNmYjk0NTQ1OTI5NWJmZTc3Zjk3ODAxY2IyL3RhYmxlcmFuZ2U6M2FkMGQzM2ZiOTQ1NDU5Mjk1YmZlNzdmOTc4MDFjYjJfMy01LTEtMS0xNjU2NA_99d4c74c-66ea-457a-bd48-427898881f31">1,501</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Natuera</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i08aaf1da351148dabbc15473a8372493_D20200101-20201231" decimals="2" name="us-gaap:VariableInterestEntityOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjNhZDBkMzNmYjk0NTQ1OTI5NWJmZTc3Zjk3ODAxY2IyL3RhYmxlcmFuZ2U6M2FkMGQzM2ZiOTQ1NDU5Mjk1YmZlNzdmOTc4MDFjYjJfNS0xLTEtMS0zNjcxNQ_abeb0b9a-c88d-4d5d-944c-a177e56c2ab7"><ix:nonFraction unitRef="number" contextRef="i578db4ab78c04e03aee4c102f9d17cfe_I20201231" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjNhZDBkMzNmYjk0NTQ1OTI5NWJmZTc3Zjk3ODAxY2IyL3RhYmxlcmFuZ2U6M2FkMGQzM2ZiOTQ1NDU5Mjk1YmZlNzdmOTc4MDFjYjJfNS0xLTEtMS0zNjcxNQ_bc0fdcd5-1b05-432a-9c93-6ca263ed7f4b">50</ix:nonFraction></ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578db4ab78c04e03aee4c102f9d17cfe_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:EquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjNhZDBkMzNmYjk0NTQ1OTI5NWJmZTc3Zjk3ODAxY2IyL3RhYmxlcmFuZ2U6M2FkMGQzM2ZiOTQ1NDU5Mjk1YmZlNzdmOTc4MDFjYjJfNS0zLTEtMS0xNjQxMQ_a4c91981-79ce-4354-8c45-fa50f18fa537">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe5479ec3fef4f42a9772f4fad66332d_I20191231" decimals="-3" sign="-" name="us-gaap:EquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjNhZDBkMzNmYjk0NTQ1OTI5NWJmZTc3Zjk3ODAxY2IyL3RhYmxlcmFuZ2U6M2FkMGQzM2ZiOTQ1NDU5Mjk1YmZlNzdmOTc4MDFjYjJfNS01LTEtMS0xNjU2NA_2e74a109-adac-4ff2-9cae-b7a8865cb58b">598</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 10pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjNhZDBkMzNmYjk0NTQ1OTI5NWJmZTc3Zjk3ODAxY2IyL3RhYmxlcmFuZ2U6M2FkMGQzM2ZiOTQ1NDU5Mjk1YmZlNzdmOTc4MDFjYjJfNi0zLTEtMS0xNjQ0Mg_7f7d7897-ffa7-4993-aecb-817555ae86e9">19,235</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" name="us-gaap:EquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjNhZDBkMzNmYjk0NTQ1OTI5NWJmZTc3Zjk3ODAxY2IyL3RhYmxlcmFuZ2U6M2FkMGQzM2ZiOTQ1NDU5Mjk1YmZlNzdmOTc4MDFjYjJfNi01LTEtMS0xNjQyOA_d2b2bc0d-2824-4a77-b5cc-8e3fa4e3353b">557</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt">On October 25, 2019, Cronos Australia issued <ix:nonFraction unitRef="shares" contextRef="i943c6ce876d74af98e5d66bae1d75dd5_D20191025-20191025" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RleHRyZWdpb246MjQ0MTA2MTgwYTE5NGM2YjkyYjM5ZTUwY2E2ZTMwM2ZfMTIwOTQ2Mjc5NTI4NTE_f6f652c6-8cc3-4a8d-b592-0bcca77bc16a">40</ix:nonFraction> million new shares in an initial public offering at an offering price of A$<ix:nonFraction unitRef="audPerShare" contextRef="iaa56b775900347199fb903e36ef60844_I20191025" decimals="INF" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RleHRyZWdpb246MjQ0MTA2MTgwYTE5NGM2YjkyYjM5ZTUwY2E2ZTMwM2ZfMTIwOTQ2Mjc5NTI5MjE_955a8811-fec1-4f9e-996d-208fb76a0d11">0.50</ix:nonFraction> per share. The Company&#8217;s ownership in Cronos Australia decreased from <ix:nonFraction unitRef="number" contextRef="i8a335245090a41f88ff82b8dceb50377_D20191106-20191106" decimals="2" name="us-gaap:VariableInterestEntityOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RleHRyZWdpb246MjQ0MTA2MTgwYTE5NGM2YjkyYjM5ZTUwY2E2ZTMwM2ZfMTIwOTQ2Mjc5NTI5OTU_b64426c9-ab79-435d-8e39-9dacb6c2bde9">50</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i958145f694ac404a80377bba4d961f2a_D20191107-20191107" decimals="2" name="us-gaap:VariableInterestEntityOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RleHRyZWdpb246MjQ0MTA2MTgwYTE5NGM2YjkyYjM5ZTUwY2E2ZTMwM2ZfMTIwOTQ2Mjc5NTMwMDI_fe2479b9-828c-4464-96b0-c84022580765">31</ix:nonFraction>% on November 7, 2019 when Cronos Australia began trading on the Australian Securities Exchange. This resulted in a reconsideration event, which required the reassessment of the Company&#8217;s variable interest entity conclusion. Upon reconsideration, the Company determined that the entity was no longer a variable interest entity as of December 31, 2019 and is now reported under the equity method.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt">On September 25, 2020, the Company and 2645485 Ontario Inc. (&#8220;Mucci&#8221;), the other joint venture partner of Cronos GrowCo, agreed to capitalize certain historical advances made by each shareholder to Cronos GrowCo. Total aggregate gross advances to Cronos GrowCo, excluding any amounts advanced by the Company to Cronos GrowCo under the GrowCo Credit Facility, were C$<ix:nonFraction unitRef="cad" contextRef="ia7faa2556fad44d4a177d4471c6fe14f_D20200925-20200925" decimals="-3" format="ixt:numdotdecimal" name="cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RleHRyZWdpb246MjQ0MTA2MTgwYTE5NGM2YjkyYjM5ZTUwY2E2ZTMwM2ZfMzg0ODI5MDc1NDA1Mg_86d69ee0-fdaf-45ea-9c8e-75a1fe9b1b7a">49,300</ix:nonFraction> ($<ix:nonFraction unitRef="usd" contextRef="ia7faa2556fad44d4a177d4471c6fe14f_D20200925-20200925" decimals="-3" format="ixt:numdotdecimal" name="cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RleHRyZWdpb246MjQ0MTA2MTgwYTE5NGM2YjkyYjM5ZTUwY2E2ZTMwM2ZfMzg0ODI5MDc1NDA1OA_cf1f3b6f-ecbf-4e2b-b51e-c856cbfbbd44">37,010</ix:nonFraction>), of which the Company advanced <ix:nonFraction unitRef="number" contextRef="iac8ed3a0468448b59a2da8d6539912f4_I20200925" decimals="INF" name="cron:InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RleHRyZWdpb246MjQ0MTA2MTgwYTE5NGM2YjkyYjM5ZTUwY2E2ZTMwM2ZfMzg0ODI5MDc1NDA5NA_90eb36f7-6357-41d1-be23-07cf2aaf3918">50</ix:nonFraction>% and Mucci advanced the remaining <ix:nonFraction unitRef="number" contextRef="i6006e9a66ec247e5977546ab36704286_I20200925" decimals="INF" name="cron:InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RleHRyZWdpb246MjQ0MTA2MTgwYTE5NGM2YjkyYjM5ZTUwY2E2ZTMwM2ZfMzg0ODI5MDc1NDEzMQ_2bf376df-711c-45c3-ae96-8b57840caabf">50</ix:nonFraction>% for an amount of C$<ix:nonFraction unitRef="cad" contextRef="ic3c92d00b15c48db9d6e48e737227b0a_D20200925-20200925" decimals="-3" format="ixt:numdotdecimal" name="cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RleHRyZWdpb246MjQ0MTA2MTgwYTE5NGM2YjkyYjM5ZTUwY2E2ZTMwM2ZfMzg0ODI5MDc1NDE1Mw_b705507c-7f8d-4460-9061-59a651068c50">24,650</ix:nonFraction> ($<ix:nonFraction unitRef="usd" contextRef="ic3c92d00b15c48db9d6e48e737227b0a_D20200925-20200925" decimals="-3" format="ixt:numdotdecimal" name="cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RleHRyZWdpb246MjQ0MTA2MTgwYTE5NGM2YjkyYjM5ZTUwY2E2ZTMwM2ZfMzg0ODI5MDc1NDE1OA_52486499-b1d9-48e3-a9b3-c978263d44cf">18,505</ix:nonFraction>) each. As a result, the Company transferred the advances of C$<ix:nonFraction unitRef="cad" contextRef="ia7faa2556fad44d4a177d4471c6fe14f_D20200925-20200925" decimals="-3" format="ixt:numdotdecimal" name="cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RleHRyZWdpb246MjQ0MTA2MTgwYTE5NGM2YjkyYjM5ZTUwY2E2ZTMwM2ZfMzg0ODI5MDc1NDIyMw_8fa7caa7-6d59-4eef-adc0-877c98bdd6ab">24,650</ix:nonFraction> ($<ix:nonFraction unitRef="usd" contextRef="ia7faa2556fad44d4a177d4471c6fe14f_D20200925-20200925" decimals="-3" format="ixt:numdotdecimal" name="cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RleHRyZWdpb246MjQ0MTA2MTgwYTE5NGM2YjkyYjM5ZTUwY2E2ZTMwM2ZfMzg0ODI5MDc1NDIyOA_b044e024-9add-43ff-8b20-103464e3dfe7">18,505</ix:nonFraction>) to investments in equity accounted investees in respect of Cronos GrowCo.</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s share of net earnings (losses) from equity investments accounted for under the equity method of accounting as of and for the years ended December&#160;31:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.816%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.820%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Whistler Medicinal Marijuana Company (&#8220;Whistler&#8221;)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9154570513a2434988aa789c0e451da8_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOmI4ZGE3MGNiOTM0ZTQyOGFiZjQzYTk4ZTJiY2FkZWZlL3RhYmxlcmFuZ2U6YjhkYTcwY2I5MzRlNDI4YWJmNDNhOThlMmJjYWRlZmVfMS0xLTEtMS0yMzY2Nw_ac7a0fc5-fa87-4135-b4bf-9b6f23af141c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i311f8f928bf84db9989bd0476ea75d2c_D20190101-20191231" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOmI4ZGE3MGNiOTM0ZTQyOGFiZjQzYTk4ZTJiY2FkZWZlL3RhYmxlcmFuZ2U6YjhkYTcwY2I5MzRlNDI4YWJmNDNhOThlMmJjYWRlZmVfMi0zLTEtMS0xNjUwNw_3af55587-6e05-41e8-a0a9-1c24a9608312">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4403f97e12eb42dd960878337546ae3b_D20180101-20181231" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOmI4ZGE3MGNiOTM0ZTQyOGFiZjQzYTk4ZTJiY2FkZWZlL3RhYmxlcmFuZ2U6YjhkYTcwY2I5MzRlNDI4YWJmNDNhOThlMmJjYWRlZmVfMS01LTEtMS0yMzY0Mw_81717c77-b183-4323-b306-5aceec97ed5d">178</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos Australia</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i295d7b236249421daadace6736fa6dc7_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOmI4ZGE3MGNiOTM0ZTQyOGFiZjQzYTk4ZTJiY2FkZWZlL3RhYmxlcmFuZ2U6YjhkYTcwY2I5MzRlNDI4YWJmNDNhOThlMmJjYWRlZmVfMi0xLTEtMS0yMzY2Nw_9266a0b1-112f-474c-ba61-b9ccb886318d">363</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5f0e3243c9c049d9bd4653b87b8b4c8a_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOmI4ZGE3MGNiOTM0ZTQyOGFiZjQzYTk4ZTJiY2FkZWZlL3RhYmxlcmFuZ2U6YjhkYTcwY2I5MzRlNDI4YWJmNDNhOThlMmJjYWRlZmVfMy0zLTEtMS0xNjUwNw_204805ce-6e55-44ec-88d1-610ce89d7da1">1,101</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4252dcfecff4dad93552572230a33b7_D20180101-20181231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOmI4ZGE3MGNiOTM0ZTQyOGFiZjQzYTk4ZTJiY2FkZWZlL3RhYmxlcmFuZ2U6YjhkYTcwY2I5MzRlNDI4YWJmNDNhOThlMmJjYWRlZmVfMi01LTEtMS0yMzY0Mw_9205be2e-7234-4da1-aff9-abfd64be637d">588</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos GrowCo</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i06e71f94f83b4681be053f1be423964a_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOmI4ZGE3MGNiOTM0ZTQyOGFiZjQzYTk4ZTJiY2FkZWZlL3RhYmxlcmFuZ2U6YjhkYTcwY2I5MzRlNDI4YWJmNDNhOThlMmJjYWRlZmVfMy0xLTEtMS0yMzY2Nw_3322863e-7dc4-4f1e-a143-166f90fb9929">1,537</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib057cdc4d573476488dcb0661bea31b4_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOmI4ZGE3MGNiOTM0ZTQyOGFiZjQzYTk4ZTJiY2FkZWZlL3RhYmxlcmFuZ2U6YjhkYTcwY2I5MzRlNDI4YWJmNDNhOThlMmJjYWRlZmVfNC0zLTEtMS0xNjUwNw_e88e38db-90b9-477f-b3a2-209d8aec7e2d">167</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idfa1e87dd5eb46d78d7da772e2d321bf_D20180101-20181231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOmI4ZGE3MGNiOTM0ZTQyOGFiZjQzYTk4ZTJiY2FkZWZlL3RhYmxlcmFuZ2U6YjhkYTcwY2I5MzRlNDI4YWJmNDNhOThlMmJjYWRlZmVfMy01LTEtMS0yMzY0Mw_be9a41b0-9313-43bc-ba74-15de472b0379">100</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedMen Canada</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i439b30240d69471792a73a83983aafc9_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOmI4ZGE3MGNiOTM0ZTQyOGFiZjQzYTk4ZTJiY2FkZWZlL3RhYmxlcmFuZ2U6YjhkYTcwY2I5MzRlNDI4YWJmNDNhOThlMmJjYWRlZmVfNC0xLTEtMS0yMzY2Nw_7067e555-e87e-475c-822a-2dc1adf0c3a9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25b4f750539544e98240240c6d96fdc8_D20190101-20191231" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOmI4ZGE3MGNiOTM0ZTQyOGFiZjQzYTk4ZTJiY2FkZWZlL3RhYmxlcmFuZ2U6YjhkYTcwY2I5MzRlNDI4YWJmNDNhOThlMmJjYWRlZmVfNS0zLTEtMS0xNjUwNw_eacb3228-9ca3-42ef-b59e-4856180c5616">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9757b53f9bf46aeb73a8053c24786e3_D20180101-20181231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOmI4ZGE3MGNiOTM0ZTQyOGFiZjQzYTk4ZTJiY2FkZWZlL3RhYmxlcmFuZ2U6YjhkYTcwY2I5MzRlNDI4YWJmNDNhOThlMmJjYWRlZmVfNC01LTEtMS0yMzY0Mw_60409f9f-c6cf-4a27-8d56-c2201bca3343">213</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Natuera</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie83a15c30f9b4a8288e090fa665f59d3_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOmI4ZGE3MGNiOTM0ZTQyOGFiZjQzYTk4ZTJiY2FkZWZlL3RhYmxlcmFuZ2U6YjhkYTcwY2I5MzRlNDI4YWJmNDNhOThlMmJjYWRlZmVfNS0xLTEtMS0yMzY2Nw_ba9bc349-5cb9-4507-99a8-3f6e3c705709">2,610</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i15402ae419444f8291523f27c01226c3_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOmI4ZGE3MGNiOTM0ZTQyOGFiZjQzYTk4ZTJiY2FkZWZlL3RhYmxlcmFuZ2U6YjhkYTcwY2I5MzRlNDI4YWJmNDNhOThlMmJjYWRlZmVfNi0zLTEtMS0xNjUwNw_d47b761a-3e9c-4f5e-92be-f808eaf74874">805</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieac8a1e4f6ea44899784210564e39358_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOmI4ZGE3MGNiOTM0ZTQyOGFiZjQzYTk4ZTJiY2FkZWZlL3RhYmxlcmFuZ2U6YjhkYTcwY2I5MzRlNDI4YWJmNDNhOThlMmJjYWRlZmVfNS01LTEtMS0yMzY0Mw_4976c0b5-38a5-45c8-8213-63439a4cee7b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOmI4ZGE3MGNiOTM0ZTQyOGFiZjQzYTk4ZTJiY2FkZWZlL3RhYmxlcmFuZ2U6YjhkYTcwY2I5MzRlNDI4YWJmNDNhOThlMmJjYWRlZmVfNi0xLTEtMS0xNjYwMA_9bf54fbb-b57b-4538-af3a-cbff0004b0ed">4,510</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOmI4ZGE3MGNiOTM0ZTQyOGFiZjQzYTk4ZTJiY2FkZWZlL3RhYmxlcmFuZ2U6YjhkYTcwY2I5MzRlNDI4YWJmNDNhOThlMmJjYWRlZmVfNy0zLTEtMS0xNjUwNw_4c551605-ace7-4100-804e-0b9b22edde25">2,009</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOmI4ZGE3MGNiOTM0ZTQyOGFiZjQzYTk4ZTJiY2FkZWZlL3RhYmxlcmFuZ2U6YjhkYTcwY2I5MzRlNDI4YWJmNDNhOThlMmJjYWRlZmVfNi01LTEtMS0xNjYwMA_c339bae8-22bd-4efd-8992-3791bf686783">723</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt">Whistler was incorporated in British Columbia, Canada and is a license holder under the Cannabis Act (Canada) with production facilities in British Columbia, Canada. The Company fully divested its investment in Whistler during 2019. See Note 7.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt">The Company&#8217;s share of accumulated net losses in excess of its equity investment in Natuera has been applied as a loss allowance on the loan receivable. See Note 8.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-9pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of financial information for the Company&#8217;s equity method investments as of and for the year ended December&#160;31:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.316%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.050%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.792%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd770601469e44b7b5851f0d7ecea847_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJhMjJmMjI1Y2UzMzQzYzJiNTEyYjIyYTVhYmZlODA2L3RhYmxlcmFuZ2U6MmEyMmYyMjVjZTMzNDNjMmI1MTJiMjJhNWFiZmU4MDZfMS0xLTEtMS0xMzk3Ng_caec4964-2b44-4652-a873-800459ac3e53">19,126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic97e88f092994ad5852be234c493283e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJhMjJmMjI1Y2UzMzQzYzJiNTEyYjIyYTVhYmZlODA2L3RhYmxlcmFuZ2U6MmEyMmYyMjVjZTMzNDNjMmI1MTJiMjJhNWFiZmU4MDZfMS0zLTEtMS0xMzk2OA_116a5646-09c3-4246-a50a-a9197351f890">23,200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c04b01268f0440ca315cf7bd0d79262_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJhMjJmMjI1Y2UzMzQzYzJiNTEyYjIyYTVhYmZlODA2L3RhYmxlcmFuZ2U6MmEyMmYyMjVjZTMzNDNjMmI1MTJiMjJhNWFiZmU4MDZfMS01LTEtMS0xMzk5MA_0bdd0808-7917-4693-82a1-5ae057d0b40f">7,121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd770601469e44b7b5851f0d7ecea847_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJhMjJmMjI1Y2UzMzQzYzJiNTEyYjIyYTVhYmZlODA2L3RhYmxlcmFuZ2U6MmEyMmYyMjVjZTMzNDNjMmI1MTJiMjJhNWFiZmU4MDZfMi0xLTEtMS0xMzk3Ng_e46f9380-3fb0-4706-bf8e-2610dd17bf78">122,099</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic97e88f092994ad5852be234c493283e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJhMjJmMjI1Y2UzMzQzYzJiNTEyYjIyYTVhYmZlODA2L3RhYmxlcmFuZ2U6MmEyMmYyMjVjZTMzNDNjMmI1MTJiMjJhNWFiZmU4MDZfMi0zLTEtMS0xMzk2OA_6883360a-649e-4409-ab84-ced1ac22a80d">76,212</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c04b01268f0440ca315cf7bd0d79262_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJhMjJmMjI1Y2UzMzQzYzJiNTEyYjIyYTVhYmZlODA2L3RhYmxlcmFuZ2U6MmEyMmYyMjVjZTMzNDNjMmI1MTJiMjJhNWFiZmU4MDZfMi01LTEtMS0xMzk5MA_91e2e1f7-9428-4464-b99c-4e122ba4bfe1">27,129</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd770601469e44b7b5851f0d7ecea847_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJhMjJmMjI1Y2UzMzQzYzJiNTEyYjIyYTVhYmZlODA2L3RhYmxlcmFuZ2U6MmEyMmYyMjVjZTMzNDNjMmI1MTJiMjJhNWFiZmU4MDZfMy0xLTEtMS0xMzk3Ng_7c6e68ca-bb33-4b14-b728-5752ade8ed26">24,223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic97e88f092994ad5852be234c493283e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJhMjJmMjI1Y2UzMzQzYzJiNTEyYjIyYTVhYmZlODA2L3RhYmxlcmFuZ2U6MmEyMmYyMjVjZTMzNDNjMmI1MTJiMjJhNWFiZmU4MDZfMy0zLTEtMS0xMzk2OA_8a3824a9-47f2-49db-8213-bf933b5db29b">52,796</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c04b01268f0440ca315cf7bd0d79262_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJhMjJmMjI1Y2UzMzQzYzJiNTEyYjIyYTVhYmZlODA2L3RhYmxlcmFuZ2U6MmEyMmYyMjVjZTMzNDNjMmI1MTJiMjJhNWFiZmU4MDZfMy01LTEtMS0xMzk5MA_5a38e201-457f-481c-a039-145643a5047f">3,746</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd770601469e44b7b5851f0d7ecea847_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJhMjJmMjI1Y2UzMzQzYzJiNTEyYjIyYTVhYmZlODA2L3RhYmxlcmFuZ2U6MmEyMmYyMjVjZTMzNDNjMmI1MTJiMjJhNWFiZmU4MDZfNC0xLTEtMS0xMzk3Ng_451125d2-182e-491d-8bad-b02ebf0b0865">76,313</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic97e88f092994ad5852be234c493283e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJhMjJmMjI1Y2UzMzQzYzJiNTEyYjIyYTVhYmZlODA2L3RhYmxlcmFuZ2U6MmEyMmYyMjVjZTMzNDNjMmI1MTJiMjJhNWFiZmU4MDZfNC0zLTEtMS0xMzk2OA_00d2b9fc-2ec9-48b4-9f3d-ba8b4cf3cca9">33,189</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c04b01268f0440ca315cf7bd0d79262_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJhMjJmMjI1Y2UzMzQzYzJiNTEyYjIyYTVhYmZlODA2L3RhYmxlcmFuZ2U6MmEyMmYyMjVjZTMzNDNjMmI1MTJiMjJhNWFiZmU4MDZfNC01LTEtMS0xMzk5MA_3860cee0-f976-44be-a5c6-6fc1678add24">13,201</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62efa1de276f4f6f96606236e0b99714_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJhMjJmMjI1Y2UzMzQzYzJiNTEyYjIyYTVhYmZlODA2L3RhYmxlcmFuZ2U6MmEyMmYyMjVjZTMzNDNjMmI1MTJiMjJhNWFiZmU4MDZfNi0xLTEtMS0xMzk3Ng_599dc544-6e17-423b-8da2-46def8cdf9ae">367</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb34982583f74b8dac9d2bae655597ac_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJhMjJmMjI1Y2UzMzQzYzJiNTEyYjIyYTVhYmZlODA2L3RhYmxlcmFuZ2U6MmEyMmYyMjVjZTMzNDNjMmI1MTJiMjJhNWFiZmU4MDZfNi0zLTEtMS0xMzk2OA_c13ed206-db9f-47f5-8a4c-47ea57c56896">52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic600db9d0b4e488aa9a037277f7ff27f_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJhMjJmMjI1Y2UzMzQzYzJiNTEyYjIyYTVhYmZlODA2L3RhYmxlcmFuZ2U6MmEyMmYyMjVjZTMzNDNjMmI1MTJiMjJhNWFiZmU4MDZfNi01LTEtMS0xMzk5MA_da2e5186-f734-407d-ad17-1fcc37e93bb3">5,344</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62efa1de276f4f6f96606236e0b99714_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJhMjJmMjI1Y2UzMzQzYzJiNTEyYjIyYTVhYmZlODA2L3RhYmxlcmFuZ2U6MmEyMmYyMjVjZTMzNDNjMmI1MTJiMjJhNWFiZmU4MDZfNy0xLTEtMS0xMzk3Ng_87abc4e1-33fd-480e-b980-63636be2a8e1">631</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb34982583f74b8dac9d2bae655597ac_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJhMjJmMjI1Y2UzMzQzYzJiNTEyYjIyYTVhYmZlODA2L3RhYmxlcmFuZ2U6MmEyMmYyMjVjZTMzNDNjMmI1MTJiMjJhNWFiZmU4MDZfNy0zLTEtMS0xMzk2OA_379509ad-a82e-4d6d-be02-ed19e19830ed">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic600db9d0b4e488aa9a037277f7ff27f_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJhMjJmMjI1Y2UzMzQzYzJiNTEyYjIyYTVhYmZlODA2L3RhYmxlcmFuZ2U6MmEyMmYyMjVjZTMzNDNjMmI1MTJiMjJhNWFiZmU4MDZfNy01LTEtMS0xMzk5MA_d5467f75-4530-4338-8989-fc746f07506d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i62efa1de276f4f6f96606236e0b99714_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJhMjJmMjI1Y2UzMzQzYzJiNTEyYjIyYTVhYmZlODA2L3RhYmxlcmFuZ2U6MmEyMmYyMjVjZTMzNDNjMmI1MTJiMjJhNWFiZmU4MDZfOC0xLTEtMS0xMzk3Ng_30fe876c-add4-409f-adcc-09d69aad3131">11,453</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icb34982583f74b8dac9d2bae655597ac_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJhMjJmMjI1Y2UzMzQzYzJiNTEyYjIyYTVhYmZlODA2L3RhYmxlcmFuZ2U6MmEyMmYyMjVjZTMzNDNjMmI1MTJiMjJhNWFiZmU4MDZfOC0zLTEtMS0xMzk2OA_e5d22221-d97d-4e83-8e06-9b7818294342">2,048</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic600db9d0b4e488aa9a037277f7ff27f_D20180101-20181231" decimals="-3" sign="-" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJhMjJmMjI1Y2UzMzQzYzJiNTEyYjIyYTVhYmZlODA2L3RhYmxlcmFuZ2U6MmEyMmYyMjVjZTMzNDNjMmI1MTJiMjJhNWFiZmU4MDZfOC01LTEtMS0xMzk5MA_abfa299b-ce45-4ec6-85a8-f0e362da8153">874</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:continuation></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December 31, 2020, 2019, and 2018</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for gram and share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div></div><ix:continuation id="i8cd59785e1db4f31a1d3bdb4541c0b4f"><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt"><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:InvestmentsInAndAdvancesToAffiliatesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RleHRyZWdpb246MjQ0MTA2MTgwYTE5NGM2YjkyYjM5ZTUwY2E2ZTMwM2ZfMjMwODk3NDQyNTgzMzE_9c8fa7c6-8496-4203-8475-a4029cda5e9f" continuedAt="idcb8509d38f6490fae9d32fcf54595b4" escape="true">Advances to Joint Ventures</ix:nonNumeric></span></div><ix:continuation id="idcb8509d38f6490fae9d32fcf54595b4"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.722%"><tr><td style="width:1.0%"></td><td style="width:47.785%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.231%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.914%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.231%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.914%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.231%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.914%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.231%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.914%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">MedMen Canada</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cronos GrowCo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cronos Australia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(iii) </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Natuera</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of January 1, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6f2e75489a8480f95612249b17b7e5d_I20191231" decimals="-3" name="us-gaap:AdvancesToAffiliate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjk4MTM3MjhjYjUzZDRjNDQ5Y2I5YWRlNjlhNjgwYWE0L3RhYmxlcmFuZ2U6OTgxMzcyOGNiNTNkNGM0NDljYjlhZGU2OWE2ODBhYTRfMS0xLTEtMS0zNjg1_8fe866a8-65f9-4f90-9eda-a43dea886451">471</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief35f4e5e0e14975afdc16c2f8b07671_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdvancesToAffiliate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjk4MTM3MjhjYjUzZDRjNDQ5Y2I5YWRlNjlhNjgwYWE0L3RhYmxlcmFuZ2U6OTgxMzcyOGNiNTNkNGM0NDljYjlhZGU2OWE2ODBhYTRfMS0zLTEtMS0zNzM1_1dd6d4a1-3a1a-4f4b-b64e-0f2f00d18874">18,966</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i613b07197744400cbbef2fbf605f0d54_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AdvancesToAffiliate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjk4MTM3MjhjYjUzZDRjNDQ5Y2I5YWRlNjlhNjgwYWE0L3RhYmxlcmFuZ2U6OTgxMzcyOGNiNTNkNGM0NDljYjlhZGU2OWE2ODBhYTRfMS01LTEtMS0zNzM1_c21d2057-a4d0-444f-9827-d55cf153f100">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe5479ec3fef4f42a9772f4fad66332d_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AdvancesToAffiliate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjk4MTM3MjhjYjUzZDRjNDQ5Y2I5YWRlNjlhNjgwYWE0L3RhYmxlcmFuZ2U6OTgxMzcyOGNiNTNkNGM0NDljYjlhZGU2OWE2ODBhYTRfMS03LTEtMS0zNzM1_b58704bd-8d29-4c0c-b6d5-afa36b079e7c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdvancesToAffiliate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjk4MTM3MjhjYjUzZDRjNDQ5Y2I5YWRlNjlhNjgwYWE0L3RhYmxlcmFuZ2U6OTgxMzcyOGNiNTNkNGM0NDljYjlhZGU2OWE2ODBhYTRfMS05LTEtMS0zMDU3_82fe49b1-3f72-403a-ac87-77162cd91946">19,437</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfer to investments in equity accounted investees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i439b30240d69471792a73a83983aafc9_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjk4MTM3MjhjYjUzZDRjNDQ5Y2I5YWRlNjlhNjgwYWE0L3RhYmxlcmFuZ2U6OTgxMzcyOGNiNTNkNGM0NDljYjlhZGU2OWE2ODBhYTRfMi0xLTEtMS0zNzM1_9a50dc32-d7a4-4a5d-8d66-fb5e4102941d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i06e71f94f83b4681be053f1be423964a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjk4MTM3MjhjYjUzZDRjNDQ5Y2I5YWRlNjlhNjgwYWE0L3RhYmxlcmFuZ2U6OTgxMzcyOGNiNTNkNGM0NDljYjlhZGU2OWE2ODBhYTRfMi0zLTEtMS0zNzM1_62d4ce26-1e54-424e-81da-f88d68078d98">18,505</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i295d7b236249421daadace6736fa6dc7_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjk4MTM3MjhjYjUzZDRjNDQ5Y2I5YWRlNjlhNjgwYWE0L3RhYmxlcmFuZ2U6OTgxMzcyOGNiNTNkNGM0NDljYjlhZGU2OWE2ODBhYTRfMi01LTEtMS0zNzM1_78eea98f-8570-4614-a087-0aa90567fb0d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie83a15c30f9b4a8288e090fa665f59d3_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjk4MTM3MjhjYjUzZDRjNDQ5Y2I5YWRlNjlhNjgwYWE0L3RhYmxlcmFuZ2U6OTgxMzcyOGNiNTNkNGM0NDljYjlhZGU2OWE2ODBhYTRfMi03LTEtMS0zNzM1_f779370f-d251-40d7-ae3c-88446e761dae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjk4MTM3MjhjYjUzZDRjNDQ5Y2I5YWRlNjlhNjgwYWE0L3RhYmxlcmFuZ2U6OTgxMzcyOGNiNTNkNGM0NDljYjlhZGU2OWE2ODBhYTRfMi05LTEtMS0zMDU3_97605353-dfb9-4741-aeeb-e9ed222b37a1">18,505</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on advances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i439b30240d69471792a73a83983aafc9_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueInterestOnAdvances" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjk4MTM3MjhjYjUzZDRjNDQ5Y2I5YWRlNjlhNjgwYWE0L3RhYmxlcmFuZ2U6OTgxMzcyOGNiNTNkNGM0NDljYjlhZGU2OWE2ODBhYTRfMy0xLTEtMS02MDMw_8e7dbfa2-2781-4e46-8be7-a602ff490ad3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06e71f94f83b4681be053f1be423964a_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueInterestOnAdvances" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjk4MTM3MjhjYjUzZDRjNDQ5Y2I5YWRlNjlhNjgwYWE0L3RhYmxlcmFuZ2U6OTgxMzcyOGNiNTNkNGM0NDljYjlhZGU2OWE2ODBhYTRfMy0zLTEtMS02MDMw_39500dc1-4b72-4d04-bbf3-e1072ac29fc2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i295d7b236249421daadace6736fa6dc7_D20200101-20201231" decimals="-3" name="cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueInterestOnAdvances" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjk4MTM3MjhjYjUzZDRjNDQ5Y2I5YWRlNjlhNjgwYWE0L3RhYmxlcmFuZ2U6OTgxMzcyOGNiNTNkNGM0NDljYjlhZGU2OWE2ODBhYTRfMy01LTEtMS02MDMw_ae0d51f0-12a3-45f9-9970-d50edaf89042">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie83a15c30f9b4a8288e090fa665f59d3_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueInterestOnAdvances" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjk4MTM3MjhjYjUzZDRjNDQ5Y2I5YWRlNjlhNjgwYWE0L3RhYmxlcmFuZ2U6OTgxMzcyOGNiNTNkNGM0NDljYjlhZGU2OWE2ODBhYTRfMy03LTEtMS02MDMw_e591def0-2730-48cf-8e47-0f0b38506b81">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" name="cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueInterestOnAdvances" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjk4MTM3MjhjYjUzZDRjNDQ5Y2I5YWRlNjlhNjgwYWE0L3RhYmxlcmFuZ2U6OTgxMzcyOGNiNTNkNGM0NDljYjlhZGU2OWE2ODBhYTRfMy05LTEtMS02MDMw_4cd5e736-f1df-4a66-be66-824fe96a278d">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advances to joint ventures recovered from (applied to) carrying amount of investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i439b30240d69471792a73a83983aafc9_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueRecoveredFromAppliedToEquityMethodInvestment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjk4MTM3MjhjYjUzZDRjNDQ5Y2I5YWRlNjlhNjgwYWE0L3RhYmxlcmFuZ2U6OTgxMzcyOGNiNTNkNGM0NDljYjlhZGU2OWE2ODBhYTRfNC0xLTEtMS02MDM0_3a689d69-76a8-404e-978e-51c25d4e014e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06e71f94f83b4681be053f1be423964a_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueRecoveredFromAppliedToEquityMethodInvestment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjk4MTM3MjhjYjUzZDRjNDQ5Y2I5YWRlNjlhNjgwYWE0L3RhYmxlcmFuZ2U6OTgxMzcyOGNiNTNkNGM0NDljYjlhZGU2OWE2ODBhYTRfNC0zLTEtMS02MDM0_a8e67c17-48b5-4765-9b58-9ddabc2dde83">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i295d7b236249421daadace6736fa6dc7_D20200101-20201231" decimals="-3" sign="-" name="cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueRecoveredFromAppliedToEquityMethodInvestment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjk4MTM3MjhjYjUzZDRjNDQ5Y2I5YWRlNjlhNjgwYWE0L3RhYmxlcmFuZ2U6OTgxMzcyOGNiNTNkNGM0NDljYjlhZGU2OWE2ODBhYTRfNC01LTEtMS02MDM0_351aec54-fb6f-4184-982f-c9bb13489e93">38</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie83a15c30f9b4a8288e090fa665f59d3_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueRecoveredFromAppliedToEquityMethodInvestment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjk4MTM3MjhjYjUzZDRjNDQ5Y2I5YWRlNjlhNjgwYWE0L3RhYmxlcmFuZ2U6OTgxMzcyOGNiNTNkNGM0NDljYjlhZGU2OWE2ODBhYTRfNC03LTEtMS02MDM0_38a8a4a9-187b-439b-a25a-288ae6efa05d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" sign="-" name="cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueRecoveredFromAppliedToEquityMethodInvestment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjk4MTM3MjhjYjUzZDRjNDQ5Y2I5YWRlNjlhNjgwYWE0L3RhYmxlcmFuZ2U6OTgxMzcyOGNiNTNkNGM0NDljYjlhZGU2OWE2ODBhYTRfNC05LTEtMS02MDM0_dcbf966f-7a62-440a-a3bf-88fa6fb9c217">38</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect from foreign exchange</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i439b30240d69471792a73a83983aafc9_D20200101-20201231" decimals="-3" sign="-" name="cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueChangesDueToCurrencyTranslation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjk4MTM3MjhjYjUzZDRjNDQ5Y2I5YWRlNjlhNjgwYWE0L3RhYmxlcmFuZ2U6OTgxMzcyOGNiNTNkNGM0NDljYjlhZGU2OWE2ODBhYTRfMy0xLTEtMS0zNzM1_2c9df658-bc58-4fe3-b04a-f01ab2dd4501">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i06e71f94f83b4681be053f1be423964a_D20200101-20201231" decimals="-3" sign="-" name="cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueChangesDueToCurrencyTranslation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjk4MTM3MjhjYjUzZDRjNDQ5Y2I5YWRlNjlhNjgwYWE0L3RhYmxlcmFuZ2U6OTgxMzcyOGNiNTNkNGM0NDljYjlhZGU2OWE2ODBhYTRfMy0zLTEtMS0zNzM1_c0f91fc8-6cfe-49a4-bbe4-807998f05e54">461</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i295d7b236249421daadace6736fa6dc7_D20200101-20201231" decimals="-3" name="cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueChangesDueToCurrencyTranslation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjk4MTM3MjhjYjUzZDRjNDQ5Y2I5YWRlNjlhNjgwYWE0L3RhYmxlcmFuZ2U6OTgxMzcyOGNiNTNkNGM0NDljYjlhZGU2OWE2ODBhYTRfMy01LTEtMS0zNzM1_c41fedcb-07de-423c-9586-0d001dfe3542">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie83a15c30f9b4a8288e090fa665f59d3_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueChangesDueToCurrencyTranslation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjk4MTM3MjhjYjUzZDRjNDQ5Y2I5YWRlNjlhNjgwYWE0L3RhYmxlcmFuZ2U6OTgxMzcyOGNiNTNkNGM0NDljYjlhZGU2OWE2ODBhYTRfMy03LTEtMS0zNzM1_a1f9c722-6be2-4194-b080-c98f151f5b46">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" sign="-" name="cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueChangesDueToCurrencyTranslation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjk4MTM3MjhjYjUzZDRjNDQ5Y2I5YWRlNjlhNjgwYWE0L3RhYmxlcmFuZ2U6OTgxMzcyOGNiNTNkNGM0NDljYjlhZGU2OWE2ODBhYTRfMy05LTEtMS0zMDU3_404b307b-0d5f-4c6b-bd2a-356d8033d3cb"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" sign="-" name="cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueChangesDueToCurrencyTranslation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjk4MTM3MjhjYjUzZDRjNDQ5Y2I5YWRlNjlhNjgwYWE0L3RhYmxlcmFuZ2U6OTgxMzcyOGNiNTNkNGM0NDljYjlhZGU2OWE2ODBhYTRfMy05LTEtMS0zMDU3_651db593-8d40-43fc-8ce2-28e6286a3e27">464</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of December&#160;31, 2020</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i056cd5603b3a4298a98af34735228c93_I20201231" decimals="-3" name="us-gaap:AdvancesToAffiliate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjk4MTM3MjhjYjUzZDRjNDQ5Y2I5YWRlNjlhNjgwYWE0L3RhYmxlcmFuZ2U6OTgxMzcyOGNiNTNkNGM0NDljYjlhZGU2OWE2ODBhYTRfNS0xLTEtMS0zMDU3_122d225d-4591-4022-9c8d-4198a424918a">467</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb8971bbe440425c985b311295f2cec9_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:AdvancesToAffiliate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjk4MTM3MjhjYjUzZDRjNDQ5Y2I5YWRlNjlhNjgwYWE0L3RhYmxlcmFuZ2U6OTgxMzcyOGNiNTNkNGM0NDljYjlhZGU2OWE2ODBhYTRfNS0zLTEtMS0zMDU3_3bf52c26-2466-4603-a7b3-1d3ec30e5820">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a854431fb9b495d990aeb067616e389_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:AdvancesToAffiliate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjk4MTM3MjhjYjUzZDRjNDQ5Y2I5YWRlNjlhNjgwYWE0L3RhYmxlcmFuZ2U6OTgxMzcyOGNiNTNkNGM0NDljYjlhZGU2OWE2ODBhYTRfNS01LTEtMS0zMDU3_7bef8842-c5db-40af-8641-4011b4d3f23f">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i578db4ab78c04e03aee4c102f9d17cfe_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:AdvancesToAffiliate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjk4MTM3MjhjYjUzZDRjNDQ5Y2I5YWRlNjlhNjgwYWE0L3RhYmxlcmFuZ2U6OTgxMzcyOGNiNTNkNGM0NDljYjlhZGU2OWE2ODBhYTRfNS03LTEtMS0zMDU3_0b37a57a-009d-4fd8-a3f5-7035c13e1621">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" name="us-gaap:AdvancesToAffiliate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjk4MTM3MjhjYjUzZDRjNDQ5Y2I5YWRlNjlhNjgwYWE0L3RhYmxlcmFuZ2U6OTgxMzcyOGNiNTNkNGM0NDljYjlhZGU2OWE2ODBhYTRfNS05LTEtMS0zMDU3_4da51fc8-5e51-421f-adcc-6509e827aa1f">467</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:29.25pt;text-align:justify;text-indent:-27pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:47.856%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.218%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.912%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.218%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.912%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.218%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.912%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.218%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.912%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.224%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">MedMen Canada</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cronos GrowCo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cronos Australia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(iii) </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Natuera</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of January 1, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec6bf60d93124adcb6973cf1ba60f17f_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdvancesToAffiliate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjIyOGFiOTgxYjEzNDRhNWRiYTllZWFjMzk3NWVkNWE4L3RhYmxlcmFuZ2U6MjI4YWI5ODFiMTM0NGE1ZGJhOWVlYWMzOTc1ZWQ1YThfNy0xLTEtMS00Njkw_ae3f67f3-423d-402f-8082-d66ff12300d1">1,244</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07f4be74463d40aebfc7310e82d1c3a4_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdvancesToAffiliate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjIyOGFiOTgxYjEzNDRhNWRiYTllZWFjMzk3NWVkNWE4L3RhYmxlcmFuZ2U6MjI4YWI5ODFiMTM0NGE1ZGJhOWVlYWMzOTc1ZWQ1YThfNy0zLTEtMS00Njkw_a0d244bb-3bc1-4f95-aef5-42fccaab3590">2,970</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc08a58aedc6433cab75cda9cb8d60e1_I20181231" decimals="-3" name="us-gaap:AdvancesToAffiliate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjIyOGFiOTgxYjEzNDRhNWRiYTllZWFjMzk3NWVkNWE4L3RhYmxlcmFuZ2U6MjI4YWI5ODFiMTM0NGE1ZGJhOWVlYWMzOTc1ZWQ1YThfNy01LTEtMS00Njkw_fe526135-ff76-4cde-9680-e4aa603abeec">475</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefbc11d906474a07a4a0e90e2eb80824_I20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:AdvancesToAffiliate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjIyOGFiOTgxYjEzNDRhNWRiYTllZWFjMzk3NWVkNWE4L3RhYmxlcmFuZ2U6MjI4YWI5ODFiMTM0NGE1ZGJhOWVlYWMzOTc1ZWQ1YThfNy03LTEtMS00Njkw_81696505-ddb8-4280-8b68-0dcdbb6329db">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9717dc3b24b24c93ab09a6bfa9b52c89_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdvancesToAffiliate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjIyOGFiOTgxYjEzNDRhNWRiYTllZWFjMzk3NWVkNWE4L3RhYmxlcmFuZ2U6MjI4YWI5ODFiMTM0NGE1ZGJhOWVlYWMzOTc1ZWQ1YThfNy05LTEtMS00Njkw_fc437a92-a568-43d0-bb60-28cf861fc38b">4,689</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advances (repayments)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i25b4f750539544e98240240c6d96fdc8_D20190101-20191231" decimals="-3" sign="-" name="cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjIyOGFiOTgxYjEzNDRhNWRiYTllZWFjMzk3NWVkNWE4L3RhYmxlcmFuZ2U6MjI4YWI5ODFiMTM0NGE1ZGJhOWVlYWMzOTc1ZWQ1YThfOC0xLTEtMS00Njkw_db446d23-53f1-4156-ac8e-88b8e47170f2">852</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib057cdc4d573476488dcb0661bea31b4_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjIyOGFiOTgxYjEzNDRhNWRiYTllZWFjMzk3NWVkNWE4L3RhYmxlcmFuZ2U6MjI4YWI5ODFiMTM0NGE1ZGJhOWVlYWMzOTc1ZWQ1YThfOC0zLTEtMS00Njkw_774e4960-c7a5-43c9-a2c4-678dde80eb92">15,494</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f0e3243c9c049d9bd4653b87b8b4c8a_D20190101-20191231" decimals="-3" name="cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjIyOGFiOTgxYjEzNDRhNWRiYTllZWFjMzk3NWVkNWE4L3RhYmxlcmFuZ2U6MjI4YWI5ODFiMTM0NGE1ZGJhOWVlYWMzOTc1ZWQ1YThfOC01LTEtMS00Njkw_3e861e5c-7d0a-471f-8412-9c7822613cac">274</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15402ae419444f8291523f27c01226c3_D20190101-20191231" decimals="-3" name="cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjIyOGFiOTgxYjEzNDRhNWRiYTllZWFjMzk3NWVkNWE4L3RhYmxlcmFuZ2U6MjI4YWI5ODFiMTM0NGE1ZGJhOWVlYWMzOTc1ZWQ1YThfOC03LTEtMS00Njkw_840e4948-5a3d-4329-8d6e-ab6d549475bc">219</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjIyOGFiOTgxYjEzNDRhNWRiYTllZWFjMzk3NWVkNWE4L3RhYmxlcmFuZ2U6MjI4YWI5ODFiMTM0NGE1ZGJhOWVlYWMzOTc1ZWQ1YThfOC05LTEtMS00Njkw_d6210d52-79ba-442f-9949-b5676484b445">15,135</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advances to joint ventures recovered from (applied to) carrying amount of investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25b4f750539544e98240240c6d96fdc8_D20190101-20191231" decimals="-3" name="cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueRecoveredFromAppliedToEquityMethodInvestment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjIyOGFiOTgxYjEzNDRhNWRiYTllZWFjMzk3NWVkNWE4L3RhYmxlcmFuZ2U6MjI4YWI5ODFiMTM0NGE1ZGJhOWVlYWMzOTc1ZWQ1YThfOS0xLTEtMS00Njkw_3dd2b08f-0444-4519-81f8-e184efb12946">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib057cdc4d573476488dcb0661bea31b4_D20190101-20191231" decimals="-3" name="cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueRecoveredFromAppliedToEquityMethodInvestment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjIyOGFiOTgxYjEzNDRhNWRiYTllZWFjMzk3NWVkNWE4L3RhYmxlcmFuZ2U6MjI4YWI5ODFiMTM0NGE1ZGJhOWVlYWMzOTc1ZWQ1YThfOS0zLTEtMS00Njkw_95c813a9-a09d-4f10-a437-dce9b16a6461">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5f0e3243c9c049d9bd4653b87b8b4c8a_D20190101-20191231" decimals="-3" sign="-" name="cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueRecoveredFromAppliedToEquityMethodInvestment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjIyOGFiOTgxYjEzNDRhNWRiYTllZWFjMzk3NWVkNWE4L3RhYmxlcmFuZ2U6MjI4YWI5ODFiMTM0NGE1ZGJhOWVlYWMzOTc1ZWQ1YThfOS01LTEtMS00Njkw_cd13c024-0199-4b65-a734-0c213fb88c38">779</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i15402ae419444f8291523f27c01226c3_D20190101-20191231" decimals="-3" sign="-" name="cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueRecoveredFromAppliedToEquityMethodInvestment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjIyOGFiOTgxYjEzNDRhNWRiYTllZWFjMzk3NWVkNWE4L3RhYmxlcmFuZ2U6MjI4YWI5ODFiMTM0NGE1ZGJhOWVlYWMzOTc1ZWQ1YThfOS03LTEtMS00Njkw_15998349-ee78-4b72-9144-a8a80918da1a">224</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" sign="-" name="cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueRecoveredFromAppliedToEquityMethodInvestment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjIyOGFiOTgxYjEzNDRhNWRiYTllZWFjMzk3NWVkNWE4L3RhYmxlcmFuZ2U6MjI4YWI5ODFiMTM0NGE1ZGJhOWVlYWMzOTc1ZWQ1YThfOS05LTEtMS00Njkw_28e90f75-8cdf-40a5-ae64-0400d3e82b14">946</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect from foreign exchange</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25b4f750539544e98240240c6d96fdc8_D20190101-20191231" decimals="-3" name="cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueChangesDueToCurrencyTranslation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjIyOGFiOTgxYjEzNDRhNWRiYTllZWFjMzk3NWVkNWE4L3RhYmxlcmFuZ2U6MjI4YWI5ODFiMTM0NGE1ZGJhOWVlYWMzOTc1ZWQ1YThfMTAtMS0xLTEtNDY5MA_c415319e-9c42-41cd-87df-cc4797f9da68">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib057cdc4d573476488dcb0661bea31b4_D20190101-20191231" decimals="-3" name="cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueChangesDueToCurrencyTranslation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjIyOGFiOTgxYjEzNDRhNWRiYTllZWFjMzk3NWVkNWE4L3RhYmxlcmFuZ2U6MjI4YWI5ODFiMTM0NGE1ZGJhOWVlYWMzOTc1ZWQ1YThfMTAtMy0xLTEtNDY5MA_1df08810-8477-4cde-8c3a-e7150de61792">480</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f0e3243c9c049d9bd4653b87b8b4c8a_D20190101-20191231" decimals="-3" name="cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueChangesDueToCurrencyTranslation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjIyOGFiOTgxYjEzNDRhNWRiYTllZWFjMzk3NWVkNWE4L3RhYmxlcmFuZ2U6MjI4YWI5ODFiMTM0NGE1ZGJhOWVlYWMzOTc1ZWQ1YThfMTAtNS0xLTEtNDY5MA_3e6e4cfd-acb2-4c1d-8f18-c6902b05030e">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15402ae419444f8291523f27c01226c3_D20190101-20191231" decimals="-3" name="cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueChangesDueToCurrencyTranslation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjIyOGFiOTgxYjEzNDRhNWRiYTllZWFjMzk3NWVkNWE4L3RhYmxlcmFuZ2U6MjI4YWI5ODFiMTM0NGE1ZGJhOWVlYWMzOTc1ZWQ1YThfMTAtNy0xLTEtNDY5MA_77692a33-7832-4436-b66d-39889debd5aa">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" name="cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueChangesDueToCurrencyTranslation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjIyOGFiOTgxYjEzNDRhNWRiYTllZWFjMzk3NWVkNWE4L3RhYmxlcmFuZ2U6MjI4YWI5ODFiMTM0NGE1ZGJhOWVlYWMzOTc1ZWQ1YThfMTAtOS0xLTEtNDY5MA_87da735a-5566-4b6e-a133-6372bc5519ec">559</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of December&#160;31, 2019</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6f2e75489a8480f95612249b17b7e5d_I20191231" decimals="-3" name="us-gaap:AdvancesToAffiliate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjIyOGFiOTgxYjEzNDRhNWRiYTllZWFjMzk3NWVkNWE4L3RhYmxlcmFuZ2U6MjI4YWI5ODFiMTM0NGE1ZGJhOWVlYWMzOTc1ZWQ1YThfMTEtMS0xLTEtNDY5MA_8b34643d-e5cc-4136-8f9a-6e94580d49e8">471</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief35f4e5e0e14975afdc16c2f8b07671_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdvancesToAffiliate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjIyOGFiOTgxYjEzNDRhNWRiYTllZWFjMzk3NWVkNWE4L3RhYmxlcmFuZ2U6MjI4YWI5ODFiMTM0NGE1ZGJhOWVlYWMzOTc1ZWQ1YThfMTEtMy0xLTEtNDY5MA_cb7a06b7-2a03-4354-a642-5bd272bc24de">18,966</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i613b07197744400cbbef2fbf605f0d54_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AdvancesToAffiliate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjIyOGFiOTgxYjEzNDRhNWRiYTllZWFjMzk3NWVkNWE4L3RhYmxlcmFuZ2U6MjI4YWI5ODFiMTM0NGE1ZGJhOWVlYWMzOTc1ZWQ1YThfMTEtNS0xLTEtNDY5MA_15ad857f-6951-427c-98db-a5e8a6606ff0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe5479ec3fef4f42a9772f4fad66332d_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AdvancesToAffiliate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjIyOGFiOTgxYjEzNDRhNWRiYTllZWFjMzk3NWVkNWE4L3RhYmxlcmFuZ2U6MjI4YWI5ODFiMTM0NGE1ZGJhOWVlYWMzOTc1ZWQ1YThfMTEtNy0xLTEtNDY5MA_7fd62278-acfc-4990-8666-e3ec669dce88">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdvancesToAffiliate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjIyOGFiOTgxYjEzNDRhNWRiYTllZWFjMzk3NWVkNWE4L3RhYmxlcmFuZ2U6MjI4YWI5ODFiMTM0NGE1ZGJhOWVlYWMzOTc1ZWQ1YThfMTEtOS0xLTEtNDY5MA_d1778593-0e63-4830-b90f-d89085e3e04f">19,437</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="padding-left:29.25pt;text-align:justify;text-indent:-27pt"><span><br/></span></div><div style="padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Advance is unsecured, non-interest bearing, and there are no terms of repayment.</span></div><div style="margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%;padding-left:20.66pt">On September 25, 2020, the Company and Mucci agreed to capitalize historical advances made by each shareholder to Cronos GrowCo. The Company capitalized C$<ix:nonFraction unitRef="cad" contextRef="i06e71f94f83b4681be053f1be423964a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RleHRyZWdpb246MjQ0MTA2MTgwYTE5NGM2YjkyYjM5ZTUwY2E2ZTMwM2ZfODI0NjMzNzI4NzE3MA_1b7376e7-7194-4b16-8a67-c9c7b93d194d">24,650</ix:nonFraction> ($<ix:nonFraction unitRef="usd" contextRef="i06e71f94f83b4681be053f1be423964a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RleHRyZWdpb246MjQ0MTA2MTgwYTE5NGM2YjkyYjM5ZTUwY2E2ZTMwM2ZfMTM3NDM4OTU0MjI5MTA_62d4ce26-1e54-424e-81da-f88d68078d98">18,505</ix:nonFraction>) through a transfer of aggregate gross advances from advances to joint ventures to investments in equity accounted investees in respect of Cronos GrowCo. Refer to footnote (ii) to the first table set forth under Note 6(a).</span></div><div style="margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.22pt">A$<ix:nonFraction unitRef="aud" contextRef="i4a854431fb9b495d990aeb067616e389_I20201231" decimals="INF" format="ixt:numdotdecimal" name="cron:InvestmentsInAndAdvancesToAffiliatesDebtInstrumentFaceAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RleHRyZWdpb246MjQ0MTA2MTgwYTE5NGM2YjkyYjM5ZTUwY2E2ZTMwM2ZfMTA5OTUxMTYzOTkzOA_3722a151-5cb9-4113-80ca-e4a12c22de7e">1,500</ix:nonFraction> is governed by an unsecured loan bearing interest at a rate of <ix:nonFraction unitRef="number" contextRef="i4a854431fb9b495d990aeb067616e389_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RleHRyZWdpb246MjQ0MTA2MTgwYTE5NGM2YjkyYjM5ZTUwY2E2ZTMwM2ZfMTA5OTUxMTY0NTc2NQ_6c30f715-89d5-4344-9250-dc813417044a">12</ix:nonFraction>% per annum, calculated and compounded daily, in arrears, on the amounts advanced from the date of each advance. The loan is due on January 1, 2022. If the loan is overdue, the outstanding amount bears interest at an additional <ix:nonFraction unitRef="number" contextRef="i4a854431fb9b495d990aeb067616e389_I20201231" decimals="INF" name="cron:DebtInstrumentPastDueAdditionalInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RleHRyZWdpb246MjQ0MTA2MTgwYTE5NGM2YjkyYjM5ZTUwY2E2ZTMwM2ZfMTU5NDI5MTg2MzcxMzY_45bd27b0-64b1-4cac-8f5b-fc34d2778ee8">2</ix:nonFraction>% per annum.</span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined that the maximum exposure to loss on variable interest entities is limited to the Company&#8217;s initial investment, advances and/or loans for each variable interest entity. <ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:ScheduleOfVariableInterestEntitiesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RleHRyZWdpb246MjQ0MTA2MTgwYTE5NGM2YjkyYjM5ZTUwY2E2ZTMwM2ZfMjMwODk3NDQyNTgzMzI_5672ab39-9440-4658-b81a-32a9cb0e4a3a" continuedAt="ic04fd1ba8d7a4890be6fbec54013da21" escape="true">The following is a summary of the maximum exposure to loss for the year ended December&#160;31, 2020 and 2019:</ix:nonNumeric></span></div><ix:continuation id="ic04fd1ba8d7a4890be6fbec54013da21"><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.511%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.569%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ownership interest</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Net Assets (Liabilities)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maximum Exposure to Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos Australia</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4a854431fb9b495d990aeb067616e389_I20201231" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJlYTAzMzdmZWFlOTQyODU5MThmMjUxOTc4ZWI3MWY3L3RhYmxlcmFuZ2U6MmVhMDMzN2ZlYWU5NDI4NTkxOGYyNTE5NzhlYjcxZjdfMi0xLTEtMS0xOTU1NQ_50c14e5d-0e48-471f-b991-ec55d40644ba"><ix:nonFraction unitRef="number" contextRef="i1992c389e83f4ed89ee4289b28705c96_D20200101-20201231" decimals="2" name="us-gaap:VariableInterestEntityOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJlYTAzMzdmZWFlOTQyODU5MThmMjUxOTc4ZWI3MWY3L3RhYmxlcmFuZ2U6MmVhMDMzN2ZlYWU5NDI4NTkxOGYyNTE5NzhlYjcxZjdfMi0xLTEtMS0xOTU1NQ_9a563966-5cc4-4086-ba1f-14a73f94058c">31</ix:nonFraction></ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7de2974205334c71b88361a4a5309899_I20201231" decimals="-3" format="ixt:numdotdecimal" name="cron:OtherNetAssetsLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJlYTAzMzdmZWFlOTQyODU5MThmMjUxOTc4ZWI3MWY3L3RhYmxlcmFuZ2U6MmVhMDMzN2ZlYWU5NDI4NTkxOGYyNTE5NzhlYjcxZjdfMi0zLTEtMS0xOTU1NQ_472efde2-c157-4266-966a-770204a68ff2">8,976</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7de2974205334c71b88361a4a5309899_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJlYTAzMzdmZWFlOTQyODU5MThmMjUxOTc4ZWI3MWY3L3RhYmxlcmFuZ2U6MmVhMDMzN2ZlYWU5NDI4NTkxOGYyNTE5NzhlYjcxZjdfMi01LTEtMS0xOTU1NQ_a1e20703-0481-47d3-b929-5aa5c433fc25">1,530</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos GrowCo</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i291f9ace020d4518924413d4644527d9_D20200101-20201231" decimals="2" name="us-gaap:VariableInterestEntityOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJlYTAzMzdmZWFlOTQyODU5MThmMjUxOTc4ZWI3MWY3L3RhYmxlcmFuZ2U6MmVhMDMzN2ZlYWU5NDI4NTkxOGYyNTE5NzhlYjcxZjdfMy0xLTEtMS0xOTU1NQ_131ade4a-305f-4216-868e-ca581f5252a6"><ix:nonFraction unitRef="number" contextRef="ieb8971bbe440425c985b311295f2cec9_I20201231" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJlYTAzMzdmZWFlOTQyODU5MThmMjUxOTc4ZWI3MWY3L3RhYmxlcmFuZ2U6MmVhMDMzN2ZlYWU5NDI4NTkxOGYyNTE5NzhlYjcxZjdfMy0xLTEtMS0xOTU1NQ_5a7591f4-8e6a-4273-a6b3-637caaa6f476">50</ix:nonFraction></ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i742245ee0f214dceb6821001350fd31d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="cron:OtherNetAssetsLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJlYTAzMzdmZWFlOTQyODU5MThmMjUxOTc4ZWI3MWY3L3RhYmxlcmFuZ2U6MmVhMDMzN2ZlYWU5NDI4NTkxOGYyNTE5NzhlYjcxZjdfMy0zLTEtMS0xOTU1NQ_7366f7c9-0206-4ec6-9677-a9cb2ea06fae">109,329</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i742245ee0f214dceb6821001350fd31d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJlYTAzMzdmZWFlOTQyODU5MThmMjUxOTc4ZWI3MWY3L3RhYmxlcmFuZ2U6MmVhMDMzN2ZlYWU5NDI4NTkxOGYyNTE5NzhlYjcxZjdfMy01LTEtMS0xOTU1NQ_0cc5a8a7-9d4e-4127-b6c8-13062fc6ad9d">21,125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedMen Canada</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i76e00c36f9dd4ecfbf011fe23eac8c61_D20200101-20201231" decimals="2" name="us-gaap:VariableInterestEntityOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJlYTAzMzdmZWFlOTQyODU5MThmMjUxOTc4ZWI3MWY3L3RhYmxlcmFuZ2U6MmVhMDMzN2ZlYWU5NDI4NTkxOGYyNTE5NzhlYjcxZjdfNC0xLTEtMS0xOTU1NQ_6faa9b8a-17bc-41b6-8df7-017b713672cb">50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic86c74eeef9d4c4f9ebc178e09fd7f92_I20201231" decimals="-3" format="ixt:zerodash" name="cron:OtherNetAssetsLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJlYTAzMzdmZWFlOTQyODU5MThmMjUxOTc4ZWI3MWY3L3RhYmxlcmFuZ2U6MmVhMDMzN2ZlYWU5NDI4NTkxOGYyNTE5NzhlYjcxZjdfNC0zLTEtMS0xOTU1NQ_6a7b35ca-74aa-4e19-ad5a-674f92980f85">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic86c74eeef9d4c4f9ebc178e09fd7f92_I20201231" decimals="-3" name="us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJlYTAzMzdmZWFlOTQyODU5MThmMjUxOTc4ZWI3MWY3L3RhYmxlcmFuZ2U6MmVhMDMzN2ZlYWU5NDI4NTkxOGYyNTE5NzhlYjcxZjdfNC01LTEtMS0xOTU1NQ_fe401ad6-c4b0-4671-98dc-fd60aededa9d">467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Natuera</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i08aaf1da351148dabbc15473a8372493_D20200101-20201231" decimals="2" name="us-gaap:VariableInterestEntityOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJlYTAzMzdmZWFlOTQyODU5MThmMjUxOTc4ZWI3MWY3L3RhYmxlcmFuZ2U6MmVhMDMzN2ZlYWU5NDI4NTkxOGYyNTE5NzhlYjcxZjdfNS0xLTEtMS0xOTU1NQ_abeb0b9a-c88d-4d5d-944c-a177e56c2ab7"><ix:nonFraction unitRef="number" contextRef="i578db4ab78c04e03aee4c102f9d17cfe_I20201231" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJlYTAzMzdmZWFlOTQyODU5MThmMjUxOTc4ZWI3MWY3L3RhYmxlcmFuZ2U6MmVhMDMzN2ZlYWU5NDI4NTkxOGYyNTE5NzhlYjcxZjdfNS0xLTEtMS0xOTU1NQ_bc0fdcd5-1b05-432a-9c93-6ca263ed7f4b">50</ix:nonFraction></ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ac21cf5e6b74695a68d659200d9510c_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:OtherNetAssetsLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJlYTAzMzdmZWFlOTQyODU5MThmMjUxOTc4ZWI3MWY3L3RhYmxlcmFuZ2U6MmVhMDMzN2ZlYWU5NDI4NTkxOGYyNTE5NzhlYjcxZjdfNS0zLTEtMS0xOTU1NQ_b205db6c-7511-43a5-88f5-7a51defaaff0">6,849</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ac21cf5e6b74695a68d659200d9510c_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJlYTAzMzdmZWFlOTQyODU5MThmMjUxOTc4ZWI3MWY3L3RhYmxlcmFuZ2U6MmVhMDMzN2ZlYWU5NDI4NTkxOGYyNTE5NzhlYjcxZjdfNS01LTEtMS0xOTU1NQ_db1c5c0c-ac84-4ace-b529-8d6091efb414">8,154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="cron:OtherNetAssetsLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJlYTAzMzdmZWFlOTQyODU5MThmMjUxOTc4ZWI3MWY3L3RhYmxlcmFuZ2U6MmVhMDMzN2ZlYWU5NDI4NTkxOGYyNTE5NzhlYjcxZjdfNi0zLTEtMS0xOTU1NQ_b2001f49-2cf7-443c-be26-96e2977d03b8">111,456</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJlYTAzMzdmZWFlOTQyODU5MThmMjUxOTc4ZWI3MWY3L3RhYmxlcmFuZ2U6MmVhMDMzN2ZlYWU5NDI4NTkxOGYyNTE5NzhlYjcxZjdfNi01LTEtMS0xOTU1NQ_35c88296-2fab-4aaf-82f8-6298c01def59">31,276</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:-9pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.511%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.569%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ownership interest</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Net Assets (Liabilities)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maximum Exposure to Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos Australia</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie8507622f9454b6d8fc0ba0f6058f27c_D20190101-20191231" decimals="2" name="us-gaap:VariableInterestEntityOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjU3ZjFkZTYwMDJmMjQwNTJhZjVjODFjMzQ3ZjU0MWE1L3RhYmxlcmFuZ2U6NTdmMWRlNjAwMmYyNDA1MmFmNWM4MWMzNDdmNTQxYTVfNy0xLTEtMS0zNzU0Ng_2c79e1c6-9291-48b3-acfa-63bc7bf811bc">31</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica49af07e43e4dacb2f47f79e38bcf20_I20191231" decimals="-3" format="ixt:numdotdecimal" name="cron:OtherNetAssetsLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjU3ZjFkZTYwMDJmMjQwNTJhZjVjODFjMzQ3ZjU0MWE1L3RhYmxlcmFuZ2U6NTdmMWRlNjAwMmYyNDA1MmFmNWM4MWMzNDdmNTQxYTVfNy0zLTEtMS0zNzU0Ng_8b751adb-0d4e-4f70-bbb4-4be4633f1b3d">10,900</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica49af07e43e4dacb2f47f79e38bcf20_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjU3ZjFkZTYwMDJmMjQwNTJhZjVjODFjMzQ3ZjU0MWE1L3RhYmxlcmFuZ2U6NTdmMWRlNjAwMmYyNDA1MmFmNWM4MWMzNDdmNTQxYTVfNy01LTEtMS0zNzU0Ng_5bc95bd2-2c5b-4c35-8468-bb3e13622a28">1,355</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos GrowCo</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2888e238471544cfb7ff8479ad7e82f6_D20190101-20191231" decimals="2" name="us-gaap:VariableInterestEntityOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjU3ZjFkZTYwMDJmMjQwNTJhZjVjODFjMzQ3ZjU0MWE1L3RhYmxlcmFuZ2U6NTdmMWRlNjAwMmYyNDA1MmFmNWM4MWMzNDdmNTQxYTVfOC0xLTEtMS0zNzU0Ng_2e20d375-f499-4d51-b9a1-b1a54c87f48b">50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51188c76d4fe446caa292dafb0517e9f_I20191231" decimals="-3" format="ixt:numdotdecimal" name="cron:OtherNetAssetsLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjU3ZjFkZTYwMDJmMjQwNTJhZjVjODFjMzQ3ZjU0MWE1L3RhYmxlcmFuZ2U6NTdmMWRlNjAwMmYyNDA1MmFmNWM4MWMzNDdmNTQxYTVfOC0zLTEtMS0zNzU0Ng_4d3477e5-5a1b-4296-a218-f78cc8a7da2f">3,091</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51188c76d4fe446caa292dafb0517e9f_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjU3ZjFkZTYwMDJmMjQwNTJhZjVjODFjMzQ3ZjU0MWE1L3RhYmxlcmFuZ2U6NTdmMWRlNjAwMmYyNDA1MmFmNWM4MWMzNDdmNTQxYTVfOC01LTEtMS0zNzU0Ng_cf5ef996-690a-4adc-ad33-c2aadedfc297">20,700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 4pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedMen Canada</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1d96cfff4a7d4ff6a748326af07ca595_D20190101-20191231" decimals="2" name="us-gaap:VariableInterestEntityOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjU3ZjFkZTYwMDJmMjQwNTJhZjVjODFjMzQ3ZjU0MWE1L3RhYmxlcmFuZ2U6NTdmMWRlNjAwMmYyNDA1MmFmNWM4MWMzNDdmNTQxYTVfOS0xLTEtMS0zNzU0Ng_b7b737f8-3158-40dc-ad12-f1cb003223aa">50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d40be89af3b4e0497c3ad54f82f4d44_I20191231" decimals="-3" sign="-" name="cron:OtherNetAssetsLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjU3ZjFkZTYwMDJmMjQwNTJhZjVjODFjMzQ3ZjU0MWE1L3RhYmxlcmFuZ2U6NTdmMWRlNjAwMmYyNDA1MmFmNWM4MWMzNDdmNTQxYTVfOS0zLTEtMS0zNzU0Ng_0cf1fb5e-d902-4339-8c1c-2529cd5d5c7c">199</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d40be89af3b4e0497c3ad54f82f4d44_I20191231" decimals="-3" name="us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjU3ZjFkZTYwMDJmMjQwNTJhZjVjODFjMzQ3ZjU0MWE1L3RhYmxlcmFuZ2U6NTdmMWRlNjAwMmYyNDA1MmFmNWM4MWMzNDdmNTQxYTVfOS01LTEtMS0zNzU0Ng_76e22330-45e0-42e3-ba34-8bcd00e82ba7">642</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Natuera</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2575ae85f47848a3b4e481731644b697_D20190101-20191231" decimals="2" name="us-gaap:VariableInterestEntityOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjU3ZjFkZTYwMDJmMjQwNTJhZjVjODFjMzQ3ZjU0MWE1L3RhYmxlcmFuZ2U6NTdmMWRlNjAwMmYyNDA1MmFmNWM4MWMzNDdmNTQxYTVfMTAtMS0xLTEtMzc1NDY_dbb4ece9-e856-48ac-b124-b2fd08af75fb">50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5676c3dd147d44a9a8304b45e044a905_I20191231" decimals="-3" sign="-" name="cron:OtherNetAssetsLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjU3ZjFkZTYwMDJmMjQwNTJhZjVjODFjMzQ3ZjU0MWE1L3RhYmxlcmFuZ2U6NTdmMWRlNjAwMmYyNDA1MmFmNWM4MWMzNDdmNTQxYTVfMTAtMy0xLTEtMzc1NDY_701a7b2c-9ee3-477d-b6f5-ad4b73586f6a">358</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5676c3dd147d44a9a8304b45e044a905_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjU3ZjFkZTYwMDJmMjQwNTJhZjVjODFjMzQ3ZjU0MWE1L3RhYmxlcmFuZ2U6NTdmMWRlNjAwMmYyNDA1MmFmNWM4MWMzNDdmNTQxYTVfMTAtNS0xLTEtMzc1NDY_bac32d0e-45e1-45db-a10d-76f03cd0c7c2">4,888</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="cron:OtherNetAssetsLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjU3ZjFkZTYwMDJmMjQwNTJhZjVjODFjMzQ3ZjU0MWE1L3RhYmxlcmFuZ2U6NTdmMWRlNjAwMmYyNDA1MmFmNWM4MWMzNDdmNTQxYTVfMTEtMy0xLTEtMzc1NDY_d3a67aea-00dd-4a8b-84e0-ffba4b786eb3">13,434</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjU3ZjFkZTYwMDJmMjQwNTJhZjVjODFjMzQ3ZjU0MWE1L3RhYmxlcmFuZ2U6NTdmMWRlNjAwMmYyNDA1MmFmNWM4MWMzNDdmNTQxYTVfMTEtNS0xLTEtMzc1NDY_83924e2c-ab0b-4620-b0ae-1645335446ed">27,585</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:continuation></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88</span></div></div></div><div id="i1ae9134e40e74e0aac958218112e53d4_103"></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December 31, 2020, 2019, and 2018</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for gram and share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:16pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7. <ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90ZXh0cmVnaW9uOmU5MWY3OThmZWZiZDRiOWQ4MjM3NTczMTFmMzU4Mzc4XzgyNDYzMzcyMzg4MTI_c3dbf84b-561c-4ba7-a224-92bf160d0875" continuedAt="i054d0d03f5e14994b4fcc0f721d7e443" escape="true">Other Investments </ix:nonNumeric></span></div><ix:continuation id="i054d0d03f5e14994b4fcc0f721d7e443"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other investments consist of investments in common shares and warrants of several companies in the cannabis industry. As of December&#160;31, 2020 and December&#160;31, 2019, the Company did not hold any other investments. The gains and losses on sale of other investments are classified as fair value through net income (loss).</span></div><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90ZXh0cmVnaW9uOmU5MWY3OThmZWZiZDRiOWQ4MjM3NTczMTFmMzU4Mzc4XzgyNDYzMzcyMzg4MTE_d6216f75-231b-461b-804e-56f3dc91c69b" escape="true"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gains (losses) recognized in net income (loss) related to other investments were as follows:</span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.288%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gain recognized in net income (loss)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canopy Growth Corporation (&#8220;Canopy&#8221;)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc5472b8d3034929a878ea801fa0b849_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90YWJsZTowYzVlMzVjMGM4NjY0ZGFmYjZmZDZmNzViMzdlMGM1Ny90YWJsZXJhbmdlOjBjNWUzNWMwYzg2NjRkYWZiNmZkNmY3NWIzN2UwYzU3XzItMS0xLTEtODcyMw_6f1586d8-6d21-40ab-a560-e70ce5129fd0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d744562089b40b9827f8e55fbe1e1a6_D20190101-20191231" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90YWJsZTowYzVlMzVjMGM4NjY0ZGFmYjZmZDZmNzViMzdlMGM1Ny90YWJsZXJhbmdlOjBjNWUzNWMwYzg2NjRkYWZiNmZkNmY3NWIzN2UwYzU3XzItMy0xLTEtODcyOQ_a57abbd8-358a-46f2-9bfa-f16a1af7272e">51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7452ef8eb84342d198c51755bf9c43a4_D20180101-20181231" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90YWJsZTowYzVlMzVjMGM4NjY0ZGFmYjZmZDZmNzViMzdlMGM1Ny90YWJsZXJhbmdlOjBjNWUzNWMwYzg2NjRkYWZiNmZkNmY3NWIzN2UwYzU3XzItNS0xLTEtODczMw_76546f82-b9c0-41c9-9d19-445d9d6b9556">166</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vivo Cannabis (&#8220;Vivo&#8221;) - shares</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28dbe3b3d492406b844fa6b2d587faa3_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90YWJsZTowYzVlMzVjMGM4NjY0ZGFmYjZmZDZmNzViMzdlMGM1Ny90YWJsZXJhbmdlOjBjNWUzNWMwYzg2NjRkYWZiNmZkNmY3NWIzN2UwYzU3XzMtMS0xLTEtODcyMw_d611b793-382a-48af-a88f-57a835406b48">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1f2f8d063e648d79b58979418dad94b_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90YWJsZTowYzVlMzVjMGM4NjY0ZGFmYjZmZDZmNzViMzdlMGM1Ny90YWJsZXJhbmdlOjBjNWUzNWMwYzg2NjRkYWZiNmZkNmY3NWIzN2UwYzU3XzMtMy0xLTEtODcyOQ_ae3b7ed9-2e01-4975-97d1-c67b77015241">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifecc77aba9d94529a80a42fc9ce8c7af_D20180101-20181231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90YWJsZTowYzVlMzVjMGM4NjY0ZGFmYjZmZDZmNzViMzdlMGM1Ny90YWJsZXJhbmdlOjBjNWUzNWMwYzg2NjRkYWZiNmZkNmY3NWIzN2UwYzU3XzMtNS0xLTEtODczMw_de501a85-b8d1-4fb3-a1db-a49efc4af660">173</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vivo Cannabis - share warrants</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7d82a0c5320482da6d4bbdd7fd59a72_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90YWJsZTowYzVlMzVjMGM4NjY0ZGFmYjZmZDZmNzViMzdlMGM1Ny90YWJsZXJhbmdlOjBjNWUzNWMwYzg2NjRkYWZiNmZkNmY3NWIzN2UwYzU3XzQtMS0xLTEtODcyMw_e79c84f0-b4dd-4067-9cfd-8e1094fd3289">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb82fe39a45a48b684579d0e259b1be9_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90YWJsZTowYzVlMzVjMGM4NjY0ZGFmYjZmZDZmNzViMzdlMGM1Ny90YWJsZXJhbmdlOjBjNWUzNWMwYzg2NjRkYWZiNmZkNmY3NWIzN2UwYzU3XzQtMy0xLTEtODcyOQ_8384f8df-fa4d-4bea-b383-bf57b2fad439">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410fb06923684e30987bfd057a982f23_D20180101-20181231" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90YWJsZTowYzVlMzVjMGM4NjY0ZGFmYjZmZDZmNzViMzdlMGM1Ny90YWJsZXJhbmdlOjBjNWUzNWMwYzg2NjRkYWZiNmZkNmY3NWIzN2UwYzU3XzQtNS0xLTEtODczMw_86fba7ce-79d3-4238-be36-cdc347637dbd">171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Whistler</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iii)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if177335bf723452a9e53b5cbb69619d9_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90YWJsZTowYzVlMzVjMGM4NjY0ZGFmYjZmZDZmNzViMzdlMGM1Ny90YWJsZXJhbmdlOjBjNWUzNWMwYzg2NjRkYWZiNmZkNmY3NWIzN2UwYzU3XzYtMS0xLTEtODcyMw_0a8a7d23-2555-4280-800f-67515d0534d9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafde73babf68415aa902c6377f960aed_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90YWJsZTowYzVlMzVjMGM4NjY0ZGFmYjZmZDZmNzViMzdlMGM1Ny90YWJsZXJhbmdlOjBjNWUzNWMwYzg2NjRkYWZiNmZkNmY3NWIzN2UwYzU3XzYtMy0xLTEtODcyOQ_9ddad954-ba8b-47be-8caa-d947a88123e0">15,530</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94d61440c397433cae44d842da3ca067_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90YWJsZTowYzVlMzVjMGM4NjY0ZGFmYjZmZDZmNzViMzdlMGM1Ny90YWJsZXJhbmdlOjBjNWUzNWMwYzg2NjRkYWZiNmZkNmY3NWIzN2UwYzU3XzYtNS0xLTEtODczMw_cae9594e-edac-4d60-b2eb-e4c77de117a6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aurora Cannabis Inc. (&#8220;Aurora&#8221;)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iv)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3633b0f773a4aaea9ea7b4dab12ca13_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90YWJsZTowYzVlMzVjMGM4NjY0ZGFmYjZmZDZmNzViMzdlMGM1Ny90YWJsZXJhbmdlOjBjNWUzNWMwYzg2NjRkYWZiNmZkNmY3NWIzN2UwYzU3XzctMS0xLTEtMTEyMjI_bf735d40-32e7-4044-a4af-181e16e728e9">4,789</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i253fd691295241ea93a2245f1f94a988_D20190101-20191231" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90YWJsZTowYzVlMzVjMGM4NjY0ZGFmYjZmZDZmNzViMzdlMGM1Ny90YWJsZXJhbmdlOjBjNWUzNWMwYzg2NjRkYWZiNmZkNmY3NWIzN2UwYzU3XzctMy0xLTEtMTEyMTU_64261c4b-eb67-45f4-9a56-8d1897d476f3">696</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cddb3f9929c453995ab712b0ead8198_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90YWJsZTowYzVlMzVjMGM4NjY0ZGFmYjZmZDZmNzViMzdlMGM1Ny90YWJsZXJhbmdlOjBjNWUzNWMwYzg2NjRkYWZiNmZkNmY3NWIzN2UwYzU3XzctNS0xLTEtMTEyMjI_a7e6da43-19f9-4a38-8747-43c14c3b50e9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibae6d945308c4710b0b167839c583e5e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90YWJsZTowYzVlMzVjMGM4NjY0ZGFmYjZmZDZmNzViMzdlMGM1Ny90YWJsZXJhbmdlOjBjNWUzNWMwYzg2NjRkYWZiNmZkNmY3NWIzN2UwYzU3XzctMS0xLTEtODcyMw_da30366d-07f7-4adf-b0e9-cb4f84d19bc5">4,789</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i146b3a1d69a94438a07f9724ab5410a5_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90YWJsZTowYzVlMzVjMGM4NjY0ZGFmYjZmZDZmNzViMzdlMGM1Ny90YWJsZXJhbmdlOjBjNWUzNWMwYzg2NjRkYWZiNmZkNmY3NWIzN2UwYzU3XzctMy0xLTEtODcyOQ_7c29fea5-2f3f-4be8-8cc2-6d88a7c8198c">16,277</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2c79796c87c4829ad1e5b4215e49867_D20180101-20181231" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90YWJsZTowYzVlMzVjMGM4NjY0ZGFmYjZmZDZmNzViMzdlMGM1Ny90YWJsZXJhbmdlOjBjNWUzNWMwYzg2NjRkYWZiNmZkNmY3NWIzN2UwYzU3XzctNS0xLTEtODczMw_4394f291-ccba-43f2-92f6-94ae75849952">164</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt">During the year ended December&#160;31, 2019, the Company sold all remaining <ix:nonFraction unitRef="shares" contextRef="i3d744562089b40b9827f8e55fbe1e1a6_D20190101-20191231" decimals="INF" format="ixt:numdotdecimal" name="cron:InvestmentOwnedNumberOfSharesSold" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90ZXh0cmVnaW9uOmU5MWY3OThmZWZiZDRiOWQ4MjM3NTczMTFmMzU4Mzc4XzEyMDk0NjI3OTIzNTI3_e6d7ba1f-de55-499b-b60b-dc81d3bd3106">11,062</ix:nonFraction> common shares of Canopy (2018 &#8211; <ix:nonFraction unitRef="shares" contextRef="i7452ef8eb84342d198c51755bf9c43a4_D20180101-20181231" decimals="INF" format="ixt:numdotdecimal" name="cron:InvestmentOwnedNumberOfSharesSold" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90ZXh0cmVnaW9uOmU5MWY3OThmZWZiZDRiOWQ4MjM3NTczMTFmMzU4Mzc4XzE1OTQyOTE4NjE5OTYx_61c1adc6-d156-479b-924a-168f4ad6bfd3">18,436</ix:nonFraction> common shares) for net proceeds of $<ix:nonFraction unitRef="usd" contextRef="i3d744562089b40b9827f8e55fbe1e1a6_D20190101-20191231" decimals="-3" name="cron:ProceedsFromSaleOfEquitySecuritiesFVNI" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90ZXh0cmVnaW9uOmU5MWY3OThmZWZiZDRiOWQ4MjM3NTczMTFmMzU4Mzc4XzEyMDk0NjI3OTIzMjQ3_6599008e-1c04-4344-a17a-782fe1042fcf">355</ix:nonFraction> (2018 &#8211; $<ix:nonFraction unitRef="usd" contextRef="i7452ef8eb84342d198c51755bf9c43a4_D20180101-20181231" decimals="-3" name="cron:ProceedsFromSaleOfEquitySecuritiesFVNI" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90ZXh0cmVnaW9uOmU5MWY3OThmZWZiZDRiOWQ4MjM3NTczMTFmMzU4Mzc4XzE1OTQyOTE4NjE5OTcz_5b659b84-e471-45f5-9b3d-9786124549c1">530</ix:nonFraction>) recorded as a gain on disposal of other investments in other income (expense). Upon adoption of ASU 2016-01 during the year ended December&#160;31, 2018, the gains and losses on the Canopy investment were reclassified from fair value through other comprehensive income to fair value through net income.</span></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt">During the year ended December&#160;31, 2018, the Company exercised <ix:nonFraction unitRef="shares" contextRef="ifecc77aba9d94529a80a42fc9ce8c7af_D20180101-20181231" decimals="INF" format="ixt:numdotdecimal" name="cron:InvestmentOwnedNumberOfWarrantsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90ZXh0cmVnaW9uOmU5MWY3OThmZWZiZDRiOWQ4MjM3NTczMTFmMzU4Mzc4XzE1OTQyOTE4NjIwMTc1_d404653e-8d35-4211-bee4-307b113881cd">182,927</ix:nonFraction> share warrants for aggregate consideration of $<ix:nonFraction unitRef="usd" contextRef="ifecc77aba9d94529a80a42fc9ce8c7af_D20180101-20181231" decimals="-3" name="cron:PaymentsToExerciseWarrants" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90ZXh0cmVnaW9uOmU5MWY3OThmZWZiZDRiOWQ4MjM3NTczMTFmMzU4Mzc4Xzg3OTYwOTMwNTI2NTA_4c85f645-80a2-453b-8963-461bd5c4084a">87</ix:nonFraction> for additional shares of Vivo. During the year ended December&#160;31, 2018, the Company then sold all <ix:nonFraction unitRef="shares" contextRef="ifecc77aba9d94529a80a42fc9ce8c7af_D20180101-20181231" decimals="INF" format="ixt:numdotdecimal" name="cron:InvestmentOwnedNumberOfSharesSold" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90ZXh0cmVnaW9uOmU5MWY3OThmZWZiZDRiOWQ4MjM3NTczMTFmMzU4Mzc4XzEzNzQzODk1Mzc3NzIy_80915ef7-8fd6-4e22-b428-b25999e58e69">182,927</ix:nonFraction> shares of Vivo for proceeds of $<ix:nonFraction unitRef="usd" contextRef="ifecc77aba9d94529a80a42fc9ce8c7af_D20180101-20181231" decimals="-3" name="cron:ProceedsFromSaleOfEquitySecuritiesFVNI" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90ZXh0cmVnaW9uOmU5MWY3OThmZWZiZDRiOWQ4MjM3NTczMTFmMzU4Mzc4XzE1OTQyOTE4NjIwMTky_fa3322b4-187d-4a60-8670-213725e80665">216</ix:nonFraction>. Upon adoption of ASU 2016-01 during the year ended December&#160;31, 2018, the gains and losses on the Vivo Cannabis shares investment were reclassified from fair value through other comprehensive income to fair value through net income.</span></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.22pt">On March 4, 2019, the Company sold all <ix:nonFraction unitRef="shares" contextRef="i02c8c20a53a14d20b68fae9142fac983_D20190304-20190304" decimals="INF" format="ixt:numdotdecimal" name="cron:InvestmentOwnedNumberOfSharesSold" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90ZXh0cmVnaW9uOmU5MWY3OThmZWZiZDRiOWQ4MjM3NTczMTFmMzU4Mzc4Xzg3OTYwOTMwNTI2NTk_8ee5e345-db74-4b11-a05d-c0e1a106218a">2,563</ix:nonFraction> shares of Whistler, representing approximately <ix:nonFraction unitRef="number" contextRef="i02c8c20a53a14d20b68fae9142fac983_D20190304-20190304" decimals="3" name="cron:InvestmentOwnedSharesSoldPercentageOfSharesIssuedAndOutstanding" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90ZXh0cmVnaW9uOmU5MWY3OThmZWZiZDRiOWQ4MjM3NTczMTFmMzU4Mzc4Xzg3OTYwOTMwNTI2ODk_f78ad614-6646-4044-aff1-29e767821a29">19.0</ix:nonFraction>% of Whistler&#8217;s issued and outstanding common shares, to Aurora, in connection with Aurora&#8217;s acquisition of Whistler (the &#8220;Whistler Transaction&#8221;). As a result of the closing of the Whistler Transaction, the Company received <ix:nonFraction unitRef="shares" contextRef="i545d2eedc49b488a858211c0dfae5d9e_D20190304-20190304" decimals="INF" format="ixt:numdotdecimal" name="cron:InvestmentOwnedNumberOfSharesReceived" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90ZXh0cmVnaW9uOmU5MWY3OThmZWZiZDRiOWQ4MjM3NTczMTFmMzU4Mzc4Xzg3OTYwOTMwNTI2Njc_4a4b3270-a5d4-4722-ac56-9cebadc4ba06">2,524,341</ix:nonFraction> Aurora common shares. During the year ended December&#160;31, 2019, the Company sold all <ix:nonFraction unitRef="shares" contextRef="i253fd691295241ea93a2245f1f94a988_D20190101-20191231" decimals="INF" format="ixt:numdotdecimal" name="cron:InvestmentOwnedNumberOfSharesSold" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90ZXh0cmVnaW9uOmU5MWY3OThmZWZiZDRiOWQ4MjM3NTczMTFmMzU4Mzc4XzEzNzQzODk1Mzc2MjEx_98279285-d2a7-4d48-8592-66837eb229dd">2,524,341</ix:nonFraction> common shares of Aurora, for gross proceeds of $<ix:nonFraction unitRef="usd" contextRef="i253fd691295241ea93a2245f1f94a988_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="cron:ProceedsFromSaleOfEquitySecuritiesFVNI" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90ZXh0cmVnaW9uOmU5MWY3OThmZWZiZDRiOWQ4MjM3NTczMTFmMzU4Mzc4Xzg3OTYwOTMwNTI2Nzk_db733f56-7fab-449d-937f-b5834ad3382d">19,259</ix:nonFraction>. A gain on disposal of other investments was recorded in other income (expense) as a result.</span></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(iv)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.5pt">For the year ended December&#160;31, 2020, in connection with the achievement of certain milestones related to the Whistler Transaction, the Company received <ix:nonFraction unitRef="shares" contextRef="if177335bf723452a9e53b5cbb69619d9_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="cron:InvestmentOwnedNumberOfSharesReceived" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90ZXh0cmVnaW9uOmU5MWY3OThmZWZiZDRiOWQ4MjM3NTczMTFmMzU4Mzc4XzEzNzQzODk1Mzc3NzI2_7d0bb4c0-ce69-4512-b891-d23bab982680">980,662</ix:nonFraction> common shares of Aurora. During the year ended December 31, 2020, the Company sold all <ix:nonFraction unitRef="shares" contextRef="if177335bf723452a9e53b5cbb69619d9_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="cron:InvestmentOwnedNumberOfSharesSold" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90ZXh0cmVnaW9uOmU5MWY3OThmZWZiZDRiOWQ4MjM3NTczMTFmMzU4Mzc4XzEzNzQzODk1Mzc2MjI5_b5b68019-7af1-4b31-b66a-d43061313558">980,662</ix:nonFraction> of the Aurora common shares, for gross proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="ib3633b0f773a4aaea9ea7b4dab12ca13_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90ZXh0cmVnaW9uOmU5MWY3OThmZWZiZDRiOWQ4MjM3NTczMTFmMzU4Mzc4XzExNTQ0ODcyMTIxODAz_bf735d40-32e7-4044-a4af-181e16e728e9">4,789</ix:nonFraction> (C$<ix:nonFraction unitRef="cad" contextRef="ib3633b0f773a4aaea9ea7b4dab12ca13_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90ZXh0cmVnaW9uOmU5MWY3OThmZWZiZDRiOWQ4MjM3NTczMTFmMzU4Mzc4XzExNTQ0ODcyMTIxODEx_9a69e91d-48d6-422f-b0ec-6542c61a03c4">6,404</ix:nonFraction>), recorded as a gain on disposal of other investments in other income (expense).</span></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">89</span></div></div></div><div id="i1ae9134e40e74e0aac958218112e53d4_97"></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December 31, 2020, 2019, and 2018</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for gram and share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:16pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">8. <ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RleHRyZWdpb246YmU2YjZhNzQ2YmQ5NDE2NGI4MjJiMDhkOWE2YWUyMTJfMjMwODk3NDQyMjQ0OTI_88ea861c-09f6-414e-b25d-7875a8690827" continuedAt="id8aa81d199294921812bd77d245b0fa0" escape="true">Loans Receivable </ix:nonNumeric></span></div><ix:continuation id="id8aa81d199294921812bd77d245b0fa0"><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RleHRyZWdpb246YmU2YjZhNzQ2YmQ5NDE2NGI4MjJiMDhkOWE2YWUyMTJfMjMwODk3NDQyMjQ0OTM_92f21d19-372d-4b40-8bbd-b85418cf3382" escape="true"><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.348%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of </span></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2019</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Natuera Series A Loan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b816c5b52b043c8a33c4048ab073bc3_I20201231" decimals="-3" format="ixt:numdotdecimal" name="cron:FinancingReceivableBeforeAccruedInterestCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RhYmxlOjY2Y2FiZjk3YmQ3MzQwZjJhZTJmNzk2YTk3MDFhZmIzL3RhYmxlcmFuZ2U6NjZjYWJmOTdiZDczNDBmMmFlMmY3OTZhOTcwMWFmYjNfMy0zLTEtMS0w_d4d1cdd1-29db-4a4b-9678-8bfb2239a45f">3,518</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic325dca9bc664509ab8e9daef0295626_I20191231" decimals="-3" format="ixt:numdotdecimal" name="cron:FinancingReceivableBeforeAccruedInterestCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RhYmxlOjY2Y2FiZjk3YmQ3MzQwZjJhZTJmNzk2YTk3MDFhZmIzL3RhYmxlcmFuZ2U6NjZjYWJmOTdiZDczNDBmMmFlMmY3OTZhOTcwMWFmYjNfMy02LTEtMS0w_b5d0c6a4-38d8-40cb-bdeb-4d5e14e0f686">4,575</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GrowCo Credit Facility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5835cd4e2e1344e38bcc3bdeeb97d893_I20201231" decimals="-3" format="ixt:numdotdecimal" name="cron:FinancingReceivableBeforeAccruedInterestCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RhYmxlOjY2Y2FiZjk3YmQ3MzQwZjJhZTJmNzk2YTk3MDFhZmIzL3RhYmxlcmFuZ2U6NjZjYWJmOTdiZDczNDBmMmFlMmY3OTZhOTcwMWFmYjNfNC0zLTEtMS0w_8d2992c3-7433-4432-a5ec-7d60bd1588be">3,137</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d58e7e380fd4928a5a4aaf66fb7fa7d_I20191231" decimals="-3" format="ixt:zerodash" name="cron:FinancingReceivableBeforeAccruedInterestCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RhYmxlOjY2Y2FiZjk3YmQ3MzQwZjJhZTJmNzk2YTk3MDFhZmIzL3RhYmxlcmFuZ2U6NjZjYWJmOTdiZDczNDBmMmFlMmY3OTZhOTcwMWFmYjNfNC02LTEtMS0w_bc8f32ef-b0b7-4ada-975c-6228544afe5b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Accrued interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3dd9320d6fb49b8af36a67921315f6a_I20201231" decimals="-3" name="cron:FinancingReceivableAccruedInterestCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RhYmxlOjY2Y2FiZjk3YmQ3MzQwZjJhZTJmNzk2YTk3MDFhZmIzL3RhYmxlcmFuZ2U6NjZjYWJmOTdiZDczNDBmMmFlMmY3OTZhOTcwMWFmYjNfNS0zLTEtMS0w_ec93968e-5749-4b66-ba4a-7aa83039d720">428</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08888a921a2b4c88b691257e4ea48e15_I20191231" decimals="-3" name="cron:FinancingReceivableAccruedInterestCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RhYmxlOjY2Y2FiZjk3YmQ3MzQwZjJhZTJmNzk2YTk3MDFhZmIzL3RhYmxlcmFuZ2U6NjZjYWJmOTdiZDczNDBmMmFlMmY3OTZhOTcwMWFmYjNfNS02LTEtMS0w_5d6acdb2-588d-4d9f-b72a-b97bc77ac692">89</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current portion of loans receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3dd9320d6fb49b8af36a67921315f6a_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NotesAndLoansReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RhYmxlOjY2Y2FiZjk3YmQ3MzQwZjJhZTJmNzk2YTk3MDFhZmIzL3RhYmxlcmFuZ2U6NjZjYWJmOTdiZDczNDBmMmFlMmY3OTZhOTcwMWFmYjNfNi0zLTEtMS0w_0cbd966b-fd69-41b8-9c7e-1853888f7b21">7,083</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08888a921a2b4c88b691257e4ea48e15_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NotesAndLoansReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RhYmxlOjY2Y2FiZjk3YmQ3MzQwZjJhZTJmNzk2YTk3MDFhZmIzL3RhYmxlcmFuZ2U6NjZjYWJmOTdiZDczNDBmMmFlMmY3OTZhOTcwMWFmYjNfNi02LTEtMS0w_567eeaac-062c-438e-8133-75b1f393bb86">4,664</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long term portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GrowCo Credit Facility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5835cd4e2e1344e38bcc3bdeeb97d893_I20201231" decimals="-3" format="ixt:numdotdecimal" name="cron:FinancingReceivableBeforeAccruedInterestNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RhYmxlOjY2Y2FiZjk3YmQ3MzQwZjJhZTJmNzk2YTk3MDFhZmIzL3RhYmxlcmFuZ2U6NjZjYWJmOTdiZDczNDBmMmFlMmY3OTZhOTcwMWFmYjNfOC0zLTEtMS0w_ead7845e-2982-45af-a249-361680890aa1">69,939</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d58e7e380fd4928a5a4aaf66fb7fa7d_I20191231" decimals="-3" format="ixt:numdotdecimal" name="cron:FinancingReceivableBeforeAccruedInterestNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RhYmxlOjY2Y2FiZjk3YmQ3MzQwZjJhZTJmNzk2YTk3MDFhZmIzL3RhYmxlcmFuZ2U6NjZjYWJmOTdiZDczNDBmMmFlMmY3OTZhOTcwMWFmYjNfOC02LTEtMS0w_17d0afa1-697e-4315-b8ac-093228ad631c">31,678</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mucci Promissory Note</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iii)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cf7bda411034052a94e3326aff296d1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="cron:FinancingReceivableBeforeAccruedInterestNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RhYmxlOjY2Y2FiZjk3YmQ3MzQwZjJhZTJmNzk2YTk3MDFhZmIzL3RhYmxlcmFuZ2U6NjZjYWJmOTdiZDczNDBmMmFlMmY3OTZhOTcwMWFmYjNfOS0zLTEtMS0w_ed9d65f1-1589-46c0-980c-c5a7a66b7bf2">13,324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b017704f622466f9bd013c4ae05afcc_I20191231" decimals="-3" format="ixt:numdotdecimal" name="cron:FinancingReceivableBeforeAccruedInterestNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RhYmxlOjY2Y2FiZjk3YmQ3MzQwZjJhZTJmNzk2YTk3MDFhZmIzL3RhYmxlcmFuZ2U6NjZjYWJmOTdiZDczNDBmMmFlMmY3OTZhOTcwMWFmYjNfOS02LTEtMS0w_02ce445c-0f4d-416a-9c02-afbd075ecc35">12,587</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannasoul Collaboration loan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iv)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idedac3c668174711a1ce0d5786afbad3_I20201231" decimals="-3" format="ixt:numdotdecimal" name="cron:FinancingReceivableBeforeAccruedInterestNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RhYmxlOjY2Y2FiZjk3YmQ3MzQwZjJhZTJmNzk2YTk3MDFhZmIzL3RhYmxlcmFuZ2U6NjZjYWJmOTdiZDczNDBmMmFlMmY3OTZhOTcwMWFmYjNfMTAtMy0xLTEtNzc5NQ_7f42a8fb-4208-4f55-a8d8-45e3cf675951">1,261</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i039760a0355f48f39de64bb56dd8ac81_I20191231" decimals="-3" format="ixt:zerodash" name="cron:FinancingReceivableBeforeAccruedInterestNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RhYmxlOjY2Y2FiZjk3YmQ3MzQwZjJhZTJmNzk2YTk3MDFhZmIzL3RhYmxlcmFuZ2U6NjZjYWJmOTdiZDczNDBmMmFlMmY3OTZhOTcwMWFmYjNfMTAtNi0xLTEtNTY5Mw_5393384d-a6ef-431a-ba9e-aa257cfd6123">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Accrued interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3dd9320d6fb49b8af36a67921315f6a_I20201231" decimals="-3" format="ixt:numdotdecimal" name="cron:FinancingReceivableAccruedInterestNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RhYmxlOjY2Y2FiZjk3YmQ3MzQwZjJhZTJmNzk2YTk3MDFhZmIzL3RhYmxlcmFuZ2U6NjZjYWJmOTdiZDczNDBmMmFlMmY3OTZhOTcwMWFmYjNfMTAtMy0xLTEtMA_40216708-8da4-4002-8359-5d229dce6b96">2,667</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08888a921a2b4c88b691257e4ea48e15_I20191231" decimals="-3" name="cron:FinancingReceivableAccruedInterestNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RhYmxlOjY2Y2FiZjk3YmQ3MzQwZjJhZTJmNzk2YTk3MDFhZmIzL3RhYmxlcmFuZ2U6NjZjYWJmOTdiZDczNDBmMmFlMmY3OTZhOTcwMWFmYjNfMTAtNi0xLTEtMA_467afc0f-b9fa-46af-b4c5-d88b4ee3b50e">702</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term portion of loans receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3dd9320d6fb49b8af36a67921315f6a_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NotesAndLoansReceivableNetNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RhYmxlOjY2Y2FiZjk3YmQ3MzQwZjJhZTJmNzk2YTk3MDFhZmIzL3RhYmxlcmFuZ2U6NjZjYWJmOTdiZDczNDBmMmFlMmY3OTZhOTcwMWFmYjNfMTEtMy0xLTEtMA_8cbfff0e-48e0-4c4f-adca-7513b90c87ee">87,191</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08888a921a2b4c88b691257e4ea48e15_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NotesAndLoansReceivableNetNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RhYmxlOjY2Y2FiZjk3YmQ3MzQwZjJhZTJmNzk2YTk3MDFhZmIzL3RhYmxlcmFuZ2U6NjZjYWJmOTdiZDczNDBmMmFlMmY3OTZhOTcwMWFmYjNfMTEtNi0xLTEtMA_c70c0d7c-1109-4788-a9f2-8b62e6163351">44,967</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total loans receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3dd9320d6fb49b8af36a67921315f6a_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NotesReceivableNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RhYmxlOjY2Y2FiZjk3YmQ3MzQwZjJhZTJmNzk2YTk3MDFhZmIzL3RhYmxlcmFuZ2U6NjZjYWJmOTdiZDczNDBmMmFlMmY3OTZhOTcwMWFmYjNfMTItMy0xLTEtMA_7d0d9416-0080-4ce9-ac48-bb951435683d">94,274</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08888a921a2b4c88b691257e4ea48e15_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NotesReceivableNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RhYmxlOjY2Y2FiZjk3YmQ3MzQwZjJhZTJmNzk2YTk3MDFhZmIzL3RhYmxlcmFuZ2U6NjZjYWJmOTdiZDczNDBmMmFlMmY3OTZhOTcwMWFmYjNfMTItNi0xLTEtMA_2702a0e8-509d-4243-92a8-fbfaab7fcbf2">49,631</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="text-indent:-9pt"><span><br/></span></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt">On July 24, 2020, the Company and its joint venture partner entered into an amendment to the Series A Loan with Natuera to increase the principal amount of the Series A Loan by $<ix:nonFraction unitRef="usd" contextRef="i7999a4c04ba7440fac47582ee604719d_I20200724" decimals="INF" format="ixt:numdotdecimal" name="cron:FinancingReceivableAdditionalFaceAmountIncludingThirdPartyAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RleHRyZWdpb246YmU2YjZhNzQ2YmQ5NDE2NGI4MjJiMDhkOWE2YWUyMTJfMTU5NDI5MTg2Mzc5ODk_6c7a3af0-7156-4135-8183-788dde72892e">6,350</ix:nonFraction>, to an aggregate principal amount of the Series A Loan of $<ix:nonFraction unitRef="usd" contextRef="i7999a4c04ba7440fac47582ee604719d_I20200724" decimals="INF" format="ixt:numdotdecimal" name="cron:FinancingReceivableFaceAmountIncludingThirdPartyAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RleHRyZWdpb246YmU2YjZhNzQ2YmQ5NDE2NGI4MjJiMDhkOWE2YWUyMTJfMTU5NDI5MTg2Mzc5OTc_8048dc0e-6a92-498b-841d-e15192ce345e">15,500</ix:nonFraction>, of which the Company has committed to fund <ix:nonFraction unitRef="number" contextRef="i7999a4c04ba7440fac47582ee604719d_I20200724" decimals="INF" name="cron:FinancingReceivableFundingCommitmentPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RleHRyZWdpb246YmU2YjZhNzQ2YmQ5NDE2NGI4MjJiMDhkOWE2YWUyMTJfMTU5NDI5MTg2MzgwMTE_8a3c809d-0068-4d90-aa74-63bb412e63bb">50</ix:nonFraction>% and its joint venture partner has committed to fund the remaining <ix:nonFraction unitRef="number" contextRef="i41bfa3763a044d118326791c2cd608f4_I20200724" decimals="INF" name="cron:FinancingReceivableFundingCommitmentPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RleHRyZWdpb246YmU2YjZhNzQ2YmQ5NDE2NGI4MjJiMDhkOWE2YWUyMTJfMTU5NDI5MTg2Mzc5OTA_4210818b-ad6d-4ade-86ec-d97e20872732">50</ix:nonFraction>%. Outstanding principal amounts continue to bear interest at a fixed annual rate of <ix:nonFraction unitRef="number" contextRef="i7999a4c04ba7440fac47582ee604719d_I20200724" decimals="INF" name="cron:FinancingReceivableInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RleHRyZWdpb246YmU2YjZhNzQ2YmQ5NDE2NGI4MjJiMDhkOWE2YWUyMTJfMTU5NDI5MTg2MzgwMTk_3de19899-fa0c-4e1f-ade2-0403aec398ce">5.67</ix:nonFraction>%. In December 2020, the Series A Loan was amended to extend its maturity date to September 1, 2021 from March 1, 2021.</span></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, a current expected credit loss allowance of $<ix:nonFraction unitRef="usd" contextRef="i0b816c5b52b043c8a33c4048ab073bc3_I20201231" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLosses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RleHRyZWdpb246YmU2YjZhNzQ2YmQ5NDE2NGI4MjJiMDhkOWE2YWUyMTJfMTIwOTQ2Mjc5NDY4NTU_909d304b-a92d-47b9-ae7b-4d3da849ea31">685</ix:nonFraction> was recorded against the Natuera Series A loan. A loss allowance of $<ix:nonFraction unitRef="usd" contextRef="ifb88f981f5fb4f0f99e4f3ce4df9e544_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinancingReceivableAllowanceForCreditLosses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RleHRyZWdpb246YmU2YjZhNzQ2YmQ5NDE2NGI4MjJiMDhkOWE2YWUyMTJfMTIwOTQ2Mjc5NDY4MDc_73ccc638-3178-49da-9c5d-71ebf3f98b50">3,024</ix:nonFraction> was recorded against the Natuera Series A Loan related to the Company&#8217;s share of net loss from Natuera in excess of the carrying value of the equity method investment. Refer to Note 6.</span></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt">On August 23, 2019, the Company entered into a credit agreement with Cronos GrowCo in respect of a C$<ix:nonFraction unitRef="cad" contextRef="i0cb79bd1f7294820b3cd4e80384aad34_I20190823" decimals="INF" format="ixt:numdotdecimal" name="cron:FinancingReceivableFaceAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RleHRyZWdpb246YmU2YjZhNzQ2YmQ5NDE2NGI4MjJiMDhkOWE2YWUyMTJfMTI2NDQzODM3NDc5ODk_154f24f8-3620-4e9e-ac52-f35cd626eda5">100,000</ix:nonFraction> (approximately $<ix:nonFraction unitRef="usd" contextRef="i0cb79bd1f7294820b3cd4e80384aad34_I20190823" decimals="INF" format="ixt:numdotdecimal" name="cron:FinancingReceivableFaceAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RleHRyZWdpb246YmU2YjZhNzQ2YmQ5NDE2NGI4MjJiMDhkOWE2YWUyMTJfMTIwOTQ2Mjc5NDY1NTY_ce3cf33b-c6df-41fd-a01a-2bfb4151f3e2">78,430</ix:nonFraction>) secured non-revolving term loan credit facility (the &#8220;GrowCo Credit Facility&#8221;). The GrowCo Credit Facility will mature on March 31, 2031 and will bear interest at varying rates based on the Canadian prime rate as announced by the Bank of Montreal. Interest began to accrue as of the closing date of the GrowCo Credit Facility and is payable on a quarterly basis until maturity, except that any interest accrued prior to March 31, 2021 will be payable not later than December 31, 2021. Repayment of principal will be made on a quarterly basis commencing on March 31, 2021. The GrowCo Credit Facility is secured by substantially all present and after acquired property of Cronos GrowCo and its subsidiaries. Mucci, the other <ix:nonFraction unitRef="number" contextRef="i499c1e4218d94789b4afa9918d59c37c_I20201231" decimals="2" name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RleHRyZWdpb246YmU2YjZhNzQ2YmQ5NDE2NGI4MjJiMDhkOWE2YWUyMTJfMTI2NDQzODM3NTQzOTU_4b688d35-d520-47db-a966-9b1b4bf2e995">50</ix:nonFraction>% shareholder of Cronos GrowCo, has provided a limited recourse guarantee in favor of Cronos GrowCo, secured by Mucci&#8217;s shares in Cronos GrowCo. As of December&#160;31, 2020, Cronos GrowCo had drawn C$<ix:nonFraction unitRef="cad" contextRef="ic6677966de35472db8717afeb11c793f_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireLoansReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RleHRyZWdpb246YmU2YjZhNzQ2YmQ5NDE2NGI4MjJiMDhkOWE2YWUyMTJfMzg0ODI5MDc3ODE5Nw_863a5658-87a4-4703-819e-fe9582faef29">95,150</ix:nonFraction> ($<ix:nonFraction unitRef="usd" contextRef="ic6677966de35472db8717afeb11c793f_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireLoansReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RleHRyZWdpb246YmU2YjZhNzQ2YmQ5NDE2NGI4MjJiMDhkOWE2YWUyMTJfMTA5OTUxMTYzNjI3Nw_13980663-1968-4dab-8b88-3fc9639a6aab">74,626</ix:nonFraction>) from the GrowCo Credit Facility. Subsequent to December 31, 2020, the terms of the GrowCo Credit Facility were amended, such that any interest accrued from April 1, 2021 to December 31, 2021 will be payable not later than December 31, 2022, and repayment of principal will be made on a quarterly basis commencing on March 31, 2022.</span></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, a current expected credit loss allowance of $<ix:nonFraction unitRef="usd" contextRef="i5835cd4e2e1344e38bcc3bdeeb97d893_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinancingReceivableAllowanceForCreditLosses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RleHRyZWdpb246YmU2YjZhNzQ2YmQ5NDE2NGI4MjJiMDhkOWE2YWUyMTJfMTA5OTUxMTYzNjI4NA_002bfe92-5a63-4fd7-b375-927330064ba2">1,470</ix:nonFraction> was recorded against the GrowCo Credit Facility.</span></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.22pt">On June 28, 2019, the Company entered into a promissory note receivable agreement (the &#8220;Mucci Promissory Note&#8221;) for C$<ix:nonFraction unitRef="cad" contextRef="i4799e1f980174942a3388f2d435ce38c_I20190628" decimals="INF" format="ixt:numdotdecimal" name="cron:FinancingReceivableFaceAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RleHRyZWdpb246YmU2YjZhNzQ2YmQ5NDE2NGI4MjJiMDhkOWE2YWUyMTJfMTI2NDQzODM3NDgwMDQ_7460cd2d-7391-483d-8903-fd55f8ddd7f6">16,350</ix:nonFraction> (approximately $<ix:nonFraction unitRef="usd" contextRef="i4799e1f980174942a3388f2d435ce38c_I20190628" decimals="INF" format="ixt:numdotdecimal" name="cron:FinancingReceivableFaceAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RleHRyZWdpb246YmU2YjZhNzQ2YmQ5NDE2NGI4MjJiMDhkOWE2YWUyMTJfMTIwOTQ2Mjc5NDY1NjU_e2cc8e70-34f1-4961-9baa-b25e4838ac4e">12,823</ix:nonFraction>) with Mucci. The outstanding principal amount of the Mucci Promissory Note bears interest at <ix:nonFraction unitRef="number" contextRef="i4799e1f980174942a3388f2d435ce38c_I20190628" decimals="INF" name="cron:FinancingReceivableInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RleHRyZWdpb246YmU2YjZhNzQ2YmQ5NDE2NGI4MjJiMDhkOWE2YWUyMTJfODI0NjMzNzI4OTMxNg_30bb264a-581a-4baa-8a04-ca58ee587c11">3.95</ix:nonFraction>% annually and is due within <ix:nonNumeric contextRef="i14e23009552044f48cea9a365ae91305_D20190628-20190628" format="ixt-sec:durday" name="cron:FinancingReceivableDueOnDemandTerm" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RleHRyZWdpb246YmU2YjZhNzQ2YmQ5NDE2NGI4MjJiMDhkOWE2YWUyMTJfODI0NjMzNzI4OTMyMw_677e1b2b-15f8-4190-91f0-2a1147d52da8">90</ix:nonNumeric> days of demand. The Company does not intend to demand the loan within <ix:nonNumeric contextRef="i14e23009552044f48cea9a365ae91305_D20190628-20190628" format="ixt-sec:durmonth" name="cron:FinancingReceivableDueOnDemandIntendedDemandTermMinimum" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RleHRyZWdpb246YmU2YjZhNzQ2YmQ5NDE2NGI4MjJiMDhkOWE2YWUyMTJfODI0NjMzNzI4OTMzMQ_aed62d55-1877-4948-bb30-0f398113c274">12</ix:nonNumeric> months. Interest accrued under the Mucci Promissory Note until July 1, 2021 is payable by way of capitalization on the principal amount and interest thereafter must be paid in cash on a quarterly basis. The Mucci Promissory Note is secured by a general security agreement covering all the assets of Mucci. Subsequent to December 31, 2020, the terms of the Mucci Promissory Note were amended, such that interest accrued under the Mucci Promissory Note until July 1, 2022, is payable by way of capitalization on the principal amount and interest thereafter must be paid in cash on a quarterly basis.</span></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, a current expected credit loss allowance of $<ix:nonFraction unitRef="usd" contextRef="ice5cd225a5a048c281f6386df823c5e3_I20201231" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLosses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RleHRyZWdpb246YmU2YjZhNzQ2YmQ5NDE2NGI4MjJiMDhkOWE2YWUyMTJfMTA5OTUxMTYzNjMyMQ_c4c84d7a-3fb0-4679-85bf-6203e774307f">259</ix:nonFraction> has been recorded against the Mucci Promissory Note.</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(iv)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.5pt">On April 1, 2020, Cronos Israel entered into the Cannasoul Collaboration. Cronos Israel has agreed to advance approximately ILS <ix:nonFraction unitRef="ils" contextRef="if0ba41d1bbbd4426a1cae1e0e667c052_I20200401" decimals="-3" format="ixt:numdotdecimal" name="cron:CollaborativeArrangementAmountOfAdvances" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RleHRyZWdpb246YmU2YjZhNzQ2YmQ5NDE2NGI4MjJiMDhkOWE2YWUyMTJfMTI2NDQzODM3NTQ0NjY_f14fe8dc-32f2-494c-bcb3-dfbcece41a36">8,297</ix:nonFraction> (approximately $<ix:nonFraction unitRef="usd" contextRef="if0ba41d1bbbd4426a1cae1e0e667c052_I20200401" decimals="-3" format="ixt:numdotdecimal" name="cron:CollaborativeArrangementAmountOfAdvances" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RleHRyZWdpb246YmU2YjZhNzQ2YmQ5NDE2NGI4MjJiMDhkOWE2YWUyMTJfMTI2NDQzODM3NTQ0OTg_9e13633c-d9e6-4233-852f-a1d158770210">2,574</ix:nonFraction>) by a non-recourse loan to CLS over a period of <ix:nonNumeric contextRef="i3b043767918a43bfb738d4382571bc3f_D20200401-20200401" format="ixt-sec:durwordsen" name="cron:CollaborativeArrangementTermOfAgreement" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RleHRyZWdpb246YmU2YjZhNzQ2YmQ5NDE2NGI4MjJiMDhkOWE2YWUyMTJfODI0NjMzNzI4OTM0MQ_fadd8759-c5d4-47b9-a314-06688012dade">two years</ix:nonNumeric> for the capital and operating expenditures of the laboratory. The outstanding principal on the loan bears interest at <ix:nonFraction unitRef="number" contextRef="if0ba41d1bbbd4426a1cae1e0e667c052_I20200401" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RleHRyZWdpb246YmU2YjZhNzQ2YmQ5NDE2NGI4MjJiMDhkOWE2YWUyMTJfMTI2NDQzODM3NTQ2MjU_87895d4e-e5eb-4322-ae3d-fe610a7bfa75">3.5</ix:nonFraction>% annually and will be repaid through the profits generated from the Cannasoul Collaboration. For the year ended December 31, 2020, CLS has received ILS $<ix:nonFraction unitRef="ils" contextRef="ia530bf80f98848218e4aca2d29c92f27_I20201231" decimals="-3" format="ixt:numdotdecimal" name="cron:CollaborativeArrangementInstallmentsReceived" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RleHRyZWdpb246YmU2YjZhNzQ2YmQ5NDE2NGI4MjJiMDhkOWE2YWUyMTJfMTI2NDQzODM3NTQ2NDE_3dde2841-c3c9-428e-b1b8-0044d98c840d">4,148</ix:nonFraction> (approximately $<ix:nonFraction unitRef="usd" contextRef="ia530bf80f98848218e4aca2d29c92f27_I20201231" decimals="-3" format="ixt:numdotdecimal" name="cron:CollaborativeArrangementInstallmentsReceived" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RleHRyZWdpb246YmU2YjZhNzQ2YmQ5NDE2NGI4MjJiMDhkOWE2YWUyMTJfMTI2NDQzODM3NTQ2NTE_45f90fa9-74c4-404e-a07b-3fc9992420a9">1,287</ix:nonFraction>). </span></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, a current expected credit loss allowance of $<ix:nonFraction unitRef="usd" contextRef="ia530bf80f98848218e4aca2d29c92f27_I20201231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RleHRyZWdpb246YmU2YjZhNzQ2YmQ5NDE2NGI4MjJiMDhkOWE2YWUyMTJfMTIwOTQ2Mjc5NDg2MzY_c1180e44-7915-48f8-bfb3-531ca0d4e640">25</ix:nonFraction> has been recorded against the Cannasoul Collaboration loan.</span></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90</span></div></div></div><div id="i1ae9134e40e74e0aac958218112e53d4_115"></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December 31, 2020, 2019, and 2018</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for gram and share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:16pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9. <ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMTUvZnJhZzo4YWMyMWQxOWNlZTM0NDM1YjJkZGE1ZDlkZDBjMjA5MS90ZXh0cmVnaW9uOjhhYzIxZDE5Y2VlMzQ0MzViMmRkYTVkOWRkMGMyMDkxXzE5Njc_41a662b6-6a2f-49cd-8172-1c193ef9c3ed" continuedAt="ie95b2a51b5644b9d92c51cda8b327749" escape="true">Loans Payable</ix:nonNumeric></span></div><ix:continuation id="ie95b2a51b5644b9d92c51cda8b327749"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, the Company did not have any loans payable. On January 23, 2019, the Company entered into a credit agreement with the Canadian Imperial Bank of Commerce, as administrative agent and lender, and the Bank of Montreal, as lender, in respect of a C$<ix:nonFraction unitRef="cad" contextRef="if184b5d95d6e4a88b9063285a8977d46_I20190123" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMTUvZnJhZzo4YWMyMWQxOWNlZTM0NDM1YjJkZGE1ZDlkZDBjMjA5MS90ZXh0cmVnaW9uOjhhYzIxZDE5Y2VlMzQ0MzViMmRkYTVkOWRkMGMyMDkxXzExMTg_6421964a-a41d-42c7-beea-20e633a510b0">65,000</ix:nonFraction> ($<ix:nonFraction unitRef="usd" contextRef="if184b5d95d6e4a88b9063285a8977d46_I20190123" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMTUvZnJhZzo4YWMyMWQxOWNlZTM0NDM1YjJkZGE1ZDlkZDBjMjA5MS90ZXh0cmVnaW9uOjhhYzIxZDE5Y2VlMzQ0MzViMmRkYTVkOWRkMGMyMDkxXzExMjI_22851ef8-0e60-41cf-bfbe-9c47fe8cc25c">48,715</ix:nonFraction>) secured non-revolving term loan credit facility (the &#8220;Credit Facility&#8221;). The loan was guaranteed by the Company&#8217;s wholly owned Canadian subsidiaries and secured by substantially all present and after-acquired property of the Company and its wholly owned Canadian subsidiaries. The Company used the funds available under the Credit Facility to fully repay the construction loan payable, consisting of C$<ix:nonFraction unitRef="cad" contextRef="if5da93e8c4dd43b293a795770578b760_D20190123-20190123" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfSecuredDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMTUvZnJhZzo4YWMyMWQxOWNlZTM0NDM1YjJkZGE1ZDlkZDBjMjA5MS90ZXh0cmVnaW9uOjhhYzIxZDE5Y2VlMzQ0MzViMmRkYTVkOWRkMGMyMDkxXzE1MjY_17b26f95-6e55-4137-adb6-774707ec6351">21,311</ix:nonFraction> ($<ix:nonFraction unitRef="usd" contextRef="if5da93e8c4dd43b293a795770578b760_D20190123-20190123" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfSecuredDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMTUvZnJhZzo4YWMyMWQxOWNlZTM0NDM1YjJkZGE1ZDlkZDBjMjA5MS90ZXh0cmVnaW9uOjhhYzIxZDE5Y2VlMzQ0MzViMmRkYTVkOWRkMGMyMDkxXzE1MzA_5d16b9af-3359-4e88-b1da-2defec268065">15,971</ix:nonFraction>) in loan principal and C$<ix:nonFraction unitRef="cad" contextRef="if5da93e8c4dd43b293a795770578b760_D20190123-20190123" decimals="-3" name="us-gaap:InterestPaidCapitalized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMTUvZnJhZzo4YWMyMWQxOWNlZTM0NDM1YjJkZGE1ZDlkZDBjMjA5MS90ZXh0cmVnaW9uOjhhYzIxZDE5Y2VlMzQ0MzViMmRkYTVkOWRkMGMyMDkxXzE1NTY_bc084861-485a-4ad5-8239-882ee3361b56">275</ix:nonFraction> ($<ix:nonFraction unitRef="usd" contextRef="if5da93e8c4dd43b293a795770578b760_D20190123-20190123" decimals="-3" name="us-gaap:InterestPaidCapitalized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMTUvZnJhZzo4YWMyMWQxOWNlZTM0NDM1YjJkZGE1ZDlkZDBjMjA5MS90ZXh0cmVnaW9uOjhhYzIxZDE5Y2VlMzQ0MzViMmRkYTVkOWRkMGMyMDkxXzE1NjA_e5134388-73e9-482c-b32d-56cc9b627b96">206</ix:nonFraction>) in accrued interest and fees, calculated for the period from January 1, 2019 to January 22, 2019. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 8, 2019, the Credit Facility was fully repaid. In connection with the Credit Facility, the Company incurred financing costs of C$<ix:nonFraction unitRef="cad" contextRef="ie5866afdb41147fba8fa4b3c1ae2fe9d_I20190308" decimals="-3" name="us-gaap:DeferredFinanceCostsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMTUvZnJhZzo4YWMyMWQxOWNlZTM0NDM1YjJkZGE1ZDlkZDBjMjA5MS90ZXh0cmVnaW9uOjhhYzIxZDE5Y2VlMzQ0MzViMmRkYTVkOWRkMGMyMDkxXzM4NDgyOTA3MDQwOTE_ab4fc785-fe11-4c74-9a3d-29e360ebc0aa">523</ix:nonFraction> ($<ix:nonFraction unitRef="usd" contextRef="ie5866afdb41147fba8fa4b3c1ae2fe9d_I20190308" decimals="-3" name="us-gaap:DeferredFinanceCostsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMTUvZnJhZzo4YWMyMWQxOWNlZTM0NDM1YjJkZGE1ZDlkZDBjMjA5MS90ZXh0cmVnaW9uOjhhYzIxZDE5Y2VlMzQ0MzViMmRkYTVkOWRkMGMyMDkxXzM4NDgyOTA3MDQwMjc_b87b05d0-438f-4a95-b2ce-45b067b94c82">395</ix:nonFraction>) which were expensed upon repayment of the Credit Facility.</span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div id="i1ae9134e40e74e0aac958218112e53d4_121"></div><div style="margin-bottom:12pt;margin-top:16pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">10. <ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjEvZnJhZzo5MGQwNzYyMDVjMjg0MmYwOTA2MjA0NzA4MWZiYzY5Ny90ZXh0cmVnaW9uOjkwZDA3NjIwNWMyODQyZjA5MDYyMDQ3MDgxZmJjNjk3XzU5MQ_c4c076ea-eacb-4cf0-99b1-8309b429d9b1" continuedAt="i99a54dd6b49440de94aadfcb5f1a1218" escape="true">Property, Plant and Equipment</ix:nonNumeric></span></div><ix:continuation id="i99a54dd6b49440de94aadfcb5f1a1218" continuedAt="ieb51355aba7c422a827147a48d71079d"><ix:continuation id="i36eb35fa429945ed88f4bf658e4e2bea"><div style="margin-bottom:6pt;padding-left:29.25pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment, net consisted of the following:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.844%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.261%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.263%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6db5a3fb2eca4f54b3f90ed1c036dd12_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjEvZnJhZzo5MGQwNzYyMDVjMjg0MmYwOTA2MjA0NzA4MWZiYzY5Ny90YWJsZTpkNTllYjExNzI0OWE0ZmUxOTY2YzVkOWFmNWJhNzRhNi90YWJsZXJhbmdlOmQ1OWViMTE3MjQ5YTRmZTE5NjZjNWQ5YWY1YmE3NGE2XzMtMi0xLTEtMA_1e68b3a8-98aa-425e-a43d-395509d2b2a2">3,197</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77c5346ffc2148c0ac4a76f63497a058_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjEvZnJhZzo5MGQwNzYyMDVjMjg0MmYwOTA2MjA0NzA4MWZiYzY5Ny90YWJsZTpkNTllYjExNzI0OWE0ZmUxOTY2YzVkOWFmNWJhNzRhNi90YWJsZXJhbmdlOmQ1OWViMTE3MjQ5YTRmZTE5NjZjNWQ5YWY1YmE3NGE2XzMtNS0xLTEtMA_f59da546-2c85-4edd-a0bd-aa7f8da62b9b">3,071</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4bd7ce9c19347cdabdc7ac598cb48de_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjEvZnJhZzo5MGQwNzYyMDVjMjg0MmYwOTA2MjA0NzA4MWZiYzY5Ny90YWJsZTpkNTllYjExNzI0OWE0ZmUxOTY2YzVkOWFmNWJhNzRhNi90YWJsZXJhbmdlOmQ1OWViMTE3MjQ5YTRmZTE5NjZjNWQ5YWY1YmE3NGE2XzQtMi0xLTEtMA_970bea1b-ed5c-4b93-a4b5-c5b76d1c6245">158,586</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b7a48365daf408b8997db5c9fdc8a02_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjEvZnJhZzo5MGQwNzYyMDVjMjg0MmYwOTA2MjA0NzA4MWZiYzY5Ny90YWJsZTpkNTllYjExNzI0OWE0ZmUxOTY2YzVkOWFmNWJhNzRhNi90YWJsZXJhbmdlOmQ1OWViMTE3MjQ5YTRmZTE5NjZjNWQ5YWY1YmE3NGE2XzQtNS0xLTEtMA_b2bdeb6a-272f-49b3-a047-71bdb303b437">149,690</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43d67eea34364b749f11c14c15ff8a38_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjEvZnJhZzo5MGQwNzYyMDVjMjg0MmYwOTA2MjA0NzA4MWZiYzY5Ny90YWJsZTpkNTllYjExNzI0OWE0ZmUxOTY2YzVkOWFmNWJhNzRhNi90YWJsZXJhbmdlOmQ1OWViMTE3MjQ5YTRmZTE5NjZjNWQ5YWY1YmE3NGE2XzUtMi0xLTEtMA_2ed5a38b-e9b5-48c5-ae21-b7f3077e1420">18,824</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d514a8da3584157b13f718b5294267b_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjEvZnJhZzo5MGQwNzYyMDVjMjg0MmYwOTA2MjA0NzA4MWZiYzY5Ny90YWJsZTpkNTllYjExNzI0OWE0ZmUxOTY2YzVkOWFmNWJhNzRhNi90YWJsZXJhbmdlOmQ1OWViMTE3MjQ5YTRmZTE5NjZjNWQ5YWY1YmE3NGE2XzUtNS0xLTEtMA_97ec14c6-9a89-4992-a7c0-61cb6afab2fa">10,079</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03c20e15ec0844f8b17b6c80bb9144ce_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjEvZnJhZzo5MGQwNzYyMDVjMjg0MmYwOTA2MjA0NzA4MWZiYzY5Ny90YWJsZTpkNTllYjExNzI0OWE0ZmUxOTY2YzVkOWFmNWJhNzRhNi90YWJsZXJhbmdlOmQ1OWViMTE3MjQ5YTRmZTE5NjZjNWQ5YWY1YmE3NGE2XzYtMi0xLTEtMA_d3060a32-ee74-4da6-b292-a2c87371aebe">710</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d68a5e2b3a0451ab19ab24066e538cd_I20191231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjEvZnJhZzo5MGQwNzYyMDVjMjg0MmYwOTA2MjA0NzA4MWZiYzY5Ny90YWJsZTpkNTllYjExNzI0OWE0ZmUxOTY2YzVkOWFmNWJhNzRhNi90YWJsZXJhbmdlOmQ1OWViMTE3MjQ5YTRmZTE5NjZjNWQ5YWY1YmE3NGE2XzYtNS0xLTEtMA_4f37d3dd-e6ea-4dc5-970d-ce59ea9f8497">526</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78a071bcbe99463dbb1b5de598353925_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjEvZnJhZzo5MGQwNzYyMDVjMjg0MmYwOTA2MjA0NzA4MWZiYzY5Ny90YWJsZTpkNTllYjExNzI0OWE0ZmUxOTY2YzVkOWFmNWJhNzRhNi90YWJsZXJhbmdlOmQ1OWViMTE3MjQ5YTRmZTE5NjZjNWQ5YWY1YmE3NGE2XzctMi0xLTEtMA_07fda812-5fbe-4404-9ddd-e3c0f53c2d0f">3,740</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4486ec909cf8480e89364e36b9c8e464_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjEvZnJhZzo5MGQwNzYyMDVjMjg0MmYwOTA2MjA0NzA4MWZiYzY5Ny90YWJsZTpkNTllYjExNzI0OWE0ZmUxOTY2YzVkOWFmNWJhNzRhNi90YWJsZXJhbmdlOmQ1OWViMTE3MjQ5YTRmZTE5NjZjNWQ5YWY1YmE3NGE2XzctNS0xLTEtMA_f20103ed-b06f-404b-93ac-d0585bbc3195">1,758</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d7511be19f4566915140061bc540f6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjEvZnJhZzo5MGQwNzYyMDVjMjg0MmYwOTA2MjA0NzA4MWZiYzY5Ny90YWJsZTpkNTllYjExNzI0OWE0ZmUxOTY2YzVkOWFmNWJhNzRhNi90YWJsZXJhbmdlOmQ1OWViMTE3MjQ5YTRmZTE5NjZjNWQ5YWY1YmE3NGE2XzgtMi0xLTEtMA_64010529-fe75-4acf-ab9d-943b3722be22">20,837</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31a70e4a512044509cf0a927b6ac5a19_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjEvZnJhZzo5MGQwNzYyMDVjMjg0MmYwOTA2MjA0NzA4MWZiYzY5Ny90YWJsZTpkNTllYjExNzI0OWE0ZmUxOTY2YzVkOWFmNWJhNzRhNi90YWJsZXJhbmdlOmQ1OWViMTE3MjQ5YTRmZTE5NjZjNWQ5YWY1YmE3NGE2XzgtNS0xLTEtMA_7e75c5c5-6dfe-4ecd-9765-88a94b658d92">3,569</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjEvZnJhZzo5MGQwNzYyMDVjMjg0MmYwOTA2MjA0NzA4MWZiYzY5Ny90YWJsZTpkNTllYjExNzI0OWE0ZmUxOTY2YzVkOWFmNWJhNzRhNi90YWJsZXJhbmdlOmQ1OWViMTE3MjQ5YTRmZTE5NjZjNWQ5YWY1YmE3NGE2XzktMi0xLTEtMA_3c5b75ff-532a-4185-be9a-304fbe45fcdb">18,295</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjEvZnJhZzo5MGQwNzYyMDVjMjg0MmYwOTA2MjA0NzA4MWZiYzY5Ny90YWJsZTpkNTllYjExNzI0OWE0ZmUxOTY2YzVkOWFmNWJhNzRhNi90YWJsZXJhbmdlOmQ1OWViMTE3MjQ5YTRmZTE5NjZjNWQ5YWY1YmE3NGE2XzktNS0xLTEtMA_1498665e-bf4d-41c7-b162-94c95a2d4e2f">8,745</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjEvZnJhZzo5MGQwNzYyMDVjMjg0MmYwOTA2MjA0NzA4MWZiYzY5Ny90YWJsZTpkNTllYjExNzI0OWE0ZmUxOTY2YzVkOWFmNWJhNzRhNi90YWJsZXJhbmdlOmQ1OWViMTE3MjQ5YTRmZTE5NjZjNWQ5YWY1YmE3NGE2XzEwLTItMS0xLTA_1ac88188-a7cc-4c4c-86b7-21056a0f9b5d">187,599</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjEvZnJhZzo5MGQwNzYyMDVjMjg0MmYwOTA2MjA0NzA4MWZiYzY5Ny90YWJsZTpkNTllYjExNzI0OWE0ZmUxOTY2YzVkOWFmNWJhNzRhNi90YWJsZXJhbmdlOmQ1OWViMTE3MjQ5YTRmZTE5NjZjNWQ5YWY1YmE3NGE2XzEwLTUtMS0xLTA_62da9015-db9e-40b9-a9a7-f622d75a2d46">159,948</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense included in costs of sales relating to manufacturing equipment and production facilities for the year ended December&#160;31, 2020 was $<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSoldDepreciation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjEvZnJhZzo5MGQwNzYyMDVjMjg0MmYwOTA2MjA0NzA4MWZiYzY5Ny90ZXh0cmVnaW9uOjkwZDA3NjIwNWMyODQyZjA5MDYyMDQ3MDgxZmJjNjk3XzI0NA_76c0c60b-a616-4d85-b141-fe8bb07ef908">3,447</ix:nonFraction> (December&#160;31, 2019 &#8211; $<ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSoldDepreciation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjEvZnJhZzo5MGQwNzYyMDVjMjg0MmYwOTA2MjA0NzA4MWZiYzY5Ny90ZXh0cmVnaW9uOjkwZDA3NjIwNWMyODQyZjA5MDYyMDQ3MDgxZmJjNjk3XzI1Ng_87ebb27c-6004-427d-aa98-651cab906fe8">1,812</ix:nonFraction>; 2018 &#8211; $<ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSoldDepreciation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjEvZnJhZzo5MGQwNzYyMDVjMjg0MmYwOTA2MjA0NzA4MWZiYzY5Ny90ZXh0cmVnaW9uOjkwZDA3NjIwNWMyODQyZjA5MDYyMDQ3MDgxZmJjNjk3XzEyMDk0NjI3OTA2MzM1_d8589981-07ac-410e-adde-6f3de3e21b3a">374</ix:nonFraction>). Depreciation expense included in operating expenses related to general office space and equipment for the year ended December&#160;31, 2020 was $<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationNonproduction" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjEvZnJhZzo5MGQwNzYyMDVjMjg0MmYwOTA2MjA0NzA4MWZiYzY5Ny90ZXh0cmVnaW9uOjkwZDA3NjIwNWMyODQyZjA5MDYyMDQ3MDgxZmJjNjk3XzEyMDk0NjI3OTA3NDU1_161a2e72-b298-4c12-9d24-e5dabac631b3">2,058</ix:nonFraction> (December&#160;31, 2019 &#8211; $<ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationNonproduction" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjEvZnJhZzo5MGQwNzYyMDVjMjg0MmYwOTA2MjA0NzA4MWZiYzY5Ny90ZXh0cmVnaW9uOjkwZDA3NjIwNWMyODQyZjA5MDYyMDQ3MDgxZmJjNjk3XzQxMQ_3dd25d77-91ca-45ad-bf49-9cc04ed7a579">1,444</ix:nonFraction>; 2018 &#8211; $<ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" name="us-gaap:DepreciationNonproduction" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjEvZnJhZzo5MGQwNzYyMDVjMjg0MmYwOTA2MjA0NzA4MWZiYzY5Ny90ZXh0cmVnaW9uOjkwZDA3NjIwNWMyODQyZjA5MDYyMDQ3MDgxZmJjNjk3XzEyMDk0NjI3OTA2MzQy_ffd6d075-5185-4191-9a4a-717acb089328">261</ix:nonFraction>). The remaining depreciation is included in inventory. </span></div></ix:continuation><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ieb51355aba7c422a827147a48d71079d">For the year ended December&#160;31, 2020, there was <ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt-sec:numwordsen" name="us-gaap:InterestCostsCapitalized" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjEvZnJhZzo5MGQwNzYyMDVjMjg0MmYwOTA2MjA0NzA4MWZiYzY5Ny90ZXh0cmVnaW9uOjkwZDA3NjIwNWMyODQyZjA5MDYyMDQ3MDgxZmJjNjk3XzEyMDk0NjI3OTA2MjEy_50fa44e9-890e-4499-8488-3649e7440328">no</ix:nonFraction> capitalized interest included in construction in progress (2019 &#8211; $<ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt-sec:numwordsen" name="us-gaap:InterestCostsCapitalized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjEvZnJhZzo5MGQwNzYyMDVjMjg0MmYwOTA2MjA0NzA4MWZiYzY5Ny90ZXh0cmVnaW9uOjkwZDA3NjIwNWMyODQyZjA5MDYyMDQ3MDgxZmJjNjk3XzEyMDk0NjI3OTA2MjY0_11b624d4-5e20-445d-856d-3f7f240ed756">nil</ix:nonFraction>; 2018 &#8211;$<ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" name="us-gaap:InterestCostsCapitalized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjEvZnJhZzo5MGQwNzYyMDVjMjg0MmYwOTA2MjA0NzA4MWZiYzY5Ny90ZXh0cmVnaW9uOjkwZDA3NjIwNWMyODQyZjA5MDYyMDQ3MDgxZmJjNjk3XzEyMDk0NjI3OTA2MzU1_f423f72a-142a-42b6-8b23-e43cd0190407">89</ix:nonFraction>).</ix:continuation> </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div id="i1ae9134e40e74e0aac958218112e53d4_124"></div><div style="margin-bottom:12pt;margin-top:16pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">11. <ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90ZXh0cmVnaW9uOjVjYjg1MDFiMmY3NTRlMjdiOWVmZDM0NTA5Y2Q0ODk4XzgwMQ_8a0ffa7a-644e-428f-9a65-520032f04028" continuedAt="ie0661a5184804efc8899ccbab14a0674" escape="true">Intangible Assets and Goodwill </ix:nonNumeric></span></div><ix:continuation id="ie0661a5184804efc8899ccbab14a0674" continuedAt="iff8835c322ec421e8c5254a72ed4bd54"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ongoing restrictions and closures experienced by retail stores in the U.S. as a result of the COVID-19 pandemic have negatively impacted sales and demand which has resulted in slower than expected revenue growth in the U.S. reporting unit. The Company expects the revenue growth and operating results in the U.S. reporting unit to continue to be negatively impacted as the decrease in customer demand and retail closures are expected to continue as a result of the pandemic. The Company performed an interim impairment test as of June 30, 2020 on the U.S. reporting unit, which holds the Redwood goodwill, as well as the indefinite-lived intangible asset (Lord Jones&#8482; brand) to determine whether the carrying amount of the reporting unit and intangible asset exceeded their respective fair values. The Company reassessed its estimates and forecasts during the second quarter of 2020 to determine the fair values of the reporting unit and intangible asset. The fair values were determined using a discounted cash flow method on the reporting unit and the relief-from-royalty method on the Lord Jones&#8482; brand. Significant inputs include discount rate, growth rates, and cash flow projections. Based on these valuations, the carrying value exceeded the fair value resulting in an impairment on both the reporting unit as well as the Lord Jones&#8482; brand. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded $<ix:nonFraction unitRef="usd" contextRef="i3d156ad77f3343718374ed5a6b20465b_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairmentLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90ZXh0cmVnaW9uOjVjYjg1MDFiMmY3NTRlMjdiOWVmZDM0NTA5Y2Q0ODk4XzYwNDczMTM5NTgyNTQ_9388ef7c-6b26-4f9c-a65c-1136a80022d8">35,000</ix:nonFraction> of impairment charges on the U.S. reporting unit and $<ix:nonFraction unitRef="usd" contextRef="ib956a338fe1b4ef1a233bc83863cd2d7_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90ZXh0cmVnaW9uOjVjYjg1MDFiMmY3NTRlMjdiOWVmZDM0NTA5Y2Q0ODk4XzYwNDczMTM5NTgyNjI_667b95ee-7585-49a2-b105-3580dc84c7c0">5,000</ix:nonFraction> of impairment charges on the Lord Jones&#8482; brand during year ended December 31, 2020.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December 31, 2020, 2019, and 2018</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for gram and share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div></div><ix:continuation id="iff8835c322ec421e8c5254a72ed4bd54"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt">Intangible assets</span></div><ix:continuation id="i6a7721a9845d4e4bb404cd5ae2137ef7"><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90ZXh0cmVnaW9uOjVjYjg1MDFiMmY3NTRlMjdiOWVmZDM0NTA5Y2Q0ODk4XzgwMw_783a1e81-4bc1-4b15-9ed1-82ccbc72dca2" escape="true"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets are comprised of the following items: </span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:31.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.834%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.051%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.329%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.329%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.329%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.005%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average amortization period (in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2020</span></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Impairment charges</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie2c359ba7b8e4d8cbaea40e6357f543e_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTo3NzI0ZTg2M2M3NDM0OTY0OGZkNWJhMGRmNmMzZGE4My90YWJsZXJhbmdlOjc3MjRlODYzYzc0MzQ5NjQ4ZmQ1YmEwZGY2YzNkYTgzXzMtMS0xLTEtMjA0NTU_94a0d0a0-c6a0-4b44-ae31-71f71584fbe0">5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98f184049ae04decbb7e65d448f5eb64_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTo3NzI0ZTg2M2M3NDM0OTY0OGZkNWJhMGRmNmMzZGE4My90YWJsZXJhbmdlOjc3MjRlODYzYzc0MzQ5NjQ4ZmQ1YmEwZGY2YzNkYTgzXzMtMi0xLTEtMjA1MDM_12274dfc-6878-438a-a038-00c76d72bcf3">610</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98f184049ae04decbb7e65d448f5eb64_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTo3NzI0ZTg2M2M3NDM0OTY0OGZkNWJhMGRmNmMzZGE4My90YWJsZXJhbmdlOjc3MjRlODYzYzc0MzQ5NjQ4ZmQ1YmEwZGY2YzNkYTgzXzMtNC0xLTEtMjA1MDM_63692fa4-591b-4346-a526-bc14046655dc">291</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98f184049ae04decbb7e65d448f5eb64_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTo3NzI0ZTg2M2M3NDM0OTY0OGZkNWJhMGRmNmMzZGE4My90YWJsZXJhbmdlOjc3MjRlODYzYzc0MzQ5NjQ4ZmQ1YmEwZGY2YzNkYTgzXzMtOC0xLTEtMjA1MDM_19986b0a-536d-4fbc-8da5-c6fb84accfcc">319</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ERP system</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i375653de490b4cb88d420b09780d16c9_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTo3NzI0ZTg2M2M3NDM0OTY0OGZkNWJhMGRmNmMzZGE4My90YWJsZXJhbmdlOjc3MjRlODYzYzc0MzQ5NjQ4ZmQ1YmEwZGY2YzNkYTgzXzQtMS0xLTEtMjA0NTU_643dd42c-cf13-4421-a9c3-cacd34e98b27">5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08692c3f18fd499fb735fa6f9fa77a18_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTo3NzI0ZTg2M2M3NDM0OTY0OGZkNWJhMGRmNmMzZGE4My90YWJsZXJhbmdlOjc3MjRlODYzYzc0MzQ5NjQ4ZmQ1YmEwZGY2YzNkYTgzXzQtMi0xLTEtMjA1MDM_0ea6cb62-0fd7-46b9-b0e4-e4f688d2a8f7">3,955</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i08692c3f18fd499fb735fa6f9fa77a18_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTo3NzI0ZTg2M2M3NDM0OTY0OGZkNWJhMGRmNmMzZGE4My90YWJsZXJhbmdlOjc3MjRlODYzYzc0MzQ5NjQ4ZmQ1YmEwZGY2YzNkYTgzXzQtNC0xLTEtMjA1MDM_a396935f-a363-4918-952f-8925e85b436e">274</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08692c3f18fd499fb735fa6f9fa77a18_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTo3NzI0ZTg2M2M3NDM0OTY0OGZkNWJhMGRmNmMzZGE4My90YWJsZXJhbmdlOjc3MjRlODYzYzc0MzQ5NjQ4ZmQ1YmEwZGY2YzNkYTgzXzQtOC0xLTEtMjA1MDM_81c2635c-541d-4fad-92ee-83d1d502c1d8">3,681</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Canada licenses </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id267d45c88934cce96716b0f18048fbe_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTo3NzI0ZTg2M2M3NDM0OTY0OGZkNWJhMGRmNmMzZGE4My90YWJsZXJhbmdlOjc3MjRlODYzYzc0MzQ5NjQ4ZmQ1YmEwZGY2YzNkYTgzXzUtMS0xLTEtMjA0NTU_58768597-b98e-4390-a293-e4c25c85be38">17</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9aeeb3005af2414fbdd7f3f51ba719bb_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTo3NzI0ZTg2M2M3NDM0OTY0OGZkNWJhMGRmNmMzZGE4My90YWJsZXJhbmdlOjc3MjRlODYzYzc0MzQ5NjQ4ZmQ1YmEwZGY2YzNkYTgzXzUtMi0xLTEtMjA1MDM_c05b4aa7-a07b-4d02-9aa6-e866882076e9">7,526</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9aeeb3005af2414fbdd7f3f51ba719bb_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTo3NzI0ZTg2M2M3NDM0OTY0OGZkNWJhMGRmNmMzZGE4My90YWJsZXJhbmdlOjc3MjRlODYzYzc0MzQ5NjQ4ZmQ1YmEwZGY2YzNkYTgzXzUtNC0xLTEtMjA1MDM_a78c749d-5133-4128-9f33-d343820b0798">1,254</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9aeeb3005af2414fbdd7f3f51ba719bb_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTo3NzI0ZTg2M2M3NDM0OTY0OGZkNWJhMGRmNmMzZGE4My90YWJsZXJhbmdlOjc3MjRlODYzYzc0MzQ5NjQ4ZmQ1YmEwZGY2YzNkYTgzXzUtOC0xLTEtMjA1MDM_0ae96684-55c9-4daf-94af-a37bde9f2d8b">6,272</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lord Jones</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibad4f60fad3c4471be8a1d5e1b4b06a2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTo3NzI0ZTg2M2M3NDM0OTY0OGZkNWJhMGRmNmMzZGE4My90YWJsZXJhbmdlOjc3MjRlODYzYzc0MzQ5NjQ4ZmQ1YmEwZGY2YzNkYTgzXzYtMi0xLTEtMjA1MDM_218d5a1f-fe9a-4f6e-9f71-2bf3b75dedec">64,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibad4f60fad3c4471be8a1d5e1b4b06a2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="cron:IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTo3NzI0ZTg2M2M3NDM0OTY0OGZkNWJhMGRmNmMzZGE4My90YWJsZXJhbmdlOjc3MjRlODYzYzc0MzQ5NjQ4ZmQ1YmEwZGY2YzNkYTgzXzYtNi0xLTEtMjA1MDM_8dd633a1-c236-4485-bb1e-7c2dcf543c15">5,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibad4f60fad3c4471be8a1d5e1b4b06a2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTo3NzI0ZTg2M2M3NDM0OTY0OGZkNWJhMGRmNmMzZGE4My90YWJsZXJhbmdlOjc3MjRlODYzYzc0MzQ5NjQ4ZmQ1YmEwZGY2YzNkYTgzXzYtOC0xLTEtMjA1MDM_b445e1c2-c37e-425d-ade8-6ebc301cfc5a">59,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibae3047412c74ad68bb7c95a00bd81b4_I20201231" decimals="-3" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTo3NzI0ZTg2M2M3NDM0OTY0OGZkNWJhMGRmNmMzZGE4My90YWJsZXJhbmdlOjc3MjRlODYzYzc0MzQ5NjQ4ZmQ1YmEwZGY2YzNkYTgzXzctMi0xLTEtMjA1MDM_435fda10-b8d7-4224-a1d3-65cb896b72aa">148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibae3047412c74ad68bb7c95a00bd81b4_I20201231" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTo3NzI0ZTg2M2M3NDM0OTY0OGZkNWJhMGRmNmMzZGE4My90YWJsZXJhbmdlOjc3MjRlODYzYzc0MzQ5NjQ4ZmQ1YmEwZGY2YzNkYTgzXzctOC0xLTEtMjA1MDM_d742aabb-e2fb-407e-b414-704992fdece4">148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israeli codes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib297b22398ba4d26b972d07a65be9bdc_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTo3NzI0ZTg2M2M3NDM0OTY0OGZkNWJhMGRmNmMzZGE4My90YWJsZXJhbmdlOjc3MjRlODYzYzc0MzQ5NjQ4ZmQ1YmEwZGY2YzNkYTgzXzgtMS0xLTEtMjA0NTU_7f52dde1-80d4-4a9e-bef5-7843809b2679">25</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5d86bf348094cd8bbbbd47d7e3b937d_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTo3NzI0ZTg2M2M3NDM0OTY0OGZkNWJhMGRmNmMzZGE4My90YWJsZXJhbmdlOjc3MjRlODYzYzc0MzQ5NjQ4ZmQ1YmEwZGY2YzNkYTgzXzgtMi0xLTEtMjA1MDM_25a132f5-8506-4c5a-9a56-0d8c69b6346c">322</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib5d86bf348094cd8bbbbd47d7e3b937d_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTo3NzI0ZTg2M2M3NDM0OTY0OGZkNWJhMGRmNmMzZGE4My90YWJsZXJhbmdlOjc3MjRlODYzYzc0MzQ5NjQ4ZmQ1YmEwZGY2YzNkYTgzXzgtNS0xLTEtMjM3MDc_28f7d15b-c2ab-4000-8b08-7990c2060403">22</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5d86bf348094cd8bbbbd47d7e3b937d_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTo3NzI0ZTg2M2M3NDM0OTY0OGZkNWJhMGRmNmMzZGE4My90YWJsZXJhbmdlOjc3MjRlODYzYzc0MzQ5NjQ4ZmQ1YmEwZGY2YzNkYTgzXzgtOC0xLTEtMjA1MDM_064f549e-2a38-47b0-ab75-3812f85868c0">300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTo3NzI0ZTg2M2M3NDM0OTY0OGZkNWJhMGRmNmMzZGE4My90YWJsZXJhbmdlOjc3MjRlODYzYzc0MzQ5NjQ4ZmQ1YmEwZGY2YzNkYTgzXzktMi0xLTEtMjA1MDM_d20e0b3e-b520-417b-ab40-d41ebdba7ea7">76,561</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTo3NzI0ZTg2M2M3NDM0OTY0OGZkNWJhMGRmNmMzZGE4My90YWJsZXJhbmdlOjc3MjRlODYzYzc0MzQ5NjQ4ZmQ1YmEwZGY2YzNkYTgzXzktNC0xLTEtMjA1MDM_32a77a19-8d94-43a1-b498-bf56092e5f83">1,841</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="cron:IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTo3NzI0ZTg2M2M3NDM0OTY0OGZkNWJhMGRmNmMzZGE4My90YWJsZXJhbmdlOjc3MjRlODYzYzc0MzQ5NjQ4ZmQ1YmEwZGY2YzNkYTgzXzktNi0xLTEtMjA1MDM_4ebb214d-c816-4968-be6d-4a0a63b3200e">5,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTo3NzI0ZTg2M2M3NDM0OTY0OGZkNWJhMGRmNmMzZGE4My90YWJsZXJhbmdlOjc3MjRlODYzYzc0MzQ5NjQ4ZmQ1YmEwZGY2YzNkYTgzXzktOC0xLTEtMjA1MDM_4a0f237e-3a04-411c-898c-f10435dbc684">69,720</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt">The Israeli codes were transferred by non-controlling interests to Cronos Israel in exchange for their equity interests in the Cronos Israel entities specified above.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.722%"><tr><td style="width:1.0%"></td><td style="width:39.847%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.852%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.053%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.827%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.332%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.827%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.332%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.830%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:0 1pt 0 5.5pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average amortization period (in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2019</span></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i44555a708248410d80d185e52bcf7004_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTpkMTc3OGIyMDliZDA0NDBjYjI1ZDAwMmZiZDBlYmU1MC90YWJsZXJhbmdlOmQxNzc4YjIwOWJkMDQ0MGNiMjVkMDAyZmJkMGViZTUwXzMtMS0xLTEtMjA1NjU_a75a9b8d-91af-43e5-9d9d-abc210ef28da">5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i279d9d5ab1e349069775769d0b1a44cd_I20191231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTpkMTc3OGIyMDliZDA0NDBjYjI1ZDAwMmZiZDBlYmU1MC90YWJsZXJhbmdlOmQxNzc4YjIwOWJkMDQ0MGNiMjVkMDAyZmJkMGViZTUwXzMtMy0xLTEtMjA1NzU_d8be66a4-045e-45d4-9974-eef32fa012a1">541</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i279d9d5ab1e349069775769d0b1a44cd_I20191231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTpkMTc3OGIyMDliZDA0NDBjYjI1ZDAwMmZiZDBlYmU1MC90YWJsZXJhbmdlOmQxNzc4YjIwOWJkMDQ0MGNiMjVkMDAyZmJkMGViZTUwXzMtNS0xLTEtMjA1NzU_701c0b8c-677e-4625-9564-003556e7c021">202</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i279d9d5ab1e349069775769d0b1a44cd_I20191231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTpkMTc3OGIyMDliZDA0NDBjYjI1ZDAwMmZiZDBlYmU1MC90YWJsZXJhbmdlOmQxNzc4YjIwOWJkMDQ0MGNiMjVkMDAyZmJkMGViZTUwXzMtNy0xLTEtMjA1NzU_da433f93-fcf7-4414-b3b3-30409647a6df">339</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Canada licenses</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i82c727c670f445f4ab85163fb46012f1_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTpkMTc3OGIyMDliZDA0NDBjYjI1ZDAwMmZiZDBlYmU1MC90YWJsZXJhbmdlOmQxNzc4YjIwOWJkMDQ0MGNiMjVkMDAyZmJkMGViZTUwXzUtMS0xLTEtMjA1NjU_dd38539f-59e2-4c18-9929-7f13205e8ef3">17</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i921bbe51679241a68d142cd32305f8a5_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTpkMTc3OGIyMDliZDA0NDBjYjI1ZDAwMmZiZDBlYmU1MC90YWJsZXJhbmdlOmQxNzc4YjIwOWJkMDQ0MGNiMjVkMDAyZmJkMGViZTUwXzUtMy0xLTEtMjA1NzU_dd56aae9-3b4d-4a3f-bd7a-fe3829eb13da">7,387</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i921bbe51679241a68d142cd32305f8a5_I20191231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTpkMTc3OGIyMDliZDA0NDBjYjI1ZDAwMmZiZDBlYmU1MC90YWJsZXJhbmdlOmQxNzc4YjIwOWJkMDQ0MGNiMjVkMDAyZmJkMGViZTUwXzUtNS0xLTEtMjA1NzU_c87c176a-f122-45ed-9020-816e208b9917">821</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i921bbe51679241a68d142cd32305f8a5_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTpkMTc3OGIyMDliZDA0NDBjYjI1ZDAwMmZiZDBlYmU1MC90YWJsZXJhbmdlOmQxNzc4YjIwOWJkMDQ0MGNiMjVkMDAyZmJkMGViZTUwXzUtNy0xLTEtMjA1NzU_b0175a94-d136-4135-a532-2af139e68ee7">6,566</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lord Jones</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> brand</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i708ebd12fa8d48aeaf171672ac0bad61_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTpkMTc3OGIyMDliZDA0NDBjYjI1ZDAwMmZiZDBlYmU1MC90YWJsZXJhbmdlOmQxNzc4YjIwOWJkMDQ0MGNiMjVkMDAyZmJkMGViZTUwXzYtMy0xLTEtMjA1NzU_c43344f5-0e21-4e26-914c-70cc41c47f89">64,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i708ebd12fa8d48aeaf171672ac0bad61_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTpkMTc3OGIyMDliZDA0NDBjYjI1ZDAwMmZiZDBlYmU1MC90YWJsZXJhbmdlOmQxNzc4YjIwOWJkMDQ0MGNiMjVkMDAyZmJkMGViZTUwXzYtNy0xLTEtMjA1NzU_3105cf6d-9c15-42a6-9db6-012e2fe27291">64,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trademarks</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77ad87a86ffb4a1c94f873eac114b479_I20191231" decimals="-3" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTpkMTc3OGIyMDliZDA0NDBjYjI1ZDAwMmZiZDBlYmU1MC90YWJsZXJhbmdlOmQxNzc4YjIwOWJkMDQ0MGNiMjVkMDAyZmJkMGViZTUwXzctMy0xLTEtMjA1NzU_bab996bd-13b5-4073-bc07-0ad8d572c798">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77ad87a86ffb4a1c94f873eac114b479_I20191231" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTpkMTc3OGIyMDliZDA0NDBjYjI1ZDAwMmZiZDBlYmU1MC90YWJsZXJhbmdlOmQxNzc4YjIwOWJkMDQ0MGNiMjVkMDAyZmJkMGViZTUwXzctNy0xLTEtMjA1NzU_5a7fcb31-d872-4f82-b002-62fc20b2de56">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israeli codes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0d88b9a8d8e34abdb2c9b7c1bade37bb_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTpkMTc3OGIyMDliZDA0NDBjYjI1ZDAwMmZiZDBlYmU1MC90YWJsZXJhbmdlOmQxNzc4YjIwOWJkMDQ0MGNiMjVkMDAyZmJkMGViZTUwXzgtMS0xLTEtMjA1NjU_c088cac0-21ba-48a4-a67a-fcb6b18978a3">25</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e89cc544d3a428ab893432457341368_I20191231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTpkMTc3OGIyMDliZDA0NDBjYjI1ZDAwMmZiZDBlYmU1MC90YWJsZXJhbmdlOmQxNzc4YjIwOWJkMDQ0MGNiMjVkMDAyZmJkMGViZTUwXzgtMy0xLTEtMjA1NzU_c661995d-5e01-4e00-a1c8-b9a5b79ab734">298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1e89cc544d3a428ab893432457341368_I20191231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTpkMTc3OGIyMDliZDA0NDBjYjI1ZDAwMmZiZDBlYmU1MC90YWJsZXJhbmdlOmQxNzc4YjIwOWJkMDQ0MGNiMjVkMDAyZmJkMGViZTUwXzgtNS0xLTEtMjA1NzU_eb82da94-635e-483e-9254-2b71f853606d">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e89cc544d3a428ab893432457341368_I20191231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTpkMTc3OGIyMDliZDA0NDBjYjI1ZDAwMmZiZDBlYmU1MC90YWJsZXJhbmdlOmQxNzc4YjIwOWJkMDQ0MGNiMjVkMDAyZmJkMGViZTUwXzgtNy0xLTEtMjA1NzU_e1b78e8c-f514-4f06-8240-bdef2da33491">294</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTpkMTc3OGIyMDliZDA0NDBjYjI1ZDAwMmZiZDBlYmU1MC90YWJsZXJhbmdlOmQxNzc4YjIwOWJkMDQ0MGNiMjVkMDAyZmJkMGViZTUwXzktMy0xLTEtMjA1NzU_693bfd1a-2065-4ed8-947d-2c2e99bf9815">72,262</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTpkMTc3OGIyMDliZDA0NDBjYjI1ZDAwMmZiZDBlYmU1MC90YWJsZXJhbmdlOmQxNzc4YjIwOWJkMDQ0MGNiMjVkMDAyZmJkMGViZTUwXzktNS0xLTEtMjA1NzU_8afe016a-782d-4226-b0e3-7d6be07a81d9">1,027</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTpkMTc3OGIyMDliZDA0NDBjYjI1ZDAwMmZiZDBlYmU1MC90YWJsZXJhbmdlOmQxNzc4YjIwOWJkMDQ0MGNiMjVkMDAyZmJkMGViZTUwXzktNy0xLTEtMjA1NzU_869cd296-d771-4ad9-8247-94776ccb8788">71,235</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt">The Israeli codes were transferred by non-controlling interests to Cronos Israel in exchange for their equity interests in the Cronos Israel entities specified above.</span></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate amortization was $<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90ZXh0cmVnaW9uOjVjYjg1MDFiMmY3NTRlMjdiOWVmZDM0NTA5Y2Q0ODk4XzQ4NA_01a58c84-9e57-4573-b930-a5e0e2bcefac">814</ix:nonFraction> for the year ended December 31, 2020 (December&#160;31, 2019 &#8211; $<ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90ZXh0cmVnaW9uOjVjYjg1MDFiMmY3NTRlMjdiOWVmZDM0NTA5Y2Q0ODk4XzQ5NA_b1f7e876-53b8-4a77-9949-f51f925c967d">646</ix:nonFraction>; 2018 &#8211; $<ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90ZXh0cmVnaW9uOjVjYjg1MDFiMmY3NTRlMjdiOWVmZDM0NTA5Y2Q0ODk4XzEyMDk0NjI3OTA4Mjc0_33a4e443-a084-4eb7-af67-59c2ab1e8508">546</ix:nonFraction>). Intangible asset additions in 2020 primarily relate to the implementation of a new ERP system. Intangible asset additions in the year ended December&#160;31, 2019 included the Lord Jones&#8482; brand for $<ix:nonFraction unitRef="usd" contextRef="i857a1897462542f5aca388daf1e74bbf_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsToAcquireIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90ZXh0cmVnaW9uOjVjYjg1MDFiMmY3NTRlMjdiOWVmZDM0NTA5Y2Q0ODk4XzEwOTk1MTE2Mjg3MDMz_1961df02-52e6-46ee-b203-547f7c43dfab">64</ix:nonFraction> million.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> There were no material disposals of intangible assets in 2020 or 2019. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amortization expense for the next five years on intangible assets in use is estimated to be as follows: 2021 &#8211; $<ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90ZXh0cmVnaW9uOjVjYjg1MDFiMmY3NTRlMjdiOWVmZDM0NTA5Y2Q0ODk4XzEyMDk0NjI3OTA4MzIx_e2907d35-05d9-447e-8413-284493a1d8a4">1,047</ix:nonFraction>; 2022 &#8211; $<ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90ZXh0cmVnaW9uOjVjYjg1MDFiMmY3NTRlMjdiOWVmZDM0NTA5Y2Q0ODk4XzEyMDk0NjI3OTA4MzI3_a408fa39-d485-405f-9952-4ec0b19a8274">998</ix:nonFraction>; 2023: $<ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90ZXh0cmVnaW9uOjVjYjg1MDFiMmY3NTRlMjdiOWVmZDM0NTA5Y2Q0ODk4XzEyMDk0NjI3OTA4MzMy_20e997a9-73af-44c2-bde7-b84dd5d74adc">964</ix:nonFraction>; 2024 &#8211; $<ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90ZXh0cmVnaW9uOjVjYjg1MDFiMmY3NTRlMjdiOWVmZDM0NTA5Y2Q0ODk4XzEyMDk0NjI3OTA4MzM3_d4df037e-2f94-4d9a-b20c-9bba729bb194">952</ix:nonFraction>; 2025 &#8211; $<ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90ZXh0cmVnaW9uOjVjYjg1MDFiMmY3NTRlMjdiOWVmZDM0NTA5Y2Q0ODk4XzEyMDk0NjI3OTA4MzQy_ecb8fb58-7f38-4b21-bcf7-abd672ce11b0">664</ix:nonFraction>. </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt"><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90ZXh0cmVnaW9uOjVjYjg1MDFiMmY3NTRlMjdiOWVmZDM0NTA5Y2Q0ODk4XzIzMDg5NzQ0MTkyNzUx_8311f827-b786-4f24-b34c-30f6f4344bc9" continuedAt="i2f254d2cd6cb42a484442d5582a2b256" escape="true">Goodwill</ix:nonNumeric></span></div><div style="margin-bottom:12pt;text-align:justify"><ix:continuation id="i2f254d2cd6cb42a484442d5582a2b256"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.722%"><tr><td style="width:1.0%"></td><td style="width:23.273%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.827%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.053%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.966%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.053%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.245%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.053%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.245%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.053%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.832%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Impairment charges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effect of foreign exchange</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peace Naturals</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2206069e8cc487aab61dab193148424_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTplMTBkNDZlYWVhZmE0ODRmOGM2M2UwMDI3NjhlMTMyNS90YWJsZXJhbmdlOmUxMGQ0NmVhZWFmYTQ4NGY4YzYzZTAwMjc2OGUxMzI1XzItMS0xLTEtNDg1Ng_e715edf7-da0d-41a4-ae6e-9b40322d979e">1,078</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d3d1ba25f2b4f858447fd45bdf8fbad_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTplMTBkNDZlYWVhZmE0ODRmOGM2M2UwMDI3NjhlMTMyNS90YWJsZXJhbmdlOmUxMGQ0NmVhZWFmYTQ4NGY4YzYzZTAwMjc2OGUxMzI1XzEtMy0xLTEtMTc1Mjc_e886b965-2812-4819-8b97-c18c69020e06">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d3d1ba25f2b4f858447fd45bdf8fbad_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:GoodwillImpairmentLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTplMTBkNDZlYWVhZmE0ODRmOGM2M2UwMDI3NjhlMTMyNS90YWJsZXJhbmdlOmUxMGQ0NmVhZWFmYTQ4NGY4YzYzZTAwMjc2OGUxMzI1XzEtNS0xLTEtMTc1Mjc_5813249d-ae0d-4b49-b099-3bb4b151dafe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d3d1ba25f2b4f858447fd45bdf8fbad_D20200101-20201231" decimals="-3" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTplMTBkNDZlYWVhZmE0ODRmOGM2M2UwMDI3NjhlMTMyNS90YWJsZXJhbmdlOmUxMGQ0NmVhZWFmYTQ4NGY4YzYzZTAwMjc2OGUxMzI1XzEtNy0xLTEtMTc1Mjc_5cec30a6-4e5b-460d-94dc-be22c59b52fc">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8633af9ced72481c8087e79d244f37b7_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTplMTBkNDZlYWVhZmE0ODRmOGM2M2UwMDI3NjhlMTMyNS90YWJsZXJhbmdlOmUxMGQ0NmVhZWFmYTQ4NGY4YzYzZTAwMjc2OGUxMzI1XzEtOS0xLTEtMTc1Mjc_7468d419-175c-4106-bd84-d7a50168545e">1,108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redwood</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d4ddac5384e48eabee1565aa6cc8a56_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTplMTBkNDZlYWVhZmE0ODRmOGM2M2UwMDI3NjhlMTMyNS90YWJsZXJhbmdlOmUxMGQ0NmVhZWFmYTQ4NGY4YzYzZTAwMjc2OGUxMzI1XzMtMS0xLTEtNDg1Ng_e3664f89-8437-4328-bd5e-05fbf71576ea">213,414</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b13dbcbacfa4879b6f7704dc73f8b29_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTplMTBkNDZlYWVhZmE0ODRmOGM2M2UwMDI3NjhlMTMyNS90YWJsZXJhbmdlOmUxMGQ0NmVhZWFmYTQ4NGY4YzYzZTAwMjc2OGUxMzI1XzItMy0xLTEtMTc1Mjc_c1f3c238-5b16-4aa9-9924-22c67a5fc331">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1b13dbcbacfa4879b6f7704dc73f8b29_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairmentLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTplMTBkNDZlYWVhZmE0ODRmOGM2M2UwMDI3NjhlMTMyNS90YWJsZXJhbmdlOmUxMGQ0NmVhZWFmYTQ4NGY4YzYzZTAwMjc2OGUxMzI1XzItNS0xLTEtMTc1Mjc_d1b6e858-35be-429a-bbcf-c0a7153dea9e">35,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b13dbcbacfa4879b6f7704dc73f8b29_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTplMTBkNDZlYWVhZmE0ODRmOGM2M2UwMDI3NjhlMTMyNS90YWJsZXJhbmdlOmUxMGQ0NmVhZWFmYTQ4NGY4YzYzZTAwMjc2OGUxMzI1XzItNy0xLTEtMTc1Mjc_c7da68bb-3810-4700-86e9-9b75ac50e2eb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97b06a548fbf4c0cb61a9ab4fcb38d94_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTplMTBkNDZlYWVhZmE0ODRmOGM2M2UwMDI3NjhlMTMyNS90YWJsZXJhbmdlOmUxMGQ0NmVhZWFmYTQ4NGY4YzYzZTAwMjc2OGUxMzI1XzItOS0xLTEtMTc1Mjc_4ff4fe31-3e54-4e8d-8b75-5db9dd38e644">178,414</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTplMTBkNDZlYWVhZmE0ODRmOGM2M2UwMDI3NjhlMTMyNS90YWJsZXJhbmdlOmUxMGQ0NmVhZWFmYTQ4NGY4YzYzZTAwMjc2OGUxMzI1XzQtMS0xLTEtNDg1Ng_d1ab5177-4b18-41d4-bf60-c64e1449d221">214,492</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTplMTBkNDZlYWVhZmE0ODRmOGM2M2UwMDI3NjhlMTMyNS90YWJsZXJhbmdlOmUxMGQ0NmVhZWFmYTQ4NGY4YzYzZTAwMjc2OGUxMzI1XzQtMy0xLTEtNDg1Ng_f05a38c8-2c86-4b14-a89f-588c474cccae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairmentLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTplMTBkNDZlYWVhZmE0ODRmOGM2M2UwMDI3NjhlMTMyNS90YWJsZXJhbmdlOmUxMGQ0NmVhZWFmYTQ4NGY4YzYzZTAwMjc2OGUxMzI1XzMtNS0xLTEtMTc1Mjc_756f239c-fe37-4f95-9fbc-c627f5487eab">35,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTplMTBkNDZlYWVhZmE0ODRmOGM2M2UwMDI3NjhlMTMyNS90YWJsZXJhbmdlOmUxMGQ0NmVhZWFmYTQ4NGY4YzYzZTAwMjc2OGUxMzI1XzQtNS0xLTEtNDg1Ng_98760799-e3f4-44d1-9fed-3d819fae46be">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTplMTBkNDZlYWVhZmE0ODRmOGM2M2UwMDI3NjhlMTMyNS90YWJsZXJhbmdlOmUxMGQ0NmVhZWFmYTQ4NGY4YzYzZTAwMjc2OGUxMzI1XzQtNy0xLTEtNDg1Ng_029c616f-a2f8-4504-9965-2b737de4097c">179,522</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="margin-bottom:12pt;text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92</span></div></div></div><div id="i1ae9134e40e74e0aac958218112e53d4_112"></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December 31, 2020, 2019, and 2018</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for gram and share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">12. <ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMTIvZnJhZzo3NmE4MTRkYjZlZDQ0M2Q3YWRmYTU4M2YzYTE4MzQyZi90ZXh0cmVnaW9uOjc2YTgxNGRiNmVkNDQzZDdhZGZhNTgzZjNhMTgzNDJmXzg3Ng_ddabd21c-eb4c-4bd1-b529-316f40cf8627" continuedAt="i7857a06c4db7493b93c2f38f96888035" escape="true">Leases </ix:nonNumeric></span></div><ix:continuation id="i7857a06c4db7493b93c2f38f96888035"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has entered into leases primarily for the land-use rights, office premises and equipment used in the production of cannabis, U.S. hemp and related products. The Company&#8217;s leases have terms which range from <ix:nonNumeric contextRef="i62037cbff1aa4252b5cdebcd407fdc1b_I20201231" format="ixt-sec:durwordsen" name="us-gaap:LesseeOperatingLeaseTermOfContract" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMTIvZnJhZzo3NmE4MTRkYjZlZDQ0M2Q3YWRmYTU4M2YzYTE4MzQyZi90ZXh0cmVnaW9uOjc2YTgxNGRiNmVkNDQzZDdhZGZhNTgzZjNhMTgzNDJmXzg3OTYwOTMwMjMyOTk_3c6ea9c2-7fab-4be4-8c6d-ae7beb0759e6">three years</ix:nonNumeric> to <ix:nonNumeric contextRef="if7021697d1b94f34b3b9af2716c9a683_I20201231" format="ixt-sec:durwordsen" name="us-gaap:LesseeOperatingLeaseTermOfContract" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMTIvZnJhZzo3NmE4MTRkYjZlZDQ0M2Q3YWRmYTU4M2YzYTE4MzQyZi90ZXh0cmVnaW9uOjc2YTgxNGRiNmVkNDQzZDdhZGZhNTgzZjNhMTgzNDJmXzEyMDk0NjI3OTA2NDY5_8675c827-9f53-488c-a897-126990540521">six years</ix:nonNumeric>, excluding land use rights, which generally extend to <ix:nonNumeric contextRef="i6db5a3fb2eca4f54b3f90ed1c036dd12_I20201231" format="ixt-sec:duryear" name="us-gaap:LesseeOperatingLeaseTermOfContract" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMTIvZnJhZzo3NmE4MTRkYjZlZDQ0M2Q3YWRmYTU4M2YzYTE4MzQyZi90ZXh0cmVnaW9uOjc2YTgxNGRiNmVkNDQzZDdhZGZhNTgzZjNhMTgzNDJmXzMwMw_9074cbd8-aeda-47fc-873c-48e4653eba65">15</ix:nonNumeric> years. These leases often include options to extend the term of the lease for up to <ix:nonNumeric contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" format="ixt-sec:duryear" name="us-gaap:LesseeOperatingLeaseRenewalTerm" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMTIvZnJhZzo3NmE4MTRkYjZlZDQ0M2Q3YWRmYTU4M2YzYTE4MzQyZi90ZXh0cmVnaW9uOjc2YTgxNGRiNmVkNDQzZDdhZGZhNTgzZjNhMTgzNDJmXzM5MA_66abd328-7158-4024-b945-d046148f067f">10</ix:nonNumeric> years. When it is reasonably certain that the option will be exercised, the impact of the option is included in the lease term for purposes of determining total future lease payments. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases greater than one year are included in right-of-use assets and operating lease liabilities. Finance leases are included in property, plant and equipment on the Company&#8217;s consolidated balance sheet. </span></div><div style="margin-bottom:12pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s finance leases were not material for any of the periods presented. </span></div><div style="margin-bottom:6pt;margin-top:9pt"><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMTIvZnJhZzo3NmE4MTRkYjZlZDQ0M2Q3YWRmYTU4M2YzYTE4MzQyZi90ZXh0cmVnaW9uOjc2YTgxNGRiNmVkNDQzZDdhZGZhNTgzZjNhMTgzNDJmXzg3Nw_5e273aed-64a2-428f-b883-9f41c199ddd4" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.538%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.541%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMTIvZnJhZzo3NmE4MTRkYjZlZDQ0M2Q3YWRmYTU4M2YzYTE4MzQyZi90YWJsZTphY2MxM2NjMWRiZjU0ZDBiYjVkNDI0NTBlYzNhYTkwNy90YWJsZXJhbmdlOmFjYzEzY2MxZGJmNTRkMGJiNWQ0MjQ1MGVjM2FhOTA3XzItMi0xLTEtMA_c71f338f-8342-4cc8-a36d-5f5e73c9dccb">2,479</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" name="us-gaap:OperatingLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMTIvZnJhZzo3NmE4MTRkYjZlZDQ0M2Q3YWRmYTU4M2YzYTE4MzQyZi90YWJsZTphY2MxM2NjMWRiZjU0ZDBiYjVkNDI0NTBlYzNhYTkwNy90YWJsZXJhbmdlOmFjYzEzY2MxZGJmNTRkMGJiNWQ0MjQ1MGVjM2FhOTA3XzItMy0xLTEtMzYyMDc_f458ffaa-9579-4b13-9f75-0bd2ab0ddf28">760</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" name="us-gaap:ShortTermLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMTIvZnJhZzo3NmE4MTRkYjZlZDQ0M2Q3YWRmYTU4M2YzYTE4MzQyZi90YWJsZTphY2MxM2NjMWRiZjU0ZDBiYjVkNDI0NTBlYzNhYTkwNy90YWJsZXJhbmdlOmFjYzEzY2MxZGJmNTRkMGJiNWQ0MjQ1MGVjM2FhOTA3XzMtMi0xLTEtMA_e637e41c-2517-4e63-a9ce-2587fb14efd4">60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" name="us-gaap:ShortTermLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMTIvZnJhZzo3NmE4MTRkYjZlZDQ0M2Q3YWRmYTU4M2YzYTE4MzQyZi90YWJsZTphY2MxM2NjMWRiZjU0ZDBiYjVkNDI0NTBlYzNhYTkwNy90YWJsZXJhbmdlOmFjYzEzY2MxZGJmNTRkMGJiNWQ0MjQ1MGVjM2FhOTA3XzMtMy0xLTEtMzYyMDc_daadf420-3971-453f-a82e-380459715618">373</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMTIvZnJhZzo3NmE4MTRkYjZlZDQ0M2Q3YWRmYTU4M2YzYTE4MzQyZi90YWJsZTphY2MxM2NjMWRiZjU0ZDBiYjVkNDI0NTBlYzNhYTkwNy90YWJsZXJhbmdlOmFjYzEzY2MxZGJmNTRkMGJiNWQ0MjQ1MGVjM2FhOTA3XzQtMi0xLTEtMA_def98651-68ba-4351-9287-7b1da9e721ce">2,539</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMTIvZnJhZzo3NmE4MTRkYjZlZDQ0M2Q3YWRmYTU4M2YzYTE4MzQyZi90YWJsZTphY2MxM2NjMWRiZjU0ZDBiYjVkNDI0NTBlYzNhYTkwNy90YWJsZXJhbmdlOmFjYzEzY2MxZGJmNTRkMGJiNWQ0MjQ1MGVjM2FhOTA3XzQtMy0xLTEtMzYyMDc_ea466b23-4cdd-4e51-8fbf-b7cc338038b1">1,133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term &#8211; operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMTIvZnJhZzo3NmE4MTRkYjZlZDQ0M2Q3YWRmYTU4M2YzYTE4MzQyZi90YWJsZTphY2MxM2NjMWRiZjU0ZDBiYjVkNDI0NTBlYzNhYTkwNy90YWJsZXJhbmdlOmFjYzEzY2MxZGJmNTRkMGJiNWQ0MjQ1MGVjM2FhOTA3XzYtMi0xLTEtMA_ae3649ca-126b-4cd9-b81b-8e4ac8a544cd">6</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMTIvZnJhZzo3NmE4MTRkYjZlZDQ0M2Q3YWRmYTU4M2YzYTE4MzQyZi90YWJsZTphY2MxM2NjMWRiZjU0ZDBiYjVkNDI0NTBlYzNhYTkwNy90YWJsZXJhbmdlOmFjYzEzY2MxZGJmNTRkMGJiNWQ0MjQ1MGVjM2FhOTA3XzYtMy0xLTEtMzYyMTg_31c730b7-f0bb-43b4-bb0d-706cca4ceffe">5</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate &#8211; operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMTIvZnJhZzo3NmE4MTRkYjZlZDQ0M2Q3YWRmYTU4M2YzYTE4MzQyZi90YWJsZTphY2MxM2NjMWRiZjU0ZDBiYjVkNDI0NTBlYzNhYTkwNy90YWJsZXJhbmdlOmFjYzEzY2MxZGJmNTRkMGJiNWQ0MjQ1MGVjM2FhOTA3XzctMi0xLTEtMA_f67f9d54-8dbe-411f-9b17-031589d6b620">8.86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="2" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMTIvZnJhZzo3NmE4MTRkYjZlZDQ0M2Q3YWRmYTU4M2YzYTE4MzQyZi90YWJsZTphY2MxM2NjMWRiZjU0ZDBiYjVkNDI0NTBlYzNhYTkwNy90YWJsZXJhbmdlOmFjYzEzY2MxZGJmNTRkMGJiNWQ0MjQ1MGVjM2FhOTA3XzctMy0xLTEtMzYyMDc_71cedc31-66a5-43c5-a264-a1de130bb245">12.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></ix:nonNumeric></div></ix:continuation><div><span><br/></span></div><div id="i1ae9134e40e74e0aac958218112e53d4_133"></div><div style="margin-bottom:12pt;margin-top:16pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">13. <ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:AdditionalFinancialInformationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzMvZnJhZzoxODc0ZjE0MDU5YTE0ZTQ2YjEwMTdlMGI4NTNlYzQ2Ny90ZXh0cmVnaW9uOjE4NzRmMTQwNTlhMTRlNDZiMTAxN2UwYjg1M2VjNDY3XzIzMDg5NzQ0MTg0MTgy_42d83374-db02-4ce2-a7e4-ed8e5a06ca39" continuedAt="i438de7272a014e49b64a500b19cce9c3" escape="true">General and Administrative Expenses</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:continuation id="i438de7272a014e49b64a500b19cce9c3" continuedAt="ib07c2e4fddac403e867648e988de151a"> </ix:continuation></span></div><ix:continuation id="ib07c2e4fddac403e867648e988de151a"><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="cron:GeneralAndAdministrativeExpensesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzMvZnJhZzoxODc0ZjE0MDU5YTE0ZTQ2YjEwMTdlMGI4NTNlYzQ2Ny90ZXh0cmVnaW9uOjE4NzRmMTQwNTlhMTRlNDZiMTAxN2UwYjg1M2VjNDY3XzIzMDg5NzQ0MTg0MTgz_19254d56-fd79-4c8e-adbe-bea48650bc3a" escape="true"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expense are comprised of the following items: </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.791%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salaries and wages</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LaborAndRelatedExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzMvZnJhZzoxODc0ZjE0MDU5YTE0ZTQ2YjEwMTdlMGI4NTNlYzQ2Ny90YWJsZTphNjRlZjU3Mzc2NzM0MWRlODYzYjVmY2I5MDQwZWI2OC90YWJsZXJhbmdlOmE2NGVmNTczNzY3MzQxZGU4NjNiNWZjYjkwNDBlYjY4XzItMi0xLTEtMA_07cbd4b8-0c6f-4705-b45c-e01117912977">26,742</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LaborAndRelatedExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzMvZnJhZzoxODc0ZjE0MDU5YTE0ZTQ2YjEwMTdlMGI4NTNlYzQ2Ny90YWJsZTphNjRlZjU3Mzc2NzM0MWRlODYzYjVmY2I5MDQwZWI2OC90YWJsZXJhbmdlOmE2NGVmNTczNzY3MzQxZGU4NjNiNWZjYjkwNDBlYjY4XzItNC0xLTEtMA_4009b112-51d3-4751-9522-039318e750e4">17,829</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LaborAndRelatedExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzMvZnJhZzoxODc0ZjE0MDU5YTE0ZTQ2YjEwMTdlMGI4NTNlYzQ2Ny90YWJsZTphNjRlZjU3Mzc2NzM0MWRlODYzYjVmY2I5MDQwZWI2OC90YWJsZXJhbmdlOmE2NGVmNTczNzY3MzQxZGU4NjNiNWZjYjkwNDBlYjY4XzItNi0xLTEtMA_b63cd106-8efa-4728-ae3b-709cc420c2f4">4,240</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional and consulting</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="cron:ProfessionalAndConsultingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzMvZnJhZzoxODc0ZjE0MDU5YTE0ZTQ2YjEwMTdlMGI4NTNlYzQ2Ny90YWJsZTphNjRlZjU3Mzc2NzM0MWRlODYzYjVmY2I5MDQwZWI2OC90YWJsZXJhbmdlOmE2NGVmNTczNzY3MzQxZGU4NjNiNWZjYjkwNDBlYjY4XzMtMi0xLTEtMA_9651409f-5ad1-4972-b615-245340fc765e">15,135</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="cron:ProfessionalAndConsultingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzMvZnJhZzoxODc0ZjE0MDU5YTE0ZTQ2YjEwMTdlMGI4NTNlYzQ2Ny90YWJsZTphNjRlZjU3Mzc2NzM0MWRlODYzYjVmY2I5MDQwZWI2OC90YWJsZXJhbmdlOmE2NGVmNTczNzY3MzQxZGU4NjNiNWZjYjkwNDBlYjY4XzMtNC0xLTEtMA_d56b3775-dbad-4403-a1c7-55906bbfae47">15,369</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="cron:ProfessionalAndConsultingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzMvZnJhZzoxODc0ZjE0MDU5YTE0ZTQ2YjEwMTdlMGI4NTNlYzQ2Ny90YWJsZTphNjRlZjU3Mzc2NzM0MWRlODYzYjVmY2I5MDQwZWI2OC90YWJsZXJhbmdlOmE2NGVmNTczNzY3MzQxZGU4NjNiNWZjYjkwNDBlYjY4XzMtNi0xLTEtMA_4a55c406-4d5a-4308-a1a8-5d21ee5fe0ae">5,242</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office and general</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="cron:OfficeAndGeneralExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzMvZnJhZzoxODc0ZjE0MDU5YTE0ZTQ2YjEwMTdlMGI4NTNlYzQ2Ny90YWJsZTphNjRlZjU3Mzc2NzM0MWRlODYzYjVmY2I5MDQwZWI2OC90YWJsZXJhbmdlOmE2NGVmNTczNzY3MzQxZGU4NjNiNWZjYjkwNDBlYjY4XzQtMi0xLTEtMA_4f2be760-7edf-42b2-bd2b-a5eddb92da2f">17,845</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="cron:OfficeAndGeneralExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzMvZnJhZzoxODc0ZjE0MDU5YTE0ZTQ2YjEwMTdlMGI4NTNlYzQ2Ny90YWJsZTphNjRlZjU3Mzc2NzM0MWRlODYzYjVmY2I5MDQwZWI2OC90YWJsZXJhbmdlOmE2NGVmNTczNzY3MzQxZGU4NjNiNWZjYjkwNDBlYjY4XzQtNC0xLTEtMA_f9496a45-4dae-4e58-a45f-c9e223e420d9">13,407</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="cron:OfficeAndGeneralExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzMvZnJhZzoxODc0ZjE0MDU5YTE0ZTQ2YjEwMTdlMGI4NTNlYzQ2Ny90YWJsZTphNjRlZjU3Mzc2NzM0MWRlODYzYjVmY2I5MDQwZWI2OC90YWJsZXJhbmdlOmE2NGVmNTczNzY3MzQxZGU4NjNiNWZjYjkwNDBlYjY4XzQtNi0xLTEtMA_157cd39b-ec0f-4ee2-bec1-f20476e06275">3,713</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Review costs related to restatement of 2019 interim financial statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="cron:RestatementReviewExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzMvZnJhZzoxODc0ZjE0MDU5YTE0ZTQ2YjEwMTdlMGI4NTNlYzQ2Ny90YWJsZTphNjRlZjU3Mzc2NzM0MWRlODYzYjVmY2I5MDQwZWI2OC90YWJsZXJhbmdlOmE2NGVmNTczNzY3MzQxZGU4NjNiNWZjYjkwNDBlYjY4XzUtMi0xLTEtMTIyNTA_85a3bdb4-2dd7-48b6-9ca4-8a49aca214f0">9,688</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="cron:RestatementReviewExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzMvZnJhZzoxODc0ZjE0MDU5YTE0ZTQ2YjEwMTdlMGI4NTNlYzQ2Ny90YWJsZTphNjRlZjU3Mzc2NzM0MWRlODYzYjVmY2I5MDQwZWI2OC90YWJsZXJhbmdlOmE2NGVmNTczNzY3MzQxZGU4NjNiNWZjYjkwNDBlYjY4XzUtNC0xLTEtMTIyNTA_b1cad893-f8c2-4199-94fc-d35c0ee69400">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="cron:RestatementReviewExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzMvZnJhZzoxODc0ZjE0MDU5YTE0ZTQ2YjEwMTdlMGI4NTNlYzQ2Ny90YWJsZTphNjRlZjU3Mzc2NzM0MWRlODYzYjVmY2I5MDQwZWI2OC90YWJsZXJhbmdlOmE2NGVmNTczNzY3MzQxZGU4NjNiNWZjYjkwNDBlYjY4XzUtNi0xLTEtMTIyNTA_e2378daf-52af-4c29-8fa3-334f6e3888bb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current expected credit loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProvisionForLoanLossesExpensed" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzMvZnJhZzoxODc0ZjE0MDU5YTE0ZTQ2YjEwMTdlMGI4NTNlYzQ2Ny90YWJsZTphNjRlZjU3Mzc2NzM0MWRlODYzYjVmY2I5MDQwZWI2OC90YWJsZXJhbmdlOmE2NGVmNTczNzY3MzQxZGU4NjNiNWZjYjkwNDBlYjY4XzYtMS0xLTEtMzEyNTU_8c012431-99c6-4d12-86d3-35c731fe4bf4">2,512</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" name="us-gaap:ProvisionForLoanLossesExpensed" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzMvZnJhZzoxODc0ZjE0MDU5YTE0ZTQ2YjEwMTdlMGI4NTNlYzQ2Ny90YWJsZTphNjRlZjU3Mzc2NzM0MWRlODYzYjVmY2I5MDQwZWI2OC90YWJsZXJhbmdlOmE2NGVmNTczNzY3MzQxZGU4NjNiNWZjYjkwNDBlYjY4XzYtMy0xLTEtMzEyNTU_59486558-8f3f-4a59-b53d-10a106cbc353">136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:ProvisionForLoanLossesExpensed" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzMvZnJhZzoxODc0ZjE0MDU5YTE0ZTQ2YjEwMTdlMGI4NTNlYzQ2Ny90YWJsZTphNjRlZjU3Mzc2NzM0MWRlODYzYjVmY2I5MDQwZWI2OC90YWJsZXJhbmdlOmE2NGVmNTczNzY3MzQxZGU4NjNiNWZjYjkwNDBlYjY4XzYtNS0xLTEtMzEyNTU_811f23dd-5322-4231-a180-a98adb5fcfbd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzMvZnJhZzoxODc0ZjE0MDU5YTE0ZTQ2YjEwMTdlMGI4NTNlYzQ2Ny90YWJsZTphNjRlZjU3Mzc2NzM0MWRlODYzYjVmY2I5MDQwZWI2OC90YWJsZXJhbmdlOmE2NGVmNTczNzY3MzQxZGU4NjNiNWZjYjkwNDBlYjY4XzUtMi0xLTEtMA_58046cb7-6447-4499-b72d-b2932aca32b1">8,607</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzMvZnJhZzoxODc0ZjE0MDU5YTE0ZTQ2YjEwMTdlMGI4NTNlYzQ2Ny90YWJsZTphNjRlZjU3Mzc2NzM0MWRlODYzYjVmY2I5MDQwZWI2OC90YWJsZXJhbmdlOmE2NGVmNTczNzY3MzQxZGU4NjNiNWZjYjkwNDBlYjY4XzUtNC0xLTEtMA_d3ff6930-2f8c-46fe-a138-12ea693a562c">2,530</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" name="us-gaap:OtherGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzMvZnJhZzoxODc0ZjE0MDU5YTE0ZTQ2YjEwMTdlMGI4NTNlYzQ2Ny90YWJsZTphNjRlZjU3Mzc2NzM0MWRlODYzYjVmY2I5MDQwZWI2OC90YWJsZXJhbmdlOmE2NGVmNTczNzY3MzQxZGU4NjNiNWZjYjkwNDBlYjY4XzUtNi0xLTEtMA_cddb4371-1a57-4777-a735-948d23dfa6bd">154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzMvZnJhZzoxODc0ZjE0MDU5YTE0ZTQ2YjEwMTdlMGI4NTNlYzQ2Ny90YWJsZTphNjRlZjU3Mzc2NzM0MWRlODYzYjVmY2I5MDQwZWI2OC90YWJsZXJhbmdlOmE2NGVmNTczNzY3MzQxZGU4NjNiNWZjYjkwNDBlYjY4XzYtMi0xLTEtMA_b758b36a-bf98-4c91-b85b-f36f187293ff">80,529</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzMvZnJhZzoxODc0ZjE0MDU5YTE0ZTQ2YjEwMTdlMGI4NTNlYzQ2Ny90YWJsZTphNjRlZjU3Mzc2NzM0MWRlODYzYjVmY2I5MDQwZWI2OC90YWJsZXJhbmdlOmE2NGVmNTczNzY3MzQxZGU4NjNiNWZjYjkwNDBlYjY4XzYtNC0xLTEtMA_675acff3-0314-436b-bc9f-dea81eabc0c3">49,271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzMvZnJhZzoxODc0ZjE0MDU5YTE0ZTQ2YjEwMTdlMGI4NTNlYzQ2Ny90YWJsZTphNjRlZjU3Mzc2NzM0MWRlODYzYjVmY2I5MDQwZWI2OC90YWJsZXJhbmdlOmE2NGVmNTczNzY3MzQxZGU4NjNiNWZjYjkwNDBlYjY4XzYtNi0xLTEtMA_91cf880d-6f1b-4d7e-a6d0-7180113e3f23">13,349</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.1pt">These financial statement review costs include costs related to the restatement of the Company&#8217;s 2019 interim financial statements, costs related to the Company&#8217;s responses to requests for information from various regulatory authorities relating to such restatement and legal costs defending shareholder class action complaints brought against the Company as a result of the restatement.</span></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">93</span></div></div></div><div id="i1ae9134e40e74e0aac958218112e53d4_181"></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December 31, 2020, 2019, and 2018</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for gram and share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:16pt;padding-left:29.25pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">14. <ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90ZXh0cmVnaW9uOmVlYzdiZTBhMjZhYjQ3Y2U4OTMzZjc3Y2M2YWFhM2UyXzk1ODk_1c5c80ce-0f13-4aff-8ed3-bd48182de141" continuedAt="i9cfe8a85ea2146ceafe9b1ab0d992393" escape="true">Derivative Liabilities </ix:nonNumeric></span></div><ix:continuation id="i9cfe8a85ea2146ceafe9b1ab0d992393" continuedAt="i0e0c57dedbc54f0f8d418aadda5818e2"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 8, 2019, the Company closed the previously announced investment in the Company (the &#8220;Altria Investment&#8221;) by Altria Group Inc. (&#8220;Altria&#8221;), pursuant to a subscription agreement dated December 7, 2018. As of the closing date of the Altria Investment, the Altria Investment consisted of <ix:nonFraction unitRef="shares" contextRef="ifa29b1acea664089973579f536d4f49c_D20190308-20190308" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90ZXh0cmVnaW9uOmVlYzdiZTBhMjZhYjQ3Y2U4OTMzZjc3Y2M2YWFhM2UyXzI4Mw_59965b49-b01b-427b-a1c4-4b3484ea1659">149,831,154</ix:nonFraction> common shares of the Company, refer to Note 15, issued to a wholly owned subsidiary of Altria and <ix:nonFraction unitRef="warrant" contextRef="i0da6f2ce11e0487499370eb2e182ebf5_D20190308-20190308" decimals="INF" format="ixt-sec:numwordsen" name="cron:ClassOfWarrantOrRightNumberOfWarrantsIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90ZXh0cmVnaW9uOmVlYzdiZTBhMjZhYjQ3Y2U4OTMzZjc3Y2M2YWFhM2UyXzQwMg_1e3c397d-5587-4262-948b-c3f66477b3a7">one</ix:nonFraction> warrant of the Company (the &#8220;Altria Warrant&#8221;), refer to Note 16(a), issued to a wholly owned subsidiary of Altria. As of the closing date of the Altria Investment, Altria beneficially held an approximate <ix:nonFraction unitRef="number" contextRef="ib551b9ef8b1d44bcb1db52c16b0f3d77_I20190308" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90ZXh0cmVnaW9uOmVlYzdiZTBhMjZhYjQ3Y2U4OTMzZjc3Y2M2YWFhM2UyXzYwNA_16051704-8b77-4c59-a0fa-22c3300f8df6">45</ix:nonFraction>% ownership interest in the Company (calculated on a non-diluted basis). As summarized in this note, if exercised in full on such date, the exercise of the Altria Warrant would have resulted in Altria holding a total ownership interest in the Company of approximately <ix:nonFraction unitRef="number" contextRef="i082bd82cec0746e98c728d8765ac235d_I20190308" decimals="2" name="cron:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90ZXh0cmVnaW9uOmVlYzdiZTBhMjZhYjQ3Y2U4OTMzZjc3Y2M2YWFhM2UyXzg3Mw_0de52c7a-03c8-4630-9a6b-cb6e80301753">55</ix:nonFraction>% (calculated on a non-diluted basis). Pursuant to the investor rights agreement between the Company and Altria, entered into in connection with the closing of the Altria Investment (the &#8220;Investor Rights Agreement&#8221;), the Company granted Altria certain rights, among others, summarized in this note.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The summaries below are qualified entirely by the terms and conditions fully set out in the Investor Rights Agreement and the Altria Warrant, as applicable. </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">The Altria Warrant entitles the holder, subject to certain qualifications and limitations, to subscribe for and purchase up to an additional <ix:nonFraction unitRef="number" contextRef="i300b4ad7da784a87a26c8cffe4e5d5c3_I20190308" decimals="INF" name="cron:ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90ZXh0cmVnaW9uOmVlYzdiZTBhMjZhYjQ3Y2U4OTMzZjc3Y2M2YWFhM2UyXzE0NzM_60fdb3d9-e4f1-480e-a343-ea6bf6a26700">10</ix:nonFraction>% of the common shares of Cronos (approximately <ix:nonFraction unitRef="shares" contextRef="i3c2ebabdbc694319b460f7822a98d7ec_I20201231" decimals="-5" format="ixt:numdotdecimal" name="cron:ClassOfWarrantOrRightAdditionalSubscriptionNumberOfSecuritiesCalledByWarrantsOrRights" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90ZXh0cmVnaW9uOmVlYzdiZTBhMjZhYjQ3Y2U4OTMzZjc3Y2M2YWFhM2UyXzM4NDgyOTA3MTA5NTI_b6e24627-84f2-4e5f-a9e7-ac4130f494c1">80.1</ix:nonFraction>&#160;million common shares as of December 31, 2020) at a per share exercise price of C$<ix:nonFraction unitRef="cadPerShare" contextRef="if23fc6b156434a4ea635f81fa026311f_I20190308" decimals="INF" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90ZXh0cmVnaW9uOmVlYzdiZTBhMjZhYjQ3Y2U4OTMzZjc3Y2M2YWFhM2UyXzE1ODE_bb9fc75d-335c-43fe-971f-24b9f104cc01">19.00</ix:nonFraction>, which expires at 5:00 p.m. (Toronto time) on March 8, 2023. The number of common shares of the Company to which the holder is entitled, and the corresponding exercise price, is subject to adjustment in the event of a share dividend, share issuance, distribution, or share subdivision, split or other division, share consolidation, reverse-split or other aggregation, share reclassification, a capital reorganization, consolidation, amalgamation, arrangement, binding share exchange, merger or other combination, certain securities issuances, repurchases, redemptions or certain other actions that would result in a reduction in the number of common shares of the Company outstanding, in each case, executed by the Company. If and whenever there is a reclassification of the common shares or a capital reorganization of the Company, or a consolidation, amalgamation, arrangement, binding share exchange or merger of the Company, in each case executed by the Company and pursuant to which (i) in the event the consideration received by the Company&#8217;s shareholders is exclusively cash, the Company or the successor entity (as applicable) is required to purchase the Altria Warrant in cash equal to the amount by which the purchase price per share paid for the common shares acquired exceeds the exercise price of the Altria Warrant multiplied by the number of common shares that would have been issuable upon exercise of the Altria Warrant immediately prior to any such transaction, and (ii) in the event the consideration received by the Company&#8217;s shareholders is not exclusively cash, the Altria Warrant will remain outstanding in accordance with its terms until any subsequent exercise of the Altria Warrant, at which time the holder thereof will receive in lieu of each share that would have been issuable upon the exercise of the Altria Warrant immediately prior to any such transaction, the kind and amount of cash, the number of shares or other securities or property resulting from any such transaction that such holder would have been entitled to receive had such holder been the registered holder of such shares that would have been issuable upon the exercise of the Altria Warrant on the record date or effective date of the transaction (as applicable).</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The Company granted to Altria, subject to certain qualifications and limitations, upon the occurrence of certain issuances of common shares of the Company executed by the Company (including issuances pursuant to the R&amp;D partnership with Ginkgo (the &#8220;Ginkgo Agreement&#8221;), refer to Note 20(b)), the right to purchase up to such number of common shares of the Company in order to maintain their ownership percentage of issued and outstanding common shares of the Company immediately preceding any issuance of shares by the Company (&#8220;Pre-emptive Rights&#8221;), at the same price per common share of the Company at which the common shares are sold in the relevant issuance; provided that if the consideration paid in connection with any such issuance is non-cash, the price per common share of the Company that would have been received had such common shares been issued for cash consideration will be determined by an independent committee (acting reasonably and in good faith); provided further that the price per common share of the Company to be paid by Altria pursuant to its exercise of its Pre-emptive Rights related to the Ginkgo Agreement will be C$<ix:nonFraction unitRef="cadPerShare" contextRef="i4aa0595f97de4e99a81b71038dd7e232_I20190308" decimals="INF" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90ZXh0cmVnaW9uOmVlYzdiZTBhMjZhYjQ3Y2U4OTMzZjc3Y2M2YWFhM2UyXzQ5ODk_89430b10-a192-4354-af84-6b7bef2f1d20">16.25</ix:nonFraction> per common share. These rights may not be exercised if Altria&#8217;s ownership percentage of the issued and outstanding shares of the Company falls below <ix:nonFraction unitRef="number" contextRef="i4aa0595f97de4e99a81b71038dd7e232_I20190308" decimals="INF" name="cron:ClassOfWarrantOrRightMinimumOwnershipPercentageRequired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90ZXh0cmVnaW9uOmVlYzdiZTBhMjZhYjQ3Y2U4OTMzZjc3Y2M2YWFhM2UyXzUxNDE_9b85fcd2-4cda-4dee-b436-b979e1261127">20</ix:nonFraction>%. </span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">94</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December 31, 2020, 2019, and 2018</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for gram and share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div></div><ix:continuation id="i0e0c57dedbc54f0f8d418aadda5818e2" continuedAt="i6f4b31d2e8904b7dbfcfbd9ff41f210c"><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">In addition to (and without duplication of) the Pre-emptive Rights, the Company granted to Altria, subject to certain qualifications and limitations, the right to subscribe for common shares of the Company issuable in connection with the exercise, conversion or exchange of convertible securities of the Company issued prior to March 8, 2019 or thereafter (excluding any convertible securities of the Company owned by Altria or any of its subsidiaries), a share incentive plan of the Company, the exercise of any right granted by the Company pro rata to all shareholders of the Company to purchase additional common shares and/or securities of the Company, bona fide bank debt, equipment financing or non-equity interim financing transactions that contemplate an equity component or bona fide acquisitions (including acquisitions of assets or rights under a license or otherwise), mergers or similar business combination transactions or joint ventures involving the Company in order to maintain their ownership percentage of issued and outstanding common shares of the Company immediately preceding any such transactions (&#8220;Top-up Rights&#8221;). </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The price per common share to be paid by Altria pursuant to the exercise of its Top-up Rights will be, subject to certain limited exceptions, the <ix:nonNumeric contextRef="ib8b72a5bd98248bea7f4df55a0f96261_D20190308-20190308" format="ixt-sec:durday" name="cron:ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90ZXh0cmVnaW9uOmVlYzdiZTBhMjZhYjQ3Y2U4OTMzZjc3Y2M2YWFhM2UyXzY0MzM_c9f84e30-6784-4f0f-ad46-264b41b5882d">10</ix:nonNumeric>-day volume-weighted average price of the common shares of the Company on the TSX for the <ix:nonNumeric contextRef="ib8b72a5bd98248bea7f4df55a0f96261_D20190308-20190308" format="ixt-sec:durday" name="cron:ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90ZXh0cmVnaW9uOmVlYzdiZTBhMjZhYjQ3Y2U4OTMzZjc3Y2M2YWFhM2UyXzY1MjU_dac91518-dc84-4b66-8bf6-cf19fa0f0509">10</ix:nonNumeric> full days preceding such exercise by Altria; provided that the price per common share of the Company to be paid by Altria pursuant to the exercise of its Top-up Rights in connection with the issuance of common shares of the Company pursuant to the exercise of options or warrants that were outstanding as of March 8, 2019 will be C$<ix:nonFraction unitRef="cadPerShare" contextRef="i6b2888ee861546ac8f47f813f636ea76_I20190308" decimals="INF" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90ZXh0cmVnaW9uOmVlYzdiZTBhMjZhYjQ3Y2U4OTMzZjc3Y2M2YWFhM2UyXzY4NTg_d81cb944-86ef-47fb-a34f-4f83bb5dae53">16.25</ix:nonFraction> per common share without any set off, counterclaim, deduction, or withholding. These rights may not be exercised if Altria&#8217;s ownership percentage of the issued and outstanding shares of the Company falls below <ix:nonFraction unitRef="number" contextRef="i6b2888ee861546ac8f47f813f636ea76_I20190308" decimals="INF" name="cron:ClassOfWarrantOrRightMinimumOwnershipPercentageRequired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90ZXh0cmVnaW9uOmVlYzdiZTBhMjZhYjQ3Y2U4OTMzZjc3Y2M2YWFhM2UyXzcwNzE_a5ffdc2a-cb89-41a1-a3c2-84c74c645078">20</ix:nonFraction>%.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Altria Warrant, Pre-emptive Rights, and fixed price Top-up Rights have been classified as derivative liabilities; related transaction costs of $<ix:nonFraction unitRef="usd" contextRef="i4b76c45a8a2b4fbaacb62e55f214d2cf_D20190309-20191231" decimals="-3" format="ixt:numdotdecimal" name="cron:ClassOfWarrantOrRightExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90ZXh0cmVnaW9uOmVlYzdiZTBhMjZhYjQ3Y2U4OTMzZjc3Y2M2YWFhM2UyXzcyMjI_231f3cb1-5b94-44d4-a133-a876ac90f64c">22,355</ix:nonFraction> have been expensed as financing costs in 2019. </span></div><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90ZXh0cmVnaW9uOmVlYzdiZTBhMjZhYjQ3Y2U4OTMzZjc3Y2M2YWFhM2UyXzI0MTg5MjU1ODI0NTQw_8ad433d8-693f-4e4d-946a-1560d2a21167" escape="true"><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reconciliations of the carrying amounts of the derivative liability are presented below:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.288%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.050%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.155%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of January 1, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gain on revaluation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exercise of Rights</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effect of FX</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) Altria Warrant</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i463b1771900c4b5f931730e913e28045_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTozNTlhMjYzMWFiYTg0ZDUxYmY2M2YxMzMyZDk3NDJjYi90YWJsZXJhbmdlOjM1OWEyNjMxYWJhODRkNTFiZjYzZjEzMzJkOTc0MmNiXzEtMS0xLTEtMA_66852d9b-c9f3-49d8-bb67-e0de0c0b26ce">234,428</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia99e808e67ba45ec9755b053b88b09fe_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTozNTlhMjYzMWFiYTg0ZDUxYmY2M2YxMzMyZDk3NDJjYi90YWJsZXJhbmdlOjM1OWEyNjMxYWJhODRkNTFiZjYzZjEzMzJkOTc0MmNiXzEtMy0xLTEtMA_a81119fa-d4ba-4d6f-a5b9-77abb8308d1a">95,045</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia99e808e67ba45ec9755b053b88b09fe_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTozNTlhMjYzMWFiYTg0ZDUxYmY2M2YxMzMyZDk3NDJjYi90YWJsZXJhbmdlOjM1OWEyNjMxYWJhODRkNTFiZjYzZjEzMzJkOTc0MmNiXzEtNS0xLTEtMA_7f84c846-7130-4766-8f61-d87fc2a8a1e7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia99e808e67ba45ec9755b053b88b09fe_D20200101-20201231" decimals="-3" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTozNTlhMjYzMWFiYTg0ZDUxYmY2M2YxMzMyZDk3NDJjYi90YWJsZXJhbmdlOjM1OWEyNjMxYWJhODRkNTFiZjYzZjEzMzJkOTc0MmNiXzEtNy0xLTEtMA_7ef7d350-8290-40ee-8b89-6eebcc32c455">525</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i160db6daa81f47e891c5d92e0c029c65_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTozNTlhMjYzMWFiYTg0ZDUxYmY2M2YxMzMyZDk3NDJjYi90YWJsZXJhbmdlOjM1OWEyNjMxYWJhODRkNTFiZjYzZjEzMzJkOTc0MmNiXzEtOS0xLTEtMA_ce4c026d-5b8b-4bf9-a34a-efe27fb690a3">138,858</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b) Pre-emptive Rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27204cc81d264a0baff5a5819c885fff_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTozNTlhMjYzMWFiYTg0ZDUxYmY2M2YxMzMyZDk3NDJjYi90YWJsZXJhbmdlOjM1OWEyNjMxYWJhODRkNTFiZjYzZjEzMzJkOTc0MmNiXzItMS0xLTEtMA_15eea0b6-6f8a-4d0b-87ed-f120a4c0e6ed">12,787</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i865f9c6470f14034b9c3aa9527060924_D20200101-20201231" decimals="-3" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTozNTlhMjYzMWFiYTg0ZDUxYmY2M2YxMzMyZDk3NDJjYi90YWJsZXJhbmdlOjM1OWEyNjMxYWJhODRkNTFiZjYzZjEzMzJkOTc0MmNiXzItMy0xLTEtMA_993ee610-19fa-4188-9f29-bd3df504c961">885</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i865f9c6470f14034b9c3aa9527060924_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTozNTlhMjYzMWFiYTg0ZDUxYmY2M2YxMzMyZDk3NDJjYi90YWJsZXJhbmdlOjM1OWEyNjMxYWJhODRkNTFiZjYzZjEzMzJkOTc0MmNiXzItNS0xLTEtMA_114277cc-032a-4b87-8612-5a392d599b19">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i865f9c6470f14034b9c3aa9527060924_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTozNTlhMjYzMWFiYTg0ZDUxYmY2M2YxMzMyZDk3NDJjYi90YWJsZXJhbmdlOjM1OWEyNjMxYWJhODRkNTFiZjYzZjEzMzJkOTc0MmNiXzItNy0xLTEtMA_b142c578-8447-4a88-839b-19ac7b9aca75">193</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23e679f22ae84a519b217df003c4e0ca_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTozNTlhMjYzMWFiYTg0ZDUxYmY2M2YxMzMyZDk3NDJjYi90YWJsZXJhbmdlOjM1OWEyNjMxYWJhODRkNTFiZjYzZjEzMzJkOTc0MmNiXzItOS0xLTEtMA_cd77eb39-fea1-4bf9-8602-854cd5cc5320">12,095</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c) Top-up Rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9865e6634a1947ae934e34aee71371ad_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTozNTlhMjYzMWFiYTg0ZDUxYmY2M2YxMzMyZDk3NDJjYi90YWJsZXJhbmdlOjM1OWEyNjMxYWJhODRkNTFiZjYzZjEzMzJkOTc0MmNiXzMtMS0xLTEtMA_a34bffbe-0201-4e6e-bbf2-82134ac5b2a7">49,945</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic39856d934ae48b2a455091b04383ffc_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTozNTlhMjYzMWFiYTg0ZDUxYmY2M2YxMzMyZDk3NDJjYi90YWJsZXJhbmdlOjM1OWEyNjMxYWJhODRkNTFiZjYzZjEzMzJkOTc0MmNiXzMtMy0xLTEtMA_6ae9c544-7862-4dff-b454-ea4ac581e98e">33,324</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic39856d934ae48b2a455091b04383ffc_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTozNTlhMjYzMWFiYTg0ZDUxYmY2M2YxMzMyZDk3NDJjYi90YWJsZXJhbmdlOjM1OWEyNjMxYWJhODRkNTFiZjYzZjEzMzJkOTc0MmNiXzMtNS0xLTEtMA_eaa3ff89-50f5-4c65-bdf4-caf04c57c56b">3,227</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic39856d934ae48b2a455091b04383ffc_D20200101-20201231" decimals="-3" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTozNTlhMjYzMWFiYTg0ZDUxYmY2M2YxMzMyZDk3NDJjYi90YWJsZXJhbmdlOjM1OWEyNjMxYWJhODRkNTFiZjYzZjEzMzJkOTc0MmNiXzMtNy0xLTEtMA_005d9e1f-409e-4d85-9699-2028784c3a5f">937</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie513d3f3a44c445b883b46a6064152ff_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTozNTlhMjYzMWFiYTg0ZDUxYmY2M2YxMzMyZDk3NDJjYi90YWJsZXJhbmdlOjM1OWEyNjMxYWJhODRkNTFiZjYzZjEzMzJkOTc0MmNiXzMtOS0xLTEtMA_ed962f65-6a1d-414f-8674-058f1f30dc2a">12,457</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTozNTlhMjYzMWFiYTg0ZDUxYmY2M2YxMzMyZDk3NDJjYi90YWJsZXJhbmdlOjM1OWEyNjMxYWJhODRkNTFiZjYzZjEzMzJkOTc0MmNiXzQtMS0xLTEtMA_e60d994a-5ac8-4f1a-99b0-a425e7ba1292">297,160</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTozNTlhMjYzMWFiYTg0ZDUxYmY2M2YxMzMyZDk3NDJjYi90YWJsZXJhbmdlOjM1OWEyNjMxYWJhODRkNTFiZjYzZjEzMzJkOTc0MmNiXzQtMy0xLTEtMA_effe8ff0-60dd-4455-9d69-118e0c0bc866">129,254</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTozNTlhMjYzMWFiYTg0ZDUxYmY2M2YxMzMyZDk3NDJjYi90YWJsZXJhbmdlOjM1OWEyNjMxYWJhODRkNTFiZjYzZjEzMzJkOTc0MmNiXzQtNS0xLTEtMA_68029308-a9ce-4170-9f5e-fa01f9e28e0e">3,227</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTozNTlhMjYzMWFiYTg0ZDUxYmY2M2YxMzMyZDk3NDJjYi90YWJsZXJhbmdlOjM1OWEyNjMxYWJhODRkNTFiZjYzZjEzMzJkOTc0MmNiXzQtNy0xLTEtMA_30c07721-d3cd-4a9f-b5b7-ad8ce5079a2d">1,269</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTozNTlhMjYzMWFiYTg0ZDUxYmY2M2YxMzMyZDk3NDJjYi90YWJsZXJhbmdlOjM1OWEyNjMxYWJhODRkNTFiZjYzZjEzMzJkOTc0MmNiXzQtOS0xLTEtMA_205537eb-a762-4263-aa8f-cfc1031ed133">163,410</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.155%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of March 8, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gain on revaluation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exercise of Rights</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effect of FX</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) Altria Warrant</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if23fc6b156434a4ea635f81fa026311f_I20190308" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NTdkYTBmN2RiOTk0ODk3ODcxOGQ1NGViMGNmNzdkOS90YWJsZXJhbmdlOjY1N2RhMGY3ZGI5OTQ4OTc4NzE4ZDU0ZWIwY2Y3N2Q5XzEtMS0xLTEtODE0MQ_e37031b7-6346-4a44-8bc6-4ed4cb4f22c9">1,086,920</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb22be955a4449a9a766febb73b0f3a4_D20190309-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NTdkYTBmN2RiOTk0ODk3ODcxOGQ1NGViMGNmNzdkOS90YWJsZXJhbmdlOjY1N2RhMGY3ZGI5OTQ4OTc4NzE4ZDU0ZWIwY2Y3N2Q5XzEtMy0xLTEtODE0MQ_7e131aa2-279b-4005-8ef2-09d903384857">869,630</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb22be955a4449a9a766febb73b0f3a4_D20190309-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NTdkYTBmN2RiOTk0ODk3ODcxOGQ1NGViMGNmNzdkOS90YWJsZXJhbmdlOjY1N2RhMGY3ZGI5OTQ4OTc4NzE4ZDU0ZWIwY2Y3N2Q5XzEtNS0xLTEtODE0MQ_59795691-3a00-4d7d-91ee-259476cf3e4d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb22be955a4449a9a766febb73b0f3a4_D20190309-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NTdkYTBmN2RiOTk0ODk3ODcxOGQ1NGViMGNmNzdkOS90YWJsZXJhbmdlOjY1N2RhMGY3ZGI5OTQ4OTc4NzE4ZDU0ZWIwY2Y3N2Q5XzEtNy0xLTEtODE0MQ_f1499807-55fe-48c4-80aa-6e295d28060c">17,138</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i463b1771900c4b5f931730e913e28045_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NTdkYTBmN2RiOTk0ODk3ODcxOGQ1NGViMGNmNzdkOS90YWJsZXJhbmdlOjY1N2RhMGY3ZGI5OTQ4OTc4NzE4ZDU0ZWIwY2Y3N2Q5XzEtOS0xLTEtODE0MQ_57cfc3a4-1423-43fd-8ee8-ddf65ee63c72">234,428</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b) Pre-emptive Rights</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4aa0595f97de4e99a81b71038dd7e232_I20190308" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NTdkYTBmN2RiOTk0ODk3ODcxOGQ1NGViMGNmNzdkOS90YWJsZXJhbmdlOjY1N2RhMGY3ZGI5OTQ4OTc4NzE4ZDU0ZWIwY2Y3N2Q5XzItMS0xLTEtODE0MQ_b308a959-d14a-49d6-8256-fcb0ed7534d2">92,548</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ea1386c2a494e8fb6de3793f9261b99_D20190309-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NTdkYTBmN2RiOTk0ODk3ODcxOGQ1NGViMGNmNzdkOS90YWJsZXJhbmdlOjY1N2RhMGY3ZGI5OTQ4OTc4NzE4ZDU0ZWIwY2Y3N2Q5XzItMy0xLTEtODE0MQ_e7ae56ba-e70a-4b78-9550-6932e3090ef6">81,070</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ea1386c2a494e8fb6de3793f9261b99_D20190309-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NTdkYTBmN2RiOTk0ODk3ODcxOGQ1NGViMGNmNzdkOS90YWJsZXJhbmdlOjY1N2RhMGY3ZGI5OTQ4OTc4NzE4ZDU0ZWIwY2Y3N2Q5XzItNS0xLTEtODE0MQ_70d78b9f-c6cf-44bb-828e-3842c2e48041">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ea1386c2a494e8fb6de3793f9261b99_D20190309-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NTdkYTBmN2RiOTk0ODk3ODcxOGQ1NGViMGNmNzdkOS90YWJsZXJhbmdlOjY1N2RhMGY3ZGI5OTQ4OTc4NzE4ZDU0ZWIwY2Y3N2Q5XzItNy0xLTEtODE0MQ_df3ca3a0-be5b-477f-b7b4-8696aec5dadb">1,309</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27204cc81d264a0baff5a5819c885fff_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NTdkYTBmN2RiOTk0ODk3ODcxOGQ1NGViMGNmNzdkOS90YWJsZXJhbmdlOjY1N2RhMGY3ZGI5OTQ4OTc4NzE4ZDU0ZWIwY2Y3N2Q5XzItOS0xLTEtODE0MQ_7f314320-4e10-4a78-a3fe-e43393c9bcd4">12,787</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c) Top-up Rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b2888ee861546ac8f47f813f636ea76_I20190308" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NTdkYTBmN2RiOTk0ODk3ODcxOGQ1NGViMGNmNzdkOS90YWJsZXJhbmdlOjY1N2RhMGY3ZGI5OTQ4OTc4NzE4ZDU0ZWIwY2Y3N2Q5XzMtMS0xLTEtODE0MQ_6f069f46-948e-4692-82eb-384748826cad">386,152</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4b76c45a8a2b4fbaacb62e55f214d2cf_D20190309-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NTdkYTBmN2RiOTk0ODk3ODcxOGQ1NGViMGNmNzdkOS90YWJsZXJhbmdlOjY1N2RhMGY3ZGI5OTQ4OTc4NzE4ZDU0ZWIwY2Y3N2Q5XzMtMy0xLTEtODE0MQ_b34a30fc-07cf-4064-85bb-2e82c7194721">326,119</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4b76c45a8a2b4fbaacb62e55f214d2cf_D20190309-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NTdkYTBmN2RiOTk0ODk3ODcxOGQ1NGViMGNmNzdkOS90YWJsZXJhbmdlOjY1N2RhMGY3ZGI5OTQ4OTc4NzE4ZDU0ZWIwY2Y3N2Q5XzMtNS0xLTEtODE0MQ_58beb662-cecf-4093-badf-9103c3a34ce4">15,478</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b76c45a8a2b4fbaacb62e55f214d2cf_D20190309-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NTdkYTBmN2RiOTk0ODk3ODcxOGQ1NGViMGNmNzdkOS90YWJsZXJhbmdlOjY1N2RhMGY3ZGI5OTQ4OTc4NzE4ZDU0ZWIwY2Y3N2Q5XzMtNy0xLTEtODE0MQ_6bd28ab0-cc28-44ba-8688-d467f4c70595">5,390</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9865e6634a1947ae934e34aee71371ad_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NTdkYTBmN2RiOTk0ODk3ODcxOGQ1NGViMGNmNzdkOS90YWJsZXJhbmdlOjY1N2RhMGY3ZGI5OTQ4OTc4NzE4ZDU0ZWIwY2Y3N2Q5XzMtOS0xLTEtODE0MQ_738e3c87-a849-452a-84f6-1329cfbeaf15">49,945</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i813499ada2bf48288695564490d30842_I20190308" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NTdkYTBmN2RiOTk0ODk3ODcxOGQ1NGViMGNmNzdkOS90YWJsZXJhbmdlOjY1N2RhMGY3ZGI5OTQ4OTc4NzE4ZDU0ZWIwY2Y3N2Q5XzQtMS0xLTEtODE0MQ_a2f3679d-96de-47d1-99d9-e3edeecdeed3">1,565,620</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i760c8d6a27604682ac45b413f79812b7_D20190309-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NTdkYTBmN2RiOTk0ODk3ODcxOGQ1NGViMGNmNzdkOS90YWJsZXJhbmdlOjY1N2RhMGY3ZGI5OTQ4OTc4NzE4ZDU0ZWIwY2Y3N2Q5XzQtMy0xLTEtODE0MQ_fe2bc5dc-8b0a-4ad2-86c3-451f1902a4b2">1,276,819</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i760c8d6a27604682ac45b413f79812b7_D20190309-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NTdkYTBmN2RiOTk0ODk3ODcxOGQ1NGViMGNmNzdkOS90YWJsZXJhbmdlOjY1N2RhMGY3ZGI5OTQ4OTc4NzE4ZDU0ZWIwY2Y3N2Q5XzQtNS0xLTEtODE0MQ_79b01bb9-aa20-45fc-b5c1-7044387f0002">15,478</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i760c8d6a27604682ac45b413f79812b7_D20190309-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NTdkYTBmN2RiOTk0ODk3ODcxOGQ1NGViMGNmNzdkOS90YWJsZXJhbmdlOjY1N2RhMGY3ZGI5OTQ4OTc4NzE4ZDU0ZWIwY2Y3N2Q5XzQtNy0xLTEtODE0MQ_a099b33e-6560-419b-b3c1-de884b7515bb">23,837</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NTdkYTBmN2RiOTk0ODk3ODcxOGQ1NGViMGNmNzdkOS90YWJsZXJhbmdlOjY1N2RhMGY3ZGI5OTQ4OTc4NzE4ZDU0ZWIwY2Y3N2Q5XzQtOS0xLTEtODE0MQ_e14b5108-0e9c-4b81-9549-187b150f0a48">297,160</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fluctuations in the Company&#8217;s share price are a primary driver for the changes in the derivative valuations during each reporting period. As the share price decreases for each of the related derivative instruments, the liability of the instrument generally decreases. Share price is one of the significant observable inputs used in the fair value measurement of each of the Company&#8217;s derivative instruments. During the year ended December&#160;31, 2020, the Company&#8217;s share price decreased from December&#160;31, 2019 resulting in a gain on revaluation of $<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90ZXh0cmVnaW9uOmVlYzdiZTBhMjZhYjQ3Y2U4OTMzZjc3Y2M2YWFhM2UyXzM4NDgyOTA3MDc5Nzc_effe8ff0-60dd-4455-9d69-118e0c0bc866">129,254</ix:nonFraction>.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">95</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December 31, 2020, 2019, and 2018</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for gram and share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div></div><ix:continuation id="i6f4b31d2e8904b7dbfcfbd9ff41f210c" continuedAt="i270d259b4ee54f1dbe36e53c6563a14b"><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90ZXh0cmVnaW9uOmVlYzdiZTBhMjZhYjQ3Y2U4OTMzZjc3Y2M2YWFhM2UyXzk1ODc_3c771d5b-b882-4486-bff7-9faadec012d0" continuedAt="iaf889147e050441e9b37581876b0eb63" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the derivative liabilities were determined using the Black-Scholes pricing model as of December&#160;31, 2020 and December&#160;31, 2019, applying the following inputs:</span></div><div style="margin-bottom:3pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.816%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.820%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Altria Warrant</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pre-emptive Rights</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Top-up Rights</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share price at grant date (per share in C$)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="cadPerShare" contextRef="ife69a303a50649b0b6f092658ca1d499_I20201231" decimals="2" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTpmY2I1YTY4YWVkYmY0ODMwODBjZjBhODQ5MDM2Y2MzYS90YWJsZXJhbmdlOmZjYjVhNjhhZWRiZjQ4MzA4MGNmMGE4NDkwMzZjYzNhXzItNy0xLTEtMA_790d98f9-4a78-4851-a99a-18455d2a05f8">8.84</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="cadPerShare" contextRef="i1002f68219ae43b4be932a6273264a7c_I20201231" decimals="2" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTpmY2I1YTY4YWVkYmY0ODMwODBjZjBhODQ5MDM2Y2MzYS90YWJsZXJhbmdlOmZjYjVhNjhhZWRiZjQ4MzA4MGNmMGE4NDkwMzZjYzNhXzItOS0xLTEtMA_01f7eb1f-23aa-4399-9ca8-91d297ebc0a9">8.84</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="cadPerShare" contextRef="i0ffe884f9b2344429d5d6c7f367928f0_I20201231" decimals="2" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTpmY2I1YTY4YWVkYmY0ODMwODBjZjBhODQ5MDM2Y2MzYS90YWJsZXJhbmdlOmZjYjVhNjhhZWRiZjQ4MzA4MGNmMGE4NDkwMzZjYzNhXzItMTEtMS0xLTA_2360d650-30d1-4750-910b-c6d83bf39a20">8.84</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subscription price (per share in C$)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="cadPerShare" contextRef="i6c71bcd46a354ef48c615d33719c2f24_I20201231" decimals="2" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTpmY2I1YTY4YWVkYmY0ODMwODBjZjBhODQ5MDM2Y2MzYS90YWJsZXJhbmdlOmZjYjVhNjhhZWRiZjQ4MzA4MGNmMGE4NDkwMzZjYzNhXzMtNy0xLTEtMA_1336a5ed-bdb5-4ffa-be89-879117b652af">19.00</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="cadPerShare" contextRef="i8c0529bb277d40f3b988874534a3c039_I20201231" decimals="2" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTpmY2I1YTY4YWVkYmY0ODMwODBjZjBhODQ5MDM2Y2MzYS90YWJsZXJhbmdlOmZjYjVhNjhhZWRiZjQ4MzA4MGNmMGE4NDkwMzZjYzNhXzMtOS0xLTEtMA_c604a65f-80a7-4481-ae2b-8c869cff757f">16.25</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="cadPerShare" contextRef="ic392ce3b66a344a49d1bf576e9ecd60b_I20201231" decimals="2" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTpmY2I1YTY4YWVkYmY0ODMwODBjZjBhODQ5MDM2Y2MzYS90YWJsZXJhbmdlOmZjYjVhNjhhZWRiZjQ4MzA4MGNmMGE4NDkwMzZjYzNhXzMtMTEtMS0xLTA_abe78374-8087-4e3f-a767-fc826615217d">16.25</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average risk-free interest rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i62783d3a67304a879fa26fcc257f00d9_I20201231" decimals="4" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTpmY2I1YTY4YWVkYmY0ODMwODBjZjBhODQ5MDM2Y2MzYS90YWJsZXJhbmdlOmZjYjVhNjhhZWRiZjQ4MzA4MGNmMGE4NDkwMzZjYzNhXzQtNy0xLTEtMA_d4c94a54-7766-4bc6-abf5-aded5f83172e">0.21</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic1a12f35121a4490a0b734503d514f44_I20201231" decimals="4" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTpmY2I1YTY4YWVkYmY0ODMwODBjZjBhODQ5MDM2Y2MzYS90YWJsZXJhbmdlOmZjYjVhNjhhZWRiZjQ4MzA4MGNmMGE4NDkwMzZjYzNhXzQtOS0xLTEtMA_d7f37507-2c80-429f-8926-41043a4b1c17">0.17</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i53eb710ebdeb422f9560e5ed4459a65e_I20201231" decimals="4" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTpmY2I1YTY4YWVkYmY0ODMwODBjZjBhODQ5MDM2Y2MzYS90YWJsZXJhbmdlOmZjYjVhNjhhZWRiZjQ4MzA4MGNmMGE4NDkwMzZjYzNhXzQtMTEtMS0xLTA_2e4f8363-12ed-450b-962d-f0996a96e2be">0.13</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weight average expected life (in years)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6e8fcd467ee0424da748f3c4e639ee5e_D20200101-20201231" format="ixt-sec:duryear" name="cron:DerivativeLiabilityUsefulLifeTerm" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTpmY2I1YTY4YWVkYmY0ODMwODBjZjBhODQ5MDM2Y2MzYS90YWJsZXJhbmdlOmZjYjVhNjhhZWRiZjQ4MzA4MGNmMGE4NDkwMzZjYzNhXzUtNy0xLTEtMA_dc3e0b73-eb91-449f-af87-201799a816bf">2.18</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i03121ba616544c3e9f4c72c77224e550_D20200101-20201231" format="ixt-sec:duryear" name="cron:DerivativeLiabilityUsefulLifeTerm" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTpmY2I1YTY4YWVkYmY0ODMwODBjZjBhODQ5MDM2Y2MzYS90YWJsZXJhbmdlOmZjYjVhNjhhZWRiZjQ4MzA4MGNmMGE4NDkwMzZjYzNhXzUtOS0xLTEtMA_30ad9f55-dc1c-4339-a74c-4d88c199071a">1.50</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if4a40de9976a4a6ea2c284a6a976c110_D20200101-20201231" format="ixt-sec:duryear" name="cron:DerivativeLiabilityUsefulLifeTerm" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTpmY2I1YTY4YWVkYmY0ODMwODBjZjBhODQ5MDM2Y2MzYS90YWJsZXJhbmdlOmZjYjVhNjhhZWRiZjQ4MzA4MGNmMGE4NDkwMzZjYzNhXzUtMTEtMS0xLTA_b1cb6a4d-4e72-44cc-a2d7-ca8cae2aee37">0.98</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected annualized volatility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(iii)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if1d01fc2d35c4475a2aba575ab42c8f4_I20201231" decimals="2" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTpmY2I1YTY4YWVkYmY0ODMwODBjZjBhODQ5MDM2Y2MzYS90YWJsZXJhbmdlOmZjYjVhNjhhZWRiZjQ4MzA4MGNmMGE4NDkwMzZjYzNhXzYtNy0xLTEtMA_13bd1bb4-cef2-483d-8ddf-f249b9900550">81</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7b526944dcae4dbfaef739d5f4926f50_I20201231" decimals="2" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTpmY2I1YTY4YWVkYmY0ODMwODBjZjBhODQ5MDM2Y2MzYS90YWJsZXJhbmdlOmZjYjVhNjhhZWRiZjQ4MzA4MGNmMGE4NDkwMzZjYzNhXzYtOS0xLTEtMA_81335b61-4eb9-44a0-baeb-5ef846dbb46d">81</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id20cab244ae5423b89f1fbb3f050e58c_I20201231" decimals="2" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTpmY2I1YTY4YWVkYmY0ODMwODBjZjBhODQ5MDM2Y2MzYS90YWJsZXJhbmdlOmZjYjVhNjhhZWRiZjQ4MzA4MGNmMGE4NDkwMzZjYzNhXzYtMTEtMS0xLTA_b584e13d-cad6-4ab8-8108-9226760ef0a0">81</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibaa2909c766b4db18adc05215c8e5054_I20201231" decimals="INF" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTpmY2I1YTY4YWVkYmY0ODMwODBjZjBhODQ5MDM2Y2MzYS90YWJsZXJhbmdlOmZjYjVhNjhhZWRiZjQ4MzA4MGNmMGE4NDkwMzZjYzNhXzctNy0xLTEtMA_72844595-1e91-4b94-b6c0-0e5790e34909">0</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6e6e6f6026a74efc8e2d8819d52b47dd_I20201231" decimals="INF" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTpmY2I1YTY4YWVkYmY0ODMwODBjZjBhODQ5MDM2Y2MzYS90YWJsZXJhbmdlOmZjYjVhNjhhZWRiZjQ4MzA4MGNmMGE4NDkwMzZjYzNhXzctOS0xLTEtMA_77364254-e50c-4326-a874-969e28706150">0</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib82c5acab2a34945829d6e887a154631_I20201231" decimals="INF" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTpmY2I1YTY4YWVkYmY0ODMwODBjZjBhODQ5MDM2Y2MzYS90YWJsZXJhbmdlOmZjYjVhNjhhZWRiZjQ4MzA4MGNmMGE4NDkwMzZjYzNhXzctMTEtMS0xLTA_43f1d218-8843-452b-8c88-684a79318d89">0</ix:nonFraction>%</span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-indent:-27pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.816%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.820%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Altria Warrant</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pre-emptive Rights</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Top-up Rights</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share price at grant date (per share in C$)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="cadPerShare" contextRef="i532650c252fe40e8944dc186a1e32d95_I20191231" decimals="2" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NmYwMjBjYTlkMjk0YzMxOTYxN2RjOTVlMmI4MTRiYS90YWJsZXJhbmdlOjY2ZjAyMGNhOWQyOTRjMzE5NjE3ZGM5NWUyYjgxNGJhXzItMS0xLTEtMTA4NDU_a6be5cb6-0d42-429e-b490-5190a284e9d0">9.97</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="cadPerShare" contextRef="i8e7fd630e9344584911653a57e1cade2_I20191231" decimals="2" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NmYwMjBjYTlkMjk0YzMxOTYxN2RjOTVlMmI4MTRiYS90YWJsZXJhbmdlOjY2ZjAyMGNhOWQyOTRjMzE5NjE3ZGM5NWUyYjgxNGJhXzItMy0xLTEtMTA4NDU_67ab307c-e348-4da9-a9de-7e171873da08">9.97</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="cadPerShare" contextRef="ib31c0e699cee4523929ffe9f0cb71ec3_I20191231" decimals="2" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NmYwMjBjYTlkMjk0YzMxOTYxN2RjOTVlMmI4MTRiYS90YWJsZXJhbmdlOjY2ZjAyMGNhOWQyOTRjMzE5NjE3ZGM5NWUyYjgxNGJhXzItNS0xLTEtMTA4NDU_0af48483-4f82-4f89-8fe4-1cca18cc5d1a">9.97</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subscription price (per share in C$)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="cadPerShare" contextRef="i8dad115f7a854f8f8535c69c691a66bd_I20191231" decimals="2" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NmYwMjBjYTlkMjk0YzMxOTYxN2RjOTVlMmI4MTRiYS90YWJsZXJhbmdlOjY2ZjAyMGNhOWQyOTRjMzE5NjE3ZGM5NWUyYjgxNGJhXzMtMS0xLTEtMTA4NDU_d719006e-83b2-45b7-9dce-62fcb6b30919">19.00</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="cadPerShare" contextRef="i6ac25230d48a4dd3b8c55100b4962584_I20191231" decimals="2" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NmYwMjBjYTlkMjk0YzMxOTYxN2RjOTVlMmI4MTRiYS90YWJsZXJhbmdlOjY2ZjAyMGNhOWQyOTRjMzE5NjE3ZGM5NWUyYjgxNGJhXzMtMy0xLTEtMTA4NDU_d77130d2-b9c4-4a0b-a889-48fca5cf60be">16.25</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="cadPerShare" contextRef="i090d89e22cd84b90b9d10cc6c3747232_I20191231" decimals="2" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NmYwMjBjYTlkMjk0YzMxOTYxN2RjOTVlMmI4MTRiYS90YWJsZXJhbmdlOjY2ZjAyMGNhOWQyOTRjMzE5NjE3ZGM5NWUyYjgxNGJhXzMtNS0xLTEtMTA4NDU_560a2ed4-a933-4e10-b827-7e42d3aa19aa">16.25</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average risk-free interest rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie2f5b74993ca4afe861ba1252b560ab3_I20191231" decimals="4" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NmYwMjBjYTlkMjk0YzMxOTYxN2RjOTVlMmI4MTRiYS90YWJsZXJhbmdlOjY2ZjAyMGNhOWQyOTRjMzE5NjE3ZGM5NWUyYjgxNGJhXzQtMS0xLTEtMTA4NDU_72ca84e9-48c0-4160-ba30-6d37a9c19f87">1.69</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifc02dbc8bf0d4565843b395d0dac82d6_I20191231" decimals="4" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NmYwMjBjYTlkMjk0YzMxOTYxN2RjOTVlMmI4MTRiYS90YWJsZXJhbmdlOjY2ZjAyMGNhOWQyOTRjMzE5NjE3ZGM5NWUyYjgxNGJhXzQtMy0xLTEtMTA4NDU_51ed46de-6fe9-46b2-9654-1804b8a6ae60">1.73</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i67d90ff5508a41d4a7e560c59d4cd97f_I20191231" decimals="4" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NmYwMjBjYTlkMjk0YzMxOTYxN2RjOTVlMmI4MTRiYS90YWJsZXJhbmdlOjY2ZjAyMGNhOWQyOTRjMzE5NjE3ZGM5NWUyYjgxNGJhXzQtNS0xLTEtMTA4NDU_efb9a764-cb39-4759-bd19-dcbb6e10fe52">1.71</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weight average expected life (in years)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i511f22de5c4141928962bdab9879ecea_D20190101-20191231" format="ixt-sec:duryear" name="cron:DerivativeLiabilityUsefulLifeTerm" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NmYwMjBjYTlkMjk0YzMxOTYxN2RjOTVlMmI4MTRiYS90YWJsZXJhbmdlOjY2ZjAyMGNhOWQyOTRjMzE5NjE3ZGM5NWUyYjgxNGJhXzUtMS0xLTEtMTA4NDU_b3fcd0e6-c149-4db7-8229-29851a32686e">3.18</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0dce3d6d45ea4267a21a2a0361da3f85_D20190101-20191231" format="ixt-sec:duryear" name="cron:DerivativeLiabilityUsefulLifeTerm" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NmYwMjBjYTlkMjk0YzMxOTYxN2RjOTVlMmI4MTRiYS90YWJsZXJhbmdlOjY2ZjAyMGNhOWQyOTRjMzE5NjE3ZGM5NWUyYjgxNGJhXzUtMy0xLTEtMTA4NDU_2ca86daf-c2d3-41f1-9358-5421b7a83555">1.25</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i51f073ba36984f5c87fd937fb7d24eff_D20190101-20191231" format="ixt-sec:duryear" name="cron:DerivativeLiabilityUsefulLifeTerm" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NmYwMjBjYTlkMjk0YzMxOTYxN2RjOTVlMmI4MTRiYS90YWJsZXJhbmdlOjY2ZjAyMGNhOWQyOTRjMzE5NjE3ZGM5NWUyYjgxNGJhXzUtNS0xLTEtMTA4NDU_4500b239-6e62-45f5-8771-4a512f86f62a">1.66</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected annualized volatility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(iii)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8ee40ca46ccd4085930f0437fb342632_I20191231" decimals="2" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NmYwMjBjYTlkMjk0YzMxOTYxN2RjOTVlMmI4MTRiYS90YWJsZXJhbmdlOjY2ZjAyMGNhOWQyOTRjMzE5NjE3ZGM5NWUyYjgxNGJhXzYtMS0xLTEtMTA4NDU_c9833181-0801-454b-bb13-348ae7652b76">82</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1911ee2c91ef4dd592addb1a63a0fc20_I20191231" decimals="2" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NmYwMjBjYTlkMjk0YzMxOTYxN2RjOTVlMmI4MTRiYS90YWJsZXJhbmdlOjY2ZjAyMGNhOWQyOTRjMzE5NjE3ZGM5NWUyYjgxNGJhXzYtMy0xLTEtMTA4NDU_12cc75c9-bd0b-4f36-8e65-24ed30c910c4">82</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i49e6ac7b6f4a43adb3596a15ec175f15_I20191231" decimals="2" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NmYwMjBjYTlkMjk0YzMxOTYxN2RjOTVlMmI4MTRiYS90YWJsZXJhbmdlOjY2ZjAyMGNhOWQyOTRjMzE5NjE3ZGM5NWUyYjgxNGJhXzYtNS0xLTEtMTA4NDU_f1609431-1b2b-45e5-aed3-f181cfc5a95f">82</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i84cef257e8654992885dbc495e97fa6a_I20191231" decimals="INF" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NmYwMjBjYTlkMjk0YzMxOTYxN2RjOTVlMmI4MTRiYS90YWJsZXJhbmdlOjY2ZjAyMGNhOWQyOTRjMzE5NjE3ZGM5NWUyYjgxNGJhXzctMS0xLTEtMTA4NDU_82f40047-27be-4961-ab35-cd0cd9e92273">0</ix:nonFraction>%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i375b8aad8904491db84b8c4c1e23cc5d_I20191231" decimals="INF" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NmYwMjBjYTlkMjk0YzMxOTYxN2RjOTVlMmI4MTRiYS90YWJsZXJhbmdlOjY2ZjAyMGNhOWQyOTRjMzE5NjE3ZGM5NWUyYjgxNGJhXzctMy0xLTEtMTA4NDU_45946265-ceb1-4e0b-a224-e906eccfc568">0</ix:nonFraction>%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idcfe25f7b5d4403ea6a60531b21489be_I20191231" decimals="INF" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NmYwMjBjYTlkMjk0YzMxOTYxN2RjOTVlMmI4MTRiYS90YWJsZXJhbmdlOjY2ZjAyMGNhOWQyOTRjMzE5NjE3ZGM5NWUyYjgxNGJhXzctNS0xLTEtMTA4NDU_04a0bdda-e690-4ee8-a9c7-d688d7920c25">0</ix:nonFraction>%</span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The risk-free interest rate was based on Bank of Canada government treasury bills and bonds with a remaining term equal to the expected life of the derivative liabilities. The risk-free interest rate uses a range of approximately <ix:nonFraction unitRef="number" contextRef="ic9ab5c8a35da422c8b07919b72494b75_I20201231" decimals="4" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90ZXh0cmVnaW9uOmVlYzdiZTBhMjZhYjQ3Y2U4OTMzZjc3Y2M2YWFhM2UyXzEwOTk1MTE2Mzc2NzM_58cb93b9-214b-49b3-9aef-d353fce2483b">0.10</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i449c71c0a6bc41a7843b95924704320f_I20201231" decimals="4" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90ZXh0cmVnaW9uOmVlYzdiZTBhMjZhYjQ3Y2U4OTMzZjc3Y2M2YWFhM2UyXzEwOTk1MTE2Mzc2ODA_cd1f5120-5727-42b5-903d-32441e4c8afc">0.39</ix:nonFraction>% as of December&#160;31, 2020 (December&#160;31, 2019 &#8211; <ix:nonFraction unitRef="number" contextRef="ib8c37aaed6534f7495f7b25106f852b4_I20191231" decimals="4" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90ZXh0cmVnaW9uOmVlYzdiZTBhMjZhYjQ3Y2U4OTMzZjc3Y2M2YWFhM2UyXzEwOTk1MTE2Mzc2OTk_0daa1d8e-f9b9-4632-80cc-03f9508bde45">1.66</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i3afed61a87ba4d3e991bdb186e51a8eb_I20191231" decimals="4" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90ZXh0cmVnaW9uOmVlYzdiZTBhMjZhYjQ3Y2U4OTMzZjc3Y2M2YWFhM2UyXzEwOTk1MTE2Mzc3MDU_b6f9b726-2320-4e80-8c04-d09926d3aa5f">1.73</ix:nonFraction>%) for the Pre-emptive Rights and Top-up Rights.</span></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The expected life in years represents the period of time that the derivative liabilities are expected to be outstanding. The expected life of the Pre-emptive Rights and Top-up Rights is determined based on the expected term of the underlying options, warrants, and shares, to which the Pre-emptive Rights and Top-up Rights are linked. The expected life uses a range of approximately <ix:nonNumeric contextRef="i8eb7b029c40f44a1a5f9d5ceb456ed65_D20200101-20201231" format="ixt-sec:duryear" name="cron:DerivativeLiabilityUsefulLifeTerm" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90ZXh0cmVnaW9uOmVlYzdiZTBhMjZhYjQ3Y2U4OTMzZjc3Y2M2YWFhM2UyXzEwOTk1MTE2Mzc3NTU_9bbce4d5-0906-46b4-99e2-2eaf16ac7794">0.50</ix:nonNumeric> years to <ix:nonNumeric contextRef="i7ee5cf3f81f746e9a91d18e6efa4e418_D20200101-20201231" format="ixt-sec:duryear" name="cron:DerivativeLiabilityUsefulLifeTerm" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90ZXh0cmVnaW9uOmVlYzdiZTBhMjZhYjQ3Y2U4OTMzZjc3Y2M2YWFhM2UyXzEwOTk1MTE2Mzc1MzY_64a19302-c582-45d9-8fc3-e8835b7c04c5">5</ix:nonNumeric> years as of December&#160;31, 2020 (December&#160;31, 2019 &#8211; <ix:nonNumeric contextRef="i60f16583657641d1bc65b04b7fcc0429_D20190101-20191231" format="ixt-sec:duryear" name="cron:DerivativeLiabilityUsefulLifeTerm" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90ZXh0cmVnaW9uOmVlYzdiZTBhMjZhYjQ3Y2U4OTMzZjc3Y2M2YWFhM2UyXzEwOTk1MTE2Mzc3NTg_1d36acdf-e414-4e5e-a5af-2adbc12610fd">0.25</ix:nonNumeric> years to <ix:nonNumeric contextRef="i301270b5b8644233a9dc1ae42d07c539_D20190101-20191231" format="ixt-sec:duryear" name="cron:DerivativeLiabilityUsefulLifeTerm" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90ZXh0cmVnaW9uOmVlYzdiZTBhMjZhYjQ3Y2U4OTMzZjc3Y2M2YWFhM2UyXzEwOTk1MTE2Mzc3NjY_a197263f-2d54-4a66-9dca-543ee5db05a2">6</ix:nonNumeric> years).</span></div></ix:nonNumeric><div style="margin-bottom:3pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><ix:continuation id="iaf889147e050441e9b37581876b0eb63" continuedAt="i879e754dfafe4acda12c45964b099bce"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#160;&#160;&#160;&#160;</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="i879e754dfafe4acda12c45964b099bce">Volatility was based on the blended historical volatility levels of the Company and peer companies.</ix:continuation> </span></div><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="cron:SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90ZXh0cmVnaW9uOmVlYzdiZTBhMjZhYjQ3Y2U4OTMzZjc3Y2M2YWFhM2UyXzI0MTg5MjU1ODI0NTQx_a528144a-ba33-4d91-876d-90f804add9b1" escape="true"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table quantifies each of the significant inputs described above and provides a sensitivity analysis of the impact on the reported values of the derivative liabilities. The sensitivity analysis for each significant input is performed by assuming a 10% decrease in the input while other significant inputs remain constant at management&#8217;s best estimate as of the respective dates. As of December&#160;31, 2020, there would be an equal but opposite impact on net income (loss), refer to Note 15, and as of December&#160;31, 2019, there would be an equal but opposite impact on share capital.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.816%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.820%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Decrease as of December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Altria Warrant</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pre-emptive Rights</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Top-up Rights</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share price at issuance date</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i160db6daa81f47e891c5d92e0c029c65_I20201231" decimals="-3" format="ixt:numdotdecimal" name="cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZToxMzg2NDI0MjI2NjU0NTFiOWVjNjEzMzI0YjRjZjk3NC90YWJsZXJhbmdlOjEzODY0MjQyMjY2NTQ1MWI5ZWM2MTMzMjRiNGNmOTc0XzItOC0xLTEtMA_93f6214e-e50f-4727-8b10-a8b24fbd68ba">25,819</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23e679f22ae84a519b217df003c4e0ca_I20201231" decimals="-3" format="ixt:numdotdecimal" name="cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZToxMzg2NDI0MjI2NjU0NTFiOWVjNjEzMzI0YjRjZjk3NC90YWJsZXJhbmdlOjEzODY0MjQyMjY2NTQ1MWI5ZWM2MTMzMjRiNGNmOTc0XzItMTAtMS0xLTA_3881a6d5-ed39-4fb2-a272-844797986814">2,527</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie513d3f3a44c445b883b46a6064152ff_I20201231" decimals="-3" format="ixt:numdotdecimal" name="cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZToxMzg2NDI0MjI2NjU0NTFiOWVjNjEzMzI0YjRjZjk3NC90YWJsZXJhbmdlOjEzODY0MjQyMjY2NTQ1MWI5ZWM2MTMzMjRiNGNmOTc0XzItMTItMS0xLTA_c0dc4fc5-a496-4187-983e-96ea9746a013">2,989</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average expected life</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i160db6daa81f47e891c5d92e0c029c65_I20201231" decimals="-3" format="ixt:numdotdecimal" name="cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZToxMzg2NDI0MjI2NjU0NTFiOWVjNjEzMzI0YjRjZjk3NC90YWJsZXJhbmdlOjEzODY0MjQyMjY2NTQ1MWI5ZWM2MTMzMjRiNGNmOTc0XzMtOC0xLTEtMA_0bf9610a-05bf-44cd-afd5-859047ede53e">13,541</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23e679f22ae84a519b217df003c4e0ca_I20201231" decimals="-3" format="ixt:numdotdecimal" name="cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZToxMzg2NDI0MjI2NjU0NTFiOWVjNjEzMzI0YjRjZjk3NC90YWJsZXJhbmdlOjEzODY0MjQyMjY2NTQ1MWI5ZWM2MTMzMjRiNGNmOTc0XzMtMTAtMS0xLTA_ac61d561-6097-49d9-a2f5-8da56d691329">1,988</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie513d3f3a44c445b883b46a6064152ff_I20201231" decimals="-3" format="ixt:numdotdecimal" name="cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZToxMzg2NDI0MjI2NjU0NTFiOWVjNjEzMzI0YjRjZjk3NC90YWJsZXJhbmdlOjEzODY0MjQyMjY2NTQ1MWI5ZWM2MTMzMjRiNGNmOTc0XzMtMTItMS0xLTA_09afac47-5a6f-4c22-9b0b-45edcfad2545">2,121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected annualized volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i160db6daa81f47e891c5d92e0c029c65_I20201231" decimals="-3" format="ixt:numdotdecimal" name="cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZToxMzg2NDI0MjI2NjU0NTFiOWVjNjEzMzI0YjRjZjk3NC90YWJsZXJhbmdlOjEzODY0MjQyMjY2NTQ1MWI5ZWM2MTMzMjRiNGNmOTc0XzQtOC0xLTEtMA_9352ed3e-30a6-4bed-b914-a54bbc020f5a">26,183</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23e679f22ae84a519b217df003c4e0ca_I20201231" decimals="-3" format="ixt:numdotdecimal" name="cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZToxMzg2NDI0MjI2NjU0NTFiOWVjNjEzMzI0YjRjZjk3NC90YWJsZXJhbmdlOjEzODY0MjQyMjY2NTQ1MWI5ZWM2MTMzMjRiNGNmOTc0XzQtMTAtMS0xLTA_62a49bf2-ed5b-43da-8983-5b4acbbaff06">2,269</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie513d3f3a44c445b883b46a6064152ff_I20201231" decimals="-3" format="ixt:numdotdecimal" name="cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZToxMzg2NDI0MjI2NjU0NTFiOWVjNjEzMzI0YjRjZjk3NC90YWJsZXJhbmdlOjEzODY0MjQyMjY2NTQ1MWI5ZWM2MTMzMjRiNGNmOTc0XzQtMTItMS0xLTA_51c736ca-7831-45f7-b473-0d341ea262cf">2,602</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.816%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.820%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Decrease as of December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Altria Warrant</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pre-emptive Rights</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Top-up Rights</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share price at issuance date</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i463b1771900c4b5f931730e913e28045_I20191231" decimals="-3" format="ixt:numdotdecimal" name="cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTpmNzRlZTQ3ZWNhY2U0MDlkYTg4MDRjY2UxM2NmMDhjOC90YWJsZXJhbmdlOmY3NGVlNDdlY2FjZTQwOWRhODgwNGNjZTEzY2YwOGM4XzItMi0xLTEtMTA4Njg_00b20425-c7a9-4a24-9c77-60ae272671fb">36,436</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27204cc81d264a0baff5a5819c885fff_I20191231" decimals="-3" format="ixt:numdotdecimal" name="cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTpmNzRlZTQ3ZWNhY2U0MDlkYTg4MDRjY2UxM2NmMDhjOC90YWJsZXJhbmdlOmY3NGVlNDdlY2FjZTQwOWRhODgwNGNjZTEzY2YwOGM4XzItNC0xLTEtMTA4Njg_25a663bf-edec-443f-835c-5c7e695448f9">2,743</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9865e6634a1947ae934e34aee71371ad_I20191231" decimals="-3" format="ixt:numdotdecimal" name="cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTpmNzRlZTQ3ZWNhY2U0MDlkYTg4MDRjY2UxM2NmMDhjOC90YWJsZXJhbmdlOmY3NGVlNDdlY2FjZTQwOWRhODgwNGNjZTEzY2YwOGM4XzItNi0xLTEtMTA4Njg_18b2df17-b765-4b8b-8c37-a489596aa1dd">9,577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average expected life</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i463b1771900c4b5f931730e913e28045_I20191231" decimals="-3" format="ixt:numdotdecimal" name="cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTpmNzRlZTQ3ZWNhY2U0MDlkYTg4MDRjY2UxM2NmMDhjOC90YWJsZXJhbmdlOmY3NGVlNDdlY2FjZTQwOWRhODgwNGNjZTEzY2YwOGM4XzMtMi0xLTEtMTA4Njg_74347f23-8055-45f3-ac1f-f8c40aec08ec">17,471</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27204cc81d264a0baff5a5819c885fff_I20191231" decimals="-3" format="ixt:numdotdecimal" name="cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTpmNzRlZTQ3ZWNhY2U0MDlkYTg4MDRjY2UxM2NmMDhjOC90YWJsZXJhbmdlOmY3NGVlNDdlY2FjZTQwOWRhODgwNGNjZTEzY2YwOGM4XzMtNC0xLTEtMTA4Njg_4d68cb14-8267-4832-a0ab-8e043ea2a026">2,366</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9865e6634a1947ae934e34aee71371ad_I20191231" decimals="-3" format="ixt:numdotdecimal" name="cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTpmNzRlZTQ3ZWNhY2U0MDlkYTg4MDRjY2UxM2NmMDhjOC90YWJsZXJhbmdlOmY3NGVlNDdlY2FjZTQwOWRhODgwNGNjZTEzY2YwOGM4XzMtNi0xLTEtMTA4Njg_5be01af5-70e7-4618-a143-941c07ede742">2,178</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected annualized volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i463b1771900c4b5f931730e913e28045_I20191231" decimals="-3" format="ixt:numdotdecimal" name="cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTpmNzRlZTQ3ZWNhY2U0MDlkYTg4MDRjY2UxM2NmMDhjOC90YWJsZXJhbmdlOmY3NGVlNDdlY2FjZTQwOWRhODgwNGNjZTEzY2YwOGM4XzQtMi0xLTEtMTA4Njg_d5de5e07-8350-4a5d-952d-b6566308b172">33,343</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27204cc81d264a0baff5a5819c885fff_I20191231" decimals="-3" format="ixt:numdotdecimal" name="cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTpmNzRlZTQ3ZWNhY2U0MDlkYTg4MDRjY2UxM2NmMDhjOC90YWJsZXJhbmdlOmY3NGVlNDdlY2FjZTQwOWRhODgwNGNjZTEzY2YwOGM4XzQtNC0xLTEtMTA4Njg_692ee439-0e18-4d8f-9378-889b1a19abeb">2,180</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9865e6634a1947ae934e34aee71371ad_I20191231" decimals="-3" format="ixt:numdotdecimal" name="cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTpmNzRlZTQ3ZWNhY2U0MDlkYTg4MDRjY2UxM2NmMDhjOC90YWJsZXJhbmdlOmY3NGVlNDdlY2FjZTQwOWRhODgwNGNjZTEzY2YwOGM4XzQtNi0xLTEtMTA4Njg_095debb6-a91d-471c-8ecb-1a2a6448bb1c">7,714</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i270d259b4ee54f1dbe36e53c6563a14b">These inputs are classified in Level 3 on the fair value hierarchy and are subject to volatility and several uncontrollable factors, which could significantly affect the fair value of these derivative liabilities in future periods.</ix:continuation> </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96</span></div></div></div><div id="i1ae9134e40e74e0aac958218112e53d4_127"></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December 31, 2020, 2019, and 2018</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for gram and share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:16pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">15. <ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90ZXh0cmVnaW9uOmFiMTEyNjUyZTExYTQyZDFiNzczZmM1NGYwZjgxMzkzXzI0NjY_013418bf-d1f9-4c5e-83af-198b97f479cf" continuedAt="i17cff3a854ad4195aa5264c2941305ed" escape="true">Capital Stock&#160;&#160;&#160;&#160;</ix:nonNumeric></span></div><ix:continuation id="i17cff3a854ad4195aa5264c2941305ed"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is authorized to issue an unlimited number of no par value common shares. The holders of the common shares are entitled to receive dividends, which may be declared from time to time, and are entitled to <ix:nonFraction unitRef="vote" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="cron:CommonStockNumberOfVotesPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90ZXh0cmVnaW9uOmFiMTEyNjUyZTExYTQyZDFiNzczZmM1NGYwZjgxMzkzXzIyOA_b43a652f-146f-4b3c-ac0e-0392d63e4790">one</ix:nonFraction> vote per share at shareholder meetings of the Company. All common shares are ranked equally with regards to the Company&#8217;s residual net assets.</span></div><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:ScheduleOfStockByClassTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90ZXh0cmVnaW9uOmFiMTEyNjUyZTExYTQyZDFiNzczZmM1NGYwZjgxMzkzXzIzMDg5NzQ0MjA3ODc5_e4843dc7-30f2-4553-91b3-2b64ce543cf5" escape="true"><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of common shares issued, other than in connection with outstanding options and warrants (see Note 16): </span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.372%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.205%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.205%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.208%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Altria Investment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ica622cb684474ab3a25d8fbc0860181c_D20200101-20201231" decimals="INF" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90YWJsZTphNzVlNzNmZjc4ZTc0ODI3YjE2ZjFhYTI3NWJjYTk1Yy90YWJsZXJhbmdlOmE3NWU3M2ZmNzhlNzQ4MjdiMTZmMWFhMjc1YmNhOTVjXzMtMS0xLTEtMA_6bbd59f2-3541-4a38-9411-68fa4de9175f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1db6dad47a0c48f9ba16df4ee15bdba5_D20190101-20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90YWJsZTphNzVlNzNmZjc4ZTc0ODI3YjE2ZjFhYTI3NWJjYTk1Yy90YWJsZXJhbmdlOmE3NWU3M2ZmNzhlNzQ4MjdiMTZmMWFhMjc1YmNhOTVjXzMtMy0xLTEtMA_6b544f3d-c5b3-4811-a7bd-1b5d2114318e">149,831,154</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7d7e063426374ebba0b27e029f93204e_D20180101-20181231" decimals="INF" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90YWJsZTphNzVlNzNmZjc4ZTc0ODI3YjE2ZjFhYTI3NWJjYTk1Yy90YWJsZXJhbmdlOmE3NWU3M2ZmNzhlNzQ4MjdiMTZmMWFhMjc1YmNhOTVjXzMtNS0xLTEtMA_a7ffc51c-c664-43b6-87d8-b9b73681bb05">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redwood Acquisition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9d8d3d9a698948f2a7e5b7ede9faa261_D20200101-20201231" decimals="INF" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90YWJsZTphNzVlNzNmZjc4ZTc0ODI3YjE2ZjFhYTI3NWJjYTk1Yy90YWJsZXJhbmdlOmE3NWU3M2ZmNzhlNzQ4MjdiMTZmMWFhMjc1YmNhOTVjXzQtMS0xLTEtMA_a6429598-6222-47a8-b813-3d54941b5cca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i399c1d0125d94144839ad09cbfcd4e79_D20190101-20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90YWJsZTphNzVlNzNmZjc4ZTc0ODI3YjE2ZjFhYTI3NWJjYTk1Yy90YWJsZXJhbmdlOmE3NWU3M2ZmNzhlNzQ4MjdiMTZmMWFhMjc1YmNhOTVjXzQtMy0xLTEtMA_53ec6176-f97d-4a79-9dfb-46199cb18ed3">5,086,586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i63b115fac3df4d088ed98d2fe12e8da5_D20180101-20181231" decimals="INF" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90YWJsZTphNzVlNzNmZjc4ZTc0ODI3YjE2ZjFhYTI3NWJjYTk1Yy90YWJsZXJhbmdlOmE3NWU3M2ZmNzhlNzQ4MjdiMTZmMWFhMjc1YmNhOTVjXzQtNS0xLTEtMA_609c93e8-c84c-429d-917c-c0a8151b2577">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private placement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iii)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7a93d4ff964040f3961be26878cf2aa6_D20200101-20201231" decimals="INF" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90YWJsZTphNzVlNzNmZjc4ZTc0ODI3YjE2ZjFhYTI3NWJjYTk1Yy90YWJsZXJhbmdlOmE3NWU3M2ZmNzhlNzQ4MjdiMTZmMWFhMjc1YmNhOTVjXzUtMS0xLTEtMA_f13510a9-5382-479d-b79e-0d128e29695c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6385655ed7694227b1ba4c2470a26f37_D20190101-20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90YWJsZTphNzVlNzNmZjc4ZTc0ODI3YjE2ZjFhYTI3NWJjYTk1Yy90YWJsZXJhbmdlOmE3NWU3M2ZmNzhlNzQ4MjdiMTZmMWFhMjc1YmNhOTVjXzQtMy0xLTEtODY3Ng_6ce5112e-57ba-4eba-b4dc-0c71420c20d5">856,017</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i548a898f85674e398f117c44d298a956_D20180101-20181231" decimals="INF" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90YWJsZTphNzVlNzNmZjc4ZTc0ODI3YjE2ZjFhYTI3NWJjYTk1Yy90YWJsZXJhbmdlOmE3NWU3M2ZmNzhlNzQ4MjdiMTZmMWFhMjc1YmNhOTVjXzMtNS0xLTEtMjM3MzM_ac9e53fb-1318-4d52-872c-54a75639ba11">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bought deal offering</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iv)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id6e6569c5b684d46b2b88bc879497620_D20200101-20201231" decimals="INF" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90YWJsZTphNzVlNzNmZjc4ZTc0ODI3YjE2ZjFhYTI3NWJjYTk1Yy90YWJsZXJhbmdlOmE3NWU3M2ZmNzhlNzQ4MjdiMTZmMWFhMjc1YmNhOTVjXzUtMS0xLTEtMTMyNTM_ed8b88cd-409d-487a-9eb2-aa019f0232c8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib38f7a8880414aad875a0b362cbe2fb4_D20190101-20191231" decimals="INF" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90YWJsZTphNzVlNzNmZjc4ZTc0ODI3YjE2ZjFhYTI3NWJjYTk1Yy90YWJsZXJhbmdlOmE3NWU3M2ZmNzhlNzQ4MjdiMTZmMWFhMjc1YmNhOTVjXzUtMy0xLTEtMTMyNTM_94f5fe56-1b51-4c8c-8361-6efff1f9a272">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7104c544b41946c8a7fe225376901625_D20180101-20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90YWJsZTphNzVlNzNmZjc4ZTc0ODI3YjE2ZjFhYTI3NWJjYTk1Yy90YWJsZXJhbmdlOmE3NWU3M2ZmNzhlNzQ4MjdiMTZmMWFhMjc1YmNhOTVjXzUtNS0xLTEtMTMyNTM_2443227c-8109-40d6-9b1f-11ef44ad3cad">15,677,143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3783dc27237d46f6944e1a9a6f65eee6_D20200101-20201231" decimals="INF" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90YWJsZTphNzVlNzNmZjc4ZTc0ODI3YjE2ZjFhYTI3NWJjYTk1Yy90YWJsZXJhbmdlOmE3NWU3M2ZmNzhlNzQ4MjdiMTZmMWFhMjc1YmNhOTVjXzYtMS0xLTEtMA_2d4fe162-cf10-484f-afa7-5ad77ff457e3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6aa79556c9a24064ab5ea55845f31f79_D20190101-20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90YWJsZTphNzVlNzNmZjc4ZTc0ODI3YjE2ZjFhYTI3NWJjYTk1Yy90YWJsZXJhbmdlOmE3NWU3M2ZmNzhlNzQ4MjdiMTZmMWFhMjc1YmNhOTVjXzYtMy0xLTEtMA_06a77c5d-4851-444b-bb58-83d5170eda8e">155,773,757</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i85e3d76bfda8415b975e00befcd9609f_D20180101-20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90YWJsZTphNzVlNzNmZjc4ZTc0ODI3YjE2ZjFhYTI3NWJjYTk1Yy90YWJsZXJhbmdlOmE3NWU3M2ZmNzhlNzQ4MjdiMTZmMWFhMjc1YmNhOTVjXzYtNS0xLTEtMA_e9787c81-6b42-41a1-995f-4521c4ff9dfd">15,677,143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.1pt">During the year ended December&#160;31, 2019, the Company issued <ix:nonFraction unitRef="shares" contextRef="i1db6dad47a0c48f9ba16df4ee15bdba5_D20190101-20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90ZXh0cmVnaW9uOmFiMTEyNjUyZTExYTQyZDFiNzczZmM1NGYwZjgxMzkzXzEyNjQ0MzgzNzM5ODE4_6b544f3d-c5b3-4811-a7bd-1b5d2114318e">149,831,154</ix:nonFraction> common shares to Altria for aggregate gross proceeds of $<ix:nonFraction unitRef="usd" contextRef="i7926d13ed9d346928f338c20da686971_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90ZXh0cmVnaW9uOmFiMTEyNjUyZTExYTQyZDFiNzczZmM1NGYwZjgxMzkzXzEyNjQ0MzgzNzQ0NjQ4_7c13deff-0470-4b90-985a-698491901d87">1,809,556</ix:nonFraction>, net of issuance costs of $<ix:nonFraction unitRef="usd" contextRef="i7926d13ed9d346928f338c20da686971_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90ZXh0cmVnaW9uOmFiMTEyNjUyZTExYTQyZDFiNzczZmM1NGYwZjgxMzkzXzEyNjQ0MzgzNzM5OTA4_d4cbe3fb-9489-410f-b121-181236ef150b">3,722</ix:nonFraction>. The gross proceeds were first allocated to the derivative liabilities issued in connection with the Altria Investment, and the residual of $<ix:nonFraction unitRef="usd" contextRef="i1db6dad47a0c48f9ba16df4ee15bdba5_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90ZXh0cmVnaW9uOmFiMTEyNjUyZTExYTQyZDFiNzczZmM1NGYwZjgxMzkzXzEyNjQ0MzgzNzQwMDUy_6fd9865d-7d2a-4ad7-b6f1-4d5a3f94c560">248,302</ix:nonFraction> was allocated to share capital. Pursuant to the Altria Investment, the Company incurred transaction costs of $<ix:nonFraction unitRef="usd" contextRef="i7926d13ed9d346928f338c20da686971_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="cron:PaymentOfTransactionCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90ZXh0cmVnaW9uOmFiMTEyNjUyZTExYTQyZDFiNzczZmM1NGYwZjgxMzkzXzEyNjQ0MzgzNzQwMTY1_6ab0ee71-ebd4-4429-a7c1-2642608770f2">25,223</ix:nonFraction>, of which $<ix:nonFraction unitRef="usd" contextRef="i1db6dad47a0c48f9ba16df4ee15bdba5_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="cron:PaymentOfTransactionCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90ZXh0cmVnaW9uOmFiMTEyNjUyZTExYTQyZDFiNzczZmM1NGYwZjgxMzkzXzEyNjQ0MzgzNzQwMTc5_16351b4d-8822-48d0-bd6d-7e2df9a0c4bd">3,642</ix:nonFraction> was allocated to share capital and $<ix:nonFraction unitRef="usd" contextRef="id02c7b0ce1ec47f5935d8d2f571108bb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="cron:PaymentOfTransactionCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90ZXh0cmVnaW9uOmFiMTEyNjUyZTExYTQyZDFiNzczZmM1NGYwZjgxMzkzXzEyNjQ0MzgzNzQwMjE4_1acdefe2-6e07-4d8d-a20f-54a161c9c23f">21,581</ix:nonFraction> to the derivative liabilities based on the relative fair values assigned to the respective components. Refer to Note 14 for additional information.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.66pt">During the year ended December&#160;31, 2019, the Company issued <ix:nonFraction unitRef="shares" contextRef="i399c1d0125d94144839ad09cbfcd4e79_D20190101-20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90ZXh0cmVnaW9uOmFiMTEyNjUyZTExYTQyZDFiNzczZmM1NGYwZjgxMzkzXzEyNjQ0MzgzNzQwNjQ3_53ec6176-f97d-4a79-9dfb-46199cb18ed3">5,086,586</ix:nonFraction> common shares with a fair value of $<ix:nonFraction unitRef="usd" contextRef="i6846a599dce44a4fb34169f67a53da26_I20191231" decimals="-3" format="ixt:numdotdecimal" name="cron:StockIssuedDuringPeriodNewIssuesFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90ZXh0cmVnaW9uOmFiMTEyNjUyZTExYTQyZDFiNzczZmM1NGYwZjgxMzkzXzEyNjQ0MzgzNzQwNjg2_698a06a6-af46-4ac2-8a7a-4f65eea4ae4d">56,109</ix:nonFraction> related to the acquisition (the &#8220;Redwood Acquisition&#8221;) of certain subsidiaries of Redwood Holding Group, LLC (collectively, &#8220;Redwood&#8221;). Refer to Note 27 for additional information.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.22pt">During the year ended December&#160;31, 2019, the Company issued <ix:nonFraction unitRef="shares" contextRef="ib7c7fb20be7a4bf1a45f16645365481c_D20190101-20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90ZXh0cmVnaW9uOmFiMTEyNjUyZTExYTQyZDFiNzczZmM1NGYwZjgxMzkzXzEyNjQ0MzgzNzM4NDc4_6a0d249c-9f27-4d80-901d-fbca5329c15d">856,017</ix:nonFraction> common shares to Kristen Bell, an accredited investor in a private placement (&#8220;Private Placement&#8221;) in reliance on Section 4(a)(2) of the Securities Act in connection with the use of certain publicity rights in brand development. The common shares vest in <ix:nonFraction unitRef="installment" contextRef="i5a6b2b55f141445980be073e905ff0d2_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="cron:CommonStockVestingRightsNumberOfEqualInstallments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90ZXh0cmVnaW9uOmFiMTEyNjUyZTExYTQyZDFiNzczZmM1NGYwZjgxMzkzXzEyNjQ0MzgzNzM4NzIz_becdd810-83d6-4ec0-8d0e-156d9fb2754a">three</ix:nonFraction> equal installments on each of (a) January 31, 2020, (b) June 23, 2021, and (c) December 23, 2022. The issuance did not involve a public offering and was made without general solicitation or advertising. The total fair value of the consideration paid for the issuance of such common shares was approximately $<ix:nonFraction unitRef="usd" contextRef="ib7c7fb20be7a4bf1a45f16645365481c_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90ZXh0cmVnaW9uOmFiMTEyNjUyZTExYTQyZDFiNzczZmM1NGYwZjgxMzkzXzEyNjQ0MzgzNzM5MDM0_627bcf69-ee73-4cac-8338-29598787d4a8">6,000</ix:nonFraction>. The fair value of the shares was calculated using the <ix:nonNumeric contextRef="i6385655ed7694227b1ba4c2470a26f37_D20190101-20191231" format="ixt-sec:durday" name="cron:StockIssuedDuringPeriodNewIssuesWeightedAveragePricePeriod" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90ZXh0cmVnaW9uOmFiMTEyNjUyZTExYTQyZDFiNzczZmM1NGYwZjgxMzkzXzEyNjQ0MzgzNzM5MDkz_6b9e2936-a720-4535-af87-c387b558ac1b">10</ix:nonNumeric>-day volume weighted average price per share of the Company&#8217;s common shares on Nasdaq.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(iv)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.5pt">During the year ended December&#160;31, 2018, the Company issued <ix:nonFraction unitRef="shares" contextRef="i7104c544b41946c8a7fe225376901625_D20180101-20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90ZXh0cmVnaW9uOmFiMTEyNjUyZTExYTQyZDFiNzczZmM1NGYwZjgxMzkzXzIwODY_2443227c-8109-40d6-9b1f-11ef44ad3cad">15,677,143</ix:nonFraction> common shares for aggregate gross proceeds of $<ix:nonFraction unitRef="usd" contextRef="i9d7cc358c6d64ac19ef8563642446a56_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90ZXh0cmVnaW9uOmFiMTEyNjUyZTExYTQyZDFiNzczZmM1NGYwZjgxMzkzXzEyNjQ0MzgzNzI1Mzc0_c8becd59-a935-4822-bc26-4b48de6b68e4">115,510</ix:nonFraction> through bought deal offerings, net of issuance costs of $<ix:nonFraction unitRef="usd" contextRef="i9d7cc358c6d64ac19ef8563642446a56_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90ZXh0cmVnaW9uOmFiMTEyNjUyZTExYTQyZDFiNzczZmM1NGYwZjgxMzkzXzEyNjQ0MzgzNzI1Mzg5_74737333-027d-4078-91b7-e809bbb3d994">7,577</ix:nonFraction>.</span></div></ix:nonNumeric><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="shares" contextRef="i6aa79556c9a24064ab5ea55845f31f79_D20190101-20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90ZXh0cmVnaW9uOmFiMTEyNjUyZTExYTQyZDFiNzczZmM1NGYwZjgxMzkzXzI0MDM_4ce10082-dce4-41d1-9c96-44771839900e"><ix:nonFraction unitRef="shares" contextRef="i3783dc27237d46f6944e1a9a6f65eee6_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90ZXh0cmVnaW9uOmFiMTEyNjUyZTExYTQyZDFiNzczZmM1NGYwZjgxMzkzXzI0MDM_98aab4c3-4da5-4552-a7d4-a86344a02c91"><ix:nonFraction unitRef="shares" contextRef="i85e3d76bfda8415b975e00befcd9609f_D20180101-20181231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90ZXh0cmVnaW9uOmFiMTEyNjUyZTExYTQyZDFiNzczZmM1NGYwZjgxMzkzXzI0MDM_ca0ac993-2a75-4082-9da8-06936c6c6607">no</ix:nonFraction></ix:nonFraction></ix:nonFraction> share repurchases during the year ended December&#160;31, 2020, 2019 or 2018.</span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div id="i1ae9134e40e74e0aac958218112e53d4_136"></div><div style="margin-bottom:12pt;margin-top:16pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">16. <ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90ZXh0cmVnaW9uOmU2MTQ3ODYxMTRhYTRjMmZiZWJkNjc4NjJjOWJjZDRhXzkzMzE_bf107d9e-1a37-4b87-8eaf-ca312464ab28" continuedAt="i8301a7cf823b49e9b38877aa68aabc56" escape="true">Share-based Payments</ix:nonNumeric></span></div><ix:continuation id="i8301a7cf823b49e9b38877aa68aabc56" continuedAt="i39d36ebd0da84edea7f500b304897efb"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt">Warrants</span></div><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:ScheduleOfOtherShareBasedCompensationActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90ZXh0cmVnaW9uOmU2MTQ3ODYxMTRhYTRjMmZiZWJkNjc4NjJjOWJjZDRhXzI0MTg5MjU1OTMyOTc4_df425626-903e-4eb3-a211-3790eb0e67ab" continuedAt="iaa587bb9ccef4b5e9ee6a48b3c23b88f" escape="true"><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the changes in warrants during the year ended December&#160;31, 2020 and December&#160;31, 2019:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average exercise price (C$)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of warrants</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cadPerShare" contextRef="i1572dfef042a4da7bc0274d5c4a15278_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTo0OGNlOTUzZThiNzM0NGJlODhmNWUxYzZhOGQ0YTY2Zi90YWJsZXJhbmdlOjQ4Y2U5NTNlOGI3MzQ0YmU4OGY1ZTFjNmE4ZDRhNjZmXzEtMS0xLTEtMA_04c94274-5318-448d-80d2-d183526ab2a9">0.26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1572dfef042a4da7bc0274d5c4a15278_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTo0OGNlOTUzZThiNzM0NGJlODhmNWUxYzZhOGQ0YTY2Zi90YWJsZXJhbmdlOjQ4Y2U5NTNlOGI3MzQ0YmU4OGY1ZTFjNmE4ZDRhNjZmXzEtMy0xLTEtMA_ea6b87a4-089e-4989-8ea8-8690b9242b3a">18,066,662</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cadPerShare" contextRef="i5372334bf7d347cba8a470a7ae7e08dd_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTo0OGNlOTUzZThiNzM0NGJlODhmNWUxYzZhOGQ0YTY2Zi90YWJsZXJhbmdlOjQ4Y2U5NTNlOGI3MzQ0YmU4OGY1ZTFjNmE4ZDRhNjZmXzItMS0xLTEtMA_a5c25b59-c544-4484-b430-0a412ef914b8">0.27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i5372334bf7d347cba8a470a7ae7e08dd_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTo0OGNlOTUzZThiNzM0NGJlODhmNWUxYzZhOGQ0YTY2Zi90YWJsZXJhbmdlOjQ4Y2U5NTNlOGI3MzQ0YmU4OGY1ZTFjNmE4ZDRhNjZmXzItMy0xLTEtMA_58e7432e-061d-414c-be5c-2a905fa18925">10,079,313</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cadPerShare" contextRef="i3ce6c21c99f24cd2ae50be03fc1ea89d_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTo0OGNlOTUzZThiNzM0NGJlODhmNWUxYzZhOGQ0YTY2Zi90YWJsZXJhbmdlOjQ4Y2U5NTNlOGI3MzQ0YmU4OGY1ZTFjNmE4ZDRhNjZmXzQtMS0xLTEtMA_988ccab7-7dd3-4d5a-bad4-b32787b86fd7">0.25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3ce6c21c99f24cd2ae50be03fc1ea89d_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTo0OGNlOTUzZThiNzM0NGJlODhmNWUxYzZhOGQ0YTY2Zi90YWJsZXJhbmdlOjQ4Y2U5NTNlOGI3MzQ0YmU4OGY1ZTFjNmE4ZDRhNjZmXzQtMy0xLTEtMA_afd3f648-2631-416a-b2f4-a8bc7f70b4c5">7,987,349</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:42.75pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;padding-left:42.75pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average exercise price (C$)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of warrants</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cadPerShare" contextRef="id7d681ac03c543518d1de73a1d3b5d6d_I20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTo5MzZhOTRmNjExOGI0YTYyODZmMDYyYzU2ZTE3ODk2Zi90YWJsZXJhbmdlOjkzNmE5NGY2MTE4YjRhNjI4NmYwNjJjNTZlMTc4OTZmXzYtMS0xLTEtNTA3Mw_a57583e7-b3c6-41bd-a2df-1becdbc96be2">0.26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id7d681ac03c543518d1de73a1d3b5d6d_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTo5MzZhOTRmNjExOGI0YTYyODZmMDYyYzU2ZTE3ODk2Zi90YWJsZXJhbmdlOjkzNmE5NGY2MTE4YjRhNjI4NmYwNjJjNTZlMTc4OTZmXzYtMy0xLTEtNTA3Mw_73d81049-3828-41d7-9742-c76a5238b9c4">25,457,623</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cadPerShare" contextRef="iec84f453bb6e43d7a3cafa4dad5299d9_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTo5MzZhOTRmNjExOGI0YTYyODZmMDYyYzU2ZTE3ODk2Zi90YWJsZXJhbmdlOjkzNmE5NGY2MTE4YjRhNjI4NmYwNjJjNTZlMTc4OTZmXzctMS0xLTEtNTA3Mw_b2a773c8-a362-4845-aabc-62a15838b9a8">0.26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="iec84f453bb6e43d7a3cafa4dad5299d9_D20190101-20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTo5MzZhOTRmNjExOGI0YTYyODZmMDYyYzU2ZTE3ODk2Zi90YWJsZXJhbmdlOjkzNmE5NGY2MTE4YjRhNjI4NmYwNjJjNTZlMTc4OTZmXzctMy0xLTEtNTA3Mw_a834a96c-8f9f-493a-b120-4bb0419a2b8c">7,390,961</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2019</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cadPerShare" contextRef="i1572dfef042a4da7bc0274d5c4a15278_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTo5MzZhOTRmNjExOGI0YTYyODZmMDYyYzU2ZTE3ODk2Zi90YWJsZXJhbmdlOjkzNmE5NGY2MTE4YjRhNjI4NmYwNjJjNTZlMTc4OTZmXzktMS0xLTEtNTA3Mw_e3923644-6596-40a1-9514-6c9a686cac3f">0.26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1572dfef042a4da7bc0274d5c4a15278_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTo5MzZhOTRmNjExOGI0YTYyODZmMDYyYzU2ZTE3ODk2Zi90YWJsZXJhbmdlOjkzNmE5NGY2MTE4YjRhNjI4NmYwNjJjNTZlMTc4OTZmXzktMy0xLTEtNTA3Mw_c3ed3041-a502-44e2-a9f9-db3a4d56eeb1">18,066,662</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:3pt;padding-left:42.75pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a description of the Altria Warrant, see Note 14. <ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90ZXh0cmVnaW9uOmU2MTQ3ODYxMTRhYTRjMmZiZWJkNjc4NjJjOWJjZDRhXzkzMzU_ca056372-8208-469a-80b9-7c2a5c04b468" continuedAt="ib9d7d3e0305f48e497d3e47da8b43a6d" escape="true">As of December&#160;31, 2020, the Company had outstanding warrants as follows: </ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:justify"><ix:continuation id="ib9d7d3e0305f48e497d3e47da8b43a6d"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.872%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.872%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.188%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Grant date</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Expiry date</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average exercise price (C$)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of warrants</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 13 &#8211; 27, 2016</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 13 &#8211; 27, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cadPerShare" contextRef="i7708af5c622544439ec18767fd24a5c0_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTo0MDIzODMyMTE0NjU0MTcwOTFhZGVkOWZmZTkyZjc5OC90YWJsZXJhbmdlOjQwMjM4MzIxMTQ2NTQxNzA5MWFkZWQ5ZmZlOTJmNzk4XzItNi0xLTEtMA_44fe52b8-2ea0-4c14-ba6a-b3f58723f974">0.25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7708af5c622544439ec18767fd24a5c0_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTo0MDIzODMyMTE0NjU0MTcwOTFhZGVkOWZmZTkyZjc5OC90YWJsZXJhbmdlOjQwMjM4MzIxMTQ2NTQxNzA5MWFkZWQ5ZmZlOTJmNzk4XzItNy0xLTEtMjQ2OQ_48ebfcf6-8a1b-42f0-945a-11af98563361"><ix:nonFraction unitRef="shares" contextRef="i7708af5c622544439ec18767fd24a5c0_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTo0MDIzODMyMTE0NjU0MTcwOTFhZGVkOWZmZTkyZjc5OC90YWJsZXJhbmdlOjQwMjM4MzIxMTQ2NTQxNzA5MWFkZWQ5ZmZlOTJmNzk4XzItNy0xLTEtMjQ2OQ_6fa6279c-f7b8-4ee3-8f6a-fced0ec55f8b">7,987,349</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of December&#160;31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cadPerShare" contextRef="i3ce6c21c99f24cd2ae50be03fc1ea89d_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTo0MDIzODMyMTE0NjU0MTcwOTFhZGVkOWZmZTkyZjc5OC90YWJsZXJhbmdlOjQwMjM4MzIxMTQ2NTQxNzA5MWFkZWQ5ZmZlOTJmNzk4XzMtNi0xLTEtMA_e5cdc3d1-1869-4cea-9e04-20f75fef6e41">0.25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3ce6c21c99f24cd2ae50be03fc1ea89d_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTo0MDIzODMyMTE0NjU0MTcwOTFhZGVkOWZmZTkyZjc5OC90YWJsZXJhbmdlOjQwMjM4MzIxMTQ2NTQxNzA5MWFkZWQ5ZmZlOTJmNzk4XzMtNy0xLTEtMjQ2OQ_3ce42002-d6bd-4c5a-bca4-1f19ea724f75">7,987,349</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">97</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December 31, 2020, 2019, and 2018</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for gram and share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div></div><ix:continuation id="i39d36ebd0da84edea7f500b304897efb" continuedAt="i6e88981dc3864e70a867827649dcee4b"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt">Stock options</span></div><div style="margin-bottom:6pt;padding-left:47.25pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:8.57pt">Stock option plans</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company adopted an amended and restated stock option plan dated May 26, 2015 (the &#8220;2015 Stock Option Plan&#8221;), which was approved by shareholders of the Company at the annual general meeting of shareholders held on June 28, 2017. The 2015 Stock Option Plan allowed the Company&#8217;s Board of Directors (the &#8220;Board&#8221;) to award options to purchase shares to directors, officers, key employees and service providers of the Company. As of June 28, 2018, <ix:nonFraction unitRef="shares" contextRef="i759cd2f5c6b540b9be3e774364a54f77_I20180628" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90ZXh0cmVnaW9uOmU2MTQ3ODYxMTRhYTRjMmZiZWJkNjc4NjJjOWJjZDRhXzgyNDYzMzczNDMxMjg_386b52de-b086-4cf4-bcb3-771f09bc0dd5">no</ix:nonFraction> further awards will be granted under the 2015 Stock Option Plan; however, shares may be purchased via option exercise by the holders of any outstanding options previously issued under the 2015 Stock Option Plan. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 28, 2018, the shareholders of the Company approved a stock option plan (the &#8220;2018 Stock Option Plan&#8221;), which replaced the 2015 Stock Option Plan. The 2018 Stock Option Plan terminated the Company&#8217;s ability to grant equity under the 2015 Stock Option Plan. As of June 25, 2020, the date on which the 2020 Omnibus Plan (as defined below) was approved by the shareholders of the Company, <ix:nonFraction unitRef="shares" contextRef="i129cd564c18f4becbcf3f71a97fb8da3_I20200625" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90ZXh0cmVnaW9uOmU2MTQ3ODYxMTRhYTRjMmZiZWJkNjc4NjJjOWJjZDRhXzgyNDYzMzczNDMxMzY_26f8f886-bf50-40a9-a016-f57328ad8347">no</ix:nonFraction> further awards will be granted under the 2018 Stock Option Plan; however, shares may be purchased via option exercise by the holders of any outstanding options previously issued under the 2018 Stock Option Plan.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 29, 2020, the Board adopted a new omnibus equity incentive plan (the &#8220;2020 Omnibus Plan&#8221;), which was approved by the shareholders of the Company at the annual and special meeting of shareholders held on June 25, 2020. The 2020 Omnibus Plan provides for grants of stock options, share appreciation rights, restricted shares, restricted share units (&#8220;RSUs&#8221;) and other share-based or cash-based awards, which are subject to terms as determined by the Compensation Committee of the Board, and awards may be granted to eligible employees, non-employee directors and consultants. The 2020 Omnibus Plan terminated the Company&#8217;s ability to grant equity awards under the 2018 Stock Option Plan and restricted stock units under the Employment Inducement Plan.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options represent the right to purchase Company common shares on the date of exercise at a stated exercise price. The exercise price of an option generally must be at least equal to the fair market value of the Company common shares on the date of grant. The Compensation Committee of the Board (&#8220;Compensation Committee&#8221;) may provide for options to be exercised only as they vest or to be immediately exercisable with any shares issued on exercise being subject to the Company&#8217;s right of repurchase that lapses as the shares vest. Vesting conditions for grants of options are determined by the Compensation Committee. The typical vesting for stock option grants is quarterly vesting over <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90ZXh0cmVnaW9uOmU2MTQ3ODYxMTRhYTRjMmZiZWJkNjc4NjJjOWJjZDRhXzEyNjQ0MzgzODQxMzQy_918fcba7-c0e8-4f1e-a169-2b708f363c2a">three</span> to <ix:nonNumeric contextRef="i586e0fbc30bd421ea74d516bbb9228a9_D20200329-20200329" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90ZXh0cmVnaW9uOmU2MTQ3ODYxMTRhYTRjMmZiZWJkNjc4NjJjOWJjZDRhXzEyNjQ0MzgzODQxMzQ2_3680811e-bb34-4987-8d05-18c0eb3c1ff5">five years</ix:nonNumeric>. The maximum term of options granted under the 2020 Omnibus Plan is <ix:nonNumeric contextRef="ie390f249c16849189272940f0a025a2b_D20200329-20200329" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90ZXh0cmVnaW9uOmU2MTQ3ODYxMTRhYTRjMmZiZWJkNjc4NjJjOWJjZDRhXzEyNjQ0MzgzODI4NzQx_227c6805-65b3-4a62-8df5-aaff44c380aa">seven years</ix:nonNumeric>. Participants under the 2020 Omnibus Plan are eligible to be granted options to purchase shares at an exercise price established upon approval of the grant by the Compensation Committee. When options are granted, the exercise price is, with respect to a particular date, the closing price as reported by the TSX or the Nasdaq and, if the shares are not traded on the TSX or the Nasdaq, any other stock exchange on which the Company&#8217;s common shares are traded (as selected by the Compensation Committee in good faith taking into account applicable legal and tax requirements) on the immediately preceding trading day (the &#8220;Fair Market Value&#8221;). The 2020 Omnibus Plan does not authorize grants of options with an exercise price below the Fair Market Value.</span></div><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90ZXh0cmVnaW9uOmU2MTQ3ODYxMTRhYTRjMmZiZWJkNjc4NjJjOWJjZDRhXzI0MTg5MjU1OTMyOTc3_16b7e0ac-5bcd-4e15-9c25-79e70e937edf" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The equity plans described above have the following stock options outstanding: </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.594%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.594%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.597%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares outstanding as of December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 Omnibus Plan</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i264457fca61240599e96951139517526_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZToxOTUxNTQxMzE3YTg0ZDkxOTVhZTA1ODI2ZDk2ZjQ1ZC90YWJsZXJhbmdlOjE5NTE1NDEzMTdhODRkOTE5NWFlMDU4MjZkOTZmNDVkXzEtMS0xLTEtMTg3MDE_5ae144fc-2082-4244-aeda-e3416b0e9f19">2,000,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i85edbfd435fc4bd88b7c46410c6c001c_I20191231" decimals="INF" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZToxOTUxNTQxMzE3YTg0ZDkxOTVhZTA1ODI2ZDk2ZjQ1ZC90YWJsZXJhbmdlOjE5NTE1NDEzMTdhODRkOTE5NWFlMDU4MjZkOTZmNDVkXzItMy0xLTEtMTg3MTY_2d21c665-ab98-49da-bae4-4b107fae6553">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i27704c0ccaf54adaa2ecfcbaad36eab2_I20181231" decimals="INF" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZToxOTUxNTQxMzE3YTg0ZDkxOTVhZTA1ODI2ZDk2ZjQ1ZC90YWJsZXJhbmdlOjE5NTE1NDEzMTdhODRkOTE5NWFlMDU4MjZkOTZmNDVkXzEtMy0xLTEtMTg3MDE_951b6688-3b4f-4f86-870d-d2e54520f402">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018 Stock Option Plan </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idd88a7bbfa5b4fe68c3c0a9725094951_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZToxOTUxNTQxMzE3YTg0ZDkxOTVhZTA1ODI2ZDk2ZjQ1ZC90YWJsZXJhbmdlOjE5NTE1NDEzMTdhODRkOTE5NWFlMDU4MjZkOTZmNDVkXzItMS0xLTEtMTg3MDE_dfb47dc5-c00a-4c1b-bc67-bad04bb5ea62">1,627,715</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6fe8366c01de496cbedaa12a2a996bbd_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZToxOTUxNTQxMzE3YTg0ZDkxOTVhZTA1ODI2ZDk2ZjQ1ZC90YWJsZXJhbmdlOjE5NTE1NDEzMTdhODRkOTE5NWFlMDU4MjZkOTZmNDVkXzMtMy0xLTEtMTg3MTY_b830682a-23b3-4e65-8af4-38cee989525b">1,817,287</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8e81bf474eba4613a2f7dd5d05f70c4a_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZToxOTUxNTQxMzE3YTg0ZDkxOTVhZTA1ODI2ZDk2ZjQ1ZC90YWJsZXJhbmdlOjE5NTE1NDEzMTdhODRkOTE5NWFlMDU4MjZkOTZmNDVkXzItMy0xLTEtMTg3MDE_a1567a9b-14ed-4057-aadd-1412f3e47e60">285,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2015 Stock Option Plan </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i441fae4c3ad14b21962491e07d5bb03d_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZToxOTUxNTQxMzE3YTg0ZDkxOTVhZTA1ODI2ZDk2ZjQ1ZC90YWJsZXJhbmdlOjE5NTE1NDEzMTdhODRkOTE5NWFlMDU4MjZkOTZmNDVkXzMtMS0xLTEtMTg3MDE_737818a9-0e1e-40e7-aefb-a280272ad786">10,127,433</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifeb79189ae0e437a9c0cf2c3b1563883_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZToxOTUxNTQxMzE3YTg0ZDkxOTVhZTA1ODI2ZDk2ZjQ1ZC90YWJsZXJhbmdlOjE5NTE1NDEzMTdhODRkOTE5NWFlMDU4MjZkOTZmNDVkXzQtMy0xLTEtMTg3MTY_e3499334-c48d-4bb2-907e-c2172601349f">12,332,215</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1906d8b8221f4c0692fad5ac1bce6483_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZToxOTUxNTQxMzE3YTg0ZDkxOTVhZTA1ODI2ZDk2ZjQ1ZC90YWJsZXJhbmdlOjE5NTE1NDEzMTdhODRkOTE5NWFlMDU4MjZkOTZmNDVkXzMtMy0xLTEtMTg3MDE_a03343ae-374c-4eb6-97e8-e053bd46f3c4">12,617,995</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock options outstanding</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZToxOTUxNTQxMzE3YTg0ZDkxOTVhZTA1ODI2ZDk2ZjQ1ZC90YWJsZXJhbmdlOjE5NTE1NDEzMTdhODRkOTE5NWFlMDU4MjZkOTZmNDVkXzQtMS0xLTEtMTg3MDE_fedb08f7-6679-4aa8-b9f0-02083b870295">13,755,148</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZToxOTUxNTQxMzE3YTg0ZDkxOTVhZTA1ODI2ZDk2ZjQ1ZC90YWJsZXJhbmdlOjE5NTE1NDEzMTdhODRkOTE5NWFlMDU4MjZkOTZmNDVkXzUtMy0xLTEtMTg3MTY_50ed0435-7df4-4584-9c5e-f3c19ff2a693">14,149,502</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9717dc3b24b24c93ab09a6bfa9b52c89_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZToxOTUxNTQxMzE3YTg0ZDkxOTVhZTA1ODI2ZDk2ZjQ1ZC90YWJsZXJhbmdlOjE5NTE1NDEzMTdhODRkOTE5NWFlMDU4MjZkOTZmNDVkXzQtMy0xLTEtMTg3MDE_9e685ad8-8cb0-4ea7-90dc-402513783b9b">12,902,995</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">For the year ended December&#160;31, 2020, the total stock-based compensation expense associated with the equity plans was $<ix:nonFraction unitRef="usd" contextRef="i5bc534f0f44f4850a59aff8f75b91db8_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90ZXh0cmVnaW9uOmU2MTQ3ODYxMTRhYTRjMmZiZWJkNjc4NjJjOWJjZDRhXzEyNjQ0MzgzNzYwODQ0_78ab97b8-4a4b-447e-86cf-0b96018c8350">7,185</ix:nonFraction> (December&#160;31, 2019 &#8211; $<ix:nonFraction unitRef="usd" contextRef="i7b7f36b7882142ceb233b456769d9d37_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90ZXh0cmVnaW9uOmU2MTQ3ODYxMTRhYTRjMmZiZWJkNjc4NjJjOWJjZDRhXzIxOTkwMjMyNzM2MzM_7b04c5fd-d903-44b7-8b90-006280c39ec2">10,278</ix:nonFraction>; December&#160;31, 2018 - $<ix:nonFraction unitRef="usd" contextRef="id2927e2128a7487ba8176ee60d748c59_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90ZXh0cmVnaW9uOmU2MTQ3ODYxMTRhYTRjMmZiZWJkNjc4NjJjOWJjZDRhXzE0MjkzNjUxMjgyNjk2_61be66bc-091f-4c1a-b6d7-0c4a21df302a">8,151</ix:nonFraction>).</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">98</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December 31, 2020, 2019, and 2018</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for gram and share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div></div><ix:continuation id="i6e88981dc3864e70a867827649dcee4b" continuedAt="ie163280c91ad4646a266f36badda7f2b"><div style="margin-bottom:6pt;margin-top:12pt;padding-left:47.25pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:5.8pt"> Summary of changes</span></div><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90ZXh0cmVnaW9uOmU2MTQ3ODYxMTRhYTRjMmZiZWJkNjc4NjJjOWJjZDRhXzI0MTg5MjU1OTMyOTc2_7db4d9c3-1e8f-48f8-9c9e-597f6910cbcf" escape="true"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the changes in options during the year ended December&#160;31, 2020 and December&#160;31, 2019:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.844%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.094%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.094%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.097%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 5.5pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average exercise price (C$)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average remaining contractual term (years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cadPerShare" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTpjMjVhZjQ4YzdhMGQ0MjY3YjNhMjJkNzI0MTliZDdlNC90YWJsZXJhbmdlOmMyNWFmNDhjN2EwZDQyNjdiM2EyMmQ3MjQxOWJkN2U0XzEtMS0xLTEtMA_1a05637c-1b4a-4e12-b095-8bc41f327854">4.84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTpjMjVhZjQ4YzdhMGQ0MjY3YjNhMjJkNzI0MTliZDdlNC90YWJsZXJhbmdlOmMyNWFmNDhjN2EwZDQyNjdiM2EyMmQ3MjQxOWJkN2U0XzEtMy0xLTEtMA_3e3bf3fb-2d2a-4624-8511-f60e12f8452a">14,149,502</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTpjMjVhZjQ4YzdhMGQ0MjY3YjNhMjJkNzI0MTliZDdlNC90YWJsZXJhbmdlOmMyNWFmNDhjN2EwZDQyNjdiM2EyMmQ3MjQxOWJkN2U0XzEtNS0xLTEtMTA1Mg_2c5ccd6f-74e9-4ca3-8ad5-5b271375ad5e">2.56</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of options</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cadPerShare" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTpjMjVhZjQ4YzdhMGQ0MjY3YjNhMjJkNzI0MTliZDdlNC90YWJsZXJhbmdlOmMyNWFmNDhjN2EwZDQyNjdiM2EyMmQ3MjQxOWJkN2U0XzItMS0xLTEtMA_bb2d852a-dea0-43b4-a124-45d0303f68a3">6.96</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTpjMjVhZjQ4YzdhMGQ0MjY3YjNhMjJkNzI0MTliZDdlNC90YWJsZXJhbmdlOmMyNWFmNDhjN2EwZDQyNjdiM2EyMmQ3MjQxOWJkN2U0XzItMy0xLTEtMA_5931bfed-69fd-447f-a05d-4691041194ab">2,000,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cadPerShare" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTpjMjVhZjQ4YzdhMGQ0MjY3YjNhMjJkNzI0MTliZDdlNC90YWJsZXJhbmdlOmMyNWFmNDhjN2EwZDQyNjdiM2EyMmQ3MjQxOWJkN2U0XzMtMS0xLTEtMA_24cf5577-fe1a-4ddc-a3a7-1bd1acfbe0ea">2.03</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTpjMjVhZjQ4YzdhMGQ0MjY3YjNhMjJkNzI0MTliZDdlNC90YWJsZXJhbmdlOmMyNWFmNDhjN2EwZDQyNjdiM2EyMmQ3MjQxOWJkN2U0XzMtMy0xLTEtMA_787734a1-f1f9-4c6c-8fe7-bbbc1988becd">2,131,939</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancellation, forfeiture and expiry of options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cadPerShare" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTpjMjVhZjQ4YzdhMGQ0MjY3YjNhMjJkNzI0MTliZDdlNC90YWJsZXJhbmdlOmMyNWFmNDhjN2EwZDQyNjdiM2EyMmQ3MjQxOWJkN2U0XzQtMS0xLTEtMA_820f1b6d-f0ad-4403-830f-bfc8a6d365aa">14.34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTpjMjVhZjQ4YzdhMGQ0MjY3YjNhMjJkNzI0MTliZDdlNC90YWJsZXJhbmdlOmMyNWFmNDhjN2EwZDQyNjdiM2EyMmQ3MjQxOWJkN2U0XzQtMy0xLTEtMA_eeba5f13-930c-4fce-b311-72c2163d659b">262,415</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cadPerShare" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTpjMjVhZjQ4YzdhMGQ0MjY3YjNhMjJkNzI0MTliZDdlNC90YWJsZXJhbmdlOmMyNWFmNDhjN2EwZDQyNjdiM2EyMmQ3MjQxOWJkN2U0XzUtMS0xLTEtMA_82a83662-ff45-421f-8bde-ea77785eb3b4">5.40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTpjMjVhZjQ4YzdhMGQ0MjY3YjNhMjJkNzI0MTliZDdlNC90YWJsZXJhbmdlOmMyNWFmNDhjN2EwZDQyNjdiM2EyMmQ3MjQxOWJkN2U0XzUtMy0xLTEtMA_7462330e-1bb5-468c-9a8e-01d1286078ba">13,755,148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTpjMjVhZjQ4YzdhMGQ0MjY3YjNhMjJkNzI0MTliZDdlNC90YWJsZXJhbmdlOmMyNWFmNDhjN2EwZDQyNjdiM2EyMmQ3MjQxOWJkN2U0XzUtNS0xLTEtMTA1Ng_bb365258-1b3f-456d-a15e-6d5522deb192">2.30</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December&#160;31, 2020</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cadPerShare" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTpjMjVhZjQ4YzdhMGQ0MjY3YjNhMjJkNzI0MTliZDdlNC90YWJsZXJhbmdlOmMyNWFmNDhjN2EwZDQyNjdiM2EyMmQ3MjQxOWJkN2U0XzYtMS0xLTEtMA_a850fbd2-6de1-4e74-87b1-47e87a91f24d">3.75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTpjMjVhZjQ4YzdhMGQ0MjY3YjNhMjJkNzI0MTliZDdlNC90YWJsZXJhbmdlOmMyNWFmNDhjN2EwZDQyNjdiM2EyMmQ3MjQxOWJkN2U0XzYtMy0xLTEtMA_e5c23e4b-0af6-4666-9d2b-9b1daaba27ac">9,643,682</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTpjMjVhZjQ4YzdhMGQ0MjY3YjNhMjJkNzI0MTliZDdlNC90YWJsZXJhbmdlOmMyNWFmNDhjN2EwZDQyNjdiM2EyMmQ3MjQxOWJkN2U0XzYtNS0xLTEtMTA1Ng_0e950da3-384a-4a1e-a897-b06b263aa3b9">1.34</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%;padding-left:22.1pt">The weighted average exercise price reflects the conversion of foreign currency-denominated options at the exchange rates as of December&#160;31, 2020. For foreign currency-denominated options, the weighted average exercise prices are translated using exchange rates as of the settlement date.</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.844%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.094%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.094%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.097%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 5.5pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average exercise price (C$)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average remaining contractual term (years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cadPerShare" contextRef="i9717dc3b24b24c93ab09a6bfa9b52c89_I20181231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTpjMDJkMGNiOGE2ODE0ZGMzOWRlODFmNTAzM2U4MzJhMC90YWJsZXJhbmdlOmMwMmQwY2I4YTY4MTRkYzM5ZGU4MWY1MDMzZTgzMmEwXzgtMS0xLTEtNTEyMg_83286624-3f88-4e18-a4c5-1a99af88c43b">2.99</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9717dc3b24b24c93ab09a6bfa9b52c89_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTpjMDJkMGNiOGE2ODE0ZGMzOWRlODFmNTAzM2U4MzJhMC90YWJsZXJhbmdlOmMwMmQwY2I4YTY4MTRkYzM5ZGU4MWY1MDMzZTgzMmEwXzgtMy0xLTEtNTEyMg_56480472-5248-4b76-93e0-120c8419834d">12,902,995</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTpjMDJkMGNiOGE2ODE0ZGMzOWRlODFmNTAzM2U4MzJhMC90YWJsZXJhbmdlOmMwMmQwY2I4YTY4MTRkYzM5ZGU4MWY1MDMzZTgzMmEwXzgtNS0xLTEtNTEyMg_8b67549f-41ab-4489-8ecd-c44559bf94fd">3.35</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cadPerShare" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTpjMDJkMGNiOGE2ODE0ZGMzOWRlODFmNTAzM2U4MzJhMC90YWJsZXJhbmdlOmMwMmQwY2I4YTY4MTRkYzM5ZGU4MWY1MDMzZTgzMmEwXzktMS0xLTEtNTEyMg_d74ce2fa-b56e-49da-8d11-9ba30d0da824">20.08</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTpjMDJkMGNiOGE2ODE0ZGMzOWRlODFmNTAzM2U4MzJhMC90YWJsZXJhbmdlOmMwMmQwY2I4YTY4MTRkYzM5ZGU4MWY1MDMzZTgzMmEwXzktMy0xLTEtNTEyMg_87eb7d7a-17d3-4c6c-ae44-1c0f9e5d48b6">1,534,162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cadPerShare" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTpjMDJkMGNiOGE2ODE0ZGMzOWRlODFmNTAzM2U4MzJhMC90YWJsZXJhbmdlOmMwMmQwY2I4YTY4MTRkYzM5ZGU4MWY1MDMzZTgzMmEwXzEwLTEtMS0xLTUxMjI_0f7750d1-7cad-4ced-be7c-54fa60a3052f">3.48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTpjMDJkMGNiOGE2ODE0ZGMzOWRlODFmNTAzM2U4MzJhMC90YWJsZXJhbmdlOmMwMmQwY2I4YTY4MTRkYzM5ZGU4MWY1MDMzZTgzMmEwXzEwLTMtMS0xLTUxMjI_cf1b735a-8bca-4c2e-9cea-a9361f972488">282,572</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancellation, forfeiture and expiry of options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cadPerShare" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTpjMDJkMGNiOGE2ODE0ZGMzOWRlODFmNTAzM2U4MzJhMC90YWJsZXJhbmdlOmMwMmQwY2I4YTY4MTRkYzM5ZGU4MWY1MDMzZTgzMmEwXzExLTEtMS0xLTUxMjI_396d95a6-400f-49f0-bf28-9b6263c37dc6">2.27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTpjMDJkMGNiOGE2ODE0ZGMzOWRlODFmNTAzM2U4MzJhMC90YWJsZXJhbmdlOmMwMmQwY2I4YTY4MTRkYzM5ZGU4MWY1MDMzZTgzMmEwXzExLTMtMS0xLTUxMjI_b5e8683e-49cf-49ad-b761-3262fb482f96">5,083</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cadPerShare" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTpjMDJkMGNiOGE2ODE0ZGMzOWRlODFmNTAzM2U4MzJhMC90YWJsZXJhbmdlOmMwMmQwY2I4YTY4MTRkYzM5ZGU4MWY1MDMzZTgzMmEwXzEyLTEtMS0xLTUxMjI_0696e08d-3e29-40cc-8ce3-63e54b2d2677">4.84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTpjMDJkMGNiOGE2ODE0ZGMzOWRlODFmNTAzM2U4MzJhMC90YWJsZXJhbmdlOmMwMmQwY2I4YTY4MTRkYzM5ZGU4MWY1MDMzZTgzMmEwXzEyLTMtMS0xLTUxMjI_052ba040-7be8-4bb8-a3cf-adba904b9d6e">14,149,502</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTpjMDJkMGNiOGE2ODE0ZGMzOWRlODFmNTAzM2U4MzJhMC90YWJsZXJhbmdlOmMwMmQwY2I4YTY4MTRkYzM5ZGU4MWY1MDMzZTgzMmEwXzEyLTUtMS0xLTUxMjI_7b408195-cfb6-4c6f-b6f0-73a1d2f7f414">2.56</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December&#160;31, 2019</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cadPerShare" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTpjMDJkMGNiOGE2ODE0ZGMzOWRlODFmNTAzM2U4MzJhMC90YWJsZXJhbmdlOmMwMmQwY2I4YTY4MTRkYzM5ZGU4MWY1MDMzZTgzMmEwXzEzLTEtMS0xLTUxMjI_cf25563c-71fe-43d5-a26e-10cb6d077da5">2.93</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTpjMDJkMGNiOGE2ODE0ZGMzOWRlODFmNTAzM2U4MzJhMC90YWJsZXJhbmdlOmMwMmQwY2I4YTY4MTRkYzM5ZGU4MWY1MDMzZTgzMmEwXzEzLTMtMS0xLTUxMjI_822cba0c-d56d-47af-9aed-001ef3ee232a">9,034,714</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTpjMDJkMGNiOGE2ODE0ZGMzOWRlODFmNTAzM2U4MzJhMC90YWJsZXJhbmdlOmMwMmQwY2I4YTY4MTRkYzM5ZGU4MWY1MDMzZTgzMmEwXzEzLTUtMS0xLTUxMjI_3d2c80b0-2d46-468f-af79-8d5752dac09f">2.27</ix:nonNumeric></span></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:12pt;padding-left:47.25pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:3.03pt">Fair value of options issued</span></div><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90ZXh0cmVnaW9uOmU2MTQ3ODYxMTRhYTRjMmZiZWJkNjc4NjJjOWJjZDRhXzI0MTg5MjU1OTMyOTc1_6990bfeb-06d2-4c74-9921-303ae09be00c" continuedAt="ie50da0693f2b4ec6a9a7c0c964f8fd23" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the options issued during the year was determined using the Black-Scholes option pricing model, using the following inputs:</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.427%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.374%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share price at grant date (per share)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C$<ix:nonFraction unitRef="usdPerShare" contextRef="i0adf66dfd8f246e784087297c1693bb8_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTozNDQyOWZmOWU2MTk0YzJlODQwYzBjNWZiY2EwNDNjZC90YWJsZXJhbmdlOjM0NDI5ZmY5ZTYxOTRjMmU4NDBjMGM1ZmJjYTA0M2NkXzEtMS0xLTEtMA_9d823982-4ed8-47c4-8273-8b8777589f4e">6.96</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C$<ix:nonFraction unitRef="cadPerShare" contextRef="i6f915fc11f2b4dae9120fe65ba8822be_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTozNDQyOWZmOWU2MTk0YzJlODQwYzBjNWZiY2EwNDNjZC90YWJsZXJhbmdlOjM0NDI5ZmY5ZTYxOTRjMmU4NDBjMGM1ZmJjYTA0M2NkXzEtMy0xLTEtMC90ZXh0cmVnaW9uOjg5Y2RlZDkzY2U3ODQzMjk5NjQzYzE5YTlmNTgyNTEyXzEwOTk1MTE2Mjc3Nzg2_40b67c4f-c870-4259-808c-5824a066ce58">15.34</ix:nonFraction> &#8211; $<ix:nonFraction unitRef="cadPerShare" contextRef="icccaf7b279474dd2a6cc84bf9c862814_I20191231" decimals="INF" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTozNDQyOWZmOWU2MTk0YzJlODQwYzBjNWZiY2EwNDNjZC90YWJsZXJhbmdlOjM0NDI5ZmY5ZTYxOTRjMmU4NDBjMGM1ZmJjYTA0M2NkXzEtMy0xLTEtMC90ZXh0cmVnaW9uOjg5Y2RlZDkzY2U3ODQzMjk5NjQzYzE5YTlmNTgyNTEyXzEwOTk1MTE2Mjc3Nzk0_6f900c63-d837-4ad7-b0af-5cce90ad3fe4">24.75</ix:nonFraction></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise price (per option)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C$<ix:nonFraction unitRef="usdPerShare" contextRef="i0adf66dfd8f246e784087297c1693bb8_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTozNDQyOWZmOWU2MTk0YzJlODQwYzBjNWZiY2EwNDNjZC90YWJsZXJhbmdlOjM0NDI5ZmY5ZTYxOTRjMmU4NDBjMGM1ZmJjYTA0M2NkXzItMS0xLTEtMA_b6bef8d0-6bcc-493d-b354-7b5ce46424d4">6.96</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C$<ix:nonFraction unitRef="cadPerShare" contextRef="i6f915fc11f2b4dae9120fe65ba8822be_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTozNDQyOWZmOWU2MTk0YzJlODQwYzBjNWZiY2EwNDNjZC90YWJsZXJhbmdlOjM0NDI5ZmY5ZTYxOTRjMmU4NDBjMGM1ZmJjYTA0M2NkXzItMy0xLTEtMC90ZXh0cmVnaW9uOjM4ZTMwYTU2ZDY4NjQ4ZTE5MmE2MjUwN2Y0YzE0OGFmXzEwOTk1MTE2Mjc3Nzg2_e93f211b-8fee-4e47-87d4-7ee9ba8443c8">15.34</ix:nonFraction> &#8211; $<ix:nonFraction unitRef="cadPerShare" contextRef="icccaf7b279474dd2a6cc84bf9c862814_I20191231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTozNDQyOWZmOWU2MTk0YzJlODQwYzBjNWZiY2EwNDNjZC90YWJsZXJhbmdlOjM0NDI5ZmY5ZTYxOTRjMmU4NDBjMGM1ZmJjYTA0M2NkXzItMy0xLTEtMC90ZXh0cmVnaW9uOjM4ZTMwYTU2ZDY4NjQ4ZTE5MmE2MjUwN2Y0YzE0OGFmXzEwOTk1MTE2Mjc3Nzk0_1b70240b-c6dd-424e-9c3c-9142beb844fb">24.75</ix:nonFraction></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5bc534f0f44f4850a59aff8f75b91db8_D20200101-20201231" decimals="4" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTozNDQyOWZmOWU2MTk0YzJlODQwYzBjNWZiY2EwNDNjZC90YWJsZXJhbmdlOjM0NDI5ZmY5ZTYxOTRjMmU4NDBjMGM1ZmJjYTA0M2NkXzMtMS0xLTEtMA_57ebaee9-bd89-4a32-a76b-ed371f18f76a">0.43</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icac62509ad0d4163941ab71cd6a759f4_D20190101-20191231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTozNDQyOWZmOWU2MTk0YzJlODQwYzBjNWZiY2EwNDNjZC90YWJsZXJhbmdlOjM0NDI5ZmY5ZTYxOTRjMmU4NDBjMGM1ZmJjYTA0M2NkXzMtMy0xLTEtMC90ZXh0cmVnaW9uOjIyN2Q3MmEwYjk4ODQ3OWU4YjMzZDYzMjYwMTY1OTE4XzEwOTk1MTE2Mjc3Nzgy_c05e186e-b39e-4c39-8011-a85ee28aa19f">1.39</ix:nonFraction>% &#8211; <ix:nonFraction unitRef="number" contextRef="i9958a0912be6465189458f744de7bd5e_D20190101-20191231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTozNDQyOWZmOWU2MTk0YzJlODQwYzBjNWZiY2EwNDNjZC90YWJsZXJhbmdlOjM0NDI5ZmY5ZTYxOTRjMmU4NDBjMGM1ZmJjYTA0M2NkXzMtMy0xLTEtMC90ZXh0cmVnaW9uOjIyN2Q3MmEwYjk4ODQ3OWU4YjMzZDYzMjYwMTY1OTE4XzEwOTk1MTE2Mjc3Nzkw_8d087475-4986-4a16-af2c-493d28c3dd2c">1.62</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life of options (in years)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5bc534f0f44f4850a59aff8f75b91db8_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTozNDQyOWZmOWU2MTk0YzJlODQwYzBjNWZiY2EwNDNjZC90YWJsZXJhbmdlOjM0NDI5ZmY5ZTYxOTRjMmU4NDBjMGM1ZmJjYTA0M2NkXzQtMS0xLTEtMA_a0997caf-0f91-438b-8c29-c447c8e20b16">5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7b7f36b7882142ceb233b456769d9d37_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTozNDQyOWZmOWU2MTk0YzJlODQwYzBjNWZiY2EwNDNjZC90YWJsZXJhbmdlOjM0NDI5ZmY5ZTYxOTRjMmU4NDBjMGM1ZmJjYTA0M2NkXzQtMy0xLTEtMA_69fdeca8-1703-4b91-835a-711bfe0b72ce">5</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected annualized volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5bc534f0f44f4850a59aff8f75b91db8_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTozNDQyOWZmOWU2MTk0YzJlODQwYzBjNWZiY2EwNDNjZC90YWJsZXJhbmdlOjM0NDI5ZmY5ZTYxOTRjMmU4NDBjMGM1ZmJjYTA0M2NkXzUtMS0xLTEtMA_5172b674-9a55-4d93-bc94-816293d7f3f5">91</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7b7f36b7882142ceb233b456769d9d37_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTozNDQyOWZmOWU2MTk0YzJlODQwYzBjNWZiY2EwNDNjZC90YWJsZXJhbmdlOjM0NDI5ZmY5ZTYxOTRjMmU4NDBjMGM1ZmJjYTA0M2NkXzUtMy0xLTEtMA_96d78b58-9e07-43ec-a39d-afe15aa11eb8">82</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5bc534f0f44f4850a59aff8f75b91db8_D20200101-20201231" decimals="INF" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTozNDQyOWZmOWU2MTk0YzJlODQwYzBjNWZiY2EwNDNjZC90YWJsZXJhbmdlOjM0NDI5ZmY5ZTYxOTRjMmU4NDBjMGM1ZmJjYTA0M2NkXzYtMS0xLTEtMA_ab7a9041-a150-49cf-a78e-97d6f1d68a5c">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7b7f36b7882142ceb233b456769d9d37_D20190101-20191231" decimals="INF" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTozNDQyOWZmOWU2MTk0YzJlODQwYzBjNWZiY2EwNDNjZC90YWJsZXJhbmdlOjM0NDI5ZmY5ZTYxOTRjMmU4NDBjMGM1ZmJjYTA0M2NkXzYtMy0xLTEtMA_858ada46-9d99-4eb9-a468-176518a15338">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average Black-Scholes value at grant date (per option)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C$<ix:nonFraction unitRef="cadPerShare" contextRef="i5bc534f0f44f4850a59aff8f75b91db8_D20200101-20201231" decimals="2" format="ixt:numdotdecimal" name="cron:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTozNDQyOWZmOWU2MTk0YzJlODQwYzBjNWZiY2EwNDNjZC90YWJsZXJhbmdlOjM0NDI5ZmY5ZTYxOTRjMmU4NDBjMGM1ZmJjYTA0M2NkXzctMS0xLTEtMA_10b957cb-40fa-44e4-9f36-d4b8f0d4fc5d">4.84</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C$<ix:nonFraction unitRef="cadPerShare" contextRef="i7b7f36b7882142ceb233b456769d9d37_D20190101-20191231" decimals="2" format="ixt:numdotdecimal" name="cron:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTozNDQyOWZmOWU2MTk0YzJlODQwYzBjNWZiY2EwNDNjZC90YWJsZXJhbmdlOjM0NDI5ZmY5ZTYxOTRjMmU4NDBjMGM1ZmJjYTA0M2NkXzctMy0xLTEtMA_4f0b812d-a20a-44ae-899e-9dd1e821eb0b">13.03</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeiture rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5bc534f0f44f4850a59aff8f75b91db8_D20200101-20201231" decimals="INF" format="ixt:zerodash" name="cron:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsForfeitureRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTozNDQyOWZmOWU2MTk0YzJlODQwYzBjNWZiY2EwNDNjZC90YWJsZXJhbmdlOjM0NDI5ZmY5ZTYxOTRjMmU4NDBjMGM1ZmJjYTA0M2NkXzgtMS0xLTEtMA_29e90688-489b-4065-b91c-51d6f8f2a42d">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7b7f36b7882142ceb233b456769d9d37_D20190101-20191231" decimals="INF" format="ixt:zerodash" name="cron:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsForfeitureRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTozNDQyOWZmOWU2MTk0YzJlODQwYzBjNWZiY2EwNDNjZC90YWJsZXJhbmdlOjM0NDI5ZmY5ZTYxOTRjMmU4NDBjMGM1ZmJjYTA0M2NkXzgtMy0xLTEtMA_21837cec-d7bb-4156-b855-abc939083b57">&#8212;</ix:nonFraction></span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%;padding-left:22.1pt">The weighted average exercise price reflects the conversion of foreign currency-denominated options at the exchange rates as of December&#160;31, 2020. For foreign currency-denominated options, the weighted average exercise prices are translated using exchange rates as of the settlement date.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"><ix:continuation id="ie50da0693f2b4ec6a9a7c0c964f8fd23" continuedAt="ie4ced0e6a00041dab1962f3d3f8f5697">(ii)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%;padding-left:20.66pt"><ix:continuation id="ie4ced0e6a00041dab1962f3d3f8f5697">The expected life of the awards represents the period of time options are expected to be outstanding and is estimated considering vesting terms and employees&#8217; and non-employees&#8217; historical exercise and, where relevant, post-vesting employment termination behavior. Volatility was estimated by using the historical volatility of the Company&#8217;s share price, adjusted for the Company&#8217;s expectation of volatility going forward. The risk-free interest rate was based on the Bank of Canada government bonds with a remaining term equal to the expected life of the options at the grant date.</ix:continuation> </span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average fair value per share at grant date of the options during the year ended December&#160;31, 2020 was C$<ix:nonFraction unitRef="cadPerShare" contextRef="i6ab60c8d610648fbbd63e32c23006ba2_I20201231" decimals="2" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90ZXh0cmVnaW9uOmU2MTQ3ODYxMTRhYTRjMmZiZWJkNjc4NjJjOWJjZDRhXzEyNjQ0MzgzNzQwMDE2_e10d8ea3-b949-4e85-9d1e-e48055a075f9">4.84</ix:nonFraction> per share (December&#160;31, 2019 &#8211; C$<ix:nonFraction unitRef="cadPerShare" contextRef="i6ccba8359c8b4e65b7817c72779f76c1_I20191231" decimals="2" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90ZXh0cmVnaW9uOmU2MTQ3ODYxMTRhYTRjMmZiZWJkNjc4NjJjOWJjZDRhXzEyNjQ0MzgzNzQwMDM4_4350bfc6-c6ba-4dda-a9ab-5428af760a0b">13.03</ix:nonFraction> per share).</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.91pt">Restricted share units</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSUs are granted under the 2020 Omnibus Plan. RSUs represent an equivalent amount of Company common shares on the date of issuance at fair value. Fair value is determined using the closing price of the trading day immediately preceding the date of grant. RSUs issued under the 2020 Omnibus Plan typically vest over a <ix:nonNumeric contextRef="i1ea19e5d9ee04882823da13b5fd955dc_D20200101-20201231" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90ZXh0cmVnaW9uOmU2MTQ3ODYxMTRhYTRjMmZiZWJkNjc4NjJjOWJjZDRhXzgyNDYzMzczNDMxOTE_edb07606-5335-4b50-abaa-58055534badc">three-year</ix:nonNumeric> period following the grant date, have no performance requirements and no forfeiture rate.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December 31, 2020, 2019, and 2018</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for gram and share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div></div><ix:continuation id="ie163280c91ad4646a266f36badda7f2b"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 20, 2020, the Company entered into separation agreements with Robert Rosenheck and another Redwood employee pursuant to which they resigned from their employment with Redwood. In connection with such separation agreements, <ix:nonFraction unitRef="shares" contextRef="ica018a4c7d9446198ea249f354589bec_D20201001-20201231" decimals="INF" format="ixt:numdotdecimal" name="cron:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90ZXh0cmVnaW9uOmU2MTQ3ODYxMTRhYTRjMmZiZWJkNjc4NjJjOWJjZDRhXzgyNDYzMzczNDMxOTM_585d9e7c-f8ef-4dca-9828-773dec95af8a">732,972</ix:nonFraction> outstanding and unvested RSUs were accelerated and vested during the year ended December 31, 2020.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December&#160;31, 2020, the Company recorded $<ix:nonFraction unitRef="usd" contextRef="i1ea19e5d9ee04882823da13b5fd955dc_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90ZXh0cmVnaW9uOmU2MTQ3ODYxMTRhYTRjMmZiZWJkNjc4NjJjOWJjZDRhXzEyNjQ0MzgzODQxMzM0_3107471a-f7e8-4208-893f-7b5fce57d289">8,176</ix:nonFraction> (December&#160;31, 2019 &#8211; $<ix:nonFraction unitRef="usd" contextRef="i40e8761a0c0246969b0c0e0b6a135205_D20190101-20191231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90ZXh0cmVnaW9uOmU2MTQ3ODYxMTRhYTRjMmZiZWJkNjc4NjJjOWJjZDRhXzEyNjQ0MzgzODQxMzM4_6fd27359-7f41-4360-a745-335c402a1502">889</ix:nonFraction>) in share-based compensation expense related to these RSUs. <ix:nonFraction unitRef="shares" contextRef="i9b7d911f78814b9bab3743f845ab435a_D20180101-20181231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90ZXh0cmVnaW9uOmU2MTQ3ODYxMTRhYTRjMmZiZWJkNjc4NjJjOWJjZDRhXzgyNDYzMzczNDMxNzI_fee4b15b-9838-42a7-9f2e-6603365bc57f">No</ix:nonFraction> RSUs were granted in 2018.</span></div><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90ZXh0cmVnaW9uOmU2MTQ3ODYxMTRhYTRjMmZiZWJkNjc4NjJjOWJjZDRhXzI0MTg5MjU1OTMyOTc0_9f3d5c17-a713-4f5d-bae1-d6a5f7d4a85f" escape="true"><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the changes in RSUs: </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:37.842%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.663%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.329%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.666%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of RSUs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average grant date fair value (C$)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i48cd489dc3e441deb5021b45f107480e_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTozMjNhZTc2YjZjNzY0ZmI2YmE5M2JjNWZmNDJjZmVkZS90YWJsZXJhbmdlOjMyM2FlNzZiNmM3NjRmYjZiYTkzYmM1ZmY0MmNmZWRlXzEtMS0xLTEtMA_b756b0d1-b256-49e6-97ff-8afc0072c66a">732,972</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cadPerShare" contextRef="i48cd489dc3e441deb5021b45f107480e_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTozMjNhZTc2YjZjNzY0ZmI2YmE5M2JjNWZmNDJjZmVkZS90YWJsZXJhbmdlOjMyM2FlNzZiNmM3NjRmYjZiYTkzYmM1ZmY0MmNmZWRlXzEtMy0xLTEtMA_dabc4bf5-8085-4ba6-a129-70a1380c2861">15.34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1ea19e5d9ee04882823da13b5fd955dc_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTozMjNhZTc2YjZjNzY0ZmI2YmE5M2JjNWZmNDJjZmVkZS90YWJsZXJhbmdlOjMyM2FlNzZiNmM3NjRmYjZiYTkzYmM1ZmY0MmNmZWRlXzItMS0xLTEtMA_e52c0431-fc85-46c2-b36f-ab3c39168f3f">957,854</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cadPerShare" contextRef="i1ea19e5d9ee04882823da13b5fd955dc_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTozMjNhZTc2YjZjNzY0ZmI2YmE5M2JjNWZmNDJjZmVkZS90YWJsZXJhbmdlOjMyM2FlNzZiNmM3NjRmYjZiYTkzYmM1ZmY0MmNmZWRlXzItMy0xLTEtMA_718283ff-7ed4-4e3c-8a00-9f13392115c4">7.66</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i1ea19e5d9ee04882823da13b5fd955dc_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTozMjNhZTc2YjZjNzY0ZmI2YmE5M2JjNWZmNDJjZmVkZS90YWJsZXJhbmdlOjMyM2FlNzZiNmM3NjRmYjZiYTkzYmM1ZmY0MmNmZWRlXzMtMS0xLTEtNTI5MA_27957ab2-7a66-45b7-8547-82f3717018e3">732,972</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cadPerShare" contextRef="i1ea19e5d9ee04882823da13b5fd955dc_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTozMjNhZTc2YjZjNzY0ZmI2YmE5M2JjNWZmNDJjZmVkZS90YWJsZXJhbmdlOjMyM2FlNzZiNmM3NjRmYjZiYTkzYmM1ZmY0MmNmZWRlXzMtMy0xLTEtNTI5MA_4e2e7b59-9843-4ce9-b8a6-ca24d47664b0">15.34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancellation and forfeitures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i1ea19e5d9ee04882823da13b5fd955dc_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTozMjNhZTc2YjZjNzY0ZmI2YmE5M2JjNWZmNDJjZmVkZS90YWJsZXJhbmdlOjMyM2FlNzZiNmM3NjRmYjZiYTkzYmM1ZmY0MmNmZWRlXzMtMS0xLTEtMA_559ab9e2-336e-4355-a4c9-48691702705f">9,497</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cadPerShare" contextRef="i1ea19e5d9ee04882823da13b5fd955dc_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTozMjNhZTc2YjZjNzY0ZmI2YmE5M2JjNWZmNDJjZmVkZS90YWJsZXJhbmdlOjMyM2FlNzZiNmM3NjRmYjZiYTkzYmM1ZmY0MmNmZWRlXzMtMy0xLTEtMA_73b7fde5-4866-4b18-b446-460b5d786ddd">7.52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5e9d2966a37a4b5092639437289a13e7_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTozMjNhZTc2YjZjNzY0ZmI2YmE5M2JjNWZmNDJjZmVkZS90YWJsZXJhbmdlOjMyM2FlNzZiNmM3NjRmYjZiYTkzYmM1ZmY0MmNmZWRlXzQtMS0xLTEtMA_86e69cfe-4619-42fc-880e-bea4f54e4b6c">948,357</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cadPerShare" contextRef="i5e9d2966a37a4b5092639437289a13e7_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTozMjNhZTc2YjZjNzY0ZmI2YmE5M2JjNWZmNDJjZmVkZS90YWJsZXJhbmdlOjMyM2FlNzZiNmM3NjRmYjZiYTkzYmM1ZmY0MmNmZWRlXzQtMy0xLTEtMA_1a016e2a-f69a-4269-8538-77678a468eee">7.66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:37.842%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.663%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.329%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.666%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of RSUs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average grant date fair value (C$)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0a702c872ac7413cadbdd209e21825ba_I20181231" decimals="INF" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTplZmU5ZmE4YjdkYTE0MjFjODkzZGFmYzRmYTRiMjdkMy90YWJsZXJhbmdlOmVmZTlmYThiN2RhMTQyMWM4OTNkYWZjNGZhNGIyN2QzXzEtMS0xLTEtNTM0OA_55820bf0-fccd-40cd-bb78-bb5d65c05f8a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cadPerShare" contextRef="i0a702c872ac7413cadbdd209e21825ba_I20181231" decimals="2" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTplZmU5ZmE4YjdkYTE0MjFjODkzZGFmYzRmYTRiMjdkMy90YWJsZXJhbmdlOmVmZTlmYThiN2RhMTQyMWM4OTNkYWZjNGZhNGIyN2QzXzEtMy0xLTEtNTM0OA_a4fd65fd-c2d1-4fe2-b0d1-2c6195a012f8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i40e8761a0c0246969b0c0e0b6a135205_D20190101-20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTplZmU5ZmE4YjdkYTE0MjFjODkzZGFmYzRmYTRiMjdkMy90YWJsZXJhbmdlOmVmZTlmYThiN2RhMTQyMWM4OTNkYWZjNGZhNGIyN2QzXzItMS0xLTEtNTM0OA_77c6cf9a-6fc2-4d27-b46d-b0f38181dcef">732,972</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cadPerShare" contextRef="i40e8761a0c0246969b0c0e0b6a135205_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTplZmU5ZmE4YjdkYTE0MjFjODkzZGFmYzRmYTRiMjdkMy90YWJsZXJhbmdlOmVmZTlmYThiN2RhMTQyMWM4OTNkYWZjNGZhNGIyN2QzXzItMy0xLTEtNTM0OA_8a6f149e-1abb-47af-b3ca-242194f5a71b">15.34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i48cd489dc3e441deb5021b45f107480e_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTplZmU5ZmE4YjdkYTE0MjFjODkzZGFmYzRmYTRiMjdkMy90YWJsZXJhbmdlOmVmZTlmYThiN2RhMTQyMWM4OTNkYWZjNGZhNGIyN2QzXzUtMS0xLTEtNTM0OA_a9d3c704-2c5c-4cfb-b85c-fc03c211a483">732,972</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cadPerShare" contextRef="i48cd489dc3e441deb5021b45f107480e_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTplZmU5ZmE4YjdkYTE0MjFjODkzZGFmYzRmYTRiMjdkMy90YWJsZXJhbmdlOmVmZTlmYThiN2RhMTQyMWM4OTNkYWZjNGZhNGIyN2QzXzUtMy0xLTEtNTM0OA_beb46f5e-d717-4abb-9a39-11531266896d">15.34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt">Deferred share units</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 10, 2019, the Company established a cash-settled deferred share unit plan (&#8220;DSU Plan&#8221;) pursuant to which its non-executive directors receive deferred share units (&#8220;DSUs&#8221;). The DSU Plan is designed to promote a greater alignment of long-term interests between non-executive directors and shareholders. The number of DSUs granted under the DSU Plan (including fractional DSUs) is determined by dividing the amount of remuneration payable by the closing price as reported by the TSX on the trading day immediately preceding the date of grant. DSUs are payable at the time a non-executive director ceases to hold the office of director for any reason and are settled by a lump-sum cash payment, in accordance with the terms of the DSU Plan, based on the fair value of the DSUs at such time. The fair value of the cash payout is determined by multiplying the number of DSUs vested at the payout date by the closing price as reported by the TSX on the trading day immediately preceding the payout date. The fair value of the cash payout is determined at each reporting date based on the fair value of the Company&#8217;s common shares at the reporting date and is recorded within other liabilities. <ix:nonFraction unitRef="shares" contextRef="i7aedae1809744d5bae3e685f27c56a9b_D20180101-20181231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90ZXh0cmVnaW9uOmU2MTQ3ODYxMTRhYTRjMmZiZWJkNjc4NjJjOWJjZDRhXzgyNDYzMzczNDMyMDE_33104588-df28-4f36-aa1a-177c5f344c82">No</ix:nonFraction> DSUs were granted during 2018.</span></div><ix:continuation id="iaa587bb9ccef4b5e9ee6a48b3c23b88f"><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the changes in DSUs: </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.346%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of DSUs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial liability </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie7131d8a1bc5413bafda345c71101f28_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZToyNjAyODdhM2FkNTU0MWZmODEyZmMwNmY0OGVjNDAxYS90YWJsZXJhbmdlOjI2MDI4N2EzYWQ1NTQxZmY4MTJmYzA2ZjQ4ZWM0MDFhXzEtMS0xLTEtMA_aefb27bb-4d2b-4729-a4e5-f9cf634eaf81">33,397</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7131d8a1bc5413bafda345c71101f28_I20191231" decimals="-3" name="us-gaap:DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZToyNjAyODdhM2FkNTU0MWZmODEyZmMwNmY0OGVjNDAxYS90YWJsZXJhbmdlOjI2MDI4N2EzYWQ1NTQxZmY4MTJmYzA2ZjQ4ZWM0MDFhXzEtMy0xLTEtMA_da49ac41-ded1-473c-a604-b515db459b80">255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granting and vesting of DSUs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i06da2ae72791461581a87fa5b29a9243_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="cron:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsAndVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZToyNjAyODdhM2FkNTU0MWZmODEyZmMwNmY0OGVjNDAxYS90YWJsZXJhbmdlOjI2MDI4N2EzYWQ1NTQxZmY4MTJmYzA2ZjQ4ZWM0MDFhXzItMS0xLTEtMA_1cf8183b-37d9-414a-a1b1-2169dd33759d">58,380</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06da2ae72791461581a87fa5b29a9243_D20200101-20201231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZToyNjAyODdhM2FkNTU0MWZmODEyZmMwNmY0OGVjNDAxYS90YWJsZXJhbmdlOjI2MDI4N2EzYWQ1NTQxZmY4MTJmYzA2ZjQ4ZWM0MDFhXzItMy0xLTEtMA_c989a8f5-d96b-43e2-915f-bb5e12cb008a">338</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities settled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i06da2ae72791461581a87fa5b29a9243_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZToyNjAyODdhM2FkNTU0MWZmODEyZmMwNmY0OGVjNDAxYS90YWJsZXJhbmdlOjI2MDI4N2EzYWQ1NTQxZmY4MTJmYzA2ZjQ4ZWM0MDFhXzMtMS0xLTEtNTU3OA_f5584e78-f27f-41a9-9588-68a20b829779">8,484</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i06da2ae72791461581a87fa5b29a9243_D20200101-20201231" decimals="-3" name="cron:ShareBasedPaymentArrangementLiabilitiesSettled" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZToyNjAyODdhM2FkNTU0MWZmODEyZmMwNmY0OGVjNDAxYS90YWJsZXJhbmdlOjI2MDI4N2EzYWQ1NTQxZmY4MTJmYzA2ZjQ4ZWM0MDFhXzMtMy0xLTEtNTU3OA_dd22ec4d-c395-4af1-a201-70cf7cde0bc1">46</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss (gain) on revaluation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06da2ae72791461581a87fa5b29a9243_D20200101-20201231" decimals="-3" sign="-" name="cron:ShareBasedPaymentArrangementGainLossOnRevaluation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZToyNjAyODdhM2FkNTU0MWZmODEyZmMwNmY0OGVjNDAxYS90YWJsZXJhbmdlOjI2MDI4N2EzYWQ1NTQxZmY4MTJmYzA2ZjQ4ZWM0MDFhXzMtMy0xLTEtMA_fec42457-f884-49e9-aacf-2326c10f8dfe">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9c3498dbe45c4b4283bce64a55185b1f_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZToyNjAyODdhM2FkNTU0MWZmODEyZmMwNmY0OGVjNDAxYS90YWJsZXJhbmdlOjI2MDI4N2EzYWQ1NTQxZmY4MTJmYzA2ZjQ4ZWM0MDFhXzQtMS0xLTEtMA_a9052879-b6d6-4792-958b-7f82663013a7">83,293</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c3498dbe45c4b4283bce64a55185b1f_I20201231" decimals="-3" name="us-gaap:DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZToyNjAyODdhM2FkNTU0MWZmODEyZmMwNmY0OGVjNDAxYS90YWJsZXJhbmdlOjI2MDI4N2EzYWQ1NTQxZmY4MTJmYzA2ZjQ4ZWM0MDFhXzQtMy0xLTEtMA_ab6133a0-d3bc-45d7-b854-0eaefb874066">577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.346%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of DSUs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial liability </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie21e1229f5684c4f8d8a3917015fd153_I20181231" decimals="INF" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTo3MDk1OWZmZWQ0YmU0ZWU1YjJhZTUxYzllMGRmNzg1NC90YWJsZXJhbmdlOjcwOTU5ZmZlZDRiZTRlZTViMmFlNTFjOWUwZGY3ODU0XzEtMS0xLTEtNTIwMQ_5d37d807-6d8f-4992-ad8f-d37879106d1e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie21e1229f5684c4f8d8a3917015fd153_I20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTo3MDk1OWZmZWQ0YmU0ZWU1YjJhZTUxYzllMGRmNzg1NC90YWJsZXJhbmdlOjcwOTU5ZmZlZDRiZTRlZTViMmFlNTFjOWUwZGY3ODU0XzEtMy0xLTEtNTIwMQ_4245947d-02ad-4582-9f68-a2dff4efac8b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granting and vesting of DSUs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i18703331ae024841932a2cfa20e595cd_D20190101-20191231" decimals="INF" format="ixt:numdotdecimal" name="cron:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsAndVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTo3MDk1OWZmZWQ0YmU0ZWU1YjJhZTUxYzllMGRmNzg1NC90YWJsZXJhbmdlOjcwOTU5ZmZlZDRiZTRlZTViMmFlNTFjOWUwZGY3ODU0XzItMS0xLTEtNTIwMQ_c6ed4d57-8a68-4f7f-bc24-4f07737db720">33,397</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18703331ae024841932a2cfa20e595cd_D20190101-20191231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTo3MDk1OWZmZWQ0YmU0ZWU1YjJhZTUxYzllMGRmNzg1NC90YWJsZXJhbmdlOjcwOTU5ZmZlZDRiZTRlZTViMmFlNTFjOWUwZGY3ODU0XzItMy0xLTEtNTIwMQ_ca8f7793-10c2-4fd1-b01b-c796841d26cf">452</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss (gain) on revaluation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i18703331ae024841932a2cfa20e595cd_D20190101-20191231" decimals="-3" name="cron:ShareBasedPaymentArrangementGainLossOnRevaluation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTo3MDk1OWZmZWQ0YmU0ZWU1YjJhZTUxYzllMGRmNzg1NC90YWJsZXJhbmdlOjcwOTU5ZmZlZDRiZTRlZTViMmFlNTFjOWUwZGY3ODU0XzMtMy0xLTEtNTIwMQ_b7937a18-a101-4995-8226-2ff27247333f">197</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie7131d8a1bc5413bafda345c71101f28_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTo3MDk1OWZmZWQ0YmU0ZWU1YjJhZTUxYzllMGRmNzg1NC90YWJsZXJhbmdlOjcwOTU5ZmZlZDRiZTRlZTViMmFlNTFjOWUwZGY3ODU0XzQtMS0xLTEtNTIwMQ_868abb38-b20b-498c-b2ea-e8e6644c8c7b">33,397</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7131d8a1bc5413bafda345c71101f28_I20191231" decimals="-3" name="us-gaap:DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTo3MDk1OWZmZWQ0YmU0ZWU1YjJhZTUxYzllMGRmNzg1NC90YWJsZXJhbmdlOjcwOTU5ZmZlZDRiZTRlZTViMmFlNTFjOWUwZGY3ODU0XzQtMy0xLTEtNTIwMQ_1940ae24-087a-4106-87aa-7023ad3964c8">255</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100</span></div></div></div><div id="i1ae9134e40e74e0aac958218112e53d4_142"></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December 31, 2020, 2019, and 2018</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for gram and share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:16pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">17. <ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90ZXh0cmVnaW9uOjVjYWQ0ZjVlYWVmYTQxNWNhM2RkMWY3NjRkMTRkYmQ3XzM5NQ_fb496b3e-ee69-4618-8661-5b06b9404e1e" continuedAt="iac7459cd117641169e68c355cb3665f7" escape="true">Earnings (loss) Per Share</ix:nonNumeric></span></div><ix:continuation id="iac7459cd117641169e68c355cb3665f7"><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90ZXh0cmVnaW9uOjVjYWQ0ZjVlYWVmYTQxNWNhM2RkMWY3NjRkMTRkYmQ3XzI0MTg5MjU1ODE0NTk3_631be0d6-7f5a-4a7d-a00e-8b70cab0650f" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted earnings (loss) per share from continuing operations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">are</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> calculated using </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> following numerators </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> denominators:</span></div><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:55.645%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.329%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.468%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.468%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.700%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic earnings (loss) per share computation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations attributable to common shareholders of Cronos&#160;Group</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzItMi0xLTEtMA_71c78ce2-0685-4f1b-aa38-0952c08c513a">72,487</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzItNC0xLTEtMA_5f113e73-293e-4df6-a4f6-8b793996a549">1,166,869</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzItNi0xLTEtMA_960de221-cd07-4799-9fab-d481aae9a91c">20,742</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzMtMi0xLTEtMA_be179543-59b9-4f3b-9db0-f5666467f58b">351,576,848</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzMtNC0xLTEtMA_88beb3aa-dedb-4bec-8145-fc21068b2106">310,067,179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzMtNi0xLTEtMA_071648db-776f-40ac-99b6-b844d5c95d94">172,269,170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Basic earnings (loss) per share </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzQtMi0xLTEtMA_2f8c833c-8fed-42b9-9e94-c79eb0429812">0.21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzQtNC0xLTEtMA_7128b6ae-85df-47ae-aa99-06a6187416cb">3.76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzQtNi0xLTEtMA_447953bc-085b-468a-a181-cdcd6a92651d">0.12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted earnings (loss) per share computation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations used in the computation of basic earnings (loss) per share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzYtMi0xLTEtMA_f8937fe0-a8e7-4d74-8368-b2566ae314fb">72,487</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzYtNC0xLTEtMA_b63df865-dfae-4202-b153-308028db3ac9">1,166,869</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzYtNi0xLTEtMA_422920a2-b97c-4d99-a965-09fe4b30386a">20,742</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustment for gain on revaluation of derivative liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DilutiveSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzctMi0xLTEtMA_740e4a75-4f2f-4853-bf58-2b29190a07e1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DilutiveSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzctNC0xLTEtMA_7989f3e4-036f-4ed6-97fb-b3eee1d3a46c">24,416</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:DilutiveSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzctNi0xLTEtMA_c6112ad8-158d-445b-ab61-598f83602399">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations used in the computation of diluted income (loss) per share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzgtMi0xLTEtMA_09d63a4a-e301-4179-a08d-8b3042f1efcc">72,487</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzgtNC0xLTEtMA_3cbb4572-f2aa-4089-9a81-53a50e6f15a2">1,142,453</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzgtNi0xLTEtMA_09809516-0a5c-4092-ac2c-6bd62d58aafe">20,742</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding used in the computation of basic earnings (loss) per share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzEwLTItMS0xLTA_a55b0a6b-f2f1-429e-a6da-63078c45376d">351,576,848</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzEwLTQtMS0xLTA_42fe4de1-5b68-4bd9-8dee-d3f04678fcd8">310,067,179</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzEwLTYtMS0xLTA_4b588351-8add-443b-977c-40d02cf72aa2">172,269,170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5372334bf7d347cba8a470a7ae7e08dd_D20200101-20201231" decimals="0" format="ixt:zerodash" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzExLTItMS0xLTA_a4d0551b-cddf-40ec-b2ae-8c3a1839236c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iec84f453bb6e43d7a3cafa4dad5299d9_D20190101-20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzExLTQtMS0xLTA_506edaf8-d2f7-48d7-8073-b63eb3e42662">19,481,352</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic2cbf1f3457444a8a066a4b33bcc0f8d_D20180101-20181231" decimals="0" format="ixt:zerodash" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzExLTYtMS0xLTA_f7822d87-2210-44e6-aa5b-ae16fa84a404">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5bc534f0f44f4850a59aff8f75b91db8_D20200101-20201231" decimals="0" format="ixt:zerodash" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzEyLTItMS0xLTA_22fe7d9d-4308-49e5-b38d-d48a696f180f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7b7f36b7882142ceb233b456769d9d37_D20190101-20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzEyLTQtMS0xLTA_8bde68d7-45e6-49d6-ae67-5d5b00f2706b">10,649,487</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id2927e2128a7487ba8176ee60d748c59_D20180101-20181231" decimals="0" format="ixt:zerodash" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzEyLTYtMS0xLTA_c33d69a7-5b40-4fb9-b015-25a92c18c919">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of restricted share units</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1ea19e5d9ee04882823da13b5fd955dc_D20200101-20201231" decimals="0" format="ixt:zerodash" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzEzLTItMS0xLTA_1f19f00f-30f1-45e4-9e5e-85fb157fc3ed">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i40e8761a0c0246969b0c0e0b6a135205_D20190101-20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzEzLTQtMS0xLTA_8af861a2-ac5a-4d22-9762-53cd41f65bab">732,972</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9b7d911f78814b9bab3743f845ab435a_D20180101-20181231" decimals="0" format="ixt:zerodash" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzEzLTYtMS0xLTA_05a60325-cb6b-4d78-b84a-14c1e8987053">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of Altria Warrant</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia99e808e67ba45ec9755b053b88b09fe_D20200101-20201231" decimals="0" format="ixt:zerodash" name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzE0LTItMS0xLTA_8571d650-e04c-44b6-ac69-1eebdd513636">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7504a998053c4a47a4b5953d769d1663_D20190101-20191231" decimals="0" format="ixt:zerodash" name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzE0LTQtMS0xLTA_1d5054d7-66ba-4312-9f28-4df56d4c6c53">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7c037c87e1ba48679175b63b96788f53_D20180101-20181231" decimals="0" format="ixt:zerodash" name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzE0LTYtMS0xLTA_446f6e8b-7cd8-48e4-853c-e68710848fde">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of Top-up Rights &#8211; exercised and exercisable fixed price</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic39856d934ae48b2a455091b04383ffc_D20200101-20201231" decimals="0" format="ixt:zerodash" name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzE1LTItMS0xLTA_026ddf3e-5735-45ca-9feb-711b81321386">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5d1da0bebea24f23b27907644c0febb9_D20190101-20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzE1LTQtMS0xLTA_3fa9d84b-e16f-4b41-9c76-7292481892b4">1,881,002</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5f6976781f6547bb84cd70d81d6d70c4_D20180101-20181231" decimals="0" format="ixt:zerodash" name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzE1LTYtMS0xLTA_8b26bd79-8370-4774-9255-68c9b0aa0143">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares for computation of diluted income (loss) per share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzE2LTItMS0xLTA_eb56d43f-52ef-4d7e-9d99-29823c4e2dde">351,576,848</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzE2LTQtMS0xLTA_03aad8ba-f71d-4ff0-ba60-9ddff1955f1e">342,811,992</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzE2LTYtMS0xLTA_143b837b-8113-4262-aa5d-9aecaf6501f8">172,269,170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings (loss) per share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzE3LTItMS0xLTA_ba45e212-6e06-4c7d-9922-004c8e20f394">0.21</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzE3LTQtMS0xLTA_6146bb58-0a11-4724-9384-8c8059a7f671">3.33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzE3LTYtMS0xLTA_bba0f267-5876-41f7-8947-17f587397c42">0.12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.1pt">In computing diluted earnings per share, incremental common shares are not considered in periods in which a net loss is reported, as the inclusion of the common share equivalents would be anti-dilutive.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted loss per share from discontinued operations are calculated using the following numerators and denominators: </span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:55.645%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.329%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.468%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.468%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.700%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 24.62pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic loss from discontinued operations per share computation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 24.62pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations attributable to common shareholders of Cronos Group</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo0ZWM4MWZlYWM3ZWM0M2UzOTMzNGQxMDk5ZjRiMTA2Yi90YWJsZXJhbmdlOjRlYzgxZmVhYzdlYzQzZTM5MzM0ZDEwOTlmNGIxMDZiXzEtMi0xLTEtMTY4Nzc_df1f209a-9494-4f3b-bf08-1294215bb6d2">650</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo0ZWM4MWZlYWM3ZWM0M2UzOTMzNGQxMDk5ZjRiMTA2Yi90YWJsZXJhbmdlOjRlYzgxZmVhYzdlYzQzZTM5MzM0ZDEwOTlmNGIxMDZiXzEtNC0xLTEtMTY4Nzc_98dac7f4-d90a-46b8-917f-1902e4f27115">363</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo0ZWM4MWZlYWM3ZWM0M2UzOTMzNGQxMDk5ZjRiMTA2Yi90YWJsZXJhbmdlOjRlYzgxZmVhYzdlYzQzZTM5MzM0ZDEwOTlmNGIxMDZiXzEtNi0xLTEtMTY4Nzc_a5f64b95-b92e-4dab-98f8-e384a73b16fc">894</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo0ZWM4MWZlYWM3ZWM0M2UzOTMzNGQxMDk5ZjRiMTA2Yi90YWJsZXJhbmdlOjRlYzgxZmVhYzdlYzQzZTM5MzM0ZDEwOTlmNGIxMDZiXzItMi0xLTEtMTY4Nzc_92e2879e-3d9f-4be7-ae58-9e4683feb287">351,576,848</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo0ZWM4MWZlYWM3ZWM0M2UzOTMzNGQxMDk5ZjRiMTA2Yi90YWJsZXJhbmdlOjRlYzgxZmVhYzdlYzQzZTM5MzM0ZDEwOTlmNGIxMDZiXzItNC0xLTEtMTY4Nzc_ddd0f374-03b8-4c41-8c39-fa3d56ed550e">310,067,179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo0ZWM4MWZlYWM3ZWM0M2UzOTMzNGQxMDk5ZjRiMTA2Yi90YWJsZXJhbmdlOjRlYzgxZmVhYzdlYzQzZTM5MzM0ZDEwOTlmNGIxMDZiXzItNi0xLTEtMTY4Nzc_cef9e40d-292d-469c-a91e-72dad62d939a">172,269,170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic loss from discontinued operations per share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo0ZWM4MWZlYWM3ZWM0M2UzOTMzNGQxMDk5ZjRiMTA2Yi90YWJsZXJhbmdlOjRlYzgxZmVhYzdlYzQzZTM5MzM0ZDEwOTlmNGIxMDZiXzMtMi0xLTEtMTY4Nzc_1cb8db90-81c9-482f-9deb-215a7e4ad558">0.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo0ZWM4MWZlYWM3ZWM0M2UzOTMzNGQxMDk5ZjRiMTA2Yi90YWJsZXJhbmdlOjRlYzgxZmVhYzdlYzQzZTM5MzM0ZDEwOTlmNGIxMDZiXzMtNC0xLTEtMTY4Nzc_6b801087-7081-43a0-a355-5767cdc6b6cc">0.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo0ZWM4MWZlYWM3ZWM0M2UzOTMzNGQxMDk5ZjRiMTA2Yi90YWJsZXJhbmdlOjRlYzgxZmVhYzdlYzQzZTM5MzM0ZDEwOTlmNGIxMDZiXzMtNi0xLTEtMTY4Nzc_19dadd66-7257-4e81-b5e7-c425559b9887">0.01</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.1pt">In computing diluted earnings per share, incremental common shares are not considered in periods in which a net loss is reported, as the inclusion of the common share equivalents would be anti-dilutive.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90ZXh0cmVnaW9uOjVjYWQ0ZjVlYWVmYTQxNWNhM2RkMWY3NjRkMTRkYmQ3XzM5Nw_7a72878c-7228-4203-8144-67306c2be98c" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following securities were not included in the computation of diluted shares outstanding because the effect would be anti-dilutive or because conditions for contingently issuable shares were not satisfied at the end of the reporting periods. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.677%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.677%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.682%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ginkgo Equity Milestones</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iabcd6f2591c44b2ca171a367b14b3c94_D20200101-20201231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZToyMjZjYjEyYTA5ZjQ0NjRmYjVjN2Q1NjY4ZDU0MTJjOC90YWJsZXJhbmdlOjIyNmNiMTJhMDlmNDQ2NGZiNWM3ZDU2NjhkNTQxMmM4XzEtMi0xLTEtMA_c11b8555-98f0-478e-95ae-e7221ce15de6">14,674,904</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia13ef8116a4544ff98e7741be32a6862_D20190101-20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZToyMjZjYjEyYTA5ZjQ0NjRmYjVjN2Q1NjY4ZDU0MTJjOC90YWJsZXJhbmdlOjIyNmNiMTJhMDlmNDQ2NGZiNWM3ZDU2NjhkNTQxMmM4XzEtNC0xLTEtMA_3bab561d-9950-473d-b235-9149071351c3">14,674,904</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id8fe397a667c46d5a2f89689b2a80c59_D20180101-20181231" decimals="0" format="ixt:zerodash" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZToyMjZjYjEyYTA5ZjQ0NjRmYjVjN2Q1NjY4ZDU0MTJjOC90YWJsZXJhbmdlOjIyNmNiMTJhMDlmNDQ2NGZiNWM3ZDU2NjhkNTQxMmM4XzEtNi0xLTEtMA_44561e4f-105c-4971-8ac1-db4b7e5a224d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-emptive Rights</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia107f20927684430b7ec8a2ee550479f_D20200101-20201231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZToyMjZjYjEyYTA5ZjQ0NjRmYjVjN2Q1NjY4ZDU0MTJjOC90YWJsZXJhbmdlOjIyNmNiMTJhMDlmNDQ2NGZiNWM3ZDU2NjhkNTQxMmM4XzItMi0xLTEtMA_f6a71e41-9567-4c9e-bf9d-691a2302f96b">11,534,475</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if4600e9c488a42d59e3c24335cbf41e9_D20190101-20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZToyMjZjYjEyYTA5ZjQ0NjRmYjVjN2Q1NjY4ZDU0MTJjOC90YWJsZXJhbmdlOjIyNmNiMTJhMDlmNDQ2NGZiNWM3ZDU2NjhkNTQxMmM4XzItNC0xLTEtMA_eaeb39bf-7642-4a59-8462-d81c5ac8e276">12,006,740</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8b57674317f444c9babd29a3fc8677bb_D20180101-20181231" decimals="0" format="ixt:zerodash" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZToyMjZjYjEyYTA5ZjQ0NjRmYjVjN2Q1NjY4ZDU0MTJjOC90YWJsZXJhbmdlOjIyNmNiMTJhMDlmNDQ2NGZiNWM3ZDU2NjhkNTQxMmM4XzItNi0xLTEtMA_9acc122b-8025-4111-9ce4-9d624b06d618">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Top-up Rights &#8211; fixed price</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibbe78d1c31b04bcca9543cdd1b92d857_D20200101-20201231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZToyMjZjYjEyYTA5ZjQ0NjRmYjVjN2Q1NjY4ZDU0MTJjOC90YWJsZXJhbmdlOjIyNmNiMTJhMDlmNDQ2NGZiNWM3ZDU2NjhkNTQxMmM4XzQtMi0xLTEtMA_7de97061-b9ba-423c-b7a4-76ed3818d4cd">17,214,621</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i18896e52388e4a1da87bb89497c230c1_D20190101-20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZToyMjZjYjEyYTA5ZjQ0NjRmYjVjN2Q1NjY4ZDU0MTJjOC90YWJsZXJhbmdlOjIyNmNiMTJhMDlmNDQ2NGZiNWM3ZDU2NjhkNTQxMmM4XzQtNC0xLTEtMA_a665a2c5-fab9-4700-87ed-4664a2d72061">25,103,456</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id4dbef9b15d143eba0d9488a6bd1b6de_D20180101-20181231" decimals="0" format="ixt:zerodash" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZToyMjZjYjEyYTA5ZjQ0NjRmYjVjN2Q1NjY4ZDU0MTJjOC90YWJsZXJhbmdlOjIyNmNiMTJhMDlmNDQ2NGZiNWM3ZDU2NjhkNTQxMmM4XzQtNi0xLTEtMA_2fb48a67-d155-43ad-b003-0ca97f565b0d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Top-up Rights &#8211; market price</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia16bd82ebd994d52bbf2a05aea172f78_D20200101-20201231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZToyMjZjYjEyYTA5ZjQ0NjRmYjVjN2Q1NjY4ZDU0MTJjOC90YWJsZXJhbmdlOjIyNmNiMTJhMDlmNDQ2NGZiNWM3ZDU2NjhkNTQxMmM4XzUtMi0xLTEtMA_b87f6e94-bcce-4517-814b-9b65b00485b2">3,413,065</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i31e5c55249cf4472837632d6378bb9fa_D20190101-20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZToyMjZjYjEyYTA5ZjQ0NjRmYjVjN2Q1NjY4ZDU0MTJjOC90YWJsZXJhbmdlOjIyNmNiMTJhMDlmNDQ2NGZiNWM3ZDU2NjhkNTQxMmM4XzUtNC0xLTEtMA_c44769c8-66c0-43a8-9d11-afad16764842">1,255,223</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5b93f227eda545ceb826b2485055ecd7_D20180101-20181231" decimals="0" format="ixt:zerodash" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZToyMjZjYjEyYTA5ZjQ0NjRmYjVjN2Q1NjY4ZDU0MTJjOC90YWJsZXJhbmdlOjIyNmNiMTJhMDlmNDQ2NGZiNWM3ZDU2NjhkNTQxMmM4XzUtNi0xLTEtMA_730f6638-6ab5-42b5-96f2-5a759babe8c6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Altria Warrant</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i513a3a500da74d7f8646190b65ddac07_D20200101-20201231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZToyMjZjYjEyYTA5ZjQ0NjRmYjVjN2Q1NjY4ZDU0MTJjOC90YWJsZXJhbmdlOjIyNmNiMTJhMDlmNDQ2NGZiNWM3ZDU2NjhkNTQxMmM4XzYtMi0xLTEtMA_c97cd065-4318-405c-a881-0a4832d3e346">80,056,296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib5d2efd05e19469484982928396a62c5_D20190101-20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZToyMjZjYjEyYTA5ZjQ0NjRmYjVjN2Q1NjY4ZDU0MTJjOC90YWJsZXJhbmdlOjIyNmNiMTJhMDlmNDQ2NGZiNWM3ZDU2NjhkNTQxMmM4XzYtNC0xLTEtMA_688a65ad-bc5c-406d-bb99-9c40c66e397b">77,514,993</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i19d2882beeff45f18c65e01d481175ba_D20180101-20181231" decimals="0" format="ixt:zerodash" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZToyMjZjYjEyYTA5ZjQ0NjRmYjVjN2Q1NjY4ZDU0MTJjOC90YWJsZXJhbmdlOjIyNmNiMTJhMDlmNDQ2NGZiNWM3ZDU2NjhkNTQxMmM4XzYtNi0xLTEtMA_bd48bd36-5488-4950-95fe-1d2430d34e0c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibc0a4d389472474080abbcd7fc478343_D20200101-20201231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZToyMjZjYjEyYTA5ZjQ0NjRmYjVjN2Q1NjY4ZDU0MTJjOC90YWJsZXJhbmdlOjIyNmNiMTJhMDlmNDQ2NGZiNWM3ZDU2NjhkNTQxMmM4XzctMi0xLTEtMA_53710477-6858-4a1a-ba6f-3f708480951c">15,147,116</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iff46fcf5fdd440e98e0b8f5a4f556a79_D20190101-20191231" decimals="0" format="ixt:zerodash" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZToyMjZjYjEyYTA5ZjQ0NjRmYjVjN2Q1NjY4ZDU0MTJjOC90YWJsZXJhbmdlOjIyNmNiMTJhMDlmNDQ2NGZiNWM3ZDU2NjhkNTQxMmM4XzctNC0xLTEtMA_6b492991-7c22-41df-bec9-98460f525128">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9eaef38c64244f4aaea506efaee150a7_D20180101-20181231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZToyMjZjYjEyYTA5ZjQ0NjRmYjVjN2Q1NjY4ZDU0MTJjOC90YWJsZXJhbmdlOjIyNmNiMTJhMDlmNDQ2NGZiNWM3ZDU2NjhkNTQxMmM4XzctNi0xLTEtMA_885dc24c-2c00-4fa4-b9fc-870603ca629f">25,457,623</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie606d97d090a47379c20114ccad4b834_D20200101-20201231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZToyMjZjYjEyYTA5ZjQ0NjRmYjVjN2Q1NjY4ZDU0MTJjOC90YWJsZXJhbmdlOjIyNmNiMTJhMDlmNDQ2NGZiNWM3ZDU2NjhkNTQxMmM4XzctMi0xLTEtMjI0MDk_255c0ba8-e3eb-47e8-82bc-dc0a8799cf84">9,218,674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8982714a235343b797d9648803250239_D20190101-20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZToyMjZjYjEyYTA5ZjQ0NjRmYjVjN2Q1NjY4ZDU0MTJjOC90YWJsZXJhbmdlOjIyNmNiMTJhMDlmNDQ2NGZiNWM3ZDU2NjhkNTQxMmM4XzgtNC0xLTEtMTA3OA_52209589-baf4-462b-8cf0-8941b5b27065">1,315,787</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i86551ed52b054f04aea18834481b512c_D20180101-20181231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZToyMjZjYjEyYTA5ZjQ0NjRmYjVjN2Q1NjY4ZDU0MTJjOC90YWJsZXJhbmdlOjIyNmNiMTJhMDlmNDQ2NGZiNWM3ZDU2NjhkNTQxMmM4XzgtNi0xLTEtMTA3OA_6cdba066-1d39-414d-87e2-2ad2dd2f386f">12,902,995</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted share units</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7086ea760db54de69350dc668c77abf2_D20200101-20201231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZToyMjZjYjEyYTA5ZjQ0NjRmYjVjN2Q1NjY4ZDU0MTJjOC90YWJsZXJhbmdlOjIyNmNiMTJhMDlmNDQ2NGZiNWM3ZDU2NjhkNTQxMmM4XzgtMi0xLTEtMjU4ODE_13b4b448-5b9b-4c7e-af17-a0fd332a1922">79,611</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib75ab85d304848018363ecdc58cac865_D20190101-20191231" decimals="0" format="ixt:zerodash" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZToyMjZjYjEyYTA5ZjQ0NjRmYjVjN2Q1NjY4ZDU0MTJjOC90YWJsZXJhbmdlOjIyNmNiMTJhMDlmNDQ2NGZiNWM3ZDU2NjhkNTQxMmM4XzgtNC0xLTEtMjU4ODE_333a6e55-bf5d-4279-9623-35f4edf75b74">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic5e9647b572044ccb1b1d35cba81bf49_D20180101-20181231" decimals="0" format="ixt:zerodash" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZToyMjZjYjEyYTA5ZjQ0NjRmYjVjN2Q1NjY4ZDU0MTJjOC90YWJsZXJhbmdlOjIyNmNiMTJhMDlmNDQ2NGZiNWM3ZDU2NjhkNTQxMmM4XzgtNi0xLTEtMzY0NDg_7f60ad76-8256-4988-9694-b12461e07537">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total anti-dilutive securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZToyMjZjYjEyYTA5ZjQ0NjRmYjVjN2Q1NjY4ZDU0MTJjOC90YWJsZXJhbmdlOjIyNmNiMTJhMDlmNDQ2NGZiNWM3ZDU2NjhkNTQxMmM4XzgtMi0xLTEtMA_a67695b4-39be-4f60-a153-9df5f6b94fcc">151,338,762</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZToyMjZjYjEyYTA5ZjQ0NjRmYjVjN2Q1NjY4ZDU0MTJjOC90YWJsZXJhbmdlOjIyNmNiMTJhMDlmNDQ2NGZiNWM3ZDU2NjhkNTQxMmM4XzgtNC0xLTEtMA_d302ddd9-f087-44de-91b2-9f2d89f59de6">131,871,103</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZToyMjZjYjEyYTA5ZjQ0NjRmYjVjN2Q1NjY4ZDU0MTJjOC90YWJsZXJhbmdlOjIyNmNiMTJhMDlmNDQ2NGZiNWM3ZDU2NjhkNTQxMmM4XzgtNi0xLTEtMA_68620646-e89f-4dc7-a885-4896f0d548a3">38,360,618</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101</span></div></div></div><div id="i1ae9134e40e74e0aac958218112e53d4_109"></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December 31, 2020, 2019, and 2018</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for gram and share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:16pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">18. <ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDkvZnJhZzpiYmUxMjVjMjMzNWM0NTEzYjlmZGRjMGY4Y2MyNGIzMi90ZXh0cmVnaW9uOmJiZTEyNWMyMzM1YzQ1MTNiOWZkZGMwZjhjYzI0YjMyXzEwMw_2338416a-45b8-40bb-a637-d6553c8f4eda" continuedAt="i1dd340eda31a479bae0190c91ad1ff54" escape="true">Accumulated Other Comprehensive Income (Loss) </ix:nonNumeric></span></div><ix:continuation id="i1dd340eda31a479bae0190c91ad1ff54"><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDkvZnJhZzpiYmUxMjVjMjMzNWM0NTEzYjlmZGRjMGY4Y2MyNGIzMi90ZXh0cmVnaW9uOmJiZTEyNWMyMzM1YzQ1MTNiOWZkZGMwZjhjYzI0YjMyXzEwNA_b5b47923-53ea-49e3-ad6e-a22f45e473b5" escape="true"><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a continuity schedule of accumulated other comprehensive income (loss):</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:58.427%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.278%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.468%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.278%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.468%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.281%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net unrealized gain (loss) on revaluation and disposal of other investments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5185ab0b8710451b8f3f523f58af8d12_I20191231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDkvZnJhZzpiYmUxMjVjMjMzNWM0NTEzYjlmZGRjMGY4Y2MyNGIzMi90YWJsZTpjODNhYjhiMmI3MTA0YzA1OTBmMzdlMWEwY2RiNWU5Zi90YWJsZXJhbmdlOmM4M2FiOGIyYjcxMDRjMDU5MGYzN2UxYTBjZGI1ZTlmXzItMS0xLTEtMA_59c08508-cae2-44a1-8a48-67e03dfe7a14">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee60a63d4a4f449784f69d72f30688ce_I20181231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDkvZnJhZzpiYmUxMjVjMjMzNWM0NTEzYjlmZGRjMGY4Y2MyNGIzMi90YWJsZTpjODNhYjhiMmI3MTA0YzA1OTBmMzdlMWEwY2RiNWU5Zi90YWJsZXJhbmdlOmM4M2FiOGIyYjcxMDRjMDU5MGYzN2UxYTBjZGI1ZTlmXzItMy0xLTEtMA_7e430394-ec7a-4511-9255-2f2f69d82817">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i732c27b4af274e05b82f35736f73db58_I20171231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDkvZnJhZzpiYmUxMjVjMjMzNWM0NTEzYjlmZGRjMGY4Y2MyNGIzMi90YWJsZTpjODNhYjhiMmI3MTA0YzA1OTBmMzdlMWEwY2RiNWU5Zi90YWJsZXJhbmdlOmM4M2FiOGIyYjcxMDRjMDU5MGYzN2UxYTBjZGI1ZTlmXzItNS0xLTEtMA_f524d42d-ee62-46eb-a40c-e6c8d95c6cde">446</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDkvZnJhZzpiYmUxMjVjMjMzNWM0NTEzYjlmZGRjMGY4Y2MyNGIzMi90YWJsZTpjODNhYjhiMmI3MTA0YzA1OTBmMzdlMWEwY2RiNWU5Zi90YWJsZXJhbmdlOmM4M2FiOGIyYjcxMDRjMDU5MGYzN2UxYTBjZGI1ZTlmXzMtMC0xLTEtMA_f0ab88a4-f8e8-45c9-b06f-6577993eb9f0">Cumulative effect from adoption of ASU 2016-01</span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd18b2c5a9374aadb38dfb21c7374eef_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDkvZnJhZzpiYmUxMjVjMjMzNWM0NTEzYjlmZGRjMGY4Y2MyNGIzMi90YWJsZTpjODNhYjhiMmI3MTA0YzA1OTBmMzdlMWEwY2RiNWU5Zi90YWJsZXJhbmdlOmM4M2FiOGIyYjcxMDRjMDU5MGYzN2UxYTBjZGI1ZTlmXzMtMS0xLTEtMA_59c1a18a-aa7d-464a-baf7-97f7a0eece52">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib87fb7dbb00e4f129dce34dfe404bb23_I20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDkvZnJhZzpiYmUxMjVjMjMzNWM0NTEzYjlmZGRjMGY4Y2MyNGIzMi90YWJsZTpjODNhYjhiMmI3MTA0YzA1OTBmMzdlMWEwY2RiNWU5Zi90YWJsZXJhbmdlOmM4M2FiOGIyYjcxMDRjMDU5MGYzN2UxYTBjZGI1ZTlmXzMtMy0xLTEtMA_59e4cfdd-79cb-449e-970f-a5734ea32f79">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia78503404d8e4407b9a07f1fcae6747d_I20171231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDkvZnJhZzpiYmUxMjVjMjMzNWM0NTEzYjlmZGRjMGY4Y2MyNGIzMi90YWJsZTpjODNhYjhiMmI3MTA0YzA1OTBmMzdlMWEwY2RiNWU5Zi90YWJsZXJhbmdlOmM4M2FiOGIyYjcxMDRjMDU5MGYzN2UxYTBjZGI1ZTlmXzMtNS0xLTEtMA_34e6c9ef-2e0a-45f8-9649-f8d2099e4572">444</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized (loss) gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia325d120afc54411a40573cb6f7e7e7c_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDkvZnJhZzpiYmUxMjVjMjMzNWM0NTEzYjlmZGRjMGY4Y2MyNGIzMi90YWJsZTpjODNhYjhiMmI3MTA0YzA1OTBmMzdlMWEwY2RiNWU5Zi90YWJsZXJhbmdlOmM4M2FiOGIyYjcxMDRjMDU5MGYzN2UxYTBjZGI1ZTlmXzQtMS0xLTEtMA_86716620-7315-49b3-8e23-029a2c5fd826">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8386bc114f5f4f5fa2a6bad8bc56e82f_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDkvZnJhZzpiYmUxMjVjMjMzNWM0NTEzYjlmZGRjMGY4Y2MyNGIzMi90YWJsZTpjODNhYjhiMmI3MTA0YzA1OTBmMzdlMWEwY2RiNWU5Zi90YWJsZXJhbmdlOmM4M2FiOGIyYjcxMDRjMDU5MGYzN2UxYTBjZGI1ZTlmXzQtMy0xLTEtMA_6a19113c-1076-4e28-9e38-5425d70dae52">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i991881dba0a3487e84f8602ec54ef20c_D20180101-20181231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDkvZnJhZzpiYmUxMjVjMjMzNWM0NTEzYjlmZGRjMGY4Y2MyNGIzMi90YWJsZTpjODNhYjhiMmI3MTA0YzA1OTBmMzdlMWEwY2RiNWU5Zi90YWJsZXJhbmdlOmM4M2FiOGIyYjcxMDRjMDU5MGYzN2UxYTBjZGI1ZTlmXzQtNS0xLTEtMA_8cdccd1b-2ea1-439f-9877-4853151df474">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72e668280445401eb2261966b757145c_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDkvZnJhZzpiYmUxMjVjMjMzNWM0NTEzYjlmZGRjMGY4Y2MyNGIzMi90YWJsZTpjODNhYjhiMmI3MTA0YzA1OTBmMzdlMWEwY2RiNWU5Zi90YWJsZXJhbmdlOmM4M2FiOGIyYjcxMDRjMDU5MGYzN2UxYTBjZGI1ZTlmXzYtMS0xLTEtMA_fb81f7d8-c5f9-4c8c-b105-81599297f513">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5185ab0b8710451b8f3f523f58af8d12_I20191231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDkvZnJhZzpiYmUxMjVjMjMzNWM0NTEzYjlmZGRjMGY4Y2MyNGIzMi90YWJsZTpjODNhYjhiMmI3MTA0YzA1OTBmMzdlMWEwY2RiNWU5Zi90YWJsZXJhbmdlOmM4M2FiOGIyYjcxMDRjMDU5MGYzN2UxYTBjZGI1ZTlmXzYtMy0xLTEtMA_3fe1b2a1-dd8a-4446-add0-e3d0678eed00">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee60a63d4a4f449784f69d72f30688ce_I20181231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDkvZnJhZzpiYmUxMjVjMjMzNWM0NTEzYjlmZGRjMGY4Y2MyNGIzMi90YWJsZTpjODNhYjhiMmI3MTA0YzA1OTBmMzdlMWEwY2RiNWU5Zi90YWJsZXJhbmdlOmM4M2FiOGIyYjcxMDRjMDU5MGYzN2UxYTBjZGI1ZTlmXzYtNS0xLTEtMA_2347771e-7195-4bb0-b6d5-89950d0500c5">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net foreign exchange gain (loss) on translation of foreign operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice26ccbdf6064090b029f6a08543b040_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDkvZnJhZzpiYmUxMjVjMjMzNWM0NTEzYjlmZGRjMGY4Y2MyNGIzMi90YWJsZTpjODNhYjhiMmI3MTA0YzA1OTBmMzdlMWEwY2RiNWU5Zi90YWJsZXJhbmdlOmM4M2FiOGIyYjcxMDRjMDU5MGYzN2UxYTBjZGI1ZTlmXzktMS0xLTEtMA_24aed2b8-003b-4bd2-8515-bca477ce0cf9">27,833</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c9d0bafd5cc496fbef4654eb04f5f74_I20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDkvZnJhZzpiYmUxMjVjMjMzNWM0NTEzYjlmZGRjMGY4Y2MyNGIzMi90YWJsZTpjODNhYjhiMmI3MTA0YzA1OTBmMzdlMWEwY2RiNWU5Zi90YWJsZXJhbmdlOmM4M2FiOGIyYjcxMDRjMDU5MGYzN2UxYTBjZGI1ZTlmXzktMy0xLTEtMA_07668c6b-6f29-4de9-8fa1-baf57ba7185b">9,875</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfa3a59fdaac409b8d09b830494b7637_I20171231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDkvZnJhZzpiYmUxMjVjMjMzNWM0NTEzYjlmZGRjMGY4Y2MyNGIzMi90YWJsZTpjODNhYjhiMmI3MTA0YzA1OTBmMzdlMWEwY2RiNWU5Zi90YWJsZXJhbmdlOmM4M2FiOGIyYjcxMDRjMDU5MGYzN2UxYTBjZGI1ZTlmXzktNS0xLTEtMA_7b1f5ca1-deef-4747-b2e2-3f4af9bd2664">2,456</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized (loss) gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe4e4305d17f496991f192791dce1e14_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDkvZnJhZzpiYmUxMjVjMjMzNWM0NTEzYjlmZGRjMGY4Y2MyNGIzMi90YWJsZTpjODNhYjhiMmI3MTA0YzA1OTBmMzdlMWEwY2RiNWU5Zi90YWJsZXJhbmdlOmM4M2FiOGIyYjcxMDRjMDU5MGYzN2UxYTBjZGI1ZTlmXzEwLTEtMS0xLTA_24c31e95-a439-47a5-b29e-13fd9d0bfdc4">15,161</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6a29a184e724948a6d9fe82803de2b1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDkvZnJhZzpiYmUxMjVjMjMzNWM0NTEzYjlmZGRjMGY4Y2MyNGIzMi90YWJsZTpjODNhYjhiMmI3MTA0YzA1OTBmMzdlMWEwY2RiNWU5Zi90YWJsZXJhbmdlOmM4M2FiOGIyYjcxMDRjMDU5MGYzN2UxYTBjZGI1ZTlmXzEwLTMtMS0xLTA_2421d42f-fc41-4288-859b-9bb2cdf56c72">37,708</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8e3143ddfa141b9ae6ff212b5b3329b_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDkvZnJhZzpiYmUxMjVjMjMzNWM0NTEzYjlmZGRjMGY4Y2MyNGIzMi90YWJsZTpjODNhYjhiMmI3MTA0YzA1OTBmMzdlMWEwY2RiNWU5Zi90YWJsZXJhbmdlOmM4M2FiOGIyYjcxMDRjMDU5MGYzN2UxYTBjZGI1ZTlmXzEwLTUtMS0xLTA_84e39963-ef0f-42c7-b06f-25be90701aab">12,331</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib808f60258354f1e96cf215dea381edf_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDkvZnJhZzpiYmUxMjVjMjMzNWM0NTEzYjlmZGRjMGY4Y2MyNGIzMi90YWJsZTpjODNhYjhiMmI3MTA0YzA1OTBmMzdlMWEwY2RiNWU5Zi90YWJsZXJhbmdlOmM4M2FiOGIyYjcxMDRjMDU5MGYzN2UxYTBjZGI1ZTlmXzExLTEtMS0xLTA_7d45ccd1-b275-4a2a-a5c4-1a021440e455">42,994</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice26ccbdf6064090b029f6a08543b040_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDkvZnJhZzpiYmUxMjVjMjMzNWM0NTEzYjlmZGRjMGY4Y2MyNGIzMi90YWJsZTpjODNhYjhiMmI3MTA0YzA1OTBmMzdlMWEwY2RiNWU5Zi90YWJsZXJhbmdlOmM4M2FiOGIyYjcxMDRjMDU5MGYzN2UxYTBjZGI1ZTlmXzExLTMtMS0xLTA_a2e5494c-be7f-4647-ab6b-92c17b5d4a0d">27,833</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c9d0bafd5cc496fbef4654eb04f5f74_I20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDkvZnJhZzpiYmUxMjVjMjMzNWM0NTEzYjlmZGRjMGY4Y2MyNGIzMi90YWJsZTpjODNhYjhiMmI3MTA0YzA1OTBmMzdlMWEwY2RiNWU5Zi90YWJsZXJhbmdlOmM4M2FiOGIyYjcxMDRjMDU5MGYzN2UxYTBjZGI1ZTlmXzExLTUtMS0xLTA_6bb3a934-7bcd-4c97-9525-66fb6901a390">9,875</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief7afcb557114192867857af1fa9165f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDkvZnJhZzpiYmUxMjVjMjMzNWM0NTEzYjlmZGRjMGY4Y2MyNGIzMi90YWJsZTpjODNhYjhiMmI3MTA0YzA1OTBmMzdlMWEwY2RiNWU5Zi90YWJsZXJhbmdlOmM4M2FiOGIyYjcxMDRjMDU5MGYzN2UxYTBjZGI1ZTlmXzEyLTEtMS0xLTA_516ac4b5-9363-4d6d-a5b2-08519c95ea47">42,999</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6461d38acec49bd9d6a716a38310029_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDkvZnJhZzpiYmUxMjVjMjMzNWM0NTEzYjlmZGRjMGY4Y2MyNGIzMi90YWJsZTpjODNhYjhiMmI3MTA0YzA1OTBmMzdlMWEwY2RiNWU5Zi90YWJsZXJhbmdlOmM4M2FiOGIyYjcxMDRjMDU5MGYzN2UxYTBjZGI1ZTlmXzEyLTMtMS0xLTA_0ba1c364-a81d-44b8-b2ce-0b1a34ff6ea7">27,838</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f1cb8c6e56c4c8cb1070c81364c66b2_I20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDkvZnJhZzpiYmUxMjVjMjMzNWM0NTEzYjlmZGRjMGY4Y2MyNGIzMi90YWJsZTpjODNhYjhiMmI3MTA0YzA1OTBmMzdlMWEwY2RiNWU5Zi90YWJsZXJhbmdlOmM4M2FiOGIyYjcxMDRjMDU5MGYzN2UxYTBjZGI1ZTlmXzEyLTUtMS0xLTA_21090108-38ca-436c-a3ce-9e02de8904d6">9,870</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:12pt;margin-top:12pt"><span><br/></span></div><div id="i1ae9134e40e74e0aac958218112e53d4_166"></div><div style="margin-bottom:12pt;margin-top:16pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">19. <ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90ZXh0cmVnaW9uOmY0YjZkNzk5YmE3NDQ5MGNiZDc3OWFhNDBiMDg2MTE0XzI0MTg5MjU1ODE3NTg1_b0a76689-335e-4b39-80b5-d717a9f38088" continuedAt="ib6db5689f9e3418686ca9fda0c756258" escape="true">Income Taxes</ix:nonNumeric></span></div><ix:continuation id="ib6db5689f9e3418686ca9fda0c756258" continuedAt="i7bb815896c06473cbcbcb94f4de3e64e"><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90ZXh0cmVnaW9uOmY0YjZkNzk5YmE3NDQ5MGNiZDc3OWFhNDBiMDg2MTE0XzIxMTA_543f1b99-0cee-4294-8d2e-4cdcef056d54" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For financial reporting purposes, income (loss) from continuing operations before income taxes includes the following components: </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:50.638%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.608%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.225%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.608%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.947%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.608%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.366%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51c8c173d2a64e9a89da94b382ba8309_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MDc1ODAyZDM2ZWE0ZmU3YTgwODFkYTQwYWZlMzA3Yi90YWJsZXJhbmdlOjUwNzU4MDJkMzZlYTRmZTdhODA4MWRhNDBhZmUzMDdiXzItMi0xLTEtMA_a7772d6d-a98e-4410-8275-b05ded7a46af">12,679</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33a15aa601734e76889c79308df5f39a_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MDc1ODAyZDM2ZWE0ZmU3YTgwODFkYTQwYWZlMzA3Yi90YWJsZXJhbmdlOjUwNzU4MDJkMzZlYTRmZTdhODA4MWRhNDBhZmUzMDdiXzItNC0xLTEtMA_a876b28d-469f-400b-9abb-b01188ad9541">1,169,007</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2810c3b010d94bdeb71d396714ecf592_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MDc1ODAyZDM2ZWE0ZmU3YTgwODFkYTQwYWZlMzA3Yi90YWJsZXJhbmdlOjUwNzU4MDJkMzZlYTRmZTdhODA4MWRhNDBhZmUzMDdiXzItNi0xLTEtMA_1bd86a16-3b32-4b75-8775-603090ab3e85">20,923</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib5ae31aceb854001ad8f87c6ab2e2250_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MDc1ODAyZDM2ZWE0ZmU3YTgwODFkYTQwYWZlMzA3Yi90YWJsZXJhbmdlOjUwNzU4MDJkMzZlYTRmZTdhODA4MWRhNDBhZmUzMDdiXzMtMi0xLTEtMA_f92d9c11-5b42-40b1-ac52-1d68b8b70fee">85,952</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i547cfac932ed40edb1c94ffbbad4dcc1_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MDc1ODAyZDM2ZWE0ZmU3YTgwODFkYTQwYWZlMzA3Yi90YWJsZXJhbmdlOjUwNzU4MDJkMzZlYTRmZTdhODA4MWRhNDBhZmUzMDdiXzMtNC0xLTEtMA_c41526a8-9541-4287-ad02-19d6b0ca4552">3,070</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i344b2df31b18418f873d918c4651229d_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MDc1ODAyZDM2ZWE0ZmU3YTgwODFkYTQwYWZlMzA3Yi90YWJsZXJhbmdlOjUwNzU4MDJkMzZlYTRmZTdhODA4MWRhNDBhZmUzMDdiXzMtNi0xLTEtMA_22ecd11e-9d80-4999-8848-ecce9be3229b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MDc1ODAyZDM2ZWE0ZmU3YTgwODFkYTQwYWZlMzA3Yi90YWJsZXJhbmdlOjUwNzU4MDJkMzZlYTRmZTdhODA4MWRhNDBhZmUzMDdiXzQtMi0xLTEtMA_3102c757-6d26-4003-be60-a8666a78c55f">73,273</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MDc1ODAyZDM2ZWE0ZmU3YTgwODFkYTQwYWZlMzA3Yi90YWJsZXJhbmdlOjUwNzU4MDJkMzZlYTRmZTdhODA4MWRhNDBhZmUzMDdiXzQtNC0xLTEtMA_663925c7-5658-423f-972c-cf0d145dcdc4">1,165,937</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MDc1ODAyZDM2ZWE0ZmU3YTgwODFkYTQwYWZlMzA3Yi90YWJsZXJhbmdlOjUwNzU4MDJkMzZlYTRmZTdhODA4MWRhNDBhZmUzMDdiXzQtNi0xLTEtMA_6be18a22-847e-4278-9dba-2d9c886863c2">20,923</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The loss before income taxes above excludes losses from discontinued operations of $<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90ZXh0cmVnaW9uOmY0YjZkNzk5YmE3NDQ5MGNiZDc3OWFhNDBiMDg2MTE0XzEzMTk0MTM5NTQxMjY5_7ff3f4da-9f01-48a4-8f26-3cf222d861e8">650</ix:nonFraction> for the year ended December&#160;31, 2020 (December&#160;31, 2019 &#8211; $<ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90ZXh0cmVnaW9uOmY0YjZkNzk5YmE3NDQ5MGNiZDc3OWFhNDBiMDg2MTE0XzM4NDgyOTA3MTUxMjY_d52e831e-5cd5-401d-a996-2a7beb705d57">363</ix:nonFraction>; December&#160;31, 2018 &#8211; $<ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" sign="-" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90ZXh0cmVnaW9uOmY0YjZkNzk5YmE3NDQ5MGNiZDc3OWFhNDBiMDg2MTE0XzM4NDgyOTA3MTUxMjk_830bd795-7c2e-44e1-b75f-f1a6072c6b7f">894</ix:nonFraction>).</span></div><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90ZXh0cmVnaW9uOmY0YjZkNzk5YmE3NDQ5MGNiZDc3OWFhNDBiMDg2MTE0XzIxMTE_88903bf9-70fa-461c-bfd1-e6b763755d00" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense consists of the following components: </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:50.638%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.608%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.947%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.608%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.225%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.608%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.366%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51c8c173d2a64e9a89da94b382ba8309_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo4MTExYzllYWUzYmI0NGFjOTE0M2ZiN2I4NmM1NzFhYy90YWJsZXJhbmdlOjgxMTFjOWVhZTNiYjQ0YWM5MTQzZmI3Yjg2YzU3MWFjXzMtMi0xLTEtMA_47a250bb-54a7-41ad-83ec-6a3a1e55ba0c">1,024</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33a15aa601734e76889c79308df5f39a_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo4MTExYzllYWUzYmI0NGFjOTE0M2ZiN2I4NmM1NzFhYy90YWJsZXJhbmdlOjgxMTFjOWVhZTNiYjQ0YWM5MTQzZmI3Yjg2YzU3MWFjXzMtNC0xLTEtMA_fcc62e09-f3fd-46cb-aaa1-ee298cc9d7e4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2810c3b010d94bdeb71d396714ecf592_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo4MTExYzllYWUzYmI0NGFjOTE0M2ZiN2I4NmM1NzFhYy90YWJsZXJhbmdlOjgxMTFjOWVhZTNiYjQ0YWM5MTQzZmI3Yjg2YzU3MWFjXzMtNi0xLTEtMA_2845cdaa-4caf-467b-a794-55a8c598096c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5ae31aceb854001ad8f87c6ab2e2250_D20200101-20201231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo4MTExYzllYWUzYmI0NGFjOTE0M2ZiN2I4NmM1NzFhYy90YWJsZXJhbmdlOjgxMTFjOWVhZTNiYjQ0YWM5MTQzZmI3Yjg2YzU3MWFjXzQtMi0xLTEtMA_eabb094a-228b-4d70-a171-b6fdbd23fbfb">323</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i547cfac932ed40edb1c94ffbbad4dcc1_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo4MTExYzllYWUzYmI0NGFjOTE0M2ZiN2I4NmM1NzFhYy90YWJsZXJhbmdlOjgxMTFjOWVhZTNiYjQ0YWM5MTQzZmI3Yjg2YzU3MWFjXzQtNC0xLTEtMA_9ecd0022-ab19-490c-bc51-bab1aa375e91">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i344b2df31b18418f873d918c4651229d_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo4MTExYzllYWUzYmI0NGFjOTE0M2ZiN2I4NmM1NzFhYy90YWJsZXJhbmdlOjgxMTFjOWVhZTNiYjQ0YWM5MTQzZmI3Yjg2YzU3MWFjXzQtNi0xLTEtMA_81aef027-eb71-49d0-8a8c-ba03764a2691">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo4MTExYzllYWUzYmI0NGFjOTE0M2ZiN2I4NmM1NzFhYy90YWJsZXJhbmdlOjgxMTFjOWVhZTNiYjQ0YWM5MTQzZmI3Yjg2YzU3MWFjXzUtMi0xLTEtMA_d47ace51-f44c-404d-a0ab-ca91e368f639">1,347</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo4MTExYzllYWUzYmI0NGFjOTE0M2ZiN2I4NmM1NzFhYy90YWJsZXJhbmdlOjgxMTFjOWVhZTNiYjQ0YWM5MTQzZmI3Yjg2YzU3MWFjXzUtNC0xLTEtMA_b1ef2b0e-9344-405e-befc-ffd826a357ac">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo4MTExYzllYWUzYmI0NGFjOTE0M2ZiN2I4NmM1NzFhYy90YWJsZXJhbmdlOjgxMTFjOWVhZTNiYjQ0YWM5MTQzZmI3Yjg2YzU3MWFjXzUtNi0xLTEtMA_569642c7-fcf2-4f4a-b695-59aa5a7c4930">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51c8c173d2a64e9a89da94b382ba8309_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo4MTExYzllYWUzYmI0NGFjOTE0M2ZiN2I4NmM1NzFhYy90YWJsZXJhbmdlOjgxMTFjOWVhZTNiYjQ0YWM5MTQzZmI3Yjg2YzU3MWFjXzctMi0xLTEtMA_ae999a3b-57ff-4982-a202-4029a0db3932">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33a15aa601734e76889c79308df5f39a_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo4MTExYzllYWUzYmI0NGFjOTE0M2ZiN2I4NmM1NzFhYy90YWJsZXJhbmdlOjgxMTFjOWVhZTNiYjQ0YWM5MTQzZmI3Yjg2YzU3MWFjXzctNC0xLTEtMA_9575ac87-8822-4ee2-b885-6c1236e9e8df">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2810c3b010d94bdeb71d396714ecf592_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo4MTExYzllYWUzYmI0NGFjOTE0M2ZiN2I4NmM1NzFhYy90YWJsZXJhbmdlOjgxMTFjOWVhZTNiYjQ0YWM5MTQzZmI3Yjg2YzU3MWFjXzctNi0xLTEtMA_12253e89-b0ce-461e-9f0f-07f8ec89dff3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5ae31aceb854001ad8f87c6ab2e2250_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo4MTExYzllYWUzYmI0NGFjOTE0M2ZiN2I4NmM1NzFhYy90YWJsZXJhbmdlOjgxMTFjOWVhZTNiYjQ0YWM5MTQzZmI3Yjg2YzU3MWFjXzgtMi0xLTEtMA_8a39a920-776c-4748-8a1c-de3ad4ced96b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i547cfac932ed40edb1c94ffbbad4dcc1_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo4MTExYzllYWUzYmI0NGFjOTE0M2ZiN2I4NmM1NzFhYy90YWJsZXJhbmdlOjgxMTFjOWVhZTNiYjQ0YWM5MTQzZmI3Yjg2YzU3MWFjXzgtNC0xLTEtMA_daad1329-8a18-42d6-9791-a863c820edfa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i344b2df31b18418f873d918c4651229d_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo4MTExYzllYWUzYmI0NGFjOTE0M2ZiN2I4NmM1NzFhYy90YWJsZXJhbmdlOjgxMTFjOWVhZTNiYjQ0YWM5MTQzZmI3Yjg2YzU3MWFjXzgtNi0xLTEtMA_f9e3f5b4-49ad-4091-b706-83cab789dd36">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo4MTExYzllYWUzYmI0NGFjOTE0M2ZiN2I4NmM1NzFhYy90YWJsZXJhbmdlOjgxMTFjOWVhZTNiYjQ0YWM5MTQzZmI3Yjg2YzU3MWFjXzktMi0xLTEtMA_31ca04c1-f0e4-4888-9fe4-1b69aee4c5af">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo4MTExYzllYWUzYmI0NGFjOTE0M2ZiN2I4NmM1NzFhYy90YWJsZXJhbmdlOjgxMTFjOWVhZTNiYjQ0YWM5MTQzZmI3Yjg2YzU3MWFjXzktNC0xLTEtMA_3499bee8-7b10-4f3f-aefd-3263c98b65d7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo4MTExYzllYWUzYmI0NGFjOTE0M2ZiN2I4NmM1NzFhYy90YWJsZXJhbmdlOjgxMTFjOWVhZTNiYjQ0YWM5MTQzZmI3Yjg2YzU3MWFjXzktNi0xLTEtMA_d97d5a82-abb9-4c2d-a779-6eecd22d788b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in accounts payable and other liabilities as of December&#160;31, 2020 is $<ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" name="us-gaap:TaxesPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90ZXh0cmVnaW9uOmY0YjZkNzk5YmE3NDQ5MGNiZDc3OWFhNDBiMDg2MTE0XzEzMTk0MTM5NTQxNTI2_804748b0-8077-4609-ba85-40ad526e023d">865</ix:nonFraction> (December&#160;31, 2019 &#8211; $<ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:TaxesPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90ZXh0cmVnaW9uOmY0YjZkNzk5YmE3NDQ5MGNiZDc3OWFhNDBiMDg2MTE0XzEzMTk0MTM5NTQxNTU0_a3fb395d-675d-4ca6-b993-3d72110e3ff2">nil</ix:nonFraction>; December&#160;31, 2018 &#8211; $<ix:nonFraction unitRef="usd" contextRef="i9717dc3b24b24c93ab09a6bfa9b52c89_I20181231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:TaxesPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90ZXh0cmVnaW9uOmY0YjZkNzk5YmE3NDQ5MGNiZDc3OWFhNDBiMDg2MTE0XzEzMTk0MTM5NTQxNTU4_a74502c7-236e-406e-9c72-165cd57ff86d">nil</ix:nonFraction>) related to current income tax expense above.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">102</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December 31, 2020, 2019, and 2018</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for gram and share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div></div><ix:continuation id="i7bb815896c06473cbcbcb94f4de3e64e" continuedAt="ib3d5ea601be24dcfb6eb3f8c256014aa"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax differs from that computed using the combined Canadian federal and provincial statutory income tax rate of <ix:nonFraction unitRef="number" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90ZXh0cmVnaW9uOmY0YjZkNzk5YmE3NDQ5MGNiZDc3OWFhNDBiMDg2MTE0XzI5Ng_f0c17952-8032-4ce5-a427-297fddcda78d">26.5</ix:nonFraction>%. <ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90ZXh0cmVnaW9uOmY0YjZkNzk5YmE3NDQ5MGNiZDc3OWFhNDBiMDg2MTE0XzIxMTI_d21805cc-b74c-46e3-8e20-cc0c211efcbd" continuedAt="ic25739f0bfc544bfa31862ee7a8d06a7" escape="true">Reconciliation of the expected income tax to the effective tax rate in continuing operations is as follows:</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><ix:continuation id="ic25739f0bfc544bfa31862ee7a8d06a7"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.205%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.347%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzItMi0xLTEtMA_5c7b5d09-4fe4-4fda-8380-7c095d1b4320">73,273</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzItNC0xLTEtMA_50d806e9-7d70-4df3-83a8-9e9ac62bc8c3">1,165,937</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzItNi0xLTEtMA_8a1b8d66-b13a-4062-b6ad-04a251965300">20,923</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective income tax rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzMtMi0xLTEtMzQ0OTc_2ce4c718-dffc-4abd-94a6-648cff305d2b">26.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzMtNC0xLTEtMzQ0OTc_e0f647cd-bc1e-4860-b199-4cdd489bdc23">26.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzMtNi0xLTEtMzQ0OTc_3a927a2e-7fdc-4f44-86bc-52e01a371fff">26.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected income tax expense (benefit)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:EffectiveIncomeTaxRateReconciliationExpectedIncomeTaxExpenseRecoveryAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzMtMi0xLTEtMA_21a5305d-8a5d-4bce-8e8a-95674f9a428d">19,417</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="cron:EffectiveIncomeTaxRateReconciliationExpectedIncomeTaxExpenseRecoveryAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzMtNC0xLTEtMA_af4db2e9-be56-4ee6-81fb-9426f2561778">308,973</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:EffectiveIncomeTaxRateReconciliationExpectedIncomeTaxExpenseRecoveryAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzMtNi0xLTEtMA_7b3dfeb9-eca3-468d-b026-ed346aa1e29b">5,545</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-taxable income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxReconciliationTaxExemptIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzQtMi0xLTEtMA_a8a36577-5c1b-4087-8475-dbd5b856cd95">711</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationTaxExemptIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzQtNC0xLTEtMA_72e63ee3-aeaa-4757-b965-e8865abe94ff">2,156</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationTaxExemptIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzQtNi0xLTEtMA_073982db-5ab5-4918-9dfc-08104361a4c3">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible share-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzUtMi0xLTEtMA_f4d08008-1935-4962-8a66-05d3a2263567">2,498</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzUtNC0xLTEtMA_29e75ade-1145-4ba7-9a21-d601c07a0622">2,839</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzUtNi0xLTEtMA_76617302-0e52-4af0-ab95-7b4d0b51526a">2,466</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzgtMi0xLTEtMzQ1ODE_aa4048ee-d30b-49c3-a085-1256082e8eab">1,364</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzgtNC0xLTEtMzQ1ODE_10dd7f05-9a98-4f53-9e53-9d8568a920f1">764</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzgtNi0xLTEtMzQ1ODE_52eedae2-7362-4d6b-bcfc-77e75633dfda">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible transaction costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="cron:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzktMi0xLTEtMzQ1ODE_ccd405b4-e0c5-4047-b9a8-f532df93ff3f">3,146</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="cron:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzktNC0xLTEtMzQ1ODE_2271b558-2c95-45f7-9265-614a77eb1c79">1,523</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="cron:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzktNi0xLTEtMzQ1ODE_c845f770-4e22-4d6a-9f6c-453e8ceabb05">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of provincial tax rate difference</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzEwLTItMS0xLTM0NTgx_bd4df1e7-f2ce-40d8-8e79-5c43d1c32744">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzEwLTQtMS0xLTM0NTgx_a4ef3823-fd4e-4565-91d7-6cd9e22e43b5">44</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzEwLTYtMS0xLTM0NTgx_e37ec286-2fe9-435c-95b1-c6ed57f50273">64</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of tax rates outside of Canada</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzYtMi0xLTEtMA_16c9ea4f-f469-41e2-aba9-1d843734c976">362</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzYtNC0xLTEtMA_1a6141cc-d423-4b7c-8a38-a09f4875521f">70</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzYtNi0xLTEtMA_a4ab7527-246d-4259-b1ec-a50b406a8ce5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value gain on financial liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="cron:EffectiveIncomeTaxRateReconciliationFairValueGainFinancialLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzctMi0xLTEtMA_b02ddfb9-daf6-4ed9-8b0c-ff6b4b7939ed">34,250</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="cron:EffectiveIncomeTaxRateReconciliationFairValueGainFinancialLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzctNC0xLTEtMA_c31a6053-e918-41da-998d-376fb58dd668">338,409</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="cron:EffectiveIncomeTaxRateReconciliationFairValueGainFinancialLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzctNi0xLTEtMA_5f8f135e-065c-4a71-bbbd-6c055e2cc656">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in valuation allowance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzktMi0xLTEtMA_f625e156-fc9e-4631-9b26-4ce3f684eaa3">48,227</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzktNC0xLTEtMA_444d048b-07cb-4110-a47e-787fb84b8594">25,808</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzktNi0xLTEtMA_74add975-4b46-4aec-a6de-6fde1df4b9ce">3,437</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzEwLTItMS0xLTA_aa8a343c-11b5-4d09-aa00-2ee22748ab22">867</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzEwLTQtMS0xLTA_99c0331c-1ccc-4209-8ccb-6aba97eb3060">632</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzEwLTYtMS0xLTA_653b49c0-5020-4688-9c0a-2de45b405d1a">308</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (recovery), net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzExLTItMS0xLTA_ef5d7430-e30b-4a93-bdea-5ace2c3286e6">1,347</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzExLTQtMS0xLTA_a1c7f901-f759-41d9-bad0-ee2f1907a88e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzExLTYtMS0xLTA_73f30334-b4bb-43cd-b253-204acadc968b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></ix:continuation></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The valuation allowance recorded against the loss on discontinued operations is not reflected in the effective tax rate reconciliation presented above for continuing operations.</span></div><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90ZXh0cmVnaW9uOmY0YjZkNzk5YmE3NDQ5MGNiZDc3OWFhNDBiMDg2MTE0XzIxMTM_27e8ba9c-5123-47fa-ba23-4125f8dd7390" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the significant components of the Company&#8217;s deferred tax assets and liabilities as of December&#160;31, 2020 and December&#160;31, 2019: </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.042%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax loss carryforwards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzMtMi0xLTEtMA_9e4a941e-080c-44a3-9e50-5af7e1e21fb0">67,476</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzMtNC0xLTEtMA_938f9bf8-f3be-457a-b920-2026e3f7ec1e">30,908</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense carryforwards</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetInterestCarryforward" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzQtMi0xLTEtMzU1MDg_3daf7a7a-7b11-41dc-a4ae-abb88e5b8b82">1,407</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DeferredTaxAssetInterestCarryforward" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzQtNC0xLTEtMzU1MDg_8ec2dcd4-aac0-4ba9-9c52-de6f8837fabd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="cron:DeferredTaxAssetsDebtIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzQtMi0xLTEtMA_cff84d3c-279a-43af-92d8-bd3618bd2b47">4,233</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="cron:DeferredTaxAssetsDebtIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzQtNC0xLTEtMA_3d269d71-ce23-44e4-87bf-b515656b5dd2">5,690</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share issuance cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="cron:DeferredTaxAssetsShareIssuanceCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzUtMi0xLTEtMA_770aca44-1ede-40fd-8382-41ceb7f2fd55">1,573</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="cron:DeferredTaxAssetsShareIssuanceCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzUtNC0xLTEtMA_dc0b38ae-6e07-4828-a89f-0f11e1208299">2,217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease obligation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="cron:DeferredTaxAssetsFinanceLeaseLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzYtMi0xLTEtMA_bc79cb17-cc19-4699-9ce9-79c16babd729">1,953</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="cron:DeferredTaxAssetsFinanceLeaseLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzYtNC0xLTEtMA_6095c325-2714-4d61-a7a3-d101f56f931d">1,491</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plant and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzctMi0xLTEtMA_fed3c3f6-3558-4935-88e8-d68cc1b43186">5,945</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" name="us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzctNC0xLTEtMA_1bfb6efd-4b3a-40ee-8cbb-56dbbd9ea01b">871</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzgtMi0xLTEtMA_1148ccf4-6b8e-409c-9508-8ec82b2c777e">307</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" name="us-gaap:DeferredTaxAssetsInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzgtNC0xLTEtMA_93db9393-506e-4d9e-9ecb-7b4778401497">395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzktMi0xLTEtMA_20ced7aa-638b-4f24-bfc1-7b1cba5f3026">4,218</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzktNC0xLTEtMA_ffd80739-649f-4573-b99c-294aa0a79fdc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserve</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzEwLTItMS0xLTA_53755176-c868-4e5e-8357-74ba1ec21706">1,858</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzEwLTQtMS0xLTA_ed802477-de5f-457b-83bf-b5a6940d77ee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzExLTItMS0xLTA_6f0a390e-7a8c-4b6e-b4e2-2d78368523d5">570</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" name="us-gaap:DeferredTaxAssetsOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzExLTQtMS0xLTA_2213b3a5-b789-4337-8d4d-cedc7313439e">482</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzEyLTItMS0xLTA_d965660e-68a1-4616-962d-6a27a00c617d">89,540</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzEyLTQtMS0xLTA_12cb4702-9eb3-46a1-a485-6cd196c36211">42,054</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less valuation allowance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzEzLTItMS0xLTA_ebf8d2db-36f6-4ff9-9fb6-a0870280a33e">85,935</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzEzLTQtMS0xLTA_06f70def-127e-4508-8419-000102b08287">36,948</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzE0LTItMS0xLTA_aca845a7-4ccb-46e2-b79f-3e09063d8a53">3,605</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzE0LTQtMS0xLTA_f9898ae8-df2a-40c1-ac8a-932079cad12d">5,106</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzE3LTItMS0xLTA_e98b9842-907a-482f-908d-ff61f9ec8c39">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzE3LTQtMS0xLTA_0768d22b-5277-4f17-bf1e-71b4e80652a7">1,227</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plant and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzE4LTItMS0xLTA_bc9e374a-a53d-402c-a2fe-61437a68cea6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzE4LTQtMS0xLTA_69c14fcd-ee41-45f2-b7a8-5ca06c2af219">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzE5LTItMS0xLTA_a86f3860-0fb1-4516-870c-41d5990750ff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzE5LTQtMS0xLTA_48ea5b2a-eb77-4e9b-a84a-0664f56115cc">2,126</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DeferredTaxLiabilitiesInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzIwLTItMS0xLTA_2b9176f6-37ea-4d93-b68a-bd6c955230a5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DeferredTaxLiabilitiesInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzIwLTQtMS0xLTA_ccaedf0e-fad9-4461-8122-f349245a1579">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">License</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="cron:DeferredTaxLiabilitiesLicenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzIxLTItMS0xLTA_e08bcf57-6298-4d73-ab37-97e26ad2a7a4">1,662</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" name="cron:DeferredTaxLiabilitiesLicenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzIxLTQtMS0xLTA_445208b9-9d00-4fdd-a840-e43099b5a117">293</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="cron:DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzIyLTItMS0xLTA_45b38318-d980-4f66-bfa6-5bd95630a79e">1,943</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="cron:DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzIyLTQtMS0xLTA_1249b718-3d16-4248-ab55-12c546b11544">1,460</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzIzLTItMS0xLTA_40b5c594-6549-4b37-9123-eb2f4c74cc36">3,605</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzIzLTQtMS0xLTA_2403a8ba-5aba-49e6-9c75-eae2776e3264">5,106</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DeferredTaxLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzI0LTItMS0xLTA_ffd91813-b97c-477a-925f-eef6bd78c39b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DeferredTaxLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzI0LTQtMS0xLTA_370b1939-7000-450b-85d9-b0cb63bcd66d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">103</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December 31, 2020, 2019, and 2018</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for gram and share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div></div><ix:continuation id="ib3d5ea601be24dcfb6eb3f8c256014aa"><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The realization of deferred tax assets is dependent on the Company&#8217;s generating sufficient taxable income in the years that the temporary differences become deductible. A valuation allowance has been provided for the deferred tax assets that the Company determined did not meet the more-likely-than-not recognition threshold under U.S. GAAP.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the Company had net operating losses in Canada, the U.S., and Israel available to offset future years&#8217; taxable income of approximately $<ix:nonFraction unitRef="usd" contextRef="i2d7bbfdd8ccc40ebaad61885c216b6a2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLossCarryforwards" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90ZXh0cmVnaW9uOmY0YjZkNzk5YmE3NDQ5MGNiZDc3OWFhNDBiMDg2MTE0XzEzMTk0MTM5NTQzMjgy_491be220-6f08-4c94-a735-fa408a607d58">177,651</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i105f31994b814455b1dd25adfc5232aa_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLossCarryforwards" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90ZXh0cmVnaW9uOmY0YjZkNzk5YmE3NDQ5MGNiZDc3OWFhNDBiMDg2MTE0XzEzMTk0MTM5NTQzMjg3_a1eaac24-4be6-49bf-b2ee-fe3ea43923eb">62,851</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="i78c60b99d62646d091fd871d5b174040_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLossCarryforwards" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90ZXh0cmVnaW9uOmY0YjZkNzk5YmE3NDQ5MGNiZDc3OWFhNDBiMDg2MTE0XzEzMTk0MTM5NTQzMjk2_a82187cb-f844-410d-93b5-f1f4f4adfec5">14,042</ix:nonFraction>, respectively. As of December&#160;31, 2019, the Company had net operating losses in Canada, the U.S., and Israel available to offset future years&#8217; taxable income of approximately $<ix:nonFraction unitRef="usd" contextRef="ib74df11c3c8e445ea96958153ef913d4_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLossCarryforwards" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90ZXh0cmVnaW9uOmY0YjZkNzk5YmE3NDQ5MGNiZDc3OWFhNDBiMDg2MTE0XzEzMTk0MTM5NTQzNTE4_722b9500-90af-42c3-981a-99532bae1ec2">92,773</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="ib2d8a62a5a5c45949a4da4ef35ba51ac_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLossCarryforwards" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90ZXh0cmVnaW9uOmY0YjZkNzk5YmE3NDQ5MGNiZDc3OWFhNDBiMDg2MTE0XzEzMTk0MTM5NTQzNTIz_7f49c4fc-1bb5-4d4b-83cd-aeb03a724a36">14,374</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="ie931956074a74c9db1111bc5c10fe12e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLossCarryforwards" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90ZXh0cmVnaW9uOmY0YjZkNzk5YmE3NDQ5MGNiZDc3OWFhNDBiMDg2MTE0XzEzMTk0MTM5NTQzNTMy_ccae1fc9-3d15-4f9e-945f-0c5e3f7a15ba">8,763</ix:nonFraction>, respectively. The net operating losses in Canada will begin to expire, for purposes of carryforward, in fiscal year 2032. The net operating losses in the U.S. can be carried forward indefinitely for federal purposes. The net operating losses in Israel can be carried forward indefinitely.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Utilization of the net operating loss carryforwards may be subject to limitations under the tax laws applicable in each tax jurisdiction due to ownership changes that could occur in the future. These ownership changes could limit the amount of net operating loss carryforwards and other deferred tax assets that can be utilized to offset future taxable income and tax expense. Specifically, if Altria exercises its warrant the Company would recognize a change in control event and certain Canadian net operating loss carryforwards may be limited. Due to the existence of the valuation allowance, limitations created by ownership changes, if any, will not impact the Company&#8217;s effective tax rate.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files federal income tax returns in Canada, Israel and the U.S. The Company has open tax years with the taxation jurisdictions. These open years contain certain matters that could be subject to differing interpretations of applicable tax laws and regulations and tax treaties, as they relate to the amount, timing, or inclusion of revenue and expense.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:SummaryOfIncomeTaxExaminationsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90ZXh0cmVnaW9uOmY0YjZkNzk5YmE3NDQ5MGNiZDc3OWFhNDBiMDg2MTE0XzIxMTU_53010049-4d83-40ca-81b0-5e3cdb610b0a" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.068%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.462%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.070%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Jurisdiction</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Open Years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2016 &#8211; 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018 &#8211; 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 &#8211; 2020</span></td></tr></table></ix:nonNumeric></div><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:SummaryOfValuationAllowanceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90ZXh0cmVnaW9uOmY0YjZkNzk5YmE3NDQ5MGNiZDc3OWFhNDBiMDg2MTE0XzIxMTY_3ebe3e31-211a-4e1b-9ee4-910ff1f48003" escape="true"><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table outlines the movements in the valuation allowance:</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.816%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.316%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.316%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.316%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.321%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at beginning of year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change due to foreign exchange</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Increase</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at end of year</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December&#160;31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17a122330b5144cf96235a840b3602c1_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1NzBmNDQ1ODgzNzk0OWZmOGU1Nzk4YzEyMDJmMTk3Yi90YWJsZXJhbmdlOjU3MGY0NDU4ODM3OTQ5ZmY4ZTU3OThjMTIwMmYxOTdiXzEtMS0xLTEtMA_edca5837-9ad2-43bb-815e-0574f351ef25">36,948</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie0b8cf648fb646f3aa94a5539664bc50_D20200101-20201231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1NzBmNDQ1ODgzNzk0OWZmOGU1Nzk4YzEyMDJmMTk3Yi90YWJsZXJhbmdlOjU3MGY0NDU4ODM3OTQ5ZmY4ZTU3OThjMTIwMmYxOTdiXzEtMy0xLTEtMA_c9ff2e40-2848-4164-9dee-069a4c09544f">693</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie0b8cf648fb646f3aa94a5539664bc50_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1NzBmNDQ1ODgzNzk0OWZmOGU1Nzk4YzEyMDJmMTk3Yi90YWJsZXJhbmdlOjU3MGY0NDU4ODM3OTQ5ZmY4ZTU3OThjMTIwMmYxOTdiXzEtNS0xLTEtMA_a9e5edf2-0472-4c44-9f49-b6014d2922e6">48,294</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d3fb6c71a584d88aa595b49e45b8837_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1NzBmNDQ1ODgzNzk0OWZmOGU1Nzk4YzEyMDJmMTk3Yi90YWJsZXJhbmdlOjU3MGY0NDU4ODM3OTQ5ZmY4ZTU3OThjMTIwMmYxOTdiXzEtNy0xLTEtMA_567841d6-ed42-433a-b722-bda0d5057f17">85,935</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December&#160;31, 2019</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i172fd75fe227409f982d139db1b09efd_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1NzBmNDQ1ODgzNzk0OWZmOGU1Nzk4YzEyMDJmMTk3Yi90YWJsZXJhbmdlOjU3MGY0NDU4ODM3OTQ5ZmY4ZTU3OThjMTIwMmYxOTdiXzItMS0xLTEtMA_e9164a18-0ab9-478e-9f91-96de4e47d503">7,931</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5ef930d66f146f6b1ee58c6e0b38dbe_D20190101-20191231" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1NzBmNDQ1ODgzNzk0OWZmOGU1Nzk4YzEyMDJmMTk3Yi90YWJsZXJhbmdlOjU3MGY0NDU4ODM3OTQ5ZmY4ZTU3OThjMTIwMmYxOTdiXzItMy0xLTEtMA_921f4410-4227-4c22-bb72-d33a0f221033">998</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5ef930d66f146f6b1ee58c6e0b38dbe_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1NzBmNDQ1ODgzNzk0OWZmOGU1Nzk4YzEyMDJmMTk3Yi90YWJsZXJhbmdlOjU3MGY0NDU4ODM3OTQ5ZmY4ZTU3OThjMTIwMmYxOTdiXzItNS0xLTEtMA_46d87585-c6d5-491e-8bfe-b3b036672899">28,019</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17a122330b5144cf96235a840b3602c1_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1NzBmNDQ1ODgzNzk0OWZmOGU1Nzk4YzEyMDJmMTk3Yi90YWJsZXJhbmdlOjU3MGY0NDU4ODM3OTQ5ZmY4ZTU3OThjMTIwMmYxOTdiXzItNy0xLTEtMA_8683ac7c-f010-4b4c-afb2-710c3cf7b8e7">36,948</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020 and December&#160;31, 2019, the Company recorded a valuation allowance of $<ix:nonFraction unitRef="usd" contextRef="i7d3fb6c71a584d88aa595b49e45b8837_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90ZXh0cmVnaW9uOmY0YjZkNzk5YmE3NDQ5MGNiZDc3OWFhNDBiMDg2MTE0XzEzMTk0MTM5NTQ0ODgw_567841d6-ed42-433a-b722-bda0d5057f17">85,935</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i17a122330b5144cf96235a840b3602c1_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90ZXh0cmVnaW9uOmY0YjZkNzk5YmE3NDQ5MGNiZDc3OWFhNDBiMDg2MTE0XzEzMTk0MTM5NTQ0ODk4_8683ac7c-f010-4b4c-afb2-710c3cf7b8e7">36,948</ix:nonFraction>, respectively. The valuation allowance increased by $<ix:nonFraction unitRef="usd" contextRef="ie0b8cf648fb646f3aa94a5539664bc50_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90ZXh0cmVnaW9uOmY0YjZkNzk5YmE3NDQ5MGNiZDc3OWFhNDBiMDg2MTE0XzY1OTcwNjk3ODQzNjg_a9e5edf2-0472-4c44-9f49-b6014d2922e6">48,294</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ia5ef930d66f146f6b1ee58c6e0b38dbe_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowancesAndReservesAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90ZXh0cmVnaW9uOmY0YjZkNzk5YmE3NDQ5MGNiZDc3OWFhNDBiMDg2MTE0XzEzMTk0MTM5NTQ0OTQw_46d87585-c6d5-491e-8bfe-b3b036672899">28,019</ix:nonFraction> during the years ended December&#160;31, 2020 and December&#160;31, 2019, respectively. The increase in the valuation allowance during the years ended December&#160;31, 2020 and December&#160;31, 2019 was primarily due to an increase in net operating loss carryforwards, the utilization of which did not meet the more-likely-than-not recognition threshold.</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounting guidance clarifies the accounting for uncertain tax positions and prescribes a recognition threshold and measurement process for recording in the financial statements uncertain tax positions taken or expected to be taken in a tax return. Additionally, the authoritative guidance addresses the de-recognition, classification, accounting in interim periods and disclosure requirements for uncertain tax positions. Only tax positions that meet the more-likely-than-not recognition threshold may be recognized. There were no identified unrecognized tax benefits as of December&#160;31, 2020 or December&#160;31, 2019.</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all earnings and profits of its subsidiaries outside Canada to be indefinitely reinvested. As of December&#160;31, 2020 and December&#160;31, 2019, the amount of undistributed earnings upon which income taxes have not been provided is immaterial to these consolidated financial statements.</span></div></ix:continuation><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104</span></div></div></div><div id="i1ae9134e40e74e0aac958218112e53d4_154"></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December 31, 2020, 2019, and 2018</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for gram and share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">20. <ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:CommitmentsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNTQvZnJhZzphMDk1MzRkYThmOGE0ODRlOGZmYzFmOWM4NWMwNTA2OC90ZXh0cmVnaW9uOmEwOTUzNGRhOGY4YTQ4NGU4ZmZjMWY5Yzg1YzA1MDY4XzI1NDA_d3e4a2a1-c95c-4eec-81ae-2a5db5663140" continuedAt="i43631e5d49f74948a56f5bd2ae424e0a" escape="true">Commitments </ix:nonNumeric></span></div><ix:continuation id="i43631e5d49f74948a56f5bd2ae424e0a" continuedAt="if48115a8c1a14967b9ea43b7e006bbac"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt">Lease Commitments</span></div><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNTQvZnJhZzphMDk1MzRkYThmOGE0ODRlOGZmYzFmOWM4NWMwNTA2OC90ZXh0cmVnaW9uOmEwOTUzNGRhOGY4YTQ4NGU4ZmZjMWY5Yzg1YzA1MDY4XzI1NDE_fd1ed8b9-000b-4ae8-b481-282a05a2eb28" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the Company&#8217;s future minimum lease payments under operating leases for its premises due in future fiscal years: </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.455%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.679%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNTQvZnJhZzphMDk1MzRkYThmOGE0ODRlOGZmYzFmOWM4NWMwNTA2OC90YWJsZTo1NzMzYzI2YWQyM2Y0YzQ3OTZlYmU0MDU3MWY1YTE1My90YWJsZXJhbmdlOjU3MzNjMjZhZDIzZjRjNDc5NmViZTQwNTcxZjVhMTUzXzItMi0xLTEtMA_4b60a69a-609e-40cd-bac3-28579f1d8752">2,381</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNTQvZnJhZzphMDk1MzRkYThmOGE0ODRlOGZmYzFmOWM4NWMwNTA2OC90YWJsZTo1NzMzYzI2YWQyM2Y0YzQ3OTZlYmU0MDU3MWY1YTE1My90YWJsZXJhbmdlOjU3MzNjMjZhZDIzZjRjNDc5NmViZTQwNTcxZjVhMTUzXzMtMi0xLTEtMA_cf26c5aa-866a-42fb-a29f-b1b1e2df5808">2,302</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNTQvZnJhZzphMDk1MzRkYThmOGE0ODRlOGZmYzFmOWM4NWMwNTA2OC90YWJsZTo1NzMzYzI2YWQyM2Y0YzQ3OTZlYmU0MDU3MWY1YTE1My90YWJsZXJhbmdlOjU3MzNjMjZhZDIzZjRjNDc5NmViZTQwNTcxZjVhMTUzXzQtMi0xLTEtMA_93ea7cbd-577e-49c2-88da-326200ed4464">2,201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNTQvZnJhZzphMDk1MzRkYThmOGE0ODRlOGZmYzFmOWM4NWMwNTA2OC90YWJsZTo1NzMzYzI2YWQyM2Y0YzQ3OTZlYmU0MDU3MWY1YTE1My90YWJsZXJhbmdlOjU3MzNjMjZhZDIzZjRjNDc5NmViZTQwNTcxZjVhMTUzXzYtMi0xLTEtMA_c1de5a9a-4e9c-4dfc-9e80-cd3ce80f6271">1,711</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNTQvZnJhZzphMDk1MzRkYThmOGE0ODRlOGZmYzFmOWM4NWMwNTA2OC90YWJsZTo1NzMzYzI2YWQyM2Y0YzQ3OTZlYmU0MDU3MWY1YTE1My90YWJsZXJhbmdlOjU3MzNjMjZhZDIzZjRjNDc5NmViZTQwNTcxZjVhMTUzXzYtMi0xLTEtMTM1MTk_4a7d8267-7507-402a-993d-33076679c787">1,505</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 and thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNTQvZnJhZzphMDk1MzRkYThmOGE0ODRlOGZmYzFmOWM4NWMwNTA2OC90YWJsZTo1NzMzYzI2YWQyM2Y0YzQ3OTZlYmU0MDU3MWY1YTE1My90YWJsZXJhbmdlOjU3MzNjMjZhZDIzZjRjNDc5NmViZTQwNTcxZjVhMTUzXzctMi0xLTEtMTYzMDg_2d45f311-bdee-46f6-b78b-fdcbe0aef51c">1,916</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the minimum lease payments, the Company is required to pay realty taxes and other occupancy costs in accordance with the terms of the lease agreements.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt">R&amp;D commitments</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ginkgo.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> On September 4, 2018, the Company announced an R&amp;D partnership with Ginkgo Bioworks Inc. (&#8220;Ginkgo&#8221;) to develop scalable and consistent production of <ix:nonFraction unitRef="cannabinoid" contextRef="i5a2c9058e29b437fa7075ccaeaad824a_I20180904" decimals="INF" format="ixt-sec:numwordsen" name="cron:LongTermPurchaseCommitmentNumberOfTargetedUnitsToDevelopProduction" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNTQvZnJhZzphMDk1MzRkYThmOGE0ODRlOGZmYzFmOWM4NWMwNTA2OC90ZXh0cmVnaW9uOmEwOTUzNGRhOGY4YTQ4NGU4ZmZjMWY5Yzg1YzA1MDY4XzYwNDczMTM5NjA4MzQ_a3ff487d-8559-4f13-8bfe-e7931ae76def">eight</ix:nonFraction> target cannabinoids, including THC, CBD and a variety of other lesser known and rarer cannabinoids. As part of this partnership, Cronos Group has agreed to issue up to <ix:nonFraction unitRef="shares" contextRef="i28a266ca99354d2f9478d733e4baca53_D20180904-20180904" decimals="INF" format="ixt:numdotdecimal" name="cron:LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableNumberOfShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNTQvZnJhZzphMDk1MzRkYThmOGE0ODRlOGZmYzFmOWM4NWMwNTA2OC90ZXh0cmVnaW9uOmEwOTUzNGRhOGY4YTQ4NGU4ZmZjMWY5Yzg1YzA1MDY4XzY5Nw_cfc13a40-85b6-4c7c-ad5d-1706a29ab6d8">14,674,903</ix:nonFraction> common shares of the Company (aggregate value of approximately $<ix:nonFraction unitRef="usd" contextRef="i53d9abb5a7964f51a7a58f6c6614d10b_I20180717" decimals="-3" format="ixt:numdotdecimal" name="cron:LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableValueAssigned" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNTQvZnJhZzphMDk1MzRkYThmOGE0ODRlOGZmYzFmOWM4NWMwNTA2OC90ZXh0cmVnaW9uOmEwOTUzNGRhOGY4YTQ4NGU4ZmZjMWY5Yzg1YzA1MDY4Xzc2Mw_4151ded4-b2f6-44b4-bdee-79159a647c39">100,000</ix:nonFraction> as of July 17, 2018 assuming all milestones are met, collectively the &#8220;Ginkgo Equity Milestones&#8221;) in tranches and $<ix:nonFraction unitRef="usd" contextRef="i28a266ca99354d2f9478d733e4baca53_D20180904-20180904" decimals="-3" format="ixt:numdotdecimal" name="cron:LongtermPurchaseCommitmentPaymentsSubjectToMilestones" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNTQvZnJhZzphMDk1MzRkYThmOGE0ODRlOGZmYzFmOWM4NWMwNTA2OC90ZXh0cmVnaW9uOmEwOTUzNGRhOGY4YTQ4NGU4ZmZjMWY5Yzg1YzA1MDY4Xzg4MA_0f2d66b0-2c72-4b33-936d-56ea27ed491c">22,000</ix:nonFraction> in cash subject to Ginkgo&#8217;s achievement of certain milestones and to fund certain R&amp;D expenses, including foundry access fees. </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Technion.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> On October 15, 2018, the Company entered into a sponsored research agreement with the Technion Research and Development Foundation of the Technion &#8211; Israel Institute of Technology (&#8220;Technion&#8221;). Research is focused on the use of cannabinoids and their role in regulating skin health and skin disorders. The Company has committed to $<ix:nonFraction unitRef="usd" contextRef="i102273991043430aac514ac6305e4708_D20181015-20181015" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermPurchaseCommitmentAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNTQvZnJhZzphMDk1MzRkYThmOGE0ODRlOGZmYzFmOWM4NWMwNTA2OC90ZXh0cmVnaW9uOmEwOTUzNGRhOGY4YTQ4NGU4ZmZjMWY5Yzg1YzA1MDY4XzEzNTk_478af82f-b990-465c-8655-2275bee85646">1,784</ix:nonFraction> of research funding over a period of <ix:nonNumeric contextRef="i102273991043430aac514ac6305e4708_D20181015-20181015" format="ixt-sec:durwordsen" name="us-gaap:LongtermPurchaseCommitmentPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNTQvZnJhZzphMDk1MzRkYThmOGE0ODRlOGZmYzFmOWM4NWMwNTA2OC90ZXh0cmVnaW9uOmEwOTUzNGRhOGY4YTQ4NGU4ZmZjMWY5Yzg1YzA1MDY4XzgyNDYzMzcyMjc5NDM_09544d55-2a39-4336-b1da-68631c998a58">three years</ix:nonNumeric>. An additional $<ix:nonFraction unitRef="usd" contextRef="i102273991043430aac514ac6305e4708_D20181015-20181015" decimals="-3" format="ixt:numdotdecimal" name="cron:LongtermPurchaseCommitmentPaymentsSubjectToMilestones" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNTQvZnJhZzphMDk1MzRkYThmOGE0ODRlOGZmYzFmOWM4NWMwNTA2OC90ZXh0cmVnaW9uOmEwOTUzNGRhOGY4YTQ4NGU4ZmZjMWY5Yzg1YzA1MDY4XzE0MjM_421df931-f9f1-4e9f-a108-d1c460c1bb57">4,900</ix:nonFraction> of cash payments will be paid to Technion upon the achievement of certain milestones.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.91pt">Altria consulting services</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 18, 2019, the Company entered into an agreement with a wholly owned subsidiary of Altria (which agreement was subsequently amended and restated to substitute Altria Pinnacle as a party thereto), to receive strategic advisory and project management services from Altria Pinnacle (the &#8220;Services Agreement&#8221;). Pursuant to the Services Agreement, the Company will pay Altria Pinnacle a monthly fee equal to the product of <ix:nonFraction unitRef="number" contextRef="i2db9aaa38acc4fbfb93e36f09f0da429_D20190218-20190218" decimals="INF" name="cron:LongtermPurchaseCommitmentMonthlyFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNTQvZnJhZzphMDk1MzRkYThmOGE0ODRlOGZmYzFmOWM4NWMwNTA2OC90ZXh0cmVnaW9uOmEwOTUzNGRhOGY4YTQ4NGU4ZmZjMWY5Yzg1YzA1MDY4XzE5OTU_f8f06df2-072d-4938-ab95-54fbebaffe5f">105</ix:nonFraction>% and the sum of: (i) all costs directly associated with the services incurred during the monthly period, and (ii) a reasonable and appropriate allocation of indirect costs incurred during the monthly period. The Company will also pay all third-party direct charges incurred during the monthly period in connection with the services, including any reasonable and documented costs, fees and expenses associated with obtaining any consent, license or permit. The Services Agreement will remain in effect until terminated by either party. See Note 25.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt">Use of publicity rights in brand development</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 23, 2019, the Company issued <ix:nonFraction unitRef="shares" contextRef="i2415de0a4c0c4ecf9ed6ea9afe096828_D20191223-20191223" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNTQvZnJhZzphMDk1MzRkYThmOGE0ODRlOGZmYzFmOWM4NWMwNTA2OC90ZXh0cmVnaW9uOmEwOTUzNGRhOGY4YTQ4NGU4ZmZjMWY5Yzg1YzA1MDY4XzEyMDk0NjI3OTEzNTY1_636d2dc4-d71e-4422-93a6-da83758cbf6f">856,017</ix:nonFraction> restricted common shares to Kristen Bell, an accredited investor, in a private placement (&#8220;Private Placement&#8221;) in reliance on Section 4(a)(2) of the Securities Act of 1933 in connection with the use of certain publicity rights in the brand development of Happy Dance&#8482;. One-third of such common shares vested on January 31, 2020 with the remaining shares vesting in two equal installments on June 23, 2021, and December 23, 2022. The issuance did not involve a public offering and was made without general solicitation or advertising. The total fair value of the consideration paid for the issuance of such common shares was approximately $<ix:nonFraction unitRef="usd" contextRef="i14db1abc7cd640c1ad2cba6b108454c3_I20191223" decimals="-3" format="ixt:numdotdecimal" name="cron:StockIssuedDuringPeriodNewIssuesFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNTQvZnJhZzphMDk1MzRkYThmOGE0ODRlOGZmYzFmOWM4NWMwNTA2OC90ZXh0cmVnaW9uOmEwOTUzNGRhOGY4YTQ4NGU4ZmZjMWY5Yzg1YzA1MDY4XzEyMDk0NjI3OTEzNTc0_44a7caf8-e5a0-4dd9-9580-99c1263455d6">6,000</ix:nonFraction>. The fair value of the shares was calculated using the <ix:nonNumeric contextRef="i2415de0a4c0c4ecf9ed6ea9afe096828_D20191223-20191223" format="ixt-sec:durday" name="cron:StockIssuedDuringPeriodNewIssuesWeightedAveragePricePeriod" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNTQvZnJhZzphMDk1MzRkYThmOGE0ODRlOGZmYzFmOWM4NWMwNTA2OC90ZXh0cmVnaW9uOmEwOTUzNGRhOGY4YTQ4NGU4ZmZjMWY5Yzg1YzA1MDY4XzEyMDk0NjI3OTEzNTgx_4936f7a8-eef2-41e2-9681-408828d34876">10</ix:nonNumeric>-day volume weighted average price per share of the Company&#8217;s common shares on Nasdaq.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional restricted common shares are issued when certain performance milestones are achieved:</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December 31, 2020, 2019, and 2018</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for gram and share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div></div><ix:continuation id="if48115a8c1a14967b9ea43b7e006bbac"><div style="margin-bottom:6pt;margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;First Performance Issuance: if, prior to December 23, 2022, the product line generates at least $<ix:nonFraction unitRef="usd" contextRef="i26f35784de464b1abb30c3a7a284c303_I20191223" decimals="INF" format="ixt:numdotdecimal" name="cron:SaleOfStockPerformanceMilestoneTriggeringEventMinimumRevenue" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNTQvZnJhZzphMDk1MzRkYThmOGE0ODRlOGZmYzFmOWM4NWMwNTA2OC90ZXh0cmVnaW9uOmEwOTUzNGRhOGY4YTQ4NGU4ZmZjMWY5Yzg1YzA1MDY4XzEyMDk0NjI3OTEzNTQ0_d95b3051-776e-4ea8-a197-5cd1e44bffe7">50,000</ix:nonFraction> in net revenue, additional common shares with an aggregate value of $<ix:nonFraction unitRef="usd" contextRef="i26f35784de464b1abb30c3a7a284c303_I20191223" decimals="INF" format="ixt:numdotdecimal" name="cron:SaleOfStockPerformanceMilestoneTriggeringEventSharesIssuedValue" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNTQvZnJhZzphMDk1MzRkYThmOGE0ODRlOGZmYzFmOWM4NWMwNTA2OC90ZXh0cmVnaW9uOmEwOTUzNGRhOGY4YTQ4NGU4ZmZjMWY5Yzg1YzA1MDY4XzI0MTg5MjU1ODMwNDQy_cc05101d-3ba8-45e6-b933-57f926302275">1,000</ix:nonFraction> will be issued.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;Second Performance Issuance: if, prior to December 23, 2022, the product line generates at least $<ix:nonFraction unitRef="usd" contextRef="i835de760acba433eab0f8e5932ed1a6f_I20191223" decimals="INF" format="ixt:numdotdecimal" name="cron:SaleOfStockPerformanceMilestoneTriggeringEventMinimumRevenue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNTQvZnJhZzphMDk1MzRkYThmOGE0ODRlOGZmYzFmOWM4NWMwNTA2OC90ZXh0cmVnaW9uOmEwOTUzNGRhOGY4YTQ4NGU4ZmZjMWY5Yzg1YzA1MDY4XzEyMDk0NjI3OTEzNTQ2_e7b04fa7-9370-455b-8134-5a6d51eca0a1">100,000</ix:nonFraction> in net revenue, additional common shares with an aggregate value of $<ix:nonFraction unitRef="usd" contextRef="i835de760acba433eab0f8e5932ed1a6f_I20191223" decimals="INF" format="ixt:numdotdecimal" name="cron:SaleOfStockPerformanceMilestoneTriggeringEventSharesIssuedValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNTQvZnJhZzphMDk1MzRkYThmOGE0ODRlOGZmYzFmOWM4NWMwNTA2OC90ZXh0cmVnaW9uOmEwOTUzNGRhOGY4YTQ4NGU4ZmZjMWY5Yzg1YzA1MDY4XzEyMDk0NjI3OTEzNTU3_58c33e09-742c-48d0-a313-33d1923c8039">1,000</ix:nonFraction> will be issued (together with the First Performance Issuance noted above).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of common shares that would be issued upon achieving the foregoing milestones will be determined based on the <ix:nonNumeric contextRef="i2415de0a4c0c4ecf9ed6ea9afe096828_D20191223-20191223" format="ixt-sec:durday" name="cron:StockIssuedDuringPeriodNewIssuesWeightedAveragePricePeriod" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNTQvZnJhZzphMDk1MzRkYThmOGE0ODRlOGZmYzFmOWM4NWMwNTA2OC90ZXh0cmVnaW9uOmEwOTUzNGRhOGY4YTQ4NGU4ZmZjMWY5Yzg1YzA1MDY4XzgyNDYzMzcyMjc5MDk_d7de0f76-825a-40c3-969f-07b80b725b99">10</ix:nonNumeric>-day volume weighted average price per share of the Company&#8217;s common shares on Nasdaq as of the trading day immediately prior to the date of filing with the Securities and Exchange Commission of the Company&#8217;s audited year-end financial statements for the first fiscal year during which such milestones are achieved.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i1ae9134e40e74e0aac958218112e53d4_157"></div><div style="margin-bottom:12pt;margin-top:16pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">21. <ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:LossContingencyDisclosures" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNTcvZnJhZzo0NGNmOGYzMjM3ZTI0NTdjYmFlMjhiM2JiNmY5Y2RmNi90ZXh0cmVnaW9uOjQ0Y2Y4ZjMyMzdlMjQ1N2NiYWUyOGIzYmI2ZjljZGY2XzI0MTg5MjU1ODI2MDM4_c7ddd0aa-e470-4915-8453-d99cf1b00559" continuedAt="ifda946058fcd4c77a0c0d959b9687ae0" escape="true">Contingencies </ix:nonNumeric></span></div><ix:continuation id="ifda946058fcd4c77a0c0d959b9687ae0" continuedAt="i1221d370801b43ae8d3c5c9e75b5e076"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to various legal proceedings in the ordinary course of its business and in connection with its marketing, distribution and sale of its products. Many of these legal proceedings are in the early stages of litigation and seek damages that are unspecified or not quantified. Although the outcome of these matters cannot be predicted with certainty, the Company does not believe these legal proceedings, individually or in the aggregate, will have a material adverse effect on its consolidated financial condition but could be material to its results of operations for any particular reporting period depending, in part, on its results for that period.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt">Class action complaints relating to restatement</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 11 and 12, 2020, <ix:nonFraction unitRef="shareholder" contextRef="i68ef62796fa04d8f960de4f0be2cd9a0_D20200311-20200312" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyNumberOfPlaintiffs" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNTcvZnJhZzo0NGNmOGYzMjM3ZTI0NTdjYmFlMjhiM2JiNmY5Y2RmNi90ZXh0cmVnaW9uOjQ0Y2Y4ZjMyMzdlMjQ1N2NiYWUyOGIzYmI2ZjljZGY2XzEzMTk0MTM5NTQyODMw_7a6661b6-3f60-4c6e-8258-bb3c2517cb82">two</ix:nonFraction> alleged shareholders of the Company separately filed <ix:nonFraction unitRef="complaint" contextRef="i68ef62796fa04d8f960de4f0be2cd9a0_D20200311-20200312" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyNewClaimsFiledNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNTcvZnJhZzo0NGNmOGYzMjM3ZTI0NTdjYmFlMjhiM2JiNmY5Y2RmNi90ZXh0cmVnaW9uOjQ0Y2Y4ZjMyMzdlMjQ1N2NiYWUyOGIzYmI2ZjljZGY2XzEzMTk0MTM5NTQyODQw_0b0a7bed-c2df-4839-ba0b-0f8c1eb96b99">two</ix:nonFraction> putative class action complaints in the U.S. District Court for the Eastern District of New York against the Company and its former Chief Executive Officer (now Executive Chairman) and Chief Financial Officer. The court has consolidated the cases, and the consolidated amended complaint alleges violations of Section 10(b) of the Exchange Act and Rule 10b-5 promulgated thereunder against all defendants, and Section 20(a) of the Exchange Act against the individual defendants. The consolidated amended complaint generally alleges that certain of the Company&#8217;s prior public statements about revenues and internal controls were incorrect based on the Company&#8217;s March 2, 2020 disclosure that the Audit Committee of the Board was conducting a review of the appropriateness of revenue recognized in connection with certain bulk resin purchases and sales of products through the wholesale channel. The consolidated amended complaint does not quantify a damage request. Defendants moved to dismiss on February 8, 2021.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On June 3, 2020, an alleged shareholder filed a Statement of Claim, as amended on August 12, 2020, in the Ontario Superior Court of Justice in Toronto, Ontario, Canada, seeking, among other things, an order certifying the action as a class action on behalf of a putative class of shareholders and damages of an unspecified amount. The Amended Statement of Claim names the Company, its former Chief Executive Officer (now Executive Chairman), Chief Financial Officer, former Chief Financial Officer and Chief Commercial Officer, and current and former members of the Board as defendants and alleges breaches of the Ontario Securities Act, oppression under the Ontario Business Corporations Act and common law misrepresentation. The Amended Statement of Claim generally alleges that certain of the Company&#8217;s prior public statements about revenues and internal controls were misrepresentations based on the Company&#8217;s March 2, 2020 disclosure that the Audit Committee of the Board was conducting a review of the appropriateness of revenue recognized in connection with certain bulk resin purchases and sales of products through the wholesale channel, and the Company&#8217;s subsequent restatement. The Amended Statement of Claim does not quantify a damage request. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt">Regulatory reviews relating to restatement</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has been responding to requests for information from various regulatory authorities relating to its previously disclosed restatement of its financial statements for the first three quarters of 2019. The Company is responding to all such requests for information and cooperating with all regulatory authorities. The Company cannot predict the outcome of any such regulatory review or investigation and it is possible that additional investigations or one or more formal proceedings may be commenced against the Company and its current and former officers and directors in connection with these regulatory reviews and investigations. </span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">106</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December 31, 2020, 2019, and 2018</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for gram and share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div></div><ix:continuation id="i1221d370801b43ae8d3c5c9e75b5e076"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.91pt">Litigation relating to marketing, distribution and sale of products</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 16, 2020, an alleged consumer filed a Statement of Claim on behalf of a class in the Court of Queen&#8217;s Bench of Alberta in Alberta, Canada, against the Company and other Canadian cannabis manufacturers and/or distributors. On December 4, 2020, a Third Amended Statement of Claim was filed, which added a second alleged consumer. The Third Amended Statement of Claim alleges claims related to the defendants&#8217; advertised content of cannabinoids in cannabis products for medicinal use on or after June 16, 2010 and cannabis products for adult use on or after October 17, 2018. The Third Amended Statement of Claim seeks a total of C$<ix:nonFraction unitRef="cad" contextRef="i06603bc91b504293b7f98adf78675927_D20200616-20200616" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LossContingencyDamagesSoughtValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNTcvZnJhZzo0NGNmOGYzMjM3ZTI0NTdjYmFlMjhiM2JiNmY5Y2RmNi90ZXh0cmVnaW9uOjQ0Y2Y4ZjMyMzdlMjQ1N2NiYWUyOGIzYmI2ZjljZGY2XzEzMTk0MTM5NTQyODU5_d490ebe7-5f52-4aac-993f-6404745c1d3e">500</ix:nonFraction>&#160;million for breach of contract, compensatory damages, and unjust enrichment or such other amount as may be proven in trial and C$<ix:nonFraction unitRef="cad" contextRef="i06603bc91b504293b7f98adf78675927_D20200616-20200616" decimals="-6" format="ixt:numdotdecimal" name="cron:LossContingencyPunitiveDamagesSoughtValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNTcvZnJhZzo0NGNmOGYzMjM3ZTI0NTdjYmFlMjhiM2JiNmY5Y2RmNi90ZXh0cmVnaW9uOjQ0Y2Y4ZjMyMzdlMjQ1N2NiYWUyOGIzYmI2ZjljZGY2XzEzMTk0MTM5NTQyODg0_9010596d-8487-4013-a346-46b364e3d7e7">5</ix:nonFraction>&#160;million in punitive damages against each defendant, including the Company. The Third Amended Statement of Claim also seeks interest and costs associated with the action. The Company has not responded to the Third Amended Statement of Claim. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A number of claims, including purported class actions, have been brought in the U.S. against companies engaged in the U.S. hemp business alleging, among other things, violations of state consumer protection, health and advertising laws. On April 8, 2020, a putative class action complaint was filed in the U.S. District Court for the Central District of California against Redwood, alleging violations of California&#8217;s Unfair Competition Law, False Advertising Law, Consumers Legal Remedies Act, and breaches of the California Commercial Code for breach of express warranties and implied warranty of merchantability with respect to Redwood&#8217;s marketing and sale of U.S. hemp products. The complaint did not quantify a damage request. On April 10, 2020, the class action complaint was dismissed for certain pleading deficiencies and the plaintiff was granted leave until April 24, 2020 to amend the complaint to establish federal subject matter jurisdiction. On April 28, 2020, the action was dismissed without prejudice for failure to prosecute and for failure to comply with a court order. As of the date of this Annual Report, the plaintiff has not refiled the complaint.</span></div></ix:continuation><div style="margin-bottom:6pt;text-align:justify"><span><br/></span></div><div id="i1ae9134e40e74e0aac958218112e53d4_169"></div><div style="margin-bottom:12pt;margin-top:16pt;padding-left:29.25pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">22. <ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:CashFlowSupplementalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjkvZnJhZzplY2EyYmEwY2ZlOWQ0NjJmOGQ5ZTNlMGYwZTc3NTJlYi90ZXh0cmVnaW9uOmVjYTJiYTBjZmU5ZDQ2MmY4ZDllM2UwZjBlNzc1MmViXzgw_280dd4cf-e4d8-48cb-b6fc-50c4a389bbbb" continuedAt="i5d05200167de42beb2240acc383ba3cb" escape="true">Supplementary Cash Flow Information</ix:nonNumeric></span></div><ix:continuation id="i5d05200167de42beb2240acc383ba3cb"><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:CashFlowOperatingCapitalTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjkvZnJhZzplY2EyYmEwY2ZlOWQ0NjJmOGQ5ZTNlMGYwZTc3NTJlYi90ZXh0cmVnaW9uOmVjYTJiYTBjZmU5ZDQ2MmY4ZDllM2UwZjBlNzc1MmViXzI0MTg5MjU1ODExMjEz_05679b1b-5594-428a-b181-f848a019b78d" escape="true"><div style="margin-bottom:12pt;margin-top:16pt;padding-left:29.25pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net changes in non-cash working capital items are as follow:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.763%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjkvZnJhZzplY2EyYmEwY2ZlOWQ0NjJmOGQ5ZTNlMGYwZTc3NTJlYi90YWJsZTo1ZmY0ZjJmMjExZjI0ZDY4YWQ5YmIyMjEyNGM3OTMzNS90YWJsZXJhbmdlOjVmZjRmMmYyMTFmMjRkNjhhZDliYjIyMTI0Yzc5MzM1XzItMS0xLTEtMA_20c1997f-4db9-42c1-8773-6d1c14bcfc20">4,724</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjkvZnJhZzplY2EyYmEwY2ZlOWQ0NjJmOGQ5ZTNlMGYwZTc3NTJlYi90YWJsZTo1ZmY0ZjJmMjExZjI0ZDY4YWQ5YmIyMjEyNGM3OTMzNS90YWJsZXJhbmdlOjVmZjRmMmYyMTFmMjRkNjhhZDliYjIyMTI0Yzc5MzM1XzItMy0xLTEtMA_c432fe2a-4299-446f-b513-0a8e4598f380">702</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjkvZnJhZzplY2EyYmEwY2ZlOWQ0NjJmOGQ5ZTNlMGYwZTc3NTJlYi90YWJsZTo1ZmY0ZjJmMjExZjI0ZDY4YWQ5YmIyMjEyNGM3OTMzNS90YWJsZXJhbmdlOjVmZjRmMmYyMTFmMjRkNjhhZDliYjIyMTI0Yzc5MzM1XzItNS0xLTEtMTk5OTk_fe00d3d2-0a80-4e13-bbe0-f9c481fdba49">2,569</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaids and other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="cron:IncreaseDecreasePrepaidExpensesAndOtherReceivables" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjkvZnJhZzplY2EyYmEwY2ZlOWQ0NjJmOGQ5ZTNlMGYwZTc3NTJlYi90YWJsZTo1ZmY0ZjJmMjExZjI0ZDY4YWQ5YmIyMjEyNGM3OTMzNS90YWJsZXJhbmdlOjVmZjRmMmYyMTFmMjRkNjhhZDliYjIyMTI0Yzc5MzM1XzMtMS0xLTEtMA_7bfc7dff-e1d5-49b5-a38f-52b4f23e0c2a">5,300</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="cron:IncreaseDecreasePrepaidExpensesAndOtherReceivables" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjkvZnJhZzplY2EyYmEwY2ZlOWQ0NjJmOGQ5ZTNlMGYwZTc3NTJlYi90YWJsZTo1ZmY0ZjJmMjExZjI0ZDY4YWQ5YmIyMjEyNGM3OTMzNS90YWJsZXJhbmdlOjVmZjRmMmYyMTFmMjRkNjhhZDliYjIyMTI0Yzc5MzM1XzMtMy0xLTEtMA_7d2cb2e1-0134-463c-aab1-910db87e24fc">10,509</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="cron:IncreaseDecreasePrepaidExpensesAndOtherReceivables" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjkvZnJhZzplY2EyYmEwY2ZlOWQ0NjJmOGQ5ZTNlMGYwZTc3NTJlYi90YWJsZTo1ZmY0ZjJmMjExZjI0ZDY4YWQ5YmIyMjEyNGM3OTMzNS90YWJsZXJhbmdlOjVmZjRmMmYyMTFmMjRkNjhhZDliYjIyMTI0Yzc5MzM1XzMtNS0xLTEtMTk5OTk_3c5b59b5-f942-4f13-beaf-6b9a13286ce3">2,382</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of loans receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:IncreaseDecreaseInFinanceReceivables" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjkvZnJhZzplY2EyYmEwY2ZlOWQ0NjJmOGQ5ZTNlMGYwZTc3NTJlYi90YWJsZTo1ZmY0ZjJmMjExZjI0ZDY4YWQ5YmIyMjEyNGM3OTMzNS90YWJsZXJhbmdlOjVmZjRmMmYyMTFmMjRkNjhhZDliYjIyMTI0Yzc5MzM1XzQtMS0xLTEtMA_e9186213-1ec1-488d-bf98-1f7a51a5eebc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInFinanceReceivables" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjkvZnJhZzplY2EyYmEwY2ZlOWQ0NjJmOGQ5ZTNlMGYwZTc3NTJlYi90YWJsZTo1ZmY0ZjJmMjExZjI0ZDY4YWQ5YmIyMjEyNGM3OTMzNS90YWJsZXJhbmdlOjVmZjRmMmYyMTFmMjRkNjhhZDliYjIyMTI0Yzc5MzM1XzQtMy0xLTEtMA_4f5bf691-55d1-445f-8312-5cababc74ff5">4,585</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:IncreaseDecreaseInFinanceReceivables" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjkvZnJhZzplY2EyYmEwY2ZlOWQ0NjJmOGQ5ZTNlMGYwZTc3NTJlYi90YWJsZTo1ZmY0ZjJmMjExZjI0ZDY4YWQ5YmIyMjEyNGM3OTMzNS90YWJsZXJhbmdlOjVmZjRmMmYyMTFmMjRkNjhhZDliYjIyMTI0Yzc5MzM1XzQtNS0xLTEtMTk5OTk_230efc12-73b4-4066-b020-591a793df566">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjkvZnJhZzplY2EyYmEwY2ZlOWQ0NjJmOGQ5ZTNlMGYwZTc3NTJlYi90YWJsZTo1ZmY0ZjJmMjExZjI0ZDY4YWQ5YmIyMjEyNGM3OTMzNS90YWJsZXJhbmdlOjVmZjRmMmYyMTFmMjRkNjhhZDliYjIyMTI0Yzc5MzM1XzUtMS0xLTEtMA_a8f4d11a-11f0-4e3a-89d5-67809bd1cbbe">28,094</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjkvZnJhZzplY2EyYmEwY2ZlOWQ0NjJmOGQ5ZTNlMGYwZTc3NTJlYi90YWJsZTo1ZmY0ZjJmMjExZjI0ZDY4YWQ5YmIyMjEyNGM3OTMzNS90YWJsZXJhbmdlOjVmZjRmMmYyMTFmMjRkNjhhZDliYjIyMTI0Yzc5MzM1XzUtMy0xLTEtMA_ac12abc6-f51c-4ffc-b083-572fb7ff2b1b">51,888</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjkvZnJhZzplY2EyYmEwY2ZlOWQ0NjJmOGQ5ZTNlMGYwZTc3NTJlYi90YWJsZTo1ZmY0ZjJmMjExZjI0ZDY4YWQ5YmIyMjEyNGM3OTMzNS90YWJsZXJhbmdlOjVmZjRmMmYyMTFmMjRkNjhhZDliYjIyMTI0Yzc5MzM1XzUtNS0xLTEtMTk5OTk_35ff5870-ac96-4115-a820-84d88170ec04">4,092</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjkvZnJhZzplY2EyYmEwY2ZlOWQ0NjJmOGQ5ZTNlMGYwZTc3NTJlYi90YWJsZTo1ZmY0ZjJmMjExZjI0ZDY4YWQ5YmIyMjEyNGM3OTMzNS90YWJsZXJhbmdlOjVmZjRmMmYyMTFmMjRkNjhhZDliYjIyMTI0Yzc5MzM1XzYtMS0xLTEtMA_3d396ee6-9f9c-47e7-951f-98378152a6f3">4,175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjkvZnJhZzplY2EyYmEwY2ZlOWQ0NjJmOGQ5ZTNlMGYwZTc3NTJlYi90YWJsZTo1ZmY0ZjJmMjExZjI0ZDY4YWQ5YmIyMjEyNGM3OTMzNS90YWJsZXJhbmdlOjVmZjRmMmYyMTFmMjRkNjhhZDliYjIyMTI0Yzc5MzM1XzYtMy0xLTEtMA_09b957ff-7da6-4760-8df7-d6e60f3f1127">13,476</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjkvZnJhZzplY2EyYmEwY2ZlOWQ0NjJmOGQ5ZTNlMGYwZTc3NTJlYi90YWJsZTo1ZmY0ZjJmMjExZjI0ZDY4YWQ5YmIyMjEyNGM3OTMzNS90YWJsZXJhbmdlOjVmZjRmMmYyMTFmMjRkNjhhZDliYjIyMTI0Yzc5MzM1XzYtNS0xLTEtMTk5OTk_aa0d2f37-6eac-4d33-a43f-acb8e0ec2808">12,705</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOperatingCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjkvZnJhZzplY2EyYmEwY2ZlOWQ0NjJmOGQ5ZTNlMGYwZTc3NTJlYi90YWJsZTo1ZmY0ZjJmMjExZjI0ZDY4YWQ5YmIyMjEyNGM3OTMzNS90YWJsZXJhbmdlOjVmZjRmMmYyMTFmMjRkNjhhZDliYjIyMTI0Yzc5MzM1XzgtMS0xLTEtMA_f4a6ce64-951a-4efe-a4e0-e66f2e935aed">33,943</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOperatingCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjkvZnJhZzplY2EyYmEwY2ZlOWQ0NjJmOGQ5ZTNlMGYwZTc3NTJlYi90YWJsZTo1ZmY0ZjJmMjExZjI0ZDY4YWQ5YmIyMjEyNGM3OTMzNS90YWJsZXJhbmdlOjVmZjRmMmYyMTFmMjRkNjhhZDliYjIyMTI0Yzc5MzM1XzgtMy0xLTEtMA_ea980048-d959-4084-8efb-e05b74c7a5d4">54,208</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOperatingCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjkvZnJhZzplY2EyYmEwY2ZlOWQ0NjJmOGQ5ZTNlMGYwZTc3NTJlYi90YWJsZTo1ZmY0ZjJmMjExZjI0ZDY4YWQ5YmIyMjEyNGM3OTMzNS90YWJsZXJhbmdlOjVmZjRmMmYyMTFmMjRkNjhhZDliYjIyMTI0Yzc5MzM1XzktNS0xLTEtMTk5OTk_71b56b99-9ad5-42f4-888f-51d436926b6d">3,662</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="i1ae9134e40e74e0aac958218112e53d4_172"></div><div style="margin-bottom:12pt;margin-top:16pt;padding-left:29.25pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">23. <ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:ConcentrationRiskDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzIvZnJhZzo0ZGFiMjc4ODc2N2U0ZTRmYTlmMjRlNjE4MGNkZjk0Yi90ZXh0cmVnaW9uOjRkYWIyNzg4NzY3ZTRlNGZhOWYyNGU2MTgwY2RmOTRiXzYyMDU_25c6b4ce-ed53-4ef9-b985-d7558795773a" continuedAt="icf19de5adc8b471e9c3a1e55ee075d8a" escape="true">Financial Instruments </ix:nonNumeric></span></div><ix:continuation id="icf19de5adc8b471e9c3a1e55ee075d8a" continuedAt="i7dcb105809094f379a73dcd39d6f94f4"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s activities expose it to a variety of financial risks, including credit risk, liquidity risk, and market risk (including interest rate risk) and foreign currency risk.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt">Credit risk</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Credit risk is the risk of financial loss to the Company if a customer or counterparty to a financial instrument fails to meet its contractual obligations. The Company is exposed to credit risk from its operating activities, primarily accounts receivable and other receivables, and its investing activities, including cash held with banks and financial institutions, short term investments, loan receivable, and advances to joint ventures. The Company&#8217;s maximum exposure to this risk is equal to the carrying amount of these financial assets, which amounted to $<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzIvZnJhZzo0ZGFiMjc4ODc2N2U0ZTRmYTlmMjRlNjE4MGNkZjk0Yi90ZXh0cmVnaW9uOjRkYWIyNzg4NzY3ZTRlNGZhOWYyNGU2MTgwY2RmOTRiXzEyNjQ0MzgzNzI5NDE5_3319ee80-2df7-4c3e-b7cd-7c38edcacdb7">1,403,491</ix:nonFraction> as of December&#160;31, 2020 (December&#160;31, 2019 &#8211; $<ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzIvZnJhZzo0ZGFiMjc4ODc2N2U0ZTRmYTlmMjRlNjE4MGNkZjk0Yi90ZXh0cmVnaW9uOjRkYWIyNzg4NzY3ZTRlNGZhOWYyNGU2MTgwY2RmOTRiXzEyNjQ0MzgzNzI5NDE1_bec80ad5-9221-4f1c-a6fd-a30600f4b15e">1,586,978</ix:nonFraction>).</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">107</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December 31, 2020, 2019, and 2018</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for gram and share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div></div><ix:continuation id="i7dcb105809094f379a73dcd39d6f94f4" continuedAt="i04d51182d49740f9bfd0f084d53a7d0e"><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:8.57pt">Accounts receivable</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had accounts receivable of $<ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzIvZnJhZzo0ZGFiMjc4ODc2N2U0ZTRmYTlmMjRlNjE4MGNkZjk0Yi90ZXh0cmVnaW9uOjRkYWIyNzg4NzY3ZTRlNGZhOWYyNGU2MTgwY2RmOTRiXzEyMDk0NjI3OTIyMTg5_b26d3c02-aa0b-42db-858e-e2e74446e9c2">8,928</ix:nonFraction> as of December&#160;31, 2020 (December&#160;31, 2019 &#8211; $<ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzIvZnJhZzo0ZGFiMjc4ODc2N2U0ZTRmYTlmMjRlNjE4MGNkZjk0Yi90ZXh0cmVnaW9uOjRkYWIyNzg4NzY3ZTRlNGZhOWYyNGU2MTgwY2RmOTRiXzEyMDk0NjI3OTIyMTgz_0ed7fa1f-76e0-4254-b2b8-15f700c7313f">4,638</ix:nonFraction>). An impairment analysis is performed at each reporting date using a provision matrix to measure expected credit losses. The provision rates are based on the days past due for groupings of various customer segments with similar loss patterns. The calculation reflects the probability-weighted outcome, the time value of money and reasonable and supportable information that is available at the reporting date about past events, current conditions and forecasts of future economic conditions. Accounts receivable are written off when there is no reasonable expectation of recovery. Indicators that there is no reasonable expectation of recovery include, amongst others, the failure of a debtor to engage in a repayment plan, and a failure to make contractual payments for a period of greater than <ix:nonNumeric contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" format="ixt-sec:durday" name="us-gaap:AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzIvZnJhZzo0ZGFiMjc4ODc2N2U0ZTRmYTlmMjRlNjE4MGNkZjk0Yi90ZXh0cmVnaW9uOjRkYWIyNzg4NzY3ZTRlNGZhOWYyNGU2MTgwY2RmOTRiXzE0MDQ_b333961b-ebb9-4611-a0d5-3fa47088272a">120</ix:nonNumeric> days past due. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December&#160;31, 2020, the Company recognized an approximate CECL of $<ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzIvZnJhZzo0ZGFiMjc4ODc2N2U0ZTRmYTlmMjRlNjE4MGNkZjk0Yi90ZXh0cmVnaW9uOjRkYWIyNzg4NzY3ZTRlNGZhOWYyNGU2MTgwY2RmOTRiXzEyNjQ0MzgzNzI5NDIz_c96199ec-8517-4bf7-b2dc-8cea460978b6">74</ix:nonFraction> (December&#160;31, 2019 &#8211; $<ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzIvZnJhZzo0ZGFiMjc4ODc2N2U0ZTRmYTlmMjRlNjE4MGNkZjk0Yi90ZXh0cmVnaW9uOjRkYWIyNzg4NzY3ZTRlNGZhOWYyNGU2MTgwY2RmOTRiXzEyNjQ0MzgzNzI5NDI3_92f18bca-4162-4063-9d6e-6bb0d12a5e3d">136</ix:nonFraction>). The Company has assessed that there is a concentration of credit risk as <ix:nonFraction unitRef="number" contextRef="i2d2f72aaaaf343468a4dc9aae56df2af_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzIvZnJhZzo0ZGFiMjc4ODc2N2U0ZTRmYTlmMjRlNjE4MGNkZjk0Yi90ZXh0cmVnaW9uOjRkYWIyNzg4NzY3ZTRlNGZhOWYyNGU2MTgwY2RmOTRiXzEyNjQ0MzgzNzI5NDMx_0f0cfd23-7321-4340-ba07-7bf839583379">78</ix:nonFraction>% of the Company&#8217;s accounts receivable were due from four customers as of December&#160;31, 2020 (December&#160;31, 2019 &#8211; <ix:nonFraction unitRef="number" contextRef="ie3ab5c08b2f448ec82c845f60eca7697_D20190101-20191231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzIvZnJhZzo0ZGFiMjc4ODc2N2U0ZTRmYTlmMjRlNjE4MGNkZjk0Yi90ZXh0cmVnaW9uOjRkYWIyNzg4NzY3ZTRlNGZhOWYyNGU2MTgwY2RmOTRiXzEyNjQ0MzgzNzI5NDQ4_295900ba-0890-4b61-8edf-00cdedeeeb4d">56</ix:nonFraction>% due from two customers) with an established credit history with the Company.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:5.8pt"> Cash and cash equivalents, short-term investments, and other receivables</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company held cash and cash equivalents of $<ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzIvZnJhZzo0ZGFiMjc4ODc2N2U0ZTRmYTlmMjRlNjE4MGNkZjk0Yi90ZXh0cmVnaW9uOjRkYWIyNzg4NzY3ZTRlNGZhOWYyNGU2MTgwY2RmOTRiXzEyNjQ0MzgzNzI5NDYw_6ac97f4c-790e-488f-a39c-44592337de40">1,078,023</ix:nonFraction> at December&#160;31, 2020 (December&#160;31, 2019 &#8211; $<ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzIvZnJhZzo0ZGFiMjc4ODc2N2U0ZTRmYTlmMjRlNjE4MGNkZjk0Yi90ZXh0cmVnaW9uOjRkYWIyNzg4NzY3ZTRlNGZhOWYyNGU2MTgwY2RmOTRiXzEyNjQ0MzgzNzI5NDU2_ec469079-a391-4a3d-b486-19361129de96">1,199,693</ix:nonFraction>). The short-term investments and related interest receivable of $<ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzIvZnJhZzo0ZGFiMjc4ODc2N2U0ZTRmYTlmMjRlNjE4MGNkZjk0Yi90ZXh0cmVnaW9uOjRkYWIyNzg4NzY3ZTRlNGZhOWYyNGU2MTgwY2RmOTRiXzEyNjQ0MzgzNzI5NDY0_543d8fcd-9a09-4233-926d-eae2fdb27683">211,766</ix:nonFraction> (December&#160;31, 2019 &#8211; $<ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzIvZnJhZzo0ZGFiMjc4ODc2N2U0ZTRmYTlmMjRlNjE4MGNkZjk0Yi90ZXh0cmVnaW9uOjRkYWIyNzg4NzY3ZTRlNGZhOWYyNGU2MTgwY2RmOTRiXzEyNjQ0MzgzNzI5NDY4_49eafec9-586a-4b12-bc69-5e3ddb5b5afa">306,347</ix:nonFraction>) represents short-term investments with a maturity of less than a year and accrued interest as of December&#160;31, 2020. The cash and cash equivalents and short-term investments, including guaranteed investment certificates and bankers&#8217; acceptances, are held with central banks and financial institutions that are highly rated. In addition to interest receivable, other receivables include sales taxes receivable from the government. As such, the Company has assessed an insignificant loss allowance on these financial instruments. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:3.03pt">Advances to joint ventures</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had advances to joint ventures of $<ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" name="us-gaap:AdvancesToAffiliate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzIvZnJhZzo0ZGFiMjc4ODc2N2U0ZTRmYTlmMjRlNjE4MGNkZjk0Yi90ZXh0cmVnaW9uOjRkYWIyNzg4NzY3ZTRlNGZhOWYyNGU2MTgwY2RmOTRiXzEyNjQ0MzgzNzM2MTA5_bd85d597-d34d-42d5-a485-8f4211a3380e">467</ix:nonFraction> as of December&#160;31, 2020 (December&#160;31, 2019 &#8211; $<ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdvancesToAffiliate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzIvZnJhZzo0ZGFiMjc4ODc2N2U0ZTRmYTlmMjRlNjE4MGNkZjk0Yi90ZXh0cmVnaW9uOjRkYWIyNzg4NzY3ZTRlNGZhOWYyNGU2MTgwY2RmOTRiXzEyNjQ0MzgzNzM2MTAz_c6f396b6-eb6c-4286-a547-703b993fae5d">19,437</ix:nonFraction>). The Company has assessed the credit risk of advances to joint ventures based on the financial position of the borrowers, and the regulatory and economic environment of the borrowers. The expected loss rates are based on the historical credit losses experienced. Where appropriate, the historical loss rates are adjusted to reflect current and forward-looking information. The Company has assessed the loss allowance on these advances as of December&#160;31, 2020 to be $<ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="cron:AdvancesToAffiliateAllowanceForCreditLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzIvZnJhZzo0ZGFiMjc4ODc2N2U0ZTRmYTlmMjRlNjE4MGNkZjk0Yi90ZXh0cmVnaW9uOjRkYWIyNzg4NzY3ZTRlNGZhOWYyNGU2MTgwY2RmOTRiXzEyNjQ0MzgzNzI4MDA5_d8f45e1a-360d-4063-bbfe-82a5ca7658a8">nil</ix:nonFraction> (December&#160;31, 2019 &#8211; $<ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="cron:AdvancesToAffiliateAllowanceForCreditLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzIvZnJhZzo0ZGFiMjc4ODc2N2U0ZTRmYTlmMjRlNjE4MGNkZjk0Yi90ZXh0cmVnaW9uOjRkYWIyNzg4NzY3ZTRlNGZhOWYyNGU2MTgwY2RmOTRiXzEyNjQ0MzgzNzI4MDAy_f177de90-874c-4625-a971-3c7567ddec2e">nil</ix:nonFraction>).</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt">Liquidity risk</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Liquidity risk is the risk that the Company will not be able to meet its financial obligations as they become due and arises principally from the Company&#8217;s accounts payable and other liabilities. The Company had accounts payable of $<ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzIvZnJhZzo0ZGFiMjc4ODc2N2U0ZTRmYTlmMjRlNjE4MGNkZjk0Yi90ZXh0cmVnaW9uOjRkYWIyNzg4NzY3ZTRlNGZhOWYyNGU2MTgwY2RmOTRiXzEyNjQ0MzgzNzM2MjM1_0268b951-6e93-4c0c-8833-2e1695ea9c08">12,107</ix:nonFraction> as of December&#160;31, 2020 (December&#160;31, 2019 &#8211; $<ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzIvZnJhZzo0ZGFiMjc4ODc2N2U0ZTRmYTlmMjRlNjE4MGNkZjk0Yi90ZXh0cmVnaW9uOjRkYWIyNzg4NzY3ZTRlNGZhOWYyNGU2MTgwY2RmOTRiXzEyNjQ0MzgzNzM2MjI4_b815b7ed-3817-4398-a463-85b23c5dbc68">9,194</ix:nonFraction>). The Company&#8217;s policy is to review liquidity resources and ensure that sufficient funds are available to meet financial obligations as they become due. Further, the Company&#8217;s management is responsible for ensuring funds exist and are readily accessible to support business opportunities as they arise. The Company&#8217;s funding is primarily provided in the form of capital raised through the issuance of common shares and warrants. As of December&#160;31, 2020, <ix:nonFraction unitRef="number" contextRef="i95dee7cb129845bf8d27987a1caa0bb3_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzIvZnJhZzo0ZGFiMjc4ODc2N2U0ZTRmYTlmMjRlNjE4MGNkZjk0Yi90ZXh0cmVnaW9uOjRkYWIyNzg4NzY3ZTRlNGZhOWYyNGU2MTgwY2RmOTRiXzEyNjQ0MzgzNzI4MDEz_d122bcaa-de16-4335-9f4a-208e9c436493">64</ix:nonFraction>% of the Company&#8217;s payables were due to four vendors (December&#160;31, 2019 &#8211; <ix:nonFraction unitRef="number" contextRef="i79cb5a37ccf24867aa069dc4b34e18f3_D20190101-20191231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzIvZnJhZzo0ZGFiMjc4ODc2N2U0ZTRmYTlmMjRlNjE4MGNkZjk0Yi90ZXh0cmVnaW9uOjRkYWIyNzg4NzY3ZTRlNGZhOWYyNGU2MTgwY2RmOTRiXzEwOTk1MTE2MzQxNjE_efdc819f-082c-402f-933d-15fb344fbe73">42</ix:nonFraction>% due to three vendors).</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.91pt">Market risk</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Market risk is the risk that the fair value of, or future cash flows from, the Company&#8217;s financial instruments will significantly fluctuate due to changes in market prices. The value of financial instruments can be affected by changes in interest rates, market and economic conditions, and equity and commodity prices. The Company is exposed to market risk in divesting its investments, such that, unfavorable market conditions could result in dispositions of investments at less than their carrying values. Further, the revaluation of securities classified as fair value through net income could result in significant write-downs of the Company&#8217;s investments, which would have an adverse impact on the Company&#8217;s financial position.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manages risk by having a portfolio of securities from multiple issuers, such that the Company was not materially exposed to any one issuer. </span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">108</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December 31, 2020, 2019, and 2018</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for gram and share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div></div><ix:continuation id="i04d51182d49740f9bfd0f084d53a7d0e"><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt">Interest rate risk</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest rate risk is the risk that the value or yield of fixed-income investments may decline if interest rates change. Fluctuations in interest rates may impact the level of income and expense recorded on the cash equivalents and short-term investments, and the market value of all interest-earning assets, other than those which possess a short term to maturity. During the year ended December&#160;31, 2020, the Company had net interest income of $<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzIvZnJhZzo0ZGFiMjc4ODc2N2U0ZTRmYTlmMjRlNjE4MGNkZjk0Yi90ZXh0cmVnaW9uOjRkYWIyNzg4NzY3ZTRlNGZhOWYyNGU2MTgwY2RmOTRiXzEyNjQ0MzgzNzI4NTg2_2722946d-08c6-4551-b057-e0a5f70d7d65">18,415</ix:nonFraction> (December&#160;31, 2019 &#8211; $<ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzIvZnJhZzo0ZGFiMjc4ODc2N2U0ZTRmYTlmMjRlNjE4MGNkZjk0Yi90ZXh0cmVnaW9uOjRkYWIyNzg4NzY3ZTRlNGZhOWYyNGU2MTgwY2RmOTRiXzEyNjQ0MzgzNzI4NTk3_2067604f-901d-4fab-8a05-077efd4f7570">27,969</ix:nonFraction>). A 10% change in the interest rate in effect on December&#160;31, 2020 and December&#160;31, 2019, would not have a material effect on (i) fair value of the cash equivalents and short-term investments as the majority of the portfolio has a maturity date of three months or less, or (ii) interest income. Management continues to monitor external interest rates and revise the Company&#8217;s investment strategy as a result.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2020, the Company&#8217;s average variable interest rate fell <ix:nonFraction unitRef="number" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="4" name="cron:SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncomePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzIvZnJhZzo0ZGFiMjc4ODc2N2U0ZTRmYTlmMjRlNjE4MGNkZjk0Yi90ZXh0cmVnaW9uOjRkYWIyNzg4NzY3ZTRlNGZhOWYyNGU2MTgwY2RmOTRiXzEyNjQ0MzgzNzI4Nzg2_75e96db6-b2f2-4b8e-970c-7c9c8dfcfb14">1.49</ix:nonFraction>%, which resulted in a decrease of net interest income of $<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzIvZnJhZzo0ZGFiMjc4ODc2N2U0ZTRmYTlmMjRlNjE4MGNkZjk0Yi90ZXh0cmVnaW9uOjRkYWIyNzg4NzY3ZTRlNGZhOWYyNGU2MTgwY2RmOTRiXzEyNjQ0MzgzNzI5MDQ2_9f71112f-db4f-4e5b-bf9f-7d17eb980288">15,671</ix:nonFraction> in the period. During the year ended December&#160;31, 2019, the Company&#8217;s average variable interest rate did not materially change.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(e)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.91pt">Currency rate risk </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Currency rate risk is the risk that the fair value of, or future cash flows from, the Company&#8217;s financial instruments will significantly fluctuate due to changes in foreign exchange rates. The Company is exposed to this risk on advances to joint ventures denominated in A$ and C$. The Company is further exposed to this risk through subsidiaries operating in Israel and the U.S. as the Company&#8217;s functional currency is in Canadian dollars. The Company does not currently use foreign exchange contracts to hedge its exposure to currency rate risk. As such, the Company&#8217;s financial position and financial results may be adversely affected by the unfavorable fluctuations in currency exchange rates. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the Company had foreign currency gain (loss) on translation of $<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzIvZnJhZzo0ZGFiMjc4ODc2N2U0ZTRmYTlmMjRlNjE4MGNkZjk0Yi90ZXh0cmVnaW9uOjRkYWIyNzg4NzY3ZTRlNGZhOWYyNGU2MTgwY2RmOTRiXzEyNjQ0MzgzNzI5MzUz_6bc5e35a-9108-456f-89c2-92215f70dbc8">14,951</ix:nonFraction> (December&#160;31, 2019 &#8211; $<ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzIvZnJhZzo0ZGFiMjc4ODc2N2U0ZTRmYTlmMjRlNjE4MGNkZjk0Yi90ZXh0cmVnaW9uOjRkYWIyNzg4NzY3ZTRlNGZhOWYyNGU2MTgwY2RmOTRiXzYwMzY_9b99fa8d-a55f-4891-8d27-5e226b35af00">37,687</ix:nonFraction>). A 10% change in the exchange rates for the foreign currencies would affect the carrying value of net assets by approximately $<ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="cron:SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzIvZnJhZzo0ZGFiMjc4ODc2N2U0ZTRmYTlmMjRlNjE4MGNkZjk0Yi90ZXh0cmVnaW9uOjRkYWIyNzg4NzY3ZTRlNGZhOWYyNGU2MTgwY2RmOTRiXzEyNjQ0MzgzNzI5NDcy_da72aec9-196e-427e-b97b-cec0206dac00">170,817</ix:nonFraction> as of December&#160;31, 2020 (December&#160;31, 2019 &#8211; $<ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="cron:SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzIvZnJhZzo0ZGFiMjc4ODc2N2U0ZTRmYTlmMjRlNjE4MGNkZjk0Yi90ZXh0cmVnaW9uOjRkYWIyNzg4NzY3ZTRlNGZhOWYyNGU2MTgwY2RmOTRiXzEyNjQ0MzgzNzI5MzU4_f67fe027-e8a8-447f-aa4f-fe3eff9a05ca">174,902</ix:nonFraction>).</span></div></ix:continuation><div style="margin-bottom:12pt;text-align:justify"><span><br/></span></div><div id="i1ae9134e40e74e0aac958218112e53d4_178"></div><div style="margin-bottom:12pt;margin-top:16pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">24. <ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzgvZnJhZzo2MjM2ODZjYzdkZmQ0ZGQ1ODg0YzE0MTQ0MzlmYWFiNi90ZXh0cmVnaW9uOjYyMzY4NmNjN2RmZDRkZDU4ODRjMTQxNDQzOWZhYWI2XzE2MzM_826f59aa-2f30-4ca9-9185-ec5c44f2be92" continuedAt="idc328218e597473780f2aa9d6a4cdef4" escape="true">Fair Value Measurement</ix:nonNumeric></span></div><ix:continuation id="idc328218e597473780f2aa9d6a4cdef4"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company complies with ASC 820 Fair Value Measurements, for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually. In general, fair values are determined by:</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities. </span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 inputs utilize data points that are observable such as quoted prices, interest rates and yield curves. </span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 inputs are unobservable data points for the asset or liability, and includes situations where there is little, if any, market activity for the asset or liability.</span></div><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzgvZnJhZzo2MjM2ODZjYzdkZmQ0ZGQ1ODg0YzE0MTQ0MzlmYWFiNi90ZXh0cmVnaW9uOjYyMzY4NmNjN2RmZDRkZDU4ODRjMTQxNDQzOWZhYWI2XzI0MTg5MjU1ODE4MjMx_d1ee3859-9d1e-4401-9672-4ab15ff105d1" escape="true"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present information about the Company&#8217;s assets that are measured at fair value on a recurring basis as of December&#160;31, 2020 and December&#160;31, 2019 and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.194%"><tr><td style="width:1.0%"></td><td style="width:41.332%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.054%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.638%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.054%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.054%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.058%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84abf62189854b468a350b1f65034a6b_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzgvZnJhZzo2MjM2ODZjYzdkZmQ0ZGQ1ODg0YzE0MTQ0MzlmYWFiNi90YWJsZTphMjViN2ExZTkzMmQ0NzczYjVmMDEwNDc3MzYwZmYyZS90YWJsZXJhbmdlOmEyNWI3YTFlOTMyZDQ3NzNiNWYwMTA0NzczNjBmZjJlXzItNi0xLTEtNTcxOA_7de7ec9c-2f39-45e1-a085-45d8550c97f4">1,078,023</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie67dbd083d6c4c81b9b3a7623bbc8983_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzgvZnJhZzo2MjM2ODZjYzdkZmQ0ZGQ1ODg0YzE0MTQ0MzlmYWFiNi90YWJsZTphMjViN2ExZTkzMmQ0NzczYjVmMDEwNDc3MzYwZmYyZS90YWJsZXJhbmdlOmEyNWI3YTFlOTMyZDQ3NzNiNWYwMTA0NzczNjBmZjJlXzItOC0xLTEtNTcxOA_c203cfde-4978-467b-b4d5-f0e5cc2f9a3d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia65c0721a7bc4c228d88b512209d7211_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzgvZnJhZzo2MjM2ODZjYzdkZmQ0ZGQ1ODg0YzE0MTQ0MzlmYWFiNi90YWJsZTphMjViN2ExZTkzMmQ0NzczYjVmMDEwNDc3MzYwZmYyZS90YWJsZXJhbmdlOmEyNWI3YTFlOTMyZDQ3NzNiNWYwMTA0NzczNjBmZjJlXzItNS0xLTEtNTc2OA_40d0f65c-2bf4-4868-91dd-d00b0ce9dddb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea50dbe7c8794cc8aa0b34bfe4bb4eba_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzgvZnJhZzo2MjM2ODZjYzdkZmQ0ZGQ1ODg0YzE0MTQ0MzlmYWFiNi90YWJsZTphMjViN2ExZTkzMmQ0NzczYjVmMDEwNDc3MzYwZmYyZS90YWJsZXJhbmdlOmEyNWI3YTFlOTMyZDQ3NzNiNWYwMTA0NzczNjBmZjJlXzItNy0xLTEtNTc2OA_4021d96a-e67d-4d4d-993a-0b950b148665">1,078,023</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84abf62189854b468a350b1f65034a6b_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzgvZnJhZzo2MjM2ODZjYzdkZmQ0ZGQ1ODg0YzE0MTQ0MzlmYWFiNi90YWJsZTphMjViN2ExZTkzMmQ0NzczYjVmMDEwNDc3MzYwZmYyZS90YWJsZXJhbmdlOmEyNWI3YTFlOTMyZDQ3NzNiNWYwMTA0NzczNjBmZjJlXzMtNi0xLTEtNTcxOA_f3a92576-f21b-4767-8e52-79d01168736f">211,766</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie67dbd083d6c4c81b9b3a7623bbc8983_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzgvZnJhZzo2MjM2ODZjYzdkZmQ0ZGQ1ODg0YzE0MTQ0MzlmYWFiNi90YWJsZTphMjViN2ExZTkzMmQ0NzczYjVmMDEwNDc3MzYwZmYyZS90YWJsZXJhbmdlOmEyNWI3YTFlOTMyZDQ3NzNiNWYwMTA0NzczNjBmZjJlXzMtOC0xLTEtNTcxOA_085045f4-8f36-42bc-b71a-cd5aa2c62972">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia65c0721a7bc4c228d88b512209d7211_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzgvZnJhZzo2MjM2ODZjYzdkZmQ0ZGQ1ODg0YzE0MTQ0MzlmYWFiNi90YWJsZTphMjViN2ExZTkzMmQ0NzczYjVmMDEwNDc3MzYwZmYyZS90YWJsZXJhbmdlOmEyNWI3YTFlOTMyZDQ3NzNiNWYwMTA0NzczNjBmZjJlXzMtNS0xLTEtNTc2OA_959f7275-635f-447c-bf4e-cbe0da08cfb2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea50dbe7c8794cc8aa0b34bfe4bb4eba_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzgvZnJhZzo2MjM2ODZjYzdkZmQ0ZGQ1ODg0YzE0MTQ0MzlmYWFiNi90YWJsZTphMjViN2ExZTkzMmQ0NzczYjVmMDEwNDc3MzYwZmYyZS90YWJsZXJhbmdlOmEyNWI3YTFlOTMyZDQ3NzNiNWYwMTA0NzczNjBmZjJlXzMtNy0xLTEtNTc2OA_4047fb2f-4dd3-499c-a51c-88b6ad0888e1">211,766</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84abf62189854b468a350b1f65034a6b_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzgvZnJhZzo2MjM2ODZjYzdkZmQ0ZGQ1ODg0YzE0MTQ0MzlmYWFiNi90YWJsZTphMjViN2ExZTkzMmQ0NzczYjVmMDEwNDc3MzYwZmYyZS90YWJsZXJhbmdlOmEyNWI3YTFlOTMyZDQ3NzNiNWYwMTA0NzczNjBmZjJlXzYtNi0xLTEtNTcxOA_9783e5dd-cb74-41c4-97ca-e0ddc4593d79">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie67dbd083d6c4c81b9b3a7623bbc8983_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzgvZnJhZzo2MjM2ODZjYzdkZmQ0ZGQ1ODg0YzE0MTQ0MzlmYWFiNi90YWJsZTphMjViN2ExZTkzMmQ0NzczYjVmMDEwNDc3MzYwZmYyZS90YWJsZXJhbmdlOmEyNWI3YTFlOTMyZDQ3NzNiNWYwMTA0NzczNjBmZjJlXzYtOC0xLTEtNTcxOA_8aed3130-60fc-4420-bb00-c95437afd91a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia65c0721a7bc4c228d88b512209d7211_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzgvZnJhZzo2MjM2ODZjYzdkZmQ0ZGQ1ODg0YzE0MTQ0MzlmYWFiNi90YWJsZTphMjViN2ExZTkzMmQ0NzczYjVmMDEwNDc3MzYwZmYyZS90YWJsZXJhbmdlOmEyNWI3YTFlOTMyZDQ3NzNiNWYwMTA0NzczNjBmZjJlXzYtNS0xLTEtNTc2OA_a7bd51ea-3c13-4a22-8995-87e10e1fdc1b">163,410</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea50dbe7c8794cc8aa0b34bfe4bb4eba_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzgvZnJhZzo2MjM2ODZjYzdkZmQ0ZGQ1ODg0YzE0MTQ0MzlmYWFiNi90YWJsZTphMjViN2ExZTkzMmQ0NzczYjVmMDEwNDc3MzYwZmYyZS90YWJsZXJhbmdlOmEyNWI3YTFlOTMyZDQ3NzNiNWYwMTA0NzczNjBmZjJlXzYtNy0xLTEtNTc2OA_3fcfe48a-30de-4b94-b4c2-fc6c1be4ce8c">163,410</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.194%"><tr><td style="width:1.0%"></td><td style="width:41.332%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.054%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.638%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.054%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.054%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.058%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i744acfb901a1441fb9ff99ac787b5b60_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzgvZnJhZzo2MjM2ODZjYzdkZmQ0ZGQ1ODg0YzE0MTQ0MzlmYWFiNi90YWJsZTo1NmQ1YjBhOWYzYzY0Yjg0OThjYjdiMzU2ZjdhN2E2Yi90YWJsZXJhbmdlOjU2ZDViMGE5ZjNjNjRiODQ5OGNiN2IzNTZmN2E3YTZiXzItMS0xLTEtNTc2Mg_ce6b7151-c431-4c36-b54c-baf0411597e3">1,199,693</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if66e6d2d74bd44d69e598ab739cad251_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzgvZnJhZzo2MjM2ODZjYzdkZmQ0ZGQ1ODg0YzE0MTQ0MzlmYWFiNi90YWJsZTo1NmQ1YjBhOWYzYzY0Yjg0OThjYjdiMzU2ZjdhN2E2Yi90YWJsZXJhbmdlOjU2ZDViMGE5ZjNjNjRiODQ5OGNiN2IzNTZmN2E3YTZiXzItMy0xLTEtNTc2Mg_36b9bd18-4bde-4765-b52f-b4e09c08c8e8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cf5ee47f74c4feeb97ec1fa3dcfc557_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzgvZnJhZzo2MjM2ODZjYzdkZmQ0ZGQ1ODg0YzE0MTQ0MzlmYWFiNi90YWJsZTo1NmQ1YjBhOWYzYzY0Yjg0OThjYjdiMzU2ZjdhN2E2Yi90YWJsZXJhbmdlOjU2ZDViMGE5ZjNjNjRiODQ5OGNiN2IzNTZmN2E3YTZiXzItNS0xLTEtNTc3NQ_e01c2e6c-d7db-4124-bd6c-3169d95d7678">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic809b1e3fd7243ac9c58c7a16950ffcd_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzgvZnJhZzo2MjM2ODZjYzdkZmQ0ZGQ1ODg0YzE0MTQ0MzlmYWFiNi90YWJsZTo1NmQ1YjBhOWYzYzY0Yjg0OThjYjdiMzU2ZjdhN2E2Yi90YWJsZXJhbmdlOjU2ZDViMGE5ZjNjNjRiODQ5OGNiN2IzNTZmN2E3YTZiXzItNy0xLTEtNTc3NQ_070087ae-172f-43ca-a4d3-ec37709b26a3">1,199,693</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i744acfb901a1441fb9ff99ac787b5b60_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzgvZnJhZzo2MjM2ODZjYzdkZmQ0ZGQ1ODg0YzE0MTQ0MzlmYWFiNi90YWJsZTo1NmQ1YjBhOWYzYzY0Yjg0OThjYjdiMzU2ZjdhN2E2Yi90YWJsZXJhbmdlOjU2ZDViMGE5ZjNjNjRiODQ5OGNiN2IzNTZmN2E3YTZiXzMtMS0xLTEtNTc2Mg_5a19229b-259e-4c72-90c8-dadf46c57fd6">306,347</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if66e6d2d74bd44d69e598ab739cad251_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzgvZnJhZzo2MjM2ODZjYzdkZmQ0ZGQ1ODg0YzE0MTQ0MzlmYWFiNi90YWJsZTo1NmQ1YjBhOWYzYzY0Yjg0OThjYjdiMzU2ZjdhN2E2Yi90YWJsZXJhbmdlOjU2ZDViMGE5ZjNjNjRiODQ5OGNiN2IzNTZmN2E3YTZiXzMtMy0xLTEtNTc2Mg_2b46f2be-5633-40c4-955b-ef656556c470">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cf5ee47f74c4feeb97ec1fa3dcfc557_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzgvZnJhZzo2MjM2ODZjYzdkZmQ0ZGQ1ODg0YzE0MTQ0MzlmYWFiNi90YWJsZTo1NmQ1YjBhOWYzYzY0Yjg0OThjYjdiMzU2ZjdhN2E2Yi90YWJsZXJhbmdlOjU2ZDViMGE5ZjNjNjRiODQ5OGNiN2IzNTZmN2E3YTZiXzMtNS0xLTEtNTc3NQ_f090afe5-d8eb-4dc5-85e4-17de78248a01">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic809b1e3fd7243ac9c58c7a16950ffcd_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzgvZnJhZzo2MjM2ODZjYzdkZmQ0ZGQ1ODg0YzE0MTQ0MzlmYWFiNi90YWJsZTo1NmQ1YjBhOWYzYzY0Yjg0OThjYjdiMzU2ZjdhN2E2Yi90YWJsZXJhbmdlOjU2ZDViMGE5ZjNjNjRiODQ5OGNiN2IzNTZmN2E3YTZiXzMtNy0xLTEtNTc3NQ_d64040e3-4d81-41e7-ae59-72e24a6353ac">306,347</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i744acfb901a1441fb9ff99ac787b5b60_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzgvZnJhZzo2MjM2ODZjYzdkZmQ0ZGQ1ODg0YzE0MTQ0MzlmYWFiNi90YWJsZTo1NmQ1YjBhOWYzYzY0Yjg0OThjYjdiMzU2ZjdhN2E2Yi90YWJsZXJhbmdlOjU2ZDViMGE5ZjNjNjRiODQ5OGNiN2IzNTZmN2E3YTZiXzYtMS0xLTEtNTc2Mg_efe1ee3a-a895-450a-8357-2f50973b73a6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if66e6d2d74bd44d69e598ab739cad251_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzgvZnJhZzo2MjM2ODZjYzdkZmQ0ZGQ1ODg0YzE0MTQ0MzlmYWFiNi90YWJsZTo1NmQ1YjBhOWYzYzY0Yjg0OThjYjdiMzU2ZjdhN2E2Yi90YWJsZXJhbmdlOjU2ZDViMGE5ZjNjNjRiODQ5OGNiN2IzNTZmN2E3YTZiXzYtMy0xLTEtNTc2Mg_52318d47-3d77-4a86-ac03-93791e3462c0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cf5ee47f74c4feeb97ec1fa3dcfc557_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzgvZnJhZzo2MjM2ODZjYzdkZmQ0ZGQ1ODg0YzE0MTQ0MzlmYWFiNi90YWJsZTo1NmQ1YjBhOWYzYzY0Yjg0OThjYjdiMzU2ZjdhN2E2Yi90YWJsZXJhbmdlOjU2ZDViMGE5ZjNjNjRiODQ5OGNiN2IzNTZmN2E3YTZiXzYtNS0xLTEtNTc3NQ_36f612d0-dff3-4cb5-b58b-05af442ed9b6">297,160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic809b1e3fd7243ac9c58c7a16950ffcd_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzgvZnJhZzo2MjM2ODZjYzdkZmQ0ZGQ1ODg0YzE0MTQ0MzlmYWFiNi90YWJsZTo1NmQ1YjBhOWYzYzY0Yjg0OThjYjdiMzU2ZjdhN2E2Yi90YWJsZXJhbmdlOjU2ZDViMGE5ZjNjNjRiODQ5OGNiN2IzNTZmN2E3YTZiXzYtNy0xLTEtNTc3NQ_d4a8572a-bbad-4a3a-b91f-e935a80948f1">297,160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">109</span></div></div></div><div id="i1ae9134e40e74e0aac958218112e53d4_145"></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December 31, 2020, 2019, and 2018</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for gram and share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:16pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">25. <ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDUvZnJhZzphOTU0Yjk0OTM3ZjI0YmE2ODhjYmMxYTQzMGE0Njk5Yy90ZXh0cmVnaW9uOmE5NTRiOTQ5MzdmMjRiYTY4OGNiYzFhNDMwYTQ2OTljXzgxMw_9fa12c1c-e51e-4b80-ac62-5817f8713802" continuedAt="i639910265b354863bef93309f2618807" escape="true">Related Party Transactions and Balances </ix:nonNumeric></span></div><ix:continuation id="i639910265b354863bef93309f2618807" continuedAt="id460977401c14d028144921b6f533165"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 8, 2019, in connection with the Altria Investment, Altria, through certain of its wholly owned subsidiaries, purchased a <ix:nonFraction unitRef="number" contextRef="ib551b9ef8b1d44bcb1db52c16b0f3d77_I20190308" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDUvZnJhZzphOTU0Yjk0OTM3ZjI0YmE2ODhjYmMxYTQzMGE0Njk5Yy90ZXh0cmVnaW9uOmE5NTRiOTQ5MzdmMjRiYTY4OGNiYzFhNDMwYTQ2OTljXzE2NQ_08b19034-02de-415b-a4d3-968082ce9244">45</ix:nonFraction>% equity interest in the Company. </span></div><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDUvZnJhZzphOTU0Yjk0OTM3ZjI0YmE2ODhjYmMxYTQzMGE0Njk5Yy90ZXh0cmVnaW9uOmE5NTRiOTQ5MzdmMjRiYTY4OGNiYzFhNDMwYTQ2OTljXzI0MTg5MjU1ODEzMTA1_614e2ea7-568b-4c94-8750-8c576e0fb6ad" escape="true"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company incurred the following expenses for consulting services from Altria Pinnacle LLC, a subsidiary of Altria (&#8220;Altria Pinnacle&#8221;):</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.205%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.346%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Altria Pinnacle &#8211; expense</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if695526c3a384f66bf0952f4b3b10c1f_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDUvZnJhZzphOTU0Yjk0OTM3ZjI0YmE2ODhjYmMxYTQzMGE0Njk5Yy90YWJsZTplOWQ0ODQ1Y2I5YTU0YjYzODUxMmI3MWZkMzRiNTIwMS90YWJsZXJhbmdlOmU5ZDQ4NDVjYjlhNTRiNjM4NTEyYjcxZmQzNGI1MjAxXzItMS0xLTEtMTExMzU_8dc2b653-09f9-43cd-a1c8-1a867d03a102">1,199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82c99c7bc6cf41bbaf798753e7523968_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDUvZnJhZzphOTU0Yjk0OTM3ZjI0YmE2ODhjYmMxYTQzMGE0Njk5Yy90YWJsZTplOWQ0ODQ1Y2I5YTU0YjYzODUxMmI3MWZkMzRiNTIwMS90YWJsZXJhbmdlOmU5ZDQ4NDVjYjlhNTRiNjM4NTEyYjcxZmQzNGI1MjAxXzItMy0xLTEtMTExMzU_9c146914-cb02-42e4-83d0-e216b08bcffc">3,479</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56950461ca0641258302cc12456209fb_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDUvZnJhZzphOTU0Yjk0OTM3ZjI0YmE2ODhjYmMxYTQzMGE0Njk5Yy90YWJsZTplOWQ0ODQ1Y2I5YTU0YjYzODUxMmI3MWZkMzRiNTIwMS90YWJsZXJhbmdlOmU5ZDQ4NDVjYjlhNTRiNjM4NTEyYjcxZmQzNGI1MjAxXzMtMS0xLTEtMTExMzU_2dd7a63c-315c-4337-9c9f-db64cdecd39e">1,199</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id13d81de4dfa4a43aa8e25121fddb996_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDUvZnJhZzphOTU0Yjk0OTM3ZjI0YmE2ODhjYmMxYTQzMGE0Njk5Yy90YWJsZTplOWQ0ODQ1Y2I5YTU0YjYzODUxMmI3MWZkMzRiNTIwMS90YWJsZXJhbmdlOmU5ZDQ4NDVjYjlhNTRiNjM4NTEyYjcxZmQzNGI1MjAxXzMtMy0xLTEtMTExMzU_5c3cd4d9-020c-4644-8330-bb044e5da1da">3,479</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0183de7cbf5a41d98122476254d88bc7_D20180101-20181231" decimals="-3" format="ixt-sec:numwordsen" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDUvZnJhZzphOTU0Yjk0OTM3ZjI0YmE2ODhjYmMxYTQzMGE0Njk5Yy90ZXh0cmVnaW9uOmE5NTRiOTQ5MzdmMjRiYTY4OGNiYzFhNDMwYTQ2OTljXzgyNDYzMzcyMTA4MDI_aa2467d4-6315-47a2-b0cc-90c269dd82ba">No</ix:nonFraction> expenses for consulting services from Altria Pinnacle during the year ended December&#160;31, 2018.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of amounts payable related to the consulting services with Altria Pinnacle:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.205%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.346%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Altria Pinnacle &#8211; payable</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fc6d347c95c4553908e2aad286d0722_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:AccountsPayableRelatedPartiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDUvZnJhZzphOTU0Yjk0OTM3ZjI0YmE2ODhjYmMxYTQzMGE0Njk5Yy90YWJsZTpmNDJkOWRlOWUxYTA0OTZiOWIxOWQwY2M1NTI5NzhiNi90YWJsZXJhbmdlOmY0MmQ5ZGU5ZTFhMDQ5NmI5YjE5ZDBjYzU1Mjk3OGI2XzItMS0xLTEtMTExNDE_d17357af-0070-4f42-a334-8555b67040ba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc5cfb363b314f4d89d1c4f2a887ca7a_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableRelatedPartiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDUvZnJhZzphOTU0Yjk0OTM3ZjI0YmE2ODhjYmMxYTQzMGE0Njk5Yy90YWJsZTpmNDJkOWRlOWUxYTA0OTZiOWIxOWQwY2M1NTI5NzhiNi90YWJsZXJhbmdlOmY0MmQ5ZGU5ZTFhMDQ5NmI5YjE5ZDBjYzU1Mjk3OGI2XzItMy0xLTEtMTExNDE_8015fe96-e27a-42f0-88f5-3a2b7559cfc6">1,152</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if753a5d3b4dc49c6b14066a7f6662688_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:AccountsPayableRelatedPartiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDUvZnJhZzphOTU0Yjk0OTM3ZjI0YmE2ODhjYmMxYTQzMGE0Njk5Yy90YWJsZTpmNDJkOWRlOWUxYTA0OTZiOWIxOWQwY2M1NTI5NzhiNi90YWJsZXJhbmdlOmY0MmQ5ZGU5ZTFhMDQ5NmI5YjE5ZDBjYzU1Mjk3OGI2XzMtMS0xLTEtMTExNDE_0e03cd12-78b3-4934-a2c5-e984597c2ba2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19b510e302f04461a1edc4df93c4ac57_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableRelatedPartiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDUvZnJhZzphOTU0Yjk0OTM3ZjI0YmE2ODhjYmMxYTQzMGE0Njk5Yy90YWJsZTpmNDJkOWRlOWUxYTA0OTZiOWIxOWQwY2M1NTI5NzhiNi90YWJsZXJhbmdlOmY0MmQ5ZGU5ZTFhMDQ5NmI5YjE5ZDBjYzU1Mjk3OGI2XzMtMy0xLTEtMTExNDE_cd89498c-6b11-4a31-aa40-c5fe69ae1f82">1,152</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2019, the Company purchased machinery and equipment amounting to $<ix:nonFraction unitRef="usd" contextRef="ia1f93f14e6044577ba1a7b6463b04532_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDUvZnJhZzphOTU0Yjk0OTM3ZjI0YmE2ODhjYmMxYTQzMGE0Njk5Yy90ZXh0cmVnaW9uOmE5NTRiOTQ5MzdmMjRiYTY4OGNiYzFhNDMwYTQ2OTljXzQ4Mg_58b75d07-8827-4c41-9449-c6c3e1a44462">1,258</ix:nonFraction> from a subsidiary of Altria, which was fully paid for during the year.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 14 for further information on the derivative liabilities related to the Altria Investment.</span></div></ix:continuation><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="id460977401c14d028144921b6f533165">There were no other material related party transactions during the years ended December&#160;31, 2020, December&#160;31, 2019 and December&#160;31, 2018.</ix:continuation> </span></div><div style="margin-bottom:6pt;text-align:justify"><span><br/></span></div><div id="i1ae9134e40e74e0aac958218112e53d4_184"></div><div style="margin-bottom:12pt;margin-top:16pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">26. <ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:NonmonetaryTransactionsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODQvZnJhZzo4OTcyNWNlM2RiYzI0MGZkYjBiZjUzNmQ4NTQ4MTMwYy90ZXh0cmVnaW9uOjg5NzI1Y2UzZGJjMjQwZmRiMGJmNTM2ZDg1NDgxMzBjXzEzMTc_348c3576-8f15-42c1-af37-9b6079193c61" continuedAt="i215c37fe12754f758ce37df8c12c2ca4" escape="true">Non-monetary Transactions </ix:nonNumeric></span></div><ix:continuation id="i215c37fe12754f758ce37df8c12c2ca4"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had <ix:nonFraction unitRef="transaction" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="cron:NonmonetaryTransactionNumberOfTransactions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODQvZnJhZzo4OTcyNWNlM2RiYzI0MGZkYjBiZjUzNmQ4NTQ4MTMwYy90ZXh0cmVnaW9uOjg5NzI1Y2UzZGJjMjQwZmRiMGJmNTM2ZDg1NDgxMzBjXzM4NDgyOTA3MDM4ODE_122a355e-f058-42fb-8747-a796c1a9c756"><ix:nonFraction unitRef="transaction" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="INF" format="ixt-sec:numwordsen" name="cron:NonmonetaryTransactionNumberOfTransactions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODQvZnJhZzo4OTcyNWNlM2RiYzI0MGZkYjBiZjUzNmQ4NTQ4MTMwYy90ZXh0cmVnaW9uOjg5NzI1Y2UzZGJjMjQwZmRiMGJmNTM2ZDg1NDgxMzBjXzM4NDgyOTA3MDM4ODE_679a0420-475d-4347-84bf-8487aa123148">no</ix:nonFraction></ix:nonFraction> non-monetary transactions during the year ended December 31, 2020 or 2018.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 28, 2019, the Company&#160;entered into&#160;<ix:nonFraction unitRef="transaction" contextRef="i91a71d7c7ae04725bf836bbfa7b9724b_D20190328-20190328" decimals="INF" format="ixt-sec:numwordsen" name="cron:NonmonetaryTransactionNumberOfTransactions" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODQvZnJhZzo4OTcyNWNlM2RiYzI0MGZkYjBiZjUzNmQ4NTQ4MTMwYy90ZXh0cmVnaW9uOjg5NzI1Y2UzZGJjMjQwZmRiMGJmNTM2ZDg1NDgxMzBjXzM4NDgyOTA3MDM4Nzc_49263554-3940-4b3b-ac43-2e3503ff20a9">two</ix:nonFraction> transactions to simultaneously purchase and sell inventory to a third party. The Company purchased cannabis resin from the third party and in turn sold cannabis dry flower to the third party. The transactions involved the exchange of work in progress inventory and were accounted for at the carrying value of inventory transferred by the Company, which equaled the value of the cannabis resin received. <ix:nonFraction unitRef="usd" contextRef="i91a71d7c7ae04725bf836bbfa7b9724b_D20190328-20190328" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NonmonetaryTransactionGrossOperatingRevenueRecognized" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODQvZnJhZzo4OTcyNWNlM2RiYzI0MGZkYjBiZjUzNmQ4NTQ4MTMwYy90ZXh0cmVnaW9uOjg5NzI1Y2UzZGJjMjQwZmRiMGJmNTM2ZDg1NDgxMzBjXzM4NDgyOTA3MDM4Njg_71b89346-d52f-4a87-b601-97a298278e47">No</ix:nonFraction> revenue was recognized as a result of this transaction and <ix:nonFraction unitRef="usd" contextRef="i91a71d7c7ae04725bf836bbfa7b9724b_D20190328-20190328" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NonmonetaryTransactionGainLossRecognizedOnTransfer" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODQvZnJhZzo4OTcyNWNlM2RiYzI0MGZkYjBiZjUzNmQ4NTQ4MTMwYy90ZXh0cmVnaW9uOjg5NzI1Y2UzZGJjMjQwZmRiMGJmNTM2ZDg1NDgxMzBjXzM4NDgyOTA3MDM4NzI_fdfc41de-1e65-4ccd-981f-49c97046adcf">no</ix:nonFraction> gain or loss was recognized in the consolidated statements of net income (loss) and comprehensive income (loss).</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2019, the Company entered into <ix:nonFraction unitRef="transaction" contextRef="i1b5d6b4753dd4b52ac5dc0f7319ab8cd_D20190901-20190930" decimals="INF" format="ixt-sec:numwordsen" name="cron:NonmonetaryTransactionNumberOfTransactions" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODQvZnJhZzo4OTcyNWNlM2RiYzI0MGZkYjBiZjUzNmQ4NTQ4MTMwYy90ZXh0cmVnaW9uOjg5NzI1Y2UzZGJjMjQwZmRiMGJmNTM2ZDg1NDgxMzBjXzM4NDgyOTA3MDM4ODg_c8a293bb-da19-47ed-bf7c-8f9b69a58c83">three</ix:nonFraction> transactions to simultaneously purchase and sell inventory to a third party. The Company purchased cannabis resin and cannabis tincture oil and in turn sold cannabis dry flower to the third party. The transactions involved the exchange of work in progress inventory and were accounted for in accordance with ASC 845 Non-monetary transactions at the carrying value of inventory transferred by the Company. $<ix:nonFraction unitRef="usd" contextRef="i1b5d6b4753dd4b52ac5dc0f7319ab8cd_D20190901-20190930" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NonmonetaryTransactionGrossOperatingRevenueRecognized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODQvZnJhZzo4OTcyNWNlM2RiYzI0MGZkYjBiZjUzNmQ4NTQ4MTMwYy90ZXh0cmVnaW9uOjg5NzI1Y2UzZGJjMjQwZmRiMGJmNTM2ZDg1NDgxMzBjXzM4NDgyOTA3MDM4OTc_cdd0ae9a-82ee-45d2-9818-8eca98f9ccb8">2,300</ix:nonFraction> was recognized in revenue as a result of this transaction and <ix:nonFraction unitRef="usd" contextRef="i1b5d6b4753dd4b52ac5dc0f7319ab8cd_D20190901-20190930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NonmonetaryTransactionGainLossRecognizedOnTransfer" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODQvZnJhZzo4OTcyNWNlM2RiYzI0MGZkYjBiZjUzNmQ4NTQ4MTMwYy90ZXh0cmVnaW9uOjg5NzI1Y2UzZGJjMjQwZmRiMGJmNTM2ZDg1NDgxMzBjXzM4NDgyOTA3MDM5MDc_539a5c50-8a98-4045-852c-780970f9bf0c">no</ix:nonFraction> gain or loss was recognized in the consolidated statements of net income (loss) and comprehensive income (loss).</span></div></ix:continuation><div style="margin-bottom:6pt;text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">110</span></div></div></div><div id="i1ae9134e40e74e0aac958218112e53d4_148"></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December 31, 2020, 2019, and 2018</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for gram and share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:16pt;padding-left:29.25pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">27. <ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDgvZnJhZzpiYjhkNDkyNjEyYTM0YThjOGI1YmE4ZGM0M2ViZWUyYS90ZXh0cmVnaW9uOmJiOGQ0OTI2MTJhMzRhOGM4YjViYThkYzQzZWJlZTJhXzQzMzQ_c0b54ffd-c381-42a2-b726-0f17473f20c0" continuedAt="i0639fef2c17c4f74973adf6e28cf4a6c" escape="true">Business Combinations </ix:nonNumeric></span></div><ix:continuation id="i0639fef2c17c4f74973adf6e28cf4a6c" continuedAt="i5653342af4c84dcd99b3e010d0b611f3"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 5, 2019, the Company closed the Redwood Acquisition. Redwood manufactures, markets and distributes U.S. hemp-derived supplements and cosmetics product through e-commerce, retail and hospitality channels in the U.S. under the brand Lord Jones&#8482;. Redwood&#8217;s products use high quality U.S. hemp extract that retains naturally occurring phytocannabinoids and terpenes found in the plant. The Company plans to leverage Redwood&#8217;s capabilities to capitalize on the significant demand to further create and scale U.S. hemp-derived consumer products and brands.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, the Company acquired all the issued and outstanding shares of each of the <ix:nonFraction unitRef="subsidiary" contextRef="i09f6b65a08b548dea26ecf66cee73299_D20190905-20190905" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfBusinessesAcquired" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDgvZnJhZzpiYjhkNDkyNjEyYTM0YThjOGI1YmE4ZGM0M2ViZWUyYS90ZXh0cmVnaW9uOmJiOGQ0OTI2MTJhMzRhOGM4YjViYThkYzQzZWJlZTJhXzY1Mg_ccab5633-6da3-4d84-83fd-98eb17379108">four</ix:nonFraction> Redwood operating subsidiaries for an aggregate consideration of $<ix:nonFraction unitRef="usd" contextRef="i09f6b65a08b548dea26ecf66cee73299_D20190905-20190905" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDgvZnJhZzpiYjhkNDkyNjEyYTM0YThjOGI1YmE4ZGM0M2ViZWUyYS90ZXh0cmVnaW9uOmJiOGQ0OTI2MTJhMzRhOGM4YjViYThkYzQzZWJlZTJhXzEwOTk1MTE2MzIyMDU_372c41be-9913-4515-9e01-85b45301b3da">283,300</ix:nonFraction>, which included $<ix:nonFraction unitRef="usd" contextRef="i09f6b65a08b548dea26ecf66cee73299_D20190905-20190905" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDgvZnJhZzpiYjhkNDkyNjEyYTM0YThjOGI1YmE4ZGM0M2ViZWUyYS90ZXh0cmVnaW9uOmJiOGQ0OTI2MTJhMzRhOGM4YjViYThkYzQzZWJlZTJhXzEwOTk1MTE2MzIyMDg_d2e62918-3660-431b-8a62-ede7ef90def2">227,191</ix:nonFraction> in cash and <ix:nonFraction unitRef="shares" contextRef="i09f6b65a08b548dea26ecf66cee73299_D20190905-20190905" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDgvZnJhZzpiYjhkNDkyNjEyYTM0YThjOGI1YmE4ZGM0M2ViZWUyYS90ZXh0cmVnaW9uOmJiOGQ0OTI2MTJhMzRhOGM4YjViYThkYzQzZWJlZTJhXzEwOTk1MTE2MzIyMTE_613a930a-ea38-4725-83ee-d8ffcbd21bad">5,086,586</ix:nonFraction> common shares of the Company with a fair value of $<ix:nonFraction unitRef="usd" contextRef="i09f6b65a08b548dea26ecf66cee73299_D20190905-20190905" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDgvZnJhZzpiYjhkNDkyNjEyYTM0YThjOGI1YmE4ZGM0M2ViZWUyYS90ZXh0cmVnaW9uOmJiOGQ0OTI2MTJhMzRhOGM4YjViYThkYzQzZWJlZTJhXzEwOTk1MTE2MzIyMTQ_494db56f-cc87-4f6c-8558-996011710e1b">56,109</ix:nonFraction>. The fair value of the shares issued as part of the consideration paid was based on the volume weighted average trading price of the common shares on Nasdaq on each of the ten consecutive trading days prior to the date of the Membership Interest Purchase Agreement dated August 1, 2019 (the &#8220;MIPA&#8221;), by and among the Company, Redwood Holding Group, LLC, and certain Key Persons solely for the purposes as described in the MIPA, at C$<ix:nonFraction unitRef="cadPerShare" contextRef="ide715df8e0104988800b3158e6323d0b_I20190905" decimals="2" name="us-gaap:BusinessAcquisitionSharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDgvZnJhZzpiYjhkNDkyNjEyYTM0YThjOGI1YmE4ZGM0M2ViZWUyYS90ZXh0cmVnaW9uOmJiOGQ0OTI2MTJhMzRhOGM4YjViYThkYzQzZWJlZTJhXzEyMzQ_4caa017e-b744-44ca-905d-293fa99deae4">14.74</ix:nonFraction> per share. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Redwood Acquisition was unanimously approved by the board of directors of Redwood Holdings Group, LLC and by the Board following the unanimous recommendation of a special committee of independent directors (&#8220;Special Committee&#8221;). A Special Committee composed entirely of independent directors of the Company was formed to evaluate and make recommendations to the Board since one of our directors, Jason Adler, and Michael Gorenstein, our Executive Chairman and former President and Chief Executive Officer, each held an indirect interest in Redwood Holding Group, LLC by way of their interest in certain funds affiliated with Gotham Green Partners, which funds were equity holders in Redwood Holding Group, LLC. Jason Adler is the co-founder and Managing Member of Gotham Green Partners, a private equity firm focused primarily on early-stage investing in companies in the cannabis industry, and Michael Gorenstein is a co-founder and non-managing Member of Gotham Green Partners. The Special Committee engaged Perella Weinberg Partners LP as financial advisor.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Redwood Acquisition was accounted for as a business combination as defined in ASC 805 Business Combinations. As a result of the change in control of Redwood, the assets and liabilities of Redwood are recorded at fair value in the consolidated financial statements of the Company. <ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDgvZnJhZzpiYjhkNDkyNjEyYTM0YThjOGI1YmE4ZGM0M2ViZWUyYS90ZXh0cmVnaW9uOmJiOGQ0OTI2MTJhMzRhOGM4YjViYThkYzQzZWJlZTJhXzQzMzU_fb37308b-9de4-4eb2-8fc6-b627d32757da" continuedAt="ic1272563250c469b94ef715fc232e9b5" escape="true">The following table summarizes the Company&#8217;s finalized allocation of the purchase price to assets acquired and liabilities assumed at the acquisition date. </ix:nonNumeric></span></div><ix:continuation id="ic1272563250c469b94ef715fc232e9b5"><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:2.794%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:64.685%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.608%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.718%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 5, 2019</span></td></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair value of net assets acquired</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide715df8e0104988800b3158e6323d0b_I20190905" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDgvZnJhZzpiYjhkNDkyNjEyYTM0YThjOGI1YmE4ZGM0M2ViZWUyYS90YWJsZTowOTc2Y2UwMTA4NGE0ZTkxOWMzN2M2NTExMDQ1OWJlOC90YWJsZXJhbmdlOjA5NzZjZTAxMDg0YTRlOTE5YzM3YzY1MTEwNDU5YmU4XzItNC0xLTEtMA_f0ade22b-ac42-47d7-ad54-d3caffe99c55">2,896</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:1pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> (i)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide715df8e0104988800b3158e6323d0b_I20190905" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDgvZnJhZzpiYjhkNDkyNjEyYTM0YThjOGI1YmE4ZGM0M2ViZWUyYS90YWJsZTowOTc2Y2UwMTA4NGE0ZTkxOWMzN2M2NTExMDQ1OWJlOC90YWJsZXJhbmdlOjA5NzZjZTAxMDg0YTRlOTE5YzM3YzY1MTEwNDU5YmU4XzMtNC0xLTEtMA_3dc0a422-e119-468a-a980-36fcb1917575">647</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide715df8e0104988800b3158e6323d0b_I20190905" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDgvZnJhZzpiYjhkNDkyNjEyYTM0YThjOGI1YmE4ZGM0M2ViZWUyYS90YWJsZTowOTc2Y2UwMTA4NGE0ZTkxOWMzN2M2NTExMDQ1OWJlOC90YWJsZXJhbmdlOjA5NzZjZTAxMDg0YTRlOTE5YzM3YzY1MTEwNDU5YmU4XzQtNC0xLTEtMA_68bc6001-0a05-466b-bd6f-f8aad621a03e">265</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide715df8e0104988800b3158e6323d0b_I20190905" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDgvZnJhZzpiYjhkNDkyNjEyYTM0YThjOGI1YmE4ZGM0M2ViZWUyYS90YWJsZTowOTc2Y2UwMTA4NGE0ZTkxOWMzN2M2NTExMDQ1OWJlOC90YWJsZXJhbmdlOjA5NzZjZTAxMDg0YTRlOTE5YzM3YzY1MTEwNDU5YmU4XzUtNC0xLTEtMA_a46d8a30-0eda-4537-b763-4af0577c083c">2,806</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide715df8e0104988800b3158e6323d0b_I20190905" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDgvZnJhZzpiYjhkNDkyNjEyYTM0YThjOGI1YmE4ZGM0M2ViZWUyYS90YWJsZTowOTc2Y2UwMTA4NGE0ZTkxOWMzN2M2NTExMDQ1OWJlOC90YWJsZXJhbmdlOjA5NzZjZTAxMDg0YTRlOTE5YzM3YzY1MTEwNDU5YmU4XzYtNC0xLTEtMA_a4e01a96-59fc-4280-8b67-275a3d788184">1,890</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide715df8e0104988800b3158e6323d0b_I20190905" decimals="-3" format="ixt:numdotdecimal" name="cron:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDgvZnJhZzpiYjhkNDkyNjEyYTM0YThjOGI1YmE4ZGM0M2ViZWUyYS90YWJsZTowOTc2Y2UwMTA4NGE0ZTkxOWMzN2M2NTExMDQ1OWJlOC90YWJsZXJhbmdlOjA5NzZjZTAxMDg0YTRlOTE5YzM3YzY1MTEwNDU5YmU4XzctNC0xLTEtMA_5978c1df-a499-41ea-b907-911f0a36e4a4">3,533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:1pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide715df8e0104988800b3158e6323d0b_I20190905" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDgvZnJhZzpiYjhkNDkyNjEyYTM0YThjOGI1YmE4ZGM0M2ViZWUyYS90YWJsZTowOTc2Y2UwMTA4NGE0ZTkxOWMzN2M2NTExMDQ1OWJlOC90YWJsZXJhbmdlOjA5NzZjZTAxMDg0YTRlOTE5YzM3YzY1MTEwNDU5YmU4XzgtNC0xLTEtMA_1eb6b904-b507-4ec2-a510-634e6ca13bad">64,037</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide715df8e0104988800b3158e6323d0b_I20190905" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDgvZnJhZzpiYjhkNDkyNjEyYTM0YThjOGI1YmE4ZGM0M2ViZWUyYS90YWJsZTowOTc2Y2UwMTA4NGE0ZTkxOWMzN2M2NTExMDQ1OWJlOC90YWJsZXJhbmdlOjA5NzZjZTAxMDg0YTRlOTE5YzM3YzY1MTEwNDU5YmU4XzktNC0xLTEtMA_7e584a19-a70f-4ebc-b189-9b61c87a0245">213,414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide715df8e0104988800b3158e6323d0b_I20190905" decimals="-3" format="ixt:numdotdecimal" name="cron:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAndAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDgvZnJhZzpiYjhkNDkyNjEyYTM0YThjOGI1YmE4ZGM0M2ViZWUyYS90YWJsZTowOTc2Y2UwMTA4NGE0ZTkxOWMzN2M2NTExMDQ1OWJlOC90YWJsZXJhbmdlOjA5NzZjZTAxMDg0YTRlOTE5YzM3YzY1MTEwNDU5YmU4XzEwLTQtMS0xLTA_26308448-1981-4867-b875-1a6cdfc4c101">2,688</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ide715df8e0104988800b3158e6323d0b_I20190905" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDgvZnJhZzpiYjhkNDkyNjEyYTM0YThjOGI1YmE4ZGM0M2ViZWUyYS90YWJsZTowOTc2Y2UwMTA4NGE0ZTkxOWMzN2M2NTExMDQ1OWJlOC90YWJsZXJhbmdlOjA5NzZjZTAxMDg0YTRlOTE5YzM3YzY1MTEwNDU5YmU4XzExLTQtMS0xLTA_8ae3518a-ed28-4465-bc1a-b0a82a82bc73">3,500</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide715df8e0104988800b3158e6323d0b_I20190905" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDgvZnJhZzpiYjhkNDkyNjEyYTM0YThjOGI1YmE4ZGM0M2ViZWUyYS90YWJsZTowOTc2Y2UwMTA4NGE0ZTkxOWMzN2M2NTExMDQ1OWJlOC90YWJsZXJhbmdlOjA5NzZjZTAxMDg0YTRlOTE5YzM3YzY1MTEwNDU5YmU4XzEyLTQtMS0xLTA_cef5fe19-a8f0-4420-b094-f507331db4d8">283,300</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The fair value of acquired accounts receivable is $<ix:nonFraction unitRef="usd" contextRef="ide715df8e0104988800b3158e6323d0b_I20190905" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDgvZnJhZzpiYjhkNDkyNjEyYTM0YThjOGI1YmE4ZGM0M2ViZWUyYS90ZXh0cmVnaW9uOmJiOGQ0OTI2MTJhMzRhOGM4YjViYThkYzQzZWJlZTJhXzEwOTk1MTE2MzIyMDE_3dc0a422-e119-468a-a980-36fcb1917575">647</ix:nonFraction>. <ix:nonFraction unitRef="usd" contextRef="ide715df8e0104988800b3158e6323d0b_I20190905" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:BusinessCombinationAcquiredReceivablesEstimatedUncollectible" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDgvZnJhZzpiYjhkNDkyNjEyYTM0YThjOGI1YmE4ZGM0M2ViZWUyYS90ZXh0cmVnaW9uOmJiOGQ0OTI2MTJhMzRhOGM4YjViYThkYzQzZWJlZTJhXzI3ODg_3dbc1afb-f442-4a63-91b1-9b093076ad28">No</ix:nonFraction> loss allowance was recognized on acquisition.</span></div><div style="margin-bottom:3pt;margin-top:1pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Intangible assets include the fair value of brand name of $<ix:nonFraction unitRef="usd" contextRef="ia1f38277cbb04c8aa6676044144d8fa7_D20190905-20190905" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IndefinitelivedIntangibleAssetsAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDgvZnJhZzpiYjhkNDkyNjEyYTM0YThjOGI1YmE4ZGM0M2ViZWUyYS90ZXh0cmVnaW9uOmJiOGQ0OTI2MTJhMzRhOGM4YjViYThkYzQzZWJlZTJhXzI5MDU_524c23a5-85b4-427e-9d77-aeef396e44d5">64,000</ix:nonFraction>, the remaining balance relates to software.</span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2019, acquisition-related costs of $<ix:nonFraction unitRef="usd" contextRef="i8b55b8b5cf3546f08aaece9738addf85_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDgvZnJhZzpiYjhkNDkyNjEyYTM0YThjOGI1YmE4ZGM0M2ViZWUyYS90ZXh0cmVnaW9uOmJiOGQ0OTI2MTJhMzRhOGM4YjViYThkYzQzZWJlZTJhXzM4NDgyOTA3MDE3MzI_b3c363a3-5d81-4c99-9e44-78ad253872b6">8,531</ix:nonFraction> were expensed. These costs are included in the consolidated statement of net income (loss) in financing and transaction costs.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The goodwill recognized represents the excess over the fair value of the net tangible and intangible assets acquired as a part of the Redwood acquisition. This goodwill is attributable to the expertise and reputation of the assembled workforce acquired, the expected synergies, and other intangible assets that do not qualify for separate recognition. The goodwill is <ix:nonFraction unitRef="usd" contextRef="ide715df8e0104988800b3158e6323d0b_I20190905" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDgvZnJhZzpiYjhkNDkyNjEyYTM0YThjOGI1YmE4ZGM0M2ViZWUyYS90ZXh0cmVnaW9uOmJiOGQ0OTI2MTJhMzRhOGM4YjViYThkYzQzZWJlZTJhXzM1NDA_d08ce58f-c3bf-43cc-8a62-5a020820f73a">no</ix:nonFraction>t deductible for income tax purposes. The Relief-from-Royalty Method was used to value the intangible asset relating to the Lord Jones&#8482; brand. Significant inputs include discount rate, growth rates, and cash flow projections.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">111</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December 31, 2020, 2019, and 2018</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for gram and share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div></div><ix:continuation id="i5653342af4c84dcd99b3e010d0b611f3"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the period from September 5, 2019 to December 31, 2019, the Company recognized $<ix:nonFraction unitRef="usd" contextRef="i7c36b1e540204e59a5d80864743da551_D20190905-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDgvZnJhZzpiYjhkNDkyNjEyYTM0YThjOGI1YmE4ZGM0M2ViZWUyYS90ZXh0cmVnaW9uOmJiOGQ0OTI2MTJhMzRhOGM4YjViYThkYzQzZWJlZTJhXzM4NTI_78b3c242-74f3-4f59-a552-aec098397b7f">3,364</ix:nonFraction> in revenues and a net loss of $<ix:nonFraction unitRef="usd" contextRef="i7c36b1e540204e59a5d80864743da551_D20190905-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDgvZnJhZzpiYjhkNDkyNjEyYTM0YThjOGI1YmE4ZGM0M2ViZWUyYS90ZXh0cmVnaW9uOmJiOGQ0OTI2MTJhMzRhOGM4YjViYThkYzQzZWJlZTJhXzM4ODU_70e4e443-a40f-4ca4-89ed-28359da2dfb3">2,613</ix:nonFraction> from Redwood operations. If the acquisition had occurred on January 1, 2019, the Company estimates that for the year ended December 31, 2019, it would have recorded an increase of $<ix:nonFraction unitRef="usd" contextRef="i8b55b8b5cf3546f08aaece9738addf85_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionsProFormaRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDgvZnJhZzpiYjhkNDkyNjEyYTM0YThjOGI1YmE4ZGM0M2ViZWUyYS90ZXh0cmVnaW9uOmJiOGQ0OTI2MTJhMzRhOGM4YjViYThkYzQzZWJlZTJhXzQwNTE_ce0b642c-14a5-46c1-b720-4f8c77b965d2">12,266</ix:nonFraction> in revenues and a decrease of $<ix:nonFraction unitRef="usd" contextRef="i8b55b8b5cf3546f08aaece9738addf85_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDgvZnJhZzpiYjhkNDkyNjEyYTM0YThjOGI1YmE4ZGM0M2ViZWUyYS90ZXh0cmVnaW9uOmJiOGQ0OTI2MTJhMzRhOGM4YjViYThkYzQzZWJlZTJhXzQwODQ_2775d202-3909-4a52-b4fd-375696243a35">1,112</ix:nonFraction> in net income and that for the year ended December 31, 2018, it would have recorded an increase of $<ix:nonFraction unitRef="usd" contextRef="ia8399af2583a41c49612e5d2b0241e7e_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionsProFormaRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDgvZnJhZzpiYjhkNDkyNjEyYTM0YThjOGI1YmE4ZGM0M2ViZWUyYS90ZXh0cmVnaW9uOmJiOGQ0OTI2MTJhMzRhOGM4YjViYThkYzQzZWJlZTJhXzQxODY_88168807-4d8b-4ba6-a718-420571a933d2">7,630</ix:nonFraction> in revenues and an increase of $<ix:nonFraction unitRef="usd" contextRef="ia8399af2583a41c49612e5d2b0241e7e_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDgvZnJhZzpiYjhkNDkyNjEyYTM0YThjOGI1YmE4ZGM0M2ViZWUyYS90ZXh0cmVnaW9uOmJiOGQ0OTI2MTJhMzRhOGM4YjViYThkYzQzZWJlZTJhXzQyMjA_60864336-c3c3-472e-b5ca-539447a0a59b">1,533</ix:nonFraction> in net income. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="business" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfBusinessesAcquired" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDgvZnJhZzpiYjhkNDkyNjEyYTM0YThjOGI1YmE4ZGM0M2ViZWUyYS90ZXh0cmVnaW9uOmJiOGQ0OTI2MTJhMzRhOGM4YjViYThkYzQzZWJlZTJhXzQyNTA_0cbba91c-6f40-460b-8a7b-1920e0478d9e"><ix:nonFraction unitRef="business" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfBusinessesAcquired" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDgvZnJhZzpiYjhkNDkyNjEyYTM0YThjOGI1YmE4ZGM0M2ViZWUyYS90ZXh0cmVnaW9uOmJiOGQ0OTI2MTJhMzRhOGM4YjViYThkYzQzZWJlZTJhXzQyNTA_c9ef6f8f-1cb0-4d9a-9136-081f1a134b34">no</ix:nonFraction></ix:nonFraction> business combinations during the years ended December 31, 2020 or December 31, 2018.</span></div></ix:continuation><div style="margin-bottom:6pt;text-align:justify"><span><br/></span></div><div id="i1ae9134e40e74e0aac958218112e53d4_160"></div><div style="margin-bottom:12pt;margin-top:16pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">28. <ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjAvZnJhZzo1ZDZhMzc1NWNiNTA0YmM2YWQ5NjM0MGRhNTNmYjYwMC90ZXh0cmVnaW9uOjVkNmEzNzU1Y2I1MDRiYzZhZDk2MzQwZGE1M2ZiNjAwXzExNTc_80eac4ea-a766-47fe-8c75-2ddce07ed8f9" continuedAt="iaf98907148b6426f8fccd65c89d85a84" escape="true">Repurposing Charges</ix:nonNumeric></span></div><ix:continuation id="iaf98907148b6426f8fccd65c89d85a84"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2019, the Company commenced initiatives to better align its evolving business and its strategy. Certain facilities at the Peace Naturals campus were repurposed from cultivation activities to provide for the following activities: additional R&amp;D activities focused on new technologies for value-added product manufacturing; production and manufacturing of derivative products; and increased vault and warehousing capabilities.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The activities associated with the repurposing were completed as of December&#160;31, 2019. <ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjAvZnJhZzo1ZDZhMzc1NWNiNTA0YmM2YWQ5NjM0MGRhNTNmYjYwMC90ZXh0cmVnaW9uOjVkNmEzNzU1Y2I1MDRiYzZhZDk2MzQwZGE1M2ZiNjAwXzExNTg_fc3a6e96-29a2-40dd-9e90-dde47779f11e" continuedAt="i835412d5b618487fb702079db8a8dd7c" escape="true">The following table presents information associated with this plan:</ix:nonNumeric></span></div><div style="margin-bottom:6pt"><ix:continuation id="i835412d5b618487fb702079db8a8dd7c"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.706%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December&#160;31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee termination benefits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" name="us-gaap:SeveranceCosts1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjAvZnJhZzo1ZDZhMzc1NWNiNTA0YmM2YWQ5NjM0MGRhNTNmYjYwMC90YWJsZTo1MmNkN2RiMWE1ZjI0NGMwOGMxMzRkZDI0MDEzYzI1OC90YWJsZXJhbmdlOjUyY2Q3ZGIxYTVmMjQ0YzA4YzEzNGRkMjQwMTNjMjU4XzEtMS0xLTEtMA_2e7aff5c-484d-49e2-b1e7-9c87be93e2df">889</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment costs associated with plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjAvZnJhZzo1ZDZhMzc1NWNiNTA0YmM2YWQ5NjM0MGRhNTNmYjYwMC90YWJsZTo1MmNkN2RiMWE1ZjI0NGMwOGMxMzRkZDI0MDEzYzI1OC90YWJsZXJhbmdlOjUyY2Q3ZGIxYTVmMjQ0YzA4YzEzNGRkMjQwMTNjMjU4XzItMS0xLTEtMA_dfbe51bb-e1ff-436e-a1fc-3acf35fd3717">4,439</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestructuringSettlementAndImpairmentProvisions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjAvZnJhZzo1ZDZhMzc1NWNiNTA0YmM2YWQ5NjM0MGRhNTNmYjYwMC90YWJsZTo1MmNkN2RiMWE1ZjI0NGMwOGMxMzRkZDI0MDEzYzI1OC90YWJsZXJhbmdlOjUyY2Q3ZGIxYTVmMjQ0YzA4YzEzNGRkMjQwMTNjMjU4XzMtMS0xLTEtMA_c50075be-9887-4b37-8480-1e2a18a71efe">5,328</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></ix:continuation></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2019, an inventory write-down associated with the repurposing cost of $<ix:nonFraction unitRef="usd" contextRef="i82d2a5bf06814c99a17bdeb480f3837f_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryWriteDown" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjAvZnJhZzo1ZDZhMzc1NWNiNTA0YmM2YWQ5NjM0MGRhNTNmYjYwMC90ZXh0cmVnaW9uOjVkNmEzNzU1Y2I1MDRiYzZhZDk2MzQwZGE1M2ZiNjAwXzEyNjQ0MzgzNzIwODA2_a369ee18-95e4-4a0d-a2ad-025bd4ccb2d2">1,940</ix:nonFraction> was included as part of inventory write-down on the consolidated statements of net income (loss) and comprehensive income (loss). The Company did not incur any further significant costs related to the repurposing activities.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:RestructuringSettlementAndImpairmentProvisions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjAvZnJhZzo1ZDZhMzc1NWNiNTA0YmM2YWQ5NjM0MGRhNTNmYjYwMC90ZXh0cmVnaW9uOjVkNmEzNzU1Y2I1MDRiYzZhZDk2MzQwZGE1M2ZiNjAwXzg3OTYwOTMwMjQ0MTM_503e02bc-192e-4f95-827a-2c08a28f82d9"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:RestructuringSettlementAndImpairmentProvisions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjAvZnJhZzo1ZDZhMzc1NWNiNTA0YmM2YWQ5NjM0MGRhNTNmYjYwMC90ZXh0cmVnaW9uOjVkNmEzNzU1Y2I1MDRiYzZhZDk2MzQwZGE1M2ZiNjAwXzg3OTYwOTMwMjQ0MTM_f0445c26-94f9-40a1-a7d2-5f8183865800">No</ix:nonFraction></ix:nonFraction> repurposing costs were incurred during the years ended December 31, 2020 or December 31, 2018. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, there was <ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:RestructuringReserve" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjAvZnJhZzo1ZDZhMzc1NWNiNTA0YmM2YWQ5NjM0MGRhNTNmYjYwMC90ZXh0cmVnaW9uOjVkNmEzNzU1Y2I1MDRiYzZhZDk2MzQwZGE1M2ZiNjAwXzg3OTYwOTMwMjQ0MjI_d27f4d94-08cd-48f7-b3a5-62e94f469159">no</ix:nonFraction> accrued liability associated with the Company&#8217;s repurposing initiative (December&#160;31, 2019 - $<ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" name="us-gaap:RestructuringReserve" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjAvZnJhZzo1ZDZhMzc1NWNiNTA0YmM2YWQ5NjM0MGRhNTNmYjYwMC90ZXh0cmVnaW9uOjVkNmEzNzU1Y2I1MDRiYzZhZDk2MzQwZGE1M2ZiNjAwXzEyNjQ0MzgzNzIwOTI1_a508deb0-e128-45e8-88f8-3a13ec70d340">907</ix:nonFraction>). All repurposing related charges were incurred within the Rest of World segment.</span></div></ix:continuation><div id="i1ae9134e40e74e0aac958218112e53d4_187"></div><div style="margin-bottom:12pt;margin-top:16pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">29. <ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90ZXh0cmVnaW9uOjkxYTQyNWEyY2NhZTQ0MjRhZjI5NDM4OTAwZTRkZDU0XzI5OTU_d4c84ed2-edb8-430c-afa3-658767ba9752" continuedAt="iaa6f149d41ca4113a1298d34456976de" escape="true">Segment Information</ix:nonNumeric></span></div><ix:continuation id="iaa6f149d41ca4113a1298d34456976de" continuedAt="i05db1ecb24f9496d9d559a2aa10e704c"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment reporting is prepared on the same basis that the Company&#8217;s chief operating decision makers (the &#8220;CODMs&#8221;) manage the business, make operating decisions and assess the Company&#8217;s performance. For the years ended December&#160;31, 2020 and December&#160;31, 2019, the Company determined that it has the following <ix:nonFraction unitRef="segment" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90ZXh0cmVnaW9uOjkxYTQyNWEyY2NhZTQ0MjRhZjI5NDM4OTAwZTRkZDU0XzI4OQ_2a71fa80-4162-4af6-9361-0fa67c035b36">two</ix:nonFraction> reportable segments: United States and Rest of World. </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The United States operating segment consists of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">manufacture and distribution of hemp-derived CBD infused products. </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Rest of World operating segment is involved in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These <ix:nonFraction unitRef="segment" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90ZXh0cmVnaW9uOjkxYTQyNWEyY2NhZTQ0MjRhZjI5NDM4OTAwZTRkZDU0XzY0Nw_5de47f8a-8724-423b-94e7-84600a840f97">two</ix:nonFraction> segments represent the geographic regions in which the Company operates and the different product offerings within each geographic region. The results of each segment are regularly reviewed by the CODMs to assess the performance of the segment and make decisions regarding the allocation of resources. The CODMs review adjusted earnings (loss) before interest, tax, depreciation and amortization (&#8220;Adjusted EBITDA&#8221;) as the measure of segment profit or loss to evaluate performance of and allocate resources for its reportable segments. Adjusted EBITDA is defined as earnings before interest, tax, depreciation, non-cash items and items that do not reflect management&#8217;s assessment of on-going business performance.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reporting by operating segments follows the same accounting policies as those used to prepare the consolidated financial statements. The operating segments are presented in accordance with the same criteria used for internal reporting prepared for the CODMs. Inter-segment transactions are recorded at the stated values as agreed to by the segments.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">112</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December 31, 2020, 2019, and 2018</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for gram and share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div></div><ix:continuation id="i05db1ecb24f9496d9d559a2aa10e704c" continuedAt="i71908af1da014389add1c266cfa2d685"><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90ZXh0cmVnaW9uOjkxYTQyNWEyY2NhZTQ0MjRhZjI5NDM4OTAwZTRkZDU0XzIzNjM5NTAwMDAyNDY2_c0b8bd90-11b0-4f60-865a-0555338e3986" continuedAt="i4f2d03712a024ce3b52942ab6c9d3409" escape="true"><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment data was as follows for the year ended December&#160;31, 2020: </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.455%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.349%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rest of World</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated statements of net income (loss) and comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cannabis flower</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5679f6a0de14f3187b78de4a56cf6f2_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzMtMi0xLTEtMA_ad4f7c38-ee5a-4a84-9b9a-6b10588fafa7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb3e170b4cfb469091d30d5359ec73e7_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzMtNC0xLTEtMA_10442920-4b8a-4fbe-b429-e35c4153d496">27,932</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic74b0207681843f4ae87a38e8e52aa6c_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzMtNi0xLTEtMA_ca33d0de-c124-42f6-9c0d-ea892d5b1244">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb7e744f257046829976b63a309059b9_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzMtOC0xLTEtMA_f8be79fc-c0ac-401f-9556-ce875164d395">27,932</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cannabis extracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73f1c6d398cd46d4acef80d0079dbfb5_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzQtMi0xLTEtMA_23e93f8e-ae76-46d9-9598-77bdab4afd9c">9,495</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86784f31af7f422abd4f659805b08838_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzQtNC0xLTEtMA_5caeea29-875b-4bbe-8604-28a53461522c">8,759</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b0b9f9e9cf7455390995395ccc1002a_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzQtNi0xLTEtMA_fa368dae-52a8-4a0d-82ec-1d6881e86933">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i158da074fdac41459e9ec56ee32c9222_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzQtOC0xLTEtMA_3bcd992c-2957-4fb4-a146-096461e22479">18,254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45f14c47e08249fa81b790dc77e17686_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzUtMi0xLTEtMA_1d174149-3024-4e60-b942-38e93401036f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9065255599649529185c91762527139_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzUtNC0xLTEtMA_70cf2737-b3e6-4655-a400-6347cb38e57b">533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5db08a8f1b08405081996c824923fc8d_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzUtNi0xLTEtMA_12b75804-b53a-4c8d-8991-357734af4ca0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63f66899247a46fa95fe02f9bd08dfaa_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzUtOC0xLTEtMA_3f070988-6e00-4395-9028-6a14ca8407f6">533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d31023501b14c078a65f246b312debe_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzYtMi0xLTEtMA_76523a93-7bf5-4aa7-b38d-4937ec7830db">9,495</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5954e81faf64c3ba7298da392a8d7ee_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzYtNC0xLTEtMA_4e03e3c7-fd6c-491a-a728-9f4f67467b2d">37,224</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3097ac22f054b5ebd188c0484e23f18_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzYtNi0xLTEtMA_fd290bed-3190-461f-a8dd-318e591e568a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzYtOC0xLTEtMA_fce1d177-12b5-4952-97b1-ce129cec0b96">46,719</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share of loss from equity accounted investees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d31023501b14c078a65f246b312debe_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzgtMi0xLTEtMA_b3ff08be-784a-4bf9-ab69-3cf7e18bd54d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5954e81faf64c3ba7298da392a8d7ee_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzgtNC0xLTEtMA_bb15b47b-7900-46f8-bf79-f47153021ea6">4,510</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3097ac22f054b5ebd188c0484e23f18_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzgtNi0xLTEtMA_025575dc-14d3-48ed-b29c-94a86508d335">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzgtOC0xLTEtMA_a8f9fc6c-80cb-40fd-b0a9-043ac4421d41">4,510</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d31023501b14c078a65f246b312debe_D20200101-20201231" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzEwLTItMS0xLTA_84d11531-7069-4c05-a9a6-32b6ad5491f1">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5954e81faf64c3ba7298da392a8d7ee_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzEwLTQtMS0xLTA_138a5628-7ead-4c6d-9b17-ed0e0da578ed">18,585</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3097ac22f054b5ebd188c0484e23f18_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzEwLTYtMS0xLTA_c634f951-2472-4685-88ee-886cc6e10c21">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzEwLTgtMS0xLTA_c694bdb3-33c1-4244-b4be-a712332e9c59">18,601</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d31023501b14c078a65f246b312debe_D20200101-20201231" decimals="-3" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzExLTItMS0xLTA_7caa34da-9bc2-4da5-99ee-0b773e6855dc">34</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5954e81faf64c3ba7298da392a8d7ee_D20200101-20201231" decimals="-3" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzExLTQtMS0xLTA_bb4511f2-428b-4c09-87dc-793e7c361925">152</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3097ac22f054b5ebd188c0484e23f18_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzExLTYtMS0xLTA_b5ef5da7-277f-46c7-aaae-f8893e6dbbb6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzExLTgtMS0xLTA_d2bc5d9f-7494-4746-a7b6-b713674570b6">186</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income (expense), net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d31023501b14c078a65f246b312debe_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzEyLTItMS0xLTA_cab457f9-bffa-4034-9bd4-2a6b43289909">18</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5954e81faf64c3ba7298da392a8d7ee_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzEyLTQtMS0xLTA_d224bd09-ea95-4e93-8293-7f3607e10559">18,433</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3097ac22f054b5ebd188c0484e23f18_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzEyLTYtMS0xLTA_7c789b0b-397d-4803-aab4-d892a2ca6d33">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzEyLTgtMS0xLTA_64be69f5-2257-4230-a4e7-757e3e986b3b">18,415</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d31023501b14c078a65f246b312debe_D20200101-20201231" decimals="-3" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzE0LTItMS0xLTA_c0d4720c-5ad2-488b-a5f2-1989da89e5dd">234</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5954e81faf64c3ba7298da392a8d7ee_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzE0LTQtMS0xLTA_81e8335a-3ac4-4cda-af12-8b470195c96f">2,638</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3097ac22f054b5ebd188c0484e23f18_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzE0LTYtMS0xLTA_716b2816-643a-431e-9afd-cb09e34af542">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzE0LTgtMS0xLTA_f900da4f-e6f5-481c-8077-235c92bf5679">2,872</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d31023501b14c078a65f246b312debe_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzE1LTItMS0xLTA_77ab5359-f992-4ef6-a8f5-a48164e810cd">323</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5954e81faf64c3ba7298da392a8d7ee_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzE1LTQtMS0xLTA_73cb6202-4c00-4990-9004-bd5cb6211759">1,024</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3097ac22f054b5ebd188c0484e23f18_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzE1LTYtMS0xLTA_e2cae3cd-3aae-4f4c-8118-ed0af28f76f3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzE1LTgtMS0xLTA_0e420f10-da4e-41f3-ae40-d9b84434a479">1,347</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss from discontinued operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d31023501b14c078a65f246b312debe_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzE2LTItMS0xLTI3ODU4_d5e0e5d0-ae1b-49e8-a0b9-7ba15a63f021">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5954e81faf64c3ba7298da392a8d7ee_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzE2LTQtMS0xLTI3ODUy_3065e8fd-e981-41ee-99f9-9ad580f4ce2c">650</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3097ac22f054b5ebd188c0484e23f18_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzE2LTYtMS0xLTI3ODU1_8b705dca-76d7-4448-853e-8573fb7ac6de">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzE2LTgtMS0xLTI3ODU1_89c47c94-c734-4fa5-957d-ed2ddb11d593">650</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d31023501b14c078a65f246b312debe_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzE2LTItMS0xLTA_3858dc07-4621-4b01-9e72-475a856a01c6">28,019</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5954e81faf64c3ba7298da392a8d7ee_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzE2LTQtMS0xLTA_ee149989-530b-4d8b-878b-680f9e99130f">98,349</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic3097ac22f054b5ebd188c0484e23f18_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzE2LTYtMS0xLTA_43331a20-167a-4f50-87c3-9736693be1c8">20,885</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzE2LTgtMS0xLTA_c16a682e-b43c-4bc3-ba4e-55e5dad0d6e2">147,253</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated balance sheets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49db693fb9be41b0a5889e6879f777d0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzE5LTItMS0xLTA_76314b5b-4f15-4860-8cfc-a4b3d8ba6a1d">253,745</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b096543d02048f3936893861bbb9c57_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzE5LTQtMS0xLTA_a7f8f65d-8d0c-481a-b998-0c94bb8e8ea9">388,351</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbf8d53ce8964a6cb53e6e367fb6b9a5_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzE5LTYtMS0xLTA_ba17112e-a231-4e54-9a92-09c6e98fa390">1,283,586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzE5LTgtMS0xLTA_e77bd16b-7884-4149-8119-cbb8b50bd9fe">1,925,682</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments in equity accounted investees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49db693fb9be41b0a5889e6879f777d0_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:EquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzIwLTItMS0xLTA_a28488ef-1b20-42bc-8ec6-5d546989a71e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b096543d02048f3936893861bbb9c57_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzIwLTQtMS0xLTA_32860581-cda0-4bcb-a5b9-2a728487130f">19,235</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbf8d53ce8964a6cb53e6e367fb6b9a5_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:EquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzIwLTYtMS0xLTA_79876da5-3560-43a2-ac81-86761dff0c49">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzIwLTgtMS0xLTA_ec7c167a-4202-4ab1-be39-4d2c1ee7b17f">19,235</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49db693fb9be41b0a5889e6879f777d0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzIxLTItMS0xLTA_fc4cb35e-ec4a-4d89-80b7-32cafd0389c4">178,414</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b096543d02048f3936893861bbb9c57_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzIxLTQtMS0xLTA_c3cbd6cf-0ed8-4d8e-b574-d9c756c1f661">1,108</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbf8d53ce8964a6cb53e6e367fb6b9a5_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzIxLTYtMS0xLTA_a38ed6c1-8d60-4619-9d64-e5ffa6a665fe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzIxLTgtMS0xLTA_4f0ff331-f005-415b-905c-d89c1ff4a369">179,522</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of property, plant and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d31023501b14c078a65f246b312debe_D20200101-20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAdditions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzIyLTItMS0xLTA_f7d71c14-a202-49ba-9b91-c268e04ba839">385</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5954e81faf64c3ba7298da392a8d7ee_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAdditions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzIyLTQtMS0xLTA_bd890d68-40d8-44f0-81a4-d8aab091809e">31,027</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3097ac22f054b5ebd188c0484e23f18_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:PropertyPlantAndEquipmentAdditions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzIyLTYtMS0xLTA_73e3a45c-e475-446c-88e3-862d0358f851">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAdditions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzIyLTgtMS0xLTA_8fc4bd55-00b2-4766-832a-32c6836a30f5">31,412</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment data was as follows for the year ended December&#160;31, 2019:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.544%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.464%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.464%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.464%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.464%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.328%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rest of World</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated statements of net income (loss) and comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cannabis flower</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87e3d771deca41988f620fd82eacf084_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzMtMi0xLTEtMA_af67dc73-63d7-4eaa-8a5f-65c3409433f0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28e5d16c824541219fc781472e67c692_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzMtNC0xLTEtMA_6100a3f9-355b-4634-9d58-200ce0d4643a">15,020</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic24540413fdd498693ce6bf7a6976a31_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzMtNi0xLTEtMA_87987430-ea7e-4d6b-b780-d0214312587a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icacdfb65bc3149b38b733a4732feeebb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzMtOC0xLTEtMA_f32906ca-a116-44e5-b30f-6644626234a1">15,020</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cannabis extracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59f625a78ed547beb8ff59308e54c2e5_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzQtMi0xLTEtMA_a5789ed7-cf33-4c7a-8cff-ddf1238a66d5">3,364</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c61172a844842b28da319f1cee9e445_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzQtNC0xLTEtMA_60737ad3-f8fc-436d-8b08-409c930769b2">5,338</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i800f69cd597e4aeca9c474e6c7edd75b_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzQtNi0xLTEtMA_bf77cda1-bbbc-4c3b-9291-2b42a0ebca7b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib13faff76de54e4d94e71c14d2ef55b9_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzQtOC0xLTEtMA_9d1e0baa-2663-4e20-91c4-bd736028a40d">8,702</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb03c1afaee344b99a3f11897f6b00a4_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzUtMi0xLTEtMA_99ecf844-329b-4fc1-895b-3738643fd169">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e57dab2b0d04fc68e252c1b8917c76a_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzUtNC0xLTEtMA_ba935f6a-28b2-45d0-90b7-bbc1e9630919">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd1d6f418f5d4c8e9280169b3a3fb722_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzUtNi0xLTEtMA_9578eb90-3f0e-4816-8c09-077d0974e4b1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68edd065b3774520abe09eb1c8de7c1f_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzUtOC0xLTEtMA_4e62531f-81ac-4760-b389-89bf87f6c9d1">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26a43a36f7b84e17a5c4a3f441a8d61b_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzYtMi0xLTEtMA_9e5bff97-cef7-4fc4-8763-91b440b78f1f">3,364</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc0349f558524b69a56d1b79ef3651be_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzYtNC0xLTEtMA_cbdb2cf5-a2f2-45d7-a3ca-059d784a968e">20,386</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee19945c297442c99fabe50468a25677_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzYtNi0xLTEtMA_f1d3b449-2591-4c1a-a065-a4cd4d5e0846">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzYtOC0xLTEtMA_e649175d-0162-4b3c-b62b-8cf9546c2bf6">23,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share of loss from equity accounted investees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26a43a36f7b84e17a5c4a3f441a8d61b_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzgtMi0xLTEtMA_12482b5d-4863-4da2-92c7-3757a9f8310a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icc0349f558524b69a56d1b79ef3651be_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzgtNC0xLTEtMA_15fef223-e558-4e45-8fda-9c366ce868ca">2,009</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee19945c297442c99fabe50468a25677_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzgtNi0xLTEtMA_dc0064ba-97b2-4795-ad36-d1bfefe41b07">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzgtOC0xLTEtMA_95feb0f7-d16a-4298-b230-b197ae05fb07">2,009</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26a43a36f7b84e17a5c4a3f441a8d61b_D20190101-20191231" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzEwLTItMS0xLTA_483855a8-5c81-43de-8dd7-dc69ac9eaacb">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc0349f558524b69a56d1b79ef3651be_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzEwLTQtMS0xLTA_73a5dfd2-0e20-421a-afc1-f4438880bfee">29,207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee19945c297442c99fabe50468a25677_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzEwLTYtMS0xLTA_56f9c9b8-f300-4955-93e7-45160c96e81f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzEwLTgtMS0xLTA_741d90b1-4abf-42b1-a394-a85b2aa3da3f">29,213</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26a43a36f7b84e17a5c4a3f441a8d61b_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzExLTItMS0xLTA_7f218481-8250-4770-87af-c441aff82261">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icc0349f558524b69a56d1b79ef3651be_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzExLTQtMS0xLTA_68c47a78-0f91-49e2-98a0-104e316540ab">1,244</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee19945c297442c99fabe50468a25677_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzExLTYtMS0xLTA_b78c852d-aa45-42b4-8213-6199fefea8f4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzExLTgtMS0xLTA_30f80ee1-8252-4c6b-a56b-c5a994fcd8df">1,244</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26a43a36f7b84e17a5c4a3f441a8d61b_D20190101-20191231" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzEyLTItMS0xLTA_8b6cc1b6-774a-4a95-b1ed-5926450a34ab">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc0349f558524b69a56d1b79ef3651be_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzEyLTQtMS0xLTA_45d0431d-a0fd-4dfb-93e2-96f487283f6c">27,963</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee19945c297442c99fabe50468a25677_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzEyLTYtMS0xLTA_54640d05-3902-4011-abd8-2bca36ee8eec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzEyLTgtMS0xLTA_52ac803e-950e-46d9-9adf-31fbc5455105">27,969</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26a43a36f7b84e17a5c4a3f441a8d61b_D20190101-20191231" decimals="-3" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzE0LTItMS0xLTA_ea9d7098-94fa-42e9-b534-e75e7b611dda">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc0349f558524b69a56d1b79ef3651be_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzE0LTQtMS0xLTA_e362871f-cc6f-400d-bdb4-32b3d7d95053">2,044</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee19945c297442c99fabe50468a25677_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzE0LTYtMS0xLTA_7a795165-f74e-455d-9a69-9dab6e8b2da2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzE0LTgtMS0xLTA_e5ec5344-ca31-462d-85aa-48b5bf8a3777">2,090</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26a43a36f7b84e17a5c4a3f441a8d61b_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzE1LTItMS0xLTA_29e2e2a7-583a-4f9e-bf14-9fffc3669d65">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc0349f558524b69a56d1b79ef3651be_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzE1LTQtMS0xLTA_d980ce15-8aed-437c-bc3e-db848328c8ef">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee19945c297442c99fabe50468a25677_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzE1LTYtMS0xLTA_dfe7dfaf-8358-4e28-8398-2e7bc913caba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzE1LTgtMS0xLTA_a97a8d92-a5ec-4fd7-852e-dd267c36abe4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss from discontinued operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26a43a36f7b84e17a5c4a3f441a8d61b_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzE2LTItMS0xLTI3ODYy_85383f27-aa51-4125-85a7-ea2f37583878">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icc0349f558524b69a56d1b79ef3651be_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzE2LTQtMS0xLTI3ODYy_2aee1753-5715-4199-ac54-bcd0cbdc6f57">363</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee19945c297442c99fabe50468a25677_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzE2LTYtMS0xLTI3ODY1_e9ddeadc-9847-4b79-879a-1c90fd8bb474">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzE2LTgtMS0xLTI3ODY1_1c882509-8357-4a25-b175-bcfc84ee640f">363</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i26a43a36f7b84e17a5c4a3f441a8d61b_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzE2LTItMS0xLTA_450b24a0-0e8b-4747-a61c-47489fc8a106">1,703</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icc0349f558524b69a56d1b79ef3651be_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzE2LTQtMS0xLTA_4d238ea1-1065-4fa0-ab82-da3c27eea1d8">84,826</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iee19945c297442c99fabe50468a25677_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzE2LTYtMS0xLTA_0ef8c085-29db-46c6-9f04-11ecb08f39dd">11,779</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzE2LTgtMS0xLTA_5fddecc4-7b43-4d57-a442-6bb924a89213">98,308</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated balance sheets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b5ddf61e50c4278b9972461d7753caf_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzE5LTItMS0xLTA_c74c7e5b-65af-49c8-968b-706fe4c06fcf">293,985</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a85a077911e4fc5bdd4f6817869ec0e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzE5LTQtMS0xLTA_2dba05f1-62f2-40f8-8618-d8b670f4775c">309,854</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcea1837f8ed4b229e10b2a1aa122696_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzE5LTYtMS0xLTA_cb62a095-cfd9-423e-9296-1159df1f365f">1,486,603</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzE5LTgtMS0xLTA_71613568-e5ce-44e2-85b8-d324e3851f22">2,090,442</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments in equity accounted investees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b5ddf61e50c4278b9972461d7753caf_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:EquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzIwLTItMS0xLTA_78ac7609-e910-4ec8-be42-1887f2a89541">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a85a077911e4fc5bdd4f6817869ec0e_I20191231" decimals="-3" name="us-gaap:EquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzIwLTQtMS0xLTA_d120f812-2896-48ae-8201-264077f181da">557</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcea1837f8ed4b229e10b2a1aa122696_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:EquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzIwLTYtMS0xLTA_49b3ccd2-11d3-4723-9f99-64359a762566">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" name="us-gaap:EquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzIwLTgtMS0xLTA_ff203da7-dff4-4fec-9cec-06a8e9d1cb95">557</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b5ddf61e50c4278b9972461d7753caf_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzIxLTItMS0xLTA_b18142e7-a59e-40f1-bde3-00e0433eaf6d">213,414</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a85a077911e4fc5bdd4f6817869ec0e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzIxLTQtMS0xLTA_abc96fc7-9fab-437f-86f2-8f2b24a6b7fb">1,078</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcea1837f8ed4b229e10b2a1aa122696_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzIxLTYtMS0xLTA_6ff0f512-e41b-4c56-b964-74f16d9e5396">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzIxLTgtMS0xLTA_f82da0df-25b3-49ac-be71-baf71259a7de">214,492</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of property, plant and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26a43a36f7b84e17a5c4a3f441a8d61b_D20190101-20191231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAdditions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzIyLTItMS0xLTA_2aba7e82-7254-46c9-ab93-60599af282ce">259</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc0349f558524b69a56d1b79ef3651be_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAdditions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzIyLTQtMS0xLTA_58e5bd69-a15b-4333-8a32-18fd959a4e5a">38,405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee19945c297442c99fabe50468a25677_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:PropertyPlantAndEquipmentAdditions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzIyLTYtMS0xLTA_1c18e3a8-74b3-4515-8134-66e6499d559e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAdditions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzIyLTgtMS0xLTA_a0b282ac-c1e1-46a8-beaf-4e5d0abc06e4">38,664</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">113</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December 31, 2020, 2019, and 2018</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for gram and share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div></div><ix:continuation id="i71908af1da014389add1c266cfa2d685" continuedAt="ic8a122f7bf3c44ed866262066c0d37f4"><ix:continuation id="i4f2d03712a024ce3b52942ab6c9d3409" continuedAt="ief642357ba3845c4ae64390d5294862d"><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment data was as follows for the year ended December&#160;31, 2018: </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.594%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.188%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.349%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rest of World</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated statements of net income (loss) and comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cannabis flower</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice17379b564a4ac8b872312066dc43c9_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzMtMi0xLTEtMzc4Mg_fad197dd-32ea-4a87-ba53-631d47f294b5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic30fa899f34b4e0785f35d709b796c68_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzMtNC0xLTEtMzc4Mg_8c891ed0-133c-4f99-90a3-8687a2aa0144">9,210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacacb166b362411ab04c61d50004c298_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzMtOC0xLTEtMzc4Mg_c5b524fc-6636-4794-aae2-c76339866451">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10910e1c9ff24da3a8beeb51e8fc6acf_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzMtMTAtMS0xLTM3ODI_a598a1c0-baff-4529-8589-79187f9ef73e">9,210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cannabis extracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80f7ba51cebb4bd485ecda47d16121b2_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzQtMi0xLTEtMzc4Mg_c386c22f-862c-4078-b424-b7bed699a63e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35a6164687bf4736be585df4b9716950_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzQtNC0xLTEtMzc4Mg_2c5dbb8c-698d-4d71-b528-82227715a429">2,732</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7744b3aecb5149939539b0f65c16f9e8_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzQtOC0xLTEtMzc4Mg_f1ba5f22-adf2-4835-9964-d8bb9b4f2f16">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idca36084581840b492066eea650a5de4_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzQtMTAtMS0xLTM3ODI_c951c2c2-6e2d-4521-a446-c3ee773f7966">2,732</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0086f87b13ed455fad8a005cb0c06132_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzUtMi0xLTEtMzc4Mg_524124b4-b4cb-4cae-b65d-df86943e3c6a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5bec23ced2546878d05f11ba1514eb0_D20180101-20181231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzUtNC0xLTEtMzc4Mg_c4ca55e2-0475-4af8-9af6-47706d1484d6">179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f04fed468264acaba7cd3b71598765d_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzUtOC0xLTEtMzc4Mg_4d1cfbae-c1ad-4fe5-ba34-5c58e31bd916">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45ffa1a1923c4ad9a143f62075390ee2_D20180101-20181231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzUtMTAtMS0xLTM3ODI_b882f733-7d86-4517-b47f-8c4106ffe35f">179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa76c191d29f4ff1b49de04caf646517_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzYtMi0xLTEtMzc4Mg_f674147f-2f68-4720-9370-b9fddc611382">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdd45fb7a8f94242bcc47ddfad9317d5_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzYtNC0xLTEtMzc4Mg_0db983f6-3ad7-4fba-ae24-c2a1e588b8a4">12,121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie88f3bf44b8f4d0398751e5198d4d80b_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzYtOC0xLTEtMzc4Mg_924e3640-1659-410e-b185-6a4e2f807c9f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzYtMTAtMS0xLTM3ODI_7a0ccb9a-251a-425e-baee-f1b9c7cc978e">12,121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share of loss from equity accounted investees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa76c191d29f4ff1b49de04caf646517_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzctMi0xLTEtMzc4Mg_cba4f82f-ced8-4fea-9427-2f8471bc10a2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifdd45fb7a8f94242bcc47ddfad9317d5_D20180101-20181231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzctNC0xLTEtMzc4Mg_7c04f31e-c8f7-4fed-9e74-5fed8e2dba70">723</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie88f3bf44b8f4d0398751e5198d4d80b_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzctOC0xLTEtMzc4Mg_e7dd9c5a-327b-4742-9615-44615dc6a030">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzctMTAtMS0xLTM3ODI_bfd0772b-b4e7-4a44-8712-a791d5b8c22b">723</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa76c191d29f4ff1b49de04caf646517_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzgtMi0xLTEtMzc4Mg_42f6ffe6-cbc6-41cc-976b-d6a3d7e29920">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdd45fb7a8f94242bcc47ddfad9317d5_D20180101-20181231" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzgtNC0xLTEtMzc4Mg_0a186aaa-6770-4712-b1c7-982aae393911">220</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie88f3bf44b8f4d0398751e5198d4d80b_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzgtOC0xLTEtMzc4Mg_61001d46-58dc-4e94-b431-4df015443d84">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzgtMTAtMS0xLTM3ODI_4b10a1f1-2f82-47d8-a620-7c258fe6c41a">220</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa76c191d29f4ff1b49de04caf646517_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzktMi0xLTEtMzc4Mg_0c0b2a1b-4309-4680-97ae-cf3d31f584af">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifdd45fb7a8f94242bcc47ddfad9317d5_D20180101-20181231" decimals="-3" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzktNC0xLTEtMzc4Mg_a762abb9-1f9c-4365-a00b-e84cff42bf86">139</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie88f3bf44b8f4d0398751e5198d4d80b_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzktOC0xLTEtMzc4Mg_c2e0b9e3-3b00-461a-b484-dd1f208751ee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzktMTAtMS0xLTM3ODI_06fc8ed0-c149-4230-91a8-0859c5d89784">139</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa76c191d29f4ff1b49de04caf646517_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzEwLTItMS0xLTM3ODI_b23457ee-4408-4503-a47a-44708388d65e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdd45fb7a8f94242bcc47ddfad9317d5_D20180101-20181231" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzEwLTQtMS0xLTM3ODI_d7ee0d71-ed84-4c99-b6fd-af3d5f90ea6a">81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie88f3bf44b8f4d0398751e5198d4d80b_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzEwLTgtMS0xLTM3ODI_c36ede31-43e4-46b9-877a-a7b0644636bd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzEwLTEwLTEtMS0zNzgy_337d7afc-8592-445e-bd08-d7d0bc63bd93">81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa76c191d29f4ff1b49de04caf646517_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzExLTItMS0xLTM3ODI_c5109763-9718-4795-87ee-53e6100fdc61">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdd45fb7a8f94242bcc47ddfad9317d5_D20180101-20181231" decimals="-3" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzExLTQtMS0xLTM3ODI_29a37337-d2dd-4441-b233-726238584d20">807</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie88f3bf44b8f4d0398751e5198d4d80b_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzExLTgtMS0xLTM3ODI_62cd95a9-effe-4b2f-bf44-ca00be88415f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzExLTEwLTEtMS0zNzgy_a4c7a0a2-6c78-4366-9c42-ac7ca9f090e3">807</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa76c191d29f4ff1b49de04caf646517_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzEyLTItMS0xLTM3ODI_a05dfce1-bd65-4994-8419-30b4d8394423">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdd45fb7a8f94242bcc47ddfad9317d5_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzEyLTQtMS0xLTM3ODI_ca742e1c-0db1-49d6-b9a5-12af57b5bcfa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie88f3bf44b8f4d0398751e5198d4d80b_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzEyLTgtMS0xLTM3ODI_6994aaca-7cc9-47c3-b9ec-40634c1d3515">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzEyLTEwLTEtMS0zNzgy_482a0f33-02f0-4b0b-b9e3-3c3edc7f0e45">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss from discontinued operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa76c191d29f4ff1b49de04caf646517_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzE1LTItMS0xLTI3ODY5_34710d6a-0328-4005-b8ab-083ce6aa4757">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifdd45fb7a8f94242bcc47ddfad9317d5_D20180101-20181231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzE1LTQtMS0xLTI3ODY5_84c470e2-719f-4862-bffc-87b404455bc6">894</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie88f3bf44b8f4d0398751e5198d4d80b_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzE1LTYtMS0xLTI3ODcy_bb132efc-616d-475a-8a30-47c2456e78cd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzE1LTgtMS0xLTI3ODcy_61192980-4d70-45c5-af7a-924d79d18db7">894</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa76c191d29f4ff1b49de04caf646517_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzEzLTItMS0xLTM3ODI_30484e98-53f5-4f0f-820e-24436d0e61f0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifdd45fb7a8f94242bcc47ddfad9317d5_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzEzLTQtMS0xLTM3ODI_19059884-20bb-4379-baa0-b7f043e573f0">10,357</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie88f3bf44b8f4d0398751e5198d4d80b_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzEzLTgtMS0xLTM3ODI_da7fd0cd-cc3c-4351-973b-62b03d6736af">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzEzLTEwLTEtMS0zNzgy_873340cd-0694-417b-8744-4a0157f3a98e">10,357</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated balance sheets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb62e4fdf37447a3b94f42364a71921e_I20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzE2LTItMS0xLTM3ODI_5e61efd2-da57-4629-8498-02b3fac998cd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifee12228e043414085a5b8c975e48649_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzE2LTQtMS0xLTM3ODI_85b037e5-ae92-4105-bae3-b954dc870817">183,471</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ffe119a68b34b9abbb2f8b5078b5b89_I20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzE2LTgtMS0xLTM3ODI_95921306-740a-4a44-af7f-fee9af05fb7f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9717dc3b24b24c93ab09a6bfa9b52c89_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzE2LTEwLTEtMS0zNzgy_1b4cbdc7-5e1b-461d-a419-dd637e908bf4">183,471</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments in equity accounted investees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb62e4fdf37447a3b94f42364a71921e_I20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:EquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzE3LTItMS0xLTM3ODI_7c8dca3c-2a97-4ea8-896b-e046a6833153">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifee12228e043414085a5b8c975e48649_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzE3LTQtMS0xLTM3ODI_36891757-b6db-420c-a1e9-b10cf4afe6b0">2,960</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ffe119a68b34b9abbb2f8b5078b5b89_I20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:EquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzE3LTgtMS0xLTM3ODI_39162c8d-2d13-4504-91df-b24e051e42b9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9717dc3b24b24c93ab09a6bfa9b52c89_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzE3LTEwLTEtMS0zNzgy_b434ed69-1760-4aa2-81b3-eb0de38efcb6">2,960</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb62e4fdf37447a3b94f42364a71921e_I20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzE4LTItMS0xLTM3ODI_c86e3462-7b96-4c48-acad-f4999d41eaaa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifee12228e043414085a5b8c975e48649_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzE4LTQtMS0xLTM3ODI_95078cfb-62a5-465a-a7f7-6d279cd8d161">1,314</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ffe119a68b34b9abbb2f8b5078b5b89_I20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzE4LTgtMS0xLTM3ODI_23a51cf0-0389-480c-9782-77bdf2fb6404">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9717dc3b24b24c93ab09a6bfa9b52c89_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzE4LTEwLTEtMS0zNzgy_91ae5e94-d445-4bf3-9e6d-0e0117424c12">1,314</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of property, plant and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa76c191d29f4ff1b49de04caf646517_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:PropertyPlantAndEquipmentAdditions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzE5LTItMS0xLTM3ODI_cc28e64a-3ac3-4424-a2e6-6da8f5fa58af">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdd45fb7a8f94242bcc47ddfad9317d5_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAdditions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzE5LTQtMS0xLTM3ODI_575c33ff-e574-44c3-95e0-b5308e0fa060">88,308</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie88f3bf44b8f4d0398751e5198d4d80b_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:PropertyPlantAndEquipmentAdditions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzE5LTgtMS0xLTM3ODI_674b0421-c031-4282-bb8d-680d8187e5f6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAdditions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzE5LTEwLTEtMS0zNzgy_2cc0bf4d-5612-4d9f-a9d0-bfabc9c9650f">88,308</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted EBITDA is reconciled to net income (loss) as follows for the years ended December&#160;31, 2020, 2019 and 2018:</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.677%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.483%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.483%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.483%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.486%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands of U.S. dollars)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December&#160;31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ROW</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate<br/>Expenses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d31023501b14c078a65f246b312debe_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzItMi0xLTEtMzEyMTY_1f798361-437f-428f-b9a0-85b18520367b">77,368</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5954e81faf64c3ba7298da392a8d7ee_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzItNC0xLTEtMzEyMTY_a84d10b4-3e3d-40cd-b587-a76825b7e421">32,671</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic3097ac22f054b5ebd188c0484e23f18_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzItNi0xLTEtMzEyMTY_3908a4c2-1426-4531-afa4-1420efe9d72c">30,573</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzItOC0xLTEtMzEyMTY_ae546382-c533-4daf-adc9-1a73f7c7e17b">75,270</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense (income), net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d31023501b14c078a65f246b312debe_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzQtMi0xLTEtMzEyMTY_2242652a-7ee0-4b19-b174-5db1aabafb3a">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5954e81faf64c3ba7298da392a8d7ee_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzQtNC0xLTEtMzEyMTY_7d40cc1e-33dc-45cf-80cc-97db3a5cfc98">18,433</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3097ac22f054b5ebd188c0484e23f18_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzQtNi0xLTEtMzEyMTY_3d0d8469-ec76-496e-a85b-c7f62aa9eaca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzQtOC0xLTEtMzEyMTY_d3dd9ed9-53f9-4839-94b3-90b6485c8927">18,415</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d31023501b14c078a65f246b312debe_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzUtMi0xLTEtMzEyMTY_4c5873d1-8673-4001-93cb-b5603b23d050">323</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5954e81faf64c3ba7298da392a8d7ee_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzUtNC0xLTEtMzEyMTY_e3ddbb4e-e0b1-4356-9416-b9caba41cab4">1,024</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3097ac22f054b5ebd188c0484e23f18_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzUtNi0xLTEtMzEyMTY_b79819af-ef8b-4ee4-ad74-e39d8baecd2c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzUtOC0xLTEtMzEyMTY_b19c0310-967e-4e4d-92b0-9ab2686cb24f">1,347</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairment loss on goodwill and intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d31023501b14c078a65f246b312debe_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzYtMi0xLTEtMzEyMTY_49846468-68f8-4d83-849f-2fb77119fb46">40,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5954e81faf64c3ba7298da392a8d7ee_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzYtNC0xLTEtMzEyMTY_1b717078-c8de-49cf-8bc3-6c083b1f8381">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3097ac22f054b5ebd188c0484e23f18_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzYtNi0xLTEtMzEyMTY_a1189b09-ada7-4659-bc62-3750e5b70f05">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzYtOC0xLTEtMzEyMTY_b6113472-c36c-4fa7-bd48-dec63c141b6f">40,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financing and transaction costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d31023501b14c078a65f246b312debe_D20200101-20201231" decimals="-3" name="us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzgtMi0xLTEtMzEyMTY_4693e53c-2124-42b7-ad85-470f1f3c2db1">40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5954e81faf64c3ba7298da392a8d7ee_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzgtNC0xLTEtMzEyMTY_96d0f9f5-79c2-4fcc-93cc-a171dccbccf3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3097ac22f054b5ebd188c0484e23f18_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzgtNi0xLTEtMzEyMTY_c9a04f84-d25d-4937-b163-74edd744dd43">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" name="us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzgtOC0xLTEtMzEyMTY_d126ee13-94c7-4534-ad82-dde4bc458484">40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain on revaluation of derivative liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d31023501b14c078a65f246b312debe_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzktMi0xLTEtMzEyMTY_c3a47236-7551-4c2f-9219-96e8b3d4b66f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5954e81faf64c3ba7298da392a8d7ee_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzktNC0xLTEtMzEyMTY_16fcd9ba-be1f-4d8e-8635-96c5c6889ab8">129,254</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3097ac22f054b5ebd188c0484e23f18_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzktNi0xLTEtMzEyMTY_a8c8d3dd-57d8-4436-8a09-3220e2fbbf5f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzktOC0xLTEtMzEyMTY_4e8c4d72-acf0-4466-8913-4f50a45e01e8">129,254</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain on disposal of other investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d31023501b14c078a65f246b312debe_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzExLTItMS0xLTMxMjE2_aece9194-52d1-482a-a740-58313af1996f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5954e81faf64c3ba7298da392a8d7ee_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzExLTQtMS0xLTMxMjE2_5bd7b8aa-ea88-4c65-9f50-e2b882bab833">4,789</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3097ac22f054b5ebd188c0484e23f18_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzExLTYtMS0xLTMxMjE2_85a267ff-a7cd-483a-a438-832d3899a128">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzExLTgtMS0xLTMxMjE2_a15c34d7-650f-4d4e-8c74-230f0f981bf2">4,789</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share of loss from equity accounted investees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d31023501b14c078a65f246b312debe_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzEyLTItMS0xLTMxMjE2_b589520d-b583-4b3b-83c8-eb5dd0338d06">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5954e81faf64c3ba7298da392a8d7ee_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzEyLTQtMS0xLTMxMjE2_243c6b52-c70e-42ca-8bc0-b6793583d073">4,510</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3097ac22f054b5ebd188c0484e23f18_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzEyLTYtMS0xLTMxMjE2_c202c803-1b74-4b18-be43-d86f16799b15">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzEyLTgtMS0xLTMxMjE2_48865ce7-21d7-4d95-b7ae-7789dded61ef">4,510</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss from discontinued operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d31023501b14c078a65f246b312debe_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzE1LTItMS0xLTMxMjE2_e2319dad-3ae6-42d1-aa46-7086a64f9c43">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5954e81faf64c3ba7298da392a8d7ee_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzE1LTQtMS0xLTMxMjE2_1d84f1e2-fd32-46f3-b365-757cf1fcfc17">650</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3097ac22f054b5ebd188c0484e23f18_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzE1LTYtMS0xLTMxMjE2_6e9490ed-8423-4def-934b-7c2810b77666">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzE1LTgtMS0xLTMxMjE2_d0547e3c-85e2-4920-bb0b-603e25c8c857">650</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other loss (income)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d31023501b14c078a65f246b312debe_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzE3LTItMS0xLTMxMjE2_7768c254-4001-4e5a-94de-77adfb9b6b23">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5954e81faf64c3ba7298da392a8d7ee_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzE3LTQtMS0xLTMxMjE2_1a86b8ef-ba48-466b-93f8-e26fae21b826">1,814</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3097ac22f054b5ebd188c0484e23f18_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzE3LTYtMS0xLTMxMjE2_83e826aa-f998-4aa1-977a-95c2aaa9a6be">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzE3LTgtMS0xLTMxMjE2_bb435387-4fbf-47d4-aa43-35e1bfbc8c97">1,834</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Review costs related to restatement of 2019 interim financial statements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d31023501b14c078a65f246b312debe_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="cron:RestatementReviewExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzE2LTItMS0xLTMyMzIy_ebaf3f64-446b-46d4-b467-e23167caeead">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5954e81faf64c3ba7298da392a8d7ee_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="cron:RestatementReviewExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzE2LTQtMS0xLTMyMzIy_eee78547-191c-4690-8db3-fb2d3c31195d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3097ac22f054b5ebd188c0484e23f18_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="cron:RestatementReviewExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzE2LTYtMS0xLTMyMzIy_822b9074-7151-4fc5-926a-cc67849dfb75">9,688</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="cron:RestatementReviewExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzE2LTgtMS0xLTMyMzIy_dade2f56-8a0c-4afd-acf5-9d1218607aa6">9,688</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d31023501b14c078a65f246b312debe_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzE4LTItMS0xLTMxMjE2_2c9582c7-8fc9-4d82-bfd7-a86fbb26e53c">8,714</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5954e81faf64c3ba7298da392a8d7ee_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzE4LTQtMS0xLTMxMjE2_225651d9-8bf5-465c-89ee-0b5b20e92405">6,647</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3097ac22f054b5ebd188c0484e23f18_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzE4LTYtMS0xLTMxMjE2_a61a82df-2ce9-4137-bfb7-03ad4154d85b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzE4LTgtMS0xLTMxMjE2_37c7cc29-5e11-4e7c-97a0-26525a992730">15,361</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBIT</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d31023501b14c078a65f246b312debe_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:AdjustedEarningsBeforeInterestAndTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzE5LTItMS0xLTMxMjE2_0d7e10b3-3ea0-4978-97d3-4b8e1ae27b09">28,253</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5954e81faf64c3ba7298da392a8d7ee_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:AdjustedEarningsBeforeInterestAndTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzE5LTQtMS0xLTMxMjE2_1bcecfb5-0323-4ad0-82b3-d70f43b973d8">105,160</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic3097ac22f054b5ebd188c0484e23f18_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:AdjustedEarningsBeforeInterestAndTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzE5LTYtMS0xLTMxMjE2_afb1989e-4f4c-4c21-9102-edf8ad3c36fe">20,885</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:AdjustedEarningsBeforeInterestAndTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzE5LTgtMS0xLTMxMjE2_ead625fa-dde8-4b96-8592-5b0310c91b7d">154,298</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d31023501b14c078a65f246b312debe_D20200101-20201231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzIxLTItMS0xLTMxMjE2_f3a5f08a-72ef-4d28-b2df-3cb35cf591aa">234</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5954e81faf64c3ba7298da392a8d7ee_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzIxLTQtMS0xLTMxMjE2_5cb657dc-b3ad-49a5-8f9f-16f04975a390">6,811</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3097ac22f054b5ebd188c0484e23f18_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzIxLTYtMS0xLTMxMjE2_c128aa38-71c6-4f26-848e-7276f57b59cb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzIxLTgtMS0xLTMxMjE2_ba7bf55e-ffaf-42f0-8293-034bfdf9ba00">7,045</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d31023501b14c078a65f246b312debe_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzIyLTItMS0xLTMxMjE2_3e1745d1-cd23-437b-abdf-8aaa7ca4c113">28,019</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5954e81faf64c3ba7298da392a8d7ee_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzIyLTQtMS0xLTMxMjE2_9a55bdf2-512c-46dd-9aab-1036fe9bcffc">98,349</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic3097ac22f054b5ebd188c0484e23f18_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzIyLTYtMS0xLTMxMjE2_1eff6b97-cf68-4962-9c7e-fe2f3a524f9a">20,885</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzIyLTgtMS0xLTMxMjE2_c1578f60-801a-4905-ac90-a6943b5ff679">147,253</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">114</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December 31, 2020, 2019, and 2018</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for gram and share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div></div><ix:continuation id="ic8a122f7bf3c44ed866262066c0d37f4" continuedAt="i6eb82403b0624184a2ca42b471e97ba3"><ix:continuation id="ief642357ba3845c4ae64390d5294862d"><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.347%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands of U.S. dollars)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December&#160;31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ROW</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate<br/>Expenses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i26a43a36f7b84e17a5c4a3f441a8d61b_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzItMi0xLTEtMzEyMTY_9a41fbe2-0a2a-4c4a-9ce5-b7cff18a28d5">3,070</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc0349f558524b69a56d1b79ef3651be_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzItNC0xLTEtMzEyMTY_68f1e610-e082-4a9f-b5e4-dfba0c123c2c">1,180,241</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iee19945c297442c99fabe50468a25677_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzItNi0xLTEtMzEyMTY_e902c04d-4797-41e7-b0e3-1effb8234ec7">11,597</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzItOC0xLTEtMzEyMTY_de794a77-fbe2-458c-b90e-69dd07998ef3">1,165,574</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i26a43a36f7b84e17a5c4a3f441a8d61b_D20190101-20191231" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzQtMi0xLTEtMzEyMTY_b13fb6a8-1572-44ce-8649-c62d42317d21">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icc0349f558524b69a56d1b79ef3651be_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzQtNC0xLTEtMzEyMTY_a00e9527-72fd-4cb9-9f1a-8b13b0122d97">27,963</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee19945c297442c99fabe50468a25677_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzQtNi0xLTEtMzEyMTY_9f4d3f07-d074-4c0d-aa76-8025d782e05e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzQtOC0xLTEtMzEyMTY_b9d4ce5e-878f-495a-9b8a-4e466c7c0cd0">27,969</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairment loss on goodwill and intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26a43a36f7b84e17a5c4a3f441a8d61b_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzYtMi0xLTEtMzEyMTY_c92b1f1f-894e-4608-a728-05c3413e72b0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc0349f558524b69a56d1b79ef3651be_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzYtNC0xLTEtMzEyMTY_8d6b5e08-73a3-4d2c-829e-f6b5c78d8387">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee19945c297442c99fabe50468a25677_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzYtNi0xLTEtMzEyMTY_db00355f-2789-4d52-91c3-f68b4bd82868">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzYtOC0xLTEtMzEyMTY_31e6349c-cacf-491d-9516-dcba8938b5f8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurposing charges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26a43a36f7b84e17a5c4a3f441a8d61b_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzctMi0xLTEtMzEyMTY_00715867-f97f-44c1-8a49-9547c2979677">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc0349f558524b69a56d1b79ef3651be_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzctNC0xLTEtMzEyMTY_d4c74646-f4ea-492d-aa00-0ab54bf4fa4b">7,268</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee19945c297442c99fabe50468a25677_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzctNi0xLTEtMzEyMTY_d8936a48-9a5e-497c-b1ae-db596cb7fc8c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzctOC0xLTEtMzEyMTY_14172f4c-b9a6-4f6b-88d0-658a506c40b9">7,268</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financing and transaction costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26a43a36f7b84e17a5c4a3f441a8d61b_D20190101-20191231" decimals="-3" name="us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzgtMi0xLTEtMzEyMTY_f8440ad1-9ab6-4f14-9a3a-fe4e989c1f0c">117</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc0349f558524b69a56d1b79ef3651be_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzgtNC0xLTEtMzEyMTY_de0e4c00-02db-4799-a896-b2755fa784ec">32,091</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee19945c297442c99fabe50468a25677_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzgtNi0xLTEtMzEyMTY_7aca6f68-b618-40a4-8060-67f8c145483b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzgtOC0xLTEtMzEyMTY_a68b1f9f-dde5-42b7-a06b-18b1d5eec6c4">32,208</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain on revaluation of derivative liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26a43a36f7b84e17a5c4a3f441a8d61b_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzktMi0xLTEtMzEyMTY_772c61b6-5134-47dd-a36d-6a3eba20658f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icc0349f558524b69a56d1b79ef3651be_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzktNC0xLTEtMzEyMTY_154b4a6d-baea-4331-b4bd-3cfd592da1bf">1,276,819</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee19945c297442c99fabe50468a25677_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzktNi0xLTEtMzEyMTY_f060c8a6-7037-4966-b188-69f5fa014476">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzktOC0xLTEtMzEyMTY_50553164-0fef-43ba-8ba3-87612b232925">1,276,819</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain on disposal of other investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26a43a36f7b84e17a5c4a3f441a8d61b_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzExLTItMS0xLTMxMjE2_8f7042ce-4172-419b-bbcd-6e742c11a8df">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icc0349f558524b69a56d1b79ef3651be_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzExLTQtMS0xLTMxMjE2_b1f30b46-1cdb-4213-b31e-240bb8f8dda3">16,277</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee19945c297442c99fabe50468a25677_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzExLTYtMS0xLTMxMjE2_24e936ac-e227-44e7-a031-a6f2adc83ee2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzExLTgtMS0xLTMxMjE2_2c2a879e-6eda-4de1-900d-53cb88f9fb63">16,277</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share of loss from equity accounted investees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26a43a36f7b84e17a5c4a3f441a8d61b_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzEyLTItMS0xLTMxMjE2_2711c04d-201e-4b1a-b2d6-65d496efcde0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc0349f558524b69a56d1b79ef3651be_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzEyLTQtMS0xLTMxMjE2_029944de-45d7-4b05-a300-6d36825c15e5">2,009</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee19945c297442c99fabe50468a25677_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzEyLTYtMS0xLTMxMjE2_292a0151-3a55-4421-87d4-cd4596b087ff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzEyLTgtMS0xLTMxMjE2_435f00f6-f4b0-4245-98a7-53ceedd436bf">2,009</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss from discontinued operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26a43a36f7b84e17a5c4a3f441a8d61b_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzE1LTItMS0xLTMxMjE2_433864c2-9202-4d95-8c66-d251b87b1301">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc0349f558524b69a56d1b79ef3651be_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzE1LTQtMS0xLTMxMjE2_e05384e2-4628-4533-ad7e-115fc84ba8ca">363</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee19945c297442c99fabe50468a25677_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzE1LTYtMS0xLTMxMjE2_67fd454b-d92e-419b-8a9b-2e1e0dcbf7ec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzE1LTgtMS0xLTMxMjE2_c8f58683-df69-480f-8070-6d6b5a3727b4">363</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other loss (income)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26a43a36f7b84e17a5c4a3f441a8d61b_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzE4LTItMS0xLTMyMjU5_247ca44d-b389-4ca3-af0c-de26a35ab1da">182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icc0349f558524b69a56d1b79ef3651be_D20190101-20191231" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzE4LTQtMS0xLTMyMjU5_37821ab3-76b7-41be-91f7-4d331fb23820">197</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iee19945c297442c99fabe50468a25677_D20190101-20191231" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzE4LTYtMS0xLTMyMjU5_75c9f07c-bb91-427f-b7f1-e957d05c54f2">182</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzE4LTgtMS0xLTMyMjU5_6f06984b-e718-4f9c-aeb6-6d5a3061b4b1">197</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based payments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26a43a36f7b84e17a5c4a3f441a8d61b_D20190101-20191231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzE4LTItMS0xLTMxMjE2_64363f3e-0a30-4ee4-bbc9-078e75d0f6a4">900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc0349f558524b69a56d1b79ef3651be_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzE4LTQtMS0xLTMxMjE2_5bbecd7e-a873-469b-9f7c-f3e21664b38c">10,719</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee19945c297442c99fabe50468a25677_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzE4LTYtMS0xLTMxMjE2_d97281dd-26ad-45d2-8b9c-8d4ab61cb4b5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzE4LTgtMS0xLTMxMjE2_9bdfa1ee-55aa-4171-b5ee-fcdf61ba6f36">11,619</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBIT</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i26a43a36f7b84e17a5c4a3f441a8d61b_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:AdjustedEarningsBeforeInterestAndTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzE5LTItMS0xLTMxMjE2_514a7072-bbbd-4896-b097-cc7d03b54cbe">1,877</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icc0349f558524b69a56d1b79ef3651be_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:AdjustedEarningsBeforeInterestAndTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzE5LTQtMS0xLTMxMjE2_b224e35d-caca-47b6-9e36-c6407f90cdea">88,565</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iee19945c297442c99fabe50468a25677_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:AdjustedEarningsBeforeInterestAndTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzE5LTYtMS0xLTMxMjE2_aba4cb19-014e-4bcb-87b5-900f9eabd310">11,779</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:AdjustedEarningsBeforeInterestAndTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzE5LTgtMS0xLTMxMjE2_bd02f91b-5f3c-4331-a58f-9adb4e8b6a9e">102,221</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26a43a36f7b84e17a5c4a3f441a8d61b_D20190101-20191231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzIxLTItMS0xLTMxMjE2_1292c1be-bcda-4a3a-8376-1ef76e5c5b9f">174</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc0349f558524b69a56d1b79ef3651be_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzIxLTQtMS0xLTMxMjE2_2116fccf-6a5b-4d4a-816b-c299f2c65ddb">3,739</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee19945c297442c99fabe50468a25677_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzIxLTYtMS0xLTMxMjE2_79312b74-b007-4a3c-85c5-f2e76246ce70">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzIxLTgtMS0xLTMxMjE2_70fa8aee-aeae-48a8-8789-fdcb89b3096f">3,913</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i26a43a36f7b84e17a5c4a3f441a8d61b_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzIyLTItMS0xLTMxMjE2_af36e2b3-84b2-46bb-994b-772c17ced9f7">1,703</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icc0349f558524b69a56d1b79ef3651be_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzIyLTQtMS0xLTMxMjE2_299f2ca7-b9ee-4775-b475-c813f6f5f6e3">84,826</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iee19945c297442c99fabe50468a25677_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzIyLTYtMS0xLTMxMjE2_edb17d6b-93c9-4819-8927-a223dfa93a0e">11,779</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzIyLTgtMS0xLTMxMjE2_f59d5d73-3767-4b32-b99c-7e768b96b69e">98,308</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.372%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.901%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands of U.S. dollars)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31, 2018</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZToyYjQ3MGU2ODIwYzM0OGQ5YTIwNTdjZTYwOWE4YWZhMC90YWJsZXJhbmdlOjJiNDcwZTY4MjBjMzQ4ZDlhMjA1N2NlNjA5YThhZmEwXzItOS0xLTEtMjc4ODg_80b9193e-9291-489b-bdb8-d54632627f4f">21,817</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZToyYjQ3MGU2ODIwYzM0OGQ5YTIwNTdjZTYwOWE4YWZhMC90YWJsZXJhbmdlOjJiNDcwZTY4MjBjMzQ4ZDlhMjA1N2NlNjA5YThhZmEwXzQtOS0xLTEtMjc4ODg_7b07833d-9a5d-43e3-8ef2-afe0e9c9f1e2">81</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss (gain) on disposal of other investments</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZToyYjQ3MGU2ODIwYzM0OGQ5YTIwNTdjZTYwOWE4YWZhMC90YWJsZXJhbmdlOjJiNDcwZTY4MjBjMzQ4ZDlhMjA1N2NlNjA5YThhZmEwXzExLTktMS0xLTI3ODg4_4430c489-dd8f-4447-9af5-f4b5e5650a41">164</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share of loss (income) from equity accounted investees</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZToyYjQ3MGU2ODIwYzM0OGQ5YTIwNTdjZTYwOWE4YWZhMC90YWJsZXJhbmdlOjJiNDcwZTY4MjBjMzQ4ZDlhMjA1N2NlNjA5YThhZmEwXzEyLTktMS0xLTI3ODg4_5d54bffe-1fde-4e74-9e98-8f973b4be246">723</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss from discontinued operations</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZToyYjQ3MGU2ODIwYzM0OGQ5YTIwNTdjZTYwOWE4YWZhMC90YWJsZXJhbmdlOjJiNDcwZTY4MjBjMzQ4ZDlhMjA1N2NlNjA5YThhZmEwXzE1LTktMS0xLTI3ODg4_b64322c9-b8ed-4a15-b664-1a54f90e3926">894</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based payments</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZToyYjQ3MGU2ODIwYzM0OGQ5YTIwNTdjZTYwOWE4YWZhMC90YWJsZXJhbmdlOjJiNDcwZTY4MjBjMzQ4ZDlhMjA1N2NlNjA5YThhZmEwXzE4LTktMS0xLTI3ODg4_7f3efd80-cfd7-4a4e-bdbb-0bb99826dc52">8,151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBIT</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:AdjustedEarningsBeforeInterestAndTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZToyYjQ3MGU2ODIwYzM0OGQ5YTIwNTdjZTYwOWE4YWZhMC90YWJsZXJhbmdlOjJiNDcwZTY4MjBjMzQ4ZDlhMjA1N2NlNjA5YThhZmEwXzIwLTktMS0xLTI3ODg4_c6a2627e-cd55-414e-b130-cfa08a5619b3">12,294</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZToyYjQ3MGU2ODIwYzM0OGQ5YTIwNTdjZTYwOWE4YWZhMC90YWJsZXJhbmdlOjJiNDcwZTY4MjBjMzQ4ZDlhMjA1N2NlNjA5YThhZmEwXzIyLTktMS0xLTMyMDA5_0dbb1f08-6a16-484a-a8f7-d98abe751b0d">1,937</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZToyYjQ3MGU2ODIwYzM0OGQ5YTIwNTdjZTYwOWE4YWZhMC90YWJsZXJhbmdlOjJiNDcwZTY4MjBjMzQ4ZDlhMjA1N2NlNjA5YThhZmEwXzIzLTktMS0xLTMyMDA5_b3358276-2b2a-4120-8643-79d076be4c1e">10,357</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sources of net revenue were as follows:</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.844%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.594%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.596%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannabis flower</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb7e744f257046829976b63a309059b9_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZToyYWNiMDI4NTlkMDE0N2Y4YWQzNWI2ZDE4YzdlMzYzZS90YWJsZXJhbmdlOjJhY2IwMjg1OWQwMTQ3ZjhhZDM1YjZkMThjN2UzNjNlXzItMS0xLTEtMjIzNA_6739e065-1f0f-46d7-b00b-ea84bd4599e5">27,932</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icacdfb65bc3149b38b733a4732feeebb_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZToyYWNiMDI4NTlkMDE0N2Y4YWQzNWI2ZDE4YzdlMzYzZS90YWJsZXJhbmdlOjJhY2IwMjg1OWQwMTQ3ZjhhZDM1YjZkMThjN2UzNjNlXzItMy0xLTEtMjIzNA_ba08dacc-8765-49a2-aa79-e64168536e50">15,020</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannabis extracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i158da074fdac41459e9ec56ee32c9222_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZToyYWNiMDI4NTlkMDE0N2Y4YWQzNWI2ZDE4YzdlMzYzZS90YWJsZXJhbmdlOjJhY2IwMjg1OWQwMTQ3ZjhhZDM1YjZkMThjN2UzNjNlXzMtMS0xLTEtMjIzNA_5c722ad2-5211-451f-a7f0-f378f250285e">18,254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib13faff76de54e4d94e71c14d2ef55b9_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZToyYWNiMDI4NTlkMDE0N2Y4YWQzNWI2ZDE4YzdlMzYzZS90YWJsZXJhbmdlOjJhY2IwMjg1OWQwMTQ3ZjhhZDM1YjZkMThjN2UzNjNlXzMtMy0xLTEtMjIzNA_87fced5d-3933-41cf-b9ee-9ad295059c79">8,702</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63f66899247a46fa95fe02f9bd08dfaa_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZToyYWNiMDI4NTlkMDE0N2Y4YWQzNWI2ZDE4YzdlMzYzZS90YWJsZXJhbmdlOjJhY2IwMjg1OWQwMTQ3ZjhhZDM1YjZkMThjN2UzNjNlXzQtMS0xLTEtMjIzNA_cfc0e0cf-e28c-4d3b-b383-affcba00566a">533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68edd065b3774520abe09eb1c8de7c1f_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZToyYWNiMDI4NTlkMDE0N2Y4YWQzNWI2ZDE4YzdlMzYzZS90YWJsZXJhbmdlOjJhY2IwMjg1OWQwMTQ3ZjhhZDM1YjZkMThjN2UzNjNlXzQtMy0xLTEtMjIzNA_ab71cbc2-05ff-4c06-a0bc-cd186cdf4d3c">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZToyYWNiMDI4NTlkMDE0N2Y4YWQzNWI2ZDE4YzdlMzYzZS90YWJsZXJhbmdlOjJhY2IwMjg1OWQwMTQ3ZjhhZDM1YjZkMThjN2UzNjNlXzUtMS0xLTEtMjIzNA_2b159de6-ab40-41ba-be6d-f2eb50888016">46,719</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZToyYWNiMDI4NTlkMDE0N2Y4YWQzNWI2ZDE4YzdlMzYzZS90YWJsZXJhbmdlOjJhY2IwMjg1OWQwMTQ3ZjhhZDM1YjZkMThjN2UzNjNlXzUtMy0xLTEtMjIzNA_87077f53-fcfa-4807-8f3f-5b77b707d1fc">23,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div></ix:continuation><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90ZXh0cmVnaW9uOjkxYTQyNWEyY2NhZTQ0MjRhZjI5NDM4OTAwZTRkZDU0XzIzNjM5NTAwMDAyNDY4_3d23af6a-e9dc-4198-8bcd-62ae97feb4f5" escape="true"><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenue attributed to a geographic region based on the location of the customer were as follows:</span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.844%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.594%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.596%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib40ea4716ab44dde9b0cc0ccf563964b_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZDM3YTRhYTA2YmY0NDdkYmQ1YmZmZjIxYTgzM2IzMS90YWJsZXJhbmdlOjBkMzdhNGFhMDZiZjQ0N2RiZDViZmZmMjFhODMzYjMxXzItMS0xLTEtMA_ed5639b8-ddd5-4bd8-8682-e075f76c57cc">34,538</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4158b30eaf8f4fb4928372059c234242_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZDM3YTRhYTA2YmY0NDdkYmQ1YmZmZjIxYTgzM2IzMS90YWJsZXJhbmdlOjBkMzdhNGFhMDZiZjQ0N2RiZDViZmZmMjFhODMzYjMxXzItMy0xLTEtMA_44052b13-5630-4404-86f1-2b07671ab64d">20,202</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5ae31aceb854001ad8f87c6ab2e2250_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZDM3YTRhYTA2YmY0NDdkYmQ1YmZmZjIxYTgzM2IzMS90YWJsZXJhbmdlOjBkMzdhNGFhMDZiZjQ0N2RiZDViZmZmMjFhODMzYjMxXzMtMS0xLTEtMA_a09ec46a-2906-460d-a27f-d6059c464f79">9,495</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i547cfac932ed40edb1c94ffbbad4dcc1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZDM3YTRhYTA2YmY0NDdkYmQ1YmZmZjIxYTgzM2IzMS90YWJsZXJhbmdlOjBkMzdhNGFhMDZiZjQ0N2RiZDViZmZmMjFhODMzYjMxXzMtMy0xLTEtMA_801ffea2-9fa8-4c9c-ab4f-b07981fdd34b">3,364</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other countries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ce234a38db449af89d262f77eca0633_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZDM3YTRhYTA2YmY0NDdkYmQ1YmZmZjIxYTgzM2IzMS90YWJsZXJhbmdlOjBkMzdhNGFhMDZiZjQ0N2RiZDViZmZmMjFhODMzYjMxXzQtMS0xLTEtMA_5be11a4b-03f4-4ce4-bba4-c98af1c1cc9b">2,686</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3eb48e3b8cdf43109bd6c4aec124b38c_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZDM3YTRhYTA2YmY0NDdkYmQ1YmZmZjIxYTgzM2IzMS90YWJsZXJhbmdlOjBkMzdhNGFhMDZiZjQ0N2RiZDViZmZmMjFhODMzYjMxXzQtMy0xLTEtMA_0cf952fd-71f9-460e-ac1a-6692de82ad1c">184</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZDM3YTRhYTA2YmY0NDdkYmQ1YmZmZjIxYTgzM2IzMS90YWJsZXJhbmdlOjBkMzdhNGFhMDZiZjQ0N2RiZDViZmZmMjFhODMzYjMxXzUtMS0xLTEtMA_4361d996-d05a-4545-b349-9e9385e0d336">46,719</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZDM3YTRhYTA2YmY0NDdkYmQ1YmZmZjIxYTgzM2IzMS90YWJsZXJhbmdlOjBkMzdhNGFhMDZiZjQ0N2RiZDViZmZmMjFhODMzYjMxXzUtMy0xLTEtMA_e4ba8387-48f1-412d-a119-4b840ee6a463">23,750</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">115</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December 31, 2020, 2019, and 2018</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for gram and share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div></div><ix:continuation id="i6eb82403b0624184a2ca42b471e97ba3"><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90ZXh0cmVnaW9uOjkxYTQyNWEyY2NhZTQ0MjRhZjI5NDM4OTAwZTRkZDU0XzIzNjM5NTAwMDAyNDY5_f860c41e-e1d9-407a-a7f3-6a0837888173" escape="true"><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment assets were physically located in the following geographic regions: </span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.844%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.594%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.596%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2a8cc1e89df42f890fd0544f7d58036_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTplZGQyYzY0MDM3YmY0ODAzYmJmZDAyODlkNzViMjRkMi90YWJsZXJhbmdlOmVkZDJjNjQwMzdiZjQ4MDNiYmZkMDI4OWQ3NWIyNGQyXzEtMi0xLTEtMA_692a3d58-8ccc-4b33-ba68-932a519de58e">162,163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibacf20036dff4b1cafe624b96ee80e2b_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTplZGQyYzY0MDM3YmY0ODAzYmJmZDAyODlkNzViMjRkMi90YWJsZXJhbmdlOmVkZDJjNjQwMzdiZjQ4MDNiYmZkMDI4OWQ3NWIyNGQyXzEtMy0xLTEtMzYzMg_80a5bea1-de05-4c73-b5a1-a3937df357de">139,160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49c555e7906f4ba3bd9c50b3f3e63909_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTplZGQyYzY0MDM3YmY0ODAzYmJmZDAyODlkNzViMjRkMi90YWJsZXJhbmdlOmVkZDJjNjQwMzdiZjQ4MDNiYmZkMDI4OWQ3NWIyNGQyXzItMi0xLTEtMA_8c6cab12-53c2-4c49-9d32-03bfe51e1e2e">2,293</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i147481f9ccf54c42aab89c6b4142bc85_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTplZGQyYzY0MDM3YmY0ODAzYmJmZDAyODlkNzViMjRkMi90YWJsZXJhbmdlOmVkZDJjNjQwMzdiZjQ4MDNiYmZkMDI4OWQ3NWIyNGQyXzItMy0xLTEtMzYzMg_00aaa524-a4b8-4b1d-88f9-a907336754c0">2,103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other countries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff5acdedd7bc45eda6a7ff33e8f0c2ff_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTplZGQyYzY0MDM3YmY0ODAzYmJmZDAyODlkNzViMjRkMi90YWJsZXJhbmdlOmVkZDJjNjQwMzdiZjQ4MDNiYmZkMDI4OWQ3NWIyNGQyXzMtMi0xLTEtMA_d1767900-2f31-4cb3-b1f7-14fa219c4f26">23,143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6216f2542b024e11b06a97e92eb7a918_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTplZGQyYzY0MDM3YmY0ODAzYmJmZDAyODlkNzViMjRkMi90YWJsZXJhbmdlOmVkZDJjNjQwMzdiZjQ4MDNiYmZkMDI4OWQ3NWIyNGQyXzMtMy0xLTEtMzYzMg_267d7ac5-6471-47da-b15d-0d146044c924">18,685</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTplZGQyYzY0MDM3YmY0ODAzYmJmZDAyODlkNzViMjRkMi90YWJsZXJhbmdlOmVkZDJjNjQwMzdiZjQ4MDNiYmZkMDI4OWQ3NWIyNGQyXzQtMi0xLTEtMA_002fab25-d00b-49c0-b2e1-22bac24ba399">187,599</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTplZGQyYzY0MDM3YmY0ODAzYmJmZDAyODlkNzViMjRkMi90YWJsZXJhbmdlOmVkZDJjNjQwMzdiZjQ4MDNiYmZkMDI4OWQ3NWIyNGQyXzQtMy0xLTEtMzYzMg_acbb93b7-25a2-4383-b994-15a045dd84b5">159,948</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sells products through a limited number of major customers. Major customers are defined as customers that each individually accounted for greater than 10% of the Company&#8217;s annual revenues and greater than 10% of accounts receivable.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">United States</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2020 and December&#160;31, 2019, the Company had no major customers in the U.S. segment. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, $<ix:nonFraction unitRef="usd" contextRef="ibf0cace378954c33a3cfab1cad1ec952_I20201231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90ZXh0cmVnaW9uOjkxYTQyNWEyY2NhZTQ0MjRhZjI5NDM4OTAwZTRkZDU0XzI0ODY_b10a77a3-03e5-4bc6-bfca-172fc0538ae2">65</ix:nonFraction> in expected credit losses has been recognized on receivables from contract with customers (December&#160;31, 2019 &#8211; $<ix:nonFraction unitRef="usd" contextRef="i6a1719ab03cd42e2b05239b317a45891_I20191231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90ZXh0cmVnaW9uOjkxYTQyNWEyY2NhZTQ0MjRhZjI5NDM4OTAwZTRkZDU0XzEwOTk1MTE2MjgzMjkz_ef3449fe-57d2-4ee2-a77b-c5dd72fccfdd">12</ix:nonFraction>). Refer to Note 23(a).</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Rest of World</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2020, the Company earned a total net revenue before excise taxes of $<ix:nonFraction unitRef="usd" contextRef="id96e82b9cf384477a9af4880138f28ff_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90ZXh0cmVnaW9uOjkxYTQyNWEyY2NhZTQ0MjRhZjI5NDM4OTAwZTRkZDU0XzI3MDE_fc3b85a9-4bcb-44ec-ba2f-49d0d14b7593">34,295</ix:nonFraction> from four major customers (December&#160;31, 2019 &#8211; $<ix:nonFraction unitRef="usd" contextRef="ica7d2c4edb04482398d2b6d385a68007_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90ZXh0cmVnaW9uOjkxYTQyNWEyY2NhZTQ0MjRhZjI5NDM4OTAwZTRkZDU0XzI3MzU_022448e9-ad72-4333-bb17-c6127b1f3321">7,597</ix:nonFraction>; December&#160;31, 2018 &#8211; $<ix:nonFraction unitRef="usd" contextRef="ib5a5a7b93a18452991b71bf6eb470705_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90ZXh0cmVnaW9uOjkxYTQyNWEyY2NhZTQ0MjRhZjI5NDM4OTAwZTRkZDU0XzI3NDc_16bead25-1803-4f52-9150-98861cfd4403">2,186</ix:nonFraction> from two and one major customers, respectively), accounting for <ix:nonFraction unitRef="number" contextRef="ifc2b8542eb104b93bf4d861b434940bb_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90ZXh0cmVnaW9uOjkxYTQyNWEyY2NhZTQ0MjRhZjI5NDM4OTAwZTRkZDU0XzEwOTk1MTE2MzEyNjU_848b4bc5-2d15-4ef4-90b1-bf45d48fdb26">63</ix:nonFraction>% of the Company&#8217;s revenues (December&#160;31, 2019 &#8211; <ix:nonFraction unitRef="number" contextRef="iade5a2ef289d4446ada902ad69bd2ed7_D20190101-20191231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90ZXh0cmVnaW9uOjkxYTQyNWEyY2NhZTQ0MjRhZjI5NDM4OTAwZTRkZDU0XzEwOTk1MTE2MzEyNjg_c7b42ee4-c4a9-4a0b-ad6b-94686c247fdd">32</ix:nonFraction>%; December&#160;31, 2018 &#8211; <ix:nonFraction unitRef="number" contextRef="ibc2bd3e2f45e4164b7257955608b6e46_D20180101-20181231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90ZXh0cmVnaW9uOjkxYTQyNWEyY2NhZTQ0MjRhZjI5NDM4OTAwZTRkZDU0XzEwOTk1MTE2MzEyNzE_f2d8bd74-1e20-4cd6-b59c-deb73787cf19">17</ix:nonFraction>%).</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, $<ix:nonFraction unitRef="usd" contextRef="if3eb5650187c4de5bbc98d6b7274d811_I20201231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90ZXh0cmVnaW9uOjkxYTQyNWEyY2NhZTQ0MjRhZjI5NDM4OTAwZTRkZDU0XzI4NzY_5dab7ab3-3a39-4169-b46f-7db02b1320d6">9</ix:nonFraction> (December&#160;31, 2019 &#8211; $<ix:nonFraction unitRef="usd" contextRef="i8b7d1cb41ba640babfa7a78721a319f5_I20191231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90ZXh0cmVnaW9uOjkxYTQyNWEyY2NhZTQ0MjRhZjI5NDM4OTAwZTRkZDU0XzI4ODU_1f41656d-77f7-40af-a515-c6a9a744c28a">124</ix:nonFraction>; December&#160;31, 2018 &#8211; $<ix:nonFraction unitRef="usd" contextRef="i5058324201ad4dc6b28728f9d5d3d612_I20181231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90ZXh0cmVnaW9uOjkxYTQyNWEyY2NhZTQ0MjRhZjI5NDM4OTAwZTRkZDU0XzEzMTk0MTM5NTM3MDg0_a0f15c80-c71b-4107-aef7-382e71f7a580">nil</ix:nonFraction>) in expected credit losses has been recognized on receivables from contract with customers. Refer to Note 23(a).</span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div id="i1ae9134e40e74e0aac958218112e53d4_2369"></div><div style="margin-bottom:12pt;margin-top:16pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">30. <ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGV4dHJlZ2lvbjpjMDE0OTg3MWU3YmM0OTY5OTA3NjJmMGI5ZTc3ZTZjYl84MjQ2MzM3MjE0Mjkx_e9db51c4-fec1-4454-956f-6c1621ffcba8" continuedAt="i6dd3f4360b1548e2bf59e3a0f48da4b7" escape="true">Discontinued Operations and Held-for-sale Assets</ix:nonNumeric></span></div><ix:continuation id="i6dd3f4360b1548e2bf59e3a0f48da4b7" continuedAt="ib8579697fe7d412780c473b885d2c95f"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2020, the Company advanced its plans for the sale and disposal of substantially all of the assets of OGBC. As a result, OGBC&#8217;s results of operations have been reclassified as discontinued operations in the accompanying consolidated financial statements. Accordingly, the property, plant and equipment assets of OGBC are separately reported as assets and liabilities held-for-sale as of December&#160;31, 2020 on the consolidated balance sheet. For comparative purposes, amounts in the prior periods have been reclassified to conform to current year presentation, as disclosed below. For the year ended December&#160;31, 2020, the Company recorded $<ix:nonFraction unitRef="usd" contextRef="i056a3d33bb7244a2b1da220202bcbb81_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGV4dHJlZ2lvbjpjMDE0OTg3MWU3YmM0OTY5OTA3NjJmMGI5ZTc3ZTZjYl8xMjY0NDM4MzcyMzkxMg_22808186-9030-45e6-8222-4bc2d933902e">1,860</ix:nonFraction> as a loss on held-for-sale assets, including $<ix:nonFraction unitRef="usd" contextRef="i056a3d33bb7244a2b1da220202bcbb81_D20200101-20201231" decimals="-3" name="cron:DiscontinuedOperationAssetsValuationAllowanceValuationIncrease" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGV4dHJlZ2lvbjpjMDE0OTg3MWU3YmM0OTY5OTA3NjJmMGI5ZTc3ZTZjYl8yMDM0MDk2NTExODM3OA_f4ae494d-b434-4b58-9582-bcc8d59a4130">919</ix:nonFraction> as a valuation allowance loss upon reclassification of property, plant and equipment assets as held-for-sale in Q3 2020, and a further $<ix:nonFraction unitRef="usd" contextRef="i056a3d33bb7244a2b1da220202bcbb81_D20200101-20201231" decimals="-3" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGV4dHJlZ2lvbjpjMDE0OTg3MWU3YmM0OTY5OTA3NjJmMGI5ZTc3ZTZjYl8xMjY0NDM4MzcyMzc5NA_fc330c6a-2a78-412e-b64e-0c487665e617">941</ix:nonFraction> impairment charge on held-for-sale assets in Q4 2020 upon surrender of the OGBC Health Canada licenses. OGBC was formerly included within the Rest of World segment.</span></div><ix:nonNumeric contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" name="us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGV4dHJlZ2lvbjpjMDE0OTg3MWU3YmM0OTY5OTA3NjJmMGI5ZTc3ZTZjYl84Nzk2MDkzMDI4MTc0_4c563d74-5fb2-43fc-9cc3-8d3ead8d23a8" continuedAt="ia61d2352ab16457aaa364a5bd1e78bfa" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the financial information for discontinued operations as of December&#160;31, 2020:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.050%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.050%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated statements of net income (loss) and comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OGBC income (loss) from discontinued operations, net of income taxes</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6ZGI1OTdkNzU5NmFiNDJhOGJhZDVjMjVmNjQyYjQzZDMvdGFibGVyYW5nZTpkYjU5N2Q3NTk2YWI0MmE4YmFkNWMyNWY2NDJiNDNkM18zLTEtMS0xLTE3MDUy_c50e788b-be68-4735-9e81-9272edf10c39">650</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6ZGI1OTdkNzU5NmFiNDJhOGJhZDVjMjVmNjQyYjQzZDMvdGFibGVyYW5nZTpkYjU5N2Q3NTk2YWI0MmE4YmFkNWMyNWY2NDJiNDNkM18zLTMtMS0xLTE3MDUy_d52e831e-5cd5-401d-a996-2a7beb705d57">363</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" sign="-" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6ZGI1OTdkNzU5NmFiNDJhOGJhZDVjMjVmNjQyYjQzZDMvdGFibGVyYW5nZTpkYjU5N2Q3NTk2YWI0MmE4YmFkNWMyNWY2NDJiNDNkM18zLTUtMS0xLTIwMDIx_830bd795-7c2e-44e1-b75f-f1a6072c6b7f">894</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.427%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.594%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.596%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated balance sheets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term assets classified as discontinued operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6NDY2NmYxODMyMGMzNDFlNGE4ZWUxNDc2YWQxMmI4N2MvdGFibGVyYW5nZTo0NjY2ZjE4MzIwYzM0MWU0YThlZTE0NzZhZDEyYjg3Y18yLTEtMS0xLTE3MDYy_63bf8f10-704e-45dd-b7d9-95434a4ecde6">1,176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6NDY2NmYxODMyMGMzNDFlNGE4ZWUxNDc2YWQxMmI4N2MvdGFibGVyYW5nZTo0NjY2ZjE4MzIwYzM0MWU0YThlZTE0NzZhZDEyYjg3Y18yLTMtMS0xLTE3MDYy_3dbab08a-0b84-4511-96bc-99c625458092">3,248</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">116</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group Inc.</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the years ended December 31, 2020, 2019, and 2018</span></div><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands of U.S. dollars, except for gram and share amounts)</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">Table of Contents</a></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div></div><ix:continuation id="ib8579697fe7d412780c473b885d2c95f"><ix:continuation id="ia61d2352ab16457aaa364a5bd1e78bfa"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a reconciliation of the carrying amounts of major classes of assets and liabilities of the discontinued operations to total assets and liabilities of the disposal group classified as held-for-sale in the consolidated balance sheet of December&#160;31, 2019:</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.705%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.705%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.709%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As previously disclosed</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Held-for-sale adjustment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjusted balance</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf1081084a8046e199cfa22c963ee2b1_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6NDRhNmNiZTZjYjU1NDE1ZGI2ZWJkMDJjZGU1YzNiM2UvdGFibGVyYW5nZTo0NGE2Y2JlNmNiNTU0MTVkYjZlYmQwMmNkZTVjM2IzZV8yLTItMS0xLTE2OTg5_8457e083-9ea4-428f-b5d6-5f93fdd2d09d">161,809</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0190bb591a841c1a6f34ddeea55db58_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6NDRhNmNiZTZjYjU1NDE1ZGI2ZWJkMDJjZGU1YzNiM2UvdGFibGVyYW5nZTo0NGE2Y2JlNmNiNTU0MTVkYjZlYmQwMmNkZTVjM2IzZV8yLTQtMS0xLTE2OTg5_d82f90c4-ede9-4340-8449-762cd8686c34">1,861</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6NDRhNmNiZTZjYjU1NDE1ZGI2ZWJkMDJjZGU1YzNiM2UvdGFibGVyYW5nZTo0NGE2Y2JlNmNiNTU0MTVkYjZlYmQwMmNkZTVjM2IzZV8yLTYtMS0xLTE2OTQ1_da5b92ee-8867-4683-9103-9bfb7b8d424d">159,948</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf1081084a8046e199cfa22c963ee2b1_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6NDRhNmNiZTZjYjU1NDE1ZGI2ZWJkMDJjZGU1YzNiM2UvdGFibGVyYW5nZTo0NGE2Y2JlNmNiNTU0MTVkYjZlYmQwMmNkZTVjM2IzZV8zLTItMS0xLTE2OTg5_6f70e9ee-f0e3-4eda-b27d-896d4ccc164a">72,320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0190bb591a841c1a6f34ddeea55db58_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6NDRhNmNiZTZjYjU1NDE1ZGI2ZWJkMDJjZGU1YzNiM2UvdGFibGVyYW5nZTo0NGE2Y2JlNmNiNTU0MTVkYjZlYmQwMmNkZTVjM2IzZV8zLTQtMS0xLTE2OTg5_eacc6a48-3080-4bf3-87ae-0b4ad46f8127">1,085</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6NDRhNmNiZTZjYjU1NDE1ZGI2ZWJkMDJjZGU1YzNiM2UvdGFibGVyYW5nZTo0NGE2Y2JlNmNiNTU0MTVkYjZlYmQwMmNkZTVjM2IzZV8zLTYtMS0xLTE2OTQ1_7916c275-e86f-4d66-a689-668a95208d36">71,235</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf1081084a8046e199cfa22c963ee2b1_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6NDRhNmNiZTZjYjU1NDE1ZGI2ZWJkMDJjZGU1YzNiM2UvdGFibGVyYW5nZTo0NGE2Y2JlNmNiNTU0MTVkYjZlYmQwMmNkZTVjM2IzZV80LTItMS0xLTE2OTg5_b30ca9de-32bf-4594-bc93-9107e2742371">214,794</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0190bb591a841c1a6f34ddeea55db58_I20191231" decimals="-3" sign="-" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6NDRhNmNiZTZjYjU1NDE1ZGI2ZWJkMDJjZGU1YzNiM2UvdGFibGVyYW5nZTo0NGE2Y2JlNmNiNTU0MTVkYjZlYmQwMmNkZTVjM2IzZV80LTQtMS0xLTE2OTg5_f6a8ccb0-a7e7-4ae5-b091-58ec86c8f6b4">302</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6NDRhNmNiZTZjYjU1NDE1ZGI2ZWJkMDJjZGU1YzNiM2UvdGFibGVyYW5nZTo0NGE2Y2JlNmNiNTU0MTVkYjZlYmQwMmNkZTVjM2IzZV80LTYtMS0xLTE2OTQ1_4598c416-64e0-46c3-9336-c5c5066d3e22">214,492</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a reconciliation of the major classes of line items constituting reported operating loss of discontinued operations to net loss of discontinued operations for the years ended December&#160;31, 2019 and December&#160;31, 2018:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.511%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.793%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As previously disclosed</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Held-for-sale adjustment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjusted balance</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory write-down</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48cd8878f431419a9261e7d977504c74_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryWriteDown" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6MzhmNmI2ZmY3NzNlNDVlMWE2NGM3YjNmN2ZiZjQzNWEvdGFibGVyYW5nZTozOGY2YjZmZjc3M2U0NWUxYTY0YzdiM2Y3ZmJmNDM1YV8yLTItMS0xLTIwMjk1_f2162289-6c61-4b98-aadf-83cb4d5dc4c2">29,440</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i483325ccf32a4f0b99f1a6f997a0eb31_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:InventoryWriteDown" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6MzhmNmI2ZmY3NzNlNDVlMWE2NGM3YjNmN2ZiZjQzNWEvdGFibGVyYW5nZTozOGY2YjZmZjc3M2U0NWUxYTY0YzdiM2Y3ZmJmNDM1YV8yLTQtMS0xLTIwMjk1_64e37efd-eb58-419f-82e1-ecf6436ad339">267</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryWriteDown" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6MzhmNmI2ZmY3NzNlNDVlMWE2NGM3YjNmN2ZiZjQzNWEvdGFibGVyYW5nZTozOGY2YjZmZjc3M2U0NWUxYTY0YzdiM2Y3ZmJmNDM1YV8yLTYtMS0xLTIwMjk1_01c8df05-ebef-4eeb-bce0-0c7538f6fd21">29,173</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48cd8878f431419a9261e7d977504c74_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6MzhmNmI2ZmY3NzNlNDVlMWE2NGM3YjNmN2ZiZjQzNWEvdGFibGVyYW5nZTozOGY2YjZmZjc3M2U0NWUxYTY0YzdiM2Y3ZmJmNDM1YV8yLTItMS0xLTE2OTc4_29ccd036-6b3b-45b7-9303-d6df07f37539">103,620</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i483325ccf32a4f0b99f1a6f997a0eb31_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6MzhmNmI2ZmY3NzNlNDVlMWE2NGM3YjNmN2ZiZjQzNWEvdGFibGVyYW5nZTozOGY2YjZmZjc3M2U0NWUxYTY0YzdiM2Y3ZmJmNDM1YV8yLTQtMS0xLTE2OTc4_79e597a3-ae83-4b1e-a8c7-86a9a16ea950">109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6MzhmNmI2ZmY3NzNlNDVlMWE2NGM3YjNmN2ZiZjQzNWEvdGFibGVyYW5nZTozOGY2YjZmZjc3M2U0NWUxYTY0YzdiM2Y3ZmJmNDM1YV8yLTEyLTEtMS0xNjk0NQ_46505ff8-b920-45a3-b991-4bb5ef5e08da">103,511</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48cd8878f431419a9261e7d977504c74_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6MzhmNmI2ZmY3NzNlNDVlMWE2NGM3YjNmN2ZiZjQzNWEvdGFibGVyYW5nZTozOGY2YjZmZjc3M2U0NWUxYTY0YzdiM2Y3ZmJmNDM1YV8zLTItMS0xLTE2OTc4_4558a67b-d504-4708-8361-9a090c0b5be8">1,287,058</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i483325ccf32a4f0b99f1a6f997a0eb31_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6MzhmNmI2ZmY3NzNlNDVlMWE2NGM3YjNmN2ZiZjQzNWEvdGFibGVyYW5nZTozOGY2YjZmZjc3M2U0NWUxYTY0YzdiM2Y3ZmJmNDM1YV8zLTQtMS0xLTE2OTc4_9094c162-43de-4963-932c-6795745df08f">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6MzhmNmI2ZmY3NzNlNDVlMWE2NGM3YjNmN2ZiZjQzNWEvdGFibGVyYW5nZTozOGY2YjZmZjc3M2U0NWUxYTY0YzdiM2Y3ZmJmNDM1YV8zLTEyLTEtMS0xNjk0NQ_f3de27f6-28c3-4b8e-bd3e-1fbfd114c93c">1,287,045</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) from continuing operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48cd8878f431419a9261e7d977504c74_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6MzhmNmI2ZmY3NzNlNDVlMWE2NGM3YjNmN2ZiZjQzNWEvdGFibGVyYW5nZTozOGY2YjZmZjc3M2U0NWUxYTY0YzdiM2Y3ZmJmNDM1YV80LTItMS0xLTE2OTc4_7baff811-92f1-4f14-9a1b-473e77314ab9">1,165,574</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i483325ccf32a4f0b99f1a6f997a0eb31_D20190101-20191231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6MzhmNmI2ZmY3NzNlNDVlMWE2NGM3YjNmN2ZiZjQzNWEvdGFibGVyYW5nZTozOGY2YjZmZjc3M2U0NWUxYTY0YzdiM2Y3ZmJmNDM1YV80LTQtMS0xLTE2OTc4_b6fa9525-6c87-4407-970f-b2b40d1fff17">363</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6MzhmNmI2ZmY3NzNlNDVlMWE2NGM3YjNmN2ZiZjQzNWEvdGFibGVyYW5nZTozOGY2YjZmZjc3M2U0NWUxYTY0YzdiM2Y3ZmJmNDM1YV80LTEyLTEtMS0xNjk0NQ_c7fb9b3c-1883-400d-b552-378b461e0a32">1,165,937</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.511%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.793%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31, 2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As previously disclosed</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Held-for-sale adjustment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjusted balance</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieb6f16121fdc4f85b37accd34c0b8570_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6YmM5OWMyOTUyZmUzNGIzMGEzYmM3OTBmOTdkODQ2YTEvdGFibGVyYW5nZTpiYzk5YzI5NTJmZTM0YjMwYTNiYzc5MGY5N2Q4NDZhMV8yLTItMS0xLTIwMDM3_2ef8bc7c-4f4b-4f98-9aaa-19a18aa393f3">27,554</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5ba3e945f134460b59d45bf05722a40_D20180101-20181231" decimals="-3" sign="-" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6YmM5OWMyOTUyZmUzNGIzMGEzYmM3OTBmOTdkODQ2YTEvdGFibGVyYW5nZTpiYzk5YzI5NTJmZTM0YjMwYTNiYzc5MGY5N2Q4NDZhMV8yLTQtMS0xLTIwMDM3_a9609561-a96e-49a6-a645-3c09330572de">896</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6YmM5OWMyOTUyZmUzNGIzMGEzYmM3OTBmOTdkODQ2YTEvdGFibGVyYW5nZTpiYzk5YzI5NTJmZTM0YjMwYTNiYzc5MGY5N2Q4NDZhMV8yLTYtMS0xLTIwMDM3_b89ebf85-693c-43a0-874e-544693c6366f">26,658</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieb6f16121fdc4f85b37accd34c0b8570_D20180101-20181231" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6YmM5OWMyOTUyZmUzNGIzMGEzYmM3OTBmOTdkODQ2YTEvdGFibGVyYW5nZTpiYzk5YzI5NTJmZTM0YjMwYTNiYzc5MGY5N2Q4NDZhMV8zLTItMS0xLTIwMDM3_ee5d6231-ba9f-4346-907b-a67e2cb83115">476</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5ba3e945f134460b59d45bf05722a40_D20180101-20181231" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6YmM5OWMyOTUyZmUzNGIzMGEzYmM3OTBmOTdkODQ2YTEvdGFibGVyYW5nZTpiYzk5YzI5NTJmZTM0YjMwYTNiYzc5MGY5N2Q4NDZhMV8zLTQtMS0xLTIwMDM3_4a4122df-8e04-435e-9b09-e3fbae8de050">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6YmM5OWMyOTUyZmUzNGIzMGEzYmM3OTBmOTdkODQ2YTEvdGFibGVyYW5nZTpiYzk5YzI5NTJmZTM0YjMwYTNiYzc5MGY5N2Q4NDZhMV8zLTYtMS0xLTIwMDM3_c62491e3-50ef-45de-b0b0-ffb3bb61b5ee">478</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) from continuing operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieb6f16121fdc4f85b37accd34c0b8570_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6YmM5OWMyOTUyZmUzNGIzMGEzYmM3OTBmOTdkODQ2YTEvdGFibGVyYW5nZTpiYzk5YzI5NTJmZTM0YjMwYTNiYzc5MGY5N2Q4NDZhMV80LTItMS0xLTIwMDM3_2260e60e-2582-42ce-97db-ca5d6bd4a6c3">21,817</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5ba3e945f134460b59d45bf05722a40_D20180101-20181231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6YmM5OWMyOTUyZmUzNGIzMGEzYmM3OTBmOTdkODQ2YTEvdGFibGVyYW5nZTpiYzk5YzI5NTJmZTM0YjMwYTNiYzc5MGY5N2Q4NDZhMV80LTQtMS0xLTIwMDM3_b1d0ebf8-e832-4877-88b4-793d1444af47">894</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6YmM5OWMyOTUyZmUzNGIzMGEzYmM3OTBmOTdkODQ2YTEvdGFibGVyYW5nZTpiYzk5YzI5NTJmZTM0YjMwYTNiYzc5MGY5N2Q4NDZhMV80LTYtMS0xLTIwMDM3_8fefb751-6cd9-497a-9bc9-bd46626a327d">20,923</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">117</span></div></div></div><div id="i1ae9134e40e74e0aac958218112e53d4_196"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">T</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">able of Contents</a></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div id="i1ae9134e40e74e0aac958218112e53d4_199"></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9A. CONTROLS AND PROCEDURES.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Evaluation of disclosure controls and procedures. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Chief Executive Officer and Chief Financial Officer performed an evaluation of our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act. Our disclosure controls and procedures are designed to ensure that information required to be disclosed by us in reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC, and to ensure that the information required to be disclosed by us in reports that we file or submit under the Exchange Act, is accumulated and communicated to our management, including the principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure. Based on this evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were not effective as of December&#160;31,&#160;2020 due to the material weakness described below.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)(i)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management&#8217;s Report on Internal Control Over Financial Reporting.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act). Management conducted an assessment of the effectiveness of the Company&#8217;s internal control over financial reporting based on the criteria set forth in Internal Control - Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework). Based on the Company&#8217;s assessment, management has concluded that its internal control over financial reporting was not effective as of December 31, 2020 to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements in accordance with GAAP, due to the material weakness described below.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A material weakness is a deficiency, or combination of deficiencies in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2020 Material Weakness &#8211; Inventory Verification</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management failed to properly design and execute sufficient procedures to verify inventory quantities. Specifically, while inventory counts were performed in the fourth quarter, (i) the aggregate value of items excluded from the count exceeded the Company&#8217;s materiality threshold, and (ii) human error in count execution, data transposition and reconciliation analysis resulted in inaccurate adjustments. This deficiency did not result in errors that were quantitatively material. Nevertheless, the deficiency creates a reasonable possibility that a material misstatement to the consolidated financial statements will not be prevented or detected on a timely basis. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effectiveness of internal control over financial reporting has been audited by KPMG LLP, an independent registered public accounting firm, who has issued an adverse opinion on the effectiveness of our internal control over financial reporting as of December 31, 2020 as stated in their report which is included in the financial statements in Part II, Item 8 of this 10-K.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Internal control systems, no matter how well designed, have inherent limitations. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)(ii)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Remediation of 2020 Material Weakness</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contributing factors included restrictions in the ability to perform physical inventory counts at third party logistics and subcontract manufacturing locations, resource turnover and the organization&#8217;s experience in processing count results within their new ERP system implemented at the beginning of the third quarter of 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management will (i) enhance their count procedures to ensure appropriate consideration and coverage of their total inventory balance, (ii) implement cycle counts as a redundant control to supplement the annual physical count, and (iii) provide training to inventory teams on count procedures and inventory management control expectations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)       </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Changes in internal control over financial reporting. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year, the Company implemented a new ERP system across the Canadian business. The new ERP system is a meaningful component of our internal control over financial reporting and is expected to enable us to realize efficiencies throughout our finance, supply chain and operations processes. In connection with the ERP implementation, we updated the processes and controls that constitute our internal control over financial reporting, as necessary, to accommodate related changes to our accounting procedures and business processes. </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">118</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">T</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">able of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has implemented its processes and internal controls over financial reporting in the U.S. segment for the year ended December 31, 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Closure of 2019 Material Weakness</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As disclosed in Part II Item 9A, Controls and Procedures, in our Annual Report on Form 10-K/A for the fiscal year ended December 31, 2019 (the &#8220;2019 Annual Report&#8221;), during the fourth quarter of 2019 we identified material weaknesses in internal controls related to risk assessment, segregation of duties, and non-routine transactions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020, management implemented our previously disclosed remediation plan that included: (i) enhancement of our quarterly review of the risk assessment model and its risk control matrices, (ii) establishing a risk committee, which reviews the risk assessment for changes in the business on a quarterly basis, (iii) enhancement of our delegation of authority matrix, to further limit groups that may authorize sales or purchases of inventory, (iv) the establishment of a review process and internal database to identify entities that are both vendors and customers of the Company, in order to identify potential related transactions, (v) the implementation of revenue recognition training, (vi) the creation and implementation of a non-routine transaction policy, (vii) implementation of procedures for the preparation of business cases for all non-routine business-to-business unbranded sales and purchases, and (viii) expansion of the sub-certification processes to additional members of management to ensure that non routine transactions are identified.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2020, we completed our testing of the operating effectiveness of the implemented controls and found them to be effective. As a result, we have concluded the material weaknesses reported in the 2019 Annual Report have been remediated as of December 31, 2020.</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The completed remediation to date is described below:</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:12.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:53.205%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.594%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.596%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Material Weakness</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Control, Control Enhancement or Mitigant</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Implementation Status</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Management Testing Status</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Remediation Status</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:21pt"><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk Assessment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;padding-left:14.85pt">Enhance quarterly review of risk assessment model and risk control matrices</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Implemented</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tested</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Remediated</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;padding-left:14.85pt">Establish a risk committee which reviews the risk assessment for changes in the business on a quarterly basis</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Implemented</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tested</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Remediated</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:26pt"><td colspan="3" rowspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Segregation of Duties</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;padding-left:14.85pt">Enhance Delegation of Authority matrix to further limit groups that may authorize sales or purchases of inventory</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Implemented</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tested</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Remediated</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:26pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;padding-left:14.85pt">Establish review process and internal database to identify entities that are both vendors and customers of the Company</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Implemented</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tested</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Remediated</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;padding-left:14.85pt">Create and implement revenue recognition training</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Implemented</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tested</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Remediated</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:18pt"><td colspan="3" rowspan="6" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-Routine Transactions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;padding-left:14.85pt">Create and implement a Non-Routine Transactions Policy to include:</span></div></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Implemented</span></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tested</span></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Remediated</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:48pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;padding-left:14.81pt">Definition of Non-Routine Transactions</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:48pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;padding-left:14.81pt">Accounting memorandum completion</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:48pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;padding-left:14.81pt">CEO/CFO approval</span></div></td></tr><tr style="height:32pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;padding-left:14.85pt">Formalization of business cases for all non-routine business to business unbranded sales and purchases to be reviewed on a quarterly basis to ensure alignment with the objectives of the business</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Implemented</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tested</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Remediated</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:26pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;padding-left:14.85pt">Expand the sub-certification process to additional members of management to ensure that non routine transactions are identified</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Implemented</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tested</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Remediated</span></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2020, there was no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act), other than noted above.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div id="i1ae9134e40e74e0aac958218112e53d4_202"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9B. OTHER INFORMATION.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">119</span></div></div></div><div id="i1ae9134e40e74e0aac958218112e53d4_205"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">T</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">able of Contents</a></span></div></div><div><span><br/></span></div><div id="i1ae9134e40e74e0aac958218112e53d4_208"></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART III</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The information required under this Item is incorporated herein by reference to our definitive proxy statement or to an amendment to this Annual Report on Form 10-K to be filed with the SEC no later than 120 days after the close of our fiscal year ended December&#160;31, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div><span><br/></span></div><div id="i1ae9134e40e74e0aac958218112e53d4_211"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 11. EXECUTIVE COMPENSATION</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required under this Item is incorporated herein by reference to our definitive proxy statement or to an amendment to this Annual Report on Form 10-K to be filed with the SEC no later than 120 days after the close of our fiscal year ended December&#160;31, 2020.</span></div><div><span><br/></span></div><div id="i1ae9134e40e74e0aac958218112e53d4_214"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required under this Item is incorporated herein by reference to our definitive proxy statement or to an amendment to this Annual Report on Form 10-K to be filed with the SEC no later than 120 days after the close of our fiscal year ended December&#160;31, 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</span></div><div><span><br/></span></div><div id="i1ae9134e40e74e0aac958218112e53d4_217"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required under this Item is incorporated herein by reference to our definitive proxy statement or to an amendment to this Annual Report on Form 10-K to be filed with the SEC no later than 120 days after the close of our fiscal year ended December&#160;31, 2020.</span></div><div><span><br/></span></div><div id="i1ae9134e40e74e0aac958218112e53d4_220"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required under this Item is incorporated herein by reference to our definitive proxy statement or to an amendment to this Annual Report on Form 10-K to be filed with the SEC no later than 120 days after the close of our fiscal year ended December&#160;31, 2020.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">120</span></div></div></div><div id="i1ae9134e40e74e0aac958218112e53d4_223"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="-sec-extract:summary;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">T</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">able of Contents</a></span></div></div><div style="-sec-extract:summary;margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART IV</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following documents are filed as part of this Annual Report on Form 10-K, or incorporated herein by reference:</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The following financial statements of Cronos Group Inc. are filed as part of this Annual Report on Form 10-K on the pages indicated.</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:81.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.207%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CRONOS GROUP INC. AND SUBSIDIARIES</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Page No.</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reports of Independent Registered Public Accounting Firm</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i1ae9134e40e74e0aac958218112e53d4_49">67</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Balance Sheets as of December 31, 2020 and 2019</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i1ae9134e40e74e0aac958218112e53d4_55">71</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Statements of Net Income (Loss) and Comprehensive Income (Loss) for the years ended December 31, 2020, 2019, and 2018</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i1ae9134e40e74e0aac958218112e53d4_61">72</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Statements of Changes in Shareholders&#8217; (Deficit) Equity for the years ended December 31, 2020, 2019, and 2018</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i1ae9134e40e74e0aac958218112e53d4_64">74</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Statements of Cash Flows for the years ended December 2020, 2019, and 2018</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i1ae9134e40e74e0aac958218112e53d4_2511">76</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes to Consolidated Financial Statements</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i1ae9134e40e74e0aac958218112e53d4_70">77</a></span></div></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)(2)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Statement Schedules</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Schedules are omitted because the required information is inapplicable, not material, or the information is presented in the consolidated financial statements or related notes.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)(3)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Exhibits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The exhibits listed in the Exhibit Index immediately below are filed as part of this Annual Report on Form 10-K, or are incorporated by reference herein.</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.262%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit Description </span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000119312519211814/d760406dex991.htm">Membership Interest Purchase Agreement, among Cronos Group Inc., Redwood Holdings Group, LLC and certain key persons, dated as of August 1, 2019 (incorporated by reference to Exhibit 99.1 to the Company&#8217;s Current Report of Foreign Private Issuer, filed August 2, 2019).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000119312518216185/d278879dex41.htm">Certificate of Continuance, Notice </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000119312518216185/d278879dex41.htm">of</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000119312518216185/d278879dex41.htm"> Articles and Articles of Cronos Group Inc. (incorporated by reference to Exhibit </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000119312518216185/d278879dex41.htm">4</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000119312518216185/d278879dex41.htm">.1 to the Quarterly Report on Form 10-Q of Cronos Group Inc., filed August 6, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647220000011/a41.htm">Form of Cronos Group Inc. Common Share certificate </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647220000011/a41.htm">(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647220000011/a41.htm">incorporated by reference to the corresponding exhibit to the Annual Report on Form 10-K of Cronos Group Inc., filed on March 2, 2020</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647220000011/a41.htm">)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647220000011/a41.htm">.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a421.htm">Description of Capital Stock of Cronos Group Inc.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000119312518345276/d671304dex991.htm">Subscription Agreement, dated as of December 7, 2018, by and among Cronos Group Inc., Altria Summit LLC, and, solely for the purposes specified therein, Altria Group, Inc. (incorporated by reference to Exhibit 99.1 to the Company&#8217;s Current Report of Foreign Private Issuer, filed December 10, 2018).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000119312519076836/d690389dex991.htm">Investor Rights Agreement, dated as of March 8, 2019, by and between Cronos Group Inc. and Altria Group, Inc. (incorporated by reference to Exhibit 99.1 to the Company&#8217;s Current Report of Foreign Private Issuer, filed March 15, 2019).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000119312518265476/d618057dex993.htm">Collaboration and License Agreement, dated as of September 1, 2018, by and between Cronos Group Inc. and Ginkgo Bioworks, Inc. (incorporated by reference to Exhibit 99.3 to the Company&#8217;s Current Report of Foreign Private Issuer, filed September 4, 2018).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647220000011/a104.htm">First Amendment to Collaboration and License Agreement, dated as of May 9, 2019 (incorporated by reference to the corresponding exhibit to the Annual Report on Form 10-K of Cronos Group Inc., filed on March 2, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000119312518216185/d278879dex43.htm">Cronos Group Inc. 2015 Amended and Restated Stock Option Plan, dated as of May 26, 2015 (incorporated by reference to Exhibit 4.3 to the Registration Statement on Form S-8 of Cronos Group Inc., filed July 11, 2018).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647220000011/a106.htm">Form of Option Certificate to 2015 Amended and Restated Stock Option Plan (incorporated by reference to the corresponding exhibit to the Annual Report on Form 10-K of Cronos Group Inc., filed on March 2, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647220000011/a107.htm">First Amendment to the Cronos Group Inc. 2015 Amended and Restated Stock Option Plan, dated as of August 7, 2019 (incorporated by reference to the corresponding exhibit to the Annual Report on Form 10-K of Cronos Group Inc., filed on March 2, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647220000011/a108.htm">Cronos Group Inc. Amended and Restated 2018 Stock Option Plan, dated as of November 11, 2019 (incorporated by reference to the corresponding exhibit to the Annual Report on Form 10-K of Cronos Group Inc., filed on March 2, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647220000011/a109.htm">Cronos Group Inc. Deferred Shared Unit Plan for Non-Executive Directors, dated as of August 7, 2019 (incorporated by reference to the corresponding exhibit to the Annual Report on Form 10-K of Cronos Group Inc., filed on March 2, 2020).</a></span></div></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">121</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="-sec-extract:summary;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">T</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">able of Contents</a></span></div></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.262%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647220000011/a1010.htm">Employment Agreement, by and between Cronos Group Inc. (</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647220000011/a1010.htm">Employment Agreement, by and between Cronos Group Inc. (f/k/a PharmaCan Capital Corporation) and Michael Gorenstein, effective as of August 10, 2016 (incorporated by reference to the corresponding exhibit to the Annual Report on Form 10-K of Cronos Group Inc., filed on March 2, 2020)</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.11&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647220000011/a1011.htm">Description of Oral Amendment, effective as of June 2019, to Employment Agreement, by and between Cronos Group Inc. (f/k/a PharmaCan Capital Corporation) and Michael Gorenstein, effective as of August 10, 2016 (incorporated by reference to the corresponding exhibit to the Annual Report on Form 10-K of Cronos Group Inc., filed on March 2, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.12&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647220000011/a1012.htm">Executive Employment Agreement, by and among Hortican Inc., Jerry Barbato and, solely for the purposes specified therein, Cronos Group Inc., effective as of April 15, 2019. (incorporated by reference to the corresponding exhibit to the Annual Report on Form 10-K of Cronos Group Inc., filed on March 2, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.13&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647220000011/a1013.htm">Employment Agreement, by and between Hortican Inc. and Xiuming Shum, effective as of August 21, 2017 (incorporated by reference to the corresponding exhibit to the Annual Report on Form 10-K of Cronos Group Inc., filed on March 2, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.14&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647220000011/a1014.htm">Executive Employment Agreement, by and among Hortican Inc., Xiuming Shum and, solely for the purposes specified therein, Cronos Group Inc., effective as of May 21, 2019 (incorporated by reference to the corresponding exhibit to the Annual Report on Form 10-K of Cronos Group Inc., filed on March 2, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.15&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647220000011/a1015.htm">Executive Employment Agreement, by and among Redwood Wellness, LLC, Robert Rosenheck and, solely for the purposes specified therein, Cronos Group Inc., dated as of September 5, 2019 (incorporated by reference to the corresponding exhibit to the Annual Report on Form 10-K of Cronos Group Inc., filed on March 2, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.16&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647220000011/a1016.htm">Restricted Share Unit Agreement, by and between Cronos Group Inc. and Robert Rosenheck, dated as of September 5, 2019 (incorporated by reference to the corresponding exhibit to the Annual Report on Form 10-K of Cronos Group Inc., filed on March 2, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.17&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1656472/000165647220000011/a1017.htm">Executive Employment Agreement, by and between Hortican Inc. and David Hsu, effective as of June 12, 2018 (incorporated by reference to the corresponding exhibit to the Annual Report on Form 10-K of Cronos Group Inc., filed on March 2, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.18&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647220000011/a1018.htm">Executive Employment Agreement, by and among Hortican Inc., David Hsu and, solely for the purposes specified therein, Cronos Group Inc., effective as of May 13, 2019 (incorporated by reference to the corresponding exhibit to the Annual Report on Form 10-K of Cronos Group Inc., filed on March 2, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.19&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647220000011/a1019.htm">Executive Employment Agreement, by and among Hortican Inc., William Lawrence Hilson and, solely for the purposes specified therein, Cronos Group Inc., effective as of May 15, 2019 (incorporated by reference to the corresponding exhibit to the Annual Report on Form 10-K of Cronos Group Inc., filed on March 2, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.20&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647220000011/a1020.htm">Service Agreement, by and between The Peace Naturals Project Inc. and Hillhurst Management Inc., entered into as of October 1, 2015 (incorporated by reference to the corresponding exhibit to the Annual Report on Form 10-K of Cronos Group Inc., filed on March 2, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.21&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647220000011/a1021.htm">Cronos Group Inc. Employment Inducement Award Plan #1 (incorporated by reference to the corresponding exhibit to the Annual Report on Form 10-K of Cronos Group Inc., filed on March 2, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.22&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647220000011/a1022.htm">Termination and Release Agreement, by and among Cronos Group Inc. and David Hsu, dated as of November 15, 2019 (incorporated by reference to the corresponding exhibit to the Annual Report on Form 10-K of Cronos Group Inc., filed on March 2, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.23&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647220000011/a1023.htm">Termination and Release Agreement, by and among Cronos Group Inc. and William Lawrence Hilson, dated as of November 15, 2019 (incorporated by reference to the corresponding exhibit to the Annual Report on Form 10-K of Cronos Group Inc., filed on March 2, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.24&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647220000011/a1024.htm">Form of Director and Officer Indemnity Agreement (incorporated by reference to the corresponding exhibit to the Annual Report on Form 10-K of Cronos Group Inc., filed on March 2, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.25&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1656472/000165647220000065/exh101.htm">Separation Agreement, dated as of July 20, 2020, by and among Robert Rosenheck, Redwood Wellness, LLC and Cronos Group Inc. (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K of Cronos Group Inc., filed July 20, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.26&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1656472/000165647220000073/ex101omnibusplan1.htm">Cronos Group Inc. 2020 Omnibus Equity Incentive Plan (incorporated by reference to Exhibit 10.1 to the Quarterly Report on Form 10-Q of Cronos Group Inc., filed August 6, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.27&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1656472/000165647220000073/a102rsuawardagreement.htm">Form of Restricted Share Unit Award Agreement to Cronos Group Inc. 2020 Omnibus Equity Incentive Plan (incorporated by reference to Exhibit 10.2 to the Quarterly Report on Form 10-Q of Cronos Group Inc., filed August 6, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.28&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1656472/000165647220000073/a103rsuawardagreementi.htm">Form of Restricted Share Unit Award Agreement (Israel) to Cronos Group Inc. 2020 Omnibus Equity Incentive Plan (incorporated by reference to Exhibit 10.3 to the Quarterly Report on Form 10-Q of Cronos Group Inc., filed August 6, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.29&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1656472/000165647220000079/exhibit101.htm">Executive Employment Agreement, dated as of September 9, 2020, by and among Cronos USA Client Services LLC, Cronos Group Inc. and Kurt Schmidt (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K of Cronos Group Inc., filed September 9, 2020).</a></span></div></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">122</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="-sec-extract:summary;margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">T</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">able of Contents</a></span></div></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.262%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.30&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1656472/000165647220000079/exhibit102.htm">Amended and Restated Employment Agreement, dated as of September 9, 2020, by and among Cronos USA Client Services LLC, Cronos Group Inc., and Michael Gorenstein (incorporated by reference to Exhibit 10.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1656472/000165647220000079/exhibit102.htm">2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1656472/000165647220000079/exhibit102.htm"> to the Current Report on Form 8-K of Cronos Group Inc., filed September 9, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a1411.htm">Cronos Group Inc. Code of Business Conduct and Ethics</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit211.htm">List of Subsidiaries of Cronos Group Inc.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a2311.htm">Consent of KPMG LLP, Independent Registered Public Accounting Firm.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_226">Power of Attorney (included on signature page hereto).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="cronceoex3111.htm">Certification of the Principal Executive Officer pursuant to Rules 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="croncfoex3121.htm">Certification of the Principal Financial Officer pursuant to Rules 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="cronceoex3211.htm">Certification of the Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="croncfoex3221.htm">Certification of the Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Schema Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Calculation Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Definition Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Label Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Presentation Linkbase Document.</span></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:43.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.400%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8224;&#160;&#160;&#160;&#160;Management contract or compensatory plan or arrangement.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Filed herewith.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">**&#160;&#160;&#160;&#160;Furnished herewith and not &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-36pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">123</span></div></div></div><div id="i1ae9134e40e74e0aac958218112e53d4_226"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">T</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ae9134e40e74e0aac958218112e53d4_10">able of Contents</a></span></div></div><div style="padding-left:13.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">SIGNATURES</span></div><div style="margin-bottom:3pt;text-align:justify;text-indent:-36pt"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.960%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.778%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.962%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CRONOS GROUP INC.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Kurt Schmidt</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kurt Schmidt</span></div><div style="margin-bottom:2pt;margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: February 26, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">Power of Attorney</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints each of Kurt Schmidt and Jerry Barbato, severally, his or her attorneys-in-fact, each with the power of substitution, for him or her in any and all capacities, to sign any amendments to this Annual Report on Form 10-K, and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that each of said attorneys-in-fact, or his substitute or substitutes, may do or cause to be done by virtue hereof.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.372%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.374%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Date</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Kurt Schmidt</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer <br/>(Principal Executive Officer)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 26, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kurt Schmidt</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Jerry Barbato</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer<br/>(Principal Financial Officer)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 26, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jerry Barbato</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Puneet Mathur</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice President, Controller<br/>(Principal Accounting Officer)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 26, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Puneet Mathur</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Bronwen Evans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 26, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bronwen Evans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Heather Newman</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 26, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Heather Newman</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ James Rudyk</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 26, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">James Rudyk</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Jody Begley</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 26, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jody Begley</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Jason Adler</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 26, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jason Adler</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Michael Gorenstein</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Director, Executive Chairman</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 26, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael Gorenstein</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Murray Garnick</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 26, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Murray Garnick</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">124</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>2
<FILENAME>a421.htm
<DESCRIPTION>EX-4.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i980b522743434b98b467e549e1a1a57f_1"></div><div style="min-height:36pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 4.2</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">DESCRIPTION OF CAPITAL STOCK</font></div><div style="margin-bottom:6pt;margin-top:6pt"><font><br></font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following description of the capital stock of Cronos Group Inc. (the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our&#8221;) is a summary and is not complete, may not contain all the information you should consider before investing in our capital stock and is qualified in its entirety by reference to, our Certificate of Continuation, Notice of Articles and Articles (the &#8220;Articles&#8221;), which have been publicly filed with the Securities and Exchange Commission (&#8220;SEC&#8221;). The terms of these securities may also be affected by the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Corporations Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (British Columbia) (the &#8220;Act&#8221;). All references to the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our&#8221; refer solely to Cronos Group Inc. and do not include any subsidiary or affiliate of Cronos Group Inc.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Authorized Shares</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The authorized capital of the Company consists of an unlimited number of no par value common shares (the &#8220;Common Shares&#8221;). Our Common Shares are currently listed on the Toronto Stock Exchange (&#8220;TSX&#8221;) and on the NASDAQ Global Market (&#8220;Nasdaq&#8221;) under the trading symbol &#8220;CRON&#8221;.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Voting Rights</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The holders of Common Shares are entitled to one vote per share at all meetings of the shareholders of the Company either in person or by proxy. </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our Articles, the presence at a meeting of shareholders, in person or represented by proxy, of any number of shareholders holding not less than 33 1&#47;3% of the outstanding Common Shares will constitute a quorum for the purpose of transacting business at the meeting of shareholders. Any matter, other than the election of Directors, brought before any meeting of shareholders shall be decided by the affirmative vote of the majority of Common Shares present in person or represented by proxy at the meeting and entitled to vote on the matter, unless the question is one upon which, by express provision of law or under our Articles, a different vote is required or permitted, in which case such provision will control.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Directors are elected by a plurality of the votes cast at a meeting of shareholders. The Board&#8217;s majority voting policy (the &#8220;Majority Voting Policy&#8221;) requires that any nominee for director who does not receive a greater number of votes &#8220;for&#8221; his or her election as a director than votes &#8220;withheld&#8221; from voting tender his or her resignation to the Board for consideration by the independent directors of the Company promptly following the meeting. This policy applies only to uncontested elections, meaning elections where the number of nominees of directors is equal to the number of directors to be elected. The independent directors of the Company will consider the resignation and will provide a recommendation to the Board within 45 days following the meeting. The Board will consider the recommendation of the independent directors of the Company and determine whether to accept such recommendation within 90 days of the meeting. Absent exceptional circumstances, the Board will accept the resignation which will be effective upon such acceptance. A news release will be issued promptly by the Company announcing the Board&#8217;s determination, including, if applicable, the reasons for rejecting the resignation. A director who tenders his or her resignation will not participate in any meetings to consider whether the resignation will be accepted. </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dividends and Other Distributions</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The holders of Common Shares are entitled to dividends, if and when declared by the directors of the Company, and the distribution of the residual assets of the Company in the event of a liquidation, dissolution or winding up of the Company.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Common Shares rank equally as to all benefits which might accrue to the holders thereof, including the right to receive dividends, voting powers, and participation in assets and in all other respects, on liquidation, dissolution or winding-up of the Company, whether voluntary or involuntary, or any other disposition of the assets of the Company among its shareholders for the purpose of winding up its affairs after the Company has paid out its liabilities. </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Advance Notice for Shareholder Director Nominations</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Articles contain advance notice provisions setting out advance notice requirements for the nomination of directors of the Company by a shareholder (who must also meet certain qualifications outlined in the Articles) (the &#8220;Nominating Shareholder&#8221;) at any annual meeting of shareholders, or for any special meeting of shareholders if one of the purposes for which the special meeting was called was the election of directors (the &#8220;Advance Notice By-Law&#8221;). </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to any other applicable requirements, for a nomination to be made by a Nominating Shareholder, the Nominating Shareholder must give timely notice of such nomination in proper written form to the Corporate Secretary of the Company at the principal executive offices of the Company. To be timely, a Nominating Shareholder&#8217;s notice to the Corporate Secretary must be made&#58; (i) in the case of an annual meeting of shareholders, not less than 30 nor more than 65 days prior to the date of the annual meeting of shareholders&#894; provided, however, that in the event that the annual meeting of shareholders is to be held on a date that is less than 50 days after the date (the &#8220;Notice Date&#8221;) on which the first public announcement by the Company by press release of the date of the annual meeting was made, notice by the Nominating Shareholder may be made not later than the close of business on the 10th day following the Notice Date&#894; and (ii) in the case of a special meeting (which is not also an annual meeting) of shareholders called for the purpose of electing directors (whether or not called for other purposes as well), not later than the close of business on the 15th day following the day on which the first public announcement by the Company by press release of the date of the special meeting of Shareholders was made. The Company&#8217;s Articles also prescribe the proper written form for a Nominating Shareholder&#8217;s notice. </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The chairperson of the meeting has the power and duty to determine whether a nomination was made in accordance with the notice procedures set forth in the Articles and, if any proposed nomination is not in compliance with such provisions, the discretion to declare that such defective nomination will be disregarded. </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Provisions</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Common Shares are not subject to call or assessment rights or any pre-emptive or conversion rights. There are no provisions for redemption, purchase for cancellation, surrender or purchase of funds. </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Transfer Agent</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transfer agent and registrar for the Common Shares is TSX Trust Company.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Ownership of Our Common Shares</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is no limitation imposed by the Articles on the right of a non-Canadian resident to hold or vote our Common Shares. The following provides a summary of certain limitations imposed by Canadian laws on the right of a non-Canadian resident to hold or vote our Common Shares&#58;</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Competition Act</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Limitations on the ability to acquire and hold our Common Shares may be imposed by the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Competition Act </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Canada). This legislation permits the Commissioner of Competition of Canada, or Commissioner, to review any acquisition or establishment, directly or indirectly, including through the acquisition of shares, of control over or of a significant interest in us. This legislation grants the Commissioner jurisdiction, for up to one year after the acquisition has been substantially completed, to seek a remedial order, including an order to prohibit the acquisition or require divestitures, from the Canadian Competition Tribunal, which order may be granted where the Competition Tribunal finds that the acquisition prevents or lessens, or is likely to prevent or lessen, competition substantially.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This legislation also requires any person or persons who intend to acquire  our voting shares such that the person or persons would own more than 20% of our voting shares after the acquisition, or if such person or persons already own more than 20% of our voting shares prior to the acquisition, more than 50% of our voting shares, to file a notification with the Commissioner if certain financial thresholds are exceeded (unless an exemption is available). Where a notification is required, the legislation prohibits completion of the acquisition until the expiration of the applicable statutory waiting period, unless the Commissioner either waives or terminates such waiting period.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment Canada Act</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment Canada Act </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">requires each &#8220;non-Canadian&#8221; (as determined pursuant to the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment Canada Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) who acquires &#8220;control&#8221; of an existing &#8220;Canadian business&#8221; to file a notification in prescribed form with the responsible Canadian federal government department or departments not later than 30 days after closing, provided the acquisition of control is not a reviewable transaction by Canadian authorities. Subject to certain exemptions, a transaction that is reviewable under the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment Canada </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Act may not be implemented until an application for review has been filed and either the responsible Minister of the federal cabinet has determined that the investment is likely to be of &#8220;net benefit to Canada&#8221; taking into account certain factors set out in the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment Canada Act </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or the responsible Minister has been deemed to be satisfied that the investment is likely to be of &#8220;net benefit to Canada&#8221;. Under the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment Canada Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, an investment in our Common Shares by a non-Canadian who is either&#58; (a) a WTO investor (i.e., controlled ultimately by nationals or permanent residents of World Trade Organization member countries, including the United States) or (b) a trade agreement investor (i.e., controlled ultimately by nationals or permanent residents of countries with whom Canada has a trade agreement, including the United States) but who is not a state-owned enterprise, would be reviewable only if it were an investment to acquire control of us pursuant to the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment Canada Act </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and our enterprise value was equal to or greater than specified amounts, which vary annually. The specified review threshold amounts, as of January 1, 2021, for WTO investors and trade agreement investors who are not state-owned enterprises are C$1.043 billion and C$1.565 billion in enterprise value, respectively. Any changes to the review thresholds will be published in the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Canada Gazette</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment Canada Act </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">contains various rules to determine if there has been an acquisition of control by a non-Canadian. For example, for purposes of determining whether an investor has acquired control of a corporation by acquiring shares, the following general rules apply, subject to certain exceptions&#58; the acquisition of a majority of the undivided ownership interests in the voting shares of a corporation is deemed to be acquisition of control of that corporation&#59; the acquisition of less than a majority, but one-third or more, of the voting shares of a corporation or of an equivalent undivided ownership interest in the voting shares of the corporation is presumed to be acquisition of control of that corporation unless it can be established that, on the acquisition, the corporation is not controlled in fact by the acquirer through the ownership of voting shares&#59; and the acquisition of less than one third of the voting shares of a corporation or of an equivalent undivided ownership interest in the voting shares of the corporation is deemed not to be acquisition of control of that corporation.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the national security review regime in the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment Canada Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, review on a discretionary basis may also be undertaken by the federal government in respect to a much broader range of investments by a non-Canadian to &#8220;acquire, in whole or part, or to establish an entity carrying on all or any part of its operations in Canada&#8221; where that entity satisfies specific criteria related to its Canadian presence. No financial threshold applies to a national security review. The relevant consideration is whether such investment by a non-Canadian could be &#8220;injurious to national security&#8221;. The federal government has broad discretion to determine whether an investor is a non-Canadian and therefore subject to national security review. Review on national security grounds is at the discretion of the Canadian government, and may occur on a pre- or post-closing basis.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain transactions relating to our Common Shares will generally be exempt from the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment Canada Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, subject to the federal government&#8217;s prerogative to conduct a national security review, including&#58;</font></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the acquisition of our Common Shares by a person in the ordinary course of that person&#8217;s business as a trader or dealer in securities&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the acquisition of control of us in connection with the realization of security granted for a loan or other financial assistance and not for any purpose related to the provisions of the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment Canada Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#59; and</font></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the acquisition of control of us by reason of an amalgamation, merger, consolidation or corporate reorganization following which the ultimate direct or indirect control in fact of us, through ownership of our Common Shares, remains unchanged.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certain Canadian Income Tax Considerations for United States Shareholders</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes, as of the date hereof, certain Canadian federal income tax considerations generally applicable under the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Tax Act </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Canada) and the regulations thereunder (collectively, the &#8220;Canadian Tax Act&#8221;) and the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Canada-United States Tax Convention (1980)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as amended (the &#8220;Convention&#8221;) to the holding and disposition of our Common Shares. </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This summary is restricted to beneficial owners of our Common Shares each of whom, at all relevant times and for purposes of the Canadian Tax Act and the Convention&#58; (i) is neither resident nor deemed to be resident in Canada&#59; (ii) is resident solely in the United States and is entitled to benefits of the Convention&#59; (iii) does not use or hold, and is not deemed to use or hold, our Common Shares in, or in the course of, carrying on a business in Canada&#59; (iv) deals at arm&#8217;s length with and is not affiliated with the Company&#59; (v) holds our Common Shares as capital property&#59; and (vi) is not an &#8220;authorized foreign bank&#8221; (as defined in the Canadian Tax Act) or an insurer that carries on business in Canada and elsewhere (each such holder, a &#8220;U.S. Resident Holder&#8221;). Generally, a U.S. Resident Holder&#8217;s Common Shares will be considered to be capital property of the holder provided that the holder is not a trader or dealer in securities, does not acquire, hold or dispose of (or is not deemed to have acquired, held or disposed of) our Common Shares in one or more transactions considered to be an adventure or concern in the nature of trade, and does not hold or use (or is not deemed to hold or use) our Common Shares in the course of carrying on a business.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This summary is based upon the current provisions of the Canadian Tax Act and the Convention in effect as of the date hereof, and the Company&#8217;s understanding of the current published administrative policies and assessing practices of the Canada Revenue Agency (&#8220;CRA&#8221;) published in writing prior to the date hereof. This summary does not anticipate or take into account any changes in law or in the administrative policies or assessing practices of the CRA, whether by legislative, governmental or judicial decision or action, except specific proposals to amend the Canadian Tax Act publicly and officially announced by or on behalf of the Minister of Finance (Canada) prior to the date hereof (the &#8220;Tax Proposals&#8221;). This summary assumes that the Tax Proposals will be enacted in the form proposed. This summary does not take into account any other federal or any provincial, territorial or foreign tax legislation or considerations, which may differ significantly from those set out herein. No assurances can be given that the Tax Proposals will be enacted as proposed or at all, or that legislative, judicial or administrative changes will not modify or change the statements expressed herein.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This summary is of a general nature only, is not exhaustive of all possible Canadian federal income tax considerations, and is not intended and should not be construed as legal or tax advice to any particular U.S. Resident Holder. Accordingly, prospective purchasers or holders of our Common Shares are urged to consult their own tax advisors with respect to their own particular circumstances.</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Taxation of Dividends</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Canadian Tax Act, dividends paid or credited, or deemed to be paid or credited, to a U.S. Resident Holder on our Common Shares will be subject to Canadian withholding tax at a rate of 25% of the gross amount of such dividends, unless the rate is reduced under the Convention. Under the Convention, the rate of withholding tax on dividends applicable to U.S. Resident Holders who are entitled to benefits under the Convention and beneficially own the dividends is generally reduced to 15% (or, if the U.S. Resident Holder is a company that owns at least 10% of the voting shares of the Company, 5%) of the gross amount of such dividends.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disposition of Common Shares</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generally, a U.S. Resident Holder will not be subject to tax under the Canadian Tax Act in respect of any capital gain realized by such U.S. Resident Holder on a disposition or deemed disposition of our Common Shares unless our Common Shares constitute &#8220;taxable Canadian property&#8221; of the U.S. Resident Holder and are not &#8220;treaty-protected property&#8221; (each as defined in the Canadian Tax Act). Common Shares of the Company generally will not be &#8220;taxable Canadian property&#8221; to a holder provided that, at the time of the disposition or deemed disposition, the Common Shares are listed on a &#8220;designated stock exchange&#8221; for purposes of the Canadian Tax Act (which currently includes the NASDAQ and the TSX), unless at any time during the 60-month period immediately preceding the disposition of the Common Shares the following two conditions are met concurrently&#58; (a) (i) the U.S. Resident Holder, (ii) persons with whom the U.S. Resident Holder did not deal at arm&#8217;s length, (iii) partnerships in which the U.S. Resident Holder or a person described in (ii) holds a membership interest directly or indirectly through one or more partnerships, or (iv) any combination of the persons and partnerships described in (i) through (iii), owned 25% or more of the issued shares of any class or series of the capital stock of the Company&#59; and (b) more than 50% of the fair market value of the Common Shares was derived directly or indirectly, from one or any combination of real or immovable property situated in Canada, &#8220;Canadian resource properties&#8221;, &#8220;timber resource properties&#8221; (each as defined in the Canadian Tax Act), and options in respect of or interests in, or for civil law rights in, any such properties (whether or not such property exists). In certain circumstances set out in the Canadian Tax Act, the Common Shares may be deemed to be &#8220;taxable Canadian property&#8221;.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if the Common Shares are taxable Canadian property to a U.S. Resident Holder, any capital gain realized on the disposition or deemed disposition of such Common Shares will not be subject to tax under the Canadian Tax Act provided that the value of such Common Shares is not derived principally from real property situated in Canada (within the meaning of the Convention).</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A U.S. Resident Holder contemplating a disposition of our Common Shares that may constitute taxable Canadian property should consult a tax advisor prior to such disposition.</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-14.1
<SEQUENCE>3
<FILENAME>a1411.htm
<DESCRIPTION>EX-14.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i01ea7639f4554b0d8ab73d7eb5cf1f0a_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;margin-top:9pt;text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div><font><br></font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;14.1</font></div><div style="margin-bottom:24pt;margin-top:60pt;text-align:center"><img alt="cronoslogoa021.jpg" src="cronoslogoa021.jpg" style="height:129px;margin-bottom:5pt;vertical-align:text-bottom;width:414px"></div><div style="margin-bottom:24pt;margin-top:60pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:22pt;font-weight:700;line-height:120%">Code of Business Conduct and Ethics</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Cronos Group Inc.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Effective as of November 1, 2018</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:6pt;text-align:justify"><font><br></font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:12.996%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.804%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Department&#58;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Legal</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Policy Owner&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Xiuming Shum, General Counsel</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Policy Validator&#58;</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Board of Directors of Cronos Group Inc.</font></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">For updates or additions, please contact the Legal Department at corporate.secretary&#64;thecronosgroup.com</font></div></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">This document is uncontrolled when printed.  For the current, official copy of this policy, please refer to the Legal Department at corporate.secretary&#64;thecronosgroup.com </font></div></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:432pt;text-align:justify"><font style="color:#828282;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Version 2018B</font></div></td></tr></table></div><div style="margin-bottom:8pt;text-align:justify"><font><br></font></div></div></div><div id="i01ea7639f4554b0d8ab73d7eb5cf1f0a_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;margin-top:9pt;text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div><font><br></font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:8pt;padding-left:4.5pt;padding-right:4.5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;padding-left:4.5pt;padding-right:4.5pt;text-align:center"><font style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">TABLE OF CONTENTS</font></div></td></tr></table></div><div style="margin-bottom:8pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:130%">SECTION 1&#58;  OVERVIEW AND STANDARDS........................................................................................................................&#160;&#160;&#160;&#160;3</font></div><div style="margin-bottom:8pt;margin-top:3pt;padding-left:11.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%">UNDERSTANDING OUR CODE..............................................................................................................................................&#160;&#160;&#160;&#160;4</font></div><div style="margin-bottom:8pt;margin-top:3pt;padding-left:11.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%">STANDARDS OF CONDUCT....................................................................................................................................................&#160;&#160;&#160;&#160;7</font></div><div style="margin-bottom:8pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:130%">SECTION 2&#58;  RESPONSIBILITIES UNDER THE CODE.....................................................................................................&#160;&#160;&#160;&#160;10</font></div><div style="margin-bottom:8pt;margin-top:3pt;padding-left:11.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%">RESPONSIBILITIES TO EACH OTHER AS COLLEAGUES...............................................................................................&#160;&#160;&#160;&#160;11</font></div><div style="margin-bottom:8pt;margin-top:3pt;padding-left:11.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%">RESPONSIBILITIES TO OUR COMMUNITIES AND PARTNERS.....................................................................................&#160;&#160;&#160;&#160;12</font></div><div style="margin-bottom:8pt;margin-top:3pt;padding-left:11.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%">RESPONSIBILITIES TO COMPLY WITH THE LAW AND  THIS CODE, AND REPORT NON-COMPLIANCE&#160;&#160;&#160;&#160;13</font></div><div style="margin-bottom:8pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:130%">SECTION 3&#58;  REPORTING NON-COMPLIANCE................................................................................................................&#160;&#160;&#160;&#160;14</font></div><div style="margin-bottom:8pt;margin-top:3pt;padding-left:11.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%">REPORTING CODE AND NON-CODE CONCERNS AT CRONOS-OPERATED SITES AND OFFICES&#160;&#160;&#160;&#160;15</font></div><div style="margin-bottom:8pt;margin-top:3pt;padding-left:11.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%">COMPLIANCE HOTLINE.......................................................................................................................................................&#160;&#160;&#160;&#160;17</font></div><div style="margin-bottom:8pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:130%">SECTION 4&#58;  APPENDIX...........................................................................................................................................................&#160;&#160;&#160;&#160;18</font></div><div style="margin-bottom:8pt;margin-top:3pt;padding-left:11.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%">APPENDIX 1&#58;  POLICY REVISION HISTORY......................................................................................................................&#160;&#160;&#160;&#160;19</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2</font></div></div></div><div id="i01ea7639f4554b0d8ab73d7eb5cf1f0a_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><img alt="cronoslogoa021.jpg" src="cronoslogoa021.jpg" style="height:32px;margin-bottom:5pt;vertical-align:text-bottom;width:102px"></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:22pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;    </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:22pt;font-weight:700;line-height:120%">Section 1&#58;  Overview and Standards</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><img alt="cronoslogoa021.jpg" src="cronoslogoa021.jpg" style="height:32px;margin-bottom:5pt;vertical-align:text-bottom;width:102px"></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font><br></font></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;padding-left:2.25pt;padding-right:2.25pt;text-align:center"><font style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:130%">TABLE OF CONTENTS</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Scope</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Code applies to all Employees of Cronos Group Inc. and its subsidiaries and affiliates controlled by, or under common control of, Cronos Group Inc. (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cronos Group</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; or the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). This Code applies to Cronos Group, together with its subsidiaries and affiliates, every Cronos Group employee, including the Chief Executive Officer, other senior executives and financial officers, and members of the Board of Directors (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). This Code also applies to all Cronos Group contractors and suppliers, and third-party vendors also are expected to meet the standards contained in this Code.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Code may be amended from time to time to reflect changing circumstances and supersedes all prior versions.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Purpose</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board of Cronos Group has adopted this Code of Business Conduct and Ethics (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) which embodies the Company&#8217;s commitment to conduct its business in accordance with all applicable laws, rules and regulations and the highest ethical standards. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">What does the Code encompass&#63;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Being a responsible company means upholding the highest ethical standards and complying with all applicable laws and regulations, industry practices and international norms, as well as this Code and all other Cronos Group policies or requirements. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If you have questions about the Code, contact the Legal Department at </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">corporate.secretary&#64;thecronosgroup.com </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">What are my responsibilities as an employee or contractor&#63;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Everyone at Cronos Group has a responsibility to act ethically. As employees, we have a duty to understand and follow the Code and all laws, regulations and company policies that apply to our jobs. We are all expected to conduct business according to the highest ethical standards, and report issues and concerns that we may have.  Contractors have a similar expectation when they perform work for Cronos Group.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the Code forms a strong foundation for ethical business conduct, it is not a substitute for common sense and good judgment, nor does it address every situation we encounter. If you are ever unsure about what to do in a particular situation, ask yourself&#58;</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Does the action comply with the Code and other Cronos Group policies&#63;</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Is the action legal&#63;</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Does it feel right and am&#160;I comfortable with the decision&#63;</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Am I confident that&#160;I don&#8217;t need to consult anyone else&#63;</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Would the person&#160;I respect most support this decision&#63;</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Have&#160;I applied the &#8220;newspaper test&#8221; (e.g., how would it look on the front page)&#63;</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Am&#160;I confident our shareholders and external partners would react positively&#63;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If you have any doubts about what&#8217;s right or what you should do, ask questions and voice your concerns. If you think an actual or potential violation has occurred, it&#8217;s important to come forward and report your concerns immediately. The end of this Code describes how to report a concern.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Misconduct cannot be justified by saying it was ordered by someone else, even in management. Nobody has the authority to require you to act in a way that is illegal or violates Cronos Group&#8217;s policies.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><img alt="cronoslogoa021.jpg" src="cronoslogoa021.jpg" style="height:32px;margin-bottom:5pt;vertical-align:text-bottom;width:102px"></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You should also be alert to potential improper conduct, including fraudulent or unlawful activities. That obligation extends to your own functional unit and others, as we all have an obligation to prevent improper conduct from occurring and report it when it does.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">What are my responsibilities as a manager&#63;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Managers must act as leaders. You are expected to demonstrate a personal commitment to Cronos Group standards and foster an environment where employees feel comfortable asking questions and reporting issues. Managers must also make direct reports aware of their obligations under the Code and the policies and procedures that apply to them.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You are expected to be open to questions about the Code and our policies, and to identify the right resource for employees who have good faith questions or concerns. We advise employees to seek guidance from your manager on the best course of action if they have concerns over potential violations of the Code, our policies, or the law. When you are approached, be ready to give honest, ethical and appropriate answers&#59; if you do not have the answer, refer the employee to the Legal Department.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">What happens when a report is made&#63;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When we receive a report of a potential violation of the Code, we investigate it promptly and take corrective action as appropriate based on the findings. We expect all employees to cooperate in investigations fully and candidly. Obstructing an investigation, providing false or misleading information, or failing to cooperate may lead to disciplinary action up to and including immediate termination.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Legal Department will promptly address all Code allegations and recommending corrective actions to local or head office management, as appropriate.  The General Counsel is responsible for allegations that raise the most serious violations of the Code. The General Counsel reports regularly to the Audit Committee of the Board on serious Code violations and suspected Code violations.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Which employees have a significant role in Cronos Group internal controls&#63;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Members of the Executive Committee, heads of departments, employees who work in the internal audit, finance and accounting or legal functions, and other employees who are designated as holding positions of trust. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">What kind of discipline is there for Code violations&#63;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If employees, contractors, or third-party vendors are found to violate the Code, they will be subject to disciplinary action or contractual remedies. The nature of the discipline is determined by several factors, including the seriousness and frequency of the violation, past misconduct, relevant knowledge or intent, and prior training. Common disciplinary actions for employees are&#58;</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">mentoring or counseling</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">verbal warning</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">suspension</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">focused training</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">written warning or reprimand</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">termination</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In appropriate cases (for example, reports of serious human rights violations), referrals may be made to law enforcement, and&#47;or repayment or restitution may be sought.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We do not tolerate retaliation and encourage good faith reporting.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will not tolerate retaliation by anyone, regardless of their level or position, against an employee, contractor or other third-party vendor for raising concerns or questions regarding ethics, or for reporting suspected Code violations in good faith. We take claims of retaliation very seriously and investigate them in the same manner as allegations of Code breaches.  Anyone </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><img alt="cronoslogoa021.jpg" src="cronoslogoa021.jpg" style="height:32px;margin-bottom:5pt;vertical-align:text-bottom;width:102px"></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">found to be engaging in any form of retaliation or reprisal may be subject to disciplinary action up to and including termination of employment.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To be clear, we encourage employees to raise concerns, and try to protect those that do.  An employee or contractor who in good faith seeks advice, asks a question or reports known or suspected misconduct is doing the right thing. We encourage and expect our workforce to voice concerns and questions. The Company&#8217;s policy on whistleblowers provides employees with a means to report any wrong-doing and means for the Company to investigate and follow-through with any allegations. Employees will have an avenue to report any wrong-doing and&#47;or unethical behavior about fellow Cronos Group employees or Cronos Group management or members of the Board and ensure their legitimate concerns are followed up on. Moreover, whistleblowers will be confident that they will be protected from any retaliation.  However vexatious allegations made in bad faith will not be subject to such protection.  </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, reasonable efforts will be made to keep any allegations about suspected Code violations confidential throughout the investigation process, taking into account the need to obtain sufficient information to conduct a thorough investigation. If you prefer to report an allegation anonymously through the Compliance Hotline, please provide enough details and information about the incident or situation to allow Cronos Group to investigate properly. Information about the hotline is included at the end of this Code.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><img alt="cronoslogoa021.jpg" src="cronoslogoa021.jpg" style="height:32px;margin-bottom:5pt;vertical-align:text-bottom;width:102px"></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:8pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:center"><font style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">STANDARDS OF CONDUCT</font></div></td></tr></table></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Responsibilities to Our Shareholders</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Conflicts of Interest</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advancing together means we put the interests of Cronos Group before our own. We avoid conflicts of interest where someone might question whether we are acting for Cronos Group&#8217;s benefit or for personal gain.  Conflict situations arise when an employee or director takes actions or has private interests that may make it difficult to perform his or her company work objectively and effectively. These types of situations may cause us to make decisions based on personal gain rather than the best interests of Cronos Group.  They make it appear that we are using our positions at Cronos Group to obtain an improper personal benefit for ourselves. Where Cronos Group employees believe they or others may face circumstances that create, or could be seen as creating, a conflict of interest, they should raise the issue with their manager, their manager&#8217;s manager or the Legal Department.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is important to remember, we respect the right of employees and directors to take part in activities outside of their jobs. These might be financial activities, business activities, or charitable or social activities. When these activities are pursued, they must be free of conflict with responsibilities as Cronos Group employees and directors. In addition, where employees wish to serve as directors, officers, employees or consultants of a competitor, business partner or potential business partner, they must obtain prior approval of the relevant head of Department and the Legal Department.  For Cronos Group directors in particular, serving as directors or officers of a competitor or business partner, or otherwise professionally engaging with a competitor or business partner, requires prior approval of the Board.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Similar conflict situations can also arise when employees and directors invest or trade in shares of a competitor, or an actual or potential business partner.  These kinds of investments may also run afoul of relevant laws.  Under our policies, employees and directors generally may not make investments in competitors or actual or potential partners, except for shares of a publicly traded company involving less than five percent of a company&#8217;s issued shares.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Gifts</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At heart, our business is a partnership.  By always looking for ways to create mutual prosperity, we become the trusted partner.  This means conducting our business based on sound decisions and fair dealings.  The ethical conduct of our suppliers and contractors, as with our employees, is vital to our success.  Business gifts and entertainment can build goodwill, but they can also make it harder to be objective about the person who provides them.  We must not either ask for or accept any gifts or other benefits from actual or potential business partners, where doing so might impair or be seen to impair our ability to perform our duties in a fair and unbiased manner.  Gifts of cash or cash equivalent, such as vouchers, must never be accepted.  </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Public Disclosure</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we work together to create mutual value with our partners, we also must respect the information our shareholders need to make informed investments in our company.  We are committed to providing timely, factual and accurate disclosure of material information about the company to our shareholders, the financial community and the public at large, including in filings with government authorities.  Employees and directors are not permitted to make any disclosure of material, non-public information about the company to anyone outside of the company unless it is permitted by our Disclosure Policy, which contains our requirements surrounding public disclosure.  If an employee or director believes that the Disclosure Policy has been violated, he or she must notify their head of Department.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Controls and Records</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is vital that we maintain accurate financial records and a system of financial controls.  Our financial records serve as a basis for managing our business and helping to fulfill our responsibilities to our shareholders, employees and other partners.  The integrity of our financial records is also important to our compliance with accounting, tax, public disclosure laws and regulations and other requirements.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><img alt="cronoslogoa021.jpg" src="cronoslogoa021.jpg" style="height:32px;margin-bottom:5pt;vertical-align:text-bottom;width:102px"></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We all have a responsibility to help maintain appropriate accounting and financial records and follow our system of internal financial controls and relevant legal requirements.  Whether we are creating company records or receiving documents from third parties, documents should be created in a timely manner, be accurate, be complete, and have reasonable detail of the transaction.  This applies to all company records, whether it is an expense report we create or an invoice we receive.  Employees with control over company assets and transactions must establish and&#47;or maintain a system of internal controls in their area of responsibility that is designed to (a)&#160;prevent unauthorized, unrecorded or inaccurately recorded transactions&#59; and (b)&#160;permit the preparation of financial statements according to generally accepted accounting principles or the International Financial Reporting Standards, as appropriate.  </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Anti-Money Laundering</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are directly or indirectly subject to a variety of anti-money laundering laws that apply to our operations, including Canada&#8217;s Proceeds of Crime (Money Laundering) and Terrorist Financing Act, the Criminal Code of Canada, the U.S.  Bank Secrecy Act (including the amendments thereto in the USA PATRIOT Act) and others in the jurisdictions where we operate.  Money laundering is the process of transforming the proceeds of illegal activity into apparently legitimate assets.  Any act or attempt to disguise the source of money or assets derived from criminal activity, or to deal in such money or assets or their proceeds, can be considering money laundering.  These crimes include illegal drug trafficking, illegal arms sales, smuggling, prostitution, human trafficking, illegal immigration, embezzlement, insider trading, bribery, fraud, and any other criminal act.  Money laundering is illegal and can result in significant penalties even if the person or business concealing the proceeds had no involvement in the underlying crimes.  We will not provide financial support or assistance to anyone engaged in criminal activity, nor will we be involved in or support any process by which individuals or entities try to conceal the proceeds of criminal activity or otherwise try to make these funds look legitimate.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Insider Trading</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trading on inside information is strictly prohibited and a criminal offense.  Inside information is information important enough to potentially affect a company&#8217;s stock price, but which is not yet public.  Examples of inside information include&#58; financial results, earnings projections, changes in senior management, or information about acquisitions, divestments, option agreements or partnership agreements.  Inside information may relate to Cronos Group, as well as other companies, including our contractors and business partners.  Consequently, if we have access to inside information about Cronos Group or one of our business partners, we may not trade in that company&#8217;s stock (including equity securities, convertible securities, options, bonds and any stock index containing the security), until after the information is made public.  Nor may we &#8220;tip&#8221; others to do so.  Trading on inside information, or &#8220;tipping&#8221; others, is known as insider trading and is a violation of U.S., Canadian, and other laws.  We have an Insider Trading Policy to help make sure we comply with these requirements.  If you have any questions about the policy or the law, contact the Legal Department.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business Opportunities</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advancing together means protecting and advancing the company&#8217;s legitimate interests.  None of us should compete with the company.  We may not take improper advantage of business opportunities discovered through the use of company property, information or position.  We are also prohibited from using company property, information or position for personal gain.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Examples of business opportunities include&#58;</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">marketing or selling a process you developed at Cronos Group&#59; and</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">investing in the technology of a third party you meet because of your position at Cronos Group, in which Cronos Group also may have an interest in investing.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Protection and Proper Use of Company Assets</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advancing together means protecting company property.  Our assets can be physical, such as equipment and vehicles, computers and software, and reports and records. Assets can also be non-physical, such as the company name, trade secrets, banking information, strategies and even our time at work. Protecting our assets from loss, damage, theft, misuse, and waste is the responsibility of every employee because it directly impacts our profitability and our reputation. That includes being </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><img alt="cronoslogoa021.jpg" src="cronoslogoa021.jpg" style="height:32px;margin-bottom:5pt;vertical-align:text-bottom;width:102px"></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">prudent in incurring and approving business expenses, working to minimize expenses and ensuring that expenses are reasonable and serve the company&#8217;s business interests.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Group&#8217;s anti-fraud and anti-corruption policies set out the Company&#8217;s expectations and requirements relating to suspected fraudulent activities and misappropriation.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Confidentiality of Information</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information is an asset, and our partners and shareholders depend on our diligence in protecting company assets.  We must protect our financial results, our prospects or our technical data just as we protect our equipment.  Our business partners likewise depend on our diligence in protecting confidential information that they provide us, and only using that information for its intended purpose.  We all need to hold confidential information in strict confidence, which may continue even after our employment ends.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For further details on maintaining confidentiality, see our Disclosure Policy.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><img alt="cronoslogoa021.jpg" src="cronoslogoa021.jpg" style="height:32px;margin-bottom:5pt;vertical-align:text-bottom;width:102px"></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font><br></font></div></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:22pt;font-weight:700;line-height:120%">Section 2&#58;  Responsibilities Under the Code</font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><img alt="cronoslogoa021.jpg" src="cronoslogoa021.jpg" style="height:32px;margin-bottom:5pt;vertical-align:text-bottom;width:102px"></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;padding-right:4.5pt"><font style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">RESPONSIBILITIES TO EACH OTHER AS COLLEAGUES</font></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Workplace Violence, Harassment or Discrimination</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advancing together means following fair employment practices and maintaining a workplace in which all individuals are treated with dignity and respect.  We believe in a diverse and inclusive working environment.  We see our success as dependent on the full participation of all of our colleagues - regardless of race, gender, age, color, sex, religion, sexual orientation, gender identity or expression, disability, military or veteran status, or other characteristics protected by applicable laws and regulations.  We do not tolerate or condone violence or harassment of any sort, including sexual harassment.  We also do not tolerate or condone any type of discrimination prohibited by law.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For further details on such matters, see our Workplace Violence and Harassment Policy and Program, and our Diversity and Discrimination Policy. </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Health and Safety</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To grow sustainable, long-term wealth for our company and our partners, we must work together to keep our people safe.  Our safety and health vision is that every person will go home safe and healthy every day.  Achieving this goal is everyone&#8217;s responsibility.  We are committed to providing a safe and healthy workplace and adequate resources to meet that commitment through training programs, safety incentive programs, and occupational health programs.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If at any time you do not feel that a job can be performed in a safe manner, whether by you or a co-worker or contractor, you have the authority and are expected to stop the job immediately and talk to a manager without fear of repercussion.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a safety incident occurs, make sure it is reported promptly to your manager.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We all have a responsibility to maintain a safe working environment by avoiding at-risk behaviors, as well as occupational and health and safety hazards.  We also strive to share best practices, near misses, and other practical safety-related information throughout the organization so we can learn from each other and improve our work on the ground.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For further details on health and safety, see our Occupational Health and Safety Policy and our Occupational Health and Safety Manual (Ontario).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><img alt="cronoslogoa021.jpg" src="cronoslogoa021.jpg" style="height:32px;margin-bottom:5pt;vertical-align:text-bottom;width:102px"></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font><br></font></div></div><div style="margin-top:5pt;padding-left:4.5pt;padding-right:4.5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;padding-right:4.5pt"><font style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">RESPONSIBILITIES TO OUR COMMUNITIES AND PARTNERS</font></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Dealing</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The true currency of our business is trust.  This means that we act with the highest degree of integrity.  We endeavor to deal fairly with our fellow employees and our business partners.  We do not seek to take advantage of anyone through manipulation, abuse of privileged information, or any other unfair-dealing practice.  We do not pursue deceptive or illegal means of getting confidential information from competitors or use such confidential information if we obtain it.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Anti-Corruption</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advancing together means that we do not engage in improper, unethical, or questionable business practices.  We are directly or indirectly subject to a variety of anti-corruption laws that apply to our operations, including Canada&#8217;s Corruption of Foreign Public Officials Act, the U.S. Foreign Corrupt Practices Act, and others in the jurisdictions where we operate.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These laws prohibit us from paying, offering, or promising anything of value, directly or indirectly, to any third party, including any government official, to obtain an improper advantage or improperly influence an official act or decision related to our business.  Our policies also prohibit us from improperly seeking or accepting anything of value to provide an improper advantage to vendors or other business partners.</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In meeting our anti-corruption obligations, there are a few important things to keep in mind.</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">When we talk about things of value, they can include cash, gifts, promises, meals and entertainment, travel, and hiring relatives of a third party.</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">There is no exception for small amounts.  Even small payments can violate the law and may be unethical.</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may encounter intense pressure to make improper payments in countries where extraordinary competition exists.  We should be particularly vigilant not to be tempted by statements that these kinds of practices are common, customary or condoned.</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">It is important for all of us to note that our policies prohibit improper payments to any third party, whether they are government officials or in the private sector, and the receipt of improper payments or gifts.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All employees should be familiar with our anti-bribery, anti-corruption and anti-money laundering policy and other related standards and procedures.  For additional guidance, or if you have any questions about whether a specific situation falls under our policies, raise the matter promptly with your manager, who may escalate the matter to the General Counsel.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Human Rights</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advancing together means we are committed to acting with respect toward our internal and external partners.  At every location that we operate, all of our employees and third parties who provide us with goods or services must respect the human rights of internal and external partners, including the local community.  We do not tolerate violations of human rights.  We actively seek to improve human rights in the locations in which we operate, prevent negative human rights impacts from occurring, and provide a remedy when they do.  We expect our employees, directors, and third party suppliers and contractors to understand and follow our Human Rights Policy and its implementing procedures.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Environmental Practices</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Responsible business practices means minimizing the impact our operations have on the environment.  Sound environmental practices are in the best interests of our business, our employees, our shareholders and the communities in which we operate.  We strive at all times to conduct our business in accordance with recognized industry standards, to institute policies that meet or exceed applicable environmental and safety and health laws and regulations, and to continuously look for ways to improve our environmental performance.  Goals and benchmarks are established to measure environmental performance.</font></div><div style="margin-bottom:8pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><img alt="cronoslogoa021.jpg" src="cronoslogoa021.jpg" style="height:32px;margin-bottom:5pt;vertical-align:text-bottom;width:102px"></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font><br></font></div></div><div style="margin-top:5pt;padding-left:4.5pt;padding-right:4.5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:center"><font style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">RESPONSIBILITIES TO COMPLY WITH THE LAW AND </font></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:center"><font style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">THIS CODE, AND REPORT NON-COMPLIANCE</font></div></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal Compliance</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is vital that we respect the legal institutions in every jurisdiction where we do business and follow all applicable laws, rules, and regulations.  This is something that applies to all of us, including every director, officer, employee and contractor.  It is important that we all understand the laws, rules and regulations that govern our work.  If there are any questions, you are encouraged to contact the Legal Department.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Waivers of this Code</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Responsible business practices means doing the right thing, no matter what.  In seeking to do the right thing, you may feel that it is necessary to seek a waiver of some aspect of the Code.  Although rare, waivers may be granted by the General Counsel or the Chief Executive Officer.  When they are granted, they are reported to the Board or a Committee of the Board.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an executive officer - including members of senior management or the General Counsel - wishes to obtain a waiver of some aspect of the Code, the waiver can only be granted by the Board or a Committee of the Board.  Waivers given to executive officers will be disclosed to shareholders as required by applicable rules and regulations.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Annual Acknowledgement of the Code</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Once each year, as a condition of employment, you may be asked to acknowledge that you have received Code of Conduct training, understand its rules, and are not aware of any unreported violations of the Code.  New employees will sign an acknowledgement that they have received, read and understand the Code, and undertaken relevant training when they start with the company.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These acknowledgements serve to confirm that employees have reviewed and understand the Code, agreed to comply with it and report concerns about Code violations, and that they are unaware of potential actions that run afoul of the Code that have not already been reported.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><img alt="cronoslogoa021.jpg" src="cronoslogoa021.jpg" style="height:32px;margin-bottom:5pt;vertical-align:text-bottom;width:102px"></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font><br></font></div></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:22pt;font-weight:700;line-height:120%">Section 3&#58;  Reporting Non-Compliance</font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><img alt="cronoslogoa021.jpg" src="cronoslogoa021.jpg" style="height:32px;margin-bottom:5pt;vertical-align:text-bottom;width:102px"></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font><br></font></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:center"><font style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">REPORTING CODE AND NON-CODE CONCERNS AT CRONOS-OPERATED SITES AND OFFICES</font></div></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating responsibly means reporting potential violations of the law and this Code and being open to hearing and addressing the complaints and concerns of internal and external partners.  We all have a responsibility to prevent a violation of this Code, to identify and raise potential issues before they lead to problems, and to seek additional guidance when necessary.  As mentioned, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">we will not tolerate retaliation of any sort against employees, contractors or suppliers for raising good faith concerns about violations of the Code or Cronos Group policies.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also maintain a procedure for Code related reports to be escalated to appropriate levels of management, including the Audit Committee of the Board.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bear in mind, however, that not all reports that we receive involve potential violations of the Code, and therefore they may not be investigated as such.  For instance, some reports might involve human resources-related concerns, or complaints by contractors.  Reports that do not involve potential violations of the Code are typically referred to the department best suited to address the grievance or concern, such as Human Resources or Operations.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Of course, there may be instances in which you do not know whether your concern violates this Code or a law that applies to our business.  As a general guideline, if you have any questions regarding the best course of action in a particular situation, or if you suspect a possible violation of a law, regulation or this Code, you should address the matter promptly in accordance with the guidance below.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Suspected Code Violations</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As general guidance, if you do have any concern that the Code may have been violated, it should be reported promptly to local management.  Below is a list of local management contacts that are most appropriate to receive suspected Code-related concerns.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">There may be various reasons why reporting a concern or complaint to local management is not possible or advisable.  Or you may feel that taking a concern or complaint to local management will not resolve the matter, or you are simply uncomfortable raising the issue with local management.  In those instances, employees should promptly contact the General Counsel or report the matter through the Compliance Hotline by telephone or the Internet.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Suspected Serious Code Violations and Formal Reporting Channels</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are certain suspected violations of the Code that could bring serious consequences, whether legal, reputational, or related to our license to operate.  Employees and suppliers are expected to use certain formal reporting channels (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Formal Reporting Channels</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) to report these types of allegations.  These are the same categories of issues mentioned previously, on which the General Counsel reports regularly to the Audit Committee of the Board and involve serious Code violations and suspected Code violations.  Again, they are&#58;</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">An alleged misstatement in Cronos Group&#8217;s publicly released financial statements&#59;</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">An alleged misrepresentation in Cronos Group&#8217;s other public disclosures&#59;</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Any other matter that could reasonably be expected to result in a restatement of Cronos Group&#8217;s publicly released financial statements&#59;</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Alleged bribery of a government official or other alleged violation of anti-corruption laws&#59;</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Known or suspected cases of severe human rights violations&#59;</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Known or suspected fraud that involves a potential cost or loss to Cronos Group&#59;</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Known or suspected fraud, regardless of amount, that involves an officer of Cronos Group&#59;</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Known or suspected fraud, regardless of amount, that involves an employee who has a significant role in Cronos Group&#8217;s internal controls, which include the Chief Executive Officer, other senior executives and financial officers, members of the Board, other senior personnel at Cronos Group, employees who work in internal audit, finance and accounting or legal functions, and other employees who are designated as holding positions of trust&#59; or</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;15</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><img alt="cronoslogoa021.jpg" src="cronoslogoa021.jpg" style="height:32px;margin-bottom:5pt;vertical-align:text-bottom;width:102px"></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font><br></font></div></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">An event or series of events indicative of a deterioration in the overall internal control environment at a Cronos Group site or office, including a known or suspected incident or repeated incidents which indicate significant or systemic non-compliance with applicable regulatory requirements.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If there is any doubt as to whether a matter falls within a category set out above, one of the Formal Reporting Channels described next must be used.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For concerns that fall, or which may fall into these categories, employees and suppliers are expected to use one of the following Formal Reporting Channels&#58;</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">to the Legal Department, in person or by telephone or email&#59;</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">through the Compliance Hotline&#59;</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">for matters regarding accounting, internal accounting controls and other auditing matters, to the Audit Committee&#59;</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">for matters involving the Chief Executive Office or any other senior executive or financial officer of Cronos Group, to any member of the Board (and to the General Counsel and the Compliance Hotline).</font></div><div style="margin-bottom:8pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;16</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><img alt="cronoslogoa021.jpg" src="cronoslogoa021.jpg" style="height:32px;margin-bottom:5pt;vertical-align:text-bottom;width:102px"></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font><br></font></div></div><div style="margin-top:5pt;padding-left:4.5pt;padding-right:4.5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;padding-right:4.5pt"><font style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">COMPLIANCE HOTLINE </font></div></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compliance Hotline can be accessed anonymously to report concerns, taking into account the need to obtain sufficient information to conduct a thorough investigation.  The Hotline is&#58;</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a confidential reporting service operated by an outside service provider&#59;</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">available to all employees, as well as contractors and suppliers&#59; and</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">available 24 hours a day, 365 days per year.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Concerns can be lodged through the Compliance Hotline by telephone or via an Internet portal.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Hotline Follow-up Tool</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Hotline also provides a follow-up tool that allows individuals who report a Code violation to communicate anonymously with those who are investigating his or her report.  Through this tool, the reporter can&#58;</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">check on the status of the report&#59;</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">ask questions or add comments&#59; or</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">upload information to support his or her report, such as documents, email messages, pictures, audio or video files.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Likewise, those investigating the report can also post questions or request further information from the reporter on an anonymous basis.  The Hotline follow-up tool can be accessed via the same telephone numbers and Internet portal specified below.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">For the Internet Portal&#58;</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compliance Hotline internet portal can be found at&#58; </font></div><div style="margin-bottom:12pt"><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">https&#58;&#47;&#47;www.integritycounts.ca&#47;org&#47;cronosgroup</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">For the Telephone Service&#58;</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">In Canada and the United States</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Call toll-free by dialing 1 (866) 921-6714.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">In Israel</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Call toll-free by dialing to 00 or 014 800-2002-0033.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;17</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><img alt="cronoslogoa021.jpg" src="cronoslogoa021.jpg" style="height:32px;margin-bottom:5pt;vertical-align:text-bottom;width:102px"></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font><br></font></div></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:22pt;font-weight:700;line-height:120%">Section 4&#58;  Appendix</font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;18</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><img alt="cronoslogoa021.jpg" src="cronoslogoa021.jpg" style="height:32px;margin-bottom:5pt;vertical-align:text-bottom;width:102px"></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font><br></font></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:center"><font style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">APPENDIX 1&#58;  POLICY REVISION HISTORY</font></div></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:22.507%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.735%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.680%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.678%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Requested By</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Updated By</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Summary of Revisions</font></td></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2, 2018</font></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Board of Directors</font></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal (Xiuming Shum)</font></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Original Version </font></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 1, 2018</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N&#47;A</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legal (Xiuming Shum)</font></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Version 2018B&#58; general update</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;19</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>4
<FILENAME>exhibit211.htm
<DESCRIPTION>EX-21.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i5c130cbd31cf4376967c8ce3318d2fc1_32"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 21.1</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:130%">SUBSIDIARIES OF CRONOS GROUP INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:130%">As of December 31, 2020</font></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Subsidiaries</font></div></td><td colspan="3" style="border-left:1pt solid #00000a;border-right:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">State or other jurisdiction of incorporation or organization</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Hortican Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #00000a;border-right:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Canada</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Peace Naturals Project Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #00000a;border-right:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Canada</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Cronos Global Holdings Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #00000a;border-right:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Canada</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Cronos Canada Holdings Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #00000a;border-right:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Canada</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Original BC Ltd.</font></div></td><td colspan="3" style="border-left:1pt solid #00000a;border-right:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Canada</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Cronos Malta Holdings Limited</font></div></td><td colspan="3" style="border-left:1pt solid #00000a;border-right:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Malta</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Cronos Research Labs Ltd.</font></div></td><td colspan="3" style="border-left:1pt solid #00000a;border-right:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Israel</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Cronos Israel G.S. Store Ltd.</font></div></td><td colspan="3" style="border-left:1pt solid #00000a;border-right:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Israel</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Cronos Israel G.S. Cultivation Ltd.</font></div></td><td colspan="3" style="border-left:1pt solid #00000a;border-right:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Israel</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Cronos Israel G.S. Pharmacy Ltd.</font></div></td><td colspan="3" style="border-left:1pt solid #00000a;border-right:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Israel</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Cronos Israel G.S. Manufacturing Ltd.</font></div></td><td colspan="3" style="border-left:1pt solid #00000a;border-right:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Israel</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Cronos Group Celtic Holdings Ltd.</font></div></td><td colspan="3" style="border-left:1pt solid #00000a;border-right:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Ireland</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Cronos Group USA Holdings Company Limited</font></div></td><td colspan="3" style="border-left:1pt solid #00000a;border-right:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">British Columbia, Canada</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Cronos USA Holdings Inc.</font></div></td><td colspan="3" style="border-left:1pt solid #00000a;border-right:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Delaware, USA</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Cronos USA Client Services LLC</font></div></td><td colspan="3" style="border-left:1pt solid #00000a;border-right:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Delaware, USA</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Zeus Cannabinoids LLC</font></div></td><td colspan="3" style="border-left:1pt solid #00000a;border-right:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Delaware, USA</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Redwood Wellness, LLC</font></div></td><td colspan="3" style="border-left:1pt solid #00000a;border-right:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Delaware, USA</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Redwood IP Holding, LLC</font></div></td><td colspan="3" style="border-left:1pt solid #00000a;border-right:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Delaware, USA</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Redwood Retail, LLC</font></div></td><td colspan="3" style="border-left:1pt solid #00000a;border-right:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">California, USA</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Redwood Operations CA, LLC</font></div></td><td colspan="3" style="border-left:1pt solid #00000a;border-right:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">California, USA</font></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #00000a;border-left:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">Thanos Holdings Ltd. d&#47;b&#47;a Cronos Fermentation</font></div></td><td colspan="3" style="border-bottom:1pt solid #00000a;border-left:1pt solid #00000a;border-right:1pt solid #00000a;border-top:1pt solid #00000a;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">British Columbia, Canada</font></div></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>5
<FILENAME>a2311.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ie5ee7bbd07b54398ba7082b145d97ac7_1"></div><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;23.1</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consent of Independent Registered Public Accounting Firm</font></div><div style="margin-bottom:6pt;margin-top:6pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We, KPMG LLP, consent to the incorporation by reference in Registration Statements on Form S-8 No. 333-237528 and No. 333-226131 of Cronos Group Inc. (the &#8220;Company&#8221;), of our reports dated February 26, 2021, with respect to the consolidated financial statements of the Company, which comprise the consolidated balance sheets as of December 31, 2020 and December 31, 2019, the related consolidated statements of net income (loss) and comprehensive income (loss), changes in shareholders&#8217; equity (deficit) and cash flows for each of the years in the three-year period ended December 31, 2020, and the related notes (collectively, the &#8220;consolidated financial statements&#8221;) and the effectiveness of internal control over financial reporting included herein. </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our report dated February 26, 2021, on the effectiveness of internal control over financial reporting as of December 31, 2020, expresses our opinion that the Company did not maintain effective internal control over financial reporting as of December 31, 2020 because of the effect of a material weakness on the achievement of the objectives of the control criteria and contains an explanatory paragraph that states&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company&#8217;s annual or interim financial statements will not be prevented or detected on a timely basis.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A material weakness was identified relating to the following&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Management failed to properly design and execute sufficient procedures to verify inventory quantities. Specifically, while inventory counts were performed in the fourth quarter, (i) the aggregate value of items excluded from the count exceeded the Company&#8217;s materiality threshold, and (ii) human error in count execution, data transposition and reconciliation analysis resulted in inaccurate adjustments. </font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#47;s&#47; KPMG LLP</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Chartered Professional Accountants, Licensed Public Accountants</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">February 26, 2021</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Vaughan, Canada</font></div><div><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>6
<FILENAME>cronceoex3111.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i17dc02ae20a14deba516e57f0417a44b_1"></div><div style="min-height:49.5pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;31.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION&#160;302 OF</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Kurt Schmidt, certify that&#58;</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this Annual Report on Form&#160;10&#8209;K of Cronos Group Inc.&#59;</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a&#8209;15(e) and 15d&#8209;15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a&#8209;15(f) and 15d&#8209;15(f)) for the registrant and have&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:38.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:58.871%"></td><td style="width:0.1%"></td></tr><tr style="height:0pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#47;s&#47; Kurt Schmidt</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kurt Schmidt</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Principal Executive Officer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; February&#160;26, 2021</font></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;margin-top:10pt;text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>7
<FILENAME>croncfoex3121.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="if403571fbed047e7bcc15a8c5780c374_1"></div><div style="min-height:49.5pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;31.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION&#160;302 OF</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Jerry Barbato, certify that&#58;</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this Annual Report on Form&#160;10&#8209;K of Cronos Group Inc.&#59;</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a&#8209;15(e) and 15d&#8209;15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a&#8209;15(f) and 15d&#8209;15(f)) for the registrant and have&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:38.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:58.871%"></td><td style="width:0.1%"></td></tr><tr style="height:0pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Jerry Barbato</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jerry Barbato</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Principal Financial Officer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; February&#160;26, 2021</font></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;margin-top:10pt;text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>8
<FILENAME>cronceoex3211.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i2e6d477589494426bceff024e956c64a_1"></div><div style="min-height:63pt;width:100%"><div style="margin-bottom:10pt;margin-top:10pt"><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;32.1</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 18 U.S.C. SECTION&#160;1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION&#160;906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Annual Report on Form&#160;10-K for the fiscal year ended December&#160;31, 2020 of Cronos Group&#160;Inc. (the &#8220;Company&#8221;) as filed with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) on the date hereof (the &#8220;Report&#8221;),&#160;I, Kurt Schmidt, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The Report fully complies with the requirements of Section&#160;13(a)&#160;or Section&#160;15(d), as applicable,&#160;of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="text-indent:2.25pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:85.030%"><tr><td style="width:1.0%"></td><td style="width:47.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.262%"></td><td style="width:0.1%"></td></tr><tr style="height:0pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#47;s&#47; Kurt Schmidt</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kurt Schmidt</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Principal Executive Officer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; February&#160;26, 2021</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section&#160;906 has been provided to the Company and will be retained by the Company and furnished to the SEC or its staff upon request.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This certification accompanies the Form&#160;10-K to which it relates, is not deemed filed with the SEC and is not to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form&#160;10-K), irrespective of any general incorporation language contained in such filing.</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;margin-top:10pt;text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>9
<FILENAME>croncfoex3221.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ifc3b20462b464aa9a3f5b37c41e1a84d_1"></div><div style="min-height:63pt;width:100%"><div style="margin-bottom:10pt;margin-top:10pt"><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;32.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 18 U.S.C. SECTION&#160;1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION&#160;906</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Annual Report on Form&#160;10-K for the fiscal year ended December&#160;31, 2020 of Cronos Group&#160;Inc. (the &#8220;Company&#8221;) as filed with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) on the date hereof (the &#8220;Report&#8221;),&#160;I, Jerry Barbato, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The Report fully complies with the requirements of Section&#160;13(a)&#160;or Section&#160;15(d), as applicable,&#160;of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:85.030%"><tr><td style="width:1.0%"></td><td style="width:47.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.262%"></td><td style="width:0.1%"></td></tr><tr style="height:0pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Jerry Barbato</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jerry Barbato</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Principal Financial Officer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; February&#160;26, 2021</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section&#160;906 has been provided to the Company and will be retained by the Company and furnished to the SEC or its staff upon request.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This certification accompanies the Form&#160;10-K to which it relates, is not deemed filed with the SEC and is not to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form&#160;10-K), irrespective of any general incorporation language contained in such filing.</font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;margin-top:10pt;text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>10
<FILENAME>cron-20201231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:7f6b4332-a8eb-41ec-8082-7450606ea80c,g:9b8782dc-b83f-424a-b83c-bbf680d16be6-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cron="http://thecronosgroup.com/20201231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:num="http://www.xbrl.org/dtr/type/numeric" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://thecronosgroup.com/20201231">
  <xs:import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cron-20201231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cron-20201231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cron-20201231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cron-20201231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://thecronosgroup.com/role/CoverPage">
        <link:definition>000010001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheet" roleURI="http://thecronosgroup.com/role/ConsolidatedBalanceSheet">
        <link:definition>100010002 - Statement - Consolidated Balance Sheet</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetParenthetical" roleURI="http://thecronosgroup.com/role/ConsolidatedBalanceSheetParenthetical">
        <link:definition>100020003 - Statement - Consolidated Balance Sheet (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss" roleURI="http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss">
        <link:definition>100030004 - Statement - Consolidated Statements of Net Income (Loss) and Comprehensive Income (Loss)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofStockholdersEquityDeficit" roleURI="http://thecronosgroup.com/role/ConsolidatedStatementsofStockholdersEquityDeficit">
        <link:definition>100040005 - Statement - Consolidated Statements of Stockholders' Equity (Deficit)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlows" roleURI="http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows">
        <link:definition>100050006 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Background" roleURI="http://thecronosgroup.com/role/Background">
        <link:definition>210011001 - Disclosure - Background</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BackgroundDetails" roleURI="http://thecronosgroup.com/role/BackgroundDetails">
        <link:definition>240024001 - Disclosure - Background (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://thecronosgroup.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>210031002 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>220042001 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesTables" roleURI="http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesTables">
        <link:definition>230053001 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesScheduleofConsolidatedEntitiesDetails" roleURI="http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesScheduleofConsolidatedEntitiesDetails">
        <link:definition>240064002 - Disclosure - Summary of Significant Accounting Policies - Schedule of Consolidated Entities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsAmortizationMethodsandRatesDetails" roleURI="http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsAmortizationMethodsandRatesDetails">
        <link:definition>240074003 - Disclosure - Summary of Significant Accounting Policies - Schedule of Intangible Assets Amortization Methods and Rates (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantEquipmentUsefulLivesDetails" roleURI="http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantEquipmentUsefulLivesDetails">
        <link:definition>240084004 - Disclosure - Summary of Significant Accounting Policies - Schedule of Property, Plant &amp; Equipment, Useful Lives (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesImpairmentofLonglivedAssetsDetails" roleURI="http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesImpairmentofLonglivedAssetsDetails">
        <link:definition>240094005 - Disclosure - Summary of Significant Accounting Policies - Impairment of Long-lived Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NewAccountingPronouncements" roleURI="http://thecronosgroup.com/role/NewAccountingPronouncements">
        <link:definition>210101003 - Disclosure - New Accounting Pronouncements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuesfromContractswithCustomers" roleURI="http://thecronosgroup.com/role/RevenuesfromContractswithCustomers">
        <link:definition>210111004 - Disclosure - Revenues from Contracts with Customers</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuesfromContractswithCustomersNarrativeDetails" roleURI="http://thecronosgroup.com/role/RevenuesfromContractswithCustomersNarrativeDetails">
        <link:definition>240124006 - Disclosure - Revenues from Contracts with Customers - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Inventory" roleURI="http://thecronosgroup.com/role/Inventory">
        <link:definition>210131005 - Disclosure - Inventory</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoryTables" roleURI="http://thecronosgroup.com/role/InventoryTables">
        <link:definition>230143002 - Disclosure - Inventory (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoryDetails" roleURI="http://thecronosgroup.com/role/InventoryDetails">
        <link:definition>240154007 - Disclosure - Inventory (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Investments" roleURI="http://thecronosgroup.com/role/Investments">
        <link:definition>210161006 - Disclosure - Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsTables" roleURI="http://thecronosgroup.com/role/InvestmentsTables">
        <link:definition>230173003 - Disclosure - Investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsNarrativeDetails" roleURI="http://thecronosgroup.com/role/InvestmentsNarrativeDetails">
        <link:definition>240184008 - Disclosure - Investments - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsScheduleofEquityMethodInvestmentsDetails" roleURI="http://thecronosgroup.com/role/InvestmentsScheduleofEquityMethodInvestmentsDetails">
        <link:definition>240194009 - Disclosure - Investments - Schedule of Equity Method Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsScheduleofAdvancestoJointVenturesDetails" roleURI="http://thecronosgroup.com/role/InvestmentsScheduleofAdvancestoJointVenturesDetails">
        <link:definition>240204010 - Disclosure - Investments - Schedule of Advances to Joint Ventures (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsScheduleofVariableInterestEntitiesDetails" roleURI="http://thecronosgroup.com/role/InvestmentsScheduleofVariableInterestEntitiesDetails">
        <link:definition>240214011 - Disclosure - Investments - Schedule of Variable Interest Entities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherInvestments" roleURI="http://thecronosgroup.com/role/OtherInvestments">
        <link:definition>210221007 - Disclosure - Other Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherInvestmentsTables" roleURI="http://thecronosgroup.com/role/OtherInvestmentsTables">
        <link:definition>230233004 - Disclosure - Other Investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherInvestmentsSummaryofOtherInvestmentsDetails" roleURI="http://thecronosgroup.com/role/OtherInvestmentsSummaryofOtherInvestmentsDetails">
        <link:definition>240244012 - Disclosure - Other Investments - Summary of Other Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LoanReceivable" roleURI="http://thecronosgroup.com/role/LoanReceivable">
        <link:definition>210251008 - Disclosure - Loan Receivable</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LoanReceivableTables" roleURI="http://thecronosgroup.com/role/LoanReceivableTables">
        <link:definition>230263005 - Disclosure - Loan Receivable (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LoanReceivableScheduleofLoanReceivableDetails" roleURI="http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails">
        <link:definition>240274013 - Disclosure - Loan Receivable - Schedule of Loan Receivable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LoansPayable" roleURI="http://thecronosgroup.com/role/LoansPayable">
        <link:definition>210281009 - Disclosure - Loans Payable</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LoansPayableLongtermNarrativeDetails" roleURI="http://thecronosgroup.com/role/LoansPayableLongtermNarrativeDetails">
        <link:definition>240294014 - Disclosure - Loans Payable - Long-term Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipment" roleURI="http://thecronosgroup.com/role/PropertyPlantandEquipment">
        <link:definition>210301010 - Disclosure - Property, Plant and Equipment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipmentTables" roleURI="http://thecronosgroup.com/role/PropertyPlantandEquipmentTables">
        <link:definition>230313006 - Disclosure - Property, Plant and Equipment (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipmentScheduleofPropertyPlantEquipmentUsefulLivesDetails" roleURI="http://thecronosgroup.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantEquipmentUsefulLivesDetails">
        <link:definition>240324015 - Disclosure - Property, Plant and Equipment - Schedule of Property, Plant &amp; Equipment, Useful Lives (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipmentNarrativeDetails" roleURI="http://thecronosgroup.com/role/PropertyPlantandEquipmentNarrativeDetails">
        <link:definition>240334016 - Disclosure - Property, Plant, and Equipment - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsandGoodwill" roleURI="http://thecronosgroup.com/role/IntangibleAssetsandGoodwill">
        <link:definition>210341011 - Disclosure - Intangible Assets and Goodwill</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsandGoodwillTables" roleURI="http://thecronosgroup.com/role/IntangibleAssetsandGoodwillTables">
        <link:definition>230353007 - Disclosure - Intangible Assets and Goodwill (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsandGoodwillNarrativeDetails" roleURI="http://thecronosgroup.com/role/IntangibleAssetsandGoodwillNarrativeDetails">
        <link:definition>240364017 - Disclosure - Intangible Assets and Goodwill - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails" roleURI="http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails">
        <link:definition>240374018 - Disclosure - Intangible Assets and Goodwill - Schedule of Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsandGoodwillScheduleofGoodwillDetails" roleURI="http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofGoodwillDetails">
        <link:definition>240384019 - Disclosure - Intangible Assets and Goodwill - Schedule of Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://thecronosgroup.com/role/Leases">
        <link:definition>210391012 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://thecronosgroup.com/role/LeasesTables">
        <link:definition>230403008 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNarrativeDetails" roleURI="http://thecronosgroup.com/role/LeasesNarrativeDetails">
        <link:definition>240414020 - Disclosure - Leases - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleofLeaseCostandOtherInformationDetails" roleURI="http://thecronosgroup.com/role/LeasesScheduleofLeaseCostandOtherInformationDetails">
        <link:definition>240424021 - Disclosure - Leases - Schedule of Lease Cost and Other Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GeneralandAdministrativeExpenses" roleURI="http://thecronosgroup.com/role/GeneralandAdministrativeExpenses">
        <link:definition>210431013 - Disclosure - General and Administrative Expenses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GeneralandAdministrativeExpensesTables" roleURI="http://thecronosgroup.com/role/GeneralandAdministrativeExpensesTables">
        <link:definition>230443009 - Disclosure - General and Administrative Expenses (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GeneralandAdministrativeExpensesScheduleofGeneralandAdministrativeExpensesDetails" roleURI="http://thecronosgroup.com/role/GeneralandAdministrativeExpensesScheduleofGeneralandAdministrativeExpensesDetails">
        <link:definition>240454022 - Disclosure - General and Administrative Expenses - Schedule of General and Administrative Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeLiabilities" roleURI="http://thecronosgroup.com/role/DerivativeLiabilities">
        <link:definition>210461014 - Disclosure - Derivative Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeLiabilitiesTables" roleURI="http://thecronosgroup.com/role/DerivativeLiabilitiesTables">
        <link:definition>230473010 - Disclosure - Derivative Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeLiabilitiesNarrativeDetails" roleURI="http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails">
        <link:definition>240484023 - Disclosure - Derivative Liabilities - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails" roleURI="http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails">
        <link:definition>240494024 - Disclosure - Derivative Liabilities - Schedule of Reconciliation of Carrying Amounts (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails" roleURI="http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails">
        <link:definition>240504025 - Disclosure - Derivative Liabilities - Schedule of Fair Values of Derivative Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails" roleURI="http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails">
        <link:definition>240514026 - Disclosure - Derivative Liabilities - Schedule of Sensitivity Analysis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalStock" roleURI="http://thecronosgroup.com/role/CapitalStock">
        <link:definition>210521015 - Disclosure - Capital Stock</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalStockTables" roleURI="http://thecronosgroup.com/role/CapitalStockTables">
        <link:definition>230533011 - Disclosure - Capital Stock (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalStockNarrativeDetails" roleURI="http://thecronosgroup.com/role/CapitalStockNarrativeDetails">
        <link:definition>240544027 - Disclosure - Capital Stock - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalStockScheduleofCommonSharesIssuedDetails" roleURI="http://thecronosgroup.com/role/CapitalStockScheduleofCommonSharesIssuedDetails">
        <link:definition>240554028 - Disclosure - Capital Stock - Schedule of Common Shares Issued (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedPayments" roleURI="http://thecronosgroup.com/role/SharebasedPayments">
        <link:definition>210561016 - Disclosure - Share-based Payments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedPaymentsTables" roleURI="http://thecronosgroup.com/role/SharebasedPaymentsTables">
        <link:definition>230573012 - Disclosure - Share-based Payments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedPaymentsSummaryofChangesinWarrantsDetails" roleURI="http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinWarrantsDetails">
        <link:definition>240584029 - Disclosure - Share-based Payments - Summary of Changes in Warrants (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedPaymentsSummaryofOutstandingWarrantsDetails" roleURI="http://thecronosgroup.com/role/SharebasedPaymentsSummaryofOutstandingWarrantsDetails">
        <link:definition>240594030 - Disclosure - Share-based Payments - Summary of Outstanding Warrants (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedPaymentsStockOptionsNarrativeDetails" roleURI="http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails">
        <link:definition>240604031 - Disclosure - Share-based Payments - Stock Options Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedPaymentsScheduleofStockOptionsOutstandingDetails" roleURI="http://thecronosgroup.com/role/SharebasedPaymentsScheduleofStockOptionsOutstandingDetails">
        <link:definition>240614032 - Disclosure - Share-based Payments - Schedule of Stock Options Outstanding (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedPaymentsSummaryoftheChangesinOptionsDetails" roleURI="http://thecronosgroup.com/role/SharebasedPaymentsSummaryoftheChangesinOptionsDetails">
        <link:definition>240624033 - Disclosure - Share-based Payments - Summary of the Changes in Options (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedPaymentsFairValueofOptionsIssuedDetails" roleURI="http://thecronosgroup.com/role/SharebasedPaymentsFairValueofOptionsIssuedDetails">
        <link:definition>240634034 - Disclosure - Share-based Payments - Fair Value of Options Issued (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedPaymentsRestrictedShareUnitsNarrativeDetails" roleURI="http://thecronosgroup.com/role/SharebasedPaymentsRestrictedShareUnitsNarrativeDetails">
        <link:definition>240644035 - Disclosure - Share-based Payments - Restricted Share Units Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedPaymentsSummaryofRestrictedShareUnitsActivityDetails" roleURI="http://thecronosgroup.com/role/SharebasedPaymentsSummaryofRestrictedShareUnitsActivityDetails">
        <link:definition>240654036 - Disclosure - Share-based Payments - Summary of Restricted Share Units Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedPaymentsDeferredShareUnitsNarrativeDetails" roleURI="http://thecronosgroup.com/role/SharebasedPaymentsDeferredShareUnitsNarrativeDetails">
        <link:definition>240664037 - Disclosure - Share-based Payments - Deferred Share Units Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedPaymentsSummaryofDeferredShareUnitsActivityDetails" roleURI="http://thecronosgroup.com/role/SharebasedPaymentsSummaryofDeferredShareUnitsActivityDetails">
        <link:definition>240674038 - Disclosure - Share-based Payments - Summary of Deferred Share Units Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningslossPerShare" roleURI="http://thecronosgroup.com/role/EarningslossPerShare">
        <link:definition>210681017 - Disclosure - Earnings (loss) Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningslossPerShareTables" roleURI="http://thecronosgroup.com/role/EarningslossPerShareTables">
        <link:definition>230693013 - Disclosure - Earnings (loss) Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningslossPerShareScheduleofEarningsLossPerShareDetails" roleURI="http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails">
        <link:definition>240704039 - Disclosure - Earnings (loss) Per Share - Schedule of Earnings (Loss) Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningslossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedSharesOutstandingDetails" roleURI="http://thecronosgroup.com/role/EarningslossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedSharesOutstandingDetails">
        <link:definition>240714040 - Disclosure - Earnings (loss) Per Share - Schedule of Antidilutive Securities Excluded from Computation of Diluted Shares Outstanding (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveIncomeLoss" roleURI="http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLoss">
        <link:definition>210721018 - Disclosure - Accumulated Other Comprehensive Income (Loss)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveIncomeLossTables" roleURI="http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLossTables">
        <link:definition>230733014 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveIncomeLossDetails" roleURI="http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails">
        <link:definition>240744041 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://thecronosgroup.com/role/IncomeTaxes">
        <link:definition>210751019 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://thecronosgroup.com/role/IncomeTaxesTables">
        <link:definition>230763015 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofIncomeLossbeforeIncomeTaxesDetails" roleURI="http://thecronosgroup.com/role/IncomeTaxesScheduleofIncomeLossbeforeIncomeTaxesDetails">
        <link:definition>240774042 - Disclosure - Income Taxes - Schedule of Income (Loss) before Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://thecronosgroup.com/role/IncomeTaxesNarrativeDetails">
        <link:definition>240784043 - Disclosure - Income Taxes - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesExpenseforIncomeTaxesDetails" roleURI="http://thecronosgroup.com/role/IncomeTaxesExpenseforIncomeTaxesDetails">
        <link:definition>240794044 - Disclosure - Income Taxes - Expense for Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesEffectiveTaxRateReconciliationDetails" roleURI="http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails">
        <link:definition>240804045 - Disclosure - Income Taxes - Effective Tax Rate Reconciliation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails" roleURI="http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails">
        <link:definition>240814046 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesSummaryofValuationAllowanceDetails" roleURI="http://thecronosgroup.com/role/IncomeTaxesSummaryofValuationAllowanceDetails">
        <link:definition>240824047 - Disclosure - Income Taxes - Summary of Valuation Allowance (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Commitments" roleURI="http://thecronosgroup.com/role/Commitments">
        <link:definition>210831020 - Disclosure - Commitments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsTables" roleURI="http://thecronosgroup.com/role/CommitmentsTables">
        <link:definition>230843016 - Disclosure - Commitments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsSummaryofFutureMinimumLeasePaymentsUnderOperatingLeasesDetails" roleURI="http://thecronosgroup.com/role/CommitmentsSummaryofFutureMinimumLeasePaymentsUnderOperatingLeasesDetails">
        <link:definition>240854048 - Disclosure - Commitments - Summary of Future Minimum Lease Payments Under Operating Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsRDCommitmentsDetails" roleURI="http://thecronosgroup.com/role/CommitmentsRDCommitmentsDetails">
        <link:definition>240864049 - Disclosure - Commitments - R&amp;D Commitments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsUseofPublicityRightsinBrandDevelopmentDetails" roleURI="http://thecronosgroup.com/role/CommitmentsUseofPublicityRightsinBrandDevelopmentDetails">
        <link:definition>240874050 - Disclosure - Commitments - Use of Publicity Rights in Brand Development (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Contingencies" roleURI="http://thecronosgroup.com/role/Contingencies">
        <link:definition>210881021 - Disclosure - Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesDetails" roleURI="http://thecronosgroup.com/role/ContingenciesDetails">
        <link:definition>240894051 - Disclosure - Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementaryCashFlowInformation" roleURI="http://thecronosgroup.com/role/SupplementaryCashFlowInformation">
        <link:definition>210901022 - Disclosure - Supplementary Cash Flow Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementaryCashFlowInformationTables" roleURI="http://thecronosgroup.com/role/SupplementaryCashFlowInformationTables">
        <link:definition>230913017 - Disclosure - Supplementary Cash Flow Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementaryCashFlowInformationDetails" roleURI="http://thecronosgroup.com/role/SupplementaryCashFlowInformationDetails">
        <link:definition>240924052 - Disclosure - Supplementary Cash Flow Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstruments" roleURI="http://thecronosgroup.com/role/FinancialInstruments">
        <link:definition>210931023 - Disclosure - Financial Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsCreditRiskNarrativeDetails" roleURI="http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails">
        <link:definition>240944053 - Disclosure - Financial Instruments - Credit Risk Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsLiquidityRiskNarrativeDetails" roleURI="http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskNarrativeDetails">
        <link:definition>240954054 - Disclosure - Financial Instruments - Liquidity Risk Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsInterestRateRiskDetails" roleURI="http://thecronosgroup.com/role/FinancialInstrumentsInterestRateRiskDetails">
        <link:definition>240964055 - Disclosure - Financial Instruments - Interest Rate Risk (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsCurrencyRateRiskNarrativeDetails" roleURI="http://thecronosgroup.com/role/FinancialInstrumentsCurrencyRateRiskNarrativeDetails">
        <link:definition>240974056 - Disclosure - Financial Instruments - Currency Rate Risk Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurement" roleURI="http://thecronosgroup.com/role/FairValueMeasurement">
        <link:definition>210981024 - Disclosure - Fair Value Measurement</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasuresandDisclosuresTables" roleURI="http://thecronosgroup.com/role/FairValueMeasuresandDisclosuresTables">
        <link:definition>230993018 - Disclosure - Fair Value Measures and Disclosures (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementDetails" roleURI="http://thecronosgroup.com/role/FairValueMeasurementDetails">
        <link:definition>241004057 - Disclosure - Fair Value Measurement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactionsandBalances" roleURI="http://thecronosgroup.com/role/RelatedPartyTransactionsandBalances">
        <link:definition>211011025 - Disclosure - Related Party Transactions and Balances</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyDisclosuresTables" roleURI="http://thecronosgroup.com/role/RelatedPartyDisclosuresTables">
        <link:definition>231023019 - Disclosure - Related Party Disclosures (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactionsandBalancesNarrativeDetails" roleURI="http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesNarrativeDetails">
        <link:definition>241034058 - Disclosure - Related Party Transactions and Balances - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactionsandBalancesScheduleofRelatedPartyTransactionsDetails" roleURI="http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesScheduleofRelatedPartyTransactionsDetails">
        <link:definition>241044059 - Disclosure - Related Party Transactions and Balances - Schedule of Related Party Transactions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NonmonetaryTransactions" roleURI="http://thecronosgroup.com/role/NonmonetaryTransactions">
        <link:definition>211051026 - Disclosure - Non-monetary Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NonmonetaryTransactionsDetails" roleURI="http://thecronosgroup.com/role/NonmonetaryTransactionsDetails">
        <link:definition>241064060 - Disclosure - Non-monetary Transactions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinations" roleURI="http://thecronosgroup.com/role/BusinessCombinations">
        <link:definition>211071027 - Disclosure - Business Combinations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsTables" roleURI="http://thecronosgroup.com/role/BusinessCombinationsTables">
        <link:definition>231083020 - Disclosure - Business Combinations (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsNarrativeDetails" roleURI="http://thecronosgroup.com/role/BusinessCombinationsNarrativeDetails">
        <link:definition>241094061 - Disclosure - Business Combinations - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsScheduleofFairValueofNetAssetsAcquiredDetails" roleURI="http://thecronosgroup.com/role/BusinessCombinationsScheduleofFairValueofNetAssetsAcquiredDetails">
        <link:definition>241104062 - Disclosure - Business Combinations - Schedule of Fair Value of Net Assets Acquired (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RepurposingCharges" roleURI="http://thecronosgroup.com/role/RepurposingCharges">
        <link:definition>211111028 - Disclosure - Repurposing Charges</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RepurposingChargesTables" roleURI="http://thecronosgroup.com/role/RepurposingChargesTables">
        <link:definition>231123021 - Disclosure - Repurposing Charges (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RepurposingChargesScheduleofPlanInformationDetails" roleURI="http://thecronosgroup.com/role/RepurposingChargesScheduleofPlanInformationDetails">
        <link:definition>241134063 - Disclosure - Repurposing Charges - Schedule of Plan Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RepurposingChargesNarrativeDetails" roleURI="http://thecronosgroup.com/role/RepurposingChargesNarrativeDetails">
        <link:definition>241144064 - Disclosure - Repurposing Charges - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformation" roleURI="http://thecronosgroup.com/role/SegmentInformation">
        <link:definition>211151029 - Disclosure - Segment Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationTables" roleURI="http://thecronosgroup.com/role/SegmentInformationTables">
        <link:definition>231163022 - Disclosure - Segment Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationNarrativeDetails" roleURI="http://thecronosgroup.com/role/SegmentInformationNarrativeDetails">
        <link:definition>241174065 - Disclosure - Segment Information - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationScheduleofSegmentDataDetails" roleURI="http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails">
        <link:definition>241184066 - Disclosure - Segment Information - Schedule of Segment Data (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationScheduleofAdjustedEBITDADetails" roleURI="http://thecronosgroup.com/role/SegmentInformationScheduleofAdjustedEBITDADetails">
        <link:definition>241194067 - Disclosure - Segment Information - Schedule of Adjusted EBITDA (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails" roleURI="http://thecronosgroup.com/role/SegmentInformationScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails">
        <link:definition>241204068 - Disclosure - Segment Information - Schedule of Revenue from External Customers by Geographic Areas (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationScheduleofLonglivedAssetsbyGeographicAreasDetails" roleURI="http://thecronosgroup.com/role/SegmentInformationScheduleofLonglivedAssetsbyGeographicAreasDetails">
        <link:definition>241214069 - Disclosure - Segment Information - Schedule of Long-lived Assets by Geographic Areas (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DiscontinuedOperationsandHeldforsaleAssets" roleURI="http://thecronosgroup.com/role/DiscontinuedOperationsandHeldforsaleAssets">
        <link:definition>211221030 - Disclosure - Discontinued Operations and Held-for-sale Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DiscontinuedOperationsandHeldforsaleAssetsTables" roleURI="http://thecronosgroup.com/role/DiscontinuedOperationsandHeldforsaleAssetsTables">
        <link:definition>231233023 - Disclosure - Discontinued Operations and Held-for-sale Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DiscontinuedOperationsandHeldforsaleAssetsDetails" roleURI="http://thecronosgroup.com/role/DiscontinuedOperationsandHeldforsaleAssetsDetails">
        <link:definition>241244070 - Disclosure - Discontinued Operations and Held-for-sale Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="cron_GrantedMay132016ThroughMay272016Member" abstract="true" name="GrantedMay132016ThroughMay272016Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_ShareBasedPaymentArrangementGainLossOnRevaluation" abstract="false" name="ShareBasedPaymentArrangementGainLossOnRevaluation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_SaleOfStockPerformanceMilestoneAxis" abstract="true" name="SaleOfStockPerformanceMilestoneAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="cron_WhistlerMedicalMarijuanaCompanyMember" abstract="true" name="WhistlerMedicalMarijuanaCompanyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_NumberOfStrategicJointVentures" abstract="false" name="NumberOfStrategicJointVentures" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cron_RedwoodHoldingGroupLLCMember" abstract="true" name="RedwoodHoldingGroupLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_FinancingReceivableAdditionalFaceAmountIncludingThirdPartyAmount" abstract="false" name="FinancingReceivableAdditionalFaceAmountIncludingThirdPartyAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_OtherComprehensiveIncomeLossAccumulatedGainLossDebtSecuritiesRevaluationAndDisposalOfOtherInvestments" abstract="false" name="OtherComprehensiveIncomeLossAccumulatedGainLossDebtSecuritiesRevaluationAndDisposalOfOtherInvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_NonrevolvingTermLoanFacilityMember" abstract="true" name="NonrevolvingTermLoanFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncomePercent" abstract="false" name="SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncomePercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="cron_FinancingReceivableAccruedInterestNoncurrent" abstract="false" name="FinancingReceivableAccruedInterestNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss" abstract="false" name="SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_OGBCMember" abstract="true" name="OGBCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_BoughtDealOfferingsMember" abstract="true" name="BoughtDealOfferingsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_FinancingReceivableFaceAmount" abstract="false" name="FinancingReceivableFaceAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_DebtInstrumentPastDueAdditionalInterestRateStatedPercentage" abstract="false" name="DebtInstrumentPastDueAdditionalInterestRateStatedPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="cron_OtherCountriesMember" abstract="true" name="OtherCountriesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_CollaborativeArrangementInstallmentsReceived" abstract="false" name="CollaborativeArrangementInstallmentsReceived" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_MucciMember" abstract="true" name="MucciMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_CronosGroupInc.Member" abstract="true" name="CronosGroupInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_NatuEraSeriesALoanMember" abstract="true" name="NatuEraSeriesALoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_LossContingencyPunitiveDamagesSoughtValue" abstract="false" name="LossContingencyPunitiveDamagesSoughtValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueChangesDueToCurrencyTranslation" abstract="false" name="InvestmentsInAndAdvancesToAffiliatesAtFairValueChangesDueToCurrencyTranslation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_SaleOfStockPerformanceMilestoneTwoMember" abstract="true" name="SaleOfStockPerformanceMilestoneTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_AltriaGroupInc.Member" abstract="true" name="AltriaGroupInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_A2015StockOptionPlanMember" abstract="true" name="A2015StockOptionPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_IncreaseDecreasePrepaidExpensesAndOtherReceivables" abstract="false" name="IncreaseDecreasePrepaidExpensesAndOtherReceivables" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncome" abstract="false" name="SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisesInPeriod" abstract="false" name="SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisesInPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cron_AltriaPinnacleLLC.Member" abstract="true" name="AltriaPinnacleLLC.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cron_RestOfWorldSegmentMember" abstract="true" name="RestOfWorldSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_FinancingReceivableDueOnDemandIntendedDemandTermMinimum" abstract="false" name="FinancingReceivableDueOnDemandIntendedDemandTermMinimum" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cron_GinkgoEquityMilestonesMember" abstract="true" name="GinkgoEquityMilestonesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsAndVestedInPeriod" abstract="false" name="SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsAndVestedInPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cron_ClassOfWarrantOrRightNumberOfWarrantsIssued" abstract="false" name="ClassOfWarrantOrRightNumberOfWarrantsIssued" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cron_ThreeVendorsMember" abstract="true" name="ThreeVendorsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_AdditionalPaidinCapitalAttributableToConvertibleOptionMember" abstract="true" name="AdditionalPaidinCapitalAttributableToConvertibleOptionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" abstract="false" name="AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_NatuEraMember" abstract="true" name="NatuEraMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_TopUpRightsMarketPriceMember" abstract="true" name="TopUpRightsMarketPriceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsForfeitureRate" abstract="false" name="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsForfeitureRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="cron_InvestmentsInAndAdvancesToAffiliatesDebtInstrumentFaceAmount" abstract="false" name="InvestmentsInAndAdvancesToAffiliatesDebtInstrumentFaceAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_CommonStockNumberOfVotesPerShare" abstract="false" name="CommonStockNumberOfVotesPerShare" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cron_PreEmptiveRightsAndTopUpRightsMember" abstract="true" name="PreEmptiveRightsAndTopUpRightsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss" abstract="false" name="SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_PaymentsToExerciseWarrants" abstract="false" name="PaymentsToExerciseWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_FourVendorsMember" abstract="true" name="FourVendorsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_CreditFacilityMember" abstract="true" name="CreditFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_ProceedsFromWarrantExercisedAndStockOptionsExercised" abstract="false" name="ProceedsFromWarrantExercisedAndStockOptionsExercised" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_BuildingAndEquipmentMember" abstract="true" name="BuildingAndEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_NumberOfContinentsWithInternationalProductionAndDistribution" abstract="false" name="NumberOfContinentsWithInternationalProductionAndDistribution" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cron_TopupRightsMember" abstract="true" name="TopupRightsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward" abstract="true" name="DeferredCompensationSharebasedArrangementsLiabilityRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cron_AltriaInvestmentMember" abstract="true" name="AltriaInvestmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_SaleOfStockPerformanceMilestoneTriggeringEventMinimumRevenue" abstract="false" name="SaleOfStockPerformanceMilestoneTriggeringEventMinimumRevenue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_NumberOfAdultuseBrands" abstract="false" name="NumberOfAdultuseBrands" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cron_AdjustedEarningsBeforeInterestAndTaxes" abstract="false" name="AdjustedEarningsBeforeInterestAndTaxes" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_OtherNetAssetsLiabilities" abstract="false" name="OtherNetAssetsLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_GinkgoBioworksInc.Member" abstract="true" name="GinkgoBioworksInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_FinancingReceivableInterestRateStatedPercentage" abstract="false" name="FinancingReceivableInterestRateStatedPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="cron_PreemptiveRightsMember" abstract="true" name="PreemptiveRightsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_FinancingReceivableAccruedInterestCurrent" abstract="false" name="FinancingReceivableAccruedInterestCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_EffectiveIncomeTaxRateReconciliationExpectedIncomeTaxExpenseRecoveryAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationExpectedIncomeTaxExpenseRecoveryAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_RedwoodAcquisitionMember" abstract="true" name="RedwoodAcquisitionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract" abstract="true" name="SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cron_CollaborativeArrangementPercentageOfProfitsToBeReceived" abstract="false" name="CollaborativeArrangementPercentageOfProfitsToBeReceived" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="cron_AuroraCannabisInc.Member" abstract="true" name="AuroraCannabisInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_InvestmentOwnedSharesSoldPercentageOfSharesIssuedAndOutstanding" abstract="false" name="InvestmentOwnedSharesSoldPercentageOfSharesIssuedAndOutstanding" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="cron_ClassOfWarrantOrRightAdditionalSubscriptionNumberOfSecuritiesCalledByWarrantsOrRights" abstract="false" name="ClassOfWarrantOrRightAdditionalSubscriptionNumberOfSecuritiesCalledByWarrantsOrRights" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cron_IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment" abstract="false" name="IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_ProceedsFromRightExercises" abstract="false" name="ProceedsFromRightExercises" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage" abstract="false" name="InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="cron_U.S.DistrictCourtofEasternDistrictofNewYorkVs.CronosMember" abstract="true" name="U.S.DistrictCourtofEasternDistrictofNewYorkVs.CronosMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_InvestmentOwnedNumberOfWarrantsExercised" abstract="false" name="InvestmentOwnedNumberOfWarrantsExercised" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cron_DeferredTaxAssetsFinanceLeaseLiabilities" abstract="false" name="DeferredTaxAssetsFinanceLeaseLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_DeferredTaxAssetsShareIssuanceCost" abstract="false" name="DeferredTaxAssetsShareIssuanceCost" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_ShareBasedPaymentArrangementLiabilitiesSettled" abstract="false" name="ShareBasedPaymentArrangementLiabilitiesSettled" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_PaymentOfTransactionCosts" abstract="false" name="PaymentOfTransactionCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_CannasoulAnalyticsLtdMember" abstract="true" name="CannasoulAnalyticsLtdMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_CommonStockVestingRightsNumberOfEqualInstallments" abstract="false" name="CommonStockVestingRightsNumberOfEqualInstallments" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cron_SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate" abstract="false" name="SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_CronosIsraelG.S.ManufacturingLtd.Member" abstract="true" name="CronosIsraelG.S.ManufacturingLtd.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_OfficeAndGeneralExpense" abstract="false" name="OfficeAndGeneralExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_StockIssuedDuringPeriodSharesTopupRightsExercised" abstract="false" name="StockIssuedDuringPeriodSharesTopupRightsExercised" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cron_DeferredTaxAssetsDebtIssuanceCosts" abstract="false" name="DeferredTaxAssetsDebtIssuanceCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised" abstract="false" name="SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="cron_EffectiveIncomeTaxRateReconciliationFairValueGainFinancialLiabilities" abstract="false" name="EffectiveIncomeTaxRateReconciliationFairValueGainFinancialLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise" abstract="false" name="ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cron_SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock" abstract="false" name="SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="cron_CronosIsraelG.S.PharmaciesLtd.Member" abstract="true" name="CronosIsraelG.S.PharmaciesLtd.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_FinancingReceivableDueOnDemandTerm" abstract="false" name="FinancingReceivableDueOnDemandTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cron_ProceedsFromSaleOfEquitySecuritiesFVNI" abstract="false" name="ProceedsFromSaleOfEquitySecuritiesFVNI" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod" abstract="false" name="ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableValueAssigned" abstract="false" name="LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableValueAssigned" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_FourCustomersMember" abstract="true" name="FourCustomersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableNumberOfShares" abstract="false" name="LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableNumberOfShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cron_CronosGrowCoCreditFacilityMember" abstract="true" name="CronosGrowCoCreditFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_CollaborativeArrangementTermOfAgreement" abstract="false" name="CollaborativeArrangementTermOfAgreement" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cron_EnterpriseResourcePlanningSystemMember" abstract="true" name="EnterpriseResourcePlanningSystemMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_SaleOfStockPerformanceMilestoneDomain" abstract="true" name="SaleOfStockPerformanceMilestoneDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_LoanReceivableNameAxis" abstract="true" name="LoanReceivableNameAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="cron_DeferredTaxLiabilitiesLicenses" abstract="false" name="DeferredTaxLiabilitiesLicenses" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_StockIssuedDuringPeriodValueNewIssuesIssuanceCosts" abstract="false" name="StockIssuedDuringPeriodValueNewIssuesIssuanceCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_MeasurementInputSubscriptionPriceMember" abstract="true" name="MeasurementInputSubscriptionPriceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_CannabisFlowerMember" abstract="true" name="CannabisFlowerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_InventoryDryCannabisMember" abstract="true" name="InventoryDryCannabisMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_FinancingReceivableFaceAmountIncludingThirdPartyAmount" abstract="false" name="FinancingReceivableFaceAmountIncludingThirdPartyAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_ConsultingServicesArrangementMember" abstract="true" name="ConsultingServicesArrangementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments" abstract="false" name="InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_NumberOfHempderivedCannabidiolPersonalCareBrands" abstract="false" name="NumberOfHempderivedCannabidiolPersonalCareBrands" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cron_InvestmentOwnedNumberOfSharesSold" abstract="false" name="InvestmentOwnedNumberOfSharesSold" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cron_DerivativeInstrumentsRollForward" abstract="true" name="DerivativeInstrumentsRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cron_AdvancesToAffiliateAllowanceForCreditLoss" abstract="false" name="AdvancesToAffiliateAllowanceForCreditLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees" abstract="false" name="InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_IsraeliCodesLicensingAgreementsMember" abstract="true" name="IsraeliCodesLicensingAgreementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueInterestOnAdvances" abstract="false" name="InvestmentsInAndAdvancesToAffiliatesAtFairValueInterestOnAdvances" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueRecoveredFromAppliedToEquityMethodInvestment" abstract="false" name="InvestmentsInAndAdvancesToAffiliatesAtFairValueRecoveredFromAppliedToEquityMethodInvestment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_OtherCostOfGoodsAndServicesSold" abstract="false" name="OtherCostOfGoodsAndServicesSold" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_CronosIsraelG.S.StoreLtd.Member" abstract="true" name="CronosIsraelG.S.StoreLtd.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_VariableInterestEntityQualitativeOrQuantitativeInformationLicenseTerm" abstract="false" name="VariableInterestEntityQualitativeOrQuantitativeInformationLicenseTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss" abstract="false" name="SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_RestatementReviewExpense" abstract="false" name="RestatementReviewExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_UnitedStatesSegmentMember" abstract="true" name="UnitedStatesSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_AOCIAccumulatedGainLossRevaluationAndDisposalOfOtherInvestmentsParentMemberMember" abstract="true" name="AOCIAccumulatedGainLossRevaluationAndDisposalOfOtherInvestmentsParentMemberMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_AltriaWarrantMember" abstract="true" name="AltriaWarrantMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_LongtermPurchaseCommitmentPaymentsSubjectToMilestones" abstract="false" name="LongtermPurchaseCommitmentPaymentsSubjectToMilestones" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet" abstract="false" name="CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="cron_CannabisExtractsMember" abstract="true" name="CannabisExtractsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_LongTermPurchaseCommitmentNumberOfTargetedUnitsToDevelopProduction" abstract="false" name="LongTermPurchaseCommitmentNumberOfTargetedUnitsToDevelopProduction" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cron_FinancingReceivableBeforeAccruedInterestNoncurrent" abstract="false" name="FinancingReceivableBeforeAccruedInterestNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_DiscontinuedOperationAssetsValuationAllowanceValuationIncrease" abstract="false" name="DiscontinuedOperationAssetsValuationAllowanceValuationIncrease" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_NonmonetaryTransactionNumberOfTransactions" abstract="false" name="NonmonetaryTransactionNumberOfTransactions" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cron_PurchaseOfMachineryAndEquipmentMember" abstract="true" name="PurchaseOfMachineryAndEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_GeneralAndAdministrativeExpensesTableTextBlock" abstract="false" name="GeneralAndAdministrativeExpensesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="cron_StockIssuedDuringPeriodNewIssuesFairValue" abstract="false" name="StockIssuedDuringPeriodNewIssuesFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced" abstract="false" name="CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="cron_InvestmentOwnedNumberOfSharesReceived" abstract="false" name="InvestmentOwnedNumberOfSharesReceived" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cron_A2020OmnibusPlanMember" abstract="true" name="A2020OmnibusPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_StockIssuedDuringPeriodValueWarrantsExercised" abstract="false" name="StockIssuedDuringPeriodValueWarrantsExercised" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_CanopyGrowthCorporationMember" abstract="true" name="CanopyGrowthCorporationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_InventoryCannabisExtractsMember" abstract="true" name="InventoryCannabisExtractsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_A2018StockOptionPlanMember" abstract="true" name="A2018StockOptionPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_CollaborativeArrangementAmountOfAdvances" abstract="false" name="CollaborativeArrangementAmountOfAdvances" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAndAccruedLiabilities" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAndAccruedLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_AltriaVenturesInc.Member" abstract="true" name="AltriaVenturesInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_VivoCannabisMember" abstract="true" name="VivoCannabisMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_PeaceNaturalsReportingUnitMember" abstract="true" name="PeaceNaturalsReportingUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_TwoMajorCustomersMember" abstract="true" name="TwoMajorCustomersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionCosts" abstract="false" name="EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_SaleOfStockPerformanceMilestoneTriggeringEventSharesIssuedValue" abstract="false" name="SaleOfStockPerformanceMilestoneTriggeringEventSharesIssuedValue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_CronosGrowingCompanyInc.Member" abstract="true" name="CronosGrowingCompanyInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_ProceedsFromEquitySecuritiesFVNIAndEquitySecuritiesWithoutDeterminableFairValue" abstract="false" name="ProceedsFromEquitySecuritiesFVNIAndEquitySecuritiesWithoutDeterminableFairValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_NoncashSellingAndMarketingExpense" abstract="false" name="NoncashSellingAndMarketingExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_DerivativeLiabilityUsefulLifeTerm" abstract="false" name="DerivativeLiabilityUsefulLifeTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cron_HealthCanadaLicensingAgreementsMember" abstract="true" name="HealthCanadaLicensingAgreementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_StockIssuedDuringPeriodNewIssuesWeightedAveragePricePeriod" abstract="false" name="StockIssuedDuringPeriodNewIssuesWeightedAveragePricePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cron_OneMajorCustomerMember" abstract="true" name="OneMajorCustomerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset" abstract="false" name="DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_MedMenCanadaInc.Member" abstract="true" name="MedMenCanadaInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_LoanReceivableNameDomain" abstract="true" name="LoanReceivableNameDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_ClassOfWarrantOrRightMinimumOwnershipPercentageRequired" abstract="false" name="ClassOfWarrantOrRightMinimumOwnershipPercentageRequired" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="cron_CronosIsraelG.S.CultivationsLtd.Member" abstract="true" name="CronosIsraelG.S.CultivationsLtd.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_TechnionResearchAndDevelopmentFoundationMember" abstract="true" name="TechnionResearchAndDevelopmentFoundationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_ClassOfWarrantOrRightExpense" abstract="false" name="ClassOfWarrantOrRightExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage" abstract="false" name="ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="cron_FourMajorCustomersMember" abstract="true" name="FourMajorCustomersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_ConsultingServicesMember" abstract="true" name="ConsultingServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_TopUpRightsFixedPriceMember" abstract="true" name="TopUpRightsFixedPriceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_A2645485OntarioInc.MucciPromissoryNoteMember" abstract="true" name="A2645485OntarioInc.MucciPromissoryNoteMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_FinancingReceivableBeforeAccruedInterestCurrent" abstract="false" name="FinancingReceivableBeforeAccruedInterestCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_LongtermPurchaseCommitmentMonthlyFeePercentage" abstract="false" name="LongtermPurchaseCommitmentMonthlyFeePercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="cron_FinancingReceivableFundingCommitmentPercentage" abstract="false" name="FinancingReceivableFundingCommitmentPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue" abstract="false" name="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="cron_ProfessionalAndConsultingExpense" abstract="false" name="ProfessionalAndConsultingExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_NatuEraSeriesALoanShareOfNetLossInExcessOfCarryingValueOfEquityInvestmentMember" abstract="true" name="NatuEraSeriesALoanShareOfNetLossInExcessOfCarryingValueOfEquityInvestmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_RepurposingPlanMember" abstract="true" name="RepurposingPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_CronosAustraliaLimitedMember" abstract="true" name="CronosAustraliaLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_SaleOfStockPerformanceMilestoneOneMember" abstract="true" name="SaleOfStockPerformanceMilestoneOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_StockIssuedDuringPeriodValueTopupRightsExercised" abstract="false" name="StockIssuedDuringPeriodValueTopupRightsExercised" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_PaymentsForLeaseObligationsFinancingActivities" abstract="false" name="PaymentsForLeaseObligationsFinancingActivities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_DeferredShareUnitsDSUsMember" abstract="true" name="DeferredShareUnitsDSUsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_CannasoulCollaborationLoanMember" abstract="true" name="CannasoulCollaborationLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_RedwoodReportingUnitMember" abstract="true" name="RedwoodReportingUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cron_ConstructionLoanAgreementMember" abstract="true" name="ConstructionLoanAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>11
<FILENAME>cron-20201231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:7f6b4332-a8eb-41ec-8082-7450606ea80c,g:9b8782dc-b83f-424a-b83c-bbf680d16be6-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://thecronosgroup.com/role/CoverPage" xlink:type="simple" xlink:href="cron-20201231.xsd#CoverPage"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/CoverPage" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/ConsolidatedBalanceSheet" xlink:type="simple" xlink:href="cron-20201231.xsd#ConsolidatedBalanceSheet"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/ConsolidatedBalanceSheet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_abb1dd88-23f7-49e5-8012-0ea53c7cf8e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_06a4e304-e369-4937-9a0e-64c9a9581fd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_abb1dd88-23f7-49e5-8012-0ea53c7cf8e3" xlink:to="loc_us-gaap_LiabilitiesCurrent_06a4e304-e369-4937-9a0e-64c9a9581fd5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToRelatedPartiesNoncurrent_07881092-b195-4ec2-8bc4-62ffe80a4918" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueToRelatedPartiesNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_abb1dd88-23f7-49e5-8012-0ea53c7cf8e3" xlink:to="loc_us-gaap_DueToRelatedPartiesNoncurrent_07881092-b195-4ec2-8bc4-62ffe80a4918" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_ddf6bc38-4f04-4ef2-940f-2d52e2eb2b5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_abb1dd88-23f7-49e5-8012-0ea53c7cf8e3" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_ddf6bc38-4f04-4ef2-940f-2d52e2eb2b5a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_d295060c-4707-4066-94d7-53e2f3fe3ca4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_b9d1e2a3-232a-4083-8058-e6634a36e44b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_d295060c-4707-4066-94d7-53e2f3fe3ca4" xlink:to="loc_us-gaap_CommonStockValue_b9d1e2a3-232a-4083-8058-e6634a36e44b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_46382147-42de-438f-aff7-ee1959db9233" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_d295060c-4707-4066-94d7-53e2f3fe3ca4" xlink:to="loc_us-gaap_AdditionalPaidInCapital_46382147-42de-438f-aff7-ee1959db9233" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_6c3e9495-013e-4c4d-af59-0f40835d50c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_d295060c-4707-4066-94d7-53e2f3fe3ca4" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_6c3e9495-013e-4c4d-af59-0f40835d50c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_5add8b30-1483-43d8-826d-68a7604aba57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_d295060c-4707-4066-94d7-53e2f3fe3ca4" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_5add8b30-1483-43d8-826d-68a7604aba57" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_e5bb54f3-8632-44a1-8b8d-1ed5fab0d6c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_96886166-7ab5-47e4-9922-b665ba67d4bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_e5bb54f3-8632-44a1-8b8d-1ed5fab0d6c9" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_96886166-7ab5-47e4-9922-b665ba67d4bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_138365c5-3cec-4107-881e-c16883ae7a1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_e5bb54f3-8632-44a1-8b8d-1ed5fab0d6c9" xlink:to="loc_us-gaap_Liabilities_138365c5-3cec-4107-881e-c16883ae7a1e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_3ea09ddb-519d-432d-b03a-0f0a0ae8bba3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_e5bb54f3-8632-44a1-8b8d-1ed5fab0d6c9" xlink:to="loc_us-gaap_CommitmentsAndContingencies_3ea09ddb-519d-432d-b03a-0f0a0ae8bba3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_2eed6228-59c8-48b2-9a05-0195120c3400" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f8283b24-3400-4cec-9e23-52206973a666" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_2eed6228-59c8-48b2-9a05-0195120c3400" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f8283b24-3400-4cec-9e23-52206973a666" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_180fd616-c167-47db-8e59-fe7002de2cba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_2eed6228-59c8-48b2-9a05-0195120c3400" xlink:to="loc_us-gaap_ShortTermInvestments_180fd616-c167-47db-8e59-fe7002de2cba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_51e43bf6-11c4-447e-931c-0a286b5b69e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_2eed6228-59c8-48b2-9a05-0195120c3400" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_51e43bf6-11c4-447e-931c-0a286b5b69e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_2ffa33fd-80c4-413d-924d-dc41603602b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_2eed6228-59c8-48b2-9a05-0195120c3400" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_2ffa33fd-80c4-413d-924d-dc41603602b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetCurrent_77f521e7-ba5c-4ff6-bf18-0b233d7a6785" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesAndLoansReceivableNetCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_2eed6228-59c8-48b2-9a05-0195120c3400" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetCurrent_77f521e7-ba5c-4ff6-bf18-0b233d7a6785" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_00527623-3ea2-4a4f-87f8-07b5bb3d0ae7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_2eed6228-59c8-48b2-9a05-0195120c3400" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_00527623-3ea2-4a4f-87f8-07b5bb3d0ae7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_a757d36e-0650-409b-afb2-2c88551a8ddc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_2eed6228-59c8-48b2-9a05-0195120c3400" xlink:to="loc_us-gaap_InventoryNet_a757d36e-0650-409b-afb2-2c88551a8ddc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent_3d19a514-191b-4dda-842a-a013e095ba2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_2eed6228-59c8-48b2-9a05-0195120c3400" xlink:to="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent_3d19a514-191b-4dda-842a-a013e095ba2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_35b651b5-eb4b-46a2-970b-4470a7f802c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_2c791964-b4c5-4cd9-b247-5dc7c1329d8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_35b651b5-eb4b-46a2-970b-4470a7f802c9" xlink:to="loc_us-gaap_StockholdersEquity_2c791964-b4c5-4cd9-b247-5dc7c1329d8d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_25583fe2-ddf4-4795-9897-18f6f25e9b8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_35b651b5-eb4b-46a2-970b-4470a7f802c9" xlink:to="loc_us-gaap_MinorityInterest_25583fe2-ddf4-4795-9897-18f6f25e9b8e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_e407e1ab-cb2d-4cb3-9df8-93fbeaadb8d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_451bae98-2cec-4702-96e6-93d2bd7b0c04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_e407e1ab-cb2d-4cb3-9df8-93fbeaadb8d1" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_451bae98-2cec-4702-96e6-93d2bd7b0c04" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent_c8859dfa-160f-4950-9510-5349fae467c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_e407e1ab-cb2d-4cb3-9df8-93fbeaadb8d1" xlink:to="loc_us-gaap_DerivativeLiabilitiesCurrent_c8859dfa-160f-4950-9510-5349fae467c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_993d93af-586e-4fc1-be41-43325c1f3f5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_e407e1ab-cb2d-4cb3-9df8-93fbeaadb8d1" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_993d93af-586e-4fc1-be41-43325c1f3f5b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_eddba2b1-476e-4804-a4f9-8a16939ee938" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_f699adc1-99a3-4813-bf89-b6bb2e1c3379" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_eddba2b1-476e-4804-a4f9-8a16939ee938" xlink:to="loc_us-gaap_AssetsCurrent_f699adc1-99a3-4813-bf89-b6bb2e1c3379" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_e7b3fa6a-f863-4018-98e1-85feb2aaa75b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_eddba2b1-476e-4804-a4f9-8a16939ee938" xlink:to="loc_us-gaap_EquityMethodInvestments_e7b3fa6a-f863-4018-98e1-85feb2aaa75b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvancesToAffiliate_194c6717-1204-4935-a532-ec50b93b2de6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdvancesToAffiliate"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_eddba2b1-476e-4804-a4f9-8a16939ee938" xlink:to="loc_us-gaap_AdvancesToAffiliate_194c6717-1204-4935-a532-ec50b93b2de6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent_7ffc56b3-e9ed-4cbc-a5d6-bff30064a077" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesAndLoansReceivableNetNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_eddba2b1-476e-4804-a4f9-8a16939ee938" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent_7ffc56b3-e9ed-4cbc-a5d6-bff30064a077" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_d4218460-a43c-48db-90cf-4131496bacdc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_eddba2b1-476e-4804-a4f9-8a16939ee938" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_d4218460-a43c-48db-90cf-4131496bacdc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_674ebab3-c5f9-4288-9b01-1e60ad93a443" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_eddba2b1-476e-4804-a4f9-8a16939ee938" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_674ebab3-c5f9-4288-9b01-1e60ad93a443" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_1c93ba51-5c2c-4765-b168-7c99d3c0fa7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_eddba2b1-476e-4804-a4f9-8a16939ee938" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_1c93ba51-5c2c-4765-b168-7c99d3c0fa7f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_6ecd2946-e455-4597-ac3c-8867831f6d5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_eddba2b1-476e-4804-a4f9-8a16939ee938" xlink:to="loc_us-gaap_Goodwill_6ecd2946-e455-4597-ac3c-8867831f6d5f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/ConsolidatedBalanceSheetParenthetical" xlink:type="simple" xlink:href="cron-20201231.xsd#ConsolidatedBalanceSheetParenthetical"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/ConsolidatedBalanceSheetParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss" xlink:type="simple" xlink:href="cron-20201231.xsd#ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_c53b09cf-eed9-4b49-a9f1-55ebd08ce9bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_5e99ff7c-7a59-464a-9198-33e44659fe29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_c53b09cf-eed9-4b49-a9f1-55ebd08ce9bd" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_5e99ff7c-7a59-464a-9198-33e44659fe29" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_88ee29dd-2519-4489-a22c-7f8b2a929cb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_c53b09cf-eed9-4b49-a9f1-55ebd08ce9bd" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_88ee29dd-2519-4489-a22c-7f8b2a929cb0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_21017e81-f87d-4f87-ba80-60b8e8095e51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_577882ac-bc9b-43cd-a3d9-efb2016bfca1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_21017e81-f87d-4f87-ba80-60b8e8095e51" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_577882ac-bc9b-43cd-a3d9-efb2016bfca1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_20425597-e2fe-407f-8441-29c33a5e1a8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_21017e81-f87d-4f87-ba80-60b8e8095e51" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_20425597-e2fe-407f-8441-29c33a5e1a8c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_9c0293a4-81cf-4269-89b7-b26d17ab7243" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_21017e81-f87d-4f87-ba80-60b8e8095e51" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_9c0293a4-81cf-4269-89b7-b26d17ab7243" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_01afe82a-54e0-4548-b37f-112cb39e1944" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_21017e81-f87d-4f87-ba80-60b8e8095e51" xlink:to="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_01afe82a-54e0-4548-b37f-112cb39e1944" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_9365a194-966c-4036-96bb-9285a5f61e25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_21017e81-f87d-4f87-ba80-60b8e8095e51" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_9365a194-966c-4036-96bb-9285a5f61e25" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_6c25c128-3dad-4c08-8531-54a91d5ccf72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_21017e81-f87d-4f87-ba80-60b8e8095e51" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_6c25c128-3dad-4c08-8531-54a91d5ccf72" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts_c5ebf60c-f6ea-4415-a987-e231db5b5ef4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_21017e81-f87d-4f87-ba80-60b8e8095e51" xlink:to="loc_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts_c5ebf60c-f6ea-4415-a987-e231db5b5ef4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_0de155ef-dffb-4b2e-82f9-d78fc8e74c4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_09f447e7-bdef-4d86-b859-36b6af5c9bcd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_0de155ef-dffb-4b2e-82f9-d78fc8e74c4e" xlink:to="loc_us-gaap_OperatingExpenses_09f447e7-bdef-4d86-b859-36b6af5c9bcd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_c57a1ec4-39c4-4f5d-b2f0-d7d1d38ecc39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_0de155ef-dffb-4b2e-82f9-d78fc8e74c4e" xlink:to="loc_us-gaap_GrossProfit_c57a1ec4-39c4-4f5d-b2f0-d7d1d38ecc39" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_21161ce9-cd14-4c20-8b27-33c6ab7b1c09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_589415c2-4b7e-41f5-8c32-84cc212d52ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_21161ce9-cd14-4c20-8b27-33c6ab7b1c09" xlink:to="loc_us-gaap_SellingAndMarketingExpense_589415c2-4b7e-41f5-8c32-84cc212d52ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_93123ca5-a32e-4448-8387-4a486b1ee526" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_21161ce9-cd14-4c20-8b27-33c6ab7b1c09" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_93123ca5-a32e-4448-8387-4a486b1ee526" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_994bbb98-513d-4b79-b788-a0a099f233da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_21161ce9-cd14-4c20-8b27-33c6ab7b1c09" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_994bbb98-513d-4b79-b788-a0a099f233da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_18da82ce-3c5e-41ff-ad5c-256d08de0fc2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_21161ce9-cd14-4c20-8b27-33c6ab7b1c09" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_18da82ce-3c5e-41ff-ad5c-256d08de0fc2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_2a6f81d5-5835-4a2f-800d-a8dfa896f5c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_21161ce9-cd14-4c20-8b27-33c6ab7b1c09" xlink:to="loc_us-gaap_DepreciationAndAmortization_2a6f81d5-5835-4a2f-800d-a8dfa896f5c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions_3455f324-98c2-4f5b-8b69-b09d99f8e519" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringSettlementAndImpairmentProvisions"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_21161ce9-cd14-4c20-8b27-33c6ab7b1c09" xlink:to="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions_3455f324-98c2-4f5b-8b69-b09d99f8e519" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8138a507-1b7d-4efc-b6dc-51f2e7f98ac5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_6ea88f87-87e0-4f99-940c-2903761192e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8138a507-1b7d-4efc-b6dc-51f2e7f98ac5" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_6ea88f87-87e0-4f99-940c-2903761192e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExciseAndSalesTaxes_c0a65153-c717-4afb-a801-35d44b1bc8ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExciseAndSalesTaxes"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8138a507-1b7d-4efc-b6dc-51f2e7f98ac5" xlink:to="loc_us-gaap_ExciseAndSalesTaxes_c0a65153-c717-4afb-a801-35d44b1bc8ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_d89f470e-22d5-47e0-b320-06d875e88d44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ca4ce362-ddc3-422c-aeba-72fde4f37667" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_d89f470e-22d5-47e0-b320-06d875e88d44" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ca4ce362-ddc3-422c-aeba-72fde4f37667" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_OtherCostOfGoodsAndServicesSold_7c34af5b-e3bf-42b2-9bec-97917e4be5d8" xlink:href="cron-20201231.xsd#cron_OtherCostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_d89f470e-22d5-47e0-b320-06d875e88d44" xlink:to="loc_cron_OtherCostOfGoodsAndServicesSold_7c34af5b-e3bf-42b2-9bec-97917e4be5d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_3e6fd9bc-e68e-498c-a7b1-14491db19216" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_d89f470e-22d5-47e0-b320-06d875e88d44" xlink:to="loc_us-gaap_InventoryWriteDown_3e6fd9bc-e68e-498c-a7b1-14491db19216" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_60648b9d-9727-4d1f-b9ca-1d24360c6311" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_a5d3bc5a-e9d2-458f-8d27-1f3b366a98bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_60648b9d-9727-4d1f-b9ca-1d24360c6311" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_a5d3bc5a-e9d2-458f-8d27-1f3b366a98bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_081d2e1a-70a2-48eb-bcda-ad254dc7288e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_60648b9d-9727-4d1f-b9ca-1d24360c6311" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_081d2e1a-70a2-48eb-bcda-ad254dc7288e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_43a0eca9-32fe-4238-a705-8683d898fa52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_7e5a37a4-d505-4e8d-9ed3-f9d155e3ef28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_43a0eca9-32fe-4238-a705-8683d898fa52" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_7e5a37a4-d505-4e8d-9ed3-f9d155e3ef28" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_26855205-2348-43df-a6d6-6cda13cb99d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_43a0eca9-32fe-4238-a705-8683d898fa52" xlink:to="loc_us-gaap_OperatingIncomeLoss_26855205-2348-43df-a6d6-6cda13cb99d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_f3d068cb-1f18-4631-8e58-11e2bc39d5e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_4c20094d-39ec-4d74-95dd-0eb4011a1641" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_f3d068cb-1f18-4631-8e58-11e2bc39d5e5" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_4c20094d-39ec-4d74-95dd-0eb4011a1641" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_3cc0dccd-99f0-4fe3-be66-91f4e6245ff0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_f3d068cb-1f18-4631-8e58-11e2bc39d5e5" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_3cc0dccd-99f0-4fe3-be66-91f4e6245ff0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_20637a4e-b28d-478b-a5df-ea6a680ea6b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_ffeefb8c-b420-4804-889c-914957a37aa5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_20637a4e-b28d-478b-a5df-ea6a680ea6b5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_ffeefb8c-b420-4804-889c-914957a37aa5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_OtherComprehensiveIncomeLossAccumulatedGainLossDebtSecuritiesRevaluationAndDisposalOfOtherInvestments_011a4ef8-441f-4196-af6d-39f75f2aa495" xlink:href="cron-20201231.xsd#cron_OtherComprehensiveIncomeLossAccumulatedGainLossDebtSecuritiesRevaluationAndDisposalOfOtherInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_20637a4e-b28d-478b-a5df-ea6a680ea6b5" xlink:to="loc_cron_OtherComprehensiveIncomeLossAccumulatedGainLossDebtSecuritiesRevaluationAndDisposalOfOtherInvestments_011a4ef8-441f-4196-af6d-39f75f2aa495" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c728ba01-e191-44d4-9711-5f7e1afd0f77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_efd8a07e-bc34-4e38-9a8e-1ec2ad8aa747" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_c728ba01-e191-44d4-9711-5f7e1afd0f77" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_efd8a07e-bc34-4e38-9a8e-1ec2ad8aa747" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_e80fa85e-2165-4b76-86c1-13da3cf8ab88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_c728ba01-e191-44d4-9711-5f7e1afd0f77" xlink:to="loc_us-gaap_ProfitLoss_e80fa85e-2165-4b76-86c1-13da3cf8ab88" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_99ab0a5a-8126-4466-8a7c-b2bdc2a5ed03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_6fd3f65d-1407-4c02-abda-798cb9729215" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_99ab0a5a-8126-4466-8a7c-b2bdc2a5ed03" xlink:to="loc_us-gaap_ProfitLoss_6fd3f65d-1407-4c02-abda-798cb9729215" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c33b8967-e947-4b82-ac09-b8659e01884c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_99ab0a5a-8126-4466-8a7c-b2bdc2a5ed03" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c33b8967-e947-4b82-ac09-b8659e01884c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/ConsolidatedStatementsofStockholdersEquityDeficit" xlink:type="simple" xlink:href="cron-20201231.xsd#ConsolidatedStatementsofStockholdersEquityDeficit"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/ConsolidatedStatementsofStockholdersEquityDeficit" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="cron-20201231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0c563f92-1405-46ef-8d48-f82f230e71cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_111a9f28-29be-4430-8648-ec62ecd47ecf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0c563f92-1405-46ef-8d48-f82f230e71cc" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_111a9f28-29be-4430-8648-ec62ecd47ecf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_4449dfef-df88-442e-b37d-6f643a1bad0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0c563f92-1405-46ef-8d48-f82f230e71cc" xlink:to="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_4449dfef-df88-442e-b37d-6f643a1bad0f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_b668ef89-ed16-4ce9-be8f-9cb510a5ed25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0c563f92-1405-46ef-8d48-f82f230e71cc" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_b668ef89-ed16-4ce9-be8f-9cb510a5ed25" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_babfebb8-6667-455c-941d-0bb43e8d863c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0c563f92-1405-46ef-8d48-f82f230e71cc" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_babfebb8-6667-455c-941d-0bb43e8d863c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_82c434a3-a74d-46c3-bd84-2232d1c833d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0c563f92-1405-46ef-8d48-f82f230e71cc" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_82c434a3-a74d-46c3-bd84-2232d1c833d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_eff58888-7af2-4c0f-ba1a-0524de518df9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0c563f92-1405-46ef-8d48-f82f230e71cc" xlink:to="loc_us-gaap_ProfitLoss_eff58888-7af2-4c0f-ba1a-0524de518df9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_eaa3fb8c-5b33-4a4b-a204-c56844b5f60f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0c563f92-1405-46ef-8d48-f82f230e71cc" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_eaa3fb8c-5b33-4a4b-a204-c56844b5f60f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_c6a547ed-4a62-45b8-8c13-c481aa6f8455" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0c563f92-1405-46ef-8d48-f82f230e71cc" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_c6a547ed-4a62-45b8-8c13-c481aa6f8455" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NoncashSellingAndMarketingExpense_908384a1-a9d9-4cbc-b6fd-a4978c851ad6" xlink:href="cron-20201231.xsd#cron_NoncashSellingAndMarketingExpense"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0c563f92-1405-46ef-8d48-f82f230e71cc" xlink:to="loc_cron_NoncashSellingAndMarketingExpense_908384a1-a9d9-4cbc-b6fd-a4978c851ad6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_787578d5-2b10-4e65-abbf-6a93043d0bc3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0c563f92-1405-46ef-8d48-f82f230e71cc" xlink:to="loc_us-gaap_ShareBasedCompensation_787578d5-2b10-4e65-abbf-6a93043d0bc3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_d82aa44f-db86-4c03-bea1-589307b24b36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0c563f92-1405-46ef-8d48-f82f230e71cc" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_d82aa44f-db86-4c03-bea1-589307b24b36" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts_6ddc542d-40bc-48b8-ae1d-3548cd0532e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCosts"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0c563f92-1405-46ef-8d48-f82f230e71cc" xlink:to="loc_us-gaap_RestructuringCosts_6ddc542d-40bc-48b8-ae1d-3548cd0532e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_09279c9d-5643-4db3-9a7a-9fca5da9b5d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0c563f92-1405-46ef-8d48-f82f230e71cc" xlink:to="loc_us-gaap_InventoryWriteDown_09279c9d-5643-4db3-9a7a-9fca5da9b5d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapital_94c8c492-f40d-4060-a227-f5ce43ef6f7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapital"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0c563f92-1405-46ef-8d48-f82f230e71cc" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapital_94c8c492-f40d-4060-a227-f5ce43ef6f7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0d3e9960-8428-4590-97a2-767488eef2a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_d05cb5ad-a180-40bc-ab39-27a2ca7a7799" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInterestInJointVenture"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0d3e9960-8428-4590-97a2-767488eef2a1" xlink:to="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_d05cb5ad-a180-40bc-ab39-27a2ca7a7799" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_4e019157-096b-42d7-9532-777451b6847d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0d3e9960-8428-4590-97a2-767488eef2a1" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_4e019157-096b-42d7-9532-777451b6847d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireLoansReceivable_c3518e16-3475-45c9-98cb-182a1b0d9364" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireLoansReceivable"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0d3e9960-8428-4590-97a2-767488eef2a1" xlink:to="loc_us-gaap_PaymentsToAcquireLoansReceivable_c3518e16-3475-45c9-98cb-182a1b0d9364" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_91e36dc9-fa86-4d92-9251-febcc39314ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0d3e9960-8428-4590-97a2-767488eef2a1" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_91e36dc9-fa86-4d92-9251-febcc39314ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_ad678e37-167d-4de7-981b-9fc9a67cda9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0d3e9960-8428-4590-97a2-767488eef2a1" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_ad678e37-167d-4de7-981b-9fc9a67cda9a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_9dec59a6-052d-4b92-8750-7f08f93632e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0d3e9960-8428-4590-97a2-767488eef2a1" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_9dec59a6-052d-4b92-8750-7f08f93632e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_f625f3fe-d70a-4686-9e91-7ec563187d92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0d3e9960-8428-4590-97a2-767488eef2a1" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_f625f3fe-d70a-4686-9e91-7ec563187d92" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_c1b230fa-dd67-4a8d-888c-884a6e5432b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0d3e9960-8428-4590-97a2-767488eef2a1" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_c1b230fa-dd67-4a8d-888c-884a6e5432b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ProceedsFromEquitySecuritiesFVNIAndEquitySecuritiesWithoutDeterminableFairValue_4247b87d-c67c-420e-9b74-9706235c0cfd" xlink:href="cron-20201231.xsd#cron_ProceedsFromEquitySecuritiesFVNIAndEquitySecuritiesWithoutDeterminableFairValue"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0d3e9960-8428-4590-97a2-767488eef2a1" xlink:to="loc_cron_ProceedsFromEquitySecuritiesFVNIAndEquitySecuritiesWithoutDeterminableFairValue_4247b87d-c67c-420e-9b74-9706235c0cfd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_462da408-5bef-450d-b227-426e61d5bfe0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0d3e9960-8428-4590-97a2-767488eef2a1" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_462da408-5bef-450d-b227-426e61d5bfe0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f6df67a9-54ce-481d-823f-28726af0b6b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_418c10a2-aeff-4eb6-8e1c-9429a53eef87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f6df67a9-54ce-481d-823f-28726af0b6b2" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_418c10a2-aeff-4eb6-8e1c-9429a53eef87" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7bf85799-3ce9-4629-919d-67efa573a3e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f6df67a9-54ce-481d-823f-28726af0b6b2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7bf85799-3ce9-4629-919d-67efa573a3e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_94534c21-5233-468d-b1c1-3a3e10550c0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f6df67a9-54ce-481d-823f-28726af0b6b2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_94534c21-5233-468d-b1c1-3a3e10550c0d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_47046c33-3a86-4dd9-8c9f-9d907d0a4ec8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f6df67a9-54ce-481d-823f-28726af0b6b2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_47046c33-3a86-4dd9-8c9f-9d907d0a4ec8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0a420f7b-4c7c-4fb8-a768-9b77d8e52d57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_b8643981-0003-46f6-8813-7ec9aac08131" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0a420f7b-4c7c-4fb8-a768-9b77d8e52d57" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_b8643981-0003-46f6-8813-7ec9aac08131" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2a02527a-f604-4db9-be0d-746ed9bd1f12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0a420f7b-4c7c-4fb8-a768-9b77d8e52d57" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2a02527a-f604-4db9-be0d-746ed9bd1f12" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_8f9f7b2e-af91-401d-a3d1-84a8526b1839" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0a420f7b-4c7c-4fb8-a768-9b77d8e52d57" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_8f9f7b2e-af91-401d-a3d1-84a8526b1839" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_694bfe5d-c680-48c7-ae15-18cb4e313bb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0a420f7b-4c7c-4fb8-a768-9b77d8e52d57" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_694bfe5d-c680-48c7-ae15-18cb4e313bb6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ProceedsFromRightExercises_d25ce081-724b-4ff0-8ba9-d9eefe1a22cb" xlink:href="cron-20201231.xsd#cron_ProceedsFromRightExercises"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0a420f7b-4c7c-4fb8-a768-9b77d8e52d57" xlink:to="loc_cron_ProceedsFromRightExercises_d25ce081-724b-4ff0-8ba9-d9eefe1a22cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PaymentsForLeaseObligationsFinancingActivities_21c68f77-6f0d-48c6-a3f4-55760f7e90c1" xlink:href="cron-20201231.xsd#cron_PaymentsForLeaseObligationsFinancingActivities"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0a420f7b-4c7c-4fb8-a768-9b77d8e52d57" xlink:to="loc_cron_PaymentsForLeaseObligationsFinancingActivities_21c68f77-6f0d-48c6-a3f4-55760f7e90c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt_596a41ad-a303-4d25-86f0-15b03c7ca876" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfSecuredDebt"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0a420f7b-4c7c-4fb8-a768-9b77d8e52d57" xlink:to="loc_us-gaap_RepaymentsOfSecuredDebt_596a41ad-a303-4d25-86f0-15b03c7ca876" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ProceedsFromWarrantExercisedAndStockOptionsExercised_985bd0c9-3a93-4059-ab36-2a496075196c" xlink:href="cron-20201231.xsd#cron_ProceedsFromWarrantExercisedAndStockOptionsExercised"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0a420f7b-4c7c-4fb8-a768-9b77d8e52d57" xlink:to="loc_cron_ProceedsFromWarrantExercisedAndStockOptionsExercised_985bd0c9-3a93-4059-ab36-2a496075196c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_c0dea088-4484-417a-b629-93b089772ac8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0a420f7b-4c7c-4fb8-a768-9b77d8e52d57" xlink:to="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_c0dea088-4484-417a-b629-93b089772ac8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_6fa963e2-708e-47b3-99de-673940aa682f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0a420f7b-4c7c-4fb8-a768-9b77d8e52d57" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_6fa963e2-708e-47b3-99de-673940aa682f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_9d31b608-5d18-4a13-9ab4-4825fe53171d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0a420f7b-4c7c-4fb8-a768-9b77d8e52d57" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_9d31b608-5d18-4a13-9ab4-4825fe53171d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/Background" xlink:type="simple" xlink:href="cron-20201231.xsd#Background"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/Background" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/BackgroundDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#BackgroundDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/BackgroundDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="cron-20201231.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="cron-20201231.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="cron-20201231.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesScheduleofConsolidatedEntitiesDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#SummaryofSignificantAccountingPoliciesScheduleofConsolidatedEntitiesDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesScheduleofConsolidatedEntitiesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsAmortizationMethodsandRatesDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsAmortizationMethodsandRatesDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsAmortizationMethodsandRatesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantEquipmentUsefulLivesDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantEquipmentUsefulLivesDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantEquipmentUsefulLivesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesImpairmentofLonglivedAssetsDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#SummaryofSignificantAccountingPoliciesImpairmentofLonglivedAssetsDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesImpairmentofLonglivedAssetsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/NewAccountingPronouncements" xlink:type="simple" xlink:href="cron-20201231.xsd#NewAccountingPronouncements"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/NewAccountingPronouncements" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/RevenuesfromContractswithCustomers" xlink:type="simple" xlink:href="cron-20201231.xsd#RevenuesfromContractswithCustomers"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/RevenuesfromContractswithCustomers" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/RevenuesfromContractswithCustomersNarrativeDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#RevenuesfromContractswithCustomersNarrativeDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/RevenuesfromContractswithCustomersNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/Inventory" xlink:type="simple" xlink:href="cron-20201231.xsd#Inventory"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/Inventory" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/InventoryTables" xlink:type="simple" xlink:href="cron-20201231.xsd#InventoryTables"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/InventoryTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/InventoryDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#InventoryDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/InventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_71f80369-94d0-4d92-96f0-f960931f4526" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_5f941d0a-af16-44aa-9429-94fcf1e29484" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_71f80369-94d0-4d92-96f0-f960931f4526" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_5f941d0a-af16-44aa-9429-94fcf1e29484" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_46efa16d-9c11-449b-a658-1cecebd80066" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_71f80369-94d0-4d92-96f0-f960931f4526" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_46efa16d-9c11-449b-a658-1cecebd80066" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_c964af01-7a58-459b-85d7-d415d6951527" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_71f80369-94d0-4d92-96f0-f960931f4526" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_c964af01-7a58-459b-85d7-d415d6951527" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventorySuppliesNetOfReserves_2023c51e-2888-4e6c-8177-db4ac58261c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventorySuppliesNetOfReserves"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_71f80369-94d0-4d92-96f0-f960931f4526" xlink:to="loc_us-gaap_InventorySuppliesNetOfReserves_2023c51e-2888-4e6c-8177-db4ac58261c4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/Investments" xlink:type="simple" xlink:href="cron-20201231.xsd#Investments"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/Investments" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/InvestmentsTables" xlink:type="simple" xlink:href="cron-20201231.xsd#InvestmentsTables"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/InvestmentsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/InvestmentsNarrativeDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#InvestmentsNarrativeDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/InvestmentsNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/InvestmentsScheduleofEquityMethodInvestmentsDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#InvestmentsScheduleofEquityMethodInvestmentsDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/InvestmentsScheduleofEquityMethodInvestmentsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/InvestmentsScheduleofAdvancestoJointVenturesDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#InvestmentsScheduleofAdvancestoJointVenturesDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/InvestmentsScheduleofAdvancestoJointVenturesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/InvestmentsScheduleofVariableInterestEntitiesDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#InvestmentsScheduleofVariableInterestEntitiesDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/InvestmentsScheduleofVariableInterestEntitiesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/OtherInvestments" xlink:type="simple" xlink:href="cron-20201231.xsd#OtherInvestments"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/OtherInvestments" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/OtherInvestmentsTables" xlink:type="simple" xlink:href="cron-20201231.xsd#OtherInvestmentsTables"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/OtherInvestmentsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/OtherInvestmentsSummaryofOtherInvestmentsDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#OtherInvestmentsSummaryofOtherInvestmentsDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/OtherInvestmentsSummaryofOtherInvestmentsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/LoanReceivable" xlink:type="simple" xlink:href="cron-20201231.xsd#LoanReceivable"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/LoanReceivable" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/LoanReceivableTables" xlink:type="simple" xlink:href="cron-20201231.xsd#LoanReceivableTables"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/LoanReceivableTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#LoanReceivableScheduleofLoanReceivableDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableNet_72fec0a3-d08e-4cb3-b984-d156081a1011" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesReceivableNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetCurrent_7ecff5c8-cad4-4487-b57b-9b49b9098bdf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesAndLoansReceivableNetCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NotesReceivableNet_72fec0a3-d08e-4cb3-b984-d156081a1011" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetCurrent_7ecff5c8-cad4-4487-b57b-9b49b9098bdf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent_fbacf45a-e94d-4950-80da-21d28be627ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesAndLoansReceivableNetNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NotesReceivableNet_72fec0a3-d08e-4cb3-b984-d156081a1011" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent_fbacf45a-e94d-4950-80da-21d28be627ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetCurrent_97eea934-3e39-4900-a06b-58b10a1d60a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesAndLoansReceivableNetCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableBeforeAccruedInterestCurrent_d9cbbfeb-5ab7-4fcb-92a4-0625d1d68eb2" xlink:href="cron-20201231.xsd#cron_FinancingReceivableBeforeAccruedInterestCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NotesAndLoansReceivableNetCurrent_97eea934-3e39-4900-a06b-58b10a1d60a9" xlink:to="loc_cron_FinancingReceivableBeforeAccruedInterestCurrent_d9cbbfeb-5ab7-4fcb-92a4-0625d1d68eb2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableAccruedInterestCurrent_8936beff-eb33-4e2a-9958-2857111eddd6" xlink:href="cron-20201231.xsd#cron_FinancingReceivableAccruedInterestCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NotesAndLoansReceivableNetCurrent_97eea934-3e39-4900-a06b-58b10a1d60a9" xlink:to="loc_cron_FinancingReceivableAccruedInterestCurrent_8936beff-eb33-4e2a-9958-2857111eddd6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent_32528105-0da0-40b7-86af-cea38ec3b5f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesAndLoansReceivableNetNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableBeforeAccruedInterestNoncurrent_f0c94876-a8da-4407-86ae-fb0a9441765c" xlink:href="cron-20201231.xsd#cron_FinancingReceivableBeforeAccruedInterestNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent_32528105-0da0-40b7-86af-cea38ec3b5f8" xlink:to="loc_cron_FinancingReceivableBeforeAccruedInterestNoncurrent_f0c94876-a8da-4407-86ae-fb0a9441765c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableAccruedInterestNoncurrent_8b39c46b-2e32-418a-a6b1-384920bd5c3e" xlink:href="cron-20201231.xsd#cron_FinancingReceivableAccruedInterestNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent_32528105-0da0-40b7-86af-cea38ec3b5f8" xlink:to="loc_cron_FinancingReceivableAccruedInterestNoncurrent_8b39c46b-2e32-418a-a6b1-384920bd5c3e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/LoansPayable" xlink:type="simple" xlink:href="cron-20201231.xsd#LoansPayable"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/LoansPayable" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/LoansPayableLongtermNarrativeDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#LoansPayableLongtermNarrativeDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/LoansPayableLongtermNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/PropertyPlantandEquipment" xlink:type="simple" xlink:href="cron-20201231.xsd#PropertyPlantandEquipment"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/PropertyPlantandEquipment" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/PropertyPlantandEquipmentTables" xlink:type="simple" xlink:href="cron-20201231.xsd#PropertyPlantandEquipmentTables"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/PropertyPlantandEquipmentTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantEquipmentUsefulLivesDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#PropertyPlantandEquipmentScheduleofPropertyPlantEquipmentUsefulLivesDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantEquipmentUsefulLivesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_5bd006e9-f9b8-4ecc-b63c-58cdc05a41e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_b9c52783-85fe-4d9b-901f-7ea118a79c6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_5bd006e9-f9b8-4ecc-b63c-58cdc05a41e1" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_b9c52783-85fe-4d9b-901f-7ea118a79c6d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_fc3dbcec-b740-4e0d-ae7e-d4fc3db30b74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_5bd006e9-f9b8-4ecc-b63c-58cdc05a41e1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_fc3dbcec-b740-4e0d-ae7e-d4fc3db30b74" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/PropertyPlantandEquipmentNarrativeDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#PropertyPlantandEquipmentNarrativeDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/PropertyPlantandEquipmentNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/IntangibleAssetsandGoodwill" xlink:type="simple" xlink:href="cron-20201231.xsd#IntangibleAssetsandGoodwill"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/IntangibleAssetsandGoodwill" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/IntangibleAssetsandGoodwillTables" xlink:type="simple" xlink:href="cron-20201231.xsd#IntangibleAssetsandGoodwillTables"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/IntangibleAssetsandGoodwillTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/IntangibleAssetsandGoodwillNarrativeDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#IntangibleAssetsandGoodwillNarrativeDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/IntangibleAssetsandGoodwillNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8c9052e0-5c77-4610-b8f5-7db965b26e08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_664e5bc2-217b-4181-97f3-b9d52f8d335e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8c9052e0-5c77-4610-b8f5-7db965b26e08" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_664e5bc2-217b-4181-97f3-b9d52f8d335e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_a6c13bfa-c5d9-4dd9-aca1-d4a9a4c35431" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8c9052e0-5c77-4610-b8f5-7db965b26e08" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_a6c13bfa-c5d9-4dd9-aca1-d4a9a4c35431" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_7b36c2a0-cacf-4e53-9fb5-3d667b489411" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_413fa451-5655-4384-90e8-b1b7df39380e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_7b36c2a0-cacf-4e53-9fb5-3d667b489411" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_413fa451-5655-4384-90e8-b1b7df39380e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment_b7370269-5715-4faa-8544-e2700a4bc7a3" xlink:href="cron-20201231.xsd#cron_IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_7b36c2a0-cacf-4e53-9fb5-3d667b489411" xlink:to="loc_cron_IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment_b7370269-5715-4faa-8544-e2700a4bc7a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_a9a959f4-55b5-4f27-a271-ba4a1cfaecdf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_7b36c2a0-cacf-4e53-9fb5-3d667b489411" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_a9a959f4-55b5-4f27-a271-ba4a1cfaecdf" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofGoodwillDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#IntangibleAssetsandGoodwillScheduleofGoodwillDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofGoodwillDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/Leases" xlink:type="simple" xlink:href="cron-20201231.xsd#Leases"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/Leases" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/LeasesTables" xlink:type="simple" xlink:href="cron-20201231.xsd#LeasesTables"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/LeasesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#LeasesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/LeasesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/LeasesScheduleofLeaseCostandOtherInformationDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#LeasesScheduleofLeaseCostandOtherInformationDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/LeasesScheduleofLeaseCostandOtherInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_a0811c44-7ef0-4a5c-8a7a-50f65ce15547" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_f53fb66b-31fc-49ba-8b7f-69181a485dcb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_a0811c44-7ef0-4a5c-8a7a-50f65ce15547" xlink:to="loc_us-gaap_OperatingLeaseCost_f53fb66b-31fc-49ba-8b7f-69181a485dcb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_466b30a9-37ec-44f9-8495-5e6a82f0abc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_a0811c44-7ef0-4a5c-8a7a-50f65ce15547" xlink:to="loc_us-gaap_ShortTermLeaseCost_466b30a9-37ec-44f9-8495-5e6a82f0abc9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/GeneralandAdministrativeExpenses" xlink:type="simple" xlink:href="cron-20201231.xsd#GeneralandAdministrativeExpenses"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/GeneralandAdministrativeExpenses" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/GeneralandAdministrativeExpensesTables" xlink:type="simple" xlink:href="cron-20201231.xsd#GeneralandAdministrativeExpensesTables"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/GeneralandAdministrativeExpensesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/GeneralandAdministrativeExpensesScheduleofGeneralandAdministrativeExpensesDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#GeneralandAdministrativeExpensesScheduleofGeneralandAdministrativeExpensesDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/GeneralandAdministrativeExpensesScheduleofGeneralandAdministrativeExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_21cc777d-b370-47b5-8ed5-b80f7f3dc9f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LaborAndRelatedExpense_7588948e-bbe0-456a-a5e0-8356c3c0e3e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LaborAndRelatedExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense_21cc777d-b370-47b5-8ed5-b80f7f3dc9f5" xlink:to="loc_us-gaap_LaborAndRelatedExpense_7588948e-bbe0-456a-a5e0-8356c3c0e3e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ProfessionalAndConsultingExpense_55ce87eb-6608-4020-a2c9-b7bcd093f82b" xlink:href="cron-20201231.xsd#cron_ProfessionalAndConsultingExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense_21cc777d-b370-47b5-8ed5-b80f7f3dc9f5" xlink:to="loc_cron_ProfessionalAndConsultingExpense_55ce87eb-6608-4020-a2c9-b7bcd093f82b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_OfficeAndGeneralExpense_db7bf345-73d6-4e80-a554-83a9c15fcfc7" xlink:href="cron-20201231.xsd#cron_OfficeAndGeneralExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense_21cc777d-b370-47b5-8ed5-b80f7f3dc9f5" xlink:to="loc_cron_OfficeAndGeneralExpense_db7bf345-73d6-4e80-a554-83a9c15fcfc7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_RestatementReviewExpense_4a58ad02-953a-4612-b0ea-791f5d5562ad" xlink:href="cron-20201231.xsd#cron_RestatementReviewExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense_21cc777d-b370-47b5-8ed5-b80f7f3dc9f5" xlink:to="loc_cron_RestatementReviewExpense_4a58ad02-953a-4612-b0ea-791f5d5562ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherGeneralAndAdministrativeExpense_af5e0475-2360-4934-a854-c667e4ccedf6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense_21cc777d-b370-47b5-8ed5-b80f7f3dc9f5" xlink:to="loc_us-gaap_OtherGeneralAndAdministrativeExpense_af5e0475-2360-4934-a854-c667e4ccedf6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForLoanLossesExpensed_00778584-ab37-4fd0-8903-364ca9e3422c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForLoanLossesExpensed"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense_21cc777d-b370-47b5-8ed5-b80f7f3dc9f5" xlink:to="loc_us-gaap_ProvisionForLoanLossesExpensed_00778584-ab37-4fd0-8903-364ca9e3422c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/DerivativeLiabilities" xlink:type="simple" xlink:href="cron-20201231.xsd#DerivativeLiabilities"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/DerivativeLiabilities" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/DerivativeLiabilitiesTables" xlink:type="simple" xlink:href="cron-20201231.xsd#DerivativeLiabilitiesTables"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/DerivativeLiabilitiesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#DerivativeLiabilitiesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/CapitalStock" xlink:type="simple" xlink:href="cron-20201231.xsd#CapitalStock"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/CapitalStock" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/CapitalStockTables" xlink:type="simple" xlink:href="cron-20201231.xsd#CapitalStockTables"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/CapitalStockTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/CapitalStockNarrativeDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#CapitalStockNarrativeDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/CapitalStockNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/CapitalStockScheduleofCommonSharesIssuedDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#CapitalStockScheduleofCommonSharesIssuedDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/CapitalStockScheduleofCommonSharesIssuedDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedPayments" xlink:type="simple" xlink:href="cron-20201231.xsd#SharebasedPayments"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/SharebasedPayments" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedPaymentsTables" xlink:type="simple" xlink:href="cron-20201231.xsd#SharebasedPaymentsTables"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/SharebasedPaymentsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinWarrantsDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#SharebasedPaymentsSummaryofChangesinWarrantsDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinWarrantsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedPaymentsSummaryofOutstandingWarrantsDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#SharebasedPaymentsSummaryofOutstandingWarrantsDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/SharebasedPaymentsSummaryofOutstandingWarrantsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#SharebasedPaymentsStockOptionsNarrativeDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedPaymentsScheduleofStockOptionsOutstandingDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#SharebasedPaymentsScheduleofStockOptionsOutstandingDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/SharebasedPaymentsScheduleofStockOptionsOutstandingDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedPaymentsSummaryoftheChangesinOptionsDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#SharebasedPaymentsSummaryoftheChangesinOptionsDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/SharebasedPaymentsSummaryoftheChangesinOptionsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedPaymentsFairValueofOptionsIssuedDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#SharebasedPaymentsFairValueofOptionsIssuedDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/SharebasedPaymentsFairValueofOptionsIssuedDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedPaymentsRestrictedShareUnitsNarrativeDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#SharebasedPaymentsRestrictedShareUnitsNarrativeDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/SharebasedPaymentsRestrictedShareUnitsNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedPaymentsSummaryofRestrictedShareUnitsActivityDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#SharebasedPaymentsSummaryofRestrictedShareUnitsActivityDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/SharebasedPaymentsSummaryofRestrictedShareUnitsActivityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedPaymentsDeferredShareUnitsNarrativeDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#SharebasedPaymentsDeferredShareUnitsNarrativeDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/SharebasedPaymentsDeferredShareUnitsNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedPaymentsSummaryofDeferredShareUnitsActivityDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#SharebasedPaymentsSummaryofDeferredShareUnitsActivityDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/SharebasedPaymentsSummaryofDeferredShareUnitsActivityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/EarningslossPerShare" xlink:type="simple" xlink:href="cron-20201231.xsd#EarningslossPerShare"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/EarningslossPerShare" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/EarningslossPerShareTables" xlink:type="simple" xlink:href="cron-20201231.xsd#EarningslossPerShareTables"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/EarningslossPerShareTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#EarningslossPerShareScheduleofEarningsLossPerShareDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted_13aae0e3-a231-4e61-b18c-3fb23b50747a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_1acfa2f6-f184-4ab1-b396-88422952db5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted_13aae0e3-a231-4e61-b18c-3fb23b50747a" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_1acfa2f6-f184-4ab1-b396-88422952db5a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DilutiveSecurities_1c21efcd-6330-44cb-93ad-17ec79cc1e27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DilutiveSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted_13aae0e3-a231-4e61-b18c-3fb23b50747a" xlink:to="loc_us-gaap_DilutiveSecurities_1c21efcd-6330-44cb-93ad-17ec79cc1e27" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2472f95f-6c0d-4f83-8118-a0c88c3237af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_95b3638b-a8bf-4c88-9295-ab12b4678e83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2472f95f-6c0d-4f83-8118-a0c88c3237af" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_95b3638b-a8bf-4c88-9295-ab12b4678e83" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_c6ff6ada-8d19-43e9-844c-af9c22d4d953" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2472f95f-6c0d-4f83-8118-a0c88c3237af" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_c6ff6ada-8d19-43e9-844c-af9c22d4d953" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_326fa2e9-221b-4aeb-94a1-89838340ac85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2472f95f-6c0d-4f83-8118-a0c88c3237af" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_326fa2e9-221b-4aeb-94a1-89838340ac85" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/EarningslossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedSharesOutstandingDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#EarningslossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedSharesOutstandingDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/EarningslossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedSharesOutstandingDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLoss" xlink:type="simple" xlink:href="cron-20201231.xsd#AccumulatedOtherComprehensiveIncomeLoss"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLoss" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLossTables" xlink:type="simple" xlink:href="cron-20201231.xsd#AccumulatedOtherComprehensiveIncomeLossTables"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLossTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#AccumulatedOtherComprehensiveIncomeLossDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/IncomeTaxes" xlink:type="simple" xlink:href="cron-20201231.xsd#IncomeTaxes"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/IncomeTaxes" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="cron-20201231.xsd#IncomeTaxesTables"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/IncomeTaxesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/IncomeTaxesScheduleofIncomeLossbeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#IncomeTaxesScheduleofIncomeLossbeforeIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/IncomeTaxesScheduleofIncomeLossbeforeIncomeTaxesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/IncomeTaxesExpenseforIncomeTaxesDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#IncomeTaxesExpenseforIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/IncomeTaxesExpenseforIncomeTaxesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#IncomeTaxesEffectiveTaxRateReconciliationDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_c71bc517-f16c-4831-bbf5-cfa9b560c81d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_EffectiveIncomeTaxRateReconciliationExpectedIncomeTaxExpenseRecoveryAmount_2cd9baa9-8fe0-4cf3-b04d-eb06dbdf3a04" xlink:href="cron-20201231.xsd#cron_EffectiveIncomeTaxRateReconciliationExpectedIncomeTaxExpenseRecoveryAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_c71bc517-f16c-4831-bbf5-cfa9b560c81d" xlink:to="loc_cron_EffectiveIncomeTaxRateReconciliationExpectedIncomeTaxExpenseRecoveryAmount_2cd9baa9-8fe0-4cf3-b04d-eb06dbdf3a04" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxExemptIncome_bdc77339-396b-4f3f-9f23-c9f8b4c73cca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxExemptIncome"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_c71bc517-f16c-4831-bbf5-cfa9b560c81d" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxExemptIncome_bdc77339-396b-4f3f-9f23-c9f8b4c73cca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_465340d5-b908-4bad-9f35-ea9fcc97d2b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_c71bc517-f16c-4831-bbf5-cfa9b560c81d" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_465340d5-b908-4bad-9f35-ea9fcc97d2b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_d3ee1f92-3384-4546-8f51-e36f16122eb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_c71bc517-f16c-4831-bbf5-cfa9b560c81d" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_d3ee1f92-3384-4546-8f51-e36f16122eb8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionCosts_958bf05d-c985-460b-a844-2074609c0662" xlink:href="cron-20201231.xsd#cron_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionCosts"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_c71bc517-f16c-4831-bbf5-cfa9b560c81d" xlink:to="loc_cron_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionCosts_958bf05d-c985-460b-a844-2074609c0662" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_EffectiveIncomeTaxRateReconciliationFairValueGainFinancialLiabilities_fe17c0ff-a90c-45b5-b13d-5b9bac2b5b8d" xlink:href="cron-20201231.xsd#cron_EffectiveIncomeTaxRateReconciliationFairValueGainFinancialLiabilities"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_c71bc517-f16c-4831-bbf5-cfa9b560c81d" xlink:to="loc_cron_EffectiveIncomeTaxRateReconciliationFairValueGainFinancialLiabilities_fe17c0ff-a90c-45b5-b13d-5b9bac2b5b8d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_18a7f450-c560-4b21-bc51-090f1ec88c31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_c71bc517-f16c-4831-bbf5-cfa9b560c81d" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_18a7f450-c560-4b21-bc51-090f1ec88c31" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_3126f15a-dd06-4321-8e29-93f491364908" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_c71bc517-f16c-4831-bbf5-cfa9b560c81d" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_3126f15a-dd06-4321-8e29-93f491364908" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_a72e5fad-0d43-4060-8b07-d24c0a315b9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_c71bc517-f16c-4831-bbf5-cfa9b560c81d" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_a72e5fad-0d43-4060-8b07-d24c0a315b9e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_09a37b19-8420-4438-8175-5eca29d98bff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_c71bc517-f16c-4831-bbf5-cfa9b560c81d" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_09a37b19-8420-4438-8175-5eca29d98bff" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_234319c9-bbe0-4b1f-bd85-a54f23c59a77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_7fdff404-8c89-47ef-9f71-04db6414860c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_234319c9-bbe0-4b1f-bd85-a54f23c59a77" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_7fdff404-8c89-47ef-9f71-04db6414860c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_85df52d0-ee1d-4b78-9d02-1ac33bec8654" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_234319c9-bbe0-4b1f-bd85-a54f23c59a77" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_85df52d0-ee1d-4b78-9d02-1ac33bec8654" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_0b8c1d75-443b-4ded-99ae-99153ef4deef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_cfe71ff5-f75c-4ca8-9f41-25632ca7a8d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_0b8c1d75-443b-4ded-99ae-99153ef4deef" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_cfe71ff5-f75c-4ca8-9f41-25632ca7a8d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DeferredTaxAssetsDebtIssuanceCosts_51bf0f02-2129-4eba-8efb-29d37ca4f2b6" xlink:href="cron-20201231.xsd#cron_DeferredTaxAssetsDebtIssuanceCosts"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_0b8c1d75-443b-4ded-99ae-99153ef4deef" xlink:to="loc_cron_DeferredTaxAssetsDebtIssuanceCosts_51bf0f02-2129-4eba-8efb-29d37ca4f2b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DeferredTaxAssetsShareIssuanceCost_d64f5809-c43b-438a-a403-6cfd1f23f435" xlink:href="cron-20201231.xsd#cron_DeferredTaxAssetsShareIssuanceCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_0b8c1d75-443b-4ded-99ae-99153ef4deef" xlink:to="loc_cron_DeferredTaxAssetsShareIssuanceCost_d64f5809-c43b-438a-a403-6cfd1f23f435" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DeferredTaxAssetsFinanceLeaseLiabilities_cc98fb22-c11a-4199-ac88-70bd23b1e044" xlink:href="cron-20201231.xsd#cron_DeferredTaxAssetsFinanceLeaseLiabilities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_0b8c1d75-443b-4ded-99ae-99153ef4deef" xlink:to="loc_cron_DeferredTaxAssetsFinanceLeaseLiabilities_cc98fb22-c11a-4199-ac88-70bd23b1e044" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_01664b50-f08f-4252-8d54-4a66937b8a2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_0b8c1d75-443b-4ded-99ae-99153ef4deef" xlink:to="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_01664b50-f08f-4252-8d54-4a66937b8a2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInvestments_79d847fa-c8c2-496f-81d2-1a42f987c84d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsInvestments"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_0b8c1d75-443b-4ded-99ae-99153ef4deef" xlink:to="loc_us-gaap_DeferredTaxAssetsInvestments_79d847fa-c8c2-496f-81d2-1a42f987c84d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_f7cb3c6c-c6fd-4288-a375-9e39e607ceb9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_0b8c1d75-443b-4ded-99ae-99153ef4deef" xlink:to="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_f7cb3c6c-c6fd-4288-a375-9e39e607ceb9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_e93e5684-5d0f-4fac-b82c-aceb2ee1f4be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_0b8c1d75-443b-4ded-99ae-99153ef4deef" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_e93e5684-5d0f-4fac-b82c-aceb2ee1f4be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_ea218fea-6f8f-4901-be77-d12eaf1ffc52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_0b8c1d75-443b-4ded-99ae-99153ef4deef" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_ea218fea-6f8f-4901-be77-d12eaf1ffc52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetInterestCarryforward_706d6568-173e-4f9a-8380-5a3bb1d483df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetInterestCarryforward"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_0b8c1d75-443b-4ded-99ae-99153ef4deef" xlink:to="loc_us-gaap_DeferredTaxAssetInterestCarryforward_706d6568-173e-4f9a-8380-5a3bb1d483df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_863724a7-9334-42ed-94b7-ce12c688ab4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_c47ac6ad-8208-40b8-bc4f-4c970d081787" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_863724a7-9334-42ed-94b7-ce12c688ab4e" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_c47ac6ad-8208-40b8-bc4f-4c970d081787" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_4434a4be-27ff-4c52-ba42-90bd45eaa1a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_863724a7-9334-42ed-94b7-ce12c688ab4e" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_4434a4be-27ff-4c52-ba42-90bd45eaa1a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_95c64edd-dee1-4e58-8312-6e46bb0c37a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts_c68698f3-84e2-40fa-8e46-adde564554f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_95c64edd-dee1-4e58-8312-6e46bb0c37a6" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts_c68698f3-84e2-40fa-8e46-adde564554f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_067fa777-4b9a-427c-b28f-438246221a67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_95c64edd-dee1-4e58-8312-6e46bb0c37a6" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_067fa777-4b9a-427c-b28f-438246221a67" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_83e5c132-d02c-45ab-ac6d-a82b0851d3d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_95c64edd-dee1-4e58-8312-6e46bb0c37a6" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_83e5c132-d02c-45ab-ac6d-a82b0851d3d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesInvestments_c3bdd85d-26fe-435a-8908-9485d3064331" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesInvestments"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_95c64edd-dee1-4e58-8312-6e46bb0c37a6" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesInvestments_c3bdd85d-26fe-435a-8908-9485d3064331" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DeferredTaxLiabilitiesLicenses_8b138044-c186-4c01-82c1-c8806ca83d6a" xlink:href="cron-20201231.xsd#cron_DeferredTaxLiabilitiesLicenses"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_95c64edd-dee1-4e58-8312-6e46bb0c37a6" xlink:to="loc_cron_DeferredTaxLiabilitiesLicenses_8b138044-c186-4c01-82c1-c8806ca83d6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset_08efc0f9-d130-4337-b75b-4e6addafc381" xlink:href="cron-20201231.xsd#cron_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_95c64edd-dee1-4e58-8312-6e46bb0c37a6" xlink:to="loc_cron_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset_08efc0f9-d130-4337-b75b-4e6addafc381" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/IncomeTaxesSummaryofValuationAllowanceDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#IncomeTaxesSummaryofValuationAllowanceDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/IncomeTaxesSummaryofValuationAllowanceDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/Commitments" xlink:type="simple" xlink:href="cron-20201231.xsd#Commitments"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/Commitments" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/CommitmentsTables" xlink:type="simple" xlink:href="cron-20201231.xsd#CommitmentsTables"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/CommitmentsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/CommitmentsSummaryofFutureMinimumLeasePaymentsUnderOperatingLeasesDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#CommitmentsSummaryofFutureMinimumLeasePaymentsUnderOperatingLeasesDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/CommitmentsSummaryofFutureMinimumLeasePaymentsUnderOperatingLeasesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/CommitmentsRDCommitmentsDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#CommitmentsRDCommitmentsDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/CommitmentsRDCommitmentsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/CommitmentsUseofPublicityRightsinBrandDevelopmentDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#CommitmentsUseofPublicityRightsinBrandDevelopmentDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/CommitmentsUseofPublicityRightsinBrandDevelopmentDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/Contingencies" xlink:type="simple" xlink:href="cron-20201231.xsd#Contingencies"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/Contingencies" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/ContingenciesDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#ContingenciesDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/ContingenciesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SupplementaryCashFlowInformation" xlink:type="simple" xlink:href="cron-20201231.xsd#SupplementaryCashFlowInformation"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/SupplementaryCashFlowInformation" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SupplementaryCashFlowInformationTables" xlink:type="simple" xlink:href="cron-20201231.xsd#SupplementaryCashFlowInformationTables"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/SupplementaryCashFlowInformationTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SupplementaryCashFlowInformationDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#SupplementaryCashFlowInformationDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/SupplementaryCashFlowInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapital_2b5c00bb-7b77-49db-95df-22fe03c3d0b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapital"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_50fcf3c7-f7b8-4676-992c-b7e22e3bbbfe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapital_2b5c00bb-7b77-49db-95df-22fe03c3d0b2" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_50fcf3c7-f7b8-4676-992c-b7e22e3bbbfe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_IncreaseDecreasePrepaidExpensesAndOtherReceivables_9fe2e5fd-1712-4b69-a3be-193ae301f129" xlink:href="cron-20201231.xsd#cron_IncreaseDecreasePrepaidExpensesAndOtherReceivables"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapital_2b5c00bb-7b77-49db-95df-22fe03c3d0b2" xlink:to="loc_cron_IncreaseDecreasePrepaidExpensesAndOtherReceivables_9fe2e5fd-1712-4b69-a3be-193ae301f129" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInFinanceReceivables_6dd5e437-9094-4dc3-af56-4aecce5daf8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInFinanceReceivables"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapital_2b5c00bb-7b77-49db-95df-22fe03c3d0b2" xlink:to="loc_us-gaap_IncreaseDecreaseInFinanceReceivables_6dd5e437-9094-4dc3-af56-4aecce5daf8c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_57ffad73-d223-4c99-b6bd-6022d2fb6252" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapital_2b5c00bb-7b77-49db-95df-22fe03c3d0b2" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_57ffad73-d223-4c99-b6bd-6022d2fb6252" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_c975abff-66c2-4ccd-ad12-d0a595455193" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapital_2b5c00bb-7b77-49db-95df-22fe03c3d0b2" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_c975abff-66c2-4ccd-ad12-d0a595455193" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/FinancialInstruments" xlink:type="simple" xlink:href="cron-20201231.xsd#FinancialInstruments"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/FinancialInstruments" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#FinancialInstrumentsCreditRiskNarrativeDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskNarrativeDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#FinancialInstrumentsLiquidityRiskNarrativeDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/FinancialInstrumentsInterestRateRiskDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#FinancialInstrumentsInterestRateRiskDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/FinancialInstrumentsInterestRateRiskDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/FinancialInstrumentsCurrencyRateRiskNarrativeDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#FinancialInstrumentsCurrencyRateRiskNarrativeDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/FinancialInstrumentsCurrencyRateRiskNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/FairValueMeasurement" xlink:type="simple" xlink:href="cron-20201231.xsd#FairValueMeasurement"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/FairValueMeasurement" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/FairValueMeasuresandDisclosuresTables" xlink:type="simple" xlink:href="cron-20201231.xsd#FairValueMeasuresandDisclosuresTables"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/FairValueMeasuresandDisclosuresTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/FairValueMeasurementDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#FairValueMeasurementDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/FairValueMeasurementDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/RelatedPartyTransactionsandBalances" xlink:type="simple" xlink:href="cron-20201231.xsd#RelatedPartyTransactionsandBalances"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/RelatedPartyTransactionsandBalances" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/RelatedPartyDisclosuresTables" xlink:type="simple" xlink:href="cron-20201231.xsd#RelatedPartyDisclosuresTables"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/RelatedPartyDisclosuresTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesNarrativeDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#RelatedPartyTransactionsandBalancesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesScheduleofRelatedPartyTransactionsDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#RelatedPartyTransactionsandBalancesScheduleofRelatedPartyTransactionsDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesScheduleofRelatedPartyTransactionsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/NonmonetaryTransactions" xlink:type="simple" xlink:href="cron-20201231.xsd#NonmonetaryTransactions"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/NonmonetaryTransactions" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/NonmonetaryTransactionsDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#NonmonetaryTransactionsDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/NonmonetaryTransactionsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/BusinessCombinations" xlink:type="simple" xlink:href="cron-20201231.xsd#BusinessCombinations"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/BusinessCombinations" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/BusinessCombinationsTables" xlink:type="simple" xlink:href="cron-20201231.xsd#BusinessCombinationsTables"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/BusinessCombinationsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/BusinessCombinationsNarrativeDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#BusinessCombinationsNarrativeDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/BusinessCombinationsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_e40bdc86-8d7a-4325-ab87-cdc252c5d9c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_d3bb1fe4-0005-4f79-8f49-5a1274ecc513" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_e40bdc86-8d7a-4325-ab87-cdc252c5d9c9" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_d3bb1fe4-0005-4f79-8f49-5a1274ecc513" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_ea508ebb-890b-4075-866d-bd53891d7418" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_e40bdc86-8d7a-4325-ab87-cdc252c5d9c9" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_ea508ebb-890b-4075-866d-bd53891d7418" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/BusinessCombinationsScheduleofFairValueofNetAssetsAcquiredDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#BusinessCombinationsScheduleofFairValueofNetAssetsAcquiredDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/BusinessCombinationsScheduleofFairValueofNetAssetsAcquiredDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_d046d954-e23d-4ac0-a95f-d17506f7b85f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_1949a757-d4a7-46ab-9e57-eefc7e275005" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_d046d954-e23d-4ac0-a95f-d17506f7b85f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_1949a757-d4a7-46ab-9e57-eefc7e275005" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_e37ca35c-cc2b-46bb-8347-7bd28a7deb94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_d046d954-e23d-4ac0-a95f-d17506f7b85f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_e37ca35c-cc2b-46bb-8347-7bd28a7deb94" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_fc9ac64b-f1c5-47e9-84e2-fafae75d7c61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_d046d954-e23d-4ac0-a95f-d17506f7b85f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_fc9ac64b-f1c5-47e9-84e2-fafae75d7c61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_efbca79e-c172-449e-a3f6-c21d0c6cef42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_d046d954-e23d-4ac0-a95f-d17506f7b85f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_efbca79e-c172-449e-a3f6-c21d0c6cef42" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_c8d13062-bc09-4a60-881d-172fcf91ad5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_d046d954-e23d-4ac0-a95f-d17506f7b85f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_c8d13062-bc09-4a60-881d-172fcf91ad5a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_b99b4c8b-4d2e-46aa-a2f7-a3ea217900b9" xlink:href="cron-20201231.xsd#cron_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_d046d954-e23d-4ac0-a95f-d17506f7b85f" xlink:to="loc_cron_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_b99b4c8b-4d2e-46aa-a2f7-a3ea217900b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_a3bf5d46-042a-4809-939a-b3b7f75c5238" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_d046d954-e23d-4ac0-a95f-d17506f7b85f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_a3bf5d46-042a-4809-939a-b3b7f75c5238" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_a39aec24-41cb-4062-bee1-1c2582c4c7bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_d046d954-e23d-4ac0-a95f-d17506f7b85f" xlink:to="loc_us-gaap_Goodwill_a39aec24-41cb-4062-bee1-1c2582c4c7bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAndAccruedLiabilities_f891804c-6fe8-4e52-b130-30190d6a9b04" xlink:href="cron-20201231.xsd#cron_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_d046d954-e23d-4ac0-a95f-d17506f7b85f" xlink:to="loc_cron_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAndAccruedLiabilities_f891804c-6fe8-4e52-b130-30190d6a9b04" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_57507870-a6a5-4f18-90d7-ba8094cbde41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_d046d954-e23d-4ac0-a95f-d17506f7b85f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_57507870-a6a5-4f18-90d7-ba8094cbde41" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/RepurposingCharges" xlink:type="simple" xlink:href="cron-20201231.xsd#RepurposingCharges"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/RepurposingCharges" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/RepurposingChargesTables" xlink:type="simple" xlink:href="cron-20201231.xsd#RepurposingChargesTables"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/RepurposingChargesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/RepurposingChargesScheduleofPlanInformationDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#RepurposingChargesScheduleofPlanInformationDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/RepurposingChargesScheduleofPlanInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions_35f2b911-592d-459c-b9e0-362a99ba62be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringSettlementAndImpairmentProvisions"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_76d1c747-1dbd-48d8-b44d-5530dd2e53aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions_35f2b911-592d-459c-b9e0-362a99ba62be" xlink:to="loc_us-gaap_SeveranceCosts1_76d1c747-1dbd-48d8-b44d-5530dd2e53aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_b35f1336-64f5-4882-9be6-b4dc93709c9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions_35f2b911-592d-459c-b9e0-362a99ba62be" xlink:to="loc_us-gaap_AssetImpairmentCharges_b35f1336-64f5-4882-9be6-b4dc93709c9b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/RepurposingChargesNarrativeDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#RepurposingChargesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/RepurposingChargesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SegmentInformation" xlink:type="simple" xlink:href="cron-20201231.xsd#SegmentInformation"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/SegmentInformation" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SegmentInformationTables" xlink:type="simple" xlink:href="cron-20201231.xsd#SegmentInformationTables"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/SegmentInformationTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SegmentInformationNarrativeDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#SegmentInformationNarrativeDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/SegmentInformationNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#SegmentInformationScheduleofSegmentDataDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_1a992ade-8cea-45bd-b2cd-de6c0fbd310d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_c882af7a-fda3-4390-ba8b-a38decfd3e7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_1a992ade-8cea-45bd-b2cd-de6c0fbd310d" xlink:to="loc_us-gaap_InvestmentIncomeInterest_c882af7a-fda3-4390-ba8b-a38decfd3e7d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_e04a6455-b35b-4a65-9f07-d25105bf617d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_1a992ade-8cea-45bd-b2cd-de6c0fbd310d" xlink:to="loc_us-gaap_InterestExpense_e04a6455-b35b-4a65-9f07-d25105bf617d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SegmentInformationScheduleofAdjustedEBITDADetails" xlink:type="simple" xlink:href="cron-20201231.xsd#SegmentInformationScheduleofAdjustedEBITDADetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/SegmentInformationScheduleofAdjustedEBITDADetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SegmentInformationScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#SegmentInformationScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/SegmentInformationScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SegmentInformationScheduleofLonglivedAssetsbyGeographicAreasDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#SegmentInformationScheduleofLonglivedAssetsbyGeographicAreasDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/SegmentInformationScheduleofLonglivedAssetsbyGeographicAreasDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/DiscontinuedOperationsandHeldforsaleAssets" xlink:type="simple" xlink:href="cron-20201231.xsd#DiscontinuedOperationsandHeldforsaleAssets"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/DiscontinuedOperationsandHeldforsaleAssets" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/DiscontinuedOperationsandHeldforsaleAssetsTables" xlink:type="simple" xlink:href="cron-20201231.xsd#DiscontinuedOperationsandHeldforsaleAssetsTables"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/DiscontinuedOperationsandHeldforsaleAssetsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/DiscontinuedOperationsandHeldforsaleAssetsDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#DiscontinuedOperationsandHeldforsaleAssetsDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/DiscontinuedOperationsandHeldforsaleAssetsDetails" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>12
<FILENAME>cron-20201231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:7f6b4332-a8eb-41ec-8082-7450606ea80c,g:9b8782dc-b83f-424a-b83c-bbf680d16be6-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/CoverPage" xlink:type="simple" xlink:href="cron-20201231.xsd#CoverPage"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/CoverPage" xlink:type="extended" id="i70a1ab5ef6964a5daafc31d1dec69d0f_CoverPage"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/ConsolidatedBalanceSheet" xlink:type="simple" xlink:href="cron-20201231.xsd#ConsolidatedBalanceSheet"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/ConsolidatedBalanceSheet" xlink:type="extended" id="i758dd51585b44eafb805dadc558c1116_ConsolidatedBalanceSheet"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/ConsolidatedBalanceSheetParenthetical" xlink:type="simple" xlink:href="cron-20201231.xsd#ConsolidatedBalanceSheetParenthetical"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/ConsolidatedBalanceSheetParenthetical" xlink:type="extended" id="i1a389ee06e384968badac550dba0b88d_ConsolidatedBalanceSheetParenthetical"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss" xlink:type="simple" xlink:href="cron-20201231.xsd#ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss" xlink:type="extended" id="ia29329abe3a94865ad9c520900bc1151_ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/ConsolidatedStatementsofStockholdersEquityDeficit" xlink:type="simple" xlink:href="cron-20201231.xsd#ConsolidatedStatementsofStockholdersEquityDeficit"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/ConsolidatedStatementsofStockholdersEquityDeficit" xlink:type="extended" id="id6cdff8aad894412b8e1f322bfa621b0_ConsolidatedStatementsofStockholdersEquityDeficit">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_edfd70a8-b42d-4591-9576-7e92ae2966fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b6eb595f-5476-4992-bdfc-fc080a8cf486" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_edfd70a8-b42d-4591-9576-7e92ae2966fb" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b6eb595f-5476-4992-bdfc-fc080a8cf486" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_6f3d38b4-8f33-49a4-8df8-15f260be2f63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b6eb595f-5476-4992-bdfc-fc080a8cf486" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_6f3d38b4-8f33-49a4-8df8-15f260be2f63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8de76e45-ec0d-42c5-8470-a5943e334aaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b6eb595f-5476-4992-bdfc-fc080a8cf486" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8de76e45-ec0d-42c5-8470-a5943e334aaa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_327a844c-941a-4040-838f-1ab45c3a8e4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b6eb595f-5476-4992-bdfc-fc080a8cf486" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_327a844c-941a-4040-838f-1ab45c3a8e4b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_e5aff8fe-f027-4485-ba85-a78143370f6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b6eb595f-5476-4992-bdfc-fc080a8cf486" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_e5aff8fe-f027-4485-ba85-a78143370f6d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_StockIssuedDuringPeriodValueNewIssuesIssuanceCosts_54a8f916-963f-4a11-adaa-1d52d037af53" xlink:href="cron-20201231.xsd#cron_StockIssuedDuringPeriodValueNewIssuesIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b6eb595f-5476-4992-bdfc-fc080a8cf486" xlink:to="loc_cron_StockIssuedDuringPeriodValueNewIssuesIssuanceCosts_54a8f916-963f-4a11-adaa-1d52d037af53" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_c96d3f4e-d3d6-4ac9-a798-d605a5686507" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b6eb595f-5476-4992-bdfc-fc080a8cf486" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_c96d3f4e-d3d6-4ac9-a798-d605a5686507" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_9e218884-f1d3-421c-96e0-824cdde24314" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b6eb595f-5476-4992-bdfc-fc080a8cf486" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_9e218884-f1d3-421c-96e0-824cdde24314" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_52b6059b-dd06-4f9d-a121-92bb7e0ecc08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b6eb595f-5476-4992-bdfc-fc080a8cf486" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_52b6059b-dd06-4f9d-a121-92bb7e0ecc08" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c5a65966-fa44-4882-b997-3375872e3520" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b6eb595f-5476-4992-bdfc-fc080a8cf486" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c5a65966-fa44-4882-b997-3375872e3520" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisesInPeriod_d8f4f726-f3b8-4033-9061-ea354b17aaa1" xlink:href="cron-20201231.xsd#cron_SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisesInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b6eb595f-5476-4992-bdfc-fc080a8cf486" xlink:to="loc_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisesInPeriod_d8f4f726-f3b8-4033-9061-ea354b17aaa1" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_StockIssuedDuringPeriodValueWarrantsExercised_4b312564-c570-419d-a623-b9393c531f4a" xlink:href="cron-20201231.xsd#cron_StockIssuedDuringPeriodValueWarrantsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b6eb595f-5476-4992-bdfc-fc080a8cf486" xlink:to="loc_cron_StockIssuedDuringPeriodValueWarrantsExercised_4b312564-c570-419d-a623-b9393c531f4a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_a7bee0c2-52cb-4042-9d69-bf3fb515a48e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b6eb595f-5476-4992-bdfc-fc080a8cf486" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_a7bee0c2-52cb-4042-9d69-bf3fb515a48e" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_752eda83-9b4f-4536-8a22-c68d3353aab6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b6eb595f-5476-4992-bdfc-fc080a8cf486" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_752eda83-9b4f-4536-8a22-c68d3353aab6" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_038cc6db-5206-42b5-80fd-a62f4907e92a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b6eb595f-5476-4992-bdfc-fc080a8cf486" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_038cc6db-5206-42b5-80fd-a62f4907e92a" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_9956cef9-411a-4b77-994e-078fffeaf783" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b6eb595f-5476-4992-bdfc-fc080a8cf486" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_9956cef9-411a-4b77-994e-078fffeaf783" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_StockIssuedDuringPeriodSharesTopupRightsExercised_fd64816e-e6c3-49f2-86af-dd8b40705972" xlink:href="cron-20201231.xsd#cron_StockIssuedDuringPeriodSharesTopupRightsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b6eb595f-5476-4992-bdfc-fc080a8cf486" xlink:to="loc_cron_StockIssuedDuringPeriodSharesTopupRightsExercised_fd64816e-e6c3-49f2-86af-dd8b40705972" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_StockIssuedDuringPeriodValueTopupRightsExercised_bb3f3971-4aa2-44fb-940a-6384e812a8a7" xlink:href="cron-20201231.xsd#cron_StockIssuedDuringPeriodValueTopupRightsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b6eb595f-5476-4992-bdfc-fc080a8cf486" xlink:to="loc_cron_StockIssuedDuringPeriodValueTopupRightsExercised_bb3f3971-4aa2-44fb-940a-6384e812a8a7" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_4fef436b-a9b1-4e0f-a5a3-49a7463c1259" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b6eb595f-5476-4992-bdfc-fc080a8cf486" xlink:to="loc_us-gaap_ProfitLoss_4fef436b-a9b1-4e0f-a5a3-49a7463c1259" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_be8c1492-ed92-4c75-9af5-3fda458031d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b6eb595f-5476-4992-bdfc-fc080a8cf486" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_be8c1492-ed92-4c75-9af5-3fda458031d7" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_0b1ce283-8f75-41cb-8ef8-80b8addc0114" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6566ee05-0e63-490d-96f9-004ee15d14f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_24772287-648f-4101-8e45-da1b8e115689" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_edfd70a8-b42d-4591-9576-7e92ae2966fb" xlink:to="loc_us-gaap_StatementTable_24772287-648f-4101-8e45-da1b8e115689" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b41bf05f-0bd3-4f15-b946-d343a076c61d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_24772287-648f-4101-8e45-da1b8e115689" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b41bf05f-0bd3-4f15-b946-d343a076c61d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b41bf05f-0bd3-4f15-b946-d343a076c61d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b41bf05f-0bd3-4f15-b946-d343a076c61d" xlink:to="loc_us-gaap_EquityComponentDomain_b41bf05f-0bd3-4f15-b946-d343a076c61d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_db355b76-cce3-412b-a4bf-c17dbf00ec76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b41bf05f-0bd3-4f15-b946-d343a076c61d" xlink:to="loc_us-gaap_EquityComponentDomain_db355b76-cce3-412b-a4bf-c17dbf00ec76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_2c019349-7495-4583-b73f-853c4f4f308f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_db355b76-cce3-412b-a4bf-c17dbf00ec76" xlink:to="loc_us-gaap_CommonStockMember_2c019349-7495-4583-b73f-853c4f4f308f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_4e12459a-acec-4829-be4b-17bf742d11ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_db355b76-cce3-412b-a4bf-c17dbf00ec76" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_4e12459a-acec-4829-be4b-17bf742d11ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_4ee2bd1a-13fc-4a8f-8fc4-0d8e61860df3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_db355b76-cce3-412b-a4bf-c17dbf00ec76" xlink:to="loc_us-gaap_RetainedEarningsMember_4ee2bd1a-13fc-4a8f-8fc4-0d8e61860df3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_08fc5625-005a-458c-8077-9c8796d98746" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_db355b76-cce3-412b-a4bf-c17dbf00ec76" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_08fc5625-005a-458c-8077-9c8796d98746" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_9e8ae227-4e23-4605-812e-7b866a2a197b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_db355b76-cce3-412b-a4bf-c17dbf00ec76" xlink:to="loc_us-gaap_NoncontrollingInterestMember_9e8ae227-4e23-4605-812e-7b866a2a197b" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="cron-20201231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended" id="if6ae0a1c2eb84dc3bea08ec599ad398b_ConsolidatedStatementsofCashFlows">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f4e290e5-50bc-441c-bda5-d4f1d5506779" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_6b91a129-2667-442d-84f4-f9804f69f784" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f4e290e5-50bc-441c-bda5-d4f1d5506779" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_6b91a129-2667-442d-84f4-f9804f69f784" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_e14b9269-c262-435d-a3da-32ab7796d6ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_6b91a129-2667-442d-84f4-f9804f69f784" xlink:to="loc_us-gaap_ProfitLoss_e14b9269-c262-435d-a3da-32ab7796d6ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_571bdfa6-f54d-4379-9984-13f109937b59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_6b91a129-2667-442d-84f4-f9804f69f784" xlink:to="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_571bdfa6-f54d-4379-9984-13f109937b59" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_79fb5f6b-7874-426c-9961-68a31e81a241" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_571bdfa6-f54d-4379-9984-13f109937b59" xlink:to="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_79fb5f6b-7874-426c-9961-68a31e81a241" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_7da5816f-c6b1-444e-82b4-ddf5b6804191" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_571bdfa6-f54d-4379-9984-13f109937b59" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_7da5816f-c6b1-444e-82b4-ddf5b6804191" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_09796bfa-4622-4cab-a6c2-cbfb07c63b59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_571bdfa6-f54d-4379-9984-13f109937b59" xlink:to="loc_us-gaap_InventoryWriteDown_09796bfa-4622-4cab-a6c2-cbfb07c63b59" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_58fb45ea-cc77-45a2-b291-f606aeac162f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_571bdfa6-f54d-4379-9984-13f109937b59" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_58fb45ea-cc77-45a2-b291-f606aeac162f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_5b1a0a14-39aa-4ad0-b0aa-c0f758df7602" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_571bdfa6-f54d-4379-9984-13f109937b59" xlink:to="loc_us-gaap_ShareBasedCompensation_5b1a0a14-39aa-4ad0-b0aa-c0f758df7602" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_eb62a221-dae3-4006-afaf-030542a11086" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_571bdfa6-f54d-4379-9984-13f109937b59" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_eb62a221-dae3-4006-afaf-030542a11086" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_5be058f8-7727-44ae-af3e-b0d22af02dad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_571bdfa6-f54d-4379-9984-13f109937b59" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_5be058f8-7727-44ae-af3e-b0d22af02dad" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_9e7f6142-b51e-4423-81ab-c3ff5ecde4d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_571bdfa6-f54d-4379-9984-13f109937b59" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_9e7f6142-b51e-4423-81ab-c3ff5ecde4d5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NoncashSellingAndMarketingExpense_d018bd3d-f343-4f01-9177-6bbe0edca0bb" xlink:href="cron-20201231.xsd#cron_NoncashSellingAndMarketingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_571bdfa6-f54d-4379-9984-13f109937b59" xlink:to="loc_cron_NoncashSellingAndMarketingExpense_d018bd3d-f343-4f01-9177-6bbe0edca0bb" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_ed44f145-bc73-42b8-80af-43de397eb50c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_571bdfa6-f54d-4379-9984-13f109937b59" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_ed44f145-bc73-42b8-80af-43de397eb50c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts_b5391d0a-43e7-436c-b722-b7c087913146" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_571bdfa6-f54d-4379-9984-13f109937b59" xlink:to="loc_us-gaap_RestructuringCosts_b5391d0a-43e7-436c-b722-b7c087913146" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_06d7bd68-f1b6-488e-9f67-bc7313209b88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_571bdfa6-f54d-4379-9984-13f109937b59" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_06d7bd68-f1b6-488e-9f67-bc7313209b88" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapital_69f73203-d31f-4ca4-b37f-7a02ca3cb60c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_6b91a129-2667-442d-84f4-f9804f69f784" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapital_69f73203-d31f-4ca4-b37f-7a02ca3cb60c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_34e64727-1662-43c5-9772-1964915c2fb3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_6b91a129-2667-442d-84f4-f9804f69f784" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_34e64727-1662-43c5-9772-1964915c2fb3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b1528a0a-41ac-4d6e-a78f-0e6a47d1f5f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f4e290e5-50bc-441c-bda5-d4f1d5506779" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b1528a0a-41ac-4d6e-a78f-0e6a47d1f5f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_eddfdbad-7605-4358-a66f-a3fc7f2099b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b1528a0a-41ac-4d6e-a78f-0e6a47d1f5f0" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_eddfdbad-7605-4358-a66f-a3fc7f2099b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_3166c7ef-bea1-4c65-bc69-4a7bc502926e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b1528a0a-41ac-4d6e-a78f-0e6a47d1f5f0" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_3166c7ef-bea1-4c65-bc69-4a7bc502926e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_7e451f4b-5143-437b-a822-4b12638d29c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b1528a0a-41ac-4d6e-a78f-0e6a47d1f5f0" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_7e451f4b-5143-437b-a822-4b12638d29c3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ProceedsFromEquitySecuritiesFVNIAndEquitySecuritiesWithoutDeterminableFairValue_20822444-314f-47d2-90d9-d8cb79fa486d" xlink:href="cron-20201231.xsd#cron_ProceedsFromEquitySecuritiesFVNIAndEquitySecuritiesWithoutDeterminableFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b1528a0a-41ac-4d6e-a78f-0e6a47d1f5f0" xlink:to="loc_cron_ProceedsFromEquitySecuritiesFVNIAndEquitySecuritiesWithoutDeterminableFairValue_20822444-314f-47d2-90d9-d8cb79fa486d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_19991a79-76df-49b9-8960-f762fe214a49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInterestInJointVenture"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b1528a0a-41ac-4d6e-a78f-0e6a47d1f5f0" xlink:to="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_19991a79-76df-49b9-8960-f762fe214a49" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_857b3c2c-4f84-41f7-b72b-107b368b7739" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b1528a0a-41ac-4d6e-a78f-0e6a47d1f5f0" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_857b3c2c-4f84-41f7-b72b-107b368b7739" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_85fe4c28-1e77-49f2-ba8b-798bb04ea3f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b1528a0a-41ac-4d6e-a78f-0e6a47d1f5f0" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_85fe4c28-1e77-49f2-ba8b-798bb04ea3f4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_20bc43c7-6470-42f9-b185-a816bc5250a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b1528a0a-41ac-4d6e-a78f-0e6a47d1f5f0" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_20bc43c7-6470-42f9-b185-a816bc5250a5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireLoansReceivable_09982b6d-6bb0-404a-bb7a-22d2ec995ac7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireLoansReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b1528a0a-41ac-4d6e-a78f-0e6a47d1f5f0" xlink:to="loc_us-gaap_PaymentsToAcquireLoansReceivable_09982b6d-6bb0-404a-bb7a-22d2ec995ac7" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_830af805-9fdf-4a40-aceb-0332f2711143" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b1528a0a-41ac-4d6e-a78f-0e6a47d1f5f0" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_830af805-9fdf-4a40-aceb-0332f2711143" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4575d454-83be-419f-9be2-142793ca9b14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b1528a0a-41ac-4d6e-a78f-0e6a47d1f5f0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4575d454-83be-419f-9be2-142793ca9b14" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_668ca7e5-f557-433b-b473-1888c78ebddc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f4e290e5-50bc-441c-bda5-d4f1d5506779" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_668ca7e5-f557-433b-b473-1888c78ebddc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_fc716dba-a3bb-4c10-afff-fd61648b5735" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_668ca7e5-f557-433b-b473-1888c78ebddc" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_fc716dba-a3bb-4c10-afff-fd61648b5735" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PaymentsForLeaseObligationsFinancingActivities_94e2d3d5-9a59-4c11-bbd0-a7b0edd1baf7" xlink:href="cron-20201231.xsd#cron_PaymentsForLeaseObligationsFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_668ca7e5-f557-433b-b473-1888c78ebddc" xlink:to="loc_cron_PaymentsForLeaseObligationsFinancingActivities_94e2d3d5-9a59-4c11-bbd0-a7b0edd1baf7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2e484eed-14b0-46cc-b109-1978574a4ebf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_668ca7e5-f557-433b-b473-1888c78ebddc" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2e484eed-14b0-46cc-b109-1978574a4ebf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_29a8a0f2-dd9b-4564-a3db-41b21b4aa023" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_668ca7e5-f557-433b-b473-1888c78ebddc" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_29a8a0f2-dd9b-4564-a3db-41b21b4aa023" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ProceedsFromRightExercises_0668b0fc-1377-460e-b0d7-0169e8499af8" xlink:href="cron-20201231.xsd#cron_ProceedsFromRightExercises"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_668ca7e5-f557-433b-b473-1888c78ebddc" xlink:to="loc_cron_ProceedsFromRightExercises_0668b0fc-1377-460e-b0d7-0169e8499af8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ProceedsFromWarrantExercisedAndStockOptionsExercised_915eec36-2eae-49a4-9e0e-cdc2f6c3949b" xlink:href="cron-20201231.xsd#cron_ProceedsFromWarrantExercisedAndStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_668ca7e5-f557-433b-b473-1888c78ebddc" xlink:to="loc_cron_ProceedsFromWarrantExercisedAndStockOptionsExercised_915eec36-2eae-49a4-9e0e-cdc2f6c3949b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_b3579994-bdb6-4af6-b8fb-32d3e2e25171" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_668ca7e5-f557-433b-b473-1888c78ebddc" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_b3579994-bdb6-4af6-b8fb-32d3e2e25171" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_56716ec2-71ad-4bf1-8b2d-db07bd903847" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_668ca7e5-f557-433b-b473-1888c78ebddc" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_56716ec2-71ad-4bf1-8b2d-db07bd903847" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt_5c2a9007-0b7d-4014-91f1-b90eba37ddac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfSecuredDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_668ca7e5-f557-433b-b473-1888c78ebddc" xlink:to="loc_us-gaap_RepaymentsOfSecuredDebt_5c2a9007-0b7d-4014-91f1-b90eba37ddac" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_ef34da60-8938-4dfc-8734-d6306744e3cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_668ca7e5-f557-433b-b473-1888c78ebddc" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_ef34da60-8938-4dfc-8734-d6306744e3cd" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_0e949f79-5456-4923-bace-d7e03f470299" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_668ca7e5-f557-433b-b473-1888c78ebddc" xlink:to="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_0e949f79-5456-4923-bace-d7e03f470299" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c24f6e0a-03c2-4aed-b372-d671898be848" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_668ca7e5-f557-433b-b473-1888c78ebddc" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c24f6e0a-03c2-4aed-b372-d671898be848" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c9a484da-f8c8-4546-8503-eed7ca67fd68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f4e290e5-50bc-441c-bda5-d4f1d5506779" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c9a484da-f8c8-4546-8503-eed7ca67fd68" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f5f9ab46-3445-4212-9156-37e91299187f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f4e290e5-50bc-441c-bda5-d4f1d5506779" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f5f9ab46-3445-4212-9156-37e91299187f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e933e9b3-6e9e-4a75-9cf6-60fbdecaa30f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f4e290e5-50bc-441c-bda5-d4f1d5506779" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e933e9b3-6e9e-4a75-9cf6-60fbdecaa30f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_951fcc84-386d-4ebf-abdc-0a004f511e23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_8dec0c09-dd4d-4999-98cb-d21283fd5692" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_f4e290e5-50bc-441c-bda5-d4f1d5506779" xlink:to="loc_us-gaap_StatementTable_8dec0c09-dd4d-4999-98cb-d21283fd5692" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_7eb9f7d7-5697-4f99-9701-dacb60b95907" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_8dec0c09-dd4d-4999-98cb-d21283fd5692" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_7eb9f7d7-5697-4f99-9701-dacb60b95907" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_7eb9f7d7-5697-4f99-9701-dacb60b95907_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_7eb9f7d7-5697-4f99-9701-dacb60b95907" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_7eb9f7d7-5697-4f99-9701-dacb60b95907_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8fa000fb-296e-4b85-bc41-642ea8e01cf4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_7eb9f7d7-5697-4f99-9701-dacb60b95907" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8fa000fb-296e-4b85-bc41-642ea8e01cf4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaInvestmentMember_dfee0199-b818-476c-9983-0e353b311e3d" xlink:href="cron-20201231.xsd#cron_AltriaInvestmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8fa000fb-296e-4b85-bc41-642ea8e01cf4" xlink:to="loc_cron_AltriaInvestmentMember_dfee0199-b818-476c-9983-0e353b311e3d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_BoughtDealOfferingsMember_a493368f-4297-4910-bd53-1482107655d7" xlink:href="cron-20201231.xsd#cron_BoughtDealOfferingsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8fa000fb-296e-4b85-bc41-642ea8e01cf4" xlink:to="loc_cron_BoughtDealOfferingsMember_a493368f-4297-4910-bd53-1482107655d7" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/Background" xlink:type="simple" xlink:href="cron-20201231.xsd#Background"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/Background" xlink:type="extended" id="ie6b6a8e843bc49bab2dc9111e2f792e8_Background"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/BackgroundDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#BackgroundDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/BackgroundDetails" xlink:type="extended" id="i0be504e55032426eb4369f2c7c9b0c7b_BackgroundDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_ce894bbf-1f9c-40a4-8fe5-c4d22ea57b8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NumberOfContinentsWithInternationalProductionAndDistribution_108b0a40-2507-4a72-b84f-5ab1b966353b" xlink:href="cron-20201231.xsd#cron_NumberOfContinentsWithInternationalProductionAndDistribution"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_ce894bbf-1f9c-40a4-8fe5-c4d22ea57b8c" xlink:to="loc_cron_NumberOfContinentsWithInternationalProductionAndDistribution_108b0a40-2507-4a72-b84f-5ab1b966353b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NumberOfAdultuseBrands_5bc1fc69-faa1-4430-98f7-41bc9bc32ea3" xlink:href="cron-20201231.xsd#cron_NumberOfAdultuseBrands"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_ce894bbf-1f9c-40a4-8fe5-c4d22ea57b8c" xlink:to="loc_cron_NumberOfAdultuseBrands_5bc1fc69-faa1-4430-98f7-41bc9bc32ea3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NumberOfHempderivedCannabidiolPersonalCareBrands_f4e90895-ed5d-40e8-b5f5-d3867693a18c" xlink:href="cron-20201231.xsd#cron_NumberOfHempderivedCannabidiolPersonalCareBrands"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_ce894bbf-1f9c-40a4-8fe5-c4d22ea57b8c" xlink:to="loc_cron_NumberOfHempderivedCannabidiolPersonalCareBrands_f4e90895-ed5d-40e8-b5f5-d3867693a18c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NumberOfStrategicJointVentures_e50c8bb3-9e8e-4e4d-b4c9-7fe10b07a1a1" xlink:href="cron-20201231.xsd#cron_NumberOfStrategicJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_ce894bbf-1f9c-40a4-8fe5-c4d22ea57b8c" xlink:to="loc_cron_NumberOfStrategicJointVentures_e50c8bb3-9e8e-4e4d-b4c9-7fe10b07a1a1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_4643e83f-4b2a-4b45-96d3-5059bced63d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_ce894bbf-1f9c-40a4-8fe5-c4d22ea57b8c" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_4643e83f-4b2a-4b45-96d3-5059bced63d1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_0f12c8ab-e48e-4f07-96a2-2806034504a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_ce894bbf-1f9c-40a4-8fe5-c4d22ea57b8c" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_0f12c8ab-e48e-4f07-96a2-2806034504a5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_e905d00b-b231-4003-99e8-dbed4a36da4d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_0f12c8ab-e48e-4f07-96a2-2806034504a5" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_e905d00b-b231-4003-99e8-dbed4a36da4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_e905d00b-b231-4003-99e8-dbed4a36da4d_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_e905d00b-b231-4003-99e8-dbed4a36da4d" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_e905d00b-b231-4003-99e8-dbed4a36da4d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_32fc4e76-b994-41a7-b10d-eb3c82cf8184" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_e905d00b-b231-4003-99e8-dbed4a36da4d" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_32fc4e76-b994-41a7-b10d-eb3c82cf8184" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosAustraliaLimitedMember_fe2091e5-202a-40f5-9115-5c51f6c5deb9" xlink:href="cron-20201231.xsd#cron_CronosAustraliaLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_32fc4e76-b994-41a7-b10d-eb3c82cf8184" xlink:to="loc_cron_CronosAustraliaLimitedMember_fe2091e5-202a-40f5-9115-5c51f6c5deb9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="cron-20201231.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended" id="id3970d999fd64f9f8c6d24744db429a2_SummaryofSignificantAccountingPolicies"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="cron-20201231.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended" id="iee918d5665ea401eba7f2c40e857d31a_SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="cron-20201231.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended" id="iaf4e5261bb7642c6ab4eb6e0de95d398_SummaryofSignificantAccountingPoliciesTables"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesScheduleofConsolidatedEntitiesDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#SummaryofSignificantAccountingPoliciesScheduleofConsolidatedEntitiesDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesScheduleofConsolidatedEntitiesDetails" xlink:type="extended" id="ic6660a5b33784b9db48741f23d55148f_SummaryofSignificantAccountingPoliciesScheduleofConsolidatedEntitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_cdaa5d58-efa1-40f7-9417-68bb5c81f830" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_8e676dd6-7599-401c-a71d-5a08cd4fc05b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_cdaa5d58-efa1-40f7-9417-68bb5c81f830" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_8e676dd6-7599-401c-a71d-5a08cd4fc05b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_7e91fd07-e7e8-483c-a10d-e7db1e69485c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_cdaa5d58-efa1-40f7-9417-68bb5c81f830" xlink:to="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_7e91fd07-e7e8-483c-a10d-e7db1e69485c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_1b12e9ee-15b2-4f27-9364-d0a966d2dec4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_7e91fd07-e7e8-483c-a10d-e7db1e69485c" xlink:to="loc_srt_ConsolidatedEntitiesAxis_1b12e9ee-15b2-4f27-9364-d0a966d2dec4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_1b12e9ee-15b2-4f27-9364-d0a966d2dec4_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_1b12e9ee-15b2-4f27-9364-d0a966d2dec4" xlink:to="loc_srt_ConsolidatedEntitiesDomain_1b12e9ee-15b2-4f27-9364-d0a966d2dec4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_1018e746-8846-4daf-8b4c-c0c69c688e0b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_1b12e9ee-15b2-4f27-9364-d0a966d2dec4" xlink:to="loc_srt_ConsolidatedEntitiesDomain_1018e746-8846-4daf-8b4c-c0c69c688e0b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosIsraelG.S.CultivationsLtd.Member_d856e21c-b6cf-4d79-bb8f-d39b9790f203" xlink:href="cron-20201231.xsd#cron_CronosIsraelG.S.CultivationsLtd.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_1018e746-8846-4daf-8b4c-c0c69c688e0b" xlink:to="loc_cron_CronosIsraelG.S.CultivationsLtd.Member_d856e21c-b6cf-4d79-bb8f-d39b9790f203" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosIsraelG.S.ManufacturingLtd.Member_55da55fb-bd5b-4206-862f-ebf6ebe5f4c9" xlink:href="cron-20201231.xsd#cron_CronosIsraelG.S.ManufacturingLtd.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_1018e746-8846-4daf-8b4c-c0c69c688e0b" xlink:to="loc_cron_CronosIsraelG.S.ManufacturingLtd.Member_55da55fb-bd5b-4206-862f-ebf6ebe5f4c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosIsraelG.S.StoreLtd.Member_a8f6d9cd-6156-4447-a7a7-c2f74bfa87f4" xlink:href="cron-20201231.xsd#cron_CronosIsraelG.S.StoreLtd.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_1018e746-8846-4daf-8b4c-c0c69c688e0b" xlink:to="loc_cron_CronosIsraelG.S.StoreLtd.Member_a8f6d9cd-6156-4447-a7a7-c2f74bfa87f4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosIsraelG.S.PharmaciesLtd.Member_caf521b8-3664-420d-b7b9-772cfa692a10" xlink:href="cron-20201231.xsd#cron_CronosIsraelG.S.PharmaciesLtd.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_1018e746-8846-4daf-8b4c-c0c69c688e0b" xlink:to="loc_cron_CronosIsraelG.S.PharmaciesLtd.Member_caf521b8-3664-420d-b7b9-772cfa692a10" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsAmortizationMethodsandRatesDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsAmortizationMethodsandRatesDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsAmortizationMethodsandRatesDetails" xlink:type="extended" id="id152e6ba11aa44189f7aab530b71ec07_SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsAmortizationMethodsandRatesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_dfa73e82-108a-4acc-8fac-8d9609436b89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_05176d21-08ce-4751-aa32-71d4b50132f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_dfa73e82-108a-4acc-8fac-8d9609436b89" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_05176d21-08ce-4751-aa32-71d4b50132f3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_0a708346-aa54-4242-97ad-ae5e2c316b55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_dfa73e82-108a-4acc-8fac-8d9609436b89" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_0a708346-aa54-4242-97ad-ae5e2c316b55" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6a59e7b7-a289-429e-b016-531ca34f52b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_0a708346-aa54-4242-97ad-ae5e2c316b55" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6a59e7b7-a289-429e-b016-531ca34f52b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6a59e7b7-a289-429e-b016-531ca34f52b4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6a59e7b7-a289-429e-b016-531ca34f52b4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6a59e7b7-a289-429e-b016-531ca34f52b4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7ec4ce9e-aada-4f3f-8dfa-b310cc8c1924" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6a59e7b7-a289-429e-b016-531ca34f52b4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7ec4ce9e-aada-4f3f-8dfa-b310cc8c1924" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_860859b6-772f-4666-9081-b43ea56940a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7ec4ce9e-aada-4f3f-8dfa-b310cc8c1924" xlink:to="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_860859b6-772f-4666-9081-b43ea56940a8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_EnterpriseResourcePlanningSystemMember_fd3b8784-0d16-48cb-b23e-b7d4c82d8a98" xlink:href="cron-20201231.xsd#cron_EnterpriseResourcePlanningSystemMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7ec4ce9e-aada-4f3f-8dfa-b310cc8c1924" xlink:to="loc_cron_EnterpriseResourcePlanningSystemMember_fd3b8784-0d16-48cb-b23e-b7d4c82d8a98" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantEquipmentUsefulLivesDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantEquipmentUsefulLivesDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantEquipmentUsefulLivesDetails" xlink:type="extended" id="id74b1135c2f44b20a6cf17ca17f6777a_SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantEquipmentUsefulLivesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f801bd62-d1e8-43ee-b7e0-ea628c406f0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_1927e4f9-dbd7-4c89-a0eb-ac83ff5b7183" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f801bd62-d1e8-43ee-b7e0-ea628c406f0b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_1927e4f9-dbd7-4c89-a0eb-ac83ff5b7183" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b66b6fc9-c589-43a6-b119-20082854fa27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f801bd62-d1e8-43ee-b7e0-ea628c406f0b" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b66b6fc9-c589-43a6-b119-20082854fa27" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9b69a53f-6924-4278-867e-27d4c02c5ed5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b66b6fc9-c589-43a6-b119-20082854fa27" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9b69a53f-6924-4278-867e-27d4c02c5ed5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9b69a53f-6924-4278-867e-27d4c02c5ed5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9b69a53f-6924-4278-867e-27d4c02c5ed5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9b69a53f-6924-4278-867e-27d4c02c5ed5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ac86dd28-1738-493d-a211-c89f5d92ce73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9b69a53f-6924-4278-867e-27d4c02c5ed5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ac86dd28-1738-493d-a211-c89f5d92ce73" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_f63469b2-8df0-4ef6-983f-414b5594bab2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ac86dd28-1738-493d-a211-c89f5d92ce73" xlink:to="loc_us-gaap_BuildingMember_f63469b2-8df0-4ef6-983f-414b5594bab2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_3444078c-aaf5-453b-a78b-4b6d53041604" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ac86dd28-1738-493d-a211-c89f5d92ce73" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_3444078c-aaf5-453b-a78b-4b6d53041604" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_dd8f4fae-31b1-42e9-8b06-38b4c602805d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ac86dd28-1738-493d-a211-c89f5d92ce73" xlink:to="loc_us-gaap_ComputerEquipmentMember_dd8f4fae-31b1-42e9-8b06-38b4c602805d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f037a4b7-ff9a-43e0-bf03-537d4e63acf2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b66b6fc9-c589-43a6-b119-20082854fa27" xlink:to="loc_srt_RangeAxis_f037a4b7-ff9a-43e0-bf03-537d4e63acf2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f037a4b7-ff9a-43e0-bf03-537d4e63acf2_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_f037a4b7-ff9a-43e0-bf03-537d4e63acf2" xlink:to="loc_srt_RangeMember_f037a4b7-ff9a-43e0-bf03-537d4e63acf2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ff899fa5-9df5-41d0-b83a-295d4f7e5cf9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_f037a4b7-ff9a-43e0-bf03-537d4e63acf2" xlink:to="loc_srt_RangeMember_ff899fa5-9df5-41d0-b83a-295d4f7e5cf9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_4d1b01bf-9791-465c-812b-c0dd76a32145" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ff899fa5-9df5-41d0-b83a-295d4f7e5cf9" xlink:to="loc_srt_MinimumMember_4d1b01bf-9791-465c-812b-c0dd76a32145" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_6fea9ab1-74b6-4268-be3c-819671e6950e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ff899fa5-9df5-41d0-b83a-295d4f7e5cf9" xlink:to="loc_srt_MaximumMember_6fea9ab1-74b6-4268-be3c-819671e6950e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesImpairmentofLonglivedAssetsDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#SummaryofSignificantAccountingPoliciesImpairmentofLonglivedAssetsDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesImpairmentofLonglivedAssetsDetails" xlink:type="extended" id="ifbb21a01186d4d59948cd9851db18f88_SummaryofSignificantAccountingPoliciesImpairmentofLonglivedAssetsDetails"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/NewAccountingPronouncements" xlink:type="simple" xlink:href="cron-20201231.xsd#NewAccountingPronouncements"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/NewAccountingPronouncements" xlink:type="extended" id="iec608d392db04d159019a224ffdbdce7_NewAccountingPronouncements"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/RevenuesfromContractswithCustomers" xlink:type="simple" xlink:href="cron-20201231.xsd#RevenuesfromContractswithCustomers"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/RevenuesfromContractswithCustomers" xlink:type="extended" id="i6b76a5bc98f3450785dfb6185518ef94_RevenuesfromContractswithCustomers"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/RevenuesfromContractswithCustomersNarrativeDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#RevenuesfromContractswithCustomersNarrativeDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/RevenuesfromContractswithCustomersNarrativeDetails" xlink:type="extended" id="iedae9e5ec62b408d98be2cb517b03069_RevenuesfromContractswithCustomersNarrativeDetails"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/Inventory" xlink:type="simple" xlink:href="cron-20201231.xsd#Inventory"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/Inventory" xlink:type="extended" id="ia2aff47b4cfa4d0783c891d94305330f_Inventory"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/InventoryTables" xlink:type="simple" xlink:href="cron-20201231.xsd#InventoryTables"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/InventoryTables" xlink:type="extended" id="ic631172442e2462eaeada4ee383d6c51_InventoryTables"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/InventoryDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#InventoryDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/InventoryDetails" xlink:type="extended" id="icd26198f9cc7439d8fabee150b36b0be_InventoryDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLineItems_96a8a78f-7b7c-4773-b674-61a31525f112" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_dc6e7148-4884-45c4-8dbb-a14f3132fee9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InventoryLineItems_96a8a78f-7b7c-4773-b674-61a31525f112" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_dc6e7148-4884-45c4-8dbb-a14f3132fee9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_71db960a-672c-45e0-88c8-f2243094260d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InventoryLineItems_96a8a78f-7b7c-4773-b674-61a31525f112" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_71db960a-672c-45e0-88c8-f2243094260d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_bc968e10-fa36-410a-85b9-f5f8f14586a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InventoryLineItems_96a8a78f-7b7c-4773-b674-61a31525f112" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_bc968e10-fa36-410a-85b9-f5f8f14586a2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventorySuppliesNetOfReserves_bbd6b545-466f-423d-a568-487b62a3d900" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventorySuppliesNetOfReserves"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InventoryLineItems_96a8a78f-7b7c-4773-b674-61a31525f112" xlink:to="loc_us-gaap_InventorySuppliesNetOfReserves_bbd6b545-466f-423d-a568-487b62a3d900" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_c25e9909-4eb3-4c5d-8111-43e3b2a8b652" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InventoryLineItems_96a8a78f-7b7c-4773-b674-61a31525f112" xlink:to="loc_us-gaap_InventoryNet_c25e9909-4eb3-4c5d-8111-43e3b2a8b652" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_731c3696-af4d-4137-a3ac-41a29f90a870" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InventoryLineItems_96a8a78f-7b7c-4773-b674-61a31525f112" xlink:to="loc_us-gaap_InventoryWriteDown_731c3696-af4d-4137-a3ac-41a29f90a870" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves_76b439b9-b828-4bb7-9204-1810cea712d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryValuationReserves"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InventoryLineItems_96a8a78f-7b7c-4773-b674-61a31525f112" xlink:to="loc_us-gaap_InventoryValuationReserves_76b439b9-b828-4bb7-9204-1810cea712d3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryCurrentTable_5ea2a494-0b6e-4f05-bc8a-4145aef3a9ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryCurrentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_InventoryLineItems_96a8a78f-7b7c-4773-b674-61a31525f112" xlink:to="loc_us-gaap_InventoryCurrentTable_5ea2a494-0b6e-4f05-bc8a-4145aef3a9ad" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PublicUtilitiesInventoryAxis_4c60d2ae-9f8e-4c3e-b43d-16f8d637d3a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PublicUtilitiesInventoryAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_InventoryCurrentTable_5ea2a494-0b6e-4f05-bc8a-4145aef3a9ad" xlink:to="loc_us-gaap_PublicUtilitiesInventoryAxis_4c60d2ae-9f8e-4c3e-b43d-16f8d637d3a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_4c60d2ae-9f8e-4c3e-b43d-16f8d637d3a9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PublicUtilitiesInventoryTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PublicUtilitiesInventoryAxis_4c60d2ae-9f8e-4c3e-b43d-16f8d637d3a9" xlink:to="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_4c60d2ae-9f8e-4c3e-b43d-16f8d637d3a9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_6ef7c3d5-e2a4-40f9-a522-345f56c1fbc0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PublicUtilitiesInventoryTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PublicUtilitiesInventoryAxis_4c60d2ae-9f8e-4c3e-b43d-16f8d637d3a9" xlink:to="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_6ef7c3d5-e2a4-40f9-a522-345f56c1fbc0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InventoryDryCannabisMember_16c039a7-9899-43a8-8ae8-ce803d078000" xlink:href="cron-20201231.xsd#cron_InventoryDryCannabisMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_6ef7c3d5-e2a4-40f9-a522-345f56c1fbc0" xlink:to="loc_cron_InventoryDryCannabisMember_16c039a7-9899-43a8-8ae8-ce803d078000" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InventoryCannabisExtractsMember_5bd00943-f580-443d-97c4-983f48b2a4b6" xlink:href="cron-20201231.xsd#cron_InventoryCannabisExtractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_6ef7c3d5-e2a4-40f9-a522-345f56c1fbc0" xlink:to="loc_cron_InventoryCannabisExtractsMember_5bd00943-f580-443d-97c4-983f48b2a4b6" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/Investments" xlink:type="simple" xlink:href="cron-20201231.xsd#Investments"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/Investments" xlink:type="extended" id="i79aa2eaf89d74a8fb723a448524b301a_Investments"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/InvestmentsTables" xlink:type="simple" xlink:href="cron-20201231.xsd#InvestmentsTables"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/InvestmentsTables" xlink:type="extended" id="i5bfa66761f0b4619a49e0f2062ebc46e_InvestmentsTables"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/InvestmentsNarrativeDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#InvestmentsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/InvestmentsNarrativeDetails" xlink:type="extended" id="i8d95a03cce16487c9b927a011b9f4efd_InvestmentsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_6a9e692b-5b84-42c8-9573-9471dcda9374" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityOwnershipPercentage_e6f9a358-e967-4010-8945-773925c57424" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_6a9e692b-5b84-42c8-9573-9471dcda9374" xlink:to="loc_us-gaap_VariableInterestEntityOwnershipPercentage_e6f9a358-e967-4010-8945-773925c57424" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_VariableInterestEntityQualitativeOrQuantitativeInformationLicenseTerm_d92390ba-78f4-4ece-b4f8-c7f06ac0c9bd" xlink:href="cron-20201231.xsd#cron_VariableInterestEntityQualitativeOrQuantitativeInformationLicenseTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_6a9e692b-5b84-42c8-9573-9471dcda9374" xlink:to="loc_cron_VariableInterestEntityQualitativeOrQuantitativeInformationLicenseTerm_d92390ba-78f4-4ece-b4f8-c7f06ac0c9bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CollaborativeArrangementAmountOfAdvances_53de1c5f-dc6a-47cb-8910-a6a488fd525a" xlink:href="cron-20201231.xsd#cron_CollaborativeArrangementAmountOfAdvances"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_6a9e692b-5b84-42c8-9573-9471dcda9374" xlink:to="loc_cron_CollaborativeArrangementAmountOfAdvances_53de1c5f-dc6a-47cb-8910-a6a488fd525a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CollaborativeArrangementTermOfAgreement_589caa1b-f540-4ccf-b0c5-1b570562b1da" xlink:href="cron-20201231.xsd#cron_CollaborativeArrangementTermOfAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_6a9e692b-5b84-42c8-9573-9471dcda9374" xlink:to="loc_cron_CollaborativeArrangementTermOfAgreement_589caa1b-f540-4ccf-b0c5-1b570562b1da" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_5567eb5e-c7a1-47dd-a362-222b5ed07069" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_6a9e692b-5b84-42c8-9573-9471dcda9374" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_5567eb5e-c7a1-47dd-a362-222b5ed07069" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CollaborativeArrangementPercentageOfProfitsToBeReceived_c44612aa-2ee7-41e2-9373-18151069465b" xlink:href="cron-20201231.xsd#cron_CollaborativeArrangementPercentageOfProfitsToBeReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_6a9e692b-5b84-42c8-9573-9471dcda9374" xlink:to="loc_cron_CollaborativeArrangementPercentageOfProfitsToBeReceived_c44612aa-2ee7-41e2-9373-18151069465b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced_b1c3c4aa-8c6a-4658-8929-e9b408cc3066" xlink:href="cron-20201231.xsd#cron_CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_6a9e692b-5b84-42c8-9573-9471dcda9374" xlink:to="loc_cron_CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced_b1c3c4aa-8c6a-4658-8929-e9b408cc3066" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet_6df051d7-505c-4a71-bbf7-8ccf893807cc" xlink:href="cron-20201231.xsd#cron_CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_6a9e692b-5b84-42c8-9573-9471dcda9374" xlink:to="loc_cron_CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet_6df051d7-505c-4a71-bbf7-8ccf893807cc" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_b6c22675-fb6d-48e1-811e-2b4efba2b5ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_6a9e692b-5b84-42c8-9573-9471dcda9374" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_b6c22675-fb6d-48e1-811e-2b4efba2b5ed" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_937c3913-5b1b-4713-94cd-b4b8b9fe04a6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_b6c22675-fb6d-48e1-811e-2b4efba2b5ed" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_937c3913-5b1b-4713-94cd-b4b8b9fe04a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_937c3913-5b1b-4713-94cd-b4b8b9fe04a6_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_937c3913-5b1b-4713-94cd-b4b8b9fe04a6" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_937c3913-5b1b-4713-94cd-b4b8b9fe04a6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_2e36b297-3bf5-4c5f-86dc-904d716f2921" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_937c3913-5b1b-4713-94cd-b4b8b9fe04a6" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_2e36b297-3bf5-4c5f-86dc-904d716f2921" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosGrowingCompanyInc.Member_0d309318-4909-470e-ab1b-a4cfec0ab8e9" xlink:href="cron-20201231.xsd#cron_CronosGrowingCompanyInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_2e36b297-3bf5-4c5f-86dc-904d716f2921" xlink:to="loc_cron_CronosGrowingCompanyInc.Member_0d309318-4909-470e-ab1b-a4cfec0ab8e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_MedMenCanadaInc.Member_85bffc9e-0ff2-4fa5-be98-7c45e3af4e48" xlink:href="cron-20201231.xsd#cron_MedMenCanadaInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_2e36b297-3bf5-4c5f-86dc-904d716f2921" xlink:to="loc_cron_MedMenCanadaInc.Member_85bffc9e-0ff2-4fa5-be98-7c45e3af4e48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NatuEraMember_d3d3077e-9e1c-4ac1-848f-b7f4524588af" xlink:href="cron-20201231.xsd#cron_NatuEraMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_2e36b297-3bf5-4c5f-86dc-904d716f2921" xlink:to="loc_cron_NatuEraMember_d3d3077e-9e1c-4ac1-848f-b7f4524588af" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CannasoulAnalyticsLtdMember_3c844b1b-10c2-4a02-b46c-fbe06f9a0ada" xlink:href="cron-20201231.xsd#cron_CannasoulAnalyticsLtdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_2e36b297-3bf5-4c5f-86dc-904d716f2921" xlink:to="loc_cron_CannasoulAnalyticsLtdMember_3c844b1b-10c2-4a02-b46c-fbe06f9a0ada" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosAustraliaLimitedMember_0faff6ef-f494-41b7-944a-5140cefbadb9" xlink:href="cron-20201231.xsd#cron_CronosAustraliaLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_2e36b297-3bf5-4c5f-86dc-904d716f2921" xlink:to="loc_cron_CronosAustraliaLimitedMember_0faff6ef-f494-41b7-944a-5140cefbadb9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_3d1051e4-4e92-443e-a902-811dfd641ca1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_b6c22675-fb6d-48e1-811e-2b4efba2b5ed" xlink:to="loc_us-gaap_TypeOfArrangementAxis_3d1051e4-4e92-443e-a902-811dfd641ca1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_3d1051e4-4e92-443e-a902-811dfd641ca1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_3d1051e4-4e92-443e-a902-811dfd641ca1" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_3d1051e4-4e92-443e-a902-811dfd641ca1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_2b7c76e2-3bc0-43fa-8efe-ce808f3b3919" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_3d1051e4-4e92-443e-a902-811dfd641ca1" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_2b7c76e2-3bc0-43fa-8efe-ce808f3b3919" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_c888f7b7-343c-4b82-b17d-2d7928d46494" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_2b7c76e2-3bc0-43fa-8efe-ce808f3b3919" xlink:to="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_c888f7b7-343c-4b82-b17d-2d7928d46494" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_88670b80-7289-42ec-9486-5736f1e825d4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_b6c22675-fb6d-48e1-811e-2b4efba2b5ed" xlink:to="loc_srt_RangeAxis_88670b80-7289-42ec-9486-5736f1e825d4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_88670b80-7289-42ec-9486-5736f1e825d4_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_88670b80-7289-42ec-9486-5736f1e825d4" xlink:to="loc_srt_RangeMember_88670b80-7289-42ec-9486-5736f1e825d4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_31501921-25ea-49ac-baa8-56f8e51e8295" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_88670b80-7289-42ec-9486-5736f1e825d4" xlink:to="loc_srt_RangeMember_31501921-25ea-49ac-baa8-56f8e51e8295" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_66972fde-e37a-4a4f-b3e0-110803e11b99" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_31501921-25ea-49ac-baa8-56f8e51e8295" xlink:to="loc_srt_MinimumMember_66972fde-e37a-4a4f-b3e0-110803e11b99" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LoanReceivableNameAxis_f0af95a7-b4c2-4bbb-a489-4c69fb656789" xlink:href="cron-20201231.xsd#cron_LoanReceivableNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_b6c22675-fb6d-48e1-811e-2b4efba2b5ed" xlink:to="loc_cron_LoanReceivableNameAxis_f0af95a7-b4c2-4bbb-a489-4c69fb656789" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LoanReceivableNameDomain_f0af95a7-b4c2-4bbb-a489-4c69fb656789_default" xlink:href="cron-20201231.xsd#cron_LoanReceivableNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cron_LoanReceivableNameAxis_f0af95a7-b4c2-4bbb-a489-4c69fb656789" xlink:to="loc_cron_LoanReceivableNameDomain_f0af95a7-b4c2-4bbb-a489-4c69fb656789_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LoanReceivableNameDomain_a73650a4-968b-4419-9c78-b960da5162a8" xlink:href="cron-20201231.xsd#cron_LoanReceivableNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cron_LoanReceivableNameAxis_f0af95a7-b4c2-4bbb-a489-4c69fb656789" xlink:to="loc_cron_LoanReceivableNameDomain_a73650a4-968b-4419-9c78-b960da5162a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CannasoulCollaborationLoanMember_ad15f97d-b704-4657-9053-187d9145650b" xlink:href="cron-20201231.xsd#cron_CannasoulCollaborationLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_LoanReceivableNameDomain_a73650a4-968b-4419-9c78-b960da5162a8" xlink:to="loc_cron_CannasoulCollaborationLoanMember_ad15f97d-b704-4657-9053-187d9145650b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_39e38ec5-4360-4b85-87bd-b841eaa27bc9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_b6c22675-fb6d-48e1-811e-2b4efba2b5ed" xlink:to="loc_srt_ConsolidatedEntitiesAxis_39e38ec5-4360-4b85-87bd-b841eaa27bc9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_39e38ec5-4360-4b85-87bd-b841eaa27bc9_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_39e38ec5-4360-4b85-87bd-b841eaa27bc9" xlink:to="loc_srt_ConsolidatedEntitiesDomain_39e38ec5-4360-4b85-87bd-b841eaa27bc9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_b755f7ec-193d-47fb-88f2-9093856990bb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_39e38ec5-4360-4b85-87bd-b841eaa27bc9" xlink:to="loc_srt_ConsolidatedEntitiesDomain_b755f7ec-193d-47fb-88f2-9093856990bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_cbbe21eb-71f8-4ce3-9f17-6f789752e0d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_b755f7ec-193d-47fb-88f2-9093856990bb" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_cbbe21eb-71f8-4ce3-9f17-6f789752e0d3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_512b6a36-6e87-46f2-8689-759e4988d4d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_b6c22675-fb6d-48e1-811e-2b4efba2b5ed" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_512b6a36-6e87-46f2-8689-759e4988d4d2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_512b6a36-6e87-46f2-8689-759e4988d4d2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_512b6a36-6e87-46f2-8689-759e4988d4d2" xlink:to="loc_us-gaap_ReceivableTypeDomain_512b6a36-6e87-46f2-8689-759e4988d4d2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_37f5e26d-68b3-4ada-8b60-8d3ec09b9237" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_512b6a36-6e87-46f2-8689-759e4988d4d2" xlink:to="loc_us-gaap_ReceivableTypeDomain_37f5e26d-68b3-4ada-8b60-8d3ec09b9237" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansReceivableMember_53389b92-0325-49bb-9763-9cd0f7c5068a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReceivableTypeDomain_37f5e26d-68b3-4ada-8b60-8d3ec09b9237" xlink:to="loc_us-gaap_LoansReceivableMember_53389b92-0325-49bb-9763-9cd0f7c5068a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/InvestmentsScheduleofEquityMethodInvestmentsDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#InvestmentsScheduleofEquityMethodInvestmentsDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/InvestmentsScheduleofEquityMethodInvestmentsDetails" xlink:type="extended" id="ia0126979835d4be2932cd0b427879c4a_InvestmentsScheduleofEquityMethodInvestmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_329057b9-9bb0-41a4-9df2-842fc41d6cc3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_62ef0783-a50f-48ba-804d-72c4df1ecacc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_329057b9-9bb0-41a4-9df2-842fc41d6cc3" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_62ef0783-a50f-48ba-804d-72c4df1ecacc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_ada33754-0e25-45e0-b65b-35b8bf58c99e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_329057b9-9bb0-41a4-9df2-842fc41d6cc3" xlink:to="loc_us-gaap_EquityMethodInvestments_ada33754-0e25-45e0-b65b-35b8bf58c99e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_78f83a11-2bc8-48d3-a02b-0a9449e8da1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_329057b9-9bb0-41a4-9df2-842fc41d6cc3" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_78f83a11-2bc8-48d3-a02b-0a9449e8da1f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_2aafa7fd-2d7c-423f-a592-383250f5baf9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_329057b9-9bb0-41a4-9df2-842fc41d6cc3" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_2aafa7fd-2d7c-423f-a592-383250f5baf9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityOwnershipPercentage_072ae7c0-567e-42e6-9cf2-6375737b1703" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_329057b9-9bb0-41a4-9df2-842fc41d6cc3" xlink:to="loc_us-gaap_VariableInterestEntityOwnershipPercentage_072ae7c0-567e-42e6-9cf2-6375737b1703" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments_1ffd60bc-ca5e-41ad-b7a1-3740dfff99e2" xlink:href="cron-20201231.xsd#cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_329057b9-9bb0-41a4-9df2-842fc41d6cc3" xlink:to="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments_1ffd60bc-ca5e-41ad-b7a1-3740dfff99e2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage_d1da36eb-e7fb-4f62-a199-7b631ce53420" xlink:href="cron-20201231.xsd#cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_329057b9-9bb0-41a4-9df2-842fc41d6cc3" xlink:to="loc_cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage_d1da36eb-e7fb-4f62-a199-7b631ce53420" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees_f4920af3-09f5-4fee-b78d-8937809a6679" xlink:href="cron-20201231.xsd#cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_329057b9-9bb0-41a4-9df2-842fc41d6cc3" xlink:to="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees_f4920af3-09f5-4fee-b78d-8937809a6679" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_07e78d0c-f3c5-467d-9089-715f69fe0c08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_329057b9-9bb0-41a4-9df2-842fc41d6cc3" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_07e78d0c-f3c5-467d-9089-715f69fe0c08" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAbstract_f51db5c4-707f-43cf-b667-72a657c6c321" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_329057b9-9bb0-41a4-9df2-842fc41d6cc3" xlink:to="loc_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAbstract_f51db5c4-707f-43cf-b667-72a657c6c321" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_3aa23f91-d8dc-4e07-8e5b-0908f3091dac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAbstract_f51db5c4-707f-43cf-b667-72a657c6c321" xlink:to="loc_us-gaap_AssetsCurrent_3aa23f91-d8dc-4e07-8e5b-0908f3091dac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent_67b90a5c-a534-4669-aacb-ac3c1670f4f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAbstract_f51db5c4-707f-43cf-b667-72a657c6c321" xlink:to="loc_us-gaap_AssetsNoncurrent_67b90a5c-a534-4669-aacb-ac3c1670f4f9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_05eea4ac-dc9a-407f-af48-0c6ec2953a1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAbstract_f51db5c4-707f-43cf-b667-72a657c6c321" xlink:to="loc_us-gaap_LiabilitiesCurrent_05eea4ac-dc9a-407f-af48-0c6ec2953a1a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_e99cc059-8484-422b-9275-d15c56610646" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAbstract_f51db5c4-707f-43cf-b667-72a657c6c321" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_e99cc059-8484-422b-9275-d15c56610646" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_d285a007-fdb5-4bbc-a9c2-215cf3479b5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_329057b9-9bb0-41a4-9df2-842fc41d6cc3" xlink:to="loc_us-gaap_IncomeStatementAbstract_d285a007-fdb5-4bbc-a9c2-215cf3479b5f" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7201d15d-3c97-4436-841a-b3cdb39133d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract_d285a007-fdb5-4bbc-a9c2-215cf3479b5f" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7201d15d-3c97-4436-841a-b3cdb39133d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_5044950e-d4c5-4d28-8668-ce366dda978b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract_d285a007-fdb5-4bbc-a9c2-215cf3479b5f" xlink:to="loc_us-gaap_GrossProfit_5044950e-d4c5-4d28-8668-ce366dda978b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_14e33980-5215-4b9e-92e6-0977b0ada0a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract_d285a007-fdb5-4bbc-a9c2-215cf3479b5f" xlink:to="loc_us-gaap_ProfitLoss_14e33980-5215-4b9e-92e6-0977b0ada0a0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_5e0be92e-53db-4ed4-8180-f80536c98d6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_329057b9-9bb0-41a4-9df2-842fc41d6cc3" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_5e0be92e-53db-4ed4-8180-f80536c98d6e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_93128868-da03-4140-bdb8-22e00e834b2e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_5e0be92e-53db-4ed4-8180-f80536c98d6e" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_93128868-da03-4140-bdb8-22e00e834b2e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_93128868-da03-4140-bdb8-22e00e834b2e_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_93128868-da03-4140-bdb8-22e00e834b2e" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_93128868-da03-4140-bdb8-22e00e834b2e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_d46ee047-1861-42ea-b272-2e6276d25984" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_93128868-da03-4140-bdb8-22e00e834b2e" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_d46ee047-1861-42ea-b272-2e6276d25984" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosAustraliaLimitedMember_27967178-2766-46ea-8ea6-bf98fd0a4f6c" xlink:href="cron-20201231.xsd#cron_CronosAustraliaLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_d46ee047-1861-42ea-b272-2e6276d25984" xlink:to="loc_cron_CronosAustraliaLimitedMember_27967178-2766-46ea-8ea6-bf98fd0a4f6c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosGrowingCompanyInc.Member_feca796e-1788-4a1a-b8e2-e26a4c9f43d4" xlink:href="cron-20201231.xsd#cron_CronosGrowingCompanyInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_d46ee047-1861-42ea-b272-2e6276d25984" xlink:to="loc_cron_CronosGrowingCompanyInc.Member_feca796e-1788-4a1a-b8e2-e26a4c9f43d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NatuEraMember_5f6dd485-bd45-4f8b-b9ec-2e04709e775c" xlink:href="cron-20201231.xsd#cron_NatuEraMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_d46ee047-1861-42ea-b272-2e6276d25984" xlink:to="loc_cron_NatuEraMember_5f6dd485-bd45-4f8b-b9ec-2e04709e775c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_WhistlerMedicalMarijuanaCompanyMember_59c10ee5-86a5-4375-877a-34e08b619f2b" xlink:href="cron-20201231.xsd#cron_WhistlerMedicalMarijuanaCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_d46ee047-1861-42ea-b272-2e6276d25984" xlink:to="loc_cron_WhistlerMedicalMarijuanaCompanyMember_59c10ee5-86a5-4375-877a-34e08b619f2b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_MedMenCanadaInc.Member_ef78d431-623c-4769-aafe-d7380120b803" xlink:href="cron-20201231.xsd#cron_MedMenCanadaInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_d46ee047-1861-42ea-b272-2e6276d25984" xlink:to="loc_cron_MedMenCanadaInc.Member_ef78d431-623c-4769-aafe-d7380120b803" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_e126f095-d46b-4e5a-9cbb-9bab495666d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_5e0be92e-53db-4ed4-8180-f80536c98d6e" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_e126f095-d46b-4e5a-9cbb-9bab495666d3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e126f095-d46b-4e5a-9cbb-9bab495666d3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_e126f095-d46b-4e5a-9cbb-9bab495666d3" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e126f095-d46b-4e5a-9cbb-9bab495666d3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_7741fa26-0fcb-488b-98c9-3593b3a286c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_e126f095-d46b-4e5a-9cbb-9bab495666d3" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_7741fa26-0fcb-488b-98c9-3593b3a286c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_9e4f9c81-6f17-4d30-b1eb-b960c5196c7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IPOMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_7741fa26-0fcb-488b-98c9-3593b3a286c9" xlink:to="loc_us-gaap_IPOMember_9e4f9c81-6f17-4d30-b1eb-b960c5196c7b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_a8549a2c-b321-4050-917d-f73a821adcb1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_5e0be92e-53db-4ed4-8180-f80536c98d6e" xlink:to="loc_dei_LegalEntityAxis_a8549a2c-b321-4050-917d-f73a821adcb1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_a8549a2c-b321-4050-917d-f73a821adcb1_default" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_a8549a2c-b321-4050-917d-f73a821adcb1" xlink:to="loc_dei_EntityDomain_a8549a2c-b321-4050-917d-f73a821adcb1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_738b380f-cd04-4da5-8f0a-e9e75fbc009e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_a8549a2c-b321-4050-917d-f73a821adcb1" xlink:to="loc_dei_EntityDomain_738b380f-cd04-4da5-8f0a-e9e75fbc009e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosAustraliaLimitedMember_4a3d9f66-95c4-4d84-8658-f480a47eb495" xlink:href="cron-20201231.xsd#cron_CronosAustraliaLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_738b380f-cd04-4da5-8f0a-e9e75fbc009e" xlink:to="loc_cron_CronosAustraliaLimitedMember_4a3d9f66-95c4-4d84-8658-f480a47eb495" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosGroupInc.Member_db332b38-ed92-456d-8a0c-4f231d315a19" xlink:href="cron-20201231.xsd#cron_CronosGroupInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_738b380f-cd04-4da5-8f0a-e9e75fbc009e" xlink:to="loc_cron_CronosGroupInc.Member_db332b38-ed92-456d-8a0c-4f231d315a19" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_MucciMember_5b6d1785-94d5-42f4-ba8b-4686435a1688" xlink:href="cron-20201231.xsd#cron_MucciMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_738b380f-cd04-4da5-8f0a-e9e75fbc009e" xlink:to="loc_cron_MucciMember_5b6d1785-94d5-42f4-ba8b-4686435a1688" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_c675f0a0-d872-49b5-afef-0089ef530b92" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_5e0be92e-53db-4ed4-8180-f80536c98d6e" xlink:to="loc_srt_ConsolidatedEntitiesAxis_c675f0a0-d872-49b5-afef-0089ef530b92" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_c675f0a0-d872-49b5-afef-0089ef530b92_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_c675f0a0-d872-49b5-afef-0089ef530b92" xlink:to="loc_srt_ConsolidatedEntitiesDomain_c675f0a0-d872-49b5-afef-0089ef530b92_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_6b2db0e5-2f14-4985-a591-2947af1b5e80" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_c675f0a0-d872-49b5-afef-0089ef530b92" xlink:to="loc_srt_ConsolidatedEntitiesDomain_6b2db0e5-2f14-4985-a591-2947af1b5e80" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_868a54dc-425a-4b43-ac01-6263100e09f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_6b2db0e5-2f14-4985-a591-2947af1b5e80" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_868a54dc-425a-4b43-ac01-6263100e09f4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_53c19833-7748-46ee-84a5-3ff8433ce48a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_5e0be92e-53db-4ed4-8180-f80536c98d6e" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_53c19833-7748-46ee-84a5-3ff8433ce48a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_53c19833-7748-46ee-84a5-3ff8433ce48a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_53c19833-7748-46ee-84a5-3ff8433ce48a" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_53c19833-7748-46ee-84a5-3ff8433ce48a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_e2dcc4a1-392d-456d-864f-6e17e388374c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_53c19833-7748-46ee-84a5-3ff8433ce48a" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_e2dcc4a1-392d-456d-864f-6e17e388374c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember_376d058a-24bd-4573-bbf9-89766a87d706" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_e2dcc4a1-392d-456d-864f-6e17e388374c" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember_376d058a-24bd-4573-bbf9-89766a87d706" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/InvestmentsScheduleofAdvancestoJointVenturesDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#InvestmentsScheduleofAdvancestoJointVenturesDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/InvestmentsScheduleofAdvancestoJointVenturesDetails" xlink:type="extended" id="iccb418edee454e969b74ca4091dcabd5_InvestmentsScheduleofAdvancestoJointVenturesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_7a7ad6df-3169-4368-8caf-1f52937f2e74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward_3c3f5984-9d60-4323-8e53-8f0d36164663" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_7a7ad6df-3169-4368-8caf-1f52937f2e74" xlink:to="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward_3c3f5984-9d60-4323-8e53-8f0d36164663" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvancesToAffiliate_d7705216-1f03-4b07-bd3f-4e14b9377198" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdvancesToAffiliate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward_3c3f5984-9d60-4323-8e53-8f0d36164663" xlink:to="loc_us-gaap_AdvancesToAffiliate_d7705216-1f03-4b07-bd3f-4e14b9377198" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees_1c765b1f-669c-4cef-88f9-46edcd612208" xlink:href="cron-20201231.xsd#cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward_3c3f5984-9d60-4323-8e53-8f0d36164663" xlink:to="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees_1c765b1f-669c-4cef-88f9-46edcd612208" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueInterestOnAdvances_de0f3621-ff3d-429d-92bb-77e712a48e6a" xlink:href="cron-20201231.xsd#cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueInterestOnAdvances"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward_3c3f5984-9d60-4323-8e53-8f0d36164663" xlink:to="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueInterestOnAdvances_de0f3621-ff3d-429d-92bb-77e712a48e6a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments_2fa36c74-5cd6-4e8e-b878-b9132c61e5bd" xlink:href="cron-20201231.xsd#cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward_3c3f5984-9d60-4323-8e53-8f0d36164663" xlink:to="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments_2fa36c74-5cd6-4e8e-b878-b9132c61e5bd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueRecoveredFromAppliedToEquityMethodInvestment_d6bb0f2b-d126-46b6-9239-da482ac4144e" xlink:href="cron-20201231.xsd#cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueRecoveredFromAppliedToEquityMethodInvestment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward_3c3f5984-9d60-4323-8e53-8f0d36164663" xlink:to="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueRecoveredFromAppliedToEquityMethodInvestment_d6bb0f2b-d126-46b6-9239-da482ac4144e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueChangesDueToCurrencyTranslation_b8d463a3-5f8e-4f8e-b51c-7a9b40f07504" xlink:href="cron-20201231.xsd#cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueChangesDueToCurrencyTranslation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward_3c3f5984-9d60-4323-8e53-8f0d36164663" xlink:to="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueChangesDueToCurrencyTranslation_b8d463a3-5f8e-4f8e-b51c-7a9b40f07504" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvancesToAffiliate_76031ed3-d279-4121-9cfe-9de20e010f3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdvancesToAffiliate"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentsInAndAdvancesToAffiliatesDebtInstrumentFaceAmount_25153f70-4612-44a2-969d-a481a06fd370" xlink:href="cron-20201231.xsd#cron_InvestmentsInAndAdvancesToAffiliatesDebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_7a7ad6df-3169-4368-8caf-1f52937f2e74" xlink:to="loc_cron_InvestmentsInAndAdvancesToAffiliatesDebtInstrumentFaceAmount_25153f70-4612-44a2-969d-a481a06fd370" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_0a6530cf-1f71-4ed5-9814-e7a7bba7194a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_7a7ad6df-3169-4368-8caf-1f52937f2e74" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_0a6530cf-1f71-4ed5-9814-e7a7bba7194a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DebtInstrumentPastDueAdditionalInterestRateStatedPercentage_c39c0ca9-7d5f-4aac-aaf1-a5b76a2bec35" xlink:href="cron-20201231.xsd#cron_DebtInstrumentPastDueAdditionalInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_7a7ad6df-3169-4368-8caf-1f52937f2e74" xlink:to="loc_cron_DebtInstrumentPastDueAdditionalInterestRateStatedPercentage_c39c0ca9-7d5f-4aac-aaf1-a5b76a2bec35" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_6053e44b-317b-4216-9487-acac509abfbd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_7a7ad6df-3169-4368-8caf-1f52937f2e74" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_6053e44b-317b-4216-9487-acac509abfbd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_bd24a0ad-1d68-49e0-83b6-5ad4c78d75f6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_6053e44b-317b-4216-9487-acac509abfbd" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_bd24a0ad-1d68-49e0-83b6-5ad4c78d75f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_bd24a0ad-1d68-49e0-83b6-5ad4c78d75f6_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_bd24a0ad-1d68-49e0-83b6-5ad4c78d75f6" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_bd24a0ad-1d68-49e0-83b6-5ad4c78d75f6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_4c6ba522-4e56-4fe5-a36c-c81660992597" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_bd24a0ad-1d68-49e0-83b6-5ad4c78d75f6" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_4c6ba522-4e56-4fe5-a36c-c81660992597" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_MedMenCanadaInc.Member_833be9ac-b194-42f4-a753-9b7ba26b8c23" xlink:href="cron-20201231.xsd#cron_MedMenCanadaInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_4c6ba522-4e56-4fe5-a36c-c81660992597" xlink:to="loc_cron_MedMenCanadaInc.Member_833be9ac-b194-42f4-a753-9b7ba26b8c23" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosGrowingCompanyInc.Member_8a37f561-335f-454e-8faa-dadd201ecea9" xlink:href="cron-20201231.xsd#cron_CronosGrowingCompanyInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_4c6ba522-4e56-4fe5-a36c-c81660992597" xlink:to="loc_cron_CronosGrowingCompanyInc.Member_8a37f561-335f-454e-8faa-dadd201ecea9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosAustraliaLimitedMember_31d9bb5b-f8d9-491a-9bf2-4d7999b689ca" xlink:href="cron-20201231.xsd#cron_CronosAustraliaLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_4c6ba522-4e56-4fe5-a36c-c81660992597" xlink:to="loc_cron_CronosAustraliaLimitedMember_31d9bb5b-f8d9-491a-9bf2-4d7999b689ca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NatuEraMember_078b9322-af06-48b2-963c-f7581526d14f" xlink:href="cron-20201231.xsd#cron_NatuEraMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_4c6ba522-4e56-4fe5-a36c-c81660992597" xlink:to="loc_cron_NatuEraMember_078b9322-af06-48b2-963c-f7581526d14f" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/InvestmentsScheduleofVariableInterestEntitiesDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#InvestmentsScheduleofVariableInterestEntitiesDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/InvestmentsScheduleofVariableInterestEntitiesDetails" xlink:type="extended" id="i6e28cdc39a1d401889dcc81198893442_InvestmentsScheduleofVariableInterestEntitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_eeb36034-811a-4834-9ab5-1252a8a9c331" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityOwnershipPercentage_b0d4cf03-e255-4fb7-87f0-e34140a70098" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_eeb36034-811a-4834-9ab5-1252a8a9c331" xlink:to="loc_us-gaap_VariableInterestEntityOwnershipPercentage_b0d4cf03-e255-4fb7-87f0-e34140a70098" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_OtherNetAssetsLiabilities_c9dbbb3d-2830-49a3-8db6-6f3efa9c94b6" xlink:href="cron-20201231.xsd#cron_OtherNetAssetsLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_eeb36034-811a-4834-9ab5-1252a8a9c331" xlink:to="loc_cron_OtherNetAssetsLiabilities_c9dbbb3d-2830-49a3-8db6-6f3efa9c94b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_ec3686f4-d3cf-4b2f-bc3f-e44370634815" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_eeb36034-811a-4834-9ab5-1252a8a9c331" xlink:to="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_ec3686f4-d3cf-4b2f-bc3f-e44370634815" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_ed92fca8-1cf8-450d-aed9-c5a8f9ea0294" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_eeb36034-811a-4834-9ab5-1252a8a9c331" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_ed92fca8-1cf8-450d-aed9-c5a8f9ea0294" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7d8cf170-53a8-4e63-9785-ca11c6415f9f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_ed92fca8-1cf8-450d-aed9-c5a8f9ea0294" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7d8cf170-53a8-4e63-9785-ca11c6415f9f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_7d8cf170-53a8-4e63-9785-ca11c6415f9f_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7d8cf170-53a8-4e63-9785-ca11c6415f9f" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_7d8cf170-53a8-4e63-9785-ca11c6415f9f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_ef2d77eb-39f3-4e92-bbeb-dcb3daeef425" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7d8cf170-53a8-4e63-9785-ca11c6415f9f" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_ef2d77eb-39f3-4e92-bbeb-dcb3daeef425" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosAustraliaLimitedMember_9652fb63-f43b-4d66-b9d2-b71f0e909895" xlink:href="cron-20201231.xsd#cron_CronosAustraliaLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_ef2d77eb-39f3-4e92-bbeb-dcb3daeef425" xlink:to="loc_cron_CronosAustraliaLimitedMember_9652fb63-f43b-4d66-b9d2-b71f0e909895" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosGrowingCompanyInc.Member_e8426f19-ca9e-49e4-a4fe-32770394e344" xlink:href="cron-20201231.xsd#cron_CronosGrowingCompanyInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_ef2d77eb-39f3-4e92-bbeb-dcb3daeef425" xlink:to="loc_cron_CronosGrowingCompanyInc.Member_e8426f19-ca9e-49e4-a4fe-32770394e344" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_MedMenCanadaInc.Member_23519e17-ab69-4826-87cf-334e56ecbc91" xlink:href="cron-20201231.xsd#cron_MedMenCanadaInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_ef2d77eb-39f3-4e92-bbeb-dcb3daeef425" xlink:to="loc_cron_MedMenCanadaInc.Member_23519e17-ab69-4826-87cf-334e56ecbc91" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NatuEraMember_2bb8c90c-36ca-4e15-aa4d-c3874d37f624" xlink:href="cron-20201231.xsd#cron_NatuEraMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_ef2d77eb-39f3-4e92-bbeb-dcb3daeef425" xlink:to="loc_cron_NatuEraMember_2bb8c90c-36ca-4e15-aa4d-c3874d37f624" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_912bb7a8-209d-460a-a239-04ff30a896e0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_ed92fca8-1cf8-450d-aed9-c5a8f9ea0294" xlink:to="loc_srt_ConsolidatedEntitiesAxis_912bb7a8-209d-460a-a239-04ff30a896e0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_912bb7a8-209d-460a-a239-04ff30a896e0_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_912bb7a8-209d-460a-a239-04ff30a896e0" xlink:to="loc_srt_ConsolidatedEntitiesDomain_912bb7a8-209d-460a-a239-04ff30a896e0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_d33ac962-b17e-4d83-a72b-ff3d3c0e419c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_912bb7a8-209d-460a-a239-04ff30a896e0" xlink:to="loc_srt_ConsolidatedEntitiesDomain_d33ac962-b17e-4d83-a72b-ff3d3c0e419c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_3e787f62-a353-4e78-b288-5a6a6d00b44a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_d33ac962-b17e-4d83-a72b-ff3d3c0e419c" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_3e787f62-a353-4e78-b288-5a6a6d00b44a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/OtherInvestments" xlink:type="simple" xlink:href="cron-20201231.xsd#OtherInvestments"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/OtherInvestments" xlink:type="extended" id="i5a26a5c8a19f464ca020e0b662b73e3d_OtherInvestments"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/OtherInvestmentsTables" xlink:type="simple" xlink:href="cron-20201231.xsd#OtherInvestmentsTables"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/OtherInvestmentsTables" xlink:type="extended" id="ib9d34513d2854b3687dbf71257a32cc0_OtherInvestmentsTables"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/OtherInvestmentsSummaryofOtherInvestmentsDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#OtherInvestmentsSummaryofOtherInvestmentsDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/OtherInvestmentsSummaryofOtherInvestmentsDetails" xlink:type="extended" id="i8f49dfbac5794a7dbbe60fb31f95e59d_OtherInvestmentsSummaryofOtherInvestmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_dea03238-552b-49de-b235-7ae1f393ca7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_3e2b8b4b-8696-4679-9eed-1bb29170f45b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_dea03238-552b-49de-b235-7ae1f393ca7e" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_3e2b8b4b-8696-4679-9eed-1bb29170f45b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentOwnedNumberOfSharesSold_8a242e88-235b-41c5-b44a-d9f96b5af284" xlink:href="cron-20201231.xsd#cron_InvestmentOwnedNumberOfSharesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_dea03238-552b-49de-b235-7ae1f393ca7e" xlink:to="loc_cron_InvestmentOwnedNumberOfSharesSold_8a242e88-235b-41c5-b44a-d9f96b5af284" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ProceedsFromSaleOfEquitySecuritiesFVNI_87662c0d-d6af-40e4-8d77-f1f42381a47c" xlink:href="cron-20201231.xsd#cron_ProceedsFromSaleOfEquitySecuritiesFVNI"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_dea03238-552b-49de-b235-7ae1f393ca7e" xlink:to="loc_cron_ProceedsFromSaleOfEquitySecuritiesFVNI_87662c0d-d6af-40e4-8d77-f1f42381a47c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentOwnedNumberOfWarrantsExercised_d2781b8b-1703-41e8-8cf6-7ab49a588fe1" xlink:href="cron-20201231.xsd#cron_InvestmentOwnedNumberOfWarrantsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_dea03238-552b-49de-b235-7ae1f393ca7e" xlink:to="loc_cron_InvestmentOwnedNumberOfWarrantsExercised_d2781b8b-1703-41e8-8cf6-7ab49a588fe1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PaymentsToExerciseWarrants_ee2fa9b3-d264-4982-ac3f-472e1e35f586" xlink:href="cron-20201231.xsd#cron_PaymentsToExerciseWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_dea03238-552b-49de-b235-7ae1f393ca7e" xlink:to="loc_cron_PaymentsToExerciseWarrants_ee2fa9b3-d264-4982-ac3f-472e1e35f586" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentOwnedSharesSoldPercentageOfSharesIssuedAndOutstanding_0bf2ea31-56bf-428e-bc75-76f5ee4cd9b3" xlink:href="cron-20201231.xsd#cron_InvestmentOwnedSharesSoldPercentageOfSharesIssuedAndOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_dea03238-552b-49de-b235-7ae1f393ca7e" xlink:to="loc_cron_InvestmentOwnedSharesSoldPercentageOfSharesIssuedAndOutstanding_0bf2ea31-56bf-428e-bc75-76f5ee4cd9b3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentOwnedNumberOfSharesReceived_95749602-c9b7-4433-a83a-5c0dc009c8ce" xlink:href="cron-20201231.xsd#cron_InvestmentOwnedNumberOfSharesReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_dea03238-552b-49de-b235-7ae1f393ca7e" xlink:to="loc_cron_InvestmentOwnedNumberOfSharesReceived_95749602-c9b7-4433-a83a-5c0dc009c8ce" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_b4223cb3-078e-4124-8bc0-55c6d85ba58e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_dea03238-552b-49de-b235-7ae1f393ca7e" xlink:to="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_b4223cb3-078e-4124-8bc0-55c6d85ba58e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_f3b9f831-47ec-43ac-8280-d6d0ce73c4d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_b4223cb3-078e-4124-8bc0-55c6d85ba58e" xlink:to="loc_us-gaap_InvestmentTypeAxis_f3b9f831-47ec-43ac-8280-d6d0ce73c4d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_f3b9f831-47ec-43ac-8280-d6d0ce73c4d7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_f3b9f831-47ec-43ac-8280-d6d0ce73c4d7" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_f3b9f831-47ec-43ac-8280-d6d0ce73c4d7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_18a0df90-7db2-4f32-82a3-029f5779aade" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_f3b9f831-47ec-43ac-8280-d6d0ce73c4d7" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_18a0df90-7db2-4f32-82a3-029f5779aade" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_c3c6d4f8-b9a5-443e-b16b-e3a167eb57f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_18a0df90-7db2-4f32-82a3-029f5779aade" xlink:to="loc_us-gaap_EquitySecuritiesMember_c3c6d4f8-b9a5-443e-b16b-e3a167eb57f2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_73a4962c-0fd6-4d82-898e-4320a045db66" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_b4223cb3-078e-4124-8bc0-55c6d85ba58e" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_73a4962c-0fd6-4d82-898e-4320a045db66" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_73a4962c-0fd6-4d82-898e-4320a045db66_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_73a4962c-0fd6-4d82-898e-4320a045db66" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_73a4962c-0fd6-4d82-898e-4320a045db66_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_324bd32d-3ccb-46fe-be4d-d48415d580f0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_73a4962c-0fd6-4d82-898e-4320a045db66" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_324bd32d-3ccb-46fe-be4d-d48415d580f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CanopyGrowthCorporationMember_b3ba820c-e22f-4a34-b6b2-fc7871560b0f" xlink:href="cron-20201231.xsd#cron_CanopyGrowthCorporationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_324bd32d-3ccb-46fe-be4d-d48415d580f0" xlink:to="loc_cron_CanopyGrowthCorporationMember_b3ba820c-e22f-4a34-b6b2-fc7871560b0f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_VivoCannabisMember_655e34db-89d2-455e-ac04-2abc959a05ea" xlink:href="cron-20201231.xsd#cron_VivoCannabisMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_324bd32d-3ccb-46fe-be4d-d48415d580f0" xlink:to="loc_cron_VivoCannabisMember_655e34db-89d2-455e-ac04-2abc959a05ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_WhistlerMedicalMarijuanaCompanyMember_ce3f4580-f7e2-440e-a8d6-b2b9acfe3085" xlink:href="cron-20201231.xsd#cron_WhistlerMedicalMarijuanaCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_324bd32d-3ccb-46fe-be4d-d48415d580f0" xlink:to="loc_cron_WhistlerMedicalMarijuanaCompanyMember_ce3f4580-f7e2-440e-a8d6-b2b9acfe3085" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AuroraCannabisInc.Member_82d7ba68-8487-40a4-bd99-7a8b0cb1a9f1" xlink:href="cron-20201231.xsd#cron_AuroraCannabisInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_324bd32d-3ccb-46fe-be4d-d48415d580f0" xlink:to="loc_cron_AuroraCannabisInc.Member_82d7ba68-8487-40a4-bd99-7a8b0cb1a9f1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_53b08fce-cd08-4ecd-a01f-d3c3c7cbb50a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_b4223cb3-078e-4124-8bc0-55c6d85ba58e" xlink:to="loc_us-gaap_FinancialInstrumentAxis_53b08fce-cd08-4ecd-a01f-d3c3c7cbb50a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_53b08fce-cd08-4ecd-a01f-d3c3c7cbb50a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_53b08fce-cd08-4ecd-a01f-d3c3c7cbb50a" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_53b08fce-cd08-4ecd-a01f-d3c3c7cbb50a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d4b5e3b6-84b2-4456-81a0-4c37a43aa287" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_53b08fce-cd08-4ecd-a01f-d3c3c7cbb50a" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d4b5e3b6-84b2-4456-81a0-4c37a43aa287" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_cc07293a-c42e-4b03-8d16-d56f4451319e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d4b5e3b6-84b2-4456-81a0-4c37a43aa287" xlink:to="loc_us-gaap_WarrantMember_cc07293a-c42e-4b03-8d16-d56f4451319e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/LoanReceivable" xlink:type="simple" xlink:href="cron-20201231.xsd#LoanReceivable"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/LoanReceivable" xlink:type="extended" id="ibb6e28356ffd485c98f0c83c3c1a8d6a_LoanReceivable"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/LoanReceivableTables" xlink:type="simple" xlink:href="cron-20201231.xsd#LoanReceivableTables"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/LoanReceivableTables" xlink:type="extended" id="i7a4e4912058d4e0c8885c8316299c1fc_LoanReceivableTables"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#LoanReceivableScheduleofLoanReceivableDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails" xlink:type="extended" id="ifc748bca750d4487a7ae54878e6bb6ae_LoanReceivableScheduleofLoanReceivableDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_967bb519-9298-4048-ad40-a1fd61efee80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetCurrentAbstract_b559b7c3-65d9-4f24-8718-f7f715728b31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesAndLoansReceivableNetCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_967bb519-9298-4048-ad40-a1fd61efee80" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetCurrentAbstract_b559b7c3-65d9-4f24-8718-f7f715728b31" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableBeforeAccruedInterestCurrent_5c782b9b-1152-4650-a21d-e889b5a324f1" xlink:href="cron-20201231.xsd#cron_FinancingReceivableBeforeAccruedInterestCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NotesAndLoansReceivableNetCurrentAbstract_b559b7c3-65d9-4f24-8718-f7f715728b31" xlink:to="loc_cron_FinancingReceivableBeforeAccruedInterestCurrent_5c782b9b-1152-4650-a21d-e889b5a324f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableAccruedInterestCurrent_525bb8d6-bb0c-4cb9-b153-cfc6d190f4d3" xlink:href="cron-20201231.xsd#cron_FinancingReceivableAccruedInterestCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NotesAndLoansReceivableNetCurrentAbstract_b559b7c3-65d9-4f24-8718-f7f715728b31" xlink:to="loc_cron_FinancingReceivableAccruedInterestCurrent_525bb8d6-bb0c-4cb9-b153-cfc6d190f4d3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetCurrent_07412d0f-48b5-4963-9751-46624f2dc307" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesAndLoansReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NotesAndLoansReceivableNetCurrentAbstract_b559b7c3-65d9-4f24-8718-f7f715728b31" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetCurrent_07412d0f-48b5-4963-9751-46624f2dc307" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetNoncurrentAbstract_51882e9a-f0dc-4e5f-9fef-7820b0c6fa1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesAndLoansReceivableNetNoncurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_967bb519-9298-4048-ad40-a1fd61efee80" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetNoncurrentAbstract_51882e9a-f0dc-4e5f-9fef-7820b0c6fa1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableBeforeAccruedInterestNoncurrent_fcd6ba9c-ebf9-4e71-a1d5-8bfa8c57f9c8" xlink:href="cron-20201231.xsd#cron_FinancingReceivableBeforeAccruedInterestNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NotesAndLoansReceivableNetNoncurrentAbstract_51882e9a-f0dc-4e5f-9fef-7820b0c6fa1c" xlink:to="loc_cron_FinancingReceivableBeforeAccruedInterestNoncurrent_fcd6ba9c-ebf9-4e71-a1d5-8bfa8c57f9c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableAccruedInterestNoncurrent_ec00af4a-f4e3-41c7-9f10-9e596b9a0caa" xlink:href="cron-20201231.xsd#cron_FinancingReceivableAccruedInterestNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NotesAndLoansReceivableNetNoncurrentAbstract_51882e9a-f0dc-4e5f-9fef-7820b0c6fa1c" xlink:to="loc_cron_FinancingReceivableAccruedInterestNoncurrent_ec00af4a-f4e3-41c7-9f10-9e596b9a0caa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent_1dfbce78-8594-4292-91fe-4205adbefad5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesAndLoansReceivableNetNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NotesAndLoansReceivableNetNoncurrentAbstract_51882e9a-f0dc-4e5f-9fef-7820b0c6fa1c" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent_1dfbce78-8594-4292-91fe-4205adbefad5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableNet_ab060097-20c2-4eb9-b7ba-1e0a0eac90c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesReceivableNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_967bb519-9298-4048-ad40-a1fd61efee80" xlink:to="loc_us-gaap_NotesReceivableNet_ab060097-20c2-4eb9-b7ba-1e0a0eac90c4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableAdditionalFaceAmountIncludingThirdPartyAmount_3f108455-db03-4da8-81e0-c4416f95689c" xlink:href="cron-20201231.xsd#cron_FinancingReceivableAdditionalFaceAmountIncludingThirdPartyAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_967bb519-9298-4048-ad40-a1fd61efee80" xlink:to="loc_cron_FinancingReceivableAdditionalFaceAmountIncludingThirdPartyAmount_3f108455-db03-4da8-81e0-c4416f95689c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableFaceAmountIncludingThirdPartyAmount_3884542a-6f72-4214-b758-dcfb1b9247cb" xlink:href="cron-20201231.xsd#cron_FinancingReceivableFaceAmountIncludingThirdPartyAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_967bb519-9298-4048-ad40-a1fd61efee80" xlink:to="loc_cron_FinancingReceivableFaceAmountIncludingThirdPartyAmount_3884542a-6f72-4214-b758-dcfb1b9247cb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableFundingCommitmentPercentage_ac68c040-eecf-48b3-87b6-c64b0694f317" xlink:href="cron-20201231.xsd#cron_FinancingReceivableFundingCommitmentPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_967bb519-9298-4048-ad40-a1fd61efee80" xlink:to="loc_cron_FinancingReceivableFundingCommitmentPercentage_ac68c040-eecf-48b3-87b6-c64b0694f317" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableInterestRateStatedPercentage_e5fb4042-1386-406e-b142-af4e3ff3f1b3" xlink:href="cron-20201231.xsd#cron_FinancingReceivableInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_967bb519-9298-4048-ad40-a1fd61efee80" xlink:to="loc_cron_FinancingReceivableInterestRateStatedPercentage_e5fb4042-1386-406e-b142-af4e3ff3f1b3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLosses_025b31eb-874b-48c3-b2f4-3affb7b785e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancingReceivableAllowanceForCreditLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_967bb519-9298-4048-ad40-a1fd61efee80" xlink:to="loc_us-gaap_FinancingReceivableAllowanceForCreditLosses_025b31eb-874b-48c3-b2f4-3affb7b785e8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableFaceAmount_eb3aad42-fce6-407a-bbf2-7c88d1aab915" xlink:href="cron-20201231.xsd#cron_FinancingReceivableFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_967bb519-9298-4048-ad40-a1fd61efee80" xlink:to="loc_cron_FinancingReceivableFaceAmount_eb3aad42-fce6-407a-bbf2-7c88d1aab915" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_b6822b0b-8f59-4f18-abe0-8f4a69056d8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_967bb519-9298-4048-ad40-a1fd61efee80" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_b6822b0b-8f59-4f18-abe0-8f4a69056d8c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireLoansReceivable_b3530995-28b6-47e4-9752-eb9e988ef92d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireLoansReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_967bb519-9298-4048-ad40-a1fd61efee80" xlink:to="loc_us-gaap_PaymentsToAcquireLoansReceivable_b3530995-28b6-47e4-9752-eb9e988ef92d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableDueOnDemandTerm_e38bb935-6f4a-4ba3-ad5a-a92c835bea3b" xlink:href="cron-20201231.xsd#cron_FinancingReceivableDueOnDemandTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_967bb519-9298-4048-ad40-a1fd61efee80" xlink:to="loc_cron_FinancingReceivableDueOnDemandTerm_e38bb935-6f4a-4ba3-ad5a-a92c835bea3b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableDueOnDemandIntendedDemandTermMinimum_abd18145-6b7b-4e91-9b9f-8754b65920cf" xlink:href="cron-20201231.xsd#cron_FinancingReceivableDueOnDemandIntendedDemandTermMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_967bb519-9298-4048-ad40-a1fd61efee80" xlink:to="loc_cron_FinancingReceivableDueOnDemandIntendedDemandTermMinimum_abd18145-6b7b-4e91-9b9f-8754b65920cf" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CollaborativeArrangementAmountOfAdvances_8b495da5-6a47-4581-ba10-1f43f96072df" xlink:href="cron-20201231.xsd#cron_CollaborativeArrangementAmountOfAdvances"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_967bb519-9298-4048-ad40-a1fd61efee80" xlink:to="loc_cron_CollaborativeArrangementAmountOfAdvances_8b495da5-6a47-4581-ba10-1f43f96072df" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CollaborativeArrangementTermOfAgreement_7e86a36e-f4b3-43f1-8dc0-e873ff12c97c" xlink:href="cron-20201231.xsd#cron_CollaborativeArrangementTermOfAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_967bb519-9298-4048-ad40-a1fd61efee80" xlink:to="loc_cron_CollaborativeArrangementTermOfAgreement_7e86a36e-f4b3-43f1-8dc0-e873ff12c97c" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_400ac292-0502-4295-ad91-161ce32459e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_967bb519-9298-4048-ad40-a1fd61efee80" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_400ac292-0502-4295-ad91-161ce32459e7" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CollaborativeArrangementInstallmentsReceived_384a07a6-10ed-4631-b702-1f78af41a747" xlink:href="cron-20201231.xsd#cron_CollaborativeArrangementInstallmentsReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_967bb519-9298-4048-ad40-a1fd61efee80" xlink:to="loc_cron_CollaborativeArrangementInstallmentsReceived_384a07a6-10ed-4631-b702-1f78af41a747" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_741c4044-6983-48d9-b77c-28cdc4e4533d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_967bb519-9298-4048-ad40-a1fd61efee80" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_741c4044-6983-48d9-b77c-28cdc4e4533d" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_80fbc4da-f4de-4513-b9ac-c9bc8a179cc6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_967bb519-9298-4048-ad40-a1fd61efee80" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_80fbc4da-f4de-4513-b9ac-c9bc8a179cc6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LoanReceivableNameAxis_1efe12b1-683d-4194-809d-f61edcdc77ab" xlink:href="cron-20201231.xsd#cron_LoanReceivableNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_80fbc4da-f4de-4513-b9ac-c9bc8a179cc6" xlink:to="loc_cron_LoanReceivableNameAxis_1efe12b1-683d-4194-809d-f61edcdc77ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LoanReceivableNameDomain_1efe12b1-683d-4194-809d-f61edcdc77ab_default" xlink:href="cron-20201231.xsd#cron_LoanReceivableNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cron_LoanReceivableNameAxis_1efe12b1-683d-4194-809d-f61edcdc77ab" xlink:to="loc_cron_LoanReceivableNameDomain_1efe12b1-683d-4194-809d-f61edcdc77ab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LoanReceivableNameDomain_05590975-fa41-4489-998b-355421806c8b" xlink:href="cron-20201231.xsd#cron_LoanReceivableNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cron_LoanReceivableNameAxis_1efe12b1-683d-4194-809d-f61edcdc77ab" xlink:to="loc_cron_LoanReceivableNameDomain_05590975-fa41-4489-998b-355421806c8b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NatuEraSeriesALoanMember_0d2458bb-da42-4078-b285-9ee9846b79c0" xlink:href="cron-20201231.xsd#cron_NatuEraSeriesALoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_LoanReceivableNameDomain_05590975-fa41-4489-998b-355421806c8b" xlink:to="loc_cron_NatuEraSeriesALoanMember_0d2458bb-da42-4078-b285-9ee9846b79c0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NatuEraSeriesALoanShareOfNetLossInExcessOfCarryingValueOfEquityInvestmentMember_05ff8491-2f0c-4292-853f-ad0d735c6168" xlink:href="cron-20201231.xsd#cron_NatuEraSeriesALoanShareOfNetLossInExcessOfCarryingValueOfEquityInvestmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_LoanReceivableNameDomain_05590975-fa41-4489-998b-355421806c8b" xlink:to="loc_cron_NatuEraSeriesALoanShareOfNetLossInExcessOfCarryingValueOfEquityInvestmentMember_05ff8491-2f0c-4292-853f-ad0d735c6168" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosGrowCoCreditFacilityMember_e2537e33-bc9b-485c-bdd7-f595e606092f" xlink:href="cron-20201231.xsd#cron_CronosGrowCoCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_LoanReceivableNameDomain_05590975-fa41-4489-998b-355421806c8b" xlink:to="loc_cron_CronosGrowCoCreditFacilityMember_e2537e33-bc9b-485c-bdd7-f595e606092f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_A2645485OntarioInc.MucciPromissoryNoteMember_59dacb31-84e1-4dd8-adf0-969348ceb278" xlink:href="cron-20201231.xsd#cron_A2645485OntarioInc.MucciPromissoryNoteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_LoanReceivableNameDomain_05590975-fa41-4489-998b-355421806c8b" xlink:to="loc_cron_A2645485OntarioInc.MucciPromissoryNoteMember_59dacb31-84e1-4dd8-adf0-969348ceb278" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CannasoulCollaborationLoanMember_9e6313be-57dd-47c0-910a-38f824f16d1f" xlink:href="cron-20201231.xsd#cron_CannasoulCollaborationLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_LoanReceivableNameDomain_05590975-fa41-4489-998b-355421806c8b" xlink:to="loc_cron_CannasoulCollaborationLoanMember_9e6313be-57dd-47c0-910a-38f824f16d1f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_f78a3ce8-76e9-4ca6-97da-941b357e9289" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_80fbc4da-f4de-4513-b9ac-c9bc8a179cc6" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_f78a3ce8-76e9-4ca6-97da-941b357e9289" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_f78a3ce8-76e9-4ca6-97da-941b357e9289_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_f78a3ce8-76e9-4ca6-97da-941b357e9289" xlink:to="loc_us-gaap_ReceivableTypeDomain_f78a3ce8-76e9-4ca6-97da-941b357e9289_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_62c5daab-d47d-4efe-b754-908341290a56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_f78a3ce8-76e9-4ca6-97da-941b357e9289" xlink:to="loc_us-gaap_ReceivableTypeDomain_62c5daab-d47d-4efe-b754-908341290a56" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansReceivableMember_f981483c-7df6-498a-ac8d-f31cf89bc568" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReceivableTypeDomain_62c5daab-d47d-4efe-b754-908341290a56" xlink:to="loc_us-gaap_LoansReceivableMember_f981483c-7df6-498a-ac8d-f31cf89bc568" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_e28de9fb-1c70-49f6-89c5-6af2bdc21267" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_80fbc4da-f4de-4513-b9ac-c9bc8a179cc6" xlink:to="loc_dei_LegalEntityAxis_e28de9fb-1c70-49f6-89c5-6af2bdc21267" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_e28de9fb-1c70-49f6-89c5-6af2bdc21267_default" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_e28de9fb-1c70-49f6-89c5-6af2bdc21267" xlink:to="loc_dei_EntityDomain_e28de9fb-1c70-49f6-89c5-6af2bdc21267_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_841fd8d4-e42b-40bc-bc9d-536c4b795331" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_e28de9fb-1c70-49f6-89c5-6af2bdc21267" xlink:to="loc_dei_EntityDomain_841fd8d4-e42b-40bc-bc9d-536c4b795331" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NatuEraMember_20d0458f-6a0c-4b16-ab4d-0ab8e6d79e79" xlink:href="cron-20201231.xsd#cron_NatuEraMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_841fd8d4-e42b-40bc-bc9d-536c4b795331" xlink:to="loc_cron_NatuEraMember_20d0458f-6a0c-4b16-ab4d-0ab8e6d79e79" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_MucciMember_a3ae11ab-b4ac-4089-af71-dbe03e2e6b64" xlink:href="cron-20201231.xsd#cron_MucciMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_841fd8d4-e42b-40bc-bc9d-536c4b795331" xlink:to="loc_cron_MucciMember_a3ae11ab-b4ac-4089-af71-dbe03e2e6b64" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_97d3afff-5f7a-4e50-aba4-94087ff360a6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_80fbc4da-f4de-4513-b9ac-c9bc8a179cc6" xlink:to="loc_srt_OwnershipAxis_97d3afff-5f7a-4e50-aba4-94087ff360a6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_97d3afff-5f7a-4e50-aba4-94087ff360a6_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_97d3afff-5f7a-4e50-aba4-94087ff360a6" xlink:to="loc_srt_OwnershipDomain_97d3afff-5f7a-4e50-aba4-94087ff360a6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_375007ff-3f67-43b8-885e-5ac3c3c30248" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_97d3afff-5f7a-4e50-aba4-94087ff360a6" xlink:to="loc_srt_OwnershipDomain_375007ff-3f67-43b8-885e-5ac3c3c30248" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosGrowingCompanyInc.Member_535e5155-7f68-4202-90af-cc73f6bd9daf" xlink:href="cron-20201231.xsd#cron_CronosGrowingCompanyInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_375007ff-3f67-43b8-885e-5ac3c3c30248" xlink:to="loc_cron_CronosGrowingCompanyInc.Member_535e5155-7f68-4202-90af-cc73f6bd9daf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_26efd311-3a57-478b-8955-8f15cdaf929f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_80fbc4da-f4de-4513-b9ac-c9bc8a179cc6" xlink:to="loc_us-gaap_TypeOfArrangementAxis_26efd311-3a57-478b-8955-8f15cdaf929f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_26efd311-3a57-478b-8955-8f15cdaf929f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_26efd311-3a57-478b-8955-8f15cdaf929f" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_26efd311-3a57-478b-8955-8f15cdaf929f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_f3f58128-f0a5-40e6-8828-1525008a7105" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_26efd311-3a57-478b-8955-8f15cdaf929f" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_f3f58128-f0a5-40e6-8828-1525008a7105" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_d3583f7c-d883-43a5-9f7d-6a961f11f509" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_f3f58128-f0a5-40e6-8828-1525008a7105" xlink:to="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_d3583f7c-d883-43a5-9f7d-6a961f11f509" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_fb676f8b-6cd1-47fc-ba75-20d03dc2b841" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_80fbc4da-f4de-4513-b9ac-c9bc8a179cc6" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_fb676f8b-6cd1-47fc-ba75-20d03dc2b841" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_fb676f8b-6cd1-47fc-ba75-20d03dc2b841_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_fb676f8b-6cd1-47fc-ba75-20d03dc2b841" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_fb676f8b-6cd1-47fc-ba75-20d03dc2b841_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_279ed395-9d94-4804-8c9b-8dc48e699fba" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_fb676f8b-6cd1-47fc-ba75-20d03dc2b841" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_279ed395-9d94-4804-8c9b-8dc48e699fba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CannasoulAnalyticsLtdMember_f81f626c-b528-4c23-a4b2-5e40e42c7feb" xlink:href="cron-20201231.xsd#cron_CannasoulAnalyticsLtdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_279ed395-9d94-4804-8c9b-8dc48e699fba" xlink:to="loc_cron_CannasoulAnalyticsLtdMember_f81f626c-b528-4c23-a4b2-5e40e42c7feb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_a8030c18-1b16-4a9d-996a-9af47cf9eec0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_80fbc4da-f4de-4513-b9ac-c9bc8a179cc6" xlink:to="loc_srt_ConsolidatedEntitiesAxis_a8030c18-1b16-4a9d-996a-9af47cf9eec0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_a8030c18-1b16-4a9d-996a-9af47cf9eec0_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_a8030c18-1b16-4a9d-996a-9af47cf9eec0" xlink:to="loc_srt_ConsolidatedEntitiesDomain_a8030c18-1b16-4a9d-996a-9af47cf9eec0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_eb6675f5-c12b-40ee-bffa-9e0e96251f56" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_a8030c18-1b16-4a9d-996a-9af47cf9eec0" xlink:to="loc_srt_ConsolidatedEntitiesDomain_eb6675f5-c12b-40ee-bffa-9e0e96251f56" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_36a96b5e-3d52-479c-9e70-c044d461d038" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_eb6675f5-c12b-40ee-bffa-9e0e96251f56" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_36a96b5e-3d52-479c-9e70-c044d461d038" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/LoansPayable" xlink:type="simple" xlink:href="cron-20201231.xsd#LoansPayable"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/LoansPayable" xlink:type="extended" id="ic5e8099a566a4eb194e7ed4a4549cfe3_LoansPayable"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/LoansPayableLongtermNarrativeDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#LoansPayableLongtermNarrativeDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/LoansPayableLongtermNarrativeDetails" xlink:type="extended" id="i4ac98ecddfe042bfa0e8688e99b0fac8_LoansPayableLongtermNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_4854fe7c-40a6-43d5-a01e-d9bcfb60d5a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_fa1b3db6-c229-4d3f-82e3-9da386c2750f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4854fe7c-40a6-43d5-a01e-d9bcfb60d5a3" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_fa1b3db6-c229-4d3f-82e3-9da386c2750f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt_ec49613f-b0e5-4649-9328-6228bfd32436" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfSecuredDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4854fe7c-40a6-43d5-a01e-d9bcfb60d5a3" xlink:to="loc_us-gaap_RepaymentsOfSecuredDebt_ec49613f-b0e5-4649-9328-6228bfd32436" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidCapitalized_047ef1bf-2335-4e2d-853e-ef465573c49f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidCapitalized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4854fe7c-40a6-43d5-a01e-d9bcfb60d5a3" xlink:to="loc_us-gaap_InterestPaidCapitalized_047ef1bf-2335-4e2d-853e-ef465573c49f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_26cf122f-c57f-4aed-8038-b4326cb3c71d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4854fe7c-40a6-43d5-a01e-d9bcfb60d5a3" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_26cf122f-c57f-4aed-8038-b4326cb3c71d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_a389b2f1-2e01-44d1-b2de-c58ceabd3f18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4854fe7c-40a6-43d5-a01e-d9bcfb60d5a3" xlink:to="loc_us-gaap_DebtInstrumentTable_a389b2f1-2e01-44d1-b2de-c58ceabd3f18" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_1a653d88-55e6-412f-82d9-2a37848bd2ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_a389b2f1-2e01-44d1-b2de-c58ceabd3f18" xlink:to="loc_us-gaap_CreditFacilityAxis_1a653d88-55e6-412f-82d9-2a37848bd2ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_1a653d88-55e6-412f-82d9-2a37848bd2ef_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_1a653d88-55e6-412f-82d9-2a37848bd2ef" xlink:to="loc_us-gaap_CreditFacilityDomain_1a653d88-55e6-412f-82d9-2a37848bd2ef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_bfa6e9fb-e6b1-4fde-bb0b-377190e96cbf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_1a653d88-55e6-412f-82d9-2a37848bd2ef" xlink:to="loc_us-gaap_CreditFacilityDomain_bfa6e9fb-e6b1-4fde-bb0b-377190e96cbf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NonrevolvingTermLoanFacilityMember_52de1971-d64b-489a-ac94-821193b798cd" xlink:href="cron-20201231.xsd#cron_NonrevolvingTermLoanFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_bfa6e9fb-e6b1-4fde-bb0b-377190e96cbf" xlink:to="loc_cron_NonrevolvingTermLoanFacilityMember_52de1971-d64b-489a-ac94-821193b798cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_3efa91bc-5df9-456b-a2a0-8ec5b15700cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_a389b2f1-2e01-44d1-b2de-c58ceabd3f18" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_3efa91bc-5df9-456b-a2a0-8ec5b15700cd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_3efa91bc-5df9-456b-a2a0-8ec5b15700cd_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_3efa91bc-5df9-456b-a2a0-8ec5b15700cd" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_3efa91bc-5df9-456b-a2a0-8ec5b15700cd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_77f69f8b-0547-4c08-91a5-2a4309ddc350" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_3efa91bc-5df9-456b-a2a0-8ec5b15700cd" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_77f69f8b-0547-4c08-91a5-2a4309ddc350" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_f6c6e2a0-52ad-4965-ad9e-dac111197902" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_77f69f8b-0547-4c08-91a5-2a4309ddc350" xlink:to="loc_us-gaap_SecuredDebtMember_f6c6e2a0-52ad-4965-ad9e-dac111197902" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_c4bc519d-efa1-440f-b052-1ef26892b439" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_a389b2f1-2e01-44d1-b2de-c58ceabd3f18" xlink:to="loc_us-gaap_DebtInstrumentAxis_c4bc519d-efa1-440f-b052-1ef26892b439" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c4bc519d-efa1-440f-b052-1ef26892b439_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_c4bc519d-efa1-440f-b052-1ef26892b439" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c4bc519d-efa1-440f-b052-1ef26892b439_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_f5d58129-24bf-4bff-8fa6-76161f3d9714" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_c4bc519d-efa1-440f-b052-1ef26892b439" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_f5d58129-24bf-4bff-8fa6-76161f3d9714" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CreditFacilityMember_43ed5384-c90c-4e04-8a67-b6eb47887b1b" xlink:href="cron-20201231.xsd#cron_CreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f5d58129-24bf-4bff-8fa6-76161f3d9714" xlink:to="loc_cron_CreditFacilityMember_43ed5384-c90c-4e04-8a67-b6eb47887b1b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ConstructionLoanAgreementMember_c3591e86-5a4c-474b-964e-037f4c0f39df" xlink:href="cron-20201231.xsd#cron_ConstructionLoanAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f5d58129-24bf-4bff-8fa6-76161f3d9714" xlink:to="loc_cron_ConstructionLoanAgreementMember_c3591e86-5a4c-474b-964e-037f4c0f39df" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/PropertyPlantandEquipment" xlink:type="simple" xlink:href="cron-20201231.xsd#PropertyPlantandEquipment"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/PropertyPlantandEquipment" xlink:type="extended" id="i8babc3d623d34ef9b3dbeb4d82f4eaf9_PropertyPlantandEquipment"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/PropertyPlantandEquipmentTables" xlink:type="simple" xlink:href="cron-20201231.xsd#PropertyPlantandEquipmentTables"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/PropertyPlantandEquipmentTables" xlink:type="extended" id="i4990cf6f42fa46899f60b94f367bac1f_PropertyPlantandEquipmentTables"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantEquipmentUsefulLivesDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#PropertyPlantandEquipmentScheduleofPropertyPlantEquipmentUsefulLivesDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantEquipmentUsefulLivesDetails" xlink:type="extended" id="i6c2e593c1f8149768921997e23863f96_PropertyPlantandEquipmentScheduleofPropertyPlantEquipmentUsefulLivesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_eb49689f-7dfc-4752-b59f-7dc9bdf12b16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_e2fc1a65-55bc-4c3e-ab44-158614453145" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_eb49689f-7dfc-4752-b59f-7dc9bdf12b16" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_e2fc1a65-55bc-4c3e-ab44-158614453145" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_83073e99-7731-4278-b52b-a16ab789f9e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_eb49689f-7dfc-4752-b59f-7dc9bdf12b16" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_83073e99-7731-4278-b52b-a16ab789f9e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_021bb1c3-9cb3-458b-8267-d6230f068cc5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_eb49689f-7dfc-4752-b59f-7dc9bdf12b16" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_021bb1c3-9cb3-458b-8267-d6230f068cc5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1a52c538-c5b7-4c45-afa6-846b7c16a3fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_eb49689f-7dfc-4752-b59f-7dc9bdf12b16" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1a52c538-c5b7-4c45-afa6-846b7c16a3fa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7dbea5ed-8016-482e-86fc-dac629ffb267" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1a52c538-c5b7-4c45-afa6-846b7c16a3fa" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7dbea5ed-8016-482e-86fc-dac629ffb267" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7dbea5ed-8016-482e-86fc-dac629ffb267_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7dbea5ed-8016-482e-86fc-dac629ffb267" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7dbea5ed-8016-482e-86fc-dac629ffb267_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_46d399f1-52d5-45f3-90c8-969fa766a2c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7dbea5ed-8016-482e-86fc-dac629ffb267" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_46d399f1-52d5-45f3-90c8-969fa766a2c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_c8efeb30-5621-4713-b082-b6fb90ddca9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LandMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_46d399f1-52d5-45f3-90c8-969fa766a2c9" xlink:to="loc_us-gaap_LandMember_c8efeb30-5621-4713-b082-b6fb90ddca9b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_333553ce-dbce-44b9-96b8-20ef3c15cb3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_46d399f1-52d5-45f3-90c8-969fa766a2c9" xlink:to="loc_us-gaap_BuildingMember_333553ce-dbce-44b9-96b8-20ef3c15cb3b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_2dd01a03-bacd-404f-9f52-07eb86e370b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_46d399f1-52d5-45f3-90c8-969fa766a2c9" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_2dd01a03-bacd-404f-9f52-07eb86e370b2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_8809813d-0724-448c-b8e8-4a635171d6c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_46d399f1-52d5-45f3-90c8-969fa766a2c9" xlink:to="loc_us-gaap_ComputerEquipmentMember_8809813d-0724-448c-b8e8-4a635171d6c1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_3aedc596-28e5-4f17-8a17-483e4a70f372" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_46d399f1-52d5-45f3-90c8-969fa766a2c9" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_3aedc596-28e5-4f17-8a17-483e4a70f372" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_cf159e9d-bb8b-415f-9ca6-402d6f04cee1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_46d399f1-52d5-45f3-90c8-969fa766a2c9" xlink:to="loc_us-gaap_ConstructionInProgressMember_cf159e9d-bb8b-415f-9ca6-402d6f04cee1" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/PropertyPlantandEquipmentNarrativeDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#PropertyPlantandEquipmentNarrativeDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/PropertyPlantandEquipmentNarrativeDetails" xlink:type="extended" id="i6e0d7cf3e51646688d5640c6de1822de_PropertyPlantandEquipmentNarrativeDetails"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/IntangibleAssetsandGoodwill" xlink:type="simple" xlink:href="cron-20201231.xsd#IntangibleAssetsandGoodwill"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/IntangibleAssetsandGoodwill" xlink:type="extended" id="i56d68c28333347429d06e0ad2c37d57e_IntangibleAssetsandGoodwill"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/IntangibleAssetsandGoodwillTables" xlink:type="simple" xlink:href="cron-20201231.xsd#IntangibleAssetsandGoodwillTables"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/IntangibleAssetsandGoodwillTables" xlink:type="extended" id="i733655378b624cef8f8655a07491184e_IntangibleAssetsandGoodwillTables"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/IntangibleAssetsandGoodwillNarrativeDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#IntangibleAssetsandGoodwillNarrativeDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/IntangibleAssetsandGoodwillNarrativeDetails" xlink:type="extended" id="i75c5cdbe830f4dee9950b64af10e9f47_IntangibleAssetsandGoodwillNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_874c06ca-56b3-4ece-be50-7642b6e39362" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_65fec31a-adcc-4332-bbab-f19d3b14d134" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_874c06ca-56b3-4ece-be50-7642b6e39362" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_65fec31a-adcc-4332-bbab-f19d3b14d134" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_1867d4b7-bb43-4dca-aae6-d68770766b02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_874c06ca-56b3-4ece-be50-7642b6e39362" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_1867d4b7-bb43-4dca-aae6-d68770766b02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_dc5eca54-9237-4e1b-b115-0d9a6c8efd89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_874c06ca-56b3-4ece-be50-7642b6e39362" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_dc5eca54-9237-4e1b-b115-0d9a6c8efd89" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_826c4b04-6595-468c-bf82-c5e0a961dbdd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_874c06ca-56b3-4ece-be50-7642b6e39362" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_826c4b04-6595-468c-bf82-c5e0a961dbdd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_aca369d2-501f-4d08-94c4-e326a140ae15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_874c06ca-56b3-4ece-be50-7642b6e39362" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_aca369d2-501f-4d08-94c4-e326a140ae15" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_df65d318-c4f4-4ef8-84b1-05a6bb45101a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_aca369d2-501f-4d08-94c4-e326a140ae15" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_df65d318-c4f4-4ef8-84b1-05a6bb45101a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_f5d65082-827c-488f-ba7f-266f6ce997af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_aca369d2-501f-4d08-94c4-e326a140ae15" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_f5d65082-827c-488f-ba7f-266f6ce997af" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_7e1ca09a-46b2-48d6-ac5f-b582efbf6000" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_aca369d2-501f-4d08-94c4-e326a140ae15" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_7e1ca09a-46b2-48d6-ac5f-b582efbf6000" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_dd93d219-8ec4-4c08-8416-2b8d20dab29f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_aca369d2-501f-4d08-94c4-e326a140ae15" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_dd93d219-8ec4-4c08-8416-2b8d20dab29f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_aa64c237-b20f-43b7-a052-6f7581d60d2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_aca369d2-501f-4d08-94c4-e326a140ae15" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_aa64c237-b20f-43b7-a052-6f7581d60d2f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_b450d35e-c50a-4155-bb73-6284d99ed852" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_874c06ca-56b3-4ece-be50-7642b6e39362" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_b450d35e-c50a-4155-bb73-6284d99ed852" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_4072a5af-a6ba-439f-9ef5-f0d4ce0ebcda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_b450d35e-c50a-4155-bb73-6284d99ed852" xlink:to="loc_us-gaap_ReportingUnitAxis_4072a5af-a6ba-439f-9ef5-f0d4ce0ebcda" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_4072a5af-a6ba-439f-9ef5-f0d4ce0ebcda_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReportingUnitAxis_4072a5af-a6ba-439f-9ef5-f0d4ce0ebcda" xlink:to="loc_us-gaap_ReportingUnitDomain_4072a5af-a6ba-439f-9ef5-f0d4ce0ebcda_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_2d0b66a7-8f9b-42da-966b-b142200043a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReportingUnitAxis_4072a5af-a6ba-439f-9ef5-f0d4ce0ebcda" xlink:to="loc_us-gaap_ReportingUnitDomain_2d0b66a7-8f9b-42da-966b-b142200043a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_UnitedStatesSegmentMember_2482623c-24ec-42b7-85a0-04213b37162e" xlink:href="cron-20201231.xsd#cron_UnitedStatesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_2d0b66a7-8f9b-42da-966b-b142200043a0" xlink:to="loc_cron_UnitedStatesSegmentMember_2482623c-24ec-42b7-85a0-04213b37162e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_6df09365-3806-47e3-a622-766ab926c1e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_b450d35e-c50a-4155-bb73-6284d99ed852" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_6df09365-3806-47e3-a622-766ab926c1e5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_6df09365-3806-47e3-a622-766ab926c1e5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_6df09365-3806-47e3-a622-766ab926c1e5" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_6df09365-3806-47e3-a622-766ab926c1e5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9d7fcba9-b978-43f5-95fb-16440e31dc2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_6df09365-3806-47e3-a622-766ab926c1e5" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9d7fcba9-b978-43f5-95fb-16440e31dc2f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_b6fc40ba-4da3-4f1c-8a95-470385e18b22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9d7fcba9-b978-43f5-95fb-16440e31dc2f" xlink:to="loc_us-gaap_TradeNamesMember_b6fc40ba-4da3-4f1c-8a95-470385e18b22" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails" xlink:type="extended" id="i4cc2aae41c28489b9101a30a5ef2b7c6_IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_03139686-2b7f-465d-bd14-3075b78800b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_e0c5b80b-ce18-4825-9be2-6316c16adbbd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_03139686-2b7f-465d-bd14-3075b78800b5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_e0c5b80b-ce18-4825-9be2-6316c16adbbd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_6f6c47cd-99d2-4d87-9c38-1daab4d255b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_03139686-2b7f-465d-bd14-3075b78800b5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_6f6c47cd-99d2-4d87-9c38-1daab4d255b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_d8de7afc-04c4-4f48-9985-3275d488b5d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_03139686-2b7f-465d-bd14-3075b78800b5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_d8de7afc-04c4-4f48-9985-3275d488b5d7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_59618c14-f2ee-4906-b1b4-4f934c5af38b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_03139686-2b7f-465d-bd14-3075b78800b5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_59618c14-f2ee-4906-b1b4-4f934c5af38b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_0db1697b-20f9-4366-ad75-c0fc7509174f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_03139686-2b7f-465d-bd14-3075b78800b5" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_0db1697b-20f9-4366-ad75-c0fc7509174f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1bdde3ef-e87f-4884-a876-2c77624b8722" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_0db1697b-20f9-4366-ad75-c0fc7509174f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1bdde3ef-e87f-4884-a876-2c77624b8722" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1bdde3ef-e87f-4884-a876-2c77624b8722_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1bdde3ef-e87f-4884-a876-2c77624b8722" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1bdde3ef-e87f-4884-a876-2c77624b8722_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0b44bb77-2879-418e-a6d7-c74bc6568ff9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1bdde3ef-e87f-4884-a876-2c77624b8722" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0b44bb77-2879-418e-a6d7-c74bc6568ff9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_bd3b3c0d-19ee-4f3d-bb98-49277f49910e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0b44bb77-2879-418e-a6d7-c74bc6568ff9" xlink:to="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_bd3b3c0d-19ee-4f3d-bb98-49277f49910e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_EnterpriseResourcePlanningSystemMember_76e50eda-24f1-4c2c-83c1-920edf23d07e" xlink:href="cron-20201231.xsd#cron_EnterpriseResourcePlanningSystemMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0b44bb77-2879-418e-a6d7-c74bc6568ff9" xlink:to="loc_cron_EnterpriseResourcePlanningSystemMember_76e50eda-24f1-4c2c-83c1-920edf23d07e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_HealthCanadaLicensingAgreementsMember_e0a40338-fe32-499a-bcdc-f39a73813437" xlink:href="cron-20201231.xsd#cron_HealthCanadaLicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0b44bb77-2879-418e-a6d7-c74bc6568ff9" xlink:to="loc_cron_HealthCanadaLicensingAgreementsMember_e0a40338-fe32-499a-bcdc-f39a73813437" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_IsraeliCodesLicensingAgreementsMember_941d90d3-b13c-4101-866d-5b4f44efdd84" xlink:href="cron-20201231.xsd#cron_IsraeliCodesLicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0b44bb77-2879-418e-a6d7-c74bc6568ff9" xlink:to="loc_cron_IsraeliCodesLicensingAgreementsMember_941d90d3-b13c-4101-866d-5b4f44efdd84" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_874564b0-c705-4589-88cf-e1315fea5792" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_a098fcca-968b-4a50-9c33-8dc4d16183ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_874564b0-c705-4589-88cf-e1315fea5792" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_a098fcca-968b-4a50-9c33-8dc4d16183ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment_3b442ac0-8e1f-449a-8a0c-f2ebbcd1c10c" xlink:href="cron-20201231.xsd#cron_IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_874564b0-c705-4589-88cf-e1315fea5792" xlink:to="loc_cron_IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment_3b442ac0-8e1f-449a-8a0c-f2ebbcd1c10c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_2ad74090-d403-4f01-805c-83096c0fcec6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_874564b0-c705-4589-88cf-e1315fea5792" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_2ad74090-d403-4f01-805c-83096c0fcec6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_71305756-eeea-4391-ad67-ec7a29023cf3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_874564b0-c705-4589-88cf-e1315fea5792" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_71305756-eeea-4391-ad67-ec7a29023cf3" xlink:type="arc" order="2" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_f8138a36-8a34-43cd-89e1-1ed0cbc21e87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_71305756-eeea-4391-ad67-ec7a29023cf3" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_f8138a36-8a34-43cd-89e1-1ed0cbc21e87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f8138a36-8a34-43cd-89e1-1ed0cbc21e87_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_f8138a36-8a34-43cd-89e1-1ed0cbc21e87" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f8138a36-8a34-43cd-89e1-1ed0cbc21e87_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_0a1d048d-6286-4bce-b099-4f9189d638f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_f8138a36-8a34-43cd-89e1-1ed0cbc21e87" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_0a1d048d-6286-4bce-b099-4f9189d638f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_aaeca6a7-68cd-4752-bc1a-74ff2afc1049" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_0a1d048d-6286-4bce-b099-4f9189d638f2" xlink:to="loc_us-gaap_TradeNamesMember_aaeca6a7-68cd-4752-bc1a-74ff2afc1049" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_72a9974c-61e2-4881-96a7-344a3abcb10a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_0a1d048d-6286-4bce-b099-4f9189d638f2" xlink:to="loc_us-gaap_TrademarksMember_72a9974c-61e2-4881-96a7-344a3abcb10a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofGoodwillDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#IntangibleAssetsandGoodwillScheduleofGoodwillDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofGoodwillDetails" xlink:type="extended" id="i74913277dc984200ad2fc1e3043e86f3_IntangibleAssetsandGoodwillScheduleofGoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_efa95e83-3830-4c2e-93f3-57ae2334a322" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_172eacbe-14ec-401d-91a9-9cd00fe1e13a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_efa95e83-3830-4c2e-93f3-57ae2334a322" xlink:to="loc_us-gaap_GoodwillRollForward_172eacbe-14ec-401d-91a9-9cd00fe1e13a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_1479a1b6-af15-4754-ad92-7f9109428cf3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_172eacbe-14ec-401d-91a9-9cd00fe1e13a" xlink:to="loc_us-gaap_Goodwill_1479a1b6-af15-4754-ad92-7f9109428cf3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_6e08d8bc-f3d8-41d9-a023-7bcb9479439f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_172eacbe-14ec-401d-91a9-9cd00fe1e13a" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_6e08d8bc-f3d8-41d9-a023-7bcb9479439f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_d69a4b1b-1fe6-4f69-9861-764ace0e7274" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_172eacbe-14ec-401d-91a9-9cd00fe1e13a" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_d69a4b1b-1fe6-4f69-9861-764ace0e7274" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_4883a435-7f69-4e22-ad92-61faeb988be0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_172eacbe-14ec-401d-91a9-9cd00fe1e13a" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_4883a435-7f69-4e22-ad92-61faeb988be0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_2558f6a8-dd24-4649-bdb3-75459c09fd1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_8a8b92f7-504b-4ef1-b1f8-c982ddb61b1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_efa95e83-3830-4c2e-93f3-57ae2334a322" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_8a8b92f7-504b-4ef1-b1f8-c982ddb61b1f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_f0778835-498b-4760-b2f7-91a3dc62ae84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_8a8b92f7-504b-4ef1-b1f8-c982ddb61b1f" xlink:to="loc_us-gaap_ReportingUnitAxis_f0778835-498b-4760-b2f7-91a3dc62ae84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_f0778835-498b-4760-b2f7-91a3dc62ae84_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReportingUnitAxis_f0778835-498b-4760-b2f7-91a3dc62ae84" xlink:to="loc_us-gaap_ReportingUnitDomain_f0778835-498b-4760-b2f7-91a3dc62ae84_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_6317cdd7-fb76-462f-aa9e-a01850c90486" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReportingUnitAxis_f0778835-498b-4760-b2f7-91a3dc62ae84" xlink:to="loc_us-gaap_ReportingUnitDomain_6317cdd7-fb76-462f-aa9e-a01850c90486" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PeaceNaturalsReportingUnitMember_2c96a53a-d89e-4032-970d-89274f18153a" xlink:href="cron-20201231.xsd#cron_PeaceNaturalsReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_6317cdd7-fb76-462f-aa9e-a01850c90486" xlink:to="loc_cron_PeaceNaturalsReportingUnitMember_2c96a53a-d89e-4032-970d-89274f18153a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_RedwoodReportingUnitMember_a525f26c-5bf4-4e5d-a929-8d3fa699977a" xlink:href="cron-20201231.xsd#cron_RedwoodReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_6317cdd7-fb76-462f-aa9e-a01850c90486" xlink:to="loc_cron_RedwoodReportingUnitMember_a525f26c-5bf4-4e5d-a929-8d3fa699977a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/Leases" xlink:type="simple" xlink:href="cron-20201231.xsd#Leases"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/Leases" xlink:type="extended" id="ife09499c03b24fd2b0385e56f2065c92_Leases"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/LeasesTables" xlink:type="simple" xlink:href="cron-20201231.xsd#LeasesTables"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/LeasesTables" xlink:type="extended" id="i9c5039b961124c70811d2c7956d4fd63_LeasesTables"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#LeasesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/LeasesNarrativeDetails" xlink:type="extended" id="i218347fa78034aa3a2a3e7697572d5b2_LeasesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_d84462c2-b582-462e-a983-da06c41e7287" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_da07d622-ed82-4f05-9520-0c2943b29293" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_d84462c2-b582-462e-a983-da06c41e7287" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_da07d622-ed82-4f05-9520-0c2943b29293" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_193d614f-a330-4cf5-ba32-2f3ea2dc5861" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_d84462c2-b582-462e-a983-da06c41e7287" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_193d614f-a330-4cf5-ba32-2f3ea2dc5861" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_843eb4dd-9a5e-48b7-bfd4-55d9edc946e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_d84462c2-b582-462e-a983-da06c41e7287" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_843eb4dd-9a5e-48b7-bfd4-55d9edc946e7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_3ee574e9-f240-49ad-bd9e-2296f14c55ef" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_843eb4dd-9a5e-48b7-bfd4-55d9edc946e7" xlink:to="loc_srt_RangeAxis_3ee574e9-f240-49ad-bd9e-2296f14c55ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3ee574e9-f240-49ad-bd9e-2296f14c55ef_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_3ee574e9-f240-49ad-bd9e-2296f14c55ef" xlink:to="loc_srt_RangeMember_3ee574e9-f240-49ad-bd9e-2296f14c55ef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_db735b1b-9024-4826-8115-dbce4c08ed1d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_3ee574e9-f240-49ad-bd9e-2296f14c55ef" xlink:to="loc_srt_RangeMember_db735b1b-9024-4826-8115-dbce4c08ed1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_51dc4a1a-7bbd-4971-9000-1cf07ab89e67" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_db735b1b-9024-4826-8115-dbce4c08ed1d" xlink:to="loc_srt_MinimumMember_51dc4a1a-7bbd-4971-9000-1cf07ab89e67" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_7367898e-a5e4-4de8-a42e-aa8da9d1bb94" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_db735b1b-9024-4826-8115-dbce4c08ed1d" xlink:to="loc_srt_MaximumMember_7367898e-a5e4-4de8-a42e-aa8da9d1bb94" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_69ba24b8-f26e-4a0a-a0de-6daa29bde1d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_843eb4dd-9a5e-48b7-bfd4-55d9edc946e7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_69ba24b8-f26e-4a0a-a0de-6daa29bde1d3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_69ba24b8-f26e-4a0a-a0de-6daa29bde1d3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_69ba24b8-f26e-4a0a-a0de-6daa29bde1d3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_69ba24b8-f26e-4a0a-a0de-6daa29bde1d3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_598ad02d-90ae-466d-b9ba-7401399d1097" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_69ba24b8-f26e-4a0a-a0de-6daa29bde1d3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_598ad02d-90ae-466d-b9ba-7401399d1097" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_BuildingAndEquipmentMember_1f548f64-7a6d-47cf-93b5-263f722b687e" xlink:href="cron-20201231.xsd#cron_BuildingAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_598ad02d-90ae-466d-b9ba-7401399d1097" xlink:to="loc_cron_BuildingAndEquipmentMember_1f548f64-7a6d-47cf-93b5-263f722b687e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_ddcc8280-89b0-4928-95b8-446ba047c99d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LandMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_598ad02d-90ae-466d-b9ba-7401399d1097" xlink:to="loc_us-gaap_LandMember_ddcc8280-89b0-4928-95b8-446ba047c99d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/LeasesScheduleofLeaseCostandOtherInformationDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#LeasesScheduleofLeaseCostandOtherInformationDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/LeasesScheduleofLeaseCostandOtherInformationDetails" xlink:type="extended" id="i49564f275348429db7ba7ae81c1365d5_LeasesScheduleofLeaseCostandOtherInformationDetails"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/GeneralandAdministrativeExpenses" xlink:type="simple" xlink:href="cron-20201231.xsd#GeneralandAdministrativeExpenses"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/GeneralandAdministrativeExpenses" xlink:type="extended" id="i3d1c821b60b24a9696933211eda00c58_GeneralandAdministrativeExpenses"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/GeneralandAdministrativeExpensesTables" xlink:type="simple" xlink:href="cron-20201231.xsd#GeneralandAdministrativeExpensesTables"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/GeneralandAdministrativeExpensesTables" xlink:type="extended" id="idadb32713c4e42718143022fae655a8d_GeneralandAdministrativeExpensesTables"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/GeneralandAdministrativeExpensesScheduleofGeneralandAdministrativeExpensesDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#GeneralandAdministrativeExpensesScheduleofGeneralandAdministrativeExpensesDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/GeneralandAdministrativeExpensesScheduleofGeneralandAdministrativeExpensesDetails" xlink:type="extended" id="i44461aea86b545d0aeabf1d2dd90afb0_GeneralandAdministrativeExpensesScheduleofGeneralandAdministrativeExpensesDetails"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/DerivativeLiabilities" xlink:type="simple" xlink:href="cron-20201231.xsd#DerivativeLiabilities"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/DerivativeLiabilities" xlink:type="extended" id="i9bca3588757b4b0eb536d4701a338d19_DerivativeLiabilities"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/DerivativeLiabilitiesTables" xlink:type="simple" xlink:href="cron-20201231.xsd#DerivativeLiabilitiesTables"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/DerivativeLiabilitiesTables" xlink:type="extended" id="i10e697bc8b1441429dd5dff98a91075d_DerivativeLiabilitiesTables"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#DerivativeLiabilitiesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails" xlink:type="extended" id="i4bf6ee026c2545a9b326339bbac3aebd_DerivativeLiabilitiesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_3a583543-ae29-45eb-9baf-d8a3934680ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_c391963f-9950-4198-9834-f61ae249519a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_3a583543-ae29-45eb-9baf-d8a3934680ef" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_c391963f-9950-4198-9834-f61ae249519a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ClassOfWarrantOrRightNumberOfWarrantsIssued_70a16306-ded7-4db6-a963-4c5e92c8f8dc" xlink:href="cron-20201231.xsd#cron_ClassOfWarrantOrRightNumberOfWarrantsIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_3a583543-ae29-45eb-9baf-d8a3934680ef" xlink:to="loc_cron_ClassOfWarrantOrRightNumberOfWarrantsIssued_70a16306-ded7-4db6-a963-4c5e92c8f8dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_ced00c1a-e394-4617-b334-afa50b378ba0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_3a583543-ae29-45eb-9baf-d8a3934680ef" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_ced00c1a-e394-4617-b334-afa50b378ba0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised_54140e2f-536e-4bdd-a4bd-01d708863e78" xlink:href="cron-20201231.xsd#cron_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_3a583543-ae29-45eb-9baf-d8a3934680ef" xlink:to="loc_cron_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised_54140e2f-536e-4bdd-a4bd-01d708863e78" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage_8bd85fd7-0c57-489e-85a1-ff73120384ae" xlink:href="cron-20201231.xsd#cron_ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_3a583543-ae29-45eb-9baf-d8a3934680ef" xlink:to="loc_cron_ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage_8bd85fd7-0c57-489e-85a1-ff73120384ae" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ClassOfWarrantOrRightAdditionalSubscriptionNumberOfSecuritiesCalledByWarrantsOrRights_65da0c19-20d3-4be7-b656-41442a4880e6" xlink:href="cron-20201231.xsd#cron_ClassOfWarrantOrRightAdditionalSubscriptionNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_3a583543-ae29-45eb-9baf-d8a3934680ef" xlink:to="loc_cron_ClassOfWarrantOrRightAdditionalSubscriptionNumberOfSecuritiesCalledByWarrantsOrRights_65da0c19-20d3-4be7-b656-41442a4880e6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_a733b45e-9a62-40fa-a52b-747ad3c6f7ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_3a583543-ae29-45eb-9baf-d8a3934680ef" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_a733b45e-9a62-40fa-a52b-747ad3c6f7ff" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ClassOfWarrantOrRightMinimumOwnershipPercentageRequired_9664a40a-d3bd-46a9-b5f9-adf69d2b8403" xlink:href="cron-20201231.xsd#cron_ClassOfWarrantOrRightMinimumOwnershipPercentageRequired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_3a583543-ae29-45eb-9baf-d8a3934680ef" xlink:to="loc_cron_ClassOfWarrantOrRightMinimumOwnershipPercentageRequired_9664a40a-d3bd-46a9-b5f9-adf69d2b8403" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod_37ec9eeb-ae68-46e1-b74c-f11245bca128" xlink:href="cron-20201231.xsd#cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_3a583543-ae29-45eb-9baf-d8a3934680ef" xlink:to="loc_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod_37ec9eeb-ae68-46e1-b74c-f11245bca128" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise_adf2795c-2512-4951-b149-51c7a54502d1" xlink:href="cron-20201231.xsd#cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_3a583543-ae29-45eb-9baf-d8a3934680ef" xlink:to="loc_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise_adf2795c-2512-4951-b149-51c7a54502d1" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ClassOfWarrantOrRightExpense_01930905-a619-443c-baa9-6f7f9e733f40" xlink:href="cron-20201231.xsd#cron_ClassOfWarrantOrRightExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_3a583543-ae29-45eb-9baf-d8a3934680ef" xlink:to="loc_cron_ClassOfWarrantOrRightExpense_01930905-a619-443c-baa9-6f7f9e733f40" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings_6b9fe40e-8a5d-40d1-9d8b-f9e12e37730e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_3a583543-ae29-45eb-9baf-d8a3934680ef" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings_6b9fe40e-8a5d-40d1-9d8b-f9e12e37730e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_2f0a4fea-a10c-4c22-955c-c7274f777e09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_3a583543-ae29-45eb-9baf-d8a3934680ef" xlink:to="loc_us-gaap_DerivativeTable_2f0a4fea-a10c-4c22-955c-c7274f777e09" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_1ef31f78-b4e5-4196-8875-03739054ed50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_2f0a4fea-a10c-4c22-955c-c7274f777e09" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_1ef31f78-b4e5-4196-8875-03739054ed50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1ef31f78-b4e5-4196-8875-03739054ed50_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1ef31f78-b4e5-4196-8875-03739054ed50" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1ef31f78-b4e5-4196-8875-03739054ed50_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_402fb85b-5cf9-479e-9ce3-c12adcdcb70c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1ef31f78-b4e5-4196-8875-03739054ed50" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_402fb85b-5cf9-479e-9ce3-c12adcdcb70c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaInvestmentMember_1d9bf883-9f2e-4ea8-9828-7c2ea1bc4e15" xlink:href="cron-20201231.xsd#cron_AltriaInvestmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_402fb85b-5cf9-479e-9ce3-c12adcdcb70c" xlink:to="loc_cron_AltriaInvestmentMember_1d9bf883-9f2e-4ea8-9828-7c2ea1bc4e15" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaWarrantMember_ff47e82b-86ac-44d8-a8db-5ce2ceb018b3" xlink:href="cron-20201231.xsd#cron_AltriaWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_402fb85b-5cf9-479e-9ce3-c12adcdcb70c" xlink:to="loc_cron_AltriaWarrantMember_ff47e82b-86ac-44d8-a8db-5ce2ceb018b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PreemptiveRightsMember_35164aa5-14c0-441a-b948-dde5922a35a9" xlink:href="cron-20201231.xsd#cron_PreemptiveRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_402fb85b-5cf9-479e-9ce3-c12adcdcb70c" xlink:to="loc_cron_PreemptiveRightsMember_35164aa5-14c0-441a-b948-dde5922a35a9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_TopupRightsMember_4a0d0360-0402-4dcb-bbe9-d851d31099b7" xlink:href="cron-20201231.xsd#cron_TopupRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_402fb85b-5cf9-479e-9ce3-c12adcdcb70c" xlink:to="loc_cron_TopupRightsMember_4a0d0360-0402-4dcb-bbe9-d851d31099b7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_2947a992-f8c4-4c39-b986-97d8e7c86a9c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_2f0a4fea-a10c-4c22-955c-c7274f777e09" xlink:to="loc_srt_ConsolidatedEntitiesAxis_2947a992-f8c4-4c39-b986-97d8e7c86a9c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_2947a992-f8c4-4c39-b986-97d8e7c86a9c_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_2947a992-f8c4-4c39-b986-97d8e7c86a9c" xlink:to="loc_srt_ConsolidatedEntitiesDomain_2947a992-f8c4-4c39-b986-97d8e7c86a9c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_4fd3a22f-7a68-48e0-81c2-2f8739691151" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_2947a992-f8c4-4c39-b986-97d8e7c86a9c" xlink:to="loc_srt_ConsolidatedEntitiesDomain_4fd3a22f-7a68-48e0-81c2-2f8739691151" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SubsidiariesMember_2f1b6369-4bc6-4bd2-8495-499aa7fe697b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SubsidiariesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_4fd3a22f-7a68-48e0-81c2-2f8739691151" xlink:to="loc_srt_SubsidiariesMember_2f1b6369-4bc6-4bd2-8495-499aa7fe697b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_92759ebf-16a0-4e03-90f0-6e822ecc3731" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_2f0a4fea-a10c-4c22-955c-c7274f777e09" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_92759ebf-16a0-4e03-90f0-6e822ecc3731" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_92759ebf-16a0-4e03-90f0-6e822ecc3731_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_92759ebf-16a0-4e03-90f0-6e822ecc3731" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_92759ebf-16a0-4e03-90f0-6e822ecc3731_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1a3bd006-a38c-4976-8c3e-c0fae1b8d214" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_92759ebf-16a0-4e03-90f0-6e822ecc3731" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1a3bd006-a38c-4976-8c3e-c0fae1b8d214" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaInvestmentMember_fed4c700-902e-4ec4-9b00-6b8bbc312fbc" xlink:href="cron-20201231.xsd#cron_AltriaInvestmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1a3bd006-a38c-4976-8c3e-c0fae1b8d214" xlink:to="loc_cron_AltriaInvestmentMember_fed4c700-902e-4ec4-9b00-6b8bbc312fbc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_f74d9686-15d5-4f50-a34f-89b040c22e22" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_2f0a4fea-a10c-4c22-955c-c7274f777e09" xlink:to="loc_dei_LegalEntityAxis_f74d9686-15d5-4f50-a34f-89b040c22e22" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_f74d9686-15d5-4f50-a34f-89b040c22e22_default" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_f74d9686-15d5-4f50-a34f-89b040c22e22" xlink:to="loc_dei_EntityDomain_f74d9686-15d5-4f50-a34f-89b040c22e22_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_5b0c34c2-92f5-4de4-8974-cc5c323fd430" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_f74d9686-15d5-4f50-a34f-89b040c22e22" xlink:to="loc_dei_EntityDomain_5b0c34c2-92f5-4de4-8974-cc5c323fd430" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaGroupInc.Member_5a177c07-d8f2-4414-a8a9-81e53a90a930" xlink:href="cron-20201231.xsd#cron_AltriaGroupInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_5b0c34c2-92f5-4de4-8974-cc5c323fd430" xlink:to="loc_cron_AltriaGroupInc.Member_5a177c07-d8f2-4414-a8a9-81e53a90a930" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_80f1114a-0d99-45a3-9778-f8d26b0c8acd" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_2f0a4fea-a10c-4c22-955c-c7274f777e09" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_80f1114a-0d99-45a3-9778-f8d26b0c8acd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_80f1114a-0d99-45a3-9778-f8d26b0c8acd_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_80f1114a-0d99-45a3-9778-f8d26b0c8acd" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_80f1114a-0d99-45a3-9778-f8d26b0c8acd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_e8ef8ff7-9034-4cc5-9efd-cb278150f914" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_80f1114a-0d99-45a3-9778-f8d26b0c8acd" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_e8ef8ff7-9034-4cc5-9efd-cb278150f914" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosGroupInc.Member_d14872aa-e1c5-4c3c-8178-7794433ccdc1" xlink:href="cron-20201231.xsd#cron_CronosGroupInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_e8ef8ff7-9034-4cc5-9efd-cb278150f914" xlink:to="loc_cron_CronosGroupInc.Member_d14872aa-e1c5-4c3c-8178-7794433ccdc1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails" xlink:type="extended" id="i91ebfb4a5f404ff48f75d33b85050553_DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a83a5d5a-835d-4e9f-8d4e-eed867bc5e71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DerivativeInstrumentsRollForward_ee50ec9d-9fed-4948-b338-785fbfe6e49e" xlink:href="cron-20201231.xsd#cron_DerivativeInstrumentsRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a83a5d5a-835d-4e9f-8d4e-eed867bc5e71" xlink:to="loc_cron_DerivativeInstrumentsRollForward_ee50ec9d-9fed-4948-b338-785fbfe6e49e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_b6eb208a-8ac0-432a-a88a-6a2529495895" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_DerivativeInstrumentsRollForward_ee50ec9d-9fed-4948-b338-785fbfe6e49e" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_b6eb208a-8ac0-432a-a88a-6a2529495895" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings_e790c54a-edfa-4109-a167-2ce802eae918" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_DerivativeInstrumentsRollForward_ee50ec9d-9fed-4948-b338-785fbfe6e49e" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings_e790c54a-edfa-4109-a167-2ce802eae918" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements_ded068f8-8005-4f6b-91f9-e384067de7fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_DerivativeInstrumentsRollForward_ee50ec9d-9fed-4948-b338-785fbfe6e49e" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements_ded068f8-8005-4f6b-91f9-e384067de7fc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss_aaf9d292-3c9e-4dba-881e-4e101f6681a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_DerivativeInstrumentsRollForward_ee50ec9d-9fed-4948-b338-785fbfe6e49e" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss_aaf9d292-3c9e-4dba-881e-4e101f6681a2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_0411d8a5-ab8f-40fa-8a36-0ead5bfd80f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ff103de4-7b7c-44fe-a7a3-7a76977e0238" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a83a5d5a-835d-4e9f-8d4e-eed867bc5e71" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ff103de4-7b7c-44fe-a7a3-7a76977e0238" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_0a25535b-3a8e-4103-a581-26e0d280d8d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ff103de4-7b7c-44fe-a7a3-7a76977e0238" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_0a25535b-3a8e-4103-a581-26e0d280d8d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_0a25535b-3a8e-4103-a581-26e0d280d8d6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_0a25535b-3a8e-4103-a581-26e0d280d8d6" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_0a25535b-3a8e-4103-a581-26e0d280d8d6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_4829680e-2b0c-46b9-b938-94f7e60fcd08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_0a25535b-3a8e-4103-a581-26e0d280d8d6" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_4829680e-2b0c-46b9-b938-94f7e60fcd08" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaWarrantMember_8b0cbd62-5006-43e0-bd1b-ce7145816062" xlink:href="cron-20201231.xsd#cron_AltriaWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_4829680e-2b0c-46b9-b938-94f7e60fcd08" xlink:to="loc_cron_AltriaWarrantMember_8b0cbd62-5006-43e0-bd1b-ce7145816062" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PreemptiveRightsMember_43f74298-3a23-4c5c-a48a-7e3b4756c28e" xlink:href="cron-20201231.xsd#cron_PreemptiveRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_4829680e-2b0c-46b9-b938-94f7e60fcd08" xlink:to="loc_cron_PreemptiveRightsMember_43f74298-3a23-4c5c-a48a-7e3b4756c28e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_TopupRightsMember_e99cc29d-b7b7-475b-8cbe-ea01a7bfade1" xlink:href="cron-20201231.xsd#cron_TopupRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_4829680e-2b0c-46b9-b938-94f7e60fcd08" xlink:to="loc_cron_TopupRightsMember_e99cc29d-b7b7-475b-8cbe-ea01a7bfade1" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails" xlink:type="extended" id="i7fd550ef306e46bca9d49815c49a4b6e_DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_641f125c-67d0-4e46-ae6b-0dea88dc3557" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityMeasurementInput_234d2eea-7d47-4039-b04b-6bb9ed6bfde5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilityMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_641f125c-67d0-4e46-ae6b-0dea88dc3557" xlink:to="loc_us-gaap_DerivativeLiabilityMeasurementInput_234d2eea-7d47-4039-b04b-6bb9ed6bfde5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DerivativeLiabilityUsefulLifeTerm_e084c689-71eb-42b6-af13-2ae23739b9d3" xlink:href="cron-20201231.xsd#cron_DerivativeLiabilityUsefulLifeTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_641f125c-67d0-4e46-ae6b-0dea88dc3557" xlink:to="loc_cron_DerivativeLiabilityUsefulLifeTerm_e084c689-71eb-42b6-af13-2ae23739b9d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_9ffaf790-84d1-42b8-a0e2-2ee81c843bb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_641f125c-67d0-4e46-ae6b-0dea88dc3557" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_9ffaf790-84d1-42b8-a0e2-2ee81c843bb7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_9bdc68e2-8608-4a8a-8752-ff4adebb113e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_9ffaf790-84d1-42b8-a0e2-2ee81c843bb7" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_9bdc68e2-8608-4a8a-8752-ff4adebb113e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_9bdc68e2-8608-4a8a-8752-ff4adebb113e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_9bdc68e2-8608-4a8a-8752-ff4adebb113e" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_9bdc68e2-8608-4a8a-8752-ff4adebb113e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_c4465d2e-b8ec-40a0-a651-0de42b68c410" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_9bdc68e2-8608-4a8a-8752-ff4adebb113e" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_c4465d2e-b8ec-40a0-a651-0de42b68c410" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaWarrantMember_ab772d7c-1320-4ee8-9b62-6351bdb5d620" xlink:href="cron-20201231.xsd#cron_AltriaWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_c4465d2e-b8ec-40a0-a651-0de42b68c410" xlink:to="loc_cron_AltriaWarrantMember_ab772d7c-1320-4ee8-9b62-6351bdb5d620" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PreemptiveRightsMember_cc12be04-3920-49b3-afd5-a71e62611ddb" xlink:href="cron-20201231.xsd#cron_PreemptiveRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_c4465d2e-b8ec-40a0-a651-0de42b68c410" xlink:to="loc_cron_PreemptiveRightsMember_cc12be04-3920-49b3-afd5-a71e62611ddb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_TopupRightsMember_5a996c6b-9138-4f5c-b885-a6ef1651f6b8" xlink:href="cron-20201231.xsd#cron_TopupRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_c4465d2e-b8ec-40a0-a651-0de42b68c410" xlink:to="loc_cron_TopupRightsMember_5a996c6b-9138-4f5c-b885-a6ef1651f6b8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PreEmptiveRightsAndTopUpRightsMember_663acf03-9d3b-4e02-a9c1-e7cc5ec10ee3" xlink:href="cron-20201231.xsd#cron_PreEmptiveRightsAndTopUpRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_c4465d2e-b8ec-40a0-a651-0de42b68c410" xlink:to="loc_cron_PreEmptiveRightsAndTopUpRightsMember_663acf03-9d3b-4e02-a9c1-e7cc5ec10ee3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_b1ee8e98-3527-4d10-9609-65f82b2a2152" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_9ffaf790-84d1-42b8-a0e2-2ee81c843bb7" xlink:to="loc_srt_RangeAxis_b1ee8e98-3527-4d10-9609-65f82b2a2152" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b1ee8e98-3527-4d10-9609-65f82b2a2152_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_b1ee8e98-3527-4d10-9609-65f82b2a2152" xlink:to="loc_srt_RangeMember_b1ee8e98-3527-4d10-9609-65f82b2a2152_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0e55037d-821e-43dc-8b8b-92a340897dbd" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_b1ee8e98-3527-4d10-9609-65f82b2a2152" xlink:to="loc_srt_RangeMember_0e55037d-821e-43dc-8b8b-92a340897dbd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_d8def3c0-1b19-48ba-90e8-75669ed2ff99" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_WeightedAverageMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_0e55037d-821e-43dc-8b8b-92a340897dbd" xlink:to="loc_srt_WeightedAverageMember_d8def3c0-1b19-48ba-90e8-75669ed2ff99" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_93933452-a210-4c62-869b-dbc5384974f8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_0e55037d-821e-43dc-8b8b-92a340897dbd" xlink:to="loc_srt_MinimumMember_93933452-a210-4c62-869b-dbc5384974f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_90b1f341-7540-4dbf-9d3a-a157ed14a053" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_0e55037d-821e-43dc-8b8b-92a340897dbd" xlink:to="loc_srt_MaximumMember_90b1f341-7540-4dbf-9d3a-a157ed14a053" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_58e325d8-ad99-4a17-a0a6-3b34e7002324" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_9ffaf790-84d1-42b8-a0e2-2ee81c843bb7" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_58e325d8-ad99-4a17-a0a6-3b34e7002324" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_58e325d8-ad99-4a17-a0a6-3b34e7002324_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_58e325d8-ad99-4a17-a0a6-3b34e7002324" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_58e325d8-ad99-4a17-a0a6-3b34e7002324_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_76359c52-0389-4c2b-8f51-7e6a385bc172" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_58e325d8-ad99-4a17-a0a6-3b34e7002324" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_76359c52-0389-4c2b-8f51-7e6a385bc172" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputSharePriceMember_02976b2b-5ce4-4d18-a0c6-f7d530bb4bb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputSharePriceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_76359c52-0389-4c2b-8f51-7e6a385bc172" xlink:to="loc_us-gaap_MeasurementInputSharePriceMember_02976b2b-5ce4-4d18-a0c6-f7d530bb4bb1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_MeasurementInputSubscriptionPriceMember_42e44ed2-40d4-4491-8827-90f825297ba7" xlink:href="cron-20201231.xsd#cron_MeasurementInputSubscriptionPriceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_76359c52-0389-4c2b-8f51-7e6a385bc172" xlink:to="loc_cron_MeasurementInputSubscriptionPriceMember_42e44ed2-40d4-4491-8827-90f825297ba7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_bcf380e3-d2c2-4d54-8547-053d29607b18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_76359c52-0389-4c2b-8f51-7e6a385bc172" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_bcf380e3-d2c2-4d54-8547-053d29607b18" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember_77377f44-9c93-4521-bc48-eeae57233d08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputExpectedTermMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_76359c52-0389-4c2b-8f51-7e6a385bc172" xlink:to="loc_us-gaap_MeasurementInputExpectedTermMember_77377f44-9c93-4521-bc48-eeae57233d08" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember_faab05bf-8886-47cb-bd7f-05408be3b214" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_76359c52-0389-4c2b-8f51-7e6a385bc172" xlink:to="loc_us-gaap_MeasurementInputPriceVolatilityMember_faab05bf-8886-47cb-bd7f-05408be3b214" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedDividendRateMember_183013e6-f98a-4d60-ac6f-c00c22489f2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputExpectedDividendRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_76359c52-0389-4c2b-8f51-7e6a385bc172" xlink:to="loc_us-gaap_MeasurementInputExpectedDividendRateMember_183013e6-f98a-4d60-ac6f-c00c22489f2f" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails" xlink:type="extended" id="i37adbc0cfc08447bba2218a2b0972bef_DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_4e4e4b14-d9fd-43be-90d1-548a4eadd8f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract_504a78db-78c8-420a-a5df-64ac6fc28845" xlink:href="cron-20201231.xsd#cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_4e4e4b14-d9fd-43be-90d1-548a4eadd8f6" xlink:to="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract_504a78db-78c8-420a-a5df-64ac6fc28845" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss_e045952b-2cd9-4dc3-94cd-ceb868084f9e" xlink:href="cron-20201231.xsd#cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract_504a78db-78c8-420a-a5df-64ac6fc28845" xlink:to="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss_e045952b-2cd9-4dc3-94cd-ceb868084f9e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss_664ce1b0-679f-47a5-bd83-05520ed6db82" xlink:href="cron-20201231.xsd#cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract_504a78db-78c8-420a-a5df-64ac6fc28845" xlink:to="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss_664ce1b0-679f-47a5-bd83-05520ed6db82" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss_626e802d-6408-45a4-9c81-42912ea12406" xlink:href="cron-20201231.xsd#cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract_504a78db-78c8-420a-a5df-64ac6fc28845" xlink:to="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss_626e802d-6408-45a4-9c81-42912ea12406" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_e05bfbc9-3f3f-49f8-a976-453f31b33181" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_4e4e4b14-d9fd-43be-90d1-548a4eadd8f6" xlink:to="loc_us-gaap_DerivativeTable_e05bfbc9-3f3f-49f8-a976-453f31b33181" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_76b6898f-335c-400e-8d66-750650a7f8e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_e05bfbc9-3f3f-49f8-a976-453f31b33181" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_76b6898f-335c-400e-8d66-750650a7f8e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_76b6898f-335c-400e-8d66-750650a7f8e6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_76b6898f-335c-400e-8d66-750650a7f8e6" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_76b6898f-335c-400e-8d66-750650a7f8e6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1ea9c49e-a068-47fc-8224-2f35dfbb73c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_76b6898f-335c-400e-8d66-750650a7f8e6" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1ea9c49e-a068-47fc-8224-2f35dfbb73c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaWarrantMember_9cca01a2-fb34-4dc9-8a6a-d3794fb99de7" xlink:href="cron-20201231.xsd#cron_AltriaWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1ea9c49e-a068-47fc-8224-2f35dfbb73c3" xlink:to="loc_cron_AltriaWarrantMember_9cca01a2-fb34-4dc9-8a6a-d3794fb99de7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PreemptiveRightsMember_f4e7a0b6-ed76-41e8-b5d2-b2c77a7e510a" xlink:href="cron-20201231.xsd#cron_PreemptiveRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1ea9c49e-a068-47fc-8224-2f35dfbb73c3" xlink:to="loc_cron_PreemptiveRightsMember_f4e7a0b6-ed76-41e8-b5d2-b2c77a7e510a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_TopupRightsMember_382b0e5f-6761-4358-8088-8bf7ccaee524" xlink:href="cron-20201231.xsd#cron_TopupRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1ea9c49e-a068-47fc-8224-2f35dfbb73c3" xlink:to="loc_cron_TopupRightsMember_382b0e5f-6761-4358-8088-8bf7ccaee524" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/CapitalStock" xlink:type="simple" xlink:href="cron-20201231.xsd#CapitalStock"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/CapitalStock" xlink:type="extended" id="ifa824d6bf036420b8473205eef8a9f44_CapitalStock"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/CapitalStockTables" xlink:type="simple" xlink:href="cron-20201231.xsd#CapitalStockTables"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/CapitalStockTables" xlink:type="extended" id="i40dd90c0dcfb45af8172c39ed6d088ce_CapitalStockTables"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/CapitalStockNarrativeDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#CapitalStockNarrativeDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/CapitalStockNarrativeDetails" xlink:type="extended" id="iecd14f4c32344078a51761da71cced20_CapitalStockNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_8ec982c0-12a2-45b3-bd0a-2beba7a68105" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CommonStockNumberOfVotesPerShare_c3fad50f-e1ec-41d4-b4d7-baf7b63952e8" xlink:href="cron-20201231.xsd#cron_CommonStockNumberOfVotesPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_8ec982c0-12a2-45b3-bd0a-2beba7a68105" xlink:to="loc_cron_CommonStockNumberOfVotesPerShare_c3fad50f-e1ec-41d4-b4d7-baf7b63952e8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_b80c57ca-982d-4394-9eb1-b5479c946ba9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_8ec982c0-12a2-45b3-bd0a-2beba7a68105" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_b80c57ca-982d-4394-9eb1-b5479c946ba9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_eda2cff8-8a71-41dc-aade-d82df7daeb4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_8ec982c0-12a2-45b3-bd0a-2beba7a68105" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_eda2cff8-8a71-41dc-aade-d82df7daeb4d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_8ffb7ba6-64f1-4679-af05-0f93375e1609" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_8ec982c0-12a2-45b3-bd0a-2beba7a68105" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_8ffb7ba6-64f1-4679-af05-0f93375e1609" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PaymentOfTransactionCosts_82afc2dd-5be9-4d43-ad3a-114ae2a2fa1e" xlink:href="cron-20201231.xsd#cron_PaymentOfTransactionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_8ec982c0-12a2-45b3-bd0a-2beba7a68105" xlink:to="loc_cron_PaymentOfTransactionCosts_82afc2dd-5be9-4d43-ad3a-114ae2a2fa1e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_StockIssuedDuringPeriodNewIssuesFairValue_ea245037-9644-42e3-906f-f9c586f41d15" xlink:href="cron-20201231.xsd#cron_StockIssuedDuringPeriodNewIssuesFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_8ec982c0-12a2-45b3-bd0a-2beba7a68105" xlink:to="loc_cron_StockIssuedDuringPeriodNewIssuesFairValue_ea245037-9644-42e3-906f-f9c586f41d15" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_ad501978-7797-4330-88d5-9c727ab66e47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_8ec982c0-12a2-45b3-bd0a-2beba7a68105" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_ad501978-7797-4330-88d5-9c727ab66e47" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CommonStockVestingRightsNumberOfEqualInstallments_40d9244e-64d5-4253-bdbe-c66191a0b11e" xlink:href="cron-20201231.xsd#cron_CommonStockVestingRightsNumberOfEqualInstallments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_8ec982c0-12a2-45b3-bd0a-2beba7a68105" xlink:to="loc_cron_CommonStockVestingRightsNumberOfEqualInstallments_40d9244e-64d5-4253-bdbe-c66191a0b11e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_a3039b4e-d387-4411-8ae2-7d952b671a06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_8ec982c0-12a2-45b3-bd0a-2beba7a68105" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_a3039b4e-d387-4411-8ae2-7d952b671a06" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_StockIssuedDuringPeriodNewIssuesWeightedAveragePricePeriod_360aafc9-793e-4b32-aa3d-3ec9c35e18be" xlink:href="cron-20201231.xsd#cron_StockIssuedDuringPeriodNewIssuesWeightedAveragePricePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_8ec982c0-12a2-45b3-bd0a-2beba7a68105" xlink:to="loc_cron_StockIssuedDuringPeriodNewIssuesWeightedAveragePricePeriod_360aafc9-793e-4b32-aa3d-3ec9c35e18be" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_67a4f1d5-b108-46c9-a916-ae647b57b9f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_8ec982c0-12a2-45b3-bd0a-2beba7a68105" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_67a4f1d5-b108-46c9-a916-ae647b57b9f7" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_9aa9d202-bb62-4e94-a7d7-2327a36a9cac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_8ec982c0-12a2-45b3-bd0a-2beba7a68105" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_9aa9d202-bb62-4e94-a7d7-2327a36a9cac" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_25c94175-dc95-4e54-97b2-39b961a07eb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_9aa9d202-bb62-4e94-a7d7-2327a36a9cac" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_25c94175-dc95-4e54-97b2-39b961a07eb1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_25c94175-dc95-4e54-97b2-39b961a07eb1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_25c94175-dc95-4e54-97b2-39b961a07eb1" xlink:to="loc_us-gaap_EquityComponentDomain_25c94175-dc95-4e54-97b2-39b961a07eb1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2144e6c9-ab5a-463a-b790-7fa8085f122e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_25c94175-dc95-4e54-97b2-39b961a07eb1" xlink:to="loc_us-gaap_EquityComponentDomain_2144e6c9-ab5a-463a-b790-7fa8085f122e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_0f6d1bd8-1881-43f2-969f-2269af96a883" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2144e6c9-ab5a-463a-b790-7fa8085f122e" xlink:to="loc_us-gaap_CommonStockMember_0f6d1bd8-1881-43f2-969f-2269af96a883" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AdditionalPaidinCapitalAttributableToConvertibleOptionMember_06c95432-bb29-4518-b0f1-429467c79fb1" xlink:href="cron-20201231.xsd#cron_AdditionalPaidinCapitalAttributableToConvertibleOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2144e6c9-ab5a-463a-b790-7fa8085f122e" xlink:to="loc_cron_AdditionalPaidinCapitalAttributableToConvertibleOptionMember_06c95432-bb29-4518-b0f1-429467c79fb1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_feb14cce-7b52-4f49-8e75-7a1974f080bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_9aa9d202-bb62-4e94-a7d7-2327a36a9cac" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_feb14cce-7b52-4f49-8e75-7a1974f080bc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_feb14cce-7b52-4f49-8e75-7a1974f080bc_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_feb14cce-7b52-4f49-8e75-7a1974f080bc" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_feb14cce-7b52-4f49-8e75-7a1974f080bc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5ec5d5c1-8a79-4510-9a19-9446eaba2045" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_feb14cce-7b52-4f49-8e75-7a1974f080bc" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5ec5d5c1-8a79-4510-9a19-9446eaba2045" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaInvestmentMember_03677b19-1245-4441-a55a-0f92afde830b" xlink:href="cron-20201231.xsd#cron_AltriaInvestmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5ec5d5c1-8a79-4510-9a19-9446eaba2045" xlink:to="loc_cron_AltriaInvestmentMember_03677b19-1245-4441-a55a-0f92afde830b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_RedwoodAcquisitionMember_fc454fe6-11be-4205-8dd2-08eb2eeb90a4" xlink:href="cron-20201231.xsd#cron_RedwoodAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5ec5d5c1-8a79-4510-9a19-9446eaba2045" xlink:to="loc_cron_RedwoodAcquisitionMember_fc454fe6-11be-4205-8dd2-08eb2eeb90a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember_d74723ba-5b73-440f-9a53-107661c3f2c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrivatePlacementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5ec5d5c1-8a79-4510-9a19-9446eaba2045" xlink:to="loc_us-gaap_PrivatePlacementMember_d74723ba-5b73-440f-9a53-107661c3f2c0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_BoughtDealOfferingsMember_75d4c00a-90be-4527-840e-b925c9054fcc" xlink:href="cron-20201231.xsd#cron_BoughtDealOfferingsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5ec5d5c1-8a79-4510-9a19-9446eaba2045" xlink:to="loc_cron_BoughtDealOfferingsMember_75d4c00a-90be-4527-840e-b925c9054fcc" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/CapitalStockScheduleofCommonSharesIssuedDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#CapitalStockScheduleofCommonSharesIssuedDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/CapitalStockScheduleofCommonSharesIssuedDetails" xlink:type="extended" id="ibebc9a2a16b040f6abdf6666f24b83da_CapitalStockScheduleofCommonSharesIssuedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_12d3abe3-2984-4a83-8777-1570871ae133" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_4e6ff126-4878-4ecd-8501-53d333512006" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_12d3abe3-2984-4a83-8777-1570871ae133" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_4e6ff126-4878-4ecd-8501-53d333512006" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_cbd88434-71d4-43c9-b19d-b869311615c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_12d3abe3-2984-4a83-8777-1570871ae133" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_cbd88434-71d4-43c9-b19d-b869311615c3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_0df5c3c9-2e0d-45da-9c43-17ef83f4c5e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_cbd88434-71d4-43c9-b19d-b869311615c3" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_0df5c3c9-2e0d-45da-9c43-17ef83f4c5e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0df5c3c9-2e0d-45da-9c43-17ef83f4c5e6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_0df5c3c9-2e0d-45da-9c43-17ef83f4c5e6" xlink:to="loc_us-gaap_EquityComponentDomain_0df5c3c9-2e0d-45da-9c43-17ef83f4c5e6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0b28d3ad-7dcf-4f09-83ca-5ff9f7ddd987" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_0df5c3c9-2e0d-45da-9c43-17ef83f4c5e6" xlink:to="loc_us-gaap_EquityComponentDomain_0b28d3ad-7dcf-4f09-83ca-5ff9f7ddd987" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_35142eb2-0ca1-4fd6-a67a-490221224b55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0b28d3ad-7dcf-4f09-83ca-5ff9f7ddd987" xlink:to="loc_us-gaap_CommonStockMember_35142eb2-0ca1-4fd6-a67a-490221224b55" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_b84c4f7d-eb4a-472a-85a5-42e13c0faba1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_cbd88434-71d4-43c9-b19d-b869311615c3" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_b84c4f7d-eb4a-472a-85a5-42e13c0faba1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b84c4f7d-eb4a-472a-85a5-42e13c0faba1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_b84c4f7d-eb4a-472a-85a5-42e13c0faba1" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b84c4f7d-eb4a-472a-85a5-42e13c0faba1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b204fc91-480d-4593-a966-ef0822187097" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_b84c4f7d-eb4a-472a-85a5-42e13c0faba1" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b204fc91-480d-4593-a966-ef0822187097" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaInvestmentMember_03f36df1-a80d-4e6d-b215-ee7c7ab7a9f9" xlink:href="cron-20201231.xsd#cron_AltriaInvestmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b204fc91-480d-4593-a966-ef0822187097" xlink:to="loc_cron_AltriaInvestmentMember_03f36df1-a80d-4e6d-b215-ee7c7ab7a9f9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_RedwoodAcquisitionMember_179cfc41-bddf-4dc7-9ce1-1e55f19ccf47" xlink:href="cron-20201231.xsd#cron_RedwoodAcquisitionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b204fc91-480d-4593-a966-ef0822187097" xlink:to="loc_cron_RedwoodAcquisitionMember_179cfc41-bddf-4dc7-9ce1-1e55f19ccf47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember_1080c556-57be-489c-b464-d20f331da0ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrivatePlacementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b204fc91-480d-4593-a966-ef0822187097" xlink:to="loc_us-gaap_PrivatePlacementMember_1080c556-57be-489c-b464-d20f331da0ea" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_BoughtDealOfferingsMember_9ea5ed1e-5774-4f37-b98a-cbfc26af561d" xlink:href="cron-20201231.xsd#cron_BoughtDealOfferingsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b204fc91-480d-4593-a966-ef0822187097" xlink:to="loc_cron_BoughtDealOfferingsMember_9ea5ed1e-5774-4f37-b98a-cbfc26af561d" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedPayments" xlink:type="simple" xlink:href="cron-20201231.xsd#SharebasedPayments"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/SharebasedPayments" xlink:type="extended" id="i0a298fbfd53b4fb3916ea18c92319129_SharebasedPayments"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedPaymentsTables" xlink:type="simple" xlink:href="cron-20201231.xsd#SharebasedPaymentsTables"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/SharebasedPaymentsTables" xlink:type="extended" id="i848cc6604365463cafccb9220bc28ada_SharebasedPaymentsTables"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinWarrantsDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#SharebasedPaymentsSummaryofChangesinWarrantsDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinWarrantsDetails" xlink:type="extended" id="i24a454f078c14f5eb495d5a1def30c04_SharebasedPaymentsSummaryofChangesinWarrantsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0b279add-7d78-46a1-901c-b3a463e05df8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_28ebebb6-b2fc-45ff-9afc-32c155863f5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0b279add-7d78-46a1-901c-b3a463e05df8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_28ebebb6-b2fc-45ff-9afc-32c155863f5d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_27d1004f-9572-4395-9e10-2274730a7e94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_28ebebb6-b2fc-45ff-9afc-32c155863f5d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_27d1004f-9572-4395-9e10-2274730a7e94" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_3b552011-f0ec-448b-b665-ef38295d2b7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_28ebebb6-b2fc-45ff-9afc-32c155863f5d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_3b552011-f0ec-448b-b665-ef38295d2b7d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_e919924d-8d6b-4e08-98ff-9d1edc97a8f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b06a2cfc-ffa4-445a-a6f3-df64f4552ee5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0b279add-7d78-46a1-901c-b3a463e05df8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b06a2cfc-ffa4-445a-a6f3-df64f4552ee5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_d27ec7cb-915a-492f-897a-5a41fdcebfbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b06a2cfc-ffa4-445a-a6f3-df64f4552ee5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_d27ec7cb-915a-492f-897a-5a41fdcebfbc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_dd19a655-c226-41ac-9274-274b88a94bf6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b06a2cfc-ffa4-445a-a6f3-df64f4552ee5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_dd19a655-c226-41ac-9274-274b88a94bf6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_ac29d62b-2e44-4aad-9217-9f960d6cd514" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8736d0a7-84e8-44e1-b4dc-e7eba9e0e1a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0b279add-7d78-46a1-901c-b3a463e05df8" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8736d0a7-84e8-44e1-b4dc-e7eba9e0e1a0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_bcaf0a47-1229-497e-b0f1-3d0a2df9b958" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8736d0a7-84e8-44e1-b4dc-e7eba9e0e1a0" xlink:to="loc_us-gaap_AwardTypeAxis_bcaf0a47-1229-497e-b0f1-3d0a2df9b958" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bcaf0a47-1229-497e-b0f1-3d0a2df9b958_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_bcaf0a47-1229-497e-b0f1-3d0a2df9b958" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bcaf0a47-1229-497e-b0f1-3d0a2df9b958_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ddd9f699-c351-4fd2-a178-6bf089d91fa6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_bcaf0a47-1229-497e-b0f1-3d0a2df9b958" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ddd9f699-c351-4fd2-a178-6bf089d91fa6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_0be5b876-caf1-4042-9320-d144a129a13c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ddd9f699-c351-4fd2-a178-6bf089d91fa6" xlink:to="loc_us-gaap_WarrantMember_0be5b876-caf1-4042-9320-d144a129a13c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedPaymentsSummaryofOutstandingWarrantsDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#SharebasedPaymentsSummaryofOutstandingWarrantsDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/SharebasedPaymentsSummaryofOutstandingWarrantsDetails" xlink:type="extended" id="i575767cb7cf94ee08ec1ab1327a33d9d_SharebasedPaymentsSummaryofOutstandingWarrantsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_beb3ce86-bc85-451e-8b73-9ca410038e5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_262e56da-7ac4-4e36-8229-d3ae8db9adca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_beb3ce86-bc85-451e-8b73-9ca410038e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_262e56da-7ac4-4e36-8229-d3ae8db9adca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_193a928a-58ae-429d-8ab0-e9d8aa0b9581" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_beb3ce86-bc85-451e-8b73-9ca410038e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_193a928a-58ae-429d-8ab0-e9d8aa0b9581" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_afc4f395-0fed-49b5-ba70-86eb152414d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_beb3ce86-bc85-451e-8b73-9ca410038e5e" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_afc4f395-0fed-49b5-ba70-86eb152414d2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_de780b3a-1c6b-479e-8ef1-f75017aa250b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_afc4f395-0fed-49b5-ba70-86eb152414d2" xlink:to="loc_us-gaap_AwardTypeAxis_de780b3a-1c6b-479e-8ef1-f75017aa250b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_de780b3a-1c6b-479e-8ef1-f75017aa250b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_de780b3a-1c6b-479e-8ef1-f75017aa250b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_de780b3a-1c6b-479e-8ef1-f75017aa250b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_73bc7eb9-2793-407c-ae18-aa42522058ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_de780b3a-1c6b-479e-8ef1-f75017aa250b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_73bc7eb9-2793-407c-ae18-aa42522058ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_a2619240-c740-4ff4-8b96-f899cd1c7468" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_73bc7eb9-2793-407c-ae18-aa42522058ee" xlink:to="loc_us-gaap_WarrantMember_a2619240-c740-4ff4-8b96-f899cd1c7468" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateAxis_88e05ccc-c7ac-4fdf-ae9c-9c043318ef8b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_afc4f395-0fed-49b5-ba70-86eb152414d2" xlink:to="loc_us-gaap_AwardDateAxis_88e05ccc-c7ac-4fdf-ae9c-9c043318ef8b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain_88e05ccc-c7ac-4fdf-ae9c-9c043318ef8b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardDateAxis_88e05ccc-c7ac-4fdf-ae9c-9c043318ef8b" xlink:to="loc_us-gaap_AwardDateDomain_88e05ccc-c7ac-4fdf-ae9c-9c043318ef8b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain_c64839cf-9a25-417e-9831-8a3ca7d9f1cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardDateAxis_88e05ccc-c7ac-4fdf-ae9c-9c043318ef8b" xlink:to="loc_us-gaap_AwardDateDomain_c64839cf-9a25-417e-9831-8a3ca7d9f1cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_GrantedMay132016ThroughMay272016Member_b305c287-d5c5-411e-be0d-2dc548411fe5" xlink:href="cron-20201231.xsd#cron_GrantedMay132016ThroughMay272016Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AwardDateDomain_c64839cf-9a25-417e-9831-8a3ca7d9f1cb" xlink:to="loc_cron_GrantedMay132016ThroughMay272016Member_b305c287-d5c5-411e-be0d-2dc548411fe5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#SharebasedPaymentsStockOptionsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails" xlink:type="extended" id="i61a3f4ed731f460e84613133db5dfbd6_SharebasedPaymentsStockOptionsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_18b92701-8b94-48a7-bb3a-18d26adc435b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_aa7c55e1-4c9b-43f2-a828-f0de2d484833" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_18b92701-8b94-48a7-bb3a-18d26adc435b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_aa7c55e1-4c9b-43f2-a828-f0de2d484833" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_fdc5a9c7-b776-4dd6-93ce-da73e5c8ed35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_18b92701-8b94-48a7-bb3a-18d26adc435b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_fdc5a9c7-b776-4dd6-93ce-da73e5c8ed35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_2dbb1889-7fba-48fc-881b-90e6bcb935e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_18b92701-8b94-48a7-bb3a-18d26adc435b" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_2dbb1889-7fba-48fc-881b-90e6bcb935e1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_dead86c1-d661-40d7-be72-fe3e45159f29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_18b92701-8b94-48a7-bb3a-18d26adc435b" xlink:to="loc_us-gaap_SharePrice_dead86c1-d661-40d7-be72-fe3e45159f29" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_823757a9-8cbf-40e6-848d-76def4a4b4ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_18b92701-8b94-48a7-bb3a-18d26adc435b" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_823757a9-8cbf-40e6-848d-76def4a4b4ee" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_5e40f550-6cc4-4a2c-b061-4bb12c9f4824" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_823757a9-8cbf-40e6-848d-76def4a4b4ee" xlink:to="loc_us-gaap_AwardTypeAxis_5e40f550-6cc4-4a2c-b061-4bb12c9f4824" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5e40f550-6cc4-4a2c-b061-4bb12c9f4824_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_5e40f550-6cc4-4a2c-b061-4bb12c9f4824" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5e40f550-6cc4-4a2c-b061-4bb12c9f4824_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f2aec4a1-855d-4ab2-af05-9dc9c0ff384c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_5e40f550-6cc4-4a2c-b061-4bb12c9f4824" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f2aec4a1-855d-4ab2-af05-9dc9c0ff384c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_55a70ded-8e4b-49ad-ae5b-a7f54bb87db4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f2aec4a1-855d-4ab2-af05-9dc9c0ff384c" xlink:to="loc_us-gaap_EmployeeStockOptionMember_55a70ded-8e4b-49ad-ae5b-a7f54bb87db4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c9d6e790-8a57-4e34-ae1b-f6950758cfcc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_823757a9-8cbf-40e6-848d-76def4a4b4ee" xlink:to="loc_srt_RangeAxis_c9d6e790-8a57-4e34-ae1b-f6950758cfcc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c9d6e790-8a57-4e34-ae1b-f6950758cfcc_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_c9d6e790-8a57-4e34-ae1b-f6950758cfcc" xlink:to="loc_srt_RangeMember_c9d6e790-8a57-4e34-ae1b-f6950758cfcc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_89170ac7-c3af-46d0-aed8-f6dbcee58184" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_c9d6e790-8a57-4e34-ae1b-f6950758cfcc" xlink:to="loc_srt_RangeMember_89170ac7-c3af-46d0-aed8-f6dbcee58184" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_5ab1b662-5223-4f92-bda7-bfe7bb3f32da" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_89170ac7-c3af-46d0-aed8-f6dbcee58184" xlink:to="loc_srt_MinimumMember_5ab1b662-5223-4f92-bda7-bfe7bb3f32da" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_08bf1229-de04-44f1-bc77-7335875e37eb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_89170ac7-c3af-46d0-aed8-f6dbcee58184" xlink:to="loc_srt_MaximumMember_08bf1229-de04-44f1-bc77-7335875e37eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_f1b6c085-c0f1-4f6e-9361-a262afb72d0c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_WeightedAverageMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_89170ac7-c3af-46d0-aed8-f6dbcee58184" xlink:to="loc_srt_WeightedAverageMember_f1b6c085-c0f1-4f6e-9361-a262afb72d0c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_6d358047-a1e2-4f29-a22f-6e3cce5f99c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_823757a9-8cbf-40e6-848d-76def4a4b4ee" xlink:to="loc_us-gaap_PlanNameAxis_6d358047-a1e2-4f29-a22f-6e3cce5f99c8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_6d358047-a1e2-4f29-a22f-6e3cce5f99c8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_6d358047-a1e2-4f29-a22f-6e3cce5f99c8" xlink:to="loc_us-gaap_PlanNameDomain_6d358047-a1e2-4f29-a22f-6e3cce5f99c8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_1d624712-c5d3-44f0-be59-63e560ec6b68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_6d358047-a1e2-4f29-a22f-6e3cce5f99c8" xlink:to="loc_us-gaap_PlanNameDomain_1d624712-c5d3-44f0-be59-63e560ec6b68" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_A2015StockOptionPlanMember_2d620e15-d7ab-495a-9d05-c7de90b3c2eb" xlink:href="cron-20201231.xsd#cron_A2015StockOptionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_1d624712-c5d3-44f0-be59-63e560ec6b68" xlink:to="loc_cron_A2015StockOptionPlanMember_2d620e15-d7ab-495a-9d05-c7de90b3c2eb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_A2018StockOptionPlanMember_0be25cab-0370-49bd-83bf-a085be8366e3" xlink:href="cron-20201231.xsd#cron_A2018StockOptionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_1d624712-c5d3-44f0-be59-63e560ec6b68" xlink:to="loc_cron_A2018StockOptionPlanMember_0be25cab-0370-49bd-83bf-a085be8366e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_A2020OmnibusPlanMember_c74bac48-1f09-494d-b5e3-82ca9bb478a0" xlink:href="cron-20201231.xsd#cron_A2020OmnibusPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_1d624712-c5d3-44f0-be59-63e560ec6b68" xlink:to="loc_cron_A2020OmnibusPlanMember_c74bac48-1f09-494d-b5e3-82ca9bb478a0" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedPaymentsScheduleofStockOptionsOutstandingDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#SharebasedPaymentsScheduleofStockOptionsOutstandingDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/SharebasedPaymentsScheduleofStockOptionsOutstandingDetails" xlink:type="extended" id="ibdaec6bbf6404f4e96049a46fc61be19_SharebasedPaymentsScheduleofStockOptionsOutstandingDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8e1a4d48-4bf7-459e-9d3e-1b2aa53a9cdf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1b9cec24-619f-49c1-a61f-618aa32bcd50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8e1a4d48-4bf7-459e-9d3e-1b2aa53a9cdf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1b9cec24-619f-49c1-a61f-618aa32bcd50" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c21c9e2b-6fb7-4af5-99fd-d41810b1cfd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8e1a4d48-4bf7-459e-9d3e-1b2aa53a9cdf" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c21c9e2b-6fb7-4af5-99fd-d41810b1cfd4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_23370cb9-5c47-4e02-98f6-2d1f2487b0a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c21c9e2b-6fb7-4af5-99fd-d41810b1cfd4" xlink:to="loc_us-gaap_PlanNameAxis_23370cb9-5c47-4e02-98f6-2d1f2487b0a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_23370cb9-5c47-4e02-98f6-2d1f2487b0a8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_23370cb9-5c47-4e02-98f6-2d1f2487b0a8" xlink:to="loc_us-gaap_PlanNameDomain_23370cb9-5c47-4e02-98f6-2d1f2487b0a8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_722a3f61-70bb-468a-8c61-21a46e37b88f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_23370cb9-5c47-4e02-98f6-2d1f2487b0a8" xlink:to="loc_us-gaap_PlanNameDomain_722a3f61-70bb-468a-8c61-21a46e37b88f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_A2020OmnibusPlanMember_c8626001-27ec-484c-9835-0ba6fed4486c" xlink:href="cron-20201231.xsd#cron_A2020OmnibusPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_722a3f61-70bb-468a-8c61-21a46e37b88f" xlink:to="loc_cron_A2020OmnibusPlanMember_c8626001-27ec-484c-9835-0ba6fed4486c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_A2018StockOptionPlanMember_6956c67c-87e0-482a-8679-9fc1f19cc881" xlink:href="cron-20201231.xsd#cron_A2018StockOptionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_722a3f61-70bb-468a-8c61-21a46e37b88f" xlink:to="loc_cron_A2018StockOptionPlanMember_6956c67c-87e0-482a-8679-9fc1f19cc881" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_A2015StockOptionPlanMember_b72e1922-8ccd-4b71-b8ef-f9f1a392422b" xlink:href="cron-20201231.xsd#cron_A2015StockOptionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_722a3f61-70bb-468a-8c61-21a46e37b88f" xlink:to="loc_cron_A2015StockOptionPlanMember_b72e1922-8ccd-4b71-b8ef-f9f1a392422b" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedPaymentsSummaryoftheChangesinOptionsDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#SharebasedPaymentsSummaryoftheChangesinOptionsDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/SharebasedPaymentsSummaryoftheChangesinOptionsDetails" xlink:type="extended" id="i8a73d3cd39cf4c18bd556639f0341740_SharebasedPaymentsSummaryoftheChangesinOptionsDetails"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedPaymentsFairValueofOptionsIssuedDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#SharebasedPaymentsFairValueofOptionsIssuedDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/SharebasedPaymentsFairValueofOptionsIssuedDetails" xlink:type="extended" id="ia7e79d229afc432d904d6ad61f882455_SharebasedPaymentsFairValueofOptionsIssuedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_15fff548-3098-4e3c-b0cf-807a28f44f63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_1a801fc4-cd8d-4c4f-9415-3ec66161c4a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_15fff548-3098-4e3c-b0cf-807a28f44f63" xlink:to="loc_us-gaap_SharePrice_1a801fc4-cd8d-4c4f-9415-3ec66161c4a7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_d1c53a12-26de-4749-9126-db2ca67e9bca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_15fff548-3098-4e3c-b0cf-807a28f44f63" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_d1c53a12-26de-4749-9126-db2ca67e9bca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_fec07171-4308-474e-84a8-471b71af133e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_15fff548-3098-4e3c-b0cf-807a28f44f63" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_fec07171-4308-474e-84a8-471b71af133e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_e59b8c34-d579-4441-8f7a-1ab7d58d0e74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_15fff548-3098-4e3c-b0cf-807a28f44f63" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_e59b8c34-d579-4441-8f7a-1ab7d58d0e74" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_04c712c0-fab4-44c5-b5c8-49004730be89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_15fff548-3098-4e3c-b0cf-807a28f44f63" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_04c712c0-fab4-44c5-b5c8-49004730be89" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_b7bcf21e-e53d-4ec6-9303-c7b0c42c3443" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_15fff548-3098-4e3c-b0cf-807a28f44f63" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_b7bcf21e-e53d-4ec6-9303-c7b0c42c3443" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue_e33ebd27-1a7a-4914-86ce-b604e833acb6" xlink:href="cron-20201231.xsd#cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_15fff548-3098-4e3c-b0cf-807a28f44f63" xlink:to="loc_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue_e33ebd27-1a7a-4914-86ce-b604e833acb6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsForfeitureRate_f65a295a-8d53-4c4f-8239-685b1286ace2" xlink:href="cron-20201231.xsd#cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsForfeitureRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_15fff548-3098-4e3c-b0cf-807a28f44f63" xlink:to="loc_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsForfeitureRate_f65a295a-8d53-4c4f-8239-685b1286ace2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2554beaf-db49-4c64-a145-f93c189cd37c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_15fff548-3098-4e3c-b0cf-807a28f44f63" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2554beaf-db49-4c64-a145-f93c189cd37c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_79101688-2c87-4f54-b4c3-4f05d9c43a81" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2554beaf-db49-4c64-a145-f93c189cd37c" xlink:to="loc_us-gaap_AwardTypeAxis_79101688-2c87-4f54-b4c3-4f05d9c43a81" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_79101688-2c87-4f54-b4c3-4f05d9c43a81_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_79101688-2c87-4f54-b4c3-4f05d9c43a81" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_79101688-2c87-4f54-b4c3-4f05d9c43a81_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_05d47179-cee4-4ff9-9100-fc955a7669f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_79101688-2c87-4f54-b4c3-4f05d9c43a81" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_05d47179-cee4-4ff9-9100-fc955a7669f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_14470001-1e39-4f23-8ec6-9fd954ee15da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_05d47179-cee4-4ff9-9100-fc955a7669f9" xlink:to="loc_us-gaap_EmployeeStockOptionMember_14470001-1e39-4f23-8ec6-9fd954ee15da" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5b0281e0-0737-46d4-ba0f-a866c1b2f405" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2554beaf-db49-4c64-a145-f93c189cd37c" xlink:to="loc_srt_RangeAxis_5b0281e0-0737-46d4-ba0f-a866c1b2f405" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5b0281e0-0737-46d4-ba0f-a866c1b2f405_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_5b0281e0-0737-46d4-ba0f-a866c1b2f405" xlink:to="loc_srt_RangeMember_5b0281e0-0737-46d4-ba0f-a866c1b2f405_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c85333aa-3f88-419b-aecf-bfad20bd9436" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_5b0281e0-0737-46d4-ba0f-a866c1b2f405" xlink:to="loc_srt_RangeMember_c85333aa-3f88-419b-aecf-bfad20bd9436" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_07ab48e3-1297-45dc-9610-3990360bd4ef" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c85333aa-3f88-419b-aecf-bfad20bd9436" xlink:to="loc_srt_MinimumMember_07ab48e3-1297-45dc-9610-3990360bd4ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_7bba51e1-0eb2-45f0-8039-9f956d1d0571" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c85333aa-3f88-419b-aecf-bfad20bd9436" xlink:to="loc_srt_MaximumMember_7bba51e1-0eb2-45f0-8039-9f956d1d0571" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedPaymentsRestrictedShareUnitsNarrativeDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#SharebasedPaymentsRestrictedShareUnitsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/SharebasedPaymentsRestrictedShareUnitsNarrativeDetails" xlink:type="extended" id="i28a3406c588b460a880dd5733e011ecd_SharebasedPaymentsRestrictedShareUnitsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_32bda868-0acf-4975-b934-60124440a444" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_d1eed52f-78fb-4636-a097-747815b87543" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_32bda868-0acf-4975-b934-60124440a444" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_d1eed52f-78fb-4636-a097-747815b87543" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriod_f00efbed-7a66-47e0-b20b-5e860ee793b5" xlink:href="cron-20201231.xsd#cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_32bda868-0acf-4975-b934-60124440a444" xlink:to="loc_cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriod_f00efbed-7a66-47e0-b20b-5e860ee793b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_7c8b726e-1934-444f-8329-459687e95985" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_32bda868-0acf-4975-b934-60124440a444" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_7c8b726e-1934-444f-8329-459687e95985" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_abe86842-52ce-4679-9740-0f9406ac35db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_32bda868-0acf-4975-b934-60124440a444" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_abe86842-52ce-4679-9740-0f9406ac35db" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_00c5aabd-f08b-46fc-92b3-1510753d1c1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_32bda868-0acf-4975-b934-60124440a444" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_00c5aabd-f08b-46fc-92b3-1510753d1c1f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_700102cd-f486-49ff-ab9c-01a4ba3388fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_00c5aabd-f08b-46fc-92b3-1510753d1c1f" xlink:to="loc_us-gaap_AwardTypeAxis_700102cd-f486-49ff-ab9c-01a4ba3388fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_700102cd-f486-49ff-ab9c-01a4ba3388fc_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_700102cd-f486-49ff-ab9c-01a4ba3388fc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_700102cd-f486-49ff-ab9c-01a4ba3388fc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1bc7e553-d15f-460f-ba80-95a18184c1fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_700102cd-f486-49ff-ab9c-01a4ba3388fc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1bc7e553-d15f-460f-ba80-95a18184c1fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_fb928d41-7123-4966-a8e7-1c850e158b0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1bc7e553-d15f-460f-ba80-95a18184c1fb" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_fb928d41-7123-4966-a8e7-1c850e158b0b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedPaymentsSummaryofRestrictedShareUnitsActivityDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#SharebasedPaymentsSummaryofRestrictedShareUnitsActivityDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/SharebasedPaymentsSummaryofRestrictedShareUnitsActivityDetails" xlink:type="extended" id="i7d1e2012dd2749b19957152be1bab4a8_SharebasedPaymentsSummaryofRestrictedShareUnitsActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08fbb990-fdc9-40dd-a22b-71d95874c001" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4c270678-cddc-41f6-ba2b-09cf6939caaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08fbb990-fdc9-40dd-a22b-71d95874c001" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4c270678-cddc-41f6-ba2b-09cf6939caaf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_84cff3fa-94c5-4ec6-ad74-6a2ad7236ca1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4c270678-cddc-41f6-ba2b-09cf6939caaf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_84cff3fa-94c5-4ec6-ad74-6a2ad7236ca1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_f4c45fa6-9b7f-4f57-ad6b-7760df16df6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4c270678-cddc-41f6-ba2b-09cf6939caaf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_f4c45fa6-9b7f-4f57-ad6b-7760df16df6f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_8043dc4d-a006-4ee4-96b1-f4fc6d298192" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4c270678-cddc-41f6-ba2b-09cf6939caaf" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_8043dc4d-a006-4ee4-96b1-f4fc6d298192" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_c623cdbc-216c-41c7-82b2-62c3400106e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4c270678-cddc-41f6-ba2b-09cf6939caaf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_c623cdbc-216c-41c7-82b2-62c3400106e1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_da15eab1-57cb-49d2-a566-3458dca70ef5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_5c452918-ef8c-4947-98e7-ba126ec38522" xlink:href="cron-20201231.xsd#cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08fbb990-fdc9-40dd-a22b-71d95874c001" xlink:to="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_5c452918-ef8c-4947-98e7-ba126ec38522" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_ef30de6f-0e01-4873-9a98-c45f6fb1e619" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_5c452918-ef8c-4947-98e7-ba126ec38522" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_ef30de6f-0e01-4873-9a98-c45f6fb1e619" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_052bc706-2f17-4337-b1fe-33600e21b6f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_5c452918-ef8c-4947-98e7-ba126ec38522" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_052bc706-2f17-4337-b1fe-33600e21b6f0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_79d4ee33-1290-402f-96e1-d962bbbad8c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_5c452918-ef8c-4947-98e7-ba126ec38522" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_79d4ee33-1290-402f-96e1-d962bbbad8c5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_1bc27b3b-298d-44bd-abea-01e4ebee9dd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_5c452918-ef8c-4947-98e7-ba126ec38522" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_1bc27b3b-298d-44bd-abea-01e4ebee9dd5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_9cf8cae6-2d83-42de-858d-cbe4e6c308f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4f46196d-a4b2-4298-85b0-0cf64d114c54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08fbb990-fdc9-40dd-a22b-71d95874c001" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4f46196d-a4b2-4298-85b0-0cf64d114c54" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_0cbca42f-71ed-42f9-a766-ca556f44828d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4f46196d-a4b2-4298-85b0-0cf64d114c54" xlink:to="loc_us-gaap_AwardTypeAxis_0cbca42f-71ed-42f9-a766-ca556f44828d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0cbca42f-71ed-42f9-a766-ca556f44828d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_0cbca42f-71ed-42f9-a766-ca556f44828d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0cbca42f-71ed-42f9-a766-ca556f44828d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_75289073-2354-4a67-b482-d6c510d3bc67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_0cbca42f-71ed-42f9-a766-ca556f44828d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_75289073-2354-4a67-b482-d6c510d3bc67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_0819c32e-5d21-4e3c-9144-749f6dc5f03d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_75289073-2354-4a67-b482-d6c510d3bc67" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_0819c32e-5d21-4e3c-9144-749f6dc5f03d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedPaymentsDeferredShareUnitsNarrativeDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#SharebasedPaymentsDeferredShareUnitsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/SharebasedPaymentsDeferredShareUnitsNarrativeDetails" xlink:type="extended" id="i1c28523bc9c74bfb995228ad0691cd35_SharebasedPaymentsDeferredShareUnitsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f41347a1-4d0b-4100-8afd-b71ab45a5a8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_03855763-551e-46cb-98d4-ccc19a49e995" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f41347a1-4d0b-4100-8afd-b71ab45a5a8f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_03855763-551e-46cb-98d4-ccc19a49e995" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f5d500ec-485c-498d-ae6d-b5606ba9cc9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f41347a1-4d0b-4100-8afd-b71ab45a5a8f" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f5d500ec-485c-498d-ae6d-b5606ba9cc9d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_87054fe8-94de-4c4a-9a27-d790c476f0c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f5d500ec-485c-498d-ae6d-b5606ba9cc9d" xlink:to="loc_us-gaap_AwardTypeAxis_87054fe8-94de-4c4a-9a27-d790c476f0c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_87054fe8-94de-4c4a-9a27-d790c476f0c7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_87054fe8-94de-4c4a-9a27-d790c476f0c7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_87054fe8-94de-4c4a-9a27-d790c476f0c7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_690a203c-eaa8-42a3-a60c-34b7e0969080" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_87054fe8-94de-4c4a-9a27-d790c476f0c7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_690a203c-eaa8-42a3-a60c-34b7e0969080" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DeferredShareUnitsDSUsMember_e76488d6-48c3-4228-9010-1eec7a2d76dc" xlink:href="cron-20201231.xsd#cron_DeferredShareUnitsDSUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_690a203c-eaa8-42a3-a60c-34b7e0969080" xlink:to="loc_cron_DeferredShareUnitsDSUsMember_e76488d6-48c3-4228-9010-1eec7a2d76dc" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedPaymentsSummaryofDeferredShareUnitsActivityDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#SharebasedPaymentsSummaryofDeferredShareUnitsActivityDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/SharebasedPaymentsSummaryofDeferredShareUnitsActivityDetails" xlink:type="extended" id="i94cd43b3a08648b1aa8c6dfebf15906f_SharebasedPaymentsSummaryofDeferredShareUnitsActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2129dbc6-3b4c-4bfb-a9f7-1382a226f4e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c439bca7-493f-4498-8066-4d6673c0bb95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2129dbc6-3b4c-4bfb-a9f7-1382a226f4e0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c439bca7-493f-4498-8066-4d6673c0bb95" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_59576658-b674-4475-85ee-61bce16632bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c439bca7-493f-4498-8066-4d6673c0bb95" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_59576658-b674-4475-85ee-61bce16632bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsAndVestedInPeriod_22e3c1ce-6a00-4ab2-9721-81d2d2cb4815" xlink:href="cron-20201231.xsd#cron_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsAndVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c439bca7-493f-4498-8066-4d6673c0bb95" xlink:to="loc_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsAndVestedInPeriod_22e3c1ce-6a00-4ab2-9721-81d2d2cb4815" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_ae151303-8705-46b8-a476-c4b1cdadb7fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c439bca7-493f-4498-8066-4d6673c0bb95" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_ae151303-8705-46b8-a476-c4b1cdadb7fc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_aeebc495-7e4f-4807-b530-470f3a924d54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_88a05130-7962-4ded-bc6c-31cede8baa52" xlink:href="cron-20201231.xsd#cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2129dbc6-3b4c-4bfb-a9f7-1382a226f4e0" xlink:to="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_88a05130-7962-4ded-bc6c-31cede8baa52" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent_d1c3e922-8894-4934-847b-c8faa7e008c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_88a05130-7962-4ded-bc6c-31cede8baa52" xlink:to="loc_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent_d1c3e922-8894-4934-847b-c8faa7e008c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_40ae3536-571e-4cbd-a93a-38e011e6aec1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_88a05130-7962-4ded-bc6c-31cede8baa52" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_40ae3536-571e-4cbd-a93a-38e011e6aec1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ShareBasedPaymentArrangementLiabilitiesSettled_4d949232-befc-43df-945c-f4d51ccf71fd" xlink:href="cron-20201231.xsd#cron_ShareBasedPaymentArrangementLiabilitiesSettled"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_88a05130-7962-4ded-bc6c-31cede8baa52" xlink:to="loc_cron_ShareBasedPaymentArrangementLiabilitiesSettled_4d949232-befc-43df-945c-f4d51ccf71fd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ShareBasedPaymentArrangementGainLossOnRevaluation_4f0784dd-4690-47cb-8c46-5d48e9b9399e" xlink:href="cron-20201231.xsd#cron_ShareBasedPaymentArrangementGainLossOnRevaluation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_88a05130-7962-4ded-bc6c-31cede8baa52" xlink:to="loc_cron_ShareBasedPaymentArrangementGainLossOnRevaluation_4f0784dd-4690-47cb-8c46-5d48e9b9399e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent_709d95ab-f94a-404e-9b6c-054829892ec9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a944f196-ecbc-40f5-b9f8-c64ade0b389d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2129dbc6-3b4c-4bfb-a9f7-1382a226f4e0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a944f196-ecbc-40f5-b9f8-c64ade0b389d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_d3726baf-a443-4b33-9403-9cae44a6e9aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a944f196-ecbc-40f5-b9f8-c64ade0b389d" xlink:to="loc_us-gaap_AwardTypeAxis_d3726baf-a443-4b33-9403-9cae44a6e9aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d3726baf-a443-4b33-9403-9cae44a6e9aa_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_d3726baf-a443-4b33-9403-9cae44a6e9aa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d3726baf-a443-4b33-9403-9cae44a6e9aa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_82b2d056-8f1e-4c7e-a23e-a60dc24c2096" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_d3726baf-a443-4b33-9403-9cae44a6e9aa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_82b2d056-8f1e-4c7e-a23e-a60dc24c2096" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DeferredShareUnitsDSUsMember_d518f8dd-5a45-4067-85ee-718bc1317937" xlink:href="cron-20201231.xsd#cron_DeferredShareUnitsDSUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_82b2d056-8f1e-4c7e-a23e-a60dc24c2096" xlink:to="loc_cron_DeferredShareUnitsDSUsMember_d518f8dd-5a45-4067-85ee-718bc1317937" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/EarningslossPerShare" xlink:type="simple" xlink:href="cron-20201231.xsd#EarningslossPerShare"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/EarningslossPerShare" xlink:type="extended" id="i7becbacbae654eb6aa4f4e1068d78a23_EarningslossPerShare"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/EarningslossPerShareTables" xlink:type="simple" xlink:href="cron-20201231.xsd#EarningslossPerShareTables"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/EarningslossPerShareTables" xlink:type="extended" id="ia06f551756cc4fbfa3ab74915f99ee95_EarningslossPerShareTables"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#EarningslossPerShareScheduleofEarningsLossPerShareDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails" xlink:type="extended" id="i6f6fb9ca976e41d1b9828310031fea3e_EarningslossPerShareScheduleofEarningsLossPerShareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedLineItems_df94fdde-8400-4ee5-8e1b-1279c7a6b198" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDilutedLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_571c1b84-85fe-4f87-ab96-272338ee1af2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_df94fdde-8400-4ee5-8e1b-1279c7a6b198" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_571c1b84-85fe-4f87-ab96-272338ee1af2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_3b00f69d-942a-479e-8fc6-69fc632fc5c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_571c1b84-85fe-4f87-ab96-272338ee1af2" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_3b00f69d-942a-479e-8fc6-69fc632fc5c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e530f0cf-f841-4e8e-8f00-eab0721096db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_571c1b84-85fe-4f87-ab96-272338ee1af2" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e530f0cf-f841-4e8e-8f00-eab0721096db" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_30b3e3bf-4d07-4bc1-882c-c2de79b48781" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_571c1b84-85fe-4f87-ab96-272338ee1af2" xlink:to="loc_us-gaap_EarningsPerShareBasic_30b3e3bf-4d07-4bc1-882c-c2de79b48781" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_15e4d1b8-6ac3-4038-abd6-591136c135f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_df94fdde-8400-4ee5-8e1b-1279c7a6b198" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_15e4d1b8-6ac3-4038-abd6-591136c135f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_78931767-0d51-4c4d-ba11-d6a8bc7b60f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DilutiveSecurities_76342e73-9329-4822-928b-c0450413340e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DilutiveSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_15e4d1b8-6ac3-4038-abd6-591136c135f6" xlink:to="loc_us-gaap_DilutiveSecurities_76342e73-9329-4822-928b-c0450413340e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted_3940897f-0882-4a80-8dc4-6d50c71c756b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_15e4d1b8-6ac3-4038-abd6-591136c135f6" xlink:to="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted_3940897f-0882-4a80-8dc4-6d50c71c756b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0bf23075-6421-4cdd-b986-472ee4a2a96d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_c5645765-a15b-457e-a420-ae8c2b65745f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_15e4d1b8-6ac3-4038-abd6-591136c135f6" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_c5645765-a15b-457e-a420-ae8c2b65745f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_c5690e33-5346-4fbb-a09d-bc8038d29bfc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_15e4d1b8-6ac3-4038-abd6-591136c135f6" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_c5690e33-5346-4fbb-a09d-bc8038d29bfc" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_bfa26a0d-1acb-49b2-900b-ce9e138b72a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_15e4d1b8-6ac3-4038-abd6-591136c135f6" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_bfa26a0d-1acb-49b2-900b-ce9e138b72a5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_d0533544-393c-4746-9e4d-14a90424a6b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_15e4d1b8-6ac3-4038-abd6-591136c135f6" xlink:to="loc_us-gaap_EarningsPerShareDiluted_d0533544-393c-4746-9e4d-14a90424a6b6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShareAbstract_bebf5b07-d128-492d-99e1-6c7950c7b980" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShareAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_df94fdde-8400-4ee5-8e1b-1279c7a6b198" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShareAbstract_bebf5b07-d128-492d-99e1-6c7950c7b980" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_41cb2ca6-b73d-40ab-9bb7-5e010b22a26a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShareAbstract_bebf5b07-d128-492d-99e1-6c7950c7b980" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_41cb2ca6-b73d-40ab-9bb7-5e010b22a26a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_de0563da-d16c-484a-a61f-a10def0b52cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_0d53b48c-b9c0-4b36-a636-f28f9c204f62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShareAbstract_bebf5b07-d128-492d-99e1-6c7950c7b980" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_0d53b48c-b9c0-4b36-a636-f28f9c204f62" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_bf686da2-c820-43d8-b70d-aa709b600459" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_df94fdde-8400-4ee5-8e1b-1279c7a6b198" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_bf686da2-c820-43d8-b70d-aa709b600459" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_98a1f313-6c01-4fec-b6fe-a496263e727a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_bf686da2-c820-43d8-b70d-aa709b600459" xlink:to="loc_us-gaap_AwardTypeAxis_98a1f313-6c01-4fec-b6fe-a496263e727a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_98a1f313-6c01-4fec-b6fe-a496263e727a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_98a1f313-6c01-4fec-b6fe-a496263e727a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_98a1f313-6c01-4fec-b6fe-a496263e727a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_58180b67-45d9-4e07-a34e-66330af8061c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_98a1f313-6c01-4fec-b6fe-a496263e727a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_58180b67-45d9-4e07-a34e-66330af8061c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_ab58f22c-227c-4f7a-8320-939cf6dc41e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_58180b67-45d9-4e07-a34e-66330af8061c" xlink:to="loc_us-gaap_WarrantMember_ab58f22c-227c-4f7a-8320-939cf6dc41e8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_7d66ed15-9650-44ae-87d2-200f4d9ae669" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_58180b67-45d9-4e07-a34e-66330af8061c" xlink:to="loc_us-gaap_EmployeeStockOptionMember_7d66ed15-9650-44ae-87d2-200f4d9ae669" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_1ac5ea1c-fb2b-426a-95a9-61a42e224d1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_58180b67-45d9-4e07-a34e-66330af8061c" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_1ac5ea1c-fb2b-426a-95a9-61a42e224d1b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_f894b4ee-d6f0-4254-902c-ef886692c548" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_bf686da2-c820-43d8-b70d-aa709b600459" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_f894b4ee-d6f0-4254-902c-ef886692c548" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_f894b4ee-d6f0-4254-902c-ef886692c548_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_f894b4ee-d6f0-4254-902c-ef886692c548" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_f894b4ee-d6f0-4254-902c-ef886692c548_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_c3d324ea-48e7-49df-8445-bcbf3d4de3ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_f894b4ee-d6f0-4254-902c-ef886692c548" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_c3d324ea-48e7-49df-8445-bcbf3d4de3ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaWarrantMember_bd9f186d-eb20-4490-bf16-81fd5b1221cc" xlink:href="cron-20201231.xsd#cron_AltriaWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_c3d324ea-48e7-49df-8445-bcbf3d4de3ab" xlink:to="loc_cron_AltriaWarrantMember_bd9f186d-eb20-4490-bf16-81fd5b1221cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_TopupRightsMember_62f496d5-8fcd-46f9-b178-d25a57cb53cf" xlink:href="cron-20201231.xsd#cron_TopupRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_c3d324ea-48e7-49df-8445-bcbf3d4de3ab" xlink:to="loc_cron_TopupRightsMember_62f496d5-8fcd-46f9-b178-d25a57cb53cf" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/EarningslossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedSharesOutstandingDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#EarningslossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedSharesOutstandingDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/EarningslossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedSharesOutstandingDetails" xlink:type="extended" id="if9adb026d17f438ebd9ea61f20e4971e_EarningslossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedSharesOutstandingDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_c98ca5cf-36f7-4e15-a3c8-35a29d4a3313" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_6f32e31b-f758-4732-986f-48b09def17d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_c98ca5cf-36f7-4e15-a3c8-35a29d4a3313" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_6f32e31b-f758-4732-986f-48b09def17d9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_43f40116-d8c9-42cd-99a0-83c9a071f57f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_c98ca5cf-36f7-4e15-a3c8-35a29d4a3313" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_43f40116-d8c9-42cd-99a0-83c9a071f57f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_0e31d77f-d892-4dec-a43e-f67eaa323740" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_43f40116-d8c9-42cd-99a0-83c9a071f57f" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_0e31d77f-d892-4dec-a43e-f67eaa323740" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0e31d77f-d892-4dec-a43e-f67eaa323740_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_0e31d77f-d892-4dec-a43e-f67eaa323740" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0e31d77f-d892-4dec-a43e-f67eaa323740_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5aadc198-84ee-4596-a1fe-cd6f90734670" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_0e31d77f-d892-4dec-a43e-f67eaa323740" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5aadc198-84ee-4596-a1fe-cd6f90734670" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_GinkgoEquityMilestonesMember_70e36ba5-befe-49ce-a3f7-02112b54c34e" xlink:href="cron-20201231.xsd#cron_GinkgoEquityMilestonesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5aadc198-84ee-4596-a1fe-cd6f90734670" xlink:to="loc_cron_GinkgoEquityMilestonesMember_70e36ba5-befe-49ce-a3f7-02112b54c34e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PreemptiveRightsMember_1602e791-7f44-4083-a6f9-400159feb16f" xlink:href="cron-20201231.xsd#cron_PreemptiveRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5aadc198-84ee-4596-a1fe-cd6f90734670" xlink:to="loc_cron_PreemptiveRightsMember_1602e791-7f44-4083-a6f9-400159feb16f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_TopUpRightsFixedPriceMember_8907ed5f-608d-451f-b47d-80f71e3959a0" xlink:href="cron-20201231.xsd#cron_TopUpRightsFixedPriceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5aadc198-84ee-4596-a1fe-cd6f90734670" xlink:to="loc_cron_TopUpRightsFixedPriceMember_8907ed5f-608d-451f-b47d-80f71e3959a0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_TopUpRightsMarketPriceMember_cebb5c82-9d7e-4d8e-84cd-ce7a92f3d59f" xlink:href="cron-20201231.xsd#cron_TopUpRightsMarketPriceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5aadc198-84ee-4596-a1fe-cd6f90734670" xlink:to="loc_cron_TopUpRightsMarketPriceMember_cebb5c82-9d7e-4d8e-84cd-ce7a92f3d59f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaWarrantMember_77482cb1-e5a8-46bd-80ba-6e4f54c76108" xlink:href="cron-20201231.xsd#cron_AltriaWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5aadc198-84ee-4596-a1fe-cd6f90734670" xlink:to="loc_cron_AltriaWarrantMember_77482cb1-e5a8-46bd-80ba-6e4f54c76108" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_fd88b7bc-8f97-41d8-98a5-ccf9a0a0f725" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5aadc198-84ee-4596-a1fe-cd6f90734670" xlink:to="loc_us-gaap_WarrantMember_fd88b7bc-8f97-41d8-98a5-ccf9a0a0f725" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_d3ae9b15-d95e-44e8-88ec-a8e4bd11fab7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5aadc198-84ee-4596-a1fe-cd6f90734670" xlink:to="loc_us-gaap_EmployeeStockOptionMember_d3ae9b15-d95e-44e8-88ec-a8e4bd11fab7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_ea7208c2-f262-406a-bee4-be8da8e45170" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5aadc198-84ee-4596-a1fe-cd6f90734670" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_ea7208c2-f262-406a-bee4-be8da8e45170" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLoss" xlink:type="simple" xlink:href="cron-20201231.xsd#AccumulatedOtherComprehensiveIncomeLoss"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLoss" xlink:type="extended" id="ibe569e2e4700427fb54e5922c3a3e4bc_AccumulatedOtherComprehensiveIncomeLoss"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLossTables" xlink:type="simple" xlink:href="cron-20201231.xsd#AccumulatedOtherComprehensiveIncomeLossTables"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLossTables" xlink:type="extended" id="id4431b87982a4cbd8a24fdc4bb6f38ef_AccumulatedOtherComprehensiveIncomeLossTables"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#AccumulatedOtherComprehensiveIncomeLossDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended" id="iaf5eae6d8b77455f9a4269507c51957a_AccumulatedOtherComprehensiveIncomeLossDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_c2546484-72ef-41ae-995a-aa8068930402" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_aab27bf5-147a-4603-81f9-0b84ee9e93f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_c2546484-72ef-41ae-995a-aa8068930402" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_aab27bf5-147a-4603-81f9-0b84ee9e93f9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d5895d27-7bdc-4e9b-977a-7f36e1ae0aa7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_aab27bf5-147a-4603-81f9-0b84ee9e93f9" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d5895d27-7bdc-4e9b-977a-7f36e1ae0aa7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_f3a27ac4-3094-44bd-84b2-a9304b934797" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_aab27bf5-147a-4603-81f9-0b84ee9e93f9" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_f3a27ac4-3094-44bd-84b2-a9304b934797" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_62adef8b-3930-4f59-80bc-fda122cbed87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_aab27bf5-147a-4603-81f9-0b84ee9e93f9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_62adef8b-3930-4f59-80bc-fda122cbed87" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b45fcb50-e9d5-4538-8a10-ad414a72113d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_72f900db-1d01-4f49-bd04-26712b3a66a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_c2546484-72ef-41ae-995a-aa8068930402" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_72f900db-1d01-4f49-bd04-26712b3a66a0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_4d8b6a19-c6b4-45df-8b60-a75edbb05385" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_72f900db-1d01-4f49-bd04-26712b3a66a0" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_4d8b6a19-c6b4-45df-8b60-a75edbb05385" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_4d8b6a19-c6b4-45df-8b60-a75edbb05385_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4d8b6a19-c6b4-45df-8b60-a75edbb05385" xlink:to="loc_us-gaap_EquityComponentDomain_4d8b6a19-c6b4-45df-8b60-a75edbb05385_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_456b14e2-60e5-4e1c-ab0d-c9d4cce6fb06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4d8b6a19-c6b4-45df-8b60-a75edbb05385" xlink:to="loc_us-gaap_EquityComponentDomain_456b14e2-60e5-4e1c-ab0d-c9d4cce6fb06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_cb057315-335f-4239-8b82-31d00d89b259" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_456b14e2-60e5-4e1c-ab0d-c9d4cce6fb06" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_cb057315-335f-4239-8b82-31d00d89b259" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AOCIAccumulatedGainLossRevaluationAndDisposalOfOtherInvestmentsParentMemberMember_6ffe6434-973d-42a9-9540-65d94a6b4c4d" xlink:href="cron-20201231.xsd#cron_AOCIAccumulatedGainLossRevaluationAndDisposalOfOtherInvestmentsParentMemberMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_cb057315-335f-4239-8b82-31d00d89b259" xlink:to="loc_cron_AOCIAccumulatedGainLossRevaluationAndDisposalOfOtherInvestmentsParentMemberMember_6ffe6434-973d-42a9-9540-65d94a6b4c4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_58a1707f-1929-40d5-ac4a-e7bc70ef3db8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_cb057315-335f-4239-8b82-31d00d89b259" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_58a1707f-1929-40d5-ac4a-e7bc70ef3db8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_8563240e-a2b0-4f6a-b635-f9b9cc3336e9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_72f900db-1d01-4f49-bd04-26712b3a66a0" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_8563240e-a2b0-4f6a-b635-f9b9cc3336e9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_8563240e-a2b0-4f6a-b635-f9b9cc3336e9_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_8563240e-a2b0-4f6a-b635-f9b9cc3336e9" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_8563240e-a2b0-4f6a-b635-f9b9cc3336e9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_c8b141aa-96ec-437c-bb47-da8a37843ff2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_8563240e-a2b0-4f6a-b635-f9b9cc3336e9" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_c8b141aa-96ec-437c-bb47-da8a37843ff2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_b73ab4d8-4366-482f-888f-89a8b1b8fbe3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_c8b141aa-96ec-437c-bb47-da8a37843ff2" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_b73ab4d8-4366-482f-888f-89a8b1b8fbe3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/IncomeTaxes" xlink:type="simple" xlink:href="cron-20201231.xsd#IncomeTaxes"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/IncomeTaxes" xlink:type="extended" id="i336f8dec718a43b8a531b203d6fec57e_IncomeTaxes"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="cron-20201231.xsd#IncomeTaxesTables"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/IncomeTaxesTables" xlink:type="extended" id="i217a4f5e429641a7b18c705630e57b32_IncomeTaxesTables"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/IncomeTaxesScheduleofIncomeLossbeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#IncomeTaxesScheduleofIncomeLossbeforeIncomeTaxesDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/IncomeTaxesScheduleofIncomeLossbeforeIncomeTaxesDetails" xlink:type="extended" id="i1bf58821974a4d22a1bdfc0a94c396d8_IncomeTaxesScheduleofIncomeLossbeforeIncomeTaxesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_9531169e-0823-4bd8-a3aa-03a555911470" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_4e2fe3a0-064b-4714-99b5-91ce07936fba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_9531169e-0823-4bd8-a3aa-03a555911470" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_4e2fe3a0-064b-4714-99b5-91ce07936fba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_e6776503-c6f5-43aa-8da1-e598790c24f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_9531169e-0823-4bd8-a3aa-03a555911470" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_e6776503-c6f5-43aa-8da1-e598790c24f6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_ae29ad23-a295-49d6-89d0-ff0c3d8b226e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_e6776503-c6f5-43aa-8da1-e598790c24f6" xlink:to="loc_srt_StatementGeographicalAxis_ae29ad23-a295-49d6-89d0-ff0c3d8b226e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_ae29ad23-a295-49d6-89d0-ff0c3d8b226e_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_ae29ad23-a295-49d6-89d0-ff0c3d8b226e" xlink:to="loc_srt_SegmentGeographicalDomain_ae29ad23-a295-49d6-89d0-ff0c3d8b226e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_480e4431-8ef1-47fb-b0d9-aafa816c4750" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_ae29ad23-a295-49d6-89d0-ff0c3d8b226e" xlink:to="loc_srt_SegmentGeographicalDomain_480e4431-8ef1-47fb-b0d9-aafa816c4750" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_2e874a8b-5bc2-4cb7-a4a4-726789a5a740" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_480e4431-8ef1-47fb-b0d9-aafa816c4750" xlink:to="loc_us-gaap_NonUsMember_2e874a8b-5bc2-4cb7-a4a4-726789a5a740" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_4544993e-2ab5-474e-ac67-cb4a3973b987" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_480e4431-8ef1-47fb-b0d9-aafa816c4750" xlink:to="loc_country_US_4544993e-2ab5-474e-ac67-cb4a3973b987" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended" id="ifcc3cfa312e94479b6a82eb553602293_IncomeTaxesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceLineItems_db576a13-1ad4-4100-85e4-bee92c2f1905" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowanceLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax_2da21509-2089-4f11-b08f-2b96fb4cecb9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_db576a13-1ad4-4100-85e4-bee92c2f1905" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax_2da21509-2089-4f11-b08f-2b96fb4cecb9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_19bfc351-f028-43d9-a98f-18974159983e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_db576a13-1ad4-4100-85e4-bee92c2f1905" xlink:to="loc_us-gaap_TaxesPayableCurrent_19bfc351-f028-43d9-a98f-18974159983e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dd74fa1c-aaac-4c06-8a6f-748137129248" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_db576a13-1ad4-4100-85e4-bee92c2f1905" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dd74fa1c-aaac-4c06-8a6f-748137129248" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_689cdb31-58ba-45fe-a7d9-384c32340589" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_db576a13-1ad4-4100-85e4-bee92c2f1905" xlink:to="loc_us-gaap_OperatingLossCarryforwards_689cdb31-58ba-45fe-a7d9-384c32340589" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesAdjustments_9c87e8a9-4dab-4572-bf2a-b2ee1e7ff58e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_db576a13-1ad4-4100-85e4-bee92c2f1905" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesAdjustments_9c87e8a9-4dab-4572-bf2a-b2ee1e7ff58e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceTable_7a76e2d1-2465-44c0-bf42-dd71f1d6677f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowanceTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_db576a13-1ad4-4100-85e4-bee92c2f1905" xlink:to="loc_us-gaap_ValuationAllowanceTable_7a76e2d1-2465-44c0-bf42-dd71f1d6677f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_c94869b0-344f-428e-9d3d-d8c1da1d115c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ValuationAllowanceTable_7a76e2d1-2465-44c0-bf42-dd71f1d6677f" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_c94869b0-344f-428e-9d3d-d8c1da1d115c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_c94869b0-344f-428e-9d3d-d8c1da1d115c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_c94869b0-344f-428e-9d3d-d8c1da1d115c" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_c94869b0-344f-428e-9d3d-d8c1da1d115c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_84b8d782-aae2-4ba4-b425-40bbd3873915" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_c94869b0-344f-428e-9d3d-d8c1da1d115c" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_84b8d782-aae2-4ba4-b425-40bbd3873915" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_be6cb072-d401-4cdb-b199-4a337a459581" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_84b8d782-aae2-4ba4-b425-40bbd3873915" xlink:to="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_be6cb072-d401-4cdb-b199-4a337a459581" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_cc5c1e4e-e150-4d65-bae9-777525f0290c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ValuationAllowanceTable_7a76e2d1-2465-44c0-bf42-dd71f1d6677f" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_cc5c1e4e-e150-4d65-bae9-777525f0290c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_cc5c1e4e-e150-4d65-bae9-777525f0290c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_cc5c1e4e-e150-4d65-bae9-777525f0290c" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_cc5c1e4e-e150-4d65-bae9-777525f0290c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_3c0875d7-a3a8-4817-84a0-92787e4feb89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_cc5c1e4e-e150-4d65-bae9-777525f0290c" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_3c0875d7-a3a8-4817-84a0-92787e4feb89" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CanadaRevenueAgencyMember_632a3784-afe8-4f2e-bde0-52cdf8b3310a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CanadaRevenueAgencyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_3c0875d7-a3a8-4817-84a0-92787e4feb89" xlink:to="loc_us-gaap_CanadaRevenueAgencyMember_632a3784-afe8-4f2e-bde0-52cdf8b3310a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_24cd36b0-ec18-4481-816d-cdc668c98ece" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_3c0875d7-a3a8-4817-84a0-92787e4feb89" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_24cd36b0-ec18-4481-816d-cdc668c98ece" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IsraelTaxAuthorityMember_5748409b-860d-4ee3-bddc-214fcdc0603b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IsraelTaxAuthorityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_3c0875d7-a3a8-4817-84a0-92787e4feb89" xlink:to="loc_us-gaap_IsraelTaxAuthorityMember_5748409b-860d-4ee3-bddc-214fcdc0603b" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/IncomeTaxesExpenseforIncomeTaxesDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#IncomeTaxesExpenseforIncomeTaxesDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/IncomeTaxesExpenseforIncomeTaxesDetails" xlink:type="extended" id="i2403890b66914ea8a1d74a71ce7fc188_IncomeTaxesExpenseforIncomeTaxesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_f4f1d7f9-ec54-470b-adb0-7c667ca15b52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_60a46371-ecfc-486c-a811-05a0680a47ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_f4f1d7f9-ec54-470b-adb0-7c667ca15b52" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_60a46371-ecfc-486c-a811-05a0680a47ac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_6a0aa303-f63c-48c2-9209-2b0217b98147" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_60a46371-ecfc-486c-a811-05a0680a47ac" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_6a0aa303-f63c-48c2-9209-2b0217b98147" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_25a476d4-b4ac-4a69-953a-a5406d15c0dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_f4f1d7f9-ec54-470b-adb0-7c667ca15b52" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_25a476d4-b4ac-4a69-953a-a5406d15c0dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_d2b1c114-f545-425c-b0d8-9e9e2b468772" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_25a476d4-b4ac-4a69-953a-a5406d15c0dc" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_d2b1c114-f545-425c-b0d8-9e9e2b468772" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_19953a91-56cd-45f8-b503-178e32429e00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_f4f1d7f9-ec54-470b-adb0-7c667ca15b52" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_19953a91-56cd-45f8-b503-178e32429e00" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_6568fa9e-5def-4c28-9a2d-05f5d481f27c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_19953a91-56cd-45f8-b503-178e32429e00" xlink:to="loc_srt_StatementGeographicalAxis_6568fa9e-5def-4c28-9a2d-05f5d481f27c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_6568fa9e-5def-4c28-9a2d-05f5d481f27c_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_6568fa9e-5def-4c28-9a2d-05f5d481f27c" xlink:to="loc_srt_SegmentGeographicalDomain_6568fa9e-5def-4c28-9a2d-05f5d481f27c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_b2c186fb-eefa-4394-9777-08cf890052ac" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_6568fa9e-5def-4c28-9a2d-05f5d481f27c" xlink:to="loc_srt_SegmentGeographicalDomain_b2c186fb-eefa-4394-9777-08cf890052ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_402a914c-122d-4048-9431-84548eb79867" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_b2c186fb-eefa-4394-9777-08cf890052ac" xlink:to="loc_us-gaap_NonUsMember_402a914c-122d-4048-9431-84548eb79867" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_fca3ea1a-3627-4a6e-8b06-00e8915f2d5b" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_b2c186fb-eefa-4394-9777-08cf890052ac" xlink:to="loc_country_US_fca3ea1a-3627-4a6e-8b06-00e8915f2d5b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#IncomeTaxesEffectiveTaxRateReconciliationDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails" xlink:type="extended" id="i043984d1396549deb1e7c963a0434f38_IncomeTaxesEffectiveTaxRateReconciliationDetails"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended" id="i27f6572bb3994d1ca0d83eacc0870216_IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/IncomeTaxesSummaryofValuationAllowanceDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#IncomeTaxesSummaryofValuationAllowanceDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/IncomeTaxesSummaryofValuationAllowanceDetails" xlink:type="extended" id="i6506ce87412e4825baf221d17d6c103c_IncomeTaxesSummaryofValuationAllowanceDetails">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_d73dd25a-2297-459c-9674-18286cff8c1b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_cdfaedb5-d35c-4a04-8bfc-8d23a4b1b81f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_d73dd25a-2297-459c-9674-18286cff8c1b" xlink:to="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_cdfaedb5-d35c-4a04-8bfc-8d23a4b1b81f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_16515f40-de9a-4ec0-9ca8-e3936ca5589b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_cdfaedb5-d35c-4a04-8bfc-8d23a4b1b81f" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_16515f40-de9a-4ec0-9ca8-e3936ca5589b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_f07a96f3-9a3b-41d7-87da-999b8d1cd24c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_cdfaedb5-d35c-4a04-8bfc-8d23a4b1b81f" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_f07a96f3-9a3b-41d7-87da-999b8d1cd24c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesAdjustments_a43b27c5-0714-4fa4-96a3-2f5396a687e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_cdfaedb5-d35c-4a04-8bfc-8d23a4b1b81f" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesAdjustments_a43b27c5-0714-4fa4-96a3-2f5396a687e0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_b6effd27-3ad1-416a-b2ca-f3cb9da0d384" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_40dc52f8-b827-43d9-82f2-daf899ad3850" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_d73dd25a-2297-459c-9674-18286cff8c1b" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_40dc52f8-b827-43d9-82f2-daf899ad3850" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_9f00fe42-88a9-447b-9ba5-f7e1e44d06d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_40dc52f8-b827-43d9-82f2-daf899ad3850" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_9f00fe42-88a9-447b-9ba5-f7e1e44d06d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_9f00fe42-88a9-447b-9ba5-f7e1e44d06d7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_9f00fe42-88a9-447b-9ba5-f7e1e44d06d7" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_9f00fe42-88a9-447b-9ba5-f7e1e44d06d7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_919e3d52-6682-4e26-93a6-62065c7a431a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_9f00fe42-88a9-447b-9ba5-f7e1e44d06d7" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_919e3d52-6682-4e26-93a6-62065c7a431a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_33655e46-7b50-4a5e-946a-3013a217e4db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_919e3d52-6682-4e26-93a6-62065c7a431a" xlink:to="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_33655e46-7b50-4a5e-946a-3013a217e4db" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/Commitments" xlink:type="simple" xlink:href="cron-20201231.xsd#Commitments"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/Commitments" xlink:type="extended" id="i8d16968e83b5487f9da7ac9525ceb91c_Commitments"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/CommitmentsTables" xlink:type="simple" xlink:href="cron-20201231.xsd#CommitmentsTables"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/CommitmentsTables" xlink:type="extended" id="i3710627834bf49be8c22f772865bee97_CommitmentsTables"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/CommitmentsSummaryofFutureMinimumLeasePaymentsUnderOperatingLeasesDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#CommitmentsSummaryofFutureMinimumLeasePaymentsUnderOperatingLeasesDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/CommitmentsSummaryofFutureMinimumLeasePaymentsUnderOperatingLeasesDetails" xlink:type="extended" id="i60a73e3a45d54aa9b10aa7dc82fd4bff_CommitmentsSummaryofFutureMinimumLeasePaymentsUnderOperatingLeasesDetails"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/CommitmentsRDCommitmentsDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#CommitmentsRDCommitmentsDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/CommitmentsRDCommitmentsDetails" xlink:type="extended" id="i6700f600c02d4ba986a083415f1dbbab_CommitmentsRDCommitmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentLineItems_bbdfc112-365e-4595-9168-140263c1be94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermPurchaseCommitmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LongTermPurchaseCommitmentNumberOfTargetedUnitsToDevelopProduction_ce2cc190-82e9-4b05-968d-4a6e9d81022c" xlink:href="cron-20201231.xsd#cron_LongTermPurchaseCommitmentNumberOfTargetedUnitsToDevelopProduction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_bbdfc112-365e-4595-9168-140263c1be94" xlink:to="loc_cron_LongTermPurchaseCommitmentNumberOfTargetedUnitsToDevelopProduction_ce2cc190-82e9-4b05-968d-4a6e9d81022c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableNumberOfShares_956502b6-6136-4835-b542-eede2389a85f" xlink:href="cron-20201231.xsd#cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableNumberOfShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_bbdfc112-365e-4595-9168-140263c1be94" xlink:to="loc_cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableNumberOfShares_956502b6-6136-4835-b542-eede2389a85f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableValueAssigned_3806e8d6-a9f5-4681-a570-e41f396ae0f8" xlink:href="cron-20201231.xsd#cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableValueAssigned"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_bbdfc112-365e-4595-9168-140263c1be94" xlink:to="loc_cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableValueAssigned_3806e8d6-a9f5-4681-a570-e41f396ae0f8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LongtermPurchaseCommitmentPaymentsSubjectToMilestones_61462b53-e26d-40ed-a622-84dd8da08094" xlink:href="cron-20201231.xsd#cron_LongtermPurchaseCommitmentPaymentsSubjectToMilestones"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_bbdfc112-365e-4595-9168-140263c1be94" xlink:to="loc_cron_LongtermPurchaseCommitmentPaymentsSubjectToMilestones_61462b53-e26d-40ed-a622-84dd8da08094" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentAmount_471d36d2-3985-4dd3-8575-62b9b80e5fc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermPurchaseCommitmentAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_bbdfc112-365e-4595-9168-140263c1be94" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentAmount_471d36d2-3985-4dd3-8575-62b9b80e5fc1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermPurchaseCommitmentPeriod_22878220-9c29-4d03-a8fd-f662be084a9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermPurchaseCommitmentPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_bbdfc112-365e-4595-9168-140263c1be94" xlink:to="loc_us-gaap_LongtermPurchaseCommitmentPeriod_22878220-9c29-4d03-a8fd-f662be084a9a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LongtermPurchaseCommitmentMonthlyFeePercentage_4e608af3-b63a-4ab6-a49c-188f19259bfe" xlink:href="cron-20201231.xsd#cron_LongtermPurchaseCommitmentMonthlyFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_bbdfc112-365e-4595-9168-140263c1be94" xlink:to="loc_cron_LongtermPurchaseCommitmentMonthlyFeePercentage_4e608af3-b63a-4ab6-a49c-188f19259bfe" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentTable_4108292b-a93a-4f38-ad8e-a851871598dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermPurchaseCommitmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_bbdfc112-365e-4595-9168-140263c1be94" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentTable_4108292b-a93a-4f38-ad8e-a851871598dc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_cf0dabd9-1245-4e55-a9d1-bc6d8e9cc7b1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentTable_4108292b-a93a-4f38-ad8e-a851871598dc" xlink:to="loc_srt_CounterpartyNameAxis_cf0dabd9-1245-4e55-a9d1-bc6d8e9cc7b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_cf0dabd9-1245-4e55-a9d1-bc6d8e9cc7b1_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_cf0dabd9-1245-4e55-a9d1-bc6d8e9cc7b1" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_cf0dabd9-1245-4e55-a9d1-bc6d8e9cc7b1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4b8bbadb-4fee-4585-a552-49f2cbb016e5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_cf0dabd9-1245-4e55-a9d1-bc6d8e9cc7b1" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4b8bbadb-4fee-4585-a552-49f2cbb016e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_GinkgoBioworksInc.Member_c9790030-e0ae-482d-af0c-758a625a9771" xlink:href="cron-20201231.xsd#cron_GinkgoBioworksInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4b8bbadb-4fee-4585-a552-49f2cbb016e5" xlink:to="loc_cron_GinkgoBioworksInc.Member_c9790030-e0ae-482d-af0c-758a625a9771" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_TechnionResearchAndDevelopmentFoundationMember_d427de6e-35f0-4f6f-8e2b-967da7eeb07d" xlink:href="cron-20201231.xsd#cron_TechnionResearchAndDevelopmentFoundationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4b8bbadb-4fee-4585-a552-49f2cbb016e5" xlink:to="loc_cron_TechnionResearchAndDevelopmentFoundationMember_d427de6e-35f0-4f6f-8e2b-967da7eeb07d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaVenturesInc.Member_47f12e78-904e-4a09-8621-bf70296ea52f" xlink:href="cron-20201231.xsd#cron_AltriaVenturesInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4b8bbadb-4fee-4585-a552-49f2cbb016e5" xlink:to="loc_cron_AltriaVenturesInc.Member_47f12e78-904e-4a09-8621-bf70296ea52f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_7e6f849e-ce24-4420-b599-d116fca883e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentTable_4108292b-a93a-4f38-ad8e-a851871598dc" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_7e6f849e-ce24-4420-b599-d116fca883e0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_7e6f849e-ce24-4420-b599-d116fca883e0_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_7e6f849e-ce24-4420-b599-d116fca883e0" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_7e6f849e-ce24-4420-b599-d116fca883e0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_25b16025-4cd5-453f-900b-3a8ffd0fdf63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_7e6f849e-ce24-4420-b599-d116fca883e0" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_25b16025-4cd5-453f-900b-3a8ffd0fdf63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementMember_7758aa39-1880-4813-a60d-c5642e7bf544" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_25b16025-4cd5-453f-900b-3a8ffd0fdf63" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementMember_7758aa39-1880-4813-a60d-c5642e7bf544" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ConsultingServicesArrangementMember_3d6ebe61-5fe8-41c9-ba14-5685f799224d" xlink:href="cron-20201231.xsd#cron_ConsultingServicesArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_25b16025-4cd5-453f-900b-3a8ffd0fdf63" xlink:to="loc_cron_ConsultingServicesArrangementMember_3d6ebe61-5fe8-41c9-ba14-5685f799224d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/CommitmentsUseofPublicityRightsinBrandDevelopmentDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#CommitmentsUseofPublicityRightsinBrandDevelopmentDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/CommitmentsUseofPublicityRightsinBrandDevelopmentDetails" xlink:type="extended" id="i4e89cbe05b3445d39715d7ec7e7b5728_CommitmentsUseofPublicityRightsinBrandDevelopmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_b663691f-8193-4b12-a95d-fb3cab0f3076" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_b8f07a38-ed22-4c69-9c33-f94c0ad8f361" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_b663691f-8193-4b12-a95d-fb3cab0f3076" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_b8f07a38-ed22-4c69-9c33-f94c0ad8f361" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_0b594d93-7c7f-46ef-a27b-f490365efadd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_b663691f-8193-4b12-a95d-fb3cab0f3076" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_0b594d93-7c7f-46ef-a27b-f490365efadd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_StockIssuedDuringPeriodNewIssuesFairValue_8fa5649e-c903-42aa-b261-c6981a1e075a" xlink:href="cron-20201231.xsd#cron_StockIssuedDuringPeriodNewIssuesFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_b663691f-8193-4b12-a95d-fb3cab0f3076" xlink:to="loc_cron_StockIssuedDuringPeriodNewIssuesFairValue_8fa5649e-c903-42aa-b261-c6981a1e075a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_StockIssuedDuringPeriodNewIssuesWeightedAveragePricePeriod_113a063f-5ac5-4d5f-a48c-18f0398f1931" xlink:href="cron-20201231.xsd#cron_StockIssuedDuringPeriodNewIssuesWeightedAveragePricePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_b663691f-8193-4b12-a95d-fb3cab0f3076" xlink:to="loc_cron_StockIssuedDuringPeriodNewIssuesWeightedAveragePricePeriod_113a063f-5ac5-4d5f-a48c-18f0398f1931" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SaleOfStockPerformanceMilestoneTriggeringEventMinimumRevenue_b0edd3ea-4be7-4e37-9555-e6bd7bc172d4" xlink:href="cron-20201231.xsd#cron_SaleOfStockPerformanceMilestoneTriggeringEventMinimumRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_b663691f-8193-4b12-a95d-fb3cab0f3076" xlink:to="loc_cron_SaleOfStockPerformanceMilestoneTriggeringEventMinimumRevenue_b0edd3ea-4be7-4e37-9555-e6bd7bc172d4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SaleOfStockPerformanceMilestoneTriggeringEventSharesIssuedValue_13aabc80-3f91-4f10-8b4c-1a63ef02f40a" xlink:href="cron-20201231.xsd#cron_SaleOfStockPerformanceMilestoneTriggeringEventSharesIssuedValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_b663691f-8193-4b12-a95d-fb3cab0f3076" xlink:to="loc_cron_SaleOfStockPerformanceMilestoneTriggeringEventSharesIssuedValue_13aabc80-3f91-4f10-8b4c-1a63ef02f40a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_634e18e7-1628-416e-9134-3acd70449087" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_b663691f-8193-4b12-a95d-fb3cab0f3076" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_634e18e7-1628-416e-9134-3acd70449087" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_724381b4-15d8-4b6b-aa59-01fd2d6da8b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_634e18e7-1628-416e-9134-3acd70449087" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_724381b4-15d8-4b6b-aa59-01fd2d6da8b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_724381b4-15d8-4b6b-aa59-01fd2d6da8b4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_724381b4-15d8-4b6b-aa59-01fd2d6da8b4" xlink:to="loc_us-gaap_EquityComponentDomain_724381b4-15d8-4b6b-aa59-01fd2d6da8b4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_44f2f76c-5fab-4705-9e62-1bab8f069f14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_724381b4-15d8-4b6b-aa59-01fd2d6da8b4" xlink:to="loc_us-gaap_EquityComponentDomain_44f2f76c-5fab-4705-9e62-1bab8f069f14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_8c490abf-5f1d-448e-a44c-7f0c3023ef2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_44f2f76c-5fab-4705-9e62-1bab8f069f14" xlink:to="loc_us-gaap_CommonStockMember_8c490abf-5f1d-448e-a44c-7f0c3023ef2f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_3bac5513-4122-4d19-b2f8-ebf082b42614" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_634e18e7-1628-416e-9134-3acd70449087" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_3bac5513-4122-4d19-b2f8-ebf082b42614" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3bac5513-4122-4d19-b2f8-ebf082b42614_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_3bac5513-4122-4d19-b2f8-ebf082b42614" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3bac5513-4122-4d19-b2f8-ebf082b42614_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3e8e1f54-02fb-4433-bc61-5c99591ccb3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_3bac5513-4122-4d19-b2f8-ebf082b42614" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3e8e1f54-02fb-4433-bc61-5c99591ccb3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember_8b4554d8-a9f4-41e5-92c6-56750d1fb1be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrivatePlacementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3e8e1f54-02fb-4433-bc61-5c99591ccb3c" xlink:to="loc_us-gaap_PrivatePlacementMember_8b4554d8-a9f4-41e5-92c6-56750d1fb1be" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SaleOfStockPerformanceMilestoneAxis_0430013e-087d-4c8f-b5ea-d6205b9af0fe" xlink:href="cron-20201231.xsd#cron_SaleOfStockPerformanceMilestoneAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_634e18e7-1628-416e-9134-3acd70449087" xlink:to="loc_cron_SaleOfStockPerformanceMilestoneAxis_0430013e-087d-4c8f-b5ea-d6205b9af0fe" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SaleOfStockPerformanceMilestoneDomain_0430013e-087d-4c8f-b5ea-d6205b9af0fe_default" xlink:href="cron-20201231.xsd#cron_SaleOfStockPerformanceMilestoneDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cron_SaleOfStockPerformanceMilestoneAxis_0430013e-087d-4c8f-b5ea-d6205b9af0fe" xlink:to="loc_cron_SaleOfStockPerformanceMilestoneDomain_0430013e-087d-4c8f-b5ea-d6205b9af0fe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SaleOfStockPerformanceMilestoneDomain_185517dd-85a2-43a7-a4e9-2c9f6804156b" xlink:href="cron-20201231.xsd#cron_SaleOfStockPerformanceMilestoneDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cron_SaleOfStockPerformanceMilestoneAxis_0430013e-087d-4c8f-b5ea-d6205b9af0fe" xlink:to="loc_cron_SaleOfStockPerformanceMilestoneDomain_185517dd-85a2-43a7-a4e9-2c9f6804156b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SaleOfStockPerformanceMilestoneOneMember_43527498-00eb-4a2d-8a88-e7b50e72be09" xlink:href="cron-20201231.xsd#cron_SaleOfStockPerformanceMilestoneOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_SaleOfStockPerformanceMilestoneDomain_185517dd-85a2-43a7-a4e9-2c9f6804156b" xlink:to="loc_cron_SaleOfStockPerformanceMilestoneOneMember_43527498-00eb-4a2d-8a88-e7b50e72be09" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SaleOfStockPerformanceMilestoneTwoMember_6f03a8ae-be53-417e-bc5f-ce7e768c5e7b" xlink:href="cron-20201231.xsd#cron_SaleOfStockPerformanceMilestoneTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_SaleOfStockPerformanceMilestoneDomain_185517dd-85a2-43a7-a4e9-2c9f6804156b" xlink:to="loc_cron_SaleOfStockPerformanceMilestoneTwoMember_6f03a8ae-be53-417e-bc5f-ce7e768c5e7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_fc25449b-107c-45ba-b009-b4f5486416de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_634e18e7-1628-416e-9134-3acd70449087" xlink:to="loc_us-gaap_VestingAxis_fc25449b-107c-45ba-b009-b4f5486416de" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_fc25449b-107c-45ba-b009-b4f5486416de_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VestingAxis_fc25449b-107c-45ba-b009-b4f5486416de" xlink:to="loc_us-gaap_VestingDomain_fc25449b-107c-45ba-b009-b4f5486416de_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_ad406d4a-b662-43b6-9040-ed1df8dcc365" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VestingAxis_fc25449b-107c-45ba-b009-b4f5486416de" xlink:to="loc_us-gaap_VestingDomain_ad406d4a-b662-43b6-9040-ed1df8dcc365" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_447753a9-045a-40b6-a496-243c4ed67012" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_ad406d4a-b662-43b6-9040-ed1df8dcc365" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_447753a9-045a-40b6-a496-243c4ed67012" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_76b10a23-4ba1-42a8-91fe-1adfb2c48362" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_ad406d4a-b662-43b6-9040-ed1df8dcc365" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_76b10a23-4ba1-42a8-91fe-1adfb2c48362" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_51963551-6053-4d4b-ae8c-b103d35a3c8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_ad406d4a-b662-43b6-9040-ed1df8dcc365" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_51963551-6053-4d4b-ae8c-b103d35a3c8c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_c4ca8ca9-7f3b-4765-8ee2-a0ed20b31758" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_634e18e7-1628-416e-9134-3acd70449087" xlink:to="loc_srt_StatementScenarioAxis_c4ca8ca9-7f3b-4765-8ee2-a0ed20b31758" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_c4ca8ca9-7f3b-4765-8ee2-a0ed20b31758_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_c4ca8ca9-7f3b-4765-8ee2-a0ed20b31758" xlink:to="loc_srt_ScenarioUnspecifiedDomain_c4ca8ca9-7f3b-4765-8ee2-a0ed20b31758_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_44496839-df7f-4025-9227-fdfdf244a187" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_c4ca8ca9-7f3b-4765-8ee2-a0ed20b31758" xlink:to="loc_srt_ScenarioUnspecifiedDomain_44496839-df7f-4025-9227-fdfdf244a187" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_78ce41f7-5dd6-45c2-8f45-f15cb0c5308d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_44496839-df7f-4025-9227-fdfdf244a187" xlink:to="loc_srt_ScenarioForecastMember_78ce41f7-5dd6-45c2-8f45-f15cb0c5308d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/Contingencies" xlink:type="simple" xlink:href="cron-20201231.xsd#Contingencies"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/Contingencies" xlink:type="extended" id="iee887a1241ab4145a0ca912624d69e89_Contingencies"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/ContingenciesDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#ContingenciesDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/ContingenciesDetails" xlink:type="extended" id="i289daba5fb3f4635bea4520dc8e8043b_ContingenciesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_c3325419-e3d0-4ae2-946e-0a4cb5f4083f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs_21289699-d17a-4303-95ed-3ffc73e06041" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_c3325419-e3d0-4ae2-946e-0a4cb5f4083f" xlink:to="loc_us-gaap_LossContingencyNumberOfPlaintiffs_21289699-d17a-4303-95ed-3ffc73e06041" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber_caadacc1-233d-468e-b300-2305df0d8308" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_c3325419-e3d0-4ae2-946e-0a4cb5f4083f" xlink:to="loc_us-gaap_LossContingencyNewClaimsFiledNumber_caadacc1-233d-468e-b300-2305df0d8308" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue_ebaf7ceb-f2ba-4490-a63f-ab0977591516" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_c3325419-e3d0-4ae2-946e-0a4cb5f4083f" xlink:to="loc_us-gaap_LossContingencyDamagesSoughtValue_ebaf7ceb-f2ba-4490-a63f-ab0977591516" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LossContingencyPunitiveDamagesSoughtValue_04bfae94-6b05-4d45-ac7a-24ffb1b12261" xlink:href="cron-20201231.xsd#cron_LossContingencyPunitiveDamagesSoughtValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_c3325419-e3d0-4ae2-946e-0a4cb5f4083f" xlink:to="loc_cron_LossContingencyPunitiveDamagesSoughtValue_04bfae94-6b05-4d45-ac7a-24ffb1b12261" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_08a4d9f3-2e7d-4a24-a129-e6ef48befbf8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_c3325419-e3d0-4ae2-946e-0a4cb5f4083f" xlink:to="loc_us-gaap_LossContingenciesTable_08a4d9f3-2e7d-4a24-a129-e6ef48befbf8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_028e8964-7263-4737-bcf7-b75ec9aa4cb1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_08a4d9f3-2e7d-4a24-a129-e6ef48befbf8" xlink:to="loc_srt_LitigationCaseAxis_028e8964-7263-4737-bcf7-b75ec9aa4cb1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_028e8964-7263-4737-bcf7-b75ec9aa4cb1_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_028e8964-7263-4737-bcf7-b75ec9aa4cb1" xlink:to="loc_srt_LitigationCaseTypeDomain_028e8964-7263-4737-bcf7-b75ec9aa4cb1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_21475816-f81f-4269-af8d-10317bf8dc4c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_028e8964-7263-4737-bcf7-b75ec9aa4cb1" xlink:to="loc_srt_LitigationCaseTypeDomain_21475816-f81f-4269-af8d-10317bf8dc4c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_U.S.DistrictCourtofEasternDistrictofNewYorkVs.CronosMember_bee7a407-00f1-4c2f-a91f-ac6a973a9f1b" xlink:href="cron-20201231.xsd#cron_U.S.DistrictCourtofEasternDistrictofNewYorkVs.CronosMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_21475816-f81f-4269-af8d-10317bf8dc4c" xlink:to="loc_cron_U.S.DistrictCourtofEasternDistrictofNewYorkVs.CronosMember_bee7a407-00f1-4c2f-a91f-ac6a973a9f1b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_9f2d70b6-61b3-4d14-87f5-91d75d534438" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_08a4d9f3-2e7d-4a24-a129-e6ef48befbf8" xlink:to="loc_us-gaap_LitigationStatusAxis_9f2d70b6-61b3-4d14-87f5-91d75d534438" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_9f2d70b6-61b3-4d14-87f5-91d75d534438_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_9f2d70b6-61b3-4d14-87f5-91d75d534438" xlink:to="loc_us-gaap_LitigationStatusDomain_9f2d70b6-61b3-4d14-87f5-91d75d534438_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_bd14993e-49ab-4ca7-9d2b-c77653b4d24c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_9f2d70b6-61b3-4d14-87f5-91d75d534438" xlink:to="loc_us-gaap_LitigationStatusDomain_bd14993e-49ab-4ca7-9d2b-c77653b4d24c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_70bedce1-3720-4fd1-90bc-3872a502fb84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_bd14993e-49ab-4ca7-9d2b-c77653b4d24c" xlink:to="loc_us-gaap_PendingLitigationMember_70bedce1-3720-4fd1-90bc-3872a502fb84" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_5dd2dd90-0016-4dbd-bcd9-c5dcf3c0ed01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_08a4d9f3-2e7d-4a24-a129-e6ef48befbf8" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_5dd2dd90-0016-4dbd-bcd9-c5dcf3c0ed01" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_5dd2dd90-0016-4dbd-bcd9-c5dcf3c0ed01_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_5dd2dd90-0016-4dbd-bcd9-c5dcf3c0ed01" xlink:to="loc_us-gaap_LossContingencyNatureDomain_5dd2dd90-0016-4dbd-bcd9-c5dcf3c0ed01_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_f036647b-c4ad-425f-940d-8d56097ba28e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_5dd2dd90-0016-4dbd-bcd9-c5dcf3c0ed01" xlink:to="loc_us-gaap_LossContingencyNatureDomain_f036647b-c4ad-425f-940d-8d56097ba28e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnfavorableRegulatoryActionMember_a0e94abe-a883-4765-8bdf-2162b1e33f44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnfavorableRegulatoryActionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_f036647b-c4ad-425f-940d-8d56097ba28e" xlink:to="loc_us-gaap_UnfavorableRegulatoryActionMember_a0e94abe-a883-4765-8bdf-2162b1e33f44" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SupplementaryCashFlowInformation" xlink:type="simple" xlink:href="cron-20201231.xsd#SupplementaryCashFlowInformation"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/SupplementaryCashFlowInformation" xlink:type="extended" id="ifcdb2571c13448cc9303b375ee2b25d1_SupplementaryCashFlowInformation"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SupplementaryCashFlowInformationTables" xlink:type="simple" xlink:href="cron-20201231.xsd#SupplementaryCashFlowInformationTables"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/SupplementaryCashFlowInformationTables" xlink:type="extended" id="i1670e5c93aab42e581289ab2e7bf4023_SupplementaryCashFlowInformationTables"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SupplementaryCashFlowInformationDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#SupplementaryCashFlowInformationDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/SupplementaryCashFlowInformationDetails" xlink:type="extended" id="i0a9f46e05bcc47038551fd3434e244e4_SupplementaryCashFlowInformationDetails"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/FinancialInstruments" xlink:type="simple" xlink:href="cron-20201231.xsd#FinancialInstruments"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/FinancialInstruments" xlink:type="extended" id="i45d2f09a09874f7bad9bcd0cc4865b6c_FinancialInstruments"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#FinancialInstrumentsCreditRiskNarrativeDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails" xlink:type="extended" id="ibf3dff6428e04d739d7a007060c98b03_FinancialInstrumentsCreditRiskNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_d2c61b10-5c65-441f-9b5b-4b4922e5872d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure_c4de7993-3699-41cc-affd-217a7d5d42a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_d2c61b10-5c65-441f-9b5b-4b4922e5872d" xlink:to="loc_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure_c4de7993-3699-41cc-affd-217a7d5d42a9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_80ba64c3-7bb5-43d0-a98c-fa8c3ea5f561" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_d2c61b10-5c65-441f-9b5b-4b4922e5872d" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_80ba64c3-7bb5-43d0-a98c-fa8c3ea5f561" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff_44652ec1-25c5-4a88-941e-d1436bdeda5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_d2c61b10-5c65-441f-9b5b-4b4922e5872d" xlink:to="loc_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff_44652ec1-25c5-4a88-941e-d1436bdeda5f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_7e127139-dc00-4dcf-94d1-54295c576b09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_d2c61b10-5c65-441f-9b5b-4b4922e5872d" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_7e127139-dc00-4dcf-94d1-54295c576b09" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_d306fe5d-6482-482b-b2e3-1103f5ce761f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_d2c61b10-5c65-441f-9b5b-4b4922e5872d" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_d306fe5d-6482-482b-b2e3-1103f5ce761f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3fc3bf4a-c59b-437e-b0f8-59ecc2f1985c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_d2c61b10-5c65-441f-9b5b-4b4922e5872d" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3fc3bf4a-c59b-437e-b0f8-59ecc2f1985c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_0b36d380-89a3-46ab-a001-974d2c31aa89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_d2c61b10-5c65-441f-9b5b-4b4922e5872d" xlink:to="loc_us-gaap_ShortTermInvestments_0b36d380-89a3-46ab-a001-974d2c31aa89" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvancesToAffiliate_3668f1a6-22c6-40cf-8f56-56342af673e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdvancesToAffiliate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_d2c61b10-5c65-441f-9b5b-4b4922e5872d" xlink:to="loc_us-gaap_AdvancesToAffiliate_3668f1a6-22c6-40cf-8f56-56342af673e2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AdvancesToAffiliateAllowanceForCreditLoss_7370d2d8-f5d2-497d-a07c-3028aa84f096" xlink:href="cron-20201231.xsd#cron_AdvancesToAffiliateAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_d2c61b10-5c65-441f-9b5b-4b4922e5872d" xlink:to="loc_cron_AdvancesToAffiliateAllowanceForCreditLoss_7370d2d8-f5d2-497d-a07c-3028aa84f096" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_c8454a32-a74c-403b-b64b-9ca4131e5687" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_d2c61b10-5c65-441f-9b5b-4b4922e5872d" xlink:to="loc_us-gaap_ConcentrationRiskTable_c8454a32-a74c-403b-b64b-9ca4131e5687" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_efa1615c-199f-4ffe-8f2d-9ea754c81ddc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_c8454a32-a74c-403b-b64b-9ca4131e5687" xlink:to="loc_srt_MajorCustomersAxis_efa1615c-199f-4ffe-8f2d-9ea754c81ddc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_efa1615c-199f-4ffe-8f2d-9ea754c81ddc_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_efa1615c-199f-4ffe-8f2d-9ea754c81ddc" xlink:to="loc_srt_NameOfMajorCustomerDomain_efa1615c-199f-4ffe-8f2d-9ea754c81ddc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_8ad83972-4326-47d3-9767-c85a53660f5c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_efa1615c-199f-4ffe-8f2d-9ea754c81ddc" xlink:to="loc_srt_NameOfMajorCustomerDomain_8ad83972-4326-47d3-9767-c85a53660f5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FourCustomersMember_84215a8c-6d7f-45b6-9381-cc0a7b4655ec" xlink:href="cron-20201231.xsd#cron_FourCustomersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_8ad83972-4326-47d3-9767-c85a53660f5c" xlink:to="loc_cron_FourCustomersMember_84215a8c-6d7f-45b6-9381-cc0a7b4655ec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_TwoMajorCustomersMember_05487f55-c7f9-441c-b7ea-f5718ae370f9" xlink:href="cron-20201231.xsd#cron_TwoMajorCustomersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_8ad83972-4326-47d3-9767-c85a53660f5c" xlink:to="loc_cron_TwoMajorCustomersMember_05487f55-c7f9-441c-b7ea-f5718ae370f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_8a2da189-2845-49bd-a13a-445d0ad84dd7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_c8454a32-a74c-403b-b64b-9ca4131e5687" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_8a2da189-2845-49bd-a13a-445d0ad84dd7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_8a2da189-2845-49bd-a13a-445d0ad84dd7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_8a2da189-2845-49bd-a13a-445d0ad84dd7" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_8a2da189-2845-49bd-a13a-445d0ad84dd7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_65edd823-b1a7-4787-93d8-c17c241e13f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_8a2da189-2845-49bd-a13a-445d0ad84dd7" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_65edd823-b1a7-4787-93d8-c17c241e13f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_36c54545-48d8-412c-87d7-b11dfe30cae0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_65edd823-b1a7-4787-93d8-c17c241e13f4" xlink:to="loc_us-gaap_AccountsReceivableMember_36c54545-48d8-412c-87d7-b11dfe30cae0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_928e1312-8809-49c2-b26e-91beb4cc5ee3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_c8454a32-a74c-403b-b64b-9ca4131e5687" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_928e1312-8809-49c2-b26e-91beb4cc5ee3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_928e1312-8809-49c2-b26e-91beb4cc5ee3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_928e1312-8809-49c2-b26e-91beb4cc5ee3" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_928e1312-8809-49c2-b26e-91beb4cc5ee3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_b4b9014a-a581-497d-9d91-b445650565b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_928e1312-8809-49c2-b26e-91beb4cc5ee3" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_b4b9014a-a581-497d-9d91-b445650565b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditConcentrationRiskMember_4c48928b-5519-436b-9d46-2d85da2bbe1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_b4b9014a-a581-497d-9d91-b445650565b0" xlink:to="loc_us-gaap_CreditConcentrationRiskMember_4c48928b-5519-436b-9d46-2d85da2bbe1d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskNarrativeDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#FinancialInstrumentsLiquidityRiskNarrativeDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskNarrativeDetails" xlink:type="extended" id="i021de298c99744369007c54c62aa95e9_FinancialInstrumentsLiquidityRiskNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_77d7e5e2-9728-4135-b568-14b4ba32b39c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_09c18c4a-ccd9-4df6-bc06-ea1496776cb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_77d7e5e2-9728-4135-b568-14b4ba32b39c" xlink:to="loc_us-gaap_AccountsPayableCurrent_09c18c4a-ccd9-4df6-bc06-ea1496776cb7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_3464e2be-bd20-4960-a30a-2e77df9c12e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_77d7e5e2-9728-4135-b568-14b4ba32b39c" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_3464e2be-bd20-4960-a30a-2e77df9c12e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_08ab12b5-16c5-44ba-bd56-142b6373cfb3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_77d7e5e2-9728-4135-b568-14b4ba32b39c" xlink:to="loc_us-gaap_ConcentrationRiskTable_08ab12b5-16c5-44ba-bd56-142b6373cfb3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_734e86c5-c6b1-4fc5-a583-04e4da16d65b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_08ab12b5-16c5-44ba-bd56-142b6373cfb3" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_734e86c5-c6b1-4fc5-a583-04e4da16d65b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_734e86c5-c6b1-4fc5-a583-04e4da16d65b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_734e86c5-c6b1-4fc5-a583-04e4da16d65b" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_734e86c5-c6b1-4fc5-a583-04e4da16d65b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_fd4ec720-f052-41f1-b54f-d98b6d3e304d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_734e86c5-c6b1-4fc5-a583-04e4da16d65b" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_fd4ec720-f052-41f1-b54f-d98b6d3e304d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableMember_fe7c8c48-d198-4213-8073-ce3dcf9121c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_fd4ec720-f052-41f1-b54f-d98b6d3e304d" xlink:to="loc_us-gaap_AccountsPayableMember_fe7c8c48-d198-4213-8073-ce3dcf9121c5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_b0778ed8-938d-4c7d-a80f-dd7d9ba1feba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_08ab12b5-16c5-44ba-bd56-142b6373cfb3" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_b0778ed8-938d-4c7d-a80f-dd7d9ba1feba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_b0778ed8-938d-4c7d-a80f-dd7d9ba1feba_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_b0778ed8-938d-4c7d-a80f-dd7d9ba1feba" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_b0778ed8-938d-4c7d-a80f-dd7d9ba1feba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_c4739860-f8e9-4dc3-a9f8-723a338ad739" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_b0778ed8-938d-4c7d-a80f-dd7d9ba1feba" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_c4739860-f8e9-4dc3-a9f8-723a338ad739" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierConcentrationRiskMember_a4ab37a2-68e7-45d5-8e90-818bcb0c77f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplierConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_c4739860-f8e9-4dc3-a9f8-723a338ad739" xlink:to="loc_us-gaap_SupplierConcentrationRiskMember_a4ab37a2-68e7-45d5-8e90-818bcb0c77f1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_cf9d1306-b91d-4cd2-99cc-8968825e54c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_08ab12b5-16c5-44ba-bd56-142b6373cfb3" xlink:to="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_cf9d1306-b91d-4cd2-99cc-8968825e54c9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_cf9d1306-b91d-4cd2-99cc-8968825e54c9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_cf9d1306-b91d-4cd2-99cc-8968825e54c9" xlink:to="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_cf9d1306-b91d-4cd2-99cc-8968825e54c9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_e11880f4-e00a-43a4-9ce3-0595af0ea278" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_cf9d1306-b91d-4cd2-99cc-8968825e54c9" xlink:to="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_e11880f4-e00a-43a4-9ce3-0595af0ea278" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FourVendorsMember_55c8bbcd-2ef1-4090-a08d-0c94130161a1" xlink:href="cron-20201231.xsd#cron_FourVendorsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_e11880f4-e00a-43a4-9ce3-0595af0ea278" xlink:to="loc_cron_FourVendorsMember_55c8bbcd-2ef1-4090-a08d-0c94130161a1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ThreeVendorsMember_8643384e-203d-46a9-b02a-26f7d4224ccf" xlink:href="cron-20201231.xsd#cron_ThreeVendorsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_e11880f4-e00a-43a4-9ce3-0595af0ea278" xlink:to="loc_cron_ThreeVendorsMember_8643384e-203d-46a9-b02a-26f7d4224ccf" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/FinancialInstrumentsInterestRateRiskDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#FinancialInstrumentsInterestRateRiskDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/FinancialInstrumentsInterestRateRiskDetails" xlink:type="extended" id="i8bc9da7dc4364d9882dae6509b6af397_FinancialInstrumentsInterestRateRiskDetails"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/FinancialInstrumentsCurrencyRateRiskNarrativeDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#FinancialInstrumentsCurrencyRateRiskNarrativeDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/FinancialInstrumentsCurrencyRateRiskNarrativeDetails" xlink:type="extended" id="i79938c659a904a61bacd6c6e71aef586_FinancialInstrumentsCurrencyRateRiskNarrativeDetails"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/FairValueMeasurement" xlink:type="simple" xlink:href="cron-20201231.xsd#FairValueMeasurement"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/FairValueMeasurement" xlink:type="extended" id="ia4f08a4c93954904bc494480e75c4e97_FairValueMeasurement"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/FairValueMeasuresandDisclosuresTables" xlink:type="simple" xlink:href="cron-20201231.xsd#FairValueMeasuresandDisclosuresTables"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/FairValueMeasuresandDisclosuresTables" xlink:type="extended" id="ib46cd13e72d94d03b4f77e1d1bf16db0_FairValueMeasuresandDisclosuresTables"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/FairValueMeasurementDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#FairValueMeasurementDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/FairValueMeasurementDetails" xlink:type="extended" id="ia9f9d14d10224711ac2c0833080dda8c_FairValueMeasurementDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_19a7bdda-7ac4-43e4-a36d-6c14a4702cb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_18a52d69-8c42-4c79-b976-ef830b9fbe5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_19a7bdda-7ac4-43e4-a36d-6c14a4702cb8" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_18a52d69-8c42-4c79-b976-ef830b9fbe5a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_033275fd-2b4f-42b6-98da-16792b4f2979" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_19a7bdda-7ac4-43e4-a36d-6c14a4702cb8" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_033275fd-2b4f-42b6-98da-16792b4f2979" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_c4e5dc6b-1998-4b4e-9fea-b143254477bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_19a7bdda-7ac4-43e4-a36d-6c14a4702cb8" xlink:to="loc_us-gaap_DerivativeLiabilities_c4e5dc6b-1998-4b4e-9fea-b143254477bb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_cc30a309-7ac2-49f5-8896-2fa293621fbb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_19a7bdda-7ac4-43e4-a36d-6c14a4702cb8" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_cc30a309-7ac2-49f5-8896-2fa293621fbb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_4d700092-1666-4ebb-b449-a0a04c7499b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_cc30a309-7ac2-49f5-8896-2fa293621fbb" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_4d700092-1666-4ebb-b449-a0a04c7499b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_4d700092-1666-4ebb-b449-a0a04c7499b6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_4d700092-1666-4ebb-b449-a0a04c7499b6" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_4d700092-1666-4ebb-b449-a0a04c7499b6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_f261091f-2ee1-4295-a205-21b1d9a7f1dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_4d700092-1666-4ebb-b449-a0a04c7499b6" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_f261091f-2ee1-4295-a205-21b1d9a7f1dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_71fb0651-db01-476e-a2ba-4676b01ad527" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_f261091f-2ee1-4295-a205-21b1d9a7f1dc" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_71fb0651-db01-476e-a2ba-4676b01ad527" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1ab15296-3f17-48e3-89da-ab0ede405e78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_cc30a309-7ac2-49f5-8896-2fa293621fbb" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1ab15296-3f17-48e3-89da-ab0ede405e78" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1ab15296-3f17-48e3-89da-ab0ede405e78_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1ab15296-3f17-48e3-89da-ab0ede405e78" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1ab15296-3f17-48e3-89da-ab0ede405e78_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8da1701d-757d-41ed-bb59-bc333c368331" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1ab15296-3f17-48e3-89da-ab0ede405e78" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8da1701d-757d-41ed-bb59-bc333c368331" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_456286b2-ed28-4b12-8eeb-e5772128bd7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8da1701d-757d-41ed-bb59-bc333c368331" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_456286b2-ed28-4b12-8eeb-e5772128bd7e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_8d3c19d9-cdd3-4c6b-8009-9c9e63b82411" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8da1701d-757d-41ed-bb59-bc333c368331" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_8d3c19d9-cdd3-4c6b-8009-9c9e63b82411" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_89c2f89b-da85-4790-8c86-75ef90f3fa80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8da1701d-757d-41ed-bb59-bc333c368331" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_89c2f89b-da85-4790-8c86-75ef90f3fa80" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/RelatedPartyTransactionsandBalances" xlink:type="simple" xlink:href="cron-20201231.xsd#RelatedPartyTransactionsandBalances"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/RelatedPartyTransactionsandBalances" xlink:type="extended" id="i68edc789679349c4a7bae78e09d19e03_RelatedPartyTransactionsandBalances"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/RelatedPartyDisclosuresTables" xlink:type="simple" xlink:href="cron-20201231.xsd#RelatedPartyDisclosuresTables"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/RelatedPartyDisclosuresTables" xlink:type="extended" id="i99b827348586475297ad9dd5b25d7a21_RelatedPartyDisclosuresTables"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesNarrativeDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#RelatedPartyTransactionsandBalancesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesNarrativeDetails" xlink:type="extended" id="ia55f2495ff40472d853a1e893714c62a_RelatedPartyTransactionsandBalancesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_d2d65f96-5057-4f05-b33b-10682e5b173a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_74ce12bf-58bc-4279-b85d-de289529fa41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_d2d65f96-5057-4f05-b33b-10682e5b173a" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_74ce12bf-58bc-4279-b85d-de289529fa41" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_79effd63-ae06-4c67-a158-f6c11034f86d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_d2d65f96-5057-4f05-b33b-10682e5b173a" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_79effd63-ae06-4c67-a158-f6c11034f86d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_f069974b-e59a-4cfb-9e37-07ba7e8ed15a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_d2d65f96-5057-4f05-b33b-10682e5b173a" xlink:to="loc_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_f069974b-e59a-4cfb-9e37-07ba7e8ed15a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_6c9fd8a6-5b3a-40a6-891b-18f4abc5683c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_d2d65f96-5057-4f05-b33b-10682e5b173a" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_6c9fd8a6-5b3a-40a6-891b-18f4abc5683c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d3b44b85-95c1-470c-be39-0883095b4dce" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_6c9fd8a6-5b3a-40a6-891b-18f4abc5683c" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d3b44b85-95c1-470c-be39-0883095b4dce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_d3b44b85-95c1-470c-be39-0883095b4dce_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d3b44b85-95c1-470c-be39-0883095b4dce" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_d3b44b85-95c1-470c-be39-0883095b4dce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_ddb5372c-124f-40c3-b704-65cf13cb9f62" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d3b44b85-95c1-470c-be39-0883095b4dce" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_ddb5372c-124f-40c3-b704-65cf13cb9f62" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosGroupInc.Member_ca862c77-3007-480c-aa82-f4cacdbbd5af" xlink:href="cron-20201231.xsd#cron_CronosGroupInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_ddb5372c-124f-40c3-b704-65cf13cb9f62" xlink:to="loc_cron_CronosGroupInc.Member_ca862c77-3007-480c-aa82-f4cacdbbd5af" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_8504caa4-b87e-4fe8-adc4-4273f9990fa3" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_6c9fd8a6-5b3a-40a6-891b-18f4abc5683c" xlink:to="loc_dei_LegalEntityAxis_8504caa4-b87e-4fe8-adc4-4273f9990fa3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_8504caa4-b87e-4fe8-adc4-4273f9990fa3_default" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_8504caa4-b87e-4fe8-adc4-4273f9990fa3" xlink:to="loc_dei_EntityDomain_8504caa4-b87e-4fe8-adc4-4273f9990fa3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_1394a13c-e71d-4e4f-aa31-c9ccb17aba73" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_8504caa4-b87e-4fe8-adc4-4273f9990fa3" xlink:to="loc_dei_EntityDomain_1394a13c-e71d-4e4f-aa31-c9ccb17aba73" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaGroupInc.Member_0139e618-0eba-4fca-b9ce-b8210aaf36c1" xlink:href="cron-20201231.xsd#cron_AltriaGroupInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_1394a13c-e71d-4e4f-aa31-c9ccb17aba73" xlink:to="loc_cron_AltriaGroupInc.Member_0139e618-0eba-4fca-b9ce-b8210aaf36c1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_353d8995-3434-4f3b-8396-c3ad2c173e45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_6c9fd8a6-5b3a-40a6-891b-18f4abc5683c" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_353d8995-3434-4f3b-8396-c3ad2c173e45" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_353d8995-3434-4f3b-8396-c3ad2c173e45_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_353d8995-3434-4f3b-8396-c3ad2c173e45" xlink:to="loc_us-gaap_RelatedPartyDomain_353d8995-3434-4f3b-8396-c3ad2c173e45_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_271ac26a-1ce3-47b2-8656-825eddd12976" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_353d8995-3434-4f3b-8396-c3ad2c173e45" xlink:to="loc_us-gaap_RelatedPartyDomain_271ac26a-1ce3-47b2-8656-825eddd12976" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_7add8e60-2126-4c4a-bd25-cfccb70a8e0c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AffiliatedEntityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_271ac26a-1ce3-47b2-8656-825eddd12976" xlink:to="loc_srt_AffiliatedEntityMember_7add8e60-2126-4c4a-bd25-cfccb70a8e0c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_44fc6f85-339e-40ab-8bb6-31fc82ef2be7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_6c9fd8a6-5b3a-40a6-891b-18f4abc5683c" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_44fc6f85-339e-40ab-8bb6-31fc82ef2be7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_44fc6f85-339e-40ab-8bb6-31fc82ef2be7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_44fc6f85-339e-40ab-8bb6-31fc82ef2be7" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_44fc6f85-339e-40ab-8bb6-31fc82ef2be7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_068daa96-c34e-4187-863f-f920779695c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_44fc6f85-339e-40ab-8bb6-31fc82ef2be7" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_068daa96-c34e-4187-863f-f920779695c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PurchaseOfMachineryAndEquipmentMember_4cdbd23a-24f2-485f-8ff1-e9bcc60454d1" xlink:href="cron-20201231.xsd#cron_PurchaseOfMachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_068daa96-c34e-4187-863f-f920779695c8" xlink:to="loc_cron_PurchaseOfMachineryAndEquipmentMember_4cdbd23a-24f2-485f-8ff1-e9bcc60454d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ConsultingServicesMember_52db065b-4348-4930-b9c4-8b0562267f35" xlink:href="cron-20201231.xsd#cron_ConsultingServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_068daa96-c34e-4187-863f-f920779695c8" xlink:to="loc_cron_ConsultingServicesMember_52db065b-4348-4930-b9c4-8b0562267f35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_7c106205-d398-4109-9974-03bde79d3be2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_6c9fd8a6-5b3a-40a6-891b-18f4abc5683c" xlink:to="loc_srt_CounterpartyNameAxis_7c106205-d398-4109-9974-03bde79d3be2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7c106205-d398-4109-9974-03bde79d3be2_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_7c106205-d398-4109-9974-03bde79d3be2" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7c106205-d398-4109-9974-03bde79d3be2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b339bd80-c1d9-4629-bf0b-b60fb07e182a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_7c106205-d398-4109-9974-03bde79d3be2" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b339bd80-c1d9-4629-bf0b-b60fb07e182a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaGroupInc.Member_0e4bbf56-fb92-493c-9854-5707235c156f" xlink:href="cron-20201231.xsd#cron_AltriaGroupInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b339bd80-c1d9-4629-bf0b-b60fb07e182a" xlink:to="loc_cron_AltriaGroupInc.Member_0e4bbf56-fb92-493c-9854-5707235c156f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaPinnacleLLC.Member_021d41a6-8897-4cf1-a246-0b42ff7987c4" xlink:href="cron-20201231.xsd#cron_AltriaPinnacleLLC.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b339bd80-c1d9-4629-bf0b-b60fb07e182a" xlink:to="loc_cron_AltriaPinnacleLLC.Member_021d41a6-8897-4cf1-a246-0b42ff7987c4" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesScheduleofRelatedPartyTransactionsDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#RelatedPartyTransactionsandBalancesScheduleofRelatedPartyTransactionsDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesScheduleofRelatedPartyTransactionsDetails" xlink:type="extended" id="iaeafa99ff24145569ef77a42aaa94b0c_RelatedPartyTransactionsandBalancesScheduleofRelatedPartyTransactionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_816ea0a2-b2f1-48d5-8577-167a89103ba6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_7bdb1922-fc57-457e-a469-64b559ba1e17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_816ea0a2-b2f1-48d5-8577-167a89103ba6" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_7bdb1922-fc57-457e-a469-64b559ba1e17" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableRelatedPartiesCurrent_deb6a0f4-b66f-42fa-9c24-d152a37e0ee8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_816ea0a2-b2f1-48d5-8577-167a89103ba6" xlink:to="loc_us-gaap_AccountsPayableRelatedPartiesCurrent_deb6a0f4-b66f-42fa-9c24-d152a37e0ee8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_953bff14-a766-423f-8ef3-2738a1cc7f2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_816ea0a2-b2f1-48d5-8577-167a89103ba6" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_953bff14-a766-423f-8ef3-2738a1cc7f2a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_b57d64ab-8f79-4dc1-b37d-3842da1a4892" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_953bff14-a766-423f-8ef3-2738a1cc7f2a" xlink:to="loc_srt_CounterpartyNameAxis_b57d64ab-8f79-4dc1-b37d-3842da1a4892" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b57d64ab-8f79-4dc1-b37d-3842da1a4892_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_b57d64ab-8f79-4dc1-b37d-3842da1a4892" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b57d64ab-8f79-4dc1-b37d-3842da1a4892_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_13819504-9afc-4859-a0ef-468d367abda4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_b57d64ab-8f79-4dc1-b37d-3842da1a4892" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_13819504-9afc-4859-a0ef-468d367abda4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaPinnacleLLC.Member_572e0c33-b6c8-492a-8b7d-94e3e7ef921b" xlink:href="cron-20201231.xsd#cron_AltriaPinnacleLLC.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_13819504-9afc-4859-a0ef-468d367abda4" xlink:to="loc_cron_AltriaPinnacleLLC.Member_572e0c33-b6c8-492a-8b7d-94e3e7ef921b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_b6f2ce4a-0e22-4faf-bdca-e3de9ee61ee9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_953bff14-a766-423f-8ef3-2738a1cc7f2a" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_b6f2ce4a-0e22-4faf-bdca-e3de9ee61ee9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_b6f2ce4a-0e22-4faf-bdca-e3de9ee61ee9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_b6f2ce4a-0e22-4faf-bdca-e3de9ee61ee9" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_b6f2ce4a-0e22-4faf-bdca-e3de9ee61ee9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_2b8a3f83-d2f9-4b52-80b2-8b4f9605d5e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_b6f2ce4a-0e22-4faf-bdca-e3de9ee61ee9" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_2b8a3f83-d2f9-4b52-80b2-8b4f9605d5e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ConsultingServicesMember_5527d2ae-04a9-4a6e-a192-7998cf9e9e39" xlink:href="cron-20201231.xsd#cron_ConsultingServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_2b8a3f83-d2f9-4b52-80b2-8b4f9605d5e0" xlink:to="loc_cron_ConsultingServicesMember_5527d2ae-04a9-4a6e-a192-7998cf9e9e39" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_a8e78413-f651-4db1-ba65-16ccff60654e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_953bff14-a766-423f-8ef3-2738a1cc7f2a" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_a8e78413-f651-4db1-ba65-16ccff60654e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_a8e78413-f651-4db1-ba65-16ccff60654e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_a8e78413-f651-4db1-ba65-16ccff60654e" xlink:to="loc_us-gaap_RelatedPartyDomain_a8e78413-f651-4db1-ba65-16ccff60654e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_2623ccc2-5ff0-477f-864d-1be7008dad00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_a8e78413-f651-4db1-ba65-16ccff60654e" xlink:to="loc_us-gaap_RelatedPartyDomain_2623ccc2-5ff0-477f-864d-1be7008dad00" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_590d49a6-b0ee-464c-9559-7b565f53274c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AffiliatedEntityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_2623ccc2-5ff0-477f-864d-1be7008dad00" xlink:to="loc_srt_AffiliatedEntityMember_590d49a6-b0ee-464c-9559-7b565f53274c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/NonmonetaryTransactions" xlink:type="simple" xlink:href="cron-20201231.xsd#NonmonetaryTransactions"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/NonmonetaryTransactions" xlink:type="extended" id="i8a7e7a5968d0426387bbe98a5e016c4c_NonmonetaryTransactions"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/NonmonetaryTransactionsDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#NonmonetaryTransactionsDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/NonmonetaryTransactionsDetails" xlink:type="extended" id="ia4cfbef1e3d04421a6e73d96ab3b673b_NonmonetaryTransactionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonmonetaryTransactionLineItems_b61d8847-1a13-4af5-bb26-21512d0284bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonmonetaryTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NonmonetaryTransactionNumberOfTransactions_c77a0c72-2f17-458d-864a-8786b44a15c9" xlink:href="cron-20201231.xsd#cron_NonmonetaryTransactionNumberOfTransactions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonmonetaryTransactionLineItems_b61d8847-1a13-4af5-bb26-21512d0284bf" xlink:to="loc_cron_NonmonetaryTransactionNumberOfTransactions_c77a0c72-2f17-458d-864a-8786b44a15c9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonmonetaryTransactionGrossOperatingRevenueRecognized_dbb85ec4-0ecd-4c7a-8618-688e2c61b25d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonmonetaryTransactionGrossOperatingRevenueRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonmonetaryTransactionLineItems_b61d8847-1a13-4af5-bb26-21512d0284bf" xlink:to="loc_us-gaap_NonmonetaryTransactionGrossOperatingRevenueRecognized_dbb85ec4-0ecd-4c7a-8618-688e2c61b25d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonmonetaryTransactionGainLossRecognizedOnTransfer_2cf58a34-0396-4b28-ad25-c916bfffcb30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonmonetaryTransactionGainLossRecognizedOnTransfer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonmonetaryTransactionLineItems_b61d8847-1a13-4af5-bb26-21512d0284bf" xlink:to="loc_us-gaap_NonmonetaryTransactionGainLossRecognizedOnTransfer_2cf58a34-0396-4b28-ad25-c916bfffcb30" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonmonetaryTransactionByTypeTable_8e2ba767-b75f-4bfa-9567-70bb333e2c81" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonmonetaryTransactionByTypeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NonmonetaryTransactionLineItems_b61d8847-1a13-4af5-bb26-21512d0284bf" xlink:to="loc_us-gaap_NonmonetaryTransactionByTypeTable_8e2ba767-b75f-4bfa-9567-70bb333e2c81" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonmonetaryTransactionTypeAxis_4c241b48-39e9-4a13-b9a9-6aa9d93a50bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonmonetaryTransactionTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NonmonetaryTransactionByTypeTable_8e2ba767-b75f-4bfa-9567-70bb333e2c81" xlink:to="loc_us-gaap_NonmonetaryTransactionTypeAxis_4c241b48-39e9-4a13-b9a9-6aa9d93a50bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonmonetaryTransactionTypeDomain_4c241b48-39e9-4a13-b9a9-6aa9d93a50bd_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonmonetaryTransactionTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_NonmonetaryTransactionTypeAxis_4c241b48-39e9-4a13-b9a9-6aa9d93a50bd" xlink:to="loc_us-gaap_NonmonetaryTransactionTypeDomain_4c241b48-39e9-4a13-b9a9-6aa9d93a50bd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonmonetaryTransactionTypeDomain_ed19e82c-d98e-4aae-b346-2120e1876eb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonmonetaryTransactionTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_NonmonetaryTransactionTypeAxis_4c241b48-39e9-4a13-b9a9-6aa9d93a50bd" xlink:to="loc_us-gaap_NonmonetaryTransactionTypeDomain_ed19e82c-d98e-4aae-b346-2120e1876eb2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExchangeOfProductHeldForSaleForSimilarProductMember_9b273ed5-3a07-4ec9-aa58-e21f7da5d06f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExchangeOfProductHeldForSaleForSimilarProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonmonetaryTransactionTypeDomain_ed19e82c-d98e-4aae-b346-2120e1876eb2" xlink:to="loc_us-gaap_ExchangeOfProductHeldForSaleForSimilarProductMember_9b273ed5-3a07-4ec9-aa58-e21f7da5d06f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/BusinessCombinations" xlink:type="simple" xlink:href="cron-20201231.xsd#BusinessCombinations"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/BusinessCombinations" xlink:type="extended" id="i20f48f18d2664641be56d5a27b9530c8_BusinessCombinations"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/BusinessCombinationsTables" xlink:type="simple" xlink:href="cron-20201231.xsd#BusinessCombinationsTables"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/BusinessCombinationsTables" xlink:type="extended" id="ied65fad6458f437ba939f5fd6ae126ab_BusinessCombinationsTables"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/BusinessCombinationsNarrativeDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#BusinessCombinationsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/BusinessCombinationsNarrativeDetails" xlink:type="extended" id="ibc627997e31240969991f4dda9f6d5e1_BusinessCombinationsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_887bf4a4-b608-422b-b9a5-3d7a32025169" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfBusinessesAcquired_9311c770-2455-46c3-adc3-7724819b38ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfBusinessesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_887bf4a4-b608-422b-b9a5-3d7a32025169" xlink:to="loc_us-gaap_NumberOfBusinessesAcquired_9311c770-2455-46c3-adc3-7724819b38ad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_e3d09176-7247-4f19-9f02-5a16ba729cb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_887bf4a4-b608-422b-b9a5-3d7a32025169" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_e3d09176-7247-4f19-9f02-5a16ba729cb4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_207487ea-53cd-4688-86ed-2c7f83ba6285" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_887bf4a4-b608-422b-b9a5-3d7a32025169" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_207487ea-53cd-4688-86ed-2c7f83ba6285" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_aade64b8-ad55-484b-bd9c-0e6ca82520c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_887bf4a4-b608-422b-b9a5-3d7a32025169" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_aade64b8-ad55-484b-bd9c-0e6ca82520c1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_7ceccde1-22b4-44f0-a180-a2bfaffd9665" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_887bf4a4-b608-422b-b9a5-3d7a32025169" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_7ceccde1-22b4-44f0-a180-a2bfaffd9665" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_5c9724da-5106-4b55-a7b3-9c5a394d345e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_887bf4a4-b608-422b-b9a5-3d7a32025169" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_5c9724da-5106-4b55-a7b3-9c5a394d345e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_0cbb9a13-d154-483d-8635-d58bef78ac06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_887bf4a4-b608-422b-b9a5-3d7a32025169" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_0cbb9a13-d154-483d-8635-d58bef78ac06" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_3dc37d61-1d80-4789-b0ab-0c9e066bd263" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_887bf4a4-b608-422b-b9a5-3d7a32025169" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_3dc37d61-1d80-4789-b0ab-0c9e066bd263" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_c0b2d9ad-7b54-4d85-bdc6-d3898fe0ee09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_887bf4a4-b608-422b-b9a5-3d7a32025169" xlink:to="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_c0b2d9ad-7b54-4d85-bdc6-d3898fe0ee09" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_3e543bcc-1374-4811-986e-4a46231b91d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_887bf4a4-b608-422b-b9a5-3d7a32025169" xlink:to="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_3e543bcc-1374-4811-986e-4a46231b91d8" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_d5463f70-53f4-4dfc-8816-3914c3f76820" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_887bf4a4-b608-422b-b9a5-3d7a32025169" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_d5463f70-53f4-4dfc-8816-3914c3f76820" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_1b9a5f7c-ae32-40b2-8f9e-ff2ba0038b55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_887bf4a4-b608-422b-b9a5-3d7a32025169" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_1b9a5f7c-ae32-40b2-8f9e-ff2ba0038b55" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_6ee874bc-a5da-476b-bf33-07d40a59e6cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_887bf4a4-b608-422b-b9a5-3d7a32025169" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_6ee874bc-a5da-476b-bf33-07d40a59e6cd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_92c92a39-632f-430c-ae0d-b15165f12059" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_6ee874bc-a5da-476b-bf33-07d40a59e6cd" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_92c92a39-632f-430c-ae0d-b15165f12059" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_92c92a39-632f-430c-ae0d-b15165f12059_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_92c92a39-632f-430c-ae0d-b15165f12059" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_92c92a39-632f-430c-ae0d-b15165f12059_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d821dde7-e2db-4ce0-9a6c-1df3a2e0ed64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_92c92a39-632f-430c-ae0d-b15165f12059" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d821dde7-e2db-4ce0-9a6c-1df3a2e0ed64" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_RedwoodHoldingGroupLLCMember_ed878155-a585-4784-ba03-96a04f72755d" xlink:href="cron-20201231.xsd#cron_RedwoodHoldingGroupLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d821dde7-e2db-4ce0-9a6c-1df3a2e0ed64" xlink:to="loc_cron_RedwoodHoldingGroupLLCMember_ed878155-a585-4784-ba03-96a04f72755d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/BusinessCombinationsScheduleofFairValueofNetAssetsAcquiredDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#BusinessCombinationsScheduleofFairValueofNetAssetsAcquiredDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/BusinessCombinationsScheduleofFairValueofNetAssetsAcquiredDetails" xlink:type="extended" id="ieecd3abf3c884eaa9903c84ae6733a23_BusinessCombinationsScheduleofFairValueofNetAssetsAcquiredDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_f29c0c22-c747-49e5-9f60-2ddec11c2ee1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_e119b0ff-4671-4aa9-a106-0b432ffc9a0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f29c0c22-c747-49e5-9f60-2ddec11c2ee1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_e119b0ff-4671-4aa9-a106-0b432ffc9a0b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_c9df11d5-da4c-4d40-ac05-44db8002b341" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_e119b0ff-4671-4aa9-a106-0b432ffc9a0b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_c9df11d5-da4c-4d40-ac05-44db8002b341" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_7e8a08d9-ce05-46d0-a04e-e931b4aefd53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_e119b0ff-4671-4aa9-a106-0b432ffc9a0b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_7e8a08d9-ce05-46d0-a04e-e931b4aefd53" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_3bde41dd-0d9a-434a-84dd-bb1798c480c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_e119b0ff-4671-4aa9-a106-0b432ffc9a0b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_3bde41dd-0d9a-434a-84dd-bb1798c480c3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_4e97e928-51ad-4eef-95f7-60fa72004d6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_e119b0ff-4671-4aa9-a106-0b432ffc9a0b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_4e97e928-51ad-4eef-95f7-60fa72004d6b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_72489f0a-daa6-456d-a81e-8649679b61e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_e119b0ff-4671-4aa9-a106-0b432ffc9a0b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_72489f0a-daa6-456d-a81e-8649679b61e3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_0dff4146-5945-4b7a-bd71-ed11b2e637e2" xlink:href="cron-20201231.xsd#cron_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_e119b0ff-4671-4aa9-a106-0b432ffc9a0b" xlink:to="loc_cron_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_0dff4146-5945-4b7a-bd71-ed11b2e637e2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_14d59213-0fa8-47e0-bb3c-eca5eca2f440" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_e119b0ff-4671-4aa9-a106-0b432ffc9a0b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_14d59213-0fa8-47e0-bb3c-eca5eca2f440" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_624c6665-03d6-4c0e-b807-58e65900f975" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_e119b0ff-4671-4aa9-a106-0b432ffc9a0b" xlink:to="loc_us-gaap_Goodwill_624c6665-03d6-4c0e-b807-58e65900f975" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAndAccruedLiabilities_20e46345-1c5f-4fc4-a9a2-6a825312d54e" xlink:href="cron-20201231.xsd#cron_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAndAccruedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_e119b0ff-4671-4aa9-a106-0b432ffc9a0b" xlink:to="loc_cron_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAndAccruedLiabilities_20e46345-1c5f-4fc4-a9a2-6a825312d54e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_ad456b6e-61ed-42de-a0b2-3d26481fa87e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_e119b0ff-4671-4aa9-a106-0b432ffc9a0b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_ad456b6e-61ed-42de-a0b2-3d26481fa87e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_ad3a2c90-d33a-4190-9b1c-93fc08a9fb85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_e119b0ff-4671-4aa9-a106-0b432ffc9a0b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_ad3a2c90-d33a-4190-9b1c-93fc08a9fb85" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_65d9eb0c-a587-444a-8a3a-42eb5b5fa5ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquiredReceivablesEstimatedUncollectible_03e0b821-6811-4610-b045-be4790096873" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationAcquiredReceivablesEstimatedUncollectible"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f29c0c22-c747-49e5-9f60-2ddec11c2ee1" xlink:to="loc_us-gaap_BusinessCombinationAcquiredReceivablesEstimatedUncollectible_03e0b821-6811-4610-b045-be4790096873" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_e1c83623-48e1-4bc0-bec2-d4f3e4be4c28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefinitelivedIntangibleAssetsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f29c0c22-c747-49e5-9f60-2ddec11c2ee1" xlink:to="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_e1c83623-48e1-4bc0-bec2-d4f3e4be4c28" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9637222c-a73f-4fa5-9565-054425e46133" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f29c0c22-c747-49e5-9f60-2ddec11c2ee1" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9637222c-a73f-4fa5-9565-054425e46133" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_5b245704-2903-4920-b0e3-982e3787b183" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9637222c-a73f-4fa5-9565-054425e46133" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_5b245704-2903-4920-b0e3-982e3787b183" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5b245704-2903-4920-b0e3-982e3787b183_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5b245704-2903-4920-b0e3-982e3787b183" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5b245704-2903-4920-b0e3-982e3787b183_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8ddf2f9c-723f-410f-8288-9d17b3bbdaa8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5b245704-2903-4920-b0e3-982e3787b183" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8ddf2f9c-723f-410f-8288-9d17b3bbdaa8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_RedwoodHoldingGroupLLCMember_1c41aeed-2d2b-493d-a971-7c2d83b266d5" xlink:href="cron-20201231.xsd#cron_RedwoodHoldingGroupLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8ddf2f9c-723f-410f-8288-9d17b3bbdaa8" xlink:to="loc_cron_RedwoodHoldingGroupLLCMember_1c41aeed-2d2b-493d-a971-7c2d83b266d5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_4a1e5696-d2d5-4a3e-b64c-ad948225c3c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9637222c-a73f-4fa5-9565-054425e46133" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_4a1e5696-d2d5-4a3e-b64c-ad948225c3c6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_4a1e5696-d2d5-4a3e-b64c-ad948225c3c6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_4a1e5696-d2d5-4a3e-b64c-ad948225c3c6" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_4a1e5696-d2d5-4a3e-b64c-ad948225c3c6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_1670f575-f694-4776-a1fb-a43eb64626fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_4a1e5696-d2d5-4a3e-b64c-ad948225c3c6" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_1670f575-f694-4776-a1fb-a43eb64626fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_3be65e56-08de-4dff-b1a1-1569f7b9ace8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_1670f575-f694-4776-a1fb-a43eb64626fb" xlink:to="loc_us-gaap_TradeNamesMember_3be65e56-08de-4dff-b1a1-1569f7b9ace8" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/RepurposingCharges" xlink:type="simple" xlink:href="cron-20201231.xsd#RepurposingCharges"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/RepurposingCharges" xlink:type="extended" id="i19d63412037c4dcdb334822f5579da03_RepurposingCharges"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/RepurposingChargesTables" xlink:type="simple" xlink:href="cron-20201231.xsd#RepurposingChargesTables"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/RepurposingChargesTables" xlink:type="extended" id="i7a401b684e8b4193bffb10f0a208d83b_RepurposingChargesTables"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/RepurposingChargesScheduleofPlanInformationDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#RepurposingChargesScheduleofPlanInformationDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/RepurposingChargesScheduleofPlanInformationDetails" xlink:type="extended" id="ica371117b21d4e539d116ab1246b75d7_RepurposingChargesScheduleofPlanInformationDetails"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/RepurposingChargesNarrativeDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#RepurposingChargesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/RepurposingChargesNarrativeDetails" xlink:type="extended" id="i338de40572e14a8fb2ed0c60c1e773b0_RepurposingChargesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_2263d496-9a65-46a3-9ee2-4d6b1f7e77b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_8985661e-b2bb-4f94-8690-f6b742861415" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_2263d496-9a65-46a3-9ee2-4d6b1f7e77b3" xlink:to="loc_us-gaap_InventoryWriteDown_8985661e-b2bb-4f94-8690-f6b742861415" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions_7f24d3c7-62df-4221-bc54-bd019421a2fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringSettlementAndImpairmentProvisions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_2263d496-9a65-46a3-9ee2-4d6b1f7e77b3" xlink:to="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions_7f24d3c7-62df-4221-bc54-bd019421a2fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_18ecd6fe-4f31-481e-b8f7-210718f37cc5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_2263d496-9a65-46a3-9ee2-4d6b1f7e77b3" xlink:to="loc_us-gaap_RestructuringReserve_18ecd6fe-4f31-481e-b8f7-210718f37cc5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b84c48e9-39ee-4500-8890-28743a61fb1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_2263d496-9a65-46a3-9ee2-4d6b1f7e77b3" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b84c48e9-39ee-4500-8890-28743a61fb1b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_b3f0b7a3-9cc4-445d-8891-ecc50578707a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b84c48e9-39ee-4500-8890-28743a61fb1b" xlink:to="loc_us-gaap_RestructuringPlanAxis_b3f0b7a3-9cc4-445d-8891-ecc50578707a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_b3f0b7a3-9cc4-445d-8891-ecc50578707a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_b3f0b7a3-9cc4-445d-8891-ecc50578707a" xlink:to="loc_us-gaap_RestructuringPlanDomain_b3f0b7a3-9cc4-445d-8891-ecc50578707a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_1990a573-a5f2-4432-94c0-6df7f7a04eda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_b3f0b7a3-9cc4-445d-8891-ecc50578707a" xlink:to="loc_us-gaap_RestructuringPlanDomain_1990a573-a5f2-4432-94c0-6df7f7a04eda" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_RepurposingPlanMember_b84a06ed-1e1c-4c08-abb0-566e1d8a06bd" xlink:href="cron-20201231.xsd#cron_RepurposingPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_1990a573-a5f2-4432-94c0-6df7f7a04eda" xlink:to="loc_cron_RepurposingPlanMember_b84a06ed-1e1c-4c08-abb0-566e1d8a06bd" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SegmentInformation" xlink:type="simple" xlink:href="cron-20201231.xsd#SegmentInformation"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/SegmentInformation" xlink:type="extended" id="i0661a24b316c477cb08a89c661af6109_SegmentInformation"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SegmentInformationTables" xlink:type="simple" xlink:href="cron-20201231.xsd#SegmentInformationTables"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/SegmentInformationTables" xlink:type="extended" id="i1e072f43332449dea9a1128385b3f289_SegmentInformationTables"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SegmentInformationNarrativeDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#SegmentInformationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/SegmentInformationNarrativeDetails" xlink:type="extended" id="i2df907597180487d8e9e764e762a9d38_SegmentInformationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_8a84ba2f-ae66-4c74-ab37-c8e262989617" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_d47e8f0e-ab24-42b5-8123-607eb29144c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8a84ba2f-ae66-4c74-ab37-c8e262989617" xlink:to="loc_us-gaap_NumberOfReportableSegments_d47e8f0e-ab24-42b5-8123-607eb29144c3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_a4ad6c3e-fb02-4a77-a142-cb1756db2a97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8a84ba2f-ae66-4c74-ab37-c8e262989617" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_a4ad6c3e-fb02-4a77-a142-cb1756db2a97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_4390b15b-2245-4265-be38-0eb9bf91d7e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8a84ba2f-ae66-4c74-ab37-c8e262989617" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_4390b15b-2245-4265-be38-0eb9bf91d7e3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_02d49d8b-b5e5-4763-8103-8f766a76027e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8a84ba2f-ae66-4c74-ab37-c8e262989617" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_02d49d8b-b5e5-4763-8103-8f766a76027e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_755dec07-e19b-46a9-8718-ac4f254c2cab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8a84ba2f-ae66-4c74-ab37-c8e262989617" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_755dec07-e19b-46a9-8718-ac4f254c2cab" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_b80c2f8b-ea36-4ff8-8aa5-85274c5cc366" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_755dec07-e19b-46a9-8718-ac4f254c2cab" xlink:to="loc_srt_MajorCustomersAxis_b80c2f8b-ea36-4ff8-8aa5-85274c5cc366" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_b80c2f8b-ea36-4ff8-8aa5-85274c5cc366_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_b80c2f8b-ea36-4ff8-8aa5-85274c5cc366" xlink:to="loc_srt_NameOfMajorCustomerDomain_b80c2f8b-ea36-4ff8-8aa5-85274c5cc366_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_3a64caee-c49a-4a0b-b22b-9a148e363bad" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_b80c2f8b-ea36-4ff8-8aa5-85274c5cc366" xlink:to="loc_srt_NameOfMajorCustomerDomain_3a64caee-c49a-4a0b-b22b-9a148e363bad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FourMajorCustomersMember_e3f43451-af7a-446e-9c51-080ee06a04a9" xlink:href="cron-20201231.xsd#cron_FourMajorCustomersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_3a64caee-c49a-4a0b-b22b-9a148e363bad" xlink:to="loc_cron_FourMajorCustomersMember_e3f43451-af7a-446e-9c51-080ee06a04a9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_TwoMajorCustomersMember_003aa43b-9d83-4261-a725-96306a0e53d9" xlink:href="cron-20201231.xsd#cron_TwoMajorCustomersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_3a64caee-c49a-4a0b-b22b-9a148e363bad" xlink:to="loc_cron_TwoMajorCustomersMember_003aa43b-9d83-4261-a725-96306a0e53d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_OneMajorCustomerMember_82177fbf-4a28-4a30-93ea-ddc2effa07c2" xlink:href="cron-20201231.xsd#cron_OneMajorCustomerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_3a64caee-c49a-4a0b-b22b-9a148e363bad" xlink:to="loc_cron_OneMajorCustomerMember_82177fbf-4a28-4a30-93ea-ddc2effa07c2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_ff581dc7-6669-49c0-b052-544c4361ee5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_755dec07-e19b-46a9-8718-ac4f254c2cab" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_ff581dc7-6669-49c0-b052-544c4361ee5c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ff581dc7-6669-49c0-b052-544c4361ee5c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ff581dc7-6669-49c0-b052-544c4361ee5c" xlink:to="loc_us-gaap_SegmentDomain_ff581dc7-6669-49c0-b052-544c4361ee5c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_24593cbe-edab-4d14-9bdc-4e3937d958f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ff581dc7-6669-49c0-b052-544c4361ee5c" xlink:to="loc_us-gaap_SegmentDomain_24593cbe-edab-4d14-9bdc-4e3937d958f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_UnitedStatesSegmentMember_1e5dd53b-2701-4f8c-a2bf-a256dada4894" xlink:href="cron-20201231.xsd#cron_UnitedStatesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_24593cbe-edab-4d14-9bdc-4e3937d958f6" xlink:to="loc_cron_UnitedStatesSegmentMember_1e5dd53b-2701-4f8c-a2bf-a256dada4894" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_RestOfWorldSegmentMember_3ad41cde-8b53-43f1-a6b4-a08b6998e3a6" xlink:href="cron-20201231.xsd#cron_RestOfWorldSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_24593cbe-edab-4d14-9bdc-4e3937d958f6" xlink:to="loc_cron_RestOfWorldSegmentMember_3ad41cde-8b53-43f1-a6b4-a08b6998e3a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_55d7da3d-b45a-4e1e-a0ca-3cdbfed75005" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_755dec07-e19b-46a9-8718-ac4f254c2cab" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_55d7da3d-b45a-4e1e-a0ca-3cdbfed75005" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_55d7da3d-b45a-4e1e-a0ca-3cdbfed75005_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_55d7da3d-b45a-4e1e-a0ca-3cdbfed75005" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_55d7da3d-b45a-4e1e-a0ca-3cdbfed75005_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_cfbce7fa-da7e-4e19-b3f5-f8baf861482e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_55d7da3d-b45a-4e1e-a0ca-3cdbfed75005" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_cfbce7fa-da7e-4e19-b3f5-f8baf861482e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_afcac2ed-2bff-4ebf-8f11-fd902ebbd206" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_cfbce7fa-da7e-4e19-b3f5-f8baf861482e" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_afcac2ed-2bff-4ebf-8f11-fd902ebbd206" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_d354d3ef-40da-4e48-8fa8-c8c2ec0439b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_755dec07-e19b-46a9-8718-ac4f254c2cab" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_d354d3ef-40da-4e48-8fa8-c8c2ec0439b9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_d354d3ef-40da-4e48-8fa8-c8c2ec0439b9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_d354d3ef-40da-4e48-8fa8-c8c2ec0439b9" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_d354d3ef-40da-4e48-8fa8-c8c2ec0439b9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_9b6b9d63-fc61-4c34-80eb-0d703c133c1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_d354d3ef-40da-4e48-8fa8-c8c2ec0439b9" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_9b6b9d63-fc61-4c34-80eb-0d703c133c1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_74dcca5f-7f32-42fa-bc4d-66266aae637d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_9b6b9d63-fc61-4c34-80eb-0d703c133c1d" xlink:to="loc_us-gaap_SalesRevenueNetMember_74dcca5f-7f32-42fa-bc4d-66266aae637d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#SegmentInformationScheduleofSegmentDataDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails" xlink:type="extended" id="i18be662f2d1d4c8398af801599bb9b02_SegmentInformationScheduleofSegmentDataDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_c0f42ccd-f950-4b85-b748-3fa50d5c5a06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_ae212b21-550c-47ab-aeb0-c4fab4b632d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationProfitLossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c0f42ccd-f950-4b85-b748-3fa50d5c5a06" xlink:to="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_ae212b21-550c-47ab-aeb0-c4fab4b632d2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_15b5b57f-c034-4c62-ba1f-13cf84214c2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_ae212b21-550c-47ab-aeb0-c4fab4b632d2" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_15b5b57f-c034-4c62-ba1f-13cf84214c2e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_4cb3b7a4-57b3-42d4-8f57-93757c6d5109" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c0f42ccd-f950-4b85-b748-3fa50d5c5a06" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_4cb3b7a4-57b3-42d4-8f57-93757c6d5109" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_78d74594-1281-4df1-b8a5-8358fe8932da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c0f42ccd-f950-4b85-b748-3fa50d5c5a06" xlink:to="loc_us-gaap_InvestmentIncomeInterest_78d74594-1281-4df1-b8a5-8358fe8932da" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_d616bcf5-7c39-49ec-9461-a4bd245d60ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c0f42ccd-f950-4b85-b748-3fa50d5c5a06" xlink:to="loc_us-gaap_InterestExpense_d616bcf5-7c39-49ec-9461-a4bd245d60ae" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_1244a8e9-c44e-412c-b106-8c7e54f65776" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c0f42ccd-f950-4b85-b748-3fa50d5c5a06" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_1244a8e9-c44e-412c-b106-8c7e54f65776" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_8d256326-9593-42af-9c36-90446152b0d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c0f42ccd-f950-4b85-b748-3fa50d5c5a06" xlink:to="loc_us-gaap_DepreciationAndAmortization_8d256326-9593-42af-9c36-90446152b0d5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_e13e6fe5-8035-4ca1-806a-cb29faf15765" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c0f42ccd-f950-4b85-b748-3fa50d5c5a06" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_e13e6fe5-8035-4ca1-806a-cb29faf15765" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_fb57619c-df7c-47d2-beff-35505d6ea426" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c0f42ccd-f950-4b85-b748-3fa50d5c5a06" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_fb57619c-df7c-47d2-beff-35505d6ea426" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization_55b9f9f3-e261-457a-8fca-66a6463bfd56" xlink:href="cron-20201231.xsd#cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c0f42ccd-f950-4b85-b748-3fa50d5c5a06" xlink:to="loc_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization_55b9f9f3-e261-457a-8fca-66a6463bfd56" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationAdditionalInformationAbstract_92ebeade-571d-41a9-bd27-e363e23ab6a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationAdditionalInformationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c0f42ccd-f950-4b85-b748-3fa50d5c5a06" xlink:to="loc_us-gaap_SegmentReportingInformationAdditionalInformationAbstract_92ebeade-571d-41a9-bd27-e363e23ab6a1" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_72b49615-4d22-4ad1-92b7-a6fb8fac250a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationAdditionalInformationAbstract_92ebeade-571d-41a9-bd27-e363e23ab6a1" xlink:to="loc_us-gaap_Assets_72b49615-4d22-4ad1-92b7-a6fb8fac250a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_7fed6e87-2e01-42d3-ac74-80e26a2e1f78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationAdditionalInformationAbstract_92ebeade-571d-41a9-bd27-e363e23ab6a1" xlink:to="loc_us-gaap_EquityMethodInvestments_7fed6e87-2e01-42d3-ac74-80e26a2e1f78" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_71de5505-b1b9-4b18-a09d-6074ad87c23b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationAdditionalInformationAbstract_92ebeade-571d-41a9-bd27-e363e23ab6a1" xlink:to="loc_us-gaap_Goodwill_71de5505-b1b9-4b18-a09d-6074ad87c23b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAdditions_47a1e8f9-f718-4b8d-9d39-5097e6e9cb50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAdditions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationAdditionalInformationAbstract_92ebeade-571d-41a9-bd27-e363e23ab6a1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAdditions_47a1e8f9-f718-4b8d-9d39-5097e6e9cb50" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_da47b503-6fe2-4f5b-a41c-9dbaa9e3e3c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c0f42ccd-f950-4b85-b748-3fa50d5c5a06" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_da47b503-6fe2-4f5b-a41c-9dbaa9e3e3c7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_8707f6fe-dbee-4cff-a7e0-e0a858e4db64" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_da47b503-6fe2-4f5b-a41c-9dbaa9e3e3c7" xlink:to="loc_srt_ProductOrServiceAxis_8707f6fe-dbee-4cff-a7e0-e0a858e4db64" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_8707f6fe-dbee-4cff-a7e0-e0a858e4db64_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_8707f6fe-dbee-4cff-a7e0-e0a858e4db64" xlink:to="loc_srt_ProductsAndServicesDomain_8707f6fe-dbee-4cff-a7e0-e0a858e4db64_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c185d5c9-2525-481b-888b-9fca207f0043" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_8707f6fe-dbee-4cff-a7e0-e0a858e4db64" xlink:to="loc_srt_ProductsAndServicesDomain_c185d5c9-2525-481b-888b-9fca207f0043" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CannabisFlowerMember_ded4243c-ad02-4922-aa49-e9b746ce9098" xlink:href="cron-20201231.xsd#cron_CannabisFlowerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_c185d5c9-2525-481b-888b-9fca207f0043" xlink:to="loc_cron_CannabisFlowerMember_ded4243c-ad02-4922-aa49-e9b746ce9098" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CannabisExtractsMember_7f5cae37-11af-433a-8f10-d248d8a20aad" xlink:href="cron-20201231.xsd#cron_CannabisExtractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_c185d5c9-2525-481b-888b-9fca207f0043" xlink:to="loc_cron_CannabisExtractsMember_7f5cae37-11af-433a-8f10-d248d8a20aad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_04d69db3-dc50-45d5-bcbd-49ca8ef07399" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_c185d5c9-2525-481b-888b-9fca207f0043" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_04d69db3-dc50-45d5-bcbd-49ca8ef07399" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_41f50872-7347-4774-99f3-73a2f529a129" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_da47b503-6fe2-4f5b-a41c-9dbaa9e3e3c7" xlink:to="loc_srt_ConsolidationItemsAxis_41f50872-7347-4774-99f3-73a2f529a129" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_41f50872-7347-4774-99f3-73a2f529a129_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_41f50872-7347-4774-99f3-73a2f529a129" xlink:to="loc_srt_ConsolidationItemsDomain_41f50872-7347-4774-99f3-73a2f529a129_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_ca6f26bf-83fe-4e1f-999b-8515555408fd" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_41f50872-7347-4774-99f3-73a2f529a129" xlink:to="loc_srt_ConsolidationItemsDomain_ca6f26bf-83fe-4e1f-999b-8515555408fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_39341ae9-ce75-4198-8160-f6c552e11fc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_ca6f26bf-83fe-4e1f-999b-8515555408fd" xlink:to="loc_us-gaap_OperatingSegmentsMember_39341ae9-ce75-4198-8160-f6c552e11fc1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_01388c6c-2e2a-41f3-a3d7-5c3653062440" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_ca6f26bf-83fe-4e1f-999b-8515555408fd" xlink:to="loc_us-gaap_CorporateNonSegmentMember_01388c6c-2e2a-41f3-a3d7-5c3653062440" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_cd595c65-ef00-4866-9653-35816e1799ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_da47b503-6fe2-4f5b-a41c-9dbaa9e3e3c7" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_cd595c65-ef00-4866-9653-35816e1799ab" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_cd595c65-ef00-4866-9653-35816e1799ab_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_cd595c65-ef00-4866-9653-35816e1799ab" xlink:to="loc_us-gaap_SegmentDomain_cd595c65-ef00-4866-9653-35816e1799ab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_aa987634-9c6d-4559-8769-7395be60d7f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_cd595c65-ef00-4866-9653-35816e1799ab" xlink:to="loc_us-gaap_SegmentDomain_aa987634-9c6d-4559-8769-7395be60d7f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_UnitedStatesSegmentMember_6d85dc61-1f58-4f8a-8384-7810da229793" xlink:href="cron-20201231.xsd#cron_UnitedStatesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_aa987634-9c6d-4559-8769-7395be60d7f4" xlink:to="loc_cron_UnitedStatesSegmentMember_6d85dc61-1f58-4f8a-8384-7810da229793" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_RestOfWorldSegmentMember_8df5da31-3aaa-4ff9-8778-11e7e69133ef" xlink:href="cron-20201231.xsd#cron_RestOfWorldSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_aa987634-9c6d-4559-8769-7395be60d7f4" xlink:to="loc_cron_RestOfWorldSegmentMember_8df5da31-3aaa-4ff9-8778-11e7e69133ef" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SegmentInformationScheduleofAdjustedEBITDADetails" xlink:type="simple" xlink:href="cron-20201231.xsd#SegmentInformationScheduleofAdjustedEBITDADetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/SegmentInformationScheduleofAdjustedEBITDADetails" xlink:type="extended" id="i6502564d424a453e827964b204eaa963_SegmentInformationScheduleofAdjustedEBITDADetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_9503d362-6771-4ef9-a7fe-89ceaf2a0c24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_1fece57a-7896-4f19-8784-3e06d3418d76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9503d362-6771-4ef9-a7fe-89ceaf2a0c24" xlink:to="loc_us-gaap_ProfitLoss_1fece57a-7896-4f19-8784-3e06d3418d76" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_bab56194-f89d-4a3b-b5f0-6861bbb03235" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9503d362-6771-4ef9-a7fe-89ceaf2a0c24" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_bab56194-f89d-4a3b-b5f0-6861bbb03235" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_95f8e457-d886-4783-924e-3a89f0f1e2bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9503d362-6771-4ef9-a7fe-89ceaf2a0c24" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_95f8e457-d886-4783-924e-3a89f0f1e2bf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_b87dba2d-b091-40b8-b095-3478c6ec01c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9503d362-6771-4ef9-a7fe-89ceaf2a0c24" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_b87dba2d-b091-40b8-b095-3478c6ec01c4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_6d9fee03-1d6b-45f6-acfe-7f3d2f0b134c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9503d362-6771-4ef9-a7fe-89ceaf2a0c24" xlink:to="loc_us-gaap_RestructuringCharges_6d9fee03-1d6b-45f6-acfe-7f3d2f0b134c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts_48cd07a1-408a-4769-aef6-6b2cc3614907" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9503d362-6771-4ef9-a7fe-89ceaf2a0c24" xlink:to="loc_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts_48cd07a1-408a-4769-aef6-6b2cc3614907" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_026f66c7-a94c-4984-9524-e72ed7038f86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9503d362-6771-4ef9-a7fe-89ceaf2a0c24" xlink:to="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_026f66c7-a94c-4984-9524-e72ed7038f86" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_5a90cda8-52d1-4f15-91ba-850487419eed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9503d362-6771-4ef9-a7fe-89ceaf2a0c24" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_5a90cda8-52d1-4f15-91ba-850487419eed" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_748b9ecd-3135-4d2f-82cd-7f9152990763" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9503d362-6771-4ef9-a7fe-89ceaf2a0c24" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_748b9ecd-3135-4d2f-82cd-7f9152990763" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_d39d70ef-60c6-490e-8f01-5cd618ba4541" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9503d362-6771-4ef9-a7fe-89ceaf2a0c24" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_d39d70ef-60c6-490e-8f01-5cd618ba4541" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_51eb312a-c591-4c82-acdf-8adfc0936e2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9503d362-6771-4ef9-a7fe-89ceaf2a0c24" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_51eb312a-c591-4c82-acdf-8adfc0936e2c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_RestatementReviewExpense_b40a9148-6279-46be-a8f4-8fdca0b0690f" xlink:href="cron-20201231.xsd#cron_RestatementReviewExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9503d362-6771-4ef9-a7fe-89ceaf2a0c24" xlink:to="loc_cron_RestatementReviewExpense_b40a9148-6279-46be-a8f4-8fdca0b0690f" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_8b8f6d3d-0dfa-45b0-b668-595a1ff87a4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9503d362-6771-4ef9-a7fe-89ceaf2a0c24" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_8b8f6d3d-0dfa-45b0-b668-595a1ff87a4b" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AdjustedEarningsBeforeInterestAndTaxes_c011fa7b-f2dc-4e49-a487-6b5dcf6542d0" xlink:href="cron-20201231.xsd#cron_AdjustedEarningsBeforeInterestAndTaxes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9503d362-6771-4ef9-a7fe-89ceaf2a0c24" xlink:to="loc_cron_AdjustedEarningsBeforeInterestAndTaxes_c011fa7b-f2dc-4e49-a487-6b5dcf6542d0" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_7ababa5d-1dae-4abd-a5f2-675f46715363" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9503d362-6771-4ef9-a7fe-89ceaf2a0c24" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_7ababa5d-1dae-4abd-a5f2-675f46715363" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization_330e0a65-9da0-4a26-867d-a6bfd786d5a7" xlink:href="cron-20201231.xsd#cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9503d362-6771-4ef9-a7fe-89ceaf2a0c24" xlink:to="loc_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization_330e0a65-9da0-4a26-867d-a6bfd786d5a7" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_59430215-0852-422e-9366-8492a2249b58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9503d362-6771-4ef9-a7fe-89ceaf2a0c24" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_59430215-0852-422e-9366-8492a2249b58" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_021036e6-31bb-4ce3-af97-6b367412583d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_59430215-0852-422e-9366-8492a2249b58" xlink:to="loc_srt_ConsolidationItemsAxis_021036e6-31bb-4ce3-af97-6b367412583d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_021036e6-31bb-4ce3-af97-6b367412583d_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_021036e6-31bb-4ce3-af97-6b367412583d" xlink:to="loc_srt_ConsolidationItemsDomain_021036e6-31bb-4ce3-af97-6b367412583d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_ff366357-1d93-455f-877e-3a663c528e74" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_021036e6-31bb-4ce3-af97-6b367412583d" xlink:to="loc_srt_ConsolidationItemsDomain_ff366357-1d93-455f-877e-3a663c528e74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_3a480e00-faa4-43e8-9f3f-30da88dab5ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_ff366357-1d93-455f-877e-3a663c528e74" xlink:to="loc_us-gaap_OperatingSegmentsMember_3a480e00-faa4-43e8-9f3f-30da88dab5ed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_4606ce22-d2f4-497b-acdf-8a5e5774bb74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_ff366357-1d93-455f-877e-3a663c528e74" xlink:to="loc_us-gaap_CorporateNonSegmentMember_4606ce22-d2f4-497b-acdf-8a5e5774bb74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_87463d16-ed1c-4c37-8615-1ab5ba32f809" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_59430215-0852-422e-9366-8492a2249b58" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_87463d16-ed1c-4c37-8615-1ab5ba32f809" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_87463d16-ed1c-4c37-8615-1ab5ba32f809_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_87463d16-ed1c-4c37-8615-1ab5ba32f809" xlink:to="loc_us-gaap_SegmentDomain_87463d16-ed1c-4c37-8615-1ab5ba32f809_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f5dffec2-af57-4637-a93f-3399147e23c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_87463d16-ed1c-4c37-8615-1ab5ba32f809" xlink:to="loc_us-gaap_SegmentDomain_f5dffec2-af57-4637-a93f-3399147e23c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_UnitedStatesSegmentMember_329abb99-038b-4bc8-8991-eb90aab217c5" xlink:href="cron-20201231.xsd#cron_UnitedStatesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f5dffec2-af57-4637-a93f-3399147e23c8" xlink:to="loc_cron_UnitedStatesSegmentMember_329abb99-038b-4bc8-8991-eb90aab217c5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_RestOfWorldSegmentMember_b6020f24-2d44-49b3-9a53-7e2c1c86845e" xlink:href="cron-20201231.xsd#cron_RestOfWorldSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f5dffec2-af57-4637-a93f-3399147e23c8" xlink:to="loc_cron_RestOfWorldSegmentMember_b6020f24-2d44-49b3-9a53-7e2c1c86845e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SegmentInformationScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#SegmentInformationScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/SegmentInformationScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails" xlink:type="extended" id="i9285631e24c3473badef62442ac7dc4a_SegmentInformationScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_5461d7b8-cdfd-43e6-affe-baf46f67c37b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_cf620347-02fe-4608-aa90-5fec1f251a1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_5461d7b8-cdfd-43e6-affe-baf46f67c37b" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_cf620347-02fe-4608-aa90-5fec1f251a1e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_bc4bae69-1264-402a-b43b-2bc29fee2413" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_5461d7b8-cdfd-43e6-affe-baf46f67c37b" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_bc4bae69-1264-402a-b43b-2bc29fee2413" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_3a97901a-c2ec-4352-af0d-a1aef47a4156" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_bc4bae69-1264-402a-b43b-2bc29fee2413" xlink:to="loc_srt_StatementGeographicalAxis_3a97901a-c2ec-4352-af0d-a1aef47a4156" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_3a97901a-c2ec-4352-af0d-a1aef47a4156_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_3a97901a-c2ec-4352-af0d-a1aef47a4156" xlink:to="loc_srt_SegmentGeographicalDomain_3a97901a-c2ec-4352-af0d-a1aef47a4156_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_e650f8d3-be08-44b6-8cd7-e9177169f8a6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_3a97901a-c2ec-4352-af0d-a1aef47a4156" xlink:to="loc_srt_SegmentGeographicalDomain_e650f8d3-be08-44b6-8cd7-e9177169f8a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_4e78c438-f3ad-4551-85ca-292b30b045be" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_e650f8d3-be08-44b6-8cd7-e9177169f8a6" xlink:to="loc_country_CA_4e78c438-f3ad-4551-85ca-292b30b045be" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_b0f28da7-c6ba-4e4d-b14a-b765f1f3ffc4" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_e650f8d3-be08-44b6-8cd7-e9177169f8a6" xlink:to="loc_country_US_b0f28da7-c6ba-4e4d-b14a-b765f1f3ffc4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_OtherCountriesMember_967054ea-a6a4-4865-9a01-b11b313ca46e" xlink:href="cron-20201231.xsd#cron_OtherCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_e650f8d3-be08-44b6-8cd7-e9177169f8a6" xlink:to="loc_cron_OtherCountriesMember_967054ea-a6a4-4865-9a01-b11b313ca46e" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SegmentInformationScheduleofLonglivedAssetsbyGeographicAreasDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#SegmentInformationScheduleofLonglivedAssetsbyGeographicAreasDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/SegmentInformationScheduleofLonglivedAssetsbyGeographicAreasDetails" xlink:type="extended" id="i77fc341a227b40f19cace71d95cdb3fa_SegmentInformationScheduleofLonglivedAssetsbyGeographicAreasDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_aed976d8-b558-484b-9ff7-1915e82f687f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets_23981413-bc6d-4659-be47-7ff76bd678a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_aed976d8-b558-484b-9ff7-1915e82f687f" xlink:to="loc_us-gaap_NoncurrentAssets_23981413-bc6d-4659-be47-7ff76bd678a0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_4c4fabcc-2384-46bf-8032-776d5bace98f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_aed976d8-b558-484b-9ff7-1915e82f687f" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_4c4fabcc-2384-46bf-8032-776d5bace98f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_a32b99be-c7e1-4722-a85c-cdf9bfcd24cc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_4c4fabcc-2384-46bf-8032-776d5bace98f" xlink:to="loc_srt_StatementGeographicalAxis_a32b99be-c7e1-4722-a85c-cdf9bfcd24cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_a32b99be-c7e1-4722-a85c-cdf9bfcd24cc_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_a32b99be-c7e1-4722-a85c-cdf9bfcd24cc" xlink:to="loc_srt_SegmentGeographicalDomain_a32b99be-c7e1-4722-a85c-cdf9bfcd24cc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_f17879b5-1e97-46ce-bf03-982d407e7f4d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_a32b99be-c7e1-4722-a85c-cdf9bfcd24cc" xlink:to="loc_srt_SegmentGeographicalDomain_f17879b5-1e97-46ce-bf03-982d407e7f4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_97b757cd-7ba8-49b6-9403-2f980f4e7876" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_f17879b5-1e97-46ce-bf03-982d407e7f4d" xlink:to="loc_country_CA_97b757cd-7ba8-49b6-9403-2f980f4e7876" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_3f574c77-fb61-4d93-b1a2-d9256148fb94" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_f17879b5-1e97-46ce-bf03-982d407e7f4d" xlink:to="loc_country_US_3f574c77-fb61-4d93-b1a2-d9256148fb94" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_OtherCountriesMember_83dbdf18-bbbd-49ec-a3d9-7995563ceae4" xlink:href="cron-20201231.xsd#cron_OtherCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_f17879b5-1e97-46ce-bf03-982d407e7f4d" xlink:to="loc_cron_OtherCountriesMember_83dbdf18-bbbd-49ec-a3d9-7995563ceae4" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/DiscontinuedOperationsandHeldforsaleAssets" xlink:type="simple" xlink:href="cron-20201231.xsd#DiscontinuedOperationsandHeldforsaleAssets"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/DiscontinuedOperationsandHeldforsaleAssets" xlink:type="extended" id="i3b54f3cdb7d34e8caf16e68d7c37049b_DiscontinuedOperationsandHeldforsaleAssets"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/DiscontinuedOperationsandHeldforsaleAssetsTables" xlink:type="simple" xlink:href="cron-20201231.xsd#DiscontinuedOperationsandHeldforsaleAssetsTables"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/DiscontinuedOperationsandHeldforsaleAssetsTables" xlink:type="extended" id="i54bb15fc8da24db5bd346fcf2b5166af_DiscontinuedOperationsandHeldforsaleAssetsTables"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/DiscontinuedOperationsandHeldforsaleAssetsDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#DiscontinuedOperationsandHeldforsaleAssetsDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/DiscontinuedOperationsandHeldforsaleAssetsDetails" xlink:type="extended" id="i9a5cbc28e0b64eafbeb30a04512aa401_DiscontinuedOperationsandHeldforsaleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_48c79b72-228f-45aa-b26a-820e3c99225a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_adbb3233-101f-4022-aa42-9e6cf3c5e879" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_48c79b72-228f-45aa-b26a-820e3c99225a" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_adbb3233-101f-4022-aa42-9e6cf3c5e879" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DiscontinuedOperationAssetsValuationAllowanceValuationIncrease_b6f1328b-94ea-4d6a-955f-e3c6dc5d02b7" xlink:href="cron-20201231.xsd#cron_DiscontinuedOperationAssetsValuationAllowanceValuationIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_48c79b72-228f-45aa-b26a-820e3c99225a" xlink:to="loc_cron_DiscontinuedOperationAssetsValuationAllowanceValuationIncrease_b6f1328b-94ea-4d6a-955f-e3c6dc5d02b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_42bae396-0236-4d50-ac46-3ef679cd6f98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_48c79b72-228f-45aa-b26a-820e3c99225a" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_42bae396-0236-4d50-ac46-3ef679cd6f98" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax_ba86687c-ede3-453c-b34d-7f191735782b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_48c79b72-228f-45aa-b26a-820e3c99225a" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax_ba86687c-ede3-453c-b34d-7f191735782b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent_d056e92b-1ba3-4e0b-b6f3-491e2a7d147e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_48c79b72-228f-45aa-b26a-820e3c99225a" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent_d056e92b-1ba3-4e0b-b6f3-491e2a7d147e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_a9edeba4-47a5-4ddf-8330-cd370553a9cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_48c79b72-228f-45aa-b26a-820e3c99225a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_a9edeba4-47a5-4ddf-8330-cd370553a9cc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_c87f7f33-3346-4700-9476-c58545a03142" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_48c79b72-228f-45aa-b26a-820e3c99225a" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_c87f7f33-3346-4700-9476-c58545a03142" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_fd122dbe-8b04-4dae-a0ff-6607390ecc07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_48c79b72-228f-45aa-b26a-820e3c99225a" xlink:to="loc_us-gaap_Goodwill_fd122dbe-8b04-4dae-a0ff-6607390ecc07" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_40fc6051-ec0e-4910-91d9-d907f8979017" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_48c79b72-228f-45aa-b26a-820e3c99225a" xlink:to="loc_us-gaap_InventoryWriteDown_40fc6051-ec0e-4910-91d9-d907f8979017" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_80979fc6-c748-4173-aff4-52c788d24875" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_48c79b72-228f-45aa-b26a-820e3c99225a" xlink:to="loc_us-gaap_OperatingExpenses_80979fc6-c748-4173-aff4-52c788d24875" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_9acec6da-43cc-4aa5-a600-b631c5d9ff9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_48c79b72-228f-45aa-b26a-820e3c99225a" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_9acec6da-43cc-4aa5-a600-b631c5d9ff9e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_f812dff0-d882-4f57-94a8-c33ed4ba973a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_48c79b72-228f-45aa-b26a-820e3c99225a" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_f812dff0-d882-4f57-94a8-c33ed4ba973a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_f30ad3b6-30e4-4123-acd5-99d6f8b0194d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_48c79b72-228f-45aa-b26a-820e3c99225a" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_f30ad3b6-30e4-4123-acd5-99d6f8b0194d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_2db8811e-0366-4b52-a933-95d7943f9523" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_f30ad3b6-30e4-4123-acd5-99d6f8b0194d" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_2db8811e-0366-4b52-a933-95d7943f9523" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_2db8811e-0366-4b52-a933-95d7943f9523_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_2db8811e-0366-4b52-a933-95d7943f9523" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_2db8811e-0366-4b52-a933-95d7943f9523_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_d9148ac8-fe2e-489c-943a-b939242bf969" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_2db8811e-0366-4b52-a933-95d7943f9523" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_d9148ac8-fe2e-489c-943a-b939242bf969" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_45502f81-505b-4a42-a154-78612eb80484" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsHeldforsaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_d9148ac8-fe2e-489c-943a-b939242bf969" xlink:to="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_45502f81-505b-4a42-a154-78612eb80484" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_98634a3c-28a7-401a-96c9-226bf48ef34e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_f30ad3b6-30e4-4123-acd5-99d6f8b0194d" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_98634a3c-28a7-401a-96c9-226bf48ef34e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_98634a3c-28a7-401a-96c9-226bf48ef34e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_98634a3c-28a7-401a-96c9-226bf48ef34e" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_98634a3c-28a7-401a-96c9-226bf48ef34e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e4e4ee37-9c10-45cd-8b0f-9b68b8176395" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_98634a3c-28a7-401a-96c9-226bf48ef34e" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e4e4ee37-9c10-45cd-8b0f-9b68b8176395" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_OGBCMember_458710cd-b865-4b50-8e41-6a5cd81ab632" xlink:href="cron-20201231.xsd#cron_OGBCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e4e4ee37-9c10-45cd-8b0f-9b68b8176395" xlink:to="loc_cron_OGBCMember_458710cd-b865-4b50-8e41-6a5cd81ab632" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_f3b01663-8e07-4cb5-888b-0b437bfe83f5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_f30ad3b6-30e4-4123-acd5-99d6f8b0194d" xlink:to="loc_srt_RestatementAxis_f3b01663-8e07-4cb5-888b-0b437bfe83f5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_f3b01663-8e07-4cb5-888b-0b437bfe83f5_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_f3b01663-8e07-4cb5-888b-0b437bfe83f5" xlink:to="loc_srt_RestatementDomain_f3b01663-8e07-4cb5-888b-0b437bfe83f5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_7c6f357e-230e-4a5f-87e0-cd1da68e6026" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_f3b01663-8e07-4cb5-888b-0b437bfe83f5" xlink:to="loc_srt_RestatementDomain_7c6f357e-230e-4a5f-87e0-cd1da68e6026" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_dd8225d4-bcaf-4419-8ff2-a5e9ef0d0bec" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_7c6f357e-230e-4a5f-87e0-cd1da68e6026" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_dd8225d4-bcaf-4419-8ff2-a5e9ef0d0bec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_c15a566c-b2fd-432c-a2a6-da755844322e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_7c6f357e-230e-4a5f-87e0-cd1da68e6026" xlink:to="loc_srt_RestatementAdjustmentMember_c15a566c-b2fd-432c-a2a6-da755844322e" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>13
<FILENAME>cron-20201231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:7f6b4332-a8eb-41ec-8082-7450606ea80c,g:9b8782dc-b83f-424a-b83c-bbf680d16be6-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_01dd6213-5607-4212-8c5b-210d16ea2c8c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementAxis_a45332e1-69c8-4576-992b-90e6b098270e_terseLabel_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement [Axis]</link:label>
    <link:label id="lab_srt_RestatementAxis_label_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementAxis" xlink:to="lab_srt_RestatementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_473fa0bf-95d9-4fd9-b980-bfe3b2322b54_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_194e23d7-a189-4acc-bc49-c0d245832705_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_label_en-US" xlink:label="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_f0197f07-40d7-4241-bd1e-3f618f02de2d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Subsidiary or Equity Method Investee [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Subsidiary or Equity Method Investee [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:to="lab_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_8e57e377-b561-4a6f-8420-00e5665b101f_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_RestOfWorldSegmentMember_0eeeb696-278a-422b-b229-8249100506b4_terseLabel_en-US" xlink:label="lab_cron_RestOfWorldSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of World</link:label>
    <link:label id="lab_cron_RestOfWorldSegmentMember_label_en-US" xlink:label="lab_cron_RestOfWorldSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest Of World Segment [Member]</link:label>
    <link:label id="lab_cron_RestOfWorldSegmentMember_documentation_en-US" xlink:label="lab_cron_RestOfWorldSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest Of World Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_RestOfWorldSegmentMember" xlink:href="cron-20201231.xsd#cron_RestOfWorldSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_RestOfWorldSegmentMember" xlink:to="lab_cron_RestOfWorldSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_CronosGroupInc.Member_82979472-5e64-404a-a0be-59c258f3de22_terseLabel_en-US" xlink:label="lab_cron_CronosGroupInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos Group, Inc.</link:label>
    <link:label id="lab_cron_CronosGroupInc.Member_label_en-US" xlink:label="lab_cron_CronosGroupInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos Group, Inc. [Member]</link:label>
    <link:label id="lab_cron_CronosGroupInc.Member_documentation_en-US" xlink:label="lab_cron_CronosGroupInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos Group, Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosGroupInc.Member" xlink:href="cron-20201231.xsd#cron_CronosGroupInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_CronosGroupInc.Member" xlink:to="lab_cron_CronosGroupInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_ab2387b4-f046-4123-b511-495d1fc802c5_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_OneMajorCustomerMember_66416e7f-6b5e-41a5-a660-1d590b311c80_terseLabel_en-US" xlink:label="lab_cron_OneMajorCustomerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One Major Customer</link:label>
    <link:label id="lab_cron_OneMajorCustomerMember_label_en-US" xlink:label="lab_cron_OneMajorCustomerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One Major Customer [Member]</link:label>
    <link:label id="lab_cron_OneMajorCustomerMember_documentation_en-US" xlink:label="lab_cron_OneMajorCustomerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One Major Customer [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_OneMajorCustomerMember" xlink:href="cron-20201231.xsd#cron_OneMajorCustomerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_OneMajorCustomerMember" xlink:to="lab_cron_OneMajorCustomerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_c7829c8f-939a-4dd6-919e-c1d7554e5fe9_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (purchase of) short-term investments, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_7e8eb0eb-372f-401d-b863-97f0e3ded823_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage_03e0c978-5619-4862-9a3f-dc1a185e5894_terseLabel_en-US" xlink:label="lab_cron_ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum additional subscription percentage</link:label>
    <link:label id="lab_cron_ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage_label_en-US" xlink:label="lab_cron_ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Maximum Additional Subscription Percentage</link:label>
    <link:label id="lab_cron_ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage_documentation_en-US" xlink:label="lab_cron_ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Maximum Additional Subscription Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage" xlink:href="cron-20201231.xsd#cron_ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage" xlink:to="lab_cron_ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_680ee190-fe6b-4e87-b685-2296080c1d58_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_StockIssuedDuringPeriodValueNewIssuesIssuanceCosts_3e3904b4-54f6-4fc3-80ef-2c0acf8999a1_negatedTerseLabel_en-US" xlink:label="lab_cron_StockIssuedDuringPeriodValueNewIssuesIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share issuance costs</link:label>
    <link:label id="lab_cron_StockIssuedDuringPeriodValueNewIssuesIssuanceCosts_label_en-US" xlink:label="lab_cron_StockIssuedDuringPeriodValueNewIssuesIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues, Issuance Costs</link:label>
    <link:label id="lab_cron_StockIssuedDuringPeriodValueNewIssuesIssuanceCosts_documentation_en-US" xlink:label="lab_cron_StockIssuedDuringPeriodValueNewIssuesIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues, Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_StockIssuedDuringPeriodValueNewIssuesIssuanceCosts" xlink:href="cron-20201231.xsd#cron_StockIssuedDuringPeriodValueNewIssuesIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_StockIssuedDuringPeriodValueNewIssuesIssuanceCosts" xlink:to="lab_cron_StockIssuedDuringPeriodValueNewIssuesIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_PurchaseOfMachineryAndEquipmentMember_e1e034c5-55cf-4878-a4b4-f6117f368542_terseLabel_en-US" xlink:label="lab_cron_PurchaseOfMachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of Machinery and Equipment</link:label>
    <link:label id="lab_cron_PurchaseOfMachineryAndEquipmentMember_label_en-US" xlink:label="lab_cron_PurchaseOfMachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Of Machinery And Equipment [Member]</link:label>
    <link:label id="lab_cron_PurchaseOfMachineryAndEquipmentMember_documentation_en-US" xlink:label="lab_cron_PurchaseOfMachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Of Machinery And Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PurchaseOfMachineryAndEquipmentMember" xlink:href="cron-20201231.xsd#cron_PurchaseOfMachineryAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_PurchaseOfMachineryAndEquipmentMember" xlink:to="lab_cron_PurchaseOfMachineryAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_1fbfc378-447c-4930-bde1-ce9c8063fd04_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RisksAndUncertaintiesAbstract_83131238-174a-465a-b4fc-175cb992fc60_terseLabel_en-US" xlink:label="lab_us-gaap_RisksAndUncertaintiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risks and Uncertainties [Abstract]</link:label>
    <link:label id="lab_us-gaap_RisksAndUncertaintiesAbstract_label_en-US" xlink:label="lab_us-gaap_RisksAndUncertaintiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risks and Uncertainties [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract" xlink:to="lab_us-gaap_RisksAndUncertaintiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf9214fb-8b43-41fe-a43d-8ef1648126ef_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LaborAndRelatedExpense_511e6fbc-e08d-4017-ad6f-1cb58d716e78_terseLabel_en-US" xlink:label="lab_us-gaap_LaborAndRelatedExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Salaries and wages</link:label>
    <link:label id="lab_us-gaap_LaborAndRelatedExpense_label_en-US" xlink:label="lab_us-gaap_LaborAndRelatedExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Labor and Related Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LaborAndRelatedExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LaborAndRelatedExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LaborAndRelatedExpense" xlink:to="lab_us-gaap_LaborAndRelatedExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_67b14a4c-450b-4aca-a713-667212b376bb_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss_57d8c0a7-e1fd-4ebd-b276-587663abd68f_terseLabel_en-US" xlink:label="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share price at issuance date</link:label>
    <link:label id="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss_label_en-US" xlink:label="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) In Share Price On Net Income (Loss)</link:label>
    <link:label id="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss_documentation_en-US" xlink:label="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) In Share Price On Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss" xlink:href="cron-20201231.xsd#cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss" xlink:to="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_CronosGrowingCompanyInc.Member_f2a13f2c-a497-428d-878d-794bfd0204bb_terseLabel_en-US" xlink:label="lab_cron_CronosGrowingCompanyInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos GrowCo</link:label>
    <link:label id="lab_cron_CronosGrowingCompanyInc.Member_label_en-US" xlink:label="lab_cron_CronosGrowingCompanyInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos Growing Company Inc. [Member]</link:label>
    <link:label id="lab_cron_CronosGrowingCompanyInc.Member_documentation_en-US" xlink:label="lab_cron_CronosGrowingCompanyInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos Growing Company Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosGrowingCompanyInc.Member" xlink:href="cron-20201231.xsd#cron_CronosGrowingCompanyInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_CronosGrowingCompanyInc.Member" xlink:to="lab_cron_CronosGrowingCompanyInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_179c8f40-0e90-45c6-8197-3d36b9f505a0_terseLabel_en-US" xlink:label="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-lived Assets by Geographic Areas</link:label>
    <link:label id="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-lived Assets by Geographic Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:to="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_e9043451-0cb1-4786-98a7-13bec62d85eb_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_737eac7e-9031-4246-9db8-0971dc84d3d7_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_StockIssuedDuringPeriodSharesTopupRightsExercised_13660bbc-f79c-4c7f-9446-c36af968d0b0_terseLabel_en-US" xlink:label="lab_cron_StockIssuedDuringPeriodSharesTopupRightsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Top-up Rights exercised (in shares)</link:label>
    <link:label id="lab_cron_StockIssuedDuringPeriodSharesTopupRightsExercised_label_en-US" xlink:label="lab_cron_StockIssuedDuringPeriodSharesTopupRightsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Top-up Rights Exercised</link:label>
    <link:label id="lab_cron_StockIssuedDuringPeriodSharesTopupRightsExercised_documentation_en-US" xlink:label="lab_cron_StockIssuedDuringPeriodSharesTopupRightsExercised" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Top-up Rights Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_StockIssuedDuringPeriodSharesTopupRightsExercised" xlink:href="cron-20201231.xsd#cron_StockIssuedDuringPeriodSharesTopupRightsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_StockIssuedDuringPeriodSharesTopupRightsExercised" xlink:to="lab_cron_StockIssuedDuringPeriodSharesTopupRightsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment_05e830db-1086-4124-b95f-756fe3701372_negatedTerseLabel_en-US" xlink:label="lab_cron_IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment charges</link:label>
    <link:label id="lab_cron_IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment_label_en-US" xlink:label="lab_cron_IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite Lived Intangible Assets Excluding Goodwill Accumulated Impairment</link:label>
    <link:label id="lab_cron_IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment_documentation_en-US" xlink:label="lab_cron_IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite Lived Intangible Assets Excluding Goodwill Accumulated Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment" xlink:href="cron-20201231.xsd#cron_IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment" xlink:to="lab_cron_IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_890055b5-bb01-46f0-b474-904967d8a685_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaids and other assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_85a3a6e2-e19b-46d8-9baf-d331570709e0_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b3d2c49b-e0ff-4928-8b33-9d70184e5469_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1bf83081-0271-4db0-a86d-30a8668521e1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_SaleOfStockPerformanceMilestoneTwoMember_788e39c5-5542-423e-9bee-c6c26f7d0d20_terseLabel_en-US" xlink:label="lab_cron_SaleOfStockPerformanceMilestoneTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Performance Milestone Two</link:label>
    <link:label id="lab_cron_SaleOfStockPerformanceMilestoneTwoMember_label_en-US" xlink:label="lab_cron_SaleOfStockPerformanceMilestoneTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Performance Milestone Two [Member]</link:label>
    <link:label id="lab_cron_SaleOfStockPerformanceMilestoneTwoMember_documentation_en-US" xlink:label="lab_cron_SaleOfStockPerformanceMilestoneTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Performance Milestone Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SaleOfStockPerformanceMilestoneTwoMember" xlink:href="cron-20201231.xsd#cron_SaleOfStockPerformanceMilestoneTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_SaleOfStockPerformanceMilestoneTwoMember" xlink:to="lab_cron_SaleOfStockPerformanceMilestoneTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_6f403521-bac5-480c-ab1b-6c48442e0499_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting of restricted share units</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_6aedfc32-8b23-40b0-8514-94a7c7d811ba_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_175e6b22-4dc1-4b05-a9a8-30b966c62baa_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_06a20fa4-4a0a-4b38-8ab4-d9827befb72d_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_e10d273d-7324-43bb-a35f-2496cae20d0f_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_InvestmentsInAndAdvancesToAffiliatesDebtInstrumentFaceAmount_b4360b95-4fab-49ec-8d1c-e40ee02484d7_terseLabel_en-US" xlink:label="lab_cron_InvestmentsInAndAdvancesToAffiliatesDebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Face amount</link:label>
    <link:label id="lab_cron_InvestmentsInAndAdvancesToAffiliatesDebtInstrumentFaceAmount_label_en-US" xlink:label="lab_cron_InvestmentsInAndAdvancesToAffiliatesDebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments In And Advances To Affiliates, Debt Instrument, Face Amount</link:label>
    <link:label id="lab_cron_InvestmentsInAndAdvancesToAffiliatesDebtInstrumentFaceAmount_documentation_en-US" xlink:label="lab_cron_InvestmentsInAndAdvancesToAffiliatesDebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments In And Advances To Affiliates, Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentsInAndAdvancesToAffiliatesDebtInstrumentFaceAmount" xlink:href="cron-20201231.xsd#cron_InvestmentsInAndAdvancesToAffiliatesDebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_InvestmentsInAndAdvancesToAffiliatesDebtInstrumentFaceAmount" xlink:to="lab_cron_InvestmentsInAndAdvancesToAffiliatesDebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SubsidiariesMember_403915f8-f34d-411b-a256-81b249aa1863_terseLabel_en-US" xlink:label="lab_srt_SubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos Group, Inc.</link:label>
    <link:label id="lab_srt_SubsidiariesMember_label_en-US" xlink:label="lab_srt_SubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiaries [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SubsidiariesMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SubsidiariesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SubsidiariesMember" xlink:to="lab_srt_SubsidiariesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_DerivativeInstrumentsRollForward_0ae2883a-618b-4a4c-8a8b-aa1f07219d27_terseLabel_en-US" xlink:label="lab_cron_DerivativeInstrumentsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments [Roll Forward]</link:label>
    <link:label id="lab_cron_DerivativeInstrumentsRollForward_label_en-US" xlink:label="lab_cron_DerivativeInstrumentsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments [Roll Forward]</link:label>
    <link:label id="lab_cron_DerivativeInstrumentsRollForward_documentation_en-US" xlink:label="lab_cron_DerivativeInstrumentsRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DerivativeInstrumentsRollForward" xlink:href="cron-20201231.xsd#cron_DerivativeInstrumentsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_DerivativeInstrumentsRollForward" xlink:to="lab_cron_DerivativeInstrumentsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock_854c070e-a0c8-4b9c-92c9-900eb5cc0958_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Outstanding Options</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_615cca50-ae51-4515-8751-9afa585f6c72_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_MeasurementInputSubscriptionPriceMember_a8351961-ba0b-4d73-b5a8-0c13f49dcfcf_terseLabel_en-US" xlink:label="lab_cron_MeasurementInputSubscriptionPriceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subscription price (per share in C$)</link:label>
    <link:label id="lab_cron_MeasurementInputSubscriptionPriceMember_label_en-US" xlink:label="lab_cron_MeasurementInputSubscriptionPriceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Subscription Price [Member]</link:label>
    <link:label id="lab_cron_MeasurementInputSubscriptionPriceMember_documentation_en-US" xlink:label="lab_cron_MeasurementInputSubscriptionPriceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Subscription Price [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_MeasurementInputSubscriptionPriceMember" xlink:href="cron-20201231.xsd#cron_MeasurementInputSubscriptionPriceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_MeasurementInputSubscriptionPriceMember" xlink:to="lab_cron_MeasurementInputSubscriptionPriceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_2b6a828e-6071-4195-bef3-e5695db81eb3_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireInterestInJointVenture_c6315c75-02d7-4470-a610-e48d54412577_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advances to joint ventures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInterestInJointVenture_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Interest in Joint Venture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInterestInJointVenture"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:to="lab_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3642323a-2fad-4f77-96fb-ce0715658823_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of options outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_a11e76c2-bc9d-47d2-9671-4b822b7d78df_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_40357abe-0dae-4d02-9c26-8a7af21b0a71_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_a53fb402-548a-488f-9f7d-499181c681db_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Purchases from Related Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:to="lab_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_75e8ab3b-ac63-495f-b415-c275aebd7f2a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_73cfe93e-7671-4ddc-be39-9d250842c189_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_country_CA_c7869821-cf5b-40da-87e3-27b2b586cbd5_terseLabel_en-US" xlink:label="lab_country_CA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canada</link:label>
    <link:label id="lab_country_CA_label_en-US" xlink:label="lab_country_CA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CANADA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_CA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_CA" xlink:to="lab_country_CA" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToReportingEntityAbstract_1a595562-a67a-4fe3-b750-e2b553ddced5_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToReportingEntityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) attributable to:</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToReportingEntityAbstract_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToReportingEntityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToReportingEntityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToReportingEntityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToReportingEntityAbstract" xlink:to="lab_us-gaap_NetIncomeLossAttributableToReportingEntityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_TopUpRightsMarketPriceMember_2f43befa-cf88-49b5-a07b-711a5133c455_terseLabel_en-US" xlink:label="lab_cron_TopUpRightsMarketPriceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Top-up Rights &#8211; market price</link:label>
    <link:label id="lab_cron_TopUpRightsMarketPriceMember_label_en-US" xlink:label="lab_cron_TopUpRightsMarketPriceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Top-Up Rights - Market Price [Member]</link:label>
    <link:label id="lab_cron_TopUpRightsMarketPriceMember_documentation_en-US" xlink:label="lab_cron_TopUpRightsMarketPriceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Top-Up Rights - Market Price [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_TopUpRightsMarketPriceMember" xlink:href="cron-20201231.xsd#cron_TopUpRightsMarketPriceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_TopUpRightsMarketPriceMember" xlink:to="lab_cron_TopUpRightsMarketPriceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_e20621e5-0a94-497a-bcff-83f9f5624062_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_17d85107-5b4c-47c3-a0e4-6bd2c54d7a13_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingMember_8555f18d-980f-4f26-b17b-e443b79c7e91_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building</link:label>
    <link:label id="lab_us-gaap_BuildingMember_label_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingMember" xlink:to="lab_us-gaap_BuildingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_ef944535-63ec-4b21-b52e-1f1d784f2f31_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilityMeasurementInput_2d327e11-717f-4ca4-9dfe-609c99d12086_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative liability, measurement input</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilityMeasurementInput_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityMeasurementInput" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilityMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilityMeasurementInput" xlink:to="lab_us-gaap_DerivativeLiabilityMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss_488511cf-0507-446b-be5b-cc855482b123_terseLabel_en-US" xlink:label="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected annualized volatility</link:label>
    <link:label id="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss_label_en-US" xlink:label="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) In Expected Annualized Volatility On Net Income (Loss)</link:label>
    <link:label id="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss_documentation_en-US" xlink:label="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) In Expected Annualized Volatility On Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss" xlink:href="cron-20201231.xsd#cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss" xlink:to="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_e1a508b4-aa28-4db8-9a52-41208ebeba0f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cancellation, forfeiture and expiry of options (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_6207e71a-7426-49c2-8e4e-1f9d68f535c5_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_ceba8fd3-0759-4cfc-ad74-f6475051673b_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work-in-progress</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_8f3a3c3c-28f4-4cc6-90e6-18c8c6ed5835_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:to="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b00c4c13-3049-483e-b7d6-118b4f5fd908_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of foreign currency translation on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_CommonStockNumberOfVotesPerShare_e2d58d61-8a5d-4d9f-9b43-5346f9a8fbce_terseLabel_en-US" xlink:label="lab_cron_CommonStockNumberOfVotesPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common shares, number of votes per share</link:label>
    <link:label id="lab_cron_CommonStockNumberOfVotesPerShare_label_en-US" xlink:label="lab_cron_CommonStockNumberOfVotesPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Number Of Votes Per Share</link:label>
    <link:label id="lab_cron_CommonStockNumberOfVotesPerShare_documentation_en-US" xlink:label="lab_cron_CommonStockNumberOfVotesPerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Number Of Votes Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CommonStockNumberOfVotesPerShare" xlink:href="cron-20201231.xsd#cron_CommonStockNumberOfVotesPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_CommonStockNumberOfVotesPerShare" xlink:to="lab_cron_CommonStockNumberOfVotesPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_2b0983db-0e8b-49ee-b945-c73944763cc4_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_cc4e718e-cc23-4a68-9194-81d554f5c9da_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_67cc08a6-98f3-4232-8987-e8bcb0b07f89_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_2ce52a3e-934f-40be-b0ec-644fb4388d53_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Tranche Three</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Tranche Three [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_63b5e343-7cee-461b-a20d-757836b2b3bf_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_e65c5843-b568-4f6d-9dd3-d79fda3455be_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_FinancingReceivableBeforeAccruedInterestNoncurrent_585b78f1-f6ea-44ab-ad35-8049b1a35371_terseLabel_en-US" xlink:label="lab_cron_FinancingReceivableBeforeAccruedInterestNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term portion of loans receivable, before accrued interest</link:label>
    <link:label id="lab_cron_FinancingReceivableBeforeAccruedInterestNoncurrent_label_en-US" xlink:label="lab_cron_FinancingReceivableBeforeAccruedInterestNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Before Accrued Interest, Noncurrent</link:label>
    <link:label id="lab_cron_FinancingReceivableBeforeAccruedInterestNoncurrent_documentation_en-US" xlink:label="lab_cron_FinancingReceivableBeforeAccruedInterestNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Before Accrued Interest, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableBeforeAccruedInterestNoncurrent" xlink:href="cron-20201231.xsd#cron_FinancingReceivableBeforeAccruedInterestNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_FinancingReceivableBeforeAccruedInterestNoncurrent" xlink:to="lab_cron_FinancingReceivableBeforeAccruedInterestNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityPolicyTextBlock_7b2e28ae-c3a5-4e58-a2b5-b7d443f7dc8d_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital stock</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityPolicyTextBlock" xlink:to="lab_us-gaap_StockholdersEquityPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_a7265964-7d40-4b68-9278-17c4d1a8e4be_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk, percentage</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_VivoCannabisMember_e5c5eabe-d9f0-4d96-b16b-775106e40834_terseLabel_en-US" xlink:label="lab_cron_VivoCannabisMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vivo Cannabis</link:label>
    <link:label id="lab_cron_VivoCannabisMember_label_en-US" xlink:label="lab_cron_VivoCannabisMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vivo Cannabis [Member]</link:label>
    <link:label id="lab_cron_VivoCannabisMember_documentation_en-US" xlink:label="lab_cron_VivoCannabisMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vivo Cannabis [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_VivoCannabisMember" xlink:href="cron-20201231.xsd#cron_VivoCannabisMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_VivoCannabisMember" xlink:to="lab_cron_VivoCannabisMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentAmount_8acf51df-34e3-4935-a176-d58bb27d2cc6_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of commitment</link:label>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentAmount_label_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Purchase Commitment, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermPurchaseCommitmentAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentAmount" xlink:to="lab_us-gaap_LongTermPurchaseCommitmentAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_95393d8b-96db-42a6-91e6-2cdd3ca1e305_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PublicUtilitiesInventoryAxis_12d0918c-c34a-40d0-8ab6-b666bc46c766_terseLabel_en-US" xlink:label="lab_us-gaap_PublicUtilitiesInventoryAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory [Axis]</link:label>
    <link:label id="lab_us-gaap_PublicUtilitiesInventoryAxis_label_en-US" xlink:label="lab_us-gaap_PublicUtilitiesInventoryAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PublicUtilitiesInventoryAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PublicUtilitiesInventoryAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PublicUtilitiesInventoryAxis" xlink:to="lab_us-gaap_PublicUtilitiesInventoryAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_6b86b9ac-1b1a-4192-9a03-07c5321b2aa5_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_ff1d1c67-2e49-419a-9b1e-b657b07c05ff_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Diluted Shares Outstanding</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComputerEquipmentMember_21a772a4-36cf-4a0e-83db-1801fe72b5e1_terseLabel_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer equipment</link:label>
    <link:label id="lab_us-gaap_ComputerEquipmentMember_label_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComputerEquipmentMember" xlink:to="lab_us-gaap_ComputerEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced_ecbde319-0da4-474e-b377-eef3d1bd43ac_terseLabel_en-US" xlink:label="lab_cron_CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative arrangement, profits to be received, maximum percentage of amounts advanced</link:label>
    <link:label id="lab_cron_CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced_label_en-US" xlink:label="lab_cron_CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Profits To Be Received, Maximum Percentage Of Amounts Advanced</link:label>
    <link:label id="lab_cron_CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced_documentation_en-US" xlink:label="lab_cron_CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Profits To Be Received, Maximum Percentage Of Amounts Advanced</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced" xlink:href="cron-20201231.xsd#cron_CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced" xlink:to="lab_cron_CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_3d650e69-c6cd-4f4b-8820-3de2b9f5bdae_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_0e5ac8e5-bd4e-4b89-9fdf-20247a65b565_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriod_52fab9e4-ff8d-4205-b930-10bc1fbaf604_terseLabel_en-US" xlink:label="lab_cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated and vested (in shares)</link:label>
    <link:label id="lab_cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriod_label_en-US" xlink:label="lab_cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Vested And Issued In Period</link:label>
    <link:label id="lab_cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriod_documentation_en-US" xlink:label="lab_cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Vested And Issued In Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriod" xlink:href="cron-20201231.xsd#cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriod" xlink:to="lab_cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_c791179d-07fb-42da-95c9-34f22e4fc9df_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised_896d4386-b707-43db-8e87-ecbbb5c662cf_terseLabel_en-US" xlink:label="lab_cron_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership percentage, if warrant exercised</link:label>
    <link:label id="lab_cron_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised_label_en-US" xlink:label="lab_cron_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary Or Equity Method Investee, Cumulative Percentage Ownership After All Transactions, If Warrants Exercised</link:label>
    <link:label id="lab_cron_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised_documentation_en-US" xlink:label="lab_cron_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary Or Equity Method Investee, Cumulative Percentage Ownership After All Transactions, If Warrants Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised" xlink:href="cron-20201231.xsd#cron_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised" xlink:to="lab_cron_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_AdvancesToAffiliateAllowanceForCreditLoss_d1e6665b-37f5-44e8-883e-09640bd19739_terseLabel_en-US" xlink:label="lab_cron_AdvancesToAffiliateAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advances to joint ventures, allowance for credit loss</link:label>
    <link:label id="lab_cron_AdvancesToAffiliateAllowanceForCreditLoss_label_en-US" xlink:label="lab_cron_AdvancesToAffiliateAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advances To Affiliate, Allowance For Credit Loss</link:label>
    <link:label id="lab_cron_AdvancesToAffiliateAllowanceForCreditLoss_documentation_en-US" xlink:label="lab_cron_AdvancesToAffiliateAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advances To Affiliate, Allowance For Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AdvancesToAffiliateAllowanceForCreditLoss" xlink:href="cron-20201231.xsd#cron_AdvancesToAffiliateAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_AdvancesToAffiliateAllowanceForCreditLoss" xlink:to="lab_cron_AdvancesToAffiliateAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit_1e351073-9b55-4eb6-8f22-31e54799a1e1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of Credit Facility</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:to="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_08880038-3c7c-4fa3-916a-37ebd8e64519_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_WeightedAverageMember_b4ab0e5d-9120-48fe-a8d2-62b26e99bf5f_terseLabel_en-US" xlink:label="lab_srt_WeightedAverageMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average</link:label>
    <link:label id="lab_srt_WeightedAverageMember_label_en-US" xlink:label="lab_srt_WeightedAverageMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_WeightedAverageMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_WeightedAverageMember" xlink:to="lab_srt_WeightedAverageMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationAdditionalInformationAbstract_11faa2c5-e726-4231-9af0-b5a134ed9334_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationAdditionalInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated balance sheets</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationAdditionalInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationAdditionalInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information, Additional Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationAdditionalInformationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationAdditionalInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationAdditionalInformationAbstract" xlink:to="lab_us-gaap_SegmentReportingInformationAdditionalInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_72316f61-8107-46dd-862f-59dbc8005107_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_a0638a7c-f26a-464c-a606-669923a89929_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_ad732bf9-dc31-4502-8513-d94d56c336d8_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of stock, number of shares issued in transaction (in shares)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_515a470e-230c-48b2-8091-8fa8b359a608_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_248afaf0-791d-4ad7-892c-8cbcebbf956a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Payable</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueRecoveredFromAppliedToEquityMethodInvestment_2390d376-41cd-4881-bd43-866658ac70ed_terseLabel_en-US" xlink:label="lab_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueRecoveredFromAppliedToEquityMethodInvestment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advances to joint ventures recovered from (applied to) carrying amount of investments</link:label>
    <link:label id="lab_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueRecoveredFromAppliedToEquityMethodInvestment_label_en-US" xlink:label="lab_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueRecoveredFromAppliedToEquityMethodInvestment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments In And Advances To Affiliates, At Fair Value, Recovered From (Applied To) Equity Method Investment</link:label>
    <link:label id="lab_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueRecoveredFromAppliedToEquityMethodInvestment_documentation_en-US" xlink:label="lab_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueRecoveredFromAppliedToEquityMethodInvestment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments In And Advances To Affiliates, At Fair Value, Recovered From (Applied To) Equity Method Investment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueRecoveredFromAppliedToEquityMethodInvestment" xlink:href="cron-20201231.xsd#cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueRecoveredFromAppliedToEquityMethodInvestment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueRecoveredFromAppliedToEquityMethodInvestment" xlink:to="lab_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueRecoveredFromAppliedToEquityMethodInvestment" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_CreditFacilityMember_cbb4998e-a7a2-431a-8a04-fc6fd0709316_terseLabel_en-US" xlink:label="lab_cron_CreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility</link:label>
    <link:label id="lab_cron_CreditFacilityMember_label_en-US" xlink:label="lab_cron_CreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Member]</link:label>
    <link:label id="lab_cron_CreditFacilityMember_documentation_en-US" xlink:label="lab_cron_CreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CreditFacilityMember" xlink:href="cron-20201231.xsd#cron_CreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_CreditFacilityMember" xlink:to="lab_cron_CreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_9da29d1c-8e6b-46fc-89fc-c0f277262670_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees_c616df81-3e90-472d-8f7c-be2c63618d89_terseLabel_en-US" xlink:label="lab_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer to investments in equity accounted investees</link:label>
    <link:label id="lab_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees_390b8163-a955-4ee8-a02c-ad7a76b7bfc0_negatedTerseLabel_en-US" xlink:label="lab_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer to investments in equity accounted investees</link:label>
    <link:label id="lab_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees_label_en-US" xlink:label="lab_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments In And Advances To Affiliates, At Fair Value, Transfer To Investments In Equity Accounted Investees</link:label>
    <link:label id="lab_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees_documentation_en-US" xlink:label="lab_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments In And Advances To Affiliates, At Fair Value, Transfer To Investments In Equity Accounted Investees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees" xlink:href="cron-20201231.xsd#cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees" xlink:to="lab_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_bb61bf30-c4c1-4667-afe1-721cde576789_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Outstanding Warrants</link:label>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:to="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2e16f18f-f8f2-42b4-ae2b-77398bcb3e74_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_ca7096fd-a808-4fc6-93de-5feb351f5f31_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAndAccruedLiabilities_02ec78e0-0d74-4328-8869-346eb7b262d9_negatedTerseLabel_en-US" xlink:label="lab_cron_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
    <link:label id="lab_cron_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_cron_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Liabilities, Accounts Payable And Accrued Liabilities</link:label>
    <link:label id="lab_cron_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAndAccruedLiabilities_documentation_en-US" xlink:label="lab_cron_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Liabilities, Accounts Payable And Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAndAccruedLiabilities" xlink:href="cron-20201231.xsd#cron_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAndAccruedLiabilities" xlink:to="lab_cron_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_624f1144-42da-4f3a-89bc-2f0e04cd4867_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future awards to be granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_CronosAustraliaLimitedMember_b39f5bca-1bdd-4e7e-9644-1c7deaba37fb_terseLabel_en-US" xlink:label="lab_cron_CronosAustraliaLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos Australia</link:label>
    <link:label id="lab_cron_CronosAustraliaLimitedMember_label_en-US" xlink:label="lab_cron_CronosAustraliaLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos Australia Limited [Member]</link:label>
    <link:label id="lab_cron_CronosAustraliaLimitedMember_documentation_en-US" xlink:label="lab_cron_CronosAustraliaLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos Australia Limited [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosAustraliaLimitedMember" xlink:href="cron-20201231.xsd#cron_CronosAustraliaLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_CronosAustraliaLimitedMember" xlink:to="lab_cron_CronosAustraliaLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_RepurposingPlanMember_725c697e-1726-4130-903e-4fe8621f0b5a_terseLabel_en-US" xlink:label="lab_cron_RepurposingPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurposing Plan</link:label>
    <link:label id="lab_cron_RepurposingPlanMember_label_en-US" xlink:label="lab_cron_RepurposingPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurposing Plan [Member]</link:label>
    <link:label id="lab_cron_RepurposingPlanMember_documentation_en-US" xlink:label="lab_cron_RepurposingPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurposing Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_RepurposingPlanMember" xlink:href="cron-20201231.xsd#cron_RepurposingPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_RepurposingPlanMember" xlink:to="lab_cron_RepurposingPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_32e5e170-ee1a-4a3e-81c0-017e49c3c35f_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInAndAdvancesToAffiliatesTextBlock_04f794f3-7ecd-452f-b917-f665a0deef0a_verboseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAndAdvancesToAffiliatesTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Joint Ventures</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAndAdvancesToAffiliatesTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsInAndAdvancesToAffiliatesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advances to Affiliates [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesTextBlock" xlink:to="lab_us-gaap_InvestmentsInAndAdvancesToAffiliatesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_ea4f3df5-a2b6-4707-a7ce-44e04f2b8469_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income (loss) attributable to:</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_ClassOfWarrantOrRightExpense_b61eaca8-ba82-42e4-b7e8-77ad91dd2ed7_terseLabel_en-US" xlink:label="lab_cron_ClassOfWarrantOrRightExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative transaction costs</link:label>
    <link:label id="lab_cron_ClassOfWarrantOrRightExpense_label_en-US" xlink:label="lab_cron_ClassOfWarrantOrRightExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Expense</link:label>
    <link:label id="lab_cron_ClassOfWarrantOrRightExpense_documentation_en-US" xlink:label="lab_cron_ClassOfWarrantOrRightExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ClassOfWarrantOrRightExpense" xlink:href="cron-20201231.xsd#cron_ClassOfWarrantOrRightExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_ClassOfWarrantOrRightExpense" xlink:to="lab_cron_ClassOfWarrantOrRightExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_687e29a2-5136-4ae5-9d60-433acb6ba119_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurposing Charges</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_37d62291-5d22-4d9c-8590-119169d72fd4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock_aedf661b-d26a-47e7-aae4-5ace49d09838_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Consolidated Entities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Sale of Stock by Subsidiary or Equity Method Investee Disclosure [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock" xlink:to="lab_us-gaap_ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_438a6d48-8e56-4998-b708-12b8c1008a90_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_295d26c0-5b7a-4351-ac76-11deaf00dfb2_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Exposure to Loss</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:to="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_5f767066-691d-455f-b0a3-1473cadf65e6_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:to="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_9a2ce0a3-9979-4e3f-a80e-334612295acd_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_dc1b4cb4-cba9-4e73-8a79-89ea74feab70_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, extension term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_49d5d79b-4ea4-4094-aa1a-fc977d69d1fb_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining contractual term (years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_FinancingReceivableDueOnDemandIntendedDemandTermMinimum_707f12c7-06ea-4b6a-af7c-f78dd81e53b1_terseLabel_en-US" xlink:label="lab_cron_FinancingReceivableDueOnDemandIntendedDemandTermMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due on demand, intended demand term, minimum</link:label>
    <link:label id="lab_cron_FinancingReceivableDueOnDemandIntendedDemandTermMinimum_label_en-US" xlink:label="lab_cron_FinancingReceivableDueOnDemandIntendedDemandTermMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Due On Demand, Intended Demand Term, Minimum</link:label>
    <link:label id="lab_cron_FinancingReceivableDueOnDemandIntendedDemandTermMinimum_documentation_en-US" xlink:label="lab_cron_FinancingReceivableDueOnDemandIntendedDemandTermMinimum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Due On Demand, Intended Demand Term, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableDueOnDemandIntendedDemandTermMinimum" xlink:href="cron-20201231.xsd#cron_FinancingReceivableDueOnDemandIntendedDemandTermMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_FinancingReceivableDueOnDemandIntendedDemandTermMinimum" xlink:to="lab_cron_FinancingReceivableDueOnDemandIntendedDemandTermMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_dcac78f6-dbae-40d8-8be4-0045c0e8607e_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_0d9ce849-8ce9-442f-bfc6-bc482dc9d98a_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of year</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_b4f27240-1c6a-4fa1-b8a2-e64969be7158_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of year</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_5856e4ae-fc95-47b9-8b0e-8a2c1eb47446_verboseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for credit loss</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_9f83a1f6-f9cf-45c4-ad11-2587250607ef_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current expected credit loss</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputExpectedDividendRateMember_f73dff39-55ca-45a9-a586-1be15ab03317_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected dividend yield</link:label>
    <link:label id="lab_us-gaap_MeasurementInputExpectedDividendRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Expected Dividend Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputExpectedDividendRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:to="lab_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_a4bdb898-bfe8-4938-8ec4-6c877a5a8486_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting of options</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_97e7f749-94f6-4181-a6bd-69f00cd73a09_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_96b9a814-2482-4e07-ab3b-95759a3e356f_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_85227c5a-f235-4d2b-90bd-aefd6e25a90d_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Lease Cost and Other Information</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_ef088b4d-9215-4a8f-9e47-34f2615e0768_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_153c6ba5-57e7-4901-aa31-2f1393fadfc0_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_357dc52a-cac1-4003-9148-17be9281f503_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive effect of derivative liabilities (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_1b48dfea-7ec1-4466-af16-ecf438945996_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_e97ff4db-beac-4c83-b9a8-6d7117fa4c20_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTable" xlink:to="lab_us-gaap_ConcentrationRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_EnterpriseResourcePlanningSystemMember_cbe1b25e-ede7-485c-a6cc-d82606096e9b_terseLabel_en-US" xlink:label="lab_cron_EnterpriseResourcePlanningSystemMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Enterprise resource planning (&#8220;ERP&#8221;) software</link:label>
    <link:label id="lab_cron_EnterpriseResourcePlanningSystemMember_631a3679-88d6-4986-b6d7-8487b3c86eed_verboseLabel_en-US" xlink:label="lab_cron_EnterpriseResourcePlanningSystemMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ERP system</link:label>
    <link:label id="lab_cron_EnterpriseResourcePlanningSystemMember_label_en-US" xlink:label="lab_cron_EnterpriseResourcePlanningSystemMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Enterprise Resource Planning System [Member]</link:label>
    <link:label id="lab_cron_EnterpriseResourcePlanningSystemMember_documentation_en-US" xlink:label="lab_cron_EnterpriseResourcePlanningSystemMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Enterprise Resource Planning System</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_EnterpriseResourcePlanningSystemMember" xlink:href="cron-20201231.xsd#cron_EnterpriseResourcePlanningSystemMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_EnterpriseResourcePlanningSystemMember" xlink:to="lab_cron_EnterpriseResourcePlanningSystemMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_3411fa93-3b4d-4f4a-85cf-f97c92f97664_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_11913f8b-e936-404f-8e1a-3da6f32e6a8c_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_b714d6c3-e754-4258-b109-64c0a0c530f0_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions and Balances</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_53d0cdde-8fbb-4b9e-8318-9e98698989a9_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of intangible assets, indefinite-lived (excluding goodwill)</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_8fc7810f-0947-446f-889d-ae17192fd91d_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_9254f2af-bac7-486b-b28f-c60b5800b1bd_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_47092c38-63ff-4800-b2b5-9d737a2d1943_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of warrants (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReportingUnitDomain_6c685c90-34ad-4c6f-af96-5a85647fa105_terseLabel_en-US" xlink:label="lab_us-gaap_ReportingUnitDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Domain]</link:label>
    <link:label id="lab_us-gaap_ReportingUnitDomain_label_en-US" xlink:label="lab_us-gaap_ReportingUnitDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReportingUnitDomain" xlink:to="lab_us-gaap_ReportingUnitDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_ProceedsFromWarrantExercisedAndStockOptionsExercised_fed7a191-b9bc-49b9-8d3f-39283fbb06d5_terseLabel_en-US" xlink:label="lab_cron_ProceedsFromWarrantExercisedAndStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercise of warrants and options</link:label>
    <link:label id="lab_cron_ProceedsFromWarrantExercisedAndStockOptionsExercised_label_en-US" xlink:label="lab_cron_ProceedsFromWarrantExercisedAndStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Warrant Exercised And Stock Options Exercised</link:label>
    <link:label id="lab_cron_ProceedsFromWarrantExercisedAndStockOptionsExercised_documentation_en-US" xlink:label="lab_cron_ProceedsFromWarrantExercisedAndStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Warrant Exercised And Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ProceedsFromWarrantExercisedAndStockOptionsExercised" xlink:href="cron-20201231.xsd#cron_ProceedsFromWarrantExercisedAndStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_ProceedsFromWarrantExercisedAndStockOptionsExercised" xlink:to="lab_cron_ProceedsFromWarrantExercisedAndStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationNonproduction_46baa5ef-47d4-449c-9b7c-113eeda9ac21_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationNonproduction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation expense included in operating expenses</link:label>
    <link:label id="lab_us-gaap_DepreciationNonproduction_label_en-US" xlink:label="lab_us-gaap_DepreciationNonproduction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Nonproduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationNonproduction" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationNonproduction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationNonproduction" xlink:to="lab_us-gaap_DepreciationNonproduction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_40e45358-75f5-4dc3-b21e-694a47cbc089_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_f92d4c78-08a7-4a1c-9b77-3229812cf362_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_TopUpRightsFixedPriceMember_0038a118-1cae-480e-86f2-f8398852687b_terseLabel_en-US" xlink:label="lab_cron_TopUpRightsFixedPriceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Top-up Rights &#8211; fixed price</link:label>
    <link:label id="lab_cron_TopUpRightsFixedPriceMember_label_en-US" xlink:label="lab_cron_TopUpRightsFixedPriceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Top-Up Rights - Fixed Price [Member]</link:label>
    <link:label id="lab_cron_TopUpRightsFixedPriceMember_documentation_en-US" xlink:label="lab_cron_TopUpRightsFixedPriceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Top-Up Rights - Fixed Price [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_TopUpRightsFixedPriceMember" xlink:href="cron-20201231.xsd#cron_TopUpRightsFixedPriceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_TopUpRightsFixedPriceMember" xlink:to="lab_cron_TopUpRightsFixedPriceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputSharePriceMember_3b2a54f1-22f4-4eca-99f1-e1ac36058bd3_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputSharePriceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share price at grant date (per share in C$)</link:label>
    <link:label id="lab_us-gaap_MeasurementInputSharePriceMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputSharePriceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Share Price [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputSharePriceMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputSharePriceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputSharePriceMember" xlink:to="lab_us-gaap_MeasurementInputSharePriceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy_ef42f775-6877-4102-b56a-9e4b56fe08f2_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Definite life intangible assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Finite-Lived, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:to="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightAxis_7736275f-6701-4b7e-9b98-bb0e35355e8f_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightAxis_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis" xlink:to="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_92d97c27-8c2b-491d-af29-8de5c9d5278b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-deductible share-based compensation</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_a3abfc57-6fa2-4374-b8f0-67086230ef2d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_BoughtDealOfferingsMember_5ce6250b-7bbe-4aec-939b-edfa5c658eeb_terseLabel_en-US" xlink:label="lab_cron_BoughtDealOfferingsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bought Deal Offerings</link:label>
    <link:label id="lab_cron_BoughtDealOfferingsMember_label_en-US" xlink:label="lab_cron_BoughtDealOfferingsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bought Deal Offerings [Member]</link:label>
    <link:label id="lab_cron_BoughtDealOfferingsMember_documentation_en-US" xlink:label="lab_cron_BoughtDealOfferingsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bought Deal Offerings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_BoughtDealOfferingsMember" xlink:href="cron-20201231.xsd#cron_BoughtDealOfferingsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_BoughtDealOfferingsMember" xlink:to="lab_cron_BoughtDealOfferingsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_711d2418-a42b-4f7a-a96e-64af6fe99b44_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncome_ec7ef52c-5620-40f8-8959-90c7e9497ac7_terseLabel_en-US" xlink:label="lab_cron_SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact of change in average variable rate, amount</link:label>
    <link:label id="lab_cron_SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncome_label_en-US" xlink:label="lab_cron_SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sensitivity Analysis Of Interest Rate Risk Income Statement Impact, Impact Of Change In Average Variable Rate On Interest Income</link:label>
    <link:label id="lab_cron_SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncome_documentation_en-US" xlink:label="lab_cron_SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sensitivity Analysis Of Interest Rate Risk Income Statement Impact, Impact Of Change In Average Variable Rate On Interest Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncome" xlink:href="cron-20201231.xsd#cron_SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncome" xlink:to="lab_cron_SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDamagesSoughtValue_9e8a73e2-7f59-480c-a0fe-a37c90369b53_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Damages sought</link:label>
    <link:label id="lab_us-gaap_LossContingencyDamagesSoughtValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Sought, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDamagesSoughtValue" xlink:to="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements_9ea31b39-f8c6-429e-9c92-b9762e120845_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of Rights</link:label>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements_label_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements" xlink:to="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_d9ba9014-fb78-4408-a5e2-47563537cd64_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTextBlock_007aa4a2-607d-4e02-9603-d9a52b587ac8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Common Shares Issued</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTextBlock" xlink:to="lab_us-gaap_ScheduleOfStockByClassTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1569013c-1bf5-4355-9d17-a06c9b3a9559_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_a3800698-609f-4ba7-915a-74d20a8718f5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_d2b687de-7188-4727-8ff9-697590b64ca4_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_ced6ee0c-557f-46ff-a518-3bc704a62f05_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_44890cee-d05f-47bd-aed1-0d57f99f5186_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_829a517e-6313-4fc5-9ead-7f3d5fff50a3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of warrants</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_8edccdd2-4476-4dec-bf7e-488641d8e770_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonmonetaryTransactionGrossOperatingRevenueRecognized_f4c2df26-ee50-49c6-b6ec-95d0ed6b0dac_terseLabel_en-US" xlink:label="lab_us-gaap_NonmonetaryTransactionGrossOperatingRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognized</link:label>
    <link:label id="lab_us-gaap_NonmonetaryTransactionGrossOperatingRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_NonmonetaryTransactionGrossOperatingRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonmonetary Transaction, Gross Operating Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonmonetaryTransactionGrossOperatingRevenueRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonmonetaryTransactionGrossOperatingRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonmonetaryTransactionGrossOperatingRevenueRecognized" xlink:to="lab_us-gaap_NonmonetaryTransactionGrossOperatingRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputExpectedTermMember_36a754a9-af13-4f05-971e-e477fab494cb_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputExpectedTermMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weight average expected life (in years)</link:label>
    <link:label id="lab_us-gaap_MeasurementInputExpectedTermMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputExpectedTermMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Expected Term [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputExpectedTermMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputExpectedTermMember" xlink:to="lab_us-gaap_MeasurementInputExpectedTermMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_20bd14f1-e008-4ca3-8f07-69892f2a5e37_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible asset</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Goodwill and Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:to="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_b3a4f45a-0867-456f-9f77-d7c84da07d69_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_1789f94a-f9c5-47a1-8552-201aab2598f9_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_e2d9598f-e8f1-4dd8-8df8-092c7fb2d4c9_verboseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in equity accounted investees</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_eb2c23d2-0cd5-453d-9b28-aaf63266f4e1_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in equity accounted investees</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_5bc35ee2-e7e1-48d1-b614-d941effb231a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure_8ffa5c85-10cb-42ad-9b79-de5ed73205c2_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum exposure to credit risk</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Credit Risk, Financial Instrument, Maximum Exposure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure" xlink:to="lab_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_4cdc2df8-c4f6-41d4-a8c4-c91c53848ff2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_327b7a8c-2f2e-4078-902c-3fd63cd801d7_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_NoncashSellingAndMarketingExpense_b9189b84-fe8a-4a0a-8c86-15fa618aef7e_terseLabel_en-US" xlink:label="lab_cron_NoncashSellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash sales and marketing</link:label>
    <link:label id="lab_cron_NoncashSellingAndMarketingExpense_label_en-US" xlink:label="lab_cron_NoncashSellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Selling And Marketing Expense</link:label>
    <link:label id="lab_cron_NoncashSellingAndMarketingExpense_documentation_en-US" xlink:label="lab_cron_NoncashSellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Selling And Marketing Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NoncashSellingAndMarketingExpense" xlink:href="cron-20201231.xsd#cron_NoncashSellingAndMarketingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_NoncashSellingAndMarketingExpense" xlink:to="lab_cron_NoncashSellingAndMarketingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IPOMember_38dd5811-b0a9-44d9-adf6-2db7cb71b923_terseLabel_en-US" xlink:label="lab_us-gaap_IPOMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IPO</link:label>
    <link:label id="lab_us-gaap_IPOMember_label_en-US" xlink:label="lab_us-gaap_IPOMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IPO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IPOMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IPOMember" xlink:to="lab_us-gaap_IPOMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_InvestmentOwnedNumberOfWarrantsExercised_cd0b5954-5518-4b2e-b247-fd35822c083d_terseLabel_en-US" xlink:label="lab_cron_InvestmentOwnedNumberOfWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of securities called by warrants or rights (in shares)</link:label>
    <link:label id="lab_cron_InvestmentOwnedNumberOfWarrantsExercised_label_en-US" xlink:label="lab_cron_InvestmentOwnedNumberOfWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Owned, Number Of Warrants Exercised</link:label>
    <link:label id="lab_cron_InvestmentOwnedNumberOfWarrantsExercised_documentation_en-US" xlink:label="lab_cron_InvestmentOwnedNumberOfWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Owned, Number Of Warrants Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentOwnedNumberOfWarrantsExercised" xlink:href="cron-20201231.xsd#cron_InvestmentOwnedNumberOfWarrantsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_InvestmentOwnedNumberOfWarrantsExercised" xlink:to="lab_cron_InvestmentOwnedNumberOfWarrantsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_cbfc41ab-0d42-4965-9b2b-f87e85ca3983_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c298ae9f-00d9-4b8c-aff6-0f143d6d0918_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_64fd2ade-e4a5-44f0-bfb1-0fbfa13b4074_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition of Redwood</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_682a31fa-dff0-4662-9924-812ee2c72596_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Restricted Share Units Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_238058bf-4a20-49af-9187-9c812b128be5_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue from External Customers by Geographic Areas</link:label>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Geographic Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:to="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_bffc86bd-b0f9-4cf8-8282-2d055a1bdb87_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive effect of awards (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_0326a2d0-8783-4151-8e9b-684cccfefb43_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_e0043d0c-72c6-4c41-bd32-8fab9665f34c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Data and Adjusted EBITDA</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_5ac2e5d7-1f98-4e87-9b35-a727665680a5_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_CronosGrowCoCreditFacilityMember_084032af-a1df-4c9b-b017-fa1ffab55c9f_terseLabel_en-US" xlink:label="lab_cron_CronosGrowCoCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos GrowCo Credit Facility</link:label>
    <link:label id="lab_cron_CronosGrowCoCreditFacilityMember_label_en-US" xlink:label="lab_cron_CronosGrowCoCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos GrowCo Credit Facility [Member]</link:label>
    <link:label id="lab_cron_CronosGrowCoCreditFacilityMember_documentation_en-US" xlink:label="lab_cron_CronosGrowCoCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos GrowCo Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosGrowCoCreditFacilityMember" xlink:href="cron-20201231.xsd#cron_CronosGrowCoCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_CronosGrowCoCreditFacilityMember" xlink:to="lab_cron_CronosGrowCoCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_fee96fc9-ef88-40aa-b6ab-2dbae7ebd486_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1fb1ec96-0aa1-41a0-85fb-d93a8cddd557_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_DiscontinuedOperationAssetsValuationAllowanceValuationIncrease_6544e2aa-deb6-4cc7-99c7-f61da381b4e6_terseLabel_en-US" xlink:label="lab_cron_DiscontinuedOperationAssetsValuationAllowanceValuationIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance recorded upon reclassification of assets as held-for-sale</link:label>
    <link:label id="lab_cron_DiscontinuedOperationAssetsValuationAllowanceValuationIncrease_label_en-US" xlink:label="lab_cron_DiscontinuedOperationAssetsValuationAllowanceValuationIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Assets, Valuation Allowance, Valuation Increase</link:label>
    <link:label id="lab_cron_DiscontinuedOperationAssetsValuationAllowanceValuationIncrease_documentation_en-US" xlink:label="lab_cron_DiscontinuedOperationAssetsValuationAllowanceValuationIncrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Assets, Valuation Allowance, Valuation Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DiscontinuedOperationAssetsValuationAllowanceValuationIncrease" xlink:href="cron-20201231.xsd#cron_DiscontinuedOperationAssetsValuationAllowanceValuationIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_DiscontinuedOperationAssetsValuationAllowanceValuationIncrease" xlink:to="lab_cron_DiscontinuedOperationAssetsValuationAllowanceValuationIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bb8b683a-ba62-494b-82fa-3166e5773666_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_2284d93c-f5a1-492a-bd0a-ea4203478f43_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_PaymentsForLeaseObligationsFinancingActivities_1906ed41-e300-4b9a-9113-9dcd2e922243_negatedTerseLabel_en-US" xlink:label="lab_cron_PaymentsForLeaseObligationsFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of lease obligations</link:label>
    <link:label id="lab_cron_PaymentsForLeaseObligationsFinancingActivities_label_en-US" xlink:label="lab_cron_PaymentsForLeaseObligationsFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For Lease Obligations, Financing Activities</link:label>
    <link:label id="lab_cron_PaymentsForLeaseObligationsFinancingActivities_documentation_en-US" xlink:label="lab_cron_PaymentsForLeaseObligationsFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For Lease Obligations, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PaymentsForLeaseObligationsFinancingActivities" xlink:href="cron-20201231.xsd#cron_PaymentsForLeaseObligationsFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_PaymentsForLeaseObligationsFinancingActivities" xlink:to="lab_cron_PaymentsForLeaseObligationsFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_94feb131-92de-44e5-bc2e-acb0c0d1c7b4_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_SaleOfStockPerformanceMilestoneDomain_50d8e3b0-151e-4222-9cdd-5d81c526600c_terseLabel_en-US" xlink:label="lab_cron_SaleOfStockPerformanceMilestoneDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Performance Milestone [Domain]</link:label>
    <link:label id="lab_cron_SaleOfStockPerformanceMilestoneDomain_label_en-US" xlink:label="lab_cron_SaleOfStockPerformanceMilestoneDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Performance Milestone [Domain]</link:label>
    <link:label id="lab_cron_SaleOfStockPerformanceMilestoneDomain_documentation_en-US" xlink:label="lab_cron_SaleOfStockPerformanceMilestoneDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Performance Milestone</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SaleOfStockPerformanceMilestoneDomain" xlink:href="cron-20201231.xsd#cron_SaleOfStockPerformanceMilestoneDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_SaleOfStockPerformanceMilestoneDomain" xlink:to="lab_cron_SaleOfStockPerformanceMilestoneDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShareAbstract_57a48957-8e9e-4cdc-bd36-ea70d9796f3d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic loss from discontinued operations per share computation</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShareAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic and Diluted Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShareAbstract" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DueToRelatedPartiesNoncurrent_c47ad462-d4d8-4ad4-859b-1d67026c804e_terseLabel_en-US" xlink:label="lab_us-gaap_DueToRelatedPartiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due to non-controlling interests</link:label>
    <link:label id="lab_us-gaap_DueToRelatedPartiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_DueToRelatedPartiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due to Related Parties, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToRelatedPartiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueToRelatedPartiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DueToRelatedPartiesNoncurrent" xlink:to="lab_us-gaap_DueToRelatedPartiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_PaymentsToExerciseWarrants_2361dced-393f-4d57-bc2f-60893b4519f4_terseLabel_en-US" xlink:label="lab_cron_PaymentsToExerciseWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercise of warrants</link:label>
    <link:label id="lab_cron_PaymentsToExerciseWarrants_label_en-US" xlink:label="lab_cron_PaymentsToExerciseWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments To Exercise Warrants</link:label>
    <link:label id="lab_cron_PaymentsToExerciseWarrants_documentation_en-US" xlink:label="lab_cron_PaymentsToExerciseWarrants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments To Exercise Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PaymentsToExerciseWarrants" xlink:href="cron-20201231.xsd#cron_PaymentsToExerciseWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_PaymentsToExerciseWarrants" xlink:to="lab_cron_PaymentsToExerciseWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_9fa03cff-8bf1-4252-9236-7cc8afeef1a1_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesAxis" xlink:to="lab_srt_ConsolidatedEntitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_CannasoulCollaborationLoanMember_dbce5653-d47d-41a2-9c65-35351705b28a_terseLabel_en-US" xlink:label="lab_cron_CannasoulCollaborationLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cannasoul Collaboration Loan</link:label>
    <link:label id="lab_cron_CannasoulCollaborationLoanMember_label_en-US" xlink:label="lab_cron_CannasoulCollaborationLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cannasoul Collaboration Loan [Member]</link:label>
    <link:label id="lab_cron_CannasoulCollaborationLoanMember_documentation_en-US" xlink:label="lab_cron_CannasoulCollaborationLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cannasoul Collaboration Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CannasoulCollaborationLoanMember" xlink:href="cron-20201231.xsd#cron_CannasoulCollaborationLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_CannasoulCollaborationLoanMember" xlink:to="lab_cron_CannasoulCollaborationLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_FinancingReceivableAccruedInterestNoncurrent_35f2be71-eacd-4f2d-ba26-b73960244e71_terseLabel_en-US" xlink:label="lab_cron_FinancingReceivableAccruedInterestNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Add: Accrued interest</link:label>
    <link:label id="lab_cron_FinancingReceivableAccruedInterestNoncurrent_label_en-US" xlink:label="lab_cron_FinancingReceivableAccruedInterestNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Accrued Interest, Noncurrent</link:label>
    <link:label id="lab_cron_FinancingReceivableAccruedInterestNoncurrent_documentation_en-US" xlink:label="lab_cron_FinancingReceivableAccruedInterestNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Accrued Interest, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableAccruedInterestNoncurrent" xlink:href="cron-20201231.xsd#cron_FinancingReceivableAccruedInterestNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_FinancingReceivableAccruedInterestNoncurrent" xlink:to="lab_cron_FinancingReceivableAccruedInterestNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_2eba612c-a321-45c8-be48-0341fb0c92d4_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_46b5235d-eac3-4949-bbd7-6c882ec16387_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1156967a-0262-4540-9333-0290529172d7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of property, plant and equipment, net of disposals</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementAdjustmentMember_12f360ec-7b3e-4cfe-b1d1-7d92b162f68c_terseLabel_en-US" xlink:label="lab_srt_RestatementAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held-for-sale adjustment</link:label>
    <link:label id="lab_srt_RestatementAdjustmentMember_label_en-US" xlink:label="lab_srt_RestatementAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementAdjustmentMember" xlink:to="lab_srt_RestatementAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_e1ab5765-0d6e-489c-8ada-166a7dbb3033_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts_d6f8b15d-42b8-461a-ac09-3e9cdad328f5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing and transaction costs</link:label>
    <link:label id="lab_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts_63414f99-9532-4930-9358-63b22cd797d2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing and transaction costs</link:label>
    <link:label id="lab_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Related Commitment Fees and Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts" xlink:to="lab_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_c9009356-8909-40cd-af82-fda352bafd12_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets and Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_897ffb92-16e4-48d8-a0ea-db6a9134e514_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceTable_cb324ce8-510d-4114-b7ae-1e777afc277a_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance [Table]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceTable_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowanceTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceTable" xlink:to="lab_us-gaap_ValuationAllowanceTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_dca5987a-22a2-407f-8d4e-df1ad5a955a1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share of loss from investments in equity accounted investees</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_cd0a08db-adb9-4e3d-9a66-92bce48a4bb1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share of loss (income) from equity accounted investees</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_5c038f28-4e3b-4a38-9343-10cc6486ab88_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share of loss from equity accounted investees</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_628f2248-3941-4dd8-8888-4716c65736f9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_DeferredShareUnitsDSUsMember_5670e002-5922-45f2-88f0-6789f44d1334_terseLabel_en-US" xlink:label="lab_cron_DeferredShareUnitsDSUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Share Units (DSUs)</link:label>
    <link:label id="lab_cron_DeferredShareUnitsDSUsMember_label_en-US" xlink:label="lab_cron_DeferredShareUnitsDSUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Share Units (DSUs) [Member]</link:label>
    <link:label id="lab_cron_DeferredShareUnitsDSUsMember_documentation_en-US" xlink:label="lab_cron_DeferredShareUnitsDSUsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Share Units (DSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DeferredShareUnitsDSUsMember" xlink:href="cron-20201231.xsd#cron_DeferredShareUnitsDSUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_DeferredShareUnitsDSUsMember" xlink:to="lab_cron_DeferredShareUnitsDSUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_d3b1943d-5cb6-43b1-90e7-8f753b9b16a2_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:to="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_3b22491d-f74b-4ddf-afe9-0e425b1038a1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableMember_0e790e50-6708-41e9-9657-d4994f764a05_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableMember_label_en-US" xlink:label="lab_us-gaap_AccountsPayableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableMember" xlink:to="lab_us-gaap_AccountsPayableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_e8c992cf-af8b-4fbe-8f3e-b984c304ebd4_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_SaleOfStockPerformanceMilestoneTriggeringEventSharesIssuedValue_2c7a88e1-fefe-4dc1-8b0b-2adeca7e0997_terseLabel_en-US" xlink:label="lab_cron_SaleOfStockPerformanceMilestoneTriggeringEventSharesIssuedValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of stock, performance milestone, triggering event, shares issued, value</link:label>
    <link:label id="lab_cron_SaleOfStockPerformanceMilestoneTriggeringEventSharesIssuedValue_label_en-US" xlink:label="lab_cron_SaleOfStockPerformanceMilestoneTriggeringEventSharesIssuedValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Performance Milestone, Triggering Event, Shares Issued, Value</link:label>
    <link:label id="lab_cron_SaleOfStockPerformanceMilestoneTriggeringEventSharesIssuedValue_documentation_en-US" xlink:label="lab_cron_SaleOfStockPerformanceMilestoneTriggeringEventSharesIssuedValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Performance Milestone, Triggering Event, Shares Issued, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SaleOfStockPerformanceMilestoneTriggeringEventSharesIssuedValue" xlink:href="cron-20201231.xsd#cron_SaleOfStockPerformanceMilestoneTriggeringEventSharesIssuedValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_SaleOfStockPerformanceMilestoneTriggeringEventSharesIssuedValue" xlink:to="lab_cron_SaleOfStockPerformanceMilestoneTriggeringEventSharesIssuedValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_c6b2bb7d-24f4-42f6-98e7-9c24f4dcee21_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Withholding taxes paid on equity awards</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_RestatementReviewExpense_96027395-aafc-4d8b-9d24-99ce52780437_terseLabel_en-US" xlink:label="lab_cron_RestatementReviewExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Review costs related to restatement of 2019 interim financial statements</link:label>
    <link:label id="lab_cron_RestatementReviewExpense_label_en-US" xlink:label="lab_cron_RestatementReviewExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Review Expense</link:label>
    <link:label id="lab_cron_RestatementReviewExpense_documentation_en-US" xlink:label="lab_cron_RestatementReviewExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Review Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_RestatementReviewExpense" xlink:href="cron-20201231.xsd#cron_RestatementReviewExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_RestatementReviewExpense" xlink:to="lab_cron_RestatementReviewExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_A2020OmnibusPlanMember_2fe792b4-0202-444b-a688-c2c0a519e07b_terseLabel_en-US" xlink:label="lab_cron_A2020OmnibusPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Omnibus Plan</link:label>
    <link:label id="lab_cron_A2020OmnibusPlanMember_label_en-US" xlink:label="lab_cron_A2020OmnibusPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Omnibus Plan [Member]</link:label>
    <link:label id="lab_cron_A2020OmnibusPlanMember_documentation_en-US" xlink:label="lab_cron_A2020OmnibusPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Omnibus Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_A2020OmnibusPlanMember" xlink:href="cron-20201231.xsd#cron_A2020OmnibusPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_A2020OmnibusPlanMember" xlink:to="lab_cron_A2020OmnibusPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_ee51d8b4-3dfe-4a58-81ca-69f919ad034b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Plan Information and Restructuring-Related Costs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_5244b1c5-6114-4879-92ba-bb48a7c1a7e3_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_55a25a5b-b4ce-4cd4-953e-7cdbf16fb354_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Equity Securities, FV-NI [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Equity Securities, FV-NI [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems" xlink:to="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_374b35ba-9e69-4d29-b4cb-8373b553ebcd_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant &amp; equipment, useful life</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_TechnionResearchAndDevelopmentFoundationMember_5af728f0-771d-493e-863f-7f6fc4bb6d76_terseLabel_en-US" xlink:label="lab_cron_TechnionResearchAndDevelopmentFoundationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technion</link:label>
    <link:label id="lab_cron_TechnionResearchAndDevelopmentFoundationMember_label_en-US" xlink:label="lab_cron_TechnionResearchAndDevelopmentFoundationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technion Research And Development Foundation [Member]</link:label>
    <link:label id="lab_cron_TechnionResearchAndDevelopmentFoundationMember_documentation_en-US" xlink:label="lab_cron_TechnionResearchAndDevelopmentFoundationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technion Research And Development Foundation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_TechnionResearchAndDevelopmentFoundationMember" xlink:href="cron-20201231.xsd#cron_TechnionResearchAndDevelopmentFoundationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_TechnionResearchAndDevelopmentFoundationMember" xlink:to="lab_cron_TechnionResearchAndDevelopmentFoundationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AffiliatedEntityMember_bd6a0a7e-3ca2-4041-b4e2-c4047ab0bc9b_terseLabel_en-US" xlink:label="lab_srt_AffiliatedEntityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Altria Pinnacle LLC.</link:label>
    <link:label id="lab_srt_AffiliatedEntityMember_label_en-US" xlink:label="lab_srt_AffiliatedEntityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affiliated Entity [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AffiliatedEntityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AffiliatedEntityMember" xlink:to="lab_srt_AffiliatedEntityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_3cbf6988-26af-4ef1-99b1-6ed249d68aae_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_c33195e8-2b9e-4e8d-a449-8a9d9e43e00a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_4108cad7-7abb-4f4d-a37c-36b4ac433773_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_FourCustomersMember_4bf134ea-edab-45e4-912c-ecd74357a306_terseLabel_en-US" xlink:label="lab_cron_FourCustomersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Four Customers</link:label>
    <link:label id="lab_cron_FourCustomersMember_label_en-US" xlink:label="lab_cron_FourCustomersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Four Customers [Member]</link:label>
    <link:label id="lab_cron_FourCustomersMember_documentation_en-US" xlink:label="lab_cron_FourCustomersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Four Customers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FourCustomersMember" xlink:href="cron-20201231.xsd#cron_FourCustomersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_FourCustomersMember" xlink:to="lab_cron_FourCustomersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_f4973ab0-f203-465e-b80a-6d811688a34f_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_1652f20a-9090-44e6-b25a-aebd64deb53e_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_aa4e8803-75b1-481c-93b9-3b9b722f4451_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e2498cea-df83-482e-8a02-d9b866c9e8d7_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LandMember_79f20f8a-28ee-45a4-9c45-27609723fe5b_terseLabel_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_LandMember_label_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LandMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandMember" xlink:to="lab_us-gaap_LandMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_a3efa44c-b511-4b8f-acf8-ba4d4b150b69_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesDomain" xlink:to="lab_srt_ConsolidatedEntitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_SaleOfStockPerformanceMilestoneTriggeringEventMinimumRevenue_54b47af9-3844-4c23-804e-90384e8f593f_terseLabel_en-US" xlink:label="lab_cron_SaleOfStockPerformanceMilestoneTriggeringEventMinimumRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of stock, performance milestone, triggering event, minimum revenue</link:label>
    <link:label id="lab_cron_SaleOfStockPerformanceMilestoneTriggeringEventMinimumRevenue_label_en-US" xlink:label="lab_cron_SaleOfStockPerformanceMilestoneTriggeringEventMinimumRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Performance Milestone, Triggering Event, Minimum Revenue</link:label>
    <link:label id="lab_cron_SaleOfStockPerformanceMilestoneTriggeringEventMinimumRevenue_documentation_en-US" xlink:label="lab_cron_SaleOfStockPerformanceMilestoneTriggeringEventMinimumRevenue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Performance Milestone, Triggering Event, Minimum Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SaleOfStockPerformanceMilestoneTriggeringEventMinimumRevenue" xlink:href="cron-20201231.xsd#cron_SaleOfStockPerformanceMilestoneTriggeringEventMinimumRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_SaleOfStockPerformanceMilestoneTriggeringEventMinimumRevenue" xlink:to="lab_cron_SaleOfStockPerformanceMilestoneTriggeringEventMinimumRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_eb53620c-ce8c-414b-8f58-b6a4c7697cd1_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of lease obligation</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_0804b69b-695e-4b77-b979-0809131d1e54_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cancellation and forfeitures (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_985856be-3826-43a9-bc03-4b1f07eb9823_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Options Issued</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_NatuEraSeriesALoanShareOfNetLossInExcessOfCarryingValueOfEquityInvestmentMember_b022eb71-e08f-44fe-ae27-3154ca7b024b_terseLabel_en-US" xlink:label="lab_cron_NatuEraSeriesALoanShareOfNetLossInExcessOfCarryingValueOfEquityInvestmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NatuEra Series A Loan - Share of Net Loss in Excess of Carrying Value of Equity Investment</link:label>
    <link:label id="lab_cron_NatuEraSeriesALoanShareOfNetLossInExcessOfCarryingValueOfEquityInvestmentMember_label_en-US" xlink:label="lab_cron_NatuEraSeriesALoanShareOfNetLossInExcessOfCarryingValueOfEquityInvestmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NatuEra Series A Loan - Share Of Net Loss In Excess Of Carrying Value Of Equity Investment [Member]</link:label>
    <link:label id="lab_cron_NatuEraSeriesALoanShareOfNetLossInExcessOfCarryingValueOfEquityInvestmentMember_documentation_en-US" xlink:label="lab_cron_NatuEraSeriesALoanShareOfNetLossInExcessOfCarryingValueOfEquityInvestmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NatuEra Series A Loan - Share Of Net Loss In Excess Of Carrying Value Of Equity Investment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NatuEraSeriesALoanShareOfNetLossInExcessOfCarryingValueOfEquityInvestmentMember" xlink:href="cron-20201231.xsd#cron_NatuEraSeriesALoanShareOfNetLossInExcessOfCarryingValueOfEquityInvestmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_NatuEraSeriesALoanShareOfNetLossInExcessOfCarryingValueOfEquityInvestmentMember" xlink:to="lab_cron_NatuEraSeriesALoanShareOfNetLossInExcessOfCarryingValueOfEquityInvestmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_8b774540-17eb-46c2-a866-e6ce4b98173a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_NonrevolvingTermLoanFacilityMember_88e8cb00-cc66-4408-a8dd-ebb12a65d871_terseLabel_en-US" xlink:label="lab_cron_NonrevolvingTermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-revolving Term Loan Facility</link:label>
    <link:label id="lab_cron_NonrevolvingTermLoanFacilityMember_label_en-US" xlink:label="lab_cron_NonrevolvingTermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-revolving Term Loan Facility [Member]</link:label>
    <link:label id="lab_cron_NonrevolvingTermLoanFacilityMember_documentation_en-US" xlink:label="lab_cron_NonrevolvingTermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-revolving Term Loan Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NonrevolvingTermLoanFacilityMember" xlink:href="cron-20201231.xsd#cron_NonrevolvingTermLoanFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_NonrevolvingTermLoanFacilityMember" xlink:to="lab_cron_NonrevolvingTermLoanFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_ee492530-5a72-475c-96b6-814494af6acd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock_5c3ad77e-1446-4080-8fa4-2aa5ecad7b69_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Changes in Warrants and DSUs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Outstanding Award, Activity, Excluding Option [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_DerivativeLiabilityUsefulLifeTerm_6aeffba8-e49f-4d36-adb9-5d9f857a37a5_terseLabel_en-US" xlink:label="lab_cron_DerivativeLiabilityUsefulLifeTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected life</link:label>
    <link:label id="lab_cron_DerivativeLiabilityUsefulLifeTerm_label_en-US" xlink:label="lab_cron_DerivativeLiabilityUsefulLifeTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Useful Life, Term</link:label>
    <link:label id="lab_cron_DerivativeLiabilityUsefulLifeTerm_documentation_en-US" xlink:label="lab_cron_DerivativeLiabilityUsefulLifeTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Useful Life, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DerivativeLiabilityUsefulLifeTerm" xlink:href="cron-20201231.xsd#cron_DerivativeLiabilityUsefulLifeTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_DerivativeLiabilityUsefulLifeTerm" xlink:to="lab_cron_DerivativeLiabilityUsefulLifeTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableMember_b00abe56-6b07-471f-8bb0-ed94168cf031_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableMember_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableMember" xlink:to="lab_us-gaap_AccountsReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_710b7802-1e36-444e-a7c3-068398ece0da_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_label_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityOwnershipPercentage_50d0190b-4b0c-4d64-8527-4e9a93b2070f_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership percentage</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityOwnershipPercentage_839ea8c1-3862-4d42-90ea-f44ca754b336_verboseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership interest</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:to="lab_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_dbe64786-362e-400d-8f97-4e494e9b2412_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_A2015StockOptionPlanMember_327198be-2ce5-45a7-9884-d059856d4f26_terseLabel_en-US" xlink:label="lab_cron_A2015StockOptionPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2015 Stock Option Plan</link:label>
    <link:label id="lab_cron_A2015StockOptionPlanMember_label_en-US" xlink:label="lab_cron_A2015StockOptionPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2015 Stock Option Plan [Member]</link:label>
    <link:label id="lab_cron_A2015StockOptionPlanMember_documentation_en-US" xlink:label="lab_cron_A2015StockOptionPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2015 Stock Option Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_A2015StockOptionPlanMember" xlink:href="cron-20201231.xsd#cron_A2015StockOptionPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_A2015StockOptionPlanMember" xlink:to="lab_cron_A2015StockOptionPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_b28d57cb-9c39-4e49-ba40-c9388275fff3_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_6a8167ca-ac92-4c6b-b9cb-e7df57f4dbff_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_d0d38392-e5e7-4c40-9abd-940f69438b14_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_c212acee-5b99-497d-90a3-883a5bf1d90c_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskLineItems" xlink:to="lab_us-gaap_ConcentrationRiskLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_591f939b-f2d5-4b18-879b-7d656d636377_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average discount rate &#8211; operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsNoncurrent_4222e327-724a-45cb-8242-aa174ed7c939_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current assets</link:label>
    <link:label id="lab_us-gaap_AssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_AssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrent" xlink:to="lab_us-gaap_AssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_NumberOfHempderivedCannabidiolPersonalCareBrands_d2d310d8-8a21-4dac-b5a3-376f6673812d_terseLabel_en-US" xlink:label="lab_cron_NumberOfHempderivedCannabidiolPersonalCareBrands" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of hemp-derived cannabidiol personal care brands</link:label>
    <link:label id="lab_cron_NumberOfHempderivedCannabidiolPersonalCareBrands_label_en-US" xlink:label="lab_cron_NumberOfHempderivedCannabidiolPersonalCareBrands" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Hemp-derived Cannabidiol Personal Care Brands</link:label>
    <link:label id="lab_cron_NumberOfHempderivedCannabidiolPersonalCareBrands_documentation_en-US" xlink:label="lab_cron_NumberOfHempderivedCannabidiolPersonalCareBrands" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Hemp-derived Cannabidiol Personal Care Brands</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NumberOfHempderivedCannabidiolPersonalCareBrands" xlink:href="cron-20201231.xsd#cron_NumberOfHempderivedCannabidiolPersonalCareBrands"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_NumberOfHempderivedCannabidiolPersonalCareBrands" xlink:to="lab_cron_NumberOfHempderivedCannabidiolPersonalCareBrands" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_d2b66ae5-2fa1-47d3-93c3-95ccd638a66d_terseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment costs associated with plan</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentCharges" xlink:to="lab_us-gaap_AssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_CronosIsraelG.S.PharmaciesLtd.Member_e45bc53b-76ce-415c-8e9e-d5920fb35236_terseLabel_en-US" xlink:label="lab_cron_CronosIsraelG.S.PharmaciesLtd.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos Israel G.S. Pharmacies Ltd.</link:label>
    <link:label id="lab_cron_CronosIsraelG.S.PharmaciesLtd.Member_label_en-US" xlink:label="lab_cron_CronosIsraelG.S.PharmaciesLtd.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos Israel G.S. Pharmacies Ltd. [Member]</link:label>
    <link:label id="lab_cron_CronosIsraelG.S.PharmaciesLtd.Member_documentation_en-US" xlink:label="lab_cron_CronosIsraelG.S.PharmaciesLtd.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos Israel G.S. Pharmacies Ltd. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosIsraelG.S.PharmaciesLtd.Member" xlink:href="cron-20201231.xsd#cron_CronosIsraelG.S.PharmaciesLtd.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_CronosIsraelG.S.PharmaciesLtd.Member" xlink:to="lab_cron_CronosIsraelG.S.PharmaciesLtd.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_ConsultingServicesMember_1eaea084-a25f-4d51-86f6-f80e0cfce94b_terseLabel_en-US" xlink:label="lab_cron_ConsultingServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consulting Services</link:label>
    <link:label id="lab_cron_ConsultingServicesMember_label_en-US" xlink:label="lab_cron_ConsultingServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consulting Services [Member]</link:label>
    <link:label id="lab_cron_ConsultingServicesMember_documentation_en-US" xlink:label="lab_cron_ConsultingServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consulting Services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ConsultingServicesMember" xlink:href="cron-20201231.xsd#cron_ConsultingServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_ConsultingServicesMember" xlink:to="lab_cron_ConsultingServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_0099f823-32ba-4537-9f28-d347a0b94989_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of transaction costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_87618a7d-8720-42e0-9b91-715d2ad407a0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price (C$)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_NumberOfStrategicJointVentures_ebf67b01-0b3d-404e-9762-4a7e3f5c820e_terseLabel_en-US" xlink:label="lab_cron_NumberOfStrategicJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of strategic joint ventures</link:label>
    <link:label id="lab_cron_NumberOfStrategicJointVentures_label_en-US" xlink:label="lab_cron_NumberOfStrategicJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Strategic Joint Ventures</link:label>
    <link:label id="lab_cron_NumberOfStrategicJointVentures_documentation_en-US" xlink:label="lab_cron_NumberOfStrategicJointVentures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Strategic Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NumberOfStrategicJointVentures" xlink:href="cron-20201231.xsd#cron_NumberOfStrategicJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_NumberOfStrategicJointVentures" xlink:to="lab_cron_NumberOfStrategicJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsAndVestedInPeriod_441f85ad-3c19-4209-8360-642d03c575c7_terseLabel_en-US" xlink:label="lab_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsAndVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granting and vesting of DSUs (in shares)</link:label>
    <link:label id="lab_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsAndVestedInPeriod_label_en-US" xlink:label="lab_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsAndVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement By Share-based Payment Award, Equity Instruments Other Than Options, Grants And Vested In Period</link:label>
    <link:label id="lab_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsAndVestedInPeriod_documentation_en-US" xlink:label="lab_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsAndVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement By Share-based Payment Award, Equity Instruments Other Than Options, Grants And Vested In Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsAndVestedInPeriod" xlink:href="cron-20201231.xsd#cron_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsAndVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsAndVestedInPeriod" xlink:to="lab_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsAndVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_fd753989-f9ce-43b3-b557-35e5c4feabf6_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesMember" xlink:to="lab_us-gaap_EquitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_7eb0a538-4801-49d8-90e4-5c5bdee78e0a_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_ClassOfWarrantOrRightNumberOfWarrantsIssued_0283c37a-7141-4757-93ee-7bdd50378497_terseLabel_en-US" xlink:label="lab_cron_ClassOfWarrantOrRightNumberOfWarrantsIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of warrants issued</link:label>
    <link:label id="lab_cron_ClassOfWarrantOrRightNumberOfWarrantsIssued_label_en-US" xlink:label="lab_cron_ClassOfWarrantOrRightNumberOfWarrantsIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Number Of Warrants Issued</link:label>
    <link:label id="lab_cron_ClassOfWarrantOrRightNumberOfWarrantsIssued_documentation_en-US" xlink:label="lab_cron_ClassOfWarrantOrRightNumberOfWarrantsIssued" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Number Of Warrants Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ClassOfWarrantOrRightNumberOfWarrantsIssued" xlink:href="cron-20201231.xsd#cron_ClassOfWarrantOrRightNumberOfWarrantsIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_ClassOfWarrantOrRightNumberOfWarrantsIssued" xlink:to="lab_cron_ClassOfWarrantOrRightNumberOfWarrantsIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_InvestmentOwnedSharesSoldPercentageOfSharesIssuedAndOutstanding_00c8834a-482d-4d58-83c6-5fef739915b9_terseLabel_en-US" xlink:label="lab_cron_InvestmentOwnedSharesSoldPercentageOfSharesIssuedAndOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment owned, shares sold, percentage of shares issued and outstanding</link:label>
    <link:label id="lab_cron_InvestmentOwnedSharesSoldPercentageOfSharesIssuedAndOutstanding_label_en-US" xlink:label="lab_cron_InvestmentOwnedSharesSoldPercentageOfSharesIssuedAndOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Owned, Shares Sold, Percentage Of Shares Issued And Outstanding</link:label>
    <link:label id="lab_cron_InvestmentOwnedSharesSoldPercentageOfSharesIssuedAndOutstanding_documentation_en-US" xlink:label="lab_cron_InvestmentOwnedSharesSoldPercentageOfSharesIssuedAndOutstanding" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Owned, Shares Sold, Percentage Of Shares Issued And Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentOwnedSharesSoldPercentageOfSharesIssuedAndOutstanding" xlink:href="cron-20201231.xsd#cron_InvestmentOwnedSharesSoldPercentageOfSharesIssuedAndOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_InvestmentOwnedSharesSoldPercentageOfSharesIssuedAndOutstanding" xlink:to="lab_cron_InvestmentOwnedSharesSoldPercentageOfSharesIssuedAndOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_95de7c6e-996b-480c-a7b2-a2f066df5ffa_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_bb9b62b2-6868-4251-bb52-8c047f0eac77_verboseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortization" xlink:to="lab_us-gaap_DepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_68c11eac-9331-43fc-8a76-e751c4f0293a_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring reserve</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_RedwoodReportingUnitMember_7c6745bc-ab26-4c46-b0b9-7e9f7f7fc7f5_terseLabel_en-US" xlink:label="lab_cron_RedwoodReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redwood</link:label>
    <link:label id="lab_cron_RedwoodReportingUnitMember_label_en-US" xlink:label="lab_cron_RedwoodReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redwood Reporting Unit [Member]</link:label>
    <link:label id="lab_cron_RedwoodReportingUnitMember_documentation_en-US" xlink:label="lab_cron_RedwoodReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redwood Reporting Unit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_RedwoodReportingUnitMember" xlink:href="cron-20201231.xsd#cron_RedwoodReportingUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_RedwoodReportingUnitMember" xlink:to="lab_cron_RedwoodReportingUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_5da49210-3495-4175-a370-49fc21a773d9_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_5977252d-d17a-4ce1-a182-2e3670279caa_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_cea503da-66e4-433e-9b4f-124bf27c5358_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_424d7efd-9b2e-4c2b-8b5f-7bb0bc6036e1_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_us-gaap_DeferredTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_57ccb21a-7776-41d5-96d0-f3595f6abf9f_verboseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_85262a89-235f-49b7-b7ea-7aba35ec4dbe_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_Goodwill_7991c9d0-260f-40c0-8a87-43cc86be23cf_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_Goodwill_aa244ee3-bb85-43b6-8882-81821276985b_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_a8523244-d406-4dce-a4b2-d15797758506_terseLabel_en-US" xlink:label="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Other Investments</link:label>
    <link:label id="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_label_en-US" xlink:label="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading, and Equity Securities, FV-NI [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:to="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_5dbd2d78-5ec4-4f61-93e0-71711e1938b1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Values of Derivative Liabilities</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_5cc5eb31-420d-4442-a1aa-eec0d3a8791b_terseLabel_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_label_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantMember_3074c6ed-915a-4b2f-b022-ed261277f516_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants</link:label>
    <link:label id="lab_us-gaap_WarrantMember_label_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantMember" xlink:to="lab_us-gaap_WarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_GinkgoBioworksInc.Member_ae569784-162b-40ef-8864-4a75c68e0015_terseLabel_en-US" xlink:label="lab_cron_GinkgoBioworksInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ginkgo</link:label>
    <link:label id="lab_cron_GinkgoBioworksInc.Member_label_en-US" xlink:label="lab_cron_GinkgoBioworksInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ginkgo Bioworks Inc. [Member]</link:label>
    <link:label id="lab_cron_GinkgoBioworksInc.Member_documentation_en-US" xlink:label="lab_cron_GinkgoBioworksInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ginkgo Bioworks Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_GinkgoBioworksInc.Member" xlink:href="cron-20201231.xsd#cron_GinkgoBioworksInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_GinkgoBioworksInc.Member" xlink:to="lab_cron_GinkgoBioworksInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_b7c53ab5-07b1-474b-91be-ed7330c20bee_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax loss carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_FourVendorsMember_c8086165-0ee4-4c83-b9d9-9ee91c5e6936_terseLabel_en-US" xlink:label="lab_cron_FourVendorsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Four Vendors</link:label>
    <link:label id="lab_cron_FourVendorsMember_label_en-US" xlink:label="lab_cron_FourVendorsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Four Vendors [Member]</link:label>
    <link:label id="lab_cron_FourVendorsMember_documentation_en-US" xlink:label="lab_cron_FourVendorsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Four Vendors</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FourVendorsMember" xlink:href="cron-20201231.xsd#cron_FourVendorsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_FourVendorsMember" xlink:to="lab_cron_FourVendorsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_866b46c4-bb80-4951-8ff6-ae8ed576b3f2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_8dc0dcce-9286-4df1-a6bf-fe9481747d1d_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_TopupRightsMember_3f59d53c-e652-43f7-b9fa-e446ed5772fb_verboseLabel_en-US" xlink:label="lab_cron_TopupRightsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Top-up Rights</link:label>
    <link:label id="lab_cron_TopupRightsMember_label_en-US" xlink:label="lab_cron_TopupRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Top-up Rights [Member]</link:label>
    <link:label id="lab_cron_TopupRightsMember_documentation_en-US" xlink:label="lab_cron_TopupRightsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Top-up Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_TopupRightsMember" xlink:href="cron-20201231.xsd#cron_TopupRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_TopupRightsMember" xlink:to="lab_cron_TopupRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_315425b9-cb37-4764-bc87-f21f7a1e6b6a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_5ea03d20-85e9-4f47-9f5a-42a4c52be51d_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Held-for-sale Assets</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefinitelivedIntangibleAssetsAcquired_d8986055-3c7a-4f8c-a67b-088c422dfd6e_terseLabel_en-US" xlink:label="lab_us-gaap_IndefinitelivedIntangibleAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived intangible assets acquired, fair value</link:label>
    <link:label id="lab_us-gaap_IndefinitelivedIntangibleAssetsAcquired_label_en-US" xlink:label="lab_us-gaap_IndefinitelivedIntangibleAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefinitelivedIntangibleAssetsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired" xlink:to="lab_us-gaap_IndefinitelivedIntangibleAssetsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_5c2b7148-45fc-4edd-bdd3-b543b6f5b536_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible List]</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible List]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:to="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3e19c2fc-0d2c-4076-b9d4-23166cf5a182_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of options (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_2c9c23b3-e975-44aa-adc8-d573672dcdb1_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_CronosIsraelG.S.CultivationsLtd.Member_5d38f47c-7eb3-4bed-8f7e-0e57cfd23aef_terseLabel_en-US" xlink:label="lab_cron_CronosIsraelG.S.CultivationsLtd.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos Israel G.S. Cultivations Ltd.</link:label>
    <link:label id="lab_cron_CronosIsraelG.S.CultivationsLtd.Member_label_en-US" xlink:label="lab_cron_CronosIsraelG.S.CultivationsLtd.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos Israel G.S. Cultivations Ltd. [Member]</link:label>
    <link:label id="lab_cron_CronosIsraelG.S.CultivationsLtd.Member_documentation_en-US" xlink:label="lab_cron_CronosIsraelG.S.CultivationsLtd.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos Israel G.S. Cultivations Ltd. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosIsraelG.S.CultivationsLtd.Member" xlink:href="cron-20201231.xsd#cron_CronosIsraelG.S.CultivationsLtd.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_CronosIsraelG.S.CultivationsLtd.Member" xlink:to="lab_cron_CronosIsraelG.S.CultivationsLtd.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b8f12361-6df5-44c3-a47b-25beebd109a7_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_104aaeca-febc-458c-9771-40fb8df526b2_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of common shares for computation of diluted income (loss) per share (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_06e051e8-7c36-4439-9528-add8fa608959_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cancellation and forfeitures (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_ab4300ec-0824-4a12-a282-ab0c908abcfc_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryCurrentTable_a2d4ee7d-61e6-43bc-8f31-24df9837c6ea_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryCurrentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Current [Table]</link:label>
    <link:label id="lab_us-gaap_InventoryCurrentTable_label_en-US" xlink:label="lab_us-gaap_InventoryCurrentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Current [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryCurrentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryCurrentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryCurrentTable" xlink:to="lab_us-gaap_InventoryCurrentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_353094e5-66a8-4ef2-91c2-eab5fd973bea_terseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales and marketing</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and Marketing Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpense" xlink:to="lab_us-gaap_SellingAndMarketingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_DeferredTaxAssetsShareIssuanceCost_5f15addc-1ff7-4b58-b96f-183b2e15c968_terseLabel_en-US" xlink:label="lab_cron_DeferredTaxAssetsShareIssuanceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share issuance cost</link:label>
    <link:label id="lab_cron_DeferredTaxAssetsShareIssuanceCost_label_en-US" xlink:label="lab_cron_DeferredTaxAssetsShareIssuanceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Share Issuance Cost</link:label>
    <link:label id="lab_cron_DeferredTaxAssetsShareIssuanceCost_documentation_en-US" xlink:label="lab_cron_DeferredTaxAssetsShareIssuanceCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Share Issuance Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DeferredTaxAssetsShareIssuanceCost" xlink:href="cron-20201231.xsd#cron_DeferredTaxAssetsShareIssuanceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_DeferredTaxAssetsShareIssuanceCost" xlink:to="lab_cron_DeferredTaxAssetsShareIssuanceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_StockIssuedDuringPeriodNewIssuesWeightedAveragePricePeriod_06975dfa-46f8-457b-8768-86532c033b91_terseLabel_en-US" xlink:label="lab_cron_StockIssuedDuringPeriodNewIssuesWeightedAveragePricePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock issued during period, new issues, measurement input</link:label>
    <link:label id="lab_cron_StockIssuedDuringPeriodNewIssuesWeightedAveragePricePeriod_label_en-US" xlink:label="lab_cron_StockIssuedDuringPeriodNewIssuesWeightedAveragePricePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, New Issues, Weighted Average Price, Period</link:label>
    <link:label id="lab_cron_StockIssuedDuringPeriodNewIssuesWeightedAveragePricePeriod_documentation_en-US" xlink:label="lab_cron_StockIssuedDuringPeriodNewIssuesWeightedAveragePricePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, New Issues, Weighted Average Price, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_StockIssuedDuringPeriodNewIssuesWeightedAveragePricePeriod" xlink:href="cron-20201231.xsd#cron_StockIssuedDuringPeriodNewIssuesWeightedAveragePricePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_StockIssuedDuringPeriodNewIssuesWeightedAveragePricePeriod" xlink:to="lab_cron_StockIssuedDuringPeriodNewIssuesWeightedAveragePricePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_75b20f3e-b9c9-4727-add3-4d1bb2b54705_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanAxis" xlink:to="lab_us-gaap_RestructuringPlanAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_AltriaVenturesInc.Member_238b900c-41cf-429d-9959-751d35e4f1d7_terseLabel_en-US" xlink:label="lab_cron_AltriaVenturesInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Altria Ventures</link:label>
    <link:label id="lab_cron_AltriaVenturesInc.Member_label_en-US" xlink:label="lab_cron_AltriaVenturesInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Altria Ventures Inc. [Member]</link:label>
    <link:label id="lab_cron_AltriaVenturesInc.Member_documentation_en-US" xlink:label="lab_cron_AltriaVenturesInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Altria Ventures Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaVenturesInc.Member" xlink:href="cron-20201231.xsd#cron_AltriaVenturesInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_AltriaVenturesInc.Member" xlink:to="lab_cron_AltriaVenturesInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_f2024b65-0702-4a09-8437-c265a1cf0b2b_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_909235cd-81d6-4de4-8f1d-e7bfcfeff81d_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_cba17797-21a2-4c13-8c25-4e79f5c800c3_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements and Changes in Accounting Principles [Abstract]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_b7073950-4ca5-4505-8bb6-99afa21c56a9_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_6f484097-98f3-4d62-a362-ab58b8c5e1f8_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share capital</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent_2709f54e-0dea-4ad6-904f-b550d30d3619_periodStartLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent_67a569dd-043d-49d0-9a70-0251120c58d3_periodEndLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Share-based Arrangements, Liability, Current and Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent" xlink:to="lab_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_151d4224-02d0-48af-8a5b-860f1cd1c0ec_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_974e921c-7456-470d-945f-977b2efe3eb8_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_d49edaeb-1d84-40c3-b716-4fec3ed335d5_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSecuredDebt_8e1e55ba-f58f-4626-99a7-bd3a24d029e0_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from construction loan payable</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSecuredDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Secured Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_LoanReceivableNameAxis_23aa561d-405c-4e74-ab61-da3fbc629f82_terseLabel_en-US" xlink:label="lab_cron_LoanReceivableNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan Receivable, Name [Axis]</link:label>
    <link:label id="lab_cron_LoanReceivableNameAxis_label_en-US" xlink:label="lab_cron_LoanReceivableNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan Receivable, Name [Axis]</link:label>
    <link:label id="lab_cron_LoanReceivableNameAxis_documentation_en-US" xlink:label="lab_cron_LoanReceivableNameAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan Receivable, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LoanReceivableNameAxis" xlink:href="cron-20201231.xsd#cron_LoanReceivableNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_LoanReceivableNameAxis" xlink:to="lab_cron_LoanReceivableNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_dd6ce292-00e3-44aa-a2d5-f749f9715560_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_47075773-7dba-4d5b-9ae0-f6afda4767cd_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of stock, price per share (in aud per share)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_label_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPricePerShare" xlink:to="lab_us-gaap_SaleOfStockPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_f4552b40-a02a-420b-9bf2-ea71a4fe7acd_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_386d263b-e259-492a-9394-b7732d38ac9e_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings (loss) per share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_e5339394-e54e-4bf5-a779-cb0dbd9aa298_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_340bba6b-facb-4a3e-8fce-e9cfe2b4cf08_verboseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_ProfessionalAndConsultingExpense_b8432892-76ec-4316-9757-5d4a010a367b_terseLabel_en-US" xlink:label="lab_cron_ProfessionalAndConsultingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Professional and consulting</link:label>
    <link:label id="lab_cron_ProfessionalAndConsultingExpense_label_en-US" xlink:label="lab_cron_ProfessionalAndConsultingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Professional And Consulting Expense</link:label>
    <link:label id="lab_cron_ProfessionalAndConsultingExpense_documentation_en-US" xlink:label="lab_cron_ProfessionalAndConsultingExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Professional And Consulting Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ProfessionalAndConsultingExpense" xlink:href="cron-20201231.xsd#cron_ProfessionalAndConsultingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_ProfessionalAndConsultingExpense" xlink:to="lab_cron_ProfessionalAndConsultingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_7693b147-a867-4ef5-acb8-bd9344a626f6_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:to="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_7c908e13-a596-48a4-9028-5d6596e88619_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract" xlink:to="lab_us-gaap_InventoryDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionSharePrice_ed2b2083-fd70-40c8-a757-4cfaa36ea0c1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration transferred, common shares, volume weighted average trading price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionSharePrice_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionSharePrice" xlink:to="lab_us-gaap_BusinessAcquisitionSharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_97ede0f9-ccc2-4175-b1ed-f7962c30444b_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award vesting rights, percentage</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments_54b3787e-c62c-44fe-bbe9-336321a1abef_verboseLabel_en-US" xlink:label="lab_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advances to affiliates</link:label>
    <link:label id="lab_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments_a62daff4-37bf-48ca-8d0a-4b62f33afffd_terseLabel_en-US" xlink:label="lab_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advances (repayments)</link:label>
    <link:label id="lab_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments_label_en-US" xlink:label="lab_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments In And Advances To Affiliates, At Fair Value, Advances (Repayments)</link:label>
    <link:label id="lab_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments_documentation_en-US" xlink:label="lab_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments In And Advances To Affiliates, At Fair Value, Advances (Repayments)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments" xlink:href="cron-20201231.xsd#cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments" xlink:to="lab_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_LoanReceivableNameDomain_d14cad48-e78c-438a-a3e7-94ff8d5a6138_terseLabel_en-US" xlink:label="lab_cron_LoanReceivableNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan Receivable, Name [Domain]</link:label>
    <link:label id="lab_cron_LoanReceivableNameDomain_label_en-US" xlink:label="lab_cron_LoanReceivableNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan Receivable, Name [Domain]</link:label>
    <link:label id="lab_cron_LoanReceivableNameDomain_documentation_en-US" xlink:label="lab_cron_LoanReceivableNameDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Loan Receivable, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LoanReceivableNameDomain" xlink:href="cron-20201231.xsd#cron_LoanReceivableNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_LoanReceivableNameDomain" xlink:to="lab_cron_LoanReceivableNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_a0fa3cc5-d6f7-4fdf-8b9b-9dc790589e4b_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_586a7552-7b09-449e-8bea-2389923f94eb_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_FinancingReceivableAdditionalFaceAmountIncludingThirdPartyAmount_0fc6f071-0c34-48d6-91aa-e7d0476f226e_terseLabel_en-US" xlink:label="lab_cron_FinancingReceivableAdditionalFaceAmountIncludingThirdPartyAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional principal amount</link:label>
    <link:label id="lab_cron_FinancingReceivableAdditionalFaceAmountIncludingThirdPartyAmount_label_en-US" xlink:label="lab_cron_FinancingReceivableAdditionalFaceAmountIncludingThirdPartyAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Additional Face Amount, Including Third Party Amount</link:label>
    <link:label id="lab_cron_FinancingReceivableAdditionalFaceAmountIncludingThirdPartyAmount_documentation_en-US" xlink:label="lab_cron_FinancingReceivableAdditionalFaceAmountIncludingThirdPartyAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Additional Face Amount, Including Third Party Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableAdditionalFaceAmountIncludingThirdPartyAmount" xlink:href="cron-20201231.xsd#cron_FinancingReceivableAdditionalFaceAmountIncludingThirdPartyAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_FinancingReceivableAdditionalFaceAmountIncludingThirdPartyAmount" xlink:to="lab_cron_FinancingReceivableAdditionalFaceAmountIncludingThirdPartyAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_50fe1d1c-a550-4792-a858-d535b89c3fdb_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred tax liability</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilities" xlink:to="lab_us-gaap_DeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_db68dcbb-c90b-488c-a254-1f4809ef381d_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]</link:label>
    <link:label id="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_label_en-US" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_c5f534f5-9683-4eec-9b43-2e4cc98a7be9_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_DebtInstrumentPastDueAdditionalInterestRateStatedPercentage_98892edd-f072-4752-98fb-47907280a103_terseLabel_en-US" xlink:label="lab_cron_DebtInstrumentPastDueAdditionalInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional interest rate if past due</link:label>
    <link:label id="lab_cron_DebtInstrumentPastDueAdditionalInterestRateStatedPercentage_label_en-US" xlink:label="lab_cron_DebtInstrumentPastDueAdditionalInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Past Due, Additional Interest Rate, Stated Percentage</link:label>
    <link:label id="lab_cron_DebtInstrumentPastDueAdditionalInterestRateStatedPercentage_documentation_en-US" xlink:label="lab_cron_DebtInstrumentPastDueAdditionalInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Past Due, Additional Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DebtInstrumentPastDueAdditionalInterestRateStatedPercentage" xlink:href="cron-20201231.xsd#cron_DebtInstrumentPastDueAdditionalInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_DebtInstrumentPastDueAdditionalInterestRateStatedPercentage" xlink:to="lab_cron_DebtInstrumentPastDueAdditionalInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_6224fba5-fc5b-4c45-8738-d49a37385e34_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_7c3e893e-5cf4-4b96-ad27-f1754e818203_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total equity attributable to shareholders of Cronos Group</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NatureOfOperations_786c93b2-7e58-45fb-9dab-57572643652e_verboseLabel_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Background</link:label>
    <link:label id="lab_us-gaap_NatureOfOperations_label_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Operations [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NatureOfOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfOperations" xlink:to="lab_us-gaap_NatureOfOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_d4119634-8d00-48e3-b2ab-4bde1f707dc0_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration transferred</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetInterestCarryforward_2d7ce22f-bf94-47d7-bbf4-581d81157645_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetInterestCarryforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetInterestCarryforward_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetInterestCarryforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Interest Carryforward</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetInterestCarryforward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetInterestCarryforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetInterestCarryforward" xlink:to="lab_us-gaap_DeferredTaxAssetInterestCarryforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_a61cdc44-b030-4b98-9faf-9cc7e4b14f19_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of tax rates outside of Canada</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_6b0cdfc0-bac1-4de3-a12e-837eed22775d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration transferred, common shares (in shares)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:to="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_137b2fd0-870c-4a99-9879-515d1dd497b6_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_b953f673-f7f2-4e6a-8500-1a0bb164d654_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_cebbb45c-56f5-4fbf-ac32-dc05c94eba08_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of intangible assets</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_aa668a08-41b4-4347-81fa-eb13b78abef0_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of intangible assets</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_41ae7dbc-bcb1-42a4-8615-be98f6ef14b3_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted share units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax_9261eb83-9775-4c7a-b032-5f552d498a2b_verboseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from discontinued operations, net of income taxes</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax_9e194140-e860-4224-a0c3-a2b38e5cfcf1_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OGBC income (loss) from discontinued operations, net of income taxes</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax" xlink:to="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_50f3ada5-e0ec-4d80-8fce-b2649beb7424_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_AltriaInvestmentMember_6a7655ee-460a-4483-84a2-1486fb077642_terseLabel_en-US" xlink:label="lab_cron_AltriaInvestmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Altria Investment</link:label>
    <link:label id="lab_cron_AltriaInvestmentMember_label_en-US" xlink:label="lab_cron_AltriaInvestmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Altria Investment [Member]</link:label>
    <link:label id="lab_cron_AltriaInvestmentMember_documentation_en-US" xlink:label="lab_cron_AltriaInvestmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Altria Investment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaInvestmentMember" xlink:href="cron-20201231.xsd#cron_AltriaInvestmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_AltriaInvestmentMember" xlink:to="lab_cron_AltriaInvestmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_93498405-18d7-48b1-8d57-a91c2667653c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-deductible expenses</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_f50937ed-a094-4f2c-b418-d632bf072251_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_OfficeAndGeneralExpense_c86f4dbc-d666-4ccf-b08a-bfcead3ba5c3_terseLabel_en-US" xlink:label="lab_cron_OfficeAndGeneralExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office and general</link:label>
    <link:label id="lab_cron_OfficeAndGeneralExpense_label_en-US" xlink:label="lab_cron_OfficeAndGeneralExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office And General Expense</link:label>
    <link:label id="lab_cron_OfficeAndGeneralExpense_documentation_en-US" xlink:label="lab_cron_OfficeAndGeneralExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office And General Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_OfficeAndGeneralExpense" xlink:href="cron-20201231.xsd#cron_OfficeAndGeneralExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_OfficeAndGeneralExpense" xlink:to="lab_cron_OfficeAndGeneralExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_b946d7d2-0e4a-4934-bea1-c1abf8c3ec04_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term lease cost</link:label>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_label_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermLeaseCost" xlink:to="lab_us-gaap_ShortTermLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsPolicyTextBlock_20aebf57-9c31-4370-b199-5e9246dc6d14_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for sale and discontinued operations</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsPolicyTextBlock" xlink:to="lab_us-gaap_DiscontinuedOperationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_41b64c00-7e0c-454c-b91b-ff67f86576af_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_StockIssuedDuringPeriodValueTopupRightsExercised_42cb6c26-6c6e-4454-ba1f-efe3c2731c55_terseLabel_en-US" xlink:label="lab_cron_StockIssuedDuringPeriodValueTopupRightsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Top-up Rights exercised</link:label>
    <link:label id="lab_cron_StockIssuedDuringPeriodValueTopupRightsExercised_label_en-US" xlink:label="lab_cron_StockIssuedDuringPeriodValueTopupRightsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Top-up Rights Exercised</link:label>
    <link:label id="lab_cron_StockIssuedDuringPeriodValueTopupRightsExercised_documentation_en-US" xlink:label="lab_cron_StockIssuedDuringPeriodValueTopupRightsExercised" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Top-up Rights Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_StockIssuedDuringPeriodValueTopupRightsExercised" xlink:href="cron-20201231.xsd#cron_StockIssuedDuringPeriodValueTopupRightsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_StockIssuedDuringPeriodValueTopupRightsExercised" xlink:to="lab_cron_StockIssuedDuringPeriodValueTopupRightsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset_f84549c8-dd76-4654-b382-0240d1696c2a_negatedTerseLabel_en-US" xlink:label="lab_cron_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets</link:label>
    <link:label id="lab_cron_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_cron_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Operating Lease, Right-Of-Use Asset</link:label>
    <link:label id="lab_cron_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset_documentation_en-US" xlink:label="lab_cron_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Operating Lease, Right-Of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset" xlink:href="cron-20201231.xsd#cron_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset" xlink:to="lab_cron_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_575dc86b-34d4-40b1-96d2-37adaf067f58_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_34966eff-1349-403b-a826-64b224f2f401_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="lab_us-gaap_LiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_ProceedsFromRightExercises_95bd6638-ca89-43af-be7f-d9130da12698_terseLabel_en-US" xlink:label="lab_cron_ProceedsFromRightExercises" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercise of Top-up Rights</link:label>
    <link:label id="lab_cron_ProceedsFromRightExercises_label_en-US" xlink:label="lab_cron_ProceedsFromRightExercises" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Right Exercises</link:label>
    <link:label id="lab_cron_ProceedsFromRightExercises_documentation_en-US" xlink:label="lab_cron_ProceedsFromRightExercises" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Right Exercises</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ProceedsFromRightExercises" xlink:href="cron-20201231.xsd#cron_ProceedsFromRightExercises"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_ProceedsFromRightExercises" xlink:to="lab_cron_ProceedsFromRightExercises" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_24b0cfeb-b631-469c-859b-1ba33442bccd_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_69047b1c-babb-40b2-96c4-7ab90a535348_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember" xlink:to="lab_us-gaap_ConstructionInProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_a29ce86c-541a-43b4-a6a1-701a7fcd8692_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock_167f26ce-b6fe-402d-8bf6-91189aba6631_terseLabel_en-US" xlink:label="lab_cron_SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Sensitivity Analysis</link:label>
    <link:label id="lab_cron_SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock_label_en-US" xlink:label="lab_cron_SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sensitivity Analysis, Impact On Net Income (Loss) [Table Text Block]</link:label>
    <link:label id="lab_cron_SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock_documentation_en-US" xlink:label="lab_cron_SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sensitivity Analysis, Impact On Net Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock" xlink:href="cron-20201231.xsd#cron_SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock" xlink:to="lab_cron_SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_862c3fb4-ac02-4071-bb61-dd2eec92ad0f_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_69f2e9c4-632e-4d32-91c9-12be4c1fbb88_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_2b539fbe-322e-4cd9-8975-4ed5c86fbbf7_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_57e7cc24-1b98-4cd6-857d-976e124c4e27_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableRelatedPartiesCurrent_2ff42aea-214c-4498-892a-15253ebf549e_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrual for consulting services</link:label>
    <link:label id="lab_us-gaap_AccountsPayableRelatedPartiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Related Parties, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:to="lab_us-gaap_AccountsPayableRelatedPartiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_CommonStockVestingRightsNumberOfEqualInstallments_dab9cdc3-566e-472e-9ea9-f5cc915ffbde_terseLabel_en-US" xlink:label="lab_cron_CommonStockVestingRightsNumberOfEqualInstallments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, vesting rights, number of equal installments</link:label>
    <link:label id="lab_cron_CommonStockVestingRightsNumberOfEqualInstallments_label_en-US" xlink:label="lab_cron_CommonStockVestingRightsNumberOfEqualInstallments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Vesting Rights, Number Of Equal Installments</link:label>
    <link:label id="lab_cron_CommonStockVestingRightsNumberOfEqualInstallments_documentation_en-US" xlink:label="lab_cron_CommonStockVestingRightsNumberOfEqualInstallments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Vesting Rights, Number Of Equal Installments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CommonStockVestingRightsNumberOfEqualInstallments" xlink:href="cron-20201231.xsd#cron_CommonStockVestingRightsNumberOfEqualInstallments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_CommonStockVestingRightsNumberOfEqualInstallments" xlink:to="lab_cron_CommonStockVestingRightsNumberOfEqualInstallments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_2481bc1b-48e5-469e-9359-958c81d078f0_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_9eabf9a0-2daa-4133-a657-80b7b686c07e_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_bd8794fa-cfce-4400-8321-7d4d89eda406_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_478b4bf0-6465-468b-9f0b-b5966570f55b_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-controlling interests</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_53551104-b270-40fe-8fbf-5274619bfe57_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_6114494b-1f83-4ba9-8f2a-bd2cd0b38727_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_0983ac5c-1c8c-4072-b381-17525b7e0403_verboseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurposing charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_af42b638-abfa-4eac-9dfc-da141c3ca1eb_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_efa556d8-7563-4e7a-be41-022d29f1ee71_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_ff01a27e-362a-4d45-af76-83dcc75ef929_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b51cb577-b1ae-430c-8a6f-8c614522493c_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_012d6dec-3067-488e-ab14-de419c5a5f4b_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contribution by non-controlling interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase from Subsidiary Equity Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:to="lab_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_a5d9e467-6221-4caa-887c-ec683b893001_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_a82c89e2-b9a3-49e8-b97a-95b674909807_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_FourMajorCustomersMember_c53b85ce-e302-4294-856a-372335c15554_terseLabel_en-US" xlink:label="lab_cron_FourMajorCustomersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Four Major Customers</link:label>
    <link:label id="lab_cron_FourMajorCustomersMember_label_en-US" xlink:label="lab_cron_FourMajorCustomersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Four Major Customers [Member]</link:label>
    <link:label id="lab_cron_FourMajorCustomersMember_documentation_en-US" xlink:label="lab_cron_FourMajorCustomersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Four Major Customers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FourMajorCustomersMember" xlink:href="cron-20201231.xsd#cron_FourMajorCustomersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_FourMajorCustomersMember" xlink:to="lab_cron_FourMajorCustomersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_StockIssuedDuringPeriodValueWarrantsExercised_874fdbf2-46fd-4ca9-93fd-07e4dbac1193_terseLabel_en-US" xlink:label="lab_cron_StockIssuedDuringPeriodValueWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants exercised</link:label>
    <link:label id="lab_cron_StockIssuedDuringPeriodValueWarrantsExercised_label_en-US" xlink:label="lab_cron_StockIssuedDuringPeriodValueWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Warrants Exercised</link:label>
    <link:label id="lab_cron_StockIssuedDuringPeriodValueWarrantsExercised_documentation_en-US" xlink:label="lab_cron_StockIssuedDuringPeriodValueWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Warrants Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_StockIssuedDuringPeriodValueWarrantsExercised" xlink:href="cron-20201231.xsd#cron_StockIssuedDuringPeriodValueWarrantsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_StockIssuedDuringPeriodValueWarrantsExercised" xlink:to="lab_cron_StockIssuedDuringPeriodValueWarrantsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_1190bbaf-708e-4a68-9644-137efa70a283_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_OtherCountriesMember_04c24576-68fc-47ac-a3c2-c6e1d397b95a_terseLabel_en-US" xlink:label="lab_cron_OtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other countries</link:label>
    <link:label id="lab_cron_OtherCountriesMember_label_en-US" xlink:label="lab_cron_OtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Countries [Member]</link:label>
    <link:label id="lab_cron_OtherCountriesMember_documentation_en-US" xlink:label="lab_cron_OtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Countries [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_OtherCountriesMember" xlink:href="cron-20201231.xsd#cron_OtherCountriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_OtherCountriesMember" xlink:to="lab_cron_OtherCountriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplierConcentrationRiskMember_31dfc52f-effb-4f47-889a-b1950840f3e5_terseLabel_en-US" xlink:label="lab_us-gaap_SupplierConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier Concentration Risk</link:label>
    <link:label id="lab_us-gaap_SupplierConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_SupplierConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierConcentrationRiskMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplierConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplierConcentrationRiskMember" xlink:to="lab_us-gaap_SupplierConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_LongTermPurchaseCommitmentNumberOfTargetedUnitsToDevelopProduction_9acc7bd4-c41a-41d0-9eda-4bde11ae003a_terseLabel_en-US" xlink:label="lab_cron_LongTermPurchaseCommitmentNumberOfTargetedUnitsToDevelopProduction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of cannabinoids targeted to develop scalable and consistent production</link:label>
    <link:label id="lab_cron_LongTermPurchaseCommitmentNumberOfTargetedUnitsToDevelopProduction_label_en-US" xlink:label="lab_cron_LongTermPurchaseCommitmentNumberOfTargetedUnitsToDevelopProduction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Purchase Commitment, Number Of Targeted Units to Develop Production</link:label>
    <link:label id="lab_cron_LongTermPurchaseCommitmentNumberOfTargetedUnitsToDevelopProduction_documentation_en-US" xlink:label="lab_cron_LongTermPurchaseCommitmentNumberOfTargetedUnitsToDevelopProduction" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Purchase Commitment, Number Of Targeted Units to Develop Production</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LongTermPurchaseCommitmentNumberOfTargetedUnitsToDevelopProduction" xlink:href="cron-20201231.xsd#cron_LongTermPurchaseCommitmentNumberOfTargetedUnitsToDevelopProduction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_LongTermPurchaseCommitmentNumberOfTargetedUnitsToDevelopProduction" xlink:to="lab_cron_LongTermPurchaseCommitmentNumberOfTargetedUnitsToDevelopProduction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IsraelTaxAuthorityMember_7fd05dc5-e93d-40fe-bb74-d2b78cd623ac_terseLabel_en-US" xlink:label="lab_us-gaap_IsraelTaxAuthorityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Israel</link:label>
    <link:label id="lab_us-gaap_IsraelTaxAuthorityMember_label_en-US" xlink:label="lab_us-gaap_IsraelTaxAuthorityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Israel Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IsraelTaxAuthorityMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IsraelTaxAuthorityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IsraelTaxAuthorityMember" xlink:to="lab_us-gaap_IsraelTaxAuthorityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember_0dd42ac5-b268-439f-9402-1d4945d6aecd_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee or Group of Investees [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember" xlink:to="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansReceivableMember_7593fecc-b794-4f21-8a29-8a04b62d1e35_terseLabel_en-US" xlink:label="lab_us-gaap_LoansReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Receivable</link:label>
    <link:label id="lab_us-gaap_LoansReceivableMember_label_en-US" xlink:label="lab_us-gaap_LoansReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansReceivableMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansReceivableMember" xlink:to="lab_us-gaap_LoansReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_60a90d64-266b-4871-a16d-0e6ce0f12fe8_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_8acee029-52f2-48eb-b0e8-52345aeb9a2c_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share capital</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_c007878b-7d53-4f84-9630-1a36ee013985_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Shares</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_5eec7ddf-1181-46c0-8efc-7c0ec3415689_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_963a207e-c660-40ab-b412-8f80eaecf527_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net foreign exchange gain (loss) on translation of foreign operations</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_OtherComprehensiveIncomeLossAccumulatedGainLossDebtSecuritiesRevaluationAndDisposalOfOtherInvestments_13661598-8aec-409f-b530-1d7aea92c7a9_terseLabel_en-US" xlink:label="lab_cron_OtherComprehensiveIncomeLossAccumulatedGainLossDebtSecuritiesRevaluationAndDisposalOfOtherInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on revaluation and disposal of other investments, net of tax</link:label>
    <link:label id="lab_cron_OtherComprehensiveIncomeLossAccumulatedGainLossDebtSecuritiesRevaluationAndDisposalOfOtherInvestments_label_en-US" xlink:label="lab_cron_OtherComprehensiveIncomeLossAccumulatedGainLossDebtSecuritiesRevaluationAndDisposalOfOtherInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss),Accumulated Gain (Loss), Debt Securities, Revaluation And Disposal Of Other Investments</link:label>
    <link:label id="lab_cron_OtherComprehensiveIncomeLossAccumulatedGainLossDebtSecuritiesRevaluationAndDisposalOfOtherInvestments_documentation_en-US" xlink:label="lab_cron_OtherComprehensiveIncomeLossAccumulatedGainLossDebtSecuritiesRevaluationAndDisposalOfOtherInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss),Accumulated Gain (Loss), Debt Securities, Revaluation And Disposal Of Other Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_OtherComprehensiveIncomeLossAccumulatedGainLossDebtSecuritiesRevaluationAndDisposalOfOtherInvestments" xlink:href="cron-20201231.xsd#cron_OtherComprehensiveIncomeLossAccumulatedGainLossDebtSecuritiesRevaluationAndDisposalOfOtherInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_OtherComprehensiveIncomeLossAccumulatedGainLossDebtSecuritiesRevaluationAndDisposalOfOtherInvestments" xlink:to="lab_cron_OtherComprehensiveIncomeLossAccumulatedGainLossDebtSecuritiesRevaluationAndDisposalOfOtherInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_d923a696-1126-4c59-bd7d-8bc3b8f31fd2_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonmonetaryTransactionTypeDomain_3353c170-66e8-4f07-b54e-ce1eb11f059b_terseLabel_en-US" xlink:label="lab_us-gaap_NonmonetaryTransactionTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonmonetary Transaction Type [Domain]</link:label>
    <link:label id="lab_us-gaap_NonmonetaryTransactionTypeDomain_label_en-US" xlink:label="lab_us-gaap_NonmonetaryTransactionTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonmonetary Transaction Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonmonetaryTransactionTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonmonetaryTransactionTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonmonetaryTransactionTypeDomain" xlink:to="lab_us-gaap_NonmonetaryTransactionTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_dd35721b-1d8a-4056-8c73-486e4c08f10e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected annualized volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts_dd93f437-e791-4607-91d9-0880735abc57_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_ec532d9d-d380-458f-9141-072c65b2e7af_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_label_en-US" xlink:label="lab_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xlink:to="lab_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredDebtMember_c8d30acf-403d-43af-8a2e-95ee94f31dd5_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction Loans</link:label>
    <link:label id="lab_us-gaap_SecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebtMember" xlink:to="lab_us-gaap_SecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonmonetaryTransactionsAbstract_53c78301-1200-40b7-be0a-2b72567e9f50_terseLabel_en-US" xlink:label="lab_us-gaap_NonmonetaryTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonmonetary Transactions [Abstract]</link:label>
    <link:label id="lab_us-gaap_NonmonetaryTransactionsAbstract_label_en-US" xlink:label="lab_us-gaap_NonmonetaryTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonmonetary Transactions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonmonetaryTransactionsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonmonetaryTransactionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonmonetaryTransactionsAbstract" xlink:to="lab_us-gaap_NonmonetaryTransactionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_4ba809e9-99d5-4025-9665-735f67d44f10_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_FinancingReceivableFundingCommitmentPercentage_2a8c447e-6bcb-4909-89d1-726dcc76ebd9_terseLabel_en-US" xlink:label="lab_cron_FinancingReceivableFundingCommitmentPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funding commitment percentage</link:label>
    <link:label id="lab_cron_FinancingReceivableFundingCommitmentPercentage_label_en-US" xlink:label="lab_cron_FinancingReceivableFundingCommitmentPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Funding Commitment Percentage</link:label>
    <link:label id="lab_cron_FinancingReceivableFundingCommitmentPercentage_documentation_en-US" xlink:label="lab_cron_FinancingReceivableFundingCommitmentPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Funding Commitment Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableFundingCommitmentPercentage" xlink:href="cron-20201231.xsd#cron_FinancingReceivableFundingCommitmentPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_FinancingReceivableFundingCommitmentPercentage" xlink:to="lab_cron_FinancingReceivableFundingCommitmentPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_30bb15b6-52ad-43d4-9188-0c97199b9e18_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark</link:label>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_label_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetMember" xlink:to="lab_us-gaap_SalesRevenueNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementDomain_25edefc7-69ed-4483-bdb7-c87d45598a2d_terseLabel_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement [Domain]</link:label>
    <link:label id="lab_srt_RestatementDomain_label_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementDomain" xlink:to="lab_srt_RestatementDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_c37e9bd5-7de0-4537-b1f3-b13fb73a5480_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_7e696072-9f5d-44f7-ba29-2bfc821a0744_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_AuroraCannabisInc.Member_1e64ef73-b8fb-4949-b794-c61d29b5a114_terseLabel_en-US" xlink:label="lab_cron_AuroraCannabisInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aurora</link:label>
    <link:label id="lab_cron_AuroraCannabisInc.Member_label_en-US" xlink:label="lab_cron_AuroraCannabisInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aurora Cannabis Inc. [Member]</link:label>
    <link:label id="lab_cron_AuroraCannabisInc.Member_documentation_en-US" xlink:label="lab_cron_AuroraCannabisInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aurora Cannabis Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AuroraCannabisInc.Member" xlink:href="cron-20201231.xsd#cron_AuroraCannabisInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_AuroraCannabisInc.Member" xlink:to="lab_cron_AuroraCannabisInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_AdditionalPaidinCapitalAttributableToConvertibleOptionMember_f369363a-76b3-4229-9295-58e9c5537c08_terseLabel_en-US" xlink:label="lab_cron_AdditionalPaidinCapitalAttributableToConvertibleOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:label id="lab_cron_AdditionalPaidinCapitalAttributableToConvertibleOptionMember_label_en-US" xlink:label="lab_cron_AdditionalPaidinCapitalAttributableToConvertibleOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital, Attributable To Convertible Option [Member]</link:label>
    <link:label id="lab_cron_AdditionalPaidinCapitalAttributableToConvertibleOptionMember_documentation_en-US" xlink:label="lab_cron_AdditionalPaidinCapitalAttributableToConvertibleOptionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital, Attributable To Convertible Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AdditionalPaidinCapitalAttributableToConvertibleOptionMember" xlink:href="cron-20201231.xsd#cron_AdditionalPaidinCapitalAttributableToConvertibleOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_AdditionalPaidinCapitalAttributableToConvertibleOptionMember" xlink:to="lab_cron_AdditionalPaidinCapitalAttributableToConvertibleOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_CollaborativeArrangementPercentageOfProfitsToBeReceived_546c1d7a-a714-4794-954c-75a9da712f35_terseLabel_en-US" xlink:label="lab_cron_CollaborativeArrangementPercentageOfProfitsToBeReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative arrangement, percentage of profits to be received</link:label>
    <link:label id="lab_cron_CollaborativeArrangementPercentageOfProfitsToBeReceived_label_en-US" xlink:label="lab_cron_CollaborativeArrangementPercentageOfProfitsToBeReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Percentage Of Profits To Be Received</link:label>
    <link:label id="lab_cron_CollaborativeArrangementPercentageOfProfitsToBeReceived_documentation_en-US" xlink:label="lab_cron_CollaborativeArrangementPercentageOfProfitsToBeReceived" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Percentage Of Profits To Be Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CollaborativeArrangementPercentageOfProfitsToBeReceived" xlink:href="cron-20201231.xsd#cron_CollaborativeArrangementPercentageOfProfitsToBeReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_CollaborativeArrangementPercentageOfProfitsToBeReceived" xlink:to="lab_cron_CollaborativeArrangementPercentageOfProfitsToBeReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_f38893ed-ba2a-4f86-8108-43e8ee3adca6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductAndServiceOtherMember_e01cfc22-38d5-4c8d-9e8b-593b9196d348_terseLabel_en-US" xlink:label="lab_us-gaap_ProductAndServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_ProductAndServiceOtherMember_label_en-US" xlink:label="lab_us-gaap_ProductAndServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductAndServiceOtherMember" xlink:to="lab_us-gaap_ProductAndServiceOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_41209c21-1b78-4fc2-8f3d-ee2ca89c67d1_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_f8b1e33f-5090-4294-8ffe-b2e4cd26cb21_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_bb310e26-5803-4995-bfde-f37a0173f64e_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_6d705735-b85b-49c6-9c78-a0b2bc8efa06_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_9e08f590-379b-4366-a3d3-e9a7b21d1cff_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other income (expense)</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_81f2d874-9b20-4337-869d-8ace6beade16_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (loss)</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_7ae339c6-e11a-4073-b9b9-965887ab0a58_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_label_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNatureDomain" xlink:to="lab_us-gaap_LossContingencyNatureDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_d3b67bdf-deab-4d98-bed4-f439feb3e81d_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_168002e2-6a02-4044-9ab7-403851d06477_terseLabel_en-US" xlink:label="lab_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average grant date fair value (C$)</link:label>
    <link:label id="lab_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_6266716c-0ca8-4069-8949-c80d1a3b6e8a_verboseLabel_en-US" xlink:label="lab_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial liability</link:label>
    <link:label id="lab_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_label_en-US" xlink:label="lab_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Share-based Arrangements, Liability [Roll Forward]</link:label>
    <link:label id="lab_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_documentation_en-US" xlink:label="lab_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Share-based Arrangements, Liability [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward" xlink:href="cron-20201231.xsd#cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward" xlink:to="lab_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_FinancingReceivableDueOnDemandTerm_2b37e74d-0b26-40d1-9386-19ec2b48cd91_terseLabel_en-US" xlink:label="lab_cron_FinancingReceivableDueOnDemandTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due on demand, term</link:label>
    <link:label id="lab_cron_FinancingReceivableDueOnDemandTerm_label_en-US" xlink:label="lab_cron_FinancingReceivableDueOnDemandTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Due On Demand, Term</link:label>
    <link:label id="lab_cron_FinancingReceivableDueOnDemandTerm_documentation_en-US" xlink:label="lab_cron_FinancingReceivableDueOnDemandTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Due On Demand, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableDueOnDemandTerm" xlink:href="cron-20201231.xsd#cron_FinancingReceivableDueOnDemandTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_FinancingReceivableDueOnDemandTerm" xlink:to="lab_cron_FinancingReceivableDueOnDemandTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_0a2fc127-e906-476c-98ee-5bc1fd0ba90c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange gain (loss) on translation</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_ebdb736f-8416-46f3-b245-f45125e995b4_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange gain (loss) on translation</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_TwoMajorCustomersMember_ff2ebee4-e48a-458b-9f05-b65e0ed40e73_verboseLabel_en-US" xlink:label="lab_cron_TwoMajorCustomersMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Customers</link:label>
    <link:label id="lab_cron_TwoMajorCustomersMember_37e83ccc-feb5-4f8e-9a38-6d2caedb9d3a_terseLabel_en-US" xlink:label="lab_cron_TwoMajorCustomersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Major Customers</link:label>
    <link:label id="lab_cron_TwoMajorCustomersMember_label_en-US" xlink:label="lab_cron_TwoMajorCustomersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Major Customers [Member]</link:label>
    <link:label id="lab_cron_TwoMajorCustomersMember_documentation_en-US" xlink:label="lab_cron_TwoMajorCustomersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Major Customers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_TwoMajorCustomersMember" xlink:href="cron-20201231.xsd#cron_TwoMajorCustomersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_TwoMajorCustomersMember" xlink:to="lab_cron_TwoMajorCustomersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableNumberOfShares_31ac95fb-7144-4d2a-860e-e24738da471a_terseLabel_en-US" xlink:label="lab_cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common shares issuable (up to) (in shares)</link:label>
    <link:label id="lab_cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableNumberOfShares_label_en-US" xlink:label="lab_cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Purchase Commitment, Equity Interest Issued Or Issuable, Number Of Shares</link:label>
    <link:label id="lab_cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableNumberOfShares_documentation_en-US" xlink:label="lab_cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Purchase Commitment, Equity Interest Issued Or Issuable, Number Of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableNumberOfShares" xlink:href="cron-20201231.xsd#cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableNumberOfShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableNumberOfShares" xlink:to="lab_cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableNumberOfShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExciseAndSalesTaxes_71d87358-ed8f-4468-a54a-0ac75df49e50_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ExciseAndSalesTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excise taxes</link:label>
    <link:label id="lab_us-gaap_ExciseAndSalesTaxes_label_en-US" xlink:label="lab_us-gaap_ExciseAndSalesTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excise and Sales Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExciseAndSalesTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExciseAndSalesTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExciseAndSalesTaxes" xlink:to="lab_us-gaap_ExciseAndSalesTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_44029366-beed-4b68-96f6-b79d264a3ddf_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_f2bb56ca-c113-4151-a68a-add1819c6d21_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership Interest</link:label>
    <link:label id="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_label_en-US" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" xlink:to="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipDomain_1c5eec8e-cf9e-4428-bb69-41fa03e6bd0b_terseLabel_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:label id="lab_srt_OwnershipDomain_label_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain" xlink:to="lab_srt_OwnershipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonmonetaryTransactionTypeAxis_d48393e3-5c33-4448-830b-99e29ba8bee4_terseLabel_en-US" xlink:label="lab_us-gaap_NonmonetaryTransactionTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonmonetary Transaction Type [Axis]</link:label>
    <link:label id="lab_us-gaap_NonmonetaryTransactionTypeAxis_label_en-US" xlink:label="lab_us-gaap_NonmonetaryTransactionTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonmonetary Transaction Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonmonetaryTransactionTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonmonetaryTransactionTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonmonetaryTransactionTypeAxis" xlink:to="lab_us-gaap_NonmonetaryTransactionTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_FinancingReceivableFaceAmountIncludingThirdPartyAmount_dd8003d8-0a39-4567-9b04-7ec5d904a078_terseLabel_en-US" xlink:label="lab_cron_FinancingReceivableFaceAmountIncludingThirdPartyAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total aggregate principal amount</link:label>
    <link:label id="lab_cron_FinancingReceivableFaceAmountIncludingThirdPartyAmount_label_en-US" xlink:label="lab_cron_FinancingReceivableFaceAmountIncludingThirdPartyAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Face Amount, Including Third Party Amount</link:label>
    <link:label id="lab_cron_FinancingReceivableFaceAmountIncludingThirdPartyAmount_documentation_en-US" xlink:label="lab_cron_FinancingReceivableFaceAmountIncludingThirdPartyAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Face Amount, Including Third Party Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableFaceAmountIncludingThirdPartyAmount" xlink:href="cron-20201231.xsd#cron_FinancingReceivableFaceAmountIncludingThirdPartyAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_FinancingReceivableFaceAmountIncludingThirdPartyAmount" xlink:to="lab_cron_FinancingReceivableFaceAmountIncludingThirdPartyAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableValueAssigned_5722fd85-0b97-4850-b426-10d1e0a1a79a_terseLabel_en-US" xlink:label="lab_cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableValueAssigned" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common shares issuable, value assigned</link:label>
    <link:label id="lab_cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableValueAssigned_label_en-US" xlink:label="lab_cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableValueAssigned" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Purchase Commitment, Equity Interest Issued Or Issuable, Value Assigned</link:label>
    <link:label id="lab_cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableValueAssigned_documentation_en-US" xlink:label="lab_cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableValueAssigned" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Purchase Commitment, Equity Interest Issued Or Issuable, Value Assigned</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableValueAssigned" xlink:href="cron-20201231.xsd#cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableValueAssigned"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableValueAssigned" xlink:to="lab_cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableValueAssigned" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6ca3d6e2-0432-43d0-83fa-fa0c29942314_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total shareholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1a0943c2-0a38-47c0-9597-3ab4dbe4f48d_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c350b6d1-93bb-4584-8139-f426cacbe114_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_2bac4d17-3b0d-446e-ae49-c594fe284582_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_96677385-686c-4ed7-978c-a48b1e67f022_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_7dd16f4f-aed7-49d4-a33f-7cb4ed5582dd_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_dd646bb9-b282-4c30-89a2-673c19e332ea_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted earnings (loss) per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_a5c9e3db-c166-492e-b252-70a39de63e4b_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityLineItems" xlink:to="lab_us-gaap_VariableInterestEntityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock_6006f35e-7798-4d47-8508-d8c2bcd9c3c6_terseLabel_en-US" xlink:label="lab_us-gaap_LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan Receivable</link:label>
    <link:label id="lab_us-gaap_LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock_label_en-US" xlink:label="lab_us-gaap_LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans, Notes, Trade and Other Receivables, Excluding Allowance for Credit Losses [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock" xlink:to="lab_us-gaap_LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_47d31600-77c3-4e58-8a46-a0fe3a93037d_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_label_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfArrangementAxis" xlink:to="lab_us-gaap_TypeOfArrangementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_13f384b0-ee01-45ff-b459-b5ba29f495da_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_96d1c1b5-86e3-45f8-9704-aeec42361ebe_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration transferred, common shares, amount</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Equity Interests Issued and Issuable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise_0ce5bc96-39e7-4726-a40f-6204c46c38c6_terseLabel_en-US" xlink:label="lab_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise price, volume-weighted average price, measurement period, days preceding exercise</link:label>
    <link:label id="lab_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise_label_en-US" xlink:label="lab_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Exercise Price, Volume-Weighted Average Price, Measurement Period, Days Preceding Exercise</link:label>
    <link:label id="lab_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise_documentation_en-US" xlink:label="lab_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Exercise Price, Volume-Weighted Average Price, Measurement Period, Days Preceding Exercise</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise" xlink:href="cron-20201231.xsd#cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise" xlink:to="lab_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_523e1b15-6798-4cf3-a5d7-43d256beb02b_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic earnings (loss) per share computation</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_82c4dd30-2820-43c3-9c13-38d4487b74c7_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_OtherCostOfGoodsAndServicesSold_ffc752d1-042e-43e2-8214-8c72d987c05c_terseLabel_en-US" xlink:label="lab_cron_OtherCostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_cron_OtherCostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_cron_OtherCostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Cost Of Goods And Services Sold</link:label>
    <link:label id="lab_cron_OtherCostOfGoodsAndServicesSold_documentation_en-US" xlink:label="lab_cron_OtherCostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Cost Of Goods And Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_OtherCostOfGoodsAndServicesSold" xlink:href="cron-20201231.xsd#cron_OtherCostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_OtherCostOfGoodsAndServicesSold" xlink:to="lab_cron_OtherCostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, All Other Investments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:to="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_8fce175c-e905-4701-9ced-15d2dd408ad6_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_be7366f3-5ec9-4564-8e93-4c04359e9c9b_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_ef929c98-3445-41eb-a0ea-0eb090844b38_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro forma revenue</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_792b927e-c052-4b9c-911a-eb9807460f96_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_b8644970-5d74-4da5-87d7-621a75934177_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Reconciliation of Carrying Amounts</link:label>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" xlink:to="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_03b20432-f7da-4308-98ae-d5ae5c748a04_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of assets held-for-sale</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Long-Lived Assets to be Disposed of</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:to="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_StockIssuedDuringPeriodNewIssuesFairValue_2c2a6181-a2b3-4d28-af26-d10171737aff_terseLabel_en-US" xlink:label="lab_cron_StockIssuedDuringPeriodNewIssuesFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock issued during period, new issues, fair value</link:label>
    <link:label id="lab_cron_StockIssuedDuringPeriodNewIssuesFairValue_label_en-US" xlink:label="lab_cron_StockIssuedDuringPeriodNewIssuesFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, New Issues, Fair Value</link:label>
    <link:label id="lab_cron_StockIssuedDuringPeriodNewIssuesFairValue_documentation_en-US" xlink:label="lab_cron_StockIssuedDuringPeriodNewIssuesFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, New Issues, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_StockIssuedDuringPeriodNewIssuesFairValue" xlink:href="cron-20201231.xsd#cron_StockIssuedDuringPeriodNewIssuesFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_StockIssuedDuringPeriodNewIssuesFairValue" xlink:to="lab_cron_StockIssuedDuringPeriodNewIssuesFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss_73d8eff2-929b-4b91-882f-1e7fa4dbd82b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of FX</link:label>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss_label_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Gain (Loss) Included in Other Comprehensive Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:to="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_d7d115bc-5eb4-46a6-8db4-0f74ab5e5980_negatedLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_GinkgoEquityMilestonesMember_fb346dea-2a46-4964-b58c-b3721fd938af_terseLabel_en-US" xlink:label="lab_cron_GinkgoEquityMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ginkgo Equity Milestones</link:label>
    <link:label id="lab_cron_GinkgoEquityMilestonesMember_label_en-US" xlink:label="lab_cron_GinkgoEquityMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ginkgo Equity Milestones [Member]</link:label>
    <link:label id="lab_cron_GinkgoEquityMilestonesMember_documentation_en-US" xlink:label="lab_cron_GinkgoEquityMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ginkgo Equity Milestones [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_GinkgoEquityMilestonesMember" xlink:href="cron-20201231.xsd#cron_GinkgoEquityMilestonesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_GinkgoEquityMilestonesMember" xlink:to="lab_cron_GinkgoEquityMilestonesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_a13daf99-6804-4e02-a254-6e018649af6b_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_7bf1d88f-d2f9-4b17-89a5-224001ad3457_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-controlling interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_RedwoodHoldingGroupLLCMember_c3d90cec-ce47-4732-b8b7-5e1acbdc45b9_terseLabel_en-US" xlink:label="lab_cron_RedwoodHoldingGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redwood</link:label>
    <link:label id="lab_cron_RedwoodHoldingGroupLLCMember_label_en-US" xlink:label="lab_cron_RedwoodHoldingGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redwood Holding Group, LLC [Member]</link:label>
    <link:label id="lab_cron_RedwoodHoldingGroupLLCMember_documentation_en-US" xlink:label="lab_cron_RedwoodHoldingGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redwood Holding Group, LLC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_RedwoodHoldingGroupLLCMember" xlink:href="cron-20201231.xsd#cron_RedwoodHoldingGroupLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_RedwoodHoldingGroupLLCMember" xlink:to="lab_cron_RedwoodHoldingGroupLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_817d5564-d750-405f-b5dc-3ba3a8f1abc6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskDisclosureTextBlock_30c0a143-9cd7-4e48-b1ae-48e166796923_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:to="lab_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fcc70614-de8c-41c7-855a-a8641b1b0c84_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_aa549f02-bfec-4fd2-8250-62bd9e19a4f5_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:to="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_0e557e64-b1ae-4295-be8c-1823d1b569ff_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and other liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_31a63113-4403-4516-b006-8fb213398951_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_FinancingReceivableInterestRateStatedPercentage_29526ee1-3041-4538-8ebf-fd4b0156a333_terseLabel_en-US" xlink:label="lab_cron_FinancingReceivableInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stated interest rate</link:label>
    <link:label id="lab_cron_FinancingReceivableInterestRateStatedPercentage_label_en-US" xlink:label="lab_cron_FinancingReceivableInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Interest Rate, Stated Percentage</link:label>
    <link:label id="lab_cron_FinancingReceivableInterestRateStatedPercentage_documentation_en-US" xlink:label="lab_cron_FinancingReceivableInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableInterestRateStatedPercentage" xlink:href="cron-20201231.xsd#cron_FinancingReceivableInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_FinancingReceivableInterestRateStatedPercentage" xlink:to="lab_cron_FinancingReceivableInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueInterestOnAdvances_0d976974-63b0-48ab-aeb2-76579784638d_terseLabel_en-US" xlink:label="lab_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueInterestOnAdvances" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest on advances</link:label>
    <link:label id="lab_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueInterestOnAdvances_label_en-US" xlink:label="lab_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueInterestOnAdvances" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments In And Advances To Affiliates, At Fair Value, Interest On Advances</link:label>
    <link:label id="lab_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueInterestOnAdvances_documentation_en-US" xlink:label="lab_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueInterestOnAdvances" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments In And Advances To Affiliates, At Fair Value, Interest On Advances</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueInterestOnAdvances" xlink:href="cron-20201231.xsd#cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueInterestOnAdvances"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueInterestOnAdvances" xlink:to="lab_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueInterestOnAdvances" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_b175590f-14b0-4098-ac48-7300a63871d5_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted earnings (loss) per share computation</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_20500a57-fea7-4338-8117-891bb4be1471_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_7dda6485-09e2-4ab0-a774-f3fa78492e1c_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_971d925b-503d-4cd8-bfd6-9463f5d38352_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_PreEmptiveRightsAndTopUpRightsMember_e1ae3100-410d-457b-89ea-ac92da4291d2_terseLabel_en-US" xlink:label="lab_cron_PreEmptiveRightsAndTopUpRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-Emptive Rights and Top-Up Rights</link:label>
    <link:label id="lab_cron_PreEmptiveRightsAndTopUpRightsMember_label_en-US" xlink:label="lab_cron_PreEmptiveRightsAndTopUpRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-Emptive Rights And Top-Up Rights [Member]</link:label>
    <link:label id="lab_cron_PreEmptiveRightsAndTopUpRightsMember_documentation_en-US" xlink:label="lab_cron_PreEmptiveRightsAndTopUpRightsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-Emptive Rights And Top-Up Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PreEmptiveRightsAndTopUpRightsMember" xlink:href="cron-20201231.xsd#cron_PreEmptiveRightsAndTopUpRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_PreEmptiveRightsAndTopUpRightsMember" xlink:to="lab_cron_PreEmptiveRightsAndTopUpRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfValuationAllowanceTextBlock_e9aadd98-fe3b-47f0-ad05-0abb7cf58e53_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Valuation Allowance</link:label>
    <link:label id="lab_us-gaap_SummaryOfValuationAllowanceTextBlock_label_en-US" xlink:label="lab_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Valuation Allowance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SummaryOfValuationAllowanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:to="lab_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringSettlementAndImpairmentProvisions_6ebb720d-3cfd-47e6-b26b-fb5ec08ff6bb_verboseLabel_en-US" xlink:label="lab_us-gaap_RestructuringSettlementAndImpairmentProvisions" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurposing charges</link:label>
    <link:label id="lab_us-gaap_RestructuringSettlementAndImpairmentProvisions_0c0ceed7-db13-4766-9de7-e30a1d1072ba_totalLabel_en-US" xlink:label="lab_us-gaap_RestructuringSettlementAndImpairmentProvisions" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurposing charges</link:label>
    <link:label id="lab_us-gaap_RestructuringSettlementAndImpairmentProvisions_label_en-US" xlink:label="lab_us-gaap_RestructuringSettlementAndImpairmentProvisions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, Settlement and Impairment Provisions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringSettlementAndImpairmentProvisions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions" xlink:to="lab_us-gaap_RestructuringSettlementAndImpairmentProvisions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrivatePlacementMember_8ae7cb1c-4ab1-41fe-81ae-2b937375a7a3_terseLabel_en-US" xlink:label="lab_us-gaap_PrivatePlacementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private Placements</link:label>
    <link:label id="lab_us-gaap_PrivatePlacementMember_label_en-US" xlink:label="lab_us-gaap_PrivatePlacementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private Placement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrivatePlacementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrivatePlacementMember" xlink:to="lab_us-gaap_PrivatePlacementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_InvestmentOwnedNumberOfSharesSold_2b8e184c-b004-4fb4-a90a-20decd4e1f96_terseLabel_en-US" xlink:label="lab_cron_InvestmentOwnedNumberOfSharesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment owned, number of shares sold (in shares)</link:label>
    <link:label id="lab_cron_InvestmentOwnedNumberOfSharesSold_label_en-US" xlink:label="lab_cron_InvestmentOwnedNumberOfSharesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Owned, Number Of Shares Sold</link:label>
    <link:label id="lab_cron_InvestmentOwnedNumberOfSharesSold_documentation_en-US" xlink:label="lab_cron_InvestmentOwnedNumberOfSharesSold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Owned, Number Of Shares Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentOwnedNumberOfSharesSold" xlink:href="cron-20201231.xsd#cron_InvestmentOwnedNumberOfSharesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_InvestmentOwnedNumberOfSharesSold" xlink:to="lab_cron_InvestmentOwnedNumberOfSharesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_CronosIsraelG.S.StoreLtd.Member_0a6439bb-482b-4dec-89aa-4f49118741f9_terseLabel_en-US" xlink:label="lab_cron_CronosIsraelG.S.StoreLtd.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos Israel G.S. Store Ltd.</link:label>
    <link:label id="lab_cron_CronosIsraelG.S.StoreLtd.Member_label_en-US" xlink:label="lab_cron_CronosIsraelG.S.StoreLtd.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos Israel G.S. Store Ltd. [Member]</link:label>
    <link:label id="lab_cron_CronosIsraelG.S.StoreLtd.Member_documentation_en-US" xlink:label="lab_cron_CronosIsraelG.S.StoreLtd.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos Israel G.S. Store Ltd. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosIsraelG.S.StoreLtd.Member" xlink:href="cron-20201231.xsd#cron_CronosIsraelG.S.StoreLtd.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_CronosIsraelG.S.StoreLtd.Member" xlink:to="lab_cron_CronosIsraelG.S.StoreLtd.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7fafb3b0-74c6-4e3d-9919-9d7812818b6e_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_42524797-cd14-4d2f-9086-7371c18a4aad_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_d78eb997-c3c5-498f-9cc2-3f3e29e91270_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_InventoryCannabisExtractsMember_9487d176-a687-4c8e-aba8-c98f5e0b06b9_terseLabel_en-US" xlink:label="lab_cron_InventoryCannabisExtractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cannabis Extracts</link:label>
    <link:label id="lab_cron_InventoryCannabisExtractsMember_label_en-US" xlink:label="lab_cron_InventoryCannabisExtractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Cannabis Extracts [Member]</link:label>
    <link:label id="lab_cron_InventoryCannabisExtractsMember_documentation_en-US" xlink:label="lab_cron_InventoryCannabisExtractsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Cannabis Extracts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InventoryCannabisExtractsMember" xlink:href="cron-20201231.xsd#cron_InventoryCannabisExtractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_InventoryCannabisExtractsMember" xlink:to="lab_cron_InventoryCannabisExtractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_6a5d2965-ee0b-42f6-9f4f-b82fcc1ad2ca_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_4515e87e-1b8f-4d1c-a698-175659595bf5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_CanopyGrowthCorporationMember_29cf9429-fdd5-4862-b4df-f27fc643576b_terseLabel_en-US" xlink:label="lab_cron_CanopyGrowthCorporationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canopy</link:label>
    <link:label id="lab_cron_CanopyGrowthCorporationMember_label_en-US" xlink:label="lab_cron_CanopyGrowthCorporationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canopy Growth Corporation [Member]</link:label>
    <link:label id="lab_cron_CanopyGrowthCorporationMember_documentation_en-US" xlink:label="lab_cron_CanopyGrowthCorporationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canopy Growth Corporation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CanopyGrowthCorporationMember" xlink:href="cron-20201231.xsd#cron_CanopyGrowthCorporationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_CanopyGrowthCorporationMember" xlink:to="lab_cron_CanopyGrowthCorporationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_5dcb2ee6-79b0-4fa2-9e42-5aefbf4bce16_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment structure</link:label>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_26245a13-29b9-41ba-bf8e-f3b99a5c573a_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_89ffe6e5-5b45-4334-bb5c-a7b949eec99c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsPolicy" xlink:to="lab_us-gaap_BusinessCombinationsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock_ce643043-eaf8-4a1c-889d-37bd5575dc40_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of the Changes in Options</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock Options Roll Forward [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_feb5b9a5-c248-49ec-89fd-8108d7f912a1_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_2cd68f42-0b6f-400d-8cf1-b3821090ea33_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_6ff8e724-b7c1-4177-bb43-0e193bb7229f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_b9536cb7-25f5-47c9-9b9c-26efbda88c8b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_8c5ea1b3-0f62-4a26-9dfc-af570a2ecd7d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of options (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReportingUnitAxis_66a22e90-51ce-4832-afaf-da406692f3f6_terseLabel_en-US" xlink:label="lab_us-gaap_ReportingUnitAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Axis]</link:label>
    <link:label id="lab_us-gaap_ReportingUnitAxis_label_en-US" xlink:label="lab_us-gaap_ReportingUnitAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReportingUnitAxis" xlink:to="lab_us-gaap_ReportingUnitAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_4f318236-ab99-4326-a704-12a7423e87c2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:to="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_813edadc-e08a-4f4e-8bfd-3c40b0f63819_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_9e3e9d9a-3ad5-47f7-872a-9eb5c3398d61_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_PaymentOfTransactionCosts_4431751d-acc6-45c8-9c90-61858f3480b0_terseLabel_en-US" xlink:label="lab_cron_PaymentOfTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction costs</link:label>
    <link:label id="lab_cron_PaymentOfTransactionCosts_label_en-US" xlink:label="lab_cron_PaymentOfTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment Of Transaction Costs</link:label>
    <link:label id="lab_cron_PaymentOfTransactionCosts_documentation_en-US" xlink:label="lab_cron_PaymentOfTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment Of Transaction Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PaymentOfTransactionCosts" xlink:href="cron-20201231.xsd#cron_PaymentOfTransactionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_PaymentOfTransactionCosts" xlink:to="lab_cron_PaymentOfTransactionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_47cc9f51-92fa-4477-861d-dfc4e821972c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_2e888e08-3d83-40ea-a735-0452b9c378b1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of warrants (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_f72e984f-17b0-40f3-bc85-bdc4b40eb489_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_058e7b63-b314-4f2e-b693-92f5bdc54943_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWriteDown_1d7df230-8986-42e2-97d0-2752d6ba1938_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory write-down</link:label>
    <link:label id="lab_us-gaap_InventoryWriteDown_8b8c9e2b-2cb3-4ef4-9d9b-8640b2750e6e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory write-down</link:label>
    <link:label id="lab_us-gaap_InventoryWriteDown_label_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Write-down</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWriteDown" xlink:to="lab_us-gaap_InventoryWriteDown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_c7b5b5c3-27ba-4d79-89fe-1a6f41f0ea8d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_c1fb8654-5f3f-44c5-9545-cae4ab3e619a_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchased during period (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_1f89074c-c534-4a17-a8b7-e39baf9eb895_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consulting fees</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Expenses from Transactions with Related Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:to="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_0a007db0-827a-461e-8a7a-e3d529c48eea_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Purchase Commitment, Category of Item Purchased [Domain]</link:label>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_label_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Purchase Commitment, Category of Item Purchased [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:to="lab_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_321d21f4-3177-40db-b023-1506e8a505a5_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_651e9d43-14c0-410b-a661-281630f82cf1_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_BuildingAndEquipmentMember_973b7a0f-047b-4eee-9392-0705564f6376_terseLabel_en-US" xlink:label="lab_cron_BuildingAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office Premises and Equipment</link:label>
    <link:label id="lab_cron_BuildingAndEquipmentMember_label_en-US" xlink:label="lab_cron_BuildingAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building And Equipment [Member]</link:label>
    <link:label id="lab_cron_BuildingAndEquipmentMember_documentation_en-US" xlink:label="lab_cron_BuildingAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building And Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_BuildingAndEquipmentMember" xlink:href="cron-20201231.xsd#cron_BuildingAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_BuildingAndEquipmentMember" xlink:to="lab_cron_BuildingAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_NatuEraMember_596e57c8-c900-486c-9f4b-221e239bfc40_terseLabel_en-US" xlink:label="lab_cron_NatuEraMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Natuera</link:label>
    <link:label id="lab_cron_NatuEraMember_label_en-US" xlink:label="lab_cron_NatuEraMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NatuEra [Member]</link:label>
    <link:label id="lab_cron_NatuEraMember_documentation_en-US" xlink:label="lab_cron_NatuEraMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NatuEra [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NatuEraMember" xlink:href="cron-20201231.xsd#cron_NatuEraMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_NatuEraMember" xlink:to="lab_cron_NatuEraMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_90f67afc-8d44-4130-859d-80da4a1a7448_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_c509e446-3b5f-4b84-8de7-f64e7219cea0_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_UnitedStatesSegmentMember_df35acb3-dcfa-40b7-8f69-16401067a130_terseLabel_en-US" xlink:label="lab_cron_UnitedStatesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_cron_UnitedStatesSegmentMember_label_en-US" xlink:label="lab_cron_UnitedStatesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States Segment [Member]</link:label>
    <link:label id="lab_cron_UnitedStatesSegmentMember_documentation_en-US" xlink:label="lab_cron_UnitedStatesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_UnitedStatesSegmentMember" xlink:href="cron-20201231.xsd#cron_UnitedStatesSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_UnitedStatesSegmentMember" xlink:to="lab_cron_UnitedStatesSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward_fe44ce1c-e804-48ea-9225-3503ee192c55_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward" xlink:to="lab_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_46eef910-1ba8-4936-b672-0a9ee4411aeb_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract_44fd0272-d73d-4196-b0b9-d913151577c6_terseLabel_en-US" xlink:label="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sensitivity Analysis, Impact of 10 Percent Decrease (Increase) on Net Income (Loss) [Abstract]</link:label>
    <link:label id="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract_label_en-US" xlink:label="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) On Net Income (Loss) [Abstract]</link:label>
    <link:label id="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract_documentation_en-US" xlink:label="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) On Net Income (Loss) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract" xlink:href="cron-20201231.xsd#cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract" xlink:to="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_NumberOfAdultuseBrands_44b1fd9b-44e7-48ee-b13f-cc2e00ccbc13_terseLabel_en-US" xlink:label="lab_cron_NumberOfAdultuseBrands" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of adult-use brands</link:label>
    <link:label id="lab_cron_NumberOfAdultuseBrands_label_en-US" xlink:label="lab_cron_NumberOfAdultuseBrands" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Adult-use Brands</link:label>
    <link:label id="lab_cron_NumberOfAdultuseBrands_documentation_en-US" xlink:label="lab_cron_NumberOfAdultuseBrands" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Adult-use Brands</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NumberOfAdultuseBrands" xlink:href="cron-20201231.xsd#cron_NumberOfAdultuseBrands"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_NumberOfAdultuseBrands" xlink:to="lab_cron_NumberOfAdultuseBrands" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_ClassOfWarrantOrRightAdditionalSubscriptionNumberOfSecuritiesCalledByWarrantsOrRights_efcbb7fc-4afe-433c-bfb3-eb0ce726cc43_terseLabel_en-US" xlink:label="lab_cron_ClassOfWarrantOrRightAdditionalSubscriptionNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative liability, additional subscription (in shares)</link:label>
    <link:label id="lab_cron_ClassOfWarrantOrRightAdditionalSubscriptionNumberOfSecuritiesCalledByWarrantsOrRights_label_en-US" xlink:label="lab_cron_ClassOfWarrantOrRightAdditionalSubscriptionNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Additional Subscription, Number Of Securities Called By Warrants Or Rights</link:label>
    <link:label id="lab_cron_ClassOfWarrantOrRightAdditionalSubscriptionNumberOfSecuritiesCalledByWarrantsOrRights_documentation_en-US" xlink:label="lab_cron_ClassOfWarrantOrRightAdditionalSubscriptionNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Additional Subscription, Number Of Securities Called By Warrants Or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ClassOfWarrantOrRightAdditionalSubscriptionNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="cron-20201231.xsd#cron_ClassOfWarrantOrRightAdditionalSubscriptionNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_ClassOfWarrantOrRightAdditionalSubscriptionNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="lab_cron_ClassOfWarrantOrRightAdditionalSubscriptionNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeveranceCosts1_8234d33e-168b-4237-8d99-f6eafbf871dc_terseLabel_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee termination benefits</link:label>
    <link:label id="lab_us-gaap_SeveranceCosts1_label_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeveranceCosts1" xlink:to="lab_us-gaap_SeveranceCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_89086e00-ec37-49ab-be97-f177848082c7_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of long-lived assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3b775306-bc1c-4bea-ba0c-6b93d8e9300a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_19d1ec2a-64a1-4fa2-b180-6fe5c949ff5f_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_cbb86962-5a64-41fb-b0e1-04049b61f296_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes withheld on vesting of restricted share units</link:label>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Decrease for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_89ccf44d-7258-4b59-89c9-489820a94658_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Tranche Two</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Tranche Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_0f60dd2b-a615-4ef6-bd58-a416d9c85c2b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_c6be86ca-9f5a-4255-81b5-b4dfee4b6742_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Transaction with Party to Collaborative Arrangement</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_d0e063c6-ff70-43aa-9c78-5ca83418f4f3_verboseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Establishment of a Commercial Cannabis Analytical Testing Laboratoy</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Transaction with Party to Collaborative Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:to="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_8596fb64-c7d6-4f60-ab8c-cd51eb1f8fa1_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026 and thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_2f431391-0666-4ad6-9761-c05dfdad6b74_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and equipment</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_f67ea862-93fa-4c5a-b14a-aa81feb8c839_terseLabel_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes payable, current</link:label>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_label_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxesPayableCurrent" xlink:to="lab_us-gaap_TaxesPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_a17f40b7-e2fe-42a8-b389-3095d1dec34b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_54262d04-d66a-4ddc-be57-bca9bb79e06c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise price (per option) (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_7b67ccf5-79ee-46d8-bd36-481427d943ff_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of warrants (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_3dd3e0ac-a8a0-481c-adbf-dfbc6f7dc523_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities settled (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_AltriaPinnacleLLC.Member_79bdd37e-c578-4090-8a2d-2bf8f42882fb_terseLabel_en-US" xlink:label="lab_cron_AltriaPinnacleLLC.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Altria Pinnacle LLC.</link:label>
    <link:label id="lab_cron_AltriaPinnacleLLC.Member_label_en-US" xlink:label="lab_cron_AltriaPinnacleLLC.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Altria Pinnacle LLC. [Member]</link:label>
    <link:label id="lab_cron_AltriaPinnacleLLC.Member_documentation_en-US" xlink:label="lab_cron_AltriaPinnacleLLC.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Altria Pinnacle LLC. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaPinnacleLLC.Member" xlink:href="cron-20201231.xsd#cron_AltriaPinnacleLLC.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_AltriaPinnacleLLC.Member" xlink:to="lab_cron_AltriaPinnacleLLC.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_34bbdbcc-b42d-44bc-b538-a0404d8f3415_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable, past due</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_c8e4f081-8f86-47f0-8846-bcc4fac8be59_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of foreign exchange</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_46e1a1a7-3737-426d-9037-ce86a95f09ad_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_5a7fe90b-71ad-4106-a4c6-7232f7a7b105_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_NatuEraSeriesALoanMember_216b3086-dc70-4f70-a7cd-009a46a76234_terseLabel_en-US" xlink:label="lab_cron_NatuEraSeriesALoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NatuEra Series A Loan</link:label>
    <link:label id="lab_cron_NatuEraSeriesALoanMember_label_en-US" xlink:label="lab_cron_NatuEraSeriesALoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NatuEra Series A Loan [Member]</link:label>
    <link:label id="lab_cron_NatuEraSeriesALoanMember_documentation_en-US" xlink:label="lab_cron_NatuEraSeriesALoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NatuEra Series A Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NatuEraSeriesALoanMember" xlink:href="cron-20201231.xsd#cron_NatuEraSeriesALoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_NatuEraSeriesALoanMember" xlink:to="lab_cron_NatuEraSeriesALoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_735f0528-196d-47de-85ec-d603206d6818_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plant and equipment</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_bdd674a5-debd-418a-b091-a9a01db387a7_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_21cd3b6e-10b5-461c-b6ca-5939ba68387d_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_d16a0910-a646-45a9-bdff-41aa43462dba_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet_c129a59c-5ac4-4398-820d-ed02b40351af_terseLabel_en-US" xlink:label="lab_cron_CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative arrangement, percentage of profits to be received, triggering event, subsequent to maximum percentage of amounts advanced being met</link:label>
    <link:label id="lab_cron_CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet_label_en-US" xlink:label="lab_cron_CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Percentage Of Profits To Be Received, Triggering Event, Subsequent To Maximum Percentage Of Amounts Advanced Being Met</link:label>
    <link:label id="lab_cron_CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet_documentation_en-US" xlink:label="lab_cron_CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Percentage Of Profits To Be Received, Triggering Event, Subsequent To Maximum Percentage Of Amounts Advanced Being Met</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet" xlink:href="cron-20201231.xsd#cron_CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet" xlink:to="lab_cron_CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditConcentrationRiskMember_23cf7d8a-ff06-4ef3-a5bd-3132e84db2e6_terseLabel_en-US" xlink:label="lab_us-gaap_CreditConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Concentration Risk</link:label>
    <link:label id="lab_us-gaap_CreditConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CreditConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditConcentrationRiskMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditConcentrationRiskMember" xlink:to="lab_us-gaap_CreditConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DilutiveSecurities_e48b3418-023e-451a-b822-4f05e4f883b3_terseLabel_en-US" xlink:label="lab_us-gaap_DilutiveSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment for gain on revaluation of derivative liabilities</link:label>
    <link:label id="lab_us-gaap_DilutiveSecurities_label_en-US" xlink:label="lab_us-gaap_DilutiveSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive Securities, Effect on Basic Earnings Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DilutiveSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DilutiveSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DilutiveSecurities" xlink:to="lab_us-gaap_DilutiveSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_97046d66-5d3a-4272-88d9-d8e4da1dc533_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_ff5ceb46-da90-4bd7-969f-3b5e7fda86fd_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease cost</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_0176ef96-158f-4da8-935b-2d1a30560beb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in equity accounted investees</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_df9dba81-938c-44ac-acbd-cbfeaa91e01e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionCosts_9d09ce20-0b5f-40d5-9926-1c71baff7b9a_terseLabel_en-US" xlink:label="lab_cron_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-deductible transaction costs</link:label>
    <link:label id="lab_cron_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionCosts_label_en-US" xlink:label="lab_cron_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Acquisition Costs</link:label>
    <link:label id="lab_cron_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionCosts_documentation_en-US" xlink:label="lab_cron_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Acquisition Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionCosts" xlink:href="cron-20201231.xsd#cron_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionCosts" xlink:to="lab_cron_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_31ed9fe2-c0d9-4772-b488-40d273190b66_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-cash investing activity expense (income)</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_InventoryDryCannabisMember_6b24ab4a-0d33-45d6-abbe-af263c0916a0_terseLabel_en-US" xlink:label="lab_cron_InventoryDryCannabisMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dry Cannabis</link:label>
    <link:label id="lab_cron_InventoryDryCannabisMember_label_en-US" xlink:label="lab_cron_InventoryDryCannabisMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Dry Cannabis [Member]</link:label>
    <link:label id="lab_cron_InventoryDryCannabisMember_documentation_en-US" xlink:label="lab_cron_InventoryDryCannabisMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Dry Cannabis [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InventoryDryCannabisMember" xlink:href="cron-20201231.xsd#cron_InventoryDryCannabisMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_InventoryDryCannabisMember" xlink:to="lab_cron_InventoryDryCannabisMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_7e383f56-bd8c-4002-8d75-b8f5be48f712_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cancellation of options (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_06f1dbe9-30b3-4f11-aa9e-21f45d5d2ec6_totalLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f1a25229-5408-4984-9c7d-6934cc23043d_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a3879c96-5d8b-490b-9efb-f7f201d63552_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryLineItems_ed2443ee-c6f3-4d98-b2d4-c9bcddcf120e_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory [Line Items]</link:label>
    <link:label id="lab_us-gaap_InventoryLineItems_label_en-US" xlink:label="lab_us-gaap_InventoryLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryLineItems" xlink:to="lab_us-gaap_InventoryLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharePrice_109da77c-6261-4b21-ac3d-3bb147501ea8_terseLabel_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share price at grant date (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SharePrice_label_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharePrice" xlink:to="lab_us-gaap_SharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_57b87843-9fd5-4163-80e8-7c3e256c95a7_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedLineItems_6b7bdb11-49ca-446e-aa29-89992deaa7db_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedLineItems_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDilutedLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems" xlink:to="lab_us-gaap_EarningsPerShareDilutedLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_bbcb0d43-f642-46c0-9ab2-b13c17e5eb67_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioForecastMember_6d5bb088-7181-4132-921a-679c7c5e74c3_terseLabel_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast</link:label>
    <link:label id="lab_srt_ScenarioForecastMember_label_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioForecastMember" xlink:to="lab_srt_ScenarioForecastMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_0d46694f-91d3-47a9-9a9f-f4837501917e_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) per share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLongTermLinesOfCredit_fbecc657-4b28-47e0-b1be-10548bb5d946_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advance under Credit Facility</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLongTermLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Long-term Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_29b2d84b-7968-4bdd-80a9-a77870ab2aa0_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_60f93d7c-d95a-4514-a658-5d2b2c6ade03_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_a69dba81-6d58-4eed-a26c-8e6d2c1d164d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition-related costs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_LossContingencyPunitiveDamagesSoughtValue_acbfb455-000c-4837-b0b0-31ae2774a5f5_terseLabel_en-US" xlink:label="lab_cron_LossContingencyPunitiveDamagesSoughtValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Punitive damages sought</link:label>
    <link:label id="lab_cron_LossContingencyPunitiveDamagesSoughtValue_label_en-US" xlink:label="lab_cron_LossContingencyPunitiveDamagesSoughtValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Punitive Damages Sought, Value</link:label>
    <link:label id="lab_cron_LossContingencyPunitiveDamagesSoughtValue_documentation_en-US" xlink:label="lab_cron_LossContingencyPunitiveDamagesSoughtValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Punitive Damages Sought, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LossContingencyPunitiveDamagesSoughtValue" xlink:href="cron-20201231.xsd#cron_LossContingencyPunitiveDamagesSoughtValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_LossContingencyPunitiveDamagesSoughtValue" xlink:to="lab_cron_LossContingencyPunitiveDamagesSoughtValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_46929c08-d5ca-434b-896e-c59c580962fe_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod_fd537b23-aff6-49dd-9ae5-f33e7c7f0cc4_terseLabel_en-US" xlink:label="lab_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise price, volume-weighted average price, measurement period</link:label>
    <link:label id="lab_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod_label_en-US" xlink:label="lab_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Exercise Price, Volume-Weighted Average Price, Measurement Period</link:label>
    <link:label id="lab_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod_documentation_en-US" xlink:label="lab_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Exercise Price, Volume-Weighted Average Price, Measurement Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod" xlink:href="cron-20201231.xsd#cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod" xlink:to="lab_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_c043f8b8-cc7d-4e29-bb08-3c9dc312c084_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_3f5789e2-6369-47c6-bc00-e644e33684c5_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_a8000c1d-1f5a-47cb-9e7d-6efe69f3de24_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss of acquiree since acquisition date</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:to="lab_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_36ce5e63-d26c-4939-8e5b-6cc92b27bfc4_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted_acad0a69-abcb-4030-a9d1-a207a83d98fb_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from continuing operations used in the computation of diluted income (loss) per share</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted" xlink:to="lab_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_e7980290-2e82-44e6-9e72-ee73f8c2fefc_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_555d4c55-4c16-4952-9bd9-9049da381f30_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting of common shares issued in connection with the use of certain publicity rights in brand development</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_7da36b75-9381-4d3a-8e1c-b56f3b6a420f_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of common stock</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_c523a392-5cdb-4796-aa22-9cd71dcc25a8_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_f22674d8-5c0f-450d-beb1-003054fe5df7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings (Loss) Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_DeferredTaxAssetsFinanceLeaseLiabilities_07425671-09de-4f41-a307-533f13c02348_terseLabel_en-US" xlink:label="lab_cron_DeferredTaxAssetsFinanceLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease obligation</link:label>
    <link:label id="lab_cron_DeferredTaxAssetsFinanceLeaseLiabilities_label_en-US" xlink:label="lab_cron_DeferredTaxAssetsFinanceLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Finance Lease Liabilities</link:label>
    <link:label id="lab_cron_DeferredTaxAssetsFinanceLeaseLiabilities_documentation_en-US" xlink:label="lab_cron_DeferredTaxAssetsFinanceLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Finance Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DeferredTaxAssetsFinanceLeaseLiabilities" xlink:href="cron-20201231.xsd#cron_DeferredTaxAssetsFinanceLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_DeferredTaxAssetsFinanceLeaseLiabilities" xlink:to="lab_cron_DeferredTaxAssetsFinanceLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentArrangementMember_fae44652-7a76-407b-bd73-975900be1390_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Arrangement</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentArrangementMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentArrangementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsDisclosureTextBlock_90d8c613-3987-431d-becc-d1802669a1d5_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments</link:label>
    <link:label id="lab_us-gaap_CommitmentsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_b4cd1c5e-b4c7-4aa2-a229-9773f53ed49b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value of Net Assets Acquired</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_2c6dea34-2ae3-471e-898c-f20001a43723_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_22c21ec8-8c5d-457f-9fea-e45c398054b7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value measurements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_78a2e892-0e90-4196-b306-dca83c04b5a2_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:to="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesAndLoansReceivableNetCurrentAbstract_b8e39ba6-d2c3-4e6f-ae6c-d185a0a1ac20_terseLabel_en-US" xlink:label="lab_us-gaap_NotesAndLoansReceivableNetCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion</link:label>
    <link:label id="lab_us-gaap_NotesAndLoansReceivableNetCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_NotesAndLoansReceivableNetCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, after Allowance for Credit Loss, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesAndLoansReceivableNetCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesAndLoansReceivableNetCurrentAbstract" xlink:to="lab_us-gaap_NotesAndLoansReceivableNetCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_99e5fd28-a6d4-4a19-84b1-295ede9db019_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_a0a1de23-f9a9-4ec8-9b74-7bd3f1c5f05c_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_5841193b-6645-4a82-a98f-6fc3daeb0481_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff_9a51a79f-cce1-4a2b-b7d7-042cdfb9ad68_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, threshold period past due, writeoff</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Noncurrent, Threshold Period Past Due, Writeoff</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff" xlink:to="lab_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportingUnits_6d26ba75-4679-4504-8aec-ed3ca9a9f404_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportingUnits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reporting units</link:label>
    <link:label id="lab_us-gaap_NumberOfReportingUnits_label_en-US" xlink:label="lab_us-gaap_NumberOfReportingUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reporting Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportingUnits" xlink:to="lab_us-gaap_NumberOfReportingUnits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComputerSoftwareIntangibleAssetMember_6dfa3c34-e52f-4863-ae96-8b038b77feb6_terseLabel_en-US" xlink:label="lab_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software</link:label>
    <link:label id="lab_us-gaap_ComputerSoftwareIntangibleAssetMember_1172caea-765e-409e-840d-27a15b17431d_verboseLabel_en-US" xlink:label="lab_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software</link:label>
    <link:label id="lab_us-gaap_ComputerSoftwareIntangibleAssetMember_label_en-US" xlink:label="lab_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Software, Intangible Asset [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:to="lab_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_dccb81c4-1b0c-4b50-8f18-0cd9d96d7f86_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:to="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c466e1e5-27e8-4d61-993d-b68bcc297de5_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_af22190b-dc13-4263-a5d6-aa8ff0023e06_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets Amortization Methods and Rates</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_a9f00d65-4b29-488f-9c1b-45792272716e_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock_40e95c7e-96cf-409e-8d20-b78cfeb7759e_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplementary Cash Flow Information</link:label>
    <link:label id="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Supplemental Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:to="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_0bacbced-db51-4ea5-a6c0-0c6611c99488_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_4dc000fc-5150-4130-b304-127de983f2b5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in valuation allowance</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_8dbb7bc2-493a-4de6-81a5-0b82be955852_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_ProceedsFromSaleOfEquitySecuritiesFVNI_6d98a172-ad85-44eb-9c5f-30a6a714a16a_terseLabel_en-US" xlink:label="lab_cron_ProceedsFromSaleOfEquitySecuritiesFVNI" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of equity securities, FV-NI</link:label>
    <link:label id="lab_cron_ProceedsFromSaleOfEquitySecuritiesFVNI_label_en-US" xlink:label="lab_cron_ProceedsFromSaleOfEquitySecuritiesFVNI" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Sale Of Equity Securities, FV-NI</link:label>
    <link:label id="lab_cron_ProceedsFromSaleOfEquitySecuritiesFVNI_documentation_en-US" xlink:label="lab_cron_ProceedsFromSaleOfEquitySecuritiesFVNI" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Sale Of Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ProceedsFromSaleOfEquitySecuritiesFVNI" xlink:href="cron-20201231.xsd#cron_ProceedsFromSaleOfEquitySecuritiesFVNI"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_ProceedsFromSaleOfEquitySecuritiesFVNI" xlink:to="lab_cron_ProceedsFromSaleOfEquitySecuritiesFVNI" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_6295fd4c-17e0-4b64-8999-8f6ef07a4349_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_849f7a1b-063b-4ca8-9b0b-e1226e6d3c0b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro forma net income (loss)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesAndLoansReceivableNetNoncurrentAbstract_b493a5ee-9f34-48b0-9341-8beb2ecc8b3e_terseLabel_en-US" xlink:label="lab_us-gaap_NotesAndLoansReceivableNetNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term portion</link:label>
    <link:label id="lab_us-gaap_NotesAndLoansReceivableNetNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_NotesAndLoansReceivableNetNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, after Allowance for Credit Loss, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetNoncurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesAndLoansReceivableNetNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesAndLoansReceivableNetNoncurrentAbstract" xlink:to="lab_us-gaap_NotesAndLoansReceivableNetNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestCostsCapitalized_6c1c4210-a9c8-491a-9f86-3e23edc8b628_terseLabel_en-US" xlink:label="lab_us-gaap_InterestCostsCapitalized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest costs capitalized</link:label>
    <link:label id="lab_us-gaap_InterestCostsCapitalized_label_en-US" xlink:label="lab_us-gaap_InterestCostsCapitalized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Costs Capitalized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCostsCapitalized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestCostsCapitalized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestCostsCapitalized" xlink:to="lab_us-gaap_InterestCostsCapitalized" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_16918bbb-77a9-4732-a710-89bcc0b9c6da_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding (in shares)</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_GrantedMay132016ThroughMay272016Member_13ef670d-831d-4c05-8709-ca7af1fbdeaa_terseLabel_en-US" xlink:label="lab_cron_GrantedMay132016ThroughMay272016Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">May 13 &#8211; 27, 2016</link:label>
    <link:label id="lab_cron_GrantedMay132016ThroughMay272016Member_label_en-US" xlink:label="lab_cron_GrantedMay132016ThroughMay272016Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted May 13, 2016 Through May 27, 2016 [Member]</link:label>
    <link:label id="lab_cron_GrantedMay132016ThroughMay272016Member_documentation_en-US" xlink:label="lab_cron_GrantedMay132016ThroughMay272016Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted May 13, 2016 Through May 27, 2016 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_GrantedMay132016ThroughMay272016Member" xlink:href="cron-20201231.xsd#cron_GrantedMay132016ThroughMay272016Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_GrantedMay132016ThroughMay272016Member" xlink:to="lab_cron_GrantedMay132016ThroughMay272016Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_5a45c341-8afd-4375-b8d7-98c15438e6b4_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_LongtermPurchaseCommitmentPaymentsSubjectToMilestones_f3841ed3-8228-4757-aba7-8c4fed97eb14_terseLabel_en-US" xlink:label="lab_cron_LongtermPurchaseCommitmentPaymentsSubjectToMilestones" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments subject to milestones</link:label>
    <link:label id="lab_cron_LongtermPurchaseCommitmentPaymentsSubjectToMilestones_label_en-US" xlink:label="lab_cron_LongtermPurchaseCommitmentPaymentsSubjectToMilestones" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Purchase Commitment, Payments Subject To Milestones</link:label>
    <link:label id="lab_cron_LongtermPurchaseCommitmentPaymentsSubjectToMilestones_documentation_en-US" xlink:label="lab_cron_LongtermPurchaseCommitmentPaymentsSubjectToMilestones" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Purchase Commitment, Payments Subject To Milestones</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LongtermPurchaseCommitmentPaymentsSubjectToMilestones" xlink:href="cron-20201231.xsd#cron_LongtermPurchaseCommitmentPaymentsSubjectToMilestones"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_LongtermPurchaseCommitmentPaymentsSubjectToMilestones" xlink:to="lab_cron_LongtermPurchaseCommitmentPaymentsSubjectToMilestones" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_CannasoulAnalyticsLtdMember_24c7bb1e-ee05-4030-b8e2-b48ac15513f6_terseLabel_en-US" xlink:label="lab_cron_CannasoulAnalyticsLtdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cannasoul Analytics Ltd.</link:label>
    <link:label id="lab_cron_CannasoulAnalyticsLtdMember_label_en-US" xlink:label="lab_cron_CannasoulAnalyticsLtdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cannasoul Analytics Ltd. [Member]</link:label>
    <link:label id="lab_cron_CannasoulAnalyticsLtdMember_documentation_en-US" xlink:label="lab_cron_CannasoulAnalyticsLtdMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cannasoul Analytics Ltd.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CannasoulAnalyticsLtdMember" xlink:href="cron-20201231.xsd#cron_CannasoulAnalyticsLtdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_CannasoulAnalyticsLtdMember" xlink:to="lab_cron_CannasoulAnalyticsLtdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_595aa40b-0450-4a81-b4db-02b47e3351f4_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_AltriaWarrantMember_76e6a2a1-dd91-41e0-a1f2-37d6b80bda88_verboseLabel_en-US" xlink:label="lab_cron_AltriaWarrantMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Altria Warrant</link:label>
    <link:label id="lab_cron_AltriaWarrantMember_c4ac9e7a-38cd-4314-a128-edd960180366_terseLabel_en-US" xlink:label="lab_cron_AltriaWarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Altria Warrant</link:label>
    <link:label id="lab_cron_AltriaWarrantMember_label_en-US" xlink:label="lab_cron_AltriaWarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Altria Warrant [Member]</link:label>
    <link:label id="lab_cron_AltriaWarrantMember_documentation_en-US" xlink:label="lab_cron_AltriaWarrantMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Altria Warrant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaWarrantMember" xlink:href="cron-20201231.xsd#cron_AltriaWarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_AltriaWarrantMember" xlink:to="lab_cron_AltriaWarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_1f47f273-1efe-4602-b0bc-09b8332b8e72_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" xlink:to="lab_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_580faf75-9e4f-47af-9f1d-b869a966d9b8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_PreemptiveRightsMember_52a63db3-837f-458c-acd3-71f80de7e90c_verboseLabel_en-US" xlink:label="lab_cron_PreemptiveRightsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-emptive Rights</link:label>
    <link:label id="lab_cron_PreemptiveRightsMember_ddbad3ea-f15c-409c-aff4-448f4db4dab5_terseLabel_en-US" xlink:label="lab_cron_PreemptiveRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-emptive Rights</link:label>
    <link:label id="lab_cron_PreemptiveRightsMember_label_en-US" xlink:label="lab_cron_PreemptiveRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-emptive Rights [Member]</link:label>
    <link:label id="lab_cron_PreemptiveRightsMember_documentation_en-US" xlink:label="lab_cron_PreemptiveRightsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-emptive Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PreemptiveRightsMember" xlink:href="cron-20201231.xsd#cron_PreemptiveRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_PreemptiveRightsMember" xlink:to="lab_cron_PreemptiveRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_63db8b7a-4fc5-40cf-ad55-7fdd308e79f5_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:to="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_a8ddcc21-84e0-45f8-a29f-7f9d5f4749aa_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_6be54c9d-956b-45b2-9f24-44770ccdc264_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_IncreaseDecreasePrepaidExpensesAndOtherReceivables_db6301ce-7c65-47c7-a4fd-57188a4e5978_negatedTerseLabel_en-US" xlink:label="lab_cron_IncreaseDecreasePrepaidExpensesAndOtherReceivables" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaids and other receivables</link:label>
    <link:label id="lab_cron_IncreaseDecreasePrepaidExpensesAndOtherReceivables_label_en-US" xlink:label="lab_cron_IncreaseDecreasePrepaidExpensesAndOtherReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) Prepaid Expenses And Other Receivables</link:label>
    <link:label id="lab_cron_IncreaseDecreasePrepaidExpensesAndOtherReceivables_documentation_en-US" xlink:label="lab_cron_IncreaseDecreasePrepaidExpensesAndOtherReceivables" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) Prepaid Expenses And Other Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_IncreaseDecreasePrepaidExpensesAndOtherReceivables" xlink:href="cron-20201231.xsd#cron_IncreaseDecreasePrepaidExpensesAndOtherReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_IncreaseDecreasePrepaidExpensesAndOtherReceivables" xlink:to="lab_cron_IncreaseDecreasePrepaidExpensesAndOtherReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_6be546c4-d315-4c65-8609-9c67ceebe643_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted share units settled (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_21a6b10a-996f-4e31-9be9-eb806a4ed6df_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesCurrent_1e18503b-82e2-43c9-a47b-a900dea0bda7_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilitiesCurrent" xlink:to="lab_us-gaap_DerivativeLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_ceb214cb-51ae-4d21-befd-2192e3e2604d_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_5c5a3996-aac6-4ac4-bca0-51ca219ae77b_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_416afa01-50fe-4f94-966b-dba787b91e41_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease obligations</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesInvestments_a728bc4a-8faa-4554-986c-a40202da702b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesInvestments_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesInvestments" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_31c18385-7621-4504-9f44-e30407e0bd87_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncurrentAssets_e754e756-1c9c-4506-b7ae-25f9fe75ed77_terseLabel_en-US" xlink:label="lab_us-gaap_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-lived assets</link:label>
    <link:label id="lab_us-gaap_NoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncurrentAssets" xlink:to="lab_us-gaap_NoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingDomain_759d9053-ec32-466d-be85-619c8234614c_terseLabel_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:label id="lab_us-gaap_VestingDomain_label_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingDomain" xlink:to="lab_us-gaap_VestingDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioPreviouslyReportedMember_e51e01b9-e926-4931-b406-a18b1e017641_terseLabel_en-US" xlink:label="lab_srt_ScenarioPreviouslyReportedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">As previously disclosed</link:label>
    <link:label id="lab_srt_ScenarioPreviouslyReportedMember_label_en-US" xlink:label="lab_srt_ScenarioPreviouslyReportedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Previously Reported [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioPreviouslyReportedMember" xlink:to="lab_srt_ScenarioPreviouslyReportedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_c85363c4-799c-4957-aeb0-222f01c80475_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_ed151c68-c2e8-4e11-9d12-e825da203b49_verboseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_043995f5-e411-4826-949b-3948255252a0_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_SaleOfStockPerformanceMilestoneAxis_b3dd90eb-136e-467a-b4dc-8d29dedd1fd7_terseLabel_en-US" xlink:label="lab_cron_SaleOfStockPerformanceMilestoneAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Performance Milestone [Axis]</link:label>
    <link:label id="lab_cron_SaleOfStockPerformanceMilestoneAxis_label_en-US" xlink:label="lab_cron_SaleOfStockPerformanceMilestoneAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Performance Milestone [Axis]</link:label>
    <link:label id="lab_cron_SaleOfStockPerformanceMilestoneAxis_documentation_en-US" xlink:label="lab_cron_SaleOfStockPerformanceMilestoneAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Performance Milestone</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SaleOfStockPerformanceMilestoneAxis" xlink:href="cron-20201231.xsd#cron_SaleOfStockPerformanceMilestoneAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_SaleOfStockPerformanceMilestoneAxis" xlink:to="lab_cron_SaleOfStockPerformanceMilestoneAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_43af2779-4983-4b37-80e8-7bbfc95a72ab_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Expense for Income Taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_c7d5941d-eb3c-4e46-970b-7034e8608b77_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership interest</link:label>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_label_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:to="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CanadaRevenueAgencyMember_6dd746c4-4509-4d3b-a93a-2b7c286ceaf3_terseLabel_en-US" xlink:label="lab_us-gaap_CanadaRevenueAgencyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canada</link:label>
    <link:label id="lab_us-gaap_CanadaRevenueAgencyMember_label_en-US" xlink:label="lab_us-gaap_CanadaRevenueAgencyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canada Revenue Agency [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CanadaRevenueAgencyMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CanadaRevenueAgencyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CanadaRevenueAgencyMember" xlink:to="lab_us-gaap_CanadaRevenueAgencyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_973c2fbd-c526-4d8c-8db0-5ae24a75a6f9_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_8e89d370-8274-4da2-a9b8-0c782af43fb0_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeAxis" xlink:to="lab_us-gaap_InvestmentTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowElementsAbstract_f34ac349-be27-43f1-b541-03d25e9a9a66_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowElementsAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonUsMember_b3bb3560-090e-43ee-afd3-28a9aad4f6fc_terseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of World</link:label>
    <link:label id="lab_us-gaap_NonUsMember_label_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember" xlink:to="lab_us-gaap_NonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_1d51665e-16ef-4203-8288-af6b95b81d30_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from continuing operations attributable to common shareholders of Cronos&#160;Group</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_46fdd1ec-973c-43b6-b19e-2a090a06919a_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from continuing operations used in the computation of basic earnings (loss) per share</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_ShareBasedPaymentArrangementGainLossOnRevaluation_d496260b-4e81-43e1-909c-43fe158429ad_negatedTerseLabel_en-US" xlink:label="lab_cron_ShareBasedPaymentArrangementGainLossOnRevaluation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss (gain) on revaluation</link:label>
    <link:label id="lab_cron_ShareBasedPaymentArrangementGainLossOnRevaluation_label_en-US" xlink:label="lab_cron_ShareBasedPaymentArrangementGainLossOnRevaluation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Gain (Loss) On Revaluation</link:label>
    <link:label id="lab_cron_ShareBasedPaymentArrangementGainLossOnRevaluation_documentation_en-US" xlink:label="lab_cron_ShareBasedPaymentArrangementGainLossOnRevaluation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Gain (Loss) On Revaluation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ShareBasedPaymentArrangementGainLossOnRevaluation" xlink:href="cron-20201231.xsd#cron_ShareBasedPaymentArrangementGainLossOnRevaluation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_ShareBasedPaymentArrangementGainLossOnRevaluation" xlink:to="lab_cron_ShareBasedPaymentArrangementGainLossOnRevaluation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ab5533a8-1d33-4eec-9d16-88f120cf9bad_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableAllowanceForCreditLosses_4370d6d1-9a54-42d1-b8c1-152666c25a03_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableAllowanceForCreditLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for credit loss</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableAllowanceForCreditLosses_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableAllowanceForCreditLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLosses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancingReceivableAllowanceForCreditLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLosses" xlink:to="lab_us-gaap_FinancingReceivableAllowanceForCreditLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_870917f4-c312-45b3-a309-3ffe45913123_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_NonmonetaryTransactionNumberOfTransactions_c6ed94f4-36c5-4bc7-8fd7-f28d82337ffc_terseLabel_en-US" xlink:label="lab_cron_NonmonetaryTransactionNumberOfTransactions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of transactions</link:label>
    <link:label id="lab_cron_NonmonetaryTransactionNumberOfTransactions_label_en-US" xlink:label="lab_cron_NonmonetaryTransactionNumberOfTransactions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonmonetary Transaction, Number Of Transactions</link:label>
    <link:label id="lab_cron_NonmonetaryTransactionNumberOfTransactions_documentation_en-US" xlink:label="lab_cron_NonmonetaryTransactionNumberOfTransactions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonmonetary Transaction, Number Of Transactions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NonmonetaryTransactionNumberOfTransactions" xlink:href="cron-20201231.xsd#cron_NonmonetaryTransactionNumberOfTransactions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_NonmonetaryTransactionNumberOfTransactions" xlink:to="lab_cron_NonmonetaryTransactionNumberOfTransactions" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_AOCIAccumulatedGainLossRevaluationAndDisposalOfOtherInvestmentsParentMemberMember_a7876d68-f310-4284-9185-aef27611549c_verboseLabel_en-US" xlink:label="lab_cron_AOCIAccumulatedGainLossRevaluationAndDisposalOfOtherInvestmentsParentMemberMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized gain (loss) on revaluation and disposal of other investments</link:label>
    <link:label id="lab_cron_AOCIAccumulatedGainLossRevaluationAndDisposalOfOtherInvestmentsParentMemberMember_label_en-US" xlink:label="lab_cron_AOCIAccumulatedGainLossRevaluationAndDisposalOfOtherInvestmentsParentMemberMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Revaluation And Disposal Of Other Investments, Parent [Member] [Member]</link:label>
    <link:label id="lab_cron_AOCIAccumulatedGainLossRevaluationAndDisposalOfOtherInvestmentsParentMemberMember_documentation_en-US" xlink:label="lab_cron_AOCIAccumulatedGainLossRevaluationAndDisposalOfOtherInvestmentsParentMemberMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Revaluation And Disposal Of Other Investments, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AOCIAccumulatedGainLossRevaluationAndDisposalOfOtherInvestmentsParentMemberMember" xlink:href="cron-20201231.xsd#cron_AOCIAccumulatedGainLossRevaluationAndDisposalOfOtherInvestmentsParentMemberMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_AOCIAccumulatedGainLossRevaluationAndDisposalOfOtherInvestmentsParentMemberMember" xlink:to="lab_cron_AOCIAccumulatedGainLossRevaluationAndDisposalOfOtherInvestmentsParentMemberMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_4e5016c7-dd63-4776-9e41-e988dec5b71e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_0a0406d2-056c-456a-b485-caec455e65b8_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_d99c1c73-4a3a-416b-b68c-52c99aaa6359_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueChangesDueToCurrencyTranslation_01aed28f-6595-45ec-86f4-b6d82e22019b_terseLabel_en-US" xlink:label="lab_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueChangesDueToCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect from foreign exchange</link:label>
    <link:label id="lab_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueChangesDueToCurrencyTranslation_label_en-US" xlink:label="lab_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueChangesDueToCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments In And Advances To Affiliates, At Fair Value, Changes Due To Currency Translation</link:label>
    <link:label id="lab_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueChangesDueToCurrencyTranslation_documentation_en-US" xlink:label="lab_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueChangesDueToCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments In And Advances To Affiliates, At Fair Value, Changes Due To Currency Translation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueChangesDueToCurrencyTranslation" xlink:href="cron-20201231.xsd#cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueChangesDueToCurrencyTranslation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueChangesDueToCurrencyTranslation" xlink:to="lab_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueChangesDueToCurrencyTranslation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_8beb8758-d614-4013-af9e-81071b64245c_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapital_93df582f-7145-431c-850b-f8faa2cd605c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapital" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net changes in non-cash working capital</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapital_ed09562d-da47-42eb-a664-67e3ab5ee30b_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapital" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapital_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapital" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapital" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilities_66a810b1-e7f0-4d5d-99a9-8bb7d4061883_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilities" xlink:to="lab_us-gaap_DerivativeLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_179d09d6-3999-489c-822c-bbb8ca2e8152_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_16d6f329-6e46-429a-b178-14339ddba9d0_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_ThreeVendorsMember_6f526365-b85d-4a6c-ae09-a9b2bca72304_terseLabel_en-US" xlink:label="lab_cron_ThreeVendorsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Vendors</link:label>
    <link:label id="lab_cron_ThreeVendorsMember_label_en-US" xlink:label="lab_cron_ThreeVendorsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Vendors [Member]</link:label>
    <link:label id="lab_cron_ThreeVendorsMember_documentation_en-US" xlink:label="lab_cron_ThreeVendorsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Vendors [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ThreeVendorsMember" xlink:href="cron-20201231.xsd#cron_ThreeVendorsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_ThreeVendorsMember" xlink:to="lab_cron_ThreeVendorsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_3d699c7b-d541-46d9-9924-084ecc5de8a0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of provincial tax rate difference</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_IsraeliCodesLicensingAgreementsMember_98671089-875c-43e9-8040-71927c8d27d0_terseLabel_en-US" xlink:label="lab_cron_IsraeliCodesLicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Israeli codes</link:label>
    <link:label id="lab_cron_IsraeliCodesLicensingAgreementsMember_label_en-US" xlink:label="lab_cron_IsraeliCodesLicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Israeli Codes, Licensing Agreements [Member]</link:label>
    <link:label id="lab_cron_IsraeliCodesLicensingAgreementsMember_documentation_en-US" xlink:label="lab_cron_IsraeliCodesLicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Israeli Codes, Licensing Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_IsraeliCodesLicensingAgreementsMember" xlink:href="cron-20201231.xsd#cron_IsraeliCodesLicensingAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_IsraeliCodesLicensingAgreementsMember" xlink:to="lab_cron_IsraeliCodesLicensingAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_56261709-485c-4bb8-9913-c90a009f1b9b_terseLabel_en-US" xlink:label="lab_cron_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets</link:label>
    <link:label id="lab_cron_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_label_en-US" xlink:label="lab_cron_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Operating Lease, Right-Of-Use Assets</link:label>
    <link:label id="lab_cron_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_documentation_en-US" xlink:label="lab_cron_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Operating Lease, Right-Of-Use Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:href="cron-20201231.xsd#cron_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:to="lab_cron_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_d73b2848-69a0-4e47-8af9-ef2431b4ac30_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_label_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_16bbf60c-7e40-411f-8763-bd67b9ac68fe_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Items not affecting cash:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_e4e2fc01-902b-443f-b058-3822ce4e6dec_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_a2abb770-ed55-4408-8ee8-6417c5e4c535_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Not Primary Beneficiary</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Not Primary Beneficiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:to="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncomePercent_9b4e2966-8460-46d2-9122-921c2857284e_terseLabel_en-US" xlink:label="lab_cron_SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncomePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact of change in average variable rate, percent</link:label>
    <link:label id="lab_cron_SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncomePercent_label_en-US" xlink:label="lab_cron_SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncomePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sensitivity Analysis Of Interest Rate Risk Income Statement Impact, Impact Of Change In Average Variable Rate On Interest Income, Percent</link:label>
    <link:label id="lab_cron_SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncomePercent_documentation_en-US" xlink:label="lab_cron_SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncomePercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sensitivity Analysis Of Interest Rate Risk Income Statement Impact, Impact Of Change In Average Variable Rate On Interest Income, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncomePercent" xlink:href="cron-20201231.xsd#cron_SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncomePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncomePercent" xlink:to="lab_cron_SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncomePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_8031558f-d704-4d5e-bb33-0732060ac070_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_AdjustedEarningsBeforeInterestAndTaxes_473f7d30-697a-4d8f-9894-5d582ab7831c_terseLabel_en-US" xlink:label="lab_cron_AdjustedEarningsBeforeInterestAndTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted EBIT</link:label>
    <link:label id="lab_cron_AdjustedEarningsBeforeInterestAndTaxes_label_en-US" xlink:label="lab_cron_AdjustedEarningsBeforeInterestAndTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted Earnings Before Interest And Taxes</link:label>
    <link:label id="lab_cron_AdjustedEarningsBeforeInterestAndTaxes_documentation_en-US" xlink:label="lab_cron_AdjustedEarningsBeforeInterestAndTaxes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted Earnings Before Interest And Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AdjustedEarningsBeforeInterestAndTaxes" xlink:href="cron-20201231.xsd#cron_AdjustedEarningsBeforeInterestAndTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_AdjustedEarningsBeforeInterestAndTaxes" xlink:to="lab_cron_AdjustedEarningsBeforeInterestAndTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonmonetaryTransactionByTypeTable_efdeeeac-ec4e-4923-bd22-72164cf31747_terseLabel_en-US" xlink:label="lab_us-gaap_NonmonetaryTransactionByTypeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonmonetary Transaction, by Type [Table]</link:label>
    <link:label id="lab_us-gaap_NonmonetaryTransactionByTypeTable_label_en-US" xlink:label="lab_us-gaap_NonmonetaryTransactionByTypeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonmonetary Transaction, by Type [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonmonetaryTransactionByTypeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonmonetaryTransactionByTypeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonmonetaryTransactionByTypeTable" xlink:to="lab_us-gaap_NonmonetaryTransactionByTypeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_ee85a715-c77f-43c0-a1a5-66b47398851a_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanDomain" xlink:to="lab_us-gaap_RestructuringPlanDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_CollaborativeArrangementAmountOfAdvances_dbeec094-0272-4057-a87e-4a95202d8705_terseLabel_en-US" xlink:label="lab_cron_CollaborativeArrangementAmountOfAdvances" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration agreement, amount of advances</link:label>
    <link:label id="lab_cron_CollaborativeArrangementAmountOfAdvances_label_en-US" xlink:label="lab_cron_CollaborativeArrangementAmountOfAdvances" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Amount Of Advances</link:label>
    <link:label id="lab_cron_CollaborativeArrangementAmountOfAdvances_documentation_en-US" xlink:label="lab_cron_CollaborativeArrangementAmountOfAdvances" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Amount Of Advances</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CollaborativeArrangementAmountOfAdvances" xlink:href="cron-20201231.xsd#cron_CollaborativeArrangementAmountOfAdvances"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_CollaborativeArrangementAmountOfAdvances" xlink:to="lab_cron_CollaborativeArrangementAmountOfAdvances" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxExemptIncome_681cd76a-070e-45fd-afc0-41c991c31de3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxExemptIncome" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-taxable income</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxExemptIncome_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxExemptIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Exempt Income, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxExemptIncome" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxExemptIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationTaxExemptIncome" xlink:to="lab_us-gaap_IncomeTaxReconciliationTaxExemptIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage_d47c37e9-8d15-4fb7-a900-03a8da8bee5c_terseLabel_en-US" xlink:label="lab_cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funding commitment percentage</link:label>
    <link:label id="lab_cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage_label_en-US" xlink:label="lab_cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments In And Advances To Affiliates, Funding Commitment Percentage</link:label>
    <link:label id="lab_cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage_documentation_en-US" xlink:label="lab_cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments In And Advances To Affiliates, Funding Commitment Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage" xlink:href="cron-20201231.xsd#cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage" xlink:to="lab_cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExchangeOfProductHeldForSaleForSimilarProductMember_a1e3b89c-89bd-41e8-97e4-38a29ee4edbf_terseLabel_en-US" xlink:label="lab_us-gaap_ExchangeOfProductHeldForSaleForSimilarProductMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchased Cannabis Resin and Sold Cannabis Dry Flower</link:label>
    <link:label id="lab_us-gaap_ExchangeOfProductHeldForSaleForSimilarProductMember_label_en-US" xlink:label="lab_us-gaap_ExchangeOfProductHeldForSaleForSimilarProductMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exchange of Product Held-for-sale for Similar Product [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExchangeOfProductHeldForSaleForSimilarProductMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExchangeOfProductHeldForSaleForSimilarProductMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExchangeOfProductHeldForSaleForSimilarProductMember" xlink:to="lab_us-gaap_ExchangeOfProductHeldForSaleForSimilarProductMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_15242254-8cf5-480b-83a0-5bfbc9ea7a12_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease obligation</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_da84b924-57e5-4805-ad98-64197bdfc3f2_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_A2645485OntarioInc.MucciPromissoryNoteMember_c744da5f-39e6-426c-8889-49e45af87096_terseLabel_en-US" xlink:label="lab_cron_A2645485OntarioInc.MucciPromissoryNoteMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2645485 Ontario Inc. Mucci Promissory Note</link:label>
    <link:label id="lab_cron_A2645485OntarioInc.MucciPromissoryNoteMember_label_en-US" xlink:label="lab_cron_A2645485OntarioInc.MucciPromissoryNoteMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2645485 Ontario Inc. Mucci Promissory Note [Member]</link:label>
    <link:label id="lab_cron_A2645485OntarioInc.MucciPromissoryNoteMember_documentation_en-US" xlink:label="lab_cron_A2645485OntarioInc.MucciPromissoryNoteMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2645485 Ontario Inc. Mucci Promissory Note [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_A2645485OntarioInc.MucciPromissoryNoteMember" xlink:href="cron-20201231.xsd#cron_A2645485OntarioInc.MucciPromissoryNoteMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_A2645485OntarioInc.MucciPromissoryNoteMember" xlink:to="lab_cron_A2645485OntarioInc.MucciPromissoryNoteMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue_f257b154-6281-431a-97e7-663badc07b8a_terseLabel_en-US" xlink:label="lab_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average Black-Scholes value at grant date (per option) (in dollars per share)</link:label>
    <link:label id="lab_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement By Share-based Payment Award, Fair Value Assumptions, Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue_documentation_en-US" xlink:label="lab_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement By Share-based Payment Award, Fair Value Assumptions, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue" xlink:href="cron-20201231.xsd#cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue" xlink:to="lab_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_366ec963-4dce-41d3-92b7-3747684f2b11_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_be144ce2-b33b-4ddf-a0e3-dbc4af417e45_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisition, goodwill, expected tax deductible amount</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Goodwill, Expected Tax Deductible Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:to="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_4fcdd20e-7f83-4422-9357-25c6b837aab9_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest revenue</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_FinancingReceivableFaceAmount_3e6f4ad2-0219-4752-8f7d-913e95569d37_terseLabel_en-US" xlink:label="lab_cron_FinancingReceivableFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Face amount</link:label>
    <link:label id="lab_cron_FinancingReceivableFaceAmount_label_en-US" xlink:label="lab_cron_FinancingReceivableFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Face Amount</link:label>
    <link:label id="lab_cron_FinancingReceivableFaceAmount_documentation_en-US" xlink:label="lab_cron_FinancingReceivableFaceAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableFaceAmount" xlink:href="cron-20201231.xsd#cron_FinancingReceivableFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_FinancingReceivableFaceAmount" xlink:to="lab_cron_FinancingReceivableFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_8489c0a9-34a0-4843-85ce-347f43b9dc05_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos Group</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_b247865f-f4b2-46ae-80b2-680de61898a1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_6656cead-391b-4354-9b39-7af330bebde7_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_9d87a017-26eb-48b6-9a3a-df0dd16a9d83_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_CannabisFlowerMember_e78d393c-4c54-41f6-8d9b-0de900e4411e_terseLabel_en-US" xlink:label="lab_cron_CannabisFlowerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cannabis flower</link:label>
    <link:label id="lab_cron_CannabisFlowerMember_label_en-US" xlink:label="lab_cron_CannabisFlowerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cannabis Flower [Member]</link:label>
    <link:label id="lab_cron_CannabisFlowerMember_documentation_en-US" xlink:label="lab_cron_CannabisFlowerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cannabis Flower [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CannabisFlowerMember" xlink:href="cron-20201231.xsd#cron_CannabisFlowerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_CannabisFlowerMember" xlink:to="lab_cron_CannabisFlowerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_cdc444a1-4a1e-429b-9068-3f3bc02e0aac_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_7f05ca89-b600-482c-bc78-0c805ad5dc57_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_6695b5ce-b69f-419b-94e0-040ffed4c281_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvancesToAffiliate_d71a8383-30e7-4a8a-883a-f90009828a61_terseLabel_en-US" xlink:label="lab_us-gaap_AdvancesToAffiliate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advances to joint ventures</link:label>
    <link:label id="lab_us-gaap_AdvancesToAffiliate_c98c49ce-ef0b-45e2-ba43-c2d4d72ee241_periodStartLabel_en-US" xlink:label="lab_us-gaap_AdvancesToAffiliate" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_AdvancesToAffiliate_c74a5822-9b7c-4a3b-8773-2d647b859046_periodEndLabel_en-US" xlink:label="lab_us-gaap_AdvancesToAffiliate" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_AdvancesToAffiliate_label_en-US" xlink:label="lab_us-gaap_AdvancesToAffiliate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advances to Affiliate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvancesToAffiliate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdvancesToAffiliate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvancesToAffiliate" xlink:to="lab_us-gaap_AdvancesToAffiliate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_064ae28d-f894-4697-b411-acbabc00f02e_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on revaluation of derivative liabilities</link:label>
    <link:label id="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_54e26429-04ac-470a-b714-d99ca24052ec_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on revaluation of derivative liabilities</link:label>
    <link:label id="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_label_en-US" xlink:label="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Derivative Instruments, Net, Pretax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:to="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_a0ab1064-9a06-45ee-95bf-dc601f8ab399_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_4488f8f6-dc89-4617-8f73-0a4498d39399_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_83e374a4-fd64-480c-a6cc-15c203daa4a3_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInFinanceReceivables_0d182d21-2d08-47f4-9f83-2fa28e47319d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInFinanceReceivables" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of loans receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInFinanceReceivables_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInFinanceReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Finance Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInFinanceReceivables" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInFinanceReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInFinanceReceivables" xlink:to="lab_us-gaap_IncreaseDecreaseInFinanceReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_ConstructionLoanAgreementMember_2e920cb7-336c-46b5-aed6-4f5f9df8d875_terseLabel_en-US" xlink:label="lab_cron_ConstructionLoanAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction Loan Agreement</link:label>
    <link:label id="lab_cron_ConstructionLoanAgreementMember_label_en-US" xlink:label="lab_cron_ConstructionLoanAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction Loan Agreement [Member]</link:label>
    <link:label id="lab_cron_ConstructionLoanAgreementMember_documentation_en-US" xlink:label="lab_cron_ConstructionLoanAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction Loan Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ConstructionLoanAgreementMember" xlink:href="cron-20201231.xsd#cron_ConstructionLoanAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_ConstructionLoanAgreementMember" xlink:to="lab_cron_ConstructionLoanAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisesInPeriod_0b00e3a5-c33e-444e-bce8-6079c00bcce1_terseLabel_en-US" xlink:label="lab_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisesInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants exercised (in shares)</link:label>
    <link:label id="lab_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisesInPeriod_label_en-US" xlink:label="lab_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisesInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement By Share-based Payment Award, Warrants, Exercises In Period</link:label>
    <link:label id="lab_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisesInPeriod_documentation_en-US" xlink:label="lab_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisesInPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement By Share-based Payment Award, Warrants, Exercises In Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisesInPeriod" xlink:href="cron-20201231.xsd#cron_SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisesInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisesInPeriod" xlink:to="lab_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisesInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_c8f5ac63-7457-418d-828b-748b3871c0af_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_c2287df0-4c0b-42c3-8b6e-d68d75874f48_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_8feaea7e-6bd6-49ee-b2c5-d1a1481c206e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based payments</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_c373fe6c-be58-4858-89e5-a6f5d2a41af6_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plant and equipment</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_c9fa68e8-c4b6-4d01-a540-a4df5b62bdcb_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill) [Abstract]</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_50dacb3f-408e-4a30-80de-0d8d66bb2204_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermPurchaseCommitmentPeriod_1fbbf1aa-635f-4312-a61e-0160cd175be8_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermPurchaseCommitmentPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research funding period</link:label>
    <link:label id="lab_us-gaap_LongtermPurchaseCommitmentPeriod_label_en-US" xlink:label="lab_us-gaap_LongtermPurchaseCommitmentPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Purchase Commitment, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermPurchaseCommitmentPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermPurchaseCommitmentPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermPurchaseCommitmentPeriod" xlink:to="lab_us-gaap_LongtermPurchaseCommitmentPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_953560ab-0b1a-44f8-b02d-76c4826e1b23_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_ceeee548-fa4e-4c9c-9c3f-fb0384518a66_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized (loss) gain</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_f174e304-73d2-4a77-80aa-47fa3b280255_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_0c69389a-1477-44cb-b113-6891342503ff_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income (Loss) before Income Taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_AltriaGroupInc.Member_cafcc2c3-a60d-4449-955a-6ba8d026f788_terseLabel_en-US" xlink:label="lab_cron_AltriaGroupInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Altria Group, Inc.</link:label>
    <link:label id="lab_cron_AltriaGroupInc.Member_label_en-US" xlink:label="lab_cron_AltriaGroupInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Altria Group, Inc. [Member]</link:label>
    <link:label id="lab_cron_AltriaGroupInc.Member_documentation_en-US" xlink:label="lab_cron_AltriaGroupInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Altria Group, Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaGroupInc.Member" xlink:href="cron-20201231.xsd#cron_AltriaGroupInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_AltriaGroupInc.Member" xlink:to="lab_cron_AltriaGroupInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_HealthCanadaLicensingAgreementsMember_19cd62d2-cca5-4caa-830f-4c9ec2c0b100_terseLabel_en-US" xlink:label="lab_cron_HealthCanadaLicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Canada licenses</link:label>
    <link:label id="lab_cron_HealthCanadaLicensingAgreementsMember_label_en-US" xlink:label="lab_cron_HealthCanadaLicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Canada Licensing Agreements [Member]</link:label>
    <link:label id="lab_cron_HealthCanadaLicensingAgreementsMember_documentation_en-US" xlink:label="lab_cron_HealthCanadaLicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Canada Licensing Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_HealthCanadaLicensingAgreementsMember" xlink:href="cron-20201231.xsd#cron_HealthCanadaLicensingAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_HealthCanadaLicensingAgreementsMember" xlink:to="lab_cron_HealthCanadaLicensingAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_750c12df-e3d3-4744-b78c-a6e97d8b5b96_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_CannabisExtractsMember_edda0974-5d13-47af-a216-823ff59eac88_terseLabel_en-US" xlink:label="lab_cron_CannabisExtractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cannabis extracts</link:label>
    <link:label id="lab_cron_CannabisExtractsMember_label_en-US" xlink:label="lab_cron_CannabisExtractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cannabis Extracts [Member]</link:label>
    <link:label id="lab_cron_CannabisExtractsMember_documentation_en-US" xlink:label="lab_cron_CannabisExtractsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cannabis Extracts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CannabisExtractsMember" xlink:href="cron-20201231.xsd#cron_CannabisExtractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_CannabisExtractsMember" xlink:to="lab_cron_CannabisExtractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_9127d59c-db55-4877-9235-702786383344_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_aa141e28-5202-419f-aec1-87efbea131e3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from discontinued operations attributable to common shareholders of Cronos Group</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostAbstract_e3bdf2de-0423-40a7-b25f-bdc1a590f799_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease cost</link:label>
    <link:label id="lab_us-gaap_LeaseCostAbstract_label_en-US" xlink:label="lab_us-gaap_LeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostAbstract" xlink:to="lab_us-gaap_LeaseCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardDateDomain_5e51b6bb-4c12-4bca-a175-80618d14b78d_terseLabel_en-US" xlink:label="lab_us-gaap_AwardDateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date [Domain]</link:label>
    <link:label id="lab_us-gaap_AwardDateDomain_label_en-US" xlink:label="lab_us-gaap_AwardDateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardDateDomain" xlink:to="lab_us-gaap_AwardDateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_ProceedsFromEquitySecuritiesFVNIAndEquitySecuritiesWithoutDeterminableFairValue_46737892-2df4-4999-95f8-fe719ba6ca08_terseLabel_en-US" xlink:label="lab_cron_ProceedsFromEquitySecuritiesFVNIAndEquitySecuritiesWithoutDeterminableFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of other investments</link:label>
    <link:label id="lab_cron_ProceedsFromEquitySecuritiesFVNIAndEquitySecuritiesWithoutDeterminableFairValue_label_en-US" xlink:label="lab_cron_ProceedsFromEquitySecuritiesFVNIAndEquitySecuritiesWithoutDeterminableFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Equity Securities, FV-NI And Equity Securities Without Determinable Fair Value</link:label>
    <link:label id="lab_cron_ProceedsFromEquitySecuritiesFVNIAndEquitySecuritiesWithoutDeterminableFairValue_documentation_en-US" xlink:label="lab_cron_ProceedsFromEquitySecuritiesFVNIAndEquitySecuritiesWithoutDeterminableFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Equity Securities, FV-NI And Equity Securities Without Determinable Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ProceedsFromEquitySecuritiesFVNIAndEquitySecuritiesWithoutDeterminableFairValue" xlink:href="cron-20201231.xsd#cron_ProceedsFromEquitySecuritiesFVNIAndEquitySecuritiesWithoutDeterminableFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_ProceedsFromEquitySecuritiesFVNIAndEquitySecuritiesWithoutDeterminableFairValue" xlink:to="lab_cron_ProceedsFromEquitySecuritiesFVNIAndEquitySecuritiesWithoutDeterminableFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_a079b829-2138-4f66-861e-50fb5ea43c22_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_af934d91-0357-48ef-845f-de38507a6b0c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_FinancingReceivableAccruedInterestCurrent_a35f0ca5-2ffd-4239-9e87-b6943edaa5eb_terseLabel_en-US" xlink:label="lab_cron_FinancingReceivableAccruedInterestCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Add: Accrued interest</link:label>
    <link:label id="lab_cron_FinancingReceivableAccruedInterestCurrent_label_en-US" xlink:label="lab_cron_FinancingReceivableAccruedInterestCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Accrued Interest, Current</link:label>
    <link:label id="lab_cron_FinancingReceivableAccruedInterestCurrent_documentation_en-US" xlink:label="lab_cron_FinancingReceivableAccruedInterestCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Accrued Interest, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableAccruedInterestCurrent" xlink:href="cron-20201231.xsd#cron_FinancingReceivableAccruedInterestCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_FinancingReceivableAccruedInterestCurrent" xlink:to="lab_cron_FinancingReceivableAccruedInterestCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_84264c22-d8e6-4624-8f6f-2ad303fb0071_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesAbstract_f27d84f8-e76f-44cd-96a5-461b227d6a4e_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables [Abstract]</link:label>
    <link:label id="lab_us-gaap_ReceivablesAbstract_label_en-US" xlink:label="lab_us-gaap_ReceivablesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesAbstract" xlink:to="lab_us-gaap_ReceivablesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_2d1dbfe5-bac2-495a-b175-ee9956efe965_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardDateAxis_d8e9298a-dd56-4b88-aee4-2111bd939917_terseLabel_en-US" xlink:label="lab_us-gaap_AwardDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardDateAxis_label_en-US" xlink:label="lab_us-gaap_AwardDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardDateAxis" xlink:to="lab_us-gaap_AwardDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_A2018StockOptionPlanMember_4846d884-1f4b-4851-8938-a191c5cee32c_terseLabel_en-US" xlink:label="lab_cron_A2018StockOptionPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018 Stock Option Plan</link:label>
    <link:label id="lab_cron_A2018StockOptionPlanMember_label_en-US" xlink:label="lab_cron_A2018StockOptionPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018 Stock Option Plan [Member]</link:label>
    <link:label id="lab_cron_A2018StockOptionPlanMember_documentation_en-US" xlink:label="lab_cron_A2018StockOptionPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018 Stock Option Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_A2018StockOptionPlanMember" xlink:href="cron-20201231.xsd#cron_A2018StockOptionPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_A2018StockOptionPlanMember" xlink:to="lab_cron_A2018StockOptionPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_ebd62cc1-0d60-43b2-b1cf-32cbd93fd571_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_8f1cec55-be9a-4cec-8d34-cac485311838_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-controlling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_112b4079-e19b-45f8-85f1-02ea36c32093_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_e8c8b55e-c3c6-487a-8e37-a2e4d3712f27_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_43d5c057-ef3b-4589-8ed8-6ce3e2b4cda0_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_b0ace2db-f357-46bb-be45-d18cc8dc9a2b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_018621ea-ac17-48a9-a340-5f34c9f0bb23_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_d4160fe1-1a01-4f7d-badf-b60615c5c542_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Stock</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireLoansReceivable_c9e0894b-2a5b-49c6-a1db-22bb41030b32_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireLoansReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advances on loans receivable</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireLoansReceivable_53216236-b5af-4f69-94a6-766f1f170667_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireLoansReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Draw downs</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireLoansReceivable_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireLoansReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Loans Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireLoansReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireLoansReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireLoansReceivable" xlink:to="lab_us-gaap_PaymentsToAcquireLoansReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_c02690d1-e8ec-4c23-8190-0adc87fcc592_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_c3d941f2-472d-4024-9f0b-bcc6fc56aeff_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:to="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonmonetaryTransactionLineItems_f9f7e005-f9d7-4907-8b5b-e50cdb2711db_terseLabel_en-US" xlink:label="lab_us-gaap_NonmonetaryTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonmonetary Transaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_NonmonetaryTransactionLineItems_label_en-US" xlink:label="lab_us-gaap_NonmonetaryTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonmonetary Transaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonmonetaryTransactionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonmonetaryTransactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonmonetaryTransactionLineItems" xlink:to="lab_us-gaap_NonmonetaryTransactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightDomain_40f0f68d-9dcc-4525-9e1f-f22c18de09c0_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain" xlink:to="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_8b4d9d08-02e1-4e58-a7eb-f3fcd0a80446_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_8332ab6c-1fc8-4c89-91d8-db23b7d7af89_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary or Equity Method Investee [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_label_en-US" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary or Equity Method Investee [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_5db3158f-19f4-4d1f-af51-c48a923aceaf_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_e75521c1-be69-48a4-bf1e-34a3901e32c3_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_3b3752e0-be6f-42f2-8991-f481a4fb9e0f_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_62d72ab1-1abd-4c09-b2f3-20ae9319afdd_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_InvestmentOwnedNumberOfSharesReceived_df16d1c7-323b-49c1-8be0-05ca56945a8e_terseLabel_en-US" xlink:label="lab_cron_InvestmentOwnedNumberOfSharesReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares received (in shares)</link:label>
    <link:label id="lab_cron_InvestmentOwnedNumberOfSharesReceived_label_en-US" xlink:label="lab_cron_InvestmentOwnedNumberOfSharesReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Owned, Number Of Shares Received</link:label>
    <link:label id="lab_cron_InvestmentOwnedNumberOfSharesReceived_documentation_en-US" xlink:label="lab_cron_InvestmentOwnedNumberOfSharesReceived" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Owned, Number Of Shares Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentOwnedNumberOfSharesReceived" xlink:href="cron-20201231.xsd#cron_InvestmentOwnedNumberOfSharesReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_InvestmentOwnedNumberOfSharesReceived" xlink:to="lab_cron_InvestmentOwnedNumberOfSharesReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_EffectiveIncomeTaxRateReconciliationFairValueGainFinancialLiabilities_290ffcac-8be5-40d7-8cd8-297594548248_negatedTerseLabel_en-US" xlink:label="lab_cron_EffectiveIncomeTaxRateReconciliationFairValueGainFinancialLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value gain on financial liabilities</link:label>
    <link:label id="lab_cron_EffectiveIncomeTaxRateReconciliationFairValueGainFinancialLiabilities_label_en-US" xlink:label="lab_cron_EffectiveIncomeTaxRateReconciliationFairValueGainFinancialLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Fair Value Gain, Financial Liabilities</link:label>
    <link:label id="lab_cron_EffectiveIncomeTaxRateReconciliationFairValueGainFinancialLiabilities_documentation_en-US" xlink:label="lab_cron_EffectiveIncomeTaxRateReconciliationFairValueGainFinancialLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Fair Value Gain, Financial Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_EffectiveIncomeTaxRateReconciliationFairValueGainFinancialLiabilities" xlink:href="cron-20201231.xsd#cron_EffectiveIncomeTaxRateReconciliationFairValueGainFinancialLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_EffectiveIncomeTaxRateReconciliationFairValueGainFinancialLiabilities" xlink:to="lab_cron_EffectiveIncomeTaxRateReconciliationFairValueGainFinancialLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_NumberOfContinentsWithInternationalProductionAndDistribution_ba91a366-fa0b-4415-8752-65a55ad6fed4_terseLabel_en-US" xlink:label="lab_cron_NumberOfContinentsWithInternationalProductionAndDistribution" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of continents with international production and distribution</link:label>
    <link:label id="lab_cron_NumberOfContinentsWithInternationalProductionAndDistribution_label_en-US" xlink:label="lab_cron_NumberOfContinentsWithInternationalProductionAndDistribution" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Continents With International Production And Distribution</link:label>
    <link:label id="lab_cron_NumberOfContinentsWithInternationalProductionAndDistribution_documentation_en-US" xlink:label="lab_cron_NumberOfContinentsWithInternationalProductionAndDistribution" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Continents With International Production And Distribution</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NumberOfContinentsWithInternationalProductionAndDistribution" xlink:href="cron-20201231.xsd#cron_NumberOfContinentsWithInternationalProductionAndDistribution"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_NumberOfContinentsWithInternationalProductionAndDistribution" xlink:to="lab_cron_NumberOfContinentsWithInternationalProductionAndDistribution" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_6efb80ae-778b-4c4b-9578-3f4058b26f46_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change due to foreign exchange</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_596faf52-624c-48bb-804a-e255b47f5d75_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_74e4d6f1-cdf4-4f29-9589-8735a07c26d6_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_PeaceNaturalsReportingUnitMember_8080e994-d4e6-419d-8e1b-0018919c835c_terseLabel_en-US" xlink:label="lab_cron_PeaceNaturalsReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peace Naturals</link:label>
    <link:label id="lab_cron_PeaceNaturalsReportingUnitMember_label_en-US" xlink:label="lab_cron_PeaceNaturalsReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peace Naturals Reporting Unit [Member]</link:label>
    <link:label id="lab_cron_PeaceNaturalsReportingUnitMember_documentation_en-US" xlink:label="lab_cron_PeaceNaturalsReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peace Naturals Reporting Unit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PeaceNaturalsReportingUnitMember" xlink:href="cron-20201231.xsd#cron_PeaceNaturalsReportingUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_PeaceNaturalsReportingUnitMember" xlink:to="lab_cron_PeaceNaturalsReportingUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_6a3bc483-7601-4acf-80b2-62aa767cd403_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, impairment loss</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_1ab11d92-98cf-4207-a6e9-5ea9e8f2a9ba_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment charges</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_6a7cad97-401f-4305-9951-2e155a30bc94_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_65079694-26ed-4eed-97d4-28cb976381ff_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_79e3fed4-639c-4e98-8561-f03abaa550c7_terseLabel_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities:</link:label>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Deferred Tax Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:to="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_2d1f5a19-2fa4-47fd-8552-b3e96ee59bc5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain recognized in net income (loss)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments, Net of Dividends or Distributions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_SaleOfStockPerformanceMilestoneOneMember_b632d6c4-7703-45ef-9d0a-4e19b7fc17cd_terseLabel_en-US" xlink:label="lab_cron_SaleOfStockPerformanceMilestoneOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Performance Milestone One</link:label>
    <link:label id="lab_cron_SaleOfStockPerformanceMilestoneOneMember_label_en-US" xlink:label="lab_cron_SaleOfStockPerformanceMilestoneOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Performance Milestone One [Member]</link:label>
    <link:label id="lab_cron_SaleOfStockPerformanceMilestoneOneMember_documentation_en-US" xlink:label="lab_cron_SaleOfStockPerformanceMilestoneOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Performance Milestone One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SaleOfStockPerformanceMilestoneOneMember" xlink:href="cron-20201231.xsd#cron_SaleOfStockPerformanceMilestoneOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_SaleOfStockPerformanceMilestoneOneMember" xlink:to="lab_cron_SaleOfStockPerformanceMilestoneOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_f827fcad-e43c-4249-8484-bfe4ee60d183_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksMember_d0fb39df-b39b-42c7-b1b7-ea29b1ce5a66_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks</link:label>
    <link:label id="lab_us-gaap_TrademarksMember_label_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksMember" xlink:to="lab_us-gaap_TrademarksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCosts_79685768-b6a7-415f-9555-20a10290ab68_verboseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash repurposing costs</link:label>
    <link:label id="lab_us-gaap_RestructuringCosts_label_en-US" xlink:label="lab_us-gaap_RestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCosts" xlink:to="lab_us-gaap_RestructuringCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_fcd5611c-0e0f-4108-b6e9-44678660d627_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_63853d03-8587-4003-8db3-9419af0e6a33_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_label_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis with Unobservable Inputs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" xlink:to="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_373e9e99-aa97-465c-8173-a007edafabfd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_9a7ebbb7-c3d7-4def-8d1f-dc4749ad0aa4_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_3084c522-13e2-4be1-8753-8284528c673e_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred:</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_ClassOfWarrantOrRightMinimumOwnershipPercentageRequired_031e5a5e-3b60-471a-92f8-e48ec91e83de_terseLabel_en-US" xlink:label="lab_cron_ClassOfWarrantOrRightMinimumOwnershipPercentageRequired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise rights, minimum ownership percentage</link:label>
    <link:label id="lab_cron_ClassOfWarrantOrRightMinimumOwnershipPercentageRequired_label_en-US" xlink:label="lab_cron_ClassOfWarrantOrRightMinimumOwnershipPercentageRequired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Minimum Ownership Percentage Required</link:label>
    <link:label id="lab_cron_ClassOfWarrantOrRightMinimumOwnershipPercentageRequired_documentation_en-US" xlink:label="lab_cron_ClassOfWarrantOrRightMinimumOwnershipPercentageRequired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Minimum Ownership Percentage Required</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ClassOfWarrantOrRightMinimumOwnershipPercentageRequired" xlink:href="cron-20201231.xsd#cron_ClassOfWarrantOrRightMinimumOwnershipPercentageRequired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_ClassOfWarrantOrRightMinimumOwnershipPercentageRequired" xlink:to="lab_cron_ClassOfWarrantOrRightMinimumOwnershipPercentageRequired" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsForfeitureRate_fba72a43-392d-492d-9428-4d4867d767bd_terseLabel_en-US" xlink:label="lab_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsForfeitureRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeiture rate</link:label>
    <link:label id="lab_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsForfeitureRate_label_en-US" xlink:label="lab_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsForfeitureRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement By Share-based Payment Award, Fair Value Assumptions, Forfeiture Rate</link:label>
    <link:label id="lab_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsForfeitureRate_documentation_en-US" xlink:label="lab_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsForfeitureRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement By Share-based Payment Award, Fair Value Assumptions, Forfeiture Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsForfeitureRate" xlink:href="cron-20201231.xsd#cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsForfeitureRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsForfeitureRate" xlink:to="lab_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsForfeitureRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_2fd1e3c0-666d-433a-975a-b1e0c9c56b2a_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense)</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_dc876803-8bfc-4cf7-a4b2-626bc00b334a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingAxis_81ff9a41-d330-45c2-9629-2e6c1d30713a_terseLabel_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:label id="lab_us-gaap_VestingAxis_label_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingAxis" xlink:to="lab_us-gaap_VestingAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_be56caba-953a-4ffa-b0d9-02624b899a11_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current:</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_90536620-4aa2-4921-8e43-d2629f4ff094_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic loss from discontinued operations per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesAndLoansReceivableNetCurrent_740f72e6-30aa-4fb8-a954-7e613ab0e43b_terseLabel_en-US" xlink:label="lab_us-gaap_NotesAndLoansReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of loans receivable</link:label>
    <link:label id="lab_us-gaap_NotesAndLoansReceivableNetCurrent_c40139be-3c61-47e3-9819-a438d1f19306_totalLabel_en-US" xlink:label="lab_us-gaap_NotesAndLoansReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current portion of loans receivable</link:label>
    <link:label id="lab_us-gaap_NotesAndLoansReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_NotesAndLoansReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesAndLoansReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesAndLoansReceivableNetCurrent" xlink:to="lab_us-gaap_NotesAndLoansReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_82f4bbdb-65d0-4257-bfc3-25b5bc071aea_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of net assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_a54fc60a-6c14-499c-8d38-be98c89cbcb8_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expenses</link:label>
    <link:label id="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Financial Information Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalFinancialInformationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:to="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_689b6d5a-578c-4133-90a6-6b21dfc7b70d_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_95341daf-4148-43ef-b971-3d6f75ef7683_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_8c0486a7-0e95-4e70-ae24-2befefcf6794_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_bb0bbcb0-df87-4224-9287-938b4167d318_terseLabel_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred assets:</link:label>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Deferred Tax Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_70e9f49c-fa0d-4c02-8508-75bdcb599557_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_2aba133d-1af1-4dc6-8133-ba64618e30c7_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_d17194a6-930f-4e73-bd39-acceb404ffc1_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic earnings (loss) per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDisclosures_994286b4-4600-45c7-b91f-a056c0db872c_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDisclosures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingencies</link:label>
    <link:label id="lab_us-gaap_LossContingencyDisclosures_label_en-US" xlink:label="lab_us-gaap_LossContingencyDisclosures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDisclosures" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyDisclosures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDisclosures" xlink:to="lab_us-gaap_LossContingencyDisclosures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_cc799070-4d09-46ce-a529-ee3214205c80_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected life of options (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_5186eaa5-6029-46b2-b63f-2e289bf75ca0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_79583801-5455-439c-b2fd-18d0ad9e8779_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesAndLoansReceivableNetNoncurrent_ffa33dfd-4023-4087-9fc6-2ce57e307b68_terseLabel_en-US" xlink:label="lab_us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans receivable, net</link:label>
    <link:label id="lab_us-gaap_NotesAndLoansReceivableNetNoncurrent_b54e91bf-505a-424f-bdd1-670d0a3a47ac_totalLabel_en-US" xlink:label="lab_us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term portion of loans receivable</link:label>
    <link:label id="lab_us-gaap_NotesAndLoansReceivableNetNoncurrent_label_en-US" xlink:label="lab_us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, after Allowance for Credit Loss, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesAndLoansReceivableNetNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:to="lab_us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_2b0c526e-db01-46a4-ac6c-7ec5503e73aa_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average remaining lease term &#8211; operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentLineItems_438c3a22-c65c-42c0-9f15-8fc4907f89c8_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Purchase Commitment [Line Items]</link:label>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentLineItems_label_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Purchase Commitment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermPurchaseCommitmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems" xlink:to="lab_us-gaap_LongTermPurchaseCommitmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_b541fcce-0bef-4cfb-8e83-4e5053a35abd_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from discontinued operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_64fcb87d-405d-4c38-a5e3-31b08b4fae73_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from discontinued operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_a97ca9de-6b72-45a6-ab4a-7083b8221c2f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:to="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryValuationReserves_348bb004-9dd7-458d-a4f6-3df994efe125_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryValuationReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory valuation reserves</link:label>
    <link:label id="lab_us-gaap_InventoryValuationReserves_label_en-US" xlink:label="lab_us-gaap_InventoryValuationReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Valuation Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryValuationReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryValuationReserves" xlink:to="lab_us-gaap_InventoryValuationReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_09e486d5-3d86-49f0-95df-c6eae0bce12a_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based payments</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_a904827b-6b33-4180-9088-a51dd1ab3824_verboseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granting and vesting of DSUs</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNumberOfPlaintiffs_627989af-4e82-4c36-8d67-cd1f6d7e5fb5_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of alleged shareholders</link:label>
    <link:label id="lab_us-gaap_LossContingencyNumberOfPlaintiffs_label_en-US" xlink:label="lab_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Plaintiffs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:to="lab_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_3e30ba7e-ae3c-429d-a4cc-671c8cda8b48_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net revenue, before excise taxes</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Including Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_39c2beb0-d58a-4b8d-a07f-af7b000ff7bf_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of outstanding shares</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted, Other Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d7d25986-f3cf-4c53-be57-b5b45c2f2c7e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0e18608e-4940-4852-9e16-21b70fef9577_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_1553f988-6390-465c-9892-f7f3167a815f_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAbstract_e6c61966-7814-4bb3-b5e7-a854e9516422_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency [Abstract]</link:label>
    <link:label id="lab_us-gaap_LossContingencyAbstract_label_en-US" xlink:label="lab_us-gaap_LossContingencyAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAbstract" xlink:to="lab_us-gaap_LossContingencyAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_ce4f54e6-2793-4ac9-9626-04a98c9f3d64_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Category of Item Purchased [Axis]</link:label>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_label_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Category of Item Purchased [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:to="lab_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_f3cfa282-a47b-4a7e-9206-b706d906585d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Loan Receivable</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAdditions_1ae9d6b0-2d6e-4ddc-90c5-4096cf3d6395_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAdditions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAdditions_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAdditions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Additions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAdditions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAdditions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAdditions" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAdditions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputPriceVolatilityMember_6685caac-64b1-4c7e-99bd-c5d142d3f194_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputPriceVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected annualized volatility</link:label>
    <link:label id="lab_us-gaap_MeasurementInputPriceVolatilityMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputPriceVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Price Volatility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputPriceVolatilityMember" xlink:to="lab_us-gaap_MeasurementInputPriceVolatilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivableTypeDomain_6b57ca63-7edd-4368-ad24-b6e3c70a4235_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivableTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Domain]</link:label>
    <link:label id="lab_us-gaap_ReceivableTypeDomain_label_en-US" xlink:label="lab_us-gaap_ReceivableTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivableTypeDomain" xlink:to="lab_us-gaap_ReceivableTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_e347812d-ebb8-4a6c-9699-f3b47f42fbc9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_745f99d5-5240-4f15-b9d4-05ead0b4a6dd_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-controlling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_7d3dd16a-83de-429c-8087-f89e33a85ae3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_076bf1e8-4a40-4bae-b0ec-8afe4dae83b4_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember_8c91fd49-5a12-425f-8280-cc275d9f260e_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Risk Free Interest Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:to="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_ShareBasedPaymentArrangementLiabilitiesSettled_37d488b8-b56d-47f6-b3b4-b4a3204f7862_negatedTerseLabel_en-US" xlink:label="lab_cron_ShareBasedPaymentArrangementLiabilitiesSettled" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities settled</link:label>
    <link:label id="lab_cron_ShareBasedPaymentArrangementLiabilitiesSettled_label_en-US" xlink:label="lab_cron_ShareBasedPaymentArrangementLiabilitiesSettled" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Liabilities Settled</link:label>
    <link:label id="lab_cron_ShareBasedPaymentArrangementLiabilitiesSettled_documentation_en-US" xlink:label="lab_cron_ShareBasedPaymentArrangementLiabilitiesSettled" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Liabilities Settled</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ShareBasedPaymentArrangementLiabilitiesSettled" xlink:href="cron-20201231.xsd#cron_ShareBasedPaymentArrangementLiabilitiesSettled"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_ShareBasedPaymentArrangementLiabilitiesSettled" xlink:to="lab_cron_ShareBasedPaymentArrangementLiabilitiesSettled" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_4ff3e24b-5aa5-4700-89dc-0e010e5bd170_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfIncomeTaxExaminationsTextBlock_098cc48c-78d9-4bed-b9df-92ec6445d29e_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfIncomeTaxExaminationsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Income Tax Examinations</link:label>
    <link:label id="lab_us-gaap_SummaryOfIncomeTaxExaminationsTextBlock_label_en-US" xlink:label="lab_us-gaap_SummaryOfIncomeTaxExaminationsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Income Tax Examinations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfIncomeTaxExaminationsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SummaryOfIncomeTaxExaminationsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfIncomeTaxExaminationsTextBlock" xlink:to="lab_us-gaap_SummaryOfIncomeTaxExaminationsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_FinancingReceivableBeforeAccruedInterestCurrent_7514ff19-96ba-48d6-9c0f-2133d9de4371_terseLabel_en-US" xlink:label="lab_cron_FinancingReceivableBeforeAccruedInterestCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of loans receivable, before accrued interest</link:label>
    <link:label id="lab_cron_FinancingReceivableBeforeAccruedInterestCurrent_label_en-US" xlink:label="lab_cron_FinancingReceivableBeforeAccruedInterestCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Before Accrued Interest, Current</link:label>
    <link:label id="lab_cron_FinancingReceivableBeforeAccruedInterestCurrent_documentation_en-US" xlink:label="lab_cron_FinancingReceivableBeforeAccruedInterestCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Before Accrued Interest, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableBeforeAccruedInterestCurrent" xlink:href="cron-20201231.xsd#cron_FinancingReceivableBeforeAccruedInterestCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_FinancingReceivableBeforeAccruedInterestCurrent" xlink:to="lab_cron_FinancingReceivableBeforeAccruedInterestCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusAxis_b7277c3c-b4d9-4b95-b609-c088c3006c9f_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusAxis_label_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusAxis" xlink:to="lab_us-gaap_LitigationStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_ConsultingServicesArrangementMember_2fab1fb9-2b27-4008-ac17-6ee4132f4aed_terseLabel_en-US" xlink:label="lab_cron_ConsultingServicesArrangementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consulting Services Arrangement</link:label>
    <link:label id="lab_cron_ConsultingServicesArrangementMember_label_en-US" xlink:label="lab_cron_ConsultingServicesArrangementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consulting Services Arrangement [Member]</link:label>
    <link:label id="lab_cron_ConsultingServicesArrangementMember_documentation_en-US" xlink:label="lab_cron_ConsultingServicesArrangementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consulting Services Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ConsultingServicesArrangementMember" xlink:href="cron-20201231.xsd#cron_ConsultingServicesArrangementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_ConsultingServicesArrangementMember" xlink:to="lab_cron_ConsultingServicesArrangementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate_6d1e097f-5349-4c3d-9659-0f2aa4b7f63f_terseLabel_en-US" xlink:label="lab_cron_SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact of ten percent change in exchange rate</link:label>
    <link:label id="lab_cron_SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate_label_en-US" xlink:label="lab_cron_SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sensitivity Analysis Of Carrying Value, Net Assets, Impact Of 10 Percent Change In Exchange Rate</link:label>
    <link:label id="lab_cron_SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate_documentation_en-US" xlink:label="lab_cron_SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sensitivity Analysis Of Carrying Value, Net Assets, Impact Of 10 Percent Change In Exchange Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate" xlink:href="cron-20201231.xsd#cron_SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate" xlink:to="lab_cron_SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_8184e859-c0d2-408c-bc5b-450e80b8625c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_2c6ee012-d3c6-4e08-803a-9a45d9f62881_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_2fa79d26-908c-4b3e-b0ad-ab50836e3eea_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share issuance costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_b7972dfb-ed07-46d8-8ce1-9973a5d60796_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share issuance costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Stock Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_OGBCMember_17eae717-9e1f-4aef-b2a7-52aec903ed01_terseLabel_en-US" xlink:label="lab_cron_OGBCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OGBC</link:label>
    <link:label id="lab_cron_OGBCMember_label_en-US" xlink:label="lab_cron_OGBCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OGBC [Member]</link:label>
    <link:label id="lab_cron_OGBCMember_documentation_en-US" xlink:label="lab_cron_OGBCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OGBC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_OGBCMember" xlink:href="cron-20201231.xsd#cron_OGBCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_OGBCMember" xlink:to="lab_cron_OGBCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_f4f1ba41-feb1-4a1a-b0b6-0f272c64a03c_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_DeferredTaxLiabilitiesLicenses_7363ca69-974a-41e6-9291-7702f6a7139b_negatedTerseLabel_en-US" xlink:label="lab_cron_DeferredTaxLiabilitiesLicenses" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License</link:label>
    <link:label id="lab_cron_DeferredTaxLiabilitiesLicenses_label_en-US" xlink:label="lab_cron_DeferredTaxLiabilitiesLicenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Licenses</link:label>
    <link:label id="lab_cron_DeferredTaxLiabilitiesLicenses_documentation_en-US" xlink:label="lab_cron_DeferredTaxLiabilitiesLicenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Licenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DeferredTaxLiabilitiesLicenses" xlink:href="cron-20201231.xsd#cron_DeferredTaxLiabilitiesLicenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_DeferredTaxLiabilitiesLicenses" xlink:to="lab_cron_DeferredTaxLiabilitiesLicenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_c6276ac9-0117-47c4-b3d9-0b5dce54c78c_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfBusinessesAcquired_2db045b2-877a-4db4-9831-b26f59f159f5_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfBusinessesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating subsidiaries acquired</link:label>
    <link:label id="lab_us-gaap_NumberOfBusinessesAcquired_label_en-US" xlink:label="lab_us-gaap_NumberOfBusinessesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Businesses Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfBusinessesAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfBusinessesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfBusinessesAcquired" xlink:to="lab_us-gaap_NumberOfBusinessesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_5f37ded1-f148-4a07-a736-272188bca3e9_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_DeferredTaxAssetsDebtIssuanceCosts_5d1bf2e4-3b92-4ddb-ac46-51802f59616c_terseLabel_en-US" xlink:label="lab_cron_DeferredTaxAssetsDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred financing costs</link:label>
    <link:label id="lab_cron_DeferredTaxAssetsDebtIssuanceCosts_label_en-US" xlink:label="lab_cron_DeferredTaxAssetsDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Debt Issuance Costs</link:label>
    <link:label id="lab_cron_DeferredTaxAssetsDebtIssuanceCosts_documentation_en-US" xlink:label="lab_cron_DeferredTaxAssetsDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DeferredTaxAssetsDebtIssuanceCosts" xlink:href="cron-20201231.xsd#cron_DeferredTaxAssetsDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_DeferredTaxAssetsDebtIssuanceCosts" xlink:to="lab_cron_DeferredTaxAssetsDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_24f29058-0bc7-4e7a-a1a2-b1772b2edfb5_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_8c2e8214-eb4f-470e-bd6a-ed9af258387a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrent_534a490b-983c-4c72-ae6c-f3073e35e4bd_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrent" xlink:to="lab_us-gaap_LiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldDepreciation_120ec709-7bd6-4c6d-8716-46c090b4c2bf_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldDepreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation expense included in costs of sales</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldDepreciation_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldDepreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost, Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldDepreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciation" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSoldDepreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_7adbc118-9864-48a1-a23c-b7e5b056f331_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_f16cb32c-9909-4d0f-8538-93ea19bf4a3c_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesReceivableNet_e123f697-b800-4fdb-8f55-cc85419ea5a3_totalLabel_en-US" xlink:label="lab_us-gaap_NotesReceivableNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total loans receivable</link:label>
    <link:label id="lab_us-gaap_NotesReceivableNet_label_en-US" xlink:label="lab_us-gaap_NotesReceivableNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesReceivableNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesReceivableNet" xlink:to="lab_us-gaap_NotesReceivableNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_1faa9192-4799-4f73-9fdf-088e46eec1fa_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_2c72a23b-b749-4062-bf19-ac0a46951194_totalLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_254fb224-62d3-4e00-a431-0ce220850329_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total anti-dilutive securities (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_29673912-574a-466b-a5c5-f5ae2aaadf38_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_EffectiveIncomeTaxRateReconciliationExpectedIncomeTaxExpenseRecoveryAmount_5ecfccd9-2533-4132-a052-b526b14d7864_terseLabel_en-US" xlink:label="lab_cron_EffectiveIncomeTaxRateReconciliationExpectedIncomeTaxExpenseRecoveryAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected income tax expense (benefit)</link:label>
    <link:label id="lab_cron_EffectiveIncomeTaxRateReconciliationExpectedIncomeTaxExpenseRecoveryAmount_label_en-US" xlink:label="lab_cron_EffectiveIncomeTaxRateReconciliationExpectedIncomeTaxExpenseRecoveryAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Expected Income Tax Expense (Recovery), Amount</link:label>
    <link:label id="lab_cron_EffectiveIncomeTaxRateReconciliationExpectedIncomeTaxExpenseRecoveryAmount_documentation_en-US" xlink:label="lab_cron_EffectiveIncomeTaxRateReconciliationExpectedIncomeTaxExpenseRecoveryAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Expected Income Tax Expense (Recovery), Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_EffectiveIncomeTaxRateReconciliationExpectedIncomeTaxExpenseRecoveryAmount" xlink:href="cron-20201231.xsd#cron_EffectiveIncomeTaxRateReconciliationExpectedIncomeTaxExpenseRecoveryAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_EffectiveIncomeTaxRateReconciliationExpectedIncomeTaxExpenseRecoveryAmount" xlink:to="lab_cron_EffectiveIncomeTaxRateReconciliationExpectedIncomeTaxExpenseRecoveryAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_a2d78c00-04fc-4fdb-8e5a-50e9c6e42aad_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-cash operating activity expense (income)</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_2d3dc8dd-96b5-4550-9bb9-d129fe94e8be_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, useful life</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_b9351952-3883-4d61-9a0f-4259682c90d5_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average amortization period (in years)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_f31770df-71f2-4456-a2d9-b7319cb3c0e7_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAbstract_6ae42cf8-d31f-4550-9473-9acdee61d0a1_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Summarized Financial Information [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAbstract_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Summarized Financial Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAbstract" xlink:to="lab_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_5b1bbf44-f8a8-492a-8ffb-aa1e9d2a5e2b_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Axis]</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:to="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_17a07f78-ad1c-43b1-8cf8-d190e80d5738_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit (loss)</link:label>
    <link:label id="lab_us-gaap_GrossProfit_6ea39047-7ab8-411f-8222-73cd3dae6bae_verboseLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_1e53a6dc-d875-463a-aef6-fc507edcbee4_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_970b2797-57f8-4e8c-91cb-0aba7d48804e_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance as of December 31</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_d9e3fdf6-8b28-4829-a882-f9c37011c967_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_6ba44514-02a8-478a-a762-40807bc6f846_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_8ee98308-b8c4-4f03-beff-90c7a32e86a4_totalLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income (expense), net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_59c3937b-6aed-464d-8952-374757e75a07_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense (income), net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income (Expense), Nonoperating, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:to="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_192672d0-be0c-4b26-8daa-c5186ebd6d1e_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_30c7fb3c-f8f1-43b0-b9c3-f3072fc4e787_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payments</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_b2613088-ee18-4ecf-a158-ede530dbc609_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos Group</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f8ea5ce3-0b57-480c-80f2-f73acbc403b4_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_281cc619-47d2-461c-90c7-2bbb9358a5db_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_31e7980d-682a-4e27-9392-bd1541163ee1_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advance to non-controlling interests</link:label>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_label_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToMinorityShareholders" xlink:to="lab_us-gaap_PaymentsToMinorityShareholders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForLoanLossesExpensed_4f72127c-618e-4b40-b6ea-8f5e7d437d88_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForLoanLossesExpensed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current expected credit loss</link:label>
    <link:label id="lab_us-gaap_ProvisionForLoanLossesExpensed_label_en-US" xlink:label="lab_us-gaap_ProvisionForLoanLossesExpensed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Credit Loss, Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForLoanLossesExpensed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForLoanLossesExpensed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForLoanLossesExpensed" xlink:to="lab_us-gaap_ProvisionForLoanLossesExpensed" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_2ae8bc87-dbbf-476b-9fa5-79c68615e0b0_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_6a52daee-120c-43e9-b31e-2f8b5c93e704_terseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lord Jones brand</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_212cd684-0810-4c88-8cc6-1b6ed6111a4d_verboseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Brand name</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_3711f3bc-c649-4df7-abb0-e1fb7bc0ebe4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading, and Equity Securities, FV-NI [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading, and Equity Securities, FV-NI [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable" xlink:to="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_4663c3bb-b232-4a58-bca6-fb09b3100caa_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_8383d3b6-f6fc-4418-9521-d2953cacfa26_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_VariableInterestEntityQualitativeOrQuantitativeInformationLicenseTerm_569b03dc-6abe-4c1d-b5f8-4fdb1add3d76_terseLabel_en-US" xlink:label="lab_cron_VariableInterestEntityQualitativeOrQuantitativeInformationLicenseTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License term</link:label>
    <link:label id="lab_cron_VariableInterestEntityQualitativeOrQuantitativeInformationLicenseTerm_label_en-US" xlink:label="lab_cron_VariableInterestEntityQualitativeOrQuantitativeInformationLicenseTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Qualitative Or Quantitative Information, License Term</link:label>
    <link:label id="lab_cron_VariableInterestEntityQualitativeOrQuantitativeInformationLicenseTerm_documentation_en-US" xlink:label="lab_cron_VariableInterestEntityQualitativeOrQuantitativeInformationLicenseTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Qualitative Or Quantitative Information, License Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_VariableInterestEntityQualitativeOrQuantitativeInformationLicenseTerm" xlink:href="cron-20201231.xsd#cron_VariableInterestEntityQualitativeOrQuantitativeInformationLicenseTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_VariableInterestEntityQualitativeOrQuantitativeInformationLicenseTerm" xlink:to="lab_cron_VariableInterestEntityQualitativeOrQuantitativeInformationLicenseTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_21c60fe7-e6f8-42ee-97bd-a18ae36a724c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_MucciMember_8177c27e-13d4-40ad-8ec2-9fc11575fe16_terseLabel_en-US" xlink:label="lab_cron_MucciMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mucci</link:label>
    <link:label id="lab_cron_MucciMember_label_en-US" xlink:label="lab_cron_MucciMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mucci [Member]</link:label>
    <link:label id="lab_cron_MucciMember_documentation_en-US" xlink:label="lab_cron_MucciMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mucci [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_MucciMember" xlink:href="cron-20201231.xsd#cron_MucciMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_MucciMember" xlink:to="lab_cron_MucciMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_75a17d3e-ff7c-464d-8ae9-d2d9346ce0fe_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserve</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesAdjustments_aa810c7a-c8bb-4163-833f-1ccfe53f1f13_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in valuation allowance</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesAdjustments_79aba435-bbe7-486b-90a2-50a65b8e7139_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesAdjustments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesAdjustments_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Increase (Decrease) Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesAdjustments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesAdjustments" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_7953cb42-4f15-42e7-8ed5-fd48442f4404_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_baa2b341-3423-4ae1-8473-d77bc1e3acea_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7ff8f08e-7f0a-4308-bf7f-66f50aca97e6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of options</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowOperatingCapitalTableTextBlock_15085e5d-30eb-4c95-ae84-0c35868c9eaf_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowOperatingCapitalTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Changes in Non-Cash Working Capital</link:label>
    <link:label id="lab_us-gaap_CashFlowOperatingCapitalTableTextBlock_label_en-US" xlink:label="lab_us-gaap_CashFlowOperatingCapitalTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Operating Capital [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowOperatingCapitalTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowOperatingCapitalTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowOperatingCapitalTableTextBlock" xlink:to="lab_us-gaap_CashFlowOperatingCapitalTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetImpairment_793f42ee-f8a3-475b-a602-ab4a2267c1bb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment loss on goodwill and intangible assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetImpairment_5589b5ed-99c5-47c0-83ac-55caf6661992_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment loss on goodwill and intangible assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetImpairment_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Asset Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss_1fa2544c-be64-46e1-af9e-7bbcb401eadb_terseLabel_en-US" xlink:label="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average expected life</link:label>
    <link:label id="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss_label_en-US" xlink:label="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) In Weighted Average Expected Life On Net Income (Loss)</link:label>
    <link:label id="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss_documentation_en-US" xlink:label="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) In Weighted Average Expected Life On Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss" xlink:href="cron-20201231.xsd#cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss" xlink:to="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockLineItems_745f252d-81fb-4d29-9e79-b02a5d557677_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary, Sale of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary, Sale of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventorySuppliesNetOfReserves_7d66a62b-0b30-41a1-937b-575f7b82bb94_terseLabel_en-US" xlink:label="lab_us-gaap_InventorySuppliesNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplies and consumables</link:label>
    <link:label id="lab_us-gaap_InventorySuppliesNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventorySuppliesNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Supplies, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventorySuppliesNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventorySuppliesNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventorySuppliesNetOfReserves" xlink:to="lab_us-gaap_InventorySuppliesNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInvestments_1189de9d-6425-4d08-8288-8ddd4479f4bf_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInvestments_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsInvestments" xlink:to="lab_us-gaap_DeferredTaxAssetsInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_06f34c1c-896f-462e-a09a-f9faa1c3ec53_terseLabel_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReceivablesNetCurrent" xlink:to="lab_us-gaap_OtherReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent_d849e9a7-cd00-4ba9-8321-70bb301350a9_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held-for-sale assets</link:label>
    <link:label id="lab_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets Held-for-sale, Not Part of Disposal Group, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent" xlink:to="lab_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_3546b9de-7659-44e8-b511-e233cd9cc4b2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_c788b79c-3dba-4c92-935d-8c197be991f1_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_3da3033e-c5fd-411e-976d-60bf849c47d6_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_CronosIsraelG.S.ManufacturingLtd.Member_86a33b65-6847-4607-b1ca-8f5c22d46f9e_terseLabel_en-US" xlink:label="lab_cron_CronosIsraelG.S.ManufacturingLtd.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos Israel G.S. Manufacturing Ltd.</link:label>
    <link:label id="lab_cron_CronosIsraelG.S.ManufacturingLtd.Member_label_en-US" xlink:label="lab_cron_CronosIsraelG.S.ManufacturingLtd.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos Israel G.S. Manufacturing Ltd. [Member]</link:label>
    <link:label id="lab_cron_CronosIsraelG.S.ManufacturingLtd.Member_documentation_en-US" xlink:label="lab_cron_CronosIsraelG.S.ManufacturingLtd.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos Israel G.S. Manufacturing Ltd. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosIsraelG.S.ManufacturingLtd.Member" xlink:href="cron-20201231.xsd#cron_CronosIsraelG.S.ManufacturingLtd.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_CronosIsraelG.S.ManufacturingLtd.Member" xlink:to="lab_cron_CronosIsraelG.S.ManufacturingLtd.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PublicUtilitiesInventoryTypeDomain_aa4946ca-1914-4a0b-bcac-69836178125b_terseLabel_en-US" xlink:label="lab_us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory [Domain]</link:label>
    <link:label id="lab_us-gaap_PublicUtilitiesInventoryTypeDomain_label_en-US" xlink:label="lab_us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PublicUtilitiesInventoryTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:to="lab_us-gaap_PublicUtilitiesInventoryTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_7ea23784-8703-4d18-adf6-395141bd2215_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property, Plant &amp; Equipment, Useful Lives</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_f8c9401b-b86d-45d3-8cbb-53301d49e109_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_2828ff2b-88f7-4cdd-aef7-2a8cc770e42a_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonmonetaryTransactionsDisclosureTextBlock_3c5da741-d61e-45ca-ad41-25781e824a87_terseLabel_en-US" xlink:label="lab_us-gaap_NonmonetaryTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-monetary Transactions</link:label>
    <link:label id="lab_us-gaap_NonmonetaryTransactionsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_NonmonetaryTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonmonetary Transactions Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonmonetaryTransactionsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonmonetaryTransactionsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonmonetaryTransactionsDisclosureTextBlock" xlink:to="lab_us-gaap_NonmonetaryTransactionsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsHeldforsaleMember_9ee1ecc7-6965-4196-9853-398f96cf5c5a_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsHeldforsaleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations, Held-for-sale</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsHeldforsaleMember_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsHeldforsaleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations, Held-for-sale [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsHeldforsaleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember" xlink:to="lab_us-gaap_DiscontinuedOperationsHeldforsaleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_373cc848-c84c-4c9f-aa6b-782308cfc456_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provisions for inventory and doubtful accounts</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2c212d5f-015a-4a0b-8fda-32607019f55e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings_2ad6272a-02b2-4d77-94ae-e84ea4251894_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on revaluation</link:label>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings_0c1d3d55-9d81-41da-bd29-d70a323683b3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on revaluation</link:label>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_a6a70706-e08e-4956-9a00-111bf88eb18f_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_cd752c3c-25b6-455c-9cbc-5a95880ff75c_verboseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on held-for-sale assets</link:label>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_label_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" xlink:to="lab_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_6900ffa6-c4a3-45dc-a222-6ef29d8ca02c_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Future Minimum Lease Payments Under Operating Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_WhistlerMedicalMarijuanaCompanyMember_c9c8f29f-f047-40fb-8d5c-1bafd29961e2_terseLabel_en-US" xlink:label="lab_cron_WhistlerMedicalMarijuanaCompanyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Whistler</link:label>
    <link:label id="lab_cron_WhistlerMedicalMarijuanaCompanyMember_label_en-US" xlink:label="lab_cron_WhistlerMedicalMarijuanaCompanyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Whistler Medical Marijuana Company [Member]</link:label>
    <link:label id="lab_cron_WhistlerMedicalMarijuanaCompanyMember_documentation_en-US" xlink:label="lab_cron_WhistlerMedicalMarijuanaCompanyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Whistler Medical Marijuana Company [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_WhistlerMedicalMarijuanaCompanyMember" xlink:href="cron-20201231.xsd#cron_WhistlerMedicalMarijuanaCompanyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_WhistlerMedicalMarijuanaCompanyMember" xlink:to="lab_cron_WhistlerMedicalMarijuanaCompanyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_8b702220-f629-4736-a4a0-c0631040643f_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_490ec722-7741-4cd6-ade8-c70f82b5524b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_23852b1c-1775-4fd6-ae74-9b91b4872dcd_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_575e68c1-b549-4704-a888-91d0a6781454_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of common shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_47a0dc8d-6c85-4348-ab35-20a2827b5379_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipAxis_1650a496-44a4-4b32-9fac-8a0d29fbbc7a_terseLabel_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:label id="lab_srt_OwnershipAxis_label_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis" xlink:to="lab_srt_OwnershipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationVariableInterestEntityPolicy_f6ecb0ae-68e4-4b80-80f4-088fc76fafe1_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable interest entities ("VIE")</link:label>
    <link:label id="lab_us-gaap_ConsolidationVariableInterestEntityPolicy_label_en-US" xlink:label="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Variable Interest Entity, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationVariableInterestEntityPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:to="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent_50b106ab-d0e6-42d5-8503-415ff41dfaf8_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term assets classified as discontinued operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_24b5b622-b0f9-4f1c-805c-9476814edb18_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_7afeff96-859d-4749-ba29-ec40091f0e87_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_d50a3ec7-ca3f-4aab-882b-6d50acb25e61_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_abe9e8fe-a3b5-497f-b50a-51195e20f6f7_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from Contracts with Customers</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_ad751c47-f017-4bbd-a96b-bb046d36d2e3_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership interest</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization_7bfb7c6f-96e4-4b87-8c08-6068fbf2604b_terseLabel_en-US" xlink:label="lab_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted EBITDA</link:label>
    <link:label id="lab_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization_label_en-US" xlink:label="lab_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted Earnings Before Interest, Taxes, Depreciation And Amortization</link:label>
    <link:label id="lab_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization_documentation_en-US" xlink:label="lab_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted Earnings Before Interest, Taxes, Depreciation And Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" xlink:href="cron-20201231.xsd#cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" xlink:to="lab_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_LongtermPurchaseCommitmentMonthlyFeePercentage_5f5f35e6-ae2a-471e-9b38-f13170530e94_terseLabel_en-US" xlink:label="lab_cron_LongtermPurchaseCommitmentMonthlyFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Monthly fee, percentage of direct and indirect service costs</link:label>
    <link:label id="lab_cron_LongtermPurchaseCommitmentMonthlyFeePercentage_label_en-US" xlink:label="lab_cron_LongtermPurchaseCommitmentMonthlyFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Purchase Commitment, Monthly Fee, Percentage</link:label>
    <link:label id="lab_cron_LongtermPurchaseCommitmentMonthlyFeePercentage_documentation_en-US" xlink:label="lab_cron_LongtermPurchaseCommitmentMonthlyFeePercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Purchase Commitment, Monthly Fee, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LongtermPurchaseCommitmentMonthlyFeePercentage" xlink:href="cron-20201231.xsd#cron_LongtermPurchaseCommitmentMonthlyFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_LongtermPurchaseCommitmentMonthlyFeePercentage" xlink:to="lab_cron_LongtermPurchaseCommitmentMonthlyFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_33c19f57-0281-4782-a502-1cdea96244a7_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents and short-term investments</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_551ba704-5229-4252-9572-24f2b0c57849_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_f842f21d-e349-4f82-a483-a122cbab06b0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_75f122d4-5e3e-418f-a000-667b78049eb7_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_0b93911a-5f05-4e58-b272-a98164c4e671_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense (recovery), net</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ec2f64fe-1a2b-438b-9c17-1bc9e2962c17_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c8c0b59f-54ff-412f-bb8b-39daed6d6482_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_GeneralAndAdministrativeExpensesTableTextBlock_d730e1c2-54f0-41b1-8a74-fbe4f9dd0908_terseLabel_en-US" xlink:label="lab_cron_GeneralAndAdministrativeExpensesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of General and Administrative Expenses</link:label>
    <link:label id="lab_cron_GeneralAndAdministrativeExpensesTableTextBlock_label_en-US" xlink:label="lab_cron_GeneralAndAdministrativeExpensesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General And Administrative Expenses [Table Text Block]</link:label>
    <link:label id="lab_cron_GeneralAndAdministrativeExpensesTableTextBlock_documentation_en-US" xlink:label="lab_cron_GeneralAndAdministrativeExpensesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General And Administrative Expenses [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_GeneralAndAdministrativeExpensesTableTextBlock" xlink:href="cron-20201231.xsd#cron_GeneralAndAdministrativeExpensesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_GeneralAndAdministrativeExpensesTableTextBlock" xlink:to="lab_cron_GeneralAndAdministrativeExpensesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_fcb0bc9a-3875-4b21-b026-125323cf3295_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant &amp; equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_6dd3990a-a924-4c95-a735-0611a5694bce_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (purchase of) short-term investments, net</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_6b4cdf6e-4852-4105-90f3-58278247f3ac_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on disposal of other investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_8efcbbad-f143-499c-bbfb-920e44420008_negatedLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on disposal of other investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_ccce4dfc-2b2d-4d64-9b82-7a91021c1172_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss (gain) on disposal of other investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Realized Gain (Loss) on Disposal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:to="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_7697ffda-c3aa-4a33-8a73-6500fcd4c04d_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentTable_6c312779-9c84-4051-b1ac-10dbad37a904_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Purchase Commitment [Table]</link:label>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentTable_label_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Purchase Commitment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermPurchaseCommitmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentTable" xlink:to="lab_us-gaap_LongTermPurchaseCommitmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_1880c5d4-6d90-483d-a367-1e677c73fc8a_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnfavorableRegulatoryActionMember_295938d4-fcc9-4be3-9039-648d1e239568_terseLabel_en-US" xlink:label="lab_us-gaap_UnfavorableRegulatoryActionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unfavorable Regulatory Action</link:label>
    <link:label id="lab_us-gaap_UnfavorableRegulatoryActionMember_label_en-US" xlink:label="lab_us-gaap_UnfavorableRegulatoryActionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unfavorable Regulatory Action [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnfavorableRegulatoryActionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnfavorableRegulatoryActionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnfavorableRegulatoryActionMember" xlink:to="lab_us-gaap_UnfavorableRegulatoryActionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_72aa841c-48b9-4ec8-99b4-45a17ea3126e_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to acquire businesses</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_376a7985-fe34-4113-8a8b-887b87551520_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_a7482619-75c4-4a37-9baf-ddff91092ce6_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember_43c2edd4-25e7-4ac2-940b-e1e70c5769c2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Tranche One</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Tranche One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_665bea79-6bb8-4183-bb6f-ae93bbd61725_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue of acquiree since acquisition date</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:to="lab_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_0d14d99d-12dd-4b4a-a683-525c23b8e25a_terseLabel_en-US" xlink:label="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurposing charges</link:label>
    <link:label id="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs Associated with Exit or Disposal Activities or Restructurings, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:to="lab_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_7076f631-135f-405b-a679-5f88b647f914_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_2433347d-1bc1-402f-9727-97df206a1542_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_MedMenCanadaInc.Member_204f8f2c-82f3-4ff4-b508-72748b47c40f_terseLabel_en-US" xlink:label="lab_cron_MedMenCanadaInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MedMen Canada</link:label>
    <link:label id="lab_cron_MedMenCanadaInc.Member_label_en-US" xlink:label="lab_cron_MedMenCanadaInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MedMen Canada Inc. [Member]</link:label>
    <link:label id="lab_cron_MedMenCanadaInc.Member_documentation_en-US" xlink:label="lab_cron_MedMenCanadaInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MedMen Canada Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_MedMenCanadaInc.Member" xlink:href="cron-20201231.xsd#cron_MedMenCanadaInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_MedMenCanadaInc.Member" xlink:to="lab_cron_MedMenCanadaInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonmonetaryTransactionGainLossRecognizedOnTransfer_565a64ce-693b-4093-bf63-5c0487c43486_terseLabel_en-US" xlink:label="lab_us-gaap_NonmonetaryTransactionGainLossRecognizedOnTransfer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) recognized on transfer</link:label>
    <link:label id="lab_us-gaap_NonmonetaryTransactionGainLossRecognizedOnTransfer_label_en-US" xlink:label="lab_us-gaap_NonmonetaryTransactionGainLossRecognizedOnTransfer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonmonetary Transaction, Gain (Loss) Recognized on Transfer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonmonetaryTransactionGainLossRecognizedOnTransfer" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonmonetaryTransactionGainLossRecognizedOnTransfer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonmonetaryTransactionGainLossRecognizedOnTransfer" xlink:to="lab_us-gaap_NonmonetaryTransactionGainLossRecognizedOnTransfer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidCapitalized_c29a96e4-b96d-4677-835a-928184796c58_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidCapitalized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of construction loans payable, accrued interest and fees</link:label>
    <link:label id="lab_us-gaap_InterestPaidCapitalized_label_en-US" xlink:label="lab_us-gaap_InterestPaidCapitalized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Capitalized, Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidCapitalized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidCapitalized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidCapitalized" xlink:to="lab_us-gaap_InterestPaidCapitalized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_646e005e-65a4-4246-a98d-29ffbada5235_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain" xlink:to="lab_us-gaap_RelatedPartyTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_fe204598-105d-4777-b95e-77d9d4a6e2b9_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_31e27598-21c1-4e47-89d6-9928a91b980a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_b9c037bf-00b7-415c-8fa0-d2582bd66dec_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InternalRevenueServiceIRSMember_c1d6751f-bff5-4311-bdc1-917223bf9903_terseLabel_en-US" xlink:label="lab_us-gaap_InternalRevenueServiceIRSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Untied States</link:label>
    <link:label id="lab_us-gaap_InternalRevenueServiceIRSMember_label_en-US" xlink:label="lab_us-gaap_InternalRevenueServiceIRSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal Revenue Service (IRS) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InternalRevenueServiceIRSMember" xlink:to="lab_us-gaap_InternalRevenueServiceIRSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_5521231c-63cc-493f-ad52-a399d19b2eca_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_fd62051c-22ad-473c-a3c9-2f05e5ff38c4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price (C$)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceLineItems_d21b2e05-98e9-44cb-b1a1-8da56f81ee78_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance [Line Items]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceLineItems_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowanceLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceLineItems" xlink:to="lab_us-gaap_ValuationAllowanceLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfSecuredDebt_3bd1454b-5736-4c13-b95e-19420fbe98fd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfSecuredDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of construction loan payable</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfSecuredDebt_ae36c22b-351a-47ed-9718-6f9ec17a3ae4_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfSecuredDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of construction loans payable</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfSecuredDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfSecuredDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Secured Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfSecuredDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfSecuredDebt" xlink:to="lab_us-gaap_RepaymentsOfSecuredDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationProfitLossAbstract_309288a7-5490-4bc4-a0f2-1cccd3036a19_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated statements of net income (loss) and comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationProfitLossAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information, Profit (Loss) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationProfitLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:to="lab_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_U.S.DistrictCourtofEasternDistrictofNewYorkVs.CronosMember_9a913ffb-cd86-421e-9abd-f6e0beff874b_terseLabel_en-US" xlink:label="lab_cron_U.S.DistrictCourtofEasternDistrictofNewYorkVs.CronosMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. District Court of Eastern District of New York Vs. Cronos</link:label>
    <link:label id="lab_cron_U.S.DistrictCourtofEasternDistrictofNewYorkVs.CronosMember_label_en-US" xlink:label="lab_cron_U.S.DistrictCourtofEasternDistrictofNewYorkVs.CronosMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. District Court of Eastern District of New York Vs. Cronos [Member]</link:label>
    <link:label id="lab_cron_U.S.DistrictCourtofEasternDistrictofNewYorkVs.CronosMember_documentation_en-US" xlink:label="lab_cron_U.S.DistrictCourtofEasternDistrictofNewYorkVs.CronosMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. District Court of Eastern District of New York Vs. Cronos [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_U.S.DistrictCourtofEasternDistrictofNewYorkVs.CronosMember" xlink:href="cron-20201231.xsd#cron_U.S.DistrictCourtofEasternDistrictofNewYorkVs.CronosMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_U.S.DistrictCourtofEasternDistrictofNewYorkVs.CronosMember" xlink:to="lab_cron_U.S.DistrictCourtofEasternDistrictofNewYorkVs.CronosMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_e5a97ad6-49fb-4a0a-a319-5d5669d0e519_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings (accumulated deficit)</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_RedwoodAcquisitionMember_ace012bb-9043-4ba5-8c1f-1465b51629f1_terseLabel_en-US" xlink:label="lab_cron_RedwoodAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redwood Acquisition</link:label>
    <link:label id="lab_cron_RedwoodAcquisitionMember_label_en-US" xlink:label="lab_cron_RedwoodAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redwood Acquisition [Member]</link:label>
    <link:label id="lab_cron_RedwoodAcquisitionMember_documentation_en-US" xlink:label="lab_cron_RedwoodAcquisitionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redwood Acquisition [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_RedwoodAcquisitionMember" xlink:href="cron-20201231.xsd#cron_RedwoodAcquisitionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_RedwoodAcquisitionMember" xlink:to="lab_cron_RedwoodAcquisitionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNewClaimsFiledNumber_f76feefd-c4eb-4514-9ca7-49023a0dc03b_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of putative class action complaints</link:label>
    <link:label id="lab_us-gaap_LossContingencyNewClaimsFiledNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, New Claims Filed, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:to="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_07474be2-759b-47e7-b069-1e00a8a768b8_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherGeneralAndAdministrativeExpense_6496362f-7e36-4e73-9087-9d6fa0892e23_terseLabel_en-US" xlink:label="lab_us-gaap_OtherGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_OtherGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherGeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_OtherGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PendingLitigationMember_9710d545-6a53-4624-a2c7-8133f80c4ca5_terseLabel_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation</link:label>
    <link:label id="lab_us-gaap_PendingLitigationMember_label_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PendingLitigationMember" xlink:to="lab_us-gaap_PendingLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_ebccb6ce-eb03-4b13-afc0-72a63007506f_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e544fc28-bab5-4706-9dc7-f1940e2a1288_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquiredReceivablesEstimatedUncollectible_a514a7b3-da92-4cd8-8752-8cc98b3c6719_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquiredReceivablesEstimatedUncollectible" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination, acquired receivables, estimated uncollectible</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquiredReceivablesEstimatedUncollectible_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquiredReceivablesEstimatedUncollectible" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquired Receivables, Estimated Uncollectible</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquiredReceivablesEstimatedUncollectible" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationAcquiredReceivablesEstimatedUncollectible"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquiredReceivablesEstimatedUncollectible" xlink:to="lab_us-gaap_BusinessCombinationAcquiredReceivablesEstimatedUncollectible" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_CollaborativeArrangementTermOfAgreement_cc7b2a07-35b6-42ad-9caa-5c716d5d328e_terseLabel_en-US" xlink:label="lab_cron_CollaborativeArrangementTermOfAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative arrangement, term of agreement</link:label>
    <link:label id="lab_cron_CollaborativeArrangementTermOfAgreement_label_en-US" xlink:label="lab_cron_CollaborativeArrangementTermOfAgreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Term Of Agreement</link:label>
    <link:label id="lab_cron_CollaborativeArrangementTermOfAgreement_documentation_en-US" xlink:label="lab_cron_CollaborativeArrangementTermOfAgreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Term Of Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CollaborativeArrangementTermOfAgreement" xlink:href="cron-20201231.xsd#cron_CollaborativeArrangementTermOfAgreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_CollaborativeArrangementTermOfAgreement" xlink:to="lab_cron_CollaborativeArrangementTermOfAgreement" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_OtherNetAssetsLiabilities_f3483c3d-c9a7-446a-a539-398dc009c70a_terseLabel_en-US" xlink:label="lab_cron_OtherNetAssetsLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Net Assets (Liabilities)</link:label>
    <link:label id="lab_cron_OtherNetAssetsLiabilities_label_en-US" xlink:label="lab_cron_OtherNetAssetsLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Net Assets (Liabilities)</link:label>
    <link:label id="lab_cron_OtherNetAssetsLiabilities_documentation_en-US" xlink:label="lab_cron_OtherNetAssetsLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Net Assets (Liabilities)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_OtherNetAssetsLiabilities" xlink:href="cron-20201231.xsd#cron_OtherNetAssetsLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_OtherNetAssetsLiabilities" xlink:to="lab_cron_OtherNetAssetsLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_6f21d698-7b93-4f66-8151-a240e06d24db_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_92387d11-9d90-4354-a7fa-c871ebdc88ba_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusDomain_23eaf65e-01a6-4f09-a257-63b280c3b69f_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusDomain_label_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusDomain" xlink:to="lab_us-gaap_LitigationStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_CollaborativeArrangementInstallmentsReceived_368dc68a-27e1-4a91-a3bf-516d677e867c_terseLabel_en-US" xlink:label="lab_cron_CollaborativeArrangementInstallmentsReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative arrangement, installment received</link:label>
    <link:label id="lab_cron_CollaborativeArrangementInstallmentsReceived_label_en-US" xlink:label="lab_cron_CollaborativeArrangementInstallmentsReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Installments Received</link:label>
    <link:label id="lab_cron_CollaborativeArrangementInstallmentsReceived_documentation_en-US" xlink:label="lab_cron_CollaborativeArrangementInstallmentsReceived" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Installments Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CollaborativeArrangementInstallmentsReceived" xlink:href="cron-20201231.xsd#cron_CollaborativeArrangementInstallmentsReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_CollaborativeArrangementInstallmentsReceived" xlink:to="lab_cron_CollaborativeArrangementInstallmentsReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_7a362d64-d35c-46a7-b4a8-10cf98884859_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (loss) Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_370b1959-7172-43df-8bbc-fac9d30395e0_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_cea020ca-b2e5-46d9-a730-7b5b801f8940_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_47236a6c-8b7c-42db-9345-981a3c8960a3_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New accounting pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_50ea02fb-b71d-439d-9f07-1d7c7fd65a7f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestments_eb0b817e-700e-49e8-b5bd-2d1c6e5ae892_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestments" xlink:to="lab_us-gaap_ShortTermInvestments" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>14
<FILENAME>cron-20201231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:7f6b4332-a8eb-41ec-8082-7450606ea80c,g:9b8782dc-b83f-424a-b83c-bbf680d16be6-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://thecronosgroup.com/role/CoverPage" xlink:type="simple" xlink:href="cron-20201231.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_0cdf13e4-4312-4cfe-9257-f4f1817c9e2c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_7e3fd953-d5b7-4d4b-a6ca-0c5fb0afe7c6" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0cdf13e4-4312-4cfe-9257-f4f1817c9e2c" xlink:to="loc_dei_DocumentType_7e3fd953-d5b7-4d4b-a6ca-0c5fb0afe7c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_bfbb5faf-07ae-4e38-8100-5a81a7a2ee5a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0cdf13e4-4312-4cfe-9257-f4f1817c9e2c" xlink:to="loc_dei_DocumentAnnualReport_bfbb5faf-07ae-4e38-8100-5a81a7a2ee5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_60c1e355-2b3d-43c4-8eb0-adf66eadc405" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0cdf13e4-4312-4cfe-9257-f4f1817c9e2c" xlink:to="loc_dei_DocumentPeriodEndDate_60c1e355-2b3d-43c4-8eb0-adf66eadc405" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_9d19a1e1-a51e-4958-9178-dae056a4a7d3" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0cdf13e4-4312-4cfe-9257-f4f1817c9e2c" xlink:to="loc_dei_CurrentFiscalYearEndDate_9d19a1e1-a51e-4958-9178-dae056a4a7d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_ccf13786-bfd6-4476-9e7d-36ec205ffbcf" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0cdf13e4-4312-4cfe-9257-f4f1817c9e2c" xlink:to="loc_dei_DocumentTransitionReport_ccf13786-bfd6-4476-9e7d-36ec205ffbcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_815a33e4-8de8-4e6b-b156-d4a12c6db1ee" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0cdf13e4-4312-4cfe-9257-f4f1817c9e2c" xlink:to="loc_dei_EntityFileNumber_815a33e4-8de8-4e6b-b156-d4a12c6db1ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_6937893d-691a-432c-8bc9-2e5cc4b9b58c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0cdf13e4-4312-4cfe-9257-f4f1817c9e2c" xlink:to="loc_dei_EntityRegistrantName_6937893d-691a-432c-8bc9-2e5cc4b9b58c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_77ed0004-c15d-42d5-8b7f-21e148894e9c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0cdf13e4-4312-4cfe-9257-f4f1817c9e2c" xlink:to="loc_dei_EntityIncorporationStateCountryCode_77ed0004-c15d-42d5-8b7f-21e148894e9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_0158c4a6-dd89-48a7-8d7f-1f30bb2c389d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0cdf13e4-4312-4cfe-9257-f4f1817c9e2c" xlink:to="loc_dei_EntityAddressAddressLine1_0158c4a6-dd89-48a7-8d7f-1f30bb2c389d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_bbebf29b-6fc4-469b-9ac7-40850c18bafd" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0cdf13e4-4312-4cfe-9257-f4f1817c9e2c" xlink:to="loc_dei_EntityAddressCityOrTown_bbebf29b-6fc4-469b-9ac7-40850c18bafd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_f49306d5-ce78-4f3d-b718-932799b0d9d0" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0cdf13e4-4312-4cfe-9257-f4f1817c9e2c" xlink:to="loc_dei_EntityAddressStateOrProvince_f49306d5-ce78-4f3d-b718-932799b0d9d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_126b08ea-c1cf-48e0-98a5-365edd276cc9" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0cdf13e4-4312-4cfe-9257-f4f1817c9e2c" xlink:to="loc_dei_EntityAddressPostalZipCode_126b08ea-c1cf-48e0-98a5-365edd276cc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_24d7e362-1637-4719-993d-7a25df590ed7" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0cdf13e4-4312-4cfe-9257-f4f1817c9e2c" xlink:to="loc_dei_CityAreaCode_24d7e362-1637-4719-993d-7a25df590ed7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_f6eae1ee-586c-47fc-a255-b45797653827" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0cdf13e4-4312-4cfe-9257-f4f1817c9e2c" xlink:to="loc_dei_LocalPhoneNumber_f6eae1ee-586c-47fc-a255-b45797653827" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_0b22f75e-b23c-480e-b490-da6e55dfe5a3" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0cdf13e4-4312-4cfe-9257-f4f1817c9e2c" xlink:to="loc_dei_Security12bTitle_0b22f75e-b23c-480e-b490-da6e55dfe5a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_6f5ea098-6180-40ef-af9a-bf70065d23fb" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0cdf13e4-4312-4cfe-9257-f4f1817c9e2c" xlink:to="loc_dei_TradingSymbol_6f5ea098-6180-40ef-af9a-bf70065d23fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_7179a317-535c-4408-ae5e-0b2ca15752d1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0cdf13e4-4312-4cfe-9257-f4f1817c9e2c" xlink:to="loc_dei_SecurityExchangeName_7179a317-535c-4408-ae5e-0b2ca15752d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_a9a81d6c-d5a7-408e-a11a-34bc4f5a039f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0cdf13e4-4312-4cfe-9257-f4f1817c9e2c" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_a9a81d6c-d5a7-408e-a11a-34bc4f5a039f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_17508956-df69-4026-85e0-91f789e65048" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0cdf13e4-4312-4cfe-9257-f4f1817c9e2c" xlink:to="loc_dei_EntityVoluntaryFilers_17508956-df69-4026-85e0-91f789e65048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_24c54e47-5fe8-4dee-ab99-bc3bf963e762" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0cdf13e4-4312-4cfe-9257-f4f1817c9e2c" xlink:to="loc_dei_EntityCurrentReportingStatus_24c54e47-5fe8-4dee-ab99-bc3bf963e762" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_1f1363cb-d6c1-4b11-a7a4-6bba4fc35951" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0cdf13e4-4312-4cfe-9257-f4f1817c9e2c" xlink:to="loc_dei_EntityInteractiveDataCurrent_1f1363cb-d6c1-4b11-a7a4-6bba4fc35951" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_37af023b-5cd8-449e-ad85-142cc646e4db" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0cdf13e4-4312-4cfe-9257-f4f1817c9e2c" xlink:to="loc_dei_EntityFilerCategory_37af023b-5cd8-449e-ad85-142cc646e4db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_dc396608-a3d7-4c49-8366-d67eae446869" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0cdf13e4-4312-4cfe-9257-f4f1817c9e2c" xlink:to="loc_dei_EntitySmallBusiness_dc396608-a3d7-4c49-8366-d67eae446869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_de107bb8-374d-48c9-8fe4-017e18d32738" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0cdf13e4-4312-4cfe-9257-f4f1817c9e2c" xlink:to="loc_dei_EntityEmergingGrowthCompany_de107bb8-374d-48c9-8fe4-017e18d32738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_93dd10af-b4a9-4ef7-a9c2-f51579f5d3b4" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0cdf13e4-4312-4cfe-9257-f4f1817c9e2c" xlink:to="loc_dei_IcfrAuditorAttestationFlag_93dd10af-b4a9-4ef7-a9c2-f51579f5d3b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_550d4997-86e6-4ffc-9e41-6ebef66a74a2" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0cdf13e4-4312-4cfe-9257-f4f1817c9e2c" xlink:to="loc_dei_EntityShellCompany_550d4997-86e6-4ffc-9e41-6ebef66a74a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_09fd6c7e-34fb-4fff-8267-6b030b7672d9" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0cdf13e4-4312-4cfe-9257-f4f1817c9e2c" xlink:to="loc_dei_EntityPublicFloat_09fd6c7e-34fb-4fff-8267-6b030b7672d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_335d0b87-1d34-474e-9966-f643063c3e4a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0cdf13e4-4312-4cfe-9257-f4f1817c9e2c" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_335d0b87-1d34-474e-9966-f643063c3e4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_f7cf7f2a-35cd-419d-92c0-ea76371dc782" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0cdf13e4-4312-4cfe-9257-f4f1817c9e2c" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_f7cf7f2a-35cd-419d-92c0-ea76371dc782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_247c2221-5fce-4048-a547-2560b5b6ea0e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0cdf13e4-4312-4cfe-9257-f4f1817c9e2c" xlink:to="loc_dei_AmendmentFlag_247c2221-5fce-4048-a547-2560b5b6ea0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_0237ad08-2f7b-4b52-aea1-9ed40118be9a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0cdf13e4-4312-4cfe-9257-f4f1817c9e2c" xlink:to="loc_dei_DocumentFiscalYearFocus_0237ad08-2f7b-4b52-aea1-9ed40118be9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_09bde742-5a5d-43fc-8e02-e4dd93f820ce" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0cdf13e4-4312-4cfe-9257-f4f1817c9e2c" xlink:to="loc_dei_DocumentFiscalPeriodFocus_09bde742-5a5d-43fc-8e02-e4dd93f820ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_3e2dc881-2d09-41d2-a348-56c6352f6315" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0cdf13e4-4312-4cfe-9257-f4f1817c9e2c" xlink:to="loc_dei_EntityCentralIndexKey_3e2dc881-2d09-41d2-a348-56c6352f6315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/ConsolidatedBalanceSheet" xlink:type="simple" xlink:href="cron-20201231.xsd#ConsolidatedBalanceSheet"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/ConsolidatedBalanceSheet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_23298857-780f-4fdd-bb17-13653b6b53fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_dc3a6a13-ffb2-431e-9774-ef379a80d0f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_23298857-780f-4fdd-bb17-13653b6b53fa" xlink:to="loc_us-gaap_AssetsAbstract_dc3a6a13-ffb2-431e-9774-ef379a80d0f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_22dd186a-4816-402b-b61e-b1d93e23dc27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_dc3a6a13-ffb2-431e-9774-ef379a80d0f9" xlink:to="loc_us-gaap_AssetsCurrentAbstract_22dd186a-4816-402b-b61e-b1d93e23dc27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_4c85fd18-c6d3-466e-ac94-5ee7d09ccdbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_22dd186a-4816-402b-b61e-b1d93e23dc27" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_4c85fd18-c6d3-466e-ac94-5ee7d09ccdbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_088a694a-b84e-4ac8-a0fc-38fb24b7a0b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_22dd186a-4816-402b-b61e-b1d93e23dc27" xlink:to="loc_us-gaap_ShortTermInvestments_088a694a-b84e-4ac8-a0fc-38fb24b7a0b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_73f877d9-b377-4c13-9e6f-e91f0c20eb82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_22dd186a-4816-402b-b61e-b1d93e23dc27" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_73f877d9-b377-4c13-9e6f-e91f0c20eb82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_37bdb1c1-6c08-484a-9fcf-36b142ca23e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_22dd186a-4816-402b-b61e-b1d93e23dc27" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_37bdb1c1-6c08-484a-9fcf-36b142ca23e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetCurrent_e42676a9-236c-406c-97eb-2912de1422ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesAndLoansReceivableNetCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_22dd186a-4816-402b-b61e-b1d93e23dc27" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetCurrent_e42676a9-236c-406c-97eb-2912de1422ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_027222c7-a85d-47d3-b7e7-b6c370966172" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_22dd186a-4816-402b-b61e-b1d93e23dc27" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_027222c7-a85d-47d3-b7e7-b6c370966172" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_b9a92019-97ab-42d2-b3df-aea086a9f7fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_22dd186a-4816-402b-b61e-b1d93e23dc27" xlink:to="loc_us-gaap_InventoryNet_b9a92019-97ab-42d2-b3df-aea086a9f7fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent_b9b53285-a0b3-4686-af2e-1e72683800d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_22dd186a-4816-402b-b61e-b1d93e23dc27" xlink:to="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent_b9b53285-a0b3-4686-af2e-1e72683800d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_128f69ea-86fe-4e86-9a83-73679077acdf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_22dd186a-4816-402b-b61e-b1d93e23dc27" xlink:to="loc_us-gaap_AssetsCurrent_128f69ea-86fe-4e86-9a83-73679077acdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_0beb1750-71e3-4c4e-a99a-a7117aaec5c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_dc3a6a13-ffb2-431e-9774-ef379a80d0f9" xlink:to="loc_us-gaap_EquityMethodInvestments_0beb1750-71e3-4c4e-a99a-a7117aaec5c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvancesToAffiliate_5d1d05bd-4990-4a45-a721-6e0938a5ae23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdvancesToAffiliate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_dc3a6a13-ffb2-431e-9774-ef379a80d0f9" xlink:to="loc_us-gaap_AdvancesToAffiliate_5d1d05bd-4990-4a45-a721-6e0938a5ae23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent_bc26f3f4-8be2-4718-914e-bfc601c5bf69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesAndLoansReceivableNetNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_dc3a6a13-ffb2-431e-9774-ef379a80d0f9" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent_bc26f3f4-8be2-4718-914e-bfc601c5bf69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_6384e799-1341-4e29-874d-bf8b517a6eb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_dc3a6a13-ffb2-431e-9774-ef379a80d0f9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_6384e799-1341-4e29-874d-bf8b517a6eb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_196c6c5d-67dd-4fd2-b9d5-6656101f5855" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_dc3a6a13-ffb2-431e-9774-ef379a80d0f9" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_196c6c5d-67dd-4fd2-b9d5-6656101f5855" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_10a3f131-b623-420b-93eb-4b22274f0b09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_dc3a6a13-ffb2-431e-9774-ef379a80d0f9" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_10a3f131-b623-420b-93eb-4b22274f0b09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_91cc10ed-3dcb-411e-bab5-0b06f2895e3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_dc3a6a13-ffb2-431e-9774-ef379a80d0f9" xlink:to="loc_us-gaap_Goodwill_91cc10ed-3dcb-411e-bab5-0b06f2895e3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_d3234d6e-3b1f-41bc-8d6c-fd2dbbad59b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_dc3a6a13-ffb2-431e-9774-ef379a80d0f9" xlink:to="loc_us-gaap_Assets_d3234d6e-3b1f-41bc-8d6c-fd2dbbad59b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_87e2bc0a-00da-4de8-9a57-e707ef99ffb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_23298857-780f-4fdd-bb17-13653b6b53fa" xlink:to="loc_us-gaap_LiabilitiesAbstract_87e2bc0a-00da-4de8-9a57-e707ef99ffb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_7b38f1ce-bb8e-4fe8-981d-ce3e37440ad9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_87e2bc0a-00da-4de8-9a57-e707ef99ffb0" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_7b38f1ce-bb8e-4fe8-981d-ce3e37440ad9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_7955d4c7-7f1a-4b83-9b81-aaae1ea6963c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_7b38f1ce-bb8e-4fe8-981d-ce3e37440ad9" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_7955d4c7-7f1a-4b83-9b81-aaae1ea6963c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_e207afaa-cefa-4e80-99da-06211db4d885" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_7b38f1ce-bb8e-4fe8-981d-ce3e37440ad9" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_e207afaa-cefa-4e80-99da-06211db4d885" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent_c87145c1-af1e-4abc-8c48-7d077c861c64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_7b38f1ce-bb8e-4fe8-981d-ce3e37440ad9" xlink:to="loc_us-gaap_DerivativeLiabilitiesCurrent_c87145c1-af1e-4abc-8c48-7d077c861c64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_e8dce0f6-dc9f-41dd-b8ea-42fd2ac39c55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_7b38f1ce-bb8e-4fe8-981d-ce3e37440ad9" xlink:to="loc_us-gaap_LiabilitiesCurrent_e8dce0f6-dc9f-41dd-b8ea-42fd2ac39c55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToRelatedPartiesNoncurrent_5ca9fcbe-d63d-47e1-bbd4-bb1b2fd07d26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueToRelatedPartiesNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_87e2bc0a-00da-4de8-9a57-e707ef99ffb0" xlink:to="loc_us-gaap_DueToRelatedPartiesNoncurrent_5ca9fcbe-d63d-47e1-bbd4-bb1b2fd07d26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_525bfdfa-d9d3-4217-954c-2ca6cd145436" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_87e2bc0a-00da-4de8-9a57-e707ef99ffb0" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_525bfdfa-d9d3-4217-954c-2ca6cd145436" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_bbdf1c64-e0bc-4eb6-a7c3-dca6f48b0889" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_87e2bc0a-00da-4de8-9a57-e707ef99ffb0" xlink:to="loc_us-gaap_Liabilities_bbdf1c64-e0bc-4eb6-a7c3-dca6f48b0889" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_f18abac7-1ba9-410b-8e01-24bf8fbf9e9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_23298857-780f-4fdd-bb17-13653b6b53fa" xlink:to="loc_us-gaap_CommitmentsAndContingencies_f18abac7-1ba9-410b-8e01-24bf8fbf9e9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_4ccddf4b-9b48-485c-a4bf-8ae99cc9f934" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_23298857-780f-4fdd-bb17-13653b6b53fa" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_4ccddf4b-9b48-485c-a4bf-8ae99cc9f934" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_f978a257-3d02-402f-9b33-bd15dcd2b4f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_4ccddf4b-9b48-485c-a4bf-8ae99cc9f934" xlink:to="loc_us-gaap_CommonStockValue_f978a257-3d02-402f-9b33-bd15dcd2b4f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_1d721b44-90af-42da-8258-928e4ecce5d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_4ccddf4b-9b48-485c-a4bf-8ae99cc9f934" xlink:to="loc_us-gaap_AdditionalPaidInCapital_1d721b44-90af-42da-8258-928e4ecce5d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_73aa6801-744c-4ca9-a2cf-dbfec8bcaf74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_4ccddf4b-9b48-485c-a4bf-8ae99cc9f934" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_73aa6801-744c-4ca9-a2cf-dbfec8bcaf74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d69fbe49-2a70-4c42-b047-551b9bc1ab2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_4ccddf4b-9b48-485c-a4bf-8ae99cc9f934" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d69fbe49-2a70-4c42-b047-551b9bc1ab2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_12d8464b-b130-4c92-9c87-a717393aea32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_4ccddf4b-9b48-485c-a4bf-8ae99cc9f934" xlink:to="loc_us-gaap_StockholdersEquity_12d8464b-b130-4c92-9c87-a717393aea32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_0417d4e4-8291-4947-adfb-3745def34641" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_4ccddf4b-9b48-485c-a4bf-8ae99cc9f934" xlink:to="loc_us-gaap_MinorityInterest_0417d4e4-8291-4947-adfb-3745def34641" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d2b55649-bdb7-4e65-9cdd-90fb7032b033" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_4ccddf4b-9b48-485c-a4bf-8ae99cc9f934" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d2b55649-bdb7-4e65-9cdd-90fb7032b033" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_ddecac2c-da4f-4d2e-8aec-a32b132e94ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_23298857-780f-4fdd-bb17-13653b6b53fa" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_ddecac2c-da4f-4d2e-8aec-a32b132e94ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/ConsolidatedBalanceSheetParenthetical" xlink:type="simple" xlink:href="cron-20201231.xsd#ConsolidatedBalanceSheetParenthetical"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/ConsolidatedBalanceSheetParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_c42d5eaa-df6d-401f-851f-93c746273093" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_f764a7ac-b37c-4b7a-acc6-7b50de4e7dae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c42d5eaa-df6d-401f-851f-93c746273093" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_f764a7ac-b37c-4b7a-acc6-7b50de4e7dae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_779c7949-e18c-4ef6-84d4-4cb88daca05b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c42d5eaa-df6d-401f-851f-93c746273093" xlink:to="loc_us-gaap_CommonStockSharesIssued_779c7949-e18c-4ef6-84d4-4cb88daca05b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss" xlink:type="simple" xlink:href="cron-20201231.xsd#ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_f99e3767-98a3-4f87-9b18-6dd82aee961b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_01b067ce-9209-4075-ac87-2674b7ef867b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f99e3767-98a3-4f87-9b18-6dd82aee961b" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_01b067ce-9209-4075-ac87-2674b7ef867b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExciseAndSalesTaxes_35da7958-d78e-45ea-8070-e7a3a598f2a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExciseAndSalesTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f99e3767-98a3-4f87-9b18-6dd82aee961b" xlink:to="loc_us-gaap_ExciseAndSalesTaxes_35da7958-d78e-45ea-8070-e7a3a598f2a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9e854488-3200-45fc-8cca-4fd57dadb5ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f99e3767-98a3-4f87-9b18-6dd82aee961b" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9e854488-3200-45fc-8cca-4fd57dadb5ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_OtherCostOfGoodsAndServicesSold_60028562-687b-4be9-be13-0de514f7db6a" xlink:href="cron-20201231.xsd#cron_OtherCostOfGoodsAndServicesSold"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f99e3767-98a3-4f87-9b18-6dd82aee961b" xlink:to="loc_cron_OtherCostOfGoodsAndServicesSold_60028562-687b-4be9-be13-0de514f7db6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_43823f44-2461-4fb6-8625-38d468ca26ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f99e3767-98a3-4f87-9b18-6dd82aee961b" xlink:to="loc_us-gaap_InventoryWriteDown_43823f44-2461-4fb6-8625-38d468ca26ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_a88f62ab-dbc7-414e-a966-6e359e290d7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f99e3767-98a3-4f87-9b18-6dd82aee961b" xlink:to="loc_us-gaap_GrossProfit_a88f62ab-dbc7-414e-a966-6e359e290d7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_d357ad01-e23d-4753-bb39-3034745bd604" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f99e3767-98a3-4f87-9b18-6dd82aee961b" xlink:to="loc_us-gaap_OperatingExpensesAbstract_d357ad01-e23d-4753-bb39-3034745bd604" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_98d2edbd-91bc-48be-a2b3-130bcc138b14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_d357ad01-e23d-4753-bb39-3034745bd604" xlink:to="loc_us-gaap_SellingAndMarketingExpense_98d2edbd-91bc-48be-a2b3-130bcc138b14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_419377e0-5cb4-4bce-b5e3-0eacf5afc5fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_d357ad01-e23d-4753-bb39-3034745bd604" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_419377e0-5cb4-4bce-b5e3-0eacf5afc5fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_633cb370-cc4c-4647-9918-debec0acd999" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_d357ad01-e23d-4753-bb39-3034745bd604" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_633cb370-cc4c-4647-9918-debec0acd999" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_2eb31cba-27db-46da-8f51-d5510206dc16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_d357ad01-e23d-4753-bb39-3034745bd604" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_2eb31cba-27db-46da-8f51-d5510206dc16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_c50d3616-1946-4706-b8a6-d0ea16a5862a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_d357ad01-e23d-4753-bb39-3034745bd604" xlink:to="loc_us-gaap_DepreciationAndAmortization_c50d3616-1946-4706-b8a6-d0ea16a5862a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions_ddfb5a71-b004-44ed-ab8d-97ed252e10c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringSettlementAndImpairmentProvisions"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_d357ad01-e23d-4753-bb39-3034745bd604" xlink:to="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions_ddfb5a71-b004-44ed-ab8d-97ed252e10c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_1bbcb3e2-4179-4a5f-a0ea-02e9d5d9ef83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_d357ad01-e23d-4753-bb39-3034745bd604" xlink:to="loc_us-gaap_OperatingExpenses_1bbcb3e2-4179-4a5f-a0ea-02e9d5d9ef83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_dad8f7f2-b9ba-45cf-9afd-08e3d8b6b42c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f99e3767-98a3-4f87-9b18-6dd82aee961b" xlink:to="loc_us-gaap_OperatingIncomeLoss_dad8f7f2-b9ba-45cf-9afd-08e3d8b6b42c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_b4471e51-8370-4895-9be8-d4b838987569" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f99e3767-98a3-4f87-9b18-6dd82aee961b" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_b4471e51-8370-4895-9be8-d4b838987569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_a0b5725a-eb86-496e-ba1a-869a11af3128" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_b4471e51-8370-4895-9be8-d4b838987569" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_a0b5725a-eb86-496e-ba1a-869a11af3128" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_0ca4c256-1ba5-46e7-87db-d3f00bbbb23d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_b4471e51-8370-4895-9be8-d4b838987569" xlink:to="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_0ca4c256-1ba5-46e7-87db-d3f00bbbb23d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_d4260fb4-9138-407b-a6c3-0f0076c36101" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_b4471e51-8370-4895-9be8-d4b838987569" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_d4260fb4-9138-407b-a6c3-0f0076c36101" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_a97b542a-8a98-4d1d-8008-f5f42c6b38cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_b4471e51-8370-4895-9be8-d4b838987569" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_a97b542a-8a98-4d1d-8008-f5f42c6b38cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_cad5c050-6b08-4e3c-9e7b-024428c97f98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_b4471e51-8370-4895-9be8-d4b838987569" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_cad5c050-6b08-4e3c-9e7b-024428c97f98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts_9895dcc5-f292-4991-b00f-bcc71c8d3fad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_b4471e51-8370-4895-9be8-d4b838987569" xlink:to="loc_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts_9895dcc5-f292-4991-b00f-bcc71c8d3fad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_dd8424c7-2653-4785-a914-10f431b0b173" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_b4471e51-8370-4895-9be8-d4b838987569" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_dd8424c7-2653-4785-a914-10f431b0b173" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_7cf5e1f6-1e01-4e9a-bed2-d59adce6982f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_b4471e51-8370-4895-9be8-d4b838987569" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_7cf5e1f6-1e01-4e9a-bed2-d59adce6982f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8ef8c100-6b0c-4cb3-8848-31f0d6c694a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f99e3767-98a3-4f87-9b18-6dd82aee961b" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8ef8c100-6b0c-4cb3-8848-31f0d6c694a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_bd6c547b-41cb-4e09-bb65-e3da62bd82a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f99e3767-98a3-4f87-9b18-6dd82aee961b" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_bd6c547b-41cb-4e09-bb65-e3da62bd82a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_28d3dbab-6c5f-49c1-8f27-f6de58c0f5df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f99e3767-98a3-4f87-9b18-6dd82aee961b" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_28d3dbab-6c5f-49c1-8f27-f6de58c0f5df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_e9cde661-dc0d-4743-a426-0775dabcb1c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f99e3767-98a3-4f87-9b18-6dd82aee961b" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_e9cde661-dc0d-4743-a426-0775dabcb1c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_1bb7dca0-8ea7-44ef-a3be-05973d3dc68f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f99e3767-98a3-4f87-9b18-6dd82aee961b" xlink:to="loc_us-gaap_ProfitLoss_1bb7dca0-8ea7-44ef-a3be-05973d3dc68f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToReportingEntityAbstract_da163ea0-4550-4194-af01-487f1b4c2aaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToReportingEntityAbstract"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f99e3767-98a3-4f87-9b18-6dd82aee961b" xlink:to="loc_us-gaap_NetIncomeLossAttributableToReportingEntityAbstract_da163ea0-4550-4194-af01-487f1b4c2aaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_cb11e18e-ff2f-4132-87e3-b131d24c69cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAttributableToReportingEntityAbstract_da163ea0-4550-4194-af01-487f1b4c2aaa" xlink:to="loc_us-gaap_NetIncomeLoss_cb11e18e-ff2f-4132-87e3-b131d24c69cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_8a25e99d-3b1d-44b9-a762-fd1a1e929ed1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAttributableToReportingEntityAbstract_da163ea0-4550-4194-af01-487f1b4c2aaa" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_8a25e99d-3b1d-44b9-a762-fd1a1e929ed1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_94e66b7d-4d78-4a2e-adee-72582cc0cbc3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAttributableToReportingEntityAbstract_da163ea0-4550-4194-af01-487f1b4c2aaa" xlink:to="loc_us-gaap_ProfitLoss_94e66b7d-4d78-4a2e-adee-72582cc0cbc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_e330ca13-11e8-46cc-b929-5a7b96b20796" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f99e3767-98a3-4f87-9b18-6dd82aee961b" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_e330ca13-11e8-46cc-b929-5a7b96b20796" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_2db8b637-585f-4ace-850c-f6e84efc9bf7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_e330ca13-11e8-46cc-b929-5a7b96b20796" xlink:to="loc_us-gaap_EarningsPerShareBasic_2db8b637-585f-4ace-850c-f6e84efc9bf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_ab8ec061-c771-4622-87a9-09fbc2ddd625" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_e330ca13-11e8-46cc-b929-5a7b96b20796" xlink:to="loc_us-gaap_EarningsPerShareDiluted_ab8ec061-c771-4622-87a9-09fbc2ddd625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_489eb33b-70d2-49e4-9287-908880085520" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f99e3767-98a3-4f87-9b18-6dd82aee961b" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_489eb33b-70d2-49e4-9287-908880085520" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c88aed78-a889-4642-9269-66b60aced509" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_489eb33b-70d2-49e4-9287-908880085520" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c88aed78-a889-4642-9269-66b60aced509" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1b51f2cf-1802-4004-a247-107e4b9347d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_489eb33b-70d2-49e4-9287-908880085520" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1b51f2cf-1802-4004-a247-107e4b9347d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_1df19e0f-9b1a-4656-8fed-75ed6f4bfde2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_f99e3767-98a3-4f87-9b18-6dd82aee961b" xlink:to="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_1df19e0f-9b1a-4656-8fed-75ed6f4bfde2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_be376d0a-ba4e-40aa-96ba-843f6fdc86c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_1df19e0f-9b1a-4656-8fed-75ed6f4bfde2" xlink:to="loc_us-gaap_ProfitLoss_be376d0a-ba4e-40aa-96ba-843f6fdc86c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_8e783d70-1e25-44b2-aa86-26bec24e7562" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_1df19e0f-9b1a-4656-8fed-75ed6f4bfde2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_8e783d70-1e25-44b2-aa86-26bec24e7562" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_bc56f982-f140-485f-be40-86dfdc25d2cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_8e783d70-1e25-44b2-aa86-26bec24e7562" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_bc56f982-f140-485f-be40-86dfdc25d2cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_OtherComprehensiveIncomeLossAccumulatedGainLossDebtSecuritiesRevaluationAndDisposalOfOtherInvestments_c072bf69-d1c1-49ff-91a7-da33d17272d4" xlink:href="cron-20201231.xsd#cron_OtherComprehensiveIncomeLossAccumulatedGainLossDebtSecuritiesRevaluationAndDisposalOfOtherInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_8e783d70-1e25-44b2-aa86-26bec24e7562" xlink:to="loc_cron_OtherComprehensiveIncomeLossAccumulatedGainLossDebtSecuritiesRevaluationAndDisposalOfOtherInvestments_c072bf69-d1c1-49ff-91a7-da33d17272d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_1ee0b5b8-0d82-485f-8685-a92579512386" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_8e783d70-1e25-44b2-aa86-26bec24e7562" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_1ee0b5b8-0d82-485f-8685-a92579512386" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1f010a38-81ed-45e9-b92b-eeceffd4e43d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_1df19e0f-9b1a-4656-8fed-75ed6f4bfde2" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1f010a38-81ed-45e9-b92b-eeceffd4e43d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_3765bd76-b452-496d-9652-dcd8150d66c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_1df19e0f-9b1a-4656-8fed-75ed6f4bfde2" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_3765bd76-b452-496d-9652-dcd8150d66c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_578c6ad0-9889-4774-8115-394f2bb56f18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_3765bd76-b452-496d-9652-dcd8150d66c2" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_578c6ad0-9889-4774-8115-394f2bb56f18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_7248da0f-0a2a-4a61-9fda-adf529d712ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_3765bd76-b452-496d-9652-dcd8150d66c2" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_7248da0f-0a2a-4a61-9fda-adf529d712ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_bab0ddcc-2da2-4164-955b-d1131e28a8f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_3765bd76-b452-496d-9652-dcd8150d66c2" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_bab0ddcc-2da2-4164-955b-d1131e28a8f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/ConsolidatedStatementsofStockholdersEquityDeficit" xlink:type="simple" xlink:href="cron-20201231.xsd#ConsolidatedStatementsofStockholdersEquityDeficit"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/ConsolidatedStatementsofStockholdersEquityDeficit" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_1a6b7350-b864-4438-b27e-f7bf13b8adf4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_24772287-648f-4101-8e45-da1b8e115689" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_1a6b7350-b864-4438-b27e-f7bf13b8adf4" xlink:to="loc_us-gaap_StatementTable_24772287-648f-4101-8e45-da1b8e115689" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b41bf05f-0bd3-4f15-b946-d343a076c61d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_24772287-648f-4101-8e45-da1b8e115689" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b41bf05f-0bd3-4f15-b946-d343a076c61d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_db355b76-cce3-412b-a4bf-c17dbf00ec76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b41bf05f-0bd3-4f15-b946-d343a076c61d" xlink:to="loc_us-gaap_EquityComponentDomain_db355b76-cce3-412b-a4bf-c17dbf00ec76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_2c019349-7495-4583-b73f-853c4f4f308f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_db355b76-cce3-412b-a4bf-c17dbf00ec76" xlink:to="loc_us-gaap_CommonStockMember_2c019349-7495-4583-b73f-853c4f4f308f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_4e12459a-acec-4829-be4b-17bf742d11ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_db355b76-cce3-412b-a4bf-c17dbf00ec76" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_4e12459a-acec-4829-be4b-17bf742d11ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_4ee2bd1a-13fc-4a8f-8fc4-0d8e61860df3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_db355b76-cce3-412b-a4bf-c17dbf00ec76" xlink:to="loc_us-gaap_RetainedEarningsMember_4ee2bd1a-13fc-4a8f-8fc4-0d8e61860df3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_08fc5625-005a-458c-8077-9c8796d98746" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_db355b76-cce3-412b-a4bf-c17dbf00ec76" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_08fc5625-005a-458c-8077-9c8796d98746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_9e8ae227-4e23-4605-812e-7b866a2a197b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_db355b76-cce3-412b-a4bf-c17dbf00ec76" xlink:to="loc_us-gaap_NoncontrollingInterestMember_9e8ae227-4e23-4605-812e-7b866a2a197b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_edfd70a8-b42d-4591-9576-7e92ae2966fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_24772287-648f-4101-8e45-da1b8e115689" xlink:to="loc_us-gaap_StatementLineItems_edfd70a8-b42d-4591-9576-7e92ae2966fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b6eb595f-5476-4992-bdfc-fc080a8cf486" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_edfd70a8-b42d-4591-9576-7e92ae2966fb" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b6eb595f-5476-4992-bdfc-fc080a8cf486" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_6f3d38b4-8f33-49a4-8df8-15f260be2f63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b6eb595f-5476-4992-bdfc-fc080a8cf486" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_6f3d38b4-8f33-49a4-8df8-15f260be2f63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8de76e45-ec0d-42c5-8470-a5943e334aaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b6eb595f-5476-4992-bdfc-fc080a8cf486" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8de76e45-ec0d-42c5-8470-a5943e334aaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_327a844c-941a-4040-838f-1ab45c3a8e4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b6eb595f-5476-4992-bdfc-fc080a8cf486" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_327a844c-941a-4040-838f-1ab45c3a8e4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_e5aff8fe-f027-4485-ba85-a78143370f6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b6eb595f-5476-4992-bdfc-fc080a8cf486" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_e5aff8fe-f027-4485-ba85-a78143370f6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_StockIssuedDuringPeriodValueNewIssuesIssuanceCosts_54a8f916-963f-4a11-adaa-1d52d037af53" xlink:href="cron-20201231.xsd#cron_StockIssuedDuringPeriodValueNewIssuesIssuanceCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b6eb595f-5476-4992-bdfc-fc080a8cf486" xlink:to="loc_cron_StockIssuedDuringPeriodValueNewIssuesIssuanceCosts_54a8f916-963f-4a11-adaa-1d52d037af53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_c96d3f4e-d3d6-4ac9-a798-d605a5686507" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b6eb595f-5476-4992-bdfc-fc080a8cf486" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_c96d3f4e-d3d6-4ac9-a798-d605a5686507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_9e218884-f1d3-421c-96e0-824cdde24314" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b6eb595f-5476-4992-bdfc-fc080a8cf486" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_9e218884-f1d3-421c-96e0-824cdde24314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_52b6059b-dd06-4f9d-a121-92bb7e0ecc08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b6eb595f-5476-4992-bdfc-fc080a8cf486" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_52b6059b-dd06-4f9d-a121-92bb7e0ecc08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c5a65966-fa44-4882-b997-3375872e3520" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b6eb595f-5476-4992-bdfc-fc080a8cf486" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c5a65966-fa44-4882-b997-3375872e3520" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisesInPeriod_d8f4f726-f3b8-4033-9061-ea354b17aaa1" xlink:href="cron-20201231.xsd#cron_SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisesInPeriod"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b6eb595f-5476-4992-bdfc-fc080a8cf486" xlink:to="loc_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisesInPeriod_d8f4f726-f3b8-4033-9061-ea354b17aaa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_StockIssuedDuringPeriodValueWarrantsExercised_4b312564-c570-419d-a623-b9393c531f4a" xlink:href="cron-20201231.xsd#cron_StockIssuedDuringPeriodValueWarrantsExercised"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b6eb595f-5476-4992-bdfc-fc080a8cf486" xlink:to="loc_cron_StockIssuedDuringPeriodValueWarrantsExercised_4b312564-c570-419d-a623-b9393c531f4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_a7bee0c2-52cb-4042-9d69-bf3fb515a48e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b6eb595f-5476-4992-bdfc-fc080a8cf486" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_a7bee0c2-52cb-4042-9d69-bf3fb515a48e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_752eda83-9b4f-4536-8a22-c68d3353aab6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b6eb595f-5476-4992-bdfc-fc080a8cf486" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_752eda83-9b4f-4536-8a22-c68d3353aab6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_038cc6db-5206-42b5-80fd-a62f4907e92a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b6eb595f-5476-4992-bdfc-fc080a8cf486" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_038cc6db-5206-42b5-80fd-a62f4907e92a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_9956cef9-411a-4b77-994e-078fffeaf783" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b6eb595f-5476-4992-bdfc-fc080a8cf486" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_9956cef9-411a-4b77-994e-078fffeaf783" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_StockIssuedDuringPeriodSharesTopupRightsExercised_fd64816e-e6c3-49f2-86af-dd8b40705972" xlink:href="cron-20201231.xsd#cron_StockIssuedDuringPeriodSharesTopupRightsExercised"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b6eb595f-5476-4992-bdfc-fc080a8cf486" xlink:to="loc_cron_StockIssuedDuringPeriodSharesTopupRightsExercised_fd64816e-e6c3-49f2-86af-dd8b40705972" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_StockIssuedDuringPeriodValueTopupRightsExercised_bb3f3971-4aa2-44fb-940a-6384e812a8a7" xlink:href="cron-20201231.xsd#cron_StockIssuedDuringPeriodValueTopupRightsExercised"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b6eb595f-5476-4992-bdfc-fc080a8cf486" xlink:to="loc_cron_StockIssuedDuringPeriodValueTopupRightsExercised_bb3f3971-4aa2-44fb-940a-6384e812a8a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_4fef436b-a9b1-4e0f-a5a3-49a7463c1259" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b6eb595f-5476-4992-bdfc-fc080a8cf486" xlink:to="loc_us-gaap_ProfitLoss_4fef436b-a9b1-4e0f-a5a3-49a7463c1259" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_be8c1492-ed92-4c75-9af5-3fda458031d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b6eb595f-5476-4992-bdfc-fc080a8cf486" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_be8c1492-ed92-4c75-9af5-3fda458031d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_0b1ce283-8f75-41cb-8ef8-80b8addc0114" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b6eb595f-5476-4992-bdfc-fc080a8cf486" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_0b1ce283-8f75-41cb-8ef8-80b8addc0114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6566ee05-0e63-490d-96f9-004ee15d14f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b6eb595f-5476-4992-bdfc-fc080a8cf486" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6566ee05-0e63-490d-96f9-004ee15d14f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="cron-20201231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_905905db-dd3c-4898-9fd2-dd3f02c344c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_8dec0c09-dd4d-4999-98cb-d21283fd5692" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_905905db-dd3c-4898-9fd2-dd3f02c344c6" xlink:to="loc_us-gaap_StatementTable_8dec0c09-dd4d-4999-98cb-d21283fd5692" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_7eb9f7d7-5697-4f99-9701-dacb60b95907" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_8dec0c09-dd4d-4999-98cb-d21283fd5692" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_7eb9f7d7-5697-4f99-9701-dacb60b95907" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8fa000fb-296e-4b85-bc41-642ea8e01cf4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_7eb9f7d7-5697-4f99-9701-dacb60b95907" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8fa000fb-296e-4b85-bc41-642ea8e01cf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaInvestmentMember_dfee0199-b818-476c-9983-0e353b311e3d" xlink:href="cron-20201231.xsd#cron_AltriaInvestmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8fa000fb-296e-4b85-bc41-642ea8e01cf4" xlink:to="loc_cron_AltriaInvestmentMember_dfee0199-b818-476c-9983-0e353b311e3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_BoughtDealOfferingsMember_a493368f-4297-4910-bd53-1482107655d7" xlink:href="cron-20201231.xsd#cron_BoughtDealOfferingsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8fa000fb-296e-4b85-bc41-642ea8e01cf4" xlink:to="loc_cron_BoughtDealOfferingsMember_a493368f-4297-4910-bd53-1482107655d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f4e290e5-50bc-441c-bda5-d4f1d5506779" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_8dec0c09-dd4d-4999-98cb-d21283fd5692" xlink:to="loc_us-gaap_StatementLineItems_f4e290e5-50bc-441c-bda5-d4f1d5506779" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_6b91a129-2667-442d-84f4-f9804f69f784" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f4e290e5-50bc-441c-bda5-d4f1d5506779" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_6b91a129-2667-442d-84f4-f9804f69f784" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_e14b9269-c262-435d-a3da-32ab7796d6ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_6b91a129-2667-442d-84f4-f9804f69f784" xlink:to="loc_us-gaap_ProfitLoss_e14b9269-c262-435d-a3da-32ab7796d6ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_571bdfa6-f54d-4379-9984-13f109937b59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_6b91a129-2667-442d-84f4-f9804f69f784" xlink:to="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_571bdfa6-f54d-4379-9984-13f109937b59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_79fb5f6b-7874-426c-9961-68a31e81a241" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_571bdfa6-f54d-4379-9984-13f109937b59" xlink:to="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_79fb5f6b-7874-426c-9961-68a31e81a241" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_7da5816f-c6b1-444e-82b4-ddf5b6804191" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_571bdfa6-f54d-4379-9984-13f109937b59" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_7da5816f-c6b1-444e-82b4-ddf5b6804191" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_09796bfa-4622-4cab-a6c2-cbfb07c63b59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_571bdfa6-f54d-4379-9984-13f109937b59" xlink:to="loc_us-gaap_InventoryWriteDown_09796bfa-4622-4cab-a6c2-cbfb07c63b59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_58fb45ea-cc77-45a2-b291-f606aeac162f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_571bdfa6-f54d-4379-9984-13f109937b59" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_58fb45ea-cc77-45a2-b291-f606aeac162f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_5b1a0a14-39aa-4ad0-b0aa-c0f758df7602" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_571bdfa6-f54d-4379-9984-13f109937b59" xlink:to="loc_us-gaap_ShareBasedCompensation_5b1a0a14-39aa-4ad0-b0aa-c0f758df7602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_eb62a221-dae3-4006-afaf-030542a11086" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_571bdfa6-f54d-4379-9984-13f109937b59" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_eb62a221-dae3-4006-afaf-030542a11086" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_5be058f8-7727-44ae-af3e-b0d22af02dad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_571bdfa6-f54d-4379-9984-13f109937b59" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_5be058f8-7727-44ae-af3e-b0d22af02dad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_9e7f6142-b51e-4423-81ab-c3ff5ecde4d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_571bdfa6-f54d-4379-9984-13f109937b59" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_9e7f6142-b51e-4423-81ab-c3ff5ecde4d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NoncashSellingAndMarketingExpense_d018bd3d-f343-4f01-9177-6bbe0edca0bb" xlink:href="cron-20201231.xsd#cron_NoncashSellingAndMarketingExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_571bdfa6-f54d-4379-9984-13f109937b59" xlink:to="loc_cron_NoncashSellingAndMarketingExpense_d018bd3d-f343-4f01-9177-6bbe0edca0bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_ed44f145-bc73-42b8-80af-43de397eb50c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_571bdfa6-f54d-4379-9984-13f109937b59" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_ed44f145-bc73-42b8-80af-43de397eb50c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts_b5391d0a-43e7-436c-b722-b7c087913146" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCosts"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_571bdfa6-f54d-4379-9984-13f109937b59" xlink:to="loc_us-gaap_RestructuringCosts_b5391d0a-43e7-436c-b722-b7c087913146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_06d7bd68-f1b6-488e-9f67-bc7313209b88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_571bdfa6-f54d-4379-9984-13f109937b59" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_06d7bd68-f1b6-488e-9f67-bc7313209b88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapital_69f73203-d31f-4ca4-b37f-7a02ca3cb60c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_6b91a129-2667-442d-84f4-f9804f69f784" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapital_69f73203-d31f-4ca4-b37f-7a02ca3cb60c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_34e64727-1662-43c5-9772-1964915c2fb3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_6b91a129-2667-442d-84f4-f9804f69f784" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_34e64727-1662-43c5-9772-1964915c2fb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b1528a0a-41ac-4d6e-a78f-0e6a47d1f5f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f4e290e5-50bc-441c-bda5-d4f1d5506779" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b1528a0a-41ac-4d6e-a78f-0e6a47d1f5f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_eddfdbad-7605-4358-a66f-a3fc7f2099b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b1528a0a-41ac-4d6e-a78f-0e6a47d1f5f0" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_eddfdbad-7605-4358-a66f-a3fc7f2099b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_3166c7ef-bea1-4c65-bc69-4a7bc502926e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b1528a0a-41ac-4d6e-a78f-0e6a47d1f5f0" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_3166c7ef-bea1-4c65-bc69-4a7bc502926e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_7e451f4b-5143-437b-a822-4b12638d29c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b1528a0a-41ac-4d6e-a78f-0e6a47d1f5f0" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_7e451f4b-5143-437b-a822-4b12638d29c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ProceedsFromEquitySecuritiesFVNIAndEquitySecuritiesWithoutDeterminableFairValue_20822444-314f-47d2-90d9-d8cb79fa486d" xlink:href="cron-20201231.xsd#cron_ProceedsFromEquitySecuritiesFVNIAndEquitySecuritiesWithoutDeterminableFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b1528a0a-41ac-4d6e-a78f-0e6a47d1f5f0" xlink:to="loc_cron_ProceedsFromEquitySecuritiesFVNIAndEquitySecuritiesWithoutDeterminableFairValue_20822444-314f-47d2-90d9-d8cb79fa486d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_19991a79-76df-49b9-8960-f762fe214a49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInterestInJointVenture"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b1528a0a-41ac-4d6e-a78f-0e6a47d1f5f0" xlink:to="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_19991a79-76df-49b9-8960-f762fe214a49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_857b3c2c-4f84-41f7-b72b-107b368b7739" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b1528a0a-41ac-4d6e-a78f-0e6a47d1f5f0" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_857b3c2c-4f84-41f7-b72b-107b368b7739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_85fe4c28-1e77-49f2-ba8b-798bb04ea3f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b1528a0a-41ac-4d6e-a78f-0e6a47d1f5f0" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_85fe4c28-1e77-49f2-ba8b-798bb04ea3f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_20bc43c7-6470-42f9-b185-a816bc5250a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b1528a0a-41ac-4d6e-a78f-0e6a47d1f5f0" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_20bc43c7-6470-42f9-b185-a816bc5250a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireLoansReceivable_09982b6d-6bb0-404a-bb7a-22d2ec995ac7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireLoansReceivable"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b1528a0a-41ac-4d6e-a78f-0e6a47d1f5f0" xlink:to="loc_us-gaap_PaymentsToAcquireLoansReceivable_09982b6d-6bb0-404a-bb7a-22d2ec995ac7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_830af805-9fdf-4a40-aceb-0332f2711143" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b1528a0a-41ac-4d6e-a78f-0e6a47d1f5f0" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_830af805-9fdf-4a40-aceb-0332f2711143" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4575d454-83be-419f-9be2-142793ca9b14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b1528a0a-41ac-4d6e-a78f-0e6a47d1f5f0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4575d454-83be-419f-9be2-142793ca9b14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_668ca7e5-f557-433b-b473-1888c78ebddc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f4e290e5-50bc-441c-bda5-d4f1d5506779" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_668ca7e5-f557-433b-b473-1888c78ebddc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_fc716dba-a3bb-4c10-afff-fd61648b5735" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_668ca7e5-f557-433b-b473-1888c78ebddc" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_fc716dba-a3bb-4c10-afff-fd61648b5735" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PaymentsForLeaseObligationsFinancingActivities_94e2d3d5-9a59-4c11-bbd0-a7b0edd1baf7" xlink:href="cron-20201231.xsd#cron_PaymentsForLeaseObligationsFinancingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_668ca7e5-f557-433b-b473-1888c78ebddc" xlink:to="loc_cron_PaymentsForLeaseObligationsFinancingActivities_94e2d3d5-9a59-4c11-bbd0-a7b0edd1baf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2e484eed-14b0-46cc-b109-1978574a4ebf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_668ca7e5-f557-433b-b473-1888c78ebddc" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2e484eed-14b0-46cc-b109-1978574a4ebf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_29a8a0f2-dd9b-4564-a3db-41b21b4aa023" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_668ca7e5-f557-433b-b473-1888c78ebddc" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_29a8a0f2-dd9b-4564-a3db-41b21b4aa023" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ProceedsFromRightExercises_0668b0fc-1377-460e-b0d7-0169e8499af8" xlink:href="cron-20201231.xsd#cron_ProceedsFromRightExercises"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_668ca7e5-f557-433b-b473-1888c78ebddc" xlink:to="loc_cron_ProceedsFromRightExercises_0668b0fc-1377-460e-b0d7-0169e8499af8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ProceedsFromWarrantExercisedAndStockOptionsExercised_915eec36-2eae-49a4-9e0e-cdc2f6c3949b" xlink:href="cron-20201231.xsd#cron_ProceedsFromWarrantExercisedAndStockOptionsExercised"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_668ca7e5-f557-433b-b473-1888c78ebddc" xlink:to="loc_cron_ProceedsFromWarrantExercisedAndStockOptionsExercised_915eec36-2eae-49a4-9e0e-cdc2f6c3949b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_b3579994-bdb6-4af6-b8fb-32d3e2e25171" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_668ca7e5-f557-433b-b473-1888c78ebddc" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_b3579994-bdb6-4af6-b8fb-32d3e2e25171" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_56716ec2-71ad-4bf1-8b2d-db07bd903847" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_668ca7e5-f557-433b-b473-1888c78ebddc" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSecuredDebt_56716ec2-71ad-4bf1-8b2d-db07bd903847" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt_5c2a9007-0b7d-4014-91f1-b90eba37ddac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfSecuredDebt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_668ca7e5-f557-433b-b473-1888c78ebddc" xlink:to="loc_us-gaap_RepaymentsOfSecuredDebt_5c2a9007-0b7d-4014-91f1-b90eba37ddac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_ef34da60-8938-4dfc-8734-d6306744e3cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_668ca7e5-f557-433b-b473-1888c78ebddc" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_ef34da60-8938-4dfc-8734-d6306744e3cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_0e949f79-5456-4923-bace-d7e03f470299" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_668ca7e5-f557-433b-b473-1888c78ebddc" xlink:to="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_0e949f79-5456-4923-bace-d7e03f470299" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c24f6e0a-03c2-4aed-b372-d671898be848" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_668ca7e5-f557-433b-b473-1888c78ebddc" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c24f6e0a-03c2-4aed-b372-d671898be848" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c9a484da-f8c8-4546-8503-eed7ca67fd68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f4e290e5-50bc-441c-bda5-d4f1d5506779" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c9a484da-f8c8-4546-8503-eed7ca67fd68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f5f9ab46-3445-4212-9156-37e91299187f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f4e290e5-50bc-441c-bda5-d4f1d5506779" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f5f9ab46-3445-4212-9156-37e91299187f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e933e9b3-6e9e-4a75-9cf6-60fbdecaa30f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f4e290e5-50bc-441c-bda5-d4f1d5506779" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e933e9b3-6e9e-4a75-9cf6-60fbdecaa30f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_951fcc84-386d-4ebf-abdc-0a004f511e23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f4e290e5-50bc-441c-bda5-d4f1d5506779" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_951fcc84-386d-4ebf-abdc-0a004f511e23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/Background" xlink:type="simple" xlink:href="cron-20201231.xsd#Background"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/Background" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3f5d2ff6-2fc4-4171-b896-f4fa71bbecb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations_8abc96c1-4d41-4443-83e2-7bf0248448e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NatureOfOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3f5d2ff6-2fc4-4171-b896-f4fa71bbecb8" xlink:to="loc_us-gaap_NatureOfOperations_8abc96c1-4d41-4443-83e2-7bf0248448e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/BackgroundDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#BackgroundDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/BackgroundDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f0bece1b-9959-4b49-9d50-558f364fdc05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_0f12c8ab-e48e-4f07-96a2-2806034504a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f0bece1b-9959-4b49-9d50-558f364fdc05" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_0f12c8ab-e48e-4f07-96a2-2806034504a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_e905d00b-b231-4003-99e8-dbed4a36da4d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_0f12c8ab-e48e-4f07-96a2-2806034504a5" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_e905d00b-b231-4003-99e8-dbed4a36da4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_32fc4e76-b994-41a7-b10d-eb3c82cf8184" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_e905d00b-b231-4003-99e8-dbed4a36da4d" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_32fc4e76-b994-41a7-b10d-eb3c82cf8184" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosAustraliaLimitedMember_fe2091e5-202a-40f5-9115-5c51f6c5deb9" xlink:href="cron-20201231.xsd#cron_CronosAustraliaLimitedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_32fc4e76-b994-41a7-b10d-eb3c82cf8184" xlink:to="loc_cron_CronosAustraliaLimitedMember_fe2091e5-202a-40f5-9115-5c51f6c5deb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_ce894bbf-1f9c-40a4-8fe5-c4d22ea57b8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_0f12c8ab-e48e-4f07-96a2-2806034504a5" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_ce894bbf-1f9c-40a4-8fe5-c4d22ea57b8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NumberOfContinentsWithInternationalProductionAndDistribution_108b0a40-2507-4a72-b84f-5ab1b966353b" xlink:href="cron-20201231.xsd#cron_NumberOfContinentsWithInternationalProductionAndDistribution"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_ce894bbf-1f9c-40a4-8fe5-c4d22ea57b8c" xlink:to="loc_cron_NumberOfContinentsWithInternationalProductionAndDistribution_108b0a40-2507-4a72-b84f-5ab1b966353b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NumberOfAdultuseBrands_5bc1fc69-faa1-4430-98f7-41bc9bc32ea3" xlink:href="cron-20201231.xsd#cron_NumberOfAdultuseBrands"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_ce894bbf-1f9c-40a4-8fe5-c4d22ea57b8c" xlink:to="loc_cron_NumberOfAdultuseBrands_5bc1fc69-faa1-4430-98f7-41bc9bc32ea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NumberOfHempderivedCannabidiolPersonalCareBrands_f4e90895-ed5d-40e8-b5f5-d3867693a18c" xlink:href="cron-20201231.xsd#cron_NumberOfHempderivedCannabidiolPersonalCareBrands"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_ce894bbf-1f9c-40a4-8fe5-c4d22ea57b8c" xlink:to="loc_cron_NumberOfHempderivedCannabidiolPersonalCareBrands_f4e90895-ed5d-40e8-b5f5-d3867693a18c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NumberOfStrategicJointVentures_e50c8bb3-9e8e-4e4d-b4c9-7fe10b07a1a1" xlink:href="cron-20201231.xsd#cron_NumberOfStrategicJointVentures"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_ce894bbf-1f9c-40a4-8fe5-c4d22ea57b8c" xlink:to="loc_cron_NumberOfStrategicJointVentures_e50c8bb3-9e8e-4e4d-b4c9-7fe10b07a1a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_4643e83f-4b2a-4b45-96d3-5059bced63d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_ce894bbf-1f9c-40a4-8fe5-c4d22ea57b8c" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_4643e83f-4b2a-4b45-96d3-5059bced63d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="cron-20201231.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_c0f5a90a-f234-441f-a6e4-67c80d3e163b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_8798e90f-809f-4476-9f90-807900aba051" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c0f5a90a-f234-441f-a6e4-67c80d3e163b" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_8798e90f-809f-4476-9f90-807900aba051" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="cron-20201231.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_d9dcf3db-9d4c-42e6-b216-b8fe84dbfac5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_528485d3-2361-4fbc-8c65-ec5693691c06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d9dcf3db-9d4c-42e6-b216-b8fe84dbfac5" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_528485d3-2361-4fbc-8c65-ec5693691c06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_a5443f36-ef88-4e1e-8ec2-47a4404ecdcc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d9dcf3db-9d4c-42e6-b216-b8fe84dbfac5" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_a5443f36-ef88-4e1e-8ec2-47a4404ecdcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_22753723-1e21-481e-b3ad-db7cb9128336" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d9dcf3db-9d4c-42e6-b216-b8fe84dbfac5" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_22753723-1e21-481e-b3ad-db7cb9128336" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_04baff3d-e3b4-4757-b2b4-ceda8cfb295a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d9dcf3db-9d4c-42e6-b216-b8fe84dbfac5" xlink:to="loc_us-gaap_UseOfEstimates_04baff3d-e3b4-4757-b2b4-ceda8cfb295a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_09be1b5e-9ae8-4f35-af8f-ac8353e01aaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d9dcf3db-9d4c-42e6-b216-b8fe84dbfac5" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_09be1b5e-9ae8-4f35-af8f-ac8353e01aaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationVariableInterestEntityPolicy_84e078e1-e9c3-41da-a79f-ebd21ed84930" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationVariableInterestEntityPolicy"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d9dcf3db-9d4c-42e6-b216-b8fe84dbfac5" xlink:to="loc_us-gaap_ConsolidationVariableInterestEntityPolicy_84e078e1-e9c3-41da-a79f-ebd21ed84930" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy_93dc0fb9-7fa4-4203-bed3-6934e38ff7ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d9dcf3db-9d4c-42e6-b216-b8fe84dbfac5" xlink:to="loc_us-gaap_EquityMethodInvestmentsPolicy_93dc0fb9-7fa4-4203-bed3-6934e38ff7ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_2452d9a4-e23f-4331-88f8-fa6afe58365e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d9dcf3db-9d4c-42e6-b216-b8fe84dbfac5" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_2452d9a4-e23f-4331-88f8-fa6afe58365e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsFiniteLivedPolicy_3e8027a6-feca-4781-9406-ae9d18566f3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d9dcf3db-9d4c-42e6-b216-b8fe84dbfac5" xlink:to="loc_us-gaap_IntangibleAssetsFiniteLivedPolicy_3e8027a6-feca-4781-9406-ae9d18566f3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_3c976e13-1069-4ecc-833f-f59bcfdca944" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d9dcf3db-9d4c-42e6-b216-b8fe84dbfac5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_3c976e13-1069-4ecc-833f-f59bcfdca944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_2101a9f8-c496-4c95-9062-9a34722e5585" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d9dcf3db-9d4c-42e6-b216-b8fe84dbfac5" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_2101a9f8-c496-4c95-9062-9a34722e5585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_b69cd8d4-1e93-43f0-92c4-c117a028f19a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d9dcf3db-9d4c-42e6-b216-b8fe84dbfac5" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_b69cd8d4-1e93-43f0-92c4-c117a028f19a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_b89fe038-8155-456e-96cb-91cfd7f7d1ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d9dcf3db-9d4c-42e6-b216-b8fe84dbfac5" xlink:to="loc_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock_b89fe038-8155-456e-96cb-91cfd7f7d1ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityPolicyTextBlock_a1b19b49-4cb1-4689-9624-cdd331b5452d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d9dcf3db-9d4c-42e6-b216-b8fe84dbfac5" xlink:to="loc_us-gaap_StockholdersEquityPolicyTextBlock_a1b19b49-4cb1-4689-9624-cdd331b5452d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_c3bda771-e37c-456e-8125-490ed6dc0e2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d9dcf3db-9d4c-42e6-b216-b8fe84dbfac5" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_c3bda771-e37c-456e-8125-490ed6dc0e2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_f6c917cc-d62a-41ac-a4c8-375252bec7a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d9dcf3db-9d4c-42e6-b216-b8fe84dbfac5" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_f6c917cc-d62a-41ac-a4c8-375252bec7a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_f6f82e5b-6f83-4a6f-8166-ac12fb9801f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d9dcf3db-9d4c-42e6-b216-b8fe84dbfac5" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_f6f82e5b-6f83-4a6f-8166-ac12fb9801f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_325844bb-e576-45f9-a5fd-34c6969d48df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d9dcf3db-9d4c-42e6-b216-b8fe84dbfac5" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_325844bb-e576-45f9-a5fd-34c6969d48df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_adb6a1da-ed1f-4caa-bce5-f21c35d81a2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d9dcf3db-9d4c-42e6-b216-b8fe84dbfac5" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_adb6a1da-ed1f-4caa-bce5-f21c35d81a2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_29e02058-6d81-4671-b318-4cef31a64be2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d9dcf3db-9d4c-42e6-b216-b8fe84dbfac5" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_29e02058-6d81-4671-b318-4cef31a64be2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_754c6396-a759-4cc4-a719-8ad8baee2dc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d9dcf3db-9d4c-42e6-b216-b8fe84dbfac5" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_754c6396-a759-4cc4-a719-8ad8baee2dc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy_a82f97ab-7141-419d-9bb5-d67f07e985fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d9dcf3db-9d4c-42e6-b216-b8fe84dbfac5" xlink:to="loc_us-gaap_BusinessCombinationsPolicy_a82f97ab-7141-419d-9bb5-d67f07e985fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsPolicyTextBlock_0239ef44-9fe5-4d8a-b056-cb45dc0a648c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsPolicyTextBlock"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d9dcf3db-9d4c-42e6-b216-b8fe84dbfac5" xlink:to="loc_us-gaap_DiscontinuedOperationsPolicyTextBlock_0239ef44-9fe5-4d8a-b056-cb45dc0a648c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_41ecf450-41a7-4a66-aff5-eac354899316" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d9dcf3db-9d4c-42e6-b216-b8fe84dbfac5" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_41ecf450-41a7-4a66-aff5-eac354899316" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="cron-20201231.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_1fe191f3-78bb-4ba2-84d3-6055d698139e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock_72b2699c-24e5-4878-a335-c1f03a6ae03e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1fe191f3-78bb-4ba2-84d3-6055d698139e" xlink:to="loc_us-gaap_ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock_72b2699c-24e5-4878-a335-c1f03a6ae03e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_f86ac960-3219-4894-a36b-d3c010544a02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1fe191f3-78bb-4ba2-84d3-6055d698139e" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_f86ac960-3219-4894-a36b-d3c010544a02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_955d5390-cafd-401d-b637-6126563c4014" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1fe191f3-78bb-4ba2-84d3-6055d698139e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_955d5390-cafd-401d-b637-6126563c4014" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesScheduleofConsolidatedEntitiesDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#SummaryofSignificantAccountingPoliciesScheduleofConsolidatedEntitiesDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesScheduleofConsolidatedEntitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_d73f9588-c0e2-4b95-8649-4ffcead4e1c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_7e91fd07-e7e8-483c-a10d-e7db1e69485c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d73f9588-c0e2-4b95-8649-4ffcead4e1c1" xlink:to="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_7e91fd07-e7e8-483c-a10d-e7db1e69485c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_1b12e9ee-15b2-4f27-9364-d0a966d2dec4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_7e91fd07-e7e8-483c-a10d-e7db1e69485c" xlink:to="loc_srt_ConsolidatedEntitiesAxis_1b12e9ee-15b2-4f27-9364-d0a966d2dec4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_1018e746-8846-4daf-8b4c-c0c69c688e0b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_1b12e9ee-15b2-4f27-9364-d0a966d2dec4" xlink:to="loc_srt_ConsolidatedEntitiesDomain_1018e746-8846-4daf-8b4c-c0c69c688e0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosIsraelG.S.CultivationsLtd.Member_d856e21c-b6cf-4d79-bb8f-d39b9790f203" xlink:href="cron-20201231.xsd#cron_CronosIsraelG.S.CultivationsLtd.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_1018e746-8846-4daf-8b4c-c0c69c688e0b" xlink:to="loc_cron_CronosIsraelG.S.CultivationsLtd.Member_d856e21c-b6cf-4d79-bb8f-d39b9790f203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosIsraelG.S.ManufacturingLtd.Member_55da55fb-bd5b-4206-862f-ebf6ebe5f4c9" xlink:href="cron-20201231.xsd#cron_CronosIsraelG.S.ManufacturingLtd.Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_1018e746-8846-4daf-8b4c-c0c69c688e0b" xlink:to="loc_cron_CronosIsraelG.S.ManufacturingLtd.Member_55da55fb-bd5b-4206-862f-ebf6ebe5f4c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosIsraelG.S.StoreLtd.Member_a8f6d9cd-6156-4447-a7a7-c2f74bfa87f4" xlink:href="cron-20201231.xsd#cron_CronosIsraelG.S.StoreLtd.Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_1018e746-8846-4daf-8b4c-c0c69c688e0b" xlink:to="loc_cron_CronosIsraelG.S.StoreLtd.Member_a8f6d9cd-6156-4447-a7a7-c2f74bfa87f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosIsraelG.S.PharmaciesLtd.Member_caf521b8-3664-420d-b7b9-772cfa692a10" xlink:href="cron-20201231.xsd#cron_CronosIsraelG.S.PharmaciesLtd.Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_1018e746-8846-4daf-8b4c-c0c69c688e0b" xlink:to="loc_cron_CronosIsraelG.S.PharmaciesLtd.Member_caf521b8-3664-420d-b7b9-772cfa692a10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_cdaa5d58-efa1-40f7-9417-68bb5c81f830" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable_7e91fd07-e7e8-483c-a10d-e7db1e69485c" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_cdaa5d58-efa1-40f7-9417-68bb5c81f830" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_8e676dd6-7599-401c-a71d-5a08cd4fc05b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_cdaa5d58-efa1-40f7-9417-68bb5c81f830" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions_8e676dd6-7599-401c-a71d-5a08cd4fc05b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsAmortizationMethodsandRatesDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsAmortizationMethodsandRatesDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsAmortizationMethodsandRatesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_de2913aa-9af5-479e-92b0-d8080d9da158" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_0a708346-aa54-4242-97ad-ae5e2c316b55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_de2913aa-9af5-479e-92b0-d8080d9da158" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_0a708346-aa54-4242-97ad-ae5e2c316b55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6a59e7b7-a289-429e-b016-531ca34f52b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_0a708346-aa54-4242-97ad-ae5e2c316b55" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6a59e7b7-a289-429e-b016-531ca34f52b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7ec4ce9e-aada-4f3f-8dfa-b310cc8c1924" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6a59e7b7-a289-429e-b016-531ca34f52b4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7ec4ce9e-aada-4f3f-8dfa-b310cc8c1924" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_860859b6-772f-4666-9081-b43ea56940a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7ec4ce9e-aada-4f3f-8dfa-b310cc8c1924" xlink:to="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_860859b6-772f-4666-9081-b43ea56940a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_EnterpriseResourcePlanningSystemMember_fd3b8784-0d16-48cb-b23e-b7d4c82d8a98" xlink:href="cron-20201231.xsd#cron_EnterpriseResourcePlanningSystemMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7ec4ce9e-aada-4f3f-8dfa-b310cc8c1924" xlink:to="loc_cron_EnterpriseResourcePlanningSystemMember_fd3b8784-0d16-48cb-b23e-b7d4c82d8a98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_dfa73e82-108a-4acc-8fac-8d9609436b89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_0a708346-aa54-4242-97ad-ae5e2c316b55" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_dfa73e82-108a-4acc-8fac-8d9609436b89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_05176d21-08ce-4751-aa32-71d4b50132f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_dfa73e82-108a-4acc-8fac-8d9609436b89" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_05176d21-08ce-4751-aa32-71d4b50132f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantEquipmentUsefulLivesDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantEquipmentUsefulLivesDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantEquipmentUsefulLivesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_caf33a18-6eb9-447c-821d-ca709d48ad86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b66b6fc9-c589-43a6-b119-20082854fa27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_caf33a18-6eb9-447c-821d-ca709d48ad86" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b66b6fc9-c589-43a6-b119-20082854fa27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9b69a53f-6924-4278-867e-27d4c02c5ed5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b66b6fc9-c589-43a6-b119-20082854fa27" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9b69a53f-6924-4278-867e-27d4c02c5ed5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ac86dd28-1738-493d-a211-c89f5d92ce73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9b69a53f-6924-4278-867e-27d4c02c5ed5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ac86dd28-1738-493d-a211-c89f5d92ce73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_f63469b2-8df0-4ef6-983f-414b5594bab2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ac86dd28-1738-493d-a211-c89f5d92ce73" xlink:to="loc_us-gaap_BuildingMember_f63469b2-8df0-4ef6-983f-414b5594bab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_3444078c-aaf5-453b-a78b-4b6d53041604" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ac86dd28-1738-493d-a211-c89f5d92ce73" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_3444078c-aaf5-453b-a78b-4b6d53041604" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_dd8f4fae-31b1-42e9-8b06-38b4c602805d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ac86dd28-1738-493d-a211-c89f5d92ce73" xlink:to="loc_us-gaap_ComputerEquipmentMember_dd8f4fae-31b1-42e9-8b06-38b4c602805d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f037a4b7-ff9a-43e0-bf03-537d4e63acf2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b66b6fc9-c589-43a6-b119-20082854fa27" xlink:to="loc_srt_RangeAxis_f037a4b7-ff9a-43e0-bf03-537d4e63acf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ff899fa5-9df5-41d0-b83a-295d4f7e5cf9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_f037a4b7-ff9a-43e0-bf03-537d4e63acf2" xlink:to="loc_srt_RangeMember_ff899fa5-9df5-41d0-b83a-295d4f7e5cf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_4d1b01bf-9791-465c-812b-c0dd76a32145" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ff899fa5-9df5-41d0-b83a-295d4f7e5cf9" xlink:to="loc_srt_MinimumMember_4d1b01bf-9791-465c-812b-c0dd76a32145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_6fea9ab1-74b6-4268-be3c-819671e6950e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ff899fa5-9df5-41d0-b83a-295d4f7e5cf9" xlink:to="loc_srt_MaximumMember_6fea9ab1-74b6-4268-be3c-819671e6950e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f801bd62-d1e8-43ee-b7e0-ea628c406f0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b66b6fc9-c589-43a6-b119-20082854fa27" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f801bd62-d1e8-43ee-b7e0-ea628c406f0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_1927e4f9-dbd7-4c89-a0eb-ac83ff5b7183" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_f801bd62-d1e8-43ee-b7e0-ea628c406f0b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_1927e4f9-dbd7-4c89-a0eb-ac83ff5b7183" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesImpairmentofLonglivedAssetsDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#SummaryofSignificantAccountingPoliciesImpairmentofLonglivedAssetsDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesImpairmentofLonglivedAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_be4ef3d0-a500-4a86-ab0f-70133d6fdeb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits_b7119af9-1dd7-451a-a8cf-1f82b1edae95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_be4ef3d0-a500-4a86-ab0f-70133d6fdeb4" xlink:to="loc_us-gaap_NumberOfReportingUnits_b7119af9-1dd7-451a-a8cf-1f82b1edae95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/NewAccountingPronouncements" xlink:type="simple" xlink:href="cron-20201231.xsd#NewAccountingPronouncements"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/NewAccountingPronouncements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_7e5ad601-5e67-4faf-9005-9a772f3b38b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_ba27b141-0655-4b84-874a-974c2c2a0f2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_7e5ad601-5e67-4faf-9005-9a772f3b38b0" xlink:to="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_ba27b141-0655-4b84-874a-974c2c2a0f2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/RevenuesfromContractswithCustomers" xlink:type="simple" xlink:href="cron-20201231.xsd#RevenuesfromContractswithCustomers"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/RevenuesfromContractswithCustomers" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4b457f65-1345-460b-aa12-7ed0f0189e72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_b50ddd9a-b32e-4c8b-bc09-e9106b91da61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4b457f65-1345-460b-aa12-7ed0f0189e72" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_b50ddd9a-b32e-4c8b-bc09-e9106b91da61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/RevenuesfromContractswithCustomersNarrativeDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#RevenuesfromContractswithCustomersNarrativeDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/RevenuesfromContractswithCustomersNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_e7ce10db-f8e8-4731-a095-b341cf0e324b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_0c32bbea-0124-479d-bf75-c2ffab8a4201" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_e7ce10db-f8e8-4731-a095-b341cf0e324b" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_0c32bbea-0124-479d-bf75-c2ffab8a4201" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_be19ed7f-37c7-44e6-a6ed-9f318298312b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_e7ce10db-f8e8-4731-a095-b341cf0e324b" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_be19ed7f-37c7-44e6-a6ed-9f318298312b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/Inventory" xlink:type="simple" xlink:href="cron-20201231.xsd#Inventory"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/Inventory" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_8229071d-805b-48fd-857b-2196939823fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_a9042106-f39b-41c9-b091-aab986d37f98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_8229071d-805b-48fd-857b-2196939823fe" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_a9042106-f39b-41c9-b091-aab986d37f98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/InventoryTables" xlink:type="simple" xlink:href="cron-20201231.xsd#InventoryTables"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/InventoryTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_9df6efe4-4ab8-42ff-b1af-648dac38f56b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_32534d12-6143-4261-a684-56908cba7022" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_9df6efe4-4ab8-42ff-b1af-648dac38f56b" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_32534d12-6143-4261-a684-56908cba7022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/InventoryDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#InventoryDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/InventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_9b8d0c54-fcd9-431c-899e-b2adfc320c95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryCurrentTable_5ea2a494-0b6e-4f05-bc8a-4145aef3a9ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryCurrentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_9b8d0c54-fcd9-431c-899e-b2adfc320c95" xlink:to="loc_us-gaap_InventoryCurrentTable_5ea2a494-0b6e-4f05-bc8a-4145aef3a9ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PublicUtilitiesInventoryAxis_4c60d2ae-9f8e-4c3e-b43d-16f8d637d3a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PublicUtilitiesInventoryAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryCurrentTable_5ea2a494-0b6e-4f05-bc8a-4145aef3a9ad" xlink:to="loc_us-gaap_PublicUtilitiesInventoryAxis_4c60d2ae-9f8e-4c3e-b43d-16f8d637d3a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_6ef7c3d5-e2a4-40f9-a522-345f56c1fbc0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PublicUtilitiesInventoryTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PublicUtilitiesInventoryAxis_4c60d2ae-9f8e-4c3e-b43d-16f8d637d3a9" xlink:to="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_6ef7c3d5-e2a4-40f9-a522-345f56c1fbc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InventoryDryCannabisMember_16c039a7-9899-43a8-8ae8-ce803d078000" xlink:href="cron-20201231.xsd#cron_InventoryDryCannabisMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_6ef7c3d5-e2a4-40f9-a522-345f56c1fbc0" xlink:to="loc_cron_InventoryDryCannabisMember_16c039a7-9899-43a8-8ae8-ce803d078000" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InventoryCannabisExtractsMember_5bd00943-f580-443d-97c4-983f48b2a4b6" xlink:href="cron-20201231.xsd#cron_InventoryCannabisExtractsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PublicUtilitiesInventoryTypeDomain_6ef7c3d5-e2a4-40f9-a522-345f56c1fbc0" xlink:to="loc_cron_InventoryCannabisExtractsMember_5bd00943-f580-443d-97c4-983f48b2a4b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLineItems_96a8a78f-7b7c-4773-b674-61a31525f112" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryCurrentTable_5ea2a494-0b6e-4f05-bc8a-4145aef3a9ad" xlink:to="loc_us-gaap_InventoryLineItems_96a8a78f-7b7c-4773-b674-61a31525f112" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_dc6e7148-4884-45c4-8dbb-a14f3132fee9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryLineItems_96a8a78f-7b7c-4773-b674-61a31525f112" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_dc6e7148-4884-45c4-8dbb-a14f3132fee9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_71db960a-672c-45e0-88c8-f2243094260d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryLineItems_96a8a78f-7b7c-4773-b674-61a31525f112" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_71db960a-672c-45e0-88c8-f2243094260d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_bc968e10-fa36-410a-85b9-f5f8f14586a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryLineItems_96a8a78f-7b7c-4773-b674-61a31525f112" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_bc968e10-fa36-410a-85b9-f5f8f14586a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventorySuppliesNetOfReserves_bbd6b545-466f-423d-a568-487b62a3d900" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventorySuppliesNetOfReserves"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryLineItems_96a8a78f-7b7c-4773-b674-61a31525f112" xlink:to="loc_us-gaap_InventorySuppliesNetOfReserves_bbd6b545-466f-423d-a568-487b62a3d900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_c25e9909-4eb3-4c5d-8111-43e3b2a8b652" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryLineItems_96a8a78f-7b7c-4773-b674-61a31525f112" xlink:to="loc_us-gaap_InventoryNet_c25e9909-4eb3-4c5d-8111-43e3b2a8b652" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_731c3696-af4d-4137-a3ac-41a29f90a870" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryLineItems_96a8a78f-7b7c-4773-b674-61a31525f112" xlink:to="loc_us-gaap_InventoryWriteDown_731c3696-af4d-4137-a3ac-41a29f90a870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves_76b439b9-b828-4bb7-9204-1810cea712d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryValuationReserves"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryLineItems_96a8a78f-7b7c-4773-b674-61a31525f112" xlink:to="loc_us-gaap_InventoryValuationReserves_76b439b9-b828-4bb7-9204-1810cea712d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/Investments" xlink:type="simple" xlink:href="cron-20201231.xsd#Investments"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/Investments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_9f9f8162-32d0-4b44-9e1b-a55466d3f688" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_634151c7-2553-4054-ba4f-a1daf5a4361c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_9f9f8162-32d0-4b44-9e1b-a55466d3f688" xlink:to="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_634151c7-2553-4054-ba4f-a1daf5a4361c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/InvestmentsTables" xlink:type="simple" xlink:href="cron-20201231.xsd#InvestmentsTables"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/InvestmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_a3283370-610c-45f6-8adb-778365246b75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock_511cf519-9c06-4b41-8150-d91ef2a94599" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_a3283370-610c-45f6-8adb-778365246b75" xlink:to="loc_us-gaap_EquityMethodInvestmentsTextBlock_511cf519-9c06-4b41-8150-d91ef2a94599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesTextBlock_10cacdd0-63c9-4522-ac79-19f45dd54010" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_a3283370-610c-45f6-8adb-778365246b75" xlink:to="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesTextBlock_10cacdd0-63c9-4522-ac79-19f45dd54010" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_38f2cd3d-2dad-491f-b507-9a7fb2658812" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_a3283370-610c-45f6-8adb-778365246b75" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_38f2cd3d-2dad-491f-b507-9a7fb2658812" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/InvestmentsNarrativeDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#InvestmentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/InvestmentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_bb8b6408-da48-464d-9981-03ac0e68afba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_b6c22675-fb6d-48e1-811e-2b4efba2b5ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_bb8b6408-da48-464d-9981-03ac0e68afba" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_b6c22675-fb6d-48e1-811e-2b4efba2b5ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_937c3913-5b1b-4713-94cd-b4b8b9fe04a6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_b6c22675-fb6d-48e1-811e-2b4efba2b5ed" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_937c3913-5b1b-4713-94cd-b4b8b9fe04a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_2e36b297-3bf5-4c5f-86dc-904d716f2921" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_937c3913-5b1b-4713-94cd-b4b8b9fe04a6" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_2e36b297-3bf5-4c5f-86dc-904d716f2921" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosGrowingCompanyInc.Member_0d309318-4909-470e-ab1b-a4cfec0ab8e9" xlink:href="cron-20201231.xsd#cron_CronosGrowingCompanyInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_2e36b297-3bf5-4c5f-86dc-904d716f2921" xlink:to="loc_cron_CronosGrowingCompanyInc.Member_0d309318-4909-470e-ab1b-a4cfec0ab8e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_MedMenCanadaInc.Member_85bffc9e-0ff2-4fa5-be98-7c45e3af4e48" xlink:href="cron-20201231.xsd#cron_MedMenCanadaInc.Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_2e36b297-3bf5-4c5f-86dc-904d716f2921" xlink:to="loc_cron_MedMenCanadaInc.Member_85bffc9e-0ff2-4fa5-be98-7c45e3af4e48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NatuEraMember_d3d3077e-9e1c-4ac1-848f-b7f4524588af" xlink:href="cron-20201231.xsd#cron_NatuEraMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_2e36b297-3bf5-4c5f-86dc-904d716f2921" xlink:to="loc_cron_NatuEraMember_d3d3077e-9e1c-4ac1-848f-b7f4524588af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CannasoulAnalyticsLtdMember_3c844b1b-10c2-4a02-b46c-fbe06f9a0ada" xlink:href="cron-20201231.xsd#cron_CannasoulAnalyticsLtdMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_2e36b297-3bf5-4c5f-86dc-904d716f2921" xlink:to="loc_cron_CannasoulAnalyticsLtdMember_3c844b1b-10c2-4a02-b46c-fbe06f9a0ada" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosAustraliaLimitedMember_0faff6ef-f494-41b7-944a-5140cefbadb9" xlink:href="cron-20201231.xsd#cron_CronosAustraliaLimitedMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_2e36b297-3bf5-4c5f-86dc-904d716f2921" xlink:to="loc_cron_CronosAustraliaLimitedMember_0faff6ef-f494-41b7-944a-5140cefbadb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_3d1051e4-4e92-443e-a902-811dfd641ca1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_b6c22675-fb6d-48e1-811e-2b4efba2b5ed" xlink:to="loc_us-gaap_TypeOfArrangementAxis_3d1051e4-4e92-443e-a902-811dfd641ca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_2b7c76e2-3bc0-43fa-8efe-ce808f3b3919" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_3d1051e4-4e92-443e-a902-811dfd641ca1" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_2b7c76e2-3bc0-43fa-8efe-ce808f3b3919" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_c888f7b7-343c-4b82-b17d-2d7928d46494" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_2b7c76e2-3bc0-43fa-8efe-ce808f3b3919" xlink:to="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_c888f7b7-343c-4b82-b17d-2d7928d46494" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_88670b80-7289-42ec-9486-5736f1e825d4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_b6c22675-fb6d-48e1-811e-2b4efba2b5ed" xlink:to="loc_srt_RangeAxis_88670b80-7289-42ec-9486-5736f1e825d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_31501921-25ea-49ac-baa8-56f8e51e8295" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_88670b80-7289-42ec-9486-5736f1e825d4" xlink:to="loc_srt_RangeMember_31501921-25ea-49ac-baa8-56f8e51e8295" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_66972fde-e37a-4a4f-b3e0-110803e11b99" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_31501921-25ea-49ac-baa8-56f8e51e8295" xlink:to="loc_srt_MinimumMember_66972fde-e37a-4a4f-b3e0-110803e11b99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LoanReceivableNameAxis_f0af95a7-b4c2-4bbb-a489-4c69fb656789" xlink:href="cron-20201231.xsd#cron_LoanReceivableNameAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_b6c22675-fb6d-48e1-811e-2b4efba2b5ed" xlink:to="loc_cron_LoanReceivableNameAxis_f0af95a7-b4c2-4bbb-a489-4c69fb656789" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LoanReceivableNameDomain_a73650a4-968b-4419-9c78-b960da5162a8" xlink:href="cron-20201231.xsd#cron_LoanReceivableNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_LoanReceivableNameAxis_f0af95a7-b4c2-4bbb-a489-4c69fb656789" xlink:to="loc_cron_LoanReceivableNameDomain_a73650a4-968b-4419-9c78-b960da5162a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CannasoulCollaborationLoanMember_ad15f97d-b704-4657-9053-187d9145650b" xlink:href="cron-20201231.xsd#cron_CannasoulCollaborationLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_LoanReceivableNameDomain_a73650a4-968b-4419-9c78-b960da5162a8" xlink:to="loc_cron_CannasoulCollaborationLoanMember_ad15f97d-b704-4657-9053-187d9145650b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_39e38ec5-4360-4b85-87bd-b841eaa27bc9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_b6c22675-fb6d-48e1-811e-2b4efba2b5ed" xlink:to="loc_srt_ConsolidatedEntitiesAxis_39e38ec5-4360-4b85-87bd-b841eaa27bc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_b755f7ec-193d-47fb-88f2-9093856990bb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_39e38ec5-4360-4b85-87bd-b841eaa27bc9" xlink:to="loc_srt_ConsolidatedEntitiesDomain_b755f7ec-193d-47fb-88f2-9093856990bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_cbbe21eb-71f8-4ce3-9f17-6f789752e0d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_b755f7ec-193d-47fb-88f2-9093856990bb" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_cbbe21eb-71f8-4ce3-9f17-6f789752e0d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_512b6a36-6e87-46f2-8689-759e4988d4d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_b6c22675-fb6d-48e1-811e-2b4efba2b5ed" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_512b6a36-6e87-46f2-8689-759e4988d4d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_37f5e26d-68b3-4ada-8b60-8d3ec09b9237" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_512b6a36-6e87-46f2-8689-759e4988d4d2" xlink:to="loc_us-gaap_ReceivableTypeDomain_37f5e26d-68b3-4ada-8b60-8d3ec09b9237" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansReceivableMember_53389b92-0325-49bb-9763-9cd0f7c5068a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivableTypeDomain_37f5e26d-68b3-4ada-8b60-8d3ec09b9237" xlink:to="loc_us-gaap_LoansReceivableMember_53389b92-0325-49bb-9763-9cd0f7c5068a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_6a9e692b-5b84-42c8-9573-9471dcda9374" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_b6c22675-fb6d-48e1-811e-2b4efba2b5ed" xlink:to="loc_us-gaap_VariableInterestEntityLineItems_6a9e692b-5b84-42c8-9573-9471dcda9374" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityOwnershipPercentage_e6f9a358-e967-4010-8945-773925c57424" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityOwnershipPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_6a9e692b-5b84-42c8-9573-9471dcda9374" xlink:to="loc_us-gaap_VariableInterestEntityOwnershipPercentage_e6f9a358-e967-4010-8945-773925c57424" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_VariableInterestEntityQualitativeOrQuantitativeInformationLicenseTerm_d92390ba-78f4-4ece-b4f8-c7f06ac0c9bd" xlink:href="cron-20201231.xsd#cron_VariableInterestEntityQualitativeOrQuantitativeInformationLicenseTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_6a9e692b-5b84-42c8-9573-9471dcda9374" xlink:to="loc_cron_VariableInterestEntityQualitativeOrQuantitativeInformationLicenseTerm_d92390ba-78f4-4ece-b4f8-c7f06ac0c9bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CollaborativeArrangementAmountOfAdvances_53de1c5f-dc6a-47cb-8910-a6a488fd525a" xlink:href="cron-20201231.xsd#cron_CollaborativeArrangementAmountOfAdvances"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_6a9e692b-5b84-42c8-9573-9471dcda9374" xlink:to="loc_cron_CollaborativeArrangementAmountOfAdvances_53de1c5f-dc6a-47cb-8910-a6a488fd525a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CollaborativeArrangementTermOfAgreement_589caa1b-f540-4ccf-b0c5-1b570562b1da" xlink:href="cron-20201231.xsd#cron_CollaborativeArrangementTermOfAgreement"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_6a9e692b-5b84-42c8-9573-9471dcda9374" xlink:to="loc_cron_CollaborativeArrangementTermOfAgreement_589caa1b-f540-4ccf-b0c5-1b570562b1da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_5567eb5e-c7a1-47dd-a362-222b5ed07069" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_6a9e692b-5b84-42c8-9573-9471dcda9374" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_5567eb5e-c7a1-47dd-a362-222b5ed07069" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CollaborativeArrangementPercentageOfProfitsToBeReceived_c44612aa-2ee7-41e2-9373-18151069465b" xlink:href="cron-20201231.xsd#cron_CollaborativeArrangementPercentageOfProfitsToBeReceived"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_6a9e692b-5b84-42c8-9573-9471dcda9374" xlink:to="loc_cron_CollaborativeArrangementPercentageOfProfitsToBeReceived_c44612aa-2ee7-41e2-9373-18151069465b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced_b1c3c4aa-8c6a-4658-8929-e9b408cc3066" xlink:href="cron-20201231.xsd#cron_CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_6a9e692b-5b84-42c8-9573-9471dcda9374" xlink:to="loc_cron_CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced_b1c3c4aa-8c6a-4658-8929-e9b408cc3066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet_6df051d7-505c-4a71-bbf7-8ccf893807cc" xlink:href="cron-20201231.xsd#cron_CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_6a9e692b-5b84-42c8-9573-9471dcda9374" xlink:to="loc_cron_CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet_6df051d7-505c-4a71-bbf7-8ccf893807cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/InvestmentsScheduleofEquityMethodInvestmentsDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#InvestmentsScheduleofEquityMethodInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/InvestmentsScheduleofEquityMethodInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_e714d39e-236a-4929-a88a-c0608e9f9d8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_5e0be92e-53db-4ed4-8180-f80536c98d6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_e714d39e-236a-4929-a88a-c0608e9f9d8e" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_5e0be92e-53db-4ed4-8180-f80536c98d6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_93128868-da03-4140-bdb8-22e00e834b2e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_5e0be92e-53db-4ed4-8180-f80536c98d6e" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_93128868-da03-4140-bdb8-22e00e834b2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_d46ee047-1861-42ea-b272-2e6276d25984" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_93128868-da03-4140-bdb8-22e00e834b2e" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_d46ee047-1861-42ea-b272-2e6276d25984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosAustraliaLimitedMember_27967178-2766-46ea-8ea6-bf98fd0a4f6c" xlink:href="cron-20201231.xsd#cron_CronosAustraliaLimitedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_d46ee047-1861-42ea-b272-2e6276d25984" xlink:to="loc_cron_CronosAustraliaLimitedMember_27967178-2766-46ea-8ea6-bf98fd0a4f6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosGrowingCompanyInc.Member_feca796e-1788-4a1a-b8e2-e26a4c9f43d4" xlink:href="cron-20201231.xsd#cron_CronosGrowingCompanyInc.Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_d46ee047-1861-42ea-b272-2e6276d25984" xlink:to="loc_cron_CronosGrowingCompanyInc.Member_feca796e-1788-4a1a-b8e2-e26a4c9f43d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NatuEraMember_5f6dd485-bd45-4f8b-b9ec-2e04709e775c" xlink:href="cron-20201231.xsd#cron_NatuEraMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_d46ee047-1861-42ea-b272-2e6276d25984" xlink:to="loc_cron_NatuEraMember_5f6dd485-bd45-4f8b-b9ec-2e04709e775c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_WhistlerMedicalMarijuanaCompanyMember_59c10ee5-86a5-4375-877a-34e08b619f2b" xlink:href="cron-20201231.xsd#cron_WhistlerMedicalMarijuanaCompanyMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_d46ee047-1861-42ea-b272-2e6276d25984" xlink:to="loc_cron_WhistlerMedicalMarijuanaCompanyMember_59c10ee5-86a5-4375-877a-34e08b619f2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_MedMenCanadaInc.Member_ef78d431-623c-4769-aafe-d7380120b803" xlink:href="cron-20201231.xsd#cron_MedMenCanadaInc.Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_d46ee047-1861-42ea-b272-2e6276d25984" xlink:to="loc_cron_MedMenCanadaInc.Member_ef78d431-623c-4769-aafe-d7380120b803" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_e126f095-d46b-4e5a-9cbb-9bab495666d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_5e0be92e-53db-4ed4-8180-f80536c98d6e" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_e126f095-d46b-4e5a-9cbb-9bab495666d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_7741fa26-0fcb-488b-98c9-3593b3a286c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_e126f095-d46b-4e5a-9cbb-9bab495666d3" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_7741fa26-0fcb-488b-98c9-3593b3a286c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_9e4f9c81-6f17-4d30-b1eb-b960c5196c7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IPOMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_7741fa26-0fcb-488b-98c9-3593b3a286c9" xlink:to="loc_us-gaap_IPOMember_9e4f9c81-6f17-4d30-b1eb-b960c5196c7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_a8549a2c-b321-4050-917d-f73a821adcb1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_5e0be92e-53db-4ed4-8180-f80536c98d6e" xlink:to="loc_dei_LegalEntityAxis_a8549a2c-b321-4050-917d-f73a821adcb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_738b380f-cd04-4da5-8f0a-e9e75fbc009e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_a8549a2c-b321-4050-917d-f73a821adcb1" xlink:to="loc_dei_EntityDomain_738b380f-cd04-4da5-8f0a-e9e75fbc009e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosAustraliaLimitedMember_4a3d9f66-95c4-4d84-8658-f480a47eb495" xlink:href="cron-20201231.xsd#cron_CronosAustraliaLimitedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_738b380f-cd04-4da5-8f0a-e9e75fbc009e" xlink:to="loc_cron_CronosAustraliaLimitedMember_4a3d9f66-95c4-4d84-8658-f480a47eb495" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosGroupInc.Member_db332b38-ed92-456d-8a0c-4f231d315a19" xlink:href="cron-20201231.xsd#cron_CronosGroupInc.Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_738b380f-cd04-4da5-8f0a-e9e75fbc009e" xlink:to="loc_cron_CronosGroupInc.Member_db332b38-ed92-456d-8a0c-4f231d315a19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_MucciMember_5b6d1785-94d5-42f4-ba8b-4686435a1688" xlink:href="cron-20201231.xsd#cron_MucciMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_738b380f-cd04-4da5-8f0a-e9e75fbc009e" xlink:to="loc_cron_MucciMember_5b6d1785-94d5-42f4-ba8b-4686435a1688" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_c675f0a0-d872-49b5-afef-0089ef530b92" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_5e0be92e-53db-4ed4-8180-f80536c98d6e" xlink:to="loc_srt_ConsolidatedEntitiesAxis_c675f0a0-d872-49b5-afef-0089ef530b92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_6b2db0e5-2f14-4985-a591-2947af1b5e80" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_c675f0a0-d872-49b5-afef-0089ef530b92" xlink:to="loc_srt_ConsolidatedEntitiesDomain_6b2db0e5-2f14-4985-a591-2947af1b5e80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_868a54dc-425a-4b43-ac01-6263100e09f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_6b2db0e5-2f14-4985-a591-2947af1b5e80" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_868a54dc-425a-4b43-ac01-6263100e09f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_53c19833-7748-46ee-84a5-3ff8433ce48a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_5e0be92e-53db-4ed4-8180-f80536c98d6e" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_53c19833-7748-46ee-84a5-3ff8433ce48a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_e2dcc4a1-392d-456d-864f-6e17e388374c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_53c19833-7748-46ee-84a5-3ff8433ce48a" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_e2dcc4a1-392d-456d-864f-6e17e388374c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember_376d058a-24bd-4573-bbf9-89766a87d706" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_e2dcc4a1-392d-456d-864f-6e17e388374c" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember_376d058a-24bd-4573-bbf9-89766a87d706" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_329057b9-9bb0-41a4-9df2-842fc41d6cc3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_5e0be92e-53db-4ed4-8180-f80536c98d6e" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_329057b9-9bb0-41a4-9df2-842fc41d6cc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_62ef0783-a50f-48ba-804d-72c4df1ecacc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_329057b9-9bb0-41a4-9df2-842fc41d6cc3" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_62ef0783-a50f-48ba-804d-72c4df1ecacc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_ada33754-0e25-45e0-b65b-35b8bf58c99e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_329057b9-9bb0-41a4-9df2-842fc41d6cc3" xlink:to="loc_us-gaap_EquityMethodInvestments_ada33754-0e25-45e0-b65b-35b8bf58c99e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_78f83a11-2bc8-48d3-a02b-0a9449e8da1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_329057b9-9bb0-41a4-9df2-842fc41d6cc3" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_78f83a11-2bc8-48d3-a02b-0a9449e8da1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_2aafa7fd-2d7c-423f-a592-383250f5baf9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_329057b9-9bb0-41a4-9df2-842fc41d6cc3" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_2aafa7fd-2d7c-423f-a592-383250f5baf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityOwnershipPercentage_072ae7c0-567e-42e6-9cf2-6375737b1703" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityOwnershipPercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_329057b9-9bb0-41a4-9df2-842fc41d6cc3" xlink:to="loc_us-gaap_VariableInterestEntityOwnershipPercentage_072ae7c0-567e-42e6-9cf2-6375737b1703" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments_1ffd60bc-ca5e-41ad-b7a1-3740dfff99e2" xlink:href="cron-20201231.xsd#cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_329057b9-9bb0-41a4-9df2-842fc41d6cc3" xlink:to="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments_1ffd60bc-ca5e-41ad-b7a1-3740dfff99e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage_d1da36eb-e7fb-4f62-a199-7b631ce53420" xlink:href="cron-20201231.xsd#cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_329057b9-9bb0-41a4-9df2-842fc41d6cc3" xlink:to="loc_cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage_d1da36eb-e7fb-4f62-a199-7b631ce53420" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees_f4920af3-09f5-4fee-b78d-8937809a6679" xlink:href="cron-20201231.xsd#cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_329057b9-9bb0-41a4-9df2-842fc41d6cc3" xlink:to="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees_f4920af3-09f5-4fee-b78d-8937809a6679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_07e78d0c-f3c5-467d-9089-715f69fe0c08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_329057b9-9bb0-41a4-9df2-842fc41d6cc3" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_07e78d0c-f3c5-467d-9089-715f69fe0c08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAbstract_f51db5c4-707f-43cf-b667-72a657c6c321" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_329057b9-9bb0-41a4-9df2-842fc41d6cc3" xlink:to="loc_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAbstract_f51db5c4-707f-43cf-b667-72a657c6c321" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_3aa23f91-d8dc-4e07-8e5b-0908f3091dac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAbstract_f51db5c4-707f-43cf-b667-72a657c6c321" xlink:to="loc_us-gaap_AssetsCurrent_3aa23f91-d8dc-4e07-8e5b-0908f3091dac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent_67b90a5c-a534-4669-aacb-ac3c1670f4f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAbstract_f51db5c4-707f-43cf-b667-72a657c6c321" xlink:to="loc_us-gaap_AssetsNoncurrent_67b90a5c-a534-4669-aacb-ac3c1670f4f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_05eea4ac-dc9a-407f-af48-0c6ec2953a1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAbstract_f51db5c4-707f-43cf-b667-72a657c6c321" xlink:to="loc_us-gaap_LiabilitiesCurrent_05eea4ac-dc9a-407f-af48-0c6ec2953a1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_e99cc059-8484-422b-9275-d15c56610646" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAbstract_f51db5c4-707f-43cf-b667-72a657c6c321" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_e99cc059-8484-422b-9275-d15c56610646" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_d285a007-fdb5-4bbc-a9c2-215cf3479b5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_329057b9-9bb0-41a4-9df2-842fc41d6cc3" xlink:to="loc_us-gaap_IncomeStatementAbstract_d285a007-fdb5-4bbc-a9c2-215cf3479b5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7201d15d-3c97-4436-841a-b3cdb39133d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d285a007-fdb5-4bbc-a9c2-215cf3479b5f" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7201d15d-3c97-4436-841a-b3cdb39133d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_5044950e-d4c5-4d28-8668-ce366dda978b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d285a007-fdb5-4bbc-a9c2-215cf3479b5f" xlink:to="loc_us-gaap_GrossProfit_5044950e-d4c5-4d28-8668-ce366dda978b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_14e33980-5215-4b9e-92e6-0977b0ada0a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d285a007-fdb5-4bbc-a9c2-215cf3479b5f" xlink:to="loc_us-gaap_ProfitLoss_14e33980-5215-4b9e-92e6-0977b0ada0a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/InvestmentsScheduleofAdvancestoJointVenturesDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#InvestmentsScheduleofAdvancestoJointVenturesDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/InvestmentsScheduleofAdvancestoJointVenturesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_67c7729f-ef16-48b7-a2ce-089e3f6c06b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_6053e44b-317b-4216-9487-acac509abfbd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_67c7729f-ef16-48b7-a2ce-089e3f6c06b6" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_6053e44b-317b-4216-9487-acac509abfbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_bd24a0ad-1d68-49e0-83b6-5ad4c78d75f6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_6053e44b-317b-4216-9487-acac509abfbd" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_bd24a0ad-1d68-49e0-83b6-5ad4c78d75f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_4c6ba522-4e56-4fe5-a36c-c81660992597" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_bd24a0ad-1d68-49e0-83b6-5ad4c78d75f6" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_4c6ba522-4e56-4fe5-a36c-c81660992597" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_MedMenCanadaInc.Member_833be9ac-b194-42f4-a753-9b7ba26b8c23" xlink:href="cron-20201231.xsd#cron_MedMenCanadaInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_4c6ba522-4e56-4fe5-a36c-c81660992597" xlink:to="loc_cron_MedMenCanadaInc.Member_833be9ac-b194-42f4-a753-9b7ba26b8c23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosGrowingCompanyInc.Member_8a37f561-335f-454e-8faa-dadd201ecea9" xlink:href="cron-20201231.xsd#cron_CronosGrowingCompanyInc.Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_4c6ba522-4e56-4fe5-a36c-c81660992597" xlink:to="loc_cron_CronosGrowingCompanyInc.Member_8a37f561-335f-454e-8faa-dadd201ecea9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosAustraliaLimitedMember_31d9bb5b-f8d9-491a-9bf2-4d7999b689ca" xlink:href="cron-20201231.xsd#cron_CronosAustraliaLimitedMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_4c6ba522-4e56-4fe5-a36c-c81660992597" xlink:to="loc_cron_CronosAustraliaLimitedMember_31d9bb5b-f8d9-491a-9bf2-4d7999b689ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NatuEraMember_078b9322-af06-48b2-963c-f7581526d14f" xlink:href="cron-20201231.xsd#cron_NatuEraMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_4c6ba522-4e56-4fe5-a36c-c81660992597" xlink:to="loc_cron_NatuEraMember_078b9322-af06-48b2-963c-f7581526d14f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_7a7ad6df-3169-4368-8caf-1f52937f2e74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_6053e44b-317b-4216-9487-acac509abfbd" xlink:to="loc_us-gaap_VariableInterestEntityLineItems_7a7ad6df-3169-4368-8caf-1f52937f2e74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward_3c3f5984-9d60-4323-8e53-8f0d36164663" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_7a7ad6df-3169-4368-8caf-1f52937f2e74" xlink:to="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward_3c3f5984-9d60-4323-8e53-8f0d36164663" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvancesToAffiliate_d7705216-1f03-4b07-bd3f-4e14b9377198" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdvancesToAffiliate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward_3c3f5984-9d60-4323-8e53-8f0d36164663" xlink:to="loc_us-gaap_AdvancesToAffiliate_d7705216-1f03-4b07-bd3f-4e14b9377198" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees_1c765b1f-669c-4cef-88f9-46edcd612208" xlink:href="cron-20201231.xsd#cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward_3c3f5984-9d60-4323-8e53-8f0d36164663" xlink:to="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees_1c765b1f-669c-4cef-88f9-46edcd612208" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueInterestOnAdvances_de0f3621-ff3d-429d-92bb-77e712a48e6a" xlink:href="cron-20201231.xsd#cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueInterestOnAdvances"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward_3c3f5984-9d60-4323-8e53-8f0d36164663" xlink:to="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueInterestOnAdvances_de0f3621-ff3d-429d-92bb-77e712a48e6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments_2fa36c74-5cd6-4e8e-b878-b9132c61e5bd" xlink:href="cron-20201231.xsd#cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward_3c3f5984-9d60-4323-8e53-8f0d36164663" xlink:to="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments_2fa36c74-5cd6-4e8e-b878-b9132c61e5bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueRecoveredFromAppliedToEquityMethodInvestment_d6bb0f2b-d126-46b6-9239-da482ac4144e" xlink:href="cron-20201231.xsd#cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueRecoveredFromAppliedToEquityMethodInvestment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward_3c3f5984-9d60-4323-8e53-8f0d36164663" xlink:to="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueRecoveredFromAppliedToEquityMethodInvestment_d6bb0f2b-d126-46b6-9239-da482ac4144e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueChangesDueToCurrencyTranslation_b8d463a3-5f8e-4f8e-b51c-7a9b40f07504" xlink:href="cron-20201231.xsd#cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueChangesDueToCurrencyTranslation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward_3c3f5984-9d60-4323-8e53-8f0d36164663" xlink:to="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueChangesDueToCurrencyTranslation_b8d463a3-5f8e-4f8e-b51c-7a9b40f07504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvancesToAffiliate_76031ed3-d279-4121-9cfe-9de20e010f3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdvancesToAffiliate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward_3c3f5984-9d60-4323-8e53-8f0d36164663" xlink:to="loc_us-gaap_AdvancesToAffiliate_76031ed3-d279-4121-9cfe-9de20e010f3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentsInAndAdvancesToAffiliatesDebtInstrumentFaceAmount_25153f70-4612-44a2-969d-a481a06fd370" xlink:href="cron-20201231.xsd#cron_InvestmentsInAndAdvancesToAffiliatesDebtInstrumentFaceAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_7a7ad6df-3169-4368-8caf-1f52937f2e74" xlink:to="loc_cron_InvestmentsInAndAdvancesToAffiliatesDebtInstrumentFaceAmount_25153f70-4612-44a2-969d-a481a06fd370" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_0a6530cf-1f71-4ed5-9814-e7a7bba7194a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_7a7ad6df-3169-4368-8caf-1f52937f2e74" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_0a6530cf-1f71-4ed5-9814-e7a7bba7194a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DebtInstrumentPastDueAdditionalInterestRateStatedPercentage_c39c0ca9-7d5f-4aac-aaf1-a5b76a2bec35" xlink:href="cron-20201231.xsd#cron_DebtInstrumentPastDueAdditionalInterestRateStatedPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_7a7ad6df-3169-4368-8caf-1f52937f2e74" xlink:to="loc_cron_DebtInstrumentPastDueAdditionalInterestRateStatedPercentage_c39c0ca9-7d5f-4aac-aaf1-a5b76a2bec35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/InvestmentsScheduleofVariableInterestEntitiesDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#InvestmentsScheduleofVariableInterestEntitiesDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/InvestmentsScheduleofVariableInterestEntitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_f1acf998-6028-4c3f-9e3f-703bacb00b09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_ed92fca8-1cf8-450d-aed9-c5a8f9ea0294" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_f1acf998-6028-4c3f-9e3f-703bacb00b09" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_ed92fca8-1cf8-450d-aed9-c5a8f9ea0294" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7d8cf170-53a8-4e63-9785-ca11c6415f9f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_ed92fca8-1cf8-450d-aed9-c5a8f9ea0294" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7d8cf170-53a8-4e63-9785-ca11c6415f9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_ef2d77eb-39f3-4e92-bbeb-dcb3daeef425" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7d8cf170-53a8-4e63-9785-ca11c6415f9f" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_ef2d77eb-39f3-4e92-bbeb-dcb3daeef425" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosAustraliaLimitedMember_9652fb63-f43b-4d66-b9d2-b71f0e909895" xlink:href="cron-20201231.xsd#cron_CronosAustraliaLimitedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_ef2d77eb-39f3-4e92-bbeb-dcb3daeef425" xlink:to="loc_cron_CronosAustraliaLimitedMember_9652fb63-f43b-4d66-b9d2-b71f0e909895" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosGrowingCompanyInc.Member_e8426f19-ca9e-49e4-a4fe-32770394e344" xlink:href="cron-20201231.xsd#cron_CronosGrowingCompanyInc.Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_ef2d77eb-39f3-4e92-bbeb-dcb3daeef425" xlink:to="loc_cron_CronosGrowingCompanyInc.Member_e8426f19-ca9e-49e4-a4fe-32770394e344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_MedMenCanadaInc.Member_23519e17-ab69-4826-87cf-334e56ecbc91" xlink:href="cron-20201231.xsd#cron_MedMenCanadaInc.Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_ef2d77eb-39f3-4e92-bbeb-dcb3daeef425" xlink:to="loc_cron_MedMenCanadaInc.Member_23519e17-ab69-4826-87cf-334e56ecbc91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NatuEraMember_2bb8c90c-36ca-4e15-aa4d-c3874d37f624" xlink:href="cron-20201231.xsd#cron_NatuEraMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_ef2d77eb-39f3-4e92-bbeb-dcb3daeef425" xlink:to="loc_cron_NatuEraMember_2bb8c90c-36ca-4e15-aa4d-c3874d37f624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_912bb7a8-209d-460a-a239-04ff30a896e0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_ed92fca8-1cf8-450d-aed9-c5a8f9ea0294" xlink:to="loc_srt_ConsolidatedEntitiesAxis_912bb7a8-209d-460a-a239-04ff30a896e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_d33ac962-b17e-4d83-a72b-ff3d3c0e419c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_912bb7a8-209d-460a-a239-04ff30a896e0" xlink:to="loc_srt_ConsolidatedEntitiesDomain_d33ac962-b17e-4d83-a72b-ff3d3c0e419c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_3e787f62-a353-4e78-b288-5a6a6d00b44a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_d33ac962-b17e-4d83-a72b-ff3d3c0e419c" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_3e787f62-a353-4e78-b288-5a6a6d00b44a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_eeb36034-811a-4834-9ab5-1252a8a9c331" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_ed92fca8-1cf8-450d-aed9-c5a8f9ea0294" xlink:to="loc_us-gaap_VariableInterestEntityLineItems_eeb36034-811a-4834-9ab5-1252a8a9c331" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityOwnershipPercentage_b0d4cf03-e255-4fb7-87f0-e34140a70098" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityOwnershipPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_eeb36034-811a-4834-9ab5-1252a8a9c331" xlink:to="loc_us-gaap_VariableInterestEntityOwnershipPercentage_b0d4cf03-e255-4fb7-87f0-e34140a70098" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_OtherNetAssetsLiabilities_c9dbbb3d-2830-49a3-8db6-6f3efa9c94b6" xlink:href="cron-20201231.xsd#cron_OtherNetAssetsLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_eeb36034-811a-4834-9ab5-1252a8a9c331" xlink:to="loc_cron_OtherNetAssetsLiabilities_c9dbbb3d-2830-49a3-8db6-6f3efa9c94b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_ec3686f4-d3cf-4b2f-bc3f-e44370634815" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_eeb36034-811a-4834-9ab5-1252a8a9c331" xlink:to="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_ec3686f4-d3cf-4b2f-bc3f-e44370634815" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/OtherInvestments" xlink:type="simple" xlink:href="cron-20201231.xsd#OtherInvestments"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/OtherInvestments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_f5ee2f44-8c54-42d5-81a3-735ff2a769fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_9222f690-a91b-479e-9500-498f26fe9033" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_f5ee2f44-8c54-42d5-81a3-735ff2a769fa" xlink:to="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_9222f690-a91b-479e-9500-498f26fe9033" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/OtherInvestmentsTables" xlink:type="simple" xlink:href="cron-20201231.xsd#OtherInvestmentsTables"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/OtherInvestmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_f687011d-cd39-4f70-9971-72a96ea1dde0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_a01fbda4-1d91-499e-a236-bc27e87160ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_f687011d-cd39-4f70-9971-72a96ea1dde0" xlink:to="loc_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_a01fbda4-1d91-499e-a236-bc27e87160ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/OtherInvestmentsSummaryofOtherInvestmentsDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#OtherInvestmentsSummaryofOtherInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/OtherInvestmentsSummaryofOtherInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_60366d37-4b8c-4f9c-be86-48b5143b8833" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_b4223cb3-078e-4124-8bc0-55c6d85ba58e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_60366d37-4b8c-4f9c-be86-48b5143b8833" xlink:to="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_b4223cb3-078e-4124-8bc0-55c6d85ba58e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_f3b9f831-47ec-43ac-8280-d6d0ce73c4d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_b4223cb3-078e-4124-8bc0-55c6d85ba58e" xlink:to="loc_us-gaap_InvestmentTypeAxis_f3b9f831-47ec-43ac-8280-d6d0ce73c4d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_18a0df90-7db2-4f32-82a3-029f5779aade" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_f3b9f831-47ec-43ac-8280-d6d0ce73c4d7" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_18a0df90-7db2-4f32-82a3-029f5779aade" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_c3c6d4f8-b9a5-443e-b16b-e3a167eb57f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_18a0df90-7db2-4f32-82a3-029f5779aade" xlink:to="loc_us-gaap_EquitySecuritiesMember_c3c6d4f8-b9a5-443e-b16b-e3a167eb57f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_73a4962c-0fd6-4d82-898e-4320a045db66" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_b4223cb3-078e-4124-8bc0-55c6d85ba58e" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_73a4962c-0fd6-4d82-898e-4320a045db66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_324bd32d-3ccb-46fe-be4d-d48415d580f0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_73a4962c-0fd6-4d82-898e-4320a045db66" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_324bd32d-3ccb-46fe-be4d-d48415d580f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CanopyGrowthCorporationMember_b3ba820c-e22f-4a34-b6b2-fc7871560b0f" xlink:href="cron-20201231.xsd#cron_CanopyGrowthCorporationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_324bd32d-3ccb-46fe-be4d-d48415d580f0" xlink:to="loc_cron_CanopyGrowthCorporationMember_b3ba820c-e22f-4a34-b6b2-fc7871560b0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_VivoCannabisMember_655e34db-89d2-455e-ac04-2abc959a05ea" xlink:href="cron-20201231.xsd#cron_VivoCannabisMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_324bd32d-3ccb-46fe-be4d-d48415d580f0" xlink:to="loc_cron_VivoCannabisMember_655e34db-89d2-455e-ac04-2abc959a05ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_WhistlerMedicalMarijuanaCompanyMember_ce3f4580-f7e2-440e-a8d6-b2b9acfe3085" xlink:href="cron-20201231.xsd#cron_WhistlerMedicalMarijuanaCompanyMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_324bd32d-3ccb-46fe-be4d-d48415d580f0" xlink:to="loc_cron_WhistlerMedicalMarijuanaCompanyMember_ce3f4580-f7e2-440e-a8d6-b2b9acfe3085" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AuroraCannabisInc.Member_82d7ba68-8487-40a4-bd99-7a8b0cb1a9f1" xlink:href="cron-20201231.xsd#cron_AuroraCannabisInc.Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_324bd32d-3ccb-46fe-be4d-d48415d580f0" xlink:to="loc_cron_AuroraCannabisInc.Member_82d7ba68-8487-40a4-bd99-7a8b0cb1a9f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_53b08fce-cd08-4ecd-a01f-d3c3c7cbb50a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_b4223cb3-078e-4124-8bc0-55c6d85ba58e" xlink:to="loc_us-gaap_FinancialInstrumentAxis_53b08fce-cd08-4ecd-a01f-d3c3c7cbb50a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d4b5e3b6-84b2-4456-81a0-4c37a43aa287" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_53b08fce-cd08-4ecd-a01f-d3c3c7cbb50a" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d4b5e3b6-84b2-4456-81a0-4c37a43aa287" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_cc07293a-c42e-4b03-8d16-d56f4451319e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d4b5e3b6-84b2-4456-81a0-4c37a43aa287" xlink:to="loc_us-gaap_WarrantMember_cc07293a-c42e-4b03-8d16-d56f4451319e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_dea03238-552b-49de-b235-7ae1f393ca7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_b4223cb3-078e-4124-8bc0-55c6d85ba58e" xlink:to="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_dea03238-552b-49de-b235-7ae1f393ca7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_3e2b8b4b-8696-4679-9eed-1bb29170f45b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_dea03238-552b-49de-b235-7ae1f393ca7e" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_3e2b8b4b-8696-4679-9eed-1bb29170f45b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentOwnedNumberOfSharesSold_8a242e88-235b-41c5-b44a-d9f96b5af284" xlink:href="cron-20201231.xsd#cron_InvestmentOwnedNumberOfSharesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_dea03238-552b-49de-b235-7ae1f393ca7e" xlink:to="loc_cron_InvestmentOwnedNumberOfSharesSold_8a242e88-235b-41c5-b44a-d9f96b5af284" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ProceedsFromSaleOfEquitySecuritiesFVNI_87662c0d-d6af-40e4-8d77-f1f42381a47c" xlink:href="cron-20201231.xsd#cron_ProceedsFromSaleOfEquitySecuritiesFVNI"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_dea03238-552b-49de-b235-7ae1f393ca7e" xlink:to="loc_cron_ProceedsFromSaleOfEquitySecuritiesFVNI_87662c0d-d6af-40e4-8d77-f1f42381a47c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentOwnedNumberOfWarrantsExercised_d2781b8b-1703-41e8-8cf6-7ab49a588fe1" xlink:href="cron-20201231.xsd#cron_InvestmentOwnedNumberOfWarrantsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_dea03238-552b-49de-b235-7ae1f393ca7e" xlink:to="loc_cron_InvestmentOwnedNumberOfWarrantsExercised_d2781b8b-1703-41e8-8cf6-7ab49a588fe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PaymentsToExerciseWarrants_ee2fa9b3-d264-4982-ac3f-472e1e35f586" xlink:href="cron-20201231.xsd#cron_PaymentsToExerciseWarrants"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_dea03238-552b-49de-b235-7ae1f393ca7e" xlink:to="loc_cron_PaymentsToExerciseWarrants_ee2fa9b3-d264-4982-ac3f-472e1e35f586" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentOwnedSharesSoldPercentageOfSharesIssuedAndOutstanding_0bf2ea31-56bf-428e-bc75-76f5ee4cd9b3" xlink:href="cron-20201231.xsd#cron_InvestmentOwnedSharesSoldPercentageOfSharesIssuedAndOutstanding"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_dea03238-552b-49de-b235-7ae1f393ca7e" xlink:to="loc_cron_InvestmentOwnedSharesSoldPercentageOfSharesIssuedAndOutstanding_0bf2ea31-56bf-428e-bc75-76f5ee4cd9b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentOwnedNumberOfSharesReceived_95749602-c9b7-4433-a83a-5c0dc009c8ce" xlink:href="cron-20201231.xsd#cron_InvestmentOwnedNumberOfSharesReceived"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_dea03238-552b-49de-b235-7ae1f393ca7e" xlink:to="loc_cron_InvestmentOwnedNumberOfSharesReceived_95749602-c9b7-4433-a83a-5c0dc009c8ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/LoanReceivable" xlink:type="simple" xlink:href="cron-20201231.xsd#LoanReceivable"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/LoanReceivable" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_0a6c1016-32b4-4996-a8a8-084a3bb13de1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock_d26078f6-0acb-4218-bdb5-ad41222c2a04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_0a6c1016-32b4-4996-a8a8-084a3bb13de1" xlink:to="loc_us-gaap_LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock_d26078f6-0acb-4218-bdb5-ad41222c2a04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/LoanReceivableTables" xlink:type="simple" xlink:href="cron-20201231.xsd#LoanReceivableTables"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/LoanReceivableTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_6a3086ff-eb50-4b36-8940-5e66176bfb2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_a8cbc502-d535-493a-af51-691abca99ed6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_6a3086ff-eb50-4b36-8940-5e66176bfb2e" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_a8cbc502-d535-493a-af51-691abca99ed6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#LoanReceivableScheduleofLoanReceivableDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_a0497451-1374-42bd-ad00-b02823ea147c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_80fbc4da-f4de-4513-b9ac-c9bc8a179cc6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_a0497451-1374-42bd-ad00-b02823ea147c" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_80fbc4da-f4de-4513-b9ac-c9bc8a179cc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LoanReceivableNameAxis_1efe12b1-683d-4194-809d-f61edcdc77ab" xlink:href="cron-20201231.xsd#cron_LoanReceivableNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_80fbc4da-f4de-4513-b9ac-c9bc8a179cc6" xlink:to="loc_cron_LoanReceivableNameAxis_1efe12b1-683d-4194-809d-f61edcdc77ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LoanReceivableNameDomain_05590975-fa41-4489-998b-355421806c8b" xlink:href="cron-20201231.xsd#cron_LoanReceivableNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_LoanReceivableNameAxis_1efe12b1-683d-4194-809d-f61edcdc77ab" xlink:to="loc_cron_LoanReceivableNameDomain_05590975-fa41-4489-998b-355421806c8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NatuEraSeriesALoanMember_0d2458bb-da42-4078-b285-9ee9846b79c0" xlink:href="cron-20201231.xsd#cron_NatuEraSeriesALoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_LoanReceivableNameDomain_05590975-fa41-4489-998b-355421806c8b" xlink:to="loc_cron_NatuEraSeriesALoanMember_0d2458bb-da42-4078-b285-9ee9846b79c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NatuEraSeriesALoanShareOfNetLossInExcessOfCarryingValueOfEquityInvestmentMember_05ff8491-2f0c-4292-853f-ad0d735c6168" xlink:href="cron-20201231.xsd#cron_NatuEraSeriesALoanShareOfNetLossInExcessOfCarryingValueOfEquityInvestmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_LoanReceivableNameDomain_05590975-fa41-4489-998b-355421806c8b" xlink:to="loc_cron_NatuEraSeriesALoanShareOfNetLossInExcessOfCarryingValueOfEquityInvestmentMember_05ff8491-2f0c-4292-853f-ad0d735c6168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosGrowCoCreditFacilityMember_e2537e33-bc9b-485c-bdd7-f595e606092f" xlink:href="cron-20201231.xsd#cron_CronosGrowCoCreditFacilityMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_LoanReceivableNameDomain_05590975-fa41-4489-998b-355421806c8b" xlink:to="loc_cron_CronosGrowCoCreditFacilityMember_e2537e33-bc9b-485c-bdd7-f595e606092f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_A2645485OntarioInc.MucciPromissoryNoteMember_59dacb31-84e1-4dd8-adf0-969348ceb278" xlink:href="cron-20201231.xsd#cron_A2645485OntarioInc.MucciPromissoryNoteMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_LoanReceivableNameDomain_05590975-fa41-4489-998b-355421806c8b" xlink:to="loc_cron_A2645485OntarioInc.MucciPromissoryNoteMember_59dacb31-84e1-4dd8-adf0-969348ceb278" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CannasoulCollaborationLoanMember_9e6313be-57dd-47c0-910a-38f824f16d1f" xlink:href="cron-20201231.xsd#cron_CannasoulCollaborationLoanMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_LoanReceivableNameDomain_05590975-fa41-4489-998b-355421806c8b" xlink:to="loc_cron_CannasoulCollaborationLoanMember_9e6313be-57dd-47c0-910a-38f824f16d1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_f78a3ce8-76e9-4ca6-97da-941b357e9289" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_80fbc4da-f4de-4513-b9ac-c9bc8a179cc6" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_f78a3ce8-76e9-4ca6-97da-941b357e9289" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_62c5daab-d47d-4efe-b754-908341290a56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_f78a3ce8-76e9-4ca6-97da-941b357e9289" xlink:to="loc_us-gaap_ReceivableTypeDomain_62c5daab-d47d-4efe-b754-908341290a56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansReceivableMember_f981483c-7df6-498a-ac8d-f31cf89bc568" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivableTypeDomain_62c5daab-d47d-4efe-b754-908341290a56" xlink:to="loc_us-gaap_LoansReceivableMember_f981483c-7df6-498a-ac8d-f31cf89bc568" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_e28de9fb-1c70-49f6-89c5-6af2bdc21267" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_80fbc4da-f4de-4513-b9ac-c9bc8a179cc6" xlink:to="loc_dei_LegalEntityAxis_e28de9fb-1c70-49f6-89c5-6af2bdc21267" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_841fd8d4-e42b-40bc-bc9d-536c4b795331" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_e28de9fb-1c70-49f6-89c5-6af2bdc21267" xlink:to="loc_dei_EntityDomain_841fd8d4-e42b-40bc-bc9d-536c4b795331" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NatuEraMember_20d0458f-6a0c-4b16-ab4d-0ab8e6d79e79" xlink:href="cron-20201231.xsd#cron_NatuEraMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_841fd8d4-e42b-40bc-bc9d-536c4b795331" xlink:to="loc_cron_NatuEraMember_20d0458f-6a0c-4b16-ab4d-0ab8e6d79e79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_MucciMember_a3ae11ab-b4ac-4089-af71-dbe03e2e6b64" xlink:href="cron-20201231.xsd#cron_MucciMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_841fd8d4-e42b-40bc-bc9d-536c4b795331" xlink:to="loc_cron_MucciMember_a3ae11ab-b4ac-4089-af71-dbe03e2e6b64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_97d3afff-5f7a-4e50-aba4-94087ff360a6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_80fbc4da-f4de-4513-b9ac-c9bc8a179cc6" xlink:to="loc_srt_OwnershipAxis_97d3afff-5f7a-4e50-aba4-94087ff360a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_375007ff-3f67-43b8-885e-5ac3c3c30248" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_97d3afff-5f7a-4e50-aba4-94087ff360a6" xlink:to="loc_srt_OwnershipDomain_375007ff-3f67-43b8-885e-5ac3c3c30248" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosGrowingCompanyInc.Member_535e5155-7f68-4202-90af-cc73f6bd9daf" xlink:href="cron-20201231.xsd#cron_CronosGrowingCompanyInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_375007ff-3f67-43b8-885e-5ac3c3c30248" xlink:to="loc_cron_CronosGrowingCompanyInc.Member_535e5155-7f68-4202-90af-cc73f6bd9daf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_26efd311-3a57-478b-8955-8f15cdaf929f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_80fbc4da-f4de-4513-b9ac-c9bc8a179cc6" xlink:to="loc_us-gaap_TypeOfArrangementAxis_26efd311-3a57-478b-8955-8f15cdaf929f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_f3f58128-f0a5-40e6-8828-1525008a7105" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_26efd311-3a57-478b-8955-8f15cdaf929f" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_f3f58128-f0a5-40e6-8828-1525008a7105" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_d3583f7c-d883-43a5-9f7d-6a961f11f509" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_f3f58128-f0a5-40e6-8828-1525008a7105" xlink:to="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_d3583f7c-d883-43a5-9f7d-6a961f11f509" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_fb676f8b-6cd1-47fc-ba75-20d03dc2b841" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_80fbc4da-f4de-4513-b9ac-c9bc8a179cc6" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_fb676f8b-6cd1-47fc-ba75-20d03dc2b841" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_279ed395-9d94-4804-8c9b-8dc48e699fba" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_fb676f8b-6cd1-47fc-ba75-20d03dc2b841" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_279ed395-9d94-4804-8c9b-8dc48e699fba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CannasoulAnalyticsLtdMember_f81f626c-b528-4c23-a4b2-5e40e42c7feb" xlink:href="cron-20201231.xsd#cron_CannasoulAnalyticsLtdMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_279ed395-9d94-4804-8c9b-8dc48e699fba" xlink:to="loc_cron_CannasoulAnalyticsLtdMember_f81f626c-b528-4c23-a4b2-5e40e42c7feb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_a8030c18-1b16-4a9d-996a-9af47cf9eec0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_80fbc4da-f4de-4513-b9ac-c9bc8a179cc6" xlink:to="loc_srt_ConsolidatedEntitiesAxis_a8030c18-1b16-4a9d-996a-9af47cf9eec0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_eb6675f5-c12b-40ee-bffa-9e0e96251f56" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_a8030c18-1b16-4a9d-996a-9af47cf9eec0" xlink:to="loc_srt_ConsolidatedEntitiesDomain_eb6675f5-c12b-40ee-bffa-9e0e96251f56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_36a96b5e-3d52-479c-9e70-c044d461d038" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_eb6675f5-c12b-40ee-bffa-9e0e96251f56" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_36a96b5e-3d52-479c-9e70-c044d461d038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_967bb519-9298-4048-ad40-a1fd61efee80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_80fbc4da-f4de-4513-b9ac-c9bc8a179cc6" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_967bb519-9298-4048-ad40-a1fd61efee80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetCurrentAbstract_b559b7c3-65d9-4f24-8718-f7f715728b31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesAndLoansReceivableNetCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_967bb519-9298-4048-ad40-a1fd61efee80" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetCurrentAbstract_b559b7c3-65d9-4f24-8718-f7f715728b31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableBeforeAccruedInterestCurrent_5c782b9b-1152-4650-a21d-e889b5a324f1" xlink:href="cron-20201231.xsd#cron_FinancingReceivableBeforeAccruedInterestCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NotesAndLoansReceivableNetCurrentAbstract_b559b7c3-65d9-4f24-8718-f7f715728b31" xlink:to="loc_cron_FinancingReceivableBeforeAccruedInterestCurrent_5c782b9b-1152-4650-a21d-e889b5a324f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableAccruedInterestCurrent_525bb8d6-bb0c-4cb9-b153-cfc6d190f4d3" xlink:href="cron-20201231.xsd#cron_FinancingReceivableAccruedInterestCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NotesAndLoansReceivableNetCurrentAbstract_b559b7c3-65d9-4f24-8718-f7f715728b31" xlink:to="loc_cron_FinancingReceivableAccruedInterestCurrent_525bb8d6-bb0c-4cb9-b153-cfc6d190f4d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetCurrent_07412d0f-48b5-4963-9751-46624f2dc307" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesAndLoansReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NotesAndLoansReceivableNetCurrentAbstract_b559b7c3-65d9-4f24-8718-f7f715728b31" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetCurrent_07412d0f-48b5-4963-9751-46624f2dc307" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetNoncurrentAbstract_51882e9a-f0dc-4e5f-9fef-7820b0c6fa1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesAndLoansReceivableNetNoncurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_967bb519-9298-4048-ad40-a1fd61efee80" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetNoncurrentAbstract_51882e9a-f0dc-4e5f-9fef-7820b0c6fa1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableBeforeAccruedInterestNoncurrent_fcd6ba9c-ebf9-4e71-a1d5-8bfa8c57f9c8" xlink:href="cron-20201231.xsd#cron_FinancingReceivableBeforeAccruedInterestNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NotesAndLoansReceivableNetNoncurrentAbstract_51882e9a-f0dc-4e5f-9fef-7820b0c6fa1c" xlink:to="loc_cron_FinancingReceivableBeforeAccruedInterestNoncurrent_fcd6ba9c-ebf9-4e71-a1d5-8bfa8c57f9c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableAccruedInterestNoncurrent_ec00af4a-f4e3-41c7-9f10-9e596b9a0caa" xlink:href="cron-20201231.xsd#cron_FinancingReceivableAccruedInterestNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NotesAndLoansReceivableNetNoncurrentAbstract_51882e9a-f0dc-4e5f-9fef-7820b0c6fa1c" xlink:to="loc_cron_FinancingReceivableAccruedInterestNoncurrent_ec00af4a-f4e3-41c7-9f10-9e596b9a0caa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent_1dfbce78-8594-4292-91fe-4205adbefad5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesAndLoansReceivableNetNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NotesAndLoansReceivableNetNoncurrentAbstract_51882e9a-f0dc-4e5f-9fef-7820b0c6fa1c" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent_1dfbce78-8594-4292-91fe-4205adbefad5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableNet_ab060097-20c2-4eb9-b7ba-1e0a0eac90c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesReceivableNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_967bb519-9298-4048-ad40-a1fd61efee80" xlink:to="loc_us-gaap_NotesReceivableNet_ab060097-20c2-4eb9-b7ba-1e0a0eac90c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableAdditionalFaceAmountIncludingThirdPartyAmount_3f108455-db03-4da8-81e0-c4416f95689c" xlink:href="cron-20201231.xsd#cron_FinancingReceivableAdditionalFaceAmountIncludingThirdPartyAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_967bb519-9298-4048-ad40-a1fd61efee80" xlink:to="loc_cron_FinancingReceivableAdditionalFaceAmountIncludingThirdPartyAmount_3f108455-db03-4da8-81e0-c4416f95689c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableFaceAmountIncludingThirdPartyAmount_3884542a-6f72-4214-b758-dcfb1b9247cb" xlink:href="cron-20201231.xsd#cron_FinancingReceivableFaceAmountIncludingThirdPartyAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_967bb519-9298-4048-ad40-a1fd61efee80" xlink:to="loc_cron_FinancingReceivableFaceAmountIncludingThirdPartyAmount_3884542a-6f72-4214-b758-dcfb1b9247cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableFundingCommitmentPercentage_ac68c040-eecf-48b3-87b6-c64b0694f317" xlink:href="cron-20201231.xsd#cron_FinancingReceivableFundingCommitmentPercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_967bb519-9298-4048-ad40-a1fd61efee80" xlink:to="loc_cron_FinancingReceivableFundingCommitmentPercentage_ac68c040-eecf-48b3-87b6-c64b0694f317" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableInterestRateStatedPercentage_e5fb4042-1386-406e-b142-af4e3ff3f1b3" xlink:href="cron-20201231.xsd#cron_FinancingReceivableInterestRateStatedPercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_967bb519-9298-4048-ad40-a1fd61efee80" xlink:to="loc_cron_FinancingReceivableInterestRateStatedPercentage_e5fb4042-1386-406e-b142-af4e3ff3f1b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLosses_025b31eb-874b-48c3-b2f4-3affb7b785e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancingReceivableAllowanceForCreditLosses"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_967bb519-9298-4048-ad40-a1fd61efee80" xlink:to="loc_us-gaap_FinancingReceivableAllowanceForCreditLosses_025b31eb-874b-48c3-b2f4-3affb7b785e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableFaceAmount_eb3aad42-fce6-407a-bbf2-7c88d1aab915" xlink:href="cron-20201231.xsd#cron_FinancingReceivableFaceAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_967bb519-9298-4048-ad40-a1fd61efee80" xlink:to="loc_cron_FinancingReceivableFaceAmount_eb3aad42-fce6-407a-bbf2-7c88d1aab915" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_b6822b0b-8f59-4f18-abe0-8f4a69056d8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_967bb519-9298-4048-ad40-a1fd61efee80" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_b6822b0b-8f59-4f18-abe0-8f4a69056d8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireLoansReceivable_b3530995-28b6-47e4-9752-eb9e988ef92d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireLoansReceivable"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_967bb519-9298-4048-ad40-a1fd61efee80" xlink:to="loc_us-gaap_PaymentsToAcquireLoansReceivable_b3530995-28b6-47e4-9752-eb9e988ef92d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableDueOnDemandTerm_e38bb935-6f4a-4ba3-ad5a-a92c835bea3b" xlink:href="cron-20201231.xsd#cron_FinancingReceivableDueOnDemandTerm"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_967bb519-9298-4048-ad40-a1fd61efee80" xlink:to="loc_cron_FinancingReceivableDueOnDemandTerm_e38bb935-6f4a-4ba3-ad5a-a92c835bea3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableDueOnDemandIntendedDemandTermMinimum_abd18145-6b7b-4e91-9b9f-8754b65920cf" xlink:href="cron-20201231.xsd#cron_FinancingReceivableDueOnDemandIntendedDemandTermMinimum"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_967bb519-9298-4048-ad40-a1fd61efee80" xlink:to="loc_cron_FinancingReceivableDueOnDemandIntendedDemandTermMinimum_abd18145-6b7b-4e91-9b9f-8754b65920cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CollaborativeArrangementAmountOfAdvances_8b495da5-6a47-4581-ba10-1f43f96072df" xlink:href="cron-20201231.xsd#cron_CollaborativeArrangementAmountOfAdvances"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_967bb519-9298-4048-ad40-a1fd61efee80" xlink:to="loc_cron_CollaborativeArrangementAmountOfAdvances_8b495da5-6a47-4581-ba10-1f43f96072df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CollaborativeArrangementTermOfAgreement_7e86a36e-f4b3-43f1-8dc0-e873ff12c97c" xlink:href="cron-20201231.xsd#cron_CollaborativeArrangementTermOfAgreement"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_967bb519-9298-4048-ad40-a1fd61efee80" xlink:to="loc_cron_CollaborativeArrangementTermOfAgreement_7e86a36e-f4b3-43f1-8dc0-e873ff12c97c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_400ac292-0502-4295-ad91-161ce32459e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_967bb519-9298-4048-ad40-a1fd61efee80" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_400ac292-0502-4295-ad91-161ce32459e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CollaborativeArrangementInstallmentsReceived_384a07a6-10ed-4631-b702-1f78af41a747" xlink:href="cron-20201231.xsd#cron_CollaborativeArrangementInstallmentsReceived"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_967bb519-9298-4048-ad40-a1fd61efee80" xlink:to="loc_cron_CollaborativeArrangementInstallmentsReceived_384a07a6-10ed-4631-b702-1f78af41a747" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_741c4044-6983-48d9-b77c-28cdc4e4533d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_967bb519-9298-4048-ad40-a1fd61efee80" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_741c4044-6983-48d9-b77c-28cdc4e4533d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/LoansPayable" xlink:type="simple" xlink:href="cron-20201231.xsd#LoansPayable"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/LoansPayable" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_7f36e2c4-6680-48a5-bed5-b411ac9cf17e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_fec8d789-ab36-4d93-b9f7-3a10ab9fa925" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_7f36e2c4-6680-48a5-bed5-b411ac9cf17e" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_fec8d789-ab36-4d93-b9f7-3a10ab9fa925" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/LoansPayableLongtermNarrativeDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#LoansPayableLongtermNarrativeDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/LoansPayableLongtermNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_a42d973a-7153-4d20-82bd-f222d0502f87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_a389b2f1-2e01-44d1-b2de-c58ceabd3f18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_a42d973a-7153-4d20-82bd-f222d0502f87" xlink:to="loc_us-gaap_DebtInstrumentTable_a389b2f1-2e01-44d1-b2de-c58ceabd3f18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_1a653d88-55e6-412f-82d9-2a37848bd2ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a389b2f1-2e01-44d1-b2de-c58ceabd3f18" xlink:to="loc_us-gaap_CreditFacilityAxis_1a653d88-55e6-412f-82d9-2a37848bd2ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_bfa6e9fb-e6b1-4fde-bb0b-377190e96cbf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_1a653d88-55e6-412f-82d9-2a37848bd2ef" xlink:to="loc_us-gaap_CreditFacilityDomain_bfa6e9fb-e6b1-4fde-bb0b-377190e96cbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NonrevolvingTermLoanFacilityMember_52de1971-d64b-489a-ac94-821193b798cd" xlink:href="cron-20201231.xsd#cron_NonrevolvingTermLoanFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_bfa6e9fb-e6b1-4fde-bb0b-377190e96cbf" xlink:to="loc_cron_NonrevolvingTermLoanFacilityMember_52de1971-d64b-489a-ac94-821193b798cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_3efa91bc-5df9-456b-a2a0-8ec5b15700cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a389b2f1-2e01-44d1-b2de-c58ceabd3f18" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_3efa91bc-5df9-456b-a2a0-8ec5b15700cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_77f69f8b-0547-4c08-91a5-2a4309ddc350" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_3efa91bc-5df9-456b-a2a0-8ec5b15700cd" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_77f69f8b-0547-4c08-91a5-2a4309ddc350" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_f6c6e2a0-52ad-4965-ad9e-dac111197902" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_77f69f8b-0547-4c08-91a5-2a4309ddc350" xlink:to="loc_us-gaap_SecuredDebtMember_f6c6e2a0-52ad-4965-ad9e-dac111197902" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_c4bc519d-efa1-440f-b052-1ef26892b439" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a389b2f1-2e01-44d1-b2de-c58ceabd3f18" xlink:to="loc_us-gaap_DebtInstrumentAxis_c4bc519d-efa1-440f-b052-1ef26892b439" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_f5d58129-24bf-4bff-8fa6-76161f3d9714" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_c4bc519d-efa1-440f-b052-1ef26892b439" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_f5d58129-24bf-4bff-8fa6-76161f3d9714" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CreditFacilityMember_43ed5384-c90c-4e04-8a67-b6eb47887b1b" xlink:href="cron-20201231.xsd#cron_CreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f5d58129-24bf-4bff-8fa6-76161f3d9714" xlink:to="loc_cron_CreditFacilityMember_43ed5384-c90c-4e04-8a67-b6eb47887b1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ConstructionLoanAgreementMember_c3591e86-5a4c-474b-964e-037f4c0f39df" xlink:href="cron-20201231.xsd#cron_ConstructionLoanAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f5d58129-24bf-4bff-8fa6-76161f3d9714" xlink:to="loc_cron_ConstructionLoanAgreementMember_c3591e86-5a4c-474b-964e-037f4c0f39df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_4854fe7c-40a6-43d5-a01e-d9bcfb60d5a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a389b2f1-2e01-44d1-b2de-c58ceabd3f18" xlink:to="loc_us-gaap_DebtInstrumentLineItems_4854fe7c-40a6-43d5-a01e-d9bcfb60d5a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_fa1b3db6-c229-4d3f-82e3-9da386c2750f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4854fe7c-40a6-43d5-a01e-d9bcfb60d5a3" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_fa1b3db6-c229-4d3f-82e3-9da386c2750f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt_ec49613f-b0e5-4649-9328-6228bfd32436" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfSecuredDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4854fe7c-40a6-43d5-a01e-d9bcfb60d5a3" xlink:to="loc_us-gaap_RepaymentsOfSecuredDebt_ec49613f-b0e5-4649-9328-6228bfd32436" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidCapitalized_047ef1bf-2335-4e2d-853e-ef465573c49f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidCapitalized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4854fe7c-40a6-43d5-a01e-d9bcfb60d5a3" xlink:to="loc_us-gaap_InterestPaidCapitalized_047ef1bf-2335-4e2d-853e-ef465573c49f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_26cf122f-c57f-4aed-8038-b4326cb3c71d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4854fe7c-40a6-43d5-a01e-d9bcfb60d5a3" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_26cf122f-c57f-4aed-8038-b4326cb3c71d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/PropertyPlantandEquipment" xlink:type="simple" xlink:href="cron-20201231.xsd#PropertyPlantandEquipment"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/PropertyPlantandEquipment" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_f28c2594-3e4f-4978-9602-ca42e035101d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_62278084-65e7-4ece-a685-8d0208a7fe17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_f28c2594-3e4f-4978-9602-ca42e035101d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_62278084-65e7-4ece-a685-8d0208a7fe17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/PropertyPlantandEquipmentTables" xlink:type="simple" xlink:href="cron-20201231.xsd#PropertyPlantandEquipmentTables"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/PropertyPlantandEquipmentTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_255baf00-1fb7-4749-aa6a-ac3852481037" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_1f27aca2-848c-45d9-9070-987f45269d42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_255baf00-1fb7-4749-aa6a-ac3852481037" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_1f27aca2-848c-45d9-9070-987f45269d42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantEquipmentUsefulLivesDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#PropertyPlantandEquipmentScheduleofPropertyPlantEquipmentUsefulLivesDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantEquipmentUsefulLivesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_8df75e52-b1ff-4487-a1be-989398252adc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1a52c538-c5b7-4c45-afa6-846b7c16a3fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_8df75e52-b1ff-4487-a1be-989398252adc" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1a52c538-c5b7-4c45-afa6-846b7c16a3fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7dbea5ed-8016-482e-86fc-dac629ffb267" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1a52c538-c5b7-4c45-afa6-846b7c16a3fa" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7dbea5ed-8016-482e-86fc-dac629ffb267" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_46d399f1-52d5-45f3-90c8-969fa766a2c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7dbea5ed-8016-482e-86fc-dac629ffb267" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_46d399f1-52d5-45f3-90c8-969fa766a2c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_c8efeb30-5621-4713-b082-b6fb90ddca9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LandMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_46d399f1-52d5-45f3-90c8-969fa766a2c9" xlink:to="loc_us-gaap_LandMember_c8efeb30-5621-4713-b082-b6fb90ddca9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_333553ce-dbce-44b9-96b8-20ef3c15cb3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_46d399f1-52d5-45f3-90c8-969fa766a2c9" xlink:to="loc_us-gaap_BuildingMember_333553ce-dbce-44b9-96b8-20ef3c15cb3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_2dd01a03-bacd-404f-9f52-07eb86e370b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_46d399f1-52d5-45f3-90c8-969fa766a2c9" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_2dd01a03-bacd-404f-9f52-07eb86e370b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_8809813d-0724-448c-b8e8-4a635171d6c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_46d399f1-52d5-45f3-90c8-969fa766a2c9" xlink:to="loc_us-gaap_ComputerEquipmentMember_8809813d-0724-448c-b8e8-4a635171d6c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_3aedc596-28e5-4f17-8a17-483e4a70f372" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_46d399f1-52d5-45f3-90c8-969fa766a2c9" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_3aedc596-28e5-4f17-8a17-483e4a70f372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_cf159e9d-bb8b-415f-9ca6-402d6f04cee1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_46d399f1-52d5-45f3-90c8-969fa766a2c9" xlink:to="loc_us-gaap_ConstructionInProgressMember_cf159e9d-bb8b-415f-9ca6-402d6f04cee1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_eb49689f-7dfc-4752-b59f-7dc9bdf12b16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1a52c538-c5b7-4c45-afa6-846b7c16a3fa" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_eb49689f-7dfc-4752-b59f-7dc9bdf12b16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_e2fc1a65-55bc-4c3e-ab44-158614453145" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_eb49689f-7dfc-4752-b59f-7dc9bdf12b16" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_e2fc1a65-55bc-4c3e-ab44-158614453145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_83073e99-7731-4278-b52b-a16ab789f9e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_eb49689f-7dfc-4752-b59f-7dc9bdf12b16" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_83073e99-7731-4278-b52b-a16ab789f9e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_021bb1c3-9cb3-458b-8267-d6230f068cc5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_eb49689f-7dfc-4752-b59f-7dc9bdf12b16" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_021bb1c3-9cb3-458b-8267-d6230f068cc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/PropertyPlantandEquipmentNarrativeDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#PropertyPlantandEquipmentNarrativeDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/PropertyPlantandEquipmentNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_e2aae19a-ffed-42f8-8b07-34477a46e234" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciation_28a04808-a133-4f5f-bcf5-635a26861e73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldDepreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_e2aae19a-ffed-42f8-8b07-34477a46e234" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciation_28a04808-a133-4f5f-bcf5-635a26861e73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationNonproduction_bf6b5c61-ab49-46ca-ad3e-a734347a0d07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationNonproduction"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_e2aae19a-ffed-42f8-8b07-34477a46e234" xlink:to="loc_us-gaap_DepreciationNonproduction_bf6b5c61-ab49-46ca-ad3e-a734347a0d07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestCostsCapitalized_afcaa1ac-7cea-4405-9716-5f89e1c0b291" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestCostsCapitalized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_e2aae19a-ffed-42f8-8b07-34477a46e234" xlink:to="loc_us-gaap_InterestCostsCapitalized_afcaa1ac-7cea-4405-9716-5f89e1c0b291" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/IntangibleAssetsandGoodwill" xlink:type="simple" xlink:href="cron-20201231.xsd#IntangibleAssetsandGoodwill"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/IntangibleAssetsandGoodwill" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_799a955f-edda-436f-b6f0-377aefd53be7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_e1eac102-d90d-4dcf-90e7-957af91e0269" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_799a955f-edda-436f-b6f0-377aefd53be7" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_e1eac102-d90d-4dcf-90e7-957af91e0269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/IntangibleAssetsandGoodwillTables" xlink:type="simple" xlink:href="cron-20201231.xsd#IntangibleAssetsandGoodwillTables"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/IntangibleAssetsandGoodwillTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d070a2ef-e6d1-4659-8568-f38c6adc9be7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_61c61ccc-e9b2-45a9-8f03-962b96dd8470" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d070a2ef-e6d1-4659-8568-f38c6adc9be7" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_61c61ccc-e9b2-45a9-8f03-962b96dd8470" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_48991df5-16f7-4d5d-ac7d-98ce1bcb0aa1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d070a2ef-e6d1-4659-8568-f38c6adc9be7" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_48991df5-16f7-4d5d-ac7d-98ce1bcb0aa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_9ee3cc04-9189-4244-a71e-3c4d51b9d5fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d070a2ef-e6d1-4659-8568-f38c6adc9be7" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_9ee3cc04-9189-4244-a71e-3c4d51b9d5fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/IntangibleAssetsandGoodwillNarrativeDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#IntangibleAssetsandGoodwillNarrativeDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/IntangibleAssetsandGoodwillNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_09e1c328-5f6e-485a-bcb6-f06b00c349cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_b450d35e-c50a-4155-bb73-6284d99ed852" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_09e1c328-5f6e-485a-bcb6-f06b00c349cd" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_b450d35e-c50a-4155-bb73-6284d99ed852" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_4072a5af-a6ba-439f-9ef5-f0d4ce0ebcda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_b450d35e-c50a-4155-bb73-6284d99ed852" xlink:to="loc_us-gaap_ReportingUnitAxis_4072a5af-a6ba-439f-9ef5-f0d4ce0ebcda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_2d0b66a7-8f9b-42da-966b-b142200043a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitAxis_4072a5af-a6ba-439f-9ef5-f0d4ce0ebcda" xlink:to="loc_us-gaap_ReportingUnitDomain_2d0b66a7-8f9b-42da-966b-b142200043a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_UnitedStatesSegmentMember_2482623c-24ec-42b7-85a0-04213b37162e" xlink:href="cron-20201231.xsd#cron_UnitedStatesSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_2d0b66a7-8f9b-42da-966b-b142200043a0" xlink:to="loc_cron_UnitedStatesSegmentMember_2482623c-24ec-42b7-85a0-04213b37162e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_6df09365-3806-47e3-a622-766ab926c1e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_b450d35e-c50a-4155-bb73-6284d99ed852" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_6df09365-3806-47e3-a622-766ab926c1e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9d7fcba9-b978-43f5-95fb-16440e31dc2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_6df09365-3806-47e3-a622-766ab926c1e5" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9d7fcba9-b978-43f5-95fb-16440e31dc2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_b6fc40ba-4da3-4f1c-8a95-470385e18b22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9d7fcba9-b978-43f5-95fb-16440e31dc2f" xlink:to="loc_us-gaap_TradeNamesMember_b6fc40ba-4da3-4f1c-8a95-470385e18b22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_874c06ca-56b3-4ece-be50-7642b6e39362" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_b450d35e-c50a-4155-bb73-6284d99ed852" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_874c06ca-56b3-4ece-be50-7642b6e39362" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_65fec31a-adcc-4332-bbab-f19d3b14d134" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_874c06ca-56b3-4ece-be50-7642b6e39362" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_65fec31a-adcc-4332-bbab-f19d3b14d134" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_1867d4b7-bb43-4dca-aae6-d68770766b02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_874c06ca-56b3-4ece-be50-7642b6e39362" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_1867d4b7-bb43-4dca-aae6-d68770766b02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_dc5eca54-9237-4e1b-b115-0d9a6c8efd89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_874c06ca-56b3-4ece-be50-7642b6e39362" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_dc5eca54-9237-4e1b-b115-0d9a6c8efd89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_826c4b04-6595-468c-bf82-c5e0a961dbdd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_874c06ca-56b3-4ece-be50-7642b6e39362" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_826c4b04-6595-468c-bf82-c5e0a961dbdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_aca369d2-501f-4d08-94c4-e326a140ae15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_874c06ca-56b3-4ece-be50-7642b6e39362" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_aca369d2-501f-4d08-94c4-e326a140ae15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_df65d318-c4f4-4ef8-84b1-05a6bb45101a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_aca369d2-501f-4d08-94c4-e326a140ae15" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_df65d318-c4f4-4ef8-84b1-05a6bb45101a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_f5d65082-827c-488f-ba7f-266f6ce997af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_aca369d2-501f-4d08-94c4-e326a140ae15" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_f5d65082-827c-488f-ba7f-266f6ce997af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_7e1ca09a-46b2-48d6-ac5f-b582efbf6000" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_aca369d2-501f-4d08-94c4-e326a140ae15" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_7e1ca09a-46b2-48d6-ac5f-b582efbf6000" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_dd93d219-8ec4-4c08-8416-2b8d20dab29f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_aca369d2-501f-4d08-94c4-e326a140ae15" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_dd93d219-8ec4-4c08-8416-2b8d20dab29f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_aa64c237-b20f-43b7-a052-6f7581d60d2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_aca369d2-501f-4d08-94c4-e326a140ae15" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_aa64c237-b20f-43b7-a052-6f7581d60d2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_bb199797-8bb2-46fb-8524-2949ff7bfea8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_0db1697b-20f9-4366-ad75-c0fc7509174f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_bb199797-8bb2-46fb-8524-2949ff7bfea8" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_0db1697b-20f9-4366-ad75-c0fc7509174f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1bdde3ef-e87f-4884-a876-2c77624b8722" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_0db1697b-20f9-4366-ad75-c0fc7509174f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1bdde3ef-e87f-4884-a876-2c77624b8722" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0b44bb77-2879-418e-a6d7-c74bc6568ff9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1bdde3ef-e87f-4884-a876-2c77624b8722" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0b44bb77-2879-418e-a6d7-c74bc6568ff9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_bd3b3c0d-19ee-4f3d-bb98-49277f49910e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0b44bb77-2879-418e-a6d7-c74bc6568ff9" xlink:to="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_bd3b3c0d-19ee-4f3d-bb98-49277f49910e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_EnterpriseResourcePlanningSystemMember_76e50eda-24f1-4c2c-83c1-920edf23d07e" xlink:href="cron-20201231.xsd#cron_EnterpriseResourcePlanningSystemMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0b44bb77-2879-418e-a6d7-c74bc6568ff9" xlink:to="loc_cron_EnterpriseResourcePlanningSystemMember_76e50eda-24f1-4c2c-83c1-920edf23d07e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_HealthCanadaLicensingAgreementsMember_e0a40338-fe32-499a-bcdc-f39a73813437" xlink:href="cron-20201231.xsd#cron_HealthCanadaLicensingAgreementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0b44bb77-2879-418e-a6d7-c74bc6568ff9" xlink:to="loc_cron_HealthCanadaLicensingAgreementsMember_e0a40338-fe32-499a-bcdc-f39a73813437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_IsraeliCodesLicensingAgreementsMember_941d90d3-b13c-4101-866d-5b4f44efdd84" xlink:href="cron-20201231.xsd#cron_IsraeliCodesLicensingAgreementsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0b44bb77-2879-418e-a6d7-c74bc6568ff9" xlink:to="loc_cron_IsraeliCodesLicensingAgreementsMember_941d90d3-b13c-4101-866d-5b4f44efdd84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_03139686-2b7f-465d-bd14-3075b78800b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_0db1697b-20f9-4366-ad75-c0fc7509174f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_03139686-2b7f-465d-bd14-3075b78800b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_e0c5b80b-ce18-4825-9be2-6316c16adbbd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_03139686-2b7f-465d-bd14-3075b78800b5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_e0c5b80b-ce18-4825-9be2-6316c16adbbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_6f6c47cd-99d2-4d87-9c38-1daab4d255b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_03139686-2b7f-465d-bd14-3075b78800b5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_6f6c47cd-99d2-4d87-9c38-1daab4d255b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_d8de7afc-04c4-4f48-9985-3275d488b5d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_03139686-2b7f-465d-bd14-3075b78800b5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_d8de7afc-04c4-4f48-9985-3275d488b5d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_59618c14-f2ee-4906-b1b4-4f934c5af38b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_03139686-2b7f-465d-bd14-3075b78800b5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_59618c14-f2ee-4906-b1b4-4f934c5af38b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_71305756-eeea-4391-ad67-ec7a29023cf3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_bb199797-8bb2-46fb-8524-2949ff7bfea8" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_71305756-eeea-4391-ad67-ec7a29023cf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_f8138a36-8a34-43cd-89e1-1ed0cbc21e87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_71305756-eeea-4391-ad67-ec7a29023cf3" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_f8138a36-8a34-43cd-89e1-1ed0cbc21e87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_0a1d048d-6286-4bce-b099-4f9189d638f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_f8138a36-8a34-43cd-89e1-1ed0cbc21e87" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_0a1d048d-6286-4bce-b099-4f9189d638f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_aaeca6a7-68cd-4752-bc1a-74ff2afc1049" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_0a1d048d-6286-4bce-b099-4f9189d638f2" xlink:to="loc_us-gaap_TradeNamesMember_aaeca6a7-68cd-4752-bc1a-74ff2afc1049" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_72a9974c-61e2-4881-96a7-344a3abcb10a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_0a1d048d-6286-4bce-b099-4f9189d638f2" xlink:to="loc_us-gaap_TrademarksMember_72a9974c-61e2-4881-96a7-344a3abcb10a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_874564b0-c705-4589-88cf-e1315fea5792" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_71305756-eeea-4391-ad67-ec7a29023cf3" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_874564b0-c705-4589-88cf-e1315fea5792" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_a098fcca-968b-4a50-9c33-8dc4d16183ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_874564b0-c705-4589-88cf-e1315fea5792" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_a098fcca-968b-4a50-9c33-8dc4d16183ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment_3b442ac0-8e1f-449a-8a0c-f2ebbcd1c10c" xlink:href="cron-20201231.xsd#cron_IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_874564b0-c705-4589-88cf-e1315fea5792" xlink:to="loc_cron_IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment_3b442ac0-8e1f-449a-8a0c-f2ebbcd1c10c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_2ad74090-d403-4f01-805c-83096c0fcec6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_874564b0-c705-4589-88cf-e1315fea5792" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_2ad74090-d403-4f01-805c-83096c0fcec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_056079e3-7561-4617-ad9e-506b5cd20f00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_bb199797-8bb2-46fb-8524-2949ff7bfea8" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_056079e3-7561-4617-ad9e-506b5cd20f00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_85fa1010-e514-443a-b177-082198111c19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_056079e3-7561-4617-ad9e-506b5cd20f00" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_85fa1010-e514-443a-b177-082198111c19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_f15500f6-a152-41ea-bdb2-78288e3eaf44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_056079e3-7561-4617-ad9e-506b5cd20f00" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_f15500f6-a152-41ea-bdb2-78288e3eaf44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment_eed019cc-1289-42c3-91f6-9bd2ccdf3ab1" xlink:href="cron-20201231.xsd#cron_IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_056079e3-7561-4617-ad9e-506b5cd20f00" xlink:to="loc_cron_IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment_eed019cc-1289-42c3-91f6-9bd2ccdf3ab1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a94e9311-11ff-45cf-be58-dfdaafa6553d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_056079e3-7561-4617-ad9e-506b5cd20f00" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a94e9311-11ff-45cf-be58-dfdaafa6553d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofGoodwillDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#IntangibleAssetsandGoodwillScheduleofGoodwillDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7975f9e8-fecf-4b32-99fc-460178a4d157" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_8a8b92f7-504b-4ef1-b1f8-c982ddb61b1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7975f9e8-fecf-4b32-99fc-460178a4d157" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_8a8b92f7-504b-4ef1-b1f8-c982ddb61b1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_f0778835-498b-4760-b2f7-91a3dc62ae84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_8a8b92f7-504b-4ef1-b1f8-c982ddb61b1f" xlink:to="loc_us-gaap_ReportingUnitAxis_f0778835-498b-4760-b2f7-91a3dc62ae84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_6317cdd7-fb76-462f-aa9e-a01850c90486" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitAxis_f0778835-498b-4760-b2f7-91a3dc62ae84" xlink:to="loc_us-gaap_ReportingUnitDomain_6317cdd7-fb76-462f-aa9e-a01850c90486" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PeaceNaturalsReportingUnitMember_2c96a53a-d89e-4032-970d-89274f18153a" xlink:href="cron-20201231.xsd#cron_PeaceNaturalsReportingUnitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_6317cdd7-fb76-462f-aa9e-a01850c90486" xlink:to="loc_cron_PeaceNaturalsReportingUnitMember_2c96a53a-d89e-4032-970d-89274f18153a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_RedwoodReportingUnitMember_a525f26c-5bf4-4e5d-a929-8d3fa699977a" xlink:href="cron-20201231.xsd#cron_RedwoodReportingUnitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_6317cdd7-fb76-462f-aa9e-a01850c90486" xlink:to="loc_cron_RedwoodReportingUnitMember_a525f26c-5bf4-4e5d-a929-8d3fa699977a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_efa95e83-3830-4c2e-93f3-57ae2334a322" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_8a8b92f7-504b-4ef1-b1f8-c982ddb61b1f" xlink:to="loc_us-gaap_GoodwillLineItems_efa95e83-3830-4c2e-93f3-57ae2334a322" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_172eacbe-14ec-401d-91a9-9cd00fe1e13a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_efa95e83-3830-4c2e-93f3-57ae2334a322" xlink:to="loc_us-gaap_GoodwillRollForward_172eacbe-14ec-401d-91a9-9cd00fe1e13a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_1479a1b6-af15-4754-ad92-7f9109428cf3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_172eacbe-14ec-401d-91a9-9cd00fe1e13a" xlink:to="loc_us-gaap_Goodwill_1479a1b6-af15-4754-ad92-7f9109428cf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_6e08d8bc-f3d8-41d9-a023-7bcb9479439f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_172eacbe-14ec-401d-91a9-9cd00fe1e13a" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_6e08d8bc-f3d8-41d9-a023-7bcb9479439f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_d69a4b1b-1fe6-4f69-9861-764ace0e7274" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_172eacbe-14ec-401d-91a9-9cd00fe1e13a" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_d69a4b1b-1fe6-4f69-9861-764ace0e7274" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_4883a435-7f69-4e22-ad92-61faeb988be0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_172eacbe-14ec-401d-91a9-9cd00fe1e13a" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_4883a435-7f69-4e22-ad92-61faeb988be0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_2558f6a8-dd24-4649-bdb3-75459c09fd1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_172eacbe-14ec-401d-91a9-9cd00fe1e13a" xlink:to="loc_us-gaap_Goodwill_2558f6a8-dd24-4649-bdb3-75459c09fd1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/Leases" xlink:type="simple" xlink:href="cron-20201231.xsd#Leases"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_bf304fba-629e-4af9-9748-5af7722c58fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_7e22834c-780c-4c10-8d98-ed9ed6c89960" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_bf304fba-629e-4af9-9748-5af7722c58fe" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_7e22834c-780c-4c10-8d98-ed9ed6c89960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/LeasesTables" xlink:type="simple" xlink:href="cron-20201231.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_09fed39d-2ef1-4ecf-9a77-35cf43d25562" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_3ce670d6-2839-4c55-b9e0-65c6e7019b4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_09fed39d-2ef1-4ecf-9a77-35cf43d25562" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_3ce670d6-2839-4c55-b9e0-65c6e7019b4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#LeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_cce7aed4-5173-45fa-839e-cc22edbf15d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_843eb4dd-9a5e-48b7-bfd4-55d9edc946e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_cce7aed4-5173-45fa-839e-cc22edbf15d5" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_843eb4dd-9a5e-48b7-bfd4-55d9edc946e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_3ee574e9-f240-49ad-bd9e-2296f14c55ef" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_843eb4dd-9a5e-48b7-bfd4-55d9edc946e7" xlink:to="loc_srt_RangeAxis_3ee574e9-f240-49ad-bd9e-2296f14c55ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_db735b1b-9024-4826-8115-dbce4c08ed1d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_3ee574e9-f240-49ad-bd9e-2296f14c55ef" xlink:to="loc_srt_RangeMember_db735b1b-9024-4826-8115-dbce4c08ed1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_51dc4a1a-7bbd-4971-9000-1cf07ab89e67" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_db735b1b-9024-4826-8115-dbce4c08ed1d" xlink:to="loc_srt_MinimumMember_51dc4a1a-7bbd-4971-9000-1cf07ab89e67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_7367898e-a5e4-4de8-a42e-aa8da9d1bb94" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_db735b1b-9024-4826-8115-dbce4c08ed1d" xlink:to="loc_srt_MaximumMember_7367898e-a5e4-4de8-a42e-aa8da9d1bb94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_69ba24b8-f26e-4a0a-a0de-6daa29bde1d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_843eb4dd-9a5e-48b7-bfd4-55d9edc946e7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_69ba24b8-f26e-4a0a-a0de-6daa29bde1d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_598ad02d-90ae-466d-b9ba-7401399d1097" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_69ba24b8-f26e-4a0a-a0de-6daa29bde1d3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_598ad02d-90ae-466d-b9ba-7401399d1097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_BuildingAndEquipmentMember_1f548f64-7a6d-47cf-93b5-263f722b687e" xlink:href="cron-20201231.xsd#cron_BuildingAndEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_598ad02d-90ae-466d-b9ba-7401399d1097" xlink:to="loc_cron_BuildingAndEquipmentMember_1f548f64-7a6d-47cf-93b5-263f722b687e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_ddcc8280-89b0-4928-95b8-446ba047c99d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LandMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_598ad02d-90ae-466d-b9ba-7401399d1097" xlink:to="loc_us-gaap_LandMember_ddcc8280-89b0-4928-95b8-446ba047c99d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_d84462c2-b582-462e-a983-da06c41e7287" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_843eb4dd-9a5e-48b7-bfd4-55d9edc946e7" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_d84462c2-b582-462e-a983-da06c41e7287" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_da07d622-ed82-4f05-9520-0c2943b29293" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_d84462c2-b582-462e-a983-da06c41e7287" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_da07d622-ed82-4f05-9520-0c2943b29293" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_193d614f-a330-4cf5-ba32-2f3ea2dc5861" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_d84462c2-b582-462e-a983-da06c41e7287" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_193d614f-a330-4cf5-ba32-2f3ea2dc5861" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/LeasesScheduleofLeaseCostandOtherInformationDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#LeasesScheduleofLeaseCostandOtherInformationDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/LeasesScheduleofLeaseCostandOtherInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_db55ffb2-81f1-4856-9eed-554a9b4ca0b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract_8eb87bb3-7636-424d-95e1-b7827a879ad0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_db55ffb2-81f1-4856-9eed-554a9b4ca0b3" xlink:to="loc_us-gaap_LeaseCostAbstract_8eb87bb3-7636-424d-95e1-b7827a879ad0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_4d9591e7-8549-40ed-bc13-ac1907f416ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_8eb87bb3-7636-424d-95e1-b7827a879ad0" xlink:to="loc_us-gaap_OperatingLeaseCost_4d9591e7-8549-40ed-bc13-ac1907f416ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_d063122b-b93a-405f-be51-1d09f9a90319" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_8eb87bb3-7636-424d-95e1-b7827a879ad0" xlink:to="loc_us-gaap_ShortTermLeaseCost_d063122b-b93a-405f-be51-1d09f9a90319" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_8c70b036-174d-4b60-8804-291c95a02e16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_8eb87bb3-7636-424d-95e1-b7827a879ad0" xlink:to="loc_us-gaap_LeaseCost_8c70b036-174d-4b60-8804-291c95a02e16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_a7e9bd7d-4f52-4426-9d30-1dbaf1dd7beb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_db55ffb2-81f1-4856-9eed-554a9b4ca0b3" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_a7e9bd7d-4f52-4426-9d30-1dbaf1dd7beb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_1e4c3a39-67b3-4fc4-9528-9d5da1e37029" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_db55ffb2-81f1-4856-9eed-554a9b4ca0b3" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_1e4c3a39-67b3-4fc4-9528-9d5da1e37029" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/GeneralandAdministrativeExpenses" xlink:type="simple" xlink:href="cron-20201231.xsd#GeneralandAdministrativeExpenses"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/GeneralandAdministrativeExpenses" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_57d2050a-0b0f-48c5-98e3-29e63429a188" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_c7b4a754-42e4-4d22-a0de-4a6d89703beb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalFinancialInformationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_57d2050a-0b0f-48c5-98e3-29e63429a188" xlink:to="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_c7b4a754-42e4-4d22-a0de-4a6d89703beb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/GeneralandAdministrativeExpensesTables" xlink:type="simple" xlink:href="cron-20201231.xsd#GeneralandAdministrativeExpensesTables"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/GeneralandAdministrativeExpensesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3c262c73-4505-4651-8bd8-9346b19e39f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_GeneralAndAdministrativeExpensesTableTextBlock_ab107365-cd3e-4168-9ec4-2b84a5d7cdfb" xlink:href="cron-20201231.xsd#cron_GeneralAndAdministrativeExpensesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3c262c73-4505-4651-8bd8-9346b19e39f3" xlink:to="loc_cron_GeneralAndAdministrativeExpensesTableTextBlock_ab107365-cd3e-4168-9ec4-2b84a5d7cdfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/GeneralandAdministrativeExpensesScheduleofGeneralandAdministrativeExpensesDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#GeneralandAdministrativeExpensesScheduleofGeneralandAdministrativeExpensesDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/GeneralandAdministrativeExpensesScheduleofGeneralandAdministrativeExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_78cb638e-9a3b-4100-8f10-9bb417949ecd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LaborAndRelatedExpense_e66bca1a-ea45-401f-8450-226526aea6ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LaborAndRelatedExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_78cb638e-9a3b-4100-8f10-9bb417949ecd" xlink:to="loc_us-gaap_LaborAndRelatedExpense_e66bca1a-ea45-401f-8450-226526aea6ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ProfessionalAndConsultingExpense_90470ee9-e61b-482d-8980-3fef38c17615" xlink:href="cron-20201231.xsd#cron_ProfessionalAndConsultingExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_78cb638e-9a3b-4100-8f10-9bb417949ecd" xlink:to="loc_cron_ProfessionalAndConsultingExpense_90470ee9-e61b-482d-8980-3fef38c17615" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_OfficeAndGeneralExpense_5f51c19e-de83-42f0-b50f-aa110b33dfac" xlink:href="cron-20201231.xsd#cron_OfficeAndGeneralExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_78cb638e-9a3b-4100-8f10-9bb417949ecd" xlink:to="loc_cron_OfficeAndGeneralExpense_5f51c19e-de83-42f0-b50f-aa110b33dfac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_RestatementReviewExpense_4ef26f97-79ba-4ea5-8d2c-20e08e91c5c8" xlink:href="cron-20201231.xsd#cron_RestatementReviewExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_78cb638e-9a3b-4100-8f10-9bb417949ecd" xlink:to="loc_cron_RestatementReviewExpense_4ef26f97-79ba-4ea5-8d2c-20e08e91c5c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForLoanLossesExpensed_c1e6b807-6eb7-4085-892f-6b3504aec1a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForLoanLossesExpensed"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_78cb638e-9a3b-4100-8f10-9bb417949ecd" xlink:to="loc_us-gaap_ProvisionForLoanLossesExpensed_c1e6b807-6eb7-4085-892f-6b3504aec1a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherGeneralAndAdministrativeExpense_23979150-262e-442e-9473-51e06c9a212f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_78cb638e-9a3b-4100-8f10-9bb417949ecd" xlink:to="loc_us-gaap_OtherGeneralAndAdministrativeExpense_23979150-262e-442e-9473-51e06c9a212f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_dab56bb1-0c02-472e-85dc-e452f6454a46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_78cb638e-9a3b-4100-8f10-9bb417949ecd" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_dab56bb1-0c02-472e-85dc-e452f6454a46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/DerivativeLiabilities" xlink:type="simple" xlink:href="cron-20201231.xsd#DerivativeLiabilities"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/DerivativeLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_44adfe45-0eff-400b-8810-b5f5e6a256b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_4f329884-fe5c-4e34-8271-256c8d2f8eb9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_44adfe45-0eff-400b-8810-b5f5e6a256b4" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_4f329884-fe5c-4e34-8271-256c8d2f8eb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/DerivativeLiabilitiesTables" xlink:type="simple" xlink:href="cron-20201231.xsd#DerivativeLiabilitiesTables"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/DerivativeLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_bfac55ee-b41f-47e9-849a-5e4bb286f278" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_04da03c8-d9a7-407c-9562-1ff680e45097" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_bfac55ee-b41f-47e9-849a-5e4bb286f278" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_04da03c8-d9a7-407c-9562-1ff680e45097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_d05f0eea-593c-4878-9ef4-a73a48dc263c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_bfac55ee-b41f-47e9-849a-5e4bb286f278" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_d05f0eea-593c-4878-9ef4-a73a48dc263c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock_340e75c6-987c-4f35-bf1f-de3a7d9b9cfd" xlink:href="cron-20201231.xsd#cron_SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_bfac55ee-b41f-47e9-849a-5e4bb286f278" xlink:to="loc_cron_SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock_340e75c6-987c-4f35-bf1f-de3a7d9b9cfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#DerivativeLiabilitiesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_24164e68-8b65-4ba0-9055-6198d78ae47f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_2f0a4fea-a10c-4c22-955c-c7274f777e09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_24164e68-8b65-4ba0-9055-6198d78ae47f" xlink:to="loc_us-gaap_DerivativeTable_2f0a4fea-a10c-4c22-955c-c7274f777e09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_1ef31f78-b4e5-4196-8875-03739054ed50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_2f0a4fea-a10c-4c22-955c-c7274f777e09" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_1ef31f78-b4e5-4196-8875-03739054ed50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_402fb85b-5cf9-479e-9ce3-c12adcdcb70c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1ef31f78-b4e5-4196-8875-03739054ed50" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_402fb85b-5cf9-479e-9ce3-c12adcdcb70c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaInvestmentMember_1d9bf883-9f2e-4ea8-9828-7c2ea1bc4e15" xlink:href="cron-20201231.xsd#cron_AltriaInvestmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_402fb85b-5cf9-479e-9ce3-c12adcdcb70c" xlink:to="loc_cron_AltriaInvestmentMember_1d9bf883-9f2e-4ea8-9828-7c2ea1bc4e15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaWarrantMember_ff47e82b-86ac-44d8-a8db-5ce2ceb018b3" xlink:href="cron-20201231.xsd#cron_AltriaWarrantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_402fb85b-5cf9-479e-9ce3-c12adcdcb70c" xlink:to="loc_cron_AltriaWarrantMember_ff47e82b-86ac-44d8-a8db-5ce2ceb018b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PreemptiveRightsMember_35164aa5-14c0-441a-b948-dde5922a35a9" xlink:href="cron-20201231.xsd#cron_PreemptiveRightsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_402fb85b-5cf9-479e-9ce3-c12adcdcb70c" xlink:to="loc_cron_PreemptiveRightsMember_35164aa5-14c0-441a-b948-dde5922a35a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_TopupRightsMember_4a0d0360-0402-4dcb-bbe9-d851d31099b7" xlink:href="cron-20201231.xsd#cron_TopupRightsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_402fb85b-5cf9-479e-9ce3-c12adcdcb70c" xlink:to="loc_cron_TopupRightsMember_4a0d0360-0402-4dcb-bbe9-d851d31099b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_2947a992-f8c4-4c39-b986-97d8e7c86a9c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_2f0a4fea-a10c-4c22-955c-c7274f777e09" xlink:to="loc_srt_ConsolidatedEntitiesAxis_2947a992-f8c4-4c39-b986-97d8e7c86a9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_4fd3a22f-7a68-48e0-81c2-2f8739691151" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_2947a992-f8c4-4c39-b986-97d8e7c86a9c" xlink:to="loc_srt_ConsolidatedEntitiesDomain_4fd3a22f-7a68-48e0-81c2-2f8739691151" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SubsidiariesMember_2f1b6369-4bc6-4bd2-8495-499aa7fe697b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SubsidiariesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_4fd3a22f-7a68-48e0-81c2-2f8739691151" xlink:to="loc_srt_SubsidiariesMember_2f1b6369-4bc6-4bd2-8495-499aa7fe697b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_92759ebf-16a0-4e03-90f0-6e822ecc3731" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_2f0a4fea-a10c-4c22-955c-c7274f777e09" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_92759ebf-16a0-4e03-90f0-6e822ecc3731" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1a3bd006-a38c-4976-8c3e-c0fae1b8d214" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_92759ebf-16a0-4e03-90f0-6e822ecc3731" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1a3bd006-a38c-4976-8c3e-c0fae1b8d214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaInvestmentMember_fed4c700-902e-4ec4-9b00-6b8bbc312fbc" xlink:href="cron-20201231.xsd#cron_AltriaInvestmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1a3bd006-a38c-4976-8c3e-c0fae1b8d214" xlink:to="loc_cron_AltriaInvestmentMember_fed4c700-902e-4ec4-9b00-6b8bbc312fbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_f74d9686-15d5-4f50-a34f-89b040c22e22" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_2f0a4fea-a10c-4c22-955c-c7274f777e09" xlink:to="loc_dei_LegalEntityAxis_f74d9686-15d5-4f50-a34f-89b040c22e22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_5b0c34c2-92f5-4de4-8974-cc5c323fd430" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_f74d9686-15d5-4f50-a34f-89b040c22e22" xlink:to="loc_dei_EntityDomain_5b0c34c2-92f5-4de4-8974-cc5c323fd430" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaGroupInc.Member_5a177c07-d8f2-4414-a8a9-81e53a90a930" xlink:href="cron-20201231.xsd#cron_AltriaGroupInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_5b0c34c2-92f5-4de4-8974-cc5c323fd430" xlink:to="loc_cron_AltriaGroupInc.Member_5a177c07-d8f2-4414-a8a9-81e53a90a930" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_80f1114a-0d99-45a3-9778-f8d26b0c8acd" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_2f0a4fea-a10c-4c22-955c-c7274f777e09" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_80f1114a-0d99-45a3-9778-f8d26b0c8acd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_e8ef8ff7-9034-4cc5-9efd-cb278150f914" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_80f1114a-0d99-45a3-9778-f8d26b0c8acd" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_e8ef8ff7-9034-4cc5-9efd-cb278150f914" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosGroupInc.Member_d14872aa-e1c5-4c3c-8178-7794433ccdc1" xlink:href="cron-20201231.xsd#cron_CronosGroupInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_e8ef8ff7-9034-4cc5-9efd-cb278150f914" xlink:to="loc_cron_CronosGroupInc.Member_d14872aa-e1c5-4c3c-8178-7794433ccdc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_3a583543-ae29-45eb-9baf-d8a3934680ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_2f0a4fea-a10c-4c22-955c-c7274f777e09" xlink:to="loc_us-gaap_DerivativeLineItems_3a583543-ae29-45eb-9baf-d8a3934680ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_c391963f-9950-4198-9834-f61ae249519a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_3a583543-ae29-45eb-9baf-d8a3934680ef" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_c391963f-9950-4198-9834-f61ae249519a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ClassOfWarrantOrRightNumberOfWarrantsIssued_70a16306-ded7-4db6-a963-4c5e92c8f8dc" xlink:href="cron-20201231.xsd#cron_ClassOfWarrantOrRightNumberOfWarrantsIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_3a583543-ae29-45eb-9baf-d8a3934680ef" xlink:to="loc_cron_ClassOfWarrantOrRightNumberOfWarrantsIssued_70a16306-ded7-4db6-a963-4c5e92c8f8dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_ced00c1a-e394-4617-b334-afa50b378ba0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_3a583543-ae29-45eb-9baf-d8a3934680ef" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_ced00c1a-e394-4617-b334-afa50b378ba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised_54140e2f-536e-4bdd-a4bd-01d708863e78" xlink:href="cron-20201231.xsd#cron_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_3a583543-ae29-45eb-9baf-d8a3934680ef" xlink:to="loc_cron_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised_54140e2f-536e-4bdd-a4bd-01d708863e78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage_8bd85fd7-0c57-489e-85a1-ff73120384ae" xlink:href="cron-20201231.xsd#cron_ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_3a583543-ae29-45eb-9baf-d8a3934680ef" xlink:to="loc_cron_ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage_8bd85fd7-0c57-489e-85a1-ff73120384ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ClassOfWarrantOrRightAdditionalSubscriptionNumberOfSecuritiesCalledByWarrantsOrRights_65da0c19-20d3-4be7-b656-41442a4880e6" xlink:href="cron-20201231.xsd#cron_ClassOfWarrantOrRightAdditionalSubscriptionNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_3a583543-ae29-45eb-9baf-d8a3934680ef" xlink:to="loc_cron_ClassOfWarrantOrRightAdditionalSubscriptionNumberOfSecuritiesCalledByWarrantsOrRights_65da0c19-20d3-4be7-b656-41442a4880e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_a733b45e-9a62-40fa-a52b-747ad3c6f7ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_3a583543-ae29-45eb-9baf-d8a3934680ef" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_a733b45e-9a62-40fa-a52b-747ad3c6f7ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ClassOfWarrantOrRightMinimumOwnershipPercentageRequired_9664a40a-d3bd-46a9-b5f9-adf69d2b8403" xlink:href="cron-20201231.xsd#cron_ClassOfWarrantOrRightMinimumOwnershipPercentageRequired"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_3a583543-ae29-45eb-9baf-d8a3934680ef" xlink:to="loc_cron_ClassOfWarrantOrRightMinimumOwnershipPercentageRequired_9664a40a-d3bd-46a9-b5f9-adf69d2b8403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod_37ec9eeb-ae68-46e1-b74c-f11245bca128" xlink:href="cron-20201231.xsd#cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_3a583543-ae29-45eb-9baf-d8a3934680ef" xlink:to="loc_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod_37ec9eeb-ae68-46e1-b74c-f11245bca128" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise_adf2795c-2512-4951-b149-51c7a54502d1" xlink:href="cron-20201231.xsd#cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_3a583543-ae29-45eb-9baf-d8a3934680ef" xlink:to="loc_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise_adf2795c-2512-4951-b149-51c7a54502d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ClassOfWarrantOrRightExpense_01930905-a619-443c-baa9-6f7f9e733f40" xlink:href="cron-20201231.xsd#cron_ClassOfWarrantOrRightExpense"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_3a583543-ae29-45eb-9baf-d8a3934680ef" xlink:to="loc_cron_ClassOfWarrantOrRightExpense_01930905-a619-443c-baa9-6f7f9e733f40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings_6b9fe40e-8a5d-40d1-9d8b-f9e12e37730e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_3a583543-ae29-45eb-9baf-d8a3934680ef" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings_6b9fe40e-8a5d-40d1-9d8b-f9e12e37730e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f8b1892a-c0eb-4bb6-9642-b62dbedcb89a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ff103de4-7b7c-44fe-a7a3-7a76977e0238" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f8b1892a-c0eb-4bb6-9642-b62dbedcb89a" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ff103de4-7b7c-44fe-a7a3-7a76977e0238" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_0a25535b-3a8e-4103-a581-26e0d280d8d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ff103de4-7b7c-44fe-a7a3-7a76977e0238" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_0a25535b-3a8e-4103-a581-26e0d280d8d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_4829680e-2b0c-46b9-b938-94f7e60fcd08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_0a25535b-3a8e-4103-a581-26e0d280d8d6" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_4829680e-2b0c-46b9-b938-94f7e60fcd08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaWarrantMember_8b0cbd62-5006-43e0-bd1b-ce7145816062" xlink:href="cron-20201231.xsd#cron_AltriaWarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_4829680e-2b0c-46b9-b938-94f7e60fcd08" xlink:to="loc_cron_AltriaWarrantMember_8b0cbd62-5006-43e0-bd1b-ce7145816062" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PreemptiveRightsMember_43f74298-3a23-4c5c-a48a-7e3b4756c28e" xlink:href="cron-20201231.xsd#cron_PreemptiveRightsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_4829680e-2b0c-46b9-b938-94f7e60fcd08" xlink:to="loc_cron_PreemptiveRightsMember_43f74298-3a23-4c5c-a48a-7e3b4756c28e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_TopupRightsMember_e99cc29d-b7b7-475b-8cbe-ea01a7bfade1" xlink:href="cron-20201231.xsd#cron_TopupRightsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_4829680e-2b0c-46b9-b938-94f7e60fcd08" xlink:to="loc_cron_TopupRightsMember_e99cc29d-b7b7-475b-8cbe-ea01a7bfade1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a83a5d5a-835d-4e9f-8d4e-eed867bc5e71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ff103de4-7b7c-44fe-a7a3-7a76977e0238" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a83a5d5a-835d-4e9f-8d4e-eed867bc5e71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DerivativeInstrumentsRollForward_ee50ec9d-9fed-4948-b338-785fbfe6e49e" xlink:href="cron-20201231.xsd#cron_DerivativeInstrumentsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_a83a5d5a-835d-4e9f-8d4e-eed867bc5e71" xlink:to="loc_cron_DerivativeInstrumentsRollForward_ee50ec9d-9fed-4948-b338-785fbfe6e49e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_b6eb208a-8ac0-432a-a88a-6a2529495895" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_DerivativeInstrumentsRollForward_ee50ec9d-9fed-4948-b338-785fbfe6e49e" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_b6eb208a-8ac0-432a-a88a-6a2529495895" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings_e790c54a-edfa-4109-a167-2ce802eae918" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_DerivativeInstrumentsRollForward_ee50ec9d-9fed-4948-b338-785fbfe6e49e" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings_e790c54a-edfa-4109-a167-2ce802eae918" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements_ded068f8-8005-4f6b-91f9-e384067de7fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_DerivativeInstrumentsRollForward_ee50ec9d-9fed-4948-b338-785fbfe6e49e" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements_ded068f8-8005-4f6b-91f9-e384067de7fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss_aaf9d292-3c9e-4dba-881e-4e101f6681a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_DerivativeInstrumentsRollForward_ee50ec9d-9fed-4948-b338-785fbfe6e49e" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss_aaf9d292-3c9e-4dba-881e-4e101f6681a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_0411d8a5-ab8f-40fa-8a36-0ead5bfd80f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_DerivativeInstrumentsRollForward_ee50ec9d-9fed-4948-b338-785fbfe6e49e" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_0411d8a5-ab8f-40fa-8a36-0ead5bfd80f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_93a07ac6-0707-4c70-a590-9cd3bc5aeb7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_9ffaf790-84d1-42b8-a0e2-2ee81c843bb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_93a07ac6-0707-4c70-a590-9cd3bc5aeb7e" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_9ffaf790-84d1-42b8-a0e2-2ee81c843bb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_9bdc68e2-8608-4a8a-8752-ff4adebb113e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_9ffaf790-84d1-42b8-a0e2-2ee81c843bb7" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_9bdc68e2-8608-4a8a-8752-ff4adebb113e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_c4465d2e-b8ec-40a0-a651-0de42b68c410" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_9bdc68e2-8608-4a8a-8752-ff4adebb113e" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_c4465d2e-b8ec-40a0-a651-0de42b68c410" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaWarrantMember_ab772d7c-1320-4ee8-9b62-6351bdb5d620" xlink:href="cron-20201231.xsd#cron_AltriaWarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_c4465d2e-b8ec-40a0-a651-0de42b68c410" xlink:to="loc_cron_AltriaWarrantMember_ab772d7c-1320-4ee8-9b62-6351bdb5d620" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PreemptiveRightsMember_cc12be04-3920-49b3-afd5-a71e62611ddb" xlink:href="cron-20201231.xsd#cron_PreemptiveRightsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_c4465d2e-b8ec-40a0-a651-0de42b68c410" xlink:to="loc_cron_PreemptiveRightsMember_cc12be04-3920-49b3-afd5-a71e62611ddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_TopupRightsMember_5a996c6b-9138-4f5c-b885-a6ef1651f6b8" xlink:href="cron-20201231.xsd#cron_TopupRightsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_c4465d2e-b8ec-40a0-a651-0de42b68c410" xlink:to="loc_cron_TopupRightsMember_5a996c6b-9138-4f5c-b885-a6ef1651f6b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PreEmptiveRightsAndTopUpRightsMember_663acf03-9d3b-4e02-a9c1-e7cc5ec10ee3" xlink:href="cron-20201231.xsd#cron_PreEmptiveRightsAndTopUpRightsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_c4465d2e-b8ec-40a0-a651-0de42b68c410" xlink:to="loc_cron_PreEmptiveRightsAndTopUpRightsMember_663acf03-9d3b-4e02-a9c1-e7cc5ec10ee3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_b1ee8e98-3527-4d10-9609-65f82b2a2152" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_9ffaf790-84d1-42b8-a0e2-2ee81c843bb7" xlink:to="loc_srt_RangeAxis_b1ee8e98-3527-4d10-9609-65f82b2a2152" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0e55037d-821e-43dc-8b8b-92a340897dbd" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_b1ee8e98-3527-4d10-9609-65f82b2a2152" xlink:to="loc_srt_RangeMember_0e55037d-821e-43dc-8b8b-92a340897dbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_d8def3c0-1b19-48ba-90e8-75669ed2ff99" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_WeightedAverageMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_0e55037d-821e-43dc-8b8b-92a340897dbd" xlink:to="loc_srt_WeightedAverageMember_d8def3c0-1b19-48ba-90e8-75669ed2ff99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_93933452-a210-4c62-869b-dbc5384974f8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_0e55037d-821e-43dc-8b8b-92a340897dbd" xlink:to="loc_srt_MinimumMember_93933452-a210-4c62-869b-dbc5384974f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_90b1f341-7540-4dbf-9d3a-a157ed14a053" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_0e55037d-821e-43dc-8b8b-92a340897dbd" xlink:to="loc_srt_MaximumMember_90b1f341-7540-4dbf-9d3a-a157ed14a053" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_58e325d8-ad99-4a17-a0a6-3b34e7002324" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_9ffaf790-84d1-42b8-a0e2-2ee81c843bb7" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_58e325d8-ad99-4a17-a0a6-3b34e7002324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_76359c52-0389-4c2b-8f51-7e6a385bc172" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_58e325d8-ad99-4a17-a0a6-3b34e7002324" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_76359c52-0389-4c2b-8f51-7e6a385bc172" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputSharePriceMember_02976b2b-5ce4-4d18-a0c6-f7d530bb4bb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputSharePriceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_76359c52-0389-4c2b-8f51-7e6a385bc172" xlink:to="loc_us-gaap_MeasurementInputSharePriceMember_02976b2b-5ce4-4d18-a0c6-f7d530bb4bb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_MeasurementInputSubscriptionPriceMember_42e44ed2-40d4-4491-8827-90f825297ba7" xlink:href="cron-20201231.xsd#cron_MeasurementInputSubscriptionPriceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_76359c52-0389-4c2b-8f51-7e6a385bc172" xlink:to="loc_cron_MeasurementInputSubscriptionPriceMember_42e44ed2-40d4-4491-8827-90f825297ba7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_bcf380e3-d2c2-4d54-8547-053d29607b18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_76359c52-0389-4c2b-8f51-7e6a385bc172" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_bcf380e3-d2c2-4d54-8547-053d29607b18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember_77377f44-9c93-4521-bc48-eeae57233d08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputExpectedTermMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_76359c52-0389-4c2b-8f51-7e6a385bc172" xlink:to="loc_us-gaap_MeasurementInputExpectedTermMember_77377f44-9c93-4521-bc48-eeae57233d08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember_faab05bf-8886-47cb-bd7f-05408be3b214" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_76359c52-0389-4c2b-8f51-7e6a385bc172" xlink:to="loc_us-gaap_MeasurementInputPriceVolatilityMember_faab05bf-8886-47cb-bd7f-05408be3b214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedDividendRateMember_183013e6-f98a-4d60-ac6f-c00c22489f2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputExpectedDividendRateMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_76359c52-0389-4c2b-8f51-7e6a385bc172" xlink:to="loc_us-gaap_MeasurementInputExpectedDividendRateMember_183013e6-f98a-4d60-ac6f-c00c22489f2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_641f125c-67d0-4e46-ae6b-0dea88dc3557" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_9ffaf790-84d1-42b8-a0e2-2ee81c843bb7" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_641f125c-67d0-4e46-ae6b-0dea88dc3557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityMeasurementInput_234d2eea-7d47-4039-b04b-6bb9ed6bfde5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilityMeasurementInput"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_641f125c-67d0-4e46-ae6b-0dea88dc3557" xlink:to="loc_us-gaap_DerivativeLiabilityMeasurementInput_234d2eea-7d47-4039-b04b-6bb9ed6bfde5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DerivativeLiabilityUsefulLifeTerm_e084c689-71eb-42b6-af13-2ae23739b9d3" xlink:href="cron-20201231.xsd#cron_DerivativeLiabilityUsefulLifeTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_641f125c-67d0-4e46-ae6b-0dea88dc3557" xlink:to="loc_cron_DerivativeLiabilityUsefulLifeTerm_e084c689-71eb-42b6-af13-2ae23739b9d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_b8d64d83-2d19-4ea3-b823-469e1d4e273b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_e05bfbc9-3f3f-49f8-a976-453f31b33181" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_b8d64d83-2d19-4ea3-b823-469e1d4e273b" xlink:to="loc_us-gaap_DerivativeTable_e05bfbc9-3f3f-49f8-a976-453f31b33181" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_76b6898f-335c-400e-8d66-750650a7f8e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_e05bfbc9-3f3f-49f8-a976-453f31b33181" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_76b6898f-335c-400e-8d66-750650a7f8e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1ea9c49e-a068-47fc-8224-2f35dfbb73c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_76b6898f-335c-400e-8d66-750650a7f8e6" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1ea9c49e-a068-47fc-8224-2f35dfbb73c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaWarrantMember_9cca01a2-fb34-4dc9-8a6a-d3794fb99de7" xlink:href="cron-20201231.xsd#cron_AltriaWarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1ea9c49e-a068-47fc-8224-2f35dfbb73c3" xlink:to="loc_cron_AltriaWarrantMember_9cca01a2-fb34-4dc9-8a6a-d3794fb99de7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PreemptiveRightsMember_f4e7a0b6-ed76-41e8-b5d2-b2c77a7e510a" xlink:href="cron-20201231.xsd#cron_PreemptiveRightsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1ea9c49e-a068-47fc-8224-2f35dfbb73c3" xlink:to="loc_cron_PreemptiveRightsMember_f4e7a0b6-ed76-41e8-b5d2-b2c77a7e510a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_TopupRightsMember_382b0e5f-6761-4358-8088-8bf7ccaee524" xlink:href="cron-20201231.xsd#cron_TopupRightsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1ea9c49e-a068-47fc-8224-2f35dfbb73c3" xlink:to="loc_cron_TopupRightsMember_382b0e5f-6761-4358-8088-8bf7ccaee524" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_4e4e4b14-d9fd-43be-90d1-548a4eadd8f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_e05bfbc9-3f3f-49f8-a976-453f31b33181" xlink:to="loc_us-gaap_DerivativeLineItems_4e4e4b14-d9fd-43be-90d1-548a4eadd8f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract_504a78db-78c8-420a-a5df-64ac6fc28845" xlink:href="cron-20201231.xsd#cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_4e4e4b14-d9fd-43be-90d1-548a4eadd8f6" xlink:to="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract_504a78db-78c8-420a-a5df-64ac6fc28845" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss_e045952b-2cd9-4dc3-94cd-ceb868084f9e" xlink:href="cron-20201231.xsd#cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract_504a78db-78c8-420a-a5df-64ac6fc28845" xlink:to="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss_e045952b-2cd9-4dc3-94cd-ceb868084f9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss_664ce1b0-679f-47a5-bd83-05520ed6db82" xlink:href="cron-20201231.xsd#cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract_504a78db-78c8-420a-a5df-64ac6fc28845" xlink:to="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss_664ce1b0-679f-47a5-bd83-05520ed6db82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss_626e802d-6408-45a4-9c81-42912ea12406" xlink:href="cron-20201231.xsd#cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract_504a78db-78c8-420a-a5df-64ac6fc28845" xlink:to="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss_626e802d-6408-45a4-9c81-42912ea12406" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/CapitalStock" xlink:type="simple" xlink:href="cron-20201231.xsd#CapitalStock"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/CapitalStock" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_20f3650e-e031-4f96-85d3-fa339c2f8b92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_906d3161-7c6a-433f-80dc-3a49e081bdd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_20f3650e-e031-4f96-85d3-fa339c2f8b92" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_906d3161-7c6a-433f-80dc-3a49e081bdd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/CapitalStockTables" xlink:type="simple" xlink:href="cron-20201231.xsd#CapitalStockTables"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/CapitalStockTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_3f7d6ee8-c983-4ce5-92ec-c61bf0157443" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTextBlock_b18ba5ba-7a2f-47ec-92a3-674d17e408af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_3f7d6ee8-c983-4ce5-92ec-c61bf0157443" xlink:to="loc_us-gaap_ScheduleOfStockByClassTextBlock_b18ba5ba-7a2f-47ec-92a3-674d17e408af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/CapitalStockNarrativeDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#CapitalStockNarrativeDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/CapitalStockNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_cdcdb7c5-6b76-4428-b5cb-00aa22750ea0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_9aa9d202-bb62-4e94-a7d7-2327a36a9cac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_cdcdb7c5-6b76-4428-b5cb-00aa22750ea0" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_9aa9d202-bb62-4e94-a7d7-2327a36a9cac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_25c94175-dc95-4e54-97b2-39b961a07eb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_9aa9d202-bb62-4e94-a7d7-2327a36a9cac" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_25c94175-dc95-4e54-97b2-39b961a07eb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2144e6c9-ab5a-463a-b790-7fa8085f122e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_25c94175-dc95-4e54-97b2-39b961a07eb1" xlink:to="loc_us-gaap_EquityComponentDomain_2144e6c9-ab5a-463a-b790-7fa8085f122e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_0f6d1bd8-1881-43f2-969f-2269af96a883" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2144e6c9-ab5a-463a-b790-7fa8085f122e" xlink:to="loc_us-gaap_CommonStockMember_0f6d1bd8-1881-43f2-969f-2269af96a883" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AdditionalPaidinCapitalAttributableToConvertibleOptionMember_06c95432-bb29-4518-b0f1-429467c79fb1" xlink:href="cron-20201231.xsd#cron_AdditionalPaidinCapitalAttributableToConvertibleOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2144e6c9-ab5a-463a-b790-7fa8085f122e" xlink:to="loc_cron_AdditionalPaidinCapitalAttributableToConvertibleOptionMember_06c95432-bb29-4518-b0f1-429467c79fb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_feb14cce-7b52-4f49-8e75-7a1974f080bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_9aa9d202-bb62-4e94-a7d7-2327a36a9cac" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_feb14cce-7b52-4f49-8e75-7a1974f080bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5ec5d5c1-8a79-4510-9a19-9446eaba2045" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_feb14cce-7b52-4f49-8e75-7a1974f080bc" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5ec5d5c1-8a79-4510-9a19-9446eaba2045" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaInvestmentMember_03677b19-1245-4441-a55a-0f92afde830b" xlink:href="cron-20201231.xsd#cron_AltriaInvestmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5ec5d5c1-8a79-4510-9a19-9446eaba2045" xlink:to="loc_cron_AltriaInvestmentMember_03677b19-1245-4441-a55a-0f92afde830b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_RedwoodAcquisitionMember_fc454fe6-11be-4205-8dd2-08eb2eeb90a4" xlink:href="cron-20201231.xsd#cron_RedwoodAcquisitionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5ec5d5c1-8a79-4510-9a19-9446eaba2045" xlink:to="loc_cron_RedwoodAcquisitionMember_fc454fe6-11be-4205-8dd2-08eb2eeb90a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember_d74723ba-5b73-440f-9a53-107661c3f2c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrivatePlacementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5ec5d5c1-8a79-4510-9a19-9446eaba2045" xlink:to="loc_us-gaap_PrivatePlacementMember_d74723ba-5b73-440f-9a53-107661c3f2c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_BoughtDealOfferingsMember_75d4c00a-90be-4527-840e-b925c9054fcc" xlink:href="cron-20201231.xsd#cron_BoughtDealOfferingsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5ec5d5c1-8a79-4510-9a19-9446eaba2045" xlink:to="loc_cron_BoughtDealOfferingsMember_75d4c00a-90be-4527-840e-b925c9054fcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_8ec982c0-12a2-45b3-bd0a-2beba7a68105" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_9aa9d202-bb62-4e94-a7d7-2327a36a9cac" xlink:to="loc_us-gaap_SubsidiarySaleOfStockLineItems_8ec982c0-12a2-45b3-bd0a-2beba7a68105" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CommonStockNumberOfVotesPerShare_c3fad50f-e1ec-41d4-b4d7-baf7b63952e8" xlink:href="cron-20201231.xsd#cron_CommonStockNumberOfVotesPerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_8ec982c0-12a2-45b3-bd0a-2beba7a68105" xlink:to="loc_cron_CommonStockNumberOfVotesPerShare_c3fad50f-e1ec-41d4-b4d7-baf7b63952e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_b80c57ca-982d-4394-9eb1-b5479c946ba9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_8ec982c0-12a2-45b3-bd0a-2beba7a68105" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_b80c57ca-982d-4394-9eb1-b5479c946ba9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_eda2cff8-8a71-41dc-aade-d82df7daeb4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_8ec982c0-12a2-45b3-bd0a-2beba7a68105" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_eda2cff8-8a71-41dc-aade-d82df7daeb4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_8ffb7ba6-64f1-4679-af05-0f93375e1609" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_8ec982c0-12a2-45b3-bd0a-2beba7a68105" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_8ffb7ba6-64f1-4679-af05-0f93375e1609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PaymentOfTransactionCosts_82afc2dd-5be9-4d43-ad3a-114ae2a2fa1e" xlink:href="cron-20201231.xsd#cron_PaymentOfTransactionCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_8ec982c0-12a2-45b3-bd0a-2beba7a68105" xlink:to="loc_cron_PaymentOfTransactionCosts_82afc2dd-5be9-4d43-ad3a-114ae2a2fa1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_StockIssuedDuringPeriodNewIssuesFairValue_ea245037-9644-42e3-906f-f9c586f41d15" xlink:href="cron-20201231.xsd#cron_StockIssuedDuringPeriodNewIssuesFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_8ec982c0-12a2-45b3-bd0a-2beba7a68105" xlink:to="loc_cron_StockIssuedDuringPeriodNewIssuesFairValue_ea245037-9644-42e3-906f-f9c586f41d15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_ad501978-7797-4330-88d5-9c727ab66e47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_8ec982c0-12a2-45b3-bd0a-2beba7a68105" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_ad501978-7797-4330-88d5-9c727ab66e47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CommonStockVestingRightsNumberOfEqualInstallments_40d9244e-64d5-4253-bdbe-c66191a0b11e" xlink:href="cron-20201231.xsd#cron_CommonStockVestingRightsNumberOfEqualInstallments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_8ec982c0-12a2-45b3-bd0a-2beba7a68105" xlink:to="loc_cron_CommonStockVestingRightsNumberOfEqualInstallments_40d9244e-64d5-4253-bdbe-c66191a0b11e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_a3039b4e-d387-4411-8ae2-7d952b671a06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_8ec982c0-12a2-45b3-bd0a-2beba7a68105" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_a3039b4e-d387-4411-8ae2-7d952b671a06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_StockIssuedDuringPeriodNewIssuesWeightedAveragePricePeriod_360aafc9-793e-4b32-aa3d-3ec9c35e18be" xlink:href="cron-20201231.xsd#cron_StockIssuedDuringPeriodNewIssuesWeightedAveragePricePeriod"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_8ec982c0-12a2-45b3-bd0a-2beba7a68105" xlink:to="loc_cron_StockIssuedDuringPeriodNewIssuesWeightedAveragePricePeriod_360aafc9-793e-4b32-aa3d-3ec9c35e18be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_67a4f1d5-b108-46c9-a916-ae647b57b9f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_8ec982c0-12a2-45b3-bd0a-2beba7a68105" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_67a4f1d5-b108-46c9-a916-ae647b57b9f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/CapitalStockScheduleofCommonSharesIssuedDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#CapitalStockScheduleofCommonSharesIssuedDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/CapitalStockScheduleofCommonSharesIssuedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_75ff0170-a2c1-444b-942b-2fe3182fffa3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_cbd88434-71d4-43c9-b19d-b869311615c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_75ff0170-a2c1-444b-942b-2fe3182fffa3" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_cbd88434-71d4-43c9-b19d-b869311615c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_0df5c3c9-2e0d-45da-9c43-17ef83f4c5e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_cbd88434-71d4-43c9-b19d-b869311615c3" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_0df5c3c9-2e0d-45da-9c43-17ef83f4c5e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0b28d3ad-7dcf-4f09-83ca-5ff9f7ddd987" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_0df5c3c9-2e0d-45da-9c43-17ef83f4c5e6" xlink:to="loc_us-gaap_EquityComponentDomain_0b28d3ad-7dcf-4f09-83ca-5ff9f7ddd987" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_35142eb2-0ca1-4fd6-a67a-490221224b55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0b28d3ad-7dcf-4f09-83ca-5ff9f7ddd987" xlink:to="loc_us-gaap_CommonStockMember_35142eb2-0ca1-4fd6-a67a-490221224b55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_b84c4f7d-eb4a-472a-85a5-42e13c0faba1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_cbd88434-71d4-43c9-b19d-b869311615c3" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_b84c4f7d-eb4a-472a-85a5-42e13c0faba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b204fc91-480d-4593-a966-ef0822187097" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_b84c4f7d-eb4a-472a-85a5-42e13c0faba1" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b204fc91-480d-4593-a966-ef0822187097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaInvestmentMember_03f36df1-a80d-4e6d-b215-ee7c7ab7a9f9" xlink:href="cron-20201231.xsd#cron_AltriaInvestmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b204fc91-480d-4593-a966-ef0822187097" xlink:to="loc_cron_AltriaInvestmentMember_03f36df1-a80d-4e6d-b215-ee7c7ab7a9f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_RedwoodAcquisitionMember_179cfc41-bddf-4dc7-9ce1-1e55f19ccf47" xlink:href="cron-20201231.xsd#cron_RedwoodAcquisitionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b204fc91-480d-4593-a966-ef0822187097" xlink:to="loc_cron_RedwoodAcquisitionMember_179cfc41-bddf-4dc7-9ce1-1e55f19ccf47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember_1080c556-57be-489c-b464-d20f331da0ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrivatePlacementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b204fc91-480d-4593-a966-ef0822187097" xlink:to="loc_us-gaap_PrivatePlacementMember_1080c556-57be-489c-b464-d20f331da0ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_BoughtDealOfferingsMember_9ea5ed1e-5774-4f37-b98a-cbfc26af561d" xlink:href="cron-20201231.xsd#cron_BoughtDealOfferingsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b204fc91-480d-4593-a966-ef0822187097" xlink:to="loc_cron_BoughtDealOfferingsMember_9ea5ed1e-5774-4f37-b98a-cbfc26af561d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_12d3abe3-2984-4a83-8777-1570871ae133" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_cbd88434-71d4-43c9-b19d-b869311615c3" xlink:to="loc_us-gaap_ClassOfStockLineItems_12d3abe3-2984-4a83-8777-1570871ae133" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_4e6ff126-4878-4ecd-8501-53d333512006" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_12d3abe3-2984-4a83-8777-1570871ae133" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_4e6ff126-4878-4ecd-8501-53d333512006" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedPayments" xlink:type="simple" xlink:href="cron-20201231.xsd#SharebasedPayments"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/SharebasedPayments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7d1c5fa0-c9f5-4b29-b471-48f49529fa21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_3677f737-36fd-44e6-b236-48214a6abaa0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7d1c5fa0-c9f5-4b29-b471-48f49529fa21" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_3677f737-36fd-44e6-b236-48214a6abaa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedPaymentsTables" xlink:type="simple" xlink:href="cron-20201231.xsd#SharebasedPaymentsTables"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/SharebasedPaymentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b601dfd2-d946-497f-aa85-b1649044f70a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock_e43670ce-6133-4b3d-8bab-11f8447864bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b601dfd2-d946-497f-aa85-b1649044f70a" xlink:to="loc_us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock_e43670ce-6133-4b3d-8bab-11f8447864bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_a3bd3fb9-ad9e-4634-b2aa-945693b855d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b601dfd2-d946-497f-aa85-b1649044f70a" xlink:to="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_a3bd3fb9-ad9e-4634-b2aa-945693b855d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock_e821212d-0ac2-4619-ac76-7f7c84878f09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b601dfd2-d946-497f-aa85-b1649044f70a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock_e821212d-0ac2-4619-ac76-7f7c84878f09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock_352b1480-fad2-43c9-aa4b-feb155b12a3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b601dfd2-d946-497f-aa85-b1649044f70a" xlink:to="loc_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock_352b1480-fad2-43c9-aa4b-feb155b12a3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_6d92d730-bedd-481f-a2ad-a241e31254e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b601dfd2-d946-497f-aa85-b1649044f70a" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_6d92d730-bedd-481f-a2ad-a241e31254e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_2ee2c746-e97c-4046-9299-b2eeef2888a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b601dfd2-d946-497f-aa85-b1649044f70a" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_2ee2c746-e97c-4046-9299-b2eeef2888a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinWarrantsDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#SharebasedPaymentsSummaryofChangesinWarrantsDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinWarrantsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_51e01bad-c561-4da3-974f-1991790d3665" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8736d0a7-84e8-44e1-b4dc-e7eba9e0e1a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_51e01bad-c561-4da3-974f-1991790d3665" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8736d0a7-84e8-44e1-b4dc-e7eba9e0e1a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_bcaf0a47-1229-497e-b0f1-3d0a2df9b958" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8736d0a7-84e8-44e1-b4dc-e7eba9e0e1a0" xlink:to="loc_us-gaap_AwardTypeAxis_bcaf0a47-1229-497e-b0f1-3d0a2df9b958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ddd9f699-c351-4fd2-a178-6bf089d91fa6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_bcaf0a47-1229-497e-b0f1-3d0a2df9b958" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ddd9f699-c351-4fd2-a178-6bf089d91fa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_0be5b876-caf1-4042-9320-d144a129a13c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ddd9f699-c351-4fd2-a178-6bf089d91fa6" xlink:to="loc_us-gaap_WarrantMember_0be5b876-caf1-4042-9320-d144a129a13c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0b279add-7d78-46a1-901c-b3a463e05df8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8736d0a7-84e8-44e1-b4dc-e7eba9e0e1a0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0b279add-7d78-46a1-901c-b3a463e05df8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_28ebebb6-b2fc-45ff-9afc-32c155863f5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0b279add-7d78-46a1-901c-b3a463e05df8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_28ebebb6-b2fc-45ff-9afc-32c155863f5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_27d1004f-9572-4395-9e10-2274730a7e94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_28ebebb6-b2fc-45ff-9afc-32c155863f5d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_27d1004f-9572-4395-9e10-2274730a7e94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_3b552011-f0ec-448b-b665-ef38295d2b7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_28ebebb6-b2fc-45ff-9afc-32c155863f5d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_3b552011-f0ec-448b-b665-ef38295d2b7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_e919924d-8d6b-4e08-98ff-9d1edc97a8f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_28ebebb6-b2fc-45ff-9afc-32c155863f5d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_e919924d-8d6b-4e08-98ff-9d1edc97a8f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b06a2cfc-ffa4-445a-a6f3-df64f4552ee5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0b279add-7d78-46a1-901c-b3a463e05df8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b06a2cfc-ffa4-445a-a6f3-df64f4552ee5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_d27ec7cb-915a-492f-897a-5a41fdcebfbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b06a2cfc-ffa4-445a-a6f3-df64f4552ee5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_d27ec7cb-915a-492f-897a-5a41fdcebfbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_dd19a655-c226-41ac-9274-274b88a94bf6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b06a2cfc-ffa4-445a-a6f3-df64f4552ee5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_dd19a655-c226-41ac-9274-274b88a94bf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_ac29d62b-2e44-4aad-9217-9f960d6cd514" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b06a2cfc-ffa4-445a-a6f3-df64f4552ee5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_ac29d62b-2e44-4aad-9217-9f960d6cd514" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedPaymentsSummaryofOutstandingWarrantsDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#SharebasedPaymentsSummaryofOutstandingWarrantsDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/SharebasedPaymentsSummaryofOutstandingWarrantsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ce029eb8-31bd-4471-8b18-96741efed9fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_afc4f395-0fed-49b5-ba70-86eb152414d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ce029eb8-31bd-4471-8b18-96741efed9fb" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_afc4f395-0fed-49b5-ba70-86eb152414d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_de780b3a-1c6b-479e-8ef1-f75017aa250b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_afc4f395-0fed-49b5-ba70-86eb152414d2" xlink:to="loc_us-gaap_AwardTypeAxis_de780b3a-1c6b-479e-8ef1-f75017aa250b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_73bc7eb9-2793-407c-ae18-aa42522058ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_de780b3a-1c6b-479e-8ef1-f75017aa250b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_73bc7eb9-2793-407c-ae18-aa42522058ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_a2619240-c740-4ff4-8b96-f899cd1c7468" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_73bc7eb9-2793-407c-ae18-aa42522058ee" xlink:to="loc_us-gaap_WarrantMember_a2619240-c740-4ff4-8b96-f899cd1c7468" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateAxis_88e05ccc-c7ac-4fdf-ae9c-9c043318ef8b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_afc4f395-0fed-49b5-ba70-86eb152414d2" xlink:to="loc_us-gaap_AwardDateAxis_88e05ccc-c7ac-4fdf-ae9c-9c043318ef8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain_c64839cf-9a25-417e-9831-8a3ca7d9f1cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateAxis_88e05ccc-c7ac-4fdf-ae9c-9c043318ef8b" xlink:to="loc_us-gaap_AwardDateDomain_c64839cf-9a25-417e-9831-8a3ca7d9f1cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_GrantedMay132016ThroughMay272016Member_b305c287-d5c5-411e-be0d-2dc548411fe5" xlink:href="cron-20201231.xsd#cron_GrantedMay132016ThroughMay272016Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateDomain_c64839cf-9a25-417e-9831-8a3ca7d9f1cb" xlink:to="loc_cron_GrantedMay132016ThroughMay272016Member_b305c287-d5c5-411e-be0d-2dc548411fe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_beb3ce86-bc85-451e-8b73-9ca410038e5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_afc4f395-0fed-49b5-ba70-86eb152414d2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_beb3ce86-bc85-451e-8b73-9ca410038e5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_262e56da-7ac4-4e36-8229-d3ae8db9adca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_beb3ce86-bc85-451e-8b73-9ca410038e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_262e56da-7ac4-4e36-8229-d3ae8db9adca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_193a928a-58ae-429d-8ab0-e9d8aa0b9581" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_beb3ce86-bc85-451e-8b73-9ca410038e5e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_193a928a-58ae-429d-8ab0-e9d8aa0b9581" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#SharebasedPaymentsStockOptionsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_652c797d-ec30-4b1f-8cc1-918c8b30acbb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_823757a9-8cbf-40e6-848d-76def4a4b4ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_652c797d-ec30-4b1f-8cc1-918c8b30acbb" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_823757a9-8cbf-40e6-848d-76def4a4b4ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_5e40f550-6cc4-4a2c-b061-4bb12c9f4824" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_823757a9-8cbf-40e6-848d-76def4a4b4ee" xlink:to="loc_us-gaap_AwardTypeAxis_5e40f550-6cc4-4a2c-b061-4bb12c9f4824" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f2aec4a1-855d-4ab2-af05-9dc9c0ff384c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_5e40f550-6cc4-4a2c-b061-4bb12c9f4824" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f2aec4a1-855d-4ab2-af05-9dc9c0ff384c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_55a70ded-8e4b-49ad-ae5b-a7f54bb87db4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f2aec4a1-855d-4ab2-af05-9dc9c0ff384c" xlink:to="loc_us-gaap_EmployeeStockOptionMember_55a70ded-8e4b-49ad-ae5b-a7f54bb87db4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c9d6e790-8a57-4e34-ae1b-f6950758cfcc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_823757a9-8cbf-40e6-848d-76def4a4b4ee" xlink:to="loc_srt_RangeAxis_c9d6e790-8a57-4e34-ae1b-f6950758cfcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_89170ac7-c3af-46d0-aed8-f6dbcee58184" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_c9d6e790-8a57-4e34-ae1b-f6950758cfcc" xlink:to="loc_srt_RangeMember_89170ac7-c3af-46d0-aed8-f6dbcee58184" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_5ab1b662-5223-4f92-bda7-bfe7bb3f32da" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_89170ac7-c3af-46d0-aed8-f6dbcee58184" xlink:to="loc_srt_MinimumMember_5ab1b662-5223-4f92-bda7-bfe7bb3f32da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_08bf1229-de04-44f1-bc77-7335875e37eb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_89170ac7-c3af-46d0-aed8-f6dbcee58184" xlink:to="loc_srt_MaximumMember_08bf1229-de04-44f1-bc77-7335875e37eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_f1b6c085-c0f1-4f6e-9361-a262afb72d0c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_WeightedAverageMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_89170ac7-c3af-46d0-aed8-f6dbcee58184" xlink:to="loc_srt_WeightedAverageMember_f1b6c085-c0f1-4f6e-9361-a262afb72d0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_6d358047-a1e2-4f29-a22f-6e3cce5f99c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_823757a9-8cbf-40e6-848d-76def4a4b4ee" xlink:to="loc_us-gaap_PlanNameAxis_6d358047-a1e2-4f29-a22f-6e3cce5f99c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_1d624712-c5d3-44f0-be59-63e560ec6b68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_6d358047-a1e2-4f29-a22f-6e3cce5f99c8" xlink:to="loc_us-gaap_PlanNameDomain_1d624712-c5d3-44f0-be59-63e560ec6b68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_A2015StockOptionPlanMember_2d620e15-d7ab-495a-9d05-c7de90b3c2eb" xlink:href="cron-20201231.xsd#cron_A2015StockOptionPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_1d624712-c5d3-44f0-be59-63e560ec6b68" xlink:to="loc_cron_A2015StockOptionPlanMember_2d620e15-d7ab-495a-9d05-c7de90b3c2eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_A2018StockOptionPlanMember_0be25cab-0370-49bd-83bf-a085be8366e3" xlink:href="cron-20201231.xsd#cron_A2018StockOptionPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_1d624712-c5d3-44f0-be59-63e560ec6b68" xlink:to="loc_cron_A2018StockOptionPlanMember_0be25cab-0370-49bd-83bf-a085be8366e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_A2020OmnibusPlanMember_c74bac48-1f09-494d-b5e3-82ca9bb478a0" xlink:href="cron-20201231.xsd#cron_A2020OmnibusPlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_1d624712-c5d3-44f0-be59-63e560ec6b68" xlink:to="loc_cron_A2020OmnibusPlanMember_c74bac48-1f09-494d-b5e3-82ca9bb478a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_18b92701-8b94-48a7-bb3a-18d26adc435b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_823757a9-8cbf-40e6-848d-76def4a4b4ee" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_18b92701-8b94-48a7-bb3a-18d26adc435b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_aa7c55e1-4c9b-43f2-a828-f0de2d484833" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_18b92701-8b94-48a7-bb3a-18d26adc435b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_aa7c55e1-4c9b-43f2-a828-f0de2d484833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_fdc5a9c7-b776-4dd6-93ce-da73e5c8ed35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_18b92701-8b94-48a7-bb3a-18d26adc435b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_fdc5a9c7-b776-4dd6-93ce-da73e5c8ed35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_2dbb1889-7fba-48fc-881b-90e6bcb935e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_18b92701-8b94-48a7-bb3a-18d26adc435b" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_2dbb1889-7fba-48fc-881b-90e6bcb935e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_dead86c1-d661-40d7-be72-fe3e45159f29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_18b92701-8b94-48a7-bb3a-18d26adc435b" xlink:to="loc_us-gaap_SharePrice_dead86c1-d661-40d7-be72-fe3e45159f29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedPaymentsScheduleofStockOptionsOutstandingDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#SharebasedPaymentsScheduleofStockOptionsOutstandingDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/SharebasedPaymentsScheduleofStockOptionsOutstandingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_86073d85-3fc6-4db0-b84d-3bb29f304774" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c21c9e2b-6fb7-4af5-99fd-d41810b1cfd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_86073d85-3fc6-4db0-b84d-3bb29f304774" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c21c9e2b-6fb7-4af5-99fd-d41810b1cfd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_23370cb9-5c47-4e02-98f6-2d1f2487b0a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c21c9e2b-6fb7-4af5-99fd-d41810b1cfd4" xlink:to="loc_us-gaap_PlanNameAxis_23370cb9-5c47-4e02-98f6-2d1f2487b0a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_722a3f61-70bb-468a-8c61-21a46e37b88f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_23370cb9-5c47-4e02-98f6-2d1f2487b0a8" xlink:to="loc_us-gaap_PlanNameDomain_722a3f61-70bb-468a-8c61-21a46e37b88f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_A2020OmnibusPlanMember_c8626001-27ec-484c-9835-0ba6fed4486c" xlink:href="cron-20201231.xsd#cron_A2020OmnibusPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_722a3f61-70bb-468a-8c61-21a46e37b88f" xlink:to="loc_cron_A2020OmnibusPlanMember_c8626001-27ec-484c-9835-0ba6fed4486c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_A2018StockOptionPlanMember_6956c67c-87e0-482a-8679-9fc1f19cc881" xlink:href="cron-20201231.xsd#cron_A2018StockOptionPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_722a3f61-70bb-468a-8c61-21a46e37b88f" xlink:to="loc_cron_A2018StockOptionPlanMember_6956c67c-87e0-482a-8679-9fc1f19cc881" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_A2015StockOptionPlanMember_b72e1922-8ccd-4b71-b8ef-f9f1a392422b" xlink:href="cron-20201231.xsd#cron_A2015StockOptionPlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_722a3f61-70bb-468a-8c61-21a46e37b88f" xlink:to="loc_cron_A2015StockOptionPlanMember_b72e1922-8ccd-4b71-b8ef-f9f1a392422b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8e1a4d48-4bf7-459e-9d3e-1b2aa53a9cdf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c21c9e2b-6fb7-4af5-99fd-d41810b1cfd4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8e1a4d48-4bf7-459e-9d3e-1b2aa53a9cdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1b9cec24-619f-49c1-a61f-618aa32bcd50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8e1a4d48-4bf7-459e-9d3e-1b2aa53a9cdf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1b9cec24-619f-49c1-a61f-618aa32bcd50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedPaymentsSummaryoftheChangesinOptionsDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#SharebasedPaymentsSummaryoftheChangesinOptionsDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/SharebasedPaymentsSummaryoftheChangesinOptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_19ee236f-4f2b-487e-8f03-1c107f08acb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_676405d8-7470-40db-adf0-6bf5ebf0f820" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_19ee236f-4f2b-487e-8f03-1c107f08acb7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_676405d8-7470-40db-adf0-6bf5ebf0f820" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_b4e684d7-37f5-416e-92b7-f2267ba8b19b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_676405d8-7470-40db-adf0-6bf5ebf0f820" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_b4e684d7-37f5-416e-92b7-f2267ba8b19b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_06299e3f-1e91-47de-bb6c-aada74e4cfc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_676405d8-7470-40db-adf0-6bf5ebf0f820" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_06299e3f-1e91-47de-bb6c-aada74e4cfc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c5c94f98-58d9-45c1-ab17-d151748417cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_676405d8-7470-40db-adf0-6bf5ebf0f820" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c5c94f98-58d9-45c1-ab17-d151748417cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_f9d69d26-9394-4ad3-9c4e-8c12301e1aab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_676405d8-7470-40db-adf0-6bf5ebf0f820" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_f9d69d26-9394-4ad3-9c4e-8c12301e1aab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_28d68e9f-561c-4659-a7f5-03aec971f0cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_676405d8-7470-40db-adf0-6bf5ebf0f820" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_28d68e9f-561c-4659-a7f5-03aec971f0cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_94eef0f7-6430-40d1-be3c-2111d3ba43a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_19ee236f-4f2b-487e-8f03-1c107f08acb7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_94eef0f7-6430-40d1-be3c-2111d3ba43a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_bb9af2b2-93fc-4be4-b2ef-bdc8551c5116" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_19ee236f-4f2b-487e-8f03-1c107f08acb7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_bb9af2b2-93fc-4be4-b2ef-bdc8551c5116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6ad200e4-3aa7-43a1-a569-d53eef7e2173" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_bb9af2b2-93fc-4be4-b2ef-bdc8551c5116" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6ad200e4-3aa7-43a1-a569-d53eef7e2173" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_eebd5b84-44bb-4449-b903-14e55dcea8d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_bb9af2b2-93fc-4be4-b2ef-bdc8551c5116" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_eebd5b84-44bb-4449-b903-14e55dcea8d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_0a2f9b06-6dd5-4226-a58d-6dce5dd57410" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_bb9af2b2-93fc-4be4-b2ef-bdc8551c5116" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_0a2f9b06-6dd5-4226-a58d-6dce5dd57410" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_b57144b1-3625-471a-b595-bf56c843db1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_bb9af2b2-93fc-4be4-b2ef-bdc8551c5116" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_b57144b1-3625-471a-b595-bf56c843db1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_134e98c4-ca64-4f6e-a3e1-eca55a3306d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_bb9af2b2-93fc-4be4-b2ef-bdc8551c5116" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_134e98c4-ca64-4f6e-a3e1-eca55a3306d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_d29c0f18-b117-4cd4-8bd9-b8d0371e19fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_19ee236f-4f2b-487e-8f03-1c107f08acb7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_d29c0f18-b117-4cd4-8bd9-b8d0371e19fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_543cfcc2-3f32-42d1-9f20-2b48beb3b17e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_19ee236f-4f2b-487e-8f03-1c107f08acb7" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_543cfcc2-3f32-42d1-9f20-2b48beb3b17e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_77e440a1-2695-4f72-869b-a65589e3332a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_543cfcc2-3f32-42d1-9f20-2b48beb3b17e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_77e440a1-2695-4f72-869b-a65589e3332a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_2a7c2ab1-18f8-4c41-834a-abd862407d0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_543cfcc2-3f32-42d1-9f20-2b48beb3b17e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_2a7c2ab1-18f8-4c41-834a-abd862407d0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedPaymentsFairValueofOptionsIssuedDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#SharebasedPaymentsFairValueofOptionsIssuedDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/SharebasedPaymentsFairValueofOptionsIssuedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9ab13adc-9b19-4913-a9e8-05e50c92014a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2554beaf-db49-4c64-a145-f93c189cd37c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9ab13adc-9b19-4913-a9e8-05e50c92014a" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2554beaf-db49-4c64-a145-f93c189cd37c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_79101688-2c87-4f54-b4c3-4f05d9c43a81" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2554beaf-db49-4c64-a145-f93c189cd37c" xlink:to="loc_us-gaap_AwardTypeAxis_79101688-2c87-4f54-b4c3-4f05d9c43a81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_05d47179-cee4-4ff9-9100-fc955a7669f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_79101688-2c87-4f54-b4c3-4f05d9c43a81" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_05d47179-cee4-4ff9-9100-fc955a7669f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_14470001-1e39-4f23-8ec6-9fd954ee15da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_05d47179-cee4-4ff9-9100-fc955a7669f9" xlink:to="loc_us-gaap_EmployeeStockOptionMember_14470001-1e39-4f23-8ec6-9fd954ee15da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5b0281e0-0737-46d4-ba0f-a866c1b2f405" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2554beaf-db49-4c64-a145-f93c189cd37c" xlink:to="loc_srt_RangeAxis_5b0281e0-0737-46d4-ba0f-a866c1b2f405" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c85333aa-3f88-419b-aecf-bfad20bd9436" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_5b0281e0-0737-46d4-ba0f-a866c1b2f405" xlink:to="loc_srt_RangeMember_c85333aa-3f88-419b-aecf-bfad20bd9436" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_07ab48e3-1297-45dc-9610-3990360bd4ef" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c85333aa-3f88-419b-aecf-bfad20bd9436" xlink:to="loc_srt_MinimumMember_07ab48e3-1297-45dc-9610-3990360bd4ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_7bba51e1-0eb2-45f0-8039-9f956d1d0571" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c85333aa-3f88-419b-aecf-bfad20bd9436" xlink:to="loc_srt_MaximumMember_7bba51e1-0eb2-45f0-8039-9f956d1d0571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_15fff548-3098-4e3c-b0cf-807a28f44f63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2554beaf-db49-4c64-a145-f93c189cd37c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_15fff548-3098-4e3c-b0cf-807a28f44f63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_1a801fc4-cd8d-4c4f-9415-3ec66161c4a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_15fff548-3098-4e3c-b0cf-807a28f44f63" xlink:to="loc_us-gaap_SharePrice_1a801fc4-cd8d-4c4f-9415-3ec66161c4a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_d1c53a12-26de-4749-9126-db2ca67e9bca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_15fff548-3098-4e3c-b0cf-807a28f44f63" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_d1c53a12-26de-4749-9126-db2ca67e9bca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_fec07171-4308-474e-84a8-471b71af133e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_15fff548-3098-4e3c-b0cf-807a28f44f63" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_fec07171-4308-474e-84a8-471b71af133e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_e59b8c34-d579-4441-8f7a-1ab7d58d0e74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_15fff548-3098-4e3c-b0cf-807a28f44f63" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_e59b8c34-d579-4441-8f7a-1ab7d58d0e74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_04c712c0-fab4-44c5-b5c8-49004730be89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_15fff548-3098-4e3c-b0cf-807a28f44f63" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_04c712c0-fab4-44c5-b5c8-49004730be89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_b7bcf21e-e53d-4ec6-9303-c7b0c42c3443" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_15fff548-3098-4e3c-b0cf-807a28f44f63" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_b7bcf21e-e53d-4ec6-9303-c7b0c42c3443" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue_e33ebd27-1a7a-4914-86ce-b604e833acb6" xlink:href="cron-20201231.xsd#cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_15fff548-3098-4e3c-b0cf-807a28f44f63" xlink:to="loc_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue_e33ebd27-1a7a-4914-86ce-b604e833acb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsForfeitureRate_f65a295a-8d53-4c4f-8239-685b1286ace2" xlink:href="cron-20201231.xsd#cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsForfeitureRate"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_15fff548-3098-4e3c-b0cf-807a28f44f63" xlink:to="loc_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsForfeitureRate_f65a295a-8d53-4c4f-8239-685b1286ace2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedPaymentsRestrictedShareUnitsNarrativeDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#SharebasedPaymentsRestrictedShareUnitsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/SharebasedPaymentsRestrictedShareUnitsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_cb9076c4-9649-4880-96f7-b7548f947580" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_00c5aabd-f08b-46fc-92b3-1510753d1c1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_cb9076c4-9649-4880-96f7-b7548f947580" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_00c5aabd-f08b-46fc-92b3-1510753d1c1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_700102cd-f486-49ff-ab9c-01a4ba3388fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_00c5aabd-f08b-46fc-92b3-1510753d1c1f" xlink:to="loc_us-gaap_AwardTypeAxis_700102cd-f486-49ff-ab9c-01a4ba3388fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1bc7e553-d15f-460f-ba80-95a18184c1fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_700102cd-f486-49ff-ab9c-01a4ba3388fc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1bc7e553-d15f-460f-ba80-95a18184c1fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_fb928d41-7123-4966-a8e7-1c850e158b0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1bc7e553-d15f-460f-ba80-95a18184c1fb" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_fb928d41-7123-4966-a8e7-1c850e158b0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_32bda868-0acf-4975-b934-60124440a444" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_00c5aabd-f08b-46fc-92b3-1510753d1c1f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_32bda868-0acf-4975-b934-60124440a444" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_d1eed52f-78fb-4636-a097-747815b87543" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_32bda868-0acf-4975-b934-60124440a444" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_d1eed52f-78fb-4636-a097-747815b87543" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriod_f00efbed-7a66-47e0-b20b-5e860ee793b5" xlink:href="cron-20201231.xsd#cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_32bda868-0acf-4975-b934-60124440a444" xlink:to="loc_cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriod_f00efbed-7a66-47e0-b20b-5e860ee793b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_7c8b726e-1934-444f-8329-459687e95985" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_32bda868-0acf-4975-b934-60124440a444" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_7c8b726e-1934-444f-8329-459687e95985" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_abe86842-52ce-4679-9740-0f9406ac35db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_32bda868-0acf-4975-b934-60124440a444" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_abe86842-52ce-4679-9740-0f9406ac35db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedPaymentsSummaryofRestrictedShareUnitsActivityDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#SharebasedPaymentsSummaryofRestrictedShareUnitsActivityDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/SharebasedPaymentsSummaryofRestrictedShareUnitsActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8f01a760-e431-4ce4-b59d-de5ee4d00ff2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4f46196d-a4b2-4298-85b0-0cf64d114c54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8f01a760-e431-4ce4-b59d-de5ee4d00ff2" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4f46196d-a4b2-4298-85b0-0cf64d114c54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_0cbca42f-71ed-42f9-a766-ca556f44828d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4f46196d-a4b2-4298-85b0-0cf64d114c54" xlink:to="loc_us-gaap_AwardTypeAxis_0cbca42f-71ed-42f9-a766-ca556f44828d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_75289073-2354-4a67-b482-d6c510d3bc67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_0cbca42f-71ed-42f9-a766-ca556f44828d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_75289073-2354-4a67-b482-d6c510d3bc67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_0819c32e-5d21-4e3c-9144-749f6dc5f03d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_75289073-2354-4a67-b482-d6c510d3bc67" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_0819c32e-5d21-4e3c-9144-749f6dc5f03d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08fbb990-fdc9-40dd-a22b-71d95874c001" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4f46196d-a4b2-4298-85b0-0cf64d114c54" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08fbb990-fdc9-40dd-a22b-71d95874c001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4c270678-cddc-41f6-ba2b-09cf6939caaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08fbb990-fdc9-40dd-a22b-71d95874c001" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4c270678-cddc-41f6-ba2b-09cf6939caaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_84cff3fa-94c5-4ec6-ad74-6a2ad7236ca1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4c270678-cddc-41f6-ba2b-09cf6939caaf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_84cff3fa-94c5-4ec6-ad74-6a2ad7236ca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_f4c45fa6-9b7f-4f57-ad6b-7760df16df6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4c270678-cddc-41f6-ba2b-09cf6939caaf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_f4c45fa6-9b7f-4f57-ad6b-7760df16df6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_8043dc4d-a006-4ee4-96b1-f4fc6d298192" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4c270678-cddc-41f6-ba2b-09cf6939caaf" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_8043dc4d-a006-4ee4-96b1-f4fc6d298192" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_c623cdbc-216c-41c7-82b2-62c3400106e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4c270678-cddc-41f6-ba2b-09cf6939caaf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_c623cdbc-216c-41c7-82b2-62c3400106e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_da15eab1-57cb-49d2-a566-3458dca70ef5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4c270678-cddc-41f6-ba2b-09cf6939caaf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_da15eab1-57cb-49d2-a566-3458dca70ef5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_5c452918-ef8c-4947-98e7-ba126ec38522" xlink:href="cron-20201231.xsd#cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_08fbb990-fdc9-40dd-a22b-71d95874c001" xlink:to="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_5c452918-ef8c-4947-98e7-ba126ec38522" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_ef30de6f-0e01-4873-9a98-c45f6fb1e619" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_5c452918-ef8c-4947-98e7-ba126ec38522" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_ef30de6f-0e01-4873-9a98-c45f6fb1e619" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_052bc706-2f17-4337-b1fe-33600e21b6f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_5c452918-ef8c-4947-98e7-ba126ec38522" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_052bc706-2f17-4337-b1fe-33600e21b6f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_79d4ee33-1290-402f-96e1-d962bbbad8c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_5c452918-ef8c-4947-98e7-ba126ec38522" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_79d4ee33-1290-402f-96e1-d962bbbad8c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_1bc27b3b-298d-44bd-abea-01e4ebee9dd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_5c452918-ef8c-4947-98e7-ba126ec38522" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_1bc27b3b-298d-44bd-abea-01e4ebee9dd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_9cf8cae6-2d83-42de-858d-cbe4e6c308f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_5c452918-ef8c-4947-98e7-ba126ec38522" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_9cf8cae6-2d83-42de-858d-cbe4e6c308f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedPaymentsDeferredShareUnitsNarrativeDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#SharebasedPaymentsDeferredShareUnitsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/SharebasedPaymentsDeferredShareUnitsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6682e42f-4024-4cd9-9652-b4f2f2dcc3e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f5d500ec-485c-498d-ae6d-b5606ba9cc9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6682e42f-4024-4cd9-9652-b4f2f2dcc3e0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f5d500ec-485c-498d-ae6d-b5606ba9cc9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_87054fe8-94de-4c4a-9a27-d790c476f0c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f5d500ec-485c-498d-ae6d-b5606ba9cc9d" xlink:to="loc_us-gaap_AwardTypeAxis_87054fe8-94de-4c4a-9a27-d790c476f0c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_690a203c-eaa8-42a3-a60c-34b7e0969080" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_87054fe8-94de-4c4a-9a27-d790c476f0c7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_690a203c-eaa8-42a3-a60c-34b7e0969080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DeferredShareUnitsDSUsMember_e76488d6-48c3-4228-9010-1eec7a2d76dc" xlink:href="cron-20201231.xsd#cron_DeferredShareUnitsDSUsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_690a203c-eaa8-42a3-a60c-34b7e0969080" xlink:to="loc_cron_DeferredShareUnitsDSUsMember_e76488d6-48c3-4228-9010-1eec7a2d76dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f41347a1-4d0b-4100-8afd-b71ab45a5a8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f5d500ec-485c-498d-ae6d-b5606ba9cc9d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f41347a1-4d0b-4100-8afd-b71ab45a5a8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_03855763-551e-46cb-98d4-ccc19a49e995" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f41347a1-4d0b-4100-8afd-b71ab45a5a8f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_03855763-551e-46cb-98d4-ccc19a49e995" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedPaymentsSummaryofDeferredShareUnitsActivityDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#SharebasedPaymentsSummaryofDeferredShareUnitsActivityDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/SharebasedPaymentsSummaryofDeferredShareUnitsActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ed547484-8d57-4dd9-9c5d-fdcebf05548d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a944f196-ecbc-40f5-b9f8-c64ade0b389d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ed547484-8d57-4dd9-9c5d-fdcebf05548d" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a944f196-ecbc-40f5-b9f8-c64ade0b389d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_d3726baf-a443-4b33-9403-9cae44a6e9aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a944f196-ecbc-40f5-b9f8-c64ade0b389d" xlink:to="loc_us-gaap_AwardTypeAxis_d3726baf-a443-4b33-9403-9cae44a6e9aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_82b2d056-8f1e-4c7e-a23e-a60dc24c2096" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_d3726baf-a443-4b33-9403-9cae44a6e9aa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_82b2d056-8f1e-4c7e-a23e-a60dc24c2096" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DeferredShareUnitsDSUsMember_d518f8dd-5a45-4067-85ee-718bc1317937" xlink:href="cron-20201231.xsd#cron_DeferredShareUnitsDSUsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_82b2d056-8f1e-4c7e-a23e-a60dc24c2096" xlink:to="loc_cron_DeferredShareUnitsDSUsMember_d518f8dd-5a45-4067-85ee-718bc1317937" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2129dbc6-3b4c-4bfb-a9f7-1382a226f4e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a944f196-ecbc-40f5-b9f8-c64ade0b389d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2129dbc6-3b4c-4bfb-a9f7-1382a226f4e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c439bca7-493f-4498-8066-4d6673c0bb95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2129dbc6-3b4c-4bfb-a9f7-1382a226f4e0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c439bca7-493f-4498-8066-4d6673c0bb95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_59576658-b674-4475-85ee-61bce16632bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c439bca7-493f-4498-8066-4d6673c0bb95" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_59576658-b674-4475-85ee-61bce16632bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsAndVestedInPeriod_22e3c1ce-6a00-4ab2-9721-81d2d2cb4815" xlink:href="cron-20201231.xsd#cron_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsAndVestedInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c439bca7-493f-4498-8066-4d6673c0bb95" xlink:to="loc_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsAndVestedInPeriod_22e3c1ce-6a00-4ab2-9721-81d2d2cb4815" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_ae151303-8705-46b8-a476-c4b1cdadb7fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c439bca7-493f-4498-8066-4d6673c0bb95" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_ae151303-8705-46b8-a476-c4b1cdadb7fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_aeebc495-7e4f-4807-b530-470f3a924d54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c439bca7-493f-4498-8066-4d6673c0bb95" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_aeebc495-7e4f-4807-b530-470f3a924d54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_88a05130-7962-4ded-bc6c-31cede8baa52" xlink:href="cron-20201231.xsd#cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2129dbc6-3b4c-4bfb-a9f7-1382a226f4e0" xlink:to="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_88a05130-7962-4ded-bc6c-31cede8baa52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent_d1c3e922-8894-4934-847b-c8faa7e008c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_88a05130-7962-4ded-bc6c-31cede8baa52" xlink:to="loc_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent_d1c3e922-8894-4934-847b-c8faa7e008c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_40ae3536-571e-4cbd-a93a-38e011e6aec1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_88a05130-7962-4ded-bc6c-31cede8baa52" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_40ae3536-571e-4cbd-a93a-38e011e6aec1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ShareBasedPaymentArrangementLiabilitiesSettled_4d949232-befc-43df-945c-f4d51ccf71fd" xlink:href="cron-20201231.xsd#cron_ShareBasedPaymentArrangementLiabilitiesSettled"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_88a05130-7962-4ded-bc6c-31cede8baa52" xlink:to="loc_cron_ShareBasedPaymentArrangementLiabilitiesSettled_4d949232-befc-43df-945c-f4d51ccf71fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ShareBasedPaymentArrangementGainLossOnRevaluation_4f0784dd-4690-47cb-8c46-5d48e9b9399e" xlink:href="cron-20201231.xsd#cron_ShareBasedPaymentArrangementGainLossOnRevaluation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_88a05130-7962-4ded-bc6c-31cede8baa52" xlink:to="loc_cron_ShareBasedPaymentArrangementGainLossOnRevaluation_4f0784dd-4690-47cb-8c46-5d48e9b9399e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent_709d95ab-f94a-404e-9b6c-054829892ec9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_88a05130-7962-4ded-bc6c-31cede8baa52" xlink:to="loc_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent_709d95ab-f94a-404e-9b6c-054829892ec9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/EarningslossPerShare" xlink:type="simple" xlink:href="cron-20201231.xsd#EarningslossPerShare"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/EarningslossPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_0e80ca10-c78a-4c7b-9d2f-26a69a8119c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_ac3ac1cf-b9bf-43e1-81cf-68cf0b4d8924" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0e80ca10-c78a-4c7b-9d2f-26a69a8119c6" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_ac3ac1cf-b9bf-43e1-81cf-68cf0b4d8924" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/EarningslossPerShareTables" xlink:type="simple" xlink:href="cron-20201231.xsd#EarningslossPerShareTables"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/EarningslossPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_a7476198-c609-4765-bf45-2a91278533af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_8527c85c-3787-4c46-8e05-4c5eef2973d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_a7476198-c609-4765-bf45-2a91278533af" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_8527c85c-3787-4c46-8e05-4c5eef2973d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_d2911e75-375d-4b12-8bcd-18129ee30975" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_a7476198-c609-4765-bf45-2a91278533af" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_d2911e75-375d-4b12-8bcd-18129ee30975" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#EarningslossPerShareScheduleofEarningsLossPerShareDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_da615c35-1137-4c81-a60b-0f6308787abb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_bf686da2-c820-43d8-b70d-aa709b600459" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_da615c35-1137-4c81-a60b-0f6308787abb" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_bf686da2-c820-43d8-b70d-aa709b600459" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_98a1f313-6c01-4fec-b6fe-a496263e727a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_bf686da2-c820-43d8-b70d-aa709b600459" xlink:to="loc_us-gaap_AwardTypeAxis_98a1f313-6c01-4fec-b6fe-a496263e727a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_58180b67-45d9-4e07-a34e-66330af8061c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_98a1f313-6c01-4fec-b6fe-a496263e727a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_58180b67-45d9-4e07-a34e-66330af8061c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_ab58f22c-227c-4f7a-8320-939cf6dc41e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_58180b67-45d9-4e07-a34e-66330af8061c" xlink:to="loc_us-gaap_WarrantMember_ab58f22c-227c-4f7a-8320-939cf6dc41e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_7d66ed15-9650-44ae-87d2-200f4d9ae669" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_58180b67-45d9-4e07-a34e-66330af8061c" xlink:to="loc_us-gaap_EmployeeStockOptionMember_7d66ed15-9650-44ae-87d2-200f4d9ae669" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_1ac5ea1c-fb2b-426a-95a9-61a42e224d1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_58180b67-45d9-4e07-a34e-66330af8061c" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_1ac5ea1c-fb2b-426a-95a9-61a42e224d1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_f894b4ee-d6f0-4254-902c-ef886692c548" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_bf686da2-c820-43d8-b70d-aa709b600459" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_f894b4ee-d6f0-4254-902c-ef886692c548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_c3d324ea-48e7-49df-8445-bcbf3d4de3ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_f894b4ee-d6f0-4254-902c-ef886692c548" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_c3d324ea-48e7-49df-8445-bcbf3d4de3ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaWarrantMember_bd9f186d-eb20-4490-bf16-81fd5b1221cc" xlink:href="cron-20201231.xsd#cron_AltriaWarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_c3d324ea-48e7-49df-8445-bcbf3d4de3ab" xlink:to="loc_cron_AltriaWarrantMember_bd9f186d-eb20-4490-bf16-81fd5b1221cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_TopupRightsMember_62f496d5-8fcd-46f9-b178-d25a57cb53cf" xlink:href="cron-20201231.xsd#cron_TopupRightsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_c3d324ea-48e7-49df-8445-bcbf3d4de3ab" xlink:to="loc_cron_TopupRightsMember_62f496d5-8fcd-46f9-b178-d25a57cb53cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedLineItems_df94fdde-8400-4ee5-8e1b-1279c7a6b198" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDilutedLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_bf686da2-c820-43d8-b70d-aa709b600459" xlink:to="loc_us-gaap_EarningsPerShareDilutedLineItems_df94fdde-8400-4ee5-8e1b-1279c7a6b198" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_571c1b84-85fe-4f87-ab96-272338ee1af2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_df94fdde-8400-4ee5-8e1b-1279c7a6b198" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_571c1b84-85fe-4f87-ab96-272338ee1af2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_3b00f69d-942a-479e-8fc6-69fc632fc5c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_571c1b84-85fe-4f87-ab96-272338ee1af2" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_3b00f69d-942a-479e-8fc6-69fc632fc5c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e530f0cf-f841-4e8e-8f00-eab0721096db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_571c1b84-85fe-4f87-ab96-272338ee1af2" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e530f0cf-f841-4e8e-8f00-eab0721096db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_30b3e3bf-4d07-4bc1-882c-c2de79b48781" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_571c1b84-85fe-4f87-ab96-272338ee1af2" xlink:to="loc_us-gaap_EarningsPerShareBasic_30b3e3bf-4d07-4bc1-882c-c2de79b48781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_15e4d1b8-6ac3-4038-abd6-591136c135f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_df94fdde-8400-4ee5-8e1b-1279c7a6b198" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_15e4d1b8-6ac3-4038-abd6-591136c135f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_78931767-0d51-4c4d-ba11-d6a8bc7b60f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_15e4d1b8-6ac3-4038-abd6-591136c135f6" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_78931767-0d51-4c4d-ba11-d6a8bc7b60f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DilutiveSecurities_76342e73-9329-4822-928b-c0450413340e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DilutiveSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_15e4d1b8-6ac3-4038-abd6-591136c135f6" xlink:to="loc_us-gaap_DilutiveSecurities_76342e73-9329-4822-928b-c0450413340e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted_3940897f-0882-4a80-8dc4-6d50c71c756b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_15e4d1b8-6ac3-4038-abd6-591136c135f6" xlink:to="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted_3940897f-0882-4a80-8dc4-6d50c71c756b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0bf23075-6421-4cdd-b986-472ee4a2a96d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_15e4d1b8-6ac3-4038-abd6-591136c135f6" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0bf23075-6421-4cdd-b986-472ee4a2a96d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_c5645765-a15b-457e-a420-ae8c2b65745f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_15e4d1b8-6ac3-4038-abd6-591136c135f6" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_c5645765-a15b-457e-a420-ae8c2b65745f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_c5690e33-5346-4fbb-a09d-bc8038d29bfc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_15e4d1b8-6ac3-4038-abd6-591136c135f6" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_c5690e33-5346-4fbb-a09d-bc8038d29bfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_bfa26a0d-1acb-49b2-900b-ce9e138b72a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_15e4d1b8-6ac3-4038-abd6-591136c135f6" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_bfa26a0d-1acb-49b2-900b-ce9e138b72a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_d0533544-393c-4746-9e4d-14a90424a6b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_15e4d1b8-6ac3-4038-abd6-591136c135f6" xlink:to="loc_us-gaap_EarningsPerShareDiluted_d0533544-393c-4746-9e4d-14a90424a6b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShareAbstract_bebf5b07-d128-492d-99e1-6c7950c7b980" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShareAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_df94fdde-8400-4ee5-8e1b-1279c7a6b198" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShareAbstract_bebf5b07-d128-492d-99e1-6c7950c7b980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_41cb2ca6-b73d-40ab-9bb7-5e010b22a26a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShareAbstract_bebf5b07-d128-492d-99e1-6c7950c7b980" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_41cb2ca6-b73d-40ab-9bb7-5e010b22a26a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_de0563da-d16c-484a-a61f-a10def0b52cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShareAbstract_bebf5b07-d128-492d-99e1-6c7950c7b980" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_de0563da-d16c-484a-a61f-a10def0b52cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_0d53b48c-b9c0-4b36-a636-f28f9c204f62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShareAbstract_bebf5b07-d128-492d-99e1-6c7950c7b980" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_0d53b48c-b9c0-4b36-a636-f28f9c204f62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/EarningslossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedSharesOutstandingDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#EarningslossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedSharesOutstandingDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/EarningslossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedSharesOutstandingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_3c208a33-1d06-4574-a556-2b2e20417c81" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_43f40116-d8c9-42cd-99a0-83c9a071f57f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_3c208a33-1d06-4574-a556-2b2e20417c81" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_43f40116-d8c9-42cd-99a0-83c9a071f57f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_0e31d77f-d892-4dec-a43e-f67eaa323740" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_43f40116-d8c9-42cd-99a0-83c9a071f57f" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_0e31d77f-d892-4dec-a43e-f67eaa323740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5aadc198-84ee-4596-a1fe-cd6f90734670" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_0e31d77f-d892-4dec-a43e-f67eaa323740" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5aadc198-84ee-4596-a1fe-cd6f90734670" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_GinkgoEquityMilestonesMember_70e36ba5-befe-49ce-a3f7-02112b54c34e" xlink:href="cron-20201231.xsd#cron_GinkgoEquityMilestonesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5aadc198-84ee-4596-a1fe-cd6f90734670" xlink:to="loc_cron_GinkgoEquityMilestonesMember_70e36ba5-befe-49ce-a3f7-02112b54c34e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PreemptiveRightsMember_1602e791-7f44-4083-a6f9-400159feb16f" xlink:href="cron-20201231.xsd#cron_PreemptiveRightsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5aadc198-84ee-4596-a1fe-cd6f90734670" xlink:to="loc_cron_PreemptiveRightsMember_1602e791-7f44-4083-a6f9-400159feb16f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_TopUpRightsFixedPriceMember_8907ed5f-608d-451f-b47d-80f71e3959a0" xlink:href="cron-20201231.xsd#cron_TopUpRightsFixedPriceMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5aadc198-84ee-4596-a1fe-cd6f90734670" xlink:to="loc_cron_TopUpRightsFixedPriceMember_8907ed5f-608d-451f-b47d-80f71e3959a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_TopUpRightsMarketPriceMember_cebb5c82-9d7e-4d8e-84cd-ce7a92f3d59f" xlink:href="cron-20201231.xsd#cron_TopUpRightsMarketPriceMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5aadc198-84ee-4596-a1fe-cd6f90734670" xlink:to="loc_cron_TopUpRightsMarketPriceMember_cebb5c82-9d7e-4d8e-84cd-ce7a92f3d59f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaWarrantMember_77482cb1-e5a8-46bd-80ba-6e4f54c76108" xlink:href="cron-20201231.xsd#cron_AltriaWarrantMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5aadc198-84ee-4596-a1fe-cd6f90734670" xlink:to="loc_cron_AltriaWarrantMember_77482cb1-e5a8-46bd-80ba-6e4f54c76108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_fd88b7bc-8f97-41d8-98a5-ccf9a0a0f725" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5aadc198-84ee-4596-a1fe-cd6f90734670" xlink:to="loc_us-gaap_WarrantMember_fd88b7bc-8f97-41d8-98a5-ccf9a0a0f725" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_d3ae9b15-d95e-44e8-88ec-a8e4bd11fab7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5aadc198-84ee-4596-a1fe-cd6f90734670" xlink:to="loc_us-gaap_EmployeeStockOptionMember_d3ae9b15-d95e-44e8-88ec-a8e4bd11fab7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_ea7208c2-f262-406a-bee4-be8da8e45170" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5aadc198-84ee-4596-a1fe-cd6f90734670" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_ea7208c2-f262-406a-bee4-be8da8e45170" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_c98ca5cf-36f7-4e15-a3c8-35a29d4a3313" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_43f40116-d8c9-42cd-99a0-83c9a071f57f" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_c98ca5cf-36f7-4e15-a3c8-35a29d4a3313" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_6f32e31b-f758-4732-986f-48b09def17d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_c98ca5cf-36f7-4e15-a3c8-35a29d4a3313" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_6f32e31b-f758-4732-986f-48b09def17d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLoss" xlink:type="simple" xlink:href="cron-20201231.xsd#AccumulatedOtherComprehensiveIncomeLoss"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_5daf918f-a7f0-477b-8186-ee946781ed87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_3d79c267-8619-4628-bdcd-670b9b4ac33a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5daf918f-a7f0-477b-8186-ee946781ed87" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_3d79c267-8619-4628-bdcd-670b9b4ac33a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLossTables" xlink:type="simple" xlink:href="cron-20201231.xsd#AccumulatedOtherComprehensiveIncomeLossTables"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLossTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_010ea437-1b6b-4ec9-b96e-254539068cf1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_3afc9c5f-8286-48da-802c-b5de9ef941b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_010ea437-1b6b-4ec9-b96e-254539068cf1" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_3afc9c5f-8286-48da-802c-b5de9ef941b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#AccumulatedOtherComprehensiveIncomeLossDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_364518ed-99c7-46dc-869c-6e08017dd730" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_72f900db-1d01-4f49-bd04-26712b3a66a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_364518ed-99c7-46dc-869c-6e08017dd730" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_72f900db-1d01-4f49-bd04-26712b3a66a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_4d8b6a19-c6b4-45df-8b60-a75edbb05385" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_72f900db-1d01-4f49-bd04-26712b3a66a0" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_4d8b6a19-c6b4-45df-8b60-a75edbb05385" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_456b14e2-60e5-4e1c-ab0d-c9d4cce6fb06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4d8b6a19-c6b4-45df-8b60-a75edbb05385" xlink:to="loc_us-gaap_EquityComponentDomain_456b14e2-60e5-4e1c-ab0d-c9d4cce6fb06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_cb057315-335f-4239-8b82-31d00d89b259" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_456b14e2-60e5-4e1c-ab0d-c9d4cce6fb06" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_cb057315-335f-4239-8b82-31d00d89b259" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AOCIAccumulatedGainLossRevaluationAndDisposalOfOtherInvestmentsParentMemberMember_6ffe6434-973d-42a9-9540-65d94a6b4c4d" xlink:href="cron-20201231.xsd#cron_AOCIAccumulatedGainLossRevaluationAndDisposalOfOtherInvestmentsParentMemberMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_cb057315-335f-4239-8b82-31d00d89b259" xlink:to="loc_cron_AOCIAccumulatedGainLossRevaluationAndDisposalOfOtherInvestmentsParentMemberMember_6ffe6434-973d-42a9-9540-65d94a6b4c4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_58a1707f-1929-40d5-ac4a-e7bc70ef3db8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_cb057315-335f-4239-8b82-31d00d89b259" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_58a1707f-1929-40d5-ac4a-e7bc70ef3db8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_8563240e-a2b0-4f6a-b635-f9b9cc3336e9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_72f900db-1d01-4f49-bd04-26712b3a66a0" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_8563240e-a2b0-4f6a-b635-f9b9cc3336e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_c8b141aa-96ec-437c-bb47-da8a37843ff2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_8563240e-a2b0-4f6a-b635-f9b9cc3336e9" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_c8b141aa-96ec-437c-bb47-da8a37843ff2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_b73ab4d8-4366-482f-888f-89a8b1b8fbe3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_c8b141aa-96ec-437c-bb47-da8a37843ff2" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_b73ab4d8-4366-482f-888f-89a8b1b8fbe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_c2546484-72ef-41ae-995a-aa8068930402" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_72f900db-1d01-4f49-bd04-26712b3a66a0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_c2546484-72ef-41ae-995a-aa8068930402" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_aab27bf5-147a-4603-81f9-0b84ee9e93f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_c2546484-72ef-41ae-995a-aa8068930402" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_aab27bf5-147a-4603-81f9-0b84ee9e93f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d5895d27-7bdc-4e9b-977a-7f36e1ae0aa7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_aab27bf5-147a-4603-81f9-0b84ee9e93f9" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d5895d27-7bdc-4e9b-977a-7f36e1ae0aa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_f3a27ac4-3094-44bd-84b2-a9304b934797" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_aab27bf5-147a-4603-81f9-0b84ee9e93f9" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_f3a27ac4-3094-44bd-84b2-a9304b934797" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_62adef8b-3930-4f59-80bc-fda122cbed87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_aab27bf5-147a-4603-81f9-0b84ee9e93f9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_62adef8b-3930-4f59-80bc-fda122cbed87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b45fcb50-e9d5-4538-8a10-ad414a72113d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_aab27bf5-147a-4603-81f9-0b84ee9e93f9" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b45fcb50-e9d5-4538-8a10-ad414a72113d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/IncomeTaxes" xlink:type="simple" xlink:href="cron-20201231.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_36d65523-b932-4096-bce9-988155256e87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_d90271bc-50c7-49ff-b95d-fc070d71dc58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_36d65523-b932-4096-bce9-988155256e87" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_d90271bc-50c7-49ff-b95d-fc070d71dc58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="cron-20201231.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_ce01414e-0946-4cbd-9ec6-03992411419b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_63d2315e-1d41-4e17-8bbd-1a24960fff5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ce01414e-0946-4cbd-9ec6-03992411419b" xlink:to="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_63d2315e-1d41-4e17-8bbd-1a24960fff5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_0a45da14-f742-44d0-9a8a-b471e5b8015f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ce01414e-0946-4cbd-9ec6-03992411419b" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_0a45da14-f742-44d0-9a8a-b471e5b8015f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_589860f5-f725-4d19-b2ef-cb26c0eab343" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ce01414e-0946-4cbd-9ec6-03992411419b" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_589860f5-f725-4d19-b2ef-cb26c0eab343" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_f8a4d30f-4cce-45b6-85f4-b2f7d2e37104" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ce01414e-0946-4cbd-9ec6-03992411419b" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_f8a4d30f-4cce-45b6-85f4-b2f7d2e37104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfIncomeTaxExaminationsTextBlock_178ec75c-112d-47fe-a417-f75dc95f5cff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SummaryOfIncomeTaxExaminationsTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ce01414e-0946-4cbd-9ec6-03992411419b" xlink:to="loc_us-gaap_SummaryOfIncomeTaxExaminationsTextBlock_178ec75c-112d-47fe-a417-f75dc95f5cff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfValuationAllowanceTextBlock_16fc1744-4881-4a17-ac16-19279380472b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SummaryOfValuationAllowanceTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ce01414e-0946-4cbd-9ec6-03992411419b" xlink:to="loc_us-gaap_SummaryOfValuationAllowanceTextBlock_16fc1744-4881-4a17-ac16-19279380472b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/IncomeTaxesScheduleofIncomeLossbeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#IncomeTaxesScheduleofIncomeLossbeforeIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/IncomeTaxesScheduleofIncomeLossbeforeIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_6170a55f-51ec-43f0-8e8f-31b664812bd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_e6776503-c6f5-43aa-8da1-e598790c24f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6170a55f-51ec-43f0-8e8f-31b664812bd4" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_e6776503-c6f5-43aa-8da1-e598790c24f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_ae29ad23-a295-49d6-89d0-ff0c3d8b226e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_e6776503-c6f5-43aa-8da1-e598790c24f6" xlink:to="loc_srt_StatementGeographicalAxis_ae29ad23-a295-49d6-89d0-ff0c3d8b226e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_480e4431-8ef1-47fb-b0d9-aafa816c4750" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_ae29ad23-a295-49d6-89d0-ff0c3d8b226e" xlink:to="loc_srt_SegmentGeographicalDomain_480e4431-8ef1-47fb-b0d9-aafa816c4750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_2e874a8b-5bc2-4cb7-a4a4-726789a5a740" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_480e4431-8ef1-47fb-b0d9-aafa816c4750" xlink:to="loc_us-gaap_NonUsMember_2e874a8b-5bc2-4cb7-a4a4-726789a5a740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_4544993e-2ab5-474e-ac67-cb4a3973b987" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_480e4431-8ef1-47fb-b0d9-aafa816c4750" xlink:to="loc_country_US_4544993e-2ab5-474e-ac67-cb4a3973b987" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_9531169e-0823-4bd8-a3aa-03a555911470" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_e6776503-c6f5-43aa-8da1-e598790c24f6" xlink:to="loc_us-gaap_OperatingLossCarryforwardsLineItems_9531169e-0823-4bd8-a3aa-03a555911470" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_4e2fe3a0-064b-4714-99b5-91ce07936fba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_9531169e-0823-4bd8-a3aa-03a555911470" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_4e2fe3a0-064b-4714-99b5-91ce07936fba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_ca4d0da0-6443-40c2-a4f9-f962f913b4ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceTable_7a76e2d1-2465-44c0-bf42-dd71f1d6677f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowanceTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ca4d0da0-6443-40c2-a4f9-f962f913b4ee" xlink:to="loc_us-gaap_ValuationAllowanceTable_7a76e2d1-2465-44c0-bf42-dd71f1d6677f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_c94869b0-344f-428e-9d3d-d8c1da1d115c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowanceTable_7a76e2d1-2465-44c0-bf42-dd71f1d6677f" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_c94869b0-344f-428e-9d3d-d8c1da1d115c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_84b8d782-aae2-4ba4-b425-40bbd3873915" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_c94869b0-344f-428e-9d3d-d8c1da1d115c" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_84b8d782-aae2-4ba4-b425-40bbd3873915" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_be6cb072-d401-4cdb-b199-4a337a459581" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_84b8d782-aae2-4ba4-b425-40bbd3873915" xlink:to="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_be6cb072-d401-4cdb-b199-4a337a459581" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_cc5c1e4e-e150-4d65-bae9-777525f0290c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowanceTable_7a76e2d1-2465-44c0-bf42-dd71f1d6677f" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_cc5c1e4e-e150-4d65-bae9-777525f0290c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_3c0875d7-a3a8-4817-84a0-92787e4feb89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_cc5c1e4e-e150-4d65-bae9-777525f0290c" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_3c0875d7-a3a8-4817-84a0-92787e4feb89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CanadaRevenueAgencyMember_632a3784-afe8-4f2e-bde0-52cdf8b3310a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CanadaRevenueAgencyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_3c0875d7-a3a8-4817-84a0-92787e4feb89" xlink:to="loc_us-gaap_CanadaRevenueAgencyMember_632a3784-afe8-4f2e-bde0-52cdf8b3310a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_24cd36b0-ec18-4481-816d-cdc668c98ece" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_3c0875d7-a3a8-4817-84a0-92787e4feb89" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_24cd36b0-ec18-4481-816d-cdc668c98ece" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IsraelTaxAuthorityMember_5748409b-860d-4ee3-bddc-214fcdc0603b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IsraelTaxAuthorityMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_3c0875d7-a3a8-4817-84a0-92787e4feb89" xlink:to="loc_us-gaap_IsraelTaxAuthorityMember_5748409b-860d-4ee3-bddc-214fcdc0603b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceLineItems_db576a13-1ad4-4100-85e4-bee92c2f1905" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowanceLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowanceTable_7a76e2d1-2465-44c0-bf42-dd71f1d6677f" xlink:to="loc_us-gaap_ValuationAllowanceLineItems_db576a13-1ad4-4100-85e4-bee92c2f1905" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax_2da21509-2089-4f11-b08f-2b96fb4cecb9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_db576a13-1ad4-4100-85e4-bee92c2f1905" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax_2da21509-2089-4f11-b08f-2b96fb4cecb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_19bfc351-f028-43d9-a98f-18974159983e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_db576a13-1ad4-4100-85e4-bee92c2f1905" xlink:to="loc_us-gaap_TaxesPayableCurrent_19bfc351-f028-43d9-a98f-18974159983e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dd74fa1c-aaac-4c06-8a6f-748137129248" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_db576a13-1ad4-4100-85e4-bee92c2f1905" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dd74fa1c-aaac-4c06-8a6f-748137129248" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_689cdb31-58ba-45fe-a7d9-384c32340589" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_db576a13-1ad4-4100-85e4-bee92c2f1905" xlink:to="loc_us-gaap_OperatingLossCarryforwards_689cdb31-58ba-45fe-a7d9-384c32340589" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesAdjustments_9c87e8a9-4dab-4572-bf2a-b2ee1e7ff58e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesAdjustments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowanceLineItems_db576a13-1ad4-4100-85e4-bee92c2f1905" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesAdjustments_9c87e8a9-4dab-4572-bf2a-b2ee1e7ff58e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/IncomeTaxesExpenseforIncomeTaxesDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#IncomeTaxesExpenseforIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/IncomeTaxesExpenseforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_2f04a953-d514-43e4-be29-a6c3eb9a48fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_19953a91-56cd-45f8-b503-178e32429e00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2f04a953-d514-43e4-be29-a6c3eb9a48fa" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_19953a91-56cd-45f8-b503-178e32429e00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_6568fa9e-5def-4c28-9a2d-05f5d481f27c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_19953a91-56cd-45f8-b503-178e32429e00" xlink:to="loc_srt_StatementGeographicalAxis_6568fa9e-5def-4c28-9a2d-05f5d481f27c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_b2c186fb-eefa-4394-9777-08cf890052ac" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_6568fa9e-5def-4c28-9a2d-05f5d481f27c" xlink:to="loc_srt_SegmentGeographicalDomain_b2c186fb-eefa-4394-9777-08cf890052ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_402a914c-122d-4048-9431-84548eb79867" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_b2c186fb-eefa-4394-9777-08cf890052ac" xlink:to="loc_us-gaap_NonUsMember_402a914c-122d-4048-9431-84548eb79867" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_fca3ea1a-3627-4a6e-8b06-00e8915f2d5b" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_b2c186fb-eefa-4394-9777-08cf890052ac" xlink:to="loc_country_US_fca3ea1a-3627-4a6e-8b06-00e8915f2d5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_f4f1d7f9-ec54-470b-adb0-7c667ca15b52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_19953a91-56cd-45f8-b503-178e32429e00" xlink:to="loc_us-gaap_OperatingLossCarryforwardsLineItems_f4f1d7f9-ec54-470b-adb0-7c667ca15b52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_60a46371-ecfc-486c-a811-05a0680a47ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_f4f1d7f9-ec54-470b-adb0-7c667ca15b52" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_60a46371-ecfc-486c-a811-05a0680a47ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_6a0aa303-f63c-48c2-9209-2b0217b98147" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_60a46371-ecfc-486c-a811-05a0680a47ac" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_6a0aa303-f63c-48c2-9209-2b0217b98147" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_25a476d4-b4ac-4a69-953a-a5406d15c0dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_f4f1d7f9-ec54-470b-adb0-7c667ca15b52" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_25a476d4-b4ac-4a69-953a-a5406d15c0dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_d2b1c114-f545-425c-b0d8-9e9e2b468772" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_25a476d4-b4ac-4a69-953a-a5406d15c0dc" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_d2b1c114-f545-425c-b0d8-9e9e2b468772" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#IncomeTaxesEffectiveTaxRateReconciliationDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_1027b1bf-3077-45dd-9666-7e71a9f1edfd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_4d958e2f-f0c9-4a0c-ba75-de46466ff667" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1027b1bf-3077-45dd-9666-7e71a9f1edfd" xlink:to="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_4d958e2f-f0c9-4a0c-ba75-de46466ff667" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_b7f4fc9f-bd1b-47d2-8170-9491b6105d7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1027b1bf-3077-45dd-9666-7e71a9f1edfd" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_b7f4fc9f-bd1b-47d2-8170-9491b6105d7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_EffectiveIncomeTaxRateReconciliationExpectedIncomeTaxExpenseRecoveryAmount_2e8b6b10-ed6e-47e5-9f60-e9adb8c88a4b" xlink:href="cron-20201231.xsd#cron_EffectiveIncomeTaxRateReconciliationExpectedIncomeTaxExpenseRecoveryAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1027b1bf-3077-45dd-9666-7e71a9f1edfd" xlink:to="loc_cron_EffectiveIncomeTaxRateReconciliationExpectedIncomeTaxExpenseRecoveryAmount_2e8b6b10-ed6e-47e5-9f60-e9adb8c88a4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxExemptIncome_540329a9-63f3-4a9d-8df8-9c3d90c75062" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxExemptIncome"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1027b1bf-3077-45dd-9666-7e71a9f1edfd" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxExemptIncome_540329a9-63f3-4a9d-8df8-9c3d90c75062" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_12916155-676c-4c38-9111-1446596c8a46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1027b1bf-3077-45dd-9666-7e71a9f1edfd" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_12916155-676c-4c38-9111-1446596c8a46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_8e792518-82dc-4241-a13b-4127d948e590" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1027b1bf-3077-45dd-9666-7e71a9f1edfd" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_8e792518-82dc-4241-a13b-4127d948e590" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionCosts_c7515b91-c001-434f-8e41-25e42ab2764a" xlink:href="cron-20201231.xsd#cron_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionCosts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1027b1bf-3077-45dd-9666-7e71a9f1edfd" xlink:to="loc_cron_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionCosts_c7515b91-c001-434f-8e41-25e42ab2764a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_4bfb313f-358b-4215-9f09-f03542a5e2ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1027b1bf-3077-45dd-9666-7e71a9f1edfd" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_4bfb313f-358b-4215-9f09-f03542a5e2ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_a4005c67-f33f-439c-a35e-616ab92f2869" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1027b1bf-3077-45dd-9666-7e71a9f1edfd" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_a4005c67-f33f-439c-a35e-616ab92f2869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_EffectiveIncomeTaxRateReconciliationFairValueGainFinancialLiabilities_e225b8c8-13d3-4166-bb97-a84556396dde" xlink:href="cron-20201231.xsd#cron_EffectiveIncomeTaxRateReconciliationFairValueGainFinancialLiabilities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1027b1bf-3077-45dd-9666-7e71a9f1edfd" xlink:to="loc_cron_EffectiveIncomeTaxRateReconciliationFairValueGainFinancialLiabilities_e225b8c8-13d3-4166-bb97-a84556396dde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_f263a348-2d0e-47f5-bc2e-0dbeffcc3437" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1027b1bf-3077-45dd-9666-7e71a9f1edfd" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_f263a348-2d0e-47f5-bc2e-0dbeffcc3437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_d2da14ae-7837-437b-a476-9706d6ddc66d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1027b1bf-3077-45dd-9666-7e71a9f1edfd" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_d2da14ae-7837-437b-a476-9706d6ddc66d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_60ef1d4c-5c01-4b3b-b5b0-61ffcf3221d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1027b1bf-3077-45dd-9666-7e71a9f1edfd" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_60ef1d4c-5c01-4b3b-b5b0-61ffcf3221d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_82034431-4f99-423a-8088-9f83a1355d1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_f53a3407-3702-4c61-bccb-6795000b80b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_82034431-4f99-423a-8088-9f83a1355d1d" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_f53a3407-3702-4c61-bccb-6795000b80b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_27e27a2a-5f2b-44cc-9cb1-c9c48397871b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_f53a3407-3702-4c61-bccb-6795000b80b7" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_27e27a2a-5f2b-44cc-9cb1-c9c48397871b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetInterestCarryforward_fa3f1229-eb0a-40c3-b62b-413cb402972d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetInterestCarryforward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_f53a3407-3702-4c61-bccb-6795000b80b7" xlink:to="loc_us-gaap_DeferredTaxAssetInterestCarryforward_fa3f1229-eb0a-40c3-b62b-413cb402972d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DeferredTaxAssetsDebtIssuanceCosts_8615a6e5-b144-4131-87f6-3196ebd31b7c" xlink:href="cron-20201231.xsd#cron_DeferredTaxAssetsDebtIssuanceCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_f53a3407-3702-4c61-bccb-6795000b80b7" xlink:to="loc_cron_DeferredTaxAssetsDebtIssuanceCosts_8615a6e5-b144-4131-87f6-3196ebd31b7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DeferredTaxAssetsShareIssuanceCost_67933505-13e3-42ce-b8e9-6233ce83a0dc" xlink:href="cron-20201231.xsd#cron_DeferredTaxAssetsShareIssuanceCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_f53a3407-3702-4c61-bccb-6795000b80b7" xlink:to="loc_cron_DeferredTaxAssetsShareIssuanceCost_67933505-13e3-42ce-b8e9-6233ce83a0dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DeferredTaxAssetsFinanceLeaseLiabilities_0eb389dc-482d-426d-afd6-ad4b919d2d79" xlink:href="cron-20201231.xsd#cron_DeferredTaxAssetsFinanceLeaseLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_f53a3407-3702-4c61-bccb-6795000b80b7" xlink:to="loc_cron_DeferredTaxAssetsFinanceLeaseLiabilities_0eb389dc-482d-426d-afd6-ad4b919d2d79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_2d67d0f0-ed6f-4000-b25a-b97f52f00d66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_f53a3407-3702-4c61-bccb-6795000b80b7" xlink:to="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_2d67d0f0-ed6f-4000-b25a-b97f52f00d66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInvestments_16f4229a-2d46-4871-acb1-97d6d5425988" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_f53a3407-3702-4c61-bccb-6795000b80b7" xlink:to="loc_us-gaap_DeferredTaxAssetsInvestments_16f4229a-2d46-4871-acb1-97d6d5425988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_2909eba5-f584-479e-a86d-181c2c216d2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_f53a3407-3702-4c61-bccb-6795000b80b7" xlink:to="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_2909eba5-f584-479e-a86d-181c2c216d2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_5b9e8884-1df1-4771-a584-79005b8e7046" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_f53a3407-3702-4c61-bccb-6795000b80b7" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_5b9e8884-1df1-4771-a584-79005b8e7046" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_0931051a-bf39-4497-94df-998d94885343" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_f53a3407-3702-4c61-bccb-6795000b80b7" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_0931051a-bf39-4497-94df-998d94885343" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_2c2812be-3bbc-412d-b47b-1ad23e29ee4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_f53a3407-3702-4c61-bccb-6795000b80b7" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_2c2812be-3bbc-412d-b47b-1ad23e29ee4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_408402a6-5caf-45a4-8a60-9f2a78f42510" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_f53a3407-3702-4c61-bccb-6795000b80b7" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_408402a6-5caf-45a4-8a60-9f2a78f42510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_d0d74560-3d2d-4bfa-8e56-89c36f24d64a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_f53a3407-3702-4c61-bccb-6795000b80b7" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_d0d74560-3d2d-4bfa-8e56-89c36f24d64a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_ae7bf36a-9f5e-4fce-8bb9-727a70d014cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_82034431-4f99-423a-8088-9f83a1355d1d" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_ae7bf36a-9f5e-4fce-8bb9-727a70d014cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts_a6b1bad5-8d64-4a05-b7c7-294205a74642" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_ae7bf36a-9f5e-4fce-8bb9-727a70d014cd" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts_a6b1bad5-8d64-4a05-b7c7-294205a74642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_631523a8-2237-4d36-97ab-ddea6841cac1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_ae7bf36a-9f5e-4fce-8bb9-727a70d014cd" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_631523a8-2237-4d36-97ab-ddea6841cac1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_ee7a7d50-e11f-437e-81dd-1ae0c501fc68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_ae7bf36a-9f5e-4fce-8bb9-727a70d014cd" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_ee7a7d50-e11f-437e-81dd-1ae0c501fc68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesInvestments_42522f25-f9d7-48e4-81e5-2977cede5ae4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_ae7bf36a-9f5e-4fce-8bb9-727a70d014cd" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesInvestments_42522f25-f9d7-48e4-81e5-2977cede5ae4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DeferredTaxLiabilitiesLicenses_d9e4d67e-76e0-4314-916e-d5c04aeaa2ad" xlink:href="cron-20201231.xsd#cron_DeferredTaxLiabilitiesLicenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_ae7bf36a-9f5e-4fce-8bb9-727a70d014cd" xlink:to="loc_cron_DeferredTaxLiabilitiesLicenses_d9e4d67e-76e0-4314-916e-d5c04aeaa2ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset_3c7ac96b-8b59-4211-9931-efaab77fea50" xlink:href="cron-20201231.xsd#cron_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_ae7bf36a-9f5e-4fce-8bb9-727a70d014cd" xlink:to="loc_cron_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset_3c7ac96b-8b59-4211-9931-efaab77fea50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_9649ed90-51ef-43d0-bbe1-513e7302a771" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_ae7bf36a-9f5e-4fce-8bb9-727a70d014cd" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_9649ed90-51ef-43d0-bbe1-513e7302a771" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_81d77a85-553d-4e89-ad29-83243177fd6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_ae7bf36a-9f5e-4fce-8bb9-727a70d014cd" xlink:to="loc_us-gaap_DeferredTaxLiabilities_81d77a85-553d-4e89-ad29-83243177fd6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/IncomeTaxesSummaryofValuationAllowanceDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#IncomeTaxesSummaryofValuationAllowanceDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/IncomeTaxesSummaryofValuationAllowanceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_479cff6e-aeb5-4835-8cdf-9d103d45ed7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_40dc52f8-b827-43d9-82f2-daf899ad3850" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_479cff6e-aeb5-4835-8cdf-9d103d45ed7f" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_40dc52f8-b827-43d9-82f2-daf899ad3850" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_9f00fe42-88a9-447b-9ba5-f7e1e44d06d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_40dc52f8-b827-43d9-82f2-daf899ad3850" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_9f00fe42-88a9-447b-9ba5-f7e1e44d06d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_919e3d52-6682-4e26-93a6-62065c7a431a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_9f00fe42-88a9-447b-9ba5-f7e1e44d06d7" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_919e3d52-6682-4e26-93a6-62065c7a431a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_33655e46-7b50-4a5e-946a-3013a217e4db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_919e3d52-6682-4e26-93a6-62065c7a431a" xlink:to="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_33655e46-7b50-4a5e-946a-3013a217e4db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_d73dd25a-2297-459c-9674-18286cff8c1b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_40dc52f8-b827-43d9-82f2-daf899ad3850" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_d73dd25a-2297-459c-9674-18286cff8c1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_cdfaedb5-d35c-4a04-8bfc-8d23a4b1b81f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_d73dd25a-2297-459c-9674-18286cff8c1b" xlink:to="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_cdfaedb5-d35c-4a04-8bfc-8d23a4b1b81f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_16515f40-de9a-4ec0-9ca8-e3936ca5589b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_cdfaedb5-d35c-4a04-8bfc-8d23a4b1b81f" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_16515f40-de9a-4ec0-9ca8-e3936ca5589b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_f07a96f3-9a3b-41d7-87da-999b8d1cd24c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_cdfaedb5-d35c-4a04-8bfc-8d23a4b1b81f" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_f07a96f3-9a3b-41d7-87da-999b8d1cd24c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesAdjustments_a43b27c5-0714-4fa4-96a3-2f5396a687e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesAdjustments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_cdfaedb5-d35c-4a04-8bfc-8d23a4b1b81f" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesAdjustments_a43b27c5-0714-4fa4-96a3-2f5396a687e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_b6effd27-3ad1-416a-b2ca-f3cb9da0d384" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_cdfaedb5-d35c-4a04-8bfc-8d23a4b1b81f" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_b6effd27-3ad1-416a-b2ca-f3cb9da0d384" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/Commitments" xlink:type="simple" xlink:href="cron-20201231.xsd#Commitments"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/Commitments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9cccdd5a-9ad2-4523-9692-cc9398f6452f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsDisclosureTextBlock_41cdb4c7-5db7-4b4f-a94c-330bb48abc4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9cccdd5a-9ad2-4523-9692-cc9398f6452f" xlink:to="loc_us-gaap_CommitmentsDisclosureTextBlock_41cdb4c7-5db7-4b4f-a94c-330bb48abc4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/CommitmentsTables" xlink:type="simple" xlink:href="cron-20201231.xsd#CommitmentsTables"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/CommitmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_895ce6a2-9bed-4e52-8e05-0060a13d8663" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_981fcdb4-7c74-4809-b4e6-da0649b12dde" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_895ce6a2-9bed-4e52-8e05-0060a13d8663" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_981fcdb4-7c74-4809-b4e6-da0649b12dde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/CommitmentsSummaryofFutureMinimumLeasePaymentsUnderOperatingLeasesDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#CommitmentsSummaryofFutureMinimumLeasePaymentsUnderOperatingLeasesDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/CommitmentsSummaryofFutureMinimumLeasePaymentsUnderOperatingLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9745b282-69e9-45c8-9791-e99b8e8d5371" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_f2daa6d7-4bcc-4289-947c-54024ab62ab0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9745b282-69e9-45c8-9791-e99b8e8d5371" xlink:to="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_f2daa6d7-4bcc-4289-947c-54024ab62ab0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_a7e182b3-1b42-455b-be18-d2cd1d42c8e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_f2daa6d7-4bcc-4289-947c-54024ab62ab0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_a7e182b3-1b42-455b-be18-d2cd1d42c8e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_8a982a22-84a7-494b-b5b0-7b22a51e914c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_f2daa6d7-4bcc-4289-947c-54024ab62ab0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_8a982a22-84a7-494b-b5b0-7b22a51e914c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_6915c9f2-9612-4f35-876c-0e2b23020f76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_f2daa6d7-4bcc-4289-947c-54024ab62ab0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_6915c9f2-9612-4f35-876c-0e2b23020f76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_02631760-8fd4-4293-b1ad-0fd5af170d75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_f2daa6d7-4bcc-4289-947c-54024ab62ab0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_02631760-8fd4-4293-b1ad-0fd5af170d75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_6b2f186b-ae4b-4bfc-8771-7ac55c98bab8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_f2daa6d7-4bcc-4289-947c-54024ab62ab0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_6b2f186b-ae4b-4bfc-8771-7ac55c98bab8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_a42b19e0-c7cb-4209-8dc4-a25a34970482" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_f2daa6d7-4bcc-4289-947c-54024ab62ab0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_a42b19e0-c7cb-4209-8dc4-a25a34970482" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/CommitmentsRDCommitmentsDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#CommitmentsRDCommitmentsDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/CommitmentsRDCommitmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4cfb5853-7d92-41ae-84ff-78b7a10b2bd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentTable_4108292b-a93a-4f38-ad8e-a851871598dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermPurchaseCommitmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4cfb5853-7d92-41ae-84ff-78b7a10b2bd8" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentTable_4108292b-a93a-4f38-ad8e-a851871598dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_cf0dabd9-1245-4e55-a9d1-bc6d8e9cc7b1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentTable_4108292b-a93a-4f38-ad8e-a851871598dc" xlink:to="loc_srt_CounterpartyNameAxis_cf0dabd9-1245-4e55-a9d1-bc6d8e9cc7b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4b8bbadb-4fee-4585-a552-49f2cbb016e5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_cf0dabd9-1245-4e55-a9d1-bc6d8e9cc7b1" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4b8bbadb-4fee-4585-a552-49f2cbb016e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_GinkgoBioworksInc.Member_c9790030-e0ae-482d-af0c-758a625a9771" xlink:href="cron-20201231.xsd#cron_GinkgoBioworksInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4b8bbadb-4fee-4585-a552-49f2cbb016e5" xlink:to="loc_cron_GinkgoBioworksInc.Member_c9790030-e0ae-482d-af0c-758a625a9771" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_TechnionResearchAndDevelopmentFoundationMember_d427de6e-35f0-4f6f-8e2b-967da7eeb07d" xlink:href="cron-20201231.xsd#cron_TechnionResearchAndDevelopmentFoundationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4b8bbadb-4fee-4585-a552-49f2cbb016e5" xlink:to="loc_cron_TechnionResearchAndDevelopmentFoundationMember_d427de6e-35f0-4f6f-8e2b-967da7eeb07d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaVenturesInc.Member_47f12e78-904e-4a09-8621-bf70296ea52f" xlink:href="cron-20201231.xsd#cron_AltriaVenturesInc.Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4b8bbadb-4fee-4585-a552-49f2cbb016e5" xlink:to="loc_cron_AltriaVenturesInc.Member_47f12e78-904e-4a09-8621-bf70296ea52f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_7e6f849e-ce24-4420-b599-d116fca883e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentTable_4108292b-a93a-4f38-ad8e-a851871598dc" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_7e6f849e-ce24-4420-b599-d116fca883e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_25b16025-4cd5-453f-900b-3a8ffd0fdf63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis_7e6f849e-ce24-4420-b599-d116fca883e0" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_25b16025-4cd5-453f-900b-3a8ffd0fdf63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementMember_7758aa39-1880-4813-a60d-c5642e7bf544" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_25b16025-4cd5-453f-900b-3a8ffd0fdf63" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementMember_7758aa39-1880-4813-a60d-c5642e7bf544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ConsultingServicesArrangementMember_3d6ebe61-5fe8-41c9-ba14-5685f799224d" xlink:href="cron-20201231.xsd#cron_ConsultingServicesArrangementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain_25b16025-4cd5-453f-900b-3a8ffd0fdf63" xlink:to="loc_cron_ConsultingServicesArrangementMember_3d6ebe61-5fe8-41c9-ba14-5685f799224d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentLineItems_bbdfc112-365e-4595-9168-140263c1be94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermPurchaseCommitmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentTable_4108292b-a93a-4f38-ad8e-a851871598dc" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentLineItems_bbdfc112-365e-4595-9168-140263c1be94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LongTermPurchaseCommitmentNumberOfTargetedUnitsToDevelopProduction_ce2cc190-82e9-4b05-968d-4a6e9d81022c" xlink:href="cron-20201231.xsd#cron_LongTermPurchaseCommitmentNumberOfTargetedUnitsToDevelopProduction"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_bbdfc112-365e-4595-9168-140263c1be94" xlink:to="loc_cron_LongTermPurchaseCommitmentNumberOfTargetedUnitsToDevelopProduction_ce2cc190-82e9-4b05-968d-4a6e9d81022c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableNumberOfShares_956502b6-6136-4835-b542-eede2389a85f" xlink:href="cron-20201231.xsd#cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableNumberOfShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_bbdfc112-365e-4595-9168-140263c1be94" xlink:to="loc_cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableNumberOfShares_956502b6-6136-4835-b542-eede2389a85f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableValueAssigned_3806e8d6-a9f5-4681-a570-e41f396ae0f8" xlink:href="cron-20201231.xsd#cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableValueAssigned"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_bbdfc112-365e-4595-9168-140263c1be94" xlink:to="loc_cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableValueAssigned_3806e8d6-a9f5-4681-a570-e41f396ae0f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LongtermPurchaseCommitmentPaymentsSubjectToMilestones_61462b53-e26d-40ed-a622-84dd8da08094" xlink:href="cron-20201231.xsd#cron_LongtermPurchaseCommitmentPaymentsSubjectToMilestones"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_bbdfc112-365e-4595-9168-140263c1be94" xlink:to="loc_cron_LongtermPurchaseCommitmentPaymentsSubjectToMilestones_61462b53-e26d-40ed-a622-84dd8da08094" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentAmount_471d36d2-3985-4dd3-8575-62b9b80e5fc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermPurchaseCommitmentAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_bbdfc112-365e-4595-9168-140263c1be94" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentAmount_471d36d2-3985-4dd3-8575-62b9b80e5fc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermPurchaseCommitmentPeriod_22878220-9c29-4d03-a8fd-f662be084a9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermPurchaseCommitmentPeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_bbdfc112-365e-4595-9168-140263c1be94" xlink:to="loc_us-gaap_LongtermPurchaseCommitmentPeriod_22878220-9c29-4d03-a8fd-f662be084a9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LongtermPurchaseCommitmentMonthlyFeePercentage_4e608af3-b63a-4ab6-a49c-188f19259bfe" xlink:href="cron-20201231.xsd#cron_LongtermPurchaseCommitmentMonthlyFeePercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentLineItems_bbdfc112-365e-4595-9168-140263c1be94" xlink:to="loc_cron_LongtermPurchaseCommitmentMonthlyFeePercentage_4e608af3-b63a-4ab6-a49c-188f19259bfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/CommitmentsUseofPublicityRightsinBrandDevelopmentDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#CommitmentsUseofPublicityRightsinBrandDevelopmentDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/CommitmentsUseofPublicityRightsinBrandDevelopmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_98d059d2-d7b4-45d4-b1ca-ef632fd75acc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_634e18e7-1628-416e-9134-3acd70449087" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_98d059d2-d7b4-45d4-b1ca-ef632fd75acc" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_634e18e7-1628-416e-9134-3acd70449087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_724381b4-15d8-4b6b-aa59-01fd2d6da8b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_634e18e7-1628-416e-9134-3acd70449087" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_724381b4-15d8-4b6b-aa59-01fd2d6da8b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_44f2f76c-5fab-4705-9e62-1bab8f069f14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_724381b4-15d8-4b6b-aa59-01fd2d6da8b4" xlink:to="loc_us-gaap_EquityComponentDomain_44f2f76c-5fab-4705-9e62-1bab8f069f14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_8c490abf-5f1d-448e-a44c-7f0c3023ef2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_44f2f76c-5fab-4705-9e62-1bab8f069f14" xlink:to="loc_us-gaap_CommonStockMember_8c490abf-5f1d-448e-a44c-7f0c3023ef2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_3bac5513-4122-4d19-b2f8-ebf082b42614" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_634e18e7-1628-416e-9134-3acd70449087" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_3bac5513-4122-4d19-b2f8-ebf082b42614" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3e8e1f54-02fb-4433-bc61-5c99591ccb3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_3bac5513-4122-4d19-b2f8-ebf082b42614" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3e8e1f54-02fb-4433-bc61-5c99591ccb3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember_8b4554d8-a9f4-41e5-92c6-56750d1fb1be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrivatePlacementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3e8e1f54-02fb-4433-bc61-5c99591ccb3c" xlink:to="loc_us-gaap_PrivatePlacementMember_8b4554d8-a9f4-41e5-92c6-56750d1fb1be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SaleOfStockPerformanceMilestoneAxis_0430013e-087d-4c8f-b5ea-d6205b9af0fe" xlink:href="cron-20201231.xsd#cron_SaleOfStockPerformanceMilestoneAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_634e18e7-1628-416e-9134-3acd70449087" xlink:to="loc_cron_SaleOfStockPerformanceMilestoneAxis_0430013e-087d-4c8f-b5ea-d6205b9af0fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SaleOfStockPerformanceMilestoneDomain_185517dd-85a2-43a7-a4e9-2c9f6804156b" xlink:href="cron-20201231.xsd#cron_SaleOfStockPerformanceMilestoneDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_SaleOfStockPerformanceMilestoneAxis_0430013e-087d-4c8f-b5ea-d6205b9af0fe" xlink:to="loc_cron_SaleOfStockPerformanceMilestoneDomain_185517dd-85a2-43a7-a4e9-2c9f6804156b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SaleOfStockPerformanceMilestoneOneMember_43527498-00eb-4a2d-8a88-e7b50e72be09" xlink:href="cron-20201231.xsd#cron_SaleOfStockPerformanceMilestoneOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_SaleOfStockPerformanceMilestoneDomain_185517dd-85a2-43a7-a4e9-2c9f6804156b" xlink:to="loc_cron_SaleOfStockPerformanceMilestoneOneMember_43527498-00eb-4a2d-8a88-e7b50e72be09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SaleOfStockPerformanceMilestoneTwoMember_6f03a8ae-be53-417e-bc5f-ce7e768c5e7b" xlink:href="cron-20201231.xsd#cron_SaleOfStockPerformanceMilestoneTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_SaleOfStockPerformanceMilestoneDomain_185517dd-85a2-43a7-a4e9-2c9f6804156b" xlink:to="loc_cron_SaleOfStockPerformanceMilestoneTwoMember_6f03a8ae-be53-417e-bc5f-ce7e768c5e7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_fc25449b-107c-45ba-b009-b4f5486416de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_634e18e7-1628-416e-9134-3acd70449087" xlink:to="loc_us-gaap_VestingAxis_fc25449b-107c-45ba-b009-b4f5486416de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_ad406d4a-b662-43b6-9040-ed1df8dcc365" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingAxis_fc25449b-107c-45ba-b009-b4f5486416de" xlink:to="loc_us-gaap_VestingDomain_ad406d4a-b662-43b6-9040-ed1df8dcc365" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_447753a9-045a-40b6-a496-243c4ed67012" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_ad406d4a-b662-43b6-9040-ed1df8dcc365" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_447753a9-045a-40b6-a496-243c4ed67012" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_76b10a23-4ba1-42a8-91fe-1adfb2c48362" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_ad406d4a-b662-43b6-9040-ed1df8dcc365" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_76b10a23-4ba1-42a8-91fe-1adfb2c48362" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_51963551-6053-4d4b-ae8c-b103d35a3c8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_ad406d4a-b662-43b6-9040-ed1df8dcc365" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_51963551-6053-4d4b-ae8c-b103d35a3c8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_c4ca8ca9-7f3b-4765-8ee2-a0ed20b31758" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_634e18e7-1628-416e-9134-3acd70449087" xlink:to="loc_srt_StatementScenarioAxis_c4ca8ca9-7f3b-4765-8ee2-a0ed20b31758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_44496839-df7f-4025-9227-fdfdf244a187" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_c4ca8ca9-7f3b-4765-8ee2-a0ed20b31758" xlink:to="loc_srt_ScenarioUnspecifiedDomain_44496839-df7f-4025-9227-fdfdf244a187" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_78ce41f7-5dd6-45c2-8f45-f15cb0c5308d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_44496839-df7f-4025-9227-fdfdf244a187" xlink:to="loc_srt_ScenarioForecastMember_78ce41f7-5dd6-45c2-8f45-f15cb0c5308d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_b663691f-8193-4b12-a95d-fb3cab0f3076" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_634e18e7-1628-416e-9134-3acd70449087" xlink:to="loc_us-gaap_SubsidiarySaleOfStockLineItems_b663691f-8193-4b12-a95d-fb3cab0f3076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_b8f07a38-ed22-4c69-9c33-f94c0ad8f361" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_b663691f-8193-4b12-a95d-fb3cab0f3076" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_b8f07a38-ed22-4c69-9c33-f94c0ad8f361" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_0b594d93-7c7f-46ef-a27b-f490365efadd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_b663691f-8193-4b12-a95d-fb3cab0f3076" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_0b594d93-7c7f-46ef-a27b-f490365efadd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_StockIssuedDuringPeriodNewIssuesFairValue_8fa5649e-c903-42aa-b261-c6981a1e075a" xlink:href="cron-20201231.xsd#cron_StockIssuedDuringPeriodNewIssuesFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_b663691f-8193-4b12-a95d-fb3cab0f3076" xlink:to="loc_cron_StockIssuedDuringPeriodNewIssuesFairValue_8fa5649e-c903-42aa-b261-c6981a1e075a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_StockIssuedDuringPeriodNewIssuesWeightedAveragePricePeriod_113a063f-5ac5-4d5f-a48c-18f0398f1931" xlink:href="cron-20201231.xsd#cron_StockIssuedDuringPeriodNewIssuesWeightedAveragePricePeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_b663691f-8193-4b12-a95d-fb3cab0f3076" xlink:to="loc_cron_StockIssuedDuringPeriodNewIssuesWeightedAveragePricePeriod_113a063f-5ac5-4d5f-a48c-18f0398f1931" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SaleOfStockPerformanceMilestoneTriggeringEventMinimumRevenue_b0edd3ea-4be7-4e37-9555-e6bd7bc172d4" xlink:href="cron-20201231.xsd#cron_SaleOfStockPerformanceMilestoneTriggeringEventMinimumRevenue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_b663691f-8193-4b12-a95d-fb3cab0f3076" xlink:to="loc_cron_SaleOfStockPerformanceMilestoneTriggeringEventMinimumRevenue_b0edd3ea-4be7-4e37-9555-e6bd7bc172d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SaleOfStockPerformanceMilestoneTriggeringEventSharesIssuedValue_13aabc80-3f91-4f10-8b4c-1a63ef02f40a" xlink:href="cron-20201231.xsd#cron_SaleOfStockPerformanceMilestoneTriggeringEventSharesIssuedValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_b663691f-8193-4b12-a95d-fb3cab0f3076" xlink:to="loc_cron_SaleOfStockPerformanceMilestoneTriggeringEventSharesIssuedValue_13aabc80-3f91-4f10-8b4c-1a63ef02f40a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/Contingencies" xlink:type="simple" xlink:href="cron-20201231.xsd#Contingencies"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/Contingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAbstract_53da7c46-a3ba-479b-aa71-37fedc6d703f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDisclosures_937bd30c-8baa-4b5a-92f7-e4cb149698c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyDisclosures"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyAbstract_53da7c46-a3ba-479b-aa71-37fedc6d703f" xlink:to="loc_us-gaap_LossContingencyDisclosures_937bd30c-8baa-4b5a-92f7-e4cb149698c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/ContingenciesDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#ContingenciesDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/ContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAbstract_644c1093-2f56-481f-841a-b4e0ff6516c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_08a4d9f3-2e7d-4a24-a129-e6ef48befbf8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyAbstract_644c1093-2f56-481f-841a-b4e0ff6516c6" xlink:to="loc_us-gaap_LossContingenciesTable_08a4d9f3-2e7d-4a24-a129-e6ef48befbf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_028e8964-7263-4737-bcf7-b75ec9aa4cb1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_08a4d9f3-2e7d-4a24-a129-e6ef48befbf8" xlink:to="loc_srt_LitigationCaseAxis_028e8964-7263-4737-bcf7-b75ec9aa4cb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_21475816-f81f-4269-af8d-10317bf8dc4c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_028e8964-7263-4737-bcf7-b75ec9aa4cb1" xlink:to="loc_srt_LitigationCaseTypeDomain_21475816-f81f-4269-af8d-10317bf8dc4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_U.S.DistrictCourtofEasternDistrictofNewYorkVs.CronosMember_bee7a407-00f1-4c2f-a91f-ac6a973a9f1b" xlink:href="cron-20201231.xsd#cron_U.S.DistrictCourtofEasternDistrictofNewYorkVs.CronosMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_21475816-f81f-4269-af8d-10317bf8dc4c" xlink:to="loc_cron_U.S.DistrictCourtofEasternDistrictofNewYorkVs.CronosMember_bee7a407-00f1-4c2f-a91f-ac6a973a9f1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_9f2d70b6-61b3-4d14-87f5-91d75d534438" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_08a4d9f3-2e7d-4a24-a129-e6ef48befbf8" xlink:to="loc_us-gaap_LitigationStatusAxis_9f2d70b6-61b3-4d14-87f5-91d75d534438" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_bd14993e-49ab-4ca7-9d2b-c77653b4d24c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_9f2d70b6-61b3-4d14-87f5-91d75d534438" xlink:to="loc_us-gaap_LitigationStatusDomain_bd14993e-49ab-4ca7-9d2b-c77653b4d24c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_70bedce1-3720-4fd1-90bc-3872a502fb84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_bd14993e-49ab-4ca7-9d2b-c77653b4d24c" xlink:to="loc_us-gaap_PendingLitigationMember_70bedce1-3720-4fd1-90bc-3872a502fb84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_5dd2dd90-0016-4dbd-bcd9-c5dcf3c0ed01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_08a4d9f3-2e7d-4a24-a129-e6ef48befbf8" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_5dd2dd90-0016-4dbd-bcd9-c5dcf3c0ed01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_f036647b-c4ad-425f-940d-8d56097ba28e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_5dd2dd90-0016-4dbd-bcd9-c5dcf3c0ed01" xlink:to="loc_us-gaap_LossContingencyNatureDomain_f036647b-c4ad-425f-940d-8d56097ba28e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnfavorableRegulatoryActionMember_a0e94abe-a883-4765-8bdf-2162b1e33f44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnfavorableRegulatoryActionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_f036647b-c4ad-425f-940d-8d56097ba28e" xlink:to="loc_us-gaap_UnfavorableRegulatoryActionMember_a0e94abe-a883-4765-8bdf-2162b1e33f44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_c3325419-e3d0-4ae2-946e-0a4cb5f4083f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_08a4d9f3-2e7d-4a24-a129-e6ef48befbf8" xlink:to="loc_us-gaap_LossContingenciesLineItems_c3325419-e3d0-4ae2-946e-0a4cb5f4083f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs_21289699-d17a-4303-95ed-3ffc73e06041" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_c3325419-e3d0-4ae2-946e-0a4cb5f4083f" xlink:to="loc_us-gaap_LossContingencyNumberOfPlaintiffs_21289699-d17a-4303-95ed-3ffc73e06041" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber_caadacc1-233d-468e-b300-2305df0d8308" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_c3325419-e3d0-4ae2-946e-0a4cb5f4083f" xlink:to="loc_us-gaap_LossContingencyNewClaimsFiledNumber_caadacc1-233d-468e-b300-2305df0d8308" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue_ebaf7ceb-f2ba-4490-a63f-ab0977591516" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_c3325419-e3d0-4ae2-946e-0a4cb5f4083f" xlink:to="loc_us-gaap_LossContingencyDamagesSoughtValue_ebaf7ceb-f2ba-4490-a63f-ab0977591516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LossContingencyPunitiveDamagesSoughtValue_04bfae94-6b05-4d45-ac7a-24ffb1b12261" xlink:href="cron-20201231.xsd#cron_LossContingencyPunitiveDamagesSoughtValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_c3325419-e3d0-4ae2-946e-0a4cb5f4083f" xlink:to="loc_cron_LossContingencyPunitiveDamagesSoughtValue_04bfae94-6b05-4d45-ac7a-24ffb1b12261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SupplementaryCashFlowInformation" xlink:type="simple" xlink:href="cron-20201231.xsd#SupplementaryCashFlowInformation"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/SupplementaryCashFlowInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_74f783cb-9dfc-439a-b6ba-aaf252729d7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock_fb36efb5-b4f1-4f5b-9a15-787635f9ceab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_74f783cb-9dfc-439a-b6ba-aaf252729d7f" xlink:to="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock_fb36efb5-b4f1-4f5b-9a15-787635f9ceab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SupplementaryCashFlowInformationTables" xlink:type="simple" xlink:href="cron-20201231.xsd#SupplementaryCashFlowInformationTables"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/SupplementaryCashFlowInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_d79e059b-84d1-4538-9432-f4ffeb574ffc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowOperatingCapitalTableTextBlock_bc37b35e-0702-40b5-bf0a-e28c9cf70339" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowOperatingCapitalTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_d79e059b-84d1-4538-9432-f4ffeb574ffc" xlink:to="loc_us-gaap_CashFlowOperatingCapitalTableTextBlock_bc37b35e-0702-40b5-bf0a-e28c9cf70339" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SupplementaryCashFlowInformationDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#SupplementaryCashFlowInformationDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/SupplementaryCashFlowInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_c6cd6161-57d0-481d-a4c6-7bcc35070809" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b42b3303-dda7-47d7-bc3b-f58db6910ea9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_c6cd6161-57d0-481d-a4c6-7bcc35070809" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b42b3303-dda7-47d7-bc3b-f58db6910ea9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_e374b716-8158-4ece-af87-5f1ca54eea67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b42b3303-dda7-47d7-bc3b-f58db6910ea9" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_e374b716-8158-4ece-af87-5f1ca54eea67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_IncreaseDecreasePrepaidExpensesAndOtherReceivables_42d3cc93-f006-4946-ab51-56f6dcf0a8fe" xlink:href="cron-20201231.xsd#cron_IncreaseDecreasePrepaidExpensesAndOtherReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b42b3303-dda7-47d7-bc3b-f58db6910ea9" xlink:to="loc_cron_IncreaseDecreasePrepaidExpensesAndOtherReceivables_42d3cc93-f006-4946-ab51-56f6dcf0a8fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInFinanceReceivables_efebda1c-f1c1-4e3b-b70a-9e849153ec01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInFinanceReceivables"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b42b3303-dda7-47d7-bc3b-f58db6910ea9" xlink:to="loc_us-gaap_IncreaseDecreaseInFinanceReceivables_efebda1c-f1c1-4e3b-b70a-9e849153ec01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_57c9007b-f805-4780-95df-aea21d49b166" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b42b3303-dda7-47d7-bc3b-f58db6910ea9" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_57c9007b-f805-4780-95df-aea21d49b166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_0fdf269c-55fa-451e-bf85-e66e67037f68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b42b3303-dda7-47d7-bc3b-f58db6910ea9" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_0fdf269c-55fa-451e-bf85-e66e67037f68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapital_b3ce022d-20fd-4b6c-acd7-4b1addffac5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapital"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b42b3303-dda7-47d7-bc3b-f58db6910ea9" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapital_b3ce022d-20fd-4b6c-acd7-4b1addffac5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/FinancialInstruments" xlink:type="simple" xlink:href="cron-20201231.xsd#FinancialInstruments"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/FinancialInstruments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract_4dade5de-dee4-49fd-bdde-789a987ca66d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskDisclosureTextBlock_25aec7ee-3141-4340-8ad1-8c248a1a5281" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract_4dade5de-dee4-49fd-bdde-789a987ca66d" xlink:to="loc_us-gaap_ConcentrationRiskDisclosureTextBlock_25aec7ee-3141-4340-8ad1-8c248a1a5281" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#FinancialInstrumentsCreditRiskNarrativeDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract_fbe9d58f-1bc3-414a-b76c-65d70da56a2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_c8454a32-a74c-403b-b64b-9ca4131e5687" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract_fbe9d58f-1bc3-414a-b76c-65d70da56a2f" xlink:to="loc_us-gaap_ConcentrationRiskTable_c8454a32-a74c-403b-b64b-9ca4131e5687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_efa1615c-199f-4ffe-8f2d-9ea754c81ddc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_c8454a32-a74c-403b-b64b-9ca4131e5687" xlink:to="loc_srt_MajorCustomersAxis_efa1615c-199f-4ffe-8f2d-9ea754c81ddc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_8ad83972-4326-47d3-9767-c85a53660f5c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_efa1615c-199f-4ffe-8f2d-9ea754c81ddc" xlink:to="loc_srt_NameOfMajorCustomerDomain_8ad83972-4326-47d3-9767-c85a53660f5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FourCustomersMember_84215a8c-6d7f-45b6-9381-cc0a7b4655ec" xlink:href="cron-20201231.xsd#cron_FourCustomersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_8ad83972-4326-47d3-9767-c85a53660f5c" xlink:to="loc_cron_FourCustomersMember_84215a8c-6d7f-45b6-9381-cc0a7b4655ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_TwoMajorCustomersMember_05487f55-c7f9-441c-b7ea-f5718ae370f9" xlink:href="cron-20201231.xsd#cron_TwoMajorCustomersMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_8ad83972-4326-47d3-9767-c85a53660f5c" xlink:to="loc_cron_TwoMajorCustomersMember_05487f55-c7f9-441c-b7ea-f5718ae370f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_8a2da189-2845-49bd-a13a-445d0ad84dd7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_c8454a32-a74c-403b-b64b-9ca4131e5687" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_8a2da189-2845-49bd-a13a-445d0ad84dd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_65edd823-b1a7-4787-93d8-c17c241e13f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_8a2da189-2845-49bd-a13a-445d0ad84dd7" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_65edd823-b1a7-4787-93d8-c17c241e13f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_36c54545-48d8-412c-87d7-b11dfe30cae0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_65edd823-b1a7-4787-93d8-c17c241e13f4" xlink:to="loc_us-gaap_AccountsReceivableMember_36c54545-48d8-412c-87d7-b11dfe30cae0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_928e1312-8809-49c2-b26e-91beb4cc5ee3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_c8454a32-a74c-403b-b64b-9ca4131e5687" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_928e1312-8809-49c2-b26e-91beb4cc5ee3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_b4b9014a-a581-497d-9d91-b445650565b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_928e1312-8809-49c2-b26e-91beb4cc5ee3" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_b4b9014a-a581-497d-9d91-b445650565b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditConcentrationRiskMember_4c48928b-5519-436b-9d46-2d85da2bbe1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_b4b9014a-a581-497d-9d91-b445650565b0" xlink:to="loc_us-gaap_CreditConcentrationRiskMember_4c48928b-5519-436b-9d46-2d85da2bbe1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_d2c61b10-5c65-441f-9b5b-4b4922e5872d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_c8454a32-a74c-403b-b64b-9ca4131e5687" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_d2c61b10-5c65-441f-9b5b-4b4922e5872d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure_c4de7993-3699-41cc-affd-217a7d5d42a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_d2c61b10-5c65-441f-9b5b-4b4922e5872d" xlink:to="loc_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure_c4de7993-3699-41cc-affd-217a7d5d42a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_80ba64c3-7bb5-43d0-a98c-fa8c3ea5f561" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_d2c61b10-5c65-441f-9b5b-4b4922e5872d" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_80ba64c3-7bb5-43d0-a98c-fa8c3ea5f561" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff_44652ec1-25c5-4a88-941e-d1436bdeda5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_d2c61b10-5c65-441f-9b5b-4b4922e5872d" xlink:to="loc_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff_44652ec1-25c5-4a88-941e-d1436bdeda5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_7e127139-dc00-4dcf-94d1-54295c576b09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_d2c61b10-5c65-441f-9b5b-4b4922e5872d" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_7e127139-dc00-4dcf-94d1-54295c576b09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_d306fe5d-6482-482b-b2e3-1103f5ce761f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_d2c61b10-5c65-441f-9b5b-4b4922e5872d" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_d306fe5d-6482-482b-b2e3-1103f5ce761f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3fc3bf4a-c59b-437e-b0f8-59ecc2f1985c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_d2c61b10-5c65-441f-9b5b-4b4922e5872d" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3fc3bf4a-c59b-437e-b0f8-59ecc2f1985c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_0b36d380-89a3-46ab-a001-974d2c31aa89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_d2c61b10-5c65-441f-9b5b-4b4922e5872d" xlink:to="loc_us-gaap_ShortTermInvestments_0b36d380-89a3-46ab-a001-974d2c31aa89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvancesToAffiliate_3668f1a6-22c6-40cf-8f56-56342af673e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdvancesToAffiliate"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_d2c61b10-5c65-441f-9b5b-4b4922e5872d" xlink:to="loc_us-gaap_AdvancesToAffiliate_3668f1a6-22c6-40cf-8f56-56342af673e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AdvancesToAffiliateAllowanceForCreditLoss_7370d2d8-f5d2-497d-a07c-3028aa84f096" xlink:href="cron-20201231.xsd#cron_AdvancesToAffiliateAllowanceForCreditLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_d2c61b10-5c65-441f-9b5b-4b4922e5872d" xlink:to="loc_cron_AdvancesToAffiliateAllowanceForCreditLoss_7370d2d8-f5d2-497d-a07c-3028aa84f096" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskNarrativeDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#FinancialInstrumentsLiquidityRiskNarrativeDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract_856a0557-8b77-4a46-addb-065b1c50ae9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_08ab12b5-16c5-44ba-bd56-142b6373cfb3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract_856a0557-8b77-4a46-addb-065b1c50ae9b" xlink:to="loc_us-gaap_ConcentrationRiskTable_08ab12b5-16c5-44ba-bd56-142b6373cfb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_734e86c5-c6b1-4fc5-a583-04e4da16d65b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_08ab12b5-16c5-44ba-bd56-142b6373cfb3" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_734e86c5-c6b1-4fc5-a583-04e4da16d65b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_fd4ec720-f052-41f1-b54f-d98b6d3e304d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_734e86c5-c6b1-4fc5-a583-04e4da16d65b" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_fd4ec720-f052-41f1-b54f-d98b6d3e304d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableMember_fe7c8c48-d198-4213-8073-ce3dcf9121c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_fd4ec720-f052-41f1-b54f-d98b6d3e304d" xlink:to="loc_us-gaap_AccountsPayableMember_fe7c8c48-d198-4213-8073-ce3dcf9121c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_b0778ed8-938d-4c7d-a80f-dd7d9ba1feba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_08ab12b5-16c5-44ba-bd56-142b6373cfb3" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_b0778ed8-938d-4c7d-a80f-dd7d9ba1feba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_c4739860-f8e9-4dc3-a9f8-723a338ad739" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_b0778ed8-938d-4c7d-a80f-dd7d9ba1feba" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_c4739860-f8e9-4dc3-a9f8-723a338ad739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierConcentrationRiskMember_a4ab37a2-68e7-45d5-8e90-818bcb0c77f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplierConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_c4739860-f8e9-4dc3-a9f8-723a338ad739" xlink:to="loc_us-gaap_SupplierConcentrationRiskMember_a4ab37a2-68e7-45d5-8e90-818bcb0c77f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_cf9d1306-b91d-4cd2-99cc-8968825e54c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_08ab12b5-16c5-44ba-bd56-142b6373cfb3" xlink:to="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_cf9d1306-b91d-4cd2-99cc-8968825e54c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_e11880f4-e00a-43a4-9ce3-0595af0ea278" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_cf9d1306-b91d-4cd2-99cc-8968825e54c9" xlink:to="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_e11880f4-e00a-43a4-9ce3-0595af0ea278" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FourVendorsMember_55c8bbcd-2ef1-4090-a08d-0c94130161a1" xlink:href="cron-20201231.xsd#cron_FourVendorsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_e11880f4-e00a-43a4-9ce3-0595af0ea278" xlink:to="loc_cron_FourVendorsMember_55c8bbcd-2ef1-4090-a08d-0c94130161a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ThreeVendorsMember_8643384e-203d-46a9-b02a-26f7d4224ccf" xlink:href="cron-20201231.xsd#cron_ThreeVendorsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_e11880f4-e00a-43a4-9ce3-0595af0ea278" xlink:to="loc_cron_ThreeVendorsMember_8643384e-203d-46a9-b02a-26f7d4224ccf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_77d7e5e2-9728-4135-b568-14b4ba32b39c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_08ab12b5-16c5-44ba-bd56-142b6373cfb3" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_77d7e5e2-9728-4135-b568-14b4ba32b39c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_09c18c4a-ccd9-4df6-bc06-ea1496776cb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_77d7e5e2-9728-4135-b568-14b4ba32b39c" xlink:to="loc_us-gaap_AccountsPayableCurrent_09c18c4a-ccd9-4df6-bc06-ea1496776cb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_3464e2be-bd20-4960-a30a-2e77df9c12e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_77d7e5e2-9728-4135-b568-14b4ba32b39c" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_3464e2be-bd20-4960-a30a-2e77df9c12e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/FinancialInstrumentsInterestRateRiskDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#FinancialInstrumentsInterestRateRiskDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/FinancialInstrumentsInterestRateRiskDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_e9d09df3-d33d-4ea0-a73a-3fa10af784eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_a0f8a6b0-163f-477e-91b7-f17acc006de2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_e9d09df3-d33d-4ea0-a73a-3fa10af784eb" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_a0f8a6b0-163f-477e-91b7-f17acc006de2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncomePercent_8dd5a78d-f7f9-4600-803f-798bf488b79d" xlink:href="cron-20201231.xsd#cron_SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncomePercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_e9d09df3-d33d-4ea0-a73a-3fa10af784eb" xlink:to="loc_cron_SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncomePercent_8dd5a78d-f7f9-4600-803f-798bf488b79d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncome_53027792-79a5-487c-b2b1-855a42741ede" xlink:href="cron-20201231.xsd#cron_SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_e9d09df3-d33d-4ea0-a73a-3fa10af784eb" xlink:to="loc_cron_SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncome_53027792-79a5-487c-b2b1-855a42741ede" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/FinancialInstrumentsCurrencyRateRiskNarrativeDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#FinancialInstrumentsCurrencyRateRiskNarrativeDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/FinancialInstrumentsCurrencyRateRiskNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract_d7586e0b-802f-4a90-9a76-5f60b8de00b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_7f88d458-d48f-4a2b-ac62-14b963f21e1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract_d7586e0b-802f-4a90-9a76-5f60b8de00b3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_7f88d458-d48f-4a2b-ac62-14b963f21e1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate_2106e148-5b98-4d8a-91b8-e3f038b1a87a" xlink:href="cron-20201231.xsd#cron_SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract_d7586e0b-802f-4a90-9a76-5f60b8de00b3" xlink:to="loc_cron_SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate_2106e148-5b98-4d8a-91b8-e3f038b1a87a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/FairValueMeasurement" xlink:type="simple" xlink:href="cron-20201231.xsd#FairValueMeasurement"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/FairValueMeasurement" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_e661c0e3-ff53-4ba1-9828-f3b3bda89411" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_55229156-f2e0-4f49-b1e5-e271fc168e51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_e661c0e3-ff53-4ba1-9828-f3b3bda89411" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_55229156-f2e0-4f49-b1e5-e271fc168e51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/FairValueMeasuresandDisclosuresTables" xlink:type="simple" xlink:href="cron-20201231.xsd#FairValueMeasuresandDisclosuresTables"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/FairValueMeasuresandDisclosuresTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_25a1318a-42df-4caf-9f58-f744fe8d0f4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_0645a200-d226-4a5c-aa31-37bff6349979" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_25a1318a-42df-4caf-9f58-f744fe8d0f4e" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_0645a200-d226-4a5c-aa31-37bff6349979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/FairValueMeasurementDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#FairValueMeasurementDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/FairValueMeasurementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_160836aa-7a79-40a5-98b6-a71fe9212a72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_cc30a309-7ac2-49f5-8896-2fa293621fbb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_160836aa-7a79-40a5-98b6-a71fe9212a72" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_cc30a309-7ac2-49f5-8896-2fa293621fbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_4d700092-1666-4ebb-b449-a0a04c7499b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_cc30a309-7ac2-49f5-8896-2fa293621fbb" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_4d700092-1666-4ebb-b449-a0a04c7499b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_f261091f-2ee1-4295-a205-21b1d9a7f1dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_4d700092-1666-4ebb-b449-a0a04c7499b6" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_f261091f-2ee1-4295-a205-21b1d9a7f1dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_71fb0651-db01-476e-a2ba-4676b01ad527" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_f261091f-2ee1-4295-a205-21b1d9a7f1dc" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_71fb0651-db01-476e-a2ba-4676b01ad527" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1ab15296-3f17-48e3-89da-ab0ede405e78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_cc30a309-7ac2-49f5-8896-2fa293621fbb" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1ab15296-3f17-48e3-89da-ab0ede405e78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8da1701d-757d-41ed-bb59-bc333c368331" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1ab15296-3f17-48e3-89da-ab0ede405e78" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8da1701d-757d-41ed-bb59-bc333c368331" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_456286b2-ed28-4b12-8eeb-e5772128bd7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8da1701d-757d-41ed-bb59-bc333c368331" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_456286b2-ed28-4b12-8eeb-e5772128bd7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_8d3c19d9-cdd3-4c6b-8009-9c9e63b82411" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8da1701d-757d-41ed-bb59-bc333c368331" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_8d3c19d9-cdd3-4c6b-8009-9c9e63b82411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_89c2f89b-da85-4790-8c86-75ef90f3fa80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8da1701d-757d-41ed-bb59-bc333c368331" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_89c2f89b-da85-4790-8c86-75ef90f3fa80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_19a7bdda-7ac4-43e4-a36d-6c14a4702cb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_cc30a309-7ac2-49f5-8896-2fa293621fbb" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_19a7bdda-7ac4-43e4-a36d-6c14a4702cb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_18a52d69-8c42-4c79-b976-ef830b9fbe5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_19a7bdda-7ac4-43e4-a36d-6c14a4702cb8" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_18a52d69-8c42-4c79-b976-ef830b9fbe5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_033275fd-2b4f-42b6-98da-16792b4f2979" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_19a7bdda-7ac4-43e4-a36d-6c14a4702cb8" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_033275fd-2b4f-42b6-98da-16792b4f2979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_c4e5dc6b-1998-4b4e-9fea-b143254477bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_19a7bdda-7ac4-43e4-a36d-6c14a4702cb8" xlink:to="loc_us-gaap_DerivativeLiabilities_c4e5dc6b-1998-4b4e-9fea-b143254477bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/RelatedPartyTransactionsandBalances" xlink:type="simple" xlink:href="cron-20201231.xsd#RelatedPartyTransactionsandBalances"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/RelatedPartyTransactionsandBalances" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_5a4feff6-2214-4c2d-be2d-16c5f2dda3c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_1e32489c-acfd-47cf-9342-74ed9fcf33aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_5a4feff6-2214-4c2d-be2d-16c5f2dda3c2" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_1e32489c-acfd-47cf-9342-74ed9fcf33aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/RelatedPartyDisclosuresTables" xlink:type="simple" xlink:href="cron-20201231.xsd#RelatedPartyDisclosuresTables"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/RelatedPartyDisclosuresTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_424ab2bf-0b5a-4159-86e0-589c22cf3146" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_d2c93403-543b-488f-8d66-04b68a63ff0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_424ab2bf-0b5a-4159-86e0-589c22cf3146" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_d2c93403-543b-488f-8d66-04b68a63ff0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesNarrativeDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#RelatedPartyTransactionsandBalancesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_b6740d0b-4522-42fd-bd1d-96f769c520ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_6c9fd8a6-5b3a-40a6-891b-18f4abc5683c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_b6740d0b-4522-42fd-bd1d-96f769c520ae" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_6c9fd8a6-5b3a-40a6-891b-18f4abc5683c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d3b44b85-95c1-470c-be39-0883095b4dce" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_6c9fd8a6-5b3a-40a6-891b-18f4abc5683c" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d3b44b85-95c1-470c-be39-0883095b4dce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_ddb5372c-124f-40c3-b704-65cf13cb9f62" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d3b44b85-95c1-470c-be39-0883095b4dce" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_ddb5372c-124f-40c3-b704-65cf13cb9f62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosGroupInc.Member_ca862c77-3007-480c-aa82-f4cacdbbd5af" xlink:href="cron-20201231.xsd#cron_CronosGroupInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_ddb5372c-124f-40c3-b704-65cf13cb9f62" xlink:to="loc_cron_CronosGroupInc.Member_ca862c77-3007-480c-aa82-f4cacdbbd5af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_8504caa4-b87e-4fe8-adc4-4273f9990fa3" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_6c9fd8a6-5b3a-40a6-891b-18f4abc5683c" xlink:to="loc_dei_LegalEntityAxis_8504caa4-b87e-4fe8-adc4-4273f9990fa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_1394a13c-e71d-4e4f-aa31-c9ccb17aba73" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_8504caa4-b87e-4fe8-adc4-4273f9990fa3" xlink:to="loc_dei_EntityDomain_1394a13c-e71d-4e4f-aa31-c9ccb17aba73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaGroupInc.Member_0139e618-0eba-4fca-b9ce-b8210aaf36c1" xlink:href="cron-20201231.xsd#cron_AltriaGroupInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_1394a13c-e71d-4e4f-aa31-c9ccb17aba73" xlink:to="loc_cron_AltriaGroupInc.Member_0139e618-0eba-4fca-b9ce-b8210aaf36c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_353d8995-3434-4f3b-8396-c3ad2c173e45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_6c9fd8a6-5b3a-40a6-891b-18f4abc5683c" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_353d8995-3434-4f3b-8396-c3ad2c173e45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_271ac26a-1ce3-47b2-8656-825eddd12976" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_353d8995-3434-4f3b-8396-c3ad2c173e45" xlink:to="loc_us-gaap_RelatedPartyDomain_271ac26a-1ce3-47b2-8656-825eddd12976" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_7add8e60-2126-4c4a-bd25-cfccb70a8e0c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AffiliatedEntityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_271ac26a-1ce3-47b2-8656-825eddd12976" xlink:to="loc_srt_AffiliatedEntityMember_7add8e60-2126-4c4a-bd25-cfccb70a8e0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_44fc6f85-339e-40ab-8bb6-31fc82ef2be7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_6c9fd8a6-5b3a-40a6-891b-18f4abc5683c" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_44fc6f85-339e-40ab-8bb6-31fc82ef2be7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_068daa96-c34e-4187-863f-f920779695c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_44fc6f85-339e-40ab-8bb6-31fc82ef2be7" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_068daa96-c34e-4187-863f-f920779695c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PurchaseOfMachineryAndEquipmentMember_4cdbd23a-24f2-485f-8ff1-e9bcc60454d1" xlink:href="cron-20201231.xsd#cron_PurchaseOfMachineryAndEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_068daa96-c34e-4187-863f-f920779695c8" xlink:to="loc_cron_PurchaseOfMachineryAndEquipmentMember_4cdbd23a-24f2-485f-8ff1-e9bcc60454d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ConsultingServicesMember_52db065b-4348-4930-b9c4-8b0562267f35" xlink:href="cron-20201231.xsd#cron_ConsultingServicesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_068daa96-c34e-4187-863f-f920779695c8" xlink:to="loc_cron_ConsultingServicesMember_52db065b-4348-4930-b9c4-8b0562267f35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_7c106205-d398-4109-9974-03bde79d3be2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_6c9fd8a6-5b3a-40a6-891b-18f4abc5683c" xlink:to="loc_srt_CounterpartyNameAxis_7c106205-d398-4109-9974-03bde79d3be2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b339bd80-c1d9-4629-bf0b-b60fb07e182a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_7c106205-d398-4109-9974-03bde79d3be2" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b339bd80-c1d9-4629-bf0b-b60fb07e182a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaGroupInc.Member_0e4bbf56-fb92-493c-9854-5707235c156f" xlink:href="cron-20201231.xsd#cron_AltriaGroupInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b339bd80-c1d9-4629-bf0b-b60fb07e182a" xlink:to="loc_cron_AltriaGroupInc.Member_0e4bbf56-fb92-493c-9854-5707235c156f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaPinnacleLLC.Member_021d41a6-8897-4cf1-a246-0b42ff7987c4" xlink:href="cron-20201231.xsd#cron_AltriaPinnacleLLC.Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b339bd80-c1d9-4629-bf0b-b60fb07e182a" xlink:to="loc_cron_AltriaPinnacleLLC.Member_021d41a6-8897-4cf1-a246-0b42ff7987c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_d2d65f96-5057-4f05-b33b-10682e5b173a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_6c9fd8a6-5b3a-40a6-891b-18f4abc5683c" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_d2d65f96-5057-4f05-b33b-10682e5b173a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_74ce12bf-58bc-4279-b85d-de289529fa41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_d2d65f96-5057-4f05-b33b-10682e5b173a" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_74ce12bf-58bc-4279-b85d-de289529fa41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_79effd63-ae06-4c67-a158-f6c11034f86d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_d2d65f96-5057-4f05-b33b-10682e5b173a" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_79effd63-ae06-4c67-a158-f6c11034f86d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_f069974b-e59a-4cfb-9e37-07ba7e8ed15a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_d2d65f96-5057-4f05-b33b-10682e5b173a" xlink:to="loc_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_f069974b-e59a-4cfb-9e37-07ba7e8ed15a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesScheduleofRelatedPartyTransactionsDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#RelatedPartyTransactionsandBalancesScheduleofRelatedPartyTransactionsDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesScheduleofRelatedPartyTransactionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_5a2d5bb2-5fc5-41e3-9154-35d27982db87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_953bff14-a766-423f-8ef3-2738a1cc7f2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_5a2d5bb2-5fc5-41e3-9154-35d27982db87" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_953bff14-a766-423f-8ef3-2738a1cc7f2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_b57d64ab-8f79-4dc1-b37d-3842da1a4892" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_953bff14-a766-423f-8ef3-2738a1cc7f2a" xlink:to="loc_srt_CounterpartyNameAxis_b57d64ab-8f79-4dc1-b37d-3842da1a4892" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_13819504-9afc-4859-a0ef-468d367abda4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_b57d64ab-8f79-4dc1-b37d-3842da1a4892" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_13819504-9afc-4859-a0ef-468d367abda4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaPinnacleLLC.Member_572e0c33-b6c8-492a-8b7d-94e3e7ef921b" xlink:href="cron-20201231.xsd#cron_AltriaPinnacleLLC.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_13819504-9afc-4859-a0ef-468d367abda4" xlink:to="loc_cron_AltriaPinnacleLLC.Member_572e0c33-b6c8-492a-8b7d-94e3e7ef921b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_b6f2ce4a-0e22-4faf-bdca-e3de9ee61ee9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_953bff14-a766-423f-8ef3-2738a1cc7f2a" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_b6f2ce4a-0e22-4faf-bdca-e3de9ee61ee9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_2b8a3f83-d2f9-4b52-80b2-8b4f9605d5e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_b6f2ce4a-0e22-4faf-bdca-e3de9ee61ee9" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_2b8a3f83-d2f9-4b52-80b2-8b4f9605d5e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ConsultingServicesMember_5527d2ae-04a9-4a6e-a192-7998cf9e9e39" xlink:href="cron-20201231.xsd#cron_ConsultingServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_2b8a3f83-d2f9-4b52-80b2-8b4f9605d5e0" xlink:to="loc_cron_ConsultingServicesMember_5527d2ae-04a9-4a6e-a192-7998cf9e9e39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_a8e78413-f651-4db1-ba65-16ccff60654e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_953bff14-a766-423f-8ef3-2738a1cc7f2a" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_a8e78413-f651-4db1-ba65-16ccff60654e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_2623ccc2-5ff0-477f-864d-1be7008dad00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_a8e78413-f651-4db1-ba65-16ccff60654e" xlink:to="loc_us-gaap_RelatedPartyDomain_2623ccc2-5ff0-477f-864d-1be7008dad00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_590d49a6-b0ee-464c-9559-7b565f53274c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AffiliatedEntityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_2623ccc2-5ff0-477f-864d-1be7008dad00" xlink:to="loc_srt_AffiliatedEntityMember_590d49a6-b0ee-464c-9559-7b565f53274c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_816ea0a2-b2f1-48d5-8577-167a89103ba6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_953bff14-a766-423f-8ef3-2738a1cc7f2a" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_816ea0a2-b2f1-48d5-8577-167a89103ba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_7bdb1922-fc57-457e-a469-64b559ba1e17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_816ea0a2-b2f1-48d5-8577-167a89103ba6" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_7bdb1922-fc57-457e-a469-64b559ba1e17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableRelatedPartiesCurrent_deb6a0f4-b66f-42fa-9c24-d152a37e0ee8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_816ea0a2-b2f1-48d5-8577-167a89103ba6" xlink:to="loc_us-gaap_AccountsPayableRelatedPartiesCurrent_deb6a0f4-b66f-42fa-9c24-d152a37e0ee8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/NonmonetaryTransactions" xlink:type="simple" xlink:href="cron-20201231.xsd#NonmonetaryTransactions"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/NonmonetaryTransactions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonmonetaryTransactionsAbstract_f6d1b6c1-3078-43fb-aea1-5de685bbc7aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonmonetaryTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonmonetaryTransactionsDisclosureTextBlock_74792f33-a5f2-4dee-883b-04f091aa842d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonmonetaryTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonmonetaryTransactionsAbstract_f6d1b6c1-3078-43fb-aea1-5de685bbc7aa" xlink:to="loc_us-gaap_NonmonetaryTransactionsDisclosureTextBlock_74792f33-a5f2-4dee-883b-04f091aa842d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/NonmonetaryTransactionsDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#NonmonetaryTransactionsDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/NonmonetaryTransactionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonmonetaryTransactionsAbstract_a79265d1-bdf4-460d-b3fe-430da2fa6da3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonmonetaryTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonmonetaryTransactionByTypeTable_8e2ba767-b75f-4bfa-9567-70bb333e2c81" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonmonetaryTransactionByTypeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonmonetaryTransactionsAbstract_a79265d1-bdf4-460d-b3fe-430da2fa6da3" xlink:to="loc_us-gaap_NonmonetaryTransactionByTypeTable_8e2ba767-b75f-4bfa-9567-70bb333e2c81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonmonetaryTransactionTypeAxis_4c241b48-39e9-4a13-b9a9-6aa9d93a50bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonmonetaryTransactionTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonmonetaryTransactionByTypeTable_8e2ba767-b75f-4bfa-9567-70bb333e2c81" xlink:to="loc_us-gaap_NonmonetaryTransactionTypeAxis_4c241b48-39e9-4a13-b9a9-6aa9d93a50bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonmonetaryTransactionTypeDomain_ed19e82c-d98e-4aae-b346-2120e1876eb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonmonetaryTransactionTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonmonetaryTransactionTypeAxis_4c241b48-39e9-4a13-b9a9-6aa9d93a50bd" xlink:to="loc_us-gaap_NonmonetaryTransactionTypeDomain_ed19e82c-d98e-4aae-b346-2120e1876eb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExchangeOfProductHeldForSaleForSimilarProductMember_9b273ed5-3a07-4ec9-aa58-e21f7da5d06f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExchangeOfProductHeldForSaleForSimilarProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonmonetaryTransactionTypeDomain_ed19e82c-d98e-4aae-b346-2120e1876eb2" xlink:to="loc_us-gaap_ExchangeOfProductHeldForSaleForSimilarProductMember_9b273ed5-3a07-4ec9-aa58-e21f7da5d06f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonmonetaryTransactionLineItems_b61d8847-1a13-4af5-bb26-21512d0284bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonmonetaryTransactionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonmonetaryTransactionByTypeTable_8e2ba767-b75f-4bfa-9567-70bb333e2c81" xlink:to="loc_us-gaap_NonmonetaryTransactionLineItems_b61d8847-1a13-4af5-bb26-21512d0284bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NonmonetaryTransactionNumberOfTransactions_c77a0c72-2f17-458d-864a-8786b44a15c9" xlink:href="cron-20201231.xsd#cron_NonmonetaryTransactionNumberOfTransactions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonmonetaryTransactionLineItems_b61d8847-1a13-4af5-bb26-21512d0284bf" xlink:to="loc_cron_NonmonetaryTransactionNumberOfTransactions_c77a0c72-2f17-458d-864a-8786b44a15c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonmonetaryTransactionGrossOperatingRevenueRecognized_dbb85ec4-0ecd-4c7a-8618-688e2c61b25d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonmonetaryTransactionGrossOperatingRevenueRecognized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonmonetaryTransactionLineItems_b61d8847-1a13-4af5-bb26-21512d0284bf" xlink:to="loc_us-gaap_NonmonetaryTransactionGrossOperatingRevenueRecognized_dbb85ec4-0ecd-4c7a-8618-688e2c61b25d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonmonetaryTransactionGainLossRecognizedOnTransfer_2cf58a34-0396-4b28-ad25-c916bfffcb30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonmonetaryTransactionGainLossRecognizedOnTransfer"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonmonetaryTransactionLineItems_b61d8847-1a13-4af5-bb26-21512d0284bf" xlink:to="loc_us-gaap_NonmonetaryTransactionGainLossRecognizedOnTransfer_2cf58a34-0396-4b28-ad25-c916bfffcb30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/BusinessCombinations" xlink:type="simple" xlink:href="cron-20201231.xsd#BusinessCombinations"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/BusinessCombinations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_c4d0d33d-9ad1-4c5d-834b-8aeea592af66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_3e050ddf-ad1d-4390-bbde-99b92b84280a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_c4d0d33d-9ad1-4c5d-834b-8aeea592af66" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_3e050ddf-ad1d-4390-bbde-99b92b84280a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/BusinessCombinationsTables" xlink:type="simple" xlink:href="cron-20201231.xsd#BusinessCombinationsTables"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/BusinessCombinationsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_28934364-4a40-4e96-befb-1ea120cfbe7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_2fc7c1de-0a58-49ec-bf89-8f67890fd735" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_28934364-4a40-4e96-befb-1ea120cfbe7f" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_2fc7c1de-0a58-49ec-bf89-8f67890fd735" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/BusinessCombinationsNarrativeDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#BusinessCombinationsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/BusinessCombinationsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_1a4dd21f-c06b-40fa-9150-e0112930b90b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_6ee874bc-a5da-476b-bf33-07d40a59e6cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_1a4dd21f-c06b-40fa-9150-e0112930b90b" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_6ee874bc-a5da-476b-bf33-07d40a59e6cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_92c92a39-632f-430c-ae0d-b15165f12059" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_6ee874bc-a5da-476b-bf33-07d40a59e6cd" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_92c92a39-632f-430c-ae0d-b15165f12059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d821dde7-e2db-4ce0-9a6c-1df3a2e0ed64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_92c92a39-632f-430c-ae0d-b15165f12059" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d821dde7-e2db-4ce0-9a6c-1df3a2e0ed64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_RedwoodHoldingGroupLLCMember_ed878155-a585-4784-ba03-96a04f72755d" xlink:href="cron-20201231.xsd#cron_RedwoodHoldingGroupLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d821dde7-e2db-4ce0-9a6c-1df3a2e0ed64" xlink:to="loc_cron_RedwoodHoldingGroupLLCMember_ed878155-a585-4784-ba03-96a04f72755d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_887bf4a4-b608-422b-b9a5-3d7a32025169" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_6ee874bc-a5da-476b-bf33-07d40a59e6cd" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_887bf4a4-b608-422b-b9a5-3d7a32025169" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfBusinessesAcquired_9311c770-2455-46c3-adc3-7724819b38ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfBusinessesAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_887bf4a4-b608-422b-b9a5-3d7a32025169" xlink:to="loc_us-gaap_NumberOfBusinessesAcquired_9311c770-2455-46c3-adc3-7724819b38ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_e3d09176-7247-4f19-9f02-5a16ba729cb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_887bf4a4-b608-422b-b9a5-3d7a32025169" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_e3d09176-7247-4f19-9f02-5a16ba729cb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_207487ea-53cd-4688-86ed-2c7f83ba6285" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_887bf4a4-b608-422b-b9a5-3d7a32025169" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_207487ea-53cd-4688-86ed-2c7f83ba6285" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_aade64b8-ad55-484b-bd9c-0e6ca82520c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_887bf4a4-b608-422b-b9a5-3d7a32025169" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_aade64b8-ad55-484b-bd9c-0e6ca82520c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_7ceccde1-22b4-44f0-a180-a2bfaffd9665" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_887bf4a4-b608-422b-b9a5-3d7a32025169" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_7ceccde1-22b4-44f0-a180-a2bfaffd9665" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_5c9724da-5106-4b55-a7b3-9c5a394d345e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_887bf4a4-b608-422b-b9a5-3d7a32025169" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_5c9724da-5106-4b55-a7b3-9c5a394d345e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_0cbb9a13-d154-483d-8635-d58bef78ac06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_887bf4a4-b608-422b-b9a5-3d7a32025169" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_0cbb9a13-d154-483d-8635-d58bef78ac06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_3dc37d61-1d80-4789-b0ab-0c9e066bd263" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_887bf4a4-b608-422b-b9a5-3d7a32025169" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_3dc37d61-1d80-4789-b0ab-0c9e066bd263" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_c0b2d9ad-7b54-4d85-bdc6-d3898fe0ee09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_887bf4a4-b608-422b-b9a5-3d7a32025169" xlink:to="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_c0b2d9ad-7b54-4d85-bdc6-d3898fe0ee09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_3e543bcc-1374-4811-986e-4a46231b91d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_887bf4a4-b608-422b-b9a5-3d7a32025169" xlink:to="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_3e543bcc-1374-4811-986e-4a46231b91d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_d5463f70-53f4-4dfc-8816-3914c3f76820" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_887bf4a4-b608-422b-b9a5-3d7a32025169" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_d5463f70-53f4-4dfc-8816-3914c3f76820" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_1b9a5f7c-ae32-40b2-8f9e-ff2ba0038b55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_887bf4a4-b608-422b-b9a5-3d7a32025169" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_1b9a5f7c-ae32-40b2-8f9e-ff2ba0038b55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/BusinessCombinationsScheduleofFairValueofNetAssetsAcquiredDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#BusinessCombinationsScheduleofFairValueofNetAssetsAcquiredDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/BusinessCombinationsScheduleofFairValueofNetAssetsAcquiredDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_56cbca20-38f0-4dba-98ed-46d255e6fa2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9637222c-a73f-4fa5-9565-054425e46133" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_56cbca20-38f0-4dba-98ed-46d255e6fa2e" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9637222c-a73f-4fa5-9565-054425e46133" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_5b245704-2903-4920-b0e3-982e3787b183" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9637222c-a73f-4fa5-9565-054425e46133" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_5b245704-2903-4920-b0e3-982e3787b183" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8ddf2f9c-723f-410f-8288-9d17b3bbdaa8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5b245704-2903-4920-b0e3-982e3787b183" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8ddf2f9c-723f-410f-8288-9d17b3bbdaa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_RedwoodHoldingGroupLLCMember_1c41aeed-2d2b-493d-a971-7c2d83b266d5" xlink:href="cron-20201231.xsd#cron_RedwoodHoldingGroupLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8ddf2f9c-723f-410f-8288-9d17b3bbdaa8" xlink:to="loc_cron_RedwoodHoldingGroupLLCMember_1c41aeed-2d2b-493d-a971-7c2d83b266d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_4a1e5696-d2d5-4a3e-b64c-ad948225c3c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9637222c-a73f-4fa5-9565-054425e46133" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_4a1e5696-d2d5-4a3e-b64c-ad948225c3c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_1670f575-f694-4776-a1fb-a43eb64626fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_4a1e5696-d2d5-4a3e-b64c-ad948225c3c6" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_1670f575-f694-4776-a1fb-a43eb64626fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_3be65e56-08de-4dff-b1a1-1569f7b9ace8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_1670f575-f694-4776-a1fb-a43eb64626fb" xlink:to="loc_us-gaap_TradeNamesMember_3be65e56-08de-4dff-b1a1-1569f7b9ace8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_f29c0c22-c747-49e5-9f60-2ddec11c2ee1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9637222c-a73f-4fa5-9565-054425e46133" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_f29c0c22-c747-49e5-9f60-2ddec11c2ee1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_e119b0ff-4671-4aa9-a106-0b432ffc9a0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f29c0c22-c747-49e5-9f60-2ddec11c2ee1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_e119b0ff-4671-4aa9-a106-0b432ffc9a0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_c9df11d5-da4c-4d40-ac05-44db8002b341" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_e119b0ff-4671-4aa9-a106-0b432ffc9a0b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_c9df11d5-da4c-4d40-ac05-44db8002b341" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_7e8a08d9-ce05-46d0-a04e-e931b4aefd53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_e119b0ff-4671-4aa9-a106-0b432ffc9a0b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_7e8a08d9-ce05-46d0-a04e-e931b4aefd53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_3bde41dd-0d9a-434a-84dd-bb1798c480c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_e119b0ff-4671-4aa9-a106-0b432ffc9a0b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_3bde41dd-0d9a-434a-84dd-bb1798c480c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_4e97e928-51ad-4eef-95f7-60fa72004d6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_e119b0ff-4671-4aa9-a106-0b432ffc9a0b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_4e97e928-51ad-4eef-95f7-60fa72004d6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_72489f0a-daa6-456d-a81e-8649679b61e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_e119b0ff-4671-4aa9-a106-0b432ffc9a0b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_72489f0a-daa6-456d-a81e-8649679b61e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_0dff4146-5945-4b7a-bd71-ed11b2e637e2" xlink:href="cron-20201231.xsd#cron_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_e119b0ff-4671-4aa9-a106-0b432ffc9a0b" xlink:to="loc_cron_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_0dff4146-5945-4b7a-bd71-ed11b2e637e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_14d59213-0fa8-47e0-bb3c-eca5eca2f440" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_e119b0ff-4671-4aa9-a106-0b432ffc9a0b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_14d59213-0fa8-47e0-bb3c-eca5eca2f440" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_624c6665-03d6-4c0e-b807-58e65900f975" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_e119b0ff-4671-4aa9-a106-0b432ffc9a0b" xlink:to="loc_us-gaap_Goodwill_624c6665-03d6-4c0e-b807-58e65900f975" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAndAccruedLiabilities_20e46345-1c5f-4fc4-a9a2-6a825312d54e" xlink:href="cron-20201231.xsd#cron_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_e119b0ff-4671-4aa9-a106-0b432ffc9a0b" xlink:to="loc_cron_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAndAccruedLiabilities_20e46345-1c5f-4fc4-a9a2-6a825312d54e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_ad456b6e-61ed-42de-a0b2-3d26481fa87e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_e119b0ff-4671-4aa9-a106-0b432ffc9a0b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_ad456b6e-61ed-42de-a0b2-3d26481fa87e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_ad3a2c90-d33a-4190-9b1c-93fc08a9fb85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_e119b0ff-4671-4aa9-a106-0b432ffc9a0b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_ad3a2c90-d33a-4190-9b1c-93fc08a9fb85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_65d9eb0c-a587-444a-8a3a-42eb5b5fa5ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f29c0c22-c747-49e5-9f60-2ddec11c2ee1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_65d9eb0c-a587-444a-8a3a-42eb5b5fa5ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquiredReceivablesEstimatedUncollectible_03e0b821-6811-4610-b045-be4790096873" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationAcquiredReceivablesEstimatedUncollectible"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f29c0c22-c747-49e5-9f60-2ddec11c2ee1" xlink:to="loc_us-gaap_BusinessCombinationAcquiredReceivablesEstimatedUncollectible_03e0b821-6811-4610-b045-be4790096873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_e1c83623-48e1-4bc0-bec2-d4f3e4be4c28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefinitelivedIntangibleAssetsAcquired"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f29c0c22-c747-49e5-9f60-2ddec11c2ee1" xlink:to="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_e1c83623-48e1-4bc0-bec2-d4f3e4be4c28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/RepurposingCharges" xlink:type="simple" xlink:href="cron-20201231.xsd#RepurposingCharges"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/RepurposingCharges" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_86b1c564-4bc3-43d4-a749-5aba3d2d8a80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_a470f2d8-38fe-4cc9-a53f-ea78c72d6844" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_86b1c564-4bc3-43d4-a749-5aba3d2d8a80" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_a470f2d8-38fe-4cc9-a53f-ea78c72d6844" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/RepurposingChargesTables" xlink:type="simple" xlink:href="cron-20201231.xsd#RepurposingChargesTables"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/RepurposingChargesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_c0fdd039-d9f8-4cf9-91ab-585d3660272d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_c05db090-1fa0-4cf1-9fd6-c319d38c9da9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_c0fdd039-d9f8-4cf9-91ab-585d3660272d" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_c05db090-1fa0-4cf1-9fd6-c319d38c9da9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/RepurposingChargesScheduleofPlanInformationDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#RepurposingChargesScheduleofPlanInformationDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/RepurposingChargesScheduleofPlanInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_43e30753-7923-4491-87ea-7fff5ba3a8b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_cabb0e50-77e3-4676-b0c6-a136a33775fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_43e30753-7923-4491-87ea-7fff5ba3a8b4" xlink:to="loc_us-gaap_SeveranceCosts1_cabb0e50-77e3-4676-b0c6-a136a33775fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_23c74bf5-635a-45be-92f0-bced4c35f5c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_43e30753-7923-4491-87ea-7fff5ba3a8b4" xlink:to="loc_us-gaap_AssetImpairmentCharges_23c74bf5-635a-45be-92f0-bced4c35f5c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions_797e7d95-0ece-45fd-8860-7ac3173dbd88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringSettlementAndImpairmentProvisions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_43e30753-7923-4491-87ea-7fff5ba3a8b4" xlink:to="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions_797e7d95-0ece-45fd-8860-7ac3173dbd88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/RepurposingChargesNarrativeDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#RepurposingChargesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/RepurposingChargesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_f360e404-db1a-4927-9fda-6ed3e5b00c2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b84c48e9-39ee-4500-8890-28743a61fb1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_f360e404-db1a-4927-9fda-6ed3e5b00c2c" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b84c48e9-39ee-4500-8890-28743a61fb1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_b3f0b7a3-9cc4-445d-8891-ecc50578707a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b84c48e9-39ee-4500-8890-28743a61fb1b" xlink:to="loc_us-gaap_RestructuringPlanAxis_b3f0b7a3-9cc4-445d-8891-ecc50578707a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_1990a573-a5f2-4432-94c0-6df7f7a04eda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_b3f0b7a3-9cc4-445d-8891-ecc50578707a" xlink:to="loc_us-gaap_RestructuringPlanDomain_1990a573-a5f2-4432-94c0-6df7f7a04eda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_RepurposingPlanMember_b84a06ed-1e1c-4c08-abb0-566e1d8a06bd" xlink:href="cron-20201231.xsd#cron_RepurposingPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_1990a573-a5f2-4432-94c0-6df7f7a04eda" xlink:to="loc_cron_RepurposingPlanMember_b84a06ed-1e1c-4c08-abb0-566e1d8a06bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_2263d496-9a65-46a3-9ee2-4d6b1f7e77b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b84c48e9-39ee-4500-8890-28743a61fb1b" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_2263d496-9a65-46a3-9ee2-4d6b1f7e77b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_8985661e-b2bb-4f94-8690-f6b742861415" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_2263d496-9a65-46a3-9ee2-4d6b1f7e77b3" xlink:to="loc_us-gaap_InventoryWriteDown_8985661e-b2bb-4f94-8690-f6b742861415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions_7f24d3c7-62df-4221-bc54-bd019421a2fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringSettlementAndImpairmentProvisions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_2263d496-9a65-46a3-9ee2-4d6b1f7e77b3" xlink:to="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions_7f24d3c7-62df-4221-bc54-bd019421a2fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_18ecd6fe-4f31-481e-b8f7-210718f37cc5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_2263d496-9a65-46a3-9ee2-4d6b1f7e77b3" xlink:to="loc_us-gaap_RestructuringReserve_18ecd6fe-4f31-481e-b8f7-210718f37cc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SegmentInformation" xlink:type="simple" xlink:href="cron-20201231.xsd#SegmentInformation"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/SegmentInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_24bebe0e-289c-429c-b57f-71f9c57fdcf0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_f53cdc8b-aaec-4f9e-8363-1a59fd56d173" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_24bebe0e-289c-429c-b57f-71f9c57fdcf0" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_f53cdc8b-aaec-4f9e-8363-1a59fd56d173" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SegmentInformationTables" xlink:type="simple" xlink:href="cron-20201231.xsd#SegmentInformationTables"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/SegmentInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_0a344eec-35f6-4f21-b52b-e051a509d388" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_4234dcf0-bd6d-4b01-b623-7caa918248aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0a344eec-35f6-4f21-b52b-e051a509d388" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_4234dcf0-bd6d-4b01-b623-7caa918248aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_3ceb52e0-e00a-416d-a772-ac51a240daba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0a344eec-35f6-4f21-b52b-e051a509d388" xlink:to="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_3ceb52e0-e00a-416d-a772-ac51a240daba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_632a2ac7-f786-4251-a15e-4fe73fbc8d2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0a344eec-35f6-4f21-b52b-e051a509d388" xlink:to="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_632a2ac7-f786-4251-a15e-4fe73fbc8d2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SegmentInformationNarrativeDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#SegmentInformationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/SegmentInformationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_0d5b8f25-abf5-4042-bdfb-1c567332c561" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_755dec07-e19b-46a9-8718-ac4f254c2cab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0d5b8f25-abf5-4042-bdfb-1c567332c561" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_755dec07-e19b-46a9-8718-ac4f254c2cab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_b80c2f8b-ea36-4ff8-8aa5-85274c5cc366" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_755dec07-e19b-46a9-8718-ac4f254c2cab" xlink:to="loc_srt_MajorCustomersAxis_b80c2f8b-ea36-4ff8-8aa5-85274c5cc366" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_3a64caee-c49a-4a0b-b22b-9a148e363bad" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_b80c2f8b-ea36-4ff8-8aa5-85274c5cc366" xlink:to="loc_srt_NameOfMajorCustomerDomain_3a64caee-c49a-4a0b-b22b-9a148e363bad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FourMajorCustomersMember_e3f43451-af7a-446e-9c51-080ee06a04a9" xlink:href="cron-20201231.xsd#cron_FourMajorCustomersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_3a64caee-c49a-4a0b-b22b-9a148e363bad" xlink:to="loc_cron_FourMajorCustomersMember_e3f43451-af7a-446e-9c51-080ee06a04a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_TwoMajorCustomersMember_003aa43b-9d83-4261-a725-96306a0e53d9" xlink:href="cron-20201231.xsd#cron_TwoMajorCustomersMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_3a64caee-c49a-4a0b-b22b-9a148e363bad" xlink:to="loc_cron_TwoMajorCustomersMember_003aa43b-9d83-4261-a725-96306a0e53d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_OneMajorCustomerMember_82177fbf-4a28-4a30-93ea-ddc2effa07c2" xlink:href="cron-20201231.xsd#cron_OneMajorCustomerMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_3a64caee-c49a-4a0b-b22b-9a148e363bad" xlink:to="loc_cron_OneMajorCustomerMember_82177fbf-4a28-4a30-93ea-ddc2effa07c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_ff581dc7-6669-49c0-b052-544c4361ee5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_755dec07-e19b-46a9-8718-ac4f254c2cab" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_ff581dc7-6669-49c0-b052-544c4361ee5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_24593cbe-edab-4d14-9bdc-4e3937d958f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ff581dc7-6669-49c0-b052-544c4361ee5c" xlink:to="loc_us-gaap_SegmentDomain_24593cbe-edab-4d14-9bdc-4e3937d958f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_UnitedStatesSegmentMember_1e5dd53b-2701-4f8c-a2bf-a256dada4894" xlink:href="cron-20201231.xsd#cron_UnitedStatesSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_24593cbe-edab-4d14-9bdc-4e3937d958f6" xlink:to="loc_cron_UnitedStatesSegmentMember_1e5dd53b-2701-4f8c-a2bf-a256dada4894" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_RestOfWorldSegmentMember_3ad41cde-8b53-43f1-a6b4-a08b6998e3a6" xlink:href="cron-20201231.xsd#cron_RestOfWorldSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_24593cbe-edab-4d14-9bdc-4e3937d958f6" xlink:to="loc_cron_RestOfWorldSegmentMember_3ad41cde-8b53-43f1-a6b4-a08b6998e3a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_55d7da3d-b45a-4e1e-a0ca-3cdbfed75005" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_755dec07-e19b-46a9-8718-ac4f254c2cab" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_55d7da3d-b45a-4e1e-a0ca-3cdbfed75005" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_cfbce7fa-da7e-4e19-b3f5-f8baf861482e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_55d7da3d-b45a-4e1e-a0ca-3cdbfed75005" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_cfbce7fa-da7e-4e19-b3f5-f8baf861482e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_afcac2ed-2bff-4ebf-8f11-fd902ebbd206" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_cfbce7fa-da7e-4e19-b3f5-f8baf861482e" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_afcac2ed-2bff-4ebf-8f11-fd902ebbd206" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_d354d3ef-40da-4e48-8fa8-c8c2ec0439b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_755dec07-e19b-46a9-8718-ac4f254c2cab" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_d354d3ef-40da-4e48-8fa8-c8c2ec0439b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_9b6b9d63-fc61-4c34-80eb-0d703c133c1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_d354d3ef-40da-4e48-8fa8-c8c2ec0439b9" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_9b6b9d63-fc61-4c34-80eb-0d703c133c1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_74dcca5f-7f32-42fa-bc4d-66266aae637d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_9b6b9d63-fc61-4c34-80eb-0d703c133c1d" xlink:to="loc_us-gaap_SalesRevenueNetMember_74dcca5f-7f32-42fa-bc4d-66266aae637d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_8a84ba2f-ae66-4c74-ab37-c8e262989617" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_755dec07-e19b-46a9-8718-ac4f254c2cab" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_8a84ba2f-ae66-4c74-ab37-c8e262989617" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_d47e8f0e-ab24-42b5-8123-607eb29144c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8a84ba2f-ae66-4c74-ab37-c8e262989617" xlink:to="loc_us-gaap_NumberOfReportableSegments_d47e8f0e-ab24-42b5-8123-607eb29144c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_a4ad6c3e-fb02-4a77-a142-cb1756db2a97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8a84ba2f-ae66-4c74-ab37-c8e262989617" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_a4ad6c3e-fb02-4a77-a142-cb1756db2a97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_4390b15b-2245-4265-be38-0eb9bf91d7e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8a84ba2f-ae66-4c74-ab37-c8e262989617" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_4390b15b-2245-4265-be38-0eb9bf91d7e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_02d49d8b-b5e5-4763-8103-8f766a76027e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_8a84ba2f-ae66-4c74-ab37-c8e262989617" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_02d49d8b-b5e5-4763-8103-8f766a76027e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#SegmentInformationScheduleofSegmentDataDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_4245848c-5447-4fcd-a289-a18ef9b4bd62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_da47b503-6fe2-4f5b-a41c-9dbaa9e3e3c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_4245848c-5447-4fcd-a289-a18ef9b4bd62" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_da47b503-6fe2-4f5b-a41c-9dbaa9e3e3c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_8707f6fe-dbee-4cff-a7e0-e0a858e4db64" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_da47b503-6fe2-4f5b-a41c-9dbaa9e3e3c7" xlink:to="loc_srt_ProductOrServiceAxis_8707f6fe-dbee-4cff-a7e0-e0a858e4db64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c185d5c9-2525-481b-888b-9fca207f0043" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_8707f6fe-dbee-4cff-a7e0-e0a858e4db64" xlink:to="loc_srt_ProductsAndServicesDomain_c185d5c9-2525-481b-888b-9fca207f0043" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CannabisFlowerMember_ded4243c-ad02-4922-aa49-e9b746ce9098" xlink:href="cron-20201231.xsd#cron_CannabisFlowerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_c185d5c9-2525-481b-888b-9fca207f0043" xlink:to="loc_cron_CannabisFlowerMember_ded4243c-ad02-4922-aa49-e9b746ce9098" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CannabisExtractsMember_7f5cae37-11af-433a-8f10-d248d8a20aad" xlink:href="cron-20201231.xsd#cron_CannabisExtractsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_c185d5c9-2525-481b-888b-9fca207f0043" xlink:to="loc_cron_CannabisExtractsMember_7f5cae37-11af-433a-8f10-d248d8a20aad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_04d69db3-dc50-45d5-bcbd-49ca8ef07399" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_c185d5c9-2525-481b-888b-9fca207f0043" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_04d69db3-dc50-45d5-bcbd-49ca8ef07399" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_41f50872-7347-4774-99f3-73a2f529a129" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_da47b503-6fe2-4f5b-a41c-9dbaa9e3e3c7" xlink:to="loc_srt_ConsolidationItemsAxis_41f50872-7347-4774-99f3-73a2f529a129" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_ca6f26bf-83fe-4e1f-999b-8515555408fd" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_41f50872-7347-4774-99f3-73a2f529a129" xlink:to="loc_srt_ConsolidationItemsDomain_ca6f26bf-83fe-4e1f-999b-8515555408fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_39341ae9-ce75-4198-8160-f6c552e11fc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_ca6f26bf-83fe-4e1f-999b-8515555408fd" xlink:to="loc_us-gaap_OperatingSegmentsMember_39341ae9-ce75-4198-8160-f6c552e11fc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_01388c6c-2e2a-41f3-a3d7-5c3653062440" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_ca6f26bf-83fe-4e1f-999b-8515555408fd" xlink:to="loc_us-gaap_CorporateNonSegmentMember_01388c6c-2e2a-41f3-a3d7-5c3653062440" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_cd595c65-ef00-4866-9653-35816e1799ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_da47b503-6fe2-4f5b-a41c-9dbaa9e3e3c7" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_cd595c65-ef00-4866-9653-35816e1799ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_aa987634-9c6d-4559-8769-7395be60d7f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_cd595c65-ef00-4866-9653-35816e1799ab" xlink:to="loc_us-gaap_SegmentDomain_aa987634-9c6d-4559-8769-7395be60d7f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_UnitedStatesSegmentMember_6d85dc61-1f58-4f8a-8384-7810da229793" xlink:href="cron-20201231.xsd#cron_UnitedStatesSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_aa987634-9c6d-4559-8769-7395be60d7f4" xlink:to="loc_cron_UnitedStatesSegmentMember_6d85dc61-1f58-4f8a-8384-7810da229793" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_RestOfWorldSegmentMember_8df5da31-3aaa-4ff9-8778-11e7e69133ef" xlink:href="cron-20201231.xsd#cron_RestOfWorldSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_aa987634-9c6d-4559-8769-7395be60d7f4" xlink:to="loc_cron_RestOfWorldSegmentMember_8df5da31-3aaa-4ff9-8778-11e7e69133ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_c0f42ccd-f950-4b85-b748-3fa50d5c5a06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_da47b503-6fe2-4f5b-a41c-9dbaa9e3e3c7" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_c0f42ccd-f950-4b85-b748-3fa50d5c5a06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_ae212b21-550c-47ab-aeb0-c4fab4b632d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationProfitLossAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c0f42ccd-f950-4b85-b748-3fa50d5c5a06" xlink:to="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_ae212b21-550c-47ab-aeb0-c4fab4b632d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_15b5b57f-c034-4c62-ba1f-13cf84214c2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_ae212b21-550c-47ab-aeb0-c4fab4b632d2" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_15b5b57f-c034-4c62-ba1f-13cf84214c2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_4cb3b7a4-57b3-42d4-8f57-93757c6d5109" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c0f42ccd-f950-4b85-b748-3fa50d5c5a06" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_4cb3b7a4-57b3-42d4-8f57-93757c6d5109" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_78d74594-1281-4df1-b8a5-8358fe8932da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c0f42ccd-f950-4b85-b748-3fa50d5c5a06" xlink:to="loc_us-gaap_InvestmentIncomeInterest_78d74594-1281-4df1-b8a5-8358fe8932da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_d616bcf5-7c39-49ec-9461-a4bd245d60ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c0f42ccd-f950-4b85-b748-3fa50d5c5a06" xlink:to="loc_us-gaap_InterestExpense_d616bcf5-7c39-49ec-9461-a4bd245d60ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_1244a8e9-c44e-412c-b106-8c7e54f65776" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c0f42ccd-f950-4b85-b748-3fa50d5c5a06" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_1244a8e9-c44e-412c-b106-8c7e54f65776" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_8d256326-9593-42af-9c36-90446152b0d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c0f42ccd-f950-4b85-b748-3fa50d5c5a06" xlink:to="loc_us-gaap_DepreciationAndAmortization_8d256326-9593-42af-9c36-90446152b0d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_e13e6fe5-8035-4ca1-806a-cb29faf15765" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c0f42ccd-f950-4b85-b748-3fa50d5c5a06" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_e13e6fe5-8035-4ca1-806a-cb29faf15765" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_fb57619c-df7c-47d2-beff-35505d6ea426" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c0f42ccd-f950-4b85-b748-3fa50d5c5a06" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_fb57619c-df7c-47d2-beff-35505d6ea426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization_55b9f9f3-e261-457a-8fca-66a6463bfd56" xlink:href="cron-20201231.xsd#cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c0f42ccd-f950-4b85-b748-3fa50d5c5a06" xlink:to="loc_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization_55b9f9f3-e261-457a-8fca-66a6463bfd56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationAdditionalInformationAbstract_92ebeade-571d-41a9-bd27-e363e23ab6a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationAdditionalInformationAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c0f42ccd-f950-4b85-b748-3fa50d5c5a06" xlink:to="loc_us-gaap_SegmentReportingInformationAdditionalInformationAbstract_92ebeade-571d-41a9-bd27-e363e23ab6a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_72b49615-4d22-4ad1-92b7-a6fb8fac250a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationAdditionalInformationAbstract_92ebeade-571d-41a9-bd27-e363e23ab6a1" xlink:to="loc_us-gaap_Assets_72b49615-4d22-4ad1-92b7-a6fb8fac250a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_7fed6e87-2e01-42d3-ac74-80e26a2e1f78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationAdditionalInformationAbstract_92ebeade-571d-41a9-bd27-e363e23ab6a1" xlink:to="loc_us-gaap_EquityMethodInvestments_7fed6e87-2e01-42d3-ac74-80e26a2e1f78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_71de5505-b1b9-4b18-a09d-6074ad87c23b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationAdditionalInformationAbstract_92ebeade-571d-41a9-bd27-e363e23ab6a1" xlink:to="loc_us-gaap_Goodwill_71de5505-b1b9-4b18-a09d-6074ad87c23b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAdditions_47a1e8f9-f718-4b8d-9d39-5097e6e9cb50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAdditions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationAdditionalInformationAbstract_92ebeade-571d-41a9-bd27-e363e23ab6a1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAdditions_47a1e8f9-f718-4b8d-9d39-5097e6e9cb50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SegmentInformationScheduleofAdjustedEBITDADetails" xlink:type="simple" xlink:href="cron-20201231.xsd#SegmentInformationScheduleofAdjustedEBITDADetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/SegmentInformationScheduleofAdjustedEBITDADetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_25922a20-66d6-4c14-9949-ea9fe6f29af3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_59430215-0852-422e-9366-8492a2249b58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_25922a20-66d6-4c14-9949-ea9fe6f29af3" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_59430215-0852-422e-9366-8492a2249b58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_021036e6-31bb-4ce3-af97-6b367412583d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_59430215-0852-422e-9366-8492a2249b58" xlink:to="loc_srt_ConsolidationItemsAxis_021036e6-31bb-4ce3-af97-6b367412583d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_ff366357-1d93-455f-877e-3a663c528e74" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_021036e6-31bb-4ce3-af97-6b367412583d" xlink:to="loc_srt_ConsolidationItemsDomain_ff366357-1d93-455f-877e-3a663c528e74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_3a480e00-faa4-43e8-9f3f-30da88dab5ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_ff366357-1d93-455f-877e-3a663c528e74" xlink:to="loc_us-gaap_OperatingSegmentsMember_3a480e00-faa4-43e8-9f3f-30da88dab5ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_4606ce22-d2f4-497b-acdf-8a5e5774bb74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_ff366357-1d93-455f-877e-3a663c528e74" xlink:to="loc_us-gaap_CorporateNonSegmentMember_4606ce22-d2f4-497b-acdf-8a5e5774bb74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_87463d16-ed1c-4c37-8615-1ab5ba32f809" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_59430215-0852-422e-9366-8492a2249b58" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_87463d16-ed1c-4c37-8615-1ab5ba32f809" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f5dffec2-af57-4637-a93f-3399147e23c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_87463d16-ed1c-4c37-8615-1ab5ba32f809" xlink:to="loc_us-gaap_SegmentDomain_f5dffec2-af57-4637-a93f-3399147e23c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_UnitedStatesSegmentMember_329abb99-038b-4bc8-8991-eb90aab217c5" xlink:href="cron-20201231.xsd#cron_UnitedStatesSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f5dffec2-af57-4637-a93f-3399147e23c8" xlink:to="loc_cron_UnitedStatesSegmentMember_329abb99-038b-4bc8-8991-eb90aab217c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_RestOfWorldSegmentMember_b6020f24-2d44-49b3-9a53-7e2c1c86845e" xlink:href="cron-20201231.xsd#cron_RestOfWorldSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f5dffec2-af57-4637-a93f-3399147e23c8" xlink:to="loc_cron_RestOfWorldSegmentMember_b6020f24-2d44-49b3-9a53-7e2c1c86845e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_9503d362-6771-4ef9-a7fe-89ceaf2a0c24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_59430215-0852-422e-9366-8492a2249b58" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_9503d362-6771-4ef9-a7fe-89ceaf2a0c24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_1fece57a-7896-4f19-8784-3e06d3418d76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9503d362-6771-4ef9-a7fe-89ceaf2a0c24" xlink:to="loc_us-gaap_ProfitLoss_1fece57a-7896-4f19-8784-3e06d3418d76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_bab56194-f89d-4a3b-b5f0-6861bbb03235" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9503d362-6771-4ef9-a7fe-89ceaf2a0c24" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_bab56194-f89d-4a3b-b5f0-6861bbb03235" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_95f8e457-d886-4783-924e-3a89f0f1e2bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9503d362-6771-4ef9-a7fe-89ceaf2a0c24" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_95f8e457-d886-4783-924e-3a89f0f1e2bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_b87dba2d-b091-40b8-b095-3478c6ec01c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9503d362-6771-4ef9-a7fe-89ceaf2a0c24" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_b87dba2d-b091-40b8-b095-3478c6ec01c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_6d9fee03-1d6b-45f6-acfe-7f3d2f0b134c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9503d362-6771-4ef9-a7fe-89ceaf2a0c24" xlink:to="loc_us-gaap_RestructuringCharges_6d9fee03-1d6b-45f6-acfe-7f3d2f0b134c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts_48cd07a1-408a-4769-aef6-6b2cc3614907" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9503d362-6771-4ef9-a7fe-89ceaf2a0c24" xlink:to="loc_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts_48cd07a1-408a-4769-aef6-6b2cc3614907" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_026f66c7-a94c-4984-9524-e72ed7038f86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9503d362-6771-4ef9-a7fe-89ceaf2a0c24" xlink:to="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_026f66c7-a94c-4984-9524-e72ed7038f86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_5a90cda8-52d1-4f15-91ba-850487419eed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9503d362-6771-4ef9-a7fe-89ceaf2a0c24" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_5a90cda8-52d1-4f15-91ba-850487419eed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_748b9ecd-3135-4d2f-82cd-7f9152990763" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9503d362-6771-4ef9-a7fe-89ceaf2a0c24" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_748b9ecd-3135-4d2f-82cd-7f9152990763" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_d39d70ef-60c6-490e-8f01-5cd618ba4541" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9503d362-6771-4ef9-a7fe-89ceaf2a0c24" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_d39d70ef-60c6-490e-8f01-5cd618ba4541" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_51eb312a-c591-4c82-acdf-8adfc0936e2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9503d362-6771-4ef9-a7fe-89ceaf2a0c24" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_51eb312a-c591-4c82-acdf-8adfc0936e2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_RestatementReviewExpense_b40a9148-6279-46be-a8f4-8fdca0b0690f" xlink:href="cron-20201231.xsd#cron_RestatementReviewExpense"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9503d362-6771-4ef9-a7fe-89ceaf2a0c24" xlink:to="loc_cron_RestatementReviewExpense_b40a9148-6279-46be-a8f4-8fdca0b0690f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_8b8f6d3d-0dfa-45b0-b668-595a1ff87a4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9503d362-6771-4ef9-a7fe-89ceaf2a0c24" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_8b8f6d3d-0dfa-45b0-b668-595a1ff87a4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AdjustedEarningsBeforeInterestAndTaxes_c011fa7b-f2dc-4e49-a487-6b5dcf6542d0" xlink:href="cron-20201231.xsd#cron_AdjustedEarningsBeforeInterestAndTaxes"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9503d362-6771-4ef9-a7fe-89ceaf2a0c24" xlink:to="loc_cron_AdjustedEarningsBeforeInterestAndTaxes_c011fa7b-f2dc-4e49-a487-6b5dcf6542d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_7ababa5d-1dae-4abd-a5f2-675f46715363" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9503d362-6771-4ef9-a7fe-89ceaf2a0c24" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_7ababa5d-1dae-4abd-a5f2-675f46715363" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization_330e0a65-9da0-4a26-867d-a6bfd786d5a7" xlink:href="cron-20201231.xsd#cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9503d362-6771-4ef9-a7fe-89ceaf2a0c24" xlink:to="loc_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization_330e0a65-9da0-4a26-867d-a6bfd786d5a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SegmentInformationScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#SegmentInformationScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/SegmentInformationScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_ba2f06b0-b528-4b56-8f13-fb56155cc216" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_bc4bae69-1264-402a-b43b-2bc29fee2413" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ba2f06b0-b528-4b56-8f13-fb56155cc216" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_bc4bae69-1264-402a-b43b-2bc29fee2413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_3a97901a-c2ec-4352-af0d-a1aef47a4156" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_bc4bae69-1264-402a-b43b-2bc29fee2413" xlink:to="loc_srt_StatementGeographicalAxis_3a97901a-c2ec-4352-af0d-a1aef47a4156" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_e650f8d3-be08-44b6-8cd7-e9177169f8a6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_3a97901a-c2ec-4352-af0d-a1aef47a4156" xlink:to="loc_srt_SegmentGeographicalDomain_e650f8d3-be08-44b6-8cd7-e9177169f8a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_4e78c438-f3ad-4551-85ca-292b30b045be" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_CA"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_e650f8d3-be08-44b6-8cd7-e9177169f8a6" xlink:to="loc_country_CA_4e78c438-f3ad-4551-85ca-292b30b045be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_b0f28da7-c6ba-4e4d-b14a-b765f1f3ffc4" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_e650f8d3-be08-44b6-8cd7-e9177169f8a6" xlink:to="loc_country_US_b0f28da7-c6ba-4e4d-b14a-b765f1f3ffc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_OtherCountriesMember_967054ea-a6a4-4865-9a01-b11b313ca46e" xlink:href="cron-20201231.xsd#cron_OtherCountriesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_e650f8d3-be08-44b6-8cd7-e9177169f8a6" xlink:to="loc_cron_OtherCountriesMember_967054ea-a6a4-4865-9a01-b11b313ca46e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_5461d7b8-cdfd-43e6-affe-baf46f67c37b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_bc4bae69-1264-402a-b43b-2bc29fee2413" xlink:to="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_5461d7b8-cdfd-43e6-affe-baf46f67c37b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_cf620347-02fe-4608-aa90-5fec1f251a1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_5461d7b8-cdfd-43e6-affe-baf46f67c37b" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_cf620347-02fe-4608-aa90-5fec1f251a1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SegmentInformationScheduleofLonglivedAssetsbyGeographicAreasDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#SegmentInformationScheduleofLonglivedAssetsbyGeographicAreasDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/SegmentInformationScheduleofLonglivedAssetsbyGeographicAreasDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_d96e05ba-05e4-488b-aec3-7b26910f70c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_4c4fabcc-2384-46bf-8032-776d5bace98f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_d96e05ba-05e4-488b-aec3-7b26910f70c5" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_4c4fabcc-2384-46bf-8032-776d5bace98f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_a32b99be-c7e1-4722-a85c-cdf9bfcd24cc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_4c4fabcc-2384-46bf-8032-776d5bace98f" xlink:to="loc_srt_StatementGeographicalAxis_a32b99be-c7e1-4722-a85c-cdf9bfcd24cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_f17879b5-1e97-46ce-bf03-982d407e7f4d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_a32b99be-c7e1-4722-a85c-cdf9bfcd24cc" xlink:to="loc_srt_SegmentGeographicalDomain_f17879b5-1e97-46ce-bf03-982d407e7f4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_97b757cd-7ba8-49b6-9403-2f980f4e7876" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_CA"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_f17879b5-1e97-46ce-bf03-982d407e7f4d" xlink:to="loc_country_CA_97b757cd-7ba8-49b6-9403-2f980f4e7876" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_3f574c77-fb61-4d93-b1a2-d9256148fb94" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_f17879b5-1e97-46ce-bf03-982d407e7f4d" xlink:to="loc_country_US_3f574c77-fb61-4d93-b1a2-d9256148fb94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_OtherCountriesMember_83dbdf18-bbbd-49ec-a3d9-7995563ceae4" xlink:href="cron-20201231.xsd#cron_OtherCountriesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_f17879b5-1e97-46ce-bf03-982d407e7f4d" xlink:to="loc_cron_OtherCountriesMember_83dbdf18-bbbd-49ec-a3d9-7995563ceae4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_aed976d8-b558-484b-9ff7-1915e82f687f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_4c4fabcc-2384-46bf-8032-776d5bace98f" xlink:to="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_aed976d8-b558-484b-9ff7-1915e82f687f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets_23981413-bc6d-4659-be47-7ff76bd678a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncurrentAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_aed976d8-b558-484b-9ff7-1915e82f687f" xlink:to="loc_us-gaap_NoncurrentAssets_23981413-bc6d-4659-be47-7ff76bd678a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/DiscontinuedOperationsandHeldforsaleAssets" xlink:type="simple" xlink:href="cron-20201231.xsd#DiscontinuedOperationsandHeldforsaleAssets"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/DiscontinuedOperationsandHeldforsaleAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_e40b8081-4116-4073-8df7-c2a25b7b8133" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_523733d3-857f-44d6-a3fe-5da86b9ce444" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_e40b8081-4116-4073-8df7-c2a25b7b8133" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_523733d3-857f-44d6-a3fe-5da86b9ce444" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/DiscontinuedOperationsandHeldforsaleAssetsTables" xlink:type="simple" xlink:href="cron-20201231.xsd#DiscontinuedOperationsandHeldforsaleAssetsTables"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/DiscontinuedOperationsandHeldforsaleAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_965c7771-432f-4bf3-b7a8-4e607116c2f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_666b4b65-d3ef-4310-bc70-fee916674427" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_965c7771-432f-4bf3-b7a8-4e607116c2f1" xlink:to="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_666b4b65-d3ef-4310-bc70-fee916674427" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/DiscontinuedOperationsandHeldforsaleAssetsDetails" xlink:type="simple" xlink:href="cron-20201231.xsd#DiscontinuedOperationsandHeldforsaleAssetsDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/DiscontinuedOperationsandHeldforsaleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_79cd4d1d-a7f5-4d47-b8a2-abf43d57b42a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_f30ad3b6-30e4-4123-acd5-99d6f8b0194d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_79cd4d1d-a7f5-4d47-b8a2-abf43d57b42a" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_f30ad3b6-30e4-4123-acd5-99d6f8b0194d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_2db8811e-0366-4b52-a933-95d7943f9523" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_f30ad3b6-30e4-4123-acd5-99d6f8b0194d" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_2db8811e-0366-4b52-a933-95d7943f9523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_d9148ac8-fe2e-489c-943a-b939242bf969" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_2db8811e-0366-4b52-a933-95d7943f9523" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_d9148ac8-fe2e-489c-943a-b939242bf969" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_45502f81-505b-4a42-a154-78612eb80484" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsHeldforsaleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_d9148ac8-fe2e-489c-943a-b939242bf969" xlink:to="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_45502f81-505b-4a42-a154-78612eb80484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_98634a3c-28a7-401a-96c9-226bf48ef34e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_f30ad3b6-30e4-4123-acd5-99d6f8b0194d" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_98634a3c-28a7-401a-96c9-226bf48ef34e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e4e4ee37-9c10-45cd-8b0f-9b68b8176395" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_98634a3c-28a7-401a-96c9-226bf48ef34e" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e4e4ee37-9c10-45cd-8b0f-9b68b8176395" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_OGBCMember_458710cd-b865-4b50-8e41-6a5cd81ab632" xlink:href="cron-20201231.xsd#cron_OGBCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e4e4ee37-9c10-45cd-8b0f-9b68b8176395" xlink:to="loc_cron_OGBCMember_458710cd-b865-4b50-8e41-6a5cd81ab632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_f3b01663-8e07-4cb5-888b-0b437bfe83f5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_f30ad3b6-30e4-4123-acd5-99d6f8b0194d" xlink:to="loc_srt_RestatementAxis_f3b01663-8e07-4cb5-888b-0b437bfe83f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_7c6f357e-230e-4a5f-87e0-cd1da68e6026" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_f3b01663-8e07-4cb5-888b-0b437bfe83f5" xlink:to="loc_srt_RestatementDomain_7c6f357e-230e-4a5f-87e0-cd1da68e6026" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_dd8225d4-bcaf-4419-8ff2-a5e9ef0d0bec" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_7c6f357e-230e-4a5f-87e0-cd1da68e6026" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_dd8225d4-bcaf-4419-8ff2-a5e9ef0d0bec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_c15a566c-b2fd-432c-a2a6-da755844322e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_7c6f357e-230e-4a5f-87e0-cd1da68e6026" xlink:to="loc_srt_RestatementAdjustmentMember_c15a566c-b2fd-432c-a2a6-da755844322e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_48c79b72-228f-45aa-b26a-820e3c99225a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_f30ad3b6-30e4-4123-acd5-99d6f8b0194d" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_48c79b72-228f-45aa-b26a-820e3c99225a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_adbb3233-101f-4022-aa42-9e6cf3c5e879" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_48c79b72-228f-45aa-b26a-820e3c99225a" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_adbb3233-101f-4022-aa42-9e6cf3c5e879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DiscontinuedOperationAssetsValuationAllowanceValuationIncrease_b6f1328b-94ea-4d6a-955f-e3c6dc5d02b7" xlink:href="cron-20201231.xsd#cron_DiscontinuedOperationAssetsValuationAllowanceValuationIncrease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_48c79b72-228f-45aa-b26a-820e3c99225a" xlink:to="loc_cron_DiscontinuedOperationAssetsValuationAllowanceValuationIncrease_b6f1328b-94ea-4d6a-955f-e3c6dc5d02b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_42bae396-0236-4d50-ac46-3ef679cd6f98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_48c79b72-228f-45aa-b26a-820e3c99225a" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_42bae396-0236-4d50-ac46-3ef679cd6f98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax_ba86687c-ede3-453c-b34d-7f191735782b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_48c79b72-228f-45aa-b26a-820e3c99225a" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax_ba86687c-ede3-453c-b34d-7f191735782b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent_d056e92b-1ba3-4e0b-b6f3-491e2a7d147e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_48c79b72-228f-45aa-b26a-820e3c99225a" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent_d056e92b-1ba3-4e0b-b6f3-491e2a7d147e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_a9edeba4-47a5-4ddf-8330-cd370553a9cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_48c79b72-228f-45aa-b26a-820e3c99225a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_a9edeba4-47a5-4ddf-8330-cd370553a9cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_c87f7f33-3346-4700-9476-c58545a03142" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_48c79b72-228f-45aa-b26a-820e3c99225a" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_c87f7f33-3346-4700-9476-c58545a03142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_fd122dbe-8b04-4dae-a0ff-6607390ecc07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_48c79b72-228f-45aa-b26a-820e3c99225a" xlink:to="loc_us-gaap_Goodwill_fd122dbe-8b04-4dae-a0ff-6607390ecc07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_40fc6051-ec0e-4910-91d9-d907f8979017" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_48c79b72-228f-45aa-b26a-820e3c99225a" xlink:to="loc_us-gaap_InventoryWriteDown_40fc6051-ec0e-4910-91d9-d907f8979017" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_80979fc6-c748-4173-aff4-52c788d24875" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_48c79b72-228f-45aa-b26a-820e3c99225a" xlink:to="loc_us-gaap_OperatingExpenses_80979fc6-c748-4173-aff4-52c788d24875" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_9acec6da-43cc-4aa5-a600-b631c5d9ff9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_48c79b72-228f-45aa-b26a-820e3c99225a" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_9acec6da-43cc-4aa5-a600-b631c5d9ff9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_f812dff0-d882-4f57-94a8-c33ed4ba973a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_48c79b72-228f-45aa-b26a-820e3c99225a" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_f812dff0-d882-4f57-94a8-c33ed4ba973a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>cron-20201231_g1.jpg
<TEXT>
begin 644 cron-20201231_g1.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" ". 3@# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@!'7>I&2/I7QQ^U=_P $^](^,>JS>*/!UW!X<\4SDO>0S*3:WK8^\0/]
M7(>[ $'N,\U]D4C<]LT ?CC?_P#!.OXZV=X8(?"]K>Q!MOVFWU:U"-C^(!Y%
M;GW6O<?@+_P3"O(=8MM6^*>H6YLHB'_L/3)"YE;((667&-N>H3KZBOT=VC;R
M!6;X@UJQ\.:->ZMJ-Q':6%E"]Q<7$APL<: LS'Z =J!_(_%C]KCX"O\  #XQ
M:CH]O')_PCU]F]TF1E./L[,?W>[N8S\O)[ D#-7OV,/@+%\?/C-9Z;J"9\/:
M6G]H:FH8J9(U8!8A_OL0IQVW5]X?M#^%_#'[<'[.,^O> KV/5-1T::6XTV9X
M6B=I$ \ZW(8!E+IC&1U"'I7YT_LW?&B^_9^^+^D^)HT9[2.3[+J5JV09;=R!
M(N/[R@;AD=5%'0.J/JKXY_\ !,+55UR[U/X7:C;S:9*?,71=2F,4L!/)2.7&
MUESG&X@C(R3UKQK2_P#@G1\<[^^2WN?#-GID.<&ZNM5M6C'OB-V;CGHO:OU\
MT/5K77M*L]2LITNK*\@CN(9D(*NC*&5@?0@@UH;1Z"@/D?(W[*/[!.B? S4H
M/$_B6[A\2^+UYMF2(BVL<C!,8;EGQGYR!C/ [GZXCC$?3Z4H4+T 'X4M @HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH &Z&OS]_X*:?M#+IFDVWPLT2Z87E\JW>M-$Q^6
M ',4!/JS#<1Z!?[U?<'C[Q4W@KP7K^O+;/>G3+*:[%O&#NDV(6"CZXK\&_'G
MC;5OB1XRU?Q/KDWVC5-4N'N9VY !8\(H_NJ,*!Z**!GV]_P2DM?%7]N>,[B(
ML/!GD11S^8#L>\R=GEYXW!"V['9D]J\U_P""AO[/8^$_Q2_X2?2+/R?#'B9W
MG C4"."\!W2QXQ\H;=O ]VQ]VOI7]B_]J#X+>#?@OX:\)S^(;?PQK-M&3?1Z
MHK0K+<,27D\T_)@G'5N!@50_;H_:4^#WC/X-ZYX1L=?M?%'B&22.2Q_LHF:*
M"9) ?,,P&S&TN/E8YR>E3U#I8K_\$Q_VA$USPS=_##6;HOJ.DJUUI)E8%I+4
MMEX@>Y1F! '\+>BXK[S5@RYZ=J_ /X9_$'5OA3X\T3Q5H<OEZCIMPLJ D[9%
MZ-&W^RRDJ?\ >-?O/X5UC_A(O#6EZK]GDM1?6T=R()!AH]Z!MIXZC/IVJA>9
MK4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% #)(EFC=&4,K#!##(.?7VKX@_:._X)
MJZ1X^U"]\0_#R[@\-ZQ<.99M*N 18S,222A49A).> "O/:ON*B@#\6_$?[!7
MQP\-W#1GP5-J<8;:)].NH9E;W W[L8]14GAG]@?XW^)+B./_ (0Y]*B9L>=J
M5U#"JXZDC<6Q]%K]GRN[O[4FS]/:@-#XN_9L_P""<.A?#&_L?$7CJ[A\4>(;
M=A+#8PJ?L-LX.5.&&Z9AU^8 >W>OL^%/+4#& .E244 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 &:*_('P1K7Q=^.'[0VM^"-"^)FKZ/
M/)>W[PR7.HW'DHL3NVW"G.,#C ["O8/''P%_:G^"?A^[\6:5\4KCQ)'IZ?:+
MBSMKV:9Q&@R6\J9-LB@ Y'7V-3<NQ^CV11FODK]D7]K2Z_:&^'GB>RUJ)++Q
MAH-J7FDMEV1W$3(P691GY6W(0RC@94CK@?&?[/$/QJ_:3\:ZQH.B?%75M(GL
M+5KUI+[4KG:5$BIM 4GG+C\C1<FVQ^P/XT5\ _\ #%7[1_\ T7-O_!C>_P#Q
M-?7_ ,$?!GB+P!\+=#T'Q7K7_"1Z_9I(+K4S([F<M*[J=SC<<*RKR/X:+C._
MH_&OD#_@HI\?KSX3_#/3_#WA[4)[#Q+X@G^2XM9&22"VC.7=6!R"S;%X'0O7
MCW[!?[07BO2OC)JWPZ^(^L:E>76J0JUE_:UPTK0W*+O\K+$[=\;,>#U51WI^
M8K'Z049J"XNH[6WDFFD2*&-"[R.P554#)))Z  =:_.+XI_MD?$W]H#XCW'P_
M^!44UM8J[ :I:*!<7,:$!IO,<8AB)(PPP>1SSBF/4_2///6ES7YSV_["O[1-
MY9C4+CXOQQ:LX$GD'5KTJ&/4%PO4'OM(Z]J]8_9-B_:2\,>/;_PM\3HAJGA6
MUA,BZU>S+-+O_A6&53F0,3R'&1M[=#-Q6/L#\:./6ORV_; \3>.M4_;4;P1X
M>\7ZIH<>JW&EZ?;I#?2QP0R3QQ('*J>FY]QP/6N_7]A+]H+;C_A=8_\ !C??
MX47'8_0JCOUKYS_91^ ?Q#^"\GB1O'/C;_A,!J @%J!<SR^1LW[_ /6CC=N7
MH/X:\ETG]I3QC\.?VCOB6WB62YU3X46FN1:7<WC%G&A/(N8I< ?+$S?*<\<C
MO@$N!]S456LKZ"\M8I[:9+BWE19(Y8V#*ZL,JP(/(((Y%>)?M@^+M:\&^ ?#
M%UH>IW&EW-QXJTVTEEMGVM)"\A#QD^C #BF*Q[M1FHXEV]L9YZYKYZ_:T\=^
M([>W\*_#SP)J3:;XX\8:BL,-U V'L[2,AY[@D=   /4Y8#/9@D?1.ZDW5X9^
MR?\ %#5/B=\+9+'Q&[)XQ\-W4N@ZR6R':>$[1*?]IUPQ_P!K=66W[+/B>2,K
M_P +V^(0SP=MY&#^>W^5(+'T/GWI?QKX-^$?PU\;?$+XO?%+PE=_&OQ];6GA
M*\M[>UGAU([YED1B2^1C(P.@KZ'^'G[/>M>!/%MGK5W\5_&GBF"!9%;2]9O1
M+;2;D*@LN.JD@CW%%PL>U TM?-_[*WB[7?%/CWXX6NKZM>:G;Z7XJDM+&*YF
M9UMH1OQ&@)^5?8>@KZ0H!JV@4A/I7SI^TWXPUWPY\8_@'I^E:M>:?9:MK\T%
M_;V\S(EU&!$0D@!^8 D\'U-<=\6K7Q-XX_;*TKP-:>//$_A;0[CPR=0>'0KX
MP#S4D==V,$<C';M2OT';2Y]>?C2_CFOG>Y_9C\8Z;'Y^@_';QS;:@AW1-JTT
M-_!N[;HW0!A[&M/]F'XQ>(O'K>,/"?C:WM8O&G@_4%L+Z:R!6&[5E)CG53]W
M<%/ Z]>.E,5M#W6BHVE7:?\  U\%:?\ M">.X_BY!\6I=3N/^%)ZEXA;PI!9
MNQ^S+"%"+?*,X ,J']X?1EZ4 E<^^:/QJ.+'EG'K[5\_?'GQ=K>@_M%? +2M
M.U6[LM-U>^U./4+2"4K'=*D$;(LB@X8*22,^IH!+4^A:3^*EKG_'7B>V\$^#
M]=\17H9K/2+"?4)E0 L4BC:1@!D9)"\9/XTQ'045\E?#GX6>._VD/"=CXW\>
M_$'Q'X;MM:B^UZ=X:\*W2V,-K;,,Q&1]C,[LIW9/(W#Z#T3P!\&?'_PS\<6K
MV?Q)OO%7@>97%YIGBD?:+R A?D:"=0.2< JV!C/!/2;CLCW&BOGKQ5\ O%M]
MHNJQ:!XJO_#]Y+;:K'']FOY&$YFG=K9'+AM@6/RAO0AEP<=312NQ\OF?G]^S
M=\2?#WPF_;&U;Q%XHU!=+T>&[U2-[@QM)AG:0*,*">2>U?7/QV_X*)?"ZV^'
M>LV?A34)_$VNWUK):V\,=K)%"A=2N^1W4?* 3PN2< >]?)?[,GP_\/\ Q,_;
M.U70?$VEPZQI$UUJLCVL^[:S*9"IX(Z$#H17Z4>'_P!E/X0^&KB.XL/A[H4<
M\3;DDEM1*P/U?-"&SY&_X)O_  @UWPWX*\=^.]5M9+#3M8TW[)IT<BE6G10[
MO,!_<SM4''/S>E?-/[)_[0%[^SS\0M?UNQ\,3>*I+VR>R:VAD9#&/.1]YPC=
MTQT[U^R7B2%(_#.JJJ*H6SE  &,80U^77_!-'Q=H'@WXT>+[K7];T[0[:71G
MBCFU*[CMT=OM,1VAG(R< \#T-/J2>Z>#_P#@I#KOBCQ;HFC2?"6^LX]1OH+,
MW!NI"(A)(J%R/)Z '/OBON1F_<DGCC)KSV^_:"^%UFR>;\0O"XW#C;J\#?R?
M^=>4_MA?M$Z9X+_9IU#7/"^O6MW/XAW:5I5Y8SJX8L6661&4]45'^8=&QWH'
MIH?)T<[_ +:7[>48=?MGA#0YLB,@-%]AM6&=WJ)92/\ OX!VKJO^"C7@>^^%
MOQ8\&?&3PW$;*YEECBNKB,$K]L@RT3/GN\0VX[B(^]<S^RK^Q+X]\9_#FU\;
MZ1\0KOP =9#".&UBD\V:W5R%=F61>&8,0,= #W%>C_$#_@GS\3/$GA>]M]2^
M,]]XG2&-KB'3+Z*5DEF53L W2D*2>-V/XC18+]#VSXY?&!/&'[$?B+QSH#&)
M=4T-2NUOFB,KI%(F?5"[@_[IKQ3_ ()-^$[#_A$_''B,H&U.2]BT\2D<K$L8
MD(!_VF<9_P!T5QW[!_B)OBA\+?B/\!==N3;R7%G//IRW'WH=_P DJ >B2;'V
MCN7KBOV4?C5>_L5_%[Q)X,^(EE<Z?I=[(D%\T:^8;:9"1'.H_CC*L<E>H((S
MC%/4#]9578H&<T@CVL3FO++3]I[X4WFDC4$^(OAW[/U.[48E;D9QL+;N/I7)
M^ /VUOAU\3/C /A_X=NK[4;EX7D@U2.V/V2=D4LZ*V=W"C.XKM.#STRA69\-
M_MD>))_!_P"WY#KUK8OJESI=[HU]%819#W+1) ZQ+@'EBH7@'KQ7N_\ P\:\
M;8Q_PHG7?^^I_P#XQ7C?[3VJ6NC_ /!230M0OKF.TL+36M GN+B9@J11I]G9
MG8D\  'KZ&OT''[27PJV_P#)1?#7_@SA_P#BJ!FU\*/'%W\1OA[H/B*^T>70
M;O4K83RZ;<$[[<DGY3E0<].W>O!O@%X:TWQ?\6?VFM'UBTCO]+OM=MX+BUF7
M*R(T+@@_XBOH'P=\2O"7Q >Y'AGQ%I>O&U \_P#LZZ2;RMV<;MI.,X/7TKQ+
M]E__ )+I^T9_V,5M_P"B7IZB,CX8^(M1_99^(5M\)O%MW)<^!-3D;_A#O$-T
MP)C)()L)VZ;E).TD=QZ@#:_;HN!'\,O";D$JOC+2LXY_Y:-Q7K?Q>^%>B?&;
MP3J/AC7K?S+2Z&Z.= /-MI@#LFC/9U/IZD=":^'?C5\2_$.C>$=%^#OQ":2?
MQ;H?B?2I].UIE(36M/$S*L^2?]8HPK<^O)YI>0_,_1.6X6&,NQ"JHRQ)   [
MGVKY=_9Y"_&_XY^.OC)/E]&M';PSX95LD&WB;,]P 1TD?&/]YA75?ME?$?4/
M!GPMCT+P\<^+/&%W'H&E(O+!ICMDD _V4)Y'0LM9W@7]C./P/X4T[1=+^+/Q
M&TNTMHN;73M3M8H%=CN<HOV8D L6/)/7J:.H;(Q_%GG? C]KK1O$<2FV\(_$
MJ*/1]195Q$FJ1@_9I&XX9URHSUR_IFOJ6+[N:^5_C1^Q?=^-/AWJUG#\3_'N
MNZG;QF[TVSUO4K:6U:ZC4M%N MU;D_+N# C=7JG[,OQ:'QC^#^CZW<+Y.LP;
MK#5K=N&AO(?DD##U) ;Z,*/(-U<\N_9C_P"3HOVC?^PI9_\ HMZ^IVKY7_9C
M_P"3H?VC?^PI9_\ HMZ^IY,\$9H6PGN?+G[&W_)2/VA?^QRD_P#9Z^I:^1O@
MWK$7P2_:D^*/@WQ'(-,B\:7R:[H-[=$)%>%MPDB5CQO!8#;G/RGUKZU=AL//
M/UH6PY;W/F#]K3_DNW[-G_8S3_\ H,-<]\3/&-GX%_;]T+4[^VU*[@'@^2/R
M]*TZ>^FR9GP?+A1FQQUQBM#QKK=I\=_VP_ &A:&ZZEI'P[6YU;6-0MGW11W4
MBA8( PXW*\:DC/\ >'8U;U?_ )2*:!GK_P (7+_Z.>EUN/H=%JO[97AZ]UJ[
M\->$O"_BCQ9XPAA\TZ*NE2V+Q#C#3&Y"&-2&'S!3U'K6K^S/\']>\#_\);XN
M\936[>,_&5^-0O[:T8M#9J 1%;JV?F**QR0.O3/4G[0OP/O_ !PMAXQ\$7*:
M%\3_  _^\TO4^BW$8R6M)Q]UHW_V@<$^A-;/P!^.5I\:?#%S)+:MHGBG29?L
M>N:%-D2V-R"0003DHQ5MI[X]C3ZZBZ:'*_ME>/+[P[\,XO"F@%F\6^-KI= T
MM%;!7S>)93Z*J$Y/JP-=%?\ [/FBW'[.,GPFC*C3O[*&GI.R@?O5 83$8Z^:
M _UKPQO!)_;"_:*\4Z[)KVN>'?#'@ _V'I%[H$Z0SS7Q.ZYD#O&X& =N ,X*
M=._K$/[)Z0QA6^+/Q0G/7?)KT8/Z0#]!1YE;$W['_P 3-0\<?":+2?$#,/&/
MA6X?0M:@F8&59H?E5V]0R ?-W(;TKF?VC^?VH/V:_P#L(:M_Z315Q]GX4'[(
M?[2V@7O]M:KK/A#XBI_9=]>ZU<+-/#J2$M [N%4%6!V].[>E=A^T<?\ C)[]
MFO\ [".K?^DT5/H);W/IRLGQ1X;L_%WAW5=$U%#-I^IVDME<QAB-T4B,CC(]
M58UJ[JYWQQX\T/X<Z#-KGB/4X-'TF%U22ZN"0JLS!5!X[DTR4?-/A&U^./[+
MVF+X=M?#D'Q=\"6#%--N+.[%MJ=K;C.V%T93OV@8&,XP!G& /5OA1^U%X3^*
MFOS>&EM]3\,^,;=-\WASQ!:FVNP H8E1RK+@YX/3DBO5=/OK/5]/M[VQN(KN
MTN8UEAN('#)(C %65AU!!SQZU\P?M0G2-<^/?P-T?2+=9O'L/B"+4)9K8XE@
MTN-6,ZR$?P,<8S_<?U.9V'OT/JQ6W+FBDC_U8Q15$GA/P_\ V-O!'PX^,=[\
M2]+N]9D\07<]W<21W-U&UN&N"Q?"B,-@;CC+?G7O HHH @U"S34+&XM9"PCG
MC:)BN,X(P<9[X-?(C_\ !+?X1R2,[:EXI!8Y.V_@QS_VPK["HH#R/CS_ (=:
M?"'_ *"7BO\ \#X/_C%=/KW_  3[^'/B/PGX1\-7NI^))-'\+I<)8P"^B&?/
MG::0N?)Y)9@,KCA1WYKZ<HI6 R_#OAVQ\*Z)8:1IENEIIUA EM;V\9)$<:*%
M4#)[ #OGUK1:/=3Z*8'@>G_L7^ ]%^-@^*&E3ZQI7B#[4]XUO:72"U>21660
M%#&6VN&;(W=SC%=C\6OV=_ ?QPM8XO&/A^WU.>)/+AO5+17,0R3A9$(; )/R
MG(Y/'->ET4K#NSXV_P"'5_PE^T>;_;/BX)G_ %'VZVV?3/V?=^M>^?"/]G+P
M!\#[>1?"/AVVT^YE7;-?2,TMS+CKND8EL$\[00.>@KTVBBPCYY^+G[#/PW^-
M7CJ]\6>(SK']JW:1QR?8[U8H]L:!%PNPX.%%<;_P[!^#7KXB_P#!BO\ \;KZ
MXHHL.YX]\"/V6_!O[.LFL/X2.H;M5$0N?M]R)?\ 5[]N/E&/OFNM\#_"?1?
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M8Y ]$\(:Q+K?A?2-2N0B3WEG#<.L8(4,Z*Q !/0$\9KQOX^> KJY^$^J>*=
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M6.9IW#L!V,8S@?=JW\8/"^H>(?#^GWVCW%O;ZUH=_'J]F;L-Y,C1JRO$^W)
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>cron-20201231_g2.jpg
<TEXT>
begin 644 cron-20201231_g2.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" $% 04# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I&Y5OI2T4
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M!JT%MJ*J!@%GB"NWU,B.?SJD2S]0?V2/'W_"Q/V;OA_KDS'SGTR.UE9CDO)
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MXC1^+K#Q;?ZO<);26WV>XMHT7#E23D'J-OZU)6O4^M%^Z*6D' %+F@84444
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M+1X-S#)1B/D<>ZMAOPK\+==T/Q3^SU\5#;7(DTOQ'H-\)(I "/F1P5D4]U;
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MLA.7D QT4#;_ ,"KSOX"_P#!+75KC4+34_B;?06UA&PD.DV#[I)>AVN_0#V
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M@]?0UPOQD\*Z=^U-^RS?QZ<!*->TB/4]-PXRLX19HE+>H<!6_P"!5^-7P_\
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M(GQ\\?\ Q4N7E\2^*=2U$%MPA:=EB7V5 < >U>?<GK3J*-!>H4444QA1110
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M$Y/U=0KD_5J-1W.[\2?\$G_BA83G^R-?\.:O;YX,TTUN_P!=OEL/_'JXR_\
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1HH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>cron-20201231_g3.jpg
<TEXT>
begin 644 cron-20201231_g3.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" "< 08# 2(  A$! Q$!_\0
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M+_M-:'-)IT3Z/XALE4WVBW,JL\8/21& ^>,GC=@$'J!D9/41[Q1110,****
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MC16 SUD;UK\=M/L)]5U"VLK6)I[FYE2&*-1DN[,%51[DD?G7]"GP\\+0^!/
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M_: \1?M&>/Y_$_B 1P8C%O9Z?;Y\FTA!)6-<\DY8L6/4D]!@+Y]HNN:AX=U
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M;N8@;YI"!RQ(''0 *!P */(2[L[R"!;>,(@"JH"JJC  '  'TJ2BBD6%%%%
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M.R\>?\%5_B/XFE-KX/\ #NF>&4D;;$TBM?W1)) "DA4R>.-AZUGZ'\,_VO\
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M?P_=_MG:;8J]Y;P>+(XKR_\ *D7*2$^6QCRIQNV!CG/)/0<5^B?P/^ _@WX
M^$X]%\'Z9]CCD"O=7<S;[F[D QOE? R>2< !1D[0,TR;:F1^S;^S+X4_9L\%
MII&B0_:]5N%5M2UF9 )KR0#KU^1 2=J \>I.2?7U4+T%+12*"BBB@ HHHH *
J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>cron-20201231_g4.jpg
<TEXT>
begin 644 cron-20201231_g4.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_X1#N17AI9@  34T *@    @ ! $[  (
M   ,   (2H=I  0    !   (5IR=  $    8   0SNH<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $-0+"!0<F%V
M965N   %D ,  @   !0  !"DD 0  @   !0  !"XDI$  @    ,R,   DI(
M @    ,R,   ZAP !P  " P   B8     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M*BHJ*BHJ*O_  !$( K<"N ,!(@ "$0$#$0'_Q  ?   !!0$! 0$! 0
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M2KX'8;@<>V*Z&O+/V=YC+\*PA'$5],@Y_P!UO_9J]3H$%%%% !1110 4444
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MX;^S=02/3M;0?Z@2 QW&.IC;OZ[>3CH2,F@+'I%%%% @HHHH **** "BBB@
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M[9S716'A72O%FK3^&_AO:_V=X:MV\O6-=4EY+T]?(C=LDKZX^4]<8QN ./\
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MF.!U/EN^/3 ]!6[!=:%\+OA]I]OK%Y%9VUE;K%GJTLF,MM4<L2V3P.] SJP
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MMS?7;;(+:)II&]%4$D_D*!'R]X%T+5_$>JZGI7AO54T_6=$OY+RQGER%V/\
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MZ5XW\-?!=AJGB$ZTK-J=A83&0:K=+F35+WD&49R1%'DA1W;G)(X]IH ****
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M^(-%\!K=?VC>+=_VYXINU.X-(O*1$]QN.,'U!ZDX]WH&%%%% @HHHH ****
M.%^,7BH^%/AM?3P/LN[S_0[8CJ&<')_!0Q^H%)\'?"*>$_AW9+)'MO;]1=W1
M(P06&54_[JX&/7/K7#?&"XB\1?%[PEX5G(:R@9;F[7/&UFRX/TCC)^C5VMA\
M4[>_:#R--=8Y_P"SE3=+@AKN9T QC^%%W^_3CK0,@^*;+=Z]X'TB7_57&MI<
MR>A6%<D'V^:O)[G7Y/''BZX\3WEL-4_TW^S?#>D2\Q22<'?(/[J*4=O4NH)
M%>D_$QY+[XE>%].MSAX;#4KG(Y^8VY5/R8=*\ TKQ!!I>DVS)(RSK9WMLFP_
M-%+( -_ME6VY'I[4 >L?;=)M[V:9[&W\9:U$_EW^OZU,L6FVDG4QQE_EPO.
MHSW'H/1_!&J37-M=75[K.E/:VZ#?;Z?8/;00D\[_ #)#EQ@'D8%<-X<@\3ZO
MKMYX?\#ZS:^&](\,P16P8V23R3R.H+.0PZEE8YX_')KE_'&D:QJ/C2;0]?\
M&E]K-AI5K]OU9U@6!(1U6-(U)4R-E0.."X]#0!](6=[:ZA:1W5A<PW5O(,I-
M!('1QG'##@U-7G/@[QCH&@Z1#H-V\.FO9%;<VZN75)R 6@CZO(R9&]L8W-^
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MD'8WMCWKI_\ A:%GXA\$KJFDSRZ?'(HCN+Q(OM!TR?J!-%C_ %1P1O''/;J
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M&\-^#6%M:PXRMQ=@8+>X3 'X*>YKU:@"*VM8+*UBMK.&.""%0D<4:A511T
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MD-O$L:Y[*HP/T%>5>+OC8R7+Z9\/-*DU^\$@A:[2-G@20YPJ[?OG@]P.,C-
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MX?*FCD'1HGZ%AVQSCJ,'%8=WIFJ:?KEA9>(;]+/Q)9DIH/B8C$.HI_S[7/\
MM$<8/)R2"3]X \@\1>%TTN2VN1MU'3;XDVM]9_+%=CD<9_U<P[QG@^V!GCI[
M62 ;RC^4S%5D*$ D8ROU&1D=LU]&2Z5]O@U2XT_16#YQXE\(R'AV/_+Q;'H'
M.-RLO#8]17E5S:2HSPW/^E:9<N$M]2DRD-VH^Y',V,1S*#@.>5)(;*'(!G5_
M!7XNMH4\/AKQ-<9TN0[;2Y<_\>S$_=8_W#Z_PGVZ?2V<]*^&]8TR.UAD+12V
ML]K)Y#K+$5$I 'M@. 1N'0]037M/P0^+BR1P>$_%%P%D4"/3[N1OOCM$Q]>R
MGOT],@CWB:&*Y@>&XC26*12KQNH96!X((/45Y#K/P3O-)U=]:^%^MOH=TW+6
M<C'R6]@>?E_V6##Z5[#10(\8T'_A:?A>>X*> M#NVGVF>YL9XK8SE<_,P#@9
MY/(4=:T]2^)GC+3-'GN-7^'E[81JAS=6]['/Y?'WMFWH.N#^8KU2O$OC9I#+
MXNTK7-?TV]UCPO%:M#-;VCLIMY<L?,.,=<J,Y'3&>F09P-Q\3KK4HGNKU&M'
MD:6>&XC0I$UW" \4R*2=KL/W<B@X82 GUKU#X*7(C\0^.='M (]/LM262W@!
MR(2YD#*/8>6!^%>)2W6FZEJ5C_9\<^L2VZ>7I^BVUDR0Q\EL,2[.WS$L0,EN
M<L*^A_A!X*U'PGX=N[KQ Y;6-7G^TW2ELE.N%)'!;EB<=SCM0!QGQ5\8V^K^
M+3X:U/RM/T30YXKV_GF/[ZZ8+N6*%.IW!L9]R20!SD_#'2KSQWXIMM5FL732
M;:_NM4O+B0;5FNIN%CC]0FU3GUW>JU[7K/@3POXAU%;_ %K1+2\NE 'FR)R0
M.@/J/K6U:VEO8VL=M9016UO$-L<4*!$0>@ X% 'SE\(M0;2+77_"<T0DDOKY
M[!VY&UC;SX_,PX_&MW3_ !!>)<V-QYTC6M_%HUQ<PJW$D<T4EI*"/XL/L/U4
M>@K+\6:%?>%?C[9G28U:#7+V'4( [A1YROF1<GN<R#'I*!7K>F_#[3K(6R3$
MS0P0O!Y1SAE%R)XC]4(_6@#&^!T[K\/YM)F;=)HVHW%BWKPV_P#]GKR[XJ>,
MD\3^)+B28F?P_HUP;:SLU8@:A=C[Q..=B]R.VT#!DR.DL_$)\(6_Q<DADV26
MU^)H#Z2W!=5(^AP?PKB_@1X2E\4>,(]0OB7TS0SYXC?E6F;[H';JNXG_ &5%
M '4>'?A2AT27Q5\5]5GLK8Q!FT]',*11#[J/MZ#G C4#' Z\5"1\($C1KSP+
MKMCI,[A8M7GCN!"Q/1@_F$X[]#]*F_:9U>X\[0]$BE9(&62YE3=A7;(5"?I\
M_P"=>2Q7.N6FL?8?$*:I>65I=Q#4-/,TA#A6^X>< D @'\J />QI]W\*?%&@
MS:-K%S?>$]<NTLGL[N7S!;/(,QO&W]WK^ YSP1Z_7DMM%KOQ0\5:'?W>BW&A
M>%M%F6\ACO %FNYE^Y\G91^6">3GCH[F\\3Z=XKT_3&O([K^T]6GN0$AX@TZ
M.)048XX(D9.>I+#GDB@#'^*-BWAC5=-^(VE*4GTZ5(-31./M-J[!3GU() 'U
M!_A%>FQR++&LD;!D<!E8="#WKQ+Q;XKU#Q'X=N;*X8+;2ZIJ]GB-2HD@@MI&
MC+#OAMK9]4KTOX=SR7/PT\.RS-N<Z= "3WP@']* .DKS#X[ZQJVG^"[2PT!Y
M4N]4O%MR8&(D*!68A<<\D 'VR.]>GUYU\8%GT[3-$\3V\1G30=3CN+F(#.Z%
MOD?\>1^9/:@1T?P_U9]<^'>AZA-(9)IK*,2NQR6=1M8D^[ UT5>:?""[328M
M3\&32 OID[7-@V>)[*8[TD7UY8Y]-P%>ET >)?&KX:7,MQ_PF_A)6CU*T(FN
MXHN&;9R)E_VEP,CN!GJ.>G^$_P 2XOB#HLMGJ:QQZQ:1C[3&I&V=#QYBCMZ$
M=B?<5Z-7SK/I4?@']HB2\TYA;V)F@D>!1A1!<GRG/LJR,./IZ4#.D_9WTD:3
M:>*;>9=MW!J(MI@5P0(P0/U+5[-7EO@74;>/XY>/M+MC\DI@N0#V=5"R'_OI
MZ]2H$%%%% !1110 4CHLD;)(H9&&&5AD$>E+10!XUJEE#\*=3O8-2LC?_#W7
M9/WT C+C396_V?[A[8YX&.1\QH6H_P#"L]2TXV6J?VK\/];EV6EP7WG3I6)P
MN[^X3GZ8)."#N];U+3;35],N-/U*!9[6YC,<L;CA@?\ /7M7A7@KPKY&H^-?
MA3K4Y:":,76GN_;TD'OS&2!_<8>M SW^O'_B/;G6?COX"TV $R6K&^DQV17#
MY/H/W)%=9\*_$-UKO@M(-54IJND2MIUZK'+>9'@;C[D8S[YK%\+SVVL_%;Q?
MXNNI$6PTB-=+M[AV^10@W3'/0 'G/HU 'G?[1-S<R^+=+T*QM5CM9$^TCRHP
M/M%R[%"21]Y@%4>O/TKZ*L+1-/TVVLXO]7;PI$N/10 /Y5X9?:7I^M?%WP'I
M>AVC0:=;0-JQ$A+,RF5G$CEOF)?RT/S<_.,U[W0 4444""OE7XNV4G@OXQ7-
M_# LMGJD?VEX'SLG1\K+&V/5@Q]1D$<@&OJJO(_VB/"TFL^"8-8M(]\^D2EY
M,#GR7P&/X$(?89- T9_C_P 3V=II7P^^(&AH[Z?9W!B9%.7$<B /&23]X"-U
MY[]ZX3PM,WB;QYXF^(^H*R6.CK+?1"3G,N"+>/ZC _%1ZUD>"-;OQHH\.ZY:
M/?>$K^21YE0 R0,H!>2)ASN0;7*\_+DXP2:]5^('A?3?!/P)ET;1)YIH=1O8
M!)=2L':3+*0Q( & $4 << ?B =K\(]"_L'X8Z5'(#]HO(_MMPQ^\SR_-S[A2
MH_"NTID$*6]O'!"NV.-0B@=@!@50\1:Y;>&_#E_K%\<0V<+2D9^\1T4>Y. /
M<T". ^)&JW?B?7H_A]H=P;9)(OM&N7P.!:VO79GU8=O0@="<0_ W1;&*VU[7
M]+M?L]CJ%YY%@&')MH?E5OJQ)S[BO-=%76]1T"?[7(\6I_$354@63HRVL;$R
MN!V7+A<=U![5]+Z7IMIHVE6VFZ=$(;6UB6*)!V4#'XGW[T#+5%%% CQ+]H&V
MFU;4M L+.80R6MI?ZB[]U$,0<=^^PCZFO:;>7S[6*4C'F(&QZ9&:\1\9ZA'J
M/Q,\<>:VY-'\(3VT8'9Y%!)_\B8/_P!:O9])A-MHME V28K>-#D8Z*!TH&<A
M\9]:.B?"?6'C;$MT@M$]_,.UO_'-U?.G@6]?2?!GC&]M5;[9<6L&FP$#_GO(
M0P'OM0X^E>K_ +2%ZTUGX>T*,._VFYDN9%3J%10N?R=OR-5+;1-+FO?A_P"&
M]$M?(AU2<>)KY<YVKMWHA/\ = R@^@[F@#V3POH<'AOPMIVD6R*B6ENL9VCA
MFQ\S?4MDGZUJT54U75;+1-+GU'5;E+:TMTWRRN>%']3V ')- BGXH\26'A+P
M[=:QJL@6&!?E3/S2O_"B^I)X_7H*\5\(:/?:U\2=/&K)G4Y+C_A(=9_Z=L B
MU@]B-^XCT8?W:OZCJK>)4F^)/BJW>#PUHX+:%I4_#7DO197'NV,=>!Z EN\^
M%WAFZT3P[+J>N$R:]K<GVW4)''S*6Y6/V"@].Q)[8H&<I\3?$6H^+?%EO\-/
M"<_E27'S:K=J?]5'C)3Z;>2.^57N17I&@^%-)\-^'(]$TJV6*U5</D M*V "
M[_WB<<YX[8QQ7E7P%6/6_$_C'Q7( TUW=[(S_=5W:1A]/N?]\U[+J&H6NE:?
M/>ZA,L%M;QM++(W15'4\4 >43V>J^(/&EYX(\+:O>:=HVF!9M;U-9=UU<S2<
M[1)V. !Q@#!&, +7+20_#.SFOH]&\$:SXIAL2QO=41Y'C&W[QW;@#CDYP,]>
M1S76>"O$6C^'OB/XXTO7K^#3KB\U 74$ES*(EFB89&UR1SA@1]>.]>&^/;.Q
ML/$5UHW@_5[G5M!M1]H1%E,L4+$#>01\I X&X>P)/6@#UWP_X)\"^.])N;_X
M<:G?Z#>+Q-:F0NJD]!+$Q.Y#[':>?3%<7J?@^;1]<CL-0B7PQXG5M^FZI9R&
M.RU!AVS_ ,L7/8C"Y."HR#6?X(NKKP#\5_#WS&/^T(;:.\@_NI.HX8=<C*OC
MUKZB\1>'-+\5:)-I6MVRW%M*._WHV[,I[,/6@#Q+X):GJ^I?&#7Y?%)8:N=/
M$<ZR1B-R8VC3D #G %>I?%/Q$_ACX:ZM?P,4N&B\B CJ'D.T$?0$G\*\+UQ-
M7\%>)%FE<MXA\,%)([G!']IZ<3L4MZLN=A[[21_RSS7T(T.A?$7P5$;F%;W2
MM2A60*Q(([]1RK C''0@T >*VMPVK:#I_@7PY=.OA_3XE75+NS=1+JERP+M;
MP$]<DG)Z  D_*.<J^EN&TF2WT_[/9:-"PCDAM;K[+IT;?W)+@?O+R3^\%/!Y
M!(KT/Q[!8^&] MO#FB6L>GZ:69/L,;F)K\[ [;Y<Y6!1@R/G)QMR.M>=Z#8:
MYX^U1H?"L%O,+0".36KR$"WM!_SSM82"L:^GRESPQ*9- ''%9;"Z34?#6JV5
MA)#D"73EO(T?G@;Y%Z<'[Q ZYS7IF@W-QX1TWP_\1;,I#9:G-]B\06L*A8"?
M,9!.BCY>"N<KQGIPQKJ[/X):@D?F7OQ"\0R7F.)8)VC _ L3C\17,_$+1/'W
MAKP+J&ARM#XF\/W 4B[6WV7-J0X?+*O49'WN?<CI0![IJNIVFBZ3=:EJ,HAM
M;6)I97/90,].Y]N]>.7VM_%3Q7H'_"2^'9DT>PFES8V*QP[FA&29II)3A5P.
MV<^F.:WOB78:KJO[/VR!)#=+9VT]U"%.YE7:S@CKQC<?]VN0^'_QVT"U\+Z=
MX<\6V4\:6]N+5KD1B:%HU&%WK][&W ( ;]> #GK'Q)?_ !+^(&C^%OB'JL#Z
M=&[#&G2*([F8KE=SH<$D\9'3) QG-5?B?X'T32/BQHOASP]8RV-K>1VZ28=Y
M"[R2LI9=Y/;'3C(KWIK3PEX[\#Q2O:)#I5W(%M93&('5A(8XWC/526^[T)#
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M.:4-"\+Z9I0(/V*TB@)'<JH!/XD5X_\ \)7I?B3Q;_PGOBF\6S\*Z'<-:Z-
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MAK2&XD#Z?K\,9(7T++W3D;@/F4\@D=09[Y\-O%=[,UQX0\7-Y?B/2/D8L?\
MC\A'W95/?C&?P/<@<=^T=XCD^QZ5X2L3NGOI!<3HO4J#MC7\6R?^ "J$\.HW
MD>FV'BO48=+\6Z>OF>'_ !.D@-MJ4>.(VEZ-G/?D[NAR0TFG^ /%_B3XF)XM
M^(UI!86FFJDK"&56$QA4%0H#' )&XY]Q] #K- M(M3^-]T(47[%X1TF*P@"#
M"K-(,DC_ (!N7\*]0KSKX*VTDW@^\\178_TKQ!J$]\YSR%+%57Z#:3^->BT"
M"F331V\$DT[K'%&I=W8X"@#))-/KRCXN:W?:Y>VGPY\+/NU+5<-?2 \6]OU.
MXCIG&3WP,?Q"@#SK2[S^W])^(>OX;&O7\&FV&1RYEF)VCW";#BOIRO'+;PY9
M6_Q"\*>!=&/F6'AB)M6U!SUDN#_JRW^UN(;'HW'2O6-5U2ST72;G4M2F6"UM
M8S)+(>P'\SV [F@9X9\19XO$/[16DZ!+(ZP"R-C*8V 9#/')EAG(R%D4_A71
M>!3%?_'#7_(4BW\.Z9#H]L&ZA589/_?2M^!KB/A[-%J'CW4_BIXPG33=)CFD
M^S27!/[R5P55$'5]B9' /('H<9NL:M<ZI\0K_6?@[)KK7.IY6Y$=D/+YQN8.
M22 2 ?F48.>: /H?Q3XUT#P98_:=?OX[<LI,< ^:67'94')^O0=R*\DM-;7X
MHW=SXG\;N-*\#:-)FWLY'^6ZF_V\??('8?W@HS\V<BV\-^'_  ^^_P >_:/&
M?C>\/R:/;W#3&(]A(RGKZYR #PIQFMC7=)'AW08O%'Q0%K(UL-FB^%;,!;6!
M\9"D#AL=6/(P.K9 H Z+1["\^*FNV6OZK:/8>$=-</I6FR+M:\<<":11P%'8
M?TSGU:N$^#WB#6O$_@%-5\0M&TLUU*(&CC" Q X P/0[@/8"N[H$?-GA+4[G
MX<>-M=TB[E:/3K?5HQ=IC -K*'03$]@I> _\"KOO"FB7.OVMA:ZI=/'K'A.Y
METN]6>/>E_9N!\K GD/'L()SR,XYI?BUX1?[5%XQTVR^W&V@:VU:P YN[0_>
MQC^)<Y!]@?X>>W\%WNF7_@[3I=$OVU"S6!8H[B0CS&"C $F/XP  >G/:@8:K
MX1\/ZC811WN@6%_]CA\NVCFA4E5485 Q' [5Y*_Q#A\.Z7-8ZE\'I+!0P;R4
MMU$$A5LJ2WEX." <\\C->[YSTJI8ZKI^J>=_9M_;7GD/Y<OV>99/+;^ZV#P?
M8T"/G/X?Y^*OQH/B77)[&R>R=+B.QC(628QCY !U;;M!9CD\ =.GTO7"_$KP
MGI.IZ*^IOH]]+J5KF2*^T<1K=P;06WC<Z;P,8V@DY/ SR*OPR\;7>J7-]X6\
M27$4^N:6 PNHB"E];G!29<<'AE^H93W. 9C_ !YT0SZ;H^L681;M+HZ=([#@
MPW"LC X]#T]-QQ6=^SUK-U9_VWX+U4%+G2YFEC0]5&[9(OT# '_@1KJ/C8__
M !1NG6\;%9KG6+6*' S\VXGI^!KD_%UU;?#C]H"'Q+/^[T_5M-F,Q'&Z1$/R
MCW)2+\6H A^+E[)XR^(VG^ _#H5+J5534;L+DK'_ *S83_=4?.1W.WN*]D\/
M>']/\+Z#;:1I$(BMK9-H]7/=F/=B>2:\=_9YTR?5M3\0>--4_>75U,8$D/\
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MYVW$@22WC2JI)ZY#,?\ @-?05<OX"\!Z;X T$Z?IK/-)*_F7%S( &E;&.@Z
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MC4 DX QP._L!BCXD_:-T&SW0>&+.;5)R=JSS_N(1Z'GYC],#ZT =G9:'X/\
MA/X=NM2CB2TBC3-Q>3-OGG/8;CR23T48&>U>/^*X-5\:WEC?ZY"(M3\12_9=
M"TR4\:?9YR]RX_O$=_0D]E W-/O[#Q)J::[XOU6;QA?VA#VN@Z#92RVMLW8G
MC:Q]V('J2,8XWQ ]SXI^)$NJ^.WN-,5@(;;1;,^;>RQ\X@"+RFX$Y9\9+' /
M0 'IMY\6O#?@O3[+P]X0TZYU_P"R;+)#:G$/F8P$\S!W.V"> <\UZS&S-&K.
MNQB 2I.<'TK@?A]X%_LW;K.LZ?#:76"MAIL9W1Z9$1T![RM@%WZD\=*] H$1
M75S#96<UU=.(X((VDD<]%4#)/Y"OG75_&/A;1[Z\\3?"[Q"^F7H<276CW%NX
MMK_)Y*J1@'D^GMM[_1-W:PWUE/:7*;X9XVBD7^\K#!'Y&OFSQ!X@U7X8VR^#
M=9T.SOX+4R'3=4DB4RM S;E*,RLJL"3G(/IC@$@SM] U^]\'2AKBWDBT;79H
MKRSLY7.^UB-H\]ULY! 1MHQP!D]^:\]^$6E^((+&\\6>#&:ZN[&Z,5YI4K@"
M\MRH8!3_ 'P=Q_+'HW):YXXO?$%X\H%]<WES']G,U[=>>ZH3S'&$1 @;H<#)
M!(R,G/T3\(_#:^ /A[YWB*2#3[F_G-S.)G"+"" $C))QT&<=BQ':@#"UOXCG
M6]/.L:'>RVL=C)&MQ9W*>5-I=R"P620?QPN6\IP2=N01@@BO.M$U2#3_ ([^
M'M4T61DT_59(C# 6SY"3DQO#]$D+@#_9%:WQI\3^%KCQ5:7GAR[AO+F:SN+;
M4Y+-@R2HR!8P2/E8@Y.<G&U?05Y=X8U>+2_%FC:CJ+2O;Z9<).$3DX1_,"#Z
MM_.@9],>(W/BKXX:!H46'M/#T1U6\QVE.!$I]P=K?1C7.?M.6\3>&]#N6(\V
M.[DC4=]K)D_JJUV'PDT&\M-#N_$FNC_B<>(YOMMQG_EG&<^6F.V 2<=LX[5R
M/[0,;:YK'A'PO:<W-[=,>!R@8J@/TY8_\!H$=W\(]$&A?"O1+<KB2>#[5(<<
MDRG>,_0$#\*[.H[:WCM+6*W@7;%"@C0>@ P*AU/4K71])NM1U"016UK$TLKG
MLJC)^I]J!%EMVP[,;L<9Z9KYZ^"6D^'M4U/7_P#A,(HY?$ZW,BNEXY#A&4B0
MJ,_>W%\D<CCI71Z1)XP^+-I)K<VN7'A#P\'9;.&R)6:< _?:3(XSQQP<'CN>
M4\8_"?\ X1#4E\4>(+BY\6Z*SJNHF65TNH@<*)-P8[\<=2.PQW ,R/B)K.A>
M'OBMH]YH-[]OCTRZ6YN8[?&Q2)%8QJV<$[5V\<!0B]02>*L?'OB'3=1U;4-.
MOOL]_J[[KFY1!YN"Q8A6/W021TYX%=#\9+7PWI_B32]-\'VEM!91:?'*98N3
M*9"64LQY;Y"IR?6O9/"WP&\/^'/$UGK4-_/?+;?/%#.JE6;:1N)'7DY''&!0
M,\4\/>!?%GQ%\13VD]]=)=6L"SW$NL-(&0M]T#.YCD<@\9&3]?HSX7^$]=\'
M>&I=.\1ZNFI/YY: (SNL,> -H9L'MG&,#GK69X4G6\^.?C::TE$MO#;VD$Q'
M02A3\N?;# ^]==XB\7:#X3MEG\0ZI!9*P)1'.7?_ '4&6/X"@1LT5YZ?C/H+
M*9+?2?$%Q;@C_2(M,<QGWR2*VO#7Q'\+>+)OL^D:K&;SO:3J8I?<!6QG\,T"
M.HHHHH **** .?\ &O@W3/'/AV32M54KSO@G0?/!)CAA_4=Q7R)XS\"ZWX&U
M8V>LVY\IB?(ND!,4X]5/KZ@\BOMNN8^)-C:W_P ,_$27D$<ZQ:=/,@=<[72-
MF5AZ$$ YH&?$]?57[.]^]W\+_L\MRDIM+V6-(QUB0@, ?J68_C[5X=XD\"J/
M&FCZ1X7Q(-:T^VN[9)91P9(\D%CTR5)_$5[?\!O#4_AO0]5AU32KO3=5^T+%
M<^<24F5=Q1T[?QLI*DCY10#/1/$>@6/BCP]=Z/JD8>WNHRIXY0]F'N#@CZ5\
MR:';ZEX,\4ZEX"UJX6V:XF6;3KI_]7'=K_J91G^"0?(WLV#T-?5U>=?%[X:+
MX\T-+G3@J:U8J3;L>/.7J8B>W/(/8_4T ?,^NV=]9:Q!=6<4\ #D01J"7M9(
MC\\)[[HSTSSMVGC-8U_<QWE[)<10+;^9\S1I]T-CYMH[ G) [9QVKT_1M6AU
MN.;^W8+B/4;7:NKQQ BX!BXCOXQU\V+E9%_B7GUQ<\8_!J5M'AU[1KW2O,NC
M^[M;>?:E]E=P>$,!M=N3Y(+ ?PL?N@&>5Z9KFI:.)UT^Z:.*X39/"RAXY5]'
M1@5;VR.*U]"^(7B3P]XA76;+4'DNBH2?SAN%RH[2]W//WB=P['@5WGP+L/"'
MB"?4- \2:3#)J<D;>5))(P\^/@LNW. ZD AE ;&?0YU/&OP"U#3["X/@Y8-2
MM2WF+;W"A+J'U"2# D&.,-^ )YH Y+Q%\7[K5->MM?TFS_LS6(P,SHP)4 !3
M'G $D38W;7!*L3AB, =3#X]\ >.=#*^)M$M-*\0I@K<P?Z.)&!Y*3*"5.,D"
M3*YQD]37BLEH]CJ#VNK07%M)$Q66)DVR1GW5O3TX_#K226Z1QKF7;*'*2Q2(
M5:/'?W'Z@]NF0#V[1OC*N@6 L]8N5\5:#(QA/VC:M] ,?<D0DK,N!]X$@]V'
M KA[KQE9^']<;5/ -Y/I=P2K/';*RVMP.X:%R2ASGY=TB\C!&*RXOAUK]YI]
MUJ&CQ0:M86L/G27-E,'7;W&TX<,.NTJ#@9Q6-HN@:GXBO39Z+:->7(7=Y2,-
MQ'J 3S^% 'TEX ^/FD>(WBT_Q,D>CZBV%64M_H\Q]B?N'V;CWSQ7KF<]*^$;
MGP]K%FUZMUI=Y$; J+O= P\C=]W?Q\H/8GK7IGPW^)'C/PBMC:7FEW^L:'=*
MQMXO*9G"*,L87[A0,E>@Q_#UH%8^HJY'XD^ [7Q]X5DL9-L=]!F6RG/_ "SD
MQT/^RW0_@>PK9\.>)=*\5Z/'J6AW:W-N_#8X:-NZLO52/0_RK5H$?(&M>++Z
MX\%_\(KXJ$T.M^'KM7L)W!W[0=K0L?888-W"X],_1W@74;#QKX?@\3#:\NH6
M*6=_;LJE"\9;((QGJ[\'@JPXKF/C-\*!XPLSK>@Q*-;MTP\8P/M:#^$_[8['
M\/3'E/P8^(#^!O%4FDZRS0Z7?R".X$OR_9IAP'(/3^ZWM@_PT#/9/B1\(-,\
M6:&IT.&'3M5M(A';N@VI*@'$3X_A  "_W< #CBOFVS\ ^)+[7;O1+?3_ /B:
M6A_>6<DR1R$=RH8C>._RYX.>G-?7T_C+2;?^U59IGN-) >ZM4B+2K&<$2*O5
MDP<Y&>,]^*\K^*>IV?B@6-QX>3[/K4++=:'JL+C&HQ@?/%&XZ2!C_JVYR,#E
ML4 8/AGX7>*_[-N=(M/#B:&-1C$-_JNIWD=RPCSDK#&@&W/OG_>'6O0/''BA
M/A3X$TGPYX<_TC6)HEM+!6 8C& 967H3D\#H2>X!J3X0_%-?'%B^F:P%AUVS
M3,@ P+A!QO [$'&X>X(ZX'F'Q#N+KQ!\:/$?V8F5M*TUH+9"<8RBQMCZ-,[?
MA0!RVE>)/],CO8](;7_$,UTHN;[4L3H79B$BC0Y7YB!\QYP#MV]:ZO3?%?C'
M7?$-QH?@6XEU6Z:,I>7UTP:V 'WO*A(\J.+/3*EF]L[:K7>AP>'+2]6Q C6&
M^U-D<#_GSMQ#$W)Z^;,S?4UZY\#?"T7AWX;6ET4'VO5@+N9\<E3_ *M?H%P?
MJQH H_"#P-XM\$W^J)K\]BVGWH\Y8;5^$FSU"A0%!7(P/1?2O5***!'BOQB\
M!V2Z]#XQDTV2]T]T\C68;88EC3&%N$_VE &>V%&>":\JN/$?B/P;XN;7=-U<
M:S9W"I#]N*;H;Z$# 28?WPHP0WSCUZ$_7Y (((R#U!KSC7?A';#4GUKP+>GP
M[JK<O'&NZUN.^UXNF/H,=\$T#.4\+RZCHVD1^-?AO;27OAZ^9GU+PT7R]K(#
MAV@/KQTQR,<'C;Z=H^M^&?B3X:9[;R-2LI %GM;B,%HF_NNAZ$>OX@]Z\EUE
M-/L9&C\=^&K_ ,'ZE]W_ (2'PWN%K(?[S!/7T(+?2L#3/ASXKM-0DU_X9^,K
M+6Y'8M)-;W7ES-DY/FHY(Y/)#$\]J .S\2VMY\$[^WU;P]YUYX0O)?*OM(E<
MR+;LV?FC+9P#SU[\'.1C@/B7:Z;X.\=:1XF\ WB0&^A348;6.-@(P03N7C;L
M89RN>/F&,8KN;JZ^+'BSP9>:'JWA/2[V*\B\K[='?0C:>"&(60@D'!X [5M>
M(/".EZ3\#+'3?&=G-?/IMNJ/<V,8DEM"QYD4\':N1GU"\T 7;Z*S^,GPSL]5
MT286FJVSBXM),_-:W2=4)]">_H5;'2O,/"3^*M4TZZU"&Z$OBCPA>EX=/DSY
MTELW$T)'=,C"@'CY@,96I/@MK4O@;QX^@:K+NT[7%7['=)GR9G'^K=2>S E?
M4-@'!!QU_P 7?!&J:=JB?$#P,TL&J6N&O8X.LB ?ZS'?@89>A'/8Y /2O"/B
MS3?&?AZ#5M)DRCC$L1/SP/W1AV(_48/>MNO _!DFC_$6[EU7PMJTW@WQCC?>
M06OS076.LGE'A@2>1G@GD'J>W,'QALXQ%#>>$]1'W?/GBFCD_P!XJN%_+\J!
M'3>-?%EGX+\*7>L7K+F-2L$1/,TI'RH/J>OH 3VKQ?P9XBL? 7A'4?%WB^YG
M?7?%3-);0V^TSF+G$@W<*"Q)R>,!< ]*B^(OA^^T[4+/5_B1J\WB2ZPSP:-I
M\1A@5%QN+2?P1C@$[=QXYXR/./$GB36_B;XGLT6PA\_:+6RLK*'&Q,Y"@]3C
MGDG YZ"@9F:GKMYK%U/!;M="WN[CS/L[3-+)-(<!2[GF1NGMDG &:]_^$'P8
MBT*&+7_%MLDNIL ]M:2#(M>X9AW?_P!!^O36^%OP;L?!<4>J:T([W76&0V-T
M=K[)ZMZM^ XSGU&@+A1110(**** "BBB@ HHHH **** "O/_ (L_#>#QWH'G
MVB*FM6*%K23C$@ZF)O4'MZ'V)SZ!G'6N=UWQ[X:\/Z?<W-[K5AYD$;.+9;I#
M+(0/NJN<DGITH \2^'M]%I*W.N^!I9EOK:,'6_"DY/[Q%X>2 GG(/(!R1D@G
MD ^S6][X5^(7@RWUF\MK>\TO:TQ6]C!\DKD-N'.",'^?2OE#2?&"V>MZCJ>H
M6#7%Q?3&X%S:W!MKBVD+,VZ*0 A<[B""I!XXXKWCPK\7_ .LZ!>Z;J$2^'1<
M+)]H@< )+Y@P[*Z #)SSP#0,D\&: OC_ %.#Q/J5C%8^&;"5O[ T>*,1QG#8
M\]T'&<C@?T^]W?C?QC8>!_#$^K:@P9E&RW@SAIY#T4?S)[ $UXCX*^.EGX-T
M"7P_?6<VJ0V#R1Z?=VY"^='D[ X;!'UZX/3(YX*U\<1ZWX\AUCXC13ZW8%G#
MVHE8+"K#'[M<@ #@XR,XY.>: .G^&VD:G\1?$NI7Z22VFHRS&>\UL$YMD;I'
M O\ "[<C<3\JC  [^_ZUX)M-9\$P^&);NY^Q(8A(TKF1YD1@VUV//..H(([>
ME<AX2^*'PKT2Q31]!O%TNV4[E$MO(H=CU+.0<GW8]JR-%O9/B]-=ZAKWBK^R
MM 6X:"VT2SN5ADE48P96ZG/''/?&.X!G^*/ 7P7T.1UU#79[*53S;VEWY[J?
M0KM<C\:S=,T+PO+,A\%_##6_$+?P7>K3&"W/OS\K#ZXKVOP]X%\)>'XTDT'1
M;&(C[MP%\R3_ +^-EOUKHZ /+HO"'C[Q#:)9ZMJNG^$M' Q_9^@1XD*_W3)T
M7_@.0?2NN\+> O#O@Z$C1-/1+AA^\NY?GFD]<N>?P&![5T=% @HHHH JZEJ5
MGH^F7&H:G.MO:6R&265^BJ/Y_05Y%XE\?CQ;I2#_ (0_3FT6=C]EO_$U]%:)
M,1_%&K$-^*GIUQ74_&3PSKOB[P1#I/AM%>:2^B:X5Y0B^4 V22>H#;#CKQP*
M\XU;X=?%K2M)2XAURWUE+>(+_9ZMYH"  ;5CD38PP.G4^AS0,9HFJ7W@^\FO
M-#\$>%-0E@4--_9&HB:XC4CMEW< C^Z*U]?U;3_CEX>L[?P])%;:[I5Q]I?1
MM28JLZCAERN,CW&",D';G->/:<MEX@UF6RGL(--ENRJ$JI"6USDA6 _@C9BJ
MLIX!;(Z #7O=$GTS3X-3TM)=/U.S+W-LP/[R)H&VW%NWJT9Q(I//ED@YP, &
ME??!7Q7JFJLNG>$SHRL^7:758I8$S_=P-^/Q8BKWACX6:6WQ*@T"XNX[Z/1D
M^UZU<D[8V<<K;H#_  C^(GK\WW<8KUK2OB;#??!>;QE(J"YM;9UFB'07"_*%
M]@S%3]&%>"^%;.9[":YU"20/KBRW&H76?GCTZ)MTS9]99!L'J4(_BH ^KFUG
M34M6N#?6XB6V^UDB0<08SYF/[N._2O'?A_/+\3OC)?\ CB6%H]+TB/[+IZ2=
M<D$#/OAG8CL77ZURGC#6]1B\++:^6P\1>-GC=K2/@VEBIVV\"CMN_7G->\^!
M/"T/@WP7I^C1 &2&/=<./XY6Y<_GP/8"@#H:XSXO6-UJ/PEUZWL%9IO(63"C
M)*I(KL/^^5-=G1UZT"/#M-\1^&_%7P<TW3+'Q!I>C:Y86<-NBZE,D2JZ8!/S
MJ<AMN[*C/3)ZUF>!_'VHZG?:AX.\:S&XN+E)]/G5VZ[8GP5 X!&QE8@<[HSU
M!)L?'OP-X5T3PVFLZ9I\=CJES>)$%MR563(8M^[Z#IU '/UKQN\OM0/C-KW3
MX)8KNYDW6\94,["087 [E@P(^HQG@T#.Z^!_@&U\;:KJ=[XAA:YTZUMOLZAV
M/,C#:N#_ +* X],K7JZ?#?QII]N-+T3XC75OHP78B36:23Q)V59,YX'0@KCL
M*ZCX>>$H_!7@>QT@!?M 7S;IU_CF;EN>^.%'LHJ]XD\7:#X1M([GQ%J45C'(
M2(PP+,Y'7"J"QQD=!0!R.H+I/P5^'LQT>&2\U"[F"0^<2\M[=., MCD@8S@=
MAQR>>6^':V ^(MTGBVVDU3Q*R[YM3NB#%!)NVF*)3PH5OD##JP(48!-:\NNZ
M/\0?C/X671[V/4-/TJQGU%C'G D8A%W X(92%.#R,CUKTN^T;3]1#?:K92S,
M&,B91R0I4'<,'[K,.O0F@"Z2%4LQ  &23VKR76/"<OC+Q1+'KEJDD-QN^QZE
M82K*+5U.01,D8>,A0?DDW(3T<' ,7Q5OM/G^(6D:-XTU"XL/"AL'NG$194NY
MPY'EN5YP% /X^I!KA[(V4U]:7G@O0M2\$:A>AVT:Z^UM+;ZH4_Y92(P^4L,8
MZ@D\YZT >J?#KQ-J\6M:AX(\8R>=J^EH)+>\((^W6^<!_<C(R>^>>037HE?/
M%Q\2DUWXD?#K5H+58+R>-8;IT?Y6$LKP.A!Z!2I9>3P_MS]#T""BBB@ KFOB
M/(T7PQ\2,N,G3)UY]"A!_G5G7_&OASPLRKK^L6ME(XRL3MER/78,G'OBN?U_
MQ9X:\8Z&WAO1-;M+V\UP&UCCMY=SHA&9'( .W;&&;#8R5QGF@#R.:)S\8/AO
M:!9O/M=+TU) \05<*FXE3U88SUZ$$5],5\TZS=ZPO[2K6?AR"U_M*%%L;%Y6
M=X[=/)'[P@]UC+9 XSDX/?OK:VTX-/-K7QEO)+JW+)<"VOK>V1&!Y'EE6QSF
M@9ZQ17CT?C>^TW2[[5?"WB^W\96.EQB2\L+V 0W"19Y=)55=WXJ1^@KJ=-^+
MGAC5/"8UFVN@9S\@TS<#=-,< 1JF<L22 "..<\<X!'GGQET2VB\92^(?#ER=
M-U72-/%]?7$0X9C(L<(X_C;+@YZA1FJV@:_X8^)/@/\ X1?Q,8M U'_76$F!
M%;F09'F1< #+9W1YP3G;STB^)6C:G<6ND^'F1+CQ3XIU'[=?B.?/D!5VQQ%1
M_P LT5SACQ^[<_3V-? 'A^;P78^&M3T^&^LK.%8T\Q<,& Y<,.5).22#WH&>
M"_"7PGJ-E\49K76=,>9].NE$]Q#+B2TE&623KEHW 93P00P]J^H*\@TWX3:M
MX'^(MAKG@Z^:[TR5Q;WMI=R?O(X&(!PW1@N P'!&T=:]?H Y_P 4^!?#OC*W
M\O7]-BN'482=?DE3Z..<>W3VK(UKX2>%?$&CV]GJMM+-<V\*PIJ6\+=$ 8!9
MP './[P-=O6;K7B'1_#EI]IUW4K:PB/W3/(%+'T4=6/L*!'(77P=T*..TN/#
M<]QH&KV<2I'J%EA2Y"XS)']UL\YX&<GFN2\,_ N[M/$6HGQ4VG:C878,T5W:
M;K>Y@GW9#(%4!!R?E!*\#CBNXM/C%X!O;KR(?$ENKYQF:.2)?^^G4+^.:I?$
M+XF77A#5/#T&D:4-9AU4R,P@8L[JNW'E;<@GYL]^@]<T#*EQX)\9Z,)AI.JZ
M=XGLY;=K9[?7X<7'DGK&)TY8'_:P*Y'X>_!SQ%9Z1>G4-1O_  [JD5VLD"J\
M-S:RA0K(YBY!97&02>., $5ZUX/\=:)XWLI9M$G?S8"!<6LZ;)8">S+^!Y&1
MP:Z*@#PN[\)_%+PYXS7Q)H]OI5^[86\CTYO(%\N<DRQN0N_G[R\]_6O<8G:2
M%'>,QLR@LA()4^G%/K/UK7M+\.::^H:Y?0V5JG625NI] .I/L,F@1H5Y=\4?
M@S8^-5?5-&,5AK8'S,1B.Z]GQT;_ &N?0YXQ&?B=XF\3I++X$\.1P:7&"6UK
M7)/)@ '5@H() ]03[@5PVL>./%]S#<-9^/%NVARKG2=.1+2)\<!KF4H!GU!/
ML*!G/V^NZSX9U:ST?Q>UQHVN:1\NF:NRE_+C_P">,H'^M@/.&&2O.,CBNSL+
M"+7I+F+3-,1)+G;-JWAH7"J&)^[?6$A.WKSD'!Z'MGRGQ-XN\7:MIB6?B.^_
MM"T#?NYI;6-]K=2$EV9],[6YJ3P)\2-4\$ZE;2K''J%C"S$6UPH/E[AAC&Q&
M8R1UQP>X- SV7Q)\)-7T::'Q?X6U5KGQ%IV99%\C9]O )^\ >9"ORMC ?K@$
MDGFO &O:=X@_:*N-1LX-]MK%D6:&09\J3RD=U.1SAT8?D:]O\(^,M&\:Z,NH
MZ'<B1>!+"_$D+?W67M]>A[$U3TSX;^&M(\97'B>PLC%J-P&SASY:%OO,J]B>
M_P!3ZT".!\>>')[+1[Q;@!MUGKUVNWD@23Q2K_XZ.?:O1OA](LGPT\-,AR!I
M5LOXB)0?U%6_%D,$_@[6$N@/+-A.&)&=H,; _H37+?!'5UU;X3:5\VZ2SWVL
M@SG!5CM'_?!6@#T"BBB@04444 (Z+)&R2*&1AAE89!'I7":]\&O!NN.\R:>V
ME73 C[1IK^2>>ORCY?TKO** /GW5O@-XJT2^?4O _B7=+UVEC:RGVW)\K'W.
MW-5=.^*?C_P%JB67Q'L);JR;*DW$*JY'&?+E0;9#UX.<],BOHROGGX[^+U\5
MZC8>"_"R'5)89S-<"V0R,90"JHN.X!8G'J/0T#*'Q TS0]-U33O*U=;7PIKL
M?V^Q\K+/I4Q&X2QQ#YA&QX*CCD\ JM;O@#]H.!UM=)\:(PF#"(:K']QQT#2+
MP5[9(SUZ"N6T+]GCQ;K$"3:W=V^DKM 2.5C-*!V^5> /;=GVI^L?L_W6C7UA
M%<:XTD%Y+Y7VB'3I)%A<D!0X4G )( /3KG% '4?%7X7?V(7\=^ YCI]S9M]I
MN((6PH'4R1^G7E>A&<>A]6\$^(SXK\"Z9K@1?-NH,R(IP/,4E7 ]!N4UY1>_
M!3QY#H,NG:?X^ENK9H_*-E/)-'$4Q]T?,P [8QBO+DN_''PAUU[5FFT]Y%.Z
M%R)8+A?7'*GZCD9[4 =CX_\ $]X_FR>+[N/7YXI/DTC378:=8/SM\^1>97_V
M,]CDX.*])^#?PUMO".A1ZQJ$<<NM:A$'=P!BWC;D1K^F2._'05X#??$[6-1\
M#3^%9[/3$L)9%D4V]HL31[6W84+A>2!SC/7GFNG\#_%7XBPZ FA^'M+_ +9$
M $<$QM))7@7LI*D# [;NGTQ@ ^I:*^8]0M_&]_,7^(?Q#@\.1M]^T-YF7'_7
MO"0/SP:;:^"_A5=2K]M^)%U/<L?]:8_*'YNIQ^)H ^GJ*\$?1O''PVLTUSP3
MXA/BWPXHW2VK-YH6,=2H!/'^TA!]1@&O4_ GC_2?'VB_;-+;RKB+ N;1S\\#
M'^:GG#=_8Y !'44444 %%%% !1110!0UC6],\/Z<]_K5]#96R=9)FQD^@'4G
MV'-<%-\3=;\0PRGX?>&);BU4'_B<:JWV:U4?W@#@N/Q!]JX[X;I9^-_B'JLO
MQ+F-WXBL)62UTN[QY$2@_-L3H2I[?\"Y/(]/\:?#ZV\<-9Q:EJNH0V%O(&DL
M('58I@,\' SG.WDDX . "<T#/"?$^LZ??3L/'GQ"O]<?H^G>'8@+=/I(V$/U
M"DUSZ^(/AQ!((T\$:A=1#K-/K+(Y_P" JF/UKV2R^%_AZ75?$<1T"23R(O*A
MGBC$$8^7(AA!!+-MV[ICDY8XQ7'ZM\!-4999X+-0ZA6:.SD7#$X BA5V^Z,_
M-+(P/!(4]P"GX>\"?#KXDR/!X5U74M"U15+&QO0LRD#NG(+#_@6?859G_9EU
MU9,6VO:=(GK(CH?R -=O\)_@P?!FH_V[KT\<VIA2MO#"Q9+<,""2V!N;!QTP
M,GKU'7:CXPU'2-:GCU#0IFL@?+M$LV^T75TV1^\\M?ECC^]R[#MTH X*R^ F
MG^'M'29+*/Q/K+N%VWLYM[6$$'+%5RS =,<YST%:X^!&BWR+_;,Z1C.XVVDV
ML=M&#Z;B&D8?5_P'2N@O_BAH]GKSZ7#%-<R1PNYD0JJO(HSY2$G#D#)9A\J
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M'[T:7J#W264MU@[5=@1$[8_ASE&)SP0,'I6EXMOH/''Q0\.^&-(<74&BW?\
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MYBA0MO"*"W)'5B?:O5O!WC:V\6?;;9[*XTS5=.<)>Z?= ;XB1D$$?>4]C_\
M6R =-1110(XCXN:%=ZWX F?2U+:AIDT>H6J@9)>,G./?:6Q[U\^_%SQ3:>*?
M$NC^(]&,D?FZ?'O.1^ZF1V++[%<CK[$<$5]<UX+\3O@)->WUQK?@@1AI<R3:
M:QVY;N8R>!GKM..^#T% T9?A#2?'VJ>!;KPQI.CZ7#H^J[0VJ1SQF-5/^L?Y
M6+,[< @_=Q@!<<='J_P'U+3[=T^'_BBZT^*:+9<65Q,ZQS$KM8DI_>QR"I^N
M,"O#$N?%G@6]:.-]4T*X)^=<O#O^HZ-^M7+GXI>.+N$12^)]1"@8_=2^6?S7
M![T#+_B+X4ZEX21!KNIZ?]JG(2VL+.1IKFX8G "IM&!G^(GZ GBO7O@AX,T[
M0[6+4]1E%WK$H:&%L[H[4?,6BC;."W4L1P"=N<YSX=9:EHNGXU2]GOM;UJ13
MF%F:* %@0?,DW>9)P<%1M!Z;B*]$\)V7Q-\66)M-,LXO#MG=-F[U?[+]GDE3
M@!5( .U5554( /EY- 'H'Q \87/B#5#\/O \@FU2\!CU"\0Y2QAZ/DC^+'!]
M,X^\1C&^!FCC0_"GB[4;,,\RWLMM"SC+,(4ROYES^5>A^!? &D> ='-II:F6
MXEP;F\D \R9OZ*.R]O<Y)YOX#7"W/P]N91D2MJEPTH88(8D'GWP10(O?!&*"
M/X0Z0\&"TQFDF?.2SF5@23Z\ ?@*\Z\7^(;'1_BUXNF\0#5(]0%E#!HUQ8VZ
MRM:1F+,DB;F4#&>H(QE^0:ZF.SUSX/ZG=OI6F7&N>$+V<SM!:KFXTYSU"K_$
MG3TZ<XZM>NOC;X?G5K?P_I^IZMK++MBL$LG5PQ[.2.!G&<9H \$A\#W \2Z&
M;?41>Z?KC VNI1H3\QD$?[U&S@K*Z!@<CGJ<U[!\)KJZ\/\ BP:%)$8=-UO3
MQJ5M #E;:X4[)HU_V20QQV 7W-=-X(\&VGA'X=VK^+(X/M5BLM[<2'E;;,B3
MD#']TPQGC/*<<5YWHGQ9\-7_ ,9)M>U:633-+M; V.FKY)8<ODNP4';GGMW'
MI0!Z1\:[Z"Q^$FL?:K<W G5(47'"NSC:Q^A&?J!7&>#?C1+I'A?3X?%>FF>U
MMHHX)-3T^ZCN?+'1#-&I+(2 ,DGDYP,\5WFH_$GX?76CW"W^OZ7=6DD1$MNS
M"0R+Z;.I^F*^0;?49=/N;E].<QQW$4D#(>08W!&TCOV(]" >HH ^T_$>L6A^
M'>JZO:3QSVITR:>*1#E9%\LD8^M?-WP@TX6'QF\+%/,(N+26X.\<C-O*#^&1
MQ[8KL=)FOM0_9KT3P]9L/MVNWK:?;&1B $\]W9B>3M 0@\' -;&@^'XM+^/>
MA6"+&)M+\*QB<1$LHD&8SS@$C##D@9STH ]GHHJEK.L66@:-=:IJLP@M+6,O
M(Y].P'J2< #N2*!%VN-\=?%#P_X$MF6_N!<ZB5S%80,#(WH6_N#W/X UYU)X
MI^(WQ::1/!-L?#_A\N8S?2R;'D&?[XR<^R#CH6KK_!'P5T#PI*M_J7_$[U;.
M_P"TW2?+&WJB'/.?XCD^F*!G(V'A3QE\9+J/5/'%Q+HOAT,'M]-A^5I1V.#_
M .AMSZ#!KNKF[M?!*VOA'X=Z%!<:K-'YOD;BL<$?3SIWY)YX'<UWE<:WA34-
M2\67%]>/#INF&X65K>S8F;4'3 1IY,#"# Q&,CU/:@#2\,:'JNG?:[SQ'K#:
MIJ-X5WA%,=O H'"1QY.!R<L>6XS6/X[U#4O!.B_VUX>ATX:?;9-[I[VKCS@3
M]Y7C!VMU&6&WG)-=Q10(^?=,^'OA[XJ:2DWA7Q7?:;IT$OFS:#,GG+8R/G(1
M=R[0?FPV".ON*]8\(?#?PWX*M@NDV*O=&+RI;R;YI903DY/0 ^@ ' J_K'AB
M/5'A:VU/4=(,;!F_LV58O.YSA\J<C_&MN@9RM]\,O!NHZC#?W'AZS6YAE659
M(%,664Y!8(0&_$&N<\<Q2>.]2N/#>FBPO!9QF2:RO4O+.0,#@NLR_(Z_,O&"
M.<YYKTVF2RQPINFD6-<A<NV!DG 'XF@1YAX3^!N@Z'>17]XIN6DB'VC3KJ.&
MZ@#[>0&>/=@$G!&#P,YKH=2^$_@G4[":U;P]96QE4@36L0CDC/JI'0C\O:GZ
MD]UXC:6&V\2MHEI#=F -:P[)IRH&5$DHQUS]P,./O=176_=7G)P/J: /E_P'
MH\7@7]HRWT6:>&]C226".?;RNZ-BIP?NMT!^IQD'GZAKYJU_4I-3^,7A'58)
M;>_@DU:*%-3BA\F1QYR#R)H^-LD8)&2 2I4XXKZ5H&PHHHH$%%%% !1110 4
M444 %%%% !7S_P#M/N#+X7C!!8?:B5)QP?)Q_(U] 5\\?M/_ /(2\._]<9_Y
MI0-'1_"J[NFOSJ#&SN;8)]GO=4+^5;VP ^2SM$Z$!BI9^A/3/!/JUQ/&^H?8
M&O#')-;L5BC&' S@N&[8SQ7SSX*UB+7YM%LI-,&JR6;!]*\/V<WEVMFJGFYN
MI>27)R>0>IX^8"O=_$E[*GAPWNGW=ZJHX9CI-JMW-*N<%$4@C.?XB.,'.* .
M&UOQ#JW@[PS(+[PM!)X;@8Q21ZSJRS7=X"<DX.\$G/W22?8#I3T[XEQ:K<00
M>$K'1Q'9#$%A?W[V%Q!\N&4H5*/@Y^ZQQZ"KOC?5K"\O-(%DUG9^)I(0 +W3
MS>ZA:(?F&R&(,JOR3DD ?R\J\9:):O,QUN&/2I5S(]SJ-\)=4U*3H,HK%(5.
M0/F&% SEL8H ]7B^.F@'1;J2_N]/L-20$6\"32W<;G&02Z1# SUX_&L.T^-A
MDTVY6UU>SN[YF'^DW\0M+6W_ .N<2EII?Q]!TZ5\Y2KL<AF!;/.&##\QUJW8
M:G>V&[[!>M9-@GS8B4<\?=W*-W/IG% ['U'X0U;Q'KY33]4M1+I$A9KN]UR%
M4DOMW\$-MQLC]"V<CWXKT6PTZQTJU%MIEG;V=N#D16\2QJ#]  *^)K0?V7>V
M.LRZK93W0=;@0LKSN&!R-XQMZCD%LUZYIO[1FH6R[M6M]-U!%X*P)-;RGW&0
MZG]*!6/H:BO&[;]I?PNZ_P"EZ3J\3<?ZM(G'YEQ4FH?&SP'XITRYT>Z&LPQ7
M,>UI8K?#1\@A@48D$'!Z=J!'K%II]GI_G_8;:*W^T3&>;RU"[Y" "QQW.!S3
M-3TG3]:L7LM7LH+VV?EHIXPZY]<'O[UY7X#^(=S;026=UJ:^+M-A7,-_9(?M
ML2CM-;MAV&/XU#>^<Y'?Z!X[\,>)V":)K5K<S'_E@6V2_P#?#8;]* .0OOAC
M>^%+M]:^%EZUA./GFT>XD+VMW_L\GY3Z'\BO6NJ\%>-;+QEILCQQ/9:C:-Y5
M]I\W$EM(."".XX.#_(@BL7P-:>*="\:>(=+\0O<:AI]W*;ZPU%CN1<G#1'^Z
M<%<+T^5L5C^&9H=9_:,\2:AI VVEAIZV=W(GW9I]R]?IL9?^ 4#/5Z\ _:;T
M7_D!ZY&G]^SE;'_ T'_HRO?ZYKX@^$X_&O@F^T<D+.Z^9;.?X)5Y7\#T/L30
M(S?A'XL7Q=\.[&XD?=>68^R70/7>@&&_%2I^I/I7E/QS^)4U[KUQX.LIV@TN
MWPM_)$@9YI/O;.2/E!P.W.>N *Y/X3>-IOAWXYDM=7#P6%T_V:_C<8,+J2 Y
M'JIR#[$]\4GCG2;C2/BKXBNI[?[=;-.]W)!NYFM9\L74@'A=P&[G:<'G!H&>
MY_ C^U&^%-E)JUQYZ/*_V/+EBD"X55/IAE; [#'TK)^*]ZO@7Q7IOCK3KJU-
MWY/V*\TN:3:U[ 6SE<<Y4]\8X7TP?&M'^*_B/PGI+:)X4U!O[/$C/ UU:(98
MMQR0.6'7GZD]*]3^$>@2:M?SZYXR\/WVHZI<.!_:&HF)UA&TD81G#*#@ 80X
MSC.,X .W\*>(_"GQ4\.WXMM/RC PWMM<0A7&_D_,.N2N<@YRH/! K%N?A1<Z
M=I,MG:>-O$J:-&N$T^V8-(%S]Q6'..V,8'>O2K/3[+3D=-/LX+59&WNL$2H&
M;U.!R?>K% CS#PGJ^D>!X[?14\/'16OIE%O;27"2WDL8!,EU<8.(T4#/)/0@
M =!VVD>*]*UV\6WTN9YF:SCO0WEE1Y4A(0\]SM) ].:Y3Q?X#M/L]W/I\*6=
MC=!Y]<N(3)-?7<:_-Y$9.3ACP<$=  #61F]\ _#7Q#XGU>,6VOZX0L-I&<_9
MS@QVT"XZ[%.>/0^E SGOAU\-;7Q#X'37-(OKG0]?BOK@0:C;,<,H? 5ESAEZ
MCC'X]*Z^/Q5\1?"B>5XJ\++XAMTX_M#1'R[#U,.,D_0**ZKX?>'6\*^ -(T>
M48F@@S,/21B7<?@S$?A7&3?$WSM:EU&6[FBTB'4SI6G:?:JGF:G<# 9W=ON1
M@L,8(ZY)[4 7T^->@M&5GTCQ%:3<@12::=^1U P2,UQ&L^-?&GB_4KI/#/@K
M5_LTV8HWN[BXCA9.F2JE$!(Y(+,.3UKL?'/C"[\)^(BUA)<K/#;F[:PN6\R#
M48%YE,39)BDC&XXX! Z&O0=(U2WUO1;/5+(DV]Y D\>X8.U@",^_- 'C'AKX
M&ZIJKP3_ !"OXX[.)M\>C:>!'&I_VM@"KZ':"3_>KVNPT^TTNPBLM.MHK6VA
M7;'%$H55'L!5BB@0455U/4K/1]+N-1U.=+>TMHS)+*_10/Y_3J:\AT[XH>+[
MY+GQI'I<4O@N&Y:V:SC0_:EB'6XZ8.,\C..HQQNH ]HKR_69?L_[36@&=ML<
M^B210YZ&0-*Q'UP!7HVF:G9ZSI=OJ.F3K<6ER@DBE3HP/\OIVKE?B)\/1XV@
MLKFQU&32M8TUS)9WD>?ESC(."#V'(Y'YB@#S/XE^#/%7B[XT"7PQ97%JEI!!
M$VIL3%&AY8L'XW8#8(7)XKN)_P#A)? T=C<:]XAN?$&G2Q-;3VQMHO->X;:L
M21$ ,S,Q;[QQ@$FN%\?^!OB7_P (5>W^O^,%U&"Q02-9VP*"1 ?F)PJ@X&3R
M#TKU+PAXNT_Q)HFA.L%Q=O-:K)]J6W,L4,ZKM=&<9\MQS][&0>"<T#//M7TK
M0_#/A?2%\+S75U8#7V;==2%X_M2P2B,+P%V^;@9'!9>O%9?PT^,/ACPCX%.D
MZW:7L6I0RRO.4BWFZ=F)R22,-T7GT'/I<^+GB^VMH]5\/W6C6T-H;7[)9V^U
M1//-N!68!>8XD^8J#C>6Z8)QPL'P5^(/B"UBU.YMHU>X0-_I=P%E(QP6'7.,
M=>?6@#6^$OB1KWXE^%X$EE\T1WMM*&8N1;%6DBC)ZD*X8\].*]F\>>$-?\46
MEQ#;:W;1V0 DBL&T_>SNHZ-(90""<\$8YZ'%>,?#&_L/A/X]O[3XA6$]C?21
M+%;W90ND2Y.XC&<JV%^9<XVD>M>T:Y\0[-=-CN?#&J^';I&.);F\U58TM^,@
ME "S'K\HP: /)_#?@3Q-X9^+GA_5=2T/;8"8P%[:*+;$61E!=8?N_>!W-^)-
M=OHUTMU^U!K@L)4>*+1ECNBG(WAH^"1_$,@?@1VKCK#0I?BU\6M?UC0M9O=,
MTF.**.2_M%>/[3(L:IA02, X)P<X &>M>N^!?AYH_@*SF33/-N+JZ.ZXO+@@
MR2^@XX Y/'YYH ZNBFNZ11M)(RHB@LS,<  =237G5C\:]!O/%7]FM;W$.ERS
M-;6VM2#%O/,N,J#C@<]<^G0'- CT>BBB@".>"&YA:&YB2:)AADD4,I^H-8K^
M!/",CEI/"NB,QZEM.B)/_CM;U4-0UBVTV[L;27<]UJ$WE6\*$;GP-SMR0,*H
M+'O@8 )(! &6/AS0],=7TW1M/LV7[K6]JD9'Y"M*N$\?^+IO#^E6^KZ/KME&
MDA9(H;FU::VN7!^X9X^(FZC+'&1VP36QX$\96?COPI!K-E&T)+&*>!CDQ2#&
M5SW&""#Z$=.E '1UXK\+M2B\%^/O&/@[5)/*CCG?4+7(/S)C)P!U)CV' _NG
MTKVJO,?BSX"U#5I+3Q9X0)B\1:3RJIUN(QSM]V&3QW!(]* +OB/XA!YEL/#E
MO+J3RP+.197")<RP. 5GM@0RRX(=64X;(Z8Y-_P!?7>HI=RW6KZY=B/:GV76
M-+2T> \]U1=YXYP3C\:\;\'3Z9XIU:&PCL8U'V@R2:5]H^S7.FSD_/-9R$C*
M9&3$3D$< ]:^DX(S#;QQ&1Y2BA=\ARS8'4^YH&)<6\-W:RVUU$DT$R&.2*10
MRNI&"I!X((XQ61=Z-IVF^%+K3M*6PT:V:)E#F "*+/5BH*Y_,<UL3N\=O(\4
M9E=5)6,$ N<<#)Z9KY[N/B/XD\8^()?#_B+4-/\  ]E(<!;NQ,S2#.,;I!MS
M_M?*/2@1P^J^&=&.L7=GIMWJ'B>:!\R76GVT%I:C/)8R@N, D<D =O>H;/P9
M%K^L1>'O#WDZAK-S*)+BYMY6:UL8AU <_P"L.2"S=. %SG-=UXF^&]I?>-O#
MWA.R\2:MJ]S.IN;YIYU>&VMAT9% PI/( R>H]17HOC&_T?X4>"6@\*:9;VVI
MZ@PM;""WB&^:4C =N[[<YYSDD#O0,R/">G6U]\4K72]+;S-&\"6!M4D_YZ7D
MHVN3VS@-GT(]ZU/ &-<^)WC;Q-@M EQ'I=K)VQ$O[S'L6"'\:I1I_P *>^#3
M!W\WQ#?DD8^9Y[V7@ ?WMO'UV^]=/X%TNS\"^!M,TC4[RWM[SRS-<^;,H+2N
M=S\D\X)QGT H Z^O$OVF-2N(?#6BZ;$6$5W=/)(%S\WEJ !^;YQ[#TKVQ'61
M T;!E/0J<@UY3^T/HYO?AU'J<((FTJ[27<.H1_D/_CQ0_A0(]$TZVL_#7A:W
MMSLM;/3K0!B3Q&B+R2?P))K$^'/C>3Q[H=YJITY[&W2\>&VW'/FQ@+AOKDD'
M'&1CM6/?_%SP*WA&VDUO4(+K^T;16ET^)/.<[E^9&4<#G((8BF^&O%>O^)U$
M?A[PVGAGPU#&56^OU"/LQ_RRA&%&/4DJ,=^E '877BK1[/Q'::!)>*^J7>2E
MK$"[JH4L6;'W1@=3C-3:WXBT?PW:"YUW4K>PB8D*9I I<^BCJ3]*^>?$?Q-T
M;P;<7MA\-(?M&H3LPO?$-XWGRS-WV%NO/?[OH#UI?#GA_P"*GC.VADA=]'A8
M[WU2\=TGF/\ >#G,@&.@3:G/XT#L>H:E\9_#7V*;^S?[8N-R,%NK73'98S@_
M-\X ..#S7 :9\7,7B27OQ)U![;S &CE\-0*0/]Y&./R/TK<C_9ZEOXQ_PD_C
M34]0/]U5.!^+LV?R%7O^&;O!HMR@O-7\S! D,Z9!]<;,4!H=4WC](-9 :WCO
M]"G"F'5M,E%PL)(Y$Z+DH,_Q\CD9QS4\_C6;3M;>TU70KU;)OFM]1L1]LC=.
MS.L8WIG_ '2/>ODOQ7X<OO!'C*]T=Y7\ZT?,4\>5+H1N5QCI\IY].?2L2>ZN
M+JX-Q=3R33,<F21RS'\3S0%CZY\2?%_PCIMM<V<?B'['J.S"$Z?+*8F[$H0
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MSXE:M(LZ:]XRD/426]N\<+]P5\V:+(Z]5%1>%M>6=X_$FK3VYN8QN"1.B&!
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M1AE0?OK="@E3^]M8%7!ZY! ]* /2M"^)7PXBTN*WT;6]-L+6,82 K]G"_P#
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MU8XARTAX[?+GGG)H UOAGX-L?A1X(N]?\32I!?3PB6\=N?LZ#E8AZG)YQU;
M&<"D\':5>>*_$,OQ*\7PO#;Q1M_8NGR+G[/  3YI'=B.1]<_W<;EMX<O_&NH
M6VL>-K;[-86[>98Z"QW!6[2W'9GQT3HON<UW$DD<$322NL<:#+,QP% [D]J
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M4C W2#_@/XUZ':^!O$4-DT%GXBT_P_&P_P"/?0M'CB0'W9RS'\-M=\    ,
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M<?JHJEJ.L^--7M_LVK?"&UOX0<[+C6K61<^N&6@#SA_C3\0+A$3_ (D&GJ%
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M9)D4,1&@ Y)+*W'3.TD@ F@1!\1/&FF:EXFT_5_AG=7NH>*+ _9W-A:/-#/
M3DQOQ\PSTVYZGO@CO=:\)7'Q$\/Z!JM\]SX:UZQQ<PM& YMG;&Y2IQD?*IQQ
MTP>XK@/@CXSTCPUX7N;?Q%>?V7#(ZO;->3?ZX<@LB=EXZ@'G.6)K?\;?'_P_
MH^G/%X4E75]2<81MC"&+W8G&[Z+U]10,U;CX::]XC,<'COQG/JNFQL&:PL[1
M;19R.09&4Y(]OR(KG?&1N?\ A)6\$>!KUSJ&I(([D1'Y+"UVX.\@8554[41<
M8!8DLSKBZWQJMKOX6'4[-T_X2![.;,,<3;(IH_+WGYNP$JN.HP",\&KGP$M-
M,/@#^U;:476K7T\C:E<.VZ3S YPK$\_=(/ONSWH [_P_H=IX:\/66CZ<N+>S
MB$:D]6/=C[DY)]S6C17#_$SXE6?P_P!(4*HNM7N@19VGKVWMCHH/XD\#N0".
M@\2^*M&\(Z6;_7[Z.UAY" \O*?[JJ.6/T_&O&+O5?&7QNDFATU9/#W@Z//G7
M#(6:=1V(',AX^XORCN2<5K^$_A-J7BC4H_%?Q6N9+V[D >'3&.$B7.0' X _
MV!QZYY%>RPPQV\*0V\:111J%1$4*J@=  .@H&>"_#SX3^$M7OIWN]#\0W%G"
MH*7>J@6L4[9Z+&N'QWR21Q@XKV>V\.6>E:'_ &9X;"Z)&#E6LXDR#ZD,I#$X
MP2>?>M:B@1Q.L^&_$5];&"^3P[XEM^T6I630.!Z!U+C/N$%>4>)?AKX9A9YM
M:T+6_!PR<W=LPU"Q7W8KEU&?4*/I7T;00""",@]0: /F)_!WC/PUX<DN/!;Z
M5XBTZ2*2&/5-,B62ZCB?.]!W'4]-Q&3R*\?=&CD9)%*NIPRL,$'TK[$U;X:0
M17\FK^![Y_#.K-RYME!MKCVDA^Z?J/KR:XGQ99:/JN+7XOZ$NAZB1L@\1Z8"
MUO.>V6 )4_[,@/?!% SR#2[6_P!"\)/XF\-^(FCG5Q;:C8K$Z&(.6"JQ(V2!
M@I..V>G!QDW7B26^\%V6A7BM*=.NGEM)2W^JCD'SQ_3<JL/QK=\?Z#KNA_9+
M2?7CX@T5H?M%E<P3F2/RP1&&*Y.W'"CJ.P/89GP_\)3>-?&ECI$:MY#/YETX
M_P"6<*\L?;T'N10,^K?A7IG]D?"S0+8IL9K19V!'.9"9#GW^:NMIL<:11K'$
MH1$ 5548  Z"G4$A1110 4444 %%%% !1110 4444 %%%% !7RW\>? 9\/>+
M/[?LXC_9>K2;I-@_U4_5A_P+EA[[O2OJ2LSQ%X?L/%'A^ZT?5HO,MKE-IQU0
M]F4]B#R* /!O GAK4--7PGHNCZJ;6^UJ3^VM5DMI?F2TCQY,9*]0VYN.F3ST
MKZ,KY*\*?;_A_KGC0M(?[2TK3I+*W90<^8]Q'&KI^>X?6OI#P9J&H7%I=:=J
M:$RZ0;>S>X>7>\\GV:*1V;WS)^- V=+1110(*1E#J5;D$8-+10!Y!KG@WQ39
MZ^T7A[0K>[T5IA*L;ZW/AL8X>.5BG8\!3U_"K#?%VQ\(^(;7PIK'AI-*ERB^
M7IUS')#!YG(SP@7KD^QSS7J]<I\0-,T:YT![S6O"S>(4M_O16\2M<(G<H<@\
M>@.: /%_CIX+70_$LOBF+3Q>Z9JJ[9B'93;3X^\"#CYL9&01G<,=*H? +Q[;
M>&?$%QHNKS^38ZH5,<KMA(IAP,^@8'&?4+VYKL+?Q#\.-1\!WWAK0_%=SH<-
M\-GD:FCSBW&,%0),A1W^5@01D$5Y3XL^&6H>%K.'5HKNWUO0I& .H::X=5YZ
M-UVD]CR.1SVH&?9%>:?'3QA)X8\!-:63;;W5V-JC#JD>/WC#WP0/^!9[5P7@
M3XJWG@S3[2#7;HZWX8D(BM]0B'[ZR..(Y4ZC 'W<G@':6 Q7;>/_  Q=_$M/
M#6O^!-9L2;"9V2>0[T ?9\P&"-RE/ND9^A% 'AKQZGX=6XLM/M;RV:>U,D$
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M!7QRL"/LVMW=WLS@KJH;/_?PC/XU[QK/B;1/#L/F:YJMI8 C*B>8*S?1>I_
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M%>-?$/B'QI<Z1K^J3ZG8RV,CM%=GS.0RCO[$C'2@#VWPKXST/QGIHO- O4G
M \R%OEEA/HR]1]>A[$UXC^TEH,D.NV/B P,]M<V@L_,4G$4RN7!/U4D ?[)/
M:F_$OX?R>$O%D6L>!WGT-IF'EL)?*MRY_A63.(R3_!)A3V/\(WK7XAROI/\
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M?#GPSK%ZFJ6]LVG:C]Y-0TN4V\O/?*\-G_:!KJI(TE0I*BNIZJPR#2@!5"J
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MX>WF4Y212.00?3MD=Z^3OBAH7B;1_%0E\80V_P!LO(E?[3:+B.X(&TMP -W
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M?8="TOQ-% TLV@:E#=$IU$18+(/H01GZ4 >@44V.198UDC8,C@,K#H0>].H
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MKH8K XWKGMD]Z-H#8Z=Q2-"R)GYCGKCFL_6-9MO#^BW.J:JQ6TM4W,5^\>P
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M>8GG;=_E[ANVYQG'IGO7'Z!XZ.K6\VO:E]ET3PVRE;*2_<1S76"/WN2P")U
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M"CG<.]<K\1;J0?#'7H\?>M&S^8KM&C\ILL0BM@ MTS7&_%*/;\,M>D!*C[.
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MKUJGP,\ZG\2/19$<*PR3\V0"*\P^/9)^'%FDN Z:HFWCH#')D?Y]*];D!/7
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M\@M;#2DCX>3.7D. 2Q^Z,G"J.O7-=#69JEC<3/#=Z9%91ZBI6+[3<Q;VCA+
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M68X'\Z^Y=046<-O:1C;]E@2(%&P!@>GY5\N_ 3PT/$/Q2LY9T+6VEJ;V0D<
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M+I>DVLUE8;@\WG,"\Q'0''  /.,\G'I7G-8X:BZ:YI;FM>KSNRV/JWX,,A^
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MCKP_I)>-+2]@O)[IW'W%B164Y_[Z_*@#AO#?Q;2'4-4O==N,Z=?:W<6MD9)
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MWQL\8IHVG,8;5B72UWD06Z#J[D#YC[GN<#TK7U+]GK7;#>VFZS974L1'\+Q
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MZ]I3"*]C7[LH(^29.Q5P,\<?@17E^ENOP6^-DFE.[)X:UY5,3.3MB))"G/\
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MH_E7'0C>LWV.FM*U)+N9%A#]HU"WA)QYDJIGZD"OL_Q/L34((P2ODVZ( #C
MQ7R#X0B$_C;1(F4,'OX%(/?]X*^M_%C;O$\P'1%08_X#_P#7K3&?"1A5[Q0:
M7:5"MGC/->*_'6.(ZCH]Q'N+/#)&Q/\ LL#_ .S&O9&Z BO(OCG"?)T.8!MN
M9T!QQ_ :Y,+_ !4=.(7[MGF.@:M-H7B&PU2V;;+9W"3*?=6!K[0UHV]VMGJM
MH05OK=95/9N 0?R(KX?KZ_\ !$[:I\"?#=WOW26L7E$^H4LF/T'Y5WXJ-X''
M0E:9XK\;8)+WQIHUK!\\\MJL:IT&YI& Y_&N#\6>%M1\&^);G0]8$8NK?:6,
M3%D8,H8$$@9&#7IGQ)9I/BYX3&4Y,& .HS<'K7<?M"^#&\0VXU?3K?=?Z=&-
MVT<RPXR1[D$Y'XTJ4U"G%,*D7*<K'S%7T%^SEXL^W6U]X'U%@49&NK$M_"?X
MU_DW_?5?/M:&A:U>^'=;M=5TJ9H;NUD#QL#^8/L1P1Z&NF45)69A%V=SZ=^(
M DL/A_XB#HP(LWC91V)(']:SO@P?^+(Q@8_Y"#DX[_,>:U?B?JUIXG^!MUXG
MT1T:VNK5!(N,E274$'CJ#D'\ZSO@VS#X'0,H"_\ $PD7_>^8G^M><Z;A2:\_
MT.U34ZB?];G4,W'S$8SP>E>8_'&1E\"V<?0/?KQZXC?_ !KTJ8>9] ?SKS'X
MZ1./!^FL9<*+[!CQU)C;!S[8/YUSX?\ BQ-ZW\-GA2]:^POAE\OP$\/'(8?.
M2/\ MK)7QX*^POAV53X ^'<\[E..?^FCFO4K_P -GGT?C1O12/&H)XST%<1\
M9O"O_"3>!GEM@C7VGL;F+U*A3O4?4 'ZJ*N:YXN32]?\.Z(FUKK5+Q8N1GRX
M<_,?J20!^/I7:3(89"A.[GY>.:\N/-"TSOE:5XG&?!R5&^"6AQ;PO[VXW C_
M *:O_C7E'[12R#QAI!=5P=- W#N1+)G^GYU[UINFVVCV;6NF0""T21G6%>50
MNY+8]!DGCM7C7[1FF^9#HFKPJ3&IEMI#_=SAT'_H?Y5TTJG-7OW,*D.6E8X;
MX2>.SX"\;P:A/S83K]FO !DB,D'<!ZJ0#],CO7UW=+!<VD-[8.LUK,HECEB.
MY6! (/T-?!2FO3/AI\8]5\"RQV%Z7U'03D/9DC=%GO&3TY_AZ')Z'FNRK34X
MG-3FX,^G?O'H#]:^8/BIX)'A+QS;7ME;F+2M3E$L*+TB<$;X_;D@CV(]*^E?
M#NOZ'XVT<:GX8NA,O_+6!CMDA/HR]C^A[55\5>$+/Q;HO]F:H/D619()EQNB
M=3][Z8R#[$UPTW*C/4ZI6J1T.RO2K3!>"=HXJDX)D.T]^AIOGAF'4[1C)I8R
M78D],\&IE+FE<J,>56/)OCXNWP#9YSD:HG7_ *Y2UQ/[/?\ R5B'_KTF_D*[
MW]H0 > +/CG^U4'U'E2UP7[/?_)6(?\ KTF_D*[L/I3.:M\1]6NBRQM'(H9&
M!5E(R"#VKP+PQ:)X*\>:U\,]=GN+?1=<;S=-N8I3&P)/RX?U8+L/JR =Z]_K
M@/B[X$;QGX5\[35*ZUII,]DZ'#-C[T>??&1_M >]=!@4KKPYX"^'NK:)=ZW;
M75W=W,XM[?5=1F:X\EP,IN+-A/8A>,9XZUZ->6=OJ%E-9WL*S6\Z&.6-QD.I
M&"#7CEM?#XV?!F\TJX*IXDTTJ7C;Y29D!VOCL'&Y3Z$MZ5V7P@\0R^(OAKI\
MMXS->6>ZRN=WW@\? S[[=I/N:!G%? \R>'_''C'P:7=K>SN#-;ANP5RA;_@2
MF/\ *O;*\6^&@6]_: \=W\6?+A+VYY/7S0/YQFO::!!1110 45R_B[XA:'X.
M:*WOI);K4;CBWTZS3S)Y2>F%'3/J<9[9KG)-0^*_B7>-,TO3?"=J5S'+?2BX
MG;T^500ON&7B@#TNBO+9_AMX]U"W4WOQ1O89SG>+6S"*/IM=:I+\)_',$4G_
M !=?4]J\J720Y'N3+Q^M 'K]<O\ $'P/9>//"TNFW6([E,R6EQCF&3''_ 3T
M([CW ->>:SHOQ.\,Z=)?P?$S3Y+6%5>:2_C5 @=MJGE'&"> 3CO7'^,+/XAI
M(D?B?QS%);?:K>WOUT^=A]D6;E7D0+&I7 /?&>,T#/'70QR,C8)4D'!R/SKV
M'P!KTUX/AKIP#(+'5KZ///S*1&X/T_>N/PKR?4XK*#4[F'2YWN;2.5EAGD38
MTB9X)7)QZ_C7NFC^')=#\">%O%T;*+71=%OKMGW#FYFSY:XZY^?&>VP4#/2?
M@W%)#\(M#\[=OD264EAC.^9WS_X]7;UQ7@/7;2#2?#'ACRI%O3X;@OV^4!50
M"-"#WW%F/;L:[6@D**** /&8]*3P=\=+2QOXA+HNLS27FER,2/L5V0=ZH1T#
M9P5Z$,F>E>S5Y;\7],U:TGT[Q;I5NVIVNF.C7^F.QVLB-O290.5923EAS@C.
M5# ]]X;\1:?XJ\/VNL:1+YEM<KD _>0]"K#L0>* /&/BYIVH^ OB/IWQ"\/V
MH%JY5+T1C"M)DA@^.SK@9]1GKBO;M&U>TU[1+35=.D\RUNXEEC/?!'0^A'0C
MU%5O%'AZU\5^&+[1+\E8;R/8749*,#E6'N" ?PKROX&:W<Z-JVL_#O6'!GTN
M:22U8=&4/AP/;)##_>:@9[51110(*^9/B]J__"0_&^VTXD&RT=467=RH51YT
MSX]ER".^ROINOC77DU+7O'WBR^TQ]J&\DCD;^\DDXB5 ??</P!^E T?1_@R#
MQ C6-S>S^397D+ZI?/(0QFGN&.RW&[E5C3;TQD[0.,BNAT#[19R7%AJ^J?;M
M4D8WDJ*N$@C=BJ(G'"C80,\DAC]//[76H+SX8W_B#5K^1M/LM6>_M( P_?06
M\@2"(=@I>-><8SGCFI_"?CK4-5\.W-]XD,&DZCHEP)];1(]KO:>4\D0 Y.26
M48)SPW0G% 'J=%4-#U:/7O#]AJUO%)#%?6Z3HDH 958 C./8U?H$%%5K#4;3
M5+=I]/G2XB61XBZ'@.C%6'X$$59H *\&\::'J'BZ+QEX4L+83:GI>K1:K91!
ME0RQ31_. 20.,ECZD^M>\US@L-%3XG?;TNBFMOI)B>US@2P>:").G)# CKT8
M>U 'Q*RO%(R.&1U)5E(P0>A!KJO"_P!AD\3:%="QEM8XM226:4,63R85C>3!
M/\0 9CZ;A5SXO>&;KPW\2=3%Q'&L&H3/>6QB^Z8W8G'L0<@C^F*Q=$UY[*SN
M8+A#-!%9W20( !Y<DZK&SY^F!WX&*"CUYM;:X\/Z9XON[>-1;RWWB&XMP>#*
MTHM[,'\1P>XC/>N>U/PY9-H%FBR;UT/2O[9U@R=9;VY"^7 WOD*,?W<]S6U\
M)8M.U?0-/T+5I?ML^L7GGSQ"0'RK6S ,<;CLID[=P3]:SFO9/#WB&%]=5F74
M;AO$NJJ<?-$C.;6$_5^W3,B#C!H$4-*\$/I#V%AXECDBL8+;^W==C7JL8W+!
M W^V<-\O7]ZWI7NWP\T34HH;OQ)XF4IK.LE7:W[65N,^7 H[8!)/N>>1FL;2
M=2GMM'U1KG2EU;Q#<:>FL7T/E;@)G/\ HMN!V"!,>VW=U)-=#K/B)O#7@2=M
M<OHI-:M](>YD5,+YCJH5F4#H/,=1^(H X#XQ>(+A?.N!:>5-X5UJQGM[A3S+
M')$6/_CXQ_P$>]>U*P=0R$,I&00<@BOEOQ+>ZC+X/\1VNL%W>+3]#(D<DDR&
M+/)[GYGR?5:^G=/_ .0;;?\ 7%/Y"@"Q1110(I:U8MJF@:A8(P5KJVDA5CT!
M92N?UKP?X<:S):?!KQ9X9@$=KKMF\JR13RB+8DFV-I"6.!L^;/I@>M?0M>3_
M !)^$OA+6=7_ .$EUC6/[!1L?;'W(J3XZ$%NCD#'&<\<9Z@SCO#^E2_$9K3P
MAX<:2U\"Z(5^V7@78^HR_>)/?YCD@?PC!/.T#Z!L+"UTO3X+'3X$M[6WC$<4
M2#A5 P!7C3_&_P "^"-)BT;P9IMQ?P6PPGECR8R>Y+M\Q)/4[3FN4O\ ]I3Q
M/=2!-)T?3K8,<*'#S/GT!R!^E 'TQ7AG[3L6=#T"7/W;F5<>N54_^RUQ,_QM
M^)4=TBSRPVA) V3621J3UY+CC\Q6?XKU3QW\1%L(]<MH1' 6^R2*JPQ3LQ (
M60G8S<  !N>V2: +/P@)-OK*X& T!)[GB05Z,5XY' [UYU\-H+G0M4U?2-8@
MEL;Z01,MO<*8W.W?D@'K]ZO2$8;<,<>HKQ\5_%9ZF'_AHBSM& #@^M*N.H'/
MN*F:+(]JA8-TZ_A7,;G@_P 7 1X]DW.K9MX^!_#UX-<II#,FMV+(P5A<1D,1
MP#N%=?\ &!&3QW\_&;2+ ]N:Y#2 #K=B#T-Q'G_OH5[=/^$O0\BI_$?J?8/B
MB0-KK%@>(XU8X]L_UKX[U*87.JW<R[L23.PWG)Y8GD^M?8GB1LZY(R ,GEQ]
M^#\HKX_UFW-GKM_;E0IBN)$V@Y PQ%<V%^.1OB/AB:?@+_DH?A_'7^T8.W^V
M*^K?% V^)[K/&XJ>O^R*^5OAV_E_$KP\V <:C#P1G^,5]2>(V)\3W9+ \C''
ML*6,?3^NH\+O_7D4&/&%Z?SKROXZ'_B4Z'\B#]]/\V?FZ)QCTKU(R ,#WQTK
MR+XZ,V_0UYVXF(^7O\G?\*YL-_%1OB/X;/):^J/@C.US\!C$S9\F_D1<]AN5
ML?J:^5Z^KOA+:-8? &PW,0]]=23( >V\C^25Z6(_ALX*/QH\V^(<4L'QF\*;
MD8J6MBI/1C]H;.*]UUJ4/J\ZL05XX/.?E%>(?$#Y?CIX38R$G-MG)^[_ *0W
M>O9-4)BU21'&4(7&/=<YKSZK_=Q1VTU[\F?,?Q/\'?\ ")>*G6VC9=/NQYML
M<<#^\GX$_D17&5]2>._#*^+?"=QI[,/M47[ZS9NHD X7/HW0_@>U?+TT,EO.
M\,R-')&Q5T88*D=0:[L/5]I#7=')6I\DO([3P_\ $%],^&?B'P=>1O+;:D%D
MM67!\F0,I;.?X2%'3N/>O;?A'S^S_:$C %_*!M[_ #G_ !KY;%?5GPDCQ^SS
M8%5!_P!+E8\]?WI%.NOW;%1?OHU >1N. >XKS3XZ#=X1TUO-SB^(V8Z_NSSG
MVZ?C7I@QY8P0&[<9KS'XY.G_  B.FJW$IOB0!T(\LY_F*\W#_P 5'?7_ (;/
M#!7O?@?XW>&="^&6G>'-8LM2%S9A\R6T:,K9=F!!+#LWI7@E?5O@CP9X<D^!
MV@RW6AV5Q/=A9Y998%9Y&W,1EL9(QQCTKU:KBH/F/.IW<E8\BT?Q0WC;]H'0
MM0=62V%_#';1.!F.)6RH..^<D^YKZ?OUQK,BY8+R<@=.*^=[SP?!X,^.OA>Y
ML!Y6FWUXDT:\D1,K8=/Y'Z-CM7T!?SO_ &G<.@+ MU!^Z,=?TKBKRBX1Y3II
M*2D[E?+(N4S][!XK(\4:#;>)O"^JZ3=D)#>P@QR8_P!5*N"K?0'KZC-:\CYF
M);*DLN?Q%2QKDLC?*BY4GW_SBN.+:=T=+2:LSXKUO1;[P[K5SI6JP^3=6S;7
M7.0>X(/<$$$'T-40:^K?B#\/M-\:6(\U5@OXQ^XO$'S#C[K_ -Y?;MVKYK\4
M>%-5\'ZT^G:U!LD'*2(<QRKZJW<?RKUZ-:-1>9YU2DX/R&^&O$NJ>%=:BU30
M[M[6ZC/!7[KC/*L/XE/H:^N/A[\0-/\ B5H/G6X2UU>U ^V6@)^7_:7U4_IT
M-?&%=)X'\67G@SQ98ZU8DDP/B6/M+$>&4_4?D<'M5S@IJS(C)Q>A]F.K1JBK
MSGC-2@[3P,CM4RW-MJ5C:ZC8L'MKR))HG_O*PR/T- B)R,X Y%>9*#C*QWJ2
M:N>5_M"Y/P]L#GIJ<8_\A2UP/[/?_)6(?^O2;^0KO?V@UV_#VQYX.J1\?]LI
M:X+]GO\ Y*Q#_P!>DW\A7H4/@.2K\1]7T445N8GB'Q(\/ZM\/O&8^(_@^/?;
MR'&JV@X4@D D@?PMQD]F^;OQF:)\7?#?AFZ\5:AISNT>K)'J-E8F,Y2Z8,LT
M;D<#Y@K9_NGC-?0$D:2QM'*BNC@JRL,A@>H(K@T^"?@--;.I#106W[Q;F5O)
M#?[F<8]NGM0,S?@3X<N]+\'W.N:L#_:&OS_:W+#YC'SL)^I9V^C"O4*0 *H5
M0  , #M2T""N!^)?CJ?01:>'?#86;Q+K#"*U3&1;JQQYK?3G&>."3P#7>DA5
M+,0 !DD]J\4^#D#^,/B!XE\?7P,B^>UK8EN=@/) ],1[!_P(T =WX&\!V'@>
MREN;FY:]UB^*F^U&Y?+2R' VJ3R%+'@=22,YXKL:XCPWYFN2:O!XGN1,UGXF
MF.G(7"$+&%>-<#[VT9./;/:M?PQK=U<V.GV'B01VWB*2R^U7%HBG"+OVYR,@
M<XXSZT =!7D8UN_^S>&K?5;F<*FMW?AV^!F)\X.KI$6)R6; 0ACDDY/>O2[K
M6H+&_F@NU>**&S:\>X(R@13AAZY'!KR+XBZI&+?Q');E672]3TO6X&1@0RNJ
M1EE]LK_X]GO0,S?%'A<PMH.AVVKC4DN+6?PY>.,KB6+,UL&7GE6*_@..M>9^
M,_$%Q*MA!8Z@TMO>:%8PW@!!\QHU!VM[JZ_I77^)[V[\.>-/%SR!GMX=8M=3
M4QGHKAQN7URLH'OBO':!A7T?\03%8? [PSX5\/W:WQU>6WM(95Z3 '<6'L7V
M_@:\:^&WA)?&OCNQTB=]ELQ,MP0<$QJ,L![GI[9S7O/QA2#05\/WNF G4K9)
M+'0].ACSB:0(HE _Z9J.!C[Q2@1O>$-,MKKXA:SK5G('M-+M8M M=IX_=@/+
M^3%5^H:N^KBOAM::?X:T.'P@EZESK%A"+C453+;))26.6Z9SP!UP <5VM @H
MHHH @O8)+G3[B""=K>66)D290"8R1@, >,CKS7#_  DMK2#1-3,4#6=^+]XM
M3LD.(8KE %9HEQ\JN-K8Z<X' KO\XZUY#I7CBST53XMGB7'BR.2X6U1MHB%G
M#*7?)!R7"QKCCD_F ==>>-=,G\=:5H%K?2B4W$Z2M#@QM+'$<P29Y'#AP1W0
M#UKSKQ_$/"'[17ACQ#!&(+;5-D-Q(#@.^3%(2/9'C-:'PZUG6!\0%N=5\-OI
M\/BJU^UL_D%5BN8@RD@GD!T^;GNXQU-9/[3:W,?_  C-W'@1PO< ,!RKGRR/
M_0?TH&>]T5'!+Y]O'*!CS$#8],C-% B2OG#X66T%K^T1XBL+N7RP);M8H"OR
MS,DX9>.G 4N/=1BOH^O"=#LH=+_:UU2*9<&YADFMSZL\2NW_ +.*!F99SV<'
MQ-U;09H#!X=\/1I/.KMNS;VBEDCYZ[YI-YSU.!6;X<N+/Q)\4;O3-:N+F$>(
MM,=M4,<NW$A/VE57(.T)&JQ_\!;UJ+XIPWOA7^W([]%6]\4:O),5#[O]!A?,
M0.#QO9@<=?D'TKCO&&KE;S3H[,+;WD=L;B]FA&UGN+@;Y!D<@!65,=MI% 'L
MVC>/IO&'C;P38:= =/TT3WDZPQY :&)'2'=_WRP(Z9(]*]KKY\^!^B"YU[P]
MJKGBVT:Z"C_:^U,O\I&KWG5/MW]D7?\ 9'D_;_(?[-YY.SS-IV[L=LXS0!RN
MDZ!=>$K?2[.+5HA9VUU>W^H!OE:6)_,*@+R<*TBDGU ]<5T^C:I#KFAV6JVJ
M2QP7L"3QK*H#!6 (R 2,X/K7G'C>*_T.'Q'XCUR:"::\TZ/0](MH,_.TH^<D
M'H3(<X!^ZG4\5U7@W4Y+B]U;1[:W1-*T%H-.M9@I#2ND8\S/.,+\H 'O^ (Z
MJL#Q>\NFZ/+K^G:;#?ZEID9>)74[C$64RJI'.2@..O('!K?K,\1Z'!XD\.7V
MCW3O''=Q%/,0_,AZJP]P0#^% 'D/QWT/3?$W@"P\;Z3&\TT:1#SD)P;9\D;A
MVPS#Z9(/M\[6]O-=2E+9"[JCR$#LJ*68_@%)_"OL+P&T<OAF?P5KT,+7NC1"
MQNH-OR7$!7$<H'=73KWSG-?+WC_PR_@OQUJ.D1^8L,;EK=V/+PN,KSWX.#[@
MT#19\#W%WIND^)]0L58ROIRZ?&PXVO/,B\'L=BR8KT[QI%IFO_%R/PS;R>9(
M\MJNI3G[J6]O$TDBYZ8.02/[R"O,O#M[/9:Y;:-)?I+HTE_;7%W.@.PK;Y=M
MI/95=C[X%;6AZK!?:7XAU>WCDEUV[LI89&_B>>[N0F%^D>?^^S0,]+\(>-V_
MML:Q=3+:VVL37>LZC-*H_=6$0-M;Q]S]\ \8)QQP2*L?&3P]?ZA>372,4AU"
M&QT:!<@F1WNC(^ #G^&+KUP?3-:R0^#[7P]8^'+FS2]E6:'0+F1 49VA03OE
MAR44Y8]LDBKGAO7K>_\ AS)XR\5J7MUNY]3MTD^8V\:LR1!0>,[1Q[MGK0(X
MOX^ZUHL'AF[T&PB2#4ENK,W&V-5,L9CE*<]6"A,>V5]:]LT__D&VW_7%/Y"O
ME[XUK:ZQ\52MI,3+*;:W9!@=8U.?KAP/_P!5?5- !117!?%KXBIX \,AK38^
MK7N8[2-AD)C[TA'HN1QW)';- BM\3OB]IW@.%K&R5+_6W7Y;?=\D&1PTF.>^
M0O4^W6OE[Q+XDUSQ/J7V_P 17D]S*XW1B3A$4_W%Z <=JOZ-ICZCJ=YK?BEI
M7L[6'[==/,QWW3,?W<>>N9&[_P!W<W:O0OA!\-'\;ZG)XL\61"735DQ!;LNU
M;EQQTZ>6N,8''&.@(H*V.<\ ?!K7/',2WSG^RM*/2ZG0LTOKY:<9'N2![FO9
M--_9W\%6<(%[]OU"3'+2W&P9]@@'ZYKU1$6.-4C4*BC"JHP /2N#^+7B'4])
MT'3]*\/S?9]3UZ_CT^&?.#"'."P/8]!GMDGJ*!'(ZS\,? 'AZ9TL?&\_AB][
M)_::#KZH<,1^(K*T[Q)<?"C7;-O$@TS6M#U;=Y&M:2BH[[< F14PLF,CKD\Y
M#$C%<1\1OAA>^&GNKZVBF:PM0!+<W+9><EU3S#Z%W9\+V5 <DGGB]5BTR*QT
MTZ7?RW,CP;KN%XRJP39Y"D]00%Y]J!GV5XA\-:)X\\/HMR(YDD02V=]"1OB)
M&5DC?MV/O7D-K/?:5XANO#'B'!U.T7?'.HPMY#VD'H?4>N??"?"'7O$&J_#A
M_#VG+*ZBXGL_M43,LEFLEN[Q.&!^4"12,G^\![' \427B'1_%KHRO]G@U.4;
M,;?,80W2^P,FQ@/69JQK4E4C;J:4JCIR.WC8@\'GWI7;Y3WY[5&2,AAR#R/>
MF$D* >*\0]8\&^+$K2?$*Z#Y^2&)1D]!L!_J:YO0D,OB+3HU(!:ZB4$^[BNA
M^*;N_P 0KWS%QM2(+SU'EKS6%X9B:?Q9I,48RSWL*@9QD[Q7MT_X2]#R)_Q'
MZGUMK)4ZS,I/ 5.@_P!D5\U?%C24TKQ_=&!-D5VBW*XQC+##?^/!J^D_$NV/
MQ!((UV?(H/\ WR*\A^,?AR>^TNVUBT3<+)2LX&2VQB,-] ?YUY^'ER5;/J=E
M:/-3NCS/P/<M:>/M#G0D%;^'I[N!_6OJKQ'$(?$4RX^8A3_XZ*^0M+O6T[6+
M.]C^];3I*/JK _TK[&\7*LVIVMY"V4NK97##D'Z?@16^,CI<RPLM;&(H7=ST
M]:\@^.DA_M#1H57"+!(X;U)8 C\-H_.O7%!&1V ->'_&>[\_QK#!\H-M9QHV
MUL\DL_X<,*Y\*KU3?$NU,\_1&ED2.,%F9@%4=R:^R;?2V\,>#?#/A]\++96B
MM/M/\9'/_CQ:OGGX)>#I/%?Q#M;B4;=/TEEO;N1A\HVG*K^)'Y ^E?0>KZD=
M2U2:Y *HV BGLHKJQ<TH\O<YL/%N5SQWX@%9/CMX8%M\TF;7//0^>QQ7M>I8
M?5)=Y(9<9 Z'Y0:\0\;2&+XY^%W94&UK7&WJ?W[=??\ IBO:M19X]5F60 LH
M7/'L.*Y*WP0]#II_'(KRKEOE.XCKFO$OC3X0>VU >)+"W5;6?;'=;%QME[.?
M][U]1[U[:[<9!_"J>JZ?;:QH]QI>H+YEM=QE']1W!'N#@CW K.C4=.=RZD.>
M-CY'KZO^%)5OV>=*'W,W,H./XCYK5\P:[HUUX?UNYTR_7;-;OM)'1AU##V((
M/XU]-_",^;^S_IB[AE+V48]/WC?XUZE=ITFT>?2TJ(V-N#D#M7E/QVC;^P=)
MD+Q@+<R+MW?,V5'('H,<_45ZW("B_,NUNPKRKX]&/_A&M&V[-QNI3@XW<(/Q
MQT_2O-PW\5'=7_AL\, S7V5X'(_X4;X7:0 @6R_^S8KXV6OLOP*H/P,\,!C@
M&!.?3EJ]/$?PV<%'XT5=2T6RUA]/EN=P;3[M+FW=>JL.JY/8C@_AZ5+K?B*/
MPYH]YJM[ADLX6E9"<>9V5/\ @3$#\:MKPVT<C<2/8"O%?CSXE!EL_#=I*&V!
M;J\XYW$'RUS]&)Q[K7F48.I-1.^I)0BV>N?#RYO-3^&>E:OJ<IN+O47EFDF;
MGDRN<?0#@#T&.U8NH^.QX>^-VEZ)J<@72M2T](VWGB*9I9-K^V>%/X'M6Y\-
M% ^!GAE6&04;GT.^2O"OC\TG_"R("Z[<:?%M;/WAN?G\\UU*G%UFCF<W[*Y]
M*:E$;>Z,<BG(;<,=QV-9FN>&]-\3:6UCK-G'>0-\Q1SAD/\ >5ARIK#^$GC2
M+XA>!4L+R7.OZ1&(Y-Q.9D'"OGOG&#[\]Q79)O1 &!$CG!4CD>QKGJ4W3F;P
MFIQ/E?XC_"Z]\$W!O+-GO-%D<*EP0-T1/1' [^_0^W2N$B^^*^T]7TBVU[1[
M[2[M0\%["T3 \A>.&^H."/<"OBP*5F*D9*D@UWX>JZD==T<=:FH/0^Q_@K>3
M:G\%]&:X^9K=I8%/^RLC!?R&!^%=N@RK<UR?P@L3IOP9T&%E*/+ TY#<9WNS
M _D176@?N\KTZDUE6^,NG\)Y-^T,5_X5[8@=1JD?_HJ6O,OA#HOC.7Q1'K'@
MW3X9/LX>)[F^#+;+N7!!((+$9SA<GIQ70:GX@@^*WQ/M='N;@V_A;3FEGFE#
M;0T<:DM*Q[ XV@]@WJ37K7C[Q+'X/\#VFF>#88EO]1D2PTN"W4 1,P!W =B
MP//=E)KII1<869E4:<M#RSXIZKXLTBXMK"7Q]/J&LSN?-TW28S D"XX4[#EB
M<\!AG%<>GA3XH7,)N1IWB)E;DES*&.>^"<FO4+'6]"^$MU-HVC:1-XH\4I'Y
M^K7^\((R<%LRL"549';'/)S6YIGQWMCY$OB7P[>:38SOY:ZA#,+NW#>[J!^F
M3[5J0>&#Q?\ $3P?<B*YU37-/D(XAOBY&/9) 1^E>D^"?C3XNNVB@NH]+\1.
M1\T$4@M;O\ P5'/^R@)KW:]L-,\0:5Y%_;V^H6-PH8+(HD1P1P1^?!KYS^+'
MP2;PU#)KWA)99M,7+7%J26>U']X'JR?7D=3D9( /<_#7C[1?$UY)I\)GL-5A
M_P!;IE_%Y-PGOM/4>X)KIJ^4?#WBB#5?#5O!XF34+F6Q9G@U.)L7EFBX.^"3
M@NJ9R\;$D A@< [?8? /Q%FGU"#P]XIO+>YN+B,2:7J\ VPZFGTP-L@Z%?7(
MQG&0#M_%<CQ>#=:DC8JZ6$[*PZ@B-N:\<^$]]?Z=X;\"6.G2&.WU;4[Y[S '
MSB.-L*3_ ,!S_P !KVG7[5K[PWJ=HF2UQ:2Q#'7+(1_6O"/AMXDCT[X>^$9F
M17:T\6&P;/\ "D\$@)_ R9_X#0!NZ-;WMI\3%AUD3P#_ (2^]FM"1@2)):.1
MCCI@)T_O'ZUL-JFJ:^-,\>>%;9LZAH-W9R1G#_99U#21DY W 2QLF<=QQS6C
M<P_\+(GT'7-%E^S)H6N2"5)B1YL:$HQ7'<X& >Q//KR_@#Q#>^'?#EOI<$8?
MR_&4ND3JXY2-PS9]CN^G3% '<P>.-%U#PS9G5IC!)J%C:231;"-BW7R*<G^'
M=D9&<=Z\?TFTN;Z"WT&_!-U?:/?^'F!' N+-S+%QV(4J/PKIO%>FR_$/0$\0
M>'+-X(_[,O;"Z@# -$T$@DA7 [^9%P!TW"L'5-8^P^,M,U4H8;6>YTWQ$T@&
M!''<((;C_OHA3^!H 6<67B?5O"T19!;^*?"YTR61CG9<P_,K'U*R(HKPAE*L
M5.,@XX.1^==OKETUEX7N--6Z,-YH>OW$5NJ/M=8I5(?&.<;H?_'JXJ*)YYDB
MA4O)(P5%'5B> *!GLW[-EK!)XMU"Y-E--<16VT7/ BMU)Z>[L1@#C 5NN:['
MXC>,E?X@PZ7H,-E;7^E0G[9K]\NY-,23&=@/R[R-O/))(4<DUK6UUH/P*^&]
MG;WH\[4;@;FAAQYEW<$#=C_97(&>PQU)YJZ9H<?C?6K:X^)36MO>W'^EVGAB
M!MNQ0,"6X ^9WQ@?-@ <8Y( ([?P3I&B:;X=BN?#Q>>/4 +F6^G#>=>,W/F.
M6 ))SGL.>!714B(L<:I&H5%&%51@ >E+0(**** $(#*58 @C!![U\R?%O27T
M;0=.T*WFCCA\,1^2DS.5>\^U9+!5QU41C=ST>OIROESX\)JECK"V>J74<ZW&
MH7-];@/EEA:.!$!'\('EN!ZX)H&CN_A'XMU[5M9L8+L7$]HNG+9WB<LMM-&"
MT4WHJRQ$#/\ $RGVJW^TC:B7X;VDXAWM!J49+_W%*.#^9VC\JXCX375_HOB#
M2;NUW7B20Q6FH1VX+EK>7F&?ID^7)NB8_P (0#H:])^/VFOJ'PGNY8R<V-Q%
M<%1_$-VP_EOS^% =3T/3_P#D&VW_ %Q3^0HIFE2B;1K*5<A7MXV&>N"HHH$6
MZ\0\8W']B_M3>%[QHRZ7=M'#\J]Y#+#G\,@_2O;Z\9^(DD<G[0W@:!8_,EC4
M.PP. 7;!_#:30,N?&#X=VVMW1\7:A?3R1:;:)$FF0VY8W+!V(3<&R"[.JY X
M []OG*Z0VOBL2:\5NQ]J62]\I\AR2&D3([C)!QQG.,CFOKCXJ7UUIWPSU>XL
M;^+3Y/*"&XD)RJLP#!,#.\@D+TY(Y'6OD'P_%9S:_:KJ<BQVH8M(7Z$ $X/L
M2,?C0"/>_A+?0:=J7A+2X)A(TECJD,N.A87093_WRF?QKVJ_MY+O3KFV@N'M
M9)HFC2>,?-$2,!A[CJ*^4?A7.OA+Q2GB+6/,:TLM(EOQ'']X*\GD*,$@99F&
M/8@U];4 SS3QS=^'XO"MGXC^W2ZG%X9E>*SMVD,BW5Z,1Q[V/S.RL"<@\Y8\
MXIO@>]U>WU[3O"T>!_9EDU]X@G* F2ZN,N(L]B"Y<D=< =."V]\0>$].\ V%
M_!X>8K%J#_V#ILL9#W5QN8+(BGG!+%MQ'&?4@5&^D:I9:KX5T-9F;5=0U$ZY
MKUS"V 1'@E"?[FXJBCT4>] 'J=4=;TJ'7=#O-+NF=(KN%HF>-L,F1PP/J#S^
M%7JP/'.FZIJW@G4;3P_<R6VIE%DMI(WV'>CAPN>V[;M].>:!'">'_#_B*V\7
M>'M3NI5NM1TOSM&UEXY 3/;;2\$S9.?[I.>2<5S?[3NF,5\/ZHD:[ 9K:1\<
MY.UD'OT?Z?C7875QJ>G_ !4\):\()(K;Q%IXL=0A"G$<JH94R.S#)'L%:L;]
MI<V__"$:6'G"W/\ : ,<6[EU\M]QQ[';SVS[T#/G6PL=0U:XL]-L8I)WN+@Q
MV\8'#2-M!Q_X[FO>]!^'>E_#;6(3KE^+YN=5W1# CCM(BS$@^LLH(_W%]Q7C
M'A*[GCO?LVGRNFJ7K1Z?9R G,"RL0[KZ''R_21CUKV4:)>^/_%7BJVT:01V&
MF6EOX>MI7;A8Q*AG8>IVH_U#+0,]!L/#-GXI;PSXGFMDL4%K<7DMC'G]Y-=Q
MIEF;@Y"[AG&<D=,5S?Q+UIM"TUO!]AIL/]EM:V$$"C.<O<.ICR3R-D./7)Y-
M=9JOB:/3/['L/#OD7,$EY+IL^SYC;F*WD8@8. RE!G.>,_6N<\-Z'?\ BCQ/
MI'BKQ+;1SV,GARRE#R$ "[60R!@ 1C&6;ICY\4"/([#3Y?$7[3TT$GS^7KTT
MC>@2"1FQ^48%?5U>#?!FTB\2_%GQ7XQ@B$=HLLBVX QN:5R=WUVKS_OU[S0#
M$9@BEG(50,DDX %?,>JZ5>_&'XAIJ9N&33+C4O[/L0!_RZQ*7ED'I@;?JTF.
MU>K_ !P\42^'OA[+:61/V[6'^Q1!?O!6'SD?\!^7ZL*Z3P3X4MO"OA+2--\B
M(W-E;%'FV@MO?#2X/7!8?H/04 >(^._#!F\6Z3X(LT\B?6-3>\G$>"(K9"8;
M<#V2&-VQVW5ZKKOQ \*_#J"T\/VD<MU>0QK%;Z5I\?F2 8^4'TSQUY.<X->:
M?$/Q='X8^-FM:J5!O[+1DM],!&?W\FWYNF,!7D.#UQ6)HMM%ITTBWUS?H[3F
M&^ETY2^H:M>GYI+:)NJQIN <@C)ZYRNT ]#O?BKXS60>3X.TZP!Y$>IZW!%+
MCW1F4K^(KD?B3XW\1:QX3M)M9\(W6DW-E=17EAJMI.)X!(I[L!@#!)'S'D#W
MKI[=O^$:AA,?PAL;1)/]7-<W/FRG_?=89-I_WF_K7JVDM)=:+$;[3HK)I$(>
MU5Q(B@]@0 ""/8=: //='\3Z)\;OAW>Z)/*MEJ<L(%Q;9RT;J0RR(/XDW ']
M#ZGRCQ/\/O'5UIVC>'?^$0C:72?-B74;';MND9@5W-QC!W'+8/S$D#G/T-:^
M!O"EKK4>JZ?HEC;7UNY*S6L8B*L00<A<#H>X[UNW*J]I,LBAT9&#*4+@C'3:
M.OT[T <1\(O <O@/P>;>]F26_O9/M%P8SE$X 5 >^ .OJ3VJS\6[2&Y^%>OM
M(BETLR5? R,,K8SZ94?E5WP3?3RZ%'!>PSVQC9H[=;FR6R\R-<8\N#<61%&
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MT)^M9NM3W=OX9G\.?%'P]J%I<K,DT/B/3(?-621%V)(Y! 8[0 3G<1C(!YH
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M8; S_K--N^OUP=I]C*/2MOQ;:WGA+6M?O=8AF.EP>(=/UVPE5249S(PD7/\
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M&FM+:WDMC"\GB'684"V]GC<R6R,/]9("X7:">2>I)Q>\&VMOXUOK_P ;ZK8
M0:C;G3["VNE#?Z$"=Q=3QF1BQ(Z;<#G))BT_PUHMQ\,+:R\6Z.-!T2PG^T1V
MD]YAFC4<-<$8&YBS,4R><=^!Y)\1_C?+XATNY\.>&;)+#2&/DF<'#S1+T 4
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MJMOEB-7_ (2;QK?%0;_5IE.2"S.L?]%'7T%=1I/PI\96["YBMM.C?'W+P1S
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MC#Q9?:A>2X,K1)S]-[EB?R'TKHK+X"^ -,C,EY9W%XL8RTEY=L ,=SLVC^E
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MP#>Q^ V92S?PO*RH/S9?S[<5[-XMT1O$GA'4]&CD2)[VW:)9'&0I(X)QZ&O
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M\-K,[I/9(?/T=W_C49P\)8MN7C&[ [8!H] \&^,M*\;Z!%J>D2@D@">W+?/
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M+29?&7BJSO-=\/G3H])AE>*UM;LE9;PH,G9QR2/<>G8FNAU5C_9=T8LY\A\
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MGN8R,$ ]B."%/W3VP>?J2L[7M TSQ-H\VEZW:I=6LPY5NJGLRGJ".Q% SGO
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MIZG- '>?#'Q!!:Z'I/AB0.UQ;R7UF9">%>VE7"?4I(#_ ,!-5M!_T3]I3Q/
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MN+>,7RQ,L%QD@J>=N2.HSV/K7#_#7QQ>?"K7]0L]=L;^6.XA"K91D?ZW<-K
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M>(YR$CMHP7$)/3<!R6]%'/KCC(!N^//B)HW@#2_/U)_.O) ?LUE&W[R8^O\
MLKZL?PR>*\UT_P &^+?C#?0:UX_GDTG04;?:Z7""C.O8X/3/]YLD]@ 0:WO
M/PIN#J7_  EGQ&E.IZ_.1(D$Q#);'MG'!8<8 ^5>WK7K% RGI6DV&AZ7#IVD
MVL=I:0+MCBC& !_4^I/)[UXQ\8/B];PV?B+PAIT9^U8BM3.#D,&#&8>V!M3W
M+-Z5W?Q2^(EOX!\+^?"4EU2\!2QA/()[R'_97(^I('?(\Z^&/P5EU&X7Q1\0
M4::2X?[1%8R\F1F.[?-]2<[?S]* .7\ ?"G6_B1?KKWBJ>X@TM\?OGXEN0
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MMQ<(?^FKG]U".GWB3_LU[5X8^'.N(COJ%Z=!BG4"=+*X,]_< =!+=MR,>D8
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M#4+,,^J7ZN%L[<#&5!(SA3P6/4D*%SC/*-$ZQK(4;RV)"OC@D=?YT >^Z/\
MM.?.J:_X=^7^*6RGY'_ &'_LU>@:+\;? NM%4&L"PE;_ )9WT9BQ]6^Y_P"/
M5\@ %B H))Z 5ZYX1^"MKXZ\ 6NM:)K36U^6>*XM[F,-'O4G@,N"H(VGHW6@
M1].V]S;WMNLUI-%<0N/EDB<,K?B.*ALM*T[39)Y-.L+6T>X(:9H(50RD="Q
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M'C[PMX7+)K>MVMO,O6 /OE'_  !<M^E>9Z_^TMI-MOC\.:/<7SC@373B%/J
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M_M3)GMI1@@-&<*K=""%YX(.* '6GBKXIZFGVRU\$:?9VIY2WO;W;.P_3:?\
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M\::8^H7\#"YCB\R'4=/4M. !D%=@)DZ<+@D]N:\K6/XE^#+Z?2[;Q<^I+;G
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M.P@-C@D9 ->3ZQHU]87NI_Z1=:5ITA!U;Q#(=]]J+$<06R@$H@R%&![ '!)
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M@QJ,QL? /AN^U6];A&FC.![A$RS#ZE:JZ5\*_%OC[6(=9^*^H.EM&=T6F1.
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M77KT'<?M( AW>NSG=_P(D>U>J44"&QQI#$L<*+'&@VJJC 4>@%.HHH ****
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MM%@82SY/W1)LR$/MD^V:S?"GP]U+5=>7QA\2G2[U?(:STY3F&P'4 #."P_$
M\Y)Y'1>#?AQH'@E&DTV!I[^4?OK^Y.^:0GKSV!]!C/?-=70(**** "BBB@!J
M(D:[8U51G.%&*=110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
&**** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>cron-20201231_g5.jpg
<TEXT>
begin 644 cron-20201231_g5.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  R %\# 2(  A$! Q$!_\0
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>cron-20201231_g6.jpg
<TEXT>
begin 644 cron-20201231_g6.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X0!:17AI9@  34T *@    @ !0,!  4
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
M 0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9
M&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"
M@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2
MT]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /W\HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/V)?^BC>(/\ PDM3_P#C-?R144 ?UN_\18'[$O\ T4;Q!_X26I__ !FC_B+
M_8E_Z*-X@_\ "2U/_P",U_)%10!_6[_Q%@?L2_\ 11O$'_A):G_\9H_XBP/V
M)?\ HHWB#_PDM3_^,U_)%10!_6[_ ,18'[$O_11O$'_A):G_ /&:/^(L#]B7
M_HHWB#_PDM3_ /C-?R144 ?UN_\ $6!^Q+_T4;Q!_P"$EJ?_ ,9H_P"(L#]B
M7_HHWB#_ ,)+4_\ XS7\D5% '];O_$6!^Q+_ -%&\0?^$EJ?_P 9H_XBP/V)
M?^BC>(/_  DM3_\ C-?R144 ?UU:)_P=5_L.ZK<,EQ\6-3TQ57<)+GP?K#*Y
M]!Y=LYS]0!QUKT+P1_P<0?L6_$%XUL/V@/"-N90I7^TK>\TP#=TR;F&/;[YQ
MCOBOXTZ* /[JOA+^W%\%_CY)#'X'^+GPS\7S3XV1:-XFLKV4D]!LCD+!O8C(
MKU*OX Z]P_9\_P""EG[07[*LD(^'OQD^(WA>U@(9;"VUR=M/8CINM79H&Q_M
M(: /[C**_EW_ &6/^#R7]I/X0M;VOQ(T'P3\7--CQYLTUM_8FJ28/::V'D#(
M];8\X/J#^IW[%?\ P=C_ ++/[4LUGI?BS5-7^#/B*Y81>3XHB#:8[G'W;Z'=
M$J<_?N!".#[9 /TZHK-\(>,M'^(7AFSUK0-5TW7-'U*/SK2_T^Y2YM;I.FZ.
M1"59>#R"16E0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !45]?
M0Z9937-S-%;V]NC2RRRN$2)%&2S$\   DD]*^>/^"CO_  5-^#__  2Y^$C>
M)_B=X@6*^O$;^Q_#U@5FUC79!U6"$L/E!QNE<K&F0"P+*#_,)_P5H_X.$/C5
M_P %2M5OM#DO)/A_\)VD(MO"&DW+;;M 05:_G 5KI\@':0L2D K&&RQ /VA_
MX*;?\':?P5_9$N-0\+_"&WB^-?CBW+PO=6=SY/AS3Y!Q\]V 3<D'!VVX*,,C
MSD-?@5^WS_P61_:&_P""D>KW/_"RO'VH-X=FDWP^%](+:?H=J 25 MD/[TKD
MX>=I).<;\5\O44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 >Z?L6?\%*?CA_P3W\5KJGPE^(>O>%XVE$MUI@E^T:
M5J!''[^TDW0R9&1N*[ES\K*>:_=[_@FG_P 'BWP]^-,^G>%_VBM C^&7B&;$
M0\3Z4LESX?N7]98CNGM,G ',R#DLZ#I_-;10!_?1X*\;Z+\2?"6GZ]X=U;3=
M>T/5H%N;'4-/N4N;6\B;E7CD0E64]B"16I7\6/\ P3,_X+,?'#_@E?XS2?X?
M^(GU#PA=3B75/"&K,UQH^H@XW,L><P3$ ?OH2KG:H;>HVG^H+_@DY_P7$^#O
M_!63P8L?AF]/A?XC6%L)M7\&:I,OVZVQ@/+;OPMU;AO^6B ,H*^8D98 @'V9
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !7YM_\%SO^#AGP7_P2P\/W'@GPBNG
M>-/CE?P!X-(9RUGX=C=<I<7Y4@Y((9(%(=QAB40JS<3_ ,'$G_!PC8_\$X_#
M5W\)OA7=6VI?'+6K0-<7942V_@RVE7*SR Y5[IU.8HCD*")'&W8DO\M_C#QC
MJWQ"\5:AKNO:IJ&M:UJ]P]W?7]]</<7-Y,Y+/))(Y+.S$DEB22: .J_:6_:>
M\>_MA?&/5O'WQ*\3ZGXL\5ZT^ZXO;V3.Q<DK%&@PD429(6- J*.  *X.BB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !117P-_P<:_\%,&_P"";O\
MP3OUJXT&^6U^(WQ(+^&?#!5\36C2(?M-\N#D>1"25;H)9(,@@D4 ?B)_P=)_
M\%8)/V[_ -LF7X9^$]2,WPN^#]U+80&&3,.LZN,I=79P=K+&08(CS\JR,#B4
MBORWI7=I&+,2S,<DGO24 %%%% !1110 4444 %%%% !1110 445Z9X+_ &+O
MC%\2+1;CP[\)OB9KT#$*LFG>%[ZZ1B20 #'$1R01^% 'F=%?0'_#IW]J;_HV
MG]H#_P -YJ__ ,CT?\.G?VIO^C:?V@/_  WFK_\ R/0!\_T5] ?\.G?VIO\
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M_'WQEJOQ(ULJ&FT/09)-*T6%N,H9ABZG''#J;?@_<XS7Z_? ?]G_ ,$_LO\
MPMTOP3\/?#&C^$/"NBQ^7::;IMN(88_5CW>1CRSN2[L26)))KL* /'_V<O\
M@G[\#_V1;&WA^&OPI\!^#9+886[T_1X5OG[9>Y*F:1NV7<GWKV"BB@ HHHH
M**** "BBB@ HHHH **** "BBB@ KSOX\?LC?"O\ :CTAK'XD?#GP3XYMV0H!
MK>C6]Z\8QC*/(A9&'9E(([$5Z)10!^0W[<7_  9V_L__ !VM+O4OA#J^N?!G
MQ"P+Q6JN^L:)*V!PT,S^?'N(ZI-M7<<1D +7X3?\%'O^",OQZ_X)=:[_ ,7(
M\*FX\+3S"&R\6:,S7FB7C'.U?.VAH9&P<1SK&YP2%(YK^U*LKQQX%T7XF^$-
M2\/^)-'TS7]!UB!K6_T[4;5+JUO8F&&CDC<%74CJ&!% '\#%%?MY_P %ZO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M",B#:90Z?UA:'H=EX9T6STW3;.UT_3M/@2VM;6VB6&&VB10J1HB@*JJH "@
M   5YG^Q%^Q_X3_8+_98\&_"?P7!Y>A^$;!;;SV7;+J%PQ+SW4O7]Y-*SR-C
M@%\#"@ >K4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !7\U_P#P=,?\$*+7]F3Q!=_M'?"/1UM? .OWBKXOT2SA"P^';V5L+=PJ
MH 2UG<A67&(Y6&/ED54_I0K!^*/PQT'XU?#?7O"'BG2[76O#?B:PFTS4["Y7
M=%=V\J%)$8>ZD\CD=1S0!_!#17T5_P %5OV M8_X)G_MR>-?A1J37%UIVEW
MO-!U"5<'5-+FR]M,<  MMRCXX$L<@'2OG6@ HHHH **** "BBB@ K]OO^#)W
M]J.3PM^TQ\6/@_>73"Q\7Z%#XET^)W^1;JRE$,JH/[TD-T&/J+8>E?B#7U__
M ,$#?CVW[./_  6!^ VO&=;>VU#Q+%X=NF<XC\K4D>P);MM4W ;)X!4'M0!_
M9[1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1145]?0Z9937-Q(D-O;HTDLCG"HJC))/H ,T ?Q(?\%</BTWQQ_P""H'Q^
M\3><+BWOO'>K0VDH((>V@NI((.1Q_J8H^F?J>M?.]:7C'Q/<>-?%VJZS=EFN
MM6O)KV8LY<EY'+MECR>6/)Y-9M !1110 4444 %%%% !7[@?\&67[$L/CS]H
M'XB?'C5[-9+?P#9IX<T!Y%R!?WBEKF5#V:.V41G_ &;TU^']?UT_\&K_ ,!H
M_@A_P1B^'=V85AU#Q]>ZCXHO0!]YI;EH(6SWS;6UN?T[9(!^B=%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?B+_P '
MI/[$D/CO]F[P#\>M+LPVK> ]1'AO6Y8XOF?3;LLT#R-_=BNEV*/6^:OYO:_M
ML_X+!? *']IS_@EY\=O!DD:337_@^^O+)'^Z;RTC^V6N3V'VB"(Y[=:_B3H
M**** "BBB@ HHHH *U? OC"\^'OC;1]?T]A'J&AWT&H6S'HLL4BR(?\ OI16
M510!_?5X-\4VOCGPAI6M6+;K/6+.&^MSD',<J!UY''1ATK2KPG_@ESXU/Q&_
MX)I_L^ZX\@FFU+X<Z!-.P+']]_9T D&6Y.'##)SG'4]:]VH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M HHHH *\_P#VLO\ DUCXF?\ 8J:I_P"DDM>@5Y_^UE_R:Q\3/^Q4U3_TDEH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\_\ VLO^36/B9_V*
MFJ?^DDM>@5Y_^UE_R:Q\3/\ L5-4_P#226@#^$.BBB@ HHHH **** "BBB@
MK^WS_@D[_P HLOV:?^R5>%__ $T6M?Q!U_;Y_P $G?\ E%E^S3_V2KPO_P"F
MBUH ^@**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH *_@C^*_P#R5+Q+_P!A6Z_]'-7][E?P1_%?_DJ7B7_L*W7_ *.:
M@#GZ*** "BBB@ HHHH **** /[//^" __*&W]GO_ +%6+_T;)7V!7Q__ ,$!
M_P#E#;^SW_V*L7_HV2OL"@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@/\ \H;?V>_^Q5B_]&R5]@5\?_\ ! ?_ )0V_L]_]BK%_P"C9*^P* "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\__:R_Y-8^
M)G_8J:I_Z22UZ!7G_P"UE_R:Q\3/^Q4U3_TDEH _A#HHHH **** "BBB@ HH
MHH *_M\_X)._\HLOV:?^R5>%_P#TT6M?Q!U_;Y_P2=_Y19?LT_\ 9*O"_P#Z
M:+6@#Z HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ K^"/XK_\ )4O$O_85NO\ T<U?WN5_!'\5_P#DJ7B7_L*W7_HY
MJ .?HHHH **** "BBB@ HHHH _L\_P"" _\ RAM_9[_[%6+_ -&R5]@5\?\
M_! ?_E#;^SW_ -BK%_Z-DK[ H **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ KS_ /:R_P"36/B9_P!BIJG_ *22UZ!7G_[67_)K
M'Q,_[%35/_226@#^$.BBB@ HHHH **** "BBB@ K^WS_ ()._P#*++]FG_LE
M7A?_ --%K7\0=?V^?\$G?^467[-/_9*O"_\ Z:+6@#Z HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K^"/XK_\E2\2
M_P#85NO_ $<U?WN5_!'\5_\ DJ7B7_L*W7_HYJ .?HHHH **** "BBB@ HHH
MH _L\_X(#_\ *&W]GO\ [%6+_P!&R5]@5\?_ /! ?_E#;^SW_P!BK%_Z-DK[
M H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^8FC?LTPQ;9/DFO?'ADWISUC33UVL>/XR![U^ ]% '[O?\1Q?BK_ *-V\/\
M_A7S?_(E'_$<7XJ_Z-V\/_\ A7S?_(E?A#10!^[W_$<7XJ_Z-V\/_P#A7S?_
M ")1_P 1Q?BK_HW;P_\ ^%?-_P#(E?A#10!^[W_$<7XJ_P"C=O#_ /X5\W_R
M)1_Q'%^*O^C=O#__ (5\W_R)7X0T4 ?N]_Q'%^*O^C=O#_\ X5\W_P B4?\
M$<7XJ_Z-V\/_ /A7S?\ R)7X0T4 ?N]_Q'%^*O\ HW;P_P#^%?-_\B4?\1Q?
MBK_HW;P__P"%?-_\B5^$-% '[O?\1Q?BK_HW;P__ .%?-_\ (E'_ !'%^*O^
MC=O#_P#X5\W_ ,B5^$-% '[O?\1Q?BK_ *-V\/\ _A7S?_(E'_$<7XJ_Z-V\
M/_\ A7S?_(E?A#10!^[W_$<7XJ_Z-V\/_P#A7S?_ ")1_P 1Q?BK_HW;P_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MT5\6?$'CGQKK5YXA\5>*;V34-3U"Z;,ES,YR3@8"J.%5% 5%554!0 .7HHH
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M;[KQ:7GAL<C[41CJ8@?EEKY;_P""^?\ P<C^(/\ @H+J6J?"OX/7FI^&?@E
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M1110!^CW_!J!_P IM?AQ_P!@K6__ $V7%?UO5_)#_P &H'_*;7X<?]@K6_\
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M)U2;1?%7A'4(M2TV[C_Y9RH<[6'1HV&4=#\KHS*002*X^B@#^WS_ ()A?\%
M_#/_  4U_8S\*?%?PWY5K-J<7V36],63S&T74X@HN;5CUPK,&0D M%)&^!NQ
M7T!7\H__  :N_P#!3]OV(/VZK?X<^)=26U^''QGEBTFY,[XATW5AE;*YST4.
MS>0YX&)49CB,5_5Q0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 5_._\ \'I?[>4GB#XC_#_]G71;[-CX?@'BWQ-'
M&QPUW,'BLH7]XX?.E(.<BYC/!%?T+ZSK%KX>T>ZU"^N(K6QL87N+B>5MJ0QH
MI9F8]@ "2?:OX</^"A?[5EY^W!^V[\3_ (K7DD[+XTU^XO;))O\ 66]DK>7:
M0G_KG;)#'_P"@#QNBBB@ HHHH **** "BBB@ HHK]3O^#?G_ (-WM4_X*9ZI
M;_%#XFM>Z!\#M)NS''%$3%>>,9HVP\$#@@Q6ZL-LDXY)!CC^;<\0!\N_\$R_
M^"-?QN_X*J>,VMOA[H L?"MC,(M4\6:N&M]'T_IN028)FF (/E1!F&06VJ=P
M_HE_X)Y?\&M'[-?[%EC8:KXNT5?C1XZA"O)J7B>!9--AD[^1IV3"%R 09O.<
M$9##.*_0GX3?"3PQ\"/ASI'A'P;H.E^&?#.@VZVNGZ;IUNL%O:QCLJKZ\DD\
MDDDDDDUT5 $&F:9;:+IT%G9V\%I:6J"*&"&,1QQ(!@*JC@ #@ 5/110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7XK_\
M'67_  6XD_9M\!W'[-OPOU;R?'GBZR#>,-4M9?WF@:9*O%FA4_+<7*G+9Y2!
ML@9F1T_0C_@KW_P4N\/_ /!*[]BSQ!\2-3^S7WB*8?V9X5TB0_\ (6U216\I
M" 0?*0!I9"",1QL =S*#_&+\6_BQXB^.WQ/U_P 9^+M6NM<\3>*+^74M3O[@
MYDNIY6+.QQP.3P   ,    4 <[1110 4444 %%%% !1110 4444 %%%% !17
MV_\ L%?\&\W[4/\ P4!BL]4T'P+)X-\'WF&7Q)XN+Z792(>0\,94SSJ1G#11
M,F>"PK]B_P!C7_@S*^!OPGBM-0^,?B[Q/\6-6C(>73[-CH>C'G)0K&S7+XX&
MX3QYY.T9  !_,_HNB7OB35;>PTZSNM0OKIQ'#;VT32RS,>@55!+'V KZZ_9V
M_P"" G[8'[3T,-QX=^!OB_3;"8!A>>(UCT"$H>CK]M>)G7OE%;(Z9K^N?]F_
M]B7X0_L?Z&FG_##X:^#/ \*IY;R:3I44%S<#_IK.!YLI]Y&8^]>HT ?S._!;
M_@RE^/7BR.&;QU\3OACX-AF&6BT\7>L74/LR^7#'G_=E8>]?47PQ_P"#(7X6
MZ4(O^$S^./C[7MI'F?V+I%II&\?+G'FFZV]'ZY^\.N#N_<"B@#\KO!G_  9X
M_L@>%XT6^'Q2\1E=F6U'Q(D9?;G.?L\$0^;OC'3C;79?\0G_ .Q+_P!$Y\0?
M^%;J?_QZOT?HH _.#_B$_P#V)?\ HG/B#_PK=3_^/4?\0G_[$O\ T3GQ!_X5
MNI__ !ZOT?HH _.#_B$__8E_Z)SX@_\ "MU/_P"/4?\ $)_^Q+_T3GQ!_P"%
M;J?_ ,>K]'Z* /C']CG_ (("_LQ?L&?'O2_B9\-/!NKZ/XOT>&X@M;J?Q#>W
MD:)/$T,@,<LC(<H[#D<9S7V=110 4444 %?P1_%?_DJ7B7_L*W7_ *.:O[W*
M_@C^*_\ R5+Q+_V%;K_T<U '/T444 %%%% !1110 4444 ?V>?\ ! ?_ )0V
M_L]_]BK%_P"C9*^P*^/_ /@@/_RAM_9[_P"Q5B_]&R5]@4 %%%% 'P)\9/\
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M* "OQ?\ ^#DS_@W>L?VG_#.N?'WX(Z*EK\3]+A-WXE\.V,06/Q;"H^>XA08
MO44%B!_KU4C!EQYG[044 ?P".K1L58%64X((Z4E?L/\ \'9'_!(6W_9*^/-K
M\>_ .EBU\ ?%"^>+7;2WC"PZ-K;!I&8 ?=CNE#R 8P)(Y>0'11^/% !1110
M4444 %%%% !7??LJ_M ZK^RE^TMX#^)>B9;5/ NO6>MP1[MHG\B99&B;_9=0
M48=PQ%<#10!_?-X"\;Z;\3/ VB^)-&N%N]'\06$&I6,Z])H)HUDC<?56!_&M
M:O@K_@V=_:,;]HW_ ((U_">6XG\[4O!4-QX0O!NW>6+*9H[=?PM#;<'U],5]
MZT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0!_,C_P>J?$]_$7_  47^'?A6.4O:^&? ,-TR=H[BZOKO?V[QP0'.3^&#G\<
M:_2#_@["\6#Q%_P6S^(EF)%D_L'2=$L"H0KY>[38+C!/\7^OSD>H'4&OS?H
M**** "BBB@ HHHH *^\O^#:_]CVW_;(_X*Y?#FQU*S%[X?\  9E\;:K&R;E*
M6)0VX8="AO)+16#<%6(YSBO@VOWR_P"#'OX-13^(/V@/B%/#^^M;?2/#ME+M
M/W9&N;BY7.,=8K4X!)]<<9 /Z"J*** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** $=Q&A9B%51DD] *_C*_X+O?\
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M:+_@R8\?R:9^WM\5_"^YQ%K7@$ZF1_"S6NH6D8[]<7;8X/&>1W_I=H ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#^0+_@Z
M._Y3K_'/_N ?^H_IE? %??\ _P '1W_*=?XY_P#< _\ 4?TRO@"@ HHHH **
M** "BBB@ K^EC_@R4T^&/]A7XN72QJ+B;QX(GD[LB:?;%1^!=_\ OHU_-/7]
M+W_!DO\ \F"_%?\ [* W_INLZ /V>HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHK,\:^,-/^'O@W5M?U>X2STG0[
M*;4+V=S\L$$2&21S[!5)_"@#^9;_ (/(?VT&^-/[?OA_X1Z?=,VB_!_1U:\C
M5_E;5+]8[B0D#@[;86BC/*DR#C)K\?Z] _:O_:!U+]JW]IOQ_P#$O6-ZZAXZ
MU^]UN6-FW>0)YFD6(?[**50#L% KS^@ HHHH **** "BBB@ HHKU;]AW]D7Q
M+^WC^UAX'^$OA-0-8\::DEG]H9"T=A  9+BZ<#G9#"DDC <D(0.2* /U1_X-
M+/\ @CI#^T7\5&_:2^(6F"?P7X#OC;^$K&YBS'K&KI@M=D-]Z*UR-N!AIR.0
M8&4_TJUPW[-'[.WA?]DKX ^$OAKX+L1IWA?P9IL6F6$/5V5!\TCG^*21BSNW
M5G=B>37<T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !7\$?Q7_Y*EXE_P"PK=?^CFK^]ROX(_BO_P E2\2_]A6Z_P#1S4 <_111
M0 4444 %%%% !1110!_9Y_P0'_Y0V_L]_P#8JQ?^C9*^P*^/_P#@@/\ \H;?
MV>_^Q5B_]&R5]@4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 5_/3_ ,'Q7PWCLO'_ .SOXOCAS+J6GZWH]Q*$^ZMO)931
M*6]_M,Q ]FK^A:OPA_X/B_\ DEO[.O\ V%==_P#1-C0!_/#1110 4444 %%%
M% !1110!^IG_  9\ZY)I7_!82WMT1&74_!FK6TA;JB@P2Y'OF(#Z$U_5A7\H
M/_!H=_RF2T7_ +%76/\ T4E?U?4 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!_(%_P='?\IU_CG_W /_4?TRO@"OO_ /X.
MCO\ E.O\<_\ N ?^H_IE? % !1110 4444 %%%% !7]+W_!DO_R8+\5_^R@-
M_P"FZSK^:&OZ7O\ @R7_ .3!?BO_ -E ;_TW6= '[/4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5\$?\ !S)^TY_P
MS)_P1Q^*DEO=?9M6\>Q0^"[ 9QYWVY]ERGXV2W9_"OO>OP._X/?/VAV@\/?
MOX3VMP=MU<ZAXMU*#L#&J6MF_OGS;X>V/<T ?SZ4444 %%%% !1110 4444
M%?T.?\&7?_!/U=!\">.?VD->L%^V:[(WA/PH\J<QVL3*]]<)_P!=)1%"&P"/
ML\PZ,<_SZ^#O".H_$#Q?I6@Z/:R7VK:W>0V%E;1_?N)Y7$<:#W9F _&O[E?V
M'?V6=)_8D_9#^'?PHT18C8^!]$M]->6-=HO+@+NN+@\#YIIVEE/ YD/ H ]5
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O
MX(_BO_R5+Q+_ -A6Z_\ 1S5_>Y7\"OC'7%\3>+M5U*.-HH]0O)KE48Y*!W+
M'Z9H S:*** "BBB@ HHHH **** /[//^" __ "AM_9[_ .Q5B_\ 1LE?8%?'
M_P#P0'_Y0V_L]_\ 8JQ?^C9*^P* "BBB@ HHHH **** "BBB@ HHHH ****
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M* "OZ7O^#)?_ ),%^*__ &4!O_3=9U_-#7]+W_!DO_R8+\5_^R@-_P"FZSH
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M1110 4444 %%%% !1110 4444 %%%% !1110!_(%_P '1W_*=?XY_P#< _\
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M6ET+O19M=?2-&D1]T;V-BJV<$B=@LB0B7CO*3U)KY7H **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** /Y O^#H[_E.O\<_^X!_ZC^F5\ 5]_\
M_!T=_P IU_CG_P!P#_U'],KX H **** "BBB@ HHHH *_I>_X,E_^3!?BO\
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M^VK_ ((^?LQ/^QU_P3'^"OP^N+<6NI:3X9M[K4X<?ZJ^N]UY=+[XGGE&>^*
M/I*BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "OPA_X/B_^26_LZ_\ 85UW_P!$V-?N]7X0_P#!\7_R2W]G7_L*Z[_Z
M)L: /YX:*** "BBB@ HHHH **** /T^_X-#O^4R6B_\ 8JZQ_P"BDK^KZOY0
M?^#0[_E,EHO_ &*NL?\ HI*_J^H **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@#^0+_@Z._Y3K_'/_N ?^H_IE? %?HE_P '
M5GAM]"_X+A?%BZ;S-NLV6AWB[DV@ :/9P?*?XAF$\^N1VK\[: "BBB@ HHHH
M **** "OZ7O^#)?_ ),%^*__ &4!O_3=9U_-#7]"G_!CS\4(;GP)^T%X+D9%
MN;*_T?6X5.=TJ31W4,A'.,*8(L\#_6#D]@#]Z**** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^ /^#H[_E!1\<_^X!_Z
MD&F5_(%7]?O_  ='?\H*/CG_ -P#_P!2#3*_D"H **** "BBB@ HHHH *]@_
MX)[?\G]? _\ [*!H/_IQMZ\?KV#_ ()[?\G]? __ +*!H/\ Z<;>@#^YRBBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHJ'4=1M](
MT^>[NYX;6UM8VFFFF<)'"BC+,S'@* "23P * /G_ /X*F_\ !0+P_P#\$S/V
M)O%_Q5ULP7%YIT/V+0=.D?:=7U28,+:W'.2-P+OCE8HI6YVU_%+\3/B1KGQC
M^(VO>+?$VHW&L>(O$VH3ZIJ=].<R7=S-(TDLC>[.Q/''-??'_!QO_P %@G_X
M*@_M<_V1X2OY6^#WPV>6P\.*I*QZS<' N-29?^FA4)'G[L2*<*TC@_G70 44
M44 %%%% !1110 4444 ?2W_!'C]DIOVWO^"E_P '_AW-:O=Z3J6OPWVLH!\O
M]G6F;JZ!/1=T,+H"?XG4<D@'^V:OY\O^#*#]BMKWQ#\5/V@-5LCY5C$G@KP]
M,XRK2/LN;]E]"JBS4,!TED&1R#_0;0 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 5^$/_  ?%_P#)+?V=?^PKKO\
MZ)L:_=ZOP7_X/D-7AA\#?LVV#;OM%S?>(;A!CC;''IJMS]95_6@#^>NBBB@
MHHHH **** "BBB@#]/O^#0[_ )3):+_V*NL?^BDK^KZOY0?^#0[_ )3):+_V
M*NL?^BDK^KZ@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** /Y<?^#S3X;MX2_P""J/AW7%C_ -'\5^ ;"Y,F?O30W5Y RXR>
MB1Q'@ ?,.IR:_)&OZ"O^#X+X)M-H'P"^(T$;;;:XU7PW>OC@F18+BW'M_J[K
MZ\=,'/\ /K0 4444 %%%% !1110 5^G7_!I5^U9#^SM_P5GTGPYJ%QY&D_%K
M1;OPNQ=L1I=C9=6K'_:9[<PK[W'XC\Q:W?AA\2-8^#GQ*\/^+O#MX^GZ_P"%
M]2M]6TVZ3[UO<P2K+$X^CJI_"@#^]^BO&_\ @G[^V3H/[?\ ^QUX#^+?AWRX
M[7Q?IB3W5JK[CIUXA,=U;,?6*9)$R>H4-T(KV2@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** /@#_@Z._Y04?'/_N ?^I!I
ME?R!5_7[_P '1W_*"CXY_P#< _\ 4@TROY J "BBB@ HHHH **** "O8/^">
MW_)_7P/_ .R@:#_Z<;>O'Z]@_P"">W_)_7P/_P"R@:#_ .G&WH _N<HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHI'<1H68A549)/0"@
M!:_GY_X.EO\ @OC#JT6N?LO_  9UKS(5=K/XA>(+*4%9,8SI-O(IY&<BX([C
MR<_ZY:Z#_@X3_P"#G.U\/:?KWP,_9KUY;K59@UCXE\>:=/F.Q7YEEM-.D7[T
MIZ-<J=J D1DO^\C_ )ZG=I&+,2S,<DGO0 E%%% !1110 4444 %%%% !5C2=
M*NM>U6UL;&WFN[R\E6"""%"\DTC$*J*HY+$D  =2:KU^HG_!J1_P3I?]L?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MY#LO&.BZ#^SY^T'KR6FO6BQZ=X/\8:C.=FK+D)'87LC'Y;@9"QS,<2@!&(D
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?O87]NV2I9>5DC; WQ2(5=''#HZL."* .%HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_L\_X(#_ /*&W]GO
M_L58O_1LE?QAU_9Y_P $!_\ E#;^SW_V*L7_ *-DH ^P**** /@#_@Z._P"4
M%'QS_P"X!_ZD&F5_(%7]?O\ P='?\H*/CG_W /\ U(-,K^0*@ HHHH ****
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M=LF@0."/[0N$89%S(I'E(<&)"6/[QP(OW"HHH **^8?^"B?_  6#^ __  3
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M_P"0:/\ B*-_;L_Z+E_Y9GA__P"0:^ ** /O_P#XBC?V[/\ HN7_ )9GA_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !4MC8S:G>PVUM#+<7%PZQ111(7>5V. J@<DDD
M =:[?]FK]F#Q_P#MA_%_2_ ?PS\*ZKXP\5ZNV(+&QCW%%! :61R0D42Y&Z21
ME10<E@*_IZ_X(A?\&U?@?_@F];Z7\0_B5_9GC_XV*JS0S[/,TKPJ_P#=LU<
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MC9*_C#K^SS_@@/\ \H;?V>_^Q5B_]&R4 ?8%%%% 'P!_P='?\H*/CG_W /\
MU(-,K^0*OZ_?^#H[_E!1\<_^X!_ZD&F5_(%0 4444 %%%% !1110 5[!_P $
M]O\ D_KX'_\ 90-!_P#3C;UX_7L'_!/;_D_KX'_]E T'_P!.-O0!_<Y1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M>./V=?%\GA_Q]X/\3^"=<C!)L-<TR;3[C&<;@DJJ2ON.#ZT <G1110 4444
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M=M::?BRB=/\ 9D$'F>YD)X)KY+H **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***^Q/\ @G5_
MP0I_:*_X*6WEK>^"_!TNA>"YF'F>+?$0>PTD)W,3%3)<GV@1\'&XJ.: /CNO
MU6_X(\_\&N/Q0_;QETOQQ\6EU3X4_"6;;<1">'R]>\0Q'D?9H)!^XB8<B>9>
M05*1R*=P_8+_ ()9_P#!L?\  G_@GA)IWBCQ);I\7OB?:E9EUK7+1!I^ES Y
M#65D2R1LIVD2RF20,NY&CSMK])* /.?V5OV2_AW^Q/\ !K3? 'PP\+:;X3\+
MZ6,I;6JDO<2$ ---(Q+S3-@;I)&9C@<X  ]&HHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M]$-_\O/P_P#_ "=1_P 0N/[=G_1#?_+S\/\ _P G5_7[10!_(%_Q"X_MV?\
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M_P#!T=_R@H^.?_< _P#4@TROY J "BBB@ HHHH **** "O8/^">W_)_7P/\
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M#^)S4]2N-9U*XO+J5[BZNI6FFE<Y:1V)+,?<DDU!110 4444 %%%% !1110
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M:C_B"7^ ?_16/C!_WWIW_P C4 ?S0T5_2]_Q!+_ /_HK'Q@_[[T[_P"1J/\
MB"7^ ?\ T5CXP?\ ?>G?_(U '\T-%?TO?\02_P  _P#HK'Q@_P"^]._^1J/^
M()?X!_\ 16/C!_WWIW_R-0!_-#17]+W_ !!+_ /_ **Q\8/^^]._^1J/^()?
MX!_]%8^,'_?>G?\ R-0!_-#17]+W_$$O\ _^BL?&#_OO3O\ Y&K>\,_\&5_[
M+^EBW?4O'?QPU2:,DRJ-7TV""7KCY5L"XP,='Y(].* /Y@Z*_K;^&G_!I_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M7_T;'7V!7Q__ ,%^/^4-O[0G_8JR_P#HV.@#^,.BBB@ HHHH **** "BBB@
MK^_ROX Z_O\ * "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** /@#_@Z._P"4%'QS_P"X!_ZD&F5_(%7]?O\ P='?\H*/CG_W /\
MU(-,K^0*@ HHHH **** "BBB@ KV#_@GM_R?U\#_ /LH&@_^G&WKQ^O8/^">
MW_)_7P/_ .R@:#_Z<;>@#^YRBBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "OC__ (+\?\H;?VA/^Q5E_P#1L=?8%?'_
M /P7X_Y0V_M"?]BK+_Z-CH _C#HHHH **** "BBB@ HHHH *_O\ *_@#K^_R
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MBK+_ .C8Z /XPZ*** "BBB@ HHHH **** "O[_*_@#K^_P H **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MKX__ ."_'_*&W]H3_L59?_1L=?8%?%O_  <2^*;?P?\ \$6/C_=W1 CFT&&Q
M7+!?GN+VVMTZ_P"W*O'?I0!_&K1110 4444 %%%% !1110 5_?Y7\"_@;1H?
M$?C;1]/N-XM[Z^AMY"APVUY%4X/K@U_?10 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OXG_\
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MA:CXL\<>)-:\6>)=6D,MWJ6JW;W5S.?=W).T= HX4<  <5S- !1110 4444
M%%%% !1110 5UGP%^"^N?M'?&WPCX \,VYNO$'C35[71=/CP2#-/*L:EL=%!
M;+'H "3P*Y.OV8_X,W_^"?LGQH_:\\1?'K6[-7\._">V;3M&,BY6XUF[C*EE
MSD'R+5I">A#7$# \&@#^C/\ 9Y^"&B_LT? ?P;\//#D9CT+P1HMIH=B& #-%
M;PK$K-CJ[;=S'NQ)ZFNQHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?C7_P<9?\ !N1!
M^V)9:M\<O@7I$%K\6+=#<^(?#ULHCC\8HHR9XAP%O@!R.!.!S^\P7_92B@#^
M W7-$O?#.M7FFZE9W6GZCI\[VUU:W,30S6TJ,5>-T8!E96!!4@$$$&JM?U<?
M\%U/^#<#PC_P4KT_4/B+\-5TKP3\<(8@TD[)Y.F^+ H.([S:/EGQ@+<@$X 5
MPR[6C_E[_:"_9W\;?LJ_%O6/ OQ#\-:IX3\6:%*8KS3[^+9(O]UU/W9(V'*R
M(2CJ05)!!H XNBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M/4C/3T%4_P#ARE^R/_T;E\'_ /PFK;_XF@#^*.BO[7/^'*7[(_\ T;E\'_\
MPFK;_P")H_X<I?LC_P#1N7P?_P#":MO_ (F@#^*.BO[7/^'*7[(__1N7P?\
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MX#_99^&/PKG$GA?X<^ _#<BG<'TO0+2S8'(.<QQKW53]5'I7>4 ?R0_L[_\
M!JA^V1\=YK:34? ^B_#G3;@@_;/%6MPPE%XR3!;F:X4^S1@U^B7[*/\ P9->
M!?#9AOOC1\7/$'BJ<;7;2O"MFFEVJ,#RK7$WFR2J?54A;W[U^YE% '@_['O_
M  3%^ ?[ ]BL?PG^%_A?PG>>7Y4FJ) ;K5)UYRKWDQ>X93D_*7QR>*]XHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***_&O\ X/)OCIXV
M^!G[-/P9N_!/C'Q5X.NK[Q->17,VAZM/I\EP@M00KM"ZEE!YP<C- '[*45_#
M'_P\)^/O_1</C!_X66H__'J/^'A/Q]_Z+A\8/_"RU'_X]0!_<Y17\,?_  \)
M^/O_ $7#XP?^%EJ/_P >H_X>$_'W_HN'Q@_\++4?_CU ']SE%?PQ_P##PGX^
M_P#1</C!_P"%EJ/_ ,>H_P"'A/Q]_P"BX?&#_P ++4?_ (]0!_<Y17\,?_#P
MGX^_]%P^,'_A9:C_ /'J/^'A/Q]_Z+A\8/\ PLM1_P#CU ']SE%?PQ_\/"?C
M[_T7#XP?^%EJ/_QZC_AX3\??^BX?&#_PLM1_^/4 ?W.45_#'_P /"?C[_P!%
MP^,'_A9:C_\ 'J/^'A/Q]_Z+A\8/_"RU'_X]0!_<Y17\,?\ P\)^/O\ T7#X
MP?\ A9:C_P#'J/\ AX3\??\ HN'Q@_\ "RU'_P"/4 ?W.45_#'_P\)^/O_1<
M/C!_X66H_P#QZC_AX3\??^BX?&#_ ,++4?\ X]0!_<Y17\,L/_!0_P#: MY5
MDC^.7QBCDC(967QGJ0*D="#YU=%:?\%:_P!JFRNHYD_:5^/C/"X=1)X_U612
M0<\JTY##V((/>@#^WBBOXN?"W_!>+]L3P=,)+3]H?XDS,'$F+[4!?+D>TZN,
M>W0^E>N?#_\ X.IOVV_ WEK<_%+3?$D,8PL6J^%M,;C!'+Q01R-USDL3D#MD
M$ _KJHK^9SX5_P#!Z[\?O#TD:>,/AA\*/$UNA^9M/2^TJXD&>[-/,F>W$8[<
M'O\ 6_P)_P"#V;X->+9HX?B)\(_B!X)>0X\W1[VVUZWB]V+_ &9\?[L;'VH
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M4 %%%% !117\V/\ P=;?\%?O%^J?MO:=\'_A1X\\4>%M)^%-HT>O7/A_5YK
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M]0!_<Y17\,?_  \)^/O_ $7#XP?^%EJ/_P >H_X>$_'W_HN'Q@_\++4?_CU
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M7\,?_#PGX^_]%P^,'_A9:C_\>H_X>$_'W_HN'Q@_\++4?_CU ']SE%?PQ_\
M#PGX^_\ 1</C!_X66H__ !ZC_AX3\??^BX?&#_PLM1_^/4 ?W.45_#'_ ,/"
M?C[_ -%P^,'_ (66H_\ QZC_ (>$_'W_ *+A\8/_  LM1_\ CU ']SE%?PQ_
M\/"?C[_T7#XP?^%EJ/\ \>K^GO\ X-5/BGXG^,7_  23T?6O%WB/7O%6L2>)
M]5A:_P!8U"6^NF19$"J9)69MH[#.!0!^D-%%% !1110 4444 %%%% !1110
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MC5JG_I7+7G] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M>D_$JV.N^'TDDPL>JVD9\^-!_>FM06)Y/^A(.YK^DN@ HHHH **** "BBB@
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MXN:GTS4[G1-2M[RSN)[.\LY5F@GAD,<D,BD%75ARK @$$<@B@#^_6BOYA_\
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MF_\ B:AU#X<>(M)LY+BZT'6K:WA&Z266RE1$'J25P* ,6BBB@ HHHH ****
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M:\0?^"Z;_P")H Y^BN@_X51XI_Z%KQ!_X+IO_B:/^%4>*?\ H6O$'_@NF_\
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M*XB:-P#(F#A@#0!^FM%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M445SOCGXO>$_AA+;Q^)?%'AWP[)>!FMUU/4H;0SA<;BHD8;L9&<=,B@#HJ*\
M_P#^&LOA7_T4OX?_ /A0VG_QRC_AK+X5_P#12_A__P"%#:?_ !R@#T"BO/\
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M_LN> _BGX;8?V/XXT:#5(XMVYK21UQ+;L<#+Q2AXV_VHS7I- !1110 4444
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MN;C[0>R-=3F97/.%NY.M?R 7%O):7$D,T;Q2Q,4='7:R,."".Q'I0 RBBB@
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M8GQ&^)MO8:Y^T!XVLOASILRK*_A[0-FI:UC(S'+.<VT#8R<I]H'3(Z@?O/\
ML:_L$_"/_@G_ /#1/"OPE\$:/X2TY@OVJ>"/S+[4W'_+2YN7S+,W7!=B%SA0
M!@5[!0!\7_LB?\&^W[)?[&=M:RZ!\)=#\2ZY; 9UKQ:O]N7LCC_EH!.##$WO
M#%&/;K7V9:6D5A:QP011PP0H(XXXU"K&H&  !P !Q@5)10 4444 %%%% !11
M10 4CH)$*L RL,$$<$4M% 'S+^TM_P $:OV7?VN8[AO'7P1\!WU]=9,NI:?8
M?V3J3GU:ZM#%,V/]IR/S-?F3^V/_ ,&4?@WQ-'>:E\"?BEJWA>\;<\6B>+81
MJ%BS'HBW4*K-"@]6CG;WK]T** /XG_V\?^"._P"T-_P3@O9I/B=\/=3M?#ZN
M$B\2:9_Q,-%GR<+_ *3'E8V8@X281N?[M?,=?WYZSHUGXBTFYL-0M;:^L;R)
MH;BVN(EEAGC889'5@0RD$@@C!%?D9_P55_X-*OA3^U1:ZAXL^ [:=\(?'S!I
M3I*QD>&M5?\ NF) 6LV/9H08Q_SRR=P /Y?Z*],_:T_8Z^)7[#7QCO\ P'\4
MO">I^$_$EB=PBN4W0WD6<":WF7,<T38.'C9ER",@@@>9T %%%% !4VGZC<:1
MJ$%W:3S6MU:R++#-$Y22)U.596'(8$ @CD$5#10!_3E_P;=?\'#J_MK:58?
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M4O/,O/A_JB:_HL<A^;[!?9$T:#^['<Q%S_M7G?M^VU?R/_\ !JE^T;)\ _\
M@L?X'TV2X^SZ7\2-.O\ PI>Y/#>9";FW&/4W-K H]-Y]Z_K@H **** "BBB@
M#^$/]K#_ ).F^)7_ &-6J?\ I7+7G]>@?M8?\G3?$K_L:M4_]*Y:\_H ****
M "OV>_X,F/\ D_OXK_\ 9/V_].-G7XPU^SW_  9,?\G]_%?_ +)^W_IQLZ /
MZ7J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KF?C1\7="^
M'PB\3^./%%XNG^'?".EW&L:E<''[JW@C:1R,D9;:I &>3@=ZZ:OQ+_X/*?\
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M8(8;9[&< ^7<P2=8YHR<JP]P<JS*0#^%*BOIK_@J[_P2]\<?\$H_VIK[X?\
MBL/J6BWBM>^&O$,</EVVOV.[ D49.R5#\LD1)*-ZHR.WS7I^GW&KZA!:6D$U
MU=74BQ0PQ(7DE=CA551R6)(  Y)- $-?K[_P0;_X-DM>_;?.D?%CXYVNH^%O
MA"Q%SIFB_/;ZIXO7@J^>&@LVSGS/OR ?(%5A*/IW_@@K_P &LL'@Y='^,?[4
M&BPWFK,%N]"^'UY%NBL> 4GU-3P\O<6I&U,#S-S$QI^\*((T"J JJ,  < 4
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MK:_^CEK^]R@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M*S7]'U?S@_\ !D-_R=/\</\ L5++_P!*S7]'U !1110 4444 %%%% !1110
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MG[)O_)K'PS_[%32__22*OX0Z_N\_9-_Y-8^&?_8J:7_Z214 >@4444 %%%%
M'\(?[6'_ "=-\2O^QJU3_P!*Y:\_KT#]K#_DZ;XE?]C5JG_I7+7G] !1110
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MJ.KP)7]J]I=Q7]K'/!)'-!,@DCDC8,LBD9!!'!!'.10!)1110 4444 %%%%
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M !1110 4444 %%%% !7X@_\ ![S_ ,FL_ __ +&J^_\ 205^WU?B#_P>\_\
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MC^F5\ 5]_P#_  ='?\IU_CG_ -P#_P!1_3*^ * "BBB@ K[?_P"#;W_E-K\
M_P#L*WO_ *;+NOB"OM__ (-O?^4VOP#_ .PK>_\ ILNZ /[':*** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ K^>'_ (/B_P#DJG[.W_8*US_T
M=8U_0]7\\/\ P?%_\E4_9V_[!6N?^CK&@#\(:*** "BBB@#]OO\ @R&_Y.G^
M.'_8J67_ *5FOZ/J_G!_X,AO^3I_CA_V*EE_Z5FOZ/J "BBB@ HHHH ****
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MQ;B^"GPQUC[7\*?A_?M)J>HVLN;?Q3JJ93>A'#VT'SK&P)61V=QN41-7Y%T
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MD?\ R17\0=% ']OG_#V+]EG_ *.6_9__ /#AZ1_\D4?\/8OV6?\ HY;]G_\
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M<5_ ?7]SG_!/7_DP3X'?]D_T'_TW6] 'L%%%% !1110 4444 %%%% !1110
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M_P"#(;X7#2?V5OCAXU\LAO$'BNRT0R8X;[#9F;&<=O[0]3][H,\_M]7Y8_\
M!GKX-'A?_@C[#?"(Q_\ "1^-=6U$L8=GF[5M[;=G^/\ X]\;O]G;_#7ZG4 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% '\@7_!T=_P IU_CG_P!P#_U'],KX K[_ /\
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M_P#"<^./!_@S^U?,^Q?V[K-MIWVSR]OF>7YSKOV[TW;<XWKG&17'_P##PKX
M_P#1<?@__P"%EIW_ ,>K\8?^#YS_ )M=_P"YK_\ <+7X T ?W.?\/"O@#_T7
M'X/_ /A9:=_\>H_X>%? '_HN/P?_ /"RT[_X]7\,=% ']SG_  \*^ /_ $7'
MX/\ _A9:=_\ 'J/^'A7P!_Z+C\'_ /PLM._^/5_#'10!_<Y_P\*^ /\ T7'X
M/_\ A9:=_P#'J/\ AX5\ ?\ HN/P?_\ "RT[_P"/5_#'10!_<Y_P\*^ /_1<
M?@__ .%EIW_QZC_AX5\ ?^BX_!__ ,++3O\ X]7\,=% ']SG_#PKX _]%Q^#
M_P#X66G?_'J_!3_@\U^/O@7X[?$SX!S>!_&OA+QE%INF:TEV^AZQ;ZBMJSRV
M942&%VVEMK8!QG:?2OQ.HH **** "BBB@#]E/^#-KXZ^"/@7^TQ\9KOQMXR\
M*^#K6^\,6<-M-KFK0:?'<.+HDJC3.H9@.<#)Q7]!'_#PKX _]%Q^#_\ X66G
M?_'J_ACHH _N<_X>%? '_HN/P?\ _"RT[_X]1_P\*^ /_1<?@_\ ^%EIW_QZ
MOX8Z* /[G/\ AX5\ ?\ HN/P?_\ "RT[_P"/4?\ #PKX _\ 1<?@_P#^%EIW
M_P >K^&.B@#^YS_AX5\ ?^BX_!__ ,++3O\ X]1_P\*^ /\ T7'X/_\ A9:=
M_P#'J_ACHH _N<_X>%? '_HN/P?_ /"RT[_X]1_P\*^ /_1<?@__ .%EIW_Q
MZOX8Z* /[G/^'A7P!_Z+C\'_ /PLM._^/5UOPJ_:.^'OQVN+V'P/X\\&>,I=
M-5'NTT/6[;46M5?(4R"%VVAMK8)QG:?2OX-J_=[_ (,=/^2J?M$_]@K0_P#T
M=?4 ?T/4444 %%%% !1110 4444 %%%% !7X@_\ ![S_ ,FL_ __ +&J^_\
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M#-+]O?\ X6Y^R=XJ^ NM7@?6OA9=G5=#1S\TND7DA9T7U\F[,A))Z7<0 XH
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MZC^F5\ 5]_\ _!T=_P IU_CG_P!P#_U'],KX H **** "BBB@ HHHH ****
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M[D8,,CTR*_5/_B,D_:X_Z!OP?_\ "=N?_DJORAHH _5[_B,D_:X_Z!OP?_\
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M;6-L&9\$-CRER3(T?]4-O;QV=O'##&D442A$1%VJBC@  = /2L;X:?#3P_\
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M /PK=,_^/4 ?G#17Z/?\0H'[;7_1./#_ /X5NF?_ !ZC_B% _;:_Z)QX?_\
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MH$ZJ#JUW-AO?,I/;@BOT6H **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^(/_  ;:9_\ )-'_ !#>?MM?]$#\0?\ @VTS_P"2: /B"BOM_P#XAO/VVO\
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MA!;7-O ;:)VV*Q,TB Y;C@DU[[_Q#>?MM?\ 1 _$'_@VTS_Y)H ^(**^W_\
MB&\_;:_Z('X@_P#!MIG_ ,DT?\0WG[;7_1 _$'_@VTS_ .2: /B"BOM__B&\
M_;:_Z('X@_\ !MIG_P DT?\ $-Y^VU_T0/Q!_P"#;3/_ ))H ^(**^W_ /B&
M\_;:_P"B!^(/_!MIG_R31_Q#>?MM?]$#\0?^#;3/_DF@#X@HK[?_ .(;S]MK
M_H@?B#_P;:9_\DT?\0WG[;7_ $0/Q!_X-M,_^2: /B"OW>_X,=/^2J?M$_\
M8*T/_P!'7U? '_$-Y^VU_P!$#\0?^#;3/_DFOUU_X-._^"9GQT_X)_?$'XUW
MGQA^'NH^"+;Q/IVDPZ6]S=VLXNWADNS(!Y,KD;1(GWL?>XS0!^U%%%% !111
M0 4444 %%%% !1110 5^(/\ P>\_\FL_ _\ [&J^_P#205^WU?B#_P 'O/\
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MYS_JUW_S)'_WKH _?ZBOP!_XCG/^K7?_ #)'_P!ZZ/\ B.<_ZM=_\R1_]ZZ
M/W^HK\ ?^(YS_JUW_P R1_\ >NC_ (CG/^K7?_,D?_>N@#]_J*_ '_B.<_ZM
M=_\ ,D?_ 'KH_P"(YS_JUW_S)'_WKH _?ZBOP!_XCG/^K7?_ #)'_P!ZZ/\
MB.<_ZM=_\R1_]ZZ /W^HK\ ?^(YS_JUW_P R1_\ >NC_ (CG/^K7?_,D?_>N
M@#]^-1T^WU?3Y[2[@ANK6ZC:&:&9 \<R,,,K*>"I!((/!!K^)G_@K?\ L.W'
M_!.W_@H1\2/A;Y,Z:+I.I->>'Y9<G[1I5P/.M#N_B*QN(V(_CC<<$$#];O\
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MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _D"_X.CO\ E.O\<_\
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MX[/^#DO]GS_AG?\ X++?&2UBA\K3_%E_#XLM&VD>=]OA2>=O_ EKA<_[/X
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MIE? %??_ /P='?\ *=?XY_\ < _]1_3*^ * "BBB@ K[?_X-O?\ E-K\ _\
ML*WO_ILNZ^(*^W_^#;W_ )3:_ /_ +"M[_Z;+N@#^QVBBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH *_GA_X/B_\ DJG[.W_8*US_ -'6-?T/
M5_/#_P 'Q?\ R53]G;_L%:Y_Z.L: /PAHHHH **** /V^_X,AO\ DZ?XX?\
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M"SDDD.8;I4*H&8^7.RG'ENR1, ?KY1110 4444 %%%% !1110!_(%_P='?\
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M _\ [&J^_P#205^WU?B#_P 'O/\ R:S\#_\ L:K[_P!)!0!_.#1110 4444
M=!\*/^2I>&O^PK:_^CEK^]ROX(_A1_R5+PU_V%;7_P!'+7][E !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% '\(?[6'_)TWQ*_[&K5/_2N6O/Z] _:P_Y.F^)7_8U:I_Z5RUY_
M0 4444 %?L]_P9,?\G]_%?\ [)^W_IQLZ_&&OV>_X,F/^3^_BO\ ]D_;_P!.
M-G0!_2]1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M!\ ?\0N/["?_ $0W_P O/Q!_\G5\8?\ !>__ (-N_@/\"/\ @G'XJ^(_[/\
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MOM__ (-O?^4VOP#_ .PK>_\ ILNZ^(*^W_\ @V]_Y3:_ /\ ["M[_P"FR[H
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MHHH Z#X4?\E2\-?]A6U_]'+7][E?P1_"C_DJ7AK_ +"MK_Z.6O[W* "BBB@
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MFOZ/J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MK\0?^#WG_DUGX'_]C5??^D@K]OJ_$'_@]Y_Y-9^!_P#V-5]_Z2"@#^<&BBB@
M HHHH Z#X4?\E2\-?]A6U_\ 1RU_>Y7\$?PH_P"2I>&O^PK:_P#HY:_O<H *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH _A#_:P_Y.F^)7_8U:I_Z5RUY_7H'[6'_)TWQ*_P"Q
MJU3_ -*Y:\_H **** "OV>_X,F/^3^_BO_V3]O\ TXV=?C#10!_?Y17\ =%
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M<30)*O\ H5JW *^5;E"R'E99IA7Z#T44 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !7\J__  =O_L&_\,M?\%'_ /A8VCV0M_"O
MQOM&UD>6FV.+5H-D5^@]W+0W!.>6NGX %?U45^?G_!S#^P@O[</_  2R\82:
M=9K<>+OA=GQGHK*F9'%M&_VN $<GS+5IB$'#21Q<9 ( /Y!J*** "BBB@#TS
M]C7]I[7/V+OVJ? /Q4\-LW]K>!M9@U1(@VU;N)6Q-;L?[DT1DB;'\,C5_<7\
M&OBUH?Q[^$?ACQQX9NA?>'?%^E6VLZ;/Q^]M[B)98R0"<':PR,\'(K^"BOZ;
MO^#./]OC_A=_[&'B'X(:U>^;K_PAO/M6DK))F2;1[QWD"C/+>3<^<I.<*LT*
M\ "@#]CJ*** "BBB@ HHHH _)W_@Y8_X(/+_ ,%"OAQ)\8/A;IJ#XU>#[+;=
M6,*X/C'3XU)^SX YNXQ_J6_C&8CG]V4_EKU#3[C2-0GM+N":UNK61HIH94*2
M1.IPRLIY# @@@\@BO[]J_&7_ (.,?^#<2/\ :^CUSX[_  -TY(/BG##]HU_P
MS;1I'#XM5 2]Q" !B_QC()Q.%[2<R '\SM%6M<T2]\,ZU>:;J5G=:?J.GSO;
M75K<Q-#-;2HQ5XW1@&5E8$%2 000:JT %%%% !1110!W7[/?[3?Q"_9/^(5O
MXJ^&OC+Q%X)\06I!6\TF]>W:0#^"0*=LD9Y!1PRL"000:_7C]B#_ (/0OB=\
M-[:ST?X[> ])^(UC"!&^NZ$RZ3JQ'=Y(<&VF;V00#^OXFT4 ?V&?LI_\'*'[
M'W[5\5M#;?%.S\!ZQ<8SIGC:$Z+)$3T!N')M&)Y&$G8Y^HS]O>$O&6C^/M!M
M]5T'5=-UK2[H;H;RPN4N;>8>JNA*M^!K^!6NJ^%?QT\;? O61J7@GQCXJ\':
M@IW"ZT/5I]/F!]=\+JWZT ?WI45_&S\)?^#BK]M'X,I#'IOQZ\4ZE#"1E->M
MK36S*,Y(9[N&1^>F0P;'0BO?/ W_  >'_M?^$HXEU#_A5OB@QD%FU/PV\9EP
M,<_9IX1SUXQ[8Z4 ?U545_,OI'_![%^T5#9A;_X8?!6YN,G+V]IJ<"8[?*UX
MY_'=5K_B-G^/W_1*/@__ -\:C_\ )- ']+U%?R^^*?\ @](_:EU@R)IW@OX(
MZ/%OW(R:-J,TRK_=+/?%3]0@->,_$C_@ZJ_;8^($;1VOQ-TGPO#)]Y-'\,:<
MI/T>:&1U_!A^5 ']=%>&_M+?\%,?V?\ ]CR.X7XE?&#P#X5O+7/F:;<:M'+J
M?'7;9QEKAL=]L9QQ7\<_QM_X*9_M#_M'130^./C;\4/$5G."KV-SXCNA9$'K
M_HZN(AGOA>:\-H _I>_;!_X/0?@O\-;>ZL/@WX'\4_$W55!6+4=3']AZ3G.
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MIE? %??_ /P='?\ *=?XY_\ < _]1_3*^ * "BBB@ K[?_X-O?\ E-K\ _\
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MD%?M]7X@_P#![S_R:S\#_P#L:K[_ -)!0!_.#1110 4444 =!\*/^2I>&O\
ML*VO_HY:_O<K^"/X4?\ )4O#7_85M?\ T<M?WN4 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MAA0)'"BC"JJC@*   !P * )J*** "BBB@ HHHH **** "BBB@ HHHH ****
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M%% '\@7_  ='?\IU_CG_ -P#_P!1_3*^ *^__P#@Z._Y3K_'/_N ?^H_IE?
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 5_7[_P &N/\ R@H^!G_<?_\ 4@U.OY J_K]_X-<?^4%'P,_[
MC_\ ZD&IT ??]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !7X@_\ ![S_ ,FL_ __ +&J^_\ 205^WU?D-_P=W_LB?%#]KO\
M9S^$&F_"_P  ^*O'U_H_B2[N;VWT/3Y+R2UB:U"J[A 2JEN,GO0!_+Y17T__
M ,.4_P!KC_HW+XP?^$S<_P#Q-'_#E/\ :X_Z-R^,'_A,W/\ \30!\P45]/\
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M31_PY3_:X_Z-R^,'_A,W/_Q- 'S!17T__P .4_VN/^C<OC!_X3-S_P#$T?\
M#E/]KC_HW+XP?^$S<_\ Q- 'S!17T_\ \.4_VN/^C<OC!_X3-S_\31_PY3_:
MX_Z-R^,'_A,W/_Q- 'S!17T__P .4_VN/^C<OC!_X3-S_P#$T?\ #E/]KC_H
MW+XP?^$S<_\ Q- 'S!17T_\ \.4_VN/^C<OC!_X3-S_\31_PY3_:X_Z-R^,'
M_A,W/_Q- 'S!17T__P .4_VN/^C<OC!_X3-S_P#$T?\ #E/]KC_HW+XP?^$S
M<_\ Q- 'S!17T_\ \.4_VN/^C<OC!_X3-S_\31_PY3_:X_Z-R^,'_A,W/_Q-
M 'S!17T__P .4_VN/^C<OC!_X3-S_P#$T?\ #E/]KC_HW+XP?^$S<_\ Q- '
MS!17T_\ \.4_VN/^C<OC!_X3-S_\31_PY3_:X_Z-R^,'_A,W/_Q- 'S!17T_
M_P .4_VN/^C<OC!_X3-S_P#$T?\ #E/]KC_HW+XP?^$S<_\ Q- 'S!17T_\
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M3_:X_P"C<OC!_P"$S<__ !-'_#E/]KC_ *-R^,'_ (3-S_\ $T ?,%%?3_\
MPY3_ &N/^C<OC!_X3-S_ /$T?\.4_P!KC_HW+XP?^$S<_P#Q- 'S!17T_P#\
M.4_VN/\ HW+XP?\ A,W/_P 31_PY3_:X_P"C<OC!_P"$S<__ !- 'S!17T__
M ,.4_P!KC_HW+XP?^$S<_P#Q-'_#E/\ :X_Z-R^,'_A,W/\ \30!\P45]/\
M_#E/]KC_ *-R^,'_ (3-S_\ $T?\.4_VN/\ HW+XP?\ A,W/_P 30!\P45]/
M_P##E/\ :X_Z-R^,'_A,W/\ \31_PY3_ &N/^C<OC!_X3-S_ /$T ?,%%?3_
M /PY3_:X_P"C<OC!_P"$S<__ !-'_#E/]KC_ *-R^,'_ (3-S_\ $T ?,%%?
M3_\ PY3_ &N/^C<OC!_X3-S_ /$T?\.4_P!KC_HW+XP?^$S<_P#Q- 'S!17T
M_P#\.4_VN/\ HW+XP?\ A,W/_P 31_PY3_:X_P"C<OC!_P"$S<__ !- 'S!1
M7T__ ,.4_P!KC_HW+XP?^$S<_P#Q-'_#E/\ :X_Z-R^,'_A,W/\ \30!\P5_
M7[_P:X_\H*/@9_W'_P#U(-3K^:'_ (<I_M<?]&Y?&#_PF;G_ .)K^H;_ (-U
M_@IXN_9V_P""./P>\&^._#>L>$O%6C_VU]NTG5;9K:[M/-UO4)H]\; %=T<B
M.,]5<'O0!]KT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
J4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>cron-20201231_g7.jpg
<TEXT>
begin 644 cron-20201231_g7.jpg
M_]C_X  02D9)1@ ! 0$!2@%*  #_X2R*17AI9@  34T *@    @ !@ +  (
M   F   (8@$2  ,    !  $   $Q  (    F   (B $R  (    4   (KH=I
M  0    !   (PNH<  <   @,    5@  $48<Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                     %=I;F1O=W,@4&AO=&\@161I=&]R(#$P+C N,3 P
M,3$N,38S.#0 5VEN9&]W<R!0:&]T;R!%9&ET;W(@,3 N,"XQ,# Q,2XQ-C,X
M-  R,#(Q.C R.C T(#$T.C,U.C$Y   &D ,  @   !0  !$<D 0  @   !0
M !$PDI$  @    ,P,   DI(  @    ,P,   H $  P    $  0  ZAP !P
M" P   D0     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M,C R,3HP,CHP-" Q-#HQ,3HU-  R,#(Q.C R.C T(#$T.C$Q.C4T      8!
M P #     0 &   !&@ %     0  $90!&P %     0  $9P!*  #     0 "
M   " 0 $     0  $:0" @ $     0  &MT         8     $   !@
M ?_8_]L 0P (!@8'!@4(!P<'"0D("@P4#0P+"PP9$A,/%!T:'QX=&AP<("0N
M)R B+",<'"@W*2PP,30T-!\G.3TX,CPN,S0R_]L 0P$)"0D,"PP8#0T8,B$<
M(3(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R_\  $0@ HP$  P$A  (1 0,1 ?_$ !\   $% 0$! 0$!
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MJHC;.<8Y#D#@@D'! J>7XB:;#;"Z>ROC;,,+*@C8%PGF%  Y.0H)SC'!YZ9
M+DOC&R&DV^HVUK=74=P9MB1; Q6(L';YF Q\I(YR>*6R\86NH6&H7MK9W4D-
MEZ&,&7_=!;C_ (%B@""3Q]I*V>I7,<=S,FGPP2RK&H)/FL5"KSR01S^7)J"+
MXBZ7/Y[P6E[);6\WDRW"A-BY?8C#YLLK$C! /!R<4 .M_B#8WEM'<VFG7\T+
M2&-G C78PA68@AG!X5O3J#[9M1^-+"YLEN+.WN;EGF2"*) @9W:/S, LP PH
M.<D=.,\4 07GC[3+".%Y[:[42NZ'Y4^38\:,6^;IF4'CL#^,-M\2-)NM,:_2
MUOEC7S,JR*&^02$\;O\ IDWYC\ "[K/C2QT?5)-.:VN;FYCM_/*P[,8SC;EF
M'S8^;'I52Z^(>G6:7GGV-\LMHCN\6U"Q"(S/CYL<;<=>K"@#1D\3B/3+*^&E
MWCI=3"$*CQ9C). 6^?&/H35-?'$4GD^7H^HNTYC,(!A&])"0K\R< E3P>1Z4
M 6]&\7Z;KFH-968E,B^<=S ;2(V12>O0[P1ZC-9<GQ(TY)YX5T^^=XIO*^4Q
M8)W,O]_CE#][!H O-XR@BNIH+C3;V#RY'C#L8B'*QF0XVN3]U>^.H]ZST^)V
MCLTGF6M[''&X5I"(V R6 )VL2HRIZ@>OK0!TND:JNL68NH[6X@C8*4\]0-X*
MA@1@GCFM"@ HH ** "B@ HH *J7.F6-Y<13W-I#++$,([J"5H K#PWHH0)_9
M=J5#;@#$#@^OZ5,VBZ8\4<;6%NT<8944Q@A0V"V/K@?E0!$WA[1W14;3;8JJ
M+&H\L<*O0#Z4J^'](1PZZ;;!@FP$1C@>E &9?V@W'3T\.07&GQ',6<*H8G+'
M'/'S>G9J2XNY(K*:W?PX3:.?F0$$,2WH!^-  UOY#W 3P];R(V$(2,)E48E,
MGG=S@CIC-00V-NDMK&/"4,:HR*&7;B)<#GI_#P/PH DCCE@,D:^&XF0R%_D4
M(,E0GOD[>,\<"ED_TO3KJ/\ X1M2$>,B&0 >9@A?P(7I0!*FF6,]M=22^'8$
MN"K((V0$2 #@9QT.!^0JHFGI)!,)/"UK'-]E/S;0R,7Y9,<'JS9_'ZT ,L;&
M6>[6"3PW:00J^]I)(AR,*O!W9S@MZ\ 4^2WN9I9!+X>M9!+O21C%]Y7'S#KW
MP ?SQB@"RTEU:VZVT/AY7BBE#Q@.,</P0.QQS5K2+&T=9B^B1V3^8'VE0=Q'
M(8$>A)H L)X=T:.:&:/3+5)(0!&R1@%0,>GT'Y4Z;0=)N,>=I]NY&<$H,C)+
M?S)/XF@!]QHVFW4?ESV,$B[P^&0'Y@-H/UQQ2-H>E/\ >T^V/RE>8QT))(_,
MG\S0!<BBC@A2*) D:*%15& H'  I] !10 44 %% !10 44 %% !10 5C3>'H
MY]1>\>X<%BQVJH&,KMZ_UH C_P"$8A^S^4UU.<3F=&&,JQ4*,?3&?K4D.A2Q
MB42ZK>SK)&R!9'X7( S]>/UH C7P]-'#LAU:ZBY;'EX55!Q@!1P ,'MWJ0Z)
M=/ B/K%X&5W9F1R-P88QUZ#J/>@!K>'O,M'@DOII-\WFEY/F;[@7 )Z=,TEI
MX;CM;R.X^U.Q3HNT 8V%?Z_R':@"./PP;>-(K;5KV")0!L1@!G&">/7K4\^@
M^;=O<)?7$3,NTE#\WW=H^;K@8SC/7- #[72+JWOHYWU6YFB3/[IR<'(QSSSZ
MUK4 %% !10 44 %% !10 44 %% !10 44 %% !10 44 %% !10 44 %% !10
M 44 %% !10 44 %% !5%]9TN*1HY-1M$=7,;*TR@AAC(Z]>1^8H LP7$%U L
MUO-'-$_W7C8,I^A%2T %% !10 44 %% !10 44 %% !10 44 %% !10 44 %
M% !10 5DS^&M(N99))K)':24RMDGER "?R H N6UG;V$,-M;1B.%-VU1[Y)_
M4U:H ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ K(G\3Z/;
M221S7FQHY3"Q,3X#C&1G&/XA_D4 7+6]M]0A@N;63S(7W;6P1TR#P>1R"*MT
M %% !10 44 %% !10 44 %% !10 44 %% !10 44 %% !10 50?1=,DGDF>R
MA:20DNQ7EB<9S_WR/RH GAMH;188;>)8XTSM51@#O5B@ HH ** "B@ J*YN(
M[2UEN)3A(U+&@#&L-#G;=<W]Y.9I5R(XW91%SG YY(Z9JW%<36%REK>R>9%(
M<07!&,G^XW;/H>_UZ@&G10 44 %% !10 44 %% !10 44 %% !6#=>+]*LYY
MHIFF5H93"_R9P0%.<=<?,.?\1D T;'4(-3MK>[MR3'(6QN&#P2#^H-7: "B@
M HH ** "LR^'VS4K6R_Y91G[3,/7:?D'_?7S?\ ]Z -.HKJWCN[62"5 Z.N"
M#0!E:+<WJW$MAJ+,9HHU:-W 'FKD@D8]. ?K[BMJ@ HH ** "B@ HH ** "B
M@ HH ** "JQT^R:4RM9VYD)W%S$,D\<YQ[#\J )%CCA\J.)%1%R JC 'X5+0
M 44 %% %6/4;*:^ELH[J)[J( R1*P++GU%6J "LW2C]H:ZO^JSR%8SZHOR@_
M0G)^A% &E10!GZM&RPI>Q*3-:GS !U9?XE_$?J!5Z.1)HDEC8,CJ&4CN#TH
M=10 44 %% !10 44 %% !10 44 %<]<>+K.VEN4:WG;[/,T+E0",C9_\6./:
M@#2TW48M5LK:]A5E27=@,/0D?TJ_0 44 %9FH337-RNF6CE'8![B93S%&?3_
M &FP0/3D_4 QKV#0-+O?-LI+2SU=>8Q))Y?G8ZH<\'(XSZ\]JZ:TNH[VTBN8
ML[)%W 'J/4'W'0T 5M7ED6S^SP.4N+D^3&R]5SU8?09/X5<AACMX(X(4"11J
M$11T  P!0 ^B@ K,TP?8[B?32?DC/FV^?^>;'[O_  $Y ]L4 :=% !10 44
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M>,RL H//<9SR.WK3SID<ZYOF-RY[-PJ\YX7M_/B@"W%%'!$L42A448 ':GT
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M^F!SF@!;/Q1HMZ(?+U"&.29=R13-Y;L/96P34]]IVF3IYMW# !D,9#A3GZT
M5WU/2M'2*QML/+M CMK9=[D=B0.@]S5&]TG6/$ (OKH:;:*P:*WMOGD8CO(_
M3_@*CZD]* .E P /2EH ** "B@ HH 8W^LC_ !_E3Z "B@ HH ** "B@ HH
M** "B@ K+UCP_IVN0-'>0#>4*+,A*2*#U 88.#Z=#0!4L?!^EV=HELYNKJ%
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MY$M3*?,V[C(V3P,>G^<UI4 %% !10 44 %% !10 44 %% !10 44 %% !10
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M1T]: .IHKS[_ (:$^%G_ $4OP?\ ^#ZU_P#CE'_#0GPL_P"BE^#_ /P?6O\
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M69F("@#N:X[_ (:$^%G_ $4OP?\ ^#ZU_P#CE 'H-%>??\-"?"S_ **7X/\
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M< G ]* .@HKCO#?Q<\#>,=473M \9^']<U#:7%IINJP7$I4=3L1R<#UQ78T
M%%4[Z^MM-LYKJ[N(K2VA4O)/.X1$4=2S'@#W-85C\2O".I7D-I9^*M%NKJ9@
MD4$.HPN[L>@50V2?84 =31110 4444 %%8WB+Q5HO@[3FU'7]7L-$L%8(;K4
MKE+>(,>@WN0,GTS7+_\ #0GPL_Z*7X/_ /!]:_\ QR@#T&BO/O\ AH3X6?\
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M&&X;C&>$8],C\ZZF@ HK&\2>*-'\(:6^I>(-6L=$TU&56O-1N$MX58G !=R
M"3TYK%\/?%[P+XPU1--T/QIX=UO4'5F6ST[58+B9E R2$1R2 .O% '9T45C>
M(O%6B^#M.;4=?U>PT2P5@ANM2N4MX@QZ#>Y R?3- &S17)>%_BAX-\<:A)9^
M'/%NA^(+R*/SI+?3-2AN9$0$ N51B0N2!GIDBNMH **\R7]H[X92?% _#E?&
M>FGQQYQ@_L/>WVCS GF%<8QG8,]>E>FT %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MQ\'?#=YK_B+X?W"Z)9*9+B_T^[M[U8D RSLL,C.J#NS* ,'G%?J1_P $A_\
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MP!SBJ'['G[8WBW]E[Q_IDT&J75UX&GN%75_#\DK-;O$Q >6-.B2J/F#+@DJ
M<@XK]V/B%\>OA]\*?#5YKOBKQ=I&EZ?;1F1]]TCR/_LQQJ2SL3P%4$FOYO-=
ME3QAXXU*31=/D1-4U&1K'3X4W.!)*3'$JCJ?F"@"@#^GJPOH-2L[>\MI5GMK
MB-98I4.0Z, 58>Q!%?R]>+/^1JUC_K]F_P#1C5_31\,?#]QX5^&_A/1;IF>Z
MTW2;2SE9CDEXX41B??*FOYE_%G_(U:Q_U^S?^C&H _I"\?\ Q0L?@K^S_J'C
MC5$:6ST+1%NS"O#3.(U$<8]"[E5SVW5^!_C3Q]\5?VV?C-#]I-]XL\4ZM.\>
MFZ/:D^3:H<MY4"$[8HU5<EB1PI9V)RU?M?\ M<?#O4_BQ^Q/XP\,Z+#)<:K<
M:#;W-O;PY+S-;M%<>6H'4MY6T#N6Q7X=_LW?';5/V:_C%H?C_2;&WU.XTTR1
MRV%T2J7$,B&.1-P&4.UCA@#@@9!&00#Z1MO^"/?Q\FT?[9(WA6VNMN?[/DU5
MS/G!.,K$8\\8^_CD=LD?,]Q%\2_V3_BW+;F34O GCO0Y0'\F4*ZY 8<J2DD;
M*1_>1@>X-?KU\,O^"NGP,\<0PQ>(;C5_ E^V ZZI9M<6^[_9E@WG'NRI^%=+
M\2OV9?V?/V]O$^G^.SXD_P"$FN;&R2P:3PQJ\6PQ!W=5G559E8&1NI4XX[4
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M .B#7Z55^1O_  2;_:.^&OP1^'OCRR\=>,--\,W=]JD$UM#?.P,J"$@L, \
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M?_2^WK\PO^"5O_)\7@'_ *XZE_Z07%?I[_P52_Y,=\??]=M-_P#2^WK\PO\
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M4+?2?B'X7OKR9;>TMM5M9IIGZ(BS*68^P )K^@/_ (;[_9Y_Z*QX?_[^O_\
M$T ?DM_PZ?\ VDO^A0T__P '=I_\<K[&_P""9?[&?Q5_9K^+/B?7/'VB6NE:
M=?:(;*WD@U""X+2^?$^-L;$CY4;D^E?4?_#??[//_16/#_\ W]?_ .)KTGX6
M_&;P3\:M)N]5\#>)++Q-I]I/]FGN+%B5CEVAMAR!SA@?QH [>BBB@#\OO^"C
MG[#OQ=_:*_:#M_%'@;0+74M%CT2VLFFFU&"W;S4DF9AM=P>CKSCO7QG\3/\
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M[X!^.WPY\3:SX6L8-*T7Q)INI7DR:O:N4@ANHY)&"A\L0JDX')KZ,_X(D?\
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M(F11#-'GN=Z;S[2K7Z/?\$I?CB?BS^S#9>'[VX\W6_!<W]D3!CEFM2-UJ_L
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MZ66M?9/_  5X_P"3-]1_[#5A_P"AM7QM_P $4?\ DY'QC_V*4W_I9:U]D_\
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M_'']GW2O$#>"U\&7D;&UNH+/3_LMC=R( #<6N% :-O09VL&7)P"0#Z0HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *_G+_;DMYK?]KWXN)/G>?$-TX_W6
M;<O_ (Z17]&E?B7_ ,%>O@E=^!_VAD\>P0,=#\96L;F94PD=Y!&L4D9/8E%B
M?W+/Z&@#]+_V ;V"_P#V-_A3+;[3&NCK"=O3>DCH_P".Y37T+7Y??\$F?VP?
M#&G^!%^#7BK5H='U2RNY9] FO)1'#=13.7>W5CP)!*SL%)^82<<J:_2W7O$&
MF>%='O-5UG4+72=*LXS+<WM[,L,,*#JSNQ 4>Y- &I17X1?MP?MP:S\3_P!I
M.3Q#\,O$^L:!H6@VRZ5IE]I=Y+:M=A79Y)_E(.UV; !ZHB9 R17Z>_\ !._Q
M9\3_ !_^S?I7B?XI:S)K.I:O<R7&F236T4,JV "I&7V*NXLRR.&(R593DT ?
MBM^V!;S6O[5WQB2?ESXMU1Q_NM=2,O\ XZ17[K_L27UKJ7[(_P ))K1D>)?#
M=G"2G(WQQA''U#JV??-?E?\ \%;/@9??#O\ :2N/&D-NW_".^,H8[J*9$.R.
M[BC6.>(G^\=JR^_FGT->T_\ !*G]MWPYX6\*K\'?'NJPZ(+>X>;P]JE]*([9
MEE;<]J[L<(WF,S(3PV]ER"%# 'ZLUXG^VE?0:?\ LD_%V6X8+&WAB^A!/]]X
M61!_WTRU[)]HB-OYPD4P[=_F;AMVXSG/ICO7Y<_\%5/VW/#.N>#9O@[X#UFW
MURXO+A)/$.H6$HDMX8XV#I;+(IP[F15+X)"A-IY)"@'Y_P#[)MO+=?M2?"&.
M#(E_X2_26# 9V@7D1)Q[ &OUN_X+"?\ )G[_ /8P6/\ *6OA?_@DO\$+SXE_
MM,6OB^:W8Z#X+@>^FF9"8WNI$:.WBS_>RSR_]L?>ONC_ (+"?\F?O_V,%C_*
M6@#XS_X)!>%[/QK\3OBKX<U!=UAK'@JXT^X7&<QRSQ1N/R8U\Z_LV^*KO]G3
M]KKP??ZF?LDWA_Q'_9VI\XV1F1K:Y_)'D_*OJ/\ X(F?\E\\=?\ 8LG_ -*H
M*\4_X*;?#4?#7]L;QJ(8?)LM>,6O6_\ M>>N9F_&=9Z +'_!4+XF'XD?MB>+
M8XI1+8^'8X=!MR#G'DKNF'X3R3#\*]7_ ."COPW_ .%1_LN_LL>$WB\BYT_3
M+_[5'C&+F2.SEG_\BN]?+O[,W@F[^/G[4W@;1M5:359-<U^.ZU228[GGB5S/
M=,Q[DHDA)]Z^]O\ @N1_R"_@Y_UVU;_T&SH Z'_@B+_R2OXE?]AFW_\ 1!KY
M5_X*\?\ )Y&I?]@:P_\ 0&KZJ_X(B_\ )*_B5_V&;?\ ]$&OE7_@KQ_R>1J7
M_8&L/_0&H ^=_ GQ:^+O@_P^FG>#?&?C;1=$61G6UT/5+RWM@Y^\0D3A<GN<
M9K2URZ^.?QDAMX-9E^(7CF%FW0Q7[7^H*67/*AMW(^;ITYK]=/\ @D/_ ,F;
MZ=_V&K__ -#6OM:@#\</V&?^"8_C#Q%X\T;QK\6M$E\,>%=+G6\AT/4%VWFI
M2H041XLYBB# %MX#-C:%PVX?I#^V/\;!^S]^SAXT\813"'58[0VFE\\F\F_=
MPD#OM+>81Z(U>W5^1O\ P6B^.']K>+O"7PIT^XW6VE1?VWJB*V0;B0%($8=B
MD?F-])Q0!\._LT^$?#WC[X]^#-*\7ZSINB>&)-12XU6_UF\CMK<6\>99$:21
M@H+A"@R>2XK]N_V@/BM\!OC?\%/&'@2Z^,/P\5-:TZ2W@DD\3V.V*<#=!)_K
M?X)5C;_@-?CY\ _V#_BS^TEX)E\6^#=,T]]%CO'LA-J%ZMN9)$568J".5&\#
M/3(([&O2/^'0_P"T+_T#?#__ (.$_P * /F7X2_$C4?@G\6/#/C+36_T[0=1
MCNMD<@*S*K8DCW#(*NFY"1P0QK^E;PIXGT[QIX7TCQ#I$XNM*U6TBOK2=>DD
M4B!T;\0PK^<_]HC]E[Q[^R[KFDZ7X\TZWM9M5MFN;2:SN1/%(JMM9=P_B4[2
M1Z,OK7ZI_P#!(7XY'XB?L_W7@>_G\S5O!=UY,:L<LUC,6>$^^UQ,GL%2@#\=
M_BQ_R5+QE_V&;S_T>]>J:Q^P=\>M"\-+X@G^&NJ7&DM;)=K<:?)!>$PL@<.$
MAD=B-IR>..^*\K^+'_)4O&7_ &&;S_T>]?TH_"7_ ))7X-_[ ME_Z(2@#^9;
M1=.M]2UFSLKW4;?2+6:58YKZZ21X[=2<%V6-6<@=<*I/M7[+?L,_\$X?AY\-
M9-#^*%]XKM?B?J3*E[HMW8Q[--M6[2H-S&60'HS;=I'W R@CYU_X*O\ [&:?
M#WQ$WQ@\(6"Q>&]8GV:]:P)A;.]<\7  Z),>#V$G_70 <?\ \$OOVR)_@?\
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M?+?\Y5MJ_&>;5+R;2;?37N9&T^WFEN8;<M\B22+&LC@>K"*,'_<'I0!]]?\
M!.+X;_\ &-O[4/C^>#_F4K[0K27'_3G-/<+G_P !J^=OV!/^3R/A-_V&D_\
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M5N=<_:\M=2A0FWT71;V[GDQPH=5@49]29OT/I0!^KW[:O_)I'Q?_ .Q9OO\
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M .3,/#__ &$]0_\ 1YK\[?\ @K9_R>CX@_[!FG_^B!7Z)?\ !)/_ ),P\/\
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M9 ,$8SALJ/3?'_Q*\+?"GPW=>(/&&O6/A[1[52SW5]*$!P,[5'5V/95!8G@
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MTLTBQ1)XEL6:21@JJ/-7DD]* /Z/J*R/^$LT/_H-:?\ ^!4?^-'_  EFA_\
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MU/X6_ CP%X/UIK=]6T/1K:PNFM'+Q&2.,*VUB 2,CK@5V7_"6:'_ -!K3_\
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M&'MY'QG8)4+)NQSMSG@\5]"_\$A_^3R--_[ U_\ ^@+7[1?%CX7>'OC/\/\
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M-]+_ ."?G[06HZI9VDWPQURSBGF2)KF:- D09@"[?-T&<GZ5_0Y10!Y9\5O
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M/V!OB;:_M,^$M:^(?@74O#_AG096U>2?4$4)+-",P1CDY/FF-L8^ZC5^U-%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MO@U^U?\ "3X5:9HVE7VC^,I+-+N]N_-^T0>=>- WE[7"\*,C(/- 'UU1110
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M\^M?(/[?G[;/C/\ 90\2> M*\(^'-)U^7Q)'<EEU,2E@\;Q*BIL=>OF'K[4
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M( V7V8S*W1>PKZZH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MG]NO]I37?V5O@K!XT\/:7I^K7\FK0:>;?4Q)Y021)6+?(RG(,8[]S7S_ /\
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M;ZF)/*"2)*Q;Y&4Y!C'?N:\$TG]M;]HS]HQ9[_\ 9]^$^CW_ (5T\1P76O\
MB64Q)>704-(MNKSPX3.5Q\Y (+%"P Z#_@LE_P FCVG_ &,UE_Z*N*^EOV6_
M!VF^ ?V<?AKH>DPQ0V=OH-G(?)^[)+)$LDLGU>1W<^[&@#P#]ES]O'6?'WQ8
MN_@_\8_"$?P[^*,&XV\<)86E\RJ69$5V8HVP;E(=UD )#= WVG7Y??\ !5BW
M7P/^T=^SQXYTA4A\1-=O&TD(Q*XM;JVDA!]1F>0#/J17Z@T %?EK_P $??\
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M^HOV _VP+K]I#X#:MKOC'R;?Q#X5E:WU>Z@0)'<1"+S$N=@&%+*'#*.,H2
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M8G_!2#X'^$OBY^S5XCU/Q'?6NA7WA6WDU72]:N!Q#*  86P,E9L+'M&26,9
M)4 _!W_!/&WB_:X_:8T_6OBYXH_X2'4O!&B6PT#0[\9^U" [$;IAA$<2,#\S
MNX8Y"M0!^J'[//B;Q_XR^$^BZ_\ $O1].\/>)M23[4VD::DBBTA;!C23S'8^
M9CYF'&W=MQE23Z=110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MB:]K/_!+O]K#QI-XAT74K_X+^.K@20ZQ9V^_R6WO)#SP"\/FS(T>064[P#@
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M6[-[._M8;ZSD&)+>XC62-P#G!5@0>0/RHTO2[/1+-+.PM8;&SC&([>WC6.-
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M_P"/-9K2-Q;8Q_JP1\GW5Z8Z#TH ^,?^"R7_ ":/:?\ 8S67_HJXKCOV4O\
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MXB\9W/[(_P"RG#K_ (LN=0\;ZAX3TBU74[J2[:2XO[@M''))YLN2<NY(+<X
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MI\@*EH97!:4*1N"*D<<<9/+#>W3:3E_MH^&?%/[*O[7OA_\ :?\ #N@7.O\
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M,SKP02!R!]QUPC? _P"'+>)QXB/@#PR?$/F&4:L=&MOM>\G<6\W9OSGG.>M
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MKN^1G:P'U'/\ _AE=:P-5G^'?A.74^U[)HEJT_4'[YCW=0._85WJJ(U"J H
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M;4^)GA7X^V_P,_:+T2STOQ1J&%T?Q!81B*&\=LF-6VG8ZR$%5>/;AQL9<Y(
M/OFBBB@ HK\G?"_[3G[7/QT^/7Q(\$_#/Q'HC1^&]2O L.H6-I$$MDNFA0;V
MC)8CY1SSWKT.^M?^"C5CL:*]\,:AG)*P+IHQCL=ZKU]OTH _1^BO@']DW_@H
M'XT\3?&Z3X*_'/PO;^%?'6YH+2ZM8V@66=4W^5+&69<NF621&VM\H ^8$_?U
M !1110 4444 %%%% !1110 45X[^TY^TQX5_99^&\WB[Q09+AI)/LVGZ9:D>
M?>W!4D(N>   2S'A1ZD@'XK\)_%#]N7]K:SB\2>!X]!^$_@N\!^Q37L$:BXB
M)X?=-%-,_'_+1$16ZJ* /TVHK\O_ !EXT_;N_91L9O%7BF\T;XH>$K%]]\+6
MWBN$CC_B<^7%#<(N/X\%5QE@!G/VK^RI^T[X?_:N^%=MXOT*)M/NXY#::II,
MT@>2QN0 2FX ;D((97P,@] 0R@ ]KHHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ JK>6PO+.: O)%YB%/,C;:ZY&,@]C5JB@#Q/]F?]
MD_P3^RIH^N:7X+?4Y(-7NDNKB35)TFDW*FU55E1?E')P<\L:\:_X*M?%_0/
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M]_\ 15O0!PW_  6W;4/^%._#I8A_Q*CKTIG/_3;[.WE?^.F:OO\ ^'\FC2>
M_#K>&VB;P\=-MO[-:W(,?V;RE\K;CC&S;C'%<K^T%\"O#G[1WPLU?P+XG21;
M*^VR0W4('G6DZ',<T9(^\#Q[J64\$U\-^!_V7_VV_P!GVQ_X0SX>?$OP[?\
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MX?\ @U\&]"M?%'Q4UI5>3[0/,CL%<$HNS<H\PJ#(2[!40!F!#<<'XAT?]O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M8W<JDL<BQQD8<%2&!&20.<_;K^)'Q9_;#\#Z1XSLOAKK/A?X9:+J"VFEVMY
M\E]JES/&[-<>6J_ZM$AVY&5!?&YB2%_9^B@#Y)_;@1X_^"=OB^.1622/0-.5
ME88((FML@BOD+]BO]L3Q5^R5\ ]$M_B%X \1:[\+=4^T:CX?\1:#&L_V5?/=
M)[>0,RHH\U)' 9U8;R<,&!'W#_P46M9KS]B_XG0V\4DTTEG;A8XU+,?]+AZ
M53_X)KVLMC^Q-\-(+B*2&9(;W='(I5A_I]R>0: /D3Q%'\0/^"J'QG\(L/!^
MJ>"O@5X;F,\UWJ@,;7N2OFA3C:\K!?+4)N$8+$M\V#^J-O"EK&D42+'&BA51
M1@ #@ #L*L44 <O\2_";^/?AUXI\,1W'V236M*NM.6XR1Y1FA>,-QSQNS^%?
ME?\ L?\ [25[_P $[+7Q5\+OC#\-_$EHUUJYOK75-)LEE,SLB0[079%EB/E
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M=6_:;\!:MXDU?P'>?#VXL=4;3UTZ^N7G>91%%)YH9H8B 3(5QM/W3SV'O-%
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M7#T H ^'OV*_VQ/%7[)7P#T2W^(7@#Q%KOPMU3[1J/A_Q%H,:S_95\]TGMY
MS*BCS4D<!G5AO)PP8$;7B*/X@?\ !5#XS^$6'@_5/!7P*\-S&>:[U0&-KW)7
MS0IQM>5@OEJ$W",%B6^;!^N_^":]K+8_L3?#2"XBDAF2&]W1R*58?Z?<GD&O
MIZ@"O;PI:QI%$BQQHH5448  X  ["K%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 45C^)/$.G^$]#OM6
MU6ZCL]/LXFFFFE8*%51D\D]?2N/^!?QX\(?M$>!;?Q9X,NY+K2Y99(MEPGE3
M1LCE3OCR2N2"1GJ.: /2***H-JEFMXMF]U MVPRMN9%$A'7(7.>Q_*@"_111
M0 455M+ZWO%D-O<1W C8HYB<-M8=0<=#[5:H **J75];V;1">XC@,K!(Q(X7
M>QZ 9ZGVJW0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M+ ]P: ,#Q_\ $3XQ?L/?L"_"F^\.Z'IM_J6GVT-IX@CUJUFN&TU9E9XSB.1
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MWX(^"?@#X33PWX#\/6WA_2]_FR+$6>6>0_QRRN2\C=LL3@8 P !0!Z!1110
M5RWQ0_Y)GXN_[ ]Y_P"B7KJ:Y;XH?\DS\7?]@>\_]$O0 ?"__DF?A'_L#V?_
M *)2NIKEOA?_ ,DS\(_]@>S_ /1*5U- !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7+?%#_D
MF?B[_L#WG_HEZZFN6^*'_),_%W_8'O/_ $2] !\+_P#DF?A'_L#V?_HE*ZFN
M6^%__),_"/\ V![/_P!$I74T %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<M\4/^29^+O^P/
M>?\ HEZZFN6^*'_),_%W_8'O/_1+T 'PO_Y)GX1_[ ]G_P"B4KJ:Y;X7_P#)
M,_"/_8'L_P#T2E=30 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 5RWQ0_Y)GXN_[ ]Y_Z)>NI
MKEOBA_R3/Q=_V![S_P!$O0 ?"_\ Y)GX1_[ ]G_Z)2NIKEOA?_R3/PC_ -@>
MS_\ 1*5U- !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !7+?%#_DF?B[_L#WG_ *)>NIKEOBA_
MR3/Q=_V![S_T2] !\+_^29^$?^P/9_\ HE*ZFN6^%_\ R3/PC_V![/\ ]$I7
M4T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %<M\4/^29^+O^P/>?^B7KJ:Y;XH?\DS\7?]@>
M\_\ 1+T 'PO_ .29^$?^P/9_^B4KJ:Y;X7_\DS\(_P#8'L__ $2E=30 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 5RWQ0_Y)GXN_[ ]Y_P"B7KJ:Y;XH?\DS\7?]@>\_]$O0
M ?"__DF?A'_L#V?_ *)2NIKEOA?_ ,DS\(_]@>S_ /1*5U- !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !156YN8K.WEGGE6"&)2[R2,%
M5% R22>  .]9?A/QAH/C[0X=9\-:YIWB+1YF98M0TF[CNK=RI*L%DC)4D$$'
M!X(H WJ*** "BBB@ HHHH **** "BBB@ KEOBA_R3/Q=_P!@>\_]$O74URWQ
M0_Y)GXN_[ ]Y_P"B7H /A?\ \DS\(_\ 8'L__1*5U-<M\+_^29^$?^P/9_\
MHE*ZF@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M;N2(K=!G\$%?%WPMD?PE_P %>[E;3]V&\>:M$ O "3FX5A_WS(10!^WM%%%
M!7+?%#_DF?B[_L#WG_HEZV-2UFQT6%9[^]M[&!FV+)<RK&I;!.,L1S@'CVKB
MOB1XT\/W7PY\500:]IDTTFE72)''>1LS,87   ;DD]J -WX7_P#),_"/_8'L
M_P#T2E=37+?"_P#Y)GX1_P"P/9_^B4KJ: "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHKXG_;<D\4^*_VB?V>?ASHGC[Q1X#TCQ/-K U"Y
M\+:B]E</Y,,+QDLI^;!W##9'S'C- 'VQ17Q__P ._M<_Z.=^.'_A52?X4?\
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MK6,%Y97,-[:SH)(I[>0/'(IZ,K#@CW% %VBBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K\>?^"Q/QFTW7OC%X
M,\)>&[^:37O#%A>PZG):MQ&UZL2_9\CDL8D.X>DH'7('Z$?MH?M-6/[*_P $
M=4\4?NKCQ%='[#H=C*W$UVP.&8=TC&7;U"A<@L*_/C_@E[^RS?\ QP^)=_\
M';X@K+J>FZ?J$EQ8->_,VIZJ6WO<-G[RQ,=V>AD(_N,* +O[$_PG^,7[*OV_
MQ&?V6=2\9^*]00"VUF[\2VMBUE:LHS%' T;LCL<[F)#8PN%PV[ZX_P"&K/VD
MO^C0=0_\+BT_^,5]@44 ?!WQB^-7[2'Q8^%7C'P7_P ,IZAI9\0Z3=:7]L_X
M3&TF^S^=$T?F;/)7=C=G;N&<=17TW^S#X.U;X>_L[_#CPSKUI]AUO2M!L[6\
MMMZN89EB4,A925)!R,@D<<$UZM10 4444 %%%% !7EWQ[_9V\#_M)^"YO#7C
M?2EOH1N:SOH<)=V,A&/,ADQE3TR#E6QA@1Q7J-% 'X9_$CX3_&;_ ();_%^R
M\5>&-4DU'PI>3>7;ZHD;?8M1C!+?9+V('"OC) SZM&V0=OZG_LG_ +8'@[]K
M+P8FIZ#(--\16BK_ &MX>N) 9[-CQN!X\R(G[L@'/0A3D#UOQMX)T+XD>%]1
M\->)]*MM:T+4HC!=6-VFY)%Z_4$$ AA@@@$$$ U^-G[47[)_Q!_X)\_$JQ^*
M7PKU>_;PC'<_Z+JD?S3:<S'_ (]KM<;7B;[H8C:_W6 ;&X _;6BOFG]BW]M#
MPU^UOX*#H8=)\<:;&O\ :^A[^5/3SX,\M"Q_%2=K=BWTM0 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 5RWQ0_P"29^+O^P/>?^B7KJ:Y
M;XH?\DS\7?\ 8'O/_1+T 'PO_P"29^$?^P/9_P#HE*ZFN6^%_P#R3/PC_P!@
M>S_]$I74T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %,9A&I
M9B% &23T%/KXG_X*F?M+GX'_  #E\+:5=>7XK\9B33H6C;#P68 ^TS<="598
MQTYD)'W: /A+]HSQSKW_  4<_;3T[P9X1N&?PO9W3Z5H\F"T,-JAS=7[ =GV
M%QT)58EZU^S/PS^'>A_"/X?Z#X-\.VOV/1=&M4M+:+N0.KL>[LQ+,W=F)[U\
M-_\ !(?]F,?#_P"&-U\5-:M0FO\ BR/R=-#@[H--5LY]C,ZAO]V.,CJ:_1"@
M HHHH **** "BBB@ HHHH **** "LKQ#X>TSQ;H=_HVL6%OJFDW\+6]U9W48
MDBFC88964\$$5JT4 ?B5^UM^R3XT_8+^*6G?%7X6:C>P^#UO!)8W\3%YM*E8
MG_1KC/WXF!*AFR&!*/SRWZ1?L4_MC:#^UK\/UNX_)TOQIIRJFM:(K_ZMN@GB
MSRT+GIU*GY2> 3[OXJ\,Z3XUT#4=!UW38-6T?4(&MKJRNDW1S1L,%2/\D=17
MXK?M%_ 3X@?\$U_CQI?C[X>7UT_A*XN&.EZG(I= IY?3[P# ;*CC.-X&Y<,I
MV@'[BT5XG^RK^U!X;_:L^%]KXIT(K9ZE!M@U?16D#2V%QC)4_P!Y&P2CX&X>
MA# >V4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5RWQ0_Y)GX
MN_[ ]Y_Z)>NIKEOBA_R3/Q=_V![S_P!$O0 ?"_\ Y)GX1_[ ]G_Z)2NIKEOA
M?_R3/PC_ -@>S_\ 1*5U- !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% %>XGCM87EF=8HHU+/(Q 55 R22>@K\.?&VHZC_ ,%*/V^X-.T^68^$
MOM/V*VE4$?9=&MF+23<_=:3+L,_QS*OI7Z"?\%2/VA?^%)?LXWFB:;=-!XG\
M:%])M-AP\=M@&[E'TC81Y'(,RGM7G7_!'S]GG_A!_A+J?Q/U2U5-7\6OY&GE
ME^>+3XG(R/3S)0Q([K%&>] 'W]H^DV7A[1['2M-MH[+3K&".UMK:$82*)%"H
MBCL H 'TK1HHH **** "BBB@ HHHH **** "BBB@ HHHH *Y'XF?#7PY\8/
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7+
M?%#_ ))GXN_[ ]Y_Z)>NIKEOBA_R3/Q=_P!@>\_]$O0 ?"__ ))GX1_[ ]G_
M .B4KJ:Y;X7_ /),_"/_ &![/_T2E=30 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !117S]^W+\>!^SS^S3XL\26]Q]GUVZB_LO1\-M;[9."JNOO&N
M^7_MD: /S%_:L\1:C^W=^WYI_@+P].SZ'8WJ^'+*:+YDCAB9GO;H=CR)F!_B
M2-*_:3PSX;T[P=X;TK0=(MDLM*TNUBLK2WC&%BBC0(BCZ  5^9/_  1A^ _^
MC^*_B_JENQDD8Z'H[R#M\KW4HSUR?*0-_LR#UK]3: "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH *^;/VVOV.]'_:T^&S60\K3O&FDJ\VAZLXX5
MR/F@E(Y,4F #W4@,,X(;Z3HH _&W_@GO^UUK7[+'Q(NO@G\5EFTCPU)?O:(=
M0;:="OBV"&).!!(W4_=!(<'!<G]CU8,H(.0>0:^#/^"F7[#(^.GA>7XC>"=/
MSX_T:#_2[2!/FUBT0?=P/O31C[G=E!3GY,<-_P $M_VZCXLL;/X,?$#4,:[9
M1^5X=U*Y;!NX4'_'HY/_ "T0#Y/[RC;U4;@#]+Z*** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "N6^*'_),_%W_ &![S_T2]=37+?%#_DF?B[_L#WG_ *)>
M@ ^%_P#R3/PC_P!@>S_]$I74URWPO_Y)GX1_[ ]G_P"B4KJ: "BBB@ HHHH
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M1?\ :8X4#N6%?D1_P3.^'NI_M)?MAZ_\6/$R_:XM#FFUV[E*Y1]1N7<0(,]
MN99!Z>2HH _6#]G_ .$MC\"O@SX1\"Z?Y;1Z/81P331C GN#\T\O_ Y&=O\
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ME=37+?"__DF?A'_L#V?_ *)2NIH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@#\Y/\ @LQ\<?\ A%_A3X>^&=A<;;[Q/<_;M053R+*W8%%8>CS%2/\
MK@U>S_\ !,SX'#X+_LL>'YKJW\K7?%1_MZ^W+AU651]G0]QB$1G!Z,[U^>'Q
M"FE_;Z_X*21Z/!(UWX6_M0:9&\9.U=)LBS3.K=A)MF=3_>F ]J_;JWMX[.&.
M&)%CAC4(B*,!5 P !V % %FBBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MXC_M.?#/Q'_P3E_:ZT;QSX&C:/PM>7+:EHRDD0M$3BZTZ0^@#[>YV/&<[AP
M?N%17$_"'XI:'\:_AKH/C7PY<?:-'UBW$\6[&Z-LE7B<#HZ.&1AZJ:[:@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M=._:?^!^M^#KE8XM5V_;-'OI!_Q[7J ^6V>RMDHW^R[=\5[=10!^/7_!*_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH *Y;XH?\ ),_%W_8'O/\ T2]=37+?%#_DF?B[
M_L#WG_HEZ #X7_\ ),_"/_8'L_\ T2E=37+?"_\ Y)GX1_[ ]G_Z)2NIH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH *_-_\ X+/?&C_A'?A9X8^&EE/LN_$=W_:-
M^BG_ )=+<C8K#T:9E8>\!K](*_$#XM3/^W;_ ,%+8_#UO(UWX:CU5-&C9"2J
MZ99;FN75AT#E+AU/K*HH _1C_@F[\%_^%+_LG^%8;J+RM8\1*=?OL\-NG53"
MI[@K L((['=7U/5:W@CM84BA18HHP%2-0 JJ!@  =!5F@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"L;Q;X7TWQQX7U?P[K%NM[I.K6LME=V[])(I%*.OY$ULT4 ?AU^S[XFU3_@G
M?^W=?>$?$MT\?AJXN_[$U*YD&V.6QF8-:WOH-N8I"1G ,J]<U^XF<\CD5^;_
M /P6&_9L;Q=X#TKXN:):>9JGAP"QUGRQ\TE@[_NY#Z^5(Q'^[,Q/"U[+_P $
MS?VCO^%]_LYV-CJ=SY_BKPCLTC42[9>6(+_HTY[_ #1KM)/):)SWH ^O****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH *Y;XH?\ ),_%W_8'O/\ T2]=37+?%#_DF?B[_L#WG_HEZ #X
M7_\ ),_"/_8'L_\ T2E=37+?"_\ Y)GX1_[ ]G_Z)2NIH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH \._;.^-7_"@_V;?&WBR&?R-5CLC9:6<X;[9/\ NHF'KL+>
M81Z(:^%_^"+'P9,USXW^*]_#GRPN@:;(PSECMFN6&>^/(4$?WG%4?^"T'QF;
M5O$O@KX2Z;*TJ6:?VWJ,,?S;IY-T5LF!_$J>:V/25:_03]DGX,I\ /V>/!?@
MMD5-0L[%9M1*][R4F6?GN [LH/\ =5: /8Z*** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,
MGQ-X<T[QAX=U70=7M8[W2M3M9+.[MI!\LL,BE'4^Q4D5^*GP'\3:A_P3K_;V
MU'PEKUVR^%)KO^QM0N)3A);"<J]K>'L"FZ)VQT'FJ.IK]P:_-O\ X+%?LXCQ
M5X$TCXNZ/:[M1\.[=/UC8OS26,C_ +J0_P#7.5L?28D\+0!^D><\CD4M?)'_
M  34_:''QZ_9MTJUU"[-QXI\)[='U/S&W22(J_Z/,>YWQ@ D\EHY*^MZ "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH *Y;XH?\ ),_%W_8'O/\ T2]=37+?%#_DF?B[_L#WG_HEZ #X7_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N6^*'_),_%W
M_8'O/_1+UU-<M\4/^29^+O\ L#WG_HEZ #X7_P#),_"/_8'L_P#T2E=37+?"
M_P#Y)GX1_P"P/9_^B4KJ: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ KG/''C;1_ASX/UCQ/XCU"+2]$TFV>ZN[N4\(BC/
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MJDBNA_W:[^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#X9_;,_X*9:%^SWXHO?A_
MX5T2;Q;XV2'R[J5;@0V^G2R(#&N0CF60;@2@  R 6SD#P;]D;_@K=/I_]B^$
MOC1;75Z;B=E/C59$&P/(=GG6ZQJ!&N=I="2 OW3S7A'B+QE;_LQ_\%#/B9K7
MQ"T6XU&&?4-9,,WE!I8DO1(;:[C4D C9*O0\!FQR *^E_P!A+X!_ O\ :D_9
MC\":-XXCT_Q!XK\,7&I9TNVU5K:\BAFNC(/-2)UD,9 !7/ W-CDF@#].8YDN
M(U=&5T8!E93D$'H0:^1_VWO^"@6C?LCS:+HVG:;:^+?%]Z_G7&DF],'V2UVG
M$DC*C89FP%4CD!CV&>X_:RC^(O@C]FY])^!]I?#Q9"UEI>FQV<8NIHK?<L;'
M=-N Q&.9'.1UW9YK\@/VM/V2?''[/G@_PGXP^)?B!M6\;>,;R[:]M3.;IX/+
M6)LRW!)\V1C(<XRHVC#-0!^X7P&^)<GQF^#?A#QS-8+I<NO:='?-91RF582X
MSM#$#./7 KRK]M+]M33/V-]+\*W5]X;G\37'B":XCAM8+Q;8HL*H7<DHV>94
M&/>NB_87_P"3/_A'_P!B_;_RK\W_ /@M!XR36OVA/!GAGSO]&T;0EGE(Y\N2
MXG?=QZ[(HC^(H ]6_P"'XFA_]$DU#_P>1_\ QBON/]GGX_Z=\>O@'HOQ3EL/
M^$6TO4(KN>6WNKI9!:QV]Q-"[O+A1C$);.!@'VS7P5X-_;8_8FNM6L]%O?@9
MI^E:>I2W36M2\':9,F!A?-F"%I/<D!CUXKWK]O[Q/X;^'/\ P3]UN/X=1:5I
M?AK6UM;'3/\ A'HXH;(V]S.)93$L8";9$\W.T<^8Q[F@#RGXG_\ !:?POX=\
M776G>"_A_=>+=%MYRG]KWFI_8!<J."T<7DNP4G."Y!P!E1G ^J/V2?VS?!7[
M77AV[N-"2XT;Q!IH4ZCH-\P:6%6)"R(XXDC)!&X8(/# 9&?FC_@CG\*O#T_[
M//BSQ+J6C6.HW^M:W-I\LEU;K+NLXH(L1'<#\I>24D=#D9Z5\Q_LC3?\*'_X
M*C7OA727-IHC>(-9\.M;J<![7,WD(<^CQP-_P&@#]N:*** "N6^*'_),_%W_
M &![S_T2]=37+?%#_DF?B[_L#WG_ *)>@ ^%_P#R3/PC_P!@>S_]$I74URWP
MO_Y)GX1_[ ]G_P"B4KJ: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBO/\ XW?&+0?@)\+=?\<^)9O+T[2H#((5($ES*>(X4_VW
M8A1Z9R> 30!\M?\ !3K]LA_V?_AVO@?PO?\ E>/_ !/;L!-"^'TVQ.5>?CD.
MY#)&>V';(*#/S;_P2?\ V+V\5:Y#\:?&.GYT;3)<>&[6XC(%U=*>;O!ZI&>$
M/=\GCRQGS;]E+X0^)/\ @HE^U;K?Q!\?JT_A>SNEU'6C@B%QG%MIT7^SM4*>
MXC1LG<P)_;2SMH=/M8;>VBCM[:%%CBAC4*B*!@*H'   P * +E%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M _1W]F3]G_1/V9?@]HO@C1@LDMNOGZA?*-K7MXX'FS-]2 J@]%51VKUNBB@
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M7Z6?LP?';3_VC/@?X9\=6?EQW%];^7J%K'S]EO(_EGCQU # E<\E64]ZYO\
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M5^)?[<OP\UC]B?\ ;2T?XH>#H/LFE:O>?\)#IH4%8A<!@+VT./X6+DD#@)<
M#I0!^VE%<E\,OB)I'Q:^'OA[QEH,WG:1K5G'>P$D;E##)1O1E.58=BI%=;0
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?Y.?N'&X_?6GZ?:Z/8P65A;0V5I;H(XK>WC$<<:C@*J@8 'H*^3O[8_;I_Z
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KEOBA_
MR3/Q=_V![S_T2]=37+?%#_DF?B[_ + ]Y_Z)>@ ^%_\ R3/PC_V![/\ ]$I7
M4URWPO\ ^29^$?\ L#V?_HE*ZF@ HHHH **** "BBB@ HHHH **** "BBB@
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MF_V>_P#@D;\-OB3\&_!?C'Q+XI\6Q7_B#1K75'M=,FM88X3-$LFT;X)"1AJ
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MG\#6O0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M> _MM?LZ)^TW^S]KWA6&./\ X2"WQJ6B328&R\B!VKGL)%+QD]A)GM7PO_P1
M]_:.E\-^)-;^!OB69K47<LNH:(MT=K172#%S:X/(+*OF!>,&.3NU?K-7XU_\
M%./@9JG[-_[0VA?&WP*LFF6&N7ZWIN+=<+9:Q&=[9[8F \S!^\1-VH _92BO
M*?V;/CII?[1GP7\.>/-*"Q'4(-M[9JV3:7:?+-">^ X.">JE6[UZM0 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%8/B[Q9I'@7POJOB#7=1ATG1M+MWNKN\N.$BC49+'N?H.2>
M!S3?!7C+1_B%X5TOQ+X>U&'5=#U.!;FTO;?.R6-NAY (/8@@$$$$ B@#H***
M* "BBO)OC%^U)\*?@*I3QUXWTO1+W:)!IV\SWK*>C"WB#28/9MN/>@#UFBOS
MI\0_\%I/AS9^+-/T_0_!/B#5]$>X6*[U2XECM7CC)P9(8!O,N.RLT9/M7O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MW&P9 /IC_@FW^Q9%^SA\/U\6>*+%1\2/$,"FX6106TRU.&6U7T<\-)CN O\
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M*J?P[_:/_:1^)'[7WB:^\3>(C(- T<;K72;3<+#2HW8*HR>LCD %V^9R,#
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M#H!D ^J**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MKYGR1L#WC5:^BZ** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_9CTO]E;X.Z9X5M3'/KD^+O6]2C'_'W=L!NP2,^6GW$'' R1ECGW>@ HHHH
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M7Y^?$;_@BCI7]AZS/X%\?7AUCS?-TVRUVW3[/Y>#^YEEC&[=G&) N!C!0YR
M#]/XY%FC5T8.K#*LIR"/45+7X@?"W]JOX^_\$[_&$/@3Q_HU[J7AB$X7P_K4
MA*"$'&^PNAN 7V4O'G(VALD?JG^SE^UU\-OVH-#-UX-UI?[5AC$EYH-]B*_M
M>F2T>3N7) WH67)QG/% 'ME%5[6XBNH4F@E2:)QE9(V#*P]01UJQ0 4455L[
MA+J/S(Y%E3<R[HR&&02",CN""#[B@"U1110 4444 %%%% !1110 4444 %%%
M% &1XH\,Z9XT\.:GH&M6<>H:1J=M):7=K,,I+$ZE64_4$U^(O_%3_P#!+?\
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MCL   ![4Z_L;?5;&XL[J".XM+B-H9H9%#)(C AE8'J""01[U\F?\.G_V;?\
MH4-0_P#!W=__ !RC_AT_^S;_ -"AJ'_@[N__ (Y0!B_L8WUQ^SO\;/'_ .S1
MK,TG]F6,C^)?!$T[$^=ID[DR0*3U,;D^Y83GH*^VJ^:_A-_P3]^"/P/\>Z9X
MS\)^&;RS\0Z;YGV2YFU2YF6,R1M&QV,Y4Y1V'(/7UQ7TI0 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %<M\4/\ DF?B[_L#WG_HEZZFN6^*'_),_%W_ &![S_T2] !\+_\
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MU^*__!2KX+WW[+W[4.A?%KP<9+*S\07_ /;L$V"4M=6BE629?]UV*RX)YWR
M#"T ?M117#?!7XI:7\:OA/X6\<Z.5^P:Y8QW0C#;C#(1B6(GNR2!T/NIKN:
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MVUOV5O$W[#'Q@TOXM_"J>YT_PC)?BXLKBWRQT:Z.<VTG9H7!8+NX*EHVSU<
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MV=OC9^V/\%_C5X2\!>-=!\3^)M'U"^BM)K/Q!:-=?N68"2:*_ 8GRURV3(R
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MPM%AC#E>F^9^1MBCW+N;DC<, YKUM6$BAE(8$9!'0T /HHHH **** "BBB@
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M_L6_%BT&J1W_ (3\1V4AGTS6M-E80W*CCS()APZD'#*><-M=1DBOO[_@E/\
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MV>.0@;DWRS(25![*1D8S0!H?\$G_ /DR7PA_U^ZC_P"E<M<K_P % -1\0_M
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M(S0!^FW[1'[0GA+]F?X;7/C3QA+<#3TF2UM[6SC$D]W<.&*Q1@D#<51VRQ
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M-I&W3S).1D=6:23'!%?M[HNCV/AO2;'2M,M([#3;&!+:UM8%"QPQ(H5$4#H
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MKY>\:?#;]K+]D;6)_B'K=SX@\.W>I2Q:9<>(QK4%\MUQB))W$LGRXC 7S0
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MI'B/1;D7NCZK:17UI<J,"2&1 Z-@].".#R*W: "BBB@ HHHH **** "BBB@
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M5JUK9>,_&1&CV EN%C:TMY<K/=MW1%3<H?LSJ?X37QM\?/C=^S]X'^ ?PO\
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M6**-2[N?8*"?PH _"KQMHW[8?C#QAIWPF\3ZOXPOM=\5VDEW%X:O-=C5;FV
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M9P#]#/V$/V'?^&/[?Q/=2^-&\67?B(6X_P!'M?LUM%'%O*D#>^]CYA^;(P.
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-F^*>N>)+.RUKX=6)AR -0A+RL)00\"0R!V+(02WFY*K\PF^!OP1\9?L\_\
M!1#X/>$O'CIJ.M^7]LAU=+J6=9[5M.>-(%+GA('AEC' Z'^';@ _:6BJUU=P
M6<#3SS1P0K]Z21@JCG')-<)K7[07PO\ #LCQ:M\2/".E3(65H[W7K6%E*G#
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M3Q]ON+F\[YY\Z5\_CVXZ5B_\.Q_V;GURZU)OAXKO,Y?[-_:EXMO&Q.3MC68
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M^R[^QOJ6N_M)Z_)?:IIK7$K>=?"[O?(<*L-JTX8^;,TA8 AS@.HW87@ X_\
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MQYY)CD4]<@?LW\*_B9HGQ@^'>@>-/#L_VC1]:M$NH3_$F1AHV]&1@RL.Q4T
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M/:Z/9K"]PO@^-3<3G+33$?:.KR,[>V[':O0/^'DFA_\ 1#/CA_X2$?\ \D4
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MS>,_&VB^//#]Y#KFH27T,>O-<0S0J[9$),<4@VQKA%(ZA1P*Y+X9_P#!*O\
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M\$T_V)S^SOX*/C3Q?8K'\0_$$ 'DRK\^EV;880>TK8#2>F%7^$Y /H7]E_\
M9VT']F/X2Z9X,T-5FN(QY^I:ELVO?W; >9*WH. JK_"JJ.<9/K]%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &?JVDV.N:?+8:E96^H
MV,PVRVMU$LL4@]&5@01]:Y?XG?#>#X@?"?Q%X&M;V7PW;:MI<NEQW6FJ$:T5
MXR@**,# '&T8R..*[BB@#\2==_8__:M_8DU2ZU[X>ZCJ.IZ0A\R6^\'SM.DB
MCH;BQ<9? Y.8W48^]7VC_P $X_VU_'G[4%QXH\/^.?#T$=_X?@CD.O:?;M!%
M(S.5,,R$D++P6&W (5OE&.?N6JT-O%;M(8XUC\QM[E5 W-@#)]3@#GVH P5^
M(WA63Q=)X4'B?1SXHC197T3[?%]M5",AC!NW@$<@XKIZ_,7]KS_@E+XE^(WQ
M,\2?$7X<>++:74-7NWU*;1=:9X729OF;R+A=PP6^ZK*H7@;L"N _9W\<?MJ_
M OXQ>%? OB+0/$WB+P]<ZA%:W%MKEN;^T6W+A9'CU ;M@1"6&)2HP,J1Q0!]
M_P#[9G[-EG^U%\#=8\)E8XM>@'V[1+R0 >3>(IV GLC@F-O0/G!(%?G_ /\
M!*3]IB\^%?Q&U3X$>-VFTZWU&]D&EQ7GRM8ZFI*RVK _=\S;P.TB8 S(:_1S
M]H+]J#X??LOZ'I>J>.]4FT^/4[AK:S@MK=IYIF4 NP1?X5!7+=!N4=2!7Y'?
M\%$]6^&/CSXC:-\9O@UXPL+]]4*#6+6RD:UO;2^CP8KKR'"2J'4 %PN \8).
MZ09 /W/HKY8_X)__ +6UM^U-\'89=2G5?'>A".SURWX4RMC$=TJC^&4*2<
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M)5L$;W89 .*^XJ** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *R/$/AK2/%FCW&E:[I5EK.EW Q-8
MZA;I/!(,YPR."IY]16O10!^4/_!2K]@<^$9+CXT?"?3_ .S[6U876NZ/I:^5
M]C92"+ZW5,;5& 7"XVXWCC>1[_\ \$Y_V[[?]H[PM%X,\8W<</Q*TF'_ %C$
M*-8MU'^O0?\ /51_K%'^^."0OVQ-"DT;QR(LD;@JRL,A@>H(]*_!C]NWX?Q?
MLF_MB3S_  YBO_"<2+;:]I4D9"I!*^2_V<C_ )9!U9=IX&&7&W% '[W45\P?
ML-_MG:-^UI\/3]I:#3?'ND(J:SI49P'["YA!Y,3GMU1CM/\ "S?3] !1110
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MX#*RG(8'H0?2IZ "BBB@ HHHH **** "BBB@#AOBA\&/ _QLT%M%\<>%]/\
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M"5VG .\U]MV-];ZK8V]Y:SI<6EQ&LT,T;!DD1@"K*1U!!!!]ZNT ?E[\*/\
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MCA57Q/8DD^@_>UZKG/(Y% "T444 %%%% !1110 4444 %%%% !1110 4444
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M_P""='P4^"GQ TKQIX;T?4EUW2V9K22[U.65(V9&0MLR 3M9NN1SFO>OA?\
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M7FR_ _\ ;I_9G7_BGKCQ9=Z5;\1QZ#J:ZO;'']VT+.1^,0S0!^V%%?C%H/\
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MX):^*O@3X@\*WW@O5/"&BP_%A(KB9=3U:%+J35X2&;]P\H/E,BX#0KC(7?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH *Y;XH?\DS\7?]@>\_]$O74URWQ0_Y
M)GXN_P"P/>?^B7H /A?_ ,DS\(_]@>S_ /1*5U-<M\+_ /DF?A'_ + ]G_Z)
M2NIH **** "BBB@ HHHH **** "BBB@#*U[PWI/BK3WL-:TNSUBQ?[UK?VZ3
MQ-]5<$&OGOQ]_P $Y_V>?B$TDEU\-]/T>Y;.)M DDT_9](XF6/\ -"*^F:*
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M0* /VZHK*\/^(--\5:+8:SH]]!J6DWT"7-K>6KAXIHV *NK#@@@UJT %%%%
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M0QZD*H&?TH NT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_:/";%M!9+1$&FY39B$  *,8P.@*J0,J".ZHHH **** "BBB@ HHHH ****
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MTA!,TCEL+LY&W!W#!X-?5%?&O[-W_*0S]JO_ *XZ!_Z1BOLJ@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 5RWQ0_Y)GXN_[ ]Y_P"B7KJ:
MY;XH?\DS\7?]@>\_]$O0 ?"__DF?A'_L#V?_ *)2NIKEOA?_ ,DS\(_]@>S_
M /1*5U- !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M&PN"I#*#E3P>00 #T*BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_$^C:O\ $32K74K&QNS'<"WD2=&$L)VRQ]>-RCG!%>L?\.G_ -FW_H4-0_\
M!W=__'*_/S]KG_@FOJ_[,TWA35/"WC >([?Q!K]OH>G6\\'V2\ANI0S19D#%
M",Q_?^3!(X[UH1_M+?MK?LD#[/XML]?O-%M&P6\6::=1M&QV^W+\S#Z34 ?>
M?_#I_P#9M_Z%#4/_  =W?_QRH-0_X)4_LXVMC<RIX1U /'$S*?[;N^H!/_/2
MOG'P%_P6Z*PQ0>-OAF'EX\R\\/ZAA3ZX@E4X_P"_IKW#1?\ @KM\!/$VESI?
M3^(O#<\D++Y>I:49/F/&,P-)]?I[\4 =/_P2IGEN/V*?!GFR/)Y=UJ")O8G:
MHNY< >@Y/%?7U?FS_P $Y/VQ/@Y\*_V7?#GA#Q7X]L-"\0VEU?/-9WD4R[%>
MX=T._9L.58'AN^.M?4W_  WW^SS_ -%8\/\ _?U__B: /H"BOF.__P""DG[-
MVGPN\OQ0LF"':?(TZ]F/7' 2$DCW%<3XB_X*X_L\:('^QZUKGB#;T_L[1Y4W
M?3S_ "_UH ^TJ*_-?Q5_P6V\#V:L?#7PV\0:L?X?[6O(+'/U\OS\=J\7\5?\
M%G?BMXDN!:>#O OA[17F.V,3B?4;C/\ LX:-2?JAH _9"J&JZQ8:#9O>:E>V
M^GV<?+W%U*L4:_5F( K\7O\ A97[>_Q_XTZ'QQ965PO[J33]-30X-I_NW&R+
M/UWD^]6=-_X)4_M)?%B^AO\ QWXATW392,O+K^MRZC=*#U \L2*3_P # ]Z
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MU=&#JPRK*<@CU%2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"G>6L.H6LUO<Q1W%M,C1R
MPR*&1U(P58'@@@X(-?.WCK_@GO\  GQMX%U?PU#X TOPY]OF-TNJ:-"L-Y;3
M8(5XY.<*,G]T?W?/W:^E:3I0!_.I\6_AQXP_8E_:'U#3_#WBL3ZWX8FBF@U_
M1\CRA*I:-9E((1V0_-$Q8$$CY@:[OQ!XB^&?QD_93\6>*_$?CKQ=K7QXTV6U
MD>P\3ZP9K>5'NXXW>S3: R>7(Q*$ED(/&T!C]^?L%>!X_C!^R[\4/&=]9:9J
M?B?XH:SJEW<MJT"W%N6!=+>*5&# Q1R%V"D' <X'2OQM\<>#=7^'OB[6/#>O
MVR6>LZ7=26EY;QRI(L<J'#*&0E3@^AH _1'Q)X/\<^%?']U\./V2?B!XVUN[
M@T.2;Q9I]UJ4=QI6E.\7$,$T@Q'<L=P^7YU8@!QM<)]F_P#!.F]^'DW[.EA!
MX#TF?0[VSN7M?$MCJ1W:@FJJ!YYN7(!=CP5.  I PNTJ/SH_8-_X*,6O[,6C
M_P#"%>*/"=O>>$[BZ:YDU?1XE34DD<\O*"0MP , 9*LH'!; 6OL/]F7XI>#/
M$'_!03Q]-\-->MM8\&^/O"$'B2Z2S!58M2AG6%M\9 :.0JTCL& ),N>XH ^_
M:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** /C7_@I5_P @SX!?]E3T?_T&:OLCKP>17S7^
MW#\"?&_QQ\$^"4\ 2Z.OB+PSXKL_$4<6NR21VTHA24!24!)^9TR.,C=R#BN5
M_MC]NG_H _!#_OYJ?_QV@#V+QU^R7\&?B3-+/XC^&GAN^NY<^9>)IZ07#Y]9
M8PKG\Z\#\;?\$E/V?-6AN;JPTK7?#I2-G$6FZO(Z9 )_Y;B4_K6U_;'[=/\
MT ?@A_W\U/\ ^.U'<:E^W+<6\L+Z%\$0LBE#MDU/.",?\]: /CK]C[_@F3X)
M_:8_9WT/QWJ/BS7M%UF_FNH9(K58)+=?*N'C!"LF[E5'\77)]J]>_P"'(?@C
M_HI7B#_P!@_QKZN_8B^"/B']G?\ 9T\-^!_%$]C/K=E-=S3MITK20CS;AY%
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M]Z[BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH *Y;XH?\ ),_%W_8'O/\ T2]=37+?%#_DF?B[_L#WG_HEZ #X
M7_\ ),_"/_8'L_\ T2E=37+?"_\ Y)GX1_[ ]G_Z)2NIH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@#\F_A_XX^(GP[^(WCO\ 8[^&VIZ=HUY=^*;NXLO&4EZI
M?2M)EC6:2*%,@O<JI_A.Y6,G3&]/4OVWOV6_AY\"_P#@GKKND:!H5O->Z/=6
M-TFMWT2R7\UU+=P1S3M+C.YU8J0.-N !@"OJ/]H/]D[P+^T5IL?]KV<NA^)[
M6=;O3_%.B,+?4K.X4*%D$H&6 "(,-GA5QM(4CR&Q\#_MH_#-4TW0_&_P\^)V
MD0CRX+[Q=:7-K?[1T\P08#$#'S%V8G.: /@O]IC_ ();>,_A+X5?QMX(O1XS
M\'QV8OKJWDVQ:A81;-[,R\+,BCJR8;_8 &:^-_"/C;7_ (?Z];:WX:UF^T'5
M[<YBOM-N'@F3U 92#@]QT-?MC=?LC_&?]HB:VC_:&^)]D?"$<BRR^!_ <<EM
M:794A@+BX<+(RY RN&P>592,UZM\5/V%_@G\6_"UIHFJ> ].TX6-LMK8ZCHL
M8L[RUC1=J!94&7"CHL@=>^,T ?G;\"?^"R'CSPC';:;\3-$MO&^GKA3JED5L
M]0 ]6 'E28]-J$]V-?H)\&?^"@?P-^-T<$6E>-+71-6E(7^R?$9%A<[CT5=Y
M\N0GTC=J^ ?CE_P1H\<>%EN+_P"&/B&U\:6*Y9=*U+;97X'95<GRI#[DQ]>E
M5_AW_P $</'WC#X3IJ^O^(K7P9XWDN)/+T"^B%Q#Y "B,RS1,?+<G><*)/E*
M]#D  _9&.19HU=&#JPRK*<@CU%2U^(B_ ']M;]D"1E\)MXDGT: [D7PM=_VK
M8OCDM]C(8CZM"*ZKP/\ \%B/B]\/[MM*^(7@S2?$DUL=LRM')I-]N[A\!D!^
MD0_&@#]D:*_/WP'_ ,%F_A%X@:*+Q-X?\2^$YV^]*L,=[;+_ ,"1A(?PCKWK
MP?\ \% /V>?'&Q;'XJ:':,P^[K#2:=CM@FX5!^M 'T116!X9\<>'?&EO]H\/
M>(-+UZ#&?-TR\CN%QZY1B*WZ "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N8\:_#WPQ\
M3-#DT?Q9X>TWQ'I<GS&SU2U2XCSC&X!@<,.S#D=C73T4 ?!7Q<_X(^_!WQUY
M]QX/OM5^'NH.252WD-]9 GN896W]>RRJ!TQTQ\G>(/\ @F+^TM\ ]4EU?X9>
M(%UA@?EN/"^L/IMZ5'/SI(T8/^ZKO^-?M-10!^*%M^WM^UW^S;(+'QYIEU?0
M0D(J^-- >/(SCY9XQ$TF>S%VKUKP3_P6\&R.+Q?\+LO_ !W6B:KP?I#+'Q_W
M\K]3;B%+J-XI462-U*LC#((/!!'<5Y+XR_9#^"GQ =Y==^%_AFZN'^_<0Z='
M;S-GUDB"L?SH ^<O#O\ P6.^!FL1G^T-/\7:%*HY6YT^*52>. 8IF)_$#H:\
M<_8V_;X^#7PDOOC+-XIUZ\T]?$WCK4-=TW9ID\QDM)B"C-L4[3Q]T\BOI/Q!
M_P $J?V<M9F\RW\(WVC;CN9=/U>ZVD\]I'< <]!@<"OE3]E#_@G7\*_CCJ7Q
M@37IM?MX_"OCC4/#^G)87Z1@6L+#9OW1L6;GD\9H ^F-0_X*X?L\6+.(=9US
M4 J[@;?1Y1N/]T;]O/UX]Z\R\9_\%KOAYI_F+X6\!>)-==<@-J<\%@C'M@J9
MCCZKGVKT;3/^"0_[/EAY?GV'B'4MI)/VK5V7?['RU7],5Z1X/_X)W_L[^"=C
M67POTJ^D7!+ZQ)-J&X^I6=W7\ ,>U 'Y8?&C_@H/\1_V@OC-X \4>%/#5KX>
M\1>%6NTT*UTV)]1N'DN45'W*Z[9"%0;0(QU.0>W4C]E_]L[]L"ZB?QS+KECI
M,C!BWC"].GVD1SG(LE&X'_=A["OM/X^>"?#O@7]MK]DNP\-:%I?AZQ\_7C]E
MTJSCM8N+6+'RQJ!7W)0!^;_P8_X(O^"/#KV]]\2O%-_XON%PSZ7I:FQL\]U9
M\F5Q[J8S7W;\-_A#X*^$&BC2?!7A?2_#-AQOCT^V6-I2.C2/C=(W^TQ)]Z[.
MB@ HHHH **** "BBB@ HHHH **** "O/OBK\</!?P0M="NO&VLIH5GK6HQZ7
M;74T;F$3NK,/,< K&N%.68@#N:]!KQW]J_Q!\-O#?P%\5W7Q9MHKWP6UOY5S
M9.H:6YD8_NXX!D'SBV-A!!4C=E0I( /78Y%D4,K!E89!4Y!'K7'?#SXP>$?B
MU+XCC\+:M_:K^'-5FT35!]FFA^SWD7$D7[Q%WXS]Y<J>Q-?E5X'\1?'OP+I_
MPZ\)?$3XA^+O@E\%=>>2+P]K<EM;W5Y;(6S;6EY=#9);_)]UF  !^X$4^7S?
M@35/%G[/_AWXK>)/"OQRUS3O%5E\0K[0=-\-/8IJC^+;I60&5XF8YE?<I>7#
M8R /F9<@'ZV?%+XZ>"O@RWAZ/Q;K<>G3^(-0BTS3+54:6>YF=@ORQH"VU2R[
MFQA<C)R0#Z'7YR?L:W5QXN_:M\37W[0]C>V?[0D5LL_A_3-4C1=/M-,*9/\
M9RJS+O&9-Q!) W');SC7Z-T %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M6HD'A65MY., 855 $C4 ?HK1110 4444 %%%% !1110 4444 %%%% !1110
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M4G^)7[67P\^'MA)N>WTVVME7&=ES>7+ C'^XL!_&@#]-/^&L?@A_T63X?_\
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M%% !1110 4444 %%%% !7">./@?\//B3&X\5^!O#OB-WSF74M,AFD&>X=E+
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MXA3_  G^*EE$OBU8IWLM4CM_LLL\D(S+;SP !5D"K(V5"C]VP*YY/-?M1?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MCK])?AK\5?"/Q@\,PZ_X*\16'B72Y,?O[*4-L;&=LB_>C;_98 CTKQS]J?\
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M&)89 2)4F[F4.&WL2=QYR00:]FH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MQI\)?'?PMN!_PE/A'Q!X7E5QMDU/3IK4;L\%6=0#[$&NP^'O[8WQL^%K1?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M (-_"_0? FC:=X5O--T6W^RVM]J5E<RW?EARRJQ%PJ':#L'R#Y5'?FK.K?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "N6^*'_),_%W_8'O/_1+UU-<M\4/^29^+O\
ML#WG_HEZ #X7_P#),_"/_8'L_P#T2E=37+?"_P#Y)GX1_P"P/9_^B4KJ: "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH ^>_VZOA"?C+^S1XLTVWO(=-U;2D77-,O[F984M[FU/F F1B%3<@D3>2
M N_)Z5\J_"WXF>*?^"IEQIWAS5KJ/PC\+?#-M9S>+=-L;Q5O_$5^5!,>U3NB
MM-ZL1ZXZEL>5^A_BWPGH_CWPSJ?A[Q!IT&JZ+J4#6UW8W"[HY8V&"#_0CD$
MC!%?/WQ4_8!^'?C34M,\0>#)]0^$GC+3+=+6SU[P7)]D;RD4*B2QKA74* ,C
M:Q  +$ "@#S:X\ ^&X?^"EVG^#TT.P7PN/A =/\ ['^SK]E^S_;77RO+QC;M
MXQ7S_P#M5>(M5_8)T7Q=\'M!U'3?%_PS^(&E70T?P_J]UYE[X6DE.V1L'):
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M,_L__##P6R-H'PY\*Z-(N,26.BVT3]N2RH"3P.2<\5WT<*6\:HBJB* JJHP
M!T %344 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 5\%_MO?L)^-/CQ\5[/XH^%[GPWJ-UH.G6D=KX
M5U:S95U=X9WE>&YEWA65@0!G .=I*@;S]Z44 ? 7CS]NSP'XI^$OBKX7_&#1
M/$7P&\2ZQH]SHTJZEHDU]:0^9$T7FVYA ,L:[@0,*#P 2.:I_#?]L[3=+^$/
MACX3_L_>&-<^./B;2=+BT>/5VTB33=(C*)L$UR93E%/WMA(!'&]37W_>6-MJ
M$)AN;>*YCSGRYD#KGUP:=:VL-G"D-O#'!"O"QQJ%4?0"@#XN_8L_8?\ &?[,
M/CZX\5ZAXLT6[C\2:=(?$6B6.E+&D-YYQDB6TD7;LB4.P("@':!LQM,?VS11
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %<M\4/^29^+O^P/>?^B7KJ:Y;XH?\DS\7?]@>
M\_\ 1+T 'PO_ .29^$?^P/9_^B4KJ:Y;X7_\DS\(_P#8'L__ $2E=30 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 5RWQ0_Y)GXN_[ ]Y_P"B7KJ:Y;XH?\DS\7?]@>\_]$O0
M ?"__DF?A'_L#V?_ *)2NIKEOA?_ ,DS\(_]@>S_ /1*5U- !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !7+?%#_DF?B[_L#WG_HEZZFN6^*'_),_%W_8'O/_ $2] !\+_P#D
MF?A'_L#V?_HE*ZFN6^%__),_"/\ V![/_P!$I74T %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %<M\4/^29^+O^P/>?\ HEZZFN6^*'_),_%W_8'O/_1+T 'PO_Y)GX1_[ ]G
M_P"B4KJ:Y;X7_P#),_"/_8'L_P#T2E=30 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !3&81J68A0!DD]!3Z_(;]N#QUXV_
M:N_;<LOV=]&U]O#WA:UNH; 1-(5@FG-N)Y[B9 1YC*I9$0G'R#&"YH _3+X-
M_'?P;\?]'U?5?!.J/J5GI6I2:5=L\#PLEPBHS#:X!*X=<,.#S@\&O1Z_ ;X,
M_LK?&"\\./\ $OX+WNHWWB#0_%]WX;>'2G%O<0B&&&5+@LSA3&_F,C(W PH.
MX,<?KC\3OV@O$OP0_8[NOB5XXT*'2?'=CHT(N-'\U)(AJ<A6%5!C=@8S*P?
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M9/L?VS^TM5M],QYOE^7YI/S_ '3G&.G&?45U= !1110 4444 %%%% !1110
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M'_Y(W/\ \;H_X:6^&_\ T,?_ )(W/_QNO3Z* /,/^&EOAO\ ]#'_ .2-S_\
M&Z/^&EOAO_T,?_DC<_\ QNO3Z* /,/\ AI;X;_\ 0Q_^2-S_ /&Z/^&EOAO_
M -#'_P"2-S_\;KT^B@#YRF^./@IOC=;Z^-;_ .)0N@-9-<?9)^)C<;]NW9N^
M[SG&/>N^_P"&EOAO_P!#'_Y(W/\ \;KT^B@#S#_AI;X;_P#0Q_\ DC<__&Z/
M^&EOAO\ ]#'_ .2-S_\ &Z]/HH \P_X:6^&__0Q_^2-S_P#&Z/\ AI;X;_\
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M,?\ Y(W/_P ;H_X:6^&__0Q_^2-S_P#&Z]/HH \P_P"&EOAO_P!#'_Y(W/\
M\;H_X:6^&_\ T,?_ )(W/_QNO3Z* /,/^&EOAO\ ]#'_ .2-S_\ &Z/^&EOA
MO_T,?_DC<_\ QNO3Z* /,/\ AI;X;_\ 0Q_^2-S_ /&ZX'QI\;_!.K?$;P'J
MEIKGFV.ER7C7<WV2<>4)(0J<%,G)XX!]Z^C:* /,/^&EOAO_ -#'_P"2-S_\
M;H_X:6^&_P#T,?\ Y(W/_P ;KT^B@#S#_AI;X;_]#'_Y(W/_ ,;H_P"&EOAO
M_P!#'_Y(W/\ \;KT^B@#S#_AI;X;_P#0Q_\ DC<__&Z/^&EOAO\ ]#'_ .2-
MS_\ &Z]/HH \P_X:6^&__0Q_^2-S_P#&Z/\ AI;X;_\ 0Q_^2-S_ /&Z]/HH
M \P_X:6^&_\ T,?_ )(W/_QNC_AI;X;_ /0Q_P#DC<__ !NO3Z* /,/^&EOA
MO_T,?_DC<_\ QNC_ (:6^&__ $,?_DC<_P#QNO3Z* /,/^&EOAO_ -#'_P"2
M-S_\;H_X:6^&_P#T,?\ Y(W/_P ;KT^B@#S#_AI;X;_]#'_Y(W/_ ,;H_P"&
MEOAO_P!#'_Y(W/\ \;KT^B@#S#_AI;X;_P#0Q_\ DC<__&ZX7XT_'3P1XN^&
M.MZ3I.M_:]0N5B$4/V2=-V)48\L@ X!ZFOHFB@#RNW_:4^'$=O&K>(\,J@'_
M $&Y]/\ KG4O_#2WPW_Z&/\ \D;G_P"-UZ?10!YA_P -+?#?_H8__)&Y_P#C
M='_#2WPW_P"AC_\ )&Y_^-UZ?10!YA_PTM\-_P#H8_\ R1N?_C='_#2WPW_Z
M&/\ \D;G_P"-UZ?10!YA_P -+?#?_H8__)&Y_P#C='_#2WPW_P"AC_\ )&Y_
M^-UZ?10!YA_PTM\-_P#H8_\ R1N?_C='_#2WPW_Z&/\ \D;G_P"-UZ?10!YA
M_P -+?#?_H8__)&Y_P#C='_#2WPW_P"AC_\ )&Y_^-UZ?10!YA_PTM\-_P#H
M8_\ R1N?_C='_#2WPW_Z&/\ \D;G_P"-UZ?10!YA_P -+?#?_H8__)&Y_P#C
M='_#2WPW_P"AC_\ )&Y_^-UZ?10!YA_PTM\-_P#H8_\ R1N?_C='_#2WPW_Z
M&/\ \D;G_P"-UZ?10!\Y_!3XX>"O"/PWT[2]7UO[)?PRSL\7V2=\!IG9>50C
MD$'K7>_\-+?#?_H8_P#R1N?_ (W7I]% 'F'_  TM\-_^AC_\D;G_ .-T?\-+
M?#?_ *&/_P D;G_XW7I]% 'F'_#2WPW_ .AC_P#)&Y_^-T?\-+?#?_H8_P#R
M1N?_ (W7I]% 'F'_  TM\-_^AC_\D;G_ .-T?\-+?#?_ *&/_P D;G_XW7I]
M% 'F'_#2WPW_ .AC_P#)&Y_^-T?\-+?#?_H8_P#R1N?_ (W7I]% 'F'_  TM
M\-_^AC_\D;G_ .-T?\-+?#?_ *&/_P D;G_XW7I]% 'F'_#2WPW_ .AC_P#)
M&Y_^-T?\-+?#?_H8_P#R1N?_ (W7I]% 'F'_  TM\-_^AC_\D;G_ .-T?\-+
M?#?_ *&/_P D;G_XW7I]% 'F'_#2WPW_ .AC_P#)&Y_^-T?\-+?#?_H8_P#R
M1N?_ (W7I]% 'SE-\<?!3?&ZWU\:W_Q*%T!K)KC[)/Q,;C?MV[-WW><XQ[UW
MW_#2WPW_ .AC_P#)&Y_^-UZ?10!YA_PTM\-_^AC_ /)&Y_\ C='_  TM\-_^
MAC_\D;G_ .-UZ?10!YA_PTM\-_\ H8__ "1N?_C='_#2WPW_ .AC_P#)&Y_^
M-UZ?10!YA_PTM\-_^AC_ /)&Y_\ C='_  TM\-_^AC_\D;G_ .-UZ?10!YA_
MPTM\-_\ H8__ "1N?_C='_#2WPW_ .AC_P#)&Y_^-UZ?10!YA_PTM\-_^AC_
M /)&Y_\ C='_  TM\-_^AC_\D;G_ .-UZ?10!YA_PTM\-_\ H8__ "1N?_C=
M'_#2WPW_ .AC_P#)&Y_^-UZ?10!YA_PTM\-_^AC_ /)&Y_\ C='_  TM\-_^
MAC_\D;G_ .-UZ?10!YA_PTM\-_\ H8__ "1N?_C='_#2WPW_ .AC_P#)&Y_^
M-UZ?10!\Y?%?XY>"O$UKX833=:^T-9:_9WLX^R3ILA0MO;YD&<9' Y]J[[_A
MI;X;_P#0Q_\ DC<__&Z]/HH \P_X:6^&_P#T,?\ Y(W/_P ;H_X:6^&__0Q_
M^2-S_P#&Z]/HH \P_P"&EOAO_P!#'_Y(W/\ \;H_X:6^&_\ T,?_ )(W/_QN
MO3Z* /,/^&EOAO\ ]#'_ .2-S_\ &Z/^&EOAO_T,?_DC<_\ QNO3Z* /,/\
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M+\7ZI )&L-2\2WUY9SO&R">%M@#KN .,@CZ@CJ#7K-% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MD8?[] 'TG^T#\=_#7[./PMUCQIXENDCAM(V6TM"X66^N2I,=O&.[,1^ !8\
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MN;&;&=C@$@J1RKCAAZ$,!Y]^WY^UQJ/[(?PUT'6M"TW3]7US5M4%E%:ZEO\
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MXK_X1/\ L'_A'/[-?9]M\CR_M?G;?+V^;^_W;M^><;J /T$_9U_:,\(_M/\
MPW@\7>$;B86YE-M=6-V%6YLIU )CD4$C."&!!(((/J!ZQ7Y[_P#!'CX/>*OA
MS\)O%_B+Q)8W6D67B>]MI-,L[Q#'(\,*.#<;#R%<R  GJ(\]""?T(H ****
M"BBB@ HHHH *^-/VQO\ @I)X4_95\0CPA8:)+XS\:K$DUS8I<BVM[%'&Y/-E
MVL=Y4A@BK]T@DKD9^RZ^5=:_8%^%=O\ M 3?'75;_7)]:M;R36;JSOKB*;3R
MZQMAC'Y6\"/Y64!^/+'!H \ ^#?_  64T+Q!XNM-$^)/@B3P;:7+A/[:L[TW
M$,!;&TRPM&K*F#DNK-U'RXYK](;>9+J-)8G62-U#*ZG(8'D$'N*_%?\ X* _
M&+PQ^W!\;/ >@?!31;KQ7K%K;S6DFIV^GO#)?M*T91,2*KB.$*Y+R!0OF.>
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M\%#?!W[)5];:!_94_B[QI<P"Y_LFUN5@BMHB<*T\I#%"W)50C$@9.T$$TO\
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MVW=7\'QW#/9W]EJ.ERK_  NUN_FHY'J/);!_VCZU^UU !1110 4444 %%%%
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M-\&?^"E]]X-TZ5H-*FU/7/#<L>3\T,/G/$IS_P!-+:+\J_;>@ HHHH ****
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M?_!''XZ>*O'_ ()\:>"/$-_<ZO9^&&M)M-NKJ0R20Q3^:&MRQYVJ8LJ">-S
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MR2!S7P7_ ,$IOV8_B?\  'QCX_O/'WA*Y\-V^HV%K%:///#()761RP'ENV,
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M/[!'PY'PO_9'^&FDNFRZN=+75;C(PWF73&X(;W42JO\ P&O:_%G_ "*NK_\
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M'-]:-:V^FV<@G&GP$AI SCY7F<JH^7( & QW' !YG>1K^T)_P6,@B!^U:/\
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MSO\ #WP=-#]GO-+T>!;R/^[=.OF7'_D5Y*]4H _$K_@D+_R>9K'_ &+^H?\
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M"-RDD$$'E65@5*GD%2#TKJZ *5]?0:79W-Y=W$=I:6\;337$SA(XT4$LS,>
M  22> !7YU?'O_@LEX5\&Z]<Z1\-/#!\;?9WV/K=]<-:V;D'GRD"EY%ZC<=@
MR,C<,$Z'_!8WXZ:AX%^$OASX?:1>2V<_BRXFEU!X3M+64 7,)/H\DB9QU$;
M\$@\G_P2U_8A\&:Y\*[7XL^.M#LO$^I:O<3+HUCJ48FMK6WB=HC(T3?*TC2)
M)@L#M55*X)- '":#_P %M_&,%V#K?PUT.]MO,SML+^:V<)D<9<2 G&><=QQQ
MS^@O[,7[77@3]K+PS<ZEX1N9[34K$JNH:+J(5+NU)'#$*Q#1DYPZG!Q@X.0-
M3XL?LK_"_P",W@N\\-:]X-TE+>:(QP7UC91075FV,+)#(JY1E].AZ$$$BODO
M]BW_ ()H^.?V8_C)8^.]2^(&DRQ00SVESI6FV4LJWL$BD;&D=DV881R?=;E
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MN2!WK\TO@%\5OB5\,/C1X1^.WQ&NY8O /QROY].ELY'8QZ-\_P#Q+&;)P%*
MA3_SR+L>: /U1HHHH **** "BBB@ HHHH \^^-OQJ\+?L^_#O4O&?C&^:ST>
MRPH6)=\UQ*WW(8DR-SL>@R  "20 2/S3\;?\%MO$,FJ2KX1^&VFVNG*^(WUJ
M^DGFD7)Y*QA A(QQEL>IKTO_ (+7:+K=Y\)/A_J-LLSZ!9:S,E\B E!+)"!
M[8X& LR@GN^._/!_\$W_ -J;]G3X<_"BS\)^+K73?"7CE9IOMNN:IIXDCU(-
M*S1G[2%;8%0HFQ]JC9D9+&@#K?@K_P %G]!\2>(K?2OB/X,;PK9W#+&-:TJZ
M-U#"Q.,RQ,H94'=E+G_9K]);.ZAU&TANK6:.XM9D62*:)@R2(1D,I'!!!!!%
M? /[2W_!/GP!^V1XBT?QM\)_&'A;P_!Y$D.K76APQWEO>OE3"^V!U0. 9 S$
MY(V>E?7G[./PQU/X+_!/PCX%U?65\07F@VALO[1C@,*RQJ[>4 A9B-L91>O\
M/;I0!YY^V-^VOX6_8_\ #EA+J5C-XA\2ZL7_ +.T.WF$1=5'S2RR$'RXP2%R
M%8DG@'#$?%MK_P %COB+IK6>MZU\';-?"5U*%AN(9[F$R8^\$N'0QNV".B_S
MXO\ _!:CX,ZU?77@SXH644EUH=G:G1-0PQ(M7,K20N5[!R[J6]50'J*\@^)W
M_!1;3/B#^P_H7P;M?"31^*9+.UT:^F\M19Q6]LT?E2P*#DR2"-1MP AW$9^6
M@#]9_P!GWX\>&/VD/ACIOC?PG-,^GW3-%+;W0"SVDZ??AE ) 89!X)!#*1P1
M7+_MC?M&W/[+7P6N?'=KH47B*2&^M[3[#-<F!2)&(W;PK=,=,5Y1_P $L?@9
MXH^"/[-\W_"6VTVF:CXBU-]8CTNX!62UA:&*-/,4_==A'N(/(!4'!! J?\%>
M/^3-]1_[#5A_Z&U 'S9_P_$US_HDFG_^#R3_ .,5L^%_^"W\4FI0Q^(_A0T-
M@SCS;G2];$DL:=RL3PJ'/L76G?\ !'+X;^$/'7PW^(<_B3PKHGB">#5[=(9-
M4TZ&Y:-3"20I=3@9["NK_P""JW[.OPA\(_L_R^,],\,:+X3\80ZA;6MA)I-L
MEG]NWO\ O(WCC 63$>Y]Q!8>6!D#((!]T_!WXO\ A?X\?#_2_&?@[4QJ.BWZ
MG:6&V6&0</%*G\+J>"/H02"">ZK\PO\ @B#K6H3^%?BSI,DDATFUO=.NK="W
MR":6.X64@=B5AAS]!Z5^GM ' _'+XIVGP1^$WBCQY?VS7UMH5D]V;5)!&T[#
M 2,,0=I9BJYP>O2OS]_X?B:'_P!$DU#_ ,'D?_QBO9O^"NGC;_A%?V/[_3%D
MQ)XCUBRTW /)56:Y/X?Z.!^/O7P[^QKXR_9,\"_!LCXU6%KKWC2_U>:58VTR
MYN7L[0)&D89D 4#<LCX!+?-TZ4 ?:G[+O_!4+3?VG/C)I/P^M?A]>>'Y=0AN
M)A?S:HDZIY432$;!$N<[<=>]?2?[0G[1/A#]F?X?S^+?&=W)%;E_(L[*V3?<
M7LY4L(HUZ9PI)8D* ,DBO./V6_ /[,GB:2'X@_!31O#TUY9E[?\ M#38I8KF
MV+J59)(I,/&64G[RC(.1Q7Y]?\%G/'UWKG[0WASPKYK?V;H&AI,L/.!<7$CM
M(WXI' /^ F@#TR/_ (+A,VN1[_A$J:/OP^-?W7&W^\/]'"Y[[?PSWK]#?@3\
M>/"/[17P_M/&/@S4&O=,F8Q2Q3)LGM)@ 6AE3)VN-PZ$@@@@D$$_/OC3]D'P
M'!^P-?>$D\+:7'JFG^$&OH]2%I&+G^TH[;SC.90-VYI5^8YY4E>G%?(G_!%/
MXB76F_%OQQX(:9O[/U31EU18F.5$]O,D>5]"4N&SZ[!Z"@#]"OVK_P!L+P7^
MR3X3MM1\1--J>M:AO&EZ#9D":[*XW,6(Q'&NY<N?7@,>*^+?#/\ P6ZM;KQ1
M!'KWPKDL/#TD@66>PUG[1<PID?,$:%%D(&?ERN?6OG3_ (*"ZU>?&[_@H#J/
MAE[AOLL%_IWABR'_ #R4B,/C/'^NFE;\17WA_P %%/V9OA_IW[%VN2Z%X4TG
M1;WPC%:W.EW%G:1Q21QK,D<B%U 9@T;N2"3EL,<D9H ^O?AS\1/#_P 5_!>E
M>+/"NIQ:QH&I1^=:W<((##)!!! *L&!4J0"""#75U^9O_!$WXB7.J> ?B+X*
MN)F>WTF^M=3M(V.=HN$=) OH ;=#CU<GN:_3*@ HHHH **** "BBB@ HHHH
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M8TW."G_"1'SL>N[[-CWQCVSWK[M_9=_:Q\$_M9>#[G6O"DEQ:WU@R1ZEH]Z
MMQ9NP)7."0R-AMKC@[3T((&#X[_9Y^#WPY_9=UWPWJGA;0[?PGH_AZ87-U)9
M1B7]W"2;CS,;C,6&X/G<7((.:_-O_@C/)JL?[46LK9I(VFOX9N1?%?N*OGVY
MC)[;MX '?!;MF@#]./VK?VN?!?[)?A"#5?$QFU#5]0WKI>AV9 GO63&X[CPB
M+N7<YZ9& QP*^*M#_P""WEO<>)(4UCX5266@/(%DFLM:$]U$F1E@C0HKGK\N
M5^OK\\?\%(?$5]\8/V\M1\+^>6M=/ET[P[8C_GF'6-GX/&?.GD_#%?>?[?\
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MA51%'+.S$  =2:_$"30]*T/_ (*;6&E?#,06NEVOQ#M8K".S_P!1"%ND\Y%
M/^J4^:,#C:,#BOJC_@MS\1+NWTOX:>![>5ELKJ2ZUB\C'1VC"10'\/,G_,4
M0:[_ ,%O(H]9D31OA,USI*R'$M]K8CGECW<'8L#*A([;GP3U-?<'[+?[6/@O
M]K#P7+K7A6:2VU"Q*1ZGHMY@7%C(P.W..&1MK;7'!P>A!4>)_L._LJ_#O6OV
M(?#MCKOA32M1NO%VG2WFIWTUK')<N9F?RRLA7<ICC*!,'Y2,CDDGX+_X)<^+
MKWX:_MN:=X9:XQ;:U!J&B7F/N.8XWF0X]?,MU /^T?4T ?K'^U!^U=X(_90\
M&P:WXMEN+F[OG:'3M(L0K7-Y(HR<!B J+E=SG@;AU) /PFO_  7$G_M0$_!Z
M,:?G!7_A(R9@/7/V7!]<8]L]Z];_ &[/^">/CC]K+XL6GBS1_&&BZ9I]GID.
MFVVG:C%,#&%>1W;<@8$EI/3H .U>X_%#]GCX0>!/V5_$OAJ]\+:):>%M'\/W
M&ZXDLXQ*C1P$B?S,;O.W -OSN+'KDT ='^S%^U7X)_:P\&W&N>$9Y[>ZL72'
M4M)O5"W-E(PR V"0R-AMKJ<':>A! SOVL/VP?!7[)/A.VU+Q&9M2UK4-ZZ7H
M5F0)[LKC<Q8\1QKN7+GUP QXK\UO^"+\>IM^TMXH>U8KI:^%YOMH.=K$W-OY
M8_WL[L'T#>M<9_P42\27OQH_;VU'PP]TWV*QN]/\-6(/'E*PC,GM_KII3GZ4
M ?1?AW_@MU:7'B:%-=^%4ECX?D<+)/8ZR+BZA7(^8(T**Y S\NY?KZ_I!\-?
MB-X=^+7@G2?%WA/4X]8\/ZI%YMM=1 C< 2K*5(!5E8%2I (((/2OD/\ X*(?
MLQ_#[3?V+==DT#PGI6B7GA"*UN=+N;*SCBE1%F2.1&< ,P:-W)R>6PQR17F?
M_!$OX@76I>!_B/X+N)BUKI5]::G:1MSM^T)(DH'H ;>,X]6)[F@#]-*^9/VY
MOVO+O]C[P3X<UZS\,P>)FU;46L6@N+QK81@1,^X$(V>F,8KZ;K\X/^"V_P#R
M1?X>_P#8P2?^DST >:_\/Q-<_P"B2:?_ .#R3_XQ75> ?^"VVCWVL6MMXQ^&
M=UI&G.V)=0TC51=O&">#Y#Q1Y [X?/H#TKO/^"5_PE\#^,OV3=/U'7_!GA_7
M-1;5[U#=ZEI<%Q*5#K@;W0G ],UXS_P5W^ ?PJ^&?AGPCXE\*:'IOA7QCJ>H
MO;SV.DQ+;PW5J(F9Y6A7"AE<1C<J@MYK;LX& #]2O!OB_1_B%X8TSQ)X?U&'
M5=#U.!;FSO+<Y26-AP?4'L0<$$$$ BM^OA;_ ((ZZUJ.J?LDW5O>R2-;:=XE
MO+6R$C9"PF*WE(7T'F2R\>I-4_VK?^"K/A7X">,[_P &^$O#[>.?$6FR/;ZE
M/)=&UL[*93@Q;MC-*ZD$,!M /&XD$  ^]:*_,'X5?\%GK>Z\60Z3\3O +>&[
M"614?5-)G>4VF<?-+;NH9EYR2K9 Z*QK]+=+U:RUS2[34K"ZBO=/O(4N+>ZA
M8-'+&RAE=6'!!!!!]Z -&BOS@^/'_!8?P_X/\777AOX9^%/^$Z^SR>0VM75T
MUO;22AL%88E0O*N> ^5R>@888R_L\_\ !7[0?'WC2T\+_$KPPO@>>\E^S0ZQ
M:W1FM$D)PJSHZAHAGC?E@"?F"C) !^C5%>5_M+_&*7]G_P"!_BOX@P:7'K4N
MB01S+8R3&%9M\T<>"X4X^_GH>E?"=G_P6FL5^&NH:I=> 85\6F^6UL-&AU-F
MB:'9N>XEE,0*@$A0H!+'/(P30!^H%%?+?[!_[6VO?M?>"/$>OZQX0M_#,.DW
MZ6$5S:7;317;E-[J%904**T>>3GS!TQ7U)0!YG\=/V@/!/[./@N?Q1XXU?\
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M2[R#4=-O?B]K]S:WEI*LL,\3K;,DB.I(964@A@<$$$4 ?!__  TK_P %"_\
MH$?$#_PW$/\ \@T?\-*_\%"_^@1\0/\ PW$/_P @U^U%% 'XK_\ #2O_  4+
M_P"@1\0/_#<0_P#R#1_PTK_P4+_Z!'Q _P##<0__ "#7[444 ?BO_P -*_\
M!0O_ *!'Q _\-Q#_ /(-?I#^PWXX^+GQ ^!L>J?&?1;C1?%BZC/!"MW8?8;B
MXM55"DLL&%\MBYE7&U<A%..<GZ'HH Y?XF:;<ZU\.?%>GV89KNZTF[@A"C)+
MM"ZKCWR17XD?\$G-2M=/_;2\.0W3!);S3M0M[?=CF3R&?'UVH]?N_7X<?MJ?
MLS^-/V+OV@4^)_@:&XMO"<VJ?VMH^K6L6^/3+AGW&TF'(4 DA=W#H<<D,  ?
MN/7":Y\:O GAGQM#X-UCQEHND^*9K9+N'2]0O8X)I8V9E4H'(W$E&X&3QG&*
M_.7P_P#\%NA#X1"ZW\,&N/$T<04R6.J".SGEQR^UHR\:Y_ARY_VJ^5O G@?X
ME?\ !23]IZ[UB_MV$5]<QS:SJ,,;+9Z58IA1$A.>0@VHF2S-R?XF !^KO_!3
M+G]AOXGXY'D6/_I?;5\-?\$;?@IX6^(7BGXB>*_$NA6.N3:%%96NG1ZC;+/%
M$\QF:215<$!P(4 ;J [>M?:__!1;1[/P[^P+\0-*TZW2TTZQL=.M;:WC&%BB
M2]M51![!0!^%?-__  0[_P"16^+7_7[IO_HNXH ]8_X*?7EI\%?V,-3T3P9I
M5EX;L/$6M0:?=0:5;);QA)?,GF.U  "YAVL<<ASGK7E?_!&?X)^&+[X?>*/B
M9?:9;:AXD_MIM(LKFYB61K***"*1FBR/D9S/@D<X11T)S]=?MR?L_P!U^TC^
MSCXC\):4B'7XS'J6DB1MJM<PG(0GH-Z&2,$\ N">!7Y9_L2_MLZI^PQK7BCP
M/X[\)ZI/H5U>">[T](Q!J&G7BH$9A')M#;E5 58K]Q2#U! /I/\ X+-?!7PS
M9_#WPM\2['3;6P\2_P!M+I%Y<P1+&U[%+!+(IEP/G9#!@$\X=NP&.D_85\>:
MEXT_X)D_$"TU"9YQX=L]=T>V>0DGR!9"=5SW"_:"H] H';%?)G[;'[;.I?MU
MZYX6\"^ ?"FJ6^BV][YUI82JLU_J5XRE$)CCW!0JLX"AF^^Q)Z ?H;\)_P!G
MV;]FK_@GWXI\(WX3^WI/#6K:EJYC8,HNYK60L@(X(10D>1U\O/>@#\Z?^"2O
MPUT3XC?M6B;7;"+48O#VB7&LVL4R[D%RL]O%&Y'0E?/9AGH5!Z@5]>_\%JO"
MNE7'P'\%^)7LXCK5KXECTZ*\VCS!;RVMS))'GK@M!&<>HKYU_P""*/\ R<CX
MQ_[%*;_TLM:^G_\ @M5_R:SX6_['.U_](;Z@"K_P3>\87G@?_@G1XN\26J^=
M=:')K=_;QN-PW16XE5<>A8=/>OC3_@E_\*='^/'[55W=^-8(_$$.E:9<^()+
M>_ E6\NO.BC5I5;[X#3F3G@LJYSTK[B_X)1:#9^*_P!A_4=$U%#+I^I:KJ=G
M<1@X+121QHXS]&-?G]X7U#X@?\$Q?VK&NM6T.2]MX!-9-Y@:*WUK3793OAEP
M1U6-^,[77:PX(H _5S]O/X'^%?BI^S#X]?5-(LQJ7A[1+K5=*U 0HLUI);1-
M,%1\95&$>QAT(8^@(^&O^"*'CS4;?XH^/?!8E=M)O-&76#"22J3PSQQ;AZ%E
MN,'UV+Z<6/VL_P#@K)HOQ>^#.L^!_ 'AC6-)N?$%L;/4=2UIH5\FW;B6.)(W
M?>77*;F*X#'C.,>N_P#!)G]E?Q#\+?!/B'XD^(K%M%UWQ-:I::/;7T)WQ68.
M_P Z2/*MB1_+(7*DK$#_ ! T ?%'Q$\,_%K_ ()Z_M3:CXMM-+4-'>W3Z5K%
M_9M<V&H6TY;CS,#Y]C8<!E=3GG!R?8KO_@IE\-?V@ET'3?V@_@M;ZW;:7.;B
MWU#1;QSY$C+M<BW=E)0C&5,K [5.TE16_<_\%*/B_P#"']H*^\)?M!>%["3P
MQ#YEIJ6AZ3IB+\K8\NYA,K-YR<9 +[65SSD#'E/[<7QR_9=^*/@NS7X3> FT
MCQM)>)-+JEGI::9;I" WF+)&C!9&8E?X.Q.X=& /US_9SU;X::Y\)-%O_A)%
MIMOX&G#O:0Z7;^1&CECYBM'@%9-V=P89S7J-?%7_  2?^%7B3X7?LN;_ !);
M3Z?+X@U>;6;.QN!M>.V>&&-&*]5+^47P?X2IQS7VK0!^1_\ P6\T>ZC\;?"W
M5CO-C-IU[:KQ\BR)+&S<^I$B_P#?-?9__!-?Q!9^(/V*OAO):^7FTM[BRGCC
M8$QR1W4JD,.Q(P_/9P>]:G[='[+:?M6?!&[\/6<D=MXGTV;^TM$N)3M0W"JR
MF%SV216*D]CM;G;BORD_9I_:U^)7_!/?QIKW@_Q#X6ENM+DN?,U/PMJ;&UEB
MN H43PR[6VDJ%YPR.JKCLP /JC]LCP/^V-K'[1_B^\^%=SXPC\!2_8_[/72]
M:CM[<8LX!+LC,JE?WPESP,G)[U\U_LU?M+?'*?\ :R\ ^#O%?Q(\57,8\4V^
MF:GI=YJDDL;%9]DL3C<0PR"#U!KWCQ]_P6UGN-&DA\%_#5;/5)(L+>:WJ7FP
MP/\ ]<8T4R#KR77MQVKYS_87^$GQ(^.G[5WAGXC6V@W%WI5GXC77=:UQHO(L
MT;SO-E57("LY).(TR>>@ ) !]._\%R/^07\'/^NVK?\ H-G7K?\ P3+_ &;?
MA]-^R)H.O:YX.T77=7\4/>3W]QJVGQ7+O$MQ)#'$#(I(CV1*VWIEF/>O)/\
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MG=6D;<^&;H"V3@8&2?6O1*^8_P!F*^^*G@#]D2Y\3_%C4+O7?&ZV-YKGV35
MB2VT*Q%H+>0HH.2L89MV64R%3]W \J_83_X*(>(_VN/B]J_A#5_".EZ!;6.A
M3:LMS8W$DCLZ7%O$$(;C!$Y/_ 10!]XT444 %%%% !1110 4444 %%%% !11
M10 5SWC:\UG2_!>O7?ARRCU/Q#;V%Q+IMG,VU+BY6-C%&QR,!G"@G(ZUT-%
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MQCDN/[ T1[^6&X@DQ'$-B,T"HBQ[2H7<'=<D BN6_8Z_;1^"GAGQ!\1OBO\
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MD3:T<*BT7SF90,QD,#C[O%?KWXH_;0^!?A'0WU:^^+/A.:T5#(L>G:K#>SR
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ML_\ !0SXJ^#/"?P]\*:DNGV3R0:5ILVUKN[N)MOF32A"4C55C7^(A0'8M@G
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MQRF!85WJ<)F)F*]RQSGBOO;2]-M-%TVTT^PMH[.QM8D@M[>)0L<4:@*J*!P
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M\ /V:_BSXK\$:%IOAO6FT60FZTFRCMW:7:8HI6\L#<T?F$@GICTK\V_^"/\
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MT;2=GXM+&H_4BOA[_@A_:RMXL^+5RI;R([+3HWXXW-)<%<GUPC?K7$_M9?\
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M.];EUKQ/\./"/B+6)PJRZAJVA6MU<2!5"J&DDC+$   9/  %9O\ PR=\$/\
MHC?P_P#_  E['_XU7JM% 'E7_#)WP0_Z(W\/_P#PE['_ .-5U_@OX?\ ACX;
MZ6VE^%/#FD^&--DF-PUEHUC%9PM(0 7*1JJEB%49QG"CTKIJ* "BBB@ HHHH
M **** "J&I:;::Q8SV-_:PWUE<(8YK:XC$D<B$8*LI!!!]#5^B@#PB?]AOX
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M144 <IX'^&/A#X8V=Q;>#_"FB>%(+IQ)/#H>FPV:2N!@,XB50Q XR:ZNBB@
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M&#5+.YL[NWCN[2XC:&:WF0/'(C AE93P002"#P0:Y#P7\$OAY\-=4EU/PCX
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A%% !1110 4444 %%%% !1110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>cron-20201231_g8.jpg
<TEXT>
begin 644 cron-20201231_g8.jpg
M_]C_X  02D9)1@ ! 0$!2@%*  #_X2B 17AI9@  34T *@    @ !@ +  (
M   F   (8@$2  ,    !  $   $Q  (    F   (B $R  (    4   (KH=I
M  0    !   (PNH<  <   @,    5@  $48<Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                     %=I;F1O=W,@4&AO=&\@161I=&]R(#$P+C N,3 P
M,3$N,38S.#0 5VEN9&]W<R!0:&]T;R!%9&ET;W(@,3 N,"XQ,# Q,2XQ-C,X
M-  R,#(Q.C R.C T(#$T.C,P.C,Y   &D ,  @   !0  !$<D 0  @   !0
M !$PDI$  @    ,P,   DI(  @    ,P,   H $  P    $  0  ZAP !P
M" P   D0     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M,C R,3HP,CHP-" Q-#HQ.#HS-@ R,#(Q.C R.C T(#$T.C$X.C,V      8!
M P #     0 &   !&@ %     0  $90!&P %     0  $9P!*  #     0 "
M   " 0 $     0  $:0" @ $     0  %M0         8     $   !@
M ?_8_]L 0P (!@8'!@4(!P<'"0D("@P4#0P+"PP9$A,/%!T:'QX=&AP<("0N
M)R B+",<'"@W*2PP,30T-!\G.3TX,CPN,S0R_]L 0P$)"0D,"PP8#0T8,B$<
M(3(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R_\  $0@ K $  P$A  (1 0,1 ?_$ !\   $% 0$! 0$!
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M?'EC_9XO);"]A4A&".(RQ#E@#PY'\![U!;?$G2+C[,/LMZC7)98@51@S!E7
M96()^;U[$=1B@#J[*Y-Y90W)@F@,BAO*F7:Z>Q'8U/0 44 %% !10 44 %%
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M(H JP>#+:'4UOO[1OV=9!)L,@V9#;L8QT)Z\^M=%&,;_ />- #Z* "B@ HH
M** "B@ S@9-9?VZYU#C3%00_\_<HRI_W%_B^N0/K0 /H%I<1%;QY[MSR7FD)
MY]0HPJ_@!2)H%I;Q8LGFM) 21)"_<G/*GY6_$4 /BOIK:9+?4E56<[8[A!B.
M0^G^R?8_@:TJ "B@ HH ** "B@ HH ** "L75+#6;C4X[BPU-;>W6+:T#)G<
MV\'.>V0"/QH J6^C^(DU!)IM?WVX=6:$0CD!LD9]QQ[?A711_P ?^\: 'T4
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M K+NS_:=V=/C)^SQ\W;#H?2/ZGJ?;'K0!I@!0 !@#@ 4M !10 44 %% !10
M44 ,EABG7;-$DB^CJ"*I2:%I<B,HL+>/<,%HXPA_,8- $UE8QV,>R-G88"C<
M<X S_B:M4 %% !10 5GW=]ID5X+>Z>+[08PP5DR0I; .<<#- $$6M:&]TL$5
MU;>>6 "@<Y)P/S/3ZCU%:D?\?^]0 ^B@ HH ** *>HWC6L*)$ UU.WEP)ZMC
M.3[  D_2I+*T6RM5A4ECRSN>KL>23]30!8HH ** "B@ HH ** "B@ HH **
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M8GN[:V_U]Q%%_P!='"_SH JMKFFJ>+I7_P!P%OY"D_MF$GY+:]<=BML^#^E
M%!/$=T^KR60T*_\ *1-XFP!N/'&#CU]:O_VI-WTJ^'_ 4/\ )J #^UU'WK&_
M7_MW)_E1_;-N!EX+R,>KVSC^E $<_B32[:!I9;AE51DCRFS_ "I++Q+I%_:Q
MW,-Z@C<9'F90_K0!:75M-8X74+4Y])E_QJRDL<HS&ZN/53F@!]-+HK!2RAFZ
M GDT .HH ** &1313*6BD210<$HP/-/H ** "B@ HH Q[S4M4AUV&T@TLS63
MJA>YW8V$L0P_ <UCV>E>,4N[YI-=MXX))2T(:W$K*,GOE<<8[&@"S_9'BH_\
MS2H^FGQ_X_2E;1O$S<?\)5*HS_!8PYQ^(- %0^#]4FDWW?B?4+HD\I-'$8ST
M_@"A?7MW]J9J_@_4]1TO[&-:G W*<J!'C YP%P/_ -= %^#PU)'!&DLHG*H!
MB=Y95X'HTA'IVJY#H[6V?(AL(L@_ZNT ]??Z?E0!:6WOE&!<(H]%B _K0(+_
M (S=GCK\B\]/;Z_G0!76SU47C.VHL82FT+M7KZXQC_(JQ]GON<7LG7^XGO[>
MX_*@!?(OL_\ 'VV-V<;%Z>G2D\G4,?\ 'WG_ +9K[?\ U_SH CN+749;:2-;
MM<NN!NB4@5%::;>0V<<#3J BE0$C3 '..H^GXB@![:7(XP\S$$=/*B_JE5W\
M-6DCAY(U=ACEH(#GI_TS]OU/M@ B_P"$3M ,*TL?KY0BCS_WR@_3UK-O/A_!
M=ZC:77]J:O']G!&U+YU)SGN"".O;TH T?^$2MBQ8WVN')SC^V+C'?C[_ +TX
M>$[/O=:T>>^M77_QR@ _X1'3C]YM5;@#YM9NCTQ_TT]J#X0THALQ7QSUSJ=P
M?_9Z +'AOP[;>&]/>TM7F9&D+_O7W$$GU_6MF@ HH ** "B@"O>6BWD*Q.SK
MMD20%3@Y5@P_#BL:#PE;0K;_ .EW+- RMN+#YL$D<=.] '0T4 %9%]H$-]J"
M7;7$Z$$;D4\,,$8]LACTH DTC18M'^T>5/-*)F#$2MNVX]*TZ "HKF!;FUE@
M<L%D0H2IP0",<4 8@\)VI$OF7-Q)YCNW)&!N4KC'0XSGGN!6^JA%"J,*HP!Z
M4 +10!FZKH\>JF%FGEB:(Y!0]>0>A^E1:=X>@TW4#=Q7%PQ,7E['?*X^7GZ_
M+^IH UZ* "L >%;87)F-W<D;PX7?TP^_KU//'/:@#3TO3TTO38;))9)5B! >
M0Y8Y)/\ 6KE !5+4].34[3R'EDBPP8,AY!'Z'\: ,NS\)P6FHVUX+VZ=K?[J
MLPPW!'/KU_05T- !10 44 %% !10 44 %% !10 44 %% !10 44 %% !10 4
M4 %% !10 44 %% !5>6_LX0#+=0("<#=(!S0 DVH6D$#327">6N,E3N.20
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M;Q2,OW2Z D?G4<>G64,CR1VD*R/G<P09.?>@"L_A_29)Y9WL8FDFW;V(^]N
M4_H /PJ3^Q-,W,WV& L[O(Q*9RSXW'ZG H BMO#FCVF_[/IT$>]/+;:O5<8Q
M]*C/A70S%Y9TV J=V01UW9SGZY- %G3M'L-),QLK<1&8Y<@YSU(_#D_G5^@"
MC+HNES*!)IUJP!W#,*]?RI9='TZ:!X6LH!')@,%0+G!SVH JCPQHHD$@T^$,
M#N!QT/\ GCZ4^X\.:-=X\_3K=\;R,H/XL;OSP/RH 6?P[I%S!'#-I\+Q1A@J
M%> &SG\\FH9_"FB7)<R:?%N=][$9!)Y_^*;\S0!KHBQQJB *JC  ["G4 %%
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MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$
M A$#$0 _ /U3HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH ***Y[QEX\\-_#S26U3Q1X@T
MOP[IPSFZU2\CMH\CG 9R 3[4 =#17A<?[</P"FU V:_%OPJ)1_$VH(L7./\
MEH?D[^OKZ&O7_#OB;1_%VEQ:IH6K6.LZ;-_J[S3KE+B%_HZ$@_@: -6BBB@
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M-"?"S_HI?@__ ,'UK_\ '*Z+PKXZ\-^.H)Y_#?B#2_$,$#;)I-*O8KE8V(R
MQ1C@X[&@#?HKD/$GQ;\#>#M4;3M?\9^']#U *'-IJ6JP6\H4]#L=P<'UQ6;_
M ,-"?"S_ **7X/\ _!]:_P#QR@#T&BN!M?CU\,[RX6"V^(OA2XF;.V.+6[5F
M.!DX ?T%=Q!,ES&DL3K)&ZAE=3D,#R"#W% $U%%4=5U:RT+3;B_U.\M["PMD
M,D]U=2K%%$@ZLS,0% ]2: +U%<!;_'SX8WDT4$'Q&\)SSR,$CCCURU9G8G
M DY)/:N_H ***X"X^/GPQLYI8)_B-X3@GC8I)')KEJK(P.""#)P0>U '?T5Y
M]_PT)\+/^BE^#_\ P?6O_P <J2U^//PTO9UAMOB)X4N)FZ1Q:W;,QP,G #T
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MGJ%PVR&TL]8MY99&]%17))]@* .VHHJO<7,5G;RSSRK!#$I=Y)&"JB@9))/
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M5HO@[36U'7]7L-$L%8(;O4KE+>(,>@WN0,GTS0!KT5Y]_P -"?"S_HI?@_\
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M*!^'*^,]-/CCSC!_8>]OM'F!/,*XQC.P9Z]* /3**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MQ:OE0!_USFF/_ *]2_X+;?$WR-"^''P^@FR;FXGUV\B'81KY,!/L3)<?]\T
M?DW_ "K]?O\ @B)_R2OXE?\ 89M__1!K\XO%WPW_ .$9_9=^''BR>'9<^*-?
MUKRY,??MK:.SB3\I3<5^CO\ P1$_Y)7\2O\ L,V__H@T ?*O_!7C_D\C4O\
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M4+#X*_L_ZAXXU1&EL]"T1;LPKPTSB-1'&/0NY5<]MU?S=>+/^1JUC_K]F_\
M1C5_0)^US\.M3^+'[$OC#PSHL,EQJMQH-O<V]O#DO,UNT5QY:@=2WE;0.Y;%
M 'XF^-/'WQ6_;:^,T/VDWWBSQ3JT[QZ;H]J3Y-JARWE0(3MBC55R6)'"EG8G
M+5[Y;?\ !'GX^S:.+R1O"MO=;<_V?)JKF?."<96(QYXQ]_'([9(^;?V;?CQJ
MO[-7QCT/Q_I-C;ZG<::9(Y;"Z)5+B&1#'(FX#*':QPP!P0,@C(/Z[?#'_@KM
M\#/'$,,7B&?5_ E^V ZZI9M<6^[_ &98-YQ[LJ?A0!^05Q%\2_V3_BY+;M)J
M7@3QWH<H#^3*%=<@,.5)22-E(_O(P/<&OWE_8O\ VD4_:E^ ND>,I8(K76HY
M'T[5[:#_ %<=Y&%+%1DD*RLD@!Y <#G&:\]^)7[,?[/?[>WB?3_'A\2?\)-<
MV-DE@TGAC5XMAB#NZK.JJS*P,C=2IQQVKV']GG]F;P5^R_X9U+0? \5]!INH
M7GVZ:.^NC.?-V*F02./E1?RH QOVN_VH-$_9/^$=WXLU&'^T-5N'^QZ/I>[!
MN[HJ2H8C[L:@%F;L!@<LH/X1?$;XJ_%']KKXFPS:U>:GXP\1:A.8].T>R1Y(
MX=W/E6T"Y"* .PR<98DY-?4/_!9'XF77BC]I+2_" >1=-\+Z1%B%C\IN+C][
M(X'O'Y"_\ KZ%_X(R_ G3=+^&VO?%6^LUDUS5KV32]/GD3)@M(@OF%#VWRD@
M_P#7$>] 'R=HO_!)7]H?5M)%[/HFC:5*4#"QO=7B\\Y/3]WN4'ORWZ\5X;XX
M^&?Q<_9!^(%G_;EEK/@#Q+'F6RU"SN-GFJ,9,-Q$Q5QR 0K'&<,.U?TF5X+^
MVS\"=+_:!_9U\7:#=VJ2ZM9V4NI:/<;<R07D*%TVGL'P8V_V7/M0!XA_P3@_
M;UG_ &E--N?!/C=X8_B%I4'GQ74:B-=5MEPK2;1PLJ$C<HP"&#*.& ]S_;I_
MY,_^+G_8OW'\J_!O]FCXG7'P;^/O@+QA!/)!'IFKV[W1C)!>U9PEPG_ HFD7
M\:_>3]NG_DS_ .+G_8OW'\J /YV](U6\T'5+/5-.N9++4+.9+FVN86*R0RHP
M9'4CH00"#ZBOZ&_V*OVFK+]J;X&Z5XE+QQ^)+/%AKMG'@>5=HHRX7LD@PZ^F
MXKG*FOY^? G@36OB1XA&A>'[-K_5)+6ZNX[9/O2);V\EQ(%'=O+B? ').!WK
MWG]@/]JB7]EWXXV=]J$[CP9KFS3]=A&2J1D_N[D#^]$QW="2ID Y:@#]B_V_
M/^3-_BQ_V!G_ /0TK\C?^"5G_)\7@'_KCJ7_ *07%?K9^WA<0WO[%_Q3GMI5
MG@ET-I$EC8,KJ60A@1P01WK\D_\ @E9_R?%X!_ZXZE_Z07% '[YT444 %?F;
M_P %+O\ @H?JWPYUB\^$OPQU!M/UZ) -=\06YQ+9EE#+;V[?PR;2"T@Y7("X
M;)7]%?&GB:'P3X-U[Q%<QM+!I-A<7\D:G!98HVD('N0M?S-WEYK7Q:^(TUS<
M2-?^(?$FJ%W=B29;FXE_/EWH [KX,_LU_%;]J;6[^7P;X?OO$;I+NO\ 6+R<
M1P)(W)\R>5@"YSG:"7(.<&O8?&'_  2E_:%\)Z+)J,7AW3M?\N/S9+71]2CD
MG48)("/M+L,?=3<3D8S7[5_!7X2:'\"_AAX?\$>';=8-.TFW6(NJA6N)<9DF
M?U=WW,?<^E=W0!_.?^SS^U=\3_V1_&G_ !);Z[CT^WN&34_"FIF06LS XD1X
MC_JI1@C> &!'.1D'][O@7\9O#W[07PMT+QUX9E9M-U.'<T$G^MMIE.V2&0?W
MD8$>AP",@@U^9?\ P6>^!&F>&_%/A/XH:1:):S:\9-,U?RUVK+<1J&AE/J[)
MO4GTB7WK8_X(D_$ZY_M+XC?#RXGDDMFA@UZSA).V-E;R+@CW8/;?]\4 9/\
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M]J*Q\0^,=<M?#VBII=Y"U[>$B,.R@*O /)H T?\ AT_^TE_T*&G_ /@[M/\
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M/BW_ -C!<?SK]Y_V9?\ DVWX4?\ 8I:3_P"D<5?@Q^W5_P G@?%O_L8+C^=
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M2OPQ_8Q^#<G[0G[3W@OPS=QM=Z=)??VCJS298-:P_O9@Q_V]OEY]9!0!T/\
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M^D=<3\+?C-X)^-6D7>J^!O$EEXFT^TG^S3W%BQ*QR[0VPY YPP/XUVU !7Y
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MF_!O]@OXS?'SP+;>+_!GAZTU'0KB62&.>;4[>!B\;;6&QW!X(]*]#_X*V?\
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M.K-)E@UK#^]F#'_;V^7GUD%)^VQ\%3\ /VF/&OA6"#[/I/VLZAI>T87[)/\
MO(U7V3<8_K&: /Z-*^/_ /@K!_R9+XO_ .OW3O\ TKBKT/\ 8:^.?_#07[,W
M@_Q-<3^?K5O!_9>K$G+?:X $=F]W79+])!7GG_!6#_DR7Q?_ -?NG?\ I7%0
M!^:__!)__D]KPA_UY:C_ .DDM?O17X+_ /!)_P#Y/:\(?]>6H_\ I)+7[T4
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M&"A\L0JDX')K[5_X*\?\F;ZC_P!AJP_]#:OM:OBG_@KQ_P F;ZC_ -AJP_\
M0VH ^#/^"/?_ "> G_8OWW\XJ_<FOPV_X(]_\G@)_P!B_??SBK]R: /SU_X+
M7?\ )MW@[_L;8?\ TCNJ^:O^"*/_ "<CXQ_[%*;_ -++6OI7_@M=_P FW>#O
M^QMA_P#2.ZKYJ_X(H_\ )R/C'_L4IO\ TLM: /LG_@KQ_P F;ZC_ -AJP_\
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MD [A6G0GT7<>@-?8_P#P2L_:P_X4G\63X \07GE^#?&$R11O*^([+4>%BE]
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M)D#)% '[O5_-K^V!;S6W[5WQB2?ESXNU1Q_NM=2,O_CI%?M7_P $[?%GQ/\
M'_[-NE>*/BEK,FLZEJ]S)<:9)-;10RK8 *D9?8J[BS+(X8C)5E.37YM_\%;O
M@7??#K]I*X\:PV[?\([XSACNHID0[([N*-8YXB?[QVK+[^:?0T ?JE^Q'?6N
MI?LC?".:T9'B7PW9PDIR-\<81Q]0ZMGWS7N-?E-_P2G_ &W_  YX5\*K\'/'
MNK0Z(+>X>;P]JE]*([9EE;<]J[L<(WF,S(3PV]ER"%#?JE]HB-OYPD4P[=_F
M;AMVXSG/ICO0!XW^VG?0:?\ LD_%V6X8+&WAB^A!/]]X61!_WTRU^#?[)EO-
M=_M2?"". D2_\)?I+!@,[0+R(DX]@#7Z _\ !5;]M[PSKO@R;X.> ]9M]<N+
MRX23Q#J%A*)+>&.-@Z6RR*<.YD52^"0H3:>20O@G_!);X'WGQ*_:8M?%\UNQ
MT#P7 ]]-,R$QO=2(T=O%G^]EGE_[8^] 'W5_P6$_Y,_?_L8+'^4M?&7_  2
M\+V?C;XG?%7PYJ"[K#6/!5QI]PN,YCEGBC<?DQK[-_X+"?\ )G[_ /8P6/\
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M"1#WD]J_:C]NG_DS_P"+G_8OW'\J /QW_P""7/\ R?7\,_\ N)_^FN[KI?\
M@IM^R:?V>_C+)XDT&S\GP+XMDDNK18EQ'977WI[;CA1D[T''RL5'W#7-?\$N
M?^3Z_AG_ -Q/_P!-=W7[3_M,_ /1_P!I;X-Z]X&UA5C:\C\VPO2N6L[Q 3#,
M._!.& ZJSK_%0!^97P-_:P_X63_P3W^+GPG\1WN_Q+X7\/L^E23-\UWIWF(
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MXE%O+_9FB>'Y8WN5!V">>6)8XR?4HLS ?[% '[34444 %?A7_P %3/V9]/\
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M48]7"C\:_GN_9\^)D?P=^.'@?QK/"]Q:Z)JUO>7$,?WWA#CS0O\ M%"V/?%
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MV+]]_.*ONK_@L)_R9^__ &,%C_*6OA7_ ((]_P#)X"?]B_??SBH _<FO@?\
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MN&2YG8RM&WO&&6/_ +9U[U0!^$7_  5L_P"3TO$'_8,T_P#]$"OT3_X))_\
M)E_A_P#[">H?^CS7YV?\%;/^3TO$'_8,T_\ ]$"OT3_X))_\F7^'_P#L)ZA_
MZ/- 'V57Y+_\%J/C=]NU[P?\*+"XS#8H=>U1%;(\YPT=NA]"J>:V/2537ZM:
MSJUGH.DWNIZA<):6%E ]S<7$APL<:*69B?0 $_A7\V'QV^*&I_M#?'7Q3XQ>
M*::\\0ZFS6EJ 6=8LB.WA [E8UC3WQ0!]Q_\$A=0^&OPQMO''CSQKX]\)^&=
M:O#'HVGV>LZU:VEPMNNV6:39(X;8[&$ XQF)JG_X*\:A\,?BGI?@KQWX*^('
MA+Q)X@T^1]'O[/1];M;NX>U?=+%)LC<MMC<2 G'_ "V%>.K_ ,$B?VAF4'^S
M- !/8ZPF1^E+_P .A_VA?^@;X?\ _!PG^% 'I'_!&7XY_P#"+_%+Q#\,-0N-
MMCXFM_M^G(S<"]@4EU4>KP[B?^N"U]F?\%8/^3)?%_\ U^Z=_P"E<5?B=X%\
M6:_\!?B]I&O01/9>(O"NK+*]K+\I$L,F)(7]CM9&'H2*_93_ (*1>,=-^(7_
M  3SU/Q1HTWVC2M:&D7]K)W,<EQ"ZY]#@\CL<T ?GI_P2?\ ^3VO"'_7EJ/_
M *22U^]%?@C_ ,$K;R#3_P!M+PE/=3QVT(L]0!DF<*HS:28Y-?NO_P )7H?_
M $&M/_\  J/_ !H UZ*R/^$KT/\ Z#6G_P#@5'_C6A;7$5U"DT$J31.,K)&P
M96'J".M $]?%/_!7C_DS?4?^PU8?^AM7VM7Q3_P5X_Y,WU'_ +#5A_Z&U 'X
MQ_"?X.^+_CEXN7PQX'T<Z[KK6\ETMFMQ%"3'&,N0TKJI(';.3V!K7^+7[-?Q
M.^!*VLGCSP7JGARWNFV0W5Q&'MY'QG8)4+)NQSMSG@\5]#_\$A_^3R--_P"P
M-?\ _H"U^TGQ8^%WA[XT?#_6O!OBJQ6_T35H##-&0-R'JLB'^%T8!E;L0* /
MY^?V4?V==*_:8^(47A.]^(FD^!;RX*K:QZA;2S37K=UA VQLX[*TBL<\ \U^
MZ/[,?[+7@K]E7P*?#WA*WEDN+IDFU/5KLAKF_F48#.1PJC)VHO"Y/4EB?P/_
M &A/@=XD_9A^,FK>#-9>1+S39A/8ZE$#&+JW)S#<1G/&0.Q^5E9<Y4U^R?\
MP3>_;"_X:<^%)TGQ%>++\0O#*)!J6X@-?0'B*[ [DXVOCHXSP'44 9?_  5X
M_P"3-]1_[#5A_P"AM7X\?L^_ +Q+^TI\1(?!?A*2PCUB6VENE;4IFBBV1@%O
MF56.>?2OV'_X*\?\F;ZC_P!AJP_]#:OS[_X)*WMOI_[8.G3W5Q%;0C1KX>9,
MX1<[%XR: -S_ (<V_'O_ )_/!_\ X-)?_C%'_#FWX]_\_G@__P &DO\ \8K]
MI_\ A*]#_P"@UI__ (%1_P"-'_"5Z'_T&M/_ / J/_&@#COV=? .I_"SX$>
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MN'[2G_!,R\L-:O!+XY\+ZOIMCJGF-\]U%EA#=>^\*58_WT8\!A69_P $4?\
MDY'QC_V*4W_I9:U\#3'4-%FU#3I/M%C(Q-M>6K[D)*."4D7V= <'H5]J^^?^
M"*/_ "<CXQ_[%*;_ -++6@#]D=4TNTUK3[FPU&T@OK&YC:&>UNHUDBEC889'
M5@0RD$@@\&HI- TR706T233[631VM_L;:>\*M;F#;L\HQD;2FWY=N,8XK3HH
M K6MK#9V\5O;Q)!!$HC2*-0JHH& H X  [59HHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#SOXZ? [PK^T1\.=1\%^,;
M)KO2KO#I)"VR>UF7.R:)L':ZY/J""0002#^,WQ[_ ."6/QG^$NJW4OAS1F^(
MOAM<M#?:&H-R%SPLEJ3YF_'_ #S#K[YXK]W:* /YNV_9P^/FNM#I,WPR^(EV
M+?;LM;C0KXI!G.#ADP@///'>OK']E/\ X)(^-/%VOV&M_&"'_A%/"T#K,VBI
M.KW]^!R$;82(4/<D[\9 52=P_9.B@"CI6EVNAZ9::=86T5E86<*6]O;6Z!(X
MHT4*J*HX"@   = *XGX[? WPG^T1\.=0\&>,K)KO2[HB2.:%@L]K,N=DT38.
MUUR>Q!!((()!]$HH _"OX[_\$I_C/\*]4N9O"VF#XB^' 6:*\T<JMVJYX$EL
MQW[\?\\]X]QTKPW_ (9Y^/JVO]B_\*T^(XMBOF?V?_8.H;-N<;O+\O&,G&<=
MZ_I&HH _"OX"_P#!*;XR_%;4K6;Q5IP^'/AQCNEN]7VM=LN>1':JV\-_UTV#
MW/2OV-^ _P "?"7[.GPZL/!O@VQ:UTVW)EFFF;?/=S,!OFE? W.V!V
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M_9^^(GQPU#X7/X$\):AXH338M26[-BH;R3(;;9NR1UV-_P!\FOT=HH _/O\
MX))_ GQ_\$/#OQ)M_'?A:_\ #$NHW5B]HE\H4S*B3!RN">A9?SK]!*** /E#
M_@IA\,O%7Q=_9>OO#W@[0[KQ#K4FJ6<RV5FH,A16)9N2.!7Y"_\ # ?[0W_1
M)_$'_?I/_BJ_HIHH _G6_P"& _VAO^B3^(/^_2?_ !5'_# ?[0W_ $2?Q!_W
MZ3_XJOZ*:* /SO\ ^":7PK^)/[-_P)^+-QXE\"ZI::^9Q?:7H\R 2W[QVS;8
MTP?XGPO4=:^!Y/V$_P!H_P"(GCLW>M_#W7(+W7-3\V^U2\C0(DDTN9)I#NZ
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M7RR1W56K]KJ** .:^)&GW&K?#SQ38V<+7%W<Z5=0PPKU=VA8*H]R2!7\_?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M[^%2H($QTN ;^>^9&.>QK[#_ ."@$4<W[&OQ661!(HT<L PR,B1"#]00#^%
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M?VU_B1H$7C+PG\!O#<7A*X4SVMKJ,S+>SPDDAE#W<3M\N,,(@&SE0<@#D/\
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MQX!_9_TN#P'(AN[1-6<W&HW-L1E'$*W44K;E(8;(CGC!8=?>OV'_ -LZP_;
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M%E!0'9GKC->$_P#!9RTN-1^)OP/M+2X-K=7"WD4-PI(,3M-;!7!'(P2#QZ4
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MFJ\;+V**XCG&.P+J6 _NNM?H!^S+_P FV_"C_L4M)_\ 2.*NJ_X0'PQ_8_\
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M 3G SSSBNSH _,O_ ((P_P#(5^/O_83T_P#]"O:]^_X*I_\ )COC[_KMIO\
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M8DM[F-9(W .<%6!!Y _*C3-+L]%LH[.PM8+&SB&([>VC6.- 3G 50 .2?SH
M^$_^"GGP$\::]<^ ?C9\-[.XU/Q5X#NDEEL;> S2&%)1/%,J#EQ'(IW*,Y63
M/136UX(_X*Z? O6O \.I^([[5/#7B%(0;G03IL]P_F@?,L4J*8V7(X+LAP1D
M#G'V_7":S\"_AOXDU8:KJWP^\+:IJ@9F%[>Z+;33 M]X[V0MDYYYH _/?]F?
M1?%G[<'[;@_:*U7P_=>'_AQX=3R=$6]7!N#'&Z0QHV,.0\DDSLI*JV$R:O\
M[>'_ "DL_9D_Z[:7_P"G1Z_2VWMX[2&.&*-8H8U")'&H554#   Z "L^_P##
M&CZMJEKJ-[I-C>:A:D&WNKBV1Y8<'(V.1E<'G@]: ->OS*_X)O?\GS?M0_\
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MQAJOCFQCT6Z\4/92VNE.^;J".$39,R@80MYPPN21@[@#Q7"?L0_\I-/VF/\
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M7WQZ_:R^*/B+PS^S/IVDZ/X0T&0P7'C+6HU=)GS@,"ZN@5B"514=BHW'&<
M_1BN&\<? _X=_$ZZ%SXN\">&_$]TJA%N=6TJ"YE51T =T+ ?0U\/^$_VSOC?
M^S3\:= ^'_[3FFZ7=Z%X@D$=CXPTN)8HXV+!=Y9 L;QJQ7>I1'0,&.1@']&:
M .=\'_#_ ,+_  [TU]/\*>&])\,V#-O:UT:PBM(BWJ4C4#/OBNBKY]_:[_;#
M\(?LF^!9M0U2XBU'Q5=Q-_8_AZ.0>==2<@.X'*0@_><^A RV!7)?\$VOCEXT
M_:#_ &>[WQ5X[U9=9UO^WKJT2=;6&W"PK'"RH%B11@%VY()YY)H ^KZ*\O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5>\MA>6DT
M!>2(2(4\R)MKKD8R#V-6** /%?V9_P!D_P $_LIZ-KFE^"WU.2#5[I+JXDU2
M=)I-RIM55947Y1R<'/+&O&?^"K?Q@T#P%^RKKGA:_FBFU[Q<\-GIUB2"Y6.:
M.668C^Z@0<_WG0=Z]%_;"_;1\)?LD^$UDO\ &M>,=0C8Z3X=@?$DQZ>;*>?+
MB!XW=6((4$@X^:OV7_V/_&W[17Q*B^/_ .THC7=[*5FT+PC=1E(X8P2T1EA/
M^KB3.5A/+$EI,DD, =?X5T_7_P!G_P#X)'W<-\)K76X_"=[)MERLEM]NFD9!
MCJK(MRO'8C\*Z7_@DGX1M_#O[&.@:E$JK+K^IW^HS,.K,L[6PS_P&V6O2?V_
M]%FU[]C7XKVT$?F/'H[717_9AD29C^"QD_A7%_\ !*W5(-0_8>\!01-NDL9M
M2MYAZ,;^XD _[YD7\Z .+_X+$>%+?7/V38-5>-?M6BZ_:7$4G\0619(67Z'S
M%./]D>E?3/[+OBVY\=?LW_#'7[V1IKZ^\.6$MS*S9+S>0@D8GW8,?QKYZ_X*
M\:I#I_['&H02MA[[6K"WB'JP=I,?]\QM^5>Y_L=:/+H/[*?PELIHVBE7PS82
M/&W52\"N0??YJ /E"#_@FOH/P[^&_P 1?B-\4/$=Y\5?B5_PCVHW8O=29FM;
M:X%K(1(JN2TKJ?NO(<# (12 1U/_  1M_P"31[O_ +&:]_\ 15O7U3^T)_R0
M/XE_]BSJ?_I+)7RM_P $;?\ DT>[_P"QFO?_ $5;T <-_P %N&U#_A3WPZ6(
M?\2HZ]*9S_TV^SMY7_CIFK] /A])HTG@/PXWAMHF\/'3;;^S6MR#']F\I?*V
MXXQLVXQQ7+?M!? GPY^TA\*]7\"^)T=;*^VR0W<('G6DZ',<T9(^\#Q[J64\
M$U\,^!_V7?VW/V?+'_A#/AW\3/#FH>#4D=;&;4"DGV2,G@[)X':+U\M"Z YZ
MYR0#G_\ @HAXRLO!O_!0CX#:OI4\::[IZZ>=0:,@GR6OW"H^.>4:48/.UQZB
MOU2K\5_VC/V:M3^&W[2WP&T;Q'XINO'_ ,4_%VNQ:AX@UB4L%97NK:*&*-2?
MEBC$<V&PO!/"A0J_M10 5^6O_!,O_D^3]HS_ *[7_P#Z<S7ZE5^'/P._9$TC
M]K[]K;XWZ#K'B"]T"'2M4U&^2:QA21I&-^Z;2&Z#!S0!^W]S<Q6<#SSRI##&
MI9Y)&"JH'4DGH*_)CX\>)-%_:(_X*L?"I?AO=PZPF@S:6NI:II9$L,C6ES)=
M3N)%RK*L16,MR,KMYQBO1H_^"(_@=9%+_$GQ Z9^8+9P D>QYQ7U/^S'^Q+\
M,OV4$N[GPE97=[K]Y%Y%SK^K2K-=O%D,8UVJJQIN )"J,X7<6VC !Q_[=7[:
M4_[,>G>'_#GA'28O$OQ-\42>7I>ER!I%A0L$$KQH0SEG(1$!&XAN?E(/DJ^#
M_P#@H4VA_P#"5'QUX-2]\KSO^$--M;>9C&?*W_9MF_/'^OQ_MUX;^UE>?$34
M?^"J^G)X TK3M4\8Z;96IT&TUEU6VEVV+S,Q+.@^4M,1\P^9!UZ'W[_A,O\
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MCB)']Q>]?JW7Y3>/KI/@G_P6=T;7M:!L]'\3?9Q;3MT87.G&R4Y[#[2A!/8
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M-[=>*+E;J0*-_P EO;A$)ZD '<!VWMZF@#C_ ![\;OVO?V(Y-.\2_%6Y\/\
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M%E^T[I^I>*K;]H'4+&^L8HK=M(F@2T\R1V+F7YK8*-J!5!#KDEQ@X%?55%%
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MK^VU\8/ FK^*]3\3V_AO3]2TQ;B]GD*3-;ZE!#YPB9W"%@I.,G&XC)H [/\
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MDDA5SL8%3D.W&.]?-_\ P6S_ .2!^!?^QF'_ *2SUZ_^V]_RCF\6?]B_IO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MS?6NJ:39+*9G9$AV@NR++$?*!1T9N688]/UXHH _*7]L'XN?%W]N#X0:O!X
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH _)_4/^"CWQ)^&O[0GC?X<_&R
M.QM/#4,5_I&=-TPQ/"[)_HMU]YF:-EVG@GY9MP!P!7RYX\^+G@/6/V!OA;\.
M;?&H_$;3=?O;]_+A;-A:O)/E&<C!,I:$A%S_ *O)QA<_L3^TQ^R#\-OVD]'N
M+KQ/X5AU#Q-:VDB:?J5K,UK=!MI*(TBL Z[NBR949)&,DUXC^P+_ ,$__#OP
MA\#:%XI^(_@&"#XLV]S/(TE]>I>K:@2,(6C6.1X0VS:0PRP/<&@"#Q+\0/BE
M^P__ ,$^?AKJ>D>&K+6M<T>VMK?7+76(Y7&GQ3+(X9A$RG]W(T41R>,_C5O]
MGW_@JA\,?&'P<76_B9XAT[PIXTLA*-1T>UM9]DN&8QM:J=Y<,FT8W$ALYP,$
M_:VJ:79Z[IUUIVHVD&H:?=QM!<6MU$LD4T; AD=&!#*02"",$&ODGQ)_P2D_
M9X\0:X^I)X;U+2!)(7>QTW4Y8[=B<Y 5MQ4<]%( QQ@4 ?"__!.SP_J_Q\_X
M* ZM\4;.P>ST2PO]4\0WS9PL)O!.D,&1P6+3$X[K&_I7Z#?%K_@H=\.?@W\>
M(?A-K6B>*+KQ'+/9VZW5A:VSVFZY"&,EGN%? \P9^3C!QFO</A/\'?!GP/\
M"<?AKP-X=M/#VCQMO,-L"7E? !>21B7D?  W.2< #. *^#_VK/@EI/QM_;Q\
M"V'@OPCK3^*]-U*PU7QIXHF29=/MK&)8FACC9CY9=D1ONCE@J@D[]H!D?\%K
M_A7>ZCX<\ ?$*SM6EM=,EN-)U&9%SY:R['@+'LNY)5SZNH[\P7__  40^&D_
M_!.X^%DUIA\1I/"0\*-H?V:7S1-]G%JTV_9LV>7F4'=WV_>XK],/$'A_3/%>
MBWNCZU86VJZ5?1-!<V5Y$LL4T;#!5E(P0?>OE(?\$I/V<E\0#4O^$4U#[/G=
M_99UBY-MG.?[_F8]M^* /!/^"-_P1GF^%/Q+\5ZS:LND^*C'HEIYBX\V&)91
M<.OJI:8)GUB8=J^;_P!A3XG:?^Q#^V%XGT+XFSOH=C]ENO#U]=R0NRP3+-')
M%*54%MC>5@$ C$H;IS7[<:!X?TWPKHMEH^BZ?;Z5I5E$L%M96<2Q0PQ@8"JJ
M@  >@KR#X_?L8_"7]I>[M]0\;^&O/UNWB\F/5K"X>UN@G969#B0#L'#;<G&,
MG(!^4O[:7CZP_;N_;6\-:)\-IWU?3I+>S\.6-\L#HLI\V26:?:P#!$\YR20/
MEB)Z<U]N?\%;O@[/XH_96TO5-%LVE/@O4(KF1(UW,EBT30R$>RDPL3V"D]J^
M@/@#^QG\)OV:;J>^\$^&5M]9N(_)EU>^G>ZNBG=5=R1&#W"!0<#.<#'M-Q;Q
M74$D$\:2PR*4>.10RLI&""#U!':@#\POV*_^"AWPS^$'[&,/A[Q-K36?C/PM
M'>16>DM;2N^H[Y9)K?RV5"F"9/+.2-NS)P"">"_X(M_"W4=8^+'C/XCSPM_9
M.F:8=)BG=>)+N>2.1MI[E8XCN';SD]:^Q_$G_!+']G?Q+XFDUAO"-UI@FE::
M6PT[4IH;5V8Y.$#?(N>BQE0.@ %?2?P^^'/AGX4^$K#PSX1T6UT'0;$;8+*S
M3"CU9B>68GDLQ+$\DDT =11110 5YA\=/^:??]C?I_\ [4KT^O,/CI_S3[_L
M;]/_ /:E 'I]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %>8?'3_FGW_8WZ?\ ^U*]/KS#XZ?\
MT^_[&_3_ /VI0!Z?1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !7F'QT_YI]_V-^G_^U*]/KS#X
MZ?\ -/O^QOT__P!J4 >GT444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 5YA\=/\ FGW_ &-^G_\
MM2O3Z\P^.G_-/O\ L;]/_P#:E 'I]%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M +4H ]/HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M+X;^)/A#Q#K%Q-IYAT_2]=M;JXD"WL#,5CCD+'"@DX' !-?;GA/_ )%71_\
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MV=LXZ_<.[ RRK7TG0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M'_LP?\$S?A;^SXMEJVJVB>/?&<6U_P"U-7A!@MY!SFWMSE4P<$,VYP1D,.E
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M?!GQ"=0O]FS2?Z+J#XY-K(QZGKY3?,,\%\$T ?95%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !7F'QT_YI]_V-^G_ /M2
MO3Z\P^.G_-/O^QOT_P#]J4 >GT444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !7'_%#XL>$O@OX1NO$WC77K7P_HMOPUQ=/R[8
M)"1H,M(YP<*H)..E?/7[8G_!0[P/^RW;W.BVAC\6?$%E_=Z':S 1VA(R'NI!
MGRQC!"#YVXX4'=7YT> _@W\?_P#@IYX_'BKQ/JDUIX4@E:,ZU?1M'IUDA/S0
MV4 (\Q@ ,[>X'F/D@D [?]HK_@I5\3OVG/$A^'OP/TG5=!TF_<V\3:?&7UG4
ME/!Y3/D)CDA#D $E\9%>J_LE_P#!(>UTN2T\4_'&9=2OLB:/PG9S;H4;.?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M<!\:/C;X.^ /@:[\6>-M7CTG2X/E1?O37,A&5BACZNYQT'0 DD $@ ['5-4M
M-#TVZO\ 4;N"QL;6)I[BZN9!'%%&HRSLQ.%4 $DG@5^5W[9'_!5+4?$U_/\
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MK.T\(>,9+;0/B7$FT1_ZNVU? Y>#/W9.[1?4KD9"_;= !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MT_YI]_V-^G_^U* /3Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M ((N?&K5(/&'B_X4W]U++I,UB=;T^&1LBVFCD2.=4';>LJ,1TS$3U)S]M?\
M!.AHV_8K^%GE#Y?[/E!_WOM,V[]<U^:7_!*-3)^W%<-:AA;+IFIL1Z1[E S^
M)6@#]OJ*** "O,/CI_S3[_L;]/\ _:E;?C'Q=XBT'4X[?2/!MUXAMFA$C74-
MW'"%8LP*8;G( !S_ +5>8_$'Q=XBU[4O 5MJ_@ZZ\.VR^*;"1;J:\CF#,&8!
M,+SD@DY_V: /H*BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MUY;:#93?8+34]05A<Z)(IV_9[@'YO(!& 3S'TY3[GZ_U\<?MX?\ !/\ T/\
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MMZO\/_"VJZRK%QJ-[HMM-<!CU/F,A;)]<UV5O;QVD,<,4:Q0QJ$2.-0JJH&
M !T % $]%%% !7F'QT_YI]_V-^G_ /M2O3Z\P^.G_-/O^QOT_P#]J4 >GT44
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 5FZUK>G^&='O=6U:]M]-TRRA:XN;R[D
M$<4,:C+.[$X4 #))JKXP\7:+X!\-ZEXA\1ZG;Z/H>FPM<7=[=/MCB0=R?7H
M!R20 "2*_&;]J?\ :X^('_!0+XF67PL^%>F:@/"$MSLM=,A^2;5&4Y^TW9SA
M(EQN"L=J ;F).-H!J_MG_MS>*_VP_&D/PB^#MGJ$_A&[N1;+'9Q,MWK\@.<L
M.J0#&X*<<#>^,!4^U/V$_P#@GIH/[,.EVWB?Q,EOKWQ-N(OGO -\&EJPP8K;
M(^]@D-+U/(&%)W=/^Q-^POX:_9+\,_:YO(USXA:A"%U+7-GRQ*>3;VP/*Q ]
M3PSD M@!57ZEH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** /E?\ ;>_86\.?M9>%6O+00:)\0]/A(TW6MN%F Y%O<X&6C)Z-
MRR$Y&065OSW_ &1_VP?&W[!OQ(O/A-\6-/OHO!\5WY=U8W +SZ-(QSY]OC(>
M%LARJY# [TY)#_MA7S1^VE^Q/X8_:V\&L'$.C>.M/B(TG7]AXZGR)\<O"23Z
ME"2R_P 2L ?0?AWQ%I?B[0K#6M%O[?5=)OX5N+6]M)!)%-&PR&5AP0:U*_$?
M]EW]JKQ]_P $\?BMJ'PM^)^FWC>#EN\7NFOEY-/9C_Q]VAZ/&P^8J.''(PV<
M_L[X3\5Z1XZ\-Z=X@T'4;?6-%U"%;BTOK5P\<L9Z$'^G4$$'D4 ;=%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !7F'QT_YI]_V-^G_P#M2O3Z\P^.G_-/O^QOT_\
M]J4 >GT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %>8?'3_ )I]_P!C?I__ +4K
MT^O,/CI_S3[_ +&_3_\ VI0!Z?1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KS#XZ?\T^
M_P"QOT__ -J5Z?7F'QT_YI]_V-^G_P#M2@#T^BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N2^)GQ,
M\-?![P/JOBWQ;JD.CZ%IL7F3W$IZ]E1%ZL[' 51R20!4GQ&^(OAWX3>#=4\6
M^+-4AT;0=-B,MQ=3MP.P50.69C@*HR22 !DU^+_Q>^+OQ0_X*B_'G3_!O@S3
MYK#PC9S-)8:;*Q$%G"#M>_O77(WX/OMW!$W,Q+@#/BI\4/BE_P %3?V@+#PM
MX4L9=.\)6,C/8Z?,Q%OIUOG:][>,N09"/3.,A$R22WZT_LP_LP^$?V5_AU!X
M8\,0>==R[9=3UB9 +C4)P,;W]%&2%0'"@]R6)B_9;_9=\)?LI_#J'PUX;A^U
M7\^V75=:F0"?4)P,;F_NH,D(@.%!/4EF/M% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MX'R*$V?.021Z 'Z"?#WXC>&?BMX6L_$OA#6[/Q!H5X,PWEG)N4^JL.JL.ZL
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M=<WX^\!>'_BAX1U+PQXITJ#6]!U*(PW-E=+E7'4$'JK @$,""I (((H \O\
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MZE_P1Q^%EK\([S2[35-:NO':63-!X@DN-D3704E0;< J(BV 5Y8+_'GFNO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% &9X@\/Z9XLT2^T?6+"WU32KZ%K>ZL[N,2131L,,K*>""*_'/]L']A7Q
MG^QSXTC^+GP9O=17PG8S_:UFLW+7F@MSE7ZF2W()&\Y^4E9 ?O/^S]5[BWBN
MH)()XTEAD4H\<BAE92,$$'J".U 'QE^PM_P46\/_ +2UC:^%/%CVWA_XF0Q[
M?)SLMM6 ',EOD\/@9:(\]UR,A?M6OR>_;K_X)DWOA.]NOB?\#+2>*&!_MM[X
M7T_<)K-U.[S[';SM!&[RARI&4XPJ]A^P?_P5&MO%G]G?#[XS7T=CKORVVG>+
M)B$AO#T6.[/1)?23[K?Q;6Y< _3&BDSGD<BEH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#,\1:/%X
MBT'4=*F.V&^MI+9SM#85U*DX/7K7G?[,_P  =._9E^$.E^ =+U2XUFTL9IYA
M>74:QR.996D.0O'&['T%>KT4 %5)-/MIKI+J2VADN8QA)FC!=!Z!L9'4_G5N
MB@ KY4^-'[./CK]H+]ICP5JWB2]TG3_A'X#O(=9TZSM@[WVJWV$8K,"=JHCQ
M@9X^5B,'<2OU710 52?2;*2\6\>SMWNU^[<-$ID'T;&:NT4 %03V\=U"\4T:
MRQ.-K1NH96'H0>M3T4 0PPQV\2111K%$@"JB !5 Z  =!4U%% %62RMYKB*>
M2WBDGBSY<K("R9ZX/49]JM444 %%%% !7F'QT_YI]_V-^G_^U*]/KS#XZ?\
M-/O^QOT__P!J4 >GT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !7F'QT_P":??\ 8WZ?_P"U*]/KS#XZ?\T^_P"QOT__
M -J4 >GT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M7YW_ +8G_!)WP]\1UO?%7PB6U\*^*&)EFT!_W>FWIZGR\#_1W/M^[)QPF2U
M'Z*45^*WP!_;^^+G[%OB3_A6_P 7M"U36M TW; VFZE\FI:=&.%-O*W$L6/N
MJQ*D ;'4=?U?^"/[0G@']HCPJNO>!/$-OK%NN!<6N=EU:,?X)HC\R'@X)&#C
M()'- 'I5%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5YA\=/
M^:??]C?I_P#[4KT^O,/CI_S3[_L;]/\ _:E 'I]%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%?(?CS]M3Q_9_'GQO\-/AS\"[OXCS>$5M#?W\
M?B2&PQ]HA65?W;PMQ\Q&=Q)VG@5'_P -6?M)?]&@ZA_X7%I_\8H ^P**^/\
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M /T!HKF_ 7CWP_\ %#PCIOBCPIJUOKF@:E'YMK?6S91QD@CGE6!!4J0"I!!
M((KY\_::_P""BOPI_9C\1-X:U634?$OBA4#SZ5H,<<AM,@%1.[NJH6!SM&YL
M8)4 @D ^IZ*^7OV9/^"AGPK_ &H-=_X1[19;_P .^*"ADATC74CC>[ !9_(=
M'99"H!)7(; )VX!(^C]>U[3?"^BWVL:O?6^F:58PM<75Y=2".*&-1EG9CP
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MV?KQ.GS[C_"/.VJY_P!QFKZ!AF2:-)(W62-P&5E.0P/0@^E $U%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MA/Q-9P_$GQ#-#/;^$KU;2U@DD!$=S=1F0L8^QV*^&/\ TT45^I]?E)_P2O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M]FW)EP/8QCZ4 ?MA17XOZ#_P5P^/WPSO_P"S/'OA;2-7GCXEBU339M-O>/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /Q>_:)_9A^,/[%_P"T
M!X@^)'PNTB^UGP9J1NY4N=/M&NH[>UN 3/:7<2#*1KN(#\#"HP8,,#S/X/\
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MV8_ACJ_P,LOACJFV[>ZAL;F30KNYNK;S<B7[))$?+E7<696 <!F)R1@#Z_\
M^"67[&7B#]G_ ,/ZWXZ\<V!TKQ7XAMX[6TTV3_76-D"'82C^&21PA*=5$:YP
MQ('WY10 4444 %>8?'3_ )I]_P!C?I__ +4KT^O,/CI_S3[_ +&_3_\ VI0!
MZ?1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M.IZ>WH* /)_#7_!7G]GS7=GVV^\0^'=V,_VEI+/MZ=?(:7U[9Z&O4_#7[?\
M^SSXKV?8OBMH4&_&/[2:2PZXZ^>B8Z]_?TKR_P 3?\$B?V>M>W_8M,U_PYNZ
M?V9K#OMZ]/M E]1UST'OGROQ)_P1'\"76\>'_B1XBTS.=O\ :5G!>8ZXSL\G
M/;TZ'\ #[R\/_&SX=^*]O]B>/?#&L;ON_P!GZQ;3YSG&-CGT/Y&NRCE2>-71
ME=& 964Y!!Z$&OR0U[_@B#XIM]W]B?%+2-0Z[?M^E2VN>F,[))<=_P AZ\<;
M)_P29_:0\#S._ASQ-X?EY)']CZW<VS'/'.^*/G &>3VY- '[345^*_\ PS]^
MW]\/07LM2\;7-M'\P6T\81W<>?O'$1N2>W]WGISFC_A>/_!0'X<\7>G^.+JW
MCX=KGPG%?Q\<<RBW8C[W7<,^^* /VHHK\5_^'JW[37P_^3Q)X:T5V7AO[<\/
MW%L?3G9)'W!_'/TKKM#_ ."W7C&WQ_;'PRT*_P#7[#J$UMGG_:63M_GM0!^O
M5%?F)HO_  7 \.W&S^U_A1J=CG[WV'68[G'/;=%'GCGMSQ[UZ!HG_!9SX)ZA
ML2^T+QGI4A^\TEA;2QCG'!2X+'CG[OYT ??=%?(>B_\ !57]F_5M@G\:W>DL
MW1+[1;SKG&"8XG ]<YQBO0-#_;O_ &?O$&W[+\6O#<6[I]NNOLG?'/G!<?C]
M>E 'OE%<'H?QV^&OB?9_8_Q"\*ZMOX7[#K=M-NR<#&USGGCZUVMM<174*302
MI-$XRLD;!E8>H(ZT 3T444 %%%% !1110 445R?Q.^*'ACX.>"=2\7^,=571
M/#VG!#<WLD4DNS>ZHH"1JS,2S*,*">: .LHKY4_X>C?LQ_\ 13/_ "@:I_\
M(U'_  ]&_9C_ .BF?^4#5/\ Y&H ^JZ*^5/^'HW[,?\ T4S_ ,H&J?\ R-7L
MWP7^/O@/]H;PW=>(/A[X@3Q!I-K=-93S+;36[),%5RI29$;[KJ<XP<\'@T >
MBT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !7F'QT_YI]_V-^G_^U*]/
MKS#XZ?\ -/O^QOT__P!J4 >GT444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %>8?'3_FGW_8WZ?\ ^U*]/KS#XZ?\T^_[&_3_ /VI0!Z?1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !7R9_P4&_;,M?V5OAI]CT:>&;XBZ]&T6DVS8;[)'R'O)%
M_NKT4'[SXX(5L>V_'OXW>'/V=OA=K/CGQ1.5L-/3$-LC 2WD[9$<$8/5F/Y
M%CPI-?C[^SE\)/&'_!2S]J#5_''CR28^%+.=+G69HRRQ)"#^XTZW],@8XY"A
MF)W,-P![#_P2T_8SN?&WB!?CS\1K:6\A6Y:X\/PW^7>]NMQ+W\F[E@K9V$]7
MR_\ "I/ZSU0T?2;/0=)L],TVTBL=.LX4M[:UMT"1PQ(H5$51P%    ["K] !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?)/\ P53_ .3'
M?'W_ %VTW_TOMZ^MJ\U_:#^".B_M&?"77/A_K]U>V.EZKY)>YT]E$T;13)*A
M7<K+]Z, @CH3TZT =GX3_P"15T?_ *\H?_1:UKU\>0_\$^M8@B2*+]IGXVQ1
MJH543Q0ZA0.  ,<"G_\ #OW7/^CG?CA_X54G^% 'V!7QK_P3G_Y"W[2/_94]
M7_\ 0EJU_P ._=<_Z.=^.'_A52?X5ZS^S+^S+H_[,7AG7]+TO7]:\37&N:M)
MK%_J6O3++<RSNB*Q+*HSG9N);))8DF@#V>BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH *\P^.G_-/O\ L;]/_P#:E>GUYA\=/^:??]C?I_\ [4H ]/HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@#X9_;._X*::%^SUXHO?A_X4T2;Q;XV2'R[J5;@0V^G2R(#&N0CF60;@2@
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MAHHHH *\P^.G_-/O^QOT_P#]J5Z?7F'QT_YI]_V-^G_^U* /3Z*** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M68GW>OSI_8AT7]K^Q^.UI-\9Y/$#^"?L%R)!J5Y:RQ>=M'E_+&Y;.<]JY/\
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M.GK;E9-S$-N!Y& PQ[^U?05>8?'3_FGW_8WZ?_[4H ]/HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M *_'7_@II^U-J7[0GQ4L/@7\-VFU;2;#4$M;I;%LG5M4+;%A7'WHXF.WG@ON
M/1%:OKS_ (*7?M@#]F_X4GPWX=O?*^(/BB%XK)HV^>PM?NRW7LW5(^GS$L,^
M617B/_!)']C_ /L?3S\;_%UEG4;Y&B\-07"_-%"V5DO,'^*3E$/]W>>0ZF@#
MZ]_8M_99TS]E/X,V/AR,17'B6^VW>NZE&/\ CXNBOW%/7RXP=B].A; +&O?Z
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@"IJ6GP:KI]S9W,?F6US$T,L>XC<C AAD<C@GI7+_  H^$WA3
MX(^";3PCX*TK^Q?#UH\DD-G]IFN-C2.7<[Y79SEF)Y/?BNSHH **** "O _%
MG[)]A\0_VD-%^*GBWQ3JFN6?AL1R^'?"KJD=CIMT -\^1\TC%E1QG!#*,EE"
MJOOE% !1110 4444 %%%% !1110 4444 %>8?'3_ )I]_P!C?I__ +4KT^O,
M/CI_S3[_ +&_3_\ VI0!Z?1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !7%?%WXK>'_ ()_#G7O&OB:Z^S:
M/H]N9I,'YY6Z)$@[N[%54>K#H.:[6OQ@_P""BO[2&L?M:?'72?@O\.&?5M!T
MO41911VK975-4)*-)GH8X\LBMT_UCYVD$ '*? 7X=>*?^"F/[7FK>+O&0D3P
MI:S)>ZQY;-Y5M:*2+?3X3V+!2N>#@2O][K^WVG:?:Z3I]M8V5O':65M$L$%O
M"H5(HU 554#@    #TKR/]DW]F[1OV7/@WI/@[3O+N-1Q]JU;447!O+Q@/,?
MUVC 51V55[Y)]HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "O,/CI_S3[_ +&_3_\ VI7I]>8?'3_FGW_8WZ?_ .U* /3Z
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHKAOC-\6] ^!?PTU[QOXEN/L^D:3;F9E4_//(>(X4!ZN[E5'NW.!D
MT ?+/_!3S]L(_L__  O_ .$+\,WOE>/?%4#HDD3XDTZQ.5DN..5=N40\<[V!
MRG/G'_!);]CW_A"?#(^,_BJRVZYK,!C\/VTJ?-;63?>N,'H\O13VCYR1)Q\P
M_LQ_"OQ)_P %'OVMM9\=>/%>7PM9W*:AK.TGR1&#BVTZ(]E(7;Z[$<YW$$_M
MY;VT5G;Q001+!#$H1(XU"JB@8  '  ':@"Q1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %>8?'3_ )I]_P!C?I__ +4K
MT^O,/CI_S3[_ +&_3_\ VI0!Z?1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MWLU.+;3XFXP7"[<C!P)7^]U_;VQLH-+LH+.U@CMK6WC6*&"% J1HHPJJHX
M   ]*\=_9%_9MTO]EOX*Z5X/LO*N=68?:]7U&-<?:[QP-[>NQ0 BC^Z@[DU[
M;0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 ?A;\2/$6L_L5_M]_$'7O$OAZ35K35[G5
MI[=V(5YK/4/-*7$+D8+KYF&]UD0D=1],_P#!.VX_9]^,_P"S[X&^'7CM?#7B
M#QSH5[J$EIHNN)MF'GSM(1") %FW($)5"WW>0,5[IXY^-O[-7[92^(_AU(]C
MXT\1:3I=]>6\5_I5S;2VSQ+B3R)I(T97!"DA",A3U -?E-XD_9MA\+_L=^ O
MCQI6NW,6HZEKD^DWFGR,J^7(DDYAF@888$"WY!R<G<" "* /VH_:0_9!\&?M
M,?#WP_X*UR]UCP[H&A3K<65KX=DA@12D311J5>)UVHC$  #&>M6O#OA_P!^Q
M/^S3%IE]J'D>"_"]E*9[J^"&6Y+NSL"J@!Y)'<J% ^8L!6/^SW\>(_\ AC#P
M=\4/B-JBV*PZ EUJNI71P9/+S'YF!]YY-H(4<LS@ 9(%?F;\1_B)\4_^"K/Q
MW@\)^$;6;1? &ER^=#;W!(M["')4WEV5X>9AD*@SC)5?XW(!O?\ !';PIJ/B
M+]I[Q=XOTZTDT_PYI^CW$4WEC]TKW$\9AMR?]V-V'_7*OV8KRC]FW]G7PM^R
M_P##"Q\&^%T>1$<W%[J$P'G7URP >:3'3@ !1PJJHYQD^KT ?DS_ ,%O?%UQ
M+XD^%OAA79;6&TO=2D0'AW=XXT)'JHC?'^^:^L=1^%6DK_P3%E\*&RC-O%\.
M/M?E[!_Q]K9?:?-Q_>\\;_K7Q[_P6\T&YA^(WPRUIE/V.ZTJZLT;''F13*[#
M/TF6OMK5O&UG_P .W[CQ'YZ&WD^&.]7R,>8VF[0GUWD+CUXH ^)?^".OQ*N/
M"6@?'.T=S+9Z?I4&O10,3M5XDG$A _VAY8/^X*Y3_@CAH*>+/VHO%7B34Q]N
MOM/T"XN(YYAN87$UQ"K29/\ $4,HS_MFM3_@D7X%O?%>A_M /:(<W/AR/2(F
M(X:6=;C:!ZXV#/U'K5+_ ((LZQ%8?M%>,M*G<137GAJ1XT?@LT=U!E1[X<G'
MH#Z4 4?^"P>CKX+_ &MO#GB71LV&HWV@6E^]S"-K?:H;B:-9,_W@L<(_X"*^
MA/\ @L%\1I]0_9?^&MK 3!%XEU2'49E0G#(EJSA#ZC=,A^J"O /^"SFK+J_[
M3WA;2K4FXGL_#%NCQQC+"22ZN&"X'.2NPX_VA7M'_!8+P3>Z/^SC\'W*YAT2
M^72YV7D!VM!MY_[8/0![_P#\$Y?AKHS?L%^%-(N[&.6V\2VM_+J:L@_TD3SS
M1G=Z_N@B\]E%?"/_  1Z\07?AC]K#7_#AE;[-J6A74$L/16EAFB='(]0!(/H
MYK] _P#@G+XJLKC]A?X>ZC)<HEOIMG>17+$@>5Y-U.&W>GR@'Z$&OSR_X)$:
M;<>)?VQ]4U@(3%9Z%?7LK8P!YDL48'U)EZ>Q]* /VUHHHH *\P^.G_-/O^QO
MT_\ ]J5M^,/ %YXJU6*[@\6:YH*)"(C;Z;.$C8AF.\@@_,=V/HHKS'XA> +S
MPKJO@.[N/%>N:\C^*+"(6^I3AXU)9CO  'S#;CZ,: /H*BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KS#XZ?\ -/O^
MQOT__P!J5Z?7F'QT_P":??\ 8WZ?_P"U* /3Z*** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M.K,>[,Q+,>[,3WH ZBBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O,/CI_S3[_ +&_3_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#\P_VQ/^"@
M?Q(UGXSZY\%/@9I4<]Y8_:+#4=2%NMQ<33)&3<K&K_)$D0$@9V!Y1CE0,GYS
M_9;_ &^/BO\ LK^'_!5KXDTPZ[\)M5GN'MOM4 $[1B<K<M;W .6>-R24DSU
M^4,K!G[0$/C7]A/]MWQCXP?11J.D>);C5+BRFN P@OK.^WF1$EQQ+$90#U(9
M 2"K#/T/_P $W?VD/@5<?!?P?\*_'<VEQ>,=/OKQK%?$6G(]NS3SLX$,[JR(
MS!E7#%23P,\4 ?IKH>L6?B+1;#5M.G6ZT^_MX[JVG3[LD3J&1A[$$'\:_.']
MOS_@IQ/\-]?LO!?P6UZSN=;LYVDUO6D@BN[>/ *BUC+!E9LG<[ ?+M50<[@/
MK3]L?X*^*?CG\!=0\!>!]4M_#VH7UQ:QM<RSR6\,=JC@RH?+!)4J,; ,'@'
MYK\J?V\/V)O#G['OPO\ AK%9ZE<>(/%&LW5[_:FK2*8HW$:0E(XHLD(B[VY)
M+$DDG&% !^O/[+/CS6?B=^SM\/\ Q9XAN$N];UC2(;N\GCB6-7D8<D*H 'T
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M*OPD_P"OW4O_ $7;U^E^BZ/8^'='L=)TRUCL=-L8$MK:UA7:D42*%1%'8
M?2OE#_@H7^QKXG_; T?P39>&M;TG1GT*XNI9VU7S<2"58@H7RT;IY9SG'44
M>D_L+?\ )G_PC_[%^W_E7LUQKFFVMS]FGU"UAN>!Y,DRJ_/3@G/-</\ LZ_#
M6^^#GP-\$^"=3N;>]O\ 0M,BL9[BUW>5(RCDKN ./J!7YQ_M_? 35;+]NKX:
M^-8M4T^[?QCX@TFSL-%A+F\06YMTDED&W:$W8YSW]C0!]O?M8?'CX&_".UT6
MP^-%E9ZDFI)/)I]G?:"VI)($"B7:3&R*?F0$$@_,.W-=^FJ>!/%GP!.HPIIY
M^'%_X=,XC2)([5=.:W)*[/NHHCXV_P .,=JX[]KS]DOPW^UQ\.H_#VL7+Z1J
MUC,;G2M:AB$CV<A #@ID;T< !ER,X4Y!45\ +_P2Q_:7M=#D\"6WQ:TE?A],
M^^33DUO4$M"-P8YM/*V%B?FQT) );- 'FW_!)G0=6\5_%3XH:'8Y2QU+P'?V
M=PY!VK))+"D7/3=EGQGL&KH?^",^N1^'OVF_%F@7Y-I>7_AV:..&7Y6,T-S"
MS1X/.X+YAQZ(:_1[]CO]C_PU^R'X"N-(TNY?6=?U1DFUC6I8_+-RZ A$1,G9
M&FYMJY)RS$DYX^8_VG_^"6>M^*/BM<_$KX)^+H/!WB"]N9+^YL[JXFM5ANG)
M+RVUQ K/'O+,2A& 2<, <  ^<_\ @L5K'_"6?M8>'/#^E@WM]9>'K2S:WA^9
M_M$MQ.ZQX'<J\1Q_M"O>O^"PGP_NM,_9K^%EQ#F:U\/:BFF3LH) WVNU6/H,
MP8Y[L*U_V4O^"7.L^!?BS:_$WXR>+;?Q?XCL;E;ZTL[.::Y1[H<K/<3S*KR,
MA (4#[R@EB!@_;WQH^#_ (<^/'PUUOP/XJMY)]&U6(+(T#!9875@R2QL0<.K
M*".".,$$$@@'@G_!.7X@:7_PP;X.U:YNT2VT"TOX]09F'[@07$S'=Z?N]K<]
MF%? W_!'W1+KQ1^UMK>OM$PM]/T&[N99<$J))IHD5<CN0SD>R&NYU'_@D=\<
M_#;:KX:\'_%;2AX$U.4M<6\VH7MD+A1PIGM8XWC=L8'WCT[5]V?L8_L<Z!^R
M!X!N]+L;YM;\1ZN\<^KZP\8C$K("$CC7G;&FY\ DDEV)/(  /HFBBB@#B_&7
MPF\.^.M2CU#5X;J6YCA$"^3=R1#:&9APK 9RQYKS'XA?"?P]X$U+P%?Z1#=1
MW,GBFP@;SKN24;2S,>&8C.5'-?05>8?'3_FGW_8WZ?\ ^U* /3Z*** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHJK>WD&FV<]U=3QV]K"C2RS2,%2-%&69B>
M   22: /)OVJ_P!HS1_V7O@YK'C35!'<7J#[/I6GLV#>WC@^7%Z[>"S$=%1C
MUP#^8/\ P3O_ &<]9_:X^/6K_&?XD>9JN@Z7J1OIY;I=R:IJ9(=(L=/+BRKL
MO0#RTQM)QS7[1GQ-\3?\%*?VMM'\$^"#)_PBMI</8Z/O5O*B@!!N=1E';<%W
M8X.U8U^\>?V/^#GPFT'X'_#70?!/AJV^SZ3I$ A1BH#S/UDE<CJ[N68GU8]J
M .WHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !7F'QT_YI]_V-^G_ /M2O3Z\P^.G_-/O
M^QOT_P#]J4 >GT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %4=5U2UT/3+O4;^YBL
MK"TA>XN+FX<)'%&BEF=F/ 4 $DGH!5ZORT_X*T?MAO\ -\"?!=VTEW.8W\2W
M%J<G!P8[%<<DM\KN!VV+SEQ0!X%\:?B!XJ_X*=?M?:7X4\)--#X1M9'MM*\Q
M&\NTL58&XOY5[,X .#@_ZJ/KU_9?X3_"W0/@O\.M"\%^&;06>C:/;K!"N!ND
M/5Y'('+NQ9F/<L:^<O\ @G'^Q^G[,?PF&JZ]:*OQ!\2QI<:GN +V4/6*T![;
M<[GQU<XY"+7U]0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5YA\=
M/^:??]C?I_\ [4KT^O,/CI_S3[_L;]/_ /:E 'I]%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%<Q\1OB!H7PK\$ZWXN\2WRZ=H6D6S75U<-U"CHJC^)F.%51R6( Y- '
MB7[=G[6EC^RC\';C4+=X9_&FL![30;&3!S+CYKAU[QQ ACZL47C=D?#/_!+7
M]DN^^+7CBX^/?Q!CEU&QM;Z2?2/MV7;4M1WDR7;D_>6-\X/>3)S^[(/D^AZ;
MXT_X*G_MA37EY]HTSPI;$-,5.Y-'TE'.R)3T,TF3_O.[-C:I _;;PCX3TKP+
MX7TGP]H=A%IFC:7;I:6EI",+%$@ 51Z\#J>2>3S0!N4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% $4DJ01L[LJ(H+,S'
M  '4DU5TG6M/\06*7NF7UMJ-FY(6XM)EEC8@X(#*2#@U^5/[67[8_P 8_CA^
MT1XC^"?P7NSHVDZ.]W8WMQ;[(I[LVZ-]LDDF?/EQ)LD "8+8_B+*H^??V<?V
MFOCG^R7X:^'^M61FUOX5^(+F[-KH,JK-%<>3-MNTC('F02@G>"#M.X$AAN%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^.'PY\*^*!X;UKQ_X7TCQ$S1HNCW^M6T%X6DQY8$+N'RVX8&.<C'6@#\P/\
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M/+;4FXZ_*: )_P#@M)I<=C^TKX3U"%1'+<^%H0[+P2R7=R Q]\%1GV%>P_\
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MT;\.K[P9XRLFN],N")8IH6V3VDZ@A)HFP=KKN/4$$$@@@D'\[5_X(?W/]O\
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M\13?\(_\6#9^'9I"PAU#1S-<P)GY5)295E('\6$^E?=7[+_[+?@_]E'X>_\
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MAMWW50 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M5O;Q)!!$HC2*-0JHH& H X  [4 6:*** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "O,/CI_S3[_ +&_3_\ VI7I]>8?'3_F
MGW_8WZ?_ .U* /3Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHKSSXX_''PK^SU\.=3\:>,+[['IEF-L4,>#/=S'.R
M"%21N=L=.@ +$A02 #(_:4_:.\*_LO\ PQO?%_B>8NP)AT_38F GO[D@E8DS
MTZ99NBJ"?0'\D?@M\(_B-_P5"_:)U+QIXTN[BS\'VDRKJ6H0@B&T@!W1Z?9@
MY&_:>O.W<9'W,P#PZ9IWQ/\ ^"KW[2[W5TTFC^$]./[QUR]KH5@6X1,X$D\F
M/J[#)VHGR_LW\)_A/X:^"?@#2?!OA#3UTS1--CV1QKR\C'EI)&_B=CDECU)]
M.* -?P?X/T?X?^&=+\.>'=.ATK1--@6VM+*W7"11J, #U/<D\DDDDDUN444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !17/>.O'6@_#/PK?>)/%&JV^BZ%8A6N
M;^Z)$<09U1<X'=F4?C6EHNL6?B#1['5=.N$N["^@CN;:XC^[+$ZAD<>Q!!_&
M@"_1110 4444 %%%% !1110 4444 %>8?'3_ )I]_P!C?I__ +4KT^O,/CI_
MS3[_ +&_3_\ VI0!Z?1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MIWPZ\));7$WAR.Z>.TBCGNA%:PB)!MFER2QDDY_=MR/E6O=_V2=6_:9_9O\
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MI&,_=?\ P31_;'U?]J+X?ZQI/C!X9?&OAEH5GO(E$?V^VD#".8J.!(&1U?:
M.4/&[%>A_LHZ3;I^P?X"LGC5K>X\'JTB8P&\R%F8?CN-?G3_ ,$6-2FM_P!I
MGQ58AF-M<>$YY'5>FY+NTVL?H'<?\"H _:6BBB@ KS#XZ?\ -/O^QOT__P!J
M5W.I>*-(T:X6'4-5L;&4KO$=S<I&Q7)&<,1QD'GVKS+XP>)M(UJ?P!#I^JV-
M]*OBW3Y#';7*2,%RXSA2>,D<^] 'L=%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 5S'Q'U[5/"OP_\2:WHFEC7
M-8TW3KB\M-,9RGVN6.-G6$, 2"Q&T'!Y(KIZ* /Q]^)W_!2*U_:D_95^,WA'
MQ5IFG>$?$)MM/FT6UMYW<7RK?0M.FY_XT"JVT=5W''RFO%?VS-!^'VKZM\#=
M.^%L.GS^.+_PQIT&N6F@*N&OGCA$&_R^/M+%GW?Q?<+<FOL;]OS_ ()K^$=0
M\'^+_B=\.-(UR/QKOBN#X8T.W-U;W\LEPBRO' J&1&VR.Y"';\F=HY->J_L7
M?\$\?AS\#M-\+^/+W3]2U;Q_/IUO=,=?"@:5<21*TB10!%V.I8KE]SC!P5YH
M T_VS/V\+G]C&]\+Z=>^ KCQA_;%BTL>HKJ8LH3-&P66,_N9#D!D;_@8'O72
M_$;]L+X4:I^ROKOCD>+-(N+#4M F$.E_;(VNI+B6%E%H8LAO,WG:5P,8). "
M:]2^.GP#\%_M&^!IO"?CG2O[2TUI!/!)'(8I[68 A98G'*L 3Z@@D$$$BOB6
M+_@B7\/%UQ9I/B#XF?1PP+6BP6ZSD9Y'G;=O3OY= 'F/_!$?P;JS^-/B/XK$
M<B:''I\&E^9T22X:02X'J51.?3S!ZUY+^QCJ>F?LF_\ !0K4/#_C*[AT#3[6
MXU+P^]]?.(H8LDF"1G8@!'V1X8\8D4GCFOV2^$/P?\*? OP+8>#_  9I4>D:
M+9Y81J2SRR'[TLCGEW;NQ] !@  >(_M2_P#!//X:?M4Z\GB/5GU#PWXL6%87
MU;1V0?:54803QNI#[1P&&UL #=@   ^!?^"NWQ4T+XN?&SP-X7\&ZI:>)Y-(
MT]XI6TF5;A?M5Q, ( R$@N!''P.F\#KD5ZC_ ,%5/@;?>%_V4/@;/'$9H_ <
M,7A^[:,EA&LEI#&')_N[[15SZNOK7T'^S7_P2[^%_P"SWXPL_%EQ>:EXT\1V
M!$EE-JPC2VM90<B6.%!]\=B[-@\@ @&OJCQYX#T+XG>#]5\*^)]-AUC0-4A-
MO=V<^=KJ2".0<A@0&# @@@$$$"@#XG_9I_:Y^'GAO_@G?8WE]XLTFRUSPWX?
MN=,DT>XNXUNVNHUD6"-82VYC( A7 P0QZ;6QX#_P1*\ 7=U\2/B'XW:%A966
MDQZ,DQR%>2>9)F4>I MU)]-R^M>QZA_P13^&%QX@%Q:>-_%-GHQ)+6!^SR2C
M)Z+,8P !TY1C[U]L_!GX*^$?@#X"LO"'@G25TO1[8F1OF+RW$I #32N>7=L#
M)]       =[1110!SNO^ ?#GBF\2[U?1;'4KE$$2RW,*NP0$D+D]LL3^->8_
M%3P%X<\*WG@&[T?1+'3;E_%>GQ-);0JC%"7)7([94'\*]PKS#XZ?\T^_[&_3
M_P#VI0!Z?1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?&'_
M  3RN(K.]_:5GFD2W@C^*&L.\DC!5100223P !WKWCX_?M,_#[]FGPNVM>.=
M=BLFD5C::9#B2]O6'\,,.<MS@%CA5R-S"OQ#T?QI\7?VF?&'C?P!\+K75FT'
MQIXGO?$MYHMF0@_?R<?:YQ@")%VCYB$W<X)VX /N#]M#_@K%8>&_MO@OX)SP
MZMK&3#<^+BHDMK<]"+53Q*^?^6A^08X#YR/.OV-?^"9GB'XQ:POQ,^/#:A%I
MMY-]MCT6^E<:AJKL=QENG)WQH3V)WMS]T8+?3_[&G_!,WPA^SNMEXH\7FV\9
M?$-<2).T>;'37Z_Z.C#YG!_Y:L,\#:J<Y^V: /B?]HS0]/\ #?[:W['^E:38
MV^F:9:'7(+:SM(EBBAC6UB"HBJ % '85]L5\:?M4?\GX?LD_]=M>_P#2:*OL
MN@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BJ5_K%CI,8>^O+>S4YPUQ*L8..
MO4UQ^J_'KX9Z#'OU/XB^$].0+O+76N6L0V^OS..* .]HKP;Q!^W5\ /#;R"[
M^+7AF4Q@$_V?>"\'/H80^?PKE+G_ (*<?LSVKLK_ !.A8KU\O1]1<?@5MSG\
M* .9_P""@7Q^\?\ [/NK?#75_AYK$&IZSJ%Y<V3> 9-.:Z;64,>?/!C_ '@\
MDA1A2,F0>A!\N^"/[/5M^V_\+Q\2_BC\:/$/CV6]CD\SPQH-V=.TS1Y@OS6S
MP 9,BY&6PFX$'YP0QX1?V[?@M??MY:]\4_$&O7>J>%-#\.0:-X2N+72[@_O9
M 'N9O+=59&!>>++*,AN,@ UY_P#$S]N/X8_#GXV3?$[X"2ZQ97.M.8?%OA34
M+ 6^E:U&<_Z3&0Y,5P"2=VSDDMW=9 #MOV+?V4Y/$G[)ND_%7PC\6O$7PI\9
M0/?2SWZWP.CM'!/)C[3;MA2@5>23M&22K=*]"_8\_; ^*W[4WQR\.>&=5\2Z
M%X=TOPM87%]J3:;:.6\8A9&MQ+")4'EQ X8[=IW G;_#%\._"?\ :BT>\^&/
M@[X0?$2^U?1_A%HDUQJ&KV/AF,27WB"9[AIH[>1F=!'"-PR >HSUVF/V_P"+
M/_!0#X-WWQ3^!WC3X;>$O$GAFX\ WGV&[MY-/M+=)M$==DMM&([ALLJE]BMM
M7,C$D9H _9&BOSCO/^"VGPUCM9&M/ /BN>X ^2.9[:-"?=A(Q'Y&L&X_X+A>
M'5QY/PHU1_7S-9C7^41H _3JBOR__P"'XFB?]$CU#_P>I_\ &*/^'XFB?]$C
MU#_P>I_\8H _4"BOR_\ ^'XFB?\ 1(]0_P#!ZG_QBM+2_P#@MYX-FV?VC\,M
M=M?GPWV74(9\+ZC<J9/MQ]: /TNHK\ZO^'V?PL_Z$7QA_P!\VO\ \>J*?_@M
MI\,UA)@\!>+))/[LC6J#\Q(?Y4 ?HU17YN0_\%M/A\TR++\//$R1%AO9+BW9
M@.Y W#)]LBND_P"'U/P0./\ BEOB /\ N'6/_P F4 ??]%? \7_!9_X&R2!3
MH'CF)2<%VTVTP/<XNB?TK2M/^"Q/P"N)ECDC\66RGK+)I2%5^NV4G\A0!]S4
M5\?V?_!5[]FZZ\H2^+]0L]_WC-HEV=GUV1M^F:U[?_@I]^S-<2I&GQ-0,QP#
M)HFI(OXL;8 ?C0!]4T5\S_\ #R']F[S%3_A:-CN89'^@WF/S\G KI-%_;B^
M.O,@MOBWX5C+=/MNH+:C\3+MQT[T >Z45Y;#^U/\%KCB+XO^ Y3_ +'B:R/\
MI:W=-^-7P^UIMNG^._#5\WI;:Q;R'M_=<^H_.@#M:*@M;J&\A2:WECGA;E9(
MV#*?H14] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M4$US%;M&))5C,C;$#,!N;!.!ZG /'M0!/163XA\4Z-X1TYK_ %W5['1;!2%-
MUJ%REO$">@W.0*YWPC\;/AW\0+[['X7\>^&?$EWS_H^D:S;74G&"?EC<GC(_
M.@#N**KSW$5JBM+*L:LRH"S  LQ 4#/<D@ >]6* "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M I[/0!]W>(O$6E>$=%N]8US4K71]*LT,MQ?7TZPPPJ/XF=B !]37YL_M2?\
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M784$9 7?%-)TY!W$^]0V?@O]O;XN32KN^*$ F!WQWVJ2:+"PP<@K+)"F/;%
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M4_F)LTRW_P"":W[-=ONV?"ZS.>OF:E>O_.<XKZ<HH ^:?^';O[-W_1+=/_\
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MPE=R[_8=7O8U.>P3SBJCV4"N%U/_ ((Z_ 74&S!<>+=-&22MKJD9'/;]Y"W
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MN?17X=2?L[_MY^%EG6&?XBP  -(-/\9>8&XX_P!5=G<>>V:H_P#&>?A>8_\
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MBB]\/ZD6CL-0U*0 --<)%M+CCA,A1DC&&8$ ^TO@/K'BKXE?&CX/:%\;M?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7F'QT_Y
MI]_V-^G_ /M2O3Z\P^.G_-/O^QOT_P#]J4 >GT444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445
MP/Q$^._P[^$4+/XT\;:'X;=5W"WU"^CCG<8S\L6=[<=E!H [ZBO@3XO?\%C?
MA%X,6:V\%:9JWC^_4?),D9T^R)]#)*/,_*(CWKY)\3?\%$OVGOVH-6F\/_#7
M2;C1(I?E^Q^#=/DGNPA!YDN6#,G<[T\O&/K0!^O/Q/\ C3X$^#.DG4O''BS2
MO#-KM+1_;KE5EFQU$<?WY#[(":^ OCO_ ,%H-!T<W.G?"7PM)K]PI*KK7B -
M!:9[,D"D2.#_ +31GVKR3X8_\$C_ (O_ !:U3_A(/BWXLB\,-=-YEP+B<ZMJ
MLOKO8/Y8)]3(Q'=>,5]]? G_ ()[?!3X!^1=Z7X73Q!K\.&&M>(MMY<*P_B1
M2HCC/NB \]30!^:&E_"+]K#_ (**:M!JOB.XU"W\*LPE@O-<W:?I$*GHUO;J
MO[TXR-Z(Q.,,]?<O[/'_  2@^%'P?:SU7Q:K_$GQ'$0^[5(A'IT;#^Y:@D/_
M -M6<'&<"ON"B@"O;VT5G;Q001+!#$H1(XU"JB@8  '  ':K%%% !117YO?M
MZ?$/XH:1^T7#I7P$\1^)K_QDGA&XF\2Z#I^RXM+&Q5@T<\<3\)<G<WW1O.8M
MO+8(!][>,OBIX+^'*H?%GB_0?#'F#<IUG4X+3<,XR/,9<C-6/"/Q"\+?$"T>
MZ\+^)='\26R8WS:3?Q72+D9&6C8@9'-?G5IO[-O[/GC3]B7XA_%;P^]]\1/%
MS>&]0N[KQ-XHO))M2M]0CMV<K)%OV12(V"."2-IWN"&.:_[-OP>\ ?L4^ /C
M6OB'4_A%X^A\.VEQ!XE\.W<@GO[UX<K";?>!*TASD(4)&2S;5- 'ZE45^>G_
M  3_ /B5\1OC1\<O$^H?&#Q3K.F^./#FA6=O:>"F@^PVDEE.B.;Z2$'#RL?+
M)^4;3(O8JJ?H70 4444 %%<!KG[0'PN\+R>7K'Q)\(Z3)_<OM=M83^32"O+_
M !)_P41_9T\*74EO>_%/2IG0E2=-@N+Y."1PT$;J1P>0?3U% 'T?17P]XF_X
M+!? #P_=/%8OXG\2(I($VEZ4$1N3R/M$D3?F!UKR[Q1_P6]\)6MPZ^'/A?K6
MJP9^1]4U.&Q8CW5$F _,T ?IE17Y'>(/^"X'B:Z4_P!A?"O2=../^8AJ\MWC
M_OB**N)?_@JM^TU\1BT/A7PWH\#L=J?V!H%Q=N.W_+224$_,O;KCCF@#]IZ*
M_$?6/&'[?WQ?CC9X/B18PL?W?V#3#H8P>1\T<<)(QW)/UJE=?\$ZOVO/BMJ?
MF>,8KJ1Y#\UYXF\517GMEMDTK=/:@#]B?$WQV^&W@J\>U\1?$+PKH-TAVM#J
MFM6ULZG)&"KN"#D'\J\D\1?\%(/V;_#-P\%W\4;">1/^@=9W=XI^CPQ,I_.O
M@KPQ_P $3?B1=7B)XC\?>%=+M2WS2:7'<WK@9&2%>.$$XSQN'2O6_"?_  1"
M\)6=P&\3?%#6M7M_XH])TR&P<_1I'G _*@#O?$/_  65^!VE/+'8:5XQUIE!
M\N2UTZ".)FQQDR3JP&>^T_0UYCXB_P""WVBPQ[= ^%-]>28X?4M82W"GGG"1
M/GMW&<GI7M?A'_@D+^SYX;FWZA8>(?%*_P#//5]79%[_ //LL)[^O8>^?8_"
M/[$/P$\$Q1+I?PG\,R&+E)-2LA?R YR#ON-[9![YR* /S<U__@L]\7]>N3;^
M&_!?A;3/,X19(;F]G'?Y2)44G /5#^%<WJW[3/[=/Q=@8:9I_CB"PD8 #P[X
M4:W13R/]>D&\=^KXX]J_:30/">B>%+?[/HFC6&CP8 \K3[5(%P.@P@ K7H _
M#:;]DW]M_P",>GPMKT?C&_T]R<1>)/%:(J9P3^XFN-R]OX.WM71>'_\ @C#\
M9]36";5O$O@[2%DYDC-W<W$\?/.0L&PG'/#_ (U^T]% 'Y:>'/\ @A[9QF%]
M>^+<\P(!E@T[0EBP>X61YVR/<H/I7KGA_P#X(W_ C1[B.6^O_&&N*I&Z&]U.
M%(VXY_U,",!_P+MUK[OHH ^=_#/_  3Y_9W\*;38_"K19]O0:F9K_P!>OVAW
MSU[UZSX8^$?@;P24/AWP9X?T IC9_9>E06VW&,8V(,=!^0KKZ* "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH *^,/V\K/4?@YXS^&G[2FB6WVP>![EM,\1V
MD>T27.DW3",[<D E&=MH_O3!NBFOL^O-_C)\ _!OQ^L]!L?&UA-JNFZ/J2:I
M%8?:'2WGE564+/&#ME3YONL.V.A8$ ^4?AUX?U3_ (*/>+[/XC^,XFT[X":'
M?/\ \(WX-:0%]:N(F*&[OPI(V@@@1GW7[NYI///@7^RGX6_::\+?M%Z/?*NC
M:[I?Q1U>70=>LXP)M-F!7  &-T1PH:/H0!C!"D>]^)/^"?%OX;\4:AXE^!WQ
M&U[X):GJ#^9=:;I:B[TB9_4VCLH'? R57^%0.*\_\#?\$V_B-I?_  DECKG[
M1>MP:#XFU.75M;L?"^F)I\VH7,O^M=IO,.P-T*!"I]!0!\WZ=8Z5^T5\7? 7
M[/&O?#[X?^&O&GA_Q!(_C#Q=X=M+&(:Q9V:9$4#Q*K;Y@7#QCE65254!T3]$
M]2_81_9]U;_7?";PTGR[/]&M?(X_[9E>??K6=8_L"_!+2?"?A;0]/\)#2_\
MA'=3BU:RU2RN'BU$W",I9I+I3YC!]H##.  -NW:I'T90!\MW7_!,?]F>\V&3
MX80KMZ>5K&HQ_GMN!G\:YO4/^"3/[.=XH$/AK5K#YLYM]:N"<>GSLW'ZU]D4
M4 ?#UI_P1]^ %O<3RR+XHNED.5AFU90L7/1=L8/M\Q-9^I_\$:O@1?;O(U3Q
MGIV7+?Z+J=NV!S\O[RW;C]>.M?>-% 'YK^)O^"(_@2[LY%\/?$?Q%I=T6RDN
MIVD%Z@7/0HGDDG'?</I7FFH?\$0?%$>W[#\4])N.3N^T:3+%CTQB1LU^N=%
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MO#MF[9/4Y,><^] 'YX:;_P %QKR,8O\ X.PS\CYK;Q&T>!WX:U;/YBNNT?\
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M 0H(1 #]-_AWXO;X@^!="\2'2=0T ZK9QW?]FZK$(KJVWJ#LD7)PPKIJ\_\
M@)\6++XY_!OPCX\LD6&+7+!+F2!3D0S#*S1Y[[)%=<_[->@4 %%%% !1110
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M_5QIU[_IB@#$U3_@L]\$+.,_9- \;:A)M)7R]/M43=V#%KD$9]0#7R9\(_\
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M6$L_B[\7/"?@J]^%=QH<7B#4(=-34+?7?MK0R2L$C)B^S1Y7<1N.[@9/.,4
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MQD!@;[*]NWX5]\_L3?LYZU^R[\#K?P1KOB0>)+Y;Z>]\R$.+>U60*/(AW<[
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MPZJK.VU54#:B*  ,!1U.2?F76O\ @C5\#=8UB\OH=:\;:7%<S-*ME9:A:>1
M&).Q-]JS;1G W,3CN: /R7\#Z]\4?B1XLT[PWX<\3:[J&MZC)Y-I:-K;PF:0
M]$5I)%7<>@&<D\#)KLOC#\//V@_@#9Z;=?$&X\2^&H=2D>*T\_7M[3,@!?:L
M<S' #+DXP-P]17ZN?"#_ ()3_!KX-?$30_&5C?\ BG7=2T>Y2\LX-9OH'@2=
M#F.0K%!&25;##+8R!P:]E_:4_9+\ ?M6:+I&G^.+>^+:3-)-8WFG7/DSP^8%
M$B@D,I5MB9!4_=&,4 ?SU_\ "V/&_P#T.7B#_P &D_\ \77J_P ./AC^T=\8
M?#?]O^"H/&7B/1_.:W-W8ZE(Z+*N"R']YD$!E.#V(/>OU#LO^"//P"M9B\I\
M57BXQY<VJH%^OR1*<_CWKZ?^!GP+\'_L[> (O"'@G3WT_2$GDNG\Z5I99IGQ
MND=SR3A5'L% [4 ?SF_\+0\;K<-%)XUUR(J2"_\ :L[+D>ZL<_45U7PYOOB'
M\4/'&C>$]&^(=\NL:Q<)9V2W>KW<223.<(F\C +$@#.!DCFOV6U3_@EK^SGK
M&IW=_)X+N+>2ZF:9XK75;J*)"Q)(1!)A5R>%' ' XK>^&/\ P3K^ _PD\;Z9
MXM\/^#Y5US3)/.LYKS4KFX2"4=) CN5+#L2#@\CD @ _([]HKX'_ !V_9<T_
M1;GQ[XRNK1M8>5+&WL_$$]Q++Y00R-A3@!?,3))'WAC->%_\+8\;_P#0Y>(/
M_!I/_P#%U_1C\:_V=?AU^T7H^GZ9\0_#,/B*TT^9I[3=<36\D+L,-MDA=' (
M RN<':,C@5Y!_P .N?V8_P#HF?\ Y7]4_P#DF@#\AOA7\+?VCOC=HAU?P-%X
MP\1:4MPUHUY;:JZQ+,JJS(S-* " RGG^\*\G;XK>.$8J?&7B#(.#_P 32?\
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M&-]YW+CH<YQUJSX7_P""<O[0GB.^F@?X<ZCI<<5O+.9M0>.)"4C9E09;+,S
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M,.2^792!M _B%?KK10!_-7'\$?B0HP?@UXA<^K:)J7]#7Z4?L,?L&_#?XJ?
MF'6OBW\%/["\3"_GMX1/?:I9RW5JH39.\+7&4)<R+T (0$#!K]+** /YZO'G
MPO\ BCX;^(6NV]M^S_)I26E]*D-C!X:NKZWB0,0H61]XF7&"')8,#D<&O4OV
M3O"?Q/UOX^>$=-UW]GG1=1\-7M[';ZO_ &UX!BBM[>S9AYTWF20A49%RRG/)
M 7G=@_N'10!^?7_!07X-ZE\-_ _AN?X#? 3P??7=S>R)JEYI/@2QU*[M5"J8
M@D!MW&UB9-S[#MV*,C=7Q9;>,_VS;.%(;?X8:Y!"O"QQ_".R51] -.K]V**
M/F?]A"]^)'BSX(V^K_&3PM#HOC./4)H[9[C2(]/NYK4*A266%47RWWF5<!5^
M5%..<GX1^(W[0G_!0+2O'>OVMKH/BVUM8KV988=&\$0WMFD8<[1%/]DD\Q,8
MPQ=B1U-?L-10!^4_[,OQR_;G\5?'/P=I_C#0_$LGA&;4(DUC^W_"$.F6R69.
M)G\_[-$0ZIN90&Y8*,'.#]2_\%"/$G[0'AOP%X;?X#6=Y/<S7LB:O+I=E'=W
ML<>P&()&ZMA"=^YE7(*H,@$Y^LZ* /Q6_P"%E?\ !0S_ )]/B!_X3D/_ ,8K
M](OV&=:^,NN_ N*Z^.%I+:>+?M\R6WVJW2"YDL@J>6TT: !7WF4= 2JJ2,G)
M^AZ* /QZ^(WC[_@H-I_CO7H(K+Q6L"7LHB70]$@GLA'N.T0N(FW)C&"23CKS
MFNM_9G\:?MTZM\<O!T'BZU\2#PD=1B&L_P#"0:1!:VWV+/[X[_+4[PFXKM.=
MP7J,BOU8HH ^3?\ @H5)^T!'X#\.#X#"[-PU[(-9_LM8C>^7L'D[-_1-V_<5
M^;.SMNKX(_XV&?\ 50/_ "#7[4T4 ?/'[#*_&9?@7#_PO)I3XM.H3&V^U>5]
MI%EM3RQ/Y?&_?YO7G;MSS7P%\1O ?_!0?5/'FO3QWGBIK=KR7R3H>M6]O9&/
M>=AA195PF,8R V.O.:_82B@#\IOV9? _[=.D?';P;<>+;OQ)_P (BNH1_P!L
M_P#"0:Q!=6ILL_OAL\QSO*;@A49#%>0,FOJ7_@H5X?\ V@/$?@+PVGP'O+RV
MN(KV1M7BTJ[CM;V2,JHA*2.R_(&W[E5LG<AP0#CZTHH _%;_ (5K_P %#/\
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M?_!/WX _"OQ?IGBGPW\/+>SUW39!-:7-QJ5[=B&0='5)IG3<#R&VY! (P:]
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M^U:* ///@A\"O!O[._@:+PCX'THZ7I"SO=2"25I99YG #22.Q)9B%4>@"@
M 5\^^(O^"4G[/GB+7-0U-M"U:P>\G:=K6QU.2.!&8Y(13G:N2<#.!T&!Q7V+
M10!\G?#7_@F3\"OA9XZT7Q;I&BZI<ZMH]REY9?;]1>6*.=#E)-G&2K ,,\9
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MS_$&C:?KECO$GV74K5+B+<.C;7!&1GKBL*Q^"?P\TM66S\!^&;16.66'1[=
M3ZG"5VU% %/3]-M=)LXK.QM8;*TA&V.WMXQ'&H] H& /I5>X\-Z3=S/-/I=E
M-*YRTDENC,Q]22.:U** *UI9P6%NL%O%';PKG;'&H51DY. /<U9HHH ****
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MBCX"?]$B\'_^"F+_  KT'X>_#'PE\*=%DTCP;X;TOPQIDLQN7M=+M$@C>4@
MNP4#+851D\X4#M75T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M1_PTM\-_^AC_ /)&Y_\ C=>GT4 >8?\ #2WPW_Z&/_R1N?\ XW1_PTM\-_\
MH8__ "1N?_C=>GT4 >8?\-+?#?\ Z&/_ ,D;G_XW1_PTM\-_^AC_ /)&Y_\
MC=>GT4 >8?\ #2WPW_Z&/_R1N?\ XW1_PTM\-_\ H8__ "1N?_C=>GT4 >8?
M\-+?#?\ Z&/_ ,D;G_XW1_PTM\-_^AC_ /)&Y_\ C=>GT4 >8?\ #2WPW_Z&
M/_R1N?\ XW1_PTM\-_\ H8__ "1N?_C=>GT4 >8?\-+?#?\ Z&/_ ,D;G_XW
M1_PTM\-_^AC_ /)&Y_\ C=>GT4 >8?\ #2WPW_Z&/_R1N?\ XW1_PTM\-_\
MH8__ "1N?_C=>GT4 >8?\-+?#?\ Z&/_ ,D;G_XW1_PTM\-_^AC_ /)&Y_\
MC=>GT4 >8?\ #2WPW_Z&/_R1N?\ XW1_PTM\-_\ H8__ "1N?_C=>GT4 >8?
M\-+?#?\ Z&/_ ,D;G_XW1_PTM\-_^AC_ /)&Y_\ C=>GT4 >8?\ #2WPW_Z&
M/_R1N?\ XW1_PTM\-_\ H8__ "1N?_C=>GT4 >8?\-+?#?\ Z&/_ ,D;G_XW
M1_PTM\-_^AC_ /)&Y_\ C=>GT4 >8?\ #2WPW_Z&/_R1N?\ XW1_PTM\-_\
MH8__ "1N?_C=>GT4 >8?\-+?#?\ Z&/_ ,D;G_XW1_PTM\-_^AC_ /)&Y_\
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M_P"&EOAO_P!#'_Y(W/\ \;KT^B@#S#_AI;X;_P#0Q_\ DC<__&Z/^&EOAO\
M]#'_ .2-S_\ &Z]/HH \P_X:6^&__0Q_^2-S_P#&Z/\ AI;X;_\ 0Q_^2-S_
M /&Z]/HH \P_X:6^&_\ T,?_ )(W/_QNC_AI;X;_ /0Q_P#DC<__ !NO3Z*
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M^&__ $,?_DC<_P#QNO3Z* /,/^&EOAO_ -#'_P"2-S_\;H_X:6^&_P#T,?\
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MX;_]#'_Y(W/_ ,;H_P"&EOAO_P!#'_Y(W/\ \;KT^B@#S#_AI;X;_P#0Q_\
MDC<__&Z/^&EOAO\ ]#'_ .2-S_\ &Z]/HH \P_X:6^&__0Q_^2-S_P#&Z/\
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MO3Z* /,/^&EOAO\ ]#'_ .2-S_\ &Z/^&EOAO_T,?_DC<_\ QNO3Z* /,/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** &LP522< <DU^?7C;_@JA;1_M4:'\,/ NBZ7XG\-76L6.
MBW'B%KE_FFFG6.9H=HVLB;\!NC%202I!KH_^"A'PQ_: ^.GBCPOX!^%EY<Z;
MX*U"PD;Q!=&X6TM-QD"A9I0/,==N<Q)NR#RIK\YM4^!4/[-?_!0#P#\/(=5D
MULZ3XD\.M+J#Q"+S9)6M9G*H"=JAI" "2< 9- '[XZEJ%MI%A=7][<1V=E:Q
M-//<3N$CBC4%F=F/   ))/0"OS5^*'_!:32M.\3W6F?#OX>3^)["%RJ:KJ5\
M;;[1MSN9($C9MA R&9@<=5'2OOWXT?#5?C'\*?$_@A]5N-$AUZS:QFOK5 \D
M<3X#@ \'<NY>>S5XU^Q?^P[H7['-GXE-KK7_  E.JZU)'G4[BP6VDA@13B$8
M=_E+%F.",_+D':#0!PO[(/\ P4\\)?M->+8_!VLZ#)X(\77 8V,+7@NK6^VK
MEE238A63 8A"IR!PQ/%?7_C'Q-:>"_"6M^(;\XL=)L9[^X.<?NXHV=OT4U^*
MOC"31OBI_P %7]-G^%BQR:<WC#39S<Z:@,3/;^2U]<(%&"FZ*=RW1L%LX:OT
M:_X*;?$3_A7?[&OC@Q3>5>ZX(=#M^<;O/D E7_OPLU #?^"?O[5'C+]K?P%X
MG\5>*-#T?1;.PU-=-LAI0E_>.L2R2E_,=N@EBQC'4U/^W'^V]HW[(?A&Q%I%
M9Z]XXU.139:'-,5VVX)\RXEV\JG!5>FYCQD*V//?V;? OC3X2_\ !,>Q_P"%
M>V\Y^(6K:/+K=C]EA225[BZDWPLJN"I(A:(?,,?+FO@3]J#]BWXB_"CX*M\8
M/B]XCEU#QUKFNV]BVFR7/VN2-'AF=GGGR07_ '2J$0E57^(]% /UZ_9!^.E_
M^TE\ ?#GQ"U/3+?1[S5)+I'L[21GC3RKF2$8+<\B,'\:X#]N#]N2V_8QM?")
M;PD?%]YXA>Z"VZZG]B\B. 1;G+>3)G)E4 8'0\UG_P#!*S_DQWP#_P!=M2_]
M+[BOA+_@L7XVM_$7[47AGPW/.RZ;H6B0+<^6-S1R3S/)(0/7RA#0!Z?_ ,/S
MO^J)_P#EU_\ W%7Z _LS_&S_ (:*^!WA?XB?V-_PC_\ ;:SO_9OVK[3Y/EW$
MD./,V)NSY>[[HQG';-?!G@__ (**_LFZIXB@TS4_@A#X?TAI%AAU:X\.Z?.L
M:YQOF1,NH Y.SS#[&OTD\!_\(U_PB.D2>#XM-B\,W%NMQI_]CQHEHT4GSAHP
M@"X;=NXZY)H Z*BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBOEO]O[3?C9XE^&F@>'_@>^H0
M:YJVJ_9M2N-/EC@:*S\F0L6G<CR5W!/F5@QZ#.<$ \M_;4_X*?67[-_Q!MO!
M?@O2=-\9:Q:H[:TT]RZQ6,F1L@!0<R8W%AGY?E'7('W#X9U1M<\-Z5J4D:Q/
M>6D5PT:G(4N@8@?G7\^O[8/[)NH?LG:AX,TK7-<36_$6MZ8^HZBUN#Y$$GFL
MOEQLWS/C'+D#)/0=_P!]?!D,MQ\--!B@G:VGDTBW5)E4,8V,*@-@]<'G'M0!
M\3?M*?\ !6[PM\(O'>H^#O!/A67QYJ>G7!M;O4'O1;6:S @,D15':4@Y4G"C
M(."PJC^SS_P5^\-_$CQU8>%/B!X0?P'<WTR6D&K17WVBU$[-M"S*R(T*YXW9
M< GYMHR:]'_91_X)M>&_V7?BM?>.!XFF\87LEF]M:+J6G(DEF[NI:99 YRY5
M2N=H.&;GD@_#/_!7+4O#GC;]JK1=$\(6L.H^*8--AT_5?[/0,\UX\K>3 VW[
MTJHR#N?G5?X<  _;"OC[]E?]LKQ3^T=^TA\4O!R:)I%OX&\(O<16VK6PE-S<
M,+KRH-Q+E,.B2OP/X1[U[=\2/&%S\$_V;==\1:C="?4_#?AF2=YWQ^^NHK?"
M^V6D '_ J^/_ /@C[X!O/#O[-?C?QL(W;5O$NJ2K;.WS-+':Q%8SSU/G23C\
M* /JO]JS]I?P[^RS\)]1\5:S+#/J;HT.CZ.TFV34+K'RH, D(,@NV,*ON0#P
M?[!7[7>L?M?>!?$FO:QH%CX?FTK4EL4AL9GD613$K[B6Z')Q7YV?%7]CCXY>
M-OA3XZ^.7Q]\0WEKJ.DZ<L]AI5W*DMU*6D50I1/W=K$-^=BC.<@JO6OIC_@B
M/_R1?XA?]C!'_P"DR4 ?9W[0W[1'A#]F/X<W'C#QC=2):JX@M;*U4/<WLY!*
MQ1*2 3@$DD@  DFOSV_X?>7O]N><?A%'_P (]YA3_D-M]HQZ[O(V;L'.W'MN
M[UP7_!9OQS>>(/VAO"'@Y9]FG:/HB7"K(=J"XN9GWN3Z;(H>>V#7L_C;]LS]
MD)OA>GP O;/6M1\#6EO%8-JVB:8@M5>)E/GQR;Q(7+J6,BQMN)8Y.[D ^Z?@
M)\=O"O[2'PUT[QOX/N9)M,NBT4MO<*%GM)UQOAE4$A77(/!((92"00:]'KPO
M]D;X/_"KX4_#(3?!^]DU'PGKT@U$7G]H/=QSR8V%AN.$8!0K* ""F&&17NE
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MQ!L;@ID4[<X&<>@H _-'_A^=_P!43_\ +K_^XJ]Y_8Q_X*2?\-=?%:^\%?\
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MC^$OAY^S+^Q'K/A?7X[&3PGHWAM]/E6:!4_M&Y,6T,$)/[Z:8AAR2&;.>,T
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ME0)SG/VN=CTZ(30!]Y>'=#M/"_A_3-&T]/*L=.M8K.WC_NQQH$4?@ *^'?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 ?CM_P %M_\ DM'P]_[%^3_TI>OUH^'O_(@^&?\
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M_P"Q@C_])DKZQ_;2\"Z]\3/V7?B%X7\,Z?)JVNZE8+%:6<;JK2N)HVP"Q '
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MZL/A[X*_"^06EI'I/A?PMI+.EM#PL-M;Q%L#/HJ'D\GJ:^ ?^".'ANZ\2?\
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M)+);NJ*"2 ,L0.3WH _,'_@A_P#\C]\4_P#L&67_ *-DK]/_ (N?%CPW\$/
M.K^,_%VH+IVB:;'OD?&Z21CPD4:_Q.QP /4]ADU\(_\ !*3]F+XG_ #QC\0+
MSQ_X2N?#=OJ-A:Q6CSSPR"5UD<L!Y;MC (Z^M._X*H?!KXX_M ^*O"/AWP#X
M/O==\%Z39M?SS6]U#$DE_([)AE>123'$B[3CCSG]: /F'6M:^+G_  5C^/(T
M_38WT+P)I,F](I"6LM&MF./-EQCSKEP#@=6.0-J*2/U\^!/P5\.?L]_##1O
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HKX$L?V9_AO\ M-?MS?M*I\3/#\GB
M>/P^OAF/3%?4KNV%JLVFLTJJ(94R&9%.#G!R1C<<^H?\.N?V8_\ HF?_ )7]
M4_\ DF@#ZKHKY4_X=<_LQ_\ 1,__ "OZI_\ )-9W_!.'P_8^#?"?QM\,Z1$]
MKH>A?%;7=+TVT:9Y1;6T2VRQQJSDL0!W))))))))H ^O**** "BBB@ HHHH
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MU*D#:,9.<!21\&^,O^"W6I?VU,/"GPRM1I*G$4FL:BQN)!_>98UVI_NAF^M
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M3C,L3*&5!W92Y_V:_2>SNH=0M(;JUFCN+69%DBFB8,DB$9#*1P000017Y_\
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M1110 4444 %%%% !1110 452U34K71--N]0OKB.TLK2%YY[B8[4BC52S,Q[
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M>+[KPW\,O"?_  G7V>3R&UJZNFM[:24-@K#$J%Y5SP'RN3T###&7]G?_ (+
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M>-O^"W&NR:E.GA#X;:;;6"\0S:Y?232OS]YDB"!<C^$,<>IZ5X-^WE\2-?\
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MA_XR>.-/\&^.O#2^"]2U29+;3]2M;LW%G-.[;5BD#*&B+$@!LL"3SMZG]"J
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH ^%O\ @H=\6_VF_A[XG\,6/P/\/ZM=:#<V337FIZ'H U>?[2)"#$ZF*41J
M$"$':-Q=N?EKY _X:5_X*%_] CX@?^&XA_\ D&OVHHH _%?_ (:5_P""A?\
MT"/B!_X;B'_Y!H_X:5_X*%_] CX@?^&XA_\ D&OVHHH _%?_ (:5_P""A?\
MT"/B!_X;B'_Y!H_X:5_X*%_] CX@?^&XA_\ D&OVHHH _!CP;\;OVQ]+^+'Q
M$U?PYIOB]_'VJ?V=_P )9';^"HY[A/*@9;+SH#:$09A+;<*F\<_-UKO_ /AI
M7_@H7_T"/B!_X;B'_P"0:^TOAG\6/!'PO_;J_:I'C+QEX?\ "7V[_A%/LO\
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M&_:N$VNV$6H1>'M$N-:M8IEW(+E9[>*-R.A*^>S#/0J#U K],_ '_*-32?\
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M;FQN))'9TN+>((0W&")R?^ B@#[PHHHH **** "BBB@ HHHH **** "BBB@
MK \;WFLZ9X+UZ[\.64>I^(;>PN)=-LYFVI<7*QL8HV.1@,X4$Y'6M^B@#\7[
M[]IC_@H1+>SLF@>.;52YQ#;_  \C:-.>BEK)B1[DGZU[W^PW\<?VP/&7QTL-
M&^+/AOQ W@F>VN&O;_7O"JZ2+4K$QB,<BP1!F,@1-IW<.QQQD?I+10!\+?\
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M?L?+9_!OX]23Z5INE#['X5^(#0.VFZK8+Q#%,Z@^3/&@"D-QA1D]&< ^,?\
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M5\J_\%:O@=X@^'/[0EM\7=*M9AH7B!;5VU&%"4M=1MT6,(_92R11NN?O$/\
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MG#Y#;P0<# !S7_!7'X3Z%\+?VE-,U;PU90Z.OB+24U*Z@M%$:?:UFDC>554
M*6"HQQU;<W4FOV#^ OBBZ\<? [X>>([YG>]U?P[I]_.TGWFDEMHW8GWRQK\2
M?CE\2?%/_!2K]JS2(/"GA^XLH9HH=)TZT8>:UG9K(S27-RRC  ,KNQZ*,*"V
M 3^ZW@?PO;^!_!>@>&[1S)::/I]OI\+,,%DBC6-21VX44 ;M%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110!Y]XJ_9_P#AAX\UR76?$_PW\(^(M8G"K+J&K:%:W5Q(%4*H:22,L0
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M     *^4_P#@C'X7T;QI\/?C'H^OZ38ZYI%U=Z:L]AJ5LEQ!* EP0&C<%6Y
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M4E2R(=N<94'L*[JB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ IK*&4@C(/!%.HH R/^$4T/_H"Z?_X"Q_X4?\(IH?\ T!=/_P# 6/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
E44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>cronoslogoa021.jpg
<TEXT>
begin 644 cronoslogoa021.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" #V PH# 2(  A$! Q$!_\0
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MG**XOX5_%OPG\:O"%GXG\&:W;ZYHMT/EFMV^:-N\<B'YD<=U8 BNTH ****
M"OFW]IO]N[X>_LI^)M)T+QE8Z]=7NIV9OH3I-K'*@CWLF&+R)@Y4\8-?25?C
ME_P6V_Y+?X _[%UO_2F2@#Z:_P"'S7P+_P"@1XS_ /!=;_\ R11_P^:^!?\
MT"/&?_@NM_\ Y(K\2J* /VU_X?-? O\ Z!'C/_P76_\ \D4?\/FO@7_T"/&?
M_@NM_P#Y(K\2J* /VU_X?-? O_H$>,__  76_P#\D4?\/FO@7_T"/&?_ (+K
M?_Y(K\2J* /VU_X?-? O_H$>,_\ P76__P D5=TW_@L5\ [Z8)<0^*].&?\
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MO+1T0@,LK'=F1>,>M?SZU]Z?\$9?^3J=9_[%BZ_]'V] '[:4444 %(W2EHH
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MZ1Z*^0/V-/\ @HAX-_:BCA\/ZI''X4^(2H2=(EES!>X&6>U<_>[DQGY@,XW
M$U]?T %%%% !56YNHK.WDFGD6&&)2[R2,%5% R22>@ [U:K\P_\ @K3^V--X
M>LV^"?A*^\J_OH5E\2W<#X:*!AE+0$="XPS_ .P5'1V% 'C7_!0S_@HQ>_&+
M4-0^'?PVU&6R\!PLT%_JUNY2366!P54CE;?V_P"6G4_+@5^?%%>]?LF?LB^+
M_P!K/QU_9&A+_9VA6>Q]7UZ="8;.,G@ <;Y&P=J \X)) !( /)O!O@G7_B!X
M@M=#\,Z->:]K-T=L-A80--*Y]=JCH.Y/ [U]Z_!7_@C7X^\606VH?$;Q'9>"
M+5P&.FV:"^OL8Z,01&A^C/CTK],OV=_V7O /[,?A--%\%Z0D%RZ 7NL7 #WM
M\P_BEDQTSR$&%'8"O8* /BCP3_P2.^ 'A:"+^U-/UOQ9<* 6EU34WC5C_NP"
M,8]CFO2[7_@GI^SK9Q"-/A3H[*.\KSR'\VD)KZ,HH ^8=<_X)K_LXZ]"T<GP
MTM+-F_Y:6-[=0,/IME _2O"/B9_P1>^&^O6\LO@GQ7KGA6]VG9'?[+^VSV&,
M(X'OO/TK]%:* /Y]?VBO^">_Q@_9SM[G4M2T9/$?AB'+-KN@EIXHE]94P'B'
MJ67;_M&OF&OZHY(UD1D=0RL,%2,@CTK\W/V]/^"8>E^,--U/X@_!_2X]-\21
MAKG4/#%HH6#4!U9[=1Q'+WV#Y7[ -]X _.']FS]IWQK^R[XY@\1>$[TFVD95
MU#1YV)M=0B!Y21>QZ[7'S*>G&0?WO_9Q_:)\)_M-?#2Q\8>%+C,;_N;[3I2/
M/L+@ %H9!ZC.0W1@01UK^;::&2UF>*9&CD1BKHXPRD<$$'H:][_8L_:LU;]E
M/XN6>NQ22W'A?4&2UUW35.1/;Y_UBC_GI'DLI^J]&- ']$M%9?A_7M/\5Z#I
M^LZ3=Q:AI>H6\=U:W4#92:)U#(ZGT((-:E !7XY?\%MO^2W^ /\ L76_]*9*
M_8VOQR_X+;?\EO\  '_8NM_Z4R4 ?G)7ZU_LJ_\ !,7X.?&;]G?P-XU\0/XC
M&LZQ8?:+H6FHI'%OWLORJ8S@84=Z_)2OZ(O^"?/_ "9E\*/^P3_[5DH \A_X
M<Z_ +_GIXL_\&J?_ !JC_ASK\ O^>GBS_P &J?\ QJON2B@#X;_X<Z_ +_GI
MXL_\&J?_ !JC_ASK\ O^>GBS_P &J?\ QJON2B@#X;_X<Z_ +_GIXK_\&J?_
M !JN5\6?\$6?A1J<3MX?\7^*M#G(^7[2\%Y$/^ ^6C'_ +ZK]#J* /PX^.W_
M  25^+OPKM+C5/"\EI\1](A!=ETI#%?*H[_9F)W?2-G/M7Q3>6<]C=36UQ"]
MO<0L4DAD0JZ,#@JP/((/&#7]3M?$'_!0C]@;2/V@?"FH^-/!NFQV/Q.T^$S_
M .CH%&LQJ,F&0#K+@?(_7.%/!!4 _$;2=4N]!U.TU#3[J:QU"TE6>WNK=RDD
M4BG*LK#D$$ @BOW>_P"">/[9*_M3?#.6QUV2./Q_X>5(M41 %%W$>([I%'3=
M@A@. P[!E%?@Q-"]O*\<B-&Z$JR.,$$=01V->W?L5_'2X_9W_:,\*>*3.T6D
MR7"Z?JR _+)93$+)D=]ORR#WC% ']&=%1JRR*&4AE(R".AJ2@ K+U_7M-\*Z
M+?:QJ]]!IFE6,+7%U>73A(H8U&69F/   K4K\:O^"IW[:TOQ)\77?PC\(7^/
M".BS[=8NK=^-1O$/,61UBB(QCHS@G^%30!QW[>'_  46US]HK4K_ ,&^"KFX
MT3X:1.8W*$QSZS@_?F[K%W6+OP6R<!?AVBOJW]B?]@KQ1^UGK!U2Z>7P]\/K
M*7R[S6RF7N'&,P6P/#/CJQ^5,\Y.%(!\^_#_ .&?BOXL>(X=!\'^'[_Q%J\W
M*VNGP&1@/[S$<*H[LQ '<U]]?!O_ ((O^,O$4$%]\2?%EGX3B?YFTO2HQ>W0
M'HTF1&A_W=XK]/O@S\"? _P!\)Q>'? N@6VB6*@&:6,;I[IP,>9-*?FD;W)X
MZ  <5Z+0!\6>"_\ @DG^S[X7AB_M+2=9\53H!F75-4D0,?7;!Y8_#FO2+?\
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M\XU?>G_!&7_DZG6?^Q8NO_1]O7P77WI_P1E_Y.IUG_L6+K_T?;T ?MI1110
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M[UK4+J_OKJ6\OKJ5II[B=R\DLC$EF9CR22223ZU]6_\ !4;XL7'Q._:U\26
ME9]+\+)'HEI'GA60;ICCU,KN/HH]*^2[>WDO)XX8HVDFD8(B*,LS$X  [DF@
M#?\  /P]\1_%#Q59>&_">CW?B#7+P[8;*RCWNWJQ[*HZEB0 .217Z1? O_@B
MW=7MG;ZA\5_%S:=(^&;1/#@5W4?W7N7!7/J%1AZ-7V'^PG^R'I'[+'PILDGL
MXI?'>L0)<:[J14&0.0&%LC=HX^F!]Y@6/4 ?3E 'RSX-_P""9O[.O@VW15\
M1:U.O6XUF\GN68^ZEPGY**](LOV1?@EIL7EV_P )?!J#_:T2W8_F4->O44 >
M.ZE^Q_\  _5H]EU\)?!S#&,IHL"$?0JH->5>.O\ @EO^SOXWA?R/"%QX8N&!
M N=#U"6(K[A'+Q_^.U];T4 ?CM\?_P#@CAXO\(V=QJGPN\01^,[2(%SH^I(M
MM?X&>(W!\N4^Q\OV!K\]/$'A[4_"NM7FCZUI]SI6JV<AAN;.\B:*:%QU5E8
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M(_X*:_"*U^$?[6GB1=.@%MI?B&*/7K>)5PJM-N$P&/\ ILDIQVW"ODZOT?\
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MT_X)Q?L[0_ ']G#1I+RU$/BCQ.B:SJKL,.N]<P0GT$<9''9F?UKZKH ****
M"BBB@ HHHH **** /B#_ (*5?L56W[0'@&X\;^%M/3_A8OA^W+A8EPVJVB@E
MH&Q]Z11DQGKG*_Q#'X<%2I((P1U!K^J:OP;_ ."GO[.T7P)_:*N]3TFU%MX:
M\7(VK6:(N$AG+8N8AV&'(< =!*H[4 <Y_P $\_VEYOV;_P!H'2KB]NO)\)>(
M&32]:C8_(J,W[N<^AC<@Y_NEQWK^@16# $$$'D$=Z_E:K^A3_@GK\9Y/C?\
MLK>$-3O9_M&LZ7&=%U!V.6:6WPJLWNT9B8^[&@#Z4HHHH _F3^/O_)=OB/\
M]C)J7_I5)5[]F;_DXWX6_P#8T:9_Z51U1^/O_)=OB/\ ]C)J7_I5)5[]F;_D
MXWX6_P#8T:9_Z51T ?OI^UA^S7HO[4GPAU+PAJ>VVU)0;G2-49-S65VH.Q_7
M:<[6'=2>X!'\\_Q \!ZW\,?&FL^%/$=BVFZWI-RUK=6S_P +CN#W4C!##@@@
MC@U_4%7P#_P5&_8O_P"%S^"Y?B9X1L?,\:^'K<_;K:!,OJ=BN20 /O2Q#)7N
M5W+R0HH _)?X'_&;Q!\ /BAHGCCPQ<>5J6FRY>%B1'=0GB2&0#JCKD'TX(Y
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M1R*6@ HHHH **** "BBB@ HHHH **** "BBB@ K\<O\ @MM_R6_P!_V+K?\
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M+>3J%@6Q'>VC$>9"WU !4_PLJGM7Z.?\%8/V+SXJTFX^-7@VP!UC3H0/$EG
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M*MV@)SC@G']:_GW#/V>/@Y=)?DSY:G[M17[H^SQ2TU?NBG5_0D=CZD****H
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M78<#"CO7Y(5_1%_P3Y_Y,R^%'_8)_P#:LE 'DO\ PYZ_9_\ [GBC_P &H_\
MC='_  YZ_9__ +GBC_P:C_XW7W!10!\/_P##GK]G_P#N>*/_  :C_P"-T?\
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MJ^#OAWX]?#/7/ _BBV^T:5J<)02*!YEO*.8YHR>CHV"/I@Y!(H _F6K]D_\
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M[_@II^S?H,+.?B-#?N.D5AIUW,Q_$18_6O!_B5_P6E^'FB6\T/@;PAK?B:\
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M"%IX8\&:):Z#HEJ/W=O;+R['J[L?F=SW9B2?6NQH **** "OQR_X+;?\EO\
M '_8NM_Z4R5^QM?CE_P6V_Y+?X _[%UO_2F2@#\Y*_HB_P""?/\ R9E\*/\
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MNWQ'_P"QDU+_ -*I*O?LS?\ )QOPM_[&C3/_ $JCJC\??^2[?$?_ +&34O\
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MU]Z[\?I7Z'DO#:P[5?%:S6RZ+U[L]7#X3D?/4W';12T45^@'IA1110!\1?\
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MX(S_  >\/S)-XCUWQ+XJ<$9A:>.S@;ZB-=_Y/7Z 44 >7?"O]F7X6?!.-/\
MA"? VCZ%<*,?;([<271'O.^Z0_\ ?5>HT44 %%%% !1110 4444 ?$'BS_@D
M?\%_&7BK6=?O]6\7+>ZK>S7\ZPZA $$DLC.P4& D#+'&2:D\&?\ !)?X,^ _
M&6A>)=.U;Q<^H:-?P:A;I/?P-&TD4BR*& @!*Y49 (XK[;HH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &?JFIVFA:==
MZA?74-E86L;33W5Q((XXD499F8\   DDU^=O[0'_  6.\*^#]4NM(^%OA_\
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MP_Z$SP=_X 7G_P D5R7[1@#?\%8B" 0?&FB9!&0>+2OW!_LZV_Y]X?\ OV*
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M$<^X:5W'H5!K]NJ_''_@B?K%M:_&SQ[IDD@6YN] 2:)2>6$=P@;'_?P5^QU
M!17SQ^W%\&/''QW^!K^%OA_J<.D>(#J-O<BYGO9+1?*3=O&^,$\Y'&*_/'_A
MU_\ M6_]#]IG_A37O_QJ@#]E:*_#/XW?L3?M%_ 'X9ZQXY\4>/;8Z+I?E><+
M+Q'=R3,9)%C4(K(H)W..XXS7W'_P2!UO4?$/[,>LW6J:C=ZG<KXFN4$UY.\S
MA1!;X +$D#D\>YH ^Z:*** "BBB@ HHHH **** /Q\_X+<?\E<^''_8#F_\
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MQ_R5SX<?]@.;_P!*#7ZD_ G_ )(?\//^Q=T[_P!)HZ_+7_@MT?\ B[WPX_[
M<W_I0:_4KX$'/P/^'A_ZEW3O_2:.@#NJ_(3_ (*L?LQWOPJ^(EA\=?!*RV%G
MJ5Y&VJ26>5:QU)2&CN01]T2%<D]I%SU<5^O=<I\2_A[HGQ8\!:WX/\1V@N]%
MUBU>UN8N^".&4]F4X93V*@]J /(?V(?VHK3]J?X+V&N2O'%XJTW;8Z]9Q@+L
MN0O$JKV20#</0[E_A-?1-?A%\+?%WBC_ ()F_MCW^CZ\9KCP^LPL]42-3LU#
M3)&S%=1KW91AQZ$.F>37[E:%KEAXFT:QU?2KN&_TR^@2YM;J!MT<T3J&5U/<
M$$&@#3HHHH **** "BBB@ KXJ_X*K?L_77QF_9U?7=(MFN=>\&SMJB11KN>6
MT*[;E0/90LG_ &R/K7VK44D:R(R.H96&"I&01Z4 ?FS_ ,$C/VLM/UKP6GP5
M\17RV^NZ4TD^@M.^!=VK$N\"D]7C8LP'=&X^X:_2NOR6_;0_X)B>)?"?BJ[^
M(_P)BGN+,S?;IO#NGR&.\T^;.XR69!!9,\A%.]>B[A@+PWPJ_P""N'Q>^$BC
MP_\ $3PU!XRDLB(G;4-^G:DF.-LC!2K'W:/=ZDT ?M%6?JVJ6>@:9=ZCJ-W#
M8Z?:1-/<75Q($CBC499F8\   DDU^8.J?\%PK?["?[,^$<HO".#=ZZ/+4_18
M,D?E7SIXV_: _:0_X*+:ROA'0]*N)-!:92^B^'X6@L(^>'NIV/('!_>/MSR%
MS0 S]I#XA:K_ ,%$/VSM*T'P8DTFAF5-$T9G4X2U1BT]XX[ _O)#GG8J@\BO
MW"\'^&+'P3X5T;P]ID?E:=I-G#8VR>D<:!%_117S%^PE^P?H_P"R7H,^K:K-
M!KGQ#U2$1WNI1*?)M(L@_9[?/.W(!9S@L0.  !7UO0 4444 %%%% !1110 4
M444 ?AW^UK:ZA^R3_P %'#XY6U=].EU>W\4VP5<"X@E;_2$!Z9W"=/R]:_:7
MP?XLTGQ]X9TKQ%H-]%J6C:I;)=VEU <I)&XR#_B.H.0:\'_;B_8[TK]KGX<P
MV4<L.E>,M)WS:+JDJ9568#?!+CGRWPN2,E2 P!P0?R\^&_[0W[07_!./Q)<^
M#-:T:0:'Y[2'0==C9[*0YYEM)U/ ;KE&*D]5)H _=JJ&J:G::)I]U?WUU%9V
M-K$TT]S.X2.*-02S,QX  !))]*_,&'_@N#;?V6IF^$4G]I;<$1Z\/))]<FWS
MCV_6OGKXM?ME?'O]O74/^$ \*Z%+:Z->, _ASPU&[F<9R#=3MU0$9.=B<9(X
MS0 ECJ$O[<__  4FMM2TN.6?0;O78KA7*XV:79!?G8?P[TB'!_BD ZU^Z=?(
M7[ /[#MK^R=X4NM6UR6#4?B)K<2K?W$!W164(.X6T3'KS@NW\1 QPH)^O: "
MBBB@ HHHH **** "BBB@#\,OVDH(;W_@JQ+!<0Q7$$WC+14DAF0.CJ1:@JRG
M@@C@@U^S_P#PJ+P)_P!"5X=_\%4'_P 17XQ?M&,/^'L1.1C_ (331/Y6E?N7
M0!R/_"HO G_0E>'?_!5!_P#$5OZ5H]AH=J+;3K&VT^W'2&UA6-!^"@"K]% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 5GZQH>G^(]/DL=5L+74
M[&48DM;R%98G'NK @T44 >1ZA^Q7\"-4O'N;CX2^$C,_+>7I<<8)^B@#]*[W
MP+\)_!7PRMV@\(^$=$\-(1M8:5816Y8>Y103^-%% &OX@\.Z3XPTNZT?6M,M
M-8TR;:)[*_@6:&4 AAN1@0<$ \CJ!5;PKX*\.^ -+>Q\,Z%IOA[3WD,[6NEV
MD=M$7P 6V( ,D #/L*** .AHHHH **** "BBB@ HHHH X[QC\*?!/C^\MY_%
M/A'0_$ES"ABAFU;3H;EXT)R54NI(&><"NBT^TM]-T^VMK2".VLX8UBA@A0(D
M:*,*JJ.     *** +]%%% ''>+/A'X(^(&H17OBCP?H/B.\@3R8I]5TV&YD1
M,D[0SJ2!DDX]2:W=#T'3/"NEVFDZ/IUKI6F6Z>7;65E"L4,2]=JHH 4<] **
M* -2BBB@ HHHH **** "BBB@ KC/&_P?\"_%"-1XO\':%XFPNU6U73HKAE'H
M&=21^!HHH X73_V*?@1IMTEQ!\)?"0E0Y7S-+CD /KA@1^E>MZ+X?TSPSIL=
MAI.G6FEV$7^KM;*!88D^BJ !110!I4444 %%%% !1110 4444 %%%% !6/XC
M\*Z+XQTM]/U_2+#6]/?EK74;9+B)OJK@BBB@#R=OV)O@+-=&Y/PC\);RV[:-
M,C"9_P!T#;^&*]/\)>"?#O@+218>&=!TWP_IXQ_HVEVD=M'P, [4 !-%% '0
MT444 %%%% !1110 4444 %%%% '#ZC\'? &I^)QXDO?!/AZ[\0FX2;^UI]*@
M>Z\Q,;'\TKNW+M7!SD8'I7<444 %%%% !1110 4444 %%%% !1110 4444 %
6%%% !1110 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>cron-20201231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2020-01-31"
  xmlns:cron="http://thecronosgroup.com/20201231"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2020-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="cron-20201231.xsd" xlink:type="simple"/>
    <context id="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3f1a6d5f4cc14d9da49468102df7fa77_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i05bcebde49834f16a2e8b37499a65600_I20210225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
        </entity>
        <period>
            <instant>2021-02-25</instant>
        </period>
    </context>
    <context id="ifb8c52c55d9641488fdc94ebb5b68457_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i79fc16ab48f54844a8d5db79a213fc23_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i0451ae32e2d74c6a81c9a1a7d77aea12_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i3ea5ff615f724f79bc76ea60e882c0d6_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i0b21d84a8da64ac182924657011dc8f4_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i603e76f89c54407a82af75f4644d6617_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="ia83e6fe889b142c1b548d3c600ce2460_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="ieb4bf06122354c15966cf5343aa018a5_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i85e3d76bfda8415b975e00befcd9609f_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ie73bc389412d48679e51974a3e1e0968_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="if0a8816e9f004feb8e54373b3e932949_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i005d23eef9f84c3993929eefb19a4d19_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i96223c9bb10341f4b0f7ca7353171f06_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i98a40ef3bd8f4cb7b68cb5bc1907a1e9_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i92c8255933de4ada9ebce878a6a77405_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ia7206d1e564f417f9935a0aca534849a_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i1f1cb8c6e56c4c8cb1070c81364c66b2_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i6bfe263ed9524742b183ccc53bcccba1_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i9717dc3b24b24c93ab09a6bfa9b52c89_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i6aa79556c9a24064ab5ea55845f31f79_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic77af0ad2ca04f71b6c632243f35b62b_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i7c3d39b0ddc3421a9ef11be927b7c69c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic1710fca0e7c4f9e87a86725cf4c48ff_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i6981b713441d4cea8f87dda3a39ac2be_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i46c33a2743a34787aa9be59e8b743b3c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8918c1f902e543639e6e68f052bbd4cf_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic63015dad62149c8b50e40927b2c91c6_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia6461d38acec49bd9d6a716a38310029_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i713e37bc833e40c3bea5015df9213308_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3783dc27237d46f6944e1a9a6f65eee6_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i63eed3a7d9e2479d9b72e7dbc2a9f719_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i15d5bb5d21934b388dac2f68df18d863_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic3a267e3ba2b422fb71cbfeef4f71c1d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id9981ea6f70b413c8a8fed8d7848ea09_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie01b46877add4dd9bb362674520540d1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ieb8296c494cb4a6a89b362beeaebb94d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7f46a47fa0d44ffa9cc475bb9cb26b30_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ief7afcb557114192867857af1fa9165f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i05ebae3e5a2040bca90eca82e1a3f75f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1e0536e1b0794acda99e2177b6ebf26b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cron:AltriaInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7926d13ed9d346928f338c20da686971_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cron:AltriaInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ia490cd7402e84baa81df3299a30e84ee_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cron:AltriaInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="idb90674122f048f78e4d13f37583db9f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cron:BoughtDealOfferingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id725b798c0734bb0a1f1ef33fa132b50_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cron:BoughtDealOfferingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i9d7cc358c6d64ac19ef8563642446a56_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cron:BoughtDealOfferingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i4a854431fb9b495d990aeb067616e389_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosAustraliaLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iaedfffab0889492f9c3a60cc78052b32_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cron:CronosIsraelG.S.CultivationsLtd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i842d385ef42842f5ab91f806ff707433_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cron:CronosIsraelG.S.ManufacturingLtd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2d2b8fcd2f794ec98a558ecf3b27cad4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cron:CronosIsraelG.S.StoreLtd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1088995f87474d32a8345b0ab39da192_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">cron:CronosIsraelG.S.PharmaciesLtd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie2c359ba7b8e4d8cbaea40e6357f543e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i375653de490b4cb88d420b09780d16c9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cron:EnterpriseResourcePlanningSystemMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia97ce75b78b64b17b8c28f247df84a87_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2b7cbfec44e1446b940a0588b9f08928_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia73a44b4f86a4aca8cc66989d375acd5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i318609520df948a58aa2a7750e70dc8f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2fa479bb16aa46068e50c07bb76855c0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i10a83eea249e41e6b2c310a65280d58b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">cron:InventoryDryCannabisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i96b88f05fde54eb48391a625a3fd6392_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">cron:InventoryDryCannabisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i233dc0b62902408388edf4319b001461_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">cron:InventoryCannabisExtractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i25af40180a094722bba3ac7b711fb022_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PublicUtilitiesInventoryAxis">cron:InventoryCannabisExtractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9d186ec4178c4ab29fa3a2fa261a681f_D20180614-20180614">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-06-14</startDate>
            <endDate>2018-06-14</endDate>
        </period>
    </context>
    <context id="i01dfe784ae954e5eabcb9849e4771b50_D20180313-20180313">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:MedMenCanadaInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-03-13</startDate>
            <endDate>2018-03-13</endDate>
        </period>
    </context>
    <context id="iff55fd87547140e8bb2f3c7af7f88e71_D20180313-20180313">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:MedMenCanadaInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-03-13</startDate>
            <endDate>2018-03-13</endDate>
        </period>
    </context>
    <context id="i08aaf1da351148dabbc15473a8372493_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:NatuEraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if0ba41d1bbbd4426a1cae1e0e667c052_I20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CannasoulAnalyticsLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CannasoulCollaborationLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-01</instant>
        </period>
    </context>
    <context id="i06abbbd3d08f420c89556e2d722f7d0a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CannasoulAnalyticsLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CannasoulCollaborationLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia530bf80f98848218e4aca2d29c92f27_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CannasoulAnalyticsLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CannasoulCollaborationLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i520015d24dc64ccb873f3a7698adf8e8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CannasoulAnalyticsLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1992c389e83f4ed89ee4289b28705c96_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosAustraliaLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i613b07197744400cbbef2fbf605f0d54_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosAustraliaLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i291f9ace020d4518924413d4644527d9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ieb8971bbe440425c985b311295f2cec9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ief35f4e5e0e14975afdc16c2f8b07671_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i578db4ab78c04e03aee4c102f9d17cfe_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:NatuEraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibe5479ec3fef4f42a9772f4fad66332d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:NatuEraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i943c6ce876d74af98e5d66bae1d75dd5_D20191025-20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cron:CronosAustraliaLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-25</startDate>
            <endDate>2019-10-25</endDate>
        </period>
    </context>
    <context id="iaa56b775900347199fb903e36ef60844_I20191025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cron:CronosAustraliaLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-10-25</instant>
        </period>
    </context>
    <context id="i8a335245090a41f88ff82b8dceb50377_D20191106-20191106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosAustraliaLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-06</startDate>
            <endDate>2019-11-06</endDate>
        </period>
    </context>
    <context id="i958145f694ac404a80377bba4d961f2a_D20191107-20191107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosAustraliaLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-07</startDate>
            <endDate>2019-11-07</endDate>
        </period>
    </context>
    <context id="ia7faa2556fad44d4a177d4471c6fe14f_D20200925-20200925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-25</startDate>
            <endDate>2020-09-25</endDate>
        </period>
    </context>
    <context id="iac8ed3a0468448b59a2da8d6539912f4_I20200925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cron:CronosGroupInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-25</instant>
        </period>
    </context>
    <context id="i6006e9a66ec247e5977546ab36704286_I20200925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cron:MucciMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-25</instant>
        </period>
    </context>
    <context id="ic3c92d00b15c48db9d6e48e737227b0a_D20200925-20200925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cron:MucciMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-25</startDate>
            <endDate>2020-09-25</endDate>
        </period>
    </context>
    <context id="i9154570513a2434988aa789c0e451da8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:WhistlerMedicalMarijuanaCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i311f8f928bf84db9989bd0476ea75d2c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:WhistlerMedicalMarijuanaCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i4403f97e12eb42dd960878337546ae3b_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:WhistlerMedicalMarijuanaCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i295d7b236249421daadace6736fa6dc7_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosAustraliaLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5f0e3243c9c049d9bd4653b87b8b4c8a_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosAustraliaLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id4252dcfecff4dad93552572230a33b7_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosAustraliaLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i06e71f94f83b4681be053f1be423964a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib057cdc4d573476488dcb0661bea31b4_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="idfa1e87dd5eb46d78d7da772e2d321bf_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i439b30240d69471792a73a83983aafc9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:MedMenCanadaInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i25b4f750539544e98240240c6d96fdc8_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:MedMenCanadaInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id9757b53f9bf46aeb73a8053c24786e3_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:MedMenCanadaInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ie83a15c30f9b4a8288e090fa665f59d3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:NatuEraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i15402ae419444f8291523f27c01226c3_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:NatuEraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ieac8a1e4f6ea44899784210564e39358_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:NatuEraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ifd770601469e44b7b5851f0d7ecea847_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic97e88f092994ad5852be234c493283e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9c04b01268f0440ca315cf7bd0d79262_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i62efa1de276f4f6f96606236e0b99714_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icb34982583f74b8dac9d2bae655597ac_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic600db9d0b4e488aa9a037277f7ff27f_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ie6f2e75489a8480f95612249b17b7e5d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:MedMenCanadaInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i056cd5603b3a4298a98af34735228c93_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:MedMenCanadaInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iec6bf60d93124adcb6973cf1ba60f17f_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:MedMenCanadaInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i07f4be74463d40aebfc7310e82d1c3a4_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ibc08a58aedc6433cab75cda9cb8d60e1_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosAustraliaLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="iefbc11d906474a07a4a0e90e2eb80824_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:NatuEraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i7de2974205334c71b88361a4a5309899_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosAustraliaLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i742245ee0f214dceb6821001350fd31d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i76e00c36f9dd4ecfbf011fe23eac8c61_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:MedMenCanadaInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic86c74eeef9d4c4f9ebc178e09fd7f92_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:MedMenCanadaInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8ac21cf5e6b74695a68d659200d9510c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:NatuEraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie8507622f9454b6d8fc0ba0f6058f27c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosAustraliaLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ica49af07e43e4dacb2f47f79e38bcf20_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosAustraliaLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2888e238471544cfb7ff8479ad7e82f6_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i51188c76d4fe446caa292dafb0517e9f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1d96cfff4a7d4ff6a748326af07ca595_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:MedMenCanadaInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i2d40be89af3b4e0497c3ad54f82f4d44_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:MedMenCanadaInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2575ae85f47848a3b4e481731644b697_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:NatuEraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5676c3dd147d44a9a8304b45e044a905_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:NatuEraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="idc5472b8d3034929a878ea801fa0b849_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CanopyGrowthCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3d744562089b40b9827f8e55fbe1e1a6_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CanopyGrowthCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i7452ef8eb84342d198c51755bf9c43a4_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CanopyGrowthCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i28dbe3b3d492406b844fa6b2d587faa3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:VivoCannabisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib1f2f8d063e648d79b58979418dad94b_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:VivoCannabisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ifecc77aba9d94529a80a42fc9ce8c7af_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:VivoCannabisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ia7d82a0c5320482da6d4bbdd7fd59a72_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:VivoCannabisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibb82fe39a45a48b684579d0e259b1be9_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:VivoCannabisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i410fb06923684e30987bfd057a982f23_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:VivoCannabisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="if177335bf723452a9e53b5cbb69619d9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:WhistlerMedicalMarijuanaCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iafde73babf68415aa902c6377f960aed_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:WhistlerMedicalMarijuanaCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i94d61440c397433cae44d842da3ca067_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:WhistlerMedicalMarijuanaCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ib3633b0f773a4aaea9ea7b4dab12ca13_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:AuroraCannabisInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i253fd691295241ea93a2245f1f94a988_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:AuroraCannabisInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3cddb3f9929c453995ab712b0ead8198_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:AuroraCannabisInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ibae6d945308c4710b0b167839c583e5e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i146b3a1d69a94438a07f9724ab5410a5_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ia2c79796c87c4829ad1e5b4215e49867_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i02c8c20a53a14d20b68fae9142fac983_D20190304-20190304">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:WhistlerMedicalMarijuanaCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-04</startDate>
            <endDate>2019-03-04</endDate>
        </period>
    </context>
    <context id="i545d2eedc49b488a858211c0dfae5d9e_D20190304-20190304">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:AuroraCannabisInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-04</startDate>
            <endDate>2019-03-04</endDate>
        </period>
    </context>
    <context id="i0b816c5b52b043c8a33c4048ab073bc3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:NatuEraSeriesALoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic325dca9bc664509ab8e9daef0295626_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:NatuEraSeriesALoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5835cd4e2e1344e38bcc3bdeeb97d893_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CronosGrowCoCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3d58e7e380fd4928a5a4aaf66fb7fa7d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CronosGrowCoCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia3dd9320d6fb49b8af36a67921315f6a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i08888a921a2b4c88b691257e4ea48e15_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6cf7bda411034052a94e3326aff296d1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:A2645485OntarioInc.MucciPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8b017704f622466f9bd013c4ae05afcc_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:A2645485OntarioInc.MucciPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="idedac3c668174711a1ce0d5786afbad3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CannasoulCollaborationLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i039760a0355f48f39de64bb56dd8ac81_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CannasoulCollaborationLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7999a4c04ba7440fac47582ee604719d_I20200724">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:NatuEraSeriesALoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-24</instant>
        </period>
    </context>
    <context id="i41bfa3763a044d118326791c2cd608f4_I20200724">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:NatuEraSeriesALoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cron:NatuEraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-24</instant>
        </period>
    </context>
    <context id="ifb88f981f5fb4f0f99e4f3ce4df9e544_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:NatuEraSeriesALoanShareOfNetLossInExcessOfCarryingValueOfEquityInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0cb79bd1f7294820b3cd4e80384aad34_I20190823">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CronosGrowCoCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-23</instant>
        </period>
    </context>
    <context id="i499c1e4218d94789b4afa9918d59c37c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cron:MucciMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic6677966de35472db8717afeb11c793f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CronosGrowCoCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4799e1f980174942a3388f2d435ce38c_I20190628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:A2645485OntarioInc.MucciPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-28</instant>
        </period>
    </context>
    <context id="i14e23009552044f48cea9a365ae91305_D20190628-20190628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:A2645485OntarioInc.MucciPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-28</startDate>
            <endDate>2019-06-28</endDate>
        </period>
    </context>
    <context id="ice5cd225a5a048c281f6386df823c5e3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CannasoulAnalyticsLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CannasoulCollaborationLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3b043767918a43bfb738d4382571bc3f_D20200401-20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CannasoulAnalyticsLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CannasoulCollaborationLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-01</endDate>
        </period>
    </context>
    <context id="if184b5d95d6e4a88b9063285a8977d46_I20190123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">cron:NonrevolvingTermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cron:CreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-01-23</instant>
        </period>
    </context>
    <context id="if5da93e8c4dd43b293a795770578b760_D20190123-20190123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cron:ConstructionLoanAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-23</startDate>
            <endDate>2019-01-23</endDate>
        </period>
    </context>
    <context id="ie5866afdb41147fba8fa4b3c1ae2fe9d_I20190308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">cron:NonrevolvingTermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cron:CreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-08</instant>
        </period>
    </context>
    <context id="i6db5a3fb2eca4f54b3f90ed1c036dd12_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i77c5346ffc2148c0ac4a76f63497a058_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie4bd7ce9c19347cdabdc7ac598cb48de_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7b7a48365daf408b8997db5c9fdc8a02_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i43d67eea34364b749f11c14c15ff8a38_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6d514a8da3584157b13f718b5294267b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i03c20e15ec0844f8b17b6c80bb9144ce_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4d68a5e2b3a0451ab19ab24066e538cd_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i78a071bcbe99463dbb1b5de598353925_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4486ec909cf8480e89364e36b9c8e464_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie7d7511be19f4566915140061bc540f6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i31a70e4a512044509cf0a927b6ac5a19_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3d156ad77f3343718374ed5a6b20465b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib956a338fe1b4ef1a233bc83863cd2d7_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i98f184049ae04decbb7e65d448f5eb64_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i08692c3f18fd499fb735fa6f9fa77a18_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cron:EnterpriseResourcePlanningSystemMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id267d45c88934cce96716b0f18048fbe_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cron:HealthCanadaLicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9aeeb3005af2414fbdd7f3f51ba719bb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cron:HealthCanadaLicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibad4f60fad3c4471be8a1d5e1b4b06a2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibae3047412c74ad68bb7c95a00bd81b4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib297b22398ba4d26b972d07a65be9bdc_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cron:IsraeliCodesLicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib5d86bf348094cd8bbbbd47d7e3b937d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cron:IsraeliCodesLicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i44555a708248410d80d185e52bcf7004_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i279d9d5ab1e349069775769d0b1a44cd_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i82c727c670f445f4ab85163fb46012f1_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cron:HealthCanadaLicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i921bbe51679241a68d142cd32305f8a5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cron:HealthCanadaLicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i708ebd12fa8d48aeaf171672ac0bad61_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i77ad87a86ffb4a1c94f873eac114b479_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0d88b9a8d8e34abdb2c9b7c1bade37bb_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cron:IsraeliCodesLicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i1e89cc544d3a428ab893432457341368_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cron:IsraeliCodesLicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i857a1897462542f5aca388daf1e74bbf_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ia2206069e8cc487aab61dab193148424_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cron:PeaceNaturalsReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5d3d1ba25f2b4f858447fd45bdf8fbad_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cron:PeaceNaturalsReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8633af9ced72481c8087e79d244f37b7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cron:PeaceNaturalsReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9d4ddac5384e48eabee1565aa6cc8a56_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cron:RedwoodReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1b13dbcbacfa4879b6f7704dc73f8b29_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cron:RedwoodReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i97b06a548fbf4c0cb61a9ab4fcb38d94_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cron:RedwoodReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i62037cbff1aa4252b5cdebcd407fdc1b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cron:BuildingAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if7021697d1b94f34b3b9af2716c9a683_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cron:BuildingAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifa29b1acea664089973579f536d4f49c_D20190308-20190308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cron:AltriaInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-08</startDate>
            <endDate>2019-03-08</endDate>
        </period>
    </context>
    <context id="i0da6f2ce11e0487499370eb2e182ebf5_D20190308-20190308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-08</startDate>
            <endDate>2019-03-08</endDate>
        </period>
    </context>
    <context id="ib551b9ef8b1d44bcb1db52c16b0f3d77_I20190308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGroupInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cron:AltriaGroupInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-08</instant>
        </period>
    </context>
    <context id="i082bd82cec0746e98c728d8765ac235d_I20190308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cron:AltriaGroupInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-08</instant>
        </period>
    </context>
    <context id="i300b4ad7da784a87a26c8cffe4e5d5c3_I20190308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-08</instant>
        </period>
    </context>
    <context id="i3c2ebabdbc694319b460f7822a98d7ec_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if23fc6b156434a4ea635f81fa026311f_I20190308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-08</instant>
        </period>
    </context>
    <context id="i4aa0595f97de4e99a81b71038dd7e232_I20190308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-08</instant>
        </period>
    </context>
    <context id="ib8b72a5bd98248bea7f4df55a0f96261_D20190308-20190308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-08</startDate>
            <endDate>2019-03-08</endDate>
        </period>
    </context>
    <context id="i6b2888ee861546ac8f47f813f636ea76_I20190308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-08</instant>
        </period>
    </context>
    <context id="i4b76c45a8a2b4fbaacb62e55f214d2cf_D20190309-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-09</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i463b1771900c4b5f931730e913e28045_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia99e808e67ba45ec9755b053b88b09fe_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i160db6daa81f47e891c5d92e0c029c65_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i27204cc81d264a0baff5a5819c885fff_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i865f9c6470f14034b9c3aa9527060924_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i23e679f22ae84a519b217df003c4e0ca_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9865e6634a1947ae934e34aee71371ad_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic39856d934ae48b2a455091b04383ffc_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie513d3f3a44c445b883b46a6064152ff_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idb22be955a4449a9a766febb73b0f3a4_D20190309-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-09</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5ea1386c2a494e8fb6de3793f9261b99_D20190309-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-09</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i813499ada2bf48288695564490d30842_I20190308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
        </entity>
        <period>
            <instant>2019-03-08</instant>
        </period>
    </context>
    <context id="i760c8d6a27604682ac45b413f79812b7_D20190309-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
        </entity>
        <period>
            <startDate>2019-03-09</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ife69a303a50649b0b6f092658ca1d499_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1002f68219ae43b4be932a6273264a7c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0ffe884f9b2344429d5d6c7f367928f0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6c71bcd46a354ef48c615d33719c2f24_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">cron:MeasurementInputSubscriptionPriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8c0529bb277d40f3b988874534a3c039_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">cron:MeasurementInputSubscriptionPriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic392ce3b66a344a49d1bf576e9ecd60b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">cron:MeasurementInputSubscriptionPriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i62783d3a67304a879fa26fcc257f00d9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic1a12f35121a4490a0b734503d514f44_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i53eb710ebdeb422f9560e5ed4459a65e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6e8fcd467ee0424da748f3c4e639ee5e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i03121ba616544c3e9f4c72c77224e550_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if4a40de9976a4a6ea2c284a6a976c110_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if1d01fc2d35c4475a2aba575ab42c8f4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7b526944dcae4dbfaef739d5f4926f50_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id20cab244ae5423b89f1fbb3f050e58c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibaa2909c766b4db18adc05215c8e5054_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6e6e6f6026a74efc8e2d8819d52b47dd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib82c5acab2a34945829d6e887a154631_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i532650c252fe40e8944dc186a1e32d95_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8e7fd630e9344584911653a57e1cade2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib31c0e699cee4523929ffe9f0cb71ec3_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8dad115f7a854f8f8535c69c691a66bd_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">cron:MeasurementInputSubscriptionPriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6ac25230d48a4dd3b8c55100b4962584_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">cron:MeasurementInputSubscriptionPriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i090d89e22cd84b90b9d10cc6c3747232_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">cron:MeasurementInputSubscriptionPriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie2f5b74993ca4afe861ba1252b560ab3_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ifc02dbc8bf0d4565843b395d0dac82d6_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i67d90ff5508a41d4a7e560c59d4cd97f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i511f22de5c4141928962bdab9879ecea_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0dce3d6d45ea4267a21a2a0361da3f85_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i51f073ba36984f5c87fd937fb7d24eff_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i8ee40ca46ccd4085930f0437fb342632_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1911ee2c91ef4dd592addb1a63a0fc20_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i49e6ac7b6f4a43adb3596a15ec175f15_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i84cef257e8654992885dbc495e97fa6a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i375b8aad8904491db84b8c4c1e23cc5d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="idcfe25f7b5d4403ea6a60531b21489be_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic9ab5c8a35da422c8b07919b72494b75_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreEmptiveRightsAndTopUpRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i449c71c0a6bc41a7843b95924704320f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreEmptiveRightsAndTopUpRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib8c37aaed6534f7495f7b25106f852b4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreEmptiveRightsAndTopUpRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3afed61a87ba4d3e991bdb186e51a8eb_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreEmptiveRightsAndTopUpRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8eb7b029c40f44a1a5f9d5ceb456ed65_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreEmptiveRightsAndTopUpRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7ee5cf3f81f746e9a91d18e6efa4e418_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreEmptiveRightsAndTopUpRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i60f16583657641d1bc65b04b7fcc0429_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreEmptiveRightsAndTopUpRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i301270b5b8644233a9dc1ae42d07c539_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreEmptiveRightsAndTopUpRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ica622cb684474ab3a25d8fbc0860181c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cron:AltriaInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1db6dad47a0c48f9ba16df4ee15bdba5_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cron:AltriaInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i7d7e063426374ebba0b27e029f93204e_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cron:AltriaInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i9d8d3d9a698948f2a7e5b7ede9faa261_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cron:RedwoodAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i399c1d0125d94144839ad09cbfcd4e79_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cron:RedwoodAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i63b115fac3df4d088ed98d2fe12e8da5_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cron:RedwoodAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i7a93d4ff964040f3961be26878cf2aa6_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6385655ed7694227b1ba4c2470a26f37_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i548a898f85674e398f117c44d298a956_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="id6e6569c5b684d46b2b88bc879497620_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cron:BoughtDealOfferingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib38f7a8880414aad875a0b362cbe2fb4_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cron:BoughtDealOfferingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i7104c544b41946c8a7fe225376901625_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cron:BoughtDealOfferingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="id02c7b0ce1ec47f5935d8d2f571108bb_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cron:AdditionalPaidinCapitalAttributableToConvertibleOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cron:AltriaInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i6846a599dce44a4fb34169f67a53da26_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cron:RedwoodAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib7c7fb20be7a4bf1a45f16645365481c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5a6b2b55f141445980be073e905ff0d2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1572dfef042a4da7bc0274d5c4a15278_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5372334bf7d347cba8a470a7ae7e08dd_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3ce6c21c99f24cd2ae50be03fc1ea89d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id7d681ac03c543518d1de73a1d3b5d6d_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="iec84f453bb6e43d7a3cafa4dad5299d9_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i7708af5c622544439ec18767fd24a5c0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">cron:GrantedMay132016ThroughMay272016Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i759cd2f5c6b540b9be3e774364a54f77_I20180628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:A2015StockOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-06-28</instant>
        </period>
    </context>
    <context id="i129cd564c18f4becbcf3f71a97fb8da3_I20200625">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:A2018StockOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-25</instant>
        </period>
    </context>
    <context id="i1cc8285673b64efc88c9004fdefdd8ad_D20200329-20200329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-03-29</endDate>
        </period>
    </context>
    <context id="i586e0fbc30bd421ea74d516bbb9228a9_D20200329-20200329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-03-29</endDate>
        </period>
    </context>
    <context id="ie390f249c16849189272940f0a025a2b_D20200329-20200329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:A2020OmnibusPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-03-29</endDate>
        </period>
    </context>
    <context id="i264457fca61240599e96951139517526_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:A2020OmnibusPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i85edbfd435fc4bd88b7c46410c6c001c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:A2020OmnibusPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i27704c0ccaf54adaa2ecfcbaad36eab2_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:A2020OmnibusPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="idd88a7bbfa5b4fe68c3c0a9725094951_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:A2018StockOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6fe8366c01de496cbedaa12a2a996bbd_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:A2018StockOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8e81bf474eba4613a2f7dd5d05f70c4a_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:A2018StockOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i441fae4c3ad14b21962491e07d5bb03d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:A2015StockOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifeb79189ae0e437a9c0cf2c3b1563883_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:A2015StockOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1906d8b8221f4c0692fad5ac1bce6483_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:A2015StockOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i5bc534f0f44f4850a59aff8f75b91db8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7b7f36b7882142ceb233b456769d9d37_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id2927e2128a7487ba8176ee60d748c59_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i0adf66dfd8f246e784087297c1693bb8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6f915fc11f2b4dae9120fe65ba8822be_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="icccaf7b279474dd2a6cc84bf9c862814_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="icac62509ad0d4163941ab71cd6a759f4_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i9958a0912be6465189458f744de7bd5e_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i6ab60c8d610648fbbd63e32c23006ba2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6ccba8359c8b4e65b7817c72779f76c1_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1ea19e5d9ee04882823da13b5fd955dc_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ica018a4c7d9446198ea249f354589bec_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i40e8761a0c0246969b0c0e0b6a135205_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i9b7d911f78814b9bab3743f845ab435a_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i48cd489dc3e441deb5021b45f107480e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5e9d2966a37a4b5092639437289a13e7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0a702c872ac7413cadbdd209e21825ba_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i7aedae1809744d5bae3e685f27c56a9b_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cron:DeferredShareUnitsDSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ie7131d8a1bc5413bafda345c71101f28_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cron:DeferredShareUnitsDSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i06da2ae72791461581a87fa5b29a9243_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cron:DeferredShareUnitsDSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9c3498dbe45c4b4283bce64a55185b1f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cron:DeferredShareUnitsDSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie21e1229f5684c4f8d8a3917015fd153_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cron:DeferredShareUnitsDSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i18703331ae024841932a2cfa20e595cd_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cron:DeferredShareUnitsDSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic2cbf1f3457444a8a066a4b33bcc0f8d_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i7504a998053c4a47a4b5953d769d1663_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i7c037c87e1ba48679175b63b96788f53_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i5d1da0bebea24f23b27907644c0febb9_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5f6976781f6547bb84cd70d81d6d70c4_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="iabcd6f2591c44b2ca171a367b14b3c94_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:GinkgoEquityMilestonesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia13ef8116a4544ff98e7741be32a6862_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:GinkgoEquityMilestonesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id8fe397a667c46d5a2f89689b2a80c59_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:GinkgoEquityMilestonesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ia107f20927684430b7ec8a2ee550479f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if4600e9c488a42d59e3c24335cbf41e9_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i8b57674317f444c9babd29a3fc8677bb_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ibbe78d1c31b04bcca9543cdd1b92d857_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:TopUpRightsFixedPriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i18896e52388e4a1da87bb89497c230c1_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:TopUpRightsFixedPriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id4dbef9b15d143eba0d9488a6bd1b6de_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:TopUpRightsFixedPriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ia16bd82ebd994d52bbf2a05aea172f78_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:TopUpRightsMarketPriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i31e5c55249cf4472837632d6378bb9fa_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:TopUpRightsMarketPriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5b93f227eda545ceb826b2485055ecd7_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:TopUpRightsMarketPriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i513a3a500da74d7f8646190b65ddac07_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:AltriaWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib5d2efd05e19469484982928396a62c5_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:AltriaWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i19d2882beeff45f18c65e01d481175ba_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:AltriaWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ibc0a4d389472474080abbcd7fc478343_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iff46fcf5fdd440e98e0b8f5a4f556a79_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i9eaef38c64244f4aaea506efaee150a7_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ie606d97d090a47379c20114ccad4b834_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8982714a235343b797d9648803250239_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i86551ed52b054f04aea18834481b512c_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i7086ea760db54de69350dc668c77abf2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib75ab85d304848018363ecdc58cac865_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic5e9647b572044ccb1b1d35cba81bf49_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i5185ab0b8710451b8f3f523f58af8d12_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cron:AOCIAccumulatedGainLossRevaluationAndDisposalOfOtherInvestmentsParentMemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iee60a63d4a4f449784f69d72f30688ce_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cron:AOCIAccumulatedGainLossRevaluationAndDisposalOfOtherInvestmentsParentMemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i732c27b4af274e05b82f35736f73db58_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cron:AOCIAccumulatedGainLossRevaluationAndDisposalOfOtherInvestmentsParentMemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i49297061d43f400ab77a586292c85f22_D20170101-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
        </entity>
        <period>
            <startDate>2017-01-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="ibd18b2c5a9374aadb38dfb21c7374eef_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cron:AOCIAccumulatedGainLossRevaluationAndDisposalOfOtherInvestmentsParentMemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib87fb7dbb00e4f129dce34dfe404bb23_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cron:AOCIAccumulatedGainLossRevaluationAndDisposalOfOtherInvestmentsParentMemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ia78503404d8e4407b9a07f1fcae6747d_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cron:AOCIAccumulatedGainLossRevaluationAndDisposalOfOtherInvestmentsParentMemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="ia325d120afc54411a40573cb6f7e7e7c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cron:AOCIAccumulatedGainLossRevaluationAndDisposalOfOtherInvestmentsParentMemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8386bc114f5f4f5fa2a6bad8bc56e82f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cron:AOCIAccumulatedGainLossRevaluationAndDisposalOfOtherInvestmentsParentMemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i991881dba0a3487e84f8602ec54ef20c_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cron:AOCIAccumulatedGainLossRevaluationAndDisposalOfOtherInvestmentsParentMemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i72e668280445401eb2261966b757145c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">cron:AOCIAccumulatedGainLossRevaluationAndDisposalOfOtherInvestmentsParentMemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ice26ccbdf6064090b029f6a08543b040_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2c9d0bafd5cc496fbef4654eb04f5f74_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ibfa3a59fdaac409b8d09b830494b7637_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="ibe4e4305d17f496991f192791dce1e14_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia6a29a184e724948a6d9fe82803de2b1_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib8e3143ddfa141b9ae6ff212b5b3329b_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ib808f60258354f1e96cf215dea381edf_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i51c8c173d2a64e9a89da94b382ba8309_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i33a15aa601734e76889c79308df5f39a_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i2810c3b010d94bdeb71d396714ecf592_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ib5ae31aceb854001ad8f87c6ab2e2250_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i547cfac932ed40edb1c94ffbbad4dcc1_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i344b2df31b18418f873d918c4651229d_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i2d7bbfdd8ccc40ebaad61885c216b6a2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:CanadaRevenueAgencyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i105f31994b814455b1dd25adfc5232aa_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i78c60b99d62646d091fd871d5b174040_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:IsraelTaxAuthorityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib74df11c3c8e445ea96958153ef913d4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:CanadaRevenueAgencyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib2d8a62a5a5c45949a4da4ef35ba51ac_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie931956074a74c9db1111bc5c10fe12e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:IsraelTaxAuthorityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i17a122330b5144cf96235a840b3602c1_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie0b8cf648fb646f3aa94a5539664bc50_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7d3fb6c71a584d88aa595b49e45b8837_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i172fd75fe227409f982d139db1b09efd_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ia5ef930d66f146f6b1ee58c6e0b38dbe_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5a2c9058e29b437fa7075ccaeaad824a_I20180904">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cron:GinkgoBioworksInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">us-gaap:ResearchAndDevelopmentArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-04</instant>
        </period>
    </context>
    <context id="i28a266ca99354d2f9478d733e4baca53_D20180904-20180904">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cron:GinkgoBioworksInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">us-gaap:ResearchAndDevelopmentArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-04</startDate>
            <endDate>2018-09-04</endDate>
        </period>
    </context>
    <context id="i53d9abb5a7964f51a7a58f6c6614d10b_I20180717">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cron:GinkgoBioworksInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">us-gaap:ResearchAndDevelopmentArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-07-17</instant>
        </period>
    </context>
    <context id="i102273991043430aac514ac6305e4708_D20181015-20181015">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cron:TechnionResearchAndDevelopmentFoundationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">us-gaap:ResearchAndDevelopmentArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-10-15</startDate>
            <endDate>2018-10-15</endDate>
        </period>
    </context>
    <context id="i2db9aaa38acc4fbfb93e36f09f0da429_D20190218-20190218">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cron:AltriaVenturesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis">cron:ConsultingServicesArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-02-18</startDate>
            <endDate>2019-02-18</endDate>
        </period>
    </context>
    <context id="i2415de0a4c0c4ecf9ed6ea9afe096828_D20191223-20191223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-23</startDate>
            <endDate>2019-12-23</endDate>
        </period>
    </context>
    <context id="i14db1abc7cd640c1ad2cba6b108454c3_I20191223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-23</instant>
        </period>
    </context>
    <context id="i26f35784de464b1abb30c3a7a284c303_I20191223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:SaleOfStockPerformanceMilestoneAxis">cron:SaleOfStockPerformanceMilestoneOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-23</instant>
        </period>
    </context>
    <context id="i835de760acba433eab0f8e5932ed1a6f_I20191223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:SaleOfStockPerformanceMilestoneAxis">cron:SaleOfStockPerformanceMilestoneTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-23</instant>
        </period>
    </context>
    <context id="ib73cebd3d2c240138864cc3020dbb490_D20200131-20200131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-31</startDate>
            <endDate>2020-01-31</endDate>
        </period>
    </context>
    <context id="i8e07a9cae5c34baeaf7df90ffc19aec5_D20210623-20210623">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-23</startDate>
            <endDate>2021-06-23</endDate>
        </period>
    </context>
    <context id="i1d5044d0f0bb4edf9f8a4a948776591c_D20221223-20221223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-23</startDate>
            <endDate>2022-12-23</endDate>
        </period>
    </context>
    <context id="i68ef62796fa04d8f960de4f0be2cd9a0_D20200311-20200312">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cron:U.S.DistrictCourtofEasternDistrictofNewYorkVs.CronosMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-11</startDate>
            <endDate>2020-03-12</endDate>
        </period>
    </context>
    <context id="i06603bc91b504293b7f98adf78675927_D20200616-20200616">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:UnfavorableRegulatoryActionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-16</startDate>
            <endDate>2020-06-16</endDate>
        </period>
    </context>
    <context id="i2d2f72aaaaf343468a4dc9aae56df2af_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cron:FourCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie3ab5c08b2f448ec82c845f60eca7697_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cron:TwoMajorCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i95dee7cb129845bf8d27987a1caa0bb3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis">cron:FourVendorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i79cb5a37ccf24867aa069dc4b34e18f3_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis">cron:ThreeVendorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i84abf62189854b468a350b1f65034a6b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie67dbd083d6c4c81b9b3a7623bbc8983_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia65c0721a7bc4c228d88b512209d7211_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iea50dbe7c8794cc8aa0b34bfe4bb4eba_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i744acfb901a1441fb9ff99ac787b5b60_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if66e6d2d74bd44d69e598ab739cad251_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9cf5ee47f74c4feeb97ec1fa3dcfc557_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic809b1e3fd7243ac9c58c7a16950ffcd_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if695526c3a384f66bf0952f4b3b10c1f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cron:AltriaPinnacleLLC.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cron:ConsultingServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i82c99c7bc6cf41bbaf798753e7523968_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cron:AltriaPinnacleLLC.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cron:ConsultingServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i56950461ca0641258302cc12456209fb_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cron:ConsultingServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id13d81de4dfa4a43aa8e25121fddb996_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cron:ConsultingServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0183de7cbf5a41d98122476254d88bc7_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cron:AltriaPinnacleLLC.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cron:ConsultingServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i9fc6d347c95c4553908e2aad286d0722_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cron:AltriaPinnacleLLC.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cron:ConsultingServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibc5cfb363b314f4d89d1c4f2a887ca7a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cron:AltriaPinnacleLLC.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cron:ConsultingServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if753a5d3b4dc49c6b14066a7f6662688_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cron:ConsultingServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i19b510e302f04461a1edc4df93c4ac57_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cron:ConsultingServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia1f93f14e6044577ba1a7b6463b04532_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cron:AltriaGroupInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cron:PurchaseOfMachineryAndEquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i91a71d7c7ae04725bf836bbfa7b9724b_D20190328-20190328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:NonmonetaryTransactionTypeAxis">us-gaap:ExchangeOfProductHeldForSaleForSimilarProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-28</startDate>
            <endDate>2019-03-28</endDate>
        </period>
    </context>
    <context id="i1b5d6b4753dd4b52ac5dc0f7319ab8cd_D20190901-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:NonmonetaryTransactionTypeAxis">us-gaap:ExchangeOfProductHeldForSaleForSimilarProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i09f6b65a08b548dea26ecf66cee73299_D20190905-20190905">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cron:RedwoodHoldingGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-05</startDate>
            <endDate>2019-09-05</endDate>
        </period>
    </context>
    <context id="ide715df8e0104988800b3158e6323d0b_I20190905">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cron:RedwoodHoldingGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-05</instant>
        </period>
    </context>
    <context id="ia1f38277cbb04c8aa6676044144d8fa7_D20190905-20190905">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cron:RedwoodHoldingGroupLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-05</startDate>
            <endDate>2019-09-05</endDate>
        </period>
    </context>
    <context id="i8b55b8b5cf3546f08aaece9738addf85_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cron:RedwoodHoldingGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i7c36b1e540204e59a5d80864743da551_D20190905-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cron:RedwoodHoldingGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-05</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ia8399af2583a41c49612e5d2b0241e7e_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cron:RedwoodHoldingGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i82d2a5bf06814c99a17bdeb480f3837f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">cron:RepurposingPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic5679f6a0de14f3187b78de4a56cf6f2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icb3e170b4cfb469091d30d5359ec73e7_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic74b0207681843f4ae87a38e8e52aa6c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ieb7e744f257046829976b63a309059b9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i73f1c6d398cd46d4acef80d0079dbfb5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i86784f31af7f422abd4f659805b08838_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4b0b9f9e9cf7455390995395ccc1002a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i158da074fdac41459e9ec56ee32c9222_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i45f14c47e08249fa81b790dc77e17686_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia9065255599649529185c91762527139_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5db08a8f1b08405081996c824923fc8d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i63f66899247a46fa95fe02f9bd08dfaa_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6d31023501b14c078a65f246b312debe_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie5954e81faf64c3ba7298da392a8d7ee_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic3097ac22f054b5ebd188c0484e23f18_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i49db693fb9be41b0a5889e6879f777d0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0b096543d02048f3936893861bbb9c57_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibbf8d53ce8964a6cb53e6e367fb6b9a5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i87e3d771deca41988f620fd82eacf084_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i28e5d16c824541219fc781472e67c692_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic24540413fdd498693ce6bf7a6976a31_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="icacdfb65bc3149b38b733a4732feeebb_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i59f625a78ed547beb8ff59308e54c2e5_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i7c61172a844842b28da319f1cee9e445_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i800f69cd597e4aeca9c474e6c7edd75b_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib13faff76de54e4d94e71c14d2ef55b9_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="idb03c1afaee344b99a3f11897f6b00a4_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i6e57dab2b0d04fc68e252c1b8917c76a_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="idd1d6f418f5d4c8e9280169b3a3fb722_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i68edd065b3774520abe09eb1c8de7c1f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i26a43a36f7b84e17a5c4a3f441a8d61b_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="icc0349f558524b69a56d1b79ef3651be_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iee19945c297442c99fabe50468a25677_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i1b5ddf61e50c4278b9972461d7753caf_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6a85a077911e4fc5bdd4f6817869ec0e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="idcea1837f8ed4b229e10b2a1aa122696_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ice17379b564a4ac8b872312066dc43c9_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ic30fa899f34b4e0785f35d709b796c68_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="iacacb166b362411ab04c61d50004c298_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i10910e1c9ff24da3a8beeb51e8fc6acf_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i80f7ba51cebb4bd485ecda47d16121b2_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i35a6164687bf4736be585df4b9716950_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i7744b3aecb5149939539b0f65c16f9e8_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="idca36084581840b492066eea650a5de4_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i0086f87b13ed455fad8a005cb0c06132_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ia5bec23ced2546878d05f11ba1514eb0_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i5f04fed468264acaba7cd3b71598765d_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i45ffa1a1923c4ad9a143f62075390ee2_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ifa76c191d29f4ff1b49de04caf646517_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ifdd45fb7a8f94242bcc47ddfad9317d5_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ie88f3bf44b8f4d0398751e5198d4d80b_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ieb62e4fdf37447a3b94f42364a71921e_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ifee12228e043414085a5b8c975e48649_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i8ffe119a68b34b9abbb2f8b5078b5b89_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ib40ea4716ab44dde9b0cc0ccf563964b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4158b30eaf8f4fb4928372059c234242_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3ce234a38db449af89d262f77eca0633_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cron:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3eb48e3b8cdf43109bd6c4aec124b38c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cron:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib2a8cc1e89df42f890fd0544f7d58036_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibacf20036dff4b1cafe624b96ee80e2b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i49c555e7906f4ba3bd9c50b3f3e63909_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i147481f9ccf54c42aab89c6b4142bc85_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iff5acdedd7bc45eda6a7ff33e8f0c2ff_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cron:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6216f2542b024e11b06a97e92eb7a918_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cron:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ibf0cace378954c33a3cfab1cad1ec952_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6a1719ab03cd42e2b05239b317a45891_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id96e82b9cf384477a9af4880138f28ff_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cron:FourMajorCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ica7d2c4edb04482398d2b6d385a68007_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cron:TwoMajorCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib5a5a7b93a18452991b71bf6eb470705_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cron:OneMajorCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ifc2b8542eb104b93bf4d861b434940bb_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cron:FourMajorCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iade5a2ef289d4446ada902ad69bd2ed7_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cron:TwoMajorCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ibc2bd3e2f45e4164b7257955608b6e46_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cron:OneMajorCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="if3eb5650187c4de5bbc98d6b7274d811_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8b7d1cb41ba640babfa7a78721a319f5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5058324201ad4dc6b28728f9d5d3d612_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i056a3d33bb7244a2b1da220202bcbb81_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cron:OGBCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibf1081084a8046e199cfa22c963ee2b1_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib0190bb591a841c1a6f34ddeea55db58_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i48cd8878f431419a9261e7d977504c74_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i483325ccf32a4f0b99f1a6f997a0eb31_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ieb6f16121fdc4f85b37accd34c0b8570_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ia5ba3e945f134460b59d45bf05722a40_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="continent">
        <measure>cron:continent</measure>
    </unit>
    <unit id="brand">
        <measure>cron:brand</measure>
    </unit>
    <unit id="venture">
        <measure>cron:venture</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="reportingunit">
        <measure>cron:reportingUnit</measure>
    </unit>
    <unit id="ils">
        <measure>iso4217:ILS</measure>
    </unit>
    <unit id="audPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:AUD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="cad">
        <measure>iso4217:CAD</measure>
    </unit>
    <unit id="aud">
        <measure>iso4217:AUD</measure>
    </unit>
    <unit id="warrant">
        <measure>cron:warrant</measure>
    </unit>
    <unit id="cadPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:CAD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="vote">
        <measure>cron:vote</measure>
    </unit>
    <unit id="installment">
        <measure>cron:installment</measure>
    </unit>
    <unit id="cannabinoid">
        <measure>cron:cannabinoid</measure>
    </unit>
    <unit id="shareholder">
        <measure>cron:shareholder</measure>
    </unit>
    <unit id="complaint">
        <measure>cron:complaint</measure>
    </unit>
    <unit id="transaction">
        <measure>cron:transaction</measure>
    </unit>
    <unit id="subsidiary">
        <measure>cron:subsidiary</measure>
    </unit>
    <unit id="business">
        <measure>cron:business</measure>
    </unit>
    <unit id="segment">
        <measure>cron:segment</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF80L2ZyYWc6ZGRlNDQ1ZWQxMzExNDBmOGJiZmYwMWVlYmM5OTgxY2EvdGFibGU6NmJiZWM2M2JjNjc5NDczZmJkNDk0ZjhmNjBkZmE4ZTYvdGFibGVyYW5nZTo2YmJlYzYzYmM2Nzk0NzNmYmQ0OTRmOGY2MGRmYThlNl8xLTEtMS0xLTA_20497f22-0134-42d3-b411-5ef8e671317c">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF80L2ZyYWc6ZGRlNDQ1ZWQxMzExNDBmOGJiZmYwMWVlYmM5OTgxY2EvdGFibGU6NmJiZWM2M2JjNjc5NDczZmJkNDk0ZjhmNjBkZmE4ZTYvdGFibGVyYW5nZTo2YmJlYzYzYmM2Nzk0NzNmYmQ0OTRmOGY2MGRmYThlNl80LTEtMS0xLTA_2ac61f07-d94f-45a1-81f1-de2346777622">2020</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF80L2ZyYWc6ZGRlNDQ1ZWQxMzExNDBmOGJiZmYwMWVlYmM5OTgxY2EvdGFibGU6NmJiZWM2M2JjNjc5NDczZmJkNDk0ZjhmNjBkZmE4ZTYvdGFibGVyYW5nZTo2YmJlYzYzYmM2Nzk0NzNmYmQ0OTRmOGY2MGRmYThlNl81LTEtMS0xLTA_436bc080-423a-4cf8-9b24-eb855df6e6b5">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF80L2ZyYWc6ZGRlNDQ1ZWQxMzExNDBmOGJiZmYwMWVlYmM5OTgxY2EvdGFibGU6NmJiZWM2M2JjNjc5NDczZmJkNDk0ZjhmNjBkZmE4ZTYvdGFibGVyYW5nZTo2YmJlYzYzYmM2Nzk0NzNmYmQ0OTRmOGY2MGRmYThlNl80LTEtMS0xLTM4NzY0_5bb0af61-a0c4-4db4-b7e5-6b730cc757ff">0001656472</dei:EntityCentralIndexKey>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i1cc8285673b64efc88c9004fdefdd8ad_D20200329-20200329"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90ZXh0cmVnaW9uOmU2MTQ3ODYxMTRhYTRjMmZiZWJkNjc4NjJjOWJjZDRhXzEyNjQ0MzgzODQxMzQy_918fcba7-c0e8-4f1e-a169-2b708f363c2a">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:AccountingStandardsUpdateExtensibleList
      contextRef="i49297061d43f400ab77a586292c85f22_D20170101-20171231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDkvZnJhZzpiYmUxMjVjMjMzNWM0NTEzYjlmZGRjMGY4Y2MyNGIzMi90YWJsZTpjODNhYjhiMmI3MTA0YzA1OTBmMzdlMWEwY2RiNWU5Zi90YWJsZXJhbmdlOmM4M2FiOGIyYjcxMDRjMDU5MGYzN2UxYTBjZGI1ZTlmXzMtMC0xLTEtMA_f0ab88a4-f8e8-45c9-b06f-6577993eb9f0">us-gaap:AccountingStandardsUpdate201601Member</us-gaap:AccountingStandardsUpdateExtensibleList>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="ib73cebd3d2c240138864cc3020dbb490_D20200131-20200131"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNzA0L2ZyYWc6NjhmMWY0NTIyZTA1NGIyMzhkMzY3OWRiMmY1MTM5ZTEvdGV4dHJlZ2lvbjo2OGYxZjQ1MjJlMDU0YjIzOGQzNjc5ZGIyZjUxMzllMV84MjQ2MzM3MjA4NTk2_dae13543-228b-4498-b030-244272ff3603"
      unitRef="number">0.3333</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i8e07a9cae5c34baeaf7df90ffc19aec5_D20210623-20210623"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNzA0L2ZyYWc6NjhmMWY0NTIyZTA1NGIyMzhkMzY3OWRiMmY1MTM5ZTEvdGV4dHJlZ2lvbjo2OGYxZjQ1MjJlMDU0YjIzOGQzNjc5ZGIyZjUxMzllMV84MjQ2MzM3MjA4NjA5_edb87455-e805-4e59-923c-cf5f165e974f"
      unitRef="number">0.3333</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i1d5044d0f0bb4edf9f8a4a948776591c_D20221223-20221223"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNzA0L2ZyYWc6NjhmMWY0NTIyZTA1NGIyMzhkMzY3OWRiMmY1MTM5ZTEvdGV4dHJlZ2lvbjo2OGYxZjQ1MjJlMDU0YjIzOGQzNjc5ZGIyZjUxMzllMV84MjQ2MzM3MjA4NjIy_ae9b14b1-d844-46f1-8f4a-2a21df7bcce8"
      unitRef="number">0.3333</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <dei:DocumentType
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xL2ZyYWc6OTE4MGRjOWM3MjdiNGQ1M2IyYzIxNDI4NzIyZTk2ODkvdGV4dHJlZ2lvbjo5MTgwZGM5YzcyN2I0ZDUzYjJjMjE0Mjg3MjJlOTY4OV84MjQ2MzM3MjEzMjE1_57f6a2cf-d73a-47e1-946a-c09335cf1996">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xL2ZyYWc6OTE4MGRjOWM3MjdiNGQ1M2IyYzIxNDI4NzIyZTk2ODkvdGV4dHJlZ2lvbjo5MTgwZGM5YzcyN2I0ZDUzYjJjMjE0Mjg3MjJlOTY4OV84MjQ2MzM3MjE4NDgx_78ca6ceb-5bff-4471-b45d-1a99a5f1f676">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xL2ZyYWc6OTE4MGRjOWM3MjdiNGQ1M2IyYzIxNDI4NzIyZTk2ODkvdGV4dHJlZ2lvbjo5MTgwZGM5YzcyN2I0ZDUzYjJjMjE0Mjg3MjJlOTY4OV82MDQ3MzEzOTYwMzc0_83e7667e-7667-4acb-998b-83f10a4d7005">2020-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xL2ZyYWc6OTE4MGRjOWM3MjdiNGQ1M2IyYzIxNDI4NzIyZTk2ODkvdGV4dHJlZ2lvbjo5MTgwZGM5YzcyN2I0ZDUzYjJjMjE0Mjg3MjJlOTY4OV82MDQ3MzEzOTYwMzc0_b13aa88c-fbae-4e0c-a48d-6c805b178149">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xL2ZyYWc6OTE4MGRjOWM3MjdiNGQ1M2IyYzIxNDI4NzIyZTk2ODkvdGV4dHJlZ2lvbjo5MTgwZGM5YzcyN2I0ZDUzYjJjMjE0Mjg3MjJlOTY4OV84MjQ2MzM3MjE4NDU0_6e8f51d3-db47-4708-ac02-b99d27a8edcb">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xL2ZyYWc6OTE4MGRjOWM3MjdiNGQ1M2IyYzIxNDI4NzIyZTk2ODkvdGV4dHJlZ2lvbjo5MTgwZGM5YzcyN2I0ZDUzYjJjMjE0Mjg3MjJlOTY4OV84MjQ2MzM3MjEzMjE5_aff03124-af84-4a4b-9d68-22b4ff5aacb8">001-38403</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xL2ZyYWc6OTE4MGRjOWM3MjdiNGQ1M2IyYzIxNDI4NzIyZTk2ODkvdGV4dHJlZ2lvbjo5MTgwZGM5YzcyN2I0ZDUzYjJjMjE0Mjg3MjJlOTY4OV84MjQ2MzM3MjEzMjIw_db84713d-c729-4f28-9cf6-dc3e282830e9">CRONOS GROUP INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xL2ZyYWc6OTE4MGRjOWM3MjdiNGQ1M2IyYzIxNDI4NzIyZTk2ODkvdGFibGU6NDA2NDFhN2M2N2YzNGY5NjlkZjhjNmUzZTJhMmYyOWEvdGFibGVyYW5nZTo0MDY0MWE3YzY3ZjM0Zjk2OWRmOGM2ZTNlMmEyZjI5YV8wLTAtMS0xLTE5NzY5L3RleHRyZWdpb246YThjNGFlNWEzODFiNDVlM2FlNWQ3OGRjNzJhOGRhZTBfNzE0NjgyNTU4MDU5Nw_2159972c-29e6-4381-8245-e8d05cd36aab">Z4</dei:EntityIncorporationStateCountryCode>
    <dei:EntityAddressAddressLine1
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xL2ZyYWc6OTE4MGRjOWM3MjdiNGQ1M2IyYzIxNDI4NzIyZTk2ODkvdGFibGU6NDA2NDFhN2M2N2YzNGY5NjlkZjhjNmUzZTJhMmYyOWEvdGFibGVyYW5nZTo0MDY0MWE3YzY3ZjM0Zjk2OWRmOGM2ZTNlMmEyZjI5YV80LTAtMS0xLTE5NzY0_0bd2e97c-c3cf-4396-b196-cca6bdc0a1b7">111 Peter St., Suite 300</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xL2ZyYWc6OTE4MGRjOWM3MjdiNGQ1M2IyYzIxNDI4NzIyZTk2ODkvdGFibGU6NDA2NDFhN2M2N2YzNGY5NjlkZjhjNmUzZTJhMmYyOWEvdGFibGVyYW5nZTo0MDY0MWE3YzY3ZjM0Zjk2OWRmOGM2ZTNlMmEyZjI5YV81LTAtMS0xLTIyMTM2L3RleHRyZWdpb246MDQ0NWRlOTU3NjYxNDc5ZGIzNTFmMDA0MzY3MjllNmNfNzE0NjgyNTU4MDU3MQ_6ae3e673-5d83-468c-bc16-edef0646d717">Toronto</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xL2ZyYWc6OTE4MGRjOWM3MjdiNGQ1M2IyYzIxNDI4NzIyZTk2ODkvdGFibGU6NDA2NDFhN2M2N2YzNGY5NjlkZjhjNmUzZTJhMmYyOWEvdGFibGVyYW5nZTo0MDY0MWE3YzY3ZjM0Zjk2OWRmOGM2ZTNlMmEyZjI5YV81LTAtMS0xLTIyMTM2L3RleHRyZWdpb246MDQ0NWRlOTU3NjYxNDc5ZGIzNTFmMDA0MzY3MjllNmNfNzE0NjgyNTU4MDU4MQ_8c5468c6-43d8-4eee-a6f1-7c894a79d16d">ON</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xL2ZyYWc6OTE4MGRjOWM3MjdiNGQ1M2IyYzIxNDI4NzIyZTk2ODkvdGFibGU6NDA2NDFhN2M2N2YzNGY5NjlkZjhjNmUzZTJhMmYyOWEvdGFibGVyYW5nZTo0MDY0MWE3YzY3ZjM0Zjk2OWRmOGM2ZTNlMmEyZjI5YV81LTItMS0xLTE5NzY3_60801c1b-52b6-402d-88e4-8a4b5d6d3586">M5V 2H1</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xL2ZyYWc6OTE4MGRjOWM3MjdiNGQ1M2IyYzIxNDI4NzIyZTk2ODkvdGV4dHJlZ2lvbjo5MTgwZGM5YzcyN2I0ZDUzYjJjMjE0Mjg3MjJlOTY4OV84MjQ2MzM3MjEzMjIy_c3dc9547-4add-4eda-9061-89ea321efef9">416</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xL2ZyYWc6OTE4MGRjOWM3MjdiNGQ1M2IyYzIxNDI4NzIyZTk2ODkvdGV4dHJlZ2lvbjo5MTgwZGM5YzcyN2I0ZDUzYjJjMjE0Mjg3MjJlOTY4OV84MjQ2MzM3MjEzMjI2_89aac688-ec7e-4ce4-851e-e1cda9b301e9">504-0004</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xL2ZyYWc6OTE4MGRjOWM3MjdiNGQ1M2IyYzIxNDI4NzIyZTk2ODkvdGFibGU6MDEwZTc5NGYwYzc0NGM4Njg2M2ZmYjZlNjZlODA1ZjAvdGFibGVyYW5nZTowMTBlNzk0ZjBjNzQ0Yzg2ODYzZmZiNmU2NmU4MDVmMF8xLTAtMS0xLTE5Nzgx_115fb417-48cf-4e62-9bee-a6117def0544">Common Shares, no par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xL2ZyYWc6OTE4MGRjOWM3MjdiNGQ1M2IyYzIxNDI4NzIyZTk2ODkvdGFibGU6MDEwZTc5NGYwYzc0NGM4Njg2M2ZmYjZlNjZlODA1ZjAvdGFibGVyYW5nZTowMTBlNzk0ZjBjNzQ0Yzg2ODYzZmZiNmU2NmU4MDVmMF8xLTItMS0xLTE5Nzg0_ef357467-3d4c-4e4b-a825-04edf1757014">CRON</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xL2ZyYWc6OTE4MGRjOWM3MjdiNGQ1M2IyYzIxNDI4NzIyZTk2ODkvdGFibGU6MDEwZTc5NGYwYzc0NGM4Njg2M2ZmYjZlNjZlODA1ZjAvdGFibGVyYW5nZTowMTBlNzk0ZjBjNzQ0Yzg2ODYzZmZiNmU2NmU4MDVmMF8xLTQtMS0xLTE5Nzg2_7ae071f4-549c-4f09-868d-5ebe95f4d485">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xL2ZyYWc6OTE4MGRjOWM3MjdiNGQ1M2IyYzIxNDI4NzIyZTk2ODkvdGV4dHJlZ2lvbjo5MTgwZGM5YzcyN2I0ZDUzYjJjMjE0Mjg3MjJlOTY4OV8xMjY0NDM4MzcyNzM4Mg_52fc3fbf-3421-45ee-a280-79dbc5398a11">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xL2ZyYWc6OTE4MGRjOWM3MjdiNGQ1M2IyYzIxNDI4NzIyZTk2ODkvdGV4dHJlZ2lvbjo5MTgwZGM5YzcyN2I0ZDUzYjJjMjE0Mjg3MjJlOTY4OV84MjQ2MzM3MjEzMjI4_878ebe3e-815e-4c91-ab7b-aca03a05d798">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xL2ZyYWc6OTE4MGRjOWM3MjdiNGQ1M2IyYzIxNDI4NzIyZTk2ODkvdGV4dHJlZ2lvbjo5MTgwZGM5YzcyN2I0ZDUzYjJjMjE0Mjg3MjJlOTY4OV84MjQ2MzM3MjEzMjI5_4ae83eb0-3c21-423c-9e97-185f7b1c256b">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xL2ZyYWc6OTE4MGRjOWM3MjdiNGQ1M2IyYzIxNDI4NzIyZTk2ODkvdGV4dHJlZ2lvbjo5MTgwZGM5YzcyN2I0ZDUzYjJjMjE0Mjg3MjJlOTY4OV84MjQ2MzM3MjEzMjMw_c0bf7936-177a-4a60-8bd1-5a1113ecb1f5">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xL2ZyYWc6OTE4MGRjOWM3MjdiNGQ1M2IyYzIxNDI4NzIyZTk2ODkvdGFibGU6MTdkMzk2M2NhNTQ2NGVlZWFlNjE2MzRlMjEzODY1ZDcvdGFibGVyYW5nZToxN2QzOTYzY2E1NDY0ZWVlYWU2MTYzNGUyMTM4NjVkN18wLTAtMS0xLTE5ODA4_e666f8f5-0a07-4242-a66a-61c3c38b287c">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xL2ZyYWc6OTE4MGRjOWM3MjdiNGQ1M2IyYzIxNDI4NzIyZTk2ODkvdGFibGU6MTdkMzk2M2NhNTQ2NGVlZWFlNjE2MzRlMjEzODY1ZDcvdGFibGVyYW5nZToxN2QzOTYzY2E1NDY0ZWVlYWU2MTYzNGUyMTM4NjVkN18xLTQtMS0xLTE5ODEx_df960d9c-2f5e-451d-bc97-df656acf7393">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xL2ZyYWc6OTE4MGRjOWM3MjdiNGQ1M2IyYzIxNDI4NzIyZTk2ODkvdGFibGU6MTdkMzk2M2NhNTQ2NGVlZWFlNjE2MzRlMjEzODY1ZDcvdGFibGVyYW5nZToxN2QzOTYzY2E1NDY0ZWVlYWU2MTYzNGUyMTM4NjVkN18yLTEtMS0xLTE5ODEz_67619078-6540-4949-8c44-0b64a4e4de14">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityEmergingGrowthCompany
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xL2ZyYWc6OTE4MGRjOWM3MjdiNGQ1M2IyYzIxNDI4NzIyZTk2ODkvdGV4dHJlZ2lvbjo5MTgwZGM5YzcyN2I0ZDUzYjJjMjE0Mjg3MjJlOTY4OV84MjQ2MzM3MjE4NDU3_e5f188c2-1be9-4afa-b0e0-601b5a5cde2a">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xL2ZyYWc6OTE4MGRjOWM3MjdiNGQ1M2IyYzIxNDI4NzIyZTk2ODkvdGV4dHJlZ2lvbjo5MTgwZGM5YzcyN2I0ZDUzYjJjMjE0Mjg3MjJlOTY4OV84MjQ2MzM3MjE4NDg2_2fe677cb-4967-4eb8-af3e-98dcf446fb56">true</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xL2ZyYWc6OTE4MGRjOWM3MjdiNGQ1M2IyYzIxNDI4NzIyZTk2ODkvdGV4dHJlZ2lvbjo5MTgwZGM5YzcyN2I0ZDUzYjJjMjE0Mjg3MjJlOTY4OV84MjQ2MzM3MjE4NDc0_d59569d1-061c-426c-96b7-5e4469a63f13">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="i3f1a6d5f4cc14d9da49468102df7fa77_I20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xL2ZyYWc6OTE4MGRjOWM3MjdiNGQ1M2IyYzIxNDI4NzIyZTk2ODkvdGV4dHJlZ2lvbjo5MTgwZGM5YzcyN2I0ZDUzYjJjMjE0Mjg3MjJlOTY4OV84MjQ2MzM3MjEzMjMy_541fecf2-6197-499b-a5f7-30cce4460403"
      unitRef="usd">1099685039</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i05bcebde49834f16a2e8b37499a65600_I20210225"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xL2ZyYWc6OTE4MGRjOWM3MjdiNGQ1M2IyYzIxNDI4NzIyZTk2ODkvdGV4dHJlZ2lvbjo5MTgwZGM5YzcyN2I0ZDUzYjJjMjE0Mjg3MjJlOTY4OV84MjQ2MzM3MjEzMjQ4_21c91b11-5f3e-47e3-bd8d-fd9c6a134f6c"
      unitRef="shares">360258680</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xL2ZyYWc6OTE4MGRjOWM3MjdiNGQ1M2IyYzIxNDI4NzIyZTk2ODkvdGV4dHJlZ2lvbjo5MTgwZGM5YzcyN2I0ZDUzYjJjMjE0Mjg3MjJlOTY4OV8yMzA4OTc0NDE5MDkwNw_f23b902d-ef00-42a4-8b97-82430825cbf1">Certain information required by Part III of this Annual Report on Form 10-K will either be incorporated into this Annual Report on Form 10-K by reference to the registrant&#x2019;s definitive proxy statement for its 2021 Annual Meeting of Shareholders, or will be included in an amendment to this Annual Report on Form 10-K to be filed no later than 120 days after the registrant's fiscal year ended December&#160;31, 2020.</dei:DocumentsIncorporatedByReferenceTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfNC0xLTEtMS0w_0a340667-7951-40da-ba35-66a9083ffd26"
      unitRef="usd">1078023000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfNC0zLTEtMS0w_0c33ab2d-63f1-4ef5-9a3c-810ea0eca0a5"
      unitRef="usd">1199693000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfNS0xLTEtMS0w_8277cb6c-8884-4958-9cb2-7a8660cee687"
      unitRef="usd">211766000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfNS0zLTEtMS0w_81d2faa6-71ec-4652-9633-23a2eb992159"
      unitRef="usd">306347000</us-gaap:ShortTermInvestments>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfNi0xLTEtMS0w_a0756496-0a08-44aa-a1f2-05e806899e3f"
      unitRef="usd">8928000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfNi0zLTEtMS0w_a2311b2b-e900-4984-bdec-0a7931e7bae4"
      unitRef="usd">4638000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfNy0xLTEtMS0w_e68c0831-a24b-470d-be4f-75d2aa0b2805"
      unitRef="usd">10033000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfNy0zLTEtMS0w_0a609705-a790-456c-9771-07d2f2b0e2f1"
      unitRef="usd">7232000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:NotesAndLoansReceivableNetCurrent
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfOC0xLTEtMS0w_de00f061-273f-4b07-a2d6-553769b4efcd"
      unitRef="usd">7083000</us-gaap:NotesAndLoansReceivableNetCurrent>
    <us-gaap:NotesAndLoansReceivableNetCurrent
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfOC0zLTEtMS0w_65bd8f13-8bc0-4e93-89b1-9f5dc39f0d86"
      unitRef="usd">4664000</us-gaap:NotesAndLoansReceivableNetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfOS0xLTEtMS0w_ac6207f4-b03e-4bc0-81a3-4bbab5b2e311"
      unitRef="usd">11161000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfOS0zLTEtMS0w_cd0181c0-45c2-4a05-82d2-5c14a36c9f06"
      unitRef="usd">9395000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:InventoryNet
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMTAtMS0xLTEtMA_415c89e2-6855-4dee-a8cb-55d9f4c32729"
      unitRef="usd">44002000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMTAtMy0xLTEtMA_82019157-4bfc-4447-ac48-b9713db62884"
      unitRef="usd">38043000</us-gaap:InventoryNet>
    <us-gaap:AssetsHeldForSaleNotPartOfDisposalGroupCurrent
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMTEtMS0xLTEtMTA3OTg_957b8ca2-c90d-4a40-bb3c-5cef5fbca86b"
      unitRef="usd">1176000</us-gaap:AssetsHeldForSaleNotPartOfDisposalGroupCurrent>
    <us-gaap:AssetsHeldForSaleNotPartOfDisposalGroupCurrent
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMTEtMy0xLTEtMTA3OTg_85aafe41-bf15-43f1-98c2-8e9530727db8"
      unitRef="usd">3248000</us-gaap:AssetsHeldForSaleNotPartOfDisposalGroupCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMTEtMS0xLTEtMA_f16662bb-3eac-43b7-8d8b-6b468a6f1084"
      unitRef="usd">1372172000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMTEtMy0xLTEtMA_07741b26-3faf-44f9-9009-24db206d7601"
      unitRef="usd">1573260000</us-gaap:AssetsCurrent>
    <us-gaap:EquityMethodInvestments
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMTItMS0xLTEtMA_3a9fa729-e642-46fc-9217-80e5d15f382f"
      unitRef="usd">19235000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMTItMy0xLTEtMA_176a82db-6dc9-470b-9236-d7d3ea2bc992"
      unitRef="usd">557000</us-gaap:EquityMethodInvestments>
    <us-gaap:AdvancesToAffiliate
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMTMtMS0xLTEtMA_7a489e72-44da-4f4a-a697-3270ad783bce"
      unitRef="usd">467000</us-gaap:AdvancesToAffiliate>
    <us-gaap:AdvancesToAffiliate
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMTMtMy0xLTEtMA_f426fc19-fcb1-4c8e-b2e3-70759fe6e54c"
      unitRef="usd">19437000</us-gaap:AdvancesToAffiliate>
    <us-gaap:NotesAndLoansReceivableNetNoncurrent
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMTUtMS0xLTEtMA_a47f8e0a-f538-4431-83d0-b985f9524137"
      unitRef="usd">87191000</us-gaap:NotesAndLoansReceivableNetNoncurrent>
    <us-gaap:NotesAndLoansReceivableNetNoncurrent
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMTUtMy0xLTEtMA_79143bb8-7169-4621-9b50-6dacf402dc64"
      unitRef="usd">44967000</us-gaap:NotesAndLoansReceivableNetNoncurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMTYtMS0xLTEtMA_7f1d057d-5f99-4ebd-8bc1-bcc15017e291"
      unitRef="usd">187599000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMTYtMy0xLTEtMA_5221ff38-506e-4889-a361-b644216e8064"
      unitRef="usd">159948000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMTctMS0xLTEtMA_652051a1-1ee3-462a-afe6-fab5842b8c44"
      unitRef="usd">9776000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMTctMy0xLTEtMA_dbc9dabb-c261-4d4d-be4b-a535a0318b7b"
      unitRef="usd">6546000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMTgtMS0xLTEtMA_f584e616-a6f4-4a5d-b553-bcc3dcee9794"
      unitRef="usd">69720000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMTgtMy0xLTEtMA_94d43ecd-b48c-47b5-84af-8098bd1c7a99"
      unitRef="usd">71235000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMTktMS0xLTEtMA_fc49fe16-df08-4404-9cbe-3e0a182003ed"
      unitRef="usd">179522000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMTktMy0xLTEtMA_608b6460-3ddc-42b3-89b9-064220cc2618"
      unitRef="usd">214492000</us-gaap:Goodwill>
    <us-gaap:Assets
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMjAtMS0xLTEtMA_ae87ec60-f198-4cd0-b5dd-693347d9e52f"
      unitRef="usd">1925682000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMjAtMy0xLTEtMA_e2a46784-45bf-49a5-9241-c6a9ad4c1a95"
      unitRef="usd">2090442000</us-gaap:Assets>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMjQtMS0xLTEtMA_8e0c8937-c001-4ac4-97ed-17535fec90c2"
      unitRef="usd">42102000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMjQtMy0xLTEtMA_ae2d8e0a-701f-48de-a2ad-808503fd5643"
      unitRef="usd">35301000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMjUtMS0xLTEtMA_e01b7b9b-e419-4955-aa72-3e851e84fc57"
      unitRef="usd">1322000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMjUtMy0xLTEtMA_04c2caa5-8a3c-4146-8577-ddd9ae88671a"
      unitRef="usd">427000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMjYtMS0xLTEtMA_d2c2035b-409d-4d96-80ce-8ff8af18284d"
      unitRef="usd">163410000</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMjYtMy0xLTEtMA_d5dcbf49-cd7f-40c1-9318-f3853ed34620"
      unitRef="usd">297160000</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMjctMS0xLTEtMA_72baf3f7-f5cf-4b6d-b234-0cc5747e1b88"
      unitRef="usd">206834000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMjctMy0xLTEtMA_5bedf806-8677-4660-b677-c9ad2af9261c"
      unitRef="usd">332888000</us-gaap:LiabilitiesCurrent>
    <us-gaap:DueToRelatedPartiesNoncurrent
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMjgtMS0xLTEtMA_4e9629f1-d1ae-4596-9140-ceb01a40f0bc"
      unitRef="usd">2188000</us-gaap:DueToRelatedPartiesNoncurrent>
    <us-gaap:DueToRelatedPartiesNoncurrent
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMjgtMy0xLTEtMA_a13e10c8-79a8-4ded-90bd-4072e49ab4cc"
      unitRef="usd">1844000</us-gaap:DueToRelatedPartiesNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMjktMS0xLTEtMA_963b54b6-7dd8-4610-8e1c-daaa33744753"
      unitRef="usd">8492000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMjktMy0xLTEtMA_a8584bd2-352a-41e7-a5da-283e418255d0"
      unitRef="usd">6680000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:Liabilities
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMzAtMS0xLTEtMA_02284fd7-6ffb-4363-98ee-fed2ca590dd1"
      unitRef="usd">217514000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMzAtMy0xLTEtMA_4a8d0964-7f83-484b-b141-f43df4a4a101"
      unitRef="usd">341412000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMzEtMS0xLTEtMA_bf994125-524b-467f-a561-898bad11e880"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMzEtMy0xLTEtMA_57a937e6-17cd-4abe-ae75-7bda62d7cf42"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommonStockValue
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMzMtMS0xLTEtMA_030d6cf8-63aa-4cc4-b65e-77df43789c76"
      unitRef="usd">569260000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMzMtMy0xLTEtMA_b0d849f2-438c-4c4f-902f-c1fb37890e80"
      unitRef="usd">561165000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMzQtMS0xLTEtMA_334a38a1-ea56-4ec6-a7cc-f75c0d7868d6"
      unitRef="usd">34596000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMzQtMy0xLTEtMA_c6985967-0ab8-4af8-b7cd-a69341f7e608"
      unitRef="usd">23234000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMzUtMS0xLTEtMA_57c92702-c955-4681-8ccb-57a5619fbcbc"
      unitRef="usd">1064509000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMzUtMy0xLTEtMA_b07a1411-bcb1-41bb-aa1e-b82417cb580a"
      unitRef="usd">1137646000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMzYtMS0xLTEtMA_42e22547-f369-466e-bd1f-176b6c4242ed"
      unitRef="usd">42999000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMzYtMy0xLTEtMA_ee468376-8315-4d34-9ffa-351ec470b067"
      unitRef="usd">27838000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMzctMS0xLTEtMA_7118efc8-955a-4a1b-812a-40d0736f79ed"
      unitRef="usd">1711364000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMzctMy0xLTEtMA_e2007de6-8e39-4be7-a7b7-b3edecd4466b"
      unitRef="usd">1749883000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMzgtMS0xLTEtMA_b0c8decd-53f7-415a-aa88-780fe7bb48e2"
      unitRef="usd">-3196000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMzgtMy0xLTEtMA_4a65b791-b2fa-4959-9f17-779dbed556f8"
      unitRef="usd">-853000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMzktMS0xLTEtMA_ed89c6e5-db51-4820-923f-c2bd78095aad"
      unitRef="usd">1708168000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMzktMy0xLTEtMA_4ef7da0f-365c-4015-839e-0f246d547e08"
      unitRef="usd">1749030000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfNDAtMS0xLTEtMA_3f9e68df-12dc-4df3-a967-35d3d90b6e36"
      unitRef="usd">1925682000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfNDAtMy0xLTEtMA_a7c42ea5-e639-4a2a-91cd-dd10e6e24084"
      unitRef="usd">2090442000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RleHRyZWdpb246NTRhZWU1ZTdjODkwNGYwODlhMzUxMWY2YzczNmE0ZTRfMTMxOTQxMzk1MzcxODA_a4507069-02ab-457d-b655-27abf8dbbd61"
      unitRef="usd">74000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RleHRyZWdpb246NTRhZWU1ZTdjODkwNGYwODlhMzUxMWY2YzczNmE0ZTRfMTMxOTQxMzk1MzY0MTE_4f0e82f8-b967-47e9-842f-cc363312d2d0"
      unitRef="usd">136000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:CommonStockSharesIssued
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RleHRyZWdpb246NTRhZWU1ZTdjODkwNGYwODlhMzUxMWY2YzczNmE0ZTRfMTMxOTQxMzk1MzcxODk_bb0f586c-0540-4c15-87e1-83c80bc569d8"
      unitRef="shares">360253332</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RleHRyZWdpb246NTRhZWU1ZTdjODkwNGYwODlhMzUxMWY2YzczNmE0ZTRfMTMxOTQxMzk1MzY2MjA_2cb14c3f-cc95-4c57-a8ee-4134d0b3735d"
      unitRef="shares">348817472</us-gaap:CommonStockSharesIssued>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMi0zLTEtMS0w_6e504903-dc01-4897-ade5-8b8679f9e1ea"
      unitRef="usd">54353000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMi01LTEtMS0w_a094bcaa-4801-4db5-9e6d-7036142fd4f8"
      unitRef="usd">25639000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMi03LTEtMS0w_411837db-8c08-4eb8-ab54-a4c67b25a416"
      unitRef="usd">13234000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:ExciseAndSalesTaxes
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMy0zLTEtMS0w_e470f00f-26f5-4397-9d62-945ed7b05dbc"
      unitRef="usd">7634000</us-gaap:ExciseAndSalesTaxes>
    <us-gaap:ExciseAndSalesTaxes
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMy01LTEtMS0w_e37b3b37-87e3-4b2e-81a9-a8a0e9452b16"
      unitRef="usd">1889000</us-gaap:ExciseAndSalesTaxes>
    <us-gaap:ExciseAndSalesTaxes
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMy03LTEtMS0w_dff8d81d-c929-4eff-8a62-debb6f1dfcaa"
      unitRef="usd">1113000</us-gaap:ExciseAndSalesTaxes>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNC0zLTEtMS0w_7bbdae3e-637d-47c4-b02b-8c5912d0f9cf"
      unitRef="usd">46719000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNC01LTEtMS0w_278e8696-09b9-4058-819c-fe4683d0147c"
      unitRef="usd">23750000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNC03LTEtMS0w_9c332ecd-c723-4319-acbb-1fbf91307918"
      unitRef="usd">12121000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <cron:OtherCostOfGoodsAndServicesSold
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNS0zLTEtMS0w_7e99575c-05eb-42b9-a42b-72400cd6759f"
      unitRef="usd">46497000</cron:OtherCostOfGoodsAndServicesSold>
    <cron:OtherCostOfGoodsAndServicesSold
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNS01LTEtMS0w_79fa947b-35ff-44c5-9e79-3000d5a5a543"
      unitRef="usd">12174000</cron:OtherCostOfGoodsAndServicesSold>
    <cron:OtherCostOfGoodsAndServicesSold
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNS03LTEtMS0w_4516ddbe-c161-4ce9-b149-0cb873180b1f"
      unitRef="usd">5908000</cron:OtherCostOfGoodsAndServicesSold>
    <us-gaap:InventoryWriteDown
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNi0zLTEtMS0w_08a851f2-544a-431d-823d-1dd1cafe0912"
      unitRef="usd">26055000</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNi01LTEtMS0w_7a927438-eec1-4fdc-8d1e-a54286777091"
      unitRef="usd">29173000</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNi03LTEtMS0w_070d1291-c5a3-406e-9e4f-de605ce6f1c9"
      unitRef="usd">0</us-gaap:InventoryWriteDown>
    <us-gaap:GrossProfit
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNy0zLTEtMS0w_2d13d70a-4704-416b-ba7f-87c790b5adc3"
      unitRef="usd">-25833000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNy01LTEtMS0w_b9b93a19-0ec8-4735-a39b-9504ed6fd724"
      unitRef="usd">-17597000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNy03LTEtMS0w_2a1c8463-190d-49b5-b89c-0c20e1e27cc5"
      unitRef="usd">6213000</us-gaap:GrossProfit>
    <us-gaap:SellingAndMarketingExpense
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfOS0zLTEtMS0w_cb693bb1-7ea1-43cc-9b23-d32d8cfb7ed7"
      unitRef="usd">34386000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfOS01LTEtMS0w_c8248225-75af-4b8a-9b2d-cfc9f881e33e"
      unitRef="usd">23048000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfOS03LTEtMS0w_d17ef977-48e3-4135-90a4-8719a89a959b"
      unitRef="usd">2537000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMTAtMy0xLTEtMA_fa05b824-2f63-4d26-be60-ae0f9214c01c"
      unitRef="usd">20366000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMTAtNS0xLTEtMA_5d935539-7d1a-4cf4-bb8a-d44bc37a4c8f"
      unitRef="usd">12155000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMTAtNy0xLTEtMA_c4afbfbc-aa0a-4910-a02f-931816306866"
      unitRef="usd">1814000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMTEtMy0xLTEtMA_1447e5f9-d001-433a-820c-b7e6ba7c6174"
      unitRef="usd">80529000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMTEtNS0xLTEtMA_80fe2c5a-111e-43b3-9d15-ca7079a86bd7"
      unitRef="usd">49271000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMTEtNy0xLTEtMA_0b0d248b-2e5b-4364-8e5d-c256395ba75b"
      unitRef="usd">13349000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMTItMy0xLTEtMA_6bcbfeb8-4cdd-481d-88b9-c44d2bb562d8"
      unitRef="usd">15361000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMTItNS0xLTEtMA_e2316509-2e6f-4fbf-89d4-4dd674d3b723"
      unitRef="usd">11619000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMTItNy0xLTEtMA_ce04f65d-fa02-4596-81e8-09cd0d8acb97"
      unitRef="usd">8151000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:DepreciationAndAmortization
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMTMtMy0xLTEtMA_78591308-1d4b-40d3-9085-3b8c7f1da71e"
      unitRef="usd">2872000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMTMtNS0xLTEtMA_fff50e95-c17a-469e-8adf-4c04982b13c4"
      unitRef="usd">2090000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMTMtNy0xLTEtMA_d5e0db30-afcb-4a87-91cc-688fced36cf0"
      unitRef="usd">807000</us-gaap:DepreciationAndAmortization>
    <us-gaap:RestructuringSettlementAndImpairmentProvisions
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMTQtMy0xLTEtMA_247137d6-3aba-4d85-84df-d1047bd687c5"
      unitRef="usd">0</us-gaap:RestructuringSettlementAndImpairmentProvisions>
    <us-gaap:RestructuringSettlementAndImpairmentProvisions
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMTQtNS0xLTEtMA_859669d0-4da8-4149-90a2-c9d5b3179e98"
      unitRef="usd">5328000</us-gaap:RestructuringSettlementAndImpairmentProvisions>
    <us-gaap:RestructuringSettlementAndImpairmentProvisions
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMTQtNy0xLTEtMA_d7e26c06-f1d5-4183-b2c0-97654491c829"
      unitRef="usd">0</us-gaap:RestructuringSettlementAndImpairmentProvisions>
    <us-gaap:OperatingExpenses
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMTUtMy0xLTEtMA_f6c4b7b8-6b84-4a2d-b9c2-ed92274d4aac"
      unitRef="usd">153514000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMTUtNS0xLTEtMA_bd010ae2-15ae-4e3a-918e-bd91abda1311"
      unitRef="usd">103511000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMTUtNy0xLTEtMA_219053bf-1bfb-4b35-a439-244a7597955d"
      unitRef="usd">26658000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMTYtMy0xLTEtMA_dfadae5b-4d0c-4833-a850-e9ce6c1ac492"
      unitRef="usd">-179347000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMTYtNS0xLTEtMA_5e2a753a-cb2c-4b22-a86c-47ad862732e6"
      unitRef="usd">-121108000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMTYtNy0xLTEtMA_f2ea3104-3675-41af-b12d-d1e1076fa8c1"
      unitRef="usd">-20445000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMTgtMy0xLTEtMA_31a5bd44-bbd2-47ea-8d97-74c34a07f0eb"
      unitRef="usd">18415000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMTgtNS0xLTEtMA_e3ccd18f-e7ac-49a3-99d6-49f1e6c0328a"
      unitRef="usd">27969000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMTgtNy0xLTEtMA_e1ac8d2a-36dd-46cf-99cc-414226d14247"
      unitRef="usd">81000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMTktMy0xLTEtMA_f3e00e2d-0bc3-4c5c-b051-37c080d8a31c"
      unitRef="usd">129254000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMTktNS0xLTEtMA_5aa26780-78bf-4c99-8b99-a530f71591bb"
      unitRef="usd">1276819000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMTktNy0xLTEtMA_934b407f-5480-4ec9-a08c-c47fa8742b49"
      unitRef="usd">0</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMjAtMy0xLTEtMA_87ae8b41-3f96-417c-b6ee-ed7490101169"
      unitRef="usd">40000000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMjAtNS0xLTEtMA_3f00be6f-ef2e-4624-95ff-5ccb2f294011"
      unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMjAtNy0xLTEtMA_690fbd9c-babc-40f2-b05f-4db59ac5722c"
      unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMjEtMy0xLTEtMA_3a126480-ece1-4f0c-8d6a-3f633eaefd5f"
      unitRef="usd">4789000</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMjEtNS0xLTEtMA_e87c96cd-6491-494a-9f03-25885e9c3d7a"
      unitRef="usd">16277000</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMjEtNy0xLTEtMA_5726c3f6-ef57-4a1c-8f3c-f5d5db5d8a93"
      unitRef="usd">164000</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMjMtMy0xLTEtMA_655e145b-9014-430a-bfbf-ab26144235ce"
      unitRef="usd">-4510000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMjMtNS0xLTEtMA_e5468ec7-4c2e-4dbf-be92-526f23d0eb0e"
      unitRef="usd">-2009000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMjMtNy0xLTEtMA_13179e56-bbfb-4f0b-b605-abeaaa5bdd3b"
      unitRef="usd">-723000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMjQtMy0xLTEtMA_5b60be16-b103-4d3e-8622-41df466f2ce4"
      unitRef="usd">40000</us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts>
    <us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMjQtNS0xLTEtMA_7fa857d1-e3b0-4872-9576-6809c455b123"
      unitRef="usd">32208000</us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts>
    <us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMjQtNy0xLTEtMA_96af92f8-2f22-40cc-9090-afacd29463f8"
      unitRef="usd">0</us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMjUtMy0xLTEtMTIzNjA_df5f2977-5d30-4c68-b62a-3c4933211f12"
      unitRef="usd">-1834000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMjUtNS0xLTEtMTIzNjA_75bc5afe-23fd-47e5-b9a3-0c69ce3b56c6"
      unitRef="usd">197000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMjUtNy0xLTEtMTIzNjA_9b266a9a-2b13-4e3d-a6c0-e22de3c90fc0"
      unitRef="usd">0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMjUtMy0xLTEtMA_6d6c2346-9607-4db2-8fb2-0b57dbc180fb"
      unitRef="usd">106074000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMjUtNS0xLTEtMA_bed2f4a8-bce9-4bf8-ad0d-c17a2c4897a6"
      unitRef="usd">1287045000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMjUtNy0xLTEtMA_3c81797f-fa66-4f31-a303-19527eb6780c"
      unitRef="usd">-478000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMjYtMy0xLTEtMA_35a18c2f-6458-4b09-8832-edd2c820a5d9"
      unitRef="usd">-73273000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMjYtNS0xLTEtMA_8d0ee71c-911d-4dd7-9ea4-2a746b88f269"
      unitRef="usd">1165937000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMjYtNy0xLTEtMA_f924f0a2-c05d-48bf-a97b-af01eed2a72c"
      unitRef="usd">-20923000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMjctMy0xLTEtMA_c0938543-c07e-42fb-92b8-0de60cb2e47f"
      unitRef="usd">1347000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMjctNS0xLTEtMA_e68aa0b4-7310-416f-9cb8-bc85b2a1f1da"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMjctNy0xLTEtMA_3a4d03a7-b43f-4415-b1f7-786f6d8a374a"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMjgtMy0xLTEtMTA3NzY_8f7e4a45-d51b-457f-93a0-4f22be304802"
      unitRef="usd">-74620000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMjgtNS0xLTEtMTA3NzY_dd443046-d7db-439e-b646-b5f6b2901a9c"
      unitRef="usd">1165937000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMjgtNy0xLTEtMTA3NzY_d4ceef76-ab7f-4b0c-b587-b21f32a3c48b"
      unitRef="usd">-20923000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMzAtMy0xLTEtMjMzNjc_c0001be3-6625-4ae8-aafa-d62b6961deed"
      unitRef="usd">-650000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMjktNS0xLTEtMTA3NzY_f8c1a4f3-ada3-4c08-990f-44d436224766"
      unitRef="usd">-363000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMjktNy0xLTEtMTA3NzY_8d551f93-fc15-40b1-82a4-4e4b0b35cb4c"
      unitRef="usd">-894000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:ProfitLoss
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMjgtMy0xLTEtMA_338d3114-3acb-4df6-8211-c9ff1f98f15e"
      unitRef="usd">-75270000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMjgtNS0xLTEtMA_88744763-16f9-44f4-a644-889328638db9"
      unitRef="usd">1165574000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMjgtNy0xLTEtMA_6e3259ce-3a6d-4db1-ac09-c4f0d5e2844c"
      unitRef="usd">-21817000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMzAtMy0xLTEtMA_0819561b-ebfb-4767-97ff-452150012136"
      unitRef="usd">-73137000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMzAtNS0xLTEtMA_18acf260-f51e-4357-8005-9088e2871f17"
      unitRef="usd">1166506000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMzAtNy0xLTEtMA_e03a8bfd-2d55-4c25-a885-c007579388a0"
      unitRef="usd">-21636000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMzEtMy0xLTEtMA_e2502775-6b16-419a-8f6e-cc46f9e9957b"
      unitRef="usd">-2133000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMzEtNS0xLTEtMA_4161d923-8933-4630-bf5e-ba0e5eb90d70"
      unitRef="usd">-932000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMzEtNy0xLTEtMA_02ef7282-9f87-47f1-b3c6-5e3089a44e65"
      unitRef="usd">-181000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMzItMy0xLTEtMA_5ccefe91-6ce4-40fb-9ff7-99e584108e5d"
      unitRef="usd">-75270000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMzItNS0xLTEtMA_dc81a03d-031c-4518-b906-13379c5f0913"
      unitRef="usd">1165574000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMzItNy0xLTEtMA_0fe1d26d-f684-4a91-ba03-2dfbe88d2a75"
      unitRef="usd">-21817000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMzItNy0xLTEtMA_aaa120fb-1be9-4e9c-8e53-cbfa570ae078"
      unitRef="usd">-21817000</us-gaap:ProfitLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNDQtMy0xLTEtMA_1dc8f519-1613-4b72-bcb7-69f57812a56e"
      unitRef="usdPerShare">-0.21</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNDQtNS0xLTEtMA_b7ecd45d-69a9-4730-91cd-4ee830e5c2f6"
      unitRef="usdPerShare">3.76</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNDQtNy0xLTEtMA_4ffa783c-7bcc-4659-b12b-9ccee24d62bc"
      unitRef="usdPerShare">-0.12</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNDUtMy0xLTEtMA_c9deec0e-b435-414e-9862-97b176eb4753"
      unitRef="usdPerShare">-0.21</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNDUtNS0xLTEtMA_493d04be-bc47-414c-9326-3ef9bf61406b"
      unitRef="usdPerShare">3.33</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNDUtNy0xLTEtMA_076615ad-4cea-4475-a55b-1ad3b75ff74f"
      unitRef="usdPerShare">-0.12</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNDctMy0xLTEtMA_c39cca44-6f42-4938-8962-1f058b1aadb2"
      unitRef="shares">351576848</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNDctNS0xLTEtMA_e221c2d7-3232-4a13-9403-ef2b15b677fb"
      unitRef="shares">310067179</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNDctNy0xLTEtMA_a047dd76-a5f1-4941-b25d-9d5910e70e1e"
      unitRef="shares">172269170</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNDgtMy0xLTEtMA_5d41c6cb-4657-4d84-9d61-e7b6edbd8ed4"
      unitRef="shares">351576848</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNDgtNS0xLTEtMA_43a535c7-a9f7-4574-8755-ea4af2d6fcf0"
      unitRef="shares">342811992</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNDgtNy0xLTEtMA_00e023ad-c0ff-44e6-b2d6-18456a9f0e47"
      unitRef="shares">172269170</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNjA0L2ZyYWc6NTA5YmYyOTZkMDFlNDY0YThiNjdlN2EwZWY0MjNkMWMvdGFibGU6MzkwZTUxM2ZjYzk1NDlkZjllZGRiZjc1Y2VjNzFjYzUvdGFibGVyYW5nZTozOTBlNTEzZmNjOTU0OWRmOWVkZGJmNzVjZWM3MWNjNV8zMi0zLTEtMS0zMTE0Mg_338d3114-3acb-4df6-8211-c9ff1f98f15e"
      unitRef="usd">-75270000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNjA0L2ZyYWc6NTA5YmYyOTZkMDFlNDY0YThiNjdlN2EwZWY0MjNkMWMvdGFibGU6MzkwZTUxM2ZjYzk1NDlkZjllZGRiZjc1Y2VjNzFjYzUvdGFibGVyYW5nZTozOTBlNTEzZmNjOTU0OWRmOWVkZGJmNzVjZWM3MWNjNV8zLTUtMS0xLTM2Mjg4_1cf83e56-12bb-424a-8fc4-81f2b89de629"
      unitRef="usd">1165574000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNjA0L2ZyYWc6NTA5YmYyOTZkMDFlNDY0YThiNjdlN2EwZWY0MjNkMWMvdGFibGU6MzkwZTUxM2ZjYzk1NDlkZjllZGRiZjc1Y2VjNzFjYzUvdGFibGVyYW5nZTozOTBlNTEzZmNjOTU0OWRmOWVkZGJmNzVjZWM3MWNjNV8zMi03LTEtMS0zMTE0Mg_6e3259ce-3a6d-4db1-ac09-c4f0d5e2844c"
      unitRef="usd">-21817000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNjA0L2ZyYWc6NTA5YmYyOTZkMDFlNDY0YThiNjdlN2EwZWY0MjNkMWMvdGFibGU6MzkwZTUxM2ZjYzk1NDlkZjllZGRiZjc1Y2VjNzFjYzUvdGFibGVyYW5nZTozOTBlNTEzZmNjOTU0OWRmOWVkZGJmNzVjZWM3MWNjNV8zOC0zLTEtMS0zMTE0Mg_4d59590b-f03c-4d58-b88e-5287ea33ddf7"
      unitRef="usd">14951000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNjA0L2ZyYWc6NTA5YmYyOTZkMDFlNDY0YThiNjdlN2EwZWY0MjNkMWMvdGFibGU6MzkwZTUxM2ZjYzk1NDlkZjllZGRiZjc1Y2VjNzFjYzUvdGFibGVyYW5nZTozOTBlNTEzZmNjOTU0OWRmOWVkZGJmNzVjZWM3MWNjNV8zOC01LTEtMS0zMTE0Mg_4d4782a2-fe17-4367-97f1-cde520e4c620"
      unitRef="usd">37687000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNjA0L2ZyYWc6NTA5YmYyOTZkMDFlNDY0YThiNjdlN2EwZWY0MjNkMWMvdGFibGU6MzkwZTUxM2ZjYzk1NDlkZjllZGRiZjc1Y2VjNzFjYzUvdGFibGVyYW5nZTozOTBlNTEzZmNjOTU0OWRmOWVkZGJmNzVjZWM3MWNjNV8zOC03LTEtMS0zMTE0Mg_a0bc4133-bdf1-4188-a9da-b82a0a16929f"
      unitRef="usd">-12337000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <cron:OtherComprehensiveIncomeLossAccumulatedGainLossDebtSecuritiesRevaluationAndDisposalOfOtherInvestments
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNjA0L2ZyYWc6NTA5YmYyOTZkMDFlNDY0YThiNjdlN2EwZWY0MjNkMWMvdGFibGU6MzkwZTUxM2ZjYzk1NDlkZjllZGRiZjc1Y2VjNzFjYzUvdGFibGVyYW5nZTozOTBlNTEzZmNjOTU0OWRmOWVkZGJmNzVjZWM3MWNjNV8zOS0zLTEtMS0zMTE0Mg_cb52045d-3696-4166-ac62-5236911e3bd2"
      unitRef="usd">0</cron:OtherComprehensiveIncomeLossAccumulatedGainLossDebtSecuritiesRevaluationAndDisposalOfOtherInvestments>
    <cron:OtherComprehensiveIncomeLossAccumulatedGainLossDebtSecuritiesRevaluationAndDisposalOfOtherInvestments
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNjA0L2ZyYWc6NTA5YmYyOTZkMDFlNDY0YThiNjdlN2EwZWY0MjNkMWMvdGFibGU6MzkwZTUxM2ZjYzk1NDlkZjllZGRiZjc1Y2VjNzFjYzUvdGFibGVyYW5nZTozOTBlNTEzZmNjOTU0OWRmOWVkZGJmNzVjZWM3MWNjNV8zOS01LTEtMS0zMTE0Mg_e72383b8-94f7-40a7-b717-588f18f02fda"
      unitRef="usd">0</cron:OtherComprehensiveIncomeLossAccumulatedGainLossDebtSecuritiesRevaluationAndDisposalOfOtherInvestments>
    <cron:OtherComprehensiveIncomeLossAccumulatedGainLossDebtSecuritiesRevaluationAndDisposalOfOtherInvestments
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNjA0L2ZyYWc6NTA5YmYyOTZkMDFlNDY0YThiNjdlN2EwZWY0MjNkMWMvdGFibGU6MzkwZTUxM2ZjYzk1NDlkZjllZGRiZjc1Y2VjNzFjYzUvdGFibGVyYW5nZTozOTBlNTEzZmNjOTU0OWRmOWVkZGJmNzVjZWM3MWNjNV8zOS03LTEtMS0zMTE0Mg_a5309d38-0622-4e8d-b934-db1a91986ba6"
      unitRef="usd">3000</cron:OtherComprehensiveIncomeLossAccumulatedGainLossDebtSecuritiesRevaluationAndDisposalOfOtherInvestments>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNjA0L2ZyYWc6NTA5YmYyOTZkMDFlNDY0YThiNjdlN2EwZWY0MjNkMWMvdGFibGU6MzkwZTUxM2ZjYzk1NDlkZjllZGRiZjc1Y2VjNzFjYzUvdGFibGVyYW5nZTozOTBlNTEzZmNjOTU0OWRmOWVkZGJmNzVjZWM3MWNjNV80MS0zLTEtMS0zMTE0Mg_2c41a1c4-1619-4ebf-a69a-596077d06584"
      unitRef="usd">14951000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNjA0L2ZyYWc6NTA5YmYyOTZkMDFlNDY0YThiNjdlN2EwZWY0MjNkMWMvdGFibGU6MzkwZTUxM2ZjYzk1NDlkZjllZGRiZjc1Y2VjNzFjYzUvdGFibGVyYW5nZTozOTBlNTEzZmNjOTU0OWRmOWVkZGJmNzVjZWM3MWNjNV80MS01LTEtMS0zMTE0Mg_7e0a49e9-ca28-458f-8ecc-6f6cee2817f5"
      unitRef="usd">37687000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNjA0L2ZyYWc6NTA5YmYyOTZkMDFlNDY0YThiNjdlN2EwZWY0MjNkMWMvdGFibGU6MzkwZTUxM2ZjYzk1NDlkZjllZGRiZjc1Y2VjNzFjYzUvdGFibGVyYW5nZTozOTBlNTEzZmNjOTU0OWRmOWVkZGJmNzVjZWM3MWNjNV80MS03LTEtMS0zMTE0Mg_4f4a3e9a-94f7-4cc4-a560-105871328b71"
      unitRef="usd">-12334000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNjA0L2ZyYWc6NTA5YmYyOTZkMDFlNDY0YThiNjdlN2EwZWY0MjNkMWMvdGFibGU6MzkwZTUxM2ZjYzk1NDlkZjllZGRiZjc1Y2VjNzFjYzUvdGFibGVyYW5nZTozOTBlNTEzZmNjOTU0OWRmOWVkZGJmNzVjZWM3MWNjNV80Mi0zLTEtMS0zMTE0Mg_9f1232ed-b35a-412b-a4e4-c0e8342a0dda"
      unitRef="usd">-60319000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNjA0L2ZyYWc6NTA5YmYyOTZkMDFlNDY0YThiNjdlN2EwZWY0MjNkMWMvdGFibGU6MzkwZTUxM2ZjYzk1NDlkZjllZGRiZjc1Y2VjNzFjYzUvdGFibGVyYW5nZTozOTBlNTEzZmNjOTU0OWRmOWVkZGJmNzVjZWM3MWNjNV80Mi01LTEtMS0zMTE0Mg_9a69b472-9c20-4444-bdbd-37d2a3b9289b"
      unitRef="usd">1203261000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNjA0L2ZyYWc6NTA5YmYyOTZkMDFlNDY0YThiNjdlN2EwZWY0MjNkMWMvdGFibGU6MzkwZTUxM2ZjYzk1NDlkZjllZGRiZjc1Y2VjNzFjYzUvdGFibGVyYW5nZTozOTBlNTEzZmNjOTU0OWRmOWVkZGJmNzVjZWM3MWNjNV80Mi03LTEtMS0zMTE0Mg_d2069816-de51-4dea-893e-3798840f2918"
      unitRef="usd">-34151000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNjA0L2ZyYWc6NTA5YmYyOTZkMDFlNDY0YThiNjdlN2EwZWY0MjNkMWMvdGFibGU6MzkwZTUxM2ZjYzk1NDlkZjllZGRiZjc1Y2VjNzFjYzUvdGFibGVyYW5nZTozOTBlNTEzZmNjOTU0OWRmOWVkZGJmNzVjZWM3MWNjNV80NC0zLTEtMS0zMTE0Mg_0a311a83-11b3-4500-a7a2-48ed615ddada"
      unitRef="usd">-57976000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNjA0L2ZyYWc6NTA5YmYyOTZkMDFlNDY0YThiNjdlN2EwZWY0MjNkMWMvdGFibGU6MzkwZTUxM2ZjYzk1NDlkZjllZGRiZjc1Y2VjNzFjYzUvdGFibGVyYW5nZTozOTBlNTEzZmNjOTU0OWRmOWVkZGJmNzVjZWM3MWNjNV80NC01LTEtMS0zMTE0Mg_ed26fa61-1504-447f-869b-063a5bb71644"
      unitRef="usd">1204214000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNjA0L2ZyYWc6NTA5YmYyOTZkMDFlNDY0YThiNjdlN2EwZWY0MjNkMWMvdGFibGU6MzkwZTUxM2ZjYzk1NDlkZjllZGRiZjc1Y2VjNzFjYzUvdGFibGVyYW5nZTozOTBlNTEzZmNjOTU0OWRmOWVkZGJmNzVjZWM3MWNjNV80NC03LTEtMS0zMTE0Mg_e58a9698-bf3f-4378-a1e6-5951bd392fba"
      unitRef="usd">-33964000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNjA0L2ZyYWc6NTA5YmYyOTZkMDFlNDY0YThiNjdlN2EwZWY0MjNkMWMvdGFibGU6MzkwZTUxM2ZjYzk1NDlkZjllZGRiZjc1Y2VjNzFjYzUvdGFibGVyYW5nZTozOTBlNTEzZmNjOTU0OWRmOWVkZGJmNzVjZWM3MWNjNV80NS0zLTEtMS0zMTE0Mg_2031e58e-9f9a-4351-ab8b-61762bea559b"
      unitRef="usd">-2343000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNjA0L2ZyYWc6NTA5YmYyOTZkMDFlNDY0YThiNjdlN2EwZWY0MjNkMWMvdGFibGU6MzkwZTUxM2ZjYzk1NDlkZjllZGRiZjc1Y2VjNzFjYzUvdGFibGVyYW5nZTozOTBlNTEzZmNjOTU0OWRmOWVkZGJmNzVjZWM3MWNjNV80NS01LTEtMS0zMTE0Mg_5508492e-990a-4fb3-ad0b-f7de34145db6"
      unitRef="usd">-953000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNjA0L2ZyYWc6NTA5YmYyOTZkMDFlNDY0YThiNjdlN2EwZWY0MjNkMWMvdGFibGU6MzkwZTUxM2ZjYzk1NDlkZjllZGRiZjc1Y2VjNzFjYzUvdGFibGVyYW5nZTozOTBlNTEzZmNjOTU0OWRmOWVkZGJmNzVjZWM3MWNjNV80NS03LTEtMS0zMTE0Mg_aa08139e-4751-44d5-92b7-2f31b48109db"
      unitRef="usd">-187000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNjA0L2ZyYWc6NTA5YmYyOTZkMDFlNDY0YThiNjdlN2EwZWY0MjNkMWMvdGFibGU6MzkwZTUxM2ZjYzk1NDlkZjllZGRiZjc1Y2VjNzFjYzUvdGFibGVyYW5nZTozOTBlNTEzZmNjOTU0OWRmOWVkZGJmNzVjZWM3MWNjNV80Ni0zLTEtMS0zMTE0Mg_56a5d58b-590b-4e55-959f-7c07ca4f939d"
      unitRef="usd">-60319000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNjA0L2ZyYWc6NTA5YmYyOTZkMDFlNDY0YThiNjdlN2EwZWY0MjNkMWMvdGFibGU6MzkwZTUxM2ZjYzk1NDlkZjllZGRiZjc1Y2VjNzFjYzUvdGFibGVyYW5nZTozOTBlNTEzZmNjOTU0OWRmOWVkZGJmNzVjZWM3MWNjNV80Ni01LTEtMS0zMTE0Mg_60fbf885-33d3-4c08-9144-1eace1976d24"
      unitRef="usd">1203261000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNjA0L2ZyYWc6NTA5YmYyOTZkMDFlNDY0YThiNjdlN2EwZWY0MjNkMWMvdGFibGU6MzkwZTUxM2ZjYzk1NDlkZjllZGRiZjc1Y2VjNzFjYzUvdGFibGVyYW5nZTozOTBlNTEzZmNjOTU0OWRmOWVkZGJmNzVjZWM3MWNjNV80Ni03LTEtMS0zMTE0Mg_843a437b-c6ed-46b9-8cbc-ee54ce872f3f"
      unitRef="usd">-34151000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i0451ae32e2d74c6a81c9a1a7d77aea12_I20171231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfMS03LTEtMS0w_f8850cc2-3f06-452b-83c5-818db2d94223"
      unitRef="shares">149360603</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0451ae32e2d74c6a81c9a1a7d77aea12_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfMS05LTEtMS0w_a5ce38a5-de25-4c96-b632-d34644c2d366"
      unitRef="usd">62834000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3ea5ff615f724f79bc76ea60e882c0d6_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfMS0xMS0xLTEtMA_1b94fbee-0285-41ae-a936-cb1bc43037bd"
      unitRef="usd">4734000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0b21d84a8da64ac182924657011dc8f4_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfMS0xMy0xLTEtMA_0568b22d-8152-45df-a618-a77a7ad6bb13"
      unitRef="usd">-6293000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i603e76f89c54407a82af75f4644d6617_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfMS0xNS0xLTEtMA_12363a9a-2066-437e-a03e-5a62e5675405"
      unitRef="usd">2458000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia83e6fe889b142c1b548d3c600ce2460_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfMS0xOS0xLTEtMA_c79b0327-372f-44bf-9c95-9ed9a7d03419"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ieb4bf06122354c15966cf5343aa018a5_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfMS0yMS0xLTEtMA_bea550df-4793-4263-997c-febb577dfee5"
      unitRef="usd">63733000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i85e3d76bfda8415b975e00befcd9609f_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfMi03LTEtMS0w_5deb7c72-17d3-4ae1-b5a5-a86cc94e5dd2"
      unitRef="shares">15677143</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i85e3d76bfda8415b975e00befcd9609f_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfMi05LTEtMS0w_63ba5965-41be-4d5c-baff-ee1976d81c9e"
      unitRef="usd">115510000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfMi0yMS0xLTEtMA_8cd7de5e-e614-416e-abed-9448404e25da"
      unitRef="usd">115510000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <cron:StockIssuedDuringPeriodValueNewIssuesIssuanceCosts
      contextRef="i85e3d76bfda8415b975e00befcd9609f_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfMy05LTEtMS0w_4b7b56be-b219-4c5b-ba1e-2dbcebea8c29"
      unitRef="usd">7577000</cron:StockIssuedDuringPeriodValueNewIssuesIssuanceCosts>
    <cron:StockIssuedDuringPeriodValueNewIssuesIssuanceCosts
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfMy0yMS0xLTEtMA_88bab2b8-c63e-4093-975f-ecca8f4abcc0"
      unitRef="usd">7577000</cron:StockIssuedDuringPeriodValueNewIssuesIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="ie73bc389412d48679e51974a3e1e0968_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfNC0xMS0xLTEtMA_7e4c719a-b25c-43ad-a7ef-a09f6cfb2af5"
      unitRef="usd">8151000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfNC0yMS0xLTEtMA_a9cfb4aa-adac-4e4a-8895-bee70c10bf6d"
      unitRef="usd">8151000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i85e3d76bfda8415b975e00befcd9609f_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfNS03LTEtMS0w_927acb6c-9d83-42b4-b302-bd9ff1abf640"
      unitRef="shares">567940</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i85e3d76bfda8415b975e00befcd9609f_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfNS05LTEtMS0w_e640f48a-a183-449c-baf0-ff1f28c574ed"
      unitRef="usd">671000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ie73bc389412d48679e51974a3e1e0968_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfNS0xMS0xLTEtMA_82b220fc-7c34-4447-96f1-90b6056dfd29"
      unitRef="usd">-220000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="if0a8816e9f004feb8e54373b3e932949_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfNS0xMy0xLTEtMA_eb5c83df-6f25-449d-978d-c6d6075fa5fb"
      unitRef="usd">-16000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfNS0yMS0xLTEtMA_57cfa0e2-62b6-4d3a-a2f0-f456db5e3443"
      unitRef="usd">435000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <cron:SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisesInPeriod
      contextRef="i85e3d76bfda8415b975e00befcd9609f_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfNi03LTEtMS0w_4f385c9c-bf49-4561-a627-f9b06f89b5fc"
      unitRef="shares">13114336</cron:SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisesInPeriod>
    <cron:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="i85e3d76bfda8415b975e00befcd9609f_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfNi05LTEtMS0w_410f4709-64eb-4ba4-a6cd-5e99d1051222"
      unitRef="usd">3563000</cron:StockIssuedDuringPeriodValueWarrantsExercised>
    <cron:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="ie73bc389412d48679e51974a3e1e0968_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfNi0xMS0xLTEtMA_e1d28c27-5dea-450f-8de8-5b505d83337d"
      unitRef="usd">-1402000</cron:StockIssuedDuringPeriodValueWarrantsExercised>
    <cron:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfNi0yMS0xLTEtMA_0f148d5c-7377-47e8-b52e-f78459721fad"
      unitRef="usd">2161000</cron:StockIssuedDuringPeriodValueWarrantsExercised>
    <us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
      contextRef="i005d23eef9f84c3993929eefb19a4d19_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfOC0xOS0xLTEtODM1_ae324cf8-7fa7-4239-b5fd-609349a6a960"
      unitRef="usd">287000</us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance>
    <us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfOC0yMS0xLTEtODM1_cea63972-16e8-4ced-9a8c-ea83ede5e864"
      unitRef="usd">287000</us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance>
    <us-gaap:ProfitLoss
      contextRef="if0a8816e9f004feb8e54373b3e932949_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfNy0xMy0xLTEtMA_134c8844-1698-4207-887c-b890f6f8a7e8"
      unitRef="usd">-21636000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i005d23eef9f84c3993929eefb19a4d19_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfNy0xOS0xLTEtMA_0cf2891c-fee0-4b4e-a9ac-3113c84b1107"
      unitRef="usd">-181000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfNy0yMS0xLTEtMA_d8f0a946-1e7a-4de0-9474-007f7f376b12"
      unitRef="usd">-21817000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i96223c9bb10341f4b0f7ca7353171f06_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfOC0xNS0xLTEtMA_e67e1366-dec0-4f7f-957a-87642614a524"
      unitRef="usd">-12328000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i005d23eef9f84c3993929eefb19a4d19_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfOC0xOS0xLTEtMA_ce639f13-5dba-4170-97f4-cbc8df48aca1"
      unitRef="usd">-6000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfOC0yMS0xLTEtMA_5ef029ad-a51d-4bf8-a67f-1087cc9ce1e4"
      unitRef="usd">-12334000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i98a40ef3bd8f4cb7b68cb5bc1907a1e9_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfOS03LTEtMS0w_8bbae070-08ba-4ea3-9760-5b2c77da3acc"
      unitRef="shares">178720022</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i98a40ef3bd8f4cb7b68cb5bc1907a1e9_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfOS05LTEtMS0w_abe15bee-ac74-4877-8b40-7a6e0443117c"
      unitRef="usd">175001000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i92c8255933de4ada9ebce878a6a77405_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfOS0xMS0xLTEtMA_af957da6-d40f-49cb-99bc-7201cfaf2853"
      unitRef="usd">11263000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia7206d1e564f417f9935a0aca534849a_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfOS0xMy0xLTEtMA_86ad190d-0ade-4479-9794-9eed551f94f1"
      unitRef="usd">-27945000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1f1cb8c6e56c4c8cb1070c81364c66b2_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfOS0xNS0xLTEtMA_9414897a-2544-4aec-8207-d74d476b51b3"
      unitRef="usd">-9870000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6bfe263ed9524742b183ccc53bcccba1_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfOS0xOS0xLTEtMA_5f8d7e13-95e7-4c0d-a7ca-49dee1ceffea"
      unitRef="usd">100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9717dc3b24b24c93ab09a6bfa9b52c89_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOjcwYTBkOTg1NDJiODRjNDA5ZTFhOGRlY2Q0NGYzN2Y5L3RhYmxlcmFuZ2U6NzBhMGQ5ODU0MmI4NGM0MDllMWE4ZGVjZDQ0ZjM3ZjlfOS0yMS0xLTEtMA_96ebe7f4-c546-4a9e-ae5f-1815306488b0"
      unitRef="usd">148549000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i98a40ef3bd8f4cb7b68cb5bc1907a1e9_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMTMtNy0xLTEtNDMwMw_3e0199ef-8783-47c0-a137-f06c56590e53"
      unitRef="shares">178720022</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i98a40ef3bd8f4cb7b68cb5bc1907a1e9_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMTMtOS0xLTEtNDMwMw_2a1b4e85-2d85-4ff4-a952-d6cbf9554f65"
      unitRef="usd">175001000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i92c8255933de4ada9ebce878a6a77405_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMTMtMTEtMS0xLTQzMDM_a04c3373-9713-4baa-b886-e71893448b89"
      unitRef="usd">11263000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia7206d1e564f417f9935a0aca534849a_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMTMtMTMtMS0xLTQzMDM_03172591-d2ba-4a8f-b1ac-88ceeb8bf025"
      unitRef="usd">-27945000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1f1cb8c6e56c4c8cb1070c81364c66b2_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMTMtMTUtMS0xLTQzMDM_0e607d0f-6e22-43c9-83bd-2d53deaf4bd3"
      unitRef="usd">-9870000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6bfe263ed9524742b183ccc53bcccba1_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMTMtMTktMS0xLTQzMDM_47bc91f8-ea3f-44e4-aa36-a38f861c5ee9"
      unitRef="usd">100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9717dc3b24b24c93ab09a6bfa9b52c89_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMTMtMjEtMS0xLTQzMDM_f47f445b-7456-40b5-8834-f0e7392dbff4"
      unitRef="usd">148549000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i6aa79556c9a24064ab5ea55845f31f79_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMTQtNy0xLTEtNDMwMw_d1f07695-d15b-4477-810a-b670243d5e1a"
      unitRef="shares">155773757</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i6aa79556c9a24064ab5ea55845f31f79_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMTQtOS0xLTEtNDMwMw_8c7ac2a1-2a30-411e-873c-54774f7f4007"
      unitRef="usd">304411000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="ic77af0ad2ca04f71b6c632243f35b62b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMTQtMTEtMS0xLTQzMDM_2951c220-20a5-4dc7-9105-a5a7f0b69d6d"
      unitRef="usd">410000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMTQtMjEtMS0xLTQzMDM_283da201-514e-473f-9e99-5a120562629e"
      unitRef="usd">304821000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <cron:StockIssuedDuringPeriodValueNewIssuesIssuanceCosts
      contextRef="i6aa79556c9a24064ab5ea55845f31f79_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMTUtOS0xLTEtNDMwMw_0f7e04f6-bd1c-4890-907f-f3dc7875251e"
      unitRef="usd">3722000</cron:StockIssuedDuringPeriodValueNewIssuesIssuanceCosts>
    <cron:StockIssuedDuringPeriodValueNewIssuesIssuanceCosts
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMTUtMjEtMS0xLTQzMDM_36d26524-d0ce-44b2-82fb-40d3dda0489a"
      unitRef="usd">3722000</cron:StockIssuedDuringPeriodValueNewIssuesIssuanceCosts>
    <cron:SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisesInPeriod
      contextRef="i6aa79556c9a24064ab5ea55845f31f79_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMTYtNy0xLTEtNDMwMw_e3090c7c-cd49-4033-856b-10b31f774393"
      unitRef="shares">7390961</cron:SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisesInPeriod>
    <cron:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="i6aa79556c9a24064ab5ea55845f31f79_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMTYtOS0xLTEtNDMwMw_c8db0e8a-afb2-4457-b8d5-40b6f2650b33"
      unitRef="usd">2034000</cron:StockIssuedDuringPeriodValueWarrantsExercised>
    <cron:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="ic77af0ad2ca04f71b6c632243f35b62b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMTYtMTEtMS0xLTQzMDM_60db782f-a355-4dcb-9bc7-0872ce6e81e9"
      unitRef="usd">-596000</cron:StockIssuedDuringPeriodValueWarrantsExercised>
    <cron:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMTYtMjEtMS0xLTQzMDM_bb141bba-70dd-4467-88f6-919aabca40b4"
      unitRef="usd">1438000</cron:StockIssuedDuringPeriodValueWarrantsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="ic77af0ad2ca04f71b6c632243f35b62b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMTctMTEtMS0xLTQzMDM_028bba16-3b98-477d-b561-ee7331273ce3"
      unitRef="usd">11619000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMTctMjEtMS0xLTQzMDM_4053f11a-179f-4260-852d-bb8b14d2d2ea"
      unitRef="usd">11619000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i6aa79556c9a24064ab5ea55845f31f79_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMTgtNy0xLTEtNDMwMw_4a97f271-b135-46bb-9238-1fbdc0927566"
      unitRef="shares">190349</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i6aa79556c9a24064ab5ea55845f31f79_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMTgtOS0xLTEtNDMwMw_e0160697-1785-487c-bd46-e48916049bdd"
      unitRef="usd">368000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ic77af0ad2ca04f71b6c632243f35b62b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMTgtMTEtMS0xLTQzMDM_3187ac28-2253-4c1f-859f-aeee3f3037f7"
      unitRef="usd">-351000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i7c3d39b0ddc3421a9ef11be927b7c69c_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMTgtMTMtMS0xLTQzMDM_a1e77d34-4cf6-4e27-b7e5-333ca9885072"
      unitRef="usd">-915000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMTgtMjEtMS0xLTQzMDM_8cf2d71c-7584-426e-986b-3f3dacacf689"
      unitRef="usd">-898000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="ic77af0ad2ca04f71b6c632243f35b62b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMTktMTEtMS0xLTQzMDM_3a2de3f9-879b-4342-b7a1-b34e80991009"
      unitRef="usd">889000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMTktMjEtMS0xLTQzMDM_2b1c5c6b-21ef-4e4b-a313-6f5d8caa143c"
      unitRef="usd">889000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <cron:StockIssuedDuringPeriodSharesTopupRightsExercised
      contextRef="i6aa79556c9a24064ab5ea55845f31f79_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMjEtNy0xLTEtNDMwMw_4e740bf9-cc5c-4d14-a359-0081e3f1ab2f"
      unitRef="shares">6742383</cron:StockIssuedDuringPeriodSharesTopupRightsExercised>
    <cron:StockIssuedDuringPeriodValueTopupRightsExercised
      contextRef="i6aa79556c9a24064ab5ea55845f31f79_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMjEtOS0xLTEtNDMwMw_ba72092e-121f-4c37-93d8-1bd65734dadd"
      unitRef="usd">83073000</cron:StockIssuedDuringPeriodValueTopupRightsExercised>
    <cron:StockIssuedDuringPeriodValueTopupRightsExercised
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMjEtMjEtMS0xLTQzMDM_fded2f80-e395-4117-9ffa-2e8840669088"
      unitRef="usd">83073000</cron:StockIssuedDuringPeriodValueTopupRightsExercised>
    <us-gaap:ProfitLoss
      contextRef="i7c3d39b0ddc3421a9ef11be927b7c69c_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMjItMTMtMS0xLTQzMDM_b032baad-3296-4083-9bce-55854b21e910"
      unitRef="usd">1166506000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ic1710fca0e7c4f9e87a86725cf4c48ff_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMjItMTktMS0xLTQzMDM_75779e6d-1a48-4177-886c-6a7afdae793c"
      unitRef="usd">-932000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMjItMjEtMS0xLTQzMDM_21932298-268b-4cef-bcc5-6eb73224bfd2"
      unitRef="usd">1165574000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i6981b713441d4cea8f87dda3a39ac2be_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMjMtMTUtMS0xLTQzMDM_bd538588-a1c8-4449-af8d-45c8628222cc"
      unitRef="usd">37708000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ic1710fca0e7c4f9e87a86725cf4c48ff_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMjMtMTktMS0xLTQzMDM_675381cf-9dff-4a47-ad06-6e7b525397cf"
      unitRef="usd">-21000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMjMtMjEtMS0xLTQzMDM_76aa613d-730b-4b9a-8a2c-74710325a0dd"
      unitRef="usd">37687000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i46c33a2743a34787aa9be59e8b743b3c_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMjQtNy0xLTEtNDMwMw_dcc954b8-72aa-4032-a219-89fd479f6b81"
      unitRef="shares">348817472</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i46c33a2743a34787aa9be59e8b743b3c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMjQtOS0xLTEtNDMwMw_669b91f8-10d0-45fa-85cd-0c71b7e5c325"
      unitRef="usd">561165000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8918c1f902e543639e6e68f052bbd4cf_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMjQtMTEtMS0xLTQzMDM_5e253558-21de-4deb-8b5b-ad0ae2a55a54"
      unitRef="usd">23234000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic63015dad62149c8b50e40927b2c91c6_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMjQtMTMtMS0xLTQzMDM_f5e77d31-c550-4d9d-ba27-3a815a1560fe"
      unitRef="usd">1137646000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia6461d38acec49bd9d6a716a38310029_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMjQtMTUtMS0xLTQzMDM_a565eb72-a50e-44eb-a680-04c68cce7497"
      unitRef="usd">27838000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i713e37bc833e40c3bea5015df9213308_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMjQtMTktMS0xLTQzMDM_0a402e0e-d502-4545-b6ad-e21f055ca0fb"
      unitRef="usd">-853000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmU0ZDFlNTc3M2E2MTQ2ZTM4MWY3NzFmMmMxZTVhYTVmL3RhYmxlcmFuZ2U6ZTRkMWU1NzczYTYxNDZlMzgxZjc3MWYyYzFlNWFhNWZfMjQtMjEtMS0xLTQzMDM_c58e985f-bdd5-401b-aba8-1aa3d7a14e45"
      unitRef="usd">1749030000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i46c33a2743a34787aa9be59e8b743b3c_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfMjYtNy0xLTEtNDMwNg_dcc954b8-72aa-4032-a219-89fd479f6b81"
      unitRef="shares">348817472</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i46c33a2743a34787aa9be59e8b743b3c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfMjYtOS0xLTEtNDMwNg_669b91f8-10d0-45fa-85cd-0c71b7e5c325"
      unitRef="usd">561165000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8918c1f902e543639e6e68f052bbd4cf_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfMjYtMTEtMS0xLTQzMDY_5e253558-21de-4deb-8b5b-ad0ae2a55a54"
      unitRef="usd">23234000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic63015dad62149c8b50e40927b2c91c6_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfMjYtMTMtMS0xLTQzMDY_f5e77d31-c550-4d9d-ba27-3a815a1560fe"
      unitRef="usd">1137646000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia6461d38acec49bd9d6a716a38310029_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfMjYtMTUtMS0xLTQzMDY_a565eb72-a50e-44eb-a680-04c68cce7497"
      unitRef="usd">27838000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i713e37bc833e40c3bea5015df9213308_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfMjYtMTktMS0xLTQzMDY_0a402e0e-d502-4545-b6ad-e21f055ca0fb"
      unitRef="usd">-853000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfMjYtMjEtMS0xLTQzMDY_c58e985f-bdd5-401b-aba8-1aa3d7a14e45"
      unitRef="usd">1749030000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <cron:SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisesInPeriod
      contextRef="i3783dc27237d46f6944e1a9a6f65eee6_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfMjktNy0xLTEtNDMwNg_0ab3dff0-07b5-42d1-934d-8e521c3174bd"
      unitRef="shares">9755642</cron:SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisesInPeriod>
    <cron:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="i3783dc27237d46f6944e1a9a6f65eee6_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfMjktOS0xLTEtNDMwNg_fa575326-621f-417c-b770-3655609e32d9"
      unitRef="usd">1244000</cron:StockIssuedDuringPeriodValueWarrantsExercised>
    <cron:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="i63eed3a7d9e2479d9b72e7dbc2a9f719_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfMjktMTEtMS0xLTQzMDY_327b12cd-248a-45c0-8565-4e199f979dda"
      unitRef="usd">-1137000</cron:StockIssuedDuringPeriodValueWarrantsExercised>
    <cron:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfNC0xMy0xLTEtMTE5MDk_fcb1e538-cb96-4a69-9f5b-231a696c5e9e"
      unitRef="usd">107000</cron:StockIssuedDuringPeriodValueWarrantsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="i63eed3a7d9e2479d9b72e7dbc2a9f719_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfMzAtMTEtMS0xLTQzMDY_5196f039-24a3-41f6-ad92-38f70b48e742"
      unitRef="usd">7185000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfNS0xMy0xLTEtMTE5MDk_09354b28-25c7-489f-bef1-de3a2f5bb94d"
      unitRef="usd">7185000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i3783dc27237d46f6944e1a9a6f65eee6_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfMzEtNy0xLTEtNDMwNg_ec8be51b-d31e-4d78-8222-6d5c234c60d2"
      unitRef="shares">1266130</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i3783dc27237d46f6944e1a9a6f65eee6_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfMzEtOS0xLTEtNDMwNg_a63a67c2-9ad6-434b-b066-6847bd704997"
      unitRef="usd">1586000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i63eed3a7d9e2479d9b72e7dbc2a9f719_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfMzEtMTEtMS0xLTQzMDY_267690e1-86e8-4a9f-8edd-50743eda86a3"
      unitRef="usd">-1577000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfNi0xMy0xLTEtMTE5MDk_3889804d-fbd8-497a-a02c-f442d38c015b"
      unitRef="usd">9000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="i3783dc27237d46f6944e1a9a6f65eee6_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfNy0xLTEtMS0yODE3OA_bcb53f91-3961-42a4-a6af-7af3091f32ee"
      unitRef="shares">414088</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i63eed3a7d9e2479d9b72e7dbc2a9f719_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfMzMtMTEtMS0xLTQzMDY_5ce456ba-8f6c-4bac-9404-aa4d0c40cdae"
      unitRef="usd">8176000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfOC0xNS0xLTEtNDM1Ng_18ac1b9b-d62b-499b-b817-9d74deada9bd"
      unitRef="usd">8176000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i63eed3a7d9e2479d9b72e7dbc2a9f719_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfOS01LTEtMS0zOTEwNw_ceccb0bd-32e5-4c1e-8abb-33d6b9024cf3"
      unitRef="usd">2148000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfOS0xMy0xLTEtMzkxMTE_ba6b341f-3cc6-4e99-96b7-d90ff136c302"
      unitRef="usd">2148000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="i3783dc27237d46f6944e1a9a6f65eee6_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfMzQtOS0xLTEtNDMwNg_d975b123-764c-4d72-a52b-b84a60ab12ba"
      unitRef="usd">2000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="i63eed3a7d9e2479d9b72e7dbc2a9f719_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfMzQtMTEtMS0xLTQzMDY_20ef770d-d4ce-4d14-9c5b-30a035d6c056"
      unitRef="usd">863000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfOS0xMy0xLTEtMTE5MDk_e414b761-d076-466f-8081-f2754082c45f"
      unitRef="usd">2863000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <cron:StockIssuedDuringPeriodSharesTopupRightsExercised
      contextRef="i3783dc27237d46f6944e1a9a6f65eee6_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfMzUtNy0xLTEtNDMwNg_cb767981-b949-405b-94cd-ab6a79f73853"
      unitRef="shares">0</cron:StockIssuedDuringPeriodSharesTopupRightsExercised>
    <cron:StockIssuedDuringPeriodValueTopupRightsExercised
      contextRef="i3783dc27237d46f6944e1a9a6f65eee6_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfMzUtOS0xLTEtNDMwNg_3afce97b-9ecc-4e03-a04c-79d01586f876"
      unitRef="usd">3265000</cron:StockIssuedDuringPeriodValueTopupRightsExercised>
    <cron:StockIssuedDuringPeriodValueTopupRightsExercised
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfMTAtMTMtMS0xLTExOTA5_60201ddf-158a-44fd-86d9-9f8cc4e6bca7"
      unitRef="usd">3265000</cron:StockIssuedDuringPeriodValueTopupRightsExercised>
    <us-gaap:ProfitLoss
      contextRef="i15d5bb5d21934b388dac2f68df18d863_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfMzYtMTMtMS0xLTQzMDY_88fe0543-dd5e-49da-828e-320c7c29271c"
      unitRef="usd">-73137000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ic3a267e3ba2b422fb71cbfeef4f71c1d_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfMzYtMTktMS0xLTQzMDY_da9ec304-ccdb-4699-a63e-1ed29f36fb0d"
      unitRef="usd">-2133000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfMTEtMTMtMS0xLTExOTA5_74de67d7-3627-4f57-aeb9-be1d6feb560c"
      unitRef="usd">-75270000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id9981ea6f70b413c8a8fed8d7848ea09_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfMzctMTUtMS0xLTQzMDY_7b1e4bcf-5db3-4fc1-a22e-1e17b7a3e3f2"
      unitRef="usd">15161000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ic3a267e3ba2b422fb71cbfeef4f71c1d_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfMzctMTktMS0xLTQzMDY_43f8e12b-ec8e-4b33-b701-35f2650f75e4"
      unitRef="usd">-210000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfMzctMjEtMS0xLTQzMDY_49dfea8e-5067-467b-8dc8-7752a9a8f7b1"
      unitRef="usd">14951000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ie01b46877add4dd9bb362674520540d1_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfMTMtMS0xLTEtMjM0OTI_11457be1-acfa-4adf-9940-b7e1be264a02"
      unitRef="shares">360253332</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie01b46877add4dd9bb362674520540d1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfMTMtMy0xLTEtMjM0OTQ_9e56d819-9a4d-48f2-957c-c302c0802bcf"
      unitRef="usd">569260000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ieb8296c494cb4a6a89b362beeaebb94d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfMTMtNS0xLTEtMjM0OTY_4452574e-a5b8-4925-854d-1e55232c6bfb"
      unitRef="usd">34596000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7f46a47fa0d44ffa9cc475bb9cb26b30_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfMTMtNy0xLTEtMjM0OTg_a833badc-5fd3-4c43-9f4f-a13b239b386b"
      unitRef="usd">1064509000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ief7afcb557114192867857af1fa9165f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfMTMtOS0xLTEtMjM1MDA_a4f80f3b-bee2-4dda-bece-c99857e659d6"
      unitRef="usd">42999000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i05ebae3e5a2040bca90eca82e1a3f75f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfMTMtMTEtMS0xLTIzNTAy_bdf3e259-4284-4bdd-b712-3f6821c44195"
      unitRef="usd">-3196000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82NC9mcmFnOjE5MzkxMDRjZGU4MDRkZWNhNmY3NzM0YjAyZGE1OWE1L3RhYmxlOmJhYzM0OGU2YWYyODRhMWZiMjIxZjY4NTFkZmRiZjY5L3RhYmxlcmFuZ2U6YmFjMzQ4ZTZhZjI4NGExZmIyMjFmNjg1MWRmZGJmNjlfMTMtMTMtMS0xLTIzNTA0_86933615-75e6-4854-83d7-c6f66ca804fa"
      unitRef="usd">1708168000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18zLTItMS0xLTE5ODY4_8dac2b2e-4613-4b13-85fe-55137b126bbf"
      unitRef="usd">-75270000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18zLTQtMS0xLTE5ODY4_5d7a3cfe-cf3d-46eb-a841-6f7baf7b41e0"
      unitRef="usd">1165574000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18zLTYtMS0xLTE5ODY4_d41ffc2e-4a3f-4491-9307-fbd3288940b7"
      unitRef="usd">-21817000</us-gaap:ProfitLoss>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY181LTItMS0xLTE5ODY4_d008eb2d-02f4-41de-a9e9-29d7c125013f"
      unitRef="usd">129254000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY181LTQtMS0xLTE5ODY4_a610d7fc-f428-449c-9059-7adfe180fa46"
      unitRef="usd">1276819000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY181LTYtMS0xLTE5ODY4_e7daf893-d717-4958-98f7-edf136d089fb"
      unitRef="usd">0</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY182LTItMS0xLTE5ODY4_ea377b7f-6af1-4a84-b37b-66ac9ab8eada"
      unitRef="usd">40000000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY182LTQtMS0xLTE5ODY4_e8765533-6c56-4e58-8f11-e84c462b783c"
      unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY182LTYtMS0xLTE5ODY4_7beadedc-f144-4bc4-8756-4069a55cddd2"
      unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:InventoryWriteDown
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY183LTItMS0xLTE5ODY4_7cb80009-92ac-4f6c-9f56-e723de52a3b6"
      unitRef="usd">26055000</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY183LTQtMS0xLTE5ODY4_407f5958-0ac9-4e40-8619-e3cf1a754be3"
      unitRef="usd">29173000</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY183LTYtMS0xLTE5ODY4_1c2127bc-5cbb-4537-986e-cf460b0d593f"
      unitRef="usd">0</us-gaap:InventoryWriteDown>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY184LTItMS0xLTE5ODY4_e201bd0b-5fce-46b3-890c-c1b41694d081"
      unitRef="usd">3741000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY184LTQtMS0xLTE5ODY4_fa964f1e-8b86-4740-bb8d-7fc83c41155d"
      unitRef="usd">136000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY184LTYtMS0xLTE5ODY4_306f1c39-824d-4261-bd45-0073e4f160f5"
      unitRef="usd">0</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ShareBasedCompensation
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY185LTItMS0xLTE5ODY4_52c324c6-c850-412b-b286-4b4a99de44e8"
      unitRef="usd">15361000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY185LTQtMS0xLTE5ODY4_adf29a0f-f6f1-4139-aa4a-344c1e8dd1e7"
      unitRef="usd">11619000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY185LTYtMS0xLTE5ODY4_b20956a0-bf0f-4fcb-8e99-8f9273565cea"
      unitRef="usd">8151000</us-gaap:ShareBasedCompensation>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18xMS0yLTEtMS0xOTg2OA_1c1b290a-6d17-4f67-b251-deaa82905efe"
      unitRef="usd">7045000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18xMS00LTEtMS0xOTg2OA_f548f478-e97c-455f-8bdd-fe1a1522b881"
      unitRef="usd">3913000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18xMS02LTEtMS0xOTg2OA_cf21c7f1-f9fc-4c0a-a651-83578d35d6a6"
      unitRef="usd">1937000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18xMi0yLTEtMS0xOTg2OA_69607017-ce53-4938-967b-c6688d9cba41"
      unitRef="usd">-4510000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18xMi00LTEtMS0xOTg2OA_5b37cf32-1223-4f80-9b63-4ae86eca7db7"
      unitRef="usd">-2009000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18xMi02LTEtMS0xOTg2OA_9debd7ed-f48e-4a24-81c0-d2770615fb49"
      unitRef="usd">-723000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18xNS0xLTEtMS0xOTg5Nw_2c2a8d45-0223-4ab1-a0b4-ff05c86b00d4"
      unitRef="usd">4789000</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18xNS0zLTEtMS0xOTg5Nw_06ccc102-8511-42d5-9ecc-c4a252b7179c"
      unitRef="usd">16277000</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18xNS01LTEtMS0xOTg5Nw_56b144c1-2e5e-4b2c-90f2-0d1832cfed39"
      unitRef="usd">164000</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <cron:NoncashSellingAndMarketingExpense
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18xNC0xLTEtMS0yNjQ0Ng_c445d97e-a38c-467c-885f-018070afe01b"
      unitRef="usd">2863000</cron:NoncashSellingAndMarketingExpense>
    <cron:NoncashSellingAndMarketingExpense
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18xNC0zLTEtMS0yNjQ0Ng_7308e898-96d7-4b50-8ae5-372141e2d77a"
      unitRef="usd">410000</cron:NoncashSellingAndMarketingExpense>
    <cron:NoncashSellingAndMarketingExpense
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18xNC01LTEtMS0yNjQ0Ng_fbb7be93-219f-408d-a839-9b224ed2a079"
      unitRef="usd">0</cron:NoncashSellingAndMarketingExpense>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18xNi0xLTEtMS0yNjQ0Ng_b719dcea-cae1-4e24-80aa-2f5b2a212940"
      unitRef="usd">1347000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18xNi0zLTEtMS0yNjQ0Ng_ddd62565-f2a3-4be2-bc6f-65ddb9d8080f"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18xNi01LTEtMS0yNjQ0Ng_a97437ec-1b15-422c-9a5d-1844bf038c16"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:RestructuringCosts
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18xNy0xLTEtMS0yNjQ0Ng_cedf198a-7e09-4ca4-af52-0892d68b8cd1"
      unitRef="usd">0</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18xNy0zLTEtMS0yNjQ0Ng_1e0664bd-b68a-4c24-8280-446cc023b459"
      unitRef="usd">4439000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18xNy01LTEtMS0yNjQ0Ng_6ac585f2-0c28-46c2-8be6-95f15d93d880"
      unitRef="usd">0</us-gaap:RestructuringCosts>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18xOC0xLTEtMS0yNjQ1MA_1bc4e43a-f57f-4f3f-bf83-73541b85d174"
      unitRef="usd">123000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18xOC0zLTEtMS0yNjQ1MA_0bac8268-6018-4223-9975-a01eaa2fa110"
      unitRef="usd">243000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18xOC01LTEtMS0yNjQ1MA_70afb9d6-6cd3-4c07-b0b2-574698b5a894"
      unitRef="usd">9000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInOperatingCapital
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18xOS0yLTEtMS0xOTg2OA_a01f998c-c201-49d5-b845-92e30e310f85"
      unitRef="usd">33943000</us-gaap:IncreaseDecreaseInOperatingCapital>
    <us-gaap:IncreaseDecreaseInOperatingCapital
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18xOS00LTEtMS0xOTg2OA_bd26ad3f-56a2-4856-aa4f-2c793cdd7cf9"
      unitRef="usd">54208000</us-gaap:IncreaseDecreaseInOperatingCapital>
    <us-gaap:IncreaseDecreaseInOperatingCapital
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18xOS02LTEtMS0xOTg2OA_c14b8251-5066-4e06-9159-faea425c8d20"
      unitRef="usd">-3662000</us-gaap:IncreaseDecreaseInOperatingCapital>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18yMC0yLTEtMS0xOTg2OA_c3cea6ac-a870-4a85-8af2-b43b9ced28b2"
      unitRef="usd">-142457000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18yMC00LTEtMS0xOTg2OA_9575c75d-57f0-4c00-ad36-348d291c9047"
      unitRef="usd">-130274000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18yMC02LTEtMS0xOTg2OA_f782b2cf-9e62-42e7-b419-7f28e2cdc800"
      unitRef="usd">-7517000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18yMi0yLTEtMS0xOTg2OA_6955a041-fc7f-40c0-b74d-4c766dfc8c70"
      unitRef="usd">95404000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18yMi00LTEtMS0xOTg2OA_81f20b4d-c3cb-46e0-b799-e1239f38e617"
      unitRef="usd">299923000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18yMi02LTEtMS0xOTg2OA_38b04a66-60d7-4cc1-8711-0b91e626c463"
      unitRef="usd">0</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18yNC0yLTEtMS0xOTg2OA_553184d6-02e6-4886-9e2e-4d15d8d6ab0c"
      unitRef="usd">0</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18yNC00LTEtMS0xOTg2OA_48b383da-d189-4315-a8b8-42dfc2ac1ac2"
      unitRef="usd">1658000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18yNC02LTEtMS0xOTg2OA_d37e41c7-b1a0-4539-ade8-870e4df8b5e8"
      unitRef="usd">480000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <cron:ProceedsFromEquitySecuritiesFVNIAndEquitySecuritiesWithoutDeterminableFairValue
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18yNS0yLTEtMS0xOTg2OA_e1e4f467-fab1-4675-818e-4ba2d012d0f8"
      unitRef="usd">4789000</cron:ProceedsFromEquitySecuritiesFVNIAndEquitySecuritiesWithoutDeterminableFairValue>
    <cron:ProceedsFromEquitySecuritiesFVNIAndEquitySecuritiesWithoutDeterminableFairValue
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18yNS00LTEtMS0xOTg2OA_357240a9-7d85-403c-8f92-2025c43d22fb"
      unitRef="usd">19614000</cron:ProceedsFromEquitySecuritiesFVNIAndEquitySecuritiesWithoutDeterminableFairValue>
    <cron:ProceedsFromEquitySecuritiesFVNIAndEquitySecuritiesWithoutDeterminableFairValue
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18yNS02LTEtMS0xOTg2OA_004c2134-6e36-4aa0-8185-04347d3fea27"
      unitRef="usd">747000</cron:ProceedsFromEquitySecuritiesFVNIAndEquitySecuritiesWithoutDeterminableFairValue>
    <us-gaap:PaymentsToAcquireInterestInJointVenture
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18yNi0yLTEtMS0xOTg2OA_7cca458b-8ee1-42fa-b64f-0f9c61cb7ef3"
      unitRef="usd">0</us-gaap:PaymentsToAcquireInterestInJointVenture>
    <us-gaap:PaymentsToAcquireInterestInJointVenture
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18yNi00LTEtMS0xOTg2OA_59a1fa5c-bd05-4922-bb6c-80a9698f8fad"
      unitRef="usd">15135000</us-gaap:PaymentsToAcquireInterestInJointVenture>
    <us-gaap:PaymentsToAcquireInterestInJointVenture
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18yNi02LTEtMS0xOTg2OA_277587e5-b598-4bf5-aaff-810d8f6ac1d6"
      unitRef="usd">5358000</us-gaap:PaymentsToAcquireInterestInJointVenture>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18yNy0yLTEtMS0xOTg2OA_8c383f45-5463-43ca-b921-bcf2e4017b2b"
      unitRef="usd">31412000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18yNy00LTEtMS0xOTg2OA_af9cf4a3-850b-4212-b7fb-58b81c9fc7e3"
      unitRef="usd">38664000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18yNy02LTEtMS0xOTg2OA_6f55dedf-8cbc-4c6b-9320-dbf32132fac5"
      unitRef="usd">88308000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18yOC0yLTEtMS0xOTg2OA_26517278-3999-4f8d-8770-ed9680a43d8c"
      unitRef="usd">3979000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18yOC00LTEtMS0xOTg2OA_513968f1-33c8-45e3-80bd-643c3a6e17e7"
      unitRef="usd">289000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18yOC02LTEtMS0xOTg2OA_5a1e21f0-7799-470f-8a1e-d7fb080b4b17"
      unitRef="usd">278000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18yOS0yLTEtMS0xOTg2OA_a6e84014-e580-4d0b-858b-c244129e798d"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18yOS00LTEtMS0xOTg2OA_71f31643-44ed-4cff-a9bc-10976d9be568"
      unitRef="usd">224295000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18yOS02LTEtMS0xOTg2OA_0f6ae20c-fb64-4e2d-aa99-270e63e8c4a0"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireLoansReceivable
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18zMC0yLTEtMS0xOTg2OA_cdc46be5-3cfe-4a66-bc78-2fcd5e841a94"
      unitRef="usd">44652000</us-gaap:PaymentsToAcquireLoansReceivable>
    <us-gaap:PaymentsToAcquireLoansReceivable
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18zMC00LTEtMS0xOTg2OA_4ed85ddc-6f61-4cfa-8148-930e56ebd854"
      unitRef="usd">43337000</us-gaap:PaymentsToAcquireLoansReceivable>
    <us-gaap:PaymentsToAcquireLoansReceivable
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18zMC02LTEtMS0xOTg2OA_50014830-c5a7-4cc2-9e74-c2e232c5cb49"
      unitRef="usd">0</us-gaap:PaymentsToAcquireLoansReceivable>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18zMS0yLTEtMS0xOTg2OA_44e52087-afae-4f4d-813f-b56753b5639e"
      unitRef="usd">0</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18zMS00LTEtMS0xOTg2OA_a0471e11-5597-4d45-9b6c-07a0335a55f6"
      unitRef="usd">-415000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18zMS02LTEtMS0xOTg2OA_9b964c4a-34cc-49d4-897f-a0afdc6a9aa5"
      unitRef="usd">231000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18zNS0yLTEtMS0xOTg2OA_3ca39580-9fa0-4a79-8120-cf7296b900f4"
      unitRef="usd">20150000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18zNS00LTEtMS0xOTg2OA_38c5c6e1-64f8-4e3e-b807-637b2991ba26"
      unitRef="usd">-603272000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18zNS02LTEtMS0xOTg2OA_b35e2a8d-cfc9-4657-88ad-ed7521e16669"
      unitRef="usd">-93908000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18zMy0xLTEtMS0yNjQ5NQ_21d22220-7f45-4eec-a5a7-1ea968da3d62"
      unitRef="usd">1019000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18zMy0zLTEtMS0yNjQ5NQ_3504c22b-f9ca-4578-a902-8d6337c292f0"
      unitRef="usd">0</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18zMy01LTEtMS0yNjQ5NQ_2e5548bd-7488-4106-b77c-8f4eba83a832"
      unitRef="usd">0</us-gaap:PaymentsToMinorityShareholders>
    <cron:PaymentsForLeaseObligationsFinancingActivities
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18zNC0xLTEtMS0yNjQ5NQ_881b41fe-2302-467d-aa3a-e3a05ce65d83"
      unitRef="usd">2414000</cron:PaymentsForLeaseObligationsFinancingActivities>
    <cron:PaymentsForLeaseObligationsFinancingActivities
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18zNC0zLTEtMS0yNjQ5NQ_dc63a46a-64b0-4f25-ae03-219b27eb7724"
      unitRef="usd">919000</cron:PaymentsForLeaseObligationsFinancingActivities>
    <cron:PaymentsForLeaseObligationsFinancingActivities
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18zNC01LTEtMS0yNjQ5NQ_c487536b-d809-406b-8f44-b38dec4a66c6"
      unitRef="usd">0</cron:PaymentsForLeaseObligationsFinancingActivities>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18zNS0xLTEtMS0yNjQ5NQ_597186a6-fdb5-4cac-80ff-1b1b632fbbb4"
      unitRef="usd">2148000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18zNS0zLTEtMS0yNjQ5NQ_8c05bdaa-2446-4f14-8d2a-64add38b1dcd"
      unitRef="usd">915000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18zNS01LTEtMS0yNjQ5NQ_3207ea2c-dc4f-4503-a6db-31852a395b6f"
      unitRef="usd">16000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i1e0536e1b0794acda99e2177b6ebf26b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18zNy0yLTEtMS0xOTg2OA_6c9ff1bd-5454-4467-a61b-d88516acbbef"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i7926d13ed9d346928f338c20da686971_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18zNy00LTEtMS0xOTg2OA_4c8836d5-6d92-4c24-9472-663b0c0f4e50"
      unitRef="usd">1809556000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="ia490cd7402e84baa81df3299a30e84ee_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18zNy02LTEtMS0xOTg2OA_15dc6f55-3e65-46c6-b416-b45953e10ed0"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <cron:ProceedsFromRightExercises
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18zOC0yLTEtMS0xOTg2OA_7681a905-eb4f-43f3-9320-d38a28b2fce5"
      unitRef="usd">0</cron:ProceedsFromRightExercises>
    <cron:ProceedsFromRightExercises
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18zOC00LTEtMS0xOTg2OA_7220621a-44f7-4d09-ac9a-7d2a89346dd9"
      unitRef="usd">67051000</cron:ProceedsFromRightExercises>
    <cron:ProceedsFromRightExercises
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18zOC02LTEtMS0xOTg2OA_c6620594-914a-4109-93d7-6383a7c8e05f"
      unitRef="usd">0</cron:ProceedsFromRightExercises>
    <cron:ProceedsFromWarrantExercisedAndStockOptionsExercised
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18zOS0yLTEtMS0xOTg2OA_7c8aea06-d350-489b-a254-2f0d0cc5d7e2"
      unitRef="usd">116000</cron:ProceedsFromWarrantExercisedAndStockOptionsExercised>
    <cron:ProceedsFromWarrantExercisedAndStockOptionsExercised
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18zOS00LTEtMS0xOTg2OA_a3ee4f70-b67f-4f7d-abe3-cff12dc5ec94"
      unitRef="usd">1455000</cron:ProceedsFromWarrantExercisedAndStockOptionsExercised>
    <cron:ProceedsFromWarrantExercisedAndStockOptionsExercised
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY18zOS02LTEtMS0xOTg2OA_8a058ccc-9121-4dc5-808a-d4b8133dfd85"
      unitRef="usd">2612000</cron:ProceedsFromWarrantExercisedAndStockOptionsExercised>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="idb90674122f048f78e4d13f37583db9f_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY180MC0yLTEtMS0xOTg2OA_6e874e36-cd9f-43ec-bc00-ea263daade33"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="id725b798c0734bb0a1f1ef33fa132b50_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY180MC00LTEtMS0xOTg2OA_9ffa5f10-7376-4c12-8332-65981cc565f5"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i9d7cc358c6d64ac19ef8563642446a56_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY180MC02LTEtMS0xOTg2OA_70b07465-a2bd-43d0-b6b5-005af9f1cbc3"
      unitRef="usd">115510000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY180MS0yLTEtMS0xOTg2OA_fea3f57e-5ede-4155-a926-dad3a0f84460"
      unitRef="usd">0</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY180MS00LTEtMS0xOTg2OA_bfdbb2a5-282c-4936-ba38-2883673e7319"
      unitRef="usd">3722000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY180MS02LTEtMS0xOTg2OA_4f56738d-defc-42d5-8db7-a74aae33d7c7"
      unitRef="usd">7577000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:ProceedsFromIssuanceOfSecuredDebt
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY180Mi0yLTEtMS0xOTg2OA_e1b8f0c5-42da-477f-900e-4beafff4e57f"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfSecuredDebt>
    <us-gaap:ProceedsFromIssuanceOfSecuredDebt
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY180Mi00LTEtMS0xOTg2OA_0043ace9-2525-4423-bac0-e0d300744232"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfSecuredDebt>
    <us-gaap:ProceedsFromIssuanceOfSecuredDebt
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY180Mi02LTEtMS0xOTg2OA_7c5b1290-9696-42d6-a941-6b6bed45c34f"
      unitRef="usd">11583000</us-gaap:ProceedsFromIssuanceOfSecuredDebt>
    <us-gaap:RepaymentsOfSecuredDebt
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY180My0yLTEtMS0xOTg2OA_c3437dab-fb10-4990-9b75-3a6c5afb6ed2"
      unitRef="usd">0</us-gaap:RepaymentsOfSecuredDebt>
    <us-gaap:RepaymentsOfSecuredDebt
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY180My00LTEtMS0xOTg2OA_a851ef3c-6b72-4cb4-9384-5f79580ee557"
      unitRef="usd">15971000</us-gaap:RepaymentsOfSecuredDebt>
    <us-gaap:RepaymentsOfSecuredDebt
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY180My02LTEtMS0xOTg2OA_f32ddce7-e96d-4f3d-bfbc-359e75bc50a3"
      unitRef="usd">0</us-gaap:RepaymentsOfSecuredDebt>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY180NC0yLTEtMS0xOTg2OA_4e0255e1-4e2b-4a80-b478-f3a1f13b299e"
      unitRef="usd">0</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY180NC00LTEtMS0xOTg2OA_1db93f80-da53-4317-bae3-bdd930ff8a58"
      unitRef="usd">48715000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY180NC02LTEtMS0xOTg2OA_b21cc1ff-d939-4ceb-994a-5fc23feab307"
      unitRef="usd">0</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:RepaymentsOfLongTermLinesOfCredit
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY180NS0yLTEtMS0xOTg2OA_831726e9-9eef-4c14-9261-69b23909b186"
      unitRef="usd">0</us-gaap:RepaymentsOfLongTermLinesOfCredit>
    <us-gaap:RepaymentsOfLongTermLinesOfCredit
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY180NS00LTEtMS0xOTg2OA_8b2eb6b7-7780-46e0-9739-489a5d77bd74"
      unitRef="usd">48309000</us-gaap:RepaymentsOfLongTermLinesOfCredit>
    <us-gaap:RepaymentsOfLongTermLinesOfCredit
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY180NS02LTEtMS0xOTg2OA_9fd57494-9eec-4b85-b35c-b0c244123a35"
      unitRef="usd">0</us-gaap:RepaymentsOfLongTermLinesOfCredit>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY181MS0yLTEtMS0xOTg2OA_74a08c96-d583-4d24-8c9a-f6e2e06a2c5f"
      unitRef="usd">-5465000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY181MS00LTEtMS0xOTg2OA_635e22e3-9730-46bf-885f-864e8e5fd968"
      unitRef="usd">1856941000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY181MS02LTEtMS0xOTg2OA_965958bb-d2df-4d9c-b9f0-aebac75956bb"
      unitRef="usd">122112000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY181Mi0yLTEtMS0xOTg2OA_3f4cdb2d-7add-4bae-b765-f018475fd6e8"
      unitRef="usd">6102000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY181Mi00LTEtMS0xOTg2OA_d1a0f27e-42c4-4a43-a915-ab0b1988db2a"
      unitRef="usd">52371000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY181Mi02LTEtMS0xOTg2OA_f098a1bb-df2e-4972-b85b-e443fe491c63"
      unitRef="usd">-4085000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY181My0yLTEtMS0xOTg2OA_04dfed5e-5220-46c6-b05c-7fd03a5fa34b"
      unitRef="usd">-121670000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY181My00LTEtMS0xOTg2OA_8c40ae3c-8a83-4af5-9e24-84d94599faab"
      unitRef="usd">1175766000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY181My02LTEtMS0xOTg2OA_ce2fd1ce-405b-4d8b-881f-ebb703435f93"
      unitRef="usd">16602000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY181NC0yLTEtMS0xOTg2OA_7e32501b-a925-4a8b-8604-932df0c858b6"
      unitRef="usd">1199693000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i9717dc3b24b24c93ab09a6bfa9b52c89_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY181NC00LTEtMS0xOTg2OA_9f711bc0-7c28-415d-85ab-d2ded0cb0ba6"
      unitRef="usd">23927000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ieb4bf06122354c15966cf5343aa018a5_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY181NC02LTEtMS0xOTg2OA_0078b7dd-38d1-4e53-80f5-19f7e486162b"
      unitRef="usd">7325000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY181NS0yLTEtMS0xOTg2OA_3cbddb51-2860-41ce-bd7e-cab6b414db16"
      unitRef="usd">1078023000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY181NS00LTEtMS0xOTg2OA_db85c9b7-65f1-4c68-8e58-5269c9359f24"
      unitRef="usd">1199693000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i9717dc3b24b24c93ab09a6bfa9b52c89_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY181NS02LTEtMS0xOTg2OA_680b0b6f-7824-42b7-9d37-0d5d9aa440f3"
      unitRef="usd">23927000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:NatureOfOperations
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83MC9mcmFnOjM4ZTViOTdkM2UzNzQyNmRhZjVhOGY1YmYzOGNjZWRjL3RleHRyZWdpb246MzhlNWI5N2QzZTM3NDI2ZGFmNWE4ZjViZjM4Y2NlZGNfMTY1Ng_69b0c094-4c37-4038-be6e-758520e8debe">Background&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cronos Group Inc. (&#x201c;Cronos Group&#x201d; or the &#x201c;Company&#x201d;) is incorporated in the Province of British Columbia and under the British Columbia Business Corporations Act with principal executive offices at 111 Peter St. Street, Suite 300, Toronto, Ontario, M5V 2H1. The Company&#x2019;s common shares are currently listed on the Toronto Stock Exchange (&#x201c;TSX&#x201d;) and Nasdaq Global Market (&#x201c;Nasdaq&#x201d;) under the ticker symbol &#x201c;CRON.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cronos Group is an innovative global cannabinoid company, with international production and distribution across five continents. The Company is committed to building disruptive intellectual property by advancing cannabis research, technology and product development and is seeking to build an iconic brand portfolio. Cronos Group&#x2019;s brand portfolio includes PEACE NATURALS&#x2122;, a global wellness platform; two adult-use brands, COVE&#x2122; and Spinach&#x2122;; and three U.S hemp-derived consumer products brands, Lord Jones&#x2122;, Happy Dance&#x2122; and PEACE+&#x2122;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cronos Group has established four strategic joint ventures in Canada, Israel, and Colombia. Cronos Israel (as defined herein) is consolidated for financial reporting purposes. The Company also holds approximately 31% of the issued capital of Cronos Australia Limited (&#x201c;Cronos Australia&#x201d;) and accounts for its investment in Cronos Australia under the equity method of accounting. For additional discussion regarding the joint ventures and strategic investment, see Note 6.&lt;/span&gt;&lt;/div&gt;</us-gaap:NatureOfOperations>
    <cron:NumberOfContinentsWithInternationalProductionAndDistribution
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83MC9mcmFnOjM4ZTViOTdkM2UzNzQyNmRhZjVhOGY1YmYzOGNjZWRjL3RleHRyZWdpb246MzhlNWI5N2QzZTM3NDI2ZGFmNWE4ZjViZjM4Y2NlZGNfNjA0NzMxMzk1NTI3Mg_9156dfc0-bd1c-449b-bf96-25ce8c64105e"
      unitRef="continent">5</cron:NumberOfContinentsWithInternationalProductionAndDistribution>
    <cron:NumberOfAdultuseBrands
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83MC9mcmFnOjM4ZTViOTdkM2UzNzQyNmRhZjVhOGY1YmYzOGNjZWRjL3RleHRyZWdpb246MzhlNWI5N2QzZTM3NDI2ZGFmNWE4ZjViZjM4Y2NlZGNfNjA0NzMxMzk1NTI4NQ_6a35ba44-8afe-4de3-9706-72d03884c563"
      unitRef="brand">2</cron:NumberOfAdultuseBrands>
    <cron:NumberOfHempderivedCannabidiolPersonalCareBrands
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83MC9mcmFnOjM4ZTViOTdkM2UzNzQyNmRhZjVhOGY1YmYzOGNjZWRjL3RleHRyZWdpb246MzhlNWI5N2QzZTM3NDI2ZGFmNWE4ZjViZjM4Y2NlZGNfMjMwODk3NDQxODkzNDI_94273b9f-4d9e-422c-92b8-5cf5f8f9ce35"
      unitRef="brand">3</cron:NumberOfHempderivedCannabidiolPersonalCareBrands>
    <cron:NumberOfStrategicJointVentures
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83MC9mcmFnOjM4ZTViOTdkM2UzNzQyNmRhZjVhOGY1YmYzOGNjZWRjL3RleHRyZWdpb246MzhlNWI5N2QzZTM3NDI2ZGFmNWE4ZjViZjM4Y2NlZGNfNjA0NzMxMzk1NTI5OA_88966557-b3d2-4b96-8b68-6ff5e27d2b62"
      unitRef="venture">4</cron:NumberOfStrategicJointVentures>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i4a854431fb9b495d990aeb067616e389_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83MC9mcmFnOjM4ZTViOTdkM2UzNzQyNmRhZjVhOGY1YmYzOGNjZWRjL3RleHRyZWdpb246MzhlNWI5N2QzZTM3NDI2ZGFmNWE4ZjViZjM4Y2NlZGNfMTE5OQ_3db40da1-a27d-400d-a774-cf8238d9853d"
      unitRef="number">0.31</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RleHRyZWdpb246ZjIyNzhkY2ZkYzhhNDMwMmJiMzM1YWU4Mjc1OTU2NTBfMjMwODk3NDQyMjgzOTk_a40995e0-4e9e-4aaa-a5bc-58755cd277fe">Summary of Significant Accounting Policies &lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt"&gt;Basis of presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;U.S. GAAP&#x201d;). U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities at the dates of the consolidated financial statements and the reported amounts of net revenues and expenses during the reporting periods. The accounting policies adopted in the preparation of the consolidated financial statements were effective as of January 1, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt"&gt;Segment structure&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company undertook a realignment of its management structure along geographic regions in September 2019. As a result, effective September 2019, the Company&#x2019;s results are reported through the following operating segments: United States and Rest of World. Prior period amounts contained in these consolidated financial statements have been adjusted to conform to the new segment presentation. Refer to Note 29 for additional information. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(c)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.91pt"&gt;Basis of consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying consolidated financial statements include the accounts of the Company, and all entities in which the Company has a controlling voting interest or is the primary beneficiary of a variable interest as of and for the fiscal years ended December&#160;31, 2020, December&#160;31, 2019 and December&#160;31, 2018. The Company assesses control under the variable interest entity (&#x201c;VIE&#x201d;) model to determine whether the Company is the primary beneficiary of that entity&#x2019;s operations.&#160;If an entity is not deemed to be a VIE, the Company consolidates the entity if the Company has a controlling&#160;voting interest. Subsidiaries are fully consolidated from the date on which control is transferred to the Company. They are deconsolidated from the date that control ceases. Investments in which the Company has the ability to exercise significant influence over the operating and financial policies of the investee, but does not have control, are accounted for under the equity method of accounting. The Company consolidates the financial results of the following entities, which the Company controls:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.902%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Subsidiaries &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Jurisdiction of incorporation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Incorporation date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Ownership interest &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cronos Israel G.S. Cultivation Ltd.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Israel&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 4, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cronos Israel G.S. Manufacturing Ltd.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Israel&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 4, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cronos Israel G.S. Store Ltd.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Israel&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 28, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cronos Israel G.S. Pharmacy Ltd.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Israel&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 15, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt"&gt;These Israeli entities are collectively referred to as &#x201c;Cronos Israel.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt"&gt;&#x201c;Ownership interest&#x201d; is defined as the proportionate share of net income to which the Company is entitled; equity interest may differ from ownership interest as described herein. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the consolidated statements of net income (loss) and comprehensive income (loss), the net income (loss) and comprehensive income (loss) are attributed to the equity holders of the Company and to the non-controlling interests. Non-controlling interests in the equity of Cronos Israel are presented separately in the shareholders&#x2019; equity (deficit) section of the consolidated balance sheets and consolidated statements of shareholders&#x2019; equity (deficit). All intercompany transactions and balances are eliminated upon consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(d)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt"&gt;Use of estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Significant estimates and assumptions include, among other things, valuation of derivative liabilities, fair value of assets and liabilities assumed in business combinations, impairment of goodwill, inventory write-downs, valuation allowance on deferred income tax assets and uncertain tax liabilities. Actual results could differ from those estimates. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(e)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.91pt"&gt;Revenue recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s contracts with customers for the sale of dried cannabis, cannabis oil, cannabinoid-derived products and U.S. hemp-derived personal care products consist of one performance obligation. The Company has concluded that revenue from the sale of these products should be recognized at the point in time when control is transferred to the customer, which is on shipment or delivery, depending on the contract. Revenue is recognized at the transaction price, which is the amount of consideration to which the Company expects to be entitled in exchange for transferring promised goods to a customer. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net revenue before excise taxes from sale of goods, as presented in the consolidated statements of net income (loss) and comprehensive income (loss), represents revenue from the sale of goods less expected price discounts, and allowances for customer returns. Net revenue before excise taxes excludes excise taxes, which the Company pays as principal and excludes duties and taxes collected on behalf of third parties. Excise taxes are a production tax classified as government remittances payable, which when applicable, become payable when a product is delivered to the customer and are not directly related to the value of revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company treats shipping and handling activities as a fulfillment cost, classified as cost of sales. Accordingly, the Company accrues all fulfillment costs related to the shipping and handling of consumer goods at the time of shipment. Within the Company's Rest of World segment, dried cannabis sales outside of Canada may include profit sharing arrangements with distributors which give rise to variable consideration. If the consideration in a contract includes a variable amount, the Company estimates the amount of consideration to which it will be entitled in exchange for transferring the goods to the customer. The variable consideration is estimated as the most likely amount, based on the Company&#x2019;s historical information, at contract inception.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s payment terms vary by customer and product type. For individual consumer sales, payment is due prior to the transfer of control. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company elected to treat the costs incurred to obtain a contract, primarily related to sales commissions, as an expense in the period incurred and not an asset to be capitalized, as the amortization period of the related asset would be less than one year. Accordingly, the Company will expense the costs to obtain a contract in the period incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(f)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.01pt"&gt;Investments &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Variable interest entities (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;VIE&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A VIE is an entity having either a total equity investment that is insufficient to finance its activities without additional subordinated financial support or equity investors at risk that lack the ability to control the entity&#x2019;s activities. Variable interests are investments or other interests that will absorb portions of a VIE&#x2019;s expected losses or receive portions of the VIE&#x2019;s expected residual returns. The Company evaluates whether it is the primary beneficiary of each VIE it identifies on an ongoing basis and considers the impact of any reconsideration events. The primary beneficiary is the party that has both the power to direct the activities that most significantly impact the VIE and holds a variable interest that could potentially be significant to the VIE. To make this determination the Company considers both quantitative and qualitative factors regarding the nature, size and form of its involvement with the VIE. The Company consolidates the VIE when it is determined that it is the primary beneficiary of the VIE.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Equity method investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for investments in companies over which it has the ability to exercise significant influence but does not hold a controlling financial interest, using the equity method. Under the equity method, the Company records its proportionate share of income or losses in the consolidated statements of net income (loss) and comprehensive income (loss). If the current fair value of an investment falls below its carrying amount, this may indicate that an impairment loss should be recorded. Any impairment losses recognized cannot be reversed in subsequent periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(g)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt"&gt;Inventory&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory is comprised of raw materials, finished goods and work-in-progress such as pre-harvested cannabis plants, by-products to be extracted, oils, gel caps, tinctures, and boxes. The costs of growing cannabis, including but not limited to labor, utilities, nutrition and irrigation, are capitalized into inventory until the time of harvest.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory is stated at the lower of cost and net realizable value, determined using weighted average cost. Cost includes expenditures directly related to manufacturing and distribution of the products. Primary costs include consumables (insect control, fertilizers, soil), packaging, shipping, direct labor, overhead, supplies and small tools, and the depreciation of manufacturing equipment and production facilities determined at normal capacity. Manufacturing overhead and related expenses include salaries, wages, employee benefits, rent, utilities, security, and property taxes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net realizable value is defined as the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. At the end of each reporting period, the Company performs an assessment of inventory obsolescence to measure inventory at the lower of cost and net realizable value. Factors considered in the determination of obsolescence include slow-moving or non-marketable products. During the year ended December 31, 2020, we incurred significant inventory write-downs driven by pricing pressures in the marketplace and will continue assessing pricing pressures on the value of inventory at the end of each reporting period. See Note 5.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(h)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt"&gt;Definite life intangible assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets are recorded at cost less any accumulated amortization and accumulated impairment losses. Intangible assets acquired through a business combination are measured at fair value at the acquisition date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company capitalizes certain costs incurred in connection with its enterprise software, which include external direct costs of materials and services consumed in developing or obtaining internal-use software, payroll and payroll-related costs for employees who are directly associated with and who devote time to the development of the software for the function intended. All other costs are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets with finite useful lives are amortized over their estimated useful lives using the following methods and rates:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.617%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.608%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Method&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Rate&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Straight-line&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Enterprise resource planning (&#x201c;ERP&#x201d;) software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Straight-line&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health Canada licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Straight-line&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Useful life of corresponding facilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Israeli codes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Straight-line&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Useful life of corresponding facilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;The preliminary licenses granted to Kibbutz Gan Shmuel (the Cronos Israel joint venture partner) by the Medical Cannabis&#160;Unit of the Israeli Ministry of Health in early 2017 (the &#x201c;Israeli codes&#x201d;) were transferred by non-controlling interests to Cronos Israel in exchange for equity interests in the Cronos Israel entities specified above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization begins when assets become available for use. The estimated useful life, amortization method, and rate are reviewed at the end of each reporting period, with the effect of any changes in estimate being accounted for on a prospective basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.57pt"&gt;Property, plant &amp;amp; equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment are stated at cost less accumulated depreciation and accumulated impairment losses. Depreciation is computed using the straight-line method over the estimated useful lives of the assets as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.927%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.873%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Rate&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15 to 25 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 to 7 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lesser of term of lease and useful life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment under finance lease&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lesser of term of lease and useful life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When assets are disposed of, the cost and accumulated depreciation are removed from the respective accounts and any related gain or loss is recognized. Maintenance and repairs are charged to expense as incurred. Significant expenditures, which increase productivity or extend the useful life of the asset, are capitalized. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest incurred relating to construction or expansion of buildings is capitalized to construction in progress. The Company ceases the capitalization of interest when construction activities are substantially completed and the facility is available for use. At this point, construction in progress is transferred to the appropriate asset class. Available for use is defined as the point at which the related building receives the requisite regulatory licenses to (i) possess cannabis, (ii) obtain dried cannabis, fresh cannabis, cannabis plants or cannabis plant seeds by cultivating, propagating and harvesting cannabis, and (iii) produce cannabis, other than obtaining it by cultivating, propagating, or harvesting. Depreciation commences at the point the assets are available for use.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(j)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.01pt"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company enters into leases in the normal course of business, primarily for the land-use rights, office premises, and equipment used in the production of its products. At the inception of a contract, the Company assesses whether a contract is, or contains, a lease. A contract is, or contains, a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. The Company performs an analysis over the classification of the lease agreement as either an operating lease or finance lease. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A right-of-use asset and the related lease obligation associated with the lease are recorded at the inception of the lease. The right-of-use asset&#x2019;s recorded amount is based on the present value of future lease payments over the lease term at the commencement date plus any initial direct costs incurred. If the rate implicit in the lease is not readily determinable for the Company&#x2019;s operating leases, an incremental borrowing rate is generally used based on information available at the lease commencement date to determine the present value of future lease payments. Subsequent changes to these lease payments due to rate updates are recorded as lease expense in the period incurred. Leases with a term of 12 months or less are not recorded on the balance sheet as a lease. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The right-of-use asset is subject to impairment testing whenever events or changes in circumstances indicate the carrying value of the asset may not be recoverable. The leased asset is amortized over the shorter of the lease term or its estimated useful life if title does not transfer to the Company, while the leased asset is depreciated in accordance with the Company&#x2019;s depreciation policy if the title is to eventually transfer to the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s lease agreements generally exclude non-lease components. As a result, non-lease components are accounted for separately for all classes of assets and expensed as incurred. In addition, the Company&#x2019;s lease agreements do not contain any material residual value guarantees or material restrictive covenants. For finance leases, from the commencement date to the earlier of the end of the useful life of the right-of-use asset or the end of the lease term, the right-of-use asset is amortized on a straight-line basis and the interest expense is recognized on the lease liability using the effective interest method. For operating leases, lease expense is recognized on a straight-line basis over the term of the lease and presented as a single charge in the consolidated statements of net income (loss) and comprehensive income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(k)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt"&gt;Impairment of long-lived assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. The Company groups assets at the lowest level for which cash flows are separately identifiable, referred to as an asset group. The Company prepares projected undiscounted cash flow analyses for each asset or asset group. If the sum of the undiscounted cash flow is less than the carrying value of the asset or asset group, an impairment loss is recognized equal to the excess of the carrying value over the fair value, if any. Impairment losses on assets held for sale are based on the fair value, less costs to sell.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill and indefinite life intangible assets are not amortized. Goodwill and indefinite life intangible assets are reviewed for impairment annually or more frequently when events or changes in circumstances indicate that fair value of the reporting unit has been reduced to less than its carrying value. The Company performs an impairment test annually in the fourth quarter by comparing the fair value of the reporting unit with its carrying amount, including goodwill. If the fair value of the reporting unit exceeds its carrying amount, goodwill is not considered to be impaired. An impairment charge would be recognized for the amount by which the carrying amount exceeds the reporting unit&#x2019;s fair value. The Company determined that it has two reporting units: the U.S. reporting unit and the Rest of World reporting unit. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(l)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.57pt"&gt;Repurposing charges&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s repurposing charges primarily include employee termination benefits and refurbishment costs. The recognition of repurposing charges requires the Company make certain judgments and estimates regarding the nature, timing, and amount of costs associated with the planned activity. To the extent actual results differ from estimates and assumptions, a revision to the estimated liabilities, requiring the recognition of additional repurposing charges or the reduction of liabilities already recognized may be required. At the end of each reporting period, the Company evaluates the remaining accrued balances to ensure these balances are properly stated and the utilization of the reserves are for their intended purpose in accordance with planned activity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(m)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:21.01pt"&gt;Capital stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Capital stock is presented at the fair value at the time of issuance of the shares issued. Costs related to the issuance of shares are reported in equity, net of tax, as a deduction from the issuance proceeds.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(n)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt"&gt;Foreign currency&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s functional currency is the Canadian dollar (&#x201c;C$&#x201d;). Prior to the year ended December 31, 2019, the Company reported its financial results in C$, however following the change in the Company&#x2019;s status from foreign private issuer to a United States (&#x201c;U.S.&#x201d;) domestic issuer, the financial results are now reported in U.S dollars (&#x201c;dollars&#x201d; or &#x201c;$&#x201d;). Functional currencies for the entities in these consolidated financial statements are their respective local currencies, including C$, Australian dollars (&#x201c;A$&#x201d;) and Israeli New Shekel (&#x201c;ILS&#x201d;). The assets and liabilities of the Company&#x2019;s foreign operations are translated into dollars at the exchange rate in effect as of December&#160;31, 2020 and 2019. Transactions affecting the shareholders&#x2019; equity (deficit) are translated at historical foreign exchange rates. The consolidated statements of net income (loss) and comprehensive income (loss) and the consolidated statements of cash flows of the Company&#x2019;s foreign operations are translated into dollars by applying the average foreign exchange rate in effect for the reporting period. The cumulative translation adjustments (&#x201c;CTA&#x201d;) resulting from translating the consolidated financial statements into their dollar reporting currency are recorded in other comprehensive income (loss). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Monetary assets and liabilities denominated in foreign currencies are translated to the functional currency by applying the foreign exchange rate in effect at the balance sheet date. Revenues and expenses are translated using the average foreign exchange rate for the reporting period. Realized and unrealized foreign currency differences are recognized in the consolidated statements of net income (loss) and comprehensive income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Transactions in foreign currencies are translated into the functional currency using the exchange rate prevailing at the date of the transaction and are recorded in other comprehensive income. Exchange differences arising from operating transactions are recorded in net income for the period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(o)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt"&gt;Income taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses the liability method of accounting for income taxes, under which deferred tax assets and liabilities are recognized for the future tax consequences attributable to the differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted tax rates expected to be in effect when such assets and liabilities are recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the year that includes the enactment date. The Company determines deferred tax assets including net operating losses and liabilities, based on temporary differences between the book and tax bases of assets and liabilities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A valuation allowance is established to reduce some or all net deferred tax assets to amounts that are more likely than not to be realized. The Company considers all available evidence, both positive and negative including past operating results, estimates of future taxable income, and the feasibility of tax planning strategies, in assessing the need for a valuation allowance. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has a full valuation allowance against its net deferred tax assets, and has concluded, based on the weight of all available evidence, that it is more likely than not that the net deferred tax assets will not be realized, primarily due to the historical net operating losses. The valuation allowance against the net deferred tax assets does not in any way impact the Company&#x2019;s ability to use future tax deductions such as the Company&#x2019;s net operating loss carryforwards; rather, the valuation allowance indicates, according to the provisions of Accounting Standards Codification 740, Income Taxes, it is more likely than not that the deferred tax assets will not be realized. The valuation allowance that was established will be maintained until there is sufficient positive evidence to conclude that it is more likely than not that the net deferred tax assets will be realized. The Company&#x2019;s income tax expense for future periods will be reduced to the extent of corresponding decreases in our valuation allowance. There is uncertainty regarding any future realization of the benefit by the Company of all or part of our net deferred tax assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Judgment is required to determine the recognition and measurement attributes prescribed in the accounting guidance for uncertainty in income taxes. The Company uses a two-step approach for evaluating uncertain tax positions. Step one, recognition, requires us to determine if the weight of available evidence indicates that a tax position is more likely than not to be sustained upon audit, including resolution of related appeals or litigation processes, if any. If a tax position is not considered &#x201c;more likely than not&#x201d; to be sustained, no benefits of the position are recognized. If we determine that a position is &#x201c;more likely than not&#x201d; to be sustained, then we proceed to step two, measurement, which is based on the largest amount of benefit which is more likely than not to be realized on effective settlement. This process involves estimating our actual current tax exposure, including assessing the risks associated with income tax audits, together with assessing temporary differences resulting from the different treatment of items for tax and financial reporting purposes. If actual results differ from our estimates, our net operating loss and credit carryforwards could be materially impacted in the period which such determination is made.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes uncertain income tax positions at the largest amount that is more-likely-than-not to be sustained upon examination by the relevant taxing authority. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained. Recognition or measurement is reflected in the period in which the likelihood changes. Any interest and penalties related to unrecognized tax liabilities are presented within income tax expense in the consolidated statements of net income (loss) and comprehensive income (loss). Accrued interest and penalties are included in accounts payable and other liabilities in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(p)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt"&gt;Share-based compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As described in more detail below, the Company has five share-based compensation plans under which awards have been made: the 2020 Omnibus Plan (as defined below), the 2018 Stock Option Plan (as defined below), the 2015 Stock Option Plan (as defined below), the Employment Inducement Award Plan #1 (the &#x201c;Employment Inducement Award Plan&#x201d;) and a cash-settled deferred share unit (&#x201c;DSU&#x201d;) plan for non-executive directors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation consists of equity-settled share-based awards such as stock options and restricted share units (&#x201c;RSUs&#x201d;) that are issued to eligible employees, non-executive directors, and non-employees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash-settled deferred share units (&#x201c;DSUs&#x201d;) that are issued to non-executive directors are recorded in accounts payable and other liabilities with the fair value adjustment recorded in other income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equity instruments granted are initially measured at fair value on the grant date. The fair value of the stock options are determined using the Black-Scholes option pricing model. The fair value of RSUs and DSUs are determined using the market price. This is recognized on a straight-line basis in the consolidated statements of net income (loss) and comprehensive income (loss) over the vesting period for employees, and over the contractual term for non-employees. The fair value of the payout of cash-settled DSUs is determined at each reporting date based on the fair value of the Company&#x2019;s common shares at the reporting date and is recorded within other liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The related costs for all equity-settled share-based awards are reflected in additional paid-in capital until the awards are exercised. Upon exercise, shares are issued and the amount previously reflected in the additional paid-in capital is, along with any proceeds paid upon exercise, credited to share capital. Forfeitures are estimated at the time of grant, and the Company revises these estimates in subsequent periods if there is a difference in actual forfeitures and the estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(q)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt"&gt;Net earnings (loss) per share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company presents basic and diluted net earnings (loss) per share data for its common shares. Basic net earnings (loss) per share is calculated by dividing the profit or loss attributable to common shareholders of the Company by the weighted average number of common shares outstanding during the period. Diluted net earnings (loss) per share is determined by adjusting the profit or loss attributable to common shareholders and the weighted average number of common shares outstanding for the effects of all potentially dilutive common shares that are issuable upon exercise of warrants, stock options and the Altria Warrant (as defined below) as well as the vesting of RSUs outstanding. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(r)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.91pt"&gt;Cash and cash equivalents and short-term investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents are comprised of cash and highly liquid investments that are readily convertible into known amounts of cash with original maturities of three months or less. Cash and cash equivalents include amounts held in dollars, C$ and ILS and security deposits. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term investments consist of debt securities that (i) have original maturities of greater than three months and (ii) the Company has the ability to convert into cash within one year. Short-term investments are classified as held-to-maturity.&#160;Our investments classified as held-to-maturity are recorded at cost. Interest earned on short-term investments is recorded in other receivables on the consolidated balance sheet and interest income on the consolidated statement of comprehensive income (loss). Cash inflows and outflows related to the purchase and maturity of short-term investments are classified as investing activities in the Company&#x2019;s consolidated statements of cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(s)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:25.45pt"&gt;Derivative liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For financial instruments that are not designated as hedging instruments or do not qualify for hedge accounting, changes in fair value are recorded in the consolidated statements of net income (loss) and comprehensive income (loss) each period. The Company does not enter into or hold derivative financial instruments for trading or speculative purposes. Derivative liabilities are initially recognized at fair value at the date on which the derivative contract was entered into. Any attributable transaction costs are recognized in net income (loss) as incurred. Subsequent to initial recognition, derivative liabilities are measured at fair value at each reporting date until settlement with the re-measurement gain or loss being recognized immediately in comprehensive income. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For more details on derivative liabilities consisting of the Altria Warrant, Pre-emptive Rights, and certain Top-up Rights, see Note 14. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(t)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.01pt"&gt;Fair value measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying value of the Company&#x2019;s cash and cash equivalents, accounts receivable, other receivables, loan receivable, account payables and other liabilities and holdbacks payable approximate fair value, given their short-term nature. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cronos Group uses a fair value hierarchy, which gives the highest priority to unadjusted quoted prices in active markets for identical assets and liabilities, noted as Level 1 measurements, and the lowest priority to unobservable inputs, noted as Level 3 measurements. The following are the three levels of inputs used to measure fair value: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 1 &#x2013; valuation based on quoted prices (unadjusted) in active markets for identical assets and liabilities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 2 &#x2013; valuation techniques based on inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 3 &#x2013; valuation techniques using the inputs for the asset or liability that are not based on observable market data.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s policy for determining when transfers between levels of the fair value hierarchy occur is based on the date of the event or changes in circumstances that caused the transfer.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(u)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt"&gt;Acquisitions &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accounting basis for each acquisition is dependent on whether the integrated set of assets and activities acquired constitutes a business. A business consists of inputs and processes applied to those inputs that have the ability to contribute to the creation of outputs. The cost of acquisition is allocated to the assets acquired on a relative fair value basis. No goodwill is recognized in an asset acquisition. If it is determined that a business is not acquired, the transaction is accounted for as an asset acquisition and the relevant values are finalized prior to the next reporting period. On the other hand, when a business is acquired, the acquisition method of accounting in accordance with Accounting Standards Codification (&#x201c;ASC&#x201d;) 805 is applied, which requires that once control of the business is obtained, the assets and liabilities of the acquired business, including amounts attributable to non-controlling interests, be recorded at their respective fair values as of the date of acquisition. Any excess of purchase consideration over the net fair value of tangible and identified intangible assets acquired less liabilities assumed is recorded as goodwill. The costs of business acquisitions, including fees for accounting, legal, professional consulting and valuation specialists, are expensed as incurred. Purchase price allocations may be preliminary and, during the measurement period not to exceed one year from the date of acquisition, changes in assumptions and estimates that result in adjustments to the fair value of assets acquired and liabilities assumed are recorded in the period the adjustments are determined.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For business combinations achieved in stages, the Company&#x2019;s previously held interest in the acquiree is remeasured at its subsequent acquisition date fair value, with the resulting gain or loss recorded in the consolidated statements of net income (loss) and comprehensive income (loss). For a pre-existing relationship between the Company and acquiree that is not extinguished on the business combination, such a relationship is considered effectively settled as part of the business combination even if it is not legally cancelled. At the acquisition date, it becomes an intercompany relationship and is eliminated upon consolidation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contingent consideration in a business combination is initially measured at fair value. Subsequently all liability classified as contingent consideration is remeasured at fair value at each reporting period until the contingency is resolved and any change in the fair value following the date of acquisition is recorded in the consolidated statements of net income (loss) and comprehensive income (loss). All equity classified as contingent consideration is not remeasured and its subsequent settlement is accounted for within equity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(v)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt"&gt;Assets held for sale and discontinued operations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with ASC 205-20 Presentation of Financial Statements: Discontinued Operations, a disposal of a component of an entity or a group of components of an entity is required to be reported as discontinued operations if the disposal represents a strategic shift that has (or will have) a major effect on an entity&#x2019;s operations and financial results when the components of an entity meet the criteria in paragraph 205-20-45-10. In the period in which the component meets held-for-sale or discontinued operations criteria the major current assets, other assets, current liabilities, and noncurrent liabilities shall be reported as components of total assets and liabilities separate from those balances of the continuing operations. At the same time, the results of all discontinued operations, less applicable income taxes (benefit), shall be reported as components of net income (loss) separate from the net income (loss) of continuing operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December 31, 2020, OGBC, formerly included within the Rest of World segment, met the criteria for &#x201c;held-for-sale&#x201d;. As a result, the Company has reflected amounts relating to OGBC as a disposal group classified as held-for-sale on the consolidated balance sheet and included as part of discontinued operations on the consolidated statement of net income (loss) and comprehensive income (loss) for all periods presented in this Annual Report. OGBC is no longer included in the segment reporting following the reclassification to discontinued operations. The discontinued operations of OGBC are described further in Note 30.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RleHRyZWdpb246ZjIyNzhkY2ZkYzhhNDMwMmJiMzM1YWU4Mjc1OTU2NTBfMjg4MDU_3ef0284f-c561-4565-9348-275650ef7f84">Basis of presentationThe accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;U.S. GAAP&#x201d;). U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities at the dates of the consolidated financial statements and the reported amounts of net revenues and expenses during the reporting periods. The accounting policies adopted in the preparation of the consolidated financial statements were effective as of January 1, 2020.</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RleHRyZWdpb246ZjIyNzhkY2ZkYzhhNDMwMmJiMzM1YWU4Mjc1OTU2NTBfMjMwODk3NDQyMjg0MDA_9efb66ba-be80-446f-99af-7e40c2a888ca">Segment structureThe Company undertook a realignment of its management structure along geographic regions in September 2019. As a result, effective September 2019, the Company&#x2019;s results are reported through the following operating segments: United States and Rest of World. Prior period amounts contained in these consolidated financial statements have been adjusted to conform to the new segment presentation. Refer to Note 29 for additional information.</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RleHRyZWdpb246ZjIyNzhkY2ZkYzhhNDMwMmJiMzM1YWU4Mjc1OTU2NTBfMjg3ODA_cff5b2eb-97ca-41f9-9f20-27eccea0f50d">Basis of consolidationThe accompanying consolidated financial statements include the accounts of the Company, and all entities in which the Company has a controlling voting interest or is the primary beneficiary of a variable interest as of and for the fiscal years ended December&#160;31, 2020, December&#160;31, 2019 and December&#160;31, 2018. The Company assesses control under the variable interest entity (&#x201c;VIE&#x201d;) model to determine whether the Company is the primary beneficiary of that entity&#x2019;s operations.&#160;If an entity is not deemed to be a VIE, the Company consolidates the entity if the Company has a controlling&#160;voting interest. Subsidiaries are fully consolidated from the date on which control is transferred to the Company. They are deconsolidated from the date that control ceases. Investments in which the Company has the ability to exercise significant influence over the operating and financial policies of the investee, but does not have control, are accounted for under the equity method of accounting.In the consolidated statements of net income (loss) and comprehensive income (loss), the net income (loss) and comprehensive income (loss) are attributed to the equity holders of the Company and to the non-controlling interests. Non-controlling interests in the equity of Cronos Israel are presented separately in the shareholders&#x2019; equity (deficit) section of the consolidated balance sheets and consolidated statements of shareholders&#x2019; equity (deficit). All intercompany transactions and balances are eliminated upon consolidation.</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RleHRyZWdpb246ZjIyNzhkY2ZkYzhhNDMwMmJiMzM1YWU4Mjc1OTU2NTBfMjg3ODU_c50b4d54-0176-4523-98ec-a41a38b0b166">The Company consolidates the financial results of the following entities, which the Company controls:&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.902%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Subsidiaries &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Jurisdiction of incorporation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Incorporation date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Ownership interest &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cronos Israel G.S. Cultivation Ltd.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Israel&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 4, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cronos Israel G.S. Manufacturing Ltd.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Israel&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 4, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cronos Israel G.S. Store Ltd.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Israel&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 28, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cronos Israel G.S. Pharmacy Ltd.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Israel&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 15, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt"&gt;These Israeli entities are collectively referred to as &#x201c;Cronos Israel.&#x201d;&lt;/span&gt;&lt;/div&gt;(ii)&#x201c;Ownership interest&#x201d; is defined as the proportionate share of net income to which the Company is entitled; equity interest may differ from ownership interest as described herein.</us-gaap:ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock>
    <us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions
      contextRef="iaedfffab0889492f9c3a60cc78052b32_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RhYmxlOjM4YmNjZjViZjlmYTRmYmViY2MzNDJhZjI5NzQ1N2M5L3RhYmxlcmFuZ2U6MzhiY2NmNWJmOWZhNGZiZWJjYzM0MmFmMjk3NDU3YzlfMS02LTEtMS0w_da0737b6-025f-42b4-8ea1-82a709b4ffe0"
      unitRef="number">0.70</us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions>
    <us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions
      contextRef="i842d385ef42842f5ab91f806ff707433_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RhYmxlOjM4YmNjZjViZjlmYTRmYmViY2MzNDJhZjI5NzQ1N2M5L3RhYmxlcmFuZ2U6MzhiY2NmNWJmOWZhNGZiZWJjYzM0MmFmMjk3NDU3YzlfMi02LTEtMS0w_0a135b97-45ba-4870-862f-fbc413862e58"
      unitRef="number">0.90</us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions>
    <us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions
      contextRef="i2d2b8fcd2f794ec98a558ecf3b27cad4_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RhYmxlOjM4YmNjZjViZjlmYTRmYmViY2MzNDJhZjI5NzQ1N2M5L3RhYmxlcmFuZ2U6MzhiY2NmNWJmOWZhNGZiZWJjYzM0MmFmMjk3NDU3YzlfMy02LTEtMS0w_4df4cbfa-af96-465e-aaee-6b7b1f36fb5e"
      unitRef="number">0.90</us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions>
    <us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions
      contextRef="i1088995f87474d32a8345b0ab39da192_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RhYmxlOjM4YmNjZjViZjlmYTRmYmViY2MzNDJhZjI5NzQ1N2M5L3RhYmxlcmFuZ2U6MzhiY2NmNWJmOWZhNGZiZWJjYzM0MmFmMjk3NDU3YzlfNC02LTEtMS0w_5699944c-4f85-440e-ab5f-7fe1ef485d88"
      unitRef="number">0.90</us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions>
    <us-gaap:UseOfEstimates
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RleHRyZWdpb246ZjIyNzhkY2ZkYzhhNDMwMmJiMzM1YWU4Mjc1OTU2NTBfMjMwODk3NDQyMjg0MDE_7e0ab65c-3498-4082-97d8-ea2c6da195ed">Use of estimatesThe preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Significant estimates and assumptions include, among other things, valuation of derivative liabilities, fair value of assets and liabilities assumed in business combinations, impairment of goodwill, inventory write-downs, valuation allowance on deferred income tax assets and uncertain tax liabilities. Actual results could differ from those estimates.</us-gaap:UseOfEstimates>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RleHRyZWdpb246ZjIyNzhkY2ZkYzhhNDMwMmJiMzM1YWU4Mjc1OTU2NTBfMjg4MDA_cf4a76a0-f71e-4c97-b4fb-e8d9be52e3da">Revenue recognition&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s contracts with customers for the sale of dried cannabis, cannabis oil, cannabinoid-derived products and U.S. hemp-derived personal care products consist of one performance obligation. The Company has concluded that revenue from the sale of these products should be recognized at the point in time when control is transferred to the customer, which is on shipment or delivery, depending on the contract. Revenue is recognized at the transaction price, which is the amount of consideration to which the Company expects to be entitled in exchange for transferring promised goods to a customer. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net revenue before excise taxes from sale of goods, as presented in the consolidated statements of net income (loss) and comprehensive income (loss), represents revenue from the sale of goods less expected price discounts, and allowances for customer returns. Net revenue before excise taxes excludes excise taxes, which the Company pays as principal and excludes duties and taxes collected on behalf of third parties. Excise taxes are a production tax classified as government remittances payable, which when applicable, become payable when a product is delivered to the customer and are not directly related to the value of revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company treats shipping and handling activities as a fulfillment cost, classified as cost of sales. Accordingly, the Company accrues all fulfillment costs related to the shipping and handling of consumer goods at the time of shipment. Within the Company's Rest of World segment, dried cannabis sales outside of Canada may include profit sharing arrangements with distributors which give rise to variable consideration. If the consideration in a contract includes a variable amount, the Company estimates the amount of consideration to which it will be entitled in exchange for transferring the goods to the customer. The variable consideration is estimated as the most likely amount, based on the Company&#x2019;s historical information, at contract inception.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s payment terms vary by customer and product type. For individual consumer sales, payment is due prior to the transfer of control. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company elected to treat the costs incurred to obtain a contract, primarily related to sales commissions, as an expense in the period incurred and not an asset to be capitalized, as the amortization period of the related asset would be less than one year. Accordingly, the Company will expense the costs to obtain a contract in the period incurred.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:ConsolidationVariableInterestEntityPolicy
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RleHRyZWdpb246ZjIyNzhkY2ZkYzhhNDMwMmJiMzM1YWU4Mjc1OTU2NTBfMjg3OTE_5a3cac76-aeb2-4667-baf8-1b62130eff97">&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Variable interest entities (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;VIE&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A VIE is an entity having either a total equity investment that is insufficient to finance its activities without additional subordinated financial support or equity investors at risk that lack the ability to control the entity&#x2019;s activities. Variable interests are investments or other interests that will absorb portions of a VIE&#x2019;s expected losses or receive portions of the VIE&#x2019;s expected residual returns. The Company evaluates whether it is the primary beneficiary of each VIE it identifies on an ongoing basis and considers the impact of any reconsideration events. The primary beneficiary is the party that has both the power to direct the activities that most significantly impact the VIE and holds a variable interest that could potentially be significant to the VIE. To make this determination the Company considers both quantitative and qualitative factors regarding the nature, size and form of its involvement with the VIE. The Company consolidates the VIE when it is determined that it is the primary beneficiary of the VIE.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationVariableInterestEntityPolicy>
    <us-gaap:EquityMethodInvestmentsPolicy
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RleHRyZWdpb246ZjIyNzhkY2ZkYzhhNDMwMmJiMzM1YWU4Mjc1OTU2NTBfMjg3ODM_34005ab9-dc4a-4ec0-a1ac-8093c66a1842">&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Equity method investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for investments in companies over which it has the ability to exercise significant influence but does not hold a controlling financial interest, using the equity method. Under the equity method, the Company records its proportionate share of income or losses in the consolidated statements of net income (loss) and comprehensive income (loss). If the current fair value of an investment falls below its carrying amount, this may indicate that an impairment loss should be recorded. Any impairment losses recognized cannot be reversed in subsequent periods.&lt;/span&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsPolicy>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RleHRyZWdpb246ZjIyNzhkY2ZkYzhhNDMwMmJiMzM1YWU4Mjc1OTU2NTBfMjg3OTI_bae4057e-ee39-408e-933a-95e1ed5929ec">Inventory&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory is comprised of raw materials, finished goods and work-in-progress such as pre-harvested cannabis plants, by-products to be extracted, oils, gel caps, tinctures, and boxes. The costs of growing cannabis, including but not limited to labor, utilities, nutrition and irrigation, are capitalized into inventory until the time of harvest.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory is stated at the lower of cost and net realizable value, determined using weighted average cost. Cost includes expenditures directly related to manufacturing and distribution of the products. Primary costs include consumables (insect control, fertilizers, soil), packaging, shipping, direct labor, overhead, supplies and small tools, and the depreciation of manufacturing equipment and production facilities determined at normal capacity. Manufacturing overhead and related expenses include salaries, wages, employee benefits, rent, utilities, security, and property taxes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net realizable value is defined as the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. At the end of each reporting period, the Company performs an assessment of inventory obsolescence to measure inventory at the lower of cost and net realizable value. Factors considered in the determination of obsolescence include slow-moving or non-marketable products. During the year ended December 31, 2020, we incurred significant inventory write-downs driven by pricing pressures in the marketplace and will continue assessing pricing pressures on the value of inventory at the end of each reporting period. See Note 5.&lt;/span&gt;&lt;/div&gt;</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:IntangibleAssetsFiniteLivedPolicy
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RleHRyZWdpb246ZjIyNzhkY2ZkYzhhNDMwMmJiMzM1YWU4Mjc1OTU2NTBfMjMwODk3NDQyMjg0MDg_c968b03f-bb7e-4c58-ba19-23864cefd3ac">Definite life intangible assets&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets are recorded at cost less any accumulated amortization and accumulated impairment losses. Intangible assets acquired through a business combination are measured at fair value at the acquisition date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company capitalizes certain costs incurred in connection with its enterprise software, which include external direct costs of materials and services consumed in developing or obtaining internal-use software, payroll and payroll-related costs for employees who are directly associated with and who devote time to the development of the software for the function intended. All other costs are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets with finite useful lives are amortized over their estimated useful lives using the following methods and rates:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.617%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.608%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Method&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Rate&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Straight-line&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Enterprise resource planning (&#x201c;ERP&#x201d;) software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Straight-line&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health Canada licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Straight-line&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Useful life of corresponding facilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Israeli codes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Straight-line&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Useful life of corresponding facilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;The preliminary licenses granted to Kibbutz Gan Shmuel (the Cronos Israel joint venture partner) by the Medical Cannabis&#160;Unit of the Israeli Ministry of Health in early 2017 (the &#x201c;Israeli codes&#x201d;) were transferred by non-controlling interests to Cronos Israel in exchange for equity interests in the Cronos Israel entities specified above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization begins when assets become available for use. The estimated useful life, amortization method, and rate are reviewed at the end of each reporting period, with the effect of any changes in estimate being accounted for on a prospective basis.&lt;/span&gt;&lt;/div&gt;</us-gaap:IntangibleAssetsFiniteLivedPolicy>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RleHRyZWdpb246ZjIyNzhkY2ZkYzhhNDMwMmJiMzM1YWU4Mjc1OTU2NTBfMjg4MDI_4ecef2bf-7bc0-4cae-835a-fa3b006356c7">&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets with finite useful lives are amortized over their estimated useful lives using the following methods and rates:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.617%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.608%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Method&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Rate&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Straight-line&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Enterprise resource planning (&#x201c;ERP&#x201d;) software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Straight-line&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health Canada licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Straight-line&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Useful life of corresponding facilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Israeli codes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Straight-line&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Useful life of corresponding facilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;The preliminary licenses granted to Kibbutz Gan Shmuel (the Cronos Israel joint venture partner) by the Medical Cannabis&#160;Unit of the Israeli Ministry of Health in early 2017 (the &#x201c;Israeli codes&#x201d;) were transferred by non-controlling interests to Cronos Israel in exchange for equity interests in the Cronos Israel entities specified above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets are comprised of the following items: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.834%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.051%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.000%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.000%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.000%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted average amortization period (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(291)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ERP system&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(274)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health Canada licenses &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,254)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lord Jones&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;TM&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; brand&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Israeli codes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,841)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt"&gt;The Israeli codes were transferred by non-controlling interests to Cronos Israel in exchange for their equity interests in the Cronos Israel entities specified above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.722%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.852%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.827%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.827%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.830%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt 0 5.5pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted average amortization period (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(202)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health Canada licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(821)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lord Jones&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;TM&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; brand&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Israeli codes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,027)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt"&gt;The Israeli codes were transferred by non-controlling interests to Cronos Israel in exchange for their equity interests in the Cronos Israel entities specified above.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ie2c359ba7b8e4d8cbaea40e6357f543e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RhYmxlOmYzOTZjNmQ3MzM1OTQyOWE5MDI1ZGVlMTAwNGE1NzViL3RhYmxlcmFuZ2U6ZjM5NmM2ZDczMzU5NDI5YTkwMjVkZWUxMDA0YTU3NWJfMS0zLTEtMS01OTI5_73f987dd-7d75-4432-960d-9f833dd12d0e">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i375653de490b4cb88d420b09780d16c9_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RhYmxlOmYzOTZjNmQ3MzM1OTQyOWE5MDI1ZGVlMTAwNGE1NzViL3RhYmxlcmFuZ2U6ZjM5NmM2ZDczMzU5NDI5YTkwMjVkZWUxMDA0YTU3NWJfMS0zLTEtMS0w_251fc7f7-9b4b-4f47-a94a-75ccbed82cb6">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RleHRyZWdpb246ZjIyNzhkY2ZkYzhhNDMwMmJiMzM1YWU4Mjc1OTU2NTBfMjMwODk3NDQyMjg0MDc_62bab99c-bb8d-4726-96fa-98171f9bafd8">Property, plant &amp;amp; equipment&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment are stated at cost less accumulated depreciation and accumulated impairment losses. Depreciation is computed using the straight-line method over the estimated useful lives of the assets as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.927%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.873%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Rate&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15 to 25 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 to 7 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lesser of term of lease and useful life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment under finance lease&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lesser of term of lease and useful life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When assets are disposed of, the cost and accumulated depreciation are removed from the respective accounts and any related gain or loss is recognized. Maintenance and repairs are charged to expense as incurred. Significant expenditures, which increase productivity or extend the useful life of the asset, are capitalized. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest incurred relating to construction or expansion of buildings is capitalized to construction in progress. The Company ceases the capitalization of interest when construction activities are substantially completed and the facility is available for use. At this point, construction in progress is transferred to the appropriate asset class. Available for use is defined as the point at which the related building receives the requisite regulatory licenses to (i) possess cannabis, (ii) obtain dried cannabis, fresh cannabis, cannabis plants or cannabis plant seeds by cultivating, propagating and harvesting cannabis, and (iii) produce cannabis, other than obtaining it by cultivating, propagating, or harvesting. Depreciation commences at the point the assets are available for use.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RleHRyZWdpb246ZjIyNzhkY2ZkYzhhNDMwMmJiMzM1YWU4Mjc1OTU2NTBfMjg3ODY_42099490-3b9b-4c16-b415-13c4d423fca7">Depreciation is computed using the straight-line method over the estimated useful lives of the assets as follows:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.927%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.873%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Rate&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15 to 25 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 to 7 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lesser of term of lease and useful life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment under finance lease&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lesser of term of lease and useful life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-bottom:6pt;padding-left:29.25pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment, net consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.261%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149,690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(18,295)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,745)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ia97ce75b78b64b17b8c28f247df84a87_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RhYmxlOjY5NjExMThhNmMzOTQ2MDE5NDUzMWI0MWVmMjQyZDA4L3RhYmxlcmFuZ2U6Njk2MTExOGE2YzM5NDYwMTk0NTMxYjQxZWYyNDJkMDhfMS00LTEtMS0wL3RleHRyZWdpb246ODU4ODM2YTRmNjgxNDk1YWJlMGU3YjQwZTMzMWQ2YTJfMTIwOTQ2Mjc5MDU1NTY_2071bee5-7467-445a-bd43-5ced06460083">P15Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i2b7cbfec44e1446b940a0588b9f08928_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RhYmxlOjY5NjExMThhNmMzOTQ2MDE5NDUzMWI0MWVmMjQyZDA4L3RhYmxlcmFuZ2U6Njk2MTExOGE2YzM5NDYwMTk0NTMxYjQxZWYyNDJkMDhfMS00LTEtMS0wL3RleHRyZWdpb246ODU4ODM2YTRmNjgxNDk1YWJlMGU3YjQwZTMzMWQ2YTJfMTIwOTQ2Mjc5MDU1NjE_2787e526-ec9b-4960-99c0-11f504c7a35f">P25Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ia73a44b4f86a4aca8cc66989d375acd5_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RhYmxlOjY5NjExMThhNmMzOTQ2MDE5NDUzMWI0MWVmMjQyZDA4L3RhYmxlcmFuZ2U6Njk2MTExOGE2YzM5NDYwMTk0NTMxYjQxZWYyNDJkMDhfMi00LTEtMS0wL3RleHRyZWdpb246YTMyNTQyMDgwZjg3NDM0NGE1MmY1NDQ0ZDMwMzAxODVfMTIwOTQ2Mjc5MDU1NTM_01874a39-ad14-4819-888e-33de0b80ca95">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i318609520df948a58aa2a7750e70dc8f_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RhYmxlOjY5NjExMThhNmMzOTQ2MDE5NDUzMWI0MWVmMjQyZDA4L3RhYmxlcmFuZ2U6Njk2MTExOGE2YzM5NDYwMTk0NTMxYjQxZWYyNDJkMDhfMi00LTEtMS0wL3RleHRyZWdpb246YTMyNTQyMDgwZjg3NDM0NGE1MmY1NDQ0ZDMwMzAxODVfMTIwOTQ2Mjc5MDU1NTc_19c12a16-9eae-42e5-9d93-15a8c4c69d38">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i2fa479bb16aa46068e50c07bb76855c0_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RhYmxlOjY5NjExMThhNmMzOTQ2MDE5NDUzMWI0MWVmMjQyZDA4L3RhYmxlcmFuZ2U6Njk2MTExOGE2YzM5NDYwMTk0NTMxYjQxZWYyNDJkMDhfMy00LTEtMS0w_f750e2ae-894f-4773-8c38-da1a2e0bafb5">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RleHRyZWdpb246ZjIyNzhkY2ZkYzhhNDMwMmJiMzM1YWU4Mjc1OTU2NTBfMjg3OTc_3dbae194-5cc8-41ba-add7-10e988713d6c">Leases&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company enters into leases in the normal course of business, primarily for the land-use rights, office premises, and equipment used in the production of its products. At the inception of a contract, the Company assesses whether a contract is, or contains, a lease. A contract is, or contains, a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. The Company performs an analysis over the classification of the lease agreement as either an operating lease or finance lease. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A right-of-use asset and the related lease obligation associated with the lease are recorded at the inception of the lease. The right-of-use asset&#x2019;s recorded amount is based on the present value of future lease payments over the lease term at the commencement date plus any initial direct costs incurred. If the rate implicit in the lease is not readily determinable for the Company&#x2019;s operating leases, an incremental borrowing rate is generally used based on information available at the lease commencement date to determine the present value of future lease payments. Subsequent changes to these lease payments due to rate updates are recorded as lease expense in the period incurred. Leases with a term of 12 months or less are not recorded on the balance sheet as a lease. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The right-of-use asset is subject to impairment testing whenever events or changes in circumstances indicate the carrying value of the asset may not be recoverable. The leased asset is amortized over the shorter of the lease term or its estimated useful life if title does not transfer to the Company, while the leased asset is depreciated in accordance with the Company&#x2019;s depreciation policy if the title is to eventually transfer to the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s lease agreements generally exclude non-lease components. As a result, non-lease components are accounted for separately for all classes of assets and expensed as incurred. In addition, the Company&#x2019;s lease agreements do not contain any material residual value guarantees or material restrictive covenants. For finance leases, from the commencement date to the earlier of the end of the useful life of the right-of-use asset or the end of the lease term, the right-of-use asset is amortized on a straight-line basis and the interest expense is recognized on the lease liability using the effective interest method. For operating leases, lease expense is recognized on a straight-line basis over the term of the lease and presented as a single charge in the consolidated statements of net income (loss) and comprehensive income (loss).&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RleHRyZWdpb246ZjIyNzhkY2ZkYzhhNDMwMmJiMzM1YWU4Mjc1OTU2NTBfMjg3ODQ_0783b822-aa28-4e33-a99a-ae3fa3e4bab1">Impairment of long-lived assetsThe Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. The Company groups assets at the lowest level for which cash flows are separately identifiable, referred to as an asset group. The Company prepares projected undiscounted cash flow analyses for each asset or asset group. If the sum of the undiscounted cash flow is less than the carrying value of the asset or asset group, an impairment loss is recognized equal to the excess of the carrying value over the fair value, if any. Impairment losses on assets held for sale are based on the fair value, less costs to sell.Goodwill and indefinite life intangible assets are not amortized. Goodwill and indefinite life intangible assets are reviewed for impairment annually or more frequently when events or changes in circumstances indicate that fair value of the reporting unit has been reduced to less than its carrying value. The Company performs an impairment test annually in the fourth quarter by comparing the fair value of the reporting unit with its carrying amount, including goodwill. If the fair value of the reporting unit exceeds its carrying amount, goodwill is not considered to be impaired. An impairment charge would be recognized for the amount by which the carrying amount exceeds the reporting unit&#x2019;s fair value. The Company determined that it has two reporting units: the U.S. reporting unit and the Rest of World reporting unit.</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock>
    <us-gaap:NumberOfReportingUnits
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RleHRyZWdpb246ZjIyNzhkY2ZkYzhhNDMwMmJiMzM1YWU4Mjc1OTU2NTBfNjA0NzMxMzk5MTYzMA_4b3a0281-28cc-4f45-ae23-30115329f460"
      unitRef="reportingunit">2</us-gaap:NumberOfReportingUnits>
    <us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RleHRyZWdpb246ZjIyNzhkY2ZkYzhhNDMwMmJiMzM1YWU4Mjc1OTU2NTBfMjg4MDM_162fd2e7-97e3-4049-9cb9-0584e6b24566">Repurposing chargesThe Company&#x2019;s repurposing charges primarily include employee termination benefits and refurbishment costs. The recognition of repurposing charges requires the Company make certain judgments and estimates regarding the nature, timing, and amount of costs associated with the planned activity. To the extent actual results differ from estimates and assumptions, a revision to the estimated liabilities, requiring the recognition of additional repurposing charges or the reduction of liabilities already recognized may be required. At the end of each reporting period, the Company evaluates the remaining accrued balances to ensure these balances are properly stated and the utilization of the reserves are for their intended purpose in accordance with planned activity.</us-gaap:CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock>
    <us-gaap:StockholdersEquityPolicyTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RleHRyZWdpb246ZjIyNzhkY2ZkYzhhNDMwMmJiMzM1YWU4Mjc1OTU2NTBfMjg3ODg_1ad41b1c-4099-4d04-84da-f8e8aca7f0ca">Capital stockCapital stock is presented at the fair value at the time of issuance of the shares issued. Costs related to the issuance of shares are reported in equity, net of tax, as a deduction from the issuance proceeds.</us-gaap:StockholdersEquityPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RleHRyZWdpb246ZjIyNzhkY2ZkYzhhNDMwMmJiMzM1YWU4Mjc1OTU2NTBfMjg3ODE_5ac5e0f0-877e-4f1d-a1bd-08208dee232a">Foreign currency&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s functional currency is the Canadian dollar (&#x201c;C$&#x201d;). Prior to the year ended December 31, 2019, the Company reported its financial results in C$, however following the change in the Company&#x2019;s status from foreign private issuer to a United States (&#x201c;U.S.&#x201d;) domestic issuer, the financial results are now reported in U.S dollars (&#x201c;dollars&#x201d; or &#x201c;$&#x201d;). Functional currencies for the entities in these consolidated financial statements are their respective local currencies, including C$, Australian dollars (&#x201c;A$&#x201d;) and Israeli New Shekel (&#x201c;ILS&#x201d;). The assets and liabilities of the Company&#x2019;s foreign operations are translated into dollars at the exchange rate in effect as of December&#160;31, 2020 and 2019. Transactions affecting the shareholders&#x2019; equity (deficit) are translated at historical foreign exchange rates. The consolidated statements of net income (loss) and comprehensive income (loss) and the consolidated statements of cash flows of the Company&#x2019;s foreign operations are translated into dollars by applying the average foreign exchange rate in effect for the reporting period. The cumulative translation adjustments (&#x201c;CTA&#x201d;) resulting from translating the consolidated financial statements into their dollar reporting currency are recorded in other comprehensive income (loss). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Monetary assets and liabilities denominated in foreign currencies are translated to the functional currency by applying the foreign exchange rate in effect at the balance sheet date. Revenues and expenses are translated using the average foreign exchange rate for the reporting period. Realized and unrealized foreign currency differences are recognized in the consolidated statements of net income (loss) and comprehensive income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Transactions in foreign currencies are translated into the functional currency using the exchange rate prevailing at the date of the transaction and are recorded in other comprehensive income. Exchange differences arising from operating transactions are recorded in net income for the period.&lt;/span&gt;&lt;/div&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RleHRyZWdpb246ZjIyNzhkY2ZkYzhhNDMwMmJiMzM1YWU4Mjc1OTU2NTBfMjg3OTM_6c8d0f88-1960-4533-bc35-538b0f7af52c">Income taxes&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses the liability method of accounting for income taxes, under which deferred tax assets and liabilities are recognized for the future tax consequences attributable to the differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted tax rates expected to be in effect when such assets and liabilities are recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the year that includes the enactment date. The Company determines deferred tax assets including net operating losses and liabilities, based on temporary differences between the book and tax bases of assets and liabilities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A valuation allowance is established to reduce some or all net deferred tax assets to amounts that are more likely than not to be realized. The Company considers all available evidence, both positive and negative including past operating results, estimates of future taxable income, and the feasibility of tax planning strategies, in assessing the need for a valuation allowance. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has a full valuation allowance against its net deferred tax assets, and has concluded, based on the weight of all available evidence, that it is more likely than not that the net deferred tax assets will not be realized, primarily due to the historical net operating losses. The valuation allowance against the net deferred tax assets does not in any way impact the Company&#x2019;s ability to use future tax deductions such as the Company&#x2019;s net operating loss carryforwards; rather, the valuation allowance indicates, according to the provisions of Accounting Standards Codification 740, Income Taxes, it is more likely than not that the deferred tax assets will not be realized. The valuation allowance that was established will be maintained until there is sufficient positive evidence to conclude that it is more likely than not that the net deferred tax assets will be realized. The Company&#x2019;s income tax expense for future periods will be reduced to the extent of corresponding decreases in our valuation allowance. There is uncertainty regarding any future realization of the benefit by the Company of all or part of our net deferred tax assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Judgment is required to determine the recognition and measurement attributes prescribed in the accounting guidance for uncertainty in income taxes. The Company uses a two-step approach for evaluating uncertain tax positions. Step one, recognition, requires us to determine if the weight of available evidence indicates that a tax position is more likely than not to be sustained upon audit, including resolution of related appeals or litigation processes, if any. If a tax position is not considered &#x201c;more likely than not&#x201d; to be sustained, no benefits of the position are recognized. If we determine that a position is &#x201c;more likely than not&#x201d; to be sustained, then we proceed to step two, measurement, which is based on the largest amount of benefit which is more likely than not to be realized on effective settlement. This process involves estimating our actual current tax exposure, including assessing the risks associated with income tax audits, together with assessing temporary differences resulting from the different treatment of items for tax and financial reporting purposes. If actual results differ from our estimates, our net operating loss and credit carryforwards could be materially impacted in the period which such determination is made.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes uncertain income tax positions at the largest amount that is more-likely-than-not to be sustained upon examination by the relevant taxing authority. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained. Recognition or measurement is reflected in the period in which the likelihood changes. Any interest and penalties related to unrecognized tax liabilities are presented within income tax expense in the consolidated statements of net income (loss) and comprehensive income (loss). Accrued interest and penalties are included in accounts payable and other liabilities in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RleHRyZWdpb246ZjIyNzhkY2ZkYzhhNDMwMmJiMzM1YWU4Mjc1OTU2NTBfMjg3ODk_66a550b3-ecf4-4165-9186-70a1c2291b41">Share-based compensation&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As described in more detail below, the Company has five share-based compensation plans under which awards have been made: the 2020 Omnibus Plan (as defined below), the 2018 Stock Option Plan (as defined below), the 2015 Stock Option Plan (as defined below), the Employment Inducement Award Plan #1 (the &#x201c;Employment Inducement Award Plan&#x201d;) and a cash-settled deferred share unit (&#x201c;DSU&#x201d;) plan for non-executive directors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation consists of equity-settled share-based awards such as stock options and restricted share units (&#x201c;RSUs&#x201d;) that are issued to eligible employees, non-executive directors, and non-employees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash-settled deferred share units (&#x201c;DSUs&#x201d;) that are issued to non-executive directors are recorded in accounts payable and other liabilities with the fair value adjustment recorded in other income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equity instruments granted are initially measured at fair value on the grant date. The fair value of the stock options are determined using the Black-Scholes option pricing model. The fair value of RSUs and DSUs are determined using the market price. This is recognized on a straight-line basis in the consolidated statements of net income (loss) and comprehensive income (loss) over the vesting period for employees, and over the contractual term for non-employees. The fair value of the payout of cash-settled DSUs is determined at each reporting date based on the fair value of the Company&#x2019;s common shares at the reporting date and is recorded within other liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The related costs for all equity-settled share-based awards are reflected in additional paid-in capital until the awards are exercised. Upon exercise, shares are issued and the amount previously reflected in the additional paid-in capital is, along with any proceeds paid upon exercise, credited to share capital. Forfeitures are estimated at the time of grant, and the Company revises these estimates in subsequent periods if there is a difference in actual forfeitures and the estimates.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RleHRyZWdpb246ZjIyNzhkY2ZkYzhhNDMwMmJiMzM1YWU4Mjc1OTU2NTBfMjg3OTg_9921c5b2-3c6b-4d78-9f17-128087b45af4">Net earnings (loss) per shareThe Company presents basic and diluted net earnings (loss) per share data for its common shares. Basic net earnings (loss) per share is calculated by dividing the profit or loss attributable to common shareholders of the Company by the weighted average number of common shares outstanding during the period. Diluted net earnings (loss) per share is determined by adjusting the profit or loss attributable to common shareholders and the weighted average number of common shares outstanding for the effects of all potentially dilutive common shares that are issuable upon exercise of warrants, stock options and the Altria Warrant (as defined below) as well as the vesting of RSUs outstanding.</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RleHRyZWdpb246ZjIyNzhkY2ZkYzhhNDMwMmJiMzM1YWU4Mjc1OTU2NTBfMjg4MDQ_579eeda8-2d0c-4083-b169-9bc0a1300d5a">Cash and cash equivalents and short-term investmentsCash and cash equivalents are comprised of cash and highly liquid investments that are readily convertible into known amounts of cash with original maturities of three months or less. Cash and cash equivalents include amounts held in dollars, C$ and ILS and security deposits. Short-term investments consist of debt securities that (i) have original maturities of greater than three months and (ii) the Company has the ability to convert into cash within one year. Short-term investments are classified as held-to-maturity.&#160;Our investments classified as held-to-maturity are recorded at cost. Interest earned on short-term investments is recorded in other receivables on the consolidated balance sheet and interest income on the consolidated statement of comprehensive income (loss). Cash inflows and outflows related to the purchase and maturity of short-term investments are classified as investing activities in the Company&#x2019;s consolidated statements of cash flows.</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RleHRyZWdpb246ZjIyNzhkY2ZkYzhhNDMwMmJiMzM1YWU4Mjc1OTU2NTBfMjg3Nzg_89d76e41-7e4e-4aab-bbaf-783126188ac1">Derivative liabilitiesFor financial instruments that are not designated as hedging instruments or do not qualify for hedge accounting, changes in fair value are recorded in the consolidated statements of net income (loss) and comprehensive income (loss) each period. The Company does not enter into or hold derivative financial instruments for trading or speculative purposes. Derivative liabilities are initially recognized at fair value at the date on which the derivative contract was entered into. Any attributable transaction costs are recognized in net income (loss) as incurred. Subsequent to initial recognition, derivative liabilities are measured at fair value at each reporting date until settlement with the re-measurement gain or loss being recognized immediately in comprehensive income. For more details on derivative liabilities consisting of the Altria Warrant, Pre-emptive Rights, and certain Top-up Rights, see Note 14.</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RleHRyZWdpb246ZjIyNzhkY2ZkYzhhNDMwMmJiMzM1YWU4Mjc1OTU2NTBfMjg3OTU_4717f049-2899-43e1-b2ce-ed91799b2e0b">Fair value measurements&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying value of the Company&#x2019;s cash and cash equivalents, accounts receivable, other receivables, loan receivable, account payables and other liabilities and holdbacks payable approximate fair value, given their short-term nature. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cronos Group uses a fair value hierarchy, which gives the highest priority to unadjusted quoted prices in active markets for identical assets and liabilities, noted as Level 1 measurements, and the lowest priority to unobservable inputs, noted as Level 3 measurements. The following are the three levels of inputs used to measure fair value: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 1 &#x2013; valuation based on quoted prices (unadjusted) in active markets for identical assets and liabilities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 2 &#x2013; valuation techniques based on inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 3 &#x2013; valuation techniques using the inputs for the asset or liability that are not based on observable market data.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s policy for determining when transfers between levels of the fair value hierarchy occur is based on the date of the event or changes in circumstances that caused the transfer.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:BusinessCombinationsPolicy
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RleHRyZWdpb246ZjIyNzhkY2ZkYzhhNDMwMmJiMzM1YWU4Mjc1OTU2NTBfMjg3Nzk_68246328-ec75-4c20-8bb1-d46c75ff10b6">Acquisitions &lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accounting basis for each acquisition is dependent on whether the integrated set of assets and activities acquired constitutes a business. A business consists of inputs and processes applied to those inputs that have the ability to contribute to the creation of outputs. The cost of acquisition is allocated to the assets acquired on a relative fair value basis. No goodwill is recognized in an asset acquisition. If it is determined that a business is not acquired, the transaction is accounted for as an asset acquisition and the relevant values are finalized prior to the next reporting period. On the other hand, when a business is acquired, the acquisition method of accounting in accordance with Accounting Standards Codification (&#x201c;ASC&#x201d;) 805 is applied, which requires that once control of the business is obtained, the assets and liabilities of the acquired business, including amounts attributable to non-controlling interests, be recorded at their respective fair values as of the date of acquisition. Any excess of purchase consideration over the net fair value of tangible and identified intangible assets acquired less liabilities assumed is recorded as goodwill. The costs of business acquisitions, including fees for accounting, legal, professional consulting and valuation specialists, are expensed as incurred. Purchase price allocations may be preliminary and, during the measurement period not to exceed one year from the date of acquisition, changes in assumptions and estimates that result in adjustments to the fair value of assets acquired and liabilities assumed are recorded in the period the adjustments are determined.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For business combinations achieved in stages, the Company&#x2019;s previously held interest in the acquiree is remeasured at its subsequent acquisition date fair value, with the resulting gain or loss recorded in the consolidated statements of net income (loss) and comprehensive income (loss). For a pre-existing relationship between the Company and acquiree that is not extinguished on the business combination, such a relationship is considered effectively settled as part of the business combination even if it is not legally cancelled. At the acquisition date, it becomes an intercompany relationship and is eliminated upon consolidation. &lt;/span&gt;&lt;/div&gt;Contingent consideration in a business combination is initially measured at fair value. Subsequently all liability classified as contingent consideration is remeasured at fair value at each reporting period until the contingency is resolved and any change in the fair value following the date of acquisition is recorded in the consolidated statements of net income (loss) and comprehensive income (loss). All equity classified as contingent consideration is not remeasured and its subsequent settlement is accounted for within equity.</us-gaap:BusinessCombinationsPolicy>
    <us-gaap:DiscontinuedOperationsPolicyTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83My9mcmFnOmYyMjc4ZGNmZGM4YTQzMDJiYjMzNWFlODI3NTk1NjUwL3RleHRyZWdpb246ZjIyNzhkY2ZkYzhhNDMwMmJiMzM1YWU4Mjc1OTU2NTBfMjMwODk3NDQyMjg0MDY_ada94cab-2b41-496a-8151-3fbb182c7e0f">Assets held for sale and discontinued operations&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with ASC 205-20 Presentation of Financial Statements: Discontinued Operations, a disposal of a component of an entity or a group of components of an entity is required to be reported as discontinued operations if the disposal represents a strategic shift that has (or will have) a major effect on an entity&#x2019;s operations and financial results when the components of an entity meet the criteria in paragraph 205-20-45-10. In the period in which the component meets held-for-sale or discontinued operations criteria the major current assets, other assets, current liabilities, and noncurrent liabilities shall be reported as components of total assets and liabilities separate from those balances of the continuing operations. At the same time, the results of all discontinued operations, less applicable income taxes (benefit), shall be reported as components of net income (loss) separate from the net income (loss) of continuing operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December 31, 2020, OGBC, formerly included within the Rest of World segment, met the criteria for &#x201c;held-for-sale&#x201d;. As a result, the Company has reflected amounts relating to OGBC as a disposal group classified as held-for-sale on the consolidated balance sheet and included as part of discontinued operations on the consolidated statement of net income (loss) and comprehensive income (loss) for all periods presented in this Annual Report. OGBC is no longer included in the segment reporting following the reclassification to discontinued operations. The discontinued operations of OGBC are described further in Note 30.&lt;/span&gt;&lt;/div&gt;</us-gaap:DiscontinuedOperationsPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83OS9mcmFnOjBmMDBhOWRiMWRjMTQ0ZGI4Y2YxZjgzM2Q5ZmMyZmU3L3RleHRyZWdpb246MGYwMGE5ZGIxZGMxNDRkYjhjZjFmODMzZDlmYzJmZTdfNzA1MQ_0bec261c-81b1-4662-bf92-a4e609a5f0e6">New Accounting Pronouncements&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt"&gt;Adoption of new accounting pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 1, 2020, the Company adopted ASU No. 2018-13, Disclosure Framework &#x2013; Changes to the Disclosure Requirements for Fair Value Measurement (Topic 820) (&#x201c;ASU No. 2018-13&#x201d;). ASU No. 2018-13 adds, modifies, and removes certain fair value measurement disclosure requirements. The adoption of ASU No. 2018-13 did not have a material impact on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 1, 2020, the Company adopted ASU No. 2018-15, Intangibles &#x2013; Goodwill and Other Internal-use-software (Subtopic 350-40): Customer&#x2019;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract (&#x201c;ASU No. 2018-15&#x201d;). ASU No. 2018-15 amends current guidance to align the accounting for costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing costs associated with developing or obtaining internal-use software. The guidance in ASU No. 2018-15 is effective for annual and interim periods beginning after December 15, 2019, with early adoption permitted. The adoption of ASU No. 2018-15 did not have a material impact on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 1, 2020, the Company adopted ASU No. 2017-04, Intangibles &#x2013; Goodwill and Other (Topic 350) &#x2013; Simplifying the Test for Goodwill Impairment (&#x201c;ASU No. 2017-04&#x201d;). ASU No. 2017-04 eliminates step 2 from the goodwill impairment test and instead requires an entity to measure the impairment of goodwill assigned to a reporting unit if the carrying value of assets and liabilities assigned to the reporting unit, including goodwill, exceeds the reporting unit&#x2019;s fair value. The guidance in ASU No. 2017-04 is effective for annual and interim goodwill tests completed by the Company beginning on January 1, 2020. The adoption of ASU No. 2017-04 was applied prospectively and the Company follows a one-step model for goodwill impairment. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt"&gt;New accounting pronouncements not yet adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (&#x201c;ASU No. 2019-12&#x201d;). ASU No. 2019-12 eliminates certain exceptions and simplifies the application of U.S. GAAP-related changes in enacted tax laws or rates and employee stock option plans. ASU No. 2019-12 is effective for annual and interim periods beginning after December 15, 2020. Early adoption is permitted. The Company has evaluated the impact of ASU No. 2019-12 and the adoption will not have a material impact on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2020, the Financial Accounting Standards Board&lt;/span&gt;&lt;span style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;issued ASU No. 2020-01, Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) (&#x201c;ASU No. 2020-01&#x201d;). ASU No. 2020-01 clarifies the interaction of accounting for the transition into and out of the equity method. The new standard also clarifies the accounting for measuring certain purchased options and forward contracts to acquire investments. The guidance in ASU No. 2020-01 is effective for annual and interim periods beginning after December 15, 2020. The Company has evaluated the impact of ASU No. 2020-01 and does not expect the adoption to have a material impact to the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the FASB issued ASU 2020-06, Debt &#x2013;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging &#x2013;Contracts in Entity&#x2019;s Own Equity (Subtopic 815&#x2013;40) (&#x201c;ASU No. 2020-06&#x201d;). ASU No. 2020-06 simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity&#x2019;s own equity. ASU No 2020-06 is part of the FASB&#x2019;s simplification initiative, which aims to reduce unnecessary complexity in U.S. GAAP. ASU No 2020-06 is effective for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years. The Company is currently evaluating the impact of ASU No. 2020-06 on its consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF83OS9mcmFnOjBmMDBhOWRiMWRjMTQ0ZGI4Y2YxZjgzM2Q5ZmMyZmU3L3RleHRyZWdpb246MGYwMGE5ZGIxZGMxNDRkYjhjZjFmODMzZDlmYzJmZTdfNzA1MA_990f48db-9ae3-4c3f-a710-78972819aa30">&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt"&gt;Adoption of new accounting pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 1, 2020, the Company adopted ASU No. 2018-13, Disclosure Framework &#x2013; Changes to the Disclosure Requirements for Fair Value Measurement (Topic 820) (&#x201c;ASU No. 2018-13&#x201d;). ASU No. 2018-13 adds, modifies, and removes certain fair value measurement disclosure requirements. The adoption of ASU No. 2018-13 did not have a material impact on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 1, 2020, the Company adopted ASU No. 2018-15, Intangibles &#x2013; Goodwill and Other Internal-use-software (Subtopic 350-40): Customer&#x2019;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract (&#x201c;ASU No. 2018-15&#x201d;). ASU No. 2018-15 amends current guidance to align the accounting for costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing costs associated with developing or obtaining internal-use software. The guidance in ASU No. 2018-15 is effective for annual and interim periods beginning after December 15, 2019, with early adoption permitted. The adoption of ASU No. 2018-15 did not have a material impact on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 1, 2020, the Company adopted ASU No. 2017-04, Intangibles &#x2013; Goodwill and Other (Topic 350) &#x2013; Simplifying the Test for Goodwill Impairment (&#x201c;ASU No. 2017-04&#x201d;). ASU No. 2017-04 eliminates step 2 from the goodwill impairment test and instead requires an entity to measure the impairment of goodwill assigned to a reporting unit if the carrying value of assets and liabilities assigned to the reporting unit, including goodwill, exceeds the reporting unit&#x2019;s fair value. The guidance in ASU No. 2017-04 is effective for annual and interim goodwill tests completed by the Company beginning on January 1, 2020. The adoption of ASU No. 2017-04 was applied prospectively and the Company follows a one-step model for goodwill impairment. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt"&gt;New accounting pronouncements not yet adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (&#x201c;ASU No. 2019-12&#x201d;). ASU No. 2019-12 eliminates certain exceptions and simplifies the application of U.S. GAAP-related changes in enacted tax laws or rates and employee stock option plans. ASU No. 2019-12 is effective for annual and interim periods beginning after December 15, 2020. Early adoption is permitted. The Company has evaluated the impact of ASU No. 2019-12 and the adoption will not have a material impact on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2020, the Financial Accounting Standards Board&lt;/span&gt;&lt;span style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;issued ASU No. 2020-01, Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) (&#x201c;ASU No. 2020-01&#x201d;). ASU No. 2020-01 clarifies the interaction of accounting for the transition into and out of the equity method. The new standard also clarifies the accounting for measuring certain purchased options and forward contracts to acquire investments. The guidance in ASU No. 2020-01 is effective for annual and interim periods beginning after December 15, 2020. The Company has evaluated the impact of ASU No. 2020-01 and does not expect the adoption to have a material impact to the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the FASB issued ASU 2020-06, Debt &#x2013;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging &#x2013;Contracts in Entity&#x2019;s Own Equity (Subtopic 815&#x2013;40) (&#x201c;ASU No. 2020-06&#x201d;). ASU No. 2020-06 simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity&#x2019;s own equity. ASU No 2020-06 is part of the FASB&#x2019;s simplification initiative, which aims to reduce unnecessary complexity in U.S. GAAP. ASU No 2020-06 is effective for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years. The Company is currently evaluating the impact of ASU No. 2020-06 on its consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF84Mi9mcmFnOjVkMDliOTI5NmJhMTQ5ZGFhMjFiMDExZGFkMWJiOTQxL3RleHRyZWdpb246NWQwOWI5Mjk2YmExNDlkYWEyMWIwMTFkYWQxYmI5NDFfMTgxNw_793015d7-656a-4a7b-8862-07eb5e286de4">Revenues from Contracts with Customers&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cronos Group disaggregates net revenues based on product type. For further discussion, see Note 29. Receivables were $8,928 at December&#160;31, 2020 (December&#160;31, 2019 &#x2013; $4,638). The Company recorded a current expected credit loss allowance of $74 as of December&#160;31, 2020 (December&#160;31, 2019 &#x2013; $136). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cronos Group offers discounts to customers for prompt payment and calculates cash discounts as a percentage of the list price based on historical experience and agreed-upon payment terms. Cronos Group records an allowance for cash discounts, which is included as a contra-asset against receivables on the Company&#x2019;s consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;Revenue is measured net of returns. As a result, the Company is required to estimate the amount of returns based on the historical data by customer and product type, adjusted for forward-looking information. This is included as a provision against accounts receivable on the Company&#x2019;s consolidated balance sheets. The Company estimates sales returns based principally on historical volume and return rates, as a reduction to revenues. The difference between actual sales and estimated sales returns is recorded in the period in which the actual amounts become known. These differences, if any, have not had a material impact on the Company&#x2019;s consolidated financial statements. Upon return, products can be extracted from dried cannabis, resold, or destroyed depending on the nature of the product. The Company has assessed that the amount recoverable is immaterial.</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF84Mi9mcmFnOjVkMDliOTI5NmJhMTQ5ZGFhMjFiMDExZGFkMWJiOTQxL3RleHRyZWdpb246NWQwOWI5Mjk2YmExNDlkYWEyMWIwMTFkYWQxYmI5NDFfNTQ2_6acc01e1-bf62-4db1-8c04-91e8e4eaa4db"
      unitRef="usd">8928000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF84Mi9mcmFnOjVkMDliOTI5NmJhMTQ5ZGFhMjFiMDExZGFkMWJiOTQxL3RleHRyZWdpb246NWQwOWI5Mjk2YmExNDlkYWEyMWIwMTFkYWQxYmI5NDFfNTY0_16b23a01-7ea1-43c3-9c04-ab0c232107a2"
      unitRef="usd">4638000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF84Mi9mcmFnOjVkMDliOTI5NmJhMTQ5ZGFhMjFiMDExZGFkMWJiOTQxL3RleHRyZWdpb246NWQwOWI5Mjk2YmExNDlkYWEyMWIwMTFkYWQxYmI5NDFfNjAw_a4507069-02ab-457d-b655-27abf8dbbd61"
      unitRef="usd">74000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF84Mi9mcmFnOjVkMDliOTI5NmJhMTQ5ZGFhMjFiMDExZGFkMWJiOTQxL3RleHRyZWdpb246NWQwOWI5Mjk2YmExNDlkYWEyMWIwMTFkYWQxYmI5NDFfNjIy_56892b36-c29d-4c8a-b883-256b61076a0e"
      unitRef="usd">136000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:InventoryDisclosureTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF84NS9mcmFnOmJjODJkMDI0NTEyMDRlZDA4ODFjMzEzODVhOWJkMDk4L3RleHRyZWdpb246YmM4MmQwMjQ1MTIwNGVkMDg4MWMzMTM4NWE5YmQwOThfNDQz_2c3aa465-7435-41f7-a111-8a24b8fa9a2a">Inventory&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory is comprised of the following items:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.541%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-progress &#x2013; dry cannabis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-progress &#x2013; cannabis extracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods &#x2013; dry cannabis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods &#x2013; cannabis extracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Supplies and consumables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory is written down for any obsolescence such as slow-moving or non-marketable products, or when the net realizable value of inventory is less than the carrying value. For the year ended December&#160;31, 2020, the Company recorded write-downs related to inventory of $26,055 (December&#160;31, 2019 &#x2013; $29,173, December&#160;31, 2018 - $nil) driven by pricing pressures in the Canadian marketplace. As of December&#160;31, 2020, an inventory reserve of $1,229 was recorded (December&#160;31, 2019 &#x2013; $nil) in cost of sales.&lt;/span&gt;&lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF84NS9mcmFnOmJjODJkMDI0NTEyMDRlZDA4ODFjMzEzODVhOWJkMDk4L3RleHRyZWdpb246YmM4MmQwMjQ1MTIwNGVkMDg4MWMzMTM4NWE5YmQwOThfNDQ0_56397b55-e6c1-4c8e-b2d6-c885fb6e7847">&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory is comprised of the following items:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.541%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-progress &#x2013; dry cannabis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-progress &#x2013; cannabis extracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods &#x2013; dry cannabis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods &#x2013; cannabis extracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Supplies and consumables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF84NS9mcmFnOmJjODJkMDI0NTEyMDRlZDA4ODFjMzEzODVhOWJkMDk4L3RhYmxlOmUxZmI2MDNmYTJmNjRjY2Q5NmM2NGFkNTlhNTY2YTIxL3RhYmxlcmFuZ2U6ZTFmYjYwM2ZhMmY2NGNjZDk2YzY0YWQ1OWE1NjZhMjFfMi0zLTEtMS0w_6616b4cc-e3e2-4b54-abf3-5412456ea0e8"
      unitRef="usd">11489000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF84NS9mcmFnOmJjODJkMDI0NTEyMDRlZDA4ODFjMzEzODVhOWJkMDk4L3RhYmxlOmUxZmI2MDNmYTJmNjRjY2Q5NmM2NGFkNTlhNTY2YTIxL3RhYmxlcmFuZ2U6ZTFmYjYwM2ZhMmY2NGNjZDk2YzY0YWQ1OWE1NjZhMjFfMi02LTEtMS0w_93091995-6d7e-471f-8700-4ee34ce4e7a3"
      unitRef="usd">2469000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i10a83eea249e41e6b2c310a65280d58b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF84NS9mcmFnOmJjODJkMDI0NTEyMDRlZDA4ODFjMzEzODVhOWJkMDk4L3RhYmxlOmUxZmI2MDNmYTJmNjRjY2Q5NmM2NGFkNTlhNTY2YTIxL3RhYmxlcmFuZ2U6ZTFmYjYwM2ZhMmY2NGNjZDk2YzY0YWQ1OWE1NjZhMjFfMy0zLTEtMS0w_ceb93e78-78a2-4bd1-bb6e-dc59fc45235b"
      unitRef="usd">20520000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i96b88f05fde54eb48391a625a3fd6392_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF84NS9mcmFnOmJjODJkMDI0NTEyMDRlZDA4ODFjMzEzODVhOWJkMDk4L3RhYmxlOmUxZmI2MDNmYTJmNjRjY2Q5NmM2NGFkNTlhNTY2YTIxL3RhYmxlcmFuZ2U6ZTFmYjYwM2ZhMmY2NGNjZDk2YzY0YWQ1OWE1NjZhMjFfMy02LTEtMS0w_e0ba3923-59da-4fc3-9bf9-b3c379c137f7"
      unitRef="usd">11538000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i233dc0b62902408388edf4319b001461_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF84NS9mcmFnOmJjODJkMDI0NTEyMDRlZDA4ODFjMzEzODVhOWJkMDk4L3RhYmxlOmUxZmI2MDNmYTJmNjRjY2Q5NmM2NGFkNTlhNTY2YTIxL3RhYmxlcmFuZ2U6ZTFmYjYwM2ZhMmY2NGNjZDk2YzY0YWQ1OWE1NjZhMjFfNC0zLTEtMS0w_c1f84f72-56cf-4733-af82-d3a733493903"
      unitRef="usd">5758000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i25af40180a094722bba3ac7b711fb022_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF84NS9mcmFnOmJjODJkMDI0NTEyMDRlZDA4ODFjMzEzODVhOWJkMDk4L3RhYmxlOmUxZmI2MDNmYTJmNjRjY2Q5NmM2NGFkNTlhNTY2YTIxL3RhYmxlcmFuZ2U6ZTFmYjYwM2ZhMmY2NGNjZDk2YzY0YWQ1OWE1NjZhMjFfNC02LTEtMS0w_a086ddb9-7655-466a-b9b7-d4e5b0adcdfa"
      unitRef="usd">17975000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i10a83eea249e41e6b2c310a65280d58b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF84NS9mcmFnOmJjODJkMDI0NTEyMDRlZDA4ODFjMzEzODVhOWJkMDk4L3RhYmxlOmUxZmI2MDNmYTJmNjRjY2Q5NmM2NGFkNTlhNTY2YTIxL3RhYmxlcmFuZ2U6ZTFmYjYwM2ZhMmY2NGNjZDk2YzY0YWQ1OWE1NjZhMjFfNS0zLTEtMS0w_85fc566d-dbdf-41cc-8655-30d3ea34ed22"
      unitRef="usd">4894000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i96b88f05fde54eb48391a625a3fd6392_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF84NS9mcmFnOmJjODJkMDI0NTEyMDRlZDA4ODFjMzEzODVhOWJkMDk4L3RhYmxlOmUxZmI2MDNmYTJmNjRjY2Q5NmM2NGFkNTlhNTY2YTIxL3RhYmxlcmFuZ2U6ZTFmYjYwM2ZhMmY2NGNjZDk2YzY0YWQ1OWE1NjZhMjFfNS02LTEtMS0w_eb1278e6-865f-4262-b4e6-dd9a168d119d"
      unitRef="usd">1798000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i233dc0b62902408388edf4319b001461_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF84NS9mcmFnOmJjODJkMDI0NTEyMDRlZDA4ODFjMzEzODVhOWJkMDk4L3RhYmxlOmUxZmI2MDNmYTJmNjRjY2Q5NmM2NGFkNTlhNTY2YTIxL3RhYmxlcmFuZ2U6ZTFmYjYwM2ZhMmY2NGNjZDk2YzY0YWQ1OWE1NjZhMjFfNi0zLTEtMS0w_d26326e7-f89e-40e6-a3f2-256f2365e046"
      unitRef="usd">1011000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i25af40180a094722bba3ac7b711fb022_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF84NS9mcmFnOmJjODJkMDI0NTEyMDRlZDA4ODFjMzEzODVhOWJkMDk4L3RhYmxlOmUxZmI2MDNmYTJmNjRjY2Q5NmM2NGFkNTlhNTY2YTIxL3RhYmxlcmFuZ2U6ZTFmYjYwM2ZhMmY2NGNjZDk2YzY0YWQ1OWE1NjZhMjFfNi02LTEtMS0w_a4e5128a-af59-4c4d-ad04-5487a5ee8dd3"
      unitRef="usd">2624000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventorySuppliesNetOfReserves
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF84NS9mcmFnOmJjODJkMDI0NTEyMDRlZDA4ODFjMzEzODVhOWJkMDk4L3RhYmxlOmUxZmI2MDNmYTJmNjRjY2Q5NmM2NGFkNTlhNTY2YTIxL3RhYmxlcmFuZ2U6ZTFmYjYwM2ZhMmY2NGNjZDk2YzY0YWQ1OWE1NjZhMjFfNy0zLTEtMS0w_4d6961e6-baa0-4a25-bc9a-6ea17cdaaf11"
      unitRef="usd">330000</us-gaap:InventorySuppliesNetOfReserves>
    <us-gaap:InventorySuppliesNetOfReserves
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF84NS9mcmFnOmJjODJkMDI0NTEyMDRlZDA4ODFjMzEzODVhOWJkMDk4L3RhYmxlOmUxZmI2MDNmYTJmNjRjY2Q5NmM2NGFkNTlhNTY2YTIxL3RhYmxlcmFuZ2U6ZTFmYjYwM2ZhMmY2NGNjZDk2YzY0YWQ1OWE1NjZhMjFfNy02LTEtMS0w_16e5dba7-31ca-4972-9dc1-39fc18691d23"
      unitRef="usd">1639000</us-gaap:InventorySuppliesNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF84NS9mcmFnOmJjODJkMDI0NTEyMDRlZDA4ODFjMzEzODVhOWJkMDk4L3RhYmxlOmUxZmI2MDNmYTJmNjRjY2Q5NmM2NGFkNTlhNTY2YTIxL3RhYmxlcmFuZ2U6ZTFmYjYwM2ZhMmY2NGNjZDk2YzY0YWQ1OWE1NjZhMjFfOC0zLTEtMS0w_4f2c1fc6-6bcd-4183-bcd3-078fccb4a632"
      unitRef="usd">44002000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF84NS9mcmFnOmJjODJkMDI0NTEyMDRlZDA4ODFjMzEzODVhOWJkMDk4L3RhYmxlOmUxZmI2MDNmYTJmNjRjY2Q5NmM2NGFkNTlhNTY2YTIxL3RhYmxlcmFuZ2U6ZTFmYjYwM2ZhMmY2NGNjZDk2YzY0YWQ1OWE1NjZhMjFfOC02LTEtMS0w_6d9e7d39-4ef7-4d72-a69c-0f144989b46d"
      unitRef="usd">38043000</us-gaap:InventoryNet>
    <us-gaap:InventoryWriteDown
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF84NS9mcmFnOmJjODJkMDI0NTEyMDRlZDA4ODFjMzEzODVhOWJkMDk4L3RleHRyZWdpb246YmM4MmQwMjQ1MTIwNGVkMDg4MWMzMTM4NWE5YmQwOThfMjcw_85e3be2c-6d76-4587-9b1b-3d0ce1b17676"
      unitRef="usd">26055000</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF84NS9mcmFnOmJjODJkMDI0NTEyMDRlZDA4ODFjMzEzODVhOWJkMDk4L3RleHRyZWdpb246YmM4MmQwMjQ1MTIwNGVkMDg4MWMzMTM4NWE5YmQwOThfMTI2NDQzODM3MjAwNzI_76fbdb5f-dfb4-4405-8ba4-724f2d88ce9a"
      unitRef="usd">29173000</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF84NS9mcmFnOmJjODJkMDI0NTEyMDRlZDA4ODFjMzEzODVhOWJkMDk4L3RleHRyZWdpb246YmM4MmQwMjQ1MTIwNGVkMDg4MWMzMTM4NWE5YmQwOThfMTA5OTUxMTYyNzg4NzE_d4ed9ab5-efea-43c1-9542-61ea03c1e46a"
      unitRef="usd">0</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryValuationReserves
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF84NS9mcmFnOmJjODJkMDI0NTEyMDRlZDA4ODFjMzEzODVhOWJkMDk4L3RleHRyZWdpb246YmM4MmQwMjQ1MTIwNGVkMDg4MWMzMTM4NWE5YmQwOThfMTMxOTQxMzk1MzQxNTg_522baaac-244d-4c53-8bf2-4736773a1827"
      unitRef="usd">1229000</us-gaap:InventoryValuationReserves>
    <us-gaap:InventoryValuationReserves
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF84NS9mcmFnOmJjODJkMDI0NTEyMDRlZDA4ODFjMzEzODVhOWJkMDk4L3RleHRyZWdpb246YmM4MmQwMjQ1MTIwNGVkMDg4MWMzMTM4NWE5YmQwOThfMTMxOTQxMzk1MzQxODg_aa51ced2-b34d-49c3-ada5-83798a3f8a10"
      unitRef="usd">0</us-gaap:InventoryValuationReserves>
    <us-gaap:EquityMethodInvestmentsDisclosureTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RleHRyZWdpb246MjQ0MTA2MTgwYTE5NGM2YjkyYjM5ZTUwY2E2ZTMwM2ZfMjMwODk3NDQyNTgzMjg_0548d8dd-aedc-4ed9-9d99-d8b3ee01fe01">Investments&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Variable Interest Entities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company holds variable interests in Cronos Growing Company Inc. (&#x201c;Cronos GrowCo&#x201d;), Natuera S.&#xe0;.r.l (&#x201c;Natuera&#x201d;), MedMen Canada Inc. (&#x201c;MedMen Canada&#x201d;) and Cannasoul Lab Services Ltd. (&#x201c;CLS&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cronos GrowCo is a joint venture incorporated under the Canada Business Corporations Act (&#x201c;CBCA&#x201d;) on June 14, 2018 with the objective of building a cannabis production greenhouse, applying for cannabis licenses under the Cannabis Act (Canada), and growing, cultivating, extracting, producing and selling cannabis in accordance with such licenses. Cronos Group holds variable interests in Cronos GrowCo through its ownership of 50% of Cronos GrowCo&#x2019;s common shares and senior secured debt in Cronos GrowCo. Cronos GrowCo&#x2019;s economic performance is driven by the quantity and strains of cannabis grown. The joint venture partners mutually determine the quantity and strains of cannabis grown.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;MedMen Canada is a joint venture incorporated under the CBCA on March 13, 2018, with the objective of the retail sale and marketing of cannabis products in Canada. MedMen Canada holds the exclusive license to the MedMen brand in Canada for a minimum term of 20 years. Cronos holds variable interests in MedMen Canada through its ownership of 50% of MedMen Canada&#x2019;s common shares and other subordinated debt in the entity. MedMen Canada&#x2019;s economic performance is driven by the quantity and strains of cannabis sold. Subject to applicable law, the joint venture partners mutually determine the quantity and strains of cannabis to be sold in MedMen Canada&#x2019;s retail stores, if and when stores are opened. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Natuera is a joint venture registered in Luxembourg with the objective of cultivating and commercializing medical cannabis to serve the export market. Cronos holds variable interests in Natuera through its ownership of 50% of Natuera&#x2019;s common shares and other debt in the entity. Natuera&#x2019;s economic performance is driven by the quantity and strains of cannabis to be grown. The joint venture partners mutually determine the quantity and strains of cannabis grown.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s investments in Cronos GrowCo, Natuera and MedMen Canada are exposed to economic variability from each entity&#x2019;s performance; however, the Company does not consolidate the entities as it does not have the power to direct the activities that most significantly impact each entities&#x2019; economic performance. Thus, Cronos Group is not considered the primary beneficiary of each entity. These investments are accounted for as equity method investments classified as &#x201c;Investments in equity accounted investees&#x201d; in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CLS is a wholly owned subsidiary of Cannasoul Analytics Ltd., incorporated with the purpose of establishing a commercial cannabis analytical testing laboratory located on the premises of Cronos Israel (the &#x201c;Cannasoul Collaboration&#x201d;). Cronos Israel will advance ILS 8,297 (approximately $2,574) by a non-recourse loan to CLS over a period of two years from April 1, 2020 for the capital and operating expenditures of the laboratory. The loan will bear interest at 3.5% annually. Cronos Israel will receive 70% of the profits of the laboratory until such time as it has recovered 150% of the amounts advanced to CLS, after which time it will receive 50% of the laboratory profits. As a result, the Company is exposed to economic variability from CLS&#x2019;s performance. The Company does not consolidate CLS as it does not have the power to direct the activities that most significantly impact the entity&#x2019;s economic performance; thus, the Company is not considered the primary beneficiary of the entity. The carrying amount of the non-recourse loan is recorded under loans receivable and the full loan amount, ILS 8,297, represents the Company&#x2019;s maximum potential exposure to losses through the Cannasoul Collaboration. See Note 8 for further information regarding loans receivable&lt;/span&gt;&lt;span style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt"&gt;Equity Method Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the carrying amount of the investments in associates and joint ventures is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.288%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.153%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Ownership interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cronos Australia&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(346)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cronos GrowCo&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Natuera&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(598)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 10pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt"&gt;On October 25, 2019, Cronos Australia issued 40 million new shares in an initial public offering at an offering price of A$0.50 per share. The Company&#x2019;s ownership in Cronos Australia decreased from 50% to 31% on November 7, 2019 when Cronos Australia began trading on the Australian Securities Exchange. This resulted in a reconsideration event, which required the reassessment of the Company&#x2019;s variable interest entity conclusion. Upon reconsideration, the Company determined that the entity was no longer a variable interest entity as of December 31, 2019 and is now reported under the equity method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt"&gt;On September 25, 2020, the Company and 2645485 Ontario Inc. (&#x201c;Mucci&#x201d;), the other joint venture partner of Cronos GrowCo, agreed to capitalize certain historical advances made by each shareholder to Cronos GrowCo. Total aggregate gross advances to Cronos GrowCo, excluding any amounts advanced by the Company to Cronos GrowCo under the GrowCo Credit Facility, were C$49,300 ($37,010), of which the Company advanced 50% and Mucci advanced the remaining 50% for an amount of C$24,650 ($18,505) each. As a result, the Company transferred the advances of C$24,650 ($18,505) to investments in equity accounted investees in respect of Cronos GrowCo.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s share of net earnings (losses) from equity investments accounted for under the equity method of accounting as of and for the years ended December&#160;31:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.820%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Whistler Medicinal Marijuana Company (&#x201c;Whistler&#x201d;)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cronos Australia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(363)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,101)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(588)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cronos GrowCo&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,537)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(167)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MedMen Canada&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(213)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Natuera&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,610)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(805)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,510)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,009)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(723)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt"&gt;Whistler was incorporated in British Columbia, Canada and is a license holder under the Cannabis Act (Canada) with production facilities in British Columbia, Canada. The Company fully divested its investment in Whistler during 2019. See Note 7.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt"&gt;The Company&#x2019;s share of accumulated net losses in excess of its equity investment in Natuera has been applied as a loss allowance on the loan receivable. See Note 8.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-9pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of financial information for the Company&#x2019;s equity method investments as of and for the year ended December&#160;31:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.316%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.050%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.792%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(631)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,453)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,048)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(874)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt"&gt;Advances to Joint Ventures&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.722%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.785%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.231%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.914%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.231%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.914%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.231%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.914%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.231%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.914%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.235%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;MedMen Canada&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cronos GrowCo&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cronos Australia&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(iii) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Natuera&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;As of January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfer to investments in equity accounted investees&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,505)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,505)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest on advances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Advances to joint ventures recovered from (applied to) carrying amount of investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect from foreign exchange&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(461)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(464)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;As of December&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:29.25pt;text-align:justify;text-indent:-27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.856%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.218%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.912%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.218%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.912%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.218%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.912%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.218%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.912%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.224%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;MedMen Canada&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cronos GrowCo&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cronos Australia&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(iii) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Natuera&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;As of January 1, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Advances (repayments)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(852)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Advances to joint ventures recovered from (applied to) carrying amount of investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(779)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(224)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(946)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect from foreign exchange&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;As of December&#160;31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:29.25pt;text-align:justify;text-indent:-27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Advance is unsecured, non-interest bearing, and there are no terms of repayment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%;padding-left:20.66pt"&gt;On September 25, 2020, the Company and Mucci agreed to capitalize historical advances made by each shareholder to Cronos GrowCo. The Company capitalized C$24,650 ($18,505) through a transfer of aggregate gross advances from advances to joint ventures to investments in equity accounted investees in respect of Cronos GrowCo. Refer to footnote (ii) to the first table set forth under Note 6(a).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(iii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.22pt"&gt;A$1,500 is governed by an unsecured loan bearing interest at a rate of 12% per annum, calculated and compounded daily, in arrears, on the amounts advanced from the date of each advance. The loan is due on January 1, 2022. If the loan is overdue, the outstanding amount bears interest at an additional 2% per annum.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determined that the maximum exposure to loss on variable interest entities is limited to the Company&#x2019;s initial investment, advances and/or loans for each variable interest entity. The following is a summary of the maximum exposure to loss for the year ended December&#160;31, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Ownership interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other Net Assets (Liabilities)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Maximum Exposure to Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cronos Australia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cronos GrowCo&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MedMen Canada&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Natuera&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,849)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:-9pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Ownership interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other Net Assets (Liabilities)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Maximum Exposure to Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cronos Australia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cronos GrowCo&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 4pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MedMen Canada&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(199)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Natuera&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(358)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December&#160;31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsDisclosureTextBlock>
    <us-gaap:VariableInterestEntityOwnershipPercentage
      contextRef="i9d186ec4178c4ab29fa3a2fa261a681f_D20180614-20180614"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RleHRyZWdpb246MjQ0MTA2MTgwYTE5NGM2YjkyYjM5ZTUwY2E2ZTMwM2ZfMTI2NDQzODM3NTM0NDc_c15e6e2b-0248-4303-8024-f8fb8f086759"
      unitRef="number">0.50</us-gaap:VariableInterestEntityOwnershipPercentage>
    <cron:VariableInterestEntityQualitativeOrQuantitativeInformationLicenseTerm
      contextRef="i01dfe784ae954e5eabcb9849e4771b50_D20180313-20180313"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RleHRyZWdpb246MjQ0MTA2MTgwYTE5NGM2YjkyYjM5ZTUwY2E2ZTMwM2ZfODI0NjMzNzI4NzE2Mg_4b7c2a4c-e940-4385-a499-e36d83d59a0e">P20Y</cron:VariableInterestEntityQualitativeOrQuantitativeInformationLicenseTerm>
    <us-gaap:VariableInterestEntityOwnershipPercentage
      contextRef="iff55fd87547140e8bb2f3c7af7f88e71_D20180313-20180313"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RleHRyZWdpb246MjQ0MTA2MTgwYTE5NGM2YjkyYjM5ZTUwY2E2ZTMwM2ZfMTI2NDQzODM3NTM0NTY_23dc1b95-c96b-4ab5-bd2f-154fdb92e139"
      unitRef="number">0.50</us-gaap:VariableInterestEntityOwnershipPercentage>
    <us-gaap:VariableInterestEntityOwnershipPercentage
      contextRef="i08aaf1da351148dabbc15473a8372493_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RleHRyZWdpb246MjQ0MTA2MTgwYTE5NGM2YjkyYjM5ZTUwY2E2ZTMwM2ZfMTI2NDQzODM3NTM0NjQ_04418bbc-58ef-435c-b2d5-8176bd08b680"
      unitRef="number">0.50</us-gaap:VariableInterestEntityOwnershipPercentage>
    <cron:CollaborativeArrangementAmountOfAdvances
      contextRef="if0ba41d1bbbd4426a1cae1e0e667c052_I20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RleHRyZWdpb246MjQ0MTA2MTgwYTE5NGM2YjkyYjM5ZTUwY2E2ZTMwM2ZfMTI2NDQzODM3NTM2Mjc_f14fe8dc-32f2-494c-bcb3-dfbcece41a36"
      unitRef="ils">8297000</cron:CollaborativeArrangementAmountOfAdvances>
    <cron:CollaborativeArrangementAmountOfAdvances
      contextRef="if0ba41d1bbbd4426a1cae1e0e667c052_I20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RleHRyZWdpb246MjQ0MTA2MTgwYTE5NGM2YjkyYjM5ZTUwY2E2ZTMwM2ZfMTI2NDQzODM3NTM2MzU_9e13633c-d9e6-4233-852f-a1d158770210"
      unitRef="usd">2574000</cron:CollaborativeArrangementAmountOfAdvances>
    <cron:CollaborativeArrangementTermOfAgreement
      contextRef="i06abbbd3d08f420c89556e2d722f7d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RleHRyZWdpb246MjQ0MTA2MTgwYTE5NGM2YjkyYjM5ZTUwY2E2ZTMwM2ZfODI0NjMzNzI4NzE4MA_1705d5ce-dbb6-4538-a923-8f70a985be0f">P2Y</cron:CollaborativeArrangementTermOfAgreement>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia530bf80f98848218e4aca2d29c92f27_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RleHRyZWdpb246MjQ0MTA2MTgwYTE5NGM2YjkyYjM5ZTUwY2E2ZTMwM2ZfMTI2NDQzODM3NTM0ODM_2267127f-1be6-4e55-869e-391e591b3b24"
      unitRef="number">0.035</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <cron:CollaborativeArrangementPercentageOfProfitsToBeReceived
      contextRef="i520015d24dc64ccb873f3a7698adf8e8_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RleHRyZWdpb246MjQ0MTA2MTgwYTE5NGM2YjkyYjM5ZTUwY2E2ZTMwM2ZfMTI2NDQzODM3NTM0OTQ_142ff41d-c152-4f7e-81d5-877d039d5ca9"
      unitRef="number">0.70</cron:CollaborativeArrangementPercentageOfProfitsToBeReceived>
    <cron:CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced
      contextRef="i520015d24dc64ccb873f3a7698adf8e8_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RleHRyZWdpb246MjQ0MTA2MTgwYTE5NGM2YjkyYjM5ZTUwY2E2ZTMwM2ZfODI0NjMzNzI4NzE1Ng_65632bc9-b399-4c12-b900-203e6d7cbca2"
      unitRef="number">1.50</cron:CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced>
    <cron:CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet
      contextRef="i520015d24dc64ccb873f3a7698adf8e8_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RleHRyZWdpb246MjQ0MTA2MTgwYTE5NGM2YjkyYjM5ZTUwY2E2ZTMwM2ZfMTI2NDQzODM3NTM1MTk_0891c36f-b577-4ac5-8a67-9912d197945b"
      unitRef="number">0.50</cron:CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet>
    <cron:CollaborativeArrangementAmountOfAdvances
      contextRef="if0ba41d1bbbd4426a1cae1e0e667c052_I20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RleHRyZWdpb246MjQ0MTA2MTgwYTE5NGM2YjkyYjM5ZTUwY2E2ZTMwM2ZfMTI2NDQzODM3NTM1NDk_f14fe8dc-32f2-494c-bcb3-dfbcece41a36"
      unitRef="ils">8297000</cron:CollaborativeArrangementAmountOfAdvances>
    <us-gaap:EquityMethodInvestmentsTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RleHRyZWdpb246MjQ0MTA2MTgwYTE5NGM2YjkyYjM5ZTUwY2E2ZTMwM2ZfMjMwODk3NDQyNTgzMjk_8d3d7f94-08e7-4583-becd-a70ea096f458">Equity Method Investments&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the carrying amount of the investments in associates and joint ventures is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.288%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.153%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Ownership interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cronos Australia&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(346)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cronos GrowCo&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Natuera&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(598)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 10pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt"&gt;On October 25, 2019, Cronos Australia issued 40 million new shares in an initial public offering at an offering price of A$0.50 per share. The Company&#x2019;s ownership in Cronos Australia decreased from 50% to 31% on November 7, 2019 when Cronos Australia began trading on the Australian Securities Exchange. This resulted in a reconsideration event, which required the reassessment of the Company&#x2019;s variable interest entity conclusion. Upon reconsideration, the Company determined that the entity was no longer a variable interest entity as of December 31, 2019 and is now reported under the equity method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt"&gt;On September 25, 2020, the Company and 2645485 Ontario Inc. (&#x201c;Mucci&#x201d;), the other joint venture partner of Cronos GrowCo, agreed to capitalize certain historical advances made by each shareholder to Cronos GrowCo. Total aggregate gross advances to Cronos GrowCo, excluding any amounts advanced by the Company to Cronos GrowCo under the GrowCo Credit Facility, were C$49,300 ($37,010), of which the Company advanced 50% and Mucci advanced the remaining 50% for an amount of C$24,650 ($18,505) each. As a result, the Company transferred the advances of C$24,650 ($18,505) to investments in equity accounted investees in respect of Cronos GrowCo.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s share of net earnings (losses) from equity investments accounted for under the equity method of accounting as of and for the years ended December&#160;31:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.820%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Whistler Medicinal Marijuana Company (&#x201c;Whistler&#x201d;)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cronos Australia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(363)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,101)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(588)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cronos GrowCo&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,537)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(167)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MedMen Canada&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(213)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Natuera&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,610)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(805)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,510)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,009)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(723)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt"&gt;Whistler was incorporated in British Columbia, Canada and is a license holder under the Cannabis Act (Canada) with production facilities in British Columbia, Canada. The Company fully divested its investment in Whistler during 2019. See Note 7.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt"&gt;The Company&#x2019;s share of accumulated net losses in excess of its equity investment in Natuera has been applied as a loss allowance on the loan receivable. See Note 8.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-9pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of financial information for the Company&#x2019;s equity method investments as of and for the year ended December&#160;31:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.316%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.050%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.792%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(631)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,453)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,048)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(874)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsTextBlock>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i4a854431fb9b495d990aeb067616e389_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjNhZDBkMzNmYjk0NTQ1OTI5NWJmZTc3Zjk3ODAxY2IyL3RhYmxlcmFuZ2U6M2FkMGQzM2ZiOTQ1NDU5Mjk1YmZlNzdmOTc4MDFjYjJfMi0xLTEtMS0zNjcxMw_50c14e5d-0e48-471f-b991-ec55d40644ba"
      unitRef="number">0.31</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:VariableInterestEntityOwnershipPercentage
      contextRef="i1992c389e83f4ed89ee4289b28705c96_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjNhZDBkMzNmYjk0NTQ1OTI5NWJmZTc3Zjk3ODAxY2IyL3RhYmxlcmFuZ2U6M2FkMGQzM2ZiOTQ1NDU5Mjk1YmZlNzdmOTc4MDFjYjJfMi0xLTEtMS0zNjcxMw_9a563966-5cc4-4086-ba1f-14a73f94058c"
      unitRef="number">0.31</us-gaap:VariableInterestEntityOwnershipPercentage>
    <us-gaap:EquityMethodInvestments
      contextRef="i4a854431fb9b495d990aeb067616e389_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjNhZDBkMzNmYjk0NTQ1OTI5NWJmZTc3Zjk3ODAxY2IyL3RhYmxlcmFuZ2U6M2FkMGQzM2ZiOTQ1NDU5Mjk1YmZlNzdmOTc4MDFjYjJfMi0zLTEtMS0xNjQxMQ_6e1299cd-2bf8-4be3-b76b-4cd349ba45d0"
      unitRef="usd">0</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i613b07197744400cbbef2fbf605f0d54_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjNhZDBkMzNmYjk0NTQ1OTI5NWJmZTc3Zjk3ODAxY2IyL3RhYmxlcmFuZ2U6M2FkMGQzM2ZiOTQ1NDU5Mjk1YmZlNzdmOTc4MDFjYjJfMi01LTEtMS0xNjU2NA_c06a35b4-36f8-4c0b-800c-952356c2773d"
      unitRef="usd">-346000</us-gaap:EquityMethodInvestments>
    <us-gaap:VariableInterestEntityOwnershipPercentage
      contextRef="i291f9ace020d4518924413d4644527d9_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjNhZDBkMzNmYjk0NTQ1OTI5NWJmZTc3Zjk3ODAxY2IyL3RhYmxlcmFuZ2U6M2FkMGQzM2ZiOTQ1NDU5Mjk1YmZlNzdmOTc4MDFjYjJfMy0xLTEtMS0zNjcxMw_131ade4a-305f-4216-868e-ca581f5252a6"
      unitRef="number">0.50</us-gaap:VariableInterestEntityOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="ieb8971bbe440425c985b311295f2cec9_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjNhZDBkMzNmYjk0NTQ1OTI5NWJmZTc3Zjk3ODAxY2IyL3RhYmxlcmFuZ2U6M2FkMGQzM2ZiOTQ1NDU5Mjk1YmZlNzdmOTc4MDFjYjJfMy0xLTEtMS0zNjcxMw_5a7591f4-8e6a-4273-a6b3-637caaa6f476"
      unitRef="number">0.50</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments
      contextRef="ieb8971bbe440425c985b311295f2cec9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjNhZDBkMzNmYjk0NTQ1OTI5NWJmZTc3Zjk3ODAxY2IyL3RhYmxlcmFuZ2U6M2FkMGQzM2ZiOTQ1NDU5Mjk1YmZlNzdmOTc4MDFjYjJfMy0zLTEtMS0xNjQxMQ_3b40ac73-f4e4-4e08-9519-f9c9e510fc73"
      unitRef="usd">19235000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="ief35f4e5e0e14975afdc16c2f8b07671_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjNhZDBkMzNmYjk0NTQ1OTI5NWJmZTc3Zjk3ODAxY2IyL3RhYmxlcmFuZ2U6M2FkMGQzM2ZiOTQ1NDU5Mjk1YmZlNzdmOTc4MDFjYjJfMy01LTEtMS0xNjU2NA_99d4c74c-66ea-457a-bd48-427898881f31"
      unitRef="usd">1501000</us-gaap:EquityMethodInvestments>
    <us-gaap:VariableInterestEntityOwnershipPercentage
      contextRef="i08aaf1da351148dabbc15473a8372493_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjNhZDBkMzNmYjk0NTQ1OTI5NWJmZTc3Zjk3ODAxY2IyL3RhYmxlcmFuZ2U6M2FkMGQzM2ZiOTQ1NDU5Mjk1YmZlNzdmOTc4MDFjYjJfNS0xLTEtMS0zNjcxNQ_abeb0b9a-c88d-4d5d-944c-a177e56c2ab7"
      unitRef="number">0.50</us-gaap:VariableInterestEntityOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i578db4ab78c04e03aee4c102f9d17cfe_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjNhZDBkMzNmYjk0NTQ1OTI5NWJmZTc3Zjk3ODAxY2IyL3RhYmxlcmFuZ2U6M2FkMGQzM2ZiOTQ1NDU5Mjk1YmZlNzdmOTc4MDFjYjJfNS0xLTEtMS0zNjcxNQ_bc0fdcd5-1b05-432a-9c93-6ca263ed7f4b"
      unitRef="number">0.50</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments
      contextRef="i578db4ab78c04e03aee4c102f9d17cfe_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjNhZDBkMzNmYjk0NTQ1OTI5NWJmZTc3Zjk3ODAxY2IyL3RhYmxlcmFuZ2U6M2FkMGQzM2ZiOTQ1NDU5Mjk1YmZlNzdmOTc4MDFjYjJfNS0zLTEtMS0xNjQxMQ_a4c91981-79ce-4354-8c45-fa50f18fa537"
      unitRef="usd">0</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="ibe5479ec3fef4f42a9772f4fad66332d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjNhZDBkMzNmYjk0NTQ1OTI5NWJmZTc3Zjk3ODAxY2IyL3RhYmxlcmFuZ2U6M2FkMGQzM2ZiOTQ1NDU5Mjk1YmZlNzdmOTc4MDFjYjJfNS01LTEtMS0xNjU2NA_2e74a109-adac-4ff2-9cae-b7a8865cb58b"
      unitRef="usd">-598000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjNhZDBkMzNmYjk0NTQ1OTI5NWJmZTc3Zjk3ODAxY2IyL3RhYmxlcmFuZ2U6M2FkMGQzM2ZiOTQ1NDU5Mjk1YmZlNzdmOTc4MDFjYjJfNi0zLTEtMS0xNjQ0Mg_7f7d7897-ffa7-4993-aecb-817555ae86e9"
      unitRef="usd">19235000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjNhZDBkMzNmYjk0NTQ1OTI5NWJmZTc3Zjk3ODAxY2IyL3RhYmxlcmFuZ2U6M2FkMGQzM2ZiOTQ1NDU5Mjk1YmZlNzdmOTc4MDFjYjJfNi01LTEtMS0xNjQyOA_d2b2bc0d-2824-4a77-b5cc-8e3fa4e3353b"
      unitRef="usd">557000</us-gaap:EquityMethodInvestments>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="i943c6ce876d74af98e5d66bae1d75dd5_D20191025-20191025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RleHRyZWdpb246MjQ0MTA2MTgwYTE5NGM2YjkyYjM5ZTUwY2E2ZTMwM2ZfMTIwOTQ2Mjc5NTI4NTE_f6f652c6-8cc3-4a8d-b592-0bcca77bc16a"
      unitRef="shares">40000000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="iaa56b775900347199fb903e36ef60844_I20191025"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RleHRyZWdpb246MjQ0MTA2MTgwYTE5NGM2YjkyYjM5ZTUwY2E2ZTMwM2ZfMTIwOTQ2Mjc5NTI5MjE_955a8811-fec1-4f9e-996d-208fb76a0d11"
      unitRef="audPerShare">0.50</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:VariableInterestEntityOwnershipPercentage
      contextRef="i8a335245090a41f88ff82b8dceb50377_D20191106-20191106"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RleHRyZWdpb246MjQ0MTA2MTgwYTE5NGM2YjkyYjM5ZTUwY2E2ZTMwM2ZfMTIwOTQ2Mjc5NTI5OTU_b64426c9-ab79-435d-8e39-9dacb6c2bde9"
      unitRef="number">0.50</us-gaap:VariableInterestEntityOwnershipPercentage>
    <us-gaap:VariableInterestEntityOwnershipPercentage
      contextRef="i958145f694ac404a80377bba4d961f2a_D20191107-20191107"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RleHRyZWdpb246MjQ0MTA2MTgwYTE5NGM2YjkyYjM5ZTUwY2E2ZTMwM2ZfMTIwOTQ2Mjc5NTMwMDI_fe2479b9-828c-4464-96b0-c84022580765"
      unitRef="number">0.31</us-gaap:VariableInterestEntityOwnershipPercentage>
    <cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments
      contextRef="ia7faa2556fad44d4a177d4471c6fe14f_D20200925-20200925"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RleHRyZWdpb246MjQ0MTA2MTgwYTE5NGM2YjkyYjM5ZTUwY2E2ZTMwM2ZfMzg0ODI5MDc1NDA1Mg_86d69ee0-fdaf-45ea-9c8e-75a1fe9b1b7a"
      unitRef="cad">49300000</cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments>
    <cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments
      contextRef="ia7faa2556fad44d4a177d4471c6fe14f_D20200925-20200925"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RleHRyZWdpb246MjQ0MTA2MTgwYTE5NGM2YjkyYjM5ZTUwY2E2ZTMwM2ZfMzg0ODI5MDc1NDA1OA_cf1f3b6f-ecbf-4e2b-b51e-c856cbfbbd44"
      unitRef="usd">37010000</cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments>
    <cron:InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage
      contextRef="iac8ed3a0468448b59a2da8d6539912f4_I20200925"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RleHRyZWdpb246MjQ0MTA2MTgwYTE5NGM2YjkyYjM5ZTUwY2E2ZTMwM2ZfMzg0ODI5MDc1NDA5NA_90eb36f7-6357-41d1-be23-07cf2aaf3918"
      unitRef="number">0.50</cron:InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage>
    <cron:InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage
      contextRef="i6006e9a66ec247e5977546ab36704286_I20200925"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RleHRyZWdpb246MjQ0MTA2MTgwYTE5NGM2YjkyYjM5ZTUwY2E2ZTMwM2ZfMzg0ODI5MDc1NDEzMQ_2bf376df-711c-45c3-ae96-8b57840caabf"
      unitRef="number">0.50</cron:InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage>
    <cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments
      contextRef="ic3c92d00b15c48db9d6e48e737227b0a_D20200925-20200925"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RleHRyZWdpb246MjQ0MTA2MTgwYTE5NGM2YjkyYjM5ZTUwY2E2ZTMwM2ZfMzg0ODI5MDc1NDE1Mw_b705507c-7f8d-4460-9061-59a651068c50"
      unitRef="cad">24650000</cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments>
    <cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments
      contextRef="ic3c92d00b15c48db9d6e48e737227b0a_D20200925-20200925"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RleHRyZWdpb246MjQ0MTA2MTgwYTE5NGM2YjkyYjM5ZTUwY2E2ZTMwM2ZfMzg0ODI5MDc1NDE1OA_52486499-b1d9-48e3-a9b3-c978263d44cf"
      unitRef="usd">18505000</cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments>
    <cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees
      contextRef="ia7faa2556fad44d4a177d4471c6fe14f_D20200925-20200925"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RleHRyZWdpb246MjQ0MTA2MTgwYTE5NGM2YjkyYjM5ZTUwY2E2ZTMwM2ZfMzg0ODI5MDc1NDIyMw_8fa7caa7-6d59-4eef-adc0-877c98bdd6ab"
      unitRef="cad">24650000</cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees>
    <cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees
      contextRef="ia7faa2556fad44d4a177d4471c6fe14f_D20200925-20200925"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RleHRyZWdpb246MjQ0MTA2MTgwYTE5NGM2YjkyYjM5ZTUwY2E2ZTMwM2ZfMzg0ODI5MDc1NDIyOA_b044e024-9add-43ff-8b20-103464e3dfe7"
      unitRef="usd">18505000</cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i9154570513a2434988aa789c0e451da8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOmI4ZGE3MGNiOTM0ZTQyOGFiZjQzYTk4ZTJiY2FkZWZlL3RhYmxlcmFuZ2U6YjhkYTcwY2I5MzRlNDI4YWJmNDNhOThlMmJjYWRlZmVfMS0xLTEtMS0yMzY2Nw_ac7a0fc5-fa87-4135-b4bf-9b6f23af141c"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i311f8f928bf84db9989bd0476ea75d2c_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOmI4ZGE3MGNiOTM0ZTQyOGFiZjQzYTk4ZTJiY2FkZWZlL3RhYmxlcmFuZ2U6YjhkYTcwY2I5MzRlNDI4YWJmNDNhOThlMmJjYWRlZmVfMi0zLTEtMS0xNjUwNw_3af55587-6e05-41e8-a0a9-1c24a9608312"
      unitRef="usd">29000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i4403f97e12eb42dd960878337546ae3b_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOmI4ZGE3MGNiOTM0ZTQyOGFiZjQzYTk4ZTJiY2FkZWZlL3RhYmxlcmFuZ2U6YjhkYTcwY2I5MzRlNDI4YWJmNDNhOThlMmJjYWRlZmVfMS01LTEtMS0yMzY0Mw_81717c77-b183-4323-b306-5aceec97ed5d"
      unitRef="usd">178000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i295d7b236249421daadace6736fa6dc7_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOmI4ZGE3MGNiOTM0ZTQyOGFiZjQzYTk4ZTJiY2FkZWZlL3RhYmxlcmFuZ2U6YjhkYTcwY2I5MzRlNDI4YWJmNDNhOThlMmJjYWRlZmVfMi0xLTEtMS0yMzY2Nw_9266a0b1-112f-474c-ba61-b9ccb886318d"
      unitRef="usd">-363000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i5f0e3243c9c049d9bd4653b87b8b4c8a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOmI4ZGE3MGNiOTM0ZTQyOGFiZjQzYTk4ZTJiY2FkZWZlL3RhYmxlcmFuZ2U6YjhkYTcwY2I5MzRlNDI4YWJmNDNhOThlMmJjYWRlZmVfMy0zLTEtMS0xNjUwNw_204805ce-6e55-44ec-88d1-610ce89d7da1"
      unitRef="usd">-1101000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="id4252dcfecff4dad93552572230a33b7_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOmI4ZGE3MGNiOTM0ZTQyOGFiZjQzYTk4ZTJiY2FkZWZlL3RhYmxlcmFuZ2U6YjhkYTcwY2I5MzRlNDI4YWJmNDNhOThlMmJjYWRlZmVfMi01LTEtMS0yMzY0Mw_9205be2e-7234-4da1-aff9-abfd64be637d"
      unitRef="usd">-588000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i06e71f94f83b4681be053f1be423964a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOmI4ZGE3MGNiOTM0ZTQyOGFiZjQzYTk4ZTJiY2FkZWZlL3RhYmxlcmFuZ2U6YjhkYTcwY2I5MzRlNDI4YWJmNDNhOThlMmJjYWRlZmVfMy0xLTEtMS0yMzY2Nw_3322863e-7dc4-4f1e-a143-166f90fb9929"
      unitRef="usd">-1537000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ib057cdc4d573476488dcb0661bea31b4_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOmI4ZGE3MGNiOTM0ZTQyOGFiZjQzYTk4ZTJiY2FkZWZlL3RhYmxlcmFuZ2U6YjhkYTcwY2I5MzRlNDI4YWJmNDNhOThlMmJjYWRlZmVfNC0zLTEtMS0xNjUwNw_e88e38db-90b9-477f-b3a2-209d8aec7e2d"
      unitRef="usd">-167000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="idfa1e87dd5eb46d78d7da772e2d321bf_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOmI4ZGE3MGNiOTM0ZTQyOGFiZjQzYTk4ZTJiY2FkZWZlL3RhYmxlcmFuZ2U6YjhkYTcwY2I5MzRlNDI4YWJmNDNhOThlMmJjYWRlZmVfMy01LTEtMS0yMzY0Mw_be9a41b0-9313-43bc-ba74-15de472b0379"
      unitRef="usd">-100000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i439b30240d69471792a73a83983aafc9_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOmI4ZGE3MGNiOTM0ZTQyOGFiZjQzYTk4ZTJiY2FkZWZlL3RhYmxlcmFuZ2U6YjhkYTcwY2I5MzRlNDI4YWJmNDNhOThlMmJjYWRlZmVfNC0xLTEtMS0yMzY2Nw_7067e555-e87e-475c-822a-2dc1adf0c3a9"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i25b4f750539544e98240240c6d96fdc8_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOmI4ZGE3MGNiOTM0ZTQyOGFiZjQzYTk4ZTJiY2FkZWZlL3RhYmxlcmFuZ2U6YjhkYTcwY2I5MzRlNDI4YWJmNDNhOThlMmJjYWRlZmVfNS0zLTEtMS0xNjUwNw_eacb3228-9ca3-42ef-b59e-4856180c5616"
      unitRef="usd">35000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="id9757b53f9bf46aeb73a8053c24786e3_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOmI4ZGE3MGNiOTM0ZTQyOGFiZjQzYTk4ZTJiY2FkZWZlL3RhYmxlcmFuZ2U6YjhkYTcwY2I5MzRlNDI4YWJmNDNhOThlMmJjYWRlZmVfNC01LTEtMS0yMzY0Mw_60409f9f-c6cf-4a27-8d56-c2201bca3343"
      unitRef="usd">-213000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ie83a15c30f9b4a8288e090fa665f59d3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOmI4ZGE3MGNiOTM0ZTQyOGFiZjQzYTk4ZTJiY2FkZWZlL3RhYmxlcmFuZ2U6YjhkYTcwY2I5MzRlNDI4YWJmNDNhOThlMmJjYWRlZmVfNS0xLTEtMS0yMzY2Nw_ba9bc349-5cb9-4507-99a8-3f6e3c705709"
      unitRef="usd">-2610000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i15402ae419444f8291523f27c01226c3_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOmI4ZGE3MGNiOTM0ZTQyOGFiZjQzYTk4ZTJiY2FkZWZlL3RhYmxlcmFuZ2U6YjhkYTcwY2I5MzRlNDI4YWJmNDNhOThlMmJjYWRlZmVfNi0zLTEtMS0xNjUwNw_d47b761a-3e9c-4f5e-92be-f808eaf74874"
      unitRef="usd">-805000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ieac8a1e4f6ea44899784210564e39358_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOmI4ZGE3MGNiOTM0ZTQyOGFiZjQzYTk4ZTJiY2FkZWZlL3RhYmxlcmFuZ2U6YjhkYTcwY2I5MzRlNDI4YWJmNDNhOThlMmJjYWRlZmVfNS01LTEtMS0yMzY0Mw_4976c0b5-38a5-45c8-8213-63439a4cee7b"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOmI4ZGE3MGNiOTM0ZTQyOGFiZjQzYTk4ZTJiY2FkZWZlL3RhYmxlcmFuZ2U6YjhkYTcwY2I5MzRlNDI4YWJmNDNhOThlMmJjYWRlZmVfNi0xLTEtMS0xNjYwMA_9bf54fbb-b57b-4538-af3a-cbff0004b0ed"
      unitRef="usd">-4510000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOmI4ZGE3MGNiOTM0ZTQyOGFiZjQzYTk4ZTJiY2FkZWZlL3RhYmxlcmFuZ2U6YjhkYTcwY2I5MzRlNDI4YWJmNDNhOThlMmJjYWRlZmVfNy0zLTEtMS0xNjUwNw_4c551605-ace7-4100-804e-0b9b22edde25"
      unitRef="usd">-2009000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOmI4ZGE3MGNiOTM0ZTQyOGFiZjQzYTk4ZTJiY2FkZWZlL3RhYmxlcmFuZ2U6YjhkYTcwY2I5MzRlNDI4YWJmNDNhOThlMmJjYWRlZmVfNi01LTEtMS0xNjYwMA_c339bae8-22bd-4efd-8992-3791bf686783"
      unitRef="usd">-723000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:AssetsCurrent
      contextRef="ifd770601469e44b7b5851f0d7ecea847_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJhMjJmMjI1Y2UzMzQzYzJiNTEyYjIyYTVhYmZlODA2L3RhYmxlcmFuZ2U6MmEyMmYyMjVjZTMzNDNjMmI1MTJiMjJhNWFiZmU4MDZfMS0xLTEtMS0xMzk3Ng_caec4964-2b44-4652-a873-800459ac3e53"
      unitRef="usd">19126000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ic97e88f092994ad5852be234c493283e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJhMjJmMjI1Y2UzMzQzYzJiNTEyYjIyYTVhYmZlODA2L3RhYmxlcmFuZ2U6MmEyMmYyMjVjZTMzNDNjMmI1MTJiMjJhNWFiZmU4MDZfMS0zLTEtMS0xMzk2OA_116a5646-09c3-4246-a50a-a9197351f890"
      unitRef="usd">23200000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i9c04b01268f0440ca315cf7bd0d79262_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJhMjJmMjI1Y2UzMzQzYzJiNTEyYjIyYTVhYmZlODA2L3RhYmxlcmFuZ2U6MmEyMmYyMjVjZTMzNDNjMmI1MTJiMjJhNWFiZmU4MDZfMS01LTEtMS0xMzk5MA_0bdd0808-7917-4693-82a1-5ae057d0b40f"
      unitRef="usd">7121000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="ifd770601469e44b7b5851f0d7ecea847_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJhMjJmMjI1Y2UzMzQzYzJiNTEyYjIyYTVhYmZlODA2L3RhYmxlcmFuZ2U6MmEyMmYyMjVjZTMzNDNjMmI1MTJiMjJhNWFiZmU4MDZfMi0xLTEtMS0xMzk3Ng_e46f9380-3fb0-4706-bf8e-2610dd17bf78"
      unitRef="usd">122099000</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="ic97e88f092994ad5852be234c493283e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJhMjJmMjI1Y2UzMzQzYzJiNTEyYjIyYTVhYmZlODA2L3RhYmxlcmFuZ2U6MmEyMmYyMjVjZTMzNDNjMmI1MTJiMjJhNWFiZmU4MDZfMi0zLTEtMS0xMzk2OA_6883360a-649e-4409-ab84-ced1ac22a80d"
      unitRef="usd">76212000</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="i9c04b01268f0440ca315cf7bd0d79262_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJhMjJmMjI1Y2UzMzQzYzJiNTEyYjIyYTVhYmZlODA2L3RhYmxlcmFuZ2U6MmEyMmYyMjVjZTMzNDNjMmI1MTJiMjJhNWFiZmU4MDZfMi01LTEtMS0xMzk5MA_91e2e1f7-9428-4464-b99c-4e122ba4bfe1"
      unitRef="usd">27129000</us-gaap:AssetsNoncurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ifd770601469e44b7b5851f0d7ecea847_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJhMjJmMjI1Y2UzMzQzYzJiNTEyYjIyYTVhYmZlODA2L3RhYmxlcmFuZ2U6MmEyMmYyMjVjZTMzNDNjMmI1MTJiMjJhNWFiZmU4MDZfMy0xLTEtMS0xMzk3Ng_7c6e68ca-bb33-4b14-b728-5752ade8ed26"
      unitRef="usd">24223000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ic97e88f092994ad5852be234c493283e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJhMjJmMjI1Y2UzMzQzYzJiNTEyYjIyYTVhYmZlODA2L3RhYmxlcmFuZ2U6MmEyMmYyMjVjZTMzNDNjMmI1MTJiMjJhNWFiZmU4MDZfMy0zLTEtMS0xMzk2OA_8a3824a9-47f2-49db-8213-bf933b5db29b"
      unitRef="usd">52796000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i9c04b01268f0440ca315cf7bd0d79262_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJhMjJmMjI1Y2UzMzQzYzJiNTEyYjIyYTVhYmZlODA2L3RhYmxlcmFuZ2U6MmEyMmYyMjVjZTMzNDNjMmI1MTJiMjJhNWFiZmU4MDZfMy01LTEtMS0xMzk5MA_5a38e201-457f-481c-a039-145643a5047f"
      unitRef="usd">3746000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="ifd770601469e44b7b5851f0d7ecea847_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJhMjJmMjI1Y2UzMzQzYzJiNTEyYjIyYTVhYmZlODA2L3RhYmxlcmFuZ2U6MmEyMmYyMjVjZTMzNDNjMmI1MTJiMjJhNWFiZmU4MDZfNC0xLTEtMS0xMzk3Ng_451125d2-182e-491d-8bad-b02ebf0b0865"
      unitRef="usd">76313000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="ic97e88f092994ad5852be234c493283e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJhMjJmMjI1Y2UzMzQzYzJiNTEyYjIyYTVhYmZlODA2L3RhYmxlcmFuZ2U6MmEyMmYyMjVjZTMzNDNjMmI1MTJiMjJhNWFiZmU4MDZfNC0zLTEtMS0xMzk2OA_00d2b9fc-2ec9-48b4-9f3d-ba8b4cf3cca9"
      unitRef="usd">33189000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="i9c04b01268f0440ca315cf7bd0d79262_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJhMjJmMjI1Y2UzMzQzYzJiNTEyYjIyYTVhYmZlODA2L3RhYmxlcmFuZ2U6MmEyMmYyMjVjZTMzNDNjMmI1MTJiMjJhNWFiZmU4MDZfNC01LTEtMS0xMzk5MA_3860cee0-f976-44be-a5c6-6fc1678add24"
      unitRef="usd">13201000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i62efa1de276f4f6f96606236e0b99714_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJhMjJmMjI1Y2UzMzQzYzJiNTEyYjIyYTVhYmZlODA2L3RhYmxlcmFuZ2U6MmEyMmYyMjVjZTMzNDNjMmI1MTJiMjJhNWFiZmU4MDZfNi0xLTEtMS0xMzk3Ng_599dc544-6e17-423b-8da2-46def8cdf9ae"
      unitRef="usd">367000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icb34982583f74b8dac9d2bae655597ac_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJhMjJmMjI1Y2UzMzQzYzJiNTEyYjIyYTVhYmZlODA2L3RhYmxlcmFuZ2U6MmEyMmYyMjVjZTMzNDNjMmI1MTJiMjJhNWFiZmU4MDZfNi0zLTEtMS0xMzk2OA_c13ed206-db9f-47f5-8a4c-47ea57c56896"
      unitRef="usd">52000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic600db9d0b4e488aa9a037277f7ff27f_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJhMjJmMjI1Y2UzMzQzYzJiNTEyYjIyYTVhYmZlODA2L3RhYmxlcmFuZ2U6MmEyMmYyMjVjZTMzNDNjMmI1MTJiMjJhNWFiZmU4MDZfNi01LTEtMS0xMzk5MA_da2e5186-f734-407d-ad17-1fcc37e93bb3"
      unitRef="usd">5344000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:GrossProfit
      contextRef="i62efa1de276f4f6f96606236e0b99714_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJhMjJmMjI1Y2UzMzQzYzJiNTEyYjIyYTVhYmZlODA2L3RhYmxlcmFuZ2U6MmEyMmYyMjVjZTMzNDNjMmI1MTJiMjJhNWFiZmU4MDZfNy0xLTEtMS0xMzk3Ng_87abc4e1-33fd-480e-b980-63636be2a8e1"
      unitRef="usd">-631000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="icb34982583f74b8dac9d2bae655597ac_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJhMjJmMjI1Y2UzMzQzYzJiNTEyYjIyYTVhYmZlODA2L3RhYmxlcmFuZ2U6MmEyMmYyMjVjZTMzNDNjMmI1MTJiMjJhNWFiZmU4MDZfNy0zLTEtMS0xMzk2OA_379509ad-a82e-4d6d-be02-ed19e19830ed"
      unitRef="usd">0</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ic600db9d0b4e488aa9a037277f7ff27f_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJhMjJmMjI1Y2UzMzQzYzJiNTEyYjIyYTVhYmZlODA2L3RhYmxlcmFuZ2U6MmEyMmYyMjVjZTMzNDNjMmI1MTJiMjJhNWFiZmU4MDZfNy01LTEtMS0xMzk5MA_d5467f75-4530-4338-8989-fc746f07506d"
      unitRef="usd">0</us-gaap:GrossProfit>
    <us-gaap:ProfitLoss
      contextRef="i62efa1de276f4f6f96606236e0b99714_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJhMjJmMjI1Y2UzMzQzYzJiNTEyYjIyYTVhYmZlODA2L3RhYmxlcmFuZ2U6MmEyMmYyMjVjZTMzNDNjMmI1MTJiMjJhNWFiZmU4MDZfOC0xLTEtMS0xMzk3Ng_30fe876c-add4-409f-adcc-09d69aad3131"
      unitRef="usd">-11453000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="icb34982583f74b8dac9d2bae655597ac_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJhMjJmMjI1Y2UzMzQzYzJiNTEyYjIyYTVhYmZlODA2L3RhYmxlcmFuZ2U6MmEyMmYyMjVjZTMzNDNjMmI1MTJiMjJhNWFiZmU4MDZfOC0zLTEtMS0xMzk2OA_e5d22221-d97d-4e83-8e06-9b7818294342"
      unitRef="usd">-2048000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ic600db9d0b4e488aa9a037277f7ff27f_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJhMjJmMjI1Y2UzMzQzYzJiNTEyYjIyYTVhYmZlODA2L3RhYmxlcmFuZ2U6MmEyMmYyMjVjZTMzNDNjMmI1MTJiMjJhNWFiZmU4MDZfOC01LTEtMS0xMzk5MA_abfa299b-ce45-4ec6-85a8-f0e362da8153"
      unitRef="usd">-874000</us-gaap:ProfitLoss>
    <us-gaap:InvestmentsInAndAdvancesToAffiliatesTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RleHRyZWdpb246MjQ0MTA2MTgwYTE5NGM2YjkyYjM5ZTUwY2E2ZTMwM2ZfMjMwODk3NDQyNTgzMzE_9c8fa7c6-8496-4203-8475-a4029cda5e9f">Advances to Joint Ventures&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.722%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.785%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.231%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.914%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.231%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.914%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.231%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.914%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.231%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.914%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.235%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;MedMen Canada&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cronos GrowCo&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cronos Australia&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(iii) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Natuera&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;As of January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfer to investments in equity accounted investees&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,505)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,505)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest on advances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Advances to joint ventures recovered from (applied to) carrying amount of investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect from foreign exchange&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(461)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(464)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;As of December&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:29.25pt;text-align:justify;text-indent:-27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.856%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.218%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.912%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.218%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.912%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.218%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.912%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.218%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.912%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.224%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;MedMen Canada&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cronos GrowCo&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cronos Australia&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(iii) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Natuera&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;As of January 1, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Advances (repayments)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(852)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Advances to joint ventures recovered from (applied to) carrying amount of investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(779)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(224)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(946)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect from foreign exchange&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;As of December&#160;31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:29.25pt;text-align:justify;text-indent:-27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Advance is unsecured, non-interest bearing, and there are no terms of repayment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%;padding-left:20.66pt"&gt;On September 25, 2020, the Company and Mucci agreed to capitalize historical advances made by each shareholder to Cronos GrowCo. The Company capitalized C$24,650 ($18,505) through a transfer of aggregate gross advances from advances to joint ventures to investments in equity accounted investees in respect of Cronos GrowCo. Refer to footnote (ii) to the first table set forth under Note 6(a).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(iii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.22pt"&gt;A$1,500 is governed by an unsecured loan bearing interest at a rate of 12% per annum, calculated and compounded daily, in arrears, on the amounts advanced from the date of each advance. The loan is due on January 1, 2022. If the loan is overdue, the outstanding amount bears interest at an additional 2% per annum.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentsInAndAdvancesToAffiliatesTextBlock>
    <us-gaap:AdvancesToAffiliate
      contextRef="ie6f2e75489a8480f95612249b17b7e5d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjk4MTM3MjhjYjUzZDRjNDQ5Y2I5YWRlNjlhNjgwYWE0L3RhYmxlcmFuZ2U6OTgxMzcyOGNiNTNkNGM0NDljYjlhZGU2OWE2ODBhYTRfMS0xLTEtMS0zNjg1_8fe866a8-65f9-4f90-9eda-a43dea886451"
      unitRef="usd">471000</us-gaap:AdvancesToAffiliate>
    <us-gaap:AdvancesToAffiliate
      contextRef="ief35f4e5e0e14975afdc16c2f8b07671_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjk4MTM3MjhjYjUzZDRjNDQ5Y2I5YWRlNjlhNjgwYWE0L3RhYmxlcmFuZ2U6OTgxMzcyOGNiNTNkNGM0NDljYjlhZGU2OWE2ODBhYTRfMS0zLTEtMS0zNzM1_1dd6d4a1-3a1a-4f4b-b64e-0f2f00d18874"
      unitRef="usd">18966000</us-gaap:AdvancesToAffiliate>
    <us-gaap:AdvancesToAffiliate
      contextRef="i613b07197744400cbbef2fbf605f0d54_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjk4MTM3MjhjYjUzZDRjNDQ5Y2I5YWRlNjlhNjgwYWE0L3RhYmxlcmFuZ2U6OTgxMzcyOGNiNTNkNGM0NDljYjlhZGU2OWE2ODBhYTRfMS01LTEtMS0zNzM1_c21d2057-a4d0-444f-9827-d55cf153f100"
      unitRef="usd">0</us-gaap:AdvancesToAffiliate>
    <us-gaap:AdvancesToAffiliate
      contextRef="ibe5479ec3fef4f42a9772f4fad66332d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjk4MTM3MjhjYjUzZDRjNDQ5Y2I5YWRlNjlhNjgwYWE0L3RhYmxlcmFuZ2U6OTgxMzcyOGNiNTNkNGM0NDljYjlhZGU2OWE2ODBhYTRfMS03LTEtMS0zNzM1_b58704bd-8d29-4c0c-b6d5-afa36b079e7c"
      unitRef="usd">0</us-gaap:AdvancesToAffiliate>
    <us-gaap:AdvancesToAffiliate
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjk4MTM3MjhjYjUzZDRjNDQ5Y2I5YWRlNjlhNjgwYWE0L3RhYmxlcmFuZ2U6OTgxMzcyOGNiNTNkNGM0NDljYjlhZGU2OWE2ODBhYTRfMS05LTEtMS0zMDU3_82fe49b1-3f72-403a-ac87-77162cd91946"
      unitRef="usd">19437000</us-gaap:AdvancesToAffiliate>
    <cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees
      contextRef="i439b30240d69471792a73a83983aafc9_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjk4MTM3MjhjYjUzZDRjNDQ5Y2I5YWRlNjlhNjgwYWE0L3RhYmxlcmFuZ2U6OTgxMzcyOGNiNTNkNGM0NDljYjlhZGU2OWE2ODBhYTRfMi0xLTEtMS0zNzM1_9a50dc32-d7a4-4a5d-8d66-fb5e4102941d"
      unitRef="usd">0</cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees>
    <cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees
      contextRef="i06e71f94f83b4681be053f1be423964a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjk4MTM3MjhjYjUzZDRjNDQ5Y2I5YWRlNjlhNjgwYWE0L3RhYmxlcmFuZ2U6OTgxMzcyOGNiNTNkNGM0NDljYjlhZGU2OWE2ODBhYTRfMi0zLTEtMS0zNzM1_62d4ce26-1e54-424e-81da-f88d68078d98"
      unitRef="usd">18505000</cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees>
    <cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees
      contextRef="i295d7b236249421daadace6736fa6dc7_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjk4MTM3MjhjYjUzZDRjNDQ5Y2I5YWRlNjlhNjgwYWE0L3RhYmxlcmFuZ2U6OTgxMzcyOGNiNTNkNGM0NDljYjlhZGU2OWE2ODBhYTRfMi01LTEtMS0zNzM1_78eea98f-8570-4614-a087-0aa90567fb0d"
      unitRef="usd">0</cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees>
    <cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees
      contextRef="ie83a15c30f9b4a8288e090fa665f59d3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjk4MTM3MjhjYjUzZDRjNDQ5Y2I5YWRlNjlhNjgwYWE0L3RhYmxlcmFuZ2U6OTgxMzcyOGNiNTNkNGM0NDljYjlhZGU2OWE2ODBhYTRfMi03LTEtMS0zNzM1_f779370f-d251-40d7-ae3c-88446e761dae"
      unitRef="usd">0</cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees>
    <cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjk4MTM3MjhjYjUzZDRjNDQ5Y2I5YWRlNjlhNjgwYWE0L3RhYmxlcmFuZ2U6OTgxMzcyOGNiNTNkNGM0NDljYjlhZGU2OWE2ODBhYTRfMi05LTEtMS0zMDU3_97605353-dfb9-4741-aeeb-e9ed222b37a1"
      unitRef="usd">18505000</cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees>
    <cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueInterestOnAdvances
      contextRef="i439b30240d69471792a73a83983aafc9_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjk4MTM3MjhjYjUzZDRjNDQ5Y2I5YWRlNjlhNjgwYWE0L3RhYmxlcmFuZ2U6OTgxMzcyOGNiNTNkNGM0NDljYjlhZGU2OWE2ODBhYTRfMy0xLTEtMS02MDMw_8e7dbfa2-2781-4e46-8be7-a602ff490ad3"
      unitRef="usd">0</cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueInterestOnAdvances>
    <cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueInterestOnAdvances
      contextRef="i06e71f94f83b4681be053f1be423964a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjk4MTM3MjhjYjUzZDRjNDQ5Y2I5YWRlNjlhNjgwYWE0L3RhYmxlcmFuZ2U6OTgxMzcyOGNiNTNkNGM0NDljYjlhZGU2OWE2ODBhYTRfMy0zLTEtMS02MDMw_39500dc1-4b72-4d04-bbf3-e1072ac29fc2"
      unitRef="usd">0</cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueInterestOnAdvances>
    <cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueInterestOnAdvances
      contextRef="i295d7b236249421daadace6736fa6dc7_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjk4MTM3MjhjYjUzZDRjNDQ5Y2I5YWRlNjlhNjgwYWE0L3RhYmxlcmFuZ2U6OTgxMzcyOGNiNTNkNGM0NDljYjlhZGU2OWE2ODBhYTRfMy01LTEtMS02MDMw_ae0d51f0-12a3-45f9-9970-d50edaf89042"
      unitRef="usd">37000</cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueInterestOnAdvances>
    <cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueInterestOnAdvances
      contextRef="ie83a15c30f9b4a8288e090fa665f59d3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjk4MTM3MjhjYjUzZDRjNDQ5Y2I5YWRlNjlhNjgwYWE0L3RhYmxlcmFuZ2U6OTgxMzcyOGNiNTNkNGM0NDljYjlhZGU2OWE2ODBhYTRfMy03LTEtMS02MDMw_e591def0-2730-48cf-8e47-0f0b38506b81"
      unitRef="usd">0</cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueInterestOnAdvances>
    <cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueInterestOnAdvances
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjk4MTM3MjhjYjUzZDRjNDQ5Y2I5YWRlNjlhNjgwYWE0L3RhYmxlcmFuZ2U6OTgxMzcyOGNiNTNkNGM0NDljYjlhZGU2OWE2ODBhYTRfMy05LTEtMS02MDMw_4cd5e736-f1df-4a66-be66-824fe96a278d"
      unitRef="usd">37000</cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueInterestOnAdvances>
    <cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueRecoveredFromAppliedToEquityMethodInvestment
      contextRef="i439b30240d69471792a73a83983aafc9_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjk4MTM3MjhjYjUzZDRjNDQ5Y2I5YWRlNjlhNjgwYWE0L3RhYmxlcmFuZ2U6OTgxMzcyOGNiNTNkNGM0NDljYjlhZGU2OWE2ODBhYTRfNC0xLTEtMS02MDM0_3a689d69-76a8-404e-978e-51c25d4e014e"
      unitRef="usd">0</cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueRecoveredFromAppliedToEquityMethodInvestment>
    <cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueRecoveredFromAppliedToEquityMethodInvestment
      contextRef="i06e71f94f83b4681be053f1be423964a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjk4MTM3MjhjYjUzZDRjNDQ5Y2I5YWRlNjlhNjgwYWE0L3RhYmxlcmFuZ2U6OTgxMzcyOGNiNTNkNGM0NDljYjlhZGU2OWE2ODBhYTRfNC0zLTEtMS02MDM0_a8e67c17-48b5-4765-9b58-9ddabc2dde83"
      unitRef="usd">0</cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueRecoveredFromAppliedToEquityMethodInvestment>
    <cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueRecoveredFromAppliedToEquityMethodInvestment
      contextRef="i295d7b236249421daadace6736fa6dc7_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjk4MTM3MjhjYjUzZDRjNDQ5Y2I5YWRlNjlhNjgwYWE0L3RhYmxlcmFuZ2U6OTgxMzcyOGNiNTNkNGM0NDljYjlhZGU2OWE2ODBhYTRfNC01LTEtMS02MDM0_351aec54-fb6f-4184-982f-c9bb13489e93"
      unitRef="usd">-38000</cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueRecoveredFromAppliedToEquityMethodInvestment>
    <cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueRecoveredFromAppliedToEquityMethodInvestment
      contextRef="ie83a15c30f9b4a8288e090fa665f59d3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjk4MTM3MjhjYjUzZDRjNDQ5Y2I5YWRlNjlhNjgwYWE0L3RhYmxlcmFuZ2U6OTgxMzcyOGNiNTNkNGM0NDljYjlhZGU2OWE2ODBhYTRfNC03LTEtMS02MDM0_38a8a4a9-187b-439b-a25a-288ae6efa05d"
      unitRef="usd">0</cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueRecoveredFromAppliedToEquityMethodInvestment>
    <cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueRecoveredFromAppliedToEquityMethodInvestment
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjk4MTM3MjhjYjUzZDRjNDQ5Y2I5YWRlNjlhNjgwYWE0L3RhYmxlcmFuZ2U6OTgxMzcyOGNiNTNkNGM0NDljYjlhZGU2OWE2ODBhYTRfNC05LTEtMS02MDM0_dcbf966f-7a62-440a-a3bf-88fa6fb9c217"
      unitRef="usd">-38000</cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueRecoveredFromAppliedToEquityMethodInvestment>
    <cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueChangesDueToCurrencyTranslation
      contextRef="i439b30240d69471792a73a83983aafc9_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjk4MTM3MjhjYjUzZDRjNDQ5Y2I5YWRlNjlhNjgwYWE0L3RhYmxlcmFuZ2U6OTgxMzcyOGNiNTNkNGM0NDljYjlhZGU2OWE2ODBhYTRfMy0xLTEtMS0zNzM1_2c9df658-bc58-4fe3-b04a-f01ab2dd4501"
      unitRef="usd">-4000</cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueChangesDueToCurrencyTranslation>
    <cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueChangesDueToCurrencyTranslation
      contextRef="i06e71f94f83b4681be053f1be423964a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjk4MTM3MjhjYjUzZDRjNDQ5Y2I5YWRlNjlhNjgwYWE0L3RhYmxlcmFuZ2U6OTgxMzcyOGNiNTNkNGM0NDljYjlhZGU2OWE2ODBhYTRfMy0zLTEtMS0zNzM1_c0f91fc8-6cfe-49a4-bbe4-807998f05e54"
      unitRef="usd">-461000</cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueChangesDueToCurrencyTranslation>
    <cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueChangesDueToCurrencyTranslation
      contextRef="i295d7b236249421daadace6736fa6dc7_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjk4MTM3MjhjYjUzZDRjNDQ5Y2I5YWRlNjlhNjgwYWE0L3RhYmxlcmFuZ2U6OTgxMzcyOGNiNTNkNGM0NDljYjlhZGU2OWE2ODBhYTRfMy01LTEtMS0zNzM1_c41fedcb-07de-423c-9586-0d001dfe3542"
      unitRef="usd">1000</cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueChangesDueToCurrencyTranslation>
    <cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueChangesDueToCurrencyTranslation
      contextRef="ie83a15c30f9b4a8288e090fa665f59d3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjk4MTM3MjhjYjUzZDRjNDQ5Y2I5YWRlNjlhNjgwYWE0L3RhYmxlcmFuZ2U6OTgxMzcyOGNiNTNkNGM0NDljYjlhZGU2OWE2ODBhYTRfMy03LTEtMS0zNzM1_a1f9c722-6be2-4194-b080-c98f151f5b46"
      unitRef="usd">0</cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueChangesDueToCurrencyTranslation>
    <cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueChangesDueToCurrencyTranslation
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjk4MTM3MjhjYjUzZDRjNDQ5Y2I5YWRlNjlhNjgwYWE0L3RhYmxlcmFuZ2U6OTgxMzcyOGNiNTNkNGM0NDljYjlhZGU2OWE2ODBhYTRfMy05LTEtMS0zMDU3_404b307b-0d5f-4c6b-bd2a-356d8033d3cb"
      unitRef="usd">-464000</cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueChangesDueToCurrencyTranslation>
    <cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueChangesDueToCurrencyTranslation
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjk4MTM3MjhjYjUzZDRjNDQ5Y2I5YWRlNjlhNjgwYWE0L3RhYmxlcmFuZ2U6OTgxMzcyOGNiNTNkNGM0NDljYjlhZGU2OWE2ODBhYTRfMy05LTEtMS0zMDU3_651db593-8d40-43fc-8ce2-28e6286a3e27"
      unitRef="usd">-464000</cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueChangesDueToCurrencyTranslation>
    <us-gaap:AdvancesToAffiliate
      contextRef="i056cd5603b3a4298a98af34735228c93_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjk4MTM3MjhjYjUzZDRjNDQ5Y2I5YWRlNjlhNjgwYWE0L3RhYmxlcmFuZ2U6OTgxMzcyOGNiNTNkNGM0NDljYjlhZGU2OWE2ODBhYTRfNS0xLTEtMS0zMDU3_122d225d-4591-4022-9c8d-4198a424918a"
      unitRef="usd">467000</us-gaap:AdvancesToAffiliate>
    <us-gaap:AdvancesToAffiliate
      contextRef="ieb8971bbe440425c985b311295f2cec9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjk4MTM3MjhjYjUzZDRjNDQ5Y2I5YWRlNjlhNjgwYWE0L3RhYmxlcmFuZ2U6OTgxMzcyOGNiNTNkNGM0NDljYjlhZGU2OWE2ODBhYTRfNS0zLTEtMS0zMDU3_3bf52c26-2466-4603-a7b3-1d3ec30e5820"
      unitRef="usd">0</us-gaap:AdvancesToAffiliate>
    <us-gaap:AdvancesToAffiliate
      contextRef="i4a854431fb9b495d990aeb067616e389_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjk4MTM3MjhjYjUzZDRjNDQ5Y2I5YWRlNjlhNjgwYWE0L3RhYmxlcmFuZ2U6OTgxMzcyOGNiNTNkNGM0NDljYjlhZGU2OWE2ODBhYTRfNS01LTEtMS0zMDU3_7bef8842-c5db-40af-8641-4011b4d3f23f"
      unitRef="usd">0</us-gaap:AdvancesToAffiliate>
    <us-gaap:AdvancesToAffiliate
      contextRef="i578db4ab78c04e03aee4c102f9d17cfe_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjk4MTM3MjhjYjUzZDRjNDQ5Y2I5YWRlNjlhNjgwYWE0L3RhYmxlcmFuZ2U6OTgxMzcyOGNiNTNkNGM0NDljYjlhZGU2OWE2ODBhYTRfNS03LTEtMS0zMDU3_0b37a57a-009d-4fd8-a3f5-7035c13e1621"
      unitRef="usd">0</us-gaap:AdvancesToAffiliate>
    <us-gaap:AdvancesToAffiliate
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjk4MTM3MjhjYjUzZDRjNDQ5Y2I5YWRlNjlhNjgwYWE0L3RhYmxlcmFuZ2U6OTgxMzcyOGNiNTNkNGM0NDljYjlhZGU2OWE2ODBhYTRfNS05LTEtMS0zMDU3_4da51fc8-5e51-421f-adcc-6509e827aa1f"
      unitRef="usd">467000</us-gaap:AdvancesToAffiliate>
    <us-gaap:AdvancesToAffiliate
      contextRef="iec6bf60d93124adcb6973cf1ba60f17f_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjIyOGFiOTgxYjEzNDRhNWRiYTllZWFjMzk3NWVkNWE4L3RhYmxlcmFuZ2U6MjI4YWI5ODFiMTM0NGE1ZGJhOWVlYWMzOTc1ZWQ1YThfNy0xLTEtMS00Njkw_ae3f67f3-423d-402f-8082-d66ff12300d1"
      unitRef="usd">1244000</us-gaap:AdvancesToAffiliate>
    <us-gaap:AdvancesToAffiliate
      contextRef="i07f4be74463d40aebfc7310e82d1c3a4_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjIyOGFiOTgxYjEzNDRhNWRiYTllZWFjMzk3NWVkNWE4L3RhYmxlcmFuZ2U6MjI4YWI5ODFiMTM0NGE1ZGJhOWVlYWMzOTc1ZWQ1YThfNy0zLTEtMS00Njkw_a0d244bb-3bc1-4f95-aef5-42fccaab3590"
      unitRef="usd">2970000</us-gaap:AdvancesToAffiliate>
    <us-gaap:AdvancesToAffiliate
      contextRef="ibc08a58aedc6433cab75cda9cb8d60e1_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjIyOGFiOTgxYjEzNDRhNWRiYTllZWFjMzk3NWVkNWE4L3RhYmxlcmFuZ2U6MjI4YWI5ODFiMTM0NGE1ZGJhOWVlYWMzOTc1ZWQ1YThfNy01LTEtMS00Njkw_fe526135-ff76-4cde-9680-e4aa603abeec"
      unitRef="usd">475000</us-gaap:AdvancesToAffiliate>
    <us-gaap:AdvancesToAffiliate
      contextRef="iefbc11d906474a07a4a0e90e2eb80824_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjIyOGFiOTgxYjEzNDRhNWRiYTllZWFjMzk3NWVkNWE4L3RhYmxlcmFuZ2U6MjI4YWI5ODFiMTM0NGE1ZGJhOWVlYWMzOTc1ZWQ1YThfNy03LTEtMS00Njkw_81696505-ddb8-4280-8b68-0dcdbb6329db"
      unitRef="usd">0</us-gaap:AdvancesToAffiliate>
    <us-gaap:AdvancesToAffiliate
      contextRef="i9717dc3b24b24c93ab09a6bfa9b52c89_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjIyOGFiOTgxYjEzNDRhNWRiYTllZWFjMzk3NWVkNWE4L3RhYmxlcmFuZ2U6MjI4YWI5ODFiMTM0NGE1ZGJhOWVlYWMzOTc1ZWQ1YThfNy05LTEtMS00Njkw_fc437a92-a568-43d0-bb60-28cf861fc38b"
      unitRef="usd">4689000</us-gaap:AdvancesToAffiliate>
    <cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments
      contextRef="i25b4f750539544e98240240c6d96fdc8_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjIyOGFiOTgxYjEzNDRhNWRiYTllZWFjMzk3NWVkNWE4L3RhYmxlcmFuZ2U6MjI4YWI5ODFiMTM0NGE1ZGJhOWVlYWMzOTc1ZWQ1YThfOC0xLTEtMS00Njkw_db446d23-53f1-4156-ac8e-88b8e47170f2"
      unitRef="usd">-852000</cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments>
    <cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments
      contextRef="ib057cdc4d573476488dcb0661bea31b4_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjIyOGFiOTgxYjEzNDRhNWRiYTllZWFjMzk3NWVkNWE4L3RhYmxlcmFuZ2U6MjI4YWI5ODFiMTM0NGE1ZGJhOWVlYWMzOTc1ZWQ1YThfOC0zLTEtMS00Njkw_774e4960-c7a5-43c9-a2c4-678dde80eb92"
      unitRef="usd">15494000</cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments>
    <cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments
      contextRef="i5f0e3243c9c049d9bd4653b87b8b4c8a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjIyOGFiOTgxYjEzNDRhNWRiYTllZWFjMzk3NWVkNWE4L3RhYmxlcmFuZ2U6MjI4YWI5ODFiMTM0NGE1ZGJhOWVlYWMzOTc1ZWQ1YThfOC01LTEtMS00Njkw_3e861e5c-7d0a-471f-8412-9c7822613cac"
      unitRef="usd">274000</cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments>
    <cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments
      contextRef="i15402ae419444f8291523f27c01226c3_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjIyOGFiOTgxYjEzNDRhNWRiYTllZWFjMzk3NWVkNWE4L3RhYmxlcmFuZ2U6MjI4YWI5ODFiMTM0NGE1ZGJhOWVlYWMzOTc1ZWQ1YThfOC03LTEtMS00Njkw_840e4948-5a3d-4329-8d6e-ab6d549475bc"
      unitRef="usd">219000</cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments>
    <cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjIyOGFiOTgxYjEzNDRhNWRiYTllZWFjMzk3NWVkNWE4L3RhYmxlcmFuZ2U6MjI4YWI5ODFiMTM0NGE1ZGJhOWVlYWMzOTc1ZWQ1YThfOC05LTEtMS00Njkw_d6210d52-79ba-442f-9949-b5676484b445"
      unitRef="usd">15135000</cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments>
    <cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueRecoveredFromAppliedToEquityMethodInvestment
      contextRef="i25b4f750539544e98240240c6d96fdc8_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjIyOGFiOTgxYjEzNDRhNWRiYTllZWFjMzk3NWVkNWE4L3RhYmxlcmFuZ2U6MjI4YWI5ODFiMTM0NGE1ZGJhOWVlYWMzOTc1ZWQ1YThfOS0xLTEtMS00Njkw_3dd2b08f-0444-4519-81f8-e184efb12946"
      unitRef="usd">35000</cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueRecoveredFromAppliedToEquityMethodInvestment>
    <cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueRecoveredFromAppliedToEquityMethodInvestment
      contextRef="ib057cdc4d573476488dcb0661bea31b4_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjIyOGFiOTgxYjEzNDRhNWRiYTllZWFjMzk3NWVkNWE4L3RhYmxlcmFuZ2U6MjI4YWI5ODFiMTM0NGE1ZGJhOWVlYWMzOTc1ZWQ1YThfOS0zLTEtMS00Njkw_95c813a9-a09d-4f10-a437-dce9b16a6461"
      unitRef="usd">22000</cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueRecoveredFromAppliedToEquityMethodInvestment>
    <cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueRecoveredFromAppliedToEquityMethodInvestment
      contextRef="i5f0e3243c9c049d9bd4653b87b8b4c8a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjIyOGFiOTgxYjEzNDRhNWRiYTllZWFjMzk3NWVkNWE4L3RhYmxlcmFuZ2U6MjI4YWI5ODFiMTM0NGE1ZGJhOWVlYWMzOTc1ZWQ1YThfOS01LTEtMS00Njkw_cd13c024-0199-4b65-a734-0c213fb88c38"
      unitRef="usd">-779000</cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueRecoveredFromAppliedToEquityMethodInvestment>
    <cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueRecoveredFromAppliedToEquityMethodInvestment
      contextRef="i15402ae419444f8291523f27c01226c3_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjIyOGFiOTgxYjEzNDRhNWRiYTllZWFjMzk3NWVkNWE4L3RhYmxlcmFuZ2U6MjI4YWI5ODFiMTM0NGE1ZGJhOWVlYWMzOTc1ZWQ1YThfOS03LTEtMS00Njkw_15998349-ee78-4b72-9144-a8a80918da1a"
      unitRef="usd">-224000</cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueRecoveredFromAppliedToEquityMethodInvestment>
    <cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueRecoveredFromAppliedToEquityMethodInvestment
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjIyOGFiOTgxYjEzNDRhNWRiYTllZWFjMzk3NWVkNWE4L3RhYmxlcmFuZ2U6MjI4YWI5ODFiMTM0NGE1ZGJhOWVlYWMzOTc1ZWQ1YThfOS05LTEtMS00Njkw_28e90f75-8cdf-40a5-ae64-0400d3e82b14"
      unitRef="usd">-946000</cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueRecoveredFromAppliedToEquityMethodInvestment>
    <cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueChangesDueToCurrencyTranslation
      contextRef="i25b4f750539544e98240240c6d96fdc8_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjIyOGFiOTgxYjEzNDRhNWRiYTllZWFjMzk3NWVkNWE4L3RhYmxlcmFuZ2U6MjI4YWI5ODFiMTM0NGE1ZGJhOWVlYWMzOTc1ZWQ1YThfMTAtMS0xLTEtNDY5MA_c415319e-9c42-41cd-87df-cc4797f9da68"
      unitRef="usd">44000</cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueChangesDueToCurrencyTranslation>
    <cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueChangesDueToCurrencyTranslation
      contextRef="ib057cdc4d573476488dcb0661bea31b4_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjIyOGFiOTgxYjEzNDRhNWRiYTllZWFjMzk3NWVkNWE4L3RhYmxlcmFuZ2U6MjI4YWI5ODFiMTM0NGE1ZGJhOWVlYWMzOTc1ZWQ1YThfMTAtMy0xLTEtNDY5MA_1df08810-8477-4cde-8c3a-e7150de61792"
      unitRef="usd">480000</cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueChangesDueToCurrencyTranslation>
    <cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueChangesDueToCurrencyTranslation
      contextRef="i5f0e3243c9c049d9bd4653b87b8b4c8a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjIyOGFiOTgxYjEzNDRhNWRiYTllZWFjMzk3NWVkNWE4L3RhYmxlcmFuZ2U6MjI4YWI5ODFiMTM0NGE1ZGJhOWVlYWMzOTc1ZWQ1YThfMTAtNS0xLTEtNDY5MA_3e6e4cfd-acb2-4c1d-8f18-c6902b05030e"
      unitRef="usd">30000</cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueChangesDueToCurrencyTranslation>
    <cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueChangesDueToCurrencyTranslation
      contextRef="i15402ae419444f8291523f27c01226c3_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjIyOGFiOTgxYjEzNDRhNWRiYTllZWFjMzk3NWVkNWE4L3RhYmxlcmFuZ2U6MjI4YWI5ODFiMTM0NGE1ZGJhOWVlYWMzOTc1ZWQ1YThfMTAtNy0xLTEtNDY5MA_77692a33-7832-4436-b66d-39889debd5aa"
      unitRef="usd">5000</cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueChangesDueToCurrencyTranslation>
    <cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueChangesDueToCurrencyTranslation
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjIyOGFiOTgxYjEzNDRhNWRiYTllZWFjMzk3NWVkNWE4L3RhYmxlcmFuZ2U6MjI4YWI5ODFiMTM0NGE1ZGJhOWVlYWMzOTc1ZWQ1YThfMTAtOS0xLTEtNDY5MA_87da735a-5566-4b6e-a133-6372bc5519ec"
      unitRef="usd">559000</cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueChangesDueToCurrencyTranslation>
    <us-gaap:AdvancesToAffiliate
      contextRef="ie6f2e75489a8480f95612249b17b7e5d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjIyOGFiOTgxYjEzNDRhNWRiYTllZWFjMzk3NWVkNWE4L3RhYmxlcmFuZ2U6MjI4YWI5ODFiMTM0NGE1ZGJhOWVlYWMzOTc1ZWQ1YThfMTEtMS0xLTEtNDY5MA_8b34643d-e5cc-4136-8f9a-6e94580d49e8"
      unitRef="usd">471000</us-gaap:AdvancesToAffiliate>
    <us-gaap:AdvancesToAffiliate
      contextRef="ief35f4e5e0e14975afdc16c2f8b07671_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjIyOGFiOTgxYjEzNDRhNWRiYTllZWFjMzk3NWVkNWE4L3RhYmxlcmFuZ2U6MjI4YWI5ODFiMTM0NGE1ZGJhOWVlYWMzOTc1ZWQ1YThfMTEtMy0xLTEtNDY5MA_cb7a06b7-2a03-4354-a642-5bd272bc24de"
      unitRef="usd">18966000</us-gaap:AdvancesToAffiliate>
    <us-gaap:AdvancesToAffiliate
      contextRef="i613b07197744400cbbef2fbf605f0d54_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjIyOGFiOTgxYjEzNDRhNWRiYTllZWFjMzk3NWVkNWE4L3RhYmxlcmFuZ2U6MjI4YWI5ODFiMTM0NGE1ZGJhOWVlYWMzOTc1ZWQ1YThfMTEtNS0xLTEtNDY5MA_15ad857f-6951-427c-98db-a5e8a6606ff0"
      unitRef="usd">0</us-gaap:AdvancesToAffiliate>
    <us-gaap:AdvancesToAffiliate
      contextRef="ibe5479ec3fef4f42a9772f4fad66332d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjIyOGFiOTgxYjEzNDRhNWRiYTllZWFjMzk3NWVkNWE4L3RhYmxlcmFuZ2U6MjI4YWI5ODFiMTM0NGE1ZGJhOWVlYWMzOTc1ZWQ1YThfMTEtNy0xLTEtNDY5MA_7fd62278-acfc-4990-8666-e3ec669dce88"
      unitRef="usd">0</us-gaap:AdvancesToAffiliate>
    <us-gaap:AdvancesToAffiliate
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjIyOGFiOTgxYjEzNDRhNWRiYTllZWFjMzk3NWVkNWE4L3RhYmxlcmFuZ2U6MjI4YWI5ODFiMTM0NGE1ZGJhOWVlYWMzOTc1ZWQ1YThfMTEtOS0xLTEtNDY5MA_d1778593-0e63-4830-b90f-d89085e3e04f"
      unitRef="usd">19437000</us-gaap:AdvancesToAffiliate>
    <cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees
      contextRef="i06e71f94f83b4681be053f1be423964a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RleHRyZWdpb246MjQ0MTA2MTgwYTE5NGM2YjkyYjM5ZTUwY2E2ZTMwM2ZfODI0NjMzNzI4NzE3MA_1b7376e7-7194-4b16-8a67-c9c7b93d194d"
      unitRef="cad">24650000</cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees>
    <cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees
      contextRef="i06e71f94f83b4681be053f1be423964a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RleHRyZWdpb246MjQ0MTA2MTgwYTE5NGM2YjkyYjM5ZTUwY2E2ZTMwM2ZfMTM3NDM4OTU0MjI5MTA_62d4ce26-1e54-424e-81da-f88d68078d98"
      unitRef="usd">18505000</cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees>
    <cron:InvestmentsInAndAdvancesToAffiliatesDebtInstrumentFaceAmount
      contextRef="i4a854431fb9b495d990aeb067616e389_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RleHRyZWdpb246MjQ0MTA2MTgwYTE5NGM2YjkyYjM5ZTUwY2E2ZTMwM2ZfMTA5OTUxMTYzOTkzOA_3722a151-5cb9-4113-80ca-e4a12c22de7e"
      unitRef="aud">1500000</cron:InvestmentsInAndAdvancesToAffiliatesDebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i4a854431fb9b495d990aeb067616e389_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RleHRyZWdpb246MjQ0MTA2MTgwYTE5NGM2YjkyYjM5ZTUwY2E2ZTMwM2ZfMTA5OTUxMTY0NTc2NQ_6c30f715-89d5-4344-9250-dc813417044a"
      unitRef="number">0.12</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <cron:DebtInstrumentPastDueAdditionalInterestRateStatedPercentage
      contextRef="i4a854431fb9b495d990aeb067616e389_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RleHRyZWdpb246MjQ0MTA2MTgwYTE5NGM2YjkyYjM5ZTUwY2E2ZTMwM2ZfMTU5NDI5MTg2MzcxMzY_45bd27b0-64b1-4cac-8f5b-fc34d2778ee8"
      unitRef="number">0.02</cron:DebtInstrumentPastDueAdditionalInterestRateStatedPercentage>
    <us-gaap:ScheduleOfVariableInterestEntitiesTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RleHRyZWdpb246MjQ0MTA2MTgwYTE5NGM2YjkyYjM5ZTUwY2E2ZTMwM2ZfMjMwODk3NDQyNTgzMzI_5672ab39-9440-4658-b81a-32a9cb0e4a3a">The following is a summary of the maximum exposure to loss for the year ended December&#160;31, 2020 and 2019:&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Ownership interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other Net Assets (Liabilities)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Maximum Exposure to Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cronos Australia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cronos GrowCo&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MedMen Canada&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Natuera&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,849)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:-9pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Ownership interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other Net Assets (Liabilities)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Maximum Exposure to Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cronos Australia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cronos GrowCo&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 4pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MedMen Canada&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(199)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Natuera&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(358)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December&#160;31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfVariableInterestEntitiesTextBlock>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i4a854431fb9b495d990aeb067616e389_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJlYTAzMzdmZWFlOTQyODU5MThmMjUxOTc4ZWI3MWY3L3RhYmxlcmFuZ2U6MmVhMDMzN2ZlYWU5NDI4NTkxOGYyNTE5NzhlYjcxZjdfMi0xLTEtMS0xOTU1NQ_50c14e5d-0e48-471f-b991-ec55d40644ba"
      unitRef="number">0.31</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:VariableInterestEntityOwnershipPercentage
      contextRef="i1992c389e83f4ed89ee4289b28705c96_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJlYTAzMzdmZWFlOTQyODU5MThmMjUxOTc4ZWI3MWY3L3RhYmxlcmFuZ2U6MmVhMDMzN2ZlYWU5NDI4NTkxOGYyNTE5NzhlYjcxZjdfMi0xLTEtMS0xOTU1NQ_9a563966-5cc4-4086-ba1f-14a73f94058c"
      unitRef="number">0.31</us-gaap:VariableInterestEntityOwnershipPercentage>
    <cron:OtherNetAssetsLiabilities
      contextRef="i7de2974205334c71b88361a4a5309899_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJlYTAzMzdmZWFlOTQyODU5MThmMjUxOTc4ZWI3MWY3L3RhYmxlcmFuZ2U6MmVhMDMzN2ZlYWU5NDI4NTkxOGYyNTE5NzhlYjcxZjdfMi0zLTEtMS0xOTU1NQ_472efde2-c157-4266-966a-770204a68ff2"
      unitRef="usd">8976000</cron:OtherNetAssetsLiabilities>
    <us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount
      contextRef="i7de2974205334c71b88361a4a5309899_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJlYTAzMzdmZWFlOTQyODU5MThmMjUxOTc4ZWI3MWY3L3RhYmxlcmFuZ2U6MmVhMDMzN2ZlYWU5NDI4NTkxOGYyNTE5NzhlYjcxZjdfMi01LTEtMS0xOTU1NQ_a1e20703-0481-47d3-b929-5aa5c433fc25"
      unitRef="usd">1530000</us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount>
    <us-gaap:VariableInterestEntityOwnershipPercentage
      contextRef="i291f9ace020d4518924413d4644527d9_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJlYTAzMzdmZWFlOTQyODU5MThmMjUxOTc4ZWI3MWY3L3RhYmxlcmFuZ2U6MmVhMDMzN2ZlYWU5NDI4NTkxOGYyNTE5NzhlYjcxZjdfMy0xLTEtMS0xOTU1NQ_131ade4a-305f-4216-868e-ca581f5252a6"
      unitRef="number">0.50</us-gaap:VariableInterestEntityOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="ieb8971bbe440425c985b311295f2cec9_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJlYTAzMzdmZWFlOTQyODU5MThmMjUxOTc4ZWI3MWY3L3RhYmxlcmFuZ2U6MmVhMDMzN2ZlYWU5NDI4NTkxOGYyNTE5NzhlYjcxZjdfMy0xLTEtMS0xOTU1NQ_5a7591f4-8e6a-4273-a6b3-637caaa6f476"
      unitRef="number">0.50</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <cron:OtherNetAssetsLiabilities
      contextRef="i742245ee0f214dceb6821001350fd31d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJlYTAzMzdmZWFlOTQyODU5MThmMjUxOTc4ZWI3MWY3L3RhYmxlcmFuZ2U6MmVhMDMzN2ZlYWU5NDI4NTkxOGYyNTE5NzhlYjcxZjdfMy0zLTEtMS0xOTU1NQ_7366f7c9-0206-4ec6-9677-a9cb2ea06fae"
      unitRef="usd">109329000</cron:OtherNetAssetsLiabilities>
    <us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount
      contextRef="i742245ee0f214dceb6821001350fd31d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJlYTAzMzdmZWFlOTQyODU5MThmMjUxOTc4ZWI3MWY3L3RhYmxlcmFuZ2U6MmVhMDMzN2ZlYWU5NDI4NTkxOGYyNTE5NzhlYjcxZjdfMy01LTEtMS0xOTU1NQ_0cc5a8a7-9d4e-4127-b6c8-13062fc6ad9d"
      unitRef="usd">21125000</us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount>
    <us-gaap:VariableInterestEntityOwnershipPercentage
      contextRef="i76e00c36f9dd4ecfbf011fe23eac8c61_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJlYTAzMzdmZWFlOTQyODU5MThmMjUxOTc4ZWI3MWY3L3RhYmxlcmFuZ2U6MmVhMDMzN2ZlYWU5NDI4NTkxOGYyNTE5NzhlYjcxZjdfNC0xLTEtMS0xOTU1NQ_6faa9b8a-17bc-41b6-8df7-017b713672cb"
      unitRef="number">0.50</us-gaap:VariableInterestEntityOwnershipPercentage>
    <cron:OtherNetAssetsLiabilities
      contextRef="ic86c74eeef9d4c4f9ebc178e09fd7f92_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJlYTAzMzdmZWFlOTQyODU5MThmMjUxOTc4ZWI3MWY3L3RhYmxlcmFuZ2U6MmVhMDMzN2ZlYWU5NDI4NTkxOGYyNTE5NzhlYjcxZjdfNC0zLTEtMS0xOTU1NQ_6a7b35ca-74aa-4e19-ad5a-674f92980f85"
      unitRef="usd">0</cron:OtherNetAssetsLiabilities>
    <us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount
      contextRef="ic86c74eeef9d4c4f9ebc178e09fd7f92_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJlYTAzMzdmZWFlOTQyODU5MThmMjUxOTc4ZWI3MWY3L3RhYmxlcmFuZ2U6MmVhMDMzN2ZlYWU5NDI4NTkxOGYyNTE5NzhlYjcxZjdfNC01LTEtMS0xOTU1NQ_fe401ad6-c4b0-4671-98dc-fd60aededa9d"
      unitRef="usd">467000</us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount>
    <us-gaap:VariableInterestEntityOwnershipPercentage
      contextRef="i08aaf1da351148dabbc15473a8372493_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJlYTAzMzdmZWFlOTQyODU5MThmMjUxOTc4ZWI3MWY3L3RhYmxlcmFuZ2U6MmVhMDMzN2ZlYWU5NDI4NTkxOGYyNTE5NzhlYjcxZjdfNS0xLTEtMS0xOTU1NQ_abeb0b9a-c88d-4d5d-944c-a177e56c2ab7"
      unitRef="number">0.50</us-gaap:VariableInterestEntityOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i578db4ab78c04e03aee4c102f9d17cfe_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJlYTAzMzdmZWFlOTQyODU5MThmMjUxOTc4ZWI3MWY3L3RhYmxlcmFuZ2U6MmVhMDMzN2ZlYWU5NDI4NTkxOGYyNTE5NzhlYjcxZjdfNS0xLTEtMS0xOTU1NQ_bc0fdcd5-1b05-432a-9c93-6ca263ed7f4b"
      unitRef="number">0.50</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <cron:OtherNetAssetsLiabilities
      contextRef="i8ac21cf5e6b74695a68d659200d9510c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJlYTAzMzdmZWFlOTQyODU5MThmMjUxOTc4ZWI3MWY3L3RhYmxlcmFuZ2U6MmVhMDMzN2ZlYWU5NDI4NTkxOGYyNTE5NzhlYjcxZjdfNS0zLTEtMS0xOTU1NQ_b205db6c-7511-43a5-88f5-7a51defaaff0"
      unitRef="usd">-6849000</cron:OtherNetAssetsLiabilities>
    <us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount
      contextRef="i8ac21cf5e6b74695a68d659200d9510c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJlYTAzMzdmZWFlOTQyODU5MThmMjUxOTc4ZWI3MWY3L3RhYmxlcmFuZ2U6MmVhMDMzN2ZlYWU5NDI4NTkxOGYyNTE5NzhlYjcxZjdfNS01LTEtMS0xOTU1NQ_db1c5c0c-ac84-4ace-b529-8d6091efb414"
      unitRef="usd">8154000</us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount>
    <cron:OtherNetAssetsLiabilities
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJlYTAzMzdmZWFlOTQyODU5MThmMjUxOTc4ZWI3MWY3L3RhYmxlcmFuZ2U6MmVhMDMzN2ZlYWU5NDI4NTkxOGYyNTE5NzhlYjcxZjdfNi0zLTEtMS0xOTU1NQ_b2001f49-2cf7-443c-be26-96e2977d03b8"
      unitRef="usd">111456000</cron:OtherNetAssetsLiabilities>
    <us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjJlYTAzMzdmZWFlOTQyODU5MThmMjUxOTc4ZWI3MWY3L3RhYmxlcmFuZ2U6MmVhMDMzN2ZlYWU5NDI4NTkxOGYyNTE5NzhlYjcxZjdfNi01LTEtMS0xOTU1NQ_35c88296-2fab-4aaf-82f8-6298c01def59"
      unitRef="usd">31276000</us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount>
    <us-gaap:VariableInterestEntityOwnershipPercentage
      contextRef="ie8507622f9454b6d8fc0ba0f6058f27c_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjU3ZjFkZTYwMDJmMjQwNTJhZjVjODFjMzQ3ZjU0MWE1L3RhYmxlcmFuZ2U6NTdmMWRlNjAwMmYyNDA1MmFmNWM4MWMzNDdmNTQxYTVfNy0xLTEtMS0zNzU0Ng_2c79e1c6-9291-48b3-acfa-63bc7bf811bc"
      unitRef="number">0.31</us-gaap:VariableInterestEntityOwnershipPercentage>
    <cron:OtherNetAssetsLiabilities
      contextRef="ica49af07e43e4dacb2f47f79e38bcf20_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjU3ZjFkZTYwMDJmMjQwNTJhZjVjODFjMzQ3ZjU0MWE1L3RhYmxlcmFuZ2U6NTdmMWRlNjAwMmYyNDA1MmFmNWM4MWMzNDdmNTQxYTVfNy0zLTEtMS0zNzU0Ng_8b751adb-0d4e-4f70-bbb4-4be4633f1b3d"
      unitRef="usd">10900000</cron:OtherNetAssetsLiabilities>
    <us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount
      contextRef="ica49af07e43e4dacb2f47f79e38bcf20_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjU3ZjFkZTYwMDJmMjQwNTJhZjVjODFjMzQ3ZjU0MWE1L3RhYmxlcmFuZ2U6NTdmMWRlNjAwMmYyNDA1MmFmNWM4MWMzNDdmNTQxYTVfNy01LTEtMS0zNzU0Ng_5bc95bd2-2c5b-4c35-8468-bb3e13622a28"
      unitRef="usd">1355000</us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount>
    <us-gaap:VariableInterestEntityOwnershipPercentage
      contextRef="i2888e238471544cfb7ff8479ad7e82f6_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjU3ZjFkZTYwMDJmMjQwNTJhZjVjODFjMzQ3ZjU0MWE1L3RhYmxlcmFuZ2U6NTdmMWRlNjAwMmYyNDA1MmFmNWM4MWMzNDdmNTQxYTVfOC0xLTEtMS0zNzU0Ng_2e20d375-f499-4d51-b9a1-b1a54c87f48b"
      unitRef="number">0.50</us-gaap:VariableInterestEntityOwnershipPercentage>
    <cron:OtherNetAssetsLiabilities
      contextRef="i51188c76d4fe446caa292dafb0517e9f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjU3ZjFkZTYwMDJmMjQwNTJhZjVjODFjMzQ3ZjU0MWE1L3RhYmxlcmFuZ2U6NTdmMWRlNjAwMmYyNDA1MmFmNWM4MWMzNDdmNTQxYTVfOC0zLTEtMS0zNzU0Ng_4d3477e5-5a1b-4296-a218-f78cc8a7da2f"
      unitRef="usd">3091000</cron:OtherNetAssetsLiabilities>
    <us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount
      contextRef="i51188c76d4fe446caa292dafb0517e9f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjU3ZjFkZTYwMDJmMjQwNTJhZjVjODFjMzQ3ZjU0MWE1L3RhYmxlcmFuZ2U6NTdmMWRlNjAwMmYyNDA1MmFmNWM4MWMzNDdmNTQxYTVfOC01LTEtMS0zNzU0Ng_cf5ef996-690a-4adc-ad33-c2aadedfc297"
      unitRef="usd">20700000</us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount>
    <us-gaap:VariableInterestEntityOwnershipPercentage
      contextRef="i1d96cfff4a7d4ff6a748326af07ca595_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjU3ZjFkZTYwMDJmMjQwNTJhZjVjODFjMzQ3ZjU0MWE1L3RhYmxlcmFuZ2U6NTdmMWRlNjAwMmYyNDA1MmFmNWM4MWMzNDdmNTQxYTVfOS0xLTEtMS0zNzU0Ng_b7b737f8-3158-40dc-ad12-f1cb003223aa"
      unitRef="number">0.50</us-gaap:VariableInterestEntityOwnershipPercentage>
    <cron:OtherNetAssetsLiabilities
      contextRef="i2d40be89af3b4e0497c3ad54f82f4d44_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjU3ZjFkZTYwMDJmMjQwNTJhZjVjODFjMzQ3ZjU0MWE1L3RhYmxlcmFuZ2U6NTdmMWRlNjAwMmYyNDA1MmFmNWM4MWMzNDdmNTQxYTVfOS0zLTEtMS0zNzU0Ng_0cf1fb5e-d902-4339-8c1c-2529cd5d5c7c"
      unitRef="usd">-199000</cron:OtherNetAssetsLiabilities>
    <us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount
      contextRef="i2d40be89af3b4e0497c3ad54f82f4d44_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjU3ZjFkZTYwMDJmMjQwNTJhZjVjODFjMzQ3ZjU0MWE1L3RhYmxlcmFuZ2U6NTdmMWRlNjAwMmYyNDA1MmFmNWM4MWMzNDdmNTQxYTVfOS01LTEtMS0zNzU0Ng_76e22330-45e0-42e3-ba34-8bcd00e82ba7"
      unitRef="usd">642000</us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount>
    <us-gaap:VariableInterestEntityOwnershipPercentage
      contextRef="i2575ae85f47848a3b4e481731644b697_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjU3ZjFkZTYwMDJmMjQwNTJhZjVjODFjMzQ3ZjU0MWE1L3RhYmxlcmFuZ2U6NTdmMWRlNjAwMmYyNDA1MmFmNWM4MWMzNDdmNTQxYTVfMTAtMS0xLTEtMzc1NDY_dbb4ece9-e856-48ac-b124-b2fd08af75fb"
      unitRef="number">0.50</us-gaap:VariableInterestEntityOwnershipPercentage>
    <cron:OtherNetAssetsLiabilities
      contextRef="i5676c3dd147d44a9a8304b45e044a905_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjU3ZjFkZTYwMDJmMjQwNTJhZjVjODFjMzQ3ZjU0MWE1L3RhYmxlcmFuZ2U6NTdmMWRlNjAwMmYyNDA1MmFmNWM4MWMzNDdmNTQxYTVfMTAtMy0xLTEtMzc1NDY_701a7b2c-9ee3-477d-b6f5-ad4b73586f6a"
      unitRef="usd">-358000</cron:OtherNetAssetsLiabilities>
    <us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount
      contextRef="i5676c3dd147d44a9a8304b45e044a905_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjU3ZjFkZTYwMDJmMjQwNTJhZjVjODFjMzQ3ZjU0MWE1L3RhYmxlcmFuZ2U6NTdmMWRlNjAwMmYyNDA1MmFmNWM4MWMzNDdmNTQxYTVfMTAtNS0xLTEtMzc1NDY_bac32d0e-45e1-45db-a10d-76f03cd0c7c2"
      unitRef="usd">4888000</us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount>
    <cron:OtherNetAssetsLiabilities
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjU3ZjFkZTYwMDJmMjQwNTJhZjVjODFjMzQ3ZjU0MWE1L3RhYmxlcmFuZ2U6NTdmMWRlNjAwMmYyNDA1MmFmNWM4MWMzNDdmNTQxYTVfMTEtMy0xLTEtMzc1NDY_d3a67aea-00dd-4a8b-84e0-ffba4b786eb3"
      unitRef="usd">13434000</cron:OtherNetAssetsLiabilities>
    <us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85MS9mcmFnOjI0NDEwNjE4MGExOTRjNmI5MmIzOWU1MGNhNmUzMDNmL3RhYmxlOjU3ZjFkZTYwMDJmMjQwNTJhZjVjODFjMzQ3ZjU0MWE1L3RhYmxlcmFuZ2U6NTdmMWRlNjAwMmYyNDA1MmFmNWM4MWMzNDdmNTQxYTVfMTEtNS0xLTEtMzc1NDY_83924e2c-ab0b-4620-b0ae-1645335446ed"
      unitRef="usd">27585000</us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90ZXh0cmVnaW9uOmU5MWY3OThmZWZiZDRiOWQ4MjM3NTczMTFmMzU4Mzc4XzgyNDYzMzcyMzg4MTI_c3dbf84b-561c-4ba7-a224-92bf160d0875">Other Investments &lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other investments consist of investments in common shares and warrants of several companies in the cannabis industry. As of December&#160;31, 2020 and December&#160;31, 2019, the Company did not hold any other investments. The gains and losses on sale of other investments are classified as fair value through net income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The gains (losses) recognized in net income (loss) related to other investments were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.288%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gain recognized in net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canopy Growth Corporation (&#x201c;Canopy&#x201d;)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vivo Cannabis (&#x201c;Vivo&#x201d;) - shares&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(173)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vivo Cannabis - share warrants&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Whistler&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(iii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aurora Cannabis Inc. (&#x201c;Aurora&#x201d;)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(iv)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt"&gt;During the year ended December&#160;31, 2019, the Company sold all remaining 11,062 common shares of Canopy (2018 &#x2013; 18,436 common shares) for net proceeds of $355 (2018 &#x2013; $530) recorded as a gain on disposal of other investments in other income (expense). Upon adoption of ASU 2016-01 during the year ended December&#160;31, 2018, the gains and losses on the Canopy investment were reclassified from fair value through other comprehensive income to fair value through net income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt"&gt;During the year ended December&#160;31, 2018, the Company exercised 182,927 share warrants for aggregate consideration of $87 for additional shares of Vivo. During the year ended December&#160;31, 2018, the Company then sold all 182,927 shares of Vivo for proceeds of $216. Upon adoption of ASU 2016-01 during the year ended December&#160;31, 2018, the gains and losses on the Vivo Cannabis shares investment were reclassified from fair value through other comprehensive income to fair value through net income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(iii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.22pt"&gt;On March 4, 2019, the Company sold all 2,563 shares of Whistler, representing approximately 19.0% of Whistler&#x2019;s issued and outstanding common shares, to Aurora, in connection with Aurora&#x2019;s acquisition of Whistler (the &#x201c;Whistler Transaction&#x201d;). As a result of the closing of the Whistler Transaction, the Company received 2,524,341 Aurora common shares. During the year ended December&#160;31, 2019, the Company sold all 2,524,341 common shares of Aurora, for gross proceeds of $19,259. A gain on disposal of other investments was recorded in other income (expense) as a result.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(iv)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.5pt"&gt;For the year ended December&#160;31, 2020, in connection with the achievement of certain milestones related to the Whistler Transaction, the Company received 980,662 common shares of Aurora. During the year ended December 31, 2020, the Company sold all 980,662 of the Aurora common shares, for gross proceeds of approximately $4,789 (C$6,404), recorded as a gain on disposal of other investments in other income (expense).&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90ZXh0cmVnaW9uOmU5MWY3OThmZWZiZDRiOWQ4MjM3NTczMTFmMzU4Mzc4XzgyNDYzMzcyMzg4MTE_d6216f75-231b-461b-804e-56f3dc91c69b">&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The gains (losses) recognized in net income (loss) related to other investments were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.288%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gain recognized in net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canopy Growth Corporation (&#x201c;Canopy&#x201d;)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vivo Cannabis (&#x201c;Vivo&#x201d;) - shares&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(173)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vivo Cannabis - share warrants&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Whistler&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(iii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aurora Cannabis Inc. (&#x201c;Aurora&#x201d;)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(iv)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt"&gt;During the year ended December&#160;31, 2019, the Company sold all remaining 11,062 common shares of Canopy (2018 &#x2013; 18,436 common shares) for net proceeds of $355 (2018 &#x2013; $530) recorded as a gain on disposal of other investments in other income (expense). Upon adoption of ASU 2016-01 during the year ended December&#160;31, 2018, the gains and losses on the Canopy investment were reclassified from fair value through other comprehensive income to fair value through net income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt"&gt;During the year ended December&#160;31, 2018, the Company exercised 182,927 share warrants for aggregate consideration of $87 for additional shares of Vivo. During the year ended December&#160;31, 2018, the Company then sold all 182,927 shares of Vivo for proceeds of $216. Upon adoption of ASU 2016-01 during the year ended December&#160;31, 2018, the gains and losses on the Vivo Cannabis shares investment were reclassified from fair value through other comprehensive income to fair value through net income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(iii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.22pt"&gt;On March 4, 2019, the Company sold all 2,563 shares of Whistler, representing approximately 19.0% of Whistler&#x2019;s issued and outstanding common shares, to Aurora, in connection with Aurora&#x2019;s acquisition of Whistler (the &#x201c;Whistler Transaction&#x201d;). As a result of the closing of the Whistler Transaction, the Company received 2,524,341 Aurora common shares. During the year ended December&#160;31, 2019, the Company sold all 2,524,341 common shares of Aurora, for gross proceeds of $19,259. A gain on disposal of other investments was recorded in other income (expense) as a result.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(iv)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.5pt"&gt;For the year ended December&#160;31, 2020, in connection with the achievement of certain milestones related to the Whistler Transaction, the Company received 980,662 common shares of Aurora. During the year ended December 31, 2020, the Company sold all 980,662 of the Aurora common shares, for gross proceeds of approximately $4,789 (C$6,404), recorded as a gain on disposal of other investments in other income (expense).&lt;/span&gt;&lt;/div&gt;</us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock>
    <us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
      contextRef="idc5472b8d3034929a878ea801fa0b849_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90YWJsZTowYzVlMzVjMGM4NjY0ZGFmYjZmZDZmNzViMzdlMGM1Ny90YWJsZXJhbmdlOjBjNWUzNWMwYzg2NjRkYWZiNmZkNmY3NWIzN2UwYzU3XzItMS0xLTEtODcyMw_6f1586d8-6d21-40ab-a560-e70ce5129fd0"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions>
    <us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
      contextRef="i3d744562089b40b9827f8e55fbe1e1a6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90YWJsZTowYzVlMzVjMGM4NjY0ZGFmYjZmZDZmNzViMzdlMGM1Ny90YWJsZXJhbmdlOjBjNWUzNWMwYzg2NjRkYWZiNmZkNmY3NWIzN2UwYzU3XzItMy0xLTEtODcyOQ_a57abbd8-358a-46f2-9bfa-f16a1af7272e"
      unitRef="usd">51000</us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions>
    <us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
      contextRef="i7452ef8eb84342d198c51755bf9c43a4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90YWJsZTowYzVlMzVjMGM4NjY0ZGFmYjZmZDZmNzViMzdlMGM1Ny90YWJsZXJhbmdlOjBjNWUzNWMwYzg2NjRkYWZiNmZkNmY3NWIzN2UwYzU3XzItNS0xLTEtODczMw_76546f82-b9c0-41c9-9d19-445d9d6b9556"
      unitRef="usd">166000</us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions>
    <us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
      contextRef="i28dbe3b3d492406b844fa6b2d587faa3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90YWJsZTowYzVlMzVjMGM4NjY0ZGFmYjZmZDZmNzViMzdlMGM1Ny90YWJsZXJhbmdlOjBjNWUzNWMwYzg2NjRkYWZiNmZkNmY3NWIzN2UwYzU3XzMtMS0xLTEtODcyMw_d611b793-382a-48af-a88f-57a835406b48"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions>
    <us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
      contextRef="ib1f2f8d063e648d79b58979418dad94b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90YWJsZTowYzVlMzVjMGM4NjY0ZGFmYjZmZDZmNzViMzdlMGM1Ny90YWJsZXJhbmdlOjBjNWUzNWMwYzg2NjRkYWZiNmZkNmY3NWIzN2UwYzU3XzMtMy0xLTEtODcyOQ_ae3b7ed9-2e01-4975-97d1-c67b77015241"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions>
    <us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
      contextRef="ifecc77aba9d94529a80a42fc9ce8c7af_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90YWJsZTowYzVlMzVjMGM4NjY0ZGFmYjZmZDZmNzViMzdlMGM1Ny90YWJsZXJhbmdlOjBjNWUzNWMwYzg2NjRkYWZiNmZkNmY3NWIzN2UwYzU3XzMtNS0xLTEtODczMw_de501a85-b8d1-4fb3-a1db-a49efc4af660"
      unitRef="usd">-173000</us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions>
    <us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
      contextRef="ia7d82a0c5320482da6d4bbdd7fd59a72_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90YWJsZTowYzVlMzVjMGM4NjY0ZGFmYjZmZDZmNzViMzdlMGM1Ny90YWJsZXJhbmdlOjBjNWUzNWMwYzg2NjRkYWZiNmZkNmY3NWIzN2UwYzU3XzQtMS0xLTEtODcyMw_e79c84f0-b4dd-4067-9cfd-8e1094fd3289"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions>
    <us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
      contextRef="ibb82fe39a45a48b684579d0e259b1be9_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90YWJsZTowYzVlMzVjMGM4NjY0ZGFmYjZmZDZmNzViMzdlMGM1Ny90YWJsZXJhbmdlOjBjNWUzNWMwYzg2NjRkYWZiNmZkNmY3NWIzN2UwYzU3XzQtMy0xLTEtODcyOQ_8384f8df-fa4d-4bea-b383-bf57b2fad439"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions>
    <us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
      contextRef="i410fb06923684e30987bfd057a982f23_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90YWJsZTowYzVlMzVjMGM4NjY0ZGFmYjZmZDZmNzViMzdlMGM1Ny90YWJsZXJhbmdlOjBjNWUzNWMwYzg2NjRkYWZiNmZkNmY3NWIzN2UwYzU3XzQtNS0xLTEtODczMw_86fba7ce-79d3-4238-be36-cdc347637dbd"
      unitRef="usd">171000</us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions>
    <us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
      contextRef="if177335bf723452a9e53b5cbb69619d9_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90YWJsZTowYzVlMzVjMGM4NjY0ZGFmYjZmZDZmNzViMzdlMGM1Ny90YWJsZXJhbmdlOjBjNWUzNWMwYzg2NjRkYWZiNmZkNmY3NWIzN2UwYzU3XzYtMS0xLTEtODcyMw_0a8a7d23-2555-4280-800f-67515d0534d9"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions>
    <us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
      contextRef="iafde73babf68415aa902c6377f960aed_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90YWJsZTowYzVlMzVjMGM4NjY0ZGFmYjZmZDZmNzViMzdlMGM1Ny90YWJsZXJhbmdlOjBjNWUzNWMwYzg2NjRkYWZiNmZkNmY3NWIzN2UwYzU3XzYtMy0xLTEtODcyOQ_9ddad954-ba8b-47be-8caa-d947a88123e0"
      unitRef="usd">15530000</us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions>
    <us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
      contextRef="i94d61440c397433cae44d842da3ca067_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90YWJsZTowYzVlMzVjMGM4NjY0ZGFmYjZmZDZmNzViMzdlMGM1Ny90YWJsZXJhbmdlOjBjNWUzNWMwYzg2NjRkYWZiNmZkNmY3NWIzN2UwYzU3XzYtNS0xLTEtODczMw_cae9594e-edac-4d60-b2eb-e4c77de117a6"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions>
    <us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
      contextRef="ib3633b0f773a4aaea9ea7b4dab12ca13_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90YWJsZTowYzVlMzVjMGM4NjY0ZGFmYjZmZDZmNzViMzdlMGM1Ny90YWJsZXJhbmdlOjBjNWUzNWMwYzg2NjRkYWZiNmZkNmY3NWIzN2UwYzU3XzctMS0xLTEtMTEyMjI_bf735d40-32e7-4044-a4af-181e16e728e9"
      unitRef="usd">4789000</us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions>
    <us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
      contextRef="i253fd691295241ea93a2245f1f94a988_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90YWJsZTowYzVlMzVjMGM4NjY0ZGFmYjZmZDZmNzViMzdlMGM1Ny90YWJsZXJhbmdlOjBjNWUzNWMwYzg2NjRkYWZiNmZkNmY3NWIzN2UwYzU3XzctMy0xLTEtMTEyMTU_64261c4b-eb67-45f4-9a56-8d1897d476f3"
      unitRef="usd">696000</us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions>
    <us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
      contextRef="i3cddb3f9929c453995ab712b0ead8198_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90YWJsZTowYzVlMzVjMGM4NjY0ZGFmYjZmZDZmNzViMzdlMGM1Ny90YWJsZXJhbmdlOjBjNWUzNWMwYzg2NjRkYWZiNmZkNmY3NWIzN2UwYzU3XzctNS0xLTEtMTEyMjI_a7e6da43-19f9-4a38-8747-43c14c3b50e9"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions>
    <us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
      contextRef="ibae6d945308c4710b0b167839c583e5e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90YWJsZTowYzVlMzVjMGM4NjY0ZGFmYjZmZDZmNzViMzdlMGM1Ny90YWJsZXJhbmdlOjBjNWUzNWMwYzg2NjRkYWZiNmZkNmY3NWIzN2UwYzU3XzctMS0xLTEtODcyMw_da30366d-07f7-4adf-b0e9-cb4f84d19bc5"
      unitRef="usd">4789000</us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions>
    <us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
      contextRef="i146b3a1d69a94438a07f9724ab5410a5_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90YWJsZTowYzVlMzVjMGM4NjY0ZGFmYjZmZDZmNzViMzdlMGM1Ny90YWJsZXJhbmdlOjBjNWUzNWMwYzg2NjRkYWZiNmZkNmY3NWIzN2UwYzU3XzctMy0xLTEtODcyOQ_7c29fea5-2f3f-4be8-8cc2-6d88a7c8198c"
      unitRef="usd">16277000</us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions>
    <us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
      contextRef="ia2c79796c87c4829ad1e5b4215e49867_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90YWJsZTowYzVlMzVjMGM4NjY0ZGFmYjZmZDZmNzViMzdlMGM1Ny90YWJsZXJhbmdlOjBjNWUzNWMwYzg2NjRkYWZiNmZkNmY3NWIzN2UwYzU3XzctNS0xLTEtODczMw_4394f291-ccba-43f2-92f6-94ae75849952"
      unitRef="usd">164000</us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions>
    <cron:InvestmentOwnedNumberOfSharesSold
      contextRef="i3d744562089b40b9827f8e55fbe1e1a6_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90ZXh0cmVnaW9uOmU5MWY3OThmZWZiZDRiOWQ4MjM3NTczMTFmMzU4Mzc4XzEyMDk0NjI3OTIzNTI3_e6d7ba1f-de55-499b-b60b-dc81d3bd3106"
      unitRef="shares">11062</cron:InvestmentOwnedNumberOfSharesSold>
    <cron:InvestmentOwnedNumberOfSharesSold
      contextRef="i7452ef8eb84342d198c51755bf9c43a4_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90ZXh0cmVnaW9uOmU5MWY3OThmZWZiZDRiOWQ4MjM3NTczMTFmMzU4Mzc4XzE1OTQyOTE4NjE5OTYx_61c1adc6-d156-479b-924a-168f4ad6bfd3"
      unitRef="shares">18436</cron:InvestmentOwnedNumberOfSharesSold>
    <cron:ProceedsFromSaleOfEquitySecuritiesFVNI
      contextRef="i3d744562089b40b9827f8e55fbe1e1a6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90ZXh0cmVnaW9uOmU5MWY3OThmZWZiZDRiOWQ4MjM3NTczMTFmMzU4Mzc4XzEyMDk0NjI3OTIzMjQ3_6599008e-1c04-4344-a17a-782fe1042fcf"
      unitRef="usd">355000</cron:ProceedsFromSaleOfEquitySecuritiesFVNI>
    <cron:ProceedsFromSaleOfEquitySecuritiesFVNI
      contextRef="i7452ef8eb84342d198c51755bf9c43a4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90ZXh0cmVnaW9uOmU5MWY3OThmZWZiZDRiOWQ4MjM3NTczMTFmMzU4Mzc4XzE1OTQyOTE4NjE5OTcz_5b659b84-e471-45f5-9b3d-9786124549c1"
      unitRef="usd">530000</cron:ProceedsFromSaleOfEquitySecuritiesFVNI>
    <cron:InvestmentOwnedNumberOfWarrantsExercised
      contextRef="ifecc77aba9d94529a80a42fc9ce8c7af_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90ZXh0cmVnaW9uOmU5MWY3OThmZWZiZDRiOWQ4MjM3NTczMTFmMzU4Mzc4XzE1OTQyOTE4NjIwMTc1_d404653e-8d35-4211-bee4-307b113881cd"
      unitRef="shares">182927</cron:InvestmentOwnedNumberOfWarrantsExercised>
    <cron:PaymentsToExerciseWarrants
      contextRef="ifecc77aba9d94529a80a42fc9ce8c7af_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90ZXh0cmVnaW9uOmU5MWY3OThmZWZiZDRiOWQ4MjM3NTczMTFmMzU4Mzc4Xzg3OTYwOTMwNTI2NTA_4c85f645-80a2-453b-8963-461bd5c4084a"
      unitRef="usd">87000</cron:PaymentsToExerciseWarrants>
    <cron:InvestmentOwnedNumberOfSharesSold
      contextRef="ifecc77aba9d94529a80a42fc9ce8c7af_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90ZXh0cmVnaW9uOmU5MWY3OThmZWZiZDRiOWQ4MjM3NTczMTFmMzU4Mzc4XzEzNzQzODk1Mzc3NzIy_80915ef7-8fd6-4e22-b428-b25999e58e69"
      unitRef="shares">182927</cron:InvestmentOwnedNumberOfSharesSold>
    <cron:ProceedsFromSaleOfEquitySecuritiesFVNI
      contextRef="ifecc77aba9d94529a80a42fc9ce8c7af_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90ZXh0cmVnaW9uOmU5MWY3OThmZWZiZDRiOWQ4MjM3NTczMTFmMzU4Mzc4XzE1OTQyOTE4NjIwMTky_fa3322b4-187d-4a60-8670-213725e80665"
      unitRef="usd">216000</cron:ProceedsFromSaleOfEquitySecuritiesFVNI>
    <cron:InvestmentOwnedNumberOfSharesSold
      contextRef="i02c8c20a53a14d20b68fae9142fac983_D20190304-20190304"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90ZXh0cmVnaW9uOmU5MWY3OThmZWZiZDRiOWQ4MjM3NTczMTFmMzU4Mzc4Xzg3OTYwOTMwNTI2NTk_8ee5e345-db74-4b11-a05d-c0e1a106218a"
      unitRef="shares">2563</cron:InvestmentOwnedNumberOfSharesSold>
    <cron:InvestmentOwnedSharesSoldPercentageOfSharesIssuedAndOutstanding
      contextRef="i02c8c20a53a14d20b68fae9142fac983_D20190304-20190304"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90ZXh0cmVnaW9uOmU5MWY3OThmZWZiZDRiOWQ4MjM3NTczMTFmMzU4Mzc4Xzg3OTYwOTMwNTI2ODk_f78ad614-6646-4044-aff1-29e767821a29"
      unitRef="number">0.190</cron:InvestmentOwnedSharesSoldPercentageOfSharesIssuedAndOutstanding>
    <cron:InvestmentOwnedNumberOfSharesReceived
      contextRef="i545d2eedc49b488a858211c0dfae5d9e_D20190304-20190304"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90ZXh0cmVnaW9uOmU5MWY3OThmZWZiZDRiOWQ4MjM3NTczMTFmMzU4Mzc4Xzg3OTYwOTMwNTI2Njc_4a4b3270-a5d4-4722-ac56-9cebadc4ba06"
      unitRef="shares">2524341</cron:InvestmentOwnedNumberOfSharesReceived>
    <cron:InvestmentOwnedNumberOfSharesSold
      contextRef="i253fd691295241ea93a2245f1f94a988_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90ZXh0cmVnaW9uOmU5MWY3OThmZWZiZDRiOWQ4MjM3NTczMTFmMzU4Mzc4XzEzNzQzODk1Mzc2MjEx_98279285-d2a7-4d48-8592-66837eb229dd"
      unitRef="shares">2524341</cron:InvestmentOwnedNumberOfSharesSold>
    <cron:ProceedsFromSaleOfEquitySecuritiesFVNI
      contextRef="i253fd691295241ea93a2245f1f94a988_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90ZXh0cmVnaW9uOmU5MWY3OThmZWZiZDRiOWQ4MjM3NTczMTFmMzU4Mzc4Xzg3OTYwOTMwNTI2Nzk_db733f56-7fab-449d-937f-b5834ad3382d"
      unitRef="usd">19259000</cron:ProceedsFromSaleOfEquitySecuritiesFVNI>
    <cron:InvestmentOwnedNumberOfSharesReceived
      contextRef="if177335bf723452a9e53b5cbb69619d9_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90ZXh0cmVnaW9uOmU5MWY3OThmZWZiZDRiOWQ4MjM3NTczMTFmMzU4Mzc4XzEzNzQzODk1Mzc3NzI2_7d0bb4c0-ce69-4512-b891-d23bab982680"
      unitRef="shares">980662</cron:InvestmentOwnedNumberOfSharesReceived>
    <cron:InvestmentOwnedNumberOfSharesSold
      contextRef="if177335bf723452a9e53b5cbb69619d9_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90ZXh0cmVnaW9uOmU5MWY3OThmZWZiZDRiOWQ4MjM3NTczMTFmMzU4Mzc4XzEzNzQzODk1Mzc2MjI5_b5b68019-7af1-4b31-b66a-d43061313558"
      unitRef="shares">980662</cron:InvestmentOwnedNumberOfSharesSold>
    <us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
      contextRef="ib3633b0f773a4aaea9ea7b4dab12ca13_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90ZXh0cmVnaW9uOmU5MWY3OThmZWZiZDRiOWQ4MjM3NTczMTFmMzU4Mzc4XzExNTQ0ODcyMTIxODAz_bf735d40-32e7-4044-a4af-181e16e728e9"
      unitRef="usd">4789000</us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions>
    <us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
      contextRef="ib3633b0f773a4aaea9ea7b4dab12ca13_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDMvZnJhZzplOTFmNzk4ZmVmYmQ0YjlkODIzNzU3MzExZjM1ODM3OC90ZXh0cmVnaW9uOmU5MWY3OThmZWZiZDRiOWQ4MjM3NTczMTFmMzU4Mzc4XzExNTQ0ODcyMTIxODEx_9a69e91d-48d6-422f-b0ec-6542c61a03c4"
      unitRef="cad">6404000</us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions>
    <us-gaap:LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RleHRyZWdpb246YmU2YjZhNzQ2YmQ5NDE2NGI4MjJiMDhkOWE2YWUyMTJfMjMwODk3NDQyMjQ0OTI_88ea861c-09f6-414e-b25d-7875a8690827">Loans Receivable &lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.348%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Natuera Series A Loan&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GrowCo Credit Facility&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current portion of loans receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Long term portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GrowCo Credit Facility&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mucci Promissory Note&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(iii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cannasoul Collaboration loan&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(iv)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term portion of loans receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87,191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total loans receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:-9pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt"&gt;On July 24, 2020, the Company and its joint venture partner entered into an amendment to the Series A Loan with Natuera to increase the principal amount of the Series A Loan by $6,350, to an aggregate principal amount of the Series A Loan of $15,500, of which the Company has committed to fund 50% and its joint venture partner has committed to fund the remaining 50%. Outstanding principal amounts continue to bear interest at a fixed annual rate of 5.67%. In December 2020, the Series A Loan was amended to extend its maturity date to September 1, 2021 from March 1, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:27pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, a current expected credit loss allowance of $685 was recorded against the Natuera Series A loan. A loss allowance of $3,024 was recorded against the Natuera Series A Loan related to the Company&#x2019;s share of net loss from Natuera in excess of the carrying value of the equity method investment. Refer to Note 6.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt"&gt;On August 23, 2019, the Company entered into a credit agreement with Cronos GrowCo in respect of a C$100,000 (approximately $78,430) secured non-revolving term loan credit facility (the &#x201c;GrowCo Credit Facility&#x201d;). The GrowCo Credit Facility will mature on March 31, 2031 and will bear interest at varying rates based on the Canadian prime rate as announced by the Bank of Montreal. Interest began to accrue as of the closing date of the GrowCo Credit Facility and is payable on a quarterly basis until maturity, except that any interest accrued prior to March 31, 2021 will be payable not later than December 31, 2021. Repayment of principal will be made on a quarterly basis commencing on March 31, 2021. The GrowCo Credit Facility is secured by substantially all present and after acquired property of Cronos GrowCo and its subsidiaries. Mucci, the other 50% shareholder of Cronos GrowCo, has provided a limited recourse guarantee in favor of Cronos GrowCo, secured by Mucci&#x2019;s shares in Cronos GrowCo. As of December&#160;31, 2020, Cronos GrowCo had drawn C$95,150 ($74,626) from the GrowCo Credit Facility. Subsequent to December 31, 2020, the terms of the GrowCo Credit Facility were amended, such that any interest accrued from April 1, 2021 to December 31, 2021 will be payable not later than December 31, 2022, and repayment of principal will be made on a quarterly basis commencing on March 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:27pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, a current expected credit loss allowance of $1,470 was recorded against the GrowCo Credit Facility.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(iii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.22pt"&gt;On June 28, 2019, the Company entered into a promissory note receivable agreement (the &#x201c;Mucci Promissory Note&#x201d;) for C$16,350 (approximately $12,823) with Mucci. The outstanding principal amount of the Mucci Promissory Note bears interest at 3.95% annually and is due within 90 days of demand. The Company does not intend to demand the loan within 12 months. Interest accrued under the Mucci Promissory Note until July 1, 2021 is payable by way of capitalization on the principal amount and interest thereafter must be paid in cash on a quarterly basis. The Mucci Promissory Note is secured by a general security agreement covering all the assets of Mucci. Subsequent to December 31, 2020, the terms of the Mucci Promissory Note were amended, such that interest accrued under the Mucci Promissory Note until July 1, 2022, is payable by way of capitalization on the principal amount and interest thereafter must be paid in cash on a quarterly basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:27pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, a current expected credit loss allowance of $259 has been recorded against the Mucci Promissory Note.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(iv)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.5pt"&gt;On April 1, 2020, Cronos Israel entered into the Cannasoul Collaboration. Cronos Israel has agreed to advance approximately ILS 8,297 (approximately $2,574) by a non-recourse loan to CLS over a period of two years for the capital and operating expenditures of the laboratory. The outstanding principal on the loan bears interest at 3.5% annually and will be repaid through the profits generated from the Cannasoul Collaboration. For the year ended December 31, 2020, CLS has received ILS $4,148 (approximately $1,287). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:27pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, a current expected credit loss allowance of $25 has been recorded against the Cannasoul Collaboration loan.&lt;/span&gt;&lt;/div&gt;</us-gaap:LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RleHRyZWdpb246YmU2YjZhNzQ2YmQ5NDE2NGI4MjJiMDhkOWE2YWUyMTJfMjMwODk3NDQyMjQ0OTM_92f21d19-372d-4b40-8bbd-b85418cf3382">&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.348%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December&#160;31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Natuera Series A Loan&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GrowCo Credit Facility&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current portion of loans receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Long term portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GrowCo Credit Facility&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mucci Promissory Note&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(iii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cannasoul Collaboration loan&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(iv)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term portion of loans receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87,191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total loans receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:-9pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt"&gt;On July 24, 2020, the Company and its joint venture partner entered into an amendment to the Series A Loan with Natuera to increase the principal amount of the Series A Loan by $6,350, to an aggregate principal amount of the Series A Loan of $15,500, of which the Company has committed to fund 50% and its joint venture partner has committed to fund the remaining 50%. Outstanding principal amounts continue to bear interest at a fixed annual rate of 5.67%. In December 2020, the Series A Loan was amended to extend its maturity date to September 1, 2021 from March 1, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:27pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, a current expected credit loss allowance of $685 was recorded against the Natuera Series A loan. A loss allowance of $3,024 was recorded against the Natuera Series A Loan related to the Company&#x2019;s share of net loss from Natuera in excess of the carrying value of the equity method investment. Refer to Note 6.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt"&gt;On August 23, 2019, the Company entered into a credit agreement with Cronos GrowCo in respect of a C$100,000 (approximately $78,430) secured non-revolving term loan credit facility (the &#x201c;GrowCo Credit Facility&#x201d;). The GrowCo Credit Facility will mature on March 31, 2031 and will bear interest at varying rates based on the Canadian prime rate as announced by the Bank of Montreal. Interest began to accrue as of the closing date of the GrowCo Credit Facility and is payable on a quarterly basis until maturity, except that any interest accrued prior to March 31, 2021 will be payable not later than December 31, 2021. Repayment of principal will be made on a quarterly basis commencing on March 31, 2021. The GrowCo Credit Facility is secured by substantially all present and after acquired property of Cronos GrowCo and its subsidiaries. Mucci, the other 50% shareholder of Cronos GrowCo, has provided a limited recourse guarantee in favor of Cronos GrowCo, secured by Mucci&#x2019;s shares in Cronos GrowCo. As of December&#160;31, 2020, Cronos GrowCo had drawn C$95,150 ($74,626) from the GrowCo Credit Facility. Subsequent to December 31, 2020, the terms of the GrowCo Credit Facility were amended, such that any interest accrued from April 1, 2021 to December 31, 2021 will be payable not later than December 31, 2022, and repayment of principal will be made on a quarterly basis commencing on March 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:27pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, a current expected credit loss allowance of $1,470 was recorded against the GrowCo Credit Facility.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(iii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.22pt"&gt;On June 28, 2019, the Company entered into a promissory note receivable agreement (the &#x201c;Mucci Promissory Note&#x201d;) for C$16,350 (approximately $12,823) with Mucci. The outstanding principal amount of the Mucci Promissory Note bears interest at 3.95% annually and is due within 90 days of demand. The Company does not intend to demand the loan within 12 months. Interest accrued under the Mucci Promissory Note until July 1, 2021 is payable by way of capitalization on the principal amount and interest thereafter must be paid in cash on a quarterly basis. The Mucci Promissory Note is secured by a general security agreement covering all the assets of Mucci. Subsequent to December 31, 2020, the terms of the Mucci Promissory Note were amended, such that interest accrued under the Mucci Promissory Note until July 1, 2022, is payable by way of capitalization on the principal amount and interest thereafter must be paid in cash on a quarterly basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:27pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, a current expected credit loss allowance of $259 has been recorded against the Mucci Promissory Note.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(iv)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.5pt"&gt;On April 1, 2020, Cronos Israel entered into the Cannasoul Collaboration. Cronos Israel has agreed to advance approximately ILS 8,297 (approximately $2,574) by a non-recourse loan to CLS over a period of two years for the capital and operating expenditures of the laboratory. The outstanding principal on the loan bears interest at 3.5% annually and will be repaid through the profits generated from the Cannasoul Collaboration. For the year ended December 31, 2020, CLS has received ILS $4,148 (approximately $1,287). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:27pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, a current expected credit loss allowance of $25 has been recorded against the Cannasoul Collaboration loan.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <cron:FinancingReceivableBeforeAccruedInterestCurrent
      contextRef="i0b816c5b52b043c8a33c4048ab073bc3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RhYmxlOjY2Y2FiZjk3YmQ3MzQwZjJhZTJmNzk2YTk3MDFhZmIzL3RhYmxlcmFuZ2U6NjZjYWJmOTdiZDczNDBmMmFlMmY3OTZhOTcwMWFmYjNfMy0zLTEtMS0w_d4d1cdd1-29db-4a4b-9678-8bfb2239a45f"
      unitRef="usd">3518000</cron:FinancingReceivableBeforeAccruedInterestCurrent>
    <cron:FinancingReceivableBeforeAccruedInterestCurrent
      contextRef="ic325dca9bc664509ab8e9daef0295626_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RhYmxlOjY2Y2FiZjk3YmQ3MzQwZjJhZTJmNzk2YTk3MDFhZmIzL3RhYmxlcmFuZ2U6NjZjYWJmOTdiZDczNDBmMmFlMmY3OTZhOTcwMWFmYjNfMy02LTEtMS0w_b5d0c6a4-38d8-40cb-bdeb-4d5e14e0f686"
      unitRef="usd">4575000</cron:FinancingReceivableBeforeAccruedInterestCurrent>
    <cron:FinancingReceivableBeforeAccruedInterestCurrent
      contextRef="i5835cd4e2e1344e38bcc3bdeeb97d893_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RhYmxlOjY2Y2FiZjk3YmQ3MzQwZjJhZTJmNzk2YTk3MDFhZmIzL3RhYmxlcmFuZ2U6NjZjYWJmOTdiZDczNDBmMmFlMmY3OTZhOTcwMWFmYjNfNC0zLTEtMS0w_8d2992c3-7433-4432-a5ec-7d60bd1588be"
      unitRef="usd">3137000</cron:FinancingReceivableBeforeAccruedInterestCurrent>
    <cron:FinancingReceivableBeforeAccruedInterestCurrent
      contextRef="i3d58e7e380fd4928a5a4aaf66fb7fa7d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RhYmxlOjY2Y2FiZjk3YmQ3MzQwZjJhZTJmNzk2YTk3MDFhZmIzL3RhYmxlcmFuZ2U6NjZjYWJmOTdiZDczNDBmMmFlMmY3OTZhOTcwMWFmYjNfNC02LTEtMS0w_bc8f32ef-b0b7-4ada-975c-6228544afe5b"
      unitRef="usd">0</cron:FinancingReceivableBeforeAccruedInterestCurrent>
    <cron:FinancingReceivableAccruedInterestCurrent
      contextRef="ia3dd9320d6fb49b8af36a67921315f6a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RhYmxlOjY2Y2FiZjk3YmQ3MzQwZjJhZTJmNzk2YTk3MDFhZmIzL3RhYmxlcmFuZ2U6NjZjYWJmOTdiZDczNDBmMmFlMmY3OTZhOTcwMWFmYjNfNS0zLTEtMS0w_ec93968e-5749-4b66-ba4a-7aa83039d720"
      unitRef="usd">428000</cron:FinancingReceivableAccruedInterestCurrent>
    <cron:FinancingReceivableAccruedInterestCurrent
      contextRef="i08888a921a2b4c88b691257e4ea48e15_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RhYmxlOjY2Y2FiZjk3YmQ3MzQwZjJhZTJmNzk2YTk3MDFhZmIzL3RhYmxlcmFuZ2U6NjZjYWJmOTdiZDczNDBmMmFlMmY3OTZhOTcwMWFmYjNfNS02LTEtMS0w_5d6acdb2-588d-4d9f-b72a-b97bc77ac692"
      unitRef="usd">89000</cron:FinancingReceivableAccruedInterestCurrent>
    <us-gaap:NotesAndLoansReceivableNetCurrent
      contextRef="ia3dd9320d6fb49b8af36a67921315f6a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RhYmxlOjY2Y2FiZjk3YmQ3MzQwZjJhZTJmNzk2YTk3MDFhZmIzL3RhYmxlcmFuZ2U6NjZjYWJmOTdiZDczNDBmMmFlMmY3OTZhOTcwMWFmYjNfNi0zLTEtMS0w_0cbd966b-fd69-41b8-9c7e-1853888f7b21"
      unitRef="usd">7083000</us-gaap:NotesAndLoansReceivableNetCurrent>
    <us-gaap:NotesAndLoansReceivableNetCurrent
      contextRef="i08888a921a2b4c88b691257e4ea48e15_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RhYmxlOjY2Y2FiZjk3YmQ3MzQwZjJhZTJmNzk2YTk3MDFhZmIzL3RhYmxlcmFuZ2U6NjZjYWJmOTdiZDczNDBmMmFlMmY3OTZhOTcwMWFmYjNfNi02LTEtMS0w_567eeaac-062c-438e-8133-75b1f393bb86"
      unitRef="usd">4664000</us-gaap:NotesAndLoansReceivableNetCurrent>
    <cron:FinancingReceivableBeforeAccruedInterestNoncurrent
      contextRef="i5835cd4e2e1344e38bcc3bdeeb97d893_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RhYmxlOjY2Y2FiZjk3YmQ3MzQwZjJhZTJmNzk2YTk3MDFhZmIzL3RhYmxlcmFuZ2U6NjZjYWJmOTdiZDczNDBmMmFlMmY3OTZhOTcwMWFmYjNfOC0zLTEtMS0w_ead7845e-2982-45af-a249-361680890aa1"
      unitRef="usd">69939000</cron:FinancingReceivableBeforeAccruedInterestNoncurrent>
    <cron:FinancingReceivableBeforeAccruedInterestNoncurrent
      contextRef="i3d58e7e380fd4928a5a4aaf66fb7fa7d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RhYmxlOjY2Y2FiZjk3YmQ3MzQwZjJhZTJmNzk2YTk3MDFhZmIzL3RhYmxlcmFuZ2U6NjZjYWJmOTdiZDczNDBmMmFlMmY3OTZhOTcwMWFmYjNfOC02LTEtMS0w_17d0afa1-697e-4315-b8ac-093228ad631c"
      unitRef="usd">31678000</cron:FinancingReceivableBeforeAccruedInterestNoncurrent>
    <cron:FinancingReceivableBeforeAccruedInterestNoncurrent
      contextRef="i6cf7bda411034052a94e3326aff296d1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RhYmxlOjY2Y2FiZjk3YmQ3MzQwZjJhZTJmNzk2YTk3MDFhZmIzL3RhYmxlcmFuZ2U6NjZjYWJmOTdiZDczNDBmMmFlMmY3OTZhOTcwMWFmYjNfOS0zLTEtMS0w_ed9d65f1-1589-46c0-980c-c5a7a66b7bf2"
      unitRef="usd">13324000</cron:FinancingReceivableBeforeAccruedInterestNoncurrent>
    <cron:FinancingReceivableBeforeAccruedInterestNoncurrent
      contextRef="i8b017704f622466f9bd013c4ae05afcc_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RhYmxlOjY2Y2FiZjk3YmQ3MzQwZjJhZTJmNzk2YTk3MDFhZmIzL3RhYmxlcmFuZ2U6NjZjYWJmOTdiZDczNDBmMmFlMmY3OTZhOTcwMWFmYjNfOS02LTEtMS0w_02ce445c-0f4d-416a-9c02-afbd075ecc35"
      unitRef="usd">12587000</cron:FinancingReceivableBeforeAccruedInterestNoncurrent>
    <cron:FinancingReceivableBeforeAccruedInterestNoncurrent
      contextRef="idedac3c668174711a1ce0d5786afbad3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RhYmxlOjY2Y2FiZjk3YmQ3MzQwZjJhZTJmNzk2YTk3MDFhZmIzL3RhYmxlcmFuZ2U6NjZjYWJmOTdiZDczNDBmMmFlMmY3OTZhOTcwMWFmYjNfMTAtMy0xLTEtNzc5NQ_7f42a8fb-4208-4f55-a8d8-45e3cf675951"
      unitRef="usd">1261000</cron:FinancingReceivableBeforeAccruedInterestNoncurrent>
    <cron:FinancingReceivableBeforeAccruedInterestNoncurrent
      contextRef="i039760a0355f48f39de64bb56dd8ac81_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RhYmxlOjY2Y2FiZjk3YmQ3MzQwZjJhZTJmNzk2YTk3MDFhZmIzL3RhYmxlcmFuZ2U6NjZjYWJmOTdiZDczNDBmMmFlMmY3OTZhOTcwMWFmYjNfMTAtNi0xLTEtNTY5Mw_5393384d-a6ef-431a-ba9e-aa257cfd6123"
      unitRef="usd">0</cron:FinancingReceivableBeforeAccruedInterestNoncurrent>
    <cron:FinancingReceivableAccruedInterestNoncurrent
      contextRef="ia3dd9320d6fb49b8af36a67921315f6a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RhYmxlOjY2Y2FiZjk3YmQ3MzQwZjJhZTJmNzk2YTk3MDFhZmIzL3RhYmxlcmFuZ2U6NjZjYWJmOTdiZDczNDBmMmFlMmY3OTZhOTcwMWFmYjNfMTAtMy0xLTEtMA_40216708-8da4-4002-8359-5d229dce6b96"
      unitRef="usd">2667000</cron:FinancingReceivableAccruedInterestNoncurrent>
    <cron:FinancingReceivableAccruedInterestNoncurrent
      contextRef="i08888a921a2b4c88b691257e4ea48e15_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RhYmxlOjY2Y2FiZjk3YmQ3MzQwZjJhZTJmNzk2YTk3MDFhZmIzL3RhYmxlcmFuZ2U6NjZjYWJmOTdiZDczNDBmMmFlMmY3OTZhOTcwMWFmYjNfMTAtNi0xLTEtMA_467afc0f-b9fa-46af-b4c5-d88b4ee3b50e"
      unitRef="usd">702000</cron:FinancingReceivableAccruedInterestNoncurrent>
    <us-gaap:NotesAndLoansReceivableNetNoncurrent
      contextRef="ia3dd9320d6fb49b8af36a67921315f6a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RhYmxlOjY2Y2FiZjk3YmQ3MzQwZjJhZTJmNzk2YTk3MDFhZmIzL3RhYmxlcmFuZ2U6NjZjYWJmOTdiZDczNDBmMmFlMmY3OTZhOTcwMWFmYjNfMTEtMy0xLTEtMA_8cbfff0e-48e0-4c4f-adca-7513b90c87ee"
      unitRef="usd">87191000</us-gaap:NotesAndLoansReceivableNetNoncurrent>
    <us-gaap:NotesAndLoansReceivableNetNoncurrent
      contextRef="i08888a921a2b4c88b691257e4ea48e15_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RhYmxlOjY2Y2FiZjk3YmQ3MzQwZjJhZTJmNzk2YTk3MDFhZmIzL3RhYmxlcmFuZ2U6NjZjYWJmOTdiZDczNDBmMmFlMmY3OTZhOTcwMWFmYjNfMTEtNi0xLTEtMA_c70c0d7c-1109-4788-a9f2-8b62e6163351"
      unitRef="usd">44967000</us-gaap:NotesAndLoansReceivableNetNoncurrent>
    <us-gaap:NotesReceivableNet
      contextRef="ia3dd9320d6fb49b8af36a67921315f6a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RhYmxlOjY2Y2FiZjk3YmQ3MzQwZjJhZTJmNzk2YTk3MDFhZmIzL3RhYmxlcmFuZ2U6NjZjYWJmOTdiZDczNDBmMmFlMmY3OTZhOTcwMWFmYjNfMTItMy0xLTEtMA_7d0d9416-0080-4ce9-ac48-bb951435683d"
      unitRef="usd">94274000</us-gaap:NotesReceivableNet>
    <us-gaap:NotesReceivableNet
      contextRef="i08888a921a2b4c88b691257e4ea48e15_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RhYmxlOjY2Y2FiZjk3YmQ3MzQwZjJhZTJmNzk2YTk3MDFhZmIzL3RhYmxlcmFuZ2U6NjZjYWJmOTdiZDczNDBmMmFlMmY3OTZhOTcwMWFmYjNfMTItNi0xLTEtMA_2702a0e8-509d-4243-92a8-fbfaab7fcbf2"
      unitRef="usd">49631000</us-gaap:NotesReceivableNet>
    <cron:FinancingReceivableAdditionalFaceAmountIncludingThirdPartyAmount
      contextRef="i7999a4c04ba7440fac47582ee604719d_I20200724"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RleHRyZWdpb246YmU2YjZhNzQ2YmQ5NDE2NGI4MjJiMDhkOWE2YWUyMTJfMTU5NDI5MTg2Mzc5ODk_6c7a3af0-7156-4135-8183-788dde72892e"
      unitRef="usd">6350000</cron:FinancingReceivableAdditionalFaceAmountIncludingThirdPartyAmount>
    <cron:FinancingReceivableFaceAmountIncludingThirdPartyAmount
      contextRef="i7999a4c04ba7440fac47582ee604719d_I20200724"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RleHRyZWdpb246YmU2YjZhNzQ2YmQ5NDE2NGI4MjJiMDhkOWE2YWUyMTJfMTU5NDI5MTg2Mzc5OTc_8048dc0e-6a92-498b-841d-e15192ce345e"
      unitRef="usd">15500000</cron:FinancingReceivableFaceAmountIncludingThirdPartyAmount>
    <cron:FinancingReceivableFundingCommitmentPercentage
      contextRef="i7999a4c04ba7440fac47582ee604719d_I20200724"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RleHRyZWdpb246YmU2YjZhNzQ2YmQ5NDE2NGI4MjJiMDhkOWE2YWUyMTJfMTU5NDI5MTg2MzgwMTE_8a3c809d-0068-4d90-aa74-63bb412e63bb"
      unitRef="number">0.50</cron:FinancingReceivableFundingCommitmentPercentage>
    <cron:FinancingReceivableFundingCommitmentPercentage
      contextRef="i41bfa3763a044d118326791c2cd608f4_I20200724"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RleHRyZWdpb246YmU2YjZhNzQ2YmQ5NDE2NGI4MjJiMDhkOWE2YWUyMTJfMTU5NDI5MTg2Mzc5OTA_4210818b-ad6d-4ade-86ec-d97e20872732"
      unitRef="number">0.50</cron:FinancingReceivableFundingCommitmentPercentage>
    <cron:FinancingReceivableInterestRateStatedPercentage
      contextRef="i7999a4c04ba7440fac47582ee604719d_I20200724"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RleHRyZWdpb246YmU2YjZhNzQ2YmQ5NDE2NGI4MjJiMDhkOWE2YWUyMTJfMTU5NDI5MTg2MzgwMTk_3de19899-fa0c-4e1f-ade2-0403aec398ce"
      unitRef="number">0.0567</cron:FinancingReceivableInterestRateStatedPercentage>
    <us-gaap:FinancingReceivableAllowanceForCreditLosses
      contextRef="i0b816c5b52b043c8a33c4048ab073bc3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RleHRyZWdpb246YmU2YjZhNzQ2YmQ5NDE2NGI4MjJiMDhkOWE2YWUyMTJfMTIwOTQ2Mjc5NDY4NTU_909d304b-a92d-47b9-ae7b-4d3da849ea31"
      unitRef="usd">685000</us-gaap:FinancingReceivableAllowanceForCreditLosses>
    <us-gaap:FinancingReceivableAllowanceForCreditLosses
      contextRef="ifb88f981f5fb4f0f99e4f3ce4df9e544_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RleHRyZWdpb246YmU2YjZhNzQ2YmQ5NDE2NGI4MjJiMDhkOWE2YWUyMTJfMTIwOTQ2Mjc5NDY4MDc_73ccc638-3178-49da-9c5d-71ebf3f98b50"
      unitRef="usd">3024000</us-gaap:FinancingReceivableAllowanceForCreditLosses>
    <cron:FinancingReceivableFaceAmount
      contextRef="i0cb79bd1f7294820b3cd4e80384aad34_I20190823"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RleHRyZWdpb246YmU2YjZhNzQ2YmQ5NDE2NGI4MjJiMDhkOWE2YWUyMTJfMTI2NDQzODM3NDc5ODk_154f24f8-3620-4e9e-ac52-f35cd626eda5"
      unitRef="cad">100000000</cron:FinancingReceivableFaceAmount>
    <cron:FinancingReceivableFaceAmount
      contextRef="i0cb79bd1f7294820b3cd4e80384aad34_I20190823"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RleHRyZWdpb246YmU2YjZhNzQ2YmQ5NDE2NGI4MjJiMDhkOWE2YWUyMTJfMTIwOTQ2Mjc5NDY1NTY_ce3cf33b-c6df-41fd-a01a-2bfb4151f3e2"
      unitRef="usd">78430000</cron:FinancingReceivableFaceAmount>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="i499c1e4218d94789b4afa9918d59c37c_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RleHRyZWdpb246YmU2YjZhNzQ2YmQ5NDE2NGI4MjJiMDhkOWE2YWUyMTJfMTI2NDQzODM3NTQzOTU_4b688d35-d520-47db-a966-9b1b4bf2e995"
      unitRef="number">0.50</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <us-gaap:PaymentsToAcquireLoansReceivable
      contextRef="ic6677966de35472db8717afeb11c793f_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RleHRyZWdpb246YmU2YjZhNzQ2YmQ5NDE2NGI4MjJiMDhkOWE2YWUyMTJfMzg0ODI5MDc3ODE5Nw_863a5658-87a4-4703-819e-fe9582faef29"
      unitRef="cad">95150000</us-gaap:PaymentsToAcquireLoansReceivable>
    <us-gaap:PaymentsToAcquireLoansReceivable
      contextRef="ic6677966de35472db8717afeb11c793f_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RleHRyZWdpb246YmU2YjZhNzQ2YmQ5NDE2NGI4MjJiMDhkOWE2YWUyMTJfMTA5OTUxMTYzNjI3Nw_13980663-1968-4dab-8b88-3fc9639a6aab"
      unitRef="usd">74626000</us-gaap:PaymentsToAcquireLoansReceivable>
    <us-gaap:FinancingReceivableAllowanceForCreditLosses
      contextRef="i5835cd4e2e1344e38bcc3bdeeb97d893_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RleHRyZWdpb246YmU2YjZhNzQ2YmQ5NDE2NGI4MjJiMDhkOWE2YWUyMTJfMTA5OTUxMTYzNjI4NA_002bfe92-5a63-4fd7-b375-927330064ba2"
      unitRef="usd">1470000</us-gaap:FinancingReceivableAllowanceForCreditLosses>
    <cron:FinancingReceivableFaceAmount
      contextRef="i4799e1f980174942a3388f2d435ce38c_I20190628"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RleHRyZWdpb246YmU2YjZhNzQ2YmQ5NDE2NGI4MjJiMDhkOWE2YWUyMTJfMTI2NDQzODM3NDgwMDQ_7460cd2d-7391-483d-8903-fd55f8ddd7f6"
      unitRef="cad">16350000</cron:FinancingReceivableFaceAmount>
    <cron:FinancingReceivableFaceAmount
      contextRef="i4799e1f980174942a3388f2d435ce38c_I20190628"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RleHRyZWdpb246YmU2YjZhNzQ2YmQ5NDE2NGI4MjJiMDhkOWE2YWUyMTJfMTIwOTQ2Mjc5NDY1NjU_e2cc8e70-34f1-4961-9baa-b25e4838ac4e"
      unitRef="usd">12823000</cron:FinancingReceivableFaceAmount>
    <cron:FinancingReceivableInterestRateStatedPercentage
      contextRef="i4799e1f980174942a3388f2d435ce38c_I20190628"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RleHRyZWdpb246YmU2YjZhNzQ2YmQ5NDE2NGI4MjJiMDhkOWE2YWUyMTJfODI0NjMzNzI4OTMxNg_30bb264a-581a-4baa-8a04-ca58ee587c11"
      unitRef="number">0.0395</cron:FinancingReceivableInterestRateStatedPercentage>
    <cron:FinancingReceivableDueOnDemandTerm
      contextRef="i14e23009552044f48cea9a365ae91305_D20190628-20190628"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RleHRyZWdpb246YmU2YjZhNzQ2YmQ5NDE2NGI4MjJiMDhkOWE2YWUyMTJfODI0NjMzNzI4OTMyMw_677e1b2b-15f8-4190-91f0-2a1147d52da8">P90D</cron:FinancingReceivableDueOnDemandTerm>
    <cron:FinancingReceivableDueOnDemandIntendedDemandTermMinimum
      contextRef="i14e23009552044f48cea9a365ae91305_D20190628-20190628"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RleHRyZWdpb246YmU2YjZhNzQ2YmQ5NDE2NGI4MjJiMDhkOWE2YWUyMTJfODI0NjMzNzI4OTMzMQ_aed62d55-1877-4948-bb30-0f398113c274">P12M</cron:FinancingReceivableDueOnDemandIntendedDemandTermMinimum>
    <us-gaap:FinancingReceivableAllowanceForCreditLosses
      contextRef="ice5cd225a5a048c281f6386df823c5e3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RleHRyZWdpb246YmU2YjZhNzQ2YmQ5NDE2NGI4MjJiMDhkOWE2YWUyMTJfMTA5OTUxMTYzNjMyMQ_c4c84d7a-3fb0-4679-85bf-6203e774307f"
      unitRef="usd">259000</us-gaap:FinancingReceivableAllowanceForCreditLosses>
    <cron:CollaborativeArrangementAmountOfAdvances
      contextRef="if0ba41d1bbbd4426a1cae1e0e667c052_I20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RleHRyZWdpb246YmU2YjZhNzQ2YmQ5NDE2NGI4MjJiMDhkOWE2YWUyMTJfMTI2NDQzODM3NTQ0NjY_f14fe8dc-32f2-494c-bcb3-dfbcece41a36"
      unitRef="ils">8297000</cron:CollaborativeArrangementAmountOfAdvances>
    <cron:CollaborativeArrangementAmountOfAdvances
      contextRef="if0ba41d1bbbd4426a1cae1e0e667c052_I20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RleHRyZWdpb246YmU2YjZhNzQ2YmQ5NDE2NGI4MjJiMDhkOWE2YWUyMTJfMTI2NDQzODM3NTQ0OTg_9e13633c-d9e6-4233-852f-a1d158770210"
      unitRef="usd">2574000</cron:CollaborativeArrangementAmountOfAdvances>
    <cron:CollaborativeArrangementTermOfAgreement
      contextRef="i3b043767918a43bfb738d4382571bc3f_D20200401-20200401"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RleHRyZWdpb246YmU2YjZhNzQ2YmQ5NDE2NGI4MjJiMDhkOWE2YWUyMTJfODI0NjMzNzI4OTM0MQ_fadd8759-c5d4-47b9-a314-06688012dade">P2Y</cron:CollaborativeArrangementTermOfAgreement>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if0ba41d1bbbd4426a1cae1e0e667c052_I20200401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RleHRyZWdpb246YmU2YjZhNzQ2YmQ5NDE2NGI4MjJiMDhkOWE2YWUyMTJfMTI2NDQzODM3NTQ2MjU_87895d4e-e5eb-4322-ae3d-fe610a7bfa75"
      unitRef="number">0.035</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <cron:CollaborativeArrangementInstallmentsReceived
      contextRef="ia530bf80f98848218e4aca2d29c92f27_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RleHRyZWdpb246YmU2YjZhNzQ2YmQ5NDE2NGI4MjJiMDhkOWE2YWUyMTJfMTI2NDQzODM3NTQ2NDE_3dde2841-c3c9-428e-b1b8-0044d98c840d"
      unitRef="ils">4148000</cron:CollaborativeArrangementInstallmentsReceived>
    <cron:CollaborativeArrangementInstallmentsReceived
      contextRef="ia530bf80f98848218e4aca2d29c92f27_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RleHRyZWdpb246YmU2YjZhNzQ2YmQ5NDE2NGI4MjJiMDhkOWE2YWUyMTJfMTI2NDQzODM3NTQ2NTE_45f90fa9-74c4-404e-a07b-3fc9992420a9"
      unitRef="usd">1287000</cron:CollaborativeArrangementInstallmentsReceived>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="ia530bf80f98848218e4aca2d29c92f27_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF85Ny9mcmFnOmJlNmI2YTc0NmJkOTQxNjRiODIyYjA4ZDlhNmFlMjEyL3RleHRyZWdpb246YmU2YjZhNzQ2YmQ5NDE2NGI4MjJiMDhkOWE2YWUyMTJfMTIwOTQ2Mjc5NDg2MzY_c1180e44-7915-48f8-bfb3-531ca0d4e640"
      unitRef="usd">25000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMTUvZnJhZzo4YWMyMWQxOWNlZTM0NDM1YjJkZGE1ZDlkZDBjMjA5MS90ZXh0cmVnaW9uOjhhYzIxZDE5Y2VlMzQ0MzViMmRkYTVkOWRkMGMyMDkxXzE5Njc_41a662b6-6a2f-49cd-8172-1c193ef9c3ed">Loans Payable&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2020, the Company did not have any loans payable. On January 23, 2019, the Company entered into a credit agreement with the Canadian Imperial Bank of Commerce, as administrative agent and lender, and the Bank of Montreal, as lender, in respect of a C$65,000 ($48,715) secured non-revolving term loan credit facility (the &#x201c;Credit Facility&#x201d;). The loan was guaranteed by the Company&#x2019;s wholly owned Canadian subsidiaries and secured by substantially all present and after-acquired property of the Company and its wholly owned Canadian subsidiaries. The Company used the funds available under the Credit Facility to fully repay the construction loan payable, consisting of C$21,311 ($15,971) in loan principal and C$275 ($206) in accrued interest and fees, calculated for the period from January 1, 2019 to January 22, 2019. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 8, 2019, the Credit Facility was fully repaid. In connection with the Credit Facility, the Company incurred financing costs of C$523 ($395) which were expensed upon repayment of the Credit Facility.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="if184b5d95d6e4a88b9063285a8977d46_I20190123"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMTUvZnJhZzo4YWMyMWQxOWNlZTM0NDM1YjJkZGE1ZDlkZDBjMjA5MS90ZXh0cmVnaW9uOjhhYzIxZDE5Y2VlMzQ0MzViMmRkYTVkOWRkMGMyMDkxXzExMTg_6421964a-a41d-42c7-beea-20e633a510b0"
      unitRef="cad">65000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="if184b5d95d6e4a88b9063285a8977d46_I20190123"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMTUvZnJhZzo4YWMyMWQxOWNlZTM0NDM1YjJkZGE1ZDlkZDBjMjA5MS90ZXh0cmVnaW9uOjhhYzIxZDE5Y2VlMzQ0MzViMmRkYTVkOWRkMGMyMDkxXzExMjI_22851ef8-0e60-41cf-bfbe-9c47fe8cc25c"
      unitRef="usd">48715000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:RepaymentsOfSecuredDebt
      contextRef="if5da93e8c4dd43b293a795770578b760_D20190123-20190123"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMTUvZnJhZzo4YWMyMWQxOWNlZTM0NDM1YjJkZGE1ZDlkZDBjMjA5MS90ZXh0cmVnaW9uOjhhYzIxZDE5Y2VlMzQ0MzViMmRkYTVkOWRkMGMyMDkxXzE1MjY_17b26f95-6e55-4137-adb6-774707ec6351"
      unitRef="cad">21311000</us-gaap:RepaymentsOfSecuredDebt>
    <us-gaap:RepaymentsOfSecuredDebt
      contextRef="if5da93e8c4dd43b293a795770578b760_D20190123-20190123"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMTUvZnJhZzo4YWMyMWQxOWNlZTM0NDM1YjJkZGE1ZDlkZDBjMjA5MS90ZXh0cmVnaW9uOjhhYzIxZDE5Y2VlMzQ0MzViMmRkYTVkOWRkMGMyMDkxXzE1MzA_5d16b9af-3359-4e88-b1da-2defec268065"
      unitRef="usd">15971000</us-gaap:RepaymentsOfSecuredDebt>
    <us-gaap:InterestPaidCapitalized
      contextRef="if5da93e8c4dd43b293a795770578b760_D20190123-20190123"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMTUvZnJhZzo4YWMyMWQxOWNlZTM0NDM1YjJkZGE1ZDlkZDBjMjA5MS90ZXh0cmVnaW9uOjhhYzIxZDE5Y2VlMzQ0MzViMmRkYTVkOWRkMGMyMDkxXzE1NTY_bc084861-485a-4ad5-8239-882ee3361b56"
      unitRef="cad">275000</us-gaap:InterestPaidCapitalized>
    <us-gaap:InterestPaidCapitalized
      contextRef="if5da93e8c4dd43b293a795770578b760_D20190123-20190123"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMTUvZnJhZzo4YWMyMWQxOWNlZTM0NDM1YjJkZGE1ZDlkZDBjMjA5MS90ZXh0cmVnaW9uOjhhYzIxZDE5Y2VlMzQ0MzViMmRkYTVkOWRkMGMyMDkxXzE1NjA_e5134388-73e9-482c-b32d-56cc9b627b96"
      unitRef="usd">206000</us-gaap:InterestPaidCapitalized>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="ie5866afdb41147fba8fa4b3c1ae2fe9d_I20190308"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMTUvZnJhZzo4YWMyMWQxOWNlZTM0NDM1YjJkZGE1ZDlkZDBjMjA5MS90ZXh0cmVnaW9uOjhhYzIxZDE5Y2VlMzQ0MzViMmRkYTVkOWRkMGMyMDkxXzM4NDgyOTA3MDQwOTE_ab4fc785-fe11-4c74-9a3d-29e360ebc0aa"
      unitRef="cad">523000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="ie5866afdb41147fba8fa4b3c1ae2fe9d_I20190308"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMTUvZnJhZzo4YWMyMWQxOWNlZTM0NDM1YjJkZGE1ZDlkZDBjMjA5MS90ZXh0cmVnaW9uOjhhYzIxZDE5Y2VlMzQ0MzViMmRkYTVkOWRkMGMyMDkxXzM4NDgyOTA3MDQwMjc_b87b05d0-438f-4a95-b2ce-45b067b94c82"
      unitRef="usd">395000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjEvZnJhZzo5MGQwNzYyMDVjMjg0MmYwOTA2MjA0NzA4MWZiYzY5Ny90ZXh0cmVnaW9uOjkwZDA3NjIwNWMyODQyZjA5MDYyMDQ3MDgxZmJjNjk3XzU5MQ_c4c076ea-eacb-4cf0-99b1-8309b429d9b1">Property, Plant and Equipment&lt;div style="margin-bottom:6pt;padding-left:29.25pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment, net consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.261%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149,690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(18,295)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,745)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation expense included in costs of sales relating to manufacturing equipment and production facilities for the year ended December&#160;31, 2020 was $3,447 (December&#160;31, 2019 &#x2013; $1,812; 2018 &#x2013; $374). Depreciation expense included in operating expenses related to general office space and equipment for the year ended December&#160;31, 2020 was $2,058 (December&#160;31, 2019 &#x2013; $1,444; 2018 &#x2013; $261). The remaining depreciation is included in inventory. &lt;/span&gt;&lt;/div&gt;For the year ended December&#160;31, 2020, there was no capitalized interest included in construction in progress (2019 &#x2013; $nil; 2018 &#x2013;$89).</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i6db5a3fb2eca4f54b3f90ed1c036dd12_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjEvZnJhZzo5MGQwNzYyMDVjMjg0MmYwOTA2MjA0NzA4MWZiYzY5Ny90YWJsZTpkNTllYjExNzI0OWE0ZmUxOTY2YzVkOWFmNWJhNzRhNi90YWJsZXJhbmdlOmQ1OWViMTE3MjQ5YTRmZTE5NjZjNWQ5YWY1YmE3NGE2XzMtMi0xLTEtMA_1e68b3a8-98aa-425e-a43d-395509d2b2a2"
      unitRef="usd">3197000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i77c5346ffc2148c0ac4a76f63497a058_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjEvZnJhZzo5MGQwNzYyMDVjMjg0MmYwOTA2MjA0NzA4MWZiYzY5Ny90YWJsZTpkNTllYjExNzI0OWE0ZmUxOTY2YzVkOWFmNWJhNzRhNi90YWJsZXJhbmdlOmQ1OWViMTE3MjQ5YTRmZTE5NjZjNWQ5YWY1YmE3NGE2XzMtNS0xLTEtMA_f59da546-2c85-4edd-a0bd-aa7f8da62b9b"
      unitRef="usd">3071000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ie4bd7ce9c19347cdabdc7ac598cb48de_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjEvZnJhZzo5MGQwNzYyMDVjMjg0MmYwOTA2MjA0NzA4MWZiYzY5Ny90YWJsZTpkNTllYjExNzI0OWE0ZmUxOTY2YzVkOWFmNWJhNzRhNi90YWJsZXJhbmdlOmQ1OWViMTE3MjQ5YTRmZTE5NjZjNWQ5YWY1YmE3NGE2XzQtMi0xLTEtMA_970bea1b-ed5c-4b93-a4b5-c5b76d1c6245"
      unitRef="usd">158586000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i7b7a48365daf408b8997db5c9fdc8a02_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjEvZnJhZzo5MGQwNzYyMDVjMjg0MmYwOTA2MjA0NzA4MWZiYzY5Ny90YWJsZTpkNTllYjExNzI0OWE0ZmUxOTY2YzVkOWFmNWJhNzRhNi90YWJsZXJhbmdlOmQ1OWViMTE3MjQ5YTRmZTE5NjZjNWQ5YWY1YmE3NGE2XzQtNS0xLTEtMA_b2bdeb6a-272f-49b3-a047-71bdb303b437"
      unitRef="usd">149690000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i43d67eea34364b749f11c14c15ff8a38_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjEvZnJhZzo5MGQwNzYyMDVjMjg0MmYwOTA2MjA0NzA4MWZiYzY5Ny90YWJsZTpkNTllYjExNzI0OWE0ZmUxOTY2YzVkOWFmNWJhNzRhNi90YWJsZXJhbmdlOmQ1OWViMTE3MjQ5YTRmZTE5NjZjNWQ5YWY1YmE3NGE2XzUtMi0xLTEtMA_2ed5a38b-e9b5-48c5-ae21-b7f3077e1420"
      unitRef="usd">18824000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i6d514a8da3584157b13f718b5294267b_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjEvZnJhZzo5MGQwNzYyMDVjMjg0MmYwOTA2MjA0NzA4MWZiYzY5Ny90YWJsZTpkNTllYjExNzI0OWE0ZmUxOTY2YzVkOWFmNWJhNzRhNi90YWJsZXJhbmdlOmQ1OWViMTE3MjQ5YTRmZTE5NjZjNWQ5YWY1YmE3NGE2XzUtNS0xLTEtMA_97ec14c6-9a89-4992-a7c0-61cb6afab2fa"
      unitRef="usd">10079000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i03c20e15ec0844f8b17b6c80bb9144ce_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjEvZnJhZzo5MGQwNzYyMDVjMjg0MmYwOTA2MjA0NzA4MWZiYzY5Ny90YWJsZTpkNTllYjExNzI0OWE0ZmUxOTY2YzVkOWFmNWJhNzRhNi90YWJsZXJhbmdlOmQ1OWViMTE3MjQ5YTRmZTE5NjZjNWQ5YWY1YmE3NGE2XzYtMi0xLTEtMA_d3060a32-ee74-4da6-b292-a2c87371aebe"
      unitRef="usd">710000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i4d68a5e2b3a0451ab19ab24066e538cd_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjEvZnJhZzo5MGQwNzYyMDVjMjg0MmYwOTA2MjA0NzA4MWZiYzY5Ny90YWJsZTpkNTllYjExNzI0OWE0ZmUxOTY2YzVkOWFmNWJhNzRhNi90YWJsZXJhbmdlOmQ1OWViMTE3MjQ5YTRmZTE5NjZjNWQ5YWY1YmE3NGE2XzYtNS0xLTEtMA_4f37d3dd-e6ea-4dc5-970d-ce59ea9f8497"
      unitRef="usd">526000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i78a071bcbe99463dbb1b5de598353925_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjEvZnJhZzo5MGQwNzYyMDVjMjg0MmYwOTA2MjA0NzA4MWZiYzY5Ny90YWJsZTpkNTllYjExNzI0OWE0ZmUxOTY2YzVkOWFmNWJhNzRhNi90YWJsZXJhbmdlOmQ1OWViMTE3MjQ5YTRmZTE5NjZjNWQ5YWY1YmE3NGE2XzctMi0xLTEtMA_07fda812-5fbe-4404-9ddd-e3c0f53c2d0f"
      unitRef="usd">3740000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i4486ec909cf8480e89364e36b9c8e464_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjEvZnJhZzo5MGQwNzYyMDVjMjg0MmYwOTA2MjA0NzA4MWZiYzY5Ny90YWJsZTpkNTllYjExNzI0OWE0ZmUxOTY2YzVkOWFmNWJhNzRhNi90YWJsZXJhbmdlOmQ1OWViMTE3MjQ5YTRmZTE5NjZjNWQ5YWY1YmE3NGE2XzctNS0xLTEtMA_f20103ed-b06f-404b-93ac-d0585bbc3195"
      unitRef="usd">1758000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ie7d7511be19f4566915140061bc540f6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjEvZnJhZzo5MGQwNzYyMDVjMjg0MmYwOTA2MjA0NzA4MWZiYzY5Ny90YWJsZTpkNTllYjExNzI0OWE0ZmUxOTY2YzVkOWFmNWJhNzRhNi90YWJsZXJhbmdlOmQ1OWViMTE3MjQ5YTRmZTE5NjZjNWQ5YWY1YmE3NGE2XzgtMi0xLTEtMA_64010529-fe75-4acf-ab9d-943b3722be22"
      unitRef="usd">20837000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i31a70e4a512044509cf0a927b6ac5a19_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjEvZnJhZzo5MGQwNzYyMDVjMjg0MmYwOTA2MjA0NzA4MWZiYzY5Ny90YWJsZTpkNTllYjExNzI0OWE0ZmUxOTY2YzVkOWFmNWJhNzRhNi90YWJsZXJhbmdlOmQ1OWViMTE3MjQ5YTRmZTE5NjZjNWQ5YWY1YmE3NGE2XzgtNS0xLTEtMA_7e75c5c5-6dfe-4ecd-9765-88a94b658d92"
      unitRef="usd">3569000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjEvZnJhZzo5MGQwNzYyMDVjMjg0MmYwOTA2MjA0NzA4MWZiYzY5Ny90YWJsZTpkNTllYjExNzI0OWE0ZmUxOTY2YzVkOWFmNWJhNzRhNi90YWJsZXJhbmdlOmQ1OWViMTE3MjQ5YTRmZTE5NjZjNWQ5YWY1YmE3NGE2XzktMi0xLTEtMA_3c5b75ff-532a-4185-be9a-304fbe45fcdb"
      unitRef="usd">18295000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjEvZnJhZzo5MGQwNzYyMDVjMjg0MmYwOTA2MjA0NzA4MWZiYzY5Ny90YWJsZTpkNTllYjExNzI0OWE0ZmUxOTY2YzVkOWFmNWJhNzRhNi90YWJsZXJhbmdlOmQ1OWViMTE3MjQ5YTRmZTE5NjZjNWQ5YWY1YmE3NGE2XzktNS0xLTEtMA_1498665e-bf4d-41c7-b162-94c95a2d4e2f"
      unitRef="usd">8745000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjEvZnJhZzo5MGQwNzYyMDVjMjg0MmYwOTA2MjA0NzA4MWZiYzY5Ny90YWJsZTpkNTllYjExNzI0OWE0ZmUxOTY2YzVkOWFmNWJhNzRhNi90YWJsZXJhbmdlOmQ1OWViMTE3MjQ5YTRmZTE5NjZjNWQ5YWY1YmE3NGE2XzEwLTItMS0xLTA_1ac88188-a7cc-4c4c-86b7-21056a0f9b5d"
      unitRef="usd">187599000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjEvZnJhZzo5MGQwNzYyMDVjMjg0MmYwOTA2MjA0NzA4MWZiYzY5Ny90YWJsZTpkNTllYjExNzI0OWE0ZmUxOTY2YzVkOWFmNWJhNzRhNi90YWJsZXJhbmdlOmQ1OWViMTE3MjQ5YTRmZTE5NjZjNWQ5YWY1YmE3NGE2XzEwLTUtMS0xLTA_62da9015-db9e-40b9-a9a7-f622d75a2d46"
      unitRef="usd">159948000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:CostOfGoodsAndServicesSoldDepreciation
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjEvZnJhZzo5MGQwNzYyMDVjMjg0MmYwOTA2MjA0NzA4MWZiYzY5Ny90ZXh0cmVnaW9uOjkwZDA3NjIwNWMyODQyZjA5MDYyMDQ3MDgxZmJjNjk3XzI0NA_76c0c60b-a616-4d85-b141-fe8bb07ef908"
      unitRef="usd">3447000</us-gaap:CostOfGoodsAndServicesSoldDepreciation>
    <us-gaap:CostOfGoodsAndServicesSoldDepreciation
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjEvZnJhZzo5MGQwNzYyMDVjMjg0MmYwOTA2MjA0NzA4MWZiYzY5Ny90ZXh0cmVnaW9uOjkwZDA3NjIwNWMyODQyZjA5MDYyMDQ3MDgxZmJjNjk3XzI1Ng_87ebb27c-6004-427d-aa98-651cab906fe8"
      unitRef="usd">1812000</us-gaap:CostOfGoodsAndServicesSoldDepreciation>
    <us-gaap:CostOfGoodsAndServicesSoldDepreciation
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjEvZnJhZzo5MGQwNzYyMDVjMjg0MmYwOTA2MjA0NzA4MWZiYzY5Ny90ZXh0cmVnaW9uOjkwZDA3NjIwNWMyODQyZjA5MDYyMDQ3MDgxZmJjNjk3XzEyMDk0NjI3OTA2MzM1_d8589981-07ac-410e-adde-6f3de3e21b3a"
      unitRef="usd">374000</us-gaap:CostOfGoodsAndServicesSoldDepreciation>
    <us-gaap:DepreciationNonproduction
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjEvZnJhZzo5MGQwNzYyMDVjMjg0MmYwOTA2MjA0NzA4MWZiYzY5Ny90ZXh0cmVnaW9uOjkwZDA3NjIwNWMyODQyZjA5MDYyMDQ3MDgxZmJjNjk3XzEyMDk0NjI3OTA3NDU1_161a2e72-b298-4c12-9d24-e5dabac631b3"
      unitRef="usd">2058000</us-gaap:DepreciationNonproduction>
    <us-gaap:DepreciationNonproduction
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjEvZnJhZzo5MGQwNzYyMDVjMjg0MmYwOTA2MjA0NzA4MWZiYzY5Ny90ZXh0cmVnaW9uOjkwZDA3NjIwNWMyODQyZjA5MDYyMDQ3MDgxZmJjNjk3XzQxMQ_3dd25d77-91ca-45ad-bf49-9cc04ed7a579"
      unitRef="usd">1444000</us-gaap:DepreciationNonproduction>
    <us-gaap:DepreciationNonproduction
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjEvZnJhZzo5MGQwNzYyMDVjMjg0MmYwOTA2MjA0NzA4MWZiYzY5Ny90ZXh0cmVnaW9uOjkwZDA3NjIwNWMyODQyZjA5MDYyMDQ3MDgxZmJjNjk3XzEyMDk0NjI3OTA2MzQy_ffd6d075-5185-4191-9a4a-717acb089328"
      unitRef="usd">261000</us-gaap:DepreciationNonproduction>
    <us-gaap:InterestCostsCapitalized
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjEvZnJhZzo5MGQwNzYyMDVjMjg0MmYwOTA2MjA0NzA4MWZiYzY5Ny90ZXh0cmVnaW9uOjkwZDA3NjIwNWMyODQyZjA5MDYyMDQ3MDgxZmJjNjk3XzEyMDk0NjI3OTA2MjEy_50fa44e9-890e-4499-8488-3649e7440328"
      unitRef="usd">0</us-gaap:InterestCostsCapitalized>
    <us-gaap:InterestCostsCapitalized
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjEvZnJhZzo5MGQwNzYyMDVjMjg0MmYwOTA2MjA0NzA4MWZiYzY5Ny90ZXh0cmVnaW9uOjkwZDA3NjIwNWMyODQyZjA5MDYyMDQ3MDgxZmJjNjk3XzEyMDk0NjI3OTA2MjY0_11b624d4-5e20-445d-856d-3f7f240ed756"
      unitRef="usd">0</us-gaap:InterestCostsCapitalized>
    <us-gaap:InterestCostsCapitalized
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjEvZnJhZzo5MGQwNzYyMDVjMjg0MmYwOTA2MjA0NzA4MWZiYzY5Ny90ZXh0cmVnaW9uOjkwZDA3NjIwNWMyODQyZjA5MDYyMDQ3MDgxZmJjNjk3XzEyMDk0NjI3OTA2MzU1_f423f72a-142a-42b6-8b23-e43cd0190407"
      unitRef="usd">89000</us-gaap:InterestCostsCapitalized>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90ZXh0cmVnaW9uOjVjYjg1MDFiMmY3NTRlMjdiOWVmZDM0NTA5Y2Q0ODk4XzgwMQ_8a0ffa7a-644e-428f-9a65-520032f04028">Intangible Assets and Goodwill &lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The ongoing restrictions and closures experienced by retail stores in the U.S. as a result of the COVID-19 pandemic have negatively impacted sales and demand which has resulted in slower than expected revenue growth in the U.S. reporting unit. The Company expects the revenue growth and operating results in the U.S. reporting unit to continue to be negatively impacted as the decrease in customer demand and retail closures are expected to continue as a result of the pandemic. The Company performed an interim impairment test as of June 30, 2020 on the U.S. reporting unit, which holds the Redwood goodwill, as well as the indefinite-lived intangible asset (Lord Jones&#x2122; brand) to determine whether the carrying amount of the reporting unit and intangible asset exceeded their respective fair values. The Company reassessed its estimates and forecasts during the second quarter of 2020 to determine the fair values of the reporting unit and intangible asset. The fair values were determined using a discounted cash flow method on the reporting unit and the relief-from-royalty method on the Lord Jones&#x2122; brand. Significant inputs include discount rate, growth rates, and cash flow projections. Based on these valuations, the carrying value exceeded the fair value resulting in an impairment on both the reporting unit as well as the Lord Jones&#x2122; brand. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded $35,000 of impairment charges on the U.S. reporting unit and $5,000 of impairment charges on the Lord Jones&#x2122; brand during year ended December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt"&gt;Intangible assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets are comprised of the following items: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.834%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.051%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.000%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.000%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.000%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted average amortization period (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(291)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ERP system&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(274)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health Canada licenses &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,254)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lord Jones&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;TM&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; brand&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Israeli codes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,841)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt"&gt;The Israeli codes were transferred by non-controlling interests to Cronos Israel in exchange for their equity interests in the Cronos Israel entities specified above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.722%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.852%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.827%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.827%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.830%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt 0 5.5pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted average amortization period (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(202)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health Canada licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(821)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lord Jones&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;TM&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; brand&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Israeli codes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,027)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt"&gt;The Israeli codes were transferred by non-controlling interests to Cronos Israel in exchange for their equity interests in the Cronos Israel entities specified above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The aggregate amortization was $814 for the year ended December 31, 2020 (December&#160;31, 2019 &#x2013; $646; 2018 &#x2013; $546). Intangible asset additions in 2020 primarily relate to the implementation of a new ERP system. Intangible asset additions in the year ended December&#160;31, 2019 included the Lord Jones&#x2122; brand for $64 million.&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; There were no material disposals of intangible assets in 2020 or 2019. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amortization expense for the next five years on intangible assets in use is estimated to be as follows: 2021 &#x2013; $1,047; 2022 &#x2013; $998; 2023: $964; 2024 &#x2013; $952; 2025 &#x2013; $664. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.722%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.273%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.827%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.966%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.832%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effect of foreign exchange&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Peace Naturals&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redwood&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i3d156ad77f3343718374ed5a6b20465b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90ZXh0cmVnaW9uOjVjYjg1MDFiMmY3NTRlMjdiOWVmZDM0NTA5Y2Q0ODk4XzYwNDczMTM5NTgyNTQ_9388ef7c-6b26-4f9c-a65c-1136a80022d8"
      unitRef="usd">35000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="ib956a338fe1b4ef1a233bc83863cd2d7_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90ZXh0cmVnaW9uOjVjYjg1MDFiMmY3NTRlMjdiOWVmZDM0NTA5Y2Q0ODk4XzYwNDczMTM5NTgyNjI_667b95ee-7585-49a2-b105-3580dc84c7c0"
      unitRef="usd">5000000</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90ZXh0cmVnaW9uOjVjYjg1MDFiMmY3NTRlMjdiOWVmZDM0NTA5Y2Q0ODk4XzgwMw_783a1e81-4bc1-4b15-9ed1-82ccbc72dca2">&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets are comprised of the following items: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.834%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.051%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.000%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.000%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.000%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted average amortization period (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(291)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ERP system&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(274)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health Canada licenses &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,254)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lord Jones&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;TM&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; brand&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Israeli codes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,841)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt"&gt;The Israeli codes were transferred by non-controlling interests to Cronos Israel in exchange for their equity interests in the Cronos Israel entities specified above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.722%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.852%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.827%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.827%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.830%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt 0 5.5pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted average amortization period (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:20pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(202)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health Canada licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(821)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lord Jones&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;TM&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; brand&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Israeli codes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,027)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt"&gt;The Israeli codes were transferred by non-controlling interests to Cronos Israel in exchange for their equity interests in the Cronos Israel entities specified above.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ie2c359ba7b8e4d8cbaea40e6357f543e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTo3NzI0ZTg2M2M3NDM0OTY0OGZkNWJhMGRmNmMzZGE4My90YWJsZXJhbmdlOjc3MjRlODYzYzc0MzQ5NjQ4ZmQ1YmEwZGY2YzNkYTgzXzMtMS0xLTEtMjA0NTU_94a0d0a0-c6a0-4b44-ae31-71f71584fbe0">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i98f184049ae04decbb7e65d448f5eb64_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTo3NzI0ZTg2M2M3NDM0OTY0OGZkNWJhMGRmNmMzZGE4My90YWJsZXJhbmdlOjc3MjRlODYzYzc0MzQ5NjQ4ZmQ1YmEwZGY2YzNkYTgzXzMtMi0xLTEtMjA1MDM_12274dfc-6878-438a-a038-00c76d72bcf3"
      unitRef="usd">610000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i98f184049ae04decbb7e65d448f5eb64_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTo3NzI0ZTg2M2M3NDM0OTY0OGZkNWJhMGRmNmMzZGE4My90YWJsZXJhbmdlOjc3MjRlODYzYzc0MzQ5NjQ4ZmQ1YmEwZGY2YzNkYTgzXzMtNC0xLTEtMjA1MDM_63692fa4-591b-4346-a526-bc14046655dc"
      unitRef="usd">291000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i98f184049ae04decbb7e65d448f5eb64_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTo3NzI0ZTg2M2M3NDM0OTY0OGZkNWJhMGRmNmMzZGE4My90YWJsZXJhbmdlOjc3MjRlODYzYzc0MzQ5NjQ4ZmQ1YmEwZGY2YzNkYTgzXzMtOC0xLTEtMjA1MDM_19986b0a-536d-4fbc-8da5-c6fb84accfcc"
      unitRef="usd">319000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i375653de490b4cb88d420b09780d16c9_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTo3NzI0ZTg2M2M3NDM0OTY0OGZkNWJhMGRmNmMzZGE4My90YWJsZXJhbmdlOjc3MjRlODYzYzc0MzQ5NjQ4ZmQ1YmEwZGY2YzNkYTgzXzQtMS0xLTEtMjA0NTU_643dd42c-cf13-4421-a9c3-cacd34e98b27">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i08692c3f18fd499fb735fa6f9fa77a18_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTo3NzI0ZTg2M2M3NDM0OTY0OGZkNWJhMGRmNmMzZGE4My90YWJsZXJhbmdlOjc3MjRlODYzYzc0MzQ5NjQ4ZmQ1YmEwZGY2YzNkYTgzXzQtMi0xLTEtMjA1MDM_0ea6cb62-0fd7-46b9-b0e4-e4f688d2a8f7"
      unitRef="usd">3955000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i08692c3f18fd499fb735fa6f9fa77a18_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTo3NzI0ZTg2M2M3NDM0OTY0OGZkNWJhMGRmNmMzZGE4My90YWJsZXJhbmdlOjc3MjRlODYzYzc0MzQ5NjQ4ZmQ1YmEwZGY2YzNkYTgzXzQtNC0xLTEtMjA1MDM_a396935f-a363-4918-952f-8925e85b436e"
      unitRef="usd">274000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i08692c3f18fd499fb735fa6f9fa77a18_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTo3NzI0ZTg2M2M3NDM0OTY0OGZkNWJhMGRmNmMzZGE4My90YWJsZXJhbmdlOjc3MjRlODYzYzc0MzQ5NjQ4ZmQ1YmEwZGY2YzNkYTgzXzQtOC0xLTEtMjA1MDM_81c2635c-541d-4fad-92ee-83d1d502c1d8"
      unitRef="usd">3681000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="id267d45c88934cce96716b0f18048fbe_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTo3NzI0ZTg2M2M3NDM0OTY0OGZkNWJhMGRmNmMzZGE4My90YWJsZXJhbmdlOjc3MjRlODYzYzc0MzQ5NjQ4ZmQ1YmEwZGY2YzNkYTgzXzUtMS0xLTEtMjA0NTU_58768597-b98e-4390-a293-e4c25c85be38">P17Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i9aeeb3005af2414fbdd7f3f51ba719bb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTo3NzI0ZTg2M2M3NDM0OTY0OGZkNWJhMGRmNmMzZGE4My90YWJsZXJhbmdlOjc3MjRlODYzYzc0MzQ5NjQ4ZmQ1YmEwZGY2YzNkYTgzXzUtMi0xLTEtMjA1MDM_c05b4aa7-a07b-4d02-9aa6-e866882076e9"
      unitRef="usd">7526000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i9aeeb3005af2414fbdd7f3f51ba719bb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTo3NzI0ZTg2M2M3NDM0OTY0OGZkNWJhMGRmNmMzZGE4My90YWJsZXJhbmdlOjc3MjRlODYzYzc0MzQ5NjQ4ZmQ1YmEwZGY2YzNkYTgzXzUtNC0xLTEtMjA1MDM_a78c749d-5133-4128-9f33-d343820b0798"
      unitRef="usd">1254000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i9aeeb3005af2414fbdd7f3f51ba719bb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTo3NzI0ZTg2M2M3NDM0OTY0OGZkNWJhMGRmNmMzZGE4My90YWJsZXJhbmdlOjc3MjRlODYzYzc0MzQ5NjQ4ZmQ1YmEwZGY2YzNkYTgzXzUtOC0xLTEtMjA1MDM_0ae96684-55c9-4daf-94af-a37bde9f2d8b"
      unitRef="usd">6272000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="ibad4f60fad3c4471be8a1d5e1b4b06a2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTo3NzI0ZTg2M2M3NDM0OTY0OGZkNWJhMGRmNmMzZGE4My90YWJsZXJhbmdlOjc3MjRlODYzYzc0MzQ5NjQ4ZmQ1YmEwZGY2YzNkYTgzXzYtMi0xLTEtMjA1MDM_218d5a1f-fe9a-4f6e-9f71-2bf3b75dedec"
      unitRef="usd">64000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <cron:IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment
      contextRef="ibad4f60fad3c4471be8a1d5e1b4b06a2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTo3NzI0ZTg2M2M3NDM0OTY0OGZkNWJhMGRmNmMzZGE4My90YWJsZXJhbmdlOjc3MjRlODYzYzc0MzQ5NjQ4ZmQ1YmEwZGY2YzNkYTgzXzYtNi0xLTEtMjA1MDM_8dd633a1-c236-4485-bb1e-7c2dcf543c15"
      unitRef="usd">5000000</cron:IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ibad4f60fad3c4471be8a1d5e1b4b06a2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTo3NzI0ZTg2M2M3NDM0OTY0OGZkNWJhMGRmNmMzZGE4My90YWJsZXJhbmdlOjc3MjRlODYzYzc0MzQ5NjQ4ZmQ1YmEwZGY2YzNkYTgzXzYtOC0xLTEtMjA1MDM_b445e1c2-c37e-425d-ade8-6ebc301cfc5a"
      unitRef="usd">59000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="ibae3047412c74ad68bb7c95a00bd81b4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTo3NzI0ZTg2M2M3NDM0OTY0OGZkNWJhMGRmNmMzZGE4My90YWJsZXJhbmdlOjc3MjRlODYzYzc0MzQ5NjQ4ZmQ1YmEwZGY2YzNkYTgzXzctMi0xLTEtMjA1MDM_435fda10-b8d7-4224-a1d3-65cb896b72aa"
      unitRef="usd">148000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ibae3047412c74ad68bb7c95a00bd81b4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTo3NzI0ZTg2M2M3NDM0OTY0OGZkNWJhMGRmNmMzZGE4My90YWJsZXJhbmdlOjc3MjRlODYzYzc0MzQ5NjQ4ZmQ1YmEwZGY2YzNkYTgzXzctOC0xLTEtMjA1MDM_d742aabb-e2fb-407e-b414-704992fdece4"
      unitRef="usd">148000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ib297b22398ba4d26b972d07a65be9bdc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTo3NzI0ZTg2M2M3NDM0OTY0OGZkNWJhMGRmNmMzZGE4My90YWJsZXJhbmdlOjc3MjRlODYzYzc0MzQ5NjQ4ZmQ1YmEwZGY2YzNkYTgzXzgtMS0xLTEtMjA0NTU_7f52dde1-80d4-4a9e-bef5-7843809b2679">P25Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ib5d86bf348094cd8bbbbd47d7e3b937d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTo3NzI0ZTg2M2M3NDM0OTY0OGZkNWJhMGRmNmMzZGE4My90YWJsZXJhbmdlOjc3MjRlODYzYzc0MzQ5NjQ4ZmQ1YmEwZGY2YzNkYTgzXzgtMi0xLTEtMjA1MDM_25a132f5-8506-4c5a-9a56-0d8c69b6346c"
      unitRef="usd">322000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ib5d86bf348094cd8bbbbd47d7e3b937d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTo3NzI0ZTg2M2M3NDM0OTY0OGZkNWJhMGRmNmMzZGE4My90YWJsZXJhbmdlOjc3MjRlODYzYzc0MzQ5NjQ4ZmQ1YmEwZGY2YzNkYTgzXzgtNS0xLTEtMjM3MDc_28f7d15b-c2ab-4000-8b08-7990c2060403"
      unitRef="usd">22000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ib5d86bf348094cd8bbbbd47d7e3b937d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTo3NzI0ZTg2M2M3NDM0OTY0OGZkNWJhMGRmNmMzZGE4My90YWJsZXJhbmdlOjc3MjRlODYzYzc0MzQ5NjQ4ZmQ1YmEwZGY2YzNkYTgzXzgtOC0xLTEtMjA1MDM_064f549e-2a38-47b0-ab75-3812f85868c0"
      unitRef="usd">300000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTo3NzI0ZTg2M2M3NDM0OTY0OGZkNWJhMGRmNmMzZGE4My90YWJsZXJhbmdlOjc3MjRlODYzYzc0MzQ5NjQ4ZmQ1YmEwZGY2YzNkYTgzXzktMi0xLTEtMjA1MDM_d20e0b3e-b520-417b-ab40-d41ebdba7ea7"
      unitRef="usd">76561000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTo3NzI0ZTg2M2M3NDM0OTY0OGZkNWJhMGRmNmMzZGE4My90YWJsZXJhbmdlOjc3MjRlODYzYzc0MzQ5NjQ4ZmQ1YmEwZGY2YzNkYTgzXzktNC0xLTEtMjA1MDM_32a77a19-8d94-43a1-b498-bf56092e5f83"
      unitRef="usd">1841000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <cron:IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTo3NzI0ZTg2M2M3NDM0OTY0OGZkNWJhMGRmNmMzZGE4My90YWJsZXJhbmdlOjc3MjRlODYzYzc0MzQ5NjQ4ZmQ1YmEwZGY2YzNkYTgzXzktNi0xLTEtMjA1MDM_4ebb214d-c816-4968-be6d-4a0a63b3200e"
      unitRef="usd">5000000</cron:IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTo3NzI0ZTg2M2M3NDM0OTY0OGZkNWJhMGRmNmMzZGE4My90YWJsZXJhbmdlOjc3MjRlODYzYzc0MzQ5NjQ4ZmQ1YmEwZGY2YzNkYTgzXzktOC0xLTEtMjA1MDM_4a0f237e-3a04-411c-898c-f10435dbc684"
      unitRef="usd">69720000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i44555a708248410d80d185e52bcf7004_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTpkMTc3OGIyMDliZDA0NDBjYjI1ZDAwMmZiZDBlYmU1MC90YWJsZXJhbmdlOmQxNzc4YjIwOWJkMDQ0MGNiMjVkMDAyZmJkMGViZTUwXzMtMS0xLTEtMjA1NjU_a75a9b8d-91af-43e5-9d9d-abc210ef28da">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i279d9d5ab1e349069775769d0b1a44cd_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTpkMTc3OGIyMDliZDA0NDBjYjI1ZDAwMmZiZDBlYmU1MC90YWJsZXJhbmdlOmQxNzc4YjIwOWJkMDQ0MGNiMjVkMDAyZmJkMGViZTUwXzMtMy0xLTEtMjA1NzU_d8be66a4-045e-45d4-9974-eef32fa012a1"
      unitRef="usd">541000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i279d9d5ab1e349069775769d0b1a44cd_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTpkMTc3OGIyMDliZDA0NDBjYjI1ZDAwMmZiZDBlYmU1MC90YWJsZXJhbmdlOmQxNzc4YjIwOWJkMDQ0MGNiMjVkMDAyZmJkMGViZTUwXzMtNS0xLTEtMjA1NzU_701c0b8c-677e-4625-9564-003556e7c021"
      unitRef="usd">202000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i279d9d5ab1e349069775769d0b1a44cd_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTpkMTc3OGIyMDliZDA0NDBjYjI1ZDAwMmZiZDBlYmU1MC90YWJsZXJhbmdlOmQxNzc4YjIwOWJkMDQ0MGNiMjVkMDAyZmJkMGViZTUwXzMtNy0xLTEtMjA1NzU_da433f93-fcf7-4414-b3b3-30409647a6df"
      unitRef="usd">339000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i82c727c670f445f4ab85163fb46012f1_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTpkMTc3OGIyMDliZDA0NDBjYjI1ZDAwMmZiZDBlYmU1MC90YWJsZXJhbmdlOmQxNzc4YjIwOWJkMDQ0MGNiMjVkMDAyZmJkMGViZTUwXzUtMS0xLTEtMjA1NjU_dd38539f-59e2-4c18-9929-7f13205e8ef3">P17Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i921bbe51679241a68d142cd32305f8a5_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTpkMTc3OGIyMDliZDA0NDBjYjI1ZDAwMmZiZDBlYmU1MC90YWJsZXJhbmdlOmQxNzc4YjIwOWJkMDQ0MGNiMjVkMDAyZmJkMGViZTUwXzUtMy0xLTEtMjA1NzU_dd56aae9-3b4d-4a3f-bd7a-fe3829eb13da"
      unitRef="usd">7387000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i921bbe51679241a68d142cd32305f8a5_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTpkMTc3OGIyMDliZDA0NDBjYjI1ZDAwMmZiZDBlYmU1MC90YWJsZXJhbmdlOmQxNzc4YjIwOWJkMDQ0MGNiMjVkMDAyZmJkMGViZTUwXzUtNS0xLTEtMjA1NzU_c87c176a-f122-45ed-9020-816e208b9917"
      unitRef="usd">821000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i921bbe51679241a68d142cd32305f8a5_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTpkMTc3OGIyMDliZDA0NDBjYjI1ZDAwMmZiZDBlYmU1MC90YWJsZXJhbmdlOmQxNzc4YjIwOWJkMDQ0MGNiMjVkMDAyZmJkMGViZTUwXzUtNy0xLTEtMjA1NzU_b0175a94-d136-4135-a532-2af139e68ee7"
      unitRef="usd">6566000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i708ebd12fa8d48aeaf171672ac0bad61_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTpkMTc3OGIyMDliZDA0NDBjYjI1ZDAwMmZiZDBlYmU1MC90YWJsZXJhbmdlOmQxNzc4YjIwOWJkMDQ0MGNiMjVkMDAyZmJkMGViZTUwXzYtMy0xLTEtMjA1NzU_c43344f5-0e21-4e26-914c-70cc41c47f89"
      unitRef="usd">64000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i708ebd12fa8d48aeaf171672ac0bad61_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTpkMTc3OGIyMDliZDA0NDBjYjI1ZDAwMmZiZDBlYmU1MC90YWJsZXJhbmdlOmQxNzc4YjIwOWJkMDQ0MGNiMjVkMDAyZmJkMGViZTUwXzYtNy0xLTEtMjA1NzU_3105cf6d-9c15-42a6-9db6-012e2fe27291"
      unitRef="usd">64000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i77ad87a86ffb4a1c94f873eac114b479_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTpkMTc3OGIyMDliZDA0NDBjYjI1ZDAwMmZiZDBlYmU1MC90YWJsZXJhbmdlOmQxNzc4YjIwOWJkMDQ0MGNiMjVkMDAyZmJkMGViZTUwXzctMy0xLTEtMjA1NzU_bab996bd-13b5-4073-bc07-0ad8d572c798"
      unitRef="usd">36000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i77ad87a86ffb4a1c94f873eac114b479_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTpkMTc3OGIyMDliZDA0NDBjYjI1ZDAwMmZiZDBlYmU1MC90YWJsZXJhbmdlOmQxNzc4YjIwOWJkMDQ0MGNiMjVkMDAyZmJkMGViZTUwXzctNy0xLTEtMjA1NzU_5a7fcb31-d872-4f82-b002-62fc20b2de56"
      unitRef="usd">36000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i0d88b9a8d8e34abdb2c9b7c1bade37bb_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTpkMTc3OGIyMDliZDA0NDBjYjI1ZDAwMmZiZDBlYmU1MC90YWJsZXJhbmdlOmQxNzc4YjIwOWJkMDQ0MGNiMjVkMDAyZmJkMGViZTUwXzgtMS0xLTEtMjA1NjU_c088cac0-21ba-48a4-a67a-fcb6b18978a3">P25Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i1e89cc544d3a428ab893432457341368_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTpkMTc3OGIyMDliZDA0NDBjYjI1ZDAwMmZiZDBlYmU1MC90YWJsZXJhbmdlOmQxNzc4YjIwOWJkMDQ0MGNiMjVkMDAyZmJkMGViZTUwXzgtMy0xLTEtMjA1NzU_c661995d-5e01-4e00-a1c8-b9a5b79ab734"
      unitRef="usd">298000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i1e89cc544d3a428ab893432457341368_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTpkMTc3OGIyMDliZDA0NDBjYjI1ZDAwMmZiZDBlYmU1MC90YWJsZXJhbmdlOmQxNzc4YjIwOWJkMDQ0MGNiMjVkMDAyZmJkMGViZTUwXzgtNS0xLTEtMjA1NzU_eb82da94-635e-483e-9254-2b71f853606d"
      unitRef="usd">4000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i1e89cc544d3a428ab893432457341368_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTpkMTc3OGIyMDliZDA0NDBjYjI1ZDAwMmZiZDBlYmU1MC90YWJsZXJhbmdlOmQxNzc4YjIwOWJkMDQ0MGNiMjVkMDAyZmJkMGViZTUwXzgtNy0xLTEtMjA1NzU_e1b78e8c-f514-4f06-8240-bdef2da33491"
      unitRef="usd">294000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTpkMTc3OGIyMDliZDA0NDBjYjI1ZDAwMmZiZDBlYmU1MC90YWJsZXJhbmdlOmQxNzc4YjIwOWJkMDQ0MGNiMjVkMDAyZmJkMGViZTUwXzktMy0xLTEtMjA1NzU_693bfd1a-2065-4ed8-947d-2c2e99bf9815"
      unitRef="usd">72262000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTpkMTc3OGIyMDliZDA0NDBjYjI1ZDAwMmZiZDBlYmU1MC90YWJsZXJhbmdlOmQxNzc4YjIwOWJkMDQ0MGNiMjVkMDAyZmJkMGViZTUwXzktNS0xLTEtMjA1NzU_8afe016a-782d-4226-b0e3-7d6be07a81d9"
      unitRef="usd">1027000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTpkMTc3OGIyMDliZDA0NDBjYjI1ZDAwMmZiZDBlYmU1MC90YWJsZXJhbmdlOmQxNzc4YjIwOWJkMDQ0MGNiMjVkMDAyZmJkMGViZTUwXzktNy0xLTEtMjA1NzU_869cd296-d771-4ad9-8247-94776ccb8788"
      unitRef="usd">71235000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90ZXh0cmVnaW9uOjVjYjg1MDFiMmY3NTRlMjdiOWVmZDM0NTA5Y2Q0ODk4XzQ4NA_01a58c84-9e57-4573-b930-a5e0e2bcefac"
      unitRef="usd">814000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90ZXh0cmVnaW9uOjVjYjg1MDFiMmY3NTRlMjdiOWVmZDM0NTA5Y2Q0ODk4XzQ5NA_b1f7e876-53b8-4a77-9949-f51f925c967d"
      unitRef="usd">646000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90ZXh0cmVnaW9uOjVjYjg1MDFiMmY3NTRlMjdiOWVmZDM0NTA5Y2Q0ODk4XzEyMDk0NjI3OTA4Mjc0_33a4e443-a084-4eb7-af67-59c2ab1e8508"
      unitRef="usd">546000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="i857a1897462542f5aca388daf1e74bbf_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90ZXh0cmVnaW9uOjVjYjg1MDFiMmY3NTRlMjdiOWVmZDM0NTA5Y2Q0ODk4XzEwOTk1MTE2Mjg3MDMz_1961df02-52e6-46ee-b203-547f7c43dfab"
      unitRef="usd">64000000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90ZXh0cmVnaW9uOjVjYjg1MDFiMmY3NTRlMjdiOWVmZDM0NTA5Y2Q0ODk4XzEyMDk0NjI3OTA4MzIx_e2907d35-05d9-447e-8413-284493a1d8a4"
      unitRef="usd">1047000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90ZXh0cmVnaW9uOjVjYjg1MDFiMmY3NTRlMjdiOWVmZDM0NTA5Y2Q0ODk4XzEyMDk0NjI3OTA4MzI3_a408fa39-d485-405f-9952-4ec0b19a8274"
      unitRef="usd">998000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90ZXh0cmVnaW9uOjVjYjg1MDFiMmY3NTRlMjdiOWVmZDM0NTA5Y2Q0ODk4XzEyMDk0NjI3OTA4MzMy_20e997a9-73af-44c2-bde7-b84dd5d74adc"
      unitRef="usd">964000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90ZXh0cmVnaW9uOjVjYjg1MDFiMmY3NTRlMjdiOWVmZDM0NTA5Y2Q0ODk4XzEyMDk0NjI3OTA4MzM3_d4df037e-2f94-4d9a-b20c-9bba729bb194"
      unitRef="usd">952000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90ZXh0cmVnaW9uOjVjYjg1MDFiMmY3NTRlMjdiOWVmZDM0NTA5Y2Q0ODk4XzEyMDk0NjI3OTA4MzQy_ecb8fb58-7f38-4b21-bcf7-abd672ce11b0"
      unitRef="usd">664000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90ZXh0cmVnaW9uOjVjYjg1MDFiMmY3NTRlMjdiOWVmZDM0NTA5Y2Q0ODk4XzIzMDg5NzQ0MTkyNzUx_8311f827-b786-4f24-b34c-30f6f4344bc9">Goodwill&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.722%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.273%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.827%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.966%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.832%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effect of foreign exchange&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Peace Naturals&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redwood&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="ia2206069e8cc487aab61dab193148424_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTplMTBkNDZlYWVhZmE0ODRmOGM2M2UwMDI3NjhlMTMyNS90YWJsZXJhbmdlOmUxMGQ0NmVhZWFmYTQ4NGY4YzYzZTAwMjc2OGUxMzI1XzItMS0xLTEtNDg1Ng_e715edf7-da0d-41a4-ae6e-9b40322d979e"
      unitRef="usd">1078000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i5d3d1ba25f2b4f858447fd45bdf8fbad_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTplMTBkNDZlYWVhZmE0ODRmOGM2M2UwMDI3NjhlMTMyNS90YWJsZXJhbmdlOmUxMGQ0NmVhZWFmYTQ4NGY4YzYzZTAwMjc2OGUxMzI1XzEtMy0xLTEtMTc1Mjc_e886b965-2812-4819-8b97-c18c69020e06"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i5d3d1ba25f2b4f858447fd45bdf8fbad_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTplMTBkNDZlYWVhZmE0ODRmOGM2M2UwMDI3NjhlMTMyNS90YWJsZXJhbmdlOmUxMGQ0NmVhZWFmYTQ4NGY4YzYzZTAwMjc2OGUxMzI1XzEtNS0xLTEtMTc1Mjc_5813249d-ae0d-4b49-b099-3bb4b151dafe"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i5d3d1ba25f2b4f858447fd45bdf8fbad_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTplMTBkNDZlYWVhZmE0ODRmOGM2M2UwMDI3NjhlMTMyNS90YWJsZXJhbmdlOmUxMGQ0NmVhZWFmYTQ4NGY4YzYzZTAwMjc2OGUxMzI1XzEtNy0xLTEtMTc1Mjc_5cec30a6-4e5b-460d-94dc-be22c59b52fc"
      unitRef="usd">30000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="i8633af9ced72481c8087e79d244f37b7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTplMTBkNDZlYWVhZmE0ODRmOGM2M2UwMDI3NjhlMTMyNS90YWJsZXJhbmdlOmUxMGQ0NmVhZWFmYTQ4NGY4YzYzZTAwMjc2OGUxMzI1XzEtOS0xLTEtMTc1Mjc_7468d419-175c-4106-bd84-d7a50168545e"
      unitRef="usd">1108000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i9d4ddac5384e48eabee1565aa6cc8a56_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTplMTBkNDZlYWVhZmE0ODRmOGM2M2UwMDI3NjhlMTMyNS90YWJsZXJhbmdlOmUxMGQ0NmVhZWFmYTQ4NGY4YzYzZTAwMjc2OGUxMzI1XzMtMS0xLTEtNDg1Ng_e3664f89-8437-4328-bd5e-05fbf71576ea"
      unitRef="usd">213414000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i1b13dbcbacfa4879b6f7704dc73f8b29_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTplMTBkNDZlYWVhZmE0ODRmOGM2M2UwMDI3NjhlMTMyNS90YWJsZXJhbmdlOmUxMGQ0NmVhZWFmYTQ4NGY4YzYzZTAwMjc2OGUxMzI1XzItMy0xLTEtMTc1Mjc_c1f3c238-5b16-4aa9-9924-22c67a5fc331"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i1b13dbcbacfa4879b6f7704dc73f8b29_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTplMTBkNDZlYWVhZmE0ODRmOGM2M2UwMDI3NjhlMTMyNS90YWJsZXJhbmdlOmUxMGQ0NmVhZWFmYTQ4NGY4YzYzZTAwMjc2OGUxMzI1XzItNS0xLTEtMTc1Mjc_d1b6e858-35be-429a-bbcf-c0a7153dea9e"
      unitRef="usd">35000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i1b13dbcbacfa4879b6f7704dc73f8b29_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTplMTBkNDZlYWVhZmE0ODRmOGM2M2UwMDI3NjhlMTMyNS90YWJsZXJhbmdlOmUxMGQ0NmVhZWFmYTQ4NGY4YzYzZTAwMjc2OGUxMzI1XzItNy0xLTEtMTc1Mjc_c7da68bb-3810-4700-86e9-9b75ac50e2eb"
      unitRef="usd">0</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="i97b06a548fbf4c0cb61a9ab4fcb38d94_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTplMTBkNDZlYWVhZmE0ODRmOGM2M2UwMDI3NjhlMTMyNS90YWJsZXJhbmdlOmUxMGQ0NmVhZWFmYTQ4NGY4YzYzZTAwMjc2OGUxMzI1XzItOS0xLTEtMTc1Mjc_4ff4fe31-3e54-4e8d-8b75-5db9dd38e644"
      unitRef="usd">178414000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTplMTBkNDZlYWVhZmE0ODRmOGM2M2UwMDI3NjhlMTMyNS90YWJsZXJhbmdlOmUxMGQ0NmVhZWFmYTQ4NGY4YzYzZTAwMjc2OGUxMzI1XzQtMS0xLTEtNDg1Ng_d1ab5177-4b18-41d4-bf60-c64e1449d221"
      unitRef="usd">214492000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTplMTBkNDZlYWVhZmE0ODRmOGM2M2UwMDI3NjhlMTMyNS90YWJsZXJhbmdlOmUxMGQ0NmVhZWFmYTQ4NGY4YzYzZTAwMjc2OGUxMzI1XzQtMy0xLTEtNDg1Ng_f05a38c8-2c86-4b14-a89f-588c474cccae"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTplMTBkNDZlYWVhZmE0ODRmOGM2M2UwMDI3NjhlMTMyNS90YWJsZXJhbmdlOmUxMGQ0NmVhZWFmYTQ4NGY4YzYzZTAwMjc2OGUxMzI1XzMtNS0xLTEtMTc1Mjc_756f239c-fe37-4f95-9fbc-c627f5487eab"
      unitRef="usd">35000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTplMTBkNDZlYWVhZmE0ODRmOGM2M2UwMDI3NjhlMTMyNS90YWJsZXJhbmdlOmUxMGQ0NmVhZWFmYTQ4NGY4YzYzZTAwMjc2OGUxMzI1XzQtNS0xLTEtNDg1Ng_98760799-e3f4-44d1-9fed-3d819fae46be"
      unitRef="usd">30000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjQvZnJhZzo1Y2I4NTAxYjJmNzU0ZTI3YjllZmQzNDUwOWNkNDg5OC90YWJsZTplMTBkNDZlYWVhZmE0ODRmOGM2M2UwMDI3NjhlMTMyNS90YWJsZXJhbmdlOmUxMGQ0NmVhZWFmYTQ4NGY4YzYzZTAwMjc2OGUxMzI1XzQtNy0xLTEtNDg1Ng_029c616f-a2f8-4504-9965-2b737de4097c"
      unitRef="usd">179522000</us-gaap:Goodwill>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMTIvZnJhZzo3NmE4MTRkYjZlZDQ0M2Q3YWRmYTU4M2YzYTE4MzQyZi90ZXh0cmVnaW9uOjc2YTgxNGRiNmVkNDQzZDdhZGZhNTgzZjNhMTgzNDJmXzg3Ng_ddabd21c-eb4c-4bd1-b529-316f40cf8627">Leases &lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has entered into leases primarily for the land-use rights, office premises and equipment used in the production of cannabis, U.S. hemp and related products. The Company&#x2019;s leases have terms which range from three years to six years, excluding land use rights, which generally extend to 15 years. These leases often include options to extend the term of the lease for up to 10 years. When it is reasonably certain that the option will be exercised, the impact of the option is included in the lease term for purposes of determining total future lease payments. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating leases greater than one year are included in right-of-use assets and operating lease liabilities. Finance leases are included in property, plant and equipment on the Company&#x2019;s consolidated balance sheet. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s finance leases were not material for any of the periods presented. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.541%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average remaining lease term &#x2013; operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate &#x2013; operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i62037cbff1aa4252b5cdebcd407fdc1b_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMTIvZnJhZzo3NmE4MTRkYjZlZDQ0M2Q3YWRmYTU4M2YzYTE4MzQyZi90ZXh0cmVnaW9uOjc2YTgxNGRiNmVkNDQzZDdhZGZhNTgzZjNhMTgzNDJmXzg3OTYwOTMwMjMyOTk_3c6ea9c2-7fab-4be4-8c6d-ae7beb0759e6">P3Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="if7021697d1b94f34b3b9af2716c9a683_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMTIvZnJhZzo3NmE4MTRkYjZlZDQ0M2Q3YWRmYTU4M2YzYTE4MzQyZi90ZXh0cmVnaW9uOjc2YTgxNGRiNmVkNDQzZDdhZGZhNTgzZjNhMTgzNDJmXzEyMDk0NjI3OTA2NDY5_8675c827-9f53-488c-a897-126990540521">P6Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i6db5a3fb2eca4f54b3f90ed1c036dd12_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMTIvZnJhZzo3NmE4MTRkYjZlZDQ0M2Q3YWRmYTU4M2YzYTE4MzQyZi90ZXh0cmVnaW9uOjc2YTgxNGRiNmVkNDQzZDdhZGZhNTgzZjNhMTgzNDJmXzMwMw_9074cbd8-aeda-47fc-873c-48e4653eba65">P15Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMTIvZnJhZzo3NmE4MTRkYjZlZDQ0M2Q3YWRmYTU4M2YzYTE4MzQyZi90ZXh0cmVnaW9uOjc2YTgxNGRiNmVkNDQzZDdhZGZhNTgzZjNhMTgzNDJmXzM5MA_66abd328-7158-4024-b945-d046148f067f">P10Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMTIvZnJhZzo3NmE4MTRkYjZlZDQ0M2Q3YWRmYTU4M2YzYTE4MzQyZi90ZXh0cmVnaW9uOjc2YTgxNGRiNmVkNDQzZDdhZGZhNTgzZjNhMTgzNDJmXzg3Nw_5e273aed-64a2-428f-b883-9f41c199ddd4">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.541%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average remaining lease term &#x2013; operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate &#x2013; operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMTIvZnJhZzo3NmE4MTRkYjZlZDQ0M2Q3YWRmYTU4M2YzYTE4MzQyZi90YWJsZTphY2MxM2NjMWRiZjU0ZDBiYjVkNDI0NTBlYzNhYTkwNy90YWJsZXJhbmdlOmFjYzEzY2MxZGJmNTRkMGJiNWQ0MjQ1MGVjM2FhOTA3XzItMi0xLTEtMA_c71f338f-8342-4cc8-a36d-5f5e73c9dccb"
      unitRef="usd">2479000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMTIvZnJhZzo3NmE4MTRkYjZlZDQ0M2Q3YWRmYTU4M2YzYTE4MzQyZi90YWJsZTphY2MxM2NjMWRiZjU0ZDBiYjVkNDI0NTBlYzNhYTkwNy90YWJsZXJhbmdlOmFjYzEzY2MxZGJmNTRkMGJiNWQ0MjQ1MGVjM2FhOTA3XzItMy0xLTEtMzYyMDc_f458ffaa-9579-4b13-9f75-0bd2ab0ddf28"
      unitRef="usd">760000</us-gaap:OperatingLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMTIvZnJhZzo3NmE4MTRkYjZlZDQ0M2Q3YWRmYTU4M2YzYTE4MzQyZi90YWJsZTphY2MxM2NjMWRiZjU0ZDBiYjVkNDI0NTBlYzNhYTkwNy90YWJsZXJhbmdlOmFjYzEzY2MxZGJmNTRkMGJiNWQ0MjQ1MGVjM2FhOTA3XzMtMi0xLTEtMA_e637e41c-2517-4e63-a9ce-2587fb14efd4"
      unitRef="usd">60000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMTIvZnJhZzo3NmE4MTRkYjZlZDQ0M2Q3YWRmYTU4M2YzYTE4MzQyZi90YWJsZTphY2MxM2NjMWRiZjU0ZDBiYjVkNDI0NTBlYzNhYTkwNy90YWJsZXJhbmdlOmFjYzEzY2MxZGJmNTRkMGJiNWQ0MjQ1MGVjM2FhOTA3XzMtMy0xLTEtMzYyMDc_daadf420-3971-453f-a82e-380459715618"
      unitRef="usd">373000</us-gaap:ShortTermLeaseCost>
    <us-gaap:LeaseCost
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMTIvZnJhZzo3NmE4MTRkYjZlZDQ0M2Q3YWRmYTU4M2YzYTE4MzQyZi90YWJsZTphY2MxM2NjMWRiZjU0ZDBiYjVkNDI0NTBlYzNhYTkwNy90YWJsZXJhbmdlOmFjYzEzY2MxZGJmNTRkMGJiNWQ0MjQ1MGVjM2FhOTA3XzQtMi0xLTEtMA_def98651-68ba-4351-9287-7b1da9e721ce"
      unitRef="usd">2539000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMTIvZnJhZzo3NmE4MTRkYjZlZDQ0M2Q3YWRmYTU4M2YzYTE4MzQyZi90YWJsZTphY2MxM2NjMWRiZjU0ZDBiYjVkNDI0NTBlYzNhYTkwNy90YWJsZXJhbmdlOmFjYzEzY2MxZGJmNTRkMGJiNWQ0MjQ1MGVjM2FhOTA3XzQtMy0xLTEtMzYyMDc_ea466b23-4cdd-4e51-8fbf-b7cc338038b1"
      unitRef="usd">1133000</us-gaap:LeaseCost>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMTIvZnJhZzo3NmE4MTRkYjZlZDQ0M2Q3YWRmYTU4M2YzYTE4MzQyZi90YWJsZTphY2MxM2NjMWRiZjU0ZDBiYjVkNDI0NTBlYzNhYTkwNy90YWJsZXJhbmdlOmFjYzEzY2MxZGJmNTRkMGJiNWQ0MjQ1MGVjM2FhOTA3XzYtMi0xLTEtMA_ae3649ca-126b-4cd9-b81b-8e4ac8a544cd">P6Y</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMTIvZnJhZzo3NmE4MTRkYjZlZDQ0M2Q3YWRmYTU4M2YzYTE4MzQyZi90YWJsZTphY2MxM2NjMWRiZjU0ZDBiYjVkNDI0NTBlYzNhYTkwNy90YWJsZXJhbmdlOmFjYzEzY2MxZGJmNTRkMGJiNWQ0MjQ1MGVjM2FhOTA3XzYtMy0xLTEtMzYyMTg_31c730b7-f0bb-43b4-bb0d-706cca4ceffe">P5Y</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMTIvZnJhZzo3NmE4MTRkYjZlZDQ0M2Q3YWRmYTU4M2YzYTE4MzQyZi90YWJsZTphY2MxM2NjMWRiZjU0ZDBiYjVkNDI0NTBlYzNhYTkwNy90YWJsZXJhbmdlOmFjYzEzY2MxZGJmNTRkMGJiNWQ0MjQ1MGVjM2FhOTA3XzctMi0xLTEtMA_f67f9d54-8dbe-411f-9b17-031589d6b620"
      unitRef="number">0.0886</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMTIvZnJhZzo3NmE4MTRkYjZlZDQ0M2Q3YWRmYTU4M2YzYTE4MzQyZi90YWJsZTphY2MxM2NjMWRiZjU0ZDBiYjVkNDI0NTBlYzNhYTkwNy90YWJsZXJhbmdlOmFjYzEzY2MxZGJmNTRkMGJiNWQ0MjQ1MGVjM2FhOTA3XzctMy0xLTEtMzYyMDc_71cedc31-66a5-43c5-a264-a1de130bb245"
      unitRef="number">0.1200</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:AdditionalFinancialInformationDisclosureTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzMvZnJhZzoxODc0ZjE0MDU5YTE0ZTQ2YjEwMTdlMGI4NTNlYzQ2Ny90ZXh0cmVnaW9uOjE4NzRmMTQwNTlhMTRlNDZiMTAxN2UwYjg1M2VjNDY3XzIzMDg5NzQ0MTg0MTgy_42d83374-db02-4ce2-a7e4-ed8e5a06ca39">General and Administrative Expenses &lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;General and administrative expense are comprised of the following items: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Salaries and wages&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Professional and consulting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Office and general&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Review costs related to restatement of 2019 interim financial statements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current expected credit loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.1pt"&gt;These financial statement review costs include costs related to the restatement of the Company&#x2019;s 2019 interim financial statements, costs related to the Company&#x2019;s responses to requests for information from various regulatory authorities relating to such restatement and legal costs defending shareholder class action complaints brought against the Company as a result of the restatement.&lt;/span&gt;&lt;/div&gt;</us-gaap:AdditionalFinancialInformationDisclosureTextBlock>
    <cron:GeneralAndAdministrativeExpensesTableTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzMvZnJhZzoxODc0ZjE0MDU5YTE0ZTQ2YjEwMTdlMGI4NTNlYzQ2Ny90ZXh0cmVnaW9uOjE4NzRmMTQwNTlhMTRlNDZiMTAxN2UwYjg1M2VjNDY3XzIzMDg5NzQ0MTg0MTgz_19254d56-fd79-4c8e-adbe-bea48650bc3a">&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;General and administrative expense are comprised of the following items: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Salaries and wages&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Professional and consulting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Office and general&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Review costs related to restatement of 2019 interim financial statements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current expected credit loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.1pt"&gt;These financial statement review costs include costs related to the restatement of the Company&#x2019;s 2019 interim financial statements, costs related to the Company&#x2019;s responses to requests for information from various regulatory authorities relating to such restatement and legal costs defending shareholder class action complaints brought against the Company as a result of the restatement.&lt;/span&gt;&lt;/div&gt;</cron:GeneralAndAdministrativeExpensesTableTextBlock>
    <us-gaap:LaborAndRelatedExpense
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzMvZnJhZzoxODc0ZjE0MDU5YTE0ZTQ2YjEwMTdlMGI4NTNlYzQ2Ny90YWJsZTphNjRlZjU3Mzc2NzM0MWRlODYzYjVmY2I5MDQwZWI2OC90YWJsZXJhbmdlOmE2NGVmNTczNzY3MzQxZGU4NjNiNWZjYjkwNDBlYjY4XzItMi0xLTEtMA_07cbd4b8-0c6f-4705-b45c-e01117912977"
      unitRef="usd">26742000</us-gaap:LaborAndRelatedExpense>
    <us-gaap:LaborAndRelatedExpense
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzMvZnJhZzoxODc0ZjE0MDU5YTE0ZTQ2YjEwMTdlMGI4NTNlYzQ2Ny90YWJsZTphNjRlZjU3Mzc2NzM0MWRlODYzYjVmY2I5MDQwZWI2OC90YWJsZXJhbmdlOmE2NGVmNTczNzY3MzQxZGU4NjNiNWZjYjkwNDBlYjY4XzItNC0xLTEtMA_4009b112-51d3-4751-9522-039318e750e4"
      unitRef="usd">17829000</us-gaap:LaborAndRelatedExpense>
    <us-gaap:LaborAndRelatedExpense
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzMvZnJhZzoxODc0ZjE0MDU5YTE0ZTQ2YjEwMTdlMGI4NTNlYzQ2Ny90YWJsZTphNjRlZjU3Mzc2NzM0MWRlODYzYjVmY2I5MDQwZWI2OC90YWJsZXJhbmdlOmE2NGVmNTczNzY3MzQxZGU4NjNiNWZjYjkwNDBlYjY4XzItNi0xLTEtMA_b63cd106-8efa-4728-ae3b-709cc420c2f4"
      unitRef="usd">4240000</us-gaap:LaborAndRelatedExpense>
    <cron:ProfessionalAndConsultingExpense
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzMvZnJhZzoxODc0ZjE0MDU5YTE0ZTQ2YjEwMTdlMGI4NTNlYzQ2Ny90YWJsZTphNjRlZjU3Mzc2NzM0MWRlODYzYjVmY2I5MDQwZWI2OC90YWJsZXJhbmdlOmE2NGVmNTczNzY3MzQxZGU4NjNiNWZjYjkwNDBlYjY4XzMtMi0xLTEtMA_9651409f-5ad1-4972-b615-245340fc765e"
      unitRef="usd">15135000</cron:ProfessionalAndConsultingExpense>
    <cron:ProfessionalAndConsultingExpense
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzMvZnJhZzoxODc0ZjE0MDU5YTE0ZTQ2YjEwMTdlMGI4NTNlYzQ2Ny90YWJsZTphNjRlZjU3Mzc2NzM0MWRlODYzYjVmY2I5MDQwZWI2OC90YWJsZXJhbmdlOmE2NGVmNTczNzY3MzQxZGU4NjNiNWZjYjkwNDBlYjY4XzMtNC0xLTEtMA_d56b3775-dbad-4403-a1c7-55906bbfae47"
      unitRef="usd">15369000</cron:ProfessionalAndConsultingExpense>
    <cron:ProfessionalAndConsultingExpense
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzMvZnJhZzoxODc0ZjE0MDU5YTE0ZTQ2YjEwMTdlMGI4NTNlYzQ2Ny90YWJsZTphNjRlZjU3Mzc2NzM0MWRlODYzYjVmY2I5MDQwZWI2OC90YWJsZXJhbmdlOmE2NGVmNTczNzY3MzQxZGU4NjNiNWZjYjkwNDBlYjY4XzMtNi0xLTEtMA_4a55c406-4d5a-4308-a1a8-5d21ee5fe0ae"
      unitRef="usd">5242000</cron:ProfessionalAndConsultingExpense>
    <cron:OfficeAndGeneralExpense
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzMvZnJhZzoxODc0ZjE0MDU5YTE0ZTQ2YjEwMTdlMGI4NTNlYzQ2Ny90YWJsZTphNjRlZjU3Mzc2NzM0MWRlODYzYjVmY2I5MDQwZWI2OC90YWJsZXJhbmdlOmE2NGVmNTczNzY3MzQxZGU4NjNiNWZjYjkwNDBlYjY4XzQtMi0xLTEtMA_4f2be760-7edf-42b2-bd2b-a5eddb92da2f"
      unitRef="usd">17845000</cron:OfficeAndGeneralExpense>
    <cron:OfficeAndGeneralExpense
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzMvZnJhZzoxODc0ZjE0MDU5YTE0ZTQ2YjEwMTdlMGI4NTNlYzQ2Ny90YWJsZTphNjRlZjU3Mzc2NzM0MWRlODYzYjVmY2I5MDQwZWI2OC90YWJsZXJhbmdlOmE2NGVmNTczNzY3MzQxZGU4NjNiNWZjYjkwNDBlYjY4XzQtNC0xLTEtMA_f9496a45-4dae-4e58-a45f-c9e223e420d9"
      unitRef="usd">13407000</cron:OfficeAndGeneralExpense>
    <cron:OfficeAndGeneralExpense
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzMvZnJhZzoxODc0ZjE0MDU5YTE0ZTQ2YjEwMTdlMGI4NTNlYzQ2Ny90YWJsZTphNjRlZjU3Mzc2NzM0MWRlODYzYjVmY2I5MDQwZWI2OC90YWJsZXJhbmdlOmE2NGVmNTczNzY3MzQxZGU4NjNiNWZjYjkwNDBlYjY4XzQtNi0xLTEtMA_157cd39b-ec0f-4ee2-bec1-f20476e06275"
      unitRef="usd">3713000</cron:OfficeAndGeneralExpense>
    <cron:RestatementReviewExpense
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzMvZnJhZzoxODc0ZjE0MDU5YTE0ZTQ2YjEwMTdlMGI4NTNlYzQ2Ny90YWJsZTphNjRlZjU3Mzc2NzM0MWRlODYzYjVmY2I5MDQwZWI2OC90YWJsZXJhbmdlOmE2NGVmNTczNzY3MzQxZGU4NjNiNWZjYjkwNDBlYjY4XzUtMi0xLTEtMTIyNTA_85a3bdb4-2dd7-48b6-9ca4-8a49aca214f0"
      unitRef="usd">9688000</cron:RestatementReviewExpense>
    <cron:RestatementReviewExpense
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzMvZnJhZzoxODc0ZjE0MDU5YTE0ZTQ2YjEwMTdlMGI4NTNlYzQ2Ny90YWJsZTphNjRlZjU3Mzc2NzM0MWRlODYzYjVmY2I5MDQwZWI2OC90YWJsZXJhbmdlOmE2NGVmNTczNzY3MzQxZGU4NjNiNWZjYjkwNDBlYjY4XzUtNC0xLTEtMTIyNTA_b1cad893-f8c2-4199-94fc-d35c0ee69400"
      unitRef="usd">0</cron:RestatementReviewExpense>
    <cron:RestatementReviewExpense
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzMvZnJhZzoxODc0ZjE0MDU5YTE0ZTQ2YjEwMTdlMGI4NTNlYzQ2Ny90YWJsZTphNjRlZjU3Mzc2NzM0MWRlODYzYjVmY2I5MDQwZWI2OC90YWJsZXJhbmdlOmE2NGVmNTczNzY3MzQxZGU4NjNiNWZjYjkwNDBlYjY4XzUtNi0xLTEtMTIyNTA_e2378daf-52af-4c29-8fa3-334f6e3888bb"
      unitRef="usd">0</cron:RestatementReviewExpense>
    <us-gaap:ProvisionForLoanLossesExpensed
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzMvZnJhZzoxODc0ZjE0MDU5YTE0ZTQ2YjEwMTdlMGI4NTNlYzQ2Ny90YWJsZTphNjRlZjU3Mzc2NzM0MWRlODYzYjVmY2I5MDQwZWI2OC90YWJsZXJhbmdlOmE2NGVmNTczNzY3MzQxZGU4NjNiNWZjYjkwNDBlYjY4XzYtMS0xLTEtMzEyNTU_8c012431-99c6-4d12-86d3-35c731fe4bf4"
      unitRef="usd">2512000</us-gaap:ProvisionForLoanLossesExpensed>
    <us-gaap:ProvisionForLoanLossesExpensed
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzMvZnJhZzoxODc0ZjE0MDU5YTE0ZTQ2YjEwMTdlMGI4NTNlYzQ2Ny90YWJsZTphNjRlZjU3Mzc2NzM0MWRlODYzYjVmY2I5MDQwZWI2OC90YWJsZXJhbmdlOmE2NGVmNTczNzY3MzQxZGU4NjNiNWZjYjkwNDBlYjY4XzYtMy0xLTEtMzEyNTU_59486558-8f3f-4a59-b53d-10a106cbc353"
      unitRef="usd">136000</us-gaap:ProvisionForLoanLossesExpensed>
    <us-gaap:ProvisionForLoanLossesExpensed
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzMvZnJhZzoxODc0ZjE0MDU5YTE0ZTQ2YjEwMTdlMGI4NTNlYzQ2Ny90YWJsZTphNjRlZjU3Mzc2NzM0MWRlODYzYjVmY2I5MDQwZWI2OC90YWJsZXJhbmdlOmE2NGVmNTczNzY3MzQxZGU4NjNiNWZjYjkwNDBlYjY4XzYtNS0xLTEtMzEyNTU_811f23dd-5322-4231-a180-a98adb5fcfbd"
      unitRef="usd">0</us-gaap:ProvisionForLoanLossesExpensed>
    <us-gaap:OtherGeneralAndAdministrativeExpense
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzMvZnJhZzoxODc0ZjE0MDU5YTE0ZTQ2YjEwMTdlMGI4NTNlYzQ2Ny90YWJsZTphNjRlZjU3Mzc2NzM0MWRlODYzYjVmY2I5MDQwZWI2OC90YWJsZXJhbmdlOmE2NGVmNTczNzY3MzQxZGU4NjNiNWZjYjkwNDBlYjY4XzUtMi0xLTEtMA_58046cb7-6447-4499-b72d-b2932aca32b1"
      unitRef="usd">8607000</us-gaap:OtherGeneralAndAdministrativeExpense>
    <us-gaap:OtherGeneralAndAdministrativeExpense
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzMvZnJhZzoxODc0ZjE0MDU5YTE0ZTQ2YjEwMTdlMGI4NTNlYzQ2Ny90YWJsZTphNjRlZjU3Mzc2NzM0MWRlODYzYjVmY2I5MDQwZWI2OC90YWJsZXJhbmdlOmE2NGVmNTczNzY3MzQxZGU4NjNiNWZjYjkwNDBlYjY4XzUtNC0xLTEtMA_d3ff6930-2f8c-46fe-a138-12ea693a562c"
      unitRef="usd">2530000</us-gaap:OtherGeneralAndAdministrativeExpense>
    <us-gaap:OtherGeneralAndAdministrativeExpense
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzMvZnJhZzoxODc0ZjE0MDU5YTE0ZTQ2YjEwMTdlMGI4NTNlYzQ2Ny90YWJsZTphNjRlZjU3Mzc2NzM0MWRlODYzYjVmY2I5MDQwZWI2OC90YWJsZXJhbmdlOmE2NGVmNTczNzY3MzQxZGU4NjNiNWZjYjkwNDBlYjY4XzUtNi0xLTEtMA_cddb4371-1a57-4777-a735-948d23dfa6bd"
      unitRef="usd">154000</us-gaap:OtherGeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzMvZnJhZzoxODc0ZjE0MDU5YTE0ZTQ2YjEwMTdlMGI4NTNlYzQ2Ny90YWJsZTphNjRlZjU3Mzc2NzM0MWRlODYzYjVmY2I5MDQwZWI2OC90YWJsZXJhbmdlOmE2NGVmNTczNzY3MzQxZGU4NjNiNWZjYjkwNDBlYjY4XzYtMi0xLTEtMA_b758b36a-bf98-4c91-b85b-f36f187293ff"
      unitRef="usd">80529000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzMvZnJhZzoxODc0ZjE0MDU5YTE0ZTQ2YjEwMTdlMGI4NTNlYzQ2Ny90YWJsZTphNjRlZjU3Mzc2NzM0MWRlODYzYjVmY2I5MDQwZWI2OC90YWJsZXJhbmdlOmE2NGVmNTczNzY3MzQxZGU4NjNiNWZjYjkwNDBlYjY4XzYtNC0xLTEtMA_675acff3-0314-436b-bc9f-dea81eabc0c3"
      unitRef="usd">49271000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzMvZnJhZzoxODc0ZjE0MDU5YTE0ZTQ2YjEwMTdlMGI4NTNlYzQ2Ny90YWJsZTphNjRlZjU3Mzc2NzM0MWRlODYzYjVmY2I5MDQwZWI2OC90YWJsZXJhbmdlOmE2NGVmNTczNzY3MzQxZGU4NjNiNWZjYjkwNDBlYjY4XzYtNi0xLTEtMA_91cf880d-6f1b-4d7e-a6d0-7180113e3f23"
      unitRef="usd">13349000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90ZXh0cmVnaW9uOmVlYzdiZTBhMjZhYjQ3Y2U4OTMzZjc3Y2M2YWFhM2UyXzk1ODk_1c5c80ce-0f13-4aff-8ed3-bd48182de141">Derivative Liabilities &lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 8, 2019, the Company closed the previously announced investment in the Company (the &#x201c;Altria Investment&#x201d;) by Altria Group Inc. (&#x201c;Altria&#x201d;), pursuant to a subscription agreement dated December 7, 2018. As of the closing date of the Altria Investment, the Altria Investment consisted of 149,831,154 common shares of the Company, refer to Note 15, issued to a wholly owned subsidiary of Altria and one warrant of the Company (the &#x201c;Altria Warrant&#x201d;), refer to Note 16(a), issued to a wholly owned subsidiary of Altria. As of the closing date of the Altria Investment, Altria beneficially held an approximate 45% ownership interest in the Company (calculated on a non-diluted basis). As summarized in this note, if exercised in full on such date, the exercise of the Altria Warrant would have resulted in Altria holding a total ownership interest in the Company of approximately 55% (calculated on a non-diluted basis). Pursuant to the investor rights agreement between the Company and Altria, entered into in connection with the closing of the Altria Investment (the &#x201c;Investor Rights Agreement&#x201d;), the Company granted Altria certain rights, among others, summarized in this note.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The summaries below are qualified entirely by the terms and conditions fully set out in the Investor Rights Agreement and the Altria Warrant, as applicable. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;a.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt"&gt;The Altria Warrant entitles the holder, subject to certain qualifications and limitations, to subscribe for and purchase up to an additional 10% of the common shares of Cronos (approximately 80.1&#160;million common shares as of December 31, 2020) at a per share exercise price of C$19.00, which expires at 5:00 p.m. (Toronto time) on March 8, 2023. The number of common shares of the Company to which the holder is entitled, and the corresponding exercise price, is subject to adjustment in the event of a share dividend, share issuance, distribution, or share subdivision, split or other division, share consolidation, reverse-split or other aggregation, share reclassification, a capital reorganization, consolidation, amalgamation, arrangement, binding share exchange, merger or other combination, certain securities issuances, repurchases, redemptions or certain other actions that would result in a reduction in the number of common shares of the Company outstanding, in each case, executed by the Company. If and whenever there is a reclassification of the common shares or a capital reorganization of the Company, or a consolidation, amalgamation, arrangement, binding share exchange or merger of the Company, in each case executed by the Company and pursuant to which (i) in the event the consideration received by the Company&#x2019;s shareholders is exclusively cash, the Company or the successor entity (as applicable) is required to purchase the Altria Warrant in cash equal to the amount by which the purchase price per share paid for the common shares acquired exceeds the exercise price of the Altria Warrant multiplied by the number of common shares that would have been issuable upon exercise of the Altria Warrant immediately prior to any such transaction, and (ii) in the event the consideration received by the Company&#x2019;s shareholders is not exclusively cash, the Altria Warrant will remain outstanding in accordance with its terms until any subsequent exercise of the Altria Warrant, at which time the holder thereof will receive in lieu of each share that would have been issuable upon the exercise of the Altria Warrant immediately prior to any such transaction, the kind and amount of cash, the number of shares or other securities or property resulting from any such transaction that such holder would have been entitled to receive had such holder been the registered holder of such shares that would have been issuable upon the exercise of the Altria Warrant on the record date or effective date of the transaction (as applicable).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;b.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt"&gt;The Company granted to Altria, subject to certain qualifications and limitations, upon the occurrence of certain issuances of common shares of the Company executed by the Company (including issuances pursuant to the R&amp;amp;D partnership with Ginkgo (the &#x201c;Ginkgo Agreement&#x201d;), refer to Note 20(b)), the right to purchase up to such number of common shares of the Company in order to maintain their ownership percentage of issued and outstanding common shares of the Company immediately preceding any issuance of shares by the Company (&#x201c;Pre-emptive Rights&#x201d;), at the same price per common share of the Company at which the common shares are sold in the relevant issuance; provided that if the consideration paid in connection with any such issuance is non-cash, the price per common share of the Company that would have been received had such common shares been issued for cash consideration will be determined by an independent committee (acting reasonably and in good faith); provided further that the price per common share of the Company to be paid by Altria pursuant to its exercise of its Pre-emptive Rights related to the Ginkgo Agreement will be C$16.25 per common share. These rights may not be exercised if Altria&#x2019;s ownership percentage of the issued and outstanding shares of the Company falls below 20%. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;c.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt"&gt;In addition to (and without duplication of) the Pre-emptive Rights, the Company granted to Altria, subject to certain qualifications and limitations, the right to subscribe for common shares of the Company issuable in connection with the exercise, conversion or exchange of convertible securities of the Company issued prior to March 8, 2019 or thereafter (excluding any convertible securities of the Company owned by Altria or any of its subsidiaries), a share incentive plan of the Company, the exercise of any right granted by the Company pro rata to all shareholders of the Company to purchase additional common shares and/or securities of the Company, bona fide bank debt, equipment financing or non-equity interim financing transactions that contemplate an equity component or bona fide acquisitions (including acquisitions of assets or rights under a license or otherwise), mergers or similar business combination transactions or joint ventures involving the Company in order to maintain their ownership percentage of issued and outstanding common shares of the Company immediately preceding any such transactions (&#x201c;Top-up Rights&#x201d;). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The price per common share to be paid by Altria pursuant to the exercise of its Top-up Rights will be, subject to certain limited exceptions, the 10-day volume-weighted average price of the common shares of the Company on the TSX for the 10 full days preceding such exercise by Altria; provided that the price per common share of the Company to be paid by Altria pursuant to the exercise of its Top-up Rights in connection with the issuance of common shares of the Company pursuant to the exercise of options or warrants that were outstanding as of March 8, 2019 will be C$16.25 per common share without any set off, counterclaim, deduction, or withholding. These rights may not be exercised if Altria&#x2019;s ownership percentage of the issued and outstanding shares of the Company falls below 20%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Altria Warrant, Pre-emptive Rights, and fixed price Top-up Rights have been classified as derivative liabilities; related transaction costs of $22,355 have been expensed as financing costs in 2019. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reconciliations of the carrying amounts of the derivative liability are presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.288%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.050%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.155%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gain on revaluation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Exercise of Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effect of FX&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a) Altria Warrant&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(95,045)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(525)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(b) Pre-emptive Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(885)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(c) Top-up Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33,324)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,227)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(937)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(129,254)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,227)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,269)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.155%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of March 8, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gain on revaluation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Exercise of Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effect of FX&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a) Altria Warrant&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,086,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(869,630)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(b) Pre-emptive Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(81,070)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(c) Top-up Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;386,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(326,119)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,478)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,565,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,276,819)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,478)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fluctuations in the Company&#x2019;s share price are a primary driver for the changes in the derivative valuations during each reporting period. As the share price decreases for each of the related derivative instruments, the liability of the instrument generally decreases. Share price is one of the significant observable inputs used in the fair value measurement of each of the Company&#x2019;s derivative instruments. During the year ended December&#160;31, 2020, the Company&#x2019;s share price decreased from December&#160;31, 2019 resulting in a gain on revaluation of $129,254.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair values of the derivative liabilities were determined using the Black-Scholes pricing model as of December&#160;31, 2020 and December&#160;31, 2019, applying the following inputs:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.820%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Altria Warrant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pre-emptive Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Top-up Rights&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share price at grant date (per share in C$)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$8.84&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$8.84&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$8.84&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subscription price (per share in C$)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$19.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$16.25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$16.25&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted average risk-free interest rate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.21%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.17%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.13%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weight average expected life (in years)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.18&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.98&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected annualized volatility&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(iii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-indent:-27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.820%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Altria Warrant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pre-emptive Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Top-up Rights&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share price at grant date (per share in C$)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$9.97&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$9.97&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$9.97&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subscription price (per share in C$)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$19.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$16.25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$16.25&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted average risk-free interest rate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.69%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.73%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.71%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weight average expected life (in years)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.18&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.66&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected annualized volatility&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(iii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;The risk-free interest rate was based on Bank of Canada government treasury bills and bonds with a remaining term equal to the expected life of the derivative liabilities. The risk-free interest rate uses a range of approximately 0.10% to 0.39% as of December&#160;31, 2020 (December&#160;31, 2019 &#x2013; 1.66% to 1.73%) for the Pre-emptive Rights and Top-up Rights.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;The expected life in years represents the period of time that the derivative liabilities are expected to be outstanding. The expected life of the Pre-emptive Rights and Top-up Rights is determined based on the expected term of the underlying options, warrants, and shares, to which the Pre-emptive Rights and Top-up Rights are linked. The expected life uses a range of approximately 0.50 years to 5 years as of December&#160;31, 2020 (December&#160;31, 2019 &#x2013; 0.25 years to 6 years).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(iii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Volatility was based on the blended historical volatility levels of the Company and peer companies. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table quantifies each of the significant inputs described above and provides a sensitivity analysis of the impact on the reported values of the derivative liabilities. The sensitivity analysis for each significant input is performed by assuming a 10% decrease in the input while other significant inputs remain constant at management&#x2019;s best estimate as of the respective dates. As of December&#160;31, 2020, there would be an equal but opposite impact on net income (loss), refer to Note 15, and as of December&#160;31, 2019, there would be an equal but opposite impact on share capital.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.820%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Decrease as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Altria Warrant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pre-emptive Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Top-up Rights&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share price at issuance date&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average expected life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected annualized volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.820%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Decrease as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Altria Warrant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pre-emptive Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Top-up Rights&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share price at issuance date&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average expected life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected annualized volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;These inputs are classified in Level 3 on the fair value hierarchy and are subject to volatility and several uncontrollable factors, which could significantly affect the fair value of these derivative liabilities in future periods.</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="ifa29b1acea664089973579f536d4f49c_D20190308-20190308"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90ZXh0cmVnaW9uOmVlYzdiZTBhMjZhYjQ3Y2U4OTMzZjc3Y2M2YWFhM2UyXzI4Mw_59965b49-b01b-427b-a1c4-4b3484ea1659"
      unitRef="shares">149831154</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <cron:ClassOfWarrantOrRightNumberOfWarrantsIssued
      contextRef="i0da6f2ce11e0487499370eb2e182ebf5_D20190308-20190308"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90ZXh0cmVnaW9uOmVlYzdiZTBhMjZhYjQ3Y2U4OTMzZjc3Y2M2YWFhM2UyXzQwMg_1e3c397d-5587-4262-948b-c3f66477b3a7"
      unitRef="warrant">1</cron:ClassOfWarrantOrRightNumberOfWarrantsIssued>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="ib551b9ef8b1d44bcb1db52c16b0f3d77_I20190308"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90ZXh0cmVnaW9uOmVlYzdiZTBhMjZhYjQ3Y2U4OTMzZjc3Y2M2YWFhM2UyXzYwNA_16051704-8b77-4c59-a0fa-22c3300f8df6"
      unitRef="number">0.45</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <cron:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised
      contextRef="i082bd82cec0746e98c728d8765ac235d_I20190308"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90ZXh0cmVnaW9uOmVlYzdiZTBhMjZhYjQ3Y2U4OTMzZjc3Y2M2YWFhM2UyXzg3Mw_0de52c7a-03c8-4630-9a6b-cb6e80301753"
      unitRef="number">0.55</cron:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised>
    <cron:ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage
      contextRef="i300b4ad7da784a87a26c8cffe4e5d5c3_I20190308"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90ZXh0cmVnaW9uOmVlYzdiZTBhMjZhYjQ3Y2U4OTMzZjc3Y2M2YWFhM2UyXzE0NzM_60fdb3d9-e4f1-480e-a343-ea6bf6a26700"
      unitRef="number">0.10</cron:ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage>
    <cron:ClassOfWarrantOrRightAdditionalSubscriptionNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="i3c2ebabdbc694319b460f7822a98d7ec_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90ZXh0cmVnaW9uOmVlYzdiZTBhMjZhYjQ3Y2U4OTMzZjc3Y2M2YWFhM2UyXzM4NDgyOTA3MTA5NTI_b6e24627-84f2-4e5f-a9e7-ac4130f494c1"
      unitRef="shares">80100000</cron:ClassOfWarrantOrRightAdditionalSubscriptionNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="if23fc6b156434a4ea635f81fa026311f_I20190308"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90ZXh0cmVnaW9uOmVlYzdiZTBhMjZhYjQ3Y2U4OTMzZjc3Y2M2YWFhM2UyXzE1ODE_bb9fc75d-335c-43fe-971f-24b9f104cc01"
      unitRef="cadPerShare">19.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="i4aa0595f97de4e99a81b71038dd7e232_I20190308"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90ZXh0cmVnaW9uOmVlYzdiZTBhMjZhYjQ3Y2U4OTMzZjc3Y2M2YWFhM2UyXzQ5ODk_89430b10-a192-4354-af84-6b7bef2f1d20"
      unitRef="cadPerShare">16.25</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <cron:ClassOfWarrantOrRightMinimumOwnershipPercentageRequired
      contextRef="i4aa0595f97de4e99a81b71038dd7e232_I20190308"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90ZXh0cmVnaW9uOmVlYzdiZTBhMjZhYjQ3Y2U4OTMzZjc3Y2M2YWFhM2UyXzUxNDE_9b85fcd2-4cda-4dee-b436-b979e1261127"
      unitRef="number">0.20</cron:ClassOfWarrantOrRightMinimumOwnershipPercentageRequired>
    <cron:ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod
      contextRef="ib8b72a5bd98248bea7f4df55a0f96261_D20190308-20190308"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90ZXh0cmVnaW9uOmVlYzdiZTBhMjZhYjQ3Y2U4OTMzZjc3Y2M2YWFhM2UyXzY0MzM_c9f84e30-6784-4f0f-ad46-264b41b5882d">P10D</cron:ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod>
    <cron:ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise
      contextRef="ib8b72a5bd98248bea7f4df55a0f96261_D20190308-20190308"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90ZXh0cmVnaW9uOmVlYzdiZTBhMjZhYjQ3Y2U4OTMzZjc3Y2M2YWFhM2UyXzY1MjU_dac91518-dc84-4b66-8bf6-cf19fa0f0509">P10D</cron:ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="i6b2888ee861546ac8f47f813f636ea76_I20190308"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90ZXh0cmVnaW9uOmVlYzdiZTBhMjZhYjQ3Y2U4OTMzZjc3Y2M2YWFhM2UyXzY4NTg_d81cb944-86ef-47fb-a34f-4f83bb5dae53"
      unitRef="cadPerShare">16.25</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <cron:ClassOfWarrantOrRightMinimumOwnershipPercentageRequired
      contextRef="i6b2888ee861546ac8f47f813f636ea76_I20190308"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90ZXh0cmVnaW9uOmVlYzdiZTBhMjZhYjQ3Y2U4OTMzZjc3Y2M2YWFhM2UyXzcwNzE_a5ffdc2a-cb89-41a1-a3c2-84c74c645078"
      unitRef="number">0.20</cron:ClassOfWarrantOrRightMinimumOwnershipPercentageRequired>
    <cron:ClassOfWarrantOrRightExpense
      contextRef="i4b76c45a8a2b4fbaacb62e55f214d2cf_D20190309-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90ZXh0cmVnaW9uOmVlYzdiZTBhMjZhYjQ3Y2U4OTMzZjc3Y2M2YWFhM2UyXzcyMjI_231f3cb1-5b94-44d4-a133-a876ac90f64c"
      unitRef="usd">22355000</cron:ClassOfWarrantOrRightExpense>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90ZXh0cmVnaW9uOmVlYzdiZTBhMjZhYjQ3Y2U4OTMzZjc3Y2M2YWFhM2UyXzI0MTg5MjU1ODI0NTQw_8ad433d8-693f-4e4d-946a-1560d2a21167">&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reconciliations of the carrying amounts of the derivative liability are presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.288%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.050%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.155%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gain on revaluation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Exercise of Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effect of FX&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a) Altria Warrant&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(95,045)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(525)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(b) Pre-emptive Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(885)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(c) Top-up Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33,324)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,227)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(937)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(129,254)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,227)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,269)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.155%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of March 8, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gain on revaluation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Exercise of Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Effect of FX&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a) Altria Warrant&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,086,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(869,630)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(b) Pre-emptive Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(81,070)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(c) Top-up Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;386,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(326,119)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,478)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,565,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,276,819)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,478)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="i463b1771900c4b5f931730e913e28045_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTozNTlhMjYzMWFiYTg0ZDUxYmY2M2YxMzMyZDk3NDJjYi90YWJsZXJhbmdlOjM1OWEyNjMxYWJhODRkNTFiZjYzZjEzMzJkOTc0MmNiXzEtMS0xLTEtMA_66852d9b-c9f3-49d8-bb67-e0de0c0b26ce"
      unitRef="usd">-234428000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings
      contextRef="ia99e808e67ba45ec9755b053b88b09fe_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTozNTlhMjYzMWFiYTg0ZDUxYmY2M2YxMzMyZDk3NDJjYi90YWJsZXJhbmdlOjM1OWEyNjMxYWJhODRkNTFiZjYzZjEzMzJkOTc0MmNiXzEtMy0xLTEtMA_a81119fa-d4ba-4d6f-a5b9-77abb8308d1a"
      unitRef="usd">95045000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements
      contextRef="ia99e808e67ba45ec9755b053b88b09fe_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTozNTlhMjYzMWFiYTg0ZDUxYmY2M2YxMzMyZDk3NDJjYi90YWJsZXJhbmdlOjM1OWEyNjMxYWJhODRkNTFiZjYzZjEzMzJkOTc0MmNiXzEtNS0xLTEtMA_7f84c846-7130-4766-8f61-d87fc2a8a1e7"
      unitRef="usd">0</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="ia99e808e67ba45ec9755b053b88b09fe_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTozNTlhMjYzMWFiYTg0ZDUxYmY2M2YxMzMyZDk3NDJjYi90YWJsZXJhbmdlOjM1OWEyNjMxYWJhODRkNTFiZjYzZjEzMzJkOTc0MmNiXzEtNy0xLTEtMA_7ef7d350-8290-40ee-8b89-6eebcc32c455"
      unitRef="usd">525000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="i160db6daa81f47e891c5d92e0c029c65_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTozNTlhMjYzMWFiYTg0ZDUxYmY2M2YxMzMyZDk3NDJjYi90YWJsZXJhbmdlOjM1OWEyNjMxYWJhODRkNTFiZjYzZjEzMzJkOTc0MmNiXzEtOS0xLTEtMA_ce4c026d-5b8b-4bf9-a34a-efe27fb690a3"
      unitRef="usd">-138858000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="i27204cc81d264a0baff5a5819c885fff_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTozNTlhMjYzMWFiYTg0ZDUxYmY2M2YxMzMyZDk3NDJjYi90YWJsZXJhbmdlOjM1OWEyNjMxYWJhODRkNTFiZjYzZjEzMzJkOTc0MmNiXzItMS0xLTEtMA_15eea0b6-6f8a-4d0b-87ed-f120a4c0e6ed"
      unitRef="usd">-12787000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings
      contextRef="i865f9c6470f14034b9c3aa9527060924_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTozNTlhMjYzMWFiYTg0ZDUxYmY2M2YxMzMyZDk3NDJjYi90YWJsZXJhbmdlOjM1OWEyNjMxYWJhODRkNTFiZjYzZjEzMzJkOTc0MmNiXzItMy0xLTEtMA_993ee610-19fa-4188-9f29-bd3df504c961"
      unitRef="usd">885000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements
      contextRef="i865f9c6470f14034b9c3aa9527060924_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTozNTlhMjYzMWFiYTg0ZDUxYmY2M2YxMzMyZDk3NDJjYi90YWJsZXJhbmdlOjM1OWEyNjMxYWJhODRkNTFiZjYzZjEzMzJkOTc0MmNiXzItNS0xLTEtMA_114277cc-032a-4b87-8612-5a392d599b19"
      unitRef="usd">0</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i865f9c6470f14034b9c3aa9527060924_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTozNTlhMjYzMWFiYTg0ZDUxYmY2M2YxMzMyZDk3NDJjYi90YWJsZXJhbmdlOjM1OWEyNjMxYWJhODRkNTFiZjYzZjEzMzJkOTc0MmNiXzItNy0xLTEtMA_b142c578-8447-4a88-839b-19ac7b9aca75"
      unitRef="usd">-193000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="i23e679f22ae84a519b217df003c4e0ca_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTozNTlhMjYzMWFiYTg0ZDUxYmY2M2YxMzMyZDk3NDJjYi90YWJsZXJhbmdlOjM1OWEyNjMxYWJhODRkNTFiZjYzZjEzMzJkOTc0MmNiXzItOS0xLTEtMA_cd77eb39-fea1-4bf9-8602-854cd5cc5320"
      unitRef="usd">-12095000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="i9865e6634a1947ae934e34aee71371ad_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTozNTlhMjYzMWFiYTg0ZDUxYmY2M2YxMzMyZDk3NDJjYi90YWJsZXJhbmdlOjM1OWEyNjMxYWJhODRkNTFiZjYzZjEzMzJkOTc0MmNiXzMtMS0xLTEtMA_a34bffbe-0201-4e6e-bbf2-82134ac5b2a7"
      unitRef="usd">-49945000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings
      contextRef="ic39856d934ae48b2a455091b04383ffc_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTozNTlhMjYzMWFiYTg0ZDUxYmY2M2YxMzMyZDk3NDJjYi90YWJsZXJhbmdlOjM1OWEyNjMxYWJhODRkNTFiZjYzZjEzMzJkOTc0MmNiXzMtMy0xLTEtMA_6ae9c544-7862-4dff-b454-ea4ac581e98e"
      unitRef="usd">33324000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements
      contextRef="ic39856d934ae48b2a455091b04383ffc_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTozNTlhMjYzMWFiYTg0ZDUxYmY2M2YxMzMyZDk3NDJjYi90YWJsZXJhbmdlOjM1OWEyNjMxYWJhODRkNTFiZjYzZjEzMzJkOTc0MmNiXzMtNS0xLTEtMA_eaa3ff89-50f5-4c65-bdf4-caf04c57c56b"
      unitRef="usd">3227000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="ic39856d934ae48b2a455091b04383ffc_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTozNTlhMjYzMWFiYTg0ZDUxYmY2M2YxMzMyZDk3NDJjYi90YWJsZXJhbmdlOjM1OWEyNjMxYWJhODRkNTFiZjYzZjEzMzJkOTc0MmNiXzMtNy0xLTEtMA_005d9e1f-409e-4d85-9699-2028784c3a5f"
      unitRef="usd">937000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="ie513d3f3a44c445b883b46a6064152ff_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTozNTlhMjYzMWFiYTg0ZDUxYmY2M2YxMzMyZDk3NDJjYi90YWJsZXJhbmdlOjM1OWEyNjMxYWJhODRkNTFiZjYzZjEzMzJkOTc0MmNiXzMtOS0xLTEtMA_ed962f65-6a1d-414f-8674-058f1f30dc2a"
      unitRef="usd">-12457000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTozNTlhMjYzMWFiYTg0ZDUxYmY2M2YxMzMyZDk3NDJjYi90YWJsZXJhbmdlOjM1OWEyNjMxYWJhODRkNTFiZjYzZjEzMzJkOTc0MmNiXzQtMS0xLTEtMA_e60d994a-5ac8-4f1a-99b0-a425e7ba1292"
      unitRef="usd">-297160000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTozNTlhMjYzMWFiYTg0ZDUxYmY2M2YxMzMyZDk3NDJjYi90YWJsZXJhbmdlOjM1OWEyNjMxYWJhODRkNTFiZjYzZjEzMzJkOTc0MmNiXzQtMy0xLTEtMA_effe8ff0-60dd-4455-9d69-118e0c0bc866"
      unitRef="usd">129254000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTozNTlhMjYzMWFiYTg0ZDUxYmY2M2YxMzMyZDk3NDJjYi90YWJsZXJhbmdlOjM1OWEyNjMxYWJhODRkNTFiZjYzZjEzMzJkOTc0MmNiXzQtNS0xLTEtMA_68029308-a9ce-4170-9f5e-fa01f9e28e0e"
      unitRef="usd">3227000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTozNTlhMjYzMWFiYTg0ZDUxYmY2M2YxMzMyZDk3NDJjYi90YWJsZXJhbmdlOjM1OWEyNjMxYWJhODRkNTFiZjYzZjEzMzJkOTc0MmNiXzQtNy0xLTEtMA_30c07721-d3cd-4a9f-b5b7-ad8ce5079a2d"
      unitRef="usd">1269000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTozNTlhMjYzMWFiYTg0ZDUxYmY2M2YxMzMyZDk3NDJjYi90YWJsZXJhbmdlOjM1OWEyNjMxYWJhODRkNTFiZjYzZjEzMzJkOTc0MmNiXzQtOS0xLTEtMA_205537eb-a762-4263-aa8f-cfc1031ed133"
      unitRef="usd">-163410000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="if23fc6b156434a4ea635f81fa026311f_I20190308"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NTdkYTBmN2RiOTk0ODk3ODcxOGQ1NGViMGNmNzdkOS90YWJsZXJhbmdlOjY1N2RhMGY3ZGI5OTQ4OTc4NzE4ZDU0ZWIwY2Y3N2Q5XzEtMS0xLTEtODE0MQ_e37031b7-6346-4a44-8bc6-4ed4cb4f22c9"
      unitRef="usd">-1086920000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings
      contextRef="idb22be955a4449a9a766febb73b0f3a4_D20190309-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NTdkYTBmN2RiOTk0ODk3ODcxOGQ1NGViMGNmNzdkOS90YWJsZXJhbmdlOjY1N2RhMGY3ZGI5OTQ4OTc4NzE4ZDU0ZWIwY2Y3N2Q5XzEtMy0xLTEtODE0MQ_7e131aa2-279b-4005-8ef2-09d903384857"
      unitRef="usd">869630000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements
      contextRef="idb22be955a4449a9a766febb73b0f3a4_D20190309-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NTdkYTBmN2RiOTk0ODk3ODcxOGQ1NGViMGNmNzdkOS90YWJsZXJhbmdlOjY1N2RhMGY3ZGI5OTQ4OTc4NzE4ZDU0ZWIwY2Y3N2Q5XzEtNS0xLTEtODE0MQ_59795691-3a00-4d7d-91ee-259476cf3e4d"
      unitRef="usd">0</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="idb22be955a4449a9a766febb73b0f3a4_D20190309-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NTdkYTBmN2RiOTk0ODk3ODcxOGQ1NGViMGNmNzdkOS90YWJsZXJhbmdlOjY1N2RhMGY3ZGI5OTQ4OTc4NzE4ZDU0ZWIwY2Y3N2Q5XzEtNy0xLTEtODE0MQ_f1499807-55fe-48c4-80aa-6e295d28060c"
      unitRef="usd">-17138000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="i463b1771900c4b5f931730e913e28045_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NTdkYTBmN2RiOTk0ODk3ODcxOGQ1NGViMGNmNzdkOS90YWJsZXJhbmdlOjY1N2RhMGY3ZGI5OTQ4OTc4NzE4ZDU0ZWIwY2Y3N2Q5XzEtOS0xLTEtODE0MQ_57cfc3a4-1423-43fd-8ee8-ddf65ee63c72"
      unitRef="usd">-234428000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="i4aa0595f97de4e99a81b71038dd7e232_I20190308"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NTdkYTBmN2RiOTk0ODk3ODcxOGQ1NGViMGNmNzdkOS90YWJsZXJhbmdlOjY1N2RhMGY3ZGI5OTQ4OTc4NzE4ZDU0ZWIwY2Y3N2Q5XzItMS0xLTEtODE0MQ_b308a959-d14a-49d6-8256-fcb0ed7534d2"
      unitRef="usd">-92548000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings
      contextRef="i5ea1386c2a494e8fb6de3793f9261b99_D20190309-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NTdkYTBmN2RiOTk0ODk3ODcxOGQ1NGViMGNmNzdkOS90YWJsZXJhbmdlOjY1N2RhMGY3ZGI5OTQ4OTc4NzE4ZDU0ZWIwY2Y3N2Q5XzItMy0xLTEtODE0MQ_e7ae56ba-e70a-4b78-9550-6932e3090ef6"
      unitRef="usd">81070000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements
      contextRef="i5ea1386c2a494e8fb6de3793f9261b99_D20190309-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NTdkYTBmN2RiOTk0ODk3ODcxOGQ1NGViMGNmNzdkOS90YWJsZXJhbmdlOjY1N2RhMGY3ZGI5OTQ4OTc4NzE4ZDU0ZWIwY2Y3N2Q5XzItNS0xLTEtODE0MQ_70d78b9f-c6cf-44bb-828e-3842c2e48041"
      unitRef="usd">0</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i5ea1386c2a494e8fb6de3793f9261b99_D20190309-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NTdkYTBmN2RiOTk0ODk3ODcxOGQ1NGViMGNmNzdkOS90YWJsZXJhbmdlOjY1N2RhMGY3ZGI5OTQ4OTc4NzE4ZDU0ZWIwY2Y3N2Q5XzItNy0xLTEtODE0MQ_df3ca3a0-be5b-477f-b7b4-8696aec5dadb"
      unitRef="usd">-1309000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="i27204cc81d264a0baff5a5819c885fff_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NTdkYTBmN2RiOTk0ODk3ODcxOGQ1NGViMGNmNzdkOS90YWJsZXJhbmdlOjY1N2RhMGY3ZGI5OTQ4OTc4NzE4ZDU0ZWIwY2Y3N2Q5XzItOS0xLTEtODE0MQ_7f314320-4e10-4a78-a3fe-e43393c9bcd4"
      unitRef="usd">-12787000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="i6b2888ee861546ac8f47f813f636ea76_I20190308"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NTdkYTBmN2RiOTk0ODk3ODcxOGQ1NGViMGNmNzdkOS90YWJsZXJhbmdlOjY1N2RhMGY3ZGI5OTQ4OTc4NzE4ZDU0ZWIwY2Y3N2Q5XzMtMS0xLTEtODE0MQ_6f069f46-948e-4692-82eb-384748826cad"
      unitRef="usd">-386152000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings
      contextRef="i4b76c45a8a2b4fbaacb62e55f214d2cf_D20190309-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NTdkYTBmN2RiOTk0ODk3ODcxOGQ1NGViMGNmNzdkOS90YWJsZXJhbmdlOjY1N2RhMGY3ZGI5OTQ4OTc4NzE4ZDU0ZWIwY2Y3N2Q5XzMtMy0xLTEtODE0MQ_b34a30fc-07cf-4064-85bb-2e82c7194721"
      unitRef="usd">326119000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements
      contextRef="i4b76c45a8a2b4fbaacb62e55f214d2cf_D20190309-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NTdkYTBmN2RiOTk0ODk3ODcxOGQ1NGViMGNmNzdkOS90YWJsZXJhbmdlOjY1N2RhMGY3ZGI5OTQ4OTc4NzE4ZDU0ZWIwY2Y3N2Q5XzMtNS0xLTEtODE0MQ_58beb662-cecf-4093-badf-9103c3a34ce4"
      unitRef="usd">15478000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i4b76c45a8a2b4fbaacb62e55f214d2cf_D20190309-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NTdkYTBmN2RiOTk0ODk3ODcxOGQ1NGViMGNmNzdkOS90YWJsZXJhbmdlOjY1N2RhMGY3ZGI5OTQ4OTc4NzE4ZDU0ZWIwY2Y3N2Q5XzMtNy0xLTEtODE0MQ_6bd28ab0-cc28-44ba-8688-d467f4c70595"
      unitRef="usd">-5390000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="i9865e6634a1947ae934e34aee71371ad_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NTdkYTBmN2RiOTk0ODk3ODcxOGQ1NGViMGNmNzdkOS90YWJsZXJhbmdlOjY1N2RhMGY3ZGI5OTQ4OTc4NzE4ZDU0ZWIwY2Y3N2Q5XzMtOS0xLTEtODE0MQ_738e3c87-a849-452a-84f6-1329cfbeaf15"
      unitRef="usd">-49945000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="i813499ada2bf48288695564490d30842_I20190308"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NTdkYTBmN2RiOTk0ODk3ODcxOGQ1NGViMGNmNzdkOS90YWJsZXJhbmdlOjY1N2RhMGY3ZGI5OTQ4OTc4NzE4ZDU0ZWIwY2Y3N2Q5XzQtMS0xLTEtODE0MQ_a2f3679d-96de-47d1-99d9-e3edeecdeed3"
      unitRef="usd">-1565620000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings
      contextRef="i760c8d6a27604682ac45b413f79812b7_D20190309-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NTdkYTBmN2RiOTk0ODk3ODcxOGQ1NGViMGNmNzdkOS90YWJsZXJhbmdlOjY1N2RhMGY3ZGI5OTQ4OTc4NzE4ZDU0ZWIwY2Y3N2Q5XzQtMy0xLTEtODE0MQ_fe2bc5dc-8b0a-4ad2-86c3-451f1902a4b2"
      unitRef="usd">1276819000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements
      contextRef="i760c8d6a27604682ac45b413f79812b7_D20190309-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NTdkYTBmN2RiOTk0ODk3ODcxOGQ1NGViMGNmNzdkOS90YWJsZXJhbmdlOjY1N2RhMGY3ZGI5OTQ4OTc4NzE4ZDU0ZWIwY2Y3N2Q5XzQtNS0xLTEtODE0MQ_79b01bb9-aa20-45fc-b5c1-7044387f0002"
      unitRef="usd">15478000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i760c8d6a27604682ac45b413f79812b7_D20190309-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NTdkYTBmN2RiOTk0ODk3ODcxOGQ1NGViMGNmNzdkOS90YWJsZXJhbmdlOjY1N2RhMGY3ZGI5OTQ4OTc4NzE4ZDU0ZWIwY2Y3N2Q5XzQtNy0xLTEtODE0MQ_a099b33e-6560-419b-b3c1-de884b7515bb"
      unitRef="usd">-23837000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NTdkYTBmN2RiOTk0ODk3ODcxOGQ1NGViMGNmNzdkOS90YWJsZXJhbmdlOjY1N2RhMGY3ZGI5OTQ4OTc4NzE4ZDU0ZWIwY2Y3N2Q5XzQtOS0xLTEtODE0MQ_e14b5108-0e9c-4b81-9549-187b150f0a48"
      unitRef="usd">-297160000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90ZXh0cmVnaW9uOmVlYzdiZTBhMjZhYjQ3Y2U4OTMzZjc3Y2M2YWFhM2UyXzM4NDgyOTA3MDc5Nzc_effe8ff0-60dd-4455-9d69-118e0c0bc866"
      unitRef="usd">129254000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90ZXh0cmVnaW9uOmVlYzdiZTBhMjZhYjQ3Y2U4OTMzZjc3Y2M2YWFhM2UyXzk1ODc_3c771d5b-b882-4486-bff7-9faadec012d0">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair values of the derivative liabilities were determined using the Black-Scholes pricing model as of December&#160;31, 2020 and December&#160;31, 2019, applying the following inputs:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.820%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Altria Warrant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pre-emptive Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Top-up Rights&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share price at grant date (per share in C$)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$8.84&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$8.84&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$8.84&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subscription price (per share in C$)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$19.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$16.25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$16.25&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted average risk-free interest rate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.21%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.17%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.13%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weight average expected life (in years)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.18&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.98&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected annualized volatility&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(iii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-indent:-27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.820%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Altria Warrant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pre-emptive Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Top-up Rights&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share price at grant date (per share in C$)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$9.97&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$9.97&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$9.97&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subscription price (per share in C$)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$19.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$16.25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$16.25&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted average risk-free interest rate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.69%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.73%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.71%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weight average expected life (in years)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.18&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.66&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected annualized volatility&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(iii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;The risk-free interest rate was based on Bank of Canada government treasury bills and bonds with a remaining term equal to the expected life of the derivative liabilities. The risk-free interest rate uses a range of approximately 0.10% to 0.39% as of December&#160;31, 2020 (December&#160;31, 2019 &#x2013; 1.66% to 1.73%) for the Pre-emptive Rights and Top-up Rights.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;The expected life in years represents the period of time that the derivative liabilities are expected to be outstanding. The expected life of the Pre-emptive Rights and Top-up Rights is determined based on the expected term of the underlying options, warrants, and shares, to which the Pre-emptive Rights and Top-up Rights are linked. The expected life uses a range of approximately 0.50 years to 5 years as of December&#160;31, 2020 (December&#160;31, 2019 &#x2013; 0.25 years to 6 years).&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(iii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;Volatility was based on the blended historical volatility levels of the Company and peer companies.</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="ife69a303a50649b0b6f092658ca1d499_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTpmY2I1YTY4YWVkYmY0ODMwODBjZjBhODQ5MDM2Y2MzYS90YWJsZXJhbmdlOmZjYjVhNjhhZWRiZjQ4MzA4MGNmMGE4NDkwMzZjYzNhXzItNy0xLTEtMA_790d98f9-4a78-4851-a99a-18455d2a05f8"
      unitRef="cadPerShare">8.84</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="i1002f68219ae43b4be932a6273264a7c_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTpmY2I1YTY4YWVkYmY0ODMwODBjZjBhODQ5MDM2Y2MzYS90YWJsZXJhbmdlOmZjYjVhNjhhZWRiZjQ4MzA4MGNmMGE4NDkwMzZjYzNhXzItOS0xLTEtMA_01f7eb1f-23aa-4399-9ca8-91d297ebc0a9"
      unitRef="cadPerShare">8.84</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="i0ffe884f9b2344429d5d6c7f367928f0_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTpmY2I1YTY4YWVkYmY0ODMwODBjZjBhODQ5MDM2Y2MzYS90YWJsZXJhbmdlOmZjYjVhNjhhZWRiZjQ4MzA4MGNmMGE4NDkwMzZjYzNhXzItMTEtMS0xLTA_2360d650-30d1-4750-910b-c6d83bf39a20"
      unitRef="cadPerShare">8.84</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="i6c71bcd46a354ef48c615d33719c2f24_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTpmY2I1YTY4YWVkYmY0ODMwODBjZjBhODQ5MDM2Y2MzYS90YWJsZXJhbmdlOmZjYjVhNjhhZWRiZjQ4MzA4MGNmMGE4NDkwMzZjYzNhXzMtNy0xLTEtMA_1336a5ed-bdb5-4ffa-be89-879117b652af"
      unitRef="cadPerShare">19.00</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="i8c0529bb277d40f3b988874534a3c039_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTpmY2I1YTY4YWVkYmY0ODMwODBjZjBhODQ5MDM2Y2MzYS90YWJsZXJhbmdlOmZjYjVhNjhhZWRiZjQ4MzA4MGNmMGE4NDkwMzZjYzNhXzMtOS0xLTEtMA_c604a65f-80a7-4481-ae2b-8c869cff757f"
      unitRef="cadPerShare">16.25</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="ic392ce3b66a344a49d1bf576e9ecd60b_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTpmY2I1YTY4YWVkYmY0ODMwODBjZjBhODQ5MDM2Y2MzYS90YWJsZXJhbmdlOmZjYjVhNjhhZWRiZjQ4MzA4MGNmMGE4NDkwMzZjYzNhXzMtMTEtMS0xLTA_abe78374-8087-4e3f-a767-fc826615217d"
      unitRef="cadPerShare">16.25</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="i62783d3a67304a879fa26fcc257f00d9_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTpmY2I1YTY4YWVkYmY0ODMwODBjZjBhODQ5MDM2Y2MzYS90YWJsZXJhbmdlOmZjYjVhNjhhZWRiZjQ4MzA4MGNmMGE4NDkwMzZjYzNhXzQtNy0xLTEtMA_d4c94a54-7766-4bc6-abf5-aded5f83172e"
      unitRef="number">0.0021</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="ic1a12f35121a4490a0b734503d514f44_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTpmY2I1YTY4YWVkYmY0ODMwODBjZjBhODQ5MDM2Y2MzYS90YWJsZXJhbmdlOmZjYjVhNjhhZWRiZjQ4MzA4MGNmMGE4NDkwMzZjYzNhXzQtOS0xLTEtMA_d7f37507-2c80-429f-8926-41043a4b1c17"
      unitRef="number">0.0017</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="i53eb710ebdeb422f9560e5ed4459a65e_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTpmY2I1YTY4YWVkYmY0ODMwODBjZjBhODQ5MDM2Y2MzYS90YWJsZXJhbmdlOmZjYjVhNjhhZWRiZjQ4MzA4MGNmMGE4NDkwMzZjYzNhXzQtMTEtMS0xLTA_2e4f8363-12ed-450b-962d-f0996a96e2be"
      unitRef="number">0.0013</us-gaap:DerivativeLiabilityMeasurementInput>
    <cron:DerivativeLiabilityUsefulLifeTerm
      contextRef="i6e8fcd467ee0424da748f3c4e639ee5e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTpmY2I1YTY4YWVkYmY0ODMwODBjZjBhODQ5MDM2Y2MzYS90YWJsZXJhbmdlOmZjYjVhNjhhZWRiZjQ4MzA4MGNmMGE4NDkwMzZjYzNhXzUtNy0xLTEtMA_dc3e0b73-eb91-449f-af87-201799a816bf">P2Y2M4D</cron:DerivativeLiabilityUsefulLifeTerm>
    <cron:DerivativeLiabilityUsefulLifeTerm
      contextRef="i03121ba616544c3e9f4c72c77224e550_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTpmY2I1YTY4YWVkYmY0ODMwODBjZjBhODQ5MDM2Y2MzYS90YWJsZXJhbmdlOmZjYjVhNjhhZWRiZjQ4MzA4MGNmMGE4NDkwMzZjYzNhXzUtOS0xLTEtMA_30ad9f55-dc1c-4339-a74c-4d88c199071a">P1Y6M</cron:DerivativeLiabilityUsefulLifeTerm>
    <cron:DerivativeLiabilityUsefulLifeTerm
      contextRef="if4a40de9976a4a6ea2c284a6a976c110_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTpmY2I1YTY4YWVkYmY0ODMwODBjZjBhODQ5MDM2Y2MzYS90YWJsZXJhbmdlOmZjYjVhNjhhZWRiZjQ4MzA4MGNmMGE4NDkwMzZjYzNhXzUtMTEtMS0xLTA_b1cb6a4d-4e72-44cc-a2d7-ca8cae2aee37">P0Y11M23D</cron:DerivativeLiabilityUsefulLifeTerm>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="if1d01fc2d35c4475a2aba575ab42c8f4_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTpmY2I1YTY4YWVkYmY0ODMwODBjZjBhODQ5MDM2Y2MzYS90YWJsZXJhbmdlOmZjYjVhNjhhZWRiZjQ4MzA4MGNmMGE4NDkwMzZjYzNhXzYtNy0xLTEtMA_13bd1bb4-cef2-483d-8ddf-f249b9900550"
      unitRef="number">0.81</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="i7b526944dcae4dbfaef739d5f4926f50_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTpmY2I1YTY4YWVkYmY0ODMwODBjZjBhODQ5MDM2Y2MzYS90YWJsZXJhbmdlOmZjYjVhNjhhZWRiZjQ4MzA4MGNmMGE4NDkwMzZjYzNhXzYtOS0xLTEtMA_81335b61-4eb9-44a0-baeb-5ef846dbb46d"
      unitRef="number">0.81</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="id20cab244ae5423b89f1fbb3f050e58c_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTpmY2I1YTY4YWVkYmY0ODMwODBjZjBhODQ5MDM2Y2MzYS90YWJsZXJhbmdlOmZjYjVhNjhhZWRiZjQ4MzA4MGNmMGE4NDkwMzZjYzNhXzYtMTEtMS0xLTA_b584e13d-cad6-4ab8-8108-9226760ef0a0"
      unitRef="number">0.81</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="ibaa2909c766b4db18adc05215c8e5054_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTpmY2I1YTY4YWVkYmY0ODMwODBjZjBhODQ5MDM2Y2MzYS90YWJsZXJhbmdlOmZjYjVhNjhhZWRiZjQ4MzA4MGNmMGE4NDkwMzZjYzNhXzctNy0xLTEtMA_72844595-1e91-4b94-b6c0-0e5790e34909"
      unitRef="number">0</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="i6e6e6f6026a74efc8e2d8819d52b47dd_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTpmY2I1YTY4YWVkYmY0ODMwODBjZjBhODQ5MDM2Y2MzYS90YWJsZXJhbmdlOmZjYjVhNjhhZWRiZjQ4MzA4MGNmMGE4NDkwMzZjYzNhXzctOS0xLTEtMA_77364254-e50c-4326-a874-969e28706150"
      unitRef="number">0</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="ib82c5acab2a34945829d6e887a154631_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTpmY2I1YTY4YWVkYmY0ODMwODBjZjBhODQ5MDM2Y2MzYS90YWJsZXJhbmdlOmZjYjVhNjhhZWRiZjQ4MzA4MGNmMGE4NDkwMzZjYzNhXzctMTEtMS0xLTA_43f1d218-8843-452b-8c88-684a79318d89"
      unitRef="number">0</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="i532650c252fe40e8944dc186a1e32d95_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NmYwMjBjYTlkMjk0YzMxOTYxN2RjOTVlMmI4MTRiYS90YWJsZXJhbmdlOjY2ZjAyMGNhOWQyOTRjMzE5NjE3ZGM5NWUyYjgxNGJhXzItMS0xLTEtMTA4NDU_a6be5cb6-0d42-429e-b490-5190a284e9d0"
      unitRef="cadPerShare">9.97</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="i8e7fd630e9344584911653a57e1cade2_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NmYwMjBjYTlkMjk0YzMxOTYxN2RjOTVlMmI4MTRiYS90YWJsZXJhbmdlOjY2ZjAyMGNhOWQyOTRjMzE5NjE3ZGM5NWUyYjgxNGJhXzItMy0xLTEtMTA4NDU_67ab307c-e348-4da9-a9de-7e171873da08"
      unitRef="cadPerShare">9.97</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="ib31c0e699cee4523929ffe9f0cb71ec3_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NmYwMjBjYTlkMjk0YzMxOTYxN2RjOTVlMmI4MTRiYS90YWJsZXJhbmdlOjY2ZjAyMGNhOWQyOTRjMzE5NjE3ZGM5NWUyYjgxNGJhXzItNS0xLTEtMTA4NDU_0af48483-4f82-4f89-8fe4-1cca18cc5d1a"
      unitRef="cadPerShare">9.97</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="i8dad115f7a854f8f8535c69c691a66bd_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NmYwMjBjYTlkMjk0YzMxOTYxN2RjOTVlMmI4MTRiYS90YWJsZXJhbmdlOjY2ZjAyMGNhOWQyOTRjMzE5NjE3ZGM5NWUyYjgxNGJhXzMtMS0xLTEtMTA4NDU_d719006e-83b2-45b7-9dce-62fcb6b30919"
      unitRef="cadPerShare">19.00</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="i6ac25230d48a4dd3b8c55100b4962584_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NmYwMjBjYTlkMjk0YzMxOTYxN2RjOTVlMmI4MTRiYS90YWJsZXJhbmdlOjY2ZjAyMGNhOWQyOTRjMzE5NjE3ZGM5NWUyYjgxNGJhXzMtMy0xLTEtMTA4NDU_d77130d2-b9c4-4a0b-a889-48fca5cf60be"
      unitRef="cadPerShare">16.25</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="i090d89e22cd84b90b9d10cc6c3747232_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NmYwMjBjYTlkMjk0YzMxOTYxN2RjOTVlMmI4MTRiYS90YWJsZXJhbmdlOjY2ZjAyMGNhOWQyOTRjMzE5NjE3ZGM5NWUyYjgxNGJhXzMtNS0xLTEtMTA4NDU_560a2ed4-a933-4e10-b827-7e42d3aa19aa"
      unitRef="cadPerShare">16.25</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="ie2f5b74993ca4afe861ba1252b560ab3_I20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NmYwMjBjYTlkMjk0YzMxOTYxN2RjOTVlMmI4MTRiYS90YWJsZXJhbmdlOjY2ZjAyMGNhOWQyOTRjMzE5NjE3ZGM5NWUyYjgxNGJhXzQtMS0xLTEtMTA4NDU_72ca84e9-48c0-4160-ba30-6d37a9c19f87"
      unitRef="number">0.0169</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="ifc02dbc8bf0d4565843b395d0dac82d6_I20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NmYwMjBjYTlkMjk0YzMxOTYxN2RjOTVlMmI4MTRiYS90YWJsZXJhbmdlOjY2ZjAyMGNhOWQyOTRjMzE5NjE3ZGM5NWUyYjgxNGJhXzQtMy0xLTEtMTA4NDU_51ed46de-6fe9-46b2-9654-1804b8a6ae60"
      unitRef="number">0.0173</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="i67d90ff5508a41d4a7e560c59d4cd97f_I20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NmYwMjBjYTlkMjk0YzMxOTYxN2RjOTVlMmI4MTRiYS90YWJsZXJhbmdlOjY2ZjAyMGNhOWQyOTRjMzE5NjE3ZGM5NWUyYjgxNGJhXzQtNS0xLTEtMTA4NDU_efb9a764-cb39-4759-bd19-dcbb6e10fe52"
      unitRef="number">0.0171</us-gaap:DerivativeLiabilityMeasurementInput>
    <cron:DerivativeLiabilityUsefulLifeTerm
      contextRef="i511f22de5c4141928962bdab9879ecea_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NmYwMjBjYTlkMjk0YzMxOTYxN2RjOTVlMmI4MTRiYS90YWJsZXJhbmdlOjY2ZjAyMGNhOWQyOTRjMzE5NjE3ZGM5NWUyYjgxNGJhXzUtMS0xLTEtMTA4NDU_b3fcd0e6-c149-4db7-8229-29851a32686e">P3Y2M4D</cron:DerivativeLiabilityUsefulLifeTerm>
    <cron:DerivativeLiabilityUsefulLifeTerm
      contextRef="i0dce3d6d45ea4267a21a2a0361da3f85_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NmYwMjBjYTlkMjk0YzMxOTYxN2RjOTVlMmI4MTRiYS90YWJsZXJhbmdlOjY2ZjAyMGNhOWQyOTRjMzE5NjE3ZGM5NWUyYjgxNGJhXzUtMy0xLTEtMTA4NDU_2ca86daf-c2d3-41f1-9358-5421b7a83555">P1Y3M</cron:DerivativeLiabilityUsefulLifeTerm>
    <cron:DerivativeLiabilityUsefulLifeTerm
      contextRef="i51f073ba36984f5c87fd937fb7d24eff_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NmYwMjBjYTlkMjk0YzMxOTYxN2RjOTVlMmI4MTRiYS90YWJsZXJhbmdlOjY2ZjAyMGNhOWQyOTRjMzE5NjE3ZGM5NWUyYjgxNGJhXzUtNS0xLTEtMTA4NDU_4500b239-6e62-45f5-8771-4a512f86f62a">P1Y7M28D</cron:DerivativeLiabilityUsefulLifeTerm>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="i8ee40ca46ccd4085930f0437fb342632_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NmYwMjBjYTlkMjk0YzMxOTYxN2RjOTVlMmI4MTRiYS90YWJsZXJhbmdlOjY2ZjAyMGNhOWQyOTRjMzE5NjE3ZGM5NWUyYjgxNGJhXzYtMS0xLTEtMTA4NDU_c9833181-0801-454b-bb13-348ae7652b76"
      unitRef="number">0.82</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="i1911ee2c91ef4dd592addb1a63a0fc20_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NmYwMjBjYTlkMjk0YzMxOTYxN2RjOTVlMmI4MTRiYS90YWJsZXJhbmdlOjY2ZjAyMGNhOWQyOTRjMzE5NjE3ZGM5NWUyYjgxNGJhXzYtMy0xLTEtMTA4NDU_12cc75c9-bd0b-4f36-8e65-24ed30c910c4"
      unitRef="number">0.82</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="i49e6ac7b6f4a43adb3596a15ec175f15_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NmYwMjBjYTlkMjk0YzMxOTYxN2RjOTVlMmI4MTRiYS90YWJsZXJhbmdlOjY2ZjAyMGNhOWQyOTRjMzE5NjE3ZGM5NWUyYjgxNGJhXzYtNS0xLTEtMTA4NDU_f1609431-1b2b-45e5-aed3-f181cfc5a95f"
      unitRef="number">0.82</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="i84cef257e8654992885dbc495e97fa6a_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NmYwMjBjYTlkMjk0YzMxOTYxN2RjOTVlMmI4MTRiYS90YWJsZXJhbmdlOjY2ZjAyMGNhOWQyOTRjMzE5NjE3ZGM5NWUyYjgxNGJhXzctMS0xLTEtMTA4NDU_82f40047-27be-4961-ab35-cd0cd9e92273"
      unitRef="number">0</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="i375b8aad8904491db84b8c4c1e23cc5d_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NmYwMjBjYTlkMjk0YzMxOTYxN2RjOTVlMmI4MTRiYS90YWJsZXJhbmdlOjY2ZjAyMGNhOWQyOTRjMzE5NjE3ZGM5NWUyYjgxNGJhXzctMy0xLTEtMTA4NDU_45946265-ceb1-4e0b-a224-e906eccfc568"
      unitRef="number">0</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="idcfe25f7b5d4403ea6a60531b21489be_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTo2NmYwMjBjYTlkMjk0YzMxOTYxN2RjOTVlMmI4MTRiYS90YWJsZXJhbmdlOjY2ZjAyMGNhOWQyOTRjMzE5NjE3ZGM5NWUyYjgxNGJhXzctNS0xLTEtMTA4NDU_04a0bdda-e690-4ee8-a9c7-d688d7920c25"
      unitRef="number">0</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="ic9ab5c8a35da422c8b07919b72494b75_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90ZXh0cmVnaW9uOmVlYzdiZTBhMjZhYjQ3Y2U4OTMzZjc3Y2M2YWFhM2UyXzEwOTk1MTE2Mzc2NzM_58cb93b9-214b-49b3-9aef-d353fce2483b"
      unitRef="number">0.0010</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="i449c71c0a6bc41a7843b95924704320f_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90ZXh0cmVnaW9uOmVlYzdiZTBhMjZhYjQ3Y2U4OTMzZjc3Y2M2YWFhM2UyXzEwOTk1MTE2Mzc2ODA_cd1f5120-5727-42b5-903d-32441e4c8afc"
      unitRef="number">0.0039</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="ib8c37aaed6534f7495f7b25106f852b4_I20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90ZXh0cmVnaW9uOmVlYzdiZTBhMjZhYjQ3Y2U4OTMzZjc3Y2M2YWFhM2UyXzEwOTk1MTE2Mzc2OTk_0daa1d8e-f9b9-4632-80cc-03f9508bde45"
      unitRef="number">0.0166</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="i3afed61a87ba4d3e991bdb186e51a8eb_I20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90ZXh0cmVnaW9uOmVlYzdiZTBhMjZhYjQ3Y2U4OTMzZjc3Y2M2YWFhM2UyXzEwOTk1MTE2Mzc3MDU_b6f9b726-2320-4e80-8c04-d09926d3aa5f"
      unitRef="number">0.0173</us-gaap:DerivativeLiabilityMeasurementInput>
    <cron:DerivativeLiabilityUsefulLifeTerm
      contextRef="i8eb7b029c40f44a1a5f9d5ceb456ed65_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90ZXh0cmVnaW9uOmVlYzdiZTBhMjZhYjQ3Y2U4OTMzZjc3Y2M2YWFhM2UyXzEwOTk1MTE2Mzc3NTU_9bbce4d5-0906-46b4-99e2-2eaf16ac7794">P0Y6M</cron:DerivativeLiabilityUsefulLifeTerm>
    <cron:DerivativeLiabilityUsefulLifeTerm
      contextRef="i7ee5cf3f81f746e9a91d18e6efa4e418_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90ZXh0cmVnaW9uOmVlYzdiZTBhMjZhYjQ3Y2U4OTMzZjc3Y2M2YWFhM2UyXzEwOTk1MTE2Mzc1MzY_64a19302-c582-45d9-8fc3-e8835b7c04c5">P5Y</cron:DerivativeLiabilityUsefulLifeTerm>
    <cron:DerivativeLiabilityUsefulLifeTerm
      contextRef="i60f16583657641d1bc65b04b7fcc0429_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90ZXh0cmVnaW9uOmVlYzdiZTBhMjZhYjQ3Y2U4OTMzZjc3Y2M2YWFhM2UyXzEwOTk1MTE2Mzc3NTg_1d36acdf-e414-4e5e-a5af-2adbc12610fd">P0Y3M</cron:DerivativeLiabilityUsefulLifeTerm>
    <cron:DerivativeLiabilityUsefulLifeTerm
      contextRef="i301270b5b8644233a9dc1ae42d07c539_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90ZXh0cmVnaW9uOmVlYzdiZTBhMjZhYjQ3Y2U4OTMzZjc3Y2M2YWFhM2UyXzEwOTk1MTE2Mzc3NjY_a197263f-2d54-4a66-9dca-543ee5db05a2">P6Y</cron:DerivativeLiabilityUsefulLifeTerm>
    <cron:SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90ZXh0cmVnaW9uOmVlYzdiZTBhMjZhYjQ3Y2U4OTMzZjc3Y2M2YWFhM2UyXzI0MTg5MjU1ODI0NTQx_a528144a-ba33-4d91-876d-90f804add9b1">&lt;div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table quantifies each of the significant inputs described above and provides a sensitivity analysis of the impact on the reported values of the derivative liabilities. The sensitivity analysis for each significant input is performed by assuming a 10% decrease in the input while other significant inputs remain constant at management&#x2019;s best estimate as of the respective dates. As of December&#160;31, 2020, there would be an equal but opposite impact on net income (loss), refer to Note 15, and as of December&#160;31, 2019, there would be an equal but opposite impact on share capital.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.820%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Decrease as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Altria Warrant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pre-emptive Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Top-up Rights&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share price at issuance date&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average expected life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected annualized volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.820%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Decrease as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Altria Warrant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pre-emptive Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Top-up Rights&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share price at issuance date&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average expected life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected annualized volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cron:SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock>
    <cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss
      contextRef="i160db6daa81f47e891c5d92e0c029c65_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZToxMzg2NDI0MjI2NjU0NTFiOWVjNjEzMzI0YjRjZjk3NC90YWJsZXJhbmdlOjEzODY0MjQyMjY2NTQ1MWI5ZWM2MTMzMjRiNGNmOTc0XzItOC0xLTEtMA_93f6214e-e50f-4727-8b10-a8b24fbd68ba"
      unitRef="usd">25819000</cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss>
    <cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss
      contextRef="i23e679f22ae84a519b217df003c4e0ca_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZToxMzg2NDI0MjI2NjU0NTFiOWVjNjEzMzI0YjRjZjk3NC90YWJsZXJhbmdlOjEzODY0MjQyMjY2NTQ1MWI5ZWM2MTMzMjRiNGNmOTc0XzItMTAtMS0xLTA_3881a6d5-ed39-4fb2-a272-844797986814"
      unitRef="usd">2527000</cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss>
    <cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss
      contextRef="ie513d3f3a44c445b883b46a6064152ff_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZToxMzg2NDI0MjI2NjU0NTFiOWVjNjEzMzI0YjRjZjk3NC90YWJsZXJhbmdlOjEzODY0MjQyMjY2NTQ1MWI5ZWM2MTMzMjRiNGNmOTc0XzItMTItMS0xLTA_c0dc4fc5-a496-4187-983e-96ea9746a013"
      unitRef="usd">2989000</cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss>
    <cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss
      contextRef="i160db6daa81f47e891c5d92e0c029c65_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZToxMzg2NDI0MjI2NjU0NTFiOWVjNjEzMzI0YjRjZjk3NC90YWJsZXJhbmdlOjEzODY0MjQyMjY2NTQ1MWI5ZWM2MTMzMjRiNGNmOTc0XzMtOC0xLTEtMA_0bf9610a-05bf-44cd-afd5-859047ede53e"
      unitRef="usd">13541000</cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss>
    <cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss
      contextRef="i23e679f22ae84a519b217df003c4e0ca_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZToxMzg2NDI0MjI2NjU0NTFiOWVjNjEzMzI0YjRjZjk3NC90YWJsZXJhbmdlOjEzODY0MjQyMjY2NTQ1MWI5ZWM2MTMzMjRiNGNmOTc0XzMtMTAtMS0xLTA_ac61d561-6097-49d9-a2f5-8da56d691329"
      unitRef="usd">1988000</cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss>
    <cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss
      contextRef="ie513d3f3a44c445b883b46a6064152ff_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZToxMzg2NDI0MjI2NjU0NTFiOWVjNjEzMzI0YjRjZjk3NC90YWJsZXJhbmdlOjEzODY0MjQyMjY2NTQ1MWI5ZWM2MTMzMjRiNGNmOTc0XzMtMTItMS0xLTA_09afac47-5a6f-4c22-9b0b-45edcfad2545"
      unitRef="usd">2121000</cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss>
    <cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss
      contextRef="i160db6daa81f47e891c5d92e0c029c65_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZToxMzg2NDI0MjI2NjU0NTFiOWVjNjEzMzI0YjRjZjk3NC90YWJsZXJhbmdlOjEzODY0MjQyMjY2NTQ1MWI5ZWM2MTMzMjRiNGNmOTc0XzQtOC0xLTEtMA_9352ed3e-30a6-4bed-b914-a54bbc020f5a"
      unitRef="usd">26183000</cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss>
    <cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss
      contextRef="i23e679f22ae84a519b217df003c4e0ca_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZToxMzg2NDI0MjI2NjU0NTFiOWVjNjEzMzI0YjRjZjk3NC90YWJsZXJhbmdlOjEzODY0MjQyMjY2NTQ1MWI5ZWM2MTMzMjRiNGNmOTc0XzQtMTAtMS0xLTA_62a49bf2-ed5b-43da-8983-5b4acbbaff06"
      unitRef="usd">2269000</cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss>
    <cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss
      contextRef="ie513d3f3a44c445b883b46a6064152ff_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZToxMzg2NDI0MjI2NjU0NTFiOWVjNjEzMzI0YjRjZjk3NC90YWJsZXJhbmdlOjEzODY0MjQyMjY2NTQ1MWI5ZWM2MTMzMjRiNGNmOTc0XzQtMTItMS0xLTA_51c736ca-7831-45f7-b473-0d341ea262cf"
      unitRef="usd">2602000</cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss>
    <cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss
      contextRef="i463b1771900c4b5f931730e913e28045_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTpmNzRlZTQ3ZWNhY2U0MDlkYTg4MDRjY2UxM2NmMDhjOC90YWJsZXJhbmdlOmY3NGVlNDdlY2FjZTQwOWRhODgwNGNjZTEzY2YwOGM4XzItMi0xLTEtMTA4Njg_00b20425-c7a9-4a24-9c77-60ae272671fb"
      unitRef="usd">36436000</cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss>
    <cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss
      contextRef="i27204cc81d264a0baff5a5819c885fff_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTpmNzRlZTQ3ZWNhY2U0MDlkYTg4MDRjY2UxM2NmMDhjOC90YWJsZXJhbmdlOmY3NGVlNDdlY2FjZTQwOWRhODgwNGNjZTEzY2YwOGM4XzItNC0xLTEtMTA4Njg_25a663bf-edec-443f-835c-5c7e695448f9"
      unitRef="usd">2743000</cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss>
    <cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss
      contextRef="i9865e6634a1947ae934e34aee71371ad_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTpmNzRlZTQ3ZWNhY2U0MDlkYTg4MDRjY2UxM2NmMDhjOC90YWJsZXJhbmdlOmY3NGVlNDdlY2FjZTQwOWRhODgwNGNjZTEzY2YwOGM4XzItNi0xLTEtMTA4Njg_18b2df17-b765-4b8b-8c37-a489596aa1dd"
      unitRef="usd">9577000</cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss>
    <cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss
      contextRef="i463b1771900c4b5f931730e913e28045_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTpmNzRlZTQ3ZWNhY2U0MDlkYTg4MDRjY2UxM2NmMDhjOC90YWJsZXJhbmdlOmY3NGVlNDdlY2FjZTQwOWRhODgwNGNjZTEzY2YwOGM4XzMtMi0xLTEtMTA4Njg_74347f23-8055-45f3-ac1f-f8c40aec08ec"
      unitRef="usd">17471000</cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss>
    <cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss
      contextRef="i27204cc81d264a0baff5a5819c885fff_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTpmNzRlZTQ3ZWNhY2U0MDlkYTg4MDRjY2UxM2NmMDhjOC90YWJsZXJhbmdlOmY3NGVlNDdlY2FjZTQwOWRhODgwNGNjZTEzY2YwOGM4XzMtNC0xLTEtMTA4Njg_4d68cb14-8267-4832-a0ab-8e043ea2a026"
      unitRef="usd">2366000</cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss>
    <cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss
      contextRef="i9865e6634a1947ae934e34aee71371ad_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTpmNzRlZTQ3ZWNhY2U0MDlkYTg4MDRjY2UxM2NmMDhjOC90YWJsZXJhbmdlOmY3NGVlNDdlY2FjZTQwOWRhODgwNGNjZTEzY2YwOGM4XzMtNi0xLTEtMTA4Njg_5be01af5-70e7-4618-a143-941c07ede742"
      unitRef="usd">2178000</cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss>
    <cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss
      contextRef="i463b1771900c4b5f931730e913e28045_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTpmNzRlZTQ3ZWNhY2U0MDlkYTg4MDRjY2UxM2NmMDhjOC90YWJsZXJhbmdlOmY3NGVlNDdlY2FjZTQwOWRhODgwNGNjZTEzY2YwOGM4XzQtMi0xLTEtMTA4Njg_d5de5e07-8350-4a5d-952d-b6566308b172"
      unitRef="usd">33343000</cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss>
    <cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss
      contextRef="i27204cc81d264a0baff5a5819c885fff_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTpmNzRlZTQ3ZWNhY2U0MDlkYTg4MDRjY2UxM2NmMDhjOC90YWJsZXJhbmdlOmY3NGVlNDdlY2FjZTQwOWRhODgwNGNjZTEzY2YwOGM4XzQtNC0xLTEtMTA4Njg_692ee439-0e18-4d8f-9378-889b1a19abeb"
      unitRef="usd">2180000</cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss>
    <cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss
      contextRef="i9865e6634a1947ae934e34aee71371ad_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODEvZnJhZzplZWM3YmUwYTI2YWI0N2NlODkzM2Y3N2NjNmFhYTNlMi90YWJsZTpmNzRlZTQ3ZWNhY2U0MDlkYTg4MDRjY2UxM2NmMDhjOC90YWJsZXJhbmdlOmY3NGVlNDdlY2FjZTQwOWRhODgwNGNjZTEzY2YwOGM4XzQtNi0xLTEtMTA4Njg_095debb6-a91d-471c-8ecb-1a2a6448bb1c"
      unitRef="usd">7714000</cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90ZXh0cmVnaW9uOmFiMTEyNjUyZTExYTQyZDFiNzczZmM1NGYwZjgxMzkzXzI0NjY_013418bf-d1f9-4c5e-83af-198b97f479cf">Capital Stock&#160;&#160;&#160;&#160;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is authorized to issue an unlimited number of no par value common shares. The holders of the common shares are entitled to receive dividends, which may be declared from time to time, and are entitled to one vote per share at shareholder meetings of the Company. All common shares are ranked equally with regards to the Company&#x2019;s residual net assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of common shares issued, other than in connection with outstanding options and warrants (see Note 16): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.372%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.208%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Altria Investment&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149,831,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redwood Acquisition&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,086,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Private placement&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(iii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;856,017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bought deal offering&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(iv)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,677,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155,773,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,677,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.1pt"&gt;During the year ended December&#160;31, 2019, the Company issued 149,831,154 common shares to Altria for aggregate gross proceeds of $1,809,556, net of issuance costs of $3,722. The gross proceeds were first allocated to the derivative liabilities issued in connection with the Altria Investment, and the residual of $248,302 was allocated to share capital. Pursuant to the Altria Investment, the Company incurred transaction costs of $25,223, of which $3,642 was allocated to share capital and $21,581 to the derivative liabilities based on the relative fair values assigned to the respective components. Refer to Note 14 for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.66pt"&gt;During the year ended December&#160;31, 2019, the Company issued 5,086,586 common shares with a fair value of $56,109 related to the acquisition (the &#x201c;Redwood Acquisition&#x201d;) of certain subsidiaries of Redwood Holding Group, LLC (collectively, &#x201c;Redwood&#x201d;). Refer to Note 27 for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(iii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.22pt"&gt;During the year ended December&#160;31, 2019, the Company issued 856,017 common shares to Kristen Bell, an accredited investor in a private placement (&#x201c;Private Placement&#x201d;) in reliance on Section 4(a)(2) of the Securities Act in connection with the use of certain publicity rights in brand development. The common shares vest in three equal installments on each of (a) January 31, 2020, (b) June 23, 2021, and (c) December 23, 2022. The issuance did not involve a public offering and was made without general solicitation or advertising. The total fair value of the consideration paid for the issuance of such common shares was approximately $6,000. The fair value of the shares was calculated using the 10-day volume weighted average price per share of the Company&#x2019;s common shares on Nasdaq.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(iv)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.5pt"&gt;During the year ended December&#160;31, 2018, the Company issued 15,677,143 common shares for aggregate gross proceeds of $115,510 through bought deal offerings, net of issuance costs of $7,577.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no share repurchases during the year ended December&#160;31, 2020, 2019 or 2018.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <cron:CommonStockNumberOfVotesPerShare
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90ZXh0cmVnaW9uOmFiMTEyNjUyZTExYTQyZDFiNzczZmM1NGYwZjgxMzkzXzIyOA_b43a652f-146f-4b3c-ac0e-0392d63e4790"
      unitRef="vote">1</cron:CommonStockNumberOfVotesPerShare>
    <us-gaap:ScheduleOfStockByClassTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90ZXh0cmVnaW9uOmFiMTEyNjUyZTExYTQyZDFiNzczZmM1NGYwZjgxMzkzXzIzMDg5NzQ0MjA3ODc5_e4843dc7-30f2-4553-91b3-2b64ce543cf5">&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of common shares issued, other than in connection with outstanding options and warrants (see Note 16): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.372%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.208%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Altria Investment&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149,831,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redwood Acquisition&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,086,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Private placement&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(iii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;856,017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bought deal offering&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(iv)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,677,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155,773,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,677,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.1pt"&gt;During the year ended December&#160;31, 2019, the Company issued 149,831,154 common shares to Altria for aggregate gross proceeds of $1,809,556, net of issuance costs of $3,722. The gross proceeds were first allocated to the derivative liabilities issued in connection with the Altria Investment, and the residual of $248,302 was allocated to share capital. Pursuant to the Altria Investment, the Company incurred transaction costs of $25,223, of which $3,642 was allocated to share capital and $21,581 to the derivative liabilities based on the relative fair values assigned to the respective components. Refer to Note 14 for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.66pt"&gt;During the year ended December&#160;31, 2019, the Company issued 5,086,586 common shares with a fair value of $56,109 related to the acquisition (the &#x201c;Redwood Acquisition&#x201d;) of certain subsidiaries of Redwood Holding Group, LLC (collectively, &#x201c;Redwood&#x201d;). Refer to Note 27 for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(iii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.22pt"&gt;During the year ended December&#160;31, 2019, the Company issued 856,017 common shares to Kristen Bell, an accredited investor in a private placement (&#x201c;Private Placement&#x201d;) in reliance on Section 4(a)(2) of the Securities Act in connection with the use of certain publicity rights in brand development. The common shares vest in three equal installments on each of (a) January 31, 2020, (b) June 23, 2021, and (c) December 23, 2022. The issuance did not involve a public offering and was made without general solicitation or advertising. The total fair value of the consideration paid for the issuance of such common shares was approximately $6,000. The fair value of the shares was calculated using the 10-day volume weighted average price per share of the Company&#x2019;s common shares on Nasdaq.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(iv)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.5pt"&gt;During the year ended December&#160;31, 2018, the Company issued 15,677,143 common shares for aggregate gross proceeds of $115,510 through bought deal offerings, net of issuance costs of $7,577.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfStockByClassTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="ica622cb684474ab3a25d8fbc0860181c_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90YWJsZTphNzVlNzNmZjc4ZTc0ODI3YjE2ZjFhYTI3NWJjYTk1Yy90YWJsZXJhbmdlOmE3NWU3M2ZmNzhlNzQ4MjdiMTZmMWFhMjc1YmNhOTVjXzMtMS0xLTEtMA_6bbd59f2-3541-4a38-9411-68fa4de9175f"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i1db6dad47a0c48f9ba16df4ee15bdba5_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90YWJsZTphNzVlNzNmZjc4ZTc0ODI3YjE2ZjFhYTI3NWJjYTk1Yy90YWJsZXJhbmdlOmE3NWU3M2ZmNzhlNzQ4MjdiMTZmMWFhMjc1YmNhOTVjXzMtMy0xLTEtMA_6b544f3d-c5b3-4811-a7bd-1b5d2114318e"
      unitRef="shares">149831154</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i7d7e063426374ebba0b27e029f93204e_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90YWJsZTphNzVlNzNmZjc4ZTc0ODI3YjE2ZjFhYTI3NWJjYTk1Yy90YWJsZXJhbmdlOmE3NWU3M2ZmNzhlNzQ4MjdiMTZmMWFhMjc1YmNhOTVjXzMtNS0xLTEtMA_a7ffc51c-c664-43b6-87d8-b9b73681bb05"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i9d8d3d9a698948f2a7e5b7ede9faa261_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90YWJsZTphNzVlNzNmZjc4ZTc0ODI3YjE2ZjFhYTI3NWJjYTk1Yy90YWJsZXJhbmdlOmE3NWU3M2ZmNzhlNzQ4MjdiMTZmMWFhMjc1YmNhOTVjXzQtMS0xLTEtMA_a6429598-6222-47a8-b813-3d54941b5cca"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i399c1d0125d94144839ad09cbfcd4e79_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90YWJsZTphNzVlNzNmZjc4ZTc0ODI3YjE2ZjFhYTI3NWJjYTk1Yy90YWJsZXJhbmdlOmE3NWU3M2ZmNzhlNzQ4MjdiMTZmMWFhMjc1YmNhOTVjXzQtMy0xLTEtMA_53ec6176-f97d-4a79-9dfb-46199cb18ed3"
      unitRef="shares">5086586</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i63b115fac3df4d088ed98d2fe12e8da5_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90YWJsZTphNzVlNzNmZjc4ZTc0ODI3YjE2ZjFhYTI3NWJjYTk1Yy90YWJsZXJhbmdlOmE3NWU3M2ZmNzhlNzQ4MjdiMTZmMWFhMjc1YmNhOTVjXzQtNS0xLTEtMA_609c93e8-c84c-429d-917c-c0a8151b2577"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i7a93d4ff964040f3961be26878cf2aa6_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90YWJsZTphNzVlNzNmZjc4ZTc0ODI3YjE2ZjFhYTI3NWJjYTk1Yy90YWJsZXJhbmdlOmE3NWU3M2ZmNzhlNzQ4MjdiMTZmMWFhMjc1YmNhOTVjXzUtMS0xLTEtMA_f13510a9-5382-479d-b79e-0d128e29695c"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i6385655ed7694227b1ba4c2470a26f37_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90YWJsZTphNzVlNzNmZjc4ZTc0ODI3YjE2ZjFhYTI3NWJjYTk1Yy90YWJsZXJhbmdlOmE3NWU3M2ZmNzhlNzQ4MjdiMTZmMWFhMjc1YmNhOTVjXzQtMy0xLTEtODY3Ng_6ce5112e-57ba-4eba-b4dc-0c71420c20d5"
      unitRef="shares">856017</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i548a898f85674e398f117c44d298a956_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90YWJsZTphNzVlNzNmZjc4ZTc0ODI3YjE2ZjFhYTI3NWJjYTk1Yy90YWJsZXJhbmdlOmE3NWU3M2ZmNzhlNzQ4MjdiMTZmMWFhMjc1YmNhOTVjXzMtNS0xLTEtMjM3MzM_ac9e53fb-1318-4d52-872c-54a75639ba11"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="id6e6569c5b684d46b2b88bc879497620_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90YWJsZTphNzVlNzNmZjc4ZTc0ODI3YjE2ZjFhYTI3NWJjYTk1Yy90YWJsZXJhbmdlOmE3NWU3M2ZmNzhlNzQ4MjdiMTZmMWFhMjc1YmNhOTVjXzUtMS0xLTEtMTMyNTM_ed8b88cd-409d-487a-9eb2-aa019f0232c8"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="ib38f7a8880414aad875a0b362cbe2fb4_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90YWJsZTphNzVlNzNmZjc4ZTc0ODI3YjE2ZjFhYTI3NWJjYTk1Yy90YWJsZXJhbmdlOmE3NWU3M2ZmNzhlNzQ4MjdiMTZmMWFhMjc1YmNhOTVjXzUtMy0xLTEtMTMyNTM_94f5fe56-1b51-4c8c-8361-6efff1f9a272"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i7104c544b41946c8a7fe225376901625_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90YWJsZTphNzVlNzNmZjc4ZTc0ODI3YjE2ZjFhYTI3NWJjYTk1Yy90YWJsZXJhbmdlOmE3NWU3M2ZmNzhlNzQ4MjdiMTZmMWFhMjc1YmNhOTVjXzUtNS0xLTEtMTMyNTM_2443227c-8109-40d6-9b1f-11ef44ad3cad"
      unitRef="shares">15677143</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i3783dc27237d46f6944e1a9a6f65eee6_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90YWJsZTphNzVlNzNmZjc4ZTc0ODI3YjE2ZjFhYTI3NWJjYTk1Yy90YWJsZXJhbmdlOmE3NWU3M2ZmNzhlNzQ4MjdiMTZmMWFhMjc1YmNhOTVjXzYtMS0xLTEtMA_2d4fe162-cf10-484f-afa7-5ad77ff457e3"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i6aa79556c9a24064ab5ea55845f31f79_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90YWJsZTphNzVlNzNmZjc4ZTc0ODI3YjE2ZjFhYTI3NWJjYTk1Yy90YWJsZXJhbmdlOmE3NWU3M2ZmNzhlNzQ4MjdiMTZmMWFhMjc1YmNhOTVjXzYtMy0xLTEtMA_06a77c5d-4851-444b-bb58-83d5170eda8e"
      unitRef="shares">155773757</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i85e3d76bfda8415b975e00befcd9609f_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90YWJsZTphNzVlNzNmZjc4ZTc0ODI3YjE2ZjFhYTI3NWJjYTk1Yy90YWJsZXJhbmdlOmE3NWU3M2ZmNzhlNzQ4MjdiMTZmMWFhMjc1YmNhOTVjXzYtNS0xLTEtMA_e9787c81-6b42-41a1-995f-4521c4ff9dfd"
      unitRef="shares">15677143</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i1db6dad47a0c48f9ba16df4ee15bdba5_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90ZXh0cmVnaW9uOmFiMTEyNjUyZTExYTQyZDFiNzczZmM1NGYwZjgxMzkzXzEyNjQ0MzgzNzM5ODE4_6b544f3d-c5b3-4811-a7bd-1b5d2114318e"
      unitRef="shares">149831154</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i7926d13ed9d346928f338c20da686971_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90ZXh0cmVnaW9uOmFiMTEyNjUyZTExYTQyZDFiNzczZmM1NGYwZjgxMzkzXzEyNjQ0MzgzNzQ0NjQ4_7c13deff-0470-4b90-985a-698491901d87"
      unitRef="usd">1809556000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="i7926d13ed9d346928f338c20da686971_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90ZXh0cmVnaW9uOmFiMTEyNjUyZTExYTQyZDFiNzczZmM1NGYwZjgxMzkzXzEyNjQ0MzgzNzM5OTA4_d4cbe3fb-9489-410f-b121-181236ef150b"
      unitRef="usd">3722000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i1db6dad47a0c48f9ba16df4ee15bdba5_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90ZXh0cmVnaW9uOmFiMTEyNjUyZTExYTQyZDFiNzczZmM1NGYwZjgxMzkzXzEyNjQ0MzgzNzQwMDUy_6fd9865d-7d2a-4ad7-b6f1-4d5a3f94c560"
      unitRef="usd">248302000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <cron:PaymentOfTransactionCosts
      contextRef="i7926d13ed9d346928f338c20da686971_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90ZXh0cmVnaW9uOmFiMTEyNjUyZTExYTQyZDFiNzczZmM1NGYwZjgxMzkzXzEyNjQ0MzgzNzQwMTY1_6ab0ee71-ebd4-4429-a7c1-2642608770f2"
      unitRef="usd">25223000</cron:PaymentOfTransactionCosts>
    <cron:PaymentOfTransactionCosts
      contextRef="i1db6dad47a0c48f9ba16df4ee15bdba5_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90ZXh0cmVnaW9uOmFiMTEyNjUyZTExYTQyZDFiNzczZmM1NGYwZjgxMzkzXzEyNjQ0MzgzNzQwMTc5_16351b4d-8822-48d0-bd6d-7e2df9a0c4bd"
      unitRef="usd">3642000</cron:PaymentOfTransactionCosts>
    <cron:PaymentOfTransactionCosts
      contextRef="id02c7b0ce1ec47f5935d8d2f571108bb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90ZXh0cmVnaW9uOmFiMTEyNjUyZTExYTQyZDFiNzczZmM1NGYwZjgxMzkzXzEyNjQ0MzgzNzQwMjE4_1acdefe2-6e07-4d8d-a20f-54a161c9c23f"
      unitRef="usd">21581000</cron:PaymentOfTransactionCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i399c1d0125d94144839ad09cbfcd4e79_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90ZXh0cmVnaW9uOmFiMTEyNjUyZTExYTQyZDFiNzczZmM1NGYwZjgxMzkzXzEyNjQ0MzgzNzQwNjQ3_53ec6176-f97d-4a79-9dfb-46199cb18ed3"
      unitRef="shares">5086586</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <cron:StockIssuedDuringPeriodNewIssuesFairValue
      contextRef="i6846a599dce44a4fb34169f67a53da26_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90ZXh0cmVnaW9uOmFiMTEyNjUyZTExYTQyZDFiNzczZmM1NGYwZjgxMzkzXzEyNjQ0MzgzNzQwNjg2_698a06a6-af46-4ac2-8a7a-4f65eea4ae4d"
      unitRef="usd">56109000</cron:StockIssuedDuringPeriodNewIssuesFairValue>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="ib7c7fb20be7a4bf1a45f16645365481c_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90ZXh0cmVnaW9uOmFiMTEyNjUyZTExYTQyZDFiNzczZmM1NGYwZjgxMzkzXzEyNjQ0MzgzNzM4NDc4_6a0d249c-9f27-4d80-901d-fbca5329c15d"
      unitRef="shares">856017</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <cron:CommonStockVestingRightsNumberOfEqualInstallments
      contextRef="i5a6b2b55f141445980be073e905ff0d2_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90ZXh0cmVnaW9uOmFiMTEyNjUyZTExYTQyZDFiNzczZmM1NGYwZjgxMzkzXzEyNjQ0MzgzNzM4NzIz_becdd810-83d6-4ec0-8d0e-156d9fb2754a"
      unitRef="installment">3</cron:CommonStockVestingRightsNumberOfEqualInstallments>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
      contextRef="ib7c7fb20be7a4bf1a45f16645365481c_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90ZXh0cmVnaW9uOmFiMTEyNjUyZTExYTQyZDFiNzczZmM1NGYwZjgxMzkzXzEyNjQ0MzgzNzM5MDM0_627bcf69-ee73-4cac-8338-29598787d4a8"
      unitRef="usd">6000000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <cron:StockIssuedDuringPeriodNewIssuesWeightedAveragePricePeriod
      contextRef="i6385655ed7694227b1ba4c2470a26f37_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90ZXh0cmVnaW9uOmFiMTEyNjUyZTExYTQyZDFiNzczZmM1NGYwZjgxMzkzXzEyNjQ0MzgzNzM5MDkz_6b9e2936-a720-4535-af87-c387b558ac1b">P10D</cron:StockIssuedDuringPeriodNewIssuesWeightedAveragePricePeriod>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i7104c544b41946c8a7fe225376901625_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90ZXh0cmVnaW9uOmFiMTEyNjUyZTExYTQyZDFiNzczZmM1NGYwZjgxMzkzXzIwODY_2443227c-8109-40d6-9b1f-11ef44ad3cad"
      unitRef="shares">15677143</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i9d7cc358c6d64ac19ef8563642446a56_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90ZXh0cmVnaW9uOmFiMTEyNjUyZTExYTQyZDFiNzczZmM1NGYwZjgxMzkzXzEyNjQ0MzgzNzI1Mzc0_c8becd59-a935-4822-bc26-4b48de6b68e4"
      unitRef="usd">115510000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="i9d7cc358c6d64ac19ef8563642446a56_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90ZXh0cmVnaW9uOmFiMTEyNjUyZTExYTQyZDFiNzczZmM1NGYwZjgxMzkzXzEyNjQ0MzgzNzI1Mzg5_74737333-027d-4078-91b7-e809bbb3d994"
      unitRef="usd">7577000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i6aa79556c9a24064ab5ea55845f31f79_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90ZXh0cmVnaW9uOmFiMTEyNjUyZTExYTQyZDFiNzczZmM1NGYwZjgxMzkzXzI0MDM_4ce10082-dce4-41d1-9c96-44771839900e"
      unitRef="shares">0</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i3783dc27237d46f6944e1a9a6f65eee6_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90ZXh0cmVnaW9uOmFiMTEyNjUyZTExYTQyZDFiNzczZmM1NGYwZjgxMzkzXzI0MDM_98aab4c3-4da5-4552-a7d4-a86344a02c91"
      unitRef="shares">0</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i85e3d76bfda8415b975e00befcd9609f_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMjcvZnJhZzphYjExMjY1MmUxMWE0MmQxYjc3M2ZjNTRmMGY4MTM5My90ZXh0cmVnaW9uOmFiMTEyNjUyZTExYTQyZDFiNzczZmM1NGYwZjgxMzkzXzI0MDM_ca0ac993-2a75-4082-9da8-06936c6c6607"
      unitRef="shares">0</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90ZXh0cmVnaW9uOmU2MTQ3ODYxMTRhYTRjMmZiZWJkNjc4NjJjOWJjZDRhXzkzMzE_bf107d9e-1a37-4b87-8eaf-ca312464ab28">Share-based Payments&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt"&gt;Warrants&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of the changes in warrants during the year ended December&#160;31, 2020 and December&#160;31, 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted average exercise price (C$)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of warrants&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,066,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercise of warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,079,313)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,987,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:42.75pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:42.75pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted average exercise price (C$)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of warrants&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,457,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercise of warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,390,961)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December&#160;31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,066,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:42.75pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For a description of the Altria Warrant, see Note 14. As of December&#160;31, 2020, the Company had outstanding warrants as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.188%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Grant date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Expiry date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted average exercise price (C$)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of warrants&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 13 &#x2013; 27, 2016&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 13 &#x2013; 27, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,987,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;As of December&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,987,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt"&gt;Stock options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:47.25pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:8.57pt"&gt;Stock option plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company adopted an amended and restated stock option plan dated May 26, 2015 (the &#x201c;2015 Stock Option Plan&#x201d;), which was approved by shareholders of the Company at the annual general meeting of shareholders held on June 28, 2017. The 2015 Stock Option Plan allowed the Company&#x2019;s Board of Directors (the &#x201c;Board&#x201d;) to award options to purchase shares to directors, officers, key employees and service providers of the Company. As of June 28, 2018, no further awards will be granted under the 2015 Stock Option Plan; however, shares may be purchased via option exercise by the holders of any outstanding options previously issued under the 2015 Stock Option Plan. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 28, 2018, the shareholders of the Company approved a stock option plan (the &#x201c;2018 Stock Option Plan&#x201d;), which replaced the 2015 Stock Option Plan. The 2018 Stock Option Plan terminated the Company&#x2019;s ability to grant equity under the 2015 Stock Option Plan. As of June 25, 2020, the date on which the 2020 Omnibus Plan (as defined below) was approved by the shareholders of the Company, no further awards will be granted under the 2018 Stock Option Plan; however, shares may be purchased via option exercise by the holders of any outstanding options previously issued under the 2018 Stock Option Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 29, 2020, the Board adopted a new omnibus equity incentive plan (the &#x201c;2020 Omnibus Plan&#x201d;), which was approved by the shareholders of the Company at the annual and special meeting of shareholders held on June 25, 2020. The 2020 Omnibus Plan provides for grants of stock options, share appreciation rights, restricted shares, restricted share units (&#x201c;RSUs&#x201d;) and other share-based or cash-based awards, which are subject to terms as determined by the Compensation Committee of the Board, and awards may be granted to eligible employees, non-employee directors and consultants. The 2020 Omnibus Plan terminated the Company&#x2019;s ability to grant equity awards under the 2018 Stock Option Plan and restricted stock units under the Employment Inducement Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Options represent the right to purchase Company common shares on the date of exercise at a stated exercise price. The exercise price of an option generally must be at least equal to the fair market value of the Company common shares on the date of grant. The Compensation Committee of the Board (&#x201c;Compensation Committee&#x201d;) may provide for options to be exercised only as they vest or to be immediately exercisable with any shares issued on exercise being subject to the Company&#x2019;s right of repurchase that lapses as the shares vest. Vesting conditions for grants of options are determined by the Compensation Committee. The typical vesting for stock option grants is quarterly vesting over &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90ZXh0cmVnaW9uOmU2MTQ3ODYxMTRhYTRjMmZiZWJkNjc4NjJjOWJjZDRhXzEyNjQ0MzgzODQxMzQy_918fcba7-c0e8-4f1e-a169-2b708f363c2a"&gt;three&lt;/span&gt; to five years. The maximum term of options granted under the 2020 Omnibus Plan is seven years. Participants under the 2020 Omnibus Plan are eligible to be granted options to purchase shares at an exercise price established upon approval of the grant by the Compensation Committee. When options are granted, the exercise price is, with respect to a particular date, the closing price as reported by the TSX or the Nasdaq and, if the shares are not traded on the TSX or the Nasdaq, any other stock exchange on which the Company&#x2019;s common shares are traded (as selected by the Compensation Committee in good faith taking into account applicable legal and tax requirements) on the immediately preceding trading day (the &#x201c;Fair Market Value&#x201d;). The 2020 Omnibus Plan does not authorize grants of options with an exercise price below the Fair Market Value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;The equity plans described above have the following stock options outstanding: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.594%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.594%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.597%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares outstanding as of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020 Omnibus Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018 Stock Option Plan &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,627,715&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,817,287&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2015 Stock Option Plan &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,127,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,332,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,617,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock options outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,755,148&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,149,502&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,902,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;For the year ended December&#160;31, 2020, the total stock-based compensation expense associated with the equity plans was $7,185 (December&#160;31, 2019 &#x2013; $10,278; December&#160;31, 2018 - $8,151).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;padding-left:47.25pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;(ii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:5.8pt"&gt; Summary of changes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of the changes in options during the year ended December&#160;31, 2020 and December&#160;31, 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.097%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 5.5pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted average exercise price (C$)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted average remaining contractual term (years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,149,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.56&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Issuance of options&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercise of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,131,939)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancellation, forfeiture and expiry of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(262,415)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,755,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.30&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at December&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,643,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.34&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%;padding-left:22.1pt"&gt;The weighted average exercise price reflects the conversion of foreign currency-denominated options at the exchange rates as of December&#160;31, 2020. For foreign currency-denominated options, the weighted average exercise prices are translated using exchange rates as of the settlement date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.097%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 5.5pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted average exercise price (C$)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted average remaining contractual term (years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,902,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.35&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Issuance of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,534,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercise of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(282,572)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancellation, forfeiture and expiry of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,083)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December&#160;31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,149,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.56&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at December&#160;31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,034,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.27&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;padding-left:47.25pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;(iii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:3.03pt"&gt;Fair value of options issued&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the options issued during the year was determined using the Black-Scholes option pricing model, using the following inputs:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share price at grant date (per share)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;C$6.96&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;C$15.34 &#x2013; $24.75&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercise price (per option)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;C$6.96&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;C$15.34 &#x2013; $24.75&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.43%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.39% &#x2013; 1.62%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life of options (in years)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected annualized volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average Black-Scholes value at grant date (per option)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;C$4.84&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;C$13.03&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeiture rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%;padding-left:22.1pt"&gt;The weighted average exercise price reflects the conversion of foreign currency-denominated options at the exchange rates as of December&#160;31, 2020. For foreign currency-denominated options, the weighted average exercise prices are translated using exchange rates as of the settlement date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%;padding-left:20.66pt"&gt;The expected life of the awards represents the period of time options are expected to be outstanding and is estimated considering vesting terms and employees&#x2019; and non-employees&#x2019; historical exercise and, where relevant, post-vesting employment termination behavior. Volatility was estimated by using the historical volatility of the Company&#x2019;s share price, adjusted for the Company&#x2019;s expectation of volatility going forward. The risk-free interest rate was based on the Bank of Canada government bonds with a remaining term equal to the expected life of the options at the grant date. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average fair value per share at grant date of the options during the year ended December&#160;31, 2020 was C$4.84 per share (December&#160;31, 2019 &#x2013; C$13.03 per share).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(c)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.91pt"&gt;Restricted share units&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;RSUs are granted under the 2020 Omnibus Plan. RSUs represent an equivalent amount of Company common shares on the date of issuance at fair value. Fair value is determined using the closing price of the trading day immediately preceding the date of grant. RSUs issued under the 2020 Omnibus Plan typically vest over a three-year period following the grant date, have no performance requirements and no forfeiture rate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 20, 2020, the Company entered into separation agreements with Robert Rosenheck and another Redwood employee pursuant to which they resigned from their employment with Redwood. In connection with such separation agreements, 732,972 outstanding and unvested RSUs were accelerated and vested during the year ended December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the year ended December&#160;31, 2020, the Company recorded $8,176 (December&#160;31, 2019 &#x2013; $889) in share-based compensation expense related to these RSUs. No RSUs were granted in 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of the changes in RSUs: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.663%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted average grant date fair value (C$)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;732,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;957,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(732,972)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancellation and forfeitures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,497)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;948,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.663%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted average grant date fair value (C$)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at January 1, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;732,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;732,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(d)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt"&gt;Deferred share units&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 10, 2019, the Company established a cash-settled deferred share unit plan (&#x201c;DSU Plan&#x201d;) pursuant to which its non-executive directors receive deferred share units (&#x201c;DSUs&#x201d;). The DSU Plan is designed to promote a greater alignment of long-term interests between non-executive directors and shareholders. The number of DSUs granted under the DSU Plan (including fractional DSUs) is determined by dividing the amount of remuneration payable by the closing price as reported by the TSX on the trading day immediately preceding the date of grant. DSUs are payable at the time a non-executive director ceases to hold the office of director for any reason and are settled by a lump-sum cash payment, in accordance with the terms of the DSU Plan, based on the fair value of the DSUs at such time. The fair value of the cash payout is determined by multiplying the number of DSUs vested at the payout date by the closing price as reported by the TSX on the trading day immediately preceding the payout date. The fair value of the cash payout is determined at each reporting date based on the fair value of the Company&#x2019;s common shares at the reporting date and is recorded within other liabilities. No DSUs were granted during 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of the changes in DSUs: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.927%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.346%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of DSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Financial liability &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granting and vesting of DSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities settled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,484)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss (gain) on revaluation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.927%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.346%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of DSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Financial liability &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at January 1, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granting and vesting of DSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss (gain) on revaluation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(197)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ScheduleOfOtherShareBasedCompensationActivityTableTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90ZXh0cmVnaW9uOmU2MTQ3ODYxMTRhYTRjMmZiZWJkNjc4NjJjOWJjZDRhXzI0MTg5MjU1OTMyOTc4_df425626-903e-4eb3-a211-3790eb0e67ab">&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of the changes in warrants during the year ended December&#160;31, 2020 and December&#160;31, 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted average exercise price (C$)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of warrants&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,066,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercise of warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,079,313)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,987,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:42.75pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:42.75pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted average exercise price (C$)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of warrants&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,457,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercise of warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,390,961)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December&#160;31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,066,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of the changes in DSUs: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.927%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.346%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of DSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Financial liability &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granting and vesting of DSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities settled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,484)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss (gain) on revaluation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.927%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.346%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of DSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Financial liability &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at January 1, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granting and vesting of DSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss (gain) on revaluation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(197)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherShareBasedCompensationActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i1572dfef042a4da7bc0274d5c4a15278_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTo0OGNlOTUzZThiNzM0NGJlODhmNWUxYzZhOGQ0YTY2Zi90YWJsZXJhbmdlOjQ4Y2U5NTNlOGI3MzQ0YmU4OGY1ZTFjNmE4ZDRhNjZmXzEtMS0xLTEtMA_04c94274-5318-448d-80d2-d183526ab2a9"
      unitRef="cadPerShare">0.26</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i1572dfef042a4da7bc0274d5c4a15278_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTo0OGNlOTUzZThiNzM0NGJlODhmNWUxYzZhOGQ0YTY2Zi90YWJsZXJhbmdlOjQ4Y2U5NTNlOGI3MzQ0YmU4OGY1ZTFjNmE4ZDRhNjZmXzEtMy0xLTEtMA_ea6b87a4-089e-4989-8ea8-8690b9242b3a"
      unitRef="shares">18066662</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i5372334bf7d347cba8a470a7ae7e08dd_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTo0OGNlOTUzZThiNzM0NGJlODhmNWUxYzZhOGQ0YTY2Zi90YWJsZXJhbmdlOjQ4Y2U5NTNlOGI3MzQ0YmU4OGY1ZTFjNmE4ZDRhNjZmXzItMS0xLTEtMA_a5c25b59-c544-4484-b430-0a412ef914b8"
      unitRef="cadPerShare">0.27</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i5372334bf7d347cba8a470a7ae7e08dd_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTo0OGNlOTUzZThiNzM0NGJlODhmNWUxYzZhOGQ0YTY2Zi90YWJsZXJhbmdlOjQ4Y2U5NTNlOGI3MzQ0YmU4OGY1ZTFjNmE4ZDRhNjZmXzItMy0xLTEtMA_58e7432e-061d-414c-be5c-2a905fa18925"
      unitRef="shares">10079313</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i3ce6c21c99f24cd2ae50be03fc1ea89d_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTo0OGNlOTUzZThiNzM0NGJlODhmNWUxYzZhOGQ0YTY2Zi90YWJsZXJhbmdlOjQ4Y2U5NTNlOGI3MzQ0YmU4OGY1ZTFjNmE4ZDRhNjZmXzQtMS0xLTEtMA_988ccab7-7dd3-4d5a-bad4-b32787b86fd7"
      unitRef="cadPerShare">0.25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i3ce6c21c99f24cd2ae50be03fc1ea89d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTo0OGNlOTUzZThiNzM0NGJlODhmNWUxYzZhOGQ0YTY2Zi90YWJsZXJhbmdlOjQ4Y2U5NTNlOGI3MzQ0YmU4OGY1ZTFjNmE4ZDRhNjZmXzQtMy0xLTEtMA_afd3f648-2631-416a-b2f4-a8bc7f70b4c5"
      unitRef="shares">7987349</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="id7d681ac03c543518d1de73a1d3b5d6d_I20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTo5MzZhOTRmNjExOGI0YTYyODZmMDYyYzU2ZTE3ODk2Zi90YWJsZXJhbmdlOjkzNmE5NGY2MTE4YjRhNjI4NmYwNjJjNTZlMTc4OTZmXzYtMS0xLTEtNTA3Mw_a57583e7-b3c6-41bd-a2df-1becdbc96be2"
      unitRef="cadPerShare">0.26</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="id7d681ac03c543518d1de73a1d3b5d6d_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTo5MzZhOTRmNjExOGI0YTYyODZmMDYyYzU2ZTE3ODk2Zi90YWJsZXJhbmdlOjkzNmE5NGY2MTE4YjRhNjI4NmYwNjJjNTZlMTc4OTZmXzYtMy0xLTEtNTA3Mw_73d81049-3828-41d7-9742-c76a5238b9c4"
      unitRef="shares">25457623</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="iec84f453bb6e43d7a3cafa4dad5299d9_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTo5MzZhOTRmNjExOGI0YTYyODZmMDYyYzU2ZTE3ODk2Zi90YWJsZXJhbmdlOjkzNmE5NGY2MTE4YjRhNjI4NmYwNjJjNTZlMTc4OTZmXzctMS0xLTEtNTA3Mw_b2a773c8-a362-4845-aabc-62a15838b9a8"
      unitRef="cadPerShare">0.26</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="iec84f453bb6e43d7a3cafa4dad5299d9_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTo5MzZhOTRmNjExOGI0YTYyODZmMDYyYzU2ZTE3ODk2Zi90YWJsZXJhbmdlOjkzNmE5NGY2MTE4YjRhNjI4NmYwNjJjNTZlMTc4OTZmXzctMy0xLTEtNTA3Mw_a834a96c-8f9f-493a-b120-4bb0419a2b8c"
      unitRef="shares">7390961</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i1572dfef042a4da7bc0274d5c4a15278_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTo5MzZhOTRmNjExOGI0YTYyODZmMDYyYzU2ZTE3ODk2Zi90YWJsZXJhbmdlOjkzNmE5NGY2MTE4YjRhNjI4NmYwNjJjNTZlMTc4OTZmXzktMS0xLTEtNTA3Mw_e3923644-6596-40a1-9514-6c9a686cac3f"
      unitRef="cadPerShare">0.26</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i1572dfef042a4da7bc0274d5c4a15278_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTo5MzZhOTRmNjExOGI0YTYyODZmMDYyYzU2ZTE3ODk2Zi90YWJsZXJhbmdlOjkzNmE5NGY2MTE4YjRhNjI4NmYwNjJjNTZlMTc4OTZmXzktMy0xLTEtNTA3Mw_c3ed3041-a502-44e2-a9f9-db3a4d56eeb1"
      unitRef="shares">18066662</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90ZXh0cmVnaW9uOmU2MTQ3ODYxMTRhYTRjMmZiZWJkNjc4NjJjOWJjZDRhXzkzMzU_ca056372-8208-469a-80b9-7c2a5c04b468">As of December&#160;31, 2020, the Company had outstanding warrants as follows: &lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.188%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Grant date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Expiry date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted average exercise price (C$)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of warrants&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 13 &#x2013; 27, 2016&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 13 &#x2013; 27, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,987,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;As of December&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,987,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i7708af5c622544439ec18767fd24a5c0_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTo0MDIzODMyMTE0NjU0MTcwOTFhZGVkOWZmZTkyZjc5OC90YWJsZXJhbmdlOjQwMjM4MzIxMTQ2NTQxNzA5MWFkZWQ5ZmZlOTJmNzk4XzItNi0xLTEtMA_44fe52b8-2ea0-4c14-ba6a-b3f58723f974"
      unitRef="cadPerShare">0.25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i7708af5c622544439ec18767fd24a5c0_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTo0MDIzODMyMTE0NjU0MTcwOTFhZGVkOWZmZTkyZjc5OC90YWJsZXJhbmdlOjQwMjM4MzIxMTQ2NTQxNzA5MWFkZWQ5ZmZlOTJmNzk4XzItNy0xLTEtMjQ2OQ_48ebfcf6-8a1b-42f0-945a-11af98563361"
      unitRef="shares">7987349</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i7708af5c622544439ec18767fd24a5c0_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTo0MDIzODMyMTE0NjU0MTcwOTFhZGVkOWZmZTkyZjc5OC90YWJsZXJhbmdlOjQwMjM4MzIxMTQ2NTQxNzA5MWFkZWQ5ZmZlOTJmNzk4XzItNy0xLTEtMjQ2OQ_6fa6279c-f7b8-4ee3-8f6a-fced0ec55f8b"
      unitRef="shares">7987349</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i3ce6c21c99f24cd2ae50be03fc1ea89d_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTo0MDIzODMyMTE0NjU0MTcwOTFhZGVkOWZmZTkyZjc5OC90YWJsZXJhbmdlOjQwMjM4MzIxMTQ2NTQxNzA5MWFkZWQ5ZmZlOTJmNzk4XzMtNi0xLTEtMA_e5cdc3d1-1869-4cea-9e04-20f75fef6e41"
      unitRef="cadPerShare">0.25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i3ce6c21c99f24cd2ae50be03fc1ea89d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTo0MDIzODMyMTE0NjU0MTcwOTFhZGVkOWZmZTkyZjc5OC90YWJsZXJhbmdlOjQwMjM4MzIxMTQ2NTQxNzA5MWFkZWQ5ZmZlOTJmNzk4XzMtNy0xLTEtMjQ2OQ_3ce42002-d6bd-4c5a-bca4-1f19ea724f75"
      unitRef="shares">7987349</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i759cd2f5c6b540b9be3e774364a54f77_I20180628"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90ZXh0cmVnaW9uOmU2MTQ3ODYxMTRhYTRjMmZiZWJkNjc4NjJjOWJjZDRhXzgyNDYzMzczNDMxMjg_386b52de-b086-4cf4-bcb3-771f09bc0dd5"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i129cd564c18f4becbcf3f71a97fb8da3_I20200625"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90ZXh0cmVnaW9uOmU2MTQ3ODYxMTRhYTRjMmZiZWJkNjc4NjJjOWJjZDRhXzgyNDYzMzczNDMxMzY_26f8f886-bf50-40a9-a016-f57328ad8347"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i586e0fbc30bd421ea74d516bbb9228a9_D20200329-20200329"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90ZXh0cmVnaW9uOmU2MTQ3ODYxMTRhYTRjMmZiZWJkNjc4NjJjOWJjZDRhXzEyNjQ0MzgzODQxMzQ2_3680811e-bb34-4987-8d05-18c0eb3c1ff5">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ie390f249c16849189272940f0a025a2b_D20200329-20200329"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90ZXh0cmVnaW9uOmU2MTQ3ODYxMTRhYTRjMmZiZWJkNjc4NjJjOWJjZDRhXzEyNjQ0MzgzODI4NzQx_227c6805-65b3-4a62-8df5-aaff44c380aa">P7Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90ZXh0cmVnaW9uOmU2MTQ3ODYxMTRhYTRjMmZiZWJkNjc4NjJjOWJjZDRhXzI0MTg5MjU1OTMyOTc3_16b7e0ac-5bcd-4e15-9c25-79e70e937edf">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;The equity plans described above have the following stock options outstanding: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.594%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.594%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.597%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares outstanding as of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020 Omnibus Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018 Stock Option Plan &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,627,715&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,817,287&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2015 Stock Option Plan &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,127,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,332,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,617,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock options outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,755,148&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,149,502&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,902,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i264457fca61240599e96951139517526_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZToxOTUxNTQxMzE3YTg0ZDkxOTVhZTA1ODI2ZDk2ZjQ1ZC90YWJsZXJhbmdlOjE5NTE1NDEzMTdhODRkOTE5NWFlMDU4MjZkOTZmNDVkXzEtMS0xLTEtMTg3MDE_5ae144fc-2082-4244-aeda-e3416b0e9f19"
      unitRef="shares">2000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i85edbfd435fc4bd88b7c46410c6c001c_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZToxOTUxNTQxMzE3YTg0ZDkxOTVhZTA1ODI2ZDk2ZjQ1ZC90YWJsZXJhbmdlOjE5NTE1NDEzMTdhODRkOTE5NWFlMDU4MjZkOTZmNDVkXzItMy0xLTEtMTg3MTY_2d21c665-ab98-49da-bae4-4b107fae6553"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i27704c0ccaf54adaa2ecfcbaad36eab2_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZToxOTUxNTQxMzE3YTg0ZDkxOTVhZTA1ODI2ZDk2ZjQ1ZC90YWJsZXJhbmdlOjE5NTE1NDEzMTdhODRkOTE5NWFlMDU4MjZkOTZmNDVkXzEtMy0xLTEtMTg3MDE_951b6688-3b4f-4f86-870d-d2e54520f402"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="idd88a7bbfa5b4fe68c3c0a9725094951_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZToxOTUxNTQxMzE3YTg0ZDkxOTVhZTA1ODI2ZDk2ZjQ1ZC90YWJsZXJhbmdlOjE5NTE1NDEzMTdhODRkOTE5NWFlMDU4MjZkOTZmNDVkXzItMS0xLTEtMTg3MDE_dfb47dc5-c00a-4c1b-bc67-bad04bb5ea62"
      unitRef="shares">1627715</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i6fe8366c01de496cbedaa12a2a996bbd_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZToxOTUxNTQxMzE3YTg0ZDkxOTVhZTA1ODI2ZDk2ZjQ1ZC90YWJsZXJhbmdlOjE5NTE1NDEzMTdhODRkOTE5NWFlMDU4MjZkOTZmNDVkXzMtMy0xLTEtMTg3MTY_b830682a-23b3-4e65-8af4-38cee989525b"
      unitRef="shares">1817287</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i8e81bf474eba4613a2f7dd5d05f70c4a_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZToxOTUxNTQxMzE3YTg0ZDkxOTVhZTA1ODI2ZDk2ZjQ1ZC90YWJsZXJhbmdlOjE5NTE1NDEzMTdhODRkOTE5NWFlMDU4MjZkOTZmNDVkXzItMy0xLTEtMTg3MDE_a1567a9b-14ed-4057-aadd-1412f3e47e60"
      unitRef="shares">285000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i441fae4c3ad14b21962491e07d5bb03d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZToxOTUxNTQxMzE3YTg0ZDkxOTVhZTA1ODI2ZDk2ZjQ1ZC90YWJsZXJhbmdlOjE5NTE1NDEzMTdhODRkOTE5NWFlMDU4MjZkOTZmNDVkXzMtMS0xLTEtMTg3MDE_737818a9-0e1e-40e7-aefb-a280272ad786"
      unitRef="shares">10127433</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ifeb79189ae0e437a9c0cf2c3b1563883_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZToxOTUxNTQxMzE3YTg0ZDkxOTVhZTA1ODI2ZDk2ZjQ1ZC90YWJsZXJhbmdlOjE5NTE1NDEzMTdhODRkOTE5NWFlMDU4MjZkOTZmNDVkXzQtMy0xLTEtMTg3MTY_e3499334-c48d-4bb2-907e-c2172601349f"
      unitRef="shares">12332215</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i1906d8b8221f4c0692fad5ac1bce6483_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZToxOTUxNTQxMzE3YTg0ZDkxOTVhZTA1ODI2ZDk2ZjQ1ZC90YWJsZXJhbmdlOjE5NTE1NDEzMTdhODRkOTE5NWFlMDU4MjZkOTZmNDVkXzMtMy0xLTEtMTg3MDE_a03343ae-374c-4eb6-97e8-e053bd46f3c4"
      unitRef="shares">12617995</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZToxOTUxNTQxMzE3YTg0ZDkxOTVhZTA1ODI2ZDk2ZjQ1ZC90YWJsZXJhbmdlOjE5NTE1NDEzMTdhODRkOTE5NWFlMDU4MjZkOTZmNDVkXzQtMS0xLTEtMTg3MDE_fedb08f7-6679-4aa8-b9f0-02083b870295"
      unitRef="shares">13755148</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZToxOTUxNTQxMzE3YTg0ZDkxOTVhZTA1ODI2ZDk2ZjQ1ZC90YWJsZXJhbmdlOjE5NTE1NDEzMTdhODRkOTE5NWFlMDU4MjZkOTZmNDVkXzUtMy0xLTEtMTg3MTY_50ed0435-7df4-4584-9c5e-f3c19ff2a693"
      unitRef="shares">14149502</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i9717dc3b24b24c93ab09a6bfa9b52c89_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZToxOTUxNTQxMzE3YTg0ZDkxOTVhZTA1ODI2ZDk2ZjQ1ZC90YWJsZXJhbmdlOjE5NTE1NDEzMTdhODRkOTE5NWFlMDU4MjZkOTZmNDVkXzQtMy0xLTEtMTg3MDE_9e685ad8-8cb0-4ea7-90dc-402513783b9b"
      unitRef="shares">12902995</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i5bc534f0f44f4850a59aff8f75b91db8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90ZXh0cmVnaW9uOmU2MTQ3ODYxMTRhYTRjMmZiZWJkNjc4NjJjOWJjZDRhXzEyNjQ0MzgzNzYwODQ0_78ab97b8-4a4b-447e-86cf-0b96018c8350"
      unitRef="usd">7185000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i7b7f36b7882142ceb233b456769d9d37_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90ZXh0cmVnaW9uOmU2MTQ3ODYxMTRhYTRjMmZiZWJkNjc4NjJjOWJjZDRhXzIxOTkwMjMyNzM2MzM_7b04c5fd-d903-44b7-8b90-006280c39ec2"
      unitRef="usd">10278000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="id2927e2128a7487ba8176ee60d748c59_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90ZXh0cmVnaW9uOmU2MTQ3ODYxMTRhYTRjMmZiZWJkNjc4NjJjOWJjZDRhXzE0MjkzNjUxMjgyNjk2_61be66bc-091f-4c1a-b6d7-0c4a21df302a"
      unitRef="usd">8151000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90ZXh0cmVnaW9uOmU2MTQ3ODYxMTRhYTRjMmZiZWJkNjc4NjJjOWJjZDRhXzI0MTg5MjU1OTMyOTc2_7db4d9c3-1e8f-48f8-9c9e-597f6910cbcf">&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of the changes in options during the year ended December&#160;31, 2020 and December&#160;31, 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.097%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 5.5pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted average exercise price (C$)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted average remaining contractual term (years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,149,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.56&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Issuance of options&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercise of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,131,939)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancellation, forfeiture and expiry of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(262,415)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,755,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.30&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at December&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,643,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.34&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%;padding-left:22.1pt"&gt;The weighted average exercise price reflects the conversion of foreign currency-denominated options at the exchange rates as of December&#160;31, 2020. For foreign currency-denominated options, the weighted average exercise prices are translated using exchange rates as of the settlement date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.097%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 5.5pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted average exercise price (C$)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted average remaining contractual term (years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,902,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.35&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Issuance of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,534,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercise of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(282,572)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancellation, forfeiture and expiry of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,083)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December&#160;31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,149,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.56&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at December&#160;31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,034,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.27&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTpjMjVhZjQ4YzdhMGQ0MjY3YjNhMjJkNzI0MTliZDdlNC90YWJsZXJhbmdlOmMyNWFmNDhjN2EwZDQyNjdiM2EyMmQ3MjQxOWJkN2U0XzEtMS0xLTEtMA_1a05637c-1b4a-4e12-b095-8bc41f327854"
      unitRef="cadPerShare">4.84</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTpjMjVhZjQ4YzdhMGQ0MjY3YjNhMjJkNzI0MTliZDdlNC90YWJsZXJhbmdlOmMyNWFmNDhjN2EwZDQyNjdiM2EyMmQ3MjQxOWJkN2U0XzEtMy0xLTEtMA_3e3bf3fb-2d2a-4624-8511-f60e12f8452a"
      unitRef="shares">14149502</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTpjMjVhZjQ4YzdhMGQ0MjY3YjNhMjJkNzI0MTliZDdlNC90YWJsZXJhbmdlOmMyNWFmNDhjN2EwZDQyNjdiM2EyMmQ3MjQxOWJkN2U0XzEtNS0xLTEtMTA1Mg_2c5ccd6f-74e9-4ca3-8ad5-5b271375ad5e">P2Y6M21D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTpjMjVhZjQ4YzdhMGQ0MjY3YjNhMjJkNzI0MTliZDdlNC90YWJsZXJhbmdlOmMyNWFmNDhjN2EwZDQyNjdiM2EyMmQ3MjQxOWJkN2U0XzItMS0xLTEtMA_bb2d852a-dea0-43b4-a124-45d0303f68a3"
      unitRef="cadPerShare">6.96</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTpjMjVhZjQ4YzdhMGQ0MjY3YjNhMjJkNzI0MTliZDdlNC90YWJsZXJhbmdlOmMyNWFmNDhjN2EwZDQyNjdiM2EyMmQ3MjQxOWJkN2U0XzItMy0xLTEtMA_5931bfed-69fd-447f-a05d-4691041194ab"
      unitRef="shares">2000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTpjMjVhZjQ4YzdhMGQ0MjY3YjNhMjJkNzI0MTliZDdlNC90YWJsZXJhbmdlOmMyNWFmNDhjN2EwZDQyNjdiM2EyMmQ3MjQxOWJkN2U0XzMtMS0xLTEtMA_24cf5577-fe1a-4ddc-a3a7-1bd1acfbe0ea"
      unitRef="cadPerShare">2.03</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTpjMjVhZjQ4YzdhMGQ0MjY3YjNhMjJkNzI0MTliZDdlNC90YWJsZXJhbmdlOmMyNWFmNDhjN2EwZDQyNjdiM2EyMmQ3MjQxOWJkN2U0XzMtMy0xLTEtMA_787734a1-f1f9-4c6c-8fe7-bbbc1988becd"
      unitRef="shares">2131939</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTpjMjVhZjQ4YzdhMGQ0MjY3YjNhMjJkNzI0MTliZDdlNC90YWJsZXJhbmdlOmMyNWFmNDhjN2EwZDQyNjdiM2EyMmQ3MjQxOWJkN2U0XzQtMS0xLTEtMA_820f1b6d-f0ad-4403-830f-bfc8a6d365aa"
      unitRef="cadPerShare">14.34</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTpjMjVhZjQ4YzdhMGQ0MjY3YjNhMjJkNzI0MTliZDdlNC90YWJsZXJhbmdlOmMyNWFmNDhjN2EwZDQyNjdiM2EyMmQ3MjQxOWJkN2U0XzQtMy0xLTEtMA_eeba5f13-930c-4fce-b311-72c2163d659b"
      unitRef="shares">262415</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTpjMjVhZjQ4YzdhMGQ0MjY3YjNhMjJkNzI0MTliZDdlNC90YWJsZXJhbmdlOmMyNWFmNDhjN2EwZDQyNjdiM2EyMmQ3MjQxOWJkN2U0XzUtMS0xLTEtMA_82a83662-ff45-421f-8bde-ea77785eb3b4"
      unitRef="cadPerShare">5.40</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTpjMjVhZjQ4YzdhMGQ0MjY3YjNhMjJkNzI0MTliZDdlNC90YWJsZXJhbmdlOmMyNWFmNDhjN2EwZDQyNjdiM2EyMmQ3MjQxOWJkN2U0XzUtMy0xLTEtMA_7462330e-1bb5-468c-9a8e-01d1286078ba"
      unitRef="shares">13755148</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTpjMjVhZjQ4YzdhMGQ0MjY3YjNhMjJkNzI0MTliZDdlNC90YWJsZXJhbmdlOmMyNWFmNDhjN2EwZDQyNjdiM2EyMmQ3MjQxOWJkN2U0XzUtNS0xLTEtMTA1Ng_bb365258-1b3f-456d-a15e-6d5522deb192">P2Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTpjMjVhZjQ4YzdhMGQ0MjY3YjNhMjJkNzI0MTliZDdlNC90YWJsZXJhbmdlOmMyNWFmNDhjN2EwZDQyNjdiM2EyMmQ3MjQxOWJkN2U0XzYtMS0xLTEtMA_a850fbd2-6de1-4e74-87b1-47e87a91f24d"
      unitRef="cadPerShare">3.75</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTpjMjVhZjQ4YzdhMGQ0MjY3YjNhMjJkNzI0MTliZDdlNC90YWJsZXJhbmdlOmMyNWFmNDhjN2EwZDQyNjdiM2EyMmQ3MjQxOWJkN2U0XzYtMy0xLTEtMA_e5c23e4b-0af6-4666-9d2b-9b1daaba27ac"
      unitRef="shares">9643682</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTpjMjVhZjQ4YzdhMGQ0MjY3YjNhMjJkNzI0MTliZDdlNC90YWJsZXJhbmdlOmMyNWFmNDhjN2EwZDQyNjdiM2EyMmQ3MjQxOWJkN2U0XzYtNS0xLTEtMTA1Ng_0e950da3-384a-4a1e-a897-b06b263aa3b9">P1Y4M2D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i9717dc3b24b24c93ab09a6bfa9b52c89_I20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTpjMDJkMGNiOGE2ODE0ZGMzOWRlODFmNTAzM2U4MzJhMC90YWJsZXJhbmdlOmMwMmQwY2I4YTY4MTRkYzM5ZGU4MWY1MDMzZTgzMmEwXzgtMS0xLTEtNTEyMg_83286624-3f88-4e18-a4c5-1a99af88c43b"
      unitRef="cadPerShare">2.99</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i9717dc3b24b24c93ab09a6bfa9b52c89_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTpjMDJkMGNiOGE2ODE0ZGMzOWRlODFmNTAzM2U4MzJhMC90YWJsZXJhbmdlOmMwMmQwY2I4YTY4MTRkYzM5ZGU4MWY1MDMzZTgzMmEwXzgtMy0xLTEtNTEyMg_56480472-5248-4b76-93e0-120c8419834d"
      unitRef="shares">12902995</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTpjMDJkMGNiOGE2ODE0ZGMzOWRlODFmNTAzM2U4MzJhMC90YWJsZXJhbmdlOmMwMmQwY2I4YTY4MTRkYzM5ZGU4MWY1MDMzZTgzMmEwXzgtNS0xLTEtNTEyMg_8b67549f-41ab-4489-8ecd-c44559bf94fd">P3Y4M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTpjMDJkMGNiOGE2ODE0ZGMzOWRlODFmNTAzM2U4MzJhMC90YWJsZXJhbmdlOmMwMmQwY2I4YTY4MTRkYzM5ZGU4MWY1MDMzZTgzMmEwXzktMS0xLTEtNTEyMg_d74ce2fa-b56e-49da-8d11-9ba30d0da824"
      unitRef="cadPerShare">20.08</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTpjMDJkMGNiOGE2ODE0ZGMzOWRlODFmNTAzM2U4MzJhMC90YWJsZXJhbmdlOmMwMmQwY2I4YTY4MTRkYzM5ZGU4MWY1MDMzZTgzMmEwXzktMy0xLTEtNTEyMg_87eb7d7a-17d3-4c6c-ae44-1c0f9e5d48b6"
      unitRef="shares">1534162</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTpjMDJkMGNiOGE2ODE0ZGMzOWRlODFmNTAzM2U4MzJhMC90YWJsZXJhbmdlOmMwMmQwY2I4YTY4MTRkYzM5ZGU4MWY1MDMzZTgzMmEwXzEwLTEtMS0xLTUxMjI_0f7750d1-7cad-4ced-be7c-54fa60a3052f"
      unitRef="cadPerShare">3.48</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTpjMDJkMGNiOGE2ODE0ZGMzOWRlODFmNTAzM2U4MzJhMC90YWJsZXJhbmdlOmMwMmQwY2I4YTY4MTRkYzM5ZGU4MWY1MDMzZTgzMmEwXzEwLTMtMS0xLTUxMjI_cf1b735a-8bca-4c2e-9cea-a9361f972488"
      unitRef="shares">282572</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTpjMDJkMGNiOGE2ODE0ZGMzOWRlODFmNTAzM2U4MzJhMC90YWJsZXJhbmdlOmMwMmQwY2I4YTY4MTRkYzM5ZGU4MWY1MDMzZTgzMmEwXzExLTEtMS0xLTUxMjI_396d95a6-400f-49f0-bf28-9b6263c37dc6"
      unitRef="cadPerShare">2.27</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTpjMDJkMGNiOGE2ODE0ZGMzOWRlODFmNTAzM2U4MzJhMC90YWJsZXJhbmdlOmMwMmQwY2I4YTY4MTRkYzM5ZGU4MWY1MDMzZTgzMmEwXzExLTMtMS0xLTUxMjI_b5e8683e-49cf-49ad-b761-3262fb482f96"
      unitRef="shares">5083</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTpjMDJkMGNiOGE2ODE0ZGMzOWRlODFmNTAzM2U4MzJhMC90YWJsZXJhbmdlOmMwMmQwY2I4YTY4MTRkYzM5ZGU4MWY1MDMzZTgzMmEwXzEyLTEtMS0xLTUxMjI_0696e08d-3e29-40cc-8ce3-63e54b2d2677"
      unitRef="cadPerShare">4.84</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTpjMDJkMGNiOGE2ODE0ZGMzOWRlODFmNTAzM2U4MzJhMC90YWJsZXJhbmdlOmMwMmQwY2I4YTY4MTRkYzM5ZGU4MWY1MDMzZTgzMmEwXzEyLTMtMS0xLTUxMjI_052ba040-7be8-4bb8-a3cf-adba904b9d6e"
      unitRef="shares">14149502</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTpjMDJkMGNiOGE2ODE0ZGMzOWRlODFmNTAzM2U4MzJhMC90YWJsZXJhbmdlOmMwMmQwY2I4YTY4MTRkYzM5ZGU4MWY1MDMzZTgzMmEwXzEyLTUtMS0xLTUxMjI_7b408195-cfb6-4c6f-b6f0-73a1d2f7f414">P2Y6M21D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTpjMDJkMGNiOGE2ODE0ZGMzOWRlODFmNTAzM2U4MzJhMC90YWJsZXJhbmdlOmMwMmQwY2I4YTY4MTRkYzM5ZGU4MWY1MDMzZTgzMmEwXzEzLTEtMS0xLTUxMjI_cf25563c-71fe-43d5-a26e-10cb6d077da5"
      unitRef="cadPerShare">2.93</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTpjMDJkMGNiOGE2ODE0ZGMzOWRlODFmNTAzM2U4MzJhMC90YWJsZXJhbmdlOmMwMmQwY2I4YTY4MTRkYzM5ZGU4MWY1MDMzZTgzMmEwXzEzLTMtMS0xLTUxMjI_822cba0c-d56d-47af-9aed-001ef3ee232a"
      unitRef="shares">9034714</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTpjMDJkMGNiOGE2ODE0ZGMzOWRlODFmNTAzM2U4MzJhMC90YWJsZXJhbmdlOmMwMmQwY2I4YTY4MTRkYzM5ZGU4MWY1MDMzZTgzMmEwXzEzLTUtMS0xLTUxMjI_3d2c80b0-2d46-468f-af79-8d5752dac09f">P2Y3M7D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90ZXh0cmVnaW9uOmU2MTQ3ODYxMTRhYTRjMmZiZWJkNjc4NjJjOWJjZDRhXzI0MTg5MjU1OTMyOTc1_6990bfeb-06d2-4c74-9921-303ae09be00c">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the options issued during the year was determined using the Black-Scholes option pricing model, using the following inputs:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share price at grant date (per share)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;C$6.96&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;C$15.34 &#x2013; $24.75&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercise price (per option)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;C$6.96&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;C$15.34 &#x2013; $24.75&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.43%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.39% &#x2013; 1.62%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life of options (in years)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected annualized volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average Black-Scholes value at grant date (per option)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;C$4.84&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;C$13.03&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeiture rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%;padding-left:22.1pt"&gt;The weighted average exercise price reflects the conversion of foreign currency-denominated options at the exchange rates as of December&#160;31, 2020. For foreign currency-denominated options, the weighted average exercise prices are translated using exchange rates as of the settlement date.&lt;/span&gt;&lt;/div&gt;(ii)The expected life of the awards represents the period of time options are expected to be outstanding and is estimated considering vesting terms and employees&#x2019; and non-employees&#x2019; historical exercise and, where relevant, post-vesting employment termination behavior. Volatility was estimated by using the historical volatility of the Company&#x2019;s share price, adjusted for the Company&#x2019;s expectation of volatility going forward. The risk-free interest rate was based on the Bank of Canada government bonds with a remaining term equal to the expected life of the options at the grant date.</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:SharePrice
      contextRef="i0adf66dfd8f246e784087297c1693bb8_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTozNDQyOWZmOWU2MTk0YzJlODQwYzBjNWZiY2EwNDNjZC90YWJsZXJhbmdlOjM0NDI5ZmY5ZTYxOTRjMmU4NDBjMGM1ZmJjYTA0M2NkXzEtMS0xLTEtMA_9d823982-4ed8-47c4-8273-8b8777589f4e"
      unitRef="usdPerShare">6.96</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="i6f915fc11f2b4dae9120fe65ba8822be_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTozNDQyOWZmOWU2MTk0YzJlODQwYzBjNWZiY2EwNDNjZC90YWJsZXJhbmdlOjM0NDI5ZmY5ZTYxOTRjMmU4NDBjMGM1ZmJjYTA0M2NkXzEtMy0xLTEtMC90ZXh0cmVnaW9uOjg5Y2RlZDkzY2U3ODQzMjk5NjQzYzE5YTlmNTgyNTEyXzEwOTk1MTE2Mjc3Nzg2_40b67c4f-c870-4259-808c-5824a066ce58"
      unitRef="cadPerShare">15.34</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="icccaf7b279474dd2a6cc84bf9c862814_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTozNDQyOWZmOWU2MTk0YzJlODQwYzBjNWZiY2EwNDNjZC90YWJsZXJhbmdlOjM0NDI5ZmY5ZTYxOTRjMmU4NDBjMGM1ZmJjYTA0M2NkXzEtMy0xLTEtMC90ZXh0cmVnaW9uOjg5Y2RlZDkzY2U3ODQzMjk5NjQzYzE5YTlmNTgyNTEyXzEwOTk1MTE2Mjc3Nzk0_6f900c63-d837-4ad7-b0af-5cce90ad3fe4"
      unitRef="cadPerShare">24.75</us-gaap:SharePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="i0adf66dfd8f246e784087297c1693bb8_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTozNDQyOWZmOWU2MTk0YzJlODQwYzBjNWZiY2EwNDNjZC90YWJsZXJhbmdlOjM0NDI5ZmY5ZTYxOTRjMmU4NDBjMGM1ZmJjYTA0M2NkXzItMS0xLTEtMA_b6bef8d0-6bcc-493d-b354-7b5ce46424d4"
      unitRef="usdPerShare">6.96</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="i6f915fc11f2b4dae9120fe65ba8822be_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTozNDQyOWZmOWU2MTk0YzJlODQwYzBjNWZiY2EwNDNjZC90YWJsZXJhbmdlOjM0NDI5ZmY5ZTYxOTRjMmU4NDBjMGM1ZmJjYTA0M2NkXzItMy0xLTEtMC90ZXh0cmVnaW9uOjM4ZTMwYTU2ZDY4NjQ4ZTE5MmE2MjUwN2Y0YzE0OGFmXzEwOTk1MTE2Mjc3Nzg2_e93f211b-8fee-4e47-87d4-7ee9ba8443c8"
      unitRef="cadPerShare">15.34</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="icccaf7b279474dd2a6cc84bf9c862814_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTozNDQyOWZmOWU2MTk0YzJlODQwYzBjNWZiY2EwNDNjZC90YWJsZXJhbmdlOjM0NDI5ZmY5ZTYxOTRjMmU4NDBjMGM1ZmJjYTA0M2NkXzItMy0xLTEtMC90ZXh0cmVnaW9uOjM4ZTMwYTU2ZDY4NjQ4ZTE5MmE2MjUwN2Y0YzE0OGFmXzEwOTk1MTE2Mjc3Nzk0_1b70240b-c6dd-424e-9c3c-9142beb844fb"
      unitRef="cadPerShare">24.75</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i5bc534f0f44f4850a59aff8f75b91db8_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTozNDQyOWZmOWU2MTk0YzJlODQwYzBjNWZiY2EwNDNjZC90YWJsZXJhbmdlOjM0NDI5ZmY5ZTYxOTRjMmU4NDBjMGM1ZmJjYTA0M2NkXzMtMS0xLTEtMA_57ebaee9-bd89-4a32-a76b-ed371f18f76a"
      unitRef="number">0.43</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="icac62509ad0d4163941ab71cd6a759f4_D20190101-20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTozNDQyOWZmOWU2MTk0YzJlODQwYzBjNWZiY2EwNDNjZC90YWJsZXJhbmdlOjM0NDI5ZmY5ZTYxOTRjMmU4NDBjMGM1ZmJjYTA0M2NkXzMtMy0xLTEtMC90ZXh0cmVnaW9uOjIyN2Q3MmEwYjk4ODQ3OWU4YjMzZDYzMjYwMTY1OTE4XzEwOTk1MTE2Mjc3Nzgy_c05e186e-b39e-4c39-8011-a85ee28aa19f"
      unitRef="number">0.0139</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i9958a0912be6465189458f744de7bd5e_D20190101-20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTozNDQyOWZmOWU2MTk0YzJlODQwYzBjNWZiY2EwNDNjZC90YWJsZXJhbmdlOjM0NDI5ZmY5ZTYxOTRjMmU4NDBjMGM1ZmJjYTA0M2NkXzMtMy0xLTEtMC90ZXh0cmVnaW9uOjIyN2Q3MmEwYjk4ODQ3OWU4YjMzZDYzMjYwMTY1OTE4XzEwOTk1MTE2Mjc3Nzkw_8d087475-4986-4a16-af2c-493d28c3dd2c"
      unitRef="number">0.0162</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i5bc534f0f44f4850a59aff8f75b91db8_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTozNDQyOWZmOWU2MTk0YzJlODQwYzBjNWZiY2EwNDNjZC90YWJsZXJhbmdlOjM0NDI5ZmY5ZTYxOTRjMmU4NDBjMGM1ZmJjYTA0M2NkXzQtMS0xLTEtMA_a0997caf-0f91-438b-8c29-c447c8e20b16">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i7b7f36b7882142ceb233b456769d9d37_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTozNDQyOWZmOWU2MTk0YzJlODQwYzBjNWZiY2EwNDNjZC90YWJsZXJhbmdlOjM0NDI5ZmY5ZTYxOTRjMmU4NDBjMGM1ZmJjYTA0M2NkXzQtMy0xLTEtMA_69fdeca8-1703-4b91-835a-711bfe0b72ce">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="i5bc534f0f44f4850a59aff8f75b91db8_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTozNDQyOWZmOWU2MTk0YzJlODQwYzBjNWZiY2EwNDNjZC90YWJsZXJhbmdlOjM0NDI5ZmY5ZTYxOTRjMmU4NDBjMGM1ZmJjYTA0M2NkXzUtMS0xLTEtMA_5172b674-9a55-4d93-bc94-816293d7f3f5"
      unitRef="number">0.91</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="i7b7f36b7882142ceb233b456769d9d37_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTozNDQyOWZmOWU2MTk0YzJlODQwYzBjNWZiY2EwNDNjZC90YWJsZXJhbmdlOjM0NDI5ZmY5ZTYxOTRjMmU4NDBjMGM1ZmJjYTA0M2NkXzUtMy0xLTEtMA_96d78b58-9e07-43ec-a39d-afe15aa11eb8"
      unitRef="number">0.82</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i5bc534f0f44f4850a59aff8f75b91db8_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTozNDQyOWZmOWU2MTk0YzJlODQwYzBjNWZiY2EwNDNjZC90YWJsZXJhbmdlOjM0NDI5ZmY5ZTYxOTRjMmU4NDBjMGM1ZmJjYTA0M2NkXzYtMS0xLTEtMA_ab7a9041-a150-49cf-a78e-97d6f1d68a5c"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i7b7f36b7882142ceb233b456769d9d37_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTozNDQyOWZmOWU2MTk0YzJlODQwYzBjNWZiY2EwNDNjZC90YWJsZXJhbmdlOjM0NDI5ZmY5ZTYxOTRjMmU4NDBjMGM1ZmJjYTA0M2NkXzYtMy0xLTEtMA_858ada46-9d99-4eb9-a468-176518a15338"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <cron:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue
      contextRef="i5bc534f0f44f4850a59aff8f75b91db8_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTozNDQyOWZmOWU2MTk0YzJlODQwYzBjNWZiY2EwNDNjZC90YWJsZXJhbmdlOjM0NDI5ZmY5ZTYxOTRjMmU4NDBjMGM1ZmJjYTA0M2NkXzctMS0xLTEtMA_10b957cb-40fa-44e4-9f36-d4b8f0d4fc5d"
      unitRef="cadPerShare">4.84</cron:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue>
    <cron:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue
      contextRef="i7b7f36b7882142ceb233b456769d9d37_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTozNDQyOWZmOWU2MTk0YzJlODQwYzBjNWZiY2EwNDNjZC90YWJsZXJhbmdlOjM0NDI5ZmY5ZTYxOTRjMmU4NDBjMGM1ZmJjYTA0M2NkXzctMy0xLTEtMA_4f0b812d-a20a-44ae-899e-9dd1e821eb0b"
      unitRef="cadPerShare">13.03</cron:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue>
    <cron:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsForfeitureRate
      contextRef="i5bc534f0f44f4850a59aff8f75b91db8_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTozNDQyOWZmOWU2MTk0YzJlODQwYzBjNWZiY2EwNDNjZC90YWJsZXJhbmdlOjM0NDI5ZmY5ZTYxOTRjMmU4NDBjMGM1ZmJjYTA0M2NkXzgtMS0xLTEtMA_29e90688-489b-4065-b91c-51d6f8f2a42d"
      unitRef="number">0</cron:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsForfeitureRate>
    <cron:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsForfeitureRate
      contextRef="i7b7f36b7882142ceb233b456769d9d37_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTozNDQyOWZmOWU2MTk0YzJlODQwYzBjNWZiY2EwNDNjZC90YWJsZXJhbmdlOjM0NDI5ZmY5ZTYxOTRjMmU4NDBjMGM1ZmJjYTA0M2NkXzgtMy0xLTEtMA_21837cec-d7bb-4156-b855-abc939083b57"
      unitRef="number">0</cron:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsForfeitureRate>
    <us-gaap:SharePrice
      contextRef="i6ab60c8d610648fbbd63e32c23006ba2_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90ZXh0cmVnaW9uOmU2MTQ3ODYxMTRhYTRjMmZiZWJkNjc4NjJjOWJjZDRhXzEyNjQ0MzgzNzQwMDE2_e10d8ea3-b949-4e85-9d1e-e48055a075f9"
      unitRef="cadPerShare">4.84</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="i6ccba8359c8b4e65b7817c72779f76c1_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90ZXh0cmVnaW9uOmU2MTQ3ODYxMTRhYTRjMmZiZWJkNjc4NjJjOWJjZDRhXzEyNjQ0MzgzNzQwMDM4_4350bfc6-c6ba-4dda-a9ab-5428af760a0b"
      unitRef="cadPerShare">13.03</us-gaap:SharePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i1ea19e5d9ee04882823da13b5fd955dc_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90ZXh0cmVnaW9uOmU2MTQ3ODYxMTRhYTRjMmZiZWJkNjc4NjJjOWJjZDRhXzgyNDYzMzczNDMxOTE_edb07606-5335-4b50-abaa-58055534badc">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <cron:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriod
      contextRef="ica018a4c7d9446198ea249f354589bec_D20201001-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90ZXh0cmVnaW9uOmU2MTQ3ODYxMTRhYTRjMmZiZWJkNjc4NjJjOWJjZDRhXzgyNDYzMzczNDMxOTM_585d9e7c-f8ef-4dca-9828-773dec95af8a"
      unitRef="shares">732972</cron:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriod>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i1ea19e5d9ee04882823da13b5fd955dc_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90ZXh0cmVnaW9uOmU2MTQ3ODYxMTRhYTRjMmZiZWJkNjc4NjJjOWJjZDRhXzEyNjQ0MzgzODQxMzM0_3107471a-f7e8-4208-893f-7b5fce57d289"
      unitRef="usd">8176000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i40e8761a0c0246969b0c0e0b6a135205_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90ZXh0cmVnaW9uOmU2MTQ3ODYxMTRhYTRjMmZiZWJkNjc4NjJjOWJjZDRhXzEyNjQ0MzgzODQxMzM4_6fd27359-7f41-4360-a745-335c402a1502"
      unitRef="usd">889000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i9b7d911f78814b9bab3743f845ab435a_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90ZXh0cmVnaW9uOmU2MTQ3ODYxMTRhYTRjMmZiZWJkNjc4NjJjOWJjZDRhXzgyNDYzMzczNDMxNzI_fee4b15b-9838-42a7-9f2e-6603365bc57f"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90ZXh0cmVnaW9uOmU2MTQ3ODYxMTRhYTRjMmZiZWJkNjc4NjJjOWJjZDRhXzI0MTg5MjU1OTMyOTc0_9f3d5c17-a713-4f5d-bae1-d6a5f7d4a85f">&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of the changes in RSUs: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.663%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted average grant date fair value (C$)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;732,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;957,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(732,972)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancellation and forfeitures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,497)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;948,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.663%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted average grant date fair value (C$)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at January 1, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;732,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;732,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i48cd489dc3e441deb5021b45f107480e_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTozMjNhZTc2YjZjNzY0ZmI2YmE5M2JjNWZmNDJjZmVkZS90YWJsZXJhbmdlOjMyM2FlNzZiNmM3NjRmYjZiYTkzYmM1ZmY0MmNmZWRlXzEtMS0xLTEtMA_b756b0d1-b256-49e6-97ff-8afc0072c66a"
      unitRef="shares">732972</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i48cd489dc3e441deb5021b45f107480e_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTozMjNhZTc2YjZjNzY0ZmI2YmE5M2JjNWZmNDJjZmVkZS90YWJsZXJhbmdlOjMyM2FlNzZiNmM3NjRmYjZiYTkzYmM1ZmY0MmNmZWRlXzEtMy0xLTEtMA_dabc4bf5-8085-4ba6-a129-70a1380c2861"
      unitRef="cadPerShare">15.34</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i1ea19e5d9ee04882823da13b5fd955dc_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTozMjNhZTc2YjZjNzY0ZmI2YmE5M2JjNWZmNDJjZmVkZS90YWJsZXJhbmdlOjMyM2FlNzZiNmM3NjRmYjZiYTkzYmM1ZmY0MmNmZWRlXzItMS0xLTEtMA_e52c0431-fc85-46c2-b36f-ab3c39168f3f"
      unitRef="shares">957854</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i1ea19e5d9ee04882823da13b5fd955dc_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTozMjNhZTc2YjZjNzY0ZmI2YmE5M2JjNWZmNDJjZmVkZS90YWJsZXJhbmdlOjMyM2FlNzZiNmM3NjRmYjZiYTkzYmM1ZmY0MmNmZWRlXzItMy0xLTEtMA_718283ff-7ed4-4e3c-8a00-9f13392115c4"
      unitRef="cadPerShare">7.66</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i1ea19e5d9ee04882823da13b5fd955dc_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTozMjNhZTc2YjZjNzY0ZmI2YmE5M2JjNWZmNDJjZmVkZS90YWJsZXJhbmdlOjMyM2FlNzZiNmM3NjRmYjZiYTkzYmM1ZmY0MmNmZWRlXzMtMS0xLTEtNTI5MA_27957ab2-7a66-45b7-8547-82f3717018e3"
      unitRef="shares">732972</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i1ea19e5d9ee04882823da13b5fd955dc_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTozMjNhZTc2YjZjNzY0ZmI2YmE5M2JjNWZmNDJjZmVkZS90YWJsZXJhbmdlOjMyM2FlNzZiNmM3NjRmYjZiYTkzYmM1ZmY0MmNmZWRlXzMtMy0xLTEtNTI5MA_4e2e7b59-9843-4ce9-b8a6-ca24d47664b0"
      unitRef="cadPerShare">15.34</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i1ea19e5d9ee04882823da13b5fd955dc_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTozMjNhZTc2YjZjNzY0ZmI2YmE5M2JjNWZmNDJjZmVkZS90YWJsZXJhbmdlOjMyM2FlNzZiNmM3NjRmYjZiYTkzYmM1ZmY0MmNmZWRlXzMtMS0xLTEtMA_559ab9e2-336e-4355-a4c9-48691702705f"
      unitRef="shares">9497</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i1ea19e5d9ee04882823da13b5fd955dc_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTozMjNhZTc2YjZjNzY0ZmI2YmE5M2JjNWZmNDJjZmVkZS90YWJsZXJhbmdlOjMyM2FlNzZiNmM3NjRmYjZiYTkzYmM1ZmY0MmNmZWRlXzMtMy0xLTEtMA_73b7fde5-4866-4b18-b446-460b5d786ddd"
      unitRef="cadPerShare">7.52</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i5e9d2966a37a4b5092639437289a13e7_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTozMjNhZTc2YjZjNzY0ZmI2YmE5M2JjNWZmNDJjZmVkZS90YWJsZXJhbmdlOjMyM2FlNzZiNmM3NjRmYjZiYTkzYmM1ZmY0MmNmZWRlXzQtMS0xLTEtMA_86e69cfe-4619-42fc-880e-bea4f54e4b6c"
      unitRef="shares">948357</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i5e9d2966a37a4b5092639437289a13e7_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTozMjNhZTc2YjZjNzY0ZmI2YmE5M2JjNWZmNDJjZmVkZS90YWJsZXJhbmdlOjMyM2FlNzZiNmM3NjRmYjZiYTkzYmM1ZmY0MmNmZWRlXzQtMy0xLTEtMA_1a016e2a-f69a-4269-8538-77678a468eee"
      unitRef="cadPerShare">7.66</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i0a702c872ac7413cadbdd209e21825ba_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTplZmU5ZmE4YjdkYTE0MjFjODkzZGFmYzRmYTRiMjdkMy90YWJsZXJhbmdlOmVmZTlmYThiN2RhMTQyMWM4OTNkYWZjNGZhNGIyN2QzXzEtMS0xLTEtNTM0OA_55820bf0-fccd-40cd-bb78-bb5d65c05f8a"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i0a702c872ac7413cadbdd209e21825ba_I20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTplZmU5ZmE4YjdkYTE0MjFjODkzZGFmYzRmYTRiMjdkMy90YWJsZXJhbmdlOmVmZTlmYThiN2RhMTQyMWM4OTNkYWZjNGZhNGIyN2QzXzEtMy0xLTEtNTM0OA_a4fd65fd-c2d1-4fe2-b0d1-2c6195a012f8"
      unitRef="cadPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i40e8761a0c0246969b0c0e0b6a135205_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTplZmU5ZmE4YjdkYTE0MjFjODkzZGFmYzRmYTRiMjdkMy90YWJsZXJhbmdlOmVmZTlmYThiN2RhMTQyMWM4OTNkYWZjNGZhNGIyN2QzXzItMS0xLTEtNTM0OA_77c6cf9a-6fc2-4d27-b46d-b0f38181dcef"
      unitRef="shares">732972</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i40e8761a0c0246969b0c0e0b6a135205_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTplZmU5ZmE4YjdkYTE0MjFjODkzZGFmYzRmYTRiMjdkMy90YWJsZXJhbmdlOmVmZTlmYThiN2RhMTQyMWM4OTNkYWZjNGZhNGIyN2QzXzItMy0xLTEtNTM0OA_8a6f149e-1abb-47af-b3ca-242194f5a71b"
      unitRef="cadPerShare">15.34</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i48cd489dc3e441deb5021b45f107480e_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTplZmU5ZmE4YjdkYTE0MjFjODkzZGFmYzRmYTRiMjdkMy90YWJsZXJhbmdlOmVmZTlmYThiN2RhMTQyMWM4OTNkYWZjNGZhNGIyN2QzXzUtMS0xLTEtNTM0OA_a9d3c704-2c5c-4cfb-b85c-fc03c211a483"
      unitRef="shares">732972</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i48cd489dc3e441deb5021b45f107480e_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTplZmU5ZmE4YjdkYTE0MjFjODkzZGFmYzRmYTRiMjdkMy90YWJsZXJhbmdlOmVmZTlmYThiN2RhMTQyMWM4OTNkYWZjNGZhNGIyN2QzXzUtMy0xLTEtNTM0OA_beb46f5e-d717-4abb-9a39-11531266896d"
      unitRef="cadPerShare">15.34</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i7aedae1809744d5bae3e685f27c56a9b_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90ZXh0cmVnaW9uOmU2MTQ3ODYxMTRhYTRjMmZiZWJkNjc4NjJjOWJjZDRhXzgyNDYzMzczNDMyMDE_33104588-df28-4f36-aa1a-177c5f344c82"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ie7131d8a1bc5413bafda345c71101f28_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZToyNjAyODdhM2FkNTU0MWZmODEyZmMwNmY0OGVjNDAxYS90YWJsZXJhbmdlOjI2MDI4N2EzYWQ1NTQxZmY4MTJmYzA2ZjQ4ZWM0MDFhXzEtMS0xLTEtMA_aefb27bb-4d2b-4729-a4e5-f9cf634eaf81"
      unitRef="shares">33397</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent
      contextRef="ie7131d8a1bc5413bafda345c71101f28_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZToyNjAyODdhM2FkNTU0MWZmODEyZmMwNmY0OGVjNDAxYS90YWJsZXJhbmdlOjI2MDI4N2EzYWQ1NTQxZmY4MTJmYzA2ZjQ4ZWM0MDFhXzEtMy0xLTEtMA_da49ac41-ded1-473c-a604-b515db459b80"
      unitRef="usd">255000</us-gaap:DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent>
    <cron:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsAndVestedInPeriod
      contextRef="i06da2ae72791461581a87fa5b29a9243_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZToyNjAyODdhM2FkNTU0MWZmODEyZmMwNmY0OGVjNDAxYS90YWJsZXJhbmdlOjI2MDI4N2EzYWQ1NTQxZmY4MTJmYzA2ZjQ4ZWM0MDFhXzItMS0xLTEtMA_1cf8183b-37d9-414a-a1b1-2169dd33759d"
      unitRef="shares">58380</cron:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsAndVestedInPeriod>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i06da2ae72791461581a87fa5b29a9243_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZToyNjAyODdhM2FkNTU0MWZmODEyZmMwNmY0OGVjNDAxYS90YWJsZXJhbmdlOjI2MDI4N2EzYWQ1NTQxZmY4MTJmYzA2ZjQ4ZWM0MDFhXzItMy0xLTEtMA_c989a8f5-d96b-43e2-915f-bb5e12cb008a"
      unitRef="usd">338000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i06da2ae72791461581a87fa5b29a9243_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZToyNjAyODdhM2FkNTU0MWZmODEyZmMwNmY0OGVjNDAxYS90YWJsZXJhbmdlOjI2MDI4N2EzYWQ1NTQxZmY4MTJmYzA2ZjQ4ZWM0MDFhXzMtMS0xLTEtNTU3OA_f5584e78-f27f-41a9-9588-68a20b829779"
      unitRef="shares">8484</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <cron:ShareBasedPaymentArrangementLiabilitiesSettled
      contextRef="i06da2ae72791461581a87fa5b29a9243_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZToyNjAyODdhM2FkNTU0MWZmODEyZmMwNmY0OGVjNDAxYS90YWJsZXJhbmdlOjI2MDI4N2EzYWQ1NTQxZmY4MTJmYzA2ZjQ4ZWM0MDFhXzMtMy0xLTEtNTU3OA_dd22ec4d-c395-4af1-a201-70cf7cde0bc1"
      unitRef="usd">46000</cron:ShareBasedPaymentArrangementLiabilitiesSettled>
    <cron:ShareBasedPaymentArrangementGainLossOnRevaluation
      contextRef="i06da2ae72791461581a87fa5b29a9243_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZToyNjAyODdhM2FkNTU0MWZmODEyZmMwNmY0OGVjNDAxYS90YWJsZXJhbmdlOjI2MDI4N2EzYWQ1NTQxZmY4MTJmYzA2ZjQ4ZWM0MDFhXzMtMy0xLTEtMA_fec42457-f884-49e9-aacf-2326c10f8dfe"
      unitRef="usd">-30000</cron:ShareBasedPaymentArrangementGainLossOnRevaluation>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i9c3498dbe45c4b4283bce64a55185b1f_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZToyNjAyODdhM2FkNTU0MWZmODEyZmMwNmY0OGVjNDAxYS90YWJsZXJhbmdlOjI2MDI4N2EzYWQ1NTQxZmY4MTJmYzA2ZjQ4ZWM0MDFhXzQtMS0xLTEtMA_a9052879-b6d6-4792-958b-7f82663013a7"
      unitRef="shares">83293</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent
      contextRef="i9c3498dbe45c4b4283bce64a55185b1f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZToyNjAyODdhM2FkNTU0MWZmODEyZmMwNmY0OGVjNDAxYS90YWJsZXJhbmdlOjI2MDI4N2EzYWQ1NTQxZmY4MTJmYzA2ZjQ4ZWM0MDFhXzQtMy0xLTEtMA_ab6133a0-d3bc-45d7-b854-0eaefb874066"
      unitRef="usd">577000</us-gaap:DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ie21e1229f5684c4f8d8a3917015fd153_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTo3MDk1OWZmZWQ0YmU0ZWU1YjJhZTUxYzllMGRmNzg1NC90YWJsZXJhbmdlOjcwOTU5ZmZlZDRiZTRlZTViMmFlNTFjOWUwZGY3ODU0XzEtMS0xLTEtNTIwMQ_5d37d807-6d8f-4992-ad8f-d37879106d1e"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent
      contextRef="ie21e1229f5684c4f8d8a3917015fd153_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTo3MDk1OWZmZWQ0YmU0ZWU1YjJhZTUxYzllMGRmNzg1NC90YWJsZXJhbmdlOjcwOTU5ZmZlZDRiZTRlZTViMmFlNTFjOWUwZGY3ODU0XzEtMy0xLTEtNTIwMQ_4245947d-02ad-4582-9f68-a2dff4efac8b"
      unitRef="usd">0</us-gaap:DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent>
    <cron:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsAndVestedInPeriod
      contextRef="i18703331ae024841932a2cfa20e595cd_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTo3MDk1OWZmZWQ0YmU0ZWU1YjJhZTUxYzllMGRmNzg1NC90YWJsZXJhbmdlOjcwOTU5ZmZlZDRiZTRlZTViMmFlNTFjOWUwZGY3ODU0XzItMS0xLTEtNTIwMQ_c6ed4d57-8a68-4f7f-bc24-4f07737db720"
      unitRef="shares">33397</cron:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsAndVestedInPeriod>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i18703331ae024841932a2cfa20e595cd_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTo3MDk1OWZmZWQ0YmU0ZWU1YjJhZTUxYzllMGRmNzg1NC90YWJsZXJhbmdlOjcwOTU5ZmZlZDRiZTRlZTViMmFlNTFjOWUwZGY3ODU0XzItMy0xLTEtNTIwMQ_ca8f7793-10c2-4fd1-b01b-c796841d26cf"
      unitRef="usd">452000</us-gaap:AllocatedShareBasedCompensationExpense>
    <cron:ShareBasedPaymentArrangementGainLossOnRevaluation
      contextRef="i18703331ae024841932a2cfa20e595cd_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTo3MDk1OWZmZWQ0YmU0ZWU1YjJhZTUxYzllMGRmNzg1NC90YWJsZXJhbmdlOjcwOTU5ZmZlZDRiZTRlZTViMmFlNTFjOWUwZGY3ODU0XzMtMy0xLTEtNTIwMQ_b7937a18-a101-4995-8226-2ff27247333f"
      unitRef="usd">197000</cron:ShareBasedPaymentArrangementGainLossOnRevaluation>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ie7131d8a1bc5413bafda345c71101f28_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTo3MDk1OWZmZWQ0YmU0ZWU1YjJhZTUxYzllMGRmNzg1NC90YWJsZXJhbmdlOjcwOTU5ZmZlZDRiZTRlZTViMmFlNTFjOWUwZGY3ODU0XzQtMS0xLTEtNTIwMQ_868abb38-b20b-498c-b2ea-e8e6644c8c7b"
      unitRef="shares">33397</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent
      contextRef="ie7131d8a1bc5413bafda345c71101f28_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90YWJsZTo3MDk1OWZmZWQ0YmU0ZWU1YjJhZTUxYzllMGRmNzg1NC90YWJsZXJhbmdlOjcwOTU5ZmZlZDRiZTRlZTViMmFlNTFjOWUwZGY3ODU0XzQtMy0xLTEtNTIwMQ_1940ae24-087a-4106-87aa-7023ad3964c8"
      unitRef="usd">255000</us-gaap:DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90ZXh0cmVnaW9uOjVjYWQ0ZjVlYWVmYTQxNWNhM2RkMWY3NjRkMTRkYmQ3XzM5NQ_fb496b3e-ee69-4618-8661-5b06b9404e1e">Earnings (loss) Per Share&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic and diluted earnings (loss) per share from continuing operations &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;are&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; calculated using &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;the&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; following numerators &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; denominators:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.645%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.468%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.468%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basic earnings (loss) per share computation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations attributable to common shareholders of Cronos&#160;Group&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(72,487)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,166,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,742)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351,576,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310,067,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172,269,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Basic earnings (loss) per share &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Diluted earnings (loss) per share computation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations used in the computation of basic earnings (loss) per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(72,487)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,166,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,742)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustment for gain on revaluation of derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,416)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations used in the computation of diluted income (loss) per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(72,487)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,142,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,742)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares outstanding used in the computation of basic earnings (loss) per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351,576,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310,067,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172,269,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,481,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,649,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of restricted share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;732,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of Altria Warrant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of Top-up Rights &#x2013; exercised and exercisable fixed price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,881,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares for computation of diluted income (loss) per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351,576,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;342,811,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172,269,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted earnings (loss) per share&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.1pt"&gt;In computing diluted earnings per share, incremental common shares are not considered in periods in which a net loss is reported, as the inclusion of the common share equivalents would be anti-dilutive.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic and diluted loss per share from discontinued operations are calculated using the following numerators and denominators: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.645%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.468%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.468%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 24.62pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basic loss from discontinued operations per share computation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 24.62pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from discontinued operations attributable to common shareholders of Cronos Group&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(650)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(363)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(894)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351,576,848&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310,067,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172,269,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic loss from discontinued operations per share&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.01)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.1pt"&gt;In computing diluted earnings per share, incremental common shares are not considered in periods in which a net loss is reported, as the inclusion of the common share equivalents would be anti-dilutive.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following securities were not included in the computation of diluted shares outstanding because the effect would be anti-dilutive or because conditions for contingently issuable shares were not satisfied at the end of the reporting periods. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ginkgo Equity Milestones&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,674,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,674,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pre-emptive Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,534,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,006,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Top-up Rights &#x2013; fixed price&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,214,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,103,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Top-up Rights &#x2013; market price&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,413,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,255,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Altria Warrant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,056,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,514,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,147,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,457,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,218,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,315,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,902,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total anti-dilutive securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151,338,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131,871,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,360,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90ZXh0cmVnaW9uOjVjYWQ0ZjVlYWVmYTQxNWNhM2RkMWY3NjRkMTRkYmQ3XzI0MTg5MjU1ODE0NTk3_631be0d6-7f5a-4a7d-a00e-8b70cab0650f">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic and diluted earnings (loss) per share from continuing operations &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;are&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; calculated using &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;the&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; following numerators &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; denominators:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.645%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.468%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.468%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basic earnings (loss) per share computation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations attributable to common shareholders of Cronos&#160;Group&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(72,487)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,166,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,742)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351,576,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310,067,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172,269,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Basic earnings (loss) per share &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Diluted earnings (loss) per share computation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations used in the computation of basic earnings (loss) per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(72,487)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,166,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,742)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustment for gain on revaluation of derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,416)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from continuing operations used in the computation of diluted income (loss) per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(72,487)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,142,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,742)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares outstanding used in the computation of basic earnings (loss) per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351,576,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310,067,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172,269,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,481,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,649,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of restricted share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;732,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of Altria Warrant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of Top-up Rights &#x2013; exercised and exercisable fixed price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,881,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares for computation of diluted income (loss) per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351,576,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;342,811,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172,269,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted earnings (loss) per share&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.1pt"&gt;In computing diluted earnings per share, incremental common shares are not considered in periods in which a net loss is reported, as the inclusion of the common share equivalents would be anti-dilutive.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic and diluted loss per share from discontinued operations are calculated using the following numerators and denominators: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.645%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.468%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.468%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 24.62pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basic loss from discontinued operations per share computation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 24.62pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from discontinued operations attributable to common shareholders of Cronos Group&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(650)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(363)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(894)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351,576,848&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310,067,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172,269,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic loss from discontinued operations per share&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.01)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.1pt"&gt;In computing diluted earnings per share, incremental common shares are not considered in periods in which a net loss is reported, as the inclusion of the common share equivalents would be anti-dilutive.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzItMi0xLTEtMA_71c78ce2-0685-4f1b-aa38-0952c08c513a"
      unitRef="usd">-72487000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzItNC0xLTEtMA_5f113e73-293e-4df6-a4f6-8b793996a549"
      unitRef="usd">1166869000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzItNi0xLTEtMA_960de221-cd07-4799-9fab-d481aae9a91c"
      unitRef="usd">-20742000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzMtMi0xLTEtMA_be179543-59b9-4f3b-9db0-f5666467f58b"
      unitRef="shares">351576848</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzMtNC0xLTEtMA_88beb3aa-dedb-4bec-8145-fc21068b2106"
      unitRef="shares">310067179</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzMtNi0xLTEtMA_071648db-776f-40ac-99b6-b844d5c95d94"
      unitRef="shares">172269170</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzQtMi0xLTEtMA_2f8c833c-8fed-42b9-9e94-c79eb0429812"
      unitRef="usdPerShare">-0.21</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzQtNC0xLTEtMA_7128b6ae-85df-47ae-aa99-06a6187416cb"
      unitRef="usdPerShare">3.76</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzQtNi0xLTEtMA_447953bc-085b-468a-a181-cdcd6a92651d"
      unitRef="usdPerShare">-0.12</us-gaap:EarningsPerShareBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzYtMi0xLTEtMA_f8937fe0-a8e7-4d74-8368-b2566ae314fb"
      unitRef="usd">-72487000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzYtNC0xLTEtMA_b63df865-dfae-4202-b153-308028db3ac9"
      unitRef="usd">1166869000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzYtNi0xLTEtMA_422920a2-b97c-4d99-a965-09fe4b30386a"
      unitRef="usd">-20742000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:DilutiveSecurities
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzctMi0xLTEtMA_740e4a75-4f2f-4853-bf58-2b29190a07e1"
      unitRef="usd">0</us-gaap:DilutiveSecurities>
    <us-gaap:DilutiveSecurities
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzctNC0xLTEtMA_7989f3e4-036f-4ed6-97fb-b3eee1d3a46c"
      unitRef="usd">-24416000</us-gaap:DilutiveSecurities>
    <us-gaap:DilutiveSecurities
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzctNi0xLTEtMA_c6112ad8-158d-445b-ab61-598f83602399"
      unitRef="usd">0</us-gaap:DilutiveSecurities>
    <us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzgtMi0xLTEtMA_09d63a4a-e301-4179-a08d-8b3042f1efcc"
      unitRef="usd">-72487000</us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted>
    <us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzgtNC0xLTEtMA_3cbb4572-f2aa-4089-9a81-53a50e6f15a2"
      unitRef="usd">1142453000</us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted>
    <us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzgtNi0xLTEtMA_09809516-0a5c-4092-ac2c-6bd62d58aafe"
      unitRef="usd">-20742000</us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzEwLTItMS0xLTA_a55b0a6b-f2f1-429e-a6da-63078c45376d"
      unitRef="shares">351576848</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzEwLTQtMS0xLTA_42fe4de1-5b68-4bd9-8dee-d3f04678fcd8"
      unitRef="shares">310067179</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzEwLTYtMS0xLTA_4b588351-8add-443b-977c-40d02cf72aa2"
      unitRef="shares">172269170</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i5372334bf7d347cba8a470a7ae7e08dd_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzExLTItMS0xLTA_a4d0551b-cddf-40ec-b2ae-8c3a1839236c"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="iec84f453bb6e43d7a3cafa4dad5299d9_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzExLTQtMS0xLTA_506edaf8-d2f7-48d7-8073-b63eb3e42662"
      unitRef="shares">19481352</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ic2cbf1f3457444a8a066a4b33bcc0f8d_D20180101-20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzExLTYtMS0xLTA_f7822d87-2210-44e6-aa5b-ae16fa84a404"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i5bc534f0f44f4850a59aff8f75b91db8_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzEyLTItMS0xLTA_22fe7d9d-4308-49e5-b38d-d48a696f180f"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i7b7f36b7882142ceb233b456769d9d37_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzEyLTQtMS0xLTA_8bde68d7-45e6-49d6-ae67-5d5b00f2706b"
      unitRef="shares">10649487</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="id2927e2128a7487ba8176ee60d748c59_D20180101-20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzEyLTYtMS0xLTA_c33d69a7-5b40-4fb9-b015-25a92c18c919"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i1ea19e5d9ee04882823da13b5fd955dc_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzEzLTItMS0xLTA_1f19f00f-30f1-45e4-9e5e-85fb157fc3ed"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i40e8761a0c0246969b0c0e0b6a135205_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzEzLTQtMS0xLTA_8af861a2-ac5a-4d22-9762-53cd41f65bab"
      unitRef="shares">732972</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i9b7d911f78814b9bab3743f845ab435a_D20180101-20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzEzLTYtMS0xLTA_05a60325-cb6b-4d78-b84a-14c1e8987053"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants
      contextRef="ia99e808e67ba45ec9755b053b88b09fe_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzE0LTItMS0xLTA_8571d650-e04c-44b6-ac69-1eebdd513636"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants
      contextRef="i7504a998053c4a47a4b5953d769d1663_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzE0LTQtMS0xLTA_1d5054d7-66ba-4312-9f28-4df56d4c6c53"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants
      contextRef="i7c037c87e1ba48679175b63b96788f53_D20180101-20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzE0LTYtMS0xLTA_446f6e8b-7cd8-48e4-853c-e68710848fde"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants
      contextRef="ic39856d934ae48b2a455091b04383ffc_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzE1LTItMS0xLTA_026ddf3e-5735-45ca-9feb-711b81321386"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants
      contextRef="i5d1da0bebea24f23b27907644c0febb9_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzE1LTQtMS0xLTA_3fa9d84b-e16f-4b41-9c76-7292481892b4"
      unitRef="shares">1881002</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants
      contextRef="i5f6976781f6547bb84cd70d81d6d70c4_D20180101-20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzE1LTYtMS0xLTA_8b26bd79-8370-4774-9255-68c9b0aa0143"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzE2LTItMS0xLTA_eb56d43f-52ef-4d7e-9d99-29823c4e2dde"
      unitRef="shares">351576848</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzE2LTQtMS0xLTA_03aad8ba-f71d-4ff0-ba60-9ddff1955f1e"
      unitRef="shares">342811992</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzE2LTYtMS0xLTA_143b837b-8113-4262-aa5d-9aecaf6501f8"
      unitRef="shares">172269170</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzE3LTItMS0xLTA_ba45e212-6e06-4c7d-9922-004c8e20f394"
      unitRef="usdPerShare">-0.21</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzE3LTQtMS0xLTA_6146bb58-0a11-4724-9384-8c8059a7f671"
      unitRef="usdPerShare">3.33</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo1MzQwMzQxZmI4OWY0YjUxODc0NGYzYzBkMGZhMDM4Mi90YWJsZXJhbmdlOjUzNDAzNDFmYjg5ZjRiNTE4NzQ0ZjNjMGQwZmEwMzgyXzE3LTYtMS0xLTA_bba0f267-5876-41f7-8947-17f587397c42"
      unitRef="usdPerShare">-0.12</us-gaap:EarningsPerShareDiluted>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo0ZWM4MWZlYWM3ZWM0M2UzOTMzNGQxMDk5ZjRiMTA2Yi90YWJsZXJhbmdlOjRlYzgxZmVhYzdlYzQzZTM5MzM0ZDEwOTlmNGIxMDZiXzEtMi0xLTEtMTY4Nzc_df1f209a-9494-4f3b-bf08-1294215bb6d2"
      unitRef="usd">-650000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo0ZWM4MWZlYWM3ZWM0M2UzOTMzNGQxMDk5ZjRiMTA2Yi90YWJsZXJhbmdlOjRlYzgxZmVhYzdlYzQzZTM5MzM0ZDEwOTlmNGIxMDZiXzEtNC0xLTEtMTY4Nzc_98dac7f4-d90a-46b8-917f-1902e4f27115"
      unitRef="usd">-363000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo0ZWM4MWZlYWM3ZWM0M2UzOTMzNGQxMDk5ZjRiMTA2Yi90YWJsZXJhbmdlOjRlYzgxZmVhYzdlYzQzZTM5MzM0ZDEwOTlmNGIxMDZiXzEtNi0xLTEtMTY4Nzc_a5f64b95-b92e-4dab-98f8-e384a73b16fc"
      unitRef="usd">-894000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo0ZWM4MWZlYWM3ZWM0M2UzOTMzNGQxMDk5ZjRiMTA2Yi90YWJsZXJhbmdlOjRlYzgxZmVhYzdlYzQzZTM5MzM0ZDEwOTlmNGIxMDZiXzItMi0xLTEtMTY4Nzc_92e2879e-3d9f-4be7-ae58-9e4683feb287"
      unitRef="shares">351576848</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo0ZWM4MWZlYWM3ZWM0M2UzOTMzNGQxMDk5ZjRiMTA2Yi90YWJsZXJhbmdlOjRlYzgxZmVhYzdlYzQzZTM5MzM0ZDEwOTlmNGIxMDZiXzItNC0xLTEtMTY4Nzc_ddd0f374-03b8-4c41-8c39-fa3d56ed550e"
      unitRef="shares">310067179</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo0ZWM4MWZlYWM3ZWM0M2UzOTMzNGQxMDk5ZjRiMTA2Yi90YWJsZXJhbmdlOjRlYzgxZmVhYzdlYzQzZTM5MzM0ZDEwOTlmNGIxMDZiXzItNi0xLTEtMTY4Nzc_cef9e40d-292d-469c-a91e-72dad62d939a"
      unitRef="shares">172269170</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo0ZWM4MWZlYWM3ZWM0M2UzOTMzNGQxMDk5ZjRiMTA2Yi90YWJsZXJhbmdlOjRlYzgxZmVhYzdlYzQzZTM5MzM0ZDEwOTlmNGIxMDZiXzMtMi0xLTEtMTY4Nzc_1cb8db90-81c9-482f-9deb-215a7e4ad558"
      unitRef="usdPerShare">-0.00</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo0ZWM4MWZlYWM3ZWM0M2UzOTMzNGQxMDk5ZjRiMTA2Yi90YWJsZXJhbmdlOjRlYzgxZmVhYzdlYzQzZTM5MzM0ZDEwOTlmNGIxMDZiXzMtNC0xLTEtMTY4Nzc_6b801087-7081-43a0-a355-5767cdc6b6cc"
      unitRef="usdPerShare">-0.00</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZTo0ZWM4MWZlYWM3ZWM0M2UzOTMzNGQxMDk5ZjRiMTA2Yi90YWJsZXJhbmdlOjRlYzgxZmVhYzdlYzQzZTM5MzM0ZDEwOTlmNGIxMDZiXzMtNi0xLTEtMTY4Nzc_19dadd66-7257-4e81-b5e7-c425559b9887"
      unitRef="usdPerShare">-0.01</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90ZXh0cmVnaW9uOjVjYWQ0ZjVlYWVmYTQxNWNhM2RkMWY3NjRkMTRkYmQ3XzM5Nw_7a72878c-7228-4203-8144-67306c2be98c">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following securities were not included in the computation of diluted shares outstanding because the effect would be anti-dilutive or because conditions for contingently issuable shares were not satisfied at the end of the reporting periods. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ginkgo Equity Milestones&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,674,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,674,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pre-emptive Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,534,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,006,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Top-up Rights &#x2013; fixed price&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,214,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,103,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Top-up Rights &#x2013; market price&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,413,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,255,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Altria Warrant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,056,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,514,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,147,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,457,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,218,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,315,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,902,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total anti-dilutive securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151,338,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131,871,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,360,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="iabcd6f2591c44b2ca171a367b14b3c94_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZToyMjZjYjEyYTA5ZjQ0NjRmYjVjN2Q1NjY4ZDU0MTJjOC90YWJsZXJhbmdlOjIyNmNiMTJhMDlmNDQ2NGZiNWM3ZDU2NjhkNTQxMmM4XzEtMi0xLTEtMA_c11b8555-98f0-478e-95ae-e7221ce15de6"
      unitRef="shares">14674904</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ia13ef8116a4544ff98e7741be32a6862_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZToyMjZjYjEyYTA5ZjQ0NjRmYjVjN2Q1NjY4ZDU0MTJjOC90YWJsZXJhbmdlOjIyNmNiMTJhMDlmNDQ2NGZiNWM3ZDU2NjhkNTQxMmM4XzEtNC0xLTEtMA_3bab561d-9950-473d-b235-9149071351c3"
      unitRef="shares">14674904</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="id8fe397a667c46d5a2f89689b2a80c59_D20180101-20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZToyMjZjYjEyYTA5ZjQ0NjRmYjVjN2Q1NjY4ZDU0MTJjOC90YWJsZXJhbmdlOjIyNmNiMTJhMDlmNDQ2NGZiNWM3ZDU2NjhkNTQxMmM4XzEtNi0xLTEtMA_44561e4f-105c-4971-8ac1-db4b7e5a224d"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ia107f20927684430b7ec8a2ee550479f_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZToyMjZjYjEyYTA5ZjQ0NjRmYjVjN2Q1NjY4ZDU0MTJjOC90YWJsZXJhbmdlOjIyNmNiMTJhMDlmNDQ2NGZiNWM3ZDU2NjhkNTQxMmM4XzItMi0xLTEtMA_f6a71e41-9567-4c9e-bf9d-691a2302f96b"
      unitRef="shares">11534475</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="if4600e9c488a42d59e3c24335cbf41e9_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZToyMjZjYjEyYTA5ZjQ0NjRmYjVjN2Q1NjY4ZDU0MTJjOC90YWJsZXJhbmdlOjIyNmNiMTJhMDlmNDQ2NGZiNWM3ZDU2NjhkNTQxMmM4XzItNC0xLTEtMA_eaeb39bf-7642-4a59-8462-d81c5ac8e276"
      unitRef="shares">12006740</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i8b57674317f444c9babd29a3fc8677bb_D20180101-20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZToyMjZjYjEyYTA5ZjQ0NjRmYjVjN2Q1NjY4ZDU0MTJjOC90YWJsZXJhbmdlOjIyNmNiMTJhMDlmNDQ2NGZiNWM3ZDU2NjhkNTQxMmM4XzItNi0xLTEtMA_9acc122b-8025-4111-9ce4-9d624b06d618"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ibbe78d1c31b04bcca9543cdd1b92d857_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZToyMjZjYjEyYTA5ZjQ0NjRmYjVjN2Q1NjY4ZDU0MTJjOC90YWJsZXJhbmdlOjIyNmNiMTJhMDlmNDQ2NGZiNWM3ZDU2NjhkNTQxMmM4XzQtMi0xLTEtMA_7de97061-b9ba-423c-b7a4-76ed3818d4cd"
      unitRef="shares">17214621</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i18896e52388e4a1da87bb89497c230c1_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZToyMjZjYjEyYTA5ZjQ0NjRmYjVjN2Q1NjY4ZDU0MTJjOC90YWJsZXJhbmdlOjIyNmNiMTJhMDlmNDQ2NGZiNWM3ZDU2NjhkNTQxMmM4XzQtNC0xLTEtMA_a665a2c5-fab9-4700-87ed-4664a2d72061"
      unitRef="shares">25103456</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="id4dbef9b15d143eba0d9488a6bd1b6de_D20180101-20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZToyMjZjYjEyYTA5ZjQ0NjRmYjVjN2Q1NjY4ZDU0MTJjOC90YWJsZXJhbmdlOjIyNmNiMTJhMDlmNDQ2NGZiNWM3ZDU2NjhkNTQxMmM4XzQtNi0xLTEtMA_2fb48a67-d155-43ad-b003-0ca97f565b0d"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ia16bd82ebd994d52bbf2a05aea172f78_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZToyMjZjYjEyYTA5ZjQ0NjRmYjVjN2Q1NjY4ZDU0MTJjOC90YWJsZXJhbmdlOjIyNmNiMTJhMDlmNDQ2NGZiNWM3ZDU2NjhkNTQxMmM4XzUtMi0xLTEtMA_b87f6e94-bcce-4517-814b-9b65b00485b2"
      unitRef="shares">3413065</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i31e5c55249cf4472837632d6378bb9fa_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZToyMjZjYjEyYTA5ZjQ0NjRmYjVjN2Q1NjY4ZDU0MTJjOC90YWJsZXJhbmdlOjIyNmNiMTJhMDlmNDQ2NGZiNWM3ZDU2NjhkNTQxMmM4XzUtNC0xLTEtMA_c44769c8-66c0-43a8-9d11-afad16764842"
      unitRef="shares">1255223</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i5b93f227eda545ceb826b2485055ecd7_D20180101-20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZToyMjZjYjEyYTA5ZjQ0NjRmYjVjN2Q1NjY4ZDU0MTJjOC90YWJsZXJhbmdlOjIyNmNiMTJhMDlmNDQ2NGZiNWM3ZDU2NjhkNTQxMmM4XzUtNi0xLTEtMA_730f6638-6ab5-42b5-96f2-5a759babe8c6"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i513a3a500da74d7f8646190b65ddac07_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZToyMjZjYjEyYTA5ZjQ0NjRmYjVjN2Q1NjY4ZDU0MTJjOC90YWJsZXJhbmdlOjIyNmNiMTJhMDlmNDQ2NGZiNWM3ZDU2NjhkNTQxMmM4XzYtMi0xLTEtMA_c97cd065-4318-405c-a881-0a4832d3e346"
      unitRef="shares">80056296</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ib5d2efd05e19469484982928396a62c5_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZToyMjZjYjEyYTA5ZjQ0NjRmYjVjN2Q1NjY4ZDU0MTJjOC90YWJsZXJhbmdlOjIyNmNiMTJhMDlmNDQ2NGZiNWM3ZDU2NjhkNTQxMmM4XzYtNC0xLTEtMA_688a65ad-bc5c-406d-bb99-9c40c66e397b"
      unitRef="shares">77514993</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i19d2882beeff45f18c65e01d481175ba_D20180101-20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZToyMjZjYjEyYTA5ZjQ0NjRmYjVjN2Q1NjY4ZDU0MTJjOC90YWJsZXJhbmdlOjIyNmNiMTJhMDlmNDQ2NGZiNWM3ZDU2NjhkNTQxMmM4XzYtNi0xLTEtMA_bd48bd36-5488-4950-95fe-1d2430d34e0c"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ibc0a4d389472474080abbcd7fc478343_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZToyMjZjYjEyYTA5ZjQ0NjRmYjVjN2Q1NjY4ZDU0MTJjOC90YWJsZXJhbmdlOjIyNmNiMTJhMDlmNDQ2NGZiNWM3ZDU2NjhkNTQxMmM4XzctMi0xLTEtMA_53710477-6858-4a1a-ba6f-3f708480951c"
      unitRef="shares">15147116</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="iff46fcf5fdd440e98e0b8f5a4f556a79_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZToyMjZjYjEyYTA5ZjQ0NjRmYjVjN2Q1NjY4ZDU0MTJjOC90YWJsZXJhbmdlOjIyNmNiMTJhMDlmNDQ2NGZiNWM3ZDU2NjhkNTQxMmM4XzctNC0xLTEtMA_6b492991-7c22-41df-bec9-98460f525128"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i9eaef38c64244f4aaea506efaee150a7_D20180101-20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZToyMjZjYjEyYTA5ZjQ0NjRmYjVjN2Q1NjY4ZDU0MTJjOC90YWJsZXJhbmdlOjIyNmNiMTJhMDlmNDQ2NGZiNWM3ZDU2NjhkNTQxMmM4XzctNi0xLTEtMA_885dc24c-2c00-4fa4-b9fc-870603ca629f"
      unitRef="shares">25457623</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ie606d97d090a47379c20114ccad4b834_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZToyMjZjYjEyYTA5ZjQ0NjRmYjVjN2Q1NjY4ZDU0MTJjOC90YWJsZXJhbmdlOjIyNmNiMTJhMDlmNDQ2NGZiNWM3ZDU2NjhkNTQxMmM4XzctMi0xLTEtMjI0MDk_255c0ba8-e3eb-47e8-82bc-dc0a8799cf84"
      unitRef="shares">9218674</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i8982714a235343b797d9648803250239_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZToyMjZjYjEyYTA5ZjQ0NjRmYjVjN2Q1NjY4ZDU0MTJjOC90YWJsZXJhbmdlOjIyNmNiMTJhMDlmNDQ2NGZiNWM3ZDU2NjhkNTQxMmM4XzgtNC0xLTEtMTA3OA_52209589-baf4-462b-8cf0-8941b5b27065"
      unitRef="shares">1315787</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i86551ed52b054f04aea18834481b512c_D20180101-20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZToyMjZjYjEyYTA5ZjQ0NjRmYjVjN2Q1NjY4ZDU0MTJjOC90YWJsZXJhbmdlOjIyNmNiMTJhMDlmNDQ2NGZiNWM3ZDU2NjhkNTQxMmM4XzgtNi0xLTEtMTA3OA_6cdba066-1d39-414d-87e2-2ad2dd2f386f"
      unitRef="shares">12902995</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i7086ea760db54de69350dc668c77abf2_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZToyMjZjYjEyYTA5ZjQ0NjRmYjVjN2Q1NjY4ZDU0MTJjOC90YWJsZXJhbmdlOjIyNmNiMTJhMDlmNDQ2NGZiNWM3ZDU2NjhkNTQxMmM4XzgtMi0xLTEtMjU4ODE_13b4b448-5b9b-4c7e-af17-a0fd332a1922"
      unitRef="shares">79611</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ib75ab85d304848018363ecdc58cac865_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZToyMjZjYjEyYTA5ZjQ0NjRmYjVjN2Q1NjY4ZDU0MTJjOC90YWJsZXJhbmdlOjIyNmNiMTJhMDlmNDQ2NGZiNWM3ZDU2NjhkNTQxMmM4XzgtNC0xLTEtMjU4ODE_333a6e55-bf5d-4279-9623-35f4edf75b74"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ic5e9647b572044ccb1b1d35cba81bf49_D20180101-20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZToyMjZjYjEyYTA5ZjQ0NjRmYjVjN2Q1NjY4ZDU0MTJjOC90YWJsZXJhbmdlOjIyNmNiMTJhMDlmNDQ2NGZiNWM3ZDU2NjhkNTQxMmM4XzgtNi0xLTEtMzY0NDg_7f60ad76-8256-4988-9694-b12461e07537"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZToyMjZjYjEyYTA5ZjQ0NjRmYjVjN2Q1NjY4ZDU0MTJjOC90YWJsZXJhbmdlOjIyNmNiMTJhMDlmNDQ2NGZiNWM3ZDU2NjhkNTQxMmM4XzgtMi0xLTEtMA_a67695b4-39be-4f60-a153-9df5f6b94fcc"
      unitRef="shares">151338762</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZToyMjZjYjEyYTA5ZjQ0NjRmYjVjN2Q1NjY4ZDU0MTJjOC90YWJsZXJhbmdlOjIyNmNiMTJhMDlmNDQ2NGZiNWM3ZDU2NjhkNTQxMmM4XzgtNC0xLTEtMA_d302ddd9-f087-44de-91b2-9f2d89f59de6"
      unitRef="shares">131871103</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDIvZnJhZzo1Y2FkNGY1ZWFlZmE0MTVjYTNkZDFmNzY0ZDE0ZGJkNy90YWJsZToyMjZjYjEyYTA5ZjQ0NjRmYjVjN2Q1NjY4ZDU0MTJjOC90YWJsZXJhbmdlOjIyNmNiMTJhMDlmNDQ2NGZiNWM3ZDU2NjhkNTQxMmM4XzgtNi0xLTEtMA_68620646-e89f-4dc7-a885-4896f0d548a3"
      unitRef="shares">38360618</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDkvZnJhZzpiYmUxMjVjMjMzNWM0NTEzYjlmZGRjMGY4Y2MyNGIzMi90ZXh0cmVnaW9uOmJiZTEyNWMyMzM1YzQ1MTNiOWZkZGMwZjhjYzI0YjMyXzEwMw_2338416a-45b8-40bb-a637-d6553c8f4eda">Accumulated Other Comprehensive Income (Loss) &lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a continuity schedule of accumulated other comprehensive income (loss):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.278%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.468%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.278%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.468%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.281%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net unrealized gain (loss) on revaluation and disposal of other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDkvZnJhZzpiYmUxMjVjMjMzNWM0NTEzYjlmZGRjMGY4Y2MyNGIzMi90YWJsZTpjODNhYjhiMmI3MTA0YzA1OTBmMzdlMWEwY2RiNWU5Zi90YWJsZXJhbmdlOmM4M2FiOGIyYjcxMDRjMDU5MGYzN2UxYTBjZGI1ZTlmXzMtMC0xLTEtMA_f0ab88a4-f8e8-45c9-b06f-6577993eb9f0"&gt;Cumulative effect from adoption of ASU 2016-01&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(444)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net unrealized (loss) gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net foreign exchange gain (loss) on translation of foreign operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at January 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,875)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net unrealized (loss) gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,331)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,875)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,870)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDkvZnJhZzpiYmUxMjVjMjMzNWM0NTEzYjlmZGRjMGY4Y2MyNGIzMi90ZXh0cmVnaW9uOmJiZTEyNWMyMzM1YzQ1MTNiOWZkZGMwZjhjYzI0YjMyXzEwNA_b5b47923-53ea-49e3-ad6e-a22f45e473b5">&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a continuity schedule of accumulated other comprehensive income (loss):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.278%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.468%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.278%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.468%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.281%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net unrealized gain (loss) on revaluation and disposal of other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDkvZnJhZzpiYmUxMjVjMjMzNWM0NTEzYjlmZGRjMGY4Y2MyNGIzMi90YWJsZTpjODNhYjhiMmI3MTA0YzA1OTBmMzdlMWEwY2RiNWU5Zi90YWJsZXJhbmdlOmM4M2FiOGIyYjcxMDRjMDU5MGYzN2UxYTBjZGI1ZTlmXzMtMC0xLTEtMA_f0ab88a4-f8e8-45c9-b06f-6577993eb9f0"&gt;Cumulative effect from adoption of ASU 2016-01&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(444)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net unrealized (loss) gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net foreign exchange gain (loss) on translation of foreign operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at January 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,875)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net unrealized (loss) gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,331)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,875)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,870)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5185ab0b8710451b8f3f523f58af8d12_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDkvZnJhZzpiYmUxMjVjMjMzNWM0NTEzYjlmZGRjMGY4Y2MyNGIzMi90YWJsZTpjODNhYjhiMmI3MTA0YzA1OTBmMzdlMWEwY2RiNWU5Zi90YWJsZXJhbmdlOmM4M2FiOGIyYjcxMDRjMDU5MGYzN2UxYTBjZGI1ZTlmXzItMS0xLTEtMA_59c08508-cae2-44a1-8a48-67e03dfe7a14"
      unitRef="usd">5000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iee60a63d4a4f449784f69d72f30688ce_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDkvZnJhZzpiYmUxMjVjMjMzNWM0NTEzYjlmZGRjMGY4Y2MyNGIzMi90YWJsZTpjODNhYjhiMmI3MTA0YzA1OTBmMzdlMWEwY2RiNWU5Zi90YWJsZXJhbmdlOmM4M2FiOGIyYjcxMDRjMDU5MGYzN2UxYTBjZGI1ZTlmXzItMy0xLTEtMA_7e430394-ec7a-4511-9255-2f2f69d82817"
      unitRef="usd">5000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i732c27b4af274e05b82f35736f73db58_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDkvZnJhZzpiYmUxMjVjMjMzNWM0NTEzYjlmZGRjMGY4Y2MyNGIzMi90YWJsZTpjODNhYjhiMmI3MTA0YzA1OTBmMzdlMWEwY2RiNWU5Zi90YWJsZXJhbmdlOmM4M2FiOGIyYjcxMDRjMDU5MGYzN2UxYTBjZGI1ZTlmXzItNS0xLTEtMA_f524d42d-ee62-46eb-a40c-e6c8d95c6cde"
      unitRef="usd">446000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibd18b2c5a9374aadb38dfb21c7374eef_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDkvZnJhZzpiYmUxMjVjMjMzNWM0NTEzYjlmZGRjMGY4Y2MyNGIzMi90YWJsZTpjODNhYjhiMmI3MTA0YzA1OTBmMzdlMWEwY2RiNWU5Zi90YWJsZXJhbmdlOmM4M2FiOGIyYjcxMDRjMDU5MGYzN2UxYTBjZGI1ZTlmXzMtMS0xLTEtMA_59c1a18a-aa7d-464a-baf7-97f7a0eece52"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib87fb7dbb00e4f129dce34dfe404bb23_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDkvZnJhZzpiYmUxMjVjMjMzNWM0NTEzYjlmZGRjMGY4Y2MyNGIzMi90YWJsZTpjODNhYjhiMmI3MTA0YzA1OTBmMzdlMWEwY2RiNWU5Zi90YWJsZXJhbmdlOmM4M2FiOGIyYjcxMDRjMDU5MGYzN2UxYTBjZGI1ZTlmXzMtMy0xLTEtMA_59e4cfdd-79cb-449e-970f-a5734ea32f79"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia78503404d8e4407b9a07f1fcae6747d_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDkvZnJhZzpiYmUxMjVjMjMzNWM0NTEzYjlmZGRjMGY4Y2MyNGIzMi90YWJsZTpjODNhYjhiMmI3MTA0YzA1OTBmMzdlMWEwY2RiNWU5Zi90YWJsZXJhbmdlOmM4M2FiOGIyYjcxMDRjMDU5MGYzN2UxYTBjZGI1ZTlmXzMtNS0xLTEtMA_34e6c9ef-2e0a-45f8-9649-f8d2099e4572"
      unitRef="usd">-444000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ia325d120afc54411a40573cb6f7e7e7c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDkvZnJhZzpiYmUxMjVjMjMzNWM0NTEzYjlmZGRjMGY4Y2MyNGIzMi90YWJsZTpjODNhYjhiMmI3MTA0YzA1OTBmMzdlMWEwY2RiNWU5Zi90YWJsZXJhbmdlOmM4M2FiOGIyYjcxMDRjMDU5MGYzN2UxYTBjZGI1ZTlmXzQtMS0xLTEtMA_86716620-7315-49b3-8e23-029a2c5fd826"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i8386bc114f5f4f5fa2a6bad8bc56e82f_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDkvZnJhZzpiYmUxMjVjMjMzNWM0NTEzYjlmZGRjMGY4Y2MyNGIzMi90YWJsZTpjODNhYjhiMmI3MTA0YzA1OTBmMzdlMWEwY2RiNWU5Zi90YWJsZXJhbmdlOmM4M2FiOGIyYjcxMDRjMDU5MGYzN2UxYTBjZGI1ZTlmXzQtMy0xLTEtMA_6a19113c-1076-4e28-9e38-5425d70dae52"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i991881dba0a3487e84f8602ec54ef20c_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDkvZnJhZzpiYmUxMjVjMjMzNWM0NTEzYjlmZGRjMGY4Y2MyNGIzMi90YWJsZTpjODNhYjhiMmI3MTA0YzA1OTBmMzdlMWEwY2RiNWU5Zi90YWJsZXJhbmdlOmM4M2FiOGIyYjcxMDRjMDU5MGYzN2UxYTBjZGI1ZTlmXzQtNS0xLTEtMA_8cdccd1b-2ea1-439f-9877-4853151df474"
      unitRef="usd">3000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i72e668280445401eb2261966b757145c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDkvZnJhZzpiYmUxMjVjMjMzNWM0NTEzYjlmZGRjMGY4Y2MyNGIzMi90YWJsZTpjODNhYjhiMmI3MTA0YzA1OTBmMzdlMWEwY2RiNWU5Zi90YWJsZXJhbmdlOmM4M2FiOGIyYjcxMDRjMDU5MGYzN2UxYTBjZGI1ZTlmXzYtMS0xLTEtMA_fb81f7d8-c5f9-4c8c-b105-81599297f513"
      unitRef="usd">5000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5185ab0b8710451b8f3f523f58af8d12_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDkvZnJhZzpiYmUxMjVjMjMzNWM0NTEzYjlmZGRjMGY4Y2MyNGIzMi90YWJsZTpjODNhYjhiMmI3MTA0YzA1OTBmMzdlMWEwY2RiNWU5Zi90YWJsZXJhbmdlOmM4M2FiOGIyYjcxMDRjMDU5MGYzN2UxYTBjZGI1ZTlmXzYtMy0xLTEtMA_3fe1b2a1-dd8a-4446-add0-e3d0678eed00"
      unitRef="usd">5000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iee60a63d4a4f449784f69d72f30688ce_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDkvZnJhZzpiYmUxMjVjMjMzNWM0NTEzYjlmZGRjMGY4Y2MyNGIzMi90YWJsZTpjODNhYjhiMmI3MTA0YzA1OTBmMzdlMWEwY2RiNWU5Zi90YWJsZXJhbmdlOmM4M2FiOGIyYjcxMDRjMDU5MGYzN2UxYTBjZGI1ZTlmXzYtNS0xLTEtMA_2347771e-7195-4bb0-b6d5-89950d0500c5"
      unitRef="usd">5000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ice26ccbdf6064090b029f6a08543b040_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDkvZnJhZzpiYmUxMjVjMjMzNWM0NTEzYjlmZGRjMGY4Y2MyNGIzMi90YWJsZTpjODNhYjhiMmI3MTA0YzA1OTBmMzdlMWEwY2RiNWU5Zi90YWJsZXJhbmdlOmM4M2FiOGIyYjcxMDRjMDU5MGYzN2UxYTBjZGI1ZTlmXzktMS0xLTEtMA_24aed2b8-003b-4bd2-8515-bca477ce0cf9"
      unitRef="usd">27833000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2c9d0bafd5cc496fbef4654eb04f5f74_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDkvZnJhZzpiYmUxMjVjMjMzNWM0NTEzYjlmZGRjMGY4Y2MyNGIzMi90YWJsZTpjODNhYjhiMmI3MTA0YzA1OTBmMzdlMWEwY2RiNWU5Zi90YWJsZXJhbmdlOmM4M2FiOGIyYjcxMDRjMDU5MGYzN2UxYTBjZGI1ZTlmXzktMy0xLTEtMA_07668c6b-6f29-4de9-8fa1-baf57ba7185b"
      unitRef="usd">-9875000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibfa3a59fdaac409b8d09b830494b7637_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDkvZnJhZzpiYmUxMjVjMjMzNWM0NTEzYjlmZGRjMGY4Y2MyNGIzMi90YWJsZTpjODNhYjhiMmI3MTA0YzA1OTBmMzdlMWEwY2RiNWU5Zi90YWJsZXJhbmdlOmM4M2FiOGIyYjcxMDRjMDU5MGYzN2UxYTBjZGI1ZTlmXzktNS0xLTEtMA_7b1f5ca1-deef-4747-b2e2-3f4af9bd2664"
      unitRef="usd">2456000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ibe4e4305d17f496991f192791dce1e14_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDkvZnJhZzpiYmUxMjVjMjMzNWM0NTEzYjlmZGRjMGY4Y2MyNGIzMi90YWJsZTpjODNhYjhiMmI3MTA0YzA1OTBmMzdlMWEwY2RiNWU5Zi90YWJsZXJhbmdlOmM4M2FiOGIyYjcxMDRjMDU5MGYzN2UxYTBjZGI1ZTlmXzEwLTEtMS0xLTA_24c31e95-a439-47a5-b29e-13fd9d0bfdc4"
      unitRef="usd">15161000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ia6a29a184e724948a6d9fe82803de2b1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDkvZnJhZzpiYmUxMjVjMjMzNWM0NTEzYjlmZGRjMGY4Y2MyNGIzMi90YWJsZTpjODNhYjhiMmI3MTA0YzA1OTBmMzdlMWEwY2RiNWU5Zi90YWJsZXJhbmdlOmM4M2FiOGIyYjcxMDRjMDU5MGYzN2UxYTBjZGI1ZTlmXzEwLTMtMS0xLTA_2421d42f-fc41-4288-859b-9bb2cdf56c72"
      unitRef="usd">37708000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ib8e3143ddfa141b9ae6ff212b5b3329b_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDkvZnJhZzpiYmUxMjVjMjMzNWM0NTEzYjlmZGRjMGY4Y2MyNGIzMi90YWJsZTpjODNhYjhiMmI3MTA0YzA1OTBmMzdlMWEwY2RiNWU5Zi90YWJsZXJhbmdlOmM4M2FiOGIyYjcxMDRjMDU5MGYzN2UxYTBjZGI1ZTlmXzEwLTUtMS0xLTA_84e39963-ef0f-42c7-b06f-25be90701aab"
      unitRef="usd">-12331000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib808f60258354f1e96cf215dea381edf_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDkvZnJhZzpiYmUxMjVjMjMzNWM0NTEzYjlmZGRjMGY4Y2MyNGIzMi90YWJsZTpjODNhYjhiMmI3MTA0YzA1OTBmMzdlMWEwY2RiNWU5Zi90YWJsZXJhbmdlOmM4M2FiOGIyYjcxMDRjMDU5MGYzN2UxYTBjZGI1ZTlmXzExLTEtMS0xLTA_7d45ccd1-b275-4a2a-a5c4-1a021440e455"
      unitRef="usd">42994000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ice26ccbdf6064090b029f6a08543b040_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDkvZnJhZzpiYmUxMjVjMjMzNWM0NTEzYjlmZGRjMGY4Y2MyNGIzMi90YWJsZTpjODNhYjhiMmI3MTA0YzA1OTBmMzdlMWEwY2RiNWU5Zi90YWJsZXJhbmdlOmM4M2FiOGIyYjcxMDRjMDU5MGYzN2UxYTBjZGI1ZTlmXzExLTMtMS0xLTA_a2e5494c-be7f-4647-ab6b-92c17b5d4a0d"
      unitRef="usd">27833000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2c9d0bafd5cc496fbef4654eb04f5f74_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDkvZnJhZzpiYmUxMjVjMjMzNWM0NTEzYjlmZGRjMGY4Y2MyNGIzMi90YWJsZTpjODNhYjhiMmI3MTA0YzA1OTBmMzdlMWEwY2RiNWU5Zi90YWJsZXJhbmdlOmM4M2FiOGIyYjcxMDRjMDU5MGYzN2UxYTBjZGI1ZTlmXzExLTUtMS0xLTA_6bb3a934-7bcd-4c97-9525-66fb6901a390"
      unitRef="usd">-9875000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ief7afcb557114192867857af1fa9165f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDkvZnJhZzpiYmUxMjVjMjMzNWM0NTEzYjlmZGRjMGY4Y2MyNGIzMi90YWJsZTpjODNhYjhiMmI3MTA0YzA1OTBmMzdlMWEwY2RiNWU5Zi90YWJsZXJhbmdlOmM4M2FiOGIyYjcxMDRjMDU5MGYzN2UxYTBjZGI1ZTlmXzEyLTEtMS0xLTA_516ac4b5-9363-4d6d-a5b2-08519c95ea47"
      unitRef="usd">42999000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia6461d38acec49bd9d6a716a38310029_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDkvZnJhZzpiYmUxMjVjMjMzNWM0NTEzYjlmZGRjMGY4Y2MyNGIzMi90YWJsZTpjODNhYjhiMmI3MTA0YzA1OTBmMzdlMWEwY2RiNWU5Zi90YWJsZXJhbmdlOmM4M2FiOGIyYjcxMDRjMDU5MGYzN2UxYTBjZGI1ZTlmXzEyLTMtMS0xLTA_0ba1c364-a81d-44b8-b2ce-0b1a34ff6ea7"
      unitRef="usd">27838000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1f1cb8c6e56c4c8cb1070c81364c66b2_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDkvZnJhZzpiYmUxMjVjMjMzNWM0NTEzYjlmZGRjMGY4Y2MyNGIzMi90YWJsZTpjODNhYjhiMmI3MTA0YzA1OTBmMzdlMWEwY2RiNWU5Zi90YWJsZXJhbmdlOmM4M2FiOGIyYjcxMDRjMDU5MGYzN2UxYTBjZGI1ZTlmXzEyLTUtMS0xLTA_21090108-38ca-436c-a3ce-9e02de8904d6"
      unitRef="usd">-9870000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90ZXh0cmVnaW9uOmY0YjZkNzk5YmE3NDQ5MGNiZDc3OWFhNDBiMDg2MTE0XzI0MTg5MjU1ODE3NTg1_b0a76689-335e-4b39-80b5-d717a9f38088">Income Taxes&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For financial reporting purposes, income (loss) from continuing operations before income taxes includes the following components: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.608%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.225%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.608%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.947%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.608%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.366%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,169,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,923)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(85,952)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,070)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73,273)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,165,937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,923)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The loss before income taxes above excludes losses from discontinued operations of $650 for the year ended December&#160;31, 2020 (December&#160;31, 2019 &#x2013; $363; December&#160;31, 2018 &#x2013; $894).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income tax expense consists of the following components: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.608%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.947%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.608%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.225%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.608%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.366%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of world&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Included in accounts payable and other liabilities as of December&#160;31, 2020 is $865 (December&#160;31, 2019 &#x2013; $nil; December&#160;31, 2018 &#x2013; $nil) related to current income tax expense above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income tax differs from that computed using the combined Canadian federal and provincial statutory income tax rate of 26.5%. Reconciliation of the expected income tax to the effective tax rate in continuing operations is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73,273)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,165,937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,923)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected income tax expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,417)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;308,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,545)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-taxable income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(711)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,156)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-deductible share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-deductible expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-deductible transaction costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of provincial tax rate difference&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of tax rates outside of Canada&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(362)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value gain on financial liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34,250)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(338,409)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(308)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense (recovery), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The valuation allowance recorded against the loss on discontinued operations is not reflected in the effective tax rate reconciliation presented above for continuing operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the significant components of the Company&#x2019;s deferred tax assets and liabilities as of December&#160;31, 2020 and December&#160;31, 2019: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.042%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share issuance cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reserve&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(85,935)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36,948)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,227)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,126)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;License&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,662)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(293)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,943)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,460)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,605)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,106)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The realization of deferred tax assets is dependent on the Company&#x2019;s generating sufficient taxable income in the years that the temporary differences become deductible. A valuation allowance has been provided for the deferred tax assets that the Company determined did not meet the more-likely-than-not recognition threshold under U.S. GAAP.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, the Company had net operating losses in Canada, the U.S., and Israel available to offset future years&#x2019; taxable income of approximately $177,651, $62,851, and $14,042, respectively. As of December&#160;31, 2019, the Company had net operating losses in Canada, the U.S., and Israel available to offset future years&#x2019; taxable income of approximately $92,773, $14,374, and $8,763, respectively. The net operating losses in Canada will begin to expire, for purposes of carryforward, in fiscal year 2032. The net operating losses in the U.S. can be carried forward indefinitely for federal purposes. The net operating losses in Israel can be carried forward indefinitely.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Utilization of the net operating loss carryforwards may be subject to limitations under the tax laws applicable in each tax jurisdiction due to ownership changes that could occur in the future. These ownership changes could limit the amount of net operating loss carryforwards and other deferred tax assets that can be utilized to offset future taxable income and tax expense. Specifically, if Altria exercises its warrant the Company would recognize a change in control event and certain Canadian net operating loss carryforwards may be limited. Due to the existence of the valuation allowance, limitations created by ownership changes, if any, will not impact the Company&#x2019;s effective tax rate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company files federal income tax returns in Canada, Israel and the U.S. The Company has open tax years with the taxation jurisdictions. These open years contain certain matters that could be subject to differing interpretations of applicable tax laws and regulations and tax treaties, as they relate to the amount, timing, or inclusion of revenue and expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.068%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.070%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Jurisdiction&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Open Years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canada&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2016 &#x2013; 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018 &#x2013; 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Israel&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 &#x2013; 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table outlines the movements in the valuation allowance:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.316%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.316%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.316%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.321%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Change due to foreign exchange&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Increase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance at end of year&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year ended December&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36,948)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(693)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(48,294)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(85,935)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year ended December&#160;31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,931)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(998)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28,019)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36,948)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020 and December&#160;31, 2019, the Company recorded a valuation allowance of $85,935 and $36,948, respectively. The valuation allowance increased by $48,294 and $28,019 during the years ended December&#160;31, 2020 and December&#160;31, 2019, respectively. The increase in the valuation allowance during the years ended December&#160;31, 2020 and December&#160;31, 2019 was primarily due to an increase in net operating loss carryforwards, the utilization of which did not meet the more-likely-than-not recognition threshold.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounting guidance clarifies the accounting for uncertain tax positions and prescribes a recognition threshold and measurement process for recording in the financial statements uncertain tax positions taken or expected to be taken in a tax return. Additionally, the authoritative guidance addresses the de-recognition, classification, accounting in interim periods and disclosure requirements for uncertain tax positions. Only tax positions that meet the more-likely-than-not recognition threshold may be recognized. There were no identified unrecognized tax benefits as of December&#160;31, 2020 or December&#160;31, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers all earnings and profits of its subsidiaries outside Canada to be indefinitely reinvested. As of December&#160;31, 2020 and December&#160;31, 2019, the amount of undistributed earnings upon which income taxes have not been provided is immaterial to these consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90ZXh0cmVnaW9uOmY0YjZkNzk5YmE3NDQ5MGNiZDc3OWFhNDBiMDg2MTE0XzIxMTA_543f1b99-0cee-4294-8d2e-4cdcef056d54">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For financial reporting purposes, income (loss) from continuing operations before income taxes includes the following components: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.608%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.225%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.608%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.947%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.608%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.366%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,169,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,923)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(85,952)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,070)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73,273)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,165,937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,923)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i51c8c173d2a64e9a89da94b382ba8309_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MDc1ODAyZDM2ZWE0ZmU3YTgwODFkYTQwYWZlMzA3Yi90YWJsZXJhbmdlOjUwNzU4MDJkMzZlYTRmZTdhODA4MWRhNDBhZmUzMDdiXzItMi0xLTEtMA_a7772d6d-a98e-4410-8275-b05ded7a46af"
      unitRef="usd">12679000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i33a15aa601734e76889c79308df5f39a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MDc1ODAyZDM2ZWE0ZmU3YTgwODFkYTQwYWZlMzA3Yi90YWJsZXJhbmdlOjUwNzU4MDJkMzZlYTRmZTdhODA4MWRhNDBhZmUzMDdiXzItNC0xLTEtMA_a876b28d-469f-400b-9abb-b01188ad9541"
      unitRef="usd">1169007000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i2810c3b010d94bdeb71d396714ecf592_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MDc1ODAyZDM2ZWE0ZmU3YTgwODFkYTQwYWZlMzA3Yi90YWJsZXJhbmdlOjUwNzU4MDJkMzZlYTRmZTdhODA4MWRhNDBhZmUzMDdiXzItNi0xLTEtMA_1bd86a16-3b32-4b75-8775-603090ab3e85"
      unitRef="usd">-20923000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ib5ae31aceb854001ad8f87c6ab2e2250_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MDc1ODAyZDM2ZWE0ZmU3YTgwODFkYTQwYWZlMzA3Yi90YWJsZXJhbmdlOjUwNzU4MDJkMzZlYTRmZTdhODA4MWRhNDBhZmUzMDdiXzMtMi0xLTEtMA_f92d9c11-5b42-40b1-ac52-1d68b8b70fee"
      unitRef="usd">-85952000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i547cfac932ed40edb1c94ffbbad4dcc1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MDc1ODAyZDM2ZWE0ZmU3YTgwODFkYTQwYWZlMzA3Yi90YWJsZXJhbmdlOjUwNzU4MDJkMzZlYTRmZTdhODA4MWRhNDBhZmUzMDdiXzMtNC0xLTEtMA_c41526a8-9541-4287-ad02-19d6b0ca4552"
      unitRef="usd">-3070000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i344b2df31b18418f873d918c4651229d_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MDc1ODAyZDM2ZWE0ZmU3YTgwODFkYTQwYWZlMzA3Yi90YWJsZXJhbmdlOjUwNzU4MDJkMzZlYTRmZTdhODA4MWRhNDBhZmUzMDdiXzMtNi0xLTEtMA_22ecd11e-9d80-4999-8848-ecce9be3229b"
      unitRef="usd">0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MDc1ODAyZDM2ZWE0ZmU3YTgwODFkYTQwYWZlMzA3Yi90YWJsZXJhbmdlOjUwNzU4MDJkMzZlYTRmZTdhODA4MWRhNDBhZmUzMDdiXzQtMi0xLTEtMA_3102c757-6d26-4003-be60-a8666a78c55f"
      unitRef="usd">-73273000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MDc1ODAyZDM2ZWE0ZmU3YTgwODFkYTQwYWZlMzA3Yi90YWJsZXJhbmdlOjUwNzU4MDJkMzZlYTRmZTdhODA4MWRhNDBhZmUzMDdiXzQtNC0xLTEtMA_663925c7-5658-423f-972c-cf0d145dcdc4"
      unitRef="usd">1165937000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MDc1ODAyZDM2ZWE0ZmU3YTgwODFkYTQwYWZlMzA3Yi90YWJsZXJhbmdlOjUwNzU4MDJkMzZlYTRmZTdhODA4MWRhNDBhZmUzMDdiXzQtNi0xLTEtMA_6be18a22-847e-4278-9dba-2d9c886863c2"
      unitRef="usd">-20923000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90ZXh0cmVnaW9uOmY0YjZkNzk5YmE3NDQ5MGNiZDc3OWFhNDBiMDg2MTE0XzEzMTk0MTM5NTQxMjY5_7ff3f4da-9f01-48a4-8f26-3cf222d861e8"
      unitRef="usd">-650000</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90ZXh0cmVnaW9uOmY0YjZkNzk5YmE3NDQ5MGNiZDc3OWFhNDBiMDg2MTE0XzM4NDgyOTA3MTUxMjY_d52e831e-5cd5-401d-a996-2a7beb705d57"
      unitRef="usd">-363000</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90ZXh0cmVnaW9uOmY0YjZkNzk5YmE3NDQ5MGNiZDc3OWFhNDBiMDg2MTE0XzM4NDgyOTA3MTUxMjk_830bd795-7c2e-44e1-b75f-f1a6072c6b7f"
      unitRef="usd">-894000</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90ZXh0cmVnaW9uOmY0YjZkNzk5YmE3NDQ5MGNiZDc3OWFhNDBiMDg2MTE0XzIxMTE_88903bf9-70fa-461c-bfd1-e6b763755d00">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income tax expense consists of the following components: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.608%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.947%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.608%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.225%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.608%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.366%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of world&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i51c8c173d2a64e9a89da94b382ba8309_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo4MTExYzllYWUzYmI0NGFjOTE0M2ZiN2I4NmM1NzFhYy90YWJsZXJhbmdlOjgxMTFjOWVhZTNiYjQ0YWM5MTQzZmI3Yjg2YzU3MWFjXzMtMi0xLTEtMA_47a250bb-54a7-41ad-83ec-6a3a1e55ba0c"
      unitRef="usd">1024000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i33a15aa601734e76889c79308df5f39a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo4MTExYzllYWUzYmI0NGFjOTE0M2ZiN2I4NmM1NzFhYy90YWJsZXJhbmdlOjgxMTFjOWVhZTNiYjQ0YWM5MTQzZmI3Yjg2YzU3MWFjXzMtNC0xLTEtMA_fcc62e09-f3fd-46cb-aaa1-ee298cc9d7e4"
      unitRef="usd">0</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i2810c3b010d94bdeb71d396714ecf592_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo4MTExYzllYWUzYmI0NGFjOTE0M2ZiN2I4NmM1NzFhYy90YWJsZXJhbmdlOjgxMTFjOWVhZTNiYjQ0YWM5MTQzZmI3Yjg2YzU3MWFjXzMtNi0xLTEtMA_2845cdaa-4caf-467b-a794-55a8c598096c"
      unitRef="usd">0</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="ib5ae31aceb854001ad8f87c6ab2e2250_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo4MTExYzllYWUzYmI0NGFjOTE0M2ZiN2I4NmM1NzFhYy90YWJsZXJhbmdlOjgxMTFjOWVhZTNiYjQ0YWM5MTQzZmI3Yjg2YzU3MWFjXzQtMi0xLTEtMA_eabb094a-228b-4d70-a171-b6fdbd23fbfb"
      unitRef="usd">323000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i547cfac932ed40edb1c94ffbbad4dcc1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo4MTExYzllYWUzYmI0NGFjOTE0M2ZiN2I4NmM1NzFhYy90YWJsZXJhbmdlOjgxMTFjOWVhZTNiYjQ0YWM5MTQzZmI3Yjg2YzU3MWFjXzQtNC0xLTEtMA_9ecd0022-ab19-490c-bc51-bab1aa375e91"
      unitRef="usd">0</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i344b2df31b18418f873d918c4651229d_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo4MTExYzllYWUzYmI0NGFjOTE0M2ZiN2I4NmM1NzFhYy90YWJsZXJhbmdlOjgxMTFjOWVhZTNiYjQ0YWM5MTQzZmI3Yjg2YzU3MWFjXzQtNi0xLTEtMA_81aef027-eb71-49d0-8a8c-ba03764a2691"
      unitRef="usd">0</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo4MTExYzllYWUzYmI0NGFjOTE0M2ZiN2I4NmM1NzFhYy90YWJsZXJhbmdlOjgxMTFjOWVhZTNiYjQ0YWM5MTQzZmI3Yjg2YzU3MWFjXzUtMi0xLTEtMA_d47ace51-f44c-404d-a0ab-ca91e368f639"
      unitRef="usd">1347000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo4MTExYzllYWUzYmI0NGFjOTE0M2ZiN2I4NmM1NzFhYy90YWJsZXJhbmdlOjgxMTFjOWVhZTNiYjQ0YWM5MTQzZmI3Yjg2YzU3MWFjXzUtNC0xLTEtMA_b1ef2b0e-9344-405e-befc-ffd826a357ac"
      unitRef="usd">0</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo4MTExYzllYWUzYmI0NGFjOTE0M2ZiN2I4NmM1NzFhYy90YWJsZXJhbmdlOjgxMTFjOWVhZTNiYjQ0YWM5MTQzZmI3Yjg2YzU3MWFjXzUtNi0xLTEtMA_569642c7-fcf2-4f4a-b695-59aa5a7c4930"
      unitRef="usd">0</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i51c8c173d2a64e9a89da94b382ba8309_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo4MTExYzllYWUzYmI0NGFjOTE0M2ZiN2I4NmM1NzFhYy90YWJsZXJhbmdlOjgxMTFjOWVhZTNiYjQ0YWM5MTQzZmI3Yjg2YzU3MWFjXzctMi0xLTEtMA_ae999a3b-57ff-4982-a202-4029a0db3932"
      unitRef="usd">0</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i33a15aa601734e76889c79308df5f39a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo4MTExYzllYWUzYmI0NGFjOTE0M2ZiN2I4NmM1NzFhYy90YWJsZXJhbmdlOjgxMTFjOWVhZTNiYjQ0YWM5MTQzZmI3Yjg2YzU3MWFjXzctNC0xLTEtMA_9575ac87-8822-4ee2-b885-6c1236e9e8df"
      unitRef="usd">0</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i2810c3b010d94bdeb71d396714ecf592_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo4MTExYzllYWUzYmI0NGFjOTE0M2ZiN2I4NmM1NzFhYy90YWJsZXJhbmdlOjgxMTFjOWVhZTNiYjQ0YWM5MTQzZmI3Yjg2YzU3MWFjXzctNi0xLTEtMA_12253e89-b0ce-461e-9f0f-07f8ec89dff3"
      unitRef="usd">0</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ib5ae31aceb854001ad8f87c6ab2e2250_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo4MTExYzllYWUzYmI0NGFjOTE0M2ZiN2I4NmM1NzFhYy90YWJsZXJhbmdlOjgxMTFjOWVhZTNiYjQ0YWM5MTQzZmI3Yjg2YzU3MWFjXzgtMi0xLTEtMA_8a39a920-776c-4748-8a1c-de3ad4ced96b"
      unitRef="usd">0</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i547cfac932ed40edb1c94ffbbad4dcc1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo4MTExYzllYWUzYmI0NGFjOTE0M2ZiN2I4NmM1NzFhYy90YWJsZXJhbmdlOjgxMTFjOWVhZTNiYjQ0YWM5MTQzZmI3Yjg2YzU3MWFjXzgtNC0xLTEtMA_daad1329-8a18-42d6-9791-a863c820edfa"
      unitRef="usd">0</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i344b2df31b18418f873d918c4651229d_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo4MTExYzllYWUzYmI0NGFjOTE0M2ZiN2I4NmM1NzFhYy90YWJsZXJhbmdlOjgxMTFjOWVhZTNiYjQ0YWM5MTQzZmI3Yjg2YzU3MWFjXzgtNi0xLTEtMA_f9e3f5b4-49ad-4091-b706-83cab789dd36"
      unitRef="usd">0</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo4MTExYzllYWUzYmI0NGFjOTE0M2ZiN2I4NmM1NzFhYy90YWJsZXJhbmdlOjgxMTFjOWVhZTNiYjQ0YWM5MTQzZmI3Yjg2YzU3MWFjXzktMi0xLTEtMA_31ca04c1-f0e4-4888-9fe4-1b69aee4c5af"
      unitRef="usd">0</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo4MTExYzllYWUzYmI0NGFjOTE0M2ZiN2I4NmM1NzFhYy90YWJsZXJhbmdlOjgxMTFjOWVhZTNiYjQ0YWM5MTQzZmI3Yjg2YzU3MWFjXzktNC0xLTEtMA_3499bee8-7b10-4f3f-aefd-3263c98b65d7"
      unitRef="usd">0</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo4MTExYzllYWUzYmI0NGFjOTE0M2ZiN2I4NmM1NzFhYy90YWJsZXJhbmdlOjgxMTFjOWVhZTNiYjQ0YWM5MTQzZmI3Yjg2YzU3MWFjXzktNi0xLTEtMA_d97d5a82-abb9-4c2d-a779-6eecd22d788b"
      unitRef="usd">0</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:TaxesPayableCurrent
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90ZXh0cmVnaW9uOmY0YjZkNzk5YmE3NDQ5MGNiZDc3OWFhNDBiMDg2MTE0XzEzMTk0MTM5NTQxNTI2_804748b0-8077-4609-ba85-40ad526e023d"
      unitRef="usd">865000</us-gaap:TaxesPayableCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90ZXh0cmVnaW9uOmY0YjZkNzk5YmE3NDQ5MGNiZDc3OWFhNDBiMDg2MTE0XzEzMTk0MTM5NTQxNTU0_a3fb395d-675d-4ca6-b993-3d72110e3ff2"
      unitRef="usd">0</us-gaap:TaxesPayableCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="i9717dc3b24b24c93ab09a6bfa9b52c89_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90ZXh0cmVnaW9uOmY0YjZkNzk5YmE3NDQ5MGNiZDc3OWFhNDBiMDg2MTE0XzEzMTk0MTM5NTQxNTU4_a74502c7-236e-406e-9c72-165cd57ff86d"
      unitRef="usd">0</us-gaap:TaxesPayableCurrent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90ZXh0cmVnaW9uOmY0YjZkNzk5YmE3NDQ5MGNiZDc3OWFhNDBiMDg2MTE0XzI5Ng_f0c17952-8032-4ce5-a427-297fddcda78d"
      unitRef="number">0.265</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90ZXh0cmVnaW9uOmY0YjZkNzk5YmE3NDQ5MGNiZDc3OWFhNDBiMDg2MTE0XzIxMTI_d21805cc-b74c-46e3-8e20-cc0c211efcbd">Reconciliation of the expected income tax to the effective tax rate in continuing operations is as follows:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73,273)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,165,937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,923)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected income tax expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,417)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;308,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,545)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-taxable income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(711)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,156)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-deductible share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-deductible expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-deductible transaction costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of provincial tax rate difference&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of tax rates outside of Canada&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(362)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value gain on financial liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34,250)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(338,409)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(308)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense (recovery), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzItMi0xLTEtMA_5c7b5d09-4fe4-4fda-8380-7c095d1b4320"
      unitRef="usd">-73273000</us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzItNC0xLTEtMA_50d806e9-7d70-4df3-83a8-9e9ac62bc8c3"
      unitRef="usd">1165937000</us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzItNi0xLTEtMA_8a1b8d66-b13a-4062-b6ad-04a251965300"
      unitRef="usd">-20923000</us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzMtMi0xLTEtMzQ0OTc_2ce4c718-dffc-4abd-94a6-648cff305d2b"
      unitRef="number">0.265</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzMtNC0xLTEtMzQ0OTc_e0f647cd-bc1e-4860-b199-4cdd489bdc23"
      unitRef="number">0.265</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzMtNi0xLTEtMzQ0OTc_3a927a2e-7fdc-4f44-86bc-52e01a371fff"
      unitRef="number">0.265</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <cron:EffectiveIncomeTaxRateReconciliationExpectedIncomeTaxExpenseRecoveryAmount
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzMtMi0xLTEtMA_21a5305d-8a5d-4bce-8e8a-95674f9a428d"
      unitRef="usd">-19417000</cron:EffectiveIncomeTaxRateReconciliationExpectedIncomeTaxExpenseRecoveryAmount>
    <cron:EffectiveIncomeTaxRateReconciliationExpectedIncomeTaxExpenseRecoveryAmount
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzMtNC0xLTEtMA_af4db2e9-be56-4ee6-81fb-9426f2561778"
      unitRef="usd">308973000</cron:EffectiveIncomeTaxRateReconciliationExpectedIncomeTaxExpenseRecoveryAmount>
    <cron:EffectiveIncomeTaxRateReconciliationExpectedIncomeTaxExpenseRecoveryAmount
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzMtNi0xLTEtMA_7b3dfeb9-eca3-468d-b026-ed346aa1e29b"
      unitRef="usd">-5545000</cron:EffectiveIncomeTaxRateReconciliationExpectedIncomeTaxExpenseRecoveryAmount>
    <us-gaap:IncomeTaxReconciliationTaxExemptIncome
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzQtMi0xLTEtMA_a8a36577-5c1b-4087-8475-dbd5b856cd95"
      unitRef="usd">711000</us-gaap:IncomeTaxReconciliationTaxExemptIncome>
    <us-gaap:IncomeTaxReconciliationTaxExemptIncome
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzQtNC0xLTEtMA_72e63ee3-aeaa-4757-b965-e8865abe94ff"
      unitRef="usd">2156000</us-gaap:IncomeTaxReconciliationTaxExemptIncome>
    <us-gaap:IncomeTaxReconciliationTaxExemptIncome
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzQtNi0xLTEtMA_073982db-5ab5-4918-9dfc-08104361a4c3"
      unitRef="usd">-14000</us-gaap:IncomeTaxReconciliationTaxExemptIncome>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzUtMi0xLTEtMA_f4d08008-1935-4962-8a66-05d3a2263567"
      unitRef="usd">2498000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzUtNC0xLTEtMA_29e75ade-1145-4ba7-9a21-d601c07a0622"
      unitRef="usd">2839000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzUtNi0xLTEtMA_76617302-0e52-4af0-ab95-7b4d0b51526a"
      unitRef="usd">2466000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzgtMi0xLTEtMzQ1ODE_aa4048ee-d30b-49c3-a085-1256082e8eab"
      unitRef="usd">1364000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzgtNC0xLTEtMzQ1ODE_10dd7f05-9a98-4f53-9e53-9d8568a920f1"
      unitRef="usd">764000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzgtNi0xLTEtMzQ1ODE_52eedae2-7362-4d6b-bcfc-77e75633dfda"
      unitRef="usd">0</us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther>
    <cron:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionCosts
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzktMi0xLTEtMzQ1ODE_ccd405b4-e0c5-4047-b9a8-f532df93ff3f"
      unitRef="usd">3146000</cron:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionCosts>
    <cron:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionCosts
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzktNC0xLTEtMzQ1ODE_2271b558-2c95-45f7-9265-614a77eb1c79"
      unitRef="usd">1523000</cron:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionCosts>
    <cron:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionCosts
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzktNi0xLTEtMzQ1ODE_c845f770-4e22-4d6a-9f6c-453e8ceabb05"
      unitRef="usd">0</cron:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionCosts>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzEwLTItMS0xLTM0NTgx_bd4df1e7-f2ce-40d8-8e79-5c43d1c32744"
      unitRef="usd">-15000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzEwLTQtMS0xLTM0NTgx_a4ef3823-fd4e-4565-91d7-6cd9e22e43b5"
      unitRef="usd">-44000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzEwLTYtMS0xLTM0NTgx_e37ec286-2fe9-435c-95b1-c6ed57f50273"
      unitRef="usd">-64000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzYtMi0xLTEtMA_16c9ea4f-f469-41e2-aba9-1d843734c976"
      unitRef="usd">-362000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzYtNC0xLTEtMA_1a6141cc-d423-4b7c-8a38-a09f4875521f"
      unitRef="usd">70000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzYtNi0xLTEtMA_a4ab7527-246d-4259-b1ec-a50b406a8ce5"
      unitRef="usd">0</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <cron:EffectiveIncomeTaxRateReconciliationFairValueGainFinancialLiabilities
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzctMi0xLTEtMA_b02ddfb9-daf6-4ed9-8b0c-ff6b4b7939ed"
      unitRef="usd">34250000</cron:EffectiveIncomeTaxRateReconciliationFairValueGainFinancialLiabilities>
    <cron:EffectiveIncomeTaxRateReconciliationFairValueGainFinancialLiabilities
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzctNC0xLTEtMA_c31a6053-e918-41da-998d-376fb58dd668"
      unitRef="usd">338409000</cron:EffectiveIncomeTaxRateReconciliationFairValueGainFinancialLiabilities>
    <cron:EffectiveIncomeTaxRateReconciliationFairValueGainFinancialLiabilities
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzctNi0xLTEtMA_5f8f135e-065c-4a71-bbbd-6c055e2cc656"
      unitRef="usd">0</cron:EffectiveIncomeTaxRateReconciliationFairValueGainFinancialLiabilities>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzktMi0xLTEtMA_f625e156-fc9e-4631-9b26-4ce3f684eaa3"
      unitRef="usd">48227000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzktNC0xLTEtMA_444d048b-07cb-4110-a47e-787fb84b8594"
      unitRef="usd">25808000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzktNi0xLTEtMA_74add975-4b46-4aec-a6de-6fde1df4b9ce"
      unitRef="usd">3437000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzEwLTItMS0xLTA_aa8a343c-11b5-4d09-aa00-2ee22748ab22"
      unitRef="usd">867000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzEwLTQtMS0xLTA_99c0331c-1ccc-4209-8ccb-6aba97eb3060"
      unitRef="usd">632000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzEwLTYtMS0xLTA_653b49c0-5020-4688-9c0a-2de45b405d1a"
      unitRef="usd">-308000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzExLTItMS0xLTA_ef5d7430-e30b-4a93-bdea-5ace2c3286e6"
      unitRef="usd">1347000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzExLTQtMS0xLTA_a1c7f901-f759-41d9-bad0-ee2f1907a88e"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1MGM0ZmVmZDYxZjU0ODgzYTY2YWY5MzU1NGU5MDc1ZS90YWJsZXJhbmdlOjUwYzRmZWZkNjFmNTQ4ODNhNjZhZjkzNTU0ZTkwNzVlXzExLTYtMS0xLTA_73f30334-b4bb-43cd-b253-204acadc968b"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90ZXh0cmVnaW9uOmY0YjZkNzk5YmE3NDQ5MGNiZDc3OWFhNDBiMDg2MTE0XzIxMTM_27e8ba9c-5123-47fa-ba23-4125f8dd7390">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the significant components of the Company&#x2019;s deferred tax assets and liabilities as of December&#160;31, 2020 and December&#160;31, 2019: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.042%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share issuance cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reserve&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(85,935)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36,948)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,227)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,126)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;License&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,662)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(293)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,943)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,460)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,605)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,106)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzMtMi0xLTEtMA_9e4a941e-080c-44a3-9e50-5af7e1e21fb0"
      unitRef="usd">67476000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzMtNC0xLTEtMA_938f9bf8-f3be-457a-b920-2026e3f7ec1e"
      unitRef="usd">30908000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetInterestCarryforward
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzQtMi0xLTEtMzU1MDg_3daf7a7a-7b11-41dc-a4ae-abb88e5b8b82"
      unitRef="usd">1407000</us-gaap:DeferredTaxAssetInterestCarryforward>
    <us-gaap:DeferredTaxAssetInterestCarryforward
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzQtNC0xLTEtMzU1MDg_8ec2dcd4-aac0-4ba9-9c52-de6f8837fabd"
      unitRef="usd">0</us-gaap:DeferredTaxAssetInterestCarryforward>
    <cron:DeferredTaxAssetsDebtIssuanceCosts
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzQtMi0xLTEtMA_cff84d3c-279a-43af-92d8-bd3618bd2b47"
      unitRef="usd">4233000</cron:DeferredTaxAssetsDebtIssuanceCosts>
    <cron:DeferredTaxAssetsDebtIssuanceCosts
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzQtNC0xLTEtMA_3d269d71-ce23-44e4-87bf-b515656b5dd2"
      unitRef="usd">5690000</cron:DeferredTaxAssetsDebtIssuanceCosts>
    <cron:DeferredTaxAssetsShareIssuanceCost
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzUtMi0xLTEtMA_770aca44-1ede-40fd-8382-41ceb7f2fd55"
      unitRef="usd">1573000</cron:DeferredTaxAssetsShareIssuanceCost>
    <cron:DeferredTaxAssetsShareIssuanceCost
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzUtNC0xLTEtMA_dc0b38ae-6e07-4828-a89f-0f11e1208299"
      unitRef="usd">2217000</cron:DeferredTaxAssetsShareIssuanceCost>
    <cron:DeferredTaxAssetsFinanceLeaseLiabilities
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzYtMi0xLTEtMA_bc79cb17-cc19-4699-9ce9-79c16babd729"
      unitRef="usd">1953000</cron:DeferredTaxAssetsFinanceLeaseLiabilities>
    <cron:DeferredTaxAssetsFinanceLeaseLiabilities
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzYtNC0xLTEtMA_6095c325-2714-4d61-a7a3-d101f56f931d"
      unitRef="usd">1491000</cron:DeferredTaxAssetsFinanceLeaseLiabilities>
    <us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzctMi0xLTEtMA_fed3c3f6-3558-4935-88e8-d68cc1b43186"
      unitRef="usd">5945000</us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzctNC0xLTEtMA_1bfb6efd-4b3a-40ee-8cbb-56dbbd9ea01b"
      unitRef="usd">871000</us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxAssetsInvestments
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzgtMi0xLTEtMA_1148ccf4-6b8e-409c-9508-8ec82b2c777e"
      unitRef="usd">307000</us-gaap:DeferredTaxAssetsInvestments>
    <us-gaap:DeferredTaxAssetsInvestments
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzgtNC0xLTEtMA_93db9393-506e-4d9e-9ecb-7b4778401497"
      unitRef="usd">395000</us-gaap:DeferredTaxAssetsInvestments>
    <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzktMi0xLTEtMA_20ced7aa-638b-4f24-bfc1-7b1cba5f3026"
      unitRef="usd">4218000</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzktNC0xLTEtMA_ffd80739-649f-4573-b99c-294aa0a79fdc"
      unitRef="usd">0</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzEwLTItMS0xLTA_53755176-c868-4e5e-8357-74ba1ec21706"
      unitRef="usd">1858000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzEwLTQtMS0xLTA_ed802477-de5f-457b-83bf-b5a6940d77ee"
      unitRef="usd">0</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzExLTItMS0xLTA_6f0a390e-7a8c-4b6e-b4e2-2d78368523d5"
      unitRef="usd">570000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzExLTQtMS0xLTA_2213b3a5-b789-4337-8d4d-cedc7313439e"
      unitRef="usd">482000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzEyLTItMS0xLTA_d965660e-68a1-4616-962d-6a27a00c617d"
      unitRef="usd">89540000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzEyLTQtMS0xLTA_12cb4702-9eb3-46a1-a485-6cd196c36211"
      unitRef="usd">42054000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzEzLTItMS0xLTA_ebf8d2db-36f6-4ff9-9fb6-a0870280a33e"
      unitRef="usd">85935000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzEzLTQtMS0xLTA_06f70def-127e-4508-8419-000102b08287"
      unitRef="usd">36948000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzE0LTItMS0xLTA_aca845a7-4ccb-46e2-b79f-3e09063d8a53"
      unitRef="usd">3605000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzE0LTQtMS0xLTA_f9898ae8-df2a-40c1-ac8a-932079cad12d"
      unitRef="usd">5106000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzE3LTItMS0xLTA_e98b9842-907a-482f-908d-ff61f9ec8c39"
      unitRef="usd">0</us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts>
    <us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzE3LTQtMS0xLTA_0768d22b-5277-4f17-bf1e-71b4e80652a7"
      unitRef="usd">1227000</us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzE4LTItMS0xLTA_bc9e374a-a53d-402c-a2fe-61437a68cea6"
      unitRef="usd">0</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzE4LTQtMS0xLTA_69c14fcd-ee41-45f2-b7a8-5ca06c2af219"
      unitRef="usd">0</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzE5LTItMS0xLTA_a86f3860-0fb1-4516-870c-41d5990750ff"
      unitRef="usd">0</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzE5LTQtMS0xLTA_48ea5b2a-eb77-4e9b-a84a-0664f56115cc"
      unitRef="usd">2126000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesInvestments
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzIwLTItMS0xLTA_2b9176f6-37ea-4d93-b68a-bd6c955230a5"
      unitRef="usd">0</us-gaap:DeferredTaxLiabilitiesInvestments>
    <us-gaap:DeferredTaxLiabilitiesInvestments
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzIwLTQtMS0xLTA_ccaedf0e-fad9-4461-8122-f349245a1579"
      unitRef="usd">0</us-gaap:DeferredTaxLiabilitiesInvestments>
    <cron:DeferredTaxLiabilitiesLicenses
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzIxLTItMS0xLTA_e08bcf57-6298-4d73-ab37-97e26ad2a7a4"
      unitRef="usd">1662000</cron:DeferredTaxLiabilitiesLicenses>
    <cron:DeferredTaxLiabilitiesLicenses
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzIxLTQtMS0xLTA_445208b9-9d00-4fdd-a840-e43099b5a117"
      unitRef="usd">293000</cron:DeferredTaxLiabilitiesLicenses>
    <cron:DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzIyLTItMS0xLTA_45b38318-d980-4f66-bfa6-5bd95630a79e"
      unitRef="usd">1943000</cron:DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset>
    <cron:DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzIyLTQtMS0xLTA_1249b718-3d16-4248-ab55-12c546b11544"
      unitRef="usd">1460000</cron:DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzIzLTItMS0xLTA_40b5c594-6549-4b37-9123-eb2f4c74cc36"
      unitRef="usd">3605000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzIzLTQtMS0xLTA_2403a8ba-5aba-49e6-9c75-eae2776e3264"
      unitRef="usd">5106000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzI0LTItMS0xLTA_ffd91813-b97c-477a-925f-eef6bd78c39b"
      unitRef="usd">0</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo3YzMxMWJhNDhmNWY0YTYxOTJiNWUwYjI0NGUxZTRjYS90YWJsZXJhbmdlOjdjMzExYmE0OGY1ZjRhNjE5MmI1ZTBiMjQ0ZTFlNGNhXzI0LTQtMS0xLTA_370b1939-7000-450b-85d9-b0cb63bcd66d"
      unitRef="usd">0</us-gaap:DeferredTaxLiabilities>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i2d7bbfdd8ccc40ebaad61885c216b6a2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90ZXh0cmVnaW9uOmY0YjZkNzk5YmE3NDQ5MGNiZDc3OWFhNDBiMDg2MTE0XzEzMTk0MTM5NTQzMjgy_491be220-6f08-4c94-a735-fa408a607d58"
      unitRef="usd">177651000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i105f31994b814455b1dd25adfc5232aa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90ZXh0cmVnaW9uOmY0YjZkNzk5YmE3NDQ5MGNiZDc3OWFhNDBiMDg2MTE0XzEzMTk0MTM5NTQzMjg3_a1eaac24-4be6-49bf-b2ee-fe3ea43923eb"
      unitRef="usd">62851000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i78c60b99d62646d091fd871d5b174040_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90ZXh0cmVnaW9uOmY0YjZkNzk5YmE3NDQ5MGNiZDc3OWFhNDBiMDg2MTE0XzEzMTk0MTM5NTQzMjk2_a82187cb-f844-410d-93b5-f1f4f4adfec5"
      unitRef="usd">14042000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="ib74df11c3c8e445ea96958153ef913d4_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90ZXh0cmVnaW9uOmY0YjZkNzk5YmE3NDQ5MGNiZDc3OWFhNDBiMDg2MTE0XzEzMTk0MTM5NTQzNTE4_722b9500-90af-42c3-981a-99532bae1ec2"
      unitRef="usd">92773000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="ib2d8a62a5a5c45949a4da4ef35ba51ac_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90ZXh0cmVnaW9uOmY0YjZkNzk5YmE3NDQ5MGNiZDc3OWFhNDBiMDg2MTE0XzEzMTk0MTM5NTQzNTIz_7f49c4fc-1bb5-4d4b-83cd-aeb03a724a36"
      unitRef="usd">14374000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="ie931956074a74c9db1111bc5c10fe12e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90ZXh0cmVnaW9uOmY0YjZkNzk5YmE3NDQ5MGNiZDc3OWFhNDBiMDg2MTE0XzEzMTk0MTM5NTQzNTMy_ccae1fc9-3d15-4f9e-945f-0c5e3f7a15ba"
      unitRef="usd">8763000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:SummaryOfIncomeTaxExaminationsTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90ZXh0cmVnaW9uOmY0YjZkNzk5YmE3NDQ5MGNiZDc3OWFhNDBiMDg2MTE0XzIxMTU_53010049-4d83-40ca-81b0-5e3cdb610b0a">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.068%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.070%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Jurisdiction&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Open Years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canada&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2016 &#x2013; 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018 &#x2013; 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Israel&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 &#x2013; 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:SummaryOfIncomeTaxExaminationsTextBlock>
    <us-gaap:SummaryOfValuationAllowanceTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90ZXh0cmVnaW9uOmY0YjZkNzk5YmE3NDQ5MGNiZDc3OWFhNDBiMDg2MTE0XzIxMTY_3ebe3e31-211a-4e1b-9ee4-910ff1f48003">&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table outlines the movements in the valuation allowance:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.316%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.316%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.316%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.321%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Change due to foreign exchange&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Increase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance at end of year&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year ended December&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36,948)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(693)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(48,294)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(85,935)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year ended December&#160;31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,931)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(998)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28,019)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36,948)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SummaryOfValuationAllowanceTextBlock>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i17a122330b5144cf96235a840b3602c1_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1NzBmNDQ1ODgzNzk0OWZmOGU1Nzk4YzEyMDJmMTk3Yi90YWJsZXJhbmdlOjU3MGY0NDU4ODM3OTQ5ZmY4ZTU3OThjMTIwMmYxOTdiXzEtMS0xLTEtMA_edca5837-9ad2-43bb-815e-0574f351ef25"
      unitRef="usd">36948000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="ie0b8cf648fb646f3aa94a5539664bc50_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1NzBmNDQ1ODgzNzk0OWZmOGU1Nzk4YzEyMDJmMTk3Yi90YWJsZXJhbmdlOjU3MGY0NDU4ODM3OTQ5ZmY4ZTU3OThjMTIwMmYxOTdiXzEtMy0xLTEtMA_c9ff2e40-2848-4164-9dee-069a4c09544f"
      unitRef="usd">693000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesAdjustments
      contextRef="ie0b8cf648fb646f3aa94a5539664bc50_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1NzBmNDQ1ODgzNzk0OWZmOGU1Nzk4YzEyMDJmMTk3Yi90YWJsZXJhbmdlOjU3MGY0NDU4ODM3OTQ5ZmY4ZTU3OThjMTIwMmYxOTdiXzEtNS0xLTEtMA_a9e5edf2-0472-4c44-9f49-b6014d2922e6"
      unitRef="usd">48294000</us-gaap:ValuationAllowancesAndReservesAdjustments>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i7d3fb6c71a584d88aa595b49e45b8837_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1NzBmNDQ1ODgzNzk0OWZmOGU1Nzk4YzEyMDJmMTk3Yi90YWJsZXJhbmdlOjU3MGY0NDU4ODM3OTQ5ZmY4ZTU3OThjMTIwMmYxOTdiXzEtNy0xLTEtMA_567841d6-ed42-433a-b722-bda0d5057f17"
      unitRef="usd">85935000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i172fd75fe227409f982d139db1b09efd_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1NzBmNDQ1ODgzNzk0OWZmOGU1Nzk4YzEyMDJmMTk3Yi90YWJsZXJhbmdlOjU3MGY0NDU4ODM3OTQ5ZmY4ZTU3OThjMTIwMmYxOTdiXzItMS0xLTEtMA_e9164a18-0ab9-478e-9f91-96de4e47d503"
      unitRef="usd">7931000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="ia5ef930d66f146f6b1ee58c6e0b38dbe_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1NzBmNDQ1ODgzNzk0OWZmOGU1Nzk4YzEyMDJmMTk3Yi90YWJsZXJhbmdlOjU3MGY0NDU4ODM3OTQ5ZmY4ZTU3OThjMTIwMmYxOTdiXzItMy0xLTEtMA_921f4410-4227-4c22-bb72-d33a0f221033"
      unitRef="usd">998000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesAdjustments
      contextRef="ia5ef930d66f146f6b1ee58c6e0b38dbe_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1NzBmNDQ1ODgzNzk0OWZmOGU1Nzk4YzEyMDJmMTk3Yi90YWJsZXJhbmdlOjU3MGY0NDU4ODM3OTQ5ZmY4ZTU3OThjMTIwMmYxOTdiXzItNS0xLTEtMA_46d87585-c6d5-491e-8bfe-b3b036672899"
      unitRef="usd">28019000</us-gaap:ValuationAllowancesAndReservesAdjustments>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i17a122330b5144cf96235a840b3602c1_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90YWJsZTo1NzBmNDQ1ODgzNzk0OWZmOGU1Nzk4YzEyMDJmMTk3Yi90YWJsZXJhbmdlOjU3MGY0NDU4ODM3OTQ5ZmY4ZTU3OThjMTIwMmYxOTdiXzItNy0xLTEtMA_8683ac7c-f010-4b4c-afb2-710c3cf7b8e7"
      unitRef="usd">36948000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i7d3fb6c71a584d88aa595b49e45b8837_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90ZXh0cmVnaW9uOmY0YjZkNzk5YmE3NDQ5MGNiZDc3OWFhNDBiMDg2MTE0XzEzMTk0MTM5NTQ0ODgw_567841d6-ed42-433a-b722-bda0d5057f17"
      unitRef="usd">85935000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i17a122330b5144cf96235a840b3602c1_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90ZXh0cmVnaW9uOmY0YjZkNzk5YmE3NDQ5MGNiZDc3OWFhNDBiMDg2MTE0XzEzMTk0MTM5NTQ0ODk4_8683ac7c-f010-4b4c-afb2-710c3cf7b8e7"
      unitRef="usd">36948000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesAdjustments
      contextRef="ie0b8cf648fb646f3aa94a5539664bc50_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90ZXh0cmVnaW9uOmY0YjZkNzk5YmE3NDQ5MGNiZDc3OWFhNDBiMDg2MTE0XzY1OTcwNjk3ODQzNjg_a9e5edf2-0472-4c44-9f49-b6014d2922e6"
      unitRef="usd">48294000</us-gaap:ValuationAllowancesAndReservesAdjustments>
    <us-gaap:ValuationAllowancesAndReservesAdjustments
      contextRef="ia5ef930d66f146f6b1ee58c6e0b38dbe_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjYvZnJhZzpmNGI2ZDc5OWJhNzQ0OTBjYmQ3NzlhYTQwYjA4NjExNC90ZXh0cmVnaW9uOmY0YjZkNzk5YmE3NDQ5MGNiZDc3OWFhNDBiMDg2MTE0XzEzMTk0MTM5NTQ0OTQw_46d87585-c6d5-491e-8bfe-b3b036672899"
      unitRef="usd">28019000</us-gaap:ValuationAllowancesAndReservesAdjustments>
    <us-gaap:CommitmentsDisclosureTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNTQvZnJhZzphMDk1MzRkYThmOGE0ODRlOGZmYzFmOWM4NWMwNTA2OC90ZXh0cmVnaW9uOmEwOTUzNGRhOGY4YTQ4NGU4ZmZjMWY5Yzg1YzA1MDY4XzI1NDA_d3e4a2a1-c95c-4eec-81ae-2a5db5663140">Commitments &lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt"&gt;Lease Commitments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of the Company&#x2019;s future minimum lease payments under operating leases for its premises due in future fiscal years: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.455%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.679%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to the minimum lease payments, the Company is required to pay realty taxes and other occupancy costs in accordance with the terms of the lease agreements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt"&gt;R&amp;amp;D commitments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(i)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Ginkgo.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; On September 4, 2018, the Company announced an R&amp;amp;D partnership with Ginkgo Bioworks Inc. (&#x201c;Ginkgo&#x201d;) to develop scalable and consistent production of eight target cannabinoids, including THC, CBD and a variety of other lesser known and rarer cannabinoids. As part of this partnership, Cronos Group has agreed to issue up to 14,674,903 common shares of the Company (aggregate value of approximately $100,000 as of July 17, 2018 assuming all milestones are met, collectively the &#x201c;Ginkgo Equity Milestones&#x201d;) in tranches and $22,000 in cash subject to Ginkgo&#x2019;s achievement of certain milestones and to fund certain R&amp;amp;D expenses, including foundry access fees. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(ii)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Technion.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; On October 15, 2018, the Company entered into a sponsored research agreement with the Technion Research and Development Foundation of the Technion &#x2013; Israel Institute of Technology (&#x201c;Technion&#x201d;). Research is focused on the use of cannabinoids and their role in regulating skin health and skin disorders. The Company has committed to $1,784 of research funding over a period of three years. An additional $4,900 of cash payments will be paid to Technion upon the achievement of certain milestones.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(c)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.91pt"&gt;Altria consulting services&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 18, 2019, the Company entered into an agreement with a wholly owned subsidiary of Altria (which agreement was subsequently amended and restated to substitute Altria Pinnacle as a party thereto), to receive strategic advisory and project management services from Altria Pinnacle (the &#x201c;Services Agreement&#x201d;). Pursuant to the Services Agreement, the Company will pay Altria Pinnacle a monthly fee equal to the product of 105% and the sum of: (i) all costs directly associated with the services incurred during the monthly period, and (ii) a reasonable and appropriate allocation of indirect costs incurred during the monthly period. The Company will also pay all third-party direct charges incurred during the monthly period in connection with the services, including any reasonable and documented costs, fees and expenses associated with obtaining any consent, license or permit. The Services Agreement will remain in effect until terminated by either party. See Note 25.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(d)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt"&gt;Use of publicity rights in brand development&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 23, 2019, the Company issued 856,017 restricted common shares to Kristen Bell, an accredited investor, in a private placement (&#x201c;Private Placement&#x201d;) in reliance on Section 4(a)(2) of the Securities Act of 1933 in connection with the use of certain publicity rights in the brand development of Happy Dance&#x2122;. One-third of such common shares vested on January 31, 2020 with the remaining shares vesting in two equal installments on June 23, 2021, and December 23, 2022. The issuance did not involve a public offering and was made without general solicitation or advertising. The total fair value of the consideration paid for the issuance of such common shares was approximately $6,000. The fair value of the shares was calculated using the 10-day volume weighted average price per share of the Company&#x2019;s common shares on Nasdaq.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additional restricted common shares are issued when certain performance milestones are achieved:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(i)&#160;&#160;&#160;&#160;First Performance Issuance: if, prior to December 23, 2022, the product line generates at least $50,000 in net revenue, additional common shares with an aggregate value of $1,000 will be issued.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(ii)&#160;&#160;&#160;&#160;Second Performance Issuance: if, prior to December 23, 2022, the product line generates at least $100,000 in net revenue, additional common shares with an aggregate value of $1,000 will be issued (together with the First Performance Issuance noted above).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The number of common shares that would be issued upon achieving the foregoing milestones will be determined based on the 10-day volume weighted average price per share of the Company&#x2019;s common shares on Nasdaq as of the trading day immediately prior to the date of filing with the Securities and Exchange Commission of the Company&#x2019;s audited year-end financial statements for the first fiscal year during which such milestones are achieved.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsDisclosureTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNTQvZnJhZzphMDk1MzRkYThmOGE0ODRlOGZmYzFmOWM4NWMwNTA2OC90ZXh0cmVnaW9uOmEwOTUzNGRhOGY4YTQ4NGU4ZmZjMWY5Yzg1YzA1MDY4XzI1NDE_fd1ed8b9-000b-4ae8-b481-282a05a2eb28">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of the Company&#x2019;s future minimum lease payments under operating leases for its premises due in future fiscal years: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.455%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.679%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNTQvZnJhZzphMDk1MzRkYThmOGE0ODRlOGZmYzFmOWM4NWMwNTA2OC90YWJsZTo1NzMzYzI2YWQyM2Y0YzQ3OTZlYmU0MDU3MWY1YTE1My90YWJsZXJhbmdlOjU3MzNjMjZhZDIzZjRjNDc5NmViZTQwNTcxZjVhMTUzXzItMi0xLTEtMA_4b60a69a-609e-40cd-bac3-28579f1d8752"
      unitRef="usd">2381000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNTQvZnJhZzphMDk1MzRkYThmOGE0ODRlOGZmYzFmOWM4NWMwNTA2OC90YWJsZTo1NzMzYzI2YWQyM2Y0YzQ3OTZlYmU0MDU3MWY1YTE1My90YWJsZXJhbmdlOjU3MzNjMjZhZDIzZjRjNDc5NmViZTQwNTcxZjVhMTUzXzMtMi0xLTEtMA_cf26c5aa-866a-42fb-a29f-b1b1e2df5808"
      unitRef="usd">2302000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNTQvZnJhZzphMDk1MzRkYThmOGE0ODRlOGZmYzFmOWM4NWMwNTA2OC90YWJsZTo1NzMzYzI2YWQyM2Y0YzQ3OTZlYmU0MDU3MWY1YTE1My90YWJsZXJhbmdlOjU3MzNjMjZhZDIzZjRjNDc5NmViZTQwNTcxZjVhMTUzXzQtMi0xLTEtMA_93ea7cbd-577e-49c2-88da-326200ed4464"
      unitRef="usd">2201000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNTQvZnJhZzphMDk1MzRkYThmOGE0ODRlOGZmYzFmOWM4NWMwNTA2OC90YWJsZTo1NzMzYzI2YWQyM2Y0YzQ3OTZlYmU0MDU3MWY1YTE1My90YWJsZXJhbmdlOjU3MzNjMjZhZDIzZjRjNDc5NmViZTQwNTcxZjVhMTUzXzYtMi0xLTEtMA_c1de5a9a-4e9c-4dfc-9e80-cd3ce80f6271"
      unitRef="usd">1711000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNTQvZnJhZzphMDk1MzRkYThmOGE0ODRlOGZmYzFmOWM4NWMwNTA2OC90YWJsZTo1NzMzYzI2YWQyM2Y0YzQ3OTZlYmU0MDU3MWY1YTE1My90YWJsZXJhbmdlOjU3MzNjMjZhZDIzZjRjNDc5NmViZTQwNTcxZjVhMTUzXzYtMi0xLTEtMTM1MTk_4a7d8267-7507-402a-993d-33076679c787"
      unitRef="usd">1505000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNTQvZnJhZzphMDk1MzRkYThmOGE0ODRlOGZmYzFmOWM4NWMwNTA2OC90YWJsZTo1NzMzYzI2YWQyM2Y0YzQ3OTZlYmU0MDU3MWY1YTE1My90YWJsZXJhbmdlOjU3MzNjMjZhZDIzZjRjNDc5NmViZTQwNTcxZjVhMTUzXzctMi0xLTEtMTYzMDg_2d45f311-bdee-46f6-b78b-fdcbe0aef51c"
      unitRef="usd">1916000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <cron:LongTermPurchaseCommitmentNumberOfTargetedUnitsToDevelopProduction
      contextRef="i5a2c9058e29b437fa7075ccaeaad824a_I20180904"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNTQvZnJhZzphMDk1MzRkYThmOGE0ODRlOGZmYzFmOWM4NWMwNTA2OC90ZXh0cmVnaW9uOmEwOTUzNGRhOGY4YTQ4NGU4ZmZjMWY5Yzg1YzA1MDY4XzYwNDczMTM5NjA4MzQ_a3ff487d-8559-4f13-8bfe-e7931ae76def"
      unitRef="cannabinoid">8</cron:LongTermPurchaseCommitmentNumberOfTargetedUnitsToDevelopProduction>
    <cron:LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableNumberOfShares
      contextRef="i28a266ca99354d2f9478d733e4baca53_D20180904-20180904"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNTQvZnJhZzphMDk1MzRkYThmOGE0ODRlOGZmYzFmOWM4NWMwNTA2OC90ZXh0cmVnaW9uOmEwOTUzNGRhOGY4YTQ4NGU4ZmZjMWY5Yzg1YzA1MDY4XzY5Nw_cfc13a40-85b6-4c7c-ad5d-1706a29ab6d8"
      unitRef="shares">14674903</cron:LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableNumberOfShares>
    <cron:LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableValueAssigned
      contextRef="i53d9abb5a7964f51a7a58f6c6614d10b_I20180717"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNTQvZnJhZzphMDk1MzRkYThmOGE0ODRlOGZmYzFmOWM4NWMwNTA2OC90ZXh0cmVnaW9uOmEwOTUzNGRhOGY4YTQ4NGU4ZmZjMWY5Yzg1YzA1MDY4Xzc2Mw_4151ded4-b2f6-44b4-bdee-79159a647c39"
      unitRef="usd">100000000</cron:LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableValueAssigned>
    <cron:LongtermPurchaseCommitmentPaymentsSubjectToMilestones
      contextRef="i28a266ca99354d2f9478d733e4baca53_D20180904-20180904"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNTQvZnJhZzphMDk1MzRkYThmOGE0ODRlOGZmYzFmOWM4NWMwNTA2OC90ZXh0cmVnaW9uOmEwOTUzNGRhOGY4YTQ4NGU4ZmZjMWY5Yzg1YzA1MDY4Xzg4MA_0f2d66b0-2c72-4b33-936d-56ea27ed491c"
      unitRef="usd">22000000</cron:LongtermPurchaseCommitmentPaymentsSubjectToMilestones>
    <us-gaap:LongTermPurchaseCommitmentAmount
      contextRef="i102273991043430aac514ac6305e4708_D20181015-20181015"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNTQvZnJhZzphMDk1MzRkYThmOGE0ODRlOGZmYzFmOWM4NWMwNTA2OC90ZXh0cmVnaW9uOmEwOTUzNGRhOGY4YTQ4NGU4ZmZjMWY5Yzg1YzA1MDY4XzEzNTk_478af82f-b990-465c-8655-2275bee85646"
      unitRef="usd">1784000</us-gaap:LongTermPurchaseCommitmentAmount>
    <us-gaap:LongtermPurchaseCommitmentPeriod
      contextRef="i102273991043430aac514ac6305e4708_D20181015-20181015"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNTQvZnJhZzphMDk1MzRkYThmOGE0ODRlOGZmYzFmOWM4NWMwNTA2OC90ZXh0cmVnaW9uOmEwOTUzNGRhOGY4YTQ4NGU4ZmZjMWY5Yzg1YzA1MDY4XzgyNDYzMzcyMjc5NDM_09544d55-2a39-4336-b1da-68631c998a58">P3Y</us-gaap:LongtermPurchaseCommitmentPeriod>
    <cron:LongtermPurchaseCommitmentPaymentsSubjectToMilestones
      contextRef="i102273991043430aac514ac6305e4708_D20181015-20181015"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNTQvZnJhZzphMDk1MzRkYThmOGE0ODRlOGZmYzFmOWM4NWMwNTA2OC90ZXh0cmVnaW9uOmEwOTUzNGRhOGY4YTQ4NGU4ZmZjMWY5Yzg1YzA1MDY4XzE0MjM_421df931-f9f1-4e9f-a108-d1c460c1bb57"
      unitRef="usd">4900000</cron:LongtermPurchaseCommitmentPaymentsSubjectToMilestones>
    <cron:LongtermPurchaseCommitmentMonthlyFeePercentage
      contextRef="i2db9aaa38acc4fbfb93e36f09f0da429_D20190218-20190218"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNTQvZnJhZzphMDk1MzRkYThmOGE0ODRlOGZmYzFmOWM4NWMwNTA2OC90ZXh0cmVnaW9uOmEwOTUzNGRhOGY4YTQ4NGU4ZmZjMWY5Yzg1YzA1MDY4XzE5OTU_f8f06df2-072d-4938-ab95-54fbebaffe5f"
      unitRef="number">1.05</cron:LongtermPurchaseCommitmentMonthlyFeePercentage>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i2415de0a4c0c4ecf9ed6ea9afe096828_D20191223-20191223"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNTQvZnJhZzphMDk1MzRkYThmOGE0ODRlOGZmYzFmOWM4NWMwNTA2OC90ZXh0cmVnaW9uOmEwOTUzNGRhOGY4YTQ4NGU4ZmZjMWY5Yzg1YzA1MDY4XzEyMDk0NjI3OTEzNTY1_636d2dc4-d71e-4422-93a6-da83758cbf6f"
      unitRef="shares">856017</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <cron:StockIssuedDuringPeriodNewIssuesFairValue
      contextRef="i14db1abc7cd640c1ad2cba6b108454c3_I20191223"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNTQvZnJhZzphMDk1MzRkYThmOGE0ODRlOGZmYzFmOWM4NWMwNTA2OC90ZXh0cmVnaW9uOmEwOTUzNGRhOGY4YTQ4NGU4ZmZjMWY5Yzg1YzA1MDY4XzEyMDk0NjI3OTEzNTc0_44a7caf8-e5a0-4dd9-9580-99c1263455d6"
      unitRef="usd">6000</cron:StockIssuedDuringPeriodNewIssuesFairValue>
    <cron:StockIssuedDuringPeriodNewIssuesWeightedAveragePricePeriod
      contextRef="i2415de0a4c0c4ecf9ed6ea9afe096828_D20191223-20191223"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNTQvZnJhZzphMDk1MzRkYThmOGE0ODRlOGZmYzFmOWM4NWMwNTA2OC90ZXh0cmVnaW9uOmEwOTUzNGRhOGY4YTQ4NGU4ZmZjMWY5Yzg1YzA1MDY4XzEyMDk0NjI3OTEzNTgx_4936f7a8-eef2-41e2-9681-408828d34876">P10D</cron:StockIssuedDuringPeriodNewIssuesWeightedAveragePricePeriod>
    <cron:SaleOfStockPerformanceMilestoneTriggeringEventMinimumRevenue
      contextRef="i26f35784de464b1abb30c3a7a284c303_I20191223"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNTQvZnJhZzphMDk1MzRkYThmOGE0ODRlOGZmYzFmOWM4NWMwNTA2OC90ZXh0cmVnaW9uOmEwOTUzNGRhOGY4YTQ4NGU4ZmZjMWY5Yzg1YzA1MDY4XzEyMDk0NjI3OTEzNTQ0_d95b3051-776e-4ea8-a197-5cd1e44bffe7"
      unitRef="usd">50000</cron:SaleOfStockPerformanceMilestoneTriggeringEventMinimumRevenue>
    <cron:SaleOfStockPerformanceMilestoneTriggeringEventSharesIssuedValue
      contextRef="i26f35784de464b1abb30c3a7a284c303_I20191223"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNTQvZnJhZzphMDk1MzRkYThmOGE0ODRlOGZmYzFmOWM4NWMwNTA2OC90ZXh0cmVnaW9uOmEwOTUzNGRhOGY4YTQ4NGU4ZmZjMWY5Yzg1YzA1MDY4XzI0MTg5MjU1ODMwNDQy_cc05101d-3ba8-45e6-b933-57f926302275"
      unitRef="usd">1000</cron:SaleOfStockPerformanceMilestoneTriggeringEventSharesIssuedValue>
    <cron:SaleOfStockPerformanceMilestoneTriggeringEventMinimumRevenue
      contextRef="i835de760acba433eab0f8e5932ed1a6f_I20191223"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNTQvZnJhZzphMDk1MzRkYThmOGE0ODRlOGZmYzFmOWM4NWMwNTA2OC90ZXh0cmVnaW9uOmEwOTUzNGRhOGY4YTQ4NGU4ZmZjMWY5Yzg1YzA1MDY4XzEyMDk0NjI3OTEzNTQ2_e7b04fa7-9370-455b-8134-5a6d51eca0a1"
      unitRef="usd">100000</cron:SaleOfStockPerformanceMilestoneTriggeringEventMinimumRevenue>
    <cron:SaleOfStockPerformanceMilestoneTriggeringEventSharesIssuedValue
      contextRef="i835de760acba433eab0f8e5932ed1a6f_I20191223"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNTQvZnJhZzphMDk1MzRkYThmOGE0ODRlOGZmYzFmOWM4NWMwNTA2OC90ZXh0cmVnaW9uOmEwOTUzNGRhOGY4YTQ4NGU4ZmZjMWY5Yzg1YzA1MDY4XzEyMDk0NjI3OTEzNTU3_58c33e09-742c-48d0-a313-33d1923c8039"
      unitRef="usd">1000</cron:SaleOfStockPerformanceMilestoneTriggeringEventSharesIssuedValue>
    <cron:StockIssuedDuringPeriodNewIssuesWeightedAveragePricePeriod
      contextRef="i2415de0a4c0c4ecf9ed6ea9afe096828_D20191223-20191223"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNTQvZnJhZzphMDk1MzRkYThmOGE0ODRlOGZmYzFmOWM4NWMwNTA2OC90ZXh0cmVnaW9uOmEwOTUzNGRhOGY4YTQ4NGU4ZmZjMWY5Yzg1YzA1MDY4XzgyNDYzMzcyMjc5MDk_d7de0f76-825a-40c3-969f-07b80b725b99">P10D</cron:StockIssuedDuringPeriodNewIssuesWeightedAveragePricePeriod>
    <us-gaap:LossContingencyDisclosures
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNTcvZnJhZzo0NGNmOGYzMjM3ZTI0NTdjYmFlMjhiM2JiNmY5Y2RmNi90ZXh0cmVnaW9uOjQ0Y2Y4ZjMyMzdlMjQ1N2NiYWUyOGIzYmI2ZjljZGY2XzI0MTg5MjU1ODI2MDM4_c7ddd0aa-e470-4915-8453-d99cf1b00559">Contingencies &lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is subject to various legal proceedings in the ordinary course of its business and in connection with its marketing, distribution and sale of its products. Many of these legal proceedings are in the early stages of litigation and seek damages that are unspecified or not quantified. Although the outcome of these matters cannot be predicted with certainty, the Company does not believe these legal proceedings, individually or in the aggregate, will have a material adverse effect on its consolidated financial condition but could be material to its results of operations for any particular reporting period depending, in part, on its results for that period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt"&gt;Class action complaints relating to restatement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 11 and 12, 2020, two alleged shareholders of the Company separately filed two putative class action complaints in the U.S. District Court for the Eastern District of New York against the Company and its former Chief Executive Officer (now Executive Chairman) and Chief Financial Officer. The court has consolidated the cases, and the consolidated amended complaint alleges violations of Section 10(b) of the Exchange Act and Rule 10b-5 promulgated thereunder against all defendants, and Section 20(a) of the Exchange Act against the individual defendants. The consolidated amended complaint generally alleges that certain of the Company&#x2019;s prior public statements about revenues and internal controls were incorrect based on the Company&#x2019;s March 2, 2020 disclosure that the Audit Committee of the Board was conducting a review of the appropriateness of revenue recognized in connection with certain bulk resin purchases and sales of products through the wholesale channel. The consolidated amended complaint does not quantify a damage request. Defendants moved to dismiss on February 8, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On June 3, 2020, an alleged shareholder filed a Statement of Claim, as amended on August 12, 2020, in the Ontario Superior Court of Justice in Toronto, Ontario, Canada, seeking, among other things, an order certifying the action as a class action on behalf of a putative class of shareholders and damages of an unspecified amount. The Amended Statement of Claim names the Company, its former Chief Executive Officer (now Executive Chairman), Chief Financial Officer, former Chief Financial Officer and Chief Commercial Officer, and current and former members of the Board as defendants and alleges breaches of the Ontario Securities Act, oppression under the Ontario Business Corporations Act and common law misrepresentation. The Amended Statement of Claim generally alleges that certain of the Company&#x2019;s prior public statements about revenues and internal controls were misrepresentations based on the Company&#x2019;s March 2, 2020 disclosure that the Audit Committee of the Board was conducting a review of the appropriateness of revenue recognized in connection with certain bulk resin purchases and sales of products through the wholesale channel, and the Company&#x2019;s subsequent restatement. The Amended Statement of Claim does not quantify a damage request. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt"&gt;Regulatory reviews relating to restatement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has been responding to requests for information from various regulatory authorities relating to its previously disclosed restatement of its financial statements for the first three quarters of 2019. The Company is responding to all such requests for information and cooperating with all regulatory authorities. The Company cannot predict the outcome of any such regulatory review or investigation and it is possible that additional investigations or one or more formal proceedings may be commenced against the Company and its current and former officers and directors in connection with these regulatory reviews and investigations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(c)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.91pt"&gt;Litigation relating to marketing, distribution and sale of products&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 16, 2020, an alleged consumer filed a Statement of Claim on behalf of a class in the Court of Queen&#x2019;s Bench of Alberta in Alberta, Canada, against the Company and other Canadian cannabis manufacturers and/or distributors. On December 4, 2020, a Third Amended Statement of Claim was filed, which added a second alleged consumer. The Third Amended Statement of Claim alleges claims related to the defendants&#x2019; advertised content of cannabinoids in cannabis products for medicinal use on or after June 16, 2010 and cannabis products for adult use on or after October 17, 2018. The Third Amended Statement of Claim seeks a total of C$500&#160;million for breach of contract, compensatory damages, and unjust enrichment or such other amount as may be proven in trial and C$5&#160;million in punitive damages against each defendant, including the Company. The Third Amended Statement of Claim also seeks interest and costs associated with the action. The Company has not responded to the Third Amended Statement of Claim. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A number of claims, including purported class actions, have been brought in the U.S. against companies engaged in the U.S. hemp business alleging, among other things, violations of state consumer protection, health and advertising laws. On April 8, 2020, a putative class action complaint was filed in the U.S. District Court for the Central District of California against Redwood, alleging violations of California&#x2019;s Unfair Competition Law, False Advertising Law, Consumers Legal Remedies Act, and breaches of the California Commercial Code for breach of express warranties and implied warranty of merchantability with respect to Redwood&#x2019;s marketing and sale of U.S. hemp products. The complaint did not quantify a damage request. On April 10, 2020, the class action complaint was dismissed for certain pleading deficiencies and the plaintiff was granted leave until April 24, 2020 to amend the complaint to establish federal subject matter jurisdiction. On April 28, 2020, the action was dismissed without prejudice for failure to prosecute and for failure to comply with a court order. As of the date of this Annual Report, the plaintiff has not refiled the complaint.&lt;/span&gt;&lt;/div&gt;</us-gaap:LossContingencyDisclosures>
    <us-gaap:LossContingencyNumberOfPlaintiffs
      contextRef="i68ef62796fa04d8f960de4f0be2cd9a0_D20200311-20200312"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNTcvZnJhZzo0NGNmOGYzMjM3ZTI0NTdjYmFlMjhiM2JiNmY5Y2RmNi90ZXh0cmVnaW9uOjQ0Y2Y4ZjMyMzdlMjQ1N2NiYWUyOGIzYmI2ZjljZGY2XzEzMTk0MTM5NTQyODMw_7a6661b6-3f60-4c6e-8258-bb3c2517cb82"
      unitRef="shareholder">2</us-gaap:LossContingencyNumberOfPlaintiffs>
    <us-gaap:LossContingencyNewClaimsFiledNumber
      contextRef="i68ef62796fa04d8f960de4f0be2cd9a0_D20200311-20200312"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNTcvZnJhZzo0NGNmOGYzMjM3ZTI0NTdjYmFlMjhiM2JiNmY5Y2RmNi90ZXh0cmVnaW9uOjQ0Y2Y4ZjMyMzdlMjQ1N2NiYWUyOGIzYmI2ZjljZGY2XzEzMTk0MTM5NTQyODQw_0b0a7bed-c2df-4839-ba0b-0f8c1eb96b99"
      unitRef="complaint">2</us-gaap:LossContingencyNewClaimsFiledNumber>
    <us-gaap:LossContingencyDamagesSoughtValue
      contextRef="i06603bc91b504293b7f98adf78675927_D20200616-20200616"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNTcvZnJhZzo0NGNmOGYzMjM3ZTI0NTdjYmFlMjhiM2JiNmY5Y2RmNi90ZXh0cmVnaW9uOjQ0Y2Y4ZjMyMzdlMjQ1N2NiYWUyOGIzYmI2ZjljZGY2XzEzMTk0MTM5NTQyODU5_d490ebe7-5f52-4aac-993f-6404745c1d3e"
      unitRef="cad">500000000</us-gaap:LossContingencyDamagesSoughtValue>
    <cron:LossContingencyPunitiveDamagesSoughtValue
      contextRef="i06603bc91b504293b7f98adf78675927_D20200616-20200616"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNTcvZnJhZzo0NGNmOGYzMjM3ZTI0NTdjYmFlMjhiM2JiNmY5Y2RmNi90ZXh0cmVnaW9uOjQ0Y2Y4ZjMyMzdlMjQ1N2NiYWUyOGIzYmI2ZjljZGY2XzEzMTk0MTM5NTQyODg0_9010596d-8487-4013-a346-46b364e3d7e7"
      unitRef="cad">5000000</cron:LossContingencyPunitiveDamagesSoughtValue>
    <us-gaap:CashFlowSupplementalDisclosuresTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjkvZnJhZzplY2EyYmEwY2ZlOWQ0NjJmOGQ5ZTNlMGYwZTc3NTJlYi90ZXh0cmVnaW9uOmVjYTJiYTBjZmU5ZDQ2MmY4ZDllM2UwZjBlNzc1MmViXzgw_280dd4cf-e4d8-48cb-b6fc-50c4a389bbbb">Supplementary Cash Flow Information&lt;div style="margin-bottom:12pt;margin-top:16pt;padding-left:29.25pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The net changes in non-cash working capital items are as follow:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.763%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,724)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(702)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,569)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaids and other receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,300)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,509)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,382)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of loans receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,585)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28,094)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51,888)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,092)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33,943)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54,208)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:CashFlowSupplementalDisclosuresTextBlock>
    <us-gaap:CashFlowOperatingCapitalTableTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjkvZnJhZzplY2EyYmEwY2ZlOWQ0NjJmOGQ5ZTNlMGYwZTc3NTJlYi90ZXh0cmVnaW9uOmVjYTJiYTBjZmU5ZDQ2MmY4ZDllM2UwZjBlNzc1MmViXzI0MTg5MjU1ODExMjEz_05679b1b-5594-428a-b181-f848a019b78d">&lt;div style="margin-bottom:12pt;margin-top:16pt;padding-left:29.25pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The net changes in non-cash working capital items are as follow:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.763%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,724)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(702)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,569)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaids and other receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,300)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,509)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,382)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of loans receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,585)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28,094)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51,888)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,092)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33,943)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54,208)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:CashFlowOperatingCapitalTableTextBlock>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjkvZnJhZzplY2EyYmEwY2ZlOWQ0NjJmOGQ5ZTNlMGYwZTc3NTJlYi90YWJsZTo1ZmY0ZjJmMjExZjI0ZDY4YWQ5YmIyMjEyNGM3OTMzNS90YWJsZXJhbmdlOjVmZjRmMmYyMTFmMjRkNjhhZDliYjIyMTI0Yzc5MzM1XzItMS0xLTEtMA_20c1997f-4db9-42c1-8773-6d1c14bcfc20"
      unitRef="usd">4724000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjkvZnJhZzplY2EyYmEwY2ZlOWQ0NjJmOGQ5ZTNlMGYwZTc3NTJlYi90YWJsZTo1ZmY0ZjJmMjExZjI0ZDY4YWQ5YmIyMjEyNGM3OTMzNS90YWJsZXJhbmdlOjVmZjRmMmYyMTFmMjRkNjhhZDliYjIyMTI0Yzc5MzM1XzItMy0xLTEtMA_c432fe2a-4299-446f-b513-0a8e4598f380"
      unitRef="usd">702000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjkvZnJhZzplY2EyYmEwY2ZlOWQ0NjJmOGQ5ZTNlMGYwZTc3NTJlYi90YWJsZTo1ZmY0ZjJmMjExZjI0ZDY4YWQ5YmIyMjEyNGM3OTMzNS90YWJsZXJhbmdlOjVmZjRmMmYyMTFmMjRkNjhhZDliYjIyMTI0Yzc5MzM1XzItNS0xLTEtMTk5OTk_fe00d3d2-0a80-4e13-bbe0-f9c481fdba49"
      unitRef="usd">2569000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <cron:IncreaseDecreasePrepaidExpensesAndOtherReceivables
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjkvZnJhZzplY2EyYmEwY2ZlOWQ0NjJmOGQ5ZTNlMGYwZTc3NTJlYi90YWJsZTo1ZmY0ZjJmMjExZjI0ZDY4YWQ5YmIyMjEyNGM3OTMzNS90YWJsZXJhbmdlOjVmZjRmMmYyMTFmMjRkNjhhZDliYjIyMTI0Yzc5MzM1XzMtMS0xLTEtMA_7bfc7dff-e1d5-49b5-a38f-52b4f23e0c2a"
      unitRef="usd">5300000</cron:IncreaseDecreasePrepaidExpensesAndOtherReceivables>
    <cron:IncreaseDecreasePrepaidExpensesAndOtherReceivables
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjkvZnJhZzplY2EyYmEwY2ZlOWQ0NjJmOGQ5ZTNlMGYwZTc3NTJlYi90YWJsZTo1ZmY0ZjJmMjExZjI0ZDY4YWQ5YmIyMjEyNGM3OTMzNS90YWJsZXJhbmdlOjVmZjRmMmYyMTFmMjRkNjhhZDliYjIyMTI0Yzc5MzM1XzMtMy0xLTEtMA_7d2cb2e1-0134-463c-aab1-910db87e24fc"
      unitRef="usd">10509000</cron:IncreaseDecreasePrepaidExpensesAndOtherReceivables>
    <cron:IncreaseDecreasePrepaidExpensesAndOtherReceivables
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjkvZnJhZzplY2EyYmEwY2ZlOWQ0NjJmOGQ5ZTNlMGYwZTc3NTJlYi90YWJsZTo1ZmY0ZjJmMjExZjI0ZDY4YWQ5YmIyMjEyNGM3OTMzNS90YWJsZXJhbmdlOjVmZjRmMmYyMTFmMjRkNjhhZDliYjIyMTI0Yzc5MzM1XzMtNS0xLTEtMTk5OTk_3c5b59b5-f942-4f13-beaf-6b9a13286ce3"
      unitRef="usd">2382000</cron:IncreaseDecreasePrepaidExpensesAndOtherReceivables>
    <us-gaap:IncreaseDecreaseInFinanceReceivables
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjkvZnJhZzplY2EyYmEwY2ZlOWQ0NjJmOGQ5ZTNlMGYwZTc3NTJlYi90YWJsZTo1ZmY0ZjJmMjExZjI0ZDY4YWQ5YmIyMjEyNGM3OTMzNS90YWJsZXJhbmdlOjVmZjRmMmYyMTFmMjRkNjhhZDliYjIyMTI0Yzc5MzM1XzQtMS0xLTEtMA_e9186213-1ec1-488d-bf98-1f7a51a5eebc"
      unitRef="usd">0</us-gaap:IncreaseDecreaseInFinanceReceivables>
    <us-gaap:IncreaseDecreaseInFinanceReceivables
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjkvZnJhZzplY2EyYmEwY2ZlOWQ0NjJmOGQ5ZTNlMGYwZTc3NTJlYi90YWJsZTo1ZmY0ZjJmMjExZjI0ZDY4YWQ5YmIyMjEyNGM3OTMzNS90YWJsZXJhbmdlOjVmZjRmMmYyMTFmMjRkNjhhZDliYjIyMTI0Yzc5MzM1XzQtMy0xLTEtMA_4f5bf691-55d1-445f-8312-5cababc74ff5"
      unitRef="usd">4585000</us-gaap:IncreaseDecreaseInFinanceReceivables>
    <us-gaap:IncreaseDecreaseInFinanceReceivables
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjkvZnJhZzplY2EyYmEwY2ZlOWQ0NjJmOGQ5ZTNlMGYwZTc3NTJlYi90YWJsZTo1ZmY0ZjJmMjExZjI0ZDY4YWQ5YmIyMjEyNGM3OTMzNS90YWJsZXJhbmdlOjVmZjRmMmYyMTFmMjRkNjhhZDliYjIyMTI0Yzc5MzM1XzQtNS0xLTEtMTk5OTk_230efc12-73b4-4066-b020-591a793df566"
      unitRef="usd">0</us-gaap:IncreaseDecreaseInFinanceReceivables>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjkvZnJhZzplY2EyYmEwY2ZlOWQ0NjJmOGQ5ZTNlMGYwZTc3NTJlYi90YWJsZTo1ZmY0ZjJmMjExZjI0ZDY4YWQ5YmIyMjEyNGM3OTMzNS90YWJsZXJhbmdlOjVmZjRmMmYyMTFmMjRkNjhhZDliYjIyMTI0Yzc5MzM1XzUtMS0xLTEtMA_a8f4d11a-11f0-4e3a-89d5-67809bd1cbbe"
      unitRef="usd">28094000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjkvZnJhZzplY2EyYmEwY2ZlOWQ0NjJmOGQ5ZTNlMGYwZTc3NTJlYi90YWJsZTo1ZmY0ZjJmMjExZjI0ZDY4YWQ5YmIyMjEyNGM3OTMzNS90YWJsZXJhbmdlOjVmZjRmMmYyMTFmMjRkNjhhZDliYjIyMTI0Yzc5MzM1XzUtMy0xLTEtMA_ac12abc6-f51c-4ffc-b083-572fb7ff2b1b"
      unitRef="usd">51888000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjkvZnJhZzplY2EyYmEwY2ZlOWQ0NjJmOGQ5ZTNlMGYwZTc3NTJlYi90YWJsZTo1ZmY0ZjJmMjExZjI0ZDY4YWQ5YmIyMjEyNGM3OTMzNS90YWJsZXJhbmdlOjVmZjRmMmYyMTFmMjRkNjhhZDliYjIyMTI0Yzc5MzM1XzUtNS0xLTEtMTk5OTk_35ff5870-ac96-4115-a820-84d88170ec04"
      unitRef="usd">4092000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjkvZnJhZzplY2EyYmEwY2ZlOWQ0NjJmOGQ5ZTNlMGYwZTc3NTJlYi90YWJsZTo1ZmY0ZjJmMjExZjI0ZDY4YWQ5YmIyMjEyNGM3OTMzNS90YWJsZXJhbmdlOjVmZjRmMmYyMTFmMjRkNjhhZDliYjIyMTI0Yzc5MzM1XzYtMS0xLTEtMA_3d396ee6-9f9c-47e7-951f-98378152a6f3"
      unitRef="usd">4175000</us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjkvZnJhZzplY2EyYmEwY2ZlOWQ0NjJmOGQ5ZTNlMGYwZTc3NTJlYi90YWJsZTo1ZmY0ZjJmMjExZjI0ZDY4YWQ5YmIyMjEyNGM3OTMzNS90YWJsZXJhbmdlOjVmZjRmMmYyMTFmMjRkNjhhZDliYjIyMTI0Yzc5MzM1XzYtMy0xLTEtMA_09b957ff-7da6-4760-8df7-d6e60f3f1127"
      unitRef="usd">13476000</us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjkvZnJhZzplY2EyYmEwY2ZlOWQ0NjJmOGQ5ZTNlMGYwZTc3NTJlYi90YWJsZTo1ZmY0ZjJmMjExZjI0ZDY4YWQ5YmIyMjEyNGM3OTMzNS90YWJsZXJhbmdlOjVmZjRmMmYyMTFmMjRkNjhhZDliYjIyMTI0Yzc5MzM1XzYtNS0xLTEtMTk5OTk_aa0d2f37-6eac-4d33-a43f-acb8e0ec2808"
      unitRef="usd">12705000</us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOperatingCapital
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjkvZnJhZzplY2EyYmEwY2ZlOWQ0NjJmOGQ5ZTNlMGYwZTc3NTJlYi90YWJsZTo1ZmY0ZjJmMjExZjI0ZDY4YWQ5YmIyMjEyNGM3OTMzNS90YWJsZXJhbmdlOjVmZjRmMmYyMTFmMjRkNjhhZDliYjIyMTI0Yzc5MzM1XzgtMS0xLTEtMA_f4a6ce64-951a-4efe-a4e0-e66f2e935aed"
      unitRef="usd">33943000</us-gaap:IncreaseDecreaseInOperatingCapital>
    <us-gaap:IncreaseDecreaseInOperatingCapital
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjkvZnJhZzplY2EyYmEwY2ZlOWQ0NjJmOGQ5ZTNlMGYwZTc3NTJlYi90YWJsZTo1ZmY0ZjJmMjExZjI0ZDY4YWQ5YmIyMjEyNGM3OTMzNS90YWJsZXJhbmdlOjVmZjRmMmYyMTFmMjRkNjhhZDliYjIyMTI0Yzc5MzM1XzgtMy0xLTEtMA_ea980048-d959-4084-8efb-e05b74c7a5d4"
      unitRef="usd">54208000</us-gaap:IncreaseDecreaseInOperatingCapital>
    <us-gaap:IncreaseDecreaseInOperatingCapital
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjkvZnJhZzplY2EyYmEwY2ZlOWQ0NjJmOGQ5ZTNlMGYwZTc3NTJlYi90YWJsZTo1ZmY0ZjJmMjExZjI0ZDY4YWQ5YmIyMjEyNGM3OTMzNS90YWJsZXJhbmdlOjVmZjRmMmYyMTFmMjRkNjhhZDliYjIyMTI0Yzc5MzM1XzktNS0xLTEtMTk5OTk_71b56b99-9ad5-42f4-888f-51d436926b6d"
      unitRef="usd">-3662000</us-gaap:IncreaseDecreaseInOperatingCapital>
    <us-gaap:ConcentrationRiskDisclosureTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzIvZnJhZzo0ZGFiMjc4ODc2N2U0ZTRmYTlmMjRlNjE4MGNkZjk0Yi90ZXh0cmVnaW9uOjRkYWIyNzg4NzY3ZTRlNGZhOWYyNGU2MTgwY2RmOTRiXzYyMDU_25c6b4ce-ed53-4ef9-b985-d7558795773a">Financial Instruments &lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s activities expose it to a variety of financial risks, including credit risk, liquidity risk, and market risk (including interest rate risk) and foreign currency risk.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt"&gt;Credit risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Credit risk is the risk of financial loss to the Company if a customer or counterparty to a financial instrument fails to meet its contractual obligations. The Company is exposed to credit risk from its operating activities, primarily accounts receivable and other receivables, and its investing activities, including cash held with banks and financial institutions, short term investments, loan receivable, and advances to joint ventures. The Company&#x2019;s maximum exposure to this risk is equal to the carrying amount of these financial assets, which amounted to $1,403,491 as of December&#160;31, 2020 (December&#160;31, 2019 &#x2013; $1,586,978).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:8.57pt"&gt;Accounts receivable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company had accounts receivable of $8,928 as of December&#160;31, 2020 (December&#160;31, 2019 &#x2013; $4,638). An impairment analysis is performed at each reporting date using a provision matrix to measure expected credit losses. The provision rates are based on the days past due for groupings of various customer segments with similar loss patterns. The calculation reflects the probability-weighted outcome, the time value of money and reasonable and supportable information that is available at the reporting date about past events, current conditions and forecasts of future economic conditions. Accounts receivable are written off when there is no reasonable expectation of recovery. Indicators that there is no reasonable expectation of recovery include, amongst others, the failure of a debtor to engage in a repayment plan, and a failure to make contractual payments for a period of greater than 120 days past due. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the year ended December&#160;31, 2020, the Company recognized an approximate CECL of $74 (December&#160;31, 2019 &#x2013; $136). The Company has assessed that there is a concentration of credit risk as 78% of the Company&#x2019;s accounts receivable were due from four customers as of December&#160;31, 2020 (December&#160;31, 2019 &#x2013; 56% due from two customers) with an established credit history with the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;(ii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:5.8pt"&gt; Cash and cash equivalents, short-term investments, and other receivables&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company held cash and cash equivalents of $1,078,023 at December&#160;31, 2020 (December&#160;31, 2019 &#x2013; $1,199,693). The short-term investments and related interest receivable of $211,766 (December&#160;31, 2019 &#x2013; $306,347) represents short-term investments with a maturity of less than a year and accrued interest as of December&#160;31, 2020. The cash and cash equivalents and short-term investments, including guaranteed investment certificates and bankers&#x2019; acceptances, are held with central banks and financial institutions that are highly rated. In addition to interest receivable, other receivables include sales taxes receivable from the government. As such, the Company has assessed an insignificant loss allowance on these financial instruments. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;(iii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:3.03pt"&gt;Advances to joint ventures&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company had advances to joint ventures of $467 as of December&#160;31, 2020 (December&#160;31, 2019 &#x2013; $19,437). The Company has assessed the credit risk of advances to joint ventures based on the financial position of the borrowers, and the regulatory and economic environment of the borrowers. The expected loss rates are based on the historical credit losses experienced. Where appropriate, the historical loss rates are adjusted to reflect current and forward-looking information. The Company has assessed the loss allowance on these advances as of December&#160;31, 2020 to be $nil (December&#160;31, 2019 &#x2013; $nil).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt"&gt;Liquidity risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Liquidity risk is the risk that the Company will not be able to meet its financial obligations as they become due and arises principally from the Company&#x2019;s accounts payable and other liabilities. The Company had accounts payable of $12,107 as of December&#160;31, 2020 (December&#160;31, 2019 &#x2013; $9,194). The Company&#x2019;s policy is to review liquidity resources and ensure that sufficient funds are available to meet financial obligations as they become due. Further, the Company&#x2019;s management is responsible for ensuring funds exist and are readily accessible to support business opportunities as they arise. The Company&#x2019;s funding is primarily provided in the form of capital raised through the issuance of common shares and warrants. As of December&#160;31, 2020, 64% of the Company&#x2019;s payables were due to four vendors (December&#160;31, 2019 &#x2013; 42% due to three vendors).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(c)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.91pt"&gt;Market risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Market risk is the risk that the fair value of, or future cash flows from, the Company&#x2019;s financial instruments will significantly fluctuate due to changes in market prices. The value of financial instruments can be affected by changes in interest rates, market and economic conditions, and equity and commodity prices. The Company is exposed to market risk in divesting its investments, such that, unfavorable market conditions could result in dispositions of investments at less than their carrying values. Further, the revaluation of securities classified as fair value through net income could result in significant write-downs of the Company&#x2019;s investments, which would have an adverse impact on the Company&#x2019;s financial position.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company manages risk by having a portfolio of securities from multiple issuers, such that the Company was not materially exposed to any one issuer. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(d)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt"&gt;Interest rate risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest rate risk is the risk that the value or yield of fixed-income investments may decline if interest rates change. Fluctuations in interest rates may impact the level of income and expense recorded on the cash equivalents and short-term investments, and the market value of all interest-earning assets, other than those which possess a short term to maturity. During the year ended December&#160;31, 2020, the Company had net interest income of $18,415 (December&#160;31, 2019 &#x2013; $27,969). A 10% change in the interest rate in effect on December&#160;31, 2020 and December&#160;31, 2019, would not have a material effect on (i) fair value of the cash equivalents and short-term investments as the majority of the portfolio has a maturity date of three months or less, or (ii) interest income. Management continues to monitor external interest rates and revise the Company&#x2019;s investment strategy as a result.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2020, the Company&#x2019;s average variable interest rate fell 1.49%, which resulted in a decrease of net interest income of $15,671 in the period. During the year ended December&#160;31, 2019, the Company&#x2019;s average variable interest rate did not materially change.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(e)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.91pt"&gt;Currency rate risk &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Currency rate risk is the risk that the fair value of, or future cash flows from, the Company&#x2019;s financial instruments will significantly fluctuate due to changes in foreign exchange rates. The Company is exposed to this risk on advances to joint ventures denominated in A$ and C$. The Company is further exposed to this risk through subsidiaries operating in Israel and the U.S. as the Company&#x2019;s functional currency is in Canadian dollars. The Company does not currently use foreign exchange contracts to hedge its exposure to currency rate risk. As such, the Company&#x2019;s financial position and financial results may be adversely affected by the unfavorable fluctuations in currency exchange rates. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, the Company had foreign currency gain (loss) on translation of $14,951 (December&#160;31, 2019 &#x2013; $37,687). A 10% change in the exchange rates for the foreign currencies would affect the carrying value of net assets by approximately $170,817 as of December&#160;31, 2020 (December&#160;31, 2019 &#x2013; $174,902).&lt;/span&gt;&lt;/div&gt;</us-gaap:ConcentrationRiskDisclosureTextBlock>
    <us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzIvZnJhZzo0ZGFiMjc4ODc2N2U0ZTRmYTlmMjRlNjE4MGNkZjk0Yi90ZXh0cmVnaW9uOjRkYWIyNzg4NzY3ZTRlNGZhOWYyNGU2MTgwY2RmOTRiXzEyNjQ0MzgzNzI5NDE5_3319ee80-2df7-4c3e-b7cd-7c38edcacdb7"
      unitRef="usd">1403491000</us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure>
    <us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzIvZnJhZzo0ZGFiMjc4ODc2N2U0ZTRmYTlmMjRlNjE4MGNkZjk0Yi90ZXh0cmVnaW9uOjRkYWIyNzg4NzY3ZTRlNGZhOWYyNGU2MTgwY2RmOTRiXzEyNjQ0MzgzNzI5NDE1_bec80ad5-9221-4f1c-a6fd-a30600f4b15e"
      unitRef="usd">1586978000</us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzIvZnJhZzo0ZGFiMjc4ODc2N2U0ZTRmYTlmMjRlNjE4MGNkZjk0Yi90ZXh0cmVnaW9uOjRkYWIyNzg4NzY3ZTRlNGZhOWYyNGU2MTgwY2RmOTRiXzEyMDk0NjI3OTIyMTg5_b26d3c02-aa0b-42db-858e-e2e74446e9c2"
      unitRef="usd">8928000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzIvZnJhZzo0ZGFiMjc4ODc2N2U0ZTRmYTlmMjRlNjE4MGNkZjk0Yi90ZXh0cmVnaW9uOjRkYWIyNzg4NzY3ZTRlNGZhOWYyNGU2MTgwY2RmOTRiXzEyMDk0NjI3OTIyMTgz_0ed7fa1f-76e0-4254-b2b8-15f700c7313f"
      unitRef="usd">4638000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzIvZnJhZzo0ZGFiMjc4ODc2N2U0ZTRmYTlmMjRlNjE4MGNkZjk0Yi90ZXh0cmVnaW9uOjRkYWIyNzg4NzY3ZTRlNGZhOWYyNGU2MTgwY2RmOTRiXzE0MDQ_b333961b-ebb9-4611-a0d5-3fa47088272a">P120D</us-gaap:AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzIvZnJhZzo0ZGFiMjc4ODc2N2U0ZTRmYTlmMjRlNjE4MGNkZjk0Yi90ZXh0cmVnaW9uOjRkYWIyNzg4NzY3ZTRlNGZhOWYyNGU2MTgwY2RmOTRiXzEyNjQ0MzgzNzI5NDIz_c96199ec-8517-4bf7-b2dc-8cea460978b6"
      unitRef="usd">74000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzIvZnJhZzo0ZGFiMjc4ODc2N2U0ZTRmYTlmMjRlNjE4MGNkZjk0Yi90ZXh0cmVnaW9uOjRkYWIyNzg4NzY3ZTRlNGZhOWYyNGU2MTgwY2RmOTRiXzEyNjQ0MzgzNzI5NDI3_92f18bca-4162-4063-9d6e-6bb0d12a5e3d"
      unitRef="usd">136000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i2d2f72aaaaf343468a4dc9aae56df2af_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzIvZnJhZzo0ZGFiMjc4ODc2N2U0ZTRmYTlmMjRlNjE4MGNkZjk0Yi90ZXh0cmVnaW9uOjRkYWIyNzg4NzY3ZTRlNGZhOWYyNGU2MTgwY2RmOTRiXzEyNjQ0MzgzNzI5NDMx_0f0cfd23-7321-4340-ba07-7bf839583379"
      unitRef="number">0.78</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ie3ab5c08b2f448ec82c845f60eca7697_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzIvZnJhZzo0ZGFiMjc4ODc2N2U0ZTRmYTlmMjRlNjE4MGNkZjk0Yi90ZXh0cmVnaW9uOjRkYWIyNzg4NzY3ZTRlNGZhOWYyNGU2MTgwY2RmOTRiXzEyNjQ0MzgzNzI5NDQ4_295900ba-0890-4b61-8edf-00cdedeeeb4d"
      unitRef="number">0.56</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzIvZnJhZzo0ZGFiMjc4ODc2N2U0ZTRmYTlmMjRlNjE4MGNkZjk0Yi90ZXh0cmVnaW9uOjRkYWIyNzg4NzY3ZTRlNGZhOWYyNGU2MTgwY2RmOTRiXzEyNjQ0MzgzNzI5NDYw_6ac97f4c-790e-488f-a39c-44592337de40"
      unitRef="usd">1078023000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzIvZnJhZzo0ZGFiMjc4ODc2N2U0ZTRmYTlmMjRlNjE4MGNkZjk0Yi90ZXh0cmVnaW9uOjRkYWIyNzg4NzY3ZTRlNGZhOWYyNGU2MTgwY2RmOTRiXzEyNjQ0MzgzNzI5NDU2_ec469079-a391-4a3d-b486-19361129de96"
      unitRef="usd">1199693000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzIvZnJhZzo0ZGFiMjc4ODc2N2U0ZTRmYTlmMjRlNjE4MGNkZjk0Yi90ZXh0cmVnaW9uOjRkYWIyNzg4NzY3ZTRlNGZhOWYyNGU2MTgwY2RmOTRiXzEyNjQ0MzgzNzI5NDY0_543d8fcd-9a09-4233-926d-eae2fdb27683"
      unitRef="usd">211766000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzIvZnJhZzo0ZGFiMjc4ODc2N2U0ZTRmYTlmMjRlNjE4MGNkZjk0Yi90ZXh0cmVnaW9uOjRkYWIyNzg4NzY3ZTRlNGZhOWYyNGU2MTgwY2RmOTRiXzEyNjQ0MzgzNzI5NDY4_49eafec9-586a-4b12-bc69-5e3ddb5b5afa"
      unitRef="usd">306347000</us-gaap:ShortTermInvestments>
    <us-gaap:AdvancesToAffiliate
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzIvZnJhZzo0ZGFiMjc4ODc2N2U0ZTRmYTlmMjRlNjE4MGNkZjk0Yi90ZXh0cmVnaW9uOjRkYWIyNzg4NzY3ZTRlNGZhOWYyNGU2MTgwY2RmOTRiXzEyNjQ0MzgzNzM2MTA5_bd85d597-d34d-42d5-a485-8f4211a3380e"
      unitRef="usd">467000</us-gaap:AdvancesToAffiliate>
    <us-gaap:AdvancesToAffiliate
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzIvZnJhZzo0ZGFiMjc4ODc2N2U0ZTRmYTlmMjRlNjE4MGNkZjk0Yi90ZXh0cmVnaW9uOjRkYWIyNzg4NzY3ZTRlNGZhOWYyNGU2MTgwY2RmOTRiXzEyNjQ0MzgzNzM2MTAz_c6f396b6-eb6c-4286-a547-703b993fae5d"
      unitRef="usd">19437000</us-gaap:AdvancesToAffiliate>
    <cron:AdvancesToAffiliateAllowanceForCreditLoss
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzIvZnJhZzo0ZGFiMjc4ODc2N2U0ZTRmYTlmMjRlNjE4MGNkZjk0Yi90ZXh0cmVnaW9uOjRkYWIyNzg4NzY3ZTRlNGZhOWYyNGU2MTgwY2RmOTRiXzEyNjQ0MzgzNzI4MDA5_d8f45e1a-360d-4063-bbfe-82a5ca7658a8"
      unitRef="usd">0</cron:AdvancesToAffiliateAllowanceForCreditLoss>
    <cron:AdvancesToAffiliateAllowanceForCreditLoss
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzIvZnJhZzo0ZGFiMjc4ODc2N2U0ZTRmYTlmMjRlNjE4MGNkZjk0Yi90ZXh0cmVnaW9uOjRkYWIyNzg4NzY3ZTRlNGZhOWYyNGU2MTgwY2RmOTRiXzEyNjQ0MzgzNzI4MDAy_f177de90-874c-4625-a971-3c7567ddec2e"
      unitRef="usd">0</cron:AdvancesToAffiliateAllowanceForCreditLoss>
    <us-gaap:AccountsPayableCurrent
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzIvZnJhZzo0ZGFiMjc4ODc2N2U0ZTRmYTlmMjRlNjE4MGNkZjk0Yi90ZXh0cmVnaW9uOjRkYWIyNzg4NzY3ZTRlNGZhOWYyNGU2MTgwY2RmOTRiXzEyNjQ0MzgzNzM2MjM1_0268b951-6e93-4c0c-8833-2e1695ea9c08"
      unitRef="usd">12107000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzIvZnJhZzo0ZGFiMjc4ODc2N2U0ZTRmYTlmMjRlNjE4MGNkZjk0Yi90ZXh0cmVnaW9uOjRkYWIyNzg4NzY3ZTRlNGZhOWYyNGU2MTgwY2RmOTRiXzEyNjQ0MzgzNzM2MjI4_b815b7ed-3817-4398-a463-85b23c5dbc68"
      unitRef="usd">9194000</us-gaap:AccountsPayableCurrent>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i95dee7cb129845bf8d27987a1caa0bb3_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzIvZnJhZzo0ZGFiMjc4ODc2N2U0ZTRmYTlmMjRlNjE4MGNkZjk0Yi90ZXh0cmVnaW9uOjRkYWIyNzg4NzY3ZTRlNGZhOWYyNGU2MTgwY2RmOTRiXzEyNjQ0MzgzNzI4MDEz_d122bcaa-de16-4335-9f4a-208e9c436493"
      unitRef="number">0.64</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i79cb5a37ccf24867aa069dc4b34e18f3_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzIvZnJhZzo0ZGFiMjc4ODc2N2U0ZTRmYTlmMjRlNjE4MGNkZjk0Yi90ZXh0cmVnaW9uOjRkYWIyNzg4NzY3ZTRlNGZhOWYyNGU2MTgwY2RmOTRiXzEwOTk1MTE2MzQxNjE_efdc819f-082c-402f-933d-15fb344fbe73"
      unitRef="number">0.42</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzIvZnJhZzo0ZGFiMjc4ODc2N2U0ZTRmYTlmMjRlNjE4MGNkZjk0Yi90ZXh0cmVnaW9uOjRkYWIyNzg4NzY3ZTRlNGZhOWYyNGU2MTgwY2RmOTRiXzEyNjQ0MzgzNzI4NTg2_2722946d-08c6-4551-b057-e0a5f70d7d65"
      unitRef="usd">18415000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzIvZnJhZzo0ZGFiMjc4ODc2N2U0ZTRmYTlmMjRlNjE4MGNkZjk0Yi90ZXh0cmVnaW9uOjRkYWIyNzg4NzY3ZTRlNGZhOWYyNGU2MTgwY2RmOTRiXzEyNjQ0MzgzNzI4NTk3_2067604f-901d-4fab-8a05-077efd4f7570"
      unitRef="usd">27969000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <cron:SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncomePercent
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzIvZnJhZzo0ZGFiMjc4ODc2N2U0ZTRmYTlmMjRlNjE4MGNkZjk0Yi90ZXh0cmVnaW9uOjRkYWIyNzg4NzY3ZTRlNGZhOWYyNGU2MTgwY2RmOTRiXzEyNjQ0MzgzNzI4Nzg2_75e96db6-b2f2-4b8e-970c-7c9c8dfcfb14"
      unitRef="number">0.0149</cron:SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncomePercent>
    <cron:SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncome
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzIvZnJhZzo0ZGFiMjc4ODc2N2U0ZTRmYTlmMjRlNjE4MGNkZjk0Yi90ZXh0cmVnaW9uOjRkYWIyNzg4NzY3ZTRlNGZhOWYyNGU2MTgwY2RmOTRiXzEyNjQ0MzgzNzI5MDQ2_9f71112f-db4f-4e5b-bf9f-7d17eb980288"
      unitRef="usd">-15671000</cron:SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncome>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzIvZnJhZzo0ZGFiMjc4ODc2N2U0ZTRmYTlmMjRlNjE4MGNkZjk0Yi90ZXh0cmVnaW9uOjRkYWIyNzg4NzY3ZTRlNGZhOWYyNGU2MTgwY2RmOTRiXzEyNjQ0MzgzNzI5MzUz_6bc5e35a-9108-456f-89c2-92215f70dbc8"
      unitRef="usd">14951000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzIvZnJhZzo0ZGFiMjc4ODc2N2U0ZTRmYTlmMjRlNjE4MGNkZjk0Yi90ZXh0cmVnaW9uOjRkYWIyNzg4NzY3ZTRlNGZhOWYyNGU2MTgwY2RmOTRiXzYwMzY_9b99fa8d-a55f-4891-8d27-5e226b35af00"
      unitRef="usd">37687000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <cron:SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzIvZnJhZzo0ZGFiMjc4ODc2N2U0ZTRmYTlmMjRlNjE4MGNkZjk0Yi90ZXh0cmVnaW9uOjRkYWIyNzg4NzY3ZTRlNGZhOWYyNGU2MTgwY2RmOTRiXzEyNjQ0MzgzNzI5NDcy_da72aec9-196e-427e-b97b-cec0206dac00"
      unitRef="usd">170817000</cron:SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate>
    <cron:SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzIvZnJhZzo0ZGFiMjc4ODc2N2U0ZTRmYTlmMjRlNjE4MGNkZjk0Yi90ZXh0cmVnaW9uOjRkYWIyNzg4NzY3ZTRlNGZhOWYyNGU2MTgwY2RmOTRiXzEyNjQ0MzgzNzI5MzU4_f67fe027-e8a8-447f-aa4f-fe3eff9a05ca"
      unitRef="usd">174902000</cron:SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzgvZnJhZzo2MjM2ODZjYzdkZmQ0ZGQ1ODg0YzE0MTQ0MzlmYWFiNi90ZXh0cmVnaW9uOjYyMzY4NmNjN2RmZDRkZDU4ODRjMTQxNDQzOWZhYWI2XzE2MzM_826f59aa-2f30-4ca9-9185-ec5c44f2be92">Fair Value Measurement&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company complies with ASC 820 Fair Value Measurements, for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually. In general, fair values are determined by:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 2 inputs utilize data points that are observable such as quoted prices, interest rates and yield curves. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 3 inputs are unobservable data points for the asset or liability, and includes situations where there is little, if any, market activity for the asset or liability.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present information about the Company&#x2019;s assets that are measured at fair value on a recurring basis as of December&#160;31, 2020 and December&#160;31, 2019 and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.194%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.054%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.054%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.054%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.058%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,078,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,078,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.194%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.054%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.054%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.054%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.058%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,199,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,199,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;306,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;306,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzgvZnJhZzo2MjM2ODZjYzdkZmQ0ZGQ1ODg0YzE0MTQ0MzlmYWFiNi90ZXh0cmVnaW9uOjYyMzY4NmNjN2RmZDRkZDU4ODRjMTQxNDQzOWZhYWI2XzI0MTg5MjU1ODE4MjMx_d1ee3859-9d1e-4401-9672-4ab15ff105d1">&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present information about the Company&#x2019;s assets that are measured at fair value on a recurring basis as of December&#160;31, 2020 and December&#160;31, 2019 and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.194%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.054%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.054%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.054%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.058%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,078,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,078,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.194%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.054%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.054%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.054%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.058%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,199,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,199,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;306,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;306,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i84abf62189854b468a350b1f65034a6b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzgvZnJhZzo2MjM2ODZjYzdkZmQ0ZGQ1ODg0YzE0MTQ0MzlmYWFiNi90YWJsZTphMjViN2ExZTkzMmQ0NzczYjVmMDEwNDc3MzYwZmYyZS90YWJsZXJhbmdlOmEyNWI3YTFlOTMyZDQ3NzNiNWYwMTA0NzczNjBmZjJlXzItNi0xLTEtNTcxOA_7de7ec9c-2f39-45e1-a085-45d8550c97f4"
      unitRef="usd">1078023000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ie67dbd083d6c4c81b9b3a7623bbc8983_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzgvZnJhZzo2MjM2ODZjYzdkZmQ0ZGQ1ODg0YzE0MTQ0MzlmYWFiNi90YWJsZTphMjViN2ExZTkzMmQ0NzczYjVmMDEwNDc3MzYwZmYyZS90YWJsZXJhbmdlOmEyNWI3YTFlOTMyZDQ3NzNiNWYwMTA0NzczNjBmZjJlXzItOC0xLTEtNTcxOA_c203cfde-4978-467b-b4d5-f0e5cc2f9a3d"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ia65c0721a7bc4c228d88b512209d7211_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzgvZnJhZzo2MjM2ODZjYzdkZmQ0ZGQ1ODg0YzE0MTQ0MzlmYWFiNi90YWJsZTphMjViN2ExZTkzMmQ0NzczYjVmMDEwNDc3MzYwZmYyZS90YWJsZXJhbmdlOmEyNWI3YTFlOTMyZDQ3NzNiNWYwMTA0NzczNjBmZjJlXzItNS0xLTEtNTc2OA_40d0f65c-2bf4-4868-91dd-d00b0ce9dddb"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="iea50dbe7c8794cc8aa0b34bfe4bb4eba_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzgvZnJhZzo2MjM2ODZjYzdkZmQ0ZGQ1ODg0YzE0MTQ0MzlmYWFiNi90YWJsZTphMjViN2ExZTkzMmQ0NzczYjVmMDEwNDc3MzYwZmYyZS90YWJsZXJhbmdlOmEyNWI3YTFlOTMyZDQ3NzNiNWYwMTA0NzczNjBmZjJlXzItNy0xLTEtNTc2OA_4021d96a-e67d-4d4d-993a-0b950b148665"
      unitRef="usd">1078023000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i84abf62189854b468a350b1f65034a6b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzgvZnJhZzo2MjM2ODZjYzdkZmQ0ZGQ1ODg0YzE0MTQ0MzlmYWFiNi90YWJsZTphMjViN2ExZTkzMmQ0NzczYjVmMDEwNDc3MzYwZmYyZS90YWJsZXJhbmdlOmEyNWI3YTFlOTMyZDQ3NzNiNWYwMTA0NzczNjBmZjJlXzMtNi0xLTEtNTcxOA_f3a92576-f21b-4767-8e52-79d01168736f"
      unitRef="usd">211766000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie67dbd083d6c4c81b9b3a7623bbc8983_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzgvZnJhZzo2MjM2ODZjYzdkZmQ0ZGQ1ODg0YzE0MTQ0MzlmYWFiNi90YWJsZTphMjViN2ExZTkzMmQ0NzczYjVmMDEwNDc3MzYwZmYyZS90YWJsZXJhbmdlOmEyNWI3YTFlOTMyZDQ3NzNiNWYwMTA0NzczNjBmZjJlXzMtOC0xLTEtNTcxOA_085045f4-8f36-42bc-b71a-cd5aa2c62972"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia65c0721a7bc4c228d88b512209d7211_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzgvZnJhZzo2MjM2ODZjYzdkZmQ0ZGQ1ODg0YzE0MTQ0MzlmYWFiNi90YWJsZTphMjViN2ExZTkzMmQ0NzczYjVmMDEwNDc3MzYwZmYyZS90YWJsZXJhbmdlOmEyNWI3YTFlOTMyZDQ3NzNiNWYwMTA0NzczNjBmZjJlXzMtNS0xLTEtNTc2OA_959f7275-635f-447c-bf4e-cbe0da08cfb2"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iea50dbe7c8794cc8aa0b34bfe4bb4eba_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzgvZnJhZzo2MjM2ODZjYzdkZmQ0ZGQ1ODg0YzE0MTQ0MzlmYWFiNi90YWJsZTphMjViN2ExZTkzMmQ0NzczYjVmMDEwNDc3MzYwZmYyZS90YWJsZXJhbmdlOmEyNWI3YTFlOTMyZDQ3NzNiNWYwMTA0NzczNjBmZjJlXzMtNy0xLTEtNTc2OA_4047fb2f-4dd3-499c-a51c-88b6ad0888e1"
      unitRef="usd">211766000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:DerivativeLiabilities
      contextRef="i84abf62189854b468a350b1f65034a6b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzgvZnJhZzo2MjM2ODZjYzdkZmQ0ZGQ1ODg0YzE0MTQ0MzlmYWFiNi90YWJsZTphMjViN2ExZTkzMmQ0NzczYjVmMDEwNDc3MzYwZmYyZS90YWJsZXJhbmdlOmEyNWI3YTFlOTMyZDQ3NzNiNWYwMTA0NzczNjBmZjJlXzYtNi0xLTEtNTcxOA_9783e5dd-cb74-41c4-97ca-e0ddc4593d79"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="ie67dbd083d6c4c81b9b3a7623bbc8983_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzgvZnJhZzo2MjM2ODZjYzdkZmQ0ZGQ1ODg0YzE0MTQ0MzlmYWFiNi90YWJsZTphMjViN2ExZTkzMmQ0NzczYjVmMDEwNDc3MzYwZmYyZS90YWJsZXJhbmdlOmEyNWI3YTFlOTMyZDQ3NzNiNWYwMTA0NzczNjBmZjJlXzYtOC0xLTEtNTcxOA_8aed3130-60fc-4420-bb00-c95437afd91a"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="ia65c0721a7bc4c228d88b512209d7211_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzgvZnJhZzo2MjM2ODZjYzdkZmQ0ZGQ1ODg0YzE0MTQ0MzlmYWFiNi90YWJsZTphMjViN2ExZTkzMmQ0NzczYjVmMDEwNDc3MzYwZmYyZS90YWJsZXJhbmdlOmEyNWI3YTFlOTMyZDQ3NzNiNWYwMTA0NzczNjBmZjJlXzYtNS0xLTEtNTc2OA_a7bd51ea-3c13-4a22-8995-87e10e1fdc1b"
      unitRef="usd">163410000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="iea50dbe7c8794cc8aa0b34bfe4bb4eba_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzgvZnJhZzo2MjM2ODZjYzdkZmQ0ZGQ1ODg0YzE0MTQ0MzlmYWFiNi90YWJsZTphMjViN2ExZTkzMmQ0NzczYjVmMDEwNDc3MzYwZmYyZS90YWJsZXJhbmdlOmEyNWI3YTFlOTMyZDQ3NzNiNWYwMTA0NzczNjBmZjJlXzYtNy0xLTEtNTc2OA_3fcfe48a-30de-4b94-b4c2-fc6c1be4ce8c"
      unitRef="usd">163410000</us-gaap:DerivativeLiabilities>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i744acfb901a1441fb9ff99ac787b5b60_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzgvZnJhZzo2MjM2ODZjYzdkZmQ0ZGQ1ODg0YzE0MTQ0MzlmYWFiNi90YWJsZTo1NmQ1YjBhOWYzYzY0Yjg0OThjYjdiMzU2ZjdhN2E2Yi90YWJsZXJhbmdlOjU2ZDViMGE5ZjNjNjRiODQ5OGNiN2IzNTZmN2E3YTZiXzItMS0xLTEtNTc2Mg_ce6b7151-c431-4c36-b54c-baf0411597e3"
      unitRef="usd">1199693000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="if66e6d2d74bd44d69e598ab739cad251_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzgvZnJhZzo2MjM2ODZjYzdkZmQ0ZGQ1ODg0YzE0MTQ0MzlmYWFiNi90YWJsZTo1NmQ1YjBhOWYzYzY0Yjg0OThjYjdiMzU2ZjdhN2E2Yi90YWJsZXJhbmdlOjU2ZDViMGE5ZjNjNjRiODQ5OGNiN2IzNTZmN2E3YTZiXzItMy0xLTEtNTc2Mg_36b9bd18-4bde-4765-b52f-b4e09c08c8e8"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i9cf5ee47f74c4feeb97ec1fa3dcfc557_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzgvZnJhZzo2MjM2ODZjYzdkZmQ0ZGQ1ODg0YzE0MTQ0MzlmYWFiNi90YWJsZTo1NmQ1YjBhOWYzYzY0Yjg0OThjYjdiMzU2ZjdhN2E2Yi90YWJsZXJhbmdlOjU2ZDViMGE5ZjNjNjRiODQ5OGNiN2IzNTZmN2E3YTZiXzItNS0xLTEtNTc3NQ_e01c2e6c-d7db-4124-bd6c-3169d95d7678"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ic809b1e3fd7243ac9c58c7a16950ffcd_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzgvZnJhZzo2MjM2ODZjYzdkZmQ0ZGQ1ODg0YzE0MTQ0MzlmYWFiNi90YWJsZTo1NmQ1YjBhOWYzYzY0Yjg0OThjYjdiMzU2ZjdhN2E2Yi90YWJsZXJhbmdlOjU2ZDViMGE5ZjNjNjRiODQ5OGNiN2IzNTZmN2E3YTZiXzItNy0xLTEtNTc3NQ_070087ae-172f-43ca-a4d3-ec37709b26a3"
      unitRef="usd">1199693000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i744acfb901a1441fb9ff99ac787b5b60_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzgvZnJhZzo2MjM2ODZjYzdkZmQ0ZGQ1ODg0YzE0MTQ0MzlmYWFiNi90YWJsZTo1NmQ1YjBhOWYzYzY0Yjg0OThjYjdiMzU2ZjdhN2E2Yi90YWJsZXJhbmdlOjU2ZDViMGE5ZjNjNjRiODQ5OGNiN2IzNTZmN2E3YTZiXzMtMS0xLTEtNTc2Mg_5a19229b-259e-4c72-90c8-dadf46c57fd6"
      unitRef="usd">306347000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if66e6d2d74bd44d69e598ab739cad251_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzgvZnJhZzo2MjM2ODZjYzdkZmQ0ZGQ1ODg0YzE0MTQ0MzlmYWFiNi90YWJsZTo1NmQ1YjBhOWYzYzY0Yjg0OThjYjdiMzU2ZjdhN2E2Yi90YWJsZXJhbmdlOjU2ZDViMGE5ZjNjNjRiODQ5OGNiN2IzNTZmN2E3YTZiXzMtMy0xLTEtNTc2Mg_2b46f2be-5633-40c4-955b-ef656556c470"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9cf5ee47f74c4feeb97ec1fa3dcfc557_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzgvZnJhZzo2MjM2ODZjYzdkZmQ0ZGQ1ODg0YzE0MTQ0MzlmYWFiNi90YWJsZTo1NmQ1YjBhOWYzYzY0Yjg0OThjYjdiMzU2ZjdhN2E2Yi90YWJsZXJhbmdlOjU2ZDViMGE5ZjNjNjRiODQ5OGNiN2IzNTZmN2E3YTZiXzMtNS0xLTEtNTc3NQ_f090afe5-d8eb-4dc5-85e4-17de78248a01"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic809b1e3fd7243ac9c58c7a16950ffcd_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzgvZnJhZzo2MjM2ODZjYzdkZmQ0ZGQ1ODg0YzE0MTQ0MzlmYWFiNi90YWJsZTo1NmQ1YjBhOWYzYzY0Yjg0OThjYjdiMzU2ZjdhN2E2Yi90YWJsZXJhbmdlOjU2ZDViMGE5ZjNjNjRiODQ5OGNiN2IzNTZmN2E3YTZiXzMtNy0xLTEtNTc3NQ_d64040e3-4d81-41e7-ae59-72e24a6353ac"
      unitRef="usd">306347000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:DerivativeLiabilities
      contextRef="i744acfb901a1441fb9ff99ac787b5b60_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzgvZnJhZzo2MjM2ODZjYzdkZmQ0ZGQ1ODg0YzE0MTQ0MzlmYWFiNi90YWJsZTo1NmQ1YjBhOWYzYzY0Yjg0OThjYjdiMzU2ZjdhN2E2Yi90YWJsZXJhbmdlOjU2ZDViMGE5ZjNjNjRiODQ5OGNiN2IzNTZmN2E3YTZiXzYtMS0xLTEtNTc2Mg_efe1ee3a-a895-450a-8357-2f50973b73a6"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="if66e6d2d74bd44d69e598ab739cad251_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzgvZnJhZzo2MjM2ODZjYzdkZmQ0ZGQ1ODg0YzE0MTQ0MzlmYWFiNi90YWJsZTo1NmQ1YjBhOWYzYzY0Yjg0OThjYjdiMzU2ZjdhN2E2Yi90YWJsZXJhbmdlOjU2ZDViMGE5ZjNjNjRiODQ5OGNiN2IzNTZmN2E3YTZiXzYtMy0xLTEtNTc2Mg_52318d47-3d77-4a86-ac03-93791e3462c0"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i9cf5ee47f74c4feeb97ec1fa3dcfc557_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzgvZnJhZzo2MjM2ODZjYzdkZmQ0ZGQ1ODg0YzE0MTQ0MzlmYWFiNi90YWJsZTo1NmQ1YjBhOWYzYzY0Yjg0OThjYjdiMzU2ZjdhN2E2Yi90YWJsZXJhbmdlOjU2ZDViMGE5ZjNjNjRiODQ5OGNiN2IzNTZmN2E3YTZiXzYtNS0xLTEtNTc3NQ_36f612d0-dff3-4cb5-b58b-05af442ed9b6"
      unitRef="usd">297160000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="ic809b1e3fd7243ac9c58c7a16950ffcd_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNzgvZnJhZzo2MjM2ODZjYzdkZmQ0ZGQ1ODg0YzE0MTQ0MzlmYWFiNi90YWJsZTo1NmQ1YjBhOWYzYzY0Yjg0OThjYjdiMzU2ZjdhN2E2Yi90YWJsZXJhbmdlOjU2ZDViMGE5ZjNjNjRiODQ5OGNiN2IzNTZmN2E3YTZiXzYtNy0xLTEtNTc3NQ_d4a8572a-bbad-4a3a-b91f-e935a80948f1"
      unitRef="usd">297160000</us-gaap:DerivativeLiabilities>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDUvZnJhZzphOTU0Yjk0OTM3ZjI0YmE2ODhjYmMxYTQzMGE0Njk5Yy90ZXh0cmVnaW9uOmE5NTRiOTQ5MzdmMjRiYTY4OGNiYzFhNDMwYTQ2OTljXzgxMw_9fa12c1c-e51e-4b80-ac62-5817f8713802">Related Party Transactions and Balances &lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 8, 2019, in connection with the Altria Investment, Altria, through certain of its wholly owned subsidiaries, purchased a 45% equity interest in the Company. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company incurred the following expenses for consulting services from Altria Pinnacle LLC, a subsidiary of Altria (&#x201c;Altria Pinnacle&#x201d;):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.346%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Altria Pinnacle &#x2013; expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No expenses for consulting services from Altria Pinnacle during the year ended December&#160;31, 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of amounts payable related to the consulting services with Altria Pinnacle:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.346%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Altria Pinnacle &#x2013; payable&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2019, the Company purchased machinery and equipment amounting to $1,258 from a subsidiary of Altria, which was fully paid for during the year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to Note 14 for further information on the derivative liabilities related to the Altria Investment.&lt;/span&gt;&lt;/div&gt;There were no other material related party transactions during the years ended December&#160;31, 2020, December&#160;31, 2019 and December&#160;31, 2018.</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="ib551b9ef8b1d44bcb1db52c16b0f3d77_I20190308"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDUvZnJhZzphOTU0Yjk0OTM3ZjI0YmE2ODhjYmMxYTQzMGE0Njk5Yy90ZXh0cmVnaW9uOmE5NTRiOTQ5MzdmMjRiYTY4OGNiYzFhNDMwYTQ2OTljXzE2NQ_08b19034-02de-415b-a4d3-968082ce9244"
      unitRef="number">0.45</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDUvZnJhZzphOTU0Yjk0OTM3ZjI0YmE2ODhjYmMxYTQzMGE0Njk5Yy90ZXh0cmVnaW9uOmE5NTRiOTQ5MzdmMjRiYTY4OGNiYzFhNDMwYTQ2OTljXzI0MTg5MjU1ODEzMTA1_614e2ea7-568b-4c94-8750-8c576e0fb6ad">&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company incurred the following expenses for consulting services from Altria Pinnacle LLC, a subsidiary of Altria (&#x201c;Altria Pinnacle&#x201d;):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.346%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Altria Pinnacle &#x2013; expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No expenses for consulting services from Altria Pinnacle during the year ended December&#160;31, 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of amounts payable related to the consulting services with Altria Pinnacle:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.346%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Altria Pinnacle &#x2013; payable&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="if695526c3a384f66bf0952f4b3b10c1f_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDUvZnJhZzphOTU0Yjk0OTM3ZjI0YmE2ODhjYmMxYTQzMGE0Njk5Yy90YWJsZTplOWQ0ODQ1Y2I5YTU0YjYzODUxMmI3MWZkMzRiNTIwMS90YWJsZXJhbmdlOmU5ZDQ4NDVjYjlhNTRiNjM4NTEyYjcxZmQzNGI1MjAxXzItMS0xLTEtMTExMzU_8dc2b653-09f9-43cd-a1c8-1a867d03a102"
      unitRef="usd">1199000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="i82c99c7bc6cf41bbaf798753e7523968_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDUvZnJhZzphOTU0Yjk0OTM3ZjI0YmE2ODhjYmMxYTQzMGE0Njk5Yy90YWJsZTplOWQ0ODQ1Y2I5YTU0YjYzODUxMmI3MWZkMzRiNTIwMS90YWJsZXJhbmdlOmU5ZDQ4NDVjYjlhNTRiNjM4NTEyYjcxZmQzNGI1MjAxXzItMy0xLTEtMTExMzU_9c146914-cb02-42e4-83d0-e216b08bcffc"
      unitRef="usd">3479000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="i56950461ca0641258302cc12456209fb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDUvZnJhZzphOTU0Yjk0OTM3ZjI0YmE2ODhjYmMxYTQzMGE0Njk5Yy90YWJsZTplOWQ0ODQ1Y2I5YTU0YjYzODUxMmI3MWZkMzRiNTIwMS90YWJsZXJhbmdlOmU5ZDQ4NDVjYjlhNTRiNjM4NTEyYjcxZmQzNGI1MjAxXzMtMS0xLTEtMTExMzU_2dd7a63c-315c-4337-9c9f-db64cdecd39e"
      unitRef="usd">1199000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="id13d81de4dfa4a43aa8e25121fddb996_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDUvZnJhZzphOTU0Yjk0OTM3ZjI0YmE2ODhjYmMxYTQzMGE0Njk5Yy90YWJsZTplOWQ0ODQ1Y2I5YTU0YjYzODUxMmI3MWZkMzRiNTIwMS90YWJsZXJhbmdlOmU5ZDQ4NDVjYjlhNTRiNjM4NTEyYjcxZmQzNGI1MjAxXzMtMy0xLTEtMTExMzU_5c3cd4d9-020c-4644-8330-bb044e5da1da"
      unitRef="usd">3479000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="i0183de7cbf5a41d98122476254d88bc7_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDUvZnJhZzphOTU0Yjk0OTM3ZjI0YmE2ODhjYmMxYTQzMGE0Njk5Yy90ZXh0cmVnaW9uOmE5NTRiOTQ5MzdmMjRiYTY4OGNiYzFhNDMwYTQ2OTljXzgyNDYzMzcyMTA4MDI_aa2467d4-6315-47a2-b0cc-90c269dd82ba"
      unitRef="usd">0</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:AccountsPayableRelatedPartiesCurrent
      contextRef="i9fc6d347c95c4553908e2aad286d0722_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDUvZnJhZzphOTU0Yjk0OTM3ZjI0YmE2ODhjYmMxYTQzMGE0Njk5Yy90YWJsZTpmNDJkOWRlOWUxYTA0OTZiOWIxOWQwY2M1NTI5NzhiNi90YWJsZXJhbmdlOmY0MmQ5ZGU5ZTFhMDQ5NmI5YjE5ZDBjYzU1Mjk3OGI2XzItMS0xLTEtMTExNDE_d17357af-0070-4f42-a334-8555b67040ba"
      unitRef="usd">0</us-gaap:AccountsPayableRelatedPartiesCurrent>
    <us-gaap:AccountsPayableRelatedPartiesCurrent
      contextRef="ibc5cfb363b314f4d89d1c4f2a887ca7a_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDUvZnJhZzphOTU0Yjk0OTM3ZjI0YmE2ODhjYmMxYTQzMGE0Njk5Yy90YWJsZTpmNDJkOWRlOWUxYTA0OTZiOWIxOWQwY2M1NTI5NzhiNi90YWJsZXJhbmdlOmY0MmQ5ZGU5ZTFhMDQ5NmI5YjE5ZDBjYzU1Mjk3OGI2XzItMy0xLTEtMTExNDE_8015fe96-e27a-42f0-88f5-3a2b7559cfc6"
      unitRef="usd">1152000</us-gaap:AccountsPayableRelatedPartiesCurrent>
    <us-gaap:AccountsPayableRelatedPartiesCurrent
      contextRef="if753a5d3b4dc49c6b14066a7f6662688_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDUvZnJhZzphOTU0Yjk0OTM3ZjI0YmE2ODhjYmMxYTQzMGE0Njk5Yy90YWJsZTpmNDJkOWRlOWUxYTA0OTZiOWIxOWQwY2M1NTI5NzhiNi90YWJsZXJhbmdlOmY0MmQ5ZGU5ZTFhMDQ5NmI5YjE5ZDBjYzU1Mjk3OGI2XzMtMS0xLTEtMTExNDE_0e03cd12-78b3-4934-a2c5-e984597c2ba2"
      unitRef="usd">0</us-gaap:AccountsPayableRelatedPartiesCurrent>
    <us-gaap:AccountsPayableRelatedPartiesCurrent
      contextRef="i19b510e302f04461a1edc4df93c4ac57_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDUvZnJhZzphOTU0Yjk0OTM3ZjI0YmE2ODhjYmMxYTQzMGE0Njk5Yy90YWJsZTpmNDJkOWRlOWUxYTA0OTZiOWIxOWQwY2M1NTI5NzhiNi90YWJsZXJhbmdlOmY0MmQ5ZGU5ZTFhMDQ5NmI5YjE5ZDBjYzU1Mjk3OGI2XzMtMy0xLTEtMTExNDE_cd89498c-6b11-4a31-aa40-c5fe69ae1f82"
      unitRef="usd">1152000</us-gaap:AccountsPayableRelatedPartiesCurrent>
    <us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty
      contextRef="ia1f93f14e6044577ba1a7b6463b04532_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDUvZnJhZzphOTU0Yjk0OTM3ZjI0YmE2ODhjYmMxYTQzMGE0Njk5Yy90ZXh0cmVnaW9uOmE5NTRiOTQ5MzdmMjRiYTY4OGNiYzFhNDMwYTQ2OTljXzQ4Mg_58b75d07-8827-4c41-9449-c6c3e1a44462"
      unitRef="usd">1258000</us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty>
    <us-gaap:NonmonetaryTransactionsDisclosureTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODQvZnJhZzo4OTcyNWNlM2RiYzI0MGZkYjBiZjUzNmQ4NTQ4MTMwYy90ZXh0cmVnaW9uOjg5NzI1Y2UzZGJjMjQwZmRiMGJmNTM2ZDg1NDgxMzBjXzEzMTc_348c3576-8f15-42c1-af37-9b6079193c61">Non-monetary Transactions &lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company had no non-monetary transactions during the year ended December 31, 2020 or 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 28, 2019, the Company&#160;entered into&#160;two transactions to simultaneously purchase and sell inventory to a third party. The Company purchased cannabis resin from the third party and in turn sold cannabis dry flower to the third party. The transactions involved the exchange of work in progress inventory and were accounted for at the carrying value of inventory transferred by the Company, which equaled the value of the cannabis resin received. No revenue was recognized as a result of this transaction and no gain or loss was recognized in the consolidated statements of net income (loss) and comprehensive income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2019, the Company entered into three transactions to simultaneously purchase and sell inventory to a third party. The Company purchased cannabis resin and cannabis tincture oil and in turn sold cannabis dry flower to the third party. The transactions involved the exchange of work in progress inventory and were accounted for in accordance with ASC 845 Non-monetary transactions at the carrying value of inventory transferred by the Company. $2,300 was recognized in revenue as a result of this transaction and no gain or loss was recognized in the consolidated statements of net income (loss) and comprehensive income (loss).&lt;/span&gt;&lt;/div&gt;</us-gaap:NonmonetaryTransactionsDisclosureTextBlock>
    <cron:NonmonetaryTransactionNumberOfTransactions
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODQvZnJhZzo4OTcyNWNlM2RiYzI0MGZkYjBiZjUzNmQ4NTQ4MTMwYy90ZXh0cmVnaW9uOjg5NzI1Y2UzZGJjMjQwZmRiMGJmNTM2ZDg1NDgxMzBjXzM4NDgyOTA3MDM4ODE_122a355e-f058-42fb-8747-a796c1a9c756"
      unitRef="transaction">0</cron:NonmonetaryTransactionNumberOfTransactions>
    <cron:NonmonetaryTransactionNumberOfTransactions
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODQvZnJhZzo4OTcyNWNlM2RiYzI0MGZkYjBiZjUzNmQ4NTQ4MTMwYy90ZXh0cmVnaW9uOjg5NzI1Y2UzZGJjMjQwZmRiMGJmNTM2ZDg1NDgxMzBjXzM4NDgyOTA3MDM4ODE_679a0420-475d-4347-84bf-8487aa123148"
      unitRef="transaction">0</cron:NonmonetaryTransactionNumberOfTransactions>
    <cron:NonmonetaryTransactionNumberOfTransactions
      contextRef="i91a71d7c7ae04725bf836bbfa7b9724b_D20190328-20190328"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODQvZnJhZzo4OTcyNWNlM2RiYzI0MGZkYjBiZjUzNmQ4NTQ4MTMwYy90ZXh0cmVnaW9uOjg5NzI1Y2UzZGJjMjQwZmRiMGJmNTM2ZDg1NDgxMzBjXzM4NDgyOTA3MDM4Nzc_49263554-3940-4b3b-ac43-2e3503ff20a9"
      unitRef="transaction">2</cron:NonmonetaryTransactionNumberOfTransactions>
    <us-gaap:NonmonetaryTransactionGrossOperatingRevenueRecognized
      contextRef="i91a71d7c7ae04725bf836bbfa7b9724b_D20190328-20190328"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODQvZnJhZzo4OTcyNWNlM2RiYzI0MGZkYjBiZjUzNmQ4NTQ4MTMwYy90ZXh0cmVnaW9uOjg5NzI1Y2UzZGJjMjQwZmRiMGJmNTM2ZDg1NDgxMzBjXzM4NDgyOTA3MDM4Njg_71b89346-d52f-4a87-b601-97a298278e47"
      unitRef="usd">0</us-gaap:NonmonetaryTransactionGrossOperatingRevenueRecognized>
    <us-gaap:NonmonetaryTransactionGainLossRecognizedOnTransfer
      contextRef="i91a71d7c7ae04725bf836bbfa7b9724b_D20190328-20190328"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODQvZnJhZzo4OTcyNWNlM2RiYzI0MGZkYjBiZjUzNmQ4NTQ4MTMwYy90ZXh0cmVnaW9uOjg5NzI1Y2UzZGJjMjQwZmRiMGJmNTM2ZDg1NDgxMzBjXzM4NDgyOTA3MDM4NzI_fdfc41de-1e65-4ccd-981f-49c97046adcf"
      unitRef="usd">0</us-gaap:NonmonetaryTransactionGainLossRecognizedOnTransfer>
    <cron:NonmonetaryTransactionNumberOfTransactions
      contextRef="i1b5d6b4753dd4b52ac5dc0f7319ab8cd_D20190901-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODQvZnJhZzo4OTcyNWNlM2RiYzI0MGZkYjBiZjUzNmQ4NTQ4MTMwYy90ZXh0cmVnaW9uOjg5NzI1Y2UzZGJjMjQwZmRiMGJmNTM2ZDg1NDgxMzBjXzM4NDgyOTA3MDM4ODg_c8a293bb-da19-47ed-bf7c-8f9b69a58c83"
      unitRef="transaction">3</cron:NonmonetaryTransactionNumberOfTransactions>
    <us-gaap:NonmonetaryTransactionGrossOperatingRevenueRecognized
      contextRef="i1b5d6b4753dd4b52ac5dc0f7319ab8cd_D20190901-20190930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODQvZnJhZzo4OTcyNWNlM2RiYzI0MGZkYjBiZjUzNmQ4NTQ4MTMwYy90ZXh0cmVnaW9uOjg5NzI1Y2UzZGJjMjQwZmRiMGJmNTM2ZDg1NDgxMzBjXzM4NDgyOTA3MDM4OTc_cdd0ae9a-82ee-45d2-9818-8eca98f9ccb8"
      unitRef="usd">2300000</us-gaap:NonmonetaryTransactionGrossOperatingRevenueRecognized>
    <us-gaap:NonmonetaryTransactionGainLossRecognizedOnTransfer
      contextRef="i1b5d6b4753dd4b52ac5dc0f7319ab8cd_D20190901-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODQvZnJhZzo4OTcyNWNlM2RiYzI0MGZkYjBiZjUzNmQ4NTQ4MTMwYy90ZXh0cmVnaW9uOjg5NzI1Y2UzZGJjMjQwZmRiMGJmNTM2ZDg1NDgxMzBjXzM4NDgyOTA3MDM5MDc_539a5c50-8a98-4045-852c-780970f9bf0c"
      unitRef="usd">0</us-gaap:NonmonetaryTransactionGainLossRecognizedOnTransfer>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDgvZnJhZzpiYjhkNDkyNjEyYTM0YThjOGI1YmE4ZGM0M2ViZWUyYS90ZXh0cmVnaW9uOmJiOGQ0OTI2MTJhMzRhOGM4YjViYThkYzQzZWJlZTJhXzQzMzQ_c0b54ffd-c381-42a2-b726-0f17473f20c0">Business Combinations &lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 5, 2019, the Company closed the Redwood Acquisition. Redwood manufactures, markets and distributes U.S. hemp-derived supplements and cosmetics product through e-commerce, retail and hospitality channels in the U.S. under the brand Lord Jones&#x2122;. Redwood&#x2019;s products use high quality U.S. hemp extract that retains naturally occurring phytocannabinoids and terpenes found in the plant. The Company plans to leverage Redwood&#x2019;s capabilities to capitalize on the significant demand to further create and scale U.S. hemp-derived consumer products and brands.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2019, the Company acquired all the issued and outstanding shares of each of the four Redwood operating subsidiaries for an aggregate consideration of $283,300, which included $227,191 in cash and 5,086,586 common shares of the Company with a fair value of $56,109. The fair value of the shares issued as part of the consideration paid was based on the volume weighted average trading price of the common shares on Nasdaq on each of the ten consecutive trading days prior to the date of the Membership Interest Purchase Agreement dated August 1, 2019 (the &#x201c;MIPA&#x201d;), by and among the Company, Redwood Holding Group, LLC, and certain Key Persons solely for the purposes as described in the MIPA, at C$14.74 per share. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Redwood Acquisition was unanimously approved by the board of directors of Redwood Holdings Group, LLC and by the Board following the unanimous recommendation of a special committee of independent directors (&#x201c;Special Committee&#x201d;). A Special Committee composed entirely of independent directors of the Company was formed to evaluate and make recommendations to the Board since one of our directors, Jason Adler, and Michael Gorenstein, our Executive Chairman and former President and Chief Executive Officer, each held an indirect interest in Redwood Holding Group, LLC by way of their interest in certain funds affiliated with Gotham Green Partners, which funds were equity holders in Redwood Holding Group, LLC. Jason Adler is the co-founder and Managing Member of Gotham Green Partners, a private equity firm focused primarily on early-stage investing in companies in the cannabis industry, and Michael Gorenstein is a co-founder and non-managing Member of Gotham Green Partners. The Special Committee engaged Perella Weinberg Partners LP as financial advisor.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Redwood Acquisition was accounted for as a business combination as defined in ASC 805 Business Combinations. As a result of the change in control of Redwood, the assets and liabilities of Redwood are recorded at fair value in the consolidated financial statements of the Company. The following table summarizes the Company&#x2019;s finalized allocation of the purchase price to assets acquired and liabilities assumed at the acquisition date. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.794%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.685%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.608%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 5, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair value of net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-top:1pt;padding-left:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-top:1pt;padding-left:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,688)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;The fair value of acquired accounts receivable is $647. No loss allowance was recognized on acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:1pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Intangible assets include the fair value of brand name of $64,000, the remaining balance relates to software.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the year ended December 31, 2019, acquisition-related costs of $8,531 were expensed. These costs are included in the consolidated statement of net income (loss) in financing and transaction costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The goodwill recognized represents the excess over the fair value of the net tangible and intangible assets acquired as a part of the Redwood acquisition. This goodwill is attributable to the expertise and reputation of the assembled workforce acquired, the expected synergies, and other intangible assets that do not qualify for separate recognition. The goodwill is not deductible for income tax purposes. The Relief-from-Royalty Method was used to value the intangible asset relating to the Lord Jones&#x2122; brand. Significant inputs include discount rate, growth rates, and cash flow projections.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the period from September 5, 2019 to December 31, 2019, the Company recognized $3,364 in revenues and a net loss of $2,613 from Redwood operations. If the acquisition had occurred on January 1, 2019, the Company estimates that for the year ended December 31, 2019, it would have recorded an increase of $12,266 in revenues and a decrease of $1,112 in net income and that for the year ended December 31, 2018, it would have recorded an increase of $7,630 in revenues and an increase of $1,533 in net income. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no business combinations during the years ended December 31, 2020 or December 31, 2018.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="i09f6b65a08b548dea26ecf66cee73299_D20190905-20190905"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDgvZnJhZzpiYjhkNDkyNjEyYTM0YThjOGI1YmE4ZGM0M2ViZWUyYS90ZXh0cmVnaW9uOmJiOGQ0OTI2MTJhMzRhOGM4YjViYThkYzQzZWJlZTJhXzY1Mg_ccab5633-6da3-4d84-83fd-98eb17379108"
      unitRef="subsidiary">4</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i09f6b65a08b548dea26ecf66cee73299_D20190905-20190905"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDgvZnJhZzpiYjhkNDkyNjEyYTM0YThjOGI1YmE4ZGM0M2ViZWUyYS90ZXh0cmVnaW9uOmJiOGQ0OTI2MTJhMzRhOGM4YjViYThkYzQzZWJlZTJhXzEwOTk1MTE2MzIyMDU_372c41be-9913-4515-9e01-85b45301b3da"
      unitRef="usd">283300000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i09f6b65a08b548dea26ecf66cee73299_D20190905-20190905"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDgvZnJhZzpiYjhkNDkyNjEyYTM0YThjOGI1YmE4ZGM0M2ViZWUyYS90ZXh0cmVnaW9uOmJiOGQ0OTI2MTJhMzRhOGM4YjViYThkYzQzZWJlZTJhXzEwOTk1MTE2MzIyMDg_d2e62918-3660-431b-8a62-ede7ef90def2"
      unitRef="usd">227191000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="i09f6b65a08b548dea26ecf66cee73299_D20190905-20190905"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDgvZnJhZzpiYjhkNDkyNjEyYTM0YThjOGI1YmE4ZGM0M2ViZWUyYS90ZXh0cmVnaW9uOmJiOGQ0OTI2MTJhMzRhOGM4YjViYThkYzQzZWJlZTJhXzEwOTk1MTE2MzIyMTE_613a930a-ea38-4725-83ee-d8ffcbd21bad"
      unitRef="shares">5086586</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
      contextRef="i09f6b65a08b548dea26ecf66cee73299_D20190905-20190905"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDgvZnJhZzpiYjhkNDkyNjEyYTM0YThjOGI1YmE4ZGM0M2ViZWUyYS90ZXh0cmVnaW9uOmJiOGQ0OTI2MTJhMzRhOGM4YjViYThkYzQzZWJlZTJhXzEwOTk1MTE2MzIyMTQ_494db56f-cc87-4f6c-8558-996011710e1b"
      unitRef="usd">56109000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="ide715df8e0104988800b3158e6323d0b_I20190905"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDgvZnJhZzpiYjhkNDkyNjEyYTM0YThjOGI1YmE4ZGM0M2ViZWUyYS90ZXh0cmVnaW9uOmJiOGQ0OTI2MTJhMzRhOGM4YjViYThkYzQzZWJlZTJhXzEyMzQ_4caa017e-b744-44ca-905d-293fa99deae4"
      unitRef="cadPerShare">14.74</us-gaap:BusinessAcquisitionSharePrice>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDgvZnJhZzpiYjhkNDkyNjEyYTM0YThjOGI1YmE4ZGM0M2ViZWUyYS90ZXh0cmVnaW9uOmJiOGQ0OTI2MTJhMzRhOGM4YjViYThkYzQzZWJlZTJhXzQzMzU_fb37308b-9de4-4eb2-8fc6-b627d32757da">The following table summarizes the Company&#x2019;s finalized allocation of the purchase price to assets acquired and liabilities assumed at the acquisition date. &lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.794%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.685%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.608%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 5, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair value of net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-top:1pt;padding-left:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-top:1pt;padding-left:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,688)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;The fair value of acquired accounts receivable is $647. No loss allowance was recognized on acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:1pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Intangible assets include the fair value of brand name of $64,000, the remaining balance relates to software.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="ide715df8e0104988800b3158e6323d0b_I20190905"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDgvZnJhZzpiYjhkNDkyNjEyYTM0YThjOGI1YmE4ZGM0M2ViZWUyYS90YWJsZTowOTc2Y2UwMTA4NGE0ZTkxOWMzN2M2NTExMDQ1OWJlOC90YWJsZXJhbmdlOjA5NzZjZTAxMDg0YTRlOTE5YzM3YzY1MTEwNDU5YmU4XzItNC0xLTEtMA_f0ade22b-ac42-47d7-ad54-d3caffe99c55"
      unitRef="usd">2896000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="ide715df8e0104988800b3158e6323d0b_I20190905"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDgvZnJhZzpiYjhkNDkyNjEyYTM0YThjOGI1YmE4ZGM0M2ViZWUyYS90YWJsZTowOTc2Y2UwMTA4NGE0ZTkxOWMzN2M2NTExMDQ1OWJlOC90YWJsZXJhbmdlOjA5NzZjZTAxMDg0YTRlOTE5YzM3YzY1MTEwNDU5YmU4XzMtNC0xLTEtMA_3dc0a422-e119-468a-a980-36fcb1917575"
      unitRef="usd">647000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="ide715df8e0104988800b3158e6323d0b_I20190905"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDgvZnJhZzpiYjhkNDkyNjEyYTM0YThjOGI1YmE4ZGM0M2ViZWUyYS90YWJsZTowOTc2Y2UwMTA4NGE0ZTkxOWMzN2M2NTExMDQ1OWJlOC90YWJsZXJhbmdlOjA5NzZjZTAxMDg0YTRlOTE5YzM3YzY1MTEwNDU5YmU4XzQtNC0xLTEtMA_68bc6001-0a05-466b-bd6f-f8aad621a03e"
      unitRef="usd">265000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="ide715df8e0104988800b3158e6323d0b_I20190905"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDgvZnJhZzpiYjhkNDkyNjEyYTM0YThjOGI1YmE4ZGM0M2ViZWUyYS90YWJsZTowOTc2Y2UwMTA4NGE0ZTkxOWMzN2M2NTExMDQ1OWJlOC90YWJsZXJhbmdlOjA5NzZjZTAxMDg0YTRlOTE5YzM3YzY1MTEwNDU5YmU4XzUtNC0xLTEtMA_a46d8a30-0eda-4537-b763-4af0577c083c"
      unitRef="usd">2806000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="ide715df8e0104988800b3158e6323d0b_I20190905"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDgvZnJhZzpiYjhkNDkyNjEyYTM0YThjOGI1YmE4ZGM0M2ViZWUyYS90YWJsZTowOTc2Y2UwMTA4NGE0ZTkxOWMzN2M2NTExMDQ1OWJlOC90YWJsZXJhbmdlOjA5NzZjZTAxMDg0YTRlOTE5YzM3YzY1MTEwNDU5YmU4XzYtNC0xLTEtMA_a4e01a96-59fc-4280-8b67-275a3d788184"
      unitRef="usd">1890000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <cron:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets
      contextRef="ide715df8e0104988800b3158e6323d0b_I20190905"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDgvZnJhZzpiYjhkNDkyNjEyYTM0YThjOGI1YmE4ZGM0M2ViZWUyYS90YWJsZTowOTc2Y2UwMTA4NGE0ZTkxOWMzN2M2NTExMDQ1OWJlOC90YWJsZXJhbmdlOjA5NzZjZTAxMDg0YTRlOTE5YzM3YzY1MTEwNDU5YmU4XzctNC0xLTEtMA_5978c1df-a499-41ea-b907-911f0a36e4a4"
      unitRef="usd">3533000</cron:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="ide715df8e0104988800b3158e6323d0b_I20190905"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDgvZnJhZzpiYjhkNDkyNjEyYTM0YThjOGI1YmE4ZGM0M2ViZWUyYS90YWJsZTowOTc2Y2UwMTA4NGE0ZTkxOWMzN2M2NTExMDQ1OWJlOC90YWJsZXJhbmdlOjA5NzZjZTAxMDg0YTRlOTE5YzM3YzY1MTEwNDU5YmU4XzgtNC0xLTEtMA_1eb6b904-b507-4ec2-a510-634e6ca13bad"
      unitRef="usd">64037000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:Goodwill
      contextRef="ide715df8e0104988800b3158e6323d0b_I20190905"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDgvZnJhZzpiYjhkNDkyNjEyYTM0YThjOGI1YmE4ZGM0M2ViZWUyYS90YWJsZTowOTc2Y2UwMTA4NGE0ZTkxOWMzN2M2NTExMDQ1OWJlOC90YWJsZXJhbmdlOjA5NzZjZTAxMDg0YTRlOTE5YzM3YzY1MTEwNDU5YmU4XzktNC0xLTEtMA_7e584a19-a70f-4ebc-b189-9b61c87a0245"
      unitRef="usd">213414000</us-gaap:Goodwill>
    <cron:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAndAccruedLiabilities
      contextRef="ide715df8e0104988800b3158e6323d0b_I20190905"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDgvZnJhZzpiYjhkNDkyNjEyYTM0YThjOGI1YmE4ZGM0M2ViZWUyYS90YWJsZTowOTc2Y2UwMTA4NGE0ZTkxOWMzN2M2NTExMDQ1OWJlOC90YWJsZXJhbmdlOjA5NzZjZTAxMDg0YTRlOTE5YzM3YzY1MTEwNDU5YmU4XzEwLTQtMS0xLTA_26308448-1981-4867-b875-1a6cdfc4c101"
      unitRef="usd">2688000</cron:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAndAccruedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation
      contextRef="ide715df8e0104988800b3158e6323d0b_I20190905"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDgvZnJhZzpiYjhkNDkyNjEyYTM0YThjOGI1YmE4ZGM0M2ViZWUyYS90YWJsZTowOTc2Y2UwMTA4NGE0ZTkxOWMzN2M2NTExMDQ1OWJlOC90YWJsZXJhbmdlOjA5NzZjZTAxMDg0YTRlOTE5YzM3YzY1MTEwNDU5YmU4XzExLTQtMS0xLTA_8ae3518a-ed28-4465-bc1a-b0a82a82bc73"
      unitRef="usd">3500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="ide715df8e0104988800b3158e6323d0b_I20190905"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDgvZnJhZzpiYjhkNDkyNjEyYTM0YThjOGI1YmE4ZGM0M2ViZWUyYS90YWJsZTowOTc2Y2UwMTA4NGE0ZTkxOWMzN2M2NTExMDQ1OWJlOC90YWJsZXJhbmdlOjA5NzZjZTAxMDg0YTRlOTE5YzM3YzY1MTEwNDU5YmU4XzEyLTQtMS0xLTA_cef5fe19-a8f0-4420-b094-f507331db4d8"
      unitRef="usd">283300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="ide715df8e0104988800b3158e6323d0b_I20190905"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDgvZnJhZzpiYjhkNDkyNjEyYTM0YThjOGI1YmE4ZGM0M2ViZWUyYS90ZXh0cmVnaW9uOmJiOGQ0OTI2MTJhMzRhOGM4YjViYThkYzQzZWJlZTJhXzEwOTk1MTE2MzIyMDE_3dc0a422-e119-468a-a980-36fcb1917575"
      unitRef="usd">647000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationAcquiredReceivablesEstimatedUncollectible
      contextRef="ide715df8e0104988800b3158e6323d0b_I20190905"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDgvZnJhZzpiYjhkNDkyNjEyYTM0YThjOGI1YmE4ZGM0M2ViZWUyYS90ZXh0cmVnaW9uOmJiOGQ0OTI2MTJhMzRhOGM4YjViYThkYzQzZWJlZTJhXzI3ODg_3dbc1afb-f442-4a63-91b1-9b093076ad28"
      unitRef="usd">0</us-gaap:BusinessCombinationAcquiredReceivablesEstimatedUncollectible>
    <us-gaap:IndefinitelivedIntangibleAssetsAcquired
      contextRef="ia1f38277cbb04c8aa6676044144d8fa7_D20190905-20190905"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDgvZnJhZzpiYjhkNDkyNjEyYTM0YThjOGI1YmE4ZGM0M2ViZWUyYS90ZXh0cmVnaW9uOmJiOGQ0OTI2MTJhMzRhOGM4YjViYThkYzQzZWJlZTJhXzI5MDU_524c23a5-85b4-427e-9d77-aeef396e44d5"
      unitRef="usd">64000000</us-gaap:IndefinitelivedIntangibleAssetsAcquired>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i8b55b8b5cf3546f08aaece9738addf85_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDgvZnJhZzpiYjhkNDkyNjEyYTM0YThjOGI1YmE4ZGM0M2ViZWUyYS90ZXh0cmVnaW9uOmJiOGQ0OTI2MTJhMzRhOGM4YjViYThkYzQzZWJlZTJhXzM4NDgyOTA3MDE3MzI_b3c363a3-5d81-4c99-9e44-78ad253872b6"
      unitRef="usd">8531000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="ide715df8e0104988800b3158e6323d0b_I20190905"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDgvZnJhZzpiYjhkNDkyNjEyYTM0YThjOGI1YmE4ZGM0M2ViZWUyYS90ZXh0cmVnaW9uOmJiOGQ0OTI2MTJhMzRhOGM4YjViYThkYzQzZWJlZTJhXzM1NDA_d08ce58f-c3bf-43cc-8a62-5a020820f73a"
      unitRef="usd">0</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual
      contextRef="i7c36b1e540204e59a5d80864743da551_D20190905-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDgvZnJhZzpiYjhkNDkyNjEyYTM0YThjOGI1YmE4ZGM0M2ViZWUyYS90ZXh0cmVnaW9uOmJiOGQ0OTI2MTJhMzRhOGM4YjViYThkYzQzZWJlZTJhXzM4NTI_78b3c242-74f3-4f59-a552-aec098397b7f"
      unitRef="usd">3364000</us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual>
    <us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual
      contextRef="i7c36b1e540204e59a5d80864743da551_D20190905-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDgvZnJhZzpiYjhkNDkyNjEyYTM0YThjOGI1YmE4ZGM0M2ViZWUyYS90ZXh0cmVnaW9uOmJiOGQ0OTI2MTJhMzRhOGM4YjViYThkYzQzZWJlZTJhXzM4ODU_70e4e443-a40f-4ca4-89ed-28359da2dfb3"
      unitRef="usd">-2613000</us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="i8b55b8b5cf3546f08aaece9738addf85_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDgvZnJhZzpiYjhkNDkyNjEyYTM0YThjOGI1YmE4ZGM0M2ViZWUyYS90ZXh0cmVnaW9uOmJiOGQ0OTI2MTJhMzRhOGM4YjViYThkYzQzZWJlZTJhXzQwNTE_ce0b642c-14a5-46c1-b720-4f8c77b965d2"
      unitRef="usd">12266000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="i8b55b8b5cf3546f08aaece9738addf85_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDgvZnJhZzpiYjhkNDkyNjEyYTM0YThjOGI1YmE4ZGM0M2ViZWUyYS90ZXh0cmVnaW9uOmJiOGQ0OTI2MTJhMzRhOGM4YjViYThkYzQzZWJlZTJhXzQwODQ_2775d202-3909-4a52-b4fd-375696243a35"
      unitRef="usd">1112000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="ia8399af2583a41c49612e5d2b0241e7e_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDgvZnJhZzpiYjhkNDkyNjEyYTM0YThjOGI1YmE4ZGM0M2ViZWUyYS90ZXh0cmVnaW9uOmJiOGQ0OTI2MTJhMzRhOGM4YjViYThkYzQzZWJlZTJhXzQxODY_88168807-4d8b-4ba6-a718-420571a933d2"
      unitRef="usd">7630000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="ia8399af2583a41c49612e5d2b0241e7e_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDgvZnJhZzpiYjhkNDkyNjEyYTM0YThjOGI1YmE4ZGM0M2ViZWUyYS90ZXh0cmVnaW9uOmJiOGQ0OTI2MTJhMzRhOGM4YjViYThkYzQzZWJlZTJhXzQyMjA_60864336-c3c3-472e-b5ca-539447a0a59b"
      unitRef="usd">1533000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDgvZnJhZzpiYjhkNDkyNjEyYTM0YThjOGI1YmE4ZGM0M2ViZWUyYS90ZXh0cmVnaW9uOmJiOGQ0OTI2MTJhMzRhOGM4YjViYThkYzQzZWJlZTJhXzQyNTA_0cbba91c-6f40-460b-8a7b-1920e0478d9e"
      unitRef="business">0</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNDgvZnJhZzpiYjhkNDkyNjEyYTM0YThjOGI1YmE4ZGM0M2ViZWUyYS90ZXh0cmVnaW9uOmJiOGQ0OTI2MTJhMzRhOGM4YjViYThkYzQzZWJlZTJhXzQyNTA_c9ef6f8f-1cb0-4d9a-9136-081f1a134b34"
      unitRef="business">0</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjAvZnJhZzo1ZDZhMzc1NWNiNTA0YmM2YWQ5NjM0MGRhNTNmYjYwMC90ZXh0cmVnaW9uOjVkNmEzNzU1Y2I1MDRiYzZhZDk2MzQwZGE1M2ZiNjAwXzExNTc_80eac4ea-a766-47fe-8c75-2ddce07ed8f9">Repurposing Charges&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December 31, 2019, the Company commenced initiatives to better align its evolving business and its strategy. Certain facilities at the Peace Naturals campus were repurposed from cultivation activities to provide for the following activities: additional R&amp;amp;D activities focused on new technologies for value-added product manufacturing; production and manufacturing of derivative products; and increased vault and warehousing capabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The activities associated with the repurposing were completed as of December&#160;31, 2019. The following table presents information associated with this plan:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December&#160;31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee termination benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment costs associated with plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December 31, 2019, an inventory write-down associated with the repurposing cost of $1,940 was included as part of inventory write-down on the consolidated statements of net income (loss) and comprehensive income (loss). The Company did not incur any further significant costs related to the repurposing activities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No repurposing costs were incurred during the years ended December 31, 2020 or December 31, 2018. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2020, there was no accrued liability associated with the Company&#x2019;s repurposing initiative (December&#160;31, 2019 - $907). All repurposing related charges were incurred within the Rest of World segment.&lt;/span&gt;&lt;/div&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjAvZnJhZzo1ZDZhMzc1NWNiNTA0YmM2YWQ5NjM0MGRhNTNmYjYwMC90ZXh0cmVnaW9uOjVkNmEzNzU1Y2I1MDRiYzZhZDk2MzQwZGE1M2ZiNjAwXzExNTg_fc3a6e96-29a2-40dd-9e90-dde47779f11e">The following table presents information associated with this plan:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December&#160;31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee termination benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment costs associated with plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <us-gaap:SeveranceCosts1
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjAvZnJhZzo1ZDZhMzc1NWNiNTA0YmM2YWQ5NjM0MGRhNTNmYjYwMC90YWJsZTo1MmNkN2RiMWE1ZjI0NGMwOGMxMzRkZDI0MDEzYzI1OC90YWJsZXJhbmdlOjUyY2Q3ZGIxYTVmMjQ0YzA4YzEzNGRkMjQwMTNjMjU4XzEtMS0xLTEtMA_2e7aff5c-484d-49e2-b1e7-9c87be93e2df"
      unitRef="usd">889000</us-gaap:SeveranceCosts1>
    <us-gaap:AssetImpairmentCharges
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjAvZnJhZzo1ZDZhMzc1NWNiNTA0YmM2YWQ5NjM0MGRhNTNmYjYwMC90YWJsZTo1MmNkN2RiMWE1ZjI0NGMwOGMxMzRkZDI0MDEzYzI1OC90YWJsZXJhbmdlOjUyY2Q3ZGIxYTVmMjQ0YzA4YzEzNGRkMjQwMTNjMjU4XzItMS0xLTEtMA_dfbe51bb-e1ff-436e-a1fc-3acf35fd3717"
      unitRef="usd">4439000</us-gaap:AssetImpairmentCharges>
    <us-gaap:RestructuringSettlementAndImpairmentProvisions
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjAvZnJhZzo1ZDZhMzc1NWNiNTA0YmM2YWQ5NjM0MGRhNTNmYjYwMC90YWJsZTo1MmNkN2RiMWE1ZjI0NGMwOGMxMzRkZDI0MDEzYzI1OC90YWJsZXJhbmdlOjUyY2Q3ZGIxYTVmMjQ0YzA4YzEzNGRkMjQwMTNjMjU4XzMtMS0xLTEtMA_c50075be-9887-4b37-8480-1e2a18a71efe"
      unitRef="usd">5328000</us-gaap:RestructuringSettlementAndImpairmentProvisions>
    <us-gaap:InventoryWriteDown
      contextRef="i82d2a5bf06814c99a17bdeb480f3837f_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjAvZnJhZzo1ZDZhMzc1NWNiNTA0YmM2YWQ5NjM0MGRhNTNmYjYwMC90ZXh0cmVnaW9uOjVkNmEzNzU1Y2I1MDRiYzZhZDk2MzQwZGE1M2ZiNjAwXzEyNjQ0MzgzNzIwODA2_a369ee18-95e4-4a0d-a2ad-025bd4ccb2d2"
      unitRef="usd">1940000</us-gaap:InventoryWriteDown>
    <us-gaap:RestructuringSettlementAndImpairmentProvisions
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjAvZnJhZzo1ZDZhMzc1NWNiNTA0YmM2YWQ5NjM0MGRhNTNmYjYwMC90ZXh0cmVnaW9uOjVkNmEzNzU1Y2I1MDRiYzZhZDk2MzQwZGE1M2ZiNjAwXzg3OTYwOTMwMjQ0MTM_503e02bc-192e-4f95-827a-2c08a28f82d9"
      unitRef="usd">0</us-gaap:RestructuringSettlementAndImpairmentProvisions>
    <us-gaap:RestructuringSettlementAndImpairmentProvisions
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjAvZnJhZzo1ZDZhMzc1NWNiNTA0YmM2YWQ5NjM0MGRhNTNmYjYwMC90ZXh0cmVnaW9uOjVkNmEzNzU1Y2I1MDRiYzZhZDk2MzQwZGE1M2ZiNjAwXzg3OTYwOTMwMjQ0MTM_f0445c26-94f9-40a1-a7d2-5f8183865800"
      unitRef="usd">0</us-gaap:RestructuringSettlementAndImpairmentProvisions>
    <us-gaap:RestructuringReserve
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjAvZnJhZzo1ZDZhMzc1NWNiNTA0YmM2YWQ5NjM0MGRhNTNmYjYwMC90ZXh0cmVnaW9uOjVkNmEzNzU1Y2I1MDRiYzZhZDk2MzQwZGE1M2ZiNjAwXzg3OTYwOTMwMjQ0MjI_d27f4d94-08cd-48f7-b3a5-62e94f469159"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xNjAvZnJhZzo1ZDZhMzc1NWNiNTA0YmM2YWQ5NjM0MGRhNTNmYjYwMC90ZXh0cmVnaW9uOjVkNmEzNzU1Y2I1MDRiYzZhZDk2MzQwZGE1M2ZiNjAwXzEyNjQ0MzgzNzIwOTI1_a508deb0-e128-45e8-88f8-3a13ec70d340"
      unitRef="usd">907000</us-gaap:RestructuringReserve>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90ZXh0cmVnaW9uOjkxYTQyNWEyY2NhZTQ0MjRhZjI5NDM4OTAwZTRkZDU0XzI5OTU_d4c84ed2-edb8-430c-afa3-658767ba9752">Segment Information&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Segment reporting is prepared on the same basis that the Company&#x2019;s chief operating decision makers (the &#x201c;CODMs&#x201d;) manage the business, make operating decisions and assess the Company&#x2019;s performance. For the years ended December&#160;31, 2020 and December&#160;31, 2019, the Company determined that it has the following two reportable segments: United States and Rest of World. &lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The United States operating segment consists of the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;manufacture and distribution of hemp-derived CBD infused products. &lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Rest of World operating segment is involved in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These two segments represent the geographic regions in which the Company operates and the different product offerings within each geographic region. The results of each segment are regularly reviewed by the CODMs to assess the performance of the segment and make decisions regarding the allocation of resources. The CODMs review adjusted earnings (loss) before interest, tax, depreciation and amortization (&#x201c;Adjusted EBITDA&#x201d;) as the measure of segment profit or loss to evaluate performance of and allocate resources for its reportable segments. Adjusted EBITDA is defined as earnings before interest, tax, depreciation, non-cash items and items that do not reflect management&#x2019;s assessment of on-going business performance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reporting by operating segments follows the same accounting policies as those used to prepare the consolidated financial statements. The operating segments are presented in accordance with the same criteria used for internal reporting prepared for the CODMs. Inter-segment transactions are recorded at the stated values as agreed to by the segments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Segment data was as follows for the year ended December&#160;31, 2020: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.455%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.349%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated statements of net income (loss) and comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cannabis flower&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cannabis extracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Share of loss from equity accounted investees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,510)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,510)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(152)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Loss from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(650)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(650)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjusted EBITDA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(28,019)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(98,349)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20,885)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(147,253)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated balance sheets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;253,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;388,351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,283,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,925,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Investments in equity accounted investees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;178,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;179,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Purchase of property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Segment data was as follows for the year ended December&#160;31, 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.464%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.464%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.464%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.464%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.328%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated statements of net income (loss) and comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cannabis flower&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cannabis extracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Share of loss from equity accounted investees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,009)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,009)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,244)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,244)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Loss from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(363)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(363)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjusted EBITDA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,703)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(84,826)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(11,779)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(98,308)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated balance sheets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;293,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;309,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,486,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,090,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Investments in equity accounted investees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;213,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;214,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Purchase of property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Segment data was as follows for the year ended December&#160;31, 2018: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.594%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.188%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.349%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated statements of net income (loss) and comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cannabis flower&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cannabis extracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Share of loss from equity accounted investees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(723)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(723)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(139)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(139)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Loss from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(894)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(894)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjusted EBITDA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(10,357)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(10,357)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated balance sheets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;183,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;183,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Investments in equity accounted investees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Purchase of property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;88,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;88,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Adjusted EBITDA is reconciled to net income (loss) as follows for the years ended December&#160;31, 2020, 2019 and 2018:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.486%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands of U.S. dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;US&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;ROW&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Corporate&lt;br/&gt;Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(77,368)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(30,573)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(75,270)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense (income), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(18,433)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(18,415)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Impairment loss on goodwill and intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Financing and transaction costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gain on revaluation of derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(129,254)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(129,254)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gain on disposal of other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,789)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,789)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Share of loss from equity accounted investees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Loss from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other loss (income)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Review costs related to restatement of 2019 interim financial statements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Share-based payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjusted EBIT&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(28,253)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(105,160)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20,885)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(154,298)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjusted EBITDA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(28,019)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(98,349)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20,885)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(147,253)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands of U.S. dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December&#160;31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;US&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;ROW&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Corporate&lt;br/&gt;Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,070)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,180,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(11,597)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,165,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(27,963)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(27,969)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Impairment loss on goodwill and intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Repurposing charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Financing and transaction costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gain on revaluation of derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,276,819)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,276,819)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gain on disposal of other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(16,277)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(16,277)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Share of loss from equity accounted investees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Loss from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other loss (income)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(197)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(182)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(197)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Share-based payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjusted EBIT&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,877)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(88,565)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(11,779)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(102,221)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjusted EBITDA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,703)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(84,826)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(11,779)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(98,308)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.372%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.901%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands of U.S. dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(21,817)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(81)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Loss (gain) on disposal of other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(164)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Share of loss (income) from equity accounted investees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Loss from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Share-based payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjusted EBIT&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12,294)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjusted EBITDA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(10,357)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sources of net revenue were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.594%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cannabis flower&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cannabis extracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net revenue attributed to a geographic region based on the location of the customer were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.594%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canada&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other countries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment assets were physically located in the following geographic regions: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.594%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canada&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other countries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company sells products through a limited number of major customers. Major customers are defined as customers that each individually accounted for greater than 10% of the Company&#x2019;s annual revenues and greater than 10% of accounts receivable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;United States&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the years ended December&#160;31, 2020 and December&#160;31, 2019, the Company had no major customers in the U.S. segment. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, $65 in expected credit losses has been recognized on receivables from contract with customers (December&#160;31, 2019 &#x2013; $12). Refer to Note 23(a).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Rest of World&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2020, the Company earned a total net revenue before excise taxes of $34,295 from four major customers (December&#160;31, 2019 &#x2013; $7,597; December&#160;31, 2018 &#x2013; $2,186 from two and one major customers, respectively), accounting for 63% of the Company&#x2019;s revenues (December&#160;31, 2019 &#x2013; 32%; December&#160;31, 2018 &#x2013; 17%).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, $9 (December&#160;31, 2019 &#x2013; $124; December&#160;31, 2018 &#x2013; $nil) in expected credit losses has been recognized on receivables from contract with customers. Refer to Note 23(a).&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90ZXh0cmVnaW9uOjkxYTQyNWEyY2NhZTQ0MjRhZjI5NDM4OTAwZTRkZDU0XzI4OQ_2a71fa80-4162-4af6-9361-0fa67c035b36"
      unitRef="segment">2</us-gaap:NumberOfReportableSegments>
    <us-gaap:NumberOfReportableSegments
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90ZXh0cmVnaW9uOjkxYTQyNWEyY2NhZTQ0MjRhZjI5NDM4OTAwZTRkZDU0XzY0Nw_5de47f8a-8724-423b-94e7-84600a840f97"
      unitRef="segment">2</us-gaap:NumberOfReportableSegments>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90ZXh0cmVnaW9uOjkxYTQyNWEyY2NhZTQ0MjRhZjI5NDM4OTAwZTRkZDU0XzIzNjM5NTAwMDAyNDY2_c0b8bd90-11b0-4f60-865a-0555338e3986">&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Segment data was as follows for the year ended December&#160;31, 2020: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.455%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.349%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated statements of net income (loss) and comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cannabis flower&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cannabis extracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Share of loss from equity accounted investees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,510)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,510)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(152)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Loss from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(650)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(650)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjusted EBITDA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(28,019)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(98,349)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20,885)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(147,253)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated balance sheets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;253,745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;388,351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,283,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,925,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Investments in equity accounted investees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;178,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;179,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Purchase of property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Segment data was as follows for the year ended December&#160;31, 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.464%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.464%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.464%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.464%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.328%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated statements of net income (loss) and comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cannabis flower&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cannabis extracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Share of loss from equity accounted investees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,009)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,009)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,244)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,244)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Loss from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(363)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(363)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjusted EBITDA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,703)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(84,826)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(11,779)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(98,308)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated balance sheets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;293,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;309,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,486,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,090,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Investments in equity accounted investees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;213,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;214,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Purchase of property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Segment data was as follows for the year ended December&#160;31, 2018: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.594%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.188%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.349%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated statements of net income (loss) and comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cannabis flower&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cannabis extracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Share of loss from equity accounted investees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(723)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(723)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(139)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(139)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Loss from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(894)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(894)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjusted EBITDA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(10,357)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(10,357)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated balance sheets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;183,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;183,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Investments in equity accounted investees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Purchase of property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;88,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;88,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Adjusted EBITDA is reconciled to net income (loss) as follows for the years ended December&#160;31, 2020, 2019 and 2018:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.486%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands of U.S. dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;US&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;ROW&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Corporate&lt;br/&gt;Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(77,368)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(30,573)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(75,270)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest expense (income), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(18,433)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(18,415)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Impairment loss on goodwill and intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Financing and transaction costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gain on revaluation of derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(129,254)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(129,254)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gain on disposal of other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,789)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,789)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Share of loss from equity accounted investees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Loss from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other loss (income)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Review costs related to restatement of 2019 interim financial statements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Share-based payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjusted EBIT&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(28,253)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(105,160)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20,885)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(154,298)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjusted EBITDA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(28,019)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(98,349)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(20,885)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(147,253)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands of U.S. dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December&#160;31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;US&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;ROW&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Corporate&lt;br/&gt;Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,070)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,180,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(11,597)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,165,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(27,963)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(27,969)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Impairment loss on goodwill and intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Repurposing charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Financing and transaction costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gain on revaluation of derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,276,819)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,276,819)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gain on disposal of other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(16,277)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(16,277)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Share of loss from equity accounted investees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Loss from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other loss (income)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(197)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(182)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(197)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Share-based payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjusted EBIT&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,877)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(88,565)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(11,779)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(102,221)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjusted EBITDA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,703)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(84,826)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(11,779)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(98,308)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.372%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.901%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands of U.S. dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(21,817)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Interest income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(81)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Loss (gain) on disposal of other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(164)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Share of loss (income) from equity accounted investees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Loss from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Share-based payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjusted EBIT&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12,294)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adjusted EBITDA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(10,357)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sources of net revenue were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.594%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cannabis flower&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cannabis extracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic5679f6a0de14f3187b78de4a56cf6f2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzMtMi0xLTEtMA_ad4f7c38-ee5a-4a84-9b9a-6b10588fafa7"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icb3e170b4cfb469091d30d5359ec73e7_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzMtNC0xLTEtMA_10442920-4b8a-4fbe-b429-e35c4153d496"
      unitRef="usd">27932000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic74b0207681843f4ae87a38e8e52aa6c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzMtNi0xLTEtMA_ca33d0de-c124-42f6-9c0d-ea892d5b1244"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ieb7e744f257046829976b63a309059b9_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzMtOC0xLTEtMA_f8be79fc-c0ac-401f-9556-ce875164d395"
      unitRef="usd">27932000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i73f1c6d398cd46d4acef80d0079dbfb5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzQtMi0xLTEtMA_23e93f8e-ae76-46d9-9598-77bdab4afd9c"
      unitRef="usd">9495000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i86784f31af7f422abd4f659805b08838_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzQtNC0xLTEtMA_5caeea29-875b-4bbe-8604-28a53461522c"
      unitRef="usd">8759000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4b0b9f9e9cf7455390995395ccc1002a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzQtNi0xLTEtMA_fa368dae-52a8-4a0d-82ec-1d6881e86933"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i158da074fdac41459e9ec56ee32c9222_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzQtOC0xLTEtMA_3bcd992c-2957-4fb4-a146-096461e22479"
      unitRef="usd">18254000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i45f14c47e08249fa81b790dc77e17686_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzUtMi0xLTEtMA_1d174149-3024-4e60-b942-38e93401036f"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia9065255599649529185c91762527139_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzUtNC0xLTEtMA_70cf2737-b3e6-4655-a400-6347cb38e57b"
      unitRef="usd">533000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5db08a8f1b08405081996c824923fc8d_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzUtNi0xLTEtMA_12b75804-b53a-4c8d-8991-357734af4ca0"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i63f66899247a46fa95fe02f9bd08dfaa_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzUtOC0xLTEtMA_3f070988-6e00-4395-9028-6a14ca8407f6"
      unitRef="usd">533000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6d31023501b14c078a65f246b312debe_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzYtMi0xLTEtMA_76523a93-7bf5-4aa7-b38d-4937ec7830db"
      unitRef="usd">9495000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie5954e81faf64c3ba7298da392a8d7ee_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzYtNC0xLTEtMA_4e03e3c7-fd6c-491a-a728-9f4f67467b2d"
      unitRef="usd">37224000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic3097ac22f054b5ebd188c0484e23f18_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzYtNi0xLTEtMA_fd290bed-3190-461f-a8dd-318e591e568a"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzYtOC0xLTEtMA_fce1d177-12b5-4952-97b1-ce129cec0b96"
      unitRef="usd">46719000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i6d31023501b14c078a65f246b312debe_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzgtMi0xLTEtMA_b3ff08be-784a-4bf9-ab69-3cf7e18bd54d"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ie5954e81faf64c3ba7298da392a8d7ee_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzgtNC0xLTEtMA_bb15b47b-7900-46f8-bf79-f47153021ea6"
      unitRef="usd">-4510000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ic3097ac22f054b5ebd188c0484e23f18_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzgtNi0xLTEtMA_025575dc-14d3-48ed-b29c-94a86508d335"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzgtOC0xLTEtMA_a8f9fc6c-80cb-40fd-b0a9-043ac4421d41"
      unitRef="usd">-4510000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i6d31023501b14c078a65f246b312debe_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzEwLTItMS0xLTA_84d11531-7069-4c05-a9a6-32b6ad5491f1"
      unitRef="usd">16000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="ie5954e81faf64c3ba7298da392a8d7ee_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzEwLTQtMS0xLTA_138a5628-7ead-4c6d-9b17-ed0e0da578ed"
      unitRef="usd">18585000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="ic3097ac22f054b5ebd188c0484e23f18_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzEwLTYtMS0xLTA_c634f951-2472-4685-88ee-886cc6e10c21"
      unitRef="usd">0</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzEwLTgtMS0xLTA_c694bdb3-33c1-4244-b4be-a712332e9c59"
      unitRef="usd">18601000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpense
      contextRef="i6d31023501b14c078a65f246b312debe_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzExLTItMS0xLTA_7caa34da-9bc2-4da5-99ee-0b773e6855dc"
      unitRef="usd">34000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ie5954e81faf64c3ba7298da392a8d7ee_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzExLTQtMS0xLTA_bb4511f2-428b-4c09-87dc-793e7c361925"
      unitRef="usd">152000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ic3097ac22f054b5ebd188c0484e23f18_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzExLTYtMS0xLTA_b5ef5da7-277f-46c7-aaae-f8893e6dbbb6"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzExLTgtMS0xLTA_d2bc5d9f-7494-4746-a7b6-b713674570b6"
      unitRef="usd">186000</us-gaap:InterestExpense>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i6d31023501b14c078a65f246b312debe_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzEyLTItMS0xLTA_cab457f9-bffa-4034-9bd4-2a6b43289909"
      unitRef="usd">-18000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="ie5954e81faf64c3ba7298da392a8d7ee_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzEyLTQtMS0xLTA_d224bd09-ea95-4e93-8293-7f3607e10559"
      unitRef="usd">18433000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="ic3097ac22f054b5ebd188c0484e23f18_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzEyLTYtMS0xLTA_7c789b0b-397d-4803-aab4-d892a2ca6d33"
      unitRef="usd">0</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzEyLTgtMS0xLTA_64be69f5-2257-4230-a4e7-757e3e986b3b"
      unitRef="usd">18415000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:DepreciationAndAmortization
      contextRef="i6d31023501b14c078a65f246b312debe_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzE0LTItMS0xLTA_c0d4720c-5ad2-488b-a5f2-1989da89e5dd"
      unitRef="usd">234000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ie5954e81faf64c3ba7298da392a8d7ee_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzE0LTQtMS0xLTA_81e8335a-3ac4-4cda-af12-8b470195c96f"
      unitRef="usd">2638000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ic3097ac22f054b5ebd188c0484e23f18_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzE0LTYtMS0xLTA_716b2816-643a-431e-9afd-cb09e34af542"
      unitRef="usd">0</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzE0LTgtMS0xLTA_f900da4f-e6f5-481c-8077-235c92bf5679"
      unitRef="usd">2872000</us-gaap:DepreciationAndAmortization>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i6d31023501b14c078a65f246b312debe_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzE1LTItMS0xLTA_77ab5359-f992-4ef6-a8f5-a48164e810cd"
      unitRef="usd">323000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ie5954e81faf64c3ba7298da392a8d7ee_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzE1LTQtMS0xLTA_73cb6202-4c00-4990-9004-bd5cb6211759"
      unitRef="usd">1024000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ic3097ac22f054b5ebd188c0484e23f18_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzE1LTYtMS0xLTA_e2cae3cd-3aae-4f4c-8118-ed0af28f76f3"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzE1LTgtMS0xLTA_0e420f10-da4e-41f3-ae40-d9b84434a479"
      unitRef="usd">1347000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i6d31023501b14c078a65f246b312debe_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzE2LTItMS0xLTI3ODU4_d5e0e5d0-ae1b-49e8-a0b9-7ba15a63f021"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="ie5954e81faf64c3ba7298da392a8d7ee_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzE2LTQtMS0xLTI3ODUy_3065e8fd-e981-41ee-99f9-9ad580f4ce2c"
      unitRef="usd">-650000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="ic3097ac22f054b5ebd188c0484e23f18_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzE2LTYtMS0xLTI3ODU1_8b705dca-76d7-4448-853e-8573fb7ac6de"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzE2LTgtMS0xLTI3ODU1_89c47c94-c734-4fa5-957d-ed2ddb11d593"
      unitRef="usd">-650000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i6d31023501b14c078a65f246b312debe_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzE2LTItMS0xLTA_3858dc07-4621-4b01-9e72-475a856a01c6"
      unitRef="usd">-28019000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="ie5954e81faf64c3ba7298da392a8d7ee_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzE2LTQtMS0xLTA_ee149989-530b-4d8b-878b-680f9e99130f"
      unitRef="usd">-98349000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="ic3097ac22f054b5ebd188c0484e23f18_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzE2LTYtMS0xLTA_43331a20-167a-4f50-87c3-9736693be1c8"
      unitRef="usd">-20885000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzE2LTgtMS0xLTA_c16a682e-b43c-4bc3-ba4e-55e5dad0d6e2"
      unitRef="usd">-147253000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <us-gaap:Assets
      contextRef="i49db693fb9be41b0a5889e6879f777d0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzE5LTItMS0xLTA_76314b5b-4f15-4860-8cfc-a4b3d8ba6a1d"
      unitRef="usd">253745000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i0b096543d02048f3936893861bbb9c57_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzE5LTQtMS0xLTA_a7f8f65d-8d0c-481a-b998-0c94bb8e8ea9"
      unitRef="usd">388351000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ibbf8d53ce8964a6cb53e6e367fb6b9a5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzE5LTYtMS0xLTA_ba17112e-a231-4e54-9a92-09c6e98fa390"
      unitRef="usd">1283586000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzE5LTgtMS0xLTA_e77bd16b-7884-4149-8119-cbb8b50bd9fe"
      unitRef="usd">1925682000</us-gaap:Assets>
    <us-gaap:EquityMethodInvestments
      contextRef="i49db693fb9be41b0a5889e6879f777d0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzIwLTItMS0xLTA_a28488ef-1b20-42bc-8ec6-5d546989a71e"
      unitRef="usd">0</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i0b096543d02048f3936893861bbb9c57_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzIwLTQtMS0xLTA_32860581-cda0-4bcb-a5b9-2a728487130f"
      unitRef="usd">19235000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="ibbf8d53ce8964a6cb53e6e367fb6b9a5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzIwLTYtMS0xLTA_79876da5-3560-43a2-ac81-86761dff0c49"
      unitRef="usd">0</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzIwLTgtMS0xLTA_ec7c167a-4202-4ab1-be39-4d2c1ee7b17f"
      unitRef="usd">19235000</us-gaap:EquityMethodInvestments>
    <us-gaap:Goodwill
      contextRef="i49db693fb9be41b0a5889e6879f777d0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzIxLTItMS0xLTA_fc4cb35e-ec4a-4d89-80b7-32cafd0389c4"
      unitRef="usd">178414000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i0b096543d02048f3936893861bbb9c57_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzIxLTQtMS0xLTA_c3cbd6cf-0ed8-4d8e-b574-d9c756c1f661"
      unitRef="usd">1108000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ibbf8d53ce8964a6cb53e6e367fb6b9a5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzIxLTYtMS0xLTA_a38ed6c1-8d60-4619-9d64-e5ffa6a665fe"
      unitRef="usd">0</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzIxLTgtMS0xLTA_4f0ff331-f005-415b-905c-d89c1ff4a369"
      unitRef="usd">179522000</us-gaap:Goodwill>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="i6d31023501b14c078a65f246b312debe_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzIyLTItMS0xLTA_f7d71c14-a202-49ba-9b91-c268e04ba839"
      unitRef="usd">385000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="ie5954e81faf64c3ba7298da392a8d7ee_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzIyLTQtMS0xLTA_bd890d68-40d8-44f0-81a4-d8aab091809e"
      unitRef="usd">31027000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="ic3097ac22f054b5ebd188c0484e23f18_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzIyLTYtMS0xLTA_73e3a45c-e475-446c-88e3-862d0358f851"
      unitRef="usd">0</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpkYmU1M2Q0MjFlOGI0OWM4OTlmOTBjYzgwZGY3YmVhOS90YWJsZXJhbmdlOmRiZTUzZDQyMWU4YjQ5Yzg5OWY5MGNjODBkZjdiZWE5XzIyLTgtMS0xLTA_8fc4bd55-00b2-4766-832a-32c6836a30f5"
      unitRef="usd">31412000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i87e3d771deca41988f620fd82eacf084_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzMtMi0xLTEtMA_af67dc73-63d7-4eaa-8a5f-65c3409433f0"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i28e5d16c824541219fc781472e67c692_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzMtNC0xLTEtMA_6100a3f9-355b-4634-9d58-200ce0d4643a"
      unitRef="usd">15020000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic24540413fdd498693ce6bf7a6976a31_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzMtNi0xLTEtMA_87987430-ea7e-4d6b-b780-d0214312587a"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icacdfb65bc3149b38b733a4732feeebb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzMtOC0xLTEtMA_f32906ca-a116-44e5-b30f-6644626234a1"
      unitRef="usd">15020000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i59f625a78ed547beb8ff59308e54c2e5_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzQtMi0xLTEtMA_a5789ed7-cf33-4c7a-8cff-ddf1238a66d5"
      unitRef="usd">3364000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7c61172a844842b28da319f1cee9e445_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzQtNC0xLTEtMA_60737ad3-f8fc-436d-8b08-409c930769b2"
      unitRef="usd">5338000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i800f69cd597e4aeca9c474e6c7edd75b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzQtNi0xLTEtMA_bf77cda1-bbbc-4c3b-9291-2b42a0ebca7b"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib13faff76de54e4d94e71c14d2ef55b9_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzQtOC0xLTEtMA_9d1e0baa-2663-4e20-91c4-bd736028a40d"
      unitRef="usd">8702000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idb03c1afaee344b99a3f11897f6b00a4_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzUtMi0xLTEtMA_99ecf844-329b-4fc1-895b-3738643fd169"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6e57dab2b0d04fc68e252c1b8917c76a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzUtNC0xLTEtMA_ba935f6a-28b2-45d0-90b7-bbc1e9630919"
      unitRef="usd">28000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idd1d6f418f5d4c8e9280169b3a3fb722_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzUtNi0xLTEtMA_9578eb90-3f0e-4816-8c09-077d0974e4b1"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i68edd065b3774520abe09eb1c8de7c1f_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzUtOC0xLTEtMA_4e62531f-81ac-4760-b389-89bf87f6c9d1"
      unitRef="usd">28000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i26a43a36f7b84e17a5c4a3f441a8d61b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzYtMi0xLTEtMA_9e5bff97-cef7-4fc4-8763-91b440b78f1f"
      unitRef="usd">3364000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icc0349f558524b69a56d1b79ef3651be_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzYtNC0xLTEtMA_cbdb2cf5-a2f2-45d7-a3ca-059d784a968e"
      unitRef="usd">20386000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iee19945c297442c99fabe50468a25677_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzYtNi0xLTEtMA_f1d3b449-2591-4c1a-a065-a4cd4d5e0846"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzYtOC0xLTEtMA_e649175d-0162-4b3c-b62b-8cf9546c2bf6"
      unitRef="usd">23750000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i26a43a36f7b84e17a5c4a3f441a8d61b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzgtMi0xLTEtMA_12482b5d-4863-4da2-92c7-3757a9f8310a"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="icc0349f558524b69a56d1b79ef3651be_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzgtNC0xLTEtMA_15fef223-e558-4e45-8fda-9c366ce868ca"
      unitRef="usd">-2009000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="iee19945c297442c99fabe50468a25677_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzgtNi0xLTEtMA_dc0064ba-97b2-4795-ad36-d1bfefe41b07"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzgtOC0xLTEtMA_95feb0f7-d16a-4298-b230-b197ae05fb07"
      unitRef="usd">-2009000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i26a43a36f7b84e17a5c4a3f441a8d61b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzEwLTItMS0xLTA_483855a8-5c81-43de-8dd7-dc69ac9eaacb"
      unitRef="usd">6000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="icc0349f558524b69a56d1b79ef3651be_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzEwLTQtMS0xLTA_73a5dfd2-0e20-421a-afc1-f4438880bfee"
      unitRef="usd">29207000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="iee19945c297442c99fabe50468a25677_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzEwLTYtMS0xLTA_56f9c9b8-f300-4955-93e7-45160c96e81f"
      unitRef="usd">0</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzEwLTgtMS0xLTA_741d90b1-4abf-42b1-a394-a85b2aa3da3f"
      unitRef="usd">29213000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpense
      contextRef="i26a43a36f7b84e17a5c4a3f441a8d61b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzExLTItMS0xLTA_7f218481-8250-4770-87af-c441aff82261"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="icc0349f558524b69a56d1b79ef3651be_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzExLTQtMS0xLTA_68c47a78-0f91-49e2-98a0-104e316540ab"
      unitRef="usd">1244000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="iee19945c297442c99fabe50468a25677_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzExLTYtMS0xLTA_b78c852d-aa45-42b4-8213-6199fefea8f4"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzExLTgtMS0xLTA_30f80ee1-8252-4c6b-a56b-c5a994fcd8df"
      unitRef="usd">1244000</us-gaap:InterestExpense>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i26a43a36f7b84e17a5c4a3f441a8d61b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzEyLTItMS0xLTA_8b6cc1b6-774a-4a95-b1ed-5926450a34ab"
      unitRef="usd">6000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="icc0349f558524b69a56d1b79ef3651be_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzEyLTQtMS0xLTA_45d0431d-a0fd-4dfb-93e2-96f487283f6c"
      unitRef="usd">27963000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="iee19945c297442c99fabe50468a25677_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzEyLTYtMS0xLTA_54640d05-3902-4011-abd8-2bca36ee8eec"
      unitRef="usd">0</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzEyLTgtMS0xLTA_52ac803e-950e-46d9-9adf-31fbc5455105"
      unitRef="usd">27969000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:DepreciationAndAmortization
      contextRef="i26a43a36f7b84e17a5c4a3f441a8d61b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzE0LTItMS0xLTA_ea9d7098-94fa-42e9-b534-e75e7b611dda"
      unitRef="usd">46000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="icc0349f558524b69a56d1b79ef3651be_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzE0LTQtMS0xLTA_e362871f-cc6f-400d-bdb4-32b3d7d95053"
      unitRef="usd">2044000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="iee19945c297442c99fabe50468a25677_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzE0LTYtMS0xLTA_7a795165-f74e-455d-9a69-9dab6e8b2da2"
      unitRef="usd">0</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzE0LTgtMS0xLTA_e5ec5344-ca31-462d-85aa-48b5bf8a3777"
      unitRef="usd">2090000</us-gaap:DepreciationAndAmortization>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i26a43a36f7b84e17a5c4a3f441a8d61b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzE1LTItMS0xLTA_29e2e2a7-583a-4f9e-bf14-9fffc3669d65"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="icc0349f558524b69a56d1b79ef3651be_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzE1LTQtMS0xLTA_d980ce15-8aed-437c-bc3e-db848328c8ef"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="iee19945c297442c99fabe50468a25677_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzE1LTYtMS0xLTA_dfe7dfaf-8358-4e28-8398-2e7bc913caba"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzE1LTgtMS0xLTA_a97a8d92-a5ec-4fd7-852e-dd267c36abe4"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i26a43a36f7b84e17a5c4a3f441a8d61b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzE2LTItMS0xLTI3ODYy_85383f27-aa51-4125-85a7-ea2f37583878"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="icc0349f558524b69a56d1b79ef3651be_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzE2LTQtMS0xLTI3ODYy_2aee1753-5715-4199-ac54-bcd0cbdc6f57"
      unitRef="usd">-363000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="iee19945c297442c99fabe50468a25677_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzE2LTYtMS0xLTI3ODY1_e9ddeadc-9847-4b79-879a-1c90fd8bb474"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzE2LTgtMS0xLTI3ODY1_1c882509-8357-4a25-b175-bcfc84ee640f"
      unitRef="usd">-363000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i26a43a36f7b84e17a5c4a3f441a8d61b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzE2LTItMS0xLTA_450b24a0-0e8b-4747-a61c-47489fc8a106"
      unitRef="usd">-1703000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="icc0349f558524b69a56d1b79ef3651be_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzE2LTQtMS0xLTA_4d238ea1-1065-4fa0-ab82-da3c27eea1d8"
      unitRef="usd">-84826000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="iee19945c297442c99fabe50468a25677_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzE2LTYtMS0xLTA_0ef8c085-29db-46c6-9f04-11ecb08f39dd"
      unitRef="usd">-11779000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzE2LTgtMS0xLTA_5fddecc4-7b43-4d57-a442-6bb924a89213"
      unitRef="usd">-98308000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <us-gaap:Assets
      contextRef="i1b5ddf61e50c4278b9972461d7753caf_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzE5LTItMS0xLTA_c74c7e5b-65af-49c8-968b-706fe4c06fcf"
      unitRef="usd">293985000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i6a85a077911e4fc5bdd4f6817869ec0e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzE5LTQtMS0xLTA_2dba05f1-62f2-40f8-8618-d8b670f4775c"
      unitRef="usd">309854000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="idcea1837f8ed4b229e10b2a1aa122696_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzE5LTYtMS0xLTA_cb62a095-cfd9-423e-9296-1159df1f365f"
      unitRef="usd">1486603000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzE5LTgtMS0xLTA_71613568-e5ce-44e2-85b8-d324e3851f22"
      unitRef="usd">2090442000</us-gaap:Assets>
    <us-gaap:EquityMethodInvestments
      contextRef="i1b5ddf61e50c4278b9972461d7753caf_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzIwLTItMS0xLTA_78ac7609-e910-4ec8-be42-1887f2a89541"
      unitRef="usd">0</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i6a85a077911e4fc5bdd4f6817869ec0e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzIwLTQtMS0xLTA_d120f812-2896-48ae-8201-264077f181da"
      unitRef="usd">557000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="idcea1837f8ed4b229e10b2a1aa122696_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzIwLTYtMS0xLTA_49b3ccd2-11d3-4723-9f99-64359a762566"
      unitRef="usd">0</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzIwLTgtMS0xLTA_ff203da7-dff4-4fec-9cec-06a8e9d1cb95"
      unitRef="usd">557000</us-gaap:EquityMethodInvestments>
    <us-gaap:Goodwill
      contextRef="i1b5ddf61e50c4278b9972461d7753caf_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzIxLTItMS0xLTA_b18142e7-a59e-40f1-bde3-00e0433eaf6d"
      unitRef="usd">213414000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i6a85a077911e4fc5bdd4f6817869ec0e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzIxLTQtMS0xLTA_abc96fc7-9fab-437f-86f2-8f2b24a6b7fb"
      unitRef="usd">1078000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="idcea1837f8ed4b229e10b2a1aa122696_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzIxLTYtMS0xLTA_6ff0f512-e41b-4c56-b964-74f16d9e5396"
      unitRef="usd">0</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzIxLTgtMS0xLTA_f82da0df-25b3-49ac-be71-baf71259a7de"
      unitRef="usd">214492000</us-gaap:Goodwill>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="i26a43a36f7b84e17a5c4a3f441a8d61b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzIyLTItMS0xLTA_2aba7e82-7254-46c9-ab93-60599af282ce"
      unitRef="usd">259000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="icc0349f558524b69a56d1b79ef3651be_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzIyLTQtMS0xLTA_58e5bd69-a15b-4333-8a32-18fd959a4e5a"
      unitRef="usd">38405000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="iee19945c297442c99fabe50468a25677_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzIyLTYtMS0xLTA_1c18e3a8-74b3-4515-8134-66e6499d559e"
      unitRef="usd">0</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowMTEyYzZiNTc0MmY0MjM1ODJjODY4MjUwMzAyOTJhYi90YWJsZXJhbmdlOjAxMTJjNmI1NzQyZjQyMzU4MmM4NjgyNTAzMDI5MmFiXzIyLTgtMS0xLTA_a0b282ac-c1e1-46a8-beaf-4e5d0abc06e4"
      unitRef="usd">38664000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ice17379b564a4ac8b872312066dc43c9_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzMtMi0xLTEtMzc4Mg_fad197dd-32ea-4a87-ba53-631d47f294b5"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic30fa899f34b4e0785f35d709b796c68_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzMtNC0xLTEtMzc4Mg_8c891ed0-133c-4f99-90a3-8687a2aa0144"
      unitRef="usd">9210000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iacacb166b362411ab04c61d50004c298_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzMtOC0xLTEtMzc4Mg_c5b524fc-6636-4794-aae2-c76339866451"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i10910e1c9ff24da3a8beeb51e8fc6acf_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzMtMTAtMS0xLTM3ODI_a598a1c0-baff-4529-8589-79187f9ef73e"
      unitRef="usd">9210000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i80f7ba51cebb4bd485ecda47d16121b2_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzQtMi0xLTEtMzc4Mg_c386c22f-862c-4078-b424-b7bed699a63e"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i35a6164687bf4736be585df4b9716950_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzQtNC0xLTEtMzc4Mg_2c5dbb8c-698d-4d71-b528-82227715a429"
      unitRef="usd">2732000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7744b3aecb5149939539b0f65c16f9e8_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzQtOC0xLTEtMzc4Mg_f1ba5f22-adf2-4835-9964-d8bb9b4f2f16"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idca36084581840b492066eea650a5de4_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzQtMTAtMS0xLTM3ODI_c951c2c2-6e2d-4521-a446-c3ee773f7966"
      unitRef="usd">2732000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0086f87b13ed455fad8a005cb0c06132_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzUtMi0xLTEtMzc4Mg_524124b4-b4cb-4cae-b65d-df86943e3c6a"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia5bec23ced2546878d05f11ba1514eb0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzUtNC0xLTEtMzc4Mg_c4ca55e2-0475-4af8-9af6-47706d1484d6"
      unitRef="usd">179000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5f04fed468264acaba7cd3b71598765d_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzUtOC0xLTEtMzc4Mg_4d1cfbae-c1ad-4fe5-ba34-5c58e31bd916"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i45ffa1a1923c4ad9a143f62075390ee2_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzUtMTAtMS0xLTM3ODI_b882f733-7d86-4517-b47f-8c4106ffe35f"
      unitRef="usd">179000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifa76c191d29f4ff1b49de04caf646517_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzYtMi0xLTEtMzc4Mg_f674147f-2f68-4720-9370-b9fddc611382"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifdd45fb7a8f94242bcc47ddfad9317d5_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzYtNC0xLTEtMzc4Mg_0db983f6-3ad7-4fba-ae24-c2a1e588b8a4"
      unitRef="usd">12121000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie88f3bf44b8f4d0398751e5198d4d80b_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzYtOC0xLTEtMzc4Mg_924e3640-1659-410e-b185-6a4e2f807c9f"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzYtMTAtMS0xLTM3ODI_7a0ccb9a-251a-425e-baee-f1b9c7cc978e"
      unitRef="usd">12121000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ifa76c191d29f4ff1b49de04caf646517_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzctMi0xLTEtMzc4Mg_cba4f82f-ced8-4fea-9427-2f8471bc10a2"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ifdd45fb7a8f94242bcc47ddfad9317d5_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzctNC0xLTEtMzc4Mg_7c04f31e-c8f7-4fed-9e74-5fed8e2dba70"
      unitRef="usd">-723000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ie88f3bf44b8f4d0398751e5198d4d80b_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzctOC0xLTEtMzc4Mg_e7dd9c5a-327b-4742-9615-44615dc6a030"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzctMTAtMS0xLTM3ODI_bfd0772b-b4e7-4a44-8712-a791d5b8c22b"
      unitRef="usd">-723000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:InvestmentIncomeInterest
      contextRef="ifa76c191d29f4ff1b49de04caf646517_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzgtMi0xLTEtMzc4Mg_42f6ffe6-cbc6-41cc-976b-d6a3d7e29920"
      unitRef="usd">0</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="ifdd45fb7a8f94242bcc47ddfad9317d5_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzgtNC0xLTEtMzc4Mg_0a186aaa-6770-4712-b1c7-982aae393911"
      unitRef="usd">220000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="ie88f3bf44b8f4d0398751e5198d4d80b_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzgtOC0xLTEtMzc4Mg_61001d46-58dc-4e94-b431-4df015443d84"
      unitRef="usd">0</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzgtMTAtMS0xLTM3ODI_4b10a1f1-2f82-47d8-a620-7c258fe6c41a"
      unitRef="usd">220000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpense
      contextRef="ifa76c191d29f4ff1b49de04caf646517_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzktMi0xLTEtMzc4Mg_0c0b2a1b-4309-4680-97ae-cf3d31f584af"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ifdd45fb7a8f94242bcc47ddfad9317d5_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzktNC0xLTEtMzc4Mg_a762abb9-1f9c-4365-a00b-e84cff42bf86"
      unitRef="usd">139000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ie88f3bf44b8f4d0398751e5198d4d80b_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzktOC0xLTEtMzc4Mg_c2e0b9e3-3b00-461a-b484-dd1f208751ee"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzktMTAtMS0xLTM3ODI_06fc8ed0-c149-4230-91a8-0859c5d89784"
      unitRef="usd">139000</us-gaap:InterestExpense>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="ifa76c191d29f4ff1b49de04caf646517_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzEwLTItMS0xLTM3ODI_b23457ee-4408-4503-a47a-44708388d65e"
      unitRef="usd">0</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="ifdd45fb7a8f94242bcc47ddfad9317d5_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzEwLTQtMS0xLTM3ODI_d7ee0d71-ed84-4c99-b6fd-af3d5f90ea6a"
      unitRef="usd">81000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="ie88f3bf44b8f4d0398751e5198d4d80b_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzEwLTgtMS0xLTM3ODI_c36ede31-43e4-46b9-877a-a7b0644636bd"
      unitRef="usd">0</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzEwLTEwLTEtMS0zNzgy_337d7afc-8592-445e-bd08-d7d0bc63bd93"
      unitRef="usd">81000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:DepreciationAndAmortization
      contextRef="ifa76c191d29f4ff1b49de04caf646517_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzExLTItMS0xLTM3ODI_c5109763-9718-4795-87ee-53e6100fdc61"
      unitRef="usd">0</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ifdd45fb7a8f94242bcc47ddfad9317d5_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzExLTQtMS0xLTM3ODI_29a37337-d2dd-4441-b233-726238584d20"
      unitRef="usd">807000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ie88f3bf44b8f4d0398751e5198d4d80b_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzExLTgtMS0xLTM3ODI_62cd95a9-effe-4b2f-bf44-ca00be88415f"
      unitRef="usd">0</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzExLTEwLTEtMS0zNzgy_a4c7a0a2-6c78-4366-9c42-ac7ca9f090e3"
      unitRef="usd">807000</us-gaap:DepreciationAndAmortization>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ifa76c191d29f4ff1b49de04caf646517_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzEyLTItMS0xLTM3ODI_a05dfce1-bd65-4994-8419-30b4d8394423"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ifdd45fb7a8f94242bcc47ddfad9317d5_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzEyLTQtMS0xLTM3ODI_ca742e1c-0db1-49d6-b9a5-12af57b5bcfa"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ie88f3bf44b8f4d0398751e5198d4d80b_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzEyLTgtMS0xLTM3ODI_6994aaca-7cc9-47c3-b9ec-40634c1d3515"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzEyLTEwLTEtMS0zNzgy_482a0f33-02f0-4b0b-b9e3-3c3edc7f0e45"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="ifa76c191d29f4ff1b49de04caf646517_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzE1LTItMS0xLTI3ODY5_34710d6a-0328-4005-b8ab-083ce6aa4757"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="ifdd45fb7a8f94242bcc47ddfad9317d5_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzE1LTQtMS0xLTI3ODY5_84c470e2-719f-4862-bffc-87b404455bc6"
      unitRef="usd">-894000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="ie88f3bf44b8f4d0398751e5198d4d80b_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzE1LTYtMS0xLTI3ODcy_bb132efc-616d-475a-8a30-47c2456e78cd"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzE1LTgtMS0xLTI3ODcy_61192980-4d70-45c5-af7a-924d79d18db7"
      unitRef="usd">-894000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="ifa76c191d29f4ff1b49de04caf646517_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzEzLTItMS0xLTM3ODI_30484e98-53f5-4f0f-820e-24436d0e61f0"
      unitRef="usd">0</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="ifdd45fb7a8f94242bcc47ddfad9317d5_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzEzLTQtMS0xLTM3ODI_19059884-20bb-4379-baa0-b7f043e573f0"
      unitRef="usd">-10357000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="ie88f3bf44b8f4d0398751e5198d4d80b_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzEzLTgtMS0xLTM3ODI_da7fd0cd-cc3c-4351-973b-62b03d6736af"
      unitRef="usd">0</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzEzLTEwLTEtMS0zNzgy_873340cd-0694-417b-8744-4a0157f3a98e"
      unitRef="usd">-10357000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <us-gaap:Assets
      contextRef="ieb62e4fdf37447a3b94f42364a71921e_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzE2LTItMS0xLTM3ODI_5e61efd2-da57-4629-8498-02b3fac998cd"
      unitRef="usd">0</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ifee12228e043414085a5b8c975e48649_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzE2LTQtMS0xLTM3ODI_85b037e5-ae92-4105-bae3-b954dc870817"
      unitRef="usd">183471000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i8ffe119a68b34b9abbb2f8b5078b5b89_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzE2LTgtMS0xLTM3ODI_95921306-740a-4a44-af7f-fee9af05fb7f"
      unitRef="usd">0</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i9717dc3b24b24c93ab09a6bfa9b52c89_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzE2LTEwLTEtMS0zNzgy_1b4cbdc7-5e1b-461d-a419-dd637e908bf4"
      unitRef="usd">183471000</us-gaap:Assets>
    <us-gaap:EquityMethodInvestments
      contextRef="ieb62e4fdf37447a3b94f42364a71921e_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzE3LTItMS0xLTM3ODI_7c8dca3c-2a97-4ea8-896b-e046a6833153"
      unitRef="usd">0</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="ifee12228e043414085a5b8c975e48649_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzE3LTQtMS0xLTM3ODI_36891757-b6db-420c-a1e9-b10cf4afe6b0"
      unitRef="usd">2960000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i8ffe119a68b34b9abbb2f8b5078b5b89_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzE3LTgtMS0xLTM3ODI_39162c8d-2d13-4504-91df-b24e051e42b9"
      unitRef="usd">0</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i9717dc3b24b24c93ab09a6bfa9b52c89_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzE3LTEwLTEtMS0zNzgy_b434ed69-1760-4aa2-81b3-eb0de38efcb6"
      unitRef="usd">2960000</us-gaap:EquityMethodInvestments>
    <us-gaap:Goodwill
      contextRef="ieb62e4fdf37447a3b94f42364a71921e_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzE4LTItMS0xLTM3ODI_c86e3462-7b96-4c48-acad-f4999d41eaaa"
      unitRef="usd">0</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ifee12228e043414085a5b8c975e48649_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzE4LTQtMS0xLTM3ODI_95078cfb-62a5-465a-a7f7-6d279cd8d161"
      unitRef="usd">1314000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i8ffe119a68b34b9abbb2f8b5078b5b89_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzE4LTgtMS0xLTM3ODI_23a51cf0-0389-480c-9782-77bdf2fb6404"
      unitRef="usd">0</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i9717dc3b24b24c93ab09a6bfa9b52c89_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzE4LTEwLTEtMS0zNzgy_91ae5e94-d445-4bf3-9e6d-0e0117424c12"
      unitRef="usd">1314000</us-gaap:Goodwill>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="ifa76c191d29f4ff1b49de04caf646517_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzE5LTItMS0xLTM3ODI_cc28e64a-3ac3-4424-a2e6-6da8f5fa58af"
      unitRef="usd">0</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="ifdd45fb7a8f94242bcc47ddfad9317d5_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzE5LTQtMS0xLTM3ODI_575c33ff-e574-44c3-95e0-b5308e0fa060"
      unitRef="usd">88308000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="ie88f3bf44b8f4d0398751e5198d4d80b_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzE5LTgtMS0xLTM3ODI_674b0421-c031-4282-bb8d-680d8187e5f6"
      unitRef="usd">0</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZTJjNjRkNmQ2NGQ0OTNhYjNkOTAzNWU1YmExODljMy90YWJsZXJhbmdlOjBlMmM2NGQ2ZDY0ZDQ5M2FiM2Q5MDM1ZTViYTE4OWMzXzE5LTEwLTEtMS0zNzgy_2cc0bf4d-5612-4d9f-a9d0-bfabc9c9650f"
      unitRef="usd">88308000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:ProfitLoss
      contextRef="i6d31023501b14c078a65f246b312debe_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzItMi0xLTEtMzEyMTY_1f798361-437f-428f-b9a0-85b18520367b"
      unitRef="usd">-77368000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ie5954e81faf64c3ba7298da392a8d7ee_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzItNC0xLTEtMzEyMTY_a84d10b4-3e3d-40cd-b587-a76825b7e421"
      unitRef="usd">32671000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ic3097ac22f054b5ebd188c0484e23f18_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzItNi0xLTEtMzEyMTY_3908a4c2-1426-4531-afa4-1420efe9d72c"
      unitRef="usd">-30573000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzItOC0xLTEtMzEyMTY_ae546382-c533-4daf-adc9-1a73f7c7e17b"
      unitRef="usd">-75270000</us-gaap:ProfitLoss>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i6d31023501b14c078a65f246b312debe_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzQtMi0xLTEtMzEyMTY_2242652a-7ee0-4b19-b174-5db1aabafb3a"
      unitRef="usd">-18000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="ie5954e81faf64c3ba7298da392a8d7ee_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzQtNC0xLTEtMzEyMTY_7d40cc1e-33dc-45cf-80cc-97db3a5cfc98"
      unitRef="usd">18433000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="ic3097ac22f054b5ebd188c0484e23f18_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzQtNi0xLTEtMzEyMTY_3d0d8469-ec76-496e-a85b-c7f62aa9eaca"
      unitRef="usd">0</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzQtOC0xLTEtMzEyMTY_d3dd9ed9-53f9-4839-94b3-90b6485c8927"
      unitRef="usd">18415000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i6d31023501b14c078a65f246b312debe_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzUtMi0xLTEtMzEyMTY_4c5873d1-8673-4001-93cb-b5603b23d050"
      unitRef="usd">323000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ie5954e81faf64c3ba7298da392a8d7ee_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzUtNC0xLTEtMzEyMTY_e3ddbb4e-e0b1-4356-9416-b9caba41cab4"
      unitRef="usd">1024000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ic3097ac22f054b5ebd188c0484e23f18_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzUtNi0xLTEtMzEyMTY_b79819af-ef8b-4ee4-ad74-e39d8baecd2c"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzUtOC0xLTEtMzEyMTY_b19c0310-967e-4e4d-92b0-9ab2686cb24f"
      unitRef="usd">1347000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i6d31023501b14c078a65f246b312debe_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzYtMi0xLTEtMzEyMTY_49846468-68f8-4d83-849f-2fb77119fb46"
      unitRef="usd">40000000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="ie5954e81faf64c3ba7298da392a8d7ee_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzYtNC0xLTEtMzEyMTY_1b717078-c8de-49cf-8bc3-6c083b1f8381"
      unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="ic3097ac22f054b5ebd188c0484e23f18_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzYtNi0xLTEtMzEyMTY_a1189b09-ada7-4659-bc62-3750e5b70f05"
      unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzYtOC0xLTEtMzEyMTY_b6113472-c36c-4fa7-bd48-dec63c141b6f"
      unitRef="usd">40000000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts
      contextRef="i6d31023501b14c078a65f246b312debe_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzgtMi0xLTEtMzEyMTY_4693e53c-2124-42b7-ad85-470f1f3c2db1"
      unitRef="usd">40000</us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts>
    <us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts
      contextRef="ie5954e81faf64c3ba7298da392a8d7ee_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzgtNC0xLTEtMzEyMTY_96d0f9f5-79c2-4fcc-93cc-a171dccbccf3"
      unitRef="usd">0</us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts>
    <us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts
      contextRef="ic3097ac22f054b5ebd188c0484e23f18_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzgtNi0xLTEtMzEyMTY_c9a04f84-d25d-4937-b163-74edd744dd43"
      unitRef="usd">0</us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts>
    <us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzgtOC0xLTEtMzEyMTY_d126ee13-94c7-4534-ad82-dde4bc458484"
      unitRef="usd">40000</us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i6d31023501b14c078a65f246b312debe_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzktMi0xLTEtMzEyMTY_c3a47236-7551-4c2f-9219-96e8b3d4b66f"
      unitRef="usd">0</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="ie5954e81faf64c3ba7298da392a8d7ee_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzktNC0xLTEtMzEyMTY_16fcd9ba-be1f-4d8e-8635-96c5c6889ab8"
      unitRef="usd">129254000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="ic3097ac22f054b5ebd188c0484e23f18_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzktNi0xLTEtMzEyMTY_a8c8d3dd-57d8-4436-8a09-3220e2fbbf5f"
      unitRef="usd">0</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzktOC0xLTEtMzEyMTY_4e8c4d72-acf0-4466-8913-4f50a45e01e8"
      unitRef="usd">129254000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="i6d31023501b14c078a65f246b312debe_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzExLTItMS0xLTMxMjE2_aece9194-52d1-482a-a740-58313af1996f"
      unitRef="usd">0</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="ie5954e81faf64c3ba7298da392a8d7ee_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzExLTQtMS0xLTMxMjE2_5bd7b8aa-ea88-4c65-9f50-e2b882bab833"
      unitRef="usd">4789000</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="ic3097ac22f054b5ebd188c0484e23f18_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzExLTYtMS0xLTMxMjE2_85a267ff-a7cd-483a-a438-832d3899a128"
      unitRef="usd">0</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzExLTgtMS0xLTMxMjE2_a15c34d7-650f-4d4e-8c74-230f0f981bf2"
      unitRef="usd">4789000</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i6d31023501b14c078a65f246b312debe_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzEyLTItMS0xLTMxMjE2_b589520d-b583-4b3b-83c8-eb5dd0338d06"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ie5954e81faf64c3ba7298da392a8d7ee_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzEyLTQtMS0xLTMxMjE2_243c6b52-c70e-42ca-8bc0-b6793583d073"
      unitRef="usd">-4510000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ic3097ac22f054b5ebd188c0484e23f18_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzEyLTYtMS0xLTMxMjE2_c202c803-1b74-4b18-be43-d86f16799b15"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzEyLTgtMS0xLTMxMjE2_48865ce7-21d7-4d95-b7ae-7789dded61ef"
      unitRef="usd">-4510000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i6d31023501b14c078a65f246b312debe_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzE1LTItMS0xLTMxMjE2_e2319dad-3ae6-42d1-aa46-7086a64f9c43"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="ie5954e81faf64c3ba7298da392a8d7ee_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzE1LTQtMS0xLTMxMjE2_1d84f1e2-fd32-46f3-b365-757cf1fcfc17"
      unitRef="usd">-650000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="ic3097ac22f054b5ebd188c0484e23f18_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzE1LTYtMS0xLTMxMjE2_6e9490ed-8423-4def-934b-7c2810b77666"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzE1LTgtMS0xLTMxMjE2_d0547e3c-85e2-4920-bb0b-603e25c8c857"
      unitRef="usd">-650000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i6d31023501b14c078a65f246b312debe_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzE3LTItMS0xLTMxMjE2_7768c254-4001-4e5a-94de-77adfb9b6b23"
      unitRef="usd">-20000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ie5954e81faf64c3ba7298da392a8d7ee_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzE3LTQtMS0xLTMxMjE2_1a86b8ef-ba48-466b-93f8-e26fae21b826"
      unitRef="usd">-1814000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ic3097ac22f054b5ebd188c0484e23f18_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzE3LTYtMS0xLTMxMjE2_83e826aa-f998-4aa1-977a-95c2aaa9a6be"
      unitRef="usd">0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzE3LTgtMS0xLTMxMjE2_bb435387-4fbf-47d4-aa43-35e1bfbc8c97"
      unitRef="usd">-1834000</us-gaap:OtherNonoperatingIncomeExpense>
    <cron:RestatementReviewExpense
      contextRef="i6d31023501b14c078a65f246b312debe_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzE2LTItMS0xLTMyMzIy_ebaf3f64-446b-46d4-b467-e23167caeead"
      unitRef="usd">0</cron:RestatementReviewExpense>
    <cron:RestatementReviewExpense
      contextRef="ie5954e81faf64c3ba7298da392a8d7ee_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzE2LTQtMS0xLTMyMzIy_eee78547-191c-4690-8db3-fb2d3c31195d"
      unitRef="usd">0</cron:RestatementReviewExpense>
    <cron:RestatementReviewExpense
      contextRef="ic3097ac22f054b5ebd188c0484e23f18_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzE2LTYtMS0xLTMyMzIy_822b9074-7151-4fc5-926a-cc67849dfb75"
      unitRef="usd">9688000</cron:RestatementReviewExpense>
    <cron:RestatementReviewExpense
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzE2LTgtMS0xLTMyMzIy_dade2f56-8a0c-4afd-acf5-9d1218607aa6"
      unitRef="usd">9688000</cron:RestatementReviewExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i6d31023501b14c078a65f246b312debe_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzE4LTItMS0xLTMxMjE2_2c9582c7-8fc9-4d82-bfd7-a86fbb26e53c"
      unitRef="usd">8714000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie5954e81faf64c3ba7298da392a8d7ee_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzE4LTQtMS0xLTMxMjE2_225651d9-8bf5-465c-89ee-0b5b20e92405"
      unitRef="usd">6647000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ic3097ac22f054b5ebd188c0484e23f18_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzE4LTYtMS0xLTMxMjE2_a61a82df-2ce9-4137-bfb7-03ad4154d85b"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzE4LTgtMS0xLTMxMjE2_37c7cc29-5e11-4e7c-97a0-26525a992730"
      unitRef="usd">15361000</us-gaap:AllocatedShareBasedCompensationExpense>
    <cron:AdjustedEarningsBeforeInterestAndTaxes
      contextRef="i6d31023501b14c078a65f246b312debe_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzE5LTItMS0xLTMxMjE2_0d7e10b3-3ea0-4978-97d3-4b8e1ae27b09"
      unitRef="usd">-28253000</cron:AdjustedEarningsBeforeInterestAndTaxes>
    <cron:AdjustedEarningsBeforeInterestAndTaxes
      contextRef="ie5954e81faf64c3ba7298da392a8d7ee_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzE5LTQtMS0xLTMxMjE2_1bcecfb5-0323-4ad0-82b3-d70f43b973d8"
      unitRef="usd">-105160000</cron:AdjustedEarningsBeforeInterestAndTaxes>
    <cron:AdjustedEarningsBeforeInterestAndTaxes
      contextRef="ic3097ac22f054b5ebd188c0484e23f18_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzE5LTYtMS0xLTMxMjE2_afb1989e-4f4c-4c21-9102-edf8ad3c36fe"
      unitRef="usd">-20885000</cron:AdjustedEarningsBeforeInterestAndTaxes>
    <cron:AdjustedEarningsBeforeInterestAndTaxes
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzE5LTgtMS0xLTMxMjE2_ead625fa-dde8-4b96-8592-5b0310c91b7d"
      unitRef="usd">-154298000</cron:AdjustedEarningsBeforeInterestAndTaxes>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i6d31023501b14c078a65f246b312debe_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzIxLTItMS0xLTMxMjE2_f3a5f08a-72ef-4d28-b2df-3cb35cf591aa"
      unitRef="usd">234000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ie5954e81faf64c3ba7298da392a8d7ee_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzIxLTQtMS0xLTMxMjE2_5cb657dc-b3ad-49a5-8f9f-16f04975a390"
      unitRef="usd">6811000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ic3097ac22f054b5ebd188c0484e23f18_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzIxLTYtMS0xLTMxMjE2_c128aa38-71c6-4f26-848e-7276f57b59cb"
      unitRef="usd">0</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzIxLTgtMS0xLTMxMjE2_ba7bf55e-ffaf-42f0-8293-034bfdf9ba00"
      unitRef="usd">7045000</us-gaap:DepreciationDepletionAndAmortization>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i6d31023501b14c078a65f246b312debe_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzIyLTItMS0xLTMxMjE2_3e1745d1-cd23-437b-abdf-8aaa7ca4c113"
      unitRef="usd">-28019000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="ie5954e81faf64c3ba7298da392a8d7ee_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzIyLTQtMS0xLTMxMjE2_9a55bdf2-512c-46dd-9aab-1036fe9bcffc"
      unitRef="usd">-98349000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="ic3097ac22f054b5ebd188c0484e23f18_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzIyLTYtMS0xLTMxMjE2_1eff6b97-cf68-4962-9c7e-fe2f3a524f9a"
      unitRef="usd">-20885000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTo3MTUyZjE5ODY3NmE0ZjRmYWRkMWRkNGQzZTk2MmRjZC90YWJsZXJhbmdlOjcxNTJmMTk4Njc2YTRmNGZhZGQxZGQ0ZDNlOTYyZGNkXzIyLTgtMS0xLTMxMjE2_c1578f60-801a-4905-ac90-a6943b5ff679"
      unitRef="usd">-147253000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <us-gaap:ProfitLoss
      contextRef="i26a43a36f7b84e17a5c4a3f441a8d61b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzItMi0xLTEtMzEyMTY_9a41fbe2-0a2a-4c4a-9ce5-b7cff18a28d5"
      unitRef="usd">-3070000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="icc0349f558524b69a56d1b79ef3651be_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzItNC0xLTEtMzEyMTY_68f1e610-e082-4a9f-b5e4-dfba0c123c2c"
      unitRef="usd">1180241000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="iee19945c297442c99fabe50468a25677_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzItNi0xLTEtMzEyMTY_e902c04d-4797-41e7-b0e3-1effb8234ec7"
      unitRef="usd">-11597000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzItOC0xLTEtMzEyMTY_de794a77-fbe2-458c-b90e-69dd07998ef3"
      unitRef="usd">1165574000</us-gaap:ProfitLoss>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i26a43a36f7b84e17a5c4a3f441a8d61b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzQtMi0xLTEtMzEyMTY_b13fb6a8-1572-44ce-8649-c62d42317d21"
      unitRef="usd">6000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="icc0349f558524b69a56d1b79ef3651be_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzQtNC0xLTEtMzEyMTY_a00e9527-72fd-4cb9-9f1a-8b13b0122d97"
      unitRef="usd">27963000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="iee19945c297442c99fabe50468a25677_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzQtNi0xLTEtMzEyMTY_9f4d3f07-d074-4c0d-aa76-8025d782e05e"
      unitRef="usd">0</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzQtOC0xLTEtMzEyMTY_b9d4ce5e-878f-495a-9b8a-4e466c7c0cd0"
      unitRef="usd">27969000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i26a43a36f7b84e17a5c4a3f441a8d61b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzYtMi0xLTEtMzEyMTY_c92b1f1f-894e-4608-a728-05c3413e72b0"
      unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="icc0349f558524b69a56d1b79ef3651be_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzYtNC0xLTEtMzEyMTY_8d6b5e08-73a3-4d2c-829e-f6b5c78d8387"
      unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="iee19945c297442c99fabe50468a25677_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzYtNi0xLTEtMzEyMTY_db00355f-2789-4d52-91c3-f68b4bd82868"
      unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzYtOC0xLTEtMzEyMTY_31e6349c-cacf-491d-9516-dcba8938b5f8"
      unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:RestructuringCharges
      contextRef="i26a43a36f7b84e17a5c4a3f441a8d61b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzctMi0xLTEtMzEyMTY_00715867-f97f-44c1-8a49-9547c2979677"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="icc0349f558524b69a56d1b79ef3651be_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzctNC0xLTEtMzEyMTY_d4c74646-f4ea-492d-aa00-0ab54bf4fa4b"
      unitRef="usd">7268000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="iee19945c297442c99fabe50468a25677_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzctNi0xLTEtMzEyMTY_d8936a48-9a5e-497c-b1ae-db596cb7fc8c"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzctOC0xLTEtMzEyMTY_14172f4c-b9a6-4f6b-88d0-658a506c40b9"
      unitRef="usd">7268000</us-gaap:RestructuringCharges>
    <us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts
      contextRef="i26a43a36f7b84e17a5c4a3f441a8d61b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzgtMi0xLTEtMzEyMTY_f8440ad1-9ab6-4f14-9a3a-fe4e989c1f0c"
      unitRef="usd">117000</us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts>
    <us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts
      contextRef="icc0349f558524b69a56d1b79ef3651be_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzgtNC0xLTEtMzEyMTY_de0e4c00-02db-4799-a896-b2755fa784ec"
      unitRef="usd">32091000</us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts>
    <us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts
      contextRef="iee19945c297442c99fabe50468a25677_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzgtNi0xLTEtMzEyMTY_7aca6f68-b618-40a4-8060-67f8c145483b"
      unitRef="usd">0</us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts>
    <us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzgtOC0xLTEtMzEyMTY_a68b1f9f-dde5-42b7-a06b-18b1d5eec6c4"
      unitRef="usd">32208000</us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i26a43a36f7b84e17a5c4a3f441a8d61b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzktMi0xLTEtMzEyMTY_772c61b6-5134-47dd-a36d-6a3eba20658f"
      unitRef="usd">0</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="icc0349f558524b69a56d1b79ef3651be_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzktNC0xLTEtMzEyMTY_154b4a6d-baea-4331-b4bd-3cfd592da1bf"
      unitRef="usd">1276819000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="iee19945c297442c99fabe50468a25677_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzktNi0xLTEtMzEyMTY_f060c8a6-7037-4966-b188-69f5fa014476"
      unitRef="usd">0</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzktOC0xLTEtMzEyMTY_50553164-0fef-43ba-8ba3-87612b232925"
      unitRef="usd">1276819000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="i26a43a36f7b84e17a5c4a3f441a8d61b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzExLTItMS0xLTMxMjE2_8f7042ce-4172-419b-bbcd-6e742c11a8df"
      unitRef="usd">0</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="icc0349f558524b69a56d1b79ef3651be_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzExLTQtMS0xLTMxMjE2_b1f30b46-1cdb-4213-b31e-240bb8f8dda3"
      unitRef="usd">16277000</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="iee19945c297442c99fabe50468a25677_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzExLTYtMS0xLTMxMjE2_24e936ac-e227-44e7-a031-a6f2adc83ee2"
      unitRef="usd">0</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzExLTgtMS0xLTMxMjE2_2c2a879e-6eda-4de1-900d-53cb88f9fb63"
      unitRef="usd">16277000</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i26a43a36f7b84e17a5c4a3f441a8d61b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzEyLTItMS0xLTMxMjE2_2711c04d-201e-4b1a-b2d6-65d496efcde0"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="icc0349f558524b69a56d1b79ef3651be_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzEyLTQtMS0xLTMxMjE2_029944de-45d7-4b05-a300-6d36825c15e5"
      unitRef="usd">-2009000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="iee19945c297442c99fabe50468a25677_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzEyLTYtMS0xLTMxMjE2_292a0151-3a55-4421-87d4-cd4596b087ff"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzEyLTgtMS0xLTMxMjE2_435f00f6-f4b0-4245-98a7-53ceedd436bf"
      unitRef="usd">-2009000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i26a43a36f7b84e17a5c4a3f441a8d61b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzE1LTItMS0xLTMxMjE2_433864c2-9202-4d95-8c66-d251b87b1301"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="icc0349f558524b69a56d1b79ef3651be_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzE1LTQtMS0xLTMxMjE2_e05384e2-4628-4533-ad7e-115fc84ba8ca"
      unitRef="usd">-363000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="iee19945c297442c99fabe50468a25677_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzE1LTYtMS0xLTMxMjE2_67fd454b-d92e-419b-8a9b-2e1e0dcbf7ec"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzE1LTgtMS0xLTMxMjE2_c8f58683-df69-480f-8070-6d6b5a3727b4"
      unitRef="usd">-363000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i26a43a36f7b84e17a5c4a3f441a8d61b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzE4LTItMS0xLTMyMjU5_247ca44d-b389-4ca3-af0c-de26a35ab1da"
      unitRef="usd">-182000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="icc0349f558524b69a56d1b79ef3651be_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzE4LTQtMS0xLTMyMjU5_37821ab3-76b7-41be-91f7-4d331fb23820"
      unitRef="usd">197000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="iee19945c297442c99fabe50468a25677_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzE4LTYtMS0xLTMyMjU5_75c9f07c-bb91-427f-b7f1-e957d05c54f2"
      unitRef="usd">182000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzE4LTgtMS0xLTMyMjU5_6f06984b-e718-4f9c-aeb6-6d5a3061b4b1"
      unitRef="usd">197000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i26a43a36f7b84e17a5c4a3f441a8d61b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzE4LTItMS0xLTMxMjE2_64363f3e-0a30-4ee4-bbc9-078e75d0f6a4"
      unitRef="usd">900000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="icc0349f558524b69a56d1b79ef3651be_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzE4LTQtMS0xLTMxMjE2_5bbecd7e-a873-469b-9f7c-f3e21664b38c"
      unitRef="usd">10719000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="iee19945c297442c99fabe50468a25677_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzE4LTYtMS0xLTMxMjE2_d97281dd-26ad-45d2-8b9c-8d4ab61cb4b5"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzE4LTgtMS0xLTMxMjE2_9bdfa1ee-55aa-4171-b5ee-fcdf61ba6f36"
      unitRef="usd">11619000</us-gaap:AllocatedShareBasedCompensationExpense>
    <cron:AdjustedEarningsBeforeInterestAndTaxes
      contextRef="i26a43a36f7b84e17a5c4a3f441a8d61b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzE5LTItMS0xLTMxMjE2_514a7072-bbbd-4896-b097-cc7d03b54cbe"
      unitRef="usd">-1877000</cron:AdjustedEarningsBeforeInterestAndTaxes>
    <cron:AdjustedEarningsBeforeInterestAndTaxes
      contextRef="icc0349f558524b69a56d1b79ef3651be_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzE5LTQtMS0xLTMxMjE2_b224e35d-caca-47b6-9e36-c6407f90cdea"
      unitRef="usd">-88565000</cron:AdjustedEarningsBeforeInterestAndTaxes>
    <cron:AdjustedEarningsBeforeInterestAndTaxes
      contextRef="iee19945c297442c99fabe50468a25677_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzE5LTYtMS0xLTMxMjE2_aba4cb19-014e-4bcb-87b5-900f9eabd310"
      unitRef="usd">-11779000</cron:AdjustedEarningsBeforeInterestAndTaxes>
    <cron:AdjustedEarningsBeforeInterestAndTaxes
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzE5LTgtMS0xLTMxMjE2_bd02f91b-5f3c-4331-a58f-9adb4e8b6a9e"
      unitRef="usd">-102221000</cron:AdjustedEarningsBeforeInterestAndTaxes>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i26a43a36f7b84e17a5c4a3f441a8d61b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzIxLTItMS0xLTMxMjE2_1292c1be-bcda-4a3a-8376-1ef76e5c5b9f"
      unitRef="usd">174000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="icc0349f558524b69a56d1b79ef3651be_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzIxLTQtMS0xLTMxMjE2_2116fccf-6a5b-4d4a-816b-c299f2c65ddb"
      unitRef="usd">3739000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="iee19945c297442c99fabe50468a25677_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzIxLTYtMS0xLTMxMjE2_79312b74-b007-4a3c-85c5-f2e76246ce70"
      unitRef="usd">0</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzIxLTgtMS0xLTMxMjE2_70fa8aee-aeae-48a8-8789-fdcb89b3096f"
      unitRef="usd">3913000</us-gaap:DepreciationDepletionAndAmortization>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i26a43a36f7b84e17a5c4a3f441a8d61b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzIyLTItMS0xLTMxMjE2_af36e2b3-84b2-46bb-994b-772c17ced9f7"
      unitRef="usd">-1703000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="icc0349f558524b69a56d1b79ef3651be_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzIyLTQtMS0xLTMxMjE2_299f2ca7-b9ee-4775-b475-c813f6f5f6e3"
      unitRef="usd">-84826000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="iee19945c297442c99fabe50468a25677_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzIyLTYtMS0xLTMxMjE2_edb17d6b-93c9-4819-8927-a223dfa93a0e"
      unitRef="usd">-11779000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTpiZGM0YzI2MDAzNGM0ZjE5YmQ5YjY0NjFhNjI3MGY4ZS90YWJsZXJhbmdlOmJkYzRjMjYwMDM0YzRmMTliZDliNjQ2MWE2MjcwZjhlXzIyLTgtMS0xLTMxMjE2_f59d5d73-3767-4b32-b99c-7e768b96b69e"
      unitRef="usd">-98308000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <us-gaap:ProfitLoss
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZToyYjQ3MGU2ODIwYzM0OGQ5YTIwNTdjZTYwOWE4YWZhMC90YWJsZXJhbmdlOjJiNDcwZTY4MjBjMzQ4ZDlhMjA1N2NlNjA5YThhZmEwXzItOS0xLTEtMjc4ODg_80b9193e-9291-489b-bdb8-d54632627f4f"
      unitRef="usd">-21817000</us-gaap:ProfitLoss>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZToyYjQ3MGU2ODIwYzM0OGQ5YTIwNTdjZTYwOWE4YWZhMC90YWJsZXJhbmdlOjJiNDcwZTY4MjBjMzQ4ZDlhMjA1N2NlNjA5YThhZmEwXzQtOS0xLTEtMjc4ODg_7b07833d-9a5d-43e3-8ef2-afe0e9c9f1e2"
      unitRef="usd">81000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZToyYjQ3MGU2ODIwYzM0OGQ5YTIwNTdjZTYwOWE4YWZhMC90YWJsZXJhbmdlOjJiNDcwZTY4MjBjMzQ4ZDlhMjA1N2NlNjA5YThhZmEwXzExLTktMS0xLTI3ODg4_4430c489-dd8f-4447-9af5-f4b5e5650a41"
      unitRef="usd">164000</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZToyYjQ3MGU2ODIwYzM0OGQ5YTIwNTdjZTYwOWE4YWZhMC90YWJsZXJhbmdlOjJiNDcwZTY4MjBjMzQ4ZDlhMjA1N2NlNjA5YThhZmEwXzEyLTktMS0xLTI3ODg4_5d54bffe-1fde-4e74-9e98-8f973b4be246"
      unitRef="usd">-723000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZToyYjQ3MGU2ODIwYzM0OGQ5YTIwNTdjZTYwOWE4YWZhMC90YWJsZXJhbmdlOjJiNDcwZTY4MjBjMzQ4ZDlhMjA1N2NlNjA5YThhZmEwXzE1LTktMS0xLTI3ODg4_b64322c9-b8ed-4a15-b664-1a54f90e3926"
      unitRef="usd">-894000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZToyYjQ3MGU2ODIwYzM0OGQ5YTIwNTdjZTYwOWE4YWZhMC90YWJsZXJhbmdlOjJiNDcwZTY4MjBjMzQ4ZDlhMjA1N2NlNjA5YThhZmEwXzE4LTktMS0xLTI3ODg4_7f3efd80-cfd7-4a4e-bdbb-0bb99826dc52"
      unitRef="usd">8151000</us-gaap:AllocatedShareBasedCompensationExpense>
    <cron:AdjustedEarningsBeforeInterestAndTaxes
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZToyYjQ3MGU2ODIwYzM0OGQ5YTIwNTdjZTYwOWE4YWZhMC90YWJsZXJhbmdlOjJiNDcwZTY4MjBjMzQ4ZDlhMjA1N2NlNjA5YThhZmEwXzIwLTktMS0xLTI3ODg4_c6a2627e-cd55-414e-b130-cfa08a5619b3"
      unitRef="usd">-12294000</cron:AdjustedEarningsBeforeInterestAndTaxes>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZToyYjQ3MGU2ODIwYzM0OGQ5YTIwNTdjZTYwOWE4YWZhMC90YWJsZXJhbmdlOjJiNDcwZTY4MjBjMzQ4ZDlhMjA1N2NlNjA5YThhZmEwXzIyLTktMS0xLTMyMDA5_0dbb1f08-6a16-484a-a8f7-d98abe751b0d"
      unitRef="usd">1937000</us-gaap:DepreciationDepletionAndAmortization>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZToyYjQ3MGU2ODIwYzM0OGQ5YTIwNTdjZTYwOWE4YWZhMC90YWJsZXJhbmdlOjJiNDcwZTY4MjBjMzQ4ZDlhMjA1N2NlNjA5YThhZmEwXzIzLTktMS0xLTMyMDA5_b3358276-2b2a-4120-8643-79d076be4c1e"
      unitRef="usd">-10357000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ieb7e744f257046829976b63a309059b9_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZToyYWNiMDI4NTlkMDE0N2Y4YWQzNWI2ZDE4YzdlMzYzZS90YWJsZXJhbmdlOjJhY2IwMjg1OWQwMTQ3ZjhhZDM1YjZkMThjN2UzNjNlXzItMS0xLTEtMjIzNA_6739e065-1f0f-46d7-b00b-ea84bd4599e5"
      unitRef="usd">27932000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icacdfb65bc3149b38b733a4732feeebb_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZToyYWNiMDI4NTlkMDE0N2Y4YWQzNWI2ZDE4YzdlMzYzZS90YWJsZXJhbmdlOjJhY2IwMjg1OWQwMTQ3ZjhhZDM1YjZkMThjN2UzNjNlXzItMy0xLTEtMjIzNA_ba08dacc-8765-49a2-aa79-e64168536e50"
      unitRef="usd">15020000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i158da074fdac41459e9ec56ee32c9222_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZToyYWNiMDI4NTlkMDE0N2Y4YWQzNWI2ZDE4YzdlMzYzZS90YWJsZXJhbmdlOjJhY2IwMjg1OWQwMTQ3ZjhhZDM1YjZkMThjN2UzNjNlXzMtMS0xLTEtMjIzNA_5c722ad2-5211-451f-a7f0-f378f250285e"
      unitRef="usd">18254000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib13faff76de54e4d94e71c14d2ef55b9_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZToyYWNiMDI4NTlkMDE0N2Y4YWQzNWI2ZDE4YzdlMzYzZS90YWJsZXJhbmdlOjJhY2IwMjg1OWQwMTQ3ZjhhZDM1YjZkMThjN2UzNjNlXzMtMy0xLTEtMjIzNA_87fced5d-3933-41cf-b9ee-9ad295059c79"
      unitRef="usd">8702000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i63f66899247a46fa95fe02f9bd08dfaa_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZToyYWNiMDI4NTlkMDE0N2Y4YWQzNWI2ZDE4YzdlMzYzZS90YWJsZXJhbmdlOjJhY2IwMjg1OWQwMTQ3ZjhhZDM1YjZkMThjN2UzNjNlXzQtMS0xLTEtMjIzNA_cfc0e0cf-e28c-4d3b-b383-affcba00566a"
      unitRef="usd">533000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i68edd065b3774520abe09eb1c8de7c1f_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZToyYWNiMDI4NTlkMDE0N2Y4YWQzNWI2ZDE4YzdlMzYzZS90YWJsZXJhbmdlOjJhY2IwMjg1OWQwMTQ3ZjhhZDM1YjZkMThjN2UzNjNlXzQtMy0xLTEtMjIzNA_ab71cbc2-05ff-4c06-a0bc-cd186cdf4d3c"
      unitRef="usd">28000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZToyYWNiMDI4NTlkMDE0N2Y4YWQzNWI2ZDE4YzdlMzYzZS90YWJsZXJhbmdlOjJhY2IwMjg1OWQwMTQ3ZjhhZDM1YjZkMThjN2UzNjNlXzUtMS0xLTEtMjIzNA_2b159de6-ab40-41ba-be6d-f2eb50888016"
      unitRef="usd">46719000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZToyYWNiMDI4NTlkMDE0N2Y4YWQzNWI2ZDE4YzdlMzYzZS90YWJsZXJhbmdlOjJhY2IwMjg1OWQwMTQ3ZjhhZDM1YjZkMThjN2UzNjNlXzUtMy0xLTEtMjIzNA_87077f53-fcfa-4807-8f3f-5b77b707d1fc"
      unitRef="usd">23750000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90ZXh0cmVnaW9uOjkxYTQyNWEyY2NhZTQ0MjRhZjI5NDM4OTAwZTRkZDU0XzIzNjM5NTAwMDAyNDY4_3d23af6a-e9dc-4198-8bcd-62ae97feb4f5">&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net revenue attributed to a geographic region based on the location of the customer were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.594%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canada&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other countries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib40ea4716ab44dde9b0cc0ccf563964b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZDM3YTRhYTA2YmY0NDdkYmQ1YmZmZjIxYTgzM2IzMS90YWJsZXJhbmdlOjBkMzdhNGFhMDZiZjQ0N2RiZDViZmZmMjFhODMzYjMxXzItMS0xLTEtMA_ed5639b8-ddd5-4bd8-8682-e075f76c57cc"
      unitRef="usd">34538000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4158b30eaf8f4fb4928372059c234242_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZDM3YTRhYTA2YmY0NDdkYmQ1YmZmZjIxYTgzM2IzMS90YWJsZXJhbmdlOjBkMzdhNGFhMDZiZjQ0N2RiZDViZmZmMjFhODMzYjMxXzItMy0xLTEtMA_44052b13-5630-4404-86f1-2b07671ab64d"
      unitRef="usd">20202000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib5ae31aceb854001ad8f87c6ab2e2250_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZDM3YTRhYTA2YmY0NDdkYmQ1YmZmZjIxYTgzM2IzMS90YWJsZXJhbmdlOjBkMzdhNGFhMDZiZjQ0N2RiZDViZmZmMjFhODMzYjMxXzMtMS0xLTEtMA_a09ec46a-2906-460d-a27f-d6059c464f79"
      unitRef="usd">9495000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i547cfac932ed40edb1c94ffbbad4dcc1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZDM3YTRhYTA2YmY0NDdkYmQ1YmZmZjIxYTgzM2IzMS90YWJsZXJhbmdlOjBkMzdhNGFhMDZiZjQ0N2RiZDViZmZmMjFhODMzYjMxXzMtMy0xLTEtMA_801ffea2-9fa8-4c9c-ab4f-b07981fdd34b"
      unitRef="usd">3364000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3ce234a38db449af89d262f77eca0633_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZDM3YTRhYTA2YmY0NDdkYmQ1YmZmZjIxYTgzM2IzMS90YWJsZXJhbmdlOjBkMzdhNGFhMDZiZjQ0N2RiZDViZmZmMjFhODMzYjMxXzQtMS0xLTEtMA_5be11a4b-03f4-4ce4-bba4-c98af1c1cc9b"
      unitRef="usd">2686000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3eb48e3b8cdf43109bd6c4aec124b38c_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZDM3YTRhYTA2YmY0NDdkYmQ1YmZmZjIxYTgzM2IzMS90YWJsZXJhbmdlOjBkMzdhNGFhMDZiZjQ0N2RiZDViZmZmMjFhODMzYjMxXzQtMy0xLTEtMA_0cf952fd-71f9-460e-ac1a-6692de82ad1c"
      unitRef="usd">184000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZDM3YTRhYTA2YmY0NDdkYmQ1YmZmZjIxYTgzM2IzMS90YWJsZXJhbmdlOjBkMzdhNGFhMDZiZjQ0N2RiZDViZmZmMjFhODMzYjMxXzUtMS0xLTEtMA_4361d996-d05a-4545-b349-9e9385e0d336"
      unitRef="usd">46719000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTowZDM3YTRhYTA2YmY0NDdkYmQ1YmZmZjIxYTgzM2IzMS90YWJsZXJhbmdlOjBkMzdhNGFhMDZiZjQ0N2RiZDViZmZmMjFhODMzYjMxXzUtMy0xLTEtMA_e4ba8387-48f1-412d-a119-4b840ee6a463"
      unitRef="usd">23750000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90ZXh0cmVnaW9uOjkxYTQyNWEyY2NhZTQ0MjRhZjI5NDM4OTAwZTRkZDU0XzIzNjM5NTAwMDAyNDY5_f860c41e-e1d9-407a-a7f3-6a0837888173">&lt;div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment assets were physically located in the following geographic regions: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.594%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canada&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other countries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock>
    <us-gaap:NoncurrentAssets
      contextRef="ib2a8cc1e89df42f890fd0544f7d58036_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTplZGQyYzY0MDM3YmY0ODAzYmJmZDAyODlkNzViMjRkMi90YWJsZXJhbmdlOmVkZDJjNjQwMzdiZjQ4MDNiYmZkMDI4OWQ3NWIyNGQyXzEtMi0xLTEtMA_692a3d58-8ccc-4b33-ba68-932a519de58e"
      unitRef="usd">162163000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="ibacf20036dff4b1cafe624b96ee80e2b_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTplZGQyYzY0MDM3YmY0ODAzYmJmZDAyODlkNzViMjRkMi90YWJsZXJhbmdlOmVkZDJjNjQwMzdiZjQ4MDNiYmZkMDI4OWQ3NWIyNGQyXzEtMy0xLTEtMzYzMg_80a5bea1-de05-4c73-b5a1-a3937df357de"
      unitRef="usd">139160000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i49c555e7906f4ba3bd9c50b3f3e63909_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTplZGQyYzY0MDM3YmY0ODAzYmJmZDAyODlkNzViMjRkMi90YWJsZXJhbmdlOmVkZDJjNjQwMzdiZjQ4MDNiYmZkMDI4OWQ3NWIyNGQyXzItMi0xLTEtMA_8c6cab12-53c2-4c49-9d32-03bfe51e1e2e"
      unitRef="usd">2293000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i147481f9ccf54c42aab89c6b4142bc85_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTplZGQyYzY0MDM3YmY0ODAzYmJmZDAyODlkNzViMjRkMi90YWJsZXJhbmdlOmVkZDJjNjQwMzdiZjQ4MDNiYmZkMDI4OWQ3NWIyNGQyXzItMy0xLTEtMzYzMg_00aaa524-a4b8-4b1d-88f9-a907336754c0"
      unitRef="usd">2103000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="iff5acdedd7bc45eda6a7ff33e8f0c2ff_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTplZGQyYzY0MDM3YmY0ODAzYmJmZDAyODlkNzViMjRkMi90YWJsZXJhbmdlOmVkZDJjNjQwMzdiZjQ4MDNiYmZkMDI4OWQ3NWIyNGQyXzMtMi0xLTEtMA_d1767900-2f31-4cb3-b1f7-14fa219c4f26"
      unitRef="usd">23143000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i6216f2542b024e11b06a97e92eb7a918_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTplZGQyYzY0MDM3YmY0ODAzYmJmZDAyODlkNzViMjRkMi90YWJsZXJhbmdlOmVkZDJjNjQwMzdiZjQ4MDNiYmZkMDI4OWQ3NWIyNGQyXzMtMy0xLTEtMzYzMg_267d7ac5-6471-47da-b15d-0d146044c924"
      unitRef="usd">18685000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTplZGQyYzY0MDM3YmY0ODAzYmJmZDAyODlkNzViMjRkMi90YWJsZXJhbmdlOmVkZDJjNjQwMzdiZjQ4MDNiYmZkMDI4OWQ3NWIyNGQyXzQtMi0xLTEtMA_002fab25-d00b-49c0-b2e1-22bac24ba399"
      unitRef="usd">187599000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90YWJsZTplZGQyYzY0MDM3YmY0ODAzYmJmZDAyODlkNzViMjRkMi90YWJsZXJhbmdlOmVkZDJjNjQwMzdiZjQ4MDNiYmZkMDI4OWQ3NWIyNGQyXzQtMy0xLTEtMzYzMg_acbb93b7-25a2-4383-b994-15a045dd84b5"
      unitRef="usd">159948000</us-gaap:NoncurrentAssets>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="ibf0cace378954c33a3cfab1cad1ec952_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90ZXh0cmVnaW9uOjkxYTQyNWEyY2NhZTQ0MjRhZjI5NDM4OTAwZTRkZDU0XzI0ODY_b10a77a3-03e5-4bc6-bfca-172fc0538ae2"
      unitRef="usd">65000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i6a1719ab03cd42e2b05239b317a45891_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90ZXh0cmVnaW9uOjkxYTQyNWEyY2NhZTQ0MjRhZjI5NDM4OTAwZTRkZDU0XzEwOTk1MTE2MjgzMjkz_ef3449fe-57d2-4ee2-a77b-c5dd72fccfdd"
      unitRef="usd">12000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="id96e82b9cf384477a9af4880138f28ff_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90ZXh0cmVnaW9uOjkxYTQyNWEyY2NhZTQ0MjRhZjI5NDM4OTAwZTRkZDU0XzI3MDE_fc3b85a9-4bcb-44ec-ba2f-49d0d14b7593"
      unitRef="usd">34295000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ica7d2c4edb04482398d2b6d385a68007_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90ZXh0cmVnaW9uOjkxYTQyNWEyY2NhZTQ0MjRhZjI5NDM4OTAwZTRkZDU0XzI3MzU_022448e9-ad72-4333-bb17-c6127b1f3321"
      unitRef="usd">7597000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ib5a5a7b93a18452991b71bf6eb470705_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90ZXh0cmVnaW9uOjkxYTQyNWEyY2NhZTQ0MjRhZjI5NDM4OTAwZTRkZDU0XzI3NDc_16bead25-1803-4f52-9150-98861cfd4403"
      unitRef="usd">2186000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ifc2b8542eb104b93bf4d861b434940bb_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90ZXh0cmVnaW9uOjkxYTQyNWEyY2NhZTQ0MjRhZjI5NDM4OTAwZTRkZDU0XzEwOTk1MTE2MzEyNjU_848b4bc5-2d15-4ef4-90b1-bf45d48fdb26"
      unitRef="number">0.63</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="iade5a2ef289d4446ada902ad69bd2ed7_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90ZXh0cmVnaW9uOjkxYTQyNWEyY2NhZTQ0MjRhZjI5NDM4OTAwZTRkZDU0XzEwOTk1MTE2MzEyNjg_c7b42ee4-c4a9-4a0b-ad6b-94686c247fdd"
      unitRef="number">0.32</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ibc2bd3e2f45e4164b7257955608b6e46_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90ZXh0cmVnaW9uOjkxYTQyNWEyY2NhZTQ0MjRhZjI5NDM4OTAwZTRkZDU0XzEwOTk1MTE2MzEyNzE_f2d8bd74-1e20-4cd6-b59c-deb73787cf19"
      unitRef="number">0.17</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="if3eb5650187c4de5bbc98d6b7274d811_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90ZXh0cmVnaW9uOjkxYTQyNWEyY2NhZTQ0MjRhZjI5NDM4OTAwZTRkZDU0XzI4NzY_5dab7ab3-3a39-4169-b46f-7db02b1320d6"
      unitRef="usd">9000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i8b7d1cb41ba640babfa7a78721a319f5_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90ZXh0cmVnaW9uOjkxYTQyNWEyY2NhZTQ0MjRhZjI5NDM4OTAwZTRkZDU0XzI4ODU_1f41656d-77f7-40af-a515-c6a9a744c28a"
      unitRef="usd">124000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i5058324201ad4dc6b28728f9d5d3d612_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xODcvZnJhZzo5MWE0MjVhMmNjYWU0NDI0YWYyOTQzODkwMGU0ZGQ1NC90ZXh0cmVnaW9uOjkxYTQyNWEyY2NhZTQ0MjRhZjI5NDM4OTAwZTRkZDU0XzEzMTk0MTM5NTM3MDg0_a0f15c80-c71b-4107-aef7-382e71f7a580"
      unitRef="usd">0</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGV4dHJlZ2lvbjpjMDE0OTg3MWU3YmM0OTY5OTA3NjJmMGI5ZTc3ZTZjYl84MjQ2MzM3MjE0Mjkx_e9db51c4-fec1-4454-956f-6c1621ffcba8">Discontinued Operations and Held-for-sale Assets&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2020, the Company advanced its plans for the sale and disposal of substantially all of the assets of OGBC. As a result, OGBC&#x2019;s results of operations have been reclassified as discontinued operations in the accompanying consolidated financial statements. Accordingly, the property, plant and equipment assets of OGBC are separately reported as assets and liabilities held-for-sale as of December&#160;31, 2020 on the consolidated balance sheet. For comparative purposes, amounts in the prior periods have been reclassified to conform to current year presentation, as disclosed below. For the year ended December&#160;31, 2020, the Company recorded $1,860 as a loss on held-for-sale assets, including $919 as a valuation allowance loss upon reclassification of property, plant and equipment assets as held-for-sale in Q3 2020, and a further $941 impairment charge on held-for-sale assets in Q4 2020 upon surrender of the OGBC Health Canada licenses. OGBC was formerly included within the Rest of World segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the financial information for discontinued operations as of December&#160;31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.050%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.050%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated statements of net income (loss) and comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;OGBC income (loss) from discontinued operations, net of income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(650)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(363)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(894)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.594%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated balance sheets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term assets classified as discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents a reconciliation of the carrying amounts of major classes of assets and liabilities of the discontinued operations to total assets and liabilities of the disposal group classified as held-for-sale in the consolidated balance sheet of December&#160;31, 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As previously disclosed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Held-for-sale adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjusted balance&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,861)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,085)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(302)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents a reconciliation of the major classes of line items constituting reported operating loss of discontinued operations to net loss of discontinued operations for the years ended December&#160;31, 2019 and December&#160;31, 2018:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.793%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As previously disclosed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Held-for-sale adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjusted balance&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory write-down&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29,440)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29,173)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(103,620)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(103,511)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,287,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,287,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss) from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,165,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,165,937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.793%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As previously disclosed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Held-for-sale adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjusted balance&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27,554)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26,658)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(476)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(478)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss) from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21,817)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,923)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock>
    <us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown
      contextRef="i056a3d33bb7244a2b1da220202bcbb81_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGV4dHJlZ2lvbjpjMDE0OTg3MWU3YmM0OTY5OTA3NjJmMGI5ZTc3ZTZjYl8xMjY0NDM4MzcyMzkxMg_22808186-9030-45e6-8222-4bc2d933902e"
      unitRef="usd">1860000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
    <cron:DiscontinuedOperationAssetsValuationAllowanceValuationIncrease
      contextRef="i056a3d33bb7244a2b1da220202bcbb81_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGV4dHJlZ2lvbjpjMDE0OTg3MWU3YmM0OTY5OTA3NjJmMGI5ZTc3ZTZjYl8yMDM0MDk2NTExODM3OA_f4ae494d-b434-4b58-9582-bcc8d59a4130"
      unitRef="usd">919000</cron:DiscontinuedOperationAssetsValuationAllowanceValuationIncrease>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="i056a3d33bb7244a2b1da220202bcbb81_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGV4dHJlZ2lvbjpjMDE0OTg3MWU3YmM0OTY5OTA3NjJmMGI5ZTc3ZTZjYl8xMjY0NDM4MzcyMzc5NA_fc330c6a-2a78-412e-b64e-0c487665e617"
      unitRef="usd">941000</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGV4dHJlZ2lvbjpjMDE0OTg3MWU3YmM0OTY5OTA3NjJmMGI5ZTc3ZTZjYl84Nzk2MDkzMDI4MTc0_4c563d74-5fb2-43fc-9cc3-8d3ead8d23a8">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the financial information for discontinued operations as of December&#160;31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.050%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.050%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated statements of net income (loss) and comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;OGBC income (loss) from discontinued operations, net of income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(650)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(363)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(894)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.594%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Consolidated balance sheets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term assets classified as discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents a reconciliation of the carrying amounts of major classes of assets and liabilities of the discontinued operations to total assets and liabilities of the disposal group classified as held-for-sale in the consolidated balance sheet of December&#160;31, 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As previously disclosed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Held-for-sale adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjusted balance&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,861)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,085)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(302)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents a reconciliation of the major classes of line items constituting reported operating loss of discontinued operations to net loss of discontinued operations for the years ended December&#160;31, 2019 and December&#160;31, 2018:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.793%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As previously disclosed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Held-for-sale adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjusted balance&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory write-down&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29,440)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29,173)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(103,620)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(103,511)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,287,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,287,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss) from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,165,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,165,937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.793%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As previously disclosed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Held-for-sale adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjusted balance&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27,554)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26,658)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(476)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(478)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss) from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21,817)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,923)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
      contextRef="i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6ZGI1OTdkNzU5NmFiNDJhOGJhZDVjMjVmNjQyYjQzZDMvdGFibGVyYW5nZTpkYjU5N2Q3NTk2YWI0MmE4YmFkNWMyNWY2NDJiNDNkM18zLTEtMS0xLTE3MDUy_c50e788b-be68-4735-9e81-9272edf10c39"
      unitRef="usd">-650000</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6ZGI1OTdkNzU5NmFiNDJhOGJhZDVjMjVmNjQyYjQzZDMvdGFibGVyYW5nZTpkYjU5N2Q3NTk2YWI0MmE4YmFkNWMyNWY2NDJiNDNkM18zLTMtMS0xLTE3MDUy_d52e831e-5cd5-401d-a996-2a7beb705d57"
      unitRef="usd">-363000</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6ZGI1OTdkNzU5NmFiNDJhOGJhZDVjMjVmNjQyYjQzZDMvdGFibGVyYW5nZTpkYjU5N2Q3NTk2YWI0MmE4YmFkNWMyNWY2NDJiNDNkM18zLTUtMS0xLTIwMDIx_830bd795-7c2e-44e1-b75f-f1a6072c6b7f"
      unitRef="usd">-894000</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
      contextRef="ifb8c52c55d9641488fdc94ebb5b68457_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6NDY2NmYxODMyMGMzNDFlNGE4ZWUxNDc2YWQxMmI4N2MvdGFibGVyYW5nZTo0NjY2ZjE4MzIwYzM0MWU0YThlZTE0NzZhZDEyYjg3Y18yLTEtMS0xLTE3MDYy_63bf8f10-704e-45dd-b7d9-95434a4ecde6"
      unitRef="usd">1176000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6NDY2NmYxODMyMGMzNDFlNGE4ZWUxNDc2YWQxMmI4N2MvdGFibGVyYW5nZTo0NjY2ZjE4MzIwYzM0MWU0YThlZTE0NzZhZDEyYjg3Y18yLTMtMS0xLTE3MDYy_3dbab08a-0b84-4511-96bc-99c625458092"
      unitRef="usd">3248000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ibf1081084a8046e199cfa22c963ee2b1_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6NDRhNmNiZTZjYjU1NDE1ZGI2ZWJkMDJjZGU1YzNiM2UvdGFibGVyYW5nZTo0NGE2Y2JlNmNiNTU0MTVkYjZlYmQwMmNkZTVjM2IzZV8yLTItMS0xLTE2OTg5_8457e083-9ea4-428f-b5d6-5f93fdd2d09d"
      unitRef="usd">161809000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ib0190bb591a841c1a6f34ddeea55db58_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6NDRhNmNiZTZjYjU1NDE1ZGI2ZWJkMDJjZGU1YzNiM2UvdGFibGVyYW5nZTo0NGE2Y2JlNmNiNTU0MTVkYjZlYmQwMmNkZTVjM2IzZV8yLTQtMS0xLTE2OTg5_d82f90c4-ede9-4340-8449-762cd8686c34"
      unitRef="usd">-1861000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6NDRhNmNiZTZjYjU1NDE1ZGI2ZWJkMDJjZGU1YzNiM2UvdGFibGVyYW5nZTo0NGE2Y2JlNmNiNTU0MTVkYjZlYmQwMmNkZTVjM2IzZV8yLTYtMS0xLTE2OTQ1_da5b92ee-8867-4683-9103-9bfb7b8d424d"
      unitRef="usd">159948000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ibf1081084a8046e199cfa22c963ee2b1_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6NDRhNmNiZTZjYjU1NDE1ZGI2ZWJkMDJjZGU1YzNiM2UvdGFibGVyYW5nZTo0NGE2Y2JlNmNiNTU0MTVkYjZlYmQwMmNkZTVjM2IzZV8zLTItMS0xLTE2OTg5_6f70e9ee-f0e3-4eda-b27d-896d4ccc164a"
      unitRef="usd">72320000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ib0190bb591a841c1a6f34ddeea55db58_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6NDRhNmNiZTZjYjU1NDE1ZGI2ZWJkMDJjZGU1YzNiM2UvdGFibGVyYW5nZTo0NGE2Y2JlNmNiNTU0MTVkYjZlYmQwMmNkZTVjM2IzZV8zLTQtMS0xLTE2OTg5_eacc6a48-3080-4bf3-87ae-0b4ad46f8127"
      unitRef="usd">-1085000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6NDRhNmNiZTZjYjU1NDE1ZGI2ZWJkMDJjZGU1YzNiM2UvdGFibGVyYW5nZTo0NGE2Y2JlNmNiNTU0MTVkYjZlYmQwMmNkZTVjM2IzZV8zLTYtMS0xLTE2OTQ1_7916c275-e86f-4d66-a689-668a95208d36"
      unitRef="usd">71235000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill
      contextRef="ibf1081084a8046e199cfa22c963ee2b1_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6NDRhNmNiZTZjYjU1NDE1ZGI2ZWJkMDJjZGU1YzNiM2UvdGFibGVyYW5nZTo0NGE2Y2JlNmNiNTU0MTVkYjZlYmQwMmNkZTVjM2IzZV80LTItMS0xLTE2OTg5_b30ca9de-32bf-4594-bc93-9107e2742371"
      unitRef="usd">214794000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ib0190bb591a841c1a6f34ddeea55db58_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6NDRhNmNiZTZjYjU1NDE1ZGI2ZWJkMDJjZGU1YzNiM2UvdGFibGVyYW5nZTo0NGE2Y2JlNmNiNTU0MTVkYjZlYmQwMmNkZTVjM2IzZV80LTQtMS0xLTE2OTg5_f6a8ccb0-a7e7-4ae5-b091-58ec86c8f6b4"
      unitRef="usd">-302000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i79fc16ab48f54844a8d5db79a213fc23_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6NDRhNmNiZTZjYjU1NDE1ZGI2ZWJkMDJjZGU1YzNiM2UvdGFibGVyYW5nZTo0NGE2Y2JlNmNiNTU0MTVkYjZlYmQwMmNkZTVjM2IzZV80LTYtMS0xLTE2OTQ1_4598c416-64e0-46c3-9336-c5c5066d3e22"
      unitRef="usd">214492000</us-gaap:Goodwill>
    <us-gaap:InventoryWriteDown
      contextRef="i48cd8878f431419a9261e7d977504c74_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6MzhmNmI2ZmY3NzNlNDVlMWE2NGM3YjNmN2ZiZjQzNWEvdGFibGVyYW5nZTozOGY2YjZmZjc3M2U0NWUxYTY0YzdiM2Y3ZmJmNDM1YV8yLTItMS0xLTIwMjk1_f2162289-6c61-4b98-aadf-83cb4d5dc4c2"
      unitRef="usd">29440000</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown
      contextRef="i483325ccf32a4f0b99f1a6f997a0eb31_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6MzhmNmI2ZmY3NzNlNDVlMWE2NGM3YjNmN2ZiZjQzNWEvdGFibGVyYW5nZTozOGY2YjZmZjc3M2U0NWUxYTY0YzdiM2Y3ZmJmNDM1YV8yLTQtMS0xLTIwMjk1_64e37efd-eb58-419f-82e1-ecf6436ad339"
      unitRef="usd">-267000</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6MzhmNmI2ZmY3NzNlNDVlMWE2NGM3YjNmN2ZiZjQzNWEvdGFibGVyYW5nZTozOGY2YjZmZjc3M2U0NWUxYTY0YzdiM2Y3ZmJmNDM1YV8yLTYtMS0xLTIwMjk1_01c8df05-ebef-4eeb-bce0-0c7538f6fd21"
      unitRef="usd">29173000</us-gaap:InventoryWriteDown>
    <us-gaap:OperatingExpenses
      contextRef="i48cd8878f431419a9261e7d977504c74_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6MzhmNmI2ZmY3NzNlNDVlMWE2NGM3YjNmN2ZiZjQzNWEvdGFibGVyYW5nZTozOGY2YjZmZjc3M2U0NWUxYTY0YzdiM2Y3ZmJmNDM1YV8yLTItMS0xLTE2OTc4_29ccd036-6b3b-45b7-9303-d6df07f37539"
      unitRef="usd">103620000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i483325ccf32a4f0b99f1a6f997a0eb31_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6MzhmNmI2ZmY3NzNlNDVlMWE2NGM3YjNmN2ZiZjQzNWEvdGFibGVyYW5nZTozOGY2YjZmZjc3M2U0NWUxYTY0YzdiM2Y3ZmJmNDM1YV8yLTQtMS0xLTE2OTc4_79e597a3-ae83-4b1e-a8c7-86a9a16ea950"
      unitRef="usd">-109000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6MzhmNmI2ZmY3NzNlNDVlMWE2NGM3YjNmN2ZiZjQzNWEvdGFibGVyYW5nZTozOGY2YjZmZjc3M2U0NWUxYTY0YzdiM2Y3ZmJmNDM1YV8yLTEyLTEtMS0xNjk0NQ_46505ff8-b920-45a3-b991-4bb5ef5e08da"
      unitRef="usd">103511000</us-gaap:OperatingExpenses>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i48cd8878f431419a9261e7d977504c74_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6MzhmNmI2ZmY3NzNlNDVlMWE2NGM3YjNmN2ZiZjQzNWEvdGFibGVyYW5nZTozOGY2YjZmZjc3M2U0NWUxYTY0YzdiM2Y3ZmJmNDM1YV8zLTItMS0xLTE2OTc4_4558a67b-d504-4708-8361-9a090c0b5be8"
      unitRef="usd">1287058000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i483325ccf32a4f0b99f1a6f997a0eb31_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6MzhmNmI2ZmY3NzNlNDVlMWE2NGM3YjNmN2ZiZjQzNWEvdGFibGVyYW5nZTozOGY2YjZmZjc3M2U0NWUxYTY0YzdiM2Y3ZmJmNDM1YV8zLTQtMS0xLTE2OTc4_9094c162-43de-4963-932c-6795745df08f"
      unitRef="usd">-13000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6MzhmNmI2ZmY3NzNlNDVlMWE2NGM3YjNmN2ZiZjQzNWEvdGFibGVyYW5nZTozOGY2YjZmZjc3M2U0NWUxYTY0YzdiM2Y3ZmJmNDM1YV8zLTEyLTEtMS0xNjk0NQ_f3de27f6-28c3-4b8e-bd3e-1fbfd114c93c"
      unitRef="usd">1287045000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i48cd8878f431419a9261e7d977504c74_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6MzhmNmI2ZmY3NzNlNDVlMWE2NGM3YjNmN2ZiZjQzNWEvdGFibGVyYW5nZTozOGY2YjZmZjc3M2U0NWUxYTY0YzdiM2Y3ZmJmNDM1YV80LTItMS0xLTE2OTc4_7baff811-92f1-4f14-9a1b-473e77314ab9"
      unitRef="usd">1165574000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i483325ccf32a4f0b99f1a6f997a0eb31_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6MzhmNmI2ZmY3NzNlNDVlMWE2NGM3YjNmN2ZiZjQzNWEvdGFibGVyYW5nZTozOGY2YjZmZjc3M2U0NWUxYTY0YzdiM2Y3ZmJmNDM1YV80LTQtMS0xLTE2OTc4_b6fa9525-6c87-4407-970f-b2b40d1fff17"
      unitRef="usd">363000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6MzhmNmI2ZmY3NzNlNDVlMWE2NGM3YjNmN2ZiZjQzNWEvdGFibGVyYW5nZTozOGY2YjZmZjc3M2U0NWUxYTY0YzdiM2Y3ZmJmNDM1YV80LTEyLTEtMS0xNjk0NQ_c7fb9b3c-1883-400d-b552-378b461e0a32"
      unitRef="usd">1165937000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OperatingExpenses
      contextRef="ieb6f16121fdc4f85b37accd34c0b8570_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6YmM5OWMyOTUyZmUzNGIzMGEzYmM3OTBmOTdkODQ2YTEvdGFibGVyYW5nZTpiYzk5YzI5NTJmZTM0YjMwYTNiYzc5MGY5N2Q4NDZhMV8yLTItMS0xLTIwMDM3_2ef8bc7c-4f4b-4f98-9aaa-19a18aa393f3"
      unitRef="usd">27554000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="ia5ba3e945f134460b59d45bf05722a40_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6YmM5OWMyOTUyZmUzNGIzMGEzYmM3OTBmOTdkODQ2YTEvdGFibGVyYW5nZTpiYzk5YzI5NTJmZTM0YjMwYTNiYzc5MGY5N2Q4NDZhMV8yLTQtMS0xLTIwMDM3_a9609561-a96e-49a6-a645-3c09330572de"
      unitRef="usd">-896000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6YmM5OWMyOTUyZmUzNGIzMGEzYmM3OTBmOTdkODQ2YTEvdGFibGVyYW5nZTpiYzk5YzI5NTJmZTM0YjMwYTNiYzc5MGY5N2Q4NDZhMV8yLTYtMS0xLTIwMDM3_b89ebf85-693c-43a0-874e-544693c6366f"
      unitRef="usd">26658000</us-gaap:OperatingExpenses>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ieb6f16121fdc4f85b37accd34c0b8570_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6YmM5OWMyOTUyZmUzNGIzMGEzYmM3OTBmOTdkODQ2YTEvdGFibGVyYW5nZTpiYzk5YzI5NTJmZTM0YjMwYTNiYzc5MGY5N2Q4NDZhMV8zLTItMS0xLTIwMDM3_ee5d6231-ba9f-4346-907b-a67e2cb83115"
      unitRef="usd">-476000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ia5ba3e945f134460b59d45bf05722a40_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6YmM5OWMyOTUyZmUzNGIzMGEzYmM3OTBmOTdkODQ2YTEvdGFibGVyYW5nZTpiYzk5YzI5NTJmZTM0YjMwYTNiYzc5MGY5N2Q4NDZhMV8zLTQtMS0xLTIwMDM3_4a4122df-8e04-435e-9b09-e3fbae8de050"
      unitRef="usd">-2000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6YmM5OWMyOTUyZmUzNGIzMGEzYmM3OTBmOTdkODQ2YTEvdGFibGVyYW5nZTpiYzk5YzI5NTJmZTM0YjMwYTNiYzc5MGY5N2Q4NDZhMV8zLTYtMS0xLTIwMDM3_c62491e3-50ef-45de-b0b0-ffb3bb61b5ee"
      unitRef="usd">-478000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ieb6f16121fdc4f85b37accd34c0b8570_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6YmM5OWMyOTUyZmUzNGIzMGEzYmM3OTBmOTdkODQ2YTEvdGFibGVyYW5nZTpiYzk5YzI5NTJmZTM0YjMwYTNiYzc5MGY5N2Q4NDZhMV80LTItMS0xLTIwMDM3_2260e60e-2582-42ce-97db-ca5d6bd4a6c3"
      unitRef="usd">-21817000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia5ba3e945f134460b59d45bf05722a40_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6YmM5OWMyOTUyZmUzNGIzMGEzYmM3OTBmOTdkODQ2YTEvdGFibGVyYW5nZTpiYzk5YzI5NTJmZTM0YjMwYTNiYzc5MGY5N2Q4NDZhMV80LTQtMS0xLTIwMDM3_b1d0ebf8-e832-4877-88b4-793d1444af47"
      unitRef="usd">894000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic8906be022ae40f28617755159bc9ce6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yMzY5L2ZyYWc6YzAxNDk4NzFlN2JjNDk2OTkwNzYyZjBiOWU3N2U2Y2IvdGFibGU6YmM5OWMyOTUyZmUzNGIzMGEzYmM3OTBmOTdkODQ2YTEvdGFibGVyYW5nZTpiYzk5YzI5NTJmZTM0YjMwYTNiYzc5MGY5N2Q4NDZhMV80LTYtMS0xLTIwMDM3_8fefb751-6cd9-497a-9bc9-bd46626a327d"
      unitRef="usd">-20923000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMzMtMy0xLTEtMA_b0d849f2-438c-4c4f-902f-c1fb37890e80"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMzMtMy0xLTEtMA_b0d849f2-438c-4c4f-902f-c1fb37890e80"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RleHRyZWdpb246NTRhZWU1ZTdjODkwNGYwODlhMzUxMWY2YzczNmE0ZTRfODI0NjMzNzIxMzA3NA_23299789-732b-44be-a54a-9d83261ac818" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RleHRyZWdpb246NTRhZWU1ZTdjODkwNGYwODlhMzUxMWY2YzczNmE0ZTRfODI0NjMzNzIxMzA3NA_23299789-732b-44be-a54a-9d83261ac818" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Authorized for issuance as of December&#160;31, 2020: unlimited (December 31, 2019 &#x2013; unlimited).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMzMtMy0xLTEtMA_b0d849f2-438c-4c4f-902f-c1fb37890e80"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RleHRyZWdpb246NTRhZWU1ZTdjODkwNGYwODlhMzUxMWY2YzczNmE0ZTRfODI0NjMzNzIxMzA3NA_23299789-732b-44be-a54a-9d83261ac818"
          xlink:type="arc"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RleHRyZWdpb246NTRhZWU1ZTdjODkwNGYwODlhMzUxMWY2YzczNmE0ZTRfODI0NjMzNzIxMzA3NQ_3fb97ef3-2b33-4a99-a400-62c4df723ca9" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RleHRyZWdpb246NTRhZWU1ZTdjODkwNGYwODlhMzUxMWY2YzczNmE0ZTRfODI0NjMzNzIxMzA3NQ_3fb97ef3-2b33-4a99-a400-62c4df723ca9" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Shares issued as of December&#160;31, 2020: 360,253,332 (as of December 31, 2019: 348,817,472)</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMzMtMy0xLTEtMA_b0d849f2-438c-4c4f-902f-c1fb37890e80"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RleHRyZWdpb246NTRhZWU1ZTdjODkwNGYwODlhMzUxMWY2YzczNmE0ZTRfODI0NjMzNzIxMzA3NQ_3fb97ef3-2b33-4a99-a400-62c4df723ca9"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMzMtMS0xLTEtMA_030d6cf8-63aa-4cc4-b65e-77df43789c76"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMzMtMS0xLTEtMA_030d6cf8-63aa-4cc4-b65e-77df43789c76"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMzMtMS0xLTEtMA_030d6cf8-63aa-4cc4-b65e-77df43789c76"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RleHRyZWdpb246NTRhZWU1ZTdjODkwNGYwODlhMzUxMWY2YzczNmE0ZTRfODI0NjMzNzIxMzA3NQ_3fb97ef3-2b33-4a99-a400-62c4df723ca9"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMzMtMS0xLTEtMA_030d6cf8-63aa-4cc4-b65e-77df43789c76"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RleHRyZWdpb246NTRhZWU1ZTdjODkwNGYwODlhMzUxMWY2YzczNmE0ZTRfODI0NjMzNzIxMzA3NA_23299789-732b-44be-a54a-9d83261ac818"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMjYtMS0xLTEtMA_d2c2035b-409d-4d96-80ce-8ff8af18284d"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMjYtMS0xLTEtMA_d2c2035b-409d-4d96-80ce-8ff8af18284d"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMjYtMy0xLTEtMA_d5dcbf49-cd7f-40c1-9318-f3853ed34620"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMjYtMy0xLTEtMA_d5dcbf49-cd7f-40c1-9318-f3853ed34620"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RleHRyZWdpb246NTRhZWU1ZTdjODkwNGYwODlhMzUxMWY2YzczNmE0ZTRfODI0NjMzNzIxMzA3Mg_aa4b8439-f84a-478a-8fb1-f835ca03fa1b" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RleHRyZWdpb246NTRhZWU1ZTdjODkwNGYwODlhMzUxMWY2YzczNmE0ZTRfODI0NjMzNzIxMzA3Mg_aa4b8439-f84a-478a-8fb1-f835ca03fa1b" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Refer to Note 14 in the notes to the consolidated financial statements.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMjYtMS0xLTEtMA_d2c2035b-409d-4d96-80ce-8ff8af18284d"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RleHRyZWdpb246NTRhZWU1ZTdjODkwNGYwODlhMzUxMWY2YzczNmE0ZTRfODI0NjMzNzIxMzA3Mg_aa4b8439-f84a-478a-8fb1-f835ca03fa1b"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMjYtMy0xLTEtMA_d5dcbf49-cd7f-40c1-9318-f3853ed34620"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RleHRyZWdpb246NTRhZWU1ZTdjODkwNGYwODlhMzUxMWY2YzczNmE0ZTRfODI0NjMzNzIxMzA3Mg_aa4b8439-f84a-478a-8fb1-f835ca03fa1b"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfNi0zLTEtMS0w_a2311b2b-e900-4984-bdec-0a7931e7bae4"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfNi0zLTEtMS0w_a2311b2b-e900-4984-bdec-0a7931e7bae4"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfNi0xLTEtMS0w_a0756496-0a08-44aa-a1f2-05e806899e3f"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfNi0xLTEtMS0w_a0756496-0a08-44aa-a1f2-05e806899e3f"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RleHRyZWdpb246NTRhZWU1ZTdjODkwNGYwODlhMzUxMWY2YzczNmE0ZTRfODI0NjMzNzIxMzA3MQ_c8d7bf53-21c3-41a0-9531-0c2936a525bb" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RleHRyZWdpb246NTRhZWU1ZTdjODkwNGYwODlhMzUxMWY2YzczNmE0ZTRfODI0NjMzNzIxMzA3MQ_c8d7bf53-21c3-41a0-9531-0c2936a525bb" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Net of current expected credit loss allowance of $74 as of December&#160;31, 2020 (December 31, 2019 &#x2013; $136) </link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfNi0zLTEtMS0w_a2311b2b-e900-4984-bdec-0a7931e7bae4"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RleHRyZWdpb246NTRhZWU1ZTdjODkwNGYwODlhMzUxMWY2YzczNmE0ZTRfODI0NjMzNzIxMzA3MQ_c8d7bf53-21c3-41a0-9531-0c2936a525bb"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfNi0xLTEtMS0w_a0756496-0a08-44aa-a1f2-05e806899e3f"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RleHRyZWdpb246NTRhZWU1ZTdjODkwNGYwODlhMzUxMWY2YzczNmE0ZTRfODI0NjMzNzIxMzA3MQ_c8d7bf53-21c3-41a0-9531-0c2936a525bb"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMTktMy0xLTEtMA_f3e00e2d-0bc3-4c5c-b051-37c080d8a31c"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMTktMy0xLTEtMA_f3e00e2d-0bc3-4c5c-b051-37c080d8a31c"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMTktNS0xLTEtMA_5aa26780-78bf-4c99-8b99-a530f71591bb"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMTktNS0xLTEtMA_5aa26780-78bf-4c99-8b99-a530f71591bb"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMTktNy0xLTEtMA_934b407f-5480-4ec9-a08c-c47fa8742b49"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMTktNy0xLTEtMA_934b407f-5480-4ec9-a08c-c47fa8742b49"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RleHRyZWdpb246OWJlMGFjZTUyNjA2NDczYTkzNTU1YTA2NGVmOTYzYjFfMjMwODk3NDQxODQyNjQ_1f52087e-41b2-45cb-9593-dba04a2a8a65" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RleHRyZWdpb246OWJlMGFjZTUyNjA2NDczYTkzNTU1YTA2NGVmOTYzYjFfMjMwODk3NDQxODQyNjQ_1f52087e-41b2-45cb-9593-dba04a2a8a65" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Refer to Note 14 in the notes to the consolidated financial statements</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMTktMy0xLTEtMA_f3e00e2d-0bc3-4c5c-b051-37c080d8a31c"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RleHRyZWdpb246OWJlMGFjZTUyNjA2NDczYTkzNTU1YTA2NGVmOTYzYjFfMjMwODk3NDQxODQyNjQ_1f52087e-41b2-45cb-9593-dba04a2a8a65"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMTktNS0xLTEtMA_5aa26780-78bf-4c99-8b99-a530f71591bb"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RleHRyZWdpb246OWJlMGFjZTUyNjA2NDczYTkzNTU1YTA2NGVmOTYzYjFfMjMwODk3NDQxODQyNjQ_1f52087e-41b2-45cb-9593-dba04a2a8a65"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfMTktNy0xLTEtMA_934b407f-5480-4ec9-a08c-c47fa8742b49"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RleHRyZWdpb246OWJlMGFjZTUyNjA2NDczYTkzNTU1YTA2NGVmOTYzYjFfMjMwODk3NDQxODQyNjQ_1f52087e-41b2-45cb-9593-dba04a2a8a65"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY181LTQtMS0xLTE5ODY4_a610d7fc-f428-449c-9059-7adfe180fa46"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY181LTQtMS0xLTE5ODY4_a610d7fc-f428-449c-9059-7adfe180fa46"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY181LTYtMS0xLTE5ODY4_e7daf893-d717-4958-98f7-edf136d089fb"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY181LTYtMS0xLTE5ODY4_e7daf893-d717-4958-98f7-edf136d089fb"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY181LTItMS0xLTE5ODY4_d008eb2d-02f4-41de-a9e9-29d7c125013f"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY181LTItMS0xLTE5ODY4_d008eb2d-02f4-41de-a9e9-29d7c125013f"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGV4dHJlZ2lvbjpiMjczMTZmYzE3ZGU0Zjc0Yjg2OTI3ZDY0NTdiMzM2Nl8yMzYzOTQ5OTk5NzQzMA_8ef018ed-3e46-49d1-8159-8b1ea3a11d48" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGV4dHJlZ2lvbjpiMjczMTZmYzE3ZGU0Zjc0Yjg2OTI3ZDY0NTdiMzM2Nl8yMzYzOTQ5OTk5NzQzMA_8ef018ed-3e46-49d1-8159-8b1ea3a11d48" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Refer to Note 14 in the notes to the consolidated financial statements</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY181LTQtMS0xLTE5ODY4_a610d7fc-f428-449c-9059-7adfe180fa46"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGV4dHJlZ2lvbjpiMjczMTZmYzE3ZGU0Zjc0Yjg2OTI3ZDY0NTdiMzM2Nl8yMzYzOTQ5OTk5NzQzMA_8ef018ed-3e46-49d1-8159-8b1ea3a11d48"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY181LTYtMS0xLTE5ODY4_e7daf893-d717-4958-98f7-edf136d089fb"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGV4dHJlZ2lvbjpiMjczMTZmYzE3ZGU0Zjc0Yjg2OTI3ZDY0NTdiMzM2Nl8yMzYzOTQ5OTk5NzQzMA_8ef018ed-3e46-49d1-8159-8b1ea3a11d48"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGFibGU6NDJmYzcwMWMyZDMwNDJmNWE1NWRlM2M0NmE1MTg1MmMvdGFibGVyYW5nZTo0MmZjNzAxYzJkMzA0MmY1YTU1ZGUzYzQ2YTUxODUyY181LTItMS0xLTE5ODY4_d008eb2d-02f4-41de-a9e9-29d7c125013f"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8yNTExL2ZyYWc6YjI3MzE2ZmMxN2RlNGY3NGI4NjkyN2Q2NDU3YjMzNjYvdGV4dHJlZ2lvbjpiMjczMTZmYzE3ZGU0Zjc0Yjg2OTI3ZDY0NTdiMzM2Nl8yMzYzOTQ5OTk5NzQzMA_8ef018ed-3e46-49d1-8159-8b1ea3a11d48"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNDUtNy0xLTEtMA_076615ad-4cea-4475-a55b-1ad3b75ff74f"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNDUtNy0xLTEtMA_076615ad-4cea-4475-a55b-1ad3b75ff74f"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNDgtNy0xLTEtMA_00e023ad-c0ff-44e6-b2d6-18456a9f0e47"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNDgtNy0xLTEtMA_00e023ad-c0ff-44e6-b2d6-18456a9f0e47"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNDUtMy0xLTEtMA_c9deec0e-b435-414e-9862-97b176eb4753"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNDUtMy0xLTEtMA_c9deec0e-b435-414e-9862-97b176eb4753"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNDgtMy0xLTEtMA_5d41c6cb-4657-4d84-9d61-e7b6edbd8ed4"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNDgtMy0xLTEtMA_5d41c6cb-4657-4d84-9d61-e7b6edbd8ed4"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNDUtNS0xLTEtMA_493d04be-bc47-414c-9326-3ef9bf61406b"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNDUtNS0xLTEtMA_493d04be-bc47-414c-9326-3ef9bf61406b"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNDgtNS0xLTEtMA_43a535c7-a9f7-4574-8755-ea4af2d6fcf0"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNDgtNS0xLTEtMA_43a535c7-a9f7-4574-8755-ea4af2d6fcf0"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RleHRyZWdpb246OWJlMGFjZTUyNjA2NDczYTkzNTU1YTA2NGVmOTYzYjFfMjMwODk3NDQxODQyNjU_8a1ed1c3-4e3c-44aa-80c9-fe2c7bedff36" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RleHRyZWdpb246OWJlMGFjZTUyNjA2NDczYTkzNTU1YTA2NGVmOTYzYjFfMjMwODk3NDQxODQyNjU_8a1ed1c3-4e3c-44aa-80c9-fe2c7bedff36" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">In computing diluted earnings per share, incremental common shares are not considered in periods in which a net loss is reported, as the inclusion of the common share equivalents would be anti-dilutive.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNDUtNy0xLTEtMA_076615ad-4cea-4475-a55b-1ad3b75ff74f"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RleHRyZWdpb246OWJlMGFjZTUyNjA2NDczYTkzNTU1YTA2NGVmOTYzYjFfMjMwODk3NDQxODQyNjU_8a1ed1c3-4e3c-44aa-80c9-fe2c7bedff36"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNDgtNy0xLTEtMA_00e023ad-c0ff-44e6-b2d6-18456a9f0e47"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RleHRyZWdpb246OWJlMGFjZTUyNjA2NDczYTkzNTU1YTA2NGVmOTYzYjFfMjMwODk3NDQxODQyNjU_8a1ed1c3-4e3c-44aa-80c9-fe2c7bedff36"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNDUtMy0xLTEtMA_c9deec0e-b435-414e-9862-97b176eb4753"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RleHRyZWdpb246OWJlMGFjZTUyNjA2NDczYTkzNTU1YTA2NGVmOTYzYjFfMjMwODk3NDQxODQyNjU_8a1ed1c3-4e3c-44aa-80c9-fe2c7bedff36"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNDgtMy0xLTEtMA_5d41c6cb-4657-4d84-9d61-e7b6edbd8ed4"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RleHRyZWdpb246OWJlMGFjZTUyNjA2NDczYTkzNTU1YTA2NGVmOTYzYjFfMjMwODk3NDQxODQyNjU_8a1ed1c3-4e3c-44aa-80c9-fe2c7bedff36"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNDUtNS0xLTEtMA_493d04be-bc47-414c-9326-3ef9bf61406b"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RleHRyZWdpb246OWJlMGFjZTUyNjA2NDczYTkzNTU1YTA2NGVmOTYzYjFfMjMwODk3NDQxODQyNjU_8a1ed1c3-4e3c-44aa-80c9-fe2c7bedff36"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RhYmxlOjE2MjM1Yzg5MjQ4MzRjZjY4NGIwMGIxOWM4ZWFmOTM1L3RhYmxlcmFuZ2U6MTYyMzVjODkyNDgzNGNmNjg0YjAwYjE5YzhlYWY5MzVfNDgtNS0xLTEtMA_43a535c7-a9f7-4574-8755-ea4af2d6fcf0"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF82MS9mcmFnOjliZTBhY2U1MjYwNjQ3M2E5MzU1NWEwNjRlZjk2M2IxL3RleHRyZWdpb246OWJlMGFjZTUyNjA2NDczYTkzNTU1YTA2NGVmOTYzYjFfMjMwODk3NDQxODQyNjU_8a1ed1c3-4e3c-44aa-80c9-fe2c7bedff36"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMzEtMS0xLTEtMA_bf994125-524b-467f-a561-898bad11e880"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMzEtMS0xLTEtMA_bf994125-524b-467f-a561-898bad11e880"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMzEtMy0xLTEtMA_57a937e6-17cd-4abe-ae75-7bda62d7cf42"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMzEtMy0xLTEtMA_57a937e6-17cd-4abe-ae75-7bda62d7cf42"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RleHRyZWdpb246NTRhZWU1ZTdjODkwNGYwODlhMzUxMWY2YzczNmE0ZTRfODI0NjMzNzIxMzA3Mw_eea41acf-1b2e-4562-9b1e-115e0363241f" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RleHRyZWdpb246NTRhZWU1ZTdjODkwNGYwODlhMzUxMWY2YzczNmE0ZTRfODI0NjMzNzIxMzA3Mw_eea41acf-1b2e-4562-9b1e-115e0363241f" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Refer to Note 20 and Note 21 in the notes to the consolidated financial statements.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMzEtMS0xLTEtMA_bf994125-524b-467f-a561-898bad11e880"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RleHRyZWdpb246NTRhZWU1ZTdjODkwNGYwODlhMzUxMWY2YzczNmE0ZTRfODI0NjMzNzIxMzA3Mw_eea41acf-1b2e-4562-9b1e-115e0363241f"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RhYmxlOjgwM2M0YjYxMmUzMjRlOGE5YjRjMjEzMWQ3ZDE2MDRmL3RhYmxlcmFuZ2U6ODAzYzRiNjEyZTMyNGU4YTliNGMyMTMxZDdkMTYwNGZfMzEtMy0xLTEtMA_57a937e6-17cd-4abe-ae75-7bda62d7cf42"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF81NS9mcmFnOjU0YWVlNWU3Yzg5MDRmMDg5YTM1MTFmNmM3MzZhNGU0L3RleHRyZWdpb246NTRhZWU1ZTdjODkwNGYwODlhMzUxMWY2YzczNmE0ZTRfODI0NjMzNzIxMzA3Mw_eea41acf-1b2e-4562-9b1e-115e0363241f"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689704932456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Feb. 25, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38403<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CRONOS GROUP INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">Z4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">111 Peter St., Suite 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Toronto<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">ON<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">M5V 2H1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">416<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">504-0004<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Shares, no par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CRON<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,099,685,039<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">360,258,680<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text">Certain information required by Part III of this Annual Report on Form 10-K will either be incorporated into this Annual Report on Form 10-K by reference to the registrant&#8217;s definitive proxy statement for its 2021 Annual Meeting of Shareholders, or will be included in an amendment to this Annual Report on Form 10-K to be filed no later than 120 days after the registrant's fiscal year ended December&#160;31, 2020.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001656472<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689705612088">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheet - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1,078,023<span></span>
</td>
<td class="nump">$ 1,199,693<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">211,766<span></span>
</td>
<td class="nump">306,347<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">8,928<span></span>
</td>
<td class="nump">4,638<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">10,033<span></span>
</td>
<td class="nump">7,232<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetCurrent', window );">Current portion of loans receivable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7,083<span></span>
</td>
<td class="nump">4,664<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaids and other assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">11,161<span></span>
</td>
<td class="nump">9,395<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">44,002<span></span>
</td>
<td class="nump">38,043<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent', window );">Held-for-sale assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,176<span></span>
</td>
<td class="nump">3,248<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,372,172<span></span>
</td>
<td class="nump">1,573,260<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investments in equity accounted investees</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">19,235<span></span>
</td>
<td class="nump">557<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvancesToAffiliate', window );">Advances to joint ventures</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">467<span></span>
</td>
<td class="nump">19,437<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetNoncurrent', window );">Loans receivable, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">87,191<span></span>
</td>
<td class="nump">44,967<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">187,599<span></span>
</td>
<td class="nump">159,948<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">9,776<span></span>
</td>
<td class="nump">6,546<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">69,720<span></span>
</td>
<td class="nump">71,235<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">179,522<span></span>
</td>
<td class="nump">214,492<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,925,682<span></span>
</td>
<td class="nump">2,090,442<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent', window );">Accounts payable and other liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">42,102<span></span>
</td>
<td class="nump">35,301<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of lease obligation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,322<span></span>
</td>
<td class="nump">427<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesCurrent', window );">Derivative liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">163,410<span></span>
</td>
<td class="nump">297,160<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">206,834<span></span>
</td>
<td class="nump">332,888<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesNoncurrent', window );">Due to non-controlling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,188<span></span>
</td>
<td class="nump">1,844<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Lease obligation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8,492<span></span>
</td>
<td class="nump">6,680<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">217,514<span></span>
</td>
<td class="nump">341,412<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Shareholders&#8217; equity</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Share capital</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4],[5]</sup></td>
<td class="nump">569,260<span></span>
</td>
<td class="nump">561,165<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">34,596<span></span>
</td>
<td class="nump">23,234<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,064,509<span></span>
</td>
<td class="nump">1,137,646<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">42,999<span></span>
</td>
<td class="nump">27,838<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total equity attributable to shareholders of Cronos Group</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,711,364<span></span>
</td>
<td class="nump">1,749,883<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Non-controlling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(3,196)<span></span>
</td>
<td class="num">(853)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total shareholders' equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,708,168<span></span>
</td>
<td class="nump">1,749,030<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders&#8217; equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1,925,682<span></span>
</td>
<td class="nump">$ 2,090,442<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Net of current expected credit loss allowance of $74 as of December&#160;31, 2020 (December 31, 2019 &#8211; $136)</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Refer to Note 14 in the notes to the consolidated financial statements.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Refer to Note 20 and Note 21 in the notes to the consolidated financial statements.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">Authorized for issuance as of December&#160;31, 2020: unlimited (December 31, 2019 &#8211; unlimited).</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[5]</td>
<td style="vertical-align: top;" valign="top">Shares issued as of December&#160;31, 2020: 360,253,332 (as of December 31, 2019: 348,817,472)</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvancesToAffiliate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-Term advances receivable from a party that is affiliated with the reporting entity by means of direct or indirect ownership. This does not include advances to clients.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e603758-122996<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6812-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvancesToAffiliate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets held-for-sale that are not part of a disposal group, expected to be sold within a year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 15<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121558832&amp;loc=d3e400-110220<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Portion of the carrying amount as of the balance sheet date of obligations due all related parties that is payable after one year or beyond the normal operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.23)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesAndLoansReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of financing receivable, classified as current. Includes, but is not limited to, notes and loan receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesAndLoansReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesAndLoansReceivableNetNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of financing receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesAndLoansReceivableNetNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689706047960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheet (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for credit loss</a></td>
<td class="nump">$ 74<span></span>
</td>
<td class="nump">$ 136<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">360,253,332<span></span>
</td>
<td class="nump">348,817,472<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121599878&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689700386600">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Net Income (Loss) and Comprehensive Income (Loss) - USD ($)<br></strong></div></th>
<th class="th" colspan="6">12 Months Ended</th>
</tr>
<tr>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2019</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Net revenue, before excise taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 54,353,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 25,639,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 13,234,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExciseAndSalesTaxes', window );">Excise taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(7,634,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,889,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,113,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">46,719,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">23,750,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">12,121,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_OtherCostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">46,497,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">12,174,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5,908,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Inventory write-down</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">26,055,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">29,173,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(25,833,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(17,597,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">6,213,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">34,386,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">23,048,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,537,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">20,366,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">12,155,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,814,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">80,529,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">49,271,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">13,349,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based payments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">15,361,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">11,619,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">8,151,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,872,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,090,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">807,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringSettlementAndImpairmentProvisions', window );">Repurposing charges</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5,328,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">153,514,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">103,511,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">26,658,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(179,347,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(121,108,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(20,445,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense)</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest income, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">18,415,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">27,969,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">81,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax', window );">Gain on revaluation of derivative liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">129,254,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1,276,819,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Impairment loss on goodwill and intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(40,000,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Gain on disposal of other investments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,789,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">16,277,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">164,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Share of loss from investments in equity accounted investees</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(4,510,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(2,009,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(723,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts', window );">Financing and transaction costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(40,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(32,208,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,834,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">197,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income (expense)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">106,074,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,287,045,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(478,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss) before income taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(73,273,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,165,937,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(20,923,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,347,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Income (loss) from continuing operations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(74,620,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,165,937,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(20,923,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Loss from discontinued operations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(650,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(363,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(894,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(75,270,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,165,574,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(21,817,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToReportingEntityAbstract', window );"><strong>Net income (loss) attributable to:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Cronos Group</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(73,137,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,166,506,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(21,636,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Non-controlling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2,133,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(932,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(181,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (75,270,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 1,165,574,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (21,817,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Net income (loss) per share</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (0.21)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 3.76<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (0.12)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="num">$ (0.21)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 3.33<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (0.12)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract', window );"><strong>Weighted average number of outstanding shares</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">351,576,848<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">310,067,179<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">172,269,170<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">351,576,848<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">342,811,992<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">172,269,170<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (75,270,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 1,165,574,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (21,817,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss)</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign exchange gain (loss) on translation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">14,951,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">37,687,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(12,337,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_OtherComprehensiveIncomeLossAccumulatedGainLossDebtSecuritiesRevaluationAndDisposalOfOtherInvestments', window );">Gain on revaluation and disposal of other investments, net of tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">14,951,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">37,687,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(12,334,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(60,319,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,203,261,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(34,151,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Comprehensive income (loss) attributable to:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Cronos Group</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(57,976,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,204,214,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(33,964,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Non-controlling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2,343,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(953,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(187,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (60,319,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 1,203,261,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (34,151,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="7"></td></tr>
<tr><td colspan="7"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Refer to Note 14 in the notes to the consolidated financial statements</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Refer to Note 14 in the notes to the consolidated financial statements</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">In computing diluted earnings per share, incremental common shares are not considered in periods in which a net loss is reported, as the inclusion of the common share equivalents would be anti-dilutive.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_OtherComprehensiveIncomeLossAccumulatedGainLossDebtSecuritiesRevaluationAndDisposalOfOtherInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income (Loss),Accumulated Gain (Loss), Debt Securities, Revaluation And Disposal Of Other Investments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_OtherComprehensiveIncomeLossAccumulatedGainLossDebtSecuritiesRevaluationAndDisposalOfOtherInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_OtherCostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Cost Of Goods And Services Sold</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_OtherCostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the charge against earnings during the period for commitment fees and debt issuance expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of an equity method investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExciseAndSalesTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of excise and sales taxes included in sales and revenues, which are then deducted as a cost of sales. Includes excise taxes, which are applied to specific types of transactions or items (such as gasoline or alcohol); and sales, use and value added taxes, which are applied to a broad class of revenue-producing transactions involving a wide range of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExciseAndSalesTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDerivativeInstrumentsNetPretax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109227538&amp;loc=d3e44648-109337<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNonoperatingNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of nonoperating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNonoperatingNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4542-108314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToReportingEntityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToReportingEntityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringSettlementAndImpairmentProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of restructuring charges, remediation cost, and asset impairment loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringSettlementAndImpairmentProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689703585512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Share capital</div></th>
<th class="th"><div>Additional paid-in capital</div></th>
<th class="th"><div>Retained earnings (accumulated deficit)</div></th>
<th class="th"><div>Accumulated other comprehensive income (loss)</div></th>
<th class="th"><div>Non-controlling interests</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">149,360,603<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2017</a></td>
<td class="nump">$ 63,733<span></span>
</td>
<td class="nump">$ 62,834<span></span>
</td>
<td class="nump">$ 4,734<span></span>
</td>
<td class="num">$ (6,293)<span></span>
</td>
<td class="nump">$ 2,458<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,677,143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Shares issued</a></td>
<td class="nump">115,510<span></span>
</td>
<td class="nump">$ 115,510<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_StockIssuedDuringPeriodValueNewIssuesIssuanceCosts', window );">Share issuance costs</a></td>
<td class="num">(7,577)<span></span>
</td>
<td class="num">$ (7,577)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Vesting of options</a></td>
<td class="nump">8,151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">567,940<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Options exercised</a></td>
<td class="nump">435<span></span>
</td>
<td class="nump">$ 671<span></span>
</td>
<td class="num">(220)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisesInPeriod', window );">Warrants exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,114,336<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_StockIssuedDuringPeriodValueWarrantsExercised', window );">Warrants exercised</a></td>
<td class="nump">2,161<span></span>
</td>
<td class="nump">$ 3,563<span></span>
</td>
<td class="num">(1,402)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance', window );">Contribution by non-controlling interests</a></td>
<td class="nump">287<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">287<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="num">(21,817)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(21,636)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(181)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(12,334)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12,328)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">178,720,022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Dec. 31, 2018</a></td>
<td class="nump">148,549<span></span>
</td>
<td class="nump">$ 175,001<span></span>
</td>
<td class="nump">11,263<span></span>
</td>
<td class="num">(27,945)<span></span>
</td>
<td class="num">(9,870)<span></span>
</td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">155,773,757<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Shares issued</a></td>
<td class="nump">304,821<span></span>
</td>
<td class="nump">$ 304,411<span></span>
</td>
<td class="nump">410<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_StockIssuedDuringPeriodValueNewIssuesIssuanceCosts', window );">Share issuance costs</a></td>
<td class="num">(3,722)<span></span>
</td>
<td class="num">$ (3,722)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Vesting of options</a></td>
<td class="nump">$ 11,619<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,619<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised (in shares)</a></td>
<td class="nump">282,572<span></span>
</td>
<td class="nump">190,349<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Options exercised</a></td>
<td class="num">$ (898)<span></span>
</td>
<td class="nump">$ 368<span></span>
</td>
<td class="num">(351)<span></span>
</td>
<td class="num">(915)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisesInPeriod', window );">Warrants exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,390,961<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_StockIssuedDuringPeriodValueWarrantsExercised', window );">Warrants exercised</a></td>
<td class="nump">1,438<span></span>
</td>
<td class="nump">$ 2,034<span></span>
</td>
<td class="num">(596)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Vesting of restricted share units</a></td>
<td class="nump">889<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">889<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_StockIssuedDuringPeriodSharesTopupRightsExercised', window );">Top-up Rights exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,742,383<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_StockIssuedDuringPeriodValueTopupRightsExercised', window );">Top-up Rights exercised</a></td>
<td class="nump">83,073<span></span>
</td>
<td class="nump">$ 83,073<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">1,165,574<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,166,506<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(932)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">37,687<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,708<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">348,817,472<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Dec. 31, 2019</a></td>
<td class="nump">1,749,030<span></span>
</td>
<td class="nump">$ 561,165<span></span>
</td>
<td class="nump">23,234<span></span>
</td>
<td class="nump">1,137,646<span></span>
</td>
<td class="nump">27,838<span></span>
</td>
<td class="num">(853)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Vesting of options</a></td>
<td class="nump">$ 7,185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised (in shares)</a></td>
<td class="nump">2,131,939<span></span>
</td>
<td class="nump">1,266,130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Options exercised</a></td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">$ 1,586<span></span>
</td>
<td class="num">(1,577)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Restricted share units settled (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">414,088<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisesInPeriod', window );">Warrants exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,755,642<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_StockIssuedDuringPeriodValueWarrantsExercised', window );">Warrants exercised</a></td>
<td class="nump">107<span></span>
</td>
<td class="nump">$ 1,244<span></span>
</td>
<td class="num">(1,137)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Vesting of restricted share units</a></td>
<td class="nump">8,176<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,176<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Taxes withheld on vesting of restricted share units</a></td>
<td class="num">(2,148)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,148)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition', window );">Vesting of common shares issued in connection with the use of certain publicity rights in brand development</a></td>
<td class="nump">2,863<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="nump">863<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_StockIssuedDuringPeriodSharesTopupRightsExercised', window );">Top-up Rights exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_StockIssuedDuringPeriodValueTopupRightsExercised', window );">Top-up Rights exercised</a></td>
<td class="nump">3,265<span></span>
</td>
<td class="nump">$ 3,265<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="num">(75,270)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(73,137)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,133)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">14,951<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,161<span></span>
</td>
<td class="num">(210)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">360,253,332<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Dec. 31, 2020</a></td>
<td class="nump">$ 1,708,168<span></span>
</td>
<td class="nump">$ 569,260<span></span>
</td>
<td class="nump">$ 34,596<span></span>
</td>
<td class="nump">$ 1,064,509<span></span>
</td>
<td class="nump">$ 42,999<span></span>
</td>
<td class="num">$ (3,196)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisesInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement By Share-based Payment Award, Warrants, Exercises In Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisesInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_StockIssuedDuringPeriodSharesTopupRightsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Shares, Top-up Rights Exercised</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_StockIssuedDuringPeriodSharesTopupRightsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_StockIssuedDuringPeriodValueNewIssuesIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Value, New Issues, Issuance Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_StockIssuedDuringPeriodValueNewIssuesIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_StockIssuedDuringPeriodValueTopupRightsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Value, Top-up Rights Exercised</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_StockIssuedDuringPeriodValueTopupRightsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_StockIssuedDuringPeriodValueWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Value, Warrants Exercised</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_StockIssuedDuringPeriodValueWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for restricted stock unit under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in noncontrolling interest from subsidiary issuance of equity interests to noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569655-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689702428904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br></strong></div></th>
<th class="th" colspan="6">12 Months Ended</th>
</tr>
<tr>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2019</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="num">$ (75,270,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 1,165,574,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (21,817,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Items not affecting cash:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax', window );">Gain on revaluation of derivative liabilities</a></td>
<td class="num">(129,254,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(1,276,819,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Impairment loss on goodwill and intangible assets</a></td>
<td class="nump">40,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Inventory write-down</a></td>
<td class="nump">26,055,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">29,173,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Provisions for inventory and doubtful accounts</a></td>
<td class="nump">3,741,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">136,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based payments</a></td>
<td class="nump">15,361,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">11,619,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">8,151,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">7,045,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,913,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,937,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Share of loss (income) from equity accounted investees</a></td>
<td class="nump">4,510,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,009,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">723,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Gain on disposal of other investments</a></td>
<td class="num">(4,789,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(16,277,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(164,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_NoncashSellingAndMarketingExpense', window );">Non-cash sales and marketing</a></td>
<td class="nump">2,863,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">410,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">1,347,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Non-cash repurposing costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,439,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other non-cash operating activity expense (income)</a></td>
<td class="num">(123,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(243,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(9,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapital', window );">Net changes in non-cash working capital</a></td>
<td class="num">(33,943,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(54,208,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,662,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by (used in) operating activities</a></td>
<td class="num">(142,457,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(130,274,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(7,517,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities', window );">Proceeds from (purchase of) short-term investments, net</a></td>
<td class="nump">95,404,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Proceeds from (purchase of) short-term investments, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(299,923,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Investments in equity accounted investees</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,658,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(480,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_ProceedsFromEquitySecuritiesFVNIAndEquitySecuritiesWithoutDeterminableFairValue', window );">Proceeds from sale of other investments</a></td>
<td class="nump">4,789,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">19,614,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">747,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInterestInJointVenture', window );">Advances to joint ventures</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(15,135,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(5,358,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property, plant and equipment, net of disposals</a></td>
<td class="num">(31,412,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(38,664,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(88,308,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Purchase of intangible assets</a></td>
<td class="num">(3,979,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(289,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(278,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisition of Redwood</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(224,295,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireLoansReceivable', window );">Advances on loans receivable</a></td>
<td class="num">(44,652,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(43,337,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other non-cash investing activity expense (income)</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">415,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(231,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by (used in) investing activities</a></td>
<td class="nump">20,150,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(603,272,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(93,908,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToMinorityShareholders', window );">Advance to non-controlling interests</a></td>
<td class="num">(1,019,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_PaymentsForLeaseObligationsFinancingActivities', window );">Repayment of lease obligations</a></td>
<td class="num">(2,414,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(919,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Withholding taxes paid on equity awards</a></td>
<td class="num">(2,148,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(915,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(16,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_ProceedsFromRightExercises', window );">Proceeds from exercise of Top-up Rights</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">67,051,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_ProceedsFromWarrantExercisedAndStockOptionsExercised', window );">Proceeds from exercise of warrants and options</a></td>
<td class="nump">116,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,455,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,612,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Share issuance costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(3,722,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(7,577,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSecuredDebt', window );">Proceeds from construction loan payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">11,583,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfSecuredDebt', window );">Repayment of construction loan payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(15,971,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLongTermLinesOfCredit', window );">Advance under Credit Facility</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">48,715,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermLinesOfCredit', window );">Repayment of Credit Facility</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(48,309,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="num">(5,465,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,856,941,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">122,112,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of foreign currency translation on cash and cash equivalents</a></td>
<td class="nump">6,102,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">52,371,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(4,085,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Increase in cash and cash equivalents</a></td>
<td class="num">(121,670,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,175,766,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">16,602,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, beginning of period</a></td>
<td class="nump">1,199,693,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">23,927,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">7,325,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, end of period</a></td>
<td class="nump">1,078,023,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,199,693,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">23,927,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=cron_AltriaInvestmentMember', window );">Altria Investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,809,556,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Share issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(3,722,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=cron_BoughtDealOfferingsMember', window );">Bought Deal Offerings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">115,510,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Share issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (7,577,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="7"></td></tr>
<tr><td colspan="7"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Refer to Note 14 in the notes to the consolidated financial statements</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Refer to Note 14 in the notes to the consolidated financial statements</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_NoncashSellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncash Selling And Marketing Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_NoncashSellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_PaymentsForLeaseObligationsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments For Lease Obligations, Financing Activities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_PaymentsForLeaseObligationsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_ProceedsFromEquitySecuritiesFVNIAndEquitySecuritiesWithoutDeterminableFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Equity Securities, FV-NI And Equity Securities Without Determinable Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_ProceedsFromEquitySecuritiesFVNIAndEquitySecuritiesWithoutDeterminableFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_ProceedsFromRightExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Right Exercises</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_ProceedsFromRightExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_ProceedsFromWarrantExercisedAndStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Warrant Exercised And Stock Options Exercised</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_ProceedsFromWarrantExercisedAndStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of an equity method investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDerivativeInstrumentsNetPretax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period of all assets and liabilities used in operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4542-108314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInterestInJointVenture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the investment in or advances to an entity in which the reporting entity shares control of the entity with another party or group.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInterestInJointVenture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireLoansReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchase of loan receivable arising from the financing of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireLoansReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for purchase of marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from amounts received from issuance of long-term debt that is wholly or partially secured by collateral. Excludes proceeds from tax exempt secured debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLongTermLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLongTermLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities  (held-to-maturity or available-for-sale) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the settlement of obligation drawn from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfSecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to repay long-term debt that is wholly or partially secured by collateral. Excludes repayments of tax exempt secured debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfSecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=cron_AltriaInvestmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=cron_AltriaInvestmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=cron_BoughtDealOfferingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=cron_BoughtDealOfferingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689696917048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Background<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">Background</a></td>
<td class="text">Background<div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Group Inc. (&#8220;Cronos Group&#8221; or the &#8220;Company&#8221;) is incorporated in the Province of British Columbia and under the British Columbia Business Corporations Act with principal executive offices at 111 Peter St. Street, Suite 300, Toronto, Ontario, M5V 2H1. The Company&#8217;s common shares are currently listed on the Toronto Stock Exchange (&#8220;TSX&#8221;) and Nasdaq Global Market (&#8220;Nasdaq&#8221;) under the ticker symbol &#8220;CRON.&#8221;</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Group is an innovative global cannabinoid company, with international production and distribution across five continents. The Company is committed to building disruptive intellectual property by advancing cannabis research, technology and product development and is seeking to build an iconic brand portfolio. Cronos Group&#8217;s brand portfolio includes PEACE NATURALS&#8482;, a global wellness platform; two adult-use brands, COVE&#8482; and Spinach&#8482;; and three U.S hemp-derived consumer products brands, Lord Jones&#8482;, Happy Dance&#8482; and PEACE+&#8482;.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Group has established four strategic joint ventures in Canada, Israel, and Colombia. Cronos Israel (as defined herein) is consolidated for financial reporting purposes. The Company also holds approximately 31% of the issued capital of Cronos Australia Limited (&#8220;Cronos Australia&#8221;) and accounts for its investment in Cronos Australia under the equity method of accounting. For additional discussion regarding the joint ventures and strategic investment, see Note 6.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689696589688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">Summary of Significant Accounting Policies <div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt">Basis of presentation</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;). U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities at the dates of the consolidated financial statements and the reported amounts of net revenues and expenses during the reporting periods. The accounting policies adopted in the preparation of the consolidated financial statements were effective as of January 1, 2020. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt">Segment structure</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company undertook a realignment of its management structure along geographic regions in September 2019. As a result, effective September 2019, the Company&#8217;s results are reported through the following operating segments: United States and Rest of World. Prior period amounts contained in these consolidated financial statements have been adjusted to conform to the new segment presentation. Refer to Note 29 for additional information. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.91pt">Basis of consolidation</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements include the accounts of the Company, and all entities in which the Company has a controlling voting interest or is the primary beneficiary of a variable interest as of and for the fiscal years ended December&#160;31, 2020, December&#160;31, 2019 and December&#160;31, 2018. The Company assesses control under the variable interest entity (&#8220;VIE&#8221;) model to determine whether the Company is the primary beneficiary of that entity&#8217;s operations.&#160;If an entity is not deemed to be a VIE, the Company consolidates the entity if the Company has a controlling&#160;voting interest. Subsidiaries are fully consolidated from the date on which control is transferred to the Company. They are deconsolidated from the date that control ceases. Investments in which the Company has the ability to exercise significant influence over the operating and financial policies of the investee, but does not have control, are accounted for under the equity method of accounting. The Company consolidates the financial results of the following entities, which the Company controls:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.902%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Subsidiaries </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Jurisdiction of incorporation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incorporation date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ownership interest </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Israel G.S. Cultivation Ltd.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 4, 2018</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Israel G.S. Manufacturing Ltd.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 4, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Israel G.S. Store Ltd.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 28, 2018</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Israel G.S. Pharmacy Ltd.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 15, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt">These Israeli entities are collectively referred to as &#8220;Cronos Israel.&#8221;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt">&#8220;Ownership interest&#8221; is defined as the proportionate share of net income to which the Company is entitled; equity interest may differ from ownership interest as described herein. </span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the consolidated statements of net income (loss) and comprehensive income (loss), the net income (loss) and comprehensive income (loss) are attributed to the equity holders of the Company and to the non-controlling interests. Non-controlling interests in the equity of Cronos Israel are presented separately in the shareholders&#8217; equity (deficit) section of the consolidated balance sheets and consolidated statements of shareholders&#8217; equity (deficit). All intercompany transactions and balances are eliminated upon consolidation.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt">Use of estimates</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Significant estimates and assumptions include, among other things, valuation of derivative liabilities, fair value of assets and liabilities assumed in business combinations, impairment of goodwill, inventory write-downs, valuation allowance on deferred income tax assets and uncertain tax liabilities. Actual results could differ from those estimates. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(e)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.91pt">Revenue recognition</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s contracts with customers for the sale of dried cannabis, cannabis oil, cannabinoid-derived products and U.S. hemp-derived personal care products consist of one performance obligation. The Company has concluded that revenue from the sale of these products should be recognized at the point in time when control is transferred to the customer, which is on shipment or delivery, depending on the contract. Revenue is recognized at the transaction price, which is the amount of consideration to which the Company expects to be entitled in exchange for transferring promised goods to a customer. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenue before excise taxes from sale of goods, as presented in the consolidated statements of net income (loss) and comprehensive income (loss), represents revenue from the sale of goods less expected price discounts, and allowances for customer returns. Net revenue before excise taxes excludes excise taxes, which the Company pays as principal and excludes duties and taxes collected on behalf of third parties. Excise taxes are a production tax classified as government remittances payable, which when applicable, become payable when a product is delivered to the customer and are not directly related to the value of revenue.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company treats shipping and handling activities as a fulfillment cost, classified as cost of sales. Accordingly, the Company accrues all fulfillment costs related to the shipping and handling of consumer goods at the time of shipment. Within the Company's Rest of World segment, dried cannabis sales outside of Canada may include profit sharing arrangements with distributors which give rise to variable consideration. If the consideration in a contract includes a variable amount, the Company estimates the amount of consideration to which it will be entitled in exchange for transferring the goods to the customer. The variable consideration is estimated as the most likely amount, based on the Company&#8217;s historical information, at contract inception.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s payment terms vary by customer and product type. For individual consumer sales, payment is due prior to the transfer of control. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company elected to treat the costs incurred to obtain a contract, primarily related to sales commissions, as an expense in the period incurred and not an asset to be capitalized, as the amortization period of the related asset would be less than one year. Accordingly, the Company will expense the costs to obtain a contract in the period incurred.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(f)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.01pt">Investments </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Variable interest entities (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">VIE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">)</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A VIE is an entity having either a total equity investment that is insufficient to finance its activities without additional subordinated financial support or equity investors at risk that lack the ability to control the entity&#8217;s activities. Variable interests are investments or other interests that will absorb portions of a VIE&#8217;s expected losses or receive portions of the VIE&#8217;s expected residual returns. The Company evaluates whether it is the primary beneficiary of each VIE it identifies on an ongoing basis and considers the impact of any reconsideration events. The primary beneficiary is the party that has both the power to direct the activities that most significantly impact the VIE and holds a variable interest that could potentially be significant to the VIE. To make this determination the Company considers both quantitative and qualitative factors regarding the nature, size and form of its involvement with the VIE. The Company consolidates the VIE when it is determined that it is the primary beneficiary of the VIE.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity method investments</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for investments in companies over which it has the ability to exercise significant influence but does not hold a controlling financial interest, using the equity method. Under the equity method, the Company records its proportionate share of income or losses in the consolidated statements of net income (loss) and comprehensive income (loss). If the current fair value of an investment falls below its carrying amount, this may indicate that an impairment loss should be recorded. Any impairment losses recognized cannot be reversed in subsequent periods.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(g)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt">Inventory</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory is comprised of raw materials, finished goods and work-in-progress such as pre-harvested cannabis plants, by-products to be extracted, oils, gel caps, tinctures, and boxes. The costs of growing cannabis, including but not limited to labor, utilities, nutrition and irrigation, are capitalized into inventory until the time of harvest.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory is stated at the lower of cost and net realizable value, determined using weighted average cost. Cost includes expenditures directly related to manufacturing and distribution of the products. Primary costs include consumables (insect control, fertilizers, soil), packaging, shipping, direct labor, overhead, supplies and small tools, and the depreciation of manufacturing equipment and production facilities determined at normal capacity. Manufacturing overhead and related expenses include salaries, wages, employee benefits, rent, utilities, security, and property taxes.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net realizable value is defined as the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. At the end of each reporting period, the Company performs an assessment of inventory obsolescence to measure inventory at the lower of cost and net realizable value. Factors considered in the determination of obsolescence include slow-moving or non-marketable products. During the year ended December 31, 2020, we incurred significant inventory write-downs driven by pricing pressures in the marketplace and will continue assessing pricing pressures on the value of inventory at the end of each reporting period. See Note 5.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(h)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt">Definite life intangible assets</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets are recorded at cost less any accumulated amortization and accumulated impairment losses. Intangible assets acquired through a business combination are measured at fair value at the acquisition date.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes certain costs incurred in connection with its enterprise software, which include external direct costs of materials and services consumed in developing or obtaining internal-use software, payroll and payroll-related costs for employees who are directly associated with and who devote time to the development of the software for the function intended. All other costs are expensed as incurred.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets with finite useful lives are amortized over their estimated useful lives using the following methods and rates:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"/><td style="width:35.617%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.608%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Method</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Straight-line</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Enterprise resource planning (&#8220;ERP&#8221;) software</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Straight-line</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Canada licenses</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Straight-line</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Useful life of corresponding facilities</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israeli codes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Straight-line</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Useful life of corresponding facilities</span></td></tr></table></div><div style="margin-bottom:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(i)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The preliminary licenses granted to Kibbutz Gan Shmuel (the Cronos Israel joint venture partner) by the Medical Cannabis&#160;Unit of the Israeli Ministry of Health in early 2017 (the &#8220;Israeli codes&#8221;) were transferred by non-controlling interests to Cronos Israel in exchange for equity interests in the Cronos Israel entities specified above.</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization begins when assets become available for use. The estimated useful life, amortization method, and rate are reviewed at the end of each reporting period, with the effect of any changes in estimate being accounted for on a prospective basis.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.57pt">Property, plant &amp; equipment</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment are stated at cost less accumulated depreciation and accumulated impairment losses. Depreciation is computed using the straight-line method over the estimated useful lives of the assets as follows:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.927%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:54.873%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 to 25 years</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and equipment</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 to 7 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lesser of term of lease and useful life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment under finance lease</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lesser of term of lease and useful life</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When assets are disposed of, the cost and accumulated depreciation are removed from the respective accounts and any related gain or loss is recognized. Maintenance and repairs are charged to expense as incurred. Significant expenditures, which increase productivity or extend the useful life of the asset, are capitalized. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest incurred relating to construction or expansion of buildings is capitalized to construction in progress. The Company ceases the capitalization of interest when construction activities are substantially completed and the facility is available for use. At this point, construction in progress is transferred to the appropriate asset class. Available for use is defined as the point at which the related building receives the requisite regulatory licenses to (i) possess cannabis, (ii) obtain dried cannabis, fresh cannabis, cannabis plants or cannabis plant seeds by cultivating, propagating and harvesting cannabis, and (iii) produce cannabis, other than obtaining it by cultivating, propagating, or harvesting. Depreciation commences at the point the assets are available for use.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(j)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.01pt">Leases</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company enters into leases in the normal course of business, primarily for the land-use rights, office premises, and equipment used in the production of its products. At the inception of a contract, the Company assesses whether a contract is, or contains, a lease. A contract is, or contains, a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. The Company performs an analysis over the classification of the lease agreement as either an operating lease or finance lease. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A right-of-use asset and the related lease obligation associated with the lease are recorded at the inception of the lease. The right-of-use asset&#8217;s recorded amount is based on the present value of future lease payments over the lease term at the commencement date plus any initial direct costs incurred. If the rate implicit in the lease is not readily determinable for the Company&#8217;s operating leases, an incremental borrowing rate is generally used based on information available at the lease commencement date to determine the present value of future lease payments. Subsequent changes to these lease payments due to rate updates are recorded as lease expense in the period incurred. Leases with a term of 12 months or less are not recorded on the balance sheet as a lease. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The right-of-use asset is subject to impairment testing whenever events or changes in circumstances indicate the carrying value of the asset may not be recoverable. The leased asset is amortized over the shorter of the lease term or its estimated useful life if title does not transfer to the Company, while the leased asset is depreciated in accordance with the Company&#8217;s depreciation policy if the title is to eventually transfer to the Company.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s lease agreements generally exclude non-lease components. As a result, non-lease components are accounted for separately for all classes of assets and expensed as incurred. In addition, the Company&#8217;s lease agreements do not contain any material residual value guarantees or material restrictive covenants. For finance leases, from the commencement date to the earlier of the end of the useful life of the right-of-use asset or the end of the lease term, the right-of-use asset is amortized on a straight-line basis and the interest expense is recognized on the lease liability using the effective interest method. For operating leases, lease expense is recognized on a straight-line basis over the term of the lease and presented as a single charge in the consolidated statements of net income (loss) and comprehensive income (loss).</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(k)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt">Impairment of long-lived assets</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. The Company groups assets at the lowest level for which cash flows are separately identifiable, referred to as an asset group. The Company prepares projected undiscounted cash flow analyses for each asset or asset group. If the sum of the undiscounted cash flow is less than the carrying value of the asset or asset group, an impairment loss is recognized equal to the excess of the carrying value over the fair value, if any. Impairment losses on assets held for sale are based on the fair value, less costs to sell.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and indefinite life intangible assets are not amortized. Goodwill and indefinite life intangible assets are reviewed for impairment annually or more frequently when events or changes in circumstances indicate that fair value of the reporting unit has been reduced to less than its carrying value. The Company performs an impairment test annually in the fourth quarter by comparing the fair value of the reporting unit with its carrying amount, including goodwill. If the fair value of the reporting unit exceeds its carrying amount, goodwill is not considered to be impaired. An impairment charge would be recognized for the amount by which the carrying amount exceeds the reporting unit&#8217;s fair value. The Company determined that it has two reporting units: the U.S. reporting unit and the Rest of World reporting unit. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(l)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.57pt">Repurposing charges</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s repurposing charges primarily include employee termination benefits and refurbishment costs. The recognition of repurposing charges requires the Company make certain judgments and estimates regarding the nature, timing, and amount of costs associated with the planned activity. To the extent actual results differ from estimates and assumptions, a revision to the estimated liabilities, requiring the recognition of additional repurposing charges or the reduction of liabilities already recognized may be required. At the end of each reporting period, the Company evaluates the remaining accrued balances to ensure these balances are properly stated and the utilization of the reserves are for their intended purpose in accordance with planned activity.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(m)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:21.01pt">Capital stock</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capital stock is presented at the fair value at the time of issuance of the shares issued. Costs related to the issuance of shares are reported in equity, net of tax, as a deduction from the issuance proceeds.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(n)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt">Foreign currency</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s functional currency is the Canadian dollar (&#8220;C$&#8221;). Prior to the year ended December 31, 2019, the Company reported its financial results in C$, however following the change in the Company&#8217;s status from foreign private issuer to a United States (&#8220;U.S.&#8221;) domestic issuer, the financial results are now reported in U.S dollars (&#8220;dollars&#8221; or &#8220;$&#8221;). Functional currencies for the entities in these consolidated financial statements are their respective local currencies, including C$, Australian dollars (&#8220;A$&#8221;) and Israeli New Shekel (&#8220;ILS&#8221;). The assets and liabilities of the Company&#8217;s foreign operations are translated into dollars at the exchange rate in effect as of December&#160;31, 2020 and 2019. Transactions affecting the shareholders&#8217; equity (deficit) are translated at historical foreign exchange rates. The consolidated statements of net income (loss) and comprehensive income (loss) and the consolidated statements of cash flows of the Company&#8217;s foreign operations are translated into dollars by applying the average foreign exchange rate in effect for the reporting period. The cumulative translation adjustments (&#8220;CTA&#8221;) resulting from translating the consolidated financial statements into their dollar reporting currency are recorded in other comprehensive income (loss). </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Monetary assets and liabilities denominated in foreign currencies are translated to the functional currency by applying the foreign exchange rate in effect at the balance sheet date. Revenues and expenses are translated using the average foreign exchange rate for the reporting period. Realized and unrealized foreign currency differences are recognized in the consolidated statements of net income (loss) and comprehensive income (loss).</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transactions in foreign currencies are translated into the functional currency using the exchange rate prevailing at the date of the transaction and are recorded in other comprehensive income. Exchange differences arising from operating transactions are recorded in net income for the period.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(o)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt">Income taxes</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the liability method of accounting for income taxes, under which deferred tax assets and liabilities are recognized for the future tax consequences attributable to the differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted tax rates expected to be in effect when such assets and liabilities are recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the year that includes the enactment date. The Company determines deferred tax assets including net operating losses and liabilities, based on temporary differences between the book and tax bases of assets and liabilities. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A valuation allowance is established to reduce some or all net deferred tax assets to amounts that are more likely than not to be realized. The Company considers all available evidence, both positive and negative including past operating results, estimates of future taxable income, and the feasibility of tax planning strategies, in assessing the need for a valuation allowance. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a full valuation allowance against its net deferred tax assets, and has concluded, based on the weight of all available evidence, that it is more likely than not that the net deferred tax assets will not be realized, primarily due to the historical net operating losses. The valuation allowance against the net deferred tax assets does not in any way impact the Company&#8217;s ability to use future tax deductions such as the Company&#8217;s net operating loss carryforwards; rather, the valuation allowance indicates, according to the provisions of Accounting Standards Codification 740, Income Taxes, it is more likely than not that the deferred tax assets will not be realized. The valuation allowance that was established will be maintained until there is sufficient positive evidence to conclude that it is more likely than not that the net deferred tax assets will be realized. The Company&#8217;s income tax expense for future periods will be reduced to the extent of corresponding decreases in our valuation allowance. There is uncertainty regarding any future realization of the benefit by the Company of all or part of our net deferred tax assets.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Judgment is required to determine the recognition and measurement attributes prescribed in the accounting guidance for uncertainty in income taxes. The Company uses a two-step approach for evaluating uncertain tax positions. Step one, recognition, requires us to determine if the weight of available evidence indicates that a tax position is more likely than not to be sustained upon audit, including resolution of related appeals or litigation processes, if any. If a tax position is not considered &#8220;more likely than not&#8221; to be sustained, no benefits of the position are recognized. If we determine that a position is &#8220;more likely than not&#8221; to be sustained, then we proceed to step two, measurement, which is based on the largest amount of benefit which is more likely than not to be realized on effective settlement. This process involves estimating our actual current tax exposure, including assessing the risks associated with income tax audits, together with assessing temporary differences resulting from the different treatment of items for tax and financial reporting purposes. If actual results differ from our estimates, our net operating loss and credit carryforwards could be materially impacted in the period which such determination is made.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes uncertain income tax positions at the largest amount that is more-likely-than-not to be sustained upon examination by the relevant taxing authority. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained. Recognition or measurement is reflected in the period in which the likelihood changes. Any interest and penalties related to unrecognized tax liabilities are presented within income tax expense in the consolidated statements of net income (loss) and comprehensive income (loss). Accrued interest and penalties are included in accounts payable and other liabilities in the consolidated balance sheets.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(p)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt">Share-based compensation</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described in more detail below, the Company has five share-based compensation plans under which awards have been made: the 2020 Omnibus Plan (as defined below), the 2018 Stock Option Plan (as defined below), the 2015 Stock Option Plan (as defined below), the Employment Inducement Award Plan #1 (the &#8220;Employment Inducement Award Plan&#8221;) and a cash-settled deferred share unit (&#8220;DSU&#8221;) plan for non-executive directors.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation consists of equity-settled share-based awards such as stock options and restricted share units (&#8220;RSUs&#8221;) that are issued to eligible employees, non-executive directors, and non-employees.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash-settled deferred share units (&#8220;DSUs&#8221;) that are issued to non-executive directors are recorded in accounts payable and other liabilities with the fair value adjustment recorded in other income (loss).</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity instruments granted are initially measured at fair value on the grant date. The fair value of the stock options are determined using the Black-Scholes option pricing model. The fair value of RSUs and DSUs are determined using the market price. This is recognized on a straight-line basis in the consolidated statements of net income (loss) and comprehensive income (loss) over the vesting period for employees, and over the contractual term for non-employees. The fair value of the payout of cash-settled DSUs is determined at each reporting date based on the fair value of the Company&#8217;s common shares at the reporting date and is recorded within other liabilities.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The related costs for all equity-settled share-based awards are reflected in additional paid-in capital until the awards are exercised. Upon exercise, shares are issued and the amount previously reflected in the additional paid-in capital is, along with any proceeds paid upon exercise, credited to share capital. Forfeitures are estimated at the time of grant, and the Company revises these estimates in subsequent periods if there is a difference in actual forfeitures and the estimates.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(q)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt">Net earnings (loss) per share</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company presents basic and diluted net earnings (loss) per share data for its common shares. Basic net earnings (loss) per share is calculated by dividing the profit or loss attributable to common shareholders of the Company by the weighted average number of common shares outstanding during the period. Diluted net earnings (loss) per share is determined by adjusting the profit or loss attributable to common shareholders and the weighted average number of common shares outstanding for the effects of all potentially dilutive common shares that are issuable upon exercise of warrants, stock options and the Altria Warrant (as defined below) as well as the vesting of RSUs outstanding. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(r)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.91pt">Cash and cash equivalents and short-term investments</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents are comprised of cash and highly liquid investments that are readily convertible into known amounts of cash with original maturities of three months or less. Cash and cash equivalents include amounts held in dollars, C$ and ILS and security deposits. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments consist of debt securities that (i) have original maturities of greater than three months and (ii) the Company has the ability to convert into cash within one year. Short-term investments are classified as held-to-maturity.&#160;Our investments classified as held-to-maturity are recorded at cost. Interest earned on short-term investments is recorded in other receivables on the consolidated balance sheet and interest income on the consolidated statement of comprehensive income (loss). Cash inflows and outflows related to the purchase and maturity of short-term investments are classified as investing activities in the Company&#8217;s consolidated statements of cash flows.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(s)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:25.45pt">Derivative liabilities</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For financial instruments that are not designated as hedging instruments or do not qualify for hedge accounting, changes in fair value are recorded in the consolidated statements of net income (loss) and comprehensive income (loss) each period. The Company does not enter into or hold derivative financial instruments for trading or speculative purposes. Derivative liabilities are initially recognized at fair value at the date on which the derivative contract was entered into. Any attributable transaction costs are recognized in net income (loss) as incurred. Subsequent to initial recognition, derivative liabilities are measured at fair value at each reporting date until settlement with the re-measurement gain or loss being recognized immediately in comprehensive income. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For more details on derivative liabilities consisting of the Altria Warrant, Pre-emptive Rights, and certain Top-up Rights, see Note 14. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(t)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.01pt">Fair value measurements</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value of the Company&#8217;s cash and cash equivalents, accounts receivable, other receivables, loan receivable, account payables and other liabilities and holdbacks payable approximate fair value, given their short-term nature. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Group uses a fair value hierarchy, which gives the highest priority to unadjusted quoted prices in active markets for identical assets and liabilities, noted as Level 1 measurements, and the lowest priority to unobservable inputs, noted as Level 3 measurements. The following are the three levels of inputs used to measure fair value: </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 &#8211; valuation based on quoted prices (unadjusted) in active markets for identical assets and liabilities. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 &#8211; valuation techniques based on inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 &#8211; valuation techniques using the inputs for the asset or liability that are not based on observable market data.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s policy for determining when transfers between levels of the fair value hierarchy occur is based on the date of the event or changes in circumstances that caused the transfer.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(u)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt">Acquisitions </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accounting basis for each acquisition is dependent on whether the integrated set of assets and activities acquired constitutes a business. A business consists of inputs and processes applied to those inputs that have the ability to contribute to the creation of outputs. The cost of acquisition is allocated to the assets acquired on a relative fair value basis. No goodwill is recognized in an asset acquisition. If it is determined that a business is not acquired, the transaction is accounted for as an asset acquisition and the relevant values are finalized prior to the next reporting period. On the other hand, when a business is acquired, the acquisition method of accounting in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 805 is applied, which requires that once control of the business is obtained, the assets and liabilities of the acquired business, including amounts attributable to non-controlling interests, be recorded at their respective fair values as of the date of acquisition. Any excess of purchase consideration over the net fair value of tangible and identified intangible assets acquired less liabilities assumed is recorded as goodwill. The costs of business acquisitions, including fees for accounting, legal, professional consulting and valuation specialists, are expensed as incurred. Purchase price allocations may be preliminary and, during the measurement period not to exceed one year from the date of acquisition, changes in assumptions and estimates that result in adjustments to the fair value of assets acquired and liabilities assumed are recorded in the period the adjustments are determined.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For business combinations achieved in stages, the Company&#8217;s previously held interest in the acquiree is remeasured at its subsequent acquisition date fair value, with the resulting gain or loss recorded in the consolidated statements of net income (loss) and comprehensive income (loss). For a pre-existing relationship between the Company and acquiree that is not extinguished on the business combination, such a relationship is considered effectively settled as part of the business combination even if it is not legally cancelled. At the acquisition date, it becomes an intercompany relationship and is eliminated upon consolidation. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contingent consideration in a business combination is initially measured at fair value. Subsequently all liability classified as contingent consideration is remeasured at fair value at each reporting period until the contingency is resolved and any change in the fair value following the date of acquisition is recorded in the consolidated statements of net income (loss) and comprehensive income (loss). All equity classified as contingent consideration is not remeasured and its subsequent settlement is accounted for within equity.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(v)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt">Assets held for sale and discontinued operations</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with ASC 205-20 Presentation of Financial Statements: Discontinued Operations, a disposal of a component of an entity or a group of components of an entity is required to be reported as discontinued operations if the disposal represents a strategic shift that has (or will have) a major effect on an entity&#8217;s operations and financial results when the components of an entity meet the criteria in paragraph 205-20-45-10. In the period in which the component meets held-for-sale or discontinued operations criteria the major current assets, other assets, current liabilities, and noncurrent liabilities shall be reported as components of total assets and liabilities separate from those balances of the continuing operations. At the same time, the results of all discontinued operations, less applicable income taxes (benefit), shall be reported as components of net income (loss) separate from the net income (loss) of continuing operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2020, OGBC, formerly included within the Rest of World segment, met the criteria for &#8220;held-for-sale&#8221;. As a result, the Company has reflected amounts relating to OGBC as a disposal group classified as held-for-sale on the consolidated balance sheet and included as part of discontinued operations on the consolidated statement of net income (loss) and comprehensive income (loss) for all periods presented in this Annual Report. OGBC is no longer included in the segment reporting following the reclassification to discontinued operations. The discontinued operations of OGBC are described further in Note 30.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows.  Describes procedure if disclosures are provided in more than one note to the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689696609640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>New Accounting Pronouncements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract', window );"><strong>Accounting Standards Update and Change in Accounting Principle [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">New Accounting Pronouncements</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt">Adoption of new accounting pronouncements</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2020, the Company adopted ASU No. 2018-13, Disclosure Framework &#8211; Changes to the Disclosure Requirements for Fair Value Measurement (Topic 820) (&#8220;ASU No. 2018-13&#8221;). ASU No. 2018-13 adds, modifies, and removes certain fair value measurement disclosure requirements. The adoption of ASU No. 2018-13 did not have a material impact on the Company&#8217;s consolidated financial statements.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2020, the Company adopted ASU No. 2018-15, Intangibles &#8211; Goodwill and Other Internal-use-software (Subtopic 350-40): Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract (&#8220;ASU No. 2018-15&#8221;). ASU No. 2018-15 amends current guidance to align the accounting for costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing costs associated with developing or obtaining internal-use software. The guidance in ASU No. 2018-15 is effective for annual and interim periods beginning after December 15, 2019, with early adoption permitted. The adoption of ASU No. 2018-15 did not have a material impact on the Company&#8217;s consolidated financial statements.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2020, the Company adopted ASU No. 2017-04, Intangibles &#8211; Goodwill and Other (Topic 350) &#8211; Simplifying the Test for Goodwill Impairment (&#8220;ASU No. 2017-04&#8221;). ASU No. 2017-04 eliminates step 2 from the goodwill impairment test and instead requires an entity to measure the impairment of goodwill assigned to a reporting unit if the carrying value of assets and liabilities assigned to the reporting unit, including goodwill, exceeds the reporting unit&#8217;s fair value. The guidance in ASU No. 2017-04 is effective for annual and interim goodwill tests completed by the Company beginning on January 1, 2020. The adoption of ASU No. 2017-04 was applied prospectively and the Company follows a one-step model for goodwill impairment. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt">New accounting pronouncements not yet adopted</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (&#8220;ASU No. 2019-12&#8221;). ASU No. 2019-12 eliminates certain exceptions and simplifies the application of U.S. GAAP-related changes in enacted tax laws or rates and employee stock option plans. ASU No. 2019-12 is effective for annual and interim periods beginning after December 15, 2020. Early adoption is permitted. The Company has evaluated the impact of ASU No. 2019-12 and the adoption will not have a material impact on the Company&#8217;s consolidated financial statements.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the Financial Accounting Standards Board</span><span style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">issued ASU No. 2020-01, Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) (&#8220;ASU No. 2020-01&#8221;). ASU No. 2020-01 clarifies the interaction of accounting for the transition into and out of the equity method. The new standard also clarifies the accounting for measuring certain purchased options and forward contracts to acquire investments. The guidance in ASU No. 2020-01 is effective for annual and interim periods beginning after December 15, 2020. The Company has evaluated the impact of ASU No. 2020-01 and does not expect the adoption to have a material impact to the Company&#8217;s consolidated financial statements.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06, Debt &#8211;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging &#8211;Contracts in Entity&#8217;s Own Equity (Subtopic 815&#8211;40) (&#8220;ASU No. 2020-06&#8221;). ASU No. 2020-06 simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity&#8217;s own equity. ASU No 2020-06 is part of the FASB&#8217;s simplification initiative, which aims to reduce unnecessary complexity in U.S. GAAP. ASU No 2020-06 is effective for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years. The Company is currently evaluating the impact of ASU No. 2020-06 on its consolidated financial statements and related disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=113356391&amp;loc=SL49131195-203048<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI http://asc.fasb.org/topic&amp;trid=2122394<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=113356391&amp;loc=SL49131195-203048<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=112272810&amp;loc=SL108384541-122693<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (i)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=113356391&amp;loc=SL49131195-203048<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=113356391&amp;loc=SL49131195-203048<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 11.M.Q2)<br> -URI http://asc.fasb.org/extlink&amp;oid=112272810&amp;loc=d3e31137-122693<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(1)<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(2)<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689698076744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues from Contracts with Customers<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenues from Contracts with Customers</a></td>
<td class="text">Revenues from Contracts with Customers<div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Group disaggregates net revenues based on product type. For further discussion, see Note 29. Receivables were $8,928 at December&#160;31, 2020 (December&#160;31, 2019 &#8211; $4,638). The Company recorded a current expected credit loss allowance of $74 as of December&#160;31, 2020 (December&#160;31, 2019 &#8211; $136). </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Group offers discounts to customers for prompt payment and calculates cash discounts as a percentage of the list price based on historical experience and agreed-upon payment terms. Cronos Group records an allowance for cash discounts, which is included as a contra-asset against receivables on the Company&#8217;s consolidated balance sheets.</span></div>Revenue is measured net of returns. As a result, the Company is required to estimate the amount of returns based on the historical data by customer and product type, adjusted for forward-looking information. This is included as a provision against accounts receivable on the Company&#8217;s consolidated balance sheets. The Company estimates sales returns based principally on historical volume and return rates, as a reduction to revenues. The difference between actual sales and estimated sales returns is recorded in the period in which the actual amounts become known. These differences, if any, have not had a material impact on the Company&#8217;s consolidated financial statements. Upon return, products can be extracted from dried cannabis, resold, or destroyed depending on the nature of the product. The Company has assessed that the amount recoverable is immaterial.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689800474712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventory<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventory</a></td>
<td class="text">Inventory<div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory is comprised of the following items:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.538%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.541%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,489&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,469&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-progress &#8211; dry cannabis</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,520&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,538&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-progress &#8211; cannabis extracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,758&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,975&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods &#8211; dry cannabis</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,894&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,798&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods &#8211; cannabis extracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,624&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplies and consumables</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,639&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,002&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,043&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory is written down for any obsolescence such as slow-moving or non-marketable products, or when the net realizable value of inventory is less than the carrying value. For the year ended December&#160;31, 2020, the Company recorded write-downs related to inventory of $26,055 (December&#160;31, 2019 &#8211; $29,173, December&#160;31, 2018 - $nil) driven by pricing pressures in the Canadian marketplace. As of December&#160;31, 2020, an inventory reserve of $1,229 was recorded (December&#160;31, 2019 &#8211; $nil) in cost of sales.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689697907656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract', window );"><strong>Equity Method Investments and Joint Ventures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsDisclosureTextBlock', window );">Investments</a></td>
<td class="text">Investments<div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Variable Interest Entities</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds variable interests in Cronos Growing Company Inc. (&#8220;Cronos GrowCo&#8221;), Natuera S.&#224;.r.l (&#8220;Natuera&#8221;), MedMen Canada Inc. (&#8220;MedMen Canada&#8221;) and Cannasoul Lab Services Ltd. (&#8220;CLS&#8221;).</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos GrowCo is a joint venture incorporated under the Canada Business Corporations Act (&#8220;CBCA&#8221;) on June 14, 2018 with the objective of building a cannabis production greenhouse, applying for cannabis licenses under the Cannabis Act (Canada), and growing, cultivating, extracting, producing and selling cannabis in accordance with such licenses. Cronos Group holds variable interests in Cronos GrowCo through its ownership of 50% of Cronos GrowCo&#8217;s common shares and senior secured debt in Cronos GrowCo. Cronos GrowCo&#8217;s economic performance is driven by the quantity and strains of cannabis grown. The joint venture partners mutually determine the quantity and strains of cannabis grown.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MedMen Canada is a joint venture incorporated under the CBCA on March 13, 2018, with the objective of the retail sale and marketing of cannabis products in Canada. MedMen Canada holds the exclusive license to the MedMen brand in Canada for a minimum term of 20 years. Cronos holds variable interests in MedMen Canada through its ownership of 50% of MedMen Canada&#8217;s common shares and other subordinated debt in the entity. MedMen Canada&#8217;s economic performance is driven by the quantity and strains of cannabis sold. Subject to applicable law, the joint venture partners mutually determine the quantity and strains of cannabis to be sold in MedMen Canada&#8217;s retail stores, if and when stores are opened. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Natuera is a joint venture registered in Luxembourg with the objective of cultivating and commercializing medical cannabis to serve the export market. Cronos holds variable interests in Natuera through its ownership of 50% of Natuera&#8217;s common shares and other debt in the entity. Natuera&#8217;s economic performance is driven by the quantity and strains of cannabis to be grown. The joint venture partners mutually determine the quantity and strains of cannabis grown.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s investments in Cronos GrowCo, Natuera and MedMen Canada are exposed to economic variability from each entity&#8217;s performance; however, the Company does not consolidate the entities as it does not have the power to direct the activities that most significantly impact each entities&#8217; economic performance. Thus, Cronos Group is not considered the primary beneficiary of each entity. These investments are accounted for as equity method investments classified as &#8220;Investments in equity accounted investees&#8221; in the consolidated balance sheets.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CLS is a wholly owned subsidiary of Cannasoul Analytics Ltd., incorporated with the purpose of establishing a commercial cannabis analytical testing laboratory located on the premises of Cronos Israel (the &#8220;Cannasoul Collaboration&#8221;). Cronos Israel will advance ILS 8,297 (approximately $2,574) by a non-recourse loan to CLS over a period of two years from April 1, 2020 for the capital and operating expenditures of the laboratory. The loan will bear interest at 3.5% annually. Cronos Israel will receive 70% of the profits of the laboratory until such time as it has recovered 150% of the amounts advanced to CLS, after which time it will receive 50% of the laboratory profits. As a result, the Company is exposed to economic variability from CLS&#8217;s performance. The Company does not consolidate CLS as it does not have the power to direct the activities that most significantly impact the entity&#8217;s economic performance; thus, the Company is not considered the primary beneficiary of the entity. The carrying amount of the non-recourse loan is recorded under loans receivable and the full loan amount, ILS 8,297, represents the Company&#8217;s maximum potential exposure to losses through the Cannasoul Collaboration. See Note 8 for further information regarding loans receivable</span><span style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt">Equity Method Investments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the carrying amount of the investments in associates and joint ventures is as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.288%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.153%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ownership interest</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Amount</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos Australia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(346)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos GrowCo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,501&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Natuera</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(598)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 10pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,235&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">557&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt">On October 25, 2019, Cronos Australia issued 40 million new shares in an initial public offering at an offering price of A$0.50 per share. The Company&#8217;s ownership in Cronos Australia decreased from 50% to 31% on November 7, 2019 when Cronos Australia began trading on the Australian Securities Exchange. This resulted in a reconsideration event, which required the reassessment of the Company&#8217;s variable interest entity conclusion. Upon reconsideration, the Company determined that the entity was no longer a variable interest entity as of December 31, 2019 and is now reported under the equity method.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt">On September 25, 2020, the Company and 2645485 Ontario Inc. (&#8220;Mucci&#8221;), the other joint venture partner of Cronos GrowCo, agreed to capitalize certain historical advances made by each shareholder to Cronos GrowCo. Total aggregate gross advances to Cronos GrowCo, excluding any amounts advanced by the Company to Cronos GrowCo under the GrowCo Credit Facility, were C$49,300 ($37,010), of which the Company advanced 50% and Mucci advanced the remaining 50% for an amount of C$24,650 ($18,505) each. As a result, the Company transferred the advances of C$24,650 ($18,505) to investments in equity accounted investees in respect of Cronos GrowCo.</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s share of net earnings (losses) from equity investments accounted for under the equity method of accounting as of and for the years ended December&#160;31:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.816%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.820%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Whistler Medicinal Marijuana Company (&#8220;Whistler&#8221;)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos Australia</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(363)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,101)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(588)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos GrowCo</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,537)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(167)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedMen Canada</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(213)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Natuera</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,610)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(805)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,510)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,009)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(723)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt">Whistler was incorporated in British Columbia, Canada and is a license holder under the Cannabis Act (Canada) with production facilities in British Columbia, Canada. The Company fully divested its investment in Whistler during 2019. See Note 7.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt">The Company&#8217;s share of accumulated net losses in excess of its equity investment in Natuera has been applied as a loss allowance on the loan receivable. See Note 8.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-9pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of financial information for the Company&#8217;s equity method investments as of and for the year ended December&#160;31:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.316%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.050%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.792%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,126&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,200&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,121&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,099&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,223&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,796&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,746&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,189&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,344&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(631)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,453)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,048)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(874)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt">Advances to Joint Ventures</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.722%"><tr><td style="width:1.0%"/><td style="width:47.785%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.231%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.914%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.231%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.914%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.231%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.914%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.231%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.914%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.235%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">MedMen Canada</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cronos GrowCo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cronos Australia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(iii) </span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Natuera</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of January 1, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">471&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,966&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,437&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfer to investments in equity accounted investees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,505)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,505)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on advances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advances to joint ventures recovered from (applied to) carrying amount of investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect from foreign exchange</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(461)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(464)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of December&#160;31, 2020</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">467&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">467&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:29.25pt;text-align:justify;text-indent:-27pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"/><td style="width:47.856%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.218%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.912%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.218%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.912%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.218%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.912%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.218%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.912%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.224%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">MedMen Canada</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cronos GrowCo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cronos Australia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(iii) </span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Natuera</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of January 1, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,244&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,970&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,689&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advances (repayments)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(852)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,494&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,135&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advances to joint ventures recovered from (applied to) carrying amount of investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(779)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(224)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(946)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect from foreign exchange</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">559&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of December&#160;31, 2019</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">471&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,966&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,437&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="padding-left:29.25pt;text-align:justify;text-indent:-27pt"><span><br/></span></div><div style="padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Advance is unsecured, non-interest bearing, and there are no terms of repayment.</span></div><div style="margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%;padding-left:20.66pt">On September 25, 2020, the Company and Mucci agreed to capitalize historical advances made by each shareholder to Cronos GrowCo. The Company capitalized C$24,650 ($18,505) through a transfer of aggregate gross advances from advances to joint ventures to investments in equity accounted investees in respect of Cronos GrowCo. Refer to footnote (ii) to the first table set forth under Note 6(a).</span></div><div style="margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.22pt">A$1,500 is governed by an unsecured loan bearing interest at a rate of 12% per annum, calculated and compounded daily, in arrears, on the amounts advanced from the date of each advance. The loan is due on January 1, 2022. If the loan is overdue, the outstanding amount bears interest at an additional 2% per annum.</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined that the maximum exposure to loss on variable interest entities is limited to the Company&#8217;s initial investment, advances and/or loans for each variable interest entity. The following is a summary of the maximum exposure to loss for the year ended December&#160;31, 2020 and 2019:</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.511%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.569%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ownership interest</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Net Assets (Liabilities)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maximum Exposure to Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos Australia</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,976&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,530&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos GrowCo</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,329&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedMen Canada</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">467&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Natuera</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,849)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111,456&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,276&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:-9pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.511%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.569%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ownership interest</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Net Assets (Liabilities)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maximum Exposure to Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos Australia</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,900&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,355&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos GrowCo</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,091&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 4pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedMen Canada</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(199)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">642&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Natuera</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(358)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,888&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,434&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,585&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -URI http://asc.fasb.org/topic&amp;trid=2196965<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689696608200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Investments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">Other Investments</a></td>
<td class="text">Other Investments <div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other investments consist of investments in common shares and warrants of several companies in the cannabis industry. As of December&#160;31, 2020 and December&#160;31, 2019, the Company did not hold any other investments. The gains and losses on sale of other investments are classified as fair value through net income (loss).</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gains (losses) recognized in net income (loss) related to other investments were as follows:</span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.288%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gain recognized in net income (loss)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canopy Growth Corporation (&#8220;Canopy&#8221;)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vivo Cannabis (&#8220;Vivo&#8221;) - shares</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(173)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vivo Cannabis - share warrants</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Whistler</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iii)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,530&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aurora Cannabis Inc. (&#8220;Aurora&#8221;)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iv)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,789&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">696&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,789&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,277&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt">During the year ended December&#160;31, 2019, the Company sold all remaining 11,062 common shares of Canopy (2018 &#8211; 18,436 common shares) for net proceeds of $355 (2018 &#8211; $530) recorded as a gain on disposal of other investments in other income (expense). Upon adoption of ASU 2016-01 during the year ended December&#160;31, 2018, the gains and losses on the Canopy investment were reclassified from fair value through other comprehensive income to fair value through net income.</span></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt">During the year ended December&#160;31, 2018, the Company exercised 182,927 share warrants for aggregate consideration of $87 for additional shares of Vivo. During the year ended December&#160;31, 2018, the Company then sold all 182,927 shares of Vivo for proceeds of $216. Upon adoption of ASU 2016-01 during the year ended December&#160;31, 2018, the gains and losses on the Vivo Cannabis shares investment were reclassified from fair value through other comprehensive income to fair value through net income.</span></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.22pt">On March 4, 2019, the Company sold all 2,563 shares of Whistler, representing approximately 19.0% of Whistler&#8217;s issued and outstanding common shares, to Aurora, in connection with Aurora&#8217;s acquisition of Whistler (the &#8220;Whistler Transaction&#8221;). As a result of the closing of the Whistler Transaction, the Company received 2,524,341 Aurora common shares. During the year ended December&#160;31, 2019, the Company sold all 2,524,341 common shares of Aurora, for gross proceeds of $19,259. A gain on disposal of other investments was recorded in other income (expense) as a result.</span></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(iv)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.5pt">For the year ended December&#160;31, 2020, in connection with the achievement of certain milestones related to the Whistler Transaction, the Company received 980,662 common shares of Aurora. During the year ended December 31, 2020, the Company sold all 980,662 of the Aurora common shares, for gross proceeds of approximately $4,789 (C$6,404), recorded as a gain on disposal of other investments in other income (expense).</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for  investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2209399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2324412<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2176304<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689696545432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loan Receivable<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock', window );">Loan Receivable</a></td>
<td class="text">Loans Receivable <div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.348%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of </span></td></tr><tr><td colspan="6" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2019</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Natuera Series A Loan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,518&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,575&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GrowCo Credit Facility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,137&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Accrued interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">428&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current portion of loans receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,083&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,664&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long term portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GrowCo Credit Facility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,939&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,678&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mucci Promissory Note</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iii)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,324&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,587&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannasoul Collaboration loan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iv)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,261&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Accrued interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,667&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">702&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term portion of loans receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,191&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,967&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total loans receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,274&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,631&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="text-indent:-9pt"><span><br/></span></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt">On July 24, 2020, the Company and its joint venture partner entered into an amendment to the Series A Loan with Natuera to increase the principal amount of the Series A Loan by $6,350, to an aggregate principal amount of the Series A Loan of $15,500, of which the Company has committed to fund 50% and its joint venture partner has committed to fund the remaining 50%. Outstanding principal amounts continue to bear interest at a fixed annual rate of 5.67%. In December 2020, the Series A Loan was amended to extend its maturity date to September 1, 2021 from March 1, 2021.</span></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, a current expected credit loss allowance of $685 was recorded against the Natuera Series A loan. A loss allowance of $3,024 was recorded against the Natuera Series A Loan related to the Company&#8217;s share of net loss from Natuera in excess of the carrying value of the equity method investment. Refer to Note 6.</span></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt">On August 23, 2019, the Company entered into a credit agreement with Cronos GrowCo in respect of a C$100,000 (approximately $78,430) secured non-revolving term loan credit facility (the &#8220;GrowCo Credit Facility&#8221;). The GrowCo Credit Facility will mature on March 31, 2031 and will bear interest at varying rates based on the Canadian prime rate as announced by the Bank of Montreal. Interest began to accrue as of the closing date of the GrowCo Credit Facility and is payable on a quarterly basis until maturity, except that any interest accrued prior to March 31, 2021 will be payable not later than December 31, 2021. Repayment of principal will be made on a quarterly basis commencing on March 31, 2021. The GrowCo Credit Facility is secured by substantially all present and after acquired property of Cronos GrowCo and its subsidiaries. Mucci, the other 50% shareholder of Cronos GrowCo, has provided a limited recourse guarantee in favor of Cronos GrowCo, secured by Mucci&#8217;s shares in Cronos GrowCo. As of December&#160;31, 2020, Cronos GrowCo had drawn C$95,150 ($74,626) from the GrowCo Credit Facility. Subsequent to December 31, 2020, the terms of the GrowCo Credit Facility were amended, such that any interest accrued from April 1, 2021 to December 31, 2021 will be payable not later than December 31, 2022, and repayment of principal will be made on a quarterly basis commencing on March 31, 2022.</span></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, a current expected credit loss allowance of $1,470 was recorded against the GrowCo Credit Facility.</span></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.22pt">On June 28, 2019, the Company entered into a promissory note receivable agreement (the &#8220;Mucci Promissory Note&#8221;) for C$16,350 (approximately $12,823) with Mucci. The outstanding principal amount of the Mucci Promissory Note bears interest at 3.95% annually and is due within 90 days of demand. The Company does not intend to demand the loan within 12 months. Interest accrued under the Mucci Promissory Note until July 1, 2021 is payable by way of capitalization on the principal amount and interest thereafter must be paid in cash on a quarterly basis. The Mucci Promissory Note is secured by a general security agreement covering all the assets of Mucci. Subsequent to December 31, 2020, the terms of the Mucci Promissory Note were amended, such that interest accrued under the Mucci Promissory Note until July 1, 2022, is payable by way of capitalization on the principal amount and interest thereafter must be paid in cash on a quarterly basis.</span></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, a current expected credit loss allowance of $259 has been recorded against the Mucci Promissory Note.</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(iv)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.5pt">On April 1, 2020, Cronos Israel entered into the Cannasoul Collaboration. Cronos Israel has agreed to advance approximately ILS 8,297 (approximately $2,574) by a non-recourse loan to CLS over a period of two years for the capital and operating expenditures of the laboratory. The outstanding principal on the loan bears interest at 3.5% annually and will be repaid through the profits generated from the Cannasoul Collaboration. For the year ended December 31, 2020, CLS has received ILS $4,148 (approximately $1,287). </span></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, a current expected credit loss allowance of $25 has been recorded against the Cannasoul Collaboration loan.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for claims held for amounts due a company, excluding disclosure for allowance for credit losses. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Also excludes disclosure for financing receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -URI http://asc.fasb.org/subtopic&amp;trid=2196772<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689704502920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loans Payable<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Loans Payable</a></td>
<td class="text">Loans Payable<div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, the Company did not have any loans payable. On January 23, 2019, the Company entered into a credit agreement with the Canadian Imperial Bank of Commerce, as administrative agent and lender, and the Bank of Montreal, as lender, in respect of a C$65,000 ($48,715) secured non-revolving term loan credit facility (the &#8220;Credit Facility&#8221;). The loan was guaranteed by the Company&#8217;s wholly owned Canadian subsidiaries and secured by substantially all present and after-acquired property of the Company and its wholly owned Canadian subsidiaries. The Company used the funds available under the Credit Facility to fully repay the construction loan payable, consisting of C$21,311 ($15,971) in loan principal and C$275 ($206) in accrued interest and fees, calculated for the period from January 1, 2019 to January 22, 2019. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 8, 2019, the Credit Facility was fully repaid. In connection with the Credit Facility, the Company incurred financing costs of C$523 ($395) which were expensed upon repayment of the Credit Facility.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689698776280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant and Equipment<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property, Plant and Equipment</a></td>
<td class="text">Property, Plant and Equipment<div style="margin-bottom:6pt;padding-left:29.25pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment, net consisted of the following:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.844%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.261%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.263%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,197&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,071&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158,586&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,690&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,824&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,079&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">710&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">526&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,740&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,758&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,837&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,569&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,295)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,745)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187,599&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159,948&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense included in costs of sales relating to manufacturing equipment and production facilities for the year ended December&#160;31, 2020 was $3,447 (December&#160;31, 2019 &#8211; $1,812; 2018 &#8211; $374). Depreciation expense included in operating expenses related to general office space and equipment for the year ended December&#160;31, 2020 was $2,058 (December&#160;31, 2019 &#8211; $1,444; 2018 &#8211; $261). The remaining depreciation is included in inventory. </span></div>For the year ended December&#160;31, 2020, there was no capitalized interest included in construction in progress (2019 &#8211; $nil; 2018 &#8211;$89).<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689696562840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets and Goodwill<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Intangible Assets and Goodwill</a></td>
<td class="text">Intangible Assets and Goodwill <div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ongoing restrictions and closures experienced by retail stores in the U.S. as a result of the COVID-19 pandemic have negatively impacted sales and demand which has resulted in slower than expected revenue growth in the U.S. reporting unit. The Company expects the revenue growth and operating results in the U.S. reporting unit to continue to be negatively impacted as the decrease in customer demand and retail closures are expected to continue as a result of the pandemic. The Company performed an interim impairment test as of June 30, 2020 on the U.S. reporting unit, which holds the Redwood goodwill, as well as the indefinite-lived intangible asset (Lord Jones&#8482; brand) to determine whether the carrying amount of the reporting unit and intangible asset exceeded their respective fair values. The Company reassessed its estimates and forecasts during the second quarter of 2020 to determine the fair values of the reporting unit and intangible asset. The fair values were determined using a discounted cash flow method on the reporting unit and the relief-from-royalty method on the Lord Jones&#8482; brand. Significant inputs include discount rate, growth rates, and cash flow projections. Based on these valuations, the carrying value exceeded the fair value resulting in an impairment on both the reporting unit as well as the Lord Jones&#8482; brand. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded $35,000 of impairment charges on the U.S. reporting unit and $5,000 of impairment charges on the Lord Jones&#8482; brand during year ended December 31, 2020.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt">Intangible assets</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets are comprised of the following items: </span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"/><td style="width:31.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.834%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.051%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.000%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.329%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.000%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.329%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.000%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.329%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.005%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average amortization period (in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2020</span></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Impairment charges</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(291)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ERP system</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,955&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(274)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,681&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Canada licenses </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,526&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,254)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,272&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lord Jones</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israeli codes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,561&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,841)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,000)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,720&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt">The Israeli codes were transferred by non-controlling interests to Cronos Israel in exchange for their equity interests in the Cronos Israel entities specified above.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.722%"><tr><td style="width:1.0%"/><td style="width:39.847%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.852%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.053%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.827%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.332%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.827%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.332%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.830%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:0 1pt 0 5.5pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average amortization period (in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2019</span></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">541&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(202)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Canada licenses</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,387&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(821)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,566&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lord Jones</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> brand</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trademarks</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israeli codes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,262&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,027)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,235&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt">The Israeli codes were transferred by non-controlling interests to Cronos Israel in exchange for their equity interests in the Cronos Israel entities specified above.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate amortization was $814 for the year ended December 31, 2020 (December&#160;31, 2019 &#8211; $646; 2018 &#8211; $546). Intangible asset additions in 2020 primarily relate to the implementation of a new ERP system. Intangible asset additions in the year ended December&#160;31, 2019 included the Lord Jones&#8482; brand for $64 million.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> There were no material disposals of intangible assets in 2020 or 2019. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amortization expense for the next five years on intangible assets in use is estimated to be as follows: 2021 &#8211; $1,047; 2022 &#8211; $998; 2023: $964; 2024 &#8211; $952; 2025 &#8211; $664. </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt">Goodwill</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.722%"><tr><td style="width:1.0%"/><td style="width:23.273%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.827%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.053%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.966%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.053%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.245%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.053%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.245%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.053%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.832%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Impairment charges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effect of foreign exchange</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peace Naturals</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,078&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,108&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redwood</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213,414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178,414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214,492&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,000)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179,522&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689698155112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases <div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has entered into leases primarily for the land-use rights, office premises and equipment used in the production of cannabis, U.S. hemp and related products. The Company&#8217;s leases have terms which range from three years to six years, excluding land use rights, which generally extend to 15 years. These leases often include options to extend the term of the lease for up to 10 years. When it is reasonably certain that the option will be exercised, the impact of the option is included in the lease term for purposes of determining total future lease payments. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases greater than one year are included in right-of-use assets and operating lease liabilities. Finance leases are included in property, plant and equipment on the Company&#8217;s consolidated balance sheet. </span></div><div style="margin-bottom:12pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s finance leases were not material for any of the periods presented. </span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.538%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.541%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,479&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">760&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,539&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,133&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term &#8211; operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate &#8211; operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689696554072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General and Administrative Expenses<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalFinancialInformationDisclosureTextBlock', window );">General and Administrative Expenses</a></td>
<td class="text">General and Administrative Expenses <div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expense are comprised of the following items: </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.791%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salaries and wages</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,742&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,829&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,240&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional and consulting</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,135&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,369&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office and general</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,845&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,407&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,713&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Review costs related to restatement of 2019 interim financial statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,688&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current expected credit loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,607&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,530&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,529&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,271&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,349&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.1pt">These financial statement review costs include costs related to the restatement of the Company&#8217;s 2019 interim financial statements, costs related to the Company&#8217;s responses to requests for information from various regulatory authorities relating to such restatement and legal costs defending shareholder class action complaints brought against the Company as a result of the restatement.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalFinancialInformationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalFinancialInformationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689697902168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Derivative Liabilities</a></td>
<td class="text">Derivative Liabilities <div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 8, 2019, the Company closed the previously announced investment in the Company (the &#8220;Altria Investment&#8221;) by Altria Group Inc. (&#8220;Altria&#8221;), pursuant to a subscription agreement dated December 7, 2018. As of the closing date of the Altria Investment, the Altria Investment consisted of 149,831,154 common shares of the Company, refer to Note 15, issued to a wholly owned subsidiary of Altria and one warrant of the Company (the &#8220;Altria Warrant&#8221;), refer to Note 16(a), issued to a wholly owned subsidiary of Altria. As of the closing date of the Altria Investment, Altria beneficially held an approximate 45% ownership interest in the Company (calculated on a non-diluted basis). As summarized in this note, if exercised in full on such date, the exercise of the Altria Warrant would have resulted in Altria holding a total ownership interest in the Company of approximately 55% (calculated on a non-diluted basis). Pursuant to the investor rights agreement between the Company and Altria, entered into in connection with the closing of the Altria Investment (the &#8220;Investor Rights Agreement&#8221;), the Company granted Altria certain rights, among others, summarized in this note.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The summaries below are qualified entirely by the terms and conditions fully set out in the Investor Rights Agreement and the Altria Warrant, as applicable. </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">The Altria Warrant entitles the holder, subject to certain qualifications and limitations, to subscribe for and purchase up to an additional 10% of the common shares of Cronos (approximately 80.1&#160;million common shares as of December 31, 2020) at a per share exercise price of C$19.00, which expires at 5:00 p.m. (Toronto time) on March 8, 2023. The number of common shares of the Company to which the holder is entitled, and the corresponding exercise price, is subject to adjustment in the event of a share dividend, share issuance, distribution, or share subdivision, split or other division, share consolidation, reverse-split or other aggregation, share reclassification, a capital reorganization, consolidation, amalgamation, arrangement, binding share exchange, merger or other combination, certain securities issuances, repurchases, redemptions or certain other actions that would result in a reduction in the number of common shares of the Company outstanding, in each case, executed by the Company. If and whenever there is a reclassification of the common shares or a capital reorganization of the Company, or a consolidation, amalgamation, arrangement, binding share exchange or merger of the Company, in each case executed by the Company and pursuant to which (i) in the event the consideration received by the Company&#8217;s shareholders is exclusively cash, the Company or the successor entity (as applicable) is required to purchase the Altria Warrant in cash equal to the amount by which the purchase price per share paid for the common shares acquired exceeds the exercise price of the Altria Warrant multiplied by the number of common shares that would have been issuable upon exercise of the Altria Warrant immediately prior to any such transaction, and (ii) in the event the consideration received by the Company&#8217;s shareholders is not exclusively cash, the Altria Warrant will remain outstanding in accordance with its terms until any subsequent exercise of the Altria Warrant, at which time the holder thereof will receive in lieu of each share that would have been issuable upon the exercise of the Altria Warrant immediately prior to any such transaction, the kind and amount of cash, the number of shares or other securities or property resulting from any such transaction that such holder would have been entitled to receive had such holder been the registered holder of such shares that would have been issuable upon the exercise of the Altria Warrant on the record date or effective date of the transaction (as applicable).</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The Company granted to Altria, subject to certain qualifications and limitations, upon the occurrence of certain issuances of common shares of the Company executed by the Company (including issuances pursuant to the R&amp;D partnership with Ginkgo (the &#8220;Ginkgo Agreement&#8221;), refer to Note 20(b)), the right to purchase up to such number of common shares of the Company in order to maintain their ownership percentage of issued and outstanding common shares of the Company immediately preceding any issuance of shares by the Company (&#8220;Pre-emptive Rights&#8221;), at the same price per common share of the Company at which the common shares are sold in the relevant issuance; provided that if the consideration paid in connection with any such issuance is non-cash, the price per common share of the Company that would have been received had such common shares been issued for cash consideration will be determined by an independent committee (acting reasonably and in good faith); provided further that the price per common share of the Company to be paid by Altria pursuant to its exercise of its Pre-emptive Rights related to the Ginkgo Agreement will be C$16.25 per common share. These rights may not be exercised if Altria&#8217;s ownership percentage of the issued and outstanding shares of the Company falls below 20%. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">In addition to (and without duplication of) the Pre-emptive Rights, the Company granted to Altria, subject to certain qualifications and limitations, the right to subscribe for common shares of the Company issuable in connection with the exercise, conversion or exchange of convertible securities of the Company issued prior to March 8, 2019 or thereafter (excluding any convertible securities of the Company owned by Altria or any of its subsidiaries), a share incentive plan of the Company, the exercise of any right granted by the Company pro rata to all shareholders of the Company to purchase additional common shares and/or securities of the Company, bona fide bank debt, equipment financing or non-equity interim financing transactions that contemplate an equity component or bona fide acquisitions (including acquisitions of assets or rights under a license or otherwise), mergers or similar business combination transactions or joint ventures involving the Company in order to maintain their ownership percentage of issued and outstanding common shares of the Company immediately preceding any such transactions (&#8220;Top-up Rights&#8221;). </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The price per common share to be paid by Altria pursuant to the exercise of its Top-up Rights will be, subject to certain limited exceptions, the 10-day volume-weighted average price of the common shares of the Company on the TSX for the 10 full days preceding such exercise by Altria; provided that the price per common share of the Company to be paid by Altria pursuant to the exercise of its Top-up Rights in connection with the issuance of common shares of the Company pursuant to the exercise of options or warrants that were outstanding as of March 8, 2019 will be C$16.25 per common share without any set off, counterclaim, deduction, or withholding. These rights may not be exercised if Altria&#8217;s ownership percentage of the issued and outstanding shares of the Company falls below 20%.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Altria Warrant, Pre-emptive Rights, and fixed price Top-up Rights have been classified as derivative liabilities; related transaction costs of $22,355 have been expensed as financing costs in 2019. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reconciliations of the carrying amounts of the derivative liability are presented below:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:17.094%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.288%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.050%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.155%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of January 1, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gain on revaluation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exercise of Rights</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effect of FX</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) Altria Warrant</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234,428&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95,045)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(525)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,858&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b) Pre-emptive Rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,787&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(885)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,095&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c) Top-up Rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,945&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33,324)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,227)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(937)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,457&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297,160&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(129,254)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,227)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,269)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,410&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:17.094%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.155%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of March 8, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gain on revaluation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exercise of Rights</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effect of FX</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) Altria Warrant</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,086,920&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(869,630)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,138&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234,428&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b) Pre-emptive Rights</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,548&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81,070)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,309&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,787&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c) Top-up Rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">386,152&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(326,119)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,478)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,390&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,945&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,565,620&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,276,819)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,478)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,837&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297,160&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fluctuations in the Company&#8217;s share price are a primary driver for the changes in the derivative valuations during each reporting period. As the share price decreases for each of the related derivative instruments, the liability of the instrument generally decreases. Share price is one of the significant observable inputs used in the fair value measurement of each of the Company&#8217;s derivative instruments. During the year ended December&#160;31, 2020, the Company&#8217;s share price decreased from December&#160;31, 2019 resulting in a gain on revaluation of $129,254.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the derivative liabilities were determined using the Black-Scholes pricing model as of December&#160;31, 2020 and December&#160;31, 2019, applying the following inputs:</span></div><div style="margin-bottom:3pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.816%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.820%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Altria Warrant</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pre-emptive Rights</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Top-up Rights</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share price at grant date (per share in C$)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$8.84</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$8.84</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$8.84</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subscription price (per share in C$)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$19.00</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$16.25</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$16.25</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average risk-free interest rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.21%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.17%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.13%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weight average expected life (in years)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.18</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.98</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected annualized volatility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(iii)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0%</span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-indent:-27pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.816%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.820%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Altria Warrant</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pre-emptive Rights</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Top-up Rights</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share price at grant date (per share in C$)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$9.97</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$9.97</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$9.97</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subscription price (per share in C$)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$19.00</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$16.25</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$16.25</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average risk-free interest rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.69%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.73%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.71%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weight average expected life (in years)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.18</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.25</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.66</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected annualized volatility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(iii)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0%</span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The risk-free interest rate was based on Bank of Canada government treasury bills and bonds with a remaining term equal to the expected life of the derivative liabilities. The risk-free interest rate uses a range of approximately 0.10% to 0.39% as of December&#160;31, 2020 (December&#160;31, 2019 &#8211; 1.66% to 1.73%) for the Pre-emptive Rights and Top-up Rights.</span></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The expected life in years represents the period of time that the derivative liabilities are expected to be outstanding. The expected life of the Pre-emptive Rights and Top-up Rights is determined based on the expected term of the underlying options, warrants, and shares, to which the Pre-emptive Rights and Top-up Rights are linked. The expected life uses a range of approximately 0.50 years to 5 years as of December&#160;31, 2020 (December&#160;31, 2019 &#8211; 0.25 years to 6 years).</span></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Volatility was based on the blended historical volatility levels of the Company and peer companies. </span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table quantifies each of the significant inputs described above and provides a sensitivity analysis of the impact on the reported values of the derivative liabilities. The sensitivity analysis for each significant input is performed by assuming a 10% decrease in the input while other significant inputs remain constant at management&#8217;s best estimate as of the respective dates. As of December&#160;31, 2020, there would be an equal but opposite impact on net income (loss), refer to Note 15, and as of December&#160;31, 2019, there would be an equal but opposite impact on share capital.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.816%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.820%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Decrease as of December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Altria Warrant</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pre-emptive Rights</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Top-up Rights</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share price at issuance date</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,819&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,527&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,989&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average expected life</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,541&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,988&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected annualized volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,183&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,269&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,602&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.816%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.820%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Decrease as of December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Altria Warrant</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pre-emptive Rights</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Top-up Rights</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share price at issuance date</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,436&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,743&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,577&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average expected life</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,471&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,366&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,178&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected annualized volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,343&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,180&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,714&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div>These inputs are classified in Level 3 on the fair value hierarchy and are subject to volatility and several uncontrollable factors, which could significantly affect the fair value of these derivative liabilities in future periods.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI http://asc.fasb.org/topic&amp;trid=2229140<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689696907208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Stock<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Capital Stock</a></td>
<td class="text">Capital Stock&#160;&#160;&#160;&#160;<div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is authorized to issue an unlimited number of no par value common shares. The holders of the common shares are entitled to receive dividends, which may be declared from time to time, and are entitled to one vote per share at shareholder meetings of the Company. All common shares are ranked equally with regards to the Company&#8217;s residual net assets.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of common shares issued, other than in connection with outstanding options and warrants (see Note 16): </span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.372%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.208%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Altria Investment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,831,154&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redwood Acquisition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,086,586&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private placement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iii)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">856,017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bought deal offering</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iv)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,677,143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,773,757&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,677,143&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.1pt">During the year ended December&#160;31, 2019, the Company issued 149,831,154 common shares to Altria for aggregate gross proceeds of $1,809,556, net of issuance costs of $3,722. The gross proceeds were first allocated to the derivative liabilities issued in connection with the Altria Investment, and the residual of $248,302 was allocated to share capital. Pursuant to the Altria Investment, the Company incurred transaction costs of $25,223, of which $3,642 was allocated to share capital and $21,581 to the derivative liabilities based on the relative fair values assigned to the respective components. Refer to Note 14 for additional information.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.66pt">During the year ended December&#160;31, 2019, the Company issued 5,086,586 common shares with a fair value of $56,109 related to the acquisition (the &#8220;Redwood Acquisition&#8221;) of certain subsidiaries of Redwood Holding Group, LLC (collectively, &#8220;Redwood&#8221;). Refer to Note 27 for additional information.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.22pt">During the year ended December&#160;31, 2019, the Company issued 856,017 common shares to Kristen Bell, an accredited investor in a private placement (&#8220;Private Placement&#8221;) in reliance on Section 4(a)(2) of the Securities Act in connection with the use of certain publicity rights in brand development. The common shares vest in three equal installments on each of (a) January 31, 2020, (b) June 23, 2021, and (c) December 23, 2022. The issuance did not involve a public offering and was made without general solicitation or advertising. The total fair value of the consideration paid for the issuance of such common shares was approximately $6,000. The fair value of the shares was calculated using the 10-day volume weighted average price per share of the Company&#8217;s common shares on Nasdaq.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(iv)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.5pt">During the year ended December&#160;31, 2018, the Company issued 15,677,143 common shares for aggregate gross proceeds of $115,510 through bought deal offerings, net of issuance costs of $7,577.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no share repurchases during the year ended December&#160;31, 2020, 2019 or 2018.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689698053304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based Payments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Share-based Payments</a></td>
<td class="text">Share-based Payments<div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt">Warrants</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the changes in warrants during the year ended December&#160;31, 2020 and December&#160;31, 2019:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average exercise price (C$)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of warrants</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.26&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,066,662&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,079,313)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,987,349&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:42.75pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;padding-left:42.75pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average exercise price (C$)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of warrants</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.26&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,457,623&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,390,961)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2019</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.26&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,066,662&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:42.75pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a description of the Altria Warrant, see Note 14. As of December&#160;31, 2020, the Company had outstanding warrants as follows: </span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.872%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.872%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.188%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Grant date</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Expiry date</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average exercise price (C$)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of warrants</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 13 &#8211; 27, 2016</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 13 &#8211; 27, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,987,349&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of December&#160;31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,987,349&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt">Stock options</span></div><div style="margin-bottom:6pt;padding-left:47.25pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:8.57pt">Stock option plans</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company adopted an amended and restated stock option plan dated May 26, 2015 (the &#8220;2015 Stock Option Plan&#8221;), which was approved by shareholders of the Company at the annual general meeting of shareholders held on June 28, 2017. The 2015 Stock Option Plan allowed the Company&#8217;s Board of Directors (the &#8220;Board&#8221;) to award options to purchase shares to directors, officers, key employees and service providers of the Company. As of June 28, 2018, no further awards will be granted under the 2015 Stock Option Plan; however, shares may be purchased via option exercise by the holders of any outstanding options previously issued under the 2015 Stock Option Plan. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 28, 2018, the shareholders of the Company approved a stock option plan (the &#8220;2018 Stock Option Plan&#8221;), which replaced the 2015 Stock Option Plan. The 2018 Stock Option Plan terminated the Company&#8217;s ability to grant equity under the 2015 Stock Option Plan. As of June 25, 2020, the date on which the 2020 Omnibus Plan (as defined below) was approved by the shareholders of the Company, no further awards will be granted under the 2018 Stock Option Plan; however, shares may be purchased via option exercise by the holders of any outstanding options previously issued under the 2018 Stock Option Plan.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 29, 2020, the Board adopted a new omnibus equity incentive plan (the &#8220;2020 Omnibus Plan&#8221;), which was approved by the shareholders of the Company at the annual and special meeting of shareholders held on June 25, 2020. The 2020 Omnibus Plan provides for grants of stock options, share appreciation rights, restricted shares, restricted share units (&#8220;RSUs&#8221;) and other share-based or cash-based awards, which are subject to terms as determined by the Compensation Committee of the Board, and awards may be granted to eligible employees, non-employee directors and consultants. The 2020 Omnibus Plan terminated the Company&#8217;s ability to grant equity awards under the 2018 Stock Option Plan and restricted stock units under the Employment Inducement Plan.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options represent the right to purchase Company common shares on the date of exercise at a stated exercise price. The exercise price of an option generally must be at least equal to the fair market value of the Company common shares on the date of grant. The Compensation Committee of the Board (&#8220;Compensation Committee&#8221;) may provide for options to be exercised only as they vest or to be immediately exercisable with any shares issued on exercise being subject to the Company&#8217;s right of repurchase that lapses as the shares vest. Vesting conditions for grants of options are determined by the Compensation Committee. The typical vesting for stock option grants is quarterly vesting over <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMzYvZnJhZzplNjE0Nzg2MTE0YWE0YzJmYmViZDY3ODYyYzliY2Q0YS90ZXh0cmVnaW9uOmU2MTQ3ODYxMTRhYTRjMmZiZWJkNjc4NjJjOWJjZDRhXzEyNjQ0MzgzODQxMzQy_918fcba7-c0e8-4f1e-a169-2b708f363c2a">three</span> to five years. The maximum term of options granted under the 2020 Omnibus Plan is seven years. Participants under the 2020 Omnibus Plan are eligible to be granted options to purchase shares at an exercise price established upon approval of the grant by the Compensation Committee. When options are granted, the exercise price is, with respect to a particular date, the closing price as reported by the TSX or the Nasdaq and, if the shares are not traded on the TSX or the Nasdaq, any other stock exchange on which the Company&#8217;s common shares are traded (as selected by the Compensation Committee in good faith taking into account applicable legal and tax requirements) on the immediately preceding trading day (the &#8220;Fair Market Value&#8221;). The 2020 Omnibus Plan does not authorize grants of options with an exercise price below the Fair Market Value.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The equity plans described above have the following stock options outstanding: </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.594%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.594%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.597%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares outstanding as of December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 Omnibus Plan</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018 Stock Option Plan </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,627,715</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,817,287</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2015 Stock Option Plan </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,127,433&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,332,215&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,617,995&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock options outstanding</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,755,148</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,149,502</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,902,995&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">For the year ended December&#160;31, 2020, the total stock-based compensation expense associated with the equity plans was $7,185 (December&#160;31, 2019 &#8211; $10,278; December&#160;31, 2018 - $8,151).</span></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:47.25pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:5.8pt"> Summary of changes</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the changes in options during the year ended December&#160;31, 2020 and December&#160;31, 2019:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.844%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.094%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.094%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.097%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 5.5pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average exercise price (C$)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average remaining contractual term (years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.84&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,149,502&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.56</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of options</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.03&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,131,939)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancellation, forfeiture and expiry of options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(262,415)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.40&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,755,148&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.30</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December&#160;31, 2020</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.75&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,643,682&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.34</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%;padding-left:22.1pt">The weighted average exercise price reflects the conversion of foreign currency-denominated options at the exchange rates as of December&#160;31, 2020. For foreign currency-denominated options, the weighted average exercise prices are translated using exchange rates as of the settlement date.</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.844%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.094%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.094%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.097%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 5.5pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average exercise price (C$)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average remaining contractual term (years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.99&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,902,995&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.35</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.08&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,534,162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(282,572)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancellation, forfeiture and expiry of options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,083)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.84&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,149,502&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.56</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December&#160;31, 2019</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.93&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,034,714&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.27</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:47.25pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:3.03pt">Fair value of options issued</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the options issued during the year was determined using the Black-Scholes option pricing model, using the following inputs:</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.427%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.374%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share price at grant date (per share)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C$6.96</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C$15.34 &#8211; $24.75</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise price (per option)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C$6.96</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C$15.34 &#8211; $24.75</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.43%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.39% &#8211; 1.62%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life of options (in years)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected annualized volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average Black-Scholes value at grant date (per option)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C$4.84</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C$13.03</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeiture rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%;padding-left:22.1pt">The weighted average exercise price reflects the conversion of foreign currency-denominated options at the exchange rates as of December&#160;31, 2020. For foreign currency-denominated options, the weighted average exercise prices are translated using exchange rates as of the settlement date.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%;padding-left:20.66pt">The expected life of the awards represents the period of time options are expected to be outstanding and is estimated considering vesting terms and employees&#8217; and non-employees&#8217; historical exercise and, where relevant, post-vesting employment termination behavior. Volatility was estimated by using the historical volatility of the Company&#8217;s share price, adjusted for the Company&#8217;s expectation of volatility going forward. The risk-free interest rate was based on the Bank of Canada government bonds with a remaining term equal to the expected life of the options at the grant date. </span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average fair value per share at grant date of the options during the year ended December&#160;31, 2020 was C$4.84 per share (December&#160;31, 2019 &#8211; C$13.03 per share).</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.91pt">Restricted share units</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSUs are granted under the 2020 Omnibus Plan. RSUs represent an equivalent amount of Company common shares on the date of issuance at fair value. Fair value is determined using the closing price of the trading day immediately preceding the date of grant. RSUs issued under the 2020 Omnibus Plan typically vest over a three-year period following the grant date, have no performance requirements and no forfeiture rate.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 20, 2020, the Company entered into separation agreements with Robert Rosenheck and another Redwood employee pursuant to which they resigned from their employment with Redwood. In connection with such separation agreements, 732,972 outstanding and unvested RSUs were accelerated and vested during the year ended December 31, 2020.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December&#160;31, 2020, the Company recorded $8,176 (December&#160;31, 2019 &#8211; $889) in share-based compensation expense related to these RSUs. No RSUs were granted in 2018.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the changes in RSUs: </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"/><td style="width:37.842%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.663%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.329%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.666%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of RSUs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average grant date fair value (C$)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">732,972&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.34&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">957,854&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.66&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(732,972)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancellation and forfeitures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,497)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">948,357&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.66&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"/><td style="width:37.842%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.663%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.329%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.666%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of RSUs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average grant date fair value (C$)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">732,972&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">732,972&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.34&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt">Deferred share units</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 10, 2019, the Company established a cash-settled deferred share unit plan (&#8220;DSU Plan&#8221;) pursuant to which its non-executive directors receive deferred share units (&#8220;DSUs&#8221;). The DSU Plan is designed to promote a greater alignment of long-term interests between non-executive directors and shareholders. The number of DSUs granted under the DSU Plan (including fractional DSUs) is determined by dividing the amount of remuneration payable by the closing price as reported by the TSX on the trading day immediately preceding the date of grant. DSUs are payable at the time a non-executive director ceases to hold the office of director for any reason and are settled by a lump-sum cash payment, in accordance with the terms of the DSU Plan, based on the fair value of the DSUs at such time. The fair value of the cash payout is determined by multiplying the number of DSUs vested at the payout date by the closing price as reported by the TSX on the trading day immediately preceding the payout date. The fair value of the cash payout is determined at each reporting date based on the fair value of the Company&#8217;s common shares at the reporting date and is recorded within other liabilities. No DSUs were granted during 2018.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the changes in DSUs: </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.927%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.883%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.346%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of DSUs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial liability </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,397&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granting and vesting of DSUs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">338&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities settled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,484)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss (gain) on revaluation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,293&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.927%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.883%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.346%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of DSUs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial liability </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granting and vesting of DSUs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,397&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">452&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss (gain) on revaluation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(197)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,397&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689698010200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings (loss) Per Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings (loss) Per Share</a></td>
<td class="text">Earnings (loss) Per Share<div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted earnings (loss) per share from continuing operations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">are</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> calculated using </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> following numerators </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> denominators:</span></div><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"/><td style="width:55.645%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.329%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.468%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.468%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.700%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic earnings (loss) per share computation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations attributable to common shareholders of Cronos&#160;Group</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72,487)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,166,869&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,742)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351,576,848&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310,067,179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,269,170&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Basic earnings (loss) per share </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.21)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.76&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.12)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted earnings (loss) per share computation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations used in the computation of basic earnings (loss) per share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72,487)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,166,869&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,742)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustment for gain on revaluation of derivative liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,416)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations used in the computation of diluted income (loss) per share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72,487)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,142,453&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,742)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding used in the computation of basic earnings (loss) per share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351,576,848&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310,067,179&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,269,170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,481,352&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,649,487&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of restricted share units</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">732,972&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of Altria Warrant</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of Top-up Rights &#8211; exercised and exercisable fixed price</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,881,002&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares for computation of diluted income (loss) per share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351,576,848&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342,811,992&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,269,170&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings (loss) per share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.21)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.33&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.12)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.1pt">In computing diluted earnings per share, incremental common shares are not considered in periods in which a net loss is reported, as the inclusion of the common share equivalents would be anti-dilutive.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted loss per share from discontinued operations are calculated using the following numerators and denominators: </span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"/><td style="width:55.645%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.329%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.468%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.468%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.700%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 24.62pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic loss from discontinued operations per share computation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 24.62pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations attributable to common shareholders of Cronos Group</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(650)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(363)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(894)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351,576,848</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310,067,179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,269,170&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic loss from discontinued operations per share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.00&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.00&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.01)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.1pt">In computing diluted earnings per share, incremental common shares are not considered in periods in which a net loss is reported, as the inclusion of the common share equivalents would be anti-dilutive.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following securities were not included in the computation of diluted shares outstanding because the effect would be anti-dilutive or because conditions for contingently issuable shares were not satisfied at the end of the reporting periods. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.677%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.677%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.682%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ginkgo Equity Milestones</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,674,904&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,674,904&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-emptive Rights</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,534,475&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,006,740&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Top-up Rights &#8211; fixed price</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,214,621&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,103,456&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Top-up Rights &#8211; market price</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,413,065&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,255,223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Altria Warrant</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,056,296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,514,993&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,147,116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,457,623&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,218,674&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,315,787&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,902,995&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted share units</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,611&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total anti-dilutive securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151,338,762&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,871,103&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,360,618&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689697977704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income (Loss)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text">Accumulated Other Comprehensive Income (Loss) <div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a continuity schedule of accumulated other comprehensive income (loss):</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"/><td style="width:58.427%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.278%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.468%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.278%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.468%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.281%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net unrealized gain (loss) on revaluation and disposal of other investments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDkvZnJhZzpiYmUxMjVjMjMzNWM0NTEzYjlmZGRjMGY4Y2MyNGIzMi90YWJsZTpjODNhYjhiMmI3MTA0YzA1OTBmMzdlMWEwY2RiNWU5Zi90YWJsZXJhbmdlOmM4M2FiOGIyYjcxMDRjMDU5MGYzN2UxYTBjZGI1ZTlmXzMtMC0xLTEtMA_f0ab88a4-f8e8-45c9-b06f-6577993eb9f0">Cumulative effect from adoption of ASU 2016-01</span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(444)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized (loss) gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net foreign exchange gain (loss) on translation of foreign operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,833&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,875)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,456&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized (loss) gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,161&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,708&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,331)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,994&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,833&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,875)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,999&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,838&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,870)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI http://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689708646808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For financial reporting purposes, income (loss) from continuing operations before income taxes includes the following components: </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"/><td style="width:50.638%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.608%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.225%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.608%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.947%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.608%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.366%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,679&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,169,007&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,923)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85,952)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,070)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73,273)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,165,937&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,923)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The loss before income taxes above excludes losses from discontinued operations of $650 for the year ended December&#160;31, 2020 (December&#160;31, 2019 &#8211; $363; December&#160;31, 2018 &#8211; $894).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense consists of the following components: </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"/><td style="width:50.638%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.608%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.947%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.608%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.225%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.608%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.366%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,024&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,347&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in accounts payable and other liabilities as of December&#160;31, 2020 is $865 (December&#160;31, 2019 &#8211; $nil; December&#160;31, 2018 &#8211; $nil) related to current income tax expense above.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax differs from that computed using the combined Canadian federal and provincial statutory income tax rate of 26.5%. Reconciliation of the expected income tax to the effective tax rate in continuing operations is as follows:</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.883%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.347%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73,273)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,165,937&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,923)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective income tax rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected income tax expense (benefit)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,417)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308,973&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,545)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-taxable income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(711)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,156)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible share-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,498&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,839&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,364&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">764&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible transaction costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,523&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of provincial tax rate difference</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of tax rates outside of Canada</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(362)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value gain on financial liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,250)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(338,409)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in valuation allowance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,808&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,437&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">867&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">632&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(308)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (recovery), net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,347&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The valuation allowance recorded against the loss on discontinued operations is not reflected in the effective tax rate reconciliation presented above for continuing operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the significant components of the Company&#8217;s deferred tax assets and liabilities as of December&#160;31, 2020 and December&#160;31, 2019: </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.042%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax loss carryforwards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,476&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,908&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense carryforwards</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,407&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,233&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,690&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share issuance cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,573&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,217&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease obligation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,953&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,491&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plant and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,945&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">871&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserve</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,858&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">570&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">482&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,540&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,054&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less valuation allowance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85,935)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,948)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,605&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,106&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,227)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plant and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,126)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">License</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,662)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(293)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,943)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,460)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,605)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,106)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The realization of deferred tax assets is dependent on the Company&#8217;s generating sufficient taxable income in the years that the temporary differences become deductible. A valuation allowance has been provided for the deferred tax assets that the Company determined did not meet the more-likely-than-not recognition threshold under U.S. GAAP.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the Company had net operating losses in Canada, the U.S., and Israel available to offset future years&#8217; taxable income of approximately $177,651, $62,851, and $14,042, respectively. As of December&#160;31, 2019, the Company had net operating losses in Canada, the U.S., and Israel available to offset future years&#8217; taxable income of approximately $92,773, $14,374, and $8,763, respectively. The net operating losses in Canada will begin to expire, for purposes of carryforward, in fiscal year 2032. The net operating losses in the U.S. can be carried forward indefinitely for federal purposes. The net operating losses in Israel can be carried forward indefinitely.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Utilization of the net operating loss carryforwards may be subject to limitations under the tax laws applicable in each tax jurisdiction due to ownership changes that could occur in the future. These ownership changes could limit the amount of net operating loss carryforwards and other deferred tax assets that can be utilized to offset future taxable income and tax expense. Specifically, if Altria exercises its warrant the Company would recognize a change in control event and certain Canadian net operating loss carryforwards may be limited. Due to the existence of the valuation allowance, limitations created by ownership changes, if any, will not impact the Company&#8217;s effective tax rate.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files federal income tax returns in Canada, Israel and the U.S. The Company has open tax years with the taxation jurisdictions. These open years contain certain matters that could be subject to differing interpretations of applicable tax laws and regulations and tax treaties, as they relate to the amount, timing, or inclusion of revenue and expense.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.068%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.462%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.070%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Jurisdiction</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Open Years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2016 &#8211; 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018 &#8211; 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 &#8211; 2020</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table outlines the movements in the valuation allowance:</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.816%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.316%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.316%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.316%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.321%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at beginning of year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change due to foreign exchange</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Increase</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at end of year</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December&#160;31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,948)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(693)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48,294)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85,935)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December&#160;31, 2019</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,931)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(998)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,019)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,948)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020 and December&#160;31, 2019, the Company recorded a valuation allowance of $85,935 and $36,948, respectively. The valuation allowance increased by $48,294 and $28,019 during the years ended December&#160;31, 2020 and December&#160;31, 2019, respectively. The increase in the valuation allowance during the years ended December&#160;31, 2020 and December&#160;31, 2019 was primarily due to an increase in net operating loss carryforwards, the utilization of which did not meet the more-likely-than-not recognition threshold.</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounting guidance clarifies the accounting for uncertain tax positions and prescribes a recognition threshold and measurement process for recording in the financial statements uncertain tax positions taken or expected to be taken in a tax return. Additionally, the authoritative guidance addresses the de-recognition, classification, accounting in interim periods and disclosure requirements for uncertain tax positions. Only tax positions that meet the more-likely-than-not recognition threshold may be recognized. There were no identified unrecognized tax benefits as of December&#160;31, 2020 or December&#160;31, 2019.</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all earnings and profits of its subsidiaries outside Canada to be indefinitely reinvested. As of December&#160;31, 2020 and December&#160;31, 2019, the amount of undistributed earnings upon which income taxes have not been provided is immaterial to these consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689704562632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsDisclosureTextBlock', window );">Commitments</a></td>
<td class="text">Commitments <div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt">Lease Commitments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the Company&#8217;s future minimum lease payments under operating leases for its premises due in future fiscal years: </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.455%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.679%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,381&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,302&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,711&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,505&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 and thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,916&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the minimum lease payments, the Company is required to pay realty taxes and other occupancy costs in accordance with the terms of the lease agreements.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt">R&amp;D commitments</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ginkgo.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> On September 4, 2018, the Company announced an R&amp;D partnership with Ginkgo Bioworks Inc. (&#8220;Ginkgo&#8221;) to develop scalable and consistent production of eight target cannabinoids, including THC, CBD and a variety of other lesser known and rarer cannabinoids. As part of this partnership, Cronos Group has agreed to issue up to 14,674,903 common shares of the Company (aggregate value of approximately $100,000 as of July 17, 2018 assuming all milestones are met, collectively the &#8220;Ginkgo Equity Milestones&#8221;) in tranches and $22,000 in cash subject to Ginkgo&#8217;s achievement of certain milestones and to fund certain R&amp;D expenses, including foundry access fees. </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Technion.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> On October 15, 2018, the Company entered into a sponsored research agreement with the Technion Research and Development Foundation of the Technion &#8211; Israel Institute of Technology (&#8220;Technion&#8221;). Research is focused on the use of cannabinoids and their role in regulating skin health and skin disorders. The Company has committed to $1,784 of research funding over a period of three years. An additional $4,900 of cash payments will be paid to Technion upon the achievement of certain milestones.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.91pt">Altria consulting services</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 18, 2019, the Company entered into an agreement with a wholly owned subsidiary of Altria (which agreement was subsequently amended and restated to substitute Altria Pinnacle as a party thereto), to receive strategic advisory and project management services from Altria Pinnacle (the &#8220;Services Agreement&#8221;). Pursuant to the Services Agreement, the Company will pay Altria Pinnacle a monthly fee equal to the product of 105% and the sum of: (i) all costs directly associated with the services incurred during the monthly period, and (ii) a reasonable and appropriate allocation of indirect costs incurred during the monthly period. The Company will also pay all third-party direct charges incurred during the monthly period in connection with the services, including any reasonable and documented costs, fees and expenses associated with obtaining any consent, license or permit. The Services Agreement will remain in effect until terminated by either party. See Note 25.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt">Use of publicity rights in brand development</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 23, 2019, the Company issued 856,017 restricted common shares to Kristen Bell, an accredited investor, in a private placement (&#8220;Private Placement&#8221;) in reliance on Section 4(a)(2) of the Securities Act of 1933 in connection with the use of certain publicity rights in the brand development of Happy Dance&#8482;. One-third of such common shares vested on January 31, 2020 with the remaining shares vesting in two equal installments on June 23, 2021, and December 23, 2022. The issuance did not involve a public offering and was made without general solicitation or advertising. The total fair value of the consideration paid for the issuance of such common shares was approximately $6,000. The fair value of the shares was calculated using the 10-day volume weighted average price per share of the Company&#8217;s common shares on Nasdaq.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional restricted common shares are issued when certain performance milestones are achieved:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;First Performance Issuance: if, prior to December 23, 2022, the product line generates at least $50,000 in net revenue, additional common shares with an aggregate value of $1,000 will be issued.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;Second Performance Issuance: if, prior to December 23, 2022, the product line generates at least $100,000 in net revenue, additional common shares with an aggregate value of $1,000 will be issued (together with the First Performance Issuance noted above).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of common shares that would be issued upon achieving the foregoing milestones will be determined based on the 10-day volume weighted average price per share of the Company&#8217;s common shares on Nasdaq as of the trading day immediately prior to the date of filing with the Securities and Exchange Commission of the Company&#8217;s audited year-end financial statements for the first fiscal year during which such milestones are achieved.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant arrangements with third parties, which includes operating lease arrangements and arrangements in which the entity has agreed to expend funds to procure goods or services, or has agreed to commit resources to supply goods or services, and operating lease arrangements. Descriptions may include identification of the specific goods and services, period of time covered, minimum quantities and amounts, and cancellation rights.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689696909704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAbstract', window );"><strong>Loss Contingency [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDisclosures', window );">Contingencies</a></td>
<td class="text">Contingencies <div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to various legal proceedings in the ordinary course of its business and in connection with its marketing, distribution and sale of its products. Many of these legal proceedings are in the early stages of litigation and seek damages that are unspecified or not quantified. Although the outcome of these matters cannot be predicted with certainty, the Company does not believe these legal proceedings, individually or in the aggregate, will have a material adverse effect on its consolidated financial condition but could be material to its results of operations for any particular reporting period depending, in part, on its results for that period.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt">Class action complaints relating to restatement</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 11 and 12, 2020, two alleged shareholders of the Company separately filed two putative class action complaints in the U.S. District Court for the Eastern District of New York against the Company and its former Chief Executive Officer (now Executive Chairman) and Chief Financial Officer. The court has consolidated the cases, and the consolidated amended complaint alleges violations of Section 10(b) of the Exchange Act and Rule 10b-5 promulgated thereunder against all defendants, and Section 20(a) of the Exchange Act against the individual defendants. The consolidated amended complaint generally alleges that certain of the Company&#8217;s prior public statements about revenues and internal controls were incorrect based on the Company&#8217;s March 2, 2020 disclosure that the Audit Committee of the Board was conducting a review of the appropriateness of revenue recognized in connection with certain bulk resin purchases and sales of products through the wholesale channel. The consolidated amended complaint does not quantify a damage request. Defendants moved to dismiss on February 8, 2021.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On June 3, 2020, an alleged shareholder filed a Statement of Claim, as amended on August 12, 2020, in the Ontario Superior Court of Justice in Toronto, Ontario, Canada, seeking, among other things, an order certifying the action as a class action on behalf of a putative class of shareholders and damages of an unspecified amount. The Amended Statement of Claim names the Company, its former Chief Executive Officer (now Executive Chairman), Chief Financial Officer, former Chief Financial Officer and Chief Commercial Officer, and current and former members of the Board as defendants and alleges breaches of the Ontario Securities Act, oppression under the Ontario Business Corporations Act and common law misrepresentation. The Amended Statement of Claim generally alleges that certain of the Company&#8217;s prior public statements about revenues and internal controls were misrepresentations based on the Company&#8217;s March 2, 2020 disclosure that the Audit Committee of the Board was conducting a review of the appropriateness of revenue recognized in connection with certain bulk resin purchases and sales of products through the wholesale channel, and the Company&#8217;s subsequent restatement. The Amended Statement of Claim does not quantify a damage request. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt">Regulatory reviews relating to restatement</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has been responding to requests for information from various regulatory authorities relating to its previously disclosed restatement of its financial statements for the first three quarters of 2019. The Company is responding to all such requests for information and cooperating with all regulatory authorities. The Company cannot predict the outcome of any such regulatory review or investigation and it is possible that additional investigations or one or more formal proceedings may be commenced against the Company and its current and former officers and directors in connection with these regulatory reviews and investigations. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.91pt">Litigation relating to marketing, distribution and sale of products</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 16, 2020, an alleged consumer filed a Statement of Claim on behalf of a class in the Court of Queen&#8217;s Bench of Alberta in Alberta, Canada, against the Company and other Canadian cannabis manufacturers and/or distributors. On December 4, 2020, a Third Amended Statement of Claim was filed, which added a second alleged consumer. The Third Amended Statement of Claim alleges claims related to the defendants&#8217; advertised content of cannabinoids in cannabis products for medicinal use on or after June 16, 2010 and cannabis products for adult use on or after October 17, 2018. The Third Amended Statement of Claim seeks a total of C$500&#160;million for breach of contract, compensatory damages, and unjust enrichment or such other amount as may be proven in trial and C$5&#160;million in punitive damages against each defendant, including the Company. The Third Amended Statement of Claim also seeks interest and costs associated with the action. The Company has not responded to the Third Amended Statement of Claim. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A number of claims, including purported class actions, have been brought in the U.S. against companies engaged in the U.S. hemp business alleging, among other things, violations of state consumer protection, health and advertising laws. On April 8, 2020, a putative class action complaint was filed in the U.S. District Court for the Central District of California against Redwood, alleging violations of California&#8217;s Unfair Competition Law, False Advertising Law, Consumers Legal Remedies Act, and breaches of the California Commercial Code for breach of express warranties and implied warranty of merchantability with respect to Redwood&#8217;s marketing and sale of U.S. hemp products. The complaint did not quantify a damage request. On April 10, 2020, the class action complaint was dismissed for certain pleading deficiencies and the plaintiff was granted leave until April 24, 2020 to amend the complaint to establish federal subject matter jurisdiction. On April 28, 2020, the action was dismissed without prejudice for failure to prosecute and for failure to comply with a court order. As of the date of this Annual Report, the plaintiff has not refiled the complaint.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDisclosures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for loss and gain contingencies. Describes any existing condition, situation, or set of circumstances involving uncertainty as of the balance sheet date (or prior to issuance of the financial statements) as to a probable or reasonably possible loss incurred by an entity that will ultimately be resolved when one or more future events occur or fail to occur, and typically discloses the amount of loss recorded or a range of possible loss, or an assertion that no reasonable estimate can be made.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 30<br> -URI http://asc.fasb.org/subtopic&amp;trid=2127197<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2127163<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDisclosures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689698230600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplementary Cash Flow Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock', window );">Supplementary Cash Flow Information</a></td>
<td class="text">Supplementary Cash Flow Information<div style="margin-bottom:12pt;margin-top:16pt;padding-left:29.25pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net changes in non-cash working capital items are as follow:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.983%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.763%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,724)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(702)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,569)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaids and other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,300)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,509)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,382)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of loans receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,585)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,094)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51,888)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,092)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,476&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33,943)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54,208)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,662&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -URI http://asc.fasb.org/topic&amp;trid=2134446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowSupplementalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689698609576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RisksAndUncertaintiesAbstract', window );"><strong>Risks and Uncertainties [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskDisclosureTextBlock', window );">Financial Instruments</a></td>
<td class="text">Financial Instruments <div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s activities expose it to a variety of financial risks, including credit risk, liquidity risk, and market risk (including interest rate risk) and foreign currency risk.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt">Credit risk</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Credit risk is the risk of financial loss to the Company if a customer or counterparty to a financial instrument fails to meet its contractual obligations. The Company is exposed to credit risk from its operating activities, primarily accounts receivable and other receivables, and its investing activities, including cash held with banks and financial institutions, short term investments, loan receivable, and advances to joint ventures. The Company&#8217;s maximum exposure to this risk is equal to the carrying amount of these financial assets, which amounted to $1,403,491 as of December&#160;31, 2020 (December&#160;31, 2019 &#8211; $1,586,978).</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:8.57pt">Accounts receivable</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had accounts receivable of $8,928 as of December&#160;31, 2020 (December&#160;31, 2019 &#8211; $4,638). An impairment analysis is performed at each reporting date using a provision matrix to measure expected credit losses. The provision rates are based on the days past due for groupings of various customer segments with similar loss patterns. The calculation reflects the probability-weighted outcome, the time value of money and reasonable and supportable information that is available at the reporting date about past events, current conditions and forecasts of future economic conditions. Accounts receivable are written off when there is no reasonable expectation of recovery. Indicators that there is no reasonable expectation of recovery include, amongst others, the failure of a debtor to engage in a repayment plan, and a failure to make contractual payments for a period of greater than 120 days past due. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December&#160;31, 2020, the Company recognized an approximate CECL of $74 (December&#160;31, 2019 &#8211; $136). The Company has assessed that there is a concentration of credit risk as 78% of the Company&#8217;s accounts receivable were due from four customers as of December&#160;31, 2020 (December&#160;31, 2019 &#8211; 56% due from two customers) with an established credit history with the Company.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:5.8pt"> Cash and cash equivalents, short-term investments, and other receivables</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company held cash and cash equivalents of $1,078,023 at December&#160;31, 2020 (December&#160;31, 2019 &#8211; $1,199,693). The short-term investments and related interest receivable of $211,766 (December&#160;31, 2019 &#8211; $306,347) represents short-term investments with a maturity of less than a year and accrued interest as of December&#160;31, 2020. The cash and cash equivalents and short-term investments, including guaranteed investment certificates and bankers&#8217; acceptances, are held with central banks and financial institutions that are highly rated. In addition to interest receivable, other receivables include sales taxes receivable from the government. As such, the Company has assessed an insignificant loss allowance on these financial instruments. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:3.03pt">Advances to joint ventures</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had advances to joint ventures of $467 as of December&#160;31, 2020 (December&#160;31, 2019 &#8211; $19,437). The Company has assessed the credit risk of advances to joint ventures based on the financial position of the borrowers, and the regulatory and economic environment of the borrowers. The expected loss rates are based on the historical credit losses experienced. Where appropriate, the historical loss rates are adjusted to reflect current and forward-looking information. The Company has assessed the loss allowance on these advances as of December&#160;31, 2020 to be $nil (December&#160;31, 2019 &#8211; $nil).</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt">Liquidity risk</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Liquidity risk is the risk that the Company will not be able to meet its financial obligations as they become due and arises principally from the Company&#8217;s accounts payable and other liabilities. The Company had accounts payable of $12,107 as of December&#160;31, 2020 (December&#160;31, 2019 &#8211; $9,194). The Company&#8217;s policy is to review liquidity resources and ensure that sufficient funds are available to meet financial obligations as they become due. Further, the Company&#8217;s management is responsible for ensuring funds exist and are readily accessible to support business opportunities as they arise. The Company&#8217;s funding is primarily provided in the form of capital raised through the issuance of common shares and warrants. As of December&#160;31, 2020, 64% of the Company&#8217;s payables were due to four vendors (December&#160;31, 2019 &#8211; 42% due to three vendors).</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.91pt">Market risk</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Market risk is the risk that the fair value of, or future cash flows from, the Company&#8217;s financial instruments will significantly fluctuate due to changes in market prices. The value of financial instruments can be affected by changes in interest rates, market and economic conditions, and equity and commodity prices. The Company is exposed to market risk in divesting its investments, such that, unfavorable market conditions could result in dispositions of investments at less than their carrying values. Further, the revaluation of securities classified as fair value through net income could result in significant write-downs of the Company&#8217;s investments, which would have an adverse impact on the Company&#8217;s financial position.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manages risk by having a portfolio of securities from multiple issuers, such that the Company was not materially exposed to any one issuer. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt">Interest rate risk</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest rate risk is the risk that the value or yield of fixed-income investments may decline if interest rates change. Fluctuations in interest rates may impact the level of income and expense recorded on the cash equivalents and short-term investments, and the market value of all interest-earning assets, other than those which possess a short term to maturity. During the year ended December&#160;31, 2020, the Company had net interest income of $18,415 (December&#160;31, 2019 &#8211; $27,969). A 10% change in the interest rate in effect on December&#160;31, 2020 and December&#160;31, 2019, would not have a material effect on (i) fair value of the cash equivalents and short-term investments as the majority of the portfolio has a maturity date of three months or less, or (ii) interest income. Management continues to monitor external interest rates and revise the Company&#8217;s investment strategy as a result.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2020, the Company&#8217;s average variable interest rate fell 1.49%, which resulted in a decrease of net interest income of $15,671 in the period. During the year ended December&#160;31, 2019, the Company&#8217;s average variable interest rate did not materially change.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(e)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.91pt">Currency rate risk </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Currency rate risk is the risk that the fair value of, or future cash flows from, the Company&#8217;s financial instruments will significantly fluctuate due to changes in foreign exchange rates. The Company is exposed to this risk on advances to joint ventures denominated in A$ and C$. The Company is further exposed to this risk through subsidiaries operating in Israel and the U.S. as the Company&#8217;s functional currency is in Canadian dollars. The Company does not currently use foreign exchange contracts to hedge its exposure to currency rate risk. As such, the Company&#8217;s financial position and financial results may be adversely affected by the unfavorable fluctuations in currency exchange rates. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the Company had foreign currency gain (loss) on translation of $14,951 (December&#160;31, 2019 &#8211; $37,687). A 10% change in the exchange rates for the foreign currencies would affect the carrying value of net assets by approximately $170,817 as of December&#160;31, 2020 (December&#160;31, 2019 &#8211; $174,902).</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RisksAndUncertaintiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RisksAndUncertaintiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689698240008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurement<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurement</a></td>
<td class="text">Fair Value Measurement<div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company complies with ASC 820 Fair Value Measurements, for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually. In general, fair values are determined by:</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities. </span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 inputs utilize data points that are observable such as quoted prices, interest rates and yield curves. </span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 inputs are unobservable data points for the asset or liability, and includes situations where there is little, if any, market activity for the asset or liability.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present information about the Company&#8217;s assets that are measured at fair value on a recurring basis as of December&#160;31, 2020 and December&#160;31, 2019 and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.194%"><tr><td style="width:1.0%"/><td style="width:41.332%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.054%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.638%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.054%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.054%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.058%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,078,023&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,078,023&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211,766&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211,766&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,410&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,410&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.194%"><tr><td style="width:1.0%"/><td style="width:41.332%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.054%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.638%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.054%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.054%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.058%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,199,693&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,199,693&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306,347&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306,347&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297,160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297,160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689698047960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions and Balances<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions and Balances</a></td>
<td class="text">Related Party Transactions and Balances <div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 8, 2019, in connection with the Altria Investment, Altria, through certain of its wholly owned subsidiaries, purchased a 45% equity interest in the Company. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company incurred the following expenses for consulting services from Altria Pinnacle LLC, a subsidiary of Altria (&#8220;Altria Pinnacle&#8221;):</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.205%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.346%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Altria Pinnacle &#8211; expense</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,199&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,479&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,199&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,479&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No expenses for consulting services from Altria Pinnacle during the year ended December&#160;31, 2018.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of amounts payable related to the consulting services with Altria Pinnacle:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.205%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.346%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Altria Pinnacle &#8211; payable</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,152&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,152&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2019, the Company purchased machinery and equipment amounting to $1,258 from a subsidiary of Altria, which was fully paid for during the year.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 14 for further information on the derivative liabilities related to the Altria Investment.</span></div>There were no other material related party transactions during the years ended December&#160;31, 2020, December&#160;31, 2019 and December&#160;31, 2018.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI http://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689696680776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Non-monetary Transactions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonmonetaryTransactionsAbstract', window );"><strong>Nonmonetary Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonmonetaryTransactionsDisclosureTextBlock', window );">Non-monetary Transactions</a></td>
<td class="text">Non-monetary Transactions <div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had no non-monetary transactions during the year ended December 31, 2020 or 2018.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 28, 2019, the Company&#160;entered into&#160;two transactions to simultaneously purchase and sell inventory to a third party. The Company purchased cannabis resin from the third party and in turn sold cannabis dry flower to the third party. The transactions involved the exchange of work in progress inventory and were accounted for at the carrying value of inventory transferred by the Company, which equaled the value of the cannabis resin received. No revenue was recognized as a result of this transaction and no gain or loss was recognized in the consolidated statements of net income (loss) and comprehensive income (loss).</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2019, the Company entered into three transactions to simultaneously purchase and sell inventory to a third party. The Company purchased cannabis resin and cannabis tincture oil and in turn sold cannabis dry flower to the third party. The transactions involved the exchange of work in progress inventory and were accounted for in accordance with ASC 845 Non-monetary transactions at the carrying value of inventory transferred by the Company. $2,300 was recognized in revenue as a result of this transaction and no gain or loss was recognized in the consolidated statements of net income (loss) and comprehensive income (loss).</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonmonetaryTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonmonetaryTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonmonetaryTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for exchanges with other entities that involve principally nonmonetary assets or liabilities or relate to a transfer of nonmonetary assets for which the entity receives no assets in return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 845<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=68069686&amp;loc=d3e32049-108421<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 845<br> -URI http://asc.fasb.org/topic&amp;trid=2127423<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonmonetaryTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689698607016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Business Combinations</a></td>
<td class="text">Business Combinations <div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 5, 2019, the Company closed the Redwood Acquisition. Redwood manufactures, markets and distributes U.S. hemp-derived supplements and cosmetics product through e-commerce, retail and hospitality channels in the U.S. under the brand Lord Jones&#8482;. Redwood&#8217;s products use high quality U.S. hemp extract that retains naturally occurring phytocannabinoids and terpenes found in the plant. The Company plans to leverage Redwood&#8217;s capabilities to capitalize on the significant demand to further create and scale U.S. hemp-derived consumer products and brands.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, the Company acquired all the issued and outstanding shares of each of the four Redwood operating subsidiaries for an aggregate consideration of $283,300, which included $227,191 in cash and 5,086,586 common shares of the Company with a fair value of $56,109. The fair value of the shares issued as part of the consideration paid was based on the volume weighted average trading price of the common shares on Nasdaq on each of the ten consecutive trading days prior to the date of the Membership Interest Purchase Agreement dated August 1, 2019 (the &#8220;MIPA&#8221;), by and among the Company, Redwood Holding Group, LLC, and certain Key Persons solely for the purposes as described in the MIPA, at C$14.74 per share. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Redwood Acquisition was unanimously approved by the board of directors of Redwood Holdings Group, LLC and by the Board following the unanimous recommendation of a special committee of independent directors (&#8220;Special Committee&#8221;). A Special Committee composed entirely of independent directors of the Company was formed to evaluate and make recommendations to the Board since one of our directors, Jason Adler, and Michael Gorenstein, our Executive Chairman and former President and Chief Executive Officer, each held an indirect interest in Redwood Holding Group, LLC by way of their interest in certain funds affiliated with Gotham Green Partners, which funds were equity holders in Redwood Holding Group, LLC. Jason Adler is the co-founder and Managing Member of Gotham Green Partners, a private equity firm focused primarily on early-stage investing in companies in the cannabis industry, and Michael Gorenstein is a co-founder and non-managing Member of Gotham Green Partners. The Special Committee engaged Perella Weinberg Partners LP as financial advisor.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Redwood Acquisition was accounted for as a business combination as defined in ASC 805 Business Combinations. As a result of the change in control of Redwood, the assets and liabilities of Redwood are recorded at fair value in the consolidated financial statements of the Company. The following table summarizes the Company&#8217;s finalized allocation of the purchase price to assets acquired and liabilities assumed at the acquisition date. </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"/><td style="width:2.794%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:64.685%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.608%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.718%"/><td style="width:0.1%"/></tr><tr><td colspan="9" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 5, 2019</span></td></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair value of net assets acquired</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="9" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,896&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:1pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> (i)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">647&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,806&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,890&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:1pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,037&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213,414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,688)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,500)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="padding:0 1pt"/><td colspan="3" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283,300&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The fair value of acquired accounts receivable is $647. No loss allowance was recognized on acquisition.</span></div><div style="margin-bottom:3pt;margin-top:1pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Intangible assets include the fair value of brand name of $64,000, the remaining balance relates to software.</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2019, acquisition-related costs of $8,531 were expensed. These costs are included in the consolidated statement of net income (loss) in financing and transaction costs.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The goodwill recognized represents the excess over the fair value of the net tangible and intangible assets acquired as a part of the Redwood acquisition. This goodwill is attributable to the expertise and reputation of the assembled workforce acquired, the expected synergies, and other intangible assets that do not qualify for separate recognition. The goodwill is not deductible for income tax purposes. The Relief-from-Royalty Method was used to value the intangible asset relating to the Lord Jones&#8482; brand. Significant inputs include discount rate, growth rates, and cash flow projections.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the period from September 5, 2019 to December 31, 2019, the Company recognized $3,364 in revenues and a net loss of $2,613 from Redwood operations. If the acquisition had occurred on January 1, 2019, the Company estimates that for the year ended December 31, 2019, it would have recorded an increase of $12,266 in revenues and a decrease of $1,112 in net income and that for the year ended December 31, 2018, it would have recorded an increase of $7,630 in revenues and an increase of $1,533 in net income. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no business combinations during the years ended December 31, 2020 or December 31, 2018.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689696901256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Repurposing Charges<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">Repurposing Charges</a></td>
<td class="text">Repurposing Charges<div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2019, the Company commenced initiatives to better align its evolving business and its strategy. Certain facilities at the Peace Naturals campus were repurposed from cultivation activities to provide for the following activities: additional R&amp;D activities focused on new technologies for value-added product manufacturing; production and manufacturing of derivative products; and increased vault and warehousing capabilities.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The activities associated with the repurposing were completed as of December&#160;31, 2019. The following table presents information associated with this plan:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.094%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:40.706%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December&#160;31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee termination benefits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">889&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment costs associated with plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,439&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,328&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2019, an inventory write-down associated with the repurposing cost of $1,940 was included as part of inventory write-down on the consolidated statements of net income (loss) and comprehensive income (loss). The Company did not incur any further significant costs related to the repurposing activities.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No repurposing costs were incurred during the years ended December 31, 2020 or December 31, 2018. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, there was no accrued liability associated with the Company&#8217;s repurposing initiative (December&#160;31, 2019 - $907). All repurposing related charges were incurred within the Rest of World segment.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI http://asc.fasb.org/topic&amp;trid=2175745<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689696853208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Information</a></td>
<td class="text">Segment Information<div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment reporting is prepared on the same basis that the Company&#8217;s chief operating decision makers (the &#8220;CODMs&#8221;) manage the business, make operating decisions and assess the Company&#8217;s performance. For the years ended December&#160;31, 2020 and December&#160;31, 2019, the Company determined that it has the following two reportable segments: United States and Rest of World. </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The United States operating segment consists of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">manufacture and distribution of hemp-derived CBD infused products. </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Rest of World operating segment is involved in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These two segments represent the geographic regions in which the Company operates and the different product offerings within each geographic region. The results of each segment are regularly reviewed by the CODMs to assess the performance of the segment and make decisions regarding the allocation of resources. The CODMs review adjusted earnings (loss) before interest, tax, depreciation and amortization (&#8220;Adjusted EBITDA&#8221;) as the measure of segment profit or loss to evaluate performance of and allocate resources for its reportable segments. Adjusted EBITDA is defined as earnings before interest, tax, depreciation, non-cash items and items that do not reflect management&#8217;s assessment of on-going business performance.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reporting by operating segments follows the same accounting policies as those used to prepare the consolidated financial statements. The operating segments are presented in accordance with the same criteria used for internal reporting prepared for the CODMs. Inter-segment transactions are recorded at the stated values as agreed to by the segments.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment data was as follows for the year ended December&#160;31, 2020: </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:34.455%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.349%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rest of World</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated statements of net income (loss) and comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cannabis flower</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,932&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,932&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cannabis extracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,495&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,759&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,495&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,224&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,719&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share of loss from equity accounted investees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,510)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,510)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,585&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,601&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(152)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(186)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income (expense), net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,433&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,415&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,638&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,872&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,024&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,347&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss from discontinued operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(650)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(650)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(28,019)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(98,349)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20,885)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(147,253)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated balance sheets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">253,745&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">388,351&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,283,586&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,925,682&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments in equity accounted investees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,235&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,235&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">178,414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,108&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">179,522&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of property, plant and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">385&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,027&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,412&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment data was as follows for the year ended December&#160;31, 2019:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:34.544%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.464%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.324%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.464%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.324%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.464%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.324%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.464%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.328%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rest of World</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated statements of net income (loss) and comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cannabis flower</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,020&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,020&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cannabis extracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,364&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,338&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,702&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,364&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,386&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,750&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share of loss from equity accounted investees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,009)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,009)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,244)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,244)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,963&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,969&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,044&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,090&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss from discontinued operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(363)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(363)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,703)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(84,826)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,779)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(98,308)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated balance sheets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">293,985&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">309,854&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,486,603&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,090,442&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments in equity accounted investees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">557&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">557&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">213,414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,078&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">214,492&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of property, plant and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,405&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,664&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment data was as follows for the year ended December&#160;31, 2018: </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:34.594%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.188%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.349%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rest of World</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated statements of net income (loss) and comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cannabis flower</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,210&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,210&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cannabis extracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,732&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,732&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,121&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,121&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share of loss from equity accounted investees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(723)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(723)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">220&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">220&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(139)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(139)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">807&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">807&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss from discontinued operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(894)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(894)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10,357)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10,357)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated balance sheets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">183,471&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">183,471&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments in equity accounted investees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,960&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,960&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,314&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,314&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of property, plant and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88,308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88,308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted EBITDA is reconciled to net income (loss) as follows for the years ended December&#160;31, 2020, 2019 and 2018:</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.677%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.486%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands of U.S. dollars)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December&#160;31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ROW</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate<br/>Expenses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(77,368)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,671&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30,573)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(75,270)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense (income), net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,433)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,415)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,024&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,347&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairment loss on goodwill and intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financing and transaction costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain on revaluation of derivative liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(129,254)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(129,254)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain on disposal of other investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,789)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,789)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share of loss from equity accounted investees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,510&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,510&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss from discontinued operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other loss (income)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,814&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,834&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Review costs related to restatement of 2019 interim financial statements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,688&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,688&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,714&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,647&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,361&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBIT</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(28,253)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(105,160)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20,885)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(154,298)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,811&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,045&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(28,019)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(98,349)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20,885)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(147,253)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.347%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands of U.S. dollars)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December&#160;31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ROW</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate<br/>Expenses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,070)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,180,241&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,597)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,165,574&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27,963)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27,969)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairment loss on goodwill and intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurposing charges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,268&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,268&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financing and transaction costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,091&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,208&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain on revaluation of derivative liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,276,819)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,276,819)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain on disposal of other investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16,277)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16,277)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share of loss from equity accounted investees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,009&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,009&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss from discontinued operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">363&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">363&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other loss (income)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(197)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(182)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(197)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based payments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">900&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,719&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,619&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBIT</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,877)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(88,565)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,779)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(102,221)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,739&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,913&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,703)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(84,826)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,779)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(98,308)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.372%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.901%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands of U.S. dollars)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31, 2018</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21,817)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss (gain) on disposal of other investments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(164)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share of loss (income) from equity accounted investees</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">723&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss from discontinued operations</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">894&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based payments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,151&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBIT</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,294)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,937&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10,357)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sources of net revenue were as follows:</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.844%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.594%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.596%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannabis flower</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,932&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,020&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannabis extracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,702&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,719&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,750&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenue attributed to a geographic region based on the location of the customer were as follows:</span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.844%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.594%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.596%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,538&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,202&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,495&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,364&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other countries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,686&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,719&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,750&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment assets were physically located in the following geographic regions: </span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.844%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.594%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.596%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,163&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139,160&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other countries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,685&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187,599&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159,948&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sells products through a limited number of major customers. Major customers are defined as customers that each individually accounted for greater than 10% of the Company&#8217;s annual revenues and greater than 10% of accounts receivable.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">United States</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2020 and December&#160;31, 2019, the Company had no major customers in the U.S. segment. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, $65 in expected credit losses has been recognized on receivables from contract with customers (December&#160;31, 2019 &#8211; $12). Refer to Note 23(a).</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Rest of World</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2020, the Company earned a total net revenue before excise taxes of $34,295 from four major customers (December&#160;31, 2019 &#8211; $7,597; December&#160;31, 2018 &#8211; $2,186 from two and one major customers, respectively), accounting for 63% of the Company&#8217;s revenues (December&#160;31, 2019 &#8211; 32%; December&#160;31, 2018 &#8211; 17%).</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, $9 (December&#160;31, 2019 &#8211; $124; December&#160;31, 2018 &#8211; $nil) in expected credit losses has been recognized on receivables from contract with customers. Refer to Note 23(a).</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689696604184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Discontinued Operations and Held-for-sale Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock', window );">Discontinued Operations and Held-for-sale Assets</a></td>
<td class="text">Discontinued Operations and Held-for-sale Assets<div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2020, the Company advanced its plans for the sale and disposal of substantially all of the assets of OGBC. As a result, OGBC&#8217;s results of operations have been reclassified as discontinued operations in the accompanying consolidated financial statements. Accordingly, the property, plant and equipment assets of OGBC are separately reported as assets and liabilities held-for-sale as of December&#160;31, 2020 on the consolidated balance sheet. For comparative purposes, amounts in the prior periods have been reclassified to conform to current year presentation, as disclosed below. For the year ended December&#160;31, 2020, the Company recorded $1,860 as a loss on held-for-sale assets, including $919 as a valuation allowance loss upon reclassification of property, plant and equipment assets as held-for-sale in Q3 2020, and a further $941 impairment charge on held-for-sale assets in Q4 2020 upon surrender of the OGBC Health Canada licenses. OGBC was formerly included within the Rest of World segment.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the financial information for discontinued operations as of December&#160;31, 2020:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.050%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.050%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated statements of net income (loss) and comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OGBC income (loss) from discontinued operations, net of income taxes</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(650)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(363)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(894)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.427%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.594%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.883%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.596%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated balance sheets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term assets classified as discontinued operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,176&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,248&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a reconciliation of the carrying amounts of major classes of assets and liabilities of the discontinued operations to total assets and liabilities of the disposal group classified as held-for-sale in the consolidated balance sheet of December&#160;31, 2019:</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.709%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As previously disclosed</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Held-for-sale adjustment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjusted balance</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161,809&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,861)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159,948&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,085)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214,794&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(302)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214,492&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a reconciliation of the major classes of line items constituting reported operating loss of discontinued operations to net loss of discontinued operations for the years ended December&#160;31, 2019 and December&#160;31, 2018:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.511%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.793%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As previously disclosed</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Held-for-sale adjustment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjusted balance</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory write-down</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,440)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,173)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(103,620)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(103,511)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,287,058&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,287,045&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) from continuing operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,165,574&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,165,937&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.511%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.793%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31, 2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As previously disclosed</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Held-for-sale adjustment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjusted balance</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,554)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">896&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26,658)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(476)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(478)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) from continuing operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,817)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">894&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,923)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2122178<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689705007912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of presentation</a></td>
<td class="text">Basis of presentationThe accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;). U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities at the dates of the consolidated financial statements and the reported amounts of net revenues and expenses during the reporting periods. The accounting policies adopted in the preparation of the consolidated financial statements were effective as of January 1, 2020.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment structure</a></td>
<td class="text">Segment structureThe Company undertook a realignment of its management structure along geographic regions in September 2019. As a result, effective September 2019, the Company&#8217;s results are reported through the following operating segments: United States and Rest of World. Prior period amounts contained in these consolidated financial statements have been adjusted to conform to the new segment presentation. Refer to Note 29 for additional information.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Basis of consolidation</a></td>
<td class="text">Basis of consolidationThe accompanying consolidated financial statements include the accounts of the Company, and all entities in which the Company has a controlling voting interest or is the primary beneficiary of a variable interest as of and for the fiscal years ended December&#160;31, 2020, December&#160;31, 2019 and December&#160;31, 2018. The Company assesses control under the variable interest entity (&#8220;VIE&#8221;) model to determine whether the Company is the primary beneficiary of that entity&#8217;s operations.&#160;If an entity is not deemed to be a VIE, the Company consolidates the entity if the Company has a controlling&#160;voting interest. Subsidiaries are fully consolidated from the date on which control is transferred to the Company. They are deconsolidated from the date that control ceases. Investments in which the Company has the ability to exercise significant influence over the operating and financial policies of the investee, but does not have control, are accounted for under the equity method of accounting.In the consolidated statements of net income (loss) and comprehensive income (loss), the net income (loss) and comprehensive income (loss) are attributed to the equity holders of the Company and to the non-controlling interests. Non-controlling interests in the equity of Cronos Israel are presented separately in the shareholders&#8217; equity (deficit) section of the consolidated balance sheets and consolidated statements of shareholders&#8217; equity (deficit). All intercompany transactions and balances are eliminated upon consolidation.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of estimates</a></td>
<td class="text">Use of estimatesThe preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Significant estimates and assumptions include, among other things, valuation of derivative liabilities, fair value of assets and liabilities assumed in business combinations, impairment of goodwill, inventory write-downs, valuation allowance on deferred income tax assets and uncertain tax liabilities. Actual results could differ from those estimates.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue recognition</a></td>
<td class="text">Revenue recognition<div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s contracts with customers for the sale of dried cannabis, cannabis oil, cannabinoid-derived products and U.S. hemp-derived personal care products consist of one performance obligation. The Company has concluded that revenue from the sale of these products should be recognized at the point in time when control is transferred to the customer, which is on shipment or delivery, depending on the contract. Revenue is recognized at the transaction price, which is the amount of consideration to which the Company expects to be entitled in exchange for transferring promised goods to a customer. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenue before excise taxes from sale of goods, as presented in the consolidated statements of net income (loss) and comprehensive income (loss), represents revenue from the sale of goods less expected price discounts, and allowances for customer returns. Net revenue before excise taxes excludes excise taxes, which the Company pays as principal and excludes duties and taxes collected on behalf of third parties. Excise taxes are a production tax classified as government remittances payable, which when applicable, become payable when a product is delivered to the customer and are not directly related to the value of revenue.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company treats shipping and handling activities as a fulfillment cost, classified as cost of sales. Accordingly, the Company accrues all fulfillment costs related to the shipping and handling of consumer goods at the time of shipment. Within the Company's Rest of World segment, dried cannabis sales outside of Canada may include profit sharing arrangements with distributors which give rise to variable consideration. If the consideration in a contract includes a variable amount, the Company estimates the amount of consideration to which it will be entitled in exchange for transferring the goods to the customer. The variable consideration is estimated as the most likely amount, based on the Company&#8217;s historical information, at contract inception.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s payment terms vary by customer and product type. For individual consumer sales, payment is due prior to the transfer of control. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company elected to treat the costs incurred to obtain a contract, primarily related to sales commissions, as an expense in the period incurred and not an asset to be capitalized, as the amortization period of the related asset would be less than one year. Accordingly, the Company will expense the costs to obtain a contract in the period incurred.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationVariableInterestEntityPolicy', window );">Variable interest entities ("VIE")</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Variable interest entities (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">VIE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">)</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A VIE is an entity having either a total equity investment that is insufficient to finance its activities without additional subordinated financial support or equity investors at risk that lack the ability to control the entity&#8217;s activities. Variable interests are investments or other interests that will absorb portions of a VIE&#8217;s expected losses or receive portions of the VIE&#8217;s expected residual returns. The Company evaluates whether it is the primary beneficiary of each VIE it identifies on an ongoing basis and considers the impact of any reconsideration events. The primary beneficiary is the party that has both the power to direct the activities that most significantly impact the VIE and holds a variable interest that could potentially be significant to the VIE. To make this determination the Company considers both quantitative and qualitative factors regarding the nature, size and form of its involvement with the VIE. The Company consolidates the VIE when it is determined that it is the primary beneficiary of the VIE.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsPolicy', window );">Equity method investments</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity method investments</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for investments in companies over which it has the ability to exercise significant influence but does not hold a controlling financial interest, using the equity method. Under the equity method, the Company records its proportionate share of income or losses in the consolidated statements of net income (loss) and comprehensive income (loss). If the current fair value of an investment falls below its carrying amount, this may indicate that an impairment loss should be recorded. Any impairment losses recognized cannot be reversed in subsequent periods.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventory</a></td>
<td class="text">Inventory<div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory is comprised of raw materials, finished goods and work-in-progress such as pre-harvested cannabis plants, by-products to be extracted, oils, gel caps, tinctures, and boxes. The costs of growing cannabis, including but not limited to labor, utilities, nutrition and irrigation, are capitalized into inventory until the time of harvest.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory is stated at the lower of cost and net realizable value, determined using weighted average cost. Cost includes expenditures directly related to manufacturing and distribution of the products. Primary costs include consumables (insect control, fertilizers, soil), packaging, shipping, direct labor, overhead, supplies and small tools, and the depreciation of manufacturing equipment and production facilities determined at normal capacity. Manufacturing overhead and related expenses include salaries, wages, employee benefits, rent, utilities, security, and property taxes.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net realizable value is defined as the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. At the end of each reporting period, the Company performs an assessment of inventory obsolescence to measure inventory at the lower of cost and net realizable value. Factors considered in the determination of obsolescence include slow-moving or non-marketable products. During the year ended December 31, 2020, we incurred significant inventory write-downs driven by pricing pressures in the marketplace and will continue assessing pricing pressures on the value of inventory at the end of each reporting period. See Note 5.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsFiniteLivedPolicy', window );">Definite life intangible assets</a></td>
<td class="text">Definite life intangible assets<div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets are recorded at cost less any accumulated amortization and accumulated impairment losses. Intangible assets acquired through a business combination are measured at fair value at the acquisition date.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes certain costs incurred in connection with its enterprise software, which include external direct costs of materials and services consumed in developing or obtaining internal-use software, payroll and payroll-related costs for employees who are directly associated with and who devote time to the development of the software for the function intended. All other costs are expensed as incurred.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets with finite useful lives are amortized over their estimated useful lives using the following methods and rates:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"/><td style="width:35.617%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.608%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Method</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Straight-line</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Enterprise resource planning (&#8220;ERP&#8221;) software</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Straight-line</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Canada licenses</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Straight-line</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Useful life of corresponding facilities</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israeli codes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Straight-line</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Useful life of corresponding facilities</span></td></tr></table></div><div style="margin-bottom:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(i)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The preliminary licenses granted to Kibbutz Gan Shmuel (the Cronos Israel joint venture partner) by the Medical Cannabis&#160;Unit of the Israeli Ministry of Health in early 2017 (the &#8220;Israeli codes&#8221;) were transferred by non-controlling interests to Cronos Israel in exchange for equity interests in the Cronos Israel entities specified above.</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization begins when assets become available for use. The estimated useful life, amortization method, and rate are reviewed at the end of each reporting period, with the effect of any changes in estimate being accounted for on a prospective basis.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property, plant &amp; equipment</a></td>
<td class="text">Property, plant &amp; equipment<div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment are stated at cost less accumulated depreciation and accumulated impairment losses. Depreciation is computed using the straight-line method over the estimated useful lives of the assets as follows:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.927%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:54.873%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 to 25 years</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and equipment</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 to 7 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lesser of term of lease and useful life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment under finance lease</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lesser of term of lease and useful life</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When assets are disposed of, the cost and accumulated depreciation are removed from the respective accounts and any related gain or loss is recognized. Maintenance and repairs are charged to expense as incurred. Significant expenditures, which increase productivity or extend the useful life of the asset, are capitalized. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest incurred relating to construction or expansion of buildings is capitalized to construction in progress. The Company ceases the capitalization of interest when construction activities are substantially completed and the facility is available for use. At this point, construction in progress is transferred to the appropriate asset class. Available for use is defined as the point at which the related building receives the requisite regulatory licenses to (i) possess cannabis, (ii) obtain dried cannabis, fresh cannabis, cannabis plants or cannabis plant seeds by cultivating, propagating and harvesting cannabis, and (iii) produce cannabis, other than obtaining it by cultivating, propagating, or harvesting. Depreciation commences at the point the assets are available for use.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company enters into leases in the normal course of business, primarily for the land-use rights, office premises, and equipment used in the production of its products. At the inception of a contract, the Company assesses whether a contract is, or contains, a lease. A contract is, or contains, a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. The Company performs an analysis over the classification of the lease agreement as either an operating lease or finance lease. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A right-of-use asset and the related lease obligation associated with the lease are recorded at the inception of the lease. The right-of-use asset&#8217;s recorded amount is based on the present value of future lease payments over the lease term at the commencement date plus any initial direct costs incurred. If the rate implicit in the lease is not readily determinable for the Company&#8217;s operating leases, an incremental borrowing rate is generally used based on information available at the lease commencement date to determine the present value of future lease payments. Subsequent changes to these lease payments due to rate updates are recorded as lease expense in the period incurred. Leases with a term of 12 months or less are not recorded on the balance sheet as a lease. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The right-of-use asset is subject to impairment testing whenever events or changes in circumstances indicate the carrying value of the asset may not be recoverable. The leased asset is amortized over the shorter of the lease term or its estimated useful life if title does not transfer to the Company, while the leased asset is depreciated in accordance with the Company&#8217;s depreciation policy if the title is to eventually transfer to the Company.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s lease agreements generally exclude non-lease components. As a result, non-lease components are accounted for separately for all classes of assets and expensed as incurred. In addition, the Company&#8217;s lease agreements do not contain any material residual value guarantees or material restrictive covenants. For finance leases, from the commencement date to the earlier of the end of the useful life of the right-of-use asset or the end of the lease term, the right-of-use asset is amortized on a straight-line basis and the interest expense is recognized on the lease liability using the effective interest method. For operating leases, lease expense is recognized on a straight-line basis over the term of the lease and presented as a single charge in the consolidated statements of net income (loss) and comprehensive income (loss).</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock', window );">Impairment of long-lived assets</a></td>
<td class="text">Impairment of long-lived assetsThe Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. The Company groups assets at the lowest level for which cash flows are separately identifiable, referred to as an asset group. The Company prepares projected undiscounted cash flow analyses for each asset or asset group. If the sum of the undiscounted cash flow is less than the carrying value of the asset or asset group, an impairment loss is recognized equal to the excess of the carrying value over the fair value, if any. Impairment losses on assets held for sale are based on the fair value, less costs to sell.Goodwill and indefinite life intangible assets are not amortized. Goodwill and indefinite life intangible assets are reviewed for impairment annually or more frequently when events or changes in circumstances indicate that fair value of the reporting unit has been reduced to less than its carrying value. The Company performs an impairment test annually in the fourth quarter by comparing the fair value of the reporting unit with its carrying amount, including goodwill. If the fair value of the reporting unit exceeds its carrying amount, goodwill is not considered to be impaired. An impairment charge would be recognized for the amount by which the carrying amount exceeds the reporting unit&#8217;s fair value. The Company determined that it has two reporting units: the U.S. reporting unit and the Rest of World reporting unit.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock', window );">Repurposing charges</a></td>
<td class="text">Repurposing chargesThe Company&#8217;s repurposing charges primarily include employee termination benefits and refurbishment costs. The recognition of repurposing charges requires the Company make certain judgments and estimates regarding the nature, timing, and amount of costs associated with the planned activity. To the extent actual results differ from estimates and assumptions, a revision to the estimated liabilities, requiring the recognition of additional repurposing charges or the reduction of liabilities already recognized may be required. At the end of each reporting period, the Company evaluates the remaining accrued balances to ensure these balances are properly stated and the utilization of the reserves are for their intended purpose in accordance with planned activity.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityPolicyTextBlock', window );">Capital stock</a></td>
<td class="text">Capital stockCapital stock is presented at the fair value at the time of issuance of the shares issued. Costs related to the issuance of shares are reported in equity, net of tax, as a deduction from the issuance proceeds.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign currency</a></td>
<td class="text">Foreign currency<div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s functional currency is the Canadian dollar (&#8220;C$&#8221;). Prior to the year ended December 31, 2019, the Company reported its financial results in C$, however following the change in the Company&#8217;s status from foreign private issuer to a United States (&#8220;U.S.&#8221;) domestic issuer, the financial results are now reported in U.S dollars (&#8220;dollars&#8221; or &#8220;$&#8221;). Functional currencies for the entities in these consolidated financial statements are their respective local currencies, including C$, Australian dollars (&#8220;A$&#8221;) and Israeli New Shekel (&#8220;ILS&#8221;). The assets and liabilities of the Company&#8217;s foreign operations are translated into dollars at the exchange rate in effect as of December&#160;31, 2020 and 2019. Transactions affecting the shareholders&#8217; equity (deficit) are translated at historical foreign exchange rates. The consolidated statements of net income (loss) and comprehensive income (loss) and the consolidated statements of cash flows of the Company&#8217;s foreign operations are translated into dollars by applying the average foreign exchange rate in effect for the reporting period. The cumulative translation adjustments (&#8220;CTA&#8221;) resulting from translating the consolidated financial statements into their dollar reporting currency are recorded in other comprehensive income (loss). </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Monetary assets and liabilities denominated in foreign currencies are translated to the functional currency by applying the foreign exchange rate in effect at the balance sheet date. Revenues and expenses are translated using the average foreign exchange rate for the reporting period. Realized and unrealized foreign currency differences are recognized in the consolidated statements of net income (loss) and comprehensive income (loss).</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transactions in foreign currencies are translated into the functional currency using the exchange rate prevailing at the date of the transaction and are recorded in other comprehensive income. Exchange differences arising from operating transactions are recorded in net income for the period.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income taxes</a></td>
<td class="text">Income taxes<div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the liability method of accounting for income taxes, under which deferred tax assets and liabilities are recognized for the future tax consequences attributable to the differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted tax rates expected to be in effect when such assets and liabilities are recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the year that includes the enactment date. The Company determines deferred tax assets including net operating losses and liabilities, based on temporary differences between the book and tax bases of assets and liabilities. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A valuation allowance is established to reduce some or all net deferred tax assets to amounts that are more likely than not to be realized. The Company considers all available evidence, both positive and negative including past operating results, estimates of future taxable income, and the feasibility of tax planning strategies, in assessing the need for a valuation allowance. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a full valuation allowance against its net deferred tax assets, and has concluded, based on the weight of all available evidence, that it is more likely than not that the net deferred tax assets will not be realized, primarily due to the historical net operating losses. The valuation allowance against the net deferred tax assets does not in any way impact the Company&#8217;s ability to use future tax deductions such as the Company&#8217;s net operating loss carryforwards; rather, the valuation allowance indicates, according to the provisions of Accounting Standards Codification 740, Income Taxes, it is more likely than not that the deferred tax assets will not be realized. The valuation allowance that was established will be maintained until there is sufficient positive evidence to conclude that it is more likely than not that the net deferred tax assets will be realized. The Company&#8217;s income tax expense for future periods will be reduced to the extent of corresponding decreases in our valuation allowance. There is uncertainty regarding any future realization of the benefit by the Company of all or part of our net deferred tax assets.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Judgment is required to determine the recognition and measurement attributes prescribed in the accounting guidance for uncertainty in income taxes. The Company uses a two-step approach for evaluating uncertain tax positions. Step one, recognition, requires us to determine if the weight of available evidence indicates that a tax position is more likely than not to be sustained upon audit, including resolution of related appeals or litigation processes, if any. If a tax position is not considered &#8220;more likely than not&#8221; to be sustained, no benefits of the position are recognized. If we determine that a position is &#8220;more likely than not&#8221; to be sustained, then we proceed to step two, measurement, which is based on the largest amount of benefit which is more likely than not to be realized on effective settlement. This process involves estimating our actual current tax exposure, including assessing the risks associated with income tax audits, together with assessing temporary differences resulting from the different treatment of items for tax and financial reporting purposes. If actual results differ from our estimates, our net operating loss and credit carryforwards could be materially impacted in the period which such determination is made.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes uncertain income tax positions at the largest amount that is more-likely-than-not to be sustained upon examination by the relevant taxing authority. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained. Recognition or measurement is reflected in the period in which the likelihood changes. Any interest and penalties related to unrecognized tax liabilities are presented within income tax expense in the consolidated statements of net income (loss) and comprehensive income (loss). Accrued interest and penalties are included in accounts payable and other liabilities in the consolidated balance sheets.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-based compensation</a></td>
<td class="text">Share-based compensation<div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described in more detail below, the Company has five share-based compensation plans under which awards have been made: the 2020 Omnibus Plan (as defined below), the 2018 Stock Option Plan (as defined below), the 2015 Stock Option Plan (as defined below), the Employment Inducement Award Plan #1 (the &#8220;Employment Inducement Award Plan&#8221;) and a cash-settled deferred share unit (&#8220;DSU&#8221;) plan for non-executive directors.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation consists of equity-settled share-based awards such as stock options and restricted share units (&#8220;RSUs&#8221;) that are issued to eligible employees, non-executive directors, and non-employees.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash-settled deferred share units (&#8220;DSUs&#8221;) that are issued to non-executive directors are recorded in accounts payable and other liabilities with the fair value adjustment recorded in other income (loss).</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity instruments granted are initially measured at fair value on the grant date. The fair value of the stock options are determined using the Black-Scholes option pricing model. The fair value of RSUs and DSUs are determined using the market price. This is recognized on a straight-line basis in the consolidated statements of net income (loss) and comprehensive income (loss) over the vesting period for employees, and over the contractual term for non-employees. The fair value of the payout of cash-settled DSUs is determined at each reporting date based on the fair value of the Company&#8217;s common shares at the reporting date and is recorded within other liabilities.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The related costs for all equity-settled share-based awards are reflected in additional paid-in capital until the awards are exercised. Upon exercise, shares are issued and the amount previously reflected in the additional paid-in capital is, along with any proceeds paid upon exercise, credited to share capital. Forfeitures are estimated at the time of grant, and the Company revises these estimates in subsequent periods if there is a difference in actual forfeitures and the estimates.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net earnings (loss) per share</a></td>
<td class="text">Net earnings (loss) per shareThe Company presents basic and diluted net earnings (loss) per share data for its common shares. Basic net earnings (loss) per share is calculated by dividing the profit or loss attributable to common shareholders of the Company by the weighted average number of common shares outstanding during the period. Diluted net earnings (loss) per share is determined by adjusting the profit or loss attributable to common shareholders and the weighted average number of common shares outstanding for the effects of all potentially dilutive common shares that are issuable upon exercise of warrants, stock options and the Altria Warrant (as defined below) as well as the vesting of RSUs outstanding.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and cash equivalents and short-term investments</a></td>
<td class="text">Cash and cash equivalents and short-term investmentsCash and cash equivalents are comprised of cash and highly liquid investments that are readily convertible into known amounts of cash with original maturities of three months or less. Cash and cash equivalents include amounts held in dollars, C$ and ILS and security deposits. Short-term investments consist of debt securities that (i) have original maturities of greater than three months and (ii) the Company has the ability to convert into cash within one year. Short-term investments are classified as held-to-maturity.&#160;Our investments classified as held-to-maturity are recorded at cost. Interest earned on short-term investments is recorded in other receivables on the consolidated balance sheet and interest income on the consolidated statement of comprehensive income (loss). Cash inflows and outflows related to the purchase and maturity of short-term investments are classified as investing activities in the Company&#8217;s consolidated statements of cash flows.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivative liabilities</a></td>
<td class="text">Derivative liabilitiesFor financial instruments that are not designated as hedging instruments or do not qualify for hedge accounting, changes in fair value are recorded in the consolidated statements of net income (loss) and comprehensive income (loss) each period. The Company does not enter into or hold derivative financial instruments for trading or speculative purposes. Derivative liabilities are initially recognized at fair value at the date on which the derivative contract was entered into. Any attributable transaction costs are recognized in net income (loss) as incurred. Subsequent to initial recognition, derivative liabilities are measured at fair value at each reporting date until settlement with the re-measurement gain or loss being recognized immediately in comprehensive income. For more details on derivative liabilities consisting of the Altria Warrant, Pre-emptive Rights, and certain Top-up Rights, see Note 14.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair value measurements</a></td>
<td class="text">Fair value measurements<div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value of the Company&#8217;s cash and cash equivalents, accounts receivable, other receivables, loan receivable, account payables and other liabilities and holdbacks payable approximate fair value, given their short-term nature. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Group uses a fair value hierarchy, which gives the highest priority to unadjusted quoted prices in active markets for identical assets and liabilities, noted as Level 1 measurements, and the lowest priority to unobservable inputs, noted as Level 3 measurements. The following are the three levels of inputs used to measure fair value: </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 &#8211; valuation based on quoted prices (unadjusted) in active markets for identical assets and liabilities. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 &#8211; valuation techniques based on inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 &#8211; valuation techniques using the inputs for the asset or liability that are not based on observable market data.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s policy for determining when transfers between levels of the fair value hierarchy occur is based on the date of the event or changes in circumstances that caused the transfer.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsPolicy', window );">Acquisitions</a></td>
<td class="text">Acquisitions <div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accounting basis for each acquisition is dependent on whether the integrated set of assets and activities acquired constitutes a business. A business consists of inputs and processes applied to those inputs that have the ability to contribute to the creation of outputs. The cost of acquisition is allocated to the assets acquired on a relative fair value basis. No goodwill is recognized in an asset acquisition. If it is determined that a business is not acquired, the transaction is accounted for as an asset acquisition and the relevant values are finalized prior to the next reporting period. On the other hand, when a business is acquired, the acquisition method of accounting in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 805 is applied, which requires that once control of the business is obtained, the assets and liabilities of the acquired business, including amounts attributable to non-controlling interests, be recorded at their respective fair values as of the date of acquisition. Any excess of purchase consideration over the net fair value of tangible and identified intangible assets acquired less liabilities assumed is recorded as goodwill. The costs of business acquisitions, including fees for accounting, legal, professional consulting and valuation specialists, are expensed as incurred. Purchase price allocations may be preliminary and, during the measurement period not to exceed one year from the date of acquisition, changes in assumptions and estimates that result in adjustments to the fair value of assets acquired and liabilities assumed are recorded in the period the adjustments are determined.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For business combinations achieved in stages, the Company&#8217;s previously held interest in the acquiree is remeasured at its subsequent acquisition date fair value, with the resulting gain or loss recorded in the consolidated statements of net income (loss) and comprehensive income (loss). For a pre-existing relationship between the Company and acquiree that is not extinguished on the business combination, such a relationship is considered effectively settled as part of the business combination even if it is not legally cancelled. At the acquisition date, it becomes an intercompany relationship and is eliminated upon consolidation. </span></div>Contingent consideration in a business combination is initially measured at fair value. Subsequently all liability classified as contingent consideration is remeasured at fair value at each reporting period until the contingency is resolved and any change in the fair value following the date of acquisition is recorded in the consolidated statements of net income (loss) and comprehensive income (loss). All equity classified as contingent consideration is not remeasured and its subsequent settlement is accounted for within equity.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsPolicyTextBlock', window );">Assets held for sale and discontinued operations</a></td>
<td class="text">Assets held for sale and discontinued operations<div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with ASC 205-20 Presentation of Financial Statements: Discontinued Operations, a disposal of a component of an entity or a group of components of an entity is required to be reported as discontinued operations if the disposal represents a strategic shift that has (or will have) a major effect on an entity&#8217;s operations and financial results when the components of an entity meet the criteria in paragraph 205-20-45-10. In the period in which the component meets held-for-sale or discontinued operations criteria the major current assets, other assets, current liabilities, and noncurrent liabilities shall be reported as components of total assets and liabilities separate from those balances of the continuing operations. At the same time, the results of all discontinued operations, less applicable income taxes (benefit), shall be reported as components of net income (loss) separate from the net income (loss) of continuing operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2020, OGBC, formerly included within the Rest of World segment, met the criteria for &#8220;held-for-sale&#8221;. As a result, the Company has reflected amounts relating to OGBC as a disposal group classified as held-for-sale on the consolidated balance sheet and included as part of discontinued operations on the consolidated statement of net income (loss) and comprehensive income (loss) for all periods presented in this Annual Report. OGBC is no longer included in the segment reporting following the reclassification to discontinued operations. The discontinued operations of OGBC are described further in Note 30.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New accounting pronouncements</a></td>
<td class="text">New Accounting Pronouncements<div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt">Adoption of new accounting pronouncements</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2020, the Company adopted ASU No. 2018-13, Disclosure Framework &#8211; Changes to the Disclosure Requirements for Fair Value Measurement (Topic 820) (&#8220;ASU No. 2018-13&#8221;). ASU No. 2018-13 adds, modifies, and removes certain fair value measurement disclosure requirements. The adoption of ASU No. 2018-13 did not have a material impact on the Company&#8217;s consolidated financial statements.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2020, the Company adopted ASU No. 2018-15, Intangibles &#8211; Goodwill and Other Internal-use-software (Subtopic 350-40): Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract (&#8220;ASU No. 2018-15&#8221;). ASU No. 2018-15 amends current guidance to align the accounting for costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing costs associated with developing or obtaining internal-use software. The guidance in ASU No. 2018-15 is effective for annual and interim periods beginning after December 15, 2019, with early adoption permitted. The adoption of ASU No. 2018-15 did not have a material impact on the Company&#8217;s consolidated financial statements.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2020, the Company adopted ASU No. 2017-04, Intangibles &#8211; Goodwill and Other (Topic 350) &#8211; Simplifying the Test for Goodwill Impairment (&#8220;ASU No. 2017-04&#8221;). ASU No. 2017-04 eliminates step 2 from the goodwill impairment test and instead requires an entity to measure the impairment of goodwill assigned to a reporting unit if the carrying value of assets and liabilities assigned to the reporting unit, including goodwill, exceeds the reporting unit&#8217;s fair value. The guidance in ASU No. 2017-04 is effective for annual and interim goodwill tests completed by the Company beginning on January 1, 2020. The adoption of ASU No. 2017-04 was applied prospectively and the Company follows a one-step model for goodwill impairment. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt">New accounting pronouncements not yet adopted</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (&#8220;ASU No. 2019-12&#8221;). ASU No. 2019-12 eliminates certain exceptions and simplifies the application of U.S. GAAP-related changes in enacted tax laws or rates and employee stock option plans. ASU No. 2019-12 is effective for annual and interim periods beginning after December 15, 2020. Early adoption is permitted. The Company has evaluated the impact of ASU No. 2019-12 and the adoption will not have a material impact on the Company&#8217;s consolidated financial statements.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the Financial Accounting Standards Board</span><span style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">issued ASU No. 2020-01, Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) (&#8220;ASU No. 2020-01&#8221;). ASU No. 2020-01 clarifies the interaction of accounting for the transition into and out of the equity method. The new standard also clarifies the accounting for measuring certain purchased options and forward contracts to acquire investments. The guidance in ASU No. 2020-01 is effective for annual and interim periods beginning after December 15, 2020. The Company has evaluated the impact of ASU No. 2020-01 and does not expect the adoption to have a material impact to the Company&#8217;s consolidated financial statements.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06, Debt &#8211;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging &#8211;Contracts in Entity&#8217;s Own Equity (Subtopic 815&#8211;40) (&#8220;ASU No. 2020-06&#8221;). ASU No. 2020-06 simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity&#8217;s own equity. ASU No 2020-06 is part of the FASB&#8217;s simplification initiative, which aims to reduce unnecessary complexity in U.S. GAAP. ASU No 2020-06 is effective for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years. The Company is currently evaluating the impact of ASU No. 2020-06 on its consolidated financial statements and related disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (a)-(d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6909625&amp;loc=d3e227-128457<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationVariableInterestEntityPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for consolidation to describe the significant judgments and assumptions made in determining whether a variable interest held by the entity requires the variable interest entity to be consolidated and (or) disclose information about its involvement with the variable interest entity; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; and the significant factors considered and judgments made in determining that the power to direct the activities that significantly impact the economic performance of the variable interest entity are shared (as defined).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5728-111685<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=SL6759159-111685<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2AA<br> -Subparagraph a<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=SL6759068-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationVariableInterestEntityPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and reporting costs associated with exiting, disposing of, and restructuring certain operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41638-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41675-113959<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(n))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for discontinued operations. Includes, but is not limited to, method of interest allocation to a discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section S99<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=26872618&amp;loc=d3e7436-122677<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21D<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=SL94080555-108585<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI http://asc.fasb.org/topic&amp;trid=2175825<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32847-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32840-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116657188&amp;loc=SL116659661-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32280-109318<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsFiniteLivedPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 920<br> -SubTopic 350<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120155617&amp;loc=SL120155638-234783<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 920<br> -SubTopic 350<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120155617&amp;loc=SL120155628-234783<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 920<br> -SubTopic 350<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120155617&amp;loc=SL120155628-234783<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsFiniteLivedPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116846552&amp;loc=d3e543-108305<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its capital stock transactions, including dividends and accumulated other comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21459-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18726-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689704614872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock', window );">Schedule of Consolidated Entities</a></td>
<td class="text">The Company consolidates the financial results of the following entities, which the Company controls:<div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.902%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Subsidiaries </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Jurisdiction of incorporation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incorporation date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ownership interest </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Israel G.S. Cultivation Ltd.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 4, 2018</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Israel G.S. Manufacturing Ltd.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 4, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Israel G.S. Store Ltd.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 28, 2018</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Israel G.S. Pharmacy Ltd.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 15, 2018</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt">These Israeli entities are collectively referred to as &#8220;Cronos Israel.&#8221;</span></div>(ii)&#8220;Ownership interest&#8221; is defined as the proportionate share of net income to which the Company is entitled; equity interest may differ from ownership interest as described herein.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Intangible Assets Amortization Methods and Rates</a></td>
<td class="text"><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets with finite useful lives are amortized over their estimated useful lives using the following methods and rates:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"/><td style="width:35.617%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.608%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Method</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Straight-line</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Enterprise resource planning (&#8220;ERP&#8221;) software</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Straight-line</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Canada licenses</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Straight-line</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Useful life of corresponding facilities</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israeli codes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Straight-line</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Useful life of corresponding facilities</span></td></tr></table></div><div style="margin-bottom:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(i)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The preliminary licenses granted to Kibbutz Gan Shmuel (the Cronos Israel joint venture partner) by the Medical Cannabis&#160;Unit of the Israeli Ministry of Health in early 2017 (the &#8220;Israeli codes&#8221;) were transferred by non-controlling interests to Cronos Israel in exchange for equity interests in the Cronos Israel entities specified above.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets are comprised of the following items: </span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"/><td style="width:31.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.834%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.051%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.000%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.329%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.000%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.329%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.000%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.329%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.005%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average amortization period (in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2020</span></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Impairment charges</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(291)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ERP system</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,955&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(274)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,681&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Canada licenses </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,526&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,254)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,272&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lord Jones</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israeli codes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,561&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,841)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,000)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,720&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt">The Israeli codes were transferred by non-controlling interests to Cronos Israel in exchange for their equity interests in the Cronos Israel entities specified above.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.722%"><tr><td style="width:1.0%"/><td style="width:39.847%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.852%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.053%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.827%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.332%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.827%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.332%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.830%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:0 1pt 0 5.5pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average amortization period (in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2019</span></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">541&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(202)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Canada licenses</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,387&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(821)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,566&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lord Jones</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> brand</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trademarks</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israeli codes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,262&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,027)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,235&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt">The Israeli codes were transferred by non-controlling interests to Cronos Israel in exchange for their equity interests in the Cronos Israel entities specified above.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property, Plant &amp; Equipment, Useful Lives</a></td>
<td class="text">Depreciation is computed using the straight-line method over the estimated useful lives of the assets as follows:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.927%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:54.873%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 to 25 years</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and equipment</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 to 7 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lesser of term of lease and useful life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment under finance lease</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lesser of term of lease and useful life</span></td></tr></table><div style="margin-bottom:6pt;padding-left:29.25pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment, net consisted of the following:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.844%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.261%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.263%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,197&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,071&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158,586&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,690&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,824&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,079&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">710&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">526&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,740&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,758&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,837&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,569&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,295)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,745)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187,599&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159,948&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of sales of stock or previously unissued stock made by subsidiary or equity method investee to investors outside the consolidated group. This includes stock issued in a business combination in exchange for shares of an acquired entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689696903976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventory (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventory</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory is comprised of the following items:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.538%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.541%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,489&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,469&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-progress &#8211; dry cannabis</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,520&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,538&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-progress &#8211; cannabis extracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,758&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,975&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods &#8211; dry cannabis</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,894&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,798&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods &#8211; cannabis extracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,624&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplies and consumables</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,639&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,002&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,043&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689701995080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract', window );"><strong>Equity Method Investments and Joint Ventures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsTextBlock', window );">Schedule of Equity Method Investments</a></td>
<td class="text">Equity Method Investments<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the carrying amount of the investments in associates and joint ventures is as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.288%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.153%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ownership interest</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Amount</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos Australia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(346)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos GrowCo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,501&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Natuera</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(598)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 10pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,235&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">557&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt">On October 25, 2019, Cronos Australia issued 40 million new shares in an initial public offering at an offering price of A$0.50 per share. The Company&#8217;s ownership in Cronos Australia decreased from 50% to 31% on November 7, 2019 when Cronos Australia began trading on the Australian Securities Exchange. This resulted in a reconsideration event, which required the reassessment of the Company&#8217;s variable interest entity conclusion. Upon reconsideration, the Company determined that the entity was no longer a variable interest entity as of December 31, 2019 and is now reported under the equity method.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt">On September 25, 2020, the Company and 2645485 Ontario Inc. (&#8220;Mucci&#8221;), the other joint venture partner of Cronos GrowCo, agreed to capitalize certain historical advances made by each shareholder to Cronos GrowCo. Total aggregate gross advances to Cronos GrowCo, excluding any amounts advanced by the Company to Cronos GrowCo under the GrowCo Credit Facility, were C$49,300 ($37,010), of which the Company advanced 50% and Mucci advanced the remaining 50% for an amount of C$24,650 ($18,505) each. As a result, the Company transferred the advances of C$24,650 ($18,505) to investments in equity accounted investees in respect of Cronos GrowCo.</span></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s share of net earnings (losses) from equity investments accounted for under the equity method of accounting as of and for the years ended December&#160;31:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.816%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.820%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Whistler Medicinal Marijuana Company (&#8220;Whistler&#8221;)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos Australia</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(363)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,101)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(588)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos GrowCo</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,537)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(167)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedMen Canada</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(213)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Natuera</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,610)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(805)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,510)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,009)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(723)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt">Whistler was incorporated in British Columbia, Canada and is a license holder under the Cannabis Act (Canada) with production facilities in British Columbia, Canada. The Company fully divested its investment in Whistler during 2019. See Note 7.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt">The Company&#8217;s share of accumulated net losses in excess of its equity investment in Natuera has been applied as a loss allowance on the loan receivable. See Note 8.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-9pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of financial information for the Company&#8217;s equity method investments as of and for the year ended December&#160;31:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.316%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.050%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.792%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,126&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,200&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,121&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,099&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,223&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,796&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,746&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,189&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,344&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(631)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,453)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,048)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(874)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesTextBlock', window );">Schedule of Joint Ventures</a></td>
<td class="text">Advances to Joint Ventures<div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.722%"><tr><td style="width:1.0%"/><td style="width:47.785%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.231%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.914%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.231%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.914%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.231%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.914%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.231%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.914%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.235%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">MedMen Canada</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cronos GrowCo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cronos Australia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(iii) </span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Natuera</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of January 1, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">471&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,966&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,437&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfer to investments in equity accounted investees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,505)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,505)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on advances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advances to joint ventures recovered from (applied to) carrying amount of investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect from foreign exchange</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(461)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(464)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of December&#160;31, 2020</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">467&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">467&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:29.25pt;text-align:justify;text-indent:-27pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"/><td style="width:47.856%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.218%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.912%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.218%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.912%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.218%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.912%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.218%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.912%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.224%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">MedMen Canada</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cronos GrowCo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cronos Australia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(iii) </span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Natuera</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of January 1, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,244&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,970&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,689&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advances (repayments)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(852)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,494&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,135&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advances to joint ventures recovered from (applied to) carrying amount of investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(779)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(224)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(946)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect from foreign exchange</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">559&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of December&#160;31, 2019</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">471&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,966&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,437&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="padding-left:29.25pt;text-align:justify;text-indent:-27pt"><span><br/></span></div><div style="padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Advance is unsecured, non-interest bearing, and there are no terms of repayment.</span></div><div style="margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%;padding-left:20.66pt">On September 25, 2020, the Company and Mucci agreed to capitalize historical advances made by each shareholder to Cronos GrowCo. The Company capitalized C$24,650 ($18,505) through a transfer of aggregate gross advances from advances to joint ventures to investments in equity accounted investees in respect of Cronos GrowCo. Refer to footnote (ii) to the first table set forth under Note 6(a).</span></div><div style="margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.22pt">A$1,500 is governed by an unsecured loan bearing interest at a rate of 12% per annum, calculated and compounded daily, in arrears, on the amounts advanced from the date of each advance. The loan is due on January 1, 2022. If the loan is overdue, the outstanding amount bears interest at an additional 2% per annum.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock', window );">Schedule of Variable Interest Entities</a></td>
<td class="text">The following is a summary of the maximum exposure to loss for the year ended December&#160;31, 2020 and 2019:<div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.511%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.569%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ownership interest</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Net Assets (Liabilities)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maximum Exposure to Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos Australia</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,976&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,530&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos GrowCo</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,329&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedMen Canada</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">467&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Natuera</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,849)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111,456&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,276&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:-9pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.511%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.569%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ownership interest</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Net Assets (Liabilities)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maximum Exposure to Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos Australia</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,900&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,355&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos GrowCo</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,091&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 4pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedMen Canada</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(199)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">642&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Natuera</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(358)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,888&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,434&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,585&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investments in and advances to affiliates.  Does not include the tabular disclosure of the disaggregation of investments in and advances to affiliates across legal entities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120401592&amp;loc=d3e611322-123010<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAndAdvancesToAffiliatesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=SL6759159-111685<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5747-111685<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=SL6228884-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5728-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfVariableInterestEntitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689800474712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock', window );">Summary of Other Investments</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gains (losses) recognized in net income (loss) related to other investments were as follows:</span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.288%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gain recognized in net income (loss)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canopy Growth Corporation (&#8220;Canopy&#8221;)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vivo Cannabis (&#8220;Vivo&#8221;) - shares</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(173)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vivo Cannabis - share warrants</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Whistler</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iii)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,530&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aurora Cannabis Inc. (&#8220;Aurora&#8221;)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iv)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,789&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">696&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,789&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,277&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt">During the year ended December&#160;31, 2019, the Company sold all remaining 11,062 common shares of Canopy (2018 &#8211; 18,436 common shares) for net proceeds of $355 (2018 &#8211; $530) recorded as a gain on disposal of other investments in other income (expense). Upon adoption of ASU 2016-01 during the year ended December&#160;31, 2018, the gains and losses on the Canopy investment were reclassified from fair value through other comprehensive income to fair value through net income.</span></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt">During the year ended December&#160;31, 2018, the Company exercised 182,927 share warrants for aggregate consideration of $87 for additional shares of Vivo. During the year ended December&#160;31, 2018, the Company then sold all 182,927 shares of Vivo for proceeds of $216. Upon adoption of ASU 2016-01 during the year ended December&#160;31, 2018, the gains and losses on the Vivo Cannabis shares investment were reclassified from fair value through other comprehensive income to fair value through net income.</span></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.22pt">On March 4, 2019, the Company sold all 2,563 shares of Whistler, representing approximately 19.0% of Whistler&#8217;s issued and outstanding common shares, to Aurora, in connection with Aurora&#8217;s acquisition of Whistler (the &#8220;Whistler Transaction&#8221;). As a result of the closing of the Whistler Transaction, the Company received 2,524,341 Aurora common shares. During the year ended December&#160;31, 2019, the Company sold all 2,524,341 common shares of Aurora, for gross proceeds of $19,259. A gain on disposal of other investments was recorded in other income (expense) as a result.</span></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(iv)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.5pt">For the year ended December&#160;31, 2020, in connection with the achievement of certain milestones related to the Whistler Transaction, the Company received 980,662 common shares of Aurora. During the year ended December 31, 2020, the Company sold all 980,662 of the Aurora common shares, for gross proceeds of approximately $4,789 (C$6,404), recorded as a gain on disposal of other investments in other income (expense).</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689698185096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loan Receivable (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">Schedule of Loan Receivable</a></td>
<td class="text"><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.348%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of </span></td></tr><tr><td colspan="6" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December&#160;31, 2019</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Natuera Series A Loan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,518&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,575&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GrowCo Credit Facility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,137&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Accrued interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">428&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current portion of loans receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,083&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,664&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long term portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GrowCo Credit Facility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,939&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,678&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mucci Promissory Note</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iii)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,324&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,587&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannasoul Collaboration loan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iv)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,261&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Accrued interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,667&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">702&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term portion of loans receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,191&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,967&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total loans receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,274&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,631&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="text-indent:-9pt"><span><br/></span></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt">On July 24, 2020, the Company and its joint venture partner entered into an amendment to the Series A Loan with Natuera to increase the principal amount of the Series A Loan by $6,350, to an aggregate principal amount of the Series A Loan of $15,500, of which the Company has committed to fund 50% and its joint venture partner has committed to fund the remaining 50%. Outstanding principal amounts continue to bear interest at a fixed annual rate of 5.67%. In December 2020, the Series A Loan was amended to extend its maturity date to September 1, 2021 from March 1, 2021.</span></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, a current expected credit loss allowance of $685 was recorded against the Natuera Series A loan. A loss allowance of $3,024 was recorded against the Natuera Series A Loan related to the Company&#8217;s share of net loss from Natuera in excess of the carrying value of the equity method investment. Refer to Note 6.</span></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt">On August 23, 2019, the Company entered into a credit agreement with Cronos GrowCo in respect of a C$100,000 (approximately $78,430) secured non-revolving term loan credit facility (the &#8220;GrowCo Credit Facility&#8221;). The GrowCo Credit Facility will mature on March 31, 2031 and will bear interest at varying rates based on the Canadian prime rate as announced by the Bank of Montreal. Interest began to accrue as of the closing date of the GrowCo Credit Facility and is payable on a quarterly basis until maturity, except that any interest accrued prior to March 31, 2021 will be payable not later than December 31, 2021. Repayment of principal will be made on a quarterly basis commencing on March 31, 2021. The GrowCo Credit Facility is secured by substantially all present and after acquired property of Cronos GrowCo and its subsidiaries. Mucci, the other 50% shareholder of Cronos GrowCo, has provided a limited recourse guarantee in favor of Cronos GrowCo, secured by Mucci&#8217;s shares in Cronos GrowCo. As of December&#160;31, 2020, Cronos GrowCo had drawn C$95,150 ($74,626) from the GrowCo Credit Facility. Subsequent to December 31, 2020, the terms of the GrowCo Credit Facility were amended, such that any interest accrued from April 1, 2021 to December 31, 2021 will be payable not later than December 31, 2022, and repayment of principal will be made on a quarterly basis commencing on March 31, 2022.</span></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, a current expected credit loss allowance of $1,470 was recorded against the GrowCo Credit Facility.</span></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.22pt">On June 28, 2019, the Company entered into a promissory note receivable agreement (the &#8220;Mucci Promissory Note&#8221;) for C$16,350 (approximately $12,823) with Mucci. The outstanding principal amount of the Mucci Promissory Note bears interest at 3.95% annually and is due within 90 days of demand. The Company does not intend to demand the loan within 12 months. Interest accrued under the Mucci Promissory Note until July 1, 2021 is payable by way of capitalization on the principal amount and interest thereafter must be paid in cash on a quarterly basis. The Mucci Promissory Note is secured by a general security agreement covering all the assets of Mucci. Subsequent to December 31, 2020, the terms of the Mucci Promissory Note were amended, such that interest accrued under the Mucci Promissory Note until July 1, 2022, is payable by way of capitalization on the principal amount and interest thereafter must be paid in cash on a quarterly basis.</span></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, a current expected credit loss allowance of $259 has been recorded against the Mucci Promissory Note.</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(iv)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.5pt">On April 1, 2020, Cronos Israel entered into the Cannasoul Collaboration. Cronos Israel has agreed to advance approximately ILS 8,297 (approximately $2,574) by a non-recourse loan to CLS over a period of two years for the capital and operating expenditures of the laboratory. The outstanding principal on the loan bears interest at 3.5% annually and will be repaid through the profits generated from the Cannasoul Collaboration. For the year ended December 31, 2020, CLS has received ILS $4,148 (approximately $1,287). </span></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, a current expected credit loss allowance of $25 has been recorded against the Cannasoul Collaboration loan.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3,4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689704711624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant and Equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property, Plant &amp; Equipment, Useful Lives</a></td>
<td class="text">Depreciation is computed using the straight-line method over the estimated useful lives of the assets as follows:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.927%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:54.873%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 to 25 years</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and equipment</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 to 7 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lesser of term of lease and useful life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment under finance lease</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lesser of term of lease and useful life</span></td></tr></table><div style="margin-bottom:6pt;padding-left:29.25pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment, net consisted of the following:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.844%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.261%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.263%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,197&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,071&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158,586&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,690&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,824&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,079&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">710&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">526&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,740&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,758&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,837&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,569&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,295)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,745)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187,599&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159,948&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689705788008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets and Goodwill (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Finite-Lived Intangible Assets</a></td>
<td class="text"><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets with finite useful lives are amortized over their estimated useful lives using the following methods and rates:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"/><td style="width:35.617%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.608%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Method</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Straight-line</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Enterprise resource planning (&#8220;ERP&#8221;) software</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Straight-line</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Canada licenses</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Straight-line</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Useful life of corresponding facilities</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israeli codes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Straight-line</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Useful life of corresponding facilities</span></td></tr></table></div><div style="margin-bottom:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(i)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The preliminary licenses granted to Kibbutz Gan Shmuel (the Cronos Israel joint venture partner) by the Medical Cannabis&#160;Unit of the Israeli Ministry of Health in early 2017 (the &#8220;Israeli codes&#8221;) were transferred by non-controlling interests to Cronos Israel in exchange for equity interests in the Cronos Israel entities specified above.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets are comprised of the following items: </span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"/><td style="width:31.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.834%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.051%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.000%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.329%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.000%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.329%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.000%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.329%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.005%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average amortization period (in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2020</span></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Impairment charges</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(291)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ERP system</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,955&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(274)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,681&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Canada licenses </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,526&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,254)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,272&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lord Jones</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israeli codes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,561&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,841)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,000)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,720&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt">The Israeli codes were transferred by non-controlling interests to Cronos Israel in exchange for their equity interests in the Cronos Israel entities specified above.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.722%"><tr><td style="width:1.0%"/><td style="width:39.847%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.852%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.053%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.827%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.332%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.827%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.332%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.830%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:0 1pt 0 5.5pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average amortization period (in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2019</span></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">541&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(202)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Canada licenses</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,387&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(821)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,566&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lord Jones</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> brand</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trademarks</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israeli codes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,262&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,027)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,235&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt">The Israeli codes were transferred by non-controlling interests to Cronos Israel in exchange for their equity interests in the Cronos Israel entities specified above.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Indefinite-Lived Intangible Assets</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets are comprised of the following items: </span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"/><td style="width:31.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.834%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.051%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.000%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.329%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.000%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.329%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.000%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.329%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.005%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average amortization period (in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2020</span></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Impairment charges</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(291)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ERP system</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,955&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(274)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,681&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Canada licenses </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,526&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,254)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,272&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lord Jones</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israeli codes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,561&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,841)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,000)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,720&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt">The Israeli codes were transferred by non-controlling interests to Cronos Israel in exchange for their equity interests in the Cronos Israel entities specified above.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.722%"><tr><td style="width:1.0%"/><td style="width:39.847%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.852%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.053%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.827%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.332%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.827%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.332%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.830%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:0 1pt 0 5.5pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average amortization period (in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2019</span></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">541&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(202)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Canada licenses</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,387&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(821)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,566&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lord Jones</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> brand</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trademarks</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israeli codes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,262&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,027)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,235&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt">The Israeli codes were transferred by non-controlling interests to Cronos Israel in exchange for their equity interests in the Cronos Israel entities specified above.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Goodwill</a></td>
<td class="text">Goodwill<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.722%"><tr><td style="width:1.0%"/><td style="width:23.273%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.827%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.053%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.966%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.053%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.245%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.053%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.245%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.053%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.832%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Impairment charges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effect of foreign exchange</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peace Naturals</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,078&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,108&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redwood</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213,414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178,414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214,492&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,000)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179,522&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b),(d)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689698279752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of Lease Cost and Other Information</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.538%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.541%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,479&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">760&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,539&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,133&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term &#8211; operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate &#8211; operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689698133352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General and Administrative Expenses (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_GeneralAndAdministrativeExpensesTableTextBlock', window );">Schedule of General and Administrative Expenses</a></td>
<td class="text"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expense are comprised of the following items: </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.791%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salaries and wages</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,742&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,829&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,240&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional and consulting</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,135&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,369&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office and general</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,845&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,407&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,713&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Review costs related to restatement of 2019 interim financial statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,688&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current expected credit loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,607&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,530&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,529&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,271&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,349&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.1pt">These financial statement review costs include costs related to the restatement of the Company&#8217;s 2019 interim financial statements, costs related to the Company&#8217;s responses to requests for information from various regulatory authorities relating to such restatement and legal costs defending shareholder class action complaints brought against the Company as a result of the restatement.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_GeneralAndAdministrativeExpensesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>General And Administrative Expenses [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_GeneralAndAdministrativeExpensesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689803330040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock', window );">Schedule of Reconciliation of Carrying Amounts</a></td>
<td class="text"><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reconciliations of the carrying amounts of the derivative liability are presented below:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:17.094%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.288%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.050%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.155%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of January 1, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gain on revaluation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exercise of Rights</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effect of FX</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) Altria Warrant</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234,428&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95,045)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(525)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,858&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b) Pre-emptive Rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,787&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(885)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,095&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c) Top-up Rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,945&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33,324)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,227)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(937)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,457&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297,160&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(129,254)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,227)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,269)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,410&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:17.094%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.155%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of March 8, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gain on revaluation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exercise of Rights</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effect of FX</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) Altria Warrant</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,086,920&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(869,630)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,138&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234,428&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b) Pre-emptive Rights</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,548&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81,070)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,309&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,787&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c) Top-up Rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">386,152&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(326,119)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,478)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,390&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,945&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,565,620&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,276,819)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,478)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,837&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297,160&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">Schedule of Fair Values of Derivative Liabilities</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the derivative liabilities were determined using the Black-Scholes pricing model as of December&#160;31, 2020 and December&#160;31, 2019, applying the following inputs:</span></div><div style="margin-bottom:3pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.816%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.820%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Altria Warrant</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pre-emptive Rights</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Top-up Rights</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share price at grant date (per share in C$)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$8.84</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$8.84</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$8.84</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subscription price (per share in C$)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$19.00</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$16.25</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$16.25</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average risk-free interest rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.21%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.17%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.13%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weight average expected life (in years)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.18</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.98</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected annualized volatility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(iii)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0%</span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-indent:-27pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.816%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.820%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Altria Warrant</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pre-emptive Rights</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Top-up Rights</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share price at grant date (per share in C$)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$9.97</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$9.97</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$9.97</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subscription price (per share in C$)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$19.00</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$16.25</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$16.25</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average risk-free interest rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.69%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.73%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.71%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weight average expected life (in years)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.18</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.25</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.66</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected annualized volatility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(iii)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0%</span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The risk-free interest rate was based on Bank of Canada government treasury bills and bonds with a remaining term equal to the expected life of the derivative liabilities. The risk-free interest rate uses a range of approximately 0.10% to 0.39% as of December&#160;31, 2020 (December&#160;31, 2019 &#8211; 1.66% to 1.73%) for the Pre-emptive Rights and Top-up Rights.</span></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The expected life in years represents the period of time that the derivative liabilities are expected to be outstanding. The expected life of the Pre-emptive Rights and Top-up Rights is determined based on the expected term of the underlying options, warrants, and shares, to which the Pre-emptive Rights and Top-up Rights are linked. The expected life uses a range of approximately 0.50 years to 5 years as of December&#160;31, 2020 (December&#160;31, 2019 &#8211; 0.25 years to 6 years).</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#160;&#160;&#160;&#160;</span>Volatility was based on the blended historical volatility levels of the Company and peer companies.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock', window );">Schedule of Sensitivity Analysis</a></td>
<td class="text"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table quantifies each of the significant inputs described above and provides a sensitivity analysis of the impact on the reported values of the derivative liabilities. The sensitivity analysis for each significant input is performed by assuming a 10% decrease in the input while other significant inputs remain constant at management&#8217;s best estimate as of the respective dates. As of December&#160;31, 2020, there would be an equal but opposite impact on net income (loss), refer to Note 15, and as of December&#160;31, 2019, there would be an equal but opposite impact on share capital.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.816%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.820%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Decrease as of December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Altria Warrant</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pre-emptive Rights</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Top-up Rights</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share price at issuance date</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,819&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,527&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,989&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average expected life</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,541&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,988&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected annualized volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,183&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,269&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,602&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.816%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.820%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Decrease as of December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Altria Warrant</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pre-emptive Rights</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Top-up Rights</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share price at issuance date</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,436&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,743&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,577&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average expected life</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,471&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,366&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,178&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected annualized volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,343&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,180&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,714&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sensitivity Analysis, Impact On Net Income (Loss) [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset) using recurring unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19279-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689698243288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Stock (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfStockByClassTextBlock', window );">Schedule of Common Shares Issued</a></td>
<td class="text"><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of common shares issued, other than in connection with outstanding options and warrants (see Note 16): </span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.372%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.208%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Altria Investment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,831,154&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redwood Acquisition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,086,586&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private placement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iii)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">856,017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bought deal offering</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iv)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,677,143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,773,757&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,677,143&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.1pt">During the year ended December&#160;31, 2019, the Company issued 149,831,154 common shares to Altria for aggregate gross proceeds of $1,809,556, net of issuance costs of $3,722. The gross proceeds were first allocated to the derivative liabilities issued in connection with the Altria Investment, and the residual of $248,302 was allocated to share capital. Pursuant to the Altria Investment, the Company incurred transaction costs of $25,223, of which $3,642 was allocated to share capital and $21,581 to the derivative liabilities based on the relative fair values assigned to the respective components. Refer to Note 14 for additional information.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.66pt">During the year ended December&#160;31, 2019, the Company issued 5,086,586 common shares with a fair value of $56,109 related to the acquisition (the &#8220;Redwood Acquisition&#8221;) of certain subsidiaries of Redwood Holding Group, LLC (collectively, &#8220;Redwood&#8221;). Refer to Note 27 for additional information.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.22pt">During the year ended December&#160;31, 2019, the Company issued 856,017 common shares to Kristen Bell, an accredited investor in a private placement (&#8220;Private Placement&#8221;) in reliance on Section 4(a)(2) of the Securities Act in connection with the use of certain publicity rights in brand development. The common shares vest in three equal installments on each of (a) January 31, 2020, (b) June 23, 2021, and (c) December 23, 2022. The issuance did not involve a public offering and was made without general solicitation or advertising. The total fair value of the consideration paid for the issuance of such common shares was approximately $6,000. The fair value of the shares was calculated using the 10-day volume weighted average price per share of the Company&#8217;s common shares on Nasdaq.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(iv)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.5pt">During the year ended December&#160;31, 2018, the Company issued 15,677,143 common shares for aggregate gross proceeds of $115,510 through bought deal offerings, net of issuance costs of $7,577.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockByClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's stock, including par or stated value per share, number and dollar amount of share subscriptions, shares authorized, shares issued, shares outstanding, number and dollar amount of shares held in an employee trust, dividend per share, total dividends, share conversion features, par value plus additional paid in capital, the value of treasury stock and other information necessary to a fair presentation, and EPS information.  Stock by class includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. Includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity. If more than one issue is outstanding, state the title of each issue and the corresponding dollar amount; dollar amount of any shares subscribed but unissued and the deduction of subscriptions receivable there from; number of shares authorized, issued, and outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=65888546&amp;loc=d3e21300-112643<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21553-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=d3e177068-122764<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21538-112644<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21521-112644<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21488-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21506-112644<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21484-112644<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockByClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689706050536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based Payments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock', window );">Summary of Changes in Warrants and DSUs</a></td>
<td class="text"><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the changes in warrants during the year ended December&#160;31, 2020 and December&#160;31, 2019:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average exercise price (C$)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of warrants</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.26&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,066,662&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,079,313)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,987,349&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:42.75pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;padding-left:42.75pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average exercise price (C$)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of warrants</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.26&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,457,623&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,390,961)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2019</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.26&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,066,662&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the changes in DSUs: </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.927%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.883%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.346%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of DSUs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial liability </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,397&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granting and vesting of DSUs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">338&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities settled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,484)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss (gain) on revaluation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,293&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.927%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.883%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.346%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of DSUs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial liability </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granting and vesting of DSUs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,397&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">452&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss (gain) on revaluation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(197)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,397&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock', window );">Summary of Outstanding Warrants</a></td>
<td class="text">As of December&#160;31, 2020, the Company had outstanding warrants as follows: <table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.872%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.872%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.188%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Grant date</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Expiry date</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average exercise price (C$)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of warrants</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 13 &#8211; 27, 2016</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 13 &#8211; 27, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,987,349&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of December&#160;31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,987,349&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock', window );">Summary of Outstanding Options</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The equity plans described above have the following stock options outstanding: </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.594%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.594%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.597%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares outstanding as of December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 Omnibus Plan</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018 Stock Option Plan </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,627,715</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,817,287</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2015 Stock Option Plan </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,127,433&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,332,215&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,617,995&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock options outstanding</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,755,148</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,149,502</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,902,995&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock', window );">Summary of the Changes in Options</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the changes in options during the year ended December&#160;31, 2020 and December&#160;31, 2019:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.844%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.094%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.094%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.097%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 5.5pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average exercise price (C$)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average remaining contractual term (years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.84&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,149,502&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.56</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of options</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.03&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,131,939)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancellation, forfeiture and expiry of options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(262,415)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.40&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,755,148&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.30</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December&#160;31, 2020</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.75&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,643,682&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.34</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%;padding-left:22.1pt">The weighted average exercise price reflects the conversion of foreign currency-denominated options at the exchange rates as of December&#160;31, 2020. For foreign currency-denominated options, the weighted average exercise prices are translated using exchange rates as of the settlement date.</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.844%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.094%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.094%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.097%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 5.5pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average exercise price (C$)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average remaining contractual term (years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.99&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,902,995&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.35</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.08&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,534,162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(282,572)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancellation, forfeiture and expiry of options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,083)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.84&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,149,502&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.56</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December&#160;31, 2019</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.93&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,034,714&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.27</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Fair Value of Options Issued</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the options issued during the year was determined using the Black-Scholes option pricing model, using the following inputs:</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.427%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.374%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share price at grant date (per share)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C$6.96</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C$15.34 &#8211; $24.75</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise price (per option)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C$6.96</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C$15.34 &#8211; $24.75</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.43%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.39% &#8211; 1.62%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life of options (in years)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected annualized volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average Black-Scholes value at grant date (per option)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C$4.84</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">C$13.03</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeiture rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%;padding-left:22.1pt">The weighted average exercise price reflects the conversion of foreign currency-denominated options at the exchange rates as of December&#160;31, 2020. For foreign currency-denominated options, the weighted average exercise prices are translated using exchange rates as of the settlement date.</span></div>(ii)The expected life of the awards represents the period of time options are expected to be outstanding and is estimated considering vesting terms and employees&#8217; and non-employees&#8217; historical exercise and, where relevant, post-vesting employment termination behavior. Volatility was estimated by using the historical volatility of the Company&#8217;s share price, adjusted for the Company&#8217;s expectation of volatility going forward. The risk-free interest rate was based on the Bank of Canada government bonds with a remaining term equal to the expected life of the options at the grant date.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock', window );">Summary of Restricted Share Units Activity</a></td>
<td class="text"><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the changes in RSUs: </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"/><td style="width:37.842%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.663%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.329%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.666%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of RSUs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average grant date fair value (C$)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">732,972&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.34&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">957,854&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.66&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(732,972)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancellation and forfeitures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,497)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">948,357&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.66&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"/><td style="width:37.842%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.663%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.329%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.666%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of RSUs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average grant date fair value (C$)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">732,972&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">732,972&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.34&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of activity for outstanding award under share-based payment arrangement excluding share and unit options and nonvested award.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for outstanding and exercisable options that are fully vested and expected to vest. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689698730968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings (loss) Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings (Loss) Per Share</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted earnings (loss) per share from continuing operations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">are</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> calculated using </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> following numerators </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> denominators:</span></div><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"/><td style="width:55.645%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.329%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.468%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.468%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.700%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 2.12pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic earnings (loss) per share computation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations attributable to common shareholders of Cronos&#160;Group</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72,487)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,166,869&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,742)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351,576,848&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310,067,179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,269,170&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Basic earnings (loss) per share </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.21)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.76&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.12)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted earnings (loss) per share computation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations used in the computation of basic earnings (loss) per share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72,487)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,166,869&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,742)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustment for gain on revaluation of derivative liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,416)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations used in the computation of diluted income (loss) per share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72,487)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,142,453&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,742)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding used in the computation of basic earnings (loss) per share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351,576,848&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310,067,179&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,269,170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,481,352&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,649,487&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of restricted share units</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">732,972&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of Altria Warrant</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of Top-up Rights &#8211; exercised and exercisable fixed price</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,881,002&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares for computation of diluted income (loss) per share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351,576,848&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342,811,992&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,269,170&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings (loss) per share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.21)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.33&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.12)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.1pt">In computing diluted earnings per share, incremental common shares are not considered in periods in which a net loss is reported, as the inclusion of the common share equivalents would be anti-dilutive.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted loss per share from discontinued operations are calculated using the following numerators and denominators: </span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"/><td style="width:55.645%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.329%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.468%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.468%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.700%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 24.62pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic loss from discontinued operations per share computation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 24.62pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations attributable to common shareholders of Cronos Group</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(650)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(363)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(894)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351,576,848</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310,067,179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,269,170&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic loss from discontinued operations per share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.00&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.00&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.01)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.1pt">In computing diluted earnings per share, incremental common shares are not considered in periods in which a net loss is reported, as the inclusion of the common share equivalents would be anti-dilutive.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Antidilutive Securities Excluded from Computation of Diluted Shares Outstanding</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following securities were not included in the computation of diluted shares outstanding because the effect would be anti-dilutive or because conditions for contingently issuable shares were not satisfied at the end of the reporting periods. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.677%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.677%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.682%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ginkgo Equity Milestones</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,674,904&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,674,904&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-emptive Rights</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,534,475&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,006,740&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Top-up Rights &#8211; fixed price</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,214,621&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,103,456&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Top-up Rights &#8211; market price</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,413,065&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,255,223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Altria Warrant</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,056,296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,514,993&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,147,116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,457,623&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,218,674&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,315,787&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,902,995&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted share units</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,611&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total anti-dilutive securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151,338,762&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,871,103&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,360,618&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689696894264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income (Loss) (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text"><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a continuity schedule of accumulated other comprehensive income (loss):</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"/><td style="width:58.427%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.278%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.468%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.278%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.468%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.281%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net unrealized gain (loss) on revaluation and disposal of other investments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjFhZTkxMzRlNDBlNzRlMGFhYzk1ODIxODExMmU1M2Q0L3NlYzoxYWU5MTM0ZTQwZTc0ZTBhYWM5NTgyMTgxMTJlNTNkNF8xMDkvZnJhZzpiYmUxMjVjMjMzNWM0NTEzYjlmZGRjMGY4Y2MyNGIzMi90YWJsZTpjODNhYjhiMmI3MTA0YzA1OTBmMzdlMWEwY2RiNWU5Zi90YWJsZXJhbmdlOmM4M2FiOGIyYjcxMDRjMDU5MGYzN2UxYTBjZGI1ZTlmXzMtMC0xLTEtMA_f0ab88a4-f8e8-45c9-b06f-6577993eb9f0">Cumulative effect from adoption of ASU 2016-01</span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(444)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized (loss) gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net foreign exchange gain (loss) on translation of foreign operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,833&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,875)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,456&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized (loss) gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,161&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,708&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,331)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,994&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,833&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,875)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,999&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,838&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,870)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689705965832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Schedule of Income (Loss) before Income Taxes</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For financial reporting purposes, income (loss) from continuing operations before income taxes includes the following components: </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"/><td style="width:50.638%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.608%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.225%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.608%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.947%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.608%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.366%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,679&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,169,007&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,923)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85,952)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,070)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73,273)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,165,937&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,923)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Expense for Income Taxes</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense consists of the following components: </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"/><td style="width:50.638%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.608%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.947%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.608%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.225%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.608%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.366%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,024&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,347&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Effective Income Tax Rate Reconciliation</a></td>
<td class="text">Reconciliation of the expected income tax to the effective tax rate in continuing operations is as follows:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.883%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.347%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73,273)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,165,937&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,923)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective income tax rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected income tax expense (benefit)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,417)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308,973&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,545)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-taxable income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(711)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,156)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible share-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,498&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,839&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,364&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">764&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible transaction costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,523&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of provincial tax rate difference</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of tax rates outside of Canada</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(362)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value gain on financial liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,250)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(338,409)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in valuation allowance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,808&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,437&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">867&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">632&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(308)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (recovery), net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,347&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets and Liabilities</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the significant components of the Company&#8217;s deferred tax assets and liabilities as of December&#160;31, 2020 and December&#160;31, 2019: </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.042%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax loss carryforwards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,476&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,908&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense carryforwards</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,407&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,233&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,690&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share issuance cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,573&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,217&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease obligation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,953&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,491&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plant and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,945&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">871&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserve</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,858&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">570&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">482&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,540&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,054&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less valuation allowance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85,935)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,948)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,605&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,106&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,227)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plant and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,126)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">License</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,662)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(293)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,943)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,460)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,605)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,106)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SummaryOfIncomeTaxExaminationsTextBlock', window );">Summary of Income Tax Examinations</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.068%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.462%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.070%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Jurisdiction</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Open Years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2016 &#8211; 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018 &#8211; 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 &#8211; 2020</span></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SummaryOfValuationAllowanceTextBlock', window );">Summary of Valuation Allowance</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table outlines the movements in the valuation allowance:</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.816%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.316%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.316%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.316%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.321%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at beginning of year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change due to foreign exchange</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Increase</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at end of year</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December&#160;31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,948)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(693)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48,294)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85,935)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December&#160;31, 2019</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,931)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(998)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,019)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,948)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfIncomeTaxExaminationsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income tax examinations that an enterprise is currently subject to or that have been completed in the current period typically including a description of the examination, the jurisdiction conducting the examination, the tax year(s) under examination, the likelihood of an unfavorable settlement, the range of possible losses, the liability recorded, the increase or decrease in the liability from the prior period, and any penalties and interest that have been recorded.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 55<br> -Paragraph 217<br> -URI http://asc.fasb.org/extlink&amp;oid=121610041&amp;loc=d3e36027-109320<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfIncomeTaxExaminationsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfValuationAllowanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of valuation allowances to reduce deferred tax assets to net realizable value, including identification of the deferred tax asset more likely than not will not be fully realized and the corresponding amount of the valuation allowance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfValuationAllowanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689708583976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Summary of Future Minimum Lease Payments Under Operating Leases</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the Company&#8217;s future minimum lease payments under operating leases for its premises due in future fiscal years: </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.455%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.679%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,381&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,302&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,711&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,505&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 and thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,916&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689696899256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplementary Cash Flow Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowOperatingCapitalTableTextBlock', window );">Schedule of Net Changes in Non-Cash Working Capital</a></td>
<td class="text"><div style="margin-bottom:12pt;margin-top:16pt;padding-left:29.25pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net changes in non-cash working capital items are as follow:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.983%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.763%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,724)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(702)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,569)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaids and other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,300)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,509)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,382)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of loans receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,585)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,094)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51,888)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,092)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,476&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33,943)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54,208)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,662&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowOperatingCapitalTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the net increase (decrease) in operating capital in the operating section of the statement of cash flows, represents the entire footnote disclosure that provides details regarding the net change during the reporting period of all assets and liabilities used in operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowOperatingCapitalTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689701832520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measures and Disclosures (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present information about the Company&#8217;s assets that are measured at fair value on a recurring basis as of December&#160;31, 2020 and December&#160;31, 2019 and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.194%"><tr><td style="width:1.0%"/><td style="width:41.332%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.054%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.638%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.054%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.054%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.058%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,078,023&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,078,023&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211,766&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211,766&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,410&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,410&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.194%"><tr><td style="width:1.0%"/><td style="width:41.332%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.054%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.638%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.054%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.054%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.058%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,199,693&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,199,693&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306,347&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306,347&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297,160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297,160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689698217720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Disclosures (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock', window );">Schedule of Related Party Transactions</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company incurred the following expenses for consulting services from Altria Pinnacle LLC, a subsidiary of Altria (&#8220;Altria Pinnacle&#8221;):</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.205%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.346%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Altria Pinnacle &#8211; expense</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,199&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,479&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,199&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,479&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No expenses for consulting services from Altria Pinnacle during the year ended December&#160;31, 2018.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of amounts payable related to the consulting services with Altria Pinnacle:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.205%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.346%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Altria Pinnacle &#8211; payable</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,152&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,152&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689696565368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Fair Value of Net Assets Acquired</a></td>
<td class="text">The following table summarizes the Company&#8217;s finalized allocation of the purchase price to assets acquired and liabilities assumed at the acquisition date. <div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"/><td style="width:2.794%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:64.685%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.608%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.718%"/><td style="width:0.1%"/></tr><tr><td colspan="9" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 5, 2019</span></td></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair value of net assets acquired</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="9" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,896&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:1pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> (i)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">647&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,806&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,890&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:1pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,037&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213,414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,688)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,500)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="padding:0 1pt"/><td colspan="3" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283,300&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The fair value of acquired accounts receivable is $647. No loss allowance was recognized on acquisition.</span></div><div style="margin-bottom:3pt;margin-top:1pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Intangible assets include the fair value of brand name of $64,000, the remaining balance relates to software.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689698047960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Repurposing Charges (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Schedule of Plan Information and Restructuring-Related Costs</a></td>
<td class="text">The following table presents information associated with this plan:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.094%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:40.706%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December&#160;31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee termination benefits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">889&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment costs associated with plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,439&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,328&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689804557576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Segment Data and Adjusted EBITDA</a></td>
<td class="text"><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment data was as follows for the year ended December&#160;31, 2020: </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:34.455%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.349%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rest of World</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated statements of net income (loss) and comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cannabis flower</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,932&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,932&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cannabis extracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,495&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,759&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,495&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,224&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,719&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share of loss from equity accounted investees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,510)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,510)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,585&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,601&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(152)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(186)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income (expense), net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,433&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,415&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,638&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,872&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,024&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,347&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss from discontinued operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(650)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(650)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(28,019)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(98,349)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20,885)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(147,253)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated balance sheets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">253,745&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">388,351&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,283,586&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,925,682&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments in equity accounted investees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,235&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,235&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">178,414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,108&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">179,522&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of property, plant and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">385&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,027&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,412&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment data was as follows for the year ended December&#160;31, 2019:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:34.544%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.464%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.324%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.464%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.324%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.464%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.324%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.464%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.328%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rest of World</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated statements of net income (loss) and comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cannabis flower</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,020&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,020&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cannabis extracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,364&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,338&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,702&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,364&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,386&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,750&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share of loss from equity accounted investees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,009)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,009)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,244)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,244)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,963&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,969&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,044&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,090&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss from discontinued operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(363)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(363)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,703)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(84,826)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,779)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(98,308)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated balance sheets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">293,985&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">309,854&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,486,603&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,090,442&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments in equity accounted investees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">557&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">557&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">213,414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,078&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">214,492&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of property, plant and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,405&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,664&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment data was as follows for the year ended December&#160;31, 2018: </span></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:34.594%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.188%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.349%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rest of World</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated statements of net income (loss) and comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cannabis flower</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,210&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,210&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cannabis extracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,732&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,732&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,121&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,121&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share of loss from equity accounted investees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(723)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(723)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">220&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">220&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(139)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(139)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">807&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">807&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss from discontinued operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(894)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(894)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10,357)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10,357)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated balance sheets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">183,471&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">183,471&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments in equity accounted investees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,960&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,960&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,314&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,314&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of property, plant and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88,308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88,308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted EBITDA is reconciled to net income (loss) as follows for the years ended December&#160;31, 2020, 2019 and 2018:</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.677%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.486%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands of U.S. dollars)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December&#160;31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ROW</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate<br/>Expenses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(77,368)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,671&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30,573)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(75,270)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense (income), net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,433)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,415)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,024&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,347&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairment loss on goodwill and intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financing and transaction costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain on revaluation of derivative liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(129,254)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(129,254)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain on disposal of other investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,789)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,789)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share of loss from equity accounted investees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,510&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,510&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss from discontinued operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other loss (income)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,814&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,834&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Review costs related to restatement of 2019 interim financial statements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,688&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,688&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,714&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,647&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,361&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBIT</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(28,253)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(105,160)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20,885)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(154,298)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,811&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,045&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(28,019)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(98,349)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20,885)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(147,253)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.347%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands of U.S. dollars)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December&#160;31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">US</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ROW</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate<br/>Expenses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,070)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,180,241&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,597)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,165,574&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27,963)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27,969)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairment loss on goodwill and intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurposing charges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,268&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,268&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financing and transaction costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,091&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,208&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain on revaluation of derivative liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,276,819)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,276,819)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain on disposal of other investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16,277)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16,277)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share of loss from equity accounted investees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,009&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,009&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss from discontinued operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">363&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">363&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other loss (income)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(197)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(182)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(197)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based payments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">900&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,719&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,619&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBIT</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,877)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(88,565)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,779)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(102,221)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,739&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,913&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,703)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(84,826)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,779)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(98,308)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.372%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.901%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands of U.S. dollars)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31, 2018</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21,817)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss (gain) on disposal of other investments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(164)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share of loss (income) from equity accounted investees</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">723&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss from discontinued operations</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">894&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based payments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,151&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBIT</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,294)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,937&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10,357)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sources of net revenue were as follows:</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.844%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.594%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.596%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannabis flower</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,932&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,020&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannabis extracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,702&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,719&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,750&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock', window );">Schedule of Revenue from External Customers by Geographic Areas</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenue attributed to a geographic region based on the location of the customer were as follows:</span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.844%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.594%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.596%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,538&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,202&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,495&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,364&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other countries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,686&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,719&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,750&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock', window );">Schedule of Long-lived Assets by Geographic Areas</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment assets were physically located in the following geographic regions: </span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.844%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.594%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.596%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,163&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139,160&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other countries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,685&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187,599&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159,948&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph a<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689697961464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Discontinued Operations and Held-for-sale Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock', window );">Summary of Discontinued Operations</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the financial information for discontinued operations as of December&#160;31, 2020:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.050%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.050%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated statements of net income (loss) and comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OGBC income (loss) from discontinued operations, net of income taxes</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(650)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(363)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(894)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.427%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.594%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.883%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.596%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated balance sheets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term assets classified as discontinued operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,176&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,248&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a reconciliation of the carrying amounts of major classes of assets and liabilities of the discontinued operations to total assets and liabilities of the disposal group classified as held-for-sale in the consolidated balance sheet of December&#160;31, 2019:</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.705%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.709%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As previously disclosed</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Held-for-sale adjustment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjusted balance</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161,809&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,861)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159,948&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,085)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214,794&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(302)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214,492&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a reconciliation of the major classes of line items constituting reported operating loss of discontinued operations to net loss of discontinued operations for the years ended December&#160;31, 2019 and December&#160;31, 2018:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.511%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.793%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As previously disclosed</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Held-for-sale adjustment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjusted balance</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory write-down</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,440)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,173)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(103,620)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(103,511)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,287,058&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,287,045&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) from continuing operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,165,574&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,165,937&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.511%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.793%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended December 31, 2018</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As previously disclosed</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Held-for-sale adjustment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjusted balance</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,554)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">896&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26,658)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(476)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(478)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) from continuing operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,817)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">894&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,923)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=SL51724579-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1474-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5D<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721677-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721659-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721665-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721671-107760<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721663-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689708435576">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Background (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>venture </div>
<div>continent </div>
<div>brand</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_NumberOfContinentsWithInternationalProductionAndDistribution', window );">Number of continents with international production and distribution | continent</a></td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_NumberOfAdultuseBrands', window );">Number of adult-use brands</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_NumberOfHempderivedCannabidiolPersonalCareBrands', window );">Number of hemp-derived cannabidiol personal care brands</a></td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_NumberOfStrategicJointVentures', window );">Number of strategic joint ventures | venture</a></td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosAustraliaLimitedMember', window );">Cronos Australia</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest</a></td>
<td class="nump">31.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_NumberOfAdultuseBrands">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Adult-use Brands</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_NumberOfAdultuseBrands</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_NumberOfContinentsWithInternationalProductionAndDistribution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Continents With International Production And Distribution</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_NumberOfContinentsWithInternationalProductionAndDistribution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_NumberOfHempderivedCannabidiolPersonalCareBrands">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Hemp-derived Cannabidiol Personal Care Brands</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_NumberOfHempderivedCannabidiolPersonalCareBrands</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_NumberOfStrategicJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Strategic Joint Ventures</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_NumberOfStrategicJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosAustraliaLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosAustraliaLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689704729096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Consolidated Entities (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cron_CronosIsraelG.S.CultivationsLtd.Member', window );">Cronos Israel G.S. Cultivations Ltd.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions', window );">Ownership Interest</a></td>
<td class="nump">70.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cron_CronosIsraelG.S.ManufacturingLtd.Member', window );">Cronos Israel G.S. Manufacturing Ltd.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions', window );">Ownership Interest</a></td>
<td class="nump">90.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cron_CronosIsraelG.S.StoreLtd.Member', window );">Cronos Israel G.S. Store Ltd.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions', window );">Ownership Interest</a></td>
<td class="nump">90.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=cron_CronosIsraelG.S.PharmaciesLtd.Member', window );">Cronos Israel G.S. Pharmacies Ltd.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions', window );">Ownership Interest</a></td>
<td class="nump">90.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of subsidiary's or equity method investee's stock owned by parent immediately after all stock transactions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=cron_CronosIsraelG.S.CultivationsLtd.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=cron_CronosIsraelG.S.CultivationsLtd.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=cron_CronosIsraelG.S.ManufacturingLtd.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=cron_CronosIsraelG.S.ManufacturingLtd.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=cron_CronosIsraelG.S.StoreLtd.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=cron_CronosIsraelG.S.StoreLtd.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=cron_CronosIsraelG.S.PharmaciesLtd.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=cron_CronosIsraelG.S.PharmaciesLtd.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689696728408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Intangible Assets Amortization Methods and Rates (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember', window );">Software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible assets, useful life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cron_EnterpriseResourcePlanningSystemMember', window );">Enterprise resource planning (&#8220;ERP&#8221;) software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible assets, useful life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cron_EnterpriseResourcePlanningSystemMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cron_EnterpriseResourcePlanningSystemMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689708522952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Property, Plant &amp; Equipment, Useful Lives (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Building | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant &amp; equipment, useful life</a></td>
<td class="text">15 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Building | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant &amp; equipment, useful life</a></td>
<td class="text">25 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and equipment | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant &amp; equipment, useful life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and equipment | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant &amp; equipment, useful life</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer equipment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant &amp; equipment, useful life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689696680776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Impairment of Long-lived Assets (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2020 </div>
<div>reportingUnit</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportingUnits', window );">Number of reporting units</a></td>
<td class="nump">2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportingUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportingUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689703033832">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Revenues from Contracts with Customers - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 8,928<span></span>
</td>
<td class="nump">$ 4,638<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for credit loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 74<span></span>
</td>
<td class="nump">$ 136<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Net of current expected credit loss allowance of $74 as of December&#160;31, 2020 (December 31, 2019 &#8211; $136)</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121599878&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689703623560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventory (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryLineItems', window );"><strong>Inventory [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">$ 11,489,000<span></span>
</td>
<td class="nump">$ 2,469,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventorySuppliesNetOfReserves', window );">Supplies and consumables</a></td>
<td class="nump">330,000<span></span>
</td>
<td class="nump">1,639,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total</a></td>
<td class="nump">44,002,000<span></span>
</td>
<td class="nump">38,043,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Inventory write-down</a></td>
<td class="nump">26,055,000<span></span>
</td>
<td class="nump">29,173,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryValuationReserves', window );">Inventory valuation reserves</a></td>
<td class="nump">1,229,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PublicUtilitiesInventoryAxis=cron_InventoryDryCannabisMember', window );">Dry Cannabis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryLineItems', window );"><strong>Inventory [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work-in-progress</a></td>
<td class="nump">20,520,000<span></span>
</td>
<td class="nump">11,538,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">4,894,000<span></span>
</td>
<td class="nump">1,798,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PublicUtilitiesInventoryAxis=cron_InventoryCannabisExtractsMember', window );">Cannabis Extracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryLineItems', window );"><strong>Inventory [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work-in-progress</a></td>
<td class="nump">5,758,000<span></span>
</td>
<td class="nump">17,975,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">$ 1,011,000<span></span>
</td>
<td class="nump">$ 2,624,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventorySuppliesNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of products used directly or indirectly in the manufacturing or production process, which may or may not become part of the final product. May also include items used in the storage, presentation or transportation of physical goods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventorySuppliesNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryValuationReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation reserve for inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryValuationReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4542-108314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PublicUtilitiesInventoryAxis=cron_InventoryDryCannabisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PublicUtilitiesInventoryAxis=cron_InventoryDryCannabisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PublicUtilitiesInventoryAxis=cron_InventoryCannabisExtractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PublicUtilitiesInventoryAxis=cron_InventoryCannabisExtractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689702684472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments - Narrative (Details)<br> &#8362; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Apr. 01, 2020 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th"><div>Nov. 07, 2019</div></th>
<th class="th"><div>Nov. 06, 2019</div></th>
<th class="th"><div>Jun. 14, 2018</div></th>
<th class="th"><div>Mar. 13, 2018</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th">
<div>Apr. 01, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosGrowingCompanyInc.Member', window );">Cronos GrowCo | Variable Interest Entity, Not Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityOwnershipPercentage', window );">Ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_MedMenCanadaInc.Member', window );">MedMen Canada | Variable Interest Entity, Not Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityOwnershipPercentage', window );">Ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_MedMenCanadaInc.Member', window );">MedMen Canada | Minimum | Variable Interest Entity, Not Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_VariableInterestEntityQualitativeOrQuantitativeInformationLicenseTerm', window );">License term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_NatuEraMember', window );">Natuera | Variable Interest Entity, Not Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityOwnershipPercentage', window );">Ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CannasoulAnalyticsLtdMember', window );">Cannasoul Analytics Ltd. | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement | Variable Interest Entity, Not Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_CollaborativeArrangementPercentageOfProfitsToBeReceived', window );">Collaborative arrangement, percentage of profits to be received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced', window );">Collaborative arrangement, profits to be received, maximum percentage of amounts advanced</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet', window );">Collaborative arrangement, percentage of profits to be received, triggering event, subsequent to maximum percentage of amounts advanced being met</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CannasoulAnalyticsLtdMember', window );">Cannasoul Analytics Ltd. | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement | Cannasoul Collaboration Loan | Loans Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_CollaborativeArrangementTermOfAgreement', window );">Collaborative arrangement, term of agreement</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CannasoulAnalyticsLtdMember', window );">Cannasoul Analytics Ltd. | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement | Cannasoul Collaboration Loan | Variable Interest Entity, Not Primary Beneficiary | Loans Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_CollaborativeArrangementAmountOfAdvances', window );">Collaboration agreement, amount of advances</a></td>
<td class="nump">&#8362; 8,297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,574<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_CollaborativeArrangementTermOfAgreement', window );">Collaborative arrangement, term of agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosAustraliaLimitedMember', window );">Cronos Australia</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosAustraliaLimitedMember', window );">Cronos Australia | Variable Interest Entity, Not Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityOwnershipPercentage', window );">Ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31.00%<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31.00%<span></span>
</td>
<td class="nump">31.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_CollaborativeArrangementAmountOfAdvances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Amount Of Advances</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_CollaborativeArrangementAmountOfAdvances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_CollaborativeArrangementPercentageOfProfitsToBeReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Percentage Of Profits To Be Received</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_CollaborativeArrangementPercentageOfProfitsToBeReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Percentage Of Profits To Be Received, Triggering Event, Subsequent To Maximum Percentage Of Amounts Advanced Being Met</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Profits To Be Received, Maximum Percentage Of Amounts Advanced</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_CollaborativeArrangementTermOfAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Term Of Agreement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_CollaborativeArrangementTermOfAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_VariableInterestEntityQualitativeOrQuantitativeInformationLicenseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Variable Interest Entity, Qualitative Or Quantitative Information, License Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_VariableInterestEntityQualitativeOrQuantitativeInformationLicenseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=SL6759159-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosGrowingCompanyInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosGrowingCompanyInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_MedMenCanadaInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_MedMenCanadaInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_NatuEraMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_NatuEraMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CannasoulAnalyticsLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CannasoulAnalyticsLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_LoanReceivableNameAxis=cron_CannasoulCollaborationLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_LoanReceivableNameAxis=cron_CannasoulCollaborationLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_LoansReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_LoansReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosAustraliaLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosAustraliaLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689791971288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments - Schedule of Equity Method Investments (Details)<br> $ in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 25, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 25, 2020 </div>
<div>CAD ($)</div>
</th>
<th class="th"><div>Nov. 07, 2019</div></th>
<th class="th"><div>Nov. 06, 2019</div></th>
<th class="th">
<div>Oct. 25, 2019 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th"><div>Jun. 14, 2018</div></th>
<th class="th"><div>Mar. 13, 2018</div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investments in equity accounted investees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 557<span></span>
</td>
<td class="nump">$ 2,960<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments', window );">Advances to affiliates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,135<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees', window );">Transfer to investments in equity accounted investees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,505<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Share of loss from investments in equity accounted investees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,510)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,009)<span></span>
</td>
<td class="num">(723)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAbstract', window );"><strong>Equity Method Investment, Summarized Financial Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,372,172<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,573,260<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">206,834<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">332,888<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46,719<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,750<span></span>
</td>
<td class="nump">12,121<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(25,833)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17,597)<span></span>
</td>
<td class="nump">6,213<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(75,270)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,165,574<span></span>
</td>
<td class="num">(21,817)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember', window );">Equity Method Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAbstract', window );"><strong>Equity Method Investment, Summarized Financial Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,126<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,200<span></span>
</td>
<td class="nump">7,121<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Non-current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">122,099<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76,212<span></span>
</td>
<td class="nump">27,129<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,796<span></span>
</td>
<td class="nump">3,746<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Non-current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76,313<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,189<span></span>
</td>
<td class="nump">13,201<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">367<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52<span></span>
</td>
<td class="nump">5,344<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(631)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (11,453)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,048)<span></span>
</td>
<td class="num">(874)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO | Cronos Australia</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock, number of shares issued in transaction (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price per share (in aud per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosAustraliaLimitedMember', window );">Cronos Australia</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investments in equity accounted investees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(346)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments', window );">Advances to affiliates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">274<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees', window );">Transfer to investments in equity accounted investees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Share of loss from investments in equity accounted investees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (363)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,101)<span></span>
</td>
<td class="num">(588)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosAustraliaLimitedMember', window );">Cronos Australia | Variable Interest Entity, Not Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityOwnershipPercentage', window );">Ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31.00%<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31.00%<span></span>
</td>
<td class="nump">31.00%<span></span>
</td>
<td class="nump">31.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosGrowingCompanyInc.Member', window );">Cronos GrowCo</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investments in equity accounted investees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,501<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments', window );">Advances to affiliates</a></td>
<td class="nump">$ 37,010<span></span>
</td>
<td class="nump">$ 49,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,494<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees', window );">Transfer to investments in equity accounted investees</a></td>
<td class="nump">$ 18,505<span></span>
</td>
<td class="nump">$ 24,650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,505<span></span>
</td>
<td class="nump">$ 24,650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Share of loss from investments in equity accounted investees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,537)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (167)<span></span>
</td>
<td class="num">(100)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosGrowingCompanyInc.Member', window );">Cronos GrowCo | Variable Interest Entity, Not Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityOwnershipPercentage', window );">Ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosGrowingCompanyInc.Member', window );">Cronos GrowCo | Cronos Group, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage', window );">Funding commitment percentage</a></td>
<td class="nump">0.50<span></span>
</td>
<td class="nump">0.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosGrowingCompanyInc.Member', window );">Cronos GrowCo | Mucci</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments', window );">Advances to affiliates</a></td>
<td class="nump">$ 18,505<span></span>
</td>
<td class="nump">$ 24,650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage', window );">Funding commitment percentage</a></td>
<td class="nump">0.50<span></span>
</td>
<td class="nump">0.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_NatuEraMember', window );">Natuera</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investments in equity accounted investees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (598)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments', window );">Advances to affiliates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">219<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees', window );">Transfer to investments in equity accounted investees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Share of loss from investments in equity accounted investees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,610)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (805)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_NatuEraMember', window );">Natuera | Variable Interest Entity, Not Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityOwnershipPercentage', window );">Ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_WhistlerMedicalMarijuanaCompanyMember', window );">Whistler</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Share of loss from investments in equity accounted investees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
<td class="nump">178<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_MedMenCanadaInc.Member', window );">MedMen Canada</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments', window );">Advances to affiliates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(852)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees', window );">Transfer to investments in equity accounted investees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Share of loss from investments in equity accounted investees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35<span></span>
</td>
<td class="num">$ (213)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_MedMenCanadaInc.Member', window );">MedMen Canada | Variable Interest Entity, Not Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityOwnershipPercentage', window );">Ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investments In And Advances To Affiliates, At Fair Value, Advances (Repayments)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investments In And Advances To Affiliates, At Fair Value, Transfer To Investments In Equity Accounted Investees</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investments In And Advances To Affiliates, Funding Commitment Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=SL6759159-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=cron_CronosAustraliaLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=cron_CronosAustraliaLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosAustraliaLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosAustraliaLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosGrowingCompanyInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosGrowingCompanyInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=cron_CronosGroupInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=cron_CronosGroupInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=cron_MucciMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=cron_MucciMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_NatuEraMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_NatuEraMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_WhistlerMedicalMarijuanaCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_WhistlerMedicalMarijuanaCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_MedMenCanadaInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_MedMenCanadaInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689791317080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments - Schedule of Advances to Joint Ventures (Details)<br> $ in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 25, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 25, 2020 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>AUD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvancesToAffiliate', window );">Balance at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,437<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,689<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees', window );">Transfer to investments in equity accounted investees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18,505)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueInterestOnAdvances', window );">Interest on advances</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments', window );">Advances (repayments)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,135<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueRecoveredFromAppliedToEquityMethodInvestment', window );">Advances to joint ventures recovered from (applied to) carrying amount of investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(38)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(946)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueChangesDueToCurrencyTranslation', window );">Effect from foreign exchange</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(464)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">559<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvancesToAffiliate', window );">Balance at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">467<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,437<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_MedMenCanadaInc.Member', window );">MedMen Canada</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvancesToAffiliate', window );">Balance at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">471<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees', window );">Transfer to investments in equity accounted investees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueInterestOnAdvances', window );">Interest on advances</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments', window );">Advances (repayments)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(852)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueRecoveredFromAppliedToEquityMethodInvestment', window );">Advances to joint ventures recovered from (applied to) carrying amount of investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueChangesDueToCurrencyTranslation', window );">Effect from foreign exchange</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvancesToAffiliate', window );">Balance at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">467<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">471<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosGrowingCompanyInc.Member', window );">Cronos GrowCo</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvancesToAffiliate', window );">Balance at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,966<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,970<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees', window );">Transfer to investments in equity accounted investees</a></td>
<td class="num">$ (18,505)<span></span>
</td>
<td class="num">$ (24,650)<span></span>
</td>
<td class="num">(18,505)<span></span>
</td>
<td class="num">$ (24,650)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueInterestOnAdvances', window );">Interest on advances</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments', window );">Advances (repayments)</a></td>
<td class="nump">$ 37,010<span></span>
</td>
<td class="nump">$ 49,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,494<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueRecoveredFromAppliedToEquityMethodInvestment', window );">Advances to joint ventures recovered from (applied to) carrying amount of investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueChangesDueToCurrencyTranslation', window );">Effect from foreign exchange</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(461)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvancesToAffiliate', window );">Balance at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,966<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosAustraliaLimitedMember', window );">Cronos Australia</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvancesToAffiliate', window );">Balance at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">475<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees', window );">Transfer to investments in equity accounted investees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueInterestOnAdvances', window );">Interest on advances</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments', window );">Advances (repayments)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">274<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueRecoveredFromAppliedToEquityMethodInvestment', window );">Advances to joint ventures recovered from (applied to) carrying amount of investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(38)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(779)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueChangesDueToCurrencyTranslation', window );">Effect from foreign exchange</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvancesToAffiliate', window );">Balance at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_InvestmentsInAndAdvancesToAffiliatesDebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_DebtInstrumentPastDueAdditionalInterestRateStatedPercentage', window );">Additional interest rate if past due</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_NatuEraMember', window );">Natuera</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward', window );"><strong>Investments in and Advances to Affiliates, at Fair Value [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvancesToAffiliate', window );">Balance at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees', window );">Transfer to investments in equity accounted investees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueInterestOnAdvances', window );">Interest on advances</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments', window );">Advances (repayments)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">219<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueRecoveredFromAppliedToEquityMethodInvestment', window );">Advances to joint ventures recovered from (applied to) carrying amount of investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(224)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueChangesDueToCurrencyTranslation', window );">Effect from foreign exchange</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvancesToAffiliate', window );">Balance at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_DebtInstrumentPastDueAdditionalInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Past Due, Additional Interest Rate, Stated Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_DebtInstrumentPastDueAdditionalInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investments In And Advances To Affiliates, At Fair Value, Advances (Repayments)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueChangesDueToCurrencyTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investments In And Advances To Affiliates, At Fair Value, Changes Due To Currency Translation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueChangesDueToCurrencyTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueInterestOnAdvances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investments In And Advances To Affiliates, At Fair Value, Interest On Advances</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueInterestOnAdvances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueRecoveredFromAppliedToEquityMethodInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investments In And Advances To Affiliates, At Fair Value, Recovered From (Applied To) Equity Method Investment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueRecoveredFromAppliedToEquityMethodInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investments In And Advances To Affiliates, At Fair Value, Transfer To Investments In Equity Accounted Investees</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_InvestmentsInAndAdvancesToAffiliatesDebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investments In And Advances To Affiliates, Debt Instrument, Face Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_InvestmentsInAndAdvancesToAffiliatesDebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvancesToAffiliate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-Term advances receivable from a party that is affiliated with the reporting entity by means of direct or indirect ownership. This does not include advances to clients.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e603758-122996<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6812-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvancesToAffiliate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_MedMenCanadaInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_MedMenCanadaInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosGrowingCompanyInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosGrowingCompanyInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosAustraliaLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosAustraliaLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_NatuEraMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_NatuEraMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689803715000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments - Schedule of Variable Interest Entities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 07, 2019</div></th>
<th class="th"><div>Nov. 06, 2019</div></th>
<th class="th"><div>Jun. 14, 2018</div></th>
<th class="th"><div>Mar. 13, 2018</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_OtherNetAssetsLiabilities', window );">Other Net Assets (Liabilities)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 111,456<span></span>
</td>
<td class="nump">$ 13,434<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount', window );">Maximum Exposure to Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 31,276<span></span>
</td>
<td class="nump">$ 27,585<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosAustraliaLimitedMember', window );">Cronos Australia | Variable Interest Entity, Not Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityOwnershipPercentage', window );">Ownership interest</a></td>
<td class="nump">31.00%<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31.00%<span></span>
</td>
<td class="nump">31.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_OtherNetAssetsLiabilities', window );">Other Net Assets (Liabilities)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,976<span></span>
</td>
<td class="nump">$ 10,900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount', window );">Maximum Exposure to Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,530<span></span>
</td>
<td class="nump">$ 1,355<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosGrowingCompanyInc.Member', window );">Cronos GrowCo | Variable Interest Entity, Not Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityOwnershipPercentage', window );">Ownership interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_OtherNetAssetsLiabilities', window );">Other Net Assets (Liabilities)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 109,329<span></span>
</td>
<td class="nump">$ 3,091<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount', window );">Maximum Exposure to Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,125<span></span>
</td>
<td class="nump">$ 20,700<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_MedMenCanadaInc.Member', window );">MedMen Canada | Variable Interest Entity, Not Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityOwnershipPercentage', window );">Ownership interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_OtherNetAssetsLiabilities', window );">Other Net Assets (Liabilities)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (199)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount', window );">Maximum Exposure to Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 467<span></span>
</td>
<td class="nump">$ 642<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_NatuEraMember', window );">Natuera | Variable Interest Entity, Not Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityOwnershipPercentage', window );">Ownership interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_OtherNetAssetsLiabilities', window );">Other Net Assets (Liabilities)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (6,849)<span></span>
</td>
<td class="num">$ (358)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount', window );">Maximum Exposure to Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,154<span></span>
</td>
<td class="nump">$ 4,888<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_OtherNetAssetsLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Net Assets (Liabilities)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_OtherNetAssetsLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The reporting entity's maximum amount of exposure to loss as a result of its involvement with the Variable Interest Entity (VIE).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5747-111685<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5728-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=SL6759159-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosAustraliaLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosAustraliaLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosGrowingCompanyInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosGrowingCompanyInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_MedMenCanadaInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_MedMenCanadaInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_NatuEraMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_NatuEraMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689701797032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Investments - Summary of Other Investments (Details) - Equity Securities<br> $ in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 04, 2019 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>CAD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems', window );"><strong>Debt and Equity Securities, FV-NI [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions', window );">Gain recognized in net income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,789<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,277<span></span>
</td>
<td class="nump">$ 164<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_EquitySecuritiesMember', window );">Canopy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems', window );"><strong>Debt and Equity Securities, FV-NI [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions', window );">Gain recognized in net income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 51<span></span>
</td>
<td class="nump">$ 166<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_InvestmentOwnedNumberOfSharesSold', window );">Investment owned, number of shares sold (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,062<span></span>
</td>
<td class="nump">18,436<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_ProceedsFromSaleOfEquitySecuritiesFVNI', window );">Proceeds from sale of equity securities, FV-NI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 355<span></span>
</td>
<td class="nump">$ 530<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_EquitySecuritiesMember', window );">Vivo Cannabis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems', window );"><strong>Debt and Equity Securities, FV-NI [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions', window );">Gain recognized in net income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">$ (173)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_InvestmentOwnedNumberOfSharesSold', window );">Investment owned, number of shares sold (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">182,927<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_ProceedsFromSaleOfEquitySecuritiesFVNI', window );">Proceeds from sale of equity securities, FV-NI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 216<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_InvestmentOwnedNumberOfWarrantsExercised', window );">Number of securities called by warrants or rights (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">182,927<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_PaymentsToExerciseWarrants', window );">Proceeds from exercise of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 87<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_EquitySecuritiesMember', window );">Vivo Cannabis | Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems', window );"><strong>Debt and Equity Securities, FV-NI [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions', window );">Gain recognized in net income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">171<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_EquitySecuritiesMember', window );">Whistler</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems', window );"><strong>Debt and Equity Securities, FV-NI [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions', window );">Gain recognized in net income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,530<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_InvestmentOwnedNumberOfSharesSold', window );">Investment owned, number of shares sold (in shares) | shares</a></td>
<td class="nump">2,563<span></span>
</td>
<td class="nump">980,662<span></span>
</td>
<td class="nump">980,662<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_InvestmentOwnedSharesSoldPercentageOfSharesIssuedAndOutstanding', window );">Investment owned, shares sold, percentage of shares issued and outstanding</a></td>
<td class="nump">19.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_InvestmentOwnedNumberOfSharesReceived', window );">Shares received (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">980,662<span></span>
</td>
<td class="nump">980,662<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_EquitySecuritiesMember', window );">Aurora</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems', window );"><strong>Debt and Equity Securities, FV-NI [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions', window );">Gain recognized in net income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,789<span></span>
</td>
<td class="nump">$ 6,404<span></span>
</td>
<td class="nump">$ 696<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_InvestmentOwnedNumberOfSharesSold', window );">Investment owned, number of shares sold (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,524,341<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_ProceedsFromSaleOfEquitySecuritiesFVNI', window );">Proceeds from sale of equity securities, FV-NI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,259<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_InvestmentOwnedNumberOfSharesReceived', window );">Shares received (in shares) | shares</a></td>
<td class="nump">2,524,341<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_InvestmentOwnedNumberOfSharesReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment Owned, Number Of Shares Received</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_InvestmentOwnedNumberOfSharesReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_InvestmentOwnedNumberOfSharesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment Owned, Number Of Shares Sold</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_InvestmentOwnedNumberOfSharesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_InvestmentOwnedNumberOfWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment Owned, Number Of Warrants Exercised</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_InvestmentOwnedNumberOfWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_InvestmentOwnedSharesSoldPercentageOfSharesIssuedAndOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment Owned, Shares Sold, Percentage Of Shares Issued And Outstanding</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_InvestmentOwnedSharesSoldPercentageOfSharesIssuedAndOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_PaymentsToExerciseWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments To Exercise Warrants</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_PaymentsToExerciseWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_ProceedsFromSaleOfEquitySecuritiesFVNI">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Sale Of Equity Securities, FV-NI</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_ProceedsFromSaleOfEquitySecuritiesFVNI</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the undistributed income (or loss) of equity method investments, net of dividends or other distributions received from unconsolidated subsidiaries, certain corporate joint ventures, and certain noncontrolled corporations; such investments are accounted for under the equity method of accounting. This element excludes distributions that constitute a return of investment, which are classified as investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CanopyGrowthCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CanopyGrowthCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_VivoCannabisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_VivoCannabisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_WhistlerMedicalMarijuanaCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_WhistlerMedicalMarijuanaCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_AuroraCannabisInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_AuroraCannabisInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689701714072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loan Receivable - Schedule of Loan Receivable (Details)<br> &#8362; in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Apr. 01, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 28, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Jul. 24, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 01, 2020 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Aug. 23, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 23, 2019 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Jun. 28, 2019 </div>
<div>CAD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetCurrentAbstract', window );"><strong>Current portion</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetCurrent', window );">Total current portion of loans receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,083,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,664,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetNoncurrentAbstract', window );"><strong>Long term portion</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetNoncurrent', window );">Total long-term portion of loans receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">87,191,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,967,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireLoansReceivable', window );">Draw downs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,652,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,337,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Current expected credit loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 74,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">136,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=cron_MucciMember', window );">Mucci | Cronos GrowCo</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetNoncurrentAbstract', window );"><strong>Long term portion</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners', window );">Ownership interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_LoansReceivableMember', window );">Loans Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetCurrentAbstract', window );"><strong>Current portion</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_FinancingReceivableAccruedInterestCurrent', window );">Add: Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 428,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetCurrent', window );">Total current portion of loans receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,083,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,664,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetNoncurrentAbstract', window );"><strong>Long term portion</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_FinancingReceivableAccruedInterestNoncurrent', window );">Add: Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,667,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">702,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetNoncurrent', window );">Total long-term portion of loans receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">87,191,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,967,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesReceivableNet', window );">Total loans receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">94,274,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,631,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_LoanReceivableNameAxis=cron_NatuEraSeriesALoanMember', window );">NatuEra Series A Loan | Loans Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetCurrentAbstract', window );"><strong>Current portion</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_FinancingReceivableBeforeAccruedInterestCurrent', window );">Current portion of loans receivable, before accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,518,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,575,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetNoncurrentAbstract', window );"><strong>Long term portion</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_FinancingReceivableAdditionalFaceAmountIncludingThirdPartyAmount', window );">Additional principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,350,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_FinancingReceivableFaceAmountIncludingThirdPartyAmount', window );">Total aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_FinancingReceivableFundingCommitmentPercentage', window );">Funding commitment percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_FinancingReceivableInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.67%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLosses', window );">Allowance for credit loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">685,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_LoanReceivableNameAxis=cron_NatuEraSeriesALoanMember', window );">NatuEra Series A Loan | Loans Receivable | Natuera</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetNoncurrentAbstract', window );"><strong>Long term portion</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_FinancingReceivableFundingCommitmentPercentage', window );">Funding commitment percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_LoanReceivableNameAxis=cron_NatuEraSeriesALoanShareOfNetLossInExcessOfCarryingValueOfEquityInvestmentMember', window );">NatuEra Series A Loan - Share of Net Loss in Excess of Carrying Value of Equity Investment | Loans Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetNoncurrentAbstract', window );"><strong>Long term portion</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLosses', window );">Allowance for credit loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,024,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_LoanReceivableNameAxis=cron_CronosGrowCoCreditFacilityMember', window );">Cronos GrowCo Credit Facility | Loans Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetCurrentAbstract', window );"><strong>Current portion</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_FinancingReceivableBeforeAccruedInterestCurrent', window );">Current portion of loans receivable, before accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,137,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetNoncurrentAbstract', window );"><strong>Long term portion</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_FinancingReceivableBeforeAccruedInterestNoncurrent', window );">Long term portion of loans receivable, before accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69,939,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,678,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLosses', window );">Allowance for credit loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,470,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_FinancingReceivableFaceAmount', window );">Face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 78,430,000<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireLoansReceivable', window );">Draw downs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,626,000<span></span>
</td>
<td class="nump">$ 95,150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_LoanReceivableNameAxis=cron_A2645485OntarioInc.MucciPromissoryNoteMember', window );">2645485 Ontario Inc. Mucci Promissory Note | Loans Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetNoncurrentAbstract', window );"><strong>Long term portion</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_FinancingReceivableBeforeAccruedInterestNoncurrent', window );">Long term portion of loans receivable, before accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,324,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,587,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_FinancingReceivableInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.95%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_FinancingReceivableFaceAmount', window );">Face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,823,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,350,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_FinancingReceivableDueOnDemandTerm', window );">Due on demand, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_FinancingReceivableDueOnDemandIntendedDemandTermMinimum', window );">Due on demand, intended demand term, minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_LoanReceivableNameAxis=cron_CannasoulCollaborationLoanMember', window );">Cannasoul Collaboration Loan | Loans Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetNoncurrentAbstract', window );"><strong>Long term portion</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_FinancingReceivableBeforeAccruedInterestNoncurrent', window );">Long term portion of loans receivable, before accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,261,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_LoanReceivableNameAxis=cron_CannasoulCollaborationLoanMember', window );">Cannasoul Collaboration Loan | Loans Receivable | Establishment of a Commercial Cannabis Analytical Testing Laboratoy | Cannasoul Analytics Ltd.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetNoncurrentAbstract', window );"><strong>Long term portion</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLosses', window );">Allowance for credit loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 259,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_CollaborativeArrangementTermOfAgreement', window );">Collaborative arrangement, term of agreement</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_LoanReceivableNameAxis=cron_CannasoulCollaborationLoanMember', window );">Cannasoul Collaboration Loan | Loans Receivable | Establishment of a Commercial Cannabis Analytical Testing Laboratoy | Cannasoul Analytics Ltd. | Variable Interest Entity, Not Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetNoncurrentAbstract', window );"><strong>Long term portion</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_CollaborativeArrangementAmountOfAdvances', window );">Collaboration agreement, amount of advances</a></td>
<td class="nump">$ 2,574,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 8,297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_CollaborativeArrangementTermOfAgreement', window );">Collaborative arrangement, term of agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_CollaborativeArrangementInstallmentsReceived', window );">Collaborative arrangement, installment received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,287,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 4,148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Current expected credit loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_CollaborativeArrangementAmountOfAdvances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Amount Of Advances</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_CollaborativeArrangementAmountOfAdvances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_CollaborativeArrangementInstallmentsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Installments Received</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_CollaborativeArrangementInstallmentsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_CollaborativeArrangementTermOfAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Term Of Agreement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_CollaborativeArrangementTermOfAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_FinancingReceivableAccruedInterestCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Financing Receivable, Accrued Interest, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_FinancingReceivableAccruedInterestCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_FinancingReceivableAccruedInterestNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Financing Receivable, Accrued Interest, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_FinancingReceivableAccruedInterestNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_FinancingReceivableAdditionalFaceAmountIncludingThirdPartyAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Financing Receivable, Additional Face Amount, Including Third Party Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_FinancingReceivableAdditionalFaceAmountIncludingThirdPartyAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_FinancingReceivableBeforeAccruedInterestCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Financing Receivable, Before Accrued Interest, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_FinancingReceivableBeforeAccruedInterestCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_FinancingReceivableBeforeAccruedInterestNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Financing Receivable, Before Accrued Interest, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_FinancingReceivableBeforeAccruedInterestNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_FinancingReceivableDueOnDemandIntendedDemandTermMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Financing Receivable, Due On Demand, Intended Demand Term, Minimum</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_FinancingReceivableDueOnDemandIntendedDemandTermMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_FinancingReceivableDueOnDemandTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Financing Receivable, Due On Demand, Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_FinancingReceivableDueOnDemandTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_FinancingReceivableFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Financing Receivable, Face Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_FinancingReceivableFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_FinancingReceivableFaceAmountIncludingThirdPartyAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Financing Receivable, Face Amount, Including Third Party Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_FinancingReceivableFaceAmountIncludingThirdPartyAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_FinancingReceivableFundingCommitmentPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Financing Receivable, Funding Commitment Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_FinancingReceivableFundingCommitmentPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_FinancingReceivableInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Financing Receivable, Interest Rate, Stated Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_FinancingReceivableInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121599878&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableAllowanceForCreditLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on financing receivable. Excludes allowance for financing receivable covered under loss sharing agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=SL6953423-111524<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(7)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121599878&amp;loc=SL82895884-210446<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableAllowanceForCreditLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesAndLoansReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of financing receivable, classified as current. Includes, but is not limited to, notes and loan receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesAndLoansReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesAndLoansReceivableNetCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesAndLoansReceivableNetCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesAndLoansReceivableNetNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of financing receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesAndLoansReceivableNetNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesAndLoansReceivableNetNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesAndLoansReceivableNetNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of financing receivable. Excludes financing receivable covered under loss sharing agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919230-210447<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireLoansReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchase of loan receivable arising from the financing of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireLoansReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=cron_MucciMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=cron_MucciMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=cron_CronosGrowingCompanyInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=cron_CronosGrowingCompanyInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_LoansReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_LoansReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_LoanReceivableNameAxis=cron_NatuEraSeriesALoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_LoanReceivableNameAxis=cron_NatuEraSeriesALoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=cron_NatuEraMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=cron_NatuEraMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_LoanReceivableNameAxis=cron_NatuEraSeriesALoanShareOfNetLossInExcessOfCarryingValueOfEquityInvestmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_LoanReceivableNameAxis=cron_NatuEraSeriesALoanShareOfNetLossInExcessOfCarryingValueOfEquityInvestmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_LoanReceivableNameAxis=cron_CronosGrowCoCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_LoanReceivableNameAxis=cron_CronosGrowCoCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_LoanReceivableNameAxis=cron_A2645485OntarioInc.MucciPromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_LoanReceivableNameAxis=cron_A2645485OntarioInc.MucciPromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_LoanReceivableNameAxis=cron_CannasoulCollaborationLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_LoanReceivableNameAxis=cron_CannasoulCollaborationLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CannasoulAnalyticsLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CannasoulAnalyticsLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689703607208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loans Payable - Long-term Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jan. 23, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 23, 2019 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 08, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 08, 2019 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Jan. 23, 2019 </div>
<div>CAD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfSecuredDebt', window );">Repayments of construction loans payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 15,971<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Construction Loans | Construction Loan Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfSecuredDebt', window );">Repayments of construction loans payable</a></td>
<td class="nump">$ 15,971<span></span>
</td>
<td class="nump">$ 21,311,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidCapitalized', window );">Repayments of construction loans payable, accrued interest and fees</a></td>
<td class="nump">206<span></span>
</td>
<td class="nump">$ 275,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=cron_NonrevolvingTermLoanFacilityMember', window );">Non-revolving Term Loan Facility | Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">$ 48,715<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 65,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Payments of transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 395<span></span>
</td>
<td class="nump">$ 523,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidCapitalized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest capitalized, classified as investing activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidCapitalized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfSecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to repay long-term debt that is wholly or partially secured by collateral. Excludes repayments of tax exempt secured debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfSecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cron_ConstructionLoanAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cron_ConstructionLoanAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=cron_NonrevolvingTermLoanFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=cron_NonrevolvingTermLoanFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cron_CreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cron_CreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689700781192">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property, Plant and Equipment - Schedule of Property, Plant &amp; Equipment, Useful Lives (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation and amortization</a></td>
<td class="num">$ (18,295)<span></span>
</td>
<td class="num">$ (8,745)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Balance as of December 31</a></td>
<td class="nump">187,599<span></span>
</td>
<td class="nump">159,948<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember', window );">Land</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">3,197<span></span>
</td>
<td class="nump">3,071<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Building</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">158,586<span></span>
</td>
<td class="nump">149,690<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">18,824<span></span>
</td>
<td class="nump">10,079<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">710<span></span>
</td>
<td class="nump">526<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">3,740<span></span>
</td>
<td class="nump">1,758<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">$ 20,837<span></span>
</td>
<td class="nump">$ 3,569<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689706016744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant, and Equipment - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldDepreciation', window );">Depreciation expense included in costs of sales</a></td>
<td class="nump">$ 3,447<span></span>
</td>
<td class="nump">$ 1,812<span></span>
</td>
<td class="nump">$ 374<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationNonproduction', window );">Depreciation expense included in operating expenses</a></td>
<td class="nump">2,058<span></span>
</td>
<td class="nump">1,444<span></span>
</td>
<td class="nump">261<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestCostsCapitalized', window );">Interest costs capitalized</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 89<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSoldDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for allocation of cost of tangible asset over its useful life directly used in production of good and rendering of service.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSoldDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationNonproduction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The expense recognized in the current period that allocates the cost of nonproduction tangible assets over their useful lives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationNonproduction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestCostsCapitalized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest capitalized during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestCostsCapitalized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689708907032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets and Goodwill - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, impairment loss</a></td>
<td class="nump">$ 35,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">814<span></span>
</td>
<td class="nump">$ 646<span></span>
</td>
<td class="nump">$ 546<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Purchase of intangible assets</a></td>
<td class="nump">3,979<span></span>
</td>
<td class="nump">289<span></span>
</td>
<td class="nump">$ 278<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract', window );"><strong>Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2021</a></td>
<td class="nump">1,047<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2022</a></td>
<td class="nump">998<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2023</a></td>
<td class="nump">964<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2024</a></td>
<td class="nump">952<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2025</a></td>
<td class="nump">664<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Lord Jones brand</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill', window );">Impairment of intangible assets, indefinite-lived (excluding goodwill)</a></td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Purchase of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 64,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReportingUnitAxis=cron_UnitedStatesSegmentMember', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, impairment loss</a></td>
<td class="nump">$ 35,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitAxis=cron_UnitedStatesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitAxis=cron_UnitedStatesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689702503736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets and Goodwill - Schedule of Intangible Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">$ (1,841)<span></span>
</td>
<td class="num">$ (1,027)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Cost</a></td>
<td class="nump">76,561<span></span>
</td>
<td class="nump">72,262<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment', window );">Impairment charges</a></td>
<td class="num">(5,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Intangible Assets, Net (Excluding Goodwill) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Cost</a></td>
<td class="nump">76,561<span></span>
</td>
<td class="nump">72,262<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(1,841)<span></span>
</td>
<td class="num">(1,027)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment', window );">Impairment charges</a></td>
<td class="num">(5,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net</a></td>
<td class="nump">69,720<span></span>
</td>
<td class="nump">71,235<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Lord Jones brand</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Cost</a></td>
<td class="nump">64,000<span></span>
</td>
<td class="nump">64,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment', window );">Impairment charges</a></td>
<td class="num">(5,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Net</a></td>
<td class="nump">59,000<span></span>
</td>
<td class="nump">64,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Intangible Assets, Net (Excluding Goodwill) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Cost</a></td>
<td class="nump">64,000<span></span>
</td>
<td class="nump">64,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment', window );">Impairment charges</a></td>
<td class="num">(5,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Cost</a></td>
<td class="nump">148<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Net</a></td>
<td class="nump">148<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Intangible Assets, Net (Excluding Goodwill) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Cost</a></td>
<td class="nump">$ 148<span></span>
</td>
<td class="nump">$ 36<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember', window );">Software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted average amortization period (in years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Cost</a></td>
<td class="nump">$ 610<span></span>
</td>
<td class="nump">$ 541<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(291)<span></span>
</td>
<td class="num">(202)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">319<span></span>
</td>
<td class="nump">339<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Intangible Assets, Net (Excluding Goodwill) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">$ (291)<span></span>
</td>
<td class="num">$ (202)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cron_EnterpriseResourcePlanningSystemMember', window );">ERP system</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted average amortization period (in years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Cost</a></td>
<td class="nump">$ 3,955<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(274)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">3,681<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Intangible Assets, Net (Excluding Goodwill) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">$ (274)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cron_HealthCanadaLicensingAgreementsMember', window );">Health Canada licenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted average amortization period (in years)</a></td>
<td class="text">17 years<span></span>
</td>
<td class="text">17 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Cost</a></td>
<td class="nump">$ 7,526<span></span>
</td>
<td class="nump">$ 7,387<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(1,254)<span></span>
</td>
<td class="num">(821)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">6,272<span></span>
</td>
<td class="nump">6,566<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Intangible Assets, Net (Excluding Goodwill) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">$ (1,254)<span></span>
</td>
<td class="num">$ (821)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cron_IsraeliCodesLicensingAgreementsMember', window );">Israeli codes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted average amortization period (in years)</a></td>
<td class="text">25 years<span></span>
</td>
<td class="text">25 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Cost</a></td>
<td class="nump">$ 322<span></span>
</td>
<td class="nump">$ 298<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(22)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">300<span></span>
</td>
<td class="nump">294<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Intangible Assets, Net (Excluding Goodwill) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">$ (22)<span></span>
</td>
<td class="num">$ (4)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indefinite Lived Intangible Assets Excluding Goodwill Accumulated Impairment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cron_EnterpriseResourcePlanningSystemMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cron_EnterpriseResourcePlanningSystemMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cron_HealthCanadaLicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cron_HealthCanadaLicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cron_IsraeliCodesLicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cron_IsraeliCodesLicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689700652888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets and Goodwill - Schedule of Goodwill (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance at beginning of period</a></td>
<td class="nump">$ 214,492<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Additions</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairment charges</a></td>
<td class="num">(35,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Effect of foreign exchange</a></td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance at end of period</a></td>
<td class="nump">179,522<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReportingUnitAxis=cron_PeaceNaturalsReportingUnitMember', window );">Peace Naturals</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance at beginning of period</a></td>
<td class="nump">1,078<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Additions</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairment charges</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Effect of foreign exchange</a></td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance at end of period</a></td>
<td class="nump">1,108<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReportingUnitAxis=cron_RedwoodReportingUnitMember', window );">Redwood</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance at beginning of period</a></td>
<td class="nump">213,414<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Additions</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairment charges</a></td>
<td class="num">(35,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Effect of foreign exchange</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance at end of period</a></td>
<td class="nump">$ 178,414<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitAxis=cron_PeaceNaturalsReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitAxis=cron_PeaceNaturalsReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitAxis=cron_RedwoodReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitAxis=cron_RedwoodReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689706136328">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Narrative (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Operating lease, extension term</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember', window );">Land</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Operating lease, term</a></td>
<td class="text">15 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Office Premises and Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Operating lease, term</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Office Premises and Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Operating lease, term</a></td>
<td class="text">6 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=cron_BuildingAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=cron_BuildingAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689703542984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Schedule of Lease Cost and Other Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostAbstract', window );"><strong>Lease cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">$ 2,479<span></span>
</td>
<td class="nump">$ 760<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermLeaseCost', window );">Short-term lease cost</a></td>
<td class="nump">60<span></span>
</td>
<td class="nump">373<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease cost</a></td>
<td class="nump">$ 2,539<span></span>
</td>
<td class="nump">$ 1,133<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average remaining lease term &#8211; operating leases</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate &#8211; operating leases</a></td>
<td class="nump">8.86%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term lease cost, excluding expense for lease with term of one month or less.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689698403144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General and Administrative Expenses - Schedule of General and Administrative Expenses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LaborAndRelatedExpense', window );">Salaries and wages</a></td>
<td class="nump">$ 26,742<span></span>
</td>
<td class="nump">$ 17,829<span></span>
</td>
<td class="nump">$ 4,240<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_ProfessionalAndConsultingExpense', window );">Professional and consulting</a></td>
<td class="nump">15,135<span></span>
</td>
<td class="nump">15,369<span></span>
</td>
<td class="nump">5,242<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_OfficeAndGeneralExpense', window );">Office and general</a></td>
<td class="nump">17,845<span></span>
</td>
<td class="nump">13,407<span></span>
</td>
<td class="nump">3,713<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_RestatementReviewExpense', window );">Review costs related to restatement of 2019 interim financial statements</a></td>
<td class="nump">9,688<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForLoanLossesExpensed', window );">Current expected credit loss</a></td>
<td class="nump">2,512<span></span>
</td>
<td class="nump">136<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherGeneralAndAdministrativeExpense', window );">Other</a></td>
<td class="nump">8,607<span></span>
</td>
<td class="nump">2,530<span></span>
</td>
<td class="nump">154<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">Total</a></td>
<td class="nump">$ 80,529<span></span>
</td>
<td class="nump">$ 49,271<span></span>
</td>
<td class="nump">$ 13,349<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_OfficeAndGeneralExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Office And General Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_OfficeAndGeneralExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_ProfessionalAndConsultingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Professional And Consulting Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_ProfessionalAndConsultingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_RestatementReviewExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restatement Review Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_RestatementReviewExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LaborAndRelatedExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LaborAndRelatedExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of general and administrative expense classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForLoanLossesExpensed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of credit loss expense (reversal of expense) for financing receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForLoanLossesExpensed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689700926728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Liabilities - Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">10 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 08, 2019 </div>
<div>warrant </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings', window );">Gain on revaluation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,276,819<span></span>
</td>
<td class="nump">$ 129,254<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=cron_AltriaGroupInc.Member', window );">Altria Group, Inc. | Cronos Group, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest</a></td>
<td class="nump">45.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=cron_AltriaInvestmentMember', window );">Altria Investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued (in shares) | shares</a></td>
<td class="nump">149,831,154<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=srt_SubsidiariesMember', window );">Cronos Group, Inc. | Altria Group, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised', window );">Ownership percentage, if warrant exercised</a></td>
<td class="nump">55.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_AltriaInvestmentMember', window );">Altria Investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage', window );">Maximum additional subscription percentage</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_ClassOfWarrantOrRightAdditionalSubscriptionNumberOfSecuritiesCalledByWarrantsOrRights', window );">Derivative liability, additional subscription (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80,100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_AltriaWarrantMember', window );">Altria Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_ClassOfWarrantOrRightNumberOfWarrantsIssued', window );">Number of warrants issued | warrant</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 19.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings', window );">Gain on revaluation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">869,630<span></span>
</td>
<td class="nump">$ 95,045<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_PreemptiveRightsMember', window );">Pre-emptive Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 16.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_ClassOfWarrantOrRightMinimumOwnershipPercentageRequired', window );">Exercise rights, minimum ownership percentage</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings', window );">Gain on revaluation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81,070<span></span>
</td>
<td class="nump">885<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_TopupRightsMember', window );">Top-up Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 16.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_ClassOfWarrantOrRightMinimumOwnershipPercentageRequired', window );">Exercise rights, minimum ownership percentage</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod', window );">Exercise price, volume-weighted average price, measurement period</a></td>
<td class="text">10 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise', window );">Exercise price, volume-weighted average price, measurement period, days preceding exercise</a></td>
<td class="text">10 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_ClassOfWarrantOrRightExpense', window );">Derivative transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,355<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings', window );">Gain on revaluation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 326,119<span></span>
</td>
<td class="nump">$ 33,324<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_ClassOfWarrantOrRightAdditionalSubscriptionNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Additional Subscription, Number Of Securities Called By Warrants Or Rights</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_ClassOfWarrantOrRightAdditionalSubscriptionNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Exercise Price, Volume-Weighted Average Price, Measurement Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Exercise Price, Volume-Weighted Average Price, Measurement Period, Days Preceding Exercise</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_ClassOfWarrantOrRightExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_ClassOfWarrantOrRightExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Maximum Additional Subscription Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_ClassOfWarrantOrRightMinimumOwnershipPercentageRequired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Minimum Ownership Percentage Required</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_ClassOfWarrantOrRightMinimumOwnershipPercentageRequired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_ClassOfWarrantOrRightNumberOfWarrantsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Number Of Warrants Issued</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_ClassOfWarrantOrRightNumberOfWarrantsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Subsidiary Or Equity Method Investee, Cumulative Percentage Ownership After All Transactions, If Warrants Exercised</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from derivative asset (liability) after deduction of derivative liability (asset), measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=cron_AltriaGroupInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=cron_AltriaGroupInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosGroupInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosGroupInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=cron_AltriaInvestmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=cron_AltriaInvestmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=srt_SubsidiariesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=srt_SubsidiariesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cron_AltriaInvestmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cron_AltriaInvestmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cron_AltriaWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cron_AltriaWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cron_PreemptiveRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cron_PreemptiveRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cron_TopupRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cron_TopupRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689700918168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Liabilities - Schedule of Reconciliation of Carrying Amounts (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">10 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_DerivativeInstrumentsRollForward', window );"><strong>Derivative Instruments [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs', window );">Beginning balance</a></td>
<td class="nump">$ 1,565,620<span></span>
</td>
<td class="nump">$ 297,160<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings', window );">Gain on revaluation</a></td>
<td class="num">(1,276,819)<span></span>
</td>
<td class="num">(129,254)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements', window );">Exercise of Rights</a></td>
<td class="num">(15,478)<span></span>
</td>
<td class="num">(3,227)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss', window );">Effect of FX</a></td>
<td class="nump">23,837<span></span>
</td>
<td class="num">(1,269)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs', window );">Ending balance</a></td>
<td class="nump">297,160<span></span>
</td>
<td class="nump">163,410<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_AltriaWarrantMember', window );">Altria Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_DerivativeInstrumentsRollForward', window );"><strong>Derivative Instruments [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs', window );">Beginning balance</a></td>
<td class="nump">1,086,920<span></span>
</td>
<td class="nump">234,428<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings', window );">Gain on revaluation</a></td>
<td class="num">(869,630)<span></span>
</td>
<td class="num">(95,045)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements', window );">Exercise of Rights</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss', window );">Effect of FX</a></td>
<td class="nump">17,138<span></span>
</td>
<td class="num">(525)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs', window );">Ending balance</a></td>
<td class="nump">234,428<span></span>
</td>
<td class="nump">138,858<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_PreemptiveRightsMember', window );">Pre-emptive Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_DerivativeInstrumentsRollForward', window );"><strong>Derivative Instruments [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs', window );">Beginning balance</a></td>
<td class="nump">92,548<span></span>
</td>
<td class="nump">12,787<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings', window );">Gain on revaluation</a></td>
<td class="num">(81,070)<span></span>
</td>
<td class="num">(885)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements', window );">Exercise of Rights</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss', window );">Effect of FX</a></td>
<td class="nump">1,309<span></span>
</td>
<td class="nump">193<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs', window );">Ending balance</a></td>
<td class="nump">12,787<span></span>
</td>
<td class="nump">12,095<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_TopupRightsMember', window );">Top-up Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_DerivativeInstrumentsRollForward', window );"><strong>Derivative Instruments [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs', window );">Beginning balance</a></td>
<td class="nump">386,152<span></span>
</td>
<td class="nump">49,945<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings', window );">Gain on revaluation</a></td>
<td class="num">(326,119)<span></span>
</td>
<td class="num">(33,324)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements', window );">Exercise of Rights</a></td>
<td class="num">(15,478)<span></span>
</td>
<td class="num">(3,227)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss', window );">Effect of FX</a></td>
<td class="nump">5,390<span></span>
</td>
<td class="num">(937)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs', window );">Ending balance</a></td>
<td class="nump">$ 49,945<span></span>
</td>
<td class="nump">$ 12,457<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_DerivativeInstrumentsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Derivative Instruments [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_DerivativeInstrumentsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from derivative asset (liability) after deduction of derivative liability (asset), measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in other comprehensive income from derivative asset (liability) after deduction of derivative liability (asset), measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19279-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of settlements of financial instrument classified as a derivative asset (liability) after deduction of derivative liability, measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19279-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as derivative asset (liability) after deduction of derivative liability (asset), measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cron_AltriaWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cron_AltriaWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cron_PreemptiveRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cron_PreemptiveRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cron_TopupRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cron_TopupRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689791830536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Liabilities - Schedule of Fair Values of Derivative Liabilities (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_AltriaWarrantMember', window );">Altria Warrant | Share price at grant date (per share in C$)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability, measurement input</a></td>
<td class="nump">8.84<span></span>
</td>
<td class="nump">9.97<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_AltriaWarrantMember', window );">Altria Warrant | Subscription price (per share in C$)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability, measurement input</a></td>
<td class="nump">19.00<span></span>
</td>
<td class="nump">19.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_AltriaWarrantMember', window );">Altria Warrant | Expected annualized volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability, measurement input</a></td>
<td class="nump">0.81<span></span>
</td>
<td class="nump">0.82<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_AltriaWarrantMember', window );">Altria Warrant | Expected dividend yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability, measurement input</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_AltriaWarrantMember', window );">Altria Warrant | Weighted Average | Weighted average risk-free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability, measurement input</a></td>
<td class="nump">0.0021<span></span>
</td>
<td class="nump">0.0169<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_AltriaWarrantMember', window );">Altria Warrant | Weighted Average | Weight average expected life (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_DerivativeLiabilityUsefulLifeTerm', window );">Expected life</a></td>
<td class="text">2 years 2 months 4 days<span></span>
</td>
<td class="text">3 years 2 months 4 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_PreemptiveRightsMember', window );">Pre-emptive Rights | Share price at grant date (per share in C$)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability, measurement input</a></td>
<td class="nump">8.84<span></span>
</td>
<td class="nump">9.97<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_PreemptiveRightsMember', window );">Pre-emptive Rights | Subscription price (per share in C$)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability, measurement input</a></td>
<td class="nump">16.25<span></span>
</td>
<td class="nump">16.25<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_PreemptiveRightsMember', window );">Pre-emptive Rights | Expected annualized volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability, measurement input</a></td>
<td class="nump">0.81<span></span>
</td>
<td class="nump">0.82<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_PreemptiveRightsMember', window );">Pre-emptive Rights | Expected dividend yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability, measurement input</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_PreemptiveRightsMember', window );">Pre-emptive Rights | Weighted Average | Weighted average risk-free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability, measurement input</a></td>
<td class="nump">0.0017<span></span>
</td>
<td class="nump">0.0173<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_PreemptiveRightsMember', window );">Pre-emptive Rights | Weighted Average | Weight average expected life (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_DerivativeLiabilityUsefulLifeTerm', window );">Expected life</a></td>
<td class="text">1 year 6 months<span></span>
</td>
<td class="text">1 year 3 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_TopupRightsMember', window );">Top-up Rights | Share price at grant date (per share in C$)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability, measurement input</a></td>
<td class="nump">8.84<span></span>
</td>
<td class="nump">9.97<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_TopupRightsMember', window );">Top-up Rights | Subscription price (per share in C$)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability, measurement input</a></td>
<td class="nump">16.25<span></span>
</td>
<td class="nump">16.25<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_TopupRightsMember', window );">Top-up Rights | Expected annualized volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability, measurement input</a></td>
<td class="nump">0.81<span></span>
</td>
<td class="nump">0.82<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_TopupRightsMember', window );">Top-up Rights | Expected dividend yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability, measurement input</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_TopupRightsMember', window );">Top-up Rights | Weighted Average | Weighted average risk-free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability, measurement input</a></td>
<td class="nump">0.0013<span></span>
</td>
<td class="nump">0.0171<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_TopupRightsMember', window );">Top-up Rights | Weighted Average | Weight average expected life (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_DerivativeLiabilityUsefulLifeTerm', window );">Expected life</a></td>
<td class="text">11 months 23 days<span></span>
</td>
<td class="text">1 year 7 months 28 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_PreEmptiveRightsAndTopUpRightsMember', window );">Pre-Emptive Rights and Top-Up Rights | Minimum | Weighted average risk-free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability, measurement input</a></td>
<td class="nump">0.0010<span></span>
</td>
<td class="nump">0.0166<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_PreEmptiveRightsAndTopUpRightsMember', window );">Pre-Emptive Rights and Top-Up Rights | Minimum | Weight average expected life (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_DerivativeLiabilityUsefulLifeTerm', window );">Expected life</a></td>
<td class="text">6 months<span></span>
</td>
<td class="text">3 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_PreEmptiveRightsAndTopUpRightsMember', window );">Pre-Emptive Rights and Top-Up Rights | Maximum | Weighted average risk-free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability, measurement input</a></td>
<td class="nump">0.0039<span></span>
</td>
<td class="nump">0.0173<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_PreEmptiveRightsAndTopUpRightsMember', window );">Pre-Emptive Rights and Top-Up Rights | Maximum | Weight average expected life (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_DerivativeLiabilityUsefulLifeTerm', window );">Expected life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">6 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_DerivativeLiabilityUsefulLifeTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Derivative Liability, Useful Life, Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_DerivativeLiabilityUsefulLifeTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure derivative liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cron_AltriaWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cron_AltriaWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=cron_MeasurementInputSubscriptionPriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=cron_MeasurementInputSubscriptionPriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_WeightedAverageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_WeightedAverageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cron_PreemptiveRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cron_PreemptiveRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cron_TopupRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cron_TopupRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cron_PreEmptiveRightsAndTopUpRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cron_PreEmptiveRightsAndTopUpRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689708684536">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivative Liabilities - Schedule of Sensitivity Analysis (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_AltriaWarrantMember', window );">Altria Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract', window );"><strong>Sensitivity Analysis, Impact of 10 Percent Decrease (Increase) on Net Income (Loss) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss', window );">Share price at issuance date</a></td>
<td class="nump">$ 25,819<span></span>
</td>
<td class="nump">$ 36,436<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss', window );">Weighted average expected life</a></td>
<td class="nump">13,541<span></span>
</td>
<td class="nump">17,471<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss', window );">Expected annualized volatility</a></td>
<td class="nump">26,183<span></span>
</td>
<td class="nump">33,343<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_PreemptiveRightsMember', window );">Pre-emptive Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract', window );"><strong>Sensitivity Analysis, Impact of 10 Percent Decrease (Increase) on Net Income (Loss) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss', window );">Share price at issuance date</a></td>
<td class="nump">2,527<span></span>
</td>
<td class="nump">2,743<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss', window );">Weighted average expected life</a></td>
<td class="nump">1,988<span></span>
</td>
<td class="nump">2,366<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss', window );">Expected annualized volatility</a></td>
<td class="nump">2,269<span></span>
</td>
<td class="nump">2,180<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_TopupRightsMember', window );">Top-up Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract', window );"><strong>Sensitivity Analysis, Impact of 10 Percent Decrease (Increase) on Net Income (Loss) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss', window );">Share price at issuance date</a></td>
<td class="nump">2,989<span></span>
</td>
<td class="nump">9,577<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss', window );">Weighted average expected life</a></td>
<td class="nump">2,121<span></span>
</td>
<td class="nump">2,178<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss', window );">Expected annualized volatility</a></td>
<td class="nump">$ 2,602<span></span>
</td>
<td class="nump">$ 7,714<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) In Expected Annualized Volatility On Net Income (Loss)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) In Share Price On Net Income (Loss)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) In Weighted Average Expected Life On Net Income (Loss)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) On Net Income (Loss) [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cron_AltriaWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cron_AltriaWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cron_PreemptiveRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cron_PreemptiveRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cron_TopupRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cron_TopupRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689701958184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Stock - Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 23, 2019 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 08, 2019 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>vote </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>installment </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_CommonStockNumberOfVotesPerShare', window );">Common shares, number of votes per share | vote</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 304,821<span></span>
</td>
<td class="nump">$ 115,510<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Share issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">3,722<span></span>
</td>
<td class="nump">7,577<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=cron_AltriaInvestmentMember', window );">Altria Investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">149,831,154<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,809,556<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Share issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,722<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_PaymentOfTransactionCosts', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=cron_RedwoodAcquisitionMember', window );">Redwood Acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_StockIssuedDuringPeriodNewIssuesFairValue', window );">Stock issued during period, new issues, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 56,109<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Consideration transferred, common shares (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">856,017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_CommonStockVestingRightsNumberOfEqualInstallments', window );">Common stock, vesting rights, number of equal installments | installment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Consideration transferred, common shares, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=cron_BoughtDealOfferingsMember', window );">Bought Deal Offerings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">115,510<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Share issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,577<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">155,773,757<span></span>
</td>
<td class="nump">15,677,143<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 304,411<span></span>
</td>
<td class="nump">$ 115,510<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Stock repurchased during period (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Shares | Altria Investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">149,831,154<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 248,302<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_PaymentOfTransactionCosts', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,642<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Shares | Redwood Acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,086,586<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Shares | Private Placements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued (in shares) | shares</a></td>
<td class="nump">856,017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">856,017<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_StockIssuedDuringPeriodNewIssuesFairValue', window );">Stock issued during period, new issues, fair value</a></td>
<td class="nump">$ 6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_StockIssuedDuringPeriodNewIssuesWeightedAveragePricePeriod', window );">Stock issued during period, new issues, measurement input</a></td>
<td class="text">10 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Shares | Bought Deal Offerings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">15,677,143<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=cron_AdditionalPaidinCapitalAttributableToConvertibleOptionMember', window );">Derivative Liability | Altria Investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_PaymentOfTransactionCosts', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,581<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_CommonStockNumberOfVotesPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Number Of Votes Per Share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_CommonStockNumberOfVotesPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_CommonStockVestingRightsNumberOfEqualInstallments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Vesting Rights, Number Of Equal Installments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_CommonStockVestingRightsNumberOfEqualInstallments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_PaymentOfTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payment Of Transaction Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_PaymentOfTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_StockIssuedDuringPeriodNewIssuesFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, New Issues, Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_StockIssuedDuringPeriodNewIssuesFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_StockIssuedDuringPeriodNewIssuesWeightedAveragePricePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, New Issues, Weighted Average Price, Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_StockIssuedDuringPeriodNewIssuesWeightedAveragePricePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=cron_AltriaInvestmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=cron_AltriaInvestmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=cron_RedwoodAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=cron_RedwoodAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=cron_BoughtDealOfferingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=cron_BoughtDealOfferingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=cron_AdditionalPaidinCapitalAttributableToConvertibleOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=cron_AdditionalPaidinCapitalAttributableToConvertibleOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689701408232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Stock - Schedule of Common Shares Issued (Details) - shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 23, 2019</div></th>
<th class="th"><div>Mar. 08, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=cron_AltriaInvestmentMember', window );">Altria Investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">149,831,154<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">155,773,757<span></span>
</td>
<td class="nump">15,677,143<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Shares | Altria Investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">149,831,154<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Shares | Redwood Acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,086,586<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Shares | Private Placements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued (in shares)</a></td>
<td class="nump">856,017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">856,017<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Shares | Bought Deal Offerings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">15,677,143<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=cron_AltriaInvestmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=cron_AltriaInvestmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=cron_RedwoodAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=cron_RedwoodAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=cron_BoughtDealOfferingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=cron_BoughtDealOfferingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689705636936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based Payments - Summary of Changes in Warrants (Details) - Warrants - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted average exercise price (C$)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Balance at beginning of period (in dollars per share)</a></td>
<td class="nump">$ 0.26<span></span>
</td>
<td class="nump">$ 0.26<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Exercise of warrants (in dollars per share)</a></td>
<td class="nump">0.27<span></span>
</td>
<td class="nump">0.26<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Balance at end of period (in dollars per share)</a></td>
<td class="nump">$ 0.25<span></span>
</td>
<td class="nump">$ 0.26<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of warrants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Balance at beginning of period (in shares)</a></td>
<td class="nump">18,066,662<span></span>
</td>
<td class="nump">25,457,623<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Exercise of warrants (in shares)</a></td>
<td class="num">(10,079,313)<span></span>
</td>
<td class="num">(7,390,961)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Balance at end of period (in shares)</a></td>
<td class="nump">7,987,349<span></span>
</td>
<td class="nump">18,066,662<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689698745688">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Share-based Payments - Summary of Outstanding Warrants (Details) - Warrants - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted average exercise price (in dollars per share)</a></td>
<td class="nump">$ 0.25<span></span>
</td>
<td class="nump">$ 0.26<span></span>
</td>
<td class="nump">$ 0.26<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Number of warrants (in shares)</a></td>
<td class="nump">7,987,349<span></span>
</td>
<td class="nump">18,066,662<span></span>
</td>
<td class="nump">25,457,623<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_WarrantMember', window );">May 13 &#8211; 27, 2016</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted average exercise price (in dollars per share)</a></td>
<td class="nump">$ 0.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Number of warrants (in shares)</a></td>
<td class="nump">7,987,349<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=cron_GrantedMay132016ThroughMay272016Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=cron_GrantedMay132016ThroughMay272016Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689791945384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based Payments - Stock Options Narrative (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 29, 2020</div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jun. 25, 2020 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jun. 28, 2018 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based payments | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,361<span></span>
</td>
<td class="nump">$ 11,619<span></span>
</td>
<td class="nump">$ 8,151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based payments | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,185<span></span>
</td>
<td class="nump">$ 10,278<span></span>
</td>
<td class="nump">$ 8,151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price at grant date (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options | 2015 Stock Option Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Future awards to be granted (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options | 2018 Stock Option Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Future awards to be granted (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options | 2020 Omnibus Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price at grant date (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15.34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price at grant date (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options | Weighted Average</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price at grant date (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=cron_A2015StockOptionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=cron_A2015StockOptionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=cron_A2018StockOptionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=cron_A2018StockOptionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=cron_A2020OmnibusPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=cron_A2020OmnibusPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_WeightedAverageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_WeightedAverageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689698773080">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Share-based Payments - Schedule of Stock Options Outstanding (Details) - shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of options outstanding (in shares)</a></td>
<td class="nump">13,755,148<span></span>
</td>
<td class="nump">14,149,502<span></span>
</td>
<td class="nump">12,902,995<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=cron_A2020OmnibusPlanMember', window );">2020 Omnibus Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of options outstanding (in shares)</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=cron_A2018StockOptionPlanMember', window );">2018 Stock Option Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of options outstanding (in shares)</a></td>
<td class="nump">1,627,715<span></span>
</td>
<td class="nump">1,817,287<span></span>
</td>
<td class="nump">285,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=cron_A2015StockOptionPlanMember', window );">2015 Stock Option Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of options outstanding (in shares)</a></td>
<td class="nump">10,127,433<span></span>
</td>
<td class="nump">12,332,215<span></span>
</td>
<td class="nump">12,617,995<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=cron_A2020OmnibusPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=cron_A2020OmnibusPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=cron_A2018StockOptionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=cron_A2018StockOptionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=cron_A2015StockOptionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=cron_A2015StockOptionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689704611448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based Payments - Summary of the Changes in Options (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted average exercise price (C$)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Balance at beginning of period (in dollars per share)</a></td>
<td class="nump">$ 4.84<span></span>
</td>
<td class="nump">$ 2.99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Issuance of options (in dollars per share)</a></td>
<td class="nump">6.96<span></span>
</td>
<td class="nump">20.08<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share)</a></td>
<td class="nump">2.03<span></span>
</td>
<td class="nump">3.48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Cancellation, forfeiture and expiry of options (in dollars per share)</a></td>
<td class="nump">14.34<span></span>
</td>
<td class="nump">2.27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Balance at end of period (in dollars per share)</a></td>
<td class="nump">5.40<span></span>
</td>
<td class="nump">4.84<span></span>
</td>
<td class="nump">$ 2.99<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable (in dollars per share)</a></td>
<td class="nump">$ 3.75<span></span>
</td>
<td class="nump">$ 2.93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of options</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Balance at beginning of period (in shares)</a></td>
<td class="nump">14,149,502<span></span>
</td>
<td class="nump">12,902,995<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Issuance of options (in shares)</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="nump">1,534,162<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="num">(2,131,939)<span></span>
</td>
<td class="num">(282,572)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Cancellation of options (in shares)</a></td>
<td class="num">(262,415)<span></span>
</td>
<td class="num">(5,083)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Balance at end of period (in shares)</a></td>
<td class="nump">13,755,148<span></span>
</td>
<td class="nump">14,149,502<span></span>
</td>
<td class="nump">12,902,995<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable (in shares)</a></td>
<td class="nump">9,643,682<span></span>
</td>
<td class="nump">9,034,714<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract', window );"><strong>Weighted average remaining contractual term (years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Outstanding</a></td>
<td class="text">2 years 3 months 18 days<span></span>
</td>
<td class="text">2 years 6 months 21 days<span></span>
</td>
<td class="text">3 years 4 months 6 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Exercisable</a></td>
<td class="text">1 year 4 months 2 days<span></span>
</td>
<td class="text">2 years 3 months 7 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689703649080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based Payments - Fair Value of Options Issued (Details) - Stock options<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>$ / shares </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price at grant date (in dollars per share)</a></td>
<td class="nump">$ 6.96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price (per option) (in dollars per share)</a></td>
<td class="nump">$ 6.96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">43.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life of options (in years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate', window );">Expected annualized volatility</a></td>
<td class="nump">91.00%<span></span>
</td>
<td class="nump">82.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue', window );">Weighted average Black-Scholes value at grant date (per option) (in dollars per share)</a></td>
<td class="nump">$ 4.84<span></span>
</td>
<td class="nump">$ 13.03<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsForfeitureRate', window );">Forfeiture rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price at grant date (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15.34<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price (per option) (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15.34<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.39%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price at grant date (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24.75<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price (per option) (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24.75<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.62%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsForfeitureRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement By Share-based Payment Award, Fair Value Assumptions, Forfeiture Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsForfeitureRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement By Share-based Payment Award, Fair Value Assumptions, Weighted Average Grant Date Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Rate of weighted-average expected volatility for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689702560264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based Payments - Restricted Share Units Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,361<span></span>
</td>
<td class="nump">$ 11,619<span></span>
</td>
<td class="nump">$ 8,151<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted share units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriod', window );">Accelerated and vested (in shares)</a></td>
<td class="nump">732,972<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,176<span></span>
</td>
<td class="nump">$ 889<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">957,854<span></span>
</td>
<td class="nump">732,972<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Vested And Issued In Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689701683768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based Payments - Summary of Restricted Share Units Activity (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of warrants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="num">(2,131,939)<span></span>
</td>
<td class="num">(282,572)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward', window );"><strong>Weighted average grant date fair value (C$)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share)</a></td>
<td class="nump">$ 2.03<span></span>
</td>
<td class="nump">$ 3.48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted share units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of warrants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Balance at beginning of period (in shares)</a></td>
<td class="nump">732,972<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">957,854<span></span>
</td>
<td class="nump">732,972<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="num">(732,972)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Cancellation and forfeitures (in shares)</a></td>
<td class="num">(9,497)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Balance at end of period (in shares)</a></td>
<td class="nump">948,357<span></span>
</td>
<td class="nump">732,972<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward', window );"><strong>Weighted average grant date fair value (C$)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Balance at beginning of period (in dollars per share)</a></td>
<td class="nump">$ 15.34<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share)</a></td>
<td class="nump">7.66<span></span>
</td>
<td class="nump">15.34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share)</a></td>
<td class="nump">15.34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Cancellation and forfeitures (in dollars per share)</a></td>
<td class="nump">7.52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Balance at end of period (in dollars per share)</a></td>
<td class="nump">$ 7.66<span></span>
</td>
<td class="nump">$ 15.34<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Compensation Share-based Arrangements, Liability [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689812966760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based Payments - Deferred Share Units Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2018 </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=cron_DeferredShareUnitsDSUsMember', window );">Deferred Share Units (DSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=cron_DeferredShareUnitsDSUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=cron_DeferredShareUnitsDSUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689706132472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based Payments - Summary of Deferred Share Units Activity (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward', window );"><strong>Financial liability</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Granting and vesting of DSUs</a></td>
<td class="nump">$ 15,361<span></span>
</td>
<td class="nump">$ 11,619<span></span>
</td>
<td class="nump">$ 8,151<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=cron_DeferredShareUnitsDSUsMember', window );">Deferred Share Units (DSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of warrants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Balance at beginning of period (in shares)</a></td>
<td class="nump">33,397<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsAndVestedInPeriod', window );">Granting and vesting of DSUs (in shares)</a></td>
<td class="nump">58,380<span></span>
</td>
<td class="nump">33,397<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Liabilities settled (in shares)</a></td>
<td class="num">(8,484)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Balance at end of period (in shares)</a></td>
<td class="nump">83,293<span></span>
</td>
<td class="nump">33,397<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward', window );"><strong>Financial liability</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent', window );">Balance at beginning of period</a></td>
<td class="nump">$ 255<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Granting and vesting of DSUs</a></td>
<td class="nump">338<span></span>
</td>
<td class="nump">452<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_ShareBasedPaymentArrangementLiabilitiesSettled', window );">Liabilities settled</a></td>
<td class="num">(46)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_ShareBasedPaymentArrangementGainLossOnRevaluation', window );">Loss (gain) on revaluation</a></td>
<td class="nump">30<span></span>
</td>
<td class="num">(197)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent', window );">Balance at end of period</a></td>
<td class="nump">$ 577<span></span>
</td>
<td class="nump">$ 255<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Compensation Share-based Arrangements, Liability [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_ShareBasedPaymentArrangementGainLossOnRevaluation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Payment Arrangement, Gain (Loss) On Revaluation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_ShareBasedPaymentArrangementGainLossOnRevaluation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_ShareBasedPaymentArrangementLiabilitiesSettled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Payment Arrangement, Liabilities Settled</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_ShareBasedPaymentArrangementLiabilitiesSettled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsAndVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement By Share-based Payment Award, Equity Instruments Other Than Options, Grants And Vested In Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsAndVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying value as of the balance sheet date of the liabilities for stock option plans and other equity-based compensation arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=cron_DeferredShareUnitsDSUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=cron_DeferredShareUnitsDSUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689703669816">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Earnings (loss) Per Share - Schedule of Earnings (Loss) Per Share (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract', window );"><strong>Basic earnings (loss) per share computation</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Income (loss) from continuing operations attributable to common shareholders of Cronos&#160;Group</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (72,487)<span></span>
</td>
<td class="nump">$ 1,166,869<span></span>
</td>
<td class="num">$ (20,742)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average number of common shares outstanding (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">351,576,848<span></span>
</td>
<td class="nump">310,067,179<span></span>
</td>
<td class="nump">172,269,170<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic earnings (loss) per share (in dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (0.21)<span></span>
</td>
<td class="nump">$ 3.76<span></span>
</td>
<td class="num">$ (0.12)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Diluted earnings (loss) per share computation</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Income (loss) from continuing operations used in the computation of basic earnings (loss) per share</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (72,487)<span></span>
</td>
<td class="nump">$ 1,166,869<span></span>
</td>
<td class="num">$ (20,742)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DilutiveSecurities', window );">Adjustment for gain on revaluation of derivative liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="num">(24,416)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted', window );">Income (loss) from continuing operations used in the computation of diluted income (loss) per share</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (72,487)<span></span>
</td>
<td class="nump">$ 1,142,453<span></span>
</td>
<td class="num">$ (20,742)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average number of common shares outstanding (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">351,576,848<span></span>
</td>
<td class="nump">310,067,179<span></span>
</td>
<td class="nump">172,269,170<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average number of common shares for computation of diluted income (loss) per share (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">351,576,848<span></span>
</td>
<td class="nump">342,811,992<span></span>
</td>
<td class="nump">172,269,170<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted earnings (loss) per share (in dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">$ (0.21)<span></span>
</td>
<td class="nump">$ 3.33<span></span>
</td>
<td class="num">$ (0.12)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShareAbstract', window );"><strong>Basic loss from discontinued operations per share computation</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity', window );">Loss from discontinued operations attributable to common shareholders of Cronos Group</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (650)<span></span>
</td>
<td class="num">$ (363)<span></span>
</td>
<td class="num">$ (894)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average number of common shares outstanding (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">351,576,848<span></span>
</td>
<td class="nump">310,067,179<span></span>
</td>
<td class="nump">172,269,170<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare', window );">Basic loss from discontinued operations per share (in dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ (0.00)<span></span>
</td>
<td class="nump">$ (0.00)<span></span>
</td>
<td class="num">$ (0.01)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_AltriaWarrantMember', window );">Altria Warrant</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Diluted earnings (loss) per share computation</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants', window );">Dilutive effect of derivative liabilities (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_TopupRightsMember', window );">Top-up Rights</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Diluted earnings (loss) per share computation</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants', window );">Dilutive effect of derivative liabilities (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,881,002<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_WarrantMember', window );">Warrants</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Diluted earnings (loss) per share computation</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive effect of awards (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">19,481,352<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Diluted earnings (loss) per share computation</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive effect of awards (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">10,649,487<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted share units</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Diluted earnings (loss) per share computation</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive effect of awards (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">732,972<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">In computing diluted earnings per share, incremental common shares are not considered in periods in which a net loss is reported, as the inclusion of the common share equivalents would be anti-dilutive.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DilutiveSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) to net income used for calculating diluted earnings per share (EPS), resulting from the assumed exercise stock options, restrictive stock units (RSUs), convertible preferred stock of an employee stock ownership plan (ESOP), and other dilutive convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DilutiveSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1278-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1828-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1757-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1707-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1707-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1500-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) from continuing operations available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cron_AltriaWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cron_AltriaWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cron_TopupRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cron_TopupRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689791942520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings (loss) Per Share - Schedule of Antidilutive Securities Excluded from Computation of Diluted Shares Outstanding (Details) - shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total anti-dilutive securities (in shares)</a></td>
<td class="nump">151,338,762<span></span>
</td>
<td class="nump">131,871,103<span></span>
</td>
<td class="nump">38,360,618<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cron_GinkgoEquityMilestonesMember', window );">Ginkgo Equity Milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total anti-dilutive securities (in shares)</a></td>
<td class="nump">14,674,904<span></span>
</td>
<td class="nump">14,674,904<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cron_PreemptiveRightsMember', window );">Pre-emptive Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total anti-dilutive securities (in shares)</a></td>
<td class="nump">11,534,475<span></span>
</td>
<td class="nump">12,006,740<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cron_TopUpRightsFixedPriceMember', window );">Top-up Rights &#8211; fixed price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total anti-dilutive securities (in shares)</a></td>
<td class="nump">17,214,621<span></span>
</td>
<td class="nump">25,103,456<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cron_TopUpRightsMarketPriceMember', window );">Top-up Rights &#8211; market price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total anti-dilutive securities (in shares)</a></td>
<td class="nump">3,413,065<span></span>
</td>
<td class="nump">1,255,223<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cron_AltriaWarrantMember', window );">Altria Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total anti-dilutive securities (in shares)</a></td>
<td class="nump">80,056,296<span></span>
</td>
<td class="nump">77,514,993<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total anti-dilutive securities (in shares)</a></td>
<td class="nump">15,147,116<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">25,457,623<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total anti-dilutive securities (in shares)</a></td>
<td class="nump">9,218,674<span></span>
</td>
<td class="nump">1,315,787<span></span>
</td>
<td class="nump">12,902,995<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted share units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total anti-dilutive securities (in shares)</a></td>
<td class="nump">79,611<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cron_GinkgoEquityMilestonesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cron_GinkgoEquityMilestonesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cron_PreemptiveRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cron_PreemptiveRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cron_TopUpRightsFixedPriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cron_TopUpRightsFixedPriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cron_TopUpRightsMarketPriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cron_TopUpRightsMarketPriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cron_AltriaWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cron_AltriaWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689791328088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income (Loss) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="nump">$ 1,749,030<span></span>
</td>
<td class="nump">$ 148,549<span></span>
</td>
<td class="nump">$ 63,733<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Accounting Standards Update [Extensible List]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">us-gaap:AccountingStandardsUpdate201601Member<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="nump">1,708,168<span></span>
</td>
<td class="nump">1,749,030<span></span>
</td>
<td class="nump">148,549<span></span>
</td>
<td class="nump">$ 63,733<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated other comprehensive income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="nump">27,838<span></span>
</td>
<td class="num">(9,870)<span></span>
</td>
<td class="nump">2,458<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="nump">42,999<span></span>
</td>
<td class="nump">27,838<span></span>
</td>
<td class="num">(9,870)<span></span>
</td>
<td class="nump">2,458<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=cron_AOCIAccumulatedGainLossRevaluationAndDisposalOfOtherInvestmentsParentMemberMember', window );">Net unrealized gain (loss) on revaluation and disposal of other investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">446<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Net unrealized (loss) gain</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">446<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=cron_AOCIAccumulatedGainLossRevaluationAndDisposalOfOtherInvestmentsParentMemberMember', window );">Net unrealized gain (loss) on revaluation and disposal of other investments | Cumulative Effect, Period of Adoption, Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(444)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(444)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Net foreign exchange gain (loss) on translation of foreign operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="nump">27,833<span></span>
</td>
<td class="num">(9,875)<span></span>
</td>
<td class="nump">2,456<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Net unrealized (loss) gain</a></td>
<td class="nump">15,161<span></span>
</td>
<td class="nump">37,708<span></span>
</td>
<td class="num">(12,331)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="nump">$ 42,994<span></span>
</td>
<td class="nump">$ 27,833<span></span>
</td>
<td class="num">$ (9,875)<span></span>
</td>
<td class="nump">$ 2,456<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingStandardsUpdateExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates amendment to accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 24: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:extensibleListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=cron_AOCIAccumulatedGainLossRevaluationAndDisposalOfOtherInvestmentsParentMemberMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=cron_AOCIAccumulatedGainLossRevaluationAndDisposalOfOtherInvestmentsParentMemberMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R102.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689698238296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Income (Loss) before Income Taxes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income (loss) before income taxes</a></td>
<td class="num">$ (73,273)<span></span>
</td>
<td class="nump">$ 1,165,937<span></span>
</td>
<td class="num">$ (20,923)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">Rest of World</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income (loss) before income taxes</a></td>
<td class="nump">12,679<span></span>
</td>
<td class="nump">1,169,007<span></span>
</td>
<td class="num">(20,923)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income (loss) before income taxes</a></td>
<td class="num">$ (85,952)<span></span>
</td>
<td class="num">$ (3,070)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R103.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689700623656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceLineItems', window );"><strong>Valuation Allowance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax', window );">Income (loss) from discontinued operations, net of income taxes</a></td>
<td class="num">$ (650,000)<span></span>
</td>
<td class="num">$ (363,000)<span></span>
</td>
<td class="num">$ (894,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrent', window );">Taxes payable, current</a></td>
<td class="nump">$ 865,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Effective income tax rate</a></td>
<td class="nump">26.50%<span></span>
</td>
<td class="nump">26.50%<span></span>
</td>
<td class="nump">26.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_CanadaRevenueAgencyMember', window );">Canada</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceLineItems', window );"><strong>Valuation Allowance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">$ 177,651,000<span></span>
</td>
<td class="nump">$ 92,773,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember', window );">Untied States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceLineItems', window );"><strong>Valuation Allowance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">62,851,000<span></span>
</td>
<td class="nump">14,374,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_IsraelTaxAuthorityMember', window );">Israel</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceLineItems', window );"><strong>Valuation Allowance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">14,042,000<span></span>
</td>
<td class="nump">8,763,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember', window );">SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceLineItems', window );"><strong>Valuation Allowance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesAdjustments', window );">Increase in valuation allowance</a></td>
<td class="nump">$ 48,294,000<span></span>
</td>
<td class="nump">$ 28,019,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from operations classified as a discontinued operation. Excludes gain (loss) on disposal and provision for gain (loss) until disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in valuation and qualifying accounts and reserves from adjustment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_CanadaRevenueAgencyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_CanadaRevenueAgencyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_IsraelTaxAuthorityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_IsraelTaxAuthorityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R104.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689695288584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Expense for Income Taxes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total</a></td>
<td class="nump">$ 1,347<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">Rest of World</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total</a></td>
<td class="nump">1,024<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total</a></td>
<td class="nump">323<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>R105.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689695328088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Effective Tax Rate Reconciliation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest', window );">Income (loss) before income taxes</a></td>
<td class="num">$ (73,273)<span></span>
</td>
<td class="nump">$ 1,165,937<span></span>
</td>
<td class="num">$ (20,923)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Effective income tax rate</a></td>
<td class="nump">26.50%<span></span>
</td>
<td class="nump">26.50%<span></span>
</td>
<td class="nump">26.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_EffectiveIncomeTaxRateReconciliationExpectedIncomeTaxExpenseRecoveryAmount', window );">Expected income tax expense (benefit)</a></td>
<td class="num">$ (19,417)<span></span>
</td>
<td class="nump">$ 308,973<span></span>
</td>
<td class="num">$ (5,545)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxExemptIncome', window );">Non-taxable income</a></td>
<td class="num">(711)<span></span>
</td>
<td class="num">(2,156)<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Non-deductible share-based compensation</a></td>
<td class="nump">2,498<span></span>
</td>
<td class="nump">2,839<span></span>
</td>
<td class="nump">2,466<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther', window );">Non-deductible expenses</a></td>
<td class="nump">1,364<span></span>
</td>
<td class="nump">764<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionCosts', window );">Non-deductible transaction costs</a></td>
<td class="nump">3,146<span></span>
</td>
<td class="nump">1,523<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">Effect of provincial tax rate difference</a></td>
<td class="num">(15)<span></span>
</td>
<td class="num">(44)<span></span>
</td>
<td class="num">(64)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential', window );">Effect of tax rates outside of Canada</a></td>
<td class="num">(362)<span></span>
</td>
<td class="nump">70<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_EffectiveIncomeTaxRateReconciliationFairValueGainFinancialLiabilities', window );">Fair value gain on financial liabilities</a></td>
<td class="num">(34,250)<span></span>
</td>
<td class="num">(338,409)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Changes in valuation allowance</a></td>
<td class="nump">48,227<span></span>
</td>
<td class="nump">25,808<span></span>
</td>
<td class="nump">3,437<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherAdjustments', window );">Other</a></td>
<td class="nump">867<span></span>
</td>
<td class="nump">632<span></span>
</td>
<td class="num">(308)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense (recovery), net</a></td>
<td class="nump">$ 1,347<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_EffectiveIncomeTaxRateReconciliationExpectedIncomeTaxExpenseRecoveryAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Expected Income Tax Expense (Recovery), Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_EffectiveIncomeTaxRateReconciliationExpectedIncomeTaxExpenseRecoveryAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_EffectiveIncomeTaxRateReconciliationFairValueGainFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Fair Value Gain, Financial Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_EffectiveIncomeTaxRateReconciliationFairValueGainFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Nondeductible Expense, Acquisition Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of income (loss) including portion attributable to noncontrolling interest. Includes, but is not limited to, income (loss) from continuing operations, discontinued operations and equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.18)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxExemptIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income (loss) exempt from income taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxExemptIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>R106.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689704608456">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract', window );"><strong>Deferred assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Tax loss carryforwards</a></td>
<td class="nump">$ 67,476<span></span>
</td>
<td class="nump">$ 30,908<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetInterestCarryforward', window );">Interest expense carryforwards</a></td>
<td class="nump">1,407<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_DeferredTaxAssetsDebtIssuanceCosts', window );">Deferred financing costs</a></td>
<td class="nump">4,233<span></span>
</td>
<td class="nump">5,690<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_DeferredTaxAssetsShareIssuanceCost', window );">Share issuance cost</a></td>
<td class="nump">1,573<span></span>
</td>
<td class="nump">2,217<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_DeferredTaxAssetsFinanceLeaseLiabilities', window );">Finance lease obligation</a></td>
<td class="nump">1,953<span></span>
</td>
<td class="nump">1,491<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment', window );">Plant and equipment</a></td>
<td class="nump">5,945<span></span>
</td>
<td class="nump">871<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInvestments', window );">Investment</a></td>
<td class="nump">307<span></span>
</td>
<td class="nump">395<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets', window );">Intangible asset</a></td>
<td class="nump">4,218<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves', window );">Reserve</a></td>
<td class="nump">1,858<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">570<span></span>
</td>
<td class="nump">482<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred tax assets</a></td>
<td class="nump">89,540<span></span>
</td>
<td class="nump">42,054<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less valuation allowance</a></td>
<td class="num">(85,935)<span></span>
</td>
<td class="num">(36,948)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Net deferred tax assets</a></td>
<td class="nump">3,605<span></span>
</td>
<td class="nump">5,106<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract', window );"><strong>Deferred tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts', window );">Inventory</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,227)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Plant and equipment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets', window );">Intangible assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(2,126)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesInvestments', window );">Investment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_DeferredTaxLiabilitiesLicenses', window );">License</a></td>
<td class="num">(1,662)<span></span>
</td>
<td class="num">(293)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset', window );">Right-of-use assets</a></td>
<td class="num">(1,943)<span></span>
</td>
<td class="num">(1,460)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="num">(3,605)<span></span>
</td>
<td class="num">(5,106)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Net deferred tax liability</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_DeferredTaxAssetsDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Debt Issuance Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_DeferredTaxAssetsDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_DeferredTaxAssetsFinanceLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Finance Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_DeferredTaxAssetsFinanceLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_DeferredTaxAssetsShareIssuanceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Share Issuance Cost</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_DeferredTaxAssetsShareIssuanceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_DeferredTaxLiabilitiesLicenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities, Licenses</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_DeferredTaxLiabilitiesLicenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities, Operating Lease, Right-Of-Use Asset</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetInterestCarryforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible interest carryforward.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetInterestCarryforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from investments (excludes investments in subsidiaries and equity method investments).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from reserves, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax consequences attributable to taxable temporary differences derived from inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from investments (excludes investments in subsidiaries and equity method investments).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>131
<FILENAME>R107.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689696774024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Summary of Valuation Allowance (Details) - SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>Valuation Allowance [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at beginning of year</a></td>
<td class="num">$ (36,948)<span></span>
</td>
<td class="num">$ (7,931)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Change due to foreign exchange</a></td>
<td class="num">(693)<span></span>
</td>
<td class="num">(998)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesAdjustments', window );">Increase</a></td>
<td class="num">(48,294)<span></span>
</td>
<td class="num">(28,019)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at end of year</a></td>
<td class="num">$ (85,935)<span></span>
</td>
<td class="num">$ (36,948)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInValuationAllowancesAndReservesRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in valuation and qualifying accounts and reserves from adjustment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column B))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column E))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>R108.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689701189304">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments - Summary of Future Minimum Lease Payments Under Operating Leases (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Lessee, Operating Lease, Liability, Payment, Due [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2021</a></td>
<td class="nump">$ 2,381<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2022</a></td>
<td class="nump">2,302<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2023</a></td>
<td class="nump">2,201<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2024</a></td>
<td class="nump">1,711<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2025</a></td>
<td class="nump">1,505<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">2026 and thereafter</a></td>
<td class="nump">$ 1,916<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>133
<FILENAME>R109.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689705008200">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments - R&amp;D Commitments (Details)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Feb. 18, 2019</div></th>
<th class="th">
<div>Oct. 15, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 04, 2018 </div>
<div>USD ($) </div>
<div>cannabinoid </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 17, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=cron_GinkgoBioworksInc.Member', window );">Ginkgo | Research and Development Arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentLineItems', window );"><strong>Long-term Purchase Commitment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_LongTermPurchaseCommitmentNumberOfTargetedUnitsToDevelopProduction', window );">Number of cannabinoids targeted to develop scalable and consistent production | cannabinoid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableNumberOfShares', window );">Common shares issuable (up to) (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,674,903<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableValueAssigned', window );">Common shares issuable, value assigned</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_LongtermPurchaseCommitmentPaymentsSubjectToMilestones', window );">Payments subject to milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=cron_TechnionResearchAndDevelopmentFoundationMember', window );">Technion | Research and Development Arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentLineItems', window );"><strong>Long-term Purchase Commitment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_LongtermPurchaseCommitmentPaymentsSubjectToMilestones', window );">Payments subject to milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentAmount', window );">Amount of commitment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,784<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermPurchaseCommitmentPeriod', window );">Research funding period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=cron_AltriaVenturesInc.Member', window );">Altria Ventures | Consulting Services Arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentLineItems', window );"><strong>Long-term Purchase Commitment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_LongtermPurchaseCommitmentMonthlyFeePercentage', window );">Monthly fee, percentage of direct and indirect service costs</a></td>
<td class="nump">105.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_LongTermPurchaseCommitmentNumberOfTargetedUnitsToDevelopProduction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-term Purchase Commitment, Number Of Targeted Units to Develop Production</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_LongTermPurchaseCommitmentNumberOfTargetedUnitsToDevelopProduction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-term Purchase Commitment, Equity Interest Issued Or Issuable, Number Of Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableValueAssigned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-term Purchase Commitment, Equity Interest Issued Or Issuable, Value Assigned</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableValueAssigned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_LongtermPurchaseCommitmentMonthlyFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-term Purchase Commitment, Monthly Fee, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_LongtermPurchaseCommitmentMonthlyFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_LongtermPurchaseCommitmentPaymentsSubjectToMilestones">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-term Purchase Commitment, Payments Subject To Milestones</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_LongtermPurchaseCommitmentPaymentsSubjectToMilestones</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermPurchaseCommitmentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The minimum amount the entity agreed to spend under the long-term purchase commitment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermPurchaseCommitmentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermPurchaseCommitmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermPurchaseCommitmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermPurchaseCommitmentPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period covered by the long-term purchase commitment, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermPurchaseCommitmentPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=cron_GinkgoBioworksInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=cron_GinkgoBioworksInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=us-gaap_ResearchAndDevelopmentArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=us-gaap_ResearchAndDevelopmentArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=cron_TechnionResearchAndDevelopmentFoundationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=cron_TechnionResearchAndDevelopmentFoundationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=cron_AltriaVenturesInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=cron_AltriaVenturesInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=cron_ConsultingServicesArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis=cron_ConsultingServicesArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>134
<FILENAME>R110.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689791902968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments - Use of Publicity Rights in Brand Development (Details) - Common Shares - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 23, 2022</div></th>
<th class="th"><div>Jun. 23, 2021</div></th>
<th class="th"><div>Jan. 31, 2020</div></th>
<th class="th"><div>Dec. 23, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">155,773,757<span></span>
</td>
<td class="nump">15,677,143<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Private Placements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">856,017<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">856,017<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_StockIssuedDuringPeriodNewIssuesFairValue', window );">Stock issued during period, new issues, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_StockIssuedDuringPeriodNewIssuesWeightedAveragePricePeriod', window );">Stock issued during period, new issues, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Private Placements | Share-based Payment Arrangement, Tranche One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting rights, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33.33%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Private Placements | Share-based Payment Arrangement, Tranche Two | Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting rights, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33.33%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Private Placements | Share-based Payment Arrangement, Tranche Three | Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting rights, percentage</a></td>
<td class="nump">33.33%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Private Placements | Sale Of Stock, Performance Milestone One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_SaleOfStockPerformanceMilestoneTriggeringEventMinimumRevenue', window );">Sale of stock, performance milestone, triggering event, minimum revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_SaleOfStockPerformanceMilestoneTriggeringEventSharesIssuedValue', window );">Sale of stock, performance milestone, triggering event, shares issued, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Private Placements | Sale Of Stock, Performance Milestone Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_SaleOfStockPerformanceMilestoneTriggeringEventMinimumRevenue', window );">Sale of stock, performance milestone, triggering event, minimum revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_SaleOfStockPerformanceMilestoneTriggeringEventSharesIssuedValue', window );">Sale of stock, performance milestone, triggering event, shares issued, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_SaleOfStockPerformanceMilestoneTriggeringEventMinimumRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Performance Milestone, Triggering Event, Minimum Revenue</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_SaleOfStockPerformanceMilestoneTriggeringEventMinimumRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_SaleOfStockPerformanceMilestoneTriggeringEventSharesIssuedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Performance Milestone, Triggering Event, Shares Issued, Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_SaleOfStockPerformanceMilestoneTriggeringEventSharesIssuedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_StockIssuedDuringPeriodNewIssuesFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, New Issues, Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_StockIssuedDuringPeriodNewIssuesFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_StockIssuedDuringPeriodNewIssuesWeightedAveragePricePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, New Issues, Weighted Average Price, Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_StockIssuedDuringPeriodNewIssuesWeightedAveragePricePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_SaleOfStockPerformanceMilestoneAxis=cron_SaleOfStockPerformanceMilestoneOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_SaleOfStockPerformanceMilestoneAxis=cron_SaleOfStockPerformanceMilestoneOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_SaleOfStockPerformanceMilestoneAxis=cron_SaleOfStockPerformanceMilestoneTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_SaleOfStockPerformanceMilestoneAxis=cron_SaleOfStockPerformanceMilestoneTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>135
<FILENAME>R111.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689695216376">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Contingencies (Details) - Pending Litigation<br> $ in Millions</strong></div></th>
<th class="th">
<div>Jun. 16, 2020 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Mar. 12, 2020 </div>
<div>shareholder </div>
<div>complaint</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember', window );">Unfavorable Regulatory Action</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesSoughtValue', window );">Damages sought</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_LossContingencyPunitiveDamagesSoughtValue', window );">Punitive damages sought</a></td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=cron_U.S.DistrictCourtofEasternDistrictofNewYorkVs.CronosMember', window );">U.S. District Court of Eastern District of New York Vs. Cronos</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNumberOfPlaintiffs', window );">Number of alleged shareholders | shareholder</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNewClaimsFiledNumber', window );">Number of putative class action complaints | complaint</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_LossContingencyPunitiveDamagesSoughtValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Punitive Damages Sought, Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_LossContingencyPunitiveDamagesSoughtValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesSoughtValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value (monetary amount) of the award the plaintiff seeks in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesSoughtValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyNewClaimsFiledNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total number of new claims filed pertaining to a loss contingency during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyNewClaimsFiledNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyNumberOfPlaintiffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of plaintiffs that have filed claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyNumberOfPlaintiffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=us-gaap_UnfavorableRegulatoryActionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=us-gaap_UnfavorableRegulatoryActionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=cron_U.S.DistrictCourtofEasternDistrictofNewYorkVs.CronosMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=cron_U.S.DistrictCourtofEasternDistrictofNewYorkVs.CronosMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>136
<FILENAME>R112.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689706007000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplementary Cash Flow Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Increase (Decrease) in Operating Capital [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">$ (4,724)<span></span>
</td>
<td class="num">$ (702)<span></span>
</td>
<td class="num">$ (2,569)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_IncreaseDecreasePrepaidExpensesAndOtherReceivables', window );">Prepaids and other receivables</a></td>
<td class="num">(5,300)<span></span>
</td>
<td class="num">(10,509)<span></span>
</td>
<td class="num">(2,382)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInFinanceReceivables', window );">Current portion of loans receivable</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(4,585)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="num">(28,094)<span></span>
</td>
<td class="num">(51,888)<span></span>
</td>
<td class="num">(4,092)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities', window );">Accounts payable and other liabilities</a></td>
<td class="nump">4,175<span></span>
</td>
<td class="nump">13,476<span></span>
</td>
<td class="nump">12,705<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapital', window );">Total</a></td>
<td class="num">$ (33,943)<span></span>
</td>
<td class="num">$ (54,208)<span></span>
</td>
<td class="nump">$ 3,662<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_IncreaseDecreasePrepaidExpensesAndOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) Prepaid Expenses And Other Receivables</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_IncreaseDecreasePrepaidExpensesAndOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligations incurred but not paid, and operating obligations classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInFinanceReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in outstanding loans including accrued interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInFinanceReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period of all assets and liabilities used in operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>137
<FILENAME>R113.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689704582520">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments - Credit Risk Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure', window );">Maximum exposure to credit risk</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1,403,491,000<span></span>
</td>
<td class="nump">$ 1,586,978,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 8,928,000<span></span>
</td>
<td class="nump">4,638,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff', window );">Accounts receivable, threshold period past due, writeoff</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">120 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Current expected credit loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 74,000<span></span>
</td>
<td class="nump">136,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,078,023,000<span></span>
</td>
<td class="nump">1,199,693,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">211,766,000<span></span>
</td>
<td class="nump">306,347,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvancesToAffiliate', window );">Advances to joint ventures</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">467,000<span></span>
</td>
<td class="nump">19,437,000<span></span>
</td>
<td class="nump">$ 4,689,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_AdvancesToAffiliateAllowanceForCreditLoss', window );">Advances to joint ventures, allowance for credit loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=cron_FourCustomersMember', window );">Four Customers | Accounts Receivable | Credit Concentration Risk</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">78.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=cron_TwoMajorCustomersMember', window );">Two Customers | Accounts Receivable | Credit Concentration Risk</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Net of current expected credit loss allowance of $74 as of December&#160;31, 2020 (December 31, 2019 &#8211; $136)</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_AdvancesToAffiliateAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Advances To Affiliate, Allowance For Credit Loss</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_AdvancesToAffiliateAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Threshold period for when accounts receivable, classified as noncurrent, is considered past due to write off as uncollectible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919253-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvancesToAffiliate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-Term advances receivable from a party that is affiliated with the reporting entity by means of direct or indirect ownership. This does not include advances to clients.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e603758-122996<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6812-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvancesToAffiliate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121599878&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum amount of loss due to credit risk that, based on the gross fair value of the financial instrument, the entity would incur if parties to the financial instruments that make up the concentration failed completely to perform according to the terms of the contracts and the collateral or other security, if any, for the amount due proved to be of no value to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13537-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=cron_FourCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=cron_FourCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CreditConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CreditConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=cron_TwoMajorCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=cron_TwoMajorCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>138
<FILENAME>R114.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689704762888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments - Liquidity Risk Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable, past due</a></td>
<td class="nump">$ 12,107<span></span>
</td>
<td class="nump">$ 9,194<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsPayableMember', window );">Accounts Payable | Supplier Concentration Risk | Four Vendors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">64.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsPayableMember', window );">Accounts Payable | Supplier Concentration Risk | Three Vendors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis=cron_FourVendorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis=cron_FourVendorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis=cron_ThreeVendorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis=cron_ThreeVendorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>139
<FILENAME>R115.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689698146552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments - Interest Rate Risk (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsAllOtherInvestmentsAbstract', window );"><strong>Investments, All Other Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest income, net</a></td>
<td class="nump">$ 18,415<span></span>
</td>
<td class="nump">$ 27,969<span></span>
</td>
<td class="nump">$ 81<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncomePercent', window );">Impact of change in average variable rate, percent</a></td>
<td class="nump">1.49%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncome', window );">Impact of change in average variable rate, amount</a></td>
<td class="num">$ (15,671)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sensitivity Analysis Of Interest Rate Risk Income Statement Impact, Impact Of Change In Average Variable Rate On Interest Income</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncomePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sensitivity Analysis Of Interest Rate Risk Income Statement Impact, Impact Of Change In Average Variable Rate On Interest Income, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncomePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNonoperatingNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of nonoperating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNonoperatingNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAllOtherInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAllOtherInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>140
<FILENAME>R116.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689708430904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments - Currency Rate Risk Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RisksAndUncertaintiesAbstract', window );"><strong>Risks and Uncertainties [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign exchange gain (loss) on translation</a></td>
<td class="nump">$ 14,951<span></span>
</td>
<td class="nump">$ 37,687<span></span>
</td>
<td class="num">$ (12,337)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate', window );">Impact of ten percent change in exchange rate</a></td>
<td class="nump">$ 170,817<span></span>
</td>
<td class="nump">$ 174,902<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sensitivity Analysis Of Carrying Value, Net Assets, Impact Of 10 Percent Change In Exchange Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RisksAndUncertaintiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RisksAndUncertaintiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>141
<FILENAME>R117.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689704364056">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurement (Details) - Fair Value, Recurring - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 1,078,023<span></span>
</td>
<td class="nump">$ 1,199,693<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Short-term investments</a></td>
<td class="nump">211,766<span></span>
</td>
<td class="nump">306,347<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="nump">163,410<span></span>
</td>
<td class="nump">297,160<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">1,078,023<span></span>
</td>
<td class="nump">1,199,693<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Short-term investments</a></td>
<td class="nump">211,766<span></span>
</td>
<td class="nump">306,347<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Short-term investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Short-term investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="nump">$ 163,410<span></span>
</td>
<td class="nump">$ 297,160<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>142
<FILENAME>R118.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689705022520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions and Balances - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Mar. 08, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember', window );">Altria Pinnacle LLC. | Purchase of Machinery and Equipment | Altria Group, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty', window );">Purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,258<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember', window );">Altria Pinnacle LLC. | Consulting Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty', window );">Consulting fees</a></td>
<td class="nump">$ 1,199<span></span>
</td>
<td class="nump">3,479<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember', window );">Altria Pinnacle LLC. | Consulting Services | Altria Pinnacle LLC.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty', window );">Consulting fees</a></td>
<td class="nump">$ 1,199<span></span>
</td>
<td class="nump">$ 3,479<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosGroupInc.Member', window );">Cronos Group, Inc. | Altria Group, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchases during the period (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=cron_PurchaseOfMachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=cron_PurchaseOfMachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=cron_AltriaGroupInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=cron_AltriaGroupInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=cron_ConsultingServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=cron_ConsultingServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=cron_AltriaPinnacleLLC.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=cron_AltriaPinnacleLLC.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosGroupInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosGroupInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=cron_AltriaGroupInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=cron_AltriaGroupInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>143
<FILENAME>R119.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689704739224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions and Balances - Schedule of Related Party Transactions (Details) - Consulting Services - Altria Pinnacle LLC. - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty', window );">Consulting fees</a></td>
<td class="nump">$ 1,199<span></span>
</td>
<td class="nump">$ 3,479<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableRelatedPartiesCurrent', window );">Accrual for consulting services</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,152<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=cron_AltriaPinnacleLLC.Member', window );">Altria Pinnacle LLC.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty', window );">Consulting fees</a></td>
<td class="nump">1,199<span></span>
</td>
<td class="nump">3,479<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableRelatedPartiesCurrent', window );">Accrual for consulting services</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,152<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount for accounts payable to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=cron_ConsultingServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=cron_ConsultingServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=cron_AltriaPinnacleLLC.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=cron_AltriaPinnacleLLC.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>144
<FILENAME>R120.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689695015736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Non-monetary Transactions (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 28, 2019 </div>
<div>USD ($) </div>
<div>transaction</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($) </div>
<div>transaction</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>transaction</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>transaction</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonmonetaryTransactionLineItems', window );"><strong>Nonmonetary Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_NonmonetaryTransactionNumberOfTransactions', window );">Number of transactions | transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonmonetaryTransactionTypeAxis=us-gaap_ExchangeOfProductHeldForSaleForSimilarProductMember', window );">Purchased Cannabis Resin and Sold Cannabis Dry Flower</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonmonetaryTransactionLineItems', window );"><strong>Nonmonetary Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_NonmonetaryTransactionNumberOfTransactions', window );">Number of transactions | transaction</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonmonetaryTransactionGrossOperatingRevenueRecognized', window );">Revenue recognized | $</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonmonetaryTransactionGainLossRecognizedOnTransfer', window );">Gain (loss) recognized on transfer | $</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_NonmonetaryTransactionNumberOfTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nonmonetary Transaction, Number Of Transactions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_NonmonetaryTransactionNumberOfTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonmonetaryTransactionGainLossRecognizedOnTransfer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the difference in values (gain (loss)) between the nonmonetary assets or liabilities exchanged with another entity inclusive of boot (small monetary consideration).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 845<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6457341&amp;loc=d3e32102-108422<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 845<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=68069686&amp;loc=d3e32049-108421<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonmonetaryTransactionGainLossRecognizedOnTransfer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonmonetaryTransactionGrossOperatingRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of gross operating revenue recognized in a nonmonetary transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 845<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68069686&amp;loc=d3e32049-108421<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonmonetaryTransactionGrossOperatingRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonmonetaryTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonmonetaryTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonmonetaryTransactionTypeAxis=us-gaap_ExchangeOfProductHeldForSaleForSimilarProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonmonetaryTransactionTypeAxis=us-gaap_ExchangeOfProductHeldForSaleForSimilarProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>145
<FILENAME>R121.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689704539736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 05, 2019 </div>
<div>USD ($) </div>
<div>subsidiary </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>business</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($) </div>
<div>business</div>
</th>
<th class="th">
<div>Sep. 05, 2019 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of operating subsidiaries acquired | business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cron_RedwoodHoldingGroupLLCMember', window );">Redwood</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of operating subsidiaries acquired | subsidiary</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="nump">$ 283,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to acquire businesses</a></td>
<td class="nump">$ 227,191,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Consideration transferred, common shares (in shares) | shares</a></td>
<td class="nump">5,086,586<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Consideration transferred, common shares, amount</a></td>
<td class="nump">$ 56,109,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionSharePrice', window );">Consideration transferred, common shares, volume weighted average trading price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14.74<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Acquisition-related costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,531,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Business acquisition, goodwill, expected tax deductible amount</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual', window );">Revenue of acquiree since acquisition date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,364,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual', window );">Loss of acquiree since acquisition date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,613,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Pro forma revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,266,000<span></span>
</td>
<td class="nump">$ 7,630,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Pro forma net income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,112,000<span></span>
</td>
<td class="nump">$ 1,533,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=116868678&amp;loc=d3e1043-128460<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of earnings or loss of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of revenue of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfBusinessesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of businesses acquired by the entity during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfBusinessesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=cron_RedwoodHoldingGroupLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=cron_RedwoodHoldingGroupLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>146
<FILENAME>R122.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689701616584">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Business Combinations - Schedule of Fair Value of Net Assets Acquired (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 05, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract', window );"><strong>Fair value of net assets acquired</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 179,522,000<span></span>
</td>
<td class="nump">$ 214,492,000<span></span>
</td>
<td class="nump">$ 1,314,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cron_RedwoodHoldingGroupLLCMember', window );">Redwood</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract', window );"><strong>Fair value of net assets acquired</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash</a></td>
<td class="nump">$ 2,896,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="nump">647,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="nump">265,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventory</a></td>
<td class="nump">2,806,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="nump">1,890,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets', window );">Right-of-use assets</a></td>
<td class="nump">3,533,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="nump">64,037,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">213,414,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued liabilities</a></td>
<td class="num">(2,688,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation', window );">Lease obligations</a></td>
<td class="num">(3,500,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Net assets acquired</a></td>
<td class="nump">283,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="nump">647,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquiredReceivablesEstimatedUncollectible', window );">Business combination, acquired receivables, estimated uncollectible</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cron_RedwoodHoldingGroupLLCMember', window );">Redwood | Brand name</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract', window );"><strong>Fair value of net assets acquired</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefinitelivedIntangibleAssetsAcquired', window );">Indefinite-lived intangible assets acquired, fair value</a></td>
<td class="nump">$ 64,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Liabilities, Accounts Payable And Accrued Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Operating Lease, Right-Of-Use Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquiredReceivablesEstimatedUncollectible">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For receivables acquired in a business combination, excluding certain loans and debt securities acquired in a transfer (as defined), this element represents the best estimate at the acquisition date of the contractual cash flows not expected to be collected, by major class of receivable, such as loans, direct finance leases (as defined), and any other class of receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquiredReceivablesEstimatedUncollectible</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease obligation assumed in business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefinitelivedIntangibleAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in assets, excluding financial assets and goodwill, lacking physical substance with an indefinite life, from an acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefinitelivedIntangibleAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=cron_RedwoodHoldingGroupLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=cron_RedwoodHoldingGroupLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>147
<FILENAME>R123.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689705341032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Repurposing Charges - Schedule of Plan Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Employee termination benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 889,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment costs associated with plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,439,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringSettlementAndImpairmentProvisions', window );">Repurposing charges</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 5,328,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringSettlementAndImpairmentProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of restructuring charges, remediation cost, and asset impairment loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringSettlementAndImpairmentProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>148
<FILENAME>R124.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689702307736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Repurposing Charges - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Inventory write-down</a></td>
<td class="nump">$ 26,055,000<span></span>
</td>
<td class="nump">$ 29,173,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringSettlementAndImpairmentProvisions', window );">Repurposing charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,328,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring reserve</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">907,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=cron_RepurposingPlanMember', window );">Repurposing Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Inventory write-down</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,940,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4542-108314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringSettlementAndImpairmentProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of restructuring charges, remediation cost, and asset impairment loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringSettlementAndImpairmentProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=cron_RepurposingPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=cron_RepurposingPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>149
<FILENAME>R125.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689702497176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for credit loss</a></td>
<td class="nump">$ 74,000<span></span>
</td>
<td class="nump">$ 136,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Net revenue, before excise taxes</a></td>
<td class="nump">54,353,000<span></span>
</td>
<td class="nump">25,639,000<span></span>
</td>
<td class="nump">$ 13,234,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cron_UnitedStatesSegmentMember', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for credit loss</a></td>
<td class="nump">65,000<span></span>
</td>
<td class="nump">12,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cron_RestOfWorldSegmentMember', window );">Rest of World</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for credit loss</a></td>
<td class="nump">9,000<span></span>
</td>
<td class="nump">124,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=cron_FourMajorCustomersMember', window );">Four Major Customers | Rest of World</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Net revenue, before excise taxes</a></td>
<td class="nump">$ 34,295,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=cron_FourMajorCustomersMember', window );">Four Major Customers | Rest of World | Customer Concentration Risk | Revenue Benchmark</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">63.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=cron_TwoMajorCustomersMember', window );">Two Major Customers | Rest of World</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Net revenue, before excise taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,597,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=cron_TwoMajorCustomersMember', window );">Two Major Customers | Rest of World | Customer Concentration Risk | Revenue Benchmark</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=cron_OneMajorCustomerMember', window );">One Major Customer | Rest of World</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Net revenue, before excise taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,186,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=cron_OneMajorCustomerMember', window );">One Major Customer | Rest of World | Customer Concentration Risk | Revenue Benchmark</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121599878&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cron_UnitedStatesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cron_UnitedStatesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cron_RestOfWorldSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cron_RestOfWorldSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=cron_FourMajorCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=cron_FourMajorCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=cron_TwoMajorCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=cron_TwoMajorCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=cron_OneMajorCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=cron_OneMajorCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>150
<FILENAME>R126.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689791981928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information - Schedule of Segment Data (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Consolidated statements of net income (loss) and comprehensive income (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">$ 46,719<span></span>
</td>
<td class="nump">$ 23,750<span></span>
</td>
<td class="nump">$ 12,121<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Share of loss from equity accounted investees</a></td>
<td class="num">(4,510)<span></span>
</td>
<td class="num">(2,009)<span></span>
</td>
<td class="num">(723)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest revenue</a></td>
<td class="nump">18,601<span></span>
</td>
<td class="nump">29,213<span></span>
</td>
<td class="nump">220<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(186)<span></span>
</td>
<td class="num">(1,244)<span></span>
</td>
<td class="num">(139)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest income (expense), net</a></td>
<td class="nump">18,415<span></span>
</td>
<td class="nump">27,969<span></span>
</td>
<td class="nump">81<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">2,872<span></span>
</td>
<td class="nump">2,090<span></span>
</td>
<td class="nump">807<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">1,347<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Loss from discontinued operations</a></td>
<td class="num">(650)<span></span>
</td>
<td class="num">(363)<span></span>
</td>
<td class="num">(894)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization', window );">Adjusted EBITDA</a></td>
<td class="num">(147,253)<span></span>
</td>
<td class="num">(98,308)<span></span>
</td>
<td class="num">(10,357)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationAdditionalInformationAbstract', window );"><strong>Consolidated balance sheets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">1,925,682<span></span>
</td>
<td class="nump">2,090,442<span></span>
</td>
<td class="nump">183,471<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investments in equity accounted investees</a></td>
<td class="nump">19,235<span></span>
</td>
<td class="nump">557<span></span>
</td>
<td class="nump">2,960<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">179,522<span></span>
</td>
<td class="nump">214,492<span></span>
</td>
<td class="nump">1,314<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAdditions', window );">Purchase of property, plant and equipment</a></td>
<td class="nump">31,412<span></span>
</td>
<td class="nump">38,664<span></span>
</td>
<td class="nump">88,308<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Consolidated statements of net income (loss) and comprehensive income (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">9,495<span></span>
</td>
<td class="nump">3,364<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Share of loss from equity accounted investees</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest revenue</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(34)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest income (expense), net</a></td>
<td class="num">(18)<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">234<span></span>
</td>
<td class="nump">46<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">323<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Loss from discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization', window );">Adjusted EBITDA</a></td>
<td class="num">(28,019)<span></span>
</td>
<td class="num">(1,703)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationAdditionalInformationAbstract', window );"><strong>Consolidated balance sheets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">253,745<span></span>
</td>
<td class="nump">293,985<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investments in equity accounted investees</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">178,414<span></span>
</td>
<td class="nump">213,414<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAdditions', window );">Purchase of property, plant and equipment</a></td>
<td class="nump">385<span></span>
</td>
<td class="nump">259<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Rest of World</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Consolidated statements of net income (loss) and comprehensive income (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">37,224<span></span>
</td>
<td class="nump">20,386<span></span>
</td>
<td class="nump">12,121<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Share of loss from equity accounted investees</a></td>
<td class="num">(4,510)<span></span>
</td>
<td class="num">(2,009)<span></span>
</td>
<td class="num">(723)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest revenue</a></td>
<td class="nump">18,585<span></span>
</td>
<td class="nump">29,207<span></span>
</td>
<td class="nump">220<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(152)<span></span>
</td>
<td class="num">(1,244)<span></span>
</td>
<td class="num">(139)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest income (expense), net</a></td>
<td class="nump">18,433<span></span>
</td>
<td class="nump">27,963<span></span>
</td>
<td class="nump">81<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">2,638<span></span>
</td>
<td class="nump">2,044<span></span>
</td>
<td class="nump">807<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">1,024<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Loss from discontinued operations</a></td>
<td class="num">(650)<span></span>
</td>
<td class="num">(363)<span></span>
</td>
<td class="num">(894)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization', window );">Adjusted EBITDA</a></td>
<td class="num">(98,349)<span></span>
</td>
<td class="num">(84,826)<span></span>
</td>
<td class="num">(10,357)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationAdditionalInformationAbstract', window );"><strong>Consolidated balance sheets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">388,351<span></span>
</td>
<td class="nump">309,854<span></span>
</td>
<td class="nump">183,471<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investments in equity accounted investees</a></td>
<td class="nump">19,235<span></span>
</td>
<td class="nump">557<span></span>
</td>
<td class="nump">2,960<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">1,108<span></span>
</td>
<td class="nump">1,078<span></span>
</td>
<td class="nump">1,314<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAdditions', window );">Purchase of property, plant and equipment</a></td>
<td class="nump">31,027<span></span>
</td>
<td class="nump">38,405<span></span>
</td>
<td class="nump">88,308<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Consolidated statements of net income (loss) and comprehensive income (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Share of loss from equity accounted investees</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest income (expense), net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Loss from discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization', window );">Adjusted EBITDA</a></td>
<td class="num">(20,885)<span></span>
</td>
<td class="num">(11,779)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationAdditionalInformationAbstract', window );"><strong>Consolidated balance sheets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">1,283,586<span></span>
</td>
<td class="nump">1,486,603<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investments in equity accounted investees</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAdditions', window );">Purchase of property, plant and equipment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cron_CannabisFlowerMember', window );">Cannabis flower</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Consolidated statements of net income (loss) and comprehensive income (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">27,932<span></span>
</td>
<td class="nump">15,020<span></span>
</td>
<td class="nump">9,210<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cron_CannabisFlowerMember', window );">Cannabis flower | Operating Segments | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Consolidated statements of net income (loss) and comprehensive income (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cron_CannabisFlowerMember', window );">Cannabis flower | Operating Segments | Rest of World</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Consolidated statements of net income (loss) and comprehensive income (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">27,932<span></span>
</td>
<td class="nump">15,020<span></span>
</td>
<td class="nump">9,210<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cron_CannabisFlowerMember', window );">Cannabis flower | Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Consolidated statements of net income (loss) and comprehensive income (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cron_CannabisExtractsMember', window );">Cannabis extracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Consolidated statements of net income (loss) and comprehensive income (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">18,254<span></span>
</td>
<td class="nump">8,702<span></span>
</td>
<td class="nump">2,732<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cron_CannabisExtractsMember', window );">Cannabis extracts | Operating Segments | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Consolidated statements of net income (loss) and comprehensive income (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">9,495<span></span>
</td>
<td class="nump">3,364<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cron_CannabisExtractsMember', window );">Cannabis extracts | Operating Segments | Rest of World</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Consolidated statements of net income (loss) and comprehensive income (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">8,759<span></span>
</td>
<td class="nump">5,338<span></span>
</td>
<td class="nump">2,732<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cron_CannabisExtractsMember', window );">Cannabis extracts | Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Consolidated statements of net income (loss) and comprehensive income (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Consolidated statements of net income (loss) and comprehensive income (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">533<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="nump">179<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember', window );">Other | Operating Segments | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Consolidated statements of net income (loss) and comprehensive income (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember', window );">Other | Operating Segments | Rest of World</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Consolidated statements of net income (loss) and comprehensive income (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">533<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="nump">179<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember', window );">Other | Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Consolidated statements of net income (loss) and comprehensive income (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjusted Earnings Before Interest, Taxes, Depreciation And Amortization</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109227538&amp;loc=d3e44648-109337<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNonoperatingNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of nonoperating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNonoperatingNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of acquisition of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationAdditionalInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationAdditionalInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationProfitLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationProfitLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cron_UnitedStatesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cron_UnitedStatesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cron_RestOfWorldSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cron_RestOfWorldSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cron_CannabisFlowerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cron_CannabisFlowerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cron_CannabisExtractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cron_CannabisExtractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>151
<FILENAME>R127.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689701443256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information - Schedule of Adjusted EBITDA (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="6">12 Months Ended</th>
</tr>
<tr>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2019</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="num">$ (75,270)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 1,165,574<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (21,817)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest expense (income), net</a></td>
<td class="num">(18,415)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(27,969)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(81)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">1,347<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Impairment loss on goodwill and intangible assets</a></td>
<td class="nump">40,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Repurposing charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">7,268<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts', window );">Financing and transaction costs</a></td>
<td class="nump">40<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">32,208<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax', window );">Gain on revaluation of derivative liabilities</a></td>
<td class="num">(129,254)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(1,276,819)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Loss (gain) on disposal of other investments</a></td>
<td class="num">(4,789)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(16,277)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(164)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Share of loss (income) from equity accounted investees</a></td>
<td class="nump">4,510<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,009<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">723<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Loss from discontinued operations</a></td>
<td class="nump">650<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">363<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">894<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (loss)</a></td>
<td class="nump">1,834<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(197)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_RestatementReviewExpense', window );">Review costs related to restatement of 2019 interim financial statements</a></td>
<td class="nump">9,688<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based payments</a></td>
<td class="nump">15,361<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">11,619<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">8,151<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_AdjustedEarningsBeforeInterestAndTaxes', window );">Adjusted EBIT</a></td>
<td class="num">(154,298)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(102,221)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(12,294)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">7,045<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,913<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,937<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization', window );">Adjusted EBITDA</a></td>
<td class="num">(147,253)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(98,308)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(10,357)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="num">(77,368)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(3,070)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest expense (income), net</a></td>
<td class="nump">18<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(6)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">323<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Impairment loss on goodwill and intangible assets</a></td>
<td class="nump">40,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Repurposing charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts', window );">Financing and transaction costs</a></td>
<td class="nump">40<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">117<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax', window );">Gain on revaluation of derivative liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Loss (gain) on disposal of other investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Share of loss (income) from equity accounted investees</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Loss from discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (loss)</a></td>
<td class="nump">20<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">182<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_RestatementReviewExpense', window );">Review costs related to restatement of 2019 interim financial statements</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based payments</a></td>
<td class="nump">8,714<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">900<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_AdjustedEarningsBeforeInterestAndTaxes', window );">Adjusted EBIT</a></td>
<td class="num">(28,253)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,877)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">234<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">174<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization', window );">Adjusted EBITDA</a></td>
<td class="num">(28,019)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,703)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Rest of World</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">32,671<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,180,241<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest expense (income), net</a></td>
<td class="num">(18,433)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(27,963)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(81)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">1,024<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Impairment loss on goodwill and intangible assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Repurposing charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">7,268<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts', window );">Financing and transaction costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">32,091<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax', window );">Gain on revaluation of derivative liabilities</a></td>
<td class="num">(129,254)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,276,819)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Loss (gain) on disposal of other investments</a></td>
<td class="num">(4,789)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(16,277)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Share of loss (income) from equity accounted investees</a></td>
<td class="nump">4,510<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,009<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">723<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Loss from discontinued operations</a></td>
<td class="nump">650<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">363<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">894<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (loss)</a></td>
<td class="nump">1,814<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(197)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_RestatementReviewExpense', window );">Review costs related to restatement of 2019 interim financial statements</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based payments</a></td>
<td class="nump">6,647<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">10,719<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_AdjustedEarningsBeforeInterestAndTaxes', window );">Adjusted EBIT</a></td>
<td class="num">(105,160)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(88,565)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">6,811<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,739<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization', window );">Adjusted EBITDA</a></td>
<td class="num">(98,349)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(84,826)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(10,357)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="num">(30,573)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(11,597)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest expense (income), net</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Impairment loss on goodwill and intangible assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Repurposing charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts', window );">Financing and transaction costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax', window );">Gain on revaluation of derivative liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Loss (gain) on disposal of other investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Share of loss (income) from equity accounted investees</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Loss from discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(182)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_RestatementReviewExpense', window );">Review costs related to restatement of 2019 interim financial statements</a></td>
<td class="nump">9,688<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based payments</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_AdjustedEarningsBeforeInterestAndTaxes', window );">Adjusted EBIT</a></td>
<td class="num">(20,885)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(11,779)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization', window );">Adjusted EBITDA</a></td>
<td class="num">$ (20,885)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (11,779)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="7"></td></tr>
<tr><td colspan="7"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Refer to Note 14 in the notes to the consolidated financial statements</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Refer to Note 14 in the notes to the consolidated financial statements</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_AdjustedEarningsBeforeInterestAndTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjusted Earnings Before Interest And Taxes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_AdjustedEarningsBeforeInterestAndTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjusted Earnings Before Interest, Taxes, Depreciation And Amortization</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_RestatementReviewExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restatement Review Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_RestatementReviewExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the charge against earnings during the period for commitment fees and debt issuance expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of an equity method investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDerivativeInstrumentsNetPretax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109227538&amp;loc=d3e44648-109337<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNonoperatingNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of nonoperating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNonoperatingNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cron_UnitedStatesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cron_UnitedStatesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cron_RestOfWorldSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cron_RestOfWorldSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>152
<FILENAME>R128.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689705469080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information - Schedule of Revenue from External Customers by Geographic Areas (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">$ 46,719<span></span>
</td>
<td class="nump">$ 23,750<span></span>
</td>
<td class="nump">$ 12,121<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CA', window );">Canada</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">34,538<span></span>
</td>
<td class="nump">20,202<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">9,495<span></span>
</td>
<td class="nump">3,364<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=cron_OtherCountriesMember', window );">Other countries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">$ 2,686<span></span>
</td>
<td class="nump">$ 184<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=cron_OtherCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=cron_OtherCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>153
<FILENAME>R129.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689700653608">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Segment Information - Schedule of Long-lived Assets by Geographic Areas (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">$ 187,599<span></span>
</td>
<td class="nump">$ 159,948<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CA', window );">Canada</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">162,163<span></span>
</td>
<td class="nump">139,160<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">2,293<span></span>
</td>
<td class="nump">2,103<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=cron_OtherCountriesMember', window );">Other countries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">$ 23,143<span></span>
</td>
<td class="nump">$ 18,685<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=cron_OtherCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=cron_OtherCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>154
<FILENAME>R130.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139689701962344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Discontinued Operations and Held-for-sale Assets (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax', window );">OGBC income (loss) from discontinued operations, net of income taxes</a></td>
<td class="num">$ (650,000)<span></span>
</td>
<td class="num">$ (363,000)<span></span>
</td>
<td class="num">$ (894,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent', window );">Long-term assets classified as discontinued operations</a></td>
<td class="nump">1,176,000<span></span>
</td>
<td class="nump">3,248,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment</a></td>
<td class="nump">187,599,000<span></span>
</td>
<td class="nump">159,948,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets</a></td>
<td class="nump">69,720,000<span></span>
</td>
<td class="nump">71,235,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">179,522,000<span></span>
</td>
<td class="nump">214,492,000<span></span>
</td>
<td class="nump">1,314,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Inventory write-down</a></td>
<td class="num">(26,055,000)<span></span>
</td>
<td class="num">(29,173,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Operating expenses</a></td>
<td class="num">(153,514,000)<span></span>
</td>
<td class="num">(103,511,000)<span></span>
</td>
<td class="num">(26,658,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other income (loss)</a></td>
<td class="nump">106,074,000<span></span>
</td>
<td class="nump">1,287,045,000<span></span>
</td>
<td class="num">(478,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Income (loss) from continuing operations</a></td>
<td class="num">(74,620,000)<span></span>
</td>
<td class="nump">1,165,937,000<span></span>
</td>
<td class="num">(20,923,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">As previously disclosed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">161,809,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">72,320,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">214,794,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Inventory write-down</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(29,440,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Operating expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(103,620,000)<span></span>
</td>
<td class="num">(27,554,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,287,058,000<span></span>
</td>
<td class="num">(476,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Income (loss) from continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,165,574,000<span></span>
</td>
<td class="num">(21,817,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_RestatementAdjustmentMember', window );">Held-for-sale adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,861,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,085,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(302,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Inventory write-down</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">267,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Operating expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">109,000<span></span>
</td>
<td class="nump">896,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,000)<span></span>
</td>
<td class="num">(2,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Income (loss) from continuing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 363,000<span></span>
</td>
<td class="nump">$ 894,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldforsaleMember', window );">Discontinued Operations, Held-for-sale | OGBC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Loss on held-for-sale assets</a></td>
<td class="nump">1,860,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_DiscontinuedOperationAssetsValuationAllowanceValuationIncrease', window );">Valuation allowance recorded upon reclassification of assets as held-for-sale</a></td>
<td class="nump">919,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf', window );">Impairment of assets held-for-sale</a></td>
<td class="nump">$ 941,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_DiscontinuedOperationAssetsValuationAllowanceValuationIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discontinued Operation, Assets, Valuation Allowance, Valuation Increase</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_DiscontinuedOperationAssetsValuationAllowanceValuationIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from operations classified as a discontinued operation. Excludes gain (loss) on disposal and provision for gain (loss) until disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2510-110228<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of (gain) loss recognized for the (reversal of write-down) write-down to fair value, less cost to sell, of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2443-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2611-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4542-108314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_RestatementAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_RestatementAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldforsaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldforsaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cron_OGBCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cron_OGBCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>155
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M[KNQUS<!]HFO$5^KO6-BFC(7XM&<3(+SEF,8\9C[VD P^'GB(Q['!@EX_"Q
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M<8&,)S)RB;A RN _+Y%D1R0)$KG136MB3).7^)@D"!61)2X5%PCM2]S!F[I
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M?_O0ZG5W7_Q1MZU>=3^7*H=Q-0#X_J3!M_L'4\'NWUE<_0]02P,$%     @
M2SQ:4N\G&G!:"   5"D  !@   !X;"]W;W)K<VAE971S+W-H965T-2YX;6S%
MFMMNXS80AE^%, IT%ZC7XDF4BB1 G5-[T7:1;-N+HA>*S,3"RJ(KR<GNVY>4
M%5/BR7)0M#>)90]'/X=#?D-*9R^B_MRL.6_!ETU9->>S==MNOU\LFGS--UGS
M06QY)7]Y%/4F:^5E_;1HMC7/5EVC3;E 410O-EE1S2[.NN\^UA=G8M>61<4_
MUJ#9;399_77)2_%R/H.SUR_NBJ=UJ[Y87)QMLR=^S]O?MA]K>;4X>%D5&UXU
MA:A S1_/9S_ [V]II!IT%K\7_*49? :J*P]"?%87/ZW.9Y%2Q$N>M\I%)O\]
M\TM>ELJ3U/%W[W1VN*=J./S\ZOVFZ[SLS$/6\$M1_E&LVO7Y+)F!%7_,=F5[
M)UY^Y'V'J/*7B[+I_H*7WC::@7S7M&+3-Y8*-D6U_Y]]Z0,Q: "QIP'J&R"S
M ?$TP'T#;#1 S-. ] V(T8#X^D#[!M1L$'L:Q'V#V)3D:\#Z!JP;K'UTNZ&Y
MRMKLXJP6+Z!6UM*;^M"-;]=:CDA1J52\;VOY:R';M1>7HFI$6:RREJ_ ?2O_
MR3QK&R >Y97(/Z]%N>)U\RVX_GM7M%_!NRO^6.1%^Q[,P6_W5^#=-^_!-Z"H
MP*>UV#59M6K.%JW4I;PO\E[#<J\!>31\$FU6.II=AIO=K[.:@SS;%N[F5^'F
M/ZQ6A9H-60FV6;&:RS[X?5V'?=WQ5LYZ&4&>U551/37@79;GN\VN[.*ZZF/F
M<'QS1.3 BVC7O :YV,@U9ZT6@V<N R^O.7A7BJ9QN;\-N_]%5/-<5&TM2OG3
MDW37\IHWK3&("YE4A\Q"A\Q"G6_B\;WD3T6E@B&7BC*K<JE2AKA1@]:\!UD+
MKGC^ 6#X'4 19*[AW_N/._]J27V^@"3%<11'^&SQ[)"&#]+PB=(FR%GN?=*!
MG!@SK*7L13NL4(+)V.K*MB+,-+JVC>8Q2HT;WMA6B-!D;'1K&T7N$))#"$G7
M!'M"^%.52_(U7"T(^T_OU2K@7#/^O)/I!20Y7K)Z]5<@M>CAYC0X?MW,;T#1
M-#LY+P9IY<HB:F<1C1F#Q)-$\4%$/%V$*U]B^\:04A@9"1-;0V.8C=2Q@SIV
M7%TGKLOO7%B3>B^262+GC#)F:&1V)HZL1A*3@\0D*/%WN="H.2A1([9J)78*
M3"R!":30F$Y'C$;RTH.\-"COU[TFP+_P.B^:XXF66B)DGJ7$,Y PTH2.3A/B
M)&QDW9U@:@QC;S1:G)@92X>G.4)&UEZ[K&#LZ>J@&('!KOZ1U76FRH_)0>\=
MCF89AG)R8Y\8S2\8!I@MQAEXFU((QM",/+(BCVF,S=#;ON:01,C3$XT[&.;=
MI4)\\;#KBO^'KZ":AOV^@]CN8&(L$+='C,:Z-6,@">K^16[%CE4XR]['.%]A
M IF9L4Z[>) G?5<<=M*=IR\:63#,K%_?4+TMH0VO.438K!1N/';(+ -<=KYY
MHCD(PR"\KE83J[S$.8,=G&0)DWMIY$M\#4$8IJ A;8*<);2)"$E"26K.:)N)
MD-$HLI93AS^(S*E_[3";(TD/:HZTPRY-6&0.M..ND8]$&M@P^>^+/JB!#,-$
M/JGL@S:.95G%&):%BSL.2!,9A8E\M/1#-AUQ1!)D8@'90)9V!)I)Y/!'?!4B
MTK1%8=I.K1&1S=@Y9H/9V7<&VE7BR&PL<["/#'-X6IV(;,)"R>'4C*1C4SDR
M&XO4B$5AQ)Y:+2Z1BYB(,BNJMAU,(TQ\BC5<41BND\K*WL=H3),T,37:5CA.
MS,@[N(K-2O[:995"ZNFLIB\*T_?TPA+9J&0XC=+84PD@S4L4YN6TNA(YL$BP
M%7E[]X@BZ[3!X6M.4P_XD:8K"M-U,#%5]5@7N3JFZF(*=E7A64QL,B6)-4O#
M1F.]&E\HO.'\)+;SW19TQ^VG9(*]NXP903CQ'" @#304!II'D#-L-LX2'#'S
M]*DWHUZS\7F9)AX.$V]2)8YM2LFU54+7.MAR&L8T,FMQA^$\Q1ZB8 T^' ;?
MFVIQ;%,0L]C<"=TXS5AD'<@YF(H\2PO6J,1A5$XOQ5-7IF,;CI@D<BM%F"_F
M@R/7,"##I;A+SA([T,>(A)]YA(;MXTT:J]0S3UT=S,7(/G=UW!?*L2:Q.=8.
M?RPQ%^E;A]D\H;XYJ0&._X<C6*R1BO_%0UALT]13OF+-41SFZ+2Z$-N$9#"Q
M,L,FY,AJ+%$3$H<)>7)5B&WP(8AABLWMI\-0[BICB'UAU93$84I.J@M['\.H
M6@IM$TB3V R\#=<Y]!XM8XU6'$;KG;,@ 0UOVW)"NMJT)9!$2>*6131'29BC
MI]>AQ$9@RBB-B6=%)IJ"Y-3#5M=($\<!:V0^'R#VU@\B8I:A#E=SM;!Z.J*I
M1R9O$*?7H<1FG02=F9['K,:*-0Q)&(:?LB]RZ7PIVO6:ERL@*O#\ICXXP((@
M,7=>1\W&O1@\ @SO( =QE[731KSF\2L3U!-U457]2R>JMT 67F GD:6:\%H]
M- ?;W4.IGHY_!?6^#I;?/<C$5(_-GWDIMNJ%!&?O[:TB2LR#M4MB[TU1%$5F
MB&Q?0U?C &E$DC BW[CA()-A230L21B6)VPUB,U"C,Q:ZI+87!U9C75J8I(P
M,2=M-(CSJ24R3T&OG79XN.+L"S27G<2N;_PU2LD1E+YEGT%L(D*2F@<E-RXS
M:CUXNG68R:[YTDGCE83Q.GFCH1X<.C+<YBN.(T0Q]FWNJ$8L#2,VN-%PREE2
M^Q@6RBT;-,^P+AV&-$Y1;"XG#CM,AB<N^_QTW3>*"8V,6NK&84A0FAIFMPZS
MN2P>35PM!J^+J?<-?\[JIT)6?"5_E.VB#TPZJ/>O\.TO6K'MWB![$&TK-MW'
M-<_D!D,9R-\?A6A?+]1+:8<7*2_^ 5!+ P04    " !+/%I2O>7!A%P*  !"
M,0  &    'AL+W=O<FMS:&5E=',O<VAE970V+GAM;+5;VW+;.!+]%91K'Y*J
M:$3<>'$YKHJMR)N'F:22G9V'K7V@1<CBAB(T)&39^_4+0)0@"DU0KIK-0RS1
M!Y>#;G0?-.&;G6Q^MBLA%'I95W7[\6JEU.9Z.FT7*['.VU_D1M3Z-TO9K'.E
MOS9/TW;3B+RPC=;5E$11/%WG97UU>V.??6MN;^16564MOC6HW:[7>?-Z)RJY
M^WB%KPX/OI=/*V4>3&]O-OF3^"'4[YMOC?XV/?92E&M1MZ6L42.6'Z\^X>L'
MGIH&%O'/4NS:D\_(4'F4\J?Y\J7X>!69&8E*+)3I(M<_GL6]J"K3DY['GUVG
M5\<Q3</3SX?>YY:\)O.8M^)>5G^4A5I]O$JO4"&6^;92W^7N[Z(CQ$U_"UFU
M]G^TVV-C#5YL6R7776,]@W59[W_F+]U"G#1(\$ #TC4@9PTP'6A NP;TO $?
M:,"Z!NS2$7C7@)\W8 ,-XJY!?.D(2=<@L<;:KZXUS2Q7^>U-(W>H,6C=F_E@
M[6M;:XN4M7'%'ZK1ORUU.W5[+^M65F61*U&@'TK_T'ZF6B27Z#YO5VBN?;5%
M$_3[CQEZ][?W-U.E!S5-IXMN@+O] &1@ $S0K[)6JQ9]K@M1]#N8ZMD>ITP.
M4[XCP1YG8O$+HO@#(A&)@ G-+FZ.,Z#Y_/+F:8 -/1J VO[H0']?-Z+)55D_
M[7=EJ4K1!KIEQVZ9[98-=/N;CF)EO9!K@=Y5LFU!R^V[X+8+$[.>;R<))TFD
M_]U,GT^7U$=B''.>, \Z!SHE.,7)*;)'B1\I\>!*?=&^V:):*I0OER:2Z35;
M:!^]#BQ7?.P[#B[7@P[:R ;7Y[S:YC9*ZBU0B*9\SDVP1%69/Y858)[]4NZ[
MCT]98Y(1[B_0?7@F_\+_AGP:[#^)4YQY WP>&8!  \S] <ZZ?7ACMST[)$<[
M),%>OJPW>=F8$(2,UQJ3/$E9[,JJ0GE=:)=6>?U4/E8"Y6TK%&B+Q*-BK !X
MM0\\=^80HD<P/1),PP3K9TU.-J]HUY1*3 JYJR$.J3<PB2/.?0X ,,,)]?>E
M#QR@DAVI9$$JWQKY7!I)TB(MB;1I#LR,H0JY?53+K;;:8B&W-6RHS)L231CV
M.?HX3&.?H0\;8(@CEQVC(,<?J[P1$Z-U"K3)7VUN!'-@Y$^1TQC@ B%Q#&SC
M.8!,,<>#<12?Y'P<9#436K8NRGV8,];*U[)1Y7_M Y >]J:21 SP1@!(,PQX
M(P#$&1U.$I@X<F3<9"9XVP#R;I\$WZ-E(]=(_+DMU>O!)T5AG;95 H[IW4"]
M0&+7WV/M _51 #*I#TP('2;M1 2F%^6OHFPWLLTKPU^JE6@ZAL..2_W$PI+4
MG_L,0N*8) E $X2R89Y.U> 162/KB<GY2',4K?5=?8+Z*8P8 .DQWS)I[/OC
M#  RP-1S #=$RND:S$=R@M5I*G]!XD6?,5L!4N% %&3^ZL\ H,<B!.FS< H*
MAP7 T32-V&P;[856G\EVP.]&]<8,@#!&H5T5ZJO/QND0'!8B7^WFJ0^<Y+E*
M?SV8ZAAA0):^?M"R#7(_ $@8%#<!8#:\L9PLP6%=8LX+BY765GI7Z5!R)&X*
M"7NAO2E57H$D?64QH30#9C^#H)R1* 6(^E :QV28JI,M.*Q;+%7#;6,$C#Z3
MHL=7]&[;VG3PWC?U@.+'OMR88$88A[8DA*41@<Y/$#;A@?,3<6J&1.$3E,T%
M%Y\UB1,4)"PHM!1<"%&T^RS[3N]_[4NMR<+O4;O2VF*B1+,^S44?4"T4M*S$
M%P:9/D4-)P_BE $)*X._;I8SXB?R"<FR#-C;<P [1,7E>Q+.]U_<',UV?9NN
M(7YZ/G=8 *(S. ?V*81D:31L+I?K23C7]\UE$O[%JH8 V1P4-0 09S$&MB6
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MSV\,VUEH_N!=;RUN?DPNSC/<E2V?*M&&"]^: YAM*U1PQ+?-,4T8!,0O6[<
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M^5A"^.$+T_P:OO]NE<WG;^%B.;E<K'Z<PF\U<49-B^:)&>;6\5T"Y,9PCDP
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ML^G5ZP1</Z/[3;!MG(M[&[B&<5GSLT9.#O#WTO*U'C828'PHM_\"4$L#!!0
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M--O4)1,!G=O3-'NPM94ESX@GMF#2E3?B\A'&BKV1QX"5E>4<=\&?1XT9U;U
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MT/OF!5^<WD?(1E"?DLA!H'38;Y6S#EATXSEG@E!.JDH0PE1PL\L,CC\VDT]
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M>%<:+IQ>^O>34^V<+OW7A<!T8&@!?I]IE$U]00=L7UC?_@502P,$%     @
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MD#QTR&9W*!K;I\M+!UUEE-J!Z339C *Y=N,DC:Q$%\(=7"46WO-$2OH1D'Z
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M7!-:H&4!/%\:4^QN6$'SC>KZ=U!+ P04    " !+/%I2 :')3N(#  "L"
M&0   'AL+W=O<FMS:&5E=',O<VAE970Q."YX;6R55DUSVS80_2L[:M*3+'[(
MLI1$THSM-)/.-%-/G-2'3@\0N10Q 0$&6$;2O^\"(!59B3WM123 ?6_?/BP
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MY^1F830=QM#RDM)9$YI8\WD/%;Q21LDRM-M&J) @'%X_[[GJL88=[Q;0AO@
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M,:/"MS/V'8H/H.@>(@A75%4(Q*/XU,A4KS7&@P%=D8Z!/+0^I,XLSD/B1)/
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M^3\R1CB<+1_A<S[FS_ +C3&VQL"J(#1[H#&B1^W_>XU!/'[8GI?A%H&X8O"
MFEY2\TN'^3*7"8"B@ PY8UQ=,>#M!,(^M7LGZ%H3XW8(W1$-!RAPH'^ZUM?
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MV\85_BL[JMPA9R"( 'B5+S.^IL[$B<=RDLYT^K DEB0B7)@%*)G]]?W.V5T
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MZGD+\BHN^&?!$S%MTXP3JAKA8;N$^KENO7 01/NF,-8]HDBGC]?G['C0141
M_:[Q:A:Z>]S_\? 1>,BV-NU,QS&X@S<M7-U8&1W!)DG! \@JR=1>X5Q3,8W
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M!2WDCR-RQFIH3ROS6M8@0KNZT>QO/);'P=31';YO4QP?,<5) 3S<2&U"3*[
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M<U$'R_X^[]AX& N*DU-?&^U40=NP"/>R"AL1Y+V*\+"D3-@\;[ EWXC<>@1
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MZ>PY",,<146G#52#JE8 FJ4'R K((R\?RN:AN#KYXF._"#;?1.#RTK=DF^Q
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M-@1;\R4..R!:6H#W"PO M3>DH/_<?/$G4$L#!!0    ( $L\6E+O90MN'@H
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M(+CXIQ3A@S<[_OG"RGAO"OYSBYY365J []?&^/H#'=#\GN7]?P%02P,$%
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M;6F+$^;P[ ^[G0P7&*PB%.:Z2XF!CY&P8!:N95*K'A/B'\PZ]H _Z0VIWT6
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M40F'!2Q\64@GT<*?BR5+<9W\]8K%R<[B)%B<_#]B_S,(W,<87(6P06$ />7
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M:=O!Q4:E^<GKESSVL7S]LMC569KKCZ6H=IN-*N_>ZJRX?77BG+0#5^EJ7=/
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M'V9 0'+HQV$S'/A !^\P(@P/R#-**TW2/,S>.6V>/2&Z'SH1K_1V!PDKBG#
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MGXC2?,]F.G6QY6_(YD4--KFYU@KY,TW [\L"O#8=VJ#[J/#U_P%02P,$%
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MWN7KH A_D<Y>#!#;J(J=2&8@>&1'L34[;CN(D)[AO*AQB>" <0#\:U-V?M<
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MWH)JDA,QTJO&+QSD9+#>84AXV>)0J,H :0'%TWGH6= (,]2W@X0<8G!_6IL
M-LH3N''$X.64R()X6PB#88/)$4+<U]LES%F81G3M,#+8RY6[>P_@ V*J2[Z=
M#1S/SMPZWAUR,0&IL#]$7L\[9J*HP-# 2U!.&' X\(7=F'+%*%\TL!;3,$M[
M$\-"&I.2 ^$)<,!E"<P1A 1BG8.- 8QE/T%C0>JUO'8 #JT1A9O(P^QVH'CR
MUPM+1R"/R>\Z$V*KT,(A^? N-Y9-"9"GRQ;TI<:6)E+JO&B1G4XY0MM80]1=
M[':J'@,^YZ2[D<=;!1# !-;""H0*K7!9NW;6VP#\CG0GP!02">@+A('*V]2J
M 7';D-,*M*?^F*X/_S!H0K8=[@(CI)(]LB#2WYB9G&2_%2B/8P#^MTN='NJ
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MNHQVF*4 ^(!<2PSS17UCA?^S,H56?<,QX^"W8N."Q Q0#AX*>J]%KRP-Z )
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MNK[,7L=CO_=CSRB<*=?)2-]3Z20G7:(LWQ5)B$M]C=0C*^WFDJ=ZB=.+J(<
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M>#,\_OVW.[.V/YF&KG$M[0I>/3UY?OZ(+RG1#T #."0VDP+[E_[<@*)M&WP
M?E_5=:L?< +TA!!XW_\/4$L#!!0    ( $L\6E)AIM(#]@8  $X2   9
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M\N9/RP.ZN506(%AC:W@VP]G<-'\OFH'3E?]CL-+.Z=)_;@2JIB$"K*^U=MV
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M)42L2U-5>TY/#SA"/2"8##PVGDM&?R CJ4/G/#T_<'=[XQH8TU;\)*GZV4?
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MTQG&T++YG:+Y8LV.?QM8&FO-EB\W"CVA) (\ISK9?2$!_8]%5_\%4$L#!!0
M   ( $L\6E)_;9,#)P4  #P.   9    >&PO=V]R:W-H965T<R]S:&5E=#0Q
M+GAM;,57;8_;-@S^*T1V&Q+ 36SGO?<"W$O;]4/1HM=K,0S[H-B,+=267$E)
M[O;K1TFVD_22ZVT8MB^)))./2#XD)9UMI/JJ<T0#]V4A]'DG-Z9Z.1CH),>2
MZ;ZL4-"7I50E,S15V4!7"EGJE,IB$(?A9% R+CH79V[M@[HXDRM3<($?%.A5
M63+U<(6%W)QWHDZS\)%GN;$+@XNSBF5XB^:N^J!H-FA14EZBT%P*4+@\[UQ&
M+Z]&5MX)?.:XT3MCL)XLI/QJ)V_3\TYH#<("$V,1&/VM\1J+P@*1&=]JS$Z[
MI57<'3?HKYWOY,N":;R6Q1>>FOR\,^M BDNV*LQ'N?D5:W_&%B^1A7:_L/&R
M8]HQ66DCRUJ9YB47_I_=UW'849B%1Q3B6B%V=ON-G)4WS+"+,R4WH*PTH=F!
M<]5IDW%<6%)NC:*OG/3,Q7N3HX*W8HW:4*R-ANXGMBA0]\X&AO"MU""IL:X\
M5GP$*XKAG10FU_!*I)CN PS(L-:ZN+'N*GX2\0:3/@RC .(P#I_ &[;>#AW>
M\ C>CI\!W.#" !,IO/JVXN8!;C%9*6XX:OC]<J&-HHSYXXE-1^VF([?IZ,BF
MMS[?02[A4;0/!?EIM$\Y0D;%1D054FLBBFHCD9G@?V(*7("@2N8BD25Z"?N]
M8(8^&@G2&<!WZ-Z@0F :EK*@ M4OX3=D"M 22!%*L%R00D,!_41S^S.#-V3#
M#W>^9D)6#_"&(F9RN):JDHJY:NS^\M,LCL-3+^$FT6D/NKP')V"G47Q*HW%$
M/]%D I_Y6EHXP19<M]IVM=5] 3IGBMCK<D)I,)K_;C0=]KZ#J35@PY1B+O</
M:4;3"+[D7)N"(D$2.R+1.!@/PW9ZN5+DWQ;_K:#T;6SU'W<\7?=@%$QG<YC,
M)SLN^S7K=1!/IVXP<G&YH>P4&1"#\'"4HV@>.(EK659,/("610JL*(@JVZ(M
M0!0%X20&XJDD(NJ847+69'4=O<Z>B#R<!:/A9%^X1\FB'-N5D@EBZM1/AN/Q
M=\HG%!R?GLJ:2EG&7.X"0:5<5U*SPJH^SDHK4R_Z?,)[.H8T]OIP5]EFGLK*
MY1%I7][>6<<G+\((TF?%:.9CY,O(=@!?2=8L%SL?B*T]ODC(CX)IS9><()=*
MEK!D7,&:%2LD/25765Y;33;3$9G;LVN-C0]4?@<4MD73]^GW/)IG^S3C/:J$
M:Q*,9G$PCZ??9[9EC&69PHQ: =E'EJ58UZ(E;S;U(FG*[1KQLDT,6S3]?V87
MC<4V!_=L:Z'=QGN9%$>3_X+G_690&_6_L$ZTOQ?PCJDDI_I_JHSC8#P9[@2P
M:4P!&4J;:[+;!H95%-![3K<6+!X@FO?#GW>E78%.3\E;K5>V,BDV=&/3A@96
M?:_< ^N#[UZ!+4Q*'E'?J3:<VOJVL3E(EM!QJGG#VK9S6G_J7M@N?J+LU,R!
M-9VQ#Y>V3]#&=+&R"%8O(>:L8?7TD/Y^P(@V)!92&[!X% Q'4=.=]WQ[;EH_
M04>-_JB=-A&SV9TI2KS]'"?(>#PG9Y_9$3?4/=M.>K0]^A[K8]?W9PQ=7G_@
M71P>Y-4JL23GN$97#F16@LI8:TM.-T0C!>K=R\7?9&8^"X/)H8/(1^Z9U%CC
M#U+3P-<I<XC]8^3L5\^)/Y&[UR>38!2.>L&_?*(=NF(.=F[T):K,O5LT6;\2
MQE_NV]7V:73I7P1;<?^NHJZ2V?Y7X))4P_YTW 'EWRI^8F3EW@<+:>BUX88Y
M/>]060'ZOI32-!.[0?M@O/@+4$L#!!0    ( $L\6E*.N,N0( @  , 6   9
M    >&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;,58:X_;N!7]*X3K+3* UK;D
M=S(SP,QLTZ;8[ :9M/U0] ,MT38;B71(RA[WU_=<4I+?3@*D*# 86S)Y>.[K
MW"O=;K3Y;)="./92Y,K>M9;.K5YWNS9=BH+;CEX)A5_FVA3<X=(LNG9E!,_\
MIB+O)KW>J%MPJ5KWM_[>!W-_JTN72R4^&&;+HN!F^RARO;EKQ:WZQD>Y6#JZ
MT;V_7?&%>!;N;ZL/!E?=!B63A5!6:L6,F-^U'N+7CP-:[Q?\78J-W?O.R)*9
MUI_IXEUVU^H1(9&+U!$"Q\=:/(D\)R#0^%)AMIHC:>/^]QK]K;<=MLRX%4\Z
M_X?,W/*N-6FQ3,QYF;N/>O,74=DS)+Q4Y];_9YNP-L'BM+1.%]5F,"BD"I_\
MI?+#WH9)[\*&I-J0>-[A(,_R%^[X_:W1&V9H-=#HBS?5[P8YJ2@HS\[@5XE]
M[OY7S17[*%(AUWR6"_;J$WW8F]NN SJMZ:85TF- 2BX@Q0E[KY5;6O8GE8GL
M$* +6@VWI.;VF%Q%_$6D'=:/(Y;TDMX5O'YC:]_C]2_@[<RT[)\/,^L,<N)?
M5X '#?#  P\N #^C5+(2WM-S=N30<WZ\#O9@"0:VBV(F3&/_\9UXRIY*8X1R
M;*6-S_#?N"N%X>Q9& D3'P*75_*&M5D_&L83? ZBX7C(_@P#GS1[,B*3CKWE
MJ<REVV(IUO:CN#]F?_S#)(F3-^PARUZSAS0UI<B85$X881T;)!,VF;)/VO$<
M67I( ^QS'&Q1LTU:C:/>I(_#1Z,!6*D% U#1[+A&9S2-IOTI&3T:3]C[,DTE
M^V!T(:W59LM^TT[00JR,^U$_&; XB8:3,7OB2G&KRYRA8',^TX;[L_+@DS76
M1\DH_HJA"1B/V;B75+;FX/[S ?=SUD[&43R-V6 03;&[WGFTJ,VF@R@9#R@H
MTVC4CWVD?E?LKV6^9<D@A#UB;BE@0K'B:LNX C=GV;\U&+(UO%X:P5;<.(7$
M$)ZU9Z^QE'&(9U90:'!-,(>)L9%NV>0,5DB50M:M\$M7!I=R!>*\T"4@8.<I
MQ&S+VJ.H/R2:X<C%PH@%=]\*@)OM>!@->T# ]\U2ILL#BY?<LE07A70.EN&0
M>0D?#'L_?<47Y_<1LA'4JR1R$"@=]GOIK ,6W3CF3!#*254*0I@);G:9P?''
MYO(%Z,BT$GL,F0TCAIW1&,#OU*YD=Y$\"@%8^B@%CN+%B<HJ])O24!%DA(K?
MGL7*!; @"#&;HPK8>V[@L>I6AUT0CPA<ZS(5+RMT1!R8AG++M06)'-V9J]0;
MT!Y-AIX:LE4;XL87<!F,)@M.5(8RN^,_3X#Z40\5^>U0WBE&Y+P*VEXF^#H=
MO[',+KGQZ$I4Y+TC:BRI8&$JK*T3+N7&;"FZ:YZ7HKXKOI3DW4*XI::*62.F
M5"H=:/<<GL/A7EI&G2!#J,N'<E&2)/2#_!Y6YF'MU;[EJ ;A*] 7VY/12MM:
M[B29:BD81(JSIW:,,NCU>NP57ZV,?I%( @$M:(\GT:#?NV%6((@X1&GULQ%K
MG:]E+:5>UJI3YXV $D-R7-)[<UYC_8_QFYL.^X2E%W1X(_,\)"3<IZJ4"ZD%
MU:(Z]"M.ZF/-@^.I,*R?G3+:[]W&%<\D**/D"A%*AVI!*=1=BG50%EKWR-5G
M\@Y-%A"GG,JJ.F &G5%>=KQHT_8ZXL@*.C>K"M)=-LV+B(5J;+TFTYC(OI30
M$&'@>%#&CQ "F3<%&?GT6E$"DP0@]#N3J^X!F[3/H'U/H6 K+S6G*8T$!D=#
M6.JD:F/*1:SU^0,S=NI4 Q4\N\"9I$]@-;QP%#&"O1)K[*VS#"&PY8S$T4F4
M]99J&R2$)3[D.#XG[CQ%*1EO-AX5### ]3#3:ZDF.(FP4[5W0B\/5:3QSWA5
M]]6]U'F&ZV.<R*LZCEE+KR0LE]!W?"-Q*0TZUP)N %TAJ+CF?*W/@>S9YRD<
M*HNEK0<[KJCJH9E+GK',\ WVMZ?#*!ZBDMMC##W)Z":(U.5,[+!G. >J5+7K
M,X?19JIU^Y6<WB ;ZZX":TO?42_EJJ?U@-3*F[YRYO3OSMTD\D$W_X/\37Y4
MEXNCP;AWN3E=BE,8-OV<I@1+)M_0#5:[>5514]F; G<=8E^LSXZYM58S/(I3
ML_"#UTFOP/@[2?HWH>%XG%#O^LJ<4R?4^>F:=-T>"'N_,QW^5(T]>2.B&428
M3D7]3'L0WZV/4H9Q2V6!0^V>3*/,*(,(5/E.'Y9Y%GD]G ((#Y6%?ZC<$_XZ
M=3'0^?2[Q#OHMI^FZRS>DWI4_X9[K4KY2F)"E_\)#PA5ASKQD;>RYD!Z)8+^
M%:5O1@"6M !P=GDVJ8,/SG,]E%W.%@)#+,[V-WVC:O(DU6N,2X@BR3$QY=8*
MYWU=A?O[E>0\J4M"<B(BWQT)R,/_.10_1D*2X=3WI)D0ZKR*G'5()SR TDRY
MI[R[?O+.&B[R0Q6IIJ9SS[2=HWW$R.>+KRR>K3W?0YUX]^LSFT3)='PB('A\
M'@]N0AJ&0;-JKKXN ?B$K92#)&S(1(S/E$4;S;9>*$B=PMSM8^F#18,!J")I
MR:D0(9HEF^RK+(%WKDE5E0R>Q3E).E:DNLE0#Y*D+$:7BV654'I.\TBH,E>W
MP:LN?EN914:R\,1V;B" ;Y:\?L['&O)S>Q#%@\FI4D?)9'SSXU+Q*YEX[85(
MY]Q+L.[>6\5"F(5_=TJM&2487C V=YO7LP_AK>1N>7BWBP:^ !&6BSFV]CKC
M88N9\+XT7#B]\N\H9]HY7?BO2X'IP- "_#[7*)OJ@@YH7EK?_Q=02P,$%
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M'%$[ SJOE;*GA0LP_F[7_P)02P,$%     @ 2SQ:4B5[/YAH!0  N1(  !D
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M,5X [PNM7;/P!MK;JJ,_ %!+ P04    " !+/%I2T?8&G&T"  !@!0  &0
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M>@)160?:7TMI=H8-T#ZJD[]02P,$%     @ 2SQ:4LM'!F*O P  _ <  !D
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M2!]AK .&',K12D'FR=V">Y"Q!H(4;"DDWDQ/HJ>(0T*/;C_RW*$MC$P4C;\
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M\?N(&SJ ^RN-%:M](0/]%]?%?U!+ P04    " !+/%I2TO[ BC\'  #-%P
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MP7HY %5?'M</5;DT%[:3LJK*W P7@J="T03\/BO+JGD@ ^T-_M7O4$L#!!0
M   ( $L\6E*Q,8F#V04  *L1   9    >&PO=V]R:W-H965T<R]S:&5E=#4P
M+GAM;-U86V_;-A3^*X0W# F@VJ*N5IH$2-*L*]!B09TM#\,>:(FVN<BB2U)Q
M^N_WD9)E.W'MM%U?]F"+I'C.^<Z=U.E2JGL]X]R0QWE9Z;/>S)C%R6"@\QF?
M,]V7"U[AS42J.3.8JNE +Q1GA2.:EX/ ]Y/!G(FJ=W[JUF[4^:FL32DJ?J.(
MKN=SICY?\E(NSWJTMUKX**8S8Q<&YZ<+-N4C;OY8W"C,!AV70LQYI86LB.*3
ML]X%/;F,[7ZWX4_!EWIC3*PF8RGO[>1=<=;S+2!>\MQ8#@R/!W[%R](R HQ/
M+<]>)](2;HY7W']UND.7,=/\2I9WHC"SL]ZP1PH^875I/LKE;[S5QP',9:G=
M/UFV>_T>R6MMY+PE!H*YJ)HG>VSM\!*"H"4('.Y&D$/YAAEV?JKDDBB[&]SL
MP*GJJ %.5-8I(Z/P5H#.G%\S58EJJLE1*;4^)C=<D=&,*4Z.;MFXY/KX=& @
MQ^X>Y"W/RX9G\ 6>-" ?9&5FFEQ7!2^V&0P L$,9K%!>!GLYON%YGX34(X$?
M^'OXA9W6H>,7'M)ZK>Y?%V-M%(+D[SW\HXY_Y/A'7^ _0NX4=<F)G)"UA=]O
M6WB78?>SO61:Y(15!2E$61M>$/[$?0LPUTZ?B9)SDL,-HJJQ@R"-%;.)H(E]
MG;,RKTMF>=3:OC<ST,@226IG53VWVZ72C3A>202?6SAQ3L ?S>S?D#2HOHPD
ME_-%;9QL\J["C*_V[,-HC!)CD"$&B9&6R1STCN-,E@4',ACW2LE*:O)6R7I!
M?B9':>!%P_080^K1)/&&26:7 ]]+H^"8W+DDA<[L 9*FW.HY!E!PVA0 UK71
M!II;5&%,O3@%KVB(&/0]/TD]FF:$0EB09!C[!VT #'X_H!98V$^39DZ!Z,U!
M1WZ3^6H-GJ)R7MUD $7'AZ$>L.)%\0\*$RJS0<0H,D7I)ZY$/["R[N3 1>*!
MV9I+2L'&HA1&P+*__#0,:/ :W"(OHLEQM_!?Z+9*"['%:ZU;IQGTBC",P^^,
MC>^P\TO"RD6'M2"?3-#&+-LE4XI59FU(FD$EZH5QT"WM($,CR>]AQ<:$':WO
M)9&E3_?10FDD8VYMTT"O*[$!( T#+TOW2K\HP8"1NP9[M_/I<P?EK5R\0FJ[
MPT(KDKXF_)&K7%C;V^K4SERIF(A'K"X EZ^U](8PD.^O(;[8US:^OS+&MOR*
M(!M2ZF59\-RO>[/^2!QO%XTP7!<-^_)=U0*S8?BL'72,/(M3<9NLK'RBG)53
M26/33 ND:Q/*(!6RT':XG(E\1ABI<#BT (G0"(:%5)#E$:9=V(-_6>O6.&T>
M=$((_U2C"I3<1NQ2UF5!QAQ.,^)5T3J[3YZW-2?L22\KA&[K 3;\Z&[F .P5
MN[M OS](]XV-+8E]%Q!A$KKG,(M^>#O[&B,T\>KW?7_]0+3Z]/\6K7M.AW%W
M.HQ??#J\ /,5;S+B>:V:-GG]")PX/#?VO]HN0:OR,6HL\_O:N[O.E'O!V$O?
MB5ZPG)_U<*O37#WPWOGM5OKH-:PE;[W@[%@<;,0[XF_,<X:VZ:C:.K_;U 2U
M=[493B]$$W--2;;!.(6?RL]PLZY=-K7".HP:</1$V/PPC3@D?^OV)C LGC:"
M^D\+P5M1W4\EN49(F,_D@\!=R,@*_&GD)6GD97ZT.5RUEAO%7_'YPBG0=BTT
M@#C$:2>-"0W0AQ(<./R.8'>'V^QC-/4"*RF@)(@]ZH<XN"0'Z''#OD<>- Q
M0$,D.N1[01Q[01!VY$]:\Q %(4Z\($M(FGHQQ&;9>O/=ZO!!@2-"W:!K'( 6
MQ2E0AF2T==C(@'YH[03I(0A3G#9@A\S'+XO)Q]VGBS3S$DJ?'1%NI:T,VW&R
M$9\4Q2T,AUZ:H.'BPCA,J348P5*8X+ #O^Y*X,'&!1JM8NH^$VB$65V9YB[=
MK79?(BZ:"_AZ>_,9XP-34P&M2SX!J=]/D7ZJ^3303(Q<N.OX6!I<[MUPQAD*
MFMV ]Q,IS6IB!73?9\[_!5!+ P04    " !+/%I2RWR701@#  #Z!@  &0
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M5% [!_J^5,KN-HZ@_DV-?P-02P,$%     @ 2SQ:4J7Z8QYU P  / <  !D
M  !X;"]W;W)K<VAE971S+W-H965T-3<N>&ULE55M;]LV$/XK!RT8$L"UWFS'
M[6P#=KIV!=HB:+KNP[ /E'22B%*D2E)1O%_?(R4K2=<$V!>)+W?//?<<>=ST
M2G\U-:*%NT9(LPUJ:]M786CR&AMFYJI%23NET@VS--55:%J-K/!.C0B3*%J%
M#>,RV&W\VK7>;51G!9=XK<%T3</T\8!"]=L@#DX+GWA56[<0[C8MJ_ &[9_M
MM:99.*$4O$%IN)*@L=P&^_C58>'LO<$7CKUY, :72:;45S=Y5VR#R!%"@;EU
M"(Q^MWB%0C@@HO%MQ RFD,[QX?B$_L;G3KEDS."5$G_QPM;;8!U @27KA/VD
M^C]PS&?I\'(EC/]"/]@N5@'DG;&J&9V)0</E\&=WHPX/'-;1$P[)Z)!XWD,@
MS_(ULVRWT:H'[:P)S0U\JMZ;R''IBG)C->UR\K.[0V=HQ1BX4DW&)7-2&3C_
MS#*!YF(36HKA+,-\Q#L,>,D3>'$"'Y2TM8'?98'%8X"0R$T,DQ/#0_(LXFO,
MYY#&,TBB)'H&+YTR3CU>^K\R_GN?&:OIC/SS3(C%%&+A0RR>"'%#5Z?H!((J
MX0WC&KXPT?G91[IF>V/0&MCGWSJN?Y1H4.1Y^,\U0JD$W2<N*["N5..EXO^B
M 4O;E%O+Y/'77]9)?/F;@9(2%;1; "._W"?M^#C;MM-Y30<;6LUS!*N #0S9
MR!"8+$!PEG'!+:<(M-\U;MUZ &]GN,<LF,4YW&!KL<E0P]+5+7XYR'![DD&2
M##\&N6*FAC-(9NN7*Q(G5YVD;8TY\EN?XCF_@-7B$JXUMHP7@'?4F8RC0_04
M$=$GS&2UA'?R%J55^N@0HQ5Y42/3]NBMD6*VU%HLQ!0N M^+7JCR14<RC"#I
M;)FF!&.9K+B+/ZZ?<\]C%J67\%:IHN="0!*GLT6\N.?=LJ,G[:*Q/-<=/I;P
M/)FMUNL+>(].>94)7IWN'@6.H@LGQ3J=I5'D$_<U?Z3A?75^HA4W<$9:S>&C
M J'HL+NR]TQ2?7OF+54E_7GPG7&JWWQ([[]9<YF+KD!?[\<\,NURE*SQLS.G
M3!3-O*%&]RRX0YHQX8-K%'1 C#MD1I6V9QKG/[MPX8..UJ"N?-\VX!,=FMNT
M.CT-^Z$CWIL/[\H'IBM.N@HLR36:7RX#T$.O'B96M;X_9LI2M_7#FIXWU,Z
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MH;W+3U<1V':,6X-,%49G:X@',2P+?OG0>@<^SXVA@^$)NK=T]@=02P,$%
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M + K* LY=BR4!!( Q$M$Z$6*CDK -BZ?%2\!GB>>D.%0_&1M>I_E.>,Q63[
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MUZ@SH'IFZJY=3U"O?:=<:J2^ZX<%O73 . /:S[7&W<0%:-Y.X[]02P,$%
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MEX4=44$Y WN?26DV&Q>@'7KGOP%02P,$%     @ 2SQ:4OH=MUTE @  C 0
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MVT/=!"@_A?L\S>+]:?;XI$,DFCK,@84@HF^6<7<<M67?8?_<^SE]9*;FRH+
MRH4FD]OK"$S?^[U!N@W]MM/DNC<L&_=<H/$.[KS2FHZ&3S ^0/E?4$L#!!0
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MQ?/=(=3N1K)U=@;RQ*1D47:Y(C@@/ U0OR\9DV\WZ;%*<10X_A=02P,$%
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M W5_SIA\6>BOB,6'[,$/4$L#!!0    ( $L\6E)C-3"0-P@  -DK   9
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MRM16J!_;P[0'$RY@-8DSVT"1]N-G.VF6%I*EVOH"L7//\3V^)_;M;2E[XBL
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MIMCH=0Q'+T!^KW4X/@_Y\;&(A]X1^\=6./1/?$])+YED6C*7HE!:5LW!'4Z
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MUK,>[+'C<-@C#6<]K#(8MF8P VKYOU*S493KEH\8![61!"<6"-XQ*7QBB92
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MZ;6Z=-UDV9[*B19S6^$?A:9^88<I=724)H#>3X70ZXG9H/Z/,/P'4$L#!!0
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M>7,\U-P(MJM/6!Z9$*RH+[>4I)0K@'R_9DR\W*@"W2'=\C]02P,$%     @
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M ^3J46Y'UP3;_B\\V;B@"MSXI QF_^^[N;$: ?XY0S!N"<9G(YZMF 92:KX
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M_?7VLKN=6%76]\6YLGC[K(<K_$  [0QP?ZF4?9NX*VC[R3'Y'U!+ P04
M" !+/%I2\KLNS]<%  "Q'0  &0   'AL+W=O<FMS:&5E=',O<VAE970X-RYX
M;6RU65MOVS84_BN$T8<6R&*1U,V%8Z")8ZQ NP5UNST,>V L.B8JB2Y%V0VP
M'S]25DQ9%TINZY?$DL[]''[\1$WW7'S--I1*\#V)T^QFM)%R^W8\SE8;FI#L
MFF]IJIZLN4B(5)?B:9QM!251H93$8^0X_C@A+!W-IL6]!S&;\ES&+*4/ F1Y
MDA#Q?$MCOK\9P='+C4_L:2/UC?%LNB5/=$GEE^V#4%?CHY6()33-&$^!H.N;
MT3OX=N$&6J&0^(O1?5;Y#70JCYQ_U1?OHYN1HR.B,5U);8*H?SMZ1^-86U)Q
M?"N-CHX^M6+U]XOU19&\2N:19/2.QW^S2&YN1N$(1'1-\EA^XOO?:9F0I^VM
M>)P5?\'^(!O@$5CEF>1)J:PB2%AZ^$^^EX6H**"@0P&5"JBNX'0HX%(!UQ0P
M[%!P2P6WKA!V*'BE@C<T![]4\(O:'XI55'I.))E-!=\#H:65-?VC:%>AK0K,
M4CU92RG44Z;TY.R.;)DD,5A*OOH*?@-_$"&(;C9X/:>2L#A[ UX!EH+/&YYG
M)(VRZ5@JOUI[O"I]W!Y\H X?<[JZ!@A? >3 R9?E'+Q^]2;;$$';;-W9;7TD
MXAHXX<%6IY'Y@( PU$:04P:TXY)VVKL?;.^8($LS5==8+4+9:78QW&QHJ=M8
M]?S8>'1L/"J,XP[CR_PQ8Q%3:'(%EB2F@*_+(?CG@Q(%[R5-LG\MCO#1$2X<
MN5T3QI-$0<@A\"N0YLDC%=I;47&P51?%,_!?<:>MFP<'?N% 0^5N!J?C74M,
M[C$FUQK3L@@&L"S+:=36[X.Z5_&('3=$QNVA?TTQ"#T/.NW1><?HO/[HBN!(
MNJ)@Q3/9.N1>P[MS&M^]UR@<#A"J)=$4"KP@:$_!/Z;@6U-X%TO!"'B?[F@F
M]1JP#%)PM!E<=F+#HZ-P^'2 U^QE>-^H$>W&K; YI.XDQ&H@W/9:3H[A3'YN
M6"=-SZ$S\3R_W2]TS-[@_(I!O"_-=,[9J?O*U@2M[C\+DF;DP$"Z?<.&;^0A
MA#N<&WB$R.K\$XWVG$?@W>I;SC*F@[",%C1H"/%EIQ@:D(,]*%>8+<<XR@5+
MGS3<,AXI&%:<KWBB('E-F  [$N=MX'L/FR#G^="9=!38@!RTH]R#8#LB*7B(
MR8H6VZ0M:0,\T+]P?0T>P:!G9U,$.Z*:+ZD)E7I:UU0(JLJ[JFYZ0R'DOO17
MG>70\QW8 <;0 !JT(]K+'JSK< 4T)NM9$)IUGVS)]%NNN&"5NJAX*Y>M03>!
MKVOQ&<2#=L@;6MDK0!*>=\0U:<RM[S@=6S,RF(CLF'C+<U4U,*>J4'^N552J
MDE8^9N .P<M.+JIP/SNX]6TIBU+?'\ALD($_9&># [>416G&&\1*D(%$9(?$
M<B$L>UFT@3'D7;AK!MJ0G53]$"^9ET:KK:S3Q!81U>P@P*KD-;+8*NH' 70[
M%CTR<(KL<-K+<TK]&BMW89V5M\A9A]? *.HAAD5?!=WF8K4A67U7'=Z2)F0V
M6M(KLK"*G&9H@!?U 6]E?:@<SN'QV& H=B[\[FE %=LYY(^M&=PDE?4&M8@T
M^?ZA459KIWD9!,<_A^#WI7YU$2 WQ$X'*\>5UWD[@@]BY;@)W]AWNWP;^,9G
MP+?JX'DD'1M0QQ<&=6Q '5\"U'$_J+>(>$[H>Z%?'T^;K=.L#);C/FI\VJBS
MR#XV@(S#"_?)(",^XRU\:)]N<?/=O,;HRWXVY1K]'&9J835U>EIF -OM.0CX
M%6^2MZ63$T;>$9G!=[<'WP=&EE"2Y:(8/?5"L\W;7AEN>WQ!!T3DN17O?D3S
M-&.#_*X=^>M+Z]P7$M<@O7OAHPJW<AY[QH'L8!0LC=I63;_(HD7$3FE=LX^X
M]C...2UP3W].^<#((XN9?#Z35;EF)W$O?/+A&GAW[? ^B .X31J.H!?6C^['
ME8]7^F/F1R*>6)J!F*Z5GG,=* /B\'WP<"'YMOB>]<BEY$GQ<T-)1(464,_7
MG,N7"_V)[/B5=O8_4$L#!!0    ( $L\6E*V^1T-4@,  /$-   9    >&PO
M=V]R:W-H965T<R]S:&5E=#@X+GAM;+57WV_B.!#^5ZP\W4I[39S?K "IA457
MZ5:'BF[WX70/;C* 52>FMH&NM'_\VDF:0 EI*L$+V/%\GSWS32;CX9Z+)[D&
M4.@E8[D<66NE-E]L6R9KR(B\X1O(]<J2BXPH/14K6VX$D+0 9<QV'2>T,T)S
M:SPLGLW%>,BWBM$<Y@+);981\?,.&-^/+&R]/GB@J[4R#^SQ<$-6L #U[V8N
M],RN65*:02XISY& Y<BZQ5]F>&  A<5W"GMY,$;&E4?.G\SD/AU9CCD1,$B4
MH2#Z;P<38,PPZ7,\5Z16O:<!'HY?V6>%\]J91R)APMD/FJKUR(HME,*2;)EZ
MX/N_H'(H,'P)9[+X1?O2-M3&R58JGE5@?8*,YN4_>:D"<0# _AF 6P'<O@"O
M GA] 7X%\/L"@@H0] 6$%2 L8E\&JXCTE"@R'@J^1\)8:S8S*.0JT#K -#>9
MM5!"KU*-4^,)V5!%&%HHGCRA/]%"IVZZ98#X$DUXEFGQ%VLB0*)[*;>0HC^F
MH AE\I,VEL7*T%;Z((;.3JI-[\I-W3.;3B&Y0:[W&;D.'K3 )]WP;T3<("<^
M"Y_VV-W#!NXZ+?"OO>&MN\_ZP^-CN*VUJP5T:P'=@L\_PW?+E* $W><[D$J_
M\JJ#TZLYO8+3.Y<4C$AI,J#,BO_^UNOH7D$F_^]@]VMVO_/$53[1*I]H7N71
MI[9,**G"@LI4R=T8^X/8PSCPA_:NY11!?8J@\Q1'R=WA55CSA5>(652S1Q>+
MV30ZB9E3QZK,\%,+' 11Y$5!=&PY:[,,HPC[7GOXX]JAN'_XT2_TD30>U'L,
MKB )=IK2Z5Q.E(JK2Y46D]-DKVI,%]NQ.P=? OPA21X@W7.>HMOD>4LE-8U
M5]B:@H7=:\C2%"_L75 6[WU93DT")PZ#.'PK2A?7L3--K<3=Q?*M*'-!=T0!
MFC.2@'E/NFH7;HHA#JZA25,<<7@Q3>XJKL,XQD'HX#>U:=IB=Z)=/ZI9)]6Q
MSTW)QMTU^ZUT=WRKNUPT!=UN_;-<@J#YJE.]II;B^!KJ-744#R[X1@W>5^5=
MDUF+R9D/CWW0_)K+D.X.5S27B,%20YV;2&>^*.\7Y43Q3=$//W*EN^MBN-9W
M,A#&0*\O.5>O$]-BU[>\\6]02P,$%     @ 2SQ:4FY:B4($ P  30D  !D
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M.^VY##R25Q51*< =>*K3 + -D#L*%CM2;:D >06^[G6\!+A94DGR0MPJZ7?
M T(#B9DG%2D-[:T; @\U 31! "+PA55R)\"G*J/96P!/6=.:A$XF/2 KXI*N
M78#A>X!\Y(\06ERL#M,1]>7EZHG%&MP&"!L\/('WPV2NB@YYIER=1$!?*%_G
M@H(]S]<4W"S>W5JV"=IM K--,+'- RE(I>"(!"NZS:LJK[8Z^GO*<Y:!&Q7Y
MC!4%X4(OU=&^'8MVO4ULMM%%YWD>N$DP\Y[/(S 40FZ:MD)O+ A;"T*K!9^%
M.!@3%&MV2M*+:=?8Z1FCR$VC'NVA$/)=/QGG';6\(ROO3TT\KW%R-"3B^KC'
M=BB$W6"";-R2C:UD%]K#BJ%V[WN@VLZ&YO+ 5=Y4F<K,?5[7C.O]'P_(PL#%
M_;P92B$7Q>,F):U)R:693Y41?Y+SR8!6Z/:I#V6&YV*97'$NTM:^])+\(JN"
M7F%2.F""W3CLV3044G3Q.%WH=QW)MU:\?P[E2G'KTLA2WN!9GX/_M\#5+6S4
M'0UX]"8_89"&/NKY9$P2I3Y*TW#",:@S ?U1A;/Q1@,VZD:H__JTAX(PQ &,
MT 3KKG]!?$5]LW'% PIW"&*8XK1/=DPR06$\1;;K@M#>!L_KVS5N#D8(12B
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M2366F,N]&C4QUP;J_98Q^7JC%ZB&U\5_4$L#!!0    ( $L\6E*E#3^V.@(
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MRY(>)M0N@/8+I>S1< 7:IR[] U!+ P04    " !+/%I2.^B#>Z(#  #J#
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M5Y>C9(12MJ!EIC^(S>^L=FALY,U%IJJ_:%/3^B,T+Y46><T,%N2\V/ZG7^M
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MQ8X)G.@:*LH]IGM56&KW)T5/"4%4QX/>78'#6@^A\_82+WT<,S5NEL8@)#!
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M ;KV9DHI]AZF1)'10/ -$B9:LYF!O4R+UO(I,[[/E-"[5./4Z(HEO !T3UY
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MYY'.1Y3]MYPHOK(=:<Z5[F]VF.E_%A F0.\O.%?;B3F@_@L:_0=02P,$%
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M8PXE.%-6 -]74IK#B^V@+>IG/P%02P,$%     @ 2SQ:4JGI]_9>!   <Q$
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M.%="7V4Z3LWNZX)7@+[19Y!HC.9ZFBQW)2"^0G>P B%@:2ZBSU*"DHC62_3
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MK]S-X0;H$H01Z.LKSM7KB7GO[OYGF?T+4$L#!!0    ( $L\6E($:#3&TP(
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M>W&G#=2!.:Y0"$R-%YA(J7OS&EX6<[B\N((+R!D\9[R4A*5RZ"H=E)'F)G4
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M]&[Z6I2HAGFU47QCY^&2*SU=[3+3]Q\*8Z"_KSA7^XUQT-RHXW]02P,$%
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M=7488\KT0&8HZ,U>JI09FJJ#JS.%+"I :>(./6_BIHP+9SDOUC9J.9>Y2;C
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M/Y14I[2QBC(EH[PL.0]-EK:\*,5,"C&V?AZ7L[E[;-$_KO6/>_7;R)#A,F6
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M:&5E=',O<VAE970Q,3$N>&ULM5513]LP$/XKIX@'D+8F36FAJ*T$[:8Q :I
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MYL4"   J"   &@   'AL+W=O<FMS:&5E=',O<VAE970Q,30N>&ULM5;;3MM
M$/V5D44ED-KXDAM!2222%!4)JH@ ?:CZL+$G\8KUKME=$Y#X^.ZN'1-HDO(
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ML$E2!LP-&Y_BV%Y3Q^26C;^D9^/<M'&+KHVK=ES9D"9)F3$W:]R66^.J#U<
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MK3Y*4L68+#9&;MW@N)<&QY!;IOAE <HZX/.UE&:_L0&J;Y7);U!+ P04
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MF)#E#:E\T>)4-.@[H:'=+QZ/<*NDTDR [WLA]/7%]/SU/77Y+U!+ P04
M" !+/%I2*/" )^\#  !2#@  &@   'AL+W=O<FMS:&5E=',O<VAE970Q,C(N
M>&ULM5==C^(V%/TK%NK#KC1,XGSPL0*D 6;;D=K5:-!NGTUR 6N=F+4=F)'Z
MXWMM,@E3D@RMNB\0)S[WGGOB'%]/CE)]USL 0YXSD>MI;V?,_I/GZ60'&=.W
M<@\Y/ME(E3&#0[7U]%X!2QTH$U[@^P,O8SSOS2;NWJ.:361A!,_A41%=9!E3
M+W,0\CCMT=[KC2>^W1E[PYM-]FP+*S!?]X\*1UX5)>49Y)K+G"C83'MW]--]
MX !NQC<.1WUV36PI:RF_V\%#.NWYEA$(2(P-P?#O  L0PD9"'C_*H+TJIP6>
M7[]&_^R*QV+63,-"BC]Y:G;3WJA'4MBP0I@G>?P-RH)B&R^10KM?<BSG^CV2
M%-K(K 0C@XSGIW_V7 IQ!J!1"R H <&U@+ $A-<"HA(070N(2X KW3O5[H1;
M,L-F$R6/1-G9&,U>./4=&O7BN5TH*Z/P*4><F<T+C7>T)@N9K7G.[-O3I$]6
MN"+30@"1&_*9<46^,5&XT1=<O7=:@]'D+OE1< 4I^; $P[C0'Q'Y=;4D'W[Y
M./$,TK-)O*2D,C]1"5JHK&!_2_SXA@0^'3? %]WP)22W)*06'O@-\.75\,;L
M]]?#1V_A'KZ2ZKT$U7L)7+RP)9[3_/"J>8Z:LY/FK-2\(T=8Y0A=CJ@EQZ]2
MID<N1)/6)V3LD-9L#C,Z',<!^@]J>SB7]7)F0*-H?#GSOB%F2*/S>6_*B*HR
MHLXRGB ]8B4=@L15I/BGB3ZH<@PZV2Z8WC5]&X-+&4?C0:LXPRK=L#/=79+(
M(L<2%"3 #VPMH"G[*<C@+/L@&K8F'U7)1YW)'Q7L&4\)/..^I@%US%,BS0Y4
M*6P3E=$%E6 0MU(95U3&G50>\@/D1JJ7II3CRY0COUU[ZM?FZK\C .[HRKRX
MP@'7T![W6--HC?X%!SH:^^T<S@R>=G\>=JOLRTV_T- A>QGEG$ 8AV$[@=K)
M:/".](;E6XXKKRM]T+ "_;!]#=+:Y>A_MKEY"7WSZFD8=;@2K6V)=OM2]>GM
MV0MSU>,B8$FB"MPQ!6=K+KCAT"Q'=,&K'PQ&HW9:M<?1N)/6[X!]%9%KP;>G
MW;XQ?WR9/[1?86O^VO]HMP%^><]62P:#AH_2K<=6"K4GTO_%%.F_<T5:VR+M
M]L6JZ4KJINNF4N.,E;XAH W'?AAO%SDV>Z[!;N-[:9UM5&O;I-V^66ZNY"\R
M5W;]YBR#KO:FML; _VE[;5";7]!M?@\Y'AIXS@WT!1Y(4L+_:495OANRJ2@U
MJ5MFBM\Z5--Z],[:<7O:^H.I+<>N6L &H?[M$&.HTP'F-#!R[SKTM338[[O+
M'1[Z0-D)^'PCI7D=V*:_.D;._@902P,$%     @ 2SQ:4@E4>5.I @  TP8
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MU37J47Z$^HV1E1LJ&VEP1+EE@7\=4-8 OV^E-(>-==#^QR;_ %!+ P04
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MDZJS^>,2Z RX-E#?YXS)[4('J"[$!O\!4$L#!!0    ( $L\6E+41*XNCPH
M 'E'   :    >&PO=V]R:W-H965T<R]S:&5E=#$R-BYX;6S-G&UOVS@2Q[^*
M$.R+%FAJ\4$BM4@"--;>78#=VZ)I;U\K-A/K5I:RDO+0PW[XHV3'M,C14*[?
M& 4:V_F3F=&(\QN.9%V\5/6?S4JI-GA=%V5S>;9JV\>?9[-FL5+KK/E8/:I2
M_^:^JM=9J]_6#[/FL5;9LA^T+F8T#./9.LO+LZN+_K//]=5%]=06>:D^UT'S
MM%YG]?=K550OEV?D[.V#+_G#JNT^F%U=/&8/ZE:UWQX_U_K=;#?+,E^KLLFK
M,JC5_>79)_)S2L)^1"_Y3ZY>FKW70>?+757]V;VY65Z>A9U)JE"+MILCTS^>
MU5P513>5-N2O[:QGNS_:#=Q__3;[/WKOM3=W6:/F5?%'OFQ7EV?R+%BJ^^RI
M:+]4+_]26X^B;KY%533]_\'+5AN>!8NGIJW6V\':@G5>;GYFK]LCL3> Q",#
MZ'8 M0?PD0%L.X!-'<"W WA_9#:N],<AS=KLZJ*N7H*Z4^O9NA?]P>Q':_?S
ML@O\;5OKW^9Z7'MUJQYT&-O@IMR<1%TLSH-;?7XMGPH55/?!FZ*;/GB7JC;+
MB^:]%GV[38-W/[T/?@KR,OBZJIZ:K%PV%[-6F]5-/EML3;C>F$!'3" T^*TJ
MVU43_%(NU7(XP4S[LW.*OCEU3=$94[7X&##R(: A#0&#YI.'DP08GDX?+A%O
MV"Y$K)^/C<PWK\JF*O)EUJIET+3Z1Q>/IHM-J3-#7BZJM0K>%56CPZ)#$.CW
M.@FLNM7YK(:_1\SA.W-X;PX?,>??^F_6ZEF53PJ*]69PU _NLL[S%8]%=QB?
M]P/@JB@343A4I:Z*4/UOIQK8'^WLCU#[;U=9W9_8W0$)[NMJ':B_GO+VN\Y!
MB^JI[(YR7CZKIE4*/)LWT\=[5IWSB%BVSP&53L;6<4@!E: ,=C#>.1BC#MYH
M%VIM/A:EV/F[1,8AL7QP532AA%D^ "H:PBZ(G0MBF@OJ51.N 5T0[J'3/E@>
M0"+*N>4!I&()[(+<N2"GN?"V_K:NO/_0K5K((0G$A)/(\LA549'$]GGEJN3(
MLDEV_B2H/ZG2.661;PC199EL7=5M_K_^ \B=Q#54"FIY XC"Q$X#KDB& O:&
MA(9[H2<^?5C:[!4[R;:3#(+"N+"\ %2V#ZADZ,(>N@GJPJ^[!+;,FX5&:*Y7
M^S+016'=1P5F,7%/]MC.O'-(Q6)[Y4,JF? 1OZCQBZ)^?5K^5Q<^VI-?KF^^
MII] +RBP9+F@$;,= 82)9*&T78$F#%DT=IX9>),#Z'V7%5FY4$%?KS4(C(FA
M,<%Q_+5JLR+(FL:9<'NDN'L&)S2*I;T4 6&W%CFG]J$"9I1Z48PD&&+ 3' R
MW_34W10WNJ0\C,K$1:GVD]GI$Y!%D; ]=$4TB<?6J^$RP<'\SZI:ON1% 9H/
M$%DD$76B!-"6<)XX00+F8V1L:1HN$QS,GY_JQ4IOL[KZZ;'N,DW[_4/PJ,_J
MMH="%[/'+H*@CRYGM4G$<1&0R3BVH0W(Y&!A#UTTW"8XN'_?I,_RX6WGTP1_
M!]_*O#L#;[OJ&UVW!J<D.86JGAH@4AR(GKJ>N@!+>&(O+T#%F!,Z0#6RN*B!
M(<5A>'193UV8V53T2U)4,G3-\)#B/)Q2T%.77\0NA@%-;)OO2L;,-P2D[.AB
M?CO%L-[@MOVNR#G\F&1HOR$LQ0E[>"5/74*>$VE[XXJ<:+B2,6\,9"D.V8/K
M> K T V-*^*.-ZYFS!N#5.K;ZTZIXJD+0T;M2A$0.6<7)AEZ8(A*<:+^4!%/
M7?8YN<HK25')T!U#3XK3<T+M3MW-Z3F5H=,C@G1$A/8F!)"->6'@3 ^ \^2B
MG1G6,IRUOJ*=N8#46QO!;=Q"NH0ETM*E@&[D&#$#7(8#]ZAJG?EAZY>DJ&3H
MEH$MPV&+%>D,@*R0G-C9$-!1PAQ="NC&[-]K%N.T/:I"9RX^F7TRS0$1C>P&
M%" :<\V F.$@!BOS+QV9M:]_5'6!73M@AI L.H7*G!G(,1QRGLJ< 703E#HG
M);!S#)G=,4T!&=)T9X9S#.?<T?4Y [JT0-\=D@&-=T@VVGEG!G]L8M<7BQ?4
MZ(W<909T>A,:VKT*2#;6?F<&@ SO]DZIV9G;ESTGD;V;!U5N"QZ4C?7@N0$M
M]W5Y#ZW=.=#QE9S9U2(@Z_KP=G$"R,8:\=R0E^/D/;B$YRXG:<SL#0FD"IU
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M>=F\::O'_L$G=U7;5NO^Y4IE2U5W OW[^ZIJW]YT?V#WM)VK_P-02P,$%
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M/ 8A70I6?=B <7L)H\!",M/2&ZU$;.]P-JQ$(TT"\R6F_Y2)68UA88WY#I_
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M(JPDSS8+8O#4:Q:$=..VFB+"FO)<?R"&_5D0T@U[[SG6$4]\O(@M$*'SL);
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M_'I^@E-44;7N@B'L[2\X(16[ZF;=F8UPLWK[LUF>OVH*]F_JZ#=02P,$%
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M'^@&?<OO(E!H)NH#"+J6Q^X#A6:B/I6@&[3[TD,S49]5 $'C@ ^/+TC(SR^
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M[F8W0.^L>F> WEGUS@"]L^J= 7IGU3L#],ZJ=P;H753O M"[J-X%H'=1O0M
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M+GAM;%!+ 0(4 Q0    ( $L\6E)ZK6^,[@   "L"   1              "
M :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( $L\6E*97)PC$ 8
M )PG   3              "  <P!  !X;"]T:&5M92]T:&5M93$N>&UL4$L!
M A0#%     @ 2SQ:4B"G:!J&!@  OAD  !@              ("!#0@  'AL
M+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( $L\6E(1-7[(^0<
M  8A   8              " @<D.  !X;"]W;W)K<VAE971S+W-H965T,BYX
M;6Q02P$"% ,4    " !+/%I2)-^RS50"   ^!0  &               @('X
M%@  >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%     @ 2SQ:4L33
M>C5T"@  <S$  !@              ("!@AD  'AL+W=O<FMS:&5E=',O<VAE
M970T+GAM;%!+ 0(4 Q0    ( $L\6E+O)QIP6@@  %0I   8
M  " @2PD  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q02P$"% ,4    " !+
M/%I2O>7!A%P*  !",0  &               @(&\+   >&PO=V]R:W-H965T
M<R]S:&5E=#8N>&UL4$L! A0#%     @ 2SQ:4JE;MN7Z!   <PH  !@
M         ("!3C<  'AL+W=O<FMS:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0
M   ( $L\6E*<M^4N.B@  $N&   8              " @7X\  !X;"]W;W)K
M<VAE971S+W-H965T."YX;6Q02P$"% ,4    " !+/%I2I0OOPY '  !6%0
M&               @('N9   >&PO=V]R:W-H965T<R]S:&5E=#DN>&UL4$L!
M A0#%     @ 2SQ:4B!,.4@U P  - <  !D              ("!M&P  'AL
M+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"% ,4    " !+/%I2R5OQ=XT#
M  "W!P  &0              @($@<   >&PO=V]R:W-H965T<R]S:&5E=#$Q
M+GAM;%!+ 0(4 Q0    ( $L\6E+#5=\<2@X  *XI   9              "
M@>1S  !X;"]W;W)K<VAE971S+W-H965T,3(N>&UL4$L! A0#%     @ 2SQ:
M4M>71S9@!0  >0\  !D              ("!98(  'AL+W=O<FMS:&5E=',O
M<VAE970Q,RYX;6Q02P$"% ,4    " !+/%I2>12.S!0(  "\%@  &0
M        @('\AP  >&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4 Q0
M   ( $L\6E+-?]+EXP,  &P(   9              " @4>0  !X;"]W;W)K
M<VAE971S+W-H965T,34N>&UL4$L! A0#%     @ 2SQ:4B,"6H&! P  \@<
M !D              ("!890  'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q0
M2P$"% ,4    " !+/%I2K 'M]#('  "O$@  &0              @($9F
M>&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    ( $L\6E(!H<E.
MX@,  *P(   9              " @8*?  !X;"]W;W)K<VAE971S+W-H965T
M,3@N>&UL4$L! A0#%     @ 2SQ:4LQ92T.? P  "P@  !D
M ("!FZ,  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"% ,4    " !+
M/%I2D'6 50P0  ";,@  &0              @(%QIP  >&PO=V]R:W-H965T
M<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    ( $L\6E*P7[=1.08  #8/   9
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M970R-2YX;6Q02P$"% ,4    " !+/%I2:O M<R )  !Z%@  &0
M    @($2X0  >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4 Q0    (
M $L\6E+O90MN'@H   8<   9              " @6GJ  !X;"]W;W)K<VAE
M971S+W-H965T,C<N>&UL4$L! A0#%     @ 2SQ:4A^7?;'K @  .@8  !D
M             ("!OO0  'AL+W=O<FMS:&5E=',O<VAE970R."YX;6Q02P$"
M% ,4    " !+/%I2)?%Q/=T+  #;(@  &0              @('@]P  >&PO
M=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    ( $L\6E(MNUW-* 0
M %(*   9              " @?0# 0!X;"]W;W)K<VAE971S+W-H965T,S N
M>&UL4$L! A0#%     @ 2SQ:4J-^3MB" P  ;P@  !D              ("!
M4P@! 'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q02P$"% ,4    " !+/%I2
MBZ1<,'P#  ##"0  &0              @($,# $ >&PO=V]R:W-H965T<R]S
M:&5E=#,R+GAM;%!+ 0(4 Q0    ( $L\6E*1JN^YFPD  "D7   9
M      " @;\/ 0!X;"]W;W)K<VAE971S+W-H965T,S,N>&UL4$L! A0#%
M  @ 2SQ:4GI&4<!!!   W D  !D              ("!D1D! 'AL+W=O<FMS
M:&5E=',O<VAE970S-"YX;6Q02P$"% ,4    " !+/%I2VTY2\F ,  !@*
M&0              @($)'@$ >&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+
M 0(4 Q0    ( $L\6E)UE?( R@4  *4/   9              " @: J 0!X
M;"]W;W)K<VAE971S+W-H965T,S8N>&UL4$L! A0#%     @ 2SQ:4HX2E6\A
M+P  MZ<  !D              ("!H3 ! 'AL+W=O<FMS:&5E=',O<VAE970S
M-RYX;6Q02P$"% ,4    " !+/%I28:;2 _8&  !.$@  &0
M@('Y7P$ >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4 Q0    ( $L\
M6E+(O_8HO0(  -0%   9              " @29G 0!X;"]W;W)K<VAE971S
M+W-H965T,SDN>&UL4$L! A0#%     @ 2SQ:4@R%6D'*"0  .!H  !D
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M=#0T+GAM;%!+ 0(4 Q0    ( $L\6E+1]@:<;0(  & %   9
M  " @0N+ 0!X;"]W;W)K<VAE971S+W-H965T-#4N>&UL4$L! A0#%     @
M2SQ:4LM'!F*O P  _ <  !D              ("!KXT! 'AL+W=O<FMS:&5E
M=',O<VAE970T-BYX;6Q02P$"% ,4    " !+/%I2^%.M:4D'  !0%   &0
M            @(&5D0$ >&PO=V]R:W-H965T<R]S:&5E=#0W+GAM;%!+ 0(4
M Q0    ( $L\6E(S8\3XGP4  'T-   9              " @169 0!X;"]W
M;W)K<VAE971S+W-H965T-#@N>&UL4$L! A0#%     @ 2SQ:4M+^P(H_!P
MS1<  !D              ("!ZYX! 'AL+W=O<FMS:&5E=',O<VAE970T.2YX
M;6Q02P$"% ,4    " !+/%I2L3&)@]D%  "K$0  &0              @(%A
MI@$ >&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;%!+ 0(4 Q0    ( $L\6E++
M?)=!& ,  /H&   9              " @7&L 0!X;"]W;W)K<VAE971S+W-H
M965T-3$N>&UL4$L! A0#%     @ 2SQ:4MR*FP3;!@  CQ(  !D
M     ("!P*\! 'AL+W=O<FMS:&5E=',O<VAE970U,BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( $L\6E*E^F,>=0,  #P'   9              "
M@7G# 0!X;"]W;W)K<VAE971S+W-H965T-3<N>&UL4$L! A0#%     @ 2SQ:
M4D.^HRR& @  5P4  !D              ("!)<<! 'AL+W=O<FMS:&5E=',O
M<VAE970U."YX;6Q02P$"% ,4    " !+/%I2A5_2>OT(  "='@  &0
M        @('BR0$ >&PO=V]R:W-H965T<R]S:&5E=#4Y+GAM;%!+ 0(4 Q0
M   ( $L\6E(G^8.M; 0  %\+   9              " @1;3 0!X;"]W;W)K
M<VAE971S+W-H965T-C N>&UL4$L! A0#%     @ 2SQ:4DN7AL&J @  $ <
M !D              ("!N=<! 'AL+W=O<FMS:&5E=',O<VAE970V,2YX;6Q0
M2P$"% ,4    " !+/%I2]-M:M\$"  !'"0  &0              @(&:V@$
M>&PO=V]R:W-H965T<R]S:&5E=#8R+GAM;%!+ 0(4 Q0    ( $L\6E(V'LMD
MI0(  %4'   9              " @9+= 0!X;"]W;W)K<VAE971S+W-H965T
M-C,N>&UL4$L! A0#%     @ 2SQ:4NJ^#0S5 @    L  !D
M ("!;N ! 'AL+W=O<FMS:&5E=',O<VAE970V-"YX;6Q02P$"% ,4    " !+
M/%I2^AVW724"  ",!   &0              @(%ZXP$ >&PO=V]R:W-H965T
M<R]S:&5E=#8U+GAM;%!+ 0(4 Q0    ( $L\6E(0<[9KN@(   ('   9
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M970W,"YX;6Q02P$"% ,4    " !+/%I2)*/"VQX$   6%   &0
M    @($D 0( >&PO=V]R:W-H965T<R]S:&5E=#<Q+GAM;%!+ 0(4 Q0    (
M $L\6E+!_(T@RP0  -06   9              " @7D% @!X;"]W;W)K<VAE
M971S+W-H965T-S(N>&UL4$L! A0#%     @ 2SQ:4F,U,) W"   V2L  !D
M             ("!>PH" 'AL+W=O<FMS:&5E=',O<VAE970W,RYX;6Q02P$"
M% ,4    " !+/%I2TU)^SU8#   &#   &0              @('I$@( >&PO
M=V]R:W-H965T<R]S:&5E=#<T+GAM;%!+ 0(4 Q0    ( $L\6E*]\H@+E0,
M %(.   9              " @786 @!X;"]W;W)K<VAE971S+W-H965T-S4N
M>&UL4$L! A0#%     @ 2SQ:4D8* "&Y @  @@<  !D              ("!
M0AH" 'AL+W=O<FMS:&5E=',O<VAE970W-BYX;6Q02P$"% ,4    " !+/%I2
M!R8ZU+8#   A#0  &0              @($R'0( >&PO=V]R:W-H965T<R]S
M:&5E=#<W+GAM;%!+ 0(4 Q0    ( $L\6E(EO9BF"08  #(B   9
M      " @1\A @!X;"]W;W)K<VAE971S+W-H965T-S@N>&UL4$L! A0#%
M  @ 2SQ:4A2,6?)> P  OPP  !D              ("!7R<" 'AL+W=O<FMS
M:&5E=',O<VAE970W.2YX;6Q02P$"% ,4    " !+/%I2?5FA<5H"  #T!P
M&0              @('T*@( >&PO=V]R:W-H965T<R]S:&5E=#@P+GAM;%!+
M 0(4 Q0    ( $L\6E*U9]$_SP(  "\(   9              " @84M @!X
M;"]W;W)K<VAE971S+W-H965T.#$N>&UL4$L! A0#%     @ 2SQ:4MR#LL*2
M P  VPH  !D              ("!BS " 'AL+W=O<FMS:&5E=',O<VAE970X
M,BYX;6Q02P$"% ,4    " !+/%I2SG\M",P$  #G%   &0
M@(%4- ( >&PO=V]R:W-H965T<R]S:&5E=#@S+GAM;%!+ 0(4 Q0    ( $L\
M6E+H=@/.@@0  + 3   9              " @5<Y @!X;"]W;W)K<VAE971S
M+W-H965T.#0N>&UL4$L! A0#%     @ 2SQ:4LM7]PE7!@  %BP  !D
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M=#@Y+GAM;%!+ 0(4 Q0    ( $L\6E(+^>-2P0(  %L(   9
M  " @195 @!X;"]W;W)K<VAE971S+W-H965T.3 N>&UL4$L! A0#%     @
M2SQ:4NGI29Y'!   HA0  !D              ("!#E@" 'AL+W=O<FMS:&5E
M=',O<VAE970Y,2YX;6Q02P$"% ,4    " !+/%I2@1$S#>X"  #)"@  &0
M            @(&,7 ( >&PO=V]R:W-H965T<R]S:&5E=#DR+GAM;%!+ 0(4
M Q0    ( $L\6E+ZG-&Q500  -80   9              " @;%? @!X;"]W
M;W)K<VAE971S+W-H965T.3,N>&UL4$L! A0#%     @ 2SQ:4B0+?_WS P
M"A   !D              ("!/60" 'AL+W=O<FMS:&5E=',O<VAE970Y-"YX
M;6Q02P$"% ,4    " !+/%I2\)>5/!X#   1"@  &0              @(%G
M: ( >&PO=V]R:W-H965T<R]S:&5E=#DU+GAM;%!+ 0(4 Q0    ( $L\6E*K
MNC-FT0,  ,@.   9              " @;QK @!X;"]W;W)K<VAE971S+W-H
M965T.38N>&UL4$L! A0#%     @ 2SQ:4J4-/[8Z @  ]@0  !D
M     ("!Q&\" 'AL+W=O<FMS:&5E=',O<VAE970Y-RYX;6Q02P$"% ,4
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M,#$N>&UL4$L! A0#%     @ 2SQ:4@N\D<WC @  $0D  !H
M ("!-(8" 'AL+W=O<FMS:&5E=',O<VAE970Q,#(N>&UL4$L! A0#%     @
M2SQ:4BK65AVS P  8 T  !H              ("!3XD" 'AL+W=O<FMS:&5E
M=',O<VAE970Q,#,N>&UL4$L! A0#%     @ 2SQ:4C4XLH+P @  )0L  !H
M             ("!.HT" 'AL+W=O<FMS:&5E=',O<VAE970Q,#0N>&UL4$L!
M A0#%     @ 2SQ:4G !UV9J!   X \  !H              ("!8I " 'AL
M+W=O<FMS:&5E=',O<VAE970Q,#4N>&UL4$L! A0#%     @ 2SQ:4JGI]_9>
M!   <Q$  !H              ("!!)4" 'AL+W=O<FMS:&5E=',O<VAE970Q
M,#8N>&UL4$L! A0#%     @ 2SQ:4@1H-,;3 @  70<  !H
M ("!FID" 'AL+W=O<FMS:&5E=',O<VAE970Q,#<N>&UL4$L! A0#%     @
M2SQ:4J9""[AO @  /P8  !H              ("!I9P" 'AL+W=O<FMS:&5E
M=',O<VAE970Q,#@N>&UL4$L! A0#%     @ 2SQ:4G/=,<.^ P  W@L  !H
M             ("!3)\" 'AL+W=O<FMS:&5E=',O<VAE970Q,#DN>&UL4$L!
M A0#%     @ 2SQ:4NHSHVI,!   G!,  !H              ("!0J," 'AL
M+W=O<FMS:&5E=',O<VAE970Q,3 N>&UL4$L! A0#%     @ 2SQ:4M=F-*Z_
M @  1 <  !H              ("!QJ<" 'AL+W=O<FMS:&5E=',O<VAE970Q
M,3$N>&UL4$L! A0#%     @ 2SQ:4O)%JB0] P  O@D  !H
M ("!O:H" 'AL+W=O<FMS:&5E=',O<VAE970Q,3(N>&UL4$L! A0#%     @
M2SQ:4OBHN=%7!   0 \  !H              ("!,JX" 'AL+W=O<FMS:&5E
M=',O<VAE970Q,3,N>&UL4$L! A0#%     @ 2SQ:4IDB_N;% @  *@@  !H
M             ("!P;(" 'AL+W=O<FMS:&5E=',O<VAE970Q,30N>&UL4$L!
M A0#%     @ 2SQ:4IJS[L"N @  # <  !H              ("!OK4" 'AL
M+W=O<FMS:&5E=',O<VAE970Q,34N>&UL4$L! A0#%     @ 2SQ:4JSN=R.N
M @  G08  !H              ("!I+@" 'AL+W=O<FMS:&5E=',O<VAE970Q
M,38N>&UL4$L! A0#%     @ 2SQ:4E[@">Y3 P  I0X  !H
M ("!BKL" 'AL+W=O<FMS:&5E=',O<VAE970Q,3<N>&UL4$L! A0#%     @
M2SQ:4DN9Q"=  P    L  !H              ("!%;\" 'AL+W=O<FMS:&5E
M=',O<VAE970Q,3@N>&UL4$L! A0#%     @ 2SQ:4@+,2#?4 @  MP@  !H
M             ("!C<(" 'AL+W=O<FMS:&5E=',O<VAE970Q,3DN>&UL4$L!
M A0#%     @ 2SQ:4DS+,*FL @  5@@  !H              ("!F<4" 'AL
M+W=O<FMS:&5E=',O<VAE970Q,C N>&UL4$L! A0#%     @ 2SQ:4I2J-\H9
M!   LPX  !H              ("!?<@" 'AL+W=O<FMS:&5E=',O<VAE970Q
M,C$N>&UL4$L! A0#%     @ 2SQ:4BCP@"?O P  4@X  !H
M ("!SLP" 'AL+W=O<FMS:&5E=',O<VAE970Q,C(N>&UL4$L! A0#%     @
M2SQ:4@E4>5.I @  TP8  !H              ("!]= " 'AL+W=O<FMS:&5E
M=',O<VAE970Q,C,N>&UL4$L! A0#%     @ 2SQ:4G,;F5R] @  40@  !H
M             ("!UM," 'AL+W=O<FMS:&5E=',O<VAE970Q,C0N>&UL4$L!
M A0#%     @ 2SQ:4GPR\(0H!   '!,  !H              ("!R]8" 'AL
M+W=O<FMS:&5E=',O<VAE970Q,C4N>&UL4$L! A0#%     @ 2SQ:4M1$KBZ/
M"@  >4<  !H              ("!*]L" 'AL+W=O<FMS:&5E=',O<VAE970Q
M,C8N>&UL4$L! A0#%     @ 2SQ:4@5]=Y_J"0  W#D  !H
M ("!\N4" 'AL+W=O<FMS:&5E=',O<VAE970Q,C<N>&UL4$L! A0#%     @
M2SQ:4A9"%O(1 P  4PH  !H              ("!%/ " 'AL+W=O<FMS:&5E
M=',O<VAE970Q,C@N>&UL4$L! A0#%     @ 2SQ:4M.-NSG+ @  )0D  !H
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M+G)E;'-02P$"% ,4    " !+/%I2@K2FF< (  #15   #P
M@ '1_P( >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ 2SQ:4H\_#JN) P
M/4P  !H              ( !O@@# 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR
M96QS4$L! A0#%     @ 2SQ:4H,N+ VX @  [T@  !,              ( !
M?PP# %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&     (H B@ <)@  : \#

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>156
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>157
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>158
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>529</ContextCount>
  <ElementCount>602</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>155</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>23</UnitCount>
  <MyReports>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000010001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>100010002 - Statement - Consolidated Balance Sheet</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/ConsolidatedBalanceSheet</Role>
      <ShortName>Consolidated Balance Sheet</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>100020003 - Statement - Consolidated Balance Sheet (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/ConsolidatedBalanceSheetParenthetical</Role>
      <ShortName>Consolidated Balance Sheet (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>100030004 - Statement - Consolidated Statements of Net Income (Loss) and Comprehensive Income (Loss)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss</Role>
      <ShortName>Consolidated Statements of Net Income (Loss) and Comprehensive Income (Loss)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>100040005 - Statement - Consolidated Statements of Stockholders' Equity (Deficit)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/ConsolidatedStatementsofStockholdersEquityDeficit</Role>
      <ShortName>Consolidated Statements of Stockholders' Equity (Deficit)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>100050006 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>210011001 - Disclosure - Background</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/Background</Role>
      <ShortName>Background</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>210031002 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>210101003 - Disclosure - New Accounting Pronouncements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/NewAccountingPronouncements</Role>
      <ShortName>New Accounting Pronouncements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>210111004 - Disclosure - Revenues from Contracts with Customers</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/RevenuesfromContractswithCustomers</Role>
      <ShortName>Revenues from Contracts with Customers</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>210131005 - Disclosure - Inventory</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/Inventory</Role>
      <ShortName>Inventory</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>210161006 - Disclosure - Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/Investments</Role>
      <ShortName>Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>210221007 - Disclosure - Other Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/OtherInvestments</Role>
      <ShortName>Other Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>210251008 - Disclosure - Loan Receivable</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/LoanReceivable</Role>
      <ShortName>Loan Receivable</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>210281009 - Disclosure - Loans Payable</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/LoansPayable</Role>
      <ShortName>Loans Payable</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>210301010 - Disclosure - Property, Plant and Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/PropertyPlantandEquipment</Role>
      <ShortName>Property, Plant and Equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>210341011 - Disclosure - Intangible Assets and Goodwill</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/IntangibleAssetsandGoodwill</Role>
      <ShortName>Intangible Assets and Goodwill</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>210391012 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>210431013 - Disclosure - General and Administrative Expenses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/GeneralandAdministrativeExpenses</Role>
      <ShortName>General and Administrative Expenses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>210461014 - Disclosure - Derivative Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/DerivativeLiabilities</Role>
      <ShortName>Derivative Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>210521015 - Disclosure - Capital Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/CapitalStock</Role>
      <ShortName>Capital Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>210561016 - Disclosure - Share-based Payments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/SharebasedPayments</Role>
      <ShortName>Share-based Payments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>210681017 - Disclosure - Earnings (loss) Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/EarningslossPerShare</Role>
      <ShortName>Earnings (loss) Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>210721018 - Disclosure - Accumulated Other Comprehensive Income (Loss)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLoss</Role>
      <ShortName>Accumulated Other Comprehensive Income (Loss)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>210751019 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>210831020 - Disclosure - Commitments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/Commitments</Role>
      <ShortName>Commitments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>210881021 - Disclosure - Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/Contingencies</Role>
      <ShortName>Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>210901022 - Disclosure - Supplementary Cash Flow Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/SupplementaryCashFlowInformation</Role>
      <ShortName>Supplementary Cash Flow Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>210931023 - Disclosure - Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/FinancialInstruments</Role>
      <ShortName>Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>210981024 - Disclosure - Fair Value Measurement</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/FairValueMeasurement</Role>
      <ShortName>Fair Value Measurement</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>211011025 - Disclosure - Related Party Transactions and Balances</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/RelatedPartyTransactionsandBalances</Role>
      <ShortName>Related Party Transactions and Balances</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>211051026 - Disclosure - Non-monetary Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/NonmonetaryTransactions</Role>
      <ShortName>Non-monetary Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>211071027 - Disclosure - Business Combinations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/BusinessCombinations</Role>
      <ShortName>Business Combinations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>211111028 - Disclosure - Repurposing Charges</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/RepurposingCharges</Role>
      <ShortName>Repurposing Charges</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>211151029 - Disclosure - Segment Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/SegmentInformation</Role>
      <ShortName>Segment Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>211221030 - Disclosure - Discontinued Operations and Held-for-sale Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/DiscontinuedOperationsandHeldforsaleAssets</Role>
      <ShortName>Discontinued Operations and Held-for-sale Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>220042001 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>230053001 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>230143002 - Disclosure - Inventory (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/InventoryTables</Role>
      <ShortName>Inventory (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/Inventory</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>230173003 - Disclosure - Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/InvestmentsTables</Role>
      <ShortName>Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/Investments</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>230233004 - Disclosure - Other Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/OtherInvestmentsTables</Role>
      <ShortName>Other Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/OtherInvestments</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>230263005 - Disclosure - Loan Receivable (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/LoanReceivableTables</Role>
      <ShortName>Loan Receivable (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/LoanReceivable</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>230313006 - Disclosure - Property, Plant and Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/PropertyPlantandEquipmentTables</Role>
      <ShortName>Property, Plant and Equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/PropertyPlantandEquipment</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>230353007 - Disclosure - Intangible Assets and Goodwill (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/IntangibleAssetsandGoodwillTables</Role>
      <ShortName>Intangible Assets and Goodwill (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/IntangibleAssetsandGoodwill</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>230403008 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/Leases</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>230443009 - Disclosure - General and Administrative Expenses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/GeneralandAdministrativeExpensesTables</Role>
      <ShortName>General and Administrative Expenses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/GeneralandAdministrativeExpenses</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>230473010 - Disclosure - Derivative Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/DerivativeLiabilitiesTables</Role>
      <ShortName>Derivative Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/DerivativeLiabilities</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>230533011 - Disclosure - Capital Stock (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/CapitalStockTables</Role>
      <ShortName>Capital Stock (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/CapitalStock</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>230573012 - Disclosure - Share-based Payments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/SharebasedPaymentsTables</Role>
      <ShortName>Share-based Payments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/SharebasedPayments</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>230693013 - Disclosure - Earnings (loss) Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/EarningslossPerShareTables</Role>
      <ShortName>Earnings (loss) Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/EarningslossPerShare</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>230733014 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLossTables</Role>
      <ShortName>Accumulated Other Comprehensive Income (Loss) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLoss</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>230763015 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/IncomeTaxes</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>230843016 - Disclosure - Commitments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/CommitmentsTables</Role>
      <ShortName>Commitments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/Commitments</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>230913017 - Disclosure - Supplementary Cash Flow Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/SupplementaryCashFlowInformationTables</Role>
      <ShortName>Supplementary Cash Flow Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/SupplementaryCashFlowInformation</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>230993018 - Disclosure - Fair Value Measures and Disclosures (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/FairValueMeasuresandDisclosuresTables</Role>
      <ShortName>Fair Value Measures and Disclosures (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>231023019 - Disclosure - Related Party Disclosures (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/RelatedPartyDisclosuresTables</Role>
      <ShortName>Related Party Disclosures (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>231083020 - Disclosure - Business Combinations (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/BusinessCombinationsTables</Role>
      <ShortName>Business Combinations (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/BusinessCombinations</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>231123021 - Disclosure - Repurposing Charges (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/RepurposingChargesTables</Role>
      <ShortName>Repurposing Charges (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/RepurposingCharges</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>231163022 - Disclosure - Segment Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/SegmentInformationTables</Role>
      <ShortName>Segment Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/SegmentInformation</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>231233023 - Disclosure - Discontinued Operations and Held-for-sale Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/DiscontinuedOperationsandHeldforsaleAssetsTables</Role>
      <ShortName>Discontinued Operations and Held-for-sale Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/DiscontinuedOperationsandHeldforsaleAssets</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>240024001 - Disclosure - Background (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/BackgroundDetails</Role>
      <ShortName>Background (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/Background</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>240064002 - Disclosure - Summary of Significant Accounting Policies - Schedule of Consolidated Entities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesScheduleofConsolidatedEntitiesDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Consolidated Entities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>240074003 - Disclosure - Summary of Significant Accounting Policies - Schedule of Intangible Assets Amortization Methods and Rates (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsAmortizationMethodsandRatesDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Intangible Assets Amortization Methods and Rates (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>240084004 - Disclosure - Summary of Significant Accounting Policies - Schedule of Property, Plant &amp; Equipment, Useful Lives (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantEquipmentUsefulLivesDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Property, Plant &amp; Equipment, Useful Lives (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>240094005 - Disclosure - Summary of Significant Accounting Policies - Impairment of Long-lived Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesImpairmentofLonglivedAssetsDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Impairment of Long-lived Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>240124006 - Disclosure - Revenues from Contracts with Customers - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/RevenuesfromContractswithCustomersNarrativeDetails</Role>
      <ShortName>Revenues from Contracts with Customers - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>240154007 - Disclosure - Inventory (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/InventoryDetails</Role>
      <ShortName>Inventory (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/InventoryTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>240184008 - Disclosure - Investments - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/InvestmentsNarrativeDetails</Role>
      <ShortName>Investments - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>240194009 - Disclosure - Investments - Schedule of Equity Method Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/InvestmentsScheduleofEquityMethodInvestmentsDetails</Role>
      <ShortName>Investments - Schedule of Equity Method Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>240204010 - Disclosure - Investments - Schedule of Advances to Joint Ventures (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/InvestmentsScheduleofAdvancestoJointVenturesDetails</Role>
      <ShortName>Investments - Schedule of Advances to Joint Ventures (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>240214011 - Disclosure - Investments - Schedule of Variable Interest Entities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/InvestmentsScheduleofVariableInterestEntitiesDetails</Role>
      <ShortName>Investments - Schedule of Variable Interest Entities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>240244012 - Disclosure - Other Investments - Summary of Other Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/OtherInvestmentsSummaryofOtherInvestmentsDetails</Role>
      <ShortName>Other Investments - Summary of Other Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>240274013 - Disclosure - Loan Receivable - Schedule of Loan Receivable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails</Role>
      <ShortName>Loan Receivable - Schedule of Loan Receivable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>240294014 - Disclosure - Loans Payable - Long-term Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/LoansPayableLongtermNarrativeDetails</Role>
      <ShortName>Loans Payable - Long-term Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>240324015 - Disclosure - Property, Plant and Equipment - Schedule of Property, Plant &amp; Equipment, Useful Lives (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantEquipmentUsefulLivesDetails</Role>
      <ShortName>Property, Plant and Equipment - Schedule of Property, Plant &amp; Equipment, Useful Lives (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>240334016 - Disclosure - Property, Plant, and Equipment - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/PropertyPlantandEquipmentNarrativeDetails</Role>
      <ShortName>Property, Plant, and Equipment - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>240364017 - Disclosure - Intangible Assets and Goodwill - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/IntangibleAssetsandGoodwillNarrativeDetails</Role>
      <ShortName>Intangible Assets and Goodwill - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>240374018 - Disclosure - Intangible Assets and Goodwill - Schedule of Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails</Role>
      <ShortName>Intangible Assets and Goodwill - Schedule of Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>240384019 - Disclosure - Intangible Assets and Goodwill - Schedule of Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofGoodwillDetails</Role>
      <ShortName>Intangible Assets and Goodwill - Schedule of Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>240414020 - Disclosure - Leases - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/LeasesNarrativeDetails</Role>
      <ShortName>Leases - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>240424021 - Disclosure - Leases - Schedule of Lease Cost and Other Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/LeasesScheduleofLeaseCostandOtherInformationDetails</Role>
      <ShortName>Leases - Schedule of Lease Cost and Other Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>240454022 - Disclosure - General and Administrative Expenses - Schedule of General and Administrative Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/GeneralandAdministrativeExpensesScheduleofGeneralandAdministrativeExpensesDetails</Role>
      <ShortName>General and Administrative Expenses - Schedule of General and Administrative Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>240484023 - Disclosure - Derivative Liabilities - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails</Role>
      <ShortName>Derivative Liabilities - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>240494024 - Disclosure - Derivative Liabilities - Schedule of Reconciliation of Carrying Amounts (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails</Role>
      <ShortName>Derivative Liabilities - Schedule of Reconciliation of Carrying Amounts (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>240504025 - Disclosure - Derivative Liabilities - Schedule of Fair Values of Derivative Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails</Role>
      <ShortName>Derivative Liabilities - Schedule of Fair Values of Derivative Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>240514026 - Disclosure - Derivative Liabilities - Schedule of Sensitivity Analysis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails</Role>
      <ShortName>Derivative Liabilities - Schedule of Sensitivity Analysis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>240544027 - Disclosure - Capital Stock - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/CapitalStockNarrativeDetails</Role>
      <ShortName>Capital Stock - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>87</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>240554028 - Disclosure - Capital Stock - Schedule of Common Shares Issued (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/CapitalStockScheduleofCommonSharesIssuedDetails</Role>
      <ShortName>Capital Stock - Schedule of Common Shares Issued (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>88</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>240584029 - Disclosure - Share-based Payments - Summary of Changes in Warrants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinWarrantsDetails</Role>
      <ShortName>Share-based Payments - Summary of Changes in Warrants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>89</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>240594030 - Disclosure - Share-based Payments - Summary of Outstanding Warrants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/SharebasedPaymentsSummaryofOutstandingWarrantsDetails</Role>
      <ShortName>Share-based Payments - Summary of Outstanding Warrants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>90</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>240604031 - Disclosure - Share-based Payments - Stock Options Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails</Role>
      <ShortName>Share-based Payments - Stock Options Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>91</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>240614032 - Disclosure - Share-based Payments - Schedule of Stock Options Outstanding (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/SharebasedPaymentsScheduleofStockOptionsOutstandingDetails</Role>
      <ShortName>Share-based Payments - Schedule of Stock Options Outstanding (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>92</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>240624033 - Disclosure - Share-based Payments - Summary of the Changes in Options (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/SharebasedPaymentsSummaryoftheChangesinOptionsDetails</Role>
      <ShortName>Share-based Payments - Summary of the Changes in Options (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>93</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>240634034 - Disclosure - Share-based Payments - Fair Value of Options Issued (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/SharebasedPaymentsFairValueofOptionsIssuedDetails</Role>
      <ShortName>Share-based Payments - Fair Value of Options Issued (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>94</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>240644035 - Disclosure - Share-based Payments - Restricted Share Units Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/SharebasedPaymentsRestrictedShareUnitsNarrativeDetails</Role>
      <ShortName>Share-based Payments - Restricted Share Units Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>95</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>240654036 - Disclosure - Share-based Payments - Summary of Restricted Share Units Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/SharebasedPaymentsSummaryofRestrictedShareUnitsActivityDetails</Role>
      <ShortName>Share-based Payments - Summary of Restricted Share Units Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>96</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>240664037 - Disclosure - Share-based Payments - Deferred Share Units Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/SharebasedPaymentsDeferredShareUnitsNarrativeDetails</Role>
      <ShortName>Share-based Payments - Deferred Share Units Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>97</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>240674038 - Disclosure - Share-based Payments - Summary of Deferred Share Units Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/SharebasedPaymentsSummaryofDeferredShareUnitsActivityDetails</Role>
      <ShortName>Share-based Payments - Summary of Deferred Share Units Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>98</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>240704039 - Disclosure - Earnings (loss) Per Share - Schedule of Earnings (Loss) Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails</Role>
      <ShortName>Earnings (loss) Per Share - Schedule of Earnings (Loss) Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/EarningslossPerShareTables</ParentRole>
      <Position>99</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>240714040 - Disclosure - Earnings (loss) Per Share - Schedule of Antidilutive Securities Excluded from Computation of Diluted Shares Outstanding (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/EarningslossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedSharesOutstandingDetails</Role>
      <ShortName>Earnings (loss) Per Share - Schedule of Antidilutive Securities Excluded from Computation of Diluted Shares Outstanding (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/EarningslossPerShareTables</ParentRole>
      <Position>100</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>240744041 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails</Role>
      <ShortName>Accumulated Other Comprehensive Income (Loss) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLossTables</ParentRole>
      <Position>101</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R102.htm</HtmlFileName>
      <LongName>240774042 - Disclosure - Income Taxes - Schedule of Income (Loss) before Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/IncomeTaxesScheduleofIncomeLossbeforeIncomeTaxesDetails</Role>
      <ShortName>Income Taxes - Schedule of Income (Loss) before Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>102</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R103.htm</HtmlFileName>
      <LongName>240784043 - Disclosure - Income Taxes - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>103</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R104.htm</HtmlFileName>
      <LongName>240794044 - Disclosure - Income Taxes - Expense for Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/IncomeTaxesExpenseforIncomeTaxesDetails</Role>
      <ShortName>Income Taxes - Expense for Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>104</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R105.htm</HtmlFileName>
      <LongName>240804045 - Disclosure - Income Taxes - Effective Tax Rate Reconciliation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails</Role>
      <ShortName>Income Taxes - Effective Tax Rate Reconciliation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>105</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R106.htm</HtmlFileName>
      <LongName>240814046 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails</Role>
      <ShortName>Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>106</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R107.htm</HtmlFileName>
      <LongName>240824047 - Disclosure - Income Taxes - Summary of Valuation Allowance (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/IncomeTaxesSummaryofValuationAllowanceDetails</Role>
      <ShortName>Income Taxes - Summary of Valuation Allowance (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>107</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R108.htm</HtmlFileName>
      <LongName>240854048 - Disclosure - Commitments - Summary of Future Minimum Lease Payments Under Operating Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/CommitmentsSummaryofFutureMinimumLeasePaymentsUnderOperatingLeasesDetails</Role>
      <ShortName>Commitments - Summary of Future Minimum Lease Payments Under Operating Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>108</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R109.htm</HtmlFileName>
      <LongName>240864049 - Disclosure - Commitments - R&amp;D Commitments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/CommitmentsRDCommitmentsDetails</Role>
      <ShortName>Commitments - R&amp;D Commitments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>109</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R110.htm</HtmlFileName>
      <LongName>240874050 - Disclosure - Commitments - Use of Publicity Rights in Brand Development (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/CommitmentsUseofPublicityRightsinBrandDevelopmentDetails</Role>
      <ShortName>Commitments - Use of Publicity Rights in Brand Development (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>110</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R111.htm</HtmlFileName>
      <LongName>240894051 - Disclosure - Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/ContingenciesDetails</Role>
      <ShortName>Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/Contingencies</ParentRole>
      <Position>111</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R112.htm</HtmlFileName>
      <LongName>240924052 - Disclosure - Supplementary Cash Flow Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/SupplementaryCashFlowInformationDetails</Role>
      <ShortName>Supplementary Cash Flow Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/SupplementaryCashFlowInformationTables</ParentRole>
      <Position>112</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R113.htm</HtmlFileName>
      <LongName>240944053 - Disclosure - Financial Instruments - Credit Risk Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails</Role>
      <ShortName>Financial Instruments - Credit Risk Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>113</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R114.htm</HtmlFileName>
      <LongName>240954054 - Disclosure - Financial Instruments - Liquidity Risk Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskNarrativeDetails</Role>
      <ShortName>Financial Instruments - Liquidity Risk Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>114</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R115.htm</HtmlFileName>
      <LongName>240964055 - Disclosure - Financial Instruments - Interest Rate Risk (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/FinancialInstrumentsInterestRateRiskDetails</Role>
      <ShortName>Financial Instruments - Interest Rate Risk (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>115</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R116.htm</HtmlFileName>
      <LongName>240974056 - Disclosure - Financial Instruments - Currency Rate Risk Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/FinancialInstrumentsCurrencyRateRiskNarrativeDetails</Role>
      <ShortName>Financial Instruments - Currency Rate Risk Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>116</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R117.htm</HtmlFileName>
      <LongName>241004057 - Disclosure - Fair Value Measurement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/FairValueMeasurementDetails</Role>
      <ShortName>Fair Value Measurement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/FairValueMeasuresandDisclosuresTables</ParentRole>
      <Position>117</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R118.htm</HtmlFileName>
      <LongName>241034058 - Disclosure - Related Party Transactions and Balances - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesNarrativeDetails</Role>
      <ShortName>Related Party Transactions and Balances - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>118</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R119.htm</HtmlFileName>
      <LongName>241044059 - Disclosure - Related Party Transactions and Balances - Schedule of Related Party Transactions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesScheduleofRelatedPartyTransactionsDetails</Role>
      <ShortName>Related Party Transactions and Balances - Schedule of Related Party Transactions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>119</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R120.htm</HtmlFileName>
      <LongName>241064060 - Disclosure - Non-monetary Transactions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/NonmonetaryTransactionsDetails</Role>
      <ShortName>Non-monetary Transactions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/NonmonetaryTransactions</ParentRole>
      <Position>120</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R121.htm</HtmlFileName>
      <LongName>241094061 - Disclosure - Business Combinations - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/BusinessCombinationsNarrativeDetails</Role>
      <ShortName>Business Combinations - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>121</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R122.htm</HtmlFileName>
      <LongName>241104062 - Disclosure - Business Combinations - Schedule of Fair Value of Net Assets Acquired (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/BusinessCombinationsScheduleofFairValueofNetAssetsAcquiredDetails</Role>
      <ShortName>Business Combinations - Schedule of Fair Value of Net Assets Acquired (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>122</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R123.htm</HtmlFileName>
      <LongName>241134063 - Disclosure - Repurposing Charges - Schedule of Plan Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/RepurposingChargesScheduleofPlanInformationDetails</Role>
      <ShortName>Repurposing Charges - Schedule of Plan Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>123</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R124.htm</HtmlFileName>
      <LongName>241144064 - Disclosure - Repurposing Charges - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/RepurposingChargesNarrativeDetails</Role>
      <ShortName>Repurposing Charges - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>124</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R125.htm</HtmlFileName>
      <LongName>241174065 - Disclosure - Segment Information - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/SegmentInformationNarrativeDetails</Role>
      <ShortName>Segment Information - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>125</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R126.htm</HtmlFileName>
      <LongName>241184066 - Disclosure - Segment Information - Schedule of Segment Data (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails</Role>
      <ShortName>Segment Information - Schedule of Segment Data (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>126</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R127.htm</HtmlFileName>
      <LongName>241194067 - Disclosure - Segment Information - Schedule of Adjusted EBITDA (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/SegmentInformationScheduleofAdjustedEBITDADetails</Role>
      <ShortName>Segment Information - Schedule of Adjusted EBITDA (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>127</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R128.htm</HtmlFileName>
      <LongName>241204068 - Disclosure - Segment Information - Schedule of Revenue from External Customers by Geographic Areas (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/SegmentInformationScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails</Role>
      <ShortName>Segment Information - Schedule of Revenue from External Customers by Geographic Areas (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>128</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R129.htm</HtmlFileName>
      <LongName>241214069 - Disclosure - Segment Information - Schedule of Long-lived Assets by Geographic Areas (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/SegmentInformationScheduleofLonglivedAssetsbyGeographicAreasDetails</Role>
      <ShortName>Segment Information - Schedule of Long-lived Assets by Geographic Areas (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>129</Position>
    </Report>
    <Report instance="cron-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R130.htm</HtmlFileName>
      <LongName>241244070 - Disclosure - Discontinued Operations and Held-for-sale Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/DiscontinuedOperationsandHeldforsaleAssetsDetails</Role>
      <ShortName>Discontinued Operations and Held-for-sale Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/DiscontinuedOperationsandHeldforsaleAssetsTables</ParentRole>
      <Position>130</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="cron-20201231.htm">cron-20201231.htm</File>
    <File>a1411.htm</File>
    <File>a2311.htm</File>
    <File>a421.htm</File>
    <File>cron-20201231.xsd</File>
    <File>cron-20201231_cal.xml</File>
    <File>cron-20201231_def.xml</File>
    <File>cron-20201231_lab.xml</File>
    <File>cron-20201231_pre.xml</File>
    <File>cronceoex3111.htm</File>
    <File>cronceoex3211.htm</File>
    <File>croncfoex3121.htm</File>
    <File>croncfoex3221.htm</File>
    <File>exhibit211.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>cron-20201231_g1.jpg</File>
    <File>cron-20201231_g2.jpg</File>
    <File>cron-20201231_g3.jpg</File>
    <File>cron-20201231_g4.jpg</File>
    <File>cron-20201231_g5.jpg</File>
    <File>cron-20201231_g6.jpg</File>
    <File>cron-20201231_g7.jpg</File>
    <File>cron-20201231_g8.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>161
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "cron-20201231.htm": {
   "axisCustom": 2,
   "axisStandard": 54,
   "contextCount": 529,
   "dts": {
    "calculationLink": {
     "local": [
      "cron-20201231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "cron-20201231_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "cron-20201231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cron-20201231_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cron-20201231_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "cron-20201231.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd"
     ]
    }
   },
   "elementCount": 947,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2020-01-31": 5,
    "http://xbrl.sec.gov/dei/2020-01-31": 4,
    "total": 9
   },
   "keyCustom": 105,
   "keyStandard": 497,
   "memberCustom": 74,
   "memberStandard": 68,
   "nsprefix": "cron",
   "nsuri": "http://thecronosgroup.com/20201231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000010001 - Document - Cover Page",
     "role": "http://thecronosgroup.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210111004 - Disclosure - Revenues from Contracts with Customers",
     "role": "http://thecronosgroup.com/role/RevenuesfromContractswithCustomers",
     "shortName": "Revenues from Contracts with Customers",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R100": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240714040 - Disclosure - Earnings (loss) Per Share - Schedule of Antidilutive Securities Excluded from Computation of Diluted Shares Outstanding (Details)",
     "role": "http://thecronosgroup.com/role/EarningslossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedSharesOutstandingDetails",
     "shortName": "Earnings (loss) Per Share - Schedule of Antidilutive Securities Excluded from Computation of Diluted Shares Outstanding (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R101": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i79fc16ab48f54844a8d5db79a213fc23_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240744041 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Details)",
     "role": "http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails",
     "shortName": "Accumulated Other Comprehensive Income (Loss) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "ia325d120afc54411a40573cb6f7e7e7c_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R102": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240774042 - Disclosure - Income Taxes - Schedule of Income (Loss) before Income Taxes (Details)",
     "role": "http://thecronosgroup.com/role/IncomeTaxesScheduleofIncomeLossbeforeIncomeTaxesDetails",
     "shortName": "Income Taxes - Schedule of Income (Loss) before Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R103": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240784043 - Disclosure - Income Taxes - Narrative (Details)",
     "role": "http://thecronosgroup.com/role/IncomeTaxesNarrativeDetails",
     "shortName": "Income Taxes - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "ifb8c52c55d9641488fdc94ebb5b68457_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:TaxesPayableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R104": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentIncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240794044 - Disclosure - Income Taxes - Expense for Income Taxes (Details)",
     "role": "http://thecronosgroup.com/role/IncomeTaxesExpenseforIncomeTaxesDetails",
     "shortName": "Income Taxes - Expense for Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentIncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R105": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240804045 - Disclosure - Income Taxes - Effective Tax Rate Reconciliation (Details)",
     "role": "http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails",
     "shortName": "Income Taxes - Effective Tax Rate Reconciliation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R106": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "ifb8c52c55d9641488fdc94ebb5b68457_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240814046 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)",
     "role": "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails",
     "shortName": "Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "ifb8c52c55d9641488fdc94ebb5b68457_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R107": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfValuationAllowanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i17a122330b5144cf96235a840b3602c1_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240824047 - Disclosure - Income Taxes - Summary of Valuation Allowance (Details)",
     "role": "http://thecronosgroup.com/role/IncomeTaxesSummaryofValuationAllowanceDetails",
     "shortName": "Income Taxes - Summary of Valuation Allowance (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfValuationAllowanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i172fd75fe227409f982d139db1b09efd_I20181231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R108": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "ifb8c52c55d9641488fdc94ebb5b68457_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240854048 - Disclosure - Commitments - Summary of Future Minimum Lease Payments Under Operating Leases (Details)",
     "role": "http://thecronosgroup.com/role/CommitmentsSummaryofFutureMinimumLeasePaymentsUnderOperatingLeasesDetails",
     "shortName": "Commitments - Summary of Future Minimum Lease Payments Under Operating Leases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "ifb8c52c55d9641488fdc94ebb5b68457_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R109": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i5a2c9058e29b437fa7075ccaeaad824a_I20180904",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "cron:LongTermPurchaseCommitmentNumberOfTargetedUnitsToDevelopProduction",
      "reportCount": 1,
      "unique": true,
      "unitRef": "cannabinoid",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240864049 - Disclosure - Commitments - R&D Commitments (Details)",
     "role": "http://thecronosgroup.com/role/CommitmentsRDCommitmentsDetails",
     "shortName": "Commitments - R&D Commitments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i5a2c9058e29b437fa7075ccaeaad824a_I20180904",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "cron:LongTermPurchaseCommitmentNumberOfTargetedUnitsToDevelopProduction",
      "reportCount": 1,
      "unique": true,
      "unitRef": "cannabinoid",
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210131005 - Disclosure - Inventory",
     "role": "http://thecronosgroup.com/role/Inventory",
     "shortName": "Inventory",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R110": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockByClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i3783dc27237d46f6944e1a9a6f65eee6_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240874050 - Disclosure - Commitments - Use of Publicity Rights in Brand Development (Details)",
     "role": "http://thecronosgroup.com/role/CommitmentsUseofPublicityRightsinBrandDevelopmentDetails",
     "shortName": "Commitments - Use of Publicity Rights in Brand Development (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i26f35784de464b1abb30c3a7a284c303_I20191223",
      "decimals": "INF",
      "lang": "en-US",
      "name": "cron:SaleOfStockPerformanceMilestoneTriggeringEventMinimumRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R111": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i06603bc91b504293b7f98adf78675927_D20200616-20200616",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyDamagesSoughtValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "cad",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240894051 - Disclosure - Contingencies (Details)",
     "role": "http://thecronosgroup.com/role/ContingenciesDetails",
     "shortName": "Contingencies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i06603bc91b504293b7f98adf78675927_D20200616-20200616",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyDamagesSoughtValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "cad",
      "xsiNil": "false"
     }
    },
    "R112": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:CashFlowOperatingCapitalTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncreaseDecreaseInAccountsReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240924052 - Disclosure - Supplementary Cash Flow Information (Details)",
     "role": "http://thecronosgroup.com/role/SupplementaryCashFlowInformationDetails",
     "shortName": "Supplementary Cash Flow Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:CashFlowOperatingCapitalTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncreaseDecreaseInAccountsReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R113": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240944053 - Disclosure - Financial Instruments - Credit Risk Narrative (Details)",
     "role": "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails",
     "shortName": "Financial Instruments - Credit Risk Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R114": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "ifb8c52c55d9641488fdc94ebb5b68457_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240954054 - Disclosure - Financial Instruments - Liquidity Risk Narrative (Details)",
     "role": "http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskNarrativeDetails",
     "shortName": "Financial Instruments - Liquidity Risk Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "ifb8c52c55d9641488fdc94ebb5b68457_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R115": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestIncomeExpenseNonoperatingNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240964055 - Disclosure - Financial Instruments - Interest Rate Risk (Details)",
     "role": "http://thecronosgroup.com/role/FinancialInstrumentsInterestRateRiskDetails",
     "shortName": "Financial Instruments - Interest Rate Risk (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": "4",
      "lang": "en-US",
      "name": "cron:SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncomePercent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R116": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240974056 - Disclosure - Financial Instruments - Currency Rate Risk Narrative (Details)",
     "role": "http://thecronosgroup.com/role/FinancialInstrumentsCurrencyRateRiskNarrativeDetails",
     "shortName": "Financial Instruments - Currency Rate Risk Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "ifb8c52c55d9641488fdc94ebb5b68457_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "cron:SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R117": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "iea50dbe7c8794cc8aa0b34bfe4bb4eba_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241004057 - Disclosure - Fair Value Measurement (Details)",
     "role": "http://thecronosgroup.com/role/FairValueMeasurementDetails",
     "shortName": "Fair Value Measurement (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "iea50dbe7c8794cc8aa0b34bfe4bb4eba_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R118": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "ia1f93f14e6044577ba1a7b6463b04532_D20190101-20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241034058 - Disclosure - Related Party Transactions and Balances - Narrative (Details)",
     "role": "http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesNarrativeDetails",
     "shortName": "Related Party Transactions and Balances - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "ia1f93f14e6044577ba1a7b6463b04532_D20190101-20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R119": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i56950461ca0641258302cc12456209fb_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241044059 - Disclosure - Related Party Transactions and Balances - Schedule of Related Party Transactions (Details)",
     "role": "http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesScheduleofRelatedPartyTransactionsDetails",
     "shortName": "Related Party Transactions and Balances - Schedule of Related Party Transactions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "if753a5d3b4dc49c6b14066a7f6662688_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableRelatedPartiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210161006 - Disclosure - Investments",
     "role": "http://thecronosgroup.com/role/Investments",
     "shortName": "Investments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R120": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "cron:NonmonetaryTransactionNumberOfTransactions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "transaction",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241064060 - Disclosure - Non-monetary Transactions (Details)",
     "role": "http://thecronosgroup.com/role/NonmonetaryTransactionsDetails",
     "shortName": "Non-monetary Transactions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "cron:NonmonetaryTransactionNumberOfTransactions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "transaction",
      "xsiNil": "false"
     }
    },
    "R121": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:NumberOfBusinessesAcquired",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfBusinessesAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "business",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241094061 - Disclosure - Business Combinations - Narrative (Details)",
     "role": "http://thecronosgroup.com/role/BusinessCombinationsNarrativeDetails",
     "shortName": "Business Combinations - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:NumberOfBusinessesAcquired",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfBusinessesAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "business",
      "xsiNil": "false"
     }
    },
    "R122": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "ifb8c52c55d9641488fdc94ebb5b68457_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241104062 - Disclosure - Business Combinations - Schedule of Fair Value of Net Assets Acquired (Details)",
     "role": "http://thecronosgroup.com/role/BusinessCombinationsScheduleofFairValueofNetAssetsAcquiredDetails",
     "shortName": "Business Combinations - Schedule of Fair Value of Net Assets Acquired (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "ide715df8e0104988800b3158e6323d0b_I20190905",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R123": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SeveranceCosts1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241134063 - Disclosure - Repurposing Charges - Schedule of Plan Information (Details)",
     "role": "http://thecronosgroup.com/role/RepurposingChargesScheduleofPlanInformationDetails",
     "shortName": "Repurposing Charges - Schedule of Plan Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SeveranceCosts1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R124": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryWriteDown",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241144064 - Disclosure - Repurposing Charges - Narrative (Details)",
     "role": "http://thecronosgroup.com/role/RepurposingChargesNarrativeDetails",
     "shortName": "Repurposing Charges - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "ifb8c52c55d9641488fdc94ebb5b68457_I20201231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R125": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241174065 - Disclosure - Segment Information - Narrative (Details)",
     "role": "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails",
     "shortName": "Segment Information - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R126": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241184066 - Disclosure - Segment Information - Schedule of Segment Data (Details)",
     "role": "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails",
     "shortName": "Segment Information - Schedule of Segment Data (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:InvestmentIncomeInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R127": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241194067 - Disclosure - Segment Information - Schedule of Adjusted EBITDA (Details)",
     "role": "http://thecronosgroup.com/role/SegmentInformationScheduleofAdjustedEBITDADetails",
     "shortName": "Segment Information - Schedule of Adjusted EBITDA (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i2df15a9047ab425b9d836dbf0d672aa1_D20190101-20191231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R128": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241204068 - Disclosure - Segment Information - Schedule of Revenue from External Customers by Geographic Areas (Details)",
     "role": "http://thecronosgroup.com/role/SegmentInformationScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails",
     "shortName": "Segment Information - Schedule of Revenue from External Customers by Geographic Areas (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "ib40ea4716ab44dde9b0cc0ccf563964b_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R129": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "ifb8c52c55d9641488fdc94ebb5b68457_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NoncurrentAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241214069 - Disclosure - Segment Information - Schedule of Long-lived Assets by Geographic Areas (Details)",
     "role": "http://thecronosgroup.com/role/SegmentInformationScheduleofLonglivedAssetsbyGeographicAreasDetails",
     "shortName": "Segment Information - Schedule of Long-lived Assets by Geographic Areas (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "ifb8c52c55d9641488fdc94ebb5b68457_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NoncurrentAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210221007 - Disclosure - Other Investments",
     "role": "http://thecronosgroup.com/role/OtherInvestments",
     "shortName": "Other Investments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R130": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241244070 - Disclosure - Discontinued Operations and Held-for-sale Assets (Details)",
     "role": "http://thecronosgroup.com/role/DiscontinuedOperationsandHeldforsaleAssetsDetails",
     "shortName": "Discontinued Operations and Held-for-sale Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "ifb8c52c55d9641488fdc94ebb5b68457_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210251008 - Disclosure - Loan Receivable",
     "role": "http://thecronosgroup.com/role/LoanReceivable",
     "shortName": "Loan Receivable",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210281009 - Disclosure - Loans Payable",
     "role": "http://thecronosgroup.com/role/LoansPayable",
     "shortName": "Loans Payable",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210301010 - Disclosure - Property, Plant and Equipment",
     "role": "http://thecronosgroup.com/role/PropertyPlantandEquipment",
     "shortName": "Property, Plant and Equipment",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210341011 - Disclosure - Intangible Assets and Goodwill",
     "role": "http://thecronosgroup.com/role/IntangibleAssetsandGoodwill",
     "shortName": "Intangible Assets and Goodwill",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210391012 - Disclosure - Leases",
     "role": "http://thecronosgroup.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AdditionalFinancialInformationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210431013 - Disclosure - General and Administrative Expenses",
     "role": "http://thecronosgroup.com/role/GeneralandAdministrativeExpenses",
     "shortName": "General and Administrative Expenses",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AdditionalFinancialInformationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "ifb8c52c55d9641488fdc94ebb5b68457_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100010002 - Statement - Consolidated Balance Sheet",
     "role": "http://thecronosgroup.com/role/ConsolidatedBalanceSheet",
     "shortName": "Consolidated Balance Sheet",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "ifb8c52c55d9641488fdc94ebb5b68457_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherReceivablesNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210461014 - Disclosure - Derivative Liabilities",
     "role": "http://thecronosgroup.com/role/DerivativeLiabilities",
     "shortName": "Derivative Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210521015 - Disclosure - Capital Stock",
     "role": "http://thecronosgroup.com/role/CapitalStock",
     "shortName": "Capital Stock",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210561016 - Disclosure - Share-based Payments",
     "role": "http://thecronosgroup.com/role/SharebasedPayments",
     "shortName": "Share-based Payments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210681017 - Disclosure - Earnings (loss) Per Share",
     "role": "http://thecronosgroup.com/role/EarningslossPerShare",
     "shortName": "Earnings (loss) Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210721018 - Disclosure - Accumulated Other Comprehensive Income (Loss)",
     "role": "http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLoss",
     "shortName": "Accumulated Other Comprehensive Income (Loss)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210751019 - Disclosure - Income Taxes",
     "role": "http://thecronosgroup.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210831020 - Disclosure - Commitments",
     "role": "http://thecronosgroup.com/role/Commitments",
     "shortName": "Commitments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyDisclosures",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210881021 - Disclosure - Contingencies",
     "role": "http://thecronosgroup.com/role/Contingencies",
     "shortName": "Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyDisclosures",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210901022 - Disclosure - Supplementary Cash Flow Information",
     "role": "http://thecronosgroup.com/role/SupplementaryCashFlowInformation",
     "shortName": "Supplementary Cash Flow Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210931023 - Disclosure - Financial Instruments",
     "role": "http://thecronosgroup.com/role/FinancialInstruments",
     "shortName": "Financial Instruments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "ifb8c52c55d9641488fdc94ebb5b68457_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100020003 - Statement - Consolidated Balance Sheet (Parenthetical)",
     "role": "http://thecronosgroup.com/role/ConsolidatedBalanceSheetParenthetical",
     "shortName": "Consolidated Balance Sheet (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "link:footnote",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "ifb8c52c55d9641488fdc94ebb5b68457_I20201231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210981024 - Disclosure - Fair Value Measurement",
     "role": "http://thecronosgroup.com/role/FairValueMeasurement",
     "shortName": "Fair Value Measurement",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "211011025 - Disclosure - Related Party Transactions and Balances",
     "role": "http://thecronosgroup.com/role/RelatedPartyTransactionsandBalances",
     "shortName": "Related Party Transactions and Balances",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NonmonetaryTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "211051026 - Disclosure - Non-monetary Transactions",
     "role": "http://thecronosgroup.com/role/NonmonetaryTransactions",
     "shortName": "Non-monetary Transactions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NonmonetaryTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "211071027 - Disclosure - Business Combinations",
     "role": "http://thecronosgroup.com/role/BusinessCombinations",
     "shortName": "Business Combinations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "211111028 - Disclosure - Repurposing Charges",
     "role": "http://thecronosgroup.com/role/RepurposingCharges",
     "shortName": "Repurposing Charges",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "211151029 - Disclosure - Segment Information",
     "role": "http://thecronosgroup.com/role/SegmentInformation",
     "shortName": "Segment Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "211221030 - Disclosure - Discontinued Operations and Held-for-sale Assets",
     "role": "http://thecronosgroup.com/role/DiscontinuedOperationsandHeldforsaleAssets",
     "shortName": "Discontinued Operations and Held-for-sale Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "220042001 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "role": "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230053001 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "role": "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesTables",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230143002 - Disclosure - Inventory (Tables)",
     "role": "http://thecronosgroup.com/role/InventoryTables",
     "shortName": "Inventory (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100030004 - Statement - Consolidated Statements of Net Income (Loss) and Comprehensive Income (Loss)",
     "role": "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
     "shortName": "Consolidated Statements of Net Income (Loss) and Comprehensive Income (Loss)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ExciseAndSalesTaxes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230173003 - Disclosure - Investments (Tables)",
     "role": "http://thecronosgroup.com/role/InvestmentsTables",
     "shortName": "Investments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230233004 - Disclosure - Other Investments (Tables)",
     "role": "http://thecronosgroup.com/role/OtherInvestmentsTables",
     "shortName": "Other Investments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230263005 - Disclosure - Loan Receivable (Tables)",
     "role": "http://thecronosgroup.com/role/LoanReceivableTables",
     "shortName": "Loan Receivable (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230313006 - Disclosure - Property, Plant and Equipment (Tables)",
     "role": "http://thecronosgroup.com/role/PropertyPlantandEquipmentTables",
     "shortName": "Property, Plant and Equipment (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230353007 - Disclosure - Intangible Assets and Goodwill (Tables)",
     "role": "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillTables",
     "shortName": "Intangible Assets and Goodwill (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230403008 - Disclosure - Leases (Tables)",
     "role": "http://thecronosgroup.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cron:GeneralAndAdministrativeExpensesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230443009 - Disclosure - General and Administrative Expenses (Tables)",
     "role": "http://thecronosgroup.com/role/GeneralandAdministrativeExpensesTables",
     "shortName": "General and Administrative Expenses (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cron:GeneralAndAdministrativeExpensesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230473010 - Disclosure - Derivative Liabilities (Tables)",
     "role": "http://thecronosgroup.com/role/DerivativeLiabilitiesTables",
     "shortName": "Derivative Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfStockByClassTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230533011 - Disclosure - Capital Stock (Tables)",
     "role": "http://thecronosgroup.com/role/CapitalStockTables",
     "shortName": "Capital Stock (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfStockByClassTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfOtherShareBasedCompensationActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230573012 - Disclosure - Share-based Payments (Tables)",
     "role": "http://thecronosgroup.com/role/SharebasedPaymentsTables",
     "shortName": "Share-based Payments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfOtherShareBasedCompensationActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i0451ae32e2d74c6a81c9a1a7d77aea12_I20171231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100040005 - Statement - Consolidated Statements of Stockholders' Equity (Deficit)",
     "role": "http://thecronosgroup.com/role/ConsolidatedStatementsofStockholdersEquityDeficit",
     "shortName": "Consolidated Statements of Stockholders' Equity (Deficit)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i0451ae32e2d74c6a81c9a1a7d77aea12_I20171231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230693013 - Disclosure - Earnings (loss) Per Share (Tables)",
     "role": "http://thecronosgroup.com/role/EarningslossPerShareTables",
     "shortName": "Earnings (loss) Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230733014 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Tables)",
     "role": "http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLossTables",
     "shortName": "Accumulated Other Comprehensive Income (Loss) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230763015 - Disclosure - Income Taxes (Tables)",
     "role": "http://thecronosgroup.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230843016 - Disclosure - Commitments (Tables)",
     "role": "http://thecronosgroup.com/role/CommitmentsTables",
     "shortName": "Commitments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowOperatingCapitalTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230913017 - Disclosure - Supplementary Cash Flow Information (Tables)",
     "role": "http://thecronosgroup.com/role/SupplementaryCashFlowInformationTables",
     "shortName": "Supplementary Cash Flow Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowOperatingCapitalTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230993018 - Disclosure - Fair Value Measures and Disclosures (Tables)",
     "role": "http://thecronosgroup.com/role/FairValueMeasuresandDisclosuresTables",
     "shortName": "Fair Value Measures and Disclosures (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "231023019 - Disclosure - Related Party Disclosures (Tables)",
     "role": "http://thecronosgroup.com/role/RelatedPartyDisclosuresTables",
     "shortName": "Related Party Disclosures (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "231083020 - Disclosure - Business Combinations (Tables)",
     "role": "http://thecronosgroup.com/role/BusinessCombinationsTables",
     "shortName": "Business Combinations (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "231123021 - Disclosure - Repurposing Charges (Tables)",
     "role": "http://thecronosgroup.com/role/RepurposingChargesTables",
     "shortName": "Repurposing Charges (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "231163022 - Disclosure - Segment Information (Tables)",
     "role": "http://thecronosgroup.com/role/SegmentInformationTables",
     "shortName": "Segment Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100050006 - Statement - Consolidated Statements of Cash Flows",
     "role": "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ProvisionForDoubtfulAccounts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "231233023 - Disclosure - Discontinued Operations and Held-for-sale Assets (Tables)",
     "role": "http://thecronosgroup.com/role/DiscontinuedOperationsandHeldforsaleAssetsTables",
     "shortName": "Discontinued Operations and Held-for-sale Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "ifb8c52c55d9641488fdc94ebb5b68457_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "cron:NumberOfContinentsWithInternationalProductionAndDistribution",
      "reportCount": 1,
      "unique": true,
      "unitRef": "continent",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240024001 - Disclosure - Background (Details)",
     "role": "http://thecronosgroup.com/role/BackgroundDetails",
     "shortName": "Background (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "ifb8c52c55d9641488fdc94ebb5b68457_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "cron:NumberOfContinentsWithInternationalProductionAndDistribution",
      "reportCount": 1,
      "unique": true,
      "unitRef": "continent",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "iaedfffab0889492f9c3a60cc78052b32_D20200101-20201231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240064002 - Disclosure - Summary of Significant Accounting Policies - Schedule of Consolidated Entities (Details)",
     "role": "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesScheduleofConsolidatedEntitiesDetails",
     "shortName": "Summary of Significant Accounting Policies - Schedule of Consolidated Entities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "iaedfffab0889492f9c3a60cc78052b32_D20200101-20201231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "ie2c359ba7b8e4d8cbaea40e6357f543e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240074003 - Disclosure - Summary of Significant Accounting Policies - Schedule of Intangible Assets Amortization Methods and Rates (Details)",
     "role": "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsAmortizationMethodsandRatesDetails",
     "shortName": "Summary of Significant Accounting Policies - Schedule of Intangible Assets Amortization Methods and Rates (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "ia97ce75b78b64b17b8c28f247df84a87_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240084004 - Disclosure - Summary of Significant Accounting Policies - Schedule of Property, Plant & Equipment, Useful Lives (Details)",
     "role": "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantEquipmentUsefulLivesDetails",
     "shortName": "Summary of Significant Accounting Policies - Schedule of Property, Plant & Equipment, Useful Lives (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "ia97ce75b78b64b17b8c28f247df84a87_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportingUnits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "reportingunit",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240094005 - Disclosure - Summary of Significant Accounting Policies - Impairment of Long-lived Assets (Details)",
     "role": "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesImpairmentofLonglivedAssetsDetails",
     "shortName": "Summary of Significant Accounting Policies - Impairment of Long-lived Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportingUnits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "reportingunit",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "ifb8c52c55d9641488fdc94ebb5b68457_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240124006 - Disclosure - Revenues from Contracts with Customers - Narrative (Details)",
     "role": "http://thecronosgroup.com/role/RevenuesfromContractswithCustomersNarrativeDetails",
     "shortName": "Revenues from Contracts with Customers - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "ifb8c52c55d9641488fdc94ebb5b68457_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240154007 - Disclosure - Inventory (Details)",
     "role": "http://thecronosgroup.com/role/InventoryDetails",
     "shortName": "Inventory (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "ifb8c52c55d9641488fdc94ebb5b68457_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i9d186ec4178c4ab29fa3a2fa261a681f_D20180614-20180614",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:VariableInterestEntityOwnershipPercentage",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240184008 - Disclosure - Investments - Narrative (Details)",
     "role": "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
     "shortName": "Investments - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i01dfe784ae954e5eabcb9849e4771b50_D20180313-20180313",
      "decimals": null,
      "lang": "en-US",
      "name": "cron:VariableInterestEntityQualitativeOrQuantitativeInformationLicenseTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "ifb8c52c55d9641488fdc94ebb5b68457_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestments",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240194009 - Disclosure - Investments - Schedule of Equity Method Investments (Details)",
     "role": "http://thecronosgroup.com/role/InvestmentsScheduleofEquityMethodInvestmentsDetails",
     "shortName": "Investments - Schedule of Equity Method Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "ifd770601469e44b7b5851f0d7ecea847_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AssetsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210011001 - Disclosure - Background",
     "role": "http://thecronosgroup.com/role/Background",
     "shortName": "Background",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i79fc16ab48f54844a8d5db79a213fc23_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AdvancesToAffiliate",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240204010 - Disclosure - Investments - Schedule of Advances to Joint Ventures (Details)",
     "role": "http://thecronosgroup.com/role/InvestmentsScheduleofAdvancestoJointVenturesDetails",
     "shortName": "Investments - Schedule of Advances to Joint Ventures (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueInterestOnAdvances",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "ifb8c52c55d9641488fdc94ebb5b68457_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "cron:OtherNetAssetsLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240214011 - Disclosure - Investments - Schedule of Variable Interest Entities (Details)",
     "role": "http://thecronosgroup.com/role/InvestmentsScheduleofVariableInterestEntitiesDetails",
     "shortName": "Investments - Schedule of Variable Interest Entities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "ifb8c52c55d9641488fdc94ebb5b68457_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "cron:OtherNetAssetsLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "ibae6d945308c4710b0b167839c583e5e_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240244012 - Disclosure - Other Investments - Summary of Other Investments (Details)",
     "role": "http://thecronosgroup.com/role/OtherInvestmentsSummaryofOtherInvestmentsDetails",
     "shortName": "Other Investments - Summary of Other Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "ibae6d945308c4710b0b167839c583e5e_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "ifb8c52c55d9641488fdc94ebb5b68457_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NotesAndLoansReceivableNetCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240274013 - Disclosure - Loan Receivable - Schedule of Loan Receivable (Details)",
     "role": "http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails",
     "shortName": "Loan Receivable - Schedule of Loan Receivable (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "ia3dd9320d6fb49b8af36a67921315f6a_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "cron:FinancingReceivableAccruedInterestCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RepaymentsOfSecuredDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240294014 - Disclosure - Loans Payable - Long-term Narrative (Details)",
     "role": "http://thecronosgroup.com/role/LoansPayableLongtermNarrativeDetails",
     "shortName": "Loans Payable - Long-term Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "if5da93e8c4dd43b293a795770578b760_D20190123-20190123",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RepaymentsOfSecuredDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "ifb8c52c55d9641488fdc94ebb5b68457_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240324015 - Disclosure - Property, Plant and Equipment - Schedule of Property, Plant & Equipment, Useful Lives (Details)",
     "role": "http://thecronosgroup.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantEquipmentUsefulLivesDetails",
     "shortName": "Property, Plant and Equipment - Schedule of Property, Plant & Equipment, Useful Lives (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "ifb8c52c55d9641488fdc94ebb5b68457_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSoldDepreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240334016 - Disclosure - Property, Plant, and Equipment - Narrative (Details)",
     "role": "http://thecronosgroup.com/role/PropertyPlantandEquipmentNarrativeDetails",
     "shortName": "Property, Plant, and Equipment - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSoldDepreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillImpairmentLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240364017 - Disclosure - Intangible Assets and Goodwill - Narrative (Details)",
     "role": "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillNarrativeDetails",
     "shortName": "Intangible Assets and Goodwill - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "ifb8c52c55d9641488fdc94ebb5b68457_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240374018 - Disclosure - Intangible Assets and Goodwill - Schedule of Intangible Assets (Details)",
     "role": "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails",
     "shortName": "Intangible Assets and Goodwill - Schedule of Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "ibad4f60fad3c4471be8a1d5e1b4b06a2_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i79fc16ab48f54844a8d5db79a213fc23_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240384019 - Disclosure - Intangible Assets and Goodwill - Schedule of Goodwill (Details)",
     "role": "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofGoodwillDetails",
     "shortName": "Intangible Assets and Goodwill - Schedule of Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210031002 - Disclosure - Summary of Significant Accounting Policies",
     "role": "http://thecronosgroup.com/role/SummaryofSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "ifb8c52c55d9641488fdc94ebb5b68457_I20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseRenewalTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240414020 - Disclosure - Leases - Narrative (Details)",
     "role": "http://thecronosgroup.com/role/LeasesNarrativeDetails",
     "shortName": "Leases - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "ifb8c52c55d9641488fdc94ebb5b68457_I20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseRenewalTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240424021 - Disclosure - Leases - Schedule of Lease Cost and Other Information (Details)",
     "role": "http://thecronosgroup.com/role/LeasesScheduleofLeaseCostandOtherInformationDetails",
     "shortName": "Leases - Schedule of Lease Cost and Other Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cron:GeneralAndAdministrativeExpensesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LaborAndRelatedExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240454022 - Disclosure - General and Administrative Expenses - Schedule of General and Administrative Expenses (Details)",
     "role": "http://thecronosgroup.com/role/GeneralandAdministrativeExpensesScheduleofGeneralandAdministrativeExpensesDetails",
     "shortName": "General and Administrative Expenses - Schedule of General and Administrative Expenses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cron:GeneralAndAdministrativeExpensesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LaborAndRelatedExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i760c8d6a27604682ac45b413f79812b7_D20190309-20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240484023 - Disclosure - Derivative Liabilities - Narrative (Details)",
     "role": "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails",
     "shortName": "Derivative Liabilities - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i082bd82cec0746e98c728d8765ac235d_I20190308",
      "decimals": "2",
      "lang": "en-US",
      "name": "cron:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i813499ada2bf48288695564490d30842_I20190308",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240494024 - Disclosure - Derivative Liabilities - Schedule of Reconciliation of Carrying Amounts (Details)",
     "role": "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails",
     "shortName": "Derivative Liabilities - Schedule of Reconciliation of Carrying Amounts (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i813499ada2bf48288695564490d30842_I20190308",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "ife69a303a50649b0b6f092658ca1d499_I20201231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeLiabilityMeasurementInput",
      "reportCount": 1,
      "unique": true,
      "unitRef": "cadPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240504025 - Disclosure - Derivative Liabilities - Schedule of Fair Values of Derivative Liabilities (Details)",
     "role": "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails",
     "shortName": "Derivative Liabilities - Schedule of Fair Values of Derivative Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "ife69a303a50649b0b6f092658ca1d499_I20201231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeLiabilityMeasurementInput",
      "reportCount": 1,
      "unique": true,
      "unitRef": "cadPerShare",
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cron:SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i160db6daa81f47e891c5d92e0c029c65_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240514026 - Disclosure - Derivative Liabilities - Schedule of Sensitivity Analysis (Details)",
     "role": "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails",
     "shortName": "Derivative Liabilities - Schedule of Sensitivity Analysis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cron:SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i160db6daa81f47e891c5d92e0c029c65_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "ifb8c52c55d9641488fdc94ebb5b68457_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "cron:CommonStockNumberOfVotesPerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "vote",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240544027 - Disclosure - Capital Stock - Narrative (Details)",
     "role": "http://thecronosgroup.com/role/CapitalStockNarrativeDetails",
     "shortName": "Capital Stock - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "ifb8c52c55d9641488fdc94ebb5b68457_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "cron:CommonStockNumberOfVotesPerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "vote",
      "xsiNil": "false"
     }
    },
    "R88": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "ifa29b1acea664089973579f536d4f49c_D20190308-20190308",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240554028 - Disclosure - Capital Stock - Schedule of Common Shares Issued (Details)",
     "role": "http://thecronosgroup.com/role/CapitalStockScheduleofCommonSharesIssuedDetails",
     "shortName": "Capital Stock - Schedule of Common Shares Issued (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R89": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherShareBasedCompensationActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i1572dfef042a4da7bc0274d5c4a15278_I20191231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unitRef": "cadPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240584029 - Disclosure - Share-based Payments - Summary of Changes in Warrants (Details)",
     "role": "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinWarrantsDetails",
     "shortName": "Share-based Payments - Summary of Changes in Warrants (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherShareBasedCompensationActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i5372334bf7d347cba8a470a7ae7e08dd_D20200101-20201231",
      "decimals": "2",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "cadPerShare",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210101003 - Disclosure - New Accounting Pronouncements",
     "role": "http://thecronosgroup.com/role/NewAccountingPronouncements",
     "shortName": "New Accounting Pronouncements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R90": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherShareBasedCompensationActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i3ce6c21c99f24cd2ae50be03fc1ea89d_I20201231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unitRef": "cadPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240594030 - Disclosure - Share-based Payments - Summary of Outstanding Warrants (Details)",
     "role": "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofOutstandingWarrantsDetails",
     "shortName": "Share-based Payments - Summary of Outstanding Warrants (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i7708af5c622544439ec18767fd24a5c0_I20201231",
      "decimals": "2",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "cadPerShare",
      "xsiNil": "false"
     }
    },
    "R91": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240604031 - Disclosure - Share-based Payments - Stock Options Narrative (Details)",
     "role": "http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails",
     "shortName": "Share-based Payments - Stock Options Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i5bc534f0f44f4850a59aff8f75b91db8_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R92": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "ifb8c52c55d9641488fdc94ebb5b68457_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240614032 - Disclosure - Share-based Payments - Schedule of Stock Options Outstanding (Details)",
     "role": "http://thecronosgroup.com/role/SharebasedPaymentsScheduleofStockOptionsOutstandingDetails",
     "shortName": "Share-based Payments - Schedule of Stock Options Outstanding (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i264457fca61240599e96951139517526_I20201231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R93": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i79fc16ab48f54844a8d5db79a213fc23_I20191231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
      "reportCount": 1,
      "unitRef": "cadPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240624033 - Disclosure - Share-based Payments - Summary of the Changes in Options (Details)",
     "role": "http://thecronosgroup.com/role/SharebasedPaymentsSummaryoftheChangesinOptionsDetails",
     "shortName": "Share-based Payments - Summary of the Changes in Options (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": "2",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "cadPerShare",
      "xsiNil": "false"
     }
    },
    "R94": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i0adf66dfd8f246e784087297c1693bb8_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharePrice",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240634034 - Disclosure - Share-based Payments - Fair Value of Options Issued (Details)",
     "role": "http://thecronosgroup.com/role/SharebasedPaymentsFairValueofOptionsIssuedDetails",
     "shortName": "Share-based Payments - Fair Value of Options Issued (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i0adf66dfd8f246e784087297c1693bb8_I20201231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R95": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240644035 - Disclosure - Share-based Payments - Restricted Share Units Narrative (Details)",
     "role": "http://thecronosgroup.com/role/SharebasedPaymentsRestrictedShareUnitsNarrativeDetails",
     "shortName": "Share-based Payments - Restricted Share Units Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i1ea19e5d9ee04882823da13b5fd955dc_D20200101-20201231",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R96": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240654036 - Disclosure - Share-based Payments - Summary of Restricted Share Units Activity (Details)",
     "role": "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofRestrictedShareUnitsActivityDetails",
     "shortName": "Share-based Payments - Summary of Restricted Share Units Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i1ea19e5d9ee04882823da13b5fd955dc_D20200101-20201231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R97": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i7aedae1809744d5bae3e685f27c56a9b_D20180101-20181231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240664037 - Disclosure - Share-based Payments - Deferred Share Units Narrative (Details)",
     "role": "http://thecronosgroup.com/role/SharebasedPaymentsDeferredShareUnitsNarrativeDetails",
     "shortName": "Share-based Payments - Deferred Share Units Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i7aedae1809744d5bae3e685f27c56a9b_D20180101-20181231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R98": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240674038 - Disclosure - Share-based Payments - Summary of Deferred Share Units Activity (Details)",
     "role": "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofDeferredShareUnitsActivityDetails",
     "shortName": "Share-based Payments - Summary of Deferred Share Units Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i06da2ae72791461581a87fa5b29a9243_D20200101-20201231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "cron:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsAndVestedInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R99": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240704039 - Disclosure - Earnings (loss) Per Share - Schedule of Earnings (Loss) Per Share (Details)",
     "role": "http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails",
     "shortName": "Earnings (loss) Per Share - Schedule of Earnings (Loss) Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20201231.htm",
      "contextRef": "i8992f30821da461d9b8c1e77a2648dbd_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DilutiveSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 155,
   "tag": {
    "country_CA": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CANADA",
        "terseLabel": "Canada"
       }
      }
     },
     "localname": "CA",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationScheduleofLonglivedAssetsbyGeographicAreasDetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesExpenseforIncomeTaxesDetails",
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofIncomeLossbeforeIncomeTaxesDetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofLonglivedAssetsbyGeographicAreasDetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_A2015StockOptionPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2015 Stock Option Plan [Member]",
        "label": "2015 Stock Option Plan [Member]",
        "terseLabel": "2015 Stock Option Plan"
       }
      }
     },
     "localname": "A2015StockOptionPlanMember",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsScheduleofStockOptionsOutstandingDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_A2018StockOptionPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2018 Stock Option Plan [Member]",
        "label": "2018 Stock Option Plan [Member]",
        "terseLabel": "2018 Stock Option Plan"
       }
      }
     },
     "localname": "A2018StockOptionPlanMember",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsScheduleofStockOptionsOutstandingDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_A2020OmnibusPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2020 Omnibus Plan",
        "label": "2020 Omnibus Plan [Member]",
        "terseLabel": "2020 Omnibus Plan"
       }
      }
     },
     "localname": "A2020OmnibusPlanMember",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsScheduleofStockOptionsOutstandingDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_A2645485OntarioInc.MucciPromissoryNoteMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2645485 Ontario Inc. Mucci Promissory Note [Member]",
        "label": "2645485 Ontario Inc. Mucci Promissory Note [Member]",
        "terseLabel": "2645485 Ontario Inc. Mucci Promissory Note"
       }
      }
     },
     "localname": "A2645485OntarioInc.MucciPromissoryNoteMember",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_AOCIAccumulatedGainLossRevaluationAndDisposalOfOtherInvestmentsParentMemberMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "AOCI, Accumulated Gain (Loss), Revaluation And Disposal Of Other Investments, Parent [Member]",
        "label": "AOCI, Accumulated Gain (Loss), Revaluation And Disposal Of Other Investments, Parent [Member] [Member]",
        "verboseLabel": "Net unrealized gain (loss) on revaluation and disposal of other investments"
       }
      }
     },
     "localname": "AOCIAccumulatedGainLossRevaluationAndDisposalOfOtherInvestmentsParentMemberMember",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_AdditionalPaidinCapitalAttributableToConvertibleOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional Paid-in Capital, Attributable To Convertible Option [Member]",
        "label": "Additional Paid-in Capital, Attributable To Convertible Option [Member]",
        "terseLabel": "Derivative Liability"
       }
      }
     },
     "localname": "AdditionalPaidinCapitalAttributableToConvertibleOptionMember",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_AdjustedEarningsBeforeInterestAndTaxes": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjusted Earnings Before Interest And Taxes",
        "label": "Adjusted Earnings Before Interest And Taxes",
        "terseLabel": "Adjusted EBIT"
       }
      }
     },
     "localname": "AdjustedEarningsBeforeInterestAndTaxes",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationScheduleofAdjustedEBITDADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjusted Earnings Before Interest, Taxes, Depreciation And Amortization",
        "label": "Adjusted Earnings Before Interest, Taxes, Depreciation And Amortization",
        "terseLabel": "Adjusted EBITDA"
       }
      }
     },
     "localname": "AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationScheduleofAdjustedEBITDADetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_AdvancesToAffiliateAllowanceForCreditLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Advances To Affiliate, Allowance For Credit Loss",
        "label": "Advances To Affiliate, Allowance For Credit Loss",
        "terseLabel": "Advances to joint ventures, allowance for credit loss"
       }
      }
     },
     "localname": "AdvancesToAffiliateAllowanceForCreditLoss",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_AltriaGroupInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Altria Group, Inc. [Member]",
        "label": "Altria Group, Inc. [Member]",
        "terseLabel": "Altria Group, Inc."
       }
      }
     },
     "localname": "AltriaGroupInc.Member",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails",
      "http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_AltriaInvestmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Altria Investment [Member]",
        "label": "Altria Investment [Member]",
        "terseLabel": "Altria Investment"
       }
      }
     },
     "localname": "AltriaInvestmentMember",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/CapitalStockNarrativeDetails",
      "http://thecronosgroup.com/role/CapitalStockScheduleofCommonSharesIssuedDetails",
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_AltriaPinnacleLLC.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Altria Pinnacle LLC. [Member]",
        "label": "Altria Pinnacle LLC. [Member]",
        "terseLabel": "Altria Pinnacle LLC."
       }
      }
     },
     "localname": "AltriaPinnacleLLC.Member",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesNarrativeDetails",
      "http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesScheduleofRelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_AltriaVenturesInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Altria Ventures Inc. [Member]",
        "label": "Altria Ventures Inc. [Member]",
        "terseLabel": "Altria Ventures"
       }
      }
     },
     "localname": "AltriaVenturesInc.Member",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsRDCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_AltriaWarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Altria Warrant [Member]",
        "label": "Altria Warrant [Member]",
        "terseLabel": "Altria Warrant",
        "verboseLabel": "Altria Warrant"
       }
      }
     },
     "localname": "AltriaWarrantMember",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails",
      "http://thecronosgroup.com/role/EarningslossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedSharesOutstandingDetails",
      "http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_AuroraCannabisInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aurora Cannabis Inc. [Member]",
        "label": "Aurora Cannabis Inc. [Member]",
        "terseLabel": "Aurora"
       }
      }
     },
     "localname": "AuroraCannabisInc.Member",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/OtherInvestmentsSummaryofOtherInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_BoughtDealOfferingsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bought Deal Offerings [Member]",
        "label": "Bought Deal Offerings [Member]",
        "terseLabel": "Bought Deal Offerings"
       }
      }
     },
     "localname": "BoughtDealOfferingsMember",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/CapitalStockNarrativeDetails",
      "http://thecronosgroup.com/role/CapitalStockScheduleofCommonSharesIssuedDetails",
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_BuildingAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Building And Equipment",
        "label": "Building And Equipment [Member]",
        "terseLabel": "Office Premises and Equipment"
       }
      }
     },
     "localname": "BuildingAndEquipmentMember",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/BusinessCombinationsScheduleofFairValueofNetAssetsAcquiredDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Liabilities, Accounts Payable And Accrued Liabilities",
        "label": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Liabilities, Accounts Payable And Accrued Liabilities",
        "negatedTerseLabel": "Accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/BusinessCombinationsScheduleofFairValueofNetAssetsAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/BusinessCombinationsScheduleofFairValueofNetAssetsAcquiredDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Operating Lease, Right-Of-Use Assets",
        "label": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Operating Lease, Right-Of-Use Assets",
        "terseLabel": "Right-of-use assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/BusinessCombinationsScheduleofFairValueofNetAssetsAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_CannabisExtractsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cannabis Extracts [Member]",
        "label": "Cannabis Extracts [Member]",
        "terseLabel": "Cannabis extracts"
       }
      }
     },
     "localname": "CannabisExtractsMember",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_CannabisFlowerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cannabis Flower [Member]",
        "label": "Cannabis Flower [Member]",
        "terseLabel": "Cannabis flower"
       }
      }
     },
     "localname": "CannabisFlowerMember",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_CannasoulAnalyticsLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cannasoul Analytics Ltd.",
        "label": "Cannasoul Analytics Ltd. [Member]",
        "terseLabel": "Cannasoul Analytics Ltd."
       }
      }
     },
     "localname": "CannasoulAnalyticsLtdMember",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_CannasoulCollaborationLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cannasoul Collaboration Loan",
        "label": "Cannasoul Collaboration Loan [Member]",
        "terseLabel": "Cannasoul Collaboration Loan"
       }
      }
     },
     "localname": "CannasoulCollaborationLoanMember",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_CanopyGrowthCorporationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Canopy Growth Corporation [Member]",
        "label": "Canopy Growth Corporation [Member]",
        "terseLabel": "Canopy"
       }
      }
     },
     "localname": "CanopyGrowthCorporationMember",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/OtherInvestmentsSummaryofOtherInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_ClassOfWarrantOrRightAdditionalSubscriptionNumberOfSecuritiesCalledByWarrantsOrRights": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class Of Warrant Or Right, Additional Subscription, Number Of Securities Called By Warrants Or Rights",
        "label": "Class Of Warrant Or Right, Additional Subscription, Number Of Securities Called By Warrants Or Rights",
        "terseLabel": "Derivative liability, additional subscription (in shares)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightAdditionalSubscriptionNumberOfSecuritiesCalledByWarrantsOrRights",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class Of Warrant Or Right, Exercise Price, Volume-Weighted Average Price, Measurement Period",
        "label": "Class Of Warrant Or Right, Exercise Price, Volume-Weighted Average Price, Measurement Period",
        "terseLabel": "Exercise price, volume-weighted average price, measurement period"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class Of Warrant Or Right, Exercise Price, Volume-Weighted Average Price, Measurement Period, Days Preceding Exercise",
        "label": "Class Of Warrant Or Right, Exercise Price, Volume-Weighted Average Price, Measurement Period, Days Preceding Exercise",
        "terseLabel": "Exercise price, volume-weighted average price, measurement period, days preceding exercise"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cron_ClassOfWarrantOrRightExpense": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class Of Warrant Or Right, Expense",
        "label": "Class Of Warrant Or Right, Expense",
        "terseLabel": "Derivative transaction costs"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExpense",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class Of Warrant Or Right, Maximum Additional Subscription Percentage",
        "label": "Class Of Warrant Or Right, Maximum Additional Subscription Percentage",
        "terseLabel": "Maximum additional subscription percentage"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cron_ClassOfWarrantOrRightMinimumOwnershipPercentageRequired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class Of Warrant Or Right, Minimum Ownership Percentage Required",
        "label": "Class Of Warrant Or Right, Minimum Ownership Percentage Required",
        "terseLabel": "Exercise rights, minimum ownership percentage"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightMinimumOwnershipPercentageRequired",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cron_ClassOfWarrantOrRightNumberOfWarrantsIssued": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class Of Warrant Or Right, Number Of Warrants Issued",
        "label": "Class Of Warrant Or Right, Number Of Warrants Issued",
        "terseLabel": "Number of warrants issued"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfWarrantsIssued",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cron_CollaborativeArrangementAmountOfAdvances": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative Arrangement, Amount Of Advances",
        "label": "Collaborative Arrangement, Amount Of Advances",
        "terseLabel": "Collaboration agreement, amount of advances"
       }
      }
     },
     "localname": "CollaborativeArrangementAmountOfAdvances",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_CollaborativeArrangementInstallmentsReceived": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative Arrangement, Installments Received",
        "label": "Collaborative Arrangement, Installments Received",
        "terseLabel": "Collaborative arrangement, installment received"
       }
      }
     },
     "localname": "CollaborativeArrangementInstallmentsReceived",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_CollaborativeArrangementPercentageOfProfitsToBeReceived": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative Arrangement, Percentage Of Profits To Be Received",
        "label": "Collaborative Arrangement, Percentage Of Profits To Be Received",
        "terseLabel": "Collaborative arrangement, percentage of profits to be received"
       }
      }
     },
     "localname": "CollaborativeArrangementPercentageOfProfitsToBeReceived",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cron_CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative Arrangement, Percentage Of Profits To Be Received, Triggering Event, Subsequent To Maximum Percentage Of Amounts Advanced Being Met",
        "label": "Collaborative Arrangement, Percentage Of Profits To Be Received, Triggering Event, Subsequent To Maximum Percentage Of Amounts Advanced Being Met",
        "terseLabel": "Collaborative arrangement, percentage of profits to be received, triggering event, subsequent to maximum percentage of amounts advanced being met"
       }
      }
     },
     "localname": "CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cron_CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative Arrangement, Profits To Be Received, Maximum Percentage Of Amounts Advanced",
        "label": "Collaborative Arrangement, Profits To Be Received, Maximum Percentage Of Amounts Advanced",
        "terseLabel": "Collaborative arrangement, profits to be received, maximum percentage of amounts advanced"
       }
      }
     },
     "localname": "CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cron_CollaborativeArrangementTermOfAgreement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative Arrangement, Term Of Agreement",
        "label": "Collaborative Arrangement, Term Of Agreement",
        "terseLabel": "Collaborative arrangement, term of agreement"
       }
      }
     },
     "localname": "CollaborativeArrangementTermOfAgreement",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cron_CommonStockNumberOfVotesPerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, Number Of Votes Per Share",
        "label": "Common Stock, Number Of Votes Per Share",
        "terseLabel": "Common shares, number of votes per share"
       }
      }
     },
     "localname": "CommonStockNumberOfVotesPerShare",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cron_CommonStockVestingRightsNumberOfEqualInstallments": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, Vesting Rights, Number Of Equal Installments",
        "label": "Common Stock, Vesting Rights, Number Of Equal Installments",
        "terseLabel": "Common stock, vesting rights, number of equal installments"
       }
      }
     },
     "localname": "CommonStockVestingRightsNumberOfEqualInstallments",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cron_ConstructionLoanAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Construction Loan Agreement [Member]",
        "label": "Construction Loan Agreement [Member]",
        "terseLabel": "Construction Loan Agreement"
       }
      }
     },
     "localname": "ConstructionLoanAgreementMember",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/LoansPayableLongtermNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_ConsultingServicesArrangementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consulting Services Arrangement",
        "label": "Consulting Services Arrangement [Member]",
        "terseLabel": "Consulting Services Arrangement"
       }
      }
     },
     "localname": "ConsultingServicesArrangementMember",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsRDCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_ConsultingServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consulting Services [Member]",
        "label": "Consulting Services [Member]",
        "terseLabel": "Consulting Services"
       }
      }
     },
     "localname": "ConsultingServicesMember",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesNarrativeDetails",
      "http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesScheduleofRelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_CreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Credit Facility [Member]",
        "label": "Credit Facility [Member]",
        "terseLabel": "Credit Facility"
       }
      }
     },
     "localname": "CreditFacilityMember",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/LoansPayableLongtermNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_CronosAustraliaLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cronos Australia Limited [Member]",
        "label": "Cronos Australia Limited [Member]",
        "terseLabel": "Cronos Australia"
       }
      }
     },
     "localname": "CronosAustraliaLimitedMember",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundDetails",
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofAdvancestoJointVenturesDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofEquityMethodInvestmentsDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofVariableInterestEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_CronosGroupInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cronos Group, Inc. [Member]",
        "label": "Cronos Group, Inc. [Member]",
        "terseLabel": "Cronos Group, Inc."
       }
      }
     },
     "localname": "CronosGroupInc.Member",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofEquityMethodInvestmentsDetails",
      "http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_CronosGrowCoCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cronos GrowCo Credit Facility [Member]",
        "label": "Cronos GrowCo Credit Facility [Member]",
        "terseLabel": "Cronos GrowCo Credit Facility"
       }
      }
     },
     "localname": "CronosGrowCoCreditFacilityMember",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_CronosGrowingCompanyInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cronos Growing Company Inc. [Member]",
        "label": "Cronos Growing Company Inc. [Member]",
        "terseLabel": "Cronos GrowCo"
       }
      }
     },
     "localname": "CronosGrowingCompanyInc.Member",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofAdvancestoJointVenturesDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofEquityMethodInvestmentsDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofVariableInterestEntitiesDetails",
      "http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_CronosIsraelG.S.CultivationsLtd.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cronos Israel G.S. Cultivations Ltd. [Member]",
        "label": "Cronos Israel G.S. Cultivations Ltd. [Member]",
        "terseLabel": "Cronos Israel G.S. Cultivations Ltd."
       }
      }
     },
     "localname": "CronosIsraelG.S.CultivationsLtd.Member",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesScheduleofConsolidatedEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_CronosIsraelG.S.ManufacturingLtd.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cronos Israel G.S. Manufacturing Ltd. [Member]",
        "label": "Cronos Israel G.S. Manufacturing Ltd. [Member]",
        "terseLabel": "Cronos Israel G.S. Manufacturing Ltd."
       }
      }
     },
     "localname": "CronosIsraelG.S.ManufacturingLtd.Member",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesScheduleofConsolidatedEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_CronosIsraelG.S.PharmaciesLtd.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cronos Israel G.S. Pharmacies Ltd. [Member]",
        "label": "Cronos Israel G.S. Pharmacies Ltd. [Member]",
        "terseLabel": "Cronos Israel G.S. Pharmacies Ltd."
       }
      }
     },
     "localname": "CronosIsraelG.S.PharmaciesLtd.Member",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesScheduleofConsolidatedEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_CronosIsraelG.S.StoreLtd.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cronos Israel G.S. Store Ltd. [Member]",
        "label": "Cronos Israel G.S. Store Ltd. [Member]",
        "terseLabel": "Cronos Israel G.S. Store Ltd."
       }
      }
     },
     "localname": "CronosIsraelG.S.StoreLtd.Member",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesScheduleofConsolidatedEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_DebtInstrumentPastDueAdditionalInterestRateStatedPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Past Due, Additional Interest Rate, Stated Percentage",
        "label": "Debt Instrument, Past Due, Additional Interest Rate, Stated Percentage",
        "terseLabel": "Additional interest rate if past due"
       }
      }
     },
     "localname": "DebtInstrumentPastDueAdditionalInterestRateStatedPercentage",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsScheduleofAdvancestoJointVenturesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Compensation Share-based Arrangements, Liability [Roll Forward]",
        "label": "Deferred Compensation Share-based Arrangements, Liability [Roll Forward]",
        "terseLabel": "Weighted average grant date fair value (C$)",
        "verboseLabel": "Financial liability"
       }
      }
     },
     "localname": "DeferredCompensationSharebasedArrangementsLiabilityRollForward",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofDeferredShareUnitsActivityDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofRestrictedShareUnitsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cron_DeferredShareUnitsDSUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Share Units (DSUs) [Member]",
        "label": "Deferred Share Units (DSUs) [Member]",
        "terseLabel": "Deferred Share Units (DSUs)"
       }
      }
     },
     "localname": "DeferredShareUnitsDSUsMember",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsDeferredShareUnitsNarrativeDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofDeferredShareUnitsActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_DeferredTaxAssetsDebtIssuanceCosts": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Debt Issuance Costs",
        "label": "Deferred Tax Assets, Debt Issuance Costs",
        "terseLabel": "Deferred financing costs"
       }
      }
     },
     "localname": "DeferredTaxAssetsDebtIssuanceCosts",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_DeferredTaxAssetsFinanceLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Finance Lease Liabilities",
        "label": "Deferred Tax Assets, Finance Lease Liabilities",
        "terseLabel": "Finance lease obligation"
       }
      }
     },
     "localname": "DeferredTaxAssetsFinanceLeaseLiabilities",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_DeferredTaxAssetsShareIssuanceCost": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Share Issuance Cost",
        "label": "Deferred Tax Assets, Share Issuance Cost",
        "terseLabel": "Share issuance cost"
       }
      }
     },
     "localname": "DeferredTaxAssetsShareIssuanceCost",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_DeferredTaxLiabilitiesLicenses": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Liabilities, Licenses",
        "label": "Deferred Tax Liabilities, Licenses",
        "negatedTerseLabel": "License"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesLicenses",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Liabilities, Operating Lease, Right-Of-Use Asset",
        "label": "Deferred Tax Liabilities, Operating Lease, Right-Of-Use Asset",
        "negatedTerseLabel": "Right-of-use assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_DerivativeInstrumentsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative Instruments [Roll Forward]",
        "label": "Derivative Instruments [Roll Forward]",
        "terseLabel": "Derivative Instruments [Roll Forward]"
       }
      }
     },
     "localname": "DerivativeInstrumentsRollForward",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cron_DerivativeLiabilityUsefulLifeTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative Liability, Useful Life, Term",
        "label": "Derivative Liability, Useful Life, Term",
        "terseLabel": "Expected life"
       }
      }
     },
     "localname": "DerivativeLiabilityUsefulLifeTerm",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cron_DiscontinuedOperationAssetsValuationAllowanceValuationIncrease": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discontinued Operation, Assets, Valuation Allowance, Valuation Increase",
        "label": "Discontinued Operation, Assets, Valuation Allowance, Valuation Increase",
        "terseLabel": "Valuation allowance recorded upon reclassification of assets as held-for-sale"
       }
      }
     },
     "localname": "DiscontinuedOperationAssetsValuationAllowanceValuationIncrease",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/DiscontinuedOperationsandHeldforsaleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_EffectiveIncomeTaxRateReconciliationExpectedIncomeTaxExpenseRecoveryAmount": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Expected Income Tax Expense (Recovery), Amount",
        "label": "Effective Income Tax Rate Reconciliation, Expected Income Tax Expense (Recovery), Amount",
        "terseLabel": "Expected income tax expense (benefit)"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationExpectedIncomeTaxExpenseRecoveryAmount",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_EffectiveIncomeTaxRateReconciliationFairValueGainFinancialLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Fair Value Gain, Financial Liabilities",
        "label": "Effective Income Tax Rate Reconciliation, Fair Value Gain, Financial Liabilities",
        "negatedTerseLabel": "Fair value gain on financial liabilities"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationFairValueGainFinancialLiabilities",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionCosts": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Acquisition Costs",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Acquisition Costs",
        "terseLabel": "Non-deductible transaction costs"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionCosts",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_EnterpriseResourcePlanningSystemMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Enterprise Resource Planning System",
        "label": "Enterprise Resource Planning System [Member]",
        "terseLabel": "Enterprise resource planning (\u201cERP\u201d) software",
        "verboseLabel": "ERP system"
       }
      }
     },
     "localname": "EnterpriseResourcePlanningSystemMember",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails",
      "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsAmortizationMethodsandRatesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_FinancingReceivableAccruedInterestCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_NotesAndLoansReceivableNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing Receivable, Accrued Interest, Current",
        "label": "Financing Receivable, Accrued Interest, Current",
        "terseLabel": "Add: Accrued interest"
       }
      }
     },
     "localname": "FinancingReceivableAccruedInterestCurrent",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_FinancingReceivableAccruedInterestNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_NotesAndLoansReceivableNetNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing Receivable, Accrued Interest, Noncurrent",
        "label": "Financing Receivable, Accrued Interest, Noncurrent",
        "terseLabel": "Add: Accrued interest"
       }
      }
     },
     "localname": "FinancingReceivableAccruedInterestNoncurrent",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_FinancingReceivableAdditionalFaceAmountIncludingThirdPartyAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing Receivable, Additional Face Amount, Including Third Party Amount",
        "label": "Financing Receivable, Additional Face Amount, Including Third Party Amount",
        "terseLabel": "Additional principal amount"
       }
      }
     },
     "localname": "FinancingReceivableAdditionalFaceAmountIncludingThirdPartyAmount",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_FinancingReceivableBeforeAccruedInterestCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_NotesAndLoansReceivableNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing Receivable, Before Accrued Interest, Current",
        "label": "Financing Receivable, Before Accrued Interest, Current",
        "terseLabel": "Current portion of loans receivable, before accrued interest"
       }
      }
     },
     "localname": "FinancingReceivableBeforeAccruedInterestCurrent",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_FinancingReceivableBeforeAccruedInterestNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_NotesAndLoansReceivableNetNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing Receivable, Before Accrued Interest, Noncurrent",
        "label": "Financing Receivable, Before Accrued Interest, Noncurrent",
        "terseLabel": "Long term portion of loans receivable, before accrued interest"
       }
      }
     },
     "localname": "FinancingReceivableBeforeAccruedInterestNoncurrent",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_FinancingReceivableDueOnDemandIntendedDemandTermMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing Receivable, Due On Demand, Intended Demand Term, Minimum",
        "label": "Financing Receivable, Due On Demand, Intended Demand Term, Minimum",
        "terseLabel": "Due on demand, intended demand term, minimum"
       }
      }
     },
     "localname": "FinancingReceivableDueOnDemandIntendedDemandTermMinimum",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cron_FinancingReceivableDueOnDemandTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing Receivable, Due On Demand, Term",
        "label": "Financing Receivable, Due On Demand, Term",
        "terseLabel": "Due on demand, term"
       }
      }
     },
     "localname": "FinancingReceivableDueOnDemandTerm",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cron_FinancingReceivableFaceAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing Receivable, Face Amount",
        "label": "Financing Receivable, Face Amount",
        "terseLabel": "Face amount"
       }
      }
     },
     "localname": "FinancingReceivableFaceAmount",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_FinancingReceivableFaceAmountIncludingThirdPartyAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing Receivable, Face Amount, Including Third Party Amount",
        "label": "Financing Receivable, Face Amount, Including Third Party Amount",
        "terseLabel": "Total aggregate principal amount"
       }
      }
     },
     "localname": "FinancingReceivableFaceAmountIncludingThirdPartyAmount",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_FinancingReceivableFundingCommitmentPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing Receivable, Funding Commitment Percentage",
        "label": "Financing Receivable, Funding Commitment Percentage",
        "terseLabel": "Funding commitment percentage"
       }
      }
     },
     "localname": "FinancingReceivableFundingCommitmentPercentage",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cron_FinancingReceivableInterestRateStatedPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing Receivable, Interest Rate, Stated Percentage",
        "label": "Financing Receivable, Interest Rate, Stated Percentage",
        "terseLabel": "Stated interest rate"
       }
      }
     },
     "localname": "FinancingReceivableInterestRateStatedPercentage",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cron_FourCustomersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Four Customers",
        "label": "Four Customers [Member]",
        "terseLabel": "Four Customers"
       }
      }
     },
     "localname": "FourCustomersMember",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_FourMajorCustomersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Four Major Customers",
        "label": "Four Major Customers [Member]",
        "terseLabel": "Four Major Customers"
       }
      }
     },
     "localname": "FourMajorCustomersMember",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_FourVendorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Four Vendors",
        "label": "Four Vendors [Member]",
        "terseLabel": "Four Vendors"
       }
      }
     },
     "localname": "FourVendorsMember",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_GeneralAndAdministrativeExpensesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "General And Administrative Expenses [Table Text Block]",
        "label": "General And Administrative Expenses [Table Text Block]",
        "terseLabel": "Schedule of General and Administrative Expenses"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpensesTableTextBlock",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/GeneralandAdministrativeExpensesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cron_GinkgoBioworksInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ginkgo Bioworks Inc. [Member]",
        "label": "Ginkgo Bioworks Inc. [Member]",
        "terseLabel": "Ginkgo"
       }
      }
     },
     "localname": "GinkgoBioworksInc.Member",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsRDCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_GinkgoEquityMilestonesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ginkgo Equity Milestones [Member]",
        "label": "Ginkgo Equity Milestones [Member]",
        "terseLabel": "Ginkgo Equity Milestones"
       }
      }
     },
     "localname": "GinkgoEquityMilestonesMember",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/EarningslossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedSharesOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_GrantedMay132016ThroughMay272016Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Granted May 13, 2016 Through May 27, 2016 [Member]",
        "label": "Granted May 13, 2016 Through May 27, 2016 [Member]",
        "terseLabel": "May 13 \u2013 27, 2016"
       }
      }
     },
     "localname": "GrantedMay132016ThroughMay272016Member",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofOutstandingWarrantsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_HealthCanadaLicensingAgreementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Canada Licensing Agreements [Member]",
        "label": "Health Canada Licensing Agreements [Member]",
        "terseLabel": "Health Canada licenses"
       }
      }
     },
     "localname": "HealthCanadaLicensingAgreementsMember",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_IncreaseDecreasePrepaidExpensesAndOtherReceivables": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/SupplementaryCashFlowInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncreaseDecreaseInOperatingCapital",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) Prepaid Expenses And Other Receivables",
        "label": "Increase (Decrease) Prepaid Expenses And Other Receivables",
        "negatedTerseLabel": "Prepaids and other receivables"
       }
      }
     },
     "localname": "IncreaseDecreasePrepaidExpensesAndOtherReceivables",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/SupplementaryCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indefinite Lived Intangible Assets Excluding Goodwill Accumulated Impairment",
        "label": "Indefinite Lived Intangible Assets Excluding Goodwill Accumulated Impairment",
        "negatedTerseLabel": "Impairment charges"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_InventoryCannabisExtractsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inventory, Cannabis Extracts [Member]",
        "label": "Inventory, Cannabis Extracts [Member]",
        "terseLabel": "Cannabis Extracts"
       }
      }
     },
     "localname": "InventoryCannabisExtractsMember",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/InventoryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_InventoryDryCannabisMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inventory, Dry Cannabis [Member]",
        "label": "Inventory, Dry Cannabis [Member]",
        "terseLabel": "Dry Cannabis"
       }
      }
     },
     "localname": "InventoryDryCannabisMember",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/InventoryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_InvestmentOwnedNumberOfSharesReceived": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment Owned, Number Of Shares Received",
        "label": "Investment Owned, Number Of Shares Received",
        "terseLabel": "Shares received (in shares)"
       }
      }
     },
     "localname": "InvestmentOwnedNumberOfSharesReceived",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/OtherInvestmentsSummaryofOtherInvestmentsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cron_InvestmentOwnedNumberOfSharesSold": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment Owned, Number Of Shares Sold",
        "label": "Investment Owned, Number Of Shares Sold",
        "terseLabel": "Investment owned, number of shares sold (in shares)"
       }
      }
     },
     "localname": "InvestmentOwnedNumberOfSharesSold",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/OtherInvestmentsSummaryofOtherInvestmentsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cron_InvestmentOwnedNumberOfWarrantsExercised": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment Owned, Number Of Warrants Exercised",
        "label": "Investment Owned, Number Of Warrants Exercised",
        "terseLabel": "Number of securities called by warrants or rights (in shares)"
       }
      }
     },
     "localname": "InvestmentOwnedNumberOfWarrantsExercised",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/OtherInvestmentsSummaryofOtherInvestmentsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cron_InvestmentOwnedSharesSoldPercentageOfSharesIssuedAndOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment Owned, Shares Sold, Percentage Of Shares Issued And Outstanding",
        "label": "Investment Owned, Shares Sold, Percentage Of Shares Issued And Outstanding",
        "terseLabel": "Investment owned, shares sold, percentage of shares issued and outstanding"
       }
      }
     },
     "localname": "InvestmentOwnedSharesSoldPercentageOfSharesIssuedAndOutstanding",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/OtherInvestmentsSummaryofOtherInvestmentsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments In And Advances To Affiliates, At Fair Value, Advances (Repayments)",
        "label": "Investments In And Advances To Affiliates, At Fair Value, Advances (Repayments)",
        "terseLabel": "Advances (repayments)",
        "verboseLabel": "Advances to affiliates"
       }
      }
     },
     "localname": "InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsScheduleofAdvancestoJointVenturesDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofEquityMethodInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueChangesDueToCurrencyTranslation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments In And Advances To Affiliates, At Fair Value, Changes Due To Currency Translation",
        "label": "Investments In And Advances To Affiliates, At Fair Value, Changes Due To Currency Translation",
        "terseLabel": "Effect from foreign exchange"
       }
      }
     },
     "localname": "InvestmentsInAndAdvancesToAffiliatesAtFairValueChangesDueToCurrencyTranslation",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsScheduleofAdvancestoJointVenturesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueInterestOnAdvances": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments In And Advances To Affiliates, At Fair Value, Interest On Advances",
        "label": "Investments In And Advances To Affiliates, At Fair Value, Interest On Advances",
        "terseLabel": "Interest on advances"
       }
      }
     },
     "localname": "InvestmentsInAndAdvancesToAffiliatesAtFairValueInterestOnAdvances",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsScheduleofAdvancestoJointVenturesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueRecoveredFromAppliedToEquityMethodInvestment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments In And Advances To Affiliates, At Fair Value, Recovered From (Applied To) Equity Method Investment",
        "label": "Investments In And Advances To Affiliates, At Fair Value, Recovered From (Applied To) Equity Method Investment",
        "terseLabel": "Advances to joint ventures recovered from (applied to) carrying amount of investments"
       }
      }
     },
     "localname": "InvestmentsInAndAdvancesToAffiliatesAtFairValueRecoveredFromAppliedToEquityMethodInvestment",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsScheduleofAdvancestoJointVenturesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments In And Advances To Affiliates, At Fair Value, Transfer To Investments In Equity Accounted Investees",
        "label": "Investments In And Advances To Affiliates, At Fair Value, Transfer To Investments In Equity Accounted Investees",
        "negatedTerseLabel": "Transfer to investments in equity accounted investees",
        "terseLabel": "Transfer to investments in equity accounted investees"
       }
      }
     },
     "localname": "InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsScheduleofAdvancestoJointVenturesDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofEquityMethodInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_InvestmentsInAndAdvancesToAffiliatesDebtInstrumentFaceAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments In And Advances To Affiliates, Debt Instrument, Face Amount",
        "label": "Investments In And Advances To Affiliates, Debt Instrument, Face Amount",
        "terseLabel": "Face amount"
       }
      }
     },
     "localname": "InvestmentsInAndAdvancesToAffiliatesDebtInstrumentFaceAmount",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsScheduleofAdvancestoJointVenturesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments In And Advances To Affiliates, Funding Commitment Percentage",
        "label": "Investments In And Advances To Affiliates, Funding Commitment Percentage",
        "terseLabel": "Funding commitment percentage"
       }
      }
     },
     "localname": "InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsScheduleofEquityMethodInvestmentsDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "cron_IsraeliCodesLicensingAgreementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Israeli Codes, Licensing Agreements [Member]",
        "label": "Israeli Codes, Licensing Agreements [Member]",
        "terseLabel": "Israeli codes"
       }
      }
     },
     "localname": "IsraeliCodesLicensingAgreementsMember",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_LoanReceivableNameAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loan Receivable, Name [Axis]",
        "label": "Loan Receivable, Name [Axis]",
        "terseLabel": "Loan Receivable, Name [Axis]"
       }
      }
     },
     "localname": "LoanReceivableNameAxis",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cron_LoanReceivableNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Loan Receivable, Name [Axis]",
        "label": "Loan Receivable, Name [Domain]",
        "terseLabel": "Loan Receivable, Name [Domain]"
       }
      }
     },
     "localname": "LoanReceivableNameDomain",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_LongTermPurchaseCommitmentNumberOfTargetedUnitsToDevelopProduction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term Purchase Commitment, Number Of Targeted Units to Develop Production",
        "label": "Long-term Purchase Commitment, Number Of Targeted Units to Develop Production",
        "terseLabel": "Number of cannabinoids targeted to develop scalable and consistent production"
       }
      }
     },
     "localname": "LongTermPurchaseCommitmentNumberOfTargetedUnitsToDevelopProduction",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsRDCommitmentsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableNumberOfShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term Purchase Commitment, Equity Interest Issued Or Issuable, Number Of Shares",
        "label": "Long-term Purchase Commitment, Equity Interest Issued Or Issuable, Number Of Shares",
        "terseLabel": "Common shares issuable (up to) (in shares)"
       }
      }
     },
     "localname": "LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableNumberOfShares",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsRDCommitmentsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cron_LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableValueAssigned": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term Purchase Commitment, Equity Interest Issued Or Issuable, Value Assigned",
        "label": "Long-term Purchase Commitment, Equity Interest Issued Or Issuable, Value Assigned",
        "terseLabel": "Common shares issuable, value assigned"
       }
      }
     },
     "localname": "LongtermPurchaseCommitmentEquityInterestIssuedOrIssuableValueAssigned",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsRDCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_LongtermPurchaseCommitmentMonthlyFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term Purchase Commitment, Monthly Fee, Percentage",
        "label": "Long-term Purchase Commitment, Monthly Fee, Percentage",
        "terseLabel": "Monthly fee, percentage of direct and indirect service costs"
       }
      }
     },
     "localname": "LongtermPurchaseCommitmentMonthlyFeePercentage",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsRDCommitmentsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cron_LongtermPurchaseCommitmentPaymentsSubjectToMilestones": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term Purchase Commitment, Payments Subject To Milestones",
        "label": "Long-term Purchase Commitment, Payments Subject To Milestones",
        "terseLabel": "Payments subject to milestones"
       }
      }
     },
     "localname": "LongtermPurchaseCommitmentPaymentsSubjectToMilestones",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsRDCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_LossContingencyPunitiveDamagesSoughtValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Punitive Damages Sought, Value",
        "label": "Loss Contingency, Punitive Damages Sought, Value",
        "terseLabel": "Punitive damages sought"
       }
      }
     },
     "localname": "LossContingencyPunitiveDamagesSoughtValue",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/ContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_MeasurementInputSubscriptionPriceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement Input, Subscription Price [Member]",
        "label": "Measurement Input, Subscription Price [Member]",
        "terseLabel": "Subscription price (per share in C$)"
       }
      }
     },
     "localname": "MeasurementInputSubscriptionPriceMember",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_MedMenCanadaInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "MedMen Canada Inc. [Member]",
        "label": "MedMen Canada Inc. [Member]",
        "terseLabel": "MedMen Canada"
       }
      }
     },
     "localname": "MedMenCanadaInc.Member",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofAdvancestoJointVenturesDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofEquityMethodInvestmentsDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofVariableInterestEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_MucciMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mucci [Member]",
        "label": "Mucci [Member]",
        "terseLabel": "Mucci"
       }
      }
     },
     "localname": "MucciMember",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsScheduleofEquityMethodInvestmentsDetails",
      "http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_NatuEraMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "NatuEra [Member]",
        "label": "NatuEra [Member]",
        "terseLabel": "Natuera"
       }
      }
     },
     "localname": "NatuEraMember",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofAdvancestoJointVenturesDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofEquityMethodInvestmentsDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofVariableInterestEntitiesDetails",
      "http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_NatuEraSeriesALoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "NatuEra Series A Loan [Member]",
        "label": "NatuEra Series A Loan [Member]",
        "terseLabel": "NatuEra Series A Loan"
       }
      }
     },
     "localname": "NatuEraSeriesALoanMember",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_NatuEraSeriesALoanShareOfNetLossInExcessOfCarryingValueOfEquityInvestmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "NatuEra Series A Loan - Share Of Net Loss In Excess Of Carrying Value Of Equity Investment",
        "label": "NatuEra Series A Loan - Share Of Net Loss In Excess Of Carrying Value Of Equity Investment [Member]",
        "terseLabel": "NatuEra Series A Loan - Share of Net Loss in Excess of Carrying Value of Equity Investment"
       }
      }
     },
     "localname": "NatuEraSeriesALoanShareOfNetLossInExcessOfCarryingValueOfEquityInvestmentMember",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_NoncashSellingAndMarketingExpense": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncash Selling And Marketing Expense",
        "label": "Noncash Selling And Marketing Expense",
        "terseLabel": "Non-cash sales and marketing"
       }
      }
     },
     "localname": "NoncashSellingAndMarketingExpense",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_NonmonetaryTransactionNumberOfTransactions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nonmonetary Transaction, Number Of Transactions",
        "label": "Nonmonetary Transaction, Number Of Transactions",
        "terseLabel": "Number of transactions"
       }
      }
     },
     "localname": "NonmonetaryTransactionNumberOfTransactions",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/NonmonetaryTransactionsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cron_NonrevolvingTermLoanFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-revolving Term Loan Facility [Member]",
        "label": "Non-revolving Term Loan Facility [Member]",
        "terseLabel": "Non-revolving Term Loan Facility"
       }
      }
     },
     "localname": "NonrevolvingTermLoanFacilityMember",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/LoansPayableLongtermNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_NumberOfAdultuseBrands": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Adult-use Brands",
        "label": "Number Of Adult-use Brands",
        "terseLabel": "Number of adult-use brands"
       }
      }
     },
     "localname": "NumberOfAdultuseBrands",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cron_NumberOfContinentsWithInternationalProductionAndDistribution": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Continents With International Production And Distribution",
        "label": "Number Of Continents With International Production And Distribution",
        "terseLabel": "Number of continents with international production and distribution"
       }
      }
     },
     "localname": "NumberOfContinentsWithInternationalProductionAndDistribution",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cron_NumberOfHempderivedCannabidiolPersonalCareBrands": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Hemp-derived Cannabidiol Personal Care Brands",
        "label": "Number Of Hemp-derived Cannabidiol Personal Care Brands",
        "terseLabel": "Number of hemp-derived cannabidiol personal care brands"
       }
      }
     },
     "localname": "NumberOfHempderivedCannabidiolPersonalCareBrands",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cron_NumberOfStrategicJointVentures": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Strategic Joint Ventures",
        "label": "Number Of Strategic Joint Ventures",
        "terseLabel": "Number of strategic joint ventures"
       }
      }
     },
     "localname": "NumberOfStrategicJointVentures",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cron_OGBCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "OGBC",
        "label": "OGBC [Member]",
        "terseLabel": "OGBC"
       }
      }
     },
     "localname": "OGBCMember",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/DiscontinuedOperationsandHeldforsaleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_OfficeAndGeneralExpense": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/GeneralandAdministrativeExpensesScheduleofGeneralandAdministrativeExpensesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_GeneralAndAdministrativeExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Office And General Expense",
        "label": "Office And General Expense",
        "terseLabel": "Office and general"
       }
      }
     },
     "localname": "OfficeAndGeneralExpense",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/GeneralandAdministrativeExpensesScheduleofGeneralandAdministrativeExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_OneMajorCustomerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One Major Customer [Member]",
        "label": "One Major Customer [Member]",
        "terseLabel": "One Major Customer"
       }
      }
     },
     "localname": "OneMajorCustomerMember",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_OtherComprehensiveIncomeLossAccumulatedGainLossDebtSecuritiesRevaluationAndDisposalOfOtherInvestments": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Comprehensive Income (Loss),Accumulated Gain (Loss), Debt Securities, Revaluation And Disposal Of Other Investments",
        "label": "Other Comprehensive Income (Loss),Accumulated Gain (Loss), Debt Securities, Revaluation And Disposal Of Other Investments",
        "terseLabel": "Gain on revaluation and disposal of other investments, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAccumulatedGainLossDebtSecuritiesRevaluationAndDisposalOfOtherInvestments",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_OtherCostOfGoodsAndServicesSold": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Cost Of Goods And Services Sold",
        "label": "Other Cost Of Goods And Services Sold",
        "terseLabel": "Cost of sales"
       }
      }
     },
     "localname": "OtherCostOfGoodsAndServicesSold",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_OtherCountriesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Countries [Member]",
        "label": "Other Countries [Member]",
        "terseLabel": "Other countries"
       }
      }
     },
     "localname": "OtherCountriesMember",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationScheduleofLonglivedAssetsbyGeographicAreasDetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_OtherNetAssetsLiabilities": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Net Assets (Liabilities)",
        "label": "Other Net Assets (Liabilities)",
        "terseLabel": "Other Net Assets (Liabilities)"
       }
      }
     },
     "localname": "OtherNetAssetsLiabilities",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsScheduleofVariableInterestEntitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_PaymentOfTransactionCosts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payment Of Transaction Costs",
        "label": "Payment Of Transaction Costs",
        "terseLabel": "Transaction costs"
       }
      }
     },
     "localname": "PaymentOfTransactionCosts",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_PaymentsForLeaseObligationsFinancingActivities": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments For Lease Obligations, Financing Activities",
        "label": "Payments For Lease Obligations, Financing Activities",
        "negatedTerseLabel": "Repayment of lease obligations"
       }
      }
     },
     "localname": "PaymentsForLeaseObligationsFinancingActivities",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_PaymentsToExerciseWarrants": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments To Exercise Warrants",
        "label": "Payments To Exercise Warrants",
        "terseLabel": "Proceeds from exercise of warrants"
       }
      }
     },
     "localname": "PaymentsToExerciseWarrants",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/OtherInvestmentsSummaryofOtherInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_PeaceNaturalsReportingUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Peace Naturals Reporting Unit [Member]",
        "label": "Peace Naturals Reporting Unit [Member]",
        "terseLabel": "Peace Naturals"
       }
      }
     },
     "localname": "PeaceNaturalsReportingUnitMember",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_PreEmptiveRightsAndTopUpRightsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pre-Emptive Rights And Top-Up Rights",
        "label": "Pre-Emptive Rights And Top-Up Rights [Member]",
        "terseLabel": "Pre-Emptive Rights and Top-Up Rights"
       }
      }
     },
     "localname": "PreEmptiveRightsAndTopUpRightsMember",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_PreemptiveRightsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pre-emptive Rights [Member]",
        "label": "Pre-emptive Rights [Member]",
        "terseLabel": "Pre-emptive Rights",
        "verboseLabel": "Pre-emptive Rights"
       }
      }
     },
     "localname": "PreemptiveRightsMember",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails",
      "http://thecronosgroup.com/role/EarningslossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedSharesOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_ProceedsFromEquitySecuritiesFVNIAndEquitySecuritiesWithoutDeterminableFairValue": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From Equity Securities, FV-NI And Equity Securities Without Determinable Fair Value",
        "label": "Proceeds From Equity Securities, FV-NI And Equity Securities Without Determinable Fair Value",
        "terseLabel": "Proceeds from sale of other investments"
       }
      }
     },
     "localname": "ProceedsFromEquitySecuritiesFVNIAndEquitySecuritiesWithoutDeterminableFairValue",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_ProceedsFromRightExercises": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From Right Exercises",
        "label": "Proceeds From Right Exercises",
        "terseLabel": "Proceeds from exercise of Top-up Rights"
       }
      }
     },
     "localname": "ProceedsFromRightExercises",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_ProceedsFromSaleOfEquitySecuritiesFVNI": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From Sale Of Equity Securities, FV-NI",
        "label": "Proceeds From Sale Of Equity Securities, FV-NI",
        "terseLabel": "Proceeds from sale of equity securities, FV-NI"
       }
      }
     },
     "localname": "ProceedsFromSaleOfEquitySecuritiesFVNI",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/OtherInvestmentsSummaryofOtherInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_ProceedsFromWarrantExercisedAndStockOptionsExercised": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From Warrant Exercised And Stock Options Exercised",
        "label": "Proceeds From Warrant Exercised And Stock Options Exercised",
        "terseLabel": "Proceeds from exercise of warrants and options"
       }
      }
     },
     "localname": "ProceedsFromWarrantExercisedAndStockOptionsExercised",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_ProfessionalAndConsultingExpense": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/GeneralandAdministrativeExpensesScheduleofGeneralandAdministrativeExpensesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_GeneralAndAdministrativeExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Professional And Consulting Expense",
        "label": "Professional And Consulting Expense",
        "terseLabel": "Professional and consulting"
       }
      }
     },
     "localname": "ProfessionalAndConsultingExpense",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/GeneralandAdministrativeExpensesScheduleofGeneralandAdministrativeExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_PurchaseOfMachineryAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase Of Machinery And Equipment [Member]",
        "label": "Purchase Of Machinery And Equipment [Member]",
        "terseLabel": "Purchase of Machinery and Equipment"
       }
      }
     },
     "localname": "PurchaseOfMachineryAndEquipmentMember",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_RedwoodAcquisitionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redwood Acquisition [Member]",
        "label": "Redwood Acquisition [Member]",
        "terseLabel": "Redwood Acquisition"
       }
      }
     },
     "localname": "RedwoodAcquisitionMember",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/CapitalStockNarrativeDetails",
      "http://thecronosgroup.com/role/CapitalStockScheduleofCommonSharesIssuedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_RedwoodHoldingGroupLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redwood Holding Group, LLC [Member]",
        "label": "Redwood Holding Group, LLC [Member]",
        "terseLabel": "Redwood"
       }
      }
     },
     "localname": "RedwoodHoldingGroupLLCMember",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/BusinessCombinationsNarrativeDetails",
      "http://thecronosgroup.com/role/BusinessCombinationsScheduleofFairValueofNetAssetsAcquiredDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_RedwoodReportingUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redwood Reporting Unit [Member]",
        "label": "Redwood Reporting Unit [Member]",
        "terseLabel": "Redwood"
       }
      }
     },
     "localname": "RedwoodReportingUnitMember",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_RepurposingPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Repurposing Plan",
        "label": "Repurposing Plan [Member]",
        "terseLabel": "Repurposing Plan"
       }
      }
     },
     "localname": "RepurposingPlanMember",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/RepurposingChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_RestOfWorldSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rest Of World Segment [Member]",
        "label": "Rest Of World Segment [Member]",
        "terseLabel": "Rest of World"
       }
      }
     },
     "localname": "RestOfWorldSegmentMember",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofAdjustedEBITDADetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_RestatementReviewExpense": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/GeneralandAdministrativeExpensesScheduleofGeneralandAdministrativeExpensesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_GeneralAndAdministrativeExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restatement Review Expense",
        "label": "Restatement Review Expense",
        "terseLabel": "Review costs related to restatement of 2019 interim financial statements"
       }
      }
     },
     "localname": "RestatementReviewExpense",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/GeneralandAdministrativeExpensesScheduleofGeneralandAdministrativeExpensesDetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofAdjustedEBITDADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_SaleOfStockPerformanceMilestoneAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale Of Stock, Performance Milestone",
        "label": "Sale Of Stock, Performance Milestone [Axis]",
        "terseLabel": "Sale Of Stock, Performance Milestone [Axis]"
       }
      }
     },
     "localname": "SaleOfStockPerformanceMilestoneAxis",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsUseofPublicityRightsinBrandDevelopmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cron_SaleOfStockPerformanceMilestoneDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale Of Stock, Performance Milestone",
        "label": "Sale Of Stock, Performance Milestone [Domain]",
        "terseLabel": "Sale Of Stock, Performance Milestone [Domain]"
       }
      }
     },
     "localname": "SaleOfStockPerformanceMilestoneDomain",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsUseofPublicityRightsinBrandDevelopmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_SaleOfStockPerformanceMilestoneOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale Of Stock, Performance Milestone One",
        "label": "Sale Of Stock, Performance Milestone One [Member]",
        "terseLabel": "Sale Of Stock, Performance Milestone One"
       }
      }
     },
     "localname": "SaleOfStockPerformanceMilestoneOneMember",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsUseofPublicityRightsinBrandDevelopmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_SaleOfStockPerformanceMilestoneTriggeringEventMinimumRevenue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale Of Stock, Performance Milestone, Triggering Event, Minimum Revenue",
        "label": "Sale Of Stock, Performance Milestone, Triggering Event, Minimum Revenue",
        "terseLabel": "Sale of stock, performance milestone, triggering event, minimum revenue"
       }
      }
     },
     "localname": "SaleOfStockPerformanceMilestoneTriggeringEventMinimumRevenue",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsUseofPublicityRightsinBrandDevelopmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_SaleOfStockPerformanceMilestoneTriggeringEventSharesIssuedValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale Of Stock, Performance Milestone, Triggering Event, Shares Issued, Value",
        "label": "Sale Of Stock, Performance Milestone, Triggering Event, Shares Issued, Value",
        "terseLabel": "Sale of stock, performance milestone, triggering event, shares issued, value"
       }
      }
     },
     "localname": "SaleOfStockPerformanceMilestoneTriggeringEventSharesIssuedValue",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsUseofPublicityRightsinBrandDevelopmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_SaleOfStockPerformanceMilestoneTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale Of Stock, Performance Milestone Two",
        "label": "Sale Of Stock, Performance Milestone Two [Member]",
        "terseLabel": "Sale Of Stock, Performance Milestone Two"
       }
      }
     },
     "localname": "SaleOfStockPerformanceMilestoneTwoMember",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsUseofPublicityRightsinBrandDevelopmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) In Expected Annualized Volatility On Net Income (Loss)",
        "label": "Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) In Expected Annualized Volatility On Net Income (Loss)",
        "terseLabel": "Expected annualized volatility"
       }
      }
     },
     "localname": "SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) In Share Price On Net Income (Loss)",
        "label": "Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) In Share Price On Net Income (Loss)",
        "terseLabel": "Share price at issuance date"
       }
      }
     },
     "localname": "SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) In Weighted Average Expected Life On Net Income (Loss)",
        "label": "Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) In Weighted Average Expected Life On Net Income (Loss)",
        "terseLabel": "Weighted average expected life"
       }
      }
     },
     "localname": "SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) On Net Income (Loss) [Abstract]",
        "label": "Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) On Net Income (Loss) [Abstract]",
        "terseLabel": "Sensitivity Analysis, Impact of 10 Percent Decrease (Increase) on Net Income (Loss) [Abstract]"
       }
      }
     },
     "localname": "SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cron_SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sensitivity Analysis, Impact On Net Income (Loss) [Table Text Block]",
        "label": "Sensitivity Analysis, Impact On Net Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Sensitivity Analysis"
       }
      }
     },
     "localname": "SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cron_SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sensitivity Analysis Of Carrying Value, Net Assets, Impact Of 10 Percent Change In Exchange Rate",
        "label": "Sensitivity Analysis Of Carrying Value, Net Assets, Impact Of 10 Percent Change In Exchange Rate",
        "terseLabel": "Impact of ten percent change in exchange rate"
       }
      }
     },
     "localname": "SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsCurrencyRateRiskNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncome": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sensitivity Analysis Of Interest Rate Risk Income Statement Impact, Impact Of Change In Average Variable Rate On Interest Income",
        "label": "Sensitivity Analysis Of Interest Rate Risk Income Statement Impact, Impact Of Change In Average Variable Rate On Interest Income",
        "terseLabel": "Impact of change in average variable rate, amount"
       }
      }
     },
     "localname": "SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncome",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsInterestRateRiskDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncomePercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sensitivity Analysis Of Interest Rate Risk Income Statement Impact, Impact Of Change In Average Variable Rate On Interest Income, Percent",
        "label": "Sensitivity Analysis Of Interest Rate Risk Income Statement Impact, Impact Of Change In Average Variable Rate On Interest Income, Percent",
        "terseLabel": "Impact of change in average variable rate, percent"
       }
      }
     },
     "localname": "SensitivityAnalysisOfInterestRateRiskIncomeStatementImpactImpactOfChangeInAverageVariableRateOnInterestIncomePercent",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsInterestRateRiskDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Vested And Issued In Period",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Vested And Issued In Period",
        "terseLabel": "Accelerated and vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriod",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsRestrictedShareUnitsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cron_ShareBasedPaymentArrangementGainLossOnRevaluation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Payment Arrangement, Gain (Loss) On Revaluation",
        "label": "Share-based Payment Arrangement, Gain (Loss) On Revaluation",
        "negatedTerseLabel": "Loss (gain) on revaluation"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementGainLossOnRevaluation",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofDeferredShareUnitsActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_ShareBasedPaymentArrangementLiabilitiesSettled": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Payment Arrangement, Liabilities Settled",
        "label": "Share-Based Payment Arrangement, Liabilities Settled",
        "negatedTerseLabel": "Liabilities settled"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementLiabilitiesSettled",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofDeferredShareUnitsActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsAndVestedInPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement By Share-based Payment Award, Equity Instruments Other Than Options, Grants And Vested In Period",
        "label": "Share-based Compensation Arrangement By Share-based Payment Award, Equity Instruments Other Than Options, Grants And Vested In Period",
        "terseLabel": "Granting and vesting of DSUs (in shares)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsAndVestedInPeriod",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofDeferredShareUnitsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsForfeitureRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement By Share-based Payment Award, Fair Value Assumptions, Forfeiture Rate",
        "label": "Share-based Compensation Arrangement By Share-based Payment Award, Fair Value Assumptions, Forfeiture Rate",
        "terseLabel": "Forfeiture rate"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsForfeitureRate",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsFairValueofOptionsIssuedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cron_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement By Share-based Payment Award, Fair Value Assumptions, Weighted Average Grant Date Fair Value",
        "label": "Share-based Compensation Arrangement By Share-based Payment Award, Fair Value Assumptions, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average Black-Scholes value at grant date (per option) (in dollars per share)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsWeightedAverageGrantDateFairValue",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsFairValueofOptionsIssuedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "cron_SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisesInPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement By Share-based Payment Award, Warrants, Exercises In Period",
        "label": "Share-based Compensation Arrangement By Share-based Payment Award, Warrants, Exercises In Period",
        "terseLabel": "Warrants exercised (in shares)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisesInPeriod",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "cron_StockIssuedDuringPeriodNewIssuesFairValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued During Period, New Issues, Fair Value",
        "label": "Stock Issued During Period, New Issues, Fair Value",
        "terseLabel": "Stock issued during period, new issues, fair value"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodNewIssuesFairValue",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/CapitalStockNarrativeDetails",
      "http://thecronosgroup.com/role/CommitmentsUseofPublicityRightsinBrandDevelopmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_StockIssuedDuringPeriodNewIssuesWeightedAveragePricePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued During Period, New Issues, Weighted Average Price, Period",
        "label": "Stock Issued During Period, New Issues, Weighted Average Price, Period",
        "terseLabel": "Stock issued during period, new issues, measurement input"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodNewIssuesWeightedAveragePricePeriod",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/CapitalStockNarrativeDetails",
      "http://thecronosgroup.com/role/CommitmentsUseofPublicityRightsinBrandDevelopmentDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cron_StockIssuedDuringPeriodSharesTopupRightsExercised": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued During Period, Shares, Top-up Rights Exercised",
        "label": "Stock Issued During Period, Shares, Top-up Rights Exercised",
        "terseLabel": "Top-up Rights exercised (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesTopupRightsExercised",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "cron_StockIssuedDuringPeriodValueNewIssuesIssuanceCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued During Period, Value, New Issues, Issuance Costs",
        "label": "Stock Issued During Period, Value, New Issues, Issuance Costs",
        "negatedTerseLabel": "Share issuance costs"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssuesIssuanceCosts",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_StockIssuedDuringPeriodValueTopupRightsExercised": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued During Period, Value, Top-up Rights Exercised",
        "label": "Stock Issued During Period, Value, Top-up Rights Exercised",
        "terseLabel": "Top-up Rights exercised"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueTopupRightsExercised",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_StockIssuedDuringPeriodValueWarrantsExercised": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued During Period, Value, Warrants Exercised",
        "label": "Stock Issued During Period, Value, Warrants Exercised",
        "terseLabel": "Warrants exercised"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueWarrantsExercised",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Subsidiary Or Equity Method Investee, Cumulative Percentage Ownership After All Transactions, If Warrants Exercised",
        "label": "Subsidiary Or Equity Method Investee, Cumulative Percentage Ownership After All Transactions, If Warrants Exercised",
        "terseLabel": "Ownership percentage, if warrant exercised"
       }
      }
     },
     "localname": "SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cron_TechnionResearchAndDevelopmentFoundationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technion Research And Development Foundation [Member]",
        "label": "Technion Research And Development Foundation [Member]",
        "terseLabel": "Technion"
       }
      }
     },
     "localname": "TechnionResearchAndDevelopmentFoundationMember",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsRDCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_ThreeVendorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Three Vendors [Member]",
        "label": "Three Vendors [Member]",
        "terseLabel": "Three Vendors"
       }
      }
     },
     "localname": "ThreeVendorsMember",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_TopUpRightsFixedPriceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Top-Up Rights - Fixed Price [Member]",
        "label": "Top-Up Rights - Fixed Price [Member]",
        "terseLabel": "Top-up Rights \u2013 fixed price"
       }
      }
     },
     "localname": "TopUpRightsFixedPriceMember",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/EarningslossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedSharesOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_TopUpRightsMarketPriceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Top-Up Rights - Market Price [Member]",
        "label": "Top-Up Rights - Market Price [Member]",
        "terseLabel": "Top-up Rights \u2013 market price"
       }
      }
     },
     "localname": "TopUpRightsMarketPriceMember",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/EarningslossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedSharesOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_TopupRightsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Top-up Rights [Member]",
        "label": "Top-up Rights [Member]",
        "verboseLabel": "Top-up Rights"
       }
      }
     },
     "localname": "TopupRightsMember",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails",
      "http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_TwoMajorCustomersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two Major Customers [Member]",
        "label": "Two Major Customers [Member]",
        "terseLabel": "Two Major Customers",
        "verboseLabel": "Two Customers"
       }
      }
     },
     "localname": "TwoMajorCustomersMember",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails",
      "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_U.S.DistrictCourtofEasternDistrictofNewYorkVs.CronosMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "U.S. District Court of Eastern District of New York Vs. Cronos [Member]",
        "label": "U.S. District Court of Eastern District of New York Vs. Cronos [Member]",
        "terseLabel": "U.S. District Court of Eastern District of New York Vs. Cronos"
       }
      }
     },
     "localname": "U.S.DistrictCourtofEasternDistrictofNewYorkVs.CronosMember",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/ContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_UnitedStatesSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "United States Segment [Member]",
        "label": "United States Segment [Member]",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "UnitedStatesSegmentMember",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillNarrativeDetails",
      "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofAdjustedEBITDADetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_VariableInterestEntityQualitativeOrQuantitativeInformationLicenseTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Interest Entity, Qualitative Or Quantitative Information, License Term",
        "label": "Variable Interest Entity, Qualitative Or Quantitative Information, License Term",
        "terseLabel": "License term"
       }
      }
     },
     "localname": "VariableInterestEntityQualitativeOrQuantitativeInformationLicenseTerm",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cron_VivoCannabisMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vivo Cannabis [Member]",
        "label": "Vivo Cannabis [Member]",
        "terseLabel": "Vivo Cannabis"
       }
      }
     },
     "localname": "VivoCannabisMember",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/OtherInvestmentsSummaryofOtherInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_WhistlerMedicalMarijuanaCompanyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Whistler Medical Marijuana Company [Member]",
        "label": "Whistler Medical Marijuana Company [Member]",
        "terseLabel": "Whistler"
       }
      }
     },
     "localname": "WhistlerMedicalMarijuanaCompanyMember",
     "nsuri": "http://thecronosgroup.com/20201231",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsScheduleofEquityMethodInvestmentsDetails",
      "http://thecronosgroup.com/role/OtherInvestmentsSummaryofOtherInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r848",
      "r849",
      "r850"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r851"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r846"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r852"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding (in shares)"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofEquityMethodInvestmentsDetails",
      "http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails",
      "http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r852"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r852"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r853"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r852"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r852"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r852"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r848",
      "r849",
      "r850"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofEquityMethodInvestmentsDetails",
      "http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails",
      "http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r845"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r847"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_AffiliatedEntityMember": {
     "auth_ref": [
      "r463",
      "r684",
      "r685",
      "r687",
      "r843"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Affiliated Entity [Member]",
        "terseLabel": "Altria Pinnacle LLC."
       }
      }
     },
     "localname": "AffiliatedEntityMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesNarrativeDetails",
      "http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesScheduleofRelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidatedEntitiesAxis": {
     "auth_ref": [
      "r580",
      "r581",
      "r589",
      "r590",
      "r843"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Axis]",
        "terseLabel": "Consolidated Entities [Axis]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofEquityMethodInvestmentsDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofVariableInterestEntitiesDetails",
      "http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails",
      "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesScheduleofConsolidatedEntitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesDomain": {
     "auth_ref": [
      "r580",
      "r581",
      "r589",
      "r590"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Domain]",
        "terseLabel": "Consolidated Entities [Domain]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofEquityMethodInvestmentsDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofVariableInterestEntitiesDetails",
      "http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails",
      "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesScheduleofConsolidatedEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r254",
      "r273",
      "r274",
      "r275",
      "r276",
      "r278",
      "r280",
      "r284"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationScheduleofAdjustedEBITDADetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r254",
      "r273",
      "r274",
      "r275",
      "r276",
      "r278",
      "r280",
      "r284"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationScheduleofAdjustedEBITDADetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r100",
      "r171"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsRDCommitmentsDetails",
      "http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesNarrativeDetails",
      "http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesScheduleofRelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r190",
      "r200",
      "r317",
      "r503",
      "r504",
      "r505",
      "r536",
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Cumulative Effect, Period of Adoption, Adjustment"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r190",
      "r200",
      "r317",
      "r503",
      "r504",
      "r505",
      "r536",
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r190",
      "r200",
      "r317",
      "r503",
      "r504",
      "r505",
      "r536",
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Domain]",
        "terseLabel": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundDetails",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofAdvancestoJointVenturesDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofEquityMethodInvestmentsDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofVariableInterestEntitiesDetails",
      "http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails",
      "http://thecronosgroup.com/role/OtherInvestmentsSummaryofOtherInvestmentsDetails",
      "http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r293",
      "r445",
      "r449",
      "r796"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails",
      "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r466",
      "r469",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r721",
      "r793",
      "r797"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails",
      "http://thecronosgroup.com/role/LeasesNarrativeDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsFairValueofOptionsIssuedDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails",
      "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantEquipmentUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r466",
      "r469",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r721",
      "r793",
      "r797"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails",
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/LeasesNarrativeDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsFairValueofOptionsIssuedDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails",
      "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantEquipmentUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r293",
      "r445",
      "r449",
      "r796"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails",
      "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Axis]",
        "terseLabel": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Domain]",
        "terseLabel": "Ownership [Domain]"
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r287",
      "r445",
      "r447",
      "r725",
      "r792",
      "r794"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r287",
      "r445",
      "r447",
      "r725",
      "r792",
      "r794"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r455",
      "r466",
      "r469",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r721",
      "r793",
      "r797"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails",
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/LeasesNarrativeDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsFairValueofOptionsIssuedDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails",
      "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantEquipmentUsefulLivesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r455",
      "r466",
      "r469",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r721",
      "r793",
      "r797"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails",
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/LeasesNarrativeDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsFairValueofOptionsIssuedDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails",
      "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantEquipmentUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsRDCommitmentsDetails",
      "http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesNarrativeDetails",
      "http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesScheduleofRelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RestatementAdjustmentMember": {
     "auth_ref": [
      "r186",
      "r187",
      "r188",
      "r189",
      "r193",
      "r194",
      "r198",
      "r199",
      "r200",
      "r202",
      "r203",
      "r205",
      "r206",
      "r228"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period, Adjustment [Member]",
        "terseLabel": "Held-for-sale adjustment"
       }
      }
     },
     "localname": "RestatementAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DiscontinuedOperationsandHeldforsaleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RestatementAxis": {
     "auth_ref": [
      "r186",
      "r187",
      "r188",
      "r189",
      "r193",
      "r194",
      "r198",
      "r199",
      "r200",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r228",
      "r320",
      "r321",
      "r507",
      "r537",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Axis]",
        "terseLabel": "Restatement [Axis]"
       }
      }
     },
     "localname": "RestatementAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DiscontinuedOperationsandHeldforsaleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RestatementDomain": {
     "auth_ref": [
      "r186",
      "r187",
      "r188",
      "r189",
      "r193",
      "r194",
      "r198",
      "r199",
      "r200",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r228",
      "r320",
      "r321",
      "r507",
      "r537",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Domain]",
        "terseLabel": "Restatement [Domain]"
       }
      }
     },
     "localname": "RestatementDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DiscontinuedOperationsandHeldforsaleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r467"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forecast [Member]",
        "terseLabel": "Forecast"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsUseofPublicityRightsinBrandDevelopmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioPreviouslyReportedMember": {
     "auth_ref": [
      "r186",
      "r188",
      "r189",
      "r193",
      "r194",
      "r198",
      "r199",
      "r200",
      "r202",
      "r203",
      "r205",
      "r206",
      "r228",
      "r320",
      "r321",
      "r507",
      "r537",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Previously Reported [Member]",
        "terseLabel": "As previously disclosed"
       }
      }
     },
     "localname": "ScenarioPreviouslyReportedMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DiscontinuedOperationsandHeldforsaleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r467"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsUseofPublicityRightsinBrandDevelopmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]",
        "terseLabel": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundDetails",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofAdvancestoJointVenturesDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofEquityMethodInvestmentsDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofVariableInterestEntitiesDetails",
      "http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails",
      "http://thecronosgroup.com/role/OtherInvestmentsSummaryofOtherInvestmentsDetails",
      "http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r288",
      "r289",
      "r445",
      "r448",
      "r795",
      "r834",
      "r835",
      "r836",
      "r837",
      "r838",
      "r839",
      "r840",
      "r841"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesExpenseforIncomeTaxesDetails",
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofIncomeLossbeforeIncomeTaxesDetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofLonglivedAssetsbyGeographicAreasDetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r288",
      "r289",
      "r445",
      "r448",
      "r795",
      "r829",
      "r834",
      "r835",
      "r836",
      "r837",
      "r838",
      "r839",
      "r840",
      "r841",
      "r842"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesExpenseforIncomeTaxesDetails",
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofIncomeLossbeforeIncomeTaxesDetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofLonglivedAssetsbyGeographicAreasDetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r398",
      "r467",
      "r690"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsUseofPublicityRightsinBrandDevelopmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_SubsidiariesMember": {
     "auth_ref": [
      "r463",
      "r684",
      "r685",
      "r687"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiaries [Member]",
        "terseLabel": "Cronos Group, Inc."
       }
      }
     },
     "localname": "SubsidiariesMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureLineItems",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesSummaryofValuationAllowanceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureTable": {
     "auth_ref": [
      "r184"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureTable",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesSummaryofValuationAllowanceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_WeightedAverageMember": {
     "auth_ref": [
      "r697",
      "r699",
      "r702"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average [Member]",
        "terseLabel": "Weighted Average"
       }
      }
     },
     "localname": "WeightedAverageMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdateExtensibleList": {
     "auth_ref": [
      "r193",
      "r194",
      "r195",
      "r197",
      "r314",
      "r315",
      "r316",
      "r317",
      "r320",
      "r321",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r507",
      "r536",
      "r537",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates amendment to accounting standards.",
        "label": "Accounting Standards Update [Extensible List]",
        "terseLabel": "Accounting Standards Update [Extensible List]"
       }
      }
     },
     "localname": "AccountingStandardsUpdateExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "extensibleListItemType"
    },
    "us-gaap_AccountsNotesAndLoansReceivableLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]",
        "terseLabel": "Accounts, Notes, Loans and Financing Receivable [Line Items]"
       }
      }
     },
     "localname": "AccountsNotesAndLoansReceivableLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis": {
     "auth_ref": [
      "r92"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of receivable.",
        "label": "Receivable Type [Axis]",
        "terseLabel": "Receivable Type [Axis]"
       }
      }
     },
     "localname": "AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.",
        "label": "Accounts Payable and Other Accrued Liabilities, Current",
        "terseLabel": "Accounts payable and other liabilities"
       }
      }
     },
     "localname": "AccountsPayableAndOtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r81"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable, past due"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableMember": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Obligations incurred and payable to vendors for goods and services received.",
        "label": "Accounts Payable [Member]",
        "terseLabel": "Accounts Payable"
       }
      }
     },
     "localname": "AccountsPayableMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableRelatedPartiesCurrent": {
     "auth_ref": [
      "r81",
      "r174",
      "r686",
      "r687"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount for accounts payable to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Related Parties, Current",
        "terseLabel": "Accrual for consulting services"
       }
      }
     },
     "localname": "AccountsPayableRelatedPartiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesScheduleofRelatedPartyTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold.",
        "label": "Accounts Receivable [Member]",
        "terseLabel": "Accounts Receivable"
       }
      }
     },
     "localname": "AccountsReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r29",
      "r59",
      "r295",
      "r296"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "verboseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet",
      "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails",
      "http://thecronosgroup.com/role/RevenuesfromContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff": {
     "auth_ref": [
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold period for when accounts receivable, classified as noncurrent, is considered past due to write off as uncollectible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Accounts Receivable, Noncurrent, Threshold Period Past Due, Writeoff",
        "terseLabel": "Accounts receivable, threshold period past due, writeoff"
       }
      }
     },
     "localname": "AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r79",
      "r375"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantEquipmentUsefulLivesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedTerseLabel": "Less: accumulated depreciation and amortization"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantEquipmentUsefulLivesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r62",
      "r104",
      "r105",
      "r106",
      "r776",
      "r805",
      "r809"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r648"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r103",
      "r106",
      "r107",
      "r186",
      "r187",
      "r189",
      "r587",
      "r800",
      "r801"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated other comprehensive income (loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails",
      "http://thecronosgroup.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r102",
      "r106",
      "r107",
      "r587",
      "r643",
      "r644",
      "r645",
      "r646",
      "r648"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "verboseLabel": "Net foreign exchange gain (loss) on translation of foreign operations"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalFinancialInformationDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement.",
        "label": "Additional Financial Information Disclosure [Text Block]",
        "terseLabel": "General and Administrative Expenses"
       }
      }
     },
     "localname": "AdditionalFinancialInformationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/GeneralandAdministrativeExpenses"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r60",
      "r507"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r186",
      "r187",
      "r189",
      "r503",
      "r504",
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Items not affecting cash:"
       }
      }
     },
     "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Decrease for Tax Withholding Obligation",
        "negatedTerseLabel": "Taxes withheld on vesting of restricted share units"
       }
      }
     },
     "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for restricted stock unit under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition",
        "terseLabel": "Vesting of common shares issued in connection with the use of certain publicity rights in brand development"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition",
        "terseLabel": "Vesting of options"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdvancesToAffiliate": {
     "auth_ref": [
      "r33",
      "r811"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-Term advances receivable from a party that is affiliated with the reporting entity by means of direct or indirect ownership. This does not include advances to clients.",
        "label": "Advances to Affiliate",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period",
        "terseLabel": "Advances to joint ventures"
       }
      }
     },
     "localname": "AdvancesToAffiliate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet",
      "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofAdvancestoJointVenturesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r471",
      "r497",
      "r509"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Share-based payments",
        "verboseLabel": "Granting and vesting of DSUs"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofAdjustedEBITDADetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsRestrictedShareUnitsNarrativeDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofDeferredShareUnitsActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r66",
      "r298",
      "r322"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Current expected credit loss",
        "verboseLabel": "Allowance for credit loss"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheetParenthetical",
      "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails",
      "http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails",
      "http://thecronosgroup.com/role/RevenuesfromContractswithCustomersNarrativeDetails",
      "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r156",
      "r354",
      "r361"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Total anti-dilutive securities (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/EarningslossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedSharesOutstandingDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/EarningslossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedSharesOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/EarningslossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedSharesOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/EarningslossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedSharesOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]"
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetImpairmentCharges": {
     "auth_ref": [
      "r156",
      "r371"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/RepurposingChargesScheduleofPlanInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_RestructuringSettlementAndImpairmentProvisions",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.",
        "label": "Asset Impairment Charges",
        "terseLabel": "Impairment costs associated with plan"
       }
      }
     },
     "localname": "AssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/RepurposingChargesScheduleofPlanInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r168",
      "r262",
      "r275",
      "r282",
      "r311",
      "r580",
      "r589",
      "r640",
      "r746",
      "r775"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "terseLabel": "Total assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r31",
      "r32",
      "r97",
      "r168",
      "r311",
      "r580",
      "r589",
      "r640"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "terseLabel": "Current assets",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet",
      "http://thecronosgroup.com/role/InvestmentsScheduleofEquityMethodInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent": {
     "auth_ref": [
      "r368"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": 8.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets held-for-sale that are not part of a disposal group, expected to be sold within a year or the normal operating cycle, if longer.",
        "label": "Assets Held-for-sale, Not Part of Disposal Group, Current",
        "terseLabel": "Held-for-sale assets"
       }
      }
     },
     "localname": "AssetsHeldForSaleNotPartOfDisposalGroupCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsNoncurrent": {
     "auth_ref": [
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r168",
      "r311",
      "r580",
      "r589",
      "r640"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.",
        "label": "Assets, Noncurrent",
        "terseLabel": "Non-current assets"
       }
      }
     },
     "localname": "AssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsScheduleofEquityMethodInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r301",
      "r303",
      "r332",
      "r754"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale",
        "terseLabel": "Short-term investments"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/FairValueMeasurementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardDateAxis": {
     "auth_ref": [
      "r472",
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by date or year award under share-based payment arrangement is granted.",
        "label": "Award Date [Axis]",
        "terseLabel": "Award Date [Axis]"
       }
      }
     },
     "localname": "AwardDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofOutstandingWarrantsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardDateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date or year award under share-based payment arrangement is granted.",
        "label": "Award Date [Domain]",
        "terseLabel": "Award Date [Domain]"
       }
      }
     },
     "localname": "AwardDateDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofOutstandingWarrantsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r472",
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsDeferredShareUnitsNarrativeDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsFairValueofOptionsIssuedDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsRestrictedShareUnitsNarrativeDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinWarrantsDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofDeferredShareUnitsActivityDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofOutstandingWarrantsDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofRestrictedShareUnitsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BuildingMember": {
     "auth_ref": [
      "r374"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.",
        "label": "Building [Member]",
        "terseLabel": "Building"
       }
      }
     },
     "localname": "BuildingMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantEquipmentUsefulLivesDetails",
      "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantEquipmentUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r465",
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/BusinessCombinationsNarrativeDetails",
      "http://thecronosgroup.com/role/BusinessCombinationsScheduleofFairValueofNetAssetsAcquiredDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r465",
      "r468",
      "r558",
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/BusinessCombinationsNarrativeDetails",
      "http://thecronosgroup.com/role/BusinessCombinationsScheduleofFairValueofNetAssetsAcquiredDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": {
     "auth_ref": [
      "r570"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of equity interests issued or issuable to acquire entity.",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares",
        "terseLabel": "Consideration transferred, common shares (in shares)"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/BusinessCombinationsNarrativeDetails",
      "http://thecronosgroup.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/BusinessCombinationsNarrativeDetails",
      "http://thecronosgroup.com/role/BusinessCombinationsScheduleofFairValueofNetAssetsAcquiredDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount": {
     "auth_ref": [
      "r571"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.",
        "label": "Business Acquisition, Goodwill, Expected Tax Deductible Amount",
        "terseLabel": "Business acquisition, goodwill, expected tax deductible amount"
       }
      }
     },
     "localname": "BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionSharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.",
        "label": "Business Acquisition, Share Price",
        "terseLabel": "Consideration transferred, common shares, volume weighted average trading price (in dollars per share)"
       }
      }
     },
     "localname": "BusinessAcquisitionSharePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": {
     "auth_ref": [
      "r556",
      "r557"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Net Income (Loss)",
        "terseLabel": "Pro forma net income (loss)"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaNetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaRevenue": {
     "auth_ref": [
      "r556",
      "r557"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.",
        "label": "Business Acquisition, Pro Forma Revenue",
        "terseLabel": "Pro forma revenue"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaRevenue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAcquiredReceivablesEstimatedUncollectible": {
     "auth_ref": [
      "r561"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For receivables acquired in a business combination, excluding certain loans and debt securities acquired in a transfer (as defined), this element represents the best estimate at the acquisition date of the contractual cash flows not expected to be collected, by major class of receivable, such as loans, direct finance leases (as defined), and any other class of receivables.",
        "label": "Business Combination, Acquired Receivables, Estimated Uncollectible",
        "terseLabel": "Business combination, acquired receivables, estimated uncollectible"
       }
      }
     },
     "localname": "BusinessCombinationAcquiredReceivablesEstimatedUncollectible",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/BusinessCombinationsScheduleofFairValueofNetAssetsAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAcquisitionRelatedCosts": {
     "auth_ref": [
      "r554"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.",
        "label": "Business Combination, Acquisition Related Costs",
        "terseLabel": "Acquisition-related costs"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r566",
      "r567",
      "r568"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/BusinessCombinationsNarrativeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "totalLabel": "Consideration transferred"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable": {
     "auth_ref": [
      "r566",
      "r567"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/BusinessCombinationsNarrativeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.",
        "label": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable",
        "terseLabel": "Consideration transferred, common shares, amount"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/BusinessCombinationsNarrativeDetails",
      "http://thecronosgroup.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "Business Combinations"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/BusinessCombinations"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual": {
     "auth_ref": [
      "r555"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the amount of earnings or loss of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.",
        "label": "Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual",
        "negatedTerseLabel": "Loss of acquiree since acquisition date"
       }
      }
     },
     "localname": "BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual": {
     "auth_ref": [
      "r555"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the amount of revenue of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.",
        "label": "Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual",
        "terseLabel": "Revenue of acquiree since acquisition date"
       }
      }
     },
     "localname": "BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation": {
     "auth_ref": [
      "r562"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/BusinessCombinationsScheduleofFairValueofNetAssetsAcquiredDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease obligation assumed in business combination.",
        "label": "Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation",
        "negatedTerseLabel": "Lease obligations"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/BusinessCombinationsScheduleofFairValueofNetAssetsAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "auth_ref": [
      "r562"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/BusinessCombinationsScheduleofFairValueofNetAssetsAcquiredDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/BusinessCombinationsScheduleofFairValueofNetAssetsAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": {
     "auth_ref": [
      "r562"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/BusinessCombinationsScheduleofFairValueofNetAssetsAcquiredDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets",
        "terseLabel": "Prepaid expenses and other assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/BusinessCombinationsScheduleofFairValueofNetAssetsAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "auth_ref": [
      "r562"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/BusinessCombinationsScheduleofFairValueofNetAssetsAcquiredDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/BusinessCombinationsScheduleofFairValueofNetAssetsAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r562"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/BusinessCombinationsScheduleofFairValueofNetAssetsAcquiredDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill",
        "terseLabel": "Intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/BusinessCombinationsScheduleofFairValueofNetAssetsAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
     "auth_ref": [
      "r560",
      "r562"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/BusinessCombinationsScheduleofFairValueofNetAssetsAcquiredDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of inventory recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/BusinessCombinationsScheduleofFairValueofNetAssetsAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r560",
      "r562"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/BusinessCombinationsScheduleofFairValueofNetAssetsAcquiredDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Property and equipment"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/BusinessCombinationsScheduleofFairValueofNetAssetsAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r562"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/BusinessCombinationsScheduleofFairValueofNetAssetsAcquiredDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "totalLabel": "Net assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/BusinessCombinationsScheduleofFairValueofNetAssetsAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net [Abstract]",
        "terseLabel": "Fair value of net assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/BusinessCombinationsScheduleofFairValueofNetAssetsAcquiredDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationsPolicy": {
     "auth_ref": [
      "r164",
      "r553"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.",
        "label": "Business Combinations Policy [Policy Text Block]",
        "terseLabel": "Acquisitions"
       }
      }
     },
     "localname": "BusinessCombinationsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CanadaRevenueAgencyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government of Canada.",
        "label": "Canada Revenue Agency [Member]",
        "terseLabel": "Canada"
       }
      }
     },
     "localname": "CanadaRevenueAgencyMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r27",
      "r75",
      "r158"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet",
      "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/FairValueMeasurementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r39",
      "r159",
      "r164"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and cash equivalents and short-term investments"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r153",
      "r158",
      "r161"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents, end of period",
        "periodStartLabel": "Cash and cash equivalents, beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r153",
      "r641"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Increase in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowOperatingCapitalTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the net increase (decrease) in operating capital in the operating section of the statement of cash flows, represents the entire footnote disclosure that provides details regarding the net change during the reporting period of all assets and liabilities used in operating activities.",
        "label": "Cash Flow, Operating Capital [Table Text Block]",
        "terseLabel": "Schedule of Net Changes in Non-Cash Working Capital"
       }
      }
     },
     "localname": "CashFlowOperatingCapitalTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SupplementaryCashFlowInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashFlowSupplementalDisclosuresTextBlock": {
     "auth_ref": [
      "r162"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Cash Flow, Supplemental Disclosures [Text Block]",
        "terseLabel": "Supplementary Cash Flow Information"
       }
      }
     },
     "localname": "CashFlowSupplementalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SupplementaryCashFlowInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CapitalStockScheduleofCommonSharesIssuedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "auth_ref": [
      "r426",
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of warrant or right issued.",
        "label": "Class of Warrant or Right [Axis]",
        "terseLabel": "Class of Warrant or Right [Axis]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails",
      "http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.",
        "label": "Class of Warrant or Right [Domain]",
        "terseLabel": "Class of Warrant or Right [Domain]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails",
      "http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "terseLabel": "Exercise price (in dollars per share)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember": {
     "auth_ref": [
      "r573"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement transaction between parties to collaborative arrangement.",
        "label": "Collaborative Arrangement, Transaction with Party to Collaborative Arrangement [Member]",
        "terseLabel": "Collaborative Arrangement, Transaction with Party to Collaborative Arrangement",
        "verboseLabel": "Establishment of a Commercial Cannabis Analytical Testing Laboratoy"
       }
      }
     },
     "localname": "CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r89",
      "r397",
      "r757",
      "r781"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsDisclosureTextBlock": {
     "auth_ref": [
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant arrangements with third parties, which includes operating lease arrangements and arrangements in which the entity has agreed to expend funds to procure goods or services, or has agreed to commit resources to supply goods or services, and operating lease arrangements. Descriptions may include identification of the specific goods and services, period of time covered, minimum quantities and amounts, and cancellation rights.",
        "label": "Commitments Disclosure [Text Block]",
        "terseLabel": "Commitments"
       }
      }
     },
     "localname": "CommitmentsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/Commitments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r186",
      "r187"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Shares",
        "verboseLabel": "Share capital"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CapitalStockNarrativeDetails",
      "http://thecronosgroup.com/role/CapitalStockScheduleofCommonSharesIssuedDetails",
      "http://thecronosgroup.com/role/CommitmentsUseofPublicityRightsinBrandDevelopmentDetails",
      "http://thecronosgroup.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r57"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheetParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r57",
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Share capital"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Deferred Tax Assets [Abstract]",
        "terseLabel": "Deferred assets:"
       }
      }
     },
     "localname": "ComponentsOfDeferredTaxAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Deferred Tax Liabilities [Abstract]",
        "terseLabel": "Deferred tax liabilities:"
       }
      }
     },
     "localname": "ComponentsOfDeferredTaxLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r110",
      "r112",
      "r113",
      "r125",
      "r765",
      "r788"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Cronos Group"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r110",
      "r112",
      "r124",
      "r577",
      "r578",
      "r603",
      "r764",
      "r787"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "terseLabel": "Non-controlling interests"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r110",
      "r112",
      "r123",
      "r576",
      "r603",
      "r763",
      "r786"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive income (loss)",
        "verboseLabel": "Comprehensive income (loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "Comprehensive income (loss) attributable to:"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r122",
      "r140",
      "r762",
      "r785"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLoss"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ComputerEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.",
        "label": "Computer Equipment [Member]",
        "terseLabel": "Computer equipment"
       }
      }
     },
     "localname": "ComputerEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantEquipmentUsefulLivesDetails",
      "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantEquipmentUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ComputerSoftwareIntangibleAssetMember": {
     "auth_ref": [
      "r355",
      "r359",
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collection of computer programs and related data that provide instructions to a computer, for example, but not limited to, application program, control module or operating system, that perform one or more particular functions or tasks.",
        "label": "Computer Software, Intangible Asset [Member]",
        "terseLabel": "Software",
        "verboseLabel": "Software"
       }
      }
     },
     "localname": "ComputerSoftwareIntangibleAssetMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails",
      "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsAmortizationMethodsandRatesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r242",
      "r243",
      "r293",
      "r636",
      "r637"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails",
      "http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskNarrativeDetails",
      "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r242",
      "r243",
      "r293",
      "r636",
      "r637",
      "r810"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails",
      "http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskNarrativeDetails",
      "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r242",
      "r243",
      "r293",
      "r636",
      "r637",
      "r810"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails",
      "http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskNarrativeDetails",
      "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure": {
     "auth_ref": [
      "r638"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum amount of loss due to credit risk that, based on the gross fair value of the financial instrument, the entity would incur if parties to the financial instruments that make up the concentration failed completely to perform according to the terms of the contracts and the collateral or other security, if any, for the amount due proved to be of no value to the entity.",
        "label": "Concentration Risk, Credit Risk, Financial Instrument, Maximum Exposure",
        "terseLabel": "Maximum exposure to credit risk"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConcentrationRiskDisclosureTextBlock": {
     "auth_ref": [
      "r248"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.",
        "label": "Concentration Risk Disclosure [Text Block]",
        "terseLabel": "Financial Instruments"
       }
      }
     },
     "localname": "ConcentrationRiskDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstruments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Concentration Risk [Line Items]",
        "terseLabel": "Concentration Risk [Line Items]"
       }
      }
     },
     "localname": "ConcentrationRiskLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails",
      "http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r242",
      "r243",
      "r293",
      "r636",
      "r637"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Concentration risk, percentage"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails",
      "http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskNarrativeDetails",
      "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTable": {
     "auth_ref": [
      "r240",
      "r242",
      "r243",
      "r244",
      "r636",
      "r639"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Concentration Risk [Table]",
        "terseLabel": "Concentration Risk [Table]"
       }
      }
     },
     "localname": "ConcentrationRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails",
      "http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r242",
      "r243",
      "r293",
      "r636",
      "r637"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails",
      "http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskNarrativeDetails",
      "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r164",
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Basis of consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConsolidationVariableInterestEntityPolicy": {
     "auth_ref": [
      "r164",
      "r588",
      "r592",
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for consolidation to describe the significant judgments and assumptions made in determining whether a variable interest held by the entity requires the variable interest entity to be consolidated and (or) disclose information about its involvement with the variable interest entity; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; and the significant factors considered and judgments made in determining that the power to direct the activities that significantly impact the economic performance of the variable interest entity are shared (as defined).",
        "label": "Consolidation, Variable Interest Entity, Policy [Policy Text Block]",
        "terseLabel": "Variable interest entities (\"VIE\")"
       }
      }
     },
     "localname": "ConsolidationVariableInterestEntityPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConstructionInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress [Member]",
        "terseLabel": "Construction in progress"
       }
      }
     },
     "localname": "ConstructionInProgressMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantEquipmentUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r273",
      "r274",
      "r275",
      "r276",
      "r278",
      "r284",
      "r286"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationScheduleofAdjustedEBITDADetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSoldDepreciation": {
     "auth_ref": [
      "r128",
      "r373"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for allocation of cost of tangible asset over its useful life directly used in production of good and rendering of service.",
        "label": "Cost, Depreciation",
        "terseLabel": "Depreciation expense included in costs of sales"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSoldDepreciation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/PropertyPlantandEquipmentNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock": {
     "auth_ref": [
      "r164",
      "r388",
      "r389",
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and reporting costs associated with exiting, disposing of, and restructuring certain operations.",
        "label": "Costs Associated with Exit or Disposal Activities or Restructurings, Policy [Policy Text Block]",
        "terseLabel": "Repurposing charges"
       }
      }
     },
     "localname": "CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CreditConcentrationRiskMember": {
     "auth_ref": [
      "r639"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that a specified receivable or amount at risk from a counterparty under a contractual arrangement is to a specified benchmark, such as total receivables, net revenues, pretax results. Risk is the materially adverse effects of loss attributable to (a) the failure to collect a significant receivable from a major customer or group of homogeneous accounts, or (b) a failure by a counterparty to perform under terms of a contractual arrangement.",
        "label": "Credit Concentration Risk [Member]",
        "terseLabel": "Credit Concentration Risk"
       }
      }
     },
     "localname": "CreditConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/LoansPayableLongtermNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/LoansPayableLongtermNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r169",
      "r532",
      "r543",
      "r545"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesExpenseforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Current:"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesExpenseforIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r241",
      "r293"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer Concentration Risk"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Loans Payable"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/LoansPayable"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r48",
      "r50",
      "r51",
      "r747",
      "r749",
      "r772"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/LoansPayableLongtermNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r86"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofAdvancestoJointVenturesDetails",
      "http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/LoansPayableLongtermNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r87"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/LoansPayableLongtermNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r87",
      "r172",
      "r418",
      "r421",
      "r422",
      "r423",
      "r652",
      "r653",
      "r655",
      "r770"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/LoansPayableLongtermNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts": {
     "auth_ref": [
      "r138"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 7.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the charge against earnings during the period for commitment fees and debt issuance expenses.",
        "label": "Debt Related Commitment Fees and Debt Issuance Costs",
        "negatedTerseLabel": "Financing and transaction costs",
        "terseLabel": "Financing and transaction costs"
       }
      }
     },
     "localname": "DebtRelatedCommitmentFeesAndDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofAdjustedEBITDADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for stock option plans and other equity-based compensation arrangements.",
        "label": "Deferred Compensation Share-based Arrangements, Liability, Current and Noncurrent",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period"
       }
      }
     },
     "localname": "DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofDeferredShareUnitsActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "auth_ref": [
      "r80",
      "r654"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Net",
        "verboseLabel": "Payments of transaction costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/LoansPayableLongtermNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r156",
      "r169",
      "r533",
      "r543",
      "r544",
      "r545"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesExpenseforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Deferred:"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesExpenseforIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r53",
      "r54",
      "r522",
      "r748",
      "r771"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "negatedTotalLabel": "Total deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetInterestCarryforward": {
     "auth_ref": [
      "r530"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible interest carryforward.",
        "label": "Deferred Tax Asset, Interest Carryforward",
        "terseLabel": "Interest expense carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetInterestCarryforward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.",
        "label": "Deferred Tax Assets, Goodwill and Intangible Assets",
        "terseLabel": "Intangible asset"
       }
      }
     },
     "localname": "DeferredTaxAssetsGoodwillAndIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r523"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Total deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsInvestments": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from investments (excludes investments in subsidiaries and equity method investments).",
        "label": "Deferred Tax Assets, Investments",
        "terseLabel": "Investment"
       }
      }
     },
     "localname": "DeferredTaxAssetsInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r525"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Net deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r530",
      "r531"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Tax loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r530",
      "r531"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Deferred Tax Assets, Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment.",
        "label": "Deferred Tax Assets, Property, Plant and Equipment",
        "terseLabel": "Plant and equipment"
       }
      }
     },
     "localname": "DeferredTaxAssetsPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves": {
     "auth_ref": [
      "r530",
      "r531"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from reserves, classified as other.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Reserves",
        "terseLabel": "Reserve"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r524"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedTerseLabel": "Less valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r514",
      "r525"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities, Net",
        "totalLabel": "Net deferred tax liability"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts": {
     "auth_ref": [
      "r530",
      "r531"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax consequences attributable to taxable temporary differences derived from inventory.",
        "label": "Deferred Tax Liabilities, Inventory",
        "negatedTerseLabel": "Inventory"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets": {
     "auth_ref": [
      "r530",
      "r531"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill.",
        "label": "Deferred Tax Liabilities, Intangible Assets",
        "negatedTerseLabel": "Intangible assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesInvestments": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from investments (excludes investments in subsidiaries and equity method investments).",
        "label": "Deferred Tax Liabilities, Investments",
        "negatedTerseLabel": "Investment"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "auth_ref": [
      "r530",
      "r531"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "negatedTerseLabel": "Plant and equipment"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAndAmortization": {
     "auth_ref": [
      "r156",
      "r373"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "terseLabel": "Depreciation and amortization",
        "verboseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r156",
      "r257"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization",
        "verboseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofAdjustedEBITDADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationNonproduction": {
     "auth_ref": [
      "r156",
      "r373"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The expense recognized in the current period that allocates the cost of nonproduction tangible assets over their useful lives.",
        "label": "Depreciation, Nonproduction",
        "terseLabel": "Depreciation expense included in operating expenses"
       }
      }
     },
     "localname": "DepreciationNonproduction",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/PropertyPlantandEquipmentNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r620"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "Derivative Liabilities"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r608",
      "r610",
      "r612",
      "r613",
      "r614",
      "r618",
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeLiabilities": {
     "auth_ref": [
      "r98",
      "r99",
      "r635"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability",
        "terseLabel": "Derivative liabilities"
       }
      }
     },
     "localname": "DerivativeLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/FairValueMeasurementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilitiesCurrent": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability, Current",
        "terseLabel": "Derivative liabilities"
       }
      }
     },
     "localname": "DerivativeLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilityMeasurementInput": {
     "auth_ref": [
      "r626"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of input used to measure derivative liability.",
        "label": "Derivative Liability, Measurement Input",
        "terseLabel": "Derivative liability, measurement input"
       }
      }
     },
     "localname": "DerivativeLiabilityMeasurementInput",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r611",
      "r612",
      "r615",
      "r617",
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r164",
      "r175",
      "r605",
      "r606",
      "r608",
      "r609",
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Derivative liabilities"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DilutiveSecurities": {
     "auth_ref": [
      "r225"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) to net income used for calculating diluted earnings per share (EPS), resulting from the assumed exercise stock options, restrictive stock units (RSUs), convertible preferred stock of an employee stock ownership plan (ESOP), and other dilutive convertible securities.",
        "label": "Dilutive Securities, Effect on Basic Earnings Per Share",
        "terseLabel": "Adjustment for gain on revaluation of derivative liabilities"
       }
      }
     },
     "localname": "DilutiveSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r510"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "Share-based Payments"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPayments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock": {
     "auth_ref": [
      "r472",
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of share-based payment arrangement.",
        "label": "Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]",
        "terseLabel": "Summary of Outstanding Warrants"
       }
      }
     },
     "localname": "DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax": {
     "auth_ref": [
      "r4",
      "r5",
      "r20"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from operations classified as a discontinued operation. Excludes gain (loss) on disposal and provision for gain (loss) until disposal.",
        "label": "Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, Net of Tax",
        "terseLabel": "OGBC income (loss) from discontinued operations, net of income taxes",
        "verboseLabel": "Income (loss) from discontinued operations, net of income taxes"
       }
      }
     },
     "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DiscontinuedOperationsandHeldforsaleAssetsDetails",
      "http://thecronosgroup.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discontinued Operations and Disposal Groups [Abstract]"
       }
      }
     },
     "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DiscontinuedOperationsHeldforsaleMember": {
     "auth_ref": [
      "r2",
      "r3",
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components classified as held-for-sale and representing a strategic shift that has or will have a major effect on operations and financial results. Includes a business or nonprofit activity on acquisition classified as held-for-sale.",
        "label": "Discontinued Operations, Held-for-sale [Member]",
        "terseLabel": "Discontinued Operations, Held-for-sale"
       }
      }
     },
     "localname": "DiscontinuedOperationsHeldforsaleMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DiscontinuedOperationsandHeldforsaleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DiscontinuedOperationsPolicyTextBlock": {
     "auth_ref": [
      "r10",
      "r24",
      "r164"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for discontinued operations. Includes, but is not limited to, method of interest allocation to a discontinued operation.",
        "label": "Discontinued Operations, Policy [Policy Text Block]",
        "terseLabel": "Assets held for sale and discontinued operations"
       }
      }
     },
     "localname": "DiscontinuedOperationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DiscontinuedOperationsandHeldforsaleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DiscontinuedOperationsandHeldforsaleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent": {
     "auth_ref": [
      "r0",
      "r1",
      "r17",
      "r19",
      "r23",
      "r369",
      "r378"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Assets, Noncurrent",
        "terseLabel": "Long-term assets classified as discontinued operations"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DiscontinuedOperationsandHeldforsaleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown": {
     "auth_ref": [
      "r156",
      "r372",
      "r377"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of (gain) loss recognized for the (reversal of write-down) write-down to fair value, less cost to sell, of a disposal group. Excludes discontinued operations.",
        "label": "Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down",
        "verboseLabel": "Loss on held-for-sale assets"
       }
      }
     },
     "localname": "DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DiscontinuedOperationsandHeldforsaleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": {
     "auth_ref": [
      "r25",
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]",
        "terseLabel": "Discontinued Operations and Held-for-sale Assets"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DiscontinuedOperationsandHeldforsaleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r465",
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DiscontinuedOperationsandHeldforsaleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DueToRelatedPartiesNoncurrent": {
     "auth_ref": [
      "r88",
      "r174",
      "r685"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Portion of the carrying amount as of the balance sheet date of obligations due all related parties that is payable after one year or beyond the normal operating cycle if longer.",
        "label": "Due to Related Parties, Noncurrent",
        "terseLabel": "Due to non-controlling interests"
       }
      }
     },
     "localname": "DueToRelatedPartiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r126",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r210",
      "r213",
      "r221",
      "r222",
      "r223",
      "r228",
      "r229",
      "r766",
      "r789"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic (in dollars per share)",
        "verboseLabel": "Basic earnings (loss) per share (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
      "http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted [Abstract]",
        "terseLabel": "Net income (loss) per share"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted, Other Disclosures [Abstract]",
        "terseLabel": "Weighted average number of outstanding shares"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r126",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r213",
      "r221",
      "r222",
      "r223",
      "r228",
      "r229",
      "r766",
      "r789"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted (in dollars per share)",
        "verboseLabel": "Diluted earnings (loss) per share (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
      "http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDilutedLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]",
        "terseLabel": "Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]"
       }
      }
     },
     "localname": "EarningsPerShareDilutedLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r164",
      "r224",
      "r226"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Net earnings (loss) per share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r224",
      "r226",
      "r227",
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Earnings (loss) Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/EarningslossPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r641"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "Effect of foreign currency translation on cash and cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r516",
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "Effective income tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails",
      "http://thecronosgroup.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/EarningslossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedSharesOutstandingDetails",
      "http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsFairValueofOptionsIssuedDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r186",
      "r187",
      "r189",
      "r194",
      "r203",
      "r206",
      "r232",
      "r317",
      "r417",
      "r424",
      "r503",
      "r504",
      "r505",
      "r536",
      "r537",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r648",
      "r800",
      "r801",
      "r802"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails",
      "http://thecronosgroup.com/role/CapitalStockNarrativeDetails",
      "http://thecronosgroup.com/role/CapitalStockScheduleofCommonSharesIssuedDetails",
      "http://thecronosgroup.com/role/CommitmentsUseofPublicityRightsinBrandDevelopmentDetails",
      "http://thecronosgroup.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis": {
     "auth_ref": [
      "r23",
      "r168",
      "r311",
      "r640"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by nonconsolidated equity method investee. Excludes information consolidated by reporting entity.",
        "label": "Equity Method Investment, Nonconsolidated Investee [Axis]",
        "terseLabel": "Equity Method Investment, Nonconsolidated Investee [Axis]"
       }
      }
     },
     "localname": "EquityMethodInvestmentNonconsolidatedInvesteeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsScheduleofEquityMethodInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain": {
     "auth_ref": [
      "r23",
      "r168",
      "r311",
      "r640"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nonconsolidated equity method investee. Excludes information consolidated by reporting entity.",
        "label": "Equity Method Investment, Nonconsolidated Investee [Domain]",
        "terseLabel": "Equity Method Investment, Nonconsolidated Investee [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvestmentNonconsolidatedInvesteeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsScheduleofEquityMethodInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember": {
     "auth_ref": [
      "r23",
      "r168",
      "r311",
      "r640"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nonconsolidated equity method investee or group of nonconsolidated investees. Excludes information consolidated by reporting entity.",
        "label": "Equity Method Investment, Nonconsolidated Investee or Group of Investees [Member]",
        "terseLabel": "Equity Method Investments"
       }
      }
     },
     "localname": "EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsScheduleofEquityMethodInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Ownership Percentage",
        "terseLabel": "Ownership interest"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundDetails",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofEquityMethodInvestmentsDetails",
      "http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal": {
     "auth_ref": [
      "r130",
      "r131",
      "r156"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of an equity method investment.",
        "label": "Equity Method Investment, Realized Gain (Loss) on Disposal",
        "negatedLabel": "Gain on disposal of other investments",
        "negatedTerseLabel": "Loss (gain) on disposal of other investments",
        "terseLabel": "Gain on disposal of other investments"
       }
      }
     },
     "localname": "EquityMethodInvestmentRealizedGainLossOnDisposal",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows",
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofAdjustedEBITDADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Method Investment, Summarized Financial Information [Abstract]",
        "terseLabel": "Equity Method Investment, Summarized Financial Information [Abstract]"
       }
      }
     },
     "localname": "EquityMethodInvestmentSummarizedFinancialInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsScheduleofEquityMethodInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r76",
      "r263",
      "r307"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Investments in equity accounted investees",
        "verboseLabel": "Investments in equity accounted investees"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet",
      "http://thecronosgroup.com/role/InvestmentsScheduleofEquityMethodInvestmentsDetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Method Investments and Joint Ventures [Abstract]",
        "terseLabel": "Equity Method Investments and Joint Ventures [Abstract]"
       }
      }
     },
     "localname": "EquityMethodInvestmentsAndJointVenturesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityMethodInvestmentsDisclosureTextBlock": {
     "auth_ref": [
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.",
        "label": "Equity Method Investments and Joint Ventures Disclosure [Text Block]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "EquityMethodInvestmentsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/Investments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquityMethodInvestmentsPolicy": {
     "auth_ref": [
      "r76",
      "r152",
      "r164",
      "r309",
      "r640"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.",
        "label": "Equity Method Investments [Policy Text Block]",
        "terseLabel": "Equity method investments"
       }
      }
     },
     "localname": "EquityMethodInvestmentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquityMethodInvestmentsTextBlock": {
     "auth_ref": [
      "r312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.",
        "label": "Equity Method Investments [Table Text Block]",
        "terseLabel": "Schedule of Equity Method Investments"
       }
      }
     },
     "localname": "EquityMethodInvestmentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquitySecuritiesMember": {
     "auth_ref": [
      "r42",
      "r49",
      "r306",
      "r773",
      "r825",
      "r826",
      "r827"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ownership interest or right to acquire or dispose of ownership interest in corporations and other legal entities for which ownership interest is represented by shares of common or preferred stock, convertible securities, stock rights, or stock warrants.",
        "label": "Equity Securities [Member]",
        "terseLabel": "Equity Securities"
       }
      }
     },
     "localname": "EquitySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/OtherInvestmentsSummaryofOtherInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ExchangeOfProductHeldForSaleForSimilarProductMember": {
     "auth_ref": [
      "r675",
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exchange of a product held for sale in the ordinary course of business for similar property as an accommodation, to satisfy an immediate inventory need or otherwise reduce costs or facilitate ultimate sales.",
        "label": "Exchange of Product Held-for-sale for Similar Product [Member]",
        "terseLabel": "Purchased Cannabis Resin and Sold Cannabis Dry Flower"
       }
      }
     },
     "localname": "ExchangeOfProductHeldForSaleForSimilarProductMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/NonmonetaryTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ExciseAndSalesTaxes": {
     "auth_ref": [
      "r117"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of excise and sales taxes included in sales and revenues, which are then deducted as a cost of sales. Includes excise taxes, which are applied to specific types of transactions or items (such as gasoline or alcohol); and sales, use and value added taxes, which are applied to a broad class of revenue-producing transactions involving a wide range of goods and services.",
        "label": "Excise and Sales Taxes",
        "negatedTerseLabel": "Excise taxes"
       }
      }
     },
     "localname": "ExciseAndSalesTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/FairValueMeasurementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r621",
      "r622",
      "r623",
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/FairValueMeasurementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": {
     "auth_ref": [
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": {
     "auth_ref": [
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]",
        "terseLabel": "Schedule of Fair Values of Derivative Liabilities"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r464",
      "r622",
      "r694",
      "r695",
      "r696"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/FairValueMeasurementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r621",
      "r622",
      "r625",
      "r626",
      "r634"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/FairValueMeasurementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurement"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/FairValueMeasurement"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r456",
      "r457",
      "r462",
      "r464",
      "r622",
      "r694"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/FairValueMeasurementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r456",
      "r457",
      "r462",
      "r464",
      "r622",
      "r695"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/FairValueMeasurementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r464",
      "r622",
      "r696"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/FairValueMeasurementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/FairValueMeasurementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "terseLabel": "Fair value measurements"
       }
      }
     },
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r464",
      "r694",
      "r695",
      "r696"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/FairValueMeasurementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r631",
      "r634"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Fair Value, Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/FairValueMeasurementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock": {
     "auth_ref": [
      "r627",
      "r632"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset) using recurring unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Reconciliation of Carrying Amounts"
       }
      }
     },
     "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings": {
     "auth_ref": [
      "r628",
      "r632"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from derivative asset (liability) after deduction of derivative liability (asset), measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Gain (Loss) Included in Earnings",
        "negatedTerseLabel": "Gain on revaluation",
        "verboseLabel": "Gain on revaluation"
       }
      }
     },
     "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss": {
     "auth_ref": [
      "r629",
      "r632"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in other comprehensive income from derivative asset (liability) after deduction of derivative liability (asset), measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Gain (Loss) Included in Other Comprehensive Income (Loss)",
        "negatedTerseLabel": "Effect of FX"
       }
      }
     },
     "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements": {
     "auth_ref": [
      "r630",
      "r632"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of settlements of financial instrument classified as a derivative asset (liability) after deduction of derivative liability, measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Settlements",
        "negatedTerseLabel": "Exercise of Rights"
       }
      }
     },
     "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs": {
     "auth_ref": [
      "r621",
      "r632"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as derivative asset (liability) after deduction of derivative liability (asset), measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis with Unobservable Inputs",
        "negatedPeriodEndLabel": "Ending balance",
        "negatedPeriodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r304",
      "r305",
      "r323",
      "r327",
      "r328",
      "r329",
      "r331",
      "r333",
      "r334",
      "r335",
      "r336",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/OtherInvestmentsSummaryofOtherInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancingReceivableAllowanceForCreditLosses": {
     "auth_ref": [
      "r297",
      "r322",
      "r324",
      "r326",
      "r755"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on financing receivable. Excludes allowance for financing receivable covered under loss sharing agreement.",
        "label": "Financing Receivable, Allowance for Credit Loss",
        "terseLabel": "Allowance for credit loss"
       }
      }
     },
     "localname": "FinancingReceivableAllowanceForCreditLosses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Weighted average amortization period (in years)",
        "verboseLabel": "Intangible assets, useful life"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails",
      "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsAmortizationMethodsandRatesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r360"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedLabel": "Accumulated amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r362"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r362"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r362"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r362"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r362"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r355",
      "r357",
      "r360",
      "r364",
      "r726",
      "r730"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails",
      "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsAmortizationMethodsandRatesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r360",
      "r730"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Cost"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillNarrativeDetails",
      "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails",
      "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsAmortizationMethodsandRatesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r355",
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails",
      "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsAmortizationMethodsandRatesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r360",
      "r726"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r164",
      "r649"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Foreign currency"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Furniture and equipment"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantEquipmentUsefulLivesDetails",
      "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantEquipmentUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnDerivativeInstrumentsNetPretax": {
     "auth_ref": [
      "r610"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 4.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects.",
        "label": "Gain (Loss) on Derivative Instruments, Net, Pretax",
        "negatedTerseLabel": "Gain on revaluation of derivative liabilities",
        "terseLabel": "Gain on revaluation of derivative liabilities"
       }
      }
     },
     "localname": "GainLossOnDerivativeInstrumentsNetPretax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows",
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofAdjustedEBITDADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r135"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      },
      "http://thecronosgroup.com/role/GeneralandAdministrativeExpensesScheduleofGeneralandAdministrativeExpensesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
      "http://thecronosgroup.com/role/GeneralandAdministrativeExpensesScheduleofGeneralandAdministrativeExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r343",
      "r345",
      "r745"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/BusinessCombinationsScheduleofFairValueofNetAssetsAcquiredDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      },
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period",
        "terseLabel": "Goodwill",
        "verboseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/BusinessCombinationsScheduleofFairValueofNetAssetsAcquiredDetails",
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet",
      "http://thecronosgroup.com/role/DiscontinuedOperationsandHeldforsaleAssetsDetails",
      "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofGoodwillDetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r346"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "verboseLabel": "Additions"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetImpairment": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 6.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.",
        "label": "Goodwill and Intangible Asset Impairment",
        "negatedTerseLabel": "Impairment loss on goodwill and intangible assets",
        "terseLabel": "Impairment loss on goodwill and intangible assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetImpairment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows",
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofAdjustedEBITDADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Intangible Assets and Goodwill"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IntangibleAssetsandGoodwill"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r348"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Effect of foreign exchange"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r156",
      "r344",
      "r347",
      "r351"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "negatedTerseLabel": "Impairment charges",
        "terseLabel": "Goodwill, impairment loss"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillNarrativeDetails",
      "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r132",
      "r168",
      "r262",
      "r274",
      "r278",
      "r281",
      "r284",
      "r311",
      "r640"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit (loss)",
        "verboseLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
      "http://thecronosgroup.com/role/InvestmentsScheduleofEquityMethodInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IPOMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First sale of stock by a private company to the public.",
        "label": "IPO [Member]",
        "terseLabel": "IPO"
       }
      }
     },
     "localname": "IPOMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsScheduleofEquityMethodInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill": {
     "auth_ref": [
      "r156",
      "r365"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.",
        "label": "Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)",
        "terseLabel": "Impairment of intangible assets, indefinite-lived (excluding goodwill)"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf": {
     "auth_ref": [
      "r156",
      "r370"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.",
        "label": "Impairment of Long-Lived Assets to be Disposed of",
        "terseLabel": "Impairment of assets held-for-sale"
       }
      }
     },
     "localname": "ImpairmentOfLongLivedAssetsToBeDisposedOf",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DiscontinuedOperationsandHeldforsaleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets.",
        "label": "Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Impairment of long-lived assets"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r118",
      "r262",
      "r274",
      "r278",
      "r281",
      "r284",
      "r743",
      "r760",
      "r768",
      "r790"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income (loss) before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r173",
      "r262",
      "r274",
      "r278",
      "r281",
      "r284"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "terseLabel": "Income (loss) before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofIncomeLossbeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r168",
      "r193",
      "r262",
      "r274",
      "r278",
      "r281",
      "r284",
      "r311",
      "r576",
      "r640"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Income (loss) from continuing operations",
        "totalLabel": "Income (loss) from continuing operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
      "http://thecronosgroup.com/role/DiscontinuedOperationsandHeldforsaleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic and Diluted Share [Abstract]",
        "terseLabel": "Basic loss from discontinued operations per share computation"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsAndDisposalOfDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax": {
     "auth_ref": [
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r20",
      "r23",
      "r549",
      "r783"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.",
        "label": "Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "negatedTerseLabel": "Loss from discontinued operations",
        "terseLabel": "Loss from discontinued operations"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofAdjustedEBITDADetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity": {
     "auth_ref": [
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r16",
      "r20",
      "r576"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.",
        "label": "Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent",
        "terseLabel": "Loss from discontinued operations attributable to common shareholders of Cronos Group"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare": {
     "auth_ref": [
      "r120",
      "r126",
      "r218",
      "r221",
      "r222",
      "r766",
      "r783",
      "r785",
      "r789"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.",
        "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share",
        "terseLabel": "Basic loss from discontinued operations per share (in dollars per share)"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r119",
      "r156",
      "r259",
      "r307",
      "r759",
      "r782"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 3.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "negatedTerseLabel": "Share of loss (income) from equity accounted investees",
        "terseLabel": "Share of loss from investments in equity accounted investees",
        "verboseLabel": "Share of loss from equity accounted investees"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows",
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
      "http://thecronosgroup.com/role/InvestmentsScheduleofEquityMethodInvestmentsDetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofAdjustedEBITDADetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions": {
     "auth_ref": [
      "r156"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the undistributed income (or loss) of equity method investments, net of dividends or other distributions received from unconsolidated subsidiaries, certain corporate joint ventures, and certain noncontrolled corporations; such investments are accounted for under the equity method of accounting. This element excludes distributions that constitute a return of investment, which are classified as investing activities.",
        "label": "Income (Loss) from Equity Method Investments, Net of Dividends or Distributions",
        "terseLabel": "Gain recognized in net income (loss)"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/OtherInvestmentsSummaryofOtherInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r133"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of income (loss) including portion attributable to noncontrolling interest. Includes, but is not limited to, income (loss) from continuing operations, discontinued operations and equity method investments.",
        "label": "Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax",
        "terseLabel": "Income (loss) before income taxes"
       }
      }
     },
     "localname": "IncomeLossIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsScheduleofEquityMethodInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r465",
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DiscontinuedOperationsandHeldforsaleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DiscontinuedOperationsandHeldforsaleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "auth_ref": [
      "r1",
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r15",
      "r18",
      "r21",
      "r22",
      "r23",
      "r380",
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DiscontinuedOperationsandHeldforsaleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameAxis": {
     "auth_ref": [
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of taxing authority.",
        "label": "Income Tax Authority, Name [Axis]",
        "terseLabel": "Income Tax Authority, Name [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority, Name [Domain]",
        "terseLabel": "Income Tax Authority, Name [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r517",
      "r520",
      "r527",
      "r541",
      "r547",
      "r550",
      "r551",
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r169",
      "r205",
      "r206",
      "r260",
      "r515",
      "r542",
      "r548",
      "r791"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0
      },
      "http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income tax expense",
        "totalLabel": "Income tax expense (recovery), net",
        "verboseLabel": "Income tax expense"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows",
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
      "http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofAdjustedEBITDADetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r114",
      "r164",
      "r512",
      "r513",
      "r520",
      "r521",
      "r526",
      "r534",
      "r830"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r516"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
        "terseLabel": "Changes in valuation allowance"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r516"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount",
        "terseLabel": "Effect of tax rates outside of Canada"
       }
      }
     },
     "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther": {
     "auth_ref": [
      "r516"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount",
        "terseLabel": "Non-deductible expenses"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNondeductibleExpenseOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "auth_ref": [
      "r516"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount",
        "terseLabel": "Non-deductible share-based compensation"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationOtherAdjustments": {
     "auth_ref": [
      "r516"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Amount",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "IncomeTaxReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r516"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount",
        "terseLabel": "Effect of provincial tax rate difference"
       }
      }
     },
     "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationTaxExemptIncome": {
     "auth_ref": [
      "r516"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income (loss) exempt from income taxes.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Exempt Income, Amount",
        "negatedTerseLabel": "Non-taxable income"
       }
      }
     },
     "localname": "IncomeTaxReconciliationTaxExemptIncome",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities": {
     "auth_ref": [
      "r155"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/SupplementaryCashFlowInformationDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_IncreaseDecreaseInOperatingCapital",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligations incurred but not paid, and operating obligations classified as other.",
        "label": "Increase (Decrease) in Accounts Payable and Other Operating Liabilities",
        "terseLabel": "Accounts payable and other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SupplementaryCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r155"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/SupplementaryCashFlowInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncreaseDecreaseInOperatingCapital",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedTerseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SupplementaryCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInFinanceReceivables": {
     "auth_ref": [
      "r155"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/SupplementaryCashFlowInformationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IncreaseDecreaseInOperatingCapital",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in outstanding loans including accrued interest.",
        "label": "Increase (Decrease) in Finance Receivables",
        "negatedTerseLabel": "Current portion of loans receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInFinanceReceivables",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SupplementaryCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r155"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/SupplementaryCashFlowInformationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_IncreaseDecreaseInOperatingCapital",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Inventory"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SupplementaryCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapital": {
     "auth_ref": [
      "r155"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://thecronosgroup.com/role/SupplementaryCashFlowInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period of all assets and liabilities used in operating activities.",
        "label": "Increase (Decrease) in Operating Capital",
        "negatedTerseLabel": "Net changes in non-cash working capital",
        "negatedTotalLabel": "Total"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapital",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows",
      "http://thecronosgroup.com/role/SupplementaryCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Increase (Decrease) in Operating Capital [Abstract]"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SupplementaryCashFlowInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants": {
     "auth_ref": [
      "r214",
      "r215",
      "r216",
      "r223"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants",
        "terseLabel": "Dilutive effect of derivative liabilities (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToCallOptionsAndWarrants",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r214",
      "r215",
      "r217",
      "r223"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "terseLabel": "Dilutive effect of awards (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r356",
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/BusinessCombinationsScheduleofFairValueofNetAssetsAcquiredDetails",
      "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillNarrativeDetails",
      "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Indefinite-lived Intangible Assets [Line Items]",
        "terseLabel": "Indefinite-lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r363"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Net"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r356",
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/BusinessCombinationsScheduleofFairValueofNetAssetsAcquiredDetails",
      "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillNarrativeDetails",
      "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IndefinitelivedIntangibleAssetsAcquired": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in assets, excluding financial assets and goodwill, lacking physical substance with an indefinite life, from an acquisition.",
        "label": "Indefinite-lived Intangible Assets Acquired",
        "terseLabel": "Indefinite-lived intangible assets acquired, fair value"
       }
      }
     },
     "localname": "IndefinitelivedIntangibleAssetsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/BusinessCombinationsScheduleofFairValueofNetAssetsAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsFiniteLivedPolicy": {
     "auth_ref": [
      "r164",
      "r359",
      "r722",
      "r723",
      "r724",
      "r726"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.",
        "label": "Intangible Assets, Finite-Lived, Policy [Policy Text Block]",
        "terseLabel": "Definite life intangible assets"
       }
      }
     },
     "localname": "IntangibleAssetsFiniteLivedPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "terseLabel": "Cost"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r353",
      "r358"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets",
        "totalLabel": "Net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet",
      "http://thecronosgroup.com/role/DiscontinuedOperationsandHeldforsaleAssetsDetails",
      "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets, Net (Excluding Goodwill) [Abstract]",
        "terseLabel": "Intangible Assets, Net (Excluding Goodwill) [Abstract]"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwillAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InterestCostsCapitalized": {
     "auth_ref": [
      "r651"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest capitalized during the period.",
        "label": "Interest Costs Capitalized",
        "terseLabel": "Interest costs capitalized"
       }
      }
     },
     "localname": "InterestCostsCapitalized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/PropertyPlantandEquipmentNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r116",
      "r256",
      "r650",
      "r654",
      "r767"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InterestIncomeExpenseNonoperatingNet",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedTerseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestIncomeExpenseNonoperatingNet": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 5.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      },
      "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of nonoperating interest income (expense).",
        "label": "Interest Income (Expense), Nonoperating, Net",
        "negatedLabel": "Interest expense (income), net",
        "terseLabel": "Interest income, net",
        "totalLabel": "Interest income (expense), net"
       }
      }
     },
     "localname": "InterestIncomeExpenseNonoperatingNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
      "http://thecronosgroup.com/role/FinancialInstrumentsInterestRateRiskDetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofAdjustedEBITDADetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidCapitalized": {
     "auth_ref": [
      "r144",
      "r160"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest capitalized, classified as investing activity.",
        "label": "Interest Paid, Capitalized, Investing Activities",
        "terseLabel": "Repayments of construction loans payable, accrued interest and fees"
       }
      }
     },
     "localname": "InterestPaidCapitalized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/LoansPayableLongtermNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InternalRevenueServiceIRSMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the United States of America government entitled to levy and collect income taxes from the entity.",
        "label": "Internal Revenue Service (IRS) [Member]",
        "terseLabel": "Untied States"
       }
      }
     },
     "localname": "InternalRevenueServiceIRSMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryCurrentTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about inventory expected to be sold or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Current [Table]",
        "terseLabel": "Inventory, Current [Table]"
       }
      }
     },
     "localname": "InventoryCurrentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/InventoryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]",
        "terseLabel": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/Inventory"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r67",
      "r341"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/InventoryDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/InventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Inventory [Line Items]",
        "terseLabel": "Inventory [Line Items]"
       }
      }
     },
     "localname": "InventoryLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/InventoryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r28",
      "r95"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": 7.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://thecronosgroup.com/role/InventoryDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventory, net",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet",
      "http://thecronosgroup.com/role/InventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r34",
      "r96",
      "r164",
      "r231",
      "r337",
      "r339",
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r69",
      "r341"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/InventoryDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/InventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventorySuppliesNetOfReserves": {
     "auth_ref": [
      "r94",
      "r340"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/InventoryDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of products used directly or indirectly in the manufacturing or production process, which may or may not become part of the final product. May also include items used in the storage, presentation or transportation of physical goods.",
        "label": "Inventory, Supplies, Net of Reserves",
        "terseLabel": "Supplies and consumables"
       }
      }
     },
     "localname": "InventorySuppliesNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/InventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryValuationReserves": {
     "auth_ref": [
      "r95",
      "r184",
      "r340"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation reserve for inventory.",
        "label": "Inventory Valuation Reserves",
        "terseLabel": "Inventory valuation reserves"
       }
      }
     },
     "localname": "InventoryValuationReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/InventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r68",
      "r341"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/InventoryDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work-in-progress"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/InventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWriteDown": {
     "auth_ref": [
      "r338"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 3.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.",
        "label": "Inventory Write-down",
        "negatedTerseLabel": "Inventory write-down",
        "terseLabel": "Inventory write-down"
       }
      }
     },
     "localname": "InventoryWriteDown",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows",
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
      "http://thecronosgroup.com/role/DiscontinuedOperationsandHeldforsaleAssetsDetails",
      "http://thecronosgroup.com/role/InventoryDetails",
      "http://thecronosgroup.com/role/RepurposingChargesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r136",
      "r255"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InterestIncomeExpenseNonoperatingNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "terseLabel": "Interest revenue"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentTypeAxis": {
     "auth_ref": [
      "r812",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817",
      "r818",
      "r819",
      "r820",
      "r821",
      "r822",
      "r824",
      "r825",
      "r826",
      "r827"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of investments.",
        "label": "Investment Type [Axis]",
        "terseLabel": "Investment Type [Axis]"
       }
      }
     },
     "localname": "InvestmentTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/OtherInvestmentsSummaryofOtherInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "auth_ref": [
      "r812",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817",
      "r818",
      "r819",
      "r820",
      "r821",
      "r822",
      "r824",
      "r825",
      "r826",
      "r827"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value.",
        "label": "Investments [Domain]",
        "terseLabel": "Investments [Domain]"
       }
      }
     },
     "localname": "InvestmentTypeCategorizationMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/OtherInvestmentsSummaryofOtherInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentsAllOtherInvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, All Other Investments [Abstract]"
       }
      }
     },
     "localname": "InvestmentsAllOtherInvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, Debt and Equity Securities [Abstract]",
        "terseLabel": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Investments in and Advances to Affiliates, at Fair Value [Roll Forward]",
        "terseLabel": "Investments in and Advances to Affiliates, at Fair Value [Roll Forward]"
       }
      }
     },
     "localname": "InvestmentsInAndAdvancesToAffiliatesAtFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsScheduleofAdvancestoJointVenturesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsInAndAdvancesToAffiliatesTextBlock": {
     "auth_ref": [
      "r823"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investments in and advances to affiliates.  Does not include the tabular disclosure of the disaggregation of investments in and advances to affiliates across legal entities.",
        "label": "Investments in and Advances to Affiliates [Table Text Block]",
        "verboseLabel": "Schedule of Joint Ventures"
       }
      }
     },
     "localname": "InvestmentsInAndAdvancesToAffiliatesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r306",
      "r744",
      "r769",
      "r828"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for  investments in certain debt and equity securities.",
        "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]",
        "terseLabel": "Other Investments"
       }
      }
     },
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/OtherInvestments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IsraelTaxAuthorityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government of Israel.",
        "label": "Israel Tax Authority [Member]",
        "terseLabel": "Israel"
       }
      }
     },
     "localname": "IsraelTaxAuthorityMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LaborAndRelatedExpense": {
     "auth_ref": [
      "r129"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/GeneralandAdministrativeExpensesScheduleofGeneralandAdministrativeExpensesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_GeneralAndAdministrativeExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit.",
        "label": "Labor and Related Expense",
        "terseLabel": "Salaries and wages"
       }
      }
     },
     "localname": "LaborAndRelatedExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/GeneralandAdministrativeExpensesScheduleofGeneralandAdministrativeExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LandMember": {
     "auth_ref": [
      "r447"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Part of earth's surface not covered by water.",
        "label": "Land [Member]",
        "terseLabel": "Land"
       }
      }
     },
     "localname": "LandMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/LeasesNarrativeDetails",
      "http://thecronosgroup.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantEquipmentUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r665",
      "r667"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/LeasesScheduleofLeaseCostandOtherInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "totalLabel": "Total lease cost"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/LeasesScheduleofLeaseCostandOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease, Cost [Abstract]",
        "terseLabel": "Lease cost"
       }
      }
     },
     "localname": "LeaseCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/LeasesScheduleofLeaseCostandOtherInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r665"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Schedule of Lease Cost and Other Information"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r374"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantEquipmentUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r660"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r658"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r666"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Summary of Future Minimum Lease Payments Under Operating Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r666"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "2026 and thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsSummaryofFutureMinimumLeasePaymentsUnderOperatingLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r666"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsSummaryofFutureMinimumLeasePaymentsUnderOperatingLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r666"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsSummaryofFutureMinimumLeasePaymentsUnderOperatingLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r666"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsSummaryofFutureMinimumLeasePaymentsUnderOperatingLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r666"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsSummaryofFutureMinimumLeasePaymentsUnderOperatingLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r666"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsSummaryofFutureMinimumLeasePaymentsUnderOperatingLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "auth_ref": [
      "r659"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Renewal Term",
        "terseLabel": "Operating lease, extension term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r659"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Operating lease, term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r668"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r84",
      "r168",
      "r276",
      "r311",
      "r581",
      "r589",
      "r590",
      "r640"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities [Abstract]",
        "terseLabel": "Liabilities"
       }
      }
     },
     "localname": "LiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r65",
      "r168",
      "r311",
      "r640",
      "r751",
      "r779"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and shareholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r85",
      "r168",
      "r311",
      "r581",
      "r589",
      "r590",
      "r640"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "terseLabel": "Current liabilities",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet",
      "http://thecronosgroup.com/role/InvestmentsScheduleofEquityMethodInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "auth_ref": [
      "r36",
      "r37",
      "r38",
      "r51",
      "r52",
      "r168",
      "r311",
      "r581",
      "r589",
      "r590",
      "r640"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.",
        "label": "Liabilities, Noncurrent",
        "terseLabel": "Non-current liabilities"
       }
      }
     },
     "localname": "LiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsScheduleofEquityMethodInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r82"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/LoansPayableLongtermNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationStatusAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Axis]",
        "terseLabel": "Litigation Status [Axis]"
       }
      }
     },
     "localname": "LitigationStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationStatusDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Domain]",
        "terseLabel": "Litigation Status [Domain]"
       }
      }
     },
     "localname": "LitigationStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock": {
     "auth_ref": [
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for claims held for amounts due a company, excluding disclosure for allowance for credit losses. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Also excludes disclosure for financing receivables.",
        "label": "Loans, Notes, Trade and Other Receivables, Excluding Allowance for Credit Losses [Text Block]",
        "terseLabel": "Loan Receivable"
       }
      }
     },
     "localname": "LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/LoanReceivable"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LoansReceivableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An amount of money or property, or a portion thereof, leant to a borrower (debtor) in exchange for a promise to repay the amount borrowed plus interest at a date certain in the future.",
        "label": "Loans Receivable [Member]",
        "terseLabel": "Loans Receivable"
       }
      }
     },
     "localname": "LoansReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock": {
     "auth_ref": [
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets.",
        "label": "Long-lived Assets by Geographic Areas [Table Text Block]",
        "terseLabel": "Schedule of Long-lived Assets by Geographic Areas"
       }
      }
     },
     "localname": "LongLivedAssetsByGeographicAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongTermPurchaseCommitmentAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The minimum amount the entity agreed to spend under the long-term purchase commitment.",
        "label": "Long-term Purchase Commitment, Amount",
        "terseLabel": "Amount of commitment"
       }
      }
     },
     "localname": "LongTermPurchaseCommitmentAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsRDCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by category of items purchased under a long-term purchase commitment.",
        "label": "Category of Item Purchased [Axis]",
        "terseLabel": "Category of Item Purchased [Axis]"
       }
      }
     },
     "localname": "LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsRDCommitmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "General description of the goods or services to be purchased from the counterparty to the long-term purchase commitment.",
        "label": "Long-term Purchase Commitment, Category of Item Purchased [Domain]",
        "terseLabel": "Long-term Purchase Commitment, Category of Item Purchased [Domain]"
       }
      }
     },
     "localname": "LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsRDCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermPurchaseCommitmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Long-term Purchase Commitment [Line Items]",
        "terseLabel": "Long-term Purchase Commitment [Line Items]"
       }
      }
     },
     "localname": "LongTermPurchaseCommitmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsRDCommitmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermPurchaseCommitmentTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule setting forth key provisions of an arrangement under which the entity has agreed to purchase goods or services over a period of time greater than one year or the normal operating cycle, if longer, including the item for which expenditures will be made, minimum quantities, milestones, time period and committed amount.",
        "label": "Long-term Purchase Commitment [Table]",
        "terseLabel": "Long-term Purchase Commitment [Table]"
       }
      }
     },
     "localname": "LongTermPurchaseCommitmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsRDCommitmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r87"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/LoansPayableLongtermNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r87",
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/LoansPayableLongtermNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongtermPurchaseCommitmentPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period covered by the long-term purchase commitment, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Long-term Purchase Commitment, Period",
        "terseLabel": "Research funding period"
       }
      }
     },
     "localname": "LongtermPurchaseCommitmentPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsRDCommitmentsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LossContingenciesByNatureOfContingencyAxis": {
     "auth_ref": [
      "r397",
      "r398",
      "r399",
      "r401",
      "r402",
      "r403",
      "r405",
      "r408",
      "r409"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.",
        "label": "Loss Contingency Nature [Axis]",
        "terseLabel": "Loss Contingency Nature [Axis]"
       }
      }
     },
     "localname": "LossContingenciesByNatureOfContingencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r397",
      "r398",
      "r399",
      "r401",
      "r402",
      "r403",
      "r405",
      "r408",
      "r409"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss Contingency [Abstract]",
        "terseLabel": "Loss Contingency [Abstract]"
       }
      }
     },
     "localname": "LossContingencyAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyDamagesSoughtValue": {
     "auth_ref": [
      "r397",
      "r400",
      "r404"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value (monetary amount) of the award the plaintiff seeks in the legal matter.",
        "label": "Loss Contingency, Damages Sought, Value",
        "terseLabel": "Damages sought"
       }
      }
     },
     "localname": "LossContingencyDamagesSoughtValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyDisclosures": {
     "auth_ref": [
      "r406",
      "r407"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for loss and gain contingencies. Describes any existing condition, situation, or set of circumstances involving uncertainty as of the balance sheet date (or prior to issuance of the financial statements) as to a probable or reasonably possible loss incurred by an entity that will ultimately be resolved when one or more future events occur or fail to occur, and typically discloses the amount of loss recorded or a range of possible loss, or an assertion that no reasonable estimate can be made.",
        "label": "Contingencies Disclosure [Text Block]",
        "terseLabel": "Contingencies"
       }
      }
     },
     "localname": "LossContingencyDisclosures",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/Contingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LossContingencyNatureDomain": {
     "auth_ref": [
      "r397",
      "r398",
      "r399",
      "r401",
      "r402",
      "r403",
      "r405",
      "r408",
      "r409"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.",
        "label": "Loss Contingency, Nature [Domain]",
        "terseLabel": "Loss Contingency, Nature [Domain]"
       }
      }
     },
     "localname": "LossContingencyNatureDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingencyNewClaimsFiledNumber": {
     "auth_ref": [
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total number of new claims filed pertaining to a loss contingency during the period.",
        "label": "Loss Contingency, New Claims Filed, Number",
        "terseLabel": "Number of putative class action complaints"
       }
      }
     },
     "localname": "LossContingencyNewClaimsFiledNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_LossContingencyNumberOfPlaintiffs": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of plaintiffs that have filed claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Number of Plaintiffs",
        "terseLabel": "Number of alleged shareholders"
       }
      }
     },
     "localname": "LossContingencyNumberOfPlaintiffs",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_MeasurementInputExpectedDividendRateMember": {
     "auth_ref": [
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using expected dividend rate to be paid to holder of share per year.",
        "label": "Measurement Input, Expected Dividend Rate [Member]",
        "terseLabel": "Expected dividend yield"
       }
      }
     },
     "localname": "MeasurementInputExpectedDividendRateMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputExpectedTermMember": {
     "auth_ref": [
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date.",
        "label": "Measurement Input, Expected Term [Member]",
        "terseLabel": "Weight average expected life (in years)"
       }
      }
     },
     "localname": "MeasurementInputExpectedTermMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputPriceVolatilityMember": {
     "auth_ref": [
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns.",
        "label": "Measurement Input, Price Volatility [Member]",
        "terseLabel": "Expected annualized volatility"
       }
      }
     },
     "localname": "MeasurementInputPriceVolatilityMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputRiskFreeInterestRateMember": {
     "auth_ref": [
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss.",
        "label": "Measurement Input, Risk Free Interest Rate [Member]",
        "terseLabel": "Weighted average risk-free interest rate"
       }
      }
     },
     "localname": "MeasurementInputRiskFreeInterestRateMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputSharePriceMember": {
     "auth_ref": [
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using share price of saleable stock.",
        "label": "Measurement Input, Share Price [Member]",
        "terseLabel": "Share price at grant date (per share in C$)"
       }
      }
     },
     "localname": "MeasurementInputSharePriceMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]",
        "terseLabel": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]",
        "terseLabel": "Measurement Input Type [Domain]"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r93",
      "r168",
      "r311",
      "r640",
      "r750",
      "r778"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Non-controlling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.",
        "label": "Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners",
        "terseLabel": "Ownership interest"
       }
      }
     },
     "localname": "MinorityInterestOwnershipPercentageByNoncontrollingOwners",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_MovementInValuationAllowancesAndReservesRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]",
        "terseLabel": "Valuation Allowance [Roll Forward]"
       }
      }
     },
     "localname": "MovementInValuationAllowancesAndReservesRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesSummaryofValuationAllowanceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NatureOfOperations": {
     "auth_ref": [
      "r235",
      "r248"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.",
        "label": "Nature of Operations [Text Block]",
        "verboseLabel": "Background"
       }
      }
     },
     "localname": "NatureOfOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/Background"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r153"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by (used in) financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r153"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by (used in) investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r153",
      "r154",
      "r157"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by (used in) operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r23",
      "r108",
      "r111",
      "r121",
      "r157",
      "r168",
      "r193",
      "r198",
      "r199",
      "r200",
      "r201",
      "r205",
      "r206",
      "r219",
      "r262",
      "r274",
      "r278",
      "r281",
      "r284",
      "r311",
      "r640",
      "r761",
      "r784"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Cronos Group"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r108",
      "r111",
      "r205",
      "r206",
      "r584",
      "r602"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "terseLabel": "Non-controlling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToReportingEntityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "Net income (loss) attributable to:"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToReportingEntityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r198",
      "r199",
      "r200",
      "r201",
      "r210",
      "r211",
      "r220",
      "r223",
      "r262",
      "r274",
      "r278",
      "r281",
      "r284"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "terseLabel": "Income (loss) from continuing operations attributable to common shareholders of Cronos\u00a0Group",
        "verboseLabel": "Income (loss) from continuing operations used in the computation of basic earnings (loss) per share"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]",
        "terseLabel": "Basic earnings (loss) per share computation"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted": {
     "auth_ref": [
      "r212",
      "r223"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) from continuing operations available to common shareholders.",
        "label": "Net Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted",
        "totalLabel": "Income (loss) from continuing operations used in the computation of diluted income (loss) per share"
       }
      }
     },
     "localname": "NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Standards Update and Change in Accounting Principle [Abstract]",
        "terseLabel": "New Accounting Pronouncements and Changes in Accounting Principles [Abstract]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "auth_ref": [
      "r191",
      "r192",
      "r195",
      "r196",
      "r207",
      "r208",
      "r209",
      "r318",
      "r319",
      "r450",
      "r451",
      "r452",
      "r453",
      "r506",
      "r538",
      "r539",
      "r540",
      "r727",
      "r728",
      "r729",
      "r804",
      "r805",
      "r806",
      "r807",
      "r809"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Text Block]",
        "terseLabel": "New Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/NewAccountingPronouncements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "New accounting pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Countries excluding the United States of America (US).",
        "label": "Non-US [Member]",
        "terseLabel": "Rest of World"
       }
      }
     },
     "localname": "NonUsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesExpenseforIncomeTaxesDetails",
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofIncomeLossbeforeIncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance": {
     "auth_ref": [
      "r425",
      "r579",
      "r586"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in noncontrolling interest from subsidiary issuance of equity interests to noncontrolling interest holders.",
        "label": "Noncontrolling Interest, Increase from Subsidiary Equity Issuance",
        "terseLabel": "Contribution by non-controlling interests"
       }
      }
     },
     "localname": "NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r186",
      "r187",
      "r189",
      "r424",
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Non-controlling interests"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncurrentAssets": {
     "auth_ref": [
      "r289"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.",
        "label": "Long-Lived Assets",
        "terseLabel": "Long-lived assets"
       }
      }
     },
     "localname": "NoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationScheduleofLonglivedAssetsbyGeographicAreasDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonmonetaryTransactionByTypeTable": {
     "auth_ref": [
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r679",
      "r680"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transactions involving exchanges with other entities that involve principally nonmonetary assets or liabilities or relate to a transfer of nonmonetary assets for which the Entity receives no assets in return.",
        "label": "Nonmonetary Transaction, by Type [Table]",
        "terseLabel": "Nonmonetary Transaction, by Type [Table]"
       }
      }
     },
     "localname": "NonmonetaryTransactionByTypeTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/NonmonetaryTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NonmonetaryTransactionGainLossRecognizedOnTransfer": {
     "auth_ref": [
      "r678",
      "r680"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of the difference in values (gain (loss)) between the nonmonetary assets or liabilities exchanged with another entity inclusive of boot (small monetary consideration).",
        "label": "Nonmonetary Transaction, Gain (Loss) Recognized on Transfer",
        "terseLabel": "Gain (loss) recognized on transfer"
       }
      }
     },
     "localname": "NonmonetaryTransactionGainLossRecognizedOnTransfer",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/NonmonetaryTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonmonetaryTransactionGrossOperatingRevenueRecognized": {
     "auth_ref": [
      "r679"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of gross operating revenue recognized in a nonmonetary transaction.",
        "label": "Nonmonetary Transaction, Gross Operating Revenue Recognized",
        "terseLabel": "Revenue recognized"
       }
      }
     },
     "localname": "NonmonetaryTransactionGrossOperatingRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/NonmonetaryTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonmonetaryTransactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Nonmonetary Transaction [Line Items]",
        "terseLabel": "Nonmonetary Transaction [Line Items]"
       }
      }
     },
     "localname": "NonmonetaryTransactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/NonmonetaryTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NonmonetaryTransactionTypeAxis": {
     "auth_ref": [
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r679",
      "r680"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by nature of the nonmonetary transaction or group of similar transactions, such as a barter or exchange.",
        "label": "Nonmonetary Transaction Type [Axis]",
        "terseLabel": "Nonmonetary Transaction Type [Axis]"
       }
      }
     },
     "localname": "NonmonetaryTransactionTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/NonmonetaryTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NonmonetaryTransactionTypeDomain": {
     "auth_ref": [
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r679",
      "r680"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies the nature of the nonmonetary transaction or group of similar transactions, such as a barter or exchange.",
        "label": "Nonmonetary Transaction Type [Domain]",
        "terseLabel": "Nonmonetary Transaction Type [Domain]"
       }
      }
     },
     "localname": "NonmonetaryTransactionTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/NonmonetaryTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonmonetaryTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonmonetary Transactions [Abstract]",
        "terseLabel": "Nonmonetary Transactions [Abstract]"
       }
      }
     },
     "localname": "NonmonetaryTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_NonmonetaryTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r677",
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for exchanges with other entities that involve principally nonmonetary assets or liabilities or relate to a transfer of nonmonetary assets for which the entity receives no assets in return.",
        "label": "Nonmonetary Transactions Disclosure [Text Block]",
        "terseLabel": "Non-monetary Transactions"
       }
      }
     },
     "localname": "NonmonetaryTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/NonmonetaryTransactions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r137"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "terseLabel": "Other income (loss)",
        "totalLabel": "Total other income (expense)"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
      "http://thecronosgroup.com/role/DiscontinuedOperationsandHeldforsaleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other income (expense)"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NotesAndLoansReceivableNetCurrent": {
     "auth_ref": [
      "r29",
      "r30",
      "r58",
      "r295",
      "r296",
      "r756"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_NotesReceivableNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of financing receivable, classified as current. Includes, but is not limited to, notes and loan receivable.",
        "label": "Financing Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Current portion of loans receivable",
        "totalLabel": "Total current portion of loans receivable"
       }
      }
     },
     "localname": "NotesAndLoansReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet",
      "http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NotesAndLoansReceivableNetCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financing Receivable, after Allowance for Credit Loss, Current [Abstract]",
        "terseLabel": "Current portion"
       }
      }
     },
     "localname": "NotesAndLoansReceivableNetCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NotesAndLoansReceivableNetNoncurrent": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_NotesReceivableNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of financing receivable, classified as noncurrent.",
        "label": "Financing Receivable, after Allowance for Credit Loss, Noncurrent",
        "terseLabel": "Loans receivable, net",
        "totalLabel": "Total long-term portion of loans receivable"
       }
      }
     },
     "localname": "NotesAndLoansReceivableNetNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet",
      "http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NotesAndLoansReceivableNetNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financing Receivable, after Allowance for Credit Loss, Noncurrent [Abstract]",
        "terseLabel": "Long term portion"
       }
      }
     },
     "localname": "NotesAndLoansReceivableNetNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NotesReceivableNet": {
     "auth_ref": [
      "r59",
      "r295",
      "r330"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of financing receivable. Excludes financing receivable covered under loss sharing agreement.",
        "label": "Financing Receivable, after Allowance for Credit Loss",
        "totalLabel": "Total loans receivable"
       }
      }
     },
     "localname": "NotesReceivableNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfBusinessesAcquired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of businesses acquired by the entity during the period.",
        "label": "Number of Businesses Acquired",
        "terseLabel": "Number of operating subsidiaries acquired"
       }
      }
     },
     "localname": "NumberOfBusinessesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r250"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportingUnits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment.",
        "label": "Number of Reporting Units",
        "terseLabel": "Number of reporting units"
       }
      }
     },
     "localname": "NumberOfReportingUnits",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesImpairmentofLonglivedAssetsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "negatedTerseLabel": "Operating expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
      "http://thecronosgroup.com/role/DiscontinuedOperationsandHeldforsaleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r262",
      "r274",
      "r278",
      "r281",
      "r284"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating loss"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r661",
      "r667"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/LeasesScheduleofLeaseCostandOtherInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/LeasesScheduleofLeaseCostandOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, Payment, Due [Abstract]",
        "terseLabel": "Lessee, Operating Lease, Liability, Payment, Due [Abstract]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsSummaryofFutureMinimumLeasePaymentsUnderOperatingLeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r657"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "verboseLabel": "Current portion of lease obligation"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r657"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "verboseLabel": "Lease obligation"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r656"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "verboseLabel": "Right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r664",
      "r667"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted-average discount rate \u2013 operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/LeasesScheduleofLeaseCostandOtherInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r663",
      "r667"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted-average remaining lease term \u2013 operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/LeasesScheduleofLeaseCostandOtherInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r528"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Operating loss carryforwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwardsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Operating Loss Carryforwards [Line Items]",
        "terseLabel": "Operating Loss Carryforwards [Line Items]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesExpenseforIncomeTaxesDetails",
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofIncomeLossbeforeIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLossCarryforwardsTable": {
     "auth_ref": [
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.",
        "label": "Operating Loss Carryforwards [Table]",
        "terseLabel": "Operating Loss Carryforwards [Table]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesExpenseforIncomeTaxesDetails",
      "http://thecronosgroup.com/role/IncomeTaxesScheduleofIncomeLossbeforeIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r273",
      "r274",
      "r275",
      "r276",
      "r278",
      "r284"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationScheduleofAdjustedEBITDADetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r26",
      "r185",
      "r248",
      "r604"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows.  Describes procedure if disclosures are provided in more than one note to the financial statements.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "auth_ref": [
      "r106",
      "r115",
      "r642",
      "r644",
      "r648"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "verboseLabel": "Net unrealized (loss) gain"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign exchange gain (loss) on translation",
        "verboseLabel": "Foreign exchange gain (loss) on translation"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
      "http://thecronosgroup.com/role/FinancialInstrumentsCurrencyRateRiskNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r109",
      "r112",
      "r115",
      "r122",
      "r417",
      "r642",
      "r647",
      "r648",
      "r762",
      "r785"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "totalLabel": "Total other comprehensive income (loss)",
        "verboseLabel": "Other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
      "http://thecronosgroup.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r135"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/GeneralandAdministrativeExpensesScheduleofGeneralandAdministrativeExpensesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_GeneralAndAdministrativeExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of general and administrative expense classified as other.",
        "label": "Other General and Administrative Expense",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/GeneralandAdministrativeExpensesScheduleofGeneralandAdministrativeExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r157"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedTerseLabel": "Other non-cash operating activity expense (income)"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r139"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "negatedTerseLabel": "Other income (loss)",
        "terseLabel": "Other income (loss)"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofAdjustedEBITDADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherReceivablesNetCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.",
        "label": "Other Receivables, Net, Current",
        "terseLabel": "Other receivables"
       }
      }
     },
     "localname": "OtherReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r141",
      "r145",
      "r176"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedTerseLabel": "Other non-cash investing activity expense (income)"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "auth_ref": [
      "r150"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.",
        "label": "Payments of Stock Issuance Costs",
        "negatedLabel": "Share issuance costs",
        "terseLabel": "Share issuance costs"
       }
      }
     },
     "localname": "PaymentsOfStockIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CapitalStockNarrativeDetails",
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r148"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-based Payment Arrangement",
        "negatedTerseLabel": "Withholding taxes paid on equity awards"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r143",
      "r569"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/BusinessCombinationsNarrativeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Payments to acquire businesses"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/BusinessCombinationsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r143"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedTerseLabel": "Acquisition of Redwood"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireEquityMethodInvestments": {
     "auth_ref": [
      "r143"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.",
        "label": "Payments to Acquire Equity Method Investments",
        "negatedTerseLabel": "Investments in equity accounted investees"
       }
      }
     },
     "localname": "PaymentsToAcquireEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "auth_ref": [
      "r144"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.",
        "label": "Payments to Acquire Intangible Assets",
        "negatedTerseLabel": "Purchase of intangible assets",
        "terseLabel": "Purchase of intangible assets"
       }
      }
     },
     "localname": "PaymentsToAcquireIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows",
      "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInterestInJointVenture": {
     "auth_ref": [
      "r143"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the investment in or advances to an entity in which the reporting entity shares control of the entity with another party or group.",
        "label": "Payments to Acquire Interest in Joint Venture",
        "negatedTerseLabel": "Advances to joint ventures"
       }
      }
     },
     "localname": "PaymentsToAcquireInterestInJointVenture",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireLoansReceivable": {
     "auth_ref": [
      "r142"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for the purchase of loan receivable arising from the financing of goods and services.",
        "label": "Payments to Acquire Loans Receivable",
        "negatedTerseLabel": "Advances on loans receivable",
        "terseLabel": "Draw downs"
       }
      }
     },
     "localname": "PaymentsToAcquireLoansReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows",
      "http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireMarketableSecurities": {
     "auth_ref": [
      "r302"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for purchase of marketable security.",
        "label": "Payments to Acquire Marketable Securities",
        "negatedTerseLabel": "Proceeds from (purchase of) short-term investments, net"
       }
      }
     },
     "localname": "PaymentsToAcquireMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r144"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedTerseLabel": "Purchase of property, plant and equipment, net of disposals"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToMinorityShareholders": {
     "auth_ref": [
      "r150"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.",
        "label": "Payments to Noncontrolling Interests",
        "negatedLabel": "Advance to non-controlling interests"
       }
      }
     },
     "localname": "PaymentsToMinorityShareholders",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PendingLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Risk of loss associated with the outcome of pending litigation against the entity, for example, but not limited to, litigation in arbitration or within the trial process.",
        "label": "Pending Litigation [Member]",
        "terseLabel": "Pending Litigation"
       }
      }
     },
     "localname": "PendingLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r472",
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsScheduleofStockOptionsOutstandingDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsScheduleofStockOptionsOutstandingDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r31",
      "r73",
      "r74"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaids and other assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrivatePlacementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts.",
        "label": "Private Placement [Member]",
        "terseLabel": "Private Placements"
       }
      }
     },
     "localname": "PrivatePlacementMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CapitalStockNarrativeDetails",
      "http://thecronosgroup.com/role/CapitalStockScheduleofCommonSharesIssuedDetails",
      "http://thecronosgroup.com/role/CommitmentsUseofPublicityRightsinBrandDevelopmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r146"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Proceeds from issuance of common stock"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSecuredDebt": {
     "auth_ref": [
      "r147"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from amounts received from issuance of long-term debt that is wholly or partially secured by collateral. Excludes proceeds from tax exempt secured debt.",
        "label": "Proceeds from Issuance of Secured Debt",
        "terseLabel": "Proceeds from construction loan payable"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSecuredDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLongTermLinesOfCredit": {
     "auth_ref": [
      "r147"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.",
        "label": "Proceeds from Long-term Lines of Credit",
        "terseLabel": "Advance under Credit Facility"
       }
      }
     },
     "localname": "ProceedsFromLongTermLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities  (held-to-maturity or available-for-sale) during the period.",
        "label": "Proceeds from Sale and Maturity of Marketable Securities",
        "terseLabel": "Proceeds from (purchase of) short-term investments, net"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductAndServiceOtherMember": {
     "auth_ref": [
      "r447"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery and act of providing assistance, classified as other.",
        "label": "Product and Service, Other [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "ProductAndServiceOtherMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r23",
      "r108",
      "r111",
      "r151",
      "r168",
      "r193",
      "r205",
      "r206",
      "r262",
      "r274",
      "r278",
      "r281",
      "r284",
      "r311",
      "r576",
      "r583",
      "r585",
      "r602",
      "r603",
      "r640",
      "r768"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net income (loss)",
        "totalLabel": "Net income (loss)",
        "verboseLabel": "Net loss"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows",
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
      "http://thecronosgroup.com/role/ConsolidatedStatementsofStockholdersEquityDeficit",
      "http://thecronosgroup.com/role/InvestmentsScheduleofEquityMethodInvestmentsDetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofAdjustedEBITDADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]",
        "terseLabel": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAdditions": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of acquisition of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Additions",
        "terseLabel": "Purchase of property, plant and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAdditions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r79",
      "r376"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/LeasesNarrativeDetails",
      "http://thecronosgroup.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantEquipmentUsefulLivesDetails",
      "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantEquipmentUsefulLivesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r382",
      "r831",
      "r832",
      "r833"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/PropertyPlantandEquipment"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r78",
      "r374"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantEquipmentUsefulLivesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property, plant and equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantEquipmentUsefulLivesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantEquipmentUsefulLivesDetails",
      "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantEquipmentUsefulLivesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r43",
      "r44",
      "r376",
      "r780"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://thecronosgroup.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantEquipmentUsefulLivesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant and equipment",
        "totalLabel": "Balance as of December 31",
        "verboseLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet",
      "http://thecronosgroup.com/role/DiscontinuedOperationsandHeldforsaleAssetsDetails",
      "http://thecronosgroup.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantEquipmentUsefulLivesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r77",
      "r164",
      "r376",
      "r831",
      "r832"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property, plant &amp; equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r43",
      "r376"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "verboseLabel": "Schedule of Property, Plant &amp; Equipment, Useful Lives"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/PropertyPlantandEquipmentTables",
      "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r43",
      "r374"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/LeasesNarrativeDetails",
      "http://thecronosgroup.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantEquipmentUsefulLivesDetails",
      "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantEquipmentUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Property, plant &amp; equipment, useful life"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantEquipmentUsefulLivesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r127",
      "r325"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Provisions for inventory and doubtful accounts"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProvisionForLoanLossesExpensed": {
     "auth_ref": [
      "r325",
      "r758"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/GeneralandAdministrativeExpensesScheduleofGeneralandAdministrativeExpensesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_GeneralAndAdministrativeExpense",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of credit loss expense (reversal of expense) for financing receivable.",
        "label": "Financing Receivable, Credit Loss, Expense (Reversal)",
        "terseLabel": "Current expected credit loss"
       }
      }
     },
     "localname": "ProvisionForLoanLossesExpensed",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/GeneralandAdministrativeExpensesScheduleofGeneralandAdministrativeExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PublicUtilitiesInventoryAxis": {
     "auth_ref": [
      "r70"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of inventory held.",
        "label": "Inventory [Axis]",
        "terseLabel": "Inventory [Axis]"
       }
      }
     },
     "localname": "PublicUtilitiesInventoryAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/InventoryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PublicUtilitiesInventoryTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property that is held for sale in the ordinary course of business, in process of production for such sale or is to be currently consumed in the production of goods or services to be available for sale.",
        "label": "Inventory [Domain]",
        "terseLabel": "Inventory [Domain]"
       }
      }
     },
     "localname": "PublicUtilitiesInventoryTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/InventoryDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReceivableTypeDomain": {
     "auth_ref": [
      "r92"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing arrangement representing a contractual right to receive money either on demand or on fixed and determinable dates.",
        "label": "Receivable [Domain]",
        "terseLabel": "Receivable [Domain]"
       }
      }
     },
     "localname": "ReceivableTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReceivablesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Receivables [Abstract]",
        "terseLabel": "Receivables [Abstract]"
       }
      }
     },
     "localname": "ReceivablesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]",
        "terseLabel": "AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r463",
      "r684",
      "r685"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesNarrativeDetails",
      "http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesScheduleofRelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "auth_ref": [
      "r463",
      "r684",
      "r685",
      "r687"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party transaction.",
        "label": "Related Party Transaction [Axis]",
        "terseLabel": "Related Party Transaction [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesNarrativeDetails",
      "http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesScheduleofRelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "auth_ref": [
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transaction between related party.",
        "label": "Related Party Transaction [Domain]",
        "terseLabel": "Related Party Transaction [Domain]"
       }
      }
     },
     "localname": "RelatedPartyTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesNarrativeDetails",
      "http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesScheduleofRelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty": {
     "auth_ref": [
      "r684"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.",
        "label": "Related Party Transaction, Expenses from Transactions with Related Party",
        "terseLabel": "Consulting fees"
       }
      }
     },
     "localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesNarrativeDetails",
      "http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesScheduleofRelatedPartyTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Related Party Transaction [Line Items]",
        "terseLabel": "Related Party Transaction [Line Items]"
       }
      }
     },
     "localname": "RelatedPartyTransactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesNarrativeDetails",
      "http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesScheduleofRelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchases during the period (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.",
        "label": "Related Party Transaction, Purchases from Related Party",
        "terseLabel": "Purchases"
       }
      }
     },
     "localname": "RelatedPartyTransactionPurchasesFromRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]",
        "terseLabel": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r463",
      "r684",
      "r687",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesNarrativeDetails",
      "http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesScheduleofRelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r682",
      "r683",
      "r685",
      "r688",
      "r689"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "terseLabel": "Related Party Transactions and Balances"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/RelatedPartyTransactionsandBalances"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfLongTermLinesOfCredit": {
     "auth_ref": [
      "r149"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for the settlement of obligation drawn from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.",
        "label": "Repayments of Long-term Lines of Credit",
        "negatedTerseLabel": "Repayment of Credit Facility"
       }
      }
     },
     "localname": "RepaymentsOfLongTermLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfSecuredDebt": {
     "auth_ref": [
      "r149"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to repay long-term debt that is wholly or partially secured by collateral. Excludes repayments of tax exempt secured debt.",
        "label": "Repayments of Secured Debt",
        "negatedTerseLabel": "Repayment of construction loan payable",
        "terseLabel": "Repayments of construction loans payable"
       }
      }
     },
     "localname": "RepaymentsOfSecuredDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows",
      "http://thecronosgroup.com/role/LoansPayableLongtermNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReportingUnitAxis": {
     "auth_ref": [
      "r350",
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by reporting unit.",
        "label": "Reporting Unit [Axis]",
        "terseLabel": "Reporting Unit [Axis]"
       }
      }
     },
     "localname": "ReportingUnitAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillNarrativeDetails",
      "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReportingUnitDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Level of reporting at which goodwill is tested for impairment.",
        "label": "Reporting Unit [Domain]",
        "terseLabel": "Reporting Unit [Domain]"
       }
      }
     },
     "localname": "ReportingUnitDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillNarrativeDetails",
      "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentArrangementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual obligation to provide funding of research and development costs over periods that initially exceed one year or the normal operating cycle, if longer.",
        "label": "Research and Development Arrangement [Member]",
        "terseLabel": "Research and Development Arrangement"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsRDCommitmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r511",
      "r844"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "verboseLabel": "Restricted share units"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/EarningslossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedSharesOutstandingDetails",
      "http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsRestrictedShareUnitsNarrativeDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofRestrictedShareUnitsActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring and Related Activities [Abstract]",
        "terseLabel": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "Repurposing Charges"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/RepurposingCharges"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r156",
      "r383",
      "r388",
      "r392"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "verboseLabel": "Repurposing charges"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationScheduleofAdjustedEBITDADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/RepurposingChargesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCosts": {
     "auth_ref": [
      "r156"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Costs",
        "verboseLabel": "Non-cash repurposing costs"
       }
      }
     },
     "localname": "RestructuringCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringPlanAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by individual restructuring plan.",
        "label": "Restructuring Plan [Axis]",
        "terseLabel": "Restructuring Plan [Axis]"
       }
      }
     },
     "localname": "RestructuringPlanAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/RepurposingChargesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the individual restructuring plans.",
        "label": "Restructuring Plan [Domain]",
        "terseLabel": "Restructuring Plan [Domain]"
       }
      }
     },
     "localname": "RestructuringPlanDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/RepurposingChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r384",
      "r390"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "terseLabel": "Restructuring reserve"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/RepurposingChargesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringSettlementAndImpairmentProvisions": {
     "auth_ref": [
      "r134"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 6.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      },
      "http://thecronosgroup.com/role/RepurposingChargesScheduleofPlanInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of restructuring charges, remediation cost, and asset impairment loss.",
        "label": "Restructuring, Settlement and Impairment Provisions",
        "totalLabel": "Repurposing charges",
        "verboseLabel": "Repurposing charges"
       }
      }
     },
     "localname": "RestructuringSettlementAndImpairmentProvisions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
      "http://thecronosgroup.com/role/RepurposingChargesNarrativeDetails",
      "http://thecronosgroup.com/role/RepurposingChargesScheduleofPlanInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r61",
      "r424",
      "r507",
      "r777",
      "r804",
      "r809"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r186",
      "r187",
      "r189",
      "r194",
      "r203",
      "r206",
      "r317",
      "r503",
      "r504",
      "r505",
      "r536",
      "r537",
      "r800",
      "r802"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained earnings (accumulated deficit)"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r253",
      "r254",
      "r273",
      "r279",
      "r280",
      "r287",
      "r288",
      "r293",
      "r444",
      "r445",
      "r725"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Revenue",
        "totalLabel": "Net revenue",
        "verboseLabel": "Net revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
      "http://thecronosgroup.com/role/InvestmentsScheduleofEquityMethodInvestmentsDetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": {
     "auth_ref": [
      "r253",
      "r254",
      "r273",
      "r279",
      "r280",
      "r287",
      "r288",
      "r293",
      "r444",
      "r445",
      "r725"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.",
        "label": "Revenue from Contract with Customer, Including Assessed Tax",
        "terseLabel": "Net revenue, before excise taxes"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerIncludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
      "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r165",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r446",
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenues from Contracts with Customers"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/RevenuesfromContractswithCustomers"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": {
     "auth_ref": [
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.",
        "label": "Revenue from External Customers by Geographic Areas [Table Text Block]",
        "terseLabel": "Schedule of Revenue from External Customers by Geographic Areas"
       }
      }
     },
     "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenues from External Customers and Long-Lived Assets [Line Items]",
        "terseLabel": "Revenues from External Customers and Long-Lived Assets [Line Items]"
       }
      }
     },
     "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationScheduleofLonglivedAssetsbyGeographicAreasDetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RisksAndUncertaintiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risks and Uncertainties [Abstract]",
        "terseLabel": "Risks and Uncertainties [Abstract]"
       }
      }
     },
     "localname": "RisksAndUncertaintiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]",
        "terseLabel": "Sale of Stock [Domain]"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CapitalStockNarrativeDetails",
      "http://thecronosgroup.com/role/CapitalStockScheduleofCommonSharesIssuedDetails",
      "http://thecronosgroup.com/role/CommitmentsUseofPublicityRightsinBrandDevelopmentDetails",
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofEquityMethodInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "terseLabel": "Sale of stock, number of shares issued in transaction (in shares)"
       }
      }
     },
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsScheduleofEquityMethodInvestmentsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
        "label": "Sale of Stock, Price Per Share",
        "terseLabel": "Sale of stock, price per share (in aud per share)"
       }
      }
     },
     "localname": "SaleOfStockPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsScheduleofEquityMethodInvestmentsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r242",
      "r293"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue Benchmark [Member]",
        "terseLabel": "Revenue Benchmark"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": {
     "auth_ref": [
      "r92"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule itemizing specific types of trade accounts and notes receivable, and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]",
        "terseLabel": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": {
     "auth_ref": [
      "r92"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]",
        "terseLabel": "Schedule of Loan Receivable"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/LoanReceivableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r106",
      "r647",
      "r648"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLossTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/EarningslossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedSharesOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Diluted Shares Outstanding"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/EarningslossPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r558",
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/BusinessCombinationsNarrativeDetails",
      "http://thecronosgroup.com/role/BusinessCombinationsScheduleofFairValueofNetAssetsAcquiredDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Schedule of Expense for Income Taxes"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Deferred Tax Assets and Liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": {
     "auth_ref": [
      "r1",
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r15",
      "r18",
      "r21",
      "r22",
      "r23",
      "r380",
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]",
        "terseLabel": "Summary of Discontinued Operations"
       }
      }
     },
     "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DiscontinuedOperationsandHeldforsaleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Earnings (Loss) Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/EarningslossPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable": {
     "auth_ref": [
      "r213",
      "r218",
      "r221",
      "r223",
      "r229"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Complete disclosure pertaining to an entity's diluted earnings per share.",
        "label": "Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]",
        "terseLabel": "Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareDilutedByCommonClassTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Effective Income Tax Rate Reconciliation"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule of Equity Method Investments [Line Items]",
        "terseLabel": "Schedule of Equity Method Investments [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofEquityMethodInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsTable": {
     "auth_ref": [
      "r23",
      "r168",
      "r310",
      "r311",
      "r640"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available.",
        "label": "Schedule of Equity Method Investments [Table]",
        "terseLabel": "Schedule of Equity Method Investments [Table]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofEquityMethodInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r621",
      "r622"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/FairValueMeasuresandDisclosuresTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r355",
      "r359",
      "r726"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails",
      "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesScheduleofIntangibleAssetsAmortizationMethodsandRatesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r355",
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Intangible Assets Amortization Methods and Rates",
        "verboseLabel": "Schedule of Finite-Lived Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillTables",
      "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r349",
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r349",
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "auth_ref": [
      "r173"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "terseLabel": "Schedule of Income (Loss) before Income Taxes"
       }
      }
     },
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r363",
      "r366"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity.",
        "label": "Schedule of Indefinite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Indefinite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillNarrativeDetails",
      "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r363",
      "r366"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.",
        "label": "Schedule of Indefinite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Indefinite-Lived Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r34",
      "r70",
      "r71",
      "r72"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of Inventory"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/InventoryTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock": {
     "auth_ref": [
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of activity for outstanding award under share-based payment arrangement excluding share and unit options and nonvested award.",
        "label": "Share-based Payment Arrangement, Outstanding Award, Activity, Excluding Option [Table Text Block]",
        "terseLabel": "Summary of Changes in Warrants and DSUs"
       }
      }
     },
     "localname": "ScheduleOfOtherShareBasedCompensationActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r79",
      "r376"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/PropertyPlantandEquipmentScheduleofPropertyPlantEquipmentUsefulLivesDetails",
      "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyPlantEquipmentUsefulLivesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r563"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Schedule of Fair Value of Net Assets Acquired"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/BusinessCombinationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "auth_ref": [
      "r170",
      "r686",
      "r687"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Schedule of Related Party Transactions, by Related Party [Table]",
        "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesNarrativeDetails",
      "http://thecronosgroup.com/role/RelatedPartyTransactionsandBalancesScheduleofRelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.",
        "label": "Schedule of Related Party Transactions [Table Text Block]",
        "terseLabel": "Schedule of Related Party Transactions"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/RelatedPartyDisclosuresTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r386",
      "r387",
      "r391"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/RepurposingChargesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "auth_ref": [
      "r386",
      "r387",
      "r391"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "terseLabel": "Schedule of Plan Information and Restructuring-Related Costs"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/RepurposingChargesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": {
     "auth_ref": [
      "r117",
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material.  An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]",
        "terseLabel": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationScheduleofLonglivedAssetsbyGeographicAreasDetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of sales of stock or previously unissued stock made by subsidiary or equity method investee to investors outside the consolidated group. This includes stock issued in a business combination in exchange for shares of an acquired entity.",
        "label": "Schedule of Sale of Stock by Subsidiary or Equity Method Investee Disclosure [Table Text Block]",
        "terseLabel": "Schedule of Consolidated Entities"
       }
      }
     },
     "localname": "ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r262",
      "r265",
      "r277",
      "r349"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofAdjustedEBITDADetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r262",
      "r265",
      "r277",
      "r349"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Schedule of Segment Data and Adjusted EBITDA"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r472",
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsDeferredShareUnitsNarrativeDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsFairValueofOptionsIssuedDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsRestrictedShareUnitsNarrativeDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsScheduleofStockOptionsOutstandingDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinWarrantsDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofDeferredShareUnitsActivityDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofOutstandingWarrantsDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofRestrictedShareUnitsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": {
     "auth_ref": [
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]",
        "terseLabel": "Summary of Restricted Share Units Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Fair Value of Options Issued"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r90",
      "r166",
      "r233",
      "r234",
      "r412",
      "r414",
      "r416",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CapitalStockScheduleofCommonSharesIssuedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfStockByClassTextBlock": {
     "auth_ref": [
      "r55",
      "r56",
      "r57",
      "r413",
      "r414",
      "r416",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's stock, including par or stated value per share, number and dollar amount of share subscriptions, shares authorized, shares issued, shares outstanding, number and dollar amount of shares held in an employee trust, dividend per share, total dividends, share conversion features, par value plus additional paid in capital, the value of treasury stock and other information necessary to a fair presentation, and EPS information.  Stock by class includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. Includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity. If more than one issue is outstanding, state the title of each issue and the corresponding dollar amount; dollar amount of any shares subscribed but unissued and the deduction of subscriptions receivable there from; number of shares authorized, issued, and outstanding.",
        "label": "Schedule of Stock by Class [Table Text Block]",
        "terseLabel": "Schedule of Common Shares Issued"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CapitalStockTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in stock options.",
        "label": "Schedule of Stock Options Roll Forward [Table Text Block]",
        "terseLabel": "Summary of the Changes in Options"
       }
      }
     },
     "localname": "ScheduleOfStockOptionsRollForwardTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSubsidiaryOrEquityMethodInvesteeTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of subsidiary's sales of previously unissued stock made to investors outside the consolidated group. This includes stock issued in a business combination in exchange for shares of an acquired entity.",
        "label": "Schedule of Subsidiary or Equity Method Investee [Table]",
        "terseLabel": "Schedule of Subsidiary or Equity Method Investee [Table]"
       }
      }
     },
     "localname": "ScheduleOfSubsidiaryOrEquityMethodInvesteeTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesScheduleofConsolidatedEntitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt and Equity Securities, FV-NI [Line Items]",
        "terseLabel": "Debt and Equity Securities, FV-NI [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/OtherInvestmentsSummaryofOtherInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security with change in fair value recognized in net income (FV-NI).",
        "label": "Debt Securities, Trading, and Equity Securities, FV-NI [Table]",
        "terseLabel": "Debt Securities, Trading, and Equity Securities, FV-NI [Table]"
       }
      }
     },
     "localname": "ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/OtherInvestmentsSummaryofOtherInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfVariableInterestEntitiesTable": {
     "auth_ref": [
      "r580",
      "r581",
      "r589",
      "r590",
      "r591",
      "r594",
      "r597",
      "r599",
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of qualitative and quantitative information related to variable interests the entity holds, whether or not such variable interest entity (VIE) is included in the reporting entity's consolidated financial statements. Includes, but is not limited to, description of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a tabular comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.",
        "label": "Schedule of Variable Interest Entities [Table]",
        "terseLabel": "Schedule of Variable Interest Entities [Table]"
       }
      }
     },
     "localname": "ScheduleOfVariableInterestEntitiesTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofAdvancestoJointVenturesDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofVariableInterestEntitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfVariableInterestEntitiesTextBlock": {
     "auth_ref": [
      "r591",
      "r594",
      "r597",
      "r599",
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.",
        "label": "Schedule of Variable Interest Entities [Table Text Block]",
        "terseLabel": "Schedule of Variable Interest Entities"
       }
      }
     },
     "localname": "ScheduleOfVariableInterestEntitiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecuredDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets.",
        "label": "Secured Debt [Member]",
        "terseLabel": "Construction Loans"
       }
      }
     },
     "localname": "SecuredDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/LoansPayableLongtermNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r249",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r273",
      "r274",
      "r275",
      "r276",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r284",
      "r293",
      "r792"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofAdjustedEBITDADetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r249",
      "r251",
      "r252",
      "r262",
      "r266",
      "r278",
      "r282",
      "r283",
      "r284",
      "r285",
      "r287",
      "r292",
      "r293",
      "r294"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment Information"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationAdditionalInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting Information, Additional Information [Abstract]",
        "terseLabel": "Consolidated balance sheets"
       }
      }
     },
     "localname": "SegmentReportingInformationAdditionalInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofAdjustedEBITDADetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingInformationProfitLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting Information, Profit (Loss) [Abstract]",
        "terseLabel": "Consolidated statements of net income (loss) and comprehensive income (loss)"
       }
      }
     },
     "localname": "SegmentReportingInformationProfitLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r164",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Segment structure"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingAndMarketingExpense": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.",
        "label": "Selling and Marketing Expense",
        "terseLabel": "Sales and marketing"
       }
      }
     },
     "localname": "SellingAndMarketingExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeveranceCosts1": {
     "auth_ref": [
      "r156",
      "r383",
      "r388",
      "r392"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/RepurposingChargesScheduleofPlanInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_RestructuringSettlementAndImpairmentProvisions",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.",
        "label": "Severance Costs",
        "terseLabel": "Employee termination benefits"
       }
      }
     },
     "localname": "SeveranceCosts1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/RepurposingChargesScheduleofPlanInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r155"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-based payments"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsRestrictedShareUnitsNarrativeDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r481"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Cancellation and forfeitures (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofRestrictedShareUnitsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Cancellation and forfeitures (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofRestrictedShareUnitsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsDeferredShareUnitsNarrativeDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsRestrictedShareUnitsNarrativeDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofRestrictedShareUnitsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofRestrictedShareUnitsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Balance at end of period (in shares)",
        "periodStartLabel": "Balance at beginning of period (in shares)",
        "verboseLabel": "Number of warrants (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinWarrantsDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofDeferredShareUnitsActivityDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofOutstandingWarrantsDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofRestrictedShareUnitsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Number of warrants"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinWarrantsDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofDeferredShareUnitsActivityDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofRestrictedShareUnitsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Balance at end of period (in dollars per share)",
        "periodStartLabel": "Balance at beginning of period (in dollars per share)",
        "terseLabel": "Weighted average exercise price (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinWarrantsDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofOutstandingWarrantsDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofRestrictedShareUnitsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted average exercise price (C$)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinWarrantsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "Liabilities settled (in shares)",
        "negatedTerseLabel": "Exercise of warrants (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinWarrantsDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofDeferredShareUnitsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Exercise of warrants (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinWarrantsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price",
        "terseLabel": "Exercise price (per option) (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsFairValueofOptionsIssuedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Expected dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsFairValueofOptionsIssuedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r495"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsFairValueofOptionsIssuedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate": {
     "auth_ref": [
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rate of weighted-average expected volatility for award under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate",
        "terseLabel": "Expected annualized volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsFairValueofOptionsIssuedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsDeferredShareUnitsNarrativeDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsFairValueofOptionsIssuedDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsRestrictedShareUnitsNarrativeDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsScheduleofStockOptionsOutstandingDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinWarrantsDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofDeferredShareUnitsActivityDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofOutstandingWarrantsDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofRestrictedShareUnitsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Future awards to be granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Exercisable (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryoftheChangesinOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Exercisable (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryoftheChangesinOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "auth_ref": [
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period",
        "negatedTerseLabel": "Cancellation of options (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryoftheChangesinOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price of options that were either forfeited or expired.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Cancellation, forfeiture and expiry of options (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryoftheChangesinOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Issuance of options (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryoftheChangesinOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r478",
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Balance at end of period (in shares)",
        "periodStartLabel": "Balance at beginning of period (in shares)",
        "terseLabel": "Number of options outstanding (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsScheduleofStockOptionsOutstandingDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryoftheChangesinOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Number of options"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryoftheChangesinOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Balance at end of period (in dollars per share)",
        "periodStartLabel": "Balance at beginning of period (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryoftheChangesinOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted average exercise price (C$)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryoftheChangesinOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock": {
     "auth_ref": [
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for outstanding and exercisable options that are fully vested and expected to vest. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Table Text Block]",
        "terseLabel": "Summary of Outstanding Options"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r470",
      "r474"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsDeferredShareUnitsNarrativeDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsFairValueofOptionsIssuedDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsRestrictedShareUnitsNarrativeDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinWarrantsDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofDeferredShareUnitsActivityDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofOutstandingWarrantsDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofRestrictedShareUnitsActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofRestrictedShareUnitsActivityDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryoftheChangesinOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Issuance of options (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryoftheChangesinOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationAwardTrancheOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Share-based Payment Arrangement, Tranche One [Member]",
        "terseLabel": "Share-based Payment Arrangement, Tranche One"
       }
      }
     },
     "localname": "ShareBasedCompensationAwardTrancheOneMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsUseofPublicityRightsinBrandDevelopmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationAwardTrancheThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Third portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Share-based Payment Arrangement, Tranche Three [Member]",
        "terseLabel": "Share-based Payment Arrangement, Tranche Three"
       }
      }
     },
     "localname": "ShareBasedCompensationAwardTrancheThreeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsUseofPublicityRightsinBrandDevelopmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationAwardTrancheTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Second portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Share-based Payment Arrangement, Tranche Two [Member]",
        "terseLabel": "Share-based Payment Arrangement, Tranche Two"
       }
      }
     },
     "localname": "ShareBasedCompensationAwardTrancheTwoMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsUseofPublicityRightsinBrandDevelopmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r164",
      "r472",
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by supplier.",
        "label": "Supplier [Axis]",
        "terseLabel": "Supplier [Axis]"
       }
      }
     },
     "localname": "ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Specific identification or general nature of (for example, a construction contractor, a consulting firm) the party from whom the goods or services were or are to be received.",
        "label": "Supplier [Domain]",
        "terseLabel": "Supplier [Domain]"
       }
      }
     },
     "localname": "ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks of a company.",
        "label": "Share Price",
        "terseLabel": "Share price at grant date (in dollars per share)"
       }
      }
     },
     "localname": "SharePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsFairValueofOptionsIssuedDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": {
     "auth_ref": [
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of vesting of award under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage",
        "terseLabel": "Award vesting rights, percentage"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsUseofPublicityRightsinBrandDevelopmentDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r492",
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected life of options (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsFairValueofOptionsIssuedDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted average remaining contractual term (years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryoftheChangesinOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Outstanding"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryoftheChangesinOptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Exercisable"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryoftheChangesinOptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShortTermInvestments": {
     "auth_ref": [
      "r49",
      "r752",
      "r753",
      "r774"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.",
        "label": "Short-term Investments",
        "terseLabel": "Short-term investments"
       }
      }
     },
     "localname": "ShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet",
      "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermLeaseCost": {
     "auth_ref": [
      "r662",
      "r667"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/LeasesScheduleofLeaseCostandOtherInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less.",
        "label": "Short-term Lease, Cost",
        "terseLabel": "Short-term lease cost"
       }
      }
     },
     "localname": "ShortTermLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/LeasesScheduleofLeaseCostandOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r9",
      "r249",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r273",
      "r274",
      "r275",
      "r276",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r284",
      "r293",
      "r349",
      "r379",
      "r385",
      "r393",
      "r792"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofAdjustedEBITDADetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r91",
      "r186",
      "r187",
      "r189",
      "r194",
      "r203",
      "r206",
      "r232",
      "r317",
      "r417",
      "r424",
      "r503",
      "r504",
      "r505",
      "r536",
      "r537",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r648",
      "r800",
      "r801",
      "r802"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails",
      "http://thecronosgroup.com/role/CapitalStockNarrativeDetails",
      "http://thecronosgroup.com/role/CapitalStockScheduleofCommonSharesIssuedDetails",
      "http://thecronosgroup.com/role/CommitmentsUseofPublicityRightsinBrandDevelopmentDetails",
      "http://thecronosgroup.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows",
      "http://thecronosgroup.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r186",
      "r187",
      "r189",
      "r232",
      "r725"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows",
      "http://thecronosgroup.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r56",
      "r57",
      "r417",
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Shares issued (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CapitalStockNarrativeDetails",
      "http://thecronosgroup.com/role/CapitalStockScheduleofCommonSharesIssuedDetails",
      "http://thecronosgroup.com/role/CommitmentsUseofPublicityRightsinBrandDevelopmentDetails",
      "http://thecronosgroup.com/role/ConsolidatedStatementsofStockholdersEquityDeficit",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": {
     "auth_ref": [
      "r56",
      "r57",
      "r417",
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures",
        "terseLabel": "Restricted share units settled (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r56",
      "r57",
      "r417",
      "r424",
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedTerseLabel": "Exercised (in shares)",
        "terseLabel": "Options exercised (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofStockholdersEquityDeficit",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofRestrictedShareUnitsActivityDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryoftheChangesinOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r56",
      "r57",
      "r417",
      "r424"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Shares issued"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CapitalStockNarrativeDetails",
      "http://thecronosgroup.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures": {
     "auth_ref": [
      "r417",
      "r424"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.",
        "label": "Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures",
        "terseLabel": "Vesting of restricted share units"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r91",
      "r417",
      "r424"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Options exercised"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r56",
      "r57",
      "r417",
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Shares",
        "terseLabel": "Stock repurchased during period (in shares)"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r57",
      "r63",
      "r64",
      "r168",
      "r299",
      "r311",
      "r640"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total equity attributable to shareholders of Cronos Group"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r168",
      "r186",
      "r187",
      "r189",
      "r194",
      "r203",
      "r311",
      "r317",
      "r424",
      "r503",
      "r504",
      "r505",
      "r536",
      "r537",
      "r574",
      "r575",
      "r601",
      "r640",
      "r642",
      "r643",
      "r648",
      "r801",
      "r802"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total shareholders' equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/AccumulatedOtherComprehensiveIncomeLossDetails",
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet",
      "http://thecronosgroup.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "Shareholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r167",
      "r424",
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "verboseLabel": "Capital Stock"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CapitalStock"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StockholdersEquityPolicyTextBlock": {
     "auth_ref": [
      "r163",
      "r164",
      "r415"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its capital stock transactions, including dividends and accumulated other comprehensive income.",
        "label": "Stockholders' Equity, Policy [Policy Text Block]",
        "terseLabel": "Capital stock"
       }
      }
     },
     "localname": "StockholdersEquityPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of subsidiary's or equity method investee's stock owned by parent immediately after all stock transactions.",
        "label": "Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions",
        "terseLabel": "Ownership Interest"
       }
      }
     },
     "localname": "SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesScheduleofConsolidatedEntitiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Subsidiary or Equity Method Investee [Line Items]",
        "terseLabel": "Subsidiary or Equity Method Investee [Line Items]"
       }
      }
     },
     "localname": "SubsidiaryOrEquityMethodInvesteeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesScheduleofConsolidatedEntitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Different names of stock transactions and the different attributes of each transaction.",
        "label": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]",
        "terseLabel": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]"
       }
      }
     },
     "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CapitalStockNarrativeDetails",
      "http://thecronosgroup.com/role/CommitmentsUseofPublicityRightsinBrandDevelopmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]",
        "terseLabel": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CapitalStockNarrativeDetails",
      "http://thecronosgroup.com/role/CapitalStockScheduleofCommonSharesIssuedDetails",
      "http://thecronosgroup.com/role/CommitmentsUseofPublicityRightsinBrandDevelopmentDetails",
      "http://thecronosgroup.com/role/ConsolidatedStatementsofCashFlows",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofEquityMethodInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Subsidiary, Sale of Stock [Line Items]",
        "terseLabel": "Subsidiary, Sale of Stock [Line Items]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CapitalStockNarrativeDetails",
      "http://thecronosgroup.com/role/CommitmentsUseofPublicityRightsinBrandDevelopmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SummaryOfIncomeTaxExaminationsTextBlock": {
     "auth_ref": [
      "r519",
      "r535"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of income tax examinations that an enterprise is currently subject to or that have been completed in the current period typically including a description of the examination, the jurisdiction conducting the examination, the tax year(s) under examination, the likelihood of an unfavorable settlement, the range of possible losses, the liability recorded, the increase or decrease in the liability from the prior period, and any penalties and interest that have been recorded.",
        "label": "Summary of Income Tax Examinations [Table Text Block]",
        "terseLabel": "Summary of Income Tax Examinations"
       }
      }
     },
     "localname": "SummaryOfIncomeTaxExaminationsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SummaryOfValuationAllowanceTextBlock": {
     "auth_ref": [
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of valuation allowances to reduce deferred tax assets to net realizable value, including identification of the deferred tax asset more likely than not will not be fully realized and the corresponding amount of the valuation allowance.",
        "label": "Summary of Valuation Allowance [Table Text Block]",
        "terseLabel": "Summary of Valuation Allowance"
       }
      }
     },
     "localname": "SummaryOfValuationAllowanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowElementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Elements [Abstract]",
        "terseLabel": "Supplemental Cash Flow Elements [Abstract]"
       }
      }
     },
     "localname": "SupplementalCashFlowElementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplierConcentrationRiskMember": {
     "auth_ref": [
      "r241"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that purchases in the period from one or more significant suppliers is to cost of goods or services, as defined by the entity, such as total cost of sales or services, product line cost of sales or services, segment cost of sales or services. Risk is the materially adverse effects of loss of a material supplier or a supplier of critically needed goods or services.",
        "label": "Supplier Concentration Risk [Member]",
        "terseLabel": "Supplier Concentration Risk"
       }
      }
     },
     "localname": "SupplierConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TaxesPayableCurrent": {
     "auth_ref": [
      "r83"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Taxes Payable, Current",
        "terseLabel": "Taxes payable, current"
       }
      }
     },
     "localname": "TaxesPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "terseLabel": "Lord Jones brand",
        "verboseLabel": "Brand name"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/BusinessCombinationsScheduleofFairValueofNetAssetsAcquiredDetails",
      "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillNarrativeDetails",
      "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TrademarksMember": {
     "auth_ref": [
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.",
        "label": "Trademarks [Member]",
        "terseLabel": "Trademarks"
       }
      }
     },
     "localname": "TrademarksMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Debt Securities, Trading, and Equity Securities, FV-NI [Table Text Block]",
        "terseLabel": "Summary of Other Investments"
       }
      }
     },
     "localname": "TradingSecuritiesAndCertainTradingAssetsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/OtherInvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r304",
      "r305",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/OtherInvestmentsSummaryofOtherInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r573"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UnfavorableRegulatoryActionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A enacted or proposed action, ruling or regulation that is likely to or possibly will have an adverse effect on the entity's financial position or results of operations, excluding tax matters.",
        "label": "Unfavorable Regulatory Action [Member]",
        "terseLabel": "Unfavorable Regulatory Action"
       }
      }
     },
     "localname": "UnfavorableRegulatoryActionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r236",
      "r237",
      "r238",
      "r239",
      "r245",
      "r246",
      "r247"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowanceLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Valuation Allowance [Line Items]",
        "terseLabel": "Valuation Allowance [Line Items]"
       }
      }
     },
     "localname": "ValuationAllowanceLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember": {
     "auth_ref": [
      "r183"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation allowance of deferred tax asset attributable to deductible temporary difference and carryforward.",
        "label": "SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member]",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset"
       }
      }
     },
     "localname": "ValuationAllowanceOfDeferredTaxAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesNarrativeDetails",
      "http://thecronosgroup.com/role/IncomeTaxesSummaryofValuationAllowanceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationAllowanceTable": {
     "auth_ref": [
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A listing of an entity's valuation allowances to reduce deferred tax assets to amounts which it is more likely than not will not be realized, including a description of the deferred tax assets for which the valuation allowance has been recorded and the amount of the valuation allowance.",
        "label": "Valuation Allowance [Table]",
        "terseLabel": "Valuation Allowance [Table]"
       }
      }
     },
     "localname": "ValuationAllowanceTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesAdjustments": {
     "auth_ref": [
      "r184"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in valuation and qualifying accounts and reserves from adjustment.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Increase (Decrease) Adjustment",
        "negatedTerseLabel": "Increase",
        "terseLabel": "Increase in valuation allowance"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesNarrativeDetails",
      "http://thecronosgroup.com/role/IncomeTaxesSummaryofValuationAllowanceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesBalance": {
     "auth_ref": [
      "r177",
      "r182"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount",
        "negatedPeriodEndLabel": "Balance at end of year",
        "negatedPeriodStartLabel": "Balance at beginning of year"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesBalance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesSummaryofValuationAllowanceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": {
     "auth_ref": [
      "r180"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense",
        "negatedTerseLabel": "Change due to foreign exchange"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesSummaryofValuationAllowanceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDomain": {
     "auth_ref": [
      "r177",
      "r178",
      "r179",
      "r181",
      "r182"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesNarrativeDetails",
      "http://thecronosgroup.com/role/IncomeTaxesSummaryofValuationAllowanceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesTypeAxis": {
     "auth_ref": [
      "r177",
      "r178",
      "r179",
      "r181",
      "r182"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/IncomeTaxesNarrativeDetails",
      "http://thecronosgroup.com/role/IncomeTaxesSummaryofValuationAllowanceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount": {
     "auth_ref": [
      "r593",
      "r598"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The reporting entity's maximum amount of exposure to loss as a result of its involvement with the Variable Interest Entity (VIE).",
        "label": "Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount",
        "terseLabel": "Maximum Exposure to Loss"
       }
      }
     },
     "localname": "VariableInterestEntityEntityMaximumLossExposureAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsScheduleofVariableInterestEntitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableInterestEntityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Variable Interest Entity [Line Items]",
        "terseLabel": "Variable Interest Entity [Line Items]"
       }
      }
     },
     "localname": "VariableInterestEntityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofAdvancestoJointVenturesDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofVariableInterestEntitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Interest Entities (VIE) in which the entity does not have a controlling financial interest (as defined) and of which it is therefore not the primary beneficiary. VIEs of which the entity is not the primary beneficiary because it does not have the power to direct the activities of the VIE that most significantly impact the VIE's economic performance and for which it does not have the obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE are not included in the consolidated financial statements of the entity.",
        "label": "Variable Interest Entity, Not Primary Beneficiary [Member]",
        "terseLabel": "Variable Interest Entity, Not Primary Beneficiary"
       }
      }
     },
     "localname": "VariableInterestEntityNotPrimaryBeneficiaryMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofEquityMethodInvestmentsDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofVariableInterestEntitiesDetails",
      "http://thecronosgroup.com/role/LoanReceivableScheduleofLoanReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableInterestEntityOwnershipPercentage": {
     "auth_ref": [
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly).",
        "label": "Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage",
        "terseLabel": "Ownership percentage",
        "verboseLabel": "Ownership interest"
       }
      }
     },
     "localname": "VariableInterestEntityOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofEquityMethodInvestmentsDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofVariableInterestEntitiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_VestingAxis": {
     "auth_ref": [
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Axis]",
        "terseLabel": "Vesting [Axis]"
       }
      }
     },
     "localname": "VestingAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsUseofPublicityRightsinBrandDevelopmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VestingDomain": {
     "auth_ref": [
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Domain]",
        "terseLabel": "Vesting [Domain]"
       }
      }
     },
     "localname": "VestingDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsUseofPublicityRightsinBrandDevelopmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "Warrant [Member]",
        "terseLabel": "Warrants"
       }
      }
     },
     "localname": "WarrantMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/EarningslossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedSharesOutstandingDetails",
      "http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails",
      "http://thecronosgroup.com/role/OtherInvestmentsSummaryofOtherInvestmentsDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinWarrantsDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofOutstandingWarrantsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r212",
      "r223"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Weighted average number of common shares for computation of diluted income (loss) per share (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
      "http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r210",
      "r223"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted average number of common shares outstanding (in shares)",
        "verboseLabel": "Basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
      "http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]",
        "terseLabel": "Diluted earnings (loss) per share computation"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/EarningslossPerShareScheduleofEarningsLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 23
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116657188&loc=SL116659661-227067"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121640130&loc=d3e1436-108581"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(14))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(2))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(4))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(7)(c))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(9)(a))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.18)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "http://asc.fasb.org/topic&trid=2134417"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3000-108585"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21D",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=SL94080555-108585"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4273-108586"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "230",
   "URI": "http://asc.fasb.org/topic&trid=2134446"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18726-107790"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(e),(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h)(1)(i))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(k)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(n))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column B))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(1)))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(2)))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column D))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column E))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(ColumnA))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "27",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e22044-107793"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21728-107793"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721494-107759"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=112272810&loc=d3e31137-122693"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=112272810&loc=SL108384541-122693"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "http://asc.fasb.org/topic&trid=2122394"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1377-109256"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1707-109256"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1757-109256"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1828-109256"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1500-109256"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1278-109256"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=116846552&loc=d3e543-108305"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70229-108054"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=26872618&loc=d3e7436-122677"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/subtopic&trid=2122178"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8672-108599"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8475-108599"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "a",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "b",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=SL6953423-111524"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5074-111524"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721503-107759"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/subtopic&trid=2196772"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26610-111562"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26853-111562"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27232-111563"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=SL120269820-111563"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(b)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "323",
   "URI": "http://asc.fasb.org/topic&trid=2196965"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599878&loc=SL82895884-210446"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919244-210447"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919253-210447"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919258-210447"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6812-107765"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919230-210447"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919230-210447"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121558606&loc=SL82898722-210454"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922895-210455"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922900-210455"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(19)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b),(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=121558832&loc=d3e400-110220"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2510-110228"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(25))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2611-110228"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2420-110228"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2443-110228"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(26))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "http://asc.fasb.org/topic&trid=2175745"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e957-107759"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(10))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/subtopic&trid=2127163"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "30",
   "Topic": "450",
   "URI": "http://asc.fasb.org/subtopic&trid=2127197"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12021-110248"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12053-110248"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(11))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=d3e177068-122764"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=d3e177068-122764"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21459-112644"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21553-112644"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21484-112644"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(12))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21488-112644"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "50",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130558-203045"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130561-203045"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130563-203045"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130563-203045"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130564-203045"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130550-203045"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(i)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)-(4)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721523-107759"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32247-109318"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32280-109318"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31931-109318"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(23))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32847-109319"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121610041&loc=d3e36027-109320"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "740"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "740"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "740"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=109227538&loc=d3e44648-109337"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6909625&loc=d3e227-128457"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116868678&loc=d3e1043-128460"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121600890&loc=d3e2207-128464"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5263-128473"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5504-128473"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(4)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4613674-111683"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569655-111683"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2AA",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "a",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=SL6759068-111685"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5728-111685"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "b",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5728-111685"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5728-111685"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=SL6759159-111685"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=SL6759159-111685"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=SL6759159-111685"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5747-111685"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5747-111685"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721525-107759"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=SL6228884-111685"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579240-113959"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5580258-113959"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41638-113959"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624181-113959"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41641-113959"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41675-113959"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41678-113959"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121582272&loc=SL5629052-113961"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "http://asc.fasb.org/topic&trid=2229140"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13433-108611"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13531-108611"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "http://asc.fasb.org/topic&trid=2175825"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918666-209980"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918701-209980"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121568110&loc=SL77918982-209971"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "845",
   "URI": "http://asc.fasb.org/extlink&oid=108781845&loc=d3e29470-108402"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "845",
   "URI": "http://asc.fasb.org/extlink&oid=108781845&loc=d3e29470-108402"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "845",
   "URI": "http://asc.fasb.org/extlink&oid=108781845&loc=d3e29470-108402"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "845",
   "URI": "http://asc.fasb.org/extlink&oid=108781845&loc=d3e29470-108402"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "845",
   "URI": "http://asc.fasb.org/extlink&oid=108781845&loc=d3e29502-108402"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "845",
   "URI": "http://asc.fasb.org/extlink&oid=108781845&loc=d3e29515-108402"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "845",
   "URI": "http://asc.fasb.org/extlink&oid=108781845&loc=d3e29515-108402"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "845",
   "URI": "http://asc.fasb.org/extlink&oid=108781845&loc=d3e29515-108402"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "845",
   "URI": "http://asc.fasb.org/extlink&oid=68069686&loc=d3e32049-108421"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "845",
   "URI": "http://asc.fasb.org/extlink&oid=68069686&loc=d3e32049-108421"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "845",
   "URI": "http://asc.fasb.org/extlink&oid=68069686&loc=d3e32049-108421"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "845",
   "URI": "http://asc.fasb.org/extlink&oid=6457341&loc=d3e32102-108422"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "845",
   "URI": "http://asc.fasb.org/topic&trid=2127423"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "http://asc.fasb.org/topic&trid=2122745"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1012-107759"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "350",
   "Subparagraph": "(a)",
   "Topic": "920",
   "URI": "http://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "350",
   "Subparagraph": "(b)",
   "Topic": "920",
   "URI": "http://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "350",
   "Subparagraph": "(a)",
   "Topic": "920",
   "URI": "http://asc.fasb.org/extlink&oid=120155617&loc=SL120155638-234783"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(1)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(2)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(3)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "http://asc.fasb.org/subtopic&trid=2176304"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(4))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(7)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(7))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r762": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r763": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r764": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r765": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r766": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r767": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r768": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r769": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/subtopic&trid=2209399"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r770": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r771": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r773": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(b))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r774": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(g))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r775": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r776": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r777": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r778": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r779": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r780": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r781": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r782": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r783": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r784": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r785": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r786": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r787": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r788": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r789": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r790": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r791": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r792": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r793": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439"
  },
  "r794": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r795": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r796": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r797": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441"
  },
  "r798": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r799": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r800": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r801": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r802": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r803": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r804": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r805": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r806": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r807": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r808": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r809": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r810": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=99380617&loc=SL75241803-196195"
  },
  "r811": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04.2)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996"
  },
  "r812": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r813": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r814": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r815": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r816": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r817": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r818": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r819": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r820": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r821": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=SL120429264-123010"
  },
  "r822": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=SL120429264-123010"
  },
  "r823": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-14)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611322-123010"
  },
  "r824": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010"
  },
  "r825": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010"
  },
  "r826": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010"
  },
  "r827": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611379-123010"
  },
  "r828": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "946",
   "URI": "http://asc.fasb.org/subtopic&trid=2324412"
  },
  "r829": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r830": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "740",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650"
  },
  "r831": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r832": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r833": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916"
  },
  "r834": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r835": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r836": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r837": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r838": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r839": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r840": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r841": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r842": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r843": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r844": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r845": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r846": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r847": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r848": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r849": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r850": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r851": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r852": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r853": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.23)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.28,29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>162
<FILENAME>0001656472-21-000009-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001656472-21-000009-xbrl.zip
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M[ZGJ3KH=,07/8TF\!049QO&%B,D0QZ ZK [K\IZU'+Q_#5@<148-HB>73L$
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M-Q6=S((4#R32\A&FU_6E\!'HBE#7-A2O@?4)^ 4ZK(+4"^9PC4Q69L5P(F%
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M.S7AM;):$.D*S!\J]7/W,I,&Y YCTNM?M4ZV1%,HX#(K"NBLF4KXE*D*YQH
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M:][P3+$U% ,ZO3&?"6+;U,7=KGS==$YKP93%=45^T^YUQPRWE=&TN5B5Y#9
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M):HZ\ASU@2Z8R^E !NXJ9J$[2+BPK-8%;9.M:"H*Z$!!EF\P%U,V.C5P=K!
M59,J+C(P4PEI ,><)]JO/1B^3B?3UL"I7>X  A>*$$:Q">EA@4R*> <9718"
MOFJ"61R,M4D)<R=+JF>?L6F=FMD9]!F!&/IY0JXBIFK-&'=$S\P#7U(A+?+N
M"FA:(P128$TH@LH7([=A62%(0+YA9'4BS7P +JLKZB&( FY%1(<&VI**3.$P
M,H>5_A[&=N"G/WC6"+B-.:C.2TZL9KA]-85S-#C@#'_SR+#SEAOJQR1C3Q"_
M[636> DB2K)B)^20!?I=_^ $^0Y-&5P8>PY:1>'[=]PJX7+@L#3<R!V8C I2
MSS^->4 2@N[0H;8V0I;G/%#$/BW-]-GXQJYO3<96[+DS6C=7^%IX:GJ ^T =
MX:$1T-KQU0.5J9*D]&Y:_QHZI479MTLL,T,H4A.RY2OWT'A[Y'%3=1,''[0R
M85]:(*".CS,55,3'@A_K^"Y5C%5'9]OIL9T*5U;U<[AQE:112*%5)VBY6\BM
M& EX"3QL0Y<5&@78\*VV65?TBLHI$",;)6OX6C:K#=LYO3&6J56(!L\RVX?E
ML1*,Y&-*%T^5NPW.:2R\*E&M;+#J73)B(%<-HU5->G2J(KPV.]I8-69GZ^GE
MU?VFS7 N2L/P*JBJC(C*XT9X)GTIW1+I\5K%9%0$!)U$..P+ WO PV15G/,=
M/8F !M.HPLHC+4FUM]31@+-,W/:#,HF<DCJGT&Y3BX+>PK%!Y8GS%(<&X:03
MM#^Q"L554$3&,C>X>!57AP/=8Q-]&(%G-$4L9F:3G;&F)TPK23Y2_;VN7PET
MVSQD6T'V:&I:'G4%V7Y;0=96D#5IM[459&T%V=;>MOD59!NEO"DU94>#+Z>?
M_Q+?^L-/8OBI)SX??J.ZLNM%AIN_YN&G/C;='_<ZM*RSWNG@;"A.!B<[M/+^
MX<E1[]JU<_\(-.E'NZ8\B@H1>,, +?"M]$DYAKY Z%P;5W*#/WJ>9V3G?I*#
MQ@$IMR2EJ$CQX\*7<Z(6E*8K=W]W1)*'I@VIW 5.A78XA3">*2YJL,4YSGAL
M"O2[ 2?=!*K#+1T.SV-HU<Y8*$=9<"99)8E@Z_K@_D[\1><-S3M77YF_QHD!
MV][$$\^<R@$WKLS-A^3I848LH7F?VJW<NF%GET-72&H!YZGG07I3E+CF[)5K
MQ6_\V(1N2%MS70+.;#61_"5("LUVM%4\/ QP[2LTR$>NG"98[JV,%()(2)ZY
M2@%1*99$8R0Q[A@A>0/K.?-(< PDA]B2.IF*A*:N+#5;=!9\DH#T<_YS0Z+!
MS.,[F@9J+'K?E9=3['3 &PRC/#862BDROENG^(WM"-69C \Q1< QHW*DP^7*
MO#!]UG1AK^^2Q12T(9#60&+'T5(SG(C,&V)MI*@A=)7^.V*)L:#4+4N[FNM<
M<*@OPS((@K->Y_;5S  &:WF9!%ABD<7KBTRY17^D"#4CC%/=.5T*&Z8&DKZ*
M![)1KS9=".IJ>*DI\]##P9RA\@UK"\8T?%F;97N  5EJZ5TIF5"KLJ08;F"*
M7PM@GD)]C5 P+TPNS%*$-9K-N5)R'(=8V[GS.C9L !(Z[FF,:0['=D#]@ODD
MB?.D#!A,'EF54TXO.2H1"5-DS$AZ<68XP>=7F%= Q)?>%]%U)*=G*M8"[S_[
M 5;F4P&H6I"987 ?BAP2?#7)UL=8;J6H<&5OA8:IF>P1<PU_,M,H'Y8#FK2+
M0"W5943%[@IM+14C9X/,F23&H\P3F[\GL2KDP"3B#$]1;O+(RH^=3$V91VO?
M)3G"[\=YZ(H1?T1O3C(8HD"@V!.[60+;KNR?(,KWJ&/J+]J8>AM3;])N^R<Q
M]>:!NF_+9W>FIVX(/O_"@L_C@8IVTTD<[=PX]E8HW#;3_9/HB4=]*A^TIW)[
M*C=IM]U#IOOA^=:FL+?\MFT*^P8I;,S?]D_^H)PNI70YEPL_' U.CGIG)^?B
M<"B.S@8G@_.=P6GO['#8.Q;G_:$&3!E\_-@_N@'Z^O8@H-1$1;DLE[I#37YH
MI9-!B357BXC2>C#2]"/:[)BN!Z7&Y#D'VZ=*%G-X?9_@N76>B6)@"#QI:\@Y
M\'5EJ7XQI[(6T-(4R\OBM4MY/"Z^)3".L09-IXZ78KE!FN8TBWX<)XJ#;2%&
M3+DW'41A5I34<C)KO4.'@Z0V[X6Y+$RW17@9AF!_3&/:9@]EJ3AN7.IG2!2.
MHBU0W#4VN9 3B:ETM[#:+?G'-@S;#X#5Q$A,9#-V:2!43#:MQC4WA[;Q3NZ,
M85L5#:1[N"X^C9^:EG!2;8,"+9A>WK1R\>Y)=8.FZ8KB1((=2XPE"@L5TO*+
M-%JU"^40_ID]JD3C!\1QU6 #'3&-EUC[T.%@-,>APX* MK"#DA;PM44<+M2E
M2JE(7U !0[%[,:>##QC1?;":84)<D2G!\^@^.Q1S;JZCU*1YDQDEN,WS=>>-
M <NVF+-&QCO<2VO5VVCE;I>N"0?H!>JFHNLNCF<_K.9X?H/"AB6J)"GRT[ZM
MNN!6B30/C.RQ^M7(M0'F<SPS/P!?N\,P14 /W:5CP<#AFH%MXMA.L1N,L1,[
M296!Q- I/L-OIPG$P?'&-)!MH5PQD#S1RO3EI\[A1VEH/!.K)3\5R)1#3#].
M=)X<CPJ%K]NYI)63IV88G4!LY<60DO;,,&;I-(L779YNFZ@>GHY7QBD7A)3.
M1WK_CI/(YK2^/33I'MP5ZTI3M4=T0RL,"9TY%D<JC!L_@:(FL&?'SQ//_[1;
MM.&KJ6D(34N"R(I/RPIL 2N*1NI-XI$7CUN(+J&<H=X1H-3AQ"I:IS<BJG-S
M97'LP:[X@#)!(^!%&*14=%"]RM28&<0KW,5QFI4.5;BY.2W2$JO6E/1VRM_0
M55X(#!;GJ!]DRNA:*\=TEY9M[FFTB?R,4)(52H$:SA<X02>DF1?)AJ*N3%[<
M\"G6WL23,URX?>*DI$QA81I0<CR/X'9C+&^D,AMM4E)S(=KFK%<V2%(?Y31.
M'=W>66_JM]+HUBUN*![367FWH]U,P*!M8 +YXE.<(;>H,DF%:CY%]$)=%-4G
M=T9M:1UDH?+.%<M;1?61M?41^_E")]%Q-,7)%N%V*L:A+7[U&%K)T28U9IF>
ME$)J+^$I3DPMD+!4_9M UM("E8,*E/&HG>>9ALGOL,"5H-; _2&P&?S1=J;V
M2LWR3BMV9?8'0D^:]Q\S?PKUX&G^B*>X!()*V?U!4"DUD*Q72=!#" +19>_]
M,SY8C"Y(R0+7<%J$$EH4@%,!$3L=(I4SQ._*U"0F"" ,;7!<P48!*%014#=N
M1\3&!MVDC8POPM99PB?I54ZB'O7&KD7J[M]%>?^63TOG4[18T?TO:F(II]DB
M!-TC0M!AQ&(%W,"1)P;7"0UK-SQBH3SG!-I)WF (M@!\;1Q$"/6!<U$L*A3P
M[6W+MQ_'-]BP8.F8B86US-.#;!AW55<@(_!%RZ[[9Y>!B+:VG3W#V::6(ZX[
M=T]58$T>9NQP(PB%V9Q8_-MNS@9S6^],C=K%\8X-F&@%I*S9R^48R08(YI9Y
M]\V\_XWB9<2)!F.G>+"7=#/* JWU$AY28;^TO'D WHP3F>LZ=6U\IA1T-*%M
M#^,V\ TXZBA$6E:<+<,>AF&=RGQFAJ?M5/D8V>ZPM2.OY5S#.6<;BA%4;TJ=
M4-@YA,"0V-Z3Q*&J-51M5IZ267%(T0ST5@U2]26=EAU]I.K&0=N#IWNMK4%D
M6O(Z;K>A]68K=^$!NQ'XQK!*]Y7=@!\NE(8VXK@&6U> +G-'/U</P?4(JE?#
MTW/_^#B//*?OAA]>OC4-<5!(0Y--Q)9!+IW@:EI> DYBH?T!=V_K=Q]_1>&C
MKM]]V=;OMO6[3=IM=U&_V]HG=Q( X\([1N;5,6_Z54K#;3RI.^_!\/!5A@'I
MQ(;':#CS H/>X9JQ49I%38/52X5B</!1NHWMA]*@'*KBJ!A-Q2!P2O$IZ?XR
MM68-O:\J64AXFU6:J5G@B2B.=KPB!4@)21<9@,LHXF1EL ,HTK-M4.F;LS46
M(093]A$B">>C#,T?\.8*T'$=5V.@<:0/1<UT1@1AD1%$-<.:P 7BF4<V>5&;
M#$)CR\,(CB\BH 7#/N,TC/2R=N5FY!IK\UY%=209[$@N2@:R'%+>7>^)6*>?
MBJ12IX*=?7DZT"$Q QPA;6N)W69Z[EMAZA1>%3$)%9AV;U .JD4%:B:#L/6V
M[YTYEY9ZM/2_;_J/8Y.9<6L@"T>]XSCTA?=NHA..RT[N/D$8\=TZ-:GSEJ4_
MDJ4<ES)%79L#1^5)KM7H$7ZZ%CNJ1B7M)$6.*)7+(Y[J%HY-!1<%>$MUZS]K
M4<M;[[2-!5$LZ%4;"VIC04W:;7<1"VI1RQ]-$_5VW;;Y+=\/U.!=H'*+3X/A
MY_Y)KP)%_HA;M8>;6PT0&!51*CWL+R;<P3A:S7BP3U&N7#0EZHX-BB)I?XGL
MVTB#$FI\UC2G0BBN-Z6R<9[>5LP]P@G",;O&12LE7,/US_;]@MO%CUKGJ<YY
MDHP_Z>LBFJ*67P_!,RT"#%&+@-Y9BH/?S,=Z$%QR*S>W94LM6Q8R".F8U_CN
M3IN\Q.&*""&?ECKF2X%:+@N 7[4LN7N6[!^(*?;*8KY)KCKBQ:N7^(\4HZN$
M!_Q/TC$/1/0CDRW0)T 8^X3"?[/.M$4@44F8YC1!DP1N-)KU@1(F9D$?*8&Q
MD\_%,([#)KUW_3%NWIW@)+0^1MD<V[5DL!;=X(J_XK0I7);CP#VL.-+GNJPT
MZFA881QJ2$E+UQK0+=C8%&EJEIR#&PX0;/$&D>"!Q'A[.LJ-. 4IO55'CX.F
MAE["96_/]SO56MY4>1=F/B:V!N2V_(VIWA[<=WM*I!<.R@)/V:8]9!LR+BO6
M:\E]0W+G8!5)O^I4H!F$^FQ-!15X)'[LY<23#F<^Q0P!E29H7\T#+\-FJ0[E
M>&(^UWP5BW$0WG!V< -*+3:S\W-PH98!0Y=P7[NKN@OM0.8 'RQ87E^2;"Q
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M*'2&EB08(XC %GA5\C,<#.R5"W\V,%%YEQR&QS0ET!%>*$V& /(,-#["<XR
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M6!"6QLB9;3?,D[]$:[K;8,.X(),IQ!@9YILX3;UQ+Y@U)29?H$H!&]A8/OC
MSH=/F50-/-2-O.J-_/!(6Z".EIU="?.MN E0)._'$?(^4.SFF#FP?4R:,*%C
M4;0]7VGDUV[!X0)G)'6;PDQ\&S 5F*C-NGI' A)\*>X#)ST5?2H*<3BF9?(B
MV0$''IG0HJ?EE,C"T9(V%>8+M_T MXT(?)A]AF(3H+[*SKFW%3?IR)JTOH93
M1$[ C\G//-RDT246*9;SG5S/8.=/!JF6'QEJ$/-L!P?=$AT3HWKT_/:.M8>N
MH]UCQ,6 0CGB$9=$']%7; 5SH?0%=EWYRBA@93PJ4$?;ERVX@RL.L(*Z2;WX
MVL:UI.7^,6HX_$(-GXH:NNYR*F(J2RE@CZ+L@.;?0Y)2).8X@9#+UG*KV.@@
M>=NJ&LIAZU(JBT+QAC:#K\GW!861\B*E<;Z<183E%X[^ 7H3"_*/:01?[M=?
M=+^H4[F22D=4.PN5SU4A]5B%KN:8&HS:M<U-%LSX-)235]K&8</6;]66O_HX
MGZ1=QTG7;:J*^"MH5Y/@INBX*#;D!!II!3D!FY+C''<E??#:$B*O@09]_'69
M6K#<S]45=HUO[1RNK>L$-3NUP'<*%S?Y"@$7^,#K(207JJ-])Z>TCSRO2AI&
M8@U(3+M(;#7W*-'U\TUA"K1PVRYX7] 1'(65GC>Y()5L5T;B5HH^28E*LO.R
MGW@GX'1Z=']^N&=X=[H73FXE%A0@ ]PZ>/ID?_N6<TY ]\7&DIA4'F,[[#+@
M.>J'YIOY]CJ&#=3?W0NV8EPH%Z3<16S-E];>AX^)3Z0JL@ :ME(HGQ<;HBUL
M,?$-PH-'JJ;](D;[H:..K\5?9$_Q\2&%EBPN*26]+]0BEF341&&7\$ODMD,=
MC+MQN/9W^:J#V%5=8I8OF\3M#T,[O="/)MH@SP\+A.:\C2-/)%+4)/XV2[O7
MSHA-K!HI]Y#>&][:FW2=EZVAMP'NY399>^3H4E413,-<EW-,&D(;(MI8^$9%
MUBGBX*X9-"-,R*D2FYNE9EO\?03NGE&OV]C)UJ6<':Y2!L=M^VF%F=0*3U5Y
MT4T"G\7MR/JTLLU^6_C9-1S3P7@&8(=[_PZ@AA-$<Z?9@[M%E$N>4=\62?GM
M_;1[AIY$H95_=7J<[2;?>U&);XP-)6P/>,BF.DC>0+5]['DJDWXU49:SN"WE
MAY"R=;V)/VD),SC,?0DO,SKR)&S9:I-.Z7,Z/H0[D59!X36,>6T/DB\W;?,=
MD&(OX@;TBAKE ?;@'*6K N@OP>=1*OYAQE!.Y*,K I"' ^_3, #M@)&==F[8
MR 6[6QKUS=C]5.$!4LMC0@%_5&3 RK\!FZ9$+&JC/*:2MN]T>_&0=A2^2^##
MFGXO(1U+907E^%;L\Z1>W_X+3MRN@\O@D<K2GH11&!309:.IW02V9@]?*SD)
M2D G\PN[__!\_6Y=#([4L'IDMM>K#*V4\3UUH;N9WRK*13.E[^DO-#@&8FA(
M,@SA^Y.V'RH8LJ'L[1*N2NLYI@K7Y-<F8XF.GTIP8L8JJ:_EW(DVAL5==5"&
M( 2%]@?8IX;PG2W*4IRQSI"'!MA<%6XI;#+5"Y7/_-;CK/SOR"\%=]BKTV.H
M[RASN(5W?IOQE[JBPP'<-86.*F4[+[5-P$M%FH\<!M6S^+Y"8\<]?,#B:!.+
M*W2.@5M%CK<)UOX!?8'XXY^] $2C+"Y:['?,#^F;&(GB+S[$9=;8'9\C+9:^
M3,8U!8@T4U*4$1%149MTGV>!;?[*FR)&N;;/$@)%FA['67&"#MT%.L.!7;+V
MY!_ZCQ<68"$"D<\5X58H+Y3CO_(U#%A58+F'K)B21'R.DQ=X)17C,Z7IJX7"
M'5]R'SG\ (!U(_55HS9^1Q7EJF8IFY$O $H-#GT)IFKXS.%<^1QQ/I#3TD[1
M1\Q-"L9N-:@%[0)W2"EB,4=(@'A\6F[H:E0YKP2/VA>8"=Q4<Q;FN+,F)VHU
M%94Z^UTYRBQ&U35*+VB'15OM?##@2QIKH,G#+VFL?XT#!=ALB-F$[PS< Z;6
M9E_U581)VSM>>J%7^$'CS% SCKX-OSF"<F"&6 SJ%".9"--.ODA;5(2?LQ%'
M#_$.J@R5SI(/C\/'LN; K9R4/H3>MU$'_*C0G]XFWT+6I%2V&/ 0]..X6JQ]
M.FG?IY;RW:T!0"W:(J<L@#.$B[:P8M!Q,;0KXOVMGR?G[A&<%^,7-K%KV(,(
M$Q\ KL#@FDA^\?#Q4$9/*GT]24V !<@G@9T]Z^1@/R!\,+TQ-/P__OOVS4[F
MCF@''\DR7G;=D?>MB]H''2JMMMB]UGA-FE&V$R<;6NX4ZCTM<T6_8?R<[1.B
MHC$6H[K^X,"O/N0E]EQB\X?H8WMBR@ HJJ/.M:ZT4+4_>L_("I:2*C\?5H*M
M=V"6FK][UI^/_5\W<+3M]O;>:^+=<H?XD&X*%;'V(3_7Q*?HH0LY>!0^= P3
MO[6>!ME^)S7X^#+YAA$\Y@]::_E>:OC2V4T\UM+ N?TBJWP'F$6#?%K5^S[.
MSW[9#J)#/I5 X&5-Y:LS'^WOP-[KA72"24Q!#:JH0'2)GV()=9P#7S7I MXM
MH:A7G"=FV V'6"DTQ9[#YMLB6W2XCU';A+WIH;-1*$(=)<_,9.*5P[R3(8?T
M1#SHJ*=+L-NU'RL<G9@27"1%*@N]*. ]VJ&T%Y(JWFY2_7#SLS;D'GDOXSV1
MMD+>=?[\;S&-/LM1A\Y/+GP2)P#3V]YV6(H GR1< TD:B*PK,\IGQJ)R EPY
M5XYL)^2X43E _VOT&WY\<LE/MS>[/!&Q*(-=R.@#P%Q?.DA7*V(:%=A!V6@3
M.7)%"!8'4(6LEUZ!>2^)0P3?-U!TH\03X_O<]2.EL O@J6EXRX1O)H>Q<*^F
M'"H:&7ES!LAVLUV&A/!(J!#8;:E0^+1)"@I)3@X^Z2",O_&WP;G[M&QFHSU[
M_/N:F[0X8,&ORQ#4[QBP_>81FZKWYOE)G[F.TGU#?GU'U*MKM8U7Z/0R0X1-
M+;_',#!NA4RN42UL>3/!%339 5/FH_6>S8!1N,T#:X20"=_H\#4.[U"DNWK-
M]002YJ\VXD+^LYH;<=+M^T Z)\-BB#XP6BPE.UY]6"^D<\%K&.F!XX0GWCGO
M_%*QTZOUDXL=%%;^XMH*QW8T[MK:F]IL#?^SJ(O\F_\#4$L#!!0    ( $L\
M6E(ZG,^3UL@% (BV/0 1    8W)O;BTR,#(P,3(S,2YH=&WLO6N74[?2+?S]
M_(J\^7QZ1Y>25,K8.V=T@.20DP8VD&3#ESVJI!*8N&T>VTUH?OU;<G<3;DD@
MN-MKN9T+^+*\O+SF5-6LDE3US__S\GCZQ0M9+"?SV;^^M/\P7W[Q?[[YY_]W
M</"?;^__^,7->3DYEMGJBQL+H974+WZ;K)Y^\4N5Y:]?M,7\^(M?YHM?)R_H
MX&#]F1OSYZ>+R9.GJR^<<?:=-Q=?IQ89O'<'A,('8*4<H$%WD""8:*(0FO*_
MGWR=&1.Z6@X8?3L !]0?Z5-N$4VUD27^[_JU)<G6@X"1!&*(2@[H+%KK)/@*
M_6N?KO37Z2^<+;^N,OG7ET]7J^=??_752UY,_[&4\H\G\Q=?Z1M?Z>6: V,/
MO/WR_/#)R]='__;;;_]8?V*^>*)'6O_59#:=S*3?H8O#R_QDMEJ<?O@;SM_\
MT+<LY^!L^J.O,OI59T=<?$"_]]<_.;J_S;24B\.7B]7KHQLM>7VDOOB!2^DG
MFOS9A<R6*YH5^?T&K3Y\].\WYZO5@F;+-E\<TTKIU>]=.##NP,4WO[2^@\OY
M-\:OSMX\/_2M[_K-KX^R.>>O7G:,7\.PZ"P^/W+U5/KS^?+)8G[R_!]E?KS^
MV=;]_J-/E@=/B)Z_?X_.W_C0?5I./G0M>L7VJ_\<_?B@/)5C.GCW;KU\#[BW
M?D-_]XT;>Z#,>>O@"R;]U;W%BPO]>DJS)__Z4F8'/SWX4L>!4/WFG\>RHB_Z
M60_D?TXF+_[UY8WY;*6C^^#AZ7.]TG+V[%]?KN3EZJOU;?WJF__UO_[7/U>3
MU52^Z??RX.(&_O.KLQ?_^=79J7E>3[_Y9YV\^&*Y.IW*O[ZLD^7S*9U^/9O/
M1"]@\O+K?J LSAY.:I79^J&^?T=-S&)2SK[_Y>J^M']].<&<7?-J'6PEB+:J
M42A64B(7 2O7_][LEV*L8O,[J#,Z[E\MDZ\/U6K5;KF^F]*3+[^85#UE]3^?
M\LWYBQ_=_1>/_-%)?7;KQ>/O\[.[S[Y[^OCAKR^/7MV?WKGY[?2._GWT_7=/
M'[WZU=Z]>?OEW9NW7AX=_V2/W+_-C_[.]-&K^<M'O_P4CAX>F<</__W;XX=%
M__[VZ:-?CL*=AT].CQX^>7GT\(?IG8=W?KWS'9H?W>/31[^4^/C[?OY_V\>_
M_%N_Z]9+_:[CN]__,'E\_.BWHU]^GCXZ/@IW];./W*T7]?OO)OS]3_'.L;[_
MRY$[<C\\N_.LA#LWRZO'QS_\>N?FK^;QLZ?'=YY]^^OCXUOP^.&C\\_\K-\5
M9H\?SMVCXQ_T6O7?XR-WY]6OYLZK.\>/CO]M[CZ\K]_[R!U]?__XT<.GTSM3
M?/GCPUNKHP=&_S[\KS.04W-.>>]![6_U!PS6'@1I*#%9;U/Y\IM&TZ7\\ZNW
M(+Q,1"]<T7>39:'I(Z'%=_K*<H_M7V%KWL*62K3-I(.:07UK('N MMF#*LY#
M3"E%Y[[\IM__K4%[3\\_KWMP/PI<^R:XX",7@T;'K*<#* T/,CLX$,80:HL2
M.7SYS7>/KA#:6S/U$Z<W%-P%36_/JKS\?W*ZA_43QNP1W'GUR/PW,!MJT1Z0
M*6J4*\,!)PD'D9,WI:206OOR&Z-(Q! AN4_!V):"#D-,GB-(*X@E&P.M2JL5
MZ0)C[_+!Q8,+C,]UTM</GM)"OE7E66_,CY_+;+E6)8<+%2E/I(_M;T]_/^0>
MG?:7#G^C15W_\;,L5Y/9D[.1;[=+#SWOHQ>/9S\\??SJ^?3.LUL*TQ-W]/"6
M>?2+_O_J!X7LY\GCFX_\W9N/3A^]FDX>Z?<\>I#-X_\\->7XYQG]DD_N'O^D
MG_EW/T;/??_IHX?WGQT=/U;J*%6>%;CS[(=G=W_YX=GCF_>?_N?5K=,[S_YM
MCEX]>77W9J?BOT__FRVVPI0.BA$\@&;E@&S4^\_)8//1%T=??G//?])8ANQR
M,CJ(P3<PAEB'<<#HLBL8U.%WG&TZ'\LVO3F6+W ^+.M@1L%ZH/JV*G;+GYY7
M#0UOO53MN)SP5'Z<+%?;AO#FKQ<03AX=__3RZ-G/SXZ>';VZ\\N1N?/PUJM'
MSZ;'.OJ?'7W_"'3<G=[Y_O:KHTE6B']8/G[X_-G=FW>>/GKV=')T?-L?/3Q4
MV _MW8??'A^]JM.C7V[]]LC=G]S1ZWE\\9G__/"4C^OT[O$1'+GO)G>_OWWZ
MZ%G1Z]#ON*G7_?VC5W?<3R\?/?SVV>/O;]O'#Z?'_WEUM#JZ8<Z4U^%_F\*!
M2'"@&DL!#R4?L(GM((:4<O;"N9DOO_E+&!2W:.R1'+,L_H :WRVH],'YQ<EL
M<D:,V4D__,NWR:)VI0A77UUQH$H0,4(I7L=_989L+@R_/S/\_<&77U0IDV,5
MAO_Z$CYH(?BO+03_F86XWY,+2[431=^E)QJT=,6@WV*VR[C3.Z\.7_N5.^H'
MCGYYI$R[??KXX:%5=IT>O7KZJQH6?_>7^\JJ1U;/&QX_['[E9ZC_]X?I8S=]
MP<_F3OW R\?/_FV/GOTP5>:81\]NO[K[_;]?=5^CS#E]_$S9_&HZ/?H9X>C9
MO]W1JR-_].P0[CS\U?VWDE@?P!\XAWP D%$YY,V! W#)-34;QG_YS3^\_G/!
MC0LR?"(Y4$RB7$A"\< DU%)MV;16;"8I84T.:Z+S!Q</]N38'CF>'8;_2F5,
M$,*!H D'("$?9.?+06FAJ6:0G*!MAARV!@-033-J*$1YT=2N40;4Z")D6];D
M<-:=D6/]8$^.+9+C]NE_23);8(T#$51=1HT(L0$=.%+=WQ*7(OB'Y/CJ[8S.
M0IHL9%9D^8%$5$]T?;U<Y\B4+%^L$U]?KTZ?*Q#+R?'S:4^8K5][NNA<>BOG
M](^7RZJG^.KM<YQ]_^]?>GX-R_G)8OULG=?\^IR@9U#_G9CFXD2R#F@NGDUJ
M?]XFLOAB?4'RP:S=C=O_[VUI_NZ'O[EXZ>VS/U_KX8MGRQ4M5C?5QW]SD90T
M]N)SO[_W^C+K[X=:=^#M[U]Q]L[%\XLO^>JM&W5QGC[2US?M9'WOSUX\%EJ>
M+.2;\]STUS\]N'GQ\8NW+I[WSW\0 ]\LQ1J::@H+-2L0&2):XY1NC5+Z[^TU
M!M&; =SZLVSNZOS&QP-O7I_H_)U/O)O+;J^6[]W0<S#7;W[R'36!NV 3=?M>
M X9(3I!]@IQ)?[PQZSNJ-]B%8=U1NYX2"'_OCKYU!YJ.X^!*"#5'L(#8:LD@
MS($C0CCGU$"&\UN<>FN$?L8=2%D56"0&; '4E!/64#EE->.^%>?[';!Y<'?
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M15+E@U_Q^I:]OI)/,X!I8P;0"X76H@TM.6A)AV^*0M$(HBMJ!7<&FL-:)ST
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M]V/O;YGUOW8IATX5.6"X.]/8<3)?Q\DGI4SN+>;'D^5RONC;P\=B Y"-3<E
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M?:(J)X@N@&N!"GG$JHY0$C"W$8W40;K"[8]-<LY$C2 %2P%UH,31]A;EV5M
M<"-8$/='BT#NJ?.77I!P0=/E6P>-9/"%ZJOZ1!>:8U4S 0%2JQ"X-NSUOT>4
M@AT"1MO/L6+TGEHN4I,#M 4-)DFY.H"FNB<-/\<Z!!PO)8F:*]1*)7@$ 11B
M$1MB((JE:(P^X,9P?P7-?:F_S>=UC ;0LO65"U-II+XI<VR]J48MR3=DEW?
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M9M>[>&O,R!D1$P0/Y(OQ(Q ;&S;G>X*\E\!S13Q'M1\ &IM6RRVD*%E*C6;
M6_JN"*CK[%I<0E\]Q>1-7^B=&[G82G$A-6/J#AB/*W8M?W3$_<GRU^_4CMWN
MS1!DN;JOH>4E;#7\1?K/EWKX0A;T9#06RI)US0?K>JW2;,AP\A",[\U#&^R
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M/]YC79@,0I$()_)$P"F/2!(G'NB\KI<D')#*6R'0G!#(71($8@%83J%+6)@
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M C,EE,\H$7%$7)>&@>MC=\.$ATLR!F E@1<+E^<R&"%6/! >#7F,/:E]+W:
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M;3Y%BS!1Q(G@_Y1%#@VPOS=7@*(\#CPI 5\7E[^C^HJ,H0*_@96.AH)JQ^
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M(,IWG2B4P+<3UZ8^3X!YQYXM$N90YK*(!?[S8=ZC[L'VKX_N]]'A-QX<GNR
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M9/%?_T$"Y\WEOQ]F3;>3R1O=[I>-C];>]J?=O0/KTY>]_2\;W0/K8-<"A>,
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MM+NW<;"]9;T[M/:VWV_O;7<WM^?.31_&!W-YN'<Y'ATGQ;O17JV+',"+WF7
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MOU^P&ZX[;KPTC_77P^#W<NFOS?Q?!UWA/G/I'R8%X=;=!>^:J'.OC<X/--6
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MB]FHG@^HQ_\IJTZ3J!??Q*Z:[93'K&ZMU4YC PT?L1[ #^?(RZHEHMY#BJ!
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M6(Y+A62KA7OT>&Q1;VGYWC9N6?;+X%5\?D7Z/1*NUWE9D5/C\K$%^L=>FK=
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MEDFZ-W?(AX@UQK=,WH# 3^1R<:B$):MI,_Q[\OR%:><8Y&_6[EAB5LV^PQ'
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M"GQTNQ.UQW;<ZO&(K2Z/<4.J <;!N?#J#PCD]SMVEQ2:@67$+&'DM1R[GM-
M&5G^.6\N6<&\N48!&85!MA>QTQW[1Y^"C@]W(A'9 \-& X6H0U%]5?K?X%LS
MW[PCJ9[<*/SW;'&=>[B7MUN5MQ';]90D)9LQ_69>?22#]12$.[[SH+:0 &2^
M87\W1K26R^CO"<Q >$OI0EDX!C0,+Q^#N>K3?'^+?5+]3HL((ZA;91:+ I[)
M[Z'$&#J:A7IM"7;FGKLV!JL^G C0ODF0TV/X^53&Z,-_XZHN!'=Z3],A)2#6
M>&_AO J=[$A5TJ52DQZC2%4_.'XXZK(DL9B-*K5!K("7[<'S:SSIZKCUGI7R
M"DSGXSVF<X_IW#E6RNL0FW^Q.''*KO0I285STA!+IZ.&RRTD?SK*T5"/&N4?
MWO]/WWSVZ%&&]A[DIJ]9:TX=7WL<8O)C]M,:)AJ^=/0\794MJ3:?I]@(8%[V
M^'KE[]8+(=.REMC IL6A.ETE"UP JLF_3J("0]KW2T+W/L;-GJL#*G.&Z$H/
M%3U=Y.5R0L:I;TLMY7CP?^BM.Q+VOR$$X3V6FH9$ZW:/0&L_<E6:]F[5CGPC
M\G0U_L E<AB0;&27/KP<KJ4T<9P%2+GA<)CXH/O#*,AG8)3TK*S*A@$&(\BC
M(0O=-=,N4I>\623LRZ Y*K EK:>O9IJ "3EHET3GA)=D&TQBXEGP-C5B'!)@
MF 2=SV[AXOJ>2X+F$TG/2J^F!1!<([:D\.4FNDCU&] D9*0NC"MF9"-/$+)$
M)9N4[0Z5VDBVD2._D1;5O'B*")D;52DJS*4D*H-W<< %Z:>DL^O&-Y7$W]C7
ME<C(T.&-6 91%QZ0@8CEW"0IDH1G+"E]G2S/Y:%;WW(V%+ +='E*)D\1XLTI
M_OA^*MYW[@PH<#G;]P;J=3G7PW@2V,)XVTVNB"?7FQ,=/Q#ZL1M%K4^DSZC2
M@7+TLN?^KYY:(5 NQ"P+,[!6YQ@J%\3T/JP0GAZ%-;EK@\8\<^8']GO*O>$D
M)\(LR+,UWR0;^FON%K%=-AO6!X1^1_H> _.G)%6?DGZ/ ZCI4DG494Q-#X:K
MA0=,18.[;:.T89C6WC(7B3]C\EQ#?"%*H;_,P[]3I^*&I_\DR-YQ*,ZZ#QK@
M1A2,.-$^HG\^H&0T%1"=TZB0+266V[*>!D:<;.=A]">CUX RE[X)77QK)3<U
M^._1-\I(&7%9VQEY]Z_Y<O7#BZ3HQ\J!K-63\//3XN96AB=TCWPX)2IE&B[B
M**=K,B\1UY8 .&[X_#??N7J2H6D[[?54OBAW-MVDJUI(]@NR'54?G3N;@-@@
M?F91#[7Q);26!.)JH@<KB5>-F(ZFA U=DX>'SAS<S34K2SG8@H5K$8H7&O-!
MD# &C"W 8<^T^NB^0].E[S_=,2JS;7CONM.#0:KQ547&UQEGP8\EE+U34]QN
M  3Z.H5P1Y,6BL:1'A8^TM RSTA@C9".A/9=;7&J[5 /LQ-K%L'ZI $X1T+X
M:#W8?*2S@Y1@!7C9M%ZM/5@-'\!%WC#[! UP7G&KA(]5?7% -KD-?856!CEW
M=/!-P9CT2:=UR81(\EMCL&<KN77NHRF$@%H3HT'\E;!44J='=VH+ 9G$#6C9
MB+8>]ZRF8,0S[Z809Z Q1%-/7=$K&-S&"H+;2N-69W1X29.TR\]<C-#(0?*T
M\$',[%"-JF6\H@2$+(MWSQ#87V-8H6L(4TIHGPP(@>41F&X4/E^]-FY&5?TY
MBTNT;O1[9*:X!P,RB;R!)N0L#<QBAOV5KSGN7"(A,EJ:L\:^-7R2/Q'76H%(
MJF^X2:?P+6DH*G/2$8:^K*:L'P@-?5FVNAS^4[S%D.^FIG=N?"E^$8^+=,T9
MB?N:Q'JY8PTIKH3+LIZ1AG&H9NK"KL3'EQOF# IRV[@BU[K#'*-?#$TQGT1%
MNB=SNN\G<;,;Z7%RF+U)NXV(%HE5R.AHXCYN!U9<#T2V]EK1>YO#"0*DZ)$=
M3=NV=JU;S"9&A&>A<-AGWDXC<UUX ?H.&'+.0&@OS!\9MY9#;4WBOMN3>/#6
M!&5\26&&P3XXS\N%9\/:G(6H&>NWDU](R^Q> V\,*9"VW6I7NA]X,&\_O!&T
M?1<U()+HF,'7PK#4&12C#<-@'^;]=$XZEP;VRB^;D"EXAF^,%:$F/8:^5_0!
MS9N1^B?/7Z D3C17H0>9V]B;-<;65ET\C IL?WQQ',S8Z<*1Q48+TY<244D[
M6.HUS*^P7CSL28J$Q4J&)\&=+53.M$S M_#Q[1W5"!<.BF8M2*%36B'C\H%Y
M.$7.1""1:(2U$%#0LFY8$QX:1/:88T'@&:,KO1X5]TOM![F.I+GBY1_4)NK=
MO&R* X@]2PF/RO !T6)LE_ODC.\**^FE=NK/_1*$6M)%*WOG2-,U.%D[-;4M
M#>SH"JM;J^)J?9!;"$'ZDE,]B&(TO<1RM]IVY.(I*,GK2-S[:!XSB:]!O9:Y
MI9M:<3Z]P SH8A3:ZSD*/^5[5IQ&E-#.Z!C5HOTCBX5.WA1QJ*EVAIK.2W<N
MF'AZ,-WC+1NKKY#)8B\OM*>2XKPI\T27PI6E7<VF48<_=D>'G8M#0]627;II
MT[/3:&4',=D\N9S(HWOSE:Z/FCDS]-F.#U#[$7U'"WBW"\=H1.'VXO'CLW[.
MXKP.^T2O7+U"6$Z,;;&SVVA!R0JMI%; Y4N+(LYJ7#KT1T@ 2I37:G,C&K\&
M)PUYL8O6O'P9$PT$?6&5(KK6:&39D&9H47_5?+P/UL[65DUL^139LV=/.8%U
MP'4EJ0G]./J+<1)QU[DWYK]M?&^2??/M8\G]1FWSOGOF?Q5L!;SAZ-&W_B_6
M[^W/3-(M;T@/B&?/UAAQQM8_79Z:X)W6DBKBO\$Y@+6! CK:&[VE\SW8Z)I@
MHR=[L-$>;+1S8*.;A^Y7KFI#\.,Y9T)OK8,7#TIL@VD\-+(YSAJZ[TKK@R*W
MEK^2!S?Q!0)(_@*.NZA<S&L.1$DVV<EUW4:5EEP'QU0?22=*,M?_)MI4&(G)
MR_-\KFRJ^-R^MF[59H]GM15M3KEU"A=M'B#8K!QNEB6*JQ.&[6PY/YX8,]/A
MOIWJOODDNHZ$P\]#?SV,0='D.19,6KF3F'(4-]P\$E7'PW!Q9F^654FKDKV4
MK[[RQ3)O42S#R3=>_L@F&MT)YL?#H?"O$D,NK$,@@=X51^2F>*5\YM#P^&>7
M+QC=7]#&DTEQZFB7;O<$<EY%AS</P[OPPQNW4,CSS)<(G5AN6\U;BS)S<]W!
MUZ2/#-F=TM#9&:6W#ZOF<1/>=# S3>A .20B[L\#6_)VHN4]22@0QY;^J8\]
M7>LHQ8NI%Y;&,J^1AC-WBQ6>M$3@FCXLQ/<:D-17Z.,0F^DE) %.2O0NP!-.
MWOS7JQ<'1]^S$>JCWXS%M+;-LO:HL6TE\)WR#5GI413735>52Z7#>\+",,1_
M[:DRVYK]'62ZU0$,V;=HJ74X%IQOAW3(&NS2!LH5GCD1T,!$NSCS6I.E*FW#
MHX0A65#T>:C5+O_HP^XI<P/B/PYB*K42 ;V@D1D;:=_-:P$SL 33:OL%M 1G
M T2D+[#W%>MAY>#X"$R.CHRT09)@LI$EHL4THCBELCPCCL=!J7KAHCA2<J6<
M,I(5D67.._*3)VGB ^\]P+8=S&M4@"/8A%=PO[ PNCE(RKD%M$8%H^?.9OK@
MC:R*LJB&0K?-O?4K91$[5\T1<RNR^?JLI..D'ZX4PA*E97#_%N6L1"=PC*S5
MV&$[&9$OR&L]Y9-UV<JR6FAR\K1Q=+IFQT)2-^5;M"OP)3-T2E;]Q2# \J$1
M)^YV;P8DB!J7QIJBA!YV5.Y[L4LL"L4=&AB.)/H4FIX+Q,](HOYN!"W,80(9
MDIBG1UR(F>:D'Q4W#1=F?_*N5P*Q0A$Y*WXSV"KG"C:'?+R(XQJ^V7JL1I7"
M0K*POSJ?_ IQE7[!J=I(4X!0HZE,8]J,IFM3U0Q]Y'6( V4^KB-Z L-O+QG_
M8?;:PRPXFUP)TZG3UO:>56H8-@+!19A'XZ8-66L3,\@DKLQ<L'0X;)P2] )Z
M>IG_5BZY$V)L JNF$7:(>WD,7S!;8@FC1\U;Z5W.#(%J:;_LYFP\/+=E>0L7
M!,F:6S^7YC*(;*&# ,W&*6N1L1RRAG;5>=G4<@'3,2[/F.59,'3M1PC5&8+*
M!^CW]!'\W&:%Y*G]8;0P@1QQ'2CL.K%"@-<->:Y(-^@%TXZWF)+V&T$[(,';
M-22UW9S-#'K8\J#5.*[E5=AXB<8R8\1V59\'K$,<TIW5TYX!42F).%Y=F"C$
MR\=(2!E#.WB7W5GN-S?M.\79Y]%Y#WZE$46QW6HJQQN0.5!9;;=PIPN$9RWK
M)'3B=;4F\[K-YG4'&?#E-G$J'F%"=-(3&UT0SPP[0;Y*'G9>U@MS"R-F0ERX
MI5=I,)1R(U7"DIPMZE-Z_$ ]1UTM\*&36G*E_GB<U!6G"_S9,9-::='5SMFM
M6/-6&+2AW7XDA\3Q48MBOI<H".<>?_OXF]]5V=U/%<YIZ)_IDLY&=^,&<[XS
M*8Q?05G7< XKTQZ9=NTW:#G<F[\'.:.W]61&PUJ)0)Q22S* ,V]F[$-R7@$^
M[9*^/M4."BY)EXN1XPX,>:#&A7AZY*5POI6I"DC+5Y)]\FGF5MH*1&<C.Z9K
M8G-$_H7R#TU=<7F,@#$QM*[L^LYG[O%]2\"CLBF@0A\_.OHN^S%OEMES6#E)
MG5(,B<?@#D 6#P_W7"ZL4@I/PL"5B--H]-4]<O@,'*CM4Y'@RF L%^QPY5--
MQ_M5H9WRN2MDK?"U0S(Y/!-3J=\3E\%G;_$\<\,*;M,@&2PDA9C*E/TQESU
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M69!\GV<(%DVYE4-5&.^ZV$-3G,D&+:W^3KNX=(V/JNGYH/.P*NM28F-%DU\
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MFOWCQGN:8^2Z:=]))WE6>A\%V[)B0BP7B_MDU+ZV^\%?"MT%>@$!$M4B$\#
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M,5!\GQ:DMBMAP/=U KX.$P*HU0%95*(SW)E)0&+%MC4-_BR7&D;YM9VYBF8
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MFG^Q(.-@H5EN'ZX+U-3Z!]^69.(!4]$R&UE4VZ/$@(DLS\E]6DH1>H*\P::
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M')@3B\$7-7/C3?'>=$;!06$H1)Q9R5MM&0_#U*?N#YGD:K-29V*MRIJL \1
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M5YQC*!+S!6X-*FE$!Z'@?K;P$PQ/SW0_B?ZK7 CMEB7%F+ZC#YWBWEA^#X*
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M=P^?SGIZNKQ7L67CK]::24$YYH=J4[)*(CT'7OC>HTM<)!<LG(2, !$M4L9
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MVAJ5*F\6-2WCIQXYKCE\:!(O%*ZA&')5HUI@X.MSE>=_T4;]XV&2_O* 27K
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M-QOE76F--#G+]G]Q>"X@K0;ZSUIP2/]4G;>[VJ('!9D)IH@>V=?ZC^$WFPJ
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M9]H;-1IK:,="I8_KO^ZA#-(?]^%L2EV"C]4,9.5R510\&]K<.#R?&84_9B<
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M[=[:$Q%40-U/M_).+^>PP7<<*0;=R.C,>2/N6GE[^1E,^D?L&4+Z=P]"PXP
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ME:_MU):YG&+FQT7K7K:X5"R7:/*ULQ73!1QC/AQ]GXC2Z.5TX)MDUO"&QB+
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M(@A0[1LEP*%Z/V?L<R@)<LHLDI8F"E>=8]S3N+:M,I:EB[!G3AP.<T6'BGX
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M,W'RL!U];WUGI2.%B6F[X!OM&].H0B=_8VJ^B(ZY06CPF(SO1PC%AYRRQW7
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M(,I!XUT09ZDMFNDF5%% )H(.M.GR+R#OB\1BT]ZJ>% GZ[-;?5YTV,8$8[3
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M<G[Q=&:E7>I/QP"TLL3%FXH<#91*6->*UF6$@:[14C0QX W -!O8KJ;U3 %
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M]9VE9PSY#X(!IN*(XTH,:RN19 78*+H136X4U2E!QV%,K8FP$AU6WJ!2'#>
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MBN5[A8M,6J5R3:G7@;*V]J:,W3TY;^OF-1L_FR@GU$C)%'7 3@Q80P!A>\@
M&LBGD4Z,@,)/_\S]L5P'A95JPB,IN?"(XRW!%WK7SA 4U]!8JG.KNN>>$/PV
MJTF7LA#.UA4;"#CD79MPY!?=(0O^_@7IDT[0W  Q)T7"4!1,L&4(YRV@,L)=
M[GR]=?80GT%%@ N[Y5S>7C.+':!3XRGC3@RI$WE3/3B\["R*$ ]U0>%=*8C
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M:;ERY"*,A%,XB_C;B6)8,9E4 27<@H451]Y5D.1LY7]X<X#/7<-9Q>3?C%5
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MYV79:PH20&I\8-D.PTV<"%+:0@S9V7( EUL2$NPB+4Q-+;**>&%Q>(K7&K&
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M[';?!_UD?<<1<?G+M^5C3Q<^G5@0<><_H,!S?OC1G%NADR%!I[\*#?C$5JG
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M@CA/K34,==!KEL3XR]1:CAZZVUZ>WB1D[A%7+J0OFAR0_WQ1>DHXNUT\X@U
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M.VS>T)3F)&$H)^$@3N-BE#,#I<1[D_#3M.7L4Q(&K!4H$$ Q'J(P883P-AO
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MAGV(QJ,^B$4>JP;4):"7DO)@0).4"T$&WWZ6H%$0)$ )4HW=P3 !].#Z8/4
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MP!^$G67C/"@-A]:*U;$K.8Y;I:!1LGM0\WA8L/%XIL$(32L\W.FL@4"&PPR
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M*M#$&H>[QHNK+MS,Z+"]+<D0Q4W[@*5U1H<)' D<"1P):;=_6-HQ)XDR09&
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ME"5)=H<G+"@;Z[Y8\>\/CWRA" ^@X,L, *Q+>.VK-Y>)VQ9=\S=Y-1ZPR>)
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M<-%(/!Y7YX*B!A?R&##L;1QR'J,D3YOC<OFUQ(:X=4TGE4E.;V -_!'0&[P
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M?G44NV1'58 IP2S2619UX=4.K]9EA9H [^2>%Q3BV)\'T_I'$]>K=6)+NRZ
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M)7Z.7J?C09B-RN^/I)0,*+Y,N2%D^!K)ZS0-\3]G#6V=CMZ6/3;_@SGMP%D
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M7[7+/\_@[R_)7]]_Z!?Z^<\FM?Y,O_A^H;%XZ_=_F[#'[W]]_V9>?CB_N_@
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M[(6#<9Z"*S[*\GOI+H]'5 FSN_^?O3?O;2K9UH>_BI5[7ZFOY)6N>:"/(M%
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M=<%$YM!D+@V;5,B(VA!*^C-C*N)/41I"K+8;Q K-XMC[>'KAD^]#^? #U1#
M2KIEN]Z@@R@<I8^N?SQM%3',"*)1[V/3L['3[SG?Z_<FO;-$RH7>J&J22G]T
MI[^5DK-R=P]&J=_<V&_%50*\^?9%";MQ*A?8VOFE=^8 P,UO@5&U^66V2^W]
MC8]O\7,^&SS^]L0^'92,^*;S(M+Y7Z,T<9\KJ<]%ZA_.97_R1$AB$8@/'$20
M 3R1%+@.Q)0V/[Q,'Z+,=IE<5/;G.J9Z;3"DE]H%O$+Z;B ]&]IT2,;:$-#&
MEP88UH+Q^,-)3K)&_9KZXBOI,JVZYO:]^"JHVPCJ)16H53S?%9[/CFC+A1=$
M9Y "02U20"@3$R (G9W1@GFQN-*T5G;-:'60YULA9I.A6<RM=\-A_-3K3Z<4
M]083-WC7\_W4<>-QJ@W#URQ-\^:JS8G42W'N-YD_+"(_>T0J#<Y#@^_/S4DU
MVB7C!9HFV2H05*.EHE*"%+5HM%.JD 8%Z>+C=_N,C?OC+UX+=6;!-LJUZDS%
M\.(Q/&.:\$R(+^W!4V8)A&("K,RHV83@6696D%)UUK(J^XKD=31,*I+O ,DS
MTSLLR3Y:/(.=#U $6?R&&43TTKH@-6.A=4A>:'_P-ALEIX&?8AX,QZ5O1NX,
M3S(H/Z;QI%V3BS;?&[-,.^3)?X][DR^[:7(P1.H[E?;SA-OU-<49A\W)LU%9
M<"X6/#="E3M:)$@@A41!9!+ 1.701%&<)Y=RE!EMDJXVU<VZD<!>9NRD ON.
M@3V;H69TL"I$4,(BL*UP8#/AP*0Q,MG HW9;.U1UF6Y-H^**[);9*16^RX7O
MV;F,YH<*> A#RE*#<!3/Y<P#9!DE&BC1.%MFD:G69#3<FW!),ZZKF"--L"2/
MAH>S)@G^WDD-3CHN!%SO),63]U.+6OVM;WYNZWM<G%6W_H'/QM6<60M?YZ/&
M<\..E)2)"ND!M5(!@A,'OLQJ=)XI*@3C,J1BLDBZLBC*^1S>M7&_K@VP5]*_
MH@+[+H ]:[)(H4P*J.Z$$EM!>8)/EH%D*C,>2?*DF6)&R&5?1 7V1@![D8TI
M*GJ7@-ZS8YDV4P.D M]TYLO$@U=$XK&<G"NUKY'[K1W->#NP>V\B*7_T!FX0
M2O^]DLPU&>&E3G 8AN,:0UDS>^3BA#>/E^Z7*=*/AH>'O8;%_D!#\^$@EO>>
MCL?'*/STJ$BZDMM<Y'9N#I)$*O.)(KE1PE$UX0F,8@P$C5DH5$]"$B5UZQ;<
M5IVHK<3L<B>K5CC?'9QG+(V2=BYUI)"X)R",9F"E5J ,L4%(Z5&,6SN<==FM
M6N=52&]H7.0F^5L5S'<*YIGJ$N4RZE4&6"XG,@D!++%E/*L+D5FA>#:UNF15
MP#S?]J[$3);;\Z[Z5%;3Z;N(?;9UR;F>)I7NYJ*[F6E'^T^_[KTOG;]E9E9K
MD)&C A.4 :]*8Y,@+.>,TDQ+Y^^NX9<#Q-55VEI8+]<NJ8B]0\1^LS9.$*NE
M#]+E!(SG6/K_2?"E;1@)"I5.[J4*I5VWO74R5@5M>T&[)-.C0GFQ4+YP^%K/
ME'+6 ?.4E\EC$9P*!!)C,?%@20ZD'94C=Q?RH&R;K<.TU=4WW;[-%+9-=L,L
MLZ*D<N'"#9&';U54@7&AP"JB2[H& Y/Q!_%21Q_P',NE2P]17:+O?.SJ6CI9
M[R7NEQE0J;A?N#GS\*U/D67A#/B0+ B?#;A(\-FFR-U!&*N=:KIS&=TE5\P>
MJ<C?).2W([NK GWAQL[#MSP8JJW.^. H!2)S"HX3#M1*II,O'?K"UH[0"PB1
MWB&Z-VC ZG5#6F9B*QV?\'1,IR;/Q'UN7]7)_22_%A2C/,+[Z0V.<8=/9K$-
M!^/?F^=E^KG]\K0\^3P9.910;^!&7YY.TN$8R;6L9#3L]QMZG3:IK\PZ%[.>
M&]S*I:,FL Q*2(,J%+%@#&>08F3!,.)DM%L[FG>97D"Z; M4IV7,;5P[]FBI
MT50YHSV<,6-VF4A2TC2 I32"B%&#34X <UHH;TQFI7L@[5(ENY8O*HQ4N:.U
M<:?6#WRM1-(B(ID9F&"9R,0Q"$0BD906Z\YJ#RX3FE)$/BF-SQCIVD74ZBR:
M0#9V:NQWC3NTXSHGT:O66'.;GRF\W/F;)R1XXKCZ/0U2[E6BFX_HPJR5%8CE
M1@J.1*<3")8]6.8-D)@4"9XEH7/1F+BH'9 V$K]+ZKE<H;L8Z,ZV E#&.>(%
M:$X)"*HRV.!+R,E(SQS-R,BMR^E?&_#6=+F*W[O [VQ;41$)=QJ\X!F$H!(\
MS1JT45F5F6Q:M 2_M[0GOI.>1[=U2S+D] WB1DTCL_#-1N\,OQGIK3$X?F11
MKJ,/> ,B2/B)_G'9]+^&H_+"P\EDU//'$^?[:7]8_3<+X-9W,P5 #_G>U]=O
M3=9)."$A2NI!2(T*$G>H*F7&?.)$&,*V=K3H*K: +F@WAMS:.X+7D4/6-HY4
MF6,)S'%6B#1ECAB%0'Y0$'5$YN V@5?X3R^S\@QE[VQ88ARI,D@[S+(-B"95
M.ED&G5Q01*(H>- *G$<=1'@2D$D,&GZ,9LX<#\+X)4236A90FO9E:(T!>#7D
M__.M@35:92>F7XIMM/S6U%6]*N/N>\3Y>$;49]2YER;/\GZ=<CP?'7Z=&>_Y
M?O?KWOOP-N 31=$  Z68!.&2 >>R@ZB85Q;EFE+<VE&R=HK;. 0OLBEU1?"2
M%)H/E^RCC+SK1.;@HN,@ C%@+2E.["BX8DQHI;9VN+J--G/O$'PO39L*XN6!
M^*)[-*+,LN60 \5CF'@*ACD!(J&%XKD,7H2M'6-OTQVII6&G]E@=5X>=\!E?
M?CNX.TP,;I=-][]WDY]YTU.I[?2^DA#:7Z-A[DT*\U=>_]FPU\.WG)O(*17
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M.&KX[@NR[KB34(V(G<<II":UC]-NIWB#RT]JN\UBBW79AE4U5WS0PP.A%VZ
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MPIGHE'"!&F:94%(32F,P65S/AO,G)E9:7 TM?OE&BT0JXQF+:!I+AI9R+,,
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M=->*6^>+W;NH2_O0?2>)/#?/\?P^>JMN<2/TGN7K)$1G%@8U"UK0*VQ3/T0
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M,/V8^L.C KB:*5+=\VV34DL;5?Q\KZT+SON7Q4%9>VXM-F7A[XMM+J+5TJ/
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MZ_+H:/K6'04=3=\832^Y$71&L,N#18%3&;5VBQ06"N7:!0_V5@#^'=T(-,]
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M1G"0XLE3QOKJ6OI$YT3<1G*^W1;,'3EOGIR7<8J,HYEV8+F+3%/$I<ABEX6
MJ,T5L\[E-J@G3P7O4RP[<KX'Y'Q'&$4=6=\I6:] I1)N9,0P%SC+$/<X0PKV
M%4Z<U\"XK7041_CC+*,/,5Y Z [=>J,B6A&GL2NA\ZYGSGJ_3,<)$_5?JP&$
MXB<A4NLE,J/2^1+!='^-*S0>#0K7:R9YS_C;+5L?5V=PL+?/8&O_JG?VM[.W
ML*US7&ZWW=*.T5V-T9WM/5LQ1RRS7F?:(BUSC+B6 DD=*#*<&9!ACDI#GSPE
MG/:YV  BRJ4IZ;XX/Q\K:[@3]-6.-=PD:U@V;93(A<V%0R(/.+I3,0)+)T,,
M>#]5Q,;-CVVE<9_F&T!;Z5C# V$-=V(6=:SA)EG#LGD4<DD-M0$IGU'$J<]!
M82 *Y;#;GEIG)<:QXY,@6Z\S;"@4LP6F4GY.^77$);ND+;0)EU#WC$>5NP<<
M%\;NZHXEOYQ.2WNLQ[&1R;]ZX^-1.4$37RZT,NGWAG[RB!+XMC3<UVQ<1$%_
M P(QP9/$Q./)V4&H@$JT&?@WWL;/.L'Y$X)S7=,2(33F! 4;4_ZPQ<CDW(%V
MG6>9"U;:' 2G$GV.5U7JKK1X2RE\6T. ?^FSQ'$/1[OVOZ=%Z3NRW@Q9+YO*
MD@2*#="Q9=8@GOE(UDHA#]NG I,>3* G3ZE2?=5E\]X+DMZ^TJ".F&^(F)>-
M6R8-YCK+4(8C+J"U!,F<$(2-(F#N9I9GK,,.N$M L:XKXO;8&)=F5UVGI<UP
MK/W5()X0C$CN,H2ISQ"7,D/*4X^X(\))EVF#[=;5-W:I2 _&K.A(>V.DO6Q9
M<&F89$XC1Z1"G!&!M#2Q"LD%2[4EVL;X?#\377KA0Z/IC5<?=81[<X2[;$4X
MEGM.;(X,T1AQP132SDLP);#G+D@CO'SRE,M5=/';)]M'&ZZ(S4H>>^O#+0M/
M).#T^=A$Q:-F+HZ7_^R_VAVZY8_?%<#$II/G/H:;BF%TB[S41?F/'DR[XLHK
M\[/5NB5// \\R^$,&A(;G @D2>SK:C1UL-4.!WE>5\0N<''_:?\V#(R.]K>#
M]I>-$"9RRK%6*'=2((Z913(H&IF\L)PY2H,!(T3U,])%+1\B\6_,$NDH?#LH
M?-E:P9A;2AA'F6<9XAI,%I#N F'.>.Y8\)KF3Y[FV].SX!'%.W;=%SVT\+C)
MJ/=I5 PGO2]@HDS++L"Q70&.5S &V)3)J^$?<9?^J3:IXTY7Y4ZK65.YM9H+
M:9#TL:<*#1J9C >$@[(9L2;W87,1V<X7NHV^T#N-;W24O2G*7K8LA-(D:&&1
M<1@L"T4I,B:SL662RI0,,F@'EH7H$R:VP%':T?26Q3<ZFKY[FEZV)2ALHLR]
M0$8HB;@) FD= A@4V,F0:4M<]N2IZ+.M"%D^IMC'K#8C B><PK#.^KW3@0:3
M(C9LCYE4IY%*4H5&O,H5X]/1&*CM$<5#MA6>;86#_55OX5]Q VN?2=J^CHE=
ME8F=K9@<TC+) A=(\(PASBR8'(H29&R@(*Q(;JAY\I21/B>K"#!=0O?])NL[
M-38ZLMX@62_;&SHH&[AF2 IL$*<$[(T\&"2DD<2J8'//@*QE/\LV &G0D?56
MD?6=VAL=66^0K)=-CBP(X;P#&\,:B[C-#%*,8@0\FU'":-!6/'DJ99]="X6Q
M"UY<R^8 ,UL/CPHS\#T]'OM'U>OQWE@5K]I-VDU[U+&G*[*G@]7Z#)H)DM-<
M(J:40CQ(AV2>8^2=RB36G#EI(YJDRJ\#3M\Y.;>1F#?>ZJ6CV!N@V)6X!&%
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M8C)&@S$FYO/U"=\&^,7.B;F5!D5'R+=/R,O6A;18&*<UHIQG8%T0CJ2CT=B
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ML=/ZO4]3=S3#)KL2C%JQ1B*>BWJV@,Z0NDWN+,!NG@_G5@,U].-[(Y!.#1X
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M:POT 02O/H'<D!(7WNW5)2Y_?^[N]GO[!V_%WND?Q]V#=^(C/*=[\J;7A6?
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MH]6:ZLP@P9:AD!X)N?-!4K"M;D\1=K$H'"R^%P7CA>3@4SJ+I03M-HQ8?IN
MH57@AU7@O5=+44%0*C#E+=+8:HCWBX@L,Q362GME@BL"3:E(V:KO]ZF^/AH2
M5.&]"+ U^T*E.+ H*"P[H\3&-B;8'/5M,#C5,8$-VG!B,=*,I),$F])U!4=$
M^, +:C$KTOZ[HG']2=3W1S@JZ ;?3;@V9F#\#W9.<)N#2Z8MPY1C+S4O2*&I
MR>1%6C%CHKN.7K>M/GM"'V(Q""BP+((0 L%&$L"'$ XI2@VBWA'C(W;,Z'NK
M/FL3C!NKTU18'@L!L;T6G >M0+WA?TYZ+:-WJJVP>GKM?;\< 1AG4Q2?"#?
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M)[0Z=90U)=[[TK4G@1*EE8Z(Y5CALIW3VV 1RTG4Z%:CVRM"MSKN^(S@QZ;
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MJLRD4=$0%3DC0)TG3BI*DJ8A2<9MCG1IM4 7X[\M4,V+1\K@KP'L!P4P$36
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ML):!\L(Q=$&=!1#&H19:S<%Y"8PZ6>\'OFZLG=P/U(';G)PD/(M<$BR1JH;
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MC;NQR>_/1J<7AT_3%:7N2*C-)*%.WU(_M ?XZ;N1HP>6*7HX.?H\JL/R;OP
M-4>JT''CM+D5V&X$"DJ*1$P4Y4P68\2G!$10[1D3QK!03L0:OFSY;#1VJM9-
M19+<WEX_[;GC-&RZ&=.H>\@=^=(CU+>Z:CC=687.6[VQ'(SEXB<VEGOXN>W3
MS:WF*7I6O+6UM@O!R*Q $IQLCK92>&*L$E5KR2@#4 -N:=7,$81JY1%RRE]H
M&2\=K%(=::5Q?^#!W[N7[OPK Y_:,RNH@_?[<+ZY_H7AWZ)UOG&V:ZAE,F5-
M3([HF27.B0=NB.?(T6V2)BE[$^I<2%<E>_=URQX99FI^?C<+].5L-SLA./=
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M.][Z8P-)Y)_MYOK^E\W/[SB.";_[SXS$\A3]6=%:_W#6/$ RN;6Q:TQR1K%
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M!X%CEZW37:.$DTH:8G0Y<JJI((8A7<O)2L.S2YG;I54KE]D<<6[\<A=J5HO
M(HC UII$",,Q;)^W#C8$B@ 3UE"E!&&VVH-RGAAOD+OG8)6P3CGGD:?!,A+W
M.3RM"@-<SSI6&A_1$*+?/TK"F#;\HT!RX76#&_C+*=JL<7P98>ZDVA&]CI=4
MPUI#&M&YB##/^?8[\Q2^7!GX_A-P%5['N^\?Q'S" N=U$//>\ *MM5U*T>%+
MEA/I$&,@1TV\T))8KH6@5(%WI43F,MJ>.\0PKP&;.FIX;4G?%PX;,KO"^45Z
M7S<UN+E%T/#HLJIRM\2%+T\D70DD7O7\YQ9C'CO^1=?O1EM!6YM81@/)-%C@
M3@AC,H^ :(,@,ZKK214W=3CIR6**>Z?-]0^[&A0-D4>BA64$C(C$6*2K.4J9
M38Q19X4X,C\9[R$AQ5H&%B.D>/!I-_$03-*4",@H U8Q]+F=(Y[+A!)A7(!4
ME68U?+;!W:_#'8<*(89AH=YWDF+&7'0NH%3AO\%$_.^.\9S[RU2=#G-W6<+[
MT=9!\[QUO@&;6\UOK;U=0;WG"AR1ACD"18J,HT""DR8E:71@;&E5K-C9'?K_
M'J5"=2Y"JO$D5<+5[H[EH'5RB"8S3*XZ0WZ*E,=*R2E !A.2LTXHZ9)E@LKB
M 0]7G5PN_Q4,03,<WL23?G1G-\G!^DG:[*XGM.!Q"UVKGWN]SYJGNTKKQ#SW
MA*&U(("S2RS+E'#'&.@H>71F:=5>F([1 JXV<+(KCR96DSD$CC%;B3WD2L5C
M+$C0K?;.AQ^KH*,S/F+P3&)QB#>]L4CE%<'8J :=XJ68--O=]N')3RXMY\T/
MNRY%Q9%8$&:T1D-3'4@5E- LK&%,!*ZA&)H9::G68'!EYV8<CSCIQBJF<)U%
M&6Z\5 =?QJ&)*WLU_@Q=H6JS(;BC]C$2_?-A8>O1%M.,]:J :3R&LN&0AAL8
MAR?5;A+>N%T^@+<;[,^-5 P%??Y8)_=-7&,O=5,?O[MZL=IINN#FH8?>2;&O
M93^EC-2A?WQ<*=3($-\]/#1_4-=%AV8B0W=>";[\PDM1QX7N'1<*2:+3P*63
M:-Q-X(9E)8R*&1EBD*G.@WRRX ]:W0^[ 8*!J!T1V5,"2EMBI,]$<2J2UB"H
MSDNK7,XVJJOVPGQ*W?GQG[FJ>Q=%&;U2PBCB9XD&?5V@8) <IY!="=%?;C9N
M#/HN=2:C0:-4BGG]'5:FKBNR4]F@BI*Y^+6"CLD0P,9?'Z]WVMJ=P726+/4.
M6&3>^PC E6/!)99H4DH'*OGH  /0>];8O?(\7]-:O^^Z>Y4%'48!-O/:\"%^
M9G29V(A'QK:]FQGD9&(@@N=RL X"\<$+$K,/B-/ D$4OK9IE;F?/-#PD)%0+
MPX()P^;6WJY-3"@ARGFHI AP(=#6\$P<+A3Z\QHI-2W5D^6<0C*_#HGL,-=L
ME&Q1N6\('V\1* J++>%H1+Y>O'+Z::X_)\J1"UT.QQD'PF>OA8D@#)>:^7"Q
MT0VCC>ZAF,SQYT[1[ U2]U:24;PWE(LQ[_[)Q&'*@Z/(/#+:&Z.E)4%&&!W
M$ P(5<H8)'S11;2)QZ>]QEF)Y<TX<F6K8)C'7I'\BL67E"^<>/1F"DGM(N,[
M*0DU([=DM"Y(1KX771QY"95P/32*>#\8NA)%'+/;]>2/-Y!:]4^*\-0QQ%M
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M$> R$0<B$F%EZ2[//2_%6L4RFW.@_GZMY._7#/Y"&6I(JB'IYA[9.D@!*N?
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M7^:.VR)&I$1V1QM+D2-8("8T#EYSKSQ>V[P-25T I4-!NL ?6QNZ8F_2K'N
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M$8P,11!UB3DE0H3M <G'%Y8+K8)ZJ\W15>SU26S335P]]XB\O@.ZS16U].8
M>,+Y,ZZ:4:'R#5%Y>P:5=0B2,4N0ITPBSG/+:T<B4IX&G^LG>"(NJN%<Y<*L
M+*.O!I^/-:R;L7K%U3?DZEDO@^,<-M!3Y)G*K9=$0#9$C61TGF'BDQ<6N-JL
MF*[U$O(N=CLV]_;I_+Q6I:?GD6IQ6RNY\@M?&\,CPUQQ0KWB-DCMG/)&6(Q=
MT #DUTU%KDSA>X!G/V<*<R92L 0CI_,) DHY I'+D!3>:2-=[N*ZMDGX? OW
M*I:SVCQ;A=RJ;:JVZ4E+P,I4N5=9.&NJ!,5!VCF'(DT.<0SVBN.$(X5Y[MP
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MU 'Q4RMTC9AE;D:0QO%),^8&LJ7(:*>:K;5 ,GWX\G>M>];MQ>.K'G\!#LV
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M&KP9CV^Q#E:IW[OXEKE*1H_4'BH[R:?:7DW\FX=;<#"QT1#&@?:BXA%;ZXT
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M$!3BVDEDO.5(6VZLMY3PA-<VS;K4>H7\,)5/=;6-H//8:0?;/:QX^#YX>&0
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MWN: M[TQ<NU9S+P-16<( AJ7D$U:91T55529ERZM?:(;1$^=FRY#<0NR%\R
M0CLKB12<PWB8K+M.O5*4\B@$+NWEE>UEA$TS;(-)0J#@B4>Y<B ">(-706M/
MC,&*V+5/9$/@TEZ>RUX2MQR':(R2EEL9+?54PPL+;WA"2GMY;7L9I<_@7SH8
M)F#.4>7#4]XC2X-"WFIO([4QLL+]-'<O,.\]3/UUR)9MJW4.;;V"E_^T,TG-
MLW0E.7,9GKX[0)!(P"1Y&ICPG"MAJ756P+\=I[DPZ#/LQ)4!@KD0;G\\)<0%
MXAQ'/B8 .,T"TB$DE"@W#@@!!@:W]DF7P>D7-1[E!)6&\P"+# \NV9@4,T$D
M;JA,XCER+$OCF=-X1NBT)HP))\'S!/\3V('%R-GHD(A)<QG K&0HC>>EC2=0
M[*VC,!Q1<,J<-HDDYUC" D>AG^, 0&D\<QK/&+<6FD<""XZW02)NG48ZJ_@9
M2J62."9LYUEZWD."\C5_!JI9#[$5*I?UV SO)R?Y80C@K*4&&Z^D=+!\$FU#
MSJTDPNLHL+B%>V[5?B\QX-DQP(^=LJ,Z;Q@*1&*.WSK#D9,>(\!I97!D'$81
MW.L%K9_O/1PU;V)1A/\FB:FTBL<$-D.#U@3H)W5<A5!:SVM:SPC]5(I)3@5'
M &HYFDLELEIQ9*2)5"LL2?;=2NMYV;5'4R]L)J 6X(L+34V046MEB>"2D=)Z
M7M-Z1ODG9XD$2H!U:IY+//63^#62FEME&-%!S['XS)!H?H ZT] 44*:<'ZD:
M&D.]!2RO]Q'E=^[0@)M72:[4@5IB::65:FRI _5(':A<+:[4@2IUH)ZW"TL=
MJ%('JM2!6HFCB@+\-?#;J* I*PKK8KN':&E)9#08,;MFS3L^JMBFM=/]BVKC
MM\;^;O.DVCC!^U?5G]N[^S]K]'MC>_?O9O5TBU=WO]>GO(3&/CUH?+X$K^!X
M^\?.Y?;N]T;UZJNH-;ZR@V_0UA][E_N-HY^U;W_T=32&/O;N9_ @]@ZM=%%X
M)Q$.G.9#"!$Y;C 2Q&!+-8\F@*-M-LST(837WNAYYT:FHTI!,AP-X^"+<T.(
M%,P*%0E<%&EI9*]G9)?C1B:5=0PKCR+C&O%@#;(F1 1#I8A6+%BL2R-;1B-S
MC'@<I3'0&UQ09JA)*9J$O5,D^ENJKY5&]@)&5IM8R;!-7'/-$$]9##YE\1>@
M'XAX;XGV7H2< 'R_D<WIOJX$VUV,^-/;-W,=;"!$)&6U@)F3M&#"2P/_(U9*
M%THS?R4SKTX1UJ" F6(9D68.S%PXA4SP$4F:@,;",FN(>8+0TP/6S+=O%M)F
M'XZ!:Z M#X$Y[86 VX&'("E0SM(L7L\L+B?-0A$8*(J<\1QQBQVR&I9 KI.W
MPB>)\V'81VLWE68Q>BS,X*!-I-0'S9W!S@2"O9>>*:XH*SVOUS.+25(H)+8T
M!@[^%@-F& E&3E,%GA>G@5E+C+6E&E.IQE0>=[D][2/2!"R+&\.\Y39%+8FS
M!(B!R];E;O&!W[,>QDOAW<X4.U;4VQRTA77?8\2)S&G[#",9F++&$Y.TRJ=@
MI2D3]U_TR)C'-#BO70(R+21P9^:8$0$'ZS4-LK2A5[2A"2HM"! &&<"E3-F0
M)+B91@J.B,;<:2MME#C;D+I/5Z:TH<4F[ZI@<$I"8/!&2>!615B O#"!^V!4
M*FWH]6QHDG?'Y(Q5DB,/,)<E^@UR@1@4O',26'B*@A8V],0C,&^+7K]W"::5
M1*^92AB"D$1IB,)SPHFAVDCJ@G5&*Q-]M%D)@YB!$L80M$HEC)<"K+TIXNQ8
M\@%'B3SA %C!*:0I-8@:+8AE5&H)\XP]3F[IS4;/[A1/"CZR(('N1LNI5)82
M2RUFD@3+DA:E";RV"4SPWNPZRF 3RLH6X#LF@@P3&@E.B5-6,R%$7K-O0F6E
M"=RW"B2L&#C@TFB>A-<J!<-4<BI0#G2]-(%7-H%)VLH%QHX"8Y51YLW%))!6
MBB!N!:%)RR1I(2(F9:F)5&HBE<[Y:#9BY-A;+KT/'&MA&$Z89ZQCL/@_RYY8
MZ9S/A7+[4US7&\T8T01A#2L/%]PAYPA#C&L;E134*;GV2=,RO/62%@3606*D
MWI"8> C"4'A81ZQD%B=/<6E!KVA!$U294.^5\#FHA1WBB4FDHQ0(6%U@&(80
M>UY:T$M;$#=16J^<S#JDS ;'A)&6B.B)$HD\Q[&3TH+FM*!)IIV(Q(8S@HBC
M8$$B"F3!=E""=<DG+ZP1:0X+>D/)NH\70GK+-JUY5F\4*FHIN#%4:Q&<YT9$
MHY*5=K9-OV_-B9>R:C_%+#5-,.A<(:I<1-Q(@BR@,/(!^V"BH52QQ\JVO/4(
MTIP&P91PVMJ@#>;<D. T=]IS3R)E^9!#:1"O:A"7DP$EPR4%9NBCRUJ:.2V7
M4HZBP3+ZO-!)71K$TS0Q?8I4).5$X!RS"(N"Q((!KR!<&Q=+@WA-@Y@ZI953
MTT.P*$J#P2"B1M9XA8+4.BA#\ZGQUU(FZD_]QGFW5T^7MXH5K4K(\GF2!>:,
M /?E8:;_^2QMFA2^F-VDW>-;DY8K%[9;R7T7*@ WO]G629:Z^6);-MC*41LZ
MN94AH-+K%'AP60%T:'8K%CBZ:[="MW)1[QU7; 60PM9;,+,J<//32OS/N6U6
M>NU*[W@RI0-NG]\,UY #;_<QIQZ[&Y6[VGK>A2Z!W[*MH^(^]NRLT_X)L-:+
MS<O* RM%&NN$UY:)8#FE7CNL##%.46ZX4Z(L=7>#G ?_/L;^].^6_6'.MT__
MAM\-]?P[U<;!\7YCA^W3/;Z]FQ79/+R&._SX_;A*]R[_??7U8GOWA%1WO]+J
ME:>UJ^JAT-X9Y@R"-0J\7^,8,C8F%)A@R4?*-7-%Z;H90)@GU /C(AP0EGAL
M)7A.Q*J<?&J$H5QASBA.Y2@O?I2W-S\?^D"2 /!!0E&%.'4"&<P"8I1S$CG8
M7?)YE-F,9.R*O55NB^+*A]DR7)7_\U^:$O+K ^<'^ ],61N#%(PG!<XUL"DJ
M")9)9V'4,K'R&>;'[LDA#M:2H"-*)FOL2T:1QMXCS)(16+L0N1C?;7X*"C";
M8(2)U<I9'E@TAK@L("VC@#>C*T=YX:/,JCFS3*:\H$I$ 6N!\6J,M,<<!6P,
ME?D06HYTSDXG_R5G@Q1,85K]K* ?8VI>&W,J:$XP8OE>&'%)B6=0XG%>.LPT
M!BI[!I031KI;3+\SN'\[%+05?A_>LKT["&PERTM<WQB0R@%3/>]U>S!E89;U
M^>U,0CS/-*_4N_"[F6'# X4;WC[&L@L"/KCI.4S93O,R\_)VH87170?&7R@Q
MPJM\_T(0 UY#4R^.Z_YX_K;D)X6./8EAUE/-Q=5GIHX!("N'J?$<)\XM 9 P
M0?CHN)!YH2Y+Z3T39-=V]PZ-<S[R(! V6.830!P9$RFBT2:2MQB5X9FX3=>2
M'%C/S>(\<W!5C,(GEC0!MB6CL88$HJ.,R?+(B2X']WD&EU2O]@\E6)-AF"(O
MLDZ0"%DGR#,4M6;"*5B:/;"NJ1S7P<@N@I;/KLV,86H)S:10DL-T<%X*A\$)
M3QZ:1$V9*_IL!G]T2 (#LPX)@?5QX&@B(BML0M0&YPF5!*>0#7XZ]7D^@V=@
MPPH[X;3DG#)F3?#$9@T"K+Q@Y> ^V^ V]@_!W(%^,QC-(+(TBI19,<@BP1G@
M<'!86+KV:2JC=W#D:H)43Z;]O@C)AM_,TZG>.K>%HU<,J4U:&\)5Q +G>()Q
M3 E-M)(.1R=9W_V#:V+XG&=1/GFD! \)_$ .D]T2ZKDPDCMP1&"]6S4R_TQL
M7FS0)S2;;NB[FGV?#_ _$R/]*E[![.EV__3Y^SK#>SR>GKFT:T:8TJ%R7._V
MVIW<-R,)X95F_"<VNT.Z_J5]"@]]69#MLQ@[,(_S&SDP/MU!E7'SO(M1@[N=
M&(:5.%@N23!.>Q*5LE1R'5R82;I&H/:OV,I#_@\T^'/+-B^[]>X6M,OWMENU
MV-MJ02OC_[:[W=V\*[4+/_M;L^U/WAW^;F%H@Z@V]G+[<6UWY^>A%503<&*R
M% 5#/!B" *4",CAIS $4C8.NCEUOSZ"S>YWSV6<:!L!*Z#2R3N/H*YU\R"Y@
M:C>;[8MB%ZBH2O*?<W TZRG[Q=&";SF8YEUH+;SKLP)Y/8?-LE>;Y1I=/CCA
MVN!U%A;0:>=TL.Q&=F]F('S4GX+#N]6+J3@T-_#>VYWLA?YCF^>Q.\]VT\R;
MY^A3T>:IQF8G_"QV,D?)/CA<T^V>G^:'MA6"_SM'$/-F61%1*-I77 3.-71(
M&][HS'K^_OY9-ML<*NAEA788$7M4A!8+$JU^!6#)6V'P_\*-'A#R_D-WL^^=
MGRXKNL-SW5ZR@N+U? TX[Q?M\V;( 0J8+/T-.P<-;9\5 #_:KZV8VYFMO/*A
M"7;^RSK\8H(' >Y7:\-7B>@'$VYW$8AY\*_VI3K!,NH]VYPWP">G+*0LD;.L
M56=6JK%EB9P[:VML#D%O' (J0\PIR^2497*>NPO+,CEEF9Q%E\FI [>S+=_G
M59/3:6$5!'!E%;KF7\_W_*//W<D_N50/?FNVP7DW3!YEE#@X&:S5)'$5M2%>
M!$,C]GE'2]Z25H;86,SS8^O\-+1[@\_G=,43P7_&3H:3X5H,COG@W\6D_C//
MZ0F/_3I?@:VHMSY(ZH5V'=$:>-W5QA9\8P^\[]_KVS_^;M0:7Z^JX)GO-[XW
M#AHGK/9E,JGWZ]7VYCY<MW-9;>Q3\-I)]<>6@#90:/M5M?&]7OM6.]V&]N?2
M"]M?K@OU&I8D)3SF0KT)\9SHI!W!R&I'>7)!:F?7/E&QKLETEM-$\&O1!I4_
M?:!A+?)89@F,)3!. "-E42J3*+519TT1XRA1(6',/ =TM"4PKC8P5G<_7]=@
M9EH3*X- ,60)Q.0HLE11I#E71ADM->& C.N"3A>D*8&Q!,9W!8Q1$!988I9S
MS[EP6C/'\T$NR8F@Z984]1(85P<8MZZ!T>/@>?("66XDXD0K9#2+R,AHC8)1
MQX1E8#1Z91CC@V,"J?C/2L4$IBI C*4ZWAIDH@_KA9F0OM+0MIS.\' T/_<'
M<R@^D=.&2JQ["M951[UC[)*1!%N$A0/OF/N ; )*J(7!,!="%"Q796+K@D\+
M83\0ZV9#RK/RO(F?O#5 _.XQ8#G]OA(#G@T#1AU!ZR4)0A(DL5&(FV# $<S*
MHL$*&:0AC.:*A<!W=(D!;Q<#EM/%*3'@&3'@QN?!QB;KN4+"2B "GE)D'"Z$
MSX)/-E"1CWK2=4*7B0>\AZW.^;2*'P1G,WKA[<'9<KHUP]'\?#V8-UG))9X]
M!<]VQG?]!(V!1<2PE8B[&) SA",KN',P 7 2>==/KA,]?:KY<3&<)8I?ER"P
MW'Y-"0+/!P*CCHVDEAN7*(I! )5AP2)M-$/"<>N=LREAF4D-G5%ML@2!-P,"
MR^G8E"#PG"!PX]D(XA63WB*E62XFD!1R7#&$ ^,D6BJI3QD$))[6<GX]$'B(
M@.#,TQ3])KO._WPJSV2\N6,.*]78%3B3 9-S&0]DY(S$\D!&>2#C>;NP/)!1
M'L@H#V24Z76OZ:)QR1Q1BAB,/7<B&484P]$0%JG&_);*.&5ZW=,<LK/3W![X
M'7;PHW:\3_=P=;-YLK][Q*N;W\'-VOM9I;73ZN9Q8WO2(3N%>W[[&YXI-/?I
M[XW<UNT?WX^W-X\NP!&#O[]>[=/]B^UO55ZDU]5'5-8;1X>YBB7F5""OK$'<
M4HZ,5PI);"-55"J2W-HG)M<YF]867=(<NS+YN$3'9XIB*S 6[S4)5.;R!#8E
M884FQFLM4C^ 5:+CZJ)C[<LX.E)A)2R("448+<0Y2T@SX9'P*DHC.-?)Y)"5
MXHO:O"K!L03'97KP!X"CT5)$,)>LFLF5C8;Q"'_$J A3Q-Y2;ZH$QY4!QPGJ
M2+2C(1&%G)("<:<=RN4!D.7:Y'*:EH2P]LFL"[4RQ];>4)'()Q_">-M;D<OI
MY[Z[',N70J_JE.,+E(VK1!G26(B\&\F0]22AI#T'W]=C'?W:)Z+6N7I@HN7S
ML;0'9!B\;>M=3C^LM-YGL]Y)QXP'J;TC'&DJ%>*:462Q!0(2,6?14HMID5#$
M9E3$*8VW]!-*XWU)XYU8>H6+F-@DD,(1C%<2C2SA#!E./,YG'16GQ1$']<!C
M3N5)AO(DP_MS&MY?_N)+0=?.E-<01(@B8I7#P!AQ*P(R@@;DI( 5#6N8'@!=
MC*VSA46$ERCH6R+!<CL@)1(\'Q),>B#2T!@Y,PA'X"\\Z(0,4QII;1P!9FM=
M= 6)T=.5>4L@>#- L)S.3 D$SP@$DQDT!CB!<Q+EVGR(*^*1CMXA8JF5G&OG
MB%_[I-85X4L$!#..-4P6K)HN,?2 (PO+4VAE=I$BJG"@PC@>H^")!!>9C()Y
MX'$,G%%7%&CIQF&]D:*T1M-VN[DZ2\BE2OXW5R*JL&$=E63KG7X-E<IQ/79L
MQQ_WZQ+E*[OGK@'VF.M_C-0R*LJ)QAQN: +"Y"9V\CF.?,XCP?QH=W+QT:+&
MJ"]J@(R406G"U2D5MQS_[7Z!D^ZMY5:AX>F\=]X9UFF=HU#20@;]G@,P@P%C
M1>VSJ7I9UZ=5\FB.7#5H![ZYQ+INNWG>N_V2J<3E5YJ41DX4BQOY9VYN,4>)
MS:XECQQ'Q2.VUANA*=&$4)BJ@1\2JM:&5QUW;J(@1Q$Y6 E.D$WPB!]M\\)>
M=M?^9WPL8=@&33*YS;?UV,@(XPTA%E_*>:K'IK*ZBQ[[ JMANUOY!H!X5H'E
MZ]X*-Z_>XESJIZCW^*7=*K:J;0ZY_%YOV9:O@\W_U8,W<KVB[M(_RN^#VN+]
M$I;] FU3-4N&=8LRKL$KO0Q/5=SQ8ZZ(5/=SF.6'K8SF[7.X:RC. >UM_+51
M"1F6,QK'GS[">IMK71UU[.E-0>B*/85UNM?]94[HG%&9[/8^2.G9@*@/V, [
MVYT"^S_V"V 7%0C_KUV:ME2..YEL_]<<B(AAX2Z64!B\+YFH%^9EGW3V\K8%
M[(&#3%Z(%DU6I9QMTD1LW%U6_/%%$,^[Z,C:LX]_]=K^Y+C=A&'L?OW/.7">
M#(F;]:YOMKO 09:E]&&UX8>>Q_%^ ^[5V"=POY_5'U]Q]73GYW[#LRH]:-1V
MOY]6O^USN*^H7DZ6/OR]7MW]>EEK[%V"Q_!S?W?G\F#S]WKMRE\=G%9)[=O^
MQ4$#?O?JY"J7/LSE9C%,9:)=0H$D@[@7$6EF$R)&.Z,25\:GR=JL1/F4F-6"
MV\")$=8*&!!/#2<,BQ@FJR-^Z=>#JQ1C<7M1T4GJ/SK-9_+G>]MQCY$MC7NP
M.U)'M Y$_QSPOU/LB,#*G4]/%97WSEO-^FD]K]_@JN=%#^"EU:Z<V2'Q!G?Z
M=%B$;U G<3#SAT4'Q[Y1N 6 3?5>L_]+'5A-BWJ$]5S#$5:?(?<_M9>Y^A_@
M(JQ!\-W4:9]6>M #^:K\[_5K-V/T?K>&,/X!$YR(820P;4&]$,%(3KC6*7C#
MP:<53FHNU&Q9AJW:[].5IZ%W+MJ=T(VML2C&E^+9BSE8*_IO._V=V=&?L5/D
M9UX'(?#[@X++[<^'CC,K!073YUGTS3&/K,<1869HD"P"%,#"UF[%J0A")8]G
M=N:&1*37?]&??)73&,%PCR8KYFY4/C>;,V9DQ[9.8/X4=2;!Q[RH]XYA9AY9
M&-%BNMW<X;K&)EQ:#[DL9:YZ"0YR['4WIO#C.1<9?QS#>3-NIV)Z_7;Y);OI
M[WAIN:IN'HG:U0ZN-CZS[4TO#B/7G 6O$,.)(BX$0X8XAJ@#Q(Z",Y_$ ZOJ
M+A5\WY31K1?%;\]/H<67><J/S_ "S</ZH*IL[QA:VZ\AVXI]D"SF>_N\EVO*
MY@A;I7V6W^\6"'O1/]G>K7SHQCBHXRI_^?B0:,G,7ELR90^F-IBBB]>?T!L4
MBV<0RY"/O.O;:JQ>A++'XR5[GU; 8/DD!*9*L)8==E^'34BDE!UV;X?IU]"F
MN'[F8K5ZC<W5@5#,5NN?V.WE\.>P&Q;:&+DAYFC-C,V&'*E!K+AZLNML-_9#
M8Q_J$X&^Q^R+WWJ8Z9$[YL\SFY^Z8]ZG7A,.I[>24I^=2ZZX=<Q2$71R'FL)
M9D'\3-I_N^?Y\2IVVL%VCV<&H+8*UK=YWH$N_;/8]"I<SBX\>?%1=^6=S\$.
M^''MZF]H4^WTH.%Y_BUH$X/[P!5YMWR+U7[\T=C?/2'[EY,[X%_AL[U\[]/:
MU3'<8X=7&P&<#G O?OQ^#.TB^Z>UX^W=OQO%49J_KN5]I7-!&/ JF. $<<MT
MSN(E2.ID>8B&*)'6/A7.(OWUN4\!/G)C_-IP7BM#YATC 2F4P0-7%OM\F-Y9
M(D/B,1+A@K,B(P$Q R28SJ.90H*9B30E'#PO'%R.P('@/#&8X,(QQ#4@@54N
M(.)$H(1P1G2N8L3-NF9DG8A%9<24D/!V($$%%;%DG$JF<A#:8D?A'6J2813S
M6$""'D*"+LG!<J%![88<6)62%\0C+R5'G#F)M H:.>,4DYHXA\5JD8,7JM[X
M^D[:]Q@NVNU0^>S_<U[ONTBKZ*8]R4][4JVI%0)<$W1@P5AIM $.1JV*PN5C
M>"992R4IO;$E!MR=46_,2DZ-,!J!>TT1D&K 6DT88D%P<,N<\-XN#'"?5#WJ
M<03KU2O(K9!5,V,\"6"M(L#0<ZZ9L0$;[Y(//"I3>E8K8-HWGI5@T4NB)$I&
M!<2M,LB$Y/+I:1AH!WY58&N?Q#K6<EWH)TMUEL:]U,:=SR$3D:QG(?& -8R^
MT8&F2&C,Q4)+'VFI[7K$1Y( R89%C;SF'L'R'9 A"EPF;#41Q%&AU#(NV>]F
MN^K/XAQ-K)PUK8^KNEWU-$?H20<Y5PA5E34L\)2,Y)CCQ(PD+E*IE?;@%5E9
M.D)+C*I[HXY0(DP0; T23&='"%#5*1,1#H3J2(TTPB\Z\K2,D>:G ?*JV[-D
M6D@A8E#2<$J5(\YR3[G"ELK$5.D"+;M1W[A VYO[K'9T*'T4^; /$LI9Q"/\
MP_'@$?:*<(H]Q4&L?8)A7\=D6G7V41E*KRZ%L$(6)[BVVN@$ Z!X9/"* )GE
M/%"CK1&R]$N6V-A&]FX:55:]JAY:;Z)@R2'""HT309%6U"/!K1*2Y=UZLHS+
MZ+O9IOFM?0Y_@ 799J6=4LRFL(K^R3_E/LW]X!IDE$(:7YS*"EPZZK1V7BO#
MC9(4E^[)$H/KB'NR6[VL[58/8] P?CX@CL$]X5I99**CR%K@H@E31KU>QLA/
M&<]=O&D[II.R6FO,";<V:"4L=DQ2[R)-CC_44RE-^V5-^W+<M U/(D4A<]X;
M0=QKCS23!$D@.(DD8VE6B2Q-^SV8MB*8>\&YX\1PZ;55*5(JF))@SY(^>*NF
M#$*\O'W7)I9NRCFC5(%5$VQ@_0X2&4<2(B0FSFU@WH:LL+$NE5HG3U>"7:)]
MFP4DM0X.Q#)X@M ^SX=?B_R\=YSRRI1FP<.BP!3P^B0-YY%88^&EB#&6&P_+
M# _[HQL/-/ 4 =:13P0#J><)V605$C8HE1(7*K)G2GE]DEDMRX9%B2)/V.ZP
M5ADAI =^R;'DUHEHA="YMA%)9<;72D#)3<87EE8I+W)H(#L1P""1<T*#)Q$$
M43@&6YRE$6)=*;:NQ(*+[)5P\L[A1(O(@I(NP43C1#BC1,38Q>2#D=BDTG%9
M?C@9232+1FGE-4'2<8HXL009(Q+B@A*?DUY"6JC/L@1H,D/C^B%BQH,FH+SU
M\Y'HF?H]_;?JK1!;O8\H?VG1MBTV)O4<9XIGWK+S0C?TG$(&SZJ!,;O)8_W+
M-@H,[UO_M=CLA-9L?P[V!6>SU&QO3+POH\?MPG?E^>.EUR[+W]O!U:NCJ]I5
M54#[^0).%$^(@/7:E8$"29;QM4='6=^N%RN 7MUNY:S3!MSJ:__^ZP%E()2A
M,A 6@PF,2T-U8DSG;!0KM32*W#./YJH'<<\T^COK4$[/HM<NZ_"ZLV@'PVM^
MJ#QA 98CA+D"M]P9C(P6%DFCN<GC$K2"6;2NL5D'#VIJ#JT7ZH8P)S+(V);/
M:I[=WE+/DC_M9:$M/M!%W!HT_$MN=SDYAA"S^YD?!NY=S%DNAFL#S @GY @E
MJ."T,B8BL%O[!"X6I5,3HZ_T.H$=%[$3*ZG>Z?8JMMEL^T+W?2"?>5M=AO[B
M-4..,%\T)9G4UWS-'UW+;SYP*CYQX2L!Z[D ZZ*ZN7=Y*%/(E84"4H%:Q&U0
MR,E$<@Z69<EP+R1>^T2Y7F=X>E96+FQW?.KUQ6%]7PQZH_+G>2?#06\X*V=,
ML#%JU?+GG2P^W.L VQM,KJ5%P$)Q> !_VVGWILDE]HW-L]U]<BBMP[E6%8HN
M<,0Y-4"O/'2^Y%1BK11.N12K6*=TVB-<SZ/?5ZE>-N@IY\"<<\"+0R*9((X'
MI'4^-:X#1BY(@)Y(0S)YD%S(ZQ],B8<B3;%,/61N!$R]<MA'$CU721@F0C[8
M*!0A6#M7SHV7FQL-<+^(]<";(T4R%SWE,!;(4B!(@H/1$F\\90GP@:P+3:8G
MQ]V<)X<APK!^UC!L,5+,JIOEQ.M'K1OR!&0GU[7+7P.G[JS=R@1WHP)3)^LY
MMP>BS+SOV850!$1@$M9;_3D!?]U;->B=AX.6)QY$-J1\A8!0*9NPO(@$K]F3
MA1 FPD&%CV4G2N@]9,62FDLKC D^<FYY<HP3:9)45K!@J7QR =#9<^1Z=OP.
M+2\\J7+ANIXF1_10&FVQM!+9Q"5,$T^1M@I<J2*EQG(;.9 :(=<)-M-SI$#-
MFW7'WJA@53[D-W("!\6_SE#)*CXAO_Y25!\ G+7@TG?/'3CI==O)JQZ\/[SL
M_[6;196!HJ;=>N5___=+Y4,6_.\O<<W+]8G?&=Y[<L6CJESQ'K_B+<^2AS<H
M?84ESRFODJ/8166Y2\1RD8B47# I^$"->6%+WF_G7>B$;G?$9/JEP;:R0GL$
M M['NNU.$;%TS3@L&-1?%?N?EDMB/X#):YN>@Q./ ^7&(Y-H0=(QRB%ME)R'
M18@"H1'A]D.QT_LC_U^GWNW%5N6WV&SF2"/@G^_$4)2_JA<A(D ;P#5;.9L4
MQZA\&$#64#;CS^$GU\ (%X*)UHLH.OSL7X-@)_]@?_E ?QD6*H*WP0H*/^&S
M[]T6&#WOQE&@/3MWS;K/M76+W>&BW*WK9!\TY&J][;/<D'[(=ORA\S/E+]]J
M./56%]S99KY^\LBKS0>Q!)A,IHO":+ CK%@T6*0$XS)[_7]D\:R_H9T #=^+
MIQL:QM=<K6GKIH$E8;RVCJNMJT,7?0B:X)PX!4P@>G@5<$1$R&  ]Q3XLFN?
M>L>=.*.Z5E$)JS(R^MT\9Z/UQWG>P92M_&%;Y[G:T$T5U \.WCUOP;K,BK=(
M/UK_P?]R4S-U\!'M3\;K7:50#Y56.T_%?]I-\'+M8$I?'^X<5"+J5DYMB(4=
MM,][E:/8*JI(Y_P)F/[],GT%(R@6/D#<H_X/]=HY*#-5+SK/:& HL5]XLW)F
MH1EI4/+UNFWPU>YY48QZC#_G^,_96:?]$V9V#TC+@\CS$Y>>!^U"#%<>,"=7
M;]E^P&?DL8M $/0R(-W,%>ES*PR7I))J#_;/JIM5?"BI<CY)@V)4#'%O\VDG
MIE$A1:FT"MSJM4^P^&!\R_[9](0<F5W0T_Z\3\?S"/9YT5U%Y1XE^S&)Q>&\
M$^SE@SRQ'P6Q@XF22[H?15@!?>Q_Y=W/DI.K0^E,I(:!0Z8H1F#A EPSK9!G
M6L'RJ:TG;NT3P9.U2!$,0P70$/ZL7 QZN&+[79SYAQ^M?CA>Y?"Z1N$X9,&K
MFNT&^Y_2-9KW5/[K>T;B@8Z17H!C5![=6R9,V;K8WMQ_^M&["3!89!*8"<I[
M)K2707+ ,Q.S$ Z3'!HM[;WJ-V5.Q3.M0%ND>N7QH=?9%1 &60.+#\^;G<Y3
M< D<UR%*)W7D,'5@[@@RS50 3CI9;:7B9FBN=!>4(/:2,ZA,$)MKXAR)0\45
M4XPQA&G><L!*Y_JY"D6-C7..!6-@XJAUH::C*Q,<8[+0^NI4V>W$?E[;JYY)
MNR5,,@:*W^/9><<?Y\WEZ87T/:^?&+RU0^XCP5A3E/>K$">!(.,-@"!7BFAF
M#,;QE8\OEX/\U$$VVEK'/3CCP8I<\)N"UQ4XLEHR($F8>D->^3A8.<A/'61O
ML?7&,$2M@D'.-FU@;!"6X&5[^*_$:NU3JSU#!?.^-P;>=.>Z_[N5,+?KE4.@
M&<MS #+/A!DK8)Y8]=:Y[?_Z0_SN6U?$3__7=?[GT[1#7TP-8J,AC$>.H^(1
M6^@WH2E,4D*C8($?$B;7[@T#%$OR2'O(G0U:W!(]Z>-/%10NEF@B-^Z,BFEC
M:&(P2TBP7))@G/8D*F6I!/KKPDR0'C?*S7K7-]O=\T[<3MFQCJUN,83?^[OE
M!7,LC/.W;+)#?KD+3?BM">;\VG9ZM3^TTV:M\177KHXHV!S>!SO=O_KC=/_T
M[_K!YCX#+_-R_ZI9WX??V?]KTD[WX)J=_!VX]_?C_=WOC>KI0?W@QQ\GM8;G
MM<8?C>T??S0.-K\?_QMLM7KU]= E@E4P$1'+%#@;6B$=;4+>,D)YID14][$6
M3"*&SQD?-</$*I\T98Z;:!S3&H;*R@SL7LBU2@3T.X.QZ77.8;TN>AWU$^J&
M_3[%-<=L8\(*^T-S_\^.-Y.9P&1T ><U(8)'I)* -8%AKHV*R:W=8]ROP&]G
M&\\'^SRAKKE^?CS61?D&XSG8]<-V.K88QXEQ>T8+_\L?QW#>!/O>!J3OW!CS
MJ+E_SNDI]=[E;MX*>;_6#:OP[I&H-O;(]F[U<GO7\\.0.!622F0PBUF=FB%+
M"4%,&1P=CE)9-VE#U@JMG#/>Q\3!.S) F"W7CGDP0JW3I*FOD,L(?*_9;%]D
MWE#O5FRE>WYZFK=*AYN.Q[9U%(M-^HO!7'\0S2CV0F=GQ7Q\0&1_9H\5A\:O
M#[?W3ZGGU"Q[UHT?AR]^#?7N6=->?JRWBN<O+IH,J -3^/6B'GK'681A _>%
M& 8"7(/[#S[>*#Z:.%C?_XRS#8-O_QAOD%L_N^NV5&P(*1]UV[M_DC_RKO<V
M5L]UVWM$SAY0-N$.16@?\_[PRPA\3&Z93"TCQ>3X,;D]%G_&CJ]WA_MD'[[\
MZY<Y)/#?:O?T\V6*,TN32^MK5#1Z%;UPVRR"T[:(3 ]35P9XNK!2NW/)XRQ=
MW_SK^9Y_166!O U_#DC@Y!$^H6A(,6%.+0]6.8^IXD%X;HF@2L].>J-3=',V
MO\S&>50D#?YV.>5/?@;CO4[0Z0(GZF]B9+JZ"X1B^RS?HEMK%WF*,4PD97S+
M=K\)WNITVORKQY$>R6#[FD)MO/VMUMS>W;LZV#VNUZZJN/;MC^;VYO%I[<?>
MS_VK@^/M;_#]W7UZ4)_0%&KL\'VZ!VV"Z[]ML>H5?.]TCV]_VR<'N[\W:J=?
M>6:\M<;!Z;^OOHZJ'6+N#8>!1Z*H#P%>!M(X4!2(9H)*\&RM6?N$-^B3ZU$^
MU.163X#LD3"Z0G R6X#G44CRP-2*YX>9/K<HL>2A6'(C=QBM=%I9CK VX#L;
M;7*83",M#7:&<NJ87?M$]#J6<EW*Z:/(2XHH"ZI%T[=]MN0<ZNO0X;B-9+]C
M=?C;V91@BC+&75*!<>6=U38GJRH;5<0ZS [<O0JM^KL NZU6?R.NY%:+Q<.M
M46YEA:?""8-R!F+F5APYSC#"EA,:DR'<Z8);/5GWM2P@\<(0\>&!1?6>!@_+
MPI7&L:.$AH="PPU5$CHJSFA$6)* ..$>N2@\ F\+BV2)-E3D5/IUK,PZ(],Y
ML%-1P%6H/+$*,:3Q^-KL;8N%*N@^4:-ZZ3KPL4&X)_?.<J\8CR"5S$?I*?'&
M),I]H#:*?#*5)4_ K3(A.]:ORB7+$-TSK14[HS32:.V]=0JI$%@A'XB<#< E
M&55:.2U34 6-%"\A^#V_0:Y> .]9 'J%H&AV:O"C4&A9*&L9WGLB#MUP5IL"
M2Y)K1"4CP%DEX!!-.279>944=MR+?(;":+7.^+0DSTJ"T4,*$+#)4Z6<;BCQ
MF)37U[A]F4A3)M*\G4R1,I&F3*1Y="(-,64B39E(,Z>7'E20FEB/F1><":(#
M"5$Q2P)S(LB"'T\?IBJ]]&=DQZ*:&?#N]U.X]B>PW,R$+[<W#TZKQ??WZ,'N
M5[CV9 8[/KD"!BQJW_;S[_']1F;"6[QVNG^14\=KNP?-ZJ[GV[N9'=^4#:WM
M?F;5BT,KE- L*G#-O02&[++4<DB(Y%/KSAOI(BV3:<IDFCN\[<>A2>EMOQ$\
MN1S#$\6RZATWB&FJ\TEOA8SB%'DEK:!,.^-Y4=J!"[4N9Y1W6%)466A"#=V@
M8LGI5)E3\QAB%;WFB0OFG(R<!669MREG& 9!C0GW"4^4.35O!!;]),URU"K%
MO$:6R5SMA N4#[<B22T!_@6P:/5B:%:95[/<>35/A(AEH4UO,Z_FY>!AG#59
MS;@UTB.=3$+<,)N+ >::D0YS8BQUVN=]"F;PNI'3-6^6,;5F&%V'=L:[$>6E
MOOG^0H2SSRF_1C7MMQU$?%K7+/?Z5A[4*U>VN5>VDTGB&YFA3'*.I,AZ;]@2
M9 2!/[W)Q3>]];F4V^+CBT^RR-4+/2X>FU<(B,HC?B4*3:+0.+_V+ 8&3!I9
M@<']YI$B:Y)!P3&8'$+&Z,CS'?-[%2R:D04TMPSL,Z?M3$G:+96$T.]9FQL@
MH>L[];-^39,T6JYZH)"U7NG&.*S]^:(B>/>B3O<VV'F_LEE9%&\OBU<*R11%
MFF*-N#06:>P,4IY:X3%W7$Z)XCD35& 1,RP2UY&;_!=7P6K'F95A4BGK\QV'
M,,:K QS;4&F?][H]VRH*\EW+4=GN0,.J^[%RMY[>PS/C9BKPW?N,2Y=11\R&
M5G1%4M]6JK'/EE1(]'S9?P]MK)HOL7)!&WBO$[Z8+T.N\%XK =S7.=($'Q_&
M?UN=]O7G6;USN>R]MGSIF O*5BT[])GS6Q^2&7&?G9[60VC&5W+_J_:R0EA1
MG)B07RM4%<%L^:@Y-F\ YMWW+R7/T;\OGYK\JCW[FJG)K_K@C]@Z4 IKFX27
ME K..3/1$ZVD2H'R[*.5!XA?_N!>=7/K:GNS>IFOJ37V<'777VSO0IN__7VR
M_>/@%-I^>=#P8OO+U,&]BVJCRJM76]">'5K;W?E9N_HLJC]^/SGXL2/@RN;V
M[A^GM:L3GL4F:O7K@WN<IRBHTXA&BQ'WA"-G\^D]E@3X4BP9Q9_C /$B$PBO
M3:],2WZ-#8#'(4FY ?!&L&1X"+BQ0[=W#KF.+ODDD;;$(4X31H8+BPBQR>1B
M=TP^N#91.<'*"78]P62RDBKC45*P:O$8&=()%JSD8\#1"Y&TN^ND^?(N8W,D
M?9E'YL%/;2HM'76_*YK_'-&-^ZY[O+3 6W>=%M]!;\ZW*L69WNMR51WUK:+P
MP;- $-'2@&\5+3(1<T1Q4B+%)",GB_&M%FZ3S^U\+? DPS,C]:I[9Z5$T[M&
MHW'R#).!4XPI"M(%0*0L%^<M1R01$ZVB'(!I@3)-KPA+=^5H394HG:-TZ< "
M6<[W.&MWZ_D+'SNY,F;]GWB39I'-<^2JP2/CFTNL@Z<[[]U^R=36V2ME9QDU
M4=AUY)_'G1MAFZ.(7"?:$V03-/:C;5[8R^[:_XRGS-1;PYN;_.NW/?M(JAK>
M$*)8$I[WV6?7B_S2:;?:W<HWF,QGE:V6W[@O&>C56YS3X[J57KOR!4 SFT^N
MV%KYO=ZR+5^WS<I?/7AC4#=TR1\EIP4."P1V)RH$5L9K$*\7-0*SZ,$R/%5Q
MQX_U'ABOG\/ /FRUX#G;YW#74#B_>QM_;0 R-IOPW.N5^--'0#M8@RM''7M:
M/&F_;K,]!8SM=7]Y9!*HO*L/4GHV2.E#-C"(=J> UX^P4,1._A8TQRY-6RK'
MG<R;_FN.JM)X[5-1)#4/WI?,N0KSL@])'9PY+K-R?.\HZWMOF=Z)1$L9M3::
M@&NB)8\*6RV5IDIR$WR,?(7*^KKE*>O+-I3. UA4MJ^T^^SU 1-A/ M<3>E6
M#'JZ_U8=9FNK]Q'\RE?!LUM&H_[<H_&@!HWWJ-X0:G)X*F=-^Z Q6IK,^=V1
MY&8;X&ER=E@+%H;^:IF7"G $>P4'Z$X^<:7/#7(6"I7%.BHJ'_*"FQ-2*/ZU
M>*/?3WTGK/(G7%5\2'[]9;UR<5SWQY4+VZW8L[-.^Q^XE[OL+TW'[2; :'>8
MQW_=Q%[QIVT!;#4K1[$5._#OTQA[.1L;OCQV\7%LA@K\ZA_GK5BANFBAVJCD
M9Y[=M(K-*=S0C)'?+))KU*_=RF]M<#.+T'*]$WVO#3\P^K#%Q\-GR_S)7A3?
M[]MO?N/LO../P6_M-[)X*PQOM0XW3G4?\ZN3>%F)IV?-]F6$;Q6K=>S\DQ/T
M<B?59_3+1J4?]!Y]4/CG _?&A &G/F^..<&Q,RZRJ!1GDEL!WISJ:T)AF8O0
MW^[>PT3TV<6_ $>L&UL+\^_[7OO@)$7W\S^VWLP+)E"\(M*X\N[\X\])'%W6
M-O>OJE?^JK99_5EM'!W":NP$#>!.82W!-T\<?'/'D%(D8>,\#@%\\U9[RBFO
MI/-.#IOTYVZW<E%O-BLN9MK8RI9><)MBXLVVGU\KQV ^X#^O#^?X*6 #W& X
M]4/EG[H=0LAU]BD8?;[GB,UG6Q\]9S&THK-._*<.1+=Y6:EWN^=S-&FCLHJP
MO-V:M.7\A'<BXQ!![0R<G@!E?3\H=R)<Z =(>%O/#H!TQNTJX,"#JUXL#[.P
MU+IZL]Z[S!!8S*U*+,)W<XSF*-")T2,Z>2W*8-]O?_\6%%>V3UMU=][MM^H#
M+#4A)NAN6&DB0/TO4ZO//?W\4% E%$!52.Z)3MQ%[WQB21%K5'(Z6-:/F0*H
MBA)4EQA4K_8/J4PZ:<!3!SY1/A5OD,5$HB04H]H&S;AZ.JC.L*77!M493;HW
MBK6DF%JUT&,5:D9QHT_KKKEOI06_UAZ Q@"5ZJT</ZW_$V>AZ03&W,=N[\7Q
M,89;D+^S6 3>YF.Y TP<@O,D @X89'<8#<IG%_,-1WW-]6%T")J=?[H8]B(T
M#A]E;Z!3]X4_4,S&Z;<*2 1R/.BB[W_M=:]Y<7Z@=F$-Q5>1*^8OM,7;[O'@
MK[Z=##LPW[![[AK D_-RD1>6XKAEB/TUYJ9;1\$O_W%:[_5B''9P,<[],-_
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M24&EE?,DL1KLA0[\[V(_=R HYG)(P@%3KQS;?V+?<RNDG@I?931P,AI=^_B
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MWCSVB7KF8+%C6K/2PUA]$-B9\C BX\8PQI'G&JB,<Q09K"+RE"@J,8&/$X
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M>^]#Z__<-_Z!W'3\,Z\2;V1'_JQ1;?Q]?-#8X?M7X;CZ;0=7&_MLOU$[KC;
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M8H'!QX4TZC)0]MK-=LHB7GA;RF+A;I^->Y_NH!"8:_'->6_:?"0.0"9/^W$
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MM<^&=W^E!.48"O RYMKL3/T\[D]JR7^+R/6C_8YL@L&^LNT?]GRP]8]9C :
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M.0NZKS<J9VD(YK1VN5KF$U*<-[;=WA\Y\5YWPWCU*P!<$ #Q-+?10I$@!4;
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M ?Z/JC2Y?N-WN4&CG#$)MX,&83%I0J3E@O.4C(Y*<>(BHU9J29<8AEN!QCI
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MX;GKM?C31P!:.-%KW_JV4SSIR$5OB\-W\/M]SSS&+$+O0LI;YB"EE2'1Z+0
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M&]'FIS'HZ?L4F8*LYA-B#K?P\WU\8E[VX^N9QW]>:;*W/W0S#FMGW7Z$H5S
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M@ZY7H/E\0+,QS=N3H<%X0I!P'$ 3.X*L%Q21(+733N$4X]:.%G4CZ+HJ?#Y
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MW&8D1RX$B[@V#BFN)8)-M0'V6SAJKO&T/WTINN?@DG\UL/*8L')/#;2!E=6
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M?F*!EQGD\R+@[('[%-U%, $BF-! ;3K[*U+";Y$0WD[1P=M>DZ.Q)/Y]FE9
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M\:W^,(3"%O%B>$C:OR)9FN&?*> 9'.M!^A-P\PS(I+QHN2+ VWW7PA2-3[<
M. U!U(*'K+<V%[4S:AWK>+'OML[*WM<B@EFH 6[17,9OK2< %\&I"N<G7.9
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M1,;3R@OO D689R#C60ZX%[A")J89.ZHH]7)M@^=MJN8#SQOH:Z#OAX&^S#$
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M[><C,O3O4>7VDYK]<2RC;K\7.QIT>/@WP>^/S>7O#H,CWN5&(2 1@[CV.3+
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M)B][OJ#X'=#7F#<B9J?&\E^!P71=>&E*EU^8KWHG4KBJKKMA>45=G][]:Z2
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MC+12U.//@=N+T_[[./C=.@FHH9^:?CZ>'V*#=6:\0Y:Z@'C.%#(:&X1#U 1
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M.9@0RR08M_*VCQWK=76X[WA>QEM/\&CO4_C(]9M>>]U]5?%M7&FHX^N<#Q]
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M.(YF.+#P_':Z8@!P#F_N#!/0GO:Z_B*)DM$UW^N.C9C]X5E<J_1W,6GQ#8^
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M4;TJ^L<3[?*XZ,?BG=4E4U2Z3'35B[?&KK(Y5JRGM6J]C8$Z45%+$3O^OT-
MC$ZEYJ:0'#0?DO/]EG4O2':?.6UCK)*];C%6T)0;-VZSZ^(_[R8#W1R\K:.7
M_HZ6D48T&T/@P?FAU%9E@5N4*>QC5X> -(MUCKA0% Y:YSF.<14XR]N8SB>\
M1@O1ZS#J-L2S'/%\HH?><JEPIB+)@*"FF4.P0Q(1Q20A5#FO9"0>T +;4BW(
MEJZD^\6@6ALN.RFV81*NO,JNI+_B1/9A'MN3:304,X$;?"@X<WFP#BF-%>*
M,$A1Z9#7G@9G:";SV"B+D'8FY\6NEP8I#3U\GQ[X(5=>!V\5$KG4(($3BHR5
M\*=GS@%G"AWTV@;#LLUX-H\?T;P.L)#@XAH4J03RZ/P9ED653@&B6;^RHNO*
M1IF,\M:6PVFD^9X*.'+47"<:5>$[BT7%24#XT5"7&EZ7WCJZHF5C=ER(/@M?
M/2@&BH-N42NS<:#^;)!BO=O)13()*:_TOLZ-H>65Z23="Z)?YR*YN%STE;2B
M/%SY@GJ+0+<]+^6.7"2MOHY_#?0W/Z-G5UH2+-=1]*ATXQS76YNP7T-[/&L
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M\KWIS,-Z!4&B1<P3,/PMI4@;(Y!6D>!(4O#$O7E+)%OC!-<"_'(%^ F<^5J
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M3K*LK_)'M]<8G,3&5;2]?B-V KS(L.:Z,>S!719=KQ6U>_"37H:W*N[X:VL
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M+>_.)(!^S_:YBQ.W ?;JRN;5CF@.Z8CG<,*5+6VU(I,,WKS5&72K>,/\,F7
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MNEZ^X"_P#QM_@BO8_Y__H[FFOXU>HBC<4;^-'MUO7/1CXP3FJY'/I?(31B\
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M,R?%E[R?SSG;11!UG#:_-I&3'M>J)/7>ESBH$M2][73 Z^E7A'KE+Z/5&*[
M*,W^+(9\3E)B>8#'(%BIZH[]YURE[^Z1ITAV[W^G"+16'DNJ/ [PSN61R GK
M25ND%<WTVLPAPV,^V)086\UQ,NH.Y3'4&&,JVT)*CF/WN&?/3\!EZ<7CPO@!
M5+B$WV^$$BH@J31,_B"T4HJY7<:HWJ2;_Y#)?8;>8[1PDUL/*(\Z8 @@D@7H
M%U\;PI,M2FN.+]JVU\XL6E];\1*DVUV5H\DV73[JF##.)HRQH0H9W:R $+#Q
MQI8=W-OVPC!B:$=TKOE2&%/WHN>'U*+EP\HA ()D$QI&$BL&H^'!CHOP]()6
M%&:C/UC+'*5K\$"8Y!R6&9;;V+-L^5Z7?_BE,E$WAC?=^GU[?W-C9*Q6MMY9
MM-G!RT,;OA',=0)K$""N((:"F8BY]"?S[$[-0_'0\O7B^,U*,M5R%TS;$NN-
MJ?%D75'0WI=G8J,W__$KKS5@[Z&"]!24_]FPZ"K_-,D7W(LIM].HC/,\B)&)
M72[PD'\:;G;<O5'%-6F"KV+-T<B1SUO[EI;N5W9^?^P953UW\I?.N^V6+RN5
M,H$CP/F0YK;RJ6X?3Z81$>?XH++<Y3.>G>]0841I).1G]T+9K&,88RP&Y?.A
M:*]ERP&41+WPAUS$-O;U1H[>4#,7@K4.SC1\%0UW]@1_>+]"@2%)2XE4Q<!#
M6>E6O+H][L7RM2MT&&WDFE?W>[RZM.;5K7EU:U[=FE>WYM5=;E[='\9_I^+%
MBABL;0(?#1/.M+$A$$^E],G2(+48Y5H\?C7R]''%1.#\]ZOJPU=\<'&]<YK'
MLG'9W-RXVMD\H$<>.^V"P8B0S/Z2)$9:"HNP$((Q'9G1<GJ]>:(!,T6HQ93[
MR)R@AE/KI#?Y*-!,GV+\ $J6QC8>'A> KK-%@H,=V\/?H?N[&6S_=1Z>KIO2
M.GLFEJQ0FO%U+L2#"J6_7T3-Y?WJI.<9+&'KC#^LJKL>[ L;K'FF*OR75K!_
MXUSESJK'ES\/-PX\7O$\O.OVSK/5&U_Q'.QWP4E[.405YIX+O[@ZA'OLG;EK
M-N>YQ[TJI'[F ?4@5WN0*\US,"W/LRM7=XJF= 4;]8/$<>J-'[0^]3U6[QX+
M4G5%X:E:5V*YI>3=,!LD=U6,O<=07/-,W#/3!=QOSN9F"UB&>O_[O=H\]8-"
M*I.DQ2$2GAC1RBD=(K="^B03_4$RRW31[G7L=8/MG]RN9R@@_(]>]RS'D//
M/K<&)^\N^B SL;?U+5>;9J[&XJ2[:""[-.4.#PV)EN7^YU\.JF<W3_]H[[[?
MQKN?<PBT?;:[__OIP?7QY>'[ W9P]L_)[L>I<O^S#ZW#_4_7AYM[5\W/G_C!
MZ9Z [XO=SP>B^7[G='?S]R^'IZ%U^'E+%.7^K5&YOPT\*<\TBE%8Q*WFR#AC
MD70$"ZV335:]>5OD%]#?%E3POXB2_1JK:JSZ#E8Y%HG"COODN#38D,!P$$R8
MZ!6+:DZL^@$U20U8CPU8.^]&@$4PY]3DWEA. V E%Y&#/Z#(A.<D'T0:^>8M
M56N&W>Z&5.-5C5=+B5>*NTPQ+#71G"5NHU:6Z:BCH-9*7]M6JP-58]O*6\8"
MF,O(DR+M.->L>!Q0M-ID=FGX*Z]MJQJKEN#5YL"JZ%14G"<J%.924V.4=))9
MECOC@N]0VU:K!5B[8]LJ:1<S+P'RV'K$,4G(""&1!W4DB.2!&;&$MM6"@MNK
M%L&#(>:YO\\A]L.CJBM&_[MPM%,L$2]AXVL?N S<^I@T#KAH!Y&<J-%NE=!N
M;S+T15DT+.F(;%02P>(:0#NCD5(N6,=M"L:_>6O6N!%+1 U<"_AB!5Q+I7,X
MVR:5.*76!9XD; ,L'-::Z5K 5TO )T)%PML8+34(K)?<V]A%I"7FB&HK&)=$
M4 H"KM>46";N[UK %RO@W&%GDHG&)\6%R#W4#?PKO/=P+VKKV,KJR/98>2?+
MI XV(D&M+FEK-8T>D2"U)E%+P]C"8BNU="^M=!,!NP KGH+UG' !<AZ]D#$R
MZ@VE\YY*U^K[F45\(AK!G _&4(^H$2J?]'!D"9<(&PG*.U+*E7GSEN@U*O@2
M2?CKRB?:S7RJCYK^^CV$NV\D>941CHM$N.<J8DVY2583IPP.7JE(E-2RME]6
M!-P^308?2" *])5!#.>SH2@Q<H93Q'0TC,-J,IE>\-E0+=V5=%N#I:!"" -:
MS0AJB!;>@&!3015A]SE-J>7XJ>5X(L:@L$]4L<Q$'7,040AD85,@R;CR#J19
M*/?FK6"LEN$7*\,B.*RM3@3^AV.!-0%A]EE;4Y:\_A'-6ZVAETBR)S0T=4IH
MS)$3S"(.ZXBT,00QH13C-G%O<:VA7[YT2Y:DS"P?7%DNDS4B14R3<0'KD.Q]
MXH>U'#^U'$^&$1)6V&B-9 2]S)D1R& *OUIPJS+YHTIRV33T(C,:B%GN",)3
MU>W=(U)Z9UWE"T>XP BF3&#B0"2PTE:*1+ETC- 07:QCJ*L$?@>3808%SB6S
MAB'EDD#<VNRHZ-RZG:GHE68XN,7F.-Q/AE;H^.25@D(41O"H2;))<L^<5;GK
MAF6&6AU4K$%AQ4!A(F;!(V:1>852D!Z@@%@$JZN123Q)Q:5R-+QYR]0:I8LZ
M6*E1X66@@F?8*.LI35AP)Z(+1&N/N>:1LD3FS9:J0QW/" @3R12!&NQB0(P8
M<)$D20A /O^J00V0**2VBTZFJ!'A92#"3_:XJ.V$)8.%R7(0'_,QI4*$.G >
MC*#(*$<0_)D:'SUVN=26RS5%%I5 ^;BH4(55AJ,8L:<6,O\,/$[U/5[9/5X!
M#=?'@I.]F\I.*PF@NA'_<U&TW"U;<12],;[&_B#>BW^S3HU<DK#>7;;Z=D&$
M^!>L=M;+6\5:-^/@I!NVBV6^V8&J5L/W4</'DS$\QU+"VD6D-+>(NV20==(@
MYI.*1+L@>*A3G7]"GI\3+G]YVI!<']X7?IK#YJ[%^S'$>R(:YQP1CBN'E,GG
MDS)IY)(R*'%%!,.41)NM[#5!\.T&Y4\CUR,!62VY7A$]_40QM5J0'T60QWH:
M4R&4"!X1'ACB.@;DP$]&AELM!=:!,5'KZ165YWGT] )"8K6>7@[QGHB&69U,
M\M(CC;U#'"<0;VP-PIQ9SSDL-B?/K*?K:%=]CR6ZQRN(=FU7S7R7)8-M]13K
MTP:TIG7F4#.6VG.XFK6:G$M-;EW^M;\]:'[,JG+C2/- P'$E2&%I$*R30-98
MB1AUT@;!#4F@)XFL+> 7*ZA/F3M6R_#"9'AO),.$:2LDU4A%&T"&94#&$85B
MP!$'*Q0XMT7IO= U-];+E>,GBTS5(KP@$3X8B;"7C"<C8&6XHHA++9#6,<(_
MTGL9"?:4U-&HER_#3YF?50ORP@3Y>$*0#7?!,<28)XA3SI'C+B*K8*T8C<:+
MD@9'8K)$<ORB.DC^P/F/W\YCI_\PY_]5E^'.$U5_!.^_7+ZM<O5JD)H/I+Y-
M.OW*6\MXL. F>+ VP$5 QH"U@9U2+(+Q(8)_\Y;=+B>Y?V2\+I%?7ME<@,-?
MR^9B97/LS#O'!2$)Q))JEP-RF1 W>*0,B\HS20P58$"(VY3^M7 NJW NHQ-?
M2^S/2>S8=X=52B)8A:A2"7QWKY"U-J*D-<BL#,XY65//K*CH/G$F22VEBY72
ML6,>J/,BF(04-QQQQ27XY$XBIPB3B@N%LY02??NDZUGTZNOJDC/RS5M%)*KQ
M2^6C_VNMT8F#YSZF?TFUHD_LPX\RXV8#6QEXK.!MI]OIGL>>'<",[L0Z##DG
MVEU->OC>@ANADD$N)8LX9KE1=."(6NDXHZ"I<!&&_/G<M[HR?(FE?6FS &KQ
M?P3QWYLP=BAW 1L4K1&(1\.0IIE7*C&)52185*<0_.>)]&H<>%$X\,0!B!H"
M%@H!!Q,Q?J6-PPXQHP+B&C-DP2A 00.B4V_!N%MXRYT: UX&!CQM%D(-!(\
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M-!O 6A0E7,!L?BD'F6>R9*%8G; :W16%[I*34*K171J K^)]3I(FF7B+U\P
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M")9[IF)^)^B-38U]S6[O3EH2WN\G(CXZWE?%O+<@0%2\=QOO5XD.)";MB1;
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M[*%&**E@^<$X<,X'D%'EEVF9WO;$B+K6TEW/9IEB1(7YPF'^^B;,'4V<.)1
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M7<W3P1"B9D"=,/ P^F5*TM%,=U#?#_2<4%J,1%C 348XJ#$N4"ZU6,!<C;#
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MEQ["=IM6H-IV:*M48Z'*3-!M?(NYS*;4)PY#E]MDB?6E6D>F9CH&H00;?-'
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M'O!QTUXM)+$0:KS-DKY^-+@4:+<CIBED+DA.4!7$JU 14$Z/CLX*FT/R#4'
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M>$C6WR[6EVD ^\/ZZ>MYWUY(;9CM6#AAOZ- ^9)V9QR"Z%FA=$?R^YKY7:8
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M75TL8B)1P"?]DO/@<E2ZJ'-+>[;^ED.-G40WGH)N+!@[%9!U?4=2VN'9:O5
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M2\[V122-:^I<@!3&>J//CMFBB<:]_#/"+ K937R54"M53DT?JY1>@1O"&K.
MVK/HP?0$H>"(22Z_@=G*_A*',6Y<4%NM8&Z(7 >^29S/8,+<FFXTA@9%Z#:"
M@:^4:$"!O/&),P*KU")@J'XF+O%-)_;,5A](595OJZ'/9C+?ZE^P[N=W0+@+
M(!?S(#?F:G!JG57'8F9S=HF&/5="VE:;!KA2FT+AD1_?OR+AU+.Y-4[(D._'
M8?>><PJ!?>X'4SH?C&%S,G"<_./%UQHF_X\1WJPW6.7,)XU<QVR*\4F:Z:CL
M)#;$O;W&5YG3+<&61?!^]9QH1E9RLL6W*$S,G!T[#: E%^8BN/>)1="CD##1
M\_=M6'3SMS6K#Z"63YE8OO@G\A:>.Z#9:\1CB]F]U]H>)B)JV#'WL'+,3 LF
MB+X14T[;N 4COE:,%XEKWDCFI,T/Y[Q[E8>W\74E\\1??;V[5O+.BLC;:L!M
M5&?]&,W8AE&#K]R ,3&[CWS8< 4D\S8GUZ;CQ";,H!WYS+2#&B>WS>C$%5@Y
M&^+>UNT?7L1(WX^2W]DH%&U<*=;%)SWE8SN,C<._RK[I_5&:$/!UZ.E==)'1
M-3X"J@)-<%4;C0<3#-L3'7,JTS>OZBYQM,U]B@%E 4Q'BV#^, P1?ES EFLF
MQE*5NG%$):'M%XQ/S1QX"7'CC<1DEIDU=@=U%SU?4E6Z/2^6Y-PHN=WI#5@-
MKNA(74;6UH6SPD<6^X9?V2^!F@.J#JNVVK Y"_':G4=A/K!&(:.",GGCTS>)
M^+MRO%=\:4=ZHE0HVW@3T%'GAIZ_N/ 7217%#1%1--X<88[UC;Q,\Z_\'LW0
M<X/(P5.^1^*_P$P*<J:.9/BJD#8.OV:.X.3G!S*/;]IO*OMP&>>VJNMDF_([
MF<UMJ,T+L>-Y;5//@74HP.C((88\J%W$4V?4]%ER1<12%D>K&^N4IVQZNW>!
M$)C\:"%-&J=T85A&U_0UA9+)-W!@7<4OH9)\CRK,.J+!H:W&IZ9&8H=L8&8_
M>4N$W(,QL"Q<N$AZ;K<Q1:@MMK4'6?QH@ X].]F:8%Z(Q#,@,YK4B/_5%M#$
M\S5RDX*;&C=EG-NZ@&HV+;X'2&P\HQC,YPZ%G:]7/#V7Q.6_H\RV=G3\H [F
M$,;[!I@Z*[%&A8NUE*ZM#5X]E'R$?1?1/\LLD#6N9Y*T\\DTOW1!Q.)_(].A
M(3,]1CY\P"]C0X3Y\+ *L5=(>-*Y(>[-^WKK)4=++B / !-H\E_$_NIA$ YZ
M[-\W+9N6Y+8:5IBD/'XZX8&\4/(JBQ*L)FBK7OF"%[ILEHHA4$K<+B!H7)<,
M1L/KDO=L55^PO3?]M#62:[Z;%]1\Y[%\27$@@$IJI96BC3>@^G VR9[X&#W_
M 5KIR<ORTM<XZA5R:^VFI>8%_)7$4>B!)W]&>![JW9IOF$0JSX![/8/8!+7/
M"="!4;GIK  ;JE2SP:2)Q_SRC?6,9-M85;H5L^ZI=)XDGK GTY\0T)*X<@",
M%^2%.-X\2QTHG(+KLF[:KUAR;L#3=VWD?6@IJY8>/\#2:+&LDE&:R &63!9N
M_S5=01,O7/I-8EU6GQZOR;:URAL@34KG0N3369"+FJ]VR6NP:/S5C&3&C\:W
MIC6E+N9*4L[4JDC<N.:,;Q(QE\V,NG@MG*V#R:MXBF':NFS:$)Y=$>.0AC>D
MWBK=*(DR#BW5@96V3]'>D1LU^A96/2G-FDS"HS9I"BI%ZJ8/ZP8'^P?[HYE+
MGZ- Z071TM*-:S=1&)/&K3(]+JU=P,%\]^8+#)P-IT//GWN\%E*;7T34.,1I
M_(_>5D9*UGC#\%G>4^V'?*LH&F].U1K M3NF2Y:<V*DS:.E:N\G$<W'NT_P/
M_/ ZN#<7C =88GQ'IG+KLPU5:ZO_G?L9O\)W$:Z=B@^#EY5O? Y^I2^>6E1E
M6<G&JW]/3(O@(VVPT\!0-GQYSIV@VT6R%Y/2-=ZTIU?OUOS#4[WW5%F\\8:H
MW!^_\_"M672.04WC'6(N7:\X,GUS MIZ&J;WBD(^G:9DM[HNW[9JZ.Q"&$_L
M-S?=A5Q/RZ@:GTKYN\-EMX9C?U+^:WP;QXO""X*'1K"0LP!QF1=CXW+:.K'0
M)VT&TT?B./P-)?Y")DN@(#Y25Z!L:Z.S\-GT/9TO 1E'S@T=B\-6%"B;#TGY
MG9@.;$Q-U[1-[3!(1>+&-8',SUAV+UYRY7X=ELVC/G+)DOTCAKFJ=..XEE\T
M%"85U[RT*.'5UA7]EMBWQ.434[Z25Y5N'-_B#5GQ/>'J\HTWI31%1_R"5YI!
M*_/:/Q#N(=!+^:'"K^%XB950UB%>0GMA'5\CJ4\5=>-H/Q%KZC(G4$!,WYIB
M(!D/:\!R5U[DV@JN8UTNC3>[(@^-V#84$[7W,*!T O+3M_)'"++9J#FK59DV
M.[4QEXR.#Z:Z?//CN' [5O<V;6N:DGN+_(J^$5OAPKZ0I/$&#0Z.#X\.3X]&
M,.A!*+-7(LNBL N?T2#P_,6=%TI:J,>C\2:KQHS5>!).S*>E!T'54;VWGAM.
MG<45(0K*5I=-PX_KE"4OJ/'&ARZ;9A>5[&7C_'O'N=/+\T56),G>C[>:LZO[
M>*K&GS1?V9-_QC7VP@P57'P_NAKO-=3XTPY*KM,Q"0)F;8#5F:UO,F-.3MA6
M/Q^>;UWZ)BS@>.**.TG66:/Q'6$WQUGR=Q*LYHQ/$E*J/FB]<3&-KTX/9![Y
M<P]=?_(0BXK"C3>"[RP'$=;9H>8-G>$%*97=:!5-XTV2'%>A4T_8/'7ZYILJ
M"##;1)9\ :/6[D^3"TY7GL]\EZ-GATZXJR0U 086NQ(JBFS19=/:_DC\NTS=
MLJLF%X]?)/LZ,4WCPSY]U287VN6YN*8HOH932==XT^)'B#6"5$04C3<'[2 0
M;27]G)Z1R?T*0K(?U[!?]Z!=@34E,_.WG_X?4$L#!!0    ( $L\6E*Y/&G'
MNCD  -Q^ @ 5    8W)O;BTR,#(P,3(S,5]C86PN>&ULY7U9=UNYE>Y[?H5O
M]>M%"O.0U4DOE5U.^RZG[&4[2;]Q8=BPV461SB$IV_WK[\:A!DHB)0X =>S.
MJMB61 %[^ #L#>SAW__CZ_GDV05T\_%L^N>?V!_I3\]@&F=I//WXYY_^_N$E
ML3_]QU_^\(=__S^$_-<O[UX_>S&+RW.8+IX][\ O(#W[,EY\>O;/!//?G^5N
M=O[LG[/N]_&%)^0O_2\]GWW^UHT_?EH\XY2SNS_M_F2R#E((3KR%0"2#2"RU
MG!BIJ*8:O*7Q_W[\DPO66)XB"59D(KGTY5_X9<C:TL1T -T/.AE/?_]3^2/X
M.3Q#YJ;S_LL___1IL?C\IY]__O+ERQ^_AF[RQUGW\6=.J?CYZM,_77[\Z[W/
M?Q']IYES[N?^I]<?G8\W?1"'93__U]]>OX^?X-R3\72^\--8)IB/_S3OO_EZ
M%OVBE_FC=#W;^HGR%;GZ&"G?(HP3P?[X=9Y^^LL?GCU;B:.;3> =Y&?E[[^_
M>W4]Y>(3Q&XVG<T_=K/EYS_&V?G/Y2,_/Y\A(-[ZCX7@?H#%M\_PYY_FX_//
MD^OO?>H@__FG\OLX,:>,KZ;]MYM?_OF&@N@G<3GI&7Z-7U\.428[E!CXNH!I
M@K0^R_Y\3N>SR3@5'/_B)T5%[S\!+ YC>\M8M:2P"ZG70BES7LTZF<5;'YH4
MY,VZJ]^<^ "3_KNCY9Q\]/[SZ/78A_%DO!C#?.1#8"E92[C(AD@'"M<G@HR"
M5R*:F"V(V[*YY*1':O;ST,/U<NB?B\Q^ALEB?O6=7HJ$LDO4_ML&&E8BK,+.
M\V77X>8UHMI+$%02$-HA5\(0YRD0+:/S3EF6DVK,U24IMYE;0\A9%Y_-N@0=
M[LH_/?L"90^]W*!7=/DNWH+._>WA\A,_SY?GY_V89+R \ZO?+[MU';TO9E4%
MOM(K$G^LXE\LX</L'4S*HGGKNT+/;[-IO"+)6,NHXR0PIXB$R(D-41+-<P9+
MO73,ML# @U3M @?^G<&AGAJJ(>/-9^A0!-./KP%/SBM&OZV1E1(:)E%8(C.B
M5D+FQ$F:"4^* X? @_(MT/$H9;L@1'QG"*FKCFHH>;^8Q=\_S28HT_FO_UHB
M1:/$7;%+(Y&&(I=4:Z0C&:($\"PRB.AE"UC<)^58YI[/SL]GTW[<?_C)$D;!
M)0;<"U0@]\B:%:A 90EH+:07&J0,+5B[2\B03L0C$7 7YT?)O!JLSU(:%][]
MY*T?IU?3Y_[S>.$G(ZF%Y4PB4SP!D<)FXC.N90#<F5T*CHLFIMX6>H9T%%;&
M00T-5(/#.UCX\132K[Z;XA8\/XOHX2_[T_H%Y'$<+T8Z"G 2CV?*!-(594*Z
ME",T%\BJI&C4+9#Q.&E#.@TK@Z2R7NIM'S=TO$%WM<--[7,'GV Z'U_ JRFZ
MK/!Z-I__!HLW^8/_.E(>S8(@*&$2MS<IDB66ZT2T]493Z8-7ILFVLA^=NR!)
M?I](:JFQ:K!:LR7/IFF#!$"%H&3&$U(+3J3T#!T%FPB#I+(/-.GH&OOL&PFK
M;V6B2B;+<@/[=M;U"%PLNG%8+GR8H"=5K.+9=(& PA$_OIHNH(/Y8N2TM9HA
M+(P/Z$<9D,0YCFZ5UBIX;9(,^326Z2'D#\GHJXK$NVOQ";3=8HF.F+!"JZB(
MB(";$L--"?UX()$A9<*#\0P:K\8A&8A-,7.HW*LIOO@MXT5Y]BG</4<\(A9A
M&@M! CQU*06BF$MX6/!$ A4>;1#JJ0<;@F_B-3Q TY",PJ; J*67>K;A? Z+
MZTM?#I TYY8H%RV1-O!RZ5NL5:<8IU%(2IM8?NM4'(U]/_]4A(M_%8U=^$DO
M[L5SWW7?4-PK1SY;;D7@DA2>T!+'M>F "Z(XI]H9X;5NXB'M1-V0#M?#$7(/
M_-454^_B\!,>Y1^@.W\UO<#3NE^@(V9I3GAFEZT:+7B#2],".FL9#*7H[_,8
MFMPH;R)F2$=G/40<+?::/O)LB;._@PB(3+3DT+FZ8E$QD")D31B+$G=\ \0)
M%@GUW.J@@D: -G*(MQ(UI".S'B"JJ:'>PU/QOV_(F:_1PW/V0N1$+"WT,)&(
MXS*1%"735&C*0Y.GA>TD#>E*I!XH*JF@&B1^FRUZV_#US$\W(]68K#@#0X)7
M:/-GQ&S(S!(:N!#)H+MGFT0K/$K9+@!1WQU ZBJD&D[>=O#9C].O7S_#= Y(
M7P_DVVQ3JKC1:-Z@]8_.A)>96).1,(,;6A )#?\F=ZT[T+8+5O1WAY7:2JF&
MEF("3?$CWQ"V(V^424(#H5JA$4Q=(#XCFSQ:JQ3S-J78 A;K1.RB?_/=Z?]@
M,5=VN?\3)NGEK'N/3A!N7R7*YDU^,9Y_GLW]Y*\EE/"*69&8\XI)PAP+1*;D
MB97<$U^>D*A3P?,FK_S[D;D+6.QW!Y:&JFH8\W+0_;1 ^UFQH @$B;1KW/B<
MH:&8V=3CYD=YF\>:%J\150*'>#2..2U)D%$1&9,C@4M#5(HF,L%=LNDI H>&
M%E_3'&V//\CLI:MJ"^]OX^FLZP5PR117RHH,G*24T1DQ3A%GG2',9IVY A=L
MDQ>6NX0,Z:YH '@Y2D\MGN*NC@N0U #S@<3 $Z(V".(2FIE.Y #>IV 3>XJ8
M]L-OS][Z;T6-UU9UC-T2T@;6)2K3@[-H:4$?(8'ZU*"1]<1#,H%&VN3J9%]"
MA[3U'HF@;5=M3716+R, .G3F%^,+V$!1L=*17T^8IIE(AS8\VG24*"%=]B U
M;OXM4/0044/:?"LCIIHN6F<%7-'D$)I.^$R411]/YLA( ,E(25]4D66151/7
MZ6&RAG1S7QDA%?51V=T>04K%_<+)3)G;4DF\S(Y8S[03#L"))LE#J^GK/M-G
M[9Q/*#W\2R O3)"0+=J\.@0.+ IAFOAJ>U\/GO:->B\=;W;U#Y%P-:2N[.._
MP>+3+*T_B(()(GOM2;8:B:$,%Z,%1JS*$+CWWK39QK;0,Z03KH+B:TB]8J;'
M1<D4GG^8G>6,>Z=?P(@Y&;5AZ)_PDDGEA")>"4X@*AJ<P%T:FD2J;*!E2$=7
MC35_I+1/\**XEE%G<HY*XW$,#OJ#.2)EJ3QD94&IEIZ:)D]%NQ WO(?GHX!1
M71\5WQ1G:&,MOKV=^.D"*2R[U^>R897GC"0YLU)39%2@AV93(([&7-[%F70Z
M^-CFU>@AHH;WXGP4,JK)OY$/]*Z(\4W^^QQZ9D?:2 @>01H5<BBYQ5,LH 89
M:.J+,2YEDV#?!ZD:WLOR49BHIX&*C\D+/_TX+O<Z/7^(SE^_7MZ[_G4V2U_&
MD\F(13S/O&)$15XN=+0B@6E+3'0NB4BS-TT24'8A;GB/ST=!I+H^JB'E>G8-
M,7$G-0&I%)'*&>(C;F/6:F,%RSJI)FC81^.G?4$^2N,'R?6.5O_]Y[NR>(U?
MUR^?]-87@^83+,8XU6U:CJNE='O@MH65'F"B=NFI]PO\L_<29QE7\DU"IB\Y
M'1M3-8^5ZB%3UI?WT8Q7JG>U8:[K7-BH1* .K2Z A.=MD(YXEW%351 2M1%<
M:/)N_P!-%;*YM@U]T&NJ N=R-I$8KU!$Z*H0QYPE0H"46KD,O,G]864^AG0#
M60N1&Q+&GDSU-;,1MS&Q$]'6 I*5$N&*(='2H@ YFD@FV\"]XRZ&)FEI1]*]
MYT4I^=$ 6EVW%>_;IK,KIVU%\V4\\(@SR@Q81K(UB4C\DP1O*=$T6+#4*5!-
MGI2W4E0E?V4[O\H8:[F/)$07B!0Q$2\0!) #6B(ZY.B;\/LP64/:V>M@96-.
M2QVU-'Y_>@=^,OX?2'_UXVDQZ-Y,KV)?1YQ*KHI# SRC?T1-)E9*1G#1"N$5
M,&^;W#?N2^B07JS:P*FIZBK>2EUY!2]1+ML>WERDO%R+$<O*W2G7Z'"[@,+@
M.C'C@^%MKBQWHFY(+V!MH%1?2?7NJFYP?!V*]&HZ7W1]@?-RJ?:V@P4:-)3Y
M#+A_$B6!$JFD)4$@Q!GC,0@'S,DFX86[$CBDY[(V*&JBJIK7X[WU>8O?=4&4
MUQPGM/(X/7%:1]PBA<9_A4 <M\JKK!GP)DF<NQ WI%>U5MM09155OS$_FZ8[
MU_JOSC_[<5< /M*Q1+1Q=*R3+X_#U!*K!+I4TCN65(S9-"D9L MQ>SZ_M?5+
M&VT_M754,: Y+"Y+:]\4 WH)?;A!^=FK^7Q9[K2?S^9XS$;TP',I(I@U>/2.
MF4+/W!:K3; 45%"0FQQD>U&YYUO=]XBG=EJK'P=P8\"-: *F<#:2<D8W,G @
MEF='DK$Y6C RRB8921MHJ<;>I3J1.9=+#1#48D(.9;*:!*L<$3IHGQ4ZSK')
M1?\]2O:\K6B+_V-AL#6XX2"YUSMT.V3D;3?+XP4NKU(S+THB7"GZD55"MR-3
M9">Q)"S$*)H\7ZS1,*0;A=H:/U34]7>R:\AQQC2+X$A,#,F(J!X;N"%"1(V^
M9F"1-M'X(TM]?];>0W_[C:?&WWSW.ZP-/5+6X4$1.6K+ )$L*V*CX,3*&#DK
M;1-RFW*P6TD:TBWL<9BXET)<1PT5*[K/ 8?YU%L3%S"9]2&%5R0YP;B('HT(
M@>M82G21K4!S0GII=6  BC<JYOX 58/< :N HYXRZIU^,$4.BS=SEL['T_%\
MT?4W*M=$.1E"<):H4@$+D>M(,-823SUU+I<:1TTJ%3Y"UY N2^MBI*9"ZB6/
M3/K/0'K_R7?PBY_WSDHAJ!?0%6W,)F]Y!"+03RD[7"8>O5W"E4[4)J YMJEF
MN!-Y0[H:K8N9!NJI>"OQN8,X7@D:07U>0DK^I_]RQ+W.EB5%E!4*]SF>B:4T
M$6]3]M;I8O*WN8/82M.0KC_K@J26(FJ:)HMN&1?+#EE\#XO%I \ +!=KUS=I
MZ"Q<C$L_VOE(2*6RX)(X6VRHK +RKG'WHR[AQF=!L29@V8_,(24@5#=>6JFK
M(J0N8+J$\KQ8*J!W/B[^.5Y\>KZ<+]!_[:X#X\M]+?Z72HB29<)Z10UAH5S>
M08XDZ!3Q?,T<3';6QR:/,0?0VE@\UV%_Z^(I;9=MN=&TIKRB9>=*MST\-!P5
M1C/F>)L<T0-H'9)7V1J)]U=G6]76"P7Z&L=]=<Q2]&Z.9."V%*G7BBE!8DF/
ME3X'/'D*)%22,K 0;6SB9&R@95"1E:<&T;&Z:7(GFZS+TE @G*>^O0TE011U
MZF2- FM3HXB+;7>RISF6HI<1A"ZEQ*(@L@2N>@B>&)X3R(P+5#?)R3[Z6'K:
M??=0Y.RYGQZMLJ.72LFH&5VV<)LOWN3R+MVWE8'N8AQA_GXV22,3!:Y8-+U
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M/_>BF)\85:V?95_B,3Z-MW=P$[)5QCDB2JX9[K"...82T0:R5T9X :=\EMU
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MZ.(D34=%3YZ\4BQP*QB",CH*!P"BFU/3.[;39.)#4.2&(/3>!Q9W.G'KD/-
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M>QE81!V9<+$XLJB$@"8'][>B.@4>]"?V!FO .YS3_##_"M,Q^2:S*U0H8Q;
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MX05/"$[(W"0Y<3NDT]'_8=*^R0/;&P^>+:;3JY0*@R!!!\UXM,M>;8;%5$N
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MM^C3YN>?X@;9ESC[3E&^">DBWM8%U.;-L[.N[^.(OS<]W*[7 X38]\G.5G!
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M@)B9B%$&X7C1IDVWS8.AWT.;SJ,P\V:)QJ,JN>\@[S7(FN&57R^JC-^4]Y^
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MZ+81CF= ]BC]2=^BZ_OV\4U0RQX^;\IK7"8@O!S_^C7A;/:F/(/I]!MM2/^
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MQU]V_VYY=2_^0A=_+LK;\[_X;B2ZQ9/O/M__X9L?N^Y*A1@+BQY2ZX9N*!I
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M&]X/4#),CE?("C"VDA56I[*HF+!/CN#!Q6)[J0F3L'X_H=4A%+Z&5K>6Z?A
MV38"V4]H-2EA:HY\UX7UDQDU8'0.J(K0QLQX$?L47AQ;:+4W8D;(8;;0:M6N
M5 FX)HD<7Z1*6B#RV6/R&.M&]XSC#ZV.$L.@T.IP'LX66I4^YIJ-A%1*;2U'
M/:O))$&2M57&G.MFJ?M+"*UN+=I)^#A?:%6*UL;).K"^!8%"S)",,U"4J%K+
M@H*PQXU^1*'5;: P(=?G"ZU&0DM%$E/E62&NVD-JHP%SJEDYK-;),NBD'U=H
M=>NC/@TGYPJMKH,DJ=5QWO1AVB9Z^L"G3!(@?8ZZC1BH0!5#3;58G4Q-.DI'
M*$..3&>4*IX\3>?NO-N^9^RCG]6)CP/ZQP83<G9.&.VL<3ICS3E%I43**F#!
M![BY>Q?9^Y_Y^^7'CZQ++^KW?^+Y!UJ=GE]W;]YER.<VRW22Q,C];0A)&6RY
M6<*'+$VU;%A$6RQ*IE"++,P#0GI^P1TMQK;B=VW%YF=CHPFO+O-E6ZU1\-WG
MKS]R3=2;OW%9OH;_1%(^8FD.N1:J=2@A"LG/H49&(@E;:I?9X[N3OK.YO2T%
M-V4"JXOEY54_/8;@\@\6\56AR.K7Q54)0=EH\O"O)OH?6!WYTHWK_>+L[*?%
MLGWJB0J4*"7')D?-_ S6EN[%?],J2VN#T]7V:95Y6'S8@XHR[RFZYVXX+/Z/
MPF$/I_H!L.-$^2(%:Z40K5>MMZZ%2%* 4MYX+=!3-"_U+![1 3R$$W" IWD4
M?'LXLKOQX#]K!KP]OTH[>YX1.K61I%)"%:VWN@D)DG.634L=%*MO*ODC>U-'
M<N#U,!_F8>X)Y!Y1S0,0Z@E%&:,RI0UD2V!(!(BAB;-(*CEZ#+5+%<HA;/X(
M!'C[T"7A6I_Y#+6B8;A:!'150ZG.5,-0)NI3 CKK-H_H<CT:4V5;%!V5&O-E
MMU>M;D^*\I1]3A!EZV01587 ]QE8-+*63&V4[9$>EZL='M%)F0&J\Y^J+7!V
M5 ?JKCIU4HJ,Z*R%K%H1BL0,D4T?X/]+(6 TJ?;)U)]I@Z_':2_':0>4':=.
M?GUM8%:Q.)5 41L9@5AXH])#K-&)XG*Q\EB]80\]3SL5G#U'\NHQFJ]R8H/7
MK@ALE<#$VIDAV8;!92!/"2,)DMC'QIEJ![/UO]VS)KP7B1]*G=P5^?S#5[F6
M&:M XT&JUA$M>KKJB*9Y6ZK4F*+M$D*\0\4!)+C/"83%5 +9AYKW*".^;N.\
M_':&YRUCZ"9):,">NB;-=]C4?M+L=\#*6$UK+D$?"XA;?5-U,4+6=EVOI  E
MOSUMWG:()<J*^[%+#@:\SR3\'SAVQ\BW V:ODXMNDMD3V12\ ^82$R.,@J@9
M'D4:@U)%E+J+4^D.%0=HJ787[&(JJ3R:7=$],_5+XMJ[RXO5!9Z7T_,/?7,!
MGUBH=S;@T#UNY -:;[WS.?E<HR$2@;+$)-=]876)Y:E\P">6W'M&8**D,P4'
M*0?;.ET1A-: +&8T4@@=R'9I/_^:$7B5N^$465<0/&8#AK2#T)ZWHI%"26RP
MYBX%(8>P^0-\+:8]+X>9+30"<<>9\'?MQY118U0!P09LS35C@8!) ,42$$53
M%_M4Y;^&V8[W_&R!G1[FZ&1N)JS9U)81*"H5-IJ2A81>0'"4I%5&FJ)>/<P'
M .V]2/PP/<R%?!"I#:S/+?/+1^8CL?E4O172(RJ[V3;\U<.\*Q">]#"/$<C1
M..<&[.G5PSS>PSP**[-XZ;80]+& V.N4/:4(RD<-1O@,2#( HE%6*6$#[<=X
M/QCPCO(P'QQVQ\BWNX<9E9-1&0'9\Q^F5L/J37100XRY2/Y7UR7P^Q(]S*,$
M^Z2'>8Q4.ICSZSTV!\/Z (5 PN:<F1C,S7%>>5LQLP8LC-:2#U/HI[G=4/&J
MN6TGD Y):U^(N8;]$')Z*ET;].Q17]I.0H_)>@?V=G@V-LG*S@0=<ZO$4FP7
M2T\0@VZS-71&7V*5N>^ML&\%HXNPQW!UZJ9T:[<RE5_PL]1*2/?'G\O6G(>_
M5KY]??TV)<V[5<%#L;F1* E2:_ZK2K8F\-=ULR[HD0Y'P]:;7S?822:+O@S=
M8SBYM7^Z<:PV9>7B]"^:-H[\U J] LB#=[41.782=354O);5.$'!.*FEUB79
M4E-Q#T6.GUIK[R%CR0JF\GS?\G\-F( >TMIJ"D4Y+-EHV^4^/^*0\558X5HS
M7+WYBP79-+V?%LOUR3]!]-E:DF!R3%<CJC&H %444H6/=N@SOZ?7A@[03)L6
MUY.%IJ9$QB&%:]=_M!*:+V.#Y$GE9PIC9K9Z[\"4XB#JS,85>DTV!RKZL.J$
M']C$*[+G0D /R^1L_3-4'M[4C_^TO]*)*BG)$"+XFI#953.$(!-$02[E%#6?
MQRX&RR#ROCD$=I!:KP*]WY:GF=C$QA)<EE"<:UF?A3=+7D$E3<9*&ZN*W>ZY
M-0G?'$:VY/ZCW6 /(7<C*.VMQP@AI\H;(0?\W!?PC@5JT"33*;KS#>9N[(2]
MO4C\,',W+!E1K17@<LLN1)4AB78,^6Y6.5835)?BX1>6NS$*"$_F;HP1R+&$
MO8?LZ35W8WSNQBBLS!'_WD;0QP+BJI"R07YQK"V\M\2&?1468LDQBUIU,/OI
M G0PX!V5NW%PV!TCWQY#*C]^.EM\)KKE2KX.(EB+7A0J$,@D,!$+(-D$Z*ME
M;@5?4I<G^E&*#M!8Z2[PS0&7DTAK0O_?:GEQ\KYQ8WVX<BR.?!00T/I6,V):
MNDJ"ZJ(5WH9<\Y"[BC_T%ESXJTVHW%GUV]3BMF?\A#Z-+T1<@W (&2,4KN$X
MF/Z">%XWVD$"FS+<@7T3/@F;Y(0HO<#L(6MD6+HBF)P2F)R2,I$-,@QY  Y#
MBH\H"=,+<0S7)A;>+\RICY<?;UX$3#(YI\ JI<'4J""5YJ^HY%/25:LRI&1T
MD/CNK#S?.[T3[Q=3,&[BI_07_.<6(2*DNFYB44BT?G=50LK>@]?:!F])>QH2
M0!\FP=LK'Z$$MV;<Q&=PH[#VFJ#*@,HB6,BM$XFICB!JMCI0.84U>57$9(K1
M@Q0<GT1W9V2'X,V-*K]^+5QA- GC 24IIH7QADI5<*1S)EMCS%T2W6\3\6TJ
MOSN+HT,\9\/*&T)-3]_C(7@-MQ?/(W+>@;<=7"<;5,GBE/%20;9%MT='0"(;
MP6FR3E!VJ4_=RP&XV'H)>@Q+I\Y=?J.$M+?\+(VTZT=(,5F"I(7BL?E:+$(L
M@M\D7RB*I+/:U,L>&ZK]Z!KS^[IV8?UB>KY-J%A_(2L\3)9(I&QFBH3VHI71
M% B:WR)D/2-1T(Z1.UB<#Z]QW.*<@&\=3J<2[SZ>GZ;+U2V2LC<)LPD@JVB]
M_TR!Q.H^!)4QIF1\V&R4_+@H'_C\HQ;CKOQZ5)WN7RAPK6PNZNV$]UO=TJ8M
M&ABZ6J\"@JUVNU%,D HV-*3JC##54'3"1#2N9B<3R8<F,0]>=^^%!8$DFL*H
M-:GZ-AJ<C<"B"612B%9CS*4>5'[PSWLO++@OS9L.1BEFRLJ DY'-KYC9EG:2
MM349$+5*N=C#&I_UV$X.,#HX+9(G2[B>! L]:@@F\RED)7,DE<#5Q&S%:B'&
M6J 8&:1(,M?29S3%-Y@1N1.$]R+Q0\F(O&,U*\U*=$X1;#8M]"14&V/H0!59
ME0D^"7QU)DX+@Z><B6/$T=^U-(2:;\J9.$H\3_N8MN%M?XE[I5!7)\&+E,"X
M@!!8=0?%ERV;U3Z%T$7%/31GXH2"'L/2N=P5P2DG6 IM A^88'+K V!!)'25
MBC'!Y><,V$-V5XQB^1!WQ0A^S>A =-&Z['R&X$DP68JWZ7R$6+.L,N8<-CL(
M'Y\#<1=13L&W&=W[R2N242G>8"ZLUGH)*5"%&JM$'951ZNC=^SN)<P*^[=&9
M>#-M@7_E^S^;7KDZO6GOW&>(Q1,+]1YB,72/&][#@%X7G4OK46.R#*E8ZYR.
M56@CO1%/#;$8MMO=Y?BE4_VB7B_S=K6ZI#*I#)];I)/\1NUM0W;HR<>B5&S=
MX;0J49CBL#A90U#&V@=D]]QR>W?X2EMKM2: %C&TO,Q6M)$K!.%1A6I,=8?5
M]F1:A^]5O;+$("3+%'()?+UF4R$::4%3=DXZF0WZ;DPXXFKQ$=AYHEI\#/</
MJ;_*E[/]AH_TQZO3_>,_M,RGJYLZ>)FM1JE N4)@O&$%3"H'):F,SE-,!S9:
MYMDM?9LXW3\Z]E%2.69G[T]7__W3DNCM^04M:77Q'B_HI%(67K*N:K0(;8,$
MP6#[FV0-%JO4^K &6PW=V>LIV"M6>K6.2<]O, T[YI\H7U#Y@Y8?Y0G9F$+6
M!HIE ]P8(R%4CR Q^6)#$>3[#7/OLJ5O$_[[1T>/5CE3'NR-NH+_+,[XT\Y.
M+SZO3[@PV4N5!51,K7(D6T@VLRBB$,9KD2CT:\DTRQ:_S7-Q>.BY?T[,09V3
MFQO@A]._3@N=E_4&DT^Y*DE 5K,5Q+8/1"TT9,_B,(JO"'-8AOC0G;V>BKUB
MY?YAL#MY]R=]"Y^?E4FL]Z6B/#^(_"J:* T$EPF2$X:"UIC3Q@3W1R(&\]+]
MS8#^T#%Q'_[N<.#_TV)9Z?3B<DE7-I"SJ%KI1BA67SG"@M(17+!)JN PDYH?
MZW>)? 7V/J1]'\7^<%)"E;4F$58HR; )DYT!E,9"C3K+$'/1OD\;K6\P)70G
MO60O$C^4E-"[O<I\E$*Z$$#EX,$P2R&9W%I2"%MB-AK[3*9^84TR1P'AR2:9
M8P1R+/T%A^SIM4GF^":9H[ RRY#(+01]+"#F'1@O?81,9-ITPQ:E$@)JCJTQ
MGG.Q[L=M=S#@'=4D\^"P.T:^LS;)E,9XT3)2);%6;*K2$-:>CEJB-432#FJR
M-1IX+[U)YBB!#VZ2.49:W9IDVB14D,12]=JWADA\N%!4P.!<EDE5(X9,M_G6
MFF1NH\5MS_B.33*'D/%"FV2.DL C_16W85_')IDY6*TU(NC*[Z61,0$2V[JI
M8E$BE6BT.QHI#FJ2.840QW"M:Y-,X3&90!JDBJUZM62(3@K0,0KMF!)#0^JL
MCJE)YBC>/]HD<PSCNC;)]"FAE21!4%),2!40A&Y%)-&Z(HNP?HB3Y)B:9&XM
MP:T9]^@9[%ZN\9Y6%\O3?#/5Z]^\2J=AL8-6ZI3P/WZ7&UG_*J VPF4;0C).
M8 BB%.NU)B$EY?) UO^@-?>>^J]5*ORR!!"86T\*;R%%;<"Q*(TQ OF/@\HX
M^'GOO5X>&JA8)%&QJH(/M=5[:0<H^.+VQ@=I4_#VP!(W7LI(S3'X[3I2<PP"
MIJZ=W7HC/_[/Y>G%Y[?G?%-=KB^M=WRG+O_X$V]*R]HFJ;PY+U<52V_/K[9[
M4H6@FJB 1^? M/K2Q$\C6 I.$/FHT["1\K.3_LV@_ B0T<&5.'!(J<\A>>4(
M9&,C<Z]"T"JV_CHN>(HVABXCD%_P:-E=;N(.4NM5']#E,*WSFU9?SA OS8PT
M;4)")GY+6LV^-XRG&ED)Q:QM&3*88#YM8N0&OSE\'R1R>E023.:.%B);Q%2@
MBM#4J9HAJJ1!6BF\U45FV:<'Y3>83[03LO<B\0/-)Q)""I5Y!R:PZA-K!4PQ
M,\K0)-0ZA-HE!^Z%Y1.- L+3^40C!'(LJ1A#]O2:3[1%/M$8K,R23[2%H(\%
MQ#)E3]9J*-*VH46B0L(@(%J4;6 1G_#]*+@' ]YQ^42'AMTQ\NV V5NN]Y:C
MLG:]O__]WS<SKE)4H1@)7K;Y<]$YP$ >9 ZVC<\(270!WY-4':!)U%WPBUY2
M>]2_.E_WLX>B/V_RQ>E?;,[U:8,V9,7>_=!&[WHCS.:+I+;;4I0W,<D8K9=6
M)9()D\'P5&.T(6OO/=PF0DTI1@&UY A&E-*&-R4&=8DV>)/Y)C\HS\[^PVW/
MND!^79S_M79&OU^<G?VT6+9?.C%9>>%\@%Q*!B.KXXN(&2UBKB[JF!$/:X;%
M5ML\P%=CVC,PGR-M9Q0=4E>RX;N]'DW!+W.MNB+$UE1A74R.Q1MPJ/B_2KN,
MAW4OC=WA$9V4&: Z_ZG: F>'U.YLK!^^FFQL10<Q^=HJ/#SOT_$=YYTH5;I2
MW9$]/T<;P7E)QVD'E/6(AS8S[;J5[>7R2R[,>F^KVT/.;EH>EI,@C"[9\(LO
MA./S3P:B2Q*JJ=D5%8.,JLNY&$WJ*\*?0GA?R1]2C[-GF7O=T>%6"DQV2N>2
M,BCI&F>SAZ"2 M>:\C17G:,C4Z;N[?'U=.SE_M\-:X?4$FVTYEA06D*^,*S/
M;;AQ48#6.=#&AI+1"ZI=,K;V9*&,S #]@2HMEW=I_.HKN^W4_?D4TU5'O5MH
MMZQ'J"@#4 VYS:GU$)MS-:%4CK(.5@UK.K0;'4=TJ^SFSIA;9D=E2GTY%P.:
M@%4M"KD*@OCDFN U1(Q\:;-:[&J2Y.1AM1.=<//S'9;9T3J_>V):J!W5<;MK
M4S[/"&%5RJP;@:K2@]&:A2@K@=9."%(RN7I8$XVGYL#KP3MLT.TC\_O16/F&
M'?S8EN\.A?"QL(&LU\6_@E4*5=E6)@DE.I52PA+R?G3=2;?Y>HX. #['Z&JY
M7-* !K$RL0F?= (5VT0ADU@O3X0,>S*4B&(I1V8PCMG^Z^$Z8+@=IR/F>1[$
MS.)#:N.#@P:C"D&PS(V<F <N:S:5NPQ9/X3-'T[IC*F&;1''^#.M\03CD:60
MF&^Y.E.D--GV*>G_!DMG=LIEV8O$#[-T1N24T;3J>4E\>ZH:H76A@XS6NFI,
M4*&\ELY,"X0G2V?&".18J@Z&[.FU=&9\Z<PHK,S2SG0+01\+B+U5(0JO06EK
MP*!C+9DW!,5E*T71*;M^8VJ/ KRC2F<.#KMCY#M[Z8P(,F:M"&Q1\FKR0)3&
M@#>QNI)M%;K+,_TME,Z,$ORHTIDQ4MM?Z<R-"^%K]4:?/G0#UNE4)C-VAQO%
M,3*K8!7C(&9O4F6SPRH5L @792[ZH<GS U;<>TE,-5(;CPS,(A*8UH4Z8"W0
M)KXF8]%B.*Q4V9\/OR1F(T]4Z&"M=QJLE:TK2$X00S&0<Y81322&TD&Q^.5F
M(V^'^[UE&(]!3H\"F,DLXVJ+%8(RF&";ASFPC4QL*"?KA$L8<XY=-)=OT2FV
M$[+W(O'#=(H%+ZRI%"":0FTX'$)$Y:'X*++QKHK<Q=1[84ZQ44!XTBDV1B#'
MXD\8LJ=7I]AXI]@HK,SA6-A&T,<"8A<%*L%V+2$&, HUH!,9M$F>1.1OA_WD
MI!T,>$<YQ0X.NV/D.R%F[Z0V?+6A?_C]WZMKUPIY9T(HCM^6-K^+[7&(0@J0
M1-FC*MZ5_)R+XME5#M"\Z2[$AQ+E=Y;  ?2%N;^7OEUAGE^O=T^8D3O><'I%
MDXO12:,(+.<D&3K9E4JI2AN%JT]UA'E^Y;T[OY14L:3L0"?#NFFJ"3!6#U('
MA4JY:NBPDJF/P/GU8#U?-CJFC)[U?UW!F!89%ZU!>7'.ZRQ2.C87V(OI!S/F
M#.RY'\P8%!UU/Q@;K7?.!DC.MT[KWD*P1.!DRB2=TRH=EE/^M1_,+E#=6S^8
M,3B;6K'_JCD\O<LT>I=73G36@*^&9'SQIBM%.LO,VT,AP&!2$+V2$&111>5D
M@APQ-65.TE^/RP/'Y0A0=%13,#;VB22MU$)#<T> <2D &N\@FR1SP9)\GW;J
M<VWP]4SMY0G: 65'52RU^=0B4<HF6O!D6!I!>$A6\P7B1=48E2F=R@+VH]+-
MVT C!!0-1N"C4PQP*L 6369>9"H4$J)];: QH?TWM\PZ!$*VH/[[2_X%YM]Y
M8>CGJR].BLR:HE(00C3MJC40C$^00T7T)$2G8N&)Z#^N0L51F%GL7^#[F[!G
M!)*VVH'U+7,HMWK(J!%T6(_,=4BY2Q.T0YNPMV_4=1#7A$;%QI#*FP?B*T-N
M^'%*J]_IXN*,RHDIT42E%22J_%[H4B$:FZ&R!B-SKE[6,MR*'KSNRX=,;V%,
MJ#X_2^J_F,$_+U:K=^?OZ2\\NUSS[\14X8,IA?7\UAFA=9(+V3#HBPD44]0Q
M/AMLVV[I5_1,()(.=?-3/<I>Q!(M)JC1(!AA"&)BC@EK@HHA*LI=.I%UT<+V
MF:B+T9@JHP/*B2\44=LPPAH@.X.%1-+A-5'W(")O>Y'X82;J%NV52U@!C=',
M1ZWY$13\1T8R!AU%Q-=$W6F!\&2B[AB!'$N.XY ]O2;JCD_4'865.9(=MQ'T
ML8"X]:8NPCH(=6UF>@)4FEHB8,G*9"6B^[;!.RI1]^"P.T:^LR;JLC4::F S
MPZ*Q_+8X?Y5HX&5(66KIH_:#++]O(%%WE! ')^J.D<!<B;H_XO+\]/S#BC7'
MU6^T7-.]30+N@Y\S26+M\Q1NCE!,K#TA_W]RUE!RB(;5>"E<*#ZP&$^>HW4*
M'J[UN:U2F9_XM&[\?(C:#:ZB<-5:Z:W+V=1446/R)DI;8R2*]D&NWJ=["M[>
MZ-N+>O/=GV]]=X<L\NT7ZR:9+?:Z(3C7FG/S<QB](R.+3#&HH*406E9"30\*
M;MBRNZE7-Y_\Y5-/SRXOZ)9Q7FHTM;06BJ:E^1!9""032.5C]NB2C%V:*3Y'
MV*YZY:]T\?:<I4Z-IV_^8E:V8_+'@A^PCXOS=?^2/Q=G?.FOKE=^DU872\P7
M)];++%,P_&Y4?I=J\&W,M0/EE=:!2&+M,CQJ:XKGUP<F1=6FQCB/Y#KD30\G
MG-6DTWRBDQ#5Q<+*M$(P/C*[:G;@(O^I5<VV3^'U2#KGA]=,"-@:=^/%U\%P
MWF@5>Y6<=.T=6[V[O%A=X'GA0WI%+%DMJL@5:C"M.5-HQ/+1)$S"*\FJ=NDR
MC7X4E=\*TOJ)KD,B[N9=?PU^D33I5%OS#0^&32L(067(JI"/R00?NN1=/$C-
MMX*;W471(;5T*)BO&?'#Z:I%4"Z75YK"%[Y(2X;UY@ .6X&MT('Y4AS8**5V
M;+G;VL5E-PWY+TP%VX-,.[R08Q]T'Z*6WGD0Q<K6CZ"TR0 2BL.0LD].]!DY
MM),^MD4N0A/:Z5_T.^7+Y3K+YL0[;11Y#5&K""8H!5&%!%D8*XS4V@CJL?/[
MI,Q_D/:!]<V4S=TDTN'1OP/)GYAGWR_.+T[/+YD/[S[1<NW^?0"JC6=WW[T3
M'8T(T5<0_"B!P2 @E&S %2LROX7>NBZ*YV0[^"81N1_Y[U$[N7H!1*I*"V_!
MF=;"-A=^ 6)P;-PI(H,*6=<^,"MI/$M8L,MUT ;/;HEM]>;B8GF:+B^N!/I4
MAMWJ)%MGK'<64-H$_%<"-+PSI)!5<M8;VZ5N>W?2O\G3/+/$[Q]C.PMFO\>S
ML^N:K3?GY;]:"^)KTJ-H<\JL-GR4:TJ (K94T\!<+"JF/@6>.]#\BM*.,KX/
M3]?IE;EFUCTFGJ2*RJ$H('$]9;S55@O!VAU%DCHDK[!+,=5(.K])&/:4Y7WH
M^:G=<S=Z5Q%6:VL,Z*@S*S!\+"(S!:3!*(PRZ%(7?\HC]'R34)I"-O<A$R9X
M3&]I]FWC5\H]E5NZ_7GCR*?%"L\:]A_Z$;81WM4_\!_>W5HO7?_*UT/RA8.)
M4K5)>"A2!3X@JD#DHP$N^]AL -:PN[A5YMWF"_, 'C!&.K@[ANSV9BMW]9'W
M]&FQY!_]\"/_PL7G$R-S4AD=)*\+7Q>8(*;DP9*0(BG5WHI]@7W0#N;'\2%#
M;8M3,3U.]AX\+B2LTP699:[U-S<(Z&1E6U P0$2R*G>QH.9VBPR6[0W&UI2<
MB&)U,B%#BEFT]&C'[.$_J@HU9B5,=5T2AK:F^/6,3W3&M\=!CQX_7RJD'M$,
MOOM\95=_?X:KU54M5*HNN((*<F"(&5T"7TALRR!Z$9,3PM@N]:1;T#I7P6-7
MM:JWC ZS<#$&E%5+S>>/H6 J\1%QM7D0HU-.DU?^6RA<["3R)TL4Q[#^6*J[
MANSIM41Q?(GB**S,4>:UC:"/!<0VR""2\V!LB?R*L+*"VA XI[7 &H23^VD[
M>3#@'56B>'#8'2/?'@;>563DNB@.DPU5J0Q*>3;@JD<(FN$1=<QM-JN1U*7(
MXPX5+Z1L<91@-V,+6TNE0[G"CQ\_G2T^$ZT3S*YB:M>$^>(<%6DA.LOJAT'6
M=7U1+&5138E(SG6Q"AZEZ!4Z$TFKPTWS]%!HB=D2R@PUJ01&.81H,8*3:!0I
MU6(K/:#T+8SRW@5.TTFM@SM^;0F]J]>WY;OE^^8&7#_S-423V.2&XBIC75D#
M4? -2C4$AKG*UG1YR!ZEZ%NQ*J<1R5Q8N3X@0TCK:2@^0=M^[+V)I#@$&SN(
MH,,C]12)61>M#"&80*V)?*D0C+&0<JJZF$(:NSQ1LZ/C&8-J?G",X?S4;5S>
MG/'[AW<5\E1BE7Q% J5V09HH(%7I(,A:;))*R<TXUR/=6Q[X\/EUCLDXOYB0
M;1/:,6MZ_EA\NORTWME- QBG*MO\Q;9BW-;NLT9(T@<HRJ+U.5F=ZR AWOOH
M%R+"W5CVZ#F<H6?.UX89;\XO3LN]JID?_\EGEX5*71<L?/QT>;%6LQ>/)N]U
M:V,R,7TS=#[IR=&-9BDU8DE"N2)]-3H0WQ_4\@F4(!.]?*Y9RL24[ACH>I*8
MG^X2<U]9_QI5S#%DM+F"=I6/,[$]CSH'T!95+ :UEKI+C&RB#>P<,=R-CC<?
M%Y?G%R>N:D5:)JC>!C!>*XC!M3DT240^.M*7+IZK2:B?_WW9"WKO!2QGEWR/
MF9E?[/$=MW-EJAM=C9"L0Y60(VO<N26PH("@,__'RVI]G\&8DVYCKI2-@X#Q
M'A%P,%D?NVW\N\\/?\#:!A5\N(OWE?D1U[,",J#1!-5Y0M1*>],EB[SCGO;O
M.YP?J=/>_9,AIL< HP<IN^6^'T)?3^_D<P3N*27E4! Q"*D[BG,?L+.()<LV
M)+-Y](R-#E!6@ES8[A=>&^=GO$CWG41RK&@;(\6I7:?_XG_\L+B:F_G+Z1FM
M+A;G=.-+\KQME]"V24U,6,S$*A0K4T))J9(U69MALX^>6N50+*5M!;+HP<VI
M7:N_+8D^?FH;ON,LE$XH\E&"K\: $4$#-H^A$4+:6"E)-\R_^O#GOR313L#!
MJ<_N'XM/_[YV_OYT^@^5WY:GF:[I"KP9*K:"$Z'P/F6%9'R!(*J7I*-E=6ZH
MY_RQ15Z2>*?BY=2##F_1]0LN_YLN;A.6*26;@X)8/.^VM&Z2AE7V3!ZCJKHP
M L<*^=XJ+U3*NW%SZKF$#X7BO#=!Y22!+(8V9KPA+B$X,I5?"^^D"(.D>Q 1
MS'Y"W95W'48$WB6FEA"23QE"C1Z,+ %B8#T@Y\HW!_(MHOIT"'F!$M^=PQTZ
M&CV>SUDT4DS20HF6MVB(-QN:\1#(I")EQ=2E+?@!9=]VA<$TG._01>CIG$Q"
MKT3("JIJPU*%0S8*R/ ?H30"K>QCMQ]8)FU7:$PG@4<[_4R<)O$FY\N/EV=M
M\O8[_IEE<U<LZ<_F_OB+OI8R;Y/A,/2C)TE.V&H?&WD%B:R+I,AX(8SRE>UC
MLE&IK%'S <XG6^RHDSRVGUPT;H$Y93-@OE$Q1LL4? P*V_#W@,K4DDU*KNI
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MS83)M*)H(P,P@7A5LLPV WU_;<(4#Z ZUZ7Z^;AR+Z(QE,X:7"3M8-I>MG8
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MWX$?G?KO[47PPWHDP^ADP 3H%: -CC]FRT^8IF5Z6Z[>!=30O3T/HAF_E^<
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M14;B,GF@#&J9/T0>G#-!&-&D[=*CR"Z5)B?J8/@QA=^@>W-3I?P9]Z#D.A;
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M&2*\8U\\__(<9^G#1UBL)Q5ZD!F$#TR2R4$^0R2?0:C::L5D3L+0.8]CG>\
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MT_?U#3VTVK\_JN^+<..DAQ^]Z)>SS_3GYXLO$XW!89">&0&9:<3"@BF.65[
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ME'$6UOB<BRPA,5?GU&O!"_/2>Q:R<%'%F &:=K;Y/LH?VY*ECPY&+7\420O
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MQMA9[D!,)29TI4Z^<U@A!A95,:SX"*568'HYSNUP:WX\8O>=@QY]9-^"%IO
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M\[$4WT>X#4R"U]N4PFW[M6V/IJ"T@)I=B(Y./!$\\\+6B?')&(E"E-3D6OL
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ML "..071:2F-P ]8FS)1YUU_QX[W&O:A7-M5^FWS<?GEW2+]^LO_4$L#!!0
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M*=1NKC5Y5]'QJ+QOMB'T->]E/SJS#25]::/Q=L0N%]8(2D\#..Q()C1@*CB
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MI*H[0X)VG&8U:MG7N/(+1O\8]UUM.9\EU2U$KW5>J%*[X.CFI;,;$Z?^-UK
M1>%73H81[2:H DM$6=3M9%3_6=]S_,B$%LPW-3O]+15B#:5-K/K^$U$$6Z3\
MM-<I5NC)6I-]W.%6A2L')'74A;DI.Q5<B%X)-_4SEZCCF2.\I([3([OA": 6
M&A!'Y5YV<=D\%_'NT=_ B#H?(5YGEY4@5F6%%^VL .I!X$Q%N 7_/:5AZ[9
M(T7^87YK(X"YI!$TUZ>V2H1A7Q3QS2KL87 +/^H":_8OXUV<]<92-+_X(6G
M8P\QSP@YZGF7 1<US1>'I_D/^H!85>*354<06A6;1&>;BH!Z9U.:B[Z6,]T5
MBZ43B[$9K9]MP<=AC1#1/19H9:XMP<#M\*+:FGLCL%_^ESS<-);O[JEQ0T*]
M#8OU;C9M^,N7$K]AG4Y]'<:N>P/CK"WLV3]3?VL2\4RD5+$3$+[$+$;0^%4D
M0PQXCG)EW%HX][UY509_L02S1_<[Q/LA3VNR1,63K&(KR)W;B^OY2^FC77#D
M9U,TI9 J::;Z/ M1J:;]0/S+:YD'1YC<]B?U2AF%!JWXP_!7%G4[$F(?9Q*@
M8[OJM4F/=<7\0C^&B&%KBN1!&'AZCUDQI/N3BSCNCW?6,B3G8'O5/-UFU6'^
M0L*\V8!=QC_C%W6#(C9VT/"6WWO2.+=A$)]"JRL#5-65=:?@;9 3I6_!K+GM
MZ\-_TC+P5S%57URN&%\_Q#90ZOLN;:TQD1_B4D>0]?5SZQGP&M?D\RUL'GX$
M/N,K(M&HSM_3\.O;86$2VOC$(4J$<>IHX-:YC,3:M8MO"QI2.4ZI_J."Z_\8
M>OW,/LC /C[R9U<RT:I?2Y/0Z<4Q)S[[0F(YWYF[XS!SN.$PQ"W=^=$T/X'E
M;_23-)S*6L5SYK@H)1.2J_.]Q<V[,UY1@M,:HI$F=M1)I+__U]LRL?QV%^R@
ML\:/%>$O@:# U:@9]HX!;9X)\C=M96J>D=F3H88J-[PHXBX-X"1+/V]8&;DP
MD3LU$.#)]\B\,-G]7DD\!-63D?IR)E VYOY1 =G)M[JA85_W/,'^P;2WBM.*
M0G5B36KCE5K5N(5Q -ON:X]ECEDGQJ *>[6G_Y#T;3HZ.V:?*+WA;5IQNO5R
M\-[9VCX-SHRGM[4&&H5PQWOU;AAE$1,41%?EJ>Y]SP@'Z-)K)RZ5:T$7V-SE
M%T0R9?MT.+=9O2) HXUBVZ=I570;+#GCUE%$0$;<FU)Z72!UX6/*11EY^JQF
ML>!9MEZ\VXC]*B/1 <O%^\.$O^/D:NKS:@/Q3XI\X_Q<4@E [)W70+1!PPU"
MN3[^T=% &M_SRLR ORQ.\QM[W)4!T:Z\I6+J12*SKSPK+>IBX3:W_#2Q=[H0
M@P%\.^]]"F"INGJ5$QK4]&?"24J\3-EJ8XKL*-5F>+ZE6Y8>W^"YX:ZU^,/T
MFS^E+)][<@[5/8CGV*R[SG#(@"_ ]V<6G>GZ2+2L@51=[\J\O;"GJZ57,94%
MNG@R/#B"RJ*;"_J>QF37F]_RPY58L/&I'UAP;$_12>W5-$@Q=7L)=C*5LBKL
MQ@:*$+Z9^2DEJ+N*_G8GCB%E<KD1J/=*&?%^=1X=X[5UQIY)?SJ^'/P1OC;Q
MYH4[X7!-V)=W,XIO/D3'*C/0PU-CV%?R@KF4H&BT)%:ZJ5&\AU+P,Q5M-IDW
M>F[XI-R,<-19],^5J^7-SVF E_SZ/C#Q!ZOU\\"WH0,?1E907J0&\*0&-+77
MHQ<^^@8MO?"[\/&" 4*2USAPDM[P#Y]YR1+$TJ;0$??]=?7RY?+CT _+VL7G
M;VC+<]/IT<G6^RY\HP%G8+[*9XE8*UQ'K)]ZN@VGH?EYEL[\1P<M A]#=;5T
MD[Y?VY??8BO?3\[QW@[2Y],-5(XYU/%^<DB8"XDT/-#3O_V!EV5X@9<O>B+S
MM8#=NT)FMC1?T#]MQ)*S%=[@^AK(W3^WL_$AGAY5RP,*II;W?GDOZ]#]&%6+
M.?99&^5BWY8XCZ/"(\N6G99V',7)X;WYW9P_QZ9JY8=)0=<AJT9C#.F?L"D'
M 0EK[<;Y>//1^57^Z1[-L(#:Y)[N?&5_@0?)=S)5RCP8W\:\/5-;I&KB:+%M
MXRA!P@3PWH.8#X7GMKU?9H_4MVR/J$T.?YW.WR09=HT9W\"."AOA#$98^^1*
M*$UA<30@62'-WO"SU)++9[3NES#1C#"Y-5'"&M_AIAS9O^/EJ.-:7 ]P,<)<
M,73?J=<8HZJIT5NCT&<3RW+AYY4-R?2:H;=S($'(S3_HJDPR"+/D'&PU%[^"
M),)L.F;7[?_X5<F,6M5PJ <S/(2CO0%IW;Q9WLE5XB)>QYD8$H*^,'F8=#14
MXV,S$.*=^Z=@55XG-?'@;. O#'WTI[B9M)]F&.54ZZOQ*#_/(4W!KLI\C*+/
M_-#>V3J3EY?''%ZY"SRUXKB"9> IL$R^TKK&"^;IE.;Q[7BQH7=8BT9LN,#P
M;I\Z^@2(>2C?%:D#==QJ"^:+;^W*Q>N! IN\39W1,8@W[ 'WH^\QB>5^?LC?
MJB=Z6JBWK27VL;;/0K6\/6&UR]O(T$+.7M*5Y&_?EJVX;WY !IX?&!\8-=AR
MB)(F+M?C0G=&M1F\ O8:%/>4%#2$?^C5[06+J=VX?*9.7+,#=F-,MVI/[1<-
M&&0M-:>S5@!?FJQT_HOX\MX)OG4?MF> H^Y/7._%7XT)$\@CQ*_"F;H]E*"U
M/T:^@N\4TPU/9=6($K.R5H2\").!9LB-*9OV'^/?]7808%&R_VR/,W;GFZ;M
MS-XAA?V.$!_D[IXY<U\"TD!@R-1L]-<CF>O%C]7@X5M]6JX^61 F/QVC;NK$
M7$AM8:0$^VZ6G\5P[,4W;N\^UPV[$:,;=8AYN$KEA/ZS>QH4:8<YI7*<5$-C
MU8\U2Y%HA'^\>^)Z&D\?O<SS#=&6C,OO1@1*-FF "-GC_2DS6JUH\#:>V</I
M\@P'E#U_*.&.'W5X[6P&:.E>V93/;R&F8_Q F+ $J$KU=A0(;]'>WB'A7G#A
M;7N+-_6.A62NG28?/1^W]/)-\O=>'WUDA%5[)Z4H9&?KP9]=@N.R+F^U#M8I
MZ5U6QML&$]U@%PM<X8B$ /$C]C>7*UD+EPZ/KICZ?0O9-LL]XG_<GB!KZ]<L
ML"3IZ1[PEEQ!1Z^AN/.P>C.2$R\]FD?E@@]L>8BI-C0U.FT%Y\\EWRO/N/OX
MUI6_ P;C8S_QUE!W_/K&$)SIG>-G81?[[HY63<WXOB_NS9^;VKZ2;D.KA_RO
M25=9SWJ0_>.+?J,K62AK:8K"&TC1E"5B&[:2&(!::N06U]/0,;]E%DQ_RRU
MON320=:WMP]O,ZF-C7!NR[1?( 8'8G2^/-^8US4H)A8,7J_WKO9J;_3GD@UJ
MSJ^P83(6N1>1<82T_TX#6FX5N*;I.F.XQ""VIAVXJGCE>ND6;:-.%G^E>7OE
M$!DO!I^EFY7&YL&=./G-E/+]ADOR5TI3+B?_>QZO3UO\'U!+ P04    " !+
M/%I2CK+.+. W  ! .@  %    &-R;VXM,C R,#$R,S%?9S(N:G!GG;L'5%/?
MMRX:>A-"KT(44!!$1)I2$A!I @9$1 &)BDB)@"A-2@(HO0D(* A!BHB(4>F(
MA!Z*2E,B("5$Z4B"$#:DO?S^[][[/_?<<\<X[ZWLF3&2M7?VFGO-^:WO6VN%
M]8,U#Q(];V5K!>+@X #]9+] K&F0!8B+D_.?@UVXV0<//P\/-S>/(!\?+_\!
MP0,'A 2%A(1%Q$6%1<1$A(1$I47%)"2EI*0.@&5DI25EQ26E)/_Y$0XN]C7<
M/ (\/ *2PD+"DO^?"ZL#),;/P</!P\6A#.(4X^ 2XV#U@" @$/N[?Q70_R@<
MG.PV\O+Q"P@*L4]H$ 5Q<G!Q<7)S_=-J=FT,NQ[$+<8C?EC'G%?"Z0:?<K#D
MJ;CL%_PJ9]]W2ET<):OJWKP7+R H+2,K)W_DJ)KZ,0T]?0/#TV>,+,Y96EG;
MV)YWON1RV?7*53>O6]ZW?7S]_.^'A(:%1SR(?/@H(3$I.24U)_=)7G[!TV>%
M9>45E2^K7E6__E!7W]#8U-S2VM7=T]N'[Q\8'!O_]GV"\&-RBKA ^O5[<6EY
M996R]7=[A[H+[.W_XQ<'B(OC?Y;_TB\QME^<W-Q<W'S_^,7!&?[/"6+</(=U
M>,7-G?AN!$LHGXKCESR;_>)]IX"*[D6RU,U[HX+2JGK$(Y1_7/N79_\]Q^+_
M?WGVOQS[MU]3H -<'.S.XQ(#P4 ,Q[)4#2%!];+8_]=>U@5(@E8U\RB$'NP!
MNOZ(SW<ZO-;--S+:++_PCV,+U>EY710'YCQ@2"J@2]U4L&H>A\KXEFUT:C(:
MWAP3Z*2-=HC8J'S,9FZ 4,F(N>F5L \_9WY:!P2(R^3X/=<HB\NQ-0'QU48O
M4528@E)D=^($4-"#(^?.O/XC&A'*,P*=#3P7@Y[&#L!2YI2@AZ)O?S)4TJ98
MO7@#FLZ9_*T9!(%UB\<^S#*_#%5@?L6)H[1.0Z7(J.K79R] O_^2K<5/N'9Q
M =^O8"S6,4KH3H^=,XHD<E!L;< 30QGYG7'[J^BU)^YWT1LOL((45[KD?5)3
M2F!%SEROP3[/QUM"U[3ACY271BM<4:93GUR)FW1QG[ZIX0+#M#:7RHA[? Y]
M"NJS^W=M:&]TY>--+0IWA_E9H,YC3,GED9ZIV6HL$/\;/7$[I#&!!9KG+XIE
M@>*^)58M3M31K*-=*-R;^BQ03Y"DA^X.8B,J 5YJ1C/;%_RU24<N*#H-S:Y-
M%9.:G$U_9:(O8Z>*^:@2@ RQ__MU(.K&O>X:A(/^ /27S2_4V=8A^.1](D_A
M BQ12?P&"^00@GP 7NSW%=(EAX;6GC7X64#@9];H^NQ-+#ZCV/5%:DLK:1'N
M6#.,5YW[8-;8&6E&$5/"Y@6\&\S[&+;*X<<"]:UIT*AV@&$UUR+]%'G0AQFQ
M,MK+ I5RN&PIM@WC<0=0!!9(W@2"6=],D:=5[0;]R5C-*BVZ2Z\A1,NQ0#Q6
MP "Q^9Q;$Q62ZIP^].K*T\J.58ZX[ >[SHB0B%RFP#A9L^?\;Y,C!EF:Z0]:
M U\8>?W4-#Z!GM<GM>NR0/'6@!4+I$U$*/A/Z4S!\UZ[6T<(A2D\Z3.C"Q_V
M;TTCLT!,P>]$18>RI%ZF\+?MHX'R:P[%VLK#]RX]N@Z-JUD-2H35LT#=X'2E
M<YXRE,RBJ)B31T)6O+=. +^8O\E+2J4W<3HH978WG6+J (=5,78-XVT(7X$S
M8X'O3SJ-//TM,+!]]OM?>(H)9 '"N?H2?VU,7UC(,07W;<Z]3:1"J5G%-(;G
M$*&:(?8F#E=LBTB>XV.!@L!I,#[F<(!TZZSJF')7L;&'UMV/YK^./_LK23K=
M?3W2=9FO P&H$[JSTH0#JM;^&L;K[_$C5)P>*USUH&9&>S%I0M]"2\.A+64U
M[C.6]])4+ZBF)%K4</*;Q(OX?^'Z=R[^9_MR7PD*Q+V(UB5_6DJ.MJRVJ%RY
M[.]V=3$0&AM^,P(D"%J^W9PI.]2_H.>4?_L0B.\><@$V%<44="!N)GZ8C8@B
M+C=17),E= 9>!<[<N .L-$-FWVT[9[:<66B_Q'C#=BQ(C'Z_]>-(](E=)26R
MH_'YONE [8+']A5*HNG1S_:73"+P'7.3A+ZY>IEDJR)B@$YE'+^AX5]OK8TG
MF+;AS&:FJ #TB00JN0/(H#BS@TB6?G8*E]I0\^4>G0)Y/G?<+#LO S05^_BT
MT[3^GSD.W'P)6IQYRIJWLMJ=!>J"$/?N=NVZ7#R:?4'$*VE3U'SU!]]$.YU1
MQ )=G^.@"R3..7UJ0D@!;P)N?\.6*7D<ARVEH[OC4115RE1[\94)*&BW:ED:
MZ@^PXXJ;!0*<R"DW6PHL6:!'=5?,<V/>;CRS"#\F8O(^_G2_JD]MC$H04KBA
M+=A"W$+27TS%4E#*K ,4!G))/29YB"/RXJ@E2-+IWZ93+CP@]P8L&\'7W0X=
M^UJ\8 J&$XX_%3V,:[(]NQ3OJO(P<WZQ54.=:WXX T$^/R<8\4RM'0BO'B(B
MF355GA_AMY<4N>XKW]K/WW==(O1I3\XM\'7$N*ZC3HR<..[EE1RTT-,X?OW6
MG3R4QWRFP/ K[%ST@<O6R6VZE0#6IG5<OQ@Z=VG\C^N=B2:G)&N^=%$TQE_@
M/?">9HR:AHBB?:9KHFRP[CU*LMQ!HZ%R0F7:7+O:Q:.B?.9Y:UN$U:;UO[3+
M$0K4U-%HAI"C=&N/75&M-"4O\,;\K83AS\]@#R(V$*JH<0397B\[D&Y!+IZ\
MM5>1VQU^@O^/3?S9J+#+9W8W$"!K[124=$3WYQ1LVYD%Q5-W. TM3-M2[YK3
MS=<V>T]^8R9)F\T<VR%GK:/9J !^#R1/E(@!27KRB)0KR;7ZGN*SP)(@EC$
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MT#MGRN? ZY*@73-FTC#W"4O+YS008?%FT7IXT3,H(COVQ"@%OF1Q;+4,85@
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MANMANK 9E-8XZ2J9;F@0:#->'OY2L.UN;/AFR?Q5C%WL<@IB^:J"80UGQ&;
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MHS6^\LEK?(',]^CVD-5NKV+>O"S?DGI8F]-I7I-=N>U58E?-&6_D[##SFB4
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M%?R$,[J)0FT5UEC-E-VRT<GI98)WG5- RU.&6GY4Y:-2V/5@O2-,3>::]N3
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MYM6?9ZHZ1WA#C[!PPCR2UQ(&]J>;42Y!?6YMKU((F%52:6\ D[H\5$8'#XH
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M,.UNNL%<#Q_%#?#BTW9+&C9GFO+RZ*M/[IK5U.'(F;MC/8.>M]2PU%YW=I
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MAJ]R\Z%<^Z"V:J%111D=6RQP?)OD<BE6#GG1<O"*YNVT+9&BO4=N-(6?OA-
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M&__62X+:#'RM:32Z_PU=P@=BY?;&<'(4G..ZZR6=2DL/,;0[TM-9Z3]78&E
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MD!XL974_,(U\4]%31$$&\A**3HMS++>/MIUIG.P_VJQ$-Q/AW>>K*)ZFKM/
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M/]!BLO:J@;N675IAL^":!LG*V0XD?@#8:Q_?QLD(BH^YKYR(D'P?__,,KXU
MF6)O=AU,,-V?^WP.0CT6_<RCW$$.-?<M^X?%Y^24!P!N/AGV?T<RSU=!KCF
MJ+C]+K'&:60_V 2FOS16R==+H::X) _M4OAQP0F>'<L\?  PR7GE&XV$> ')
MHG>L1XINK3]PLX:<*TX8MLT>\3<:S%:?%$;V/J<2/W$M>#P$JO)-C_K4ALE#
M-J)+.HB-,"[OR#+EB]9YOJ=$YMP3 G\"5X>W:SP3?/D]QT!(CDT=,U'J1'@_
MXX<,QQK^3^]<-T]* */ Z617J!L:3\])H-+KG?Z4@ZV%H#R5BM<M9R89(//-
M1.;ZQ6\6Z&?T63*Y4ALF!6'V\HS!4YY4Z$T\%_S56<BZ#\\SHT^:D+J$#LUN
M&)@!+D_87X-C:I]ND,N%EE4%Q7A99 8$?VU2?@#PIYX!\JX4641]74*"2&S^
M"#P $#QH:@()IO!E._RXR);X2RMR%<M);XMRO*7_$V+W_[9K](7BY'B*,1.*
M6>ISENM4Y\QAIWWW.=I6(/.H,),/[PE',DL**\"4X]<(>+QXV66"I+K4PMNI
MOP+TUK 4&7R<^;#)$\+XV&.%QYATLW=?KGO6GD7J.>!K3E:=1Y\\LSAQXO;@
M84;G=+_BF[X+V'@G!5]C"5"X>UQ-)>#H32> ]P#X*/_X]!*0Q(G"MA7MI:R"
M^3;E.^M7]AVV]Y?"YP:M+"U;GO2J#Y(I70Q)\RF.;VX<SV1^S*W8"'@3W8FZ
M7ZY4FA!=[J!592WDN,<QOOB%6G""&"!)/T(T\M\Y^E?O\]23OIVW;YP[5M^1
M$79C+I0KAYN+!']9CU'@PVSLETR_Q@15&'XAR8.VM;;XLD>5O$6XKOJEA@PJ
MY9-U(%4'2/EZ7CH6>+;/<6@N+_(,XU_880^PI2UEFW="'HZHW1X]\";L3.(Z
M!JJ"/\SP ##A"=3E9(EZEL4BS1)<PXGJBI;0?FJ!286G"W#]*%'?.: 2#U7I
MR/K54Y4M)L(<# 9<(#N7>UD99^0TJFN2Y!Q=MDWK-]6FZ2'-3Z^L'M_NUC1[
M[%'C&2!J(@7O0/^M.2IPNGJMVFHW?R&#L[[?JO0]HJ8Z$E55Y)OX)TH/@+X]
M]$47RU01M_+T<X=-50,*"\U2P,CH"#RUASG/2LFH2P%\=FP;UX,%.C#N' DM
M0[+3/ZV[4R0&.A?YX)/MM%P0$R>%!Y%*.)GH-DX?A[_G3UDRCO019>;]VR E
M./ 3+YC&=P!@?]C%B;J.$+\7Z[^)S'.I.:R%_;>N,?U5^>G"09G'MJ#\>:+O
M+V4U3-*F%YXA-*XW4X:>UMB?2# G@%$K#EXB/Y>/"0)%RK$@NC%J<MI(4IG+
M8YLWJ\>_6QY/01X P@F*'!LDKK*W.+$*'/>%GDSRDV"K<2===^_*<RR28L_W
M;]+T/W1AR4F+VOC7NK L[3.%,0+/$\3<?,5<<CT6G.6^:;^A_T?-(&2KA 7C
MFN'Z87)T$XA"X\J,6/,[NG1Q5\A]\Q;F<\%Q]5Y*_/:6G/*+0S6F^V/6(-U5
MN'QU6/ZBAD!5@S=W0F7 0LB!VJ#T^E/YB=A #HU?F.,3\8%/SYK_?)W(\N>'
M( %Q(\[XVWD,_*[DBCC[+7FT4*F-3H71_K6GT]5>#X#ZK_7*7]S(,^+QSX5]
M9#_EXDQ('(HTB'\9[Z /?IN:#7R[$0@$T]U*.3=4[J.6S#Y5168QK+)F4+#@
MG/)]H@LL0D]UXH90F)GVV]A)S$Y';X1*?E.5IU$<!B77Y'@%T6-,5+N@:*F^
MTZ==&7[,ZEZ%*R:MS=W#6[]2@GT5<I?][ZE\'$DOOU^E\W0Q;-H769SRD5#\
M9?S; &-EFPVD7Q8*\\HA&\<2ZSV;]E)_KL>G.-;V5HR/MY9CE^W&.EA-K&52
MXG:=\"TC<DVMT<G;OH;_:-NC:X[=_GSUZ]93BN9XUT?:@8X3@10.@6RA@^<#
MN22V[1UU[2+F#KJMN&<K99^H'P 0%O@9O-#=>#=1"*($/@L)\/#U "[^GF\Q
M]_]%]=LM_/5CIH*>8?SX^.Q[*E12O^,&>5273W11F'9;=_;*.)=KW&,V_/AO
M;I-V+'$42\'"3=W1NR;3XW4%:Z..+/$I50,Y([YZ#CYLM48<0#AQVEDVI?<6
M1>CCFI=_)-3$_X''/UP4-V(0O]=7BQ>FG4A.367JOU G#@8MTE2A2V%8VE;T
MQ^+=*$$$M"US'+FL]VTLC*-LB%98[:]A6&IVMI.%DKD9(L%<0&@@4[*PK+'&
MI<24 T&5&AXDS';3<IYO-\W*[H&L261\%$'+.MW_AT7_G*58FH+GFM Q@'Y>
MYE;+!+;&-'EBF"0IV\:NL^[(I7U081;5]^[1V;1R!YJK'81T0\IT+;OE_;5C
MF$C[>1RL#O^ZV>0.:B1QJG9DI4!UEDI)M6B"F?.MRLBGTT H1GR?H,<72@40
MOC\"(TCUC=L/4<RI/&MB%_CD?1TO$Y?69#4,JS;,ZEZ%BK,&DSR)TINI\@S@
M.M29X: P,89-C>S6EPW?Y'W!-W):)OOM#&?8S_Q[N)&6BCC6TYO_-RF$8V4@
M6BVB?,6;R0@&M>2RB;45"PYWZ7TSUA3N> 7^)?6JL6I3L')_[^)71#VG;3;>
M]9)FHAB<F9E5-E=O$$3T[Q-/9]('6-E:V]#.L>,591DVGNW1S"]27:V[F;W8
M:^&N)$.8F,H]<U9,5>&:O52W2Y)FNTG6SV-TG5J*X6!5-E63-[KG?=P,);@"
MR(J)>C?CY:2LU74KCZV^K7;6(<P*'8C6!WE2JFJ!:2;O/C>AUO*0[X3>H0**
M&VEU'- C-G&I/,EINK]]79++AR]K/J-:>ES(,1ZP.;\9J?-U@98):K%?/VR7
M5)"JYEJJS)_>BPW(R6]8T$+>H*FO4M?-.&<KB>5A[?UJ#,0!DV)MB:ILZ)34
MRQLQ1%#XY3HA^(N9+,RO_8OV;EHPNVRER 9I019ALUL\F=^<702WR41BH&3F
ME(X 5/(J65-5Z87>V>XR"7FGU]ISM'<80M8F#_:RB/9MSW=5&9\'@-<C0RQN
M").X06Y>_ TQS[=U=33!0"O[_7,!D=]VZQRQ2ZAY6! QN-ZE89^QTO:\L^C
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MX3X%^";7C"ST!+;B?_.M 3@N^42#["L25,9)KY8&4FPCE?)XM7E89K8\HE2
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M(P/+BU1+-^P,8Q,'ZM1%6#5_\/0\P&$-T"K?']U$$&)5\'4]NE)=I'E!Y?>
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MD X.P#60)%>["YU: ]9 >1<3F7S(GDL\.)^$9B)V]*)%3*U!6];;WU;:"9\
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M3X#!CA.%6?56I%#H267CI8;V=1T'?AT4^V7H[U5UP?%&J_(_"? \4G)D>D8
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MU&]2'[49YPERZ504*$EQ%&/5_DW[+/.,(5X YA'VMH''EK4%+]HG_)')T:^
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M=PG1RGWCCC%ERRU?R[ 8^X_# \G;=)^#@@9S6+KH+?)N-&T$%DCFO;'_.TF
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M+&+(A9#J K^U,6WKC#%V]0\I+ G:S%<W\Q4RI_BUB[)_P4EAO7JC.=?)^@M
M5W[]9X[.%-FWWA[QNCQTH( 08B/L4PSM+RUDY1<W<OX"Y9^34MBQK[9#LB[S
M2&T+HHLKCYZ;X,9Y_79HP!<0L!)BS]7I\4MV!9QJY*FN(,!>_\3((W:S37<K
MC4R4V>!G+"QVO^>/6S>*P>)[[T"E<,G!DB0Y2B>P(NQ\5S2 _Q>S<NY9;-8=
M*R+?X>@?K!LI(8LJ@LJ#!LX,)YX C>O<HPQ^!8P7N7!IA9]YMNR?8;IT8.OV
MA/>HP8%VH0@5O);9S[<F^DM;3X!]X&1>;_7A[NEB+Y\CC"7"CXJ&OG+Z%J(&
MK^MET97QV<X!,8W[I ZUA(D3:PVFTRPFD/PJ80A+K3I>RFC">XMMO]W31T2D
M)B*OZP"800Y%_#[8=.Q$,=>NE!2"C$"JPJL]>:Y)T)20D5%FT]@%Q?@K8JU>
M&:'KQ8C\V?!<8(I_:5=%@A3E32H"S]&+[G-+5HKY(!7^[<U;M#_L+#KSC3;,
MDGK3OMV3XK;!3I0[JUE$P9W<1W JT$D"_^B4;T&.#;G9'TC03%BT5+%.VUGN
MPG5;_(,R)64*:Q_ 2-!="?HBKP]S!.KJSQ YT74WV'SL//6(^).5@*IJQW5O
MV23J9"@[?+6Y!O(;=_Z<:F/,:O#<6$?YTW?<>^5J#ZBP)J+K#:+?SZZV\[E;
M!E=]E]:H-!96Z)'(?7RW""I4>L*W1KM$B]^UY*#HXR*;^TE(LBL>W(Y\EYD2
MS9"W[Y-DN?&RS?X%B]UL=6'X(>#.%R-'?@D[B_Q;SX1C_AR$$LUM4)LYWREO
MXV3S#GNA#G\[]F\Y$_Y]5_G?E'507''XZD!5@8F*]R=B1Y*14E[<]YH\4+.'
MGOZ$KCDCTQNCK"S2\CS2]'N\PL$MRQ613=5,D(N5)F>H]/5Y1^&74KS3%J7
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MI%AB&FS/J?T?Z3IZ"];R.N?OQ\@X1$N4KX;&].B9#$ /K M*CJ"SRY=]/[V
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MZ.+$*.KTW51!<RKM9'XQ--S>ZH[^2<$3I'^U>H.7>P*P._DF1PZO"5LF\<Z
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MU-SY8841BY5^3-BY/'F 0:KO]I2:]!.^-+,1J+LAC)D+S<%KEJ'BWYWO/3L
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MS>K#S5_.>1P$R"'@5E7P3B LO2TCSL"Y?D7HT//#>MGSH2$7Z1Y&#L I?6.
MO>U6#N&M4H#5K%Y]JE:<E4;RBT? >NHK2-W.CT1"OT[Z_F76FO@NUH)]&6C,
M']LJFPPA+[5"I./F:: YX0DLM*7&8<;?!WZGTXOR_G[PPD!?[072E1W">YL_
MB<9?Z79J/ ,.0:@PS@,X24D<7<Q;'S.AZC=(C4BB"-W#67P>QAY$ZZ8D:[N;
MYZ[4)&.>0(#H%F09W'_CX]TA;>%:\4;J2??QLYM34N!P@/V(G#JZ>ZCKZ1J3
M';Y&L_/UEY(P1EC[=O.VZDRIMSO<- JK4";;(W:HLB\^Q:?O6^X!3B#J])V,
M!#WRMM9\Q%UN/7\L&TV9P0 :EL;^J?QBDOW584&L\ 8([K4O.\P8$_S</N>4
M_>^;S<SP^BXC=SLK_V9WO(<"X_G>D84\T^GG7,S>:&#:>5..A5FA86R Q 2I
MU*TJC1D>-MPFXG)RIM8[_5(%.K0")2\.G-!S#JNTGW[M.F+08WH/8#,'IWU-
M#ZH_"7?\P;RR]N;HBO"U,C9T]Z+FPSJ^A1C]+D=MY9IM5]&MU*641E!HU\-F
M/D,UG^%>0L,RR!X#O@&5OP#JM6,R?.4]!/C2ZNY1=5$A^X,7J@M0%MKALLN4
M8Y#RWVW*OD3\8S!::^4>L.%\#QC\X.[/BF(9(\4$X.$#N<;^8+/UK SCIJJ9
M.]EFC >'VUF^F1+Y/T@6H:0<4O(0=!<%]F0,8WD+-DOZ3VX 0=M(V#V I7K2
M4YKF(F.YZD/ 'Q=52N&>$P"(9&]&]:@YU?VZ[A<X! =0\+*IX0[J])$$IL:<
M$(1F:YK*'JORGJD.=4<R2891:W:A;C0(Z-^BU?&'C?@!Q.RI4$4YOX_6/2>/
M;:$LF#BAQHJ6(V110PJ56 E)Y9ODU)7CQ?S &540\W30(?(><$YR*ARQ_FP&
M*XRPM[_S_>,L=JD2\<62LO;%T%U)M;R\J+&V5_Q84>NE8-%QZI8Q5V$]=/9#
M[0\:\[C?0[ARW\12\6T@;1>CR3+&_-UF^D)10W)OEFHH8JQ907ID ,:1/.V^
M$O<5*583!7HT*TR8:%>WESXF-VJ;N>:(%%)R;Y,F&G8_2? ^>&D<GUYD4:9B
MJM79W*XXGY=F%!A1&88 $A] ^5&X%C3&[E2#=![<T91N&:6FROQ&3<$=&1K
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M_+Y8-#J9@[X26!2(/C>ZL9;3J]0+Q7YN7+BX!\08Z(5QM+L7'1*N[XY.^*=
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M#@\AO_L.2XGI#D;V+Q&.%!/VA(BWC\)E+^4@KNR$P("(G7E]<]3XC?][4).
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M. 05C?AY#PA^CZY611-GM!DG%SUC&>=5+G46>' 8N^;!XJTS83/TEYY*H'*
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MZ'*/PK0CEN*#FQOC0U\=J?V0NPSAU%2*F1;*DI(WGI_8,\3,;X8$Z^2N'R_
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M1SGU.\9&-!KN&@>>4T7D!)?@.4+\:X,+\VZ,:(\UXLH;@;[BW/:WG??#NU5
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MNJ._[S86]E7_V_I+HU_G;;CC]3$2X1'GT>6!JFCCX/VB-3+]>=7/8?CH@BX
M,*8$N>(0]'O4^S%5&?CHJ[3#[2N4F_CGK)\1&;D#/C/7VES7$*5V1?2-V6'%
MR>NK( .XH P]L+6]^MHB5.RVI6<?[G%'N;/CN-=C=OC! ]$&($ZO3@=[V-WD
M(-\:;#9X:V-T=TWO <%1PFG5]$!GZ$],<Q 3)OK;.0E*,B\L;NHS:&TM\QY@
M?@KV/] KPZW8BE4/]%/>,<#$1]0)?_^4\./XZ\'/KE2X],_]+UP1'D3.+[:@
MN &OB*:],(G"$&"2P1=]I;08?I>>K0F,@58*KLV4?X+N^YT$>)W"ZO1<XXQ*
MRA-%!.=Q;\?Y\C?0@WB%\?'.N@5VKH@$E@]A-28UF^K2)(Z"\^FH1HZA>(XT
M\V,HM&,WJK"KD=)NA(FA;IH-9?>%] G6<T^K'C&@](E@A'\@CI$2#H*4"J]K
MVF=K>;K&!0G&8:,PG%CC.[844/>DN=H@EVE0*:AP$9&YS>\U#5R!!,\A.IS<
M4<9DNQKR.?*\L[F?]:#!=[N6_I'^Z8%C#7.'N]"]V9(2XX$4#Z*XUW?L'*S3
M,W4BW]/_NVKPX!%!&V6E[I8)Z#12 +()V3'\&]X^?N$N3O'3)F7?0[4,K:%8
M,SY\3G2BNTBT#PTC+/1\M(;(NRE,01MW_H2WS+5OW[%:5_((B!.)4I7_/)8+
M#/B(D/)T!2U"%RT0^-:MI\Q-'MCN;+@E=GWQ50'/#==KM5G)D#YEAEJ]?M*/
M$_;D$V,5%,^%A$#?XR15!D6F=<;8="OV>CIB>[[16^8H[AALA5<(8_B"D4+Y
MK"9C.=L&52+O0#MK5; KVM5F2V.:0L-%&)=V<F7E+@VWYA5K8.+',_I;[:5&
M^3@5_:1P^8[8N"RO0!VMG.V^[:GOMUFVP[$<21_'D=G5Z;HK-0%OXOB29;4T
M I<KY<_WX@"B@D])9 08*[>7&5RO58RI]0SG]),M&JM.>$GVP^A?&\[L.SZ"
M#D G<]G$\AF]46L<Y-O+?D:OX>36U2#2J2\>]L6?%F8@+%1VM>TO.$9B$9]]
MN!J>53A7.+]4U&)"F@YZ)ZUF/%V"Z7<D2@RE;5A6?!<#K,$.<V<B$5U-K?4-
MU=-"/I(=*8[LXQ^K=<7NJ%@R+W;!3U"=ZM=*N^T3U]R7PR@M_Q*8I+;7(OA3
MDX3FZ<!H38UWUU9<U+"QW((/L07VN3+&N(.40B[;.B5[>T6XLWT!-,.,GRAU
MC99,N4#0S,CFP7 -@E$XSK$Z*@*!K=KRW$6D><Q_FW#GY<S0@6H3/,PZ1_9'
MD<Z#-ZJ! %XOG/C+E#I-C6P/GH_"+RO5>P^_7G4E6+NLQJ_6JZ165NC#F8P\
M#LZC6K8&%M/29<ZEQ2B/+T*G.^XHIK^,?V50/;- ?(^U-[;-\Q1(.P7?VESY
M/1UJU!Z?:^A?ZPQ*:Z(:KZ12XV.N>\IE&1<9V>'[4/8&2B2M?<!]E3*5\YVW
MCI'?6ZY((L%.[S))O+76V_($J8%&MD-HL/$MB77[C+QQ?7,'?;+VT^3T?N_B
M'!W%-;J%U]X)0/>!P4\1V(^,M-H^R=9T8CW@QKCZW>M2.WK7VQW6X5=3(.J;
M]V,5O<)<<*I!KW,EFG,Y+T?6N88$-46.N8926'4'E-\%:6,Z@OZP_@-8[)-I
MQZ*0JD*:O((SHMV;025%>T>,J1CM".?F"ZNMF!_]%/_]*G]M!Z'7%63D;DT[
MF=M? (K!6N8OV2SC5_#(J=<F;AYJ_S#RR.(]"J,GBI_V>W585CB+=5>LGZQ\
M@)H;(V=-55!Q!N NQ".ZRIJ>\:6B.=KGE=C8DM<QB*5>@^<'CXM[';*LZX3>
M(N?9O,)*/0M,./\!3Q@83::CFB'MJZ$SG)@P).!CW+E,)_4Y122MBTZ+;6S:
MXZG^K]U#F4M$[:&C-)>Q^FUZY3SQ0<Z>B+9ZAR*Z02;CR]9)\='L9^IY=8Q0
MQC&Z:N2WYP';R540TNJ3@+Z_V)RH">ZNQ-19SHX>OT VI?JAHC^,8XTT5 JW
ML#K$]X6<BX<9#5EIFGWZA-LKR+)1FF4NT[F0[ZN;CR&==1T2BB&L#OMBEHH"
M$I30I&$#QC>1:%*-W@/#Y:YAG"BO]L*"G:G62FEIW\]^B2E,((L+KHL0E.3T
MX'FR: SBRJIYJ"2#37[8[B/Y9N#&ML].(:#Z7;A;HIKR*<,KX4A%J@XQ\2&;
MI3_4HD\Z7#;\KR8_::E=)Y-W$3M-:*5*_+J=\' _P$=@M:M S7.Q]X#M?.BP
M+V!>W@EC,Y@CLTGGD84 M\T[9?2D'#5;T;C#2(8$^/L+V!5O_R;=0(-OT^\!
MZT5R]P"C>/@+PQJXWV8QAC$,\Z)YE1B[L6I,Q7=XX- ]RSM?#60AOP< 8B$W
MN'.-)0WW@#7+X)#0.^KEY/&O0S_O4A]W@YDDNV_1^@@#+60[WW_]3@WTEO*$
MN<\%(R3>47EK )(0=K7FOF;XB"/]1KYZTI?!6RT")1+_Q?ZT/SF16%58;'Y4
M_!2?0':GUF-O&+E=UYD1*J3_05LE:;"B/E*9S@P?OXPA5(ILE^L'-A:506HM
M\6;;B,G#\&QERIJXKE"B\";G_3-^BMAAY+L3.F+%;O"#3'T>HS9I:-N2]4LI
MO+L]IRWBR<<<DCHFZ2'YOTA_Y14MD\("53$*00Z%5N.74]6$"6*M&HLZ;DQH
M>>O_?V0@RX(DV^"1.K\L#9[ZJ R0U]L&^ZGI6</=TLB+KB@7=M8@^,:8W/QM
M^_P(9L?HZZH#F0$6TC&5,OE=;5"XY+9LX+$"4>2WIY*F43ZM<#-H_L[)S.Y3
MML[*-NJ-L"ZY_%VN-428+UX-FC2"M4QRO3158%:U_:A[&SYG%(*6[L15=$<C
M.I52EOU/[P'"+M03MFP&Q[@)/\ /9H#^ITCS^BD'[CN!&6L'EMM M3'6ES0.
M24/1[Q-QIZU;;Z2YUO2A/_8/U5%CUDSI@M__VU7F(\M [&.6":6JVT"V1SFH
MV<T%=;C(_"7O!\_.*%\FWP.DU(A.4UX%AQ3KP4(4 C^-ZZ;,^<P31@(3PF,4
M)VB;90+*&V1-G?*WG[M5Z7VKL^OO3K9'V5*G.6==148K.L7J"45'L-K&<9J;
M!FO1X'FJX;] 7W=6^[XHJQOWEGTROS>G08 T,Z[G9%G_(4GI*-@-]*?<N-)'
MMCI$Q5FK[J?33B>\?[]^$!KW)NT>4#JK<=?_ -J(+K!NHL2<-E&]SC_A(;J2
M'C>IGNV/9ZLZS&()Z!-OR[!W;>*$O5KN6GI<7\E_U%RED-XYX=VF!CKTH:.#
M3##^4A,L^]U0O@)'&'?X,MKAZWPQM%1BU.=.DRHCP7WJT7<[CF4\VW7]GS/+
M(8E1(RAFO(NC[0X0-S9YOFRS/O]6=L.L^XCN^(5/!*X,/;WVE7L7*:+? <Z9
M]';L-_RO_@&;?159G!=@P-W\3!.WV L8>EK[M3["CAJ*^[X,UC_\L/!;;=U'
M_S+(ITAWKC@71%(S(=JAE181 @+VYBGFSNGN7<6R<=1Q;S Q42S\R97:Q[.,
M3(LDR6V[LITS#BM9,WRU>ZQE8 R+4(MA3>*;8%4.\"[U(BYXW;4F,U3X?IR[
MPDZ$ :Q2%3TU]G">_G4)I>+ET5+Q_XO;&.,YYEO7>CO>5=RPK8J&BK!)6=P!
M_D>]0_#)RT"$WGG!I1>JZD^!33.)MRBHYH!G7R(ZTT$HR*E/I0)WQ^\U5DVP
M![J#G#UJ&=GQI0-Q-H;2'2ARV>O "_SHG;9U GS]O*8'^K*C*9XY0G!+2YK?
M8(#AJR'_% -,9:A?U,D2,";Y@T)A^(5A(S^XP2>U$1<TG&?/9V?WR+[$U,],
M/$ZFP5?XN.O/ZC(51*30N@C;=[6)ZO]8.8:"5*APNPM"TO*XVW&T.7)!DWZN
M8%+K)O;I#,W:A@FAGR\&",Q,Z9.F60\(ZS?GLHJBTGTUSX2>=$]GS%^!;Q\6
MP=%LX"[DGZ)06A&BW$R-&&B+D _+RN1@<6_=Z#HN9/QW0U,-="=%[&?+;8^%
M4^VQDU^C@@3&,"<)72Z3I%@YZ4WI40PS4JE11_&Q[PR)<C(ITR7B+UAB?I&^
M_]UPU.[+.WV*H%9<N0< BP0,#?Z 4@M:ZED:"2=U/;G6TDASQ/&NV/XG &B$
M?U5_D?<[3$;H)LZ":B]=.GRJ;]\)RP2,\@HZZ)O5,3 $+P:PQ]P"AD^1;+>I
M!XE\(5=1-U$_>(6?+ZW? Y[\_GJC NSR3P\IPCI\F)22R[&Q<^%)+#2'Q HW
M^!OI'!-V]<F2A-1TT_0PUP(CK]+J'-I][(E5H;K:'V'%%=O,88EO.OWM.LH6
M9/ " #M'!L/M@U\@%-[R&(X.0QMX^7:*+:F=U?$ZJW4,[() 0+$HP:M-I!I,
M)?7U'O"XJ9*P^Y>U,_6IOCC^,S&IOO89/]]?1#<-?I[@ *'\4S#.=IW=IN^H
MG07MN\=#4W,"8-SN5:,/UQ!Q6DA(?"3-)@="'H)!NB$);G/_%1FZU>6K _#Q
M.SPGXT>S\NEUU/!^%;,,57;D6ZMI\5[&R<T,@@@Z'PO\-^?K:5XJ=\([N%9'
M1B N;-&9XSV@_6UL;ZD932=X$/_[VNUN"0ZWL=!S[M=+M5'#3[$#G0V>.':M
MMFN .VYHV'CS^DMHO/\6.R27N>XHPNL>L"J=-$!]#U",<*CI=/9\=S15E&13
MM1?:-46#O\D@[^7:_*V1E#D7 \P_MPQGC:J$J3CF+))X6A9[7V+:]03WM/3>
M:I S5"CHJCEFSQ^N>P8!L6<^.*B;>X"=B5O ZYN]=22]3<;<G<C$8<+LVDFD
M4^+=[LV?2VT&@J5RG^B4L4K6^A]43V__J%5_2_.(*[#<E4&6WT#*A E8\)#Q
M]J$ L99.[\!5@F]W(J/,%D2,=P^9+FY7D,4W.O,-$'X&,C6S.]Q[P'3QZXS'
MU)I'%+2&V6^J8,/"J&8&L]!=">D.KP@I 86.>\#?EGO ?E=C;-T#KIXF\3;O
MGR0F=/:6,D[=:-KUMGL )8-8T'651[1_X8=,6'#[IRJ[O[,+K'T^D_[("N$_
M#FY5GL69#QV*IS2E4_UD;T*1(7M[]P \U;G<E@SBQ:-%MB*CCZ!,%7:P[*6V
M[RM1_^XW6C]0S70F<1==*<)%0*GCN2*;GX\V8_VV,"6DG>E4$]YT*/V?I#ID
M$84^V9'O=:D%@O&>/5(@]K3L2+0&\<+>6XCSFY#\$<4O=@=6\ 72=8BL:8\7
M7QCOC$;-*PJT1\8>RHH#HUYIJ.52M&49Y'(!7VN/&)<G18 6[7Q6?.3]%13J
MRGAN.+#3EZ*W9\:@J>"@8B.LNW[EI&M^"EV]+FY7RYW)-5DK8W"=!27;%]/G
MEBX[RZ$/5$A#[IA)(@G*8;.*GY6 4^5-1$#LW]?^B$L"<;&C$T:H-LJWV!H%
M]Z\VXAAEH)W;G<2+B$Q@FW@*VR61O=F37)GGQS+@<A+> \@?/[\]2L[8,W+)
M655&@D<.-#3R,LYJ)P2=3L@BT9[:R3=.L4DM54ZGI+X-GBC1>P#M:7[(CU/\
M$^1K[ XY G^GR*(M8I\:,Y$\CP^: ?]T6;T'1)![+K=;!O'I71.N)O6CR=N[
M7X0,*=T#JOYJ=P<TM6'=-$$ K+O4H48T?.=/RAG7/8 XW0<813>JA,GCB#RE
M[/#^@D;>L"X]\K +$#Y/[]KD4\]4/0.JX5SE%:9L1<2K3-](_F:?JIODH^)5
M\*YQ.0'FL^)@K[2M!:C-.54/?8W$D;Q2(Q5#EWK:85W>] ET*XDA5.CFQIH%
M@GM #O).> -8H=XC99KU7+-U7&9!,I;[QUW&3Z^IU)QYJW,[:(X,4X4RS13E
MAEI]W,PI#4?TY)IQQ9?43;G?-NC\U_F)<W*W"ZLC\&UX@NM8_J#1[< KN<2$
M:+I5CNAAOP:'1YE@$7+D+!) PRP@NX!?$$,ZSM+HX^Y::C GYV6R)US4QQ:M
M$[UA(L-T2^Q-D=,HN)K;):W=\K?;U-/XXXBJW&R<J'PZ)GX\8W7;V9,1^K=8
M6"QM8G-E.-<7LTTZU62"S5^)7>6CGS>:U4^N*%;]R,W9R.RH@+VM94)\EN;:
M,2;9NP)&53CE8S]OOV\^GGHD:?[M2N <G'F@Z:VY2@BFVFZ>3?EU224?]SB)
M[O=7L-=.9.#^!\=QYS_2JOEZ6:Z27&/%_$:/Y\0*5!_''$A?T3JDTX1H5)BQ
M)PH8ADD+MN9_K\UV_L.H:=;;!.)=!LQNB=/^_I=C2]2GR:^E[P&].B%WC>QW
M;^J7YY[BK!""Q.\F9<\8/U6V^@[#C[5>W .0RLTQ)?N@[T,VRV1GT-_]=(K,
MP0H/=95ZF,Z1#]"=OV%<W2G3[=)N7A$^SPT<1#_4AFO0/8#TAYR9U),6,C'L
M+>_Y8>M7%# 90=X'PN_V]*P%9R7H!<V.%#.\S>$5^(VNU!0E#>(K?"%U56'N
MQ?.&AHL+0SP'9X8*7VJ.#8AR4(/?SE_ NF![1E$>E@YYNA\LO9X,.DA0;T3]
MHUAJINEH?6/2J(Q'#D*% ?FH#T+YL/D-=G-\Z%JI4RTDDV?',*F-]&D_BB^X
MSKLZ<M##LJYORWV)%(@+NG:+/[2BZ?0F%8#!NQE?HZW=H5Z2@<(U]JT&F0[8
M9_^0]-5Y'\8AV-\!;D7*L-R9P?OL?"M^>A#WL@LZ9_4_>RT-FB.:7ECYDE@5
M'V4E[GVL02VKED,$/)1W@A@$=YW29TN</\BAFL/<HP15QKTY;+1?]_MPUOQL
M!&GB\=58H/RD><./9^_H8!=JU1I>&(5SFB'W"'W^<%"JH4W<#0=F@$SY'O#<
M6&.N(=\U9MTKG@]8#/"\=;X'//4FM5@;)E3)6?PL^7T@,8EZD^9U]PW>*4O-
M!6 Z'2K!UW%$M#-FW(H1A,1-46JGJ& G'^#;%7@H4G/XJ4I. ]<(P:'6S(HH
M.'TG6_5<\<'1-.1GR"R5O>:Z3%F^ >XRS9H0$69:CCXR*N!3C*,S6.(<"(".
M&Y$&USD2!71K-2&D;OK>VI..7Y2 GQS[J')Q"DLFN]8N;8Z)ZYJFOYT98X>Q
M.3OM8:?KK.[HD^30'$$-AG2<E:.N^GM5/NVI/\HW2B2VMKJ\;"F(3C,"G91)
MVWA(AQ:;WB:JZYA);KH/WTD;-CH9X4[;,8UYOUY%O))O!-$%W#:I4:H1C 0N
M.WV1KJ<]L&+]#YLQR:=9:/=N%14Z[+<ZWG*AI!2#2*5KREE\STP&7,N'GD][
MTQ/V)S>:GY\.ZHWY2';6:=;;N-69_3'>B>Z&,HN<_I#9T%46-QTB&/K$+WT1
M?".?BRUL/Z_KBN7[8>=<"[A=EWY2NB^+\I,R0VW^S,,2HD _,83MY[_T:C\U
MDD5R*<=1@R0E5BPG+$NXYBOLC,:-1GF$#24@ E.';(F"RWBNH&^N+!.:#A0P
MS^E.7^JF4;Y>'0>6&4.%=_SB6HPK?O GQ\W^*8M#4850,,E9R",?7FO62M/1
M[R!Z4MN8]MO-7Y:5_PTU<&U"(N::;UC!= <5*-F_HY-4A@MYFHRNPPB+'I:F
MOBO[)N'I>/7I!A]4_\'K\\R&.'&ZZUY6%)N,SP5I"S ;5W'TCBBP@V!*5+3\
M4D0[IBG?^_AIE_4A]7XU7:UFE,AIE^J(6$])B,RU?%H2%6U3_OF!NH)HW.^2
M9P2+X;\YZ#EG9(99@\$0<.74KP:L&1Q%K'>G,+Y?:=E<X<=_>TIUC!?P8N8E
M;#K-3'PM):/-5V)"V)AD81D6TYJU*\'6DJ'_%@%MS/U^_!:POI[X,<"EW96#
M F?759.85 MAA+X-+G:@B.GTL8___0Y@H06(7)N9O,*CT(02*XQ_JK8^O1Q#
ML<6B>$/\MCMU?/'(M*P R$>8G) \6!T?#4R];>9#_HYGA5[Q=]D$HK(/P"$<
M5A(!G:OX/:,3@Y7240V4^_S8=D[5E7+8@8L_-Z,5LVI:3$MT([67&GY'$9(B
M,IJ&05GKGV)ORY84_B,5T_B..<J1LL0IL4K61&LY*@@[9=1Z*[@#\ 64&F2
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M>Y?1);:BF(]-+%C;8[VK/RN1!RYHZH[!#/:[MP;G= EE5RF71DTE6!6K*2#
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M^F"TN@B_ZTQEB,#O\H+$_P"UCM0-#OA%K&HZ;\2='.G(\VZ0P31(26>!R-P
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MQL? T3^'O#5VNM^*]9M&TQ8;<#;:++(SREOF."=R@ ] FX]\]MJWPA-[X/\
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MJ'7]%A/]CWLG[U%'%K*>WLK=O0\>F?J.JVHZ=::MIT]AJ5O'<VMPA26*09#
MT ?&W@SQU<^&6:TN3)/ILA+&)<%HV_O+GU[BO7O!G@.^^(<8U_QD\UKH4GS6
M6EQ2%//3^_(1S@]NYZ\#&>2U3X265C\=M+\+VUPTNF7P%X48_/%""Y:,GO\
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MD]6ZUZGX6UK3OC#I\6D:]-_9OC2PCWZ=K$/R//MY&2,9(ZD?5ACF@#H?VE-
M6Z\*Z=KD48\VQN/)D8#GRY!W^C*H_P"!5R%Y^S9KZV,=QI.M:=?,R!RC!XLY
M'\)P0?J<5V*>(=1\5>&=>^''CJW6W\4)9N;9\ )?E!NC=>Q.5!XZ@$C&"!>\
M&>.;M_!OA:='647&EW=H8W'6ZME!CR1S\R(Y/U% 'A,UAXZ^%NJ"=H]0T64L
M!YL9S#+CL2,HX]CFNDU+7M3^.6M>&M*72_)U"UWI>WD)RAC8KF0C'RA0I.,G
M); ]*^F[&XL_$OANUN9(8KFSU"V24Q2H&5U=0V"#P>M>=_"2TMM$\<>/=!M(
M5@BMK^.6%%'2-PY"CV Q^= '*0WGBOX#ZQ:VVL7,FM>$+F3RTD .8?\ =!)V
M,.3MSM8 XYSCTSQAX^ATG3(X-!\R\U;4+83Z<$LYIXI%)&&)C4YXYP.>GK70
M>(_#VG^*O#]UH^KQ&2UN5PVTX9".0RGL0>17@[^)?$WP&UJ#1+[4+3Q!HLH9
MH;7S<30ID<XZQYSP#E3@X[F@#T/Q+X*TK6O"]CJ?BOP[<>(-4$*FZN+&,6UR
M 5SG9N7=MZ;#D^V:XK0=*@ *_"3XE36<Z-@:)K)QANZ[6''IPA^M>H>%?B?X
M4\7Q)_9NJ1173 9L[HB.4'T /WO^ DU!XV^%7AGQNK37]M]DO\<7UKA)#_O<
M88?7GT(H Y&P^,FL>&=8BT;XJ:$VFR.=J:A; F)QG&[&2"/4J3CTKV%'26-9
M(V5T8!E93D$'H0:^3_B!8SZ7#:^$-,\;W/BUWN@5T]+;>('Y50)-['=\V-B^
M^<< ^V^!_'^BVFBZ/X:U][C1-9M+*&W:WU6$P&5E0)N1FX8$CCG)]* ,#QY<
MQ^$_V@/"_B74#LTZ\M7LWD)P$?YUR3T _>(>?>M'X>_%6]^(/BZZTU].72H[
M%#,8O-W2O@E"&RO3++D#!! Y() [3QGX.TWQQX<ETG55(5COAF0?/#(.C#\R
M".X)%>(^ ]=7X8?%.;POKGV346NG2S&IVCY=<M\BR#O@D @_,OJ0 * /9/&-
MKXPFLQ#X#?2+*24$SW5Z7WJ>VQ50@GW;/TKP3[%XC^&6JW$OB_26O7U)VE?4
M(+@2NRKC<<=< L,DX^\/:O</&'Q*TWPSX'B\3:<D>LVT]PL$(AG"JY).?FP>
MFUN,=17G/C[XJZ+XH\!72)X>O3?6Q ;SB(Y--F)PKYZ@'D CK]UL;AF914U9
ME1DXNZ.)^(&H6-[IEAK^CW,4Q(>S?8WS%70D!AU!4@D ]S72:MX&C@\.ZO\
M$U9XHVNM/MKZQ49)BN9=GFLPQC.XG;U&7[8!KQO68Q'J1*HL?G113E%&%4R1
MJY '89;@>E>Y6,W_  DGP3\!^'$9B-4U5;6Z4?\ /&*21G'Y*II4X<D>4<Y<
MSN>07_AV33[[3K#9NO)K9);II20D#2J70$CIMCVN??=U K4\#^%?MGB6W?4%
M#106Z7;QD="W,2GZC#_2NDUZ"3Q!X@OI;/;YU]<W'V=\=[B[%G&A^D43X^IK
M7\'O!<WVNWUHFR"347AMP1R(8U"QC\%X_ UG7DXTVT71CS329UJMY,;/N^7O
MVKDM)E\9>*K.\UWP^=.CTF&5XK6UNR5EO"@R=G')(]QZ=B:Z'56/]EW1BSGR
M'P ,G.TUY?KMW=Z?\,_AS=:?*T,L+7\T;I_#(MSG=]0-OX5R86G&5VT=&(G*
M-DF=!X^N;34_ARE\IP9FB>!6ZY8C*_7&?RKZ2TF.6+1;*.XSYR6\:R9Z[@HS
M^M>(:+X9T:ZU*VUN^\+:[>7F_P"TV]II[B?2KB0\B5'.-BDG=M<C'0@]*]DU
M[Q'9>&/#[:OKC_9X(S&L@4[L,S!<#UP3^0)KMI4_9QY3EJ3YY7.7^(WPY3Q5
M+;:QI$_V'Q!8KBWN-N4E')$;CT.3SVR>M</HE_-J6F))=6S6]VCM#<P-_P L
MY$)5A^8KW*2XAB>%)9HT:=]D2LP!D;:6POJ=JL<#L">U>*W<D5OX_P!=AMPR
MQWGDZE"",;UD0*2!]4Y]S6&+A>'-V-<--J5B=FV\'.:12,9_BS^0K,U[7X]'
M:T@ALY+_ %"]E\JVM(CAI&_H,D#\:LZ=>1ZSH$%[!OA6[B+9!&Z,G@X/3(->
M;R24>9['?SJ_*MS07 .20<=C4RY P3@'TKRKQ%\,[N2U:XT[4KF_GC!;RKEM
MS/\ [I]>.G>H+'Q#'I5QI<'A%]9O+^Z(AOM$OQO"R#@>6X (R<\8^OI71'#J
M<;PE<PE6<7:4;'L*IM3+<DG IR1ETQT&<YKG]*\4^9?7&E^);0Z'JEIM+6UU
M,NUD/1E;C(^E=+;>6;</;3+,KC(D1LJWTKGE"4':2-HS4E=#2,%@6& !^O:I
MHEV0D'GD$>IJ#4KJST:U>[U2[AM8@.7E..3V^OM63HOQ$\*7LZP6^KQ&8'"B
M=&B#'V+ #GTHC"35TA.45HV;VPQ;9>C@YQZ55U"\^SZ?<7Y'$$3S=?O%5)-:
M#,4WR. YD;Y #G ]*RO%UN3X,U-(!\PT^X  ZD>4U$5[R0-Z'@&DP7=_H5\D
M"-+>:M>PV[28SE 2[Y^KF$_A7:R6H\+Z7\0Y]'_</9W2:?#L/S)$'\O/U(;.
M?49K7^$?@FXUKP1%=&2%K2YO;JWN1@?N87M\,S9()RR1J O(#EL^FKX\L3X+
M\::U<ZMI\UUX3\4(IN985)^S3 8.<=,DD]LYXSMKVJB;CH>9%VD27%SX(\(Z
M9H_A>/QCJ&B>9;QS7DFC*%DFD<!EDDG"DJ.>%'\)';%-^*/A6Z\.>%4\2MJG
MV[4=+NH6L=4=56XEB8[3#*5P),<$-U(+#Z^<V>A^'O$?B;3?#_@>RO+QI;Q)
M;F^N>0D(SN&T@84 Y)(YP!S7LGQ9\'>(/%A\-^%M!MW318WWW5Y)+O\ *V (
MNXLVYB%+'G)8GKP35)\RV)>C,C0)-?\ BP9'TVZG\.>%;=MCW$6!<W;@<A6_
MA49Z_P ^0*\G@SP3=,Z>&/ VL>+I<_-J$M]);V\I[XF9U#?501[U[/8:'INF
MZ%;Z-;6D7V"WC6-('0,N!Z@]3GG/KS7@OQ7UKQ+.TNGWURUO+)<FVLM!LI64
ME/X9&"#,P92I'S*H)(P2K*",(Q5D-R<G=F;XF^&VF06,MU<>&-5\-B/A[BTO
M4U.V@]Y5'[U0/49QZ&K'@_0-$U_3H?"<D=OHOBVQ4WFDZW8N2M\N=P;<.6Z=
M.HP<8(9:HP_ WQOH&AMXAM-1MK2^MH3.;6&9A*J@9*[@-I.!TS@^M00+]ET;
M1O&6GPBV\J]M;F-8U*I'(TDL=Q$O;:S1(X4<*'8  &J$>D>'?B)KVG:Q)H'B
MJT;_ (2*W^5K=IMD>I1A3AX"1CS20ORY56!;HPQ7/_$3Q]I<'AU+/2WNM0U;
M4) YD;:A=E41D7,2%2DZ$+M*HIS''@D K7I_Q.\)Z-XD\'WEQK"F&738)+JW
MO(N)+<JI8D'N..1W]B 1\]^#M;L](6X\9ZZ3KOB>>80:192,9',@ 'GR <X'
M"KW)!QSR 1T^C>!]/\+O;:W\2$EU[Q1JC!K'0 WF22N>C2YZ^Y;Y1SG<>*]>
MUOP?)XJ\*6R:U9Z?'K,"EH/+>98;<E@0F8W5F 4!201DC( Z5C?"WP/J-C)/
MXN\:LUSXEU+G][R;6(_P =%)[@=!A>.<]EXG\4:5X0T.75-;N5AAC'RH#EY6
M[*@[D_\ US@<T <=X@\4:C\+_#]WK'B[6O[=O;V18K&P@MUMXHR 3@?>;'<L
M2>PZ]?'/'K_$KQ'X/'BCQ07M=%DF18[%"8U56SM<QC^'( W.<Y88X-;_ (9%
MU\=/BD^KZULBT/1MK)8%P3M).U,=]Q7+-[8],?14T,=Q"T4\:2QN,,CJ"&'H
M0: /E_X>^.AH/@NYT+P?X8U74M;OU;[7>6[$&-CD*4"JQ&T'C..<GVJAK7CK
M6/#C66BZCX-TZQ-FRW7D7JS,]PY'$LV)%$ISD_,#S^5?5EK:6UC;K!96\5O"
MOW8X4"*/H!Q7S3XVL['QO^T=/IM]<?9]-MP([JX#A/+CBAWR$L>!@@C)H YJ
M;XR^*6NKZYLTTNQGU  74D&GQEI@%"@,7#9&!T/')K=^'=S\0_B#<W&G:1XI
MDTNUL859C&HBC3)PJJL8 &<'T'!KI=3^'/PYM=3AM;:.Z06NJBVO)[FY(C,<
M4!GFYXX"[5)X.6X]:ROA+X]TOPMINL0:+X?U/5-5U"]:2&RLHBX2!1^[#.<G
M@LW.#0!V:_"WXBLN9?B?>*YZA5D('_CXK,UGX-?$'6-/DLK_ ,>#4+9F!,-T
MTI4X.0<<\U0U#XQ_$;4]:_LKP]X?LH[EAN\BV'VN6(9Q\[*VU??(&.^*Z/2=
M&^-^I1B?4O%.GZ0K?\L#:PRNOX+&1_X]0!PQ_9M\70.&L]9TD-SDF65"/RC-
M+<_ 3XB,$#ZW8W(7. +Z8[?^^D'Z>E>JP:)\5;%BR^+=&U3'*I>Z?Y0;V)CP
M12S?$76?"^W_ (6!X8ELK7.TZIIDGVFW'NR_?0?7- 'D\'P@^+&GR8L-6:';
MP&@U5T_+I3M5^%_Q?U+3)++4+YK^VED5Y(7U$-O8# 8[NN,#J>P]*^B])UG3
MM>T]+[1KV&]M9/NRPN&'T/H?8\U=H"YX]\'/A3K/@[7K[7/$TL#74\!@B2.0
MR-\S!F9FQU^4>O4U[#110(*" 001D'J#110!Y!X\^ VGZS,VJ^#I5T;5%;S/
M*7*PR-G.1CF,Y[CCV[UE^'?C'KWA;7(O#GQ6TYK=AA!J(7!QT#-CY77_ &E_
M(U[G7G/QPU'P]8?#NX7Q!:Q7=S<!H]/B;[XF(^^IZ@+U)Z'@'KB@9Z#;7,%Y
M:QW-I-'/!*H:.6-@RN#T((ZBI'19(V210R,,,K#((]*\F^%^A^)/!/P^TV%+
M)[NXU:Y>:6&5L+8*T1\LL.N-RKNQR-W3(Y](\.ZC>:KX?M;S5-.DTV\D4B:T
MD.3&P)4\]P<9!]"*!'+R^'$\ SW>I>"/#]YJ']H$"XTJWNXXK=#_ ,]0K]#V
MPO&.W%;NE^']+ET*1+KPY9Z?_:2B2^L/+C=2Y'(;:-K$>M5O&WC:U\%V%L[V
MLU_?WTODV5C!]^=_Z 9&3@]1Q7#^./C&XD3PWX"@.I>(KH"(O 1)':N1R 1P
M[#GG[HZD\$4#-#X;:E#8^/O%G@_2[AI]'TQXY+)&<M]F+#][$">=H<X [8-%
M:GPK^'W_  @GA^7[?*+C6-0<37TV<\\X0'N!D\]R2:*!'=4444 <KXY^'NB>
M/=,\C58O+NHP?L][$!YD1]/=?53Q]#S7@LNL^//@QXHTVSUFYNK[1K5G^SP^
M<WV>YC(P0#V(X(4_=/;!Y^I*SM>T#3/$VCS:7K=JEU:S#E6ZJ>S*>H([$4#.
M>\!?$.R\8>"SKMV\%@89FBN4:4!83N^3)/JI7GU)KI=6T?3]>TN;3M8M(KNT
MF&'BE&0??V/H1R*^5?B)\--?^',EVUA/<W'A^]PC7$3$#;NRL<P'<$#!/!/3
MG@>D_#SXYVFJ:O>P^*KJ+2[5;.(VRRL"BR("),,%!.[Y2%.>A ]P"K=Z9K_P
M(UA]3T7SM7\&W,@^TVSG+VI) S['L&Z'HW.#7LOA[Q#IGBG18=5T2Y6XM9AP
M1P5/=6'8CTJ^RPW=L5<1SP3)@@@,KJ1^1!%>-ZUX0UCX4:]+XJ^'\4EWHDAW
M:EHH).U.[)U.!R<]5]UR  >T45C>%?%>D^,=#CU30[CS86^5T;AXF[JP['^?
M4<5LT",;QAJSZ#X*UC5(<>;:6<LL>>F\*=OZXKY]^#VAKJNCA)U,BZSK:6UX
M[\AH((C<-'Z_.VP'U%>[?$6Q;4OAKX@MH_OM82LH'<JI8#\<8K@OV;;R&X\
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MKO6+HREI@V]<OQN"*,DA<#'J,Y[5[/HWP2\":.%/]CB^E7_EI?2&7/U7A?\
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M4#;1)(K&,EE8+D8;(?\ $CX47?AEX/%FJZU>:_912Q+J+L?*N54D*&5\G/)
M&>1QU'3*^%7Q7L/AW'>Z9J-H]]IUQ+Y\=S:*!*&V@8*L0,8'KP<]0:T?&?C;
MQ5\4[,6.E:>='\-RR#]Y<D@W1!R.0"9,$ [(PQ[\\8 .VN?A<;72X]1A^)NM
M66F^6'1[ZX#HB, 1R64#\JX#6#X4GNB1JGB'QY);-@R7U]]GL(C_ +4K\CVP
M0#V/-:.F_##7-?O+6U\0ZR6DMX1Y,6I.TCPQ*H ,=HIX QQO*Y[I74Z'\/\
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M+DM\GR&4RJZK2*VCE:Q4+GBPTTZS<;Z)5^W I?\(@.OZ>K/_^HW_8?D_N7:
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MT^!-%U3DI7:#>J3?SIS3M56^)Z>2!6$OT9Y)CG69WGY==,.AA+]R=[<RTQ=
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M,0RD=MDE);?AN0H,W&6K?N&79!C]R_NZ0<S3:_[5ZI_G'%-)FJZFWGO&88:
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MIE*QRG;T G"IHK:Q][ \,OA06ZWEU<+WP[#KG":3$-11BQ$@89ZE_3;L_MB
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MD[I:YP7@%UJV?<Q [7,!7%\E-$1^'BS;K)8]\O\=G"II[RW28M/VJ%KI8=\
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M,)A#&PAPB0:ID<#FJ1[D!VEKG&$J/%+1#C/K[:30>0VO36MD7/U4MC03UP7
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MHZ!/Z(YJB'-M0(0\:O$J7?T#+.=M!>7MFSP8=!?]%$[Q?Z]X5H+_R>3\MOW
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MZ5E5H^@A';NO2._0'C&4BNZ8ZM*NVE]F_YW8G?_+[%]B__9B Q(0T,[G0>
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M3B?C8Q_:<XV8G>:AUD-#C G1&+LT[/9Q:T<4F4*97RSVFM&P.C"8M%'I&\[
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MK]R">;^9)9D&"XM"GY$[#W]V+]RKJ@2!M.1G&_JJUIHUN[W5-[ @/>)US6Q
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MU$HA^*?LZ4A45QM?XF4W1LBG5]DT=+=<IDIV=:7"G=A95[0$9O+49\Q\C#4
MBX[]^ SF,C4U&'N]A&*))S$N!_0<KM]<C1;^<N\HWL>CS^<LO'W2%8HD3LW!
M OLXP)9\=B(X&>>-^%8SJ4*N^5]=8)'\[K9C\&Q;;O:5M#DW]PW>F\QJ;Z:M
MR%;;>=! )\H5DOA<^#92Y'1I?BFAJ;0@[O%#+;[N;X=?-33L63>[ASC31@K
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M$%%Z%*+TFG +R-A6BZCF1>*K/[IV[U]#B!AV-FFX4V\3V)WU AQ7*AJ3'.4
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M_JS>3I#B@'R0_@U#H6#0X-@;W 4.4-6,J!NU@XO]\3BV68LER\O$LJRA8@[
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MSK!6SS'NL/,_U( 2>CN]9VHMM(S57&*^N?,EQ%;6/MJGTD6+L+S3^MM! 9X
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M$T'RH&HW!V!8Q@Q0#2!E2K+[J>)JT-G[42/QR$?M/389,5NZO69; <5UW!\
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M?"'"&X=/T"F:_'%H%TVU 5:GSHY.+K.!:PNJH8Y6E=8U/GZK\]0.&B8\!?D
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M4O?2#.R>LC3KE,(WD9KF4\]'9 0"K)&') EP1(<0!G[?;[@-)$M>9@,*[]F
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M>M.0[>[K4UF=;#90$ML"= 1=:)BSE!=85KEJRB%\# C^NM*0*=V[YMZ]:K&
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M]RAJX$$E0ZW>3!'WZL3H^37C$H3@Y3U_X:9_7GA!"4.9(D!*;LUST!9T&%[
M'B=.M68J779>WZ5MOW ,[GO>6?LZJ<6S4/I3Q]K09MUA7>&RNV?<%C)^*7X8
M$4</%L'7?6!G/&+BC$UA?GT!)KG_4F*XT9=5A9F(1%3ZEV$V !_,^N$*<9K^
MFT,^R@+K7J#+E*H3M="K?%SF';U"LQJ7%0N5^RP"JZ+*7Q%G5)#?[<-I(]+J
M,7YP^6M'"6[K^^\G/ESO&#3 9I<VC2Y&M98GC6_8K?E15L^MRP!9&FX/?(_S
MYNVEC_*9,M0!774-_^F*;.,JB57\%ASG<"_/<\J8&]@M;$6651\4(%%:2!L\
ME71HJ;,<P_>D!<0)IM0WRRE?@S@>99"EW>[ER$;6ID"(<<=M![^%U[L_IA$:
M-6(RMF5H9C=Y[\Y(]5 WI)XY?B:5AY5FS&F0D4770]8WAW*9*57"V,!<-3_6
M:;@:LG.L,*EX3--*FAXZM9@P;[$);6JTN[*W-V,5Y#-,OH9'$RRHM1$/(9_]
M4:P3*:DNHO<J?1/DXVW, "$>SX'?<":/U^["61 HO776$H'UKONBZM,5OSX?
MKE.Q'>*Y_45ZE'<P?<KK,QE2"ZC1C<)0$*Q9?*V]W$0>M[/7&SY'?='7MEXX
M?!??&.&"WO?[J!&_HUT%VO?VC\Q/V9575B8_3K?;Y2$3K=;R,='*^ =T@R_#
M-V&H;CFS/(Q]@5Z6-)Y&K' @EO*9\'1?T=;\CSYY7H>;&U3:O=8K6-XP[EOD
M&]WI>F3-?52KI.KR/NIEY@9Q1#@=&!Q!Q6/7:5N^$6C+Z;,_WI3A-Z_W)A03
M6SB=H8,9X07#P.^V*SD8P9?9@/PAGF\FIJ EF;::]!*SK+J2RE*CSP9NKC2J
M5817$CN.KR1VA$Z2F?%&Z'9!498&V+B.#:PD8SS[)1GC^QR\+PN62UW)C3%U
M&>5A+>: \]H J*7U2]7Z6DOF2H9'(2T"9G22EB0)4#B6@F:)KN1V#-UC Z^Z
M.)COWF,_+#*--:@H.*:E&<686\D:\?QWFNL0M8.Y <O0F#S]:4%#AGFA6RDN
M224>:Q7.&SPZ[KAJE%,&G;A[YWW49Z$8N!26!.MR5IH&A2E$6LX!@;%-'TR*
M(WMPAT,C3R78>V=?<U0X$ZYSK]%%@G.2#5PA4?=K].?0O1,W5(M3=PPG$(*\
MX:?0Q#8GLO*'SZY!)-HRL-).P V-B*\6C8'Y$5'(@YK94JM9=B\\]A/&+.W9
MH0S#D,2'(K)?*7:3NC/7D/WFQL1#)=KYBTV9HH&6P^I)<K8I'S9@ROS])_8O
M77@Q**2I&_K@.7@U@=1Y:_O6:DMIS\(6";ZG61Q&$T#.(9XO7V8TD$':X=>D
M0I'2X*Q />OH(;62I<C"T7U6IB[XBH1W*@./49]<UIN7HW?M4O[.+9$RI)B@
M?7PTCLOF<-C]2\#1W#^] N7?E5!AF)7".6.SOQ3.&3^VF^?"]L[]AA'WMUGX
MOUD!4HVOB8!Y9Q%=O$#%P*^Y(]A CE0P '_YPR!N# UI%+T ZZ1([GNRB<PC
MB0F[!6Y&8+&_= K"$I9,?&9Y5SH%D99U] !XV\2O?\]@$BE")-+K/QV._J?0
M/PTH_1'ZY:A=)OA:"G2W9HBZ(B*]L/<OY\Z+CZXXG?> ?7D:<'Q"&"9.[X=,
M%#:@"G$2Y^;_]!2?_Q3ZQ^O5?T/HT)9_Y*L)3L;=/QQ[66DJ2$+/1Y('UL--
M]N#W<_Y_Z<G,!?V2C_0NDZ[2Q@:R7.ZC1H5^S7^( (*!:0;S3Y?R_RGT+ZK-
M5L[!T&A9Z8-[=:4/+I8E)?/7/KAXS+@@J5B9%?,"095]$YQ0PP\,.#=/"M-#
MI-&?'X?\#Z%_I5+9_T*(O('Y:;]XW1]@9FQ2V<"^EK^V3OP)B/[UZ"<@^DD_
M =%/0/03$/T$1/_F])N B+X! 43:$]XC:&AC2TN(_PW3\8%)7?WK;_?J=5_-
MQNMOGTV'#29^#U-56?<W-&_'Z;,>,'E&>+\JE$29T,0R<RVTSLL'VJK>'E.3
MN"$25M$J+S&UF9/QZH_._[?EE2,R^7708W(=@IY,"83%RWO7?'YWJM#I.39C
MA#[P28\-E*G0R(\ 4/+'%F*P'56#XBV)%H8&S3J_ZL:&3$]XCVV^,.AL>C1B
M.@)+_O.[JO^G$"X'43MOJ*JXE?HU(_B]0W!SHA2X&CL5Z-X0IM8Y>X9R\]6\
M)NJ0D;P"![8I% PB%_,T2, Z3!Y:6?BXZ_'J$_>Q[@6.]\5UYO<@*"VTE^H=
MZJIS)T2[IM%'L*FJ^.*^48$XH37R7<(Q0,RO)>M7$YBWBK%78]:5L8J)AF*_
ML!Y.-SFO[_PZE[FKB7+MR*0?^=RTRA=6.OTUTP91Y-O8P/F=> 7X-5X30CT]
MH4%O:3AA7%(CIJ2LZ7&YP,'F,!LX4+!8)(L9G=TYY45_^L?@ A/!FA&O0??C
MAI)@W?9B]*H67\DI[#JFHQ=OF?+GQ->MLE-VG*RT:[<Q"^]"[*;C014,-6!N
MMI-GUAIYARILX"J/:8TC21 G_-R;9_-@5JCM67M_[J-3UTZ6G0S>G15RB&<\
M_E=YC;(E#$YH"ZP ?\)R5>NCE]O!EG39]!J]]EQCB>D6VN414J4*O!-#^0A>
M35PY[3'\/9/_N?#7*(ON+[V/7>X5\DOM^GKK;G#KNLVS*1M&2(7+_T]P^$_Z
M#?T+92++T8'OF,>_P5!M, DPRMVJIH842]16W4SWYO4()GN7<?:9^$ITX.SH
M==AV7:;L'8:*)04UJ#M,;FK3/U+IUFB-TKD9HA(7 >:0;'?'.GYT?/J%>*-O
MX@('5/'K1M7OR%1+S. WIY6T4OQ@K0!$S'K6:QMLU=*O_4E/9Y"5_ZC]6D79
M]X]V7_8$VLO'/P\8(96@(T!QIB[#"+>%.A=?O?'IH%>&.,WFJEY&6BC':R=C
ME<BC4T)"?'=%Y<(Y5MM1#V.?9U+/76:*9Y#IFVB7,*M@=<]I'VIJ8V^DU7K[
MJEM+>.':&\S77^Z5^NWB(O"+7*VH+XX#,#DQ6U(6A8<<6[0T%0KW/WC_ODSU
MR=A:LT.A'M]_9V;A!390'#6+II#ZY2F9UPTW,HU[GS%W#6,$!J7R!@<C)_34
MW&O.W.R[NO>0?7]XF(4(!P6D.F"A+;6(6EK]G!55;3SZ1*GT3G/PB]*;%)8V
MM3WDR:LHEUN[3UT]:X^RRA77OV<,;V.:C/#/B7DM#A0\N>R;Z^EPKS'U\N6C
M%8F.:=FG.^0+Q]-N)UJ,)6&/@75G,)2\6F0WAY? W8O.6MWR%>^9,@]5)V%A
M*J.UXM*=32]3<3*/1TX_G7_>L?'0NL+'AI8_8L8!%*292N$,;*,/0YDT22]0
MI^-E[3HK=6751EV':Z]OG01KQOH_$M^W@Y;)2XAHX[X"OVZG:L"\+FR MV26
MF/04YT3CZGE1T%9JXG(>WW(^I_83]:-YQ93R*TH,R^9/!\7_,40RQ%"^:/05
M6 \JP[RZH_9:@]8E@4G#N.A1[VTJ9\TLC_D&A"U\_F 9.;"C(LLXW)?P+CCJ
M<.?L0JAAB&7YQLJ2RO@'Z1MN&/C)"VB^R."[82Y'-;Z/HBC%++O!_!P,GA-@
MW4Z0\@"]ME9B:8=2A$>POX;@&\K(%XN*-Z6-VQE-(K?MJUH%,I*_:?^@N?&5
M"-;G RE?K(7Q]6+!9O69\?%/H(;AU8K>E]IM=ACF#Z^!;$QY[L1J<;+LR''H
M3RE\A>A)1XK&+ \E<R!V."!M%!N5L?E]]:GA$Z=T!Z;T7%^FBT_>.G<Q4?W"
M^W*AJ(UA<C&PH.H Z70FM)G0; TIIQ(ZKM<*0]-VU/S&F<?T5@GK'$]/3.1(
MC]%[RV:CLR?:DDIN?3-"?TP6A3 K9_+631NBNV?R+Y$&^(>3Z00<=V\O4PS?
MZ:'J&TZW$U*(#A[+_I 8O)GX82XLDWH"VR].OU$2S]2G?1MF/?NP>5,OMA9^
M6:% *S;#;3Q[:N+^<ER".^>TBNI=:DXS>@U$VSIH0K..TGY4J;#GG/_F\ZL;
MW?0#MK_=%AQL9_9WB@@21K34&E5R6Y7OB]8'CM)S(!=JBS7#+=I0/A#5T%.^
M]8MG,.M1=J!$ZR>%L,OH>\#E6W9UI.(RIG0A0QK?+J8KZ],4BY;QO.!V]AYE
MT*U'H;QET>V  QL@'U4'#?#'X*%,:E!O(QA-OYR.?HE>W<_4Z?PL*$$3JG3I
M6@@7ND S)A09#770KTP@JT<!Z_:"E"=H;@1;W\;R.S9FBN"L!!^-=YT;L(N:
MB>EXYG4>$SE$EIOMX+93E4S4W:G R7R"O%-G$J4$(X*A%*!%/DPW:F(B\;(3
M1>+O#-!N%]O=S@:M&O%K&5"/211X!AS:__"^&JJ-) [O""RCAT'7<J&B%EF%
MGFK[D1,.)EN''CW]5-/]YLNGCTG%E_AV'GX)^#K]6+,GVH/C@C0*\._)4CAY
M"DI@\ YQ;6"G7<G[2Q#5?(>U2O.CPO?&YPHG  6J:A*QGP#M &%>AG(S8>!;
M(U:VI$H;%&(JEWKK[]-4MQVUKXI[XOK6>'ZKPY[@M;UKMQE( G <&W#+#)?4
MF'E/1=>14 :[-A#V4/?%>CSHBP1VF/KP-3[KFYHM\Y.=L9CR*OP74/S_2<2,
M1!!Q)8F2]@'?E5DX'M7<P3_)!MQIJ76W;BYH1^_82K^V\0UKET^1171DX/&!
ML04YN_DE+/EQ?O; ]+)-=_Q"?LUL_(PU5U,U+7I3A@Z7O8SCQN0K<N';C)M
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M1'P,@B(8U\E+9!YF*.$05$+9^;H^?6@!$5EW]A.N),FO+7O*?5!ITQ'KY1'
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M5%1V:>_><TI [-4V;HNQHNU\N15N9VT.'0\#;Y.@K7-,Z>%1G\&1+[:0#S7
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M_&#'=PHXCP>5AX-VMN2O*:06UHXFFE6KWU+S": ]'A=,O:OI1Y*];/M5X:L
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M=G3_Z(Y"4"\G_HEGU\IH-GJ*FBEN\ZI=J[&S_*AN@CL(:V_H%%"Q?Q/\%R8
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M$G/WK3ENS"7DA2X/!KQQ%$OT\@[+&T2:Y0*2J6/?POWN;^/=(''8FLH",#Z
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M0Z)T)6L KG&,$N5S]BLPK&JELVB@YZ)N<.47N\']55NI]2\RMBRN(=PHHF=
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M//==:)4T+OB#U>2'/V$=?[*6L'C,MRL:UT%)\+L]E'\NF_5/"VIU[4)1WLN
M//^N<_]B&'OC\D(0?CL\H$.P^]5M]9#W]=^X8CX05Z^/EGJM_<SEX"S%MB>P
M+4QK=C;/'VG_NC'WK:5K[:.'JE=_77$. _,T*H,,J#^.ZJ04"R0RM.OZHS%2
MX,D ]!-7_P].'L]?Y5Y+>4GV()[D[4I3O&CB_26%E$NF%E'*"L=!Z>4;9BXV
MK$F?8@LLS;,Q=<'S[_2RKOK>F,GP96Q7W_:"E>:Y<UQO_O>J7%@<H8:,9>Q;
M7OI%+6ME )9UX54Q;T-7UZI!4@29]]NETX.G<S6)QI+^1N:2B-F!3UO9>0C4
M:PJH"-\DWQ3L:\)?6K17:/"84T]4W1@7D>!L;$='Z?CK"FWF(NXZE2%(U\_L
M+U:R=WP@LR3Q,SIYGT@P[_>%:LB,-BP#ADC@R)!):AF#U,BVZ+-,SW1-M(]Q
M<Y@P&2DUX!M/?Q$%N\R''<;'060=>Z7V#&R(^(J9%VX%W1H)K:0%X]WO%3]P
M\\<I<HH0EFKMSSSC3>NLD4?=5B PJ5Z_0^%VEAXG[UGG0"4KGR'18"M60O .
M572,.6P5@W,NO_Y4KQ(U:R.9MK&)T=S+:0 5@&=WP0C DI:"##T]@0T-:5BR
M>U[RH+-I#C>KXNBJNL(O^$ESIZ *.3H!RB137V&&QR!9PO0).BI:H7<NDP2N
M>\FV3RNVOKFQ:V[M.^'M;6$&Z+-7;V_N$&8@LB4&_ON.+HP:@?H^!5#^!'.P
MW=5(:V8,[<RMF#&'F.GGHT=JR]$Z/6,'HSK/[:A,(N3[CLG'CR^>PJ17F=F6
M=^L)S6A1;_5-]EDD>)S:G?:72;_6UC#1E<HQS2IDLA=X:EE @T =698\GECH
M3.8B> /?Q=!O;^7D8!D=I9Y(M.9AOJIZ99Y$T%7Y]C[9TMO-/."K+OMG'5*+
M=3M[/V3F.XYZ+B43C89=G$;J7W?@-NLX7.XZ=^K4<=.#/'RKO K_RA]#L"64
M&0.F",L6N.A+)\56;V/*1N--O4R=.S8NS SMPD3ORO.YDF5J*5H@Q+?*>V&,
MI0R/[76U&M[@>4D79!0J80U<=ETI65UY=]O'G4_7OK7RPSWP=5LE,05DFB,(
M)XC%1!!YEXV*ZF4ZF^&8^SI_#6]HW/X@=&CUO19)$Y[RLSBY+ NIX!U+29PJ
MFK:\!X1^C5MP$;3K"2K4FC@3^ZGVO1;N@]*CB5_*J-Z 3-%C&K;)5A$OTF>1
M2R7* 8]KAJ+OU$Z9]>;U?!#LQVL5+KT67,PU)RABA A4.FG8DMIJII3)G&K8
M>6WKE6O]A85Z)>JOK-PK8RW''Y@)-.W6H!B+P9,Y#NJ'I)(WO,'0[('L1M/3
M;T!]YDT_G<[!O L!_4D1KKD(@MUAAWGM^X2::6SI8?T3OI <7J:BO*5M>,C+
M;Z,1OC!TG#EJ3Z;K$U(HGW]!2W 1%(44+D+UJR0[0;MZ$_S,NC%>+L>;;X5$
M0RLGF+XC2;?T<W1;R:-;%AMLWRCKC6&D,-1)TK KG0^WEE0_JE;+:%F\:LEH
MO'V?H^3A%@3*11WFX00ZQ$+=%,8AU"",^,;)M*@-^.,,B8N^F@$?/,L42L].
MXH.&W>6]8YLBG][VQS9A&BG )N*,!-O27!=M" PSS>KM Z))K@%TH[MNIE-0
M<I&*_-S%#R_USV%RYX9AE]04T&;TO9VLHU+.@X>8!G;[[34M#Z$&PO<%G*OS
MB\AH<BF4#J.>08Y]$F'!<SX&YK]>F&&6R(SV4>:;+!%&Y*P=N(/&'ZGURJI9
MN4GW_.7Z2=/W&ZZG9@4G .'?>.A#F.,I ^OI!J T@974#?M\>MTVK,=X_-3P
M8/'SG9K9RM8A <J";M97!DIT#N]O;\W+AN$,1D6=J$V$FH-H(S,J*79IWU3$
MP33O\(6AXH]9J#(?NO,E!&8[[OB5(I?65 %>&:B,3,W ,O9HQY(9O]@.SFKS
M >*#I&=[/I4IK6.N'?GE15R\UBYEXPN1S3VJEL)WGD9'S6^O/&<#0U0Y_&>N
MH8*0D -;9P"/9AP]R=Y_H[ _'F]J++)V/%Y;I[W8=;:Q0@/IJ*([MJ7A3G7J
MOSPXKL[+!N^1S^W\=YTA,H':C_IB:OEK)QN>JY.F^:\%*9__M\#/LCRW8#Y>
MA>E>/W>)4@)F*3#(\2_-UF9E%!;,// L<8D7V7.J5.?ROA'JF(F?]^*GWW;U
MTZY"\#?0I0? 5.7" DSV%',@>0R=R%F-C4<!MBZP=7P!S7V-1'_7COG^8M+L
M<K]A!&H;)29+&SC%W@=Z$NNS9)AJ<=07C*K;?BWYGE>=MA1HM:S;F\"C'' >
M^[KW9W)6OM/@=IA9^%&L:1?JE=CO1<P%OUVAT0#6?Q^Y_W.:NC\E)??3F3JC
MX].97,3&IXQ.J,%&FXNP5B'1Q,F5G8,&D(TKC<A)N(6%TLQW*9W_ZQ77L(Q@
M"BB]%VI%/5$E"']6?);20$$JN6BY)!NWV2AH/EA@O@FK'"N3ESN5[H/,C2H8
M'6TXX:TZWX+<NCO66O5*=(&7@+4J X%\U\^$P81_6>KT0LMR.!C^<3F4TF3O
MD#8"&.VY%DJHM6IZ;Z,U>/.@^5I+XKIT:DSS]BL#")Y/?Y,A=R SO&S!U4V0
M' 42ZO >*_3J;&$2&Q<3ZPV,Z,,;GM]X5&<;I^H6HUC5Q*ER?>[]91K^$TWX
MI6+.D*FY6,9^+F(%N"-M]#VC'2:+9T(?F::NZ]:\J>!G]7YO;L[Y(X$1%TPT
MV'M[2MF1ZVVCN[M7XG XUR,G8J6%D.HYPH]RSF4C$$B$^@JOGV'1/EV:]3;(
MA&)+Y<VM=>O.3Z[,.[ +U6 +KHECK2$ :KXP/-(MZS(C''&@?AEE"%(XC=IR
MRZ[O5)DP(;&U;=<^@6."I'3OI65)Q%>PCS('.&)+'**Y" ^Q-4WMO5%(E\N"
M]5*-Q.V>#F>CZ):8T=CI"[Q]7U*\(-QO&]])161J+*$LDU #>V347*($/B@L
M&(?7R#_*1=0:T9/25GT,\<G7J)90D94\ZEI1=JQ*XYT3#"%L2RGE4^NNQYJN
M79E+.K^<^.H[/ XI-D%"0=2/S_;TA(QIQXY!JV;PS8/I]L_-V;KC=SH^#)5N
MN,WYN.98^<9JX.\34-JQ@!8*5"10B<"FPMS%% A5?9.*N=RU>\^Q&^WA[@GZ
MG#?5A_D*JBZVYN./&Z;R#X+54 ^AN+]>8H R)I!/Q5S*6M-KO)Y^9P-3[\YT
MJ)2VT:E+C0>/9,H[KM^2M',U=O1]*&8&]HWY^K]6C-D"['^[&B#1G"./&9JM
M-; O:Z@NO-=,>)];V,Q_-57([(7!D$$.#PPQ2A.D'A*PF0@J3#'K6,(5;XQM
MJ2+.G4E8T76:ZM7=N#W>._>Z$+JG^[>T"@3H&O4(.]8[KB#K_+.B BS20"8D
M1&&F0,(HIG2H-TW[_ )6^FAM&VNX]X# G=S\]>/E%:GQ.7+O-N$ZHF6.,'<I
M:6!S*0P+(J!?1T\!I1_-[67F75Y/!KP9+J-N4%]%W)E<NES3!I]U_JU*1(_4
M,%>,^K7'ZAQG>*KO6]Z'AA$AN'X)I,B#9S)M@"JF.,6'Z5DHA%;H>H\$GY2+
MA=:QYQ_:6IDA>I?&OM7/4^=MYR+<; ?&:9W3FQB6-D $H[).'RW+>)69H5-K
M8!.A@S!IJ,\;OW7ZU[8*->%'6Q]EAP=]4U'P$_^/8@8D,CR!OK&8?U#$>X'-
M10C UKM5&"U &"%P$0?%]I%3-_\A8_>'LR/^D<#1.P-P+86M@M^_7-/7'7-!
MP;>6BT  CYOZES"7M&9]<9]-T'M:-$]Z[W\TNTKJD7-2UF<>L/H UI:+J+L&
MNP(I2P;:22A@[PAL%G4)WS?QS//+?(:)Q@Y;%OP(<LX"-;#![.C\6H[]^[9=
M2CS?5Y/0CH(M6(T<QEO3@&X0-ZN%<?=-?#(\/&G_R7H]<.;=9O7KUJHS$X@.
M@L?A/_2"_H<$"?8A%FS$H@VB>K,V<'*,"?F>7$0)I>%QFYA9_:W+'<_JT<@*
MC_%+L_?=@M;Y'<[G4Z+VRW 1XH>6!2%&JK<2:-L#OM:9;Y=VZ.$B&.\Q0V/0
MY;8Q06BU 0:T07W;@,#7F$=BON^@ZS]]_E_O\T=,9RP10N:QCQ*Z*O#'8=-W
M&F;IETC31)9GE[:Q'GL''M,3).)9, =_7F(?^_KUYS<Y*E_7='6P$,P1X),<
M2$#,_"YD!<*#B,G]3:I @E!CJ(<2\0B)IC2A%)Q\13W9R"W/G_-O?WCT?'^\
MRPF^LZ3 )/0,8<,"6P2&#%'H%>I9!BB=" F;TG$!IH 0,VX_$$&%>[O@7IN4
MM;;"0TLSV_7#Z -9OJ/[W*XXR^O<.,_.08G^"!]^$@Q06W^,,WH?R4]30,6/
M;&M\..<17I"&4@"5@.M4K*"WT\L#4R]8N?=LO'T?#!2YE1-TWJA?;7,X+#AG
MU5PUP<ORAL2$ED-?I.E>]BHL>)HI</LXD]!XR=Y9X*;.AJ(X'I41T4_5^%CK
M2\B=D;>YB)6D?J]VAD-,(#D.+=:--[D[4// XX78M9W!1/>5]<'IC.QD]3>$
MH -VED\*=_YT3)B&@?%D<-Z44P!CFB)>CZF[VT6D24'O54IP\*R'O4?KI4.<
M\H''^9/RTLP$2!&- :7ZR:?)R6@M()*>Z.I)1_%/+CKIWU5"8W<*.>F?,NEZ
M/FN/W)9J82K#&7>87]9SVT^H65.MAK?GE =B$XG\D"*0T;2&BUA5>D7VDB:(
MR;,.VY"><UIJG?&CF/>.A4.(O$KG5ENU5(G:S1H?N0C@+''&GXNP>,^$S8=0
M)A':F/)]TSGT\7O51"XB;A/4C_I\!BN'8=RLX"+H'C]HXIU<ELW-^YIXLAQ&
M2%6KJSJY.+V<>.)S2U&CY;GA,X]$Z[SF2,?!!V6((._<SZ3)%^1$E,C7W$:?
M%+Y0HDU?:<K@XAB:^-AC\<"Q01<S6N7UM*'0$>.SFX;K--25EQ*@&K(K%Y'P
M5A6@L;4 B8:L;8SJ?"I9=LI)[^72A[B'3B8%2SC&_C+)+[[S_%*/KZD]DC&9
MX.W^+F)/DP VR8**)+;ALBQP%*702TF1B[@8R12>#R0RK@''=)]ET0^]FGJH
M\V[4;2Q@YR4K.2G-2 KL%*D1RLB@PE6V353S08I7M6@/+DH_%#V2D3Q7I_.D
M-R?E:<:^DVZC4$?E/H3RNX"4#JP4X'Z0<;HJ*-=;(9)U]=&1YA,5)2_/9Y>7
M^?>ZR G8*UW@Q5*"0N=F'&&^R ;4V'X>E)/ 4T93+5I_&'5=9G0AH9!3'&X6
MG.F>" TVE_* V[JP/8(SAV#FX01* 2D;>A=K"?'H;8![V$8GH[46NOVES9V&
M=J)=1]6-Q3IT+P35?,3>X2)*0T %7K83'AF6QTA2$@3R3]XO=?U+7WKC_/%9
MYK'XPP:1,/U[;BO-\P5K'I'12 $V.LQ(L@UU\QKA<4%JH>%O5^TY=C0T^&-!
M_%I_O_B3/OZW=S1:/B2)!WD,/%Y1D,<GV7U.ZN]S8HJ!/>P=X&Z 36!A5X1*
M-![3>S%:TO(Z<,^=7VS>9IZPV,'*%M=/8"^R\#"&N6)\.H=6?( G\$7[MT(]
MN8U3<VN\]GL^7D.H$OA0 =XU7*9MIU' M@WMZ8M8>4A?_9CQC':-TQGKA>&(
M8$,0=QD1Q=/_AO!4 I1,9*7!$S"FS=N?,4Y+KC"(.^-'85R9;.'<O'=AMBU
MOS=37OX(OJF&_8QC#C5C&;Z4Z4RV[![?,!KYPI 6F>1\/:@/;W?G+/-H8.#J
M#^I'PNL4%-AZJRS.'^:WDT.(([(E&FP!M7Y0/I?13]OR/'QQAI_>EG)IJ-W<
M#4:X"/-MGD/(O3L+KOH'G#7DDWPG;J4^ZLU:3].NH0B!_ R9E(LO5].J)&JC
M%+M[3A7=O.]HZ>Z-F(L?XSD;?C7I:DM+4=H_OPUB:09& FE"C3;9@S2D!HFL
M9<8U'N,#-)CK&ZIE^C!/H^H>>SHA%_4SHNPOY=5M;)&QPA5;3/AWI2;W,G\*
MF?\%#/ _7?]_[)J )7^K ?CE[O?VPWLI%D:!($@XM'(YSAEM""HQ?)-!@X+0
M/0U.&%;_<.D=^\'"HAGC4=_]MTR83_A#+%4,.^W\(EX+#OV[7*O_SX=,+7B0
MDU$M#YZUEFVDB(,B8_PW9%*]P\6*LI&2T1)W%-V3=\RX]$KS?,*D$*@QV*?]
M]6%N.#-6&.![IOM.!R?C>& V&C<B8I^DK9;=A RDORRIAR>"Q+017>@OJ>"Z
ME]W$"*-,C*RW,CH"%_% 6/!X=M"2PX0+;( 2(V#;E@ UAH2D6:/B7H9XI>F<
M2L!([SNH,V&P8D#I'3$\$5HGQKE,GA!APDZ]<!@!N,7!W#N'T?LL >@VL39U
MT>S*&=H)0:<=WAZ;:LB8;#?\8GM=1312(&SJV!7J'* _SE)EZ' 1NP&A[(X6
M#'-K[X*)9=%V+@(EJ_VQ*<^+'9V 8*)BL0P;B<%^:GN+P<4H?OSZUT4YN*D
M3YJ&='FG(=KW^LNQ )ZKOZJ*:PSY%)SHV3)6]CQ6(R+TL*J_Q7E)Z4#83+!D
M-/], OU_CO\</WWP< ?_"U!+ P04    " !+/%I2:.D Q)8" P!1-00 %
M &-R;VXM,C R,#$R,S%?9S<N:G!G[+QW7%/=UBZZ0H#0D=Z+@(+2>R>@TJ4J
MO0L(2.^=($@1*0(" DJ1+M($I(CTKD@5$*3WG@!"A)#<^.YW[WW.WN^]W_[.
M^?WN'^<PR)R9:V6N]<PQRQC/6 D3,XU9!*YHJ*BK ""L:( T  "SQ!>G'.#T
M$ "TM(";   0 /@ ,8"#+5W''CP 40)@;!F$_0- PO\X'PL2^:-,C2U7QC@!
MN'_4 0@ZMYD!"/:=!'ML"  4*LS;?]SS4B[E4B[E4B[E4OXO%2,G-SMW?V]V
M74=W'W=V93LG'W<O=F$A 2$!82$A86$!80E1*;'_L):(D(BPC)"(C) 8N["8
MC*BXC+ T . _!_^=E5 P/\?]1UDH)?F/,EA(" !24OY9S@/]D]W\D[D07OG=
MVDOF<BF7<BF7<BF7\G^W_,]L0UA81OQ?&<C?SF$%'P3^DU/@8S-& .^/,D#Q
M L3TC_(K$,^?=;!,! ?T]Z<G%(4X.'\O,\[]"6W]M^._O6.F,;/ ;8  'Q^"
MCT< @4 ("0F(2*A)28B)21@HJ<BI61C96%D8F9G9N02XV3GX.)F9>21O\ D)
MBXF)L7%+RTN)R F(BHG\O@F(D)"0A)B$GI247N0J\U61_[9@V@$* J  RZ!
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MRF9V[;-\QP-6T:&*/?[,NU0T+V-Q]RI1$JTMUR+M+T12OKA6B"=UCDY&P;;
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MX7F$G(G&),E5T<MV(G2_J-D'='-^R08,,Q.90,>.=THQP!*3/L4*!P/ ^I#
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MIX:_%AW$C1"<2,Q9]!L"=!Q@SK!' J[%)E<Y96-8:N>SSM*RF .WNYFOA'^
M"E8 UZ++G,KNL,[HSGF51+/I3?BRO3;/P\GDJ^F@TN1]DH!O\G21"'@GKBD!
M]-W(YN0<4$G% $KX><T3@D](7(Z_:\)I2JS+%TK-&]SW3UF/02*J@1Z/UW('
M#!F^,]J\8(:K#W-R'N;7/;M!(-*UWHB6?&#6%C:GHV,*?!QY\*<MX,UI0O!W
M4_[@V&QX'^O@Z,^1^I%)FME'%FM#''&B"U9,^*#O5T/)+M 3VL>)(I;0;/>Y
M/H4VC5I( GMS[D"D]L>CFE3J/,['Z"WI"QZ<3WU/?R;MS9H9BVWJSQA<:\$
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M[6:\XBI/W*.6 2ZB[02JO=ZE^.-MV2!=W&:5).<W,_6?BC$ _ZNF'ZJX9]8
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M[:ON2-*P%%B'#71U> '=2\RVQ@^$,>_)JO>QB%HUPN!J5D]O]^:^ST*&.6
M37A.N:<U3:)9_XMGL;-;S2;4L"D95!Z2";Z!II7LLDH09+;T/8A!29-]=!-^
MW:JU2\P;=D5=/!3K(7 MD&D7D8BNGASB',5T--<8WL1-G?G&^I!2,+II2!@#
MA.M"-ME0U*K+NDBK<S;4K=;$VRS[)0_%S%Q+2$RWGNA$3L?.J&"K31U]0Y7_
M3$43.R%$^T=:F4,4(ERRLY_^G.V/L6'\)42U>S>#[70H+ SY<:D-Q0E]?]"5
M1*M#]CF7VOEL*N.ZPD5]G9\G]]J-QCSRT6$DAR JI>VIU0E# P88Q6\UP  1
M+;"!U4=6)_C5&&"$L?4M]@P'!AC@16)GB4TV[.**\YH5DK</E:."G7S6SN07
MH%+PES!B="<;?9LC.:[R\@)>0-B4WLAJCJ9]CJO&/+[ $WPFBXZ#*1KN'L%I
MNI6^C@72>6<T!Q+FT7PM)5- \/C\8_"WI\!G63X1T;=DNX- QP;-63*VPV(P
M0*KD>-NN. P#Y%>$.JPDT3@J$&)'H +Y!CVN!=][_5$]V#>L_5;-"JY$T(;4
M[ !7.(B;&H14/:=$S[+R7+Q$P8J^6VXWF,9T97\?(S52S3)*X77\WNJ<[3L\
MP&%70]SU.!)U#1:ZM\_9&"W]P#Y%FEI$YE4TKMV54-Y?W@C<24G&DR*)3"JE
MX@%OWIGNA4 . 8T;I\1QZ,PPJEDK8Q0_W+>UI/&1[N:DYUQ@G$'+* ZD7RZR
MD94'O(PE WR"O=A<*0R\E8-3W?2]##EX0$=4LF[&Y%7%K:VR1<*[#TXR19DF
MJD0K;O98:!N\6(S<YMW"7L*ST;N$Z#HI12@/5?3EO@D(;*L6VRNYJ8]OPYO8
M+=9KB.NKWYJVR5:' 7:-PRC"NA<@<J$T,6E5J+[N=^5'RZ>GD[,7<GFXW!<E
MU*"S\G-&E(?5#-.))]S]V=KKA]]R)DP>M1P*VES\*$R<C:4$;7%,-1JM"J(H
M8E8R3M@26PS@Y;J-L\Z5MR^JBGDE<;9IB$5X]BWY*XX;JJ;> FCK5C[8@#XB
MXR+:'7H</#5J"D51'IS$3-4%LVA_[O03,9GO8/DB,#/T)EU5=]##KG\QD7?#
MZAG;X?T6^]_S9_B"]><%:\@-K)-FZ\1&">6/3H@^%YA$5'B%1ZYRLSB"X>-]
M;7!MZ SQ4EN,F^^<3KN(^59Z<ET#I9/_Y*G7G7"[FCAIDB>@%(VR=N;ETK"^
MW ^2SV#V!VQ;J4IO+2P"&(.C+*RZ#C6&W!#"H+4$&:ZW"M:?(S3"O<AX3VV7
MZ?JJ8A:(0L0#*Y'E/3,J&26S*G:AIVJ'T'/AWL+:&CD\7?6J]2.+-#F;E00-
M+3J=9*K[$W;.+ K4/Q;5;PAWOY7)?<F#-8$EY<2;XKRRP9^=#(.=8R>-BVX_
MWVRGL=E5HD%]"JA%JU38HML>8M=3@M6X:A<;^8\ HZ6V)\=FQ0[-XS[9FM(F
MB>H!2W<>A!X6MV7":&']W][!IG87SH1+P6>W$!B@AY@MHJT6G;^2H,=H)D]\
MQZR6"#XNE7#',^G6OH'WK&\8!#G>MT #<\V-'[DH7 BH[9&I.V#-+IA)79W)
M_QRH>U7V08*!EW%R9[H?-[\5EI'6]W5]TEGNV]59(2?9K![P?/O#4>)4X@2^
MVC+D-FH>^ BB/V\X(IO>$\:"'EI@J=?Y7K5"&[-R<;UWX5[C^-WDSS8^&D7=
M(E<3[_S U]VSC086'S]740+.5&;1!*>(0U>VO13)*-?*#QOG"EH&7WYU2 UV
MVP[3GR-7_0;81'\H(P1/=) -_$VI^G#NQ&-I1=AUW<HF4,Q-#76F&VSS*I!&
M\;.?\,]HHBVX:-^5+KI8-W$8CM4'<&79PRG:\[;OZ:0;K+ME2"--!.^)_44N
MU-V=:@LMJ\"% 9YDK?<.\#'JD#Q"N A#_ U>&YBD/4YN3I-:J0>"Z'9MS]5*
M]M3A;&J(%]7*KA6JG%LSG^K8ME=:XF\\*."*LK=[#NXG@T@-:9U;A$TP<N_F
MPA,/>K+BH3.,%5T72:ICI]9S<S37;E.<VNH2B_J!P>FZ?C"'JN^Y'5:UD&A?
M%D@[PDJI>)LNURU+=J= ^LCOIAVEU"\]V$W4.ZS%[$/=;49 ]ZX5(17EGA4C
MK=2>7:GYI=73=V#G(;]R2(<&*;()A:@@RQ"W3YJ1F=0SW]9+5L@IK+[:CM<%
M<P5RQO@K&-01/X\#=D4\T[E6IYH=V^#J23-,AF/*NV?7DXH^5PO5?/JV?/15
M1V=N7S?X<*&*YF<,BB)W43N[""4QU7K3RJ1\)ZM^-\LR5^YI*EZA4DAGS(=?
MZA!T8U+0Q8T\\O4IK&DB5>!']T.O\&& !K[Z) "9+O?9OM3DA\O1?=OK3+$O
MRQ,5KQJO2-G,M!E#%U]9-11B@+J<;._%7"8Y8=2ML<6CY>:$.\YO9P5H"F>D
M3'23FU1 ) RJ))"&L%DVG+JV&?")/\(OTO]1RO:DG_ZVJ7SOCP&\51X+B9P.
MN*W[B?FYT1+=[BA"!A8)8Y/#6R%P2"$X'K*<VX^WBSAYMR1 A<:C4FM+ ,(0
MZ#FV0ZSGI8/N6C6B#5#[FV=%ZY%O3;:S?+^DFT:]&O!V]2:F26'0B^0L8R%@
MOQ*J#+MCU:"*RL0NI.%SNGUH&DS!$@P7J$=P=H-OP2^RK1ZEF,Y9]+GD!MUI
M:$A95BSX&.BI *R^(CL&78#0/;EU0QE[FG!9#<2-@!4$?PZ?^*P47*Z\3B^#
M^#L7O>_Q#R/I>^KG8;"!;)0Q!J@6Q0";3E:);=6">WJ"NVV(SJ_GNJ_[(L6'
MLL(^$@S<C\^=^_'X8O/E_J;Z/7;F^K".L+FI*PMA/1B >N-#FD.$!6FANJWU
MX+8)@;4J+L5\./0:;#&M[3#$$H0!*F4RT,_-C0Y>A^'#.GAAJ\@6, 8P]Q6\
M8&^L6I !>-Y4AS@M.X90+<X%=QL)UU4[2=#1':J4X*7SS-R"-!$KLKV&P?47
MD#QN%? -XQ:D)ORSKBO4\BDP%:+DYLF?:4_RX60/)>+*7A>9UD\</6#U=3@2
M5NO>8S63:MJ6T='*UHI@*OQ8]?/90+<'5\+ $7=:N(#WZ[P,]@W\1LW/0\[+
M4]U.E6Y<V%#X"C+UOL!^=RK_4'=;KL#/BZLH.J1F/HH$:8.EQK@!?G/6XW79
MOK'-I8:-&0PI#C_]0[^$#A<!8;S(+C2ASOFM !WE#+UG7<UA;6M]ZP/.!=MZ
M S+QE(JJ,Q;1"MMNW)P,51(7.6V/%IYB@/<Z"=!ES5!_UEQWCX$RY+U[(L0F
M+YG5DB@P@ %/!U,["<$&)SLV&O_VBPH;D[Q"4A4'N/>P4B-S"TVOO9M!I-[]
MAJJ?>?]#)3__Q=G'ZS^YQZZ=YI&/"S[.99"3/U<*X1]I\5W*-*F;TV 9PLW=
M<2V^]T'-#FND<(.8<40(Q'_E8F_:C@&2SY<<+B(%8<<NOA58#361K[TOBA!,
M2WO=A^HN(QU5)IWJLTR\@72XP=7![N?+[V&+C6R'T-\/X*KM#] )B>$*TDC(
M.6N(WD517:C1/3C^,]>W)ENI%?7CPZ&D34;V/P!*(>XDC9]L2!]L;'$- ]R*
MQB)'?M1!2UNI8EDS>Y@P$K*4VY4;*]$JB&B+1MWP]BU7XKJR8_KI4_9@!"4Q
M3]I$-20^[@(/ T37(*]B.R05.Q1H&EHHRB\<*@2S;T->QP!]2='0.M6N ]J
MF"Y:PRR!I/(N_T"QH/JZ^.2RU2@CK@N@ZKO,"HH88=0!I5:8PP $_O$HZ/)P
M]>ZYT0EK&=[!]]/][^N!VK/^+B$.##/3F\[5>3BM6"TCLL,F9QIVQ^$-FJ.H
M:WY\**?EI]>BYX\<'];6)ZB^%O&CM%\QX()140Q.S?BN8@ &#&"_$(6U+UR3
MJ2%*\*BJV$I^#B$E3ZXC)3Y']6L&R[[6(MZ3X5"25A!Z $J+9?()FF:3(?)7
MVN((8>.HVU66[WM/221=1*X,<SVYH@WJ57H@(AJSG$N$,KR(;153=?66WXA
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M6"5G%E;^O QSV[G[L^GKJ?-."?.X"I8&ZQ06TJL14JSMC;2A[&5M=*+(+??
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MDCSW^^G%S'P,RSSL(KG7(WZL_*%C\T.98\T"2B?W^\!WD LNLA]#\3BR98C
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M38OG>AZHR3@X?$A!;P0DB!U84H9\7A=N]&@;2XY]P];K>&O4>YX'3LKWIR5
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MQAKGJ4P4]Z^V6RF;,&%^EC'0I<S@YVQ8<H_6Z=EV+ZX87/USF?2DQ.O!KZ
M:LJ2Z<'C-M<6=RK0L^%S[K'L]Q!D7.5^(^\Q%,(^9A@2)A.WNV?)]*CKZZCE
MZ]A^R9%W\GM VR$P[7Z<+8)[T\F#^N8)8<FAW"5N"S_D+5)0/:G \1HB.RV.
MS-J+V(1=M( %Q_Q]B.N#U6!==#,\&JE6.7ZX*S= L76\FJ@DA0A'N;)_7YM4
M7E#%GH>2JQ!TI474B!2AW)T:B:6>;:R3+['-[/1YQ-I -PD"DM!OV)/R2IR7
M*PBI1DD66>CW8<44A,_P3RR1_=/!G>V:>;TNTXS8<^N72<_"K[1?LCZ4@V8'
M6SZ>DB\^^!2QQE\ "UZ%OF4"A#!N[PC+"N1BD+^NDCI+#K5R=+\;-$QOPGB*
MIKT&Q;F6"C0=3F3*EM?@G.1D&,HH-Z+ 0Y;1DA>P16-!#3+CGWP"O5CGBU\K
M;<+(0C"VRA_E?]5'&HYN61N';\/^]6\'N ;=CHX(SB])9^"\^S29&GTZXB.F
M<>)3G&9<=;'6>MY5W-T81=H7^1=))U8E5I%LB1-4C[46C:&$Q353(OJ54X,_
MNJ15^+Z]F4>?G+JH]TSB+R=R:L+JN@9+BMM]%=>.E"O'2YGO&PA4[*K$%]O7
MK_TL?_;V;O8S(86C%WA:+CHIZ&;#9VIBIW#[V%?HA<U+0B-@5'T-!Q^M%1>Q
MW5,U'UZ.I_G-)>@5P4R];P6S++C]AOR<-+9H4!$F[AH1[WBLM =K(/S5<ZF@
M?G#;+AO]R4?A=TS??MZ/B*/0KZK,:,-'T!-/*Z<?H?T]!%0X*V5/]@&4BWT;
MWZ'IKJ](&V#N ]T_BIF+G#U_C7UT.+Z-=UF7C:;W;TPVD>5(*C=O%E^=XT(B
MIKA[YYVS]D%%,6;#>1]&1P/A!8 IP,>5'6'+@\94J*V1"V6OPPI&!K5F:L]U
M'^11?+[P:4V'+1B"?.GUCX)%VSE^ML0(\[*A(GT>(5.G[59[O=O)'+6[4?#G
MZXH?!ZL_SSDIHQ&+$OH[?R]#S!3%3DM$ (/U;X#92ZF<8[]E'%]_*AAWLX\O
M]Z\)GM?P\/70C$RX_^IBS3&#,WRA!B(PG!J$N$<V8>XTNO]$#N@W(?L]"\YX
M-)>V?'$PH?U*RR!ER'EO_"?VQX<\A&>X_ZR)G(50GSS?&LQ2P?KTLO7$OG%E
MZI2M.KUN)M_J>TX3\D\^\9?G-,\'7D'&7@UU;?AN8S_?$]]]#;K;5;N/N_B[
MMMVUO&JFK,7#,=NJLV/_XOY'K10KX!^%71.(!<BQ*S]A>'%;A!*G443\!_+6
M/9,&)$MJ81.6"@NJP!G][XH1L=4L+2[DP$61[F-PN[XZ"<,8B?<I/FE$Q##1
M2TC*>?1D1/S'X[?:-F&[O+84%O+O*_7Y9/9=TE__OI"Y\BX$F>DU;,YT9?C/
METVJZ34:GDBQ2+]*^N!X46.^-C(#>20_^7CRERJ/+N+>V5B.&=0$Y(G:BL%"
M;JL>@7.@E/ <2:V@+/L8[H+&>A'!4:TA;!UVQ9*7T8;0VI3^@-3TA0?W>5>V
MWK\%_SG2FO;' 3/99#7JNB ZIR.@%+@H]@%9 I@C=R[=[B7M =471]PJJ[I4
M"^+N?!GL/+"762\!7H$ 3!)4#J!;,M\R LN%:W1BU%&W>ER&PA^]:O\:1FP[
MDN0]LX>1A,I#T"^A1G@; 7%#.":(5EGZKKX0_-UHTUYXQM7_L$FOVNZ[_&%(
M[+OM)F>23WK.W.==W%!)9TPW:>S":M";IZ/K'$J&0.!<Q<WV@.##\3SS>?IE
M\E\US:B\J##$/J1'AQS8SDQ@F#:A>#%%M^BIKZ9F)2)*7OUN,FP7C)X0:]G5
MHBH5I+)#]N4JE.F&Y%?X$<9%[A!"HG[O)BRF73ZX2V5-A6E;PV#FL Q!%2LP
M,] /(8NZ$=<^*U+W>#[71$-,\^"[J!O#QT;AS[5Q$(-:UB%\:<@1RU8O+0NY
MRN+*C%=%E0 FT4.F#'[GZ$4R70;&">%$W+-#WH.'1UQ08&T;Q>W?#=BO98
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M:G@(D^(DI&)QE')98[!-J\6(OVHWXEO@0"^*;INX?B+8E-MH@]B0M>*?U&C
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MRI9(87J#Z8S:"43($E:(.F;>U)]V^B9]]/O=V'.77;Y<2]95R.#H0*,0AA#
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MT NWR3(WJT<5?GM-2-E]5!$KHA)YC 5$M.02_PJYQLO"^ZC,[POG(%/T1!2
MS/FKJN84Z$V$9=O]U9&J9KX00[=>\0@RI[8NU(%FPKK(C$,7\E%D3WQTNQ=
M^O;T6DO@ZA[@/DFH$1!/$$MD>'XK4491F^NRR9ODQ4V0R/[8)H701_0B)+_)
M0PQ"6:I^"[6G5F7<M3P(7[S.Q\]VH6-(_*V3%^IF#;O& N.>XLR2Y#HL/UP[
ME=E$]=6%'Q4)\9I;3)C?-F>H++[XVOFNPCR8%O$M<*=!R&JZ)*3:[>[PAKN'
MXOMS^@P#Q1W_-,:$Q<=0Q?8BM.J&MO:"U(,N&KC(?W)?"+Q]_<='0:[,+CO)
MKK:ZKEM=-S4$?0^52EV\J'^@>)-2H_:,"RXR\#-XH#<V][NWD*[CJG"![IU+
MC2^%ZN_+/$>-WB,74B*VSGV#X$U0<4]%1Z8VQAHJW0P<EEE5%V>[?8*1S2 7
M]6@-<&$-<6"B7?BF3KF6X%N]@3M%!?PG10QK5)=,6*I,%R:\Y0+>//+\D[U-
MVT$#1R>-)<;S&Y_D!@:^_@@R,>N+*5%0>]P6,)(1[5-C^;OS/>&)C5ZGF<"D
M(F?]>2Z0+0=H;\5MMX\J "'N'X.R0T_V0[%Y'(,.3P>KEU+BD(YNV D(S@"X
M#.7Y.;^2>F2P^&GS5,74)QYZ7<%M[\I7R8O[CFH$J#2P2V4)F>\[37X(Y..I
M/UMY$1<)ZDDE2%O Z,%05EVBVR%\@B?#U^Q2:-'5*?Y'O[ZQLGX8I+FZ'AD&
MO"&T&P%?J,J$IUGS?D,.0V;]LS?4]>*MMZ>"E3>@I$7S4Z3SP(,I:]K'2\@^
M(Q[/X\P&H&89$^FO>N13O+3K@SB2=V*.0=7;&F #ZG<D6%T)KN$I@([+H*L
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M+.DTF*(X.3:*_G_/O?ZP>1: ZD18)5D87NY4\#\]-LP[<:J=E>[-9251D$@
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M&A25+\JM:EF,<>YPO&1TCIM'890.'W6'?X\_?+#U -1] !H,I-M 5"OBD@]
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M)T92R@] OF;,4[WX>:L1&,M[SX8AKPJ@WZ;^>7MQA)5*>M=3&9YKY3)TI^[
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M 6Y;@G,)U@?.MK:?\Z*1+W/ PKUQO"#N&Z=RT[5.X[Z;:IPT-8K *9-"8!:
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MBP]P>[?.XE6,GM/>AGKG*O=M3HHZ(/?KC!XON>G _.X90:?VI>F7$--1HA!
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MK%WT.G-0@F36.?]4BPF@QZC@YR/)5WTQ%$7XJ[,]]LOYNN2'GY=:DZ?E;IX
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M7[+@OP?ZN)(!YEO0S:O^<+FJUC_'1^7[$'G@;*'Q:L?8B6=T!](.L&) 9.P
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M@FEF]R,KIJ+OAB*0R?JGA"V'6[3<_CC!)LWM *,7;EJ'6B@O;?_ICN^OB+]
MHPE.>P>8J2 <@A!EZ->):7&9MBMU5!D"+67[^ Z097E?2QED^B(COGX/SER9
MRDT:ZF6$<,+2TI6R69\22GRW>:V_T$W^PV*F<_;WX7BC[ZHRUB4?E+@W7-G[
MZBA0M@AN!45T]"]8KTP3/#ZZ5M'BGWNMN>BS\J[FO2NA#D.;3M-[R;?-7YDD
M*C5>2S'B^[ ' ()$/?[]YJF=&O!H@R -@SI05LO]JVLOE_JH9$S5;:0?%RE$
MSUGY]AN!XZ$5:PF5UG1%)'DJD@@6FM)''/I<QVX=*G.3<LUL]]CO$[&@]>/X
M/LE&=?2-T56%!YUS#C]V *:8%,TW0!P&NDBO*7 *RRZ*!\I'X.4_+6ZM,6I
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M6<G8(R@N)D#/( 4\#AWT=M"N9O..E+9_#.)W>_QILF0RS,U-W03CR5]ON"G
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MKN :N6[.K2AUK@V()#-,D$TW#"5A![JO]R/ 200I>M*7=*E(T_$+NKYG1(]
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M!N_NLK 3U[;0CN@.-?HQ:(?!^1ED1]I!.(@:%:E+N%&?OK=T50KL.CS3I8%
M-5Q3BG0Z&[4,+<?\FT??S$(KJSLL \9[9\")]7YRIII2/@\"WK0H,JL:GLT]
M"IS<H]?)7CI-AN9!*6;0AUNRI^B/2*CD[26+((T*A=RWDS?<LYT7LX*_3J39
M.[X\OLDXMU'22U<V:^_> 9((TOIG*+;-;S:5-JX7_%PAUVCK5K:+G6W89SYU
M+5QC@'L =PGI@8P. 5=T-('YZ&)?7+TU)DP8?JVN24G5O^:S#,S5Q=K#E:[B
MHPQL_K.7&.O%:2,LU&W6:YPG2I!NKV2W.6;+,#-Y\O!Y0X)%RKD5:;''><W&
M$0X-''GYC#-V,)X' Q6$/9NI:M!K5N-?JCTI+FF3M?=T,,#[Y.*)3O'JC"-+
M/IN9.!'<S"OH_F#HN!RMLY]]@GY9[>/B]G<2/;IMMC-%K3!8^Q[*\XYT:NQE
M,R,31 /S&/U%(=.-[D/L/;1@$Y9M7^,I,VGTQ$G=5%:K@RJWQW3+UD@FX\\^
M"^J_&,"R\) ^CGM!3>@2'/OG1X+ 8K")<P.J:+\RC![S)KX#O)_1^4V&^^FZ
MX8RV)[<.^LL7+!<]C8A>F9\!X<$M6(7LKP0?6^]V/:,^%^_1T_4%QUTSG'_8
M'\3";(JX?TQU#!,J/5>.4P-FD.T-#TBC31*>V+XUMQI<IHSA!<;EE\?LM4_5
M7S;+X?=_QG7^]N6!LP)P)"V"E8,U8(^B^.#B,Q/>PJ9TM==WQ<5/+649.C4K
M>(._/3$%Y>C'!"462IF:=\VE<VTS&,>9EX8,U1'?IKFHF1\^U%:]?VMVC'AM
M#*W^3#I5_*.'<<LR=#\G'P9"YNSIECL M#:+G52-[D^+-^09P(K302ULP?ZC
M7I@4H79E?O<'-8FFK\ZY3J6J6]^W@CMPV/D&*P][%-$G"Z8'^W&L0(NXK'R6
M90TVG7HK6XGY)BCVB*%KV7V[6L\W0"0_@Y]CAU&_,TXY@O#+@9>:0[O%RD:H
MP@,Q(_7!$6\F8=L_?&!2ECFM"-MIS%VQLU;OLQ2/&.&C_)N^6>AL0L;/-&WW
MMNP XVAB1QSS_&V%%Z6+X1IBHYGIZA4F1U.O9<B#&[/I+6P^+@8/G=$&%2N@
MCU/\K'H?5SM/$KP_7OHXU1$,G!/M*?=5EGF7DW6D6L&4W H<0+'YPAAGX&J<
MI^UNY=SF)!ZC >9?SI.IJ6#(C*3<%LVQD,X2;.ZKSLS7)3__N+^OS%3]P;I]
M5JE/WN_E)#-Z''ZAYX$[T5KF/$]]\OWR"?76"=X!YT+RSV2'JU3QYM]OE\GU
M?$T7;I<5_-R_8:D7F_F#M-YEH#IB(7Y"\<67KSGW.WR-4N\??.FP(!Z%NX/F
MAT%H9K5TR<#3M9BA$@\K,[O4@[(^XWL?W!<WN#JB'I7W]+!.&Q"FR!1LL4G<
MHEDU5)O9'D,EH(\&\S[]HW32DQ).;R'>""!QI)?R]^[K3X^B4S>]8]2,GTC%
MN>X \':?B&8<#\07-9;D1%6+8TMY:SM]BR_Y*A@LHS @Q0C[8Y<0\>IZWUG;
MF'JNQF\S(J/]!(H5;LRZ#;H';ON>>8W^.LF/M+S@7OUQ8.Z%9_:8^7@VR=/&
MX>N]4X B7\^S9U%<VT=,1*[PZLSNU[LYK#'VBD(K/Y 07K$G(J'4I-&+]E$9
MDW?@XDM&Q.@+.J-Y!Q!488)(.NCZ /=03]F<^X,39>F/W9(OM#W7@LF[>5;Y
M3"S_XRS8BOZ3%CS,>JN&O M.Q3LTHWEN1J*;MPU?U_I59^X M4/!9LCC;SH9
MG8_J,?H[@)1 O"AMGBDR0<- *GJ;?A*1(,(OA#[5S3K MQ\K7U[!J+A![2K_
MUJH/;_L#67P4Z\R94:;L+SXDZ$$+:G$K+6(C5\&TBK)R1K';8(QDF1=><N,#
M:BU37V*!>R.4YL9";5B/9\W0DF92)$ZF3Z!1[Z!*^-'J5-Z<,Y'F?/D;=E?Q
M#?[_BXOJ1/KDO"CAS'-TTK-SRBTG8-:VRO*^=L]9F9?/R2C/<4*KB+VOFB)%
M,EMA47ZV.>T C];**DM=+U0VU&<;W/RA&7;SU%?CXB@= P!=C/.%_-($)T-H
MQ^^BMBV/V;*2_C!CR#&/>AQ6HK0ER&^ :YR =1P]: =8F=@!C.,X#S&F#L?6
M,6/J(FE^.\"K\U<XQ#-%V &D2T!X*)OO/:5[)K>M/8DH"A:"6XM=';W\>5_1
M!.Z2P3<)'?!4LK8Q_W%T(HI6QOJ$])E(>ES/XU/JZ#5@;AL0X[L_%Z/(*(43
MU*M';D^2H@P;6?&(0PM0GAW %X2W;,P3CHL [?>^M^"!_V89G^,=$?(TP5/^
M6:WI'.TLND&9HMT$^11//D*5FP6G,0WV%(?QIFV85.2TWB?0DW^M>J3!]59%
MQRX9(S&!@YJ+0HAV7!6'ZLS9XZ]\;A[.Z6;-JL;/"FCC5O%NA#XWX$&'$\#Z
M4( 3T5BC*_&271EGEIXZ,LT&5BN5[X2\02=C/!Z^#%TODQ.L0-W_9E"\ HK"
M41Q CR BJBH;O8><)^&:(V[-">C7XH<>E)-ICX"B,C>3JZQ9([ &LLF)S3?)
MD0-31&B*K&@&9GY4\;S^R.P>PK4J?/]7O5T+'Y#3C[XL0]^@*G@[_""T9#J8
MB)*Y_BMP$NK\*_Q1"9R5N0[)A%&'@,:,WF/7K<-_[  ^UM'A4+(G0WLY3W90
M5453N89X"!6_1LR03R(_C;[M_D2H[H;8X^JSUQU'YT.90N*T&&0\04P3%:N[
M,N#L/:W@\7F0]#*#85C$]V0Q9NM2^7%>_=4X3>EL@)7VKQEZ]$G6:ZRV-X&C
MZ* BL)]7QH\,JEB/J[R<)6M;KY\3+Y/LFI<1#R3?+(*F0BAVD#2G^ ZUU&SQ
M)K4]O[)SW\;#,G\ZX;76JI:%#T;K!RD<GG;<"#O&^P909 H5S>2]H7;0'E)!
M[2AQ\:'2#:GWJC9+,Y[D\(9V1]RK]>$7O87Z%QQ6(L/ *S44L#4K!\%+#V@<
M,=4I*R'^K)3ZW&XX&*;8HX&R(IR8+_B0.KS\_/_*69(_0\E4ACX*?Y[V8'1#
MCS\0DH#!T7,6ZMVS2<=T'B-'+ZA)D&N>YV6L\S(%BV@)7)J<V-'M:1^_BG+L
MUQ^,2>7YRFT8[_O0K*2H$O'.@00E=U-^.K(2=@ _%3 I/B:?H9!1/(UL/O_V
M$<\=<:ZH!LQ9MIBJ!7=4%G#@.1?#V^0^5 ![U!LLAI6E1[0["4R'/"V]WA'!
M)>]_I>685/_S[XXA)TR"_TU/\ ^.^WFZ]%PB^%$ME):5K&_UFN[QI:+*SWY=
M[]Y<B$NKOV&+0I0.$F\Y&Y++T(>+4LW2-/>GRZ@/L=+'OQD.<BA+7C"<^+(L
ML#]4=I@:O^)" CW&5<2WD^6:".+!U]?NT+^\W0&:K6X_".EA)Y7<_^E4-?OH
M2?N7SP>TPR[JCNI1BVBU='>&/6(,O(?))59W;*VY0<TA=>D'T<_]X%)MG5#F
MQPQWWBZ'$W6=33_=V-*:D=Z,4/A^'+V?8DI:;KGI)FM(26F&I;5DV<]N=0?S
M?G,]O[2TE_LM5=) B7N13_G+[[)ZJA88 VU2$X M=;L](#C'XBJ3=X".2A+\
M65MJ/N_NY$V;HH;PMG^ KJ=_ALW0!CW8RG#IVP^(.OZ'0ISCEF"-Q,$6N:=-
M!LI9=%L*JAFWFRGL303S+"+'L+*8,/FX7O*9&[[>TG6YZW4ZW:?U\Y@./O]*
M7OX'/4KR1E$K^K&38C,26,:>HHKBQQ9J#2I<)K^&DV5$S4+N&'_8\N!N" ZF
MDSFJPI]5BB/J4A/A4I2>51;_N9=695;\@<$(WNX]9G:QLF;,#7G!/YKR03R#
MODQOSO7RK(\2G6Y5[/&:GPKNQV;[,7^DGM*#/S:2X>YD)66S"!1P=! RCKV_
M'ZY"7#XVN.%R=$1/SS(8'*(A(6DPMGDR3#X]3'-]GBD,I5F"*[*:,".5$Q#%
MCKSCYJN5($U$A![<0PIZAVMRED&.R8W&=OPOSECY(;V'^JP9Q64(7C)4IV:^
MUB#+?KD'M%@&'N=U.ZV ")/BY1Y+-]H==4"9-CJJL09B?\&)*0RME:X<_4R9
MVGRI$GCXG/Q XZ*(3U[)UR8CZ72?=3%K_(-9-?*Q&>CO7;1^1=,MK\<6:-O7
M\/Y/"(N'"LTDKLM_SHEZ<@!A8P=\[PY,04K!!F<A3%&]65>O;9ZB<;A>D5CV
MH%6FAY6>>=3<OC)Y8#6CUA_ON"YJ',T[@JI KHPS;-A=;,DL<XI#K"%?3LZS
MVI].0\>&CN'JYS*$S,L*[\YSV=F9W7!+-])"ND/H\J/1;"G\V/(.(-HJJT5U
M;(VQF%NT3V$-O.:^UU*#?(;Z'/B9M5FT2*LU2!:S%^L;=W+.3U6.@+4&MA=&
M?<B_Q;6@/+=&3ILH8D=!=D/6?A1Q8M.+/<:J12YP4\ZSV7>1S)"H$^P>POJ3
M7CR:_7D!O&VJO/+AEQ[M$EV*ZMRT QQ"G(1;TM$[P-[Z0[CDV<&G*G UC;5=
M4C"\>J!25TH!A.2;/K6')]+52+*V/:F(GF2%NCSLJQ)L8$@,L?(.X^L625KH
M;(PV+, JLUXA9Y[A]K%/FAF^FFE%QN4=N>6(]&C[X3V@S0AIC<J-7WT!+%<6
MK]Y5XJ9TVU (Y'._>W"HNPC.UO>F0=X4SZH0;%^ NIE0>^!<75#WWLF?F"TT
M%_T]%0L1AX<@$[%"@\Y-V5,]*[J3F9EK/\Q\WA?RICLZKG>MJ^7$<>\QO6D<
MC2SL,;N$&2GQ]PWPNUU?49-2D#=-.D7M2C[5U64J(=BTYW<;E1^$?@P2%ZQV
M8'E:AWY>RNO0<$9]=07=7M-;1<WXN(?S+?5^<R.]*^[[\/F*3@ #/0-J(T-F
M>YL(?+"?E_B>+-M;ZG]4]NQ\Z:X0;T S+WNQ5JVYD$%780C^WCF@;\(X5@P+
MN#+HT$H !:CV#&V'/\D*23]E%Z8R2;DO:I&"M3'CV7<'Z8G=R^Z3Y6$5U"OD
M':%H-1PH]6G\7,W(TO(WVZXI@*AK\X[-GC#_$66@^B_*1<HDE#"['X*!)..\
M40FX_5@A+R3(;;!>+'._9D<2STP>%.-<\F*_P"OKKXZN7HW<SXS /E>A8(Y"
M14Q!-KCH1W8 I":$K7=]FY "\4/R+U3CL:5%<(%!3)V$[(^E]1^1%G)Q\C9?
M5]I] 4 ^&]@(F(BAY56Q,MA[[CJM"+5/GQBJN)V/QQY8SKSI?B+\M66600)?
MO;\H98LI9$;SK*?BDBNMTV35+ +D,'E>&MYJ7"%U6#BK8"63,:$MNO^;R^2<
M"#J=K<*$4]'D+]2))@JL?<NZPF)-!:-\-LC1/;5K6"'WZIM4'9><!V("EM*Y
M'\[R :PM>NB,@3 Q(#H(LI=^OWM%5S;M;F;FQU1S.W!8&O6,=(6V3>NS+_D'
M"O[5,IOR8WHE]4$+9#=<-)3C626@53GY3A8BMB[R0E8?OQQMK[FV>_:!P,M
M(YD&T7F$!IU%F242'OGJ6Y*LI1;"+\>_NZ!87O^YP:KZ\;537H!\]Y-SO[AF
M1K,6()2K:>/=K4Z?%JM0(IBQ,OZ5GVID_Y*97L@ZWBM=/W TA)-*+RI_8RO
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MGB3:O.8T#?4)O/9@Y>?=-<:SP>;+B8[UJ9FIF=N&$K/_6AY/,+<&R+ @-,5
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MW=Q BU=O4?4M,=54" R,&TIZ.U.MQX+S,5TU(48,OE)[VQS VA]\:/1*7$'
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M.1GEQUDG/R0_,V=^=2F+VY=8]>^LYMXZE;AAU5Q+7*LM:OB2GU[MYR#P1B;
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M(W6!='UA.J=#V*$"QR61!FD<TS/U@#[QVG?W'2$7SW4K,I/!YD>37YL6-!I
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M*5:%>E)TV?T=>A2=*^P^/RCQ:FMO297FKXJ/)R?K'/$<TPU=,AO%A02)]H>
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M!5;0<UHU-V\MN#SA:9#FFZ_J9^3Z]G(GC10?!5T249"+3WD%E@(<R!8,CMW
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MG6ZCLP$;SL]K<=#&,[13]*Q#$/SOM"[!J0'OZ$5MKX6&TV[YN^9ZFG_GU$5
M]R(^VZ3/72F5Z1#-635\= /?QNRV3;E QJQ'$[V9'C<J KG?'V>"#>0=.[,!
MK#7I=8+;^(2#>12'8^S)^'YB$ C!EUPM OUD _T!;=97:$$+_4MJXN!28_#.
M75.Q[[E36HVLX/>)SWUOD6O@S#;-?!(/TMR8_HSVGL,TZ^&.L"O&"I$-%-RI
M2S=Y[^J1;D?VGMX@-!-,XJ\M)<V<L P]+U5"AE/ZZ3$/2541*".%J$95P-3.
MDK\]-06F_WD/XV8GZ^)A^^:"VQGQ[#)CF>4X$%TH&R=X-%PSD(K"+7H&L8V7
M77Y?;KO>6DE^9,)'M(O&%4H^(L!4^@>#TXR^!3#*Z#/*F'Q'9SUMXIM^5"8\
M4*771C'?Z-76V5<N<GQ9#YZP:3N'@?.7DIQO]S;?-3%W#F,K=.DD]''#_R@3
MQ_WV59<'4KRJ;KV3ZW0L^/#!Q:^X9V':B,%A08XF"G>JB2 [6CL-1'$C&@DF
M#G4V$ZJ;PZOSPL]ZF*Y6^7.*Z ISO1"04/6YB);"-(NB0CX!(R9C&E8QTZKI
M<.<@KJ%TDT2"1>[D8IFHJV%A4ZM[>/^E=A"Z )G>_E[AQ4[0KC?/FA@Z/-<!
MWX?Y-G>ZG'?YRXI$)"2V6'44]V3@N8[W6WF@#C^A6#<P5?%5@2A*=);(?-CG
MSIC,+.W+W/ GY2\T3Z"EJTF]E>]?VW^LV-$D_&*)23:Q,7OY95=):<=5>D,;
M'TXN^GCTNO2'B;<HAZ"756DJ=2H4#/BS='%67RM^=WDG"_S/ #Y3N%Z4G'(Y
MS8YD%>MW".+W\.E%_,JT>GLIT9!)D9C_@<?'$!\^./&2=O,(ON)1K( 5H="B
M-7@@WB73<?@74DUY9T.'0.Q^$]SA<F>KQ_T%LP3/Y6;!&JHLHY,A2G^%4BOT
M"#Z>]PT>J-/>?=_):55<6%<@_ZQ,F "H;]5<X<,#L#H0>=3-;\!ILBQ!J($H
M:5QO#@_Z/M>P._8F\9-$0*-?HI/)S4?*=>]B90/8'B@>XV)FG!@BB;<9*(^4
MFWFA+GM3UMYNI-RL&;GB(*L-NIAY[L?-&QPSG4X?)HH9$] *@UBJ'.U">'MM
M1U)(4<.O X_Q ,TGL@M*LC_3DIZS?W+V\KGA UHU9<5C 'F%=2I>,L1R7 5U
MVO^;IYC?FJ_704:>7I><S<G<G).\8=(^W9<WN4)%B3 0X$VP"9>/)O2Q69&E
MDF2_)SCG.\B1A:S?(+ZSLP3H/V;>5OBWM;?H>-YUF,'3+L)"L!C@2>M:#RC\
MT4G?@:\-3!I1&D:A\+_1!Y2J;X =2BOHL^>QG^_GW5*GB<_86#E!1HK2%[;'
M;J"?@*\-'8)<<>'!8E]'&/S V<G(F=]JT1M:21_P)=BGRZ.4XJO#?@Y@\&1N
MQCMG[[PI$W.+D'NIBA,*"B>RF/I :!OTX$+EWH;'%YH;.3J2=@H_,R=\8\2?
MH_"[<RFI-VW$W"O11CL^,;&X(:#Q#F(_2G^[D9-VA=ZHYTIV;JG2*4R+2S%G
M#$9OD->F3XJY)E7.9S^4>>O<- F>$Z\KEL<Y/LX"OX-Z>X=C!!HOH4Z5#3*$
MD-%4SCO86W9_'U"=I^B5L[)8M;X;R$>%Y8LWM+5!D&[OXXPFC*"!"BV8K-;J
M4;$AY1C8:G-K#JZ3V[X^H5F)5155Z7W.X7&#$)!X?&+YK#%ZC#$$$48PCM'X
MR=%8+T3?Y)"R_6-$DYR%+J^$XM,N:]DLA1]RE.)(Z"/P##\E%#A%REY=ZX#R
M12SPH>PPF@V$D-0A#0[8QNT2&9D5K[LOSC#X;'W-+C=G@;]"'V*GKFQ3C #G
M?"3\%AE*DTNK3?T\'9' 8BE8T>A\E4.L1"ZE['3U #-$U:IM_B(]'"V"]*;L
M1#=GJ#.F2D@*6)4OHWK*!Z'3E\5@2L??=Y@\_GG6 /%6.HRL>N_#Q"2,M .;
MPC+BO!DW-:P8)L49&$3Q#"<%"?PE!7I',.3IF03A*.]'$_47_6I5<\0+EQ0,
M[@54,@46&<Y>B6*WXC2$W$0I_4<Q1#8 6NSQGA&)?_QKHGQ?"(XPO=U078=<
M@M7)Y-3$G].+8F>_)"LB<F!27T7Q /J\J9=1)TD8[,8B57>5$E03=HS%]GR9
ML8YJ\-<W$LRS#R:^_;?%5VBWZ>5'B&S%RYC/+-=,()4MOO_Y#;#IIZ[7WCF?
M+#NJ&L2W8!9RM: .#JD3<2,&,<]A\-\6*K<]?BR@>$BL>^^^SJFE$!ROC)4^
M.B*\:0*RP%O(O'.6KDX9TUHFR1(Z^8'1SSAAH$X.C>LD@]MXF):Z<09I;I,/
MV<H+PX:#']H"-PP-(NEIAR!W!!O%&;#X@KQH=/<]X?SRJGUJ7S$FH"DHN2H+
M?[:8E/]U6=0 ]]_7LOLOM>TR"SPT=7YGJD3ENGI_G>S5[('[\_4(A ^]><X2
M"D\#/I+FP3$0#IHQ'NXPA=)"%'@\6WDZYY'/6RA(5#RAV-0D@1#I(L9M*F:!
MVS[^*X59@'ED>7O-"0CYNJJ3\2JZ-Y7:O%V^(I,816CO@#&GO)TS,=@-S3D*
M;$1Z!2V(>O,^,J>5H4W:X5T T.Q+.I1,KT%CV8MOSO5&O"HEW4,TG7+X);*\
M:5_(56^S<2I1 ]N+V+QK.#O)K#"*YP[]RLR*ED7:6 F;+UXFA$H V>IVL*M4
M% QQ1_94O'A5F*DTH3:8UDXOAN)?-Y[^YY77ELF+ED"63CL:V=:%7D,(V[M'
M#KOMIW=5.[:R-JZ6?G4ZOGX"#W7'2*"G<<<8YY&V38TR@WJ6!#7P_55>^UD'
M>.IOQA"B)S*).'I\XSE/JLCKKTW=2>V@T$,0U0W=EXJI$&Z:<VYQ=7[I%!9:
M=[7^%=/2O,S'L(PN_-N900,?,\']0]#1PW^F?U$S$*29C!FP(.>^C!3NBD\=
M3Q-<[A[7>9]<.OT#&M@[T[0A\^!D%WS'E_*"_M4 @NXYD$K+1_Z]DVZ%M:Z&
MPR^I%$X'?7$%U;' %F_:J@QZW1I]#DM:(-W2=UC$8@UD'R^(-G(A6UKHNU?"
M[U64)A5Z(]1RFN/6NGR2O_J#A#G#R"]NK!PWA/K^*4Z%XC,/014551N6I !1
M_S-CJ,!/[.N[/6B![LFVP&LY@.L)\R:03G4'2&$U&*18?(2>7M#$-!PSF@T&
MC>[I(V;RW7C/%K61]=N](?,7=_B8L"_WS OFO8(.W(./#NVPLD-0FY4 N@_&
MZV^U(>G4/PWE!0)O![I9]'B\%G]+5'YVQ:+Z^6C2^3_E3'N(__AWR.8T]F6Y
MOH5]S;#R;J'!FFTE[$*H@?C7>63:I=FA\!H3Y$\!IBI8Q@+)&C=3"HTPD*P_
M(I$O:<"R3=7,MP4'G(YE ;:6?44O#KD9%^AS3>POQALS0[U&?[.SKW?FD\//
M;[1KH]\-1MP*131K45Z]+_7:,M^5%MF<XPZ@S5P6QPG3% J1=>U0@<+ZR\YY
ML\B9]F$8QF/?5@CQM6&N@_YKZ25;7\^SRRQ2$5*OF0Y<C\9SC!Y>V"BY4AO8
M"8G-5M(W=-#XG9"[\#517X?O@IJ[VR4^@9]W]60^=OZ6=1^$B4#Q>0M,# %U
MROB\;$K'P8>@0Y 1J?[*+ZV OF8E[HOT">>-$8-HHEI4\,*&,54>PH[\VT\R
MC4599L](7C]BRO6:6@\ZSX@'HG[^EN:2VKQ3NLDX^_^0]]YA345]NF@0I4.D
M-R$H""A5JM0 BH"(L2&=J*!T @J"&A($Z4U 0%&)#5$!(TT4,:%'!$%ZAQ20
M#@E@V)+""7//<^_YRLR9^>:<F7GF_K%X*(N=O5?YO>^[]J_\*2#I,$4Q)$Q"
MH5F68G26"VV@B?C8(YSU^%J,-=^/0QO?LE%%L8H##!GVA#MT.<TX-22X7B.&
ME/:#KUG9SN+[.,% +Y]OK.G]X'>C,_%M?&I/D(\8]NA&,[0_?%2?GDDS*BZ-
MKG5ZW)CK7;_ES'Z)^J7A> *J(NK^[*"7N$#TF1E'J8,IV%Y8(H8/*4OULPZ1
M;E24[ZO7?ZW_)^=82</>[T#;'_E5LTM<GU..*@15/P,GH?T@P$%(,S3.^T!/
M/>S]0F%2ICGL]:F"B\L1I2$^$M^NYV@*YA_TV(VX*0LBX\C_GIK.RBV6<KWF
M;B_' ]Q7\JZ6S4=QB[LN2,V;BPG-"F4*%,78!O5801Y J>>PP_N $XY9&1#^
MC6W0$L/CHK3[2E8Q-H]N=(X/5WNA;4!F3Q,EU#C3.'MU)Q8$/8:;HF=2J[V%
M:!GC8<R3O9>W0:XMZH-:_6BL]3;(X@*Z["P;(-['!SL).,D3#FAF?SK\O7G_
MW06^#6QCUE@MB0FO1"RGF&^#1*[@J4_L/X[2\U1\#UMK3.-'OFV#\JT'"@*(
MEPODPZT@7_M=.B$?II:?OD0-8L"P47=A8T*=S>$@TPM^7 S!A];3+;.U%WPX
M""5HW+?QK['\?X$"5$*6N3AI-1E"O1#D)-^RI?B4K*4*2V 4$2Y4.SYT3?NC
M>_.HLK*YXHLJ2V-THQ)*,AH8AT<KLAFDR5+5DV.MCW]8/)Y4"YG/98V 9$EW
MG!&9$#ES60:4(V-/&> EHSG#$L)M74"J'"GOJ2HB&OR(.>0L*& 6<6)61F;1
MNV(;!+9E/=P&S;W>!LUP7]@&30>"F-.#. 'V )IZFN4^ZT[]\>NY<<++&YI;
MB7$_8HI/O03>ASQ"1Q'DG_+HK^%OCP,3VZ ]IAS:?I^5AW2F;K;B).6@::M.
MC\<63$\EE(4*N81]9[R\@1.OD8?HQ]F=A:.W0<T]Z&O0K4/X/U8#T#]R."E6
MO7D(0Y%YD2I53D8D%C[9RSSG]CSZ2F]$VB(?HOGD"X2)2JVK Y_7)K+,7E;K
M9RRJBJE/,\HEKX*BT1=Z##6\/$X5?1>7G'G280"[!R(]R&[<#;'1*,<V_? A
M09=W''E_#1R@^26MK'0G:!LY:3\O7OG<.WN.1VQM(FEE;+>VUPG^_?N*@E8@
M(PBVP&<B)/U$MS40>Q]I0?-]:/NI$ [D>4$9XL:ZN=T=:MRQ"BD<U)FQM19J
M-PA0":T\0=2K?)+(^YRWM^1O@AA%Y,E)C5G<S."?'K8T0@)G:8NYWJA '&!-
MJ_SV?R43/<9Z=2EF<0;/PYDN-;9$-"_%)<G\SHM G%)M;8_.R_[E#=D5,7O;
MEE.*!PZ.J@R_E_Q8<24\+BP<'LK9-CNYOVQ_ZXP>.]'+5+Y#U;8XZ60Z,9OK
M*B=9'R7]VKJJG4?UHE^6HA]?B=HJ6AAUF[D3+I"*ZBG B_S>B40RC9ML<[K2
M4_9^5:?:Y4/_O5-6V1<.'9=_H&>\LJ7OP[L;-3OYS[UU"R+CA]FMVZ" K,RI
MO7A_UI6)XI^RKZC8N)"5\PE]9!6G,(F-=9GL)>_(>2L%G26< 20#3H5Y*3L.
M("4M,T@=&+!7P'5_.O';IF@K#FHI9J6Y)KDNF=RU_J2(G[D!<&9LCR>0074A
M*:81'1$B_G7S/5>,\@OSR_ID=X,PVL;'([M:]_/P_7&V"QY:V1U>=N2>K4"J
M[KN7(+ U7(@]PI:H8A6A]*.YZ;D]$4$W7HUX:2=1@ERU'J24A4+X([[S:F=.
MW2DUSM&/]>?NPE_! ^K2!/2H,:4MC<1"--X^A1/YFAF%P_5&=#P\UWI1U3>W
MZY97F)=SV$@74R3<._N?,GWG61JP>^L(">5L2'3AZ%#360]SN<RT*/3!5]ZW
MKJ-^DB[\>?9<,([?JP2T:DB?R/B-*_5!W HR]73W/%%US"!85N4$J/20@O7N
MO3$+RR"4]TYBQKA#\Q=+]PRU8!3' \&-,<;-9_A\NDM&#PIU@JL#8UA0.W-N
MHI<X*2L^ BT8'4I@&-OTA@P.]@ZX?FR!7[SBH#*=<]I!I7#^S?_E1(<:2;22
M-G32-DCH-U]P/9R"%8X^1R?KF,J'(%QJJW+LUT[\=O-R\(S3._K-@&O\K+?S
MW^:&@/Q-X>.?O.]ZO,]A:OP:362=+76C]TQD2KJTT%5RYZ!WO$N?K)E(@*K_
M"]2HW&G7%D=/!A4J/G_];5G,VZ,]M%>]_<S"A>P_0T]1G7@09X^/E!#9>40%
M?>?/@\%+JD57Z[]DG#NA][UWKPVM,1@EN;#Q_T;G[G:4>WWSC>>3)T*^6_W5
M9ZU$S8-4)[[+!WS[U@4N=_R?$+'FEP4E/L1SX?9'-[MRV,#SP+"%VU_[:X<P
M5P>NV4\&[*O/E,BMU6PAANDW2#9&K[/Y[:B"ME1HLJ&&@KY7W$(W[-/G%'S-
M1.)&QJ/K?$KI=^'1+G^=E]+2A IABF41I6J(:/""<9WW9ZV)7QC$#8T,;]L]
MDX;7&KA!OD.OD<H[ <Q("> 0C?LDK21Q(\8A<D+K4;G*E_Z9/.5K)VS&]+C,
MW.JF;Q1N8O]N74Z>BU])$VJM[L&%-VN*1Q:VD/A%+9WEWFC,0B8?- \Y1M-@
M\S]E6#)/KE]#[%%+U/'MWG))] O2^KQQ[QJ$F00_SS%[>1!Q*#%YJ523@UTX
M%0UTMQE$;(2R_HFS(#-<LM'-YNPQ?"7V!\DC2]QK7HJP&4#*L&.<ZZF8]W4T
MGA5&C9ZU@F18@CD/\A49#/B]1?LR3U 3"\C\SQH*-;ZX&3S>!@&B9\ZB5P=B
MH-0IMN!^JE^KX@7+PWWFUL3'^:#Z*@_!1><M<Y5OZ-6?V&JF%Y4#9Y"]$>LE
MP,OF.EB*IDGKQ_*KDOT^EJD+5MA'*!5THP;>;RK9,O@C3JZ>&C/]Y'&6R)3Y
M,6HJ3&\_H/0,' J$,TXA#P&?/F#OH90 M,?G!\(?PR9?>-WHTS41 [<&]6NL
M^9"-F:)JKO<<H;$HY9')S+=7R1IJM<K#/Z28VZ"I"N]@/#='&6!&GJ+)19]H
M5R?S$"WA<Z:%"W0"9*):<QIU1.@G[W*")-#ZC ,9;E!_:$+48C'3FOK^46DG
M?E%YT.!S1$=?YJ=A9U[6EN'JY$Z:JP&DY<#@T7H?8LB=YNNU/%YZ_C5\UK\/
MUK_FGBM#/P6ALGK@1H T6T"980[\]O& IA1Z%YB%_5Q\X61V>4/']!WDS16+
MQ4DFE%PNW9I_8/W8H*9A*?0/T+=R+OK/_/K^ [&64:QZ?*"%&3T2T"IK+5DT
M,MH&[35\N"<SI:1F/" LXXBO\1W'JS[IO C=C"\#%XJ"=.@NM*$&Q B!Z)=8
M+\K;II-4.>7>.+L0=18H:F&]IL,*;^G_FLX@!,X^??>RYA:4@+^K"&:]@!*+
M1Q$)]9&7M8M?8)LCO[I>_IPS4=^/R[NP8@.V"]6?_*KSM]5Z>6LXL^K*W,O9
M&^W4'=THD 9AF\$5HM,H)<V(6'SMQ3P*AI\S@K@J(C15:O%U]#MAB,?'SUYF
M9])V"8Y<-#83K577CI8ON7+=]O;0WQ8(QG)D7^CJ,)B(;\",1+46&5"CDA &
MG $(6!O1^MHR^K3E^PO'3S[(EY_/Y]W<E[G!M87>,8$U&<3?H@#L^-D&#QG.
M3>&#/ S^66+I39XT>^-]Z*7;E?":EY%"919\%H%)S .W(2RN"(X9WI/%/(Q)
M-[]%PB;5G5R8U*")%)">ZG2ZVM(K[DB^XCFQ^QTB.VY%:9_0;+PG@FF8U0C>
MTL1P=@WU#8<S4JJYIM!-:L\Y8R8-VP8UN'*L>!9P? .ZM6N>LWT$(8 +][_.
MZ)=XC!&"!)J% H3L=2O:GCO;/>,N1H9S %:(];F,0Q)Y.DA9PN.$&S1]MUA6
MH>'^MD>"OC'OK%DK./>B5[[43Z;XFBFFA'S#3@K'9OD8NZ;"KEP*5#+H@YG_
MQ:V042\/2:%OH<71PUF'O%PO[?MRZ&RZODXS_,/J4A09-J9,=EYM@Z5E1;Z)
M=EAU_^6@XP#&3O T9MC)U-H8?=2U/"NW$1*KN',6C&<ES]).%"-H0V2GZH([
MOXR]%:OP'5\[6VL5;+S&L[^HFJ]YZ(SPLSS?Y>>'C8RV(A!"81Y-=Y43#062
MGUU2YXX%47:5_T.5B7GOHWJ@E9R'VP:-IC4;W=;)C)A_OR<]PS#C]Y-?\H_M
M+G$_"#TAH_[]@Q)QG^\N2T%@QR/'OC.GF[-LR2>49SLJ: >+[#=^M%AP+!KJ
M+<=^=D^TI>V\B\QE. 1$14&NFJ:'::89EN58/BX;L30?KI6\>'5<U_K,][DR
M7@'8U1V+ <,'"M[YM-I5SE-[]9;*Z]%)--CJDIENKTJ(A'^GJ*O?+Y5=>G>&
M%M6671C:@ _] W 5FF@X[6%Q<BIBR[)&CN<Q[%.;,7CUQ#!7W]'+F>GO.@ -
MFCYI-7,;= V>/(03IPF)SZ&4>E?$%@97)D;L]U<I3)1UQ-?$49O[=O/ 'G#/
M3R7B:R>&6K-&^T@%Z6PSU<<!I"G^UJA]D!'ZNAWBJEG;DO;HON^]#I].?/*,
M:5&Z>GK5FE6/#NWF N+)+HVK"DB9_OU#YC"2VWOM,7=_M5KXP>2+E?FR8L:^
M81 U98%.Z=4<8S0Q'W<8$">#!::B=2Y0$]/ K?=2R5?[?_N?6W#R%I/%AZW%
MS^AI<]M\^N:U#3+^46M&9&$;)G38_,TDQZF4(J$JFDO*[Z")$P2K#WTD_G+X
MA/QG2>7:1[P/W_$[$?*X_0^WO/O 6S2.;KR,@D;'V2\;3( ;Z4/GKAEX01T^
MYYSPZ1/8!.>8":%X\#"H'S1Y2LQ2&]59YY?"='QF38(GN]!=;#0<DU7B((;N
MMK6/7B#K-$@R\47\RG$:1#"@M@V*A1,ARY&7.?-.T;ZK@M(O:)Z/)'[&OF?W
MB!16WLK](>2X*3D60:RD@"7>Z?_R95=[31R[&J35VE(Q-M:4,%UX@K-4?2O4
M8D&SJK%0.</N$5XZ!1AY.]%,T8)=9$CD6FZ#EK,D6C2OGY8IKM?[X+R37^-(
M;^40*1[=J(,,* '&6BR->Y$.-+LE8]%Y2_#/4U@$8ZY0.1RM<>_RKM#QBGO"
MRB^(L67-'!,Q)LX6:"1-)=%K<3* 63A'3HA_\"^F<2E>>WKI]C7M(3&19UD3
MF?PZWX?:T970)6/*U-CY-C'D<2#^S8*1MTA=G?[D8D&9^[K;?<@CK8Z;E( '
MS-)T]2NO0 +0RJ2E+Q3LV#I%NYB"4?">\HQV0]BV?<5Z3ELLQ?,NW00:A&L#
MF9]<<_>!LV'+)7%L10!.ZBI@/2;!10)0\GW -NA$;QGEX[',:259R]E"]%VF
M^'.F,?7]8Q)&:/[FEF72ZR:EFJH:K[=R6?TYUQWWY3BHY#B\3_T_YT!&!8\)
MTAVIF\L!U"XO\)DC\VSE"K!12KE$A_LIJ^\?38Y8@B+INZ^_^,I.!;&#(S(\
MR-"E(-IPAYP3"2L/7%MJ-:Q_&7%=AZ8<&ZZBMW]??.+%W8J)^&CT5?1H?#.D
M!MXL#Q>?.Z?UNEADV#!&8=R@+J;+Y#QK.E@L*UUWX])W\V:V #<#/,P>L.1G
MC_0<2"203Z=QH_W&/THBR+(^ 1JWQ7/248N*C85X"(H+&44C+$71"AA^L-JB
MCK,5C\H,L>#)TN.U1TJO.-YZL%;&1Z0<;E"\M9M[R_)%_2HQJ@TKR/X)%][
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M_9H& +E0=_.#<L@E/;VR!H8X//(O_.OANCO%<_#3!&3,-LBK>HJE4XLMJ>>
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M)[)*CFR E'[A0@%#1@02P4I"GL. <1ISMS-KGKM=AE9&OM:X$R(5IC@X/>T
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M*U*4=HPM<)=&H*<.0DGB@ -IOEY+@71(\F.\^-3"N@[L]W.4]<]?!N?P4\_
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M9TKA29C5#?J7?6U+J""*267>I,*I3S?K J;(E(RS2,T7SX+/CQ'4_KS=->U
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MSNUC/0MRB+-[LYR=UZYS99MR>30U,Z1&*^3:[,L;\EEZKV,>K9N87)G](0Y
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ML[:&6]UK90P9E ((>\E4P+4U"V+/FM;AJC_(GGM:OKX_;7G(*NMS<N]'-'W
M5@[ZI"QOVHZ]FT0M:8&)W '3YRT@IZD?B ]'B' OA0\S_44K1LO'?8)U#WS-
M:%Z6NJWMC+A0F@\19O<1:H+7=E.+'<97H0K=P>%%#B&LJM<3TV#X85+LU<?H
M']XVC,?^!3P/RJ5N.%8O<=D'(@6]I\%95Q*T:9>MU"#:E4&7^[[.1X3:5X>/
ML46+IZ5_\3,E8ETD.Z<TN 'W6M"'6!P&[^-_#2<R(5EW^EWMPT23LY<\%E*[
MYJ$W(GY]A#SPSK:(?>_M6R-D%L:XLR(R8K=/Y>A@I/)NYG?>'QJM!*KS%U.7
M5!!/NCU:"\P&%'B7&(4'2*46P3:J7%GS"%"+?_47Q59"ZTOP%>KC_H@WY5XI
MN\*%6FY;;6?RSC6CP24.P.<S8NY(@8LCHUN@YN]J:D=U]W_ V8Z5SAG6>BE5
M61](?'!)(H#QSK+E6)?#9Z@)U^BNH =5=GNI$-MEH)JUN-(IT4*IO+B4BTI8
MZO4!_K7@"+81"@;F)\R)TVHCR1?:@[.*O(\Z[., 30F=CQGB6@WX;_I=>;M1
MP=3:>4S;11)$'.EZ.:#6WN%L]HA?_\ZK([RKQ\O;21MKR;0JDH\5!Q!8["#N
M<3XI.U/3T&B<V?LS-ISV;].-6'L'X4DP4=A\%5':_-C7=HJ8T'>5H[4.'[1Y
M?JX4_^HM![M)XOBW4$4N>G2'"H$EG["=IL%QYI+W,&-V%J\_U, +VLY@V2Q!
M@#&5L/GGK+P:FS:QA!-[29AX%:71P^J,6LS4;ND>#E"K)_T(0S1<^?>8#85C
MN*+NTC962RAX,>:Y\ OCU\'C_FJ#-?C=A/2=:TV?/_<&>ZX>?TI[UIT;AVS5
ME>,?EW)<S$HB^.;AB%+-HL@2LD:;0ZPI)H:M,K$TGG4$Q'=D/[SH:NX?2S0P
M>OL :U\6$[!/PK1NWRLPF/$ =0OTHF:UN1J!P]1F>Y\6A<+DZL5N5]GW,0N7
M,RYI9QE%\PCI"U-ZSSGMY*-90EX8./80*_&=A#@.4+V%,X0EV-YKE@,U*^R+
MD&'ME39*6:$%I4_"IK'R1\4_7E*%%CR3Q12BKE+L>5M"S1OP\89?S"R'*(RM
M[,*1!P/XT9E(2\7'CNT8!<)\.617L^(K>JZ4,7%/S?U/,</GIB=W*6>3K;Z&
M=:5HD?NET;.0&OZU^!)[$CYVRI<=?U/+UP@J7/?H3$*H_(;#Y^AR)P/OL 2
M=99+@%R8FJQG=Q>@^K3;A<VOW[PWL-MWV'"W"44<KREV)[QD _Z44.W(E.8
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MEE(7 _/$8V54#*CA(^E+P6<&S64%)<ACM[O .^?.CLOSO^'3>W1:->\TGLO
MYM.X89'I2"VFAXWZ,2_?#'P%V>/=?:%BN/S1JWB_O<DR5TY^RM+T%S.[[!
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M+\'(,F4N2#RL?C=>E7[\G?LMUXX +]^(BO*\UI(>D]3=ZN4#"0D_"QN$$86
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M4$XNZX";W"+*/8]M?#%WRWDAUBWOY,0!CXP+*@9'G_#$\$,*'W<A(SG#482
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M;%V@U#P\T44WLOR>C9#=N%WGO1=6WY\H(7FN_AQX"5U]$3D]C*>X@<3@%Y?
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M]:[.>**^=4A!SB\@>-JWET?T_!A6'$5XV537TX&="W>B(,*%:>$TU]2<4_N
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M?DH-?,MI_(>?]=PO39&Z,OU3<ZZJ!_1\$].O9]1Z%]VG#M/54HO*F;JL['W
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M%#PSZK=@I_'@WOV+_CFF45K(+,[:1#O^W35E]\/XFV\QY.AANZZ4>TE+;ON
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M?O/S_WO7X.$2J>:H$4Y'EO5Z6(-1Q**3:E9^*;;KEO-K\[RY^DM:-K'DDU3
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M2_XJYI5SD+K=)Z$-2A<6=[C!+.S*+#8SA&QHHO"1NPKK4$DU%'#1.D_H4K\
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M)8V_5I&4NQUY5);U%7_ &.E&/E)U[RV0FE:LGZ<?M+G? DGX<P&,ZH#KDD6
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MC^F71WH<@Z*H"D ,8XY$@W(20Z!22I:0K>\O4PG6N ODPY_A=MV/D01''W[
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MPKO4GWL00[F\[.57WZ(,'X9V8_-$'>XVL_!!V=J<O,X)YJOIO%NI W&^@SQ
MT5._80>VP7CR2%R(P7G4QYM'*+)^4(>W[I. IQ<8VJ34*F!+S($?!P=W89K4
M85A]TX#\,<A'!03H]B%Y]&P"A8@6G2\KUD-R2S/[^SQF%6]H<_5(QDR*'*#
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M.BH2\EVD%7J4V74,>E,'^]M\DP^YN@IWHYW_V=(?!Q]#L#&RR[M=H<P9SD2
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M7+Q,;++968F#>H+#D%RC*]8M0#56HXR7+5[L;4EGL':HZ[X^JU:=>!+_Q^Y
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M/[OO18J@H$!)_@^KUW7?]&#2U,<7[/I:^5M$%M/)DUDB8Z5!58O<1M]W_L[
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MQ$"5P4YI!.<QJ$ ==PRB6KQ@"$75J=0 %&A#4O)O!Q])HL!4<)%)A9)K5C.
M(I;*)G6%MSR+@-N=6>91*G/GU-D?%MIVN[(:ZS$,&)84Q5@)]CPM'&]X_!_*
M&(!*A#*RW3_;CCBC/-@/TSL$UFOK$TQ$8@Q9JEY>81R=.CI/UR%-CJ* EAXG
MATAWP%C_[E/NV^Y:28S4F+Z@FU60G49(8IH9VX)$A!2C:CRA5\;%CT%6SA\6
MSC9=R'TO 5(*SCUL-@ ]  H[&M035;3>\G<)Z40U%RYY\@L]+WJ<J?:;X=Z
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M@?,  % !%  M0 *VSH('-I!3 "G8AH!_ $3R;^>C(5)_M)G!=EF4$T#V1Q^
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MQ$U\7_G30UI:.RD#7]_S7<PZ2E72C,S0FXXD^RRM9KA@K&V@C.$E#%>[]X
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M5&KQS_9R'QUEI+B%]^UH).F,O8E$W)'5899)@QVM<R?#UU+RH-]F'R&9]G9
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M7BT1&$[/@\Z*3_TD7)M=Z,&'Y1(!C:LX6]!1!!"!WM7@\T2@XCER-<;EP/L
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M8_*;"+? I#F\U4'[EJ)JE1S?[''L5*R3>FZ8%<7&CGLIO_AE4I[FY8K?&JH
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MI^"=0\9_.K?+HVCD#>+,(Z?BG_K6[=E96NJX.SKVVL[1V](6PZ9)G7\N'GV
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M!&]Q89=Q;KR XROQ",VNKHWS?HGA@SZ,#U"^4*54,;F%:?OI9L,$[_"05A;
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M(&[*/:FL$H^B&EUV)CL)-G6UA]$/'O)IM0@@$11+\C/8%*I>IZ)H!RX&XX/
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M3)GX\.4/$E09K!Z</3F5=5#YAN'?R>'J#()J=44YE _///M>-#KE_2<S.#Q
MV=<4TI7 E)7ZB*D^XZ4OTJZ5_NL::6-"9^OR) M^M065+:9*JLK<D*"F6T$$
M.$8N"H@\EID">Z3^,,(,X,"$\WH$>/+OH'GY%Q#Q!C.=?L*EAD*>K/6KE]Z.
M4/IO"A17= J(\VZUEG6"8UH'(A>[0YP8\;N%HM?R \HXU7CBN9*@KQ_X:',H
MH2,86"Z%J\*$H/?Q9?T@UGD2HBL/5Q:GHH5L"?+XM_"#J;BB1SPIJ1C0HYU
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M)(Y*J:98D:4?;LYEJ"#PR3O-:FKS&SYGTT=/PU?SG&XH.@?-;3A3N,'F$!B
MM$:J9-T@*$:;B)S+KCF?2B;)'-P/!RNA3HJ'7J"<% \MV*,EI'1D4FO@GF8A
M1"MJ'@6,-0=ZAL&JX)(SV86^?_6DLNJ,11.A2647^K4.5??=3YS%;X&B$<3S
M)\[B]^9\Z6$Z<>@4Q<]18UZ,42_GA5\!X[Z3;T(AS2^1\U@TKKH%LW-]5@;)
MO3.?()P?'CXLEVV"$; >9'S>I)AU/\ 1O'N2()D("KU[R?PH%I@\21[(2+F9
M['8R#\X9<-09%KK<G+C];7C%5OZS:-8;$9>(U9NP@171>CQR%XG/-Z^+N'[I
M&!#E;MX2%'TJ)MOCG)TS8YMV2N^A1!ZIDIC7G#)'8_N+OV]L821Q%)0X/-(5
MO.]_7HIVJN@5,^!5#MD&-KTB0,V$":G'_R6Y3B-_EZ@M.*7Z7S#Q=U^XJRZR
M:R!2C\8Q/3,!4"J+8+.@IJ9&S 'A ,R@(HQD5'I5I;*NP%<JAY05Y*Z^4YJ
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MCP&-8S%P;V=&Q^T%L\]'\FVE@TU'';$ONDH;TE]+6X4+8WVN67=J6#.=DME
MD?SV%IQIR<*]H,.CC6- ^LXHZO'J&8I5';5-VQ&+>XX!Q^F(DMS[^6Q20WP#
M?*\T1 1[_!H*-F!JB%L/2/_%O:,K]GT-L5C<#V:"^["#HU=Y*> /GDXLLZ[]
MZ6N50,T;A,$?$2:F;5<88G,N8#VUZALXCD)P+62G+50=N.=*D#$.]]>9?[N.
MBC"8^/6$SUI R?3RI/"(KF' T%.]_L!K=/%;XLQ(D22$$#T(8F5K6CN.;,>
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MM8-+JH)55>:F];.?2^I1C1%'H_?BY7Z[V(D_._N,3FG3P-* ?87Y6&+$U#'
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MB>SVLOU][-\F[?Q3C.(#6M)C*$\3+,^>Z???[*+J114):H(6@V*/5\RD/9V
M"_H:_A7#-G+O#C4QT2\/H_8U:;Y9<*:OT44IHL[,S5X5_TD;D=^VT^U[](:-
M6I)&A&S/D!ZAHJ^GA^^A&&6/[HR?ZM/S#\0WW)-S#@A\?.<WLM:V-K7-2DH
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MVH7E=/-BY'7T9!XD[]U?/>'_'VU%X\%F$S9?_/P5@BB#^48*PZ<MF-SR62X
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M4WS(/D1>J@U":<6'W6U6% S'KU+M7+:['BV$[0$\AB]%%".+8@\]XG2Z('E
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MHZ*6T^2@1#R4:\5>BBQ1X)/_,_2^HE]P6 #5,9[]07@HP"[S&)!)H+G0"_<
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M+'V'5 2Q;V?5HS(VA!L]EQ9')C&T\"D)C!CDV3M"CS17-J,?-.T*-4AI5B]
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M%AQ36*!5V(,MR@CSA8*(S0UA4-W"Q%;O SQ#;\<I1G?[U5/(B9700HIF) =
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M[(+!PSA74)+D _D'GKY:KE#],K/5X95R8M0IG0XLI@&]JF 351\U!.5!X]]
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M-9+57*R)Z\="@)0 :<_N>;GS&D_P,>),/6U O<'H=:0\!L7SD:J8[M#8F+6
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M72-$4[S&3Y440;:B<SI;<[COFJPK<>;A%H0:DAVM%LQ67S!WA%#?B,T<"^1
M5+566;^2"XQQEM(2S7G^>ICUQRHNEJ)X'U(-[>BCJA?WT]Z6S6DU303$.):'
M^"% "G3A8=^$:9D\N[B]4.HZ[=DC*)K>NUA7-']BB<A,EL<)G33\X'1K0"BW
M-@2N[&VO/>2QQ "\\H6I(>0@BEOPK<4K1-"S6FC,+5)=D?M^N$9VWH!G%MM3
M!Z-/I9M+&;/I[4.M0$0TQ2Y<G"Q/3#,:P='/>4SHW!3Q'%!_B@I=&[TL!.@>
M:RHE/-EB3A1SEE<[C;P+C<R<9UDA5.1@H%R<O(M7Y>;MX]':WK\27S;9?SUQ
MXM<QD%_?XB;1H83*;TPZVT0K!TNLVTB(-R!JB8A8F51S/<>VOM-O,GURF#^Q
MNNL>3T\&HKB8!4'')QWI<SI"'75D)1_,X#WW(V/KEO/EB>9J&J].+:FL^:C<
M\+YY5C=J\=@1!>;,WR,!-T(WWRPD)SJQ?CHW=*<B6' _L/[&3XY77RYQI.PT
M!"SFO[*YQ@!8+,<*8Q?WDG!VXRX-A/YT_CQ[ES%@D4X1(&E2^3))H!;:2ZIJ
MJ>><BJ==2\@"V^+SX/)7)MD!U;D=3)+8K)QC2^&-EYBE@D 9]+/T+J08TL4"
MS;NUD(RCN&DT%CD,^OFS"![O59XP/25G9NHULV+[JR/]F&]!;AF3I%@^5;#D
MNEDEVJQ#0^'+D _6UHZT>WASTY<;4T!7WX 2;+;8Y^__[AO6;J@6;'YZR1W%
M29LRS\; EX2HI9ED 8H U8?V#G)_0S4!4LOY$@W.<O/S"5%I*TCI5M]+?R)0
M&[A._RAI%>3-;B(OFA5WP$/K*G$;+I1KX<<GPCD#'JEM]#OIMNI:WIM3J7BK
M;:0T:Z*<-.]9K]T-^$$)5\U=.88F8['IJ.PHI3#15T7AA#S'L1]3.SUH*O;@
M\9J@!Q94IZ\S@!O1_@)M">_G^A]_MDE5Z-U0'-_BI)ZG(<!,P4J.9&UL):?'
MPV!/Z]3@[I[<8T*6'_LTO@S/@G:53FYO"TC+1):95M8A,3G0JM,E%&6RA0VJ
MY0[)?S'Y>)&I2GESG)!%O<.GR ;LZZJ!]"_4CTQ:_0#%^B!2<ZGVZ @E!IA?
M/Z6GOY 0P=M_AYVT[;[A>\O\JYFW_..HMQ)SNRL0GEI5X?70DL@E(G>\RFZI
M'-$\JKA%)W0Z/<V?9_KQTNTSO<BZB,/_"$&^LA=*/E6"-_\ &\X74 8?IFJZ
MUWG)=5J:V1=7/<BUOZE2=<<A8FW!&9''L:E__%9;RS]-C9ID)OF0KX=K8J?G
ME1:XXZ6"R[(U?N%48#B$T^"X]/HV;R?83F !0C %33( "L@"(DIU=,DU^B6B
MRFGHBU2SK+<V^PI:2'MYD3:[^N+'?>:-^4D$R6X4X@)YH@$62[SDMV"/1X1N
M%A^$_^2$0J2?!?3TF4#5J]&?.$3V]O_\K,S?^/?!GIV1?Z2T9&9JIG?%WJ%K
M>$!B05/ZD/"]AUKRQ0\9 #N8+_@&)CG*2T\:4ZY$$>J<2)9Y,45[YYF4))WI
MWV;CINTJGS8?CUO[YR]LX>[.KXZ([8*@+UXB?UB8Y_^1O9P?T_60'-11\4'\
M><XC8!YL/"@M>-/O-<^7<W87/E*6__LTXQ^Q2DJ@.]R17/[;)\*Y K9$R-D;
M.#0XV=LUC74UO4G&1+>YRNK:C\Z"E>9;U-N_SU?2OXOTXMV)*%.R*@&;;SW\
MJ/4/NTOBI2X!YI:I27*APHL#)Q$6N\FY13Q,7\(/DP,6\LFGDO$AI<'-/1?^
M(!27]8>5A3R8LZHK3%79(5O<;;^\^N2Q$FT3B4 'YGL6K9,F-*R):#O[/SX9
M^K!'F[RU%+ RP   P'WY)V1*D^0]@G09>A)J\:1VZ_3BM5YTG=<EH2,_B9';
M(-3]SU;BZ39MIJ0_?T_T;_S?M:=<(;JHV=W*C(%VFH?UT&4;*."4HNFLK)O4
M[;[@Y_RLI<WIUS9G,/>&60<@A!M#TVST(0; P0"P'(3!K?3%>0&#M=0_R&E7
MJ[3M3FLM.S;^H>??^OB+_RJ(8.HSN4?GR3^6G$A7K)ZN\#PC3(5X*89/3)CO
M59P)U6OE)R6_3I$'G:%_A;-3?S>_D:"5U^6+!Q.=H!QV,^_>E.'E^X\_2?#2
MD9XR<6QK/OXMB,<"O]Q::QU(-&0Q8SFK\,=S=?;W!;<!5H )':G\%Y!I?^,_
MB7^T&"1 [CY8MX*TPH!\],#B1#+!!CNJ4?IF/31ULEN@U$5=_UJ<T8N\/ >[
M>YS#,&*U(4M$^L'U:K1*;MP&X249VHF:@R:WV'!T>HP@ANZX[;DT[AX+^4,O
MO/L5O/1D2P[]*(@BR0 ZY+&=Q-)N#?N W+MR"9W#7Y'JK3F^>UKZ(D[Q\-4\
MBY.7 8H\R8J6^RAY"HZ92,*4*_3J+SGC=2H*2I^$!6-"4O?Q&,4G(\>-';))
M_Y>4!?WC@_J#5@/'%*.1G5MQ(OD=\*=Y8LE=L%,(;K>(#R:R+R]J7ZD-)%YH
MSS9IU[X[:7U=XS6?$S-% =Y^/=R+$#/0"0.1R]_-!^>W[WWO&R%_I(=EU:FJ
MO%/\^2NU)N'9HM= G:^!P[V4>("65MC2O(C <V A4P=>76"O2Y7',6OGV0BX
M7SR+4W:G^E@WOP,F0VRUP-*6P GS<X2W.]'/DQ,H%YT(E1WB*BU2=W'>;AEH
MTAYN/?&Q[-<'*6^865+S(S<,0.5C-@/0*DT\"CLTS6PZIHRZZL-)'C6-=FT;
M0=]1-#VN&TX& =7>DF>D%>T,OQE"K@\S70J!X$]1+I&A)">R8\@BE/]$2=P]
M>WM=C@<A*(3R49,T/2Z!5U5K'WO3(N%::70.::*MB=Y%^8X(,;+DT-)1(?SM
MK<U\SZ',9O$69$<DQ/%^Y6G::P9P'W0,-@KB*-/SP=JD*Z\&1JU\6V)2S^UP
M#C]W.^4%^POCPW86H60&0"H[8(D?S FC"Q&KG971$GQ/>F!2HZN>2@/3[<HO
M(MZ+J?%T'N<^=2/=N1%VVX#U1 'WB(C2]B+)['=#,$1W<MP$D@NF$'P+=(2<
MO>_GYASDN2+#ZRAQN*7JLED7SE=HY4$5NU\[Q"/<X8"U;OTFK?,BY(_KY6KZ
M$MPZ04E!)DLO/HB<-G*<2K]Y[V&G#-=]YII"I$R #UDYM@L/M1Q3AW.$GQH5
M;0\\=UP/D1#@IWS?HN]>GH;MXMVS[3>&+GAN@::824T$%#Z(0(KP-ZY/,YFH
MG>+EA!KE=B5[2I]2_/*9D]@FZGF;K^XQ$ _LH7\3@'^8QAP-#"!^GJ]6]0F4
M:W=+)/B ZV=K)#] G4>*OGXNJ,;R<[/;ROCA9YL[T.<'1,4';6%%>PL^[PX]
M1)?("O Z?WGL^L3]LN?PVEU770UNJUB_J[Z:64>Q-X=9.0A"V*TX..8=I%ZP
M?($!")=5D:]^O]<VGJ'A<WIN\*I*+3DG48@#(<UZR(8R"_=Y\*#@.ZZ@IBY*
MU],^>$+A=O2AHOMOV3^^C3Q@^OI*O?![T"F$&2V#SK[NQ%W]LR+ %>0YOBN,
M GFV^&HB*KJ!D\F;!9OF85Y_>O3Z&_\QP 2I)D3!&HH ?1[.$[#%2PXUOS5J
MTSA>@@B4<O+4OSAXRH\C)6ICY4[KQ!\R : K#*!=UQOB-I_( &JV'K>)!^/#
MU1>XQ=9LFIYF9)]NR'&5",=+\<0!=@C)"U8<$7,&W6$ESV$:]$%H_75R,G8L
MV7G1XKB[CN/N<HO-OM5@;?T0[X+%27=I(QN64U)L?3?&F*$OYV1H.7<(2%P0
M1C59Q+K97_#M!\^T=<WL\,32Y;[4JW>RCPC?-D LB;W._1S)5L"-3D9?)!D2
MW/!G"7N==':4:D RUYH(_X:?BR=V2NHQ?Y$YOX?50@#Z61< ](2.5W*1X9]!
M51#<J&!6Q/L0"0Y"Z\MW8:68&/O4S6^?/T9*F(I_B69>43[L3!^"2T@S@)@S
MA*!N[F?HPLDRG4..'DWI(^UI U]AKJQS(1I1_ ^_8IA2#\-<J<;D.*(%G;V&
M.,=]E&PTX27T6<2A[9'&'DM"&-O#FW..Z=B5.R_>GT],ARX^9&IE "R!A'=O
M%U318=USJJ/E,J-4[9*UO>/FR\FS2C,6)V)F\O>< T&[7Y"N2E\@KO-3J([Y
M:@;0R7'@?ATE_C#6%&IZ^CD$A5(&0HIZKP),Q@=&^OK>?BL ^_V*?,(=_53C
MP(+D.XX9$Z)FLY?_8(T-"EZ\8/SQV3QH*WN_]QK9JJB2RB<(91=5&&R!<H%1
MRS@0D50/==_VHVWI^>RC>I$$^\$C*Z!G\\?JWMT@Z98K_A@4%0M)N5+1"3'-
M:$./MWBY,0"N^08B*"]FSB)&=_SGV16-G%IY5 A'LI,"\P*4+%W959I\]#Y(
M#"_^M3X4EGZDE?_8U?'@5#\I9MJ;Y2=T3,4-.ANVH"0!XJ$J$)QV ^3=-KK#
MD?!L]97W'3_U+L7O]QC \8L*0Q37.@@F!7:XE>@42S'0+Q2;(3_4/RDG'9,1
MT(!FK= X1C,NOWX0I90WCMO"1IS.?2_QXT?EB:0L&F-JC ..W S#]O<6@%\R
M&=,Y6-]61C$ 3Q^NX$RCP9BW$06WH*U?I3TC/HK&O;4[3\-4=4 P)]M^3Q]J
M#S?*MZ1ETD70GZ\<#\Z\&7LMR_+U.=E2K8L_-*_$_HAJ8:9S:)>>KJ18!-M?
MKI-;"(,<LW_;*SQP5*:IX7:#V%)%9S(I.LR8*LC1KMD$P2T2(KZLB//^>M0X
M%<*$'O9:I4_J V$,@,J7B:U(G/\$C59+:!9>KB>JE%.;LJNY=U+TMHV"0NEK
M)[>G+H4?K$*64.+A^1B()R>\,\::HE'\QM%065^@..9^KEBR)<N3M16D 0/
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MIM_G6.![S)?8 99TQ;.?CDDP?5Y!*L)]N"=S.O.KMCH80$R5W0\;"4FB44U
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ML8&]^3VI4X%9FM743VS@0 /#FSN_OTF!?A-Q$=0I0_8;8,0V"<63KWN70X/
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M-Q4DAL5MN@N &-M$IWY]*]O/T\^W)Q:ME)_<DQ:6/J(4R\4C?(B;B!HOH36
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MYN=F;=O#*^ +X)D"==8WP_O]^]8O&II/WIA^,(/6ZW[/'FCZV-@MJWX[U$B
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M6K<OL_EE#%SF_BQX8*O+],*-H'=@7RL-JWXEU";_4VX$?;)J5ZPEO0/JX!K
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M*B$\P_OYC>+TTQJ04Q#G7YOH."075;Q7NP*/$EJ\5SOU>2XS4#=H*/OT4 V
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M@&X>;.!@K)<#9COJLQN.<B02];R?CP-C0CA=:_"I']+J*M!*'-&&'9A9RE[
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MD(XF=$?'6Z7.B_:Y_@$W&AZ?L&E7"NE[8XGTWC7]KU[$^_^Z_',K^4BT,,Z
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MB<:!6,:-RL/IC7+3Y\53Z^>9Y_A;4"V?0K"?."RO@*'+&:QM9@%#O?HGX_"
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M*V'21CKA@]?M7!$SZN':[0=WJ6F7LZPO<PW SVSJ_+2D18_@QA"JE$'$)_A
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MNX*^F]77V'* 1( G>GSCD/XS=08,+_A:;PX&6=/MBZ'88,?++^QU))"N?NN
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MJ^7IVC%' 6O6ZJJ(,=/T#_>603)#B0TD1K'&W$12V4!5D_Y;\UVEO-4XL0G
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M18EOM)#[>_R#92FZ/7IFD(Y^OD$]Q]AQUO1L%7F#=0DEV:2'3IGSPZJC5M\
MR)KR6W0/A,"PBKI4)T<%]<E/NGZU Y#>J;WK@S&F8MV%ZH'<X3K7J (+S@GU
M$Z[/ZSQL!XGK 96AZH':*E^FNJ5W-7L-X_!O4'Q]\4VF483:448@,3I2:[1P
M'X49Y[+XX<LQ6>/B'S_'G>13,LRF7N3LKD;Y8"?+":OM[@^:U<<80J39/2"V
M\X-9[8X;YK6?9%T&\Z6CR*L$H^FD2U.>)M<?*G]&5!!0\>O(KSNP)"J:D-B1
M*DA40Q=7K</VA[O9!DS@ES1T<]\8?']W]59JDF!*SGC]KC#EF$C.5(A-1YC5
M@)SYRQ^RNMQ-K*\)7!YXEWI\]J*8KVH?LOU0K23)9$4NS$M9>F.C5YDE8$ZQ
MO !&8<&\=9?&?GTAWJ!H@NO-R>6=MMZ,<@&S\RHWIQ II^;G#^NB4^<YK3]"
MZ.?3P(_@N_W#.:U44/I/AI5_WP1OE^SJ=31]YH8D,W1EN\Y_N]R.Z-4*56#U
MY_$]POF0D?2SE#!T];.BD28%?/W@'MD3)RS7LP+#M!>\0O9>=O(*Y1+@/P,P
M#<$P(@V,P[L*=B1:#^MQOQWO#F/FO^TXT%@[4[2<?N]N6Z/O.AN(P4AJ-ALS
MY"AHM&;ZC<<N[VURE2ZF[VW7T(M8_6@>TD?7__.?.69@WS1:S30P3UMCC0Y:
MR B:?'N(=A$SD_KS#@V>W8#O"/EP$*@$%!P1[$MR$QEZLU;)N/ARHB=UQF4B
MY=#/S59?8*&TTHXEV1<+_W./ VQ90ASO05S2#D3/[M6:"W\-H@F'7I^ZG+XY
M:?_-TOYD9IR9X@/S"!)K "I0?*&7JMNZ^/;8U1JZ&;#)!JY>Q5%&X3SP/Q\1
M<#;0]K*;8\[]?&\'W,Q#Z*Z(?=4/7J-28#R>+I[FQ!/&<I5&EY]D;E^&@/ZH
M&,R&(X(#NN.\<5TQIA^3*?FKD_GXW87"/=3 MM5/)>F(*F24+KJ+X_O:HUE]
M\(TK)IP;H-S90%(1I.@0]KD.'/\24Y7UM/ 21D+OS1VO(ZU!AUE^(A)\#),X
M&@?OOWQ=PC%QB5DV(%,$>5V*S<%R)KY[U7E,72]8$$"O0BM;#ZLN+'V<(E'?
MXO[70Q9%D+=_L)D!.'R9>Y6>)/D PCSC]YATLA:?P]XIVG0 WUS492@8Q;<\
MR09.(U]PYI8-CF5H!KWNX,YYH/:?\-NS.W*;$(:H*QN@-O8$@AJXY35I-%E'
M&!I4C /[^2:RG%?456ORC&X;K!\[]JKUM/A-HSN*^R!&^E0,PY1$BV0#13F/
MX)3S;(#DYD,W0[6ZP*3]H'L0-XK#>9LL$(ZH-ST^;V:^7G]OOC=#NUUU715O
MKWMD.[*T:)]A.QNHQ761/;IQE**-/H5PT\T^,B? SA)G7@2T"=;8OC(7OV:2
M><_0?_[>AT/%QJ)Z4'F$'%6, "=K45 $5@G]<OCB_ 5J;FZ(1GU X:"<0>@:
M^:K6E8N*X[>T8XZ2O'BN>^109LD7Z:K6](/>T-TFUB_"WWK65%NOZ,N9:HN8
M.!=K+P3N?]+[9,;#8(H-[!:.;7+LB)Q--7&EXH@)F4'!Y4N*AZFWOH_N6&1%
M!!WK#%8W>S*^]U=\]*2-0O?!)*T,IQCD,\9U)A9FR&J5?0G:=$]T)[".698[
MV1K$E7OZ[*16E0F@HW;=O3F-"9V8_?Q%*;J.;KC .O8>-"5L4><?^R,"B=>^
M]&[LU&+$?>[T'%T7-4H&%/6O"& ?U -W=VO\QOR$$.!QL!.<QT:A&<$'NU-9
MRN'?;*8AG6/.@URFCRZ^'S^#6^L\<UM-[FZ$7:/(Y6ANUIX2HH(50XC*]T#?
MK[;Y$\?:"RS;/DP9;[^*E;R2@C$SZ3([P<-= T0'_AM4/?J_%2>6.M4@%X\3
M6BQ4&ET5LQO4^^03&*C]7/1]NVQ.F-*N\Q+6+3P[5SK#V0 YD0VH%E,369U:
M%]F M6<11(^#,HJ1WU$;%^%K#]ZBUO3O8B1P^.+9*FP2G+"/U0LFT?ZN#XF,
MSW*&OB/3P5V;?VL5E3?E)2._%W/2O9 -\+'$EO+&VJ_!DW)8HF,A?>,DJV%_
M9:I:0C7SPIG"%>\*AX#5P:.C!W/F[AQ92BF]XCG-K*JQ$T0$4+OC-U /%&4'
M[F,3C^N/%KR86)2U3;Y:0:LH5;;Z]/-PE833*87M6[?N(9D ,A/5/H"[#=]1
MQVR;C<"W93];XL/(MA0<[8F_*TPAO QQ:L?JT4S)STI_Y_VJY$2QKO@'/Z<J
M@]*"TMV?1687$Z!ISO"V<18_"".U8VI,$@,^0!((-H)RT*H/:7-^8'+$?A7E
MNRZ[P@A?"=!!'!ZM%3DKT6S(!GRUB_*^M9:HOFHL7FF@7X_H[%I_$#>79&3R
M(,9:*0]@GGM9ORJ"<*= '\J,N5&QB?>OG,MVM;D2.U5I;#Q#DL:>&(,'0&/<
M%&>TF[7 *ZZY:LO'8Z<W9$A?IS'M"V:*2^:(G H.%KR NST-O6NGT%OVK>%[
MZ''3I?LR+;>3+LW_9 :Y6'#\$6\Z*'AK;ML >00WOH7L>]UFTO=F>VRS$X@>
M,T>&SW!:\$.*6!YX#-\=/GJ_6TM/,D@X^HBV'+JKX=,JJ+7ZD)0B!X^?&%[S
MRL)<3%#BJSQEN%8$&3JLL39#9PFFWI!5KP)-@T[,SUUE6'P 3!_5W!F1XCC!
MW]E7NEOM*]+V4*^8P>T^V/,MUDAL:[$!CEW!_V3\C4DFF6P@Q>'_^,2>;\GV
M7_W-_1%_UX*I*D_2_2CE9Q/N4(;\1+_@GB2A"FY-H5H#3!#]7[18\F" .B[^
M56-]"-2>OV_N$#=M7S+#)Y\EZ$IU?1$D%6LBFWF=[)5&?JK8\<#H"\/\IANJ
MU:O9V/64J!9?RZC_\^TG"W6WFC&F0WN1"J7<M*YDAAJ'P^$Y0UIM3D.D>IT9
M:HZ>_=-H8LF-R=G*KV>&+[D4ON;H9<1\'7(N$<S1%*ROO^9ZH$TSZM9U'G29
M'A=SEX/[#^@CE+].&NO0-&WUL9OF98]OXXL9$^KRE#,'+8Q-HDUY(S"/3**)
M@9*2Q^<?U;AZULT<CU^NFG\2,=-=#\T"4&<+#X"]%'K;X6Y7ZEA"M3TN?/'X
MYR;IU1];$J3F_SC+B!36S'$7JZ8O6.XR59TATL,&7J3FK!MAYVO?U*5.F/5
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M#\\^0C@4A\-MHT^[CKR[[VKJI.'J:Z@>*.S1+W5OM]UHC'XI%L8&$AZ"5]F
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M*]%X1:%WB3E8R8P BRE7#O/]JW'52B]ZW6L[I4+ =UNFV+#'(;I]KW@U %,
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MQ;%GOP\@,JQTM0K$W$G!U^P?;F\KB=*32OTNM[$U7FF;OZ:'*D>"X!UI018
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M44BULA/(HRY'L1INL15MXI5T-<%P"2_:\_'!H$175-A>QPC_3:K&_PP&3.L
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ME\,=G&8_H2S85RL8ZA$3*2V"EX0*7C(\>F#/,-?\ >*K"&V@3F(K?S^'>XQ
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MEG"TTCM&L4#6PMD]=;BS#Y/\6YV=N9RXBNT)Q>G74^\*I;+$G"^4>=A!0B#
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M[]@_"#'ZB</.[>9 1O2=;3\1?Z<&%:T&O%C9]WJC^NA1@+],DI+S%7/=4WB
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M(%2!<2OT@@FALPQ9U?'(Z,/]F_O>N?,6(XD,8,5WVDCL$68>>M\7XOSE%R=
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MONY'].TF\X][[<P>7OXT[0'CR[A513IRIB)^O"'JVX"B9X*/USKVI.)!>P
MI"#,]R K9I&KB;"TH+G>>$^X%(C\\L".%'<AD!7?X[W.,NG[\4L'WV$9_+D[
MQ XX%P/PICG/A8''%**+N^?88FPU R!W8VH_&O#1JI[8R9P\$WWN:K5+J!U
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M.;;WS\WSLV=,O'=8]J/+/#-148_M"8@;GZ,MA]=O!V45]V9P2)XZFN[FJ@<
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ML'S!;'?6Y41K.I?_PNL:BWT?G _$SF.JBAQ4W+.4X5/XJNE0"#E4:%=['<T
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MQP#:7/7,YK!\]G;!%T%]A327,V*9 []MO:_I+3SM/,VB*$-J"*UFV<\R\F4
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M6IK77-WX?%$ARH@[23_N!4H<&"V/90#>/J"2:QX%2C7\%JSEAL]"""H4%3
M]ZS87>':4Q@=4[(7?VWH;[_L77+G7]Y^P !^M2!%Z)W)#*# ^AO[ZF8;!FI&
M0LQ!G^FYJ::L5"&?F=2,3O;+GU91<$\_'QXC$?8S >\F-&4SB&+1NTYGHSVC
M\LR[$]*W+*!SM+)WM>L4MA:+L!>R#R3=O#62=K?*<2A092.ZV#U4:53/#5^1
M6_O61\*C5L<UQ]MMM$PJ9JOKET$<\UD>_T0^S !N_J&\9PT!JJ9C[\QK2-<0
MXR955;!GAE:'3?S%I:/]<#4QDK3O@Q_6$ 4(]E"59:ADB[B[]%EB1XKYNS6^
MP"&.ERK)G^ZB)<),N9-*"MD2RMF2W%GKWK6(T$K@^(].$!I&SRT /\OC+H#<
M[)@,+CV4;S0[H:J2S_J*VI]T[X6TV'5 QWN:$RU A%.%OZ[XK[D'^Q"_ZH:<
M.*\W]5;X3P+I.!#%?RD'SGYVIEFZ)0?ZL=I&%X^06,8(!,OF@X6XI\_MRB*+
M[4O["Z;/31W5KOC%Y\OYAL^0[0#/X^O_\W>1'#;15*]\ZAFB9</\YR>HRN5]
MK3=UX]?V^+L*8EB;)&_S_@J?P6K" .I-,(.(6[!Z'JI+-6Y*5P>H?EB,9?J
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MFJ@Q#UG7S0T6KR:FFLP7J1 >>ZXTUP@_G)K2#+W^2>G<:5.YJW6 [+1QJ!U
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MVRTY.;..J+X@@M;C( 53><!>/Y]B9(3G.76J^H*R[?-3R(@Q^&ZLBO/SAL1
M%TF^_'W-,.BUH?_!/]LDA(Y@:TPBL"[0@X;E8(O'4N:6<;35<,GYFN^_PNX1
M;LJP.20.6(KX[LJSKN\2M0F+?R_!D,8)7B1S2Y(Q>D%5XM+(#DU-'S9E,7KW
ME=!1,VD3E? HVWK"D '!0%H'CJ\?ATZ&89X-)6J?/<YT4/S;%6M-ZS_VNO2K
M9EHV:'\S374V^I@3;\-8\_%CG:6[S^2?IJ.?'IB^U73 YJS\Z3,2GDF\(]\B
M#HDP@V(WU+-97I3+SR#<T\+(:ET4QS)=^I7#3S,7T8R]ARG>>GW>&L(2SY8>
M^1X^5]Z/ >54,DM0-=+5M1YR'N5S6<G!-ALG_I!_GP[RG@&DB/:U[JP[:^0R
M6EFS"$4>A/'8='1Y7; 9U2[+R)UXH?CY7M="/3&F*<,O^[4H]T/E^40N.E>(
MSZ-Y6VM;T/I81O2,0:6%2RG'QKO+"9^,(X4&$1G*N[M_9NF<)DP;3H#7O<^;
M0^EE.<(<=7&U<O3 :-L)4,]M(-L*)[173CW"3D: 087T3IALO 'Q?6J> WA^
M;&;3O+&F.NE<GNTOHV3S,+&Z+L03J[Z.4SUB.9!2F!CU$G&V<Y-UQ4F=F%TH
M79YS_]%KU8T\-C>V8N7C0+$RT\"_R,2MJ*G=K:I+#URTE8TU;TXY><.(53X%
M"?#N_DEC:LX$C/0/F4/%PC@:WF:.6#54?W_PSOGM>Y>4<Q7+<#^.[B+%SW?I
MDSH8 I1B11\.50%E\4KJ@JWB#N3:/8&)CK':BV:>W'WCXPX;P)?9)O87A_A?
M<0([7 CPQ&BV$JU$$Q.5+4 <RRA&:E\A"97%LL?P]&4_^+(E?\TR[M!P4_R1
MW2N%GT/CQ[>'B %S?0S@, /P&60%3ZQNZ5]:,B01DC"JHTI7CR$W^<V5%&7N
M2;IBD71-9-Q>.YR].:!LY>/@AY6G/#1"9?=>0L544XXTY>45]B\,H 9*%?)K
M@[+H.8<P^9Q[61!)Z=!Y@/;YH.,8KZM[ZR6^^_<#/[FB ?Q'0$ZBZL4YGS 4
MT7;P</!%DE=V^,(F)S:L<^>=J-:K\L[OF;J22ABE1(&E1 9P4LIR* 7F]%^-
MK;6)LQVSDQH==NBX==5=2J*<4<K^F)01VQHY.EM3(^UVP.FH!X+?6IZ&>=8P
M/]\;+$ L#-<SP4-$P2#SZB%_GD ?57^E!_.V*7.Y?*\6?^3P@,EI6?4<*P;0
M\M6VEWR^$)F1XM\(4%&QHW<P#E&Q&;;+8SE75J,*$WL<'VN;TD\.M#L;JY@2
MG"MLY9>Y?S\,QDVKPN(+&C/6"TEIS1!/O+(5?X?FLGK+U)GW8X377(E-%RU&
M?!SVRCD80/3\&F;'3),!4*7-F(FE<C<S /F$V4)"&,!=&GH['7L#QA\ZR!2<
MEL^S%LZ4O3GL<Q_YAF\/,@/JOY7>.YU>9]$9B_ZMJ'AN+1/XTT0.8;X@%H3.
MUR6H!&LMP+D=@F'UHPKV08[F%$.?!\U=> Z';HF+7 ]YQZXFUX>G(G*^@_Q,
MQC\)6N$ASU#5WP>BB5L203PZ7FHS9(IYS8OF)]I)6YNQAHJWE2K,JG*VS[:V
M0JNA0/-M D6=JD>RBE,W:F( [;*%JSIO=Z=HLSMG?Z7;.(\T2>[\#M-WBJ/B
M_JM"=4YU#<EE()G8/4=!9EG%DB\4WP^X=MZ;-%I0V=U@DQ#1GZ+S<:?<C):"
MPG^<$0%I"SSPME#U;U81>A8?3&5'-N0:*$:)OSJH%=XG2@7KC*SK3XE.<]R0
M@08..71W6,78L;=C#JXRPP3+/.FTG)4KKS<V\@_6JAD )R)NQ<H<!%),64M#
M/9!3="Y'%*PA$!+>(G)L)ME[H">P>+8ATS::6NW^[K+1S@RXR\Q=+BDOS/Y@
M$H7^'&2RV!8F]'FX@!B0I/<^4_6,9[C^YZV/BWT"!.L& Q5G%S9UF5K1Q,&I
M*G+?9UI2L_Z<A>5@^S?DVYK>(D+FN4V['T:+[VH-#T\,;'J_9-G5$OKCMU .
MJNJ)^T11SS'7UV 881?*YSBI.E!29[.A^L!%Y1';/1D/>V\.GY?'S_Y)>K2W
MN;Y)NG -'"%:M]'/?:^&@L;E6E.R3Q_/5@?.\;_ZXPV]_TOGX ONAY*\CS*!
MG4RF_LMHC3#IT)[:BDE/7ZLRL/+W*=7R:,W?"+U<>8YCSAVFIF<5Y1D YQO)
M(#2Z^8X;<:]UYBCI?^'M/:.:BJ)UT2 HO5=I <$*B%)%2A2DB8""@-2H*"U"
M1$!:2!"D-P$!!25(%2F17B7T(B)(+P)):*(@"25L2>&%\]Z?^\ZY;[PSQKV7
M,<*/L/9B[;7F^N;WK3*G1=[)<C5=C37K1O;Q/BYSN:5%#AC1C^P-^)71%R'U
MS*A.]U)S7^DBQ=G5+T^K^<_.N%[0>9-"3*R]<_&*C1S8GP-T(,B@C1$_@U;-
MK^G&=,%Y9Z>W'CYH_)+K^9SQG@L:7,EK<+V(+Q2R%Z-4<Y R82KN"4)UJ>(X
M]7@9]-9GA]^<_A?5UJ4:;5+[;5^FA[-SM94K_,&RTX>A7 AN_*]:7<%V::G/
M8P*R[%'^T^_Z"^@AJN<]>8S,M.1S38<06I1;#,XJ6]YV&G$W 0JX?_JU<(RX
MN6$_7COP(#5-(AQ)JS71>/GX=\[K\ZR2DN=8U\V%5[.%ZRN(QN2P"&[H7>F+
M$ZUG\:L[\&]GYC:'O)DNV =J676 SC)^VA1PV*.+;U[^E"'>[JPV.2!,*FHB
MXY-&U@/73VH8U+/A%*6W^<?D;09%NUQ!(--CX1#+7YAXU/W%N;EN=#TXH=6Z
MZ+<>2^V(_Z;(=^V"TIF%UD^5V][))XPL[,-3(X]!)J2UEK)H'[&X"FE^0)50
M8=R)9!M)2:Z;US-J^-(6BJZ9=OQ6&)UT3T'M6R&?;YW?CY13X7KT?.P%/6E&
ML[P+LUSBP9((S61N<2.FO[L2A)U.[8:,<\<L?L(M^XJ0;Q#:0!3^$!2_P#W:
M:H]WMI""=AT4GH(Y?O2+/MG!(FWS.N(_B!<H'K3^"Q../([JL-A33@37B:")
M:7"0@^=39R_-26.;E+N>4H:MUE?@BMVL0\LODG[ZD#%E$$]THC4"!$@0AF-%
M#JQ@UAY/^U2F32]'/9Y7\\4U6B?"APU&PW5OQO_3)G/3ZC'8)V50<?-0O **
M$\VKFWTNXE\EXA"D<\OB64*#M,G>]RVOG4/0[!2=PQE%4:&&'(*BPL ORO?*
MKL-A3P_>]Q9/KMSX\BQ?0PSJ-,*ZH&:W>K87#2ANHF,0WL'%B"M$9VQ<K<1Y
MG>+)/85265'WIGCU6Y\>2:I*?E[SP.1C7<' .<V7##[CWC0R9Y;>Z:)1&U7Y
MZ,<*>I/_IWXAL[S IO.THDK4]9-+3UE&6"?5_O^&6K3K7;A RDID@#4T;C:S
MB>!M:4MJ:%<6\C+7.<@8TQW:>JE\!ADH;;\QDWQ";PV$^&DVXHRXG8&%FU^0
M)SU"$\--B;G._MW-<?3!A^K\"9TMK?D(S#\8;0'(X_WD@4G2@2Q!Q>AS:$'%
M %YVK^R22#VF(*B5?6^-I]R<"]"\+=IODL*5&3\X0%?DGXIM&_P?+E#RV!&,
MNRUY$:>)>AC"EM#OR^LA/!E,N:L$BZ=7C]^9>!O'\4E+/OSJU.HA*('A=AHF
MGQ\LCP!0O-/4[(UG_,(+9>5L9]]J"PKH$U2G@(6VS[16AM9:%*!/0KG4X&P
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M1"Y !=099"&=/-U*?/[>?]1^_>!KD(%!S=O8:*W6E0B[)<J^1-P3=X_KWW]
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MQTIDC=I+.K/6+=([?&>\KC@*D?.<<(]@,K^?Y52\JA#>E[@D_871WBQ:!L*
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M][SJMK1$U(Y\PV.WSJQ9]T[5B[A[D=LCK#.+1 ?+*#TI5!12"(@10</AA-B
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M4M3D,XTE2/!G'[]QCYS!V:A=:<)BIT"11,ZBCNNH$GAC%X7I%X#?NMH$:'*
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M2H^')#S12B[]%!1C/:&T%.=/40@6>'@I>>GTZ*5[GR6CG'MZ09H07/3B-B?
M>%WG6C3MQ'8;0[I%M*(&EKV@Y!.?&4Q?O"V.\8T$JE]YZ2SM^2AJ5^+KOSD&
MP3H$G4TM14V+=QV"KGF!:"\ ;:)"!Y:+SO&+SC3FKZOGS4S1NP*729N7-[_^
MEC5'OCW1Q&DY+<QW[!A6K%6AN(>B?70/0&U(HLM2J3ZG.(BLJ\*&?_9-<:V1
M7\T>'+IO+22'O7E0@T^A"B]: %!B]5PGBI]ZG& $I.#G'H\],K$]AVM..\U6
MH96:@7-]T<BV^"YUBGEM<=H,CTI P>!SVG21Y-(GQ'4'E\:%<Q-UY_ 0=U%]
MZ%4)CV'SGJ^D=R^M0KG"D4O_GWF!=TB"Y#0:MH#4UB"<$D5U+K+O"5;T=?"@
MGTC>GE3GN<;_?;+ZI)U8UY;6'Z>M_UIF(!7^.Z+DOUE:%B@@)]):?5I5/W41
ME$1[K3R483+CHE: 'YSL"J_]E^M#D6K16--:.CF$>#V+3<G13U&!11K1>X/2
M.<\UT <UFQY+>E,@LP>'(-:W?2X*Y)2>64C"43"9V-F2*/B3/?AQ*HCX/6^R
MN616+FV4TM/PJDU<F)5;*E]E.TC1>!\[X3./ !O2FM4:/Q!AJ,Z&%+Q:,[/P
MF"79*OWCLGWFW,IRWW#6N\TUL3S>85XV^@]H@S<ZRO^-CFH^T*&C)55H8.&L
MC)]HJJ/H_5CYYZCX_/5<HFNB;=]_?EWR</0N1(3AB_EV-UG-JB<0[A0](.N.
M(TPA]-YR2QLQ:7DX*O'<H*G'WX454_K^P6+-+V82E"YN1^<091AH2BP8\)$]
M!"V+0_!%*-P'U"[;T0F:: *8?ATS&W_NOU=VL -RM$;.21<8.NV#4")L.H@V
M)4D/VQ)/.3A\Y>0J3U<J=U/7G0O!^673DH[BVNV<I7,<;?O(Z?&GVP#61(;F
MN/I+"58!I,V_$ EFT:UKX?T'FRD$^[W20[PFIP 7SFYJER*'4<S>_ACN!?68
M!!VH3J;(E&]:M<-L?J2?FGL-E92G:YS3^"P?"SY*K)SHP-J.C;.EJTSI<,-(
MQP@]G-/V7J+18DI_5=C>9PV&;;1NLH9;_,WC8SI@:"B6-EI$@'*,9B96#'G*
M<_,Q9HB9F]7PO:_2NV<7Q5<?4%54+ML8?"V[#'\3WL:07L<;ZU*1R@BM)@5*
MJ9I6@>W>XT;YE(&IG<K%=BS1?M.]UT632 X_!'$J*EG;C'MO..!@%KV7%3_E
MA&\;^;9<&?;:/00!"FL;E'+$74 [#QCK(@O\OAH3>3;7;# T0$FVZJWUT*MS
M*ZWU\1IZ\<[-S-? QO3N9\::&PG$I (9#%7NN=?3R_V)S >1T%?@JI"V"D:3
M9(B#L\MPDG3)E5F5YVR53KN;M>)[\!D,G:.4MQT]D\D;L]\FW#J!L,[OT&U+
M^&BL^' B8V9!]0KDTO8,*8KUV<=E:9@9G6V+HON'(8M[8(>@A-F*C)ZVJ(+9
M(5BQ\_>7G(,#+Y*-])';A6[7NE%"\:H=0DP'ZQA8=N!_)+"S_1)I/KKQ(#2A
M;+"4Q== /+&F1AH$$LRF.M"J4=X04>3<@G8M8$.LL6C+ZAAS4=3(1K 93C9=
MK5)0+$A*O:AY0>-8U,(RW[$07JJ(!#EWO(Y7W)$J_$/99<YP['XTQ?G>F]+F
MIE?LLE&T.W*7!Y*C"EFV(]K\:2DH;R4PV;!NO'*C360:0/?8;5A9\KEX>0M5
M.9)B3]T1?.*46,6JZ)LK? U$>TB+0+FV0&?.XI_43XT:A"V%/>WSJW#I^BI[
M&]'B,>R?XH=8[/[65PRB5@";O&0X56C)FG)[.I)P_-U0*I7;CS/R$(1(A:*0
MO1"BU;P9N1SXVL;:3!0NB3EUU7]_T3O&&A;][?&)^>+3?UHJ0^V^8HFVF!<+
M,H ?1=\1X3Q:X28N&BLR,7<GBMW,V6A>Y%+*C)G\G>:U+;Y#T#R#:QS=/CG>
M: :?'B2T8(U&GR.5%+T8ZAT_#,ANEE<0AA,"+SCV)P]:) %+?J9/[<Y.L2U6
M^$+KT%1A\3%R/.V=9=>\0J==\\6:<@GX9DOIFO&+&U:*14IDZC=QD[%,SJC^
MCN^P/UN _"%H8ZN,*@QP?H31Y:IR;DZU/GB>A79MU$_K<1?(:. I>?7-Q:Z#
M?E(TW.\:^*G=&BM59(EN@NU:I(@QGAUUQ_PXH.*.;M.B!D0!!KMV94$?W-IE
M(D$VUHCNY'I27Y=)@&5D=DR"4JO0E+6Q9 @D46Y,9N>%M)LL[&._5J_%0IAY
M" \#55FPM&*D:E"S]F*<9EEA#;5!?"I.?6+BHC[SNW/QIO;#\N'VQDZIT*>H
MCB/T&=K=HG!#&6X !H7=9HWT7.2MA4]OD0VG=M'L;]N&\! >+_'X>1.F; )>
M)LW];8N/.\M2GACS"V@\M@K=EW*<R@JL'H+X]&1_B<<D#'UY-W2_GJ#U.)ZV
MK'_1<>@^._OJS@ 7;N\DYA>X-U>TCM07N;?( U55RJQZH(?6/J/)MI)4\%!U
MD0M&[,.!NS&,,>M01\',W<9ZF[DGYK,--%)+Y^8J^YIJ/8676NI_ZM??,AE,
M8[(:S#@KPUQ$PV*]4Z(A=5,O$7HZ$-R0NR$)F1&:P7#"F^VA&DG=KT229E*&
M5RX-,W./^0ZW(:2!B?)U+-'84LSK?*!.X(%8(W%9U*3;I&HX@ L6.>?EO,GZ
M^<[Z78B'):#X>++HHX<MA+E6^\79;//-OCA%&_JH"9-L_+EEI?'MN1?]()X]
MLD4+<;\/7;NVX5@*P BZN3GX8:F@ F-/^:HQ0MH5Q4I-=N_42>/G+"J&K>Z1
MC3QO\W@',,#90]"F.?$/^0X)$D<U6P)S>"'EIGSRHN=,F\<*HK*_ZO3[:*5.
M'=_AZU_CZ/J@!=^D4.Y0K]+*=&SP&,$@[<[FK!CUEGMGZB<J \3PUB%O#7Q0
MSS<S+1<2&ZX\EF*5 F^H4^R&*2<0EB1TM-XI '8WQ6S<02',XKM8^Y>QOWG*
M5=T^7T^:9$1R)28ELO=*_&P[A^IP:O5>0L7/BB01!3OSZ9U+WI_N 3&6.Y4!
M$L7(8WU<>?DOPB_]TY)?$F+Z@^)K]0XF<=+9?@<,_A-WG-%1=?=6JWPVJB::
M>LTI=Z6U'%V!F&=8H2]P%H^.@_*WAA*@ AZ35W\#S[Z.2IB%Z;/DGEMI"K;,
MYG\AT3GWF;5^!^I'GT_[4XWJT&M]1C]O)D8UF35,][J\_B&J^J=$CM^IGJ8$
M(>Y7[%HR;FT/&1-$O+/,E91MN>2I%@"YIFQ"=PN'W$)<QLVSMI-5[8' &V.[
M"EHEL%*EVKF[#4DK]YE-;$ 2R2<L5'P=7]^Y!AXN?G\.@!U!>[RS?[GO.E8P
MT-D\8#LJA6+V-DZW_CV.QHW<HMZ-M&\&7 E ZQ4W*)]IH<N9;.^?\A'+[02E
M1),N^%QD:B3T+4,_V*1,Q[A,M-K[D=#MS4ZS7^HFF@]!G:8//%J*&H)2[_BD
MLBI&"1O@!(HTI4_&;R_6+%)%M)V(O)'^AR >JB'Q=:YREF7L=9$FUQ"9IC3U
MVWSF$K+VX.1'7(5[,N_2F-; _ 6T)J0 H'J'Y)Y O;[T1;2K&95%+EM'7$NN
M^I>F:/HJ740KT! 7B"F#X%*PXJVAI$BZR!3UK+3RI(X-#4U+)4,V80WH_AV]
MN=4G/X/F5XI]ISQV,9D06 IP?HM!N+W QQ:"6(V)4>@HQ.52'<@3TXO<>RL_
MDA]E7@(_5'1%>)APF/9JNLK0/!DC&@JP+F%>M@D"+PC*HK]$]:1K2=?'4#4R
M;=;"W^) S8MR-Y"/K->*YZ>5(GP3!9B(9_LL6<]VPX%S,?$ZYU55## (??K@
M<^L(D=")V%>ADKK(/T%0W-$Y!I:?GH'28*)ES"ZLXN*9Z-[5/O/H\Q4_LF 7
M^LL:3T@%K[7!2([WHLXP!K_*J&($8?,"R_]1%OP1LR .8N"/<W[)IB]C1 4:
MZD@YZBO%6(+C8,ZT\]>8A@9[-T=D,/M*>Y5KY0+3L#H%1F+&6;Y GD:H-A.E
MJ_!?U  O1U?OX^\TJGKK41>%<:"'&D['BGR3\K'BC,Z!1R'5:5&H)^I S(?U
M;:D3YMYU0YRW'[G593QZ'JRXC/S&K//8K_$#U]75MG0@BM&"TI$M^LF?77@P
MRQ]Q5')E1;9\^IU,D:KJU"QIK^:T,6_Y5T5\DEP'MUF'T$2S14$O""_$1Q?<
ME;E_>F,O=H];_)^KEKW(E<=O):1XY!L,T/IA7F! P9V:FQ4+V3C)T/^_7K@,
M,;HKCI:YMVE&D*-Z3VT4UXS44H)Q/TXW6E6$^5UX4_16=5(]J<AJGE./2=NA
M$0THQG1]L;Q.*ZS=$OY2B)YNIJ<<,P@2^N=&$!B0OW$("E)^/;WK"X"0D^XZ
MR89(?E2'$FJ9TLI034X!EK0SF6VUHX<@'"9;,Q8IM'Z@&=7*3Y"R7!)>*0\)
M*\[,'#B=LZAR7$!!,6I>$]&A<0(2^&+';H#Q<DEZ:R:T%H36@U )@V#8B5*6
M'U4LY0FP"Y_E SI.A.M]9 PE#M4?2:RA=P9B#RY<W>,%Y%&=$![ CNPXIN,-
M?^Q#ER,93OS,"HD\53LHI,E[[)K$23:=-$J8$_I6,(HJRDR_ 8Y"DP6_'()^
MW)E*I'=BB7?8((_!460Z+Y" -P]A*!S1-/-2#_',="XW PF3@0O',Y;L4KXG
M0]_I&<!9)+E ?E"B'?CE@6CGXJSUK8E6]<<\R6VG1JVMFB-^W/ DUV6;+-C8
M@,[?_]@GY>@7< 9[GWX,R/_3!V9NDPY*_O=^*P#%L[Z_4XL.+LR<U7P8MMV+
M%4!J(4Q)EE2A,G+YJ RQ).:OXH?L<_[OK_Z(R9Y\#I-3R])4+  Q*[1(QU_*
MJV>"-"^P$K]@7U!%\X)\?GS+S-9#PTLZOUVR/Y7D:F7L(W3[Q*;0G6O'_P]\
MI,,(F)E#$#XF17T@ "U(U22FQ-;%=98W1U=\<)AW,A'6_^@IGU@% IVP!#'9
MHX@#BRR07TE4" /L7/H.04EVGWY<D[8Y!'&])QK08Q>/[E&=WD !$\]=. $4
M/B7ZP-$3*4A<3<>':9@F==E[U%^V[QSE8WJ6^JGTH;"1[[MSNY7)_V, \0N9
M1<6S,!'5Z<79KK#'3Z.U*BKE!(Q/\4>4%_)=WU5_'@\BYJ1,PW'<DQ_WMQ&G
MB=C<K57AY!XK1<J-QFNZ$80OL$X7KA'$\0\=^0#,<&R7^Q3OGNU5[_^KO>N*
M:FI=MZ%&F@&E=S<HN*,@TFM 0$ W!JD" B(@!(RA*$0(!)4N 2F"FRZ@]!Y$
MBD 2 <5"D69H25"IRL*C&"&!N]QG/YUS'_;3?;B#-<9\_4?RK^^;WYQ9ZY]I
M=B?_N7)*D4NE?=T]VXX7D6($+\-.FK>/X,S++P11C2=&0BH"G:O","><!1\N
M!#LU#I;[!IL:UZCW@K[#2 H8A#]ER=&%H.00SY.M@P&1ON*G0MOY+UK4/$TM
M\']L>R/;CL/SYH;Z)IZ)WB"49?5W0X=9-B'2G]-6=E[*7_?Z4OMT#MJHUV!>
M&FNT0$]?^PP,T<:?3\KS 3J)]%?MV;6YX>&!:E)(X,]S7IAM_;X(M[1B="WJ
MAX[NQ(BGJX?%,!(3(IFI[W/)*6,L]>0]:T7 K(9H!X71>FX7PTRD5AQ63$0
MA00<'*]UA.\:T59^[JVKTC'),J. \GJG<WS]CO+C50N8Q#D)9D9YWV-L&\4
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M*:I<^1MME'4!EO7HY7=&[O1"A3Z#JYH"#]:^=^YK.&1SJCF9T[J6BR="IJE
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M$LBS&4:E@\/:/7^YCWRJI_/47%R[D9^*_$$4JZ=/RI:K;GGKZJ+-W$\B$=-
M1<6<^1!1+X(D)1B&'DWCF,4!)58OL>G$4WN]6VE5;*'EW>T9T%PZLZT::6H#
M0\?' ;+.$PXN =7><;%$:% 'Q73N<1T12T3V' [;[]L7R=].4>\J_BQ67W-^
M7>T?ZO'W?RJJ"E%7W[-R[L4D\"1!$!&/*/8*,<2$(LA3'"142)H$W+2J_B6"
M3(W-ME+/JBIE:M%64EI4W[_(*J?Y;$RL'?.;+<Q69?V'P.C2/@ 7R3!:XX A
MD.IV&AADO)XA%F/Y>KFJ.J@O,M8MEB]\CP=)R&$2!HKP0DHA"2,) Y3&C(C
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MEX[7LZQJ,_)M?L7^N<X*Y5(K%E'!_O7R?^?9<O6K^J5BZ3F+0Q5V)Q'T IY
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M3HUKF:IH K(9,P\,G6.BW4BK8@HE;Q5CU!)O2+25>CCJM(!H2"8TF7948K/
MX3E/V7RU'^WHJ\BU;[Y8Y-_T#LB-?"ND4$3'-;E5EY3;9$H9DI"%# 98(D4_
M+(:I)V+H8X99+'B$0RL?UF+NJ='0EW=O0'NG>P;\ 'KI#&ST 1N%=*/Z6J'*
M2ZE4LJ,L&P.949<CV%UOOUR N(-<T!X@#DER-M./2G8]<'E.>GV&Z$=^[Z04
M^F3AW7?V56],?%;.W\WR#2F_ZO^_^^<Z>R0+7:]'D:T*2?0)@_[%U9+O_J#S
MR3GU/(:8'\+00\I'PZ& -.&*)'U,D8PD3SVKMK4.9)P:F=8J:B=$YH7([I:
M58XV>P(K72*NWI+7-5>84J3:,*W^(K8JV7&J"[N;<>\+6],Q1V\-V>H'M(+:
M<EKH6?5?T)%]!K9JU;_4QGW^LW<&=K8F<(>6&)+H78@YZH+@$.?G"X?+J7ID
MLKW)[^_SY9=5SOZHZ_7>R%_SE2@_B:+:^YZ+0+G,//8A)A&'B*<2IA2%, I1
M+%,5Z5,FC!/1SLTV-=*OY6UJHL_ <M,!X5%+O3U1M4@@.@NX04+8D# Z9ML&
MP4K6MO2X3M.IY-5GB/51Y)  6B10#0GD2/E/EP)JE[%D"M#)A*.S@XR7+V2J
MSTZZC_&7+MQ4_2A6\X!Z*0XYA9[ %*)4*,\\11%D29@BE,0A8ZC7[JD:?&KL
MVMGP6]KN..R IC 1B8\%9"P((2(QAJF?(HA]'D4JGF$I)S9%!GJ#-E9]@0NP
MLMPYMD1@O"WBCR>>F/Z[P!UUG6SWZO%?9E^WH]G1#=SN9_IQV:9P9.>VQ?M"
MQ< Z4'Z;WY-L.8\3QCQ,8IABJ=[6( P@3G$"%>$QZE$OD7;U>PWFG!KS=2\/
M;40%O]?"6I[\FT!N]M(/#*1C+NB)H34W6* R)&683#LJDUC@\)Q@;+XZ:,:S
MSK/0#1S85W&KC+,I[<9$%)!0P#1$$B*/*B?+$PS&"$D5VV+,HR%:_QV>?6I<
M=# 5=)L#-P.-"J#289#4X2-F,6,I9V"[/ANRPMG!:5 OX$;(=STBP!3R4T]C
M8YA/>F:0OD%C>U=$IP6]R9>K;+G.EG=-J:(J";5)66LRUG:K:>ZFJ[79:O,X
MI)$(40@3IB)/%/L4DL#C,(D2',8TH"&5=I&4"S&G%I.U=\7J0L%5#RBV4;6M
M!:=TM0W;G)A8Q!&+L#(QC52<C&3,8<IY"'F22DY"%$74:$-W0B8>9:_B3V1B
MTQC_I0WG?+>@<X6SMME62[!5LYNC>T$!ZB&W(UQ:9MB-#2>2CKQ%XA+M_<T6
MI[/U. )\GRV5<Z(&^RR8R![U-*^%3G*X8JQ8"][.H6>N<XOG$8YH@J4/92P(
M1(@H-X&'$<0>2JE/PBA,C J:]9Q_:HO#AUS1@)KH'CPTE*'(9)&390F*C4XS
M0"NM *G5 MDYWAC$5 ;'B6X-X)CD-\*#SQVH:_E!HT#W-L9&![>P6QQ"NH5_
MI&/)X<U@=U#9'\231Y<]AAWO,+._SCO'FQ<,TW.S3I^D?LT7ZANE3F-9/7W*
M%QE[ZK3XHX$(,!&0A22"2$18A:$TTDF*"(4RX0QSJPVZ<S-.;45Y0QXR74>\
MU();[KF=1==PGVU(S%SOK75D_;]!+>T,U/*"WYL_W32],T5IT(VTLY..NWEF
MBL'>AIGQ%_L1S1LMO_*5J[7O<U;^T=1F(7?"GY,DB*,T1E!QB@<1U4D#08*A
MGS#$?8(%LML'.379Y.BE*RLHE+ SG<S6B&O'-R=!-J.:H:!SS#*[J'VN4/MT
M'C5K3C&!8T@Z.3G?J$QBHOES$C'Z3H^P^-?L,7]#EDM"L_;JDHA8)-0G(4^E
MIW-A=:'^F,(DB7PO%LC#H5%RUI'QI\826D+0BF@1+AU SB *O0P/QZ_^#A1]
M&CH=P,0B1+P,FY%"0$N,[.*[XPB<C-\.?&V\^.RXS#OQUXF/]7-[]';4K2CN
M/RG+?B6ET/FKV:JJ7G.OFXS.,6$R\KF$(1(A1&D80>(G,>01IC1(>,"8587L
M<Q-.C=AJJ?0F'=M(:N?TG(78S/$9$CC'#*A%A=4>9RLLV$H[ [6\P_E IL@,
MZ0>=G7-47\@4@>?^D/'W[,BE+%:=2Z]+_O_J&I;R*5O>7;&J=7'Y-BO9(M?Y
M71^RI;A>B?MRGD9A&G),81IS"E&@LSY]$<. <1XRXHO0,[J-WVOVJ='.F=OA
M^E;A5B_0*@:VFH'?M6Z@4L[0^>AGMM/LY=P8KG>+QK&#,>==A.<) E3C=LA/
M_>LY\?6;>!06O B3EA(O&Z2?\_5I31<9^Z4JZYN)<I-;?_4]*^=^P+W4QPRR
M$!&(/.Y!3*B*(N,XI@S%+(FM'*]3DTV-_3;"@=^U>)99[B=A-7.VA@++,3L9
MXV3M4YD ,*0_=7*^47TI$\V?^U%&W^E[ $965=+O=L6-*8YI2ACTJ:^8P4\#
MF!)/%U%C41CX-"#$JFS1_A13XX.-A#V\FA- FAYN70*/\],L*V1ZG%D=4W[8
M0ZJ]648^E3JFY?XQU-%/]GR_&^?R1EXM5QG/%FO=B>B+8.NBXI)WWW6&E^!U
M!MC]P[K>FKN1[TBQ5-[)YF;Q]LQ62I_[+$Y@('3%'C\E,*6^4)Y#E%!%$EXD
M[8KJ#R[BY/BET5!O\W1U!%LE0:MEFQRZT5-_Z:W^@OI=I68);M:K<J5B ^O6
MM0Z>!D.2>U$;NR;)2\W;*KFMF0!^OZU2?-TD"C@SQJ"D/;R4XY*^,Y3W%@UW
M,_5-=M"3B$(G4CSHU:R][.B3) D(@F',)$3$$[ J,.%CSY<B"6@DK)H/'YEG
M:O3?BED58'NPW^$_!J<9]0X DF/^W."S$='!E<,S, R;Q'!XJI'S%T[JNY^Z
M</KCO>IY+=3?\Z+J?=FY7OJIR&6V*F_SUZ).\Q3\9_(]NU_?;],E%)55)P3E
M%7_4%2WY7##*1>BGT..*0%""E,,9)@D40H;<IQR%A%D4_QI0M.G134<Y0+KW
M>A]J_?3-(2J:"P&"S\!]K60G\4J[):36$Y!&4:O*6$/:_C31O:Q%G7-CUY@[
ME[0;U<!M#EX+\'ECS$:_3CZ8+LK5J BN7MJ85C717LBHHQ50&]NXMB77'.!_
MIC[;D#..6<S- 5+/*K^YF*&??_^\?_6M&J8I[Q/R./)$G$(6,PZ11!1BK+RD
MD(N IC*BG%BE,A^?:FK+[EX7=J!E[5E)Z03"9E[_,+@Y7MSZ0F;M_)]'8TC_
M_\1LHX8 Y[5^'@48?./"8Z9J6VONB8@P+"*H_'8!$<4I3"67&E"4D#BB4=SO
MB*D:?FK,T#E$J>3K>[)48V=YJF2-R'@G2F? Z'^8M*.SDX.D>H:7.43:T>[H
M =+NIWJ$[[U;4M;7IZZ7Y:JHG.BR:@]V^Y4LFV:5OXJRZCW-K\NRNM19-PB;
M1X$D-!4(2HF5[Q!XBA_2T(.^1YDO*9&Q9WZG873QI\8Z5XR)A2[D('B51_98
MB5VU8:Z+B!OV7GZAA\$@YI^TB5W3:%7"[?7I[LJOV^[*KP]U5ZY1 !T80(4#
MT$!L>R_76  %!JC14-]H.BY/^@&RV&>8](,TTE[$M!\HNWV+%[/GR;V-\:4:
M;__CQ1#?V2-Y.2GL+S!\UC)5*:,L27T_23GT$JDO)G "TXBE,$0R" 22+.5&
M^30[HT[-&]%^:5:N,D86H!OVVR3@[L)VVD'H#<8(X4\/'*P2^/?TOC0Q?SO@
M: GW>SIT$^GW?]DGOEG3,N,9*9YNBOK]_UFLON9<9]>JEUV\J;L;9X^BLY'Z
M;:G>E:_9PY54+\W58J&+J9:$U<72Y&_58=NJ?/==?2-3'#/':<Q1B&-($R^!
M2"<[8*$+S#-*:<3B.&!&[_9H$D^--S;R=\XF9R"3X%LM.1"MY#;.Z!BF-PE@
M)F90U]RW41?<%*VW6&L,6I5G8*OTSB'7YCFH]-;]2T%7\QFXEJ!5'KR;ZD-A
M$Y1,[.$8*PZ9T$-B&76,:+#3@<88@HP86XR(ZVXX,>;$/3R8YC2WO,VOI,P6
M&5F)30O@]WGQIA \6^GRKG/NBSB.(PK#1$80(8$AUIUVO31&'N5^FH1&?6[L
MIIV:+]$*KM.?_I%GRGG0]ZC653]%TFJ@>^H"5ND =(5MBQ7$W!X&OH$3E!TO
M\!N ;W.PD7JV[34.E."@EAQ\<(6MQ1+K!..1ULG!L+9;Y*PA.[E2F8\VWG)C
MK>'.FF'_[7X'ZI_%0[U_5=[(MLS&AVPIU#_K.>:^""/?2T*8TD@7+J4QQ#((
M5%PO(I2D*?&%/U^*.WU =&M^U'YV8J-W):W?E;WIW;TO&[EU9FOS7KPG3%^I
M?;([CS\/O=D1_3!(CL/L6UDU?-L"/)6\6T2'.\LW!F?(X_WSDXYZXF^,P?,D
M /,O]KS?LR"E&JMQ9F^*S]G=UU7KTGXJ,B8VORR;WY;^W,,8*Q0P#%G"())$
M49,?$^63"LJQB%'D6S5;["7%U'S25E[PH 6N3N>YSO0L.BV]#0_J+[..&6<Y
MQ]PQCU7R:[YJA%2//:BDG&VV T"E1N<SY>9# SA1@P YZ&6E7H*,>Y7I$JSV
M+CI=-)C].=]O0@\A^-6C*,A=VU^0(D(]$7'%@,HJ"$L!">8!C ,:Q")-J8R,
MS_P.SC UGFN%!(V4YB=^AP$\?_IW,2R.J>@Y(@/>>3RK_J4'@H<''^UP\*1N
MW8/"TQ_LF<HL[K1KI7PLW6!']SV2>7%?9QIPY5NI/\FB^T-:K@K"5$#F2T("
M%D&1!+%N-NW#E$@/THCX(1(\#<U*-E\JR-2HX4V^+/-%QJM,14H6U>Y%^56(
M$^OML)8Q\WW&P-OU"5RM MCH #KRSL!6C>[/P>^M)D/F:E\(YJ!9W7UE&3?_
M^T+$]C+%+QW/CCZYR.;OEJML]?3EGBP6K]>E#DC+>:)X,):Q#[&O,R1BSB&.
M PFCE%.FXD6]AV7"BD?&GQK9U2*"2D;0"FE&<\<0/,U> ^#BF)3L(#%FFC.*
M;PFD;!FD%.RO=_GCC^J;-7FHOSSGC&.CCD(%9U1JW_!S'^O=P:99IA49/._C
M1+PXQ"1A4 8Q46\Q8I#$7@SC.$V#D&#U7[N]G1.33>V5?DW*K*PKN'>$MNY<
M<QQ<PZV9@2!SO0/3%7.<QE@FR S<Q.;X?&,WL3FK^8$F-N>_TS-T(KI(5=5J
MZ^-:AV+J']55I#:KNI,L,2<\"0,J4\B9BI10Y 401WX(>8IX%+,PC#FV"I<L
M)I\:Q6C9-<-4/?AF8%G)7_V@+@B8U?<HLB58;96PO^K5RTZ&P9,C]%T'3 WP
M7VK@/VZ ;RHQ7F^ [\@_8)34 [5!(R.;^<>-AGH@LQ<!]1FC'_.])UFAR[^+
M3LY_N?GA_Y.)0@WY]:DI\1#Y$4&))V 0>@PB3!7U>:D*D23!-(Q2Y5I949_5
M[%/C/BUGU1)!@(VDU876CU>_]JRN86<-,X)SAK%CAKL,7FM&ZP73D)1F)\"H
MG-8+F^>DUF^0?JSV5M#5MFW%-F )$"92;VTGJ<\A4IX<Q&G (&:4":I\NB@F
M-OQU9)ZI,=6'7"T7^E*L+KU@QTC'D#3CG@'P<<PR6L*=KC5. KTS. Q)(\>F
M&I4PSNC[G!K.?;Q'"GJ="E]QS+5N:W,@_;&\6FWHY[-@^:,HZE+$5P\/BTSP
MVWP_MUX/. _"U.-A$D/DZU)B&/NZ7% (L4YEQX0I!\FH\[IK0:=&0\?3W'7%
MSUJMN@SY*U)KIC[Y V"D**HN4V33DC#;@F:1JNWRF3C-AU.RM&-"[6BIRR?H
M8@H',\++&;C2B:ZMDS<#&X7!^^H9:'16W_KAX'4K\WK5SJUOD=H_D:=@I,L
M$WD:[*X2C&"BDY</7,X_WG6%$5#<N> PQGQ]BHU7><UM0G^3),8H1>K5$9 D
M)( H] G$Q$-0LEAR+_'2T#?J<7=TAJDM_;WN-1S'SV"UO105UZ=-NX#T:9=^
M$!F;(M87(C16+6I;I"Q+29] X71%Z$-?'+&P\PFY=^LSG_J@?:K,E3(YUV9_
MOR!W\Y23(.4^@UC$%*)8JK^EZC_,DT&2!'$0)YYIDLS.R%,CL(UP0$MGGA>S
M"]=IWKH(!,=\9:B_51+,05TO2'_9'6^TQ)>#:G137@Y_P/VF1G5*)$5QF^]\
ML?9QFNZ^8E,TH)RSV(^YQ I3D7H0)0&'6"8,4A&P.(Q]S+'Y97RWLDZ-'EKQ
M]=9&9W-"G[^*.E@AK0[-[Y42[H)76\N'J4>Q'X>0I-657($A\0(&"4]($M.$
M2N997,F=R@,P_F7>/_ES,/PNEL/W>K(;69N'0'WLV2C-SL5&\4WEH D]!.XV
MLQP^#)/?SQKVH7"ZH=733$/N:=F*,-EMK9Y87K*SU7?*GD?MFW.[)DGI5)G;
M\EB=V^W!,J6Q3V7H08:8KR+*.(%$"A\F@<^XB)(X,7-"'<DW-<?SR_K^7I>D
MRV6W^?+FAKCE8?_ MC1,$G@Y"[E.+MCF%;29F9">+&1> OJT\\&=2N9.FR\[
M,L.@N0T#BSAN3H0;?/=R*1Q-TS.]-%MF*_%!-W^[5L[9\BY3S^]568I5^3/Y
M1UY410\^JE>H26D,A!]+'TLHL0P@"BB"1 04)DF88LIH*!*KJ\B6\T^-W6OQ
M824_V"H :@UTT\5_Z&)J5>T0K47?M%-+*YGQND/L'?/V\+#;IZ/V V_0A%1+
M$<9-2>V'SUY2:L]A^MY4+!YTHTSQ,5\VMYS; V&2>&DL.238PQ!)%L,TY )&
M4M P\F4D0\L&]$=FFAK#;02UO99X#$DS;AH$']='Q*V,,Z"DA&V)!!<=Z,^
M,>P=Q&.3C7P!\8S.^[</SWVAQX%.>P-:N6<T6U;>F<Y+N5MF_Z4(B:LY,IF1
M#25=,17#%U6[EP_JQ_I -U.A?UFN[Y6+MRX*]87N+^I8OVP2O_7. 6/%6G2_
M//<"P1(LE*EX@B * UV!.=9-7F)!$QK$ 4]MM_Y?7JV)'@^THH.'6O;J/@NI
MI0>+K?@6F\$OC[7)J<'+2SDA8F_! !TTZH3'&@_0!:1Q.D$+2;7GW-$+-*CH
MU@,5+MU?SL#FB6NPJ;>LFR?NPY_UB;,XHGAY:2=XC/&G>@+MSCJF8^^3YR$3
M$'.\,Y,)*'OH7&5"8O4L6]&WK>#NK?*K1Y(MM(SO\^(G?6PPCP,D?1^ANND?
MDB&!.*4,!M(3'F(<X=BH]I5K0:<6S;Y?Z^M,@&C1JVM.5( [+6B?_L;.K6P6
M*D_!=HX=,I.3F9,',P<*<&STK?JV5!H/6'[#L4T&+=7A2M9QRWHX1GRO!(CK
M^7I=9<F7>7FUUN465;#Z(;O/%+&UA:/#5$:4$>A3SB$2B8!IK%80GR5<$$K"
M1%*+*RW'9YH:Y]>R@HVP5C<X3@!J$%4/!9/KC<QG"(%&T'Z77DY 9G7Y91CH
M1KL$TQ="V]LPYV$Y<ROFQ !CWHXYK\>S6S(&7^C!F9_%P[IXR%6@<?=)6;1Y
M4),@8G&J*-*O*F[[H0=3+Q3*TQ8X#GSIT<BH#LGQ*:;&DATA@9;2XI4_#*$!
M/5X,C&->?(Y)'SX\#(X%$5X,TD@,:/P V1'>2?5/,MWA;XY'<2<EW^&VTY_L
MM_5PO62%4+[G6U'_>;W<W^^X67U5GNB#*(@NX]W=OPT#$0D_\: 0/H&(*.K#
M/M/10R)0RD(6FG49&42:J5'EP4.B7$MO?T0TC+G,-@I&,X)C6F[U *]:37[0
M]W?V]K&U62I]P$:A8?>S!P5VR)#^,H%&C=L'P>YY<#[,H'V)]_QE@&T&MH=D
MDB(9PD3H4E51("%-_03*.(Z(QX60'ID_BH+FYE1K,;_-6]V5PN%6'_LJ^+JN
MG?N_JQI4OXJZ!I4MH=J8P91 '4'KG#!W+CJ2[J6H5?=2E-/\]5[H#<N*-@*,
MS((]L-EGO3Z#],V4O'\HQ%>Q++-'1:\LOQ<?Q>I&WI+OZE^+M;[D\DFWA\F7
M5ZM5D='U2C]9M_E'!4B^7"EP%E7K&.6P*:$W#94$463(901)0%7@G7@)) D3
MNO.\HLJ 8A1;MH-P(N?47-(=-=4[KO4$KW07^A\ Z>BE7O>_V29RNC&T&>-.
MP'RN]UYW+'?=6$[W^?YA!I2N>AU4VL[ 1E_0* RN=@T+=G4&K=).NG Y-LRP
M":UN1!TY'=8IWOO)M&ZGZW.X=;C]JCYZ$W,:^X(P@B$E6%]+$@C21&"8)(2G
M/N>!X$;Y$&=GFAKQOQ5%]J@B&,4=W08>+"^M*J^>!-?DH&L@R%R3;74CZ&;;
MQ/FFT\2Y$G8HS&Q.N@;";JR3KOX86AYU&>!R^JCKU  C'G49Z+%[U&7RA7YN
M^V=%QL6:J7A:L;,*$3Z+A4ZMOU*L\5AM?APJ)1_C1 0I"6#DA\HG)R*"*8\]
MB,*0,!I3XOM6/GD?(:;&N]W3CC=?27%GNS_1RQ)F3K-K?)V?NG7$KS8K&@7
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M+NZ-?)\MR9)E9'&]U*YO=7IWJV8H#_^J*?"#0DQBCC#$(E(AN7K+($T\#/V
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M*0E%&,566Z;V(DR-W;;)4&0CJQW;]3"#&>&Y!=<QY^F6#EIZT(JO<\M?:0U
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M9!G'[-[#$$X)?0!4AR3O2\09E:@'P.TY*0\QY 5]N*KSOT53J*(Z0;Y:J46
MKE?55/G^[LC6*2GG5$J&8\HA]60*$9,8X@ ',.!>%!&?<HJMRII=+M+4Z/AM
MMEBKQ5, (:5@5<1,])+:X\Q^0+L99O:,:@WGI_T;94!;,*?N:]#51V]V;$SV
M;F.R,][YT$W&!L%\\$YDETDU?KNR05 \V--LF)%[[A47^8,H5D^?U-.]TMT<
M_[G.'O3 5<7=N1<&,5'T"W&"0XC\R(=8I!3&&#'&I) 46>4UGIYN:FS;2CL#
M#UK>*GM<M!+/P)V6V7(_^#3<ACO @X'H>L]W@]^G#7[OMOC]=!(_^SU>(U@&
MW=4]/>.X^[A&VN_MW)I]Z^*]6G&G!_TL'O)B5=U\D7EQ7^T2O'YJ?KD-Y83G
MH9![#"8!BY4;B'Q(>1A + E-XSB2(;+J.-!3CJFQ43<4;V0%;\F*5*_5%?_'
MNNIS_>[U]>W;J]Z[KU:&LMYE=06_Z]W4 \AOE  =+695-D/SB9&V4/M@ZFBK
MU$J4E]H2[8/7B:W/7L/UX]-?R6)=)QPL%ODWG3:E^S5^%J4H'D5YJP:]^IZ5
M\XBP0$0\@?[_3]Z[-KF-8VV"?X41NS%;'9&HY@4D@)U/Z;1=KS=<3H_MJH[9
M^J# -<VW92E'E+*<[Z]?@!==4A(%0""3$QO=X;(S2>*<!^2#<X!S400#*,U&
M)LMR0%&*-'L6.*9.NYEVPTZ.+=_=1=TTW41)"F)R$VU5B7:ZU/39:1,9=:*_
MC$*.)2LL)\>.,L-#/C1##H>V,S>Z@1>2"BU''I7YW-!X272.=WOD\MSI/Y:5
M-C?_OELVI7O>4U[.Z]J*==I8C*'V0JD"-!%*6X/:^V1Q@H"BB=(&89YSHJQS
M>"Z--C46:^2-&H&[RE>=R XY)!=1[N>EX-@-3$>]L%U.Y?/ SR'W)B2.(^7<
M7(FG6ZZ-+3Z].387'S)>;HVM/@<Y-=8W75.EZ*M^;^I=Q&WY4R4E*10G0"JL
M;<>84L *RDP>,Y5(,@&Q4SC4F7&F1K-MV9BMG%>6ECW&U?J$Y%JTAC_V< ;*
MLZK.61C"5\0Y'NH5JMF<U?=T)9KSEWMV&>9Z)=G,37!UW=/81/*LY'>YJ,JG
MMJA-N]0EBB62DP)H=D@ 3&@,<*X8$"2CF LA\MSIE-9ZY*FQQI[@T;+N?L[W
M1>_*BS4UQQP;$EO/AAVS#(+QP%QS>W_WX>@T]3-=U;03OE.Q*T)!NQ9;#SYN
M!V-73(ZZ&3L_P,.#-(6TFW)<>I2N&E?3S.K8?=W^I#YYI96<%3F$,M6&CI#,
MG#9P! C1?Z@B$33#"8/2RN0)(,O4"&ZW@4,[F>N.QWIF1+1YU#_7_YK3JBI5
MR6F7*%-WX:OT?Z+O<BZ 6JZ *;[EX&U=.:,6ONQX\S0P2>XKLJN'>+-MX'=B
M#V[_AYU&XTV.@Z,\WB2-Y$8//5EN?G88>'N]\"N'&,]'#X/%@0<?Z)&C'+W7
MQ;49PZS F?;X:6'J7D &<*JHME6*0N8(947AFPIE*\/4%L!K#GZ]2Y[;S]@@
MY^\3+I4>;@J&/G ?OLZZO1A3/FBWJ\_N_J@@NZ)M;9*OWZ4TL5&W0M3)X'2^
M:]U3O7G6_WA<:@/WM]5R\UCI1\PW)K__)/TW$?>S-,50D(P#E9L=%))JSA4Q
M!9+"-,X@PLHMJG(DN:?&SIT&4:/"3;15(CIM:55^U#S6:^&U23R%R1[>QPD]
MS]?N20^-^H![W(.)_II[YD//QX4]^,&']]@6ZXHRO%^N/AJ/XI[-RX?FV6UC
MI,5#FXE;RFJ6D+B0 B9 9G$,(",4D"3) !%<I)*D::K7)/LZ,!XB6#'.^&5@
MM-71INAH"W1NU(B6.ST<-DX<)\1B%VL ?$<N!J,ECVK1HSW9MUW=3)GTK?C#
M(>VP)34<XB-M005%WFV_R0^[WOTEQT>.MY_DI^O!_I'G(_P\GS_T\]6[:EUJ
MKTI_$00JR9(L 205$D H<\!X*@'E+.:Q2#ABT,5!.7S\U/R(/ZIZ=T%V\KEY
M!R^@LS/B_0$9F)E;++:BW42?E_.2/T=_M?\=))WA-!PAC> 7(XQJJY[6[J5)
M>>8J#\OO*ZTW34S1E<]R56^5:#E_+^?Z#5\NY-OE#UHN9GDLL,Q8#)(\T=^X
M-O  X4* 7."$YVE1Q+%5EI7]D%/[[HW0IFIX+;9^T7>"1UO)H[\:V5V"1>WP
MM[#O@J,Z]%[MJP+J8,8%!W8DZ\T&X$#6FA-$O4::W9/&L\V<-#LPR=SN#-$_
M]/3>P.U"='L)]^KT)77=Q6_TIY;S#:U*7M\RWYAB7*::P#8P-4<48I(CD]:O
M5P$NN,FU+8"D*!8$D4+9=4AY'?&GMJ+4LD8FWJ^IS23VMR>7N^W);4'S.F)P
MT]#&-1U(!W]/7/:FISC[ Z]\)_J4GMN:-@EPVQUM;6J?N6Y;$5?C4#-]U+Q<
MS>TU&&W=S>%"L,>>R.%ZG0ZNP2NV/QUK=OH[HHXFA=^R^G8CORV_R#H4]3-=
MF2T3TQUPLS+AQ#,.$16P2(&  @.H_PYP3AA(1('BM. XAE8]4JU&F]JBI84U
MD=4+TREUKUMRV7:G==P.Z0?:;AD)!M_0!Y,-<JVD42MJTW>Z$38<(UMA$I)
M^P<<E>^L='])3W8W77&P]FW9-6WH.EW-TJQ(!)<"9"13  IM5S.>*E#$F&0,
MY@E15ONF%\:9&H-\7BVYE*(U>F77BT4;+UUS08_#FQ/P.AR)70?:6,=?WY:[
MSC7_"@J5QYG6=9"-?7[E!)W?0=5Y0*P.I4[</OX!U'D=3AXV]5SNQI35:CV[
MT];=<EX*P\#OM-UG*+@N@D(4C3.N%,!,)0"F>0J(IDZ .,=42:D2FMC09-\@
M4^/(?3FC3E"G2C.]D/938RB@!N9%+XRLOVT;$'H,*'W[GO&D__72<.I]_BA?
MOHV&W6=O=:U//1>Z6%#]2LSO3/,^MFR\O(]+NN@J93 N\R+/M*^%A$D?-N=.
M10ZR/,L3%.<LQ=2^GLN%T2;' IV\T8' D9'8I1S))9 M+*60T W-"SVH>55S
MN?B..E1S"0CC6-5<?%Y"QQHNEJCTUW"Y]) 1:[A8ZG-8P\7V)@^:W88 ?9%<
MED\F6/26\]5&B@_MOLW>KDN6JY1)E !)N:9<E0K :%H AC)2Q"F$^G?6E.LR
M\M3H]U:(_SMJI=UN<#D0AQ/J%AP\%)8#\_$N2' G]\T6UTYTJWVP*S%V(.JA
ML!Z)M -B[D;E/KCUTKK3 \>C>!\]#^C>ZP'N7O57+A=T52[_6%2/DI>JE*(-
M@$DEHT62<D"S5+O5.<> 28A!G,%$L9B35%CM/O:.,C5*[P1UC"OJ1_*R-QT$
MGX%IVAX:)Q_ZHNK7.M'G!QC-B[ZHX[X;??EB]Z_\BWS4K\%W6LG;AY6LDXSN
MEAO#(X]TM7[^I*>]?5=AP?(TRX4Q[C*3MD\ 8P*!@F.<2IX4F5W3)*=1I\8"
M^U)&1DP/.K"'_#(]# +DX+MOSA@Z\88S)M?RB/V H_&*,P;[/.-^<Z#^\6>[
MA,R2)"](@2B(4U,S)(<Q(%F6Z7^2.$])@E*!0G2//RN!U?<S?M+@YW:BS!GH
M8W\7H443YB7:,!G7AD+V<]7/6@-!_WK-Y5\T'[HY[#XT8&OYBX -VEC^_.BO
MVU;^(BH7F\I??H*/F55MZZC6'73,W[HZIZG*BEAR@%AF0J.5!"P1"4""I"PI
M4E5@JP29"^-,S93ZC_VB?1'=2NMB2)T'U<9T"@+5P(SS13Z555OP\+.V_5<F
M1+=<BIMH)W3 *J66P%QO,9T?8D0;Z:*>AU;1Y<NOB5TP1=GTXZO6]I<)93DJ
M<A"+0K,")AQ@*BA(BH(BP5@69U:U>_H&F1HE',@9U8)Z^%=G(;W,"2& &MQ[
M\L#(,W;A- CA8A=>//\58A=.:W@Z=N',M9YQXI*MVZ!1TY"UK-GDO:S;WIC?
M?:BJC4GZNEM6)LJN4)@EN0 P91C (J& \IB 3!(NJ,A2K'(/]\=)B(EZ0+OS
M"F-WKU=T45%>?QM\Z1Y4[C0K1083J @!),],(<O,.*4Y!D7&TI0+1)!(G:+Y
M@T_'B-S]BO-@YW .AN[ A&]DVX;^[R2/C.A-EI:YH),^NNM%VST=P >UH.D!
M3@*,FR[@@\U1^H#70_P6G=^62_%W.9_K1W]8K/5+5IJSP[I4\*Z V*[M*B>:
MT+.\ )CHM0;&7 "J< J4H%F>,JI$XL1O;L-/C>!V(K=UM.N/K]/)C=\<)\*.
MX(:#=V"&ZP2O 3V&>2=\]-<@56'\@ M)<HX2C,IR?NB\I#G/IW@>+)S;P=NF
MF6."E&(DU>ZTA-J[%AC06%(@6$%)DD&9)TZ%IRZ..#4V>[%K?;AI[=V6[#+P
MEH<#(>$<^DS@6B3=3P)LT0EZ '!QT''W_6TQ.-KNM[XQ5//LIN@R9UD*N<0@
M3V*3CI! P!"5()$((:IXJO^\KEOV)&MGGV@UXE<<^QRN=H02 *V!:<0'J  M
MJP>K!GUNJ%=N2MU;;?G2Y2$J+1F^,<U5U]^7VA)ZDLTY0C43G.8$(PK2E*;:
MV4(*8 $E$"JA(J<DS^UR%9U&G1I;-(5F3/WC;6FC<B>M_GL=T+!^CBCG=42*
M:'\O7:MIVDT*%S&-L6" "J8]8)D)0&A1 )(R+B&FD+'$8]\UW-R,O]]Z.$6_
M-+TGVU)$XTY.SN,,JQ2;>6$ T@P#DL$,)#'G!<0%91C/GN2*+5_MF]D??=2O
M9MR9L%N#@Z,[\(I\HM96(W342!WMB3U41:P+* U7R.K<P*]8?^H"%OUEHR[=
M'&)IOVN*3I6+AUW5J3=2+5=M"])O]*>L?B\7RY46I<O5J#=$;#ZR(M5DET(,
M,@(3 (7  &/3/!TE!2]RE!6*^!L(@\H^-3.C^[+KALD1J]7LNBBOC:+7D.2P
M;X$/U4YF;L<G[)WJ^Z41VQD_R^9UYQ_SJ!J9)M=MKV+9ATL)G5>2_BCS-=S2
M,:SXK[@ C3(O_<O8."+X-,>62JY6;2W%/Q;ENGK[]8^J#<;,"Q3+.$Y!3E(3
MO:]2O72I&!0($P6A2++,OEQ9WTA36V@Z6=L*JK6TT2]&WG^X=$+NP[9_00B*
MV."!#F?!\BF^T8N:2W?H0.B-U?OY&A0=&SM;(-/?MKGO 2,V9;;0X[#ELLT-
M?AY%2^N+!\/5=W2U>M;D_C==B;9WH\A80F F0,Y9 :#^%R"Q1  KE&>,L*2@
M3C$9%\:;&J%NQ8V,O-&!P'[G"I< MS.X \(X,,M>A:"S86N)2TAC]-*0HQJ0
MEOJ_-/IL;[NV:;LQ_A9Z!I_OFG(1]=-W<4<FCA621 "%(#-;#@I0)0F()4QS
MEL09=CN3L!UX:JRSWQM\*[EOV_4+F-OQS1!(#DP\)T&\B5JQ6^H9INV7*UK#
M=%*_,/8KM4^W0^1\SW3+^_V8ZK8YOZ@^TV?SV-9XU_:.MGERXS_&&,!$,Q(I
M<@0$) 0J5$ :YRZT='*4J7%0)V342NE&/Z>!M..:J^$9F%A>(A/0S;&"("1;
MG!YH5&KHU?4E#_1?[/;1"UG.ZNJPSUT*).:$I-P8'5B;'XI)[>9D$C""(<]B
M*)E=G:F7#Y[:I]W(YICI>(16_\=\#08#?[^VZEM_M>=TW7VH5?>E5I+_^K!\
M^J>^I?E(]5]>?IM'CQOE<SRG1/<%GOU]^$:>WU;EPX-<:7?DG5GKZUV/RN2E
M2&$BIN0LY8AB+!.@I)+:3^ )P"QF(*5"<HID3(A5::@0PDSMXZY;*6J3MVI:
M*3[NM5+\T>ET$ZVW6D7RJ2[74K=MJZ*RUNPF>C*ZA6ME>7%*+;:51YRHH5T3
MBW:7-]%.H>A=,T>-3M&'=H[^''F.PC4B#3E7$VI1>O6<!6UE:@OR-4U.+XXQ
MF?:GMFBX-$:U?N9U]<K:=,UORV_TY[_*]??OR[G08[Y?KNH1W]"JSN5\E(NJ
M^31YP5+&D  I5!# 5!6 8(D X>8'@DN9^H21^LIC]36/'UFZ)WH3A1,]TE)$
MRUW0;[T#ZE>WS'G.['SC0:=@U)IF-R;8)=J3O:5*P(SL47M5=&NZ]3S(84J;
M^:(X1*$S9UE>I>R9+V+GBJ!Y/\_#Z]@KJ&2J7,F_W_TTSY4STRL 920'E"JN
MW0GM_!.10D (EWF*< PS>W?BW"A3\Q,:X9IB&=&J+?>P7D:KG?S&C=#V &DZ
M"I0_(M74W*#S:'N-2UNWLQ-@8?R'@'5@8ML3,6K1;84,@9&#\1T"JY&L:@_,
MW&SD2UCT&K]G;Q[/JKTD_X&Y>O%B#]:\-;#<_UB4;%.9'-9V*S]5$I&40:!_
MFP(((0.TP!CPE,<T3XB,$;/FS--C3(TQC9!1*V6=>^WP69]!T8+XKL=F8-H[
M@L4G>.X,/@ZD=SU.(U&>_6ODQG3] /3RW)E;QV.Y?MD/..["I==&J!@*76WX
M>F.\^MN%V)9*TF;2+FA"RCS19B($F3 ;T#3' "><@H(HDA JX@Q:L9_G^%-C
MQOU0BYH!/BSJO9(ZO=S4ISC0"NR*BSD7:G.=*#NO>D#X1[ YM_*V4.^!.U*4
MBQ-JPP2[V(GP2C$O3OB<#WUQ>\R5)=N:VN3B;3U84P-ZEJ?:SDMX#@I33@1B
M1$QF.@6,04P13RB2F5L&=-]P+I_9.(G/MT*4=0J,9_6U4YC:,50HG :FHT[,
MFZY;@8@:2=LJX@/44.L!9)"*::?&>YWZ:#V:GZV&UG?/M:;3MQ4U>W=?)==/
MKULN+\3]^KM<M;]HJJ]]+!>R+FL\RW.:YC1G@$%N^A (: K;2H"X8"HI%,MR
MIYIHWI),S9RJ"ZQV9;W6S]%.CYOH_9_@TX?H+R-[4XS;,?W ?[I<3:D!)V%@
M%@N$_Q4&E2=VPYA6KL*\DI'EB=EY<\OW@8%K2/Y12;69?RR5G&4(:E+4!A>1
M!0%0I,1P)P,X0QG+-7<R+H)4D=R-.35NW%4_;)I._3?ZX_&_[[>=VM2B1W,M
M>Z!:DGL38'E(&Q;6H<]C^^I)WD2-S-''/CS#590\1FB4FI)[PTZCJN0Q#M9U
M)4_<ZK'M_TWR[POMZFB?4^H[O]?5P9_D?%F/\7ZY630=*KJ,>ZI0:E+L$4J$
M:4T@ 2XR!9 J%(>,%0(5UL<!;F-/C:$ZZ1UVOQW!MC@U& ["@=FH$SSJ)(]N
MZY8#6]FCG? ^!PV.4#L<0 P'^4@'$V&A=SN\\ .O]U##\9'C'7;XZ7IP".+Y
M"/=V8;=*E?/2[#(VL?_M9\%$06.*),AX73P4)MH0E2G@^J^(LIAQ8G7^<7Z(
MJ;'Z[7R]*FGTN5PL*)_+Z./'NU_M6X2=@;&?R,. ,S!?[P2,NKR:H,T!^P&X
MMC78F:>/UABL7[O]MF 7KKQNLW^WR9-QI@J",4@+J@"4*@&$L 044J20B )3
M*GU:L$QVKVW;"\1_2^T81;<]_2EN@;G!XKU[/^@.UO$@K[)/?W''Z?R%?E_U
M1UE54GZ4M))O9<57Y:,Q!79O)\^RA.12?^.,2/V-8P$HA 1@2@21,)-Q[-09
MX,)X4_OB&W%OHEK@FVA/Y"LXX!+F=HP0$,F!^>%:$)T9PQ*:D/QQ:<A1V<12
M_Y?<8GN;'].\I^6J3G3:M52JMIUW8!)C3@4"VB$PV?10TTR&.,@*!BF'68:0
M54-AF\&FQC%&UB;5;Z^;6.7=YJ@79SMJ"87>P+SB#YPSH]@@$I).>L<;E4ML
M-']))%;W>.PSO]>OSMVF6B]_Z,^R=8LA4Z8E&@524,T<N82 )"D'D@L$LQS1
M++;?3#XQP.380C\IVLKHL)EY"CR+S>$K(1F: @[0\-GC/06+PT;NE?",M%MK
M^=*X;</VJ-Z[UWKJOO$V5'ND/M@U[;O.LU[8$RWG)L+6)"S2N=S%"I@8DMV_
M9@H2E%$6 Y7&&8!%+@'#,06%P$E28$PSJ)Q*B%D./#6J^_I]N5H#/=)!HR7'
MVF*VH-M91D- .3!%U@%*^U%)6QV 6JY 17O*M;G7(G/$)VAY,MNQQZU8YHC(
M41$SU_O]R.G-IM)^7E7=+7^P<E$O1U\D7SXLRO^2XH/0'UZI2KIMB]O%AMXN
MQ$?]XW+>Q#Q5E5[-1%MLL;E2/T663^;.:I84>:HYC0(2DQA * O TIP"*IDH
MH) LSYPVC,<0>FJDN"THN-K*Z,:(H\RT'9M.;?X&9N).W6A/WYMHIW&TKW+7
M8'P;&V]"K?;4CEJ]=T5JFQOJ!W;*AR/V,:<JY*(PBMRC+BACSL3+Q6C4L7V[
MGK4E?]^7B[+Z+H4Y,:D^R76=$B57VHZ<40HEQMJV1CE+ ,0)!R1C!)@>!2A-
M%82Y8SO3BV-.;1GI)(T>C*BN+<4N0VRW  0&;F#^WBL,OH6O%O@FTB*;?-9.
MZ)#-MZP1"MLTZ_*P(S>[LL;AN$F5_:U^G+/;YKQ7^P6(]G,NZQ)%=;FJKIS1
M=E->II!@+BD0"FM_'Z<28!JG0!"&BX(3B8552:$PXDR-J2X4^O(^)[ERTNP(
M;KRI&)C[ LR",_>% 2\D+5XIT:B,&0:]EV0:Z*F>P2K:!VJWZ!%1::PP!2F6
M$L"<0D XS$&*BIB@-%,R=RJJL7OTU/C/2.887[*#R8ZE_)0?F'&,4 -T2SC6
M-6@8R.[IXT9\'&EU%-QQ?(5[A/?=<E$MYZ78AI::;<BFPC_-I*(0<L#R1/M4
M#"M N<)ZR8 "LB2/66'5 ;I_F*E]G/N21IVHCLT2+@#;_PF'@VO@S]D3*:?X
M[\M 7!L#WC/":''@E[7<CP6WN'KPI@R_:\?KQ^;'%],]8"-G.600445 AB$$
MD*<9P#&4@,3Z!Q*KG&16YYM72S(U-O%MQ_"CT2I:-6H-5N7_Q3SV,].HLS.T
M]^-9S[]5*/HR[L0,UGO!?X(FWGC!=J*&[+EP&MR #1=>###5;@NG<;BBU<*9
M!U[; ]G$27?'&EV#P9DYPR[2F ,N,0<P@0SH!4V;P06%'!4$<9&X53WK']#E
M&QRG[EEW'/FX7-4A_GH]FQO)HR6;EP_U]^_;!/DDXG8N;C@4!UYJ]EH@-^D2
M6UFW)[U#=$#N0V68!L@G1WRE_L=]VI]O?]Q[EV>!M).-#/8V6M\\[RYI=]=N
M3>>1IOK4AX4I^EAON37%A[[3Q7V=Q5&]7ZZ4+-<F%/M?LGSXKMV!6TT(]$'^
MIA^^?JO]@VW8]BS6]KCVUQDH2"ZU,X\08 01H'].DBP1B72LMC8)M:9F[M^9
M16L^WU6^53MEHE_*1226^K>KRC@"3<NU?SC6;YL$[+;%X"8A[(16@OTCEWU(
M#LY=V//I3C@&F)NN)MT>-E$-3K36Z$0M/#?1'D W40=1U&(4U2!%!J5HEW$3
ML)#=I.8]:%6\:6@V;HF]:>A\9NV>F'37%E$]+6OM%K5BF?$:'4W05?.SPR;H
M,X)SG!=,@@RG!8 9)8!QDW? $A4CR0A.G5(OPXHWM35[+^=0.S:M&FW#1M_B
MJD&FT7*1?;7)&7JQW.LJT+,@UOKM%KZMBM&>CB/5P0\Y </4<@TBX2L5> V)
M[OFJKT%'\3B&^437FW<K^E6N3%SMQR5=U!+=JT]R_7%951\6[WYR657WZHZN
M5L_:::VIZUYUZUF75=65ZHK35#*4 !EC!2!4$E"9(OV*Y)!3I']MUZID".&F
MMA*TZD6-?M%M9#2,0,,^AH9,3*C1,]*>7*.I^6FGZVX1V1KIG;X.QP2A7P"+
M(YU7G-:!UY#^&;W?F]$/VQF]/YK1^Q,SZI.8''IJ'0Z%7G&*1SHG&FZJ QT=
M#30%O:=)H<<<[X!I(+0.SIR&&L,SY%R+\:0_DB>YYY3^1LN%$>7CMI049@C!
M',8@T9X<@ 5/ <5% 63!)=2N78(RI_)==L-.;:G>2;V_%783&<&C7XSH_[BB
MG)?E5-@Y:.$!'GC1#(:M>WBX$U1!P\#M1AXWW-L)C:.P;K>[?5R5Y6(EGY;S
M)TV,W^3JAR'0]Y379V>MA8*QQ)S%,>!<4Q2$,=9D)020C"4I+7*!D55:GN5X
M4V,I+3'8BAP9F1NKI)/:Q7:\#+:-I1\4PJ&-]POH>9G@EV%TL:J#PCF6H7PU
MK(YVKS5(_:;LY<>,:)U:ZW1H<-K?%JXBXW[;6DC2/(M!3E$*(,HY( 4K $X@
M))"J@KKU#^H=;6I<O+?-_[ND1E;[C1D[>.W,P6"@#<R^YTHQ#K*';@7*T-48
M7VF'VTIWFWJ,H7K [C;#ZR/1,R>L7)N6FK9>G%GE/*,"(0DTI6B#+\8QP(I"
MD%*:2U,.UC)G*( L4R.@KYL?/^CJN=XQ_FY.I^MMY']1<U2]KNIHH;=?__!N
MB.T^5Z[GBX/.P(B1-R>2G6^B^\VZ6NLY,#91>[+8*75CM@OGF_I7]VV1ZU'.
M$[T!'^;PT%V<5SHI],;M_+&@_R,]'.N=Z[Z-1=UU=3-VXZR@4BE&,= 6G0)0
M9 6@@A&0"Z*PJ9"+:&[M5U\<;FI,^N[GH^0FGLV^RZ,EKA8N=%"TQMO)VXLY
MWVOI>%/[?T$A='"?@T(YDO=\+:1NOK,U0KVN\^6GC.<Y6VMTX#C;W^59R+<M
MP;@K6K8-GXCU#7D!"A8C[3(G"F#&8B %@4F!N8HSI[IBYP::&L5N:U)^\:Q)
M>191.ZLS!$X#D^L)B 8H;G$)B*#E=L^--6YYW0L:'Y73O73]=93P:;FN6W^;
MO;J],7:G@"B)&<)Q"A*9F3,.* %%/ -Q@3."]0VQ<#J0M1UXJI1Q$]62W]2[
MRHU?^[Y<T 4W_M/^MV)SA'C=U+AQ34C 1^*>H%A[<Y,M<$-PU<6Q7X6[;!$Y
MQV76]_MQVY]T5==T_;#0Q""K=5U%Y/G^[X6FB>_EXV>I7U-M23_(61Z+."$Q
M Y#%7#N:!00X3[4E) DE&4MC%#LU+K >>6KLMA71I.ZU,KJQECWH>MV0%'/]
MSN,BU:##%)!84J"@"=G-(<NRPBWC?!#8QTD^WP%?ML(/!;O=:C$(E ,O%YW,
M42=TVZSW)OH?&ZJ=J<:?7:[,/\TONN"?N@Q#4]-\-PV?+[__SBN),Z@AEQ+[
MP4==2YPQ>;F8N#_ O7S<)_W6W:O?Z7\NMZUUVB)G@LD"(ER K$@E@'$L %;$
MK!R0Z-6#I3!);:O'G1UE:JM$)YU'O;CS2/;S4C!\!N8@>VB<"L1=5/W:^G#G
M!QBM/-Q%'?>KPUV^V.-$XC:-DWPO">JSGMIV/R=+44(PDR#E,C=E6Q$@&$,@
MXIS@O!!0I?;=^LZ/,[4OW0AZD'L8&5D==M)[(+4XA0@#U,"?_&F,?,+V>L!R
M.&\( ]I(!PV^X+D=,%R&I/=DH>?V\8X4+NMP<)9@<;E'&=W-C\V\-IO?*27Y
M6AM7Y5+<JUNQK >Y%?^Y.<S+3+'($6> \(S41I&IJQL#3C*,4Y0KI:QR]'T&
MGQJ7[N2/&@7J,G]:!1,KTREQ$^W4<*C"ZSHOEXVM(=$>W 9S!#H@W5P#W=4U
M?EW'':_RKR<B!_6 ?9_A1G-"EK/&A?PB'TI3_7^Q-L;FK* X*1"G@'*2 L@+
M!AC1S":14#E24#!EM4=X;H"IT54C8[03,C)2VG'261#[>2<$- -SBR,JUKQQ
M2?4=-U0=.522__JP?/JGOK7A!OV7E[1P]K&C?/J7E.H^[XO77=<:M.[F5I6&
M)':'9B(6&<[TERQSB?3GK(T20ID !,:J(###+'&J%-@WV-0^[6T_QSUAKSBH
M[,79;KLY%'H#?_W^P'GWK>Q#9(A^DR?'>Y4^D7V:G^OOV'N/'XO<&:D7ZU73
M+:BL_KU[MWF:I/I%D2!G1'LW!&GZB&D&,,YHSE0B2,Q=..3\4%-CD -)(R/J
M%?S1@[ =>X3!;6BOQ!,R9^:XC$9(WN@9;536N*SU2\ZPN"-$I?47515-)I,)
M?OA"U[(]FYKE)%$D(PRH5.2F?B$&&.E_(E'DA2BR(D-.?11=!9@:NW02 ]I6
M<A6MS-'*%'/];_\'3I/DOT?+;<7QNDZ[8TZ1\RS9<=&0V _,4$<5W(\JZG;R
M1T:!F^Z,?*BR[O;@#5?HW4*&5RS];H]0?S%XA^=XAIG6S;(_:1W;Y@<P35.9
MI0B@%%( <\X 3F$**$T0E )QS8=.X:0O!I@:I9ER!*UH$:UE=0P&?0F@'1M=
M \O ;-.(9D([.^$"AFR>43MH:.;+,<8-P3RCX5&HY;GK?"KA;,R^ZKWZ#_GC
M49A4%2GNZ&)!62G*Y5P31;5<T/F=R1Y<T86H9B(561(+;<W0- %04--D4?M'
M&2I44: ,)ZE5)0:OT2?' +7\Y@CBN]8 M"I$?*>#B;FLE= _7,F(U6JX5'UQ
MG9]^#AD<]8$)I@7\7D7_L0_XGOA1)[^ICRBC-X,#[E)T9T#@QRK!$W@"' OR
M> +87Y[']:$C%NOQU/>P=(_O0ZXP"S_\>*3ERKR/=]_IZD&:=8,5!94Y2!75
MZP82&2 9UW_DG&MW&-.B<*K@<WJ8J2T0.P$C;KJ1&SMQR<NZ[^S?Y?I[]&@=
M>G4!7P?;\2K4QK @HSW86A$#VY%G(0AN31Z/-+Y->5;;DY;E^:L][,L[_<>R
M^E"MJ)S_]NO77S_K1_Z@O)35Q[7XM8U<D3!G/,\80 67 "8Y!U@2"41.TEBQ
M+$\S^T!,FQ&G1A.-S%$C=&2DCG9B1T9N!PO&"G(+,S$TD$/OQ5_$T"=\TPI,
M!Q,P-*@CF7TAP'4S]5R ZC7OK!XTGDGGHM>!&>=THP]3+Q?59FZV#[_*U5/)
M9=6^W8FDDL88 IKFIF)/G@"L?7V@<"QCKK@D#GTXSHTR.4;>RAEU@KJPQCDL
M;6@W $+#'WN^!,>+6\^AY,*G = :BT-]4',DS0MH]!/EN9M'),<+\A\2XJ6+
M?9L9*+E:2=%4(Y!WQFW[)->S."9$X30#6<K,Z4:& %$I!B*#B,:,0(*)6VKS
MF9%<7MUQ$IG;LH-URR 3R%=17@<\U"ZM:W^"T^C:N:\!$!N8&M]*MJX[\!GY
MHEK &]._)62G@5X,PK86.#W4R+T$>O4];A[0?_G(K;#;SFM[-3I?G,N^^RE7
MO*SDYY5FL"_+^5PM5^;&&49%@BD2 ",].3"5,2",)  EN4BI@+%FG5':7GNK
M,#6;;AOZT(6@R%;PZ-%('OUR]W^.U=/:_[6P(\II3_; '!R@5_6V*><>$"=B
M9SHPHAJ-Z*];9@+=^3ID3=U7F\E)=)_VU^)_CT[35\]2L*[2UTMR1?C!5Q.R
M*1]*_O\LR\7Z3RV3*0L_DTP5B.G7*6:9 #"&$A!D"@M1)#.5<YS&TCG8X/18
M4UNL=J$%52=O])]&X.BIE=CC4/L,S XQ ]>#-UJ$P%;4J)8U^C,X;AY'_]?C
M-_I!OS..?F?Z_<A8G>"?><3XY_7]NIP\G;]PBP>WUC3/+J\$[.5*T/6(W/9>
MJTO(?_M.%^T:\5O=]^%V(?Z4E5X?/BR:O-T9A(G".14@XPG1+DM, ,Z*&!0P
M%7'&<Y1SJYCWUQ%_:BM +:;9+32U,4V_3O-WO1Z85AO1+^4BJHSZE:7+\DJO
MA,72,NF)GH*K\J;75=DV_=W"$-4X1 :(G2/38!%I,*(&#=-,N,%CTB^0PQH[
MZ1=II&5[VB^4FV7P:O/9:VR,+]5X]LNK(7Y@$KV>%'Z;P\VP7R7?K,IUN3W%
M5 +E&<$$*&*BFC*6 9;G"&2YS#E4DFKGUF4#]_0P4[-:6O;8B>FVHWH&2[M=
MS^L1&GBY/P)G@+8+_2"$W-0[,]*H&V_]VK[<'+MPM6]5H0\+OEP]+INLXZ]Z
MB9=W)M5N]7RW%'*&)(MIGF$ L<80$H%-36P(<IXS(27",K;JLF YWN0(H:FN
M<R#S351+;>HVMY)'1G370D3]N/=SQ@!H#DT> 8#TJ%UD!<_5I8SZ1QFYLI&5
MRL>%CNQN\PG-F].JNE=MP\W[U1>S+]]M''5M.$W0@12S.,49SQ %*($FST(;
M'"23$B F1!YG"$-BOP?C,/#4:&>W?_YWUZ>TK 5U"5!SP-UBHV,@- >FG5IJ
MLP_<2AC=KZ):\IMHMT>\[07[84B,7>("A\%ZK%#!D)@[AA"Z ]<?5>CPO!$#
M#=VU/(P]]+C?@_@_+,R^KWGA3.\#47N]U=?E7.PZ(-RKYJ?-8-JUW3O G<4Q
MQS@SQ1AP*DSH-@9Z=2A KJ1"&2%)SJPJ,H009FH+Q$Z=:&GTN6GWTZ-*JW2S
MURNG/H-M?M6L(/6&_'*GF0/;73NA%JO,B-,T\,JS-T/WS0PU8D=?ZQG:Z5.?
M4C:_:E2J=R7O7V6&'-:H$6=JI'5KA!ES6\T"0=R[PET[QGBK7B T#E;"4,_T
M#=9_7$F33VTVB!?B]L=RM2[_J_GV2"XDXH4$A!3,;+YP0!%+ 4U57!1"Y4HY
M=;?L&6MJ:]N^J/5J1?>$=0W8/X\P8X05J8:TP 4&,,T3P%B> LQCB%0L*4?(
M-24B",;CI$6,A++=WG<@Y 9>TO>EO(GTO^9RB]Z^R'4)J<?54FQX+Y@>V1,7
M80J;07%^N)&S*"[J?9Q)<?D6/];^(LT)'5]O5GH%T/^0JR<Y*S!/$DT9@&19
M F"F., 4%4"B/.%0Q2G)G.CZU"!3X^D#&:-5(Z0;<YS$THXRKD5H8*XX!.?+
M!7"<F:!/^Y 4<'*<4;_]/DU??O2]UWKL8'R1XN_E4GR1CX8]%@]_+,JN7XVV
MS9 I_ $H2PM3K;\ +&8$($D4TO_C2.76FQ/GQYG>-U]+ZN"2]F!HL1\0!IG!
MO_5:R&@K963$]$DJ[P'+P34/ ]I(7K<O>&ZN]&5(>KWDGMO'<X OZW#@VUI<
M?FTU\655W='5ZKG-I:D^;LODYX)"DB8QR"#) 4Q0#FB&8@")XFE"$<J$4S5=
MBS&G1I5[Q:NUS-&!T%?T)K!!W\Z""HSIP"1[/9Q7%/^^"- P];[/#_M*);XO
MXG"^JO?E6SV3VS>L*D5)5\]?Z=SLUID.D[<_2\U!!*$T3P40":+:1),)H E.
M02JS L4I(IPZ^61G1YH:\QCQS+E/T\7T+R.B(\F<!]6.6H) -3"A.*'DGOE\
M"8&@"<IG!QLWC_B2SD?IOA=O\ UJO!5"ORO5YV6UIO/_MWRL8^JXI'F<"0J*
M0D( LTP"PJ "20J92A'/LQR[Q3*>&F9J;-!&WK6BWD2-L)&6UBML\22R_:P0
M#J^!*<$7*H_ Q#XDKHY'//GPD<,0^Q0\CC[LO?JZ4EC?Z,^VYX T73Z@0%()
M_>&G4ML$*0.8Y0H@QF+&BS@K9#);+[40MD<^QX,X$<!VJ.'>:BU2)%HYHS7]
MZ=7NXR2:MH<[UV$T^*E."XV6+]KV -&8:=O@3SK?M!EH\_GR;U.3*7PMK%.X
M#%$(ZV"<5ZF"=4K3<R6P3E[KQP2_+9?B[W(^G^6(<Y8F%""$"@ 3D0-2B!BH
M+">Y*BA31+D=^7:/GM[Y;B>9VV>^A0KG:9%23$":F;JIA"' D-3(44:S7'(H
MF)P]U@EH7]=TM1X.KI>## ?9&SJO"]_1=<3D0[E8M#GKCPZ)QD= (D(23O1+
MEA:Q!C+F,< 4(VU^<HX+)M.,JQ;(=PLQ-(S=$*. *!?B:O@H32&4,@.,X=SD
M(18 8^W$8^W))RDJ",ZMZO=> ]TH]1*N^USM5F(?Y0=>?2_J[;RLOE0RY%*Z
M??:HR^=+C5XNF4>_]ULFOZVHJ.O1=@F&MPMQ)U=K6B[:7S4+\C?Y<_U&R_?O
M&=6K1*:_3R!@K-=3P26@D*5 )#DB".4XCYV2A)TEF-I7_'7SXP==/1O6:ZH.
M[ (,'>UM]\FPHX!!(1[<4F?KO?3CFZB5^*:.P#I*3[Z)WO\)/GV(_OI&V5Q&
M1J.H5BG@-I\WG"%9R5V(4>G+&Z.7/.?_(#]"?$_+E?$ 9?-8/=K'DK)RWF9?
MTVJC_93[Q1<CCXDXT1=\6BY6W3_?T*JLMA[D-\F_+\K_M9%5_3KNOMM<,)$*
MA(&QJ@%416)R'F. $I0D,B$99HD+B8XB]>2(EW^78M-LZ!L :L]=UC6_WYJN
M85J9)QGM >'&QN.\"78,/KGY'9CU=],9M=K5*1H?%H\;TY+,5/#9[M+LU!F4
M]4>=@I KQ3B"C[JZC#H7+U>D<0?W;&FX*SU4->/3W4^^[1HB=-5J<LYSR4P4
M<QH+ *'I@9U0"J3DL<@H1B1Q\K@=QY_:RG*WG&MMZKH(>@79+T16A_WO_;NQ
M^->FSMCA37^]7?[0-HKC&;SKO-FM'@/.QL#KP!@3X=Z/T0_.H(T:'448MX.C
M'SY'K1T]'^/'F&T*?/M=93&"O) "D"2G +)4 1:G*9 B+9(4(94G3IL<!T^?
M&MMUV?]N5'4(F!T1><,P,,UT12O"US8[J7%()C@<8-3O_*1N+[_BTQ=YY&7\
MIG_^L'Q3+O]>KOY=?5CPKI<EE7E!$(8@*5(&8"P5P+B IN1^S@LLXSBQS\HX
M-\K4OME&3H<L@[/P]7^YP4 9^DBA%C'J9#0UQ[RZIYZ%R2$5(P1<(R5B^,'F
MEH9Q"8[>)(RS-X^7@G%)_H,$C(L7!XIK.A]C/6,FJ)&R',2(F7IJD&DKADEM
MNZ LBWD:,VG5@L1C[*FQI(GNF9O, ;XOY95!4#W0VUE! P$Z^$',B9"IO@2-
M 8.F+@,V:"Q5S_"O&V)U&9>+D5<6C_ PWM[KU_!/N1#+5;=SP7&,BZ30+"5-
M7#;'&6!$$$"D) G/94$R*P_K]..G1D1&P*B5T,$:.8;-PEJ["HRA]_7W</ Q
MSXX!<;#+K@)F)(/,ZD5QL[_.JMUK>!W?-9[%=5;B U/K_%6>267M<>*]ZF)K
M=J=TN"@8+#@T$6DFH=5TE%>J %1B*7)4L$RE3FEEY\>:&G7MG[+Z!:SU 6MG
M,06":V!R.X74H$>2%K $S3CK&6[<G+/+>A]EG5G<<DTOC:Z/Z@P+'@O.)2 I
M-N%Q*@&T8 HH22!.$$0B$>X]-+K'3XT<VO@KBS:R-MC9D8$_(@-___9@>+;(
M>*ES^-88VQ%>H27&2^U.M\(XNLK#&_FV?-P\U@60.RLR4SD1><:!+/+4E/)"
MVAM1%$@("[/ HU0QNR21TP.XO*7CI(IH$<'FL:G1[>*2'&-GX9)<A<? 7^T!
M$#X^R3$B#C[)5<B,Y),X(N3FG9P%H-<[.;YK/._DK,0'WLGYJZ[U3FX7ZU*4
M\XV);MB%Q;[[R><;(<5[+:QI0K9IWHI[]8ZN3$Y3]5FNZJ*VM3TZRY(<ICDC
M@+,, 8@*[=IPC(!*$X5H(@M6N-7)""K>U,R<?<M^7[_]OEB=AI%Y7:(]'<U-
MG9:FH'131KIU#%QK=(1]"UR]K['G=D2';:QIO<+)"XG^,'YA$ E?R94,B>YY
M[S/H*)YGB67UN*SH_+?5<O-HCBCUT'H,_6.-V;I<;*1H#P&6B\K\=+XT(:U[
MR0N2QIG0KP+.)0%0002(,F%2*84\3YG,W5S<:P6:VFJQ+WBTD[P.6?P/.1=
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M)A_EP\*TGZYW:NH2=-^^TT6[-?-^N5*R7)NSUF9W9A87,LX3B0'B6:$7O8P
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M/C70R"' /;H>!_SV7>SI+&MWJVEI\#M=_5N:N+QW/XWE(F=9GL4$RAP4!<4
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M)T9(N5<V[,WS\<7=9=\,A<T$*[#@C %.8J9-8JRI),TA2!3$,9$JPXE;F<"
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M7QYT5,ZWQN EW=O?Z,?T7[1+NRJYILDZ4.Z/1;FNOGS]XW=IG-H93*A$@G'
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M',B+HB@ Y%P!%F,*F.*2BHS1G-O733TSR-2XH!&S#DY\: 1U<'3. 6GA"0:
M9^"/OT7&]$=O9>P,D  (.?B" 9 :R1GT0,S-&;P 1:\W>.[>\=S!"](?^(.7
MKO6LNO=]N5I_DZL?]2;;W;):SQB!A4 B!;&$%$#M 0(F:0)X0IG"/),\=MJ^
M/QYB:HQ72PCT2#^BN9$QXEI(QXIZQSC:F3S7H3,PX>T!TVZWW_4AXUX\[ZSR
M08OG'8\R;O&\LUH>%<\[?V7 $*'J\W)>\F=3*ZTNE39+8RJ9RA$@/$L S% ,
MF'XW0"Y)JKF %R)Q*[MK,^K42* )[XR^R[F(U'(55::AC#&"SL1R! C;.)H(
M.\H(#N_ +'(Z6J*ZB1J1H[_:_PY2O,\)K,'C'HX&?OU AG-86$4FG+W9=WM:
M2%4NRK7\6#Y)\3+V^LWS[_0_EZN[.:VJ>E<!)JR /(X!DB9)-X<<,)(PH%2!
M%"YR5%#EMCOM-/[4*&PG/I@;^8^S#+SV=%QGQ7:W>C"L!^:SZV'VV(?V BOL
M-K2;""/O0GOA<[P)[?<8CQVG.AR\J5[0QF[5,5MU?N&WY>/F\4OY\'U=O?LI
M5[RLI)C!E+."IP4H>"$!U&0'&$T4D$IF/$59PG.KFH%>HT^-Z;2,8/,8-5)&
MLA/381O&&7^+':PA41W:TZNS1]HZ+5T<:QN]6LM_$QUB_FX,S!WVQ(;$?J3-
ML@'FP&TSS1?#WETVYX>.M_WFJ^_!OISW0[Q:P)UJ5GP8*%</=Z_^J)I%:Z:P
M7BH(QT (5 !8F'4CPRF(4QB+I"!Z3:$.F>.^<EA];^,GDM=2@J4"F\HMH=E[
M/BS6D:'@?>VFYD?!NPWZ]PIH-1K3>6#PG=JY#3H)H[5Q&V(R7+NW>2-YH6N;
M^W/'[-;FK?6++FW^SPE3PKPR:UG]GM[.Y\N_J=9]EJ-<<%PPD$$! 8Q9 D@A
M4I A*JB*"Z1RGWHD%D-/="$Q,>O14R=M1#MQKRMD?@IZRTWB0$B^5AGSJK%Y
M&S1O+Z)Y=17S'GR&+&)^:MA7K6'>@\.E$N9]MWJFGNT(;]NK.X.D**12(-%_
MT\R3,4"QV1:!S'2/3!6,G2+T3HPQM=V./1$=\\A.X&=''U>B,C!=[$DW2(/S
M'NV#9G.=&&;<A*WS>A[E9/5<ZN')?EXMN92B3FBMK9?./ZYF)&>B*#(,.,7Z
M \^H DPB!01)LEC0)"T(MM[H/#_.U#[R3M(FP[S;TJS3QO<W?1P<I!Z,+9S0
M,,@-3 1;T(R4#4+;7;% 4#FXC&$@&\DS](/.S?.[#$BO@]=S^WA^W&4=#MPU
MB\N],Q;.G4O=_EBNUN5_U2],&Q9H4F._:7#E+(4LYDHRP H3W%,0#G!.&$@8
MS3((4\:Y4Y\!3SFF1K?Z;<N<4QN\)L#.X!H!UH&YN-$ ?#QY)'Y3Q_W6A<KV
MU6D3]6M5@N9/7(-EX/P*+U'&SK^X!J\3^1E7/<Z/'TVGD/7*9(J9@BF:AA],
M\? NG9_$$+&$ T89,]M5*2 %AP!11F*:9WD&K6Q*F\&FQG3[LD;E(GILI75C
MOUYX[2@N%&@#\]A+O#I!!RBG:(-(2#;J'6]4RK'1_"6O6-WC6Y;U22XVTAAM
M>I3:N_U7N?Y^MZG6RQ]R]3).EZ:$2UQPD,.$:A>504 +F@ 4)Q0I+G!!K*J#
M^ T_-8)II8]6DB\?%G4/%]>*K4[HV['-<)@.S#\=G/4^0"=Z]+>6/>J$'S9D
MV@^YL%5?G208N0RL#SK'=6&]GN(3:*B-+/U-/IF&*@LZ?Z[*ZL,/_>JM[Q>?
M3-O1KK3<-]-<:?>1)052:6&JMA5*:HLI%0 S50"2))A01@OM3=J'&WK),#6>
M^\J_2[&9UWMR>QI%G4HND7!^DV*Q;3<\U /3WRED;Z)&A^A^4=?2/"S)^5>M
MBQ47!IL)E\C$P6=DK/C$(6?&,5+Q*DS[XQ7]'CUBU.)5NA_&+E[W*+?5J%JM
M9TUOO]_E^OM2-*6MI/RD7[FWRQ^T7,QPD?),&6N:QZE>=% "&"L2($0J)2<I
M%;%5/L_EH::VMNSJ?-U$1LKHKT9.2RJSP+9_[0B+V,!+A#M8UNQBCT./O:L?
MLF?KZG^]M',M1AF%3^RU[6C#X0X_3[PN[G2W_/&XDM\-.SW)'0UMZY471*62
M< B*+-7&J<A2;9=R I*42<@3Q1C&L_5R3>=V_K?-H$Z,L1UZN(_@FQDC6AK)
M32ODG>B']>C=/'$K]%.69T0Q";+4H,\% 9B89A%2Y*9@#F,*N;6("(W_."T?
M[E\!>[N]C]!X#LSG#9 '\AX:DL-4T'=!*>3NAM6XH^YIN"#Q<B?#Z5[?"O2T
MVHM@RY%$G*<0)(Q@PS\%P#D2@*!")BGD4*;(K;[\_N.G9ADVTMF$N=E@9\<?
M_H@,S!3V8'B4=S^E<]CB[0<CC%R:_91VQX773U[E]]7><FZ*L5:?Z;-Q'[_(
MN8G%_TQ7)H;P;K-::?M]EBH%4RHI2!/( 83Z@\;:SP-)GN:9*4H#B73YEFT&
MG=H7KF5>;;0M9ZK.Z.FL-O,Z+:>2JZ>2NX;\6J%NQP*AL1R8&SIQHU;>FZB5
M.&I%OHE:H<.1A@M$(:G$:MQ1"<8%B9>TXW2OQQ&(MDY^+!=UHNZ?VEO5'U<3
M2_MI8XZ.[Y5V:)MBHG0^KWM+S 1EA N>@;PPQ1:0]G.(I 2HG'.2Y$HQ845+
M?L-/C: :!:+*:' 3/34Z1*M:B9MH4:MAK'-I%-$NT$X3AXUX]TFR. T9%/J!
M^:Q%_6N#>BM^&P6N':(&]7L5U3I$'\9"W>'D8U#T1SKT&& 6W(XZO$'L/>5P
M?^IX!QS>&A^<;?@_Q=-)72X>3*7,MY*MO^E'U*6P4H@3QA,&():Y";[6ZTB6
M$T!RS'$B8H3=6L>?&F1JJX61L:D9:J2\B8R<7G7'3B)JZ<!>B=/0;JP'1.X.
M;0\&0=W:4^.,Z]SV:'KDXO9=Z^GHUJ'-G6^E[42F"(U!*B@%,,DR0(L< 1PS
MQ I<\!A)E[.)@Z=/\Q""-\(YU4\Y#1X3&!&H*."F822$<0QPEB8 "2@PD8+"
MN'#:#O &;PRS.AALEOZ\+QA#.^YMOG]X[_R4PD'=\(,!QO6W3^EVY%B?O,@W
MO^)HB[_;WK]=KU<EVZSK*)'E)ZV "6E<SO73'CXL]*>D[:\91)A!IF)0P,*8
M0I@!HF(&6$X*S8^QRG/FEH)QE3Q3(P/36&Q/3.U%-W(ZIVE<-TMV3#(B]L,[
MV3:'CC?1OEZFT^RA9E&G6LC<D" 8ATT?N4ZDD3-,@N!WG(02YK&>T3';LD_Z
M#;VCJ]6S6J[^IBM1S?(LSY,DAH"E* 8P5A)@Q13(4P2+A# E<Z=3T?-#38TZ
M=Y7,3-1%Q/=E=0S!. ^O'3&& 6U@SMNK_&;PNK/"RSVZXB(406,JSH\V;B3%
M1:V/XB<NW^''%>_H:J$?6WV6JZ_?Z4IN8P"*)(&00 82A3, &26:*5(*F$BY
MB%F&D5O\Q+F!IL83G9RFJ&Y42^H=57$66SN:"('8P"3A!Y8S2UQ"(B1'G!UK
M5(:XI/%+?KAXO6_&:Y-+6Y<LOM,/?I#5+"8XHSSG(.&8F_C[U-0*3D""\C1G
M2,8PSMPB.T\-X_*6CQ/)^44^;E:/R\JLB;P1TC6#]02:=EQP+4(#\\"!>-'=
M!7 \<DW/:Q\VH_3$."/GC9[7]#@[M.?:*SN_WV[6WY>K<OUL0O;K(Q6J8,I,
MP37*% 504@Z(4!P(FL"$9YPFTFEGYOQ04[,(]IJ-;V7M4DJ\&N6<Q=B."\(@
M-S C^(/FWW[]+!Z#-%H_'NUU6JJ?U?IL\_3S=WBV!VU3GN_54;'7VX78JPGY
M(CU6*IKGA<  Y85V,232WH6$"8C35*1$)5(BIR*MGG),C6_V,\A/E#RNVPUZ
M%WOUG2L[:AIA!@;F+4?P!TE>#H1FT.ZHGJ*,VT+U.KR.^JQ>^3C/.('%NA3E
M?+,NG^17R;5Q9X9X]Y//-T**IA3(C\=-$]%VKUXZ?A_+A?RPEC^JF5)Q0E,D
M05:DVF 3, =4H0+@3'".<JE(2IQ.R0,)-C6ZW=<KVBD6=9IU)7:VNAEJ.+7Q
M832,:A4=+<)@4VYYPO\*$SET<,"8<^@>81 8\*#!":%D&S>N(3"B1R$1H9_O
MW9C[<5G1^6^KY>:QTO:['EZ/<[K)[EX5!Y8GG.4( 990"6 6<X!IH0#F10+S
M-(4DXXZMNGWDF!K3=VI$M1X^%32NG1@[@AX![H'YV MIGZ[=U^ 4N(^WERAC
M=_:^!J\3O;ZO>IP?)YZ.F-"CKTQ:JJ'FKQM6:?:FJ^>F!HEINUCW1(J35!1"
M<I#%!0(08PDH2R 0$B:$YS17T&D+TU^4J3%C75W01*48TX@]1XLP<697S)4=
M4XXS P.3Y9D@L9NHTZ.Q7G>:1(TJ4:=+.$:]'L^0I'J%-*/RZO6HO:36 $\<
MJW_$>WWMC.:"2*A)M4C3!$!.*< 8<2!Y@3.&21:[M=OR$V-JK*I?ZWSH[A$U
M_'9D.3RH Q/E%;TCC":OV3IB'\G7[1Q12S+QQA'[:%W?-^+@:6ZT*&0Y>]NF
M$+_7=BV=-WV[W^N?53.*4XZ)3 $C- .02*S_AB@@.2L0)#'!L56(7.\H4R.U
M3M"HD;3M/1_5LMJ173^H_5P6#*JA'6 ?E*QYR J%'<U4'<]4DO_ZL'SZI[Z_
MH1C]EY?,TO_L48C#2KV.%^PN]J@'\EZ_#+_3_URNNG+K71\3GFN3)N<2R,S4
MGTT)!#@O*,A0FF4Y3_(\A]9E/\Z-,K7/WL@9U8)N^PNX5) X"V;_YQX,HJ$M
MDQ/H7.X$XP"30SV-$'"-5#;#Z:5R*XAQ"87>NA=G;QZOO,4E^0^J6%R\V*<C
MA*F)8;Q**=[6$88-K9KNS?)?=+6BBW75=2T4,XR@$DQI.BR4, X@ 233?XN1
MA()1GB0DLV\$X3+TU(BR$W#;G%6X]!EP MV".P>#<F!"K>6.&L&C1O+6AFHZ
MOLN;: OTN\&!=NGC,!3@8[5O" J\8[\&'^SZVS0X/7'$[@P^FAXV9?!Z@GLO
M!O/ ^I6[78C_L:'S4CWKP;I:?.:L9[ZL-BM9QT#--,W'C%$%4(PE@+3 @!00
M@B1#4E$4TQ1;+0/.(T]M%?CZ[B[JXL=NHB0%,6F^GR;ZQ$01[G2*MD4I=UJU
M@84.G1W<9JI_[1@4_Z&7CL&A=^H3X07CM6TCW 8=K8N$%Q;[327\'N!A_;;U
MRC?F6%1V3E@,>0IS5( "*PX@HAS0C*> %S(1&4&,Y-3:R#TUPM18K.M=T KI
M8%^=Q,_"7KT6E8&YI>M!T,KGX^*?1,;!P+P6H9'L2&>DW$S%/A1Z+<*3-XYG
M^/7)?6#?]5[HF::S>7R<E^:I6D[33=*\ 5_*ZM_M2YC]?]R]:W/<.)8V^%<0
ML1L[U1%"#R\@"<1^DF6[7D>X2@J7NGO?J \9N,J<3F5JR$S9FE__ KQD,J5,
M)L $*=;&])1MB23.>4 ^.#@XEU HGD0*2J481 IE$&-"(0M)$F 4J%@F3NDX
M_>/-C>Q:<<&!O, ([)AB<P9GN]-:C^B-;7"=!FZ$;MB6N'A-?CDSY+1)+G;Z
MOTEFL;QM@*UDBF7>R^+Q3K]0WVDI34W=O&J\UE;1O3>YR1LI_K'*-^7]^J-\
MELOUTUVQ%G6?[@6AG&=,(,BK5MFA"*"IXP@1$S(,J=0XV5M6E\LS-VKZ?5<\
MG=/5BK)\M<Y%"3:-&J;2F*AU .8 K,I(,_L<TR<B+S?F'/)IIYR#K>)A9BUL
MOFGG:V0RW!?M;=4!>WVZI<!;G4"EE)G"1BUP]TY3Y6"$3CME$YFLTTR=FYWK
M#^A>J]C#,-/9T/XP.;"X/3YV8/&-LJ!RV<W/;PS&3(D@$3R!DL2B+MK'6(:@
MB%B&N4BCF#JE\YP::&[+7BVG8W6-4R#:6=T^H!EYA:E%/*RL,8*=?0X)KS4U
M3HTU;46-,QJ_J:=Q[OJ!%?G>-,ZM.*B*""_7RUR8MD=M1]W;HLJ^N57M#W:^
M2B%01#5GL"C%$,5$08*""(8"$92(E$HNG,KW^9!J;@33Y%'46H&]6HYI+GYF
MS(Z@)I^'D=GLU!1<@5<Z@58'_3$U:85Z/[13; 0&] JUUQ*%7@2;MIZA3RS?
M%#_T^O"AC7WHJOPFN<R?S?:[M=P2$BO).60901"I*(281D3_)T LC40H8R>7
MZM%1YL:JE9!@+Z5K/Y]C0-J1X\7PC.X<.$1F!-+JA<!O0Y]C TW<T:='U[<M
M??HN=D\+^;3::-+YG"]E<:/YY6%=O"S2@)) I A&:6JZ>64AI&$J8"!3+@,5
M1DIBVX20(\^?VX=>BP@J&4$KI'T.R#$$^[]S#[B,;<XX0>*4\-&C^ 6I'L>>
M.EF21X]*W?2.OLL&MZEIV_XU"PS6\RD#O30GD8EBQI)!%DBL_QFCA$I&:,3=
MBAJ_&</E-9VFHG%=](C3IWQ#'?TL;Q'D09#A##.8B236M@Y&D*1Q $,:IQK:
M,";8R=:Y"+\)&]Y6(+HWX'F%GIV!<Q$F(U-?MP?J"(;-2=4]]ZYY-<C4W6B.
MZWBDO\R)"]TC?!O_M:EI^$?33+ZI5I1(R3,A% Q#'$*4\@!BJ3C,>"!YC,(D
MQ585!'M'F=M7W0A:G9\VDCH6B>H'M?]#]P;5R!_[()2<XF;/HG!IC.SI 2:+
MASVK8S?V]?S% PN.<KY]W"Z-C^2^T'ND91U@*_YK6_M1F@5*K^4T"C()>9J:
MSE%4&T@HC"!6.)!4<I5$F9N!9#?P_*PFT_!-K0N9/ZR _,F_Z]])\* G OQB
M6DO]#>A5<+-7R+@IV\O7NWI8CA5"[>;(SHCPC_O(9-,1&'QND*S;5?(7L)?[
M3?>].UIU3O5OB[@AZ+5<I]W(TQ;C=$+C3:E-M[N'Q_*_Z<AG6FEU1O]5?\'F
M1Z;G\[[FYS?YW,DY:$O>W:KJH9T3HT48IVF8$ RQ)D/-CT1!EICMC\BHI"3B
M&;4REJ83>6Z6E]'&<&>QE[^R+T1;3%(3Z;H**\_W2ER!5=U_<T-_ND?AC_Q.
M]//Q/&=Z9"YO\P).-U3MLGWU2K2-5HWNG>+.5Z"C/M#Z@UW5T5L%ZG&<CW0G
M?#G<<S[F\Y),G$0RGY=E4);*-/-FD_8RLB23Y]%,@^RQQ)R)1A[JWGX5Y/]!
MF\K?'VGQ[\8)(4@4TY2D, RC%"*>$,A$)B!F/&98Q:$2D9NOMG_ N9D:1S)5
M=A(/+ E^%G-;#Z\_)$=W^%X"X@ 'L!TR?OW!9\:<V#ULA\!;;['E?8,K<C^N
MM15.BY=J!T>K8.A[_;#FS8_C).9A%L TE1@B%61Z:X0DY#*4+ Q5D!#7NMN]
M \Z-;3KR@H[ P$@\D&W.8F['-CZ1')EM+@-Q2"5L*V0\U[ON'W/JJM96"!RI
M76UWW\ L9G/<^H&64A@C3%M@M35E*MX\2&,\?7C97W)'7\R/KDVG],\T+ZKR
M.-=EN7U\JKRP_Y+YPW=MK5T_RX(^R'^NC?=IF6]>OFD;;B%$G&11R& H,(4H
M2%*(>19#A%.)>(!5&$BGA.C)1)\; ^Y*,]/5RI3M^!_]U^>=Q([IU=.] '8D
M.L]I'9F.*XT@,RJ!KMJ@H[?I)-&]KM$=5,I? :-^75,,= "X BT$H,$ [$$
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MTT^NG+(BQYA4.W9[IZD:F0U;K4!'K2MP.'?WW;E[E<Q0MMD,QA9K]?-'H".
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MXW=7K)_S4H]>+E*I22C2%F3,E38C,YE"%J4,*I9('F"E4L86S[)@:UMZ<A/
MY>OJBC'>1_9-/FV+IW5I#DKY=UH\N"8G.<Y P ,NI<B@8":U(DM32(3,H(P#
M&HHPR")&%YOUAB[?&_^]$/__0=]NG1@/TY%7C /!K\!>]&JOU&G4NI?>WYHQ
M##6?JX>C!).N(\/0>;VB#'S*L+7EKNH6).^6^F4S#VZV<9C*C+.0FU.J$*)0
M28A-[FO$2)S%64(SZF3@'A]F;B9M(R78B>E(5"? M".DRR$:W:_P"IT1JC'W
M@^"31TZ,-"E?]&O[FA?.7'U1OL'MCY44AU%"?ZR78A$Q+$.,N,D*11 IAB E
M =6@"LD%DJ$B5G5![8:;&Q_L!09K(_$56.UB\,HZ!J_48H-?\E7S[]/-!(>@
M;^&;](KIR 32@?.VAK,):;S=A30:B;U"."B.WP.4D\?I#X-T: #^&80L ^Q/
M/>4] NC/:'0B0/[<70-(^4;_9UU^*0LJE[_^_8^__Z$G1'[=B+\WUD1 4Q03
MQB#"D?Z/YF'31X-J<D8D#'&FC37[:OAG!IL;(=?B@EI>8 0&E<3 B.S &^<P
MMB!>C\B-3+N]H TY"#J'G@/G>D1Q(L:]$$TWPK6$IY=NSSUC.K*UU.: :FWO
M&;;[O2T>Z*HI+76C-]/K92YJ'^Y*W.FWIGV=;M6N G"5[UOM#7<)*IFBBIE\
MVPSQ%"(9"TA(2" 1&0XC'&*62I?-LA>IYD;=7:6NP(%:E>.JJUC5,GY7<GFO
MFTU:RXCS;+>/GWSV1EX^IIHX9U^!5Z!]NA;\"#:I)\(KEJ\=%WX?[E[RZM-J
MDV]>_O@NETL3_T]7+PL4)1'*2 :Y")$VHB,%28!3F,59R$-,$:56=1*./WYN
MW%M+""H102.C?0FL(_#U,^'EH(Q,:4YX.)7$.JWV!76QCCQTLN)8IQ7J5LCJ
MN6I@%(Y\,%__-_ED>FJ;3G-J73Q6+/%UUZ]&FU>2$?,1QSR!B&#]$7,>P5C%
M,B*2A%$6.$7A6 PZMT^[D1GLA 8=J2_H+&0U 78&D6]81R8'#XBZA^(X0.0U
M%,=FW&E#<1R0>!.*XW+OP..2E9[(EQNZ6E&6EY]^5J9)&_M*$,Y$F*60ICB#
MB&,)*:,8<LU,B0Q8D#KTJ3PSV-QXJ)42M&(Z>O'[<+4\!O&$U@2'()6D>B_U
M&K,ASKASX#D>@'@"<<+CC^%@NA]^6*!S]NBC[QG3'GQ8://FV,/FG@L;6C9-
MT*K=WZX-6O,VIS01$4D3*#6?0A2I%!*%%&0X4IR'5$2<#NI3V3/HW*BV6VUK
M)^K OI%]6-M9=[X1')E^CX(W0B"+"RRCM%_L&_=]NBI:('&R6:+-O>_71W<7
M^GTO^?=5_M];V>FJBI(PD3B3,&1Z@XI$R+5]2# ,LR1-B/X_YM:F9FR!YTMW
MH/,6Z$W9T[;)#]PG3NS5>>>FNKUOA".QSF">)R-E_U/\+AUV;7"?6]/=7IG_
M<GUX;69@C-:\5N,.B0JBJ_73RZ_%^L?F^\VZ>%H7W1Y=$>&*H(A )40"$4XC
MR)!04$69XBF*DRQE]C%!?4/-;76HA74)7ND%TL+5X V>D4FUEA/4@H*.I(-"
M?GI1<PGX\87>5.$^PU%T#/6Q :8_T*?W"1.&^=AH<ACD8W6'GY.DN_4RYR_U
M?_>YQ8G@+)(RA1DQM8(5C2"1*(()E8HIQ+@,K>+<G4:=&Y>V)Q]M^I%K$K<5
MTL/.C"[&;^I#HRM0"PO^;/X<)X7;!:8Q#XZ.#_RN)T>]6)P[.NJ_>6@(RMV6
MZ0=^7J[I9A&E$4IH&,.(, )1R"AD"DNH8D8(37B2Q5:>S*-/GQNS- $7M82@
M$M$U_J2+73^'7(S(R%SA L: X),C2E\<>])]YL2A)T?4>1MY<NRB8>;"AVVI
MMVME>;-^9/FJ,D/*F@86F"@E4YG A*'$5*A&D+&$0YHQ@HB4G!"G\JVGAYK;
MYWO-_WN;E_FF-Y?<%4X[0\ /2"-_T:V0H"OE) ; >7A\KOH]HTVZU)_7^O7Z
M;G''I=57_]CHJ;U]JA[];;U<?EX7/V@AJ@(^>_.7RQ3% 8JAI I#1$,.,28"
MQAD329+I?0ARBUES&W]NS-(I?[3Y+L'-=_U+68)\!1I-AI9-M9L-R\W(>!B/
MO2WI%$:M9&]A!49ZT(@_;I6I8>"-4_C43H1WJG3JA,_ITJ9NCW'?RGQL'&_W
M^M:%DBQA>KL">80TG9$J&54)B,, BTR1,*+6_:.[#YX;3[6R 2.<_=;E *OS
MNY:A"(S,(G;*.VU5CFEZP2[EX'&3;5".*='=FQS]O?L']X6KXGHK<HWF]68C
MR]KE_7E)'Q81%RE6*((!2Q5$0:"_/*Y"R&(<A0$))+5K$-T_S-P^QB\WG[^!
M1E30D1488>T_SAY<SW^J?M :^<,=!I33AWP>APL^ZYZ'3_:1GU>P^\E;7#TP
M4]ETK_E]O5H_27,X8H+;3?.:3S^?Y*J4BU0I++,(099Q4Z\KRR!C>I<1R)#$
MIAQD1)13"G+O<',CA+IM4]XT:JKZ%SKF!_>CRT@2IYQE,$I4 E'&"22,<!BE
M4C%!,>:8+5;RP;09NI\49%*#_&;LOR[6=ELR?^_GR!1<P]65=-=0K!'V-'SN
M&=%6J'A-=>X?<=H<9BOMWR0GV]TUT#MD*@)]H*44)BU2/[!.>RX*X^8PIN&'
ME_TE=_2EJO-H=FO-_NU7?:%IPGLGBWPM?BWTU[; /)$T9)K;56JZB$6FN*SB
MD*HD"V@DN<BL4I='E'%NZ\.7LMQ6Y;37"JP;!XASS;8QY]32#_6^,S6VK\J(
M#IF1'73U QT% 7L!W>L:)4&EY57KW+H"M:;&C5CK:GZBM?7HU1IO*KQZOD80
M<UKOV'@XO_&@C3C4T+KO333"/U;YYOIG7B[2E$:1) %,0BXAPG&D:9\J*"@*
MTI1$*E9.84IO1I@;<^^3L(V$X$\CHV,X_UL4[=CV(FQ&YDHW6 94^3ZANM]"
MWJ\'F;A6]PD=WY;C/G7AI2>&_Z1%;KSR7U;Z4Y+EIHIER&6Y/Y]"*@YQ%*>0
M,D(@BK6M1[, P3"B&8IBB3,^L#GCV;'GQ@3=HZQ6>-!*#UKQAQX7GI\*UZ-"
MKP!/>$QX&MN)C@FM@1OGB/#\\.]T/&B-R^FC0?M'#*2VMFI7&V[1A%66U;*+
MPU@**CB4 :[*U4J(F3)M:E# ]&8VQJ%5>0RKT69'7XUL@TR8?EPMF<D76F-S
MD250[@QC X!73ND=<%H6L=']#6]8W32,*=XVRS+I=M]D*8MG63:-VXF,)1&$
MPIB:K+9,91!G$85$LH3',<$BM0HN<!ET=KSQZ0:T!'X%P@@&Y.I8I[@Z3;;5
MY7P/^.&S8D<WOK$>FW5&@MF9I5QP\TE65N-.REDN2+RF+J=[A[1SKMT_M^J^
MH*N2\KJR:;DI%PC%89:$ E)N:D$G'$/"20#3$"=8Q0AK4\>^A_.I8>;&4AWY
M #<"NK05/HEE/]/X0VAD;FF=U+<*='&Z\8:32\]E'WA-U6AY"&Z.#9;/P='?
M5?GDW1.V4CZGP6'_Y+-77^K3NN;ZW=@N331"=;)J?.F%_"Y79?XLZZ/5K^NR
M?!6'C3+.B4I"2"*EMX8HTY9>JDE4*(XDCD*214ZI-1?*,S=Z[?IG.@J!.KC@
M0*5==,%7]\B,2V?1U44V^MQ,Z#9SFI:)/&D7X3N.=VV82._D<;L(O]->N,L>
M.W$@RJ?_WN:;ER\K4Q.@VOQ7(M]_IZOFV/.?LM2*M,>>_Y+YPW?][^MG6= '
M69V)?M2:[DKK+"*),98!AK' ,42!I)!F<0(#E$2,\#C#S&E3/QO-YK9H?/HI
M"YZ7%3MI?>N("!/U(M;+)2U*\*1)JHJ F2H QON[9+G@S$7>.2U=EP?;U.B
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MP,:L)7\:DU&*"1\9[GWJ )_6^V0)WYY;AM'$KOG%OXI\(S^N?ZP6H<B$BN(
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MU_\GGV<FTA(R2:$BE.@HC&-(6(%@P42J8IZI*+-B]CDI86K15J,D:+4$M9I
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MFM,B1C3.J75;'#N94_NR]WMO5K1)T,J&(Z;:J'X%/OX3?OGDT-+%<@CZG<%
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M9*3YR Z4&317811O%B)+HS-8;95VR.]X#(Q%<FP@G,<ZIMDH#=YTZO\&6@-
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M"BIADBFB]#](43CMQKT4,+7\7$UAWK35\"$,/<#/SCM<@LK _J &I/$&H4E
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M#EE,)$RH=LTTRDE,J%MA\(#C.4Z-L/6(/E92@'(!UG?2C.;#8U,B9$:1&=.
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M90IQ071((7*8$D(@PD0'=DG"(6,,<YI('&>)+1?XX>.G]IUO-33LENXLX$<
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ME^\H+G@F$<_2S,6O.&LP-5_3&0 Z"T!C@@EWUJ"U NR8X>:$W$?(SC$-BOO
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M:*=.!90HY1 EB$",L"&0E$C*/!(Q=MH.]M9D:E- :PC@K25NL;7_@-B%U*/
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MJP)25'.]YHQ'$4M3Y.1C>F1-S;O4NH'$LW[D"):.Y1^7(31:]<956[)Q!5K
M!CCO8H')("461\2]3H7$:;M/%CCTW.+95$U6Q@/5W1\,4R"A*(8B32.(,IY
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M&<RCQ$PI+($L3Q5,9(()4\7_7]Z[]LB-8UNBW^=7$#,7Y[J 8(]$41)U#S!
M.FW7>,;E]+5=71C4AP"?MDY'1N2$(ES._O5#ZA'O!\F@E.I[@>ZRG1DB]UX,
M+6Z2FVNGG+I-*4[=CVV:Z*PW,\36?E@[ +8>;';<?8JR.0Z0Y6S0&^Q],WQ8
MQ-WYV@NXH!SL9L&PO.J%SA%7^K7B7GCLK0[G5\_ORIG\N*Y%ZO(B)0G1F*<X
M32%."@X94@+&1$14%)+D>6%;<.RP\;%Q5V,?, :"QD+[ F-'P%UFG5OAZ'O?
MS1X)IT)BYUR^H8#849.#%0X[Y\QNP;"SGPDM>_!1V]O>!5>*)HG0[RB.4*+_
M8S(D%,\@XC+-91+E+'-*D[#I=&RO\H>#^_83<_LTU*7[':Q9BF41,P73**40
M(ZP@$R*&61YI?DPHSBD/HWC@B?5@H@>SQ?P;U$/[.(3LP<X(V$5WH7'MF7\]
MQ0^VO@RA?W",W# 2"#O]CD0%X1@)>R&$$\_ZS0T/G2;T!ZE7S'](4]!&BKL?
M^J>F?HTY,>]^V>R2(1;Q%&42"J;AQQG%D/*,PUSR-(T2F2?42=S U8"QS1F=
MQ9 V)FO>:FT&,V,TJ-GMW_X+07'\[V"KF%[_TO'@QGFP[&BNSR'HF?(VIH/:
MO GHK >M^6!C?_.)P-N.OM"%Y#QG&P;E/U^$#KG0NQW?,^?Y-]/.)_U-_:[;
MO%\\/I8KLYOXH9S+]ROY6$UQ0GA"$8(\2[D.XWBD0^8XA41Q7$2Y(@5W"IDM
M^AP;^WW8Q&^=T6!K-?C3V UJPQTWZVS@MSVK#@IJSWP6 $^/DVMKA,(>85_O
M=N"S;&L<C@^U[1_M7UW6K"]CQ;F$$9/*U-M@D$BB5_52+S@3FJ34KJZ?3^?C
M8Z@KZK']B<-.,ZPX([G94TE-#GA"($UEHM\$%A&&%=71\G0NO]'F#.K%AJ-H
MAN/(DO]OCHK=O-'7=[[G"<1>F'=?<%<_-UN+^GI?NQ%SMUHM2[9>U3)=JT6]
M3:";T4[,FHI/^NV55< ] Q_$7TJ-=[P"O.>F**\V;CT*[W2??UTNUD_5YCMV
MNO?&PB\KS4'U03Z=F?VJ+]^E7-W-Q59P9B=E;$?TJL@Y+82$&<L1Q"G-(&68
MPCPB"2,(Q1PIO_/TP7P8V\SY9?WX2)?/%S2[?0_@A_M:N)[BCW*P>YXR-N+L
MC=.[<\$Y3?<F'0#TDDC[@H/13WK!<&Z\4(["X.-T/M%A>%-\EW,_=(^+Y;-)
M26LE)RNY_"&K:8()8U&$82%$KF<R(B#%*H.)4$6!I9(Q2MT6;^>Z&MN$L[&T
M5O]M$DZ7K:VNZX&S\-I&_R% ZSW6[_#:6 D^7\/+(RR_!D78(/QL;P.'W->\
M/@ZPKS[AJ0 [JP=)BNY"U7[N:RMA.HT*B4DF4DT4)(.X4!$L4J$@SR25$>.:
M-YP.YNRZ'1N'[&:D/S7IOZ[BKG9PTR+"!.5,+SB2!.*8:+@C8C9X8B%BRA*"
ML-OMU/" #W-=]=<E;82!C&+0C[;(HUDT?/F]'^CM*#P\G#W3^<G+%-O$]DDG
M5AQ0,=<)HJ RN78]#ZN-ZX3&D2"NV]-!;L(VV8$/ZM.,ED:E7%73#.4%*8P\
MI23(;#EGD(@LAUS$*A.Y3!5SBAZO]CBV":"QT/ /G<WD-_TNU=?COR]F&N;;
M+LJ>@-OV##(@B+V?0-:E&S;&3L 6T:W!O=V;/8]-C]=G3W3ZDK=HSV-PY3+M
MA0?]^.:SU#'M6IH=8].-T4KZHUQ]OU]7*[UR7F[6U^8:@?Z?45::)C*)&,TE
MI#(Q61&%6;]R#K,\YH0+2AAVRHKPL&%TG"17>B%;NS$!3*K%4@+YDY<F.XS^
M=%W<^@R*'4_U#'7/S-5:WQQZ=?:#O[0#H/-@=V^S<\*<?X6CLQL@#$EP/F8,
M2GDWX'1(@K<T%5 $ZFXNWI2SM8X 'U;?Y7)GTW"CD)@4'#%II"A30B%F9FLO
MRA6D*F=1%"G]A],AE:<=8Z/'3<YFET([WT0<B_6J,L*TYH6MXSA'KO0=*3N^
M' #_GCGSK%126[:W]F,":D]V-%3Z$;V\$<[>99<L3'EY829[O*RDFQR:NR6Q
MS>D0YO6STS%/7:-$Y *E!<F@2KA)B4L3R*0IS)@RG'*D$,^E>TI<WV:/C:GW
MCXK!1_U1IY(R P^Z[5G/V(9RT -_JU'T3.8:"M3P:6"]6_X""61#C<;IU+/!
M>O>;AW;*.1[*(VSMVL2'D8Q)%A$)<8$CB$F*8"'C#**8Y9&2JDAS)\%7I]['
M-BMTQM<QX[%VR*[TWO6H,<#@V-%^;Y#WS-Y!T7;F=2_40M*SFP&#LJP7-H=D
MZ=>(NV;+FP5?U^)8\_F:SCY+<_]^&J=IH@I"8)84FM;,M;:"% BJ7"5QEE,2
MIU8;%.<Z&!MS=3:"QDC06&FOWW(2Q,OT$P*:ON-#-U2<M%PNN7Z#GLO)9@?3
M=+GDU*ZNR\7/!3D1WLR!,N-97&09S(DI LV87N^F,H>4&.V1-,XP0C>< X\U
M%#D\O?2..,[AZG7@.\(HP@>H6\]V^PP+SG7UDN>XUZ;Z:Q\/?7/]]?.]7H)]
M6RR?'Y2YD]I]0M2;)5QBI;E!KV'R(H&8\@(6&<I@A&E!>*$2D3D5+?2T8VR,
MTIE:"R5J8S<7LX77SI?OZ-CR3N^8]\Q+_G 'O/=N!=8P=^$OFS*2^_%6>-G?
MF;=K[M:[B6UEPJH66:H5EO22:R.AM55;VEXF,T<'%!$$*<Z99LA<P@)%&61Y
ME(DBRE*2.EVKO\&6L;'DKIRLL7]'@<SWDJ#[^-AQY$"H]\R3NX!W?A@I-^W)
M!#0ZAF9_Z)0DW$"W][S1[><6GKLY+W2;SANW\[?B_)OT(]E/2R/DL'K^I+^R
M9HO_[?]>ET_UPK?=ZZ^F,96%R%@$D<@DQ$)P6$0\A3@J,FYBS:1PRE.^WN78
M*',C\*/?X*?6^@EX,O;7KZ[L/' C4 OL[7@R+*(]T^&G#8"?-@!N#)Z C<GA
MB,X>GI!\9M'KH+1EC\(A.SD\Z4="OTEJMLI-D^_G3^O5IV7)Y=\7,[HJ9^7J
M^3=9"VYG&4DYI1QFF,40<Q/3%4Q GHH8(Y&HN'!:]5KU.C8JVM1DH?7&9/E/
M_=<?&YO=^,<.=CL*"@YFSRRT8R^H#=9T9$P&6YO!GXW5 4,N)Y1"DI%=QX/R
MD1,6AY3D]K#OC8I-L+4M;IRQ-.<T2V NA8 XR0BD F'(,IGP/*(8)4[!T*E.
MQL8YN^L1IS+1%Y&TXY5;\>F91ER@\;B@<-[WL#<03O0S\!6#\YX>WR&X\%F_
M-_V-9)I&JM6R/O)KB@K)!.<D1@)*Q@C$--.KGJPHH$H8SA5&BG&KNB@7^AC;
M>[Z_,]2IFQK#P=9RSY).IR"V8X ;@1MP<^<&S)RYX0(J(:GA5#>#,L,%/P^)
MX=)'/=<EY7RQU.%$)Z XS7&JBD*D,$4FE] H2+-"8!BEDHJ(:9803MO*AQV,
MC1$^+N9P5TFR;.UTO-ISA*/EFN(&=/I^[5<+_H_VHOK_76]?Z/7"X#*<YP *
MNG(X[&/81<(9#X_6 ^<^=T.!XB-AB./2E:\/2U<VWX0=YJ^OXGS]3N</31W+
M6H&E>C__))?E0AQHX]>_?$-7<E,!<YJ+1(@XHY D0IHKVAP24_!)D4(F"24I
ME8ES/>,Q>#8VJJLME**N=BST&TN7%7B2R^8JHT_EXS& [%(H>0SVCHGA;Z^K
MW$X+NW%@<SMSI0$"#UV9Y08C/;>"!J43E5'JCP #U4ZQYL 5F<<T_L$+.(_"
MN>'K/8_"[7-GGJ,ST+-DHUS=T^K[I^7B1RFD>/W\>V7*MAJ-P5I?[8ZORA_E
MJMRYLA[E&5.Q--L*9AG!J":02.J9G2J)!94D84XG&>XFC&WVW9@*Z,96QUJ"
M[L-@-SGV"V[/LYB1LS'6@\Y\,V6],A[H^>87L(5]ZT4OZ<7^( 8M.>ANQ; %
M"+U1.BI'Z-]2F"/<SV7UCW=+*;L%V6?-N.V!(N%%K 0N8$ICI)<TJ8($D0AR
MCO)4% IED=/]?ONNQ\9Z1VHJ2VTZ5-KVS4X+6&KK;SO6O3 4?F>[80 >_H#7
MV V,X9NM&&!,'^"<]SIB?1[V7NC]14]\KZ-R[=C7H@4W.M/^S*?'8><V*/U0
M4F:.F#5S?I&KU4R*:9(+3 @CD*69@#A7&60Z@(,,TP1%6.4D0PZEHSQ,L'KM
M7J!RU-904#66VC&9SRA<IK*^0!UR+^+U>;GA7:2_](VT:*]&UNNUET)\SXA_
M$>2MIY$;L&OF$=- /3O$J)T;?)H<9'*XP==N=KBEB;$J87W8EJY5*I$(,QTN
MTU1/+U$$22$XC&041S)E(LZC<<EA?1AK"=RVXM[&=R.@5WL/:O?K5.0M 'LB
M>GK9[%-\Z8-O5=TAOV%VJX"1?F]ZGGK'^949H<;7T>#]:PE]?7B90L8O,"[#
M2WX=F^!Y*M]4.7Q0C<E?Z<^W/^EC.6]ZV5XNC K".28<YD04$#,I3):.@@62
M/,,X%:APVF"R['=LL]U.4<B6Q;3E8-=TQU-M2_@MSYS#@]KW*NPJGOU>UW0#
M+.@1JF77PQYPNN%Q=/SH^+C'/M*):YNOZXH"=YPOUV8_OMFUNE\OEYIYIWD:
MZV _-F(>C$),1 8+'BF(XB01A9 XR6,;WO+I?&SDU9H%GMH2U_JEF]57I9<;
M=S;U&6CCT6;/W&'KPW6(+':9>@2^9X([=0-=Q[L-R*WUFZWS"6@=Z!%MAYVF
M'E$?:*LI,/INFTV>\%W<;7)M<[CM)D]O]_:;?-OP5(K20?BW^@MH O5UHYG-
M<I3G/.&0X3K.+5+(LJB /"*$)U&4\<*I1L6I3L8V+VQM!(V1?M).I^"TBUMO
M!:EG#G?&QUV+Z0( 08663O4SK(K2!4^/))(N?=8C=KS70>AZ9E(UOLCECY++
M:F<_NSV]1XJR6+$"(H9RB*.(0,KC'&92XCA!"E-I=1O%ML.Q<<'69-#9O'LX
MXQ"8V*!M$?H%QK!GJK@"W_6T"#\<'8*ZP'@.%,CY?BW=(C8';"Y&:3;M#!>9
M.7BU%XVY/.>3$2+G55EGS#W?S>GLN2JK!W5/E\MGW6.=1/Q1KAKE[_>/^FNQ
M>E!Q]$GJ+]1\=?_=V/%^_O8GK_]F<E2FF8AE5.0*I@DN3.U7H1?]:0$CA2C%
M+%=98A6Z]6+=V'B^,=IL :SDW%S*,8:#QEYS;4*VMCODRO4SJC8Y*"\X5GWO
MCVY= YUOX$&!SKOFULH$F)SDQL,):(=6?RJ.0.LF:/S4:UW0>5KGZ;WDR+KD
MO+S@" ^5%?-2(^V80=/32%S.L0G=Z8!9.#WAM9^GTU<GWID\2TDK^48V?[Z?
M=PJ,VWV=*8D)EB0U.RL"Z846X9#QE$&<1I)$C&0HY0X9GBY]CS2ULS-T9SO>
M.;_E.N[6B2EA8!PLHZ0V$[SJ#/[%!#$;1"WD>'W2/ZPA"IRW<;W?H1,NK)$X
MD2EA_ZQGBD.7AM&=2][-Z^N12_G=\.8/V?ZTN\*&>":EGH&@2'@&L8P()%%"
M84&QN4J3(4*LC@P]^Q_;2F%COEDL[-G='=G[%AEQ'1C+)(C^X.X[V ^!M'L.
MA!]>07,A'$T8-B?"#Y^CW C/9CPEJ)M\;1T&UJHZ[ZMJ;3+0[A?5JC)[W'DA
M4 8+$W5AEIBKTE1 RM*())E,I*1=Z&5'<9>Z\XBV^F8TD]8.RM9(P!?.XDL7
MX65YD2.A&)0BRB'.A)X_N(QA4>0)3446Y47FI.U]*[A#3A;]0FLW X0"K&>Z
M[\PT;%\;"CI+P?U%W-S%NBT "2K3?:F_806Z+3P_DN:V><9CP_OAU]?W[7E-
MG$LJ\S@W57,5Q%0JR!#-88JHY$64:.:PSTK;MCLV-C"6.>PP[@!DL>OKYW;/
M[[0QRN>0;\=UAVU1/P@&VM"\./ANFX['?E[<+MSY^' ;?<<V[FW1G?BU7V1W
M;VR9KYIK .:N]H[\L\(J9A3'4$FCYD]CJ@,[EID3L%RO:C&-$NX2>5SH:VQ4
MLV=JHTI@C/44U[X$LET,$@BZGNG*&S7G$,0"CY 1R*7N!@U +/P^C#]L'O$(
M/]Y()9=+*;[2GSMW=S^4NJ]*5M,\R1).LP(6.:80QU(O#U$1PSR/D,IH'B<%
M<U5<N-SE2+?A6_,<)N\KR%K$,@& &J@V=FMH?4UGQU1S:;\Q-AQN#H%0./P&
M"HYNP-$M=+)#YF(X=:6)X4(L.U_VPB[+1WP3R#<MWLW%KGQU(Z<XY1G*,U-)
M.(KU6@_G'$.6"/U/E@HN4\QSHN.QQ8K.[.*Q:QTZ!66;;OO[EG\U?8#9CIR'
MN=I=J_^V=O_;?R$HSO^]KO;F6FKI*OQVD5I(4'MFWP\'2+Z]C)I'&KH=%&%3
MTJ_T.7!ZNAT"QZGJEL]YZJ&NS<KQ0;U>5^5<5IJZ[KAN5Q/;% D6X90A2/)<
MQVV"85B0)(8,92HM5*S_[U0\Z7Q78UOR-9::W=-%<RU^_@U4:U:5HJ3+^A5I
M#7<4/3V/M1VAA$&P9RK9@K<U$]Q= \Q=H_0J%D&U2,_W-JSFZ%6OC[1%KS_A
M&:,LJNJ^EH_X)N>\CGTZB9I4);F0(H8JQD8V.<HAU:M B'(4$\(X3:13-:;S
M78V-.8RE8,_4&U2%+B!L&8 $P:WOT,,3,O<8Y"H:0:./\[T-&W=<]?HHXKC^
MQ&V;1$V^:%T :N\,-A4Q4TABF+ "F=+5#%*.,YC&)$(ZY,CBS&J3V;*_L7''
M9N6N-G?+'4ZY;4%VVS,* -V0^T9=^GI3T<WNS-L+1;\=I !HOL0ND@^JWGM)
M5S"RW4\ZU\R+["E=\>G<OM*UQ_SBMCNNOT'KF=GTKDMQG$@5,S/ 1[EZ4-J(
M*<(*%5%*8,1X#K'4:T$:4P19G.>((2D4<UH&.O8_-I;>,1\LZOI ?"^?LJP]
M< OT7(?$+OKK$>B>.7T7XZ8&T\F<U5?&_%^:BTMZN:E]"!<L>H(7,H)T-6'0
ML-(3G\-8T[>96X2 =3M;=<2M$![A2!(48R@95D:Y5T(F,@JE**A"*4E(3MV5
M>T]W-C92VRKDN1;RN0BI'4^% JIG4MI1$=P:"O[L13W0!I+PBJUG^GL!B=7+
MGI_61+WRS,T'<:8^;*MTEB:8XB)B9C^<0\QS!*G,.%1)E"<R225F3H6%3_8R
M-HZHJPNW.G\[!V_>)VL[>#H?I_FA--P9V@1L+>SE$.T8@)Y.SG8Z>JGCLF-?
M+YR1G?BP;S9DI6..7Q<+49^[M3HE7Q8S\4;J$(67S=(_1I'D>53 7 <+F@HR
M 4D>Z[]E/-(,@3EB3JIN=MV.C1MV;0/RIZD/6:^$9FM1*WTV&UDF2*_HS)4S
M+$?"CD3"X]LSJQB#S=;+UKB0J9,N8(3-HK3J>>"$2A<TCG,KG9[V(Z6'[CCZ
M@[G1;+J<YE0P'L=$QR(9AIC0&%)D5"9SF;(HS522.-TI/NYB;&2SL1#,ZIOY
MAEO<&.4$C';L<1LX/3/%%I?:NDF]0QN.+,[['I(83O0R* F<]_+PA;_P2;^7
MNSNAOU\\LE;9_+/DBV_S\I]2O!<ZI"E5:50+FGWA[AC?4,Y?Y6RF66<W5ZBJ
MUH]2?)2KJ8HSSA+$85'H. 6+2$&2)IHP$DGC@BE,$Z=<P9[L=**9 5(,S:XB
MK3WP3/?I:SSMJ&H$H]0SWW4>@AT7)V#K)-CULCW$VB0B34#GZ:1.>-Q-@&R]
MK3>6P_%GSP,2DH3[,G50)N\9[\/IH._N/-,[%RNYHW=CZ$/&*%%9D4-&H@AB
M)1@D*DTAYR3%<2%I2A.7Z>"XB[$Q>9LL?E"0PC%W\QA(.QZ^#9Z>*?1T%0.J
M=!@/[F:SQ5_U2;]:+,&]_JZ6*V .8P+F<)[%)FCNYG$OP^9LGO7R*%?S_"?]
M7O]?Y5P'J;.Z,MAC.2^K^N[?#_FVV:*9QHK2(C;)5GFA0T.5)[!00L&($(DS
M*;G^@,OB\4I_8UM)MN;6 0#=,]B-'*[!C'B.]**<Z46YT0^.,@29J1Q$>41Q
M5J1Q7& 7R@T)\U#\&Q91.^X-B%//1+S[3=RW%;3&AF-=2U1"4O"U+@?E8TO_
M#\G9]C'/K"P='XIRMC8M?I%\O:SCP+<_FRWT=]H)DQJQ;O+^'M1;NISK:;OZ
M))>U,-+=HU$VG*(4*X80AAD2B1$8C"#%20PC+A&*2!HER"GQ/HA58V/])ARD
MVC78^0:JC7/@53EO+A)6OSAF<0490CMF&WQ@>N:_77_ UB'0>03,:PQV?#)G
M29U71J :U'Y-0.-9P#RPD$ 'S0X+8MBP.6,AL3S*) O:N.>9<7/RO%.CLIX:
M7NN90Y6:G8LL3XH8P;06PL@R!FG*4ZA2*A&E5*B$.)T57^QNE+3K>/)[&4_+
M$]]@*/5]TMLFU^R5JVV.TE^UUIZ?D=S/?JU@"7KF>[G'8<]ZK;P_.N.U>\KC
M=M1;I21?;7)>==M&+=]L(,YY.6O.CDUO?&5J%>YW;S[U0RZ?VP BE5QQ+@J(
MTD3'@'&"((U2O>),4<9B+'*28>M;5.'L&AL==5:W"?M@I5^W+G/E%;OVNO4Z
M@I=Y[07'I6<"W#BU2X'&+[#OV 1L!N\45W;^_7(U&NQU%!VNB+W,: YTE6SP
M476[>A8>^XM7U )V-]Q5MO 8[5UYZZ%YS_0J<P7%9)#2ZGO34;??2)&>-WFD
MPQJL>'MH)E,*TT@6/)-8A^_"HZ;,V0ZMWN/A%>R:RUASDPFN+=Y11Z&\+3"U
MF4*;:=5Q"^7\ -C%^K?A.5":5HUA:^3F*EMK9\  _RH60=.VSG8V;/;6-9^/
MDKBN/N#')._*>;F2'S2GF=+B>OC+[N3_]TJJ]>Q#J>04B41P(DPQ299"G*81
M+!@KH(A1H62!)6%RJLF-+6SYQ*9;EU=AM_/^WHBMJ6W"U02L:W/!3-OKQB!6
MP+,B2>-"KXD20O02260Q+&BD($9ID1'$BT@X76D.#?L0ZY\_9/GMNPFVJ!YD
M^DU#_[A8KLI_-KNKFMC+A:CWPI\E7;INA5N-@AVEA\:V_XP*;2ZL[04[7^S:
MX@EH; 8?+GVOG9G>!:*0I&_5[Z#\[X+$X53@]*S?K- H]IE]Z,5<+[PZ;?4D
MSO-(*)C'"D&,TPSJ<+. +$_B@K.$1S)W8:.3O8R-?AHCP<9*3SGUTXC:,<O-
M./6]'>(,D3-S7(0@)%6<[FA0;KCHZR$97/[P+6__;W+U?:$9YH>L5F;WY<OZ
M\9$N39)HFXQ'9^_G:K%\K"?B386ZC.I%)E<$BL34=:EC16S2M2@74F:QB*C3
M-9];C!DIES3.@*TW$[#U!VP< CL>>1<8O&DL7>BI_Q$:AL5Z&AQ/QKL-U?#$
MZ&G/"_#G;<B=IMD;VPS)QF8K8#&O%K-2T'JWT?Q"RKN?935-6<R8PA@J0@G$
M!:*0*,4@I;$L!**I1.QV"KY@P;\.[QXX 3HO]"NM_0C"M9=&ZA:"#83_B[&J
M+_2!F-0"OO[I\Y(1(^!,"XSLB-*F(<^+ \M%57U:+DR:39S3*%<Y@53$'.*$
MQ9#4D6A<1))$(LU-VI)#]OJV;2=&&R!3O38-/-6V@5<S(R_GF+>^@ULF:5)$
M.(<Y97J^B'7<3A!",$^X2 25&:..V[N>R VSB[N+G3]H=M3M"43/I-P@\.DR
M N[I^L>^!DW-WVE^V#3\8[^.4NY/?,2S:O72G%6NGC_I 5O=S87ATZ>:0J4F
M.)DF-!,<"I*G$&<)A52J#"J>1KD4G$F)W5[42]V-[\WMK)V )V-O?0E%=A8[
MUEB^A'.11PSE10[37$\?6!(.BY@S&%%&<X$)B;!TF4A"H3S$S/*:SNJ[E+16
M07HC>5VQ$R1Q0'Q%(1,E]!>7,*3Q):B E! $5<&3/(IC7F1.&\G!\!U@+3+4
M=]AN?@J%7,\3UA:T3QO0-J8&EC^P@21HI?!+_0U;*=S"\Z-*X3;/^(K@ZO=1
MKQ/VTAWT2F*3S&.^YCHVQ3B-,8R0V>O(B9X2\PQ!')$H9SQ3!&=N8KC7.QT;
MI70VMQG"$S"_\#[X0TVD+$@2$<@(QQ"K*(%,*@6+B.<T09)DU.ER<'"H!Y@=
M#Z &K]HTLE_Z CW54V*1Y QF5 H=\F$!29T0DN,\S66>ZB5OE\\W,.S[67U#
M 7^8M]<7\';S9^CO<,_SZ ;%PVR^>CMN8W3@&=4%I+!BT1;]#BP:;8_$L7BT
MP[.>(M*F[)JL9>+>R(HORR=SCO'52'Q,XP)E.1*1YOR(0\R0CMX%I9"G,<DD
M$YF(I9.4]/F^QC:_-J9..K7"'7/!G[7!KN72+L!L1SN!P.N9;6[ S5UR^CHB
M086G+W0WK/ST=;^/1*@M'O'CCZVL_8,R*2F:H5I]L;IP1ET4J+[$_%KW+3[1
M9[-0J+9E&!(=22J6<*B(BLT&OF8;'?_4<O5(<2QSXK0O<*,]8^.AVE3(C*V@
M,]:->6X=(#MV&A#VGAGL!.+@;KG4'Y'UW_LIJA$(OY!\=ZM)@W)B(/P.>3-4
MLYX"B7*U+3,TU>%7K)?B!$H9FQUJKB"-4_U/(=,D$HQG4>&DC;C;^M@6W?=+
M'>56X-?E8OWD*(:X!YH=>WE#T3,7&9G?O7IBX&ZU6I9LO:IE8U<+S5!ARWB<
M1"*HX.%>!\-J'9[R[4CF\.2'O$MZ+9N0J_GS_7RCRWU/GTK]%FW2+A61-.4R
M@1%+<XB)7F^12"&H\H1RQG&4,"MA!/>NQQ;Q=):#5YWMOY@B'5L!^=9^[_18
MAU&QW1#J ^O>MX7"P>Q30LP1L< %Q6Q['[J\F",J)XJ-N;;@QVQ?^'<IUC,=
M%?V=+FOEZ&ZKZNU\58M;-5L;B,2<9W$!<2X0Q%G,ZZ,#B!@S]QP)38536JIE
MOV/CM,YL<[S>&0XV&[.=Z7X[2[9#8<=E/0#<]WHM#+;.'.:(5$@"L^UZ4/9R
MQ..0NEP?]TRUZE9HB]_*^6)9KI[KU=OWQ4RW44V36.8%B03,"*)ZB85R6"0%
M@DS$*8[C+-%++[>3M\L=CN_,[4[\J%.!]-*B5M)8S%>Z]YD)",IV/!SWGZY
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M,%YPHBE10149]8](,4B$CCAC1I5 19'%TDJ,T;[+L?%B9[2#$(4=M)?YK!_
M>J:OSE[0&@PV%H/69!]=#SLX'50]@L,ZD*9'"'C=!#V<D+HHYV'7TG!B'DZ>
M[4EYN#WIJ9)K-D(?5)MB9&ZF+68E?V[^NPV)",LC';9&4&6H@#A/,D@QC2"/
MLB2.<)3AQ&E#TJ[;L3%T;;6)6Y]TJ]U;Z*B.:X>W70@:'L6>:7L#X-;D"6C,
M!7^V?_829;HA%50TUZ[G895SG= XDL]U>]JW@)JI]/B5_MP_DJG+(=R)_UAW
MI7IP$4F>ZP5U;FZ@82XT,0E)(,\C11!+4X2=5(8L^QT;,]7VN=9/LT/8CHIZ
MP*UG+GJKE.3UX7E;Q-;41_I,5_+H)+PIBK+CQ<1D :Y#YO<YPA>V\II=UP.7
M8'/"X[@6F]OC?AQU4*WVX]K$8P^JN=7_L%Y5*SH7[6$SGZ*$I(C%>D6;YRG$
MRC"5S#$L6!$S3'(DN' [37'J?WQ'*+59_JH@;NBG>2HSPF/(4FP"V A#2@B!
M12PBFN4DQJE3Q<W>L!]DIZ&K[4W;VM[SVGP3F.GWYG'1C0A8;!T9:J#LIIO>
MX.][W^*PJOK'#?*M6,Z.\9,Z78N'FV6\4 LYU[@9,.B,XX7-X;SCUXBG$I5I
M5#<DA=D/D/.JGN+NEDO]?9-F>GO]O/U(>Z9R]Q==BDW*U%U5K1^?ZE2#SV7U
MCW=+*=_/-?_(:F7BH"G.:20X$3#C1,]8"2:0LB35@TL103E+D]Q-Q*IOB\?&
ML\9&J$P%F+*U$BRUF8[J5[V/LQWECFKT>J;IVA'(C"=@UUNPXRY@SV#W<ZW+
MH/9Y K;)NF#'[PDPG@/C.NA\KQ<= 76[AAJGH))?O1L]K%K84&-P)#0V6,=N
MDU:U7$T?_IIKSOU>/MW]+*MIG*41Q44&,:888I8@6"C*(=%S#BH48SRWTMXX
M:GELD\#&./"G,<_R/.H8L,LL?1,,/;.I-0+67'?6VPN<I)_9X2/]KT,N.FYT
M$,XXZTOW;I__@%_@>*]?[<6L%#4U_)TNRR;_O7G'W\Y7Y:K=RYVJ3'(640DS
M(LT[2B)((H5A1(CB>::HDDY5RJQ['ML[W-FZC>.DL;;4Z[57__GO[]_^9\<E
ML?T0V,5FO0#;,ROLV3P!&X@W85%C]S#G0\X A@Q^[#L?-(AQQN0P&'%O($""
M>W-91Z^Q3R:%-@*)'S4 ;6'E-&)QE%$&121U+()$"DEJ=.7C5"D<"\UQQ%$"
MS->6L9%>7<5+=_38IK4#/M-_*55I-@XK('8SL!<;::0;DM\=A\Z.&@<:D)[)
M\C %?N/(V43X3K!UZTY/&?!^F/:6!.]HSLOEP?OA=C$5WK-)SVSX157=UYU\
MDW.N0Z$Z8W2*,$M9AA!DD2H@5K%>TD7FYA#.,Q)C*5CL1*BGNQD?5U85V#.S
M39IVO*5X!E0[JKL=JIY9S ,E]WSRBR $31D_W=.P6>$7O3U*_+[\:4_M0CW$
M'_6@MQ6I<KTH5*K(=!A5"(AS7$!&40$EQU%4Q"J2;FK0^\V/[;TWU@%CGF^)
MKWWP[-YS?TAZ?K\=T'"7$3SI=%#AP/T>AI4*/.G=D3C@Z4^YO;="EM-F\?6'
MG,W^YWSQU_R+I-5B+D5=AF(Y%6E$$\ESR&FB(*;45(Q #&;F%YRA5&96VSY7
M>QK;V]P8"XRU\!_&7-#9VU17L<RPNX[PY?<\*&X]O_+^D%DS@#4<6S*H.C:H
M)/_;M\6/_ZK;:(A _^7P_;_>_B!48.UFQPKV#_BJE/R0>@'Q3EMH@@:C1/!'
MN?I^OZY6BT>YW":KZZ<+292$-&$IQ$6N(--, =,X+E*)(I4IIRG?MN.QT4=K
M=P7,H(+.] K\I8T'G?6.&R36@V 7.O0!;<\,TYJ\#^H^ICW5@7 %*ZRRB67?
M RN<N"%RK'3B^+P?<QGQ3"/[M/J^$*9&:9/NNSE#^R3U5W.^HM_DE(H\C3G.
MH8KB'&+&!*1%QB!C$<Y$D@DD$Q?JLNYY;-RU/:/MCKC<>,H><CNBZ@7(OF.A
MVF;0& VV5D_ %MVMX>%XRAFKD$1EW_F@3.6,R2%5N3?@<36^N8L@1:<K]UJJ
MQ7)S1/:5_I35KGCP@6;P-&>*Y3Q3L,B:\_D<$AX1F$4944RA++*[_!3 EK'Q
M6><->/OZ_=<W=PZ7P&\<D\OT-C#2/1/>%N36$]"XLCG#GX#:F\F>HCJX.Y!1
M'VYP'*[N#S=( ]WI[WNPW.[[AX'WHA# C5T,IQ 0!HL]Z8! 37I,:29KP"0-
M?-+?V^^TDO>+Q\>RGCM_TQ'_]]GS.REWHL%4I2I)I;D+ARC$>2QAP1("59S$
M>90FD2RL[F5Y]#VV*:NU$2BCR_2T,=/<#1*E'JJF#GTY;_]AE&M++@%?5+:2
M@SX#9#&?]0=[[^>1789+9SK8VCX!W8"\,P-B$;C?C+7#]-0?Y@--1X&Q=YM]
M_-"[.-LX-CG<[.+GZ]YLXMF$9WHRK;[K^<C\8=9@/^C,7-4^%$A)$FX*3>4P
M0J:<1$X0I&F$8,R%I$6&,*9.>\Y6O8YMQC#6UI,"-W^16[OK'U;?]8S>O&+E
M9@'KN/UL-QAV6SK!(>YY=MB@6_]EQ^2!4I)=X J:CFS5\;"IR"Y8'*4A.SWL
M*U?3%J8\?#72-&;4J VDR AGH13!(LT11%@A%O$T)]CI#NVYCL9&31L[745I
MSN!H1S$AT.F9538F#L,BUQ )JR1SIJ^!I6,N>WRL%7/E\S<*6+6U55_+N53E
M:JH(1@K% LK$")$H$[A@DD :(\0995'&(B_!JOU^QL<'M<;2BOX$LC'44ZWJ
M ,X\51HXH?E5)A+BF"A(HRB"69:SG$2XD"QW4]4) .@P^CE]01JQ(BGBF,)4
M12G$,B60(3UET8+$&>989GD\72U6=#;<-W33VY!P@E=+R1=Z,)]_F8"Y=#P1
M/0>O[4QV,VB]3V0;U;1-^>C6RH#5HZ_@T(L0VD%7+R-\=MK?LT)G9S[NOP0_
M")<_Z_7CLN0K*=IP>O\'.Y^<2HY4AI6$,44,XH0P6/ XAS'CA41Z;:[_,7V2
MRW(AOJSH<F6_0/>VR>6U.;3L!9;O$\#DMW)N=NYKM=G:(O>%N_\0<L(CEA8*
MIE@I/:LB!1G3XY@4@DJ1B0P3U [AV[D8Y0!V=KW(\$G]TQ<9./N=F$&&8H =
MFLF)[9FM[6 S2(<_VWD@[)[-S<"&WLOQ-VCP/9Z;L3NU]W-[HQ['H+_JB7A)
M9^9@53R6\])4<C-BL^T\71V4G!%Y$LF8(T.XD29<%D-"<PP5DU@50D1%9'5K
MTJ/OL:T4O_#O4JQG];EGZTG] N_[TL6<+B>?CF-B<?+9'](],V<'[-UY8%VJ
M_MS^_;<_^>P/\X%./@-C[W;RZ8?>Q9-/QR:'._GT\W7OY-.S"<^;M$LCH[%Z
M-M?\5KI+,Q4]F2_DX6:XXBS2BRD*$V*DI!F*(8M0!F.4)BCA*D%%ZG3'UK+C
ML4T5G=T3\&0L!_]&'Y_^O8[$:^L=K^+:HF\78_>!:<^3PA;.VNAZUMV8/<QQ
MA2MJ0>__VO8][,U@1T2.[@R[/N_)76W1QJ^+.ZY[6,K?Z/(?<F7H\8LINEZ+
MI4TS(9*BB"BD!<(0\R*%-$]2&&5Q3-.LP(S+Z5Q^,^60OSKPETWG5B]:T;QH
M1R;T^M)Q*45[:?#54Y<,M5"_G,G@\-B+MAL=2V(+!O9 K-:5$UTM0&LQV)H,
MMC8'9#$7B()2F%7'P_*7"Q9'Y.7T<,C+@I\EG97_E,)4$#:R*0_S3FEIFC',
MA<HDQ"1%>JT>I;"(5 )3@G*"<*X2ZE32U]6 L45AQD)3:UMT&F5ZX;ZH2^9X
MIYTYCPF1.B9F5$ 5XP3BHN"0,<5@@2*),=: 1*2;6%YP5/:GE_\?C OG7&*A
M.$0,"8A%9NK=$ 1S6L01BGD<Y\ACPA]@<(:8^YMB]=^Z8O4O.5!V<W^?5-5S
M&'#^<FYG/JA?F%?&@WHX.B?ZOJA[';[^[^M>L&$$UW:O(V1W>]>B'=]D+R%5
M.2]7\D/Y0^H>5_JK5^HHI=%<_(W^QV)Y;]13=X72LB)72E#($THAIDEBMOP3
MF*51I+C /,+"+1',V8:Q11);%^#,^ "V3FST3&L_0.W(+<)K/B-FQY$]CT//
M--G/$'BD_7B#&#8ER-V,@=.%O'$Z3B7R;\I707;^[>O):T6-ZFG&DQCE>0$+
M3C#$41I#%E,.XTCH4#_1,63D5+/O2G]C8\.+-^1\Y64O(V['< %Q[)G-;H/0
M0WO6"IBP(K27NQQ8C=;*_V-96KO'W'4N/^@AFWWZOIBWI?BF,2$13P6&F2@B
MB$DB($VR',8RRW.>)XH3JZI#IQH?'W]H^T!M8%MFTEZ^\@BXR\QP*QR]TX U
M$DZJE.=<OD&(\JC)P;0GSSFS*S=Y]C-^ <#O<T5_+);F)?\LOZUG!NKG.V[2
M+WZ3]=<.%6F1$/V^*LX+B)E,8!$E!<PP$;%$29%F3FKR5WL<VTN\8S#86@P:
MD]TF_^MHVTW_03'L^<V_"!_XL[$W8 1@C4W(&.!ZIX-& =88',8!]@\&.J-^
MO:[*N=3+F^K7Y:*JICFBE."8Z\" :;:1G,"B8'KID=(XEU2O1C+IE%=SI<.Q
MD<WN42EMCTK9QN0;CYP/P?8\;;X!PA<X:-Y:.P&UO3T>,I]!IM?SY<,^7_9H
M^0P"5T^5SSWG68Y,+LL?=9;@^WFU6M8II=7=7/QW*;Z5\V^&T'[4!]>F2L]L
M4:V7\HY5M1CN-,DSFA<DA4HFFG?BV&P*$Z._GS.2IVF<(J?;P3?8,C9RVKH"
M=GRID]1:;\#6';#U!_S9>>2X67++.-J1VT"CTS/O]3DP[J7);H<T:&FR&\P9
MMC39[;@=E28+T*1[E>G[]:.)'$V.ME*2KS[5=_ >U)U8U%6MV[,<FF."LKB
M><JQ.7W+8<&H@D(H5<11@;C,;,M/VW4Y-C[=6@T:LVN=-6VX23_H3'<\77,8
M@,L,V0^L/1-A($2=JF"[@71K>6S+W@:KF^WF_6Y!;<<G_2+!+]^I#BYI)<7]
MXM%<&&G$5O^B2_%U2>?\NWR8RW;O!2<<22$P1*G,-2%Q! L<,2ACF1N=J*S@
MR"7R<^A[;,Q4FPZ9L1VTL3JX6VJCO\DF8Z=U &@/W$(ZEP&Q"^%Z@KEGIG)!
MN(==,@_00@9E+MT/&H1YX'(8=/DTX4=NW:)9]\/*>=W-I^7BW6+Y2-_/E?G#
M_*BM^**)M5EJRR^EAJ+^1U761$M7^I^KM4FLSE(F]?(79HP1H^640,8R!:DL
M$L9$%N?(Z5I;< O'1I1=:20=7K3;=1)4QOKFGXWY0&C[W6@R_-#:D>F+#EC/
ME-OY!G:<T_'A<@%J_\".@R8E=3.P=_L#N^,F,'Y.0.-I.'+N;1!"4GAX(P<E
M^MXP/IP.^NO(4UG*B-7?5=7"%!Z0PA3_>ONS7#TLNT3<[:[ P[(6YECK;I>F
MA,'A-=Q(Q%@4A8 Q$@)BABFDF9XR4I1RE# B46J5RA'>M/%-$T_KI7;![,1Q
M'1]\<SW+"3AJ=A/!RXQ%W]L#QBFP]:JI86C\TJ_0YK;![EZI_O&^<P,I3P='
M/ZBD43CKAM4W"H[JD=A1^!YN/0'[H&>?]ROY6$WS*,]4EL0P3E)EDGF9IFL=
MZZ>*$);A7!6Q4S+OB3[&QKL[!R-_&B-!;:7W*=062]?3)2^$ACLUL@+GAI.@
M(_?[.>'9=O-")S='?IX_D3G^J.<.9RO6]:"N7!\XT'M".$D2G LC"AIK-D *
M%CG*]7^$0E%&XQ2[[7;ZV3$VQMC5/MNYB?/A]$T<Q[U/SZ&RW ?M?P#ZWA-U
MPKX7A:Y 8 ;=*_4T9=A]T]OP.MI#O;$Y#[G(WZ3X3<[OZ9P*O3#G?^O2GR.L
MB$(<$J02B)7"D*41@9HJ,6$XYSA2UK*0I_L8&P4V5H+&3 ?!P3,(7F:O0+CT
MS$Q[D !CXO4S&6N ')07;P=J((5%'\#<9!0O0W%1+O',H\/)(EZV?4_^\,I'
M_6+&CXOYXV(N5W3Y;(ZD*EIG>'=W\C]+OO@V-[?T'^;UKY7^DJ992C/,)<R*
MA.EPL4@@TXM)F/(($\V""296V3K^)HR-)ANMBEFM5;'<V&MD*U:MQ6[1H<>@
MV 6&_4+=,_/N& ]VK)_L285\WH/_ZS7XG:-!?P1#!H(>5@P: _JC=!C^W="2
MKWI(4Y;Y$RW%/7TJ5XU*R92C@A:9U#%?D0F(LSR')$DI+!")"<Z+C*=.E]_.
M]#,V:OLLG[J;%'HIIH>_V:@T)YZSA08<Z%^;P'L"*.?+M30UD1O'ZIQC)5V/
M-\[A;T=P 5#MF<4Z"X$QT=1+V!@Y:860]G.T0\IX7,0FK%3'Z:X&EN.XZ.^Q
MY,;EC_O1R6<Y,]O_G^ARM4M@;=YMAC,91:D.I5**(48X,X6]!$2%4DR'>2E*
MG))L+O8V/FJIC06UM;LSNJ>*T&6H[?@C&( ]L\@-V#GSAA4F(=GC<H>#<HB5
M[X=,8O>0YQ[_:L'_\;ZJ]$S[ICXM;'*E_TYG:UG_[J'.F*[>_I1+7E9ZXE02
M13@M"(RC5 <NN0Y<6*$I)\]%(3#-)&).16^=+1@;[[3V =D9Z+AU[SP"EIOV
M?>+:]W:]L0\TQH/&^O:VQ034#DQ \Y$.^[=7L7??I_?%+^@.O;,1P^[-^V)T
MM"OOW="M1YOOKIP 3)-8HMSPG5&TA5ABO5 K1 8+O5*C1<P*$CFEHMEW/3:B
MVSU$>V=S@.88<#D,BNNY94BH!SRJO!'E&\XF;0'KYSCR:N\O= )IB\KY0T?K
M%CQ5%\NY[N1^*46Y>D=Y.3-"N?1G^;A^?+U8+A=_:6K5BU']F]7SE!4\2G*F
M8!2Q'.(XY9 H&D&!4H*8R#(AG;3N73H?&[>U=@+6&0IX:ZFC"*/+ -BQ6%^P
M]LQCQFS#88WAH+/<*,PV4&^,!_?7H'87:_3 +*ARHTO_P\HX>B!SI.GHT\8-
MV^=S.FMO,7R1RQ\EE^\_?VE/N'DLLCR-%61*I1 G<0R9T'%:$><()4P5190X
M;Z.?[V]LM/7[?%7JT.#+BJZ\-L8O(.NP01X&KR$VRK6EF_M7K:W@E;;VEQXN
MPEI"$WR?_$*7P^^77_?_Y+ZYQ6-^?-)<EM7/WOTLJVF:(I._P6&6< YQD2A(
M18H@38I"Q 5#DCNM[?9:'QM7U,8!8QWXT]CGN#K;1\Z.';SQZ)D+[*%P?NM/
MNASR'=_O8- W^J1OA^_OZ0\%U=C8BAF\?MY^I-4ZJ/MO2H3L2!,]F)([7[_3
M>;N1]'%1GXU*\8<LOWW7?][]D$OZ3?ZJFUZ9&Y'O:+FLMY\^+V:S=XNE:76J
M1(:B5/,%0M3L?2=<4P4O(%)1*E.E$L*=[KF,S+^Q,59G.Z"-\9LM=O"TK&?N
M^__KER :(2_VA;+<QQJ7U2,B\EVMDUUL=@5/ 'L&)S51C"\3T-:.VE6WJU$"
M*PU3=\ P 1ND)F#SM6S! C5:]8U]8/!JCBAZ4< ;Z3=A  &7%W-Q#"(Q+SV^
MED(T+VZF7Y1AFFL<F,T6?U$]4!\VMS$%BO4JP%0!);* &'-FRM3$D B:9HK$
M4N9.:7H7^AK;[+LQ%6QLO>&JZR60[6;!0-#U/"-YH^8\%UC@$9*7+W4W*$=:
M^'W(5S:/^.;C=?FL#ZJN6BS%&\E6TX2)&*>8P31/,HAYG#19,G&!4:28+(@2
M'K51SW1G]?T?O@3JQMJ3N;Y=JJ]K5MYIP*E,,HX0@TD:4[TTDP(6>4Q@I@K)
MXYPF5#HMS6Y!>H3YU&% MB/J -#U3-+[J+4V F-DR#3'BRB$37 \W=7 J8T7
M_3U.:KS\<<\-(_FMJ07[M%B:Q/<=':Q/RX4J5^:6QU:0/RH0(32'*38%PQC'
MD$8*P9AS+I(HR6CLELKHTOO8F.1><\=B5HHZ#[@R!TJ;%V0N5Z"<\\6C[&ZE
MF;L8^M]/2_E=1_]&YV/O]XZ;,DZ#9KEETM=0]+VAT=@--H;O:P<VMG>7TWK9
M8? !+NCZW\F 85?G/M@<K9V]&O&0'?C];U_^]J;4[91\=:^_H*N%>DLK<[C6
M_72A/LJ__M=B^8^_5W^[UX\LJO;LMZ!%G"C%(!=$1Z\HEK"@3$"5R8A)I4B.
MF;4T@;\=8Z-(XPGHC :U+X8>6V^VO]$_TPX!XQ'0+H'&)X?K_#<,W65Z''!
M>B;*V\;"1V/AAD%QT&$89G &TFKH>Y#<=!UNA_:B]L,-S0^G#W$[!GL:$@&:
M\]UW6=%R+L5;NIP;C</V19,I+7(J])Q5Z-D+TXA"FL0%3$6:986(9.H6T9_N
M9FSS4F<ED*V9X!7EO"F"H7]J9(YXN7*,RL\@;+L%<"MNO>\ M)!U%O:0 '89
MA+ ; "=[&GC]?\G;X^7_Q4][A+N?I?AKL1 [PM;M-U9_ 313,P:+""=ZE4]3
M2'BL8(RSE*5QA@H56P>SYWH9'R74=NY*RCN$.F>QM(@N0R#4^\M_!(Y/0'@6
M)8=P+P1: P5S7JBY16C7T+@8?YU]>+CHZIK]>['3U0][7@%:F(H <[.U(.?\
M64=?]S-:/E;ORID4367WJ<HS):42D&.IPZ0TQK#@--=14X02&@D>)5;K>X<^
MQT:0C55FY?&T7C52Q7Q&JPJTN@=F=U/[,'=58K6!WRZ&"@QJSYQJK 4[YD[J
M%5UC,:A-UC^IC0YXR\<>H:"7>RRZ'?9.CST.1U=Y'![U5 24JWM:??^T7/PH
MA12OGW^OS-W'C3;15IIH&N4XQTPBF*<%,V>X.6115L!81A$E-,\((]/58D5G
M=K1DW[43.VT,Z)&=Y IP;3IX:FTW28ROUE6MA_6+_G\G[$2O"SO=.BIV;-4/
MUCV3EH'96 T^[<+\>P=SO_I9[H@%E?RS[WU8J3]G5(XD_MQ;\&.V.G?Q5SF7
M2SJ[FXL[\5C.S:Y74WGTI\F+E-,,%UF2(05S:1*!9)[H=2C)82$R12-2((F<
M+BC:=#JV6*NVV8V?K+"U8Z;0B/7,24WR>6MO?="^;S%H30Y'1"X A:0@JWX'
M)1\7) YIQ^E9/\+Y).="$]@'35[?Z,Y^0Y''D4AQ"C.:)A!G"$.*> Y)G"2*
M1!QSZB3[=Z:?L=%*:R;8VNG&,>?@M*.5 "#US"3'^/2PR7T%AI!\<:ZK02GB
MBK^'K'#MXS?<BV37[U^PP_L7[2V+A_6J6M':LH-[%I^E$14T^@UZ46@R4-9T
M]E4N']%4,LY9QB64+#+;Z'$"J>(1S!'-DBC*TRBS*E?Q@CZ,C<!V7/"XQCCP
M^-NQXLA'M6?&#7 =<7/A< >)$U<.-VB '3B P2/P9<.7&<O@%PH'=F/X2X,O
M,TXG+P:^D"D]20Q4Y^XR;H4.YN*3IH&/FAA:<6B98JPX(OH59RG$>93I];X.
MR%5<X$@B&B/B=&NP#R/'-AGN:G)XZ77W,I(.L]X+CD_/TYK+T(2_TGX#=H/>
M2_>Q<UR7RV] VOF&^"U]^3']ZW55SJ4Y[GIDY;RQQYR]+Z7X++DL?YA[<M7;
M:E4^FK2YW^=\,9M)OC(*G5.:QICF+(&"%@AB+@@D>8H@X;P@+.%9[I98>(LQ
M8V/NSA=S9MXY8^JW-.Z8"E:=/Q,@.X_ >M<E-Z:_:23M&'VH\>F9N3=#<[\[
M-)TGX//NT&R< ;];#8TSTX? -"2CWV3/H,P= KE#A@[2ID>>YKUNAK)%LR^^
M,R&88/Y!W7U;ROJ?4\YSAFB4PR1EY@X2%29'B<*4YW$F4I$@(JW3-BT['1NS
M[ID-Z-;N"=#=/YKL)=K9[I"X:#L$EZFR+V![IL1]3.]V,35&@P<%[GK$U"$W
MM =L!TH5#8*Q6^JH(U@7,TEMVQHNL=31N[T\4]=G/3B]/OO\*%>-D/V'DC*C
M"6V2AU2"2<(3 7EA\DMQ1B%-DP(F!1$\B@J>VU7/N-S-V'B[.<,WV45MI897
M.\9:WL.Y JP%-P>!:Y!LAUZ1<F#<((@-Q+&>R+FQZE5 +O+H^:>'8\ZK'NQQ
MY?5/#RQDNU_WR(3D!_OB746D3T81=9HI%(NL(#!G10*QRC)(XC2&%.%(1IE
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M$9K&C3V;P$Q_'.^DP+9M=*\CR7!IDT=S0#U'<^ U(RXG3WS*BKMD&*\SX?Y
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M!A4/N.=<("E1E&=VB7C&&7$\! ,4(LKUV)[O_C"MV5]K;)@.I,1V47J^#S_
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MW1P<*K\C7"@ =TQX3QRZ&T0:!\3Q0$FRU-+DDF?*UC!KQ[A0^-%]\H1Z0ZU
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MT7^'*GDQM,0;@,W#+L/;JT8RVCO0C@>BRIAIR:,E3IE2XFU8BLD[8:K<LOZ
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M&SU53=>I:K>;(P4^^W;Y[0QB%EYHVB.9F$QC$"S$4,@&-3I:$R1/P[K3'$C
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M44F8%!]V#QP'*/?)F/9YL358CF!Y!X#Y_7(YGUW4"M$Z.OVO^JO5]4YDSEP
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MP^'J>C/Y+ FTT7/'+$9'U[(WM4U[838JPS5@$M"JJNT)LJ9MPS:]#36BT#J
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M-AF1_R_#(GE7(_4U('9$$MB3WVN@59ZFN8U^23GEZ))A-M9(M);UP2E%QCF
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M=F!CMGN2[KW7<$'19$0)PCLB(C@)SEH+7%OF+ _DN;7<--A5'U>CH.EPQG>
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MNR%[GM^?AWDM^=M6^=7^IV+(]TE2K_N9! 1N'9A8F//9\Q+:E!\U(&9:A!^
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M.K)]TS<ATT&);!F"!3()%-=JXR%K2=;#HN"VKYD!KZS68T1X-J__&(*5TWE
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M77JBBBH\V^(!DR9GS;(((4<&-AEC4^ ZZB8KWTZ^F7(?#Z658#K VC:O_\2
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M-7<M0#$(=WM(J$O4/5*<L=U4+*71&I4!&S4#%<CO]8H\8,FX#();5+E)Y_Z
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M&W=Y-]BI$^:Q TR+HU&ENQB1U1-#Y0/^M>7(F\\4FE>&W"=IVXZFHHLQ9+K
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MIFS^V@9$E\4WMPJK6-1>96*Q375',5@@"!NAD#;7FJX2\I!]=K]8<NS5]))
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M" 5)<3;%QLFG%+D-,=@QD'+[G=/8CX.%MAR!@U-O%R_.SE?S<-?0,5H"&NZ
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MYTRJXDP^HED<2G>7QPKC0/68$NT7P%=G<)OU?K>^PDR-C&K?,Q^J8Q+!H[3
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MEFM/L=^]&!I'!AV@Z8%(IO8#F>?-U>OR^F*+*.,SE)EY;@W06FK'7>[!%R9
M!VYBL,*GV-2%&D+DM%:M&>*:R6E_#"[/P]DH&'P?OM5>;>O?EULMNE&K31[
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M#00^"OLZ./;<T;.Z.5/1RO!LHX.42ZYM3PSME@4AAJ),,39)V^0F9U^">^D
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MKUR."!ZOQ4?7U39>E"P__:U-=W_T_"]02P,$%     @ 2SQ:4C)ZHPQ?!@
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MN37U]%:OZJZEA2[$1Z+PXY/:*9*Z>=S-S/_-.>8N'[^M8\ID-5<#*5HK8A;
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MR]S:[K]02P$"% ,4    " !+/%I2=':7=/H[  #ITP$ "0
M@ $     83$T,3$N:'1M4$L! A0#%     @ 2SQ:4E#1 *.@!0  OA$   D
M             ( !(3P  &$R,S$Q+FAT;5!+ 0(4 Q0    ( $L\6E(0%I=C
M2QP  .:)   (              "  >A!  !A-#(Q+FAT;5!+ 0(4 Q0    (
M $L\6E(ZG,^3UL@% (BV/0 1              "  5E>  !C<F]N+3(P,C Q
M,C,Q+FAT;5!+ 0(4 Q0    ( $L\6E*='HSL'B0   RM 0 1
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M &-R;VXM,C R,#$R,S%?9S(N:G!G4$L! A0#%     @ 2SQ:4D*79ZG^+0
M<R\  !0              ( !?-D' &-R;VXM,C R,#$R,S%?9S,N:G!G4$L!
M A0#%     @ 2SQ:4M?;)5EC7P( :'T" !0              ( !K <( &-R
M;VXM,C R,#$R,S%?9S0N:G!G4$L! A0#%     @ 2SQ:4MU)<$N?"0  ,PH
M !0              ( !06<* &-R;VXM,C R,#$R,S%?9S4N:G!G4$L! A0#
M%     @ 2SQ:4L-/ZW.IX@  ]JH! !0              ( !$G$* &-R;VXM
M,C R,#$R,S%?9S8N:G!G4$L! A0#%     @ 2SQ:4FCI ,26 @, 434$ !0
M             ( ![5,+ &-R;VXM,C R,#$R,S%?9S<N:G!G4$L! A0#%
M  @ 2SQ:4O>U%B^3HP( %]T# !0              ( !M58. &-R;VXM,C R
M,#$R,S%?9S@N:G!G4$L! A0#%     @ 2SQ:4C*RTGK[RP$ 7SP3 !4
M         ( !>OH0 &-R;VXM,C R,#$R,S%?;&%B+GAM;%!+ 0(4 Q0    (
M $L\6E(7^NV&>#8! (U\#@ 5              "  :C&$@!C<F]N+3(P,C Q
M,C,Q7W!R92YX;6Q02P$"% ,4    " !+/%I2M?<S,UT(  ":*@  $0
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>=#(Q,2YH=&U02P4&     !8 %@!V!0  _A\4

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
